Thus	O
Q	O
-	O
base	O
is	O
not	O
required	O
for	O
frameshifting	O
at	O
the	O
IBV	B-SPEC
signal	O
and	O
some	O
other	O
explanation	O
is	O
required	O
to	O
account	O
for	O
the	O
slipperiness	O
of	O
eukaryotic	O
asparaginyl	O
-	O
tRNA	O
.	O

In	O
addition	O
,	O
fMHV	O
is	O
potentially	O
the	O
ideal	O
recipient	O
virus	B-SPEC
for	O
carrying	O
out	O
reverse	O
genetics	O
of	O
MHV	B-SPEC
by	O
targeted	O
RNA	O
recombination	O
,	O
since	O
it	O
presents	O
the	O
possibility	O
of	O
selecting	O
recombinants	O
,	O
no	O
matter	O
how	O
defective	O
,	O
that	O
have	O
regained	O
the	O
ability	O
to	O
replicate	O
in	O
murine	B-SPEC
cells	O
.	O

Administration	O
of	O
RANTES	O
antisera	O
to	O
MHV	B-SPEC
-	O
infected	O
C57BL	O
/	O
6	O
mice	B-SPEC
resulted	O
in	O
a	O
significant	O
reduction	O
in	O
macrophage	O
infiltration	O
and	O
demyelination	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
001	O
)	O
compared	O
to	O
those	O
in	O
control	O
mice	B-SPEC
.	O

Thus	O
,	O
the	O
64	O
-	O
terminal	O
-	O
residue	O
sequence	O
suffices	O
to	O
draw	O
the	O
1308	O
(	O
MHV	B-SPEC
)-	O
or	O
1433	O
(	O
FIPV	O
)-	O
amino	O
-	O
acid	O
-	O
long	O
mature	O
S	O
protein	O
into	O
VLPs	O
.	O

Rectal	O
swab	O
samples	O
were	O
subjected	O
to	O
a	O
nested	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
,	O
specific	O
for	O
the	O
conservative	O
nucleocapsid	O
region	O
of	O
the	O
virus	B-SPEC
genome	O
.	O

TITLE	O
:	O
Diagnosis	O
of	O
canine	O
coronavirus	B-SPEC
infection	O
using	O
nested	O
-	O
PCR	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
sialic	O
acid	O
binding	O
activity	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
by	O
analysis	O
of	O
haemagglutination	O
-	O
deficient	O
mutants	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
agglutinates	O
erythrocytes	O
of	O
several	O
species	B-SPEC
by	O
virtue	O
of	O
sialic	O
acid	O
binding	O
activity	O
of	O
the	O
surface	O
protein	O
S	O
.	O
We	O
have	O
isolated	O
and	O
characterized	O
five	O
haemagglutination	O
-	O
defective	O
(	O
HAD	O
)	O
mutants	O
.	O

The	O
parental	O
virus	B-SPEC
was	O
found	O
to	O
have	O
an	O
increased	O
resistance	O
to	O
the	O
detergent	O
octylglucoside	O
compared	O
to	O
the	O
HAD	O
mutants	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	B-SPEC
)	O
infection	O
of	O
feline	B-SPEC
macro	O
-	O
phages	O
is	O
enhanced	O
by	O
mouse	B-SPEC
anti	O
-	O
FIPV	B-SPEC
monoclonal	O
antibody	O
(	O
MAb	O
).	O

Furthermore	O
,	O
MAb	O
showing	O
strong	O
neutralizing	O
activity	O
in	O
Felis	B-SPEC
catus	I-SPEC
whole	O
fetus	O
(	O
fcwf	O
-	O
4	O
)	O
cells	O
and	O
Crandell	O
feline	B-SPEC
kidney	O
(	O
CrFK	O
)	O
cells	O
shows	O
strong	O
enhancing	O
activity	O
in	O
feline	B-SPEC
macrophages	O
,	O
indicating	O
that	O
the	O
neutralizing	O
epitope	O
and	O
the	O
enhancing	O
epitope	O
are	O
closely	O
related	O
.	O

These	O
findings	O
indicated	O
that	O
the	O
FIPV	O
replication	O
mechanism	O
differs	O
between	O
feline	B-SPEC
macrophages	O
and	O
CrFK	O
/	O
fcwf	O
-	O
4	O
cells	O
and	O
that	O
a	O
neutralizing	O
epitope	O
that	O
can	O
prevent	O
FIPV	O
infection	O
of	O
feline	B-SPEC
macrophages	O
after	O
viral	O
absorption	O
is	O
present	O
on	O
M	O
protein	O
.	O

Finally	O
,	O
electron	O
microscopic	O
studies	O
demonstrated	O
that	O
expression	O
of	O
the	O
E	O
protein	O
in	O
cells	O
induced	O
the	O
formation	O
of	O
characteristic	O
membrane	O
structures	O
also	O
observed	O
in	O
MHV	B-SPEC
-	O
A59	O
-	O
infected	O
cells	O
,	O
apparently	O
consisting	O
of	O
masses	O
of	O
tubular	O
,	O
smooth	O
,	O
convoluted	O
membranes	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
whether	O
there	O
is	O
evidence	O
of	O
oxidative	O
injury	O
in	O
patients	O
who	O
are	O
critically	O
ill	O
with	O
severe	O
sepsis	B-SPEC
or	O
major	O
trauma	O
,	O
by	O
measuring	O
protein	O
and	O
lipid	O
oxidation	O
products	O
.	O

Three	O
predicted	O
stem	O
-	O
loop	O
structures	O
were	O
identified	O
within	O
the	O
5	O
'	O
UTR	O
of	O
IBV	B-SPEC
.	O

All	O
three	O
of	O
them	O
were	O
driven	O
by	O
a	O
strong	O
plant	B-SPEC
promoter	O
.	O

Twenty	O
-	O
one	O
adult	O
male	O
Japanese	B-SPEC
White	I-SPEC
rabbits	I-SPEC
(	O
weight	O
range	O
,	O
2	O
.	O
0	O
-	O
2	O
.	O
4	O
kg	O
).	O

Rabbits	B-SPEC
in	O
the	O
nonlung	O
-	O
injury	O
group	O
received	O
saline	O
infusion	O
instead	O
of	O
the	O
pancreatic	O
enzymes	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
inhibition	O
of	O
the	O
adhesion	O
molecule	O
CD11	O
-	O
CD18	O
on	O
polymorphonuclear	O
leukocytes	O
(	O
PMNs	O
)	O
would	O
have	O
any	O
beneficial	O
effects	O
on	O
pulmonary	O
function	O
and	O
mortality	O
in	O
an	O
animal	B-SPEC
model	O
reproducing	O
these	O
clinical	O
conditions	O
.	O

The	O
kinetics	O
of	O
viral	O
load	O
observed	O
in	O
the	O
lungs	O
and	O
kidneys	O
correlated	O
with	O
the	O
level	O
of	O
IBV	B-SPEC
-	O
specific	O
CTL	O
activity	O
of	O
effector	O
cells	O
prepared	O
from	O
spleens	O
of	O
infected	O
chicks	O
.	O

TITLE	O
:	O
Immunopathogenesis	O
of	O
haemorrhagic	O
enteritis	O
virus	B-SPEC
(	O
HEV	B-SPEC
)	O
in	O
turkeys	B-SPEC
.	O

The	O
mechanisms	O
of	O
HEV	B-SPEC
immunopathogenesis	O
and	O
immunosuppression	O
are	O
not	O
fully	O
understood	O
.	O

HEV	B-SPEC
infects	O
B	O
cells	O
and	O
macrophages	O
and	O
induces	O
necrosis	O
as	O
well	O
as	O
apoptosis	O
in	O
infected	O
and	O
possibly	O
in	O
by	O
-	O
stander	O
cells	O
.	O

While	O
a	O
massive	O
release	O
of	O
proinflammatory	O
cytokines	O
may	O
lead	O
to	O
systemic	O
shock	O
associated	O
with	O
haemorrhagic	O
enteritis	O
and	O
death	O
,	O
release	O
of	O
IFNs	O
may	O
protect	O
turkeys	B-SPEC
from	O
the	O
disease	O
.	O

TITLE	O
:	O
Downstream	O
ribosomal	O
entry	O
for	O
translation	O
of	O
coronavirus	B-SPEC
TGEV	B-SPEC
gene	O
3b	O
.	O

TITLE	O
:	O
Unique	O
N	O
-	O
linked	O
glycosylation	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
MHV	B-SPEC
-	O
2	O
membrane	O
protein	O
at	O
the	O
conserved	O
O	O
-	O
linked	O
glycosylation	O
site	O
.	O

In	O
this	O
outbreak	O
some	O
animals	B-SPEC
became	O
reinfected	O
with	O
BCV	B-SPEC
.	O

The	O
IgA	O
and	O
IgM	O
capture	O
ELISAs	O
differentiated	O
between	O
primarily	O
BCV	B-SPEC
infected	O
and	O
reinfected	O
animals	B-SPEC
.	O

TITLE	O
:	O
Characterization	O
of	O
protection	O
against	O
coronavirus	B-SPEC
infection	O
by	O
noninternal	O
image	O
antiidiotypic	O
antibody	O
.	O

A	O
recently	O
isolated	O
virus	B-SPEC
,	O
stunting	O
syndrome	O
agent	O
,	O
(	O
SSA	O
)	O
has	O
been	O
found	O
to	O
be	O
the	O
etiologic	O
agent	O
of	O
SS	O
.	O

A	O
RT	O
-	O
PCR	O
was	O
performed	O
with	O
known	O
primers	O
specific	O
for	O
NDV	B-SPEC
,	O
IBV	B-SPEC
,	O
BCV	B-SPEC
,	O
and	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
582	O
-	O
base	O
pair	O
segment	O
located	O
in	O
the	O
nucleocapsid	O
protein	O
terminal	O
part	O
of	O
the	O
S1	O
gene	O
of	O
26	O
Arkansas	O
(	O
Ark	O
)-	O
type	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
from	O
Mississippi	O
broilers	O
was	O
amplified	O
and	O
sequenced	O
.	O

Turkeys	B-SPEC
dually	O
inoculated	O
with	O
TCV	B-SPEC
and	O
R98	O
/	O
5	O
developed	O
severe	O
enteritis	O
with	O
high	O
mortality	O
(	O
38	O
/	O
48	O
,	O
79	O
%)	O
and	O
marked	O
growth	O
depression	O
.	O

AE	O
lesions	O
were	O
more	O
extensive	O
and	O
were	O
detected	O
for	O
a	O
prolonged	O
duration	O
in	O
dually	O
inoculated	O
turkeys	B-SPEC
compared	O
with	O
turkeys	B-SPEC
inoculated	O
with	O
only	O
R98	O
/	O
5	O
.	O

Marble	O
spleen	O
disease	O
and	O
pheasant	O
coronavirus	B-SPEC
-	O
associated	O
nephritis	O
,	O
two	O
viral	O
conditions	O
capable	O
of	O
causing	O
high	O
mortality	O
,	O
were	O
diagnosed	O
in	O
a	O
few	O
birds	B-SPEC
in	O
1996	O
and	O
1997	O
.	O

ABSTRACT	O
:	O
To	O
group	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
,	O
a	O
genetic	O
grouping	O
method	O
based	O
on	O
hypervariable	O
region	O
1	O
(	O
HVR	O
1	O
,	O
nucleotides	O
168	O
to	O
197	O
)	O
was	O
compared	O
with	O
that	O
based	O
on	O
the	O
whole	O
S1	O
gene	O
.	O

ABSTRACT	O
:	O
Acute	O
and	O
chronic	O
demyelination	O
are	O
hallmarks	O
of	O
CNS	O
infection	O
by	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

Although	O
infectious	O
virus	B-SPEC
is	O
cleared	O
by	O
CD8	O
+	O
T	O
cells	O
,	O
both	O
viral	O
RNA	O
and	O
activated	O
CD8	O
+	O
T	O
cells	O
remain	O
in	O
the	O
CNS	O
during	O
persistence	O
potentially	O
contributing	O
to	O
pathology	O
.	O

To	O
dissociate	O
immune	O
from	O
virus	B-SPEC
-	O
mediated	O
determinants	O
initiating	O
and	O
maintaining	O
demyelinating	O
disease	O
,	O
mice	B-SPEC
were	O
infected	O
with	O
two	O
attenuated	O
viral	O
variants	O
differing	O
in	O
a	O
hypervariable	O
region	O
of	O
the	O
spike	O
protein	O
.	O

The	O
present	O
data	O
thus	O
indicate	O
that	O
in	O
immunocompetent	O
mice	B-SPEC
,	O
effector	O
CD8	O
+	O
T	O
cells	O
control	O
infection	O
without	O
mediating	O
either	O
clinical	O
disease	O
or	O
demyelination	O
.	O

TITLE	O
:	O
The	O
viral	O
nucleocapsid	O
protein	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
cleaved	O
by	O
caspase	O
-	O
6	O
and	O
-	O
7	O
during	O
TGEV	B-SPEC
-	O
induced	O
apoptosis	O
.	O

Epitope	O
-	O
specific	O
antibodies	O
revealed	O
that	O
the	O
C	O
terminus	O
of	O
IBV	B-SPEC
E	O
is	O
cytoplasmic	O
and	O
the	O
N	O
terminus	O
is	O
translocated	O
.	O

In	O
both	O
the	O
immunohistochemical	O
methods	O
,	O
PEDV	B-SPEC
antigens	O
were	O
detected	O
in	O
the	O
cytoplasm	O
of	O
villous	O
enterocytes	O
and	O
in	O
the	O
macrophages	O
infiltrated	O
in	O
the	O
lamina	O
propria	O
at	O
18	O
to	O
110	O
hr	O
post	O
inoculation	O
.	O

ABSTRACT	O
:	O
Equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
(	O
EAV	B-SPEC
)	O
is	O
an	O
enveloped	O
,	O
positive	O
-	O
stranded	O
RNA	O
virus	B-SPEC
belonging	O
to	O
the	O
family	B-SPEC
Arteriviridae	I-SPEC
of	O
the	O
order	B-SPEC
Nidovirales	I-SPEC
.	O

The	O
two	O
32P	O
-	O
labeled	O
probes	O
that	O
interacted	O
with	O
N	O
and	O
the	O
amino	O
and	O
carboxyl	O
fragments	O
of	O
N	O
were	O
RNA	O
consisting	O
of	O
the	O
IBV	B-SPEC
N	O
gene	O
and	O
adjacent	O
3	O
'	O
non	O
-	O
coding	O
terminus	O
,	O
and	O
RNA	O
consisting	O
of	O
the	O
155	O
-	O
nucleotide	O
sequences	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
504	O
-	O
nt	O
3	O
'	O
untranslated	O
region	O
.	O

Challenge	O
of	O
injected	O
mice	B-SPEC
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
3	O
showed	O
that	O
HD	O
-	O
IFN	O
provides	O
high	O
liver	O
protection	O
.	O

Vascular	O
studies	O
showed	O
the	O
presence	O
of	O
IgG	O
-	O
IgM	O
polyclonal	O
positive	O
cryoglobulins	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
showed	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
to	O
be	O
present	O
.	O

Cerebral	O
magnetic	O
resonance	O
showed	O
ischemic	O
lesions	O
in	O
the	O
tail	O
of	O
the	O
right	O
caudate	O
nucleus	O
and	O
right	O
corona	B-SPEC
radiata	O
and	O
the	O
posteromedial	O
part	O
of	O
the	O
right	O
putamen	O
.	O

Classical	O
studies	O
of	O
pathogenesis	O
have	O
revealed	O
different	O
lung	O
cell	O
tropisms	O
and	O
replication	O
kinetics	O
for	O
each	O
of	O
these	O
viruses	B-SPEC
and	O
they	O
suggest	O
the	O
involvement	O
of	O
different	O
lung	O
inflammatory	O
responses	O
or	O
mediators	O
.	O

The	O
biological	O
effects	O
of	O
these	O
cytokines	O
and	O
their	O
involvement	O
in	O
human	B-SPEC
viral	O
respiratory	O
disease	O
are	O
discussed	O
in	O
the	O
second	O
part	O
of	O
this	O
review	O
.	O

Elastase	O
-	O
treated	O
animals	B-SPEC
with	O
mediator	O
production	O
inhibited	O
(	O
CNI	O
-	O
1493	O
)	O
had	O
attenuated	O
hepatic	O
enzymes	O
,	O
MPO	O
activity	O
,	O
TNF	O
protein	O
,	O
and	O
TNF	O
mRNA	O
.	O

The	O
overall	O
meta	B-SPEC
-	O
analyses	O
is	O
dominated	O
by	O
the	O
large	O
HIFI	O
study	O
which	O
did	O
not	O
use	O
the	O
HVS	O
recommended	O
on	O
the	O
basis	O
of	O
animal	B-SPEC
studies	O
,	O
and	O
in	O
which	O
surfactant	O
was	O
not	O
available	O
.	O

ABSTRACT	O
:	O
This	O
report	O
describes	O
the	O
clinical	O
and	O
epidemiological	O
findings	O
of	O
an	O
outbreak	O
of	O
histoplasmosis	O
in	O
Brazil	O
involving	O
four	O
persons	O
of	O
the	O
same	O
family	B-SPEC
,	O
one	O
adult	O
and	O
three	O
children	O
.	O

The	O
difference	O
between	O
the	O
two	O
trials	O
was	O
the	O
duration	O
of	O
implantation	O
of	O
the	O
tumor	O
in	O
the	O
nude	O
rat	B-SPEC
,	O
i	O
.	O
e	O
.,	O
12	O
days	O
in	O
the	O
first	O
and	O
24	O
days	O
in	O
the	O
second	O
trial	O
.	O

Duration	O
of	O
implantation	O
might	O
be	O
a	O
factor	O
in	O
the	O
decontamination	O
of	O
transplantable	O
tumors	O
infected	O
with	O
MHV	B-SPEC
by	O
passaging	O
in	O
the	O
nude	O
rat	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
have	O
isolated	O
the	O
virus	B-SPEC
from	O
a	O
fecal	O
pellet	O
in	O
the	O
colon	O
of	O
a	O
BALB	O
/	O
c	O
mouse	B-SPEC
with	O
X	O
-	O
linked	O
immunodeficiency	O
(	O
xid	O
)	O
housed	O
in	O
a	O
room	O
in	O
which	O
there	O
has	O
recently	O
been	O
an	O
epidemic	O
due	O
to	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
and	O
designated	O
it	O
as	O
the	O
MHV	B-SPEC
-	O
TY	O
strain	O
.	O

The	O
cattle	B-SPEC
with	O
HI	O
antibody	O
titers	O
of	O
>	O
or	O
=	O
160	O
and	O
the	O
SN	O
titers	O
of	O
>	O
or	O
=	O
640	O
showed	O
no	O
clinical	O
signs	O
,	O
but	O
the	O
cattle	B-SPEC
with	O
the	O
HI	O
antibody	O
titer	O
<	O
80	O
and	O
the	O
SN	O
antibody	O
titer	O
<	O
160	O
developed	O
watery	O
diarrhea	O
and	O
fever	O
after	O
challenge	O
.	O

ABSTRACT	O
:	O
The	O
construction	O
of	O
cDNA	O
clones	O
encoding	O
large	O
-	O
size	O
RNA	O
molecules	O
of	O
biological	O
interest	O
,	O
like	O
coronavirus	B-SPEC
genomes	O
,	O
which	O
are	O
among	O
the	O
largest	O
mature	O
RNA	O
molecules	O
known	O
to	O
biology	O
,	O
has	O
been	O
hampered	O
by	O
the	O
instability	O
of	O
those	O
cDNAs	O
in	O
bacteria	B-SPEC
.	O

The	O
rescued	O
coronavirus	B-SPEC
conserved	O
all	O
of	O
the	O
genetic	O
markers	O
introduced	O
throughout	O
the	O
sequence	O
and	O
showed	O
a	O
standard	O
mRNA	O
pattern	O
and	O
the	O
antigenic	O
characteristics	O
expected	O
for	O
the	O
synthetic	O
virus	B-SPEC
.	O

The	O
synthetic	O
virus	B-SPEC
replicated	O
abundantly	O
in	O
the	O
enteric	O
tract	O
and	O
was	O
fully	O
virulent	O
,	O
demonstrating	O
that	O
the	O
tropism	O
and	O
virulence	O
of	O
the	O
recovered	O
coronavirus	B-SPEC
can	O
be	O
modified	O
.	O

TITLE	O
:	O
Dying	O
with	O
acute	O
respiratory	O
failure	O
or	O
multiple	O
organ	O
system	O
failure	O
with	O
sepsis	B-SPEC
.	O

Only	O
one	O
cat	B-SPEC
,	O
which	O
was	O
also	O
infected	O
with	O
FIV	B-SPEC
,	O
developed	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

ABSTRACT	O
:	O
Phage	O
-	O
displayed	O
peptide	O
libraries	O
were	O
used	O
to	O
map	O
immunologically	O
relevant	O
epitopes	O
on	O
the	O
surface	O
(	O
S	O
)	O
glycoprotein	O
of	O
a	O
neurotropic	O
murine	B-SPEC
coronavirus	I-SPEC
(	O
MHV	B-SPEC
-	O
A59	O
).	O

Accordingly	O
,	O
the	O
immune	O
response	O
of	O
mice	B-SPEC
immunized	O
with	O
a	O
Salmonella	B-SPEC
enterica	I-SPEC
serovar	O
Typhimurium	O
vaccine	O
strain	O
expressing	O
the	O
Escherichia	B-SPEC
coli	I-SPEC
987P	O
fimbrial	O
antigen	O
on	O
its	O
surface	O
(	O
Fas	O
(+))	O
was	O
compared	O
with	O
the	O
expression	O
in	O
the	O
periplasmic	O
compartment	O
(	O
Fas	O
(-)).	O

Moreover	O
,	O
mucosal	O
IgA	O
against	O
the	O
TGEV	B-SPEC
C	O
epitope	O
was	O
only	O
detected	O
with	O
serovar	O
Typhimurium	O
chi4550	O
/	O
pCS155	O
.	O

Following	O
differential	O
centrifugation	O
of	O
lysates	O
of	O
MHV	B-SPEC
-	O
infected	O
DBT	O
cells	O
,	O
gene	O
1	O
proteins	O
as	O
well	O
as	O
the	O
structural	O
N	O
and	O
M	O
proteins	O
were	O
detected	O
almost	O
exclusively	O
in	O
a	O
high	O
-	O
speed	O
small	O
membrane	O
pellet	O
.	O

Nasal	O
swab	O
specimens	O
and	O
blood	O
samples	O
were	O
collected	O
,	O
and	O
cattle	B-SPEC
were	O
vaccinated	O
on	O
arrival	O
at	O
an	O
order	B-SPEC
-	O
buyer	O
barn	O
from	O
4	O
local	O
auction	O
houses	O
.	O

RESULTS	O
:	O
93	O
of	O
105	O
cattle	B-SPEC
and	O
106	O
of	O
120	O
cattle	B-SPEC
developed	O
signs	O
of	O
respiratory	O
tract	O
disease	O
during	O
1997	O
and	O
1998	O
,	O
respectively	O
,	O
and	O
RBCV	O
was	O
isolated	O
from	O
81	O
and	O
89	O
sick	O
cattle	B-SPEC
,	O
respectively	O
,	O
while	O
at	O
the	O
order	B-SPEC
-	O
buyer	O
'	O
s	O
barn	O
or	O
the	O
day	O
after	O
arrival	O
at	O
the	O
feedlot	O
.	O

Data	O
were	O
compared	O
with	O
data	O
from	O
control	O
(	O
sham	O
-	O
operated	O
)	O
animals	B-SPEC
(	O
SHAM	O
group	O
).	O

After	O
resolving	O
some	O
technical	O
issues	O
,	O
this	O
application	O
technique	O
was	O
used	O
successfully	O
in	O
an	O
animal	B-SPEC
model	O
of	O
acute	O
lung	O
injury	O
.	O

ABSTRACT	O
:	O
Faeces	O
samples	O
from	O
218	O
,	O
one	O
to	O
30	O
days	O
old	O
,	O
diarrheic	O
dairy	O
calves	O
in	O
65	O
dairy	O
herds	O
were	O
screened	O
for	O
the	O
presence	O
of	O
rotavirus	B-SPEC
and	O
concurrent	O
infections	O
with	O
coronavirus	B-SPEC
,	O
Cryptosporidium	B-SPEC
,	O
F5	O
+	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
Salmonella	B-SPEC
spp	O
.	O

Concurrent	O
infections	O
with	O
other	O
enteropathogen	O
(	O
s	O
)	O
were	O
detected	O
in	O
31	O
.	O
3	O
%,	O
33	O
.	O
3	O
%,	O
20	O
.	O
6	O
%	O
and	O
3	O
.	O
4	O
%	O
of	O
the	O
rotavirus	B-SPEC
infected	O
calves	O
in	O
the	O
age	O
-	O
groups	O
1	O
-	O
7	O
,	O
8	O
-	O
14	O
,	O
15	O
-	O
21	O
and	O
22	O
-	O
30	O
d	O
,	O
respectively	O
.	O

Seventeen	O
(	O
17	O
)	O
formalin	O
-	O
fixed	O
hearts	O
from	O
healthy	O
cats	B-SPEC
were	O
similarly	O
selected	O
as	O
normal	O
controls	O
.	O

The	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
was	O
used	O
to	O
evaluate	O
myocardial	O
tissue	O
for	O
the	O
presence	O
of	O
viral	O
genome	O
from	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
,	O
herpes	B-SPEC
virus	I-SPEC
,	O
calici	O
virus	B-SPEC
,	O
and	O
corona	B-SPEC
virus	B-SPEC
.	O

Neither	O
cardiomyopathic	O
or	O
control	O
cats	B-SPEC
tested	O
positive	O
by	O
PCR	O
for	O
herpes	B-SPEC
virus	I-SPEC
,	O
calici	O
virus	B-SPEC
,	O
and	O
corona	B-SPEC
virus	B-SPEC
.	O

Myocarditis	O
and	O
or	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
genome	O
was	O
detected	O
in	O
felines	O
with	O
idiopathic	O
hypertrophic	O
,	O
dilated	O
,	O
and	O
restrictive	O
cardiomyopathy	O
,	O
suggesting	O
a	O
possible	O
role	O
of	O
viral	O
infection	O
and	O
inflammation	O
in	O
the	O
pathogenesis	O
of	O
cardiomyopathy	O
in	O
this	O
species	B-SPEC
.	O

TITLE	O
:	O
Detection	O
and	O
differentiation	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
in	O
clinical	O
samples	O
by	O
multiplex	O
RT	O
-	O
PCR	O
.	O

Primers	O
from	O
PEDV	B-SPEC
did	O
not	O
react	O
with	O
any	O
TGEV	B-SPEC
tested	O
and	O
vice	O
versa	O
.	O

TITLE	O
:	O
Further	O
characterization	O
of	O
the	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
3C	O
-	O
like	O
proteinase	O
and	O
determination	O
of	O
a	O
new	O
cleavage	O
site	O
.	O

Interestingly	O
,	O
the	O
ORF7b	O
viral	O
region	O
-	O
a	O
supposed	O
virulence	O
factor	O
-	O
was	O
detected	O
in	O
fewer	O
organs	O
,	O
raising	O
the	O
possibility	O
that	O
this	O
region	O
can	O
be	O
affected	O
by	O
deletions	O
during	O
virus	B-SPEC
replication	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
a	O
novel	O
""""	O
small	O
round	O
virus	B-SPEC
""""	O
(	O
SRV	O
)	O
isolated	O
from	O
poult	O
enteritis	O
and	O
mortality	O
syndrome	O
(	O
PEMS	O
)	O
cases	O
in	O
inducing	O
PEMS	O
and	O
associated	O
immune	O
alterations	O
was	O
examined	O
in	O
this	O
study	O
.	O

ABSTRACT	O
:	O
Intestinal	O
samples	O
from	O
turkey	B-SPEC
poults	O
affected	O
with	O
poult	O
enteritis	O
and	O
mortality	O
syndrome	O
(	O
PEMS	O
)	O
were	O
examined	O
for	O
viruses	B-SPEC
by	O
immune	O
electron	O
microscopy	O
and	O
double	O
-	O
stranded	O
RNA	O
virus	B-SPEC
genome	O
electropherotyping	O
.	O

The	O
SRV	O
and	O
TCV	B-SPEC
were	O
isolated	O
and	O
propagated	O
in	O
turkey	B-SPEC
embryos	O
.	O

Degenerate	O
primers	O
CK4	O
and	O
CK2	O
,	O
utilized	O
previously	O
in	O
our	O
laboratory	O
,	O
were	O
selected	O
for	O
DACS	O
because	O
they	O
successfully	O
amplify	O
a	O
wide	O
range	O
of	O
serotypes	O
represented	O
by	O
various	O
reference	O
strains	O
and	O
field	O
isolates	O
and	O
the	O
resulting	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
product	O
contains	O
diagnostically	O
relevant	O
S	O
-	O
1	O
sequences	O
that	O
can	O
be	O
used	O
to	O
identify	O
the	O
serotype	O
of	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Fulminant	O
tracheobronchial	O
and	O
pulmonary	O
aspergillosis	O
complicating	O
imported	O
Plasmodium	B-SPEC
falciparum	I-SPEC
malaria	O
in	O
an	O
apparently	O
immunocompetent	O
woman	O
.	O

In	O
a	O
second	O
study	O
,	O
pigs	B-SPEC
were	O
inoculated	O
with	O
PRCV	O
and	O
subsequently	O
with	O
LPS	O
at	O
various	O
time	O
intervals	O
ranging	O
from	O
0	O
to	O
24	O
h	O
,	O
and	O
killed	O
5	O
h	O
after	O
inoculation	O
with	O
LPS	O
.	O

ABSTRACT	O
:	O
Sialodacryoadenitis	O
virus	B-SPEC
(	O
SDAV	O
)	O
is	O
a	O
coronavirus	B-SPEC
that	O
is	O
commonly	O
found	O
in	O
laboratory	B-SPEC
rats	I-SPEC
and	O
that	O
causes	O
sialodacryoadenitis	O
and	O
respiratory	O
illness	O
.	O

We	O
also	O
examined	O
the	O
effects	O
of	O
stem	O
segment	O
mutations	O
on	O
the	O
replication	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
defective	O
interfering	O
RNAs	O
.	O

TITLE	O
:	O
Impaired	O
entry	O
of	O
soluble	O
receptor	O
-	O
resistant	O
mutants	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
into	O
cells	O
expressing	O
MHVR2	O
receptor	O
.	O

Herein	O
,	O
we	O
show	O
that	O
equivalent	O
amounts	O
of	O
demyelination	O
were	O
evident	O
at	O
day	O
12	O
after	O
MHV	B-SPEC
infection	O
in	O
mice	B-SPEC
genetically	O
deficient	O
in	O
NOS2	O
(	O
NOS2	O
(-/-))	O
and	O
in	O
C57BL	O
/	O
6	O
mice	B-SPEC
.	O

Furthermore	O
,	O
using	O
an	O
established	O
adoptive	O
transfer	O
model	O
and	O
pharmacological	O
inhibitors	O
of	O
NOS2	O
function	O
,	O
we	O
could	O
demonstrate	O
no	O
effect	O
on	O
MHV	B-SPEC
-	O
induced	O
demyelination	O
.	O

These	O
results	O
indicate	O
that	O
NOS2	O
function	O
is	O
not	O
required	O
for	O
demyelination	O
in	O
mice	B-SPEC
infected	O
with	O
MHV	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
assess	O
patients	O
'	O
satisfaction	O
with	O
pharmacists	O
,	O
seven	O
questions	O
were	O
developed	O
with	O
semistructured	O
input	O
from	O
5	O
pharmacy	O
practice	O
faculty	O
members	O
and	O
11	O
patients	O
with	O
cancer	B-SPEC
.	O

TITLE	O
:	O
Terbutaline	O
prevents	O
circulatory	O
failure	O
and	O
mitigates	O
mortality	O
in	O
rodents	B-SPEC
with	O
endotoxemia	O
.	O

In	O
addition	O
,	O
pretreatment	O
of	O
mice	B-SPEC
with	O
terbutaline	O
also	O
improves	O
the	O
survival	O
in	O
a	O
model	O
of	O
severe	O
endotoxemia	O
.	O

ABSTRACT	O
:	O
The	O
viruses	B-SPEC
associated	O
most	O
frequently	O
with	O
the	O
""""	O
common	O
cold	O
""""	O
are	O
rhinoviruses	B-SPEC
and	O
coronaviruses	O
.	O

We	O
conclude	O
that	O
each	O
lung	O
recruitment	O
strategy	O
improved	O
oxygenation	O
in	O
premature	O
lambs	B-SPEC
with	O
established	O
lung	O
injury	O
.	O

Pulmonary	O
NF	O
-	O
kappaB	O
activation	O
,	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
gene	O
expression	O
,	O
and	O
neutrophil	O
infiltration	O
(	O
myeloperoxidase	O
)	O
were	O
determined	O
and	O
myeloperoxidase	O
experiments	O
repeated	O
in	O
p55	O
TNF	O
receptor	O
-	O
deficient	O
(	O
TNF	O
KO	O
)	O
animals	B-SPEC
.	O

In	O
this	O
study	O
,	O
the	O
individual	O
roles	O
of	O
CD4	O
and	O
CD8	O
T	O
cells	O
in	O
MHV	B-SPEC
-	O
induced	O
demyelination	O
were	O
investigated	O
using	O
recombination	O
-	O
activating	O
gene	O
1	O
-/-	O
(	O
RAG1	O
-/-)	O
mice	B-SPEC
infected	O
with	O
an	O
attenuated	O
strain	O
of	O
MHV	B-SPEC
-	O
JHM	O
.	O

These	O
animals	B-SPEC
develop	O
demyelination	O
only	O
after	O
adoptive	O
transfer	O
of	O
splenocytes	O
from	O
mice	B-SPEC
previously	O
immunized	O
to	O
MHV	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
,	O
following	O
adoptive	O
transfer	O
,	O
virus	B-SPEC
-	O
specific	O
CD4	O
and	O
CD8	O
T	O
cells	O
rapidly	O
infiltrate	O
the	O
CNS	O
of	O
MHV	B-SPEC
-	O
JHM	O
-	O
infected	O
RAG1	O
-/-	O
mice	B-SPEC
.	O

These	O
results	O
demonstrate	O
that	O
the	O
development	O
of	O
demyelination	O
following	O
MHV	B-SPEC
infection	O
may	O
be	O
initiated	O
by	O
either	O
CD4	O
or	O
CD8	O
T	O
cells	O
.	O

ABSTRACT	O
:	O
A	O
73	O
-	O
y	O
-	O
old	O
female	O
with	O
a	O
history	O
of	O
adenocarcinoma	O
of	O
colon	O
and	O
refractory	O
anemia	B-SPEC
developed	O
febrile	O
neutropenia	O
following	O
chemotherapy	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
investigate	O
the	O
ability	O
of	O
an	O
oil	O
adjuvanted	O
vaccine	O
containing	O
bovine	B-SPEC
coronavirus	B-SPEC
antigen	O
to	O
enhance	O
lactogenic	O
immunity	O
in	O
the	O
calf	O
,	O
pregnant	O
cows	B-SPEC
and	O
heifers	O
were	O
vaccinated	O
and	O
specific	O
virus	B-SPEC
neutralising	O
antibody	O
levels	O
determined	O
in	O
serum	O
,	O
colostrum	O
and	O
milk	O
.	O

By	O
contrast	O
,	O
a	O
significant	O
number	O
of	O
CD8	O
(+)	O
T	O
cells	O
which	O
contained	O
detectable	O
viral	O
RNA	O
were	O
recovered	O
from	O
spinal	O
cords	O
of	O
V	O
-	O
1	O
-	O
infected	O
mice	B-SPEC
.	O

Virus	B-SPEC
is	O
present	O
in	O
considerable	O
titres	O
in	O
tracheal	O
mucus	O
and	O
in	O
faeces	O
in	O
the	O
acute	O
and	O
recovery	O
phases	O
of	O
disease	O
,	O
respectively	O
.	O

For	O
surveillance	O
purposes	O
,	O
ELISA	O
is	O
the	O
method	O
of	O
choice	O
,	O
regardless	O
of	O
the	O
antigenic	O
type	O
of	O
IBV	B-SPEC
involved	O
.	O

Crimean	O
-	O
Congo	O
haemorrhagic	O
fever	O
is	O
transmitted	O
to	O
domestic	O
animals	B-SPEC
including	O
ostriches	B-SPEC
,	O
principally	O
by	O
ticks	B-SPEC
of	O
the	O
genus	B-SPEC
Hyalomma	B-SPEC
.	O

The	O
viraemic	O
period	O
in	O
vaccinated	O
slaughter	O
ostriches	B-SPEC
is	O
between	O
nine	O
and	O
eleven	O
days	O
and	O
there	O
are	O
no	O
indications	O
of	O
a	O
carrier	O
state	O
or	O
presence	O
of	O
the	O
virus	B-SPEC
in	O
the	O
meat	O
or	O
any	O
other	O
tissues	O
after	O
this	O
period	O
,	O
with	O
peak	O
immunoglobulin	O
G	O
response	O
reached	O
on	O
day	O
fourteen	O
post	O
infection	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
leptospiral	B-SPEC
infection	O
in	O
a	O
63	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
acquired	O
the	O
infection	O
while	O
swimming	O
in	O
canals	O
and	O
streams	O
in	O
Hawaii	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
and	O
pathogenesis	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
)	O
field	O
isolates	O
co	O
-	O
circulating	O
in	O
a	O
swine	B-SPEC
herd	O
.	O

Clinical	O
records	O
and	O
biopsy	O
or	O
necropsy	O
specimens	O
of	O
ferrets	B-SPEC
with	O
presumed	O
epizootic	O
catarrhal	O
enteritis	O
were	O
reviewed	O
.	O

Immunohistochemical	O
staining	O
for	O
coronavirus	B-SPEC
antigen	O
was	O
performed	O
on	O
paraffin	O
-	O
embedded	O
tissues	O
from	O
approximately	O
10	O
%	O
of	O
affected	O
ferrets	B-SPEC
to	O
identify	O
viral	O
antigen	O
and	O
determine	O
its	O
distribution	O
.	O

Characteristic	O
microscopic	O
lesions	O
consistent	O
with	O
intestinal	O
coronavirus	B-SPEC
infection	O
(	O
vacuolar	O
degeneration	O
and	O
necrosis	O
of	O
villus	O
enterocytes	O
;	O
villus	O
atrophy	O
,	O
fusion	O
,	O
and	O
blunting	O
;	O
and	O
lymphocytic	O
enteritis	O
)	O
were	O
consistently	O
detected	O
in	O
affected	O
ferrets	B-SPEC
.	O

Coronavirus	B-SPEC
particles	O
were	O
identified	O
in	O
feces	O
and	O
jejunal	O
enterocytes	O
by	O
use	O
of	O
transmission	O
electron	O
microscopy	O
.	O

Immunohistochemical	O
staining	O
of	O
jejunal	O
sections	O
revealed	O
coronavirus	B-SPEC
antigens	O
.	O

Antigen	O
staining	O
was	O
not	O
detected	O
in	O
healthy	O
ferrets	B-SPEC
or	O
ferrets	B-SPEC
with	O
other	O
gastrointestinal	O
tract	O
diseases	O
.	O

RESULTS	O
:	O
Characteristic	O
microscopic	O
lesions	O
consistent	O
with	O
intestinal	O
coronavirus	B-SPEC
infection	O
(	O
vacuolar	O
degeneration	O
and	O
necrosis	O
of	O
villus	O
enterocytes	O
;	O
villus	O
atrophy	O
,	O
fusion	O
,	O
and	O
blunting	O
;	O
and	O
lymphocytic	O
enteritis	O
)	O
were	O
consistently	O
detected	O
in	O
affected	O
ferrets	B-SPEC
.	O

Virus	B-SPEC
isolation	O
was	O
unsuccessful	O
,	O
and	O
other	O
similar	O
viruses	B-SPEC
were	O
not	O
detected	O
.	O

ABSTRACT	O
:	O
A	O
total	O
of	O
446	O
serum	O
samples	O
from	O
88	O
herds	O
in	O
Korea	O
were	O
examined	O
for	O
antibody	O
to	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
)	O
using	O
blocking	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
).	O

The	O
synthesis	O
of	O
both	O
viral	O
mRNA	O
and	O
virus	B-SPEC
particles	O
was	O
delayed	O
only	O
in	O
IFN	O
-	O
gamma	O
-	O
activated	O
A	O
/	O
J	O
mouse	B-SPEC
macrophages	O
compared	O
with	O
susceptible	O
BALB	O
/	O
c	O
macrophages	O
.	O

Mouse	B-SPEC
eyes	O
harvested	O
at	O
varying	O
times	O
after	O
inoculation	O
were	O
evaluated	O
for	O
apoptotic	O
and	O
immunologic	O
events	O
by	O
hematoxylin	O
and	O
eosin	O
staining	O
,	O
immunohistochemical	O
staining	O
,	O
in	O
situ	O
terminal	O
deoxynucleotidyltransferase	O
dUTP	O
nick	O
-	O
end	O
labeling	O
(	O
TUNEL	O
)	O
assay	O
,	O
and	O
electron	O
microscopy	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
and	O
Pasteurella	B-SPEC
infections	O
in	O
bovine	B-SPEC
shipping	O
fever	O
pneumonia	O
and	O
Evans	O
'	O
criteria	O
for	O
causation	O
.	O

TITLE	O
:	O
Antibody	O
titers	O
against	O
bovine	B-SPEC
coronavirus	B-SPEC
and	O
shedding	O
of	O
the	O
virus	B-SPEC
via	O
the	O
respiratory	O
tract	O
in	O
feedlot	O
cattle	B-SPEC
.	O

Although	O
only	O
a	O
few	O
cattle	B-SPEC
were	O
shedding	O
the	O
virus	B-SPEC
at	O
the	O
time	O
of	O
arrival	O
at	O
a	O
feedlot	O
,	O
most	O
of	O
the	O
cattle	B-SPEC
seroconverted	O
to	O
BCV	B-SPEC
by	O
28	O
days	O
after	O
arrival	O
.	O

Serum	O
samples	O
were	O
obtained	O
at	O
arrival	O
and	O
again	O
28	O
days	O
after	O
arrival	O
and	O
tested	O
for	O
antibodies	O
to	O
BCV	B-SPEC
,	O
using	O
an	O
antibody	O
-	O
detection	O
ELISA	O
.	O

The	O
BCV	B-SPEC
shedding	O
or	O
seroconversion	O
status	O
did	O
not	O
affect	O
average	O
daily	O
gain	O
.	O

Confounding	O
variables	O
in	O
this	O
study	O
could	O
include	O
exposure	O
to	O
domestic	O
dogs	B-SPEC
associated	O
with	O
the	O
project	O
,	O
prolonged	O
time	O
spent	O
in	O
captivity	O
,	O
and	O
concurrent	O
bacterial	O
or	O
parasitic	O
infection	O
.	O

The	O
28S	O
rRNA	O
cleavage	O
occurred	O
as	O
early	O
as	O
4	O
h	O
postinfection	O
(	O
p	O
.	O
i	O
.)	O
in	O
MHV	B-SPEC
-	O
infected	O
DBT	O
cells	O
,	O
with	O
the	O
appearance	O
of	O
subsequent	O
cleavage	O
products	O
and	O
a	O
decrease	O
in	O
the	O
amount	O
of	O
intact	O
28S	O
rRNA	O
with	O
increasing	O
times	O
of	O
infection	O
;	O
almost	O
all	O
of	O
the	O
intact	O
28S	O
rRNA	O
disappeared	O
by	O
24	O
h	O
p	O
.	O
i	O
.	O

In	O
certain	O
combination	O
of	O
cells	O
and	O
viruses	B-SPEC
,	O
pretreatment	O
of	O
virus	B-SPEC
-	O
infected	O
cells	O
with	O
interferon	O
activates	O
a	O
cellular	O
endoribonuclease	O
,	O
RNase	O
L	O
,	O
that	O
causes	O
rRNA	O
degradation	O
.	O

Furthermore	O
,	O
28S	O
rRNA	O
cleavage	O
occurred	O
in	O
an	O
MHV	B-SPEC
-	O
infected	O
mouse	B-SPEC
embryonic	O
fibroblast	O
cell	O
line	O
derived	O
from	O
RNase	O
L	O
knockout	O
mice	B-SPEC
.	O

Thus	O
,	O
MHV	B-SPEC
-	O
induced	O
28S	O
rRNA	O
cleavage	O
appeared	O
to	O
differ	O
from	O
any	O
rRNA	O
degradation	O
mechanism	O
described	O
previously	O
.	O

BMV	B-SPEC
1a	O
and	O
2a	O
can	O
direct	O
virus	B-SPEC
-	O
specific	O
RNA	O
replication	O
in	O
the	O
yeast	B-SPEC
Saccharomyces	B-SPEC
cerevisiae	I-SPEC
,	O
which	O
reproduces	O
the	O
known	O
features	O
of	O
BMV	B-SPEC
replication	O
in	O
plant	B-SPEC
cells	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
distinguish	O
between	O
opportunistic	O
and	O
disease	O
-	O
associated	O
viral	O
presence	O
in	O
human	B-SPEC
brains	O
.	O

Based	O
on	O
similarities	O
in	O
genome	O
organization	O
and	O
protein	O
expression	O
,	O
the	O
arteriviruses	B-SPEC
have	O
recently	O
been	O
grouped	O
together	O
with	O
the	O
coronaviruses	O
and	O
toroviruses	B-SPEC
in	O
the	O
newly	O
established	O
order	B-SPEC
Nidovirales	I-SPEC
.	O

Since	O
some	O
coronavirus	B-SPEC
DI	O
RNAs	O
require	O
the	O
presence	O
of	O
an	O
ORF	O
for	O
their	O
efficient	O
propagation	O
,	O
we	O
have	O
analyzed	O
the	O
importance	O
of	O
the	O
EDI	O
-	O
ORF	O
in	O
EDI	O
RNA	O
replication	O
.	O

These	O
were	O
found	O
either	O
to	O
block	O
DI	O
RNA	O
replication	O
completely	O
or	O
to	O
be	O
removed	O
within	O
one	O
virus	B-SPEC
passage	O
,	O
probably	O
due	O
to	O
homologous	O
recombination	O
with	O
the	O
helper	O
virus	B-SPEC
genome	O
.	O

Several	O
experimental	O
animal	B-SPEC
models	O
have	O
been	O
developed	O
to	O
study	O
the	O
mechanism	O
of	O
virus	B-SPEC
-	O
induced	O
demyelination	O
,	O
including	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infection	O
in	O
mice	B-SPEC
.	O

However	O
,	O
the	O
molecular	O
determinants	O
of	O
MHV	B-SPEC
-	O
induced	O
demyelination	O
are	O
still	O
unknown	O
.	O

Thus	O
,	O
determinants	O
of	O
demyelination	O
map	O
to	O
the	O
S	O
gene	O
of	O
MHV	B-SPEC
.	O

TITLE	O
:	O
The	O
arterivirus	B-SPEC
replicase	O
is	O
the	O
only	O
viral	O
protein	O
required	O
for	O
genome	O
replication	O
and	O
subgenomic	O
mRNA	O
transcription	O
.	O

TITLE	O
:	O
Comparison	O
of	O
serologic	O
testing	O
and	O
slaughter	O
evaluation	O
for	O
assessing	O
the	O
effects	O
of	O
subclinical	O
infection	O
on	O
growth	O
in	O
pigs	B-SPEC
.	O

Results	O
of	O
this	O
study	O
suggest	O
a	O
close	O
functional	O
relationship	O
between	O
the	O
arterivirus	B-SPEC
nsp10	O
and	O
the	O
coronavirus	B-SPEC
helicase	O
,	O
for	O
which	O
NTPase	O
and	O
duplex	O
-	O
unwinding	O
activities	O
were	O
recently	O
demonstrated	O
.	O

TITLE	O
:	O
Oral	O
immunogenicity	O
of	O
the	O
plant	B-SPEC
derived	O
spike	O
protein	O
from	O
swine	B-SPEC
-	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
.	O

Furthermore	O
,	O
when	O
potato	B-SPEC
tubers	B-SPEC
expressing	O
N	O
-	O
gS	O
were	O
fed	O
directly	O
to	O
mice	B-SPEC
,	O
they	O
developed	O
serum	O
antibodies	O
specific	O
for	O
gS	O
protein	O
,	O
demonstrating	O
the	O
oral	O
immunogenicity	O
of	O
the	O
plant	B-SPEC
derived	O
spike	O
protein	O
from	O
TGEV	B-SPEC
.	O

All	O
birds	B-SPEC
were	O
tested	O
to	O
be	O
free	O
from	O
Mycoplasma	B-SPEC
gallisepticum	I-SPEC
and	O
Mycoplasma	B-SPEC
synoviae	I-SPEC
.	O

The	O
nonfumigated	O
and	O
vaccinated	O
birds	B-SPEC
(	O
NFV	O
)	O
revealed	O
less	O
injury	O
on	O
the	O
epithelial	O
surface	O
and	O
a	O
more	O
rapid	O
response	O
to	O
epithelial	O
regeneration	O
than	O
the	O
in	O
only	O
fumigated	O
animals	B-SPEC
(	O
FNV	O
).	O

ABSTRACT	O
:	O
Diagnosis	O
of	O
the	O
DE072	O
strain	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
by	O
the	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
serotype	O
identification	O
test	O
was	O
not	O
possible	O
because	O
the	O
primer	O
used	O
in	O
the	O
RT	O
-	O
PCR	O
did	O
not	O
amplify	O
the	O
S1	O
gene	O
of	O
the	O
DE072	O
strain	O
.	O

Hypoproteinemia	O
is	O
significantly	O
correlated	O
with	O
fluid	O
retention	O
and	O
weight	O
gain	O
,	O
development	O
of	O
ARDS	O
and	O
poor	O
respiratory	O
outcome	O
,	O
and	O
mortality	O
in	O
patients	O
with	O
sepsis	B-SPEC
.	O

Case	O
#	O
1	O
:	O
A	O
3	O
yr	O
-	O
old	O
boy	O
with	O
Mucha	O
-	O
Haberman	O
syndrome	O
(	O
pityriasis	B-SPEC
lichenoides	O
)	O
was	O
admitted	O
to	O
the	O
PICU	B-SPEC
for	O
septic	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
capillary	O
leak	O
,	O
acute	O
renal	O
failure	O
,	O
liver	O
dysfunction	O
,	O
and	O
RHS	O
(	O
pancytopenia	O
and	O
hemophagocytosis	O
on	O
bone	O
marrow	O
aspirate	O
).	O

Length	O
of	O
stay	O
in	O
PICU	B-SPEC
was	O
2	O
months	O
.	O

TITLE	O
:	O
Survival	O
of	O
human	B-SPEC
coronaviruses	O
229E	O
and	O
OC43	O
in	O
suspension	O
and	O
after	O
drying	O
onsurfaces	O
:	O
a	O
possible	O
source	O
ofhospital	O
-	O
acquired	O
infections	O
.	O

Virus	B-SPEC
susceptibility	O
to	O
chemical	O
disinfection	O
with	O
standard	O
products	O
was	O
also	O
characterized	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
course	O
of	O
the	O
energy	O
balance	O
in	O
relation	O
to	O
leptin	O
and	O
the	O
soluble	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
receptors	O
(	O
sTNF	O
-	O
R	O
)	O
55	O
and	O
75	O
,	O
plasma	O
glucose	O
,	O
and	O
serum	O
insulin	O
in	O
patients	O
with	O
severe	O
COPD	O
during	O
the	O
first	O
7	O
d	O
of	O
hospitalization	O
for	O
an	O
acute	O
exacerbation	O
(	O
n	O
=	O
17	O
,	O
11	O
men	O
,	O
age	O
mean	O
[	O
SD	O
]	O
66	O
[	O
10	O
]	O
yr	O
,	O
FEV	B-SPEC
(	O
1	O
)	O
36	O
[	O
12	O
]	O
%	O
pred	O
).	O

The	O
results	O
in	O
this	O
study	O
indicated	O
that	O
Ig	O
Y	O
against	O
PEDV	B-SPEC
could	O
be	O
an	O
alternative	O
way	O
of	O
supplementing	O
prophylactic	O
measures	O
like	O
colostral	O
antibodies	O
from	O
sows	O
.	O

This	O
study	O
thus	O
defines	O
the	O
cis	B-SPEC
-	O
acting	O
transcription	O
signal	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
DI	O
genome	O
.	O

Host	O
range	O
phenotypes	O
of	O
the	O
molecularly	O
cloned	O
and	O
wild	O
-	O
type	O
viruses	B-SPEC
were	O
similar	O
in	O
cells	O
of	O
swine	B-SPEC
and	O
feline	B-SPEC
origin	O
.	O

The	O
method	O
that	O
we	O
have	O
designed	O
to	O
generate	O
an	O
infectious	O
cDNA	O
construct	O
of	O
TGEV	B-SPEC
could	O
theoretically	O
be	O
used	O
to	O
precisely	O
reconstruct	O
microbial	O
or	O
eukaryotic	O
genomes	O
approaching	O
several	O
million	O
base	O
pairs	O
in	O
length	O
.	O

In	O
late	O
1999	O
and	O
early	O
2000	O
,	O
an	O
outbreak	O
of	O
acute	O
illness	O
compatible	O
with	O
HPS	O
was	O
reported	O
in	O
Los	O
Santos	O
,	O
Panama	B-SPEC
,	O
with	O
the	O
death	O
of	O
3	O
of	O
the	O
12	O
(	O
25	O
%)	O
suspected	O
cases	O
.	O

TITLE	O
:	O
Serious	O
complications	O
of	O
bacteremia	O
caused	O
by	O
Viridans	O
streptococci	O
in	O
neutropenic	O
patients	O
with	O
cancer	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
a	O
major	O
structural	O
component	O
of	O
virions	O
that	O
associates	O
with	O
the	O
genomic	O
RNA	O
to	O
form	O
a	O
helical	O
nucleocapsid	O
.	O

Filter	O
binding	O
was	O
used	O
to	O
map	O
N	O
-	O
binding	O
sites	O
within	O
Drep	O
,	O
a	O
BCV	B-SPEC
-	O
defective	O
genome	O
that	O
is	O
replicated	O
and	O
packaged	O
in	O
the	O
presence	O
of	O
helper	O
virus	B-SPEC
.	O

This	O
is	O
the	O
first	O
identification	O
of	O
N	O
-	O
binding	O
sequences	O
for	O
BCV	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
defective	O
RNAs	O
(	O
D	O
-	O
RNAs	O
)	O
have	O
been	O
used	O
as	O
RNA	O
vectors	O
for	O
the	O
expression	O
of	O
heterologous	O
genes	O
and	O
as	O
vehicles	O
for	O
reverse	O
genetics	O
by	O
modifying	O
coronavirus	B-SPEC
genomes	O
by	O
targetted	O
recombination	O
.	O

TITLE	O
:	O
Evidence	O
of	O
genetic	O
diversity	O
generated	O
by	O
recombination	O
among	O
avian	B-SPEC
coronavirus	I-SPEC
IBV	B-SPEC
.	O

Predominantly	O
motor	O
GBS	O
is	O
frequently	O
preceded	O
by	O
a	O
Campylobacter	B-SPEC
jejeuni	O
infection	O
.	O

ECV	O
NC99	O
was	O
determined	O
to	O
have	O
close	O
antigenic	O
and	O
/	O
or	O
genetic	O
relationships	O
with	O
mammalian	B-SPEC
group	O
2	O
coronaviruses	O
,	O
thus	O
identifying	O
it	O
as	O
a	O
member	O
of	O
this	O
coronavirus	B-SPEC
antigenic	O
group	O
.	O

TITLE	O
:	O
Replication	O
of	O
enterotropic	O
and	O
polytropic	O
murine	B-SPEC
coronaviruses	O
in	O
cultured	O
cell	O
lines	O
of	O
mouse	B-SPEC
origin	O
.	O

The	O
results	O
indicate	O
that	O
IC	O
-	O
21	O
cells	O
were	O
the	O
most	O
sensitive	O
to	O
murine	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
noncanonical	O
signal	O
for	O
transcription	O
of	O
a	O
novel	O
subgenomic	O
mRNA	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
:	O
implication	O
for	O
the	O
mechanism	O
of	O
coronavirus	B-SPEC
RNA	O
transcription	O
.	O

ABSTRACT	O
:	O
Lemierre	O
syndrome	O
is	O
a	O
severe	O
,	O
septicemic	O
illness	O
most	O
commonly	O
caused	O
by	O
the	O
anaerobic	O
Gram	O
-	O
negative	O
bacillus	B-SPEC
Fusobacterium	B-SPEC
necrophorum	I-SPEC
.	O

TITLE	O
:	O
Construction	O
and	O
characterization	O
of	O
recombinant	O
porcine	B-SPEC
adenovirus	I-SPEC
serotype	O
5	O
expressing	O
the	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
spike	O
gene	O
.	O

Viruses	B-SPEC
expressing	O
the	O
S	O
gene	O
induced	O
TGEV	B-SPEC
-	O
and	O
PAdV	O
-	O
5	O
-	O
specific	O
virus	B-SPEC
-	O
neutralizing	O
antibodies	O
.	O

ABSTRACT	O
:	O
Numerous	O
respiratory	O
bovine	B-SPEC
coronaviruses	O
(	O
RBCV	O
)	O
were	O
isolated	O
recently	O
from	O
nasal	O
swab	O
samples	O
and	O
lung	O
tissues	O
of	O
feedlot	O
cattle	B-SPEC
with	O
acute	O
respiratory	O
tract	O
disease	O
.	O

Mutants	O
of	O
TGEV	B-SPEC
that	O
lacked	O
sialic	O
acid	O
binding	O
activity	O
due	O
to	O
a	O
point	O
mutation	O
in	O
the	O
sialic	O
acid	O
binding	O
site	O
of	O
the	O
S	O
protein	O
were	O
mainly	O
recovered	O
at	O
a	O
lower	O
-	O
density	O
position	O
on	O
the	O
sucrose	O
gradient	O
(	O
1	O
.	O
18	O
to	O
1	O
.	O
19	O
g	O
/	O
cm	O
(	O
3	O
)).	O

Although	O
it	O
is	O
not	O
clear	O
that	O
each	O
of	O
these	O
potential	O
mechanisms	O
participates	O
in	O
the	O
pathogenesis	O
of	O
human	B-SPEC
demyelinating	O
disease	O
,	O
analysis	O
of	O
the	O
diverse	O
demyelinating	O
viral	O
infections	O
of	O
both	O
humans	B-SPEC
and	O
rodents	B-SPEC
provides	O
examples	O
of	O
many	O
of	O
these	O
potential	O
mechanisms	O
.	O

,	O
Mexico	O
are	O
free	O
of	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
)	O
in	O
its	O
velogenic	O
viscerotropic	O
form	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
disease	O
status	O
of	O
backyard	O
poultry	O
.	O

This	O
suggests	O
that	O
IBV	B-SPEC
may	O
be	O
responsible	O
for	O
a	O
large	O
proportion	O
of	O
the	O
respiratory	O
disease	O
observed	O
in	O
backyard	O
chickens	B-SPEC
in	O
Yucatan	O
.	O

ABSTRACT	O
:	O
The	O
architecture	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
includes	O
three	O
different	O
structural	O
levels	O
,	O
the	O
envelope	O
,	O
an	O
internal	O
core	O
,	O
and	O
the	O
nucleocapsid	O
that	O
is	O
released	O
when	O
the	O
core	O
is	O
disrupted	O
.	O

ABSTRACT	O
:	O
Recombinant	O
mouse	B-SPEC
hepatitis	O
viruses	B-SPEC
(	O
MHV	B-SPEC
)	O
differing	O
only	O
in	O
the	O
spike	O
gene	O
,	O
containing	O
A59	O
,	O
MHV	B-SPEC
-	O
4	O
,	O
and	O
MHV	B-SPEC
-	O
2	O
spike	O
genes	O
in	O
the	O
background	O
of	O
the	O
A59	O
genome	O
,	O
were	O
compared	O
for	O
their	O
ability	O
to	O
replicate	O
in	O
the	O
liver	O
and	O
induce	O
hepatitis	O
in	O
weanling	O
C57BL	O
/	O
6	O
mice	B-SPEC
infected	O
with	O
500	O
PFU	O
of	O
each	O
virus	B-SPEC
by	O
intrahepatic	O
injection	O
.	O

ABSTRACT	O
:	O
Evaluate	O
the	O
safety	O
of	O
filgrastim	O
(	O
recombinant	O
methionyl	O
human	B-SPEC
granulocyte	O
colony	O
-	O
stimulating	O
factor	O
)	O
administration	O
,	O
combined	O
with	O
standard	O
therapy	O
,	O
in	O
patients	O
with	O
pneumonia	O
and	O
either	O
septic	O
shock	O
or	O
severe	O
sepsis	B-SPEC
who	O
were	O
receiving	O
mechanical	O
ventilation	O
.	O

Larger	O
studies	O
to	O
determine	O
the	O
benefit	O
of	O
filgrastim	O
in	O
patients	O
with	O
pneumonia	O
and	O
sepsis	B-SPEC
or	O
organ	O
dysfunction	O
are	O
warranted	O
.	O

CONCLUSIONS	O
:	O
Filgrastim	O
appeared	O
to	O
be	O
well	O
tolerated	O
in	O
this	O
population	O
of	O
patients	O
with	O
pneumonia	O
and	O
severe	O
sepsis	B-SPEC
or	O
septic	O
shock	O
.	O

The	O
role	O
of	O
toroviruses	B-SPEC
and	O
picobirnaviruses	B-SPEC
as	O
causative	O
agents	O
of	O
gastroenteritis	O
is	O
still	O
emerging	O
.	O

Our	O
final	O
diagnosis	O
was	O
ARDS	O
induced	O
by	O
fulminant	O
influenza	O
(	O
A	O
/	O
Hong	O
Kong	O
/	O
68	O
(	O
H3	O
N2	O
))	O
virus	B-SPEC
pneumonia	O
,	O
because	O
the	O
antibody	O
titers	O
of	O
H3	O
N2	O
influenza	O
of	O
paired	O
sera	O
showed	O
a	O
128	O
-	O
fold	O
increase	O
.	O

TITLE	O
:	O
Effect	O
of	O
liquid	O
paraffin	O
on	O
antibody	O
responses	O
and	O
local	O
adverse	O
reactions	O
of	O
bivalent	O
oil	O
adjuvanted	O
vaccines	O
containing	O
newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
and	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Each	O
vaccine	O
was	O
prepared	O
with	O
a	O
liquid	O
paraffin	O
such	O
as	O
Carnation	B-SPEC
,	O
Crystol	O
52	O
and	O
Lytol	O
.	O

SPF	O
chickens	B-SPEC
were	O
bled	O
several	O
times	O
after	O
their	O
introduction	O
and	O
examined	O
for	O
their	O
sero	O
-	O
conversion	O
to	O
avian	B-SPEC
pathogens	O
.	O

Sixteen	O
patients	O
had	O
minor	O
(	O
n	O
=	O
15	O
)	O
or	O
moderate	O
(	O
n	O
=	O
1	O
)	O
changes	O
on	O
a	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

Reciprocal	O
virus	B-SPEC
neutralization	O
test	O
demonstrated	O
that	O
the	O
isolate	O
was	O
closely	O
related	O
to	O
Massachusetts	O
,	O
Arkansas	O
,	O
and	O
JMK	O
.	O

Feline	B-SPEC
coronavirus	B-SPEC
serology	O
was	O
positive	O
.	O

Vaccines	O
are	O
promising	O
,	O
especially	O
for	O
rotavirus	B-SPEC
.	O

TITLE	O
:	O
Inhibition	O
of	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
NS3	O
protease	O
activity	O
by	O
product	O
-	O
based	O
peptides	O
is	O
dependent	O
on	O
helicase	O
domain	O
.	O

The	O
major	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
mechanisms	O
that	O
link	O
the	O
host	O
response	O
to	O
a	O
local	O
infection	O
in	O
the	O
peritoneal	O
cavity	O
with	O
the	O
development	O
of	O
sepsis	B-SPEC
and	O
lung	O
injury	O
.	O

The	O
absence	O
of	O
PMN	O
in	O
the	O
peritoneum	O
was	O
due	O
in	O
part	O
to	O
lysis	O
of	O
intraperitoneal	O
PMN	O
,	O
because	O
the	O
peritoneal	O
fluids	O
contained	O
free	O
myeloperoxidase	O
and	O
induced	O
rapid	O
death	O
of	O
normal	O
rabbit	B-SPEC
PMN	O
in	O
vitro	O
.	O

The	O
3	O
.	O
5	O
-	O
year	O
-	O
old	O
cat	B-SPEC
,	O
positive	O
for	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
infection	O
,	O
presented	O
with	O
a	O
left	O
testicular	O
enlargement	O
.	O

Thus	O
,	O
these	O
results	O
show	O
that	O
infection	O
of	O
the	O
CNS	O
is	O
characterized	O
by	O
a	O
large	O
influx	O
of	O
CD4	O
T	O
cells	O
specific	O
for	O
MHV	B-SPEC
and	O
that	O
these	O
cells	O
remain	O
functional	O
,	O
as	O
measured	O
by	O
cytokine	O
secretion	O
,	O
in	O
mice	B-SPEC
with	O
chronic	O
demyelination	O
.	O

Regular	O
marijuana	B-SPEC
use	O
can	O
lead	O
to	O
extensive	O
airway	O
injury	O
and	O
alterations	O
in	O
the	O
structure	O
and	O
function	O
of	O
alveolar	O
macrophages	O
,	O
potentially	O
predisposing	O
to	O
pulmonary	O
infection	O
and	O
respiratory	O
cancer	B-SPEC
.	O

Hepatitis	O
serology	O
:	O
anti	O
-	O
HBc	O
,	O
HBs	O
-	O
Ag	O
and	O
HBe	O
-	O
Ag	O
positive	O
,	O
anti	O
-	O
HBs	O
and	O
anti	O
-	O
HBe	O
negative	O
,	O
hepatitis	O
A	O
-	O
Ab	O
(	O
IgG	O
)	O
positive	O
,	O
hepatitis	O
A	O
-	O
Ab	O
(	O
IgM	O
)	O
negative	O
,	O
hepatitis	B-SPEC
C	I-SPEC
-	O
Ab	O
negative	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
with	O
RNA	O
genomes	O
often	O
capture	O
and	O
redirect	O
host	O
cell	O
components	O
to	O
assist	O
in	O
mechanisms	O
particular	O
to	O
RNA	O
-	O
dependent	O
RNA	O
synthesis	O
.	O

hnRNP	O
A1	O
thus	O
has	O
been	O
proposed	O
as	O
a	O
host	O
factor	O
in	O
MHV	B-SPEC
transcription	O
.	O

Positive	O
hybridization	O
signals	O
were	O
detected	O
in	O
duodenal	O
,	O
jejunal	O
,	O
and	O
ileal	O
enterocytes	O
from	O
21	O
pigs	B-SPEC
.	O

Respiratory	O
diseases	O
of	O
mice	B-SPEC
,	O
rats	B-SPEC
,	O
guinea	B-SPEC
pigs	I-SPEC
,	O
and	O
Syrian	B-SPEC
hamsters	I-SPEC
are	O
well	O
known	O
because	O
of	O
the	O
use	O
of	O
these	O
species	B-SPEC
in	O
research	O
,	O
whereas	O
few	O
or	O
no	O
reports	O
of	O
respiratory	O
disease	O
in	O
rodents	B-SPEC
of	O
other	O
species	B-SPEC
exist	O
.	O

Virus	B-SPEC
isolation	O
detected	O
CCV	O
shedding	O
from	O
day	O
4	O
to	O
9	O
postchallenge	O
,	O
while	O
the	O
nPCR	O
assay	O
detected	O
CCV	O
shedding	O
from	O
day	O
4	O
to	O
13	O
postchallenge	O
.	O

Echovirus	B-SPEC
type	O
6	O
was	O
isolated	O
from	O
blood	O
,	O
liver	O
,	O
and	O
lungs	O
.	O

ABSTRACT	O
:	O
Respiratory	O
bovine	B-SPEC
coronaviruses	O
(	O
RBCV	O
)	O
emerged	O
as	O
an	O
infectious	O
agent	O
most	O
frequently	O
isolated	O
from	O
respiratory	O
tract	O
samples	O
of	O
cattle	B-SPEC
with	O
acute	O
respiratory	O
tract	O
diseases	O
.	O

Cattle	B-SPEC
that	O
remained	O
negative	O
in	O
RBCV	O
isolation	O
tests	O
entered	O
this	O
epizootic	O
with	O
high	O
levels	O
of	O
serum	O
IN	O
and	O
HAI	O
antibodies	O
,	O
which	O
dramatically	O
increased	O
during	O
the	O
next	O
two	O
weeks	O
.	O

TITLE	O
:	O
Mitochondrial	O
aconitase	O
binds	O
to	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
genome	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
a	O
member	O
of	O
the	O
Coronaviridae	B-SPEC
,	O
contains	O
a	O
polyadenylated	O
positive	O
-	O
sense	O
single	O
-	O
stranded	O
genomic	O
RNA	O
which	O
is	O
31	O
kb	O
long	O
.	O

MHV	B-SPEC
replication	O
and	O
transcription	O
take	O
place	O
via	O
the	O
synthesis	O
of	O
negative	O
-	O
strand	O
RNA	O
intermediates	O
from	O
a	O
positive	O
-	O
strand	O
genomic	O
template	O
.	O

The	O
largest	O
RNA	O
-	O
protein	O
complex	O
formed	O
by	O
the	O
cis	B-SPEC
-	O
acting	O
element	O
and	O
the	O
lysate	O
from	O
uninfected	O
mouse	B-SPEC
fibroblasts	O
has	O
a	O
molecular	O
weight	O
of	O
about	O
200	O
kDa	O
.	O

The	O
objective	O
of	O
this	O
work	O
was	O
to	O
characterize	O
the	O
IFN	O
-	O
alpha	O
-	O
producing	O
cells	O
(	O
IPC	O
)	O
in	O
tissues	O
of	O
TGEV	B-SPEC
-	O
infected	O
piglets	O
.	O

Caesarean	O
-	O
derived	O
colostrum	O
-	O
deprived	O
piglets	O
were	O
infected	O
orally	O
with	O
the	O
TGEV	B-SPEC
virulent	O
Miller	O
strain	O
and	O
IPC	O
were	O
characterized	O
in	O
situ	O
by	O
immunohistochemistry	O
,	O
using	O
a	O
rabbit	B-SPEC
anti	O
-	O
pig	B-SPEC
IFN	O
-	O
alpha	O
antiserum	O
.	O

In	O
comparison	O
,	O
for	O
those	O
dogs	B-SPEC
presented	O
without	O
any	O
history	O
of	O
gastroenteritis	O
only	O
15	O
%	O
were	O
positive	O
for	O
IgM	O
and	O
30	O
%	O
positive	O
for	O
IgG	O
.	O
Serological	O
evidence	O
indicates	O
that	O
infection	O
with	O
CCV	O
in	O
dogs	B-SPEC
is	O
widespread	O
throughout	O
the	O
Australian	O
mainland	O
.	O

ABSTRACT	O
:	O
Numerous	O
studies	O
have	O
shown	O
that	O
viral	O
epitopes	O
and	O
subunits	O
of	O
bacterial	O
toxins	O
can	O
be	O
expressed	O
and	O
correctly	O
processed	O
in	O
transgenic	O
plants	B-SPEC
.	O

ABSTRACT	O
:	O
Development	O
of	O
complications	O
is	O
very	O
common	O
among	O
the	O
patients	O
suffering	O
from	O
Plasmodium	B-SPEC
falciparum	I-SPEC
infection	O
.	O

A	O
total	O
of	O
64	O
patients	O
of	O
Plasmodium	B-SPEC
falciprum	O
infections	O
were	O
admitted	O
to	O
the	O
District	O
Hospital	O
,	O
Ukhrul	O
,	O
during	O
the	O
period	O
of	O
1st	O
May	O
1996	O
to	O
15th	O
June	O
1999	O
;	O
9	O
.	O
37	O
%	O
patients	O
do	O
not	O
develop	O
complication	O
while	O
the	O
rest	O
90	O
.	O
63	O
%	O
developed	O
one	O
or	O
more	O
complications	O
.	O

ABSTRACT	O
:	O
Mice	B-SPEC
infected	O
with	O
neurotropic	O
strains	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
clear	O
infectious	O
virus	B-SPEC
;	O
nevertheless	O
,	O
viral	O
persistence	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
is	O
associated	O
with	O
ongoing	O
primary	O
demyelination	O
.	O

However	O
,	O
IFN	O
-	O
gamma	O
is	O
essential	O
for	O
controlling	O
virus	B-SPEC
replication	O
in	O
oligodendrocytes	O
.	O

TITLE	O
:	O
The	O
missing	O
link	O
in	O
coronavirus	B-SPEC
assembly	O
.	O

ABSTRACT	O
:	O
Since	O
Spring	O
1999	O
,	O
a	O
number	O
of	O
dairy	O
farms	O
have	O
reported	O
problems	O
with	O
wasting	O
in	O
cattle	B-SPEC
.	O

In	O
vivo	O
genotoxicity	O
studies	O
--	O
micronucleus	O
,	O
chromosome	O
aberration	O
,	O
dominant	O
lethal	O
and	O
Drosophila	B-SPEC
tests	O
--	O
generally	O
have	O
shown	O
no	O
activity	O
but	O
one	O
mouse	B-SPEC
intraperitoneal	O
study	O
showed	O
bone	O
marrow	O
cell	O
chromosome	O
aberrations	O
.	O

Overexposure	O
of	O
humans	B-SPEC
produces	O
typical	O
sensory	O
irritant	O
effects	O
on	O
the	O
eye	O
,	O
skin	O
and	O
respiratory	O
tract	O
.	O

There	O
was	O
no	O
evidence	O
of	O
an	O
important	O
excess	O
in	O
the	O
use	O
of	O
alcohol	O
,	O
tobacco	B-SPEC
,	O
or	O
referral	O
to	O
hospital	O
specialists	O
by	O
those	O
who	O
had	O
been	O
to	O
the	O
Gulf	O
.	O

A	O
total	O
of	O
21	O
and	O
30	O
patients	O
were	O
diagnosed	O
as	O
having	O
Pneumocystis	B-SPEC
carinii	I-SPEC
and	O
bacterial	O
pneumonia	O
,	O
respectively	O
,	O
of	O
whom	O
13	O
and	O
eight	O
died	O
during	O
their	O
ICU	O
stay	O
(	O
p	O
=	O
0	O
.	O
01	O
).	O

Logistic	O
regression	O
analysis	O
showed	O
that	O
(	O
APACHE	O
)	O
II	O
score	O
>	O
17	O
,	O
serum	O
albumin	O
level	O
<	O
25	O
g	O
.(-	O
1	O
),	O
and	O
diagnosis	O
of	O
P	B-SPEC
.	I-SPEC
carinii	I-SPEC
pneumonia	O
were	O
the	O
only	O
factors	O
at	O
entry	O
associated	O
with	O
ICU	O
mortality	O
(	O
p	O
=	O
0	O
.	O
02	O
).	O

TITLE	O
:	O
Comparison	O
of	O
the	O
sialic	O
acid	O
binding	O
activity	O
of	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
and	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
.	O

TITLE	O
:	O
[	O
A	O
survival	O
case	O
of	O
severe	O
Legionella	B-SPEC
longbeachae	I-SPEC
pneumonia	O
].	O

Legionella	B-SPEC
longbeachae	I-SPEC
was	O
isolated	O
from	O
his	O
respiratory	O
specimens	O
and	O
was	O
regarded	O
as	O
the	O
etiologic	O
agent	O
of	O
his	O
pneumonia	O
.	O

TITLE	O
:	O
Histopathology	O
of	O
viremia	O
-	O
associated	O
ana	O
-	O
aki	O
-	O
byo	O
in	O
combination	O
with	O
Aeromonas	B-SPEC
hydrophila	I-SPEC
in	O
color	O
carp	B-SPEC
Cyprinus	B-SPEC
carpio	I-SPEC
in	O
Japan	O
.	O

ABSTRACT	O
:	O
A	O
disease	O
in	O
which	O
'	O
viremia	O
-	O
associated	O
ana	O
-	O
aki	O
-	O
byo	O
'	O
is	O
combined	O
with	O
an	O
Aeromonas	B-SPEC
hydrophila	I-SPEC
infection	O
currently	O
occurs	O
and	O
is	O
highly	O
transmissible	O
in	O
color	O
carp	B-SPEC
Cyprinus	B-SPEC
carpio	I-SPEC
in	O
Japan	O
.	O

In	O
the	O
present	O
study	O
,	O
to	O
determine	O
the	O
interrelation	O
between	O
a	O
corona	B-SPEC
-	O
like	O
virus	B-SPEC
and	O
A	B-SPEC
.	I-SPEC
hydrophila	I-SPEC
,	O
we	O
conducted	O
transmission	O
trials	O
by	O
cohabiting	O
naturally	O
diseased	O
carp	B-SPEC
with	O
healthy	O
carp	B-SPEC
with	O
skin	O
that	O
had	O
been	O
slightly	O
damaged	O
artificially	O
.	O

Experimentally	O
exposed	O
fish	B-SPEC
successfully	O
replicated	O
the	O
combination	O
of	O
a	O
corona	B-SPEC
-	O
like	O
viral	O
viremia	O
and	O
A	B-SPEC
.	I-SPEC
hydrophila	I-SPEC
infection	O
.	O

In	O
addition	O
to	O
pathological	O
changes	O
due	O
to	O
the	O
corona	B-SPEC
-	O
like	O
virus	B-SPEC
infection	O
,	O
various	O
changes	O
due	O
to	O
the	O
A	B-SPEC
.	I-SPEC
hydrophila	I-SPEC
infection	O
occurred	O
.	O

Two	O
TCV	B-SPEC
-	O
specific	O
proteins	O
,	O
52	O
and	O
43	O
kDa	O
,	O
were	O
expressed	O
by	O
rBTCV	O
/	O
N	O
;	O
one	O
of	O
these	O
proteins	O
,	O
p52	O
,	O
was	O
comparable	O
in	O
size	O
to	O
native	O
TCV	B-SPEC
N	O
protein	O
.	O

Baculovirus	B-SPEC
-	O
expressed	O
N	O
proteins	O
were	O
used	O
as	O
antigen	O
in	O
an	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
for	O
detection	O
of	O
TCV	B-SPEC
-	O
specific	O
antibodies	O
.	O

Coronavirus	B-SPEC
particles	O
were	O
detected	O
by	O
immune	O
electron	O
microscopy	O
with	O
BCV	B-SPEC
antibodies	O
from	O
the	O
intestinal	O
contents	O
of	O
birds	B-SPEC
killed	O
at	O
3	O
,	O
5	O
,	O
7	O
,	O
and	O
12	O
DPI	O
.	O

TITLE	O
:	O
Identification	O
and	O
analysis	O
of	O
the	O
Georgia	O
98	O
serotype	O
,	O
a	O
new	O
serotype	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

However	O
,	O
when	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
antisera	O
raised	O
in	O
IBDV	B-SPEC
-	O
infected	O
and	O
,	O
especially	O
,	O
that	O
produced	O
in	O
IBDV	B-SPEC
plus	O
IBV	B-SPEC
-	O
infected	O
chickens	B-SPEC
were	O
supplemented	O
,	O
the	O
percentage	O
of	O
phagocytosis	O
and	O
number	O
of	O
bacteria	B-SPEC
ingested	O
per	O
phagocyte	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
less	O
.	O

By	O
immunoprecipitation	O
of	O
UV	O
-	O
cross	O
-	O
linked	O
cellular	O
proteins	O
and	O
in	O
vitro	O
binding	O
of	O
the	O
recombinant	O
protein	O
,	O
we	O
have	O
identified	O
the	O
major	O
RNA	O
-	O
binding	O
protein	O
species	B-SPEC
as	O
heterogeneous	O
nuclear	O
ribonucleoprotein	O
A1	O
(	O
hnRNP	O
A1	O
).	O

All	O
experimental	O
cattle	B-SPEC
shed	O
faecal	O
BCV	B-SPEC
with	O
development	O
of	O
diarrhoea	O
,	O
being	O
profusely	O
watery	O
with	O
small	O
amounts	O
of	O
blood	O
in	O
the	O
most	O
severely	O
affected	O
animals	B-SPEC
,	O
including	O
both	O
cows	B-SPEC
and	O
calves	O
.	O

BCV	B-SPEC
-	O
specific	O
IgG	O
was	O
detected	O
in	O
all	O
cattle	B-SPEC
during	O
the	O
experimental	O
period	O
of	O
up	O
to	O
22	O
months	O
.	O

ABSTRACT	O
:	O
Based	O
on	O
general	O
SARs	O
previously	O
described	O
for	O
anti	O
-	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
diarylsulfone	O
derivatives	O
,	O
a	O
series	O
of	O
2	O
-	O
amino	O
-	O
and	O
2	O
-	O
carboxamido	O
-	O
3	O
-	O
arylsulfonylthiophenes	O
has	O
been	O
prepared	O
and	O
evaluated	O
as	O
potential	O
antiviral	O
and	O
antitumor	O
agents	O
.	O

Based	O
on	O
the	O
activity	O
of	O
the	O
trifluoroacetamides	O
,	O
ring	O
-	O
modified	O
furan	O
,	O
N	O
-(	O
substituted	O
)	O
pyrrole	O
,	O
phenyl	O
,	O
and	O
3	O
,	O
4	O
-	O
thiophene	O
analogues	O
were	O
prepared	O
,	O
and	O
these	O
compounds	O
were	O
also	O
active	O
against	O
CMV	B-SPEC
and	O
/	O
or	O
VZV	B-SPEC
,	O
with	O
the	O
notable	O
exception	O
of	O
the	O
3	O
,	O
4	O
-	O
thiophene	O
derivative	O
.	O

A	O
common	O
trait	O
of	O
these	O
positive	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
is	O
the	O
3	O
'-	O
coterminal	O
nested	O
set	O
of	O
six	O
to	O
eight	O
leader	O
-	O
containing	O
subgenomic	O
mRNAs	O
which	O
are	O
generated	O
by	O
a	O
discontinuous	O
transcription	O
mechanism	O
and	O
from	O
which	O
the	O
viral	O
open	O
reading	O
frames	O
downstream	O
of	O
the	O
polymerase	O
gene	O
are	O
expressed	O
.	O

To	O
this	O
end	O
,	O
an	O
expression	O
cassette	O
consisting	O
of	O
the	O
gene	O
for	O
a	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
flanked	O
at	O
its	O
3	O
'	O
end	O
by	O
EAV	B-SPEC
-	O
specific	O
transcription	O
-	O
regulating	O
sequences	O
was	O
constructed	O
.	O

Reverse	O
transcription	O
-	O
PCR	O
of	O
the	O
viral	O
mRNAs	O
extracted	O
from	O
cells	O
infected	O
with	O
the	O
vector	O
virus	B-SPEC
revealed	O
that	O
it	O
directed	O
the	O
synthesis	O
of	O
nine	O
instead	O
of	O
eight	O
different	O
EAV	B-SPEC
RNAs	O
.	O

It	O
was	O
also	O
observed	O
that	O
the	O
N	O
gene	O
of	O
eight	O
TCV	B-SPEC
isolates	O
originating	O
from	O
various	O
regions	O
of	O
the	O
USA	O
could	O
not	O
be	O
amplified	O
by	O
the	O
primers	O
designed	O
from	O
the	O
N	O
gene	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
).	O

These	O
observations	O
indicate	O
that	O
local	O
infections	O
as	O
caused	O
by	O
TGEV	B-SPEC
,	O
FECV	B-SPEC
and	O
CCoV	O
do	O
not	O
strictly	O
correlate	O
with	O
apical	O
release	O
,	O
as	O
suggested	O
by	O
earlier	O
work	O
.	O

Rectal	O
swabs	O
collected	O
from	O
95	O
dogs	B-SPEC
presented	O
at	O
animal	B-SPEC
hospitals	O
during	O
a	O
period	O
from	O
January	O
to	O
June	O
of	O
2000	O
were	O
examined	O
for	O
enteric	O
pathogens	O
,	O
including	O
viruses	B-SPEC
and	O
Giardia	B-SPEC
lamblia	I-SPEC
(	O
G	B-SPEC
.	I-SPEC
lamblia	I-SPEC
).	O

TITLE	O
:	O
Study	O
of	O
protection	O
by	O
recombinant	O
fowl	O
poxvirus	B-SPEC
expressing	O
C	O
-	O
terminal	O
nucleocapsid	O
protein	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
against	O
challenge	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
C	O
-	O
terminal	O
119	O
amino	O
acid	O
of	O
the	O
nucleocapsid	O
expressed	O
by	O
FPV	B-SPEC
is	O
a	O
host	O
-	O
protective	O
antigen	O
and	O
may	O
induce	O
cross	O
-	O
protective	O
immunity	O
against	O
illness	O
among	O
some	O
IBV	B-SPEC
strains	O
.	O

TITLE	O
:	O
Spike	O
glycoprotein	O
cleavage	O
recognition	O
site	O
analysis	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
compared	O
the	O
cleavage	O
recognition	O
site	O
of	O
55	O
IBV	B-SPEC
isolates	O
to	O
determine	O
if	O
the	O
cleavage	O
recognition	O
site	O
sequence	O
,	O
which	O
consists	O
of	O
five	O
basic	O
amino	O
acid	O
residues	O
,	O
correlates	O
with	O
host	O
cell	O
range	O
,	O
serotype	O
,	O
geographic	O
origin	O
,	O
and	O
pathogenicity	O
as	O
it	O
does	O
in	O
orthomyxoviruses	B-SPEC
and	O
paramyxoviruses	O
.	O

We	O
also	O
determined	O
that	O
cleavage	O
recognition	O
site	O
sequence	O
does	O
not	O
correlate	O
with	O
pathogenicity	O
because	O
attenuated	O
and	O
pathogenic	O
isolates	O
(	O
different	O
passages	O
of	O
the	O
same	O
virus	B-SPEC
)	O
contain	O
identical	O
cleavage	O
recognition	O
site	O
sequences	O
.	O

Cleavage	O
recognition	O
site	O
sequence	O
does	O
correlate	O
with	O
viruses	B-SPEC
in	O
different	O
geographic	O
regions	O
,	O
which	O
may	O
be	O
an	O
important	O
characteristic	O
to	O
examine	O
in	O
epidemiologic	O
studies	O
.	O

An	O
IBV	B-SPEC
monoclonal	O
antibody	O
neutralization	O
-	O
resistant	O
mutant	O
(	O
NR	O
18	O
)	O
had	O
an	O
unusual	O
substitution	O
of	O
Ile	O
for	O
Arg	O
at	O
the	O
fourth	O
position	O
,	O
giving	O
the	O
sequence	O
Arg	O
-	O
Arg	O
-	O
Ser	O
-	O
Ile	O
-	O
Arg	O
,	O
which	O
likely	O
prevents	O
cleavage	O
and	O
,	O
thus	O
,	O
destroys	O
the	O
conformationally	O
dependent	O
monoclonal	O
antibody	O
binding	O
epitope	O
.	O

With	O
the	O
RFLP	O
patterns	O
and	O
the	O
deduced	O
S1	O
amino	O
acid	O
sequence	O
data	O
as	O
a	O
reference	O
,	O
none	O
of	O
the	O
IBV	B-SPEC
isolates	O
foreign	O
to	O
the	O
United	O
States	O
have	O
been	O
detected	O
in	O
the	O
United	O
States	O
.	O

Liver	O
and	O
colon	O
lesions	O
contained	O
intracellular	O
,	O
curved	O
,	O
spore	O
-	O
forming	O
,	O
gram	O
-	O
negative	O
,	O
silver	O
-	O
positive	O
rods	O
morphologically	O
consistent	O
with	O
Clostridium	B-SPEC
piliforme	I-SPEC
.	O

A	O
prospective	O
,	O
controlled	O
,	O
randomised	O
,	O
in	O
vivo	O
animal	B-SPEC
laboratory	O
study	O
.	O

TITLE	O
:	O
Antibody	O
testing	O
against	O
canine	O
coronavirus	B-SPEC
by	O
immunoperoxidase	O
plaque	O
staining	O
.	O

When	O
the	O
IP	O
test	O
and	O
NT	O
were	O
compared	O
in	O
dogs	B-SPEC
with	O
diarrhoeic	O
signs	O
.	O

The	O
possibility	O
of	O
engineering	O
the	O
tissue	O
and	O
species	B-SPEC
tropism	O
to	O
target	O
expression	O
to	O
different	O
organs	O
and	O
animal	B-SPEC
species	B-SPEC
,	O
including	O
humans	B-SPEC
,	O
increases	O
the	O
potential	O
of	O
coronaviruses	O
as	O
vectors	O
.	O

These	O
anti	O
-	O
MCMV	B-SPEC
effects	O
were	O
attributed	O
to	O
prototypical	O
NK1	O
.	O
1	O
(+)	O
CD3	O
(-)	O
NK	O
cells	O
and	O
not	O
to	O
NK1	O
.	O
1	O
(+)	O
CD3	O
(+)	O
""""	O
NK	O
/	O
T	O
""""	O
cells	O
.	O

The	O
routes	O
of	O
infection	O
,	O
in	O
descending	O
order	B-SPEC
of	O
efficacy	O
,	O
were	O
:	O
i	O
.	O
ci	O
.	O
ns	O
.	O
ci	O
.	O
pi	O
.	O
v	O
.	O
and	O
oral	O
.	O

Eight	O
-	O
week	O
-	O
old	O
rats	B-SPEC
inoculated	O
by	O
the	O
i	O
.	O
ci	O
.	O
n	O
.	O
or	O
s	O
.	O
c	O
.	O

To	O
follow	O
the	O
spread	O
of	O
virus	B-SPEC
in	O
the	O
central	O
nervous	O
system	O
,	O
4	O
-	O
week	O
-	O
old	O
rats	B-SPEC
inoculated	O
by	O
the	O
i	O
.	O
c	O
.	O

Two	O
different	O
serogroups	O
of	O
mammalian	B-SPEC
coronaviruses	O
cause	O
frequent	O
respiratory	O
infections	O
in	O
humans	B-SPEC
,	O
and	O
coronaviruses	O
and	O
toroviruses	B-SPEC
have	O
been	O
implicated	O
in	O
human	B-SPEC
diarrhoeal	O
disease	O
by	O
immunoelectron	O
microscopy	O
.	O

This	O
study	O
demonstrates	O
that	O
at	O
least	O
one	O
type	O
of	O
filtered	O
shipping	O
container	O
protects	O
mice	B-SPEC
from	O
a	O
field	O
challenge	O
of	O
MHV	B-SPEC
.	O

We	O
learned	O
that	O
(	O
i	O
)	O
mutations	O
that	O
were	O
predicted	O
to	O
unfold	O
the	O
stem	O
-	O
loop	O
in	O
various	O
ways	O
did	O
not	O
switch	O
RdRp	O
crossover	O
to	O
the	O
upstream	O
canonical	O
site	O
,	O
(	O
ii	O
)	O
a	O
totally	O
nonconforming	O
downstream	O
motif	O
resulted	O
in	O
no	O
measurable	O
transcription	O
from	O
either	O
site	O
,	O
(	O
iii	O
)	O
the	O
canonical	O
upstream	O
site	O
does	O
not	O
function	O
ectopically	O
to	O
lend	O
competence	O
to	O
the	O
downstream	O
noncanonical	O
site	O
,	O
and	O
(	O
iv	O
)	O
altering	O
flanking	O
sequences	O
downstream	O
of	O
the	O
downstream	O
noncanonical	O
motif	O
in	O
ways	O
that	O
diminish	O
sequence	O
similarity	O
with	O
the	O
virus	B-SPEC
genome	O
5	O
'	O
end	O
caused	O
a	O
dramatic	O
switch	O
to	O
the	O
upstream	O
canonical	O
site	O
.	O

Reactive	O
immunoglobulins	O
pertained	O
to	O
the	O
IgG1	O
,	O
IgG2a	O
and	O
IgG2b	O
subclasses	O
,	O
recognized	O
cryptic	O
epitopes	O
and	O
were	O
detected	O
from	O
10	O
days	O
up	O
to	O
8	O
weeks	O
after	O
MHV	B-SPEC
-	O
infection	O
.	O

The	O
40	O
-	O
kDa	O
protein	O
was	O
purified	O
from	O
mouse	B-SPEC
liver	O
extracts	O
by	O
ion	O
-	O
exchange	O
chromatography	O
,	O
gel	O
filtration	O
and	O
SDS	O
-	O
PAGE	O
.	O

The	O
apparent	O
loss	O
of	O
initial	O
T	O
cell	O
-	O
mediated	O
immune	O
control	O
in	O
the	O
absence	O
of	O
B	O
cells	O
was	O
investigated	O
by	O
comparing	O
T	O
cell	O
populations	O
in	O
CNS	O
mononuclear	O
cells	O
from	O
infected	O
muMT	O
and	O
wild	O
-	O
type	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Cats	B-SPEC
with	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
FeLV	B-SPEC
)-	O
associated	O
enteritis	O
(	O
FAE	O
),	O
enteritis	O
of	O
other	O
known	O
viral	O
etiology	O
(	O
parvovirus	B-SPEC
[	O
PV	O
],	O
enteric	B-SPEC
coronavirus	I-SPEC
[	O
CoV	O
]),	O
and	O
enteritis	O
of	O
unknown	O
etiology	O
with	O
histologic	O
features	O
similar	O
to	O
those	O
of	O
FAE	O
and	O
PV	O
enteritis	O
(	O
EUE	O
)	O
and	O
FeLV	B-SPEC
-	O
negative	O
and	O
FeLV	B-SPEC
-	O
positive	O
cats	B-SPEC
without	O
enterocyte	O
alterations	O
were	O
examined	O
.	O

Inflammatory	O
infiltration	O
was	O
generally	O
dominated	O
by	O
mononuclear	O
cells	O
and	O
was	O
moderate	O
in	O
the	O
unaltered	O
intestine	O
and	O
in	O
cats	B-SPEC
with	O
PV	O
enteritis	O
and	O
marked	O
in	O
cats	B-SPEC
with	O
FAE	O
,	O
CoV	O
enteritis	O
,	O
and	O
EUE	O
.	O

TITLE	O
:	O
Type	O
-	O
specific	O
identification	O
of	O
human	B-SPEC
adenovirus	B-SPEC
3	O
,	O
7	O
,	O
and	O
21	O
by	O
a	O
multiplex	O
PCR	O
assay	O
.	O

Two	O
monoclonal	O
antibodies	O
were	O
discovered	O
that	O
also	O
provided	O
passive	O
protection	O
for	O
baby	O
pigs	B-SPEC
.	O

Based	O
on	O
our	O
findings	O
we	O
infer	O
that	O
BCV	B-SPEC
was	O
not	O
causally	O
related	O
to	O
UBRD	O
occurrence	O
,	O
however	O
consistent	O
with	O
other	O
literature	O
,	O
BVDV	B-SPEC
may	O
be	O
causally	O
related	O
to	O
UBRD	O
occurrence	O
.	O

Vaccination	O
with	O
H	B-SPEC
.	I-SPEC
somnus	I-SPEC
in	O
combination	O
with	O
M	B-SPEC
.	I-SPEC
haemolytica	I-SPEC
and	O
with	O
M	B-SPEC
.	I-SPEC
haemolytica	I-SPEC
alone	O
reduced	O
the	O
risk	O
of	O
UBRD	O
.	O

TITLE	O
:	O
Direct	O
diagnosis	O
of	O
human	B-SPEC
respiratory	O
coronaviruses	O
229E	O
and	O
OC43	O
by	O
the	O
polymerase	O
chain	O
reaction	O
.	O

Detection	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
in	O
clinical	O
specimens	O
is	O
possible	O
using	O
this	O
method	O
:	O
348	O
respiratory	O
specimens	O
(	O
202	O
sputum	O
and	O
146	O
nasal	O
aspirates	O
)	O
were	O
tested	O
with	O
this	O
RT	O
-	O
PCR	O
-	O
hybridization	O
and	O
12	O
human	B-SPEC
coronavirus	I-SPEC
are	O
detected	O
(	O
3	O
%).	O

TITLE	O
:	O
Targeted	O
disruption	O
of	O
the	O
Ceacam1	O
(	O
MHVR	O
)	O
gene	O
leads	O
to	O
reduced	O
susceptibility	O
of	O
mice	B-SPEC
to	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
.	O

To	O
elucidate	O
the	O
mechanisms	O
responsible	O
for	O
the	O
many	O
biological	O
activities	O
of	O
CEACAM1	O
,	O
we	O
modified	O
the	O
expression	O
of	O
the	O
mouse	B-SPEC
Ceacam1	O
gene	O
in	O
vivo	O
.	O

This	O
resulted	O
in	O
the	O
markedly	O
reduced	O
expression	O
of	O
the	O
two	O
CEACAM1a	O
isoforms	O
with	O
four	O
Ig	O
domains	O
,	O
whereas	O
the	O
expression	O
of	O
the	O
two	O
isoforms	O
with	O
two	O
Ig	O
domains	O
was	O
doubled	O
relative	O
to	O
that	O
in	O
wild	O
-	O
type	O
BALB	O
/	O
c	O
(+/+)	O
mice	B-SPEC
.	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
-	O
2	O
infection	O
in	O
mice	B-SPEC
:	O
an	O
experimental	O
model	O
system	O
of	O
acute	O
meningitis	O
and	O
hepatitis	O
.	O

ABSTRACT	O
:	O
Infection	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
strain	O
A59	O
produces	O
acute	O
hepatitis	O
,	O
encephalitis	O
,	O
and	O
chronic	O
demyelination	O
in	O
mice	B-SPEC
.	O

Ten	O
patients	O
were	O
stratified	O
with	O
severe	O
sepsis	B-SPEC
,	O
and	O
eight	O
patients	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

4	O
for	O
PCV	B-SPEC
to	O
12	O
+/-	O

APRV	O
may	O
be	O
used	O
safely	O
in	O
patients	O
with	O
ALI	O
/	O
ARDS	O
,	O
and	O
decreases	O
the	O
need	O
for	O
paralysis	O
and	O
sedation	O
as	O
compared	O
with	O
PCV	B-SPEC
-	O
inverse	O
ratio	O
ventilation	O
(	O
IRV	O
).	O

ABSTRACT	O
:	O
Brain	O
tissue	O
from	O
25	O
patients	O
with	O
clinically	O
definite	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
and	O
as	O
controls	O
brain	O
tissue	O
from	O
36	O
patients	O
without	O
neurological	O
disease	O
was	O
tested	O
for	O
the	O
presence	O
of	O
human	B-SPEC
coronaviral	O
RNA	O
.	O

Four	O
PCR	O
assays	O
with	O
primers	O
specific	O
for	O
N	O
-	O
protein	O
of	O
human	B-SPEC
coronavirus	I-SPEC
strain	I-SPEC
229E	I-SPEC
and	O
three	O
PCR	O
assays	O
with	O
primers	O
specific	O
for	O
the	O
nucleocapsid	O
protein	O
of	O
human	B-SPEC
coronavirus	I-SPEC
strain	O
OC43	O
were	O
performed	O
.	O

ABSTRACT	O
:	O
This	O
paper	O
demonstrates	O
the	O
use	O
of	O
stochastic	O
genetic	O
epidemiological	O
models	O
for	O
quantifying	O
the	O
consequences	O
of	O
selecting	O
animals	B-SPEC
for	O
resistance	O
to	O
a	O
microparasitic	O
infectious	O
disease	O
.	O

Changes	O
in	O
Vuip	O
and	O
in	O
Crs	O
produced	O
by	O
HV	O
were	O
correlated	O
with	O
edema	O
severity	O
in	O
normal	O
rats	B-SPEC
or	O
rats	B-SPEC
with	O
lungs	O
preinjured	O
with	O
alpha	O
-	O
naphthylthiourea	O
.	O

The	O
present	O
study	O
demonstrated	O
that	O
DI	O
RNA	O
accumulation	O
from	O
the	O
expressed	O
negative	O
-	O
strand	O
DI	O
RNA	O
transcripts	O
in	O
MHV	B-SPEC
-	O
infected	O
cells	O
was	O
enhanced	O
by	O
the	O
coexpression	O
of	O
complementary	O
RNA	O
transcripts	O
that	O
correspond	O
to	O
the	O
5	O
'	O
region	O
of	O
positive	O
-	O
strand	O
DI	O
RNA	O
.	O

MHV	B-SPEC
N	O
protein	O
binds	O
to	O
all	O
MHV	B-SPEC
mRNAs	O
,	O
whereas	O
envelope	O
M	O
protein	O
interacts	O
only	O
with	O
mRNA	O
1	O
.	O

A	O
short	O
cis	B-SPEC
-	O
acting	O
MHV	B-SPEC
RNA	O
packaging	O
signal	O
is	O
necessary	O
and	O
sufficient	O
for	O
packaging	O
RNA	O
into	O
MHV	B-SPEC
particles	O
.	O

This	O
is	O
the	O
first	O
example	O
for	O
any	O
RNA	O
virus	B-SPEC
in	O
which	O
a	O
viral	O
envelope	O
protein	O
and	O
a	O
known	O
viral	O
RNA	O
packaging	O
signal	O
have	O
been	O
shown	O
to	O
determine	O
the	O
specificity	O
and	O
selectivity	O
of	O
RNA	O
packaging	O
into	O
virions	O
.	O

Following	O
MHV	B-SPEC
infection	O
of	O
CCR5	O
(+/+)	O
mice	B-SPEC
,	O
greater	O
than	O
50	O
%	O
of	O
cells	O
expressing	O
CCR5	O
antigen	O
were	O
activated	O
macrophage	O
/	O
microglia	O
(	O
determined	O
by	O
F4	O
/	O
80	O
antigen	O
expression	O
).	O

For	O
PCT	O
,	O
no	O
significant	O
correlations	O
(	O
Spearman	O
rank	O
)	O
were	O
found	O
to	O
the	O
lung	O
injury	O
score	O
(	O
p	O
=.	O
93	O
),	O
the	O
abbreviated	O
injury	O
scale	O
-	O
lung	O
(	O
p	O
=.	O
33	O
),	O
or	O
the	O
sepsis	B-SPEC
-	O
related	O
organ	O
failure	O
assessment	O
score	O
-	O
lung	O
(	O
p	O
=.	O
38	O
).	O

Comparison	O
of	O
the	O
TGEV	B-SPEC
polymerase	O
sequence	O
with	O
that	O
of	O
other	O
RNA	O
viruses	B-SPEC
revealed	O
high	O
sequence	O
homology	O
with	O
the	O
A	O
-	O
E	O
domains	O
of	O
the	O
palm	O
subdomain	O
of	O
nucleic	O
acid	O
polymerases	O
.	O

Patients	O
with	O
SIRS	O
and	O
sepsis	B-SPEC
are	O
exposed	O
to	O
severe	O
oxidative	O
stress	O
.	O

To	O
explore	O
the	O
possible	O
mechanism	O
of	O
the	O
emergence	O
of	O
acute	O
PRRS	O
,	O
the	O
open	O
reading	O
frame	O
5	O
(	O
ORF5	O
)	O
gene	O
encoding	O
the	O
major	O
envelope	O
protein	O
(	O
GP5	O
)	O
of	O
acute	O
PRRSV	B-SPEC
isolates	O
was	O
characterized	O
.	O

Four	O
rhinovirus	B-SPEC
,	O
four	O
coronavirus	B-SPEC
,	O
three	O
RSV	B-SPEC
,	O
one	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
,	O
and	O
one	O
influenza	O
A	O
/	O
enterovirus	B-SPEC
double	O
infection	O
were	O
confirmed	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
Pneumocystis	B-SPEC
carinii	I-SPEC
pneumonia	O
(	O
PCP	O
)	O
in	O
which	O
acute	O
lung	O
tissue	O
destruction	O
progressed	O
within	O
a	O
few	O
days	O
to	O
form	O
multiple	O
bullae	O
in	O
a	O
patient	O
with	O
no	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
infection	O
.	O

The	O
disease	O
is	O
related	O
to	O
an	O
infection	O
or	O
colonisation	O
with	O
a	O
toxin	O
(	O
TSST	O
-	O
1	O
)	O
producing	O
strain	O
of	O
Staphylococcus	B-SPEC
aureus	I-SPEC
.	O

ABSTRACT	O
:	O
Intraocular	O
coronavirus	B-SPEC
inoculation	O
results	O
in	O
a	O
biphasic	O
retinal	O
disease	O
in	O
susceptible	O
mice	B-SPEC
(	O
BALB	O
/	O
c	O
)	O
characterized	O
by	O
an	O
acute	O
inflammatory	O
response	O
,	O
followed	O
by	O
retinal	O
degeneration	O
associated	O
with	O
autoimmune	O
reactivity	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
upregulated	O
only	O
in	O
susceptible	O
mice	B-SPEC
during	O
the	O
secondary	O
(	O
retinal	O
degeneration	O
)	O
phase	O
.	O

ARF	O
necessitating	O
dialysis	B-SPEC
was	O
seen	O
in	O
92	O
%	O
of	O
patients	O
with	O
ARF	O
in	O
malaria	O
.	O

No	O
response	O
was	O
seen	O
to	O
chloroquine	O
and	O
artesunate	O
given	O
alone	O
and	O
twenty	O
patients	O
required	O
quinine	B-SPEC
.	O

Moreover	O
,	O
MHV	B-SPEC
-	O
infected	O
CCR2	O
(-/-)	O
mice	B-SPEC
displayed	O
a	O
significant	O
decrease	O
in	O
Th1	O
-	O
associated	O
factors	O
IFN	O
-	O
gamma	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
001	O
)	O
and	O
RANTES	O
/	O
CCL5	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
002	O
)	O
within	O
the	O
CNS	O
as	O
compared	O
with	O
CCR2	O
(+/+)	O
mice	B-SPEC
.	O

Besides	O
these	O
specific	O
conditions	O
,	O
infection	O
is	O
a	O
major	O
problem	O
in	O
drug	O
abusers	O
,	O
irrespective	O
of	O
the	O
drug	O
:	O
bacterial	O
pneumonia	O
,	O
tuberculosis	O
,	O
HIV	B-SPEC
infection	O
are	O
much	O
more	O
frequent	O
in	O
this	O
high	O
-	O
risk	O
group	O
.	O

MHV	B-SPEC
OBLV	O
has	O
little	O
direct	O
effect	O
on	O
the	O
olfactory	O
epithelium	O
,	O
but	O
causes	O
extensive	O
spongiotic	O
degeneration	O
and	O
destruction	O
of	O
mitral	O
cells	O
and	O
interneurons	O
in	O
the	O
olfactory	O
bulb	O
such	O
that	O
the	O
axonal	O
projection	O
from	O
the	O
bulb	O
via	O
the	O
lateral	O
olfactory	O
tract	O
is	O
markedly	O
reduced	O
.	O

Using	O
standard	O
operant	O
techniques	O
and	O
a	O
'	O
go	O
,	O
no	O
-	O
go	O
'	O
successive	O
discrimination	O
paradigm	O
,	O
six	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
trained	O
to	O
discriminate	O
between	O
the	O
presentation	O
of	O
an	O
air	O
or	O
odor	O
stimulus	O
(	O
three	O
mice	B-SPEC
for	O
each	O
of	O
the	O
odorants	O
propanol	O
and	O
propyl	O
acetate	O
).	O

In	O
contrast	O
,	O
inoculated	O
animals	B-SPEC
varied	O
in	O
their	O
capacity	O
to	O
discriminate	O
between	O
air	O
and	O
odorant	O
.	O

Five	O
of	O
the	O
six	O
inoculated	O
mice	B-SPEC
showed	O
massive	O
disruption	O
of	O
the	O
olfactory	O
bulb	O
,	O
including	O
death	O
of	O
mitral	O
cells	O
;	O
the	O
other	O
was	O
more	O
modestly	O
affected	O
.	O

Herein	O
,	O
we	O
analyzed	O
the	O
421bp	O
sequence	O
of	O
a	O
hypervariable	O
region	O
(	O
HVR	O
)	O
(	O
position	O
114	O
-	O
534	O
,	O
counting	O
from	O
the	O
ATG	O
start	O
site	O
)	O
of	O
the	O
S1	O
subunit	O
of	O
GA98	O
IBVs	O
to	O
further	O
examine	O
the	O
evolution	O
of	O
these	O
viruses	B-SPEC
.	O

To	O
evaluate	O
the	O
immunogenicity	O
of	O
the	O
construct	O
,	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
intramuscularly	O
immunized	O
with	O
different	O
doses	O
(	O
50	O
,	O
100	O
and	O
200	O
microg	O
/	O
mouse	B-SPEC
)	O
of	O
pcDNA	O
/	O
N	O
twice	O
at	O
a	O
5	O
-	O
week	O
interval	O
.	O

Total	O
Ig	O
to	O
TCV	B-SPEC
was	O
initially	O
detected	O
at	O
7	O
and	O
14	O
d	O
PI	O
in	O
Experiments	O
1	O
and	O
3	O
.	O

The	O
IgA	O
isotype	O
antibody	O
response	O
to	O
TCV	B-SPEC
was	O
very	O
low	O
as	O
detected	O
at	O
7	O
(	O
0	O
.	O
13	O
),	O
14	O
(	O
0	O
.	O
20	O
),	O
and	O
21	O
(	O
0	O
.	O
17	O
)	O
d	O
PI	O
.	O

The	O
results	O
indicate	O
that	O
humoral	O
and	O
cellular	O
immunities	O
to	O
TCV	B-SPEC
are	O
elicited	O
in	O
turkeys	B-SPEC
following	O
infection	O
with	O
TCV	B-SPEC
.	O

To	O
investigate	O
whether	O
B	O
cells	O
are	O
important	O
for	O
controlling	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
infection	O
,	O
we	O
infected	O
muMT	O
mice	B-SPEC
who	O
lack	O
membrane	O
-	O
bound	O
IgM	O
and	O
therefore	O
mature	O
B	O
lymphocytes	O
.	O

These	O
data	O
suggest	O
that	O
clearance	O
of	O
infectious	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
from	O
the	O
CNS	O
requires	O
Ab	O
production	O
and	O
perhaps	O
B	O
cell	O
support	O
of	O
T	O
cells	O
;	O
however	O
,	O
virus	B-SPEC
is	O
cleared	O
from	O
the	O
liver	O
without	O
the	O
involvement	O
of	O
Abs	O
or	O
B	O
cells	O
.	O

Meta	B-SPEC
-	O
analysis	O
of	O
the	O
eight	O
eligible	O
studies	O
comparing	O
HFOV	O
with	O
CV	O
revealed	O
that	O
there	O
is	O
no	O
difference	O
in	O
mortality	O
.	O

We	O
examined	O
using	O
ICR	O
mice	B-SPEC
whether	O
the	O
amino	O
acids	O
mutated	O
in	O
the	O
mutants	O
were	O
involved	O
in	O
the	O
neurovirulence	O
.	O

If	O
PaO2	O
did	O
not	O
reach	O
75	O
torr	O
(	O
10	O
.	O
0	O
kPa	O
),	O
and	O
time	O
permitted	O
,	O
the	O
animal	B-SPEC
was	O
crossed	O
over	O
to	O
the	O
other	O
group	O
.	O

FiO2	O
increases	O
did	O
not	O
achieve	O
a	O
PaO2	O
of	O
75	O
torr	O
(	O
10	O
.	O
0	O
kPa	O
)	O
for	O
three	O
of	O
six	O
animals	B-SPEC
despite	O
reaching	O
100	O
%	O
FiO2	O
.	O

A	O
TGEV	B-SPEC
virion	O
structure	O
integrating	O
all	O
the	O
data	O
is	O
proposed	O
.	O

The	O
IBV	B-SPEC
genomic	O
cDNA	O
was	O
assembled	O
immediately	O
downstream	O
of	O
a	O
T7	O
RNA	O
polymerase	O
promoter	O
by	O
in	O
vitro	O
ligation	O
and	O
cloned	O
directly	O
into	O
the	O
vaccinia	B-SPEC
virus	I-SPEC
genome	O
.	O

Human	B-SPEC
macrophages	O
were	O
derived	O
from	O
peripheral	O
blood	O
monocytes	O
from	O
healthy	O
volunteers	O
.	O

Acute	O
hypoxia	O
also	O
increased	O
rabbit	B-SPEC
alveolar	O
macrophage	O
IL	O
-	O
8	O
expression	O
.	O

The	O
buoyant	O
density	O
of	O
the	O
virus	B-SPEC
determined	O
in	O
sucrose	O
was	O
1	O
.	O
17	O
-	O
1	O
.	O
19	O
g	O
/	O
ml	O
.	O

RNA	O
was	O
extracted	O
from	O
the	O
intestines	O
and	O
stool	O
samples	O
that	O
were	O
collected	O
from	O
the	O
swine	B-SPEC
with	O
diarrhea	O
.	O

ABSTRACT	O
:	O
The	O
sequence	O
of	O
the	O
replicase	O
gene	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
been	O
determined	O
.	O

Percentages	O
of	O
intrahepatic	O
CD4	O
(+)	O
cells	O
decreased	O
in	O
attenuated	O
YAC	O
-	O
MHV3	O
-	O
infected	O
mice	B-SPEC
,	O
while	O
they	O
increased	O
in	O
mice	B-SPEC
infected	O
with	O
pathogenic	O
L2	O
-	O
MHV3	O
,	O
compared	O
with	O
uninfected	O
animals	B-SPEC
.	O

Sucrose	O
density	O
gradient	O
ultracentrifugation	O
of	O
the	O
virus	B-SPEC
-	O
containing	O
intestinal	O
homogenate	O
yielded	O
two	O
opalescent	O
bands	O
corresponding	O
to	O
the	O
buoyant	O
densities	O
of	O
1	O
.	O
14	O
-	O
1	O
.	O
15	O
and	O
1	O
.	O
18	O
-	O
1	O
.	O
20	O
g	O
/	O
ml	O
,	O
respectively	O
.	O

Although	O
the	O
formation	O
and	O
accumulation	O
of	O
viral	O
recombinants	O
was	O
observed	O
in	O
numerous	O
RNA	O
viruses	B-SPEC
,	O
the	O
molecular	O
basis	O
of	O
this	O
phenomenon	O
was	O
studied	O
in	O
only	O
a	O
few	O
viral	O
species	B-SPEC
.	O

Unvaccinated	O
birds	B-SPEC
in	O
Experiment	O
3	O
fed	O
an	O
Arg	O
-	O
deficient	O
diet	O
had	O
lower	O
(	O
P	O
<	O
or	O
=	O
0	O
.	O
05	O
)	O
feed	O
conversion	O
in	O
comparison	O
with	O
vaccinated	O
birds	B-SPEC
fed	O
an	O
Arg	O
-	O
deficient	O
diet	O
.	O

Immunity	O
was	O
assessed	O
as	O
antibody	O
production	O
to	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
SRBC	O
,	O
and	O
Brucella	B-SPEC
abortus	I-SPEC
(	O
BA	O
)	O
antigens	O
,	O
mitogenic	O
response	O
to	O
phytohemagglutinin	O
A	O
(	O
PHA	O
)	O
and	O
concanavalin	O
A	O
(	O
Con	O
A	O
),	O
cutaneous	O
basophil	O
hypersensitivity	O
(	O
CBH	O
)	O
to	O
PHA	O
,	O
and	O
lipopolysaccharide	O
induction	O
of	O
acute	O
-	O
phase	O
proteins	O
(	O
APP	O
)	O
and	O
heterophilia	O
.	O

The	O
PTD	O
sequence	O
was	O
constructed	O
upon	O
a	O
solid	O
support	O
,	O
from	O
C	O
-	O
terminus	O
to	O
N	O
-	O
terminus	O
,	O
followed	O
by	O
extension	O
with	O
four	O
glycine	B-SPEC
residues	O
,	O
leaving	O
the	O
amino	O
chain	O
end	O
for	O
subsequent	O
coupling	O
with	O
remaining	O
acrylic	O
acid	O
functionalities	O
present	O
on	O
the	O
surface	O
of	O
the	O
SCK	O
.	O

Increases	O
in	O
cytokine	O
expression	O
and	O
cellular	O
nitration	O
can	O
lead	O
to	O
tissue	O
damage	O
and	O
are	O
consistent	O
with	O
the	O
differences	O
between	O
genotypes	O
in	O
the	O
early	O
onset	O
of	O
pathology	O
and	O
mortality	O
in	O
Ron	O
tk	O
-/-	O
mice	B-SPEC
.	O

As	O
of	O
July	O
2001	O
,	O
the	O
VirOligo	O
database	O
contains	O
a	O
complete	O
listing	O
of	O
oligonucleotides	O
specific	O
to	O
viral	O
agents	O
associated	O
with	O
bovine	B-SPEC
respiratory	O
disease	O
that	O
were	O
published	O
in	O
English	O
in	O
peer	O
-	O
reviewed	O
journals	O
.	O

Also	O
,	O
a	O
prime	O
-	O
boost	O
protocol	O
failed	O
to	O
afford	O
protection	O
,	O
with	O
priming	O
using	O
plasmid	O
DNA	O
and	O
boosting	O
using	O
recombinant	O
vaccinia	O
viruses	B-SPEC
expressing	O
the	O
same	O
coronavirus	B-SPEC
proteins	O
.	O

Histopathology	O
reveals	O
surfactant	O
disruption	O
,	O
epithelial	O
perturbation	O
and	O
sepsis	B-SPEC
,	O
either	O
as	O
initiating	O
factors	O
or	O
as	O
secondary	O
complications	O
,	O
which	O
in	O
turn	O
increase	O
the	O
expression	O
of	O
cytokines	O
that	O
sequester	O
and	O
activate	O
inflammatory	O
cells	O
,	O
most	O
notably	O
,	O
neutrophils	O
.	O

Initial	O
results	O
are	O
encouraging	O
and	O
suggest	O
that	O
several	O
of	O
these	O
mice	B-SPEC
vary	O
in	O
their	O
susceptibility	O
to	O
oxidant	O
-	O
induced	O
lung	O
injury	O
.	O

ABSTRACT	O
:	O
Group	B-SPEC
A	I-SPEC
rotavirus	I-SPEC
(	O
RV	O
)	O
and	O
coronavirus	B-SPEC
(	O
CV	O
)	O
are	O
common	O
viral	O
pathogens	O
associated	O
with	O
neonatal	O
diarrhoea	O
in	O
numerous	O
animal	B-SPEC
species	B-SPEC
.	O

TITLE	O
:	O
A	O
serodiagnostic	O
ELISA	O
using	O
recombinant	O
antigen	O
of	O
swine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
nucleoprotein	O
.	O

No	O
cross	O
-	O
reaction	O
was	O
detected	O
with	O
antisera	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
hog	B-SPEC
cholera	I-SPEC
virus	I-SPEC
,	O
type	O
A	O
rotavirus	B-SPEC
,	O
pseudorabies	B-SPEC
virus	I-SPEC
and	O
swine	B-SPEC
vesicular	O
disease	O
virus	B-SPEC
in	O
this	O
ELISA	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infection	O
spreads	O
from	O
MHV	B-SPEC
-	O
infected	O
DBT	O
cells	O
,	O
which	O
express	O
the	O
MHV	B-SPEC
receptor	O
CEACAM1	O
(	O
MHVR	O
),	O
to	O
BHK	O
cells	O
,	O
which	O
are	O
devoid	O
of	O
the	O
receptor	O
,	O
by	O
intercellular	O
membrane	O
fusion	O
(	O
MHVR	O
-	O
independent	O
fusion	O
).	O

ABSTRACT	O
:	O
We	O
have	O
previously	O
shown	O
that	O
the	O
E	O
protein	O
of	O
the	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
localized	O
to	O
the	O
Golgi	O
complex	O
when	O
expressed	O
exogenously	O
from	O
cDNA	O
.	O

Here	O
,	O
we	O
report	O
that	O
neither	O
the	O
transmembrane	O
domain	O
nor	O
the	O
short	O
lumenal	O
domain	O
of	O
IBV	B-SPEC
E	O
is	O
required	O
for	O
Golgi	O
targeting	O
.	O

Recombinant	O
TGEV	B-SPEC
was	O
not	O
released	O
from	O
these	O
cultures	O
.	O

Under	O
identical	O
conditions	O
,	O
TGEV	B-SPEC
-	O
GFP2	O
spread	O
throughout	O
ST	O
cell	O
cultures	O
,	O
expressed	O
GFP	O
,	O
and	O
formed	O
viral	O
plaques	O
.	O

The	O
development	O
of	O
infectious	O
TGEV	B-SPEC
replicon	O
particles	O
should	O
assist	O
studies	O
of	O
TGEV	B-SPEC
replication	O
and	O
assembly	O
as	O
well	O
as	O
facilitate	O
the	O
production	O
of	O
novel	O
swine	B-SPEC
candidate	O
vaccines	O
.	O

ABSTRACT	O
:	O
On	O
August	O
17	O
,	O
1999	O
a	O
major	O
earthquake	O
hit	O
the	O
most	O
densely	O
populated	O
area	O
at	O
the	O
eastern	O
end	O
of	O
the	O
Marmara	B-SPEC
Sea	O
in	O
northwestern	O
Turkey	B-SPEC
.	O

We	O
retrospectively	O
evaluated	O
patients	O
,	O
clinic	O
and	O
laboratory	O
findings	O
,	O
surgical	O
interventions	O
,	O
and	O
frequency	O
and	O
duration	O
of	O
dialysis	B-SPEC
.	O

Mortality	O
,	O
when	O
it	O
occurs	O
,	O
is	O
mainly	O
associated	O
with	O
thoracic	O
and	O
abdominal	O
trauma	O
and	O
medical	O
problems	O
such	O
as	O
DIC	O
and	O
/	O
or	O
ARDS	O
/	O
respiratory	O
failure	O
,	O
often	O
in	O
conjunction	O
with	O
sepsis	B-SPEC
.	O

Finally	O
,	O
the	O
approaches	O
described	O
here	O
will	O
allow	O
us	O
to	O
define	O
protein	O
complementation	O
of	O
defective	O
viruses	B-SPEC
at	O
a	O
cellular	O
level	O
,	O
rather	O
than	O
being	O
dependent	O
on	O
population	O
measurements	O
of	O
RNA	O
,	O
protein	O
,	O
or	O
progeny	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Seventeen	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
field	O
isolates	O
recovered	O
from	O
commercial	O
broiler	O
flocks	O
in	O
Mexico	O
were	O
identified	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
cycle	O
sequencing	O
of	O
the	O
S1	O
gene	O
.	O

TITLE	O
:	O
Antigenic	O
and	O
genomic	O
relatedness	O
of	O
turkey	B-SPEC
-	O
origin	O
coronaviruses	O
,	O
bovine	B-SPEC
coronaviruses	O
,	O
and	O
infectious	O
bronchitis	O
virus	B-SPEC
of	O
chickens	B-SPEC
.	O

TITLE	O
:	O
Mortality	O
patterns	O
associated	O
with	O
poult	O
enteritis	O
mortality	O
syndrome	O
(	O
PEMS	O
)	O
and	O
coronaviral	O
enteritis	O
in	O
turkey	B-SPEC
flocks	O
raised	O
in	O
PEMS	O
-	O
affected	O
regions	O
.	O

Additionally	O
,	O
7	O
out	O
of	O
17	O
cases	O
of	O
TCV	B-SPEC
(	O
41	O
%)	O
did	O
not	O
experience	O
excess	O
mortality	O
(	O
PEMS	O
)	O
at	O
any	O
time	O
during	O
brooding	O
of	O
the	O
flock	O
.	O

The	O
results	O
of	O
this	O
study	O
indicate	O
that	O
TCV	B-SPEC
can	O
be	O
associated	O
with	O
PEMS	O
but	O
is	O
neither	O
necessary	O
nor	O
sufficient	O
to	O
cause	O
PEMS	O
.	O

Optimal	O
protection	O
against	O
IBV	B-SPEC
-	O
induced	O
respiratory	O
disease	O
was	O
obtained	O
after	O
intravenous	O
or	O
oral	O
administration	O
of	O
ChIFN	O
given	O
1	O
day	O
before	O
virus	B-SPEC
challenge	O
and	O
each	O
of	O
5	O
days	O
thereafter	O
.	O

In	O
contrast	O
to	O
diminished	O
T	O
cell	O
responses	O
in	O
H	O
-	O
2	O
(	O
b	O
)	O
B	O
cell	O
-	O
deficient	O
muMT	O
mice	B-SPEC
,	O
the	O
absence	O
of	O
B	O
cells	O
or	O
Ab	O
in	O
the	O
H	O
-	O
2	O
(	O
d	O
)	O
mice	B-SPEC
did	O
not	O
compromise	O
expansion	O
,	O
recruitment	O
into	O
the	O
CNS	O
,	O
or	O
function	O
of	O
virus	B-SPEC
-	O
specific	O
CD4	O
+	O
and	O
CD8	O
+	O
T	O
cells	O
.	O

Reemerging	O
virus	B-SPEC
localized	O
almost	O
exclusively	O
to	O
oligodendroglia	O
in	O
B	O
cell	O
+	O
Ab	O
-	O
deficient	O
mice	B-SPEC
,	O
whereas	O
it	O
also	O
replicated	O
in	O
astrocytes	O
in	O
B	O
cell	O
-	O
deficient	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
50	O
-	O
year	O
-	O
old	O
man	B-SPEC
swallowed	O
200	O
ml	O
of	O
an	O
insecticide	O
containing	O
the	O
organophosphates	O
dimethoate	O
and	O
phenitrotion	O
in	O
an	O
attempted	O
suicide	O
.	O

TITLE	O
:	O
Streptococcus	B-SPEC
suis	I-SPEC
infection	O
in	O
northern	O
Thailand	O
.	O

MHV	B-SPEC
-	O
S	O
,	O
MHV	B-SPEC
-	O
JHM	O
and	O
PV	O
bound	O
to	O
horse	B-SPEC
serum	O
glycoproteins	O
containing	O
Neu4	O
,	O
5Ac2	O
.	O

TITLE	O
:	O
Experimental	O
infection	O
of	O
piglets	O
with	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
:	O
a	O
comparison	O
of	O
three	O
strains	O
(	O
Korean	O
,	O
Purdue	O
and	O
Miller	O
).	O

The	O
helper	O
-	O
dependent	O
adenovirus	B-SPEC
vectors	O
meet	O
these	O
requirements	O
,	O
as	O
demonstrated	O
in	O
various	O
studies	O
in	O
the	O
literature	O
.	O

Transcriptional	O
activation	O
of	O
mIFN	O
(	O
alpha	O
)	O
induced	O
by	O
doxycycline	O
resulted	O
in	O
prolonged	O
survival	O
and	O
reduced	O
liver	O
damage	O
in	O
HD	O
-	O
TET	O
-	O
IFN	O
-	O
injected	O
mice	B-SPEC
challenged	O
with	O
a	O
lethal	O
dose	O
of	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
An	O
enzyme	O
-	O
linked	O
immunospot	O
(	O
ELISPOT	O
)	O
has	O
been	O
developed	O
to	O
detect	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)-	O
specific	O
antibody	O
secreting	O
cells	O
(	O
ASC	O
)	O
in	O
gut	O
associated	O
lymphoid	O
tissues	O
(	O
duodenum	O
and	O
ileum	O
lamina	O
propria	O
and	O
mesenteric	O
lymph	O
nodes	O
)	O
and	O
systemic	O
locations	O
(	O
spleen	O
and	O
blood	O
)	O
of	O
conventional	O
pigs	B-SPEC
so	O
as	O
to	O
characterise	O
the	O
mucosal	O
and	O
systemic	O
antibody	O
response	O
generated	O
by	O
the	O
infection	O
with	O
PEDV	B-SPEC
.	O

Inoculation	O
of	O
healthy	O
volunteers	O
with	O
human	B-SPEC
coronavirus	I-SPEC
caused	O
disruption	O
of	O
the	O
ciliated	O
epithelium	O
and	O
ciliary	O
dyskinesia	O
.	O

Expression	O
of	O
the	O
reporter	O
gene	O
beta	O
-	O
glucuronidase	O
(	O
GUS	O
)	O
(	O
2	O
-	O
8	O
microg	O
per	O
10	O
(	O
6	O
)	O
cells	O
)	O
and	O
the	O
porcine	B-SPEC
respiratory	I-SPEC
and	I-SPEC
reproductive	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
ORF5	O
(	O
1	O
-	O
2	O
microg	O
per	O
10	O
(	O
6	O
)	O
cells	O
)	O
has	O
been	O
shown	O
using	O
a	O
TGEV	B-SPEC
-	O
derived	O
minigenome	O
.	O

About	O
a	O
quarter	O
of	O
the	O
cells	O
in	O
culture	O
expressing	O
the	O
helper	O
virus	B-SPEC
also	O
produced	O
the	O
reporter	O
gene	O
as	O
determined	O
by	O
studying	O
GUS	O
mRNA	O
production	O
by	O
in	O
situ	O
hybridization	O
or	O
immunodetection	O
to	O
visualize	O
the	O
protein	O
synthesized	O
.	O

TITLE	O
:	O
Mutational	O
analysis	O
of	O
the	O
active	O
centre	O
of	O
coronavirus	B-SPEC
3C	O
-	O
like	O
proteases	O
.	O

These	O
studies	O
indicate	O
that	O
NOS2	O
-	O
generated	O
NO	O
contributes	O
to	O
apoptosis	O
of	O
neurons	O
but	O
not	O
demyelination	O
following	O
MHV	B-SPEC
infection	O
.	O

Treatment	O
with	O
CY	O
mainly	O
induced	O
B	O
cell	O
deficiency	O
as	O
indicated	O
by	O
significant	O
reductions	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
antibody	O
responses	O
to	O
sheep	B-SPEC
erythrocytes	O
7	O
days	O
after	O
injection	O
.	O

However	O
,	O
hyperoxia	O
causes	O
lung	O
damage	O
in	O
experimental	O
animals	B-SPEC
and	O
may	O
do	O
so	O
in	O
humans	B-SPEC
.	O

Exposure	O
of	O
adult	O
male	O
Sprague	B-SPEC
-	I-SPEC
Dawley	I-SPEC
rats	I-SPEC
to	O
hyperoxia	O
for	O
24	O
to	O
48	O
h	O
led	O
to	O
increased	O
expression	O
of	O
pulmonary	O
CYP1A1	O
enzyme	O
,	O
which	O
was	O
preceded	O
by	O
enhancement	O
of	O
the	O
corresponding	O
mRNA	O
,	O
followed	O
by	O
decline	O
of	O
induction	O
at	O
60	O
h	O
,	O
when	O
the	O
animals	B-SPEC
displayed	O
severe	O
respiratory	O
distress	O
and	O
lung	O
inflammation	O
.	O

To	O
prepare	O
virus	B-SPEC
is	O
time	O
consuming	O
and	O
tedious	O
.	O

The	O
results	O
show	O
that	O
the	O
S	O
-	O
fg	O
fusion	O
protein	O
is	O
highly	O
cross	O
-	O
reactive	O
among	O
different	O
IBV	B-SPEC
serotypes	O
,	O
and	O
the	O
S	O
-	O
fg	O
ELISA	O
is	O
found	O
to	O
be	O
a	O
convenient	O
,	O
economical	O
,	O
and	O
efficient	O
method	O
for	O
antibody	O
detection	O
against	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Acute	O
hepatic	O
failure	O
in	O
IFN	O
-	O
gamma	O
-	O
deficient	O
BALB	O
/	O
c	O
mice	B-SPEC
after	O
murine	B-SPEC
coronavirus	I-SPEC
infection	O
.	O

Human	B-SPEC
coronaviruses	O
can	O
survive	O
for	O
as	O
long	O
as	O
6	O
days	O
in	O
suspension	O
and	O
3	O
hours	O
after	O
drying	O
on	O
surfaces	O
,	O
suggesting	O
that	O
they	O
could	O
be	O
a	O
source	O
of	O
hospital	O
-	O
acquired	O
infections	O
.	O

No	O
cross	O
-	O
infection	O
were	O
observed	O
from	O
community	O
-	O
acquired	O
respiratory	O
-	O
syncitial	O
virus	B-SPEC
or	O
influenza	O
-	O
infected	O
children	O
to	O
neonates	O
.	O

Universal	O
precautions	O
with	O
hand	O
washing	O
and	O
surface	O
desinfection	O
could	O
be	O
proposed	O
to	O
prevent	O
coronavirus	B-SPEC
transmission	O
.	O

In	O
contrast	O
,	O
31	O
%	O
of	O
pigs	B-SPEC
exposed	O
to	O
the	O
virulent	O
PEDV	B-SPEC
developed	O
diarrhoea	O
and	O
virus	B-SPEC
shedding	O
was	O
demonstrated	O
in	O
100	O
%.	O

TITLE	O
:	O
Antibody	O
responses	O
and	O
morbidity	O
following	O
infection	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
and	O
challenge	O
with	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
in	O
lines	O
divergently	O
selected	O
on	O
antibody	O
response	O
.	O

A	O
controlled	O
-	O
challenge	O
protocol	O
was	O
developed	O
to	O
mimic	O
natural	O
infection	O
and	O
to	O
yield	O
a	O
higher	O
rate	O
of	O
mortality	O
following	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
EC	O
)	O
challenge	O
.	O

While	O
antibody	O
response	O
to	O
IBV	B-SPEC
in	O
juvenile	O
chicks	O
was	O
unaffected	O
by	O
the	O
in	O
ovo	B-SPEC
lead	O
exposure	O
,	O
IFN	O
-	O
gamma	O
-	O
like	O
cytokine	O
production	O
by	O
splenocytes	O
was	O
significantly	O
depressed	O
following	O
lead	O
exposure	O
at	O
both	O
developmental	O
stages	O
.	O

TITLE	O
:	O
Laboratory	O
profiles	O
in	O
cats	B-SPEC
with	O
different	O
pathological	O
and	O
immunohistochemical	O
findings	O
due	O
to	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

Based	O
on	O
the	O
pathological	O
findings	O
or	O
on	O
the	O
immunohistochemical	O
distribution	O
of	O
viral	O
antigen	O
,	O
FIP	O
-	O
affected	O
cats	B-SPEC
were	O
divided	O
in	O
the	O
following	O
groups	O
:	O
subacute	O
against	O
acute	O
lesions	O
;	O
low	O
against	O
strong	O
intensity	O
of	O
positivity	O
;	O
intracellular	O
against	O
extracellular	O
positivities	O
;	O
positive	O
against	O
negative	O
lymph	O
nodes	O
.	O

To	O
better	O
understand	O
the	O
distinct	O
phases	O
of	O
immune	O
control	O
within	O
the	O
CNS	O
,	O
the	O
kinetics	O
of	O
humoral	O
immune	O
responses	O
were	O
determined	O
in	O
infected	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
and	O
hemagglutinin	O
/	O
esterase	O
(	O
HE	O
)	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
are	O
the	O
two	O
envelope	O
proteins	O
that	O
recognize	O
the	O
same	O
receptor	O
-	O
determinant	O
of	O
9	O
-	O
O	O
-	O
acetylneuraminic	O
acid	O
on	O
host	O
cells	O
.	O

However	O
,	O
the	O
precise	O
and	O
relative	O
roles	O
of	O
the	O
two	O
proteins	O
in	O
BCV	B-SPEC
infectivity	O
remain	O
elusive	O
.	O

To	O
unequivocally	O
determine	O
their	O
roles	O
in	O
viral	O
cytopathogenicity	O
,	O
we	O
developed	O
a	O
system	O
in	O
which	O
phenotypically	O
chimeric	O
viruses	B-SPEC
were	O
generated	O
by	O
infecting	O
a	O
closely	O
related	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
in	O
cells	O
that	O
stably	O
express	O
an	O
individual	O
BCV	B-SPEC
protein	O
(	O
S	O
or	O
HE	O
).	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
the	O
S	O
protein	O
but	O
not	O
the	O
HE	O
protein	O
of	O
BCV	B-SPEC
is	O
necessary	O
and	O
sufficient	O
for	O
infection	O
of	O
the	O
chimeric	O
viruses	B-SPEC
in	O
HRT	O
-	O
18	O
cells	O
,	O
suggesting	O
that	O
BCV	B-SPEC
likely	O
uses	O
the	O
S	O
protein	O
as	O
a	O
primary	O
vehicle	O
to	O
infect	O
permissive	O
cells	O
.	O

After	O
instillation	O
,	O
rats	B-SPEC
were	O
exposed	O
to	O
oxygen	O
alone	O
(	O
FIO	O
(	O
2	O
)	O
100	O
%)	O
or	O
to	O
oxygen	O
(	O
FIO	O
(	O
2	O
)	O
approximately	O
100	O
%)	O
plus	O
nitric	O
oxide	O
(	O
10	O
ppm	O
)	O
during	O
24	O
hrs	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
possible	O
association	O
of	O
OAS	O
with	O
Platanus	B-SPEC
acerifolia	I-SPEC
pollinosis	O
.	O

On	O
the	O
contrary	O
low	O
inhibition	O
was	O
observed	O
when	O
plant	B-SPEC
-	O
derived	O
food	O
allergens	O
were	O
used	O
as	O
free	O
phase	O
and	O
P	B-SPEC
.	I-SPEC
acerifolia	I-SPEC
pollen	O
extract	O
as	O
solid	O
phase	O
.	O

Cross	O
-	O
reactivity	O
was	O
observed	O
among	O
P	B-SPEC
.	I-SPEC
acerifolia	I-SPEC
pollen	O
and	O
plant	B-SPEC
-	O
derived	O
foods	O
.	O

In	O
addition	O
,	O
IP	O
-	O
10	O
(-/-)	O
mice	B-SPEC
exhibited	O
an	O
impaired	O
contact	O
hypersensitivity	O
response	O
,	O
characterized	O
by	O
decreased	O
ear	O
swelling	O
and	O
reduced	O
inflammatory	O
cell	O
infiltrates	O
.	O

TITLE	O
:	O
RNA	O
replication	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
takes	O
place	O
at	O
double	O
-	O
membrane	O
vesicles	O
.	O

Biochemical	O
fractionation	O
showed	O
that	O
all	O
10	O
of	O
the	O
MHV	B-SPEC
gene	O
1	O
polyprotein	O
products	O
examined	O
pelleted	O
with	O
the	O
membrane	O
fraction	O
,	O
consistent	O
with	O
membrane	O
association	O
of	O
the	O
RC	O
.	O

ABSTRACT	O
:	O
Oligomeric	O
spike	O
(	O
S	O
)	O
glycoproteins	O
extend	O
from	O
coronavirus	B-SPEC
membranes	O
.	O

In	O
this	O
review	O
,	O
we	O
present	O
a	O
guide	O
to	O
the	O
weaknesses	O
and	O
strengths	O
of	O
using	O
traditional	O
and	O
molecular	O
methods	O
for	O
the	O
detection	O
of	O
infectious	O
agents	O
in	O
laboratory	O
animals	B-SPEC
.	O

TITLE	O
:	O
Differentiation	O
of	O
mouse	B-SPEC
hepatitis	O
viruses	B-SPEC
in	O
animal	B-SPEC
facilities	O
in	O
Japan	O
by	O
use	O
of	O
nucleotide	O
analysis	O
of	O
the	O
nucleocapsid	O
gene	O
.	O

Phylogenetic	O
analysis	O
of	O
these	O
MHV	B-SPEC
strains	O
along	O
with	O
those	O
reported	O
previously	O
indicated	O
that	O
sequence	O
analysis	O
of	O
the	O
N	O
gene	O
was	O
a	O
useful	O
tool	O
for	O
differentiation	O
of	O
MHV	B-SPEC
strains	O
,	O
although	O
most	O
MHV	B-SPEC
strains	O
in	O
Japanese	O
facilities	O
were	O
phylogenetically	O
close	O
.	O

ABSTRACT	O
:	O
Variation	O
in	O
susceptibility	O
to	O
viral	O
infection	O
is	O
well	O
documented	O
across	O
mouse	B-SPEC
strains	O
.	O

Transmission	O
occurred	O
via	O
direct	O
contact	O
with	O
seropositive	O
mice	B-SPEC
and	O
exposure	O
to	O
contaminated	O
bedding	O
.	O

ABSTRACT	O
:	O
Extracorporeal	O
blood	O
detoxification	O
by	O
sorbent	O
therapy	O
long	O
has	O
been	O
applied	O
in	O
treatment	O
of	O
hepatic	O
failure	O
and	O
encephalopathy	O
,	O
starting	O
with	O
hemoperfusion	O
columns	O
and	O
more	O
recently	O
with	O
the	O
currently	O
marketed	O
Liver	O
Dialysis	B-SPEC
Unit	O
.	O

Clinical	O
results	O
of	O
daily	O
MARS	O
treatments	O
of	O
patients	O
with	O
hepatic	O
failure	O
are	O
similar	O
to	O
that	O
of	O
Liver	O
Dialysis	B-SPEC
,	O
with	O
neurologic	O
and	O
physical	O
improvement	O
occurs	O
in	O
most	O
patients	O
with	O
AHE	O
,	O
and	O
improved	O
outcome	O
for	O
patients	O
with	O
A	O
-	O
on	O
-	O
C	O
.	O
The	O
system	O
extends	O
the	O
life	O
of	O
patients	O
with	O
hepatorenal	O
syndrome	O
.	O

Infectious	O
TGEV	B-SPEC
was	O
efficiently	O
recovered	O
from	O
cells	O
transfected	O
with	O
the	O
modified	O
cDNAs	O
.	O

ABSTRACT	O
:	O
Most	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
strains	O
,	O
as	O
their	O
name	B-SPEC
suggests	O
,	O
infect	O
the	O
liver	O
.	O

Nevertheless	O
,	O
it	O
is	O
still	O
unclear	O
exactly	O
how	O
MHV	B-SPEC
induces	O
demyelination	O
and	O
to	O
what	O
extent	O
the	O
immune	O
system	O
plays	O
a	O
role	O
in	O
this	O
pathology	O
.	O

Nine	O
sera	O
from	O
uninfected	O
pigs	B-SPEC
,	O
34	O
sera	O
from	O
16	O
pigs	B-SPEC
experimentally	O
infected	O
with	O
TGEV	B-SPEC
,	O
and	O
sera	O
from	O
10	O
pigs	B-SPEC
experimentally	O
infected	O
with	O
PRCV	O
were	O
evaluated	O
using	O
both	O
the	O
TGEV	B-SPEC
/	O
PRCV	O
blocking	O
ELISA	O
and	O
a	O
virus	B-SPEC
neutralization	O
(	O
VN	O
)	O
assay	O
.	O

The	O
blocking	O
ELISA	O
was	O
determined	O
to	O
be	O
useful	O
for	O
herd	O
monitoring	O
programs	O
and	O
could	O
be	O
used	O
alone	O
without	O
parallel	O
use	O
of	O
the	O
VN	O
assay	O
for	O
the	O
assessment	O
of	O
large	O
swine	B-SPEC
populations	O
for	O
the	O
detection	O
of	O
TGEV	B-SPEC
-	O
infected	O
herds	O
.	O

The	O
IBV	B-SPEC
strains	O
identified	O
as	O
nephropathogenic	O
induced	O
clinical	O
nephritis	O
,	O
gross	O
and	O
histological	O
kidney	O
lesions	O
,	O
and	O
mortality	O
of	O
5	O
-	O
90	O
%.	O

Severe	O
combined	O
imunodeficiency	O
syndrome	O
(	O
T	O
-,	O
B	O
+,	O
NK	O
+),	O
B	O
lymphoproliferative	O
disease	O
and	O
hemophagocytic	O
lymphohistiocytosis	O
triggered	O
by	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
(	O
EBV	O
)	O
were	O
diagnosed	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
membrane	O
(	O
M	O
)	O
protein	O
is	O
the	O
most	O
abundant	O
virion	O
protein	O
and	O
the	O
key	O
component	O
in	O
viral	O
assembly	O
and	O
morphogenesis	O
.	O

This	O
mutant	O
was	O
isolated	O
by	O
means	O
of	O
targeted	O
RNA	O
recombination	O
with	O
a	O
powerful	O
host	O
range	O
-	O
based	O
selection	O
allowed	O
by	O
the	O
interspecies	O
chimeric	O
virus	B-SPEC
fMHV	O
(	O
MHV	B-SPEC
containing	O
the	O
ectodomain	O
of	O
the	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
S	O
protein	O
).	O

Other	O
viral	O
agents	O
that	O
are	O
recognised	O
in	O
these	O
animals	B-SPEC
,	O
including	O
adenovirus	B-SPEC
,	O
parapox	O
,	O
foot	O
and	O
mouth	O
disease	O
,	O
bluetongue	O
,	O
epizootic	O
haemorrhagic	O
disease	O
,	O
bovine	B-SPEC
virus	B-SPEC
diarrhoea	O
,	O
rotavirus	B-SPEC
and	O
coronavirus	B-SPEC
,	O
are	O
also	O
discussed	O
.	O

Chronic	O
wasting	O
disease	O
is	O
principally	O
important	O
in	O
North	O
America	O
,	O
where	O
the	O
disease	O
occurs	O
in	O
wild	O
cervids	O
in	O
a	O
limited	O
area	O
and	O
has	O
been	O
reported	O
in	O
farmed	O
deer	B-SPEC
in	O
a	O
small	O
number	O
of	O
states	O
in	O
the	O
United	O
States	O
of	O
America	O
and	O
one	O
province	O
in	O
Canada	O
.	O

Nasopharyngeal	O
secretion	O
obtained	O
at	O
onset	O
of	O
illness	O
was	O
cultured	O
for	O
bacterial	O
pathogens	O
of	O
otitis	O
media	O
using	O
selective	O
agars	O
and	O
tested	O
for	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
influenza	O
A	O
and	O
B	O
,	O
and	O
parainfluenza	O
1	O
-	O
3	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
technology	O
.	O

Pathogenic	O
bacteria	B-SPEC
(	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
,	O
Haemophilus	B-SPEC
influenzae	I-SPEC
,	O
or	O
Moraxella	B-SPEC
catarrhalis	I-SPEC
)	O
were	O
detected	O
in	O
nasopharyngeal	O
secretion	O
in	O
29	O
(	O
34	O
%)	O
of	O
the	O
86	O
colds	O
;	O
the	O
bacteria	B-SPEC
were	O
in	O
high	O
titer	O
(>	O
or	O
=	O
10	O
(	O
3	O
)	O
cfu	O
/	O
mL	O
)	O
in	O
26	O
of	O
the	O
29	O
positive	O
specimens	O
.	O

Age	O
,	O
detection	O
of	O
a	O
respiratory	O
virus	B-SPEC
,	O
and	O
presence	O
of	O
bacterial	O
pathogen	O
in	O
the	O
nasopharyngeal	O
secretion	O
had	O
a	O
negligible	O
effect	O
on	O
the	O
occurrence	O
of	O
abnormal	O
tympanometry	O
.	O

Fifteen	O
piglets	O
experimentally	O
infected	O
with	O
PEDV	B-SPEC
were	O
used	O
in	O
the	O
study	O
.	O

Of	O
the	O
94	O
samples	O
,	O
63	O
were	O
positive	O
for	O
PEDV	B-SPEC
by	O
all	O
3	O
techniques	O
.	O

Reconstituted	O
fgl2	O
catalyzed	O
the	O
cleavage	O
of	O
human	B-SPEC
prothrombin	O
to	O
thrombin	O
with	O
kinetics	O
consistent	O
with	O
a	O
first	O
order	B-SPEC
reaction	O
,	O
with	O
an	O
apparent	O
V	O
(	O
max	O
)	O
value	O
of	O
6	O
mol	O
/	O
min	O
/	O
mol	O
fgl2	O
and	O
an	O
apparent	O
K	O
(	O
m	O
)	O
value	O
for	O
prothrombin	O
of	O
8	O
.	O
3	O
microM	O
.	O
The	O
catalytic	O
activity	O
was	O
totally	O
dependent	O
on	O
calcium	O
,	O
and	O
factor	O
Va	O
(	O
500	O
nM	O
)	O
enhanced	O
the	O
catalytic	O
efficiency	O
of	O
fgl2	O
by	O
increasing	O
the	O
apparent	O
V	O
(	O
max	O
)	O
value	O
to	O
3670	O
mol	O
/	O
min	O
/	O
mol	O
fgl2	O
and	O
decreasing	O
the	O
apparent	O
K	O
(	O
m	O
)	O
value	O
for	O
prothrombin	O
to	O
7	O
.	O
2	O
microM	O
.	O
By	O
a	O
combination	O
of	O
site	O
-	O
directed	O
mutagenesis	O
and	O
production	O
of	O
truncated	O
proteins	O
,	O
it	O
was	O
clearly	O
shown	O
that	O
residue	O
Ser	O
(	O
89	O
)	O
was	O
critical	O
for	O
the	O
prothrombinase	O
activity	O
of	O
fgl2	O
.	O

ABSTRACT	O
:	O
Rhinoviruses	B-SPEC
and	O
coronaviruses	O
are	O
recognized	O
as	O
the	O
major	O
causes	O
of	O
the	O
common	O
cold	O
syndrome	O
.	O

ABSTRACT	O
:	O
The	O
most	O
common	O
illnesses	O
in	O
humans	B-SPEC
are	O
the	O
respiratory	O
tract	O
infections	O
caused	O
by	O
viruses	B-SPEC
.	O

These	O
observations	O
indicate	O
that	O
the	O
experimental	O
virus	B-SPEC
infection	O
may	O
induce	O
host	O
responses	O
that	O
provoke	O
enhanced	O
immunoglobulin	O
E	O
(	O
IgE	O
)	O
synthesis	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
-	O
related	O
nosocomial	O
viral	O
respiratory	O
infections	O
in	O
a	O
neonatal	O
and	O
paediatric	O
intensive	O
care	O
unit	O
:	O
a	O
prospective	O
study	O
.	O

In	O
spite	O
of	O
a	O
high	O
rate	O
of	O
community	O
-	O
acquired	O
infection	O
in	O
hospitalized	O
children	O
,	O
the	O
incidence	O
of	O
NVRI	O
with	O
common	O
respiratory	O
viruses	B-SPEC
appears	O
low	O
in	O
neonates	O
,	O
HCoV	O
being	O
the	O
most	O
important	O
pathogen	O
of	O
NRVI	O
in	O
neonates	O
during	O
this	O
study	O
period	O
.	O

However	O
,	O
UV	O
-	O
irradiated	O
MHV	B-SPEC
failed	O
to	O
activate	O
MAPKs	O
,	O
which	O
demonstrated	O
that	O
MHV	B-SPEC
replication	O
was	O
necessary	O
for	O
their	O
activation	O
.	O

By	O
comparing	O
parental	O
TGEV	B-SPEC
with	O
mutant	O
viruses	B-SPEC
deficient	O
in	O
the	O
sialic	O
acid	O
binding	O
activity	O
,	O
we	O
determined	O
the	O
contributions	O
of	O
both	O
binding	O
activities	O
to	O
the	O
attachment	O
of	O
TGEV	B-SPEC
to	O
cultured	O
cells	O
.	O

As	O
all	O
recombinant	O
deletion	O
mutant	O
viruses	B-SPEC
appeared	O
to	O
be	O
viable	O
,	O
we	O
conclude	O
that	O
the	O
MHV	B-SPEC
group	O
-	O
specific	O
genes	O
are	O
nonessential	O
,	O
accessory	O
genes	O
.	O

Importantly	O
,	O
all	O
deletion	O
mutant	O
viruses	B-SPEC
were	O
attenuated	O
when	O
inoculated	O
into	O
their	O
natural	O
host	O
,	O
the	O
mouse	B-SPEC
.	O

Therefore	O
,	O
deletion	O
of	O
the	O
coronavirus	B-SPEC
group	I-SPEC
-	O
specific	O
genes	O
seems	O
to	O
provide	O
an	O
attractive	O
approach	O
to	O
generate	O
attenuated	O
live	O
coronavirus	B-SPEC
vaccines	O
.	O

This	O
study	O
assessed	O
hormonal	O
responses	O
to	O
ergotamine	O
in	O
heat	O
-	O
sensitive	O
and	O
heat	O
-	O
tolerant	O
cattle	B-SPEC
.	O

This	O
corroborates	O
our	O
previous	O
conclusion	O
that	O
sufficient	O
amounts	O
of	O
eukaryotic	O
protein	O
co	O
-	O
factors	O
,	O
which	O
could	O
functionally	O
replace	O
IHF	O
,	O
are	O
not	O
present	O
in	O
human	B-SPEC
cells	O
.	O

In	O
mice	B-SPEC
lacking	O
antibody	O
receptors	O
or	O
complement	O
pathway	O
activity	O
,	O
virus	B-SPEC
did	O
not	O
persist	O
yet	O
demyelination	O
was	O
similar	O
to	O
parental	O
mice	B-SPEC
.	O

Sinusitis	O
was	O
also	O
associated	O
with	O
pasteurella	B-SPEC
cultured	O
from	O
the	O
sinus	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
antibody	O
to	O
avian	B-SPEC
pneumovirus	I-SPEC
(	O
APV	B-SPEC
)	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
avian	B-SPEC
coronaviruses	O
as	O
detected	O
by	O
reverse	O
-	O
transcriptase	O
PCR	O
(	O
P	O
<	O
0	O
.	O
05	O
);	O
there	O
was	O
no	O
association	O
between	O
disease	O
and	O
APV	B-SPEC
as	O
detected	O
by	O
PCR	O
.	O

EPEC	O
isolates	O
were	O
examined	O
for	O
pathogenicity	O
and	O
ability	O
to	O
induce	O
AE	O
lesions	O
in	O
experimentally	O
inoculated	O
young	O
turkeys	B-SPEC
.	O

These	O
data	O
indicate	O
that	O
antigenic	O
and	O
genetic	O
diversity	O
among	O
IBV	B-SPEC
isolates	O
existed	O
even	O
in	O
the	O
1940s	O
.	O

This	O
finding	O
suggests	O
that	O
frequent	O
genetic	O
changes	O
are	O
not	O
inherent	O
in	O
all	O
IBV	B-SPEC
genomes	O
.	O

TITLE	O
:	O
Antigenic	O
relationship	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
isolates	O
from	O
different	O
geographic	O
locations	O
in	O
the	O
United	O
States	O
.	O

The	O
prototype	O
TCV	B-SPEC
Minnesota	O
isolate	O
(	O
TCV	B-SPEC
-	O
ATCC	O
)	O
was	O
obtained	O
from	O
the	O
American	O
Type	O
Culture	O
Collection	O
.	O

All	O
18	O
TCV	B-SPEC
isolates	O
have	O
the	O
same	O
antigenic	O
reactivity	O
pattern	O
with	O
the	O
same	O
panel	O
of	O
antibodies	O
.	O

This	O
review	O
concentrates	O
on	O
in	O
vivo	O
studies	O
of	O
cytokine	O
involvement	O
in	O
infectious	O
respiratory	O
diseases	O
of	O
swine	B-SPEC
,	O
with	O
an	O
emphasis	O
on	O
viral	O
infections	O
.	O

ABSTRACT	O
:	O
Reported	O
here	O
is	O
a	O
case	O
of	O
severe	O
necrotizing	O
pneumonia	O
following	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
infection	O
that	O
occurred	O
in	O
a	O
55	O
-	O
year	O
-	O
old	O
man	B-SPEC
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
of	O
pneumonia	O
due	O
to	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
leading	O
to	O
lung	O
transplantation	O
.	O

In	O
this	O
study	O
,	O
the	O
effects	O
of	O
dietary	O
arginine	O
on	O
leukocyte	O
population	O
changes	O
were	O
examined	O
in	O
the	O
peripheral	O
blood	O
and	O
the	O
respiratory	O
tract	O
of	O
chickens	B-SPEC
inoculated	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strain	O
M41	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
of	O
the	O
central	O
nervous	O
system	O
:	O
chemokine	O
-	O
mediated	O
regulation	O
of	O
host	O
defense	O
and	O
disease	O
.	O

MHV	B-SPEC
infection	O
triggers	O
a	O
robust	O
cell	O
-	O
mediated	O
response	O
in	O
which	O
both	O
CD4	O
+	O
and	O
CD8	O
+	O
T	O
cells	O
are	O
essential	O
in	O
controlling	O
viral	O
replication	O
and	O
spread	O
.	O

ABSTRACT	O
:	O
The	O
obesity	O
-	O
hypoventilation	O
syndrome	O
(	O
or	O
alveolar	O
hypoventilation	O
in	O
the	O
obese	O
)	O
is	O
a	O
new	O
name	B-SPEC
for	O
an	O
old	O
syndrome	O
,	O
Pickwickian	O
syndrome	O
.	O

The	O
objective	O
of	O
this	O
experiment	O
was	O
to	O
investigate	O
the	O
therapeutic	O
efficacy	O
of	O
a	O
supplemental	O
bovine	B-SPEC
serum	O
protein	O
blend	O
fed	O
to	O
calves	O
challenged	O
with	O
virulent	O
coronavirus	B-SPEC
.	O

Coronavirus	B-SPEC
challenge	O
resulted	O
in	O
an	O
immediate	O
increase	O
in	O
respiration	O
rate	O
,	O
decreasing	O
by	O
d	O
7	O
.	O

Virulent	O
BCV	B-SPEC
was	O
actively	O
introduced	O
in	O
one	O
of	O
the	O
groups	O
by	O
means	O
of	O
a	O
transmitter	O
calf	O
.	O

This	O
finding	O
supports	O
the	O
principle	O
of	O
the	O
Scandinavian	O
BVDV	B-SPEC
control	O
programmes	O
that	O
elimination	O
of	O
BVDV	B-SPEC
infection	O
from	O
cattle	B-SPEC
populations	O
can	O
be	O
achieved	O
by	O
identifying	O
and	O
removing	O
persistently	O
infected	O
(	O
PI	O
)	O
animals	B-SPEC
,	O
i	O
.	O
e	O
.	O
that	O
long	O
-	O
term	O
circulation	O
of	O
the	O
virus	B-SPEC
without	O
the	O
presence	O
of	O
PI	O
animals	B-SPEC
is	O
highly	O
unlikely	O
.	O

Here	O
,	O
the	O
crystal	O
structure	O
of	O
the	O
33	O
.	O
1	O
kDa	O
transmissible	O
gastroenteritis	O
(	O
corona	B-SPEC
)	O
virus	B-SPEC
M	O
(	O
pro	O
)	O
is	O
reported	O
.	O

We	O
diagnosed	O
miliary	O
tuberculosis	O
because	O
the	O
transbronchial	O
lung	O
biopsy	O
specimen	O
showed	O
caseous	O
granuloma	O
and	O
the	O
PCR	O
test	O
for	O
Mycobacterium	B-SPEC
tuberculosis	I-SPEC
in	O
the	O
bronchoalveolar	O
lavage	O
fluid	O
was	O
positive	O
.	O

This	O
possibility	O
was	O
examined	O
in	O
mice	B-SPEC
infected	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
a	O
well	O
-	O
described	O
model	O
of	O
virus	B-SPEC
-	O
induced	O
demyelination	O
.	O

Coagulation	O
becomes	O
activated	O
by	O
circulating	O
endotoxin	O
or	O
bacteria	B-SPEC
,	O
and	O
a	O
procoagulant	O
state	O
develops	O
in	O
the	O
vascular	O
and	O
the	O
alveolar	O
compartments	O
of	O
the	O
lung	O
.	O

TITLE	O
:	O
Detection	O
of	O
respiratory	O
and	O
enteric	O
shedding	O
of	O
bovine	B-SPEC
coronaviruses	O
in	O
cattle	B-SPEC
in	O
an	O
Ohio	O
feedlot	O
.	O

Thirty	O
-	O
two	O
cattle	B-SPEC
(	O
38	O
%)	O
showed	O
concurrent	O
enteric	O
and	O
nasal	O
shedding	O
detected	O
by	O
both	O
tests	O
.	O

Seroconversion	O
to	O
BCV	B-SPEC
was	O
inversely	O
related	O
to	O
average	O
daily	O
weight	O
gains	O
(	O
P	O
<	O
0	O
.	O
06	O
).	O

The	O
immune	O
response	O
to	O
S	O
protein	O
was	O
barely	O
detectable	O
in	O
naturally	O
infected	O
dogs	B-SPEC
,	O
whereas	O
anti	O
-	O
M	O
and	O
anti	O
-	O
N	O
antibodies	O
were	O
detected	O
with	O
a	O
very	O
strong	O
reaction	O
and	O
for	O
a	O
long	O
time	O
post	O
infection	O
.	O

A	O
lymphoproliferative	O
assay	O
was	O
developed	O
in	O
which	O
mononuclear	O
cells	O
isolated	O
from	O
lymphoid	O
tissues	O
at	O
different	O
postinoculation	O
and	O
postchallenge	O
days	O
underwent	O
a	O
secondary	O
in	O
vitro	O
stimulation	O
with	O
semipurified	O
antigen	O
obtained	O
from	O
PEDV	B-SPEC
-	O
infected	O
cell	O
cultures	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
confirms	O
the	O
presence	O
of	O
a	O
divergent	O
strain	O
of	O
canine	O
coronavirus	B-SPEC
(	O
UWSMN	O
-	O
1	O
)	O
in	O
Australia	O
.	O

Sequencing	O
of	O
various	O
regions	O
of	O
the	O
spike	O
and	O
polymerase	O
genes	O
confirms	O
that	O
UWSMN	O
-	O
1	O
is	O
widely	O
divergent	O
from	O
other	O
CCV	O
and	O
feline	B-SPEC
coronavirus	B-SPEC
strains	O
.	O

ABSTRACT	O
:	O
Three	O
unrecognized	O
field	O
isolates	O
of	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
recovered	O
from	O
commercial	O
broiler	O
chickens	B-SPEC
vaccinated	O
with	O
live	O
Mass	O
viral	O
strain	O
(	O
H120	O
).	O

TITLE	O
:	O
Nucleic	O
acid	O
deletions	O
and	O
copy	O
number	O
in	O
rats	B-SPEC
.	O

Relative	O
abundance	O
was	O
higher	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
in	O
rats	B-SPEC
of	O
the	O
high	O
folate	O
group	O
than	O
in	O
rats	B-SPEC
of	O
the	O
low	O
-	O
folate	O
or	O
folate	O
-	O
replete	O
groups	O
,	O
and	O
was	O
significantly	O
higher	O
in	O
rats	B-SPEC
of	O
the	O
cereal	O
diet	O
group	O
than	O
that	O
in	O
those	O
of	O
the	O
purified	O
diet	O
group	O
.	O

TITLE	O
:	O
Alveolar	O
macrophage	O
activation	O
after	O
trauma	O
-	O
hemorrhage	O
and	O
sepsis	B-SPEC
is	O
dependent	O
on	O
NF	O
-	O
kappaB	O
and	O
MAPK	O
/	O
ERK	O
mechanisms	O
.	O

In	O
control	O
animals	B-SPEC
,	O
AMPhi	O
were	O
stimulated	O
with	O
LPS	O
with	O
or	O
without	O
inhibitors	O
of	O
NF	O
-	O
kappaB	O
and	O
MAPK	O
.	O

TITLE	O
:	O
Weaning	O
from	O
mechanical	O
ventilation	O
by	O
long	O
-	O
term	O
nasal	O
positive	O
pressure	O
ventilation	O
in	O
two	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
associated	O
with	O
pneumococcal	O
sepsis	B-SPEC
.	O

Patients	O
with	O
ONM	O
treated	O
at	O
the	O
Hospital	O
da	O
Lagoa	B-SPEC
,	O
Rio	O
de	O
Janeiro	O
were	O
studied	O
.	O

Major	O
variations	O
were	O
observed	O
in	O
the	O
S1	O
portion	O
of	O
the	O
S	O
gene	O
of	O
both	O
HEV	B-SPEC
strains	O
,	O
with	O
only	O
73	O
/	O
71	O
%	O
amino	O
acid	O
identities	O
compared	O
with	O
those	O
of	O
the	O
two	O
other	O
haemagglutinating	O
coronaviruses	O
.	O

This	O
conserved	O
multifunctional	O
protein	O
is	O
also	O
efficient	O
in	O
inducing	O
NDV	B-SPEC
-	O
specific	O
antibody	O
in	O
chickens	B-SPEC
.	O

These	O
marked	O
-	O
NDV	B-SPEC
recombinants	O
,	O
in	O
conjunction	O
with	O
a	O
diagnostic	O
test	O
,	O
enable	O
serological	O
differentiation	O
of	O
vaccinated	O
animals	B-SPEC
from	O
infected	O
animals	B-SPEC
and	O
may	O
be	O
useful	O
tools	O
in	O
ND	O
eradication	O
programs	O
.	O

Chicken	B-SPEC
embryos	O
were	O
inoculated	O
in	O
ovo	B-SPEC
(	O
chorioallantoic	O
sac	O
)	O
with	O
the	O
Arkansas	O
(	O
Ark	O
)	O
serotype	O
of	O
IBV	B-SPEC
at	O
18	O
days	O
of	O
age	O
.	O

The	O
death	O
of	O
the	O
animal	B-SPEC
was	O
attributed	O
to	O
a	O
neutrophilic	O
and	O
emphysematous	O
colitis	O
that	O
likely	O
was	O
caused	O
by	O
an	O
infection	O
with	O
a	O
Clostridium	B-SPEC
sp	O
.	O

The	O
role	O
of	O
FGF2	O
during	O
spontaneous	O
remyelination	O
was	O
examined	O
using	O
two	O
complementary	O
mouse	B-SPEC
models	O
of	O
experimental	O
demyelination	O
.	O

Mild	O
and	O
severe	O
pancreatitis	O
models	O
in	O
the	O
rat	B-SPEC
.	O

ABSTRACT	O
:	O
Patients	O
with	O
acute	O
lung	O
injury	O
after	O
smoke	O
inhalation	O
often	O
develop	O
pneumonia	O
subsequently	O
complicated	O
by	O
sepsis	B-SPEC
.	O

Acute	O
lung	O
injury	O
was	O
produced	O
by	O
insufflating	O
the	O
lungs	O
with	O
48	O
breaths	O
of	O
cotton	B-SPEC
smoke	O
.	O

After	O
injury	O
and	O
the	O
bacterial	O
challenge	O
,	O
the	O
animals	B-SPEC
were	O
ventilated	O
mechanically	O
with	O
100	O
%	O
oxygen	O
.	O

We	O
examined	O
the	O
contribution	O
of	O
differences	O
in	O
cellular	O
tropism	O
,	O
viral	O
spread	O
,	O
and	O
the	O
immune	O
response	O
to	O
infection	O
to	O
the	O
differential	O
neurovirulence	O
of	O
S	O
(	O
4	O
)	O
R	O
and	O
S	O
(	O
A59	O
)	O
R	O
.	O
MHV	B-SPEC
-	O
4	O
spike	O
-	O
mediated	O
neurovirulence	O
was	O
associated	O
with	O
extensive	O
viral	O
spread	O
in	O
the	O
brain	O
in	O
both	O
neurons	O
and	O
astrocytes	O
.	O

Cells	O
infected	O
with	O
molecularly	O
cloned	O
MHV	B-SPEC
-	O
A59	O
virus	B-SPEC
expressed	O
replicase	O
(	O
gene	O
1	O
)	O
proteins	O
identical	O
to	O
those	O
of	O
laboratory	O
MHV	B-SPEC
-	O
A59	O
.	O

Similarly	O
,	O
two	O
parvoviruses	B-SPEC
,	O
bovine	B-SPEC
parvovirus	I-SPEC
(	O
BPV	B-SPEC
)	O
and	O
minute	B-SPEC
virus	I-SPEC
of	I-SPEC
mice	I-SPEC
(	O
MVM	O
),	O
in	O
1	O
-	O
percent	O
IgG	O
solutions	O
were	O
filtered	O
through	O
20	O
-	O
nm	O
filters	O
.	O

To	O
risk	O
-	O
adjust	O
patients	O
with	O
longer	O
,	O
more	O
severe	O
illnesses	O
like	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
several	O
models	O
of	O
organ	O
dysfunction	O
or	O
failure	O
have	O
become	O
available	O
,	O
including	O
the	O
Multiple	O
Organ	O
Dysfunction	O
Score	O
(	O
MODS	O
),	O
the	O
Sequential	O
Organ	O
Failure	O
Assessment	O
(	O
SOFA	O
),	O
and	O
the	O
Logistic	O
Organ	O
Dysfunction	O
Score	O
(	O
LODS	O
).	O

The	O
consensus	O
transcription	O
-	O
associated	O
sequence	O
of	O
IBV	B-SPEC
,	O
CTTAACAA	O
,	O
was	O
highly	O
conserved	O
in	O
the	O
TCV	B-SPEC
genome	O
with	O
regard	O
to	O
nucleotide	O
sequence	O
and	O
location	O
in	O
terms	O
of	O
the	O
initiation	O
codons	O
of	O
the	O
genes	O
5	O
and	O
N	O
.	O
The	O
similarities	O
between	O
the	O
predicted	O
amino	O
acid	O
sequences	O
of	O
ORFs	O
5a	O
and	O
5b	O
of	O
TCV	B-SPEC
isolates	O
and	O
the	O
homologous	O
genes	O
of	O
IBV	B-SPEC
strains	O
were	O
85	O
.	O
4	O
%	O
to	O
94	O
.	O
0	O
%.	O

The	O
availability	O
of	O
packaging	O
cell	O
lines	O
will	O
significantly	O
facilitate	O
the	O
production	O
of	O
safe	O
TGEV	B-SPEC
-	O
derived	O
vectors	O
for	O
vaccination	O
and	O
possibly	O
gene	O
therapy	O
.	O

To	O
study	O
the	O
phylogenetic	O
relationships	O
of	O
the	O
viruses	B-SPEC
from	O
various	O
outbreaks	O
,	O
studies	O
of	O
molecular	O
epizootiology	O
were	O
performed	O
in	O
Sweden	O
,	O
a	O
Nordic	O
region	O
,	O
where	O
the	O
occurrence	O
of	O
natural	O
cases	O
of	O
the	O
disease	O
is	O
relatively	O
low	O
and	O
the	O
occasional	O
use	O
of	O
live	O
vaccine	O
(	O
s	O
)	O
is	O
well	O
recorded	O
and	O
monitored	O
.	O

ABSTRACT	O
:	O
The	O
role	O
of	O
apoptosis	O
in	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infection	O
is	O
still	O
controversial	O
.	O

MHV	B-SPEC
-	O
A59	O
produces	O
acute	O
hepatitis	O
,	O
meningoencephalitis	O
,	O
and	O
chronic	O
demyelination	O
.	O

We	O
detected	O
apoptosis	O
by	O
electronmicroscopy	O
in	O
olfactory	O
neurons	O
during	O
acute	O
infection	O
with	O
MHV	B-SPEC
-	O
A59	O
.	O

ABSTRACT	O
:	O
The	O
cleavage	O
and	O
fusion	O
properties	O
of	O
recombinant	O
murine	B-SPEC
hepatitis	O
viruses	B-SPEC
(	O
MHV	B-SPEC
)	O
were	O
examined	O
to	O
assess	O
the	O
role	O
of	O
the	O
cleavage	O
signal	O
in	O
determining	O
the	O
extent	O
of	O
S	O
protein	O
cleavage	O
,	O
and	O
the	O
correlation	O
between	O
cleavage	O
and	O
induction	O
of	O
cell	O
-	O
to	O
-	O
cell	O
fusion	O
.	O

A	O
58	O
-	O
kDa	O
fragment	O
,	O
encompassing	O
the	O
two	O
heptad	O
repeats	O
in	O
S2	O
,	O
was	O
detected	O
when	O
srr7	O
was	O
digested	O
after	O
soMHVR	O
treatment	O
,	O
while	O
no	O
band	O
was	O
seen	O
when	O
the	O
virus	B-SPEC
was	O
untreated	O
.	O

Our	O
objective	O
was	O
to	O
determine	O
if	O
fAPN	O
can	O
serve	O
as	O
a	O
receptor	O
for	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Vaccinated	O
cows	B-SPEC
did	O
not	O
develop	O
abnormalities	O
,	O
such	O
as	O
a	O
decrease	O
in	O
milk	O
production	O
volume	O
,	O
and	O
all	O
pregnant	O
animals	B-SPEC
calved	O
normally	O
.	O

Controls	O
were	O
pigs	B-SPEC
without	O
clinical	O
signs	O
and	O
histopathological	O
lesions	O
typical	O
of	O
PMWS	O
.	O

Risk	O
for	O
PWMS	O
was	O
much	O
higher	O
(	O
OR	O
=	O
31	O
.	O
2	O
,	O
P	O
=	O
0	O
.	O
0009	O
)	O
if	O
the	O
animal	B-SPEC
was	O
concurrently	O
infected	O
with	O
PCV2	O
and	O
PRRSV	B-SPEC
,	O
suggesting	O
that	O
development	O
of	O
PMWS	O
may	O
be	O
enhanced	O
by	O
cofactor	O
(	O
s	O
).	O

Sentinel	O
pigs	B-SPEC
were	O
commingled	O
with	O
the	O
PRCV	O
-	O
infected	O
pigs	B-SPEC
at	O
8	O
weeks	O
after	O
exposure	O
,	O
and	O
no	O
virus	B-SPEC
transmission	O
occurred	O
.	O

Persistent	O
adenoviral	B-SPEC
infections	O
need	O
not	O
be	O
accompanied	O
by	O
any	O
special	O
clinical	O
symptomatology	O
.	O

The	O
results	O
indicate	O
that	O
the	O
canonical	O
coronavirus	B-SPEC
genome	O
organization	O
is	O
not	O
essential	O
for	O
replication	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

TITLE	O
:	O
Gastric	O
gross	O
and	O
microscopic	O
lesions	O
caused	O
by	O
the	O
UNAM	O
-	O
97	O
variant	O
strain	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
after	O
the	O
eighth	O
passage	O
in	O
specific	O
pathogen	O
-	O
free	O
chicken	B-SPEC
embryos	O
.	O

ABSTRACT	O
:	O
Herein	O
we	O
report	O
a	O
description	O
of	O
gross	O
and	O
microscopic	O
lesions	O
found	O
in	O
specific	O
pathogen	O
-	O
free	O
chicken	B-SPEC
embryos	O
caused	O
by	O
UNAM	O
-	O
97	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
variant	O
strain	O
after	O
the	O
eighth	O
passage	O
.	O

ABSTRACT	O
:	O
Arteri	O
-,	O
corona	B-SPEC
-,	O
toro	O
-	O
and	O
roniviruses	O
are	O
evolutionarily	O
related	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
,	O
united	O
in	O
the	O
order	B-SPEC
Nidovirales	I-SPEC
.	O

We	O
show	O
that	O
BEV	B-SPEC
mRNAs	O
3	O
-	O
5	O
lack	O
a	O
leader	O
sequence	O
.	O

Apparently	O
,	O
BEV	B-SPEC
combines	O
discontinuous	O
and	O
non	O
-	O
discontinuous	O
RNA	O
synthesis	O
to	O
produce	O
its	O
sg	O
mRNAs	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effects	O
of	O
surfactant	O
treatment	O
on	O
oxygenation	O
in	O
8	O
infants	O
(	O
age	O
range	O
:	O
1	O
mo	O
to	O
13	O
y	O
)	O
with	O
severe	O
respiratory	O
failure	O
owing	O
to	O
viral	O
,	O
bacterial	O
or	O
Pneumocystis	B-SPEC
Carinii	I-SPEC
pneumonia	O
.	O

ABSTRACT	O
:	O
Gemcitabine	O
is	O
used	O
to	O
treat	O
solid	O
tumours	O
such	O
as	O
non	O
small	O
-	O
cell	O
lung	O
cancer	B-SPEC
.	O

The	O
role	O
of	O
chemokine	O
receptor	O
CCR5	O
in	O
trafficking	O
of	O
virus	B-SPEC
-	O
specific	O
CD4	O
(+)	O
T	O
cells	O
into	O
the	O
CNS	O
of	O
MHV	B-SPEC
-	O
infected	O
mice	B-SPEC
was	O
investigated	O
.	O

Conversely	O
,	O
CD4	O
(+)	O
T	O
cells	O
from	O
CCR5	O
(-/-)	O
mice	B-SPEC
displayed	O
an	O
impaired	O
ability	O
to	O
traffic	O
into	O
the	O
CNS	O
of	O
MHV	B-SPEC
-	O
infected	O
RAG1	O
(-/-)	O
recipients	O
,	O
which	O
correlated	O
with	O
increased	O
viral	O
titers	O
,	O
diminished	O
macrophage	O
accumulation	O
,	O
and	O
limited	O
demyelination	O
.	O

We	O
observed	O
that	O
both	O
the	O
full	O
-	O
length	O
and	O
the	O
truncated	O
PTB	O
,	O
when	O
overexpressed	O
,	O
functioned	O
in	O
a	O
dominant	O
-	O
negative	O
manner	O
in	O
MHV	B-SPEC
replication	O
.	O

However	O
,	O
the	O
truncated	O
form	O
exhibited	O
more	O
severe	O
effects	O
on	O
syncytia	O
formation	O
,	O
virus	B-SPEC
production	O
,	O
and	O
synthesis	O
of	O
viral	O
RNA	O
and	O
viral	O
proteins	O
.	O

ABSTRACT	O
:	O
A	O
7	O
-	O
year	O
-	O
old	O
boy	O
with	O
Down	O
syndrome	O
developed	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
after	O
a	O
respiratory	O
infection	O
with	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
with	O
an	O
unusually	O
high	O
agglutination	O
titre	O
(	O
1	O
:	O
10240	O
).	O

CONCLUSIONS	O
:	O
our	O
case	O
suggests	O
that	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
should	O
be	O
considered	O
as	O
an	O
aetiological	O
agent	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

TITLE	O
:	O
Nephropathogenic	O
infectious	O
bronchitis	O
in	O
Pennsylvania	O
chickens	B-SPEC
1997	O
-	O
2000	O
.	O

ABSTRACT	O
:	O
Protection	O
provided	O
by	O
live	O
and	O
inactivated	O
virus	B-SPEC
vaccination	O
against	O
challenge	O
with	O
the	O
virulent	O
nephropathogenic	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
NIBV	O
)	O
strain	O
PA	O
/	O
Wolgemuth	O
/	O
98	O
was	O
assessed	O
.	O

Live	O
IBV	B-SPEC
-	O
primed	O
chickens	B-SPEC
vaccinated	O
with	O
an	O
autogenous	O
inactivated	O
PA	O
/	O
Wolgemuth	O
/	O
98	O
vaccine	O
had	O
the	O
highest	O
protection	O
against	O
homologous	O
virulent	O
NIBV	O
challenge	O
on	O
the	O
basis	O
of	O
virus	B-SPEC
isolation	O
.	O

A	O
prospective	O
longitudinal	O
study	O
was	O
conducted	O
by	O
collecting	O
farm	O
data	O
and	O
monitoring	O
weekly	O
mortality	O
in	O
54	O
commercial	O
turkey	B-SPEC
flocks	O
raised	O
in	O
PEMS	O
-	O
affected	O
regions	O
.	O

A	O
chicken	B-SPEC
usually	O
lays	O
about	O
280	O
eggs	O
in	O
a	O
year	O
,	O
and	O
egg	O
yolk	O
contains	O
100	O
-	O
150	O
mg	O
of	O
IgY	O
per	O
yolk	O
,	O
suggesting	O
that	O
more	O
than	O
40	O
g	O
of	O
IgY	O
per	O
year	O
can	O
be	O
obtained	O
from	O
each	O
chicken	B-SPEC
through	O
eggs	O
.	O

TITLE	O
:	O
Conformational	O
changes	O
in	O
the	O
spike	O
glycoprotein	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
are	O
induced	O
at	O
37	O
degrees	O
C	O
either	O
by	O
soluble	O
murine	B-SPEC
CEACAM1	O
receptors	O
or	O
by	O
pH	O
8	O
.	O

We	O
used	O
liposome	O
flotation	O
and	O
protease	O
sensitivity	O
assays	O
to	O
investigate	O
the	O
mechanism	O
of	O
receptor	O
-	O
induced	O
,	O
temperature	O
-	O
dependent	O
virus	B-SPEC
neutralization	O
.	O

Surprisingly	O
,	O
the	O
S	O
protein	O
of	O
recombinant	O
MHV	B-SPEC
-	O
A59	O
virions	O
with	O
a	O
mutation	O
,	O
H716D	O
,	O
that	O
precluded	O
cleavage	O
between	O
S1	O
and	O
S2	O
could	O
also	O
be	O
triggered	O
to	O
undergo	O
a	O
conformational	O
change	O
at	O
37	O
degrees	O
C	O
by	O
soluble	O
receptor	O
at	O
neutral	O
pH	O
or	O
by	O
pH	O
8	O
alone	O
.	O

In	O
BHK	O
cells	O
expressing	O
mCEACAM1	O
(	O
b	O
),	O
only	O
viruses	B-SPEC
expressing	O
chimeric	O
spikes	O
with	O
the	O
MHV	B-SPEC
-	O
A59	O
RBD	O
could	O
replicate	O
,	O
while	O
replication	O
of	O
viruses	B-SPEC
expressing	O
chimeric	O
spikes	O
with	O
the	O
MHV	B-SPEC
-	O
4	O
RBD	O
was	O
undetectable	O
.	O

ABSTRACT	O
:	O
The	O
genetic	O
diversity	O
of	O
16	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
samples	O
is	O
described	O
.	O

The	O
second	O
cluster	O
segregated	O
separately	O
from	O
CCoV	O
and	O
feline	B-SPEC
coronavirus	B-SPEC
genotypes	O
and	O
therefore	O
these	O
samples	O
may	O
represent	O
genetic	O
outliers	O
.	O

The	O
virus	B-SPEC
was	O
detected	O
intermittently	O
in	O
the	O
pups	O
'	O
faeces	O
by	O
PCR	O
for	O
periods	O
of	O
156	O
and	O
146	O
days	O
,	O
respectively	O
.	O

TITLE	O
:	O
Role	O
of	O
viruses	B-SPEC
and	O
atypical	O
bacteria	B-SPEC
in	O
exacerbations	O
of	O
asthma	O
in	O
hospitalized	O
children	O
:	O
a	O
prospective	O
study	O
in	O
the	O
Nord	O
-	O
Pas	O
de	O
Calais	O
region	O
(	O
France	O
).	O

ABSTRACT	O
:	O
We	O
studied	O
the	O
role	O
of	O
viruses	B-SPEC
and	O
atypical	O
bacteria	B-SPEC
in	O
children	O
hospitalized	O
with	O
exacerbated	O
asthma	O
by	O
a	O
prospective	O
study	O
of	O
children	O
with	O
acute	O
asthma	O
admitted	O
to	O
the	O
Department	O
of	O
Pediatrics	O
in	O
Lille	O
,	O
and	O
to	O
15	O
hospitals	O
in	O
the	O
Nord	O
-	O
Pas	O
de	O
Calais	O
region	O
,	O
from	O
October	O
1	O
,	O
1998	O
-	O
June	O
30	O
,	O
1999	O
.	O

Immunofluorescence	O
assays	O
(	O
IFA	O
)	O
on	O
nasopharyngeal	O
secretions	O
(	O
NPS	O
),	O
serological	O
tests	O
,	O
or	O
both	O
,	O
were	O
used	O
for	O
detection	O
of	O
influenza	B-SPEC
virus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
adenovirus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
.	O

Unfortunately	O
,	O
turkey	B-SPEC
abundance	O
has	O
declined	O
in	O
the	O
southern	O
Edwards	O
Plateau	O
since	O
the	O
late	O
1970s	O
.	O

The	O
purposes	O
of	O
this	O
study	O
were	O
to	O
assess	O
the	O
occurrence	O
of	O
RV	O
,	O
enterovirus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
infections	O
in	O
wheezing	O
infants	O
and	O
to	O
evaluate	O
the	O
association	O
of	O
these	O
viral	O
findings	O
with	O
early	O
school	O
-	O
age	O
asthma	O
.	O

As	O
single	O
viral	O
findings	O
,	O
rhinoviruses	B-SPEC
were	O
associated	O
with	O
the	O
development	O
of	O
asthma	O
(	O
P	O
=.	O
047	O
;	O
odds	O
ratio	O
,	O
4	O
.	O
14	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
02	O
-	O
16	O
.	O
77	O
versus	O
rhinovirus	B-SPEC
-	O
negative	O
cases	O
[	O
by	O
logistic	O
regression	O
adjusted	O
for	O
age	O
,	O
sex	O
,	O
and	O
atopic	O
dermatitis	O
on	O
entry	O
)].	O

CONCLUSIONS	O
:	O
Our	O
results	O
present	O
rhinoviruses	B-SPEC
as	O
important	O
inducers	O
of	O
wheezing	O
even	O
in	O
infancy	O
.	O

ABSTRACT	O
:	O
Twenty	O
-	O
nine	O
isolates	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
recovered	O
from	O
commercial	O
chicken	B-SPEC
flocks	O
in	O
California	B-SPEC
between	O
1988	O
and	O
2001	O
and	O
identified	O
as	O
California	B-SPEC
variants	O
by	O
serotype	O
and	O
direct	O
automated	O
cycle	O
sequencing	O
of	O
the	O
IBV	B-SPEC
spike	O
glycoprotein	O
S1	O
subunit	O
,	O
were	O
further	O
characterized	O
phylogenetically	O
and	O
by	O
nucleotide	O
sequence	O
comparison	O
.	O

Five	O
and	O
a	O
half	O
-	O
week	O
-	O
old	O
K	O
-	O
strain	O
chickens	B-SPEC
infected	O
with	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
served	O
as	O
the	O
model	O
for	O
these	O
experiments	O
.	O

The	O
greatest	O
enhancement	O
of	O
NK	O
cytotoxicity	O
was	O
observed	O
at	O
10	O
days	O
post	O
-	O
infection	O
in	O
those	O
chickens	B-SPEC
that	O
began	O
receiving	O
thymulin	O
after	O
infection	O
.	O

CBA	O
/	O
J	O
mice	B-SPEC
infected	O
with	O
1	O
x	O
10	O
(	O
6	O
)	O
plaque	O
-	O
forming	O
units	O
(	O
pfu	O
)	O
reovirus	B-SPEC
1	O
/	O
L	O
develop	O
follicular	O
bronchiolitis	O
and	O
intra	O
-	O
alveolar	O
fibrosis	O
similar	O
to	O
BOOP	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
determine	O
future	O
applications	O
of	O
these	O
therapies	O
in	O
humans	B-SPEC
.	O

Agents	O
with	O
zoonotic	O
potential	O
were	O
detected	O
in	O
feces	O
from	O
21	O
(	O
16	O
.	O
2	O
%)	O
of	O
130	O
dogs	B-SPEC
and	O
included	O
Giardia	B-SPEC
spp	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
uses	O
human	B-SPEC
aminopeptidase	O
N	O
(	O
hAPN	O
)	O
as	O
its	O
receptor	O
(	O
C	O
.	O
L	O
.	O
Yeager	O
et	O
al	O
.,	O
Nature	O
357	O
:	O
420	O
-	O
422	O
,	O
1992	O
).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
were	O
detected	O
and	O
differentiated	O
in	O
formalin	O
-	O
fixed	O
,	O
paraffin	O
-	O
embedded	O
tissues	O
from	O
experimentally	O
and	O
naturally	O
infected	O
pigs	B-SPEC
by	O
multiplex	O
reverse	O
transcription	O
-	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
nPCR	O
).	O

PEDV	B-SPEC
and	O
TGEV	B-SPEC
cDNAs	O
were	O
detected	O
in	O
jejunal	O
tissues	O
from	O
experimentally	O
and	O
naturally	O
infected	O
pigs	B-SPEC
by	O
multiplex	O
RT	O
-	O
nPCR	O
.	O

The	O
rate	O
of	O
conformity	O
between	O
multiplex	O
RT	O
-	O
nPCR	O
and	O
in	O
situ	O
hybridization	O
was	O
100	O
%	O
for	O
the	O
detection	O
of	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
in	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
jejunal	O
tissues	O
.	O

In	O
this	O
report	O
we	O
show	O
that	O
expressed	O
coronavirus	B-SPEC
envelope	O
protein	O
M	O
specifically	O
interacted	O
with	O
coexpressed	O
noncoronavirus	O
RNA	O
transcripts	O
containing	O
the	O
short	O
viral	O
packaging	O
signal	O
in	O
the	O
absence	O
of	O
coronavirus	B-SPEC
N	O
protein	O
.	O

HHV8	B-SPEC
infection	O
was	O
not	O
significantly	O
higher	O
in	O
men	O
(	O
9	O
.	O
0	O
%,	O
95	O
%	O
CI	O
:	O
3	O
.	O
4	O
-	O
14	O
.	O
6	O
)	O
than	O
in	O
women	O
(	O
6	O
.	O
0	O
%,	O
95	O
%	O
CI	O
:	O
1	O
.	O
3	O
-	O
10	O
.	O
7	O
).	O

The	O
seemingly	O
higher	O
incidence	O
of	O
KS	O
among	O
HHV8	B-SPEC
-	O
positive	O
men	O
suggests	O
that	O
different	O
cofactors	O
for	O
the	O
two	O
sexes	O
are	O
likely	O
to	O
play	O
a	O
role	O
in	O
KS	O
etiology	O
.	O

The	O
estimated	O
yearly	O
incidence	O
rate	O
of	O
KS	O
among	O
HHV	B-SPEC
-	O
positive	O
persons	O
was	O
twice	O
as	O
high	O
in	O
men	O
(	O
1	O
:	O
2200	O
)	O
as	O
in	O
women	O
(	O
1	O
:	O
4110	O
).	O

In	O
this	O
study	O
,	O
108	O
episodes	O
of	O
severe	O
anemia	B-SPEC
were	O
prospectively	O
evaluated	O
in	O
108	O
patients	O
with	O
hemoglobin	O
SS	O
disease	O
attending	O
the	O
pediatric	O
sickle	O
cell	O
clinic	O
of	O
the	O
University	O
of	O
Nigeria	O
Teaching	O
Hospital	O
,	O
Enugu	O
,	O
Nigeria	O
.	O

Upper	O
respiratory	O
tract	O
infections	O
are	O
the	O
most	O
commonly	O
associated	O
infections	O
in	O
patients	O
with	O
severe	O
anemia	B-SPEC
.	O

When	O
she	O
was	O
admitted	O
to	O
our	O
hospital	O
on	O
August	O
11	O
,	O
she	O
revealed	O
severe	O
hypoxemia	O
and	O
the	O
titer	O
to	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
was	O
markedly	O
elevated	O
.	O

She	O
was	O
treated	O
by	O
sparfloxacin	O
because	O
the	O
intrafamilial	O
infection	O
of	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
was	O
most	O
likely	O
.	O

However	O
,	O
the	O
highest	O
value	O
was	O
found	O
in	O
chickens	B-SPEC
inoculated	O
after	O
12	O
h	O
of	O
activity	O
.	O

Thus	O
,	O
an	O
inverse	O
relation	O
exists	O
between	O
the	O
MBL	O
response	O
and	O
the	O
IBV	B-SPEC
specific	O
antibody	O
response	O
.	O

The	O
complement	O
activation	O
was	O
directly	O
associated	O
with	O
the	O
concentration	O
of	O
MBL	O
in	O
serum	O
,	O
indicating	O
neutralization	O
of	O
the	O
virus	B-SPEC
before	O
the	O
humoral	O
antibody	O
response	O
took	O
over	O
.	O

Because	O
neutrophils	O
appear	O
to	O
play	O
a	O
major	O
role	O
in	O
the	O
development	O
of	O
ALI	O
,	O
we	O
examined	O
the	O
relationships	O
between	O
clinical	O
outcome	O
and	O
activation	O
of	O
NF	O
-	O
kappaB	O
in	O
peripheral	O
neutrophils	O
from	O
patients	O
(	O
n	O
=	O
30	O
)	O
with	O
sepsis	B-SPEC
-	O
induced	O
ALI	O
.	O

Infection	O
of	O
neutropenic	O
animals	B-SPEC
resulted	O
in	O
increased	O
levels	O
of	O
virus	B-SPEC
replication	O
and	O
mortality	O
compared	O
with	O
control	O
mice	B-SPEC
.	O

These	O
data	O
suggest	O
that	O
infiltrating	O
neutrophils	O
are	O
crucial	O
for	O
limiting	O
virus	B-SPEC
replication	O
during	O
acute	O
JHMV	O
infection	O
,	O
contribute	O
to	O
the	O
loss	O
of	O
blood	O
brain	O
barrier	O
integrity	O
and	O
play	O
a	O
role	O
in	O
shaping	O
adaptive	O
immunity	O
within	O
the	O
CNS	O
.	O

Viral	O
distribution	O
in	O
tissues	O
of	O
susceptible	O
S	O
and	O
resistant	O
W	O
chicks	O
did	O
not	O
differ	O
,	O
and	O
virus	B-SPEC
was	O
present	O
in	O
the	O
trachea	B-SPEC
,	O
lung	O
and	O
kidney	O
of	O
chicks	O
from	O
both	O
lines	O
throughout	O
the	O
acute	O
phase	O
(	O
between	O
days	O
3	O
and	O
7	O
)	O
of	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
genome	O
of	O
the	O
coronavirus	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
has	O
been	O
engineered	O
as	O
an	O
expression	O
vector	O
with	O
an	O
infectious	O
cDNA	O
.	O

The	O
engineering	O
of	O
an	O
additional	O
insertion	O
site	O
for	O
the	O
heterologous	O
gene	O
between	O
viral	O
genes	O
N	O
and	O
7	O
led	O
to	O
instability	O
and	O
to	O
a	O
new	O
genetic	O
organization	O
of	O
the	O
3	O
'	O
end	O
of	O
the	O
recombinant	O
viruses	B-SPEC
.	O

As	O
a	O
consequence	O
,	O
a	O
major	O
species	B-SPEC
of	O
subgenomic	O
mRNA	O
was	O
generated	O
from	O
a	O
TRS	O
with	O
the	O
noncanonical	O
core	O
sequence	O
5	O
'-	O
CUAAAA	O
-	O
3	O
'.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
:	O
receptor	O
binding	O
domain	O
and	O
neutralization	O
by	O
soluble	O
receptor	O
at	O
37	O
degrees	O
C	O
.	O
ABSTRACT	O
:	O
Truncated	O
human	B-SPEC
coronavirus	I-SPEC
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
spike	O
glycoproteins	O
containing	O
amino	O
acids	O
407	O
to	O
547	O
bound	O
to	O
purified	O
,	O
soluble	O
virus	B-SPEC
receptor	O
,	O
human	B-SPEC
aminopeptidase	O
N	O
(	O
hAPN	O
).	O

TITLE	O
:	O
Pulmonary	O
expression	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
in	O
sepsis	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
we	O
examined	O
the	O
role	O
of	O
inducible	O
nitric	O
oxide	O
synthase	O
(	O
iNOS	O
)	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
in	O
sheep	B-SPEC
with	O
severe	O
combined	O
burn	O
and	O
smoke	O
inhalation	O
injury	O
.	O

Treatment	O
of	O
injured	O
sheep	B-SPEC
with	O
BBS	O
-	O
2	O
attenuated	O
the	O
increases	O
in	O
tracheal	O
blood	O
flow	O
and	O
plasma	O
NOx	O
levels	O
,	O
and	O
significantly	O
attenuated	O
all	O
the	O
pulmonary	O
pathologies	O
that	O
were	O
noted	O
.	O

We	O
describe	O
here	O
the	O
development	O
and	O
use	O
of	O
a	O
reverse	O
genetics	O
strategy	O
for	O
FIPV	O
based	O
on	O
targeted	O
RNA	O
recombination	O
that	O
is	O
analogous	O
to	O
what	O
has	O
been	O
described	O
for	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
(	O
L	O
.	O
Kuo	O
et	O
al	O
.,	O
J	O
.	O
Virol	O
.	O
74	O
:	O
1393	O
-	O
1406	O
,	O
2000	O
).	O

We	O
have	O
previously	O
generated	O
E	O
gene	O
mutants	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
that	O
had	O
marked	O
defects	O
in	O
viral	O
growth	O
and	O
produced	O
virions	O
that	O
were	O
aberrantly	O
assembled	O
in	O
comparison	O
to	O
wild	O
-	O
type	O
virions	O
.	O

ABSTRACT	O
:	O
Replication	O
of	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
within	O
the	O
central	O
nervous	O
system	O
is	O
controlled	O
by	O
cellular	O
immunity	O
.	O

ABSTRACT	O
:	O
Recombinant	O
murine	B-SPEC
coronaviruses	O
,	O
differing	O
only	O
in	O
the	O
spike	O
gene	O
and	O
containing	O
the	O
strain	O
A59	O
(	O
moderately	O
hepatotropic	O
)	O
and	O
JHM	O
(	O
neurotropic	O
)	O
spike	O
genes	O
in	O
the	O
background	O
of	O
the	O
JHM	O
genome	O
,	O
were	O
compared	O
for	O
the	O
ability	O
to	O
replicate	O
in	O
the	O
liver	O
and	O
induce	O
hepatitis	O
in	O
weanling	O
C57BL	O
/	O
6	O
mice	B-SPEC
.	O

TITLE	O
:	O
Viruses	B-SPEC
causing	O
gastroenteritis	O
.	O

TITLE	O
:	O
Bystander	O
CD4	O
T	O
cells	O
do	O
not	O
mediate	O
demyelination	O
in	O
mice	B-SPEC
infected	O
with	O
a	O
neurotropic	O
coronavirus	B-SPEC
.	O

It	O
has	O
been	O
demonstrated	O
that	O
MHV	B-SPEC
-	O
specific	O
CD4	O
and	O
CD8	O
T	O
cells	O
are	O
capable	O
of	O
causing	O
demyelination	O
independent	O
of	O
the	O
other	O
T	O
cell	O
subset	O
.	O

No	O
PCR	O
products	O
were	O
amplified	O
from	O
unrelated	O
avian	B-SPEC
viruses	B-SPEC
and	O
negative	O
controls	O
.	O

More	O
importantly	O
,	O
similar	O
changes	O
have	O
been	O
reported	O
in	O
humans	B-SPEC
with	O
a	O
history	O
of	O
chronic	O
alcohol	O
abuse	O
.	O

Failure	O
of	O
adrenocorticotropic	O
hormone	O
to	O
augment	O
plasma	O
cortisol	O
appears	O
to	O
be	O
a	O
poor	O
prognostic	O
finding	O
in	O
vasopressor	O
-	O
dependent	O
sepsis	B-SPEC
and	O
may	O
indicate	O
""""	O
relative	O
adrenal	O
insufficiency	O
.	O

Some	O
patients	O
with	O
pressor	O
-	O
dependent	O
severe	O
sepsis	B-SPEC
appear	O
to	O
have	O
relative	O
adrenal	O
insufficiency	O
and	O
benefit	O
from	O
replacement	O
glucocorticoid	O
/	O
mineralocorticoid	O
therapy	O
.	O

Studies	O
of	O
HPA	O
axis	B-SPEC
activation	O
and	O
the	O
role	O
of	O
relative	O
adrenal	O
insufficiency	O
on	O
the	O
outcome	O
of	O
patients	O
with	O
acute	O
lung	O
injury	O
are	O
needed	O
.	O

Increased	O
pulmonary	O
vascular	O
permeability	O
and	O
leukocyte	O
accumulation	O
have	O
been	O
successfully	O
prevented	O
in	O
animals	B-SPEC
treated	O
with	O
tissue	O
factor	O
/	O
activated	O
factor	O
VII	O
pathway	O
inhibitor	O
.	O

Antithrombin	O
administration	O
in	O
animals	B-SPEC
has	O
shown	O
consistent	O
benefits	O
with	O
ALI	O
,	O
but	O
clinical	O
studies	O
have	O
failed	O
to	O
demonstrate	O
reductions	O
in	O
mortality	O
and	O
lung	O
injury	O
.	O

Activated	O
protein	O
C	O
administration	O
has	O
been	O
shown	O
to	O
improve	O
survival	O
and	O
lung	O
function	O
in	O
both	O
animal	B-SPEC
and	O
clinical	O
studies	O
.	O

Finally	O
,	O
plasminogen	O
activators	O
may	O
improve	O
gas	O
exchange	O
in	O
ALI	O
,	O
but	O
studies	O
in	O
humans	B-SPEC
are	O
limited	O
.	O

Sepsis	B-SPEC
and	O
its	O
sequelae	O
represent	O
a	O
continuum	O
of	O
clinical	O
syndrome	O
encompassing	O
systemic	O
inflammation	O
,	O
coagulopathy	O
,	O
and	O
hemodynamic	O
abnormalities	O
.	O

Severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
continue	O
to	O
be	O
the	O
major	O
causes	O
of	O
morbidity	O
and	O
mortality	O
in	O
the	O
United	O
States	O
;	O
sepsis	B-SPEC
deaths	O
currently	O
match	O
mortality	O
from	O
myocardial	O
infarction	O
.	O

MHV	B-SPEC
-	O
2	O
was	O
injected	O
intraperitoneally	O
into	O
4	O
-	O
week	O
-	O
old	O
ICR	O
mice	B-SPEC
,	O
IFN	O
or	O
the	O
vehicle	O
was	O
administered	O
intramuscularly	O
for	O
5	O
days	O
,	O
and	O
the	O
antiviral	O
effect	O
was	O
evaluated	O
based	O
on	O
survival	O
periods	O
,	O
liver	O
histology	O
,	O
serum	O
alanine	O
transaminase	O
(	O
ALT	O
)	O
levels	O
,	O
and	O
MHV	B-SPEC
-	O
2	O
virus	B-SPEC
titers	O
in	O
the	O
liver	O
tissues	O
.	O

This	O
is	O
consistent	O
with	O
the	O
lower	O
levels	O
of	O
hepatocellular	O
necrosis	O
and	O
serum	O
ALT	O
and	O
the	O
decreased	O
titers	O
of	O
MHV	B-SPEC
-	O
2	O
virus	B-SPEC
in	O
the	O
liver	O
tissues	O
(	O
48	O
hr	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
72	O
hr	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

This	O
virus	B-SPEC
may	O
never	O
before	O
have	O
circulated	O
in	O
the	O
U	O
.	O
S	O
.	O
population	O
.	O

A	O
novel	B-SPEC
coronavirus	I-SPEC
is	O
associated	O
with	O
this	O
outbreak	O
,	O
and	O
the	O
evidence	O
indicates	O
that	O
this	O
virus	B-SPEC
has	O
an	O
etiologic	O
role	O
in	O
SARS	O
.	O

TITLE	O
:	O
Transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
gene	O
7	O
is	O
not	O
essential	O
but	O
influences	O
in	O
vivo	O
virus	B-SPEC
replication	O
and	O
virulence	O
.	O

Interestingly	O
,	O
in	O
vivo	O
infections	O
with	O
rTGEV	O
-	O
delta7	O
showed	O
an	O
additional	O
reduction	O
in	O
virus	B-SPEC
replication	O
in	O
the	O
lung	O
and	O
gut	O
,	O
and	O
in	O
virulence	O
,	O
indicating	O
that	O
TGEV	B-SPEC
gene	O
7	O
influences	O
virus	B-SPEC
pathogenesis	O
.	O

TITLE	O
:	O
Recombinant	O
M	O
protein	O
-	O
based	O
ELISA	O
test	O
for	O
detection	O
of	O
antibodies	O
to	O
canine	O
coronavirus	B-SPEC
.	O

Coagulopathy	O
was	O
attenuated	O
,	O
and	O
plasma	O
interleukin	O
-	O
6	O
,	O
interleukin	O
-	O
8	O
,	O
and	O
soluble	O
tumor	O
necrosis	O
factor	O
receptor	O
-	O
1	O
levels	O
were	O
significantly	O
lower	O
in	O
the	O
treated	O
animals	B-SPEC
.	O

TITLE	O
:	O
In	O
vitro	O
and	O
in	O
ovo	B-SPEC
expression	O
of	O
chicken	B-SPEC
gamma	O
interferon	O
by	O
a	O
defective	O
RNA	O
of	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

D	O
-	O
RNA	O
CD	O
-	O
61	O
derived	O
from	O
the	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
was	O
used	O
as	O
an	O
RNA	O
vector	O
for	O
the	O
expression	O
of	O
chicken	B-SPEC
gamma	O
interferon	O
(	O
chIFN	O
-	O
gamma	O
).	O

TITLE	O
:	O
Characterization	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
that	O
first	O
manifested	O
in	O
humans	B-SPEC
in	O
China	O
in	O
November	O
2002	O
and	O
has	O
subsequently	O
spread	O
worldwide	O
.	O

In	O
summary	O
,	O
BoTV	O
was	O
detected	O
in	O
fecal	O
samples	O
from	O
cattle	B-SPEC
with	O
diarrhea	O
,	O
principally	O
in	O
young	O
calves	O
less	O
than	O
3	O
weeks	O
of	O
age	O
.	O

This	O
is	O
characterised	O
by	O
fever	O
of	O
sudden	O
onset	O
lasting	O
for	O
more	O
than	O
5	O
days	O
,	O
rapidly	O
changing	O
consolidations	O
in	O
chest	O
x	O
-	O
ray	B-SPEC
not	O
affected	O
by	O
antimicrobial	O
therapy	O
,	O
leuko	O
-,	O
lympho	O
-	O
as	O
well	O
as	O
thrombopenia	O
with	O
a	O
compromised	O
pulmonary	O
function	O
later	O
in	O
the	O
course	O
.	O

After	O
germination	O
on	O
the	O
ER	O
membrane	O
,	O
the	O
viruses	B-SPEC
entered	O
the	O
matrix	O
of	O
the	O
ER	O
lake	B-SPEC
to	O
mature	O
and	O
were	O
eventually	O
excreted	O
to	O
the	O
extracellular	O
space	O
.	O

CONCLUSIONS	O
:	O
The	O
ER	O
lakes	O
are	O
involved	O
in	O
the	O
maturation	O
of	O
the	O
viruses	B-SPEC
,	O
and	O
the	O
envelop	O
and	O
nuclear	O
capsid	O
of	O
the	O
virus	B-SPEC
entering	O
the	O
cells	O
from	O
extracellular	O
space	O
are	O
removed	O
and	O
degraded	O
in	O
the	O
endosome	O
/	O
lysosome	O
.	O

The	O
Result	O
of	O
Blast	O
shows	O
only	O
the	O
difference	O
in	O
one	O
nucleic	O
acid	O
from	O
the	O
TOR2	O
strain	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

It	O
is	O
postulated	O
that	O
these	O
two	O
elements	O
function	O
similarly	O
in	O
the	O
virus	B-SPEC
genome	O
.	O

We	O
investigated	O
whether	O
granulocyte	O
colony	O
-	O
stimulating	O
factor	O
(	O
25	O
microg	O
x	O
kg	O
(-	O
1	O
)	O
x	O
day	O
(-	O
1	O
),	O
4	O
days	O
)	O
enhanced	O
endotracheal	O
bleomycin	O
-	O
induced	O
(	O
5	O
mg	O
/	O
kg	O
)	O
acute	O
lung	O
injury	O
and	O
fibrosis	O
in	O
rats	B-SPEC
.	O

Lung	O
morphology	O
with	O
bleomycin	O
+	O
granulocyte	O
colony	O
-	O
stimulating	O
factor	O
showed	O
,	O
in	O
addition	O
to	O
the	O
changes	O
observed	O
with	O
bleomycin	O
alone	O
,	O
four	O
patterns	O
indicating	O
more	O
severe	O
disease	O
:	O
honeycomb	B-SPEC
foci	O
,	O
pleural	O
thickening	O
with	O
hyaline	O
fibrosis	O
,	O
interstitial	O
granuloma	O
with	O
increased	O
number	O
of	O
macrophages	O
but	O
not	O
neutrophils	O
,	O
and	O
established	O
interstitial	O
fibrosis	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
test	O
the	O
safety	O
and	O
efficacy	O
of	O
the	O
DeltaStream	O
pump	O
for	O
ECMO	O
in	O
animals	B-SPEC
with	O
normal	O
lung	O
function	O
and	O
experimental	O
acute	O
lung	O
injury	O
(	O
ALI	O
).	O

TITLE	O
:	O
Detection	O
of	O
a	O
group	O
2	O
coronavirus	B-SPEC
in	O
dogs	B-SPEC
with	O
canine	O
infectious	O
respiratory	O
disease	O
.	O

This	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCV	O
)	O
was	O
detected	O
by	O
RT	O
-	O
PCR	O
in	O
32	O
/	O
119	O
tracheal	O
and	O
20	O
/	O
119	O
lung	O
samples	O
,	O
with	O
the	O
highest	O
prevalence	O
being	O
detected	O
in	O
dogs	B-SPEC
with	O
mild	O
clinical	O
symptoms	O
.	O

ABSTRACT	O
:	O
Sendai	B-SPEC
virus	I-SPEC
may	O
induce	O
acute	O
respiratory	O
tract	O
disease	O
in	O
laboratory	O
mice	B-SPEC
and	O
is	O
a	O
common	O
contaminant	O
of	O
biological	O
materials	O
.	O

In	O
conclusion	O
,	O
these	O
fnRT	O
-	O
PCR	O
assays	O
offer	O
potentially	O
high	O
-	O
throughput	O
diagnostic	O
assays	O
to	O
detect	O
Sendai	B-SPEC
virus	I-SPEC
and	O
PVM	B-SPEC
in	O
immunodeficient	O
mice	B-SPEC
,	O
and	O
to	O
detect	O
Sendai	B-SPEC
virus	I-SPEC
in	O
contaminated	O
biological	O
materials	O
.	O

Initial	O
experiments	O
used	O
a	O
cecal	O
homogenate	O
inoculum	O
from	O
the	O
clinical	O
cases	O
that	O
contained	O
H	B-SPEC
.	I-SPEC
hepaticus	I-SPEC
and	O
MHV	B-SPEC
-	O
G	O
to	O
reproduce	O
the	O
development	O
of	O
peritonitis	O
and	O
pleuritis	O
in	O
IFN	O
-	O
gamma	O
KO	O
mice	B-SPEC
.	O

To	O
understand	O
the	O
role	O
of	O
both	O
agents	O
in	O
the	O
development	O
of	O
peritonitis	O
and	O
pleuritis	O
,	O
IFN	O
-	O
gamma	O
KO	O
mice	B-SPEC
were	O
infected	O
with	O
either	O
agent	O
or	O
were	O
co	O
-	O
infected	O
with	O
H	B-SPEC
.	I-SPEC
hepaticus	I-SPEC
and	O
MHV	B-SPEC
-	O
G	O
.	O
Infection	O
with	O
MHV	B-SPEC
-	O
G	O
induced	O
a	O
multisystemic	O
infection	O
similar	O
to	O
that	O
described	O
in	O
the	O
original	O
cases	O
,	O
with	O
multifocal	O
hepatic	O
necrosis	O
,	O
acute	O
necrotizing	O
and	O
inflammatory	O
lesions	O
of	O
the	O
gastrointestinal	O
tract	O
,	O
and	O
acute	O
peritonitis	O
and	O
pleuritis	O
with	O
adhesions	O
on	O
the	O
serosal	O
surfaces	O
of	O
the	O
viscera	O
.	O

Although	O
co	O
-	O
infection	O
with	O
H	B-SPEC
.	I-SPEC
hepaticus	I-SPEC
and	O
MHV	B-SPEC
-	O
G	O
induced	O
lesions	O
similar	O
to	O
those	O
associated	O
with	O
MHV	B-SPEC
-	O
G	O
alone	O
,	O
the	O
pathogenesis	O
of	O
the	O
MHV	B-SPEC
infection	O
was	O
modified	O
.	O

TITLE	O
:	O
Detection	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
infection	O
in	O
captive	O
cheetahs	B-SPEC
(	O
Acinonyx	B-SPEC
jubatus	I-SPEC
)	O
by	O
polymerase	O
chain	O
reaction	O
.	O

Moreover	O
,	O
MHC	O
class	B-SPEC
II	O
DR	O
-	O
expressing	O
PMNs	O
were	O
also	O
proved	O
to	O
express	O
a	O
high	O
-	O
affinity	O
receptor	O
for	O
immunoglobulin	O
E	O
(	O
IgE	O
)	O
(	O
FcepsilonRI	O
)	O
and	O
to	O
produce	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
,	O
interferon	O
-	O
gamma	O
and	O
interleukin	O
-	O
18	O
following	O
a	O
challenge	O
with	O
an	O
anti	O
-	O
MHC	O
class	B-SPEC
II	O
DR	O
monoclonal	O
Ab	O
(	O
MoAb	O
)	O
or	O
anti	O
-	O
DR	O
antiserum	O
.	O

Meanwhile	O
,	O
the	O
N	O
and	O
M	O
proteins	O
of	O
all	O
five	O
viruses	B-SPEC
were	O
analyzed	O
to	O
study	O
the	O
evolutionary	O
relationship	O
with	O
genomic	O
packaging	O
signals	O
.	O

ABSTRACT	O
:	O
To	O
constructed	O
a	O
three	O
-	O
dimensional	O
(	O
3D	O
)	O
model	O
for	O
the	O
3C	O
like	O
(	O
3CL	O
)	O
proteinase	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
to	O
design	O
inhibitors	O
of	O
the	O
3CL	O
proteinase	O
based	O
on	O
the	O
3D	O
model	O
.	O

Targeting	O
to	O
the	O
3D	O
model	O
and	O
its	O
X	O
-	O
ray	B-SPEC
crystal	O
structure	O
of	O
the	O
main	O
proteinase	O
(	O
Mpro	O
)	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
virtual	O
screening	O
was	O
performed	O
employing	O
molecular	O
docking	O
method	O
to	O
identify	O
possible	O
3CL	O
proteinase	O
inhibitors	O
from	O
small	O
molecular	O
databases	O
.	O

In	O
particular	O
,	O
the	O
primary	O
amino	O
acid	O
sequence	O
of	O
SARS	O
E	O
protein	O
is	O
much	O
more	O
similar	O
to	O
that	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
and	O
other	O
mammal	B-SPEC
coronaviruses	O
.	O

Because	O
reduced	O
concentrations	O
of	O
the	O
natural	O
form	O
of	O
PAF	O
-	O
AH	O
have	O
been	O
reported	O
in	O
septic	O
patients	O
,	O
the	O
present	O
study	O
was	O
conducted	O
to	O
determine	O
whether	O
treatment	O
with	O
recombinant	O
human	B-SPEC
PAF	O
-	O
AH	O
(	O
rPAF	O
-	O
AH	O
,	O
Pafase	O
)	O
was	O
safe	O
when	O
administered	O
after	O
the	O
onset	O
of	O
severe	O
sepsis	B-SPEC
and	O
whether	O
it	O
decreases	O
the	O
prevalence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
28	O
-	O
day	O
all	O
-	O
cause	O
mortality	O
.	O

The	O
results	O
from	O
this	O
study	O
indicate	O
that	O
rPAF	O
-	O
AH	O
was	O
well	O
tolerated	O
and	O
should	O
be	O
pursued	O
as	O
a	O
potential	O
new	O
treatment	O
to	O
decrease	O
mortality	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
is	O
assumed	O
caused	O
by	O
a	O
recently	O
identified	O
corona	B-SPEC
virus	B-SPEC
,	O
which	O
seems	O
to	O
be	O
a	O
new	O
pathogen	O
in	O
the	O
human	B-SPEC
population	O
.	O

The	O
results	O
show	O
that	O
the	O
diameter	O
of	O
newly	O
isolated	O
virus	B-SPEC
is	O
about	O
50	O
nm	O
without	O
envelope	O
or	O
100	O
nm	O
with	O
envelope	O
.	O

Due	O
to	O
the	O
efforts	O
of	O
the	O
WHO	O
-	O
led	O
network	O
of	O
laboratories	O
testing	O
for	O
SARS	O
,	O
tests	O
for	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
have	O
been	O
developed	O
with	O
unprecedented	O
speed	O
.	O

ABSTRACT	O
:	O
Community	O
-	O
acquired	O
pneumonia	O
due	O
to	O
Chlamydia	B-SPEC
pneumoniae	I-SPEC
is	O
associated	O
with	O
a	O
benign	O
clinical	O
course	O
.	O

We	O
report	O
a	O
case	O
of	O
severe	O
pneumonia	O
complicated	O
by	O
acute	O
hypoxemic	O
respiratory	O
failure	O
due	O
to	O
primary	O
infection	O
with	O
C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
in	O
a	O
previously	O
healthy	O
46	O
-	O
year	O
-	O
old	O
woman	O
.	O

We	O
found	O
that	O
the	O
construct	O
extending	O
from	O
the	O
putative	O
PLP2	O
cleavage	O
site	O
at	O
glycine	B-SPEC
2840	O
-	O
alanine	O
2841	O
was	O
most	O
similar	O
in	O
size	O
to	O
the	O
processed	O
MP1	O
replicase	O
product	O
generated	O
in	O
a	O
trans	O
-	O
cleavage	O
assay	O
.	O

SETTING	O
:	O
A	O
ten	O
-	O
bed	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
)	O
in	O
a	O
tertiary	O
children	O
'	O
s	O
university	O
hospital	O
.	O

After	O
admission	O
to	O
the	O
PICU	B-SPEC
,	O
seven	O
patients	O
(	O
63	O
%)	O
were	O
diagnosed	O
as	O
suffering	O
with	O
HLS	O
and	O
each	O
had	O
one	O
or	O
more	O
organ	O
failures	O
(	O
patients	O
3	O
-	O
7	O
,	O
9	O
,	O
and	O
10	O
).	O

Of	O
all	O
the	O
compounds	O
,	O
glycyrrhizin	O
was	O
the	O
most	O
active	O
in	O
inhibiting	O
replication	O
of	O
the	O
SARS	O
-	O
associated	O
virus	B-SPEC
.	O

TITLE	O
:	O
Partial	O
sequence	O
of	O
the	O
spike	O
glycoprotein	O
gene	O
of	O
transmissible	O
gastroenteritis	O
viruses	B-SPEC
isolated	O
in	O
Korea	O
.	O

Korean	O
TGEV	B-SPEC
strains	O
had	O
several	O
specific	O
nucleotide	O
and	O
amino	O
acid	O
sequences	O
which	O
were	O
not	O
found	O
in	O
foreign	O
TGEV	B-SPEC
or	O
PRCV	O
strains	O
.	O

Very	O
little	O
is	O
known	O
about	O
the	O
infectious	O
agent	O
(	O
a	O
coronavirus	B-SPEC
)	O
and	O
its	O
etiopathogeny	O
,	O
having	O
no	O
specific	O
treatment	O
yet	O
.	O

The	O
presence	O
of	O
this	O
packaging	O
signal	O
was	O
further	O
confirmed	O
by	O
showing	O
the	O
expression	O
and	O
rescue	O
of	O
the	O
mRNA	O
including	O
the	O
first	O
649	O
nt	O
of	O
the	O
TGEV	B-SPEC
genome	O
under	O
control	O
of	O
the	O
cytomegalovirus	B-SPEC
promoter	O
in	O
TGEV	B-SPEC
-	O
infected	O
cells	O
.	O

These	O
results	O
suggest	O
that	O
the	O
3b	O
gene	O
product	O
is	O
not	O
essential	O
for	O
the	O
replication	O
of	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Diseases	O
of	O
free	O
-	O
ranging	O
chickens	B-SPEC
in	O
the	O
Qwa	O
-	O
Qwa	O
District	O
of	O
the	O
northeastern	O
Free	O
State	O
province	O
of	O
South	O
Africa	O
.	O

ABSTRACT	O
:	O
A	O
total	O
of	O
177	O
free	O
-	O
ranging	O
chickens	B-SPEC
from	O
19	O
Qwa	O
-	O
Qwa	O
villages	O
were	O
bled	O
from	O
wing	O
veins	O
over	O
a	O
period	O
of	O
6	O
months	O
(	O
June	O
-	O
November	O
2000	O
).	O

Data	O
from	O
a	O
questionnaire	O
survey	O
indicated	O
that	O
all	O
farmers	O
interviewed	O
had	O
never	O
received	O
any	O
technical	O
support	O
and	O
that	O
their	O
chickens	B-SPEC
had	O
never	O
been	O
vaccinated	O
against	O
any	O
avian	B-SPEC
diseases	O
.	O

(	O
1	O
)	O
The	O
contagiousness	O
of	O
SARS	O
virus	B-SPEC
in	O
SARS	O
patients	O
was	O
extremely	O
strong	O
,	O
especially	O
in	O
their	O
acute	O
stage	O
.	O

IFA	O
was	O
used	O
to	O
detect	O
the	O
serum	O
antibody	O
against	O
SARS	O
coronavirus	B-SPEC
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
injected	O
with	O
the	O
recombinant	O
N	O
protein	O
of	O
SARS	O
-	O
Cov	O
into	O
the	O
foot	O
-	O
pads	O
for	O
the	O
immunization	O
,	O
and	O
the	O
popliteal	O
lymph	O
nodes	O
were	O
isolated	O
15	O
d	O
later	O
for	O
mAb	O
-	O
producing	O
hybridomas	O
,	O
from	O
which	O
the	O
mAbs	O
against	O
the	O
N	O
protein	O
of	O
SARS	O
-	O
Cov	O
were	O
screened	O
.	O

The	O
high	O
aPL	O
antibody	O
levels	O
in	O
serum	O
possibly	O
triggered	O
by	O
sepsis	B-SPEC
were	O
associated	O
with	O
high	O
aPL	O
antibody	O
levels	O
in	O
BALF	O
,	O
which	O
can	O
be	O
explained	O
by	O
high	O
capillary	O
-	O
alveolar	O
permeability	O
.	O

TITLE	O
:	O
Construction	O
,	O
characterization	O
,	O
and	O
immunogenicity	O
of	O
an	O
attenuated	O
Salmonella	B-SPEC
enterica	I-SPEC
serovar	O
typhimurium	O
pgtE	O
vaccine	O
expressing	O
fimbriae	O
with	O
integrated	O
viral	O
epitopes	O
from	O
the	O
spiC	O
promoter	O
.	O

Mice	B-SPEC
immunized	O
orally	O
with	O
the	O
Salmonella	B-SPEC
pgtE	O
vaccine	O
expressing	O
chimeric	O
fimbriae	O
from	O
the	O
spiC	O
promoter	O
elicited	O
significantly	O
higher	O
systemic	O
and	O
mucosal	O
antibody	O
titers	O
against	O
the	O
TGEV	B-SPEC
epitopes	O
compared	O
to	O
the	O
parental	O
vaccine	O
.	O

TITLE	O
:	O
Cloning	O
and	O
sequence	O
analysis	O
of	O
the	O
spike	O
gene	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
Chinju99	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
gene	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
Chinju99	O
which	O
was	O
previously	O
isolated	O
in	O
Chinju	O
,	O
Korea	O
was	O
cloned	O
and	O
sequenced	O
to	O
aid	O
in	O
the	O
development	O
of	O
genetically	O
engineered	O
vaccines	O
and	O
diagnostic	O
reagents	O
against	O
PEDV	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
Chest	O
Syndrome	O
(	O
ACS	O
)	O
describes	O
a	O
syndrome	O
characterized	O
by	O
the	O
presence	O
of	O
a	O
new	O
pulmonary	O
infiltrate	O
on	O
a	O
chest	O
X	O
-	O
ray	B-SPEC
,	O
fever	O
,	O
and	O
respiratory	O
symptoms	O
and	O
is	O
the	O
leading	O
cause	O
of	O
death	O
and	O
hospitalization	O
in	O
sickle	O
cell	O
disease	O
(	O
SCD	O
).	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SCV	B-SPEC
),	O
is	O
the	O
first	O
severe	O
infectious	O
disease	O
in	O
this	O
century	O
.	O

ABSTRACT	O
:	O
Gefitinib	O
is	O
a	O
potent	O
drug	O
used	O
in	O
the	O
treatment	O
of	O
nonsmall	O
-	O
cell	O
lung	O
cancer	B-SPEC
(	O
NSCLC	O
).	O

Electronic	O
microscopy	O
demonstrated	O
clusters	O
of	O
virus	B-SPEC
particles	O
seen	O
in	O
the	O
lung	O
tissue	O
.	O

Virus	B-SPEC
-	O
like	O
inclusions	O
occasionally	O
contained	O
cytoplasm	O
of	O
the	O
alveolar	O
epithelium	O
,	O
which	O
were	O
positive	O
by	O
histochemical	O
staining	O
.	O

The	O
potential	O
role	O
of	O
special	O
shape	O
viruses	B-SPEC
is	O
expected	O
to	O
be	O
further	O
investigated	O
.	O

ABSTRACT	O
:	O
To	O
develop	O
a	O
newly	O
real	O
-	O
time	O
RT	O
-	O
polymerase	O
chain	O
reaction	O
assay	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
related	O
coronavirus	B-SPEC
in	O
human	B-SPEC
whole	O
blood	O
.	O

In	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
,	O
the	O
extent	O
of	O
SARS	O
related	O
coronavirus	B-SPEC
amplification	O
was	O
measured	O
in	O
terms	O
of	O
the	O
increase	O
in	O
fluorescence	O
during	O
the	O
amplification	O
process	O
.	O

Virus	B-SPEC
infection	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
was	O
associated	O
with	O
an	O
increase	O
in	O
the	O
incidence	O
and	O
levels	O
of	O
systemic	O
IFN	O
-	O
gamma	O
.	O

BeauR	O
-	O
M41	O
(	O
S	O
)	O
acquired	O
the	O
same	O
cell	O
tropism	O
phenotype	O
as	O
IBV	B-SPEC
M41	O
-	O
CK	O
in	O
four	O
different	O
cell	O
types	O
,	O
demonstrating	O
that	O
the	O
IBV	B-SPEC
spike	O
glycoprotein	O
is	O
a	O
determinant	O
of	O
cell	O
tropism	O
.	O

TITLE	O
:	O
Protection	O
of	O
chickens	B-SPEC
from	O
infectious	O
bronchitis	O
by	O
in	O
ovo	B-SPEC
and	O
intramuscular	O
vaccination	O
with	O
a	O
DNA	O
vaccine	O
expressing	O
the	O
S1	O
glycoprotein	O
.	O

Transcription	O
of	O
the	O
S1	O
gene	O
was	O
confirmed	O
in	O
lung	O
tissue	O
after	O
in	O
ovo	B-SPEC
vaccination	O
by	O
an	O
antisense	O
riboprobe	O
,	O
and	O
the	O
S1	O
protein	O
was	O
detected	O
by	O
immunohistology	O
in	O
the	O
heart	O
and	O
bursa	B-SPEC
.	O

In	O
a	O
separate	O
experiment	O
,	O
birds	B-SPEC
were	O
injected	O
intramuscularly	O
with	O
either	O
50	O
,	O
100	O
,	O
or	O
150	O
microg	O
of	O
the	O
DNA	O
vaccine	O
at	O
1	O
day	O
of	O
age	O
and	O
then	O
again	O
with	O
either	O
100	O
,	O
200	O
,	O
or	O
300	O
microg	O
of	O
the	O
DNA	O
vaccine	O
,	O
respectively	O
,	O
at	O
14	O
days	O
of	O
age	O
.	O

Additionally	O
,	O
the	O
effect	O
of	O
combined	O
infection	O
on	O
TCV	B-SPEC
and	O
EPEC	O
shedding	O
was	O
determined	O
.	O

These	O
findings	O
indicate	O
that	O
TCV	B-SPEC
infection	O
predisposes	O
young	O
turkeys	B-SPEC
to	O
secondary	O
EPEC	O
infection	O
and	O
potentiates	O
the	O
expression	O
of	O
EPEC	O
pathogenicity	O
in	O
young	O
turkeys	B-SPEC
.	O

A	O
coronavirus	B-SPEC
RNA	O
-	O
polymerase	O
segment	O
(	O
440	O
bp	O
)	O
was	O
amplified	O
from	O
the	O
lung	O
tissues	O
of	O
two	O
cases	O
of	O
the	O
SARS	O
.	O

ABSTRACT	O
:	O
To	O
identify	O
the	O
transcription	O
factor	O
(	O
s	O
)	O
that	O
is	O
essential	O
for	O
activation	O
of	O
mfgl2	O
prothrombinase	O
/	O
fibroleukin	O
gene	O
in	O
response	O
to	O
nucleocapsid	O
protein	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
3	O
(	O
MHV	B-SPEC
-	O
3	O
).	O

Confocus	O
microscope	O
immunofluorescence	O
clearly	O
showed	O
that	O
N	O
protein	O
of	O
MHV	B-SPEC
entered	O
into	O
the	O
nucleus	O
of	O
infected	O
cells	O
.	O

RESULTS	O
:	O
Western	O
blotting	O
displayed	O
that	O
HNF4	O
was	O
constitutively	O
expressed	O
in	O
macrophages	O
and	O
did	O
not	O
show	O
significant	O
change	O
under	O
the	O
stimulation	O
of	O
different	O
MHV	B-SPEC
.	O

Outbreaks	O
of	O
multi	O
-	O
drug	O
resistant	O
(	O
MDR	O
)	O
tuberculosis	O
and	O
the	O
atypical	O
mycobacteria	B-SPEC
simulate	O
SARS	O
on	O
clinical	O
,	O
radiologic	O
,	O
epidemiologic	O
,	O
and	O
diagnostic	O
laboratory	O
grounds	O
and	O
it	O
is	O
only	O
logical	O
then	O
to	O
include	O
them	O
in	O
the	O
differential	O
to	O
find	O
a	O
definitive	O
cause	O
and	O
cure	O
for	O
SARS	O
.	O

TITLE	O
:	O
The	O
chest	O
X	O
-	O
ray	B-SPEC
image	O
features	O
of	O
patients	O
with	O
severe	O
SRAS	O
:	O
a	O
preliminary	O
study	O
.	O

Chest	O
X	O
-	O
ray	B-SPEC
image	O
features	O
in	O
36	O
patients	O
with	O
severe	O
SARS	O
were	O
retrospectively	O
analyzed	O
.	O

All	O
patients	O
infected	O
with	O
HIV	B-SPEC
,	O
CMV	B-SPEC
and	O
EBV	O
had	O
significantly	O
higher	O
CD8	O
(+)	O
T	O
lymphocyte	O
counts	O
in	O
comparison	O
with	O
normal	O
controls	O
.	O

We	O
tested	O
clinical	O
and	O
postmortem	O
samples	O
from	O
436	O
SARS	O
patients	O
in	O
six	O
countries	O
for	O
infection	O
with	O
SARS	O
-	O
CoV	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
and	O
other	O
respiratory	O
pathogens	O
.	O

SARS	O
-	O
CoV	O
was	O
detected	O
in	O
pneumonic	O
areas	O
by	O
virus	B-SPEC
isolation	O
and	O
RT	O
-	O
PCR	O
,	O
and	O
was	O
localised	O
to	O
alveolar	O
epithelial	O
cells	O
and	O
syncytia	O
by	O
immunohistochemistry	O
and	O
transmission	O
electron	O
microscopy	O
.	O

Specific	O
antibodies	O
of	O
IgM	O
and	O
IgG	O
against	O
SARS	O
virus	B-SPEC
in	O
267	O
serum	O
specimens	O
from	O
patients	O
with	O
SARS	O
and	O
132	O
from	O
non	O
-	O
SARS	O
patients	O
or	O
healthy	O
persons	O
were	O
assayed	O
with	O
IFA	O
or	O
ELISA	O
.	O

X	O
-	O
ray	B-SPEC
chest	O
film	O
showed	O
solitary	O
or	O
multiple	O
local	O
exudative	O
changes	O
,	O
mostly	O
in	O
pulmonary	O
lower	O
field	O
.	O

To	O
resolve	O
this	O
apparent	O
contradiction	O
,	O
we	O
engineered	O
a	O
recombinant	O
variant	O
of	O
JHM	O
that	O
expressed	O
the	O
well	O
-	O
characterized	O
gp33	O
epitope	O
of	O
lymphocytic	B-SPEC
choriomeningitis	I-SPEC
virus	I-SPEC
,	O
an	O
epitope	O
with	O
high	O
functional	O
avidity	O
.	O

SARS	O
-	O
CoV	O
virus	B-SPEC
replicase	O
polyprotein	O
ORF1b	O
is	O
undergoing	O
negative	O
selection	O
;	O
negative	O
selection	O
force	O
is	O
also	O
probably	O
operating	O
on	O
spike	O
protein	O
gene	O
.	O

CONCLUSIONS	O
:	O
SARS	O
-	O
CoV	O
virus	B-SPEC
replicase	O
polyprotein	O
ORF1b	O
is	O
undergoing	O
negative	O
selection	O
;	O
negative	O
selection	O
force	O
is	O
also	O
probably	O
operating	O
on	O
spike	O
protein	O
gene	O
.	O

In	O
order	B-SPEC
to	O
keep	O
blood	O
glucose	O
within	O
the	O
range	O
4	O
.	O
44	O
-	O
7	O
.	O
78	O
mmol	O
/	O
L	O
(	O
80	O
-	O
140	O
mg	O
/	O
dl	O
),	O
only	O
18	O
.	O
8	O
%	O
of	O
the	O
surviving	O
patients	O
needed	O
insulin	O
intervention	O
as	O
opposed	O
to	O
80	O
.	O
0	O
%	O
of	O
those	O
who	O
died	O
(	O
P	O
=	O
0	O
.	O
03	O
).	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
caused	O
by	O
a	O
recently	O
identified	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

2	O
.	O
9	O
)	O
days	O
from	O
the	O
onset	O
,	O
and	O
CT	O
scanning	O
was	O
better	O
than	O
X	O
-	O
ray	B-SPEC
in	O
the	O
early	O
diagnosis	O
.	O

RESULTS	O
:	O
Plasma	O
anti	O
-	O
SARS	O
coronavirus	B-SPEC
IgG	O
antibody	O
was	O
not	O
detected	O
in	O
normal	O
subjects	O
and	O
the	O
clinical	O
personnel	O
.	O

8	O
%	O
on	O
CT	O
)	O
and	O
mixed	O
lesions	O
of	O
GGO	O
with	O
irregular	O
consolidation	O
(	O
21	O
.	O
4	O
%	O
on	O
X	O
-	O
ray	B-SPEC
and	O
45	O
.	O
5	O
%	O
on	O
CT	O
)	O
and	O
/	O
or	O
granulomas	O
(	O
14	O
.	O
3	O
%	O
on	O
X	O
-	O
ray	B-SPEC
and	O
27	O
.	O
3	O
%	O
on	O
CT	O
).	O

Hemiquantitative	O
analysis	O
showed	O
there	O
are	O
6	O
cases	O
had	O
second	O
peak	O
in	O
X	O
ray	B-SPEC
,	O
the	O
mean	O
time	O
of	O
onset	O
is	O
13	O
.	O
2	O
days	O
,	O
and	O
lasted	O
for	O
5	O
.	O
8	O
days	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
3CL	O
proteinase	O
is	O
the	O
key	O
enzyme	O
for	O
virus	B-SPEC
replication	O
which	O
may	O
serve	O
as	O
the	O
target	O
for	O
drug	O
discovery	O
against	O
SARS	O
.	O

ABSTRACT	O
:	O
SARS	O
virus	B-SPEC
is	O
a	O
recently	O
found	O
coronavirus	B-SPEC
,	O
which	O
cause	O
human	B-SPEC
atypical	O
pneumonia	O
through	O
the	O
binding	O
of	O
its	O
spike	O
protein	O
to	O
the	O
receptor	O
on	O
human	B-SPEC
cells	O
.	O

The	O
client	O
workstations	O
were	O
set	O
in	O
the	O
SARS	O
isolation	O
region	O
(	O
at	O
the	O
SARS	O
outpatient	O
department	O
and	O
the	O
SARS	O
x	O
-	O
ray	B-SPEC
examination	O
room	O
)	O
and	O
the	O
non	O
-	O
SARS	O
isolation	O
region	O
respectively	O
.	O

TITLE	O
:	O
Antiviral	O
activity	O
of	O
limitin	O
against	O
encephalomyocarditis	B-SPEC
virus	I-SPEC
,	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
,	O
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
:	O
diverse	O
requirements	O
by	O
limitin	O
and	O
alpha	O
interferon	O
for	O
interferon	O
regulatory	O
factor	O
1	O
.	O

Limitin	O
inhibited	O
not	O
only	O
cytopathic	O
effects	O
in	O
encephalomyocarditis	B-SPEC
virus	I-SPEC
-	O
or	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
(	O
HSV	B-SPEC
)	O
type	O
1	O
-	O
infected	O
L929	O
cells	O
,	O
but	O
also	O
plaque	O
formation	O
in	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
type	O
2	O
-	O
infected	O
DBT	O
cells	O
.	O

We	O
have	O
cloned	O
,	O
expressed	O
,	O
and	O
purified	O
this	O
protein	O
as	O
an	O
N	O
-	O
terminal	O
hexahistidine	O
fusion	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
have	O
characterized	O
its	O
helicase	O
and	O
NTPase	O
activities	O
.	O

TITLE	O
:	O
Typing	O
of	O
field	O
isolates	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
based	O
on	O
the	O
sequence	O
of	O
the	O
hypervariable	O
region	O
in	O
the	O
S1	O
gene	O
.	O

TITLE	O
:	O
Amino	O
acid	O
substitutions	O
within	O
the	O
heptad	O
repeat	O
domain	O
1	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
spike	O
protein	O
restrict	O
viral	O
antigen	O
spread	O
in	O
the	O
central	O
nervous	O
system	O
.	O

In	O
contrast	O
,	O
the	O
recombinant	O
expressing	O
spike	O
with	O
L1114R	O
alone	O
mediated	O
cell	O
-	O
to	O
-	O
cell	O
fusion	O
at	O
neutral	O
pH	O
and	O
replicated	O
efficiently	O
despite	O
the	O
presence	O
of	O
lysosomotropic	O
agents	O
;	O
however	O
,	O
it	O
still	O
caused	O
only	O
subclinical	O
morbidity	O
and	O
no	O
mortality	O
in	O
animals	B-SPEC
.	O

In	O
order	B-SPEC
to	O
investigate	O
the	O
role	O
of	O
the	O
M	O
protein	O
glycosylation	O
in	O
the	O
host	O
,	O
two	O
genetically	O
modified	O
MHVs	O
were	O
generated	O
by	O
using	O
targeted	O
RNA	O
recombination	O
.	O

The	O
M	O
protein	O
glycosylation	O
state	O
did	O
not	O
influence	O
the	O
tissue	O
culture	O
growth	O
characteristics	O
of	O
the	O
recombinant	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Functional	O
analysis	O
of	O
the	O
CC	O
chemokine	O
receptor	O
5	O
(	O
CCR5	O
)	O
on	O
virus	B-SPEC
-	O
specific	O
CD8	O
+	O
T	O
cells	O
following	O
coronavirus	B-SPEC
infection	O
of	O
the	O
central	O
nervous	O
system	O
.	O

Twenty	O
-	O
two	O
female	O
sheep	B-SPEC
were	O
operatively	O
prepared	O
.	O

Eleven	O
early	O
reported	O
cases	O
in	O
the	O
communities	O
took	O
animal	B-SPEC
-	O
related	O
positions	O
.	O

RESULTS	O
:	O
The	O
construction	O
of	O
the	O
surveillance	O
system	O
in	O
such	O
a	O
model	O
as	O
""""	O
individual	O
-	O
dormitory	O
/	O
home	O
-	O
class	B-SPEC
/	O
unite	O
-	O
faculty	O
and	O
institute	O
-	O
university	O
""""	O
largely	O
contributed	O
to	O
the	O
achievement	O
of	O
the	O
goals	O
of	O
low	O
incidence	O
,	O
no	O
secondary	O
,	O
no	O
epidemic	O
,	O
and	O
no	O
death	O
.	O

TITLE	O
:	O
Activation	O
of	O
site	O
-	O
specific	O
DNA	O
integration	O
in	O
human	B-SPEC
cells	O
by	O
a	O
single	O
chain	O
integration	O
host	O
factor	O
.	O

We	O
also	O
demonstrate	O
that	O
scIHF2	O
is	O
stably	O
expressed	O
in	O
HeLa	O
cells	O
,	O
that	O
it	O
is	O
localized	O
primarily	O
in	O
the	O
cell	O
nucleus	O
and	O
that	O
it	O
triggers	O
integrative	O
recombination	O
in	O
mammalian	B-SPEC
cells	O
by	O
wild	O
-	O
type	O
integrase	O
.	O

With	O
conventional	O
laboratory	O
methods	O
,	O
it	O
has	O
been	O
determined	O
the	O
bacteria	B-SPEC
and	O
micotic	O
aetiology	O
(	O
NOVIGE	O
);	O
the	O
virology	O
diagnostic	O
with	O
electron	O
microscopy	O
;	O
and	O
the	O
use	O
of	O
the	O
statistics	O
for	O
the	O
data	O
analysis	O
.	O

CONCLUSIONS	O
:	O
siRNA	O
may	O
be	O
effective	O
in	O
inhibiting	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
replication	O
.	O

TITLE	O
:	O
Increased	O
litter	O
survival	O
rates	O
,	O
reduced	O
clinical	O
illness	O
and	O
better	O
lactogenic	O
immunity	O
against	O
TGEV	B-SPEC
in	O
gilts	O
that	O
were	O
primed	O
as	O
neonates	O
with	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
).	O

ABSTRACT	O
:	O
Multiple	O
sequence	O
alignment	O
among	O
12	O
complete	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
sequences	O
reveals	O
that	O
the	O
major	O
parts	O
of	O
29708	O
b	O
of	O
the	O
genomes	O
have	O
99	O
.	O
82	O
%	O
identical	O
bases	O
.	O

The	O
sequences	O
of	O
its	O
genes	O
and	O
encoding	O
proteins	O
are	O
substantially	O
different	O
from	O
those	O
of	O
other	O
coronavirus	B-SPEC
.	O

Intraperitoneal	O
injection	O
of	O
cerulein	O
in	O
mice	B-SPEC
resulted	O
in	O
severe	O
,	O
acute	O
pancreatitis	O
characterized	O
by	O
oedema	O
,	O
neutrophil	O
infiltration	O
and	O
necrosis	O
and	O
elevated	O
serum	O
levels	O
of	O
amylase	O
and	O
lipase	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
--	O
a	O
new	O
coronavirus	B-SPEC
from	O
the	O
Chinese	O
dragon	O
'	O
s	O
lair	O
.	O

Nevertheless	O
,	O
higher	O
antibody	O
titers	O
were	O
necessary	O
to	O
confer	O
resistance	O
in	O
HIII	O
mice	B-SPEC
than	O
in	O
LIII	O
ones	O
.	O

The	O
resistance	O
and	O
the	O
survival	O
time	O
of	O
these	O
animals	B-SPEC
increased	O
with	O
the	O
level	O
of	O
antibody	O
administered	O
.	O

ABSTRACT	O
:	O
An	O
epidemic	O
of	O
a	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
a	O
new	O
coronavirus	B-SPEC
has	O
spread	O
from	O
the	O
Guangdong	O
province	O
to	O
the	O
rest	O
of	O
China	O
and	O
to	O
the	O
world	O
,	O
with	O
a	O
puzzling	O
contagion	O
behavior	O
.	O

CONCLUSIONS	O
:	O
We	O
find	O
that	O
,	O
in	O
order	B-SPEC
to	O
reconcile	O
the	O
existing	O
data	O
and	O
the	O
spread	O
of	O
the	O
disease	O
,	O
it	O
is	O
convenient	O
to	O
suggest	O
that	O
a	O
first	O
milder	O
outbreak	O
protected	O
against	O
the	O
SARS	O
.	O

TITLE	O
:	O
Early	O
events	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
in	O
vero	O
cells	O
.	O

Quite	O
surprising	O
at	O
such	O
early	O
stages	O
of	O
infection	O
(	O
20	O
min	O
),	O
a	O
virus	B-SPEC
-	O
induced	O
change	O
in	O
the	O
infected	O
cells	O
was	O
evident	O
.	O

These	O
could	O
be	O
the	O
virus	B-SPEC
genomes	O
together	O
with	O
the	O
helical	O
nucleocapsids	O
.	O

The	O
increased	O
neurovirulence	O
mediated	O
by	O
the	O
virus	B-SPEC
encoding	O
glycine	B-SPEC
at	O
position	O
S310	O
was	O
not	O
associated	O
with	O
a	O
different	O
tropism	O
within	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
but	O
was	O
associated	O
with	O
increased	O
lateral	O
spread	O
in	O
the	O
CNS	O
,	O
leading	O
to	O
significantly	O
higher	O
brain	O
viral	O
titers	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
RNA	O
synthesis	O
is	O
mediated	O
by	O
a	O
viral	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)	O
on	O
membrane	O
-	O
bound	O
replication	O
complexes	O
in	O
the	O
host	O
cell	O
cytoplasm	O
.	O

Furthermore	O
,	O
overexpression	O
of	O
hnRNP	O
A	O
/	O
B	O
in	O
cells	O
enhanced	O
MHV	B-SPEC
RNA	O
synthesis	O
.	O

TITLE	O
:	O
[	O
Organism	O
distribution	O
and	O
drug	O
resistance	O
in	O
7	O
cases	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
death	O
patients	O
with	O
secondary	O
bacteria	B-SPEC
infection	O
].	O

By	O
univariate	O
analysis	O
,	O
risk	O
factors	O
related	O
to	O
hospital	O
mortality	O
included	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluationII	O
(	O
APACHEII	O
)	O
score	O
,	O
the	O
systemic	O
inflammatory	O
response	O
syndrome	O
,	O
sepsis	B-SPEC
,	O
severe	O
sepsis	B-SPEC
,	O
septic	O
shock	O
,	O
chronic	O
respiratory	O
dysfunction	O
,	O
sepsis	B-SPEC
-	O
related	O
organ	O
failure	O
assessment	O
(	O
SOFA	O
)	O
score	O
,	O
acute	O
respiratory	O
dysfunction	O
,	O
coagulation	O
dysfunction	O
,	O
central	O
nerves	O
system	O
dysfunction	O
,	O
cardiovascular	O
dysfunction	O
,	O
management	O
of	O
noradrenaline	O
and	O
continuous	O
venovenous	O
hemofiltration	O
(	O
CVVH	O
).	O

Among	O
the	O
10	O
index	O
cases	O
,	O
only	O
the	O
super	O
spreader	O
and	O
another	O
one	O
index	O
case	O
transmitted	O
the	O
virus	B-SPEC
to	O
their	O
contacts	O
but	O
the	O
rest	O
of	O
index	O
cases	O
did	O
not	O
cause	O
any	O
secondary	O
infection	O
.	O

Although	O
chronic	O
underlying	O
conditions	O
are	O
major	O
determinants	O
of	O
severe	O
respiratory	O
virus	B-SPEC
infections	O
,	O
few	O
data	O
about	O
coronavirus	B-SPEC
-	O
related	O
pneumonia	O
in	O
immunocompromised	O
patients	O
are	O
available	O
.	O

Since	O
it	O
is	O
a	O
member	O
of	O
the	O
Coronaviridae	B-SPEC
,	O
its	O
spike	O
protein	O
(	O
S2	O
)	O
is	O
believed	O
to	O
play	O
a	O
central	O
role	O
in	O
viral	O
entry	O
by	O
facilitating	O
fusion	O
between	O
the	O
viral	O
and	O
host	O
cell	O
membranes	O
.	O

The	O
protein	O
responsible	O
for	O
viral	O
-	O
induced	O
membrane	O
fusion	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
(	O
gp41	O
)	O
differs	O
in	O
length	O
,	O
and	O
has	O
no	O
sequence	O
homology	O
with	O
S2	O
.	O

RESULTS	O
:	O
Both	O
approaches	O
yielded	O
relationship	O
outcomes	O
that	O
are	O
consistent	O
with	O
the	O
known	O
virus	B-SPEC
classification	O
.	O

However	O
,	O
the	O
human	B-SPEC
infant	O
brain	O
is	O
more	O
than	O
1000	O
times	O
larger	O
than	O
the	O
mouse	B-SPEC
brain	O
,	O
which	O
will	O
make	O
the	O
treatment	O
of	O
global	O
neurometabolic	O
disorders	O
in	O
children	O
more	O
difficult	O
.	O

In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
ability	O
of	O
three	O
AAV	O
serotypes	O
(	O
1	O
,	O
2	O
,	O
and	O
5	O
)	O
to	O
transduce	O
cells	O
in	O
the	O
cat	B-SPEC
brain	O
as	O
a	O
model	O
of	O
a	O
large	O
mammalian	B-SPEC
brain	O
.	O

Serum	O
coronavirus	B-SPEC
nucleic	O
acid	O
was	O
positive	O
in	O
3	O
patients	O
,	O
coronavirus	B-SPEC
antibody	O
positive	O
in	O
two	O
and	O
both	O
were	O
positive	O
in	O
one	O
.	O

SARS	O
-	O
associated	O
coronavirus	B-SPEC
is	O
spread	O
by	O
multiple	O
mechanisms	O
,	O
including	O
direct	O
contact	O
and	O
large	O
-	O
droplet	O
aerosolization	O
,	O
and	O
may	O
be	O
spread	O
by	O
droplet	O
nuclei	O
as	O
well	O
.	O

TITLE	O
:	O
Halophenyl	O
furanopyrimidines	O
as	O
potent	O
and	O
selective	O
anti	O
-	O
VZV	B-SPEC
agents	O
.	O

TITLE	O
:	O
SARS	O
-	O
coronavirus	B-SPEC
replicates	O
in	O
mononuclear	O
cells	O
of	O
peripheral	O
blood	O
(	O
PBMCs	O
)	O
from	O
SARS	O
patients	O
.	O

TITLE	O
:	O
SARS	O
associated	O
coronavirus	B-SPEC
has	O
a	O
recombinant	O
polymerase	O
and	O
coronaviruses	O
have	O
a	O
history	O
of	O
host	O
-	O
shifting	O
.	O

ELISAs	O
based	O
on	O
recombinant	O
proteins	O
are	O
safe	O
(	O
no	O
live	O
virus	B-SPEC
),	O
clean	O
(	O
only	O
virus	B-SPEC
antigens	O
are	O
present	O
),	O
specific	O
(	O
single	O
proteins	O
can	O
be	O
used	O
)	O
and	O
rapid	O
(	O
to	O
respond	O
to	O
new	O
viral	O
strains	O
and	O
strains	O
that	O
cannot	O
necessarily	O
be	O
easily	O
cultured	O
).	O

Nasopharyngeal	O
swab	O
specimens	O
were	O
negative	O
for	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
by	O
an	O
in	O
-	O
house	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
in	O
all	O
25	O
children	O
.	O

Sixty	O
-	O
one	O
percent	O
of	O
the	O
patients	O
had	O
evidence	O
of	O
hemolytic	O
anemia	B-SPEC
,	O
and	O
hypocalcemia	O
and	O
hypomagnesmia	O
were	O
reported	O
in	O
58	O
%	O
and	O
46	O
%	O
of	O
patients	O
,	O
respectively	O
.	O

Infection	O
with	O
MHV	B-SPEC
was	O
confirmed	O
in	O
nude	O
sentinel	O
mice	B-SPEC
by	O
use	O
of	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
detection	O
of	O
viral	O
RNA	O
in	O
ascending	O
colon	O
and	O
feces	O
.	O

The	O
RT	O
-	O
PCR	O
-	O
analyzed	O
specimens	O
recovered	O
from	O
sentinel	O
animals	B-SPEC
were	O
sequenced	O
,	O
and	O
92	O
%	O
homology	O
to	O
the	O
N	O
region	O
of	O
the	O
MHV	B-SPEC
strain	O
S	O
genome	O
was	O
documented	O
.	O

Sixty	O
-	O
one	O
cases	O
of	O
SARS	O
with	O
positive	O
antibodies	O
to	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
were	O
classified	O
into	O
the	O
following	O
categories	O
:	O
initial	O
stage	O
(	O
3	O
-	O
7	O
days	O
),	O
peak	O
stage	O
(	O
8	O
-	O
14	O
days	O
),	O
and	O
remission	O
and	O
recovery	O
stage	O
(	O
15	O
-	O
27	O
days	O
).	O

A	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
isolate	O
named	O
ZJ01	O
was	O
obtained	O
from	O
throat	O
swab	O
samples	O
taken	O
from	O
a	O
patient	O
in	O
Hangzhou	O
,	O
Zhejing	O
province	O
.	O

Furthermore	O
,	O
theoretical	O
and	O
structural	O
considerations	O
propose	O
that	O
BN	O
is	O
converted	O
into	O
bananin	O
5	O
'-	O
monophosphate	O
(	O
BNP	O
)	O
by	O
the	O
cell	O
type	O
-	O
ubiquitous	O
human	B-SPEC
enzyme	O
pyridoxal	O
kinase	O
(	O
EC	O
2	O
.	O
7	O
.	O
1	O
.	O
35	O
).	O

Human	B-SPEC
immunodeficiency	O
Retroviridae	B-SPEC
(	O
HIVs	O
)	O
could	O
possibly	O
be	O
influenced	O
by	O
B6RA	O
and	O
BNP	O
.	O

The	O
expression	O
of	O
rat	B-SPEC
NIP3L	O
identified	O
in	O
this	O
study	O
increased	O
slightly	O
in	O
the	O
pancreas	O
after	O
induction	O
of	O
acute	O
pancreatitis	O
but	O
showed	O
a	O
marked	O
increase	O
in	O
the	O
lung	O
by	O
both	O
Northern	O
and	O
Western	O
blot	O
analysis	O
.	O

However	O
,	O
clinical	O
improvement	O
has	O
been	O
demonstrated	O
in	O
conditions	O
such	O
as	O
haemophilia	O
[	O
82	O
],	O
cardiovascular	O
disease	O
[	O
83	O
],	O
head	O
and	O
neck	O
cancer	B-SPEC
[	O
84	O
]	O
and	O
X	O
-	O
linked	O
severe	O
combined	O
immunodeficiency	O
disease	O
[	O
85	O
].	O

The	O
LID	O
vector	O
goes	B-SPEC
some	O
way	O
to	O
addressing	O
the	O
problems	O
associated	O
with	O
current	O
gene	O
delivery	O
strategies	O
.	O

We	O
studied	O
here	O
their	O
ability	O
to	O
serve	O
as	O
expression	O
vectors	O
by	O
inserting	O
two	O
different	O
foreign	O
genes	O
and	O
evaluating	O
systematically	O
the	O
genomic	O
position	O
dependence	O
of	O
their	O
expression	O
,	O
using	O
a	O
murine	B-SPEC
coronavirus	I-SPEC
as	O
a	O
model	O
.	O

Our	O
results	O
suggest	O
a	O
role	O
of	O
MGP	O
in	O
the	O
enteropathogenicity	O
of	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
examine	O
the	O
presence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
-	O
specific	O
antibodies	O
in	O
the	O
sera	O
from	O
non	O
-	O
SARS	O
children	O
.	O

This	O
study	O
provides	O
a	O
basic	O
understanding	O
of	O
the	O
enzyme	O
catalysis	O
and	O
a	O
full	O
substrate	O
specificity	O
spectrum	O
for	O
SARS	O
3C	O
-	O
like	O
proteinase	O
,	O
which	O
are	O
helpful	O
for	O
structural	O
-	O
based	O
inhibitor	O
design	O
against	O
SARS	O
and	O
other	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
identified	O
in	O
2003	O
as	O
an	O
infectious	O
disease	O
caused	O
by	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
a	O
member	O
of	O
the	O
coronavirus	B-SPEC
family	B-SPEC
not	O
observed	O
previously	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Pathogenicity	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
in	O
turkeys	B-SPEC
and	O
chickens	B-SPEC
.	O

Establishment	O
of	O
a	O
carrier	O
state	O
in	O
IBV	B-SPEC
infection	O
and	O
the	O
potential	O
for	O
the	O
persistent	O
virus	B-SPEC
to	O
undergo	O
mutations	O
and	O
recombination	O
in	O
chicken	B-SPEC
tissues	O
have	O
important	O
consequences	O
for	O
disease	O
management	O
.	O

Indeed	O
,	O
whether	O
or	O
not	O
IBV	B-SPEC
genome	O
can	O
undergo	O
genetic	O
changes	O
during	O
in	O
vivo	O
infection	O
has	O
not	O
been	O
demonstrated	O
experimentally	O
.	O

Also	O
,	O
the	O
virus	B-SPEC
was	O
recovered	O
from	O
the	O
internal	O
organs	O
(	O
spleen	O
,	O
gonad	O
,	O
kidney	O
,	O
lung	O
,	O
cecal	O
tonsil	O
,	O
and	O
cloacal	O
bursa	B-SPEC
)	O
of	O
six	O
of	O
eight	O
birds	B-SPEC
killed	O
at	O
various	O
intervals	O
between	O
27	O
and	O
163	O
days	O
postinoculation	O
(	O
DPI	O
).	O

ABSTRACT	O
:	O
In	O
1998	O
,	O
novel	O
strains	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
identified	O
in	O
chickens	B-SPEC
from	O
the	O
southeastern	O
United	O
States	O
and	O
classified	O
as	O
a	O
new	O
serotype	O
designated	O
Georgia	O
98	O
(	O
GA98	O
).	O

Routine	O
typing	O
of	O
vaccine	O
strains	O
of	O
IBV	B-SPEC
was	O
possible	O
with	O
this	O
technology	O
,	O
but	O
high	O
standard	O
deviations	O
associated	O
with	O
the	O
melting	O
curve	O
analysis	O
of	O
the	O
FRET	O
probes	O
described	O
herein	O
made	O
it	O
difficult	O
to	O
use	O
this	O
test	O
reliably	O
for	O
routine	O
typing	O
of	O
IBV	B-SPEC
field	O
isolates	O
.	O

TITLE	O
:	O
Characterization	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
by	O
slot	O
blot	O
hybridization	O
.	O

ABSTRACT	O
:	O
We	O
used	O
slot	O
blot	O
hybridization	O
of	O
the	O
hypervariable	O
regions	O
of	O
the	O
S1	O
subunit	O
of	O
spike	O
peplomer	O
gene	O
to	O
identify	O
and	O
characterize	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
.	O

The	O
causative	O
virus	B-SPEC
was	O
identified	O
by	O
a	O
WHO	O
-	O
led	O
network	O
of	O
laboratories	O
,	O
which	O
identified	O
the	O
genome	O
sequence	O
and	O
developed	O
the	O
first	O
molecular	O
assays	O
for	O
diagnosis	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
infects	O
members	O
of	O
the	O
Felidae	B-SPEC
family	B-SPEC
with	O
results	O
ranging	O
from	O
seroconversion	O
with	O
no	O
disease	O
to	O
fatal	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

We	O
recorded	O
the	O
first	O
case	O
of	O
FeLV	O
antigenemia	O
in	O
a	O
wild	O
sand	B-SPEC
cat	I-SPEC
.	O

Positive	O
results	O
to	O
FIV	B-SPEC
/	O
PLV	O
in	O
wildcats	O
and	O
feral	O
cats	B-SPEC
confirmed	O
the	O
occurrence	O
of	O
a	O
feline	B-SPEC
lentivirus	B-SPEC
in	O
the	O
sampled	O
population	O
.	O

Vasodilators	O
,	O
but	O
not	O
oxidant	O
radical	O
scavengers	B-SPEC
,	O
are	O
effective	O
in	O
the	O
prevention	O
of	O
centrogenic	O
PE	O
.	O

The	O
results	O
of	O
pairwise	O
comparisons	O
involving	O
structural	O
and	O
replicase	O
proteins	O
of	O
the	O
Coronavirus	B-SPEC
genus	B-SPEC
were	O
consistent	O
and	O
produced	O
percentages	O
of	O
sequence	O
identities	O
that	O
were	O
distributed	O
in	O
discontinuous	O
clusters	O
.	O

The	O
pairwise	O
scores	O
between	O
sequences	O
of	O
the	O
genera	O
Coronavirus	B-SPEC
and	O
Torovirus	B-SPEC
(	O
22	O
-	O
25	O
%	O
and	O
21	O
-	O
25	O
%)	O
were	O
found	O
to	O
be	O
very	O
close	O
to	O
or	O
overlapped	O
with	O
the	O
value	O
ranges	O
(	O
12	O
to	O
22	O
%	O
and	O
17	O
to	O
25	O
%)	O
obtained	O
for	O
interfamily	O
pairwise	O
comparisons	O
,	O
but	O
were	O
much	O
smaller	O
than	O
values	O
derived	O
from	O
pairwise	O
comparisons	O
within	O
the	O
Coronavirus	B-SPEC
genus	B-SPEC
(	O
63	O
-	O
71	O
%	O
and	O
59	O
-	O
67	O
%).	O

We	O
report	O
here	O
identification	O
of	O
9	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
ANPEP	O
,	O
encoding	O
human	B-SPEC
aminopeptidase	O
N	O
,	O
in	O
Chinese	O
.	O

PCP	O
is	O
a	O
weak	O
mutagen	O
but	O
the	O
available	O
data	O
for	O
humans	B-SPEC
are	O
insufficient	O
to	O
classify	O
it	O
more	O
strongly	O
than	O
as	O
a	O
probable	O
carcinogen	O
.	O

These	O
findings	O
indicate	O
a	O
key	O
role	O
for	O
the	O
anti	O
-	O
MHV	B-SPEC
antibody	O
response	O
in	O
suppressing	O
virus	B-SPEC
replication	O
,	O
thereby	O
minimizing	O
the	O
emergence	O
and	O
competitive	O
advantage	O
of	O
CTL	O
escape	O
mutants	O
.	O

Here	O
,	O
we	O
established	O
a	O
rat	B-SPEC
oligodendrocyte	O
culture	O
that	O
is	O
morphologically	O
and	O
phenotypically	O
indistinguishable	O
from	O
the	O
primary	O
rat	B-SPEC
oligodendrocytes	O
.	O

Cats	B-SPEC
with	O
diseases	O
other	O
than	O
FIP	O
also	O
had	O
decreased	O
number	O
of	O
lymphocytes	O
:	O
as	O
a	O
consequence	O
,	O
the	O
diagnostic	O
relevance	O
of	O
these	O
findings	O
is	O
very	O
low	O
.	O

TITLE	O
:	O
Vacuolating	O
encephalitis	O
in	O
mice	B-SPEC
infected	O
by	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
.	O

Here	O
,	O
a	O
reporter	O
-	O
containing	O
BCoV	O
DI	O
RNA	O
was	O
shown	O
to	O
be	O
replicated	O
by	O
all	O
five	O
BCoV	O
-	O
like	O
helper	O
viruses	B-SPEC
and	O
by	O
MHV	B-SPEC
-	O
H2	O
(	O
a	O
human	B-SPEC
cell	O
-	O
adapted	O
MHV	B-SPEC
strain	O
),	O
a	O
representative	O
of	O
the	O
MHV	B-SPEC
-	O
like	O
subgroup	O
,	O
demonstrating	O
group	O
2	O
common	O
5	O
'	O
and	O
3	O
'	O
replication	O
signaling	O
elements	O
.	O

During	O
hospitalization	O
,	O
incidence	O
of	O
diarrhea	O
(	O
53	O
%),	O
anemia	B-SPEC
(	O
53	O
%),	O
and	O
acute	O
renal	O
failure	O
(	O
6	O
%)	O
increased	O
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
causes	O
encephalitis	O
and	O
demyelination	O
in	O
the	O
central	O
nervous	O
system	O
of	O
susceptible	O
rodents	B-SPEC
.	O

This	O
report	O
describes	O
observations	O
made	O
by	O
two	O
authors	O
on	O
a	O
journey	O
from	O
Manchester	O
in	O
the	O
United	O
Kingdom	B-SPEC
to	O
Chiang	O
Mai	B-SPEC
in	O
Thailand	O
during	O
the	O
peak	O
of	O
global	O
transmission	O
.	O

The	O
findings	O
demonstrate	O
that	O
the	O
promotion	O
of	O
protective	O
personal	O
health	O
practices	O
to	O
interrupt	O
the	O
self	O
sustaining	O
transmission	O
of	O
the	O
SARS	O
virus	B-SPEC
in	O
the	O
community	O
must	O
take	O
into	O
account	O
background	O
perceptions	O
of	O
risk	O
and	O
anxiety	O
levels	O
of	O
the	O
public	O
at	O
large	O
.	O

TITLE	O
:	O
Enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
employing	O
a	O
recombinant	O
antigen	O
for	O
detection	O
of	O
protective	O
antibody	O
against	O
swine	B-SPEC
erysipelas	O
.	O

The	O
antibody	O
titers	O
of	O
pigs	B-SPEC
experimentally	O
immunized	O
with	O
commercial	O
live	O
vaccine	O
and	O
two	O
types	O
of	O
inactivated	O
vaccines	O
clearly	O
increased	O
after	O
immunization	O
,	O
and	O
all	O
pigs	B-SPEC
were	O
completely	O
protected	O
against	O
challenge	O
with	O
virulent	O
strains	O
.	O

TITLE	O
:	O
[	O
Respiratory	O
tract	O
viruses	B-SPEC
].	O

Acute	O
respiratory	O
viruses	B-SPEC
commonly	O
induce	O
inflammatory	O
chemokines	O
such	O
as	O
CCL3	O
(	O
also	O
known	O
as	O
macrophage	O
inflammatory	O
protein	O
-	O
1alpha	O
)	O
and	O
CCL5	O
(	O
RANTES	O
),	O
which	O
can	O
amplify	O
inflammatory	O
responses	O
leading	O
to	O
immunopathology	O
.	O

Human	B-SPEC
herpesvirus	I-SPEC
-	O
6	O
also	O
induces	O
production	O
of	O
CCL3	O
and	O
CCL5	O
,	O
which	O
are	O
able	O
to	O
block	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
replication	O
in	O
coinfected	O
human	B-SPEC
lymphoid	O
tissue	O
.	O

With	O
regard	O
to	O
immunomodulation	O
,	O
use	O
of	O
weak	O
or	O
attenuated	O
viruses	B-SPEC
to	O
skew	O
the	O
local	O
cytokine	O
network	O
to	O
a	O
configuration	O
able	O
to	O
inhibit	O
a	O
pathogen	O
is	O
a	O
new	O
and	O
interesting	O
concept	O
,	O
but	O
is	O
fraught	O
with	O
important	O
safety	O
issues	O
.	O

The	O
rates	O
of	O
calli	O
and	O
shoots	O
differentiation	O
were	O
100	O
%,	O
and	O
more	O
than	O
95	O
%	O
respectively	O
,	O
for	O
transgenic	O
potato	B-SPEC
with	O
S1	O
gene	O
of	O
IBV	B-SPEC
.	O

PCR	O
and	O
Southern	O
blot	O
analyses	O
showed	O
that	O
IBV	B-SPEC
S1	O
gene	O
was	O
integrated	O
into	O
genomic	O
DNA	O
of	O
the	O
potato	B-SPEC
plant	B-SPEC
and	O
most	O
transgenic	O
plants	B-SPEC
had	O
two	O
copies	O
of	O
S1	O
gene	O
of	O
IBV	B-SPEC
.	O

The	O
presence	O
of	O
HSV	B-SPEC
in	O
the	O
throat	O
was	O
a	O
risk	O
factor	O
for	O
development	O
of	O
HSV	B-SPEC
infections	O
in	O
the	O
lower	O
respiratory	O
tract	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Neurological	O
FIP	O
is	O
clinically	O
and	O
pathologically	O
more	O
homogeneous	O
than	O
systemic	O
'	O
wet	O
'	O
or	O
'	O
dry	O
'	O
FIP	O
;	O
thus	O
,	O
comparison	O
of	O
cytokine	O
profiles	O
from	O
cats	B-SPEC
with	O
neurological	O
FIP	O
,	O
wet	O
FIP	O
,	O
and	O
non	O
-	O
FIP	O
neurological	O
disease	O
may	O
provide	O
insight	O
into	O
some	O
baseline	O
characteristics	O
relating	O
to	O
the	O
immunopathogenesis	O
of	O
neurological	O
FIP	O
.	O

TITLE	O
:	O
Activation	O
of	O
AP	O
-	O
1	O
signal	O
transduction	O
pathway	O
by	O
SARS	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
.	O

ABSTRACT	O
:	O
In	O
March	O
2003	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
was	O
isolated	O
from	O
patients	O
exhibiting	O
atypical	O
pneumonia	O
and	O
subsequently	O
proven	O
to	O
be	O
the	O
causative	O
agent	O
of	O
the	O
disease	O
now	O
referred	O
to	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

The	O
SARS	O
-	O
CoV	O
nucleocapsid	O
(	O
SARS	O
-	O
CoV	O
N	O
)	O
shares	O
little	O
homology	O
with	O
other	O
members	O
of	O
the	O
coronavirus	B-SPEC
family	B-SPEC
.	O

Although	O
the	O
initial	O
severe	O
acute	O
respiratory	O
syndrome	O
epidemic	O
has	O
been	O
controlled	O
by	O
conventional	O
measures	O
,	O
the	O
animal	B-SPEC
reservoir	O
for	O
the	O
coronavirus	B-SPEC
progenitor	O
has	O
not	O
been	O
identified	O
.	O

TITLE	O
:	O
[	O
Detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
RNA	O
in	O
autopsy	O
tissues	O
with	O
in	O
situ	O
hybridization	O
].	O

Immunohistochemistry	O
identified	O
positive	O
monoclonal	O
antibody	O
against	O
SARS	O
-	O
CoV	O
nuceeocapsid	O
(	O
N	O
)	O
protein	O
in	O
the	O
alveolar	O
epithelium	O
and	O
the	O
infiltrating	O
monocytes	O
or	O
macrophages	O
in	O
the	O
lung	O
,	O
spleen	O
and	O
lymph	O
nodes	O
;	O
the	O
presence	O
of	O
the	O
antibody	O
was	O
also	O
detected	O
in	O
the	O
serous	O
gland	O
epithelium	O
of	O
the	O
trachea	B-SPEC
/	O
bronchus	B-SPEC
,	O
squamous	O
epithelium	O
of	O
the	O
esophagus	O
,	O
the	O
gastric	O
parietal	O
cells	O
,	O
the	O
epithelium	O
of	O
the	O
intestinal	O
tract	O
,	O
acidophilic	O
cells	O
in	O
the	O
parathyroids	O
and	O
pituitary	O
,	O
acinus	O
cells	O
in	O
the	O
pancreas	O
,	O
adrenal	O
cortical	O
cells	O
,	O
sweat	O
gland	O
cells	O
,	O
small	O
vessel	O
endothelium	O
,	O
bone	O
marrow	O
promyelocytes	O
,	O
epithelial	O
cells	O
of	O
the	O
distal	O
convoluted	O
tubule	O
of	O
the	O
kidney	O
,	O
brain	O
neurons	O
,	O
and	O
the	O
hepatocytes	O
near	O
the	O
central	O
vein	O
.	O

Air	O
pollution	O
was	O
evaluated	O
by	O
air	O
pollution	O
index	O
(	O
API	B-SPEC
)	O
derived	O
from	O
the	O
concentrations	O
of	O
particulate	O
matter	O
,	O
sulfur	O
dioxide	O
,	O
nitrogen	O
dioxide	O
,	O
carbon	O
monoxide	O
and	O
ground	O
-	O
level	O
ozone	O
.	O

The	O
virus	B-SPEC
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
which	O
may	O
have	O
an	O
origin	O
in	O
wild	O
animals	B-SPEC
such	O
as	O
civet	B-SPEC
cats	I-SPEC
in	O
southern	O
China	O
.	O

Irradiation	O
of	O
UV	O
for	O
60	O
min	O
on	O
the	O
virus	B-SPEC
in	O
culture	O
medium	O
resulted	O
in	O
the	O
destruction	O
of	O
viral	O
infectivity	O
at	O
an	O
undetectable	O
level	O
.	O

Serum	O
antibodies	O
to	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
were	O
measured	O
only	O
in	O
SARS	O
cases	O
.	O

The	O
number	O
of	O
total	O
B	O
cells	O
of	O
clinically	O
diagnosed	O
SARS	O
was	O
(	O
292	O
+/-	O
181	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
,	O
significantly	O
greater	O
than	O
that	O
of	O
healthy	O
adults	O
which	O
was	O
(	O
200	O
+/-	O
65	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
(	O
F	O
=	O
6	O
.	O
17	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
but	O
smaller	O
than	O
that	O
of	O
patients	O
infected	O
with	O
mycoplasma	B-SPEC
pneumonia	O
which	O
was	O
(	O
359	O
+/-	O
168	O
)	O
x	O
10	O
(	O
6	O
)/	O
L	O
(	O
F	O
=	O
6	O
.	O
28	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

It	O
was	O
suggested	O
that	O
the	O
causes	O
for	O
cardiac	O
arrest	O
in	O
SARS	O
patients	O
may	O
include	O
:	O
(	O
1	O
)	O
the	O
lung	O
injury	O
caused	O
by	O
the	O
SARS	O
virus	B-SPEC
leads	O
to	O
hypoxemia	O
and	O
thus	O
an	O
unsteady	O
state	O
of	O
the	O
myocardial	O
electricity	O
;	O
(	O
2	O
)	O
SARS	O
virus	B-SPEC
directly	O
causes	O
injury	O
to	O
the	O
myocardial	O
cells	O
and	O
/	O
or	O
the	O
conduct	O
system	O
;	O
(	O
3	O
)	O
SARS	O
infection	O
aggravates	O
the	O
original	O
myocardial	O
pathological	O
change	O
,	O
worsening	O
the	O
conduct	O
block	O
;	O
(	O
4	O
)	O
extreme	O
anxiety	O
leads	O
to	O
extra	O
secretion	O
of	O
catecholamine	O
,	O
which	O
causes	O
instability	O
of	O
myocardial	O
electricity	O
;	O
(	O
5	O
)	O
defecation	O
worsens	O
hypoxemia	O
,	O
which	O
induces	O
arrhythmia	O
(	O
ventricular	O
fibrillation	O
)	O
and	O
causes	O
cardiac	O
arrest	O
.	O

RESULTS	O
:	O
Four	O
epitopic	O
sites	O
,	O
S599	O
,	O
M137	O
,	O
N66	O
,	O
and	O
N371	O
-	O
404	O
,	O
located	O
in	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
S	O
,	O
M	O
,	O
and	O
N	O
proteins	O
,	O
respectively	O
,	O
were	O
detected	O
by	O
screening	O
synthesized	O
peptides	O
.	O

All	O
tissues	O
positive	O
for	O
virus	B-SPEC
replication	O
also	O
demonstrated	O
lymphoid	O
depletion	O
.	O

Progress	O
has	O
also	O
been	O
made	O
on	O
developing	O
near	O
-	O
patient	O
testing	O
for	O
influenza	O
that	O
may	O
assist	O
individual	O
diagnosis	O
or	O
the	O
recognition	O
of	O
widespread	O
virus	B-SPEC
circulation	O
,	O
and	O
so	O
optimise	O
clinical	O
management	O
.	O

Improvements	O
in	O
animal	B-SPEC
and	O
human	B-SPEC
surveillance	O
,	O
new	O
approaches	O
to	O
vaccination	O
,	O
and	O
increasing	O
use	O
of	O
vaccines	O
and	O
antiviral	O
drugs	O
to	O
combat	O
annual	O
influenza	O
outbreaks	O
are	O
essential	O
to	O
reduce	O
the	O
global	O
toll	O
of	O
pandemic	O
and	O
interpandemic	O
influenza	O
.	O

Direct	O
avian	B-SPEC
-	O
to	O
-	O
human	B-SPEC
influenza	O
transmission	O
was	O
unknown	O
before	O
1997	O
.	O

It	O
was	O
surprising	O
to	O
observe	O
the	O
swift	B-SPEC
growth	O
of	O
this	O
human	B-SPEC
virus	B-SPEC
in	O
Vero	O
cells	O
.	O

These	O
virus	B-SPEC
precursors	O
were	O
also	O
in	O
large	O
vacuoles	O
and	O
in	O
close	O
association	O
with	O
membrane	O
whorls	O
.	O

293T	O
cells	O
transfected	O
with	O
ACE2	O
,	O
but	O
not	O
those	O
transfected	O
with	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
-	O
1	O
receptors	O
,	O
formed	O
multinucleated	O
syncytia	O
with	O
cells	O
expressing	O
S	O
protein	O
.	O

The	O
SARS	O
coronavirus	B-SPEC
recombinant	O
N	O
protein	O
obtained	O
by	O
genetic	O
engineering	O
methods	O
can	O
be	O
used	O
for	O
further	O
functional	O
study	O
of	O
SARS	O
coronavirus	B-SPEC
N	O
protein	O
.	O

Genome	O
sequence	O
confirmed	O
the	O
isolates	O
were	O
SARS	O
-	O
coronavirus	B-SPEC
.	O

Three	O
of	O
thirteen	O
patients	O
had	O
been	O
intubated	O
or	O
received	O
tracheotomy	O
before	O
they	O
entered	O
into	O
ICU	O
,	O
the	O
other	O
patients	O
received	O
treatment	O
of	O
nasal	O
cannula	B-SPEC
or	O
oxygen	O
mask	O
.	O

TITLE	O
:	O
Genomic	O
characterisation	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
of	O
Amoy	O
Gardens	O
outbreak	O
in	O
Hong	O
Kong	O
.	O

The	O
structural	O
model	O
permits	B-SPEC
us	O
to	O
discuss	O
the	O
potential	O
functional	O
roles	O
of	O
the	O
conserved	O
motifs	O
and	O
residues	O
in	O
replication	O
and	O
their	O
potential	O
interactions	O
with	O
inhibitors	O
of	O
related	O
enzymes	O
.	O

ABSTRACT	O
:	O
The	O
SARS	O
virus	B-SPEC
origin	O
which	O
obviously	O
differs	O
from	O
the	O
theory	O
of	O
out	O
-	O
space	O
origin	O
and	O
the	O
theory	O
of	O
wildlife	O
origin	O
was	O
theoretically	O
discussed	O
based	O
on	O
principles	O
of	O
pollution	O
-	O
evolution	O
ecology	O
,	O
pathogenesis	O
and	O
infectant	O
characteristics	O
of	O
SARS	O
,	O
and	O
some	O
relevant	O
experimental	O
evidence	O
.	O

The	O
causative	O
virus	B-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
is	O
moderately	O
contagious	O
,	O
and	O
is	O
spread	O
by	O
droplets	O
and	O
contact	O
.	O

Recent	O
advances	O
have	O
been	O
made	O
in	O
our	O
knowledge	O
of	O
some	O
of	O
these	O
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
and	O
Ebola	B-SPEC
virus	I-SPEC
.	O

The	O
RT	O
-	O
PCR	O
under	O
the	O
same	O
conditions	O
as	O
above	O
could	O
effectively	O
differentiate	O
between	O
TCoV	O
and	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Effects	O
of	O
a	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
vaccine	O
in	O
monkeys	B-SPEC
.	O

Here	O
,	O
we	O
have	O
investigated	O
the	O
ability	O
of	O
adenoviral	B-SPEC
delivery	O
of	O
codon	O
-	O
optimised	O
SARS	O
-	O
CoV	O
strain	O
Urbani	O
structural	O
antigens	O
spike	O
protein	O
S1	O
fragment	O
,	O
membrane	O
protein	O
,	O
and	O
nucleocapsid	O
protein	O
to	O
induce	O
virus	B-SPEC
-	O
specific	O
broad	O
immunity	O
in	O
rhesus	B-SPEC
macaques	I-SPEC
.	O

The	O
vaccinated	O
animals	B-SPEC
all	O
had	O
antibody	O
responses	O
against	O
spike	O
protein	O
S1	O
fragment	O
and	O
T	O
-	O
cell	O
responses	O
against	O
the	O
nucleocapsid	O
protein	O
.	O

Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
functional	O
receptor	O
for	O
the	O
coronavirus	B-SPEC
(	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
CoV	O
)	O
that	O
causes	O
SARS	O
.	O

A	O
bootscan	O
recombination	O
analysis	O
of	O
the	O
spike	O
gene	O
revealed	O
high	O
nucleotide	O
identity	O
between	O
the	O
SARS	O
virus	B-SPEC
and	O
a	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
throughout	O
the	O
gene	O
,	O
except	O
for	O
a	O
200	O
-	O
base	O
-	O
pair	O
region	O
of	O
high	O
identity	O
to	O
an	O
avian	B-SPEC
sequence	O
.	O

To	O
more	O
globally	O
and	O
systematically	O
identify	O
such	O
host	O
factors	O
,	O
we	O
used	O
engineered	O
BMV	B-SPEC
derivatives	O
to	O
assay	O
viral	O
RNA	O
replication	O
in	O
each	O
strain	O
of	O
an	O
ordered	O
,	O
genome	O
-	O
wide	O
set	O
of	O
yeast	B-SPEC
single	O
-	O
gene	O
deletion	O
mutants	O
.	O

Each	O
deletion	O
strain	O
was	O
transformed	O
to	O
express	O
BMV	B-SPEC
replicase	O
proteins	O
and	O
a	O
BMV	B-SPEC
RNA	O
replication	O
template	O
with	O
the	O
capsid	O
gene	O
replaced	O
by	O
a	O
luciferase	O
reporter	O
.	O

This	O
functional	O
genomics	O
approach	O
revealed	O
nearly	O
100	O
genes	O
whose	O
absence	O
inhibited	O
or	O
stimulated	O
BMV	B-SPEC
RNA	O
replication	O
and	O
/	O
or	O
gene	O
expression	O
by	O
3	O
-	O
to	O
>	O
25	O
-	O
fold	O
.	O

In	O
this	O
work	O
,	O
the	O
M	O
protein	O
of	O
SARS	O
-	O
CoV	O
was	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
as	O
fusion	O
protein	O
with	O
maltose	O
binding	O
protein	O
at	O
N	O
-	O
terminus	O
and	O
MxeGyrA	O
intein	O
CBD	O
at	O
C	O
-	O
terminus	O
.	O

Initial	O
studies	O
of	O
the	O
role	O
of	O
the	O
IBV	B-SPEC
nucleocapsid	O
protein	O
(	O
N	O
)	O
in	O
immunity	O
suggested	O
that	O
immunization	O
with	O
bacterially	O
expressed	O
N	O
,	O
while	O
not	O
inducing	O
protection	O
directly	O
,	O
improved	O
the	O
induction	O
of	O
protection	O
by	O
a	O
subsequent	O
inoculation	O
with	O
inactivated	O
IBV	B-SPEC
.	O

Two	O
applications	O
of	O
inactivated	O
IBV	B-SPEC
are	O
much	O
more	O
efficacious	O
,	O
although	O
this	O
is	O
not	O
a	O
commercially	O
viable	O
proposition	O
in	O
the	O
poultry	O
industry	O
.	O

The	O
index	O
cases	O
played	O
an	O
important	O
role	O
in	O
transmission	O
of	O
SARS	O
virus	B-SPEC
among	O
the	O
case	O
clusters	O
,	O
and	O
their	O
infective	O
stages	O
are	O
confined	O
within	O
certain	O
phases	O
of	O
the	O
disease	O
course	O
.	O

In	O
4	O
%	O
of	O
the	O
symptom	O
-	O
free	O
control	O
periods	O
a	O
virus	B-SPEC
was	O
detected	O
.	O

At	O
the	O
same	O
time	O
,	O
we	O
separate	O
the	O
21	O
ORFs	O
into	O
four	O
classes	O
using	O
codition	O
of	O
four	O
gene	O
prediction	O
methods	O
,	O
match	O
score	O
,	O
match	O
expection	O
and	O
match	O
length	O
between	O
predicted	O
gene	O
and	O
Coronavirus	B-SPEC
known	O
gene	O
.	O

Salmonella	B-SPEC
spp	O
were	O
not	O
isolated	O
.	O

Most	O
crias	O
from	O
which	O
potential	O
pathogens	O
were	O
isolated	O
were	O
identified	O
during	O
outbreaks	O
of	O
diarrhea	O
involving	O
other	O
camelids	O
,	O
although	O
only	O
coronavirus	B-SPEC
was	O
isolated	O
from	O
crias	O
identified	O
during	O
outbreaks	O
involving	O
adult	O
camelids	O
.	O

Coronavirus	B-SPEC
was	O
detected	O
throughout	O
the	O
year	O
,	O
whereas	O
protozoa	O
were	O
most	O
commonly	O
isolated	O
during	O
the	O
fall	O
and	O
winter	O
.	O

Intracerebral	O
infection	O
of	O
RAG1	O
(-/-)	O
mice	B-SPEC
with	O
a	O
recombinant	O
CXCL10	O
-	O
expressing	O
murine	B-SPEC
coronavirus	I-SPEC
(	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
)	O
resulted	O
in	O
protection	O
from	O
disease	O
and	O
increased	O
survival	O
that	O
correlated	O
with	O
a	O
significant	O
increase	O
in	O
recruitment	O
and	O
activation	O
of	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
within	O
the	O
CNS	O
.	O

We	O
previously	O
identified	O
a	O
bulged	O
stem	O
-	O
loop	O
secondary	O
structure	O
at	O
the	O
upstream	O
end	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
(	O
3	O
'	O
UTR	O
)	O
of	O
the	O
genome	O
of	O
the	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

Other	O
investigators	O
discovered	O
an	O
adjacent	O
downstream	O
pseudoknot	O
in	O
the	O
3	O
'	O
UTR	O
of	O
the	O
closely	O
related	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
).	O

We	O
also	O
show	O
that	O
lactam	O
12	O
induces	O
apoptosis	O
in	O
human	B-SPEC
breast	O
,	O
prostate	O
,	O
and	O
head	O
-	O
and	O
-	O
neck	O
cancer	B-SPEC
cells	O
.	O

Our	O
results	O
suggest	O
that	O
there	O
is	O
potential	O
for	O
developing	O
this	O
class	B-SPEC
of	O
beta	O
-	O
lactams	O
into	O
novel	O
anticancer	O
agents	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
-	O
induced	O
demyelination	O
occurs	O
in	O
the	O
absence	O
of	O
CD28	O
costimulatory	O
signals	O
.	O

T	O
lymphocytes	O
play	O
an	O
important	O
role	O
in	O
MHV	B-SPEC
infection	O
,	O
and	O
costimulatory	O
signals	O
are	O
an	O
important	O
component	O
of	O
T	O
cell	O
function	O
.	O

Thus	O
,	O
CD28	O
,	O
the	O
costimulatory	O
T	O
cell	O
molecule	O
,	O
is	O
not	O
required	O
for	O
MHV	B-SPEC
infection	O
and	O
MHV	B-SPEC
-	O
induced	O
demyelination	O
.	O

MHV	B-SPEC
replication	O
is	O
impaired	O
in	O
autophagy	O
knockout	O
,	O
APG5	O
-/-,	O
embryonic	O
stem	O
cell	O
lines	O
,	O
but	O
wild	O
-	O
type	O
levels	O
of	O
MHV	B-SPEC
replication	O
are	O
restored	O
by	O
expression	O
of	O
Apg5	O
in	O
the	O
APG5	O
-/-	O
cells	O
.	O

TITLE	O
:	O
Detection	O
of	O
coronavirus	B-SPEC
in	O
the	O
central	O
nervous	O
system	O
of	O
a	O
child	O
with	O
acute	O
disseminated	O
encephalomyelitis	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
associated	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
and	O
causing	O
worldwide	O
outbreaks	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
therapeutic	O
effectiveness	O
of	O
monoclonal	O
TNF	O
antibody	O
(	O
infliximab	O
)	O
in	O
acute	O
edematous	O
and	O
severe	O
necrotizing	O
pancreatitis	O
models	O
in	O
rats	B-SPEC
.	O

TITLE	O
:	O
A	O
recombination	O
event	O
,	O
induced	O
in	O
ovo	B-SPEC
,	O
between	O
a	O
low	O
passage	O
infectious	O
bronchitis	O
virus	B-SPEC
field	O
isolate	O
and	O
a	O
highly	O
embryo	O
adaptedvaccine	O
strain	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
the	O
protection	O
conferred	O
by	O
commercial	O
vaccines	O
against	O
the	O
California	B-SPEC
99	O
isolate	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
An	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
was	O
isolated	O
from	O
commercial	O
broilers	O
from	O
the	O
state	O
of	O
California	B-SPEC
exhibiting	O
respiratory	O
distress	O
,	O
inflamed	O
tracheas	O
,	O
airsaculitis	O
,	O
and	O
edematous	O
lungs	O
.	O

At	O
27	O
days	O
of	O
age	O
the	O
birds	B-SPEC
were	O
challenged	O
via	O
eye	O
drop	O
with	O
the	O
isolated	O
IBV	B-SPEC
California	B-SPEC
99	O
strain	O
.	O

Lymphocyte	O
stimulation	O
test	O
showed	O
a	O
strong	O
reactivity	O
against	O
extract	O
formulation	O
of	O
Hericium	B-SPEC
erinaceum	I-SPEC
(	O
Yamabushitake	O
),	O
which	O
he	O
had	O
taken	O
four	O
months	O
before	O
onset	O
.	O

Five	O
groups	O
were	O
studied	O
:	O
naturally	O
infected	O
dogs	B-SPEC
,	O
experimentally	O
infected	O
dogs	B-SPEC
,	O
dogs	B-SPEC
inoculated	O
with	O
a	O
modified	O
live	O
(	O
ML	O
)	O
CCV	O
vaccine	O
by	O
the	O
intramuscular	O
route	O
,	O
dogs	B-SPEC
inoculated	O
with	O
an	O
ML	O
CCV	O
vaccine	O
by	O
the	O
oronasal	O
route	O
,	O
and	O
dogs	B-SPEC
given	O
an	O
inactivated	O
CCV	O
vaccine	O
.	O

TITLE	O
:	O
Detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
blood	O
of	O
infected	O
patients	O
.	O

Eighteen	O
subjects	O
were	O
investigated	O
,	O
and	O
results	O
indicated	O
that	O
blood	O
samples	O
contain	O
sufficient	O
virus	B-SPEC
for	O
detection	O
by	O
using	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

TITLE	O
:	O
High	O
-	O
resolution	O
computed	O
tomography	O
is	O
useful	O
for	O
early	O
diagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
pneumonia	O
in	O
patients	O
with	O
normal	O
chest	O
radiographs	O
.	O

Among	O
47	O
suspected	O
SARS	O
patients	O
with	O
normal	O
chest	O
radiographs	O
,	O
27	O
had	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
confirmed	O
by	O
RT	O
-	O
PCR	O
and	O
/	O
or	O
positive	O
serological	O
testing	O
.	O

Virus	B-SPEC
entered	O
cells	O
by	O
endocytosis	O
or	O
membrane	O
fusion	O
and	O
was	O
released	O
through	O
a	O
budding	O
process	O
.	O

Virus	B-SPEC
entered	O
cells	O
by	O
endocytosis	O
or	O
membrane	O
fusion	O
and	O
was	O
released	O
through	O
a	O
budding	O
process	O
.	O

Furthermore	O
mice	B-SPEC
with	O
gp33	O
-	O
41	O
-	O
specific	O
CD8	O
(+)	O
cells	O
exhibited	O
much	O
reduced	O
levels	O
of	O
viral	O
antigen	O
in	O
the	O
brain	O
as	O
measured	O
by	O
immunohistochemistry	O
using	O
an	O
antibody	O
directed	O
against	O
viral	O
nucleocapsid	O
.	O

Attention	O
to	O
the	O
psychological	O
state	O
of	O
patients	O
and	O
family	B-SPEC
members	O
should	O
not	O
be	O
overlooked	O
.	O

TITLE	O
:	O
Preparation	O
and	O
characterization	O
of	O
monoclonal	O
antibodies	O
against	O
S1	O
domain	O
at	O
N	O
-	O
terminal	O
residues	O
249	O
to	O
667	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
S1	O
protein	O
.	O

TITLE	O
:	O
Molecular	O
epidemiology	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
emerged	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
which	O
spread	O
globally	O
in	O
early	O
2003	O
,	O
affecting	O
over	O
30	O
countries	O
.	O

Adult	O
rabbits	B-SPEC
(	O
2	O
.	O
0	O
-	O
3	O
.	O
5	O
kg	O
,	O
n	O
=	O
33	O
)	O
were	O
randomized	O
to	O
receive	O
intratracheal	O
meconium	O
instillation	O
for	O
30	O
min	O
and	O
subjected	O
to	O
following	O
treatment	O
(	O
n	O
=	O
6	O
-	O
8	O
).	O

Compared	O
to	O
various	O
strains	O
among	O
SARS	O
-	O
CoV	O
Yexin	O
genotype	O
and	O
Xiaohong	O
genotype	O
,	O
GD01	O
strain	O
of	O
Yexin	O
genotype	O
is	O
more	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
like	O
-	O
virus	B-SPEC
from	O
animals	B-SPEC
.	O

Throat	O
swabs	O
or	O
nasopharyngeal	O
aspirate	O
specimens	O
were	O
collected	O
from	O
those	O
patients	O
and	O
common	O
respiratory	O
virus	B-SPEC
antigens	O
including	O
influenza	B-SPEC
virus	I-SPEC
A	O
and	O
B	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
adenovirus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
types	O
I	O
,	O
II	O
,	O
and	O
III	O
were	O
tested	O
by	O
indirect	O
immunofluorescent	O
assay	O
.	O

Antigens	O
for	O
the	O
common	O
respiratory	O
viruses	B-SPEC
were	O
all	O
negative	O
,	O
RT	O
-	O
PCR	O
for	O
HMPV	B-SPEC
,	O
RhV	O
and	O
EV	O
were	O
also	O
negative	O
while	O
RT	O
-	O
PCR	O
with	O
different	O
primer	O
pairs	O
for	O
SARS	O
virus	B-SPEC
were	O
all	O
positive	O
which	O
indicated	O
that	O
SARS	O
coronavirus	B-SPEC
gene	O
fragments	O
were	O
amplified	O
from	O
the	O
specimen	O
from	O
this	O
girl	O
.	O

TITLE	O
:	O
Expression	O
and	O
purification	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
nucleocapsid	O
protein	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

RESULTS	O
:	O
Compared	O
with	O
the	O
endotoxemic	O
group	O
,	O
both	O
the	O
pretreatment	O
and	O
simultaneously	O
treatment	O
groups	O
,	O
significantly	O
improved	O
PaO2	O
,	O
pH	O
,	O
MAP	O
and	O
5th	O
hour	O
survival	O
rate	O
of	O
rats	B-SPEC
,	O
and	O
attenuated	O
endotoxin	O
-	O
induced	O
increased	O
iNOSmRNA	O
,	O
NT	O
expression	O
,	O
MPO	O
activity	O
and	O
MDA	O
level	O
in	O
lung	O
tissue	O
,	O
and	O
decreased	O
pulmonary	O
microvascular	O
permeability	O
,	O
TNF	O
-	O
alpha	O
,	O
NO	O
in	O
plasma	O
.	O

This	O
virus	B-SPEC
commonly	O
induces	O
mild	O
to	O
severe	O
respiratory	O
signs	O
but	O
,	O
in	O
a	O
substantial	O
proportion	O
of	O
cases	O
,	O
is	O
also	O
reported	O
to	O
be	O
associated	O
with	O
paroxystic	O
respiratory	O
distress	O
syndrome	O
(	O
PRDS	O
).	O

We	O
previously	O
demonstrated	O
that	O
JHM	O
-	O
infected	O
mice	B-SPEC
that	O
only	O
have	O
CD8	O
T	O
cells	O
specific	O
for	O
an	O
epitope	O
not	O
in	O
the	O
virus	B-SPEC
develop	O
demyelination	O
on	O
specific	O
activation	O
of	O
these	O
cells	O
.	O

Infected	O
pneumocytes	O
were	O
further	O
confirmed	O
by	O
immunofluorescence	O
-	O
fluorescence	O
in	O
-	O
situ	O
hybridization	O
(	O
FISH	B-SPEC
)	O
analysis	O
.	O

ABSTRACT	O
:	O
Highly	O
pathogenic	O
avian	B-SPEC
influenza	O
A	O
viruses	B-SPEC
of	O
subtypes	O
H5	O
and	O
H7	O
are	O
the	O
causative	O
agents	O
of	O
fowl	O
plague	O
in	O
poultry	O
.	O

Because	O
H7N7	O
viruses	B-SPEC
have	O
caused	O
disease	O
in	O
mammals	B-SPEC
,	O
including	O
horses	B-SPEC
,	O
seals	B-SPEC
,	O
and	O
humans	B-SPEC
,	O
on	O
several	O
occasions	O
in	O
the	O
past	O
,	O
they	O
may	O
be	O
unusual	O
in	O
their	O
zoonotic	O
potential	O
and	O
,	O
thus	O
,	O
form	O
a	O
pandemic	O
threat	O
to	O
humans	B-SPEC
.	O

TITLE	O
:	O
Simultaneous	O
detection	O
of	O
fourteen	O
respiratory	O
viruses	B-SPEC
in	O
clinical	O
specimens	O
by	O
two	O
multiplex	O
reverse	O
transcription	O
nested	O
-	O
PCR	O
assays	O
.	O

TITLE	O
:	O
ACE2	O
X	O
-	O
ray	B-SPEC
structures	O
reveal	O
a	O
large	O
hinge	O
-	O
bending	O
motion	O
important	O
for	O
inhibitor	O
binding	O
and	O
catalysis	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
-	O
associated	O
communicable	O
respiratory	O
disease	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
spread	O
worldwide	O
after	O
an	O
outbreak	O
in	O
Guangdong	O
Province	O
of	O
the	O
People	O
'	O
s	O
Republic	O
of	O
China	O
in	O
November	O
2002	O
.	O

There	O
are	O
two	O
main	O
moments	O
marking	O
the	O
reemergence	O
and	O
evolution	O
of	O
SARS	O
:	O
firstly	O
,	O
the	O
onset	O
of	O
the	O
epidemic	O
in	O
China	O
in	O
November	O
2002	O
followed	O
by	O
the	O
worldwide	O
spread	O
of	O
the	O
epidemiological	O
process	O
,	O
and	O
secondly	O
the	O
discovery	O
of	O
SARS	O
virus	B-SPEC
as	O
a	O
mutant	O
of	O
coronaviruses	O
in	O
March	O
-	O
April	O
2003	O
in	O
USA	O
,	O
Canada	O
,	O
and	O
Hong	O
Kong	O
.	O

TITLE	O
:	O
Smallpox	B-SPEC
and	O
bioterrorism	O
.	O

ABSTRACT	O
:	O
Smallpox	B-SPEC
was	O
declared	O
to	O
be	O
eradicated	O
on	O
8	O
May	O
1980	O
,	O
during	O
the	O
Thirty	O
-	O
third	O
World	O
Health	O
Assembly	O
.	O

The	O
availability	O
of	O
complete	O
genome	O
sequence	O
of	O
several	O
strains	O
of	O
SARS	O
virus	B-SPEC
provides	O
the	O
possibility	O
of	O
identification	O
of	O
protein	O
-	O
coding	O
genes	O
and	O
defining	O
their	O
functions	O
.	O

This	O
case	O
illustrates	O
the	O
wide	O
spectrum	O
of	O
clinical	O
illness	O
caused	O
by	O
infection	O
with	O
SARS	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Mild	O
illness	O
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
:	O
lessons	O
from	O
a	O
prospective	O
seroepidemiologic	O
study	O
of	O
health	O
-	O
care	O
workers	O
in	O
a	O
teaching	O
hospital	O
in	O
Singapore	O
.	O

183	O
family	B-SPEC
medicine	O
tutors	O
affiliated	O
with	O
a	O
local	O
university	O
.	O

The	O
purpose	O
of	O
this	O
paper	O
is	O
to	O
share	O
our	O
experiences	O
in	O
caring	O
for	O
critically	O
ill	O
patients	O
with	O
SARS	O
in	O
the	O
intensive	O
care	O
unit	O
to	O
nurses	O
globally	O
in	O
order	B-SPEC
to	O
reduce	O
SARS	O
'	O
morbidity	O
and	O
mortality	O
as	O
well	O
as	O
to	O
protect	O
nurses	O
and	O
other	O
healthcare	O
workers	O
from	O
this	O
disease	O
that	O
is	O
so	O
far	O
threatening	O
the	O
community	O
at	O
large	O
.	O

Similar	O
LTH	O
structures	O
could	O
be	O
predicted	O
for	O
the	O
5	O
'-	O
proximal	O
region	O
of	O
all	O
arterivirus	B-SPEC
genomes	O
and	O
,	O
interestingly	O
,	O
also	O
for	O
most	O
coronaviruses	O
.	O

The	O
recombinant	O
N	O
-	O
terminal	O
protein	O
of	O
SARS	O
virus	B-SPEC
S1	O
subunit	O
displays	O
specific	O
reaction	O
with	O
SARS	O
antibody	O
and	O
may	O
provide	O
a	O
good	O
tool	O
for	O
further	O
research	O
of	O
immune	O
response	O
to	O
SARS	O
virus	B-SPEC
.	O

RESULTS	O
:	O
Sequencing	O
analysis	O
confirmed	O
that	O
the	O
desired	O
DNA	O
sequence	O
in	O
recombinant	O
plasmid	O
was	O
correct	O
and	O
had	O
the	O
same	O
sequence	O
of	O
natural	O
N	O
-	O
terminal	O
of	O
SARS	O
virus	B-SPEC
S1	O
subunit	O
.	O

TITLE	O
:	O
Insurance	O
and	O
epidemics	O
:	O
SARS	O
,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
and	O
Nipah	B-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
A	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
has	O
been	O
reported	O
to	O
be	O
the	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

However	O
,	O
despite	O
the	O
absence	O
of	O
detectable	O
viral	O
titers	O
,	O
approximately	O
40	O
%	O
of	O
S4R22	O
-	O
infected	O
mice	B-SPEC
succumbed	O
within	O
3	O
weeks	O
,	O
indicating	O
that	O
the	O
enhanced	O
mortality	O
following	O
S4R22	O
infection	O
was	O
not	O
associated	O
with	O
high	O
viral	O
titers	O
.	O

Currently	O
,	O
an	O
antisense	O
drug	O
targeting	O
Bcl	O
-	O
2	O
(	O
G3139	O
/	O
Genasense	O
(	O
TM	O
),	O
Genta	O
,	O
Inc	O
.)	O
is	O
in	O
late	O
-	O
stage	O
cancer	B-SPEC
trials	O
and	O
may	O
be	O
on	O
the	O
market	O
for	O
those	O
indications	O
in	O
months	O
.	O

We	O
therefore	O
suggest	O
that	O
pegylated	O
IFN	O
-	O
alpha	O
protects	O
type	O
1	O
pneumocytes	O
from	O
SCV	B-SPEC
infection	O
,	O
and	O
should	O
be	O
considered	O
a	O
candidate	O
drug	O
for	O
SARS	O
therapy	O
.	O

Placing	O
the	O
patient	O
in	O
prone	O
position	O
immediately	O
and	O
persistently	O
improved	O
oxygenation	O
:	O
the	O
ratio	O
of	O
P	O
(	O
aO	O
(	O
2	O
))	O
to	O
fraction	O
of	O
inspired	O
oxygen	O
rose	B-SPEC
from	O
47	O
to	O
180	O
mm	O
Hg	O
and	O
the	O
oxygenation	O
index	O
decreased	O
from	O
40	O
to	O
11	O
.	O

The	O
authors	O
have	O
previously	O
shown	O
that	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
gene	O
of	O
MHV	B-SPEC
contains	O
determinants	O
of	O
virulence	O
,	O
hepatitis	O
,	O
and	O
demyelination	O
.	O

GA	O
did	O
not	O
inhibit	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
thymidine	O
kinase	O
.	O

Since	O
GA	O
inhibits	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
through	O
a	O
cellular	O
mechanism	O
unique	O
among	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
agents	O
,	O
we	O
consider	O
it	O
a	O
new	O
candidate	O
agent	O
for	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
.	O

The	O
mismatch	O
distribution	O
indicated	O
that	O
SARS	O
viral	O
genomes	O
did	O
not	O
reach	O
equilibrium	O
and	O
suggested	O
a	O
recent	O
introduction	O
of	O
the	O
viruses	B-SPEC
into	O
human	B-SPEC
populations	O
.	O

The	O
RNAi	O
methodology	O
has	O
been	O
used	O
as	O
a	O
tool	O
to	O
silence	O
genes	O
in	O
cultured	O
cells	O
and	O
in	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
described	O
form	O
of	O
atypical	O
pneumonia	O
linked	O
to	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

Viral	O
particles	O
,	O
consistent	O
with	O
coronavirus	B-SPEC
,	O
could	O
be	O
detected	O
in	O
lung	O
pneumocytes	O
in	O
most	O
of	O
the	O
patients	O
.	O

TITLE	O
:	O
Requirements	O
for	O
CEACAMs	O
and	O
cholesterol	O
during	O
murine	B-SPEC
coronavirus	I-SPEC
cell	O
entry	O
.	O

Furthermore	O
,	O
engineered	O
CEACAMs	O
appended	O
to	O
glycosylphosphatidylinositol	O
anchors	O
partitioned	O
with	O
TX	O
-	O
100	O
-	O
resistant	O
lipid	O
rafts	O
,	O
but	O
cells	O
bearing	O
these	O
raft	O
-	O
associated	O
CEACAMs	O
were	O
not	O
hypersensitive	O
to	O
MHV	B-SPEC
infection	O
.	O

Northern	O
blot	O
analysis	O
demonstrated	O
that	O
the	O
IRES	O
-	O
containing	O
D	O
-	O
RNAs	O
were	O
not	O
rescued	O
on	O
serial	O
passage	O
with	O
helper	O
virus	B-SPEC
,	O
indicating	O
that	O
the	O
EMCV	B-SPEC
IRES	O
sequence	O
had	O
a	O
detrimental	O
effect	O
on	O
IBV	B-SPEC
D	O
-	O
RNA	O
rescue	O
.	O

Especially	O
,	O
Korean	O
IBV	B-SPEC
isolates	O
K069	O
-	O
01	O
,	O
K507	O
-	O
01	O
,	O
K774	O
-	O
01	O
and	O
K142	O
-	O
02	O
formed	O
a	O
separate	O
cluster	O
.	O

TITLE	O
:	O
The	O
phylogeny	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

Moreover	O
,	O
significant	O
toxicity	O
,	O
such	O
as	O
hemolytic	O
anemia	B-SPEC
,	O
has	O
been	O
attributed	O
to	O
ribavirin	O
.	O

Two	O
-	O
thirds	O
of	O
the	O
respondents	O
reported	O
SARS	O
-	O
related	O
concern	O
for	O
their	O
own	O
or	O
their	O
family	B-SPEC
'	O
s	O
health	O
.	O

Logistic	O
regression	O
analysis	O
identified	O
4	O
factors	O
as	O
being	O
significantly	O
associated	O
with	O
increased	O
levels	O
of	O
concern	O
for	O
personal	O
or	O
family	B-SPEC
health	O
:	O
perception	O
of	O
a	O
greater	O
risk	O
of	O
death	O
from	O
SARS	O
(	O
adjusted	O
odds	O
ratio	O
[	O
OR	O
]	O
5	O
.	O
0	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
2	O
.	O
6	O
-	O
9	O
.	O
6	O
),	O
living	O
with	O
children	O
(	O
adjusted	O
OR	O
1	O
.	O
8	O
,	O
95	O
%	O
CI	O
1	O
.	O
5	O
-	O
2	O
.	O
3	O
),	O
personal	O
or	O
family	B-SPEC
lifestyle	O
affected	O
by	O
SARS	O
outbreak	O
(	O
adjusted	O
OR	O
3	O
.	O
3	O
,	O
95	O
%	O
CI	O
2	O
.	O
5	O
-	O
4	O
.	O
3	O
)	O
and	O
being	O
treated	O
differently	O
by	O
people	O
because	O
of	O
working	O
in	O
a	O
hospital	O
(	O
adjusted	O
OR	O
1	O
.	O
6	O
,	O
95	O
%	O
CI	O
1	O
.	O
2	O
-	O
2	O
.	O
1	O
).	O

TITLE	O
:	O
Tracking	O
the	O
evolution	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
using	O
high	O
-	O
throughput	O
,	O
high	O
-	O
density	O
resequencing	O
arrays	O
.	O

Systematic	O
peptide	O
mapping	O
showed	O
that	O
the	O
site	O
of	O
interaction	O
between	O
the	O
HR	O
-	O
N	O
and	O
HR	O
-	O
C	O
regions	O
is	O
between	O
residues	O
916	O
-	O
950	O
of	O
HR	O
-	O
N	O
and	O
residues	O
1151	O
-	O
1185	O
of	O
HR	O
-	O
C	O
.	O
Additionally	O
,	O
interchain	O
disulfide	O
bridge	O
experiments	O
showed	O
that	O
the	O
relative	O
orientation	O
of	O
the	O
HR	O
-	O
N	O
and	O
HR	O
-	O
C	O
helices	B-SPEC
in	O
the	O
complex	O
was	O
antiparallel	O
.	O

Evidence	O
-	O
based	O
recommendations	O
can	O
be	O
made	O
regarding	O
many	O
aspects	O
of	O
the	O
acute	O
management	O
of	O
sepsis	B-SPEC
and	O
septic	O
shock	O
that	O
will	O
hopefully	O
translate	O
into	O
improved	O
outcomes	O
for	O
the	O
critically	O
ill	O
patient	O
.	O

TITLE	O
:	O
Preclinical	O
evaluation	O
of	O
two	O
real	O
-	O
time	O
,	O
reverse	O
transcription	O
-	O
PCR	O
assays	O
for	O
detection	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
replicative	O
protein	O
nsp9	O
is	O
a	O
single	O
-	O
stranded	O
RNA	O
-	O
binding	O
subunit	O
unique	O
in	O
the	O
RNA	O
virus	B-SPEC
world	O
.	O

During	O
anti	O
-	O
cancer	B-SPEC
therapy	O
,	O
she	O
developed	O
a	O
high	O
fever	O
(	O
above	O
39	O
degrees	O
C	O
)	O
and	O
a	O
chest	O
and	O
an	O
abdominal	O
CT	O
scan	O
revealed	O
splenic	O
infarction	O
.	O

TITLE	O
:	O
Effects	O
of	O
infection	O
with	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
on	O
concomitant	O
immune	O
responses	O
to	O
dietary	O
and	O
injected	O
antigens	O
.	O

The	O
results	O
suggest	O
that	O
an	O
enteric	O
virus	B-SPEC
,	O
either	O
used	O
as	O
a	O
vaccine	O
vector	O
or	O
present	O
as	O
a	O
subclinical	O
infection	O
,	O
may	O
not	O
have	O
significant	O
effects	O
on	O
the	O
development	O
of	O
dietary	O
allergies	O
but	O
may	O
have	O
effects	O
both	O
on	O
the	O
primary	O
response	O
and	O
on	O
the	O
subsequent	O
recall	O
response	O
to	O
systemic	O
antigens	O
to	O
which	O
the	O
animal	B-SPEC
is	O
exposed	O
concurrently	O
with	O
virus	B-SPEC
antigens	O
.	O

ABSTRACT	O
:	O
A	O
new	O
coronavirus	B-SPEC
(	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
[	O
SARS	O
-	O
CoV	O
])	O
has	O
been	O
identified	O
to	O
be	O
the	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

A	O
truncated	O
195	O
-	O
amino	O
-	O
acid	O
fragment	O
from	O
the	O
C	O
terminus	O
of	O
the	O
nucleocapsid	O
protein	O
(	O
N195	O
)	O
was	O
identified	O
that	O
had	O
a	O
strong	O
ability	O
to	O
detect	O
antibodies	O
against	O
SARS	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Prior	O
infection	O
and	O
passive	O
transfer	O
of	O
neutralizing	O
antibody	O
prevent	O
replication	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
the	O
respiratory	O
tract	O
of	O
mice	B-SPEC
.	O

Mice	B-SPEC
developed	O
a	O
neutralizing	O
antibody	O
response	O
and	O
were	O
protected	O
from	O
reinfection	O
28	O
days	O
following	O
primary	O
infection	O
.	O

Based	O
on	O
evolutionary	O
analyses	O
of	O
coronavirus	B-SPEC
DNA	O
sequences	O
,	O
encompassing	O
an	O
approximately	O
13kb	O
stretch	O
of	O
the	O
SARS	O
-	O
TOR2	O
genome	O
,	O
we	O
provide	O
evidence	O
that	O
SARS	O
-	O
CoV	O
has	O
a	O
recombinant	O
history	O
with	O
lineages	O
of	O
types	O
I	O
and	O
III	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
),	O
an	O
emerging	O
disease	O
characterized	O
by	O
atypical	O
pneumonia	O
,	O
has	O
recently	O
been	O
attributed	O
to	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

Our	O
aim	O
was	O
to	O
establish	O
a	O
rodent	B-SPEC
model	O
of	O
fracture	O
which	O
caused	O
lung	O
injury	O
and	O
subsequently	O
to	O
administer	O
a	O
drug	O
following	O
fracture	O
to	O
attenuate	O
the	O
lung	O
injury	O
.	O

Experiments	O
were	O
performed	O
to	O
elucidate	O
the	O
duration	O
of	O
enterotropic	O
MHV	B-SPEC
-	O
Y	O
shedding	O
by	O
immunocompetent	O
BALB	O
/	O
c	O
and	O
C57BL	O
/	O
6	O
mice	B-SPEC
and	O
immunocompromised	O
B	O
and	O
T	O
cell	O
-	O
deficient	O
mice	B-SPEC
.	O

By	O
now	O
the	O
putative	O
pathogen	O
of	O
SARS	O
has	O
been	O
identified	O
as	O
a	O
new	O
coronavirus	B-SPEC
,	O
a	O
single	O
positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
.	O

Moreover	O
,	O
finding	O
a	O
date	O
for	O
the	O
last	O
common	O
ancestor	O
of	O
SARS	O
coronavirus	B-SPEC
strains	O
would	O
be	O
useful	O
for	O
understanding	O
the	O
circumstances	O
surrounding	O
the	O
emergence	O
of	O
the	O
SARS	O
pandemic	O
and	O
the	O
rate	O
at	O
which	O
SARS	O
coronavirus	B-SPEC
diverge	O
.	O

Based	O
on	O
6	O
strains	O
with	O
accurate	O
dates	O
of	O
host	O
death	O
,	O
we	O
estimated	O
the	O
time	O
of	O
the	O
last	O
common	O
ancestor	O
to	O
be	O
about	O
August	O
or	O
September	O
2002	O
,	O
and	O
the	O
evolution	O
rate	O
to	O
be	O
about	O
0	O
.	O
16	O
base	O
/	O
day	O
,	O
that	O
is	O
,	O
the	O
SARS	O
coronavirus	B-SPEC
would	O
on	O
average	O
change	O
a	O
base	O
every	O
seven	O
days	O
.	O

RESULTS	O
:	O
Based	O
on	O
6	O
strains	O
with	O
accurate	O
dates	O
of	O
host	O
death	O
,	O
we	O
estimated	O
the	O
time	O
of	O
the	O
last	O
common	O
ancestor	O
to	O
be	O
about	O
August	O
or	O
September	O
2002	O
,	O
and	O
the	O
evolution	O
rate	O
to	O
be	O
about	O
0	O
.	O
16	O
base	O
/	O
day	O
,	O
that	O
is	O
,	O
the	O
SARS	O
coronavirus	B-SPEC
would	O
on	O
average	O
change	O
a	O
base	O
every	O
seven	O
days	O
.	O

Attempts	O
at	O
virus	B-SPEC
isolation	O
were	O
unsuccessful	O
;	O
however	O
,	O
viral	O
RNA	O
was	O
detected	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
in	O
blood	O
of	O
both	O
species	B-SPEC
during	O
the	O
first	O
week	O
after	O
inoculation	O
,	O
and	O
in	O
chicken	B-SPEC
organs	O
at	O
2	O
weeks	O
after	O
inoculation	O
.	O

Eight	O
(	O
2	O
%)	O
were	O
laboratory	O
-	O
confirmed	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infections	O
,	O
206	O
(	O
52	O
%)	O
were	O
SARS	O
-	O
CoV	O
negative	O
,	O
and	O
184	O
(	O
46	O
%)	O
had	O
undetermined	O
SARS	O
-	O
CoV	O
status	O
because	O
of	O
missing	O
convalescent	O
-	O
phase	O
serum	O
specimens	O
.	O

We	O
conducted	O
an	O
investigation	O
of	O
healthcare	O
workers	O
exposed	O
to	O
laboratory	O
-	O
confirmed	O
SARS	O
patients	O
in	O
the	O
United	O
States	O
to	O
evaluate	O
infection	O
-	O
control	O
practices	O
and	O
possible	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
transmission	O
.	O

Our	O
study	O
documents	O
lack	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
transmission	O
to	O
hospital	O
B	O
workers	O
,	O
despite	O
variable	O
infection	O
control	O
measures	O
and	O
the	O
use	O
of	O
personal	O
protective	O
equipment	O
.	O

Although	O
viral	O
RNA	O
remained	O
detectable	O
in	O
respiratory	O
secretions	O
and	O
stool	O
and	O
urine	O
specimens	O
for	O
>	O
30	O
days	O
in	O
some	O
patients	O
,	O
virus	B-SPEC
could	O
not	O
be	O
cultured	O
after	O
week	O
3	O
of	O
illness	O
.	O

A	O
balanced	O
approach	O
to	O
screening	O
that	O
allows	O
early	O
recognition	O
of	O
SARS	O
without	O
unnecessary	O
isolation	O
of	O
patients	O
with	O
other	O
respiratory	O
illnesses	O
will	O
require	O
clinicians	O
not	O
only	O
to	O
look	O
for	O
suggestive	O
clinical	O
features	O
but	O
also	O
to	O
routinely	O
seek	O
epidemiologic	O
clues	O
suggestive	O
of	O
SARS	O
coronavirus	B-SPEC
exposure	O
.	O

TITLE	O
:	O
Possible	O
central	O
nervous	O
system	O
infection	O
by	O
SARS	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
-	I-SPEC
related	I-SPEC
coronavirus	I-SPEC
is	O
inhibited	O
by	O
interferon	O
-	O
alpha	O
.	O

ABSTRACT	O
:	O
Three	O
human	B-SPEC
coronaviruses	O
are	O
known	O
to	O
exist	O
:	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
),	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Our	O
investigation	O
found	O
that	O
most	O
of	O
the	O
patients	O
with	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
/	O
AIDS	O
were	O
receiving	O
treatment	O
of	O
highly	O
active	O
antiretroviral	O
therapy	O
(	O
HAART	O
)	O
during	O
hospitalization	O
.	O

The	O
lung	O
vascular	O
permeability	O
in	O
pioglitazone	O
-	O
treated	O
animals	B-SPEC
was	O
reduced	O
by	O
55	O
%	O
of	O
the	O
increase	O
of	O
Evans	O
blue	O
dye	O
extravasation	O
relative	O
to	O
control	O
animals	B-SPEC
(	O
P	O
=	O
0	O
.	O
003	O
).	O

Previously	O
the	O
functional	O
role	O
of	O
this	O
extra	O
domain	O
has	O
been	O
completely	O
unknown	O
,	O
and	O
it	O
was	O
believed	O
that	O
the	O
coronavirus	B-SPEC
3CL	O
proteases	O
share	O
the	O
same	O
enzymatic	O
mechanism	O
with	O
picornavirus	B-SPEC
3C	O
proteases	O
,	O
which	O
contain	O
the	O
chymotrypsin	O
fold	O
but	O
have	O
no	O
extra	O
domain	O
.	O

Co	O
-	O
delivery	O
of	O
inactivated	O
pseudorabies	O
herpesvirus	B-SPEC
(	O
iPRV	O
)	O
with	O
protein	O
redirected	O
IgG1	O
-	O
dominated	O
tetanus	O
toxoid	O
-	O
specific	O
responses	O
towards	O
an	O
IgG1	O
/	O
IgG2a	O
balanced	O
response	O
.	O

Also	O
inactivated	O
preparations	O
of	O
viruses	B-SPEC
from	O
the	O
paramyxo	O
-	O
(	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
),	O
rhabdo	O
-	O
(	O
rabies	B-SPEC
virus	I-SPEC
),	O
corona	B-SPEC
-	O
(	O
infectious	O
bronchitis	O
virus	B-SPEC
)	O
and	O
reovirus	B-SPEC
(	O
avian	B-SPEC
reovirus	I-SPEC
)	O
families	O
led	O
to	O
IgG2a	O
antibody	O
responses	O
;	O
however	O
,	O
the	O
genetic	O
background	O
of	O
the	O
host	O
did	O
result	O
in	O
considerable	O
variation	O
.	O

These	O
findings	O
have	O
a	O
bearing	O
on	O
the	O
understanding	O
of	O
immune	O
responsiveness	O
to	O
virus	B-SPEC
structures	O
and	O
the	O
design	O
of	O
vaccines	O
containing	O
virus	B-SPEC
components	O
.	O

TITLE	O
:	O
Analysis	O
of	O
synonymous	O
codon	O
usage	O
in	O
SARS	O
Coronavirus	B-SPEC
and	O
other	O
viruses	B-SPEC
in	O
the	O
Nidovirales	B-SPEC
.	O

The	O
pathogenesis	O
of	O
SARS	O
might	O
involve	O
the	O
immune	O
status	O
of	O
the	O
potential	O
patients	O
,	O
and	O
immunodeficient	O
individuals	O
are	O
at	O
the	O
risk	O
of	O
becoming	O
asymptomatic	O
carriers	O
of	O
SARS	O
virus	B-SPEC
and	O
the	O
infectious	O
sources	O
.	O

ABSTRACT	O
:	O
The	O
differential	O
diagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
patients	O
with	O
cancer	B-SPEC
can	O
be	O
challenging	O
.	O

The	O
authors	O
report	O
their	O
experience	O
with	O
the	O
exclusion	O
and	O
quarantine	O
of	O
patients	O
with	O
cancer	B-SPEC
during	O
the	O
peak	O
of	O
the	O
SARS	O
epidemic	O
in	O
Beijing	O
,	O
China	O
.	O

ABSTRACT	O
:	O
Studies	O
on	O
the	O
fusion	O
-	O
inhibitory	O
peptides	O
derived	O
from	O
the	O
heptad	O
repeat	O
1	O
and	O
2	O
(	O
HR1	O
and	O
HR2	O
)	O
regions	O
of	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
envelope	O
glycoprotein	O
gp41	O
provided	O
crucial	O
information	O
on	O
the	O
viral	O
fusogenic	O
mechanism	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
fatal	O
immunity	O
-	O
mediated	O
disease	O
caused	O
by	O
mutants	O
of	O
a	O
ubiquitous	O
coronavirus	B-SPEC
.	O

The	O
FIP	O
virus	B-SPEC
(	O
FIPV	O
)	O
mutant	O
lacking	O
the	O
3abc	O
cluster	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
the	O
mutant	O
missing	O
the	O
7ab	O
cluster	O
,	O
protected	O
cats	B-SPEC
against	O
a	O
lethal	O
homologous	O
challenge	O
;	O
no	O
protection	O
was	O
obtained	O
with	O
the	O
mutant	O
devoid	O
of	O
both	O
gene	O
clusters	O
.	O

Our	O
studies	O
show	O
that	O
the	O
deletion	O
of	O
group	O
-	O
specific	O
genes	O
from	O
the	O
coronavirus	B-SPEC
genome	O
results	O
in	O
live	O
attenuated	O
candidate	O
vaccines	O
against	O
FIPV	O
.	O

In	O
the	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
section	O
,	O
the	O
new	O
recommendation	O
is	O
to	O
determine	O
,	O
on	O
a	O
case	O
-	O
by	O
-	O
case	O
basis	O
,	O
whether	O
to	O
administer	O
monoclonal	O
antibody	O
(	O
palivizumab	O
)	O
to	O
certain	O
infants	O
and	O
children	O
aged	O
<	O
24	O
months	O
who	O
were	O
born	O
prematurely	O
and	O
are	O
at	O
high	O
risk	O
for	O
RSV	B-SPEC
infection	O
.	O

TITLE	O
:	O
One	O
-	O
tube	O
nested	O
RT	O
-	O
PCR	O
enabled	O
by	O
using	O
a	O
plastic	O
film	O
and	O
its	O
application	O
for	O
the	O
rapid	O
detection	O
of	O
SARS	O
-	O
virus	B-SPEC
.	O

Whilst	O
serum	O
total	O
LD	O
could	O
only	O
achieve	O
AUC	O
of	O
0	O
.	O
68	O
(	O
CI	O
=	O
0	O
.	O
59	O
-	O
0	O
.	O
77	O
)	O
for	O
predicting	O
death	O
,	O
LD1	O
isoenzyme	O
was	O
found	O
to	O
be	O
the	O
best	O
biochemical	O
prognostic	O
indicator	B-SPEC
with	O
AUC	O
of	O
0	O
.	O
84	O
(	O
CI	O
=	O
0	O
.	O
75	O
-	O
0	O
.	O
90	O
),	O
sensitivity	O
of	O
62	O
%	O
(	O
CI	O
=	O
46	O
-	O
76	O
%),	O
specificity	O
of	O
93	O
%	O
(	O
CI	O
=	O
83	O
-	O
98	O
%)	O
at	O
cut	O
-	O
off	O
activity	O
of	O
>	O
or	O
=	O
80	O
U	O
L	O
(-	O
1	O
).	O

HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
has	O
been	O
recently	O
involved	O
in	O
nosocomial	O
respiratory	O
viral	O
infections	O
in	O
high	O
-	O
risk	O
children	O
.	O

For	O
this	O
purpose	O
,	O
we	O
investigated	O
the	O
antigenicity	O
of	O
different	O
regions	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
.	O

Infection	O
with	O
SARS	O
-	O
CoV	O
in	O
traders	O
of	O
animal	B-SPEC
markets	O
possibly	O
related	O
to	O
their	O
direct	O
exposure	O
to	O
wild	O
animals	B-SPEC
,	O
particularly	O
to	O
civet	B-SPEC
cats	I-SPEC
.	O

Preparation	O
should	O
include	O
correcting	O
coagulopathy	O
,	O
minimizing	O
preexisting	O
encephalopathy	O
,	O
preventing	O
sepsis	B-SPEC
,	O
and	O
optimizing	O
renal	O
function	O
.	O

Infection	O
was	O
diagnosed	O
by	O
serology	O
and	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
using	O
primers	O
directed	O
to	O
two	O
separate	O
but	O
highly	O
conserved	O
regions	O
of	O
the	O
MHV	B-SPEC
genome	O
.	O

From	O
published	O
studies	O
,	O
we	O
estimate	O
these	O
quantities	O
for	O
two	O
moderately	O
transmissible	O
viruses	B-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
HIV	B-SPEC
,	O
and	O
for	O
two	O
highly	O
transmissible	O
viruses	B-SPEC
,	O
smallpox	B-SPEC
and	O
pandemic	O
influenza	O
.	O

Here	O
we	O
describe	O
the	O
identification	O
and	O
characterization	O
of	O
a	O
not	O
previously	O
recognized	O
coronavirus	B-SPEC
obtained	O
from	O
an	O
8	O
-	O
mo	O
-	O
old	O
boy	O
suffering	O
from	O
pneumonia	O
.	O

The	O
entire	O
cDNA	O
genome	O
sequence	O
of	O
the	O
previously	O
undescribed	O
coronavirus	B-SPEC
was	O
determined	O
,	O
revealing	O
that	O
it	O
is	O
most	O
closely	O
related	O
to	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
and	O
HCoV	O
229E	O
.	O

The	O
results	O
confirm	O
that	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
is	O
present	O
in	O
Swedish	O
dairy	O
herds	O
and	O
might	O
have	O
clinical	O
significance	O
.	O

TITLE	O
:	O
Negative	O
-	O
pressure	O
pulmonary	O
edema	O
complicated	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
an	O
orangutan	B-SPEC
(	O
Pongo	B-SPEC
pygmaeus	I-SPEC
abelii	I-SPEC
).	O

A	O
large	O
volume	O
of	O
pink	O
-	O
tinged	O
frothy	O
fluid	O
flowed	O
from	O
the	O
trachea	B-SPEC
when	O
the	O
laryngoscope	O
was	O
inserted	O
into	O
the	O
oropharynx	O
.	O

ABSTRACT	O
:	O
To	O
improve	O
the	O
nursing	O
care	O
quality	O
in	O
acute	O
care	O
hospitals	O
in	O
Taiwan	O
after	O
the	O
2003	O
SARS	O
epidemic	O
,	O
the	O
Taipei	O
City	O
Government	O
Department	O
of	O
Health	O
has	O
allocated	O
about	O
US	O
dollars	O
6	O
million	O
for	O
nurse	O
aides	B-SPEC
'	O
salaries	O
and	O
costs	O
for	O
recruitment	O
,	O
training	O
,	O
and	O
administration	O
of	O
this	O
program	O
.	O

This	O
article	O
examines	O
the	O
roles	O
of	O
nurse	O
aides	B-SPEC
and	O
family	B-SPEC
members	O
in	O
providing	O
acute	O
patient	O
care	O
in	O
Taiwan	O
and	O
discusses	O
issues	O
of	O
nursing	O
care	O
quality	O
as	O
related	O
to	O
nurse	O
staffing	O
in	O
acute	O
care	O
hospitals	O
.	O

TITLE	O
:	O
Generation	O
and	O
characterization	O
of	O
DNA	O
vaccines	O
targeting	O
the	O
nucleocapsid	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

The	O
number	O
of	O
NK	O
cells	O
and	O
the	O
expression	O
of	O
CD158b	O
on	O
the	O
surface	O
of	O
NK	O
cells	O
changed	O
in	O
patients	O
with	O
SARS	O
and	O
correlated	O
with	O
disease	O
severity	O
and	O
the	O
presence	O
of	O
anti	O
-	O
SARS	O
coronavirus	B-SPEC
-	O
specific	O
antibodies	O
;	O
SARS	O
differed	O
from	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
infection	O
in	O
pathogenesis	O
involving	O
NK	O
cells	O
.	O

Expression	O
of	O
SARS	O
virus	B-SPEC
-	O
encoded	O
RNA	O
was	O
detected	O
in	O
all	O
3	O
cases	O
by	O
RT	O
-	O
PCR	O
,	O
and	O
the	O
SARS	O
viral	O
signal	O
was	O
localized	O
in	O
pneumocytes	O
by	O
using	O
in	O
situ	O
hybridization	O
.	O

ABSTRACT	O
:	O
Induction	O
of	O
effective	O
cytotoxic	O
T	O
lymphocyte	O
(	O
CTL	O
)	O
and	O
/	O
or	O
a	O
specific	O
antibody	O
against	O
conserved	O
viral	O
proteins	O
may	O
be	O
essential	O
to	O
the	O
development	O
of	O
a	O
safe	O
and	O
effective	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
Cov	O
)	O
vaccine	O
.	O

We	O
also	O
expressed	O
recombinant	O
N	O
proteins	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
prepared	O
N	O
protein	O
-	O
specific	O
polyclonal	O
antibodies	O
.	O

C3H	O
/	O
He	O
mice	B-SPEC
were	O
immunized	O
with	O
N	O
protein	O
-	O
expressible	O
pcDN	O
-	O
fn	O
vector	O
by	O
intramuscular	O
injections	O
.	O

The	O
proportions	O
of	O
exposure	O
in	O
the	O
cases	O
were	O
18	O
%	O
and	O
8	O
%	O
in	O
the	O
control	O
group	O
;	O
the	O
adjusted	O
OR	O
(	O
fat	O
free	O
mass	O
,	O
anti	O
-	O
cytomegalovirus	B-SPEC
antibodies	O
and	O
placental	O
weight	O
)	O
was	O
2	O
.	O
33	O
(	O
p	O
=	O
0	O
.	O
04	O
).	O

The	O
virus	B-SPEC
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
isolated	O
from	O
patients	O
exhibiting	O
atypical	O
pneumonia	O
and	O
may	O
have	O
originated	O
from	O
wild	O
animals	B-SPEC
such	O
as	O
civet	B-SPEC
cats	I-SPEC
in	O
southern	O
China	O
.	O

To	O
describe	O
the	O
spectrum	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
in	O
a	O
large	O
outbreak	O
and	O
to	O
compare	O
diagnoses	O
based	O
on	O
clinical	O
judgment	O
with	O
the	O
SARS	O
coronavirus	B-SPEC
test	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
protein	O
(	O
S	O
),	O
a	O
membrane	O
component	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
anticipated	O
to	O
be	O
an	O
important	O
component	O
of	O
candidate	O
vaccines	O
.	O

We	O
constructed	O
recombinant	O
forms	O
of	O
the	O
highly	O
attenuated	O
modified	O
vaccinia	B-SPEC
virus	I-SPEC
Ankara	O
(	O
MVA	O
)	O
containing	O
the	O
gene	O
encoding	O
full	O
-	O
length	O
SARS	O
-	O
CoV	O
S	O
with	O
and	O
without	O
a	O
C	O
-	O
terminal	O
epitope	O
tag	O
called	O
MVA	O
/	O
S	O
-	O
HA	O
and	O
MVA	O
/	O
S	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
causes	O
severe	O
disease	O
,	O
is	O
transmissible	O
to	O
the	O
community	O
and	O
there	O
is	O
no	O
effective	O
prophylaxis	O
or	O
treatment	O
--	O
perhaps	O
fulfilling	O
the	O
criteria	O
for	O
biohazard	O
group	O
3	O
or	O
4	O
.	O

ABSTRACT	O
:	O
There	O
is	O
uncertainty	O
about	O
the	O
mode	O
of	O
transmission	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
.	O

TITLE	O
:	O
Coronaviridae	B-SPEC
and	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
strain	O
HSR1	O
.	O

There	O
is	O
,	O
therefore	O
,	O
renewed	O
emphasis	O
on	O
preventive	O
strategies	O
by	O
better	O
understanding	O
of	O
the	O
relative	O
importance	O
of	O
various	O
vehicles	O
in	O
the	O
nosocomial	O
spread	O
of	O
viruses	B-SPEC
and	O
by	O
infection	O
control	O
using	O
microbicides	O
.	O

Binding	O
analysis	O
of	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
with	O
HIV	B-SPEC
,	O
psychotic	O
and	O
parasite	O
drugs	O
.	O

Laboratory	O
confirmation	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
was	O
established	O
in	O
132	O
(	O
95	O
.	O
7	O
%).	O

ABSTRACT	O
:	O
Three	O
newly	O
recognized	O
encephalitogenic	O
zoonotic	O
viruses	B-SPEC
spread	O
from	O
fruit	O
bats	B-SPEC
of	O
the	O
genus	B-SPEC
Pteropus	I-SPEC
(	O
order	B-SPEC
Chiroptera	I-SPEC
,	O
suborder	B-SPEC
Megachiroptera	B-SPEC
)	O
have	O
been	O
recognised	O
over	O
the	O
past	O
decade	O
.	O

At	O
necropsy	O
,	O
most	O
animals	B-SPEC
tested	O
positive	O
for	O
viral	O
shedding	O
and	O
FCoV	O
RNA	O
was	O
found	O
in	O
spleen	O
,	O
mesenteric	O
lymph	O
nodes	O
and	O
bone	O
marrow	O
.	O

Both	O
experimentally	O
and	O
naturally	O
infected	O
cats	B-SPEC
remained	O
clinically	O
healthy	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
origin	O
and	O
subsequent	O
spread	O
of	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
FCV	B-SPEC
),	O
feline	B-SPEC
herpesvirus	I-SPEC
(	O
FHV	O
),	O
and	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
)	O
in	O
cats	B-SPEC
relinquished	O
to	O
shelters	O
.	O

TITLE	O
:	O
Disease	O
outcome	O
and	O
cytokine	O
responses	O
in	O
cats	B-SPEC
immunized	O
with	O
an	O
avirulent	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	B-SPEC
)-	O
UCD1	O
and	O
challenge	O
-	O
exposed	O
with	O
virulent	O
FIPV	B-SPEC
-	O
UCD8	O
.	O

Crystal	O
structure	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
spike	O
protein	O
fusion	O
core	O
.	O

Our	O
results	O
also	O
indicate	O
that	O
the	O
mechanisms	O
for	O
the	O
viral	O
fusion	O
of	O
coronaviruses	O
are	O
similar	O
to	O
those	O
of	O
influenza	B-SPEC
virus	I-SPEC
and	O
HIV	B-SPEC
.	O

Highly	O
conserved	O
heptad	O
repeat	O
1	O
(	O
HR1	O
)	O
and	O
HR2	O
regions	O
in	O
coronavirus	B-SPEC
spike	O
proteins	O
indicate	O
a	O
similar	O
three	O
-	O
dimensional	O
structure	O
among	O
these	O
fusion	O
cores	O
and	O
common	O
mechanisms	O
for	O
the	O
viral	O
fusion	O
.	O

TITLE	O
:	O
Prediction	O
of	O
amino	O
acid	O
pairs	O
sensitive	O
to	O
mutations	O
in	O
the	O
spike	O
protein	O
from	O
SARS	O
related	O
coronavirus	B-SPEC
.	O

Data	O
collection	O
was	O
through	O
interview	O
using	O
structured	O
questionnaire	O
,	O
physical	O
examination	O
,	O
throat	O
swabs	O
for	O
bacterial	O
culture	O
and	O
nasal	O
swabs	O
for	O
virus	B-SPEC
identification	O
by	O
immunofluorescence	O
(	O
IF	O
)	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
).	O

RESULTS	O
:	O
Among	O
the	O
197	O
patients	O
,	O
153	O
patients	O
(	O
77	O
.	O
7	O
%)	O
have	O
positive	O
results	O
of	O
serum	O
SARS	O
coronavirus	B-SPEC
-	O
specific	O
antibodies	O
test	O
,	O
and	O
44	O
patients	O
(	O
22	O
.	O
3	O
%)	O
have	O
negative	O
results	O
.	O

PCR	O
inhibitors	O
were	O
removed	O
by	O
ethanol	O
precipitation	O
,	O
and	O
a	O
PCR	O
for	O
the	O
pig	B-SPEC
beta	O
-	O
actin	O
gene	O
was	O
used	O
as	O
a	O
positive	O
control	O
for	O
all	O
clinical	O
samples	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
evaluated	O
two	O
second	O
-	O
generation	O
,	O
replicase	O
(	O
R	O
)	O
gene	O
-	O
based	O
,	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
test	O
kits	O
--	O
the	O
RealArt	O
HPA	O
coronavirus	B-SPEC
LC	O
kit	O
(	O
Artus	O
,	O
Hamburg	O
,	O
Germany	O
)	O
and	O
the	O
LightCycler	O
SARS	O
-	O
CoV	O
quantification	O
kit	O
(	O
Roche	O
,	O
Penzberg	O
,	O
Germany	O
)--	O
and	O
a	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
for	O
the	O
nucleocapsid	O
(	O
N	O
)	O
gene	O
.	O

TITLE	O
:	O
Detection	O
of	O
specific	O
antibodies	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
for	O
serodiagnosis	O
of	O
SARS	O
coronavirus	B-SPEC
pneumonia	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
evaluation	O
of	O
recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
protein	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)-	O
based	O
antibody	O
tests	O
for	O
serodiagnosis	O
of	O
SARS	O
-	O
CoV	O
pneumonia	O
and	O
compare	O
the	O
sensitivities	O
and	O
specificities	O
of	O
this	O
ELISA	O
for	O
detection	O
of	O
immunoglobulin	O
G	O
(	O
IgG	O
),	O
IgM	O
,	O
IgA	O
,	O
and	O
their	O
combinations	O
with	O
serum	O
samples	O
from	O
149	O
healthy	O
blood	O
donors	O
who	O
donated	O
blood	O
3	O
years	O
ago	O
as	O
controls	O
and	O
106	O
SARS	O
-	O
CoV	O
pneumonia	O
patients	O
in	O
Hong	O
Kong	O
.	O

Four	O
areas	O
were	O
classified	O
as	O
more	O
important	O
using	O
factor	O
analysis	O
:	O
health	O
and	O
relationship	O
with	O
the	O
family	B-SPEC
,	O
relationship	O
with	O
friends	O
/	O
colleagues	O
,	O
work	O
and	O
spiritual	O
.	O

The	O
areas	O
for	O
coping	O
strategies	O
were	O
clear	O
directives	O
/	O
precautionary	O
measures	O
,	O
ability	O
to	O
give	O
feedback	O
to	O
/	O
obtain	O
support	O
from	O
management	O
,	O
support	O
from	O
supervisors	O
/	O
colleagues	O
,	O
support	O
from	O
the	O
family	B-SPEC
,	O
ability	O
to	O
talk	O
to	O
someone	O
and	O
religious	O
convictions	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
homology	O
modeling	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
main	O
protease	O
for	O
structure	O
based	O
drug	O
design	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
termed	O
SARS	O
-	O
CoV	O
.	O
No	O
antiviral	O
treatment	O
has	O
been	O
established	O
so	O
far	O
.	O

In	O
particular	O
,	O
Sambucus	B-SPEC
nigra	I-SPEC
agglutinin	O
I	O
and	O
Maackia	B-SPEC
amurensis	I-SPEC
agglutinin	O
lectins	O
were	O
used	O
to	O
detect	O
sialic	O
acid	O
residues	O
,	O
Aleuria	B-SPEC
aurantia	I-SPEC
lectin	O
was	O
used	O
to	O
detect	O
L	O
-	O
fucose	O
residues	O
and	O
Concanavalin	O
A	O
was	O
used	O
to	O
evaluate	O
the	O
branching	O
degree	O
.	O

The	O
non	O
-	O
myeloablative	O
conditioning	O
regimen	O
consisted	O
of	O
fludarabine	O
,	O
cyclophosphamide	O
,	O
rabbit	B-SPEC
anti	O
-	O
thymocyte	O
globulin	O
and	O
total	O
body	O
irradiation	O
.	O

Hyenas	B-SPEC
near	O
human	B-SPEC
habitation	O
appeared	O
to	O
be	O
at	O
lower	O
risk	O
to	O
have	O
CDV	B-SPEC
,	O
FIV	B-SPEC
,	O
and	O
FECV	B-SPEC
/	O
FIPV	O
antibodies	O
,	O
whereas	O
being	O
near	O
human	B-SPEC
habitation	O
increased	O
the	O
risk	O
for	O
FPLV	B-SPEC
/	O
CPV	B-SPEC
antibodies	O
.	O

These	O
results	O
indicate	O
that	O
hyenas	B-SPEC
might	O
play	O
a	O
role	O
in	O
the	O
ecology	O
of	O
these	O
viruses	B-SPEC
in	O
the	O
Serengeti	O
ecosystem	O
.	O

ABSTRACT	O
:	O
Exposure	O
of	O
bobcats	B-SPEC
(	O
Lynx	B-SPEC
rufus	I-SPEC
)	O
and	O
gray	O
foxes	O
(	O
Urocyon	B-SPEC
cinereoargenteus	I-SPEC
)	O
to	O
a	O
range	O
of	O
common	O
canine	O
and	O
feline	B-SPEC
pathogens	O
was	O
assessed	O
in	O
urban	O
and	O
rural	O
zones	O
of	O
Golden	O
Gate	O
National	O
Recreation	O
Area	O
,	O
a	O
National	O
Park	O
in	O
the	O
San	O
Francisco	O
Bay	O
Area	O
,	O
(	O
California	B-SPEC
,	O
USA	O
)	O
from	O
1992	O
to	O
1995	O
.	O

TITLE	O
:	O
Serosurvey	O
of	O
viral	O
infections	O
in	O
free	O
-	O
ranging	O
Namibian	O
cheetahs	B-SPEC
(	O
Acinonyx	B-SPEC
jubatus	I-SPEC
).	O

Further	O
,	O
we	O
define	O
its	O
cellular	O
tropism	O
and	O
demonstrate	O
that	O
virus	B-SPEC
transmission	O
occurs	O
through	O
cell	O
-	O
mediated	O
transfer	O
by	O
dendritic	O
cells	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
replication	O
in	O
actively	O
growing	O
DBT	O
and	O
17Cl	O
-	O
1	O
cells	O
resulted	O
in	O
the	O
inhibition	O
of	O
host	O
cellular	O
DNA	O
synthesis	O
and	O
the	O
accumulation	O
of	O
infected	O
cells	O
in	O
the	O
G	O
(	O
0	O
)/	O
G	O
(	O
1	O
)	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

UV	O
-	O
irradiated	O
MHV	B-SPEC
failed	O
to	O
inhibit	O
host	O
cellular	O
DNA	O
synthesis	O
.	O

MHV	B-SPEC
infection	O
in	O
quiescent	O
17Cl	O
-	O
1	O
cells	O
that	O
had	O
been	O
synchronized	O
in	O
the	O
G	O
(	O
0	O
)	O
phase	O
by	O
serum	O
deprivation	O
prevented	O
infected	O
cells	O
from	O
entering	O
the	O
S	O
phase	O
after	O
serum	O
stimulation	O
.	O

Our	O
data	O
suggested	O
that	O
a	O
reduction	O
in	O
the	O
amounts	O
of	O
G	O
(	O
1	O
)	O
cyclin	O
-	O
Cdk	O
complexes	O
in	O
MHV	B-SPEC
-	O
infected	O
cells	O
led	O
to	O
a	O
reduction	O
in	O
Cdk	O
activities	O
and	O
insufficient	O
hyperphosphorylation	O
of	O
pRb	O
,	O
resulting	O
in	O
inhibition	O
of	O
the	O
cell	O
cycle	O
in	O
the	O
G	O
(	O
0	O
)/	O
G	O
(	O
1	O
)	O
phase	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
a	O
murine	B-SPEC
monoclonal	O
antibody	O
specific	O
for	O
SARS	O
-	O
CoV	O
nucleoprotein	O
,	O
and	O
probes	O
specific	O
for	O
a	O
SARS	O
-	O
CoV	O
RNA	O
polymerase	O
gene	O
fragment	O
,	O
for	O
immunohistochemistry	O
and	O
in	O
situ	O
hybridization	O
,	O
respectively	O
,	O
to	O
detect	O
SARS	O
-	O
CoV	O
systematically	O
in	O
tissues	O
from	O
patients	O
who	O
died	O
of	O
SARS	O
.	O

TITLE	O
:	O
Remyelination	O
,	O
axonal	O
sparing	O
,	O
and	O
locomotor	O
recovery	O
following	O
transplantation	O
of	O
glial	O
-	O
committed	O
progenitor	O
cells	O
into	O
the	O
MHV	B-SPEC
model	O
of	O
multiple	O
sclerosis	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
whether	O
the	O
complex	O
and	O
reactive	O
CNS	O
environment	O
of	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
model	O
of	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
could	O
support	O
transplant	O
-	O
mediated	O
remyelination	O
.	O

Striatal	O
neural	O
precursors	O
derived	O
from	O
postnatal	O
day	O
1	O
mice	B-SPEC
were	O
committed	O
to	O
a	O
glial	O
cell	O
lineage	O
and	O
labeled	O
.	O

TITLE	O
:	O
HIV	B-SPEC
protease	O
inhibitor	O
nelfinavir	O
inhibits	O
replication	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
has	O
been	O
identified	O
as	O
an	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
belongs	O
to	O
the	O
Coronaviridea	O
family	B-SPEC
of	O
viruses	B-SPEC
.	O

We	O
found	O
that	O
the	O
membrane	O
and	O
envelope	O
proteins	O
are	O
sufficient	O
for	O
the	O
efficient	O
formation	O
of	O
virus	B-SPEC
-	O
like	O
particles	O
and	O
could	O
be	O
visualized	O
by	O
electron	O
microscopy	O
.	O

Sucrose	O
gradient	O
purification	O
followed	O
by	O
Western	O
blot	O
analysis	O
and	O
immunogold	O
labeling	O
showed	O
that	O
the	O
spike	O
protein	O
could	O
be	O
incorporated	O
into	O
the	O
virus	B-SPEC
like	O
particle	O
also	O
.	O

Biochemical	O
and	O
electron	O
microscopical	O
analyses	O
showed	O
that	O
,	O
when	O
mixed	O
,	O
SARS	O
-	O
CoV	O
HR1	O
and	O
HR2	O
peptides	O
assemble	O
into	O
a	O
six	O
-	O
helix	O
bundle	O
consisting	O
of	O
HR1	O
as	O
a	O
central	O
triple	O
-	O
stranded	O
coiled	O
coil	O
in	O
association	O
with	O
three	O
HR2	O
alpha	O
-	O
helices	B-SPEC
oriented	O
in	O
an	O
antiparallel	O
manner	O
.	O

Analogous	O
to	O
other	O
class	B-SPEC
I	O
viral	O
fusion	O
proteins	O
,	O
the	O
six	O
-	O
helix	O
complex	O
supposedly	O
represents	O
a	O
postfusion	O
conformation	O
that	O
is	O
formed	O
after	O
insertion	O
of	O
the	O
fusion	O
peptide	O
,	O
proposed	O
here	O
for	O
coronaviruses	O
to	O
be	O
located	O
immediately	O
upstream	O
of	O
HR1	O
,	O
into	O
the	O
target	O
membrane	O
.	O

TITLE	O
:	O
Effect	O
of	O
temperature	O
on	O
the	O
detection	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
in	O
fecal	O
samples	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

The	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
nucleic	O
acids	O
in	O
fecal	O
samples	O
were	O
stable	O
up	O
to	O
3	O
days	O
at	O
4	O
C	O
.	O
The	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
nucleic	O
acids	O
were	O
consistently	O
detected	O
in	O
fecal	O
samples	O
up	O
to	O
60	O
hours	O
at	O
21	O
C	O
and	O
24	O
hours	O
only	O
at	O
36	O
and	O
45	O
C	O
.	O
Thereafter	O
,	O
the	O
number	O
of	O
positive	O
signals	O
declined	O
.	O

In	O
this	O
issue	O
of	O
Critical	O
Care	O
,	O
two	O
experts	O
face	O
off	O
over	O
the	O
need	O
to	O
isolate	O
patients	O
infected	O
with	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
.	O

To	O
stimulate	O
the	O
structure	O
-	O
based	O
drug	O
design	O
against	O
SARS	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
),	O
a	O
pharmacophore	O
search	O
was	O
conducted	O
over	O
3	O
.	O
6	O
millions	O
of	O
compounds	O
based	O
on	O
the	O
atomic	O
coordinates	O
of	O
the	O
complex	O
obtained	O
by	O
docking	O
KZ7088	O
(	O
a	O
derivative	O
of	O
AG7088	O
)	O
to	O
SARS	O
CoV	O
M	O
(	O
pro	O
)	O
(	O
coronavirus	B-SPEC
main	O
proteinase	O
),	O
as	O
reportedly	O
recently	O
(	O
Chou	O
,	O
K	O
.	O
C	O
.;	O
Wei	O
,	O
D	O
.	O
Q	O
.;	O
Zhong	O
,	O
W	O
.	O
Z	O
.	O
Biochem	O
.	O

Novel	O
viruses	B-SPEC
and	O
prions	O
,	O
emerging	O
in	O
different	O
parts	O
of	O
the	O
world	O
,	O
may	O
pose	O
a	O
particular	O
threat	O
to	O
health	O
and	O
life	O
of	O
health	O
care	O
workers	O
,	O
agriculture	O
workers	O
and	O
veterinarians	O
.	O

It	O
has	O
been	O
shown	O
that	O
allergens	O
and	O
endotoxins	O
produced	O
by	O
Gram	O
-	O
negative	O
bacteria	B-SPEC
occurring	O
in	O
oil	O
mist	O
from	O
metalworking	O
fluids	O
may	O
cause	O
occupational	O
respiratory	O
diseases	O
in	O
workers	O
of	O
the	O
metallurgic	O
industry	O
.	O

TITLE	O
:	O
Immunopurification	O
applied	O
to	O
the	O
study	O
of	O
virus	B-SPEC
protein	O
composition	O
and	O
encapsidation	O
.	O

TITLE	O
:	O
Quantitation	O
of	O
canine	O
coronavirus	B-SPEC
RNA	O
in	O
the	O
faeces	O
of	O
dogs	B-SPEC
by	O
TaqMan	O
RT	O
-	O
PCR	O
.	O

A	O
total	O
of	O
78	O
faecal	O
samples	O
of	O
diarrhoeic	O
dogs	B-SPEC
were	O
tested	O
simultaneously	O
by	O
conventional	O
and	O
fluorogenic	O
RT	O
-	O
PCR	O
:	O
29	O
were	O
negative	O
by	O
both	O
techniques	O
,	O
whereas	O
27	O
tested	O
positive	O
by	O
conventional	O
RT	O
-	O
PCR	O
and	O
48	O
by	O
the	O
established	O
CCoV	O
fluorogenic	O
assay	O
.	O

To	O
determine	O
the	O
dynamics	O
and	O
associated	O
lesions	O
of	O
hMPV	B-SPEC
infection	O
,	O
six	O
cynomolgus	O
macaques	B-SPEC
(	O
Macaca	B-SPEC
fascicularis	I-SPEC
)	O
were	O
inoculated	O
with	O
hMPV	B-SPEC
and	O
examined	O
by	O
pathological	O
and	O
virological	O
assays	O
.	O

TITLE	O
:	O
Structural	O
characterization	O
of	O
the	O
fusion	O
-	O
active	O
complex	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
.	O

Thus	O
such	O
a	O
molecular	O
complex	O
is	O
expected	O
to	O
serve	O
as	O
a	O
parameter	O
for	O
the	O
diagnosis	O
of	O
thrombus	B-SPEC
formation	O
and	O
DIC	O
,	O
in	O
particular	O
its	O
early	O
stage	O
.	O

Smears	O
from	O
the	O
brain	O
and	O
the	O
conjunctiva	O
of	O
both	O
dogs	B-SPEC
tested	O
positive	O
for	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
)	O
by	O
an	O
immunofluorescent	O
assay	O
,	O
confirmed	O
by	O
the	O
identification	O
of	O
viral	O
RNA	O
using	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
The	O
zinc	O
metallopeptidase	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
the	O
only	O
known	O
human	B-SPEC
homologue	O
of	O
the	O
key	O
regulator	O
of	O
blood	O
pressure	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
).	O

Unexpectedly	O
,	O
ACE2	O
also	O
serves	O
as	O
the	O
cellular	O
entry	O
point	O
for	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
and	O
the	O
enzyme	O
is	O
therefore	O
a	O
prime	O
target	O
for	O
pharmacological	O
intervention	O
on	O
several	O
disease	O
fronts	O
.	O

Most	O
importantly	O
,	O
the	O
replicon	O
RNA	O
mediates	O
reporter	O
gene	O
expression	O
as	O
a	O
marker	O
for	O
coronavirus	B-SPEC
replication	O
.	O

Interviews	O
were	O
conducted	O
with	O
key	O
informants	O
from	O
Telehealth	O
staff	O
,	O
the	O
public	O
health	O
services	O
of	O
Ontario	O
and	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
Atlanta	B-SPEC
,	O
GA	O
,	O
USA	O
.	O

TITLE	O
:	O
A	O
survey	O
of	O
the	O
prevalence	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
type	O
4	O
/	O
91	O
in	O
Iran	O
.	O

Vero	O
E6	O
cells	O
(	O
African	B-SPEC
green	I-SPEC
monkey	I-SPEC
kidney	O
cells	O
)	O
were	O
inoculated	O
with	O
SARS	O
coronavirus	B-SPEC
for	O
3	O
,	O
7	O
,	O
24	O
,	O
48	O
,	O
and	O
72	O
hr	O
,	O
respectively	O
,	O
and	O
were	O
observed	O
under	O
electron	O
microscope	O
.	O

We	O
propose	O
a	O
scheme	O
of	O
the	O
life	O
cycle	O
of	O
SARS	O
coronavirus	B-SPEC
and	O
discuss	O
the	O
mechanism	O
of	O
its	O
replication	O
in	O
Vero	O
E6	O
cells	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
epidemiologic	O
,	O
clinical	O
,	O
laboratory	O
,	O
and	O
radiologic	O
features	O
,	O
prognostic	O
indicators	O
,	O
and	O
short	O
-	O
term	O
to	O
medium	O
-	O
term	O
outcomes	O
for	O
children	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
to	O
validate	O
the	O
performance	O
characteristics	O
of	O
a	O
clinical	O
case	O
definition	O
,	O
calculated	O
with	O
respect	O
to	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
seroconversion	O
.	O

The	O
kit	O
""""	O
AmpliSens	O
SARS	O
""""	O
for	O
qualitative	O
detection	O
of	O
SARS	O
-	O
related	O
coronavirus	B-SPEC
RNA	O
by	O
reverse	O
transcription	O
and	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
nasopharyngeal	O
wash	O
/	O
aspirates	O
,	O
naso	B-SPEC
/	O
oropharyngeal	O
swabs	O
,	O
plasma	O
,	O
and	O
extract	O
from	O
feces	O
has	O
been	O
developed	O
in	O
the	O
Central	O
Research	O
Institute	O
for	O
Epidemiology	O
of	O
the	O
RF	O
Ministry	O
of	O
Health	O
.	O

The	O
emergence	O
of	O
new	O
respiratory	O
viruses	B-SPEC
and	O
a	O
high	O
probability	O
that	O
influenza	O
will	O
cause	O
further	O
pandemics	O
highlights	O
the	O
necessity	O
for	O
developing	O
better	O
preventative	O
strategies	O
.	O

The	O
NSW	O
law	O
can	O
also	O
be	O
applied	O
to	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
or	O
HIV	B-SPEC
/	O
AIDS	O
.	O

ABSTRACT	O
:	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
new	O
corona	B-SPEC
--	O
virus	B-SPEC
SARS	O
-	O
Co	O
-	O
V	O
was	O
not	O
identified	O
at	O
humans	B-SPEC
and	O
animals	B-SPEC
up	O
to	O
this	O
time	O
.	O

Diagnosis	O
is	O
based	O
on	O
clinical	O
picture	O
and	O
epidemiological	O
data	O
supported	O
by	O
positive	O
serology	O
,	O
PCR	O
or	O
presence	O
virus	B-SPEC
in	O
cell	O
culture	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
virulent	O
canine	O
coronavirus	B-SPEC
BGF	O
strain	O
.	O

This	O
new	O
canine	O
coronavirus	B-SPEC
strain	O
could	O
help	O
to	O
identify	O
virulence	O
factors	O
in	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Outbreaks	O
of	O
infectious	O
diseases	O
such	O
as	O
HIV	B-SPEC
and	O
the	O
much	O
televised	O
and	O
attention	O
-	O
getting	O
outbreaks	O
of	O
diseases	O
such	O
as	O
Ebola	O
,	O
Hantaviruses	B-SPEC
,	O
and	O
the	O
most	O
recent	O
outbreak	O
of	O
SARS	O
have	O
induced	O
a	O
significant	O
new	O
interest	O
in	O
the	O
formulations	O
and	O
more	O
importantly	O
the	O
science	O
of	O
vaccinology	O
,	O
which	O
has	O
previously	O
to	O
a	O
large	O
extent	O
been	O
conducted	O
empirically	O
.	O

Dynamic	O
changes	O
of	O
chest	O
X	O
-	O
ray	B-SPEC
images	O
and	O
laboratory	O
tests	O
in	O
45	O
SARS	O
patients	O
managed	O
from	O
March	O
to	O
May	O
,	O
2003	O
were	O
analyzed	O
.	O

The	O
time	O
for	O
chest	O
X	O
-	O
ray	B-SPEC
image	O
to	O
be	O
absorbed	O
completely	O
were	O
18	O
to	O
46	O
(	O
25	O
.	O
9	O
+/-	O

Among	O
IBV	B-SPEC
strains	O
,	O
the	O
5	O
'	O
untranslated	O
region	O
including	O
the	O
leader	O
sequence	O
was	O
highly	O
conserved	O
(>	O
94	O
%	O
identical	O
);	O
whereas	O
,	O
the	O
N	O
-	O
terminal	O
coding	O
region	O
and	O
the	O
PL	O
(	O
pro	O
)	O
domains	O
were	O
highly	O
variable	O
ranging	O
from	O
84	O
.	O
6	O
%	O
to	O
100	O
%,	O
and	O
77	O
.	O
6	O
%	O
to	O
100	O
%	O
identity	O
,	O
respectively	O
.	O

However	O
,	O
the	O
IBV	B-SPEC
strain	O
classification	O
based	O
on	O
replicase	O
gene	O
domains	O
did	O
not	O
correlate	O
with	O
that	O
of	O
the	O
type	O
-	O
specific	O
antigenic	O
groups	O
.	O

ABSTRACT	O
:	O
The	O
complete	O
nucleotide	O
sequences	O
of	O
the	O
S1	O
and	O
N	O
genes	O
of	O
three	O
Japanese	O
and	O
one	O
Taiwanese	O
field	O
strains	O
of	O
IBV	B-SPEC
are	O
reported	O
.	O

Despite	O
recent	O
progress	O
in	O
identifying	O
and	O
analyzing	O
the	O
coronavirus	B-SPEC
that	O
is	O
responsible	O
for	O
it	O
,	O
few	O
reports	O
have	O
addressed	O
the	O
clinical	O
complications	O
of	O
SARS	O
.	O

The	O
convalescent	O
SARS	O
patients	O
'	O
immune	O
function	O
gradually	O
recovers	O
,	O
and	O
the	O
effect	O
of	O
SARS	O
virus	B-SPEC
on	O
activation	O
of	O
T	O
cells	O
gradually	O
disappears	O
.	O

TITLE	O
:	O
Susceptibility	O
to	O
SARS	O
coronavirus	B-SPEC
S	O
protein	O
-	O
driven	O
infection	O
correlates	O
with	O
expression	O
of	O
angiotensin	O
converting	O
enzyme	O
2	O
and	O
infection	O
can	O
be	O
blocked	O
by	O
soluble	O
receptor	O
.	O

TITLE	O
:	O
Phosphorylation	O
of	O
p38	O
MAPK	O
and	O
its	O
downstream	O
targets	O
in	O
SARS	O
coronavirus	B-SPEC
-	O
infected	O
cells	O
.	O

Furthermore	O
,	O
detection	O
of	O
DNA	O
ladder	O
and	O
cleaved	O
caspase	O
-	O
3	O
in	O
the	O
virus	B-SPEC
-	O
infected	O
cells	O
at	O
24h	O
.	O
p	O
.	O
i	O
.	O
indicated	O
that	O
SARS	O
-	O
CoV	O
infection	O
induced	O
apoptotic	O
cell	O
death	O
.	O

These	O
are	O
the	O
replicase	O
gene	O
1a	O
/	O
1b	O
and	O
the	O
four	O
structural	O
proteins	O
,	O
nucleocapsid	O
(	O
N	O
),	O
spike	O
(	O
S	O
),	O
membrane	O
(	O
M	O
),	O
and	O
envelope	O
(	O
E	O
),	O
and	O
these	O
proteins	O
are	O
expected	O
to	O
be	O
essential	O
for	O
the	O
replication	O
of	O
the	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Exposed	O
epitopes	O
of	O
the	O
spike	O
protein	O
may	O
be	O
recognized	O
by	O
neutralizing	O
antibodies	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

TITLE	O
:	O
Murine	B-SPEC
viral	O
hepatitis	O
involves	O
NK	O
cell	O
depletion	O
associated	O
with	O
virus	B-SPEC
-	O
induced	O
apoptosis	O
.	O

The	O
percentage	O
of	O
intrahepatic	O
NK1	O
.	O
1	O
(+)	O
T	O
cell	O
receptor	O
(	O
TCR	O
)-	O
cells	O
did	O
not	O
increase	O
while	O
NK1	O
.	O
1	O
(+)	O
TCR	O
(	O
inter	O
)	O
cells	O
decreased	O
in	O
both	O
L2	O
-	O
MHV3	O
-	O
and	O
YAC	O
-	O
MHV3	O
-	O
infected	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
study	O
found	O
infrequent	O
transmission	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
to	O
healthcare	O
workers	O
involved	O
in	O
the	O
care	O
of	O
the	O
first	O
five	O
case	O
-	O
patients	O
in	O
Taiwan	O
,	O
despite	O
a	O
substantial	O
number	O
of	O
unprotected	O
exposures	O
.	O

TITLE	O
:	O
Potential	O
targets	O
for	O
anti	O
-	O
SARS	O
drugs	O
in	O
the	O
structural	O
proteins	O
from	O
SARS	O
related	O
coronavirus	B-SPEC
.	O

Detection	O
of	O
ocular	O
infection	O
from	O
tears	O
using	O
the	O
PCR	O
technique	O
has	O
been	O
widely	O
used	O
by	O
ophthalmologists	O
to	O
diagnose	O
infections	O
for	O
other	O
viruses	B-SPEC
.	O

We	O
have	O
recently	O
shown	O
that	O
21	O
aa	O
substitutions	O
and	O
a	O
7	O
-	O
aa	O
insert	O
in	O
the	O
N	O
-	O
terminal	O
region	O
of	O
S	O
are	O
associated	O
with	O
the	O
extended	O
host	O
range	O
of	O
a	O
virus	B-SPEC
variant	O
derived	O
from	O
murine	B-SPEC
cells	O
persistently	O
infected	O
with	O
the	O
A59	O
strain	O
of	O
MHV	B-SPEC
(	O
MHV	B-SPEC
-	O
A59	O
).	O

TITLE	O
:	O
Contributions	O
of	O
the	O
structural	O
proteins	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
to	O
protective	O
immunity	O
.	O

Three	O
dialysis	B-SPEC
patients	O
had	O
persistent	O
positive	O
stool	O
PCR	O
after	O
5	O
wk	O
,	O
whereas	O
all	O
nondialysis	O
patients	O
had	O
negative	O
stool	O
PCR	O
after	O
1	O
wk	O
.	O

TITLE	O
:	O
Mucosal	O
immunisation	O
of	O
African	B-SPEC
green	I-SPEC
monkeys	I-SPEC
(	O
Cercopithecus	B-SPEC
aethiops	I-SPEC
)	O
with	O
an	O
attenuated	O
parainfluenza	O
virus	B-SPEC
expressing	O
the	O
SARS	O
coronavirus	B-SPEC
spike	O
protein	O
for	O
the	O
prevention	O
of	O
SARS	O
.	O

We	O
expressed	O
the	O
complete	O
SARS	O
coronavirus	B-SPEC
envelope	O
spike	O
(	O
S	O
)	O
protein	O
from	O
a	O
recombinant	O
attenuated	O
parainfluenza	O
virus	B-SPEC
(	O
BHPIV3	O
)	O
that	O
is	O
being	O
developed	O
as	O
a	O
live	O
attenuated	O
,	O
intranasal	O
paediatric	O
vaccine	O
against	O
human	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
type	I-SPEC
3	I-SPEC
(	O
HPIV3	O
).	O

A	O
SARS	O
-	O
coronavirus	B-SPEC
challenge	O
was	O
given	O
to	O
all	O
monkeys	B-SPEC
28	O
days	O
after	O
immunisation	O
.	O

Immunisation	O
of	O
animals	B-SPEC
with	O
BHPIV3	O
/	O
SARS	O
-	O
S	O
induced	O
the	O
production	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
-	O
neutralising	O
serum	O
antibodies	O
,	O
indicating	O
that	O
a	O
systemic	O
immune	O
response	O
resulted	O
from	O
mucosal	O
immunisation	O
.	O

When	O
expressed	O
individually	O
in	O
murine	B-SPEC
cells	O
,	O
the	O
S	O
-	O
GFP	O
chimeric	O
protein	O
induced	O
the	O
formation	O
of	O
fluorescent	O
syncytia	O
,	O
indicating	O
that	O
it	O
was	O
synthesized	O
and	O
folded	O
properly	O
,	O
trimerized	O
,	O
and	O
transported	O
to	O
the	O
plasma	O
membrane	O
,	O
where	O
it	O
exhibited	O
the	O
two	O
key	O
S	O
protein	O
functions	O
,	O
i	O
.	O
e	O
.,	O
interaction	O
with	O
virus	B-SPEC
receptor	O
molecules	O
and	O
membrane	O
fusion	O
.	O

The	O
wild	O
-	O
type	O
S	O
gene	O
of	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)	O
was	O
subsequently	O
replaced	O
by	O
the	O
chimeric	O
construct	O
through	O
targeted	O
recombination	O
.	O

Using	O
the	O
NTPase	O
active	O
site	O
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
nsp13	O
also	O
mediates	O
RNA	O
5	O
'-	O
triphosphatase	O
activity	O
,	O
which	O
may	O
be	O
involved	O
in	O
the	O
capping	O
of	O
viral	O
RNAs	O
.	O

TITLE	O
:	O
The	O
3	O
'	O
cis	B-SPEC
-	O
acting	O
genomic	O
replication	O
element	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
can	O
function	O
in	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
genome	O
.	O

Therefore	O
,	O
other	O
virus	B-SPEC
receptors	O
or	O
co	O
-	O
receptors	O
may	O
be	O
required	O
in	O
different	O
tissues	O
.	O

As	O
our	O
knowledge	O
of	O
the	O
pathogenic	O
mechanisms	O
improves	O
,	O
a	O
more	O
rational	O
approach	O
to	O
therapeutic	O
and	O
vaccine	O
development	O
can	O
be	O
designed	O
in	O
order	B-SPEC
to	O
combat	O
this	O
new	O
and	O
fatal	O
human	B-SPEC
disease	O
.	O

ABSTRACT	O
:	O
This	O
study	O
aimed	O
to	O
examine	O
the	O
significance	O
of	O
interactions	O
between	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
various	O
respiratory	O
pathogens	O
during	O
outbreaks	O
of	O
colibacillosis	O
-	O
associated	O
mortality	O
in	O
layer	O
hen	O
flocks	O
under	O
field	O
conditions	O
.	O

The	O
study	O
failed	O
to	O
detect	O
any	O
consistent	O
interactions	O
between	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
the	O
aforementioned	O
pathogens	O
.	O

TITLE	O
:	O
Microwave	O
or	O
autoclave	O
treatments	O
destroy	O
the	O
infectivity	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
and	O
avian	B-SPEC
pneumovirus	I-SPEC
but	O
allow	O
detection	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
.	O

Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
and	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
were	O
used	O
as	O
controls	O
.	O

These	O
results	O
demonstrated	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
there	O
is	O
a	O
new	O
genotype	O
of	O
nephropathogenic	O
IBV	B-SPEC
circulating	O
in	O
vaccinated	O
and	O
non	O
-	O
vaccinated	O
flocks	O
in	O
China	O
.	O

ABSTRACT	O
:	O
Influenza	O
and	O
other	O
respiratory	O
viruses	B-SPEC
circulate	O
between	O
spring	O
and	O
autumn	O
in	O
temperate	O
climates	O
and	O
all	O
year	O
in	O
tropical	O
climates	O
.	O

These	O
viruses	B-SPEC
cause	O
symptoms	O
often	O
referred	O
to	O
as	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
),	O
but	O
are	O
not	O
generally	O
distinguishable	O
on	O
clinical	O
grounds	O
alone	O
.	O

Horse	B-SPEC
polyclonal	O
antibody	O
against	O
SARS	O
-	O
CoV	O
was	O
bound	O
onto	O
the	O
PZ	O
crystal	O
surface	O
in	O
an	O
ordered	O
orientation	O
through	O
protein	O
A	O
.	O
The	O
antigen	O
sample	O
was	O
atomized	O
into	O
aerosol	O
by	O
an	O
ultrasonator	O
,	O
by	O
which	O
the	O
antibody	O
on	O
the	O
crystal	O
could	O
specifically	O
adsorb	O
SARS	O
antigen	O
and	O
the	O
changed	O
mass	O
of	O
crystal	O
would	O
lead	O
a	O
frequency	O
shift	O
.	O

ABSTRACT	O
:	O
One	O
IBV	B-SPEC
isolate	O
,	O
SC021202	O
,	O
was	O
isolated	O
from	O
the	O
kidneys	O
of	O
the	O
infected	O
young	O
chickens	B-SPEC
by	O
inoculating	O
embryonated	O
eggs	O
,	O
and	O
its	O
morphology	O
,	O
physiochemical	O
and	O
haemagglutonating	O
properties	O
were	O
detected	O
.	O

ABSTRACT	O
:	O
We	O
tested	O
the	O
ability	O
of	O
inactivated	O
SARS	O
-	O
CoV	O
vaccine	O
to	O
induce	O
neutralizing	O
antibodies	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

CONCLUSIONS	O
:	O
Job	O
that	O
dealing	O
with	O
palm	O
civets	B-SPEC
was	O
the	O
main	O
risk	O
factor	O
of	O
SARS	O
-	O
CoV	O
infection	O
in	O
animal	B-SPEC
market	O
workers	O
.	O

ABSTRACT	O
:	O
To	O
develop	O
a	O
large	O
database	O
on	O
clinical	O
presentation	O
,	O
treatment	O
and	O
prognosis	O
of	O
all	O
clinical	O
diagnosed	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
cases	O
in	O
Beijing	O
during	O
the	O
2003	O
""""	O
crisis	O
""","	O
in	O
order	B-SPEC
to	O
conduct	O
further	O
clinical	O
studies	O
.	O

TITLE	O
:	O
Longitudinal	O
profile	O
of	O
immunoglobulin	O
G	O
(	O
IgG	O
),	O
IgM	O
,	O
and	O
IgA	O
antibodies	O
against	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
in	O
patients	O
with	O
pneumonia	O
due	O
to	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

Cells	O
derived	O
from	O
three	O
species	B-SPEC
of	O
monkey	B-SPEC
were	O
susceptible	O
to	O
SARS	O
-	O
CoV	O
.	O
However	O
,	O
the	O
levels	O
of	O
SARS	O
-	O
CoV	O
produced	O
differed	O
by	O
4	O
log	O
(	O
10	O
).	O

TITLE	O
:	O
Uncertain	O
benefit	O
:	O
the	O
public	O
policy	O
of	O
approving	O
smallpox	B-SPEC
vaccine	O
research	O
.	O

Compared	O
with	O
the	O
GGO	O
group	O
,	O
the	O
GGO	O
+	O
F	O
group	O
showed	O
significantly	O
lower	O
FEV	B-SPEC
(	O
1	O
),	O
FVC	O
,	O
total	O
lung	O
capacity	O
,	O
residual	O
volume	O
,	O
and	O
DLCO	O
.	O

The	O
cytosol	O
and	O
nucleus	O
fractions	O
of	O
virus	B-SPEC
-	O
infected	O
cells	O
as	O
well	O
as	O
the	O
crude	O
virions	O
were	O
analyzed	O
either	O
by	O
one	O
-	O
dimensional	O
electrophoresis	O
followed	O
by	O
ESI	O
-	O
MS	O
/	O
MS	O
identification	O
or	O
by	O
shotgun	O
strategy	O
with	O
two	O
-	O
dimensional	O
liquid	O
chromatography	O
-	O
ESI	O
-	O
MS	O
/	O
MS	O
.	O

ABSTRACT	O
:	O
To	O
examine	O
the	O
immunological	O
reactions	O
between	O
the	O
peptides	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
Cov	O
)	O
S	O
-	O
protein	O
and	O
the	O
serum	O
of	O
SARS	O
patients	O
for	O
identifying	O
the	O
SARS	O
-	O
Cov	O
epitope	O
.	O

TITLE	O
:	O
Persistent	O
infection	O
of	O
SARS	O
coronavirus	B-SPEC
in	O
colonic	O
cells	O
in	O
vitro	O
.	O

This	O
study	O
examined	O
seven	O
established	O
human	B-SPEC
intestinal	O
cell	O
lines	O
,	O
DLD	O
-	O
1	O
,	O
HCT	O
-	O
116	O
,	O
HT	O
-	O
29	O
,	O
LoVo	O
,	O
LS	O
-	O
180	O
,	O
SW	O
-	O
480	O
and	O
SW	O
-	O
620	O
,	O
for	O
their	O
permissiveness	O
to	O
SARS	O
-	O
CoV	O
infection	O
.	O

In	O
the	O
60	O
cases	O
of	O
infective	O
exacerbations	O
of	O
chronic	O
bronchitis	O
,	O
rhinovirus	B-SPEC
was	O
detected	O
in	O
9	O
(	O
15	O
%)	O
and	O
para	O
-	O
influenza	O
3	O
virus	B-SPEC
in	O
2	O
cases	O
.	O

RESULTS	O
:	O
RSV	B-SPEC
was	O
identified	O
in	O
20	O
(	O
11	O
.	O
7	O
%)	O
of	O
170	O
influenza	O
-	O
vaccinated	O
adults	O
suffering	O
from	O
flu	O
-	O
like	O
symptoms	O
.	O

To	O
begin	O
to	O
understand	O
its	O
biochemical	O
and	O
immunological	O
properties	O
,	O
we	O
expressed	O
both	O
full	O
-	O
length	O
and	O
ectodomain	O
of	O
the	O
protein	O
in	O
various	O
primate	B-SPEC
cells	O
.	O

We	O
have	O
developed	O
a	O
scoring	O
scheme	O
for	O
identification	O
of	O
immunological	O
hot	O
spots	B-SPEC
for	O
HLA	O
class	B-SPEC
I	O
molecules	O
,	O
which	O
is	O
the	O
sum	O
of	O
the	O
highest	O
four	O
predictions	O
within	O
a	O
window	O
of	O
30	O
amino	O
acids	O
.	O

ABSTRACT	O
:	O
To	O
detect	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
RNA	O
in	O
excreta	O
and	O
oropharyngeal	O
washing	O
fluid	O
(	O
OWF	O
)	O
from	O
the	O
convalescence	O
SARS	O
patients	O
,	O
and	O
to	O
determine	O
whether	O
convalescence	O
patients	O
carry	O
the	O
SARS	O
-	O
CoV	O
,	O
and	O
whether	O
having	O
infectivity	O
.	O

Autopsy	O
material	O
from	O
the	O
lungs	O
of	O
20	O
patients	O
who	O
died	O
between	O
March	O
and	O
July	O
2003	O
were	O
characterized	O
by	O
histology	O
,	O
molecular	O
biology	O
,	O
and	O
immunohistochemistry	O
for	O
cytokeratins	O
,	O
thyroid	O
transcription	O
factor	O
-	O
1	O
,	O
CD68	O
,	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
,	O
cytomegalovirus	B-SPEC
,	O
and	O
human	B-SPEC
herpes	B-SPEC
simplex	I-SPEC
viruses	I-SPEC
.	O

Continuous	O
and	O
categorical	O
variables	O
were	O
analyzed	O
with	O
Mann	O
-	O
Whitney	O
test	O
and	O
Fisher	B-SPEC
exact	O
or	O
chi	O
(	O
2	O
)	O
test	O
,	O
respectively	O
.	O

Even	O
though	O
the	O
ATCC	O
strain	O
could	O
penetrate	O
the	O
CNS	O
more	O
effectively	O
than	O
the	O
Paris	B-SPEC
2001	O
isolate	O
,	O
these	O
results	O
suggest	O
that	O
intrinsic	O
neuroinvasive	O
properties	O
already	O
existed	O
for	O
the	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
ATCC	O
human	B-SPEC
respiratory	O
isolate	O
from	O
the	O
1960s	O
before	O
it	O
was	O
propagated	O
in	O
newborn	O
mouse	B-SPEC
brains	O
.	O

The	O
genomes	O
of	O
the	O
two	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
variants	O
display	O
71	O
,	O
53	O
.	O
1	O
,	O
and	O
51	O
.	O
2	O
%	O
identity	O
with	O
those	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
A59	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
human	B-SPEC
coronavirus	I-SPEC
Tor2	O
strain	O
(	O
SARS	O
-	O
HCoV	O
Tor2	O
),	O
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
),	O
respectively	O
.	O

TITLE	O
:	O
In	O
vitro	O
susceptibility	O
of	O
10	O
clinical	O
isolates	O
of	O
SARS	O
coronavirus	B-SPEC
to	O
selected	O
antiviral	O
compounds	O
.	O

TITLE	O
:	O
A	O
highly	O
unusual	O
palindromic	O
transmembrane	O
helical	O
hairpin	O
formed	O
by	O
SARS	O
coronavirus	B-SPEC
E	O
protein	O
.	O

Here	O
we	O
describe	O
the	O
molecular	O
characterization	O
of	O
SCoV	O
E	O
protein	O
,	O
a	O
critical	O
component	O
of	O
the	O
virus	B-SPEC
responsible	O
for	O
virion	O
envelope	O
morphogenesis	O
.	O

There	O
was	O
no	O
evidence	O
that	O
coronavirus	B-SPEC
infection	O
in	O
hyenas	B-SPEC
caused	O
clinical	O
signs	O
similar	O
to	O
feline	B-SPEC
infectious	O
peritonitis	O
in	O
domestic	B-SPEC
cats	I-SPEC
or	O
was	O
a	O
direct	O
cause	O
of	O
mortality	O
in	O
hyenas	B-SPEC
.	O

ABSTRACT	O
:	O
Introduction	O
of	O
microbiologically	O
contaminated	O
materials	O
into	O
mice	B-SPEC
can	O
cause	O
infections	O
of	O
the	O
recipients	O
and	O
jeopardize	O
experimental	O
protocols	O
.	O

Based	O
on	O
the	O
present	O
study	O
,	O
it	O
was	O
shown	O
that	O
the	O
method	O
for	O
diagnosis	O
of	O
viruses	B-SPEC
in	O
biological	O
materials	O
should	O
be	O
employed	O
only	O
after	O
the	O
sensitivity	O
has	O
been	O
determined	O
for	O
the	O
viruses	B-SPEC
of	O
interest	O
implying	O
that	O
the	O
most	O
sensitive	O
method	O
needs	O
to	O
be	O
determined	O
independently	O
for	O
each	O
virus	B-SPEC
.	O

Considerable	O
efforts	O
have	O
been	O
made	O
in	O
the	O
past	O
few	O
years	O
to	O
develop	O
novel	O
therapeutic	O
interventions	O
to	O
reduce	O
mortality	O
in	O
sepsis	B-SPEC
.	O

TITLE	O
:	O
The	O
SARS	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
induces	O
actin	O
reorganization	O
and	O
apoptosis	O
in	O
COS	O
-	O
1	O
cells	O
in	O
the	O
absence	O
of	O
growth	O
factors	O
.	O

The	O
complete	O
genome	O
of	O
the	O
SARS	O
-	O
CoV	O
(	O
SARS	O
coronavirus	B-SPEC
)	O
has	O
since	O
been	O
sequenced	O
.	O

TITLE	O
:	O
Changes	O
in	O
liquid	O
clearance	O
of	O
alveolar	O
epithelium	O
after	O
oleic	O
acid	O
-	O
induced	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

Forty	O
-	O
eight	O
Wistar	B-SPEC
rats	I-SPEC
were	O
randomly	O
divided	O
into	O
six	O
groups	O
,	O
i	O
.	O
e	O
.,	O
injured	O
,	O
amiloride	O
,	O
ouabain	O
,	O
amiloride	O
plus	O
ouabain	O
and	O
terbutaline	O
groups	O
.	O

Evidence	O
of	O
perinatal	O
transmission	O
of	O
virus	B-SPEC
was	O
assessed	O
with	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
on	O
cord	O
blood	O
,	O
placenta	O
tissue	O
,	O
and	O
subsequent	O
follow	O
-	O
up	O
of	O
the	O
neonate	O
on	O
serology	O
.	O

TITLE	O
:	O
Potent	O
inhibition	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SCOV	O
)	O
infection	O
and	O
replication	O
by	O
type	O
I	O
interferons	O
(	O
IFN	O
-	O
alpha	O
/	O
beta	O
)	O
but	O
not	O
by	O
type	O
II	O
interferon	O
(	O
IFN	O
-	O
gamma	O
).	O

Here	O
,	O
we	O
report	O
the	O
emergence	O
and	O
isolation	O
of	O
two	O
temperature	O
sensitive	O
(	O
ts	O
)	O
mutants	O
and	O
a	O
revertant	O
in	O
the	O
process	O
of	O
cold	O
-	O
adaptation	O
of	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
to	O
a	O
monkey	B-SPEC
kidney	O
cell	O
line	O
.	O

However	O
,	O
the	O
central	O
processes	O
in	O
the	O
evolution	O
of	O
emerging	O
viruses	B-SPEC
are	O
unclear	O
,	O
particularly	O
the	O
selection	O
pressures	O
faced	O
by	O
viruses	B-SPEC
in	O
new	O
host	O
species	B-SPEC
.	O

We	O
show	O
,	O
however	O
,	O
that	O
the	O
phylogenetic	O
patterns	O
cited	O
as	O
evidence	O
for	O
recombination	O
are	O
more	O
probably	O
caused	O
by	O
a	O
variation	O
in	O
substitution	O
rate	O
among	O
lineages	O
and	O
that	O
recombination	O
is	O
unlikely	O
to	O
explain	O
the	O
appearance	O
of	O
SARS	O
in	O
humans	B-SPEC
.	O

Developments	O
in	O
the	O
dissection	O
of	O
the	O
human	B-SPEC
immune	O
response	O
to	O
SARS	O
indicate	O
that	O
serological	O
tests	O
on	O
convalescent	O
sera	O
are	O
essential	O
to	O
confirm	O
SARS	O
infection	O
,	O
given	O
the	O
sub	O
-	O
optimal	O
predictive	O
value	O
of	O
molecular	O
detection	O
tests	O
performed	O
during	O
acute	O
SARS	O
illness	O
.	O

The	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
variant	O
MHV	B-SPEC
/	O
BHK	O
can	O
infect	O
hamster	B-SPEC
,	O
rat	B-SPEC
,	O
cat	B-SPEC
,	O
dog	B-SPEC
,	O
monkey	B-SPEC
,	O
and	O
human	B-SPEC
cell	O
lines	O
but	O
not	O
the	O
swine	B-SPEC
testis	O
(	O
ST	O
)	O
porcine	B-SPEC
cell	O
line	O
(	O
J	O
.	O
H	O
.	O
Schickli	O
,	O
B	O
.	O
D	O
.	O
Zelus	B-SPEC
,	O
D	O
.	O
E	O
.	O
Wentworth	O
,	O
S	O
.	O
G	O
.	O
Sawicki	O
,	O
and	O
K	O
.	O
V	O
.	O
Holmes	O
,	O
J	O
.	O
Virol	O
.	O

Thus	O
,	O
21	O
amino	O
acid	O
substitutions	O
and	O
a	O
7	O
-	O
amino	O
-	O
acid	O
insert	O
in	O
the	O
N	O
-	O
terminal	O
region	O
of	O
the	O
S	O
glycoprotein	O
of	O
MHV	B-SPEC
/	O
BHK	O
confer	O
the	O
ability	O
to	O
bind	O
and	O
in	O
some	O
cases	O
infect	O
cells	O
of	O
nonmurine	O
species	B-SPEC
.	O

TITLE	O
:	O
[	O
The	O
changes	O
in	O
effective	O
local	O
blood	O
perfusion	O
and	O
compensatory	O
ventilation	O
in	O
different	O
lung	O
areas	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
rabbits	B-SPEC
model	O
].	O

ABSTRACT	O
:	O
To	O
discuss	O
the	O
mechanism	O
of	O
severe	O
hypoxemia	O
that	O
induced	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
by	O
way	O
of	O
observing	O
the	O
effective	O
local	O
blood	O
perfusion	O
in	O
different	O
lung	O
areas	O
of	O
ARDS	O
rabbits	B-SPEC
.	O

With	O
descending	O
in	O
infectious	O
generation	O
,	O
cases	O
treated	O
with	O
methylprednisolone	O
,	O
human	B-SPEC
gamma	O
-	O
immunoglobulin	O
,	O
interferon	O
-	O
alpha	O
,	O
and	O
antiviral	O
drugs	O
(	O
oral	O
ribavirin	O
or	O
oseltamivir	O
)	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
the	O
duration	O
of	O
their	O
use	O
also	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

With	O
descending	O
in	O
infectious	O
generation	O
,	O
cases	O
treated	O
with	O
methylprednisolone	O
,	O
human	B-SPEC
gamma	O
-	O
immunoglobulin	O
,	O
interferon	O
-	O
alpha	O
,	O
and	O
antiviral	O
drugs	O
(	O
oral	O
ribavirin	O
or	O
oseltamivir	O
)	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
the	O
duration	O
of	O
their	O
use	O
also	O
increased	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Before	O
dialysis	B-SPEC
treatment	O
patients	O
must	O
take	O
temperature	O
,	O
change	O
specific	O
clothes	O
and	O
shoes	O
in	O
over	O
90	O
%	O
of	O
the	O
hemodialysis	O
units	O
.	O

Eye	O
shield	O
was	O
worn	O
in	O
22	O
.	O
8	O
%	O
(	O
18	O
/	O
79	O
)	O
of	O
the	O
dialysis	B-SPEC
units	O
centers	O
.	O

TITLE	O
:	O
[	O
Detection	O
of	O
RNA	O
of	O
SARS	O
coronavirus	B-SPEC
in	O
hospital	O
sewage	O
].	O

They	O
also	O
further	O
characterize	O
the	O
S	O
-	O
mediated	O
membrane	O
fusion	O
and	O
could	O
be	O
important	O
for	O
understanding	O
the	O
mechanisms	O
of	O
virus	B-SPEC
entry	O
,	O
and	O
in	O
the	O
development	O
of	O
therapeutics	O
and	O
vaccines	O
.	O

We	O
chose	O
aluminum	O
hydroxide	O
gel	O
(	O
alum	O
)	O
as	O
an	O
adjuvant	O
,	O
because	O
of	O
its	O
long	O
safety	O
history	O
for	O
human	B-SPEC
use	O
.	O

A	O
normal	O
HRCT	O
rules	O
out	O
the	O
diagnosis	O
of	O
Pneumocystis	B-SPEC
carinii	I-SPEC
pneumonia	O
while	O
a	O
normal	O
chest	O
radiograph	O
does	O
not	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
,	O
in	O
November	O
2002	O
,	O
as	O
a	O
novel	O
agent	O
causing	O
severe	O
respiratory	O
illness	O
.	O

Furthermore	O
,	O
APC	O
reduces	O
the	O
ischemia	O
/	O
reperfusion	O
-	O
induced	O
renal	O
injury	O
and	O
the	O
stress	O
-	O
induced	O
gastric	O
mucosal	O
injury	O
in	O
rats	B-SPEC
.	O

In	O
the	O
heat	O
-	O
induced	O
denaturation	O
in	O
phosphate	O
-	O
buffered	O
saline	O
buffer	O
,	O
N	O
-	O
protein	O
starts	O
to	O
unfold	O
at	O
35	O
degrees	O
C	O
and	O
is	O
completely	O
denatured	O
at	O
55	O
degrees	O
C	O
,	O
where	O
SARS	O
virus	B-SPEC
was	O
also	O
reported	O
to	O
be	O
inactivated	O
.	O

TITLE	O
:	O
2	O
-	O
Substituted	O
benzoxazinone	O
analogues	O
as	O
anti	O
-	O
human	B-SPEC
coronavirus	I-SPEC
(	O
anti	O
-	O
HCoV	O
)	O
and	O
ICAM	O
-	O
1	O
expression	O
inhibition	O
agents	O
.	O

Thus	O
,	O
binding	O
of	O
autoAb	O
to	O
insolubilized	O
FAH	O
could	O
be	O
inhibited	O
by	O
MHV	B-SPEC
depending	O
on	O
the	O
mouse	B-SPEC
serum	O
or	O
the	O
experimental	O
protocol	O
used	O
.	O

Additionally	O
,	O
a	O
set	O
of	O
synthetic	O
homologous	O
peptides	O
from	O
mouse	B-SPEC
FAH	O
and	O
various	O
viral	O
proteins	O
was	O
employed	O
to	O
analyze	O
the	O
Ab	O
repertoire	O
of	O
MHV	B-SPEC
-	O
infected	O
mice	B-SPEC
.	O

Acute	O
methemoglobinemia	O
can	O
present	O
as	O
a	O
syndrome	O
of	O
nonspecific	O
symptoms	O
such	O
as	O
headache	O
,	O
nausea	O
,	O
fatigue	O
,	O
dyspnea	O
,	O
and	O
lethargy	O
;	O
these	O
may	O
progress	O
to	O
respiratory	O
depression	O
,	O
coma	B-SPEC
,	O
shock	O
,	O
seizures	O
,	O
and	O
death	O
.	O

The	O
meeting	O
included	O
the	O
symposium	O
'	O
Clinical	O
Update	O
on	O
Antiviral	O
Drugs	O
',	O
plenary	O
sessions	O
dedicated	O
to	O
each	O
of	O
the	O
individual	O
classes	O
of	O
infectious	O
agents	O
,	O
a	O
symposium	O
on	O
new	O
developments	O
surrounding	O
emerging	O
pathogens	O
,	O
and	O
three	O
special	O
award	O
lectures	O
,	O
which	O
discussed	O
the	O
history	O
of	O
nucleotide	O
antiviral	O
agents	O
,	O
mechanisms	O
of	O
viral	O
persistence	O
and	O
drug	O
resistance	O
,	O
and	O
the	O
therapy	O
of	O
herpes	B-SPEC
virus	I-SPEC
infections	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
spike	O
protein	O
(	O
S	O
)	O
forms	O
the	O
distinctive	O
virion	O
surface	O
structures	O
that	O
are	O
characteristic	O
of	O
this	O
viral	O
family	B-SPEC
,	O
appearing	O
in	O
negatively	O
stained	O
electron	O
microscopy	O
as	O
stems	O
capped	O
with	O
spherical	O
bulbs	O
.	O

These	O
results	O
indicate	O
that	O
CEACAM1a	O
is	O
the	O
sole	O
receptor	O
for	O
MHV	B-SPEC
-	O
A59	O
in	O
both	O
liver	O
and	O
brain	O
and	O
that	O
its	O
deletion	O
from	O
the	O
mouse	B-SPEC
renders	O
the	O
mouse	B-SPEC
completely	O
resistant	O
to	O
infection	O
by	O
this	O
virus	B-SPEC
.	O

TITLE	O
:	O
Preventive	O
effect	O
of	O
tranilast	O
on	O
oleic	O
acid	O
-	O
induced	O
lung	O
injury	O
in	O
guinea	B-SPEC
pigs	I-SPEC
.	O

CONCLUSIONS	O
:	O
All	O
the	O
tested	O
recombinant	O
interferons	O
showed	O
anti	O
-	O
SARS	O
virus	B-SPEC
activities	O
on	O
the	O
Rda	O
cell	O
culture	O
with	O
different	O
sensitivities	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
molecular	O
mechanism	O
of	O
interferon	O
alpha2b	O
(	O
IFNalpha2b	O
)	O
inhibiting	O
the	O
SARS	O
virus	B-SPEC
replication	O
.	O

CONCLUSIONS	O
:	O
A	O
SARS	O
virus	B-SPEC
whole	O
genome	O
cDNA	O
chip	O
was	O
established	O
.	O

Indirect	O
immunofluorescence	O
test	O
showed	O
a	O
specific	O
antigen	O
-	O
antibody	O
reactivity	O
between	O
the	O
coronavirus	B-SPEC
and	O
convalescent	O
-	O
phase	O
sera	O
of	O
SARS	O
patients	O
.	O

SARS	O
coronavirus	B-SPEC
was	O
found	O
in	O
multi	O
-	O
target	O
cells	O
in	O
vivo	O
,	O
which	O
means	O
that	O
SARS	O
coronavirus	B-SPEC
might	O
cause	O
multi	O
-	O
organ	O
damages	O
which	O
were	O
predominant	O
in	O
lungs	O
.	O

The	O
fusion	O
core	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
was	O
crystallized	O
,	O
and	O
the	O
structure	O
was	O
determined	O
at	O
2	O
.	O
8	O
A	O
of	O
resolution	O
.	O

This	O
structure	O
shares	O
significant	O
similarity	O
with	O
the	O
fusion	O
core	O
structure	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
spike	O
protein	O
and	O
other	O
viral	O
fusion	O
proteins	O
,	O
suggesting	O
a	O
conserved	O
mechanism	O
of	O
membrane	O
fusion	O
.	O

Drug	O
discovery	O
strategies	O
aimed	O
at	O
inhibiting	O
viral	O
entry	O
by	O
blocking	O
hairpin	O
formation	O
,	O
which	O
have	O
been	O
successfully	O
used	O
in	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
1	I-SPEC
inhibitor	O
development	O
,	O
may	O
be	O
applicable	O
to	O
the	O
inhibition	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
on	O
the	O
basis	O
of	O
structural	O
information	O
provided	O
here	O
.	O

The	O
analysis	O
of	O
morbidity	O
in	O
tuberculosis	O
,	O
measles	O
,	O
HIV	B-SPEC
infection	O
,	O
viral	O
hepatitis	O
A	O
,	O
typhoid	O
fever	O
,	O
cholera	O
and	O
quarantine	O
infections	O
,	O
Crimean	O
hemorrhagic	O
fever	O
,	O
West	O
Nile	O
fever	O
,	O
rabies	O
,	O
malaria	O
has	O
been	O
carried	O
out	O
.	O

TITLE	O
:	O
Mutational	O
dynamics	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
in	O
cell	O
culture	O
and	O
human	B-SPEC
populations	O
isolated	O
in	O
2003	O
.	O

The	O
SARS	O
virus	B-SPEC
species	B-SPEC
can	O
be	O
analyzed	O
with	O
high	O
positive	O
rate	O
and	O
rapidity	O
on	O
the	O
microfluidic	O
chip	O
system	O
.	O

TITLE	O
:	O
Inactivation	O
of	O
the	O
coronavirus	B-SPEC
that	O
induces	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
life	O
-	O
threatening	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
termed	O
SARS	O
-	O
CoV	O
.	O
Due	O
to	O
the	O
severity	O
of	O
this	O
disease	O
,	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
recommends	O
that	O
manipulation	O
of	O
active	O
viral	O
cultures	O
of	O
SARS	O
-	O
CoV	O
be	O
performed	O
in	O
containment	O
laboratories	O
at	O
biosafety	O
level	O
3	O
(	O
BSL3	O
).	O

ABSTRACT	O
:	O
A	O
murine	B-SPEC
model	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
was	O
used	O
to	O
evaluate	O
whether	O
aquaporin	O
-	O
1	O
(	O
AQP1	O
)	O
is	O
involved	O
in	O
lung	O
inflammation	O
and	O
lung	O
edema	O
formation	O
.	O

ABSTRACT	O
:	O
The	O
human	B-SPEC
coronavirus	I-SPEC
,	O
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
),	O
was	O
identified	O
and	O
molecularly	O
characterized	O
in	O
2003	O
.	O

Although	O
bacteria	B-SPEC
and	O
other	O
pathogens	O
cause	O
significant	O
numbers	O
of	O
gastroenteritis	O
,	O
it	O
is	O
the	O
viruses	B-SPEC
that	O
are	O
dealt	O
with	O
in	O
this	O
review	O
.	O

Rotavirus	B-SPEC
remains	O
the	O
leading	O
cause	O
of	O
diarrhoeal	O
disease	O
overall	O
,	O
with	O
the	O
newly	O
designated	O
calicivirus	O
family	B-SPEC
causing	O
the	O
most	O
outbreaks	O
in	O
the	O
industrialized	O
nations	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
a	O
model	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
in	O
C57BL	O
/	O
6	O
mice	B-SPEC
.	O

Infected	O
mice	B-SPEC
had	O
a	O
relative	O
failure	O
to	O
thrive	O
,	O
gaining	O
weight	O
significantly	O
more	O
slowly	O
than	O
uninfected	O
mice	B-SPEC
.	O

In	O
this	O
species	B-SPEC
,	O
proinflammatory	O
chemokines	O
may	O
coordinate	O
a	O
rapid	O
and	O
highly	O
effective	O
innate	O
antiviral	O
response	O
in	O
the	O
lung	O
,	O
but	O
NK	O
cells	O
and	O
adaptive	O
cellular	O
immunity	O
are	O
not	O
required	O
for	O
viral	O
clearance	O
.	O

TITLE	O
:	O
Identification	O
of	O
immunodominant	O
sites	O
on	O
the	O
spike	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
:	O
implication	O
for	O
developing	O
SARS	O
diagnostics	O
and	O
vaccines	O
.	O

In	O
this	O
study	O
,	O
we	O
showed	O
that	O
the	O
S	O
protein	O
of	O
SARS	O
-	O
CoV	O
is	O
highly	O
immunogenic	O
during	O
infection	O
and	O
immunizations	O
,	O
and	O
contains	O
five	O
linear	O
immunodominant	O
sites	O
(	O
sites	O
I	O
to	O
V	O
)	O
as	O
determined	O
by	O
Pepscan	O
analysis	O
with	O
a	O
set	O
of	O
synthetic	O
peptides	O
overlapping	O
the	O
entire	O
S	O
protein	O
sequence	O
against	O
the	O
convalescent	O
sera	O
from	O
SARS	O
patients	O
and	O
antisera	O
from	O
small	O
animals	B-SPEC
immunized	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
.	O
Site	O
IV	O
located	O
in	O
the	O
middle	O
region	O
of	O
the	O
S	O
protein	O
(	O
residues	O
528	O
-	O
635	O
)	O
is	O
a	O
major	O
immunodominant	O
epitope	O
.	O

Although	O
the	O
viruses	B-SPEC
identified	O
may	O
have	O
been	O
noninfectious	O
,	O
health	O
care	O
workers	O
should	O
be	O
aware	O
that	O
SARS	O
coronavirus	B-SPEC
can	O
contaminate	O
environmental	O
surfaces	O
in	O
the	O
hospital	O
,	O
and	O
fomites	O
should	O
be	O
considered	O
to	O
be	O
a	O
possible	O
mode	O
of	O
transmission	O
of	O
SARS	O
.	O

Nasal	O
and	O
pharyngeal	O
swabs	O
were	O
examined	O
by	O
virus	B-SPEC
isolation	O
,	O
polymerase	O
chain	O
reaction	O
,	O
and	O
rapid	O
immunochromatographic	O
tests	O
.	O

An	O
option	O
fee	O
of	O
400	O
,	O
000	O
euros	B-SPEC
was	O
paid	O
pursuant	O
to	O
the	O
terms	O
of	O
the	O
option	O
agreement	O
and	O
upon	O
execution	O
of	O
the	O
Distribution	O
Agreement	O
,	O
Fujisawa	O
will	O
pay	O
Hemispherx	O
fees	O
and	O
milestone	O
payments	O
with	O
a	O
potential	O
worth	O
of	O
several	O
millions	O
of	O
dollars	O
.	O

The	O
agreement	O
stipulates	O
that	O
the	O
Guangdong	O
Medicine	O
Group	O
Corporation	O
(	O
GMC	O
)	O
will	O
conduct	O
clinical	O
trials	O
with	O
Ampligen	O
for	O
the	O
treatment	O
of	O
HIV	B-SPEC
.	O

In	O
February	O
2001	O
,	O
Hemispherx	O
Biopharma	O
announced	O
that	O
it	O
was	O
initiating	O
phase	O
II	O
/	O
III	O
trials	O
of	O
Ampligen	O
in	O
the	O
treatment	O
of	O
late	O
-	O
stage	O
,	O
multidrug	O
-	O
resistant	O
strains	O
of	O
HIV	B-SPEC
in	O
the	O
European	O
Union	O
.	O

In	O
this	O
study	O
,	O
we	O
therefore	O
examine	O
the	O
immune	O
response	O
of	O
SARS	O
-	O
CoV	O
in	O
human	B-SPEC
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMCs	O
)	O
over	O
the	O
first	O
24	O
hours	O
.	O

Protein	O
-	O
protein	O
interaction	O
analysis	O
using	O
bioinformatics	O
tools	O
indicated	O
that	O
SARS_NP	O
may	O
bind	O
to	O
human	B-SPEC
cyclophilin	O
A	O
(	O
hCypA	O
),	O
and	O
surface	O
plasmon	O
resonance	O
(	O
SPR	O
)	O
technology	O
revealed	O
this	O
binding	O
with	O
the	O
equilibrium	O
dissociation	O
constant	O
ranging	O
from	O
6	O
to	O
160nM	O
.	O
The	O
probable	O
binding	O
sites	O
of	O
these	O
two	O
proteins	O
were	O
detected	O
by	O
modeling	O
the	O
three	O
-	O
dimensional	O
structure	O
of	O
the	O
SARS_NP	O
-	O
hCypA	O
complex	O
,	O
from	O
which	O
the	O
important	O
interaction	O
residue	O
pairs	O
between	O
the	O
proteins	O
were	O
deduced	O
.	O

A	O
single	O
intramuscular	O
injection	O
of	O
CKLF1	O
plasmid	O
DNA	O
into	O
BALB	O
/	O
c	O
mice	B-SPEC
caused	O
dramatic	O
pathological	O
changes	O
in	O
the	O
lungs	O
of	O
treated	O
mice	B-SPEC
.	O

These	O
data	O
suggest	O
that	O
CKLF1	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
of	O
these	O
important	O
diseases	O
and	O
the	O
study	O
also	O
implies	O
that	O
gene	O
electro	O
-	O
transfer	O
in	O
vivo	O
could	O
serve	O
as	O
a	O
valuable	O
approach	O
for	O
evaluating	O
the	O
function	O
of	O
a	O
novel	O
gene	O
in	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
new	O
strain	O
of	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
has	O
caused	O
an	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
with	O
8098	O
individuals	O
being	O
infected	O
and	O
774	O
deaths	O
worldwide	O
.	O

SAA	O
was	O
not	O
markedly	O
increased	O
in	O
the	O
fourth	O
patient	O
,	O
who	O
had	O
low	O
x	O
-	O
ray	B-SPEC
scores	O
and	O
whose	O
clinical	O
course	O
was	O
relatively	O
mild	O
.	O

SAA	O
was	O
not	O
markedly	O
increased	O
in	O
the	O
fourth	O
patient	O
,	O
who	O
had	O
low	O
x	O
-	O
ray	B-SPEC
scores	O
and	O
whose	O
clinical	O
course	O
was	O
relatively	O
mild	O
.	O

TITLE	O
:	O
[	O
Construction	O
of	O
phage	O
antibody	O
library	O
for	O
Fab	O
fragment	O
from	O
a	O
convalescent	O
patient	O
infected	O
with	O
SARS	O
coronavirus	B-SPEC
].	O

Then	O
the	O
recombinant	O
phagemid	O
was	O
electroporated	O
into	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
XL	O
-	O
1	O
Blue	O
.	O

Finally	O
,	O
we	O
show	O
that	O
a	O
soluble	O
and	O
catalytically	O
inactive	O
form	O
of	O
ACE2	O
potently	O
blocked	O
infection	O
by	O
S	O
-	O
protein	O
-	O
pseudotyped	O
retrovirus	B-SPEC
and	O
by	O
SARS	O
-	O
CoV	O
.	O
These	O
results	O
permit	B-SPEC
studies	O
of	O
SARS	O
-	O
CoV	O
entry	O
inhibitors	O
without	O
the	O
use	O
of	O
live	O
virus	B-SPEC
and	O
suggest	O
a	O
candidate	O
therapy	O
for	O
SARS	O
.	O

Seven	O
patients	O
with	O
severe	O
head	O
trauma	O
(	O
Glasgow	O
Coma	B-SPEC
Scale	O
<	O
9	O
)	O
and	O
ALI	O
/	O
ARDS	O
.	O

SPAAN	O
had	O
optimal	O
sensitivity	O
of	O
89	O
%	O
and	O
specificity	O
of	O
100	O
%	O
on	O
a	O
defined	O
test	O
set	O
and	O
could	O
identify	O
97	O
.	O
4	O
%	O
of	O
known	O
adhesins	O
at	O
high	O
Pad	O
value	O
from	O
a	O
wide	O
range	O
of	O
bacteria	B-SPEC
.	O

Novel	O
adhesins	O
were	O
identified	O
in	O
17	O
pathogenic	O
organisms	O
causing	O
diseases	O
in	O
humans	B-SPEC
and	O
plants	B-SPEC
.	O

RESULTS	O
:	O
SPAAN	O
had	O
optimal	O
sensitivity	O
of	O
89	O
%	O
and	O
specificity	O
of	O
100	O
%	O
on	O
a	O
defined	O
test	O
set	O
and	O
could	O
identify	O
97	O
.	O
4	O
%	O
of	O
known	O
adhesins	O
at	O
high	O
Pad	O
value	O
from	O
a	O
wide	O
range	O
of	O
bacteria	B-SPEC
.	O

PPV	B-SPEC
and	O
TIVA	O
significantly	O
increased	O
Vd	O
(	O
phys	O
)	O
compared	O
with	O
baseline	O
(	O
preoperative	O
and	O
breathing	O
spontaneously	O
)	O
from	O
164	O
+/-	O

Isoflurane	O
inhalation	O
combined	O
with	O
PPV	B-SPEC
significantly	O
enhanced	O
this	O
increase	O
,	O
resulting	O
in	O
a	O
twofold	O
increase	O
in	O
Vd	O
(	O
phys	O
)	O
to	O
315	O
+/-	O

The	O
corresponding	O
T	O
values	O
of	O
the	O
parameter	O
BUA	B-SPEC
and	O
VOS	O
were	O
(-	O
1	O
.	O
49	O
+/-	O
0	O
.	O
59	O
)	O
and	O
(-	O
0	O
.	O
65	O
+/-	O
0	O
.	O
05	O
)	O
respectively	O
.	O

Epitopes	O
inducing	O
protective	O
humoral	O
responses	O
to	O
virus	B-SPEC
infection	O
were	O
located	O
mainly	O
in	O
the	O
M	O
protein	O
and	O
a	O
region	O
spanning	O
residues	O
13	O
-	O
877	O
of	O
the	O
S	O
protein	O
.	O

However	O
,	O
there	O
is	O
also	O
a	O
possibility	O
that	O
wild	O
animals	B-SPEC
as	O
the	O
source	O
of	O
infection	O
may	O
not	O
be	O
specified	O
and	O
that	O
it	O
may	O
be	O
much	O
in	O
fashion	O
again	O
.	O

Some	O
spike	O
proteins	O
of	O
coronavirus	B-SPEC
,	O
such	O
as	O
MHV	B-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
AIBV	O
and	O
BcoV	O
,	O
are	O
proteolytically	O
cleaved	O
into	O
two	O
subunits	O
,	O
S1	O
and	O
S2	O
.	O

TITLE	O
:	O
Specific	O
antibody	O
secreting	O
cells	O
from	O
chickens	B-SPEC
can	O
be	O
detected	O
by	O
three	O
days	O
and	O
memory	O
B	O
cells	O
by	O
three	O
weeks	O
post	O
-	O
infection	O
with	O
the	O
avian	B-SPEC
respiratory	O
coronavirus	B-SPEC
.	O

While	O
previous	O
studies	O
demonstrated	O
that	O
effector	O
and	O
memory	O
CD8	O
(+)	O
T	O
lymphocytes	O
are	O
critical	O
in	O
controlling	O
acute	O
IBV	B-SPEC
infection	O
and	O
disease	O
in	O
chickens	B-SPEC
,	O
here	O
chicken	B-SPEC
anti	O
-	O
IBV	B-SPEC
antibody	O
(	O
IgG	O
)	O
secreting	O
cells	O
(	O
ASC	O
)	O
in	O
both	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
and	O
spleens	O
collected	O
following	O
IBV	B-SPEC
Gray	O
infection	O
were	O
evaluated	O
using	O
an	O
ELISPOT	O
assay	O
.	O

TITLE	O
:	O
Application	O
of	O
real	O
-	O
time	O
PCR	O
for	O
testing	O
antiviral	O
compounds	O
against	O
Lassa	B-SPEC
virus	I-SPEC
,	O
SARS	O
coronavirus	B-SPEC
and	O
Ebola	B-SPEC
virus	I-SPEC
in	O
vitro	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
specific	O
cytotoxic	O
T	O
lymphocytes	O
(	O
CTLs	O
)	O
against	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
coronavirus	B-SPEC
,	O
a	O
modified	O
DimerX	O
flow	O
cytometry	O
assay	O
was	O
performed	O
with	O
peripheral	O
blood	O
mononuclear	O
cell	O
(	O
PBMC	O
)	O
from	O
HLA	O
-	O
A2	O
+	O
SARS	O
-	O
recovered	O
donors	O
at	O
different	O
time	O
points	O
post	O
disease	O
.	O

The	O
percentages	O
of	O
CD8	O
+	O
DimerX	O
-	O
S1203	O
+	O
cells	O
paralleled	O
the	O
numbers	O
of	O
interferon	O
-	O
gamma	O
-	O
positive	O
spots	B-SPEC
in	O
an	O
ELISPOT	O
assay	O
using	O
the	O
same	O
antigenic	O
peptide	O
.	O

We	O
describe	O
here	O
the	O
screening	O
of	O
Chinese	O
herbal	O
medicine	O
-	O
based	O
,	O
novel	O
small	O
molecules	O
that	O
bind	O
avidly	O
with	O
the	O
surface	O
spike	O
protein	O
of	O
SARS	O
-	O
CoV	O
and	O
thus	O
can	O
interfere	O
with	O
the	O
entry	O
of	O
the	O
virus	B-SPEC
to	O
its	O
host	O
cells	O
.	O

ABSTRACT	O
:	O
Rhesus	O
and	O
cynomolgus	O
macaques	B-SPEC
were	O
challenged	O
with	O
10	O
(	O
7	O
)	O
PFU	O
of	O
a	O
clinical	O
isolate	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Resolution	O
of	O
primary	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
requires	O
Stat1	O
.	O

Rat	B-SPEC
ACE2	O
was	O
even	O
less	O
efficient	O
,	O
at	O
near	O
background	O
levels	O
for	O
both	O
activities	O
.	O

RESULTS	O
:	O
Intranasal	O
BCV	B-SPEC
(	O
125	O
/	O
407	O
[	O
31	O
%])	O
and	O
serum	O
antibody	O
titers	O
>	O
or	O
=	O
20	O
against	O
BCV	B-SPEC
(	O
246	O
/	O
396	O
[	O
62	O
%])	O
were	O
identified	O
in	O
calves	O
entering	O
the	O
feedlot	O
.	O

ABSTRACT	O
:	O
Two	O
replicate	O
lines	O
of	O
mice	B-SPEC
,	O
selected	O
for	O
hyperactivity	O
and	O
hypoactivity	O
after	O
ethanol	O
administration	O
,	O
had	O
been	O
enzootically	O
infected	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
for	O
over	O
a	O
decade	O
.	O

Eradication	O
of	O
the	O
virus	B-SPEC
had	O
been	O
tried	O
with	O
limited	O
success	O
in	O
the	O
past	O
.	O

The	O
affected	O
animals	B-SPEC
were	O
in	O
multiple	O
breeding	O
colonies	O
comprising	O
more	O
than	O
4000	O
mice	B-SPEC
representing	O
more	O
than	O
50	O
site	O
-	O
specific	O
strains	O
,	O
lines	O
,	O
and	O
sublines	O
.	O

However	O
,	O
this	O
may	O
account	O
for	O
the	O
contamination	O
of	O
the	O
hunter	O
,	O
his	O
family	B-SPEC
and	O
relatives	O
.	O

TITLE	O
:	O
Interaction	O
between	O
genomes	O
of	O
infectious	O
bronchitis	O
and	O
Newcastle	O
disease	O
viruses	B-SPEC
studied	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

In	O
the	O
group	O
inoculated	O
with	O
both	O
vaccine	O
viruses	B-SPEC
there	O
was	O
a	O
10	O
(	O
3	O
)-	O
fold	O
reduction	O
in	O
the	O
cDNA	O
dilution	O
factor	O
on	O
day	O
4	O
p	O
.	O
v	O
.	O

for	O
both	O
IBV	B-SPEC
and	O
NDV	B-SPEC
genomes	O
.	O

On	O
the	O
other	O
hand	O
,	O
simultaneous	O
high	O
level	O
expression	O
of	O
S	O
,	O
E	O
and	O
M	O
by	O
a	O
single	O
recombinant	O
virus	B-SPEC
allowed	O
the	O
very	O
efficient	O
assembly	O
and	O
release	O
of	O
VLPs	O
.	O

TITLE	O
:	O
Immunological	O
,	O
structural	O
,	O
and	O
preliminary	O
X	O
-	O
ray	B-SPEC
diffraction	O
characterizations	O
of	O
the	O
fusion	O
core	O
of	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

Rabbit	B-SPEC
antisera	O
effectively	O
blocked	O
binding	O
of	O
S1	O
,	O
which	O
contains	O
RBD	O
,	O
to	O
ACE2	O
.	O

In	O
murine	B-SPEC
coronavirus	I-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
the	O
spike	O
(	O
S	O
)	O
protein	O
mediates	O
this	O
process	O
.	O

To	O
facilitate	O
the	O
solution	O
of	O
the	O
crystal	O
structure	O
of	O
this	O
fusion	O
core	O
,	O
we	O
deployed	O
an	O
Escherichia	B-SPEC
coli	I-SPEC
in	O
vitro	O
expression	O
system	O
to	O
express	O
the	O
HR1	O
and	O
HR2	O
regions	O
linked	O
together	O
by	O
a	O
flexible	O
linker	O
as	O
a	O
single	O
chain	O
(	O
named	O
2	O
-	O
helix	O
).	O

Finally	O
,	O
we	O
conducted	O
phylogenetic	O
analyses	O
to	O
further	O
explore	O
whether	O
recombination	O
has	O
indeed	O
occurred	O
in	O
the	O
course	O
of	O
coronaviruses	O
history	O
predating	O
the	O
emergence	O
of	O
SARS	O
-	O
CoV	O
.	O
Surprisingly	O
,	O
we	O
found	O
that	O
7	O
putative	O
recombination	O
regions	O
,	O
located	O
in	O
Replicase	O
1ab	O
and	O
Spike	O
protein	O
,	O
exist	O
between	O
SARS	O
-	O
CoV	O
and	O
other	O
6	O
coronaviruses	O
:	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	O
),	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
and	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

In	O
2003	O
,	O
outbreaks	O
of	O
interest	O
included	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
monkeypox	O
and	O
avian	B-SPEC
influenza	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
novel	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
assay	O
with	O
LUX	O
primer	O
for	O
the	O
detection	O
of	O
swine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
panel	O
of	O
murine	B-SPEC
monoclonal	O
antibodies	O
specific	O
for	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
.	O

The	O
results	O
suggest	O
that	O
optimization	O
of	O
murine	B-SPEC
mAbs	O
for	O
neutralization	O
of	O
SARS	O
-	O
CoV	O
infection	O
will	O
likely	O
be	O
possible	O
,	O
and	O
will	O
aid	O
in	O
the	O
development	O
of	O
diagnostic	O
tools	O
and	O
passive	O
treatments	O
for	O
SARS	O
-	O
CoV	O
infection	O
.	O

It	O
suggests	O
that	O
SARS	O
-	O
CoV	O
is	O
of	O
similar	O
mutation	O
frequency	O
and	O
dynamic	O
mutant	O
distributions	O
like	O
other	O
RNA	O
viruses	B-SPEC
,	O
though	O
relatively	O
less	O
identified	O
variation	O
number	O
than	O
those	O
causing	O
chronic	O
infections	O
.	O

Serum	O
anti	O
-	O
coronavirus	B-SPEC
IgG	O
was	O
positive	O
in	O
13	O
of	O
the	O
15	O
patients	O
(	O
86	O
.	O
7	O
%).	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
determine	O
highly	O
immunogenic	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
epitope	O
peptides	O
capable	O
of	O
inducing	O
long	O
-	O
lasting	O
immunity	O
,	O
we	O
first	O
screened	O
immunoglobulin	O
-	O
G	O
(	O
IgG	O
)	O
antibodies	O
reactive	O
to	O
197	O
different	O
overlapping	O
15	O
-	O
mers	O
from	O
the	O
SARS	O
-	O
CoV	O
proteins	O
in	O
the	O
sera	O
of	O
three	O
infected	O
patients	O
.	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
receptor	O
for	O
SARS	O
-	O
CoV	O
,	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
[	O
Li	B-SPEC
,	O
W	O
.	O
Moore	O
,	O
M	O
.	O
J	O
.,	O
Vasilieva	O
,	O
N	O
.,	O
Sui	O
,	O
J	O
.,	O
Wong	O
,	O
S	O
.	O
K	O
.,	O
Berne	O
,	O
M	O
.	O
A	O
.,	O
Somasundaran	O
,	O
M	O
.,	O
Sullivan	O
,	O
J	O
.	O
L	O
.,	O
Luzuriaga	B-SPEC
,	O
K	O
.,	O
Greenough	O
,	O
T	O
.	O
C	O
.,	O
et	O
al	O
.	O
(	O
2003	O
)	O
Nature	O
426	O
,	O
450	O
-	O
454	O
].	O

Sequencing	O
of	O
the	O
human	B-SPEC
lung	O
cDNA	O
inserts	O
showed	O
that	O
each	O
of	O
the	O
cloned	O
cell	O
lines	O
contained	O
cDNA	O
that	O
encoded	O
human	B-SPEC
CD209L	O
,	O
a	O
C	O
-	O
type	O
lectin	O
(	O
also	O
called	O
L	O
-	O
SIGN	O
).	O

We	O
have	O
cloned	O
and	O
overexpressed	O
the	O
SARS	O
-	O
CoV	O
Mpro	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
and	O
purified	O
the	O
recombinant	O
Mpro	O
to	O
homogeneity	O
.	O

ABSTRACT	O
:	O
The	O
major	O
biochemical	O
and	O
thermodynamic	O
features	O
of	O
nucelocapsid	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS_NP	O
)	O
were	O
characterized	O
by	O
use	O
of	O
non	O
-	O
denatured	O
gel	O
electrophoresis	O
,	O
size	O
-	O
exclusion	O
chromatographic	O
and	O
surface	O
plasmon	O
resonance	O
(	O
SPR	O
)	O
techniques	O
.	O

The	O
median	O
(	O
range	O
)	O
duration	O
of	O
virus	B-SPEC
excretion	O
in	O
sputa	O
and	O
stools	O
was	O
21	O
(	O
14	O
-	O
52	O
)	O
and	O
27	O
(	O
16	O
-	O
126	O
)	O
days	O
,	O
respectively	O
.	O

This	O
review	O
describes	O
the	O
mRNA	O
motifs	O
involved	O
in	O
programmed	O
-	O
1	O
ribosomal	O
frameshifting	O
in	O
this	O
virus	B-SPEC
.	O

TITLE	O
:	O
Nidovirus	B-SPEC
sialate	O
-	O
O	O
-	O
acetylesterases	O
:	O
evolution	O
and	O
substrate	O
specificity	O
of	O
coronaviral	O
and	O
toroviral	O
receptor	O
-	O
destroying	O
enzymes	O
.	O

There	O
are	O
striking	O
parallels	O
between	O
orthomyxo	O
-	O
and	O
nidovirus	B-SPEC
biology	O
.	O

As	O
for	O
orthomyxovirus	B-SPEC
reassortants	O
,	O
the	O
fitness	O
of	O
nidovirus	B-SPEC
recombinant	O
offspring	O
probably	O
depends	O
both	O
on	O
antigenic	O
properties	O
and	O
on	O
compatibility	O
of	O
receptor	O
-	O
binding	O
and	O
receptor	O
-	O
destroying	O
activities	O
.	O

TITLE	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
Nsp15	O
protein	O
is	O
an	O
endoribonuclease	O
that	O
prefers	O
manganese	O
as	O
a	O
cofactor	O
.	O

This	O
work	O
presents	O
an	O
initial	O
biochemical	O
characterization	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
endoribonuclease	O
.	O

ABSTRACT	O
:	O
The	O
recently	O
emerged	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
contains	O
four	O
structural	O
genes	O
,	O
two	O
replicase	O
-	O
transcriptase	O
open	O
reading	O
frames	O
,	O
and	O
more	O
than	O
five	O
potential	O
genes	O
of	O
unknown	O
function	O
.	O

In	O
this	O
report	O
,	O
we	O
immunized	O
ferrets	B-SPEC
(	O
Mustela	B-SPEC
putorius	I-SPEC
furo	I-SPEC
)	O
with	O
recombinant	O
modified	O
vaccinia	B-SPEC
virus	I-SPEC
Ankara	O
(	O
rMVA	O
)	O
expressing	O
the	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
.	O

Immunized	O
ferrets	B-SPEC
developed	O
a	O
more	O
rapid	O
and	O
vigorous	O
neutralizing	O
antibody	O
response	O
than	O
control	O
animals	B-SPEC
after	O
challenge	O
with	O
SARS	O
-	O
CoV	O
;	O
however	O
,	O
they	O
also	O
exhibited	O
strong	O
inflammatory	O
responses	O
in	O
liver	O
tissue	O
.	O

In	O
addition	O
,	O
we	O
examined	O
the	O
subcellular	O
localization	O
of	O
the	O
N	O
protein	O
by	O
confocal	O
microscopy	O
in	O
Trichoplusia	B-SPEC
ni	I-SPEC
BT1	O
Tn	O
5B1	O
-	O
4	O
cells	O
infected	O
with	O
recombinant	O
baculovirus	B-SPEC
.	O

The	O
coronavirus	B-SPEC
spike	O
proteins	O
belong	O
to	O
class	B-SPEC
I	O
fusion	O
proteins	O
,	O
and	O
are	O
characterized	O
by	O
the	O
existence	O
of	O
two	O
heptad	O
repeat	O
(	O
HR	O
)	O
regions	O
,	O
HR1	O
and	O
HR2	O
.	O

The	O
HR1	O
region	O
in	O
coronaviruses	O
is	O
predicted	O
to	O
be	O
considerably	O
longer	O
than	O
that	O
in	O
other	O
type	O
I	O
virus	B-SPEC
fusion	O
proteins	O
.	O

ABSTRACT	O
:	O
A	O
22	O
-	O
year	O
-	O
old	O
man	B-SPEC
was	O
admitted	O
to	O
the	O
acute	O
intoxication	O
unit	O
after	O
suicidal	O
intoxication	O
with	O
100	O
tablets	O
of	O
verapamil	O
,	O
diltiazem	O
and	O
isosorbide	O
mononitrate	O
.	O

The	O
detection	O
of	O
the	O
virus	B-SPEC
in	O
these	O
patients	O
,	O
its	O
absence	O
in	O
healthy	O
controls	O
or	O
other	O
patients	O
with	O
atypical	O
pneumonia	O
,	O
and	O
the	O
reproduction	O
of	O
a	O
similar	O
disease	O
in	O
a	O
relevant	O
animal	B-SPEC
model	O
fulfilled	O
Koch	O
'	O
s	O
postulates	O
for	O
implicating	O
this	O
coronavirus	B-SPEC
as	O
the	O
causal	O
agent	O
of	O
SARS	O
.	O

TITLE	O
:	O
Canine	O
coronavirus	B-SPEC
infection	O
in	O
Turkish	O
dog	B-SPEC
population	O
.	O

A	O
total	O
of	O
269	O
animals	B-SPEC
were	O
subjected	O
to	O
the	O
study	O
.	O

ABSTRACT	O
:	O
The	O
complete	O
genome	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
many	O
of	O
its	O
variants	O
has	O
been	O
determined	O
by	O
several	O
laboratories	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
administered	O
intranasally	O
and	O
intratracheally	O
to	O
rhesus	O
,	O
cynomolgus	O
and	O
African	B-SPEC
Green	I-SPEC
monkeys	I-SPEC
(	O
AGM	O
)	O
replicated	O
in	O
the	O
respiratory	O
tract	O
but	O
did	O
not	O
induce	O
illness	O
.	O

Following	O
challenge	O
of	O
AGMs	O
2	O
months	O
later	O
,	O
virus	B-SPEC
replication	O
was	O
highly	O
restricted	O
and	O
there	O
was	O
no	O
evidence	O
of	O
enhanced	O
disease	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
E	O
protein	O
forms	O
cation	O
-	O
selective	O
ion	O
channels	O
.	O

ABSTRACT	O
:	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
is	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

PCR	O
primers	O
were	O
designed	O
to	O
conserved	O
regions	O
within	O
the	O
nucleocapsid	O
gene	O
of	O
TCV	B-SPEC
and	O
to	O
the	O
polymerase	O
gene	O
of	O
TAstV	O
-	O
2	O
.	O

The	O
primer	O
pairs	O
were	O
successfully	O
used	O
in	O
a	O
multiplex	O
RT	O
-	O
PCR	O
to	O
detect	O
nucleic	O
acid	O
of	O
TAstV	O
-	O
2	O
and	O
TCV	B-SPEC
.	O

TITLE	O
:	O
S1	O
and	O
N	O
gene	O
analysis	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
viruses	B-SPEC
in	O
Taiwan	O
.	O

The	O
results	O
indicated	O
that	O
Taiwanese	O
IBV	B-SPEC
strains	O
could	O
be	O
divided	O
into	O
two	O
distinct	O
lineages	O
,	O
Taiwan	O
Group	O
I	O
and	O
Taiwan	O
Group	O
II	O
,	O
with	O
one	O
Massachusetts	O
strain	O
and	O
one	O
Chinese	O
strain	O
.	O

The	O
virus	B-SPEC
was	O
first	O
identified	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
and	O
showed	O
a	O
distinct	O
restriction	O
fragment	O
length	O
polymorphism	O
pattern	O
from	O
previously	O
described	O
Israeli	O
isolates	O
.	O

The	O
antisera	O
from	O
the	O
immunized	O
animals	B-SPEC
efficiently	O
bound	O
to	O
the	O
RBD	O
and	O
blocked	O
binding	O
of	O
RBD	O
to	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
,	O
the	O
functional	O
receptor	O
on	O
the	O
susceptible	O
cells	O
for	O
SARS	O
-	O
CoV	O
.	O
With	O
a	O
sensitive	O
and	O
quantitative	O
single	O
-	O
cycle	O
infection	O
assay	O
using	O
pseudovirus	O
bearing	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
,	O
we	O
demonstrated	O
that	O
mouse	B-SPEC
and	O
rabbit	B-SPEC
antisera	O
significantly	O
inhibited	O
S	O
protein	O
-	O
mediated	O
virus	B-SPEC
entry	O
with	O
mean	O
50	O
%	O
inhibitory	O
titers	O
of	O
1	O
:	O
7393	O
and	O
1	O
:	O
2060	O
,	O
respectively	O
.	O

Origin	O
-	O
and	O
-	O
destination	O
plots	O
showed	O
the	O
directional	O
bias	B-SPEC
and	O
radius	O
of	O
spread	O
of	O
superspreading	O
events	O
.	O

ABSTRACT	O
:	O
Nucleocapsid	O
(	O
N	O
)	O
protein	O
plays	O
an	O
important	O
role	O
in	O
reproduction	O
and	O
pathological	O
reaction	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SCoV	O
),	O
the	O
antigenicity	O
of	O
the	O
protein	O
is	O
better	O
than	O
spike	O
(	O
S	O
)	O
protein	O
.	O

Active	O
recombinant	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
rSCoVN	O
)	O
protein	O
can	O
be	O
successfully	O
expressed	O
in	O
recombinant	O
methylotrophic	O
yeast	B-SPEC
P	B-SPEC
.	I-SPEC
pastoris	I-SPEC
GS115	O
.	O

Beetles	B-SPEC
were	O
dissected	O
and	O
the	O
guts	O
removed	O
1	O
,	O
12	O
,	O
and	O
24	O
h	O
after	O
the	O
initial	O
viral	O
feeding	O
.	O

Serum	O
of	O
60	O
SARS	O
patients	O
,	O
20	O
samples	O
of	O
serum	O
and	O
20	O
samples	O
of	O
gargling	O
fluid	O
of	O
medical	O
staff	O
of	O
the	O
""""	O
Fever	O
Clinic	O
""","	O
and	O
one	O
cDNA	O
specimen	O
obtained	O
from	O
one	O
SARS	O
suspect	O
patient	O
were	O
examined	O
with	O
F	O
-	O
PCR	O
diagnosis	O
kit	O
and	O
gene	O
-	O
chip	O
technique	O
for	O
SARS	O
coronavirus	B-SPEC
.	O

RESULTS	O
:	O
Three	O
methods	O
,	O
including	O
DR	O
Chip	O
and	O
two	O
F	O
-	O
PCR	O
kit	O
from	O
Zhongshan	O
College	O
Da	O
'	O
an	O
gene	O
stock	O
company	O
and	O
Shanghai	O
Fortune	O
industrial	O
joint	O
-	O
stock	O
Co	O
,	O
Ltd	O
,	O
were	O
used	O
,	O
and	O
the	O
results	O
were	O
all	O
negative	O
for	O
all	O
specimens	O
,	O
except	O
one	O
cDNA	O
specimen	O
,	O
which	O
was	O
obtained	O
from	O
one	O
SARS	O
suspect	O
patient	O
,	O
virus	B-SPEC
could	O
be	O
amplified	O
by	O
F	O
-	O
PCR	O
.	O

We	O
assessed	O
thyroid	O
function	O
in	O
patients	O
with	O
severe	O
respiratory	O
failure	O
from	O
pulmonary	O
disorders	O
,	O
and	O
needing	O
invasive	O
or	O
noninvasive	O
mechanical	O
ventilation	O
,	O
in	O
order	B-SPEC
to	O
evaluate	O
the	O
prognostic	O
value	O
of	O
nonthyroidal	O
illness	O
syndrome	O
.	O

ABSTRACT	O
:	O
A	O
Western	O
immunoblot	O
assay	O
for	O
confirmatory	O
serodiagnosis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
developed	O
utilizing	O
viral	O
lysate	O
antigens	O
combined	O
with	O
a	O
recombinant	O
nucleocapsid	O
protein	O
,	O
GST	O
-	O
N	O
(	O
glutathione	O
S	O
-	O
transferase	O
-	O
nucleocapsid	O
)	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Specific	O
immunoglobulin	O
g	O
antibody	O
detected	O
in	O
umbilical	O
blood	O
and	O
amniotic	O
fluid	O
from	O
a	O
pregnant	O
woman	O
infected	O
by	O
the	O
coronavirus	B-SPEC
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

TITLE	O
:	O
SYNCRIP	O
,	O
a	O
member	O
of	O
the	O
heterogeneous	O
nuclear	O
ribonucleoprotein	O
family	B-SPEC
,	O
is	O
involved	O
in	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
RNA	O
synthesis	O
.	O

The	O
p70	O
was	O
cross	O
-	O
linked	O
to	O
the	O
MHV	B-SPEC
positive	O
-	O
or	O
negative	O
-	O
strand	O
UTR	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

This	O
study	O
identified	O
an	O
additional	O
cellular	O
hnRNP	O
as	O
an	O
MHV	B-SPEC
RNA	O
-	O
binding	O
protein	O
potentially	O
involved	O
in	O
viral	O
RNA	O
synthesis	O
.	O

TITLE	O
:	O
Recombinant	O
human	B-SPEC
activated	O
protein	O
C	O
in	O
the	O
treatment	O
of	O
severe	O
sepsis	B-SPEC
:	O
an	O
evidence	O
-	O
based	O
review	O
.	O

The	O
presence	O
or	O
absence	O
of	O
disseminated	O
intravascular	O
coagulation	O
should	O
not	O
influence	O
the	O
decision	O
to	O
administer	O
recombinant	O
human	B-SPEC
activated	O
protein	O
C	O
.	O
Heparin	O
should	O
be	O
withheld	O
during	O
administration	O
of	O
recombinant	O
human	B-SPEC
activated	O
protein	O
C	O
.	O

In	O
this	O
study	O
,	O
we	O
describe	O
the	O
genome	O
structure	O
and	O
the	O
transcription	O
strategy	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
by	O
experimental	O
analysis	O
of	O
the	O
viral	O
subgenomic	O
mRNAs	O
.	O

RESULTS	O
:	O
The	O
genome	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
has	O
the	O
following	O
gene	O
order	B-SPEC
:	O
1a	O
-	O
1b	O
-	O
S	O
-	O
ORF3	O
-	O
E	O
-	O
M	O
-	O
N	O
.	O
The	O
GC	O
content	O
of	O
the	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
genome	O
is	O
extremely	O
low	O
(	O
34	O
%)	O
compared	O
to	O
other	O
coronaviruses	O
,	O
and	O
we	O
therefore	O
performed	O
additional	O
analysis	O
of	O
the	O
nucleotide	O
composition	O
.	O

Recently	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
was	O
identified	O
as	O
the	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

ABSTRACT	O
:	O
Scanning	O
electron	O
and	O
atomic	O
force	O
microscopy	O
was	O
used	O
for	O
the	O
first	O
time	O
to	O
view	O
the	O
maturation	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
at	O
the	O
cell	O
surface	O
.	O

The	O
surface	O
form	O
of	O
the	O
cells	O
at	O
advanced	O
infection	O
displayed	O
prolific	O
pseudopodia	O
that	O
,	O
in	O
addition	O
to	O
the	O
rest	O
of	O
the	O
plasma	O
membrane	O
,	O
were	O
also	O
active	O
sites	O
of	O
virus	B-SPEC
release	O
.	O

The	O
cytoskeletal	O
network	O
along	O
the	O
edge	O
of	O
the	O
infected	O
cells	O
was	O
enhanced	O
and	O
could	O
be	O
involved	O
in	O
transporting	O
and	O
expelling	O
the	O
progeny	O
virus	B-SPEC
particles	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
infection	O
(	O
CVI	O
)	O
was	O
studied	O
in	O
227	O
patients	O
hospitalized	O
in	O
the	O
clinic	O
of	O
the	O
Research	O
Institute	O
of	O
Hematology	O
and	O
Transfusiology	O
in	O
1993	O
-	O
2003	O
with	O
diagnosed	O
acute	O
and	O
chronic	O
leucosis	O
,	O
multiple	O
myelogenic	O
disease	O
and	O
aplastic	O
anemia	B-SPEC
.	O

This	O
article	O
discusses	O
the	O
epidemiology	O
and	O
bacterial	O
causes	O
of	O
CAP	O
in	O
immunocompetent	O
adults	O
and	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

The	O
IFN	O
-	O
gamma	O
activation	O
of	O
macrophages	O
derived	O
from	O
A	O
/	O
J	O
or	O
BALB	O
/	O
c	O
mice	B-SPEC
yielded	O
two	O
different	O
patterns	O
of	O
antiviral	O
state	O
in	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
3	O
infection	O
,	O
which	O
were	O
related	O
to	O
a	O
down	O
-	O
regulation	O
of	O
the	O
main	O
virus	B-SPEC
receptor	O
.	O

In	O
this	O
respect	O
,	O
a	O
down	O
-	O
regulation	O
of	O
the	O
main	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
3	O
receptor	O
gene	O
was	O
detected	O
only	O
in	O
IFN	O
-	O
gamma	O
-	O
activated	O
macrophages	O
of	O
resistant	O
mice	B-SPEC
.	O

Serum	O
samples	O
from	O
35	O
close	O
contacts	O
obtained	O
after	O
day	O
28	O
had	O
a	O
negative	O
result	O
for	O
SARS	O
coronavirus	B-SPEC
antibody	O
.	O

Serum	O
samples	O
from	O
35	O
close	O
contacts	O
obtained	O
after	O
day	O
28	O
had	O
a	O
negative	O
result	O
for	O
SARS	O
coronavirus	B-SPEC
antibody	O
.	O

Thus	O
,	O
vector	O
development	O
to	O
challenge	O
dilemmas	O
in	O
vaccinology	O
or	O
immunization	O
against	O
poxvirus	B-SPEC
bio	O
-	O
threat	O
seems	O
possible	O
,	O
yet	O
the	O
right	O
choice	O
should	O
be	O
made	O
for	O
a	O
most	O
beneficial	O
use	O
.	O

These	O
frameshift	O
signals	O
originate	O
from	O
the	O
L	B-SPEC
-	I-SPEC
A	I-SPEC
virus	I-SPEC
,	O
the	O
SARS	O
-	O
associated	O
Coronavirus	B-SPEC
and	O
computationally	O
identified	O
frameshift	O
signals	O
from	O
two	O
Saccharomyces	B-SPEC
cerevisiae	I-SPEC
genes	O
.	O

And	O
group	O
3	O
corresponds	O
to	O
the	O
avian	B-SPEC
pathology	O
....	O

The	O
epidemics	O
emerged	O
on	O
February	O
2003	O
in	O
Guangdong	O
,	O
South	O
China	O
,	O
due	O
to	O
consumption	O
of	O
exotic	O
animals	B-SPEC
(	O
Civeta	O
,	O
etc	O
.),	O
and	O
it	O
spread	O
through	O
interperson	O
contagion	O
to	O
other	O
regions	O
in	O
Asia	O
,	O
America	O
and	O
Europe	O
.	O

Avian	B-SPEC
influenza	O
is	O
an	O
infection	O
caused	O
by	O
type	O
A	O
Influenza	O
Orthomixovirus	O
,	O
in	O
which	O
migration	O
birds	B-SPEC
and	O
wild	O
ducks	B-SPEC
are	O
the	O
main	O
reservoir	O
.	O

Avian	B-SPEC
viruses	B-SPEC
correspond	O
to	O
H5	O
,	O
H7	O
,	O
H9	O
.	O

ABSTRACT	O
:	O
Gene	O
1	O
of	O
the	O
coronavirus	B-SPEC
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
encodes	O
replicase	O
polyproteins	O
that	O
are	O
predicted	O
to	O
be	O
processed	O
into	O
16	O
nonstructural	O
proteins	O
(	O
nsps	O
1	O
to	O
16	O
)	O
by	O
two	O
viral	O
proteases	O
,	O
a	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
and	O
a	O
3C	O
-	O
like	O
protease	O
(	O
3CLpro	O
).	O

There	O
were	O
no	O
consistent	O
differences	O
in	O
pathogenicity	O
between	O
the	O
recombinant	O
BeauR	O
-	O
M41	O
(	O
S	O
)	O
and	O
its	O
apathogenic	O
parent	O
Beau	O
-	O
R	O
(	O
based	O
on	O
snicking	O
,	O
nasal	O
discharge	O
,	O
wheezing	O
,	O
watery	O
eyes	O
,	O
rales	O
,	O
and	O
ciliostasis	O
in	O
trachea	B-SPEC
),	O
and	O
both	O
replicated	O
poorly	O
in	O
trachea	B-SPEC
and	O
nose	O
compared	O
to	O
M41	O
;	O
the	O
S	O
protein	O
from	O
the	O
pathogenic	O
M41	O
had	O
not	O
altered	O
the	O
apathogenic	O
nature	O
of	O
Beau	O
-	O
R	O
.	O
Both	O
Beau	O
-	O
R	O
and	O
BeauR	O
-	O
M41	O
(	O
S	O
)	O
induced	O
protection	O
against	O
challenge	O
with	O
M41	O
as	O
assessed	O
by	O
absence	O
of	O
recovery	O
of	O
challenge	O
virus	B-SPEC
and	O
nasal	O
exudate	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SCoV	O
)	O
is	O
the	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Human	B-SPEC
lung	O
fibroblasts	O
were	O
transfected	O
with	O
a	O
procollagen	O
I	O
promoter	O
-	O
luciferase	O
construct	O
and	O
incubated	O
with	O
BALF	O
;	O
procollagen	O
I	O
promoter	O
activity	O
was	O
then	O
measured	O
.	O

Unfortunately	O
one	O
of	O
the	O
travellers	O
was	O
a	O
super	O
-	O
spreader	O
,	O
defined	O
as	O
a	O
person	O
with	O
high	O
efficiency	O
for	O
virus	B-SPEC
transmission	O
,	O
and	O
was	O
responsible	O
for	O
the	O
expansion	O
of	O
the	O
national	O
outbreak	O
.	O

TITLE	O
:	O
Cardiovascular	O
stability	O
during	O
arteriovenous	O
extracorporeal	O
therapy	O
:	O
a	O
randomized	O
controlled	O
study	O
in	O
lambs	B-SPEC
with	O
acute	O
lung	O
injury	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
whether	O
SARS	O
-	O
CoV	O
could	O
productively	O
infect	O
purified	O
monocytes	O
/	O
macrophages	O
(	O
PM	O
)	O
derived	O
from	O
human	B-SPEC
donor	O
cells	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
dynamic	O
changes	O
of	O
the	O
antibody	O
specific	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
in	O
convalescents	O
who	O
have	O
suffered	O
from	O
SARS	O
.	O

Eight	O
adult	O
New	B-SPEC
Zealand	I-SPEC
rabbits	I-SPEC
were	O
immunized	O
four	O
times	O
with	O
this	O
experimental	O
inactivated	O
vaccine	O
.	O

More	O
research	O
is	O
required	O
in	O
order	B-SPEC
to	O
prepare	O
for	O
if	O
this	O
respiratory	O
infection	O
recurs	O
,	O
but	O
there	O
are	O
concerns	O
that	O
adequate	O
pharmaceutical	O
support	O
may	O
be	O
lacking	O
for	O
the	O
development	O
of	O
a	O
vaccine	O
.	O

TITLE	O
:	O
The	O
cell	O
cycle	O
and	O
virus	B-SPEC
infection	O
.	O

Increasingly	O
we	O
have	O
found	O
that	O
proteomic	O
approaches	O
allow	O
the	O
rapid	O
analysis	O
of	O
a	O
whole	O
plethora	O
of	O
cell	O
cycle	O
proteins	O
that	O
may	O
be	O
affected	O
by	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
has	O
recently	O
been	O
identified	O
as	O
the	O
cause	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
).	O

The	O
ability	O
of	O
this	O
family	B-SPEC
of	O
positive	O
strand	O
RNA	O
viruses	B-SPEC
to	O
move	O
between	O
species	B-SPEC
and	O
cause	O
severe	O
disease	O
in	O
humans	B-SPEC
,	O
with	O
the	O
potential	O
for	O
pandemic	O
spread	O
,	O
has	O
been	O
confirmed	O
.	O

Numerous	O
approaches	O
to	O
the	O
development	O
of	O
SARS	O
-	O
CoV	O
vaccines	O
have	O
been	O
undertaken	O
,	O
and	O
there	O
is	O
evidence	O
that	O
antibodies	O
to	O
the	O
spike	O
protein	O
may	O
be	O
protective	O
from	O
replication	O
and	O
pathology	O
in	O
animal	B-SPEC
models	O
.	O

The	O
emergence	O
of	O
these	O
diseases	O
,	O
and	O
resurgence	O
of	O
old	O
ones	O
like	O
tuberculosis	O
and	O
cholera	O
,	O
reflects	O
various	O
changes	O
in	O
human	B-SPEC
ecology	O
:	O
rural	O
-	O
to	O
-	O
urban	O
migration	O
resulting	O
in	O
high	O
-	O
density	O
peri	O
-	O
urban	O
slums	O
;	O
increasing	O
long	O
-	O
distance	O
mobility	O
and	O
trade	O
;	O
the	O
social	O
disruption	O
of	O
war	O
and	O
conflict	O
;	O
changes	O
in	O
personal	O
behavior	O
;	O
and	O
,	O
increasingly	O
,	O
human	B-SPEC
-	O
induced	O
global	O
changes	O
,	O
including	O
widespread	O
forest	O
clearance	O
and	O
climate	O
change	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
caused	O
by	O
a	O
previously	O
unrecognized	O
animal	B-SPEC
coronavirus	B-SPEC
that	O
exploited	O
opportunities	O
provided	O
by	O
'	O
wet	O
markets	O
'	O
in	O
southern	O
China	O
to	O
adapt	O
to	O
become	O
a	O
virus	B-SPEC
readily	O
transmissible	O
between	O
humans	B-SPEC
.	O

Manuscripts	O
address	O
the	O
use	O
of	O
molecular	O
techniques	O
in	O
the	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
bacterial	O
ribosome	O
mutations	O
,	O
which	O
may	O
lead	O
to	O
ribosome	O
-	O
targeted	O
drug	O
resistance	O
;	O
pharmacogenomics	O
as	O
a	O
clinical	O
laboratory	O
service	O
and	O
example	O
of	O
warfarin	O
dosing	O
using	O
CYP2C9	O
mutation	O
analysis	O
;	O
definition	O
of	O
the	O
potential	O
of	O
cytosine	O
arabinoside	O
incorporation	O
into	O
DNA	O
to	O
disrupt	O
transcription	O
using	O
an	O
in	O
vitro	O
model	O
of	O
oligonucleotides	O
;	O
use	O
of	O
laser	B-SPEC
capture	O
microdissection	O
to	O
isolate	O
solid	O
tumor	O
cells	O
free	O
of	O
nontumor	O
cells	O
;	O
and	O
molecular	O
methods	O
used	O
to	O
classify	O
lymphomas	O
.	O

Laser	B-SPEC
capture	O
microdissection	O
of	O
tumor	O
cells	O
can	O
provide	O
an	O
adequate	O
number	O
of	O
cells	O
for	O
whole	O
genome	O
amplification	O
.	O

We	O
genotyped	O
two	O
PBEF	O
single	O
-	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
in	O
a	O
well	O
characterized	O
sample	O
of	O
white	O
patients	O
with	O
sepsis	B-SPEC
-	O
associated	O
ALI	O
,	O
patients	O
with	O
severe	O
sepsis	B-SPEC
,	O
and	O
healthy	O
subjects	O
and	O
observed	O
that	O
carriers	O
of	O
the	O
haplotype	O
GC	O
from	O
SNPs	O
T	O
-	O
1001G	O
and	O
C	O
-	O
1543T	O
had	O
a	O
7	O
.	O
7	O
-	O
fold	O
higher	O
risk	O
of	O
ALI	O
(	O
95	O
%	O
confidence	O
interval	O
3	O
.	O
01	O
-	O
19	O
.	O
75	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

Expression	O
of	O
the	O
N	O
protein	O
was	O
observed	O
in	O
COS1	O
cells	O
following	O
transfection	O
with	O
pCI	O
-	O
N	O
.	O
The	O
immune	O
responses	O
induced	O
by	O
intramuscular	O
immunization	O
with	O
pCI	O
-	O
N	O
were	O
evaluated	O
in	O
a	O
murine	B-SPEC
model	O
.	O

In	O
contrast	O
,	O
most	O
RNA	O
viruses	B-SPEC
require	O
four	O
target	O
genomes	O
and	O
no	O
near	O
-	O
neighbor	O
genomes	O
,	O
since	O
lack	O
of	O
conservation	O
among	O
strains	O
is	O
more	O
limiting	O
than	O
uniqueness	O
.	O

Here	O
,	O
we	O
examined	O
the	O
heat	O
inactivation	O
ability	O
of	O
an	O
agent	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

Two	O
hundred	O
and	O
twenty	O
-	O
three	O
SAOPP	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
:	O
pre	O
-	O
hospital	O
treatment	O
group	O
(	O
116	O
patients	O
),	O
in	O
which	O
rescue	O
equipment	O
and	O
drugs	O
were	O
carried	O
to	O
the	O
spot	B-SPEC
for	O
the	O
treatment	O
of	O
the	O
patients	O
;	O
hospital	O
treatment	O
group	O
(	O
107	O
patients	O
),	O
in	O
which	O
the	O
patients	O
received	O
emergency	O
treatment	O
after	O
reaching	O
the	O
hospital	O
.	O

Recombinant	O
baculovirus	B-SPEC
expressing	O
different	O
deletion	O
and	O
insertion	O
fragments	O
identified	O
the	O
functional	O
region	O
of	O
S	O
protein	O
from	O
aa	O
324	O
-	O
688	O
(	O
particularly	O
the	O
N	O
-	O
terminal	O
aa	O
324	O
-	O
488	O
and	O
the	O
C	O
-	O
terminal	O
aa	O
609	O
-	O
688	O
),	O
which	O
is	O
responsible	O
for	O
IL	O
-	O
8	O
production	O
.	O

Leukocyte	O
recruitment	O
is	O
a	O
well	O
-	O
orchestrated	O
process	O
that	O
includes	O
several	O
protein	O
families	O
including	O
the	O
large	O
cytokine	O
subfamily	B-SPEC
of	O
chemotactic	O
cytokines	O
,	O
the	O
chemokines	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
used	O
the	O
probabilistic	O
models	O
developed	O
by	O
us	O
over	O
the	O
last	O
several	O
years	O
to	O
analyze	O
158	O
proteins	O
from	O
coronaviruses	O
in	O
order	B-SPEC
to	O
determine	O
which	O
protein	O
is	O
more	O
vulnerable	O
to	O
mutations	O
.	O

The	O
results	O
provide	O
three	O
lines	O
of	O
evidence	O
suggesting	O
that	O
the	O
spike	O
glycoprotein	O
is	O
different	O
from	O
the	O
other	O
coronavirus	B-SPEC
proteins	O
:	O
(	O
1	O
)	O
the	O
spike	O
glycoprotein	O
is	O
more	O
sensitive	O
to	O
mutations	O
,	O
this	O
is	O
the	O
current	O
state	O
of	O
the	O
spike	O
glycoprotein	O
,	O
(	O
2	O
)	O
the	O
spike	O
glycoprotein	O
has	O
undergone	O
more	O
mutations	O
in	O
the	O
past	O
,	O
this	O
is	O
the	O
history	O
of	O
spike	O
glycoprotein	O
,	O
and	O
(	O
3	O
)	O
the	O
spike	O
glycoprotein	O
has	O
a	O
bigger	O
potential	O
towards	O
future	O
mutations	O
,	O
this	O
is	O
the	O
future	O
of	O
spike	O
glycoprotein	O
.	O

Furthermore	O
,	O
this	O
study	O
gives	O
a	O
clue	O
on	O
the	O
species	B-SPEC
susceptibility	O
regarding	O
different	O
proteins	O
.	O

TITLE	O
:	O
Implication	O
of	O
proprotein	O
convertases	O
in	O
the	O
processing	O
and	O
spread	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
causes	O
persistent	O
infection	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
in	O
rodents	B-SPEC
,	O
which	O
has	O
been	O
associated	O
with	O
demyelination	O
.	O

Such	O
a	O
phenomenon	O
resembles	O
the	O
persistent	O
MHV	B-SPEC
infection	O
in	O
animal	B-SPEC
CNS	O
.	O

ABSTRACT	O
:	O
Small	O
animal	B-SPEC
models	O
are	O
needed	O
in	O
order	B-SPEC
to	O
evaluate	O
the	O
efficacy	O
of	O
candidate	O
vaccines	O
and	O
antivirals	O
directed	O
against	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
).	O

We	O
investigated	O
the	O
ability	O
of	O
SARS	O
CoV	O
to	O
infect	O
5	O
-	O
week	O
-	O
old	O
Golden	O
Syrian	B-SPEC
hamsters	I-SPEC
.	O

Low	O
levels	O
of	O
virus	B-SPEC
were	O
present	O
in	O
the	O
nasal	O
turbinates	O
of	O
a	O
few	O
hamsters	B-SPEC
at	O
14	O
days	O
p	O
.	O
i	O
.	O

Coinfections	O
by	O
two	O
respiratory	O
viruses	B-SPEC
interested	O
11	O
(	O
5	O
.	O
3	O
%)	O
patients	O
,	O
and	O
9	O
(	O
81	O
.	O
8	O
%)	O
of	O
these	O
were	O
infected	O
by	O
hRSV	B-SPEC
in	O
association	O
with	O
another	O
respiratory	O
virus	B-SPEC
.	O

It	O
is	O
concluded	O
that	O
an	O
interferon	O
-	O
gamma	O
-	O
related	O
cytokine	O
storm	O
was	O
induced	O
post	O
SARS	O
coronavirus	B-SPEC
infection	O
,	O
and	O
this	O
cytokine	O
storm	O
might	O
be	O
involved	O
in	O
the	O
immunopathological	O
damage	O
in	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
A	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
has	O
recently	O
been	O
identified	O
as	O
the	O
causative	O
agent	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
humans	B-SPEC
.	O

Its	O
specificity	O
was	O
verified	O
by	O
inclusion	O
of	O
control	O
samples	O
containing	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
rotavirus	B-SPEC
A	I-SPEC
in	O
each	O
analysis	O
.	O

In	O
this	O
report	O
,	O
ribavirin	O
was	O
shown	O
to	O
inhibit	O
SARS	O
-	O
CoV	O
replication	O
in	O
five	O
different	O
cell	O
types	O
of	O
animal	B-SPEC
or	O
human	B-SPEC
origin	O
at	O
therapeutically	O
achievable	O
concentrations	O
.	O

Determination	O
of	O
the	O
virus	B-SPEC
yield	O
indicated	O
highly	O
synergistic	O
anti	O
-	O
SARS	O
-	O
CoV	O
action	O
of	O
the	O
combination	O
suggesting	O
the	O
consideration	O
of	O
ribavirin	O
plus	O
IFN	O
-	O
beta	O
for	O
the	O
treatment	O
of	O
SARS	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
transcription	O
:	O
a	O
perspective	O
.	O

Besides	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
,	O
RNA	O
helicase	O
,	O
and	O
protease	O
activities	O
,	O
which	O
are	O
common	O
to	O
RNA	O
viruses	B-SPEC
,	O
the	O
coronavirus	B-SPEC
replicase	O
was	O
recently	O
predicted	O
to	O
employ	O
a	O
variety	O
of	O
RNA	O
processing	O
enzymes	O
that	O
are	O
not	O
(	O
or	O
extremely	O
rarely	O
)	O
found	O
in	O
other	O
RNA	O
viruses	B-SPEC
and	O
include	O
putative	O
sequence	O
-	O
specific	O
endoribonuclease	O
,	O
3	O
'-	O
to	O
-	O
5	O
'	O
exoribonuclease	O
,	O
2	O
'-	O
O	O
-	O
ribose	O
methyltransferase	O
,	O
ADP	O
ribose	O
1	O
"""-"	O
phosphatase	O
and	O
,	O
in	O
a	O
subset	O
of	O
group	O
2	O
coronaviruses	O
,	O
cyclic	O
phosphodiesterase	O
activities	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
reverse	O
genetics	O
by	O
targeted	O
RNA	O
recombination	O
.	O

ABSTRACT	O
:	O
Knowledge	O
of	O
coronavirus	B-SPEC
replication	O
,	O
transcription	O
,	O
and	O
virus	B-SPEC
-	O
host	O
interaction	O
has	O
been	O
recently	O
improved	O
by	O
engineering	O
of	O
coronavirus	B-SPEC
infectious	O
cDNAs	O
.	O

Vector	O
biosafety	O
is	O
being	O
increased	O
by	O
relocating	O
the	O
RNA	O
packaging	O
signal	O
to	O
the	O
position	O
previously	O
occupied	O
by	O
deleted	O
essential	O
genes	O
,	O
to	O
prevent	O
the	O
rescue	O
of	O
fully	O
competent	O
viruses	B-SPEC
that	O
might	O
arise	O
from	O
recombination	O
events	O
with	O
wild	O
-	O
type	O
field	O
coronaviruses	O
.	O

This	O
system	O
represents	O
a	O
generic	O
approach	O
to	O
coronavirus	B-SPEC
reverse	O
genetics	O
and	O
was	O
first	O
described	O
for	O
the	O
generation	O
of	O
recombinant	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
representing	O
a	O
group	O
I	O
coronavirus	B-SPEC
.	O

Subsequently	O
,	O
the	O
same	O
approach	O
has	O
been	O
used	O
to	O
generate	O
recombinant	O
avian	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
and	O
,	O
recently	O
,	O
recombinant	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
representing	O
group	O
III	O
and	O
group	O
II	O
coronaviruses	O
,	O
respectively	O
.	O

Finally	O
,	O
we	O
describe	O
how	O
the	O
coronavirus	B-SPEC
reverse	O
genetic	O
system	O
has	O
now	O
been	O
extended	O
to	O
the	O
generation	O
of	O
coronavirus	B-SPEC
replicon	O
RNAs	O
.	O

ABSTRACT	O
:	O
The	O
genomes	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
have	O
been	O
generated	O
with	O
a	O
novel	O
construction	O
strategy	O
that	O
allows	O
for	O
the	O
assembly	O
of	O
very	O
large	O
RNA	O
and	O
DNA	O
genomes	O
from	O
a	O
panel	O
of	O
contiguous	O
cDNA	O
subclones	O
.	O

MHV	B-SPEC
molecular	O
viruses	B-SPEC
were	O
engineered	O
to	O
express	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
),	O
demonstrating	O
the	O
feasibility	O
of	O
the	O
systematic	O
assembly	O
approach	O
to	O
create	O
recombinant	O
viruses	B-SPEC
expressing	O
foreign	O
genes	O
.	O

The	O
systematic	O
assembly	O
approach	O
was	O
used	O
to	O
develop	O
an	O
infectious	O
clone	O
of	O
the	O
newly	O
identified	O
human	B-SPEC
coronavirus	I-SPEC
,	O
the	O
serve	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
A	O
complex	O
zinc	O
finger	O
controls	O
the	O
enzymatic	O
activities	O
of	O
nidovirus	B-SPEC
helicases	O
.	O

Rising	O
amounts	O
of	O
viral	O
RNA	O
in	O
the	O
blood	O
,	O
consistently	O
seen	O
in	O
animals	B-SPEC
with	O
end	O
-	O
stage	O
FIP	O
,	O
indicate	O
that	O
progression	O
to	O
fatal	O
disease	O
is	O
the	O
direct	O
consequence	O
of	O
a	O
loss	O
of	O
immune	O
control	O
,	O
resulting	O
in	O
unchecked	O
viral	O
replication	O
.	O

To	O
investigate	O
this	O
hypothesis	O
,	O
we	O
examined	O
the	O
kinetics	O
of	O
RNA	O
binding	O
between	O
nonphosphorylated	O
and	O
phosphorylated	O
infectious	O
bronchitis	O
virus	B-SPEC
N	O
protein	O
with	O
nonviral	O
and	O
viral	O
RNA	O
by	O
surface	O
plasmon	O
resonance	O
(	O
Biacore	O
).	O

The	O
animals	B-SPEC
(	O
20	O
guinea	B-SPEC
pigs	I-SPEC
,	O
8	O
rabbits	B-SPEC
and	O
20	O
sows	O
)	O
were	O
divided	O
into	O
4	O
groups	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
a	O
39	O
-	O
year	O
-	O
old	O
Japanese	O
man	B-SPEC
with	O
post	O
-	O
streptococcal	O
acute	O
glomerulonephritis	O
(	O
PSAGN	O
)	O
super	O
-	O
imposed	O
on	O
long	O
-	O
term	O
immunoglobulin	O
A	O
nephropathy	O
(	O
IgA	O
-	O
N	O
).	O

Patients	O
admitted	O
due	O
to	O
suspicion	O
of	O
SARS	O
with	O
a	O
subsequent	O
diagnosis	O
of	O
SARS	O
or	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
pneumonia	O
were	O
included	O
.	O

It	O
provides	O
a	O
new	O
avenue	O
for	O
the	O
exploration	O
of	O
the	O
virus	B-SPEC
-	O
host	O
interaction	O
in	O
viral	O
evolution	O
,	O
host	O
pathogenesis	O
,	O
and	O
vaccine	O
development	O
.	O

TITLE	O
:	O
The	O
structural	O
characterization	O
and	O
antigenicity	O
of	O
the	O
S	O
protein	O
of	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
The	O
corona	B-SPEC
-	O
like	O
spikes	O
or	O
peplomers	O
on	O
the	O
surface	O
of	O
the	O
virion	O
under	O
electronic	O
microscope	O
are	O
the	O
most	O
striking	O
features	O
of	O
coronaviruses	O
.	O

Phylogenetic	O
tree	O
building	O
based	O
on	O
the	O
variations	O
of	O
the	O
M	O
protein	O
appears	O
to	O
support	O
the	O
non	O
-	O
human	B-SPEC
origin	O
of	O
SARS	O
-	O
CoV	O
.	O
To	O
investigate	O
its	O
immunogenicity	O
,	O
we	O
synthesized	O
eight	O
oligopeptides	O
covering	O
69	O
.	O
2	O
%	O
of	O
the	O
entire	O
ORF	O
and	O
screened	O
them	O
by	O
using	O
ELISA	O
(	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
)	O
with	O
sera	O
from	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
R	O
(	O
replicase	O
)	O
protein	O
is	O
the	O
uniquely	O
defined	O
non	O
-	O
structural	O
protein	O
(	O
NSP	O
)	O
responsible	O
for	O
RNA	O
replication	O
,	O
mutation	O
rate	O
or	O
fidelity	O
,	O
regulation	O
of	O
transcription	O
in	O
coronaviruses	O
and	O
many	O
other	O
ssRNA	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Epidemiologic	O
linkage	O
and	O
public	O
health	O
implication	O
of	O
a	O
cluster	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
in	O
an	O
extended	O
family	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
the	O
face	O
of	O
the	O
worldwide	O
threat	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
to	O
human	B-SPEC
life	O
,	O
some	O
of	O
the	O
most	O
urgent	O
challenges	O
are	O
to	O
develop	O
fast	O
and	O
accurate	O
analytical	O
methods	O
for	O
early	O
diagnosis	O
of	O
this	O
disease	O
as	O
well	O
as	O
to	O
create	O
a	O
safe	O
anti	O
-	O
viral	O
vaccine	O
for	O
prevention	O
.	O

TITLE	O
:	O
[	O
Construction	O
and	O
screening	O
of	O
human	B-SPEC
phage	O
antibody	O
library	O
against	O
SARS	O
virus	B-SPEC
].	O

We	O
find	O
that	O
this	O
extreme	O
conservation	O
is	O
clearly	O
explained	O
by	O
the	O
requirement	O
to	O
form	O
a	O
highly	O
structured	O
RNA	O
whose	O
unique	O
tertiary	O
structure	O
includes	O
a	O
sharp	O
90	O
degrees	O
kink	O
of	O
the	O
helix	O
axis	B-SPEC
and	O
several	O
novel	O
longer	O
-	O
range	O
tertiary	O
interactions	O
.	O

Based	O
on	O
its	O
conservation	O
in	O
viral	O
pathogen	O
genomes	O
and	O
its	O
absence	O
in	O
the	O
human	B-SPEC
genome	O
,	O
we	O
suggest	O
that	O
these	O
unusual	O
structural	O
features	O
in	O
the	O
s2m	O
RNA	O
element	O
are	O
attractive	O
targets	O
for	O
the	O
design	O
of	O
anti	O
-	O
viral	O
therapeutic	O
agents	O
.	O

Treatment	O
of	O
SARS	O
-	O
CoV	O
with	O
PVP	O
-	O
I	O
products	O
for	O
2	O
min	O
reduced	O
the	O
virus	B-SPEC
infectivity	O
from	O
1	O
.	O
17	O
x	O
10	O
(	O
6	O
)	O
TCID50	O
/	O
ml	O
to	O
below	O
the	O
detectable	O
level	O
.	O

Heating	O
the	O
virus	B-SPEC
at	O
56	O
degrees	O
C	O
for	O
5	O
min	O
dramatically	O
reduced	O
the	O
infectivity	O
of	O
the	O
virus	B-SPEC
from	O
2	O
.	O
6	O
x	O
10	O
(	O
7	O
)	O
to	O
40	O
TCID50	O
/	O
ml	O
,	O
whereas	O
heating	O
the	O
virus	B-SPEC
for	O
60	O
min	O
or	O
longer	O
eliminated	O
all	O
infectivity	O
.	O

Of	O
the	O
34	O
patients	O
with	O
probable	O
SARS	O
,	O
13	O
were	O
transferred	O
to	O
medical	O
centers	O
to	O
receive	O
mechanical	O
ventilation	O
due	O
to	O
rapid	O
deterioration	O
of	O
chest	O
x	O
-	O
ray	B-SPEC
results	O
,	O
and	O
three	O
patients	O
died	O
of	O
SARS	O
despite	O
intensive	O
therapy	O
in	O
medical	O
centers	O
.	O

FIP	O
was	O
the	O
most	O
common	O
disease	O
of	O
cats	B-SPEC
younger	O
than	O
2	O
years	O
of	O
age	O
.	O

Parameters	O
studied	O
included	O
serum	O
levels	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
IgG	O
antibody	O
,	O
tests	O
of	O
lung	O
function	O
,	O
and	O
imaging	O
data	O
to	O
evaluate	O
changes	O
in	O
lung	O
fibrosis	O
.	O

A	O
significant	O
proportion	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
patients	O
remained	O
RT	O
-	O
PCR	O
positive	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
for	O
a	O
substantial	O
duration	O
after	O
discharge	O
.	O

TITLE	O
:	O
[	O
Development	O
and	O
preliminary	O
application	O
of	O
monoclonal	O
antibodies	O
against	O
N	O
protein	O
of	O
SARS	O
virus	B-SPEC
].	O

TITLE	O
:	O
[	O
Potent	O
neutralization	O
antibody	O
elicited	O
in	O
mice	B-SPEC
by	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
spike	O
protein	O
S1	O
domain	O
].	O

Among	O
all	O
the	O
patients	O
with	O
abnormal	O
X	O
-	O
ray	B-SPEC
result	O
,	O
19	O
were	O
male	O
(	O
54	O
.	O
29	O
%),	O
16	O
(	O
45	O
.	O
71	O
%)	O
were	O
female	O
,	O
P	O
>	O
0	O
.	O
01	O
;	O
7	O
(	O
58	O
.	O
33	O
%)	O
were	O
above	O
the	O
age	O
of	O
45	O
;	O
28	O
(	O
34	O
.	O
57	O
%)	O
were	O
below	O
the	O
age	O
of	O
45	O
,	O
P	O
>	O
0	O
.	O
01	O
;	O
hyperpyrexia	O
(>/=	O
39	O
),	O
26	O
(	O
50	O
.	O
00	O
%),	O
below	O
39	O
,	O
9	O
(	O
21	O
.	O
95	O
%);	O
multiple	O
-	O
lesion	O
,	O
22	O
(	O
52	O
.	O
38	O
%),	O
mono	O
-	O
lesion	O
,	O
13	O
(	O
25	O
.	O
49	O
%),	O
P	O
<	O
0	O
.	O
01	O
;	O
glucocorticoid	O
administration	O
time	O
within	O
5	O
days	O
,	O
22	O
(	O
38	O
.	O
60	O
%)	O
after	O
5	O
days	O
,	O
12	O
(	O
33	O
.	O
33	O
%),	O
P	O
>	O
0	O
.	O
01	O
;	O
within	O
7	O
days	O
,	O
21	O
(	O
30	O
.	O
00	O
%),	O
after	O
7	O
days	O
,	O
14	O
(	O
60	O
.	O
87	O
%),	O
P	O
<	O
0	O
.	O
01	O
.	O

CONCLUSIONS	O
:	O
The	O
X	O
-	O
ray	B-SPEC
results	O
of	O
SARS	O
were	O
closely	O
related	O
to	O
the	O
severity	O
of	O
the	O
disease	O
(	O
hyperpyrexia	O
and	O
bilateral	O
lung	O
field	O
lesion	O
).	O

TITLE	O
:	O
Generation	O
of	O
predictive	O
pharmacophore	O
model	O
for	O
SARS	O
-	O
coronavirus	B-SPEC
main	O
proteinase	O
.	O

In	O
this	O
study	O
,	O
we	O
developed	O
a	O
pharmacophore	O
model	O
for	O
the	O
main	O
proteinase	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
Molecular	O
characterization	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
has	O
revealed	O
genetic	O
diversity	O
among	O
isolates	O
.	O

Although	O
minor	O
differences	O
among	O
eight	O
strains	O
transmitted	O
during	O
human	B-SPEC
outbreaks	O
in	O
early	O
2003	O
were	O
found	O
,	O
substantial	O
functional	O
changes	O
were	O
detected	O
in	O
S	O
derived	O
from	O
a	O
case	O
in	O
late	O
2003	O
from	O
Guangdong	O
province	O
[	O
S	O
(	O
GD03T0013	O
)]	O
and	O
from	O
two	O
palm	O
civets	B-SPEC
,	O
S	O
(	O
SZ3	O
)	O
and	O
S	O
(	O
SZ16	O
).	O

Unexpectedly	O
,	O
Abs	O
that	O
neutralized	O
most	O
human	B-SPEC
S	O
glycoproteins	O
enhanced	O
entry	O
mediated	O
by	O
the	O
civet	B-SPEC
virus	B-SPEC
S	O
glycoproteins	O
.	O

Beneath	O
Vero	O
E6	O
cells	O
SARS	O
-	O
Coronavirus	B-SPEC
infection	O
could	O
also	O
be	O
demonstrated	O
in	O
two	O
pig	B-SPEC
cell	O
lines	O
(	O
POEK	O
,	O
PS	O
)	O
and	O
one	O
human	B-SPEC
cell	O
line	O
(	O
Huh	O
-	O
7	O
)	O
using	O
the	O
indirect	O
immunofluorescence	O
assay	O
and	O
a	O
newly	O
established	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
detected	O
in	O
the	O
nasopharyngeal	O
aspirates	O
(	O
NPA	O
)	O
of	O
16	O
of	O
840	O
specimens	O
representing	O
766	O
patients	O
(	O
2	O
%).	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
real	O
-	O
time	O
polymerase	O
-	O
chain	O
reaction	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
associated	O
coronavirus	B-SPEC
in	O
patients	O
with	O
hospitalised	O
exacerbation	O
of	O
COPD	O
.	O

Because	O
health	O
care	O
facilities	O
will	O
have	O
to	O
initiate	O
immediate	O
preventive	O
action	O
in	O
cases	O
of	O
probable	O
SARS	O
we	O
tested	O
the	O
potential	O
of	O
PCR	O
to	O
exclude	O
SARS	O
associated	O
coronavirus	B-SPEC
in	O
patients	O
hospitalized	O
with	O
respiratory	O
symptoms	O
.	O

None	O
of	O
the	O
samples	O
were	O
positive	O
for	O
SARS	O
associated	O
coronavirus	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
first	O
complete	O
genome	O
sequence	O
(	O
30	O
,	O
738	O
nucleotides	O
)	O
of	O
the	O
prototype	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
strain	O
(	O
ATCC	O
VR759	O
).	O

TITLE	O
:	O
Identification	O
of	O
the	O
membrane	O
-	O
active	O
regions	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
membrane	O
glycoprotein	O
using	O
a	O
16	O
/	O
18	O
-	O
mer	O
peptide	O
scan	O
:	O
implications	O
for	O
the	O
viral	O
fusion	O
mechanism	O
.	O

By	O
monitoring	O
the	O
effect	O
of	O
this	O
peptide	O
library	O
on	O
membrane	O
leakage	O
in	O
model	O
membranes	O
,	O
we	O
have	O
identified	O
three	O
regions	O
on	O
the	O
SARS	O
CoV	O
spike	O
glycoprotein	O
with	O
membrane	O
-	O
interacting	O
capabilities	O
:	O
region	O
1	O
,	O
located	O
immediately	O
upstream	O
of	O
heptad	O
repeat	O
1	O
(	O
HR1	O
)	O
and	O
suggested	O
to	O
be	O
the	O
fusion	O
peptide	O
;	O
region	O
2	O
,	O
located	O
between	O
HR1	O
and	O
HR2	O
,	O
which	O
would	O
be	O
analogous	O
to	O
the	O
loop	O
domain	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
;	O
and	O
region	O
3	O
,	O
which	O
would	O
correspond	O
to	O
the	O
pretransmembrane	O
region	O
.	O

ABSTRACT	O
:	O
To	O
obtain	O
monoclonal	O
antibodies	O
(	O
McAbs	O
)	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
to	O
develop	O
diagnostic	O
test	O
for	O
SARS	O
and	O
study	O
the	O
pathogenesis	O
of	O
the	O
disease	O
.	O

SARS	O
coronavirus	B-SPEC
IgG	O
antibody	O
was	O
detected	O
positive	O
in	O
6	O
of	O
the	O
9	O
patients	O
,	O
it	O
was	O
still	O
positive	O
in	O
the	O
sera	O
twelve	O
months	O
after	O
recovery	O
;	O
1	O
of	O
the	O
closely	O
contacted	O
persons	O
and	O
3	O
normal	O
subjects	O
were	O
found	O
positive	O
.	O

Serological	O
examination	O
using	O
blood	O
samples	O
collected	O
on	O
the	O
12th	O
and	O
28th	O
hospital	O
days	O
revealed	O
elevation	O
of	O
anti	O
-	O
L	B-SPEC
.	I-SPEC
pneumophila	I-SPEC
serogroup	O
I	O
antibody	O
.	O

It	O
is	O
suggested	O
that	O
administration	O
of	O
methylprednisolone	O
and	O
sivelestat	O
sodium	O
in	O
combination	O
with	O
intravenous	O
erythromycin	O
and	O
ciprofloxacin	O
in	O
a	O
case	O
of	O
severe	O
Legionella	B-SPEC
pneumonia	O
complicated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
is	O
effective	O
,	O
and	O
may	O
be	O
of	O
use	O
in	O
similar	O
cases	O
.	O

The	O
incidence	O
of	O
RSV	B-SPEC
-	O
associated	O
severe	O
LRI	O
per	O
1000	O
child	O
-	O
years	O
was	O
5	O
in	O
Mozambique	O
,	O
10	O
in	O
Indonesia	O
,	O
and	O
9	O
in	O
South	O
Africa	O
.	O

PCR	O
probes	O
that	O
target	O
regions	O
of	O
the	O
replicase	O
1a	O
gene	O
that	O
are	O
conserved	O
among	O
genetically	O
diverse	O
animal	B-SPEC
CoVs	O
and	O
HCoVs	O
were	O
designed	O
.	O

Clinical	O
trials	O
are	O
planned	O
to	O
test	O
MAb	O
201	O
,	O
a	O
fully	O
human	B-SPEC
MAb	O
specific	O
for	O
the	O
epitope	O
within	O
the	O
receptor	O
-	O
binding	O
region	O
.	O

The	O
authors	O
call	O
attention	O
to	O
the	O
danger	O
of	O
spread	O
of	O
avian	B-SPEC
influenza	O
,	O
either	O
directly	O
or	O
indirectly	O
through	O
genetic	O
rearrangements	O
.	O

The	O
authors	O
recommend	O
health	O
surveillance	O
not	O
only	O
in	O
humans	B-SPEC
but	O
also	O
in	O
animals	B-SPEC
;	O
the	O
teaching	O
of	O
zoonoses	O
,	O
and	O
research	O
on	O
animal	B-SPEC
diseases	O
transmissible	O
to	O
humans	B-SPEC
.	O

Direct	O
sequencing	O
of	O
RT	O
-	O
PCR	O
products	O
derived	O
from	O
cells	O
infected	O
with	O
the	O
plaque	O
-	O
purified	O
virus	B-SPEC
,	O
which	O
had	O
lost	O
expression	O
of	O
EGFP	O
,	O
confirmed	O
loss	O
of	O
the	O
EGFP	O
ORF	O
.	O

TITLE	O
:	O
Antibodies	O
to	O
SARS	O
coronavirus	B-SPEC
in	O
civets	B-SPEC
.	O

TITLE	O
:	O
A	O
mRNA	O
PCR	O
for	O
the	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

Of	O
a	O
group	O
of	O
81	O
animals	B-SPEC
in	O
which	O
FIP	O
had	O
been	O
confirmed	O
by	O
post	O
-	O
mortem	O
examination	O
,	O
75	O
(	O
93	O
%)	O
tested	O
positive	O
,	O
whereas	O
17	O
cats	B-SPEC
with	O
different	O
pathologies	O
(	O
non	O
-	O
FIP	O
cases	O
)	O
all	O
tested	O
negative	O
.	O

Eight	O
different	O
IBV	B-SPEC
strains	O
representing	O
seven	O
serotypes	O
were	O
tested	O
and	O
each	O
chimeric	O
oligonucleotide	O
mediated	O
cleavage	O
of	O
target	O
RNA	O
only	O
from	O
strains	O
within	O
the	O
serotype	O
that	O
the	O
chimeric	O
was	O
designed	O
against	O
.	O

These	O
pigs	B-SPEC
were	O
monitored	O
more	O
invasively	O
and	O
continuously	O
in	O
an	O
intensive	O
care	O
setting	O
for	O
48	O
h	O
and	O
followed	O
,	O
treated	O
,	O
and	O
assessed	O
in	O
a	O
similar	O
fashion	O
to	O
group	O
1	O
.	O

Group	O
1	O
(	O
FC	O
)	O
pigs	B-SPEC
survived	O
9	O
days	O
and	O
showed	O
signs	O
of	O
sepsis	B-SPEC
(	O
bacteremia	O
with	O
polymicrobial	O
organisms	O
),	O
an	O
inflammatory	O
response	O
in	O
the	O
form	O
of	O
elevated	O
cytokines	O
,	O
yet	O
no	O
physiologic	O
or	O
histologic	O
evidence	O
of	O
lung	O
injury	O
.	O

TITLE	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
:	O
a	O
possible	O
cause	O
of	O
reduced	O
fertility	O
in	O
the	O
rooster	O
.	O

ABSTRACT	O
:	O
The	O
SARS	O
coronavirus	B-SPEC
3C	O
-	O
like	O
proteinase	O
is	O
considered	O
as	O
a	O
potential	O
drug	O
design	O
target	O
for	O
the	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Owing	O
to	O
the	O
lack	O
of	O
available	O
drugs	O
for	O
the	O
treatment	O
of	O
SARS	O
,	O
the	O
discovery	O
of	O
inhibitors	O
for	O
SARS	O
coronavirus	B-SPEC
3C	O
-	O
like	O
proteinase	O
that	O
can	O
potentially	O
be	O
optimized	O
as	O
drugs	O
appears	O
to	O
be	O
highly	O
desirable	O
.	O

TITLE	O
:	O
Chinese	O
herbal	O
medicine	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
:	O
a	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
.	O

The	O
overall	O
distress	O
level	O
was	O
highly	O
and	O
significantly	O
correlated	O
with	O
the	O
six	O
sources	O
of	O
distress	O
:	O
vulnerability	O
/	O
loss	O
of	O
control	O
(	O
r	O
=	O
0	O
.	O
68	O
);	O
health	O
of	O
self	O
(	O
r	O
=	O
0	O
.	O
62	O
);	O
spread	O
of	O
virus	B-SPEC
(	O
r	O
=	O
0	O
.	O
60	O
);	O
health	O
of	O
family	B-SPEC
and	O
others	O
(	O
r	O
=	O
0	O
.	O
59	O
);	O
changes	O
in	O
work	O
(	O
r	O
=	O
0	O
.	O
46	O
);	O
being	O
isolated	O
(	O
r	O
=	O
0	O
.	O
45	O
).	O

HCA	O
were	O
significantly	O
higher	O
than	O
doctors	O
(	O
but	O
not	O
nurses	O
)	O
in	O
worrying	O
about	O
their	O
family	B-SPEC
'	O
s	O
and	O
others	O
'	O
health	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Viral	O
RNA	O
was	O
detected	O
in	O
small	O
intestine	O
and	O
associated	O
lymphoid	O
tissues	O
of	O
immunocompetent	O
mice	B-SPEC
for	O
1	O
week	O
and	O
in	O
cecum	O
and	O
colon	O
for	O
2	O
weeks	O
.	O

It	O
is	O
also	O
more	O
user	O
-	O
friendly	O
and	O
cost	O
-	O
effective	O
than	O
the	O
whole	O
virus	B-SPEC
-	O
based	O
IFA	O
.	O

Analyses	O
of	O
the	O
RNA	O
sequence	O
from	O
the	O
ORF1b	O
and	O
S	O
-	O
gene	O
regions	O
indicated	O
that	O
the	O
virus	B-SPEC
is	O
a	O
group	O
1	O
coronavirus	B-SPEC
.	O

The	O
discovery	O
of	O
SARS	O
-	O
CoV	O
-	O
like	O
viruses	B-SPEC
in	O
masked	B-SPEC
palm	I-SPEC
civets	I-SPEC
(	O
Paguma	B-SPEC
larvata	I-SPEC
)	O
raises	O
the	O
possibility	O
that	O
civets	B-SPEC
play	O
a	O
role	O
in	O
SARS	O
-	O
CoV	O
transmission	O
.	O

A	O
single	O
bolus	O
intravenous	O
injection	O
into	O
mice	B-SPEC
of	O
GL	O
(	O
200	O
mg	O
/	O
kg	O
or	O
less	O
)	O
shortly	O
before	O
(	O
or	O
simultaneously	O
with	O
)	O
LPS	O
injection	O
reduced	O
the	O
pulmonary	O
platelet	O
accumulation	O
and	O
the	O
severity	O
of	O
the	O
rapid	O
shock	O
,	O
and	O
prevented	O
death	O
in	O
both	O
the	O
early	O
and	O
later	O
periods	O
.	O

Glycyrrhizin	O
,	O
an	O
active	O
component	O
of	O
liquorice	O
roots	O
,	O
and	O
replication	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
immunological	O
characteristics	O
of	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
analyze	O
the	O
feasibility	O
of	O
using	O
this	O
protein	O
as	O
the	O
component	O
for	O
SARS	O
vaccine	O
development	O
.	O

ABSTRACT	O
:	O
Four	O
human	B-SPEC
coronaviruses	O
are	O
currently	O
known	O
to	O
infect	O
the	O
respiratory	O
tract	O
:	O
human	B-SPEC
coronaviruses	O
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
)	O
and	O
229E	O
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
),	O
SARS	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
the	O
recently	O
identified	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
).	O

Seven	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
positive	O
samples	O
were	O
identified	O
,	O
six	O
were	O
collected	O
during	O
January	O
/	O
February	O
2003	O
and	O
one	O
at	O
the	O
end	O
of	O
February	O
2004	O
.	O

RESULTS	O
:	O
Seven	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
positive	O
samples	O
were	O
identified	O
,	O
six	O
were	O
collected	O
during	O
January	O
/	O
February	O
2003	O
and	O
one	O
at	O
the	O
end	O
of	O
February	O
2004	O
.	O

Three	O
unique	O
detection	O
formats	O
were	O
developed	O
for	O
real	O
-	O
time	O
RNA	O
amplification	O
assays	O
:	O
a	O
post	O
amplification	O
detection	O
step	O
with	O
a	O
virus	B-SPEC
-	O
specific	O
internal	O
capture	O
probe	O
based	O
on	O
Taqman	O
(	O
RT	O
-	O
PCR	O
TaqMan	O
assay	O
),	O
hybridization	O
probe	O
(	O
RT	O
-	O
PCR	O
hybridization	O
probe	O
assay	O
)	O
and	O
a	O
real	O
-	O
time	O
assay	O
with	O
virus	B-SPEC
-	O
specific	O
molecular	O
beacon	O
probes	O
(	O
NASBA	O
-	O
Beacon	O
assay	O
).	O

ABSTRACT	O
:	O
A	O
producer	O
administered	O
2	O
US	O
Department	O
of	O
Agriculture	O
-	O
licensed	O
adjuvanted	O
veterinary	O
vaccines	O
(	O
inactivated	O
bovine	B-SPEC
rotavirus	B-SPEC
-	O
coronavirus	B-SPEC
vaccine	O
;	O
Clostridium	B-SPEC
perfringens	I-SPEC
type	O
C	O
-	O
Escherichia	B-SPEC
coli	I-SPEC
bacterin	O
-	O
toxoid	O
)	O
into	O
muscles	O
of	O
the	O
left	O
and	O
right	O
hips	O
of	O
469	O
pregnant	O
beef	O
cows	B-SPEC
.	O

Six	O
cattle	B-SPEC
were	O
injected	O
experimentally	O
with	O
the	O
vaccines	O
.	O

Acute	O
transient	O
lameness	O
on	O
the	O
ranch	O
was	O
attributed	O
to	O
use	O
of	O
2	O
irritating	O
biological	O
vaccines	O
in	O
the	O
hip	O
muscles	O
of	O
cows	B-SPEC
that	O
were	O
close	O
to	O
parturition	O
.	O

The	O
immunization	O
efficacy	O
was	O
evaluated	O
by	O
virus	B-SPEC
isolation	O
from	O
the	O
challenged	O
chicks	O
.	O

TITLE	O
:	O
When	O
animal	B-SPEC
viruses	B-SPEC
attack	O
:	O
SARS	O
and	O
avian	B-SPEC
influenza	O
.	O

Infected	O
children	O
also	O
play	O
a	O
central	O
role	O
in	O
disseminating	O
influenza	O
,	O
as	O
they	O
are	O
the	O
major	O
point	O
of	O
entry	O
for	O
the	O
virus	B-SPEC
into	O
the	O
household	O
,	O
from	O
which	O
adults	O
spread	O
disease	O
into	O
the	O
community	O
.	O

TITLE	O
:	O
Emergence	O
of	O
a	O
nephropathogenic	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
with	O
a	O
novel	O
genotype	O
in	O
India	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
the	O
emergence	O
of	O
a	O
nephropathogenic	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
with	O
a	O
novel	O
genotype	O
in	O
India	O
.	O

TITLE	O
:	O
Hugs	O
and	O
kisses	O
:	O
HIV	B-SPEC
-	O
infected	O
parents	O
'	O
fears	O
about	O
contagion	O
and	O
the	O
effects	O
on	O
parent	O
-	O
child	O
interaction	O
in	O
a	O
nationally	O
representative	O
sample	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
effect	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)-	O
related	O
fears	O
on	O
HIV	B-SPEC
-	O
infected	O
parents	O
'	O
interactions	O
with	O
their	O
children	O
and	O
to	O
identify	O
parents	O
who	O
might	O
be	O
at	O
greater	O
risk	O
of	O
avoiding	O
interactions	O
because	O
of	O
these	O
fears	O
.	O

We	O
present	O
a	O
patient	O
in	O
Thailand	O
who	O
was	O
infected	O
with	O
influenza	O
A	O
(	O
H5N1	O
)	O
virus	B-SPEC
.	O

There	O
are	O
huge	O
numbers	O
of	O
wild	O
animals	B-SPEC
distributed	O
throughout	O
the	O
world	O
and	O
the	O
diversity	O
of	O
wildlife	O
species	B-SPEC
is	O
immense	O
.	O

Infectious	O
pathogens	O
that	O
originate	O
in	O
wild	O
animals	B-SPEC
have	O
become	O
increasingly	O
important	O
throughout	O
the	O
world	O
in	O
recent	O
decades	O
,	O
as	O
they	O
have	O
had	O
substantial	O
impacts	O
on	O
human	B-SPEC
health	O
,	O
agricultural	O
production	O
,	O
wildlife	O
-	O
based	O
economies	O
and	O
wildlife	O
conservation	O
.	O

In	O
one	O
pattern	O
,	O
actual	O
transmission	O
of	O
the	O
pathogen	O
to	O
humans	B-SPEC
is	O
a	O
rare	O
event	O
but	O
,	O
once	O
it	O
has	O
occurred	O
,	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
maintains	O
the	O
infection	O
for	O
some	O
period	O
of	O
time	O
or	O
permanently	O
.	O

ABSTRACT	O
:	O
In	O
2002	O
,	O
a	O
new	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
emerged	O
in	O
the	O
People	O
'	O
s	O
Republic	O
of	O
China	O
,	O
associated	O
with	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
mortality	O
in	O
humans	B-SPEC
.	O

If	O
this	O
hypothesis	O
is	O
proven	O
,	O
it	O
will	O
indicate	O
that	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
modulates	O
the	O
surface	O
expression	O
of	O
the	O
spike	O
protein	O
via	O
a	O
different	O
mechanism	O
from	O
other	O
coronaviruses	O
.	O

TITLE	O
:	O
Differentiation	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
genotypes	O
by	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
.	O

ABSTRACT	O
:	O
We	O
report	O
11	O
cases	O
of	O
severe	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
in	O
Bikaner	O
(	O
western	O
India	O
).	O

Since	O
then	O
,	O
much	O
progress	O
has	O
been	O
made	O
in	O
the	O
virological	O
and	O
molecular	O
characterization	O
of	O
the	O
proteins	O
encoded	O
by	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
,	O
which	O
contains	O
14	O
potential	O
open	O
reading	O
frames	O
(	O
ORFs	O
).	O

After	O
two	O
intramuscular	O
vaccinations	O
with	O
ADS	O
-	O
MVA	O
alone	O
,	O
the	O
50	O
%	O
inhibitory	O
concentration	O
in	O
serum	O
was	O
achieved	O
with	O
reciprocal	O
sera	O
dilutions	O
of	O
more	O
than	O
1	O
,	O
000	O
-	O
to	O
10	O
,	O
000	O
-	O
fold	O
in	O
these	O
animals	B-SPEC
.	O

In	O
a	O
mouse	B-SPEC
model	O
of	O
neurological	O
infection	O
,	O
the	O
recombinant	O
and	O
parental	O
viruses	B-SPEC
are	O
equally	O
virulent	O
,	O
they	O
replicate	O
to	O
the	O
same	O
titers	O
in	O
brain	O
and	O
liver	O
,	O
and	O
they	O
induce	O
similar	O
patterns	O
of	O
acute	O
hepatitis	O
,	O
acute	O
meningoencephalitis	O
,	O
and	O
chronic	O
demyelination	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
showed	O
the	O
association	O
of	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SCoV	B-SPEC
)	O
accessory	O
protein	O
,	O
3a	O
,	O
with	O
plasma	O
membrane	O
and	O
intracellular	O
SCoV	B-SPEC
particles	O
in	O
infected	O
cells	O
.	O

The	O
study	O
was	O
carried	O
out	O
at	O
the	O
animal	B-SPEC
laboratories	O
of	O
Ataturk	O
University	O
,	O
Medical	O
Faculty	O
,	O
Erzurum	O
,	O
Turkey	B-SPEC
during	O
the	O
year	O
2002	O
,	O
and	O
performed	O
on	O
a	O
rabbit	B-SPEC
acid	O
aspiration	O
model	O
.	O

TITLE	O
:	O
Antiviral	O
activity	O
of	O
glycyrrhizic	O
acid	O
derivatives	O
against	O
SARS	O
-	O
coronavirus	B-SPEC
.	O

The	O
diagnosis	O
of	O
avian	B-SPEC
influenza	O
A	O
(	O
H5N1	O
)	O
was	O
established	O
by	O
isolation	O
of	O
the	O
virus	B-SPEC
from	O
cerebrospinal	O
fluid	O
,	O
fecal	O
,	O
throat	O
,	O
and	O
serum	O
specimens	O
.	O

Isolated	O
with	O
other	O
SARS	O
patients	O
,	O
she	O
was	O
infected	O
with	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Health	O
surveillance	O
of	O
specific	O
pathogen	O
-	O
free	O
and	O
conventionally	O
-	O
housed	O
mice	B-SPEC
and	O
rats	B-SPEC
in	O
Korea	O
.	O

A	O
navigable	O
web	O
-	O
based	O
version	O
of	O
the	O
system	O
is	O
freely	O
available	O
at	O
http	O
://	O
people	O
.	O
musc	O
.	O
edu	O
/~	O
zhengw	O
/	O
SARS	O
/	O
Software	O
-	O
Process	O
.	O
htm	O
RESULTS	O
:	O
By	O
applying	O
an	O
adapted	O
,	O
sequential	O
software	O
engineering	O
process	O
,	O
a	O
complex	O
biological	O
system	O
(	O
severe	O
acquired	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
viral	O
infection	O
)	O
has	O
been	O
reverse	O
-	O
engineered	O
and	O
represented	O
as	O
an	O
object	O
-	O
oriented	O
software	O
system	O
.	O

The	O
algorithm	O
converges	O
extremely	O
rapidly	O
,	O
gives	O
accurate	O
results	O
on	O
simulated	O
data	O
that	O
are	O
an	O
improvement	O
over	O
parsimonious	O
estimates	O
(	O
which	O
are	O
shown	O
to	O
underestimate	O
the	O
true	O
indel	O
rate	O
),	O
and	O
gives	O
plausible	O
results	O
on	O
experimental	O
data	O
(	O
coronavirus	B-SPEC
envelope	O
domains	O
).	O

ABSTRACT	O
:	O
A	O
reverse	O
genetic	O
system	O
was	O
recently	O
established	O
for	O
the	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
(	O
MHV	B-SPEC
-	O
A59	O
),	O
in	O
which	O
cDNA	O
fragments	O
of	O
the	O
RNA	O
genome	O
are	O
assembled	O
in	O
vitro	O
into	O
a	O
full	O
-	O
length	O
genome	O
cDNA	O
,	O
followed	O
by	O
electroporation	O
of	O
in	O
vitro	O
-	O
transcribed	O
genome	O
RNA	O
into	O
cells	O
with	O
recovery	O
of	O
viable	O
virus	B-SPEC
.	O

These	O
results	O
suggest	O
that	O
the	O
SARS	O
coronavirus	B-SPEC
might	O
have	O
an	O
antigenic	O
profile	O
distinct	O
from	O
those	O
of	O
other	O
human	B-SPEC
or	O
animal	B-SPEC
coronaviruses	O
.	O

Virus	B-SPEC
titer	O
was	O
maximal	O
96	O
hpi	O
in	O
CaCo	O
-	O
2	O
cells	O
,	O
and	O
virus	B-SPEC
was	O
continually	O
produced	O
from	O
infected	O
CaCo	O
-	O
2	O
cells	O
for	O
at	O
least	O
6	O
weeks	O
after	O
infection	O
.	O

Human	B-SPEC
metapneumovirus	I-SPEC
has	O
now	O
been	O
detected	O
worldwide	O
,	O
causing	O
severe	O
respiratory	O
tract	O
illnesses	O
primarily	O
in	O
very	O
young	O
,	O
elderly	O
and	O
immunocompromised	O
individuals	O
.	O

We	O
were	O
also	O
able	O
to	O
detect	O
heterogeneous	O
viral	O
sequences	O
in	O
primary	O
lung	O
tissues	O
,	O
suggesting	O
a	O
possible	O
coevolution	O
of	O
quasispecies	O
of	O
virus	B-SPEC
within	O
a	O
single	O
host	O
.	O

Although	O
M	B-SPEC
.	I-SPEC
gallisepticum	I-SPEC
could	O
not	O
be	O
cultured	O
from	O
tracheal	O
swabs	O
collected	O
on	O
several	O
consecutive	O
sampling	O
days	O
after	O
the	O
end	O
of	O
the	O
enrofloxacin	O
treatments	O
,	O
the	O
infection	O
was	O
not	O
eradicated	O
.	O

In	O
this	O
review	O
,	O
several	O
antiviral	O
substances	O
shown	O
to	O
be	O
active	O
in	O
vitro	O
will	O
be	O
introduced	O
and	O
summarized	O
in	O
the	O
order	B-SPEC
of	O
the	O
virus	B-SPEC
'	O
replication	O
steps	O
;	O
that	O
is	O
,	O
binding	O
to	O
cellular	O
receptor	O
,	O
fusion	O
and	O
entry	O
to	O
the	O
cells	O
,	O
viral	O
RNA	O
replication	O
and	O
transcription	O
,	O
protein	O
processing	O
and	O
so	O
on	O
.	O

TITLE	O
:	O
The	O
protein	O
X4	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
is	O
expressed	O
on	O
both	O
virus	B-SPEC
-	O
infected	O
cells	O
and	O
lung	O
tissue	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
patients	O
and	O
inhibits	O
growth	O
of	O
Balb	O
/	O
c	O
3T3	O
cell	O
line	O
.	O

TITLE	O
:	O
Virus	B-SPEC
-	O
specific	O
antibody	O
,	O
in	O
the	O
absence	O
of	O
T	O
cells	O
,	O
mediates	O
demyelination	O
in	O
mice	B-SPEC
infected	O
with	O
a	O
neurotropic	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Alexandra	B-SPEC
Hospital	O
(	O
AH	O
)	O
was	O
one	O
of	O
the	O
public	O
hospitals	O
in	O
Singapore	O
that	O
responded	O
to	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
crisis	O
.	O

Two	O
monoclonal	O
antibodies	O
(	O
1A5	O
and	O
2C5	O
)	O
targeting	O
at	O
the	O
RBD	O
of	O
S	O
protein	O
were	O
isolated	O
from	O
mice	B-SPEC
immunized	O
with	O
inactivated	O
SARS	O
-	O
CoV	O
.	O
Both	O
1A5	O
and	O
2C5	O
possessed	O
potent	O
neutralizing	O
activities	O
,	O
although	O
they	O
directed	O
against	O
distinct	O
conformation	O
-	O
dependant	O
epitopes	O
as	O
shown	O
by	O
ELISA	O
and	O
binding	O
competition	O
assay	O
.	O

We	O
identified	O
five	O
residues	O
in	O
S	O
(	O
S33	O
,	O
L79	O
,	O
T82	O
,	O
Y162	O
and	O
K183	O
)	O
that	O
are	O
conserved	O
in	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
MHV	B-SPEC
strains	O
,	O
but	O
not	O
in	O
related	O
coronaviruses	O
.	O

TITLE	O
:	O
Detection	O
and	O
isolation	O
of	O
winter	O
dysentery	O
bovine	B-SPEC
coronavirus	B-SPEC
circulated	O
in	O
Korea	O
during	O
2002	O
-	O
2004	O
.	O

ABSTRACT	O
:	O
The	O
3C	O
-	O
like	O
proteinase	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	B-SPEC
)	O
has	O
been	O
proposed	O
to	O
be	O
a	O
key	O
target	O
for	O
structural	O
based	O
drug	O
design	O
against	O
SARS	B-SPEC
.	O

ABSTRACT	O
:	O
Antibody	O
detection	O
with	O
a	O
recombinant	O
COOH	O
portion	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
,	O
N13	O
(	O
amino	O
acids	O
221	O
to	O
422	O
),	O
was	O
demonstrated	O
to	O
be	O
more	O
specific	O
and	O
sensitive	O
than	O
that	O
with	O
the	O
full	O
-	O
length	O
N	O
protein	O
,	O
and	O
an	O
N13	O
-	O
based	O
antigen	O
-	O
capturing	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
providing	O
a	O
convenient	O
and	O
specific	O
test	O
for	O
serodiagnosis	O
and	O
epidemiological	O
study	O
of	O
SARS	O
was	O
developed	O
.	O

In	O
addition	O
,	O
we	O
reviewed	O
relevant	O
animal	B-SPEC
and	O
mechanical	O
ventilation	O
studies	O
.	O

The	O
animals	B-SPEC
were	O
randomly	O
assigned	O
to	O
one	O
of	O
four	O
different	O
groups	O
(	O
6	O
animals	B-SPEC
/	O
group	O
).	O

Poly	O
ICLC	O
and	O
CpG	O
oligonucleotides	O
are	O
promising	O
gene	O
-	O
based	O
drugs	O
which	O
have	O
been	O
shown	O
in	O
animal	B-SPEC
studies	O
to	O
protect	O
against	O
acute	O
respiratory	O
virus	B-SPEC
infections	O
.	O

To	O
determine	O
whether	O
these	O
DNA	O
vaccines	O
could	O
induce	O
T	O
cell	O
immune	O
responses	O
in	O
humans	B-SPEC
as	O
well	O
as	O
in	O
mice	B-SPEC
,	O
SCID	O
-	O
PBL	O
/	O
hu	O
mice	B-SPEC
was	O
immunized	O
with	O
these	O
DNA	O
vaccines	O
.	O

SARS	O
-	O
N	O
and	O
SARS	O
-	O
M	O
DNA	O
vaccines	O
and	O
SCID	O
-	O
PBL	O
/	O
hu	O
mouse	B-SPEC
model	O
will	O
be	O
important	O
in	O
the	O
development	O
of	O
protective	O
vaccines	O
.	O

No	O
clinical	O
signs	O
were	O
observed	O
in	O
all	O
the	O
ferrets	B-SPEC
challenged	O
with	O
SARS	O
-	O
CoV	O
.	O
On	O
the	O
other	O
hand	O
,	O
vaccination	O
did	O
not	O
prevent	O
SARS	O
-	O
CoV	O
infection	O
in	O
ferrets	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
four	O
hospitals	O
assessed	O
in	O
this	O
study	O
use	O
active	O
surveillance	O
cultures	O
for	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
(	O
MRSA	B-SPEC
)	O
and	O
contact	O
precautions	O
for	O
MRSA	B-SPEC
-	O
positive	O
patients	O
as	O
part	O
of	O
routine	O
infection	O
control	O
practices	O
.	O

We	O
show	O
that	O
this	O
method	O
could	O
identify	O
and	O
distinguish	O
between	O
SARS	O
and	O
other	O
known	O
CoV	O
,	O
including	O
the	O
human	B-SPEC
CoV	O
229E	O
and	O
OC43	O
,	O
individually	O
and	O
in	O
a	O
mixture	O
of	O
all	O
3	O
human	B-SPEC
viruses	B-SPEC
.	O

The	O
sensitivity	O
of	O
detection	O
,	O
measured	O
by	O
using	O
titered	O
SARS	O
-	O
CoV	O
spiked	O
into	O
human	B-SPEC
serum	O
,	O
was	O
approximate	O
,	O
equals1	O
PFU	O
/	O
mL	O
.	O
This	O
approach	O
,	O
applicable	O
to	O
the	O
surveillance	O
of	O
bacterial	O
,	O
viral	O
,	O
fungal	O
,	O
or	O
protozoal	O
pathogens	O
,	O
is	O
capable	O
of	O
automated	O
analysis	O
of	O
>	O
900	O
PCR	O
reactions	O
per	O
day	O
.	O

The	O
pseudotype	O
assay	O
does	O
not	O
require	O
handling	O
live	O
SARS	O
virus	B-SPEC
;	O
it	O
is	O
a	O
useful	O
tool	O
to	O
determine	O
neutralizing	O
titers	O
during	O
natural	O
infection	O
and	O
the	O
preclinical	O
evaluation	O
of	O
candidate	O
vaccines	O
.	O

Approximately	O
16	O
%	O
showed	O
signs	O
of	O
posttraumatic	O
symptoms	O
,	O
and	O
approximately	O
equals	O
40	O
%	O
perceived	O
increased	O
stress	O
in	O
family	B-SPEC
or	O
work	O
settings	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
isolated	O
from	O
a	O
pig	B-SPEC
during	O
a	O
survey	O
for	O
possible	O
routes	O
of	O
viral	O
transmission	O
after	O
a	O
SARS	O
epidemic	O
.	O

Thirty	O
-	O
one	O
per	O
cent	O
of	O
chicks	O
receiving	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
aerosol	O
alone	O
developed	O
arthritis	O
compared	O
with	O
50	O
%	O
of	O
those	O
co	O
-	O
infected	O
with	O
IBV	B-SPEC
.	O

Virtually	O
all	O
broiler	O
and	O
layer	O
breeder	O
flocks	O
are	O
routinely	O
vaccinated	O
against	O
IBV	B-SPEC
.	O

Chicks	O
from	O
two	O
further	O
hatches	O
of	O
the	O
four	O
lines	O
were	O
vaccinated	O
appropriately	O
with	O
a	O
more	O
attenuated	O
IBV	B-SPEC
vaccine	O
,	O
and	O
only	O
limited	O
chick	O
mortality	O
was	O
seen	O
.	O

These	O
retrospective	O
data	O
from	O
two	O
repeated	O
hatches	O
confirm	O
earlier	O
data	O
indicating	O
chicken	B-SPEC
genes	O
influence	O
resistance	O
to	O
IBV	B-SPEC
,	O
and	O
indicate	O
for	O
the	O
first	O
time	O
that	O
genes	O
tightly	O
linked	O
to	O
the	O
B	O
haplotype	O
are	O
relevant	O
in	O
resistance	O
to	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Variation	O
in	O
the	O
spike	O
protein	O
of	O
the	O
793	O
/	O
B	O
type	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
,	O
in	O
the	O
field	O
and	O
during	O
alternate	O
passage	O
in	O
chickens	B-SPEC
and	O
embryonated	O
eggs	O
.	O

IFN	O
-	O
beta	O
was	O
found	O
to	O
be	O
the	O
most	O
highly	O
active	O
antiviral	O
agent	O
,	O
followed	O
by	O
natural	O
IFN	O
-	O
alpha	O
,	O
whereas	O
the	O
2	O
recombinant	O
IFN	O
-	O
alpha2	O
species	B-SPEC
were	O
poorly	O
active	O
in	O
the	O
system	O
used	O
.	O

SS2	O
is	O
significantly	O
different	O
from	O
SS1	O
:	O
older	O
age	O
,	O
more	O
surgical	O
stays	O
and	O
admission	O
from	O
external	O
transfer	O
,	O
greater	O
number	O
of	O
organ	O
supports	O
,	O
site	O
of	O
infection	O
(	O
less	O
pulmonary	O
and	O
urinary	O
tract	O
infections	O
,	O
and	O
more	O
abdominal	O
and	O
cardiovascular	O
infections	O
),	O
type	O
of	O
bacteria	B-SPEC
(	O
more	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
Pseudomonas	B-SPEC
,	O
and	O
fungus	B-SPEC
),	O
ICU	O
length	O
of	O
stay	O
(	O
20	O
.	O
4	O
d	O
vs	O
11	O
.	O
6	O
d	O
),	O
hospital	O
length	O
of	O
stay	O
(	O
33	O
d	O
vs	O
27	O
.	O
9	O
d	O
),	O
ICU	O
mortality	O
(	O
42	O
.	O
7	O
%	O
vs	O
5	O
.	O
5	O
%),	O
and	O
hospital	O
mortality	O
(	O
49	O
%	O
vs	O
11	O
.	O
3	O
%).	O

The	O
serum	O
of	O
such	O
population	O
diagnosed	O
as	O
SARS	O
convalescent	O
patients	O
,	O
non	O
-	O
SARS	O
patients	O
,	O
family	B-SPEC
consanguineous	O
contraction	O
persons	O
,	O
wild	O
animal	B-SPEC
and	O
vegetable	O
salesman	O
and	O
community	O
common	O
people	O
was	O
collected	O
.	O

The	O
importance	O
in	O
the	O
virus	B-SPEC
transmitting	O
course	O
need	O
to	O
be	O
further	O
studied	O
.	O

Overall	O
,	O
despite	O
extensive	O
diagnostic	O
evaluation	O
,	O
a	O
specific	O
diagnosis	O
could	O
not	O
be	O
made	O
in	O
37	O
%	O
of	O
cats	B-SPEC
.	O

The	O
prognosis	O
for	O
cats	B-SPEC
with	O
inflammatory	O
CSF	O
was	O
poor	O
with	O
77	O
%	O
of	O
cats	B-SPEC
surviving	O
less	O
than	O
1	O
year	O
.	O

In	O
each	O
patient	O
,	O
transpulmonary	O
thermodilution	O
was	O
used	O
to	O
measure	O
cardiovascular	O
hemodynamics	O
and	O
EVLW	O
for	O
7	O
days	O
via	O
an	O
arterial	O
catheter	O
placed	O
within	O
72	O
hours	O
of	O
meeting	O
criteria	O
for	O
severe	O
sepsis	B-SPEC
.	O

EVLW	O
may	O
improve	O
both	O
risk	O
stratification	O
and	O
management	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

ABSTRACT	O
:	O
Vero	O
E6	O
African	B-SPEC
green	I-SPEC
monkey	I-SPEC
kidney	O
cells	O
are	O
highly	O
susceptible	O
to	O
infection	O
with	O
the	O
newly	O
emerging	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
they	O
are	O
permissive	O
for	O
rapid	O
viral	O
replication	O
,	O
with	O
resultant	O
cytopathic	O
effects	O
.	O

In	O
protocol	O
two	O
,	O
both	O
agents	O
were	O
administered	O
concurrently	O
,	O
whereas	O
in	O
protocol	O
three	O
,	O
ca	O
-	O
PEDV	B-SPEC
was	O
applied	O
20	O
h	O
in	O
advance	O
of	O
the	O
Chlamydiaceae	B-SPEC
.	O

Characteristically	O
,	O
ca	O
-	O
PEDV	B-SPEC
syncytia	O
with	O
one	O
or	O
more	O
chlamydial	O
inclusions	O
were	O
detected	O
but	O
dually	O
infected	O
single	O
cells	O
were	O
absent	O
.	O

Experiments	O
with	O
C	B-SPEC
.	I-SPEC
trachomatis	I-SPEC
showed	O
significantly	O
increased	O
numbers	O
of	O
chlamydial	O
inclusions	O
in	O
dually	O
infected	O
cell	O
layers	O
compared	O
to	O
monoinfected	O
ones	O
.	O

These	O
findings	O
indicate	O
an	O
influence	O
of	O
ca	O
-	O
PEDV	B-SPEC
on	O
the	O
chlamydial	O
developmental	O
cycle	O
and	O
in	O
the	O
case	O
of	O
C	B-SPEC
.	I-SPEC
trachomatis	I-SPEC
,	O
a	O
positive	O
effect	O
on	O
chlamydial	O
colonization	O
in	O
mixed	O
infections	O
.	O

dsRNA	O
-	O
mediated	O
RNAi	O
can	O
be	O
used	O
in	O
a	O
wide	O
variety	O
of	O
eucaryotes	B-SPEC
to	O
induce	O
the	O
sequence	O
-	O
specific	O
inhibition	O
of	O
gene	O
expression	O
.	O

TITLE	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3a	O
is	O
a	O
novel	O
structural	O
protein	O
.	O

Furthermore	O
,	O
co	O
-	O
expression	O
of	O
3a	O
,	O
membrane	O
and	O
envelope	O
proteins	O
using	O
the	O
baculovirus	B-SPEC
system	O
showed	O
that	O
both	O
full	O
-	O
length	O
and	O
truncated	O
3a	O
can	O
be	O
assembled	O
into	O
virus	B-SPEC
-	O
like	O
particles	O
.	O

Serum	O
,	O
faecal	O
and	O
nasal	O
swab	O
samples	O
were	O
collected	O
from	O
a	O
total	O
of	O
96	O
cattle	B-SPEC
with	O
clinical	O
signs	O
in	O
29	O
barns	O
of	O
23	O
villages	O
in	O
Northwestern	O
Turkey	B-SPEC
.	O

The	O
cattle	B-SPEC
were	O
subdivided	O
into	O
3	O
distinct	O
age	O
groups	O
(	O
0	O
-	O
30	O
days	O
old	O
,	O
4	O
-	O
12	O
months	O
old	O
and	O
2	O
-	O
7	O
years	O
old	O
).	O

Relationships	O
between	O
BCoV	O
shedding	O
and	O
age	O
group	O
,	O
seroconversion	O
and	O
clinical	O
signs	O
in	O
cattle	B-SPEC
were	O
also	O
analysed	O
.	O

BCoV	O
antibody	O
titre	O
in	O
50	O
%	O
of	O
all	O
cattle	B-SPEC
was	O
<	O
or	O
=	O
100	O
as	O
detected	O
by	O
ELISA	O
while	O
27	O
.	O
1	O
%	O
of	O
the	O
cattle	B-SPEC
had	O
high	O
titres	O
ranging	O
between	O
1	O
,	O
600	O
and	O
25	O
,	O
600	O
.	O

The	O
seroconversion	O
rate	O
was	O
7	O
.	O
3	O
%	O
(	O
7	O
/	O
96	O
)	O
in	O
animals	B-SPEC
shedding	O
BoCV	O
in	O
the	O
faeces	O
and	O
42	O
.	O
7	O
%	O
(	O
41	O
/	O
96	O
)	O
in	O
cattle	B-SPEC
negative	O
for	O
faecal	O
shedding	O
as	O
detected	O
by	O
ELISA	O
,	O
and	O
20	O
.	O
8	O
%	O
of	O
cattle	B-SPEC
with	O
no	O
seroconversion	O
shed	O
BCoV	O
in	O
the	O
faeces	O
.	O

The	O
detection	O
of	O
antibodies	O
against	O
SARS	O
virus	B-SPEC
is	O
helpful	O
in	O
the	O
clinical	O
diagnosis	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
functional	O
receptor	O
for	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

This	O
report	O
is	O
the	O
first	O
to	O
describe	O
the	O
cellular	O
localization	O
of	O
SARS	O
-	O
CoV	O
in	O
human	B-SPEC
lung	O
tissue	O
by	O
using	O
a	O
combination	O
of	O
immunohistochemistry	O
,	O
double	O
-	O
stain	O
immunohistochemistry	O
,	O
in	O
situ	O
hybridization	O
,	O
electron	O
microscopy	O
,	O
and	O
immunogold	O
labeling	O
electron	O
microscopy	O
.	O

HIV	B-SPEC
-	O
specific	O
memory	O
CD8	O
+	O
T	O
cells	O
were	O
recruited	O
early	O
into	O
the	O
CNS	O
as	O
components	O
of	O
the	O
innate	O
immune	O
response	O
,	O
preceding	O
CD8	O
+	O
T	O
cells	O
specific	O
for	O
the	O
dominant	O
coronavirus	B-SPEC
epitope	O
,	O
designated	O
pN	O
.	O
Although	O
pN	O
-	O
specific	O
T	O
-	O
cell	O
numbers	O
gradually	O
exceeded	O
bystander	O
p18	O
-	O
specific	O
CD8	O
+	O
T	O
-	O
cell	O
numbers	O
,	O
both	O
populations	O
peaked	O
concurrently	O
within	O
the	O
CNS	O
.	O

Childhood	O
asthma	O
was	O
observed	O
in	O
40	O
,	O
4	O
%	O
of	O
children	O
without	O
any	O
associated	O
factor	O
wether	O
at	O
birth	O
or	O
in	O
PICU	B-SPEC
related	O
to	O
such	O
outcome	O
.	O

TITLE	O
:	O
Receptor	O
-	O
binding	O
domain	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
contains	O
multiple	O
conformation	O
-	O
dependent	O
epitopes	O
that	O
induce	O
highly	O
potent	O
neutralizing	O
antibodies	O
.	O

Recent	O
experiences	O
of	O
emerging	O
microbial	O
threats	O
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
new	O
influenza	O
variants	O
affecting	O
humans	B-SPEC
,	O
the	O
re	O
-	O
emergence	O
of	O
infectious	O
disease	O
problems	O
and	O
the	O
possibility	O
of	O
bioterrorism	O
have	O
evidenced	O
the	O
need	O
for	O
implementation	O
of	O
infectious	O
disease	O
surveillance	O
programmes	O
.	O

On	O
clinical	O
and	O
epidemiological	O
grounds	O
the	O
outbreaks	O
were	O
first	O
thought	O
to	O
be	O
caused	O
by	O
influenza	B-SPEC
virus	I-SPEC
.	O

The	O
hepatitis	O
associated	O
with	O
the	O
SARS	O
coronavirus	B-SPEC
,	O
Isolated	O
Ductular	O
Hyperplasia	O
in	O
patients	O
with	O
liver	O
function	O
test	O
abnormalities	O
and	O
other	O
topics	O
with	O
pathologic	O
relevance	O
are	O
reviewed	O
.	O

Streptococcus	B-SPEC
pneumoniae	I-SPEC
is	O
the	O
most	O
prevalent	O
bacterial	O
pathogen	O
in	O
all	O
ages	O
.	O

Human	B-SPEC
metapneumonovirus	O
detected	O
in	O
young	O
children	O
is	O
a	O
leading	O
cause	O
of	O
respiratory	O
disease	O
during	O
the	O
first	O
years	O
of	O
life	O
.	O

TITLE	O
:	O
Inactivation	O
of	O
viruses	B-SPEC
in	O
platelet	O
concentrates	O
by	O
photochemical	O
treatment	O
with	O
amotosalen	O
and	O
long	O
-	O
wavelength	O
ultraviolet	O
light	O
.	O

Inactivation	O
of	O
viruses	B-SPEC
in	O
PLT	O
concentrates	O
with	O
amotosalen	O
and	O
UVA	O
offers	O
the	O
potential	O
to	O
prospectively	O
prevent	O
the	O
majority	O
of	O
PLT	O
transfusion	O
-	O
associated	O
viral	O
diseases	O
.	O

CONCLUSIONS	O
:	O
The	O
ACE	O
I	O
/	O
D	O
polymorphism	O
is	O
not	O
directly	O
related	O
to	O
increased	O
susceptibility	O
to	O
SARS	O
-	O
coronavirus	B-SPEC
infection	O
and	O
is	O
not	O
associated	O
with	O
poor	O
outcomes	O
after	O
SARS	O
-	O
coronavirus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Identification	O
of	O
murine	B-SPEC
CD8	O
T	O
cell	O
epitopes	O
in	O
codon	O
-	O
optimized	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

Computation	O
fluid	O
dynamics	O
modeling	O
indicated	O
that	O
the	O
normalized	O
concentration	O
of	O
virus	B-SPEC
-	O
laden	O
aerosols	O
was	O
highest	O
in	O
the	O
same	O
bay	O
and	O
lowest	O
in	O
the	O
distant	O
bays	O
.	O

TITLE	O
:	O
Identification	O
of	O
novel	O
subgenomic	O
RNAs	O
and	O
noncanonical	O
transcription	O
initiation	O
signals	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Moreover	O
,	O
one	O
rare	O
species	B-SPEC
of	O
sgRNA	O
has	O
the	O
junction	O
sequence	O
AAA	O
,	O
indicating	O
that	O
its	O
transcription	O
could	O
result	O
from	O
a	O
noncanonical	O
transcription	O
signal	O
.	O

ABSTRACT	O
:	O
Genomic	O
RNA	O
was	O
extracted	O
from	O
a	O
Chinese	O
isolate	O
of	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
designated	O
TH	O
-	O
98	O
.	O

TITLE	O
:	O
Mutations	O
in	O
Sendai	B-SPEC
virus	I-SPEC
variant	O
F1	O
-	O
R	O
that	O
correlate	O
with	O
plaque	O
formation	O
in	O
the	O
absence	O
of	O
trypsin	O
.	O

Chest	O
X	O
-	O
ray	B-SPEC
(	O
CXR	O
)	O
scores	O
during	O
the	O
peak	O
of	O
diarrhea	O
period	O
were	O
recorded	O
by	O
a	O
respiratory	O
physician	O
.	O

The	O
monkeys	B-SPEC
were	O
inoculated	O
intramuscularly	O
(	O
i	O
.	O
m	O
.)	O
with	O
0	O
.	O
5	O
,	O
5	O
,	O
50	O
,	O
or	O
5000	O
microg	O
of	O
vaccine	O
,	O
or	O
PBS	O
as	O
control	O
,	O
and	O
boosted	O
on	O
day	O
7	O
.	O

No	O
systematic	O
side	O
effects	O
were	O
observed	O
in	O
vaccinated	O
animals	B-SPEC
post	O
-	O
immunization	O
,	O
even	O
in	O
at	O
the	O
high	O
dose	O
of	O
5000	O
microg	O
.	O

ABSTRACT	O
:	O
We	O
investigated	O
the	O
feasibility	O
of	O
using	O
Flinders	O
Technology	O
Associates	O
(	O
FTA	O
)	O
filter	O
cards	O
for	O
the	O
storage	O
of	O
allantoic	O
fluid	O
containing	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
such	O
as	O
Arkansas	O
-	O
DPI	O
,	O
Connecticut	O
,	O
and	O
Massachusetts	O
,	O
and	O
for	O
their	O
identification	O
by	O
reverse	O
transcriptase	O
(	O
RT	O
)-	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
characterization	O
by	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
or	O
nucleotide	O
sequencing	O
.	O

TITLE	O
:	O
Cells	O
of	O
human	B-SPEC
aminopeptidase	O
N	O
(	O
CD13	O
)	O
transgenic	B-SPEC
mice	I-SPEC
are	O
infected	O
by	O
human	B-SPEC
coronavirus	I-SPEC
-	O
229E	O
in	O
vitro	O
,	O
but	O
not	O
in	O
vivo	O
.	O

TITLE	O
:	O
Central	O
ions	O
and	O
lateral	O
asparagine	O
/	O
glutamine	O
zippers	O
stabilize	O
the	O
post	O
-	O
fusion	O
hairpin	O
conformation	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
is	O
a	O
class	B-SPEC
I	O
membrane	O
fusion	O
protein	O
with	O
two	O
characteristic	O
heptad	O
repeat	O
regions	O
(	O
HR1	O
and	O
HR2	O
)	O
in	O
its	O
ectodomain	O
.	O

Here	O
,	O
we	O
report	O
the	O
X	O
-	O
ray	B-SPEC
structure	O
of	O
a	O
previously	O
characterized	O
HR1	O
/	O
HR2	O
complex	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

TITLE	O
:	O
Investigation	O
into	O
the	O
causes	O
of	O
canine	O
infectious	O
respiratory	O
disease	O
:	O
antibody	O
responses	O
to	O
canine	O
respiratory	O
coronavirus	B-SPEC
and	O
canine	B-SPEC
herpesvirus	I-SPEC
in	O
two	O
kennelled	O
dog	B-SPEC
populations	O
.	O

Among	O
these	O
cases	O
,	O
664	O
cases	O
were	O
classified	O
as	O
probable	O
SARS	O
based	O
on	O
the	O
clinical	O
case	O
definitions	O
and	O
346	O
had	O
a	O
positive	O
result	O
for	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

All	O
the	O
patients	O
had	O
evidence	O
of	O
severe	O
sepsis	B-SPEC
.	O

The	O
determinants	O
of	O
health	O
-	O
be	O
they	O
a	O
SARS	O
virus	B-SPEC
or	O
a	O
predilection	O
for	O
fatty	O
foods	O
-	O
have	O
joined	O
us	O
in	O
our	O
global	O
mobility	O
.	O

TITLE	O
:	O
Development	O
of	O
three	O
multiplex	O
RT	O
-	O
PCR	O
assays	O
for	O
the	O
detection	O
of	O
12	O
respiratory	O
RNA	O
viruses	B-SPEC
.	O

The	O
RT	O
-	O
PCR	O
multiplex	O
1	O
and	O
the	O
hemi	O
-	O
nested	O
multiplex	O
1	O
detected	O
1	O
and	O
0	O
.	O
1	O
TCID50	O
of	O
RSV	B-SPEC
A	O
,	O
respectively	O
,	O
and	O
0	O
.	O
01	O
and	O
0	O
.	O
001	O
TCID50	O
of	O
influenza	B-SPEC
virus	I-SPEC
A	O
/	O
H3N2	O
,	O
respectively	O
.	O

In	O
contrast	O
,	O
APHS	O
did	O
inhibit	O
the	O
replication	O
of	O
wild	O
-	O
type	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
as	O
well	O
as	O
acyclovir	O
-	O
resistant	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
HSV	B-SPEC
-	O
2	O
mutant	O
.	O

These	O
results	O
suggest	O
that	O
APHS	O
is	O
a	O
NNRTI	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
replication	O
,	O
but	O
not	O
HIV	B-SPEC
-	I-SPEC
2	I-SPEC
replication	O
,	O
and	O
that	O
APHS	O
is	O
an	O
inhibitor	O
of	O
both	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
HSV	B-SPEC
-	O
2	O
replication	O
.	O

TITLE	O
:	O
Association	O
of	O
RANTES	O
with	O
the	O
replication	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
THP	O
-	O
1	O
cells	O
.	O

RANTES	O
itself	O
could	O
inhibit	O
the	O
replication	O
of	O
SARS	O
-	O
CoV	O
in	O
THP	O
-	O
1	O
cells	O
when	O
it	O
was	O
added	O
into	O
the	O
culture	O
before	O
or	O
at	O
the	O
same	O
time	O
with	O
the	O
virus	B-SPEC
;	O
No	O
inhibition	O
effect	O
was	O
shown	O
when	O
RANTES	O
were	O
added	O
into	O
the	O
culture	O
after	O
SARS	O
-	O
CoV	O
infected	O
the	O
cells	O
.	O

In	O
addition	O
,	O
the	O
effects	O
of	O
various	O
80R	O
-	O
binding	O
domain	O
amino	O
acid	O
substitutions	O
which	O
occur	O
in	O
SARS	O
-	O
like	O
-	O
CoV	O
from	O
civet	B-SPEC
cats	I-SPEC
,	O
and	O
which	O
evolved	O
during	O
the	O
2002	O
/	O
2003	O
outbreak	O
and	O
in	O
a	O
2003	O
/	O
2004	O
Guangdong	O
index	O
patient	O
,	O
were	O
analyzed	O
.	O

TITLE	O
:	O
Receptor	O
-	O
independent	O
spread	O
of	O
a	O
highly	O
neurotropic	O
murine	B-SPEC
coronavirus	I-SPEC
JHMV	O
strain	O
from	O
initially	O
infected	O
microglial	O
cells	O
in	O
mixed	O
neural	O
cultures	O
.	O

Treatment	O
with	O
CC1	O
of	O
mixed	O
neural	O
cell	O
cultures	O
and	O
microglia	O
cultures	O
previously	O
infected	O
with	O
wt	O
virus	B-SPEC
failed	O
to	O
block	O
the	O
spread	O
of	O
infection	O
,	O
indicating	O
that	O
wt	O
infection	O
spreads	O
in	O
an	O
MHVR	O
-	O
independent	O
fashion	O
.	O

Thus	O
,	O
the	O
present	O
study	O
indicates	O
that	O
microglial	O
cells	O
are	O
the	O
major	O
population	O
of	O
the	O
initial	O
target	O
for	O
MHV	B-SPEC
infection	O
and	O
that	O
the	O
wt	O
spreads	O
from	O
initially	O
infected	O
microglia	O
to	O
a	O
variety	O
of	O
cells	O
in	O
an	O
MHVR	O
-	O
independent	O
fashion	O
.	O

IBV	B-SPEC
3a	O
protein	O
is	O
expressed	O
in	O
infected	O
cells	O
but	O
is	O
not	O
detected	O
in	O
virions	O
.	O

Sequence	O
analysis	O
predicted	O
that	O
IBV	B-SPEC
3a	O
was	O
a	O
membrane	O
protein	O
;	O
however	O
,	O
only	O
a	O
fraction	O
behaved	O
like	O
an	O
integral	O
membrane	O
protein	O
.	O

TITLE	O
:	O
Comparative	O
host	O
gene	O
transcription	O
by	O
microarray	O
analysis	O
early	O
after	O
infection	O
of	O
the	O
Huh7	O
cell	O
line	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
.	O

No	O
human	B-SPEC
cell	O
line	O
was	O
previously	O
known	O
to	O
be	O
susceptible	O
to	O
both	O
SARS	O
-	O
CoV	O
and	O
other	O
human	B-SPEC
coronaviruses	O
.	O

Much	O
more	O
perturbation	O
of	O
cellular	O
gene	O
transcription	O
was	O
observed	O
after	O
infection	O
by	O
SARS	O
-	O
CoV	O
than	O
after	O
infection	O
by	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

TITLE	O
:	O
Immunological	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
by	O
monoclonal	O
antibodies	O
.	O

They	O
follow	O
the	O
proliferation	O
of	O
rodents	B-SPEC
,	O
notably	O
russet	O
voles	B-SPEC
,	O
the	O
reservoir	O
hosts	O
,	O
and	O
their	O
degree	O
of	O
infection	O
.	O

GST	O
pull	O
-	O
down	O
results	O
clearly	O
demonstrated	O
that	O
SARS_N	O
protein	O
could	O
directly	O
and	O
specifically	O
bind	O
to	O
human	B-SPEC
hnRNP	O
A1	O
in	O
vitro	O
.	O

It	O
is	O
suggested	O
that	O
both	O
SARS_N	O
and	O
hnRNP	O
A1	O
proteins	O
are	O
possibly	O
within	O
the	O
SARS_CoV	O
replication	O
/	O
transcription	O
complex	O
and	O
SARS_N	O
/	O
human	B-SPEC
hnRNP	O
A1	O
interaction	O
might	O
function	O
in	O
the	O
regulation	O
of	O
SARS_CoV	O
RNA	O
synthesis	O
.	O

The	O
recombinant	O
K	O
-	O
COE	O
constituted	O
up	O
to	O
0	O
.	O
1	O
%	O
of	O
the	O
total	O
soluble	O
protein	O
in	O
the	O
leaves	O
of	O
transgenic	O
tobacco	B-SPEC
plants	B-SPEC
.	O

TITLE	O
:	O
Immunofluorescence	O
assay	O
for	O
detection	O
of	O
the	O
nucleocapsid	O
antigen	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
in	O
cells	O
derived	O
from	O
throat	O
wash	O
samples	O
of	O
patients	O
with	O
SARS	O
.	O

The	O
relationship	O
between	O
incidence	O
of	O
TGEV	B-SPEC
gastroenteritis	O
and	O
the	O
spread	O
of	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
infection	O
in	O
pig	B-SPEC
farms	O
is	O
discussed	O
.	O

Within	O
a	O
matter	O
of	O
weeks	O
,	O
the	O
outbreak	O
has	O
evolved	O
to	O
become	O
a	O
global	O
health	O
threat	O
and	O
more	O
than	O
30	O
countries	O
have	O
been	O
afflicted	O
with	O
a	O
novel	B-SPEC
Coronavirus	I-SPEC
strain	O
(	O
SARS	O
-	O
CoV	O
)	O
that	O
is	O
the	O
aetiologic	O
agent	O
of	O
SARS	O
.	O

These	O
findings	O
support	O
our	O
hypothesis	O
that	O
the	O
manner	O
in	O
which	O
CMV	B-SPEC
and	O
the	O
host	O
immune	O
system	O
interact	O
is	O
critical	O
in	O
determining	O
the	O
IRP	O
and	O
hence	O
is	O
predictive	O
of	O
mortality	O
.	O

The	O
effects	O
of	O
class	B-SPEC
-	O
specific	O
protease	O
inhibitors	O
on	O
the	O
trans	O
-	O
cleavage	O
activity	O
revealed	O
that	O
this	O
enzyme	O
worked	O
more	O
like	O
a	O
serine	O
protease	O
rather	O
than	O
the	O
papain	O
protease	O
.	O

CONCLUSIONS	O
:	O
Resolution	O
of	O
pneumonitis	O
is	O
delayed	O
in	O
some	O
patients	O
during	O
SARS	O
recovery	O
and	O
may	O
be	O
associated	O
with	O
delayed	O
clearance	O
of	O
coronavirus	B-SPEC
,	O
Complete	O
resolution	O
may	O
occur	O
by	O
90	O
days	O
or	O
later	O
.	O

TITLE	O
:	O
A	O
throat	O
lozenge	O
containing	O
amyl	O
meta	B-SPEC
cresol	O
and	O
dichlorobenzyl	O
alcohol	O
has	O
a	O
direct	O
virucidal	O
effect	O
on	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
influenza	O
A	O
and	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
A	O
potent	O
virucidal	O
mixture	O
containing	O
amyl	O
metacresol	O
and	O
dichlorobenzyl	O
alcohol	O
at	O
low	O
pH	O
inactivated	O
enveloped	O
respiratory	O
viruses	B-SPEC
influenza	O
A	O
,	O
respiratory	O
synctial	O
virus	B-SPEC
(	O
RSV	B-SPEC
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
but	O
not	O
viruses	B-SPEC
with	O
icosahedral	O
symmetry	O
,	O
such	O
as	O
adenoviruses	B-SPEC
or	O
rhinoviruses	B-SPEC
.	O

Here	O
,	O
we	O
report	O
a	O
reverse	O
genetic	O
approach	O
to	O
elucidate	O
the	O
role	O
of	O
N	O
in	O
coronavirus	B-SPEC
replication	O
and	O
transcription	O
.	O

Furthermore	O
,	O
modification	O
of	O
the	O
transcription	O
signal	O
required	O
for	O
the	O
synthesis	O
of	O
N	O
protein	O
mRNAs	O
in	O
the	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
genome	O
resulted	O
in	O
the	O
selective	O
replication	O
of	O
genomes	O
that	O
are	O
able	O
to	O
express	O
the	O
N	O
protein	O
.	O

TITLE	O
:	O
Cinanserin	O
is	O
an	O
inhibitor	O
of	O
the	O
3C	O
-	O
like	O
proteinase	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
strongly	O
reduces	O
virus	B-SPEC
replication	O
in	O
vitro	O
.	O

TITLE	O
:	O
Identification	O
and	O
characterization	O
of	O
the	O
putative	O
fusion	O
peptide	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

Firstly	O
,	O
SARS	O
-	O
CoV	O
-	O
specific	O
IgGs	O
were	O
detected	O
in	O
the	O
sera	O
of	O
macaques	B-SPEC
from	O
11	O
to	O
60	O
days	O
after	O
inoculation	O
.	O

We	O
established	O
one	O
hybridoma	O
cell	O
line	O
secreting	O
specific	O
mAb	O
and	O
evaluated	O
this	O
mAb	O
with	O
murine	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
pseudotyped	O
with	O
SARS	O
-	O
CoV	O
spike	O
protein	O
(	O
MLV	O
/	O
SARS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
When	O
unexpected	O
diseases	O
such	O
as	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
avian	B-SPEC
influenza	O
become	O
a	O
serious	O
threat	O
to	O
public	O
health	O
,	O
an	O
immediate	O
response	O
is	O
imperative	O
.	O

As	O
suggested	O
by	O
in	O
silico	O
docking	O
of	O
these	O
molecules	O
to	O
a	O
theoretical	O
model	O
of	O
a	O
subunit	O
of	O
type	O
A	O
influenza	B-SPEC
virus	I-SPEC
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
,	O
there	O
also	O
exists	O
a	O
remote	O
possibility	O
that	O
these	O
PIs	O
may	O
have	O
an	O
effect	O
on	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
.	O

TITLE	O
:	O
Assays	O
for	O
the	O
assessment	O
of	O
neutralizing	O
antibody	O
activities	O
against	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
associated	O
coronavirus	B-SPEC
(	O
SCV	B-SPEC
).	O

TITLE	O
:	O
Synthesis	O
and	O
evaluation	O
of	O
isatin	O
derivatives	O
as	O
effective	O
SARS	O
coronavirus	B-SPEC
3CL	O
protease	O
inhibitors	O
.	O

Bioactivity	O
assay	O
results	O
(	O
in	O
vitro	O
tests	O
)	O
demonstrated	O
that	O
some	O
of	O
these	O
compounds	O
are	O
potent	O
and	O
selective	O
inhibitors	O
against	O
SARS	O
coronavirus	B-SPEC
3CL	O
protease	O
with	O
IC50	O
values	O
ranging	O
from	O
0	O
.	O
95	O
to	O
17	O
.	O
50	O
microM	O
.	O
Additionally	O
,	O
isatin	O
4o	O
exhibited	O
more	O
potent	O
inhibition	O
for	O
SARS	O
coronavirus	B-SPEC
protease	O
than	O
for	O
other	O
proteases	O
including	O
papain	O
,	O
chymotrypsin	O
,	O
and	O
trypsin	O
.	O

Here	O
,	O
we	O
show	O
that	O
SARS	O
-	O
CoV	O
shares	O
its	O
receptor	O
ACE2	O
with	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

An	O
alternative	O
diagnosis	O
was	O
made	O
as	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
-	O
associated	O
hemophagocytic	O
syndrome	O
,	O
based	O
on	O
the	O
proliferation	O
of	O
macrophages	O
with	O
hemophagocytosis	O
in	O
the	O
bone	O
marrow	O
and	O
Epstein	O
-	O
Barr	O
viral	O
marker	O
profiles	O
.	O

TITLE	O
:	O
Antigenic	O
cross	O
-	O
reactivity	O
between	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
and	O
human	B-SPEC
coronaviruses	O
229E	O
and	O
OC43	O
.	O

The	O
three	O
-	O
dimensional	O
structure	O
result	O
indicates	O
that	O
the	O
nsp2	O
protein	O
of	O
GD	O
strain	O
is	O
high	O
homologous	O
with	O
3CL	O
(	O
pro	O
)	O
of	O
SARS	O
-	O
CoV	O
urbani	O
strain	O
,	O
3CL	O
(	O
pro	O
)	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
and	O
3CL	O
(	O
pro	O
)	O
of	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
strain	O
,	O
which	O
further	O
suggests	O
that	O
nsp2	O
protein	O
of	O
GD	O
strain	O
possesses	O
the	O
activity	O
of	O
3CL	O
(	O
pro	O
).	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
develop	O
an	O
RNAi	O
(	O
RNA	O
interference	O
)	O
approach	O
that	O
specifically	O
targeted	O
the	O
N	O
gene	O
sequence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
by	O
synthesizing	O
short	O
hairpin	O
RNA	O
(	O
shRNA	O
)	O
in	O
vivo	O
,	O
and	O
to	O
assess	O
the	O
inhibitory	O
effect	O
of	O
this	O
shRNA	O
on	O
SARS	O
-	O
CoV	O
N	O
antigen	O
expression	O
.	O

The	O
eukaryotic	O
expression	O
plasmid	O
pEGFP	O
-	O
C1	O
-	O
N	O
,	O
containing	O
SARS	O
-	O
CoV	O
N	O
gene	O
,	O
was	O
co	O
-	O
transfected	O
into	O
293	O
cells	O
with	O
either	O
the	O
RNAi	O
plasmid	O
pshRNA	O
-	O
N	O
or	O
unrelated	O
control	O
plasmid	O
pshRNA	O
-	O
HBV	B-SPEC
-	O
C4	O
.	O

Tools	O
for	O
the	O
optimization	O
of	O
forensic	O
typing	O
using	O
Single	O
Nucleotide	O
Polymorphism	O
(	O
SNP	O
)	O
and	O
PCR	O
-	O
Restriction	O
Fragment	O
Length	O
Polymorphism	O
(	O
PCR	O
-	O
RFLP	O
)	O
analyses	O
across	O
multiple	O
isolate	O
sequences	O
of	O
a	O
species	B-SPEC
are	O
described	O
.	O

Analyses	O
of	O
mumps	O
and	O
SARS	O
viruses	B-SPEC
are	O
summarized	O
.	O

We	O
investigated	O
the	O
role	O
that	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
played	O
in	O
children	O
hospitalized	O
with	O
fever	O
and	O
acute	O
respiratory	O
symptoms	O
in	O
Hong	O
Kong	O
during	O
the	O
period	O
from	O
August	O
2001	O
through	O
August	O
2002	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
viruses	B-SPEC
appeared	O
to	O
cluster	O
into	O
2	O
evolutionary	O
lineages	O
,	O
and	O
viruses	B-SPEC
from	O
both	O
lineages	O
cocirculated	O
in	O
the	O
same	O
season	O
.	O

TITLE	O
:	O
Interferon	O
alfacon1	O
is	O
an	O
inhibitor	O
of	O
SARS	O
-	O
corona	B-SPEC
virus	B-SPEC
in	O
cell	O
-	O
based	O
models	O
.	O

Here	O
,	O
the	O
results	O
of	O
a	O
screening	O
for	O
coronavirus	B-SPEC
are	O
presented	O
,	O
using	O
a	O
universal	O
coronavirus	B-SPEC
RT	O
-	O
PCR	O
,	O
of	O
the	O
bird	B-SPEC
species	B-SPEC
graylag	B-SPEC
goose	I-SPEC
(	O
Anser	B-SPEC
anser	I-SPEC
),	O
feral	O
pigeon	B-SPEC
(	O
Columbia	O
livia	O
)	O
and	O
mallard	B-SPEC
(	O
Anas	B-SPEC
platyrhynchos	I-SPEC
).	O

In	O
the	O
graylag	B-SPEC
goose	I-SPEC
,	O
40	O
of	O
163	O
sampled	O
birds	B-SPEC
were	O
coronavirus	B-SPEC
positive	O
,	O
whereas	O
two	O
of	O
100	O
sampled	O
pigeons	B-SPEC
and	O
one	O
of	O
five	O
sampled	O
mallards	B-SPEC
tested	O
positive	O
.	O

All	O
the	O
novel	O
avian	B-SPEC
coronaviruses	O
harboured	O
the	O
conserved	O
s2m	O
RNA	O
structure	O
in	O
their	O
3	O
'	O
untranslated	O
region	O
,	O
like	O
other	O
previously	O
described	O
group	O
III	O
coronaviruses	O
,	O
and	O
like	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

RNA	O
of	O
the	O
defective	O
interfering	O
virus	B-SPEC
was	O
not	O
observed	O
in	O
the	O
persistently	O
infected	O
cells	O
by	O
Northern	O
blot	O
analysis	O
.	O

The	O
ensuing	O
challenges	O
to	O
hospital	O
and	O
public	O
health	O
workers	O
rose	B-SPEC
to	O
a	O
level	O
never	O
before	O
seen	O
in	O
healthcare	O
,	O
in	O
part	O
due	O
to	O
the	O
unknown	O
nature	O
of	O
the	O
disease	O
,	O
the	O
fear	O
of	O
the	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
and	O
the	O
significant	O
media	O
involvement	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
229E	O
is	O
a	O
group	O
1	O
coronavirus	B-SPEC
and	O
is	O
specific	O
to	O
humans	B-SPEC
.	O

Furthermore	O
,	O
these	O
mice	B-SPEC
provide	O
an	O
important	O
tool	O
for	O
the	O
evaluation	O
of	O
biosafety	O
and	O
efficacy	O
of	O
coronavirus	B-SPEC
-	O
based	O
vectors	O
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
coronavirus	I-SPEC
A59	O
strain	O
causes	O
mild	O
to	O
moderate	O
hepatitis	O
in	O
mice	B-SPEC
.	O

Macrophages	O
are	O
key	O
sentinel	O
cells	O
in	O
the	O
respiratory	O
system	O
,	O
and	O
it	O
is	O
therefore	O
relevant	O
to	O
compare	O
the	O
responses	O
of	O
human	B-SPEC
macrophages	O
to	O
infections	O
with	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
other	O
respiratory	O
viruses	B-SPEC
.	O

SARS	O
-	O
CoV	O
initiated	O
viral	O
gene	O
transcription	O
and	O
protein	O
synthesis	O
in	O
macrophages	O
,	O
but	O
replication	O
was	O
abortive	O
and	O
no	O
infectious	O
virus	B-SPEC
was	O
produced	O
.	O

Little	O
is	O
known	O
about	O
the	O
biology	O
and	O
pathophysiology	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
causes	O
SARS	O
.	O

TITLE	O
:	O
[	O
The	O
effects	O
of	O
4	O
laboratory	O
test	O
kits	O
in	O
early	O
detecting	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
].	O

ABSTRACT	O
:	O
To	O
compare	O
the	O
4	O
test	O
kits	O
on	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
gene	O
,	O
antigen	O
and	O
antibody	O
for	O
early	O
diagnose	O
of	O
SARS	O
patients	O
.	O

RESULTS	O
:	O
In	O
31	O
animals	B-SPEC
sampled	O
in	O
January	O
5	O
2004	O
before	O
culling	O
of	O
wild	O
animals	B-SPEC
at	O
Guangdong	O
Province	O
,	O
including	O
20	O
cats	B-SPEC
(	O
Felis	B-SPEC
catus	I-SPEC
),	O
5	O
red	B-SPEC
fox	I-SPEC
(	O
Vulpes	B-SPEC
vulpes	I-SPEC
)	O
and	O
6	O
Lesser	O
rice	B-SPEC
field	O
rats	B-SPEC
(	O
Rattus	B-SPEC
losea	I-SPEC
),	O
8	O
(	O
25	O
.	O
8	O
%)	O
animals	B-SPEC
were	O
tested	O
positive	O
for	O
SARS	O
-	O
CoV	O
like	O
virus	B-SPEC
by	O
RT	O
-	O
PCR	O
methods	O
,	O
of	O
which	O
4	O
cats	B-SPEC
,	O
3	O
red	B-SPEC
fox	I-SPEC
and	O
one	O
Lesser	O
rice	B-SPEC
field	O
rats	B-SPEC
were	O
included	O
.	O

Virus	B-SPEC
titres	O
were	O
determined	O
by	O
a	O
quantitative	O
test	O
(	O
endpoint	O
titration	O
)	O
in	O
96	O
-	O
well	O
microtitre	O
plates	O
.	O

ABSTRACT	O
:	O
We	O
analyzed	O
genetic	O
variations	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
considering	O
that	O
it	O
might	O
influence	O
patients	O
'	O
susceptibility	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
or	O
development	O
of	O
SARS	O
as	O
a	O
functional	O
receptor	O
.	O

In	O
them	O
,	O
ARF	O
was	O
caused	O
by	O
acute	O
interstitial	O
nephritis	O
in	O
18	O
.	O
8	O
%,	O
by	O
urosepsis	O
in	O
18	O
.	O
8	O
%,	O
by	O
non	O
-	O
urological	O
sepsis	B-SPEC
in	O
19	O
%,	O
by	O
destructive	O
pancreatitis	O
in	O
18	O
%,	O
in	O
13	O
%	O
rapidly	O
progressive	O
glomerulonephritis	O
was	O
present	O
in	O
systemic	O
vasculitis	O
.	O

TITLE	O
:	O
[	O
The	O
assessment	O
of	O
severity	O
of	O
lung	O
injury	O
in	O
sepsis	B-SPEC
].	O

TITLE	O
:	O
A	O
human	B-SPEC
SARS	O
-	O
CoV	O
neutralizing	O
antibody	O
against	O
epitope	O
on	O
S2	O
protein	O
.	O

One	O
human	B-SPEC
scFv	O
,	O
B1	O
,	O
was	O
characterized	O
extensively	O
.	O

ABSTRACT	O
:	O
To	O
detect	O
the	O
level	O
and	O
dynamic	O
change	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
coronavirus	B-SPEC
-	O
specific	O
IgG	O
antibody	O
in	O
conavalescent	O
SARS	O
patients	O
,	O
and	O
to	O
provide	O
information	O
for	O
prevention	O
and	O
vaccine	O
development	O
.	O

Crude	O
FeIFN	O
induced	O
in	O
feline	B-SPEC
cells	O
revealed	O
antiviral	O
activity	O
on	O
both	O
homologous	O
and	O
heterologous	O
animal	B-SPEC
cells	O
.	O

The	O
cytokine	O
release	O
of	O
cultured	O
peripheral	O
blood	O
mononuclear	O
cells	O
,	O
peritoneal	O
macrophages	O
,	O
splenocytes	O
,	O
and	O
splenic	O
macrophages	O
and	O
plasma	O
levels	O
of	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
and	O
interleukin	O
-	O
6	O
from	O
those	O
animals	B-SPEC
were	O
quantified	O
.	O

Positive	O
SARS	O
-	O
Co	O
virus	B-SPEC
IgG	O
antibody	O
results	O
were	O
seen	O
in	O
208	O
of	O
258	O
patients	O
,	O
with	O
21	O
.	O
3	O
%	O
(	O
55	O
of	O
258	O
patients	O
)	O
still	O
having	O
a	O
pulmonary	O
diffusion	O
abnormality	O
(	O
D	O
(	O
LCO	O
)	O
<	O
80	O
%	O
of	O
predicted	O
).	O

Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
the	O
C	O
-	O
type	O
lectin	O
CD209L	O
(	O
also	O
known	O
L	O
-	O
SIGN	O
),	O
and	O
DC	O
-	O
SIGN	O
bind	O
SARS	O
-	O
CoV	O
,	O
but	O
ACE2	O
appears	O
to	O
be	O
the	O
key	O
functional	O
receptor	O
for	O
the	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
avian	B-SPEC
coronavirus	I-SPEC
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
like	O
other	O
coronaviruses	O
,	O
expresses	O
several	O
small	O
nonstructural	O
(	O
ns	O
)	O
proteins	O
in	O
addition	O
to	O
those	O
from	O
gene	O
1	O
(	O
replicase	O
)	O
and	O
the	O
structural	O
proteins	O
.	O

The	O
aetiological	O
agent	O
of	O
this	O
disease	O
was	O
found	O
to	O
be	O
a	O
previously	O
unknown	O
coronavirus	B-SPEC
,	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Development	O
of	O
a	O
homogeneous	O
screening	O
assay	O
for	O
automated	O
detection	O
of	O
antiviral	O
agents	O
active	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
.	O

The	O
assay	O
system	O
involves	O
minimal	O
manipulation	O
after	O
assay	O
set	O
-	O
up	O
,	O
facilitates	O
automated	O
read	O
-	O
out	O
and	O
minimizes	O
risks	O
associated	O
with	O
hazardous	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Viroporin	O
activity	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
E	O
protein	O
.	O

Our	O
novel	O
findings	O
thus	O
suggest	O
that	O
the	O
acute	O
SARS	O
-	O
coronavirus	B-SPEC
infection	O
probably	O
contributes	O
to	O
the	O
initial	O
reduction	O
of	O
DC	O
and	O
T	O
-	O
cell	O
subsets	O
in	O
blood	O
,	O
and	O
that	O
high	O
-	O
dose	O
steroid	O
administration	O
may	O
subsequently	O
exacerbate	O
and	O
prolong	O
low	O
expression	O
of	O
the	O
cell	O
subsets	O
.	O

In	O
total	O
,	O
90	O
-	O
97	O
%	O
of	O
animals	B-SPEC
that	O
were	O
seropositive	O
in	O
Sample	O
1	O
remained	O
positive	O
in	O
Sample	O
2	O
.	O

TITLE	O
:	O
Using	O
DNA	O
shuffling	O
to	O
create	O
novel	O
infectious	O
bronchitis	O
virus	B-SPEC
S1	O
genes	O
:	O
implications	O
for	O
S1	O
gene	O
recombination	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
has	O
been	O
identified	O
for	O
the	O
cause	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
,	O
for	O
which	O
there	O
is	O
no	O
efficacious	O
drugs	O
or	O
vaccines	O
.	O

RNA	O
interference	O
of	O
virus	B-SPEC
-	O
specific	O
genes	O
has	O
emerged	O
as	O
a	O
potential	O
antiviral	O
mechanism	O
.	O

These	O
siRNAs	O
could	O
be	O
used	O
to	O
inhibit	O
SARS	O
-	O
coronavirus	B-SPEC
in	O
future	O
research	O
.	O

The	O
genes	O
were	O
over	O
-	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
either	O
as	O
inclusion	O
body	O
or	O
as	O
soluble	O
form	O
.	O

Meanwhile	O
,	O
the	O
FEV	B-SPEC
(	O
1	O
.	O
0	O
)/	O
FVC	O
showed	O
no	O
significant	O
change	O
.	O

Raised	O
serum	O
lactate	O
dehydrogenase	O
concentration	O
in	O
the	O
presence	O
of	O
low	O
neutrophil	O
count	O
and	O
serum	O
creatine	O
phosphokinase	O
level	O
at	O
presentation	O
also	O
indicated	O
an	O
increased	O
likelihood	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
infection	O
in	O
young	O
children	O
.	O

TITLE	O
:	O
Response	O
of	O
memory	O
CD8	O
+	O
T	O
cells	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
in	O
recovered	O
SARS	O
patients	O
and	O
healthy	O
individuals	O
.	O

We	O
applied	O
the	O
EVW	O
in	O
five	O
sheep	B-SPEC
before	O
and	O
after	O
a	O
bronchial	O
challenge	O
and	O
an	O
oleic	O
acid	O
(	O
OA	O
)	O
acute	O
lung	O
injury	O
model	O
.	O

A	O
major	O
focus	O
of	O
this	O
review	O
is	O
to	O
postulate	O
a	O
possible	O
epidemiological	O
cycle	O
for	O
BoTV	O
,	O
based	O
on	O
epidemiological	O
data	O
obtained	O
in	O
our	O
studies	O
and	O
other	O
published	O
data	O
,	O
and	O
progressing	O
from	O
the	O
newborn	O
calf	O
to	O
the	O
adult	O
animal	B-SPEC
.	O

Hopefully	O
,	O
the	O
findings	O
described	O
here	O
will	O
alert	O
others	O
to	O
the	O
existence	O
of	O
BoTV	O
in	O
cattle	B-SPEC
and	O
its	O
contribution	O
to	O
the	O
diarrheal	O
disease	O
complex	O
.	O

This	O
review	O
also	O
highlights	O
the	O
need	O
for	O
continual	O
vigilance	O
for	O
potential	O
zoonotic	O
viruses	B-SPEC
belonging	O
to	O
the	O
order	B-SPEC
Nidovirales	I-SPEC
,	O
such	O
as	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

Statistically	O
significant	O
decreases	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
were	O
noted	O
in	O
mean	O
attendance	O
at	O
peak	O
-	O
versus	O
pre	O
-	O
and	O
early	O
-	O
epidemic	O
stages	O
for	O
patients	O
with	O
cardiovascular	O
disease	O
,	O
inflammatory	O
or	O
functional	O
bowel	O
disease	O
,	O
endocrine	O
disease	O
,	O
dizziness	O
or	O
vertigo	B-SPEC
,	O
or	O
trauma	O
.	O

A	O
meta	B-SPEC
-	O
analysis	O
of	O
5	O
comparative	O
studies	O
suggests	O
that	O
a	O
dose	O
of	O
200	O
mg	O
/	O
kg	O
of	O
poractant	O
alfa	O
is	O
associated	O
with	O
lower	O
mortality	O
compared	O
with	O
100	O
mg	O
/	O
kg	O
of	O
beractant	O
.	O

TITLE	O
:	O
Phylogenetic	O
and	O
recombination	O
analysis	O
of	O
coronavirus	B-SPEC
HKU1	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
from	O
patients	O
with	O
pneumonia	O
.	O

TITLE	O
:	O
Cross	O
-	O
species	B-SPEC
transfer	O
of	O
viruses	B-SPEC
:	O
implications	O
for	O
the	O
use	O
of	O
viral	O
vectors	O
in	O
biomedical	O
research	O
,	O
gene	O
therapy	O
and	O
as	O
live	O
-	O
virus	B-SPEC
vaccines	O
.	O

Recent	O
examples	O
of	O
viruses	B-SPEC
that	O
have	O
crossed	O
the	O
species	B-SPEC
barrier	O
from	O
animal	B-SPEC
reservoirs	O
to	O
humans	B-SPEC
are	O
hantavirus	B-SPEC
,	O
haemorrhagic	O
fever	O
viruses	B-SPEC
,	O
arboviruses	O
,	O
Nipah	O
and	O
Hendra	O
viruses	B-SPEC
,	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
AI	O
),	O
monkeypox	B-SPEC
virus	I-SPEC
,	O
and	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

IV	O
-	O
injectable	O
,	O
purified	O
,	O
and	O
concentrated	O
human	B-SPEC
SARS	O
hyperimmune	O
globulins	O
were	O
prepared	O
from	O
pooled	O
convalescent	O
plasma	O
samples	O
,	O
which	O
are	O
ready	O
to	O
be	O
further	O
evaluated	O
.	O

Notably	O
,	O
the	O
cellular	O
receptor	O
for	O
the	O
virus	B-SPEC
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
was	O
expressed	O
at	O
similar	O
levels	O
on	O
Vero	O
E6	O
and	O
CaCo	O
-	O
2	O
cells	O
,	O
but	O
at	O
undetectable	O
levels	O
on	O
OL	O
and	O
C6	O
cells	O
.	O

High	O
IgG	O
levels	O
were	O
detected	O
in	O
mice	B-SPEC
immunized	O
with	O
intraperitoneal	O
(	O
i	O
.	O
p	O
.)	O
recombinant	O
spike	O
polypeptide	O
generated	O
by	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
S	O
-	O
peptide	O
),	O
mice	B-SPEC
primed	O
with	O
intramuscular	O
(	O
i	O
.	O
m	O
.)	O
tPA	O
-	O
optimize800	O
DNA	O
vaccine	O
(	O
tPA	O
-	O
S	O
-	O
DNA	O
)	O
and	O
boosted	O
with	O
i	O
.	O
p	O
.	O

S	O
-	O
peptide	O
,	O
and	O
mice	B-SPEC
primed	O
with	O
oral	O
live	O
-	O
attenuated	O
S	O
.	O
typhimurium	O
that	O
contained	O
CTLA4HingeSARS800	O
DNA	O
vaccine	O
(	O
Salmonella	B-SPEC
-	O
tPA	O
-	O
S	O
-	O
DNA	O
)	O
and	O
boosted	O
with	O
i	O
.	O
p	O
.	O

ABSTRACT	O
:	O
The	O
proteolytic	O
processing	O
of	O
polyproteins	O
by	O
the	O
3CL	O
protease	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
is	O
essential	O
for	O
the	O
viral	O
propagation	O
.	O

Breed	O
,	O
sex	O
and	O
reproductive	O
status	O
of	O
affected	O
cats	B-SPEC
were	O
compared	O
to	O
the	O
general	O
cat	B-SPEC
population	O
and	O
to	O
mixed	O
breed	O
cats	B-SPEC
evaluated	O
during	O
the	O
same	O
period	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
report	O
clinical	O
,	O
radiological	O
and	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
findings	O
in	O
patients	O
with	O
pulmonary	O
manifestations	O
of	O
HIV	B-SPEC
-	O
associated	O
multicentric	O
Castleman	O
'	O
s	O
disease	O
(	O
MCD	O
).	O

BAL	O
analysis	O
showed	O
hypercellularity	O
(	O
n	O
=	O
6	O
)	O
and	O
/	O
or	O
lymphocytosis	O
(	O
n	O
=	O
6	O
),	O
and	O
human	B-SPEC
herpesvirus	I-SPEC
-	O
8	O
DNA	O
was	O
detected	O
in	O
two	O
out	O
of	O
two	O
cases	O
.	O

Virulence	O
assays	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
(	O
H	O
-	O
2d	O
),	O
which	O
do	O
not	O
recognize	O
the	O
S510	O
epitope	O
,	O
revealed	O
that	O
attenuation	O
of	O
the	O
epitope	O
escape	O
mutants	O
was	O
not	O
due	O
to	O
the	O
loss	O
of	O
a	O
pathogenic	O
immune	O
response	O
directed	O
against	O
the	O
S510	O
epitope	O
.	O

TITLE	O
:	O
Detection	O
of	O
human	B-SPEC
coronavirus	I-SPEC
-	O
NL63	O
in	O
children	O
in	O
Japan	O
.	O

Of	O
419	O
specimens	O
that	O
were	O
negative	O
for	O
common	O
respiratory	O
viruses	B-SPEC
,	O
5	O
were	O
positive	O
for	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
,	O
and	O
these	O
specimens	O
were	O
all	O
collected	O
in	O
the	O
first	O
3	O
months	O
of	O
2003	O
.	O

TITLE	O
:	O
Sequence	O
analysis	O
and	O
structural	O
prediction	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nsp5	O
.	O

Results	O
obtained	O
by	O
the	O
recombinant	O
S	O
(	O
rS	O
)-	O
based	O
IgG	O
ELISA	O
using	O
the	O
regenerated	O
S	O
prepared	O
by	O
dialysis	B-SPEC
with	O
decreasing	O
concentrations	O
of	O
urea	O
or	O
direct	O
addition	O
of	O
different	O
coating	O
buffers	O
,	O
followed	O
by	O
addition	O
of	O
different	O
regeneration	O
buffer	O
,	O
identified	O
4	O
M	O
urea	O
and	O
1	O
M	O
sarcosine	O
for	O
plate	O
coating	O
and	O
no	O
regeneration	O
buffer	O
as	O
the	O
most	O
optimal	O
conditions	O
for	O
antibody	O
detection	O
.	O

To	O
identify	O
inapparent	O
SARS	O
-	O
CoV	O
infections	O
,	O
serum	O
samples	O
collected	O
from	O
health	O
care	O
workers	O
(	O
HCWs	O
)	O
in	O
Vietnam	O
were	O
screened	O
by	O
the	O
(	O
N	O
)	O
Delta	O
(	O
121	O
)	O
protein	O
-	O
based	O
ELISA	O
,	O
and	O
positive	O
samples	O
were	O
confirmed	O
by	O
a	O
virus	B-SPEC
neutralization	O
test	O
.	O

The	O
combination	O
of	O
hypoxia	O
with	O
anemia	B-SPEC
was	O
thus	O
significantly	O
associated	O
with	O
a	O
higher	O
mortality	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

TITLE	O
:	O
Augmentation	O
of	O
immune	O
responses	O
to	O
SARS	O
coronavirus	B-SPEC
by	O
a	O
combination	O
of	O
DNA	O
and	O
whole	O
killed	O
virus	B-SPEC
vaccines	O
.	O

These	O
results	O
demonstrate	O
that	O
combination	O
of	O
the	O
DNA	O
vaccine	O
and	O
the	O
whole	O
killed	O
virus	B-SPEC
vaccine	O
can	O
be	O
used	O
to	O
enhance	O
the	O
magnitude	O
and	O
change	O
the	O
bias	B-SPEC
of	O
the	O
immune	O
responses	O
to	O
SARS	O
-	O
CoV	O
.	O

Notably	O
,	O
injection	O
of	O
SARS	O
-	O
CoV	O
Spike	O
into	O
mice	B-SPEC
worsens	O
acute	O
lung	O
failure	O
in	O
vivo	O
that	O
can	O
be	O
attenuated	O
by	O
blocking	O
the	O
renin	O
-	O
angiotensin	O
pathway	O
.	O

Suspicious	O
areas	O
are	O
in	O
South	O
East	O
Asia	O
,	O
where	O
living	O
conditions	O
of	O
birds	B-SPEC
,	O
mammals	B-SPEC
and	O
human	B-SPEC
beings	O
are	O
so	O
close	O
that	O
there	O
are	O
always	O
risks	O
of	O
viral	O
infection	O
.	O

RESULTS	O
:	O
Salmonella	B-SPEC
enterica	I-SPEC
and	O
Brachyspira	B-SPEC
spp	O
were	O
not	O
common	O
,	O
whereas	O
other	O
pathogens	O
such	O
as	O
canine	O
coronavirus	B-SPEC
and	O
Helicobacter	B-SPEC
spp	O
were	O
common	O
among	O
the	O
dogs	B-SPEC
that	O
were	O
surveyed	O
.	O

ABSTRACT	O
:	O
gammadelta	O
T	O
cells	O
mediate	O
demyelination	O
in	O
athymic	O
(	O
nude	O
)	O
mice	B-SPEC
infected	O
with	O
the	O
neurotropic	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
JHM	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	B-SPEC
)	O
known	O
as	O
SARS	O
-	O
CoV	B-SPEC
,	O
is	O
a	O
contagious	O
and	O
life	O
-	O
threatening	O
respiratory	O
illness	O
with	O
pneumocytes	O
as	O
its	O
main	O
target	O
.	O

TITLE	O
:	O
Inhibition	O
,	O
escape	O
,	O
and	O
attenuated	O
growth	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
treated	O
with	O
antisense	O
morpholino	O
oligomers	O
.	O

In	O
this	O
study	O
,	O
we	O
defined	O
the	O
mechanism	O
and	O
extent	O
of	O
lipid	O
raft	O
involvement	O
in	O
MHV	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Recent	O
experiences	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
the	O
US	O
smallpox	B-SPEC
vaccination	O
program	O
have	O
demonstrated	O
the	O
vulnerability	O
of	O
healthcare	O
workers	O
to	O
occupationally	O
acquired	O
infectious	O
diseases	O
.	O

Rats	B-SPEC
were	O
immunized	O
either	O
subcutaneously	O
or	O
intranasally	O
with	O
Ad	O
-	O
S	O
(	O
N	O
)	O
once	O
a	O
week	O
for	O
three	O
consecutive	O
weeks	O
.	O

Nasopharyngeal	O
aspirates	O
(	O
NPA	O
)	O
were	O
taken	O
from	O
306	O
pediatric	O
patients	O
during	O
the	O
winter	O
-	O
spring	O
season	O
2003	O
-	O
2004	O
,	O
and	O
examined	O
for	O
conventional	O
respiratory	O
viruses	B-SPEC
by	O
direct	O
fluorescent	O
staining	O
and	O
cell	O
culture	O
,	O
while	O
human	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
metapneumovirus	I-SPEC
were	O
sought	O
by	O
RT	O
-	O
PCR	O
.	O

CONCLUSIONS	O
:	O
(	O
i	O
)	O
Human	B-SPEC
metapneumovirus	I-SPEC
is	O
a	O
major	O
viral	O
pathogen	O
in	O
the	O
Italian	O
pediatric	O
patient	O
population	O
;	O
(	O
ii	O
)	O
the	O
severity	O
of	O
lower	O
respiratory	O
tract	O
infections	O
approaches	O
that	O
of	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
;	O
(	O
iii	O
)	O
there	O
are	O
preliminary	O
indications	O
that	O
the	O
duration	O
of	O
virus	B-SPEC
excretion	O
may	O
reach	O
2	O
-	O
3	O
weeks	O
and	O
that	O
the	O
level	O
of	O
viral	O
load	O
in	O
NPA	O
correlates	O
with	O
the	O
clinical	O
stage	O
of	O
human	B-SPEC
metapneumovirus	I-SPEC
infection	O
.	O

However	O
,	O
SARS	O
-	O
CoV	O
membrane	O
protein	O
seems	O
to	O
be	O
more	O
sensitive	O
to	O
heat	O
treatment	O
,	O
since	O
the	O
membrane	O
protein	O
of	O
MHV	B-SPEC
-	O
JHM	O
,	O
another	O
member	O
of	O
the	O
Coronaviridae	B-SPEC
,	O
would	O
not	O
aggregate	O
after	O
the	O
same	O
treatment	O
.	O

RESULTS	O
:	O
A	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
was	O
designed	O
in	O
the	O
nsp11	O
region	O
of	O
the	O
replicase	O
1B	O
domain	O
of	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
.	O

ABSTRACT	O
:	O
A	O
capture	O
enzyme	O
-	O
enhanced	O
chemiluminescence	O
immunoassay	O
(	O
ECLIA	O
)	O
based	O
on	O
three	O
specific	O
monoclonal	O
antibodies	O
to	O
detect	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
the	O
serial	O
serum	O
samples	O
from	O
SARS	O
patients	O
was	O
developed	O
.	O

TITLE	O
:	O
Variations	O
in	O
the	O
nucleocapsid	O
protein	O
gene	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
isolated	O
in	O
Korea	O
.	O

The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
genes	O
of	O
the	O
various	O
IBVs	O
were	O
amplified	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
were	O
cloned	O
and	O
sequenced	O
,	O
and	O
the	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
were	O
compared	O
with	O
published	O
sequences	O
for	O
non	O
-	O
Korean	O
IBV	B-SPEC
strains	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
deduced	O
N	O
protein	O
amino	O
acid	O
sequences	O
resulted	O
in	O
the	O
segregation	O
of	O
Korean	O
IBV	B-SPEC
isolates	O
into	O
three	O
different	O
clusters	O
,	O
with	O
cluster	O
assignments	O
differing	O
for	O
some	O
of	O
the	O
isolates	O
from	O
those	O
obtained	O
with	O
analysis	O
of	O
the	O
S1	O
glycoprotein	O
.	O

Feline	B-SPEC
leukaemia	O
virus	B-SPEC
(	O
FeLV	O
)	O
may	O
play	O
a	O
role	O
in	O
lymphomagenesis	O
,	O
even	O
in	O
cats	B-SPEC
diagnosed	O
as	O
uninfected	O
using	O
conventional	O
criteria	O
.	O

Conversely	O
,	O
canine	O
enteric	B-SPEC
coronavirus	I-SPEC
(	O
CECV	O
)	O
shows	O
considerable	O
genetic	O
and	O
antigenic	O
diversity	O
but	O
causes	O
only	O
mild	O
,	O
self	O
-	O
limiting	O
diarrhoea	O
in	O
puppies	O
.	O

TITLE	O
:	O
Autoantibodies	O
against	O
human	B-SPEC
epithelial	O
cells	O
and	O
endothelial	O
cells	O
after	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
infection	O
.	O

In	O
this	O
study	O
,	O
the	O
development	O
of	O
autoantibodies	O
against	O
human	B-SPEC
epithelial	O
cells	O
and	O
endothelial	O
cells	O
in	O
patients	O
with	O
SARS	O
at	O
different	O
time	O
periods	O
(	O
the	O
first	O
week	O
:	O
phase	O
I	O
,	O
1	O
month	O
after	O
the	O
disease	O
onset	O
:	O
phase	O
II	O
/	O
phase	O
III	O
)	O
were	O
investigated	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
the	O
only	O
phosphorylated	O
structural	O
protein	O
of	O
the	O
coronavirus	B-SPEC
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
).	O

Whilst	O
serine	O
9	O
was	O
present	O
in	O
a	O
non	O
-	O
conserved	O
domain	O
,	O
serines	O
156	O
,	O
254	O
and	O
256	O
were	O
localized	O
close	O
to	O
highly	O
conserved	O
secondary	O
structural	O
elements	O
within	O
the	O
central	O
domain	O
of	O
coronavirus	B-SPEC
N	O
proteins	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
contains	O
a	O
single	O
spike	O
(	O
S	O
)	O
protein	O
,	O
which	O
binds	O
to	O
its	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
induces	O
membrane	O
fusion	O
and	O
serves	O
as	O
a	O
neutralizing	O
antigen	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
type	O
I	O
strain	O
from	O
a	O
cat	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
by	O
RT	O
-	O
pCR	O
and	O
phylogenetic	O
analysis	O
.	O

Lesions	O
typical	O
of	O
a	O
mixed	O
form	O
(	O
effusive	O
and	O
non	O
-	O
effusive	O
)	O
of	O
FIP	O
were	O
observed	O
and	O
by	O
RT	O
-	O
PCR	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
type	O
I	O
strain	O
was	O
detected	O
in	O
several	O
tissues	O
.	O

ABSTRACT	O
:	O
To	O
study	O
whether	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
could	O
be	O
excreted	O
from	O
digestive	O
system	O
.	O

To	O
exploit	O
a	O
new	O
strategy	O
to	O
fight	O
this	O
disease	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
interference	O
RNA	O
(	O
RNAi	O
)	O
on	O
the	O
virus	B-SPEC
infection	O
and	O
replication	O
with	O
3	O
-(	O
4	O
,	O
5	O
-	O
dimethyl	O
-	O
2	O
-	O
thiazolyl	O
)-	O
2	O
,	O
5	O
-	O
diphenyltetrazolium	O
bromide	O
(	O
MTT	O
),	O
plaque	O
-	O
forming	O
,	O
Western	O
-	O
blot	O
and	O
real	O
-	O
time	O
PCR	O
assays	O
.	O

While	O
concentrations	O
of	O
sTNFR2	O
proteins	O
were	O
elevated	O
in	O
both	O
BALB	O
/	O
c	O
(	O
p	O
<	O
0	O
.	O
00005	O
)	O
and	O
CD	O
-	O
1	O
(	O
p	O
<	O
0	O
.	O
005	O
)	O
mice	B-SPEC
compared	O
to	O
controls	O
,	O
concentrations	O
were	O
higher	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
(	O
p	O
<	O
0	O
.	O
0005	O
).	O

In	O
addition	O
,	O
we	O
provided	O
evidence	O
for	O
evolutionary	O
reclassification	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
results	O
provide	O
important	O
insights	O
into	O
the	O
biochemical	O
properties	O
of	O
the	O
coronaviral	O
PLP	O
family	B-SPEC
and	O
a	O
promising	O
therapeutic	O
way	O
to	O
fight	O
SARS	O
-	O
CoV	O
.	O

We	O
developed	O
an	O
attenuated	O
VSV	O
recombinant	O
(	O
VSV	O
-	O
S	O
)	O
expressing	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
(	O
S	O
)	O
protein	O
.	O

Mice	B-SPEC
vaccinated	O
with	O
VSV	O
-	O
S	O
developed	O
SARS	O
-	O
neutralizing	O
antibody	O
and	O
were	O
able	O
to	O
control	O
a	O
challenge	O
with	O
SARS	O
-	O
CoV	O
performed	O
at	O
1	O
month	O
or	O
4	O
months	O
after	O
a	O
single	O
vaccination	O
.	O

Based	O
on	O
the	O
potent	O
vasoactive	O
role	O
of	O
PGD	O
(	O
2	O
),	O
it	O
appears	O
that	O
the	O
chicken	B-SPEC
HG	O
is	O
a	O
site	O
of	O
active	O
mucosal	O
immunity	O
partially	O
mediated	O
by	O
PGD	O
(	O
2	O
)	O
synthesized	O
by	O
H	O
-	O
PGDS	O
in	O
the	O
gland	O
.	O

TITLE	O
:	O
Nucleolar	O
localization	O
of	O
non	O
-	O
structural	O
protein	O
3b	O
,	O
a	O
protein	O
specifically	O
encoded	O
by	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
As	O
recent	O
events	O
involving	O
SARS	O
and	O
bird	B-SPEC
flu	O
have	O
shown	O
,	O
foreign	O
travel	O
can	O
be	O
a	O
hazardous	O
undertaking	O
.	O

TITLE	O
:	O
Fatal	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
infection	O
in	O
Darier	O
disease	O
under	O
corticotherapy	O
.	O

Humans	B-SPEC
infected	O
with	O
the	O
etiological	O
agent	O
,	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
primarily	O
present	O
with	O
pneumonitis	O
but	O
may	O
also	O
develop	O
hepatic	O
,	O
gastrointestinal	O
,	O
and	O
renal	O
pathology	O
.	O

All	O
animals	B-SPEC
developed	O
a	O
multifocal	O
mononuclear	O
cell	O
interstitial	O
pneumonitis	O
,	O
accompanied	O
by	O
multinucleated	O
syncytial	O
cells	O
,	O
edema	O
,	O
and	O
bronchiolitis	O
in	O
most	O
animals	B-SPEC
.	O

Hepatic	O
inflammation	O
was	O
observed	O
in	O
most	O
animals	B-SPEC
,	O
predominantly	O
as	O
a	O
multifocal	O
lymphocytic	O
hepatitis	O
accompanied	O
by	O
necrosis	O
of	O
individual	O
hepatocytes	O
.	O

One	O
patient	O
was	O
screened	O
to	O
have	O
all	O
three	O
criteria	O
but	O
during	O
consultation	O
,	O
the	O
contact	O
history	O
was	O
found	O
to	O
be	O
unrelated	O
to	O
the	O
known	O
""""	O
hot	O
spots	B-SPEC
"""."	O

In	O
this	O
study	O
,	O
infection	O
kinetics	O
(	O
titres	O
and	O
antigen	O
expression	O
)	O
of	O
FIPV	O
79	O
-	O
1146	O
,	O
and	O
FECV	B-SPEC
79	O
-	O
1683	O
,	O
were	O
determined	O
in	O
peripheral	O
blood	O
monocytes	O
from	O
3	O
donor	O
cats	B-SPEC
and	O
compared	O
to	O
those	O
in	O
Crandell	O
feline	B-SPEC
kidney	O
(	O
CrFK	O
)	O
cells	O
.	O

Monocytes	O
from	O
1	O
cat	B-SPEC
were	O
resistant	O
to	O
both	O
FIPV	O
-	O
and	O
FECV	B-SPEC
-	O
infection	O
.	O

TITLE	O
:	O
Peptide	O
domain	O
involved	O
in	O
the	O
interaction	O
between	O
membrane	O
protein	O
and	O
nucleocapsid	O
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
contrast	O
to	O
the	O
relatively	O
ubiquitous	O
angiotensin	O
-	O
converting	O
enzyme	O
(	O
ACE	O
),	O
expression	O
of	O
the	O
mammalian	B-SPEC
ACE	O
homologue	O
,	O
ACE2	O
,	O
was	O
initially	O
described	O
in	O
the	O
heart	O
,	O
kidney	O
and	O
testis	O
.	O

TITLE	O
:	O
Cutaneous	O
lesions	O
associated	O
with	O
coronavirus	B-SPEC
-	O
induced	O
vasculitis	O
in	O
a	O
cat	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
and	O
concurrent	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
This	O
report	O
describes	O
a	O
clinical	O
case	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
with	O
multisystemic	O
involvement	O
,	O
including	O
multiple	O
nodular	O
cutaneous	O
lesions	O
,	O
in	O
a	O
cat	B-SPEC
that	O
was	O
co	O
-	O
infected	O
with	O
feline	B-SPEC
coronavirus	B-SPEC
and	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
.	O

Long	O
-	O
term	O
corticotherapy	O
,	O
chronic	O
immune	O
diseases	O
,	O
fever	O
of	O
38	O
degrees	O
C	O
or	O
higher	O
,	O
white	O
blood	O
cell	O
count	O
,	O
pulse	O
rate	O
,	O
FIM	O
,	O
SIRS	O
,	O
sepsis	B-SPEC
,	O
CRP	O
of	O
3	O
mg	O
/	O
mL	O
or	O
higher	O
,	O
and	O
PCT	O
of	O
0	O
.	O
5	O
ng	O
/	O
mL	O
or	O
higher	O
were	O
associated	O
with	O
an	O
infection	O
at	O
admission	O
.	O

TITLE	O
:	O
Serine	O
-	O
scanning	O
mutagenesis	O
studies	O
of	O
the	O
C	O
-	O
terminal	O
heptad	O
repeats	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
S	O
glycoprotein	O
highlight	O
the	O
important	O
role	O
of	O
the	O
short	O
helical	O
region	O
.	O

TITLE	O
:	O
Identification	O
of	O
immunodominant	O
epitopes	O
on	O
the	O
membrane	O
protein	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
.	O

One	O
PFU	O
of	O
SARS	O
coronavirus	B-SPEC
was	O
estimated	O
to	O
be	O
258	O
+/-	O

TITLE	O
:	O
Coordinate	O
induction	O
of	O
IFN	O
-	O
alpha	O
and	O
-	O
gamma	O
by	O
SARS	O
-	O
CoV	O
also	O
in	O
the	O
absence	O
of	O
virus	B-SPEC
replication	O
.	O

In	O
the	O
lipopolysaccharide	O
group	O
,	O
DSMSS	O
measurements	O
of	O
erythrocyte	O
velocity	O
and	O
hemoglobin	O
oxygenation	O
in	O
single	O
capillaries	O
were	O
decreased	O
significantly	O
(	O
vs	O
.	O
control	O
p	O
<	O
.	O
05	O
,	O
vs	O
.	O
sivelestat	O
p	O
<	O
.	O
01	O
),	O
whereas	O
tissue	O
blood	O
flow	O
and	O
erythrocyte	O
velocity	O
measurements	O
from	O
laser	B-SPEC
-	O
Doppler	O
flowmeter	O
were	O
increased	O
significantly	O
(	O
vs	O
.	O
control	O
p	O
<	O
.	O
05	O
,	O
vs	O
.	O
sivelestat	O
p	O
<	O
.	O
01	O
).	O

The	O
method	O
will	O
be	O
helpful	O
for	O
the	O
early	O
detection	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Pathology	O
of	O
guinea	B-SPEC
pigs	I-SPEC
experimentally	O
infected	O
with	O
a	O
novel	O
reovirus	B-SPEC
and	O
coronavirus	B-SPEC
isolated	O
from	O
SARS	O
patients	O
.	O

This	O
guinea	B-SPEC
pig	I-SPEC
model	O
may	O
provide	O
a	O
useful	O
animal	B-SPEC
model	O
for	O
SARS	O
.	O

ReoV	O
was	O
detected	O
in	O
pneumonic	O
tissue	O
by	O
virus	B-SPEC
isolation	O
and	O
RT	O
-	O
PCR	O
.	O

The	O
macaques	B-SPEC
infected	O
with	O
the	O
newly	O
isolated	O
reovirus	B-SPEC
developed	O
a	O
fever	O
,	O
diffuse	O
alveolar	O
damage	O
and	O
pulmonary	O
interstitial	O
inflammation	O
similar	O
to	O
that	O
noted	O
in	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
This	O
contribution	O
reviews	O
the	O
synthesis	O
of	O
a	O
range	O
of	O
experimental	O
drugs	O
designed	O
for	O
and	O
aiming	O
at	O
antiviral	O
chemotherapy	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)-	O
induced	O
human	B-SPEC
disease	O
conditions	O
.	O

In	O
summary	O
,	O
at	O
least	O
one	O
selected	O
compound	O
of	O
the	O
synthesized	O
test	O
materials	O
represents	O
an	O
interesting	O
drug	O
candidate	O
for	O
treatment	O
of	O
SARS	O
-	O
CoV	O
-	O
induced	O
human	B-SPEC
disease	O
(	O
SARS	O
).	O

Of	O
the	O
300	O
samples	O
,	O
28	O
(	O
9	O
.	O
3	O
%)	O
were	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

A	O
fragment	O
of	O
the	O
spike	O
protein	O
gene	O
was	O
sequenced	O
to	O
determine	O
the	O
variety	O
of	O
circulating	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

In	O
this	O
article	O
,	O
the	O
data	O
presented	O
indicate	O
that	O
murine	B-SPEC
skeletal	O
muscle	O
produces	O
potent	O
proinflammatory	O
neutrophil	O
and	O
macrophage	O
chemokines	O
during	O
reperfusion	O
,	O
but	O
not	O
during	O
ischemia	O
.	O

Several	O
zoonotic	O
paramyxoviruses	O
,	O
including	O
Nipah	O
and	O
Hendra	O
viruses	B-SPEC
,	O
have	O
emerged	O
as	O
occasional	O
causes	O
of	O
sever	O
outbreaks	O
of	O
respiratory	O
tract	O
illness	O
in	O
children	O
and	O
adults	O
.	O

TITLE	O
:	O
A	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
-	O
specific	O
protein	O
enhances	O
virulence	O
of	O
an	O
attenuated	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

To	O
develop	O
an	O
alternative	O
system	O
for	O
the	O
study	O
of	O
SARS	O
-	O
CoV	O
,	O
we	O
introduced	O
individual	O
SARS	O
-	O
CoV	O
genes	O
(	O
open	O
reading	O
frames	O
[	O
ORFs	O
])	O
into	O
the	O
genome	O
of	O
an	O
attenuated	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
one	O
of	O
the	O
four	O
structural	O
proteins	O
of	O
the	O
virus	B-SPEC
and	O
is	O
predicted	O
to	O
be	O
a	O
46	O
-	O
kDa	O
phosphoprotein	O
.	O

These	O
data	O
indicate	O
that	O
nuclear	O
localization	O
is	O
not	O
a	O
conserved	O
property	O
among	O
all	O
nidoviruses	B-SPEC
.	O

ABSTRACT	O
:	O
With	O
use	O
of	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
a	O
centrifugation	O
-	O
enhanced	O
viral	O
culture	O
method	O
,	O
we	O
characterized	O
the	O
viruses	B-SPEC
causing	O
acute	O
respiratory	O
infection	O
in	O
adults	O
during	O
an	O
influenza	O
season	O
.	O

Human	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
metapneumovirus	I-SPEC
did	O
not	O
play	O
a	O
substantial	O
role	O
.	O

CONCLUSIONS	O
:	O
Our	O
findings	O
demonstrate	O
that	O
,	O
even	O
during	O
the	O
influenza	O
season	O
,	O
rhinovirus	B-SPEC
and	O
RSV	B-SPEC
are	O
prevalent	O
and	O
must	O
be	O
considered	O
in	O
the	O
differential	O
diagnosis	O
of	O
adult	O
acute	O
respiratory	O
infection	O
before	O
prescribing	O
antiviral	O
medication	O
.	O

By	O
comparing	O
the	O
death	O
rates	O
of	O
SARS	O
patients	O
in	O
the	O
different	O
regions	O
,	O
it	O
was	O
found	O
that	O
the	O
death	O
rate	O
caused	O
by	O
the	O
viruses	B-SPEC
of	O
the	O
genotype	O
C	O
was	O
lower	O
than	O
that	O
of	O
the	O
genotype	O
T	O
.	O
SARS	O
-	O
CoVs	O
might	O
originate	O
from	O
an	O
unknown	O
ancestor	O
.	O

RESULTS	O
:	O
We	O
report	O
,	O
however	O
,	O
that	O
chloroquine	O
has	O
strong	O
antiviral	O
effects	O
on	O
SARS	O
-	O
CoV	O
infection	O
of	O
primate	B-SPEC
cells	O
.	O

TITLE	O
:	O
Anti	O
-	O
SARS	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
effects	O
of	O
Isatis	B-SPEC
indigotica	I-SPEC
root	O
and	O
plant	B-SPEC
-	O
derived	O
phenolic	O
compounds	O
.	O

ABSTRACT	O
:	O
The	O
3C	O
-	O
like	O
protease	O
(	O
3CLpro	O
)	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
mediates	O
the	O
proteolytic	O
processing	O
of	O
replicase	O
polypeptides	O
1a	O
and	O
1ab	O
into	O
functional	O
proteins	O
,	O
becoming	O
an	O
important	O
target	O
for	O
the	O
drug	O
development	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
caused	O
by	O
a	O
newly	O
identified	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2003	O
.	O

During	O
the	O
three	O
winters	O
of	O
1999	O
-	O
2000	O
,	O
2000	O
-	O
2001	O
,	O
and	O
2001	O
-	O
2002	O
,	O
of	O
the	O
1	O
,	O
226	O
(	O
23	O
.	O
3	O
%)	O
direct	O
fluorescent	O
assay	O
-	O
positive	O
nasal	O
aspirates	O
from	O
children	O
admitted	O
to	O
hospital	O
,	O
788	O
were	O
positive	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
228	O
for	O
influenza	B-SPEC
virus	I-SPEC
,	O
133	O
for	O
parainfluenza	O
virus	B-SPEC
,	O
and	O
77	O
for	O
adenovirus	B-SPEC
.	O

Predisposing	O
events	O
included	O
sepsis	B-SPEC
(	O
3	O
patients	O
),	O
pneumomia	O
(	O
7	O
patients	O
),	O
pancreatitis	O
(	O
1	O
patient	O
)	O
and	O
two	O
children	O
with	O
other	O
infections	O
.	O

CoV	O
main	O
proteases	O
(	O
M	O
(	O
pro	O
)	O
s	O
),	O
which	O
are	O
key	O
enzymes	O
in	O
viral	O
gene	O
expression	O
and	O
replication	O
,	O
were	O
revealed	O
to	O
share	O
a	O
highly	O
conservative	O
substrate	O
-	O
recognition	O
pocket	O
by	O
comparison	O
of	O
four	O
crystal	O
structures	O
and	O
a	O
homology	O
model	O
representing	O
all	O
three	O
genetic	O
clusters	O
of	O
the	O
genus	B-SPEC
Coronavirus	B-SPEC
.	O

In	O
this	O
paper	O
,	O
we	O
review	O
the	O
current	O
status	O
of	O
the	O
main	O
technologies	O
used	O
to	O
produce	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
from	O
the	O
B	O
cells	O
of	O
antigen	O
-	O
sensitized	O
animals	B-SPEC
.	O

These	O
methods	O
have	O
inherent	O
advantages	O
and	O
limitations	O
but	O
have	O
many	O
common	O
aspects	O
when	O
using	O
immunized	O
rodents	B-SPEC
.	O

Lastly	O
,	O
we	O
provide	O
parameters	O
for	O
the	O
immunisation	O
of	O
mice	B-SPEC
and	O
a	O
classification	O
system	O
which	O
describes	O
the	O
expected	O
outcome	O
for	O
mAb	O
development	O
strategies	O
when	O
using	O
classes	O
of	O
immunogens	O
to	O
generate	O
mAbs	O
with	O
desired	O
activities	O
.	O

The	O
expression	O
of	O
haPrP	O
protein	O
reduced	O
to	O
21	O
.	O
8	O
%	O
in	O
the	O
preparation	O
of	O
Sf9	O
cells	O
infected	O
with	O
recombinant	O
baculovirus	B-SPEC
exposed	O
for	O
5	O
min	O
and	O
was	O
undetectable	O
exposed	O
for	O
20	O
min	O
.	O

In	O
contrast	O
,	O
one	O
PCR	O
product	O
of	O
356	O
bp	O
corresponding	O
to	O
a	O
fragment	O
of	O
N	O
gene	O
was	O
obtained	O
for	O
IBV	B-SPEC
strains	O
and	O
one	O
PCR	O
product	O
of	O
568	O
bp	O
corresponding	O
to	O
a	O
fragment	O
of	O
S	O
gene	O
was	O
obtained	O
for	O
BCoV	O
.	O
There	O
were	O
no	O
PCR	O
products	O
with	O
the	O
same	O
primers	O
for	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
Marek	B-SPEC
'	I-SPEC
s	I-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
turkey	B-SPEC
pox	B-SPEC
virus	I-SPEC
,	O
pigeon	B-SPEC
pox	I-SPEC
virus	I-SPEC
,	O
fowl	O
pox	B-SPEC
virus	I-SPEC
,	O
reovirus	B-SPEC
,	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
enterovirus	B-SPEC
,	O
astrovirus	O
,	O
Salmonella	B-SPEC
enterica	I-SPEC
,	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
and	O
Mycoplasma	B-SPEC
gallisepticum	I-SPEC
.	O

TITLE	O
:	O
The	O
complete	O
sequence	O
of	O
the	O
bovine	B-SPEC
torovirus	I-SPEC
genome	O
.	O

Analysis	O
indicated	O
that	O
the	O
virus	B-SPEC
in	O
palm	O
civets	B-SPEC
at	O
the	O
live	O
-	O
animal	B-SPEC
market	O
had	O
evolved	O
to	O
infect	O
humans	B-SPEC
.	O

Finally	O
,	O
the	O
remaining	O
six	O
SNVs	O
caused	O
four	O
amino	O
acid	O
changes	O
,	O
at	O
positions	O
227	O
,	O
244	O
,	O
344	O
,	O
and	O
778	O
,	O
which	O
resulted	O
in	O
the	O
group	O
of	O
viruses	B-SPEC
responsible	O
for	O
the	O
global	O
epidemic	O
.	O

TITLE	O
:	O
Survival	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Knowledge	O
of	O
the	O
survival	O
characteristics	O
of	O
the	O
virus	B-SPEC
is	O
essential	O
for	O
formulating	O
appropriate	O
infection	O
-	O
control	O
measures	O
.	O

Even	O
at	O
a	O
relatively	O
high	O
concentration	O
(	O
10	O
(	O
4	O
)	O
tissue	O
culture	O
infective	O
doses	O
/	O
mL	O
),	O
the	O
virus	B-SPEC
could	O
not	O
be	O
recovered	O
after	O
drying	O
of	O
a	O
paper	O
request	O
form	O
,	O
and	O
its	O
infectivity	O
was	O
shown	O
to	O
last	O
longer	O
on	O
the	O
disposable	O
gown	O
than	O
on	O
the	O
cotton	B-SPEC
gown	O
.	O

ABSTRACT	O
:	O
A	O
dataset	O
of	O
103	O
SARS	O
-	O
CoV	O
isolates	O
(	O
101	O
human	B-SPEC
patients	O
and	O
2	O
palm	O
civets	B-SPEC
)	O
was	O
investigated	O
on	O
different	O
aspects	O
of	O
genome	O
polymorphism	O
and	O
isolate	O
classification	O
.	O

These	O
results	O
provide	O
further	O
evidence	O
of	O
the	O
importance	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
in	O
ARI	O
in	O
children	O
.	O

TITLE	O
:	O
Protection	O
of	O
mammalian	B-SPEC
cells	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
by	O
equine	B-SPEC
neutralizing	O
antibody	O
.	O

To	O
investigate	O
whether	O
a	O
neutralizing	O
antibody	O
against	O
SARS	O
-	O
CoV	O
raised	O
in	O
an	O
artiodactylous	O
host	O
can	O
have	O
a	O
protective	O
role	O
on	O
primate	B-SPEC
cells	O
,	O
we	O
prepared	O
serum	O
IgGs	O
and	O
their	O
pepsin	O
-	O
digested	O
F	O
(	O
ab	O
')	O
2	O
fragments	O
from	O
horses	B-SPEC
inoculated	O
with	O
purified	O
SARS	O
-	O
CoV	O
(	O
BJ	O
-	O
01	O
strain	O
).	O

The	O
protective	O
effect	O
of	O
the	O
F	O
(	O
ab	O
')	O
2	O
fragments	O
against	O
SARS	O
-	O
CoV	O
infection	O
was	O
determined	O
in	O
cultured	O
Vero	O
E6	O
cells	O
by	O
cytopathic	O
effect	O
(	O
CPE	O
),	O
MTT	O
and	O
plaque	O
-	O
forming	O
assays	O
and	O
in	O
a	O
Balb	O
/	O
c	O
mouse	B-SPEC
model	O
by	O
CPE	O
and	O
quantitative	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Direct	O
template	O
matching	O
reveals	O
a	O
host	O
subcellular	O
membrane	O
gyroid	O
cubic	O
structure	O
that	O
is	O
associated	O
with	O
SARS	O
virus	B-SPEC
.	O

2	O
-	O
D	O
TEM	O
micrographs	O
depicting	O
subcellular	O
membrane	O
changes	O
are	O
associated	O
with	O
subcellular	O
SARS	O
virion	O
particles	O
[	O
Goldsmith	O
CS	O
,	O
Tatti	O
KM	O
,	O
Ksiazek	O
TG	O
et	O
al	O
.	O
Ultra	O
-	O
structural	O
characterization	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
defined	O
the	O
2	O
-	O
D	O
membrane	O
pattern	O
and	O
shape	O
associated	O
with	O
the	O
SARS	O
virus	B-SPEC
infection	O
.	O

TITLE	O
:	O
The	O
interaction	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
non	O
-	O
structural	O
protein	O
10	O
with	O
the	O
cellular	O
oxido	O
-	O
reductase	O
system	O
causes	O
an	O
extensive	O
cytopathic	O
effect	O
.	O

No	O
new	O
respiratory	O
viruses	B-SPEC
were	O
discovered	O
until	O
2001	O
when	O
human	B-SPEC
metapneumovirus	I-SPEC
was	O
found	O
in	O
respiratory	O
specimens	O
from	O
children	O
with	O
bronchiolitis	O
.	O

Respiratory	O
infection	O
has	O
been	O
a	O
considerable	O
problem	O
for	O
humans	B-SPEC
for	O
centuries	O
.	O

ABSTRACT	O
:	O
The	O
210	O
-	O
nucleotide	O
(	O
nt	O
)	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
in	O
the	O
positive	O
-	O
strand	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
genome	O
is	O
predicted	O
to	O
contain	O
four	O
higher	O
-	O
order	B-SPEC
structures	O
identified	O
as	O
stem	O
-	O
loops	O
I	O
to	O
IV	O
,	O
which	O
may	O
function	O
as	O
cis	B-SPEC
-	O
acting	O
elements	O
in	O
genomic	O
RNA	O
replication	O
.	O

We	O
present	O
profiling	O
examples	O
for	O
several	O
positive	O
individuals	O
,	O
including	O
those	O
vaccinated	O
with	O
the	O
smallpox	B-SPEC
and	O
anthrax	B-SPEC
vaccines	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
protein	O
(	O
S	O
)	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
attaches	O
the	O
virus	B-SPEC
to	O
its	O
cellular	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

The	O
structure	O
of	O
the	O
RBD	O
suggests	O
ways	O
to	O
make	O
truncated	O
disulfide	O
-	O
stabilized	O
RBD	O
variants	O
for	O
use	O
in	O
the	O
design	O
of	O
coronavirus	B-SPEC
vaccines	O
.	O

Sequencing	O
and	O
analysis	O
of	O
three	O
bat	B-SPEC
-	O
SARS	O
-	O
CoV	O
genomes	O
from	O
samples	O
collected	O
at	O
different	O
dates	O
showed	O
that	O
bat	B-SPEC
-	O
SARS	O
-	O
CoV	O
is	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
from	O
humans	B-SPEC
and	O
civets	B-SPEC
.	O

The	O
human	B-SPEC
synthetic	O
single	O
-	O
chain	O
fragment	O
variable	O
(	O
scFv	O
)	O
ETH	O
-	O
2	O
phage	O
antibody	O
library	O
was	O
used	O
for	O
the	O
isolation	O
of	O
scFvs	O
against	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
SARS	O
-	O
CoV	O
using	O
a	O
bio	O
panning	O
-	O
based	O
strategy	O
.	O

CONCLUSIONS	O
:	O
The	O
human	B-SPEC
scFv	O
antibodies	O
isolated	O
and	O
described	O
in	O
this	O
study	O
represent	O
useful	O
reagents	O
for	O
rapid	O
detection	O
of	O
N	O
SARS	O
-	O
CoV	O
protein	O
and	O
SARS	O
virus	B-SPEC
particles	O
in	O
infected	O
target	O
cells	O
.	O

Western	O
-	O
blot	O
showed	O
that	O
the	O
recombinant	O
N	O
protein	O
had	O
high	O
specificity	O
against	O
mouse	B-SPEC
-	O
anti	O
-	O
N	O
protein	O
-	O
mAb	O
and	O
SARS	O
positive	O
sera	O
,	O
but	O
had	O
no	O
cross	O
-	O
reaction	O
with	O
normal	O
human	B-SPEC
sera	O
.	O

The	O
Monte	O
Carlo	O
test	O
results	O
demonstrate	O
that	O
the	O
multiple	O
univariate	O
combination	O
methods	O
of	O
Fisher	B-SPEC
and	O
Edgington	O
provide	O
the	O
most	O
robust	O
detection	O
performance	O
across	O
the	O
scenarios	O
tested	O
.	O

SARS	O
is	O
a	O
serious	O
respiratory	O
illness	O
,	O
and	O
its	O
aetiology	O
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

TITLE	O
:	O
Improved	O
detection	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
N	O
gene	O
in	O
faeces	O
of	O
calves	O
infected	O
naturally	O
by	O
a	O
semi	O
-	O
nested	O
PCR	O
assay	O
and	O
an	O
internal	O
control	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
the	O
immunological	O
responses	O
and	O
clinical	O
outcome	O
of	O
coronavirus	B-SPEC
(	O
SARS	O
)	O
infected	O
healthcare	O
workers	O
(	O
HCW	O
)	O
who	O
had	O
been	O
administered	O
with	O
convalescent	O
plasma	O
as	O
a	O
treatment	O
.	O

In	O
order	B-SPEC
to	O
investigate	O
whether	O
these	O
genetic	O
factors	O
might	O
influence	O
susceptibility	O
to	O
infection	O
with	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
Cov	O
)	O
as	O
well	O
as	O
the	O
course	O
and	O
severity	O
of	O
the	O
infection	O
,	O
we	O
evaluated	O
polymorphisms	O
of	O
FcgammaRIIA	O
and	O
MBL	O
genes	O
in	O
DNA	O
samples	O
from	O
a	O
group	O
of	O
approximately	O
180	O
people	O
from	O
Hong	O
Kong	O
who	O
were	O
infected	O
with	O
SARS	O
-	O
Cov	O
.	O

It	O
appeared	O
that	O
the	O
two	O
genes	O
exhibit	O
intrinsic	O
differences	O
,	O
the	O
Renilla	B-SPEC
gene	O
consistently	O
being	O
maintained	O
more	O
stably	O
than	O
the	O
firefly	B-SPEC
gene	O
.	O

Three	O
helices	B-SPEC
(	O
alpha2	O
to	O
alpha4	O
)	O
form	O
a	O
flat	O
up	O
-	O
down	O
-	O
up	O
antiparallel	O
alpha	O
-	O
helix	O
sheet	O
.	O

While	O
significant	O
advances	O
have	O
been	O
made	O
in	O
the	O
development	O
of	O
animal	B-SPEC
models	O
,	O
the	O
practicality	O
of	O
their	O
use	O
may	O
be	O
hampered	O
by	O
a	O
lack	O
of	O
pathological	O
similarity	O
with	O
human	B-SPEC
disease	O
.	O

ABSTRACT	O
:	O
Four	O
-	O
week	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	B-SPEC
were	O
infected	O
with	O
virulent	O
infectious	O
bronchitis	O
virus	B-SPEC
Massachusetts	O
strain	O
M41	O
via	O
the	O
ocular	O
-	O
nasal	O
route	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
a	O
case	O
of	O
acute	O
lung	O
injury	O
following	O
IV	O
injection	O
of	O
peppermint	B-SPEC
oil	O
.	O

MRI	O
and	O
X	O
-	O
ray	B-SPEC
film	O
were	O
taken	O
in	O
all	O
patients	O
including	O
both	O
hips	O
,	O
knees	O
,	O
shoulders	O
,	O
ankles	O
and	O
wrists	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
important	O
for	O
vaccine	O
development	O
.	O

Here	O
we	O
report	O
that	O
species	B-SPEC
of	O
bats	B-SPEC
are	O
a	O
natural	O
host	O
of	O
coronaviruses	O
closely	O
related	O
to	O
those	O
responsible	O
for	O
the	O
SARS	O
outbreak	O
.	O

Many	O
research	O
organizations	O
require	O
screening	O
for	O
viral	O
agents	O
of	O
all	O
cell	O
lines	O
,	O
tumours	O
,	O
sera	O
and	O
other	O
biologicals	O
before	O
implantation	O
or	O
inoculation	O
into	O
animal	B-SPEC
models	O
.	O

SARS	O
-	O
associated	O
coronavirus	B-SPEC
N	O
protein	O
gene	O
was	O
amplified	O
from	O
its	O
genomic	O
RNA	O
by	O
reverse	O
transcript	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
nested	O
-	O
PCR	O
)	O
and	O
cloned	O
into	O
pBAD	O
/	O
Thio	O
-	O
TOPO	O
prokaryotic	O
expression	O
vector	O
.	O

ABSTRACT	O
:	O
Anthrax	B-SPEC
,	O
like	O
tuberculosis	O
,	O
shows	O
a	O
new	O
epidemic	O
spread	O
in	O
industrialized	O
countries	O
,	O
revealing	O
some	O
ambiguous	O
aspects	O
to	O
the	O
disease	O
and	O
providing	O
new	O
challenges	O
to	O
medicine	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
experience	O
of	O
persevering	O
through	O
a	O
difficult	O
time	O
for	O
patients	O
,	O
family	B-SPEC
members	O
of	O
patients	O
,	O
nurses	O
,	O
and	O
allied	O
health	O
professionals	O
during	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
outbreak	O
.	O

van	O
Kaam	O
'	O
s	O
phenomenological	O
research	O
method	O
,	O
with	O
the	O
human	B-SPEC
becoming	O
theory	O
as	O
the	O
theoretical	O
perspective	O
,	O
was	O
used	O
to	O
gather	O
and	O
analyse	O
data	O
from	O
63	O
participants	O
who	O
agreed	O
to	O
describe	O
a	O
situation	O
that	O
illuminated	O
their	O
experience	O
of	O
persevering	O
through	O
a	O
difficult	O
time	O
(	O
either	O
online	O
or	O
using	O
a	O
voicemail	O
system	O
).	O

ABSTRACT	O
:	O
The	O
complete	O
genome	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
reveals	O
the	O
existence	O
of	O
putative	O
proteins	O
unique	O
to	O
SARS	O
-	O
CoV	O
.	O
Identification	O
of	O
their	O
function	O
facilitates	O
a	O
mechanistic	O
understanding	O
of	O
SARS	O
infection	O
and	O
drug	O
development	O
for	O
its	O
treatment	O
.	O

The	O
antigen	O
detection	O
limit	O
for	O
the	O
Con	O
A	O
-	O
S	O
-	O
ELISA	O
was	O
10	O
(	O
5	O
,	O
1	O
)	O
EID	O
(	O
50	O
)/	O
mL	O
.	O
Three	O
homologous	O
and	O
four	O
heterologous	O
IBV	B-SPEC
strains	O
were	O
similarly	O
detected	O
.	O

TITLE	O
:	O
In	O
vivo	O
functional	O
characterization	O
of	O
the	O
SARS	O
-	O
Coronavirus	B-SPEC
3a	O
protein	O
in	O
Drosophila	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
3a	O
locus	O
encodes	O
a	O
274	O
a	O
.	O
a	O
.	O

Misexpression	O
of	O
3a	O
in	O
Drosophila	B-SPEC
caused	O
a	O
dominant	O
rough	O
eye	O
phenotype	O
.	O

To	O
better	O
understand	O
structural	O
and	O
functional	O
characteristics	O
of	O
Nsp15	O
,	O
22	O
mutant	O
versions	O
of	O
Nsp15	O
were	O
produced	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
as	O
His	O
-	O
tagged	O
proteins	O
and	O
purified	O
by	O
metal	O
-	O
affinity	O
and	O
ion	O
-	O
exchange	O
chromatography	O
.	O

In	O
all	O
situations	O
they	O
were	O
significantly	O
more	O
likely	O
to	O
perform	O
mouth	O
-	O
to	O
-	O
mouth	O
ventilation	O
for	O
a	O
family	B-SPEC
member	O
compared	O
with	O
a	O
stranger	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
to	O
withhold	O
mouth	O
-	O
to	O
-	O
mouth	O
ventilation	O
if	O
either	O
vomit	O
or	O
blood	O
were	O
present	O
in	O
the	O
victim	O
'	O
s	O
mouth	O
.	O

TITLE	O
:	O
Risk	O
assessment	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
via	O
in	O
vitro	O
fertilization	O
and	O
embryo	O
transfer	O
by	O
the	O
use	O
of	O
zona	O
-	O
intact	O
and	O
laser	B-SPEC
-	O
microdissected	O
oocytes	O
.	O

In	O
experiment	O
1	O
,	O
10	O
out	O
of	O
14	O
embryo	O
recipients	O
seroconverted	O
to	O
MHV	B-SPEC
and	O
only	O
their	O
offspring	O
(	O
8	O
of	O
19	O
)	O
received	O
maternal	O
antibodies	O
.	O

ABSTRACT	O
:	O
The	O
seriousness	O
of	O
the	O
risk	O
that	O
healthcare	O
workers	O
faced	O
during	O
SARS	O
,	O
and	O
their	O
response	O
of	O
service	O
in	O
the	O
face	O
of	O
this	O
risk	O
,	O
brings	O
to	O
light	O
unrealistic	O
assumptions	O
about	O
duty	O
and	O
risk	O
that	O
informed	O
the	O
debate	O
on	O
duty	O
to	O
care	O
in	O
the	O
early	O
years	O
of	O
HIV	B-SPEC
/	O
AIDS	O
.	O

In	O
this	O
study	O
,	O
we	O
intended	O
to	O
identify	O
potential	O
3CL	O
(	O
pro	O
)-	O
interacting	O
cellular	O
protein	O
(	O
s	O
)	O
using	O
the	O
phage	O
-	O
displayed	O
human	B-SPEC
lung	O
cDNA	O
library	O
.	O

Murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
polyproteins	O
incorporate	O
16	O
protein	O
domains	O
(	O
nsps	O
),	O
with	O
nsp1	O
and	O
nsp2	O
being	O
the	O
most	O
variable	O
among	O
the	O
coronaviruses	O
and	O
having	O
no	O
experimentally	O
confirmed	O
or	O
predicted	O
functions	O
in	O
replication	O
.	O

Infectious	O
MHVDeltansp2	O
and	O
SARSDeltansp2	O
viruses	B-SPEC
recovered	O
from	O
electroporated	O
cells	O
had	O
0	O
.	O
5	O
to	O
1	O
log10	O
reductions	O
in	O
peak	O
titers	O
in	O
single	O
-	O
cycle	O
growth	O
assays	O
,	O
as	O
well	O
as	O
a	O
reduction	O
in	O
viral	O
RNA	O
synthesis	O
that	O
was	O
not	O
specific	O
for	O
any	O
positive	O
-	O
stranded	O
RNA	O
species	B-SPEC
.	O

The	O
Deltansp2	O
mutant	O
viruses	B-SPEC
lacked	O
expression	O
of	O
both	O
nsp2	O
and	O
an	O
nsp2	O
-	O
nsp3	O
precursor	O
,	O
but	O
cleaved	O
the	O
engineered	O
chimeric	O
nsp1	O
-	O
nsp3	O
cleavage	O
site	O
as	O
efficiently	O
as	O
the	O
native	O
nsp1	O
-	O
nsp2	O
cleavage	O
site	O
.	O

SCV	B-SPEC
also	O
failed	O
to	O
induce	O
DC	O
maturation	O
(	O
CD86	O
expression	O
)	O
or	O
enhance	O
major	O
histocompatibility	O
complex	O
class	B-SPEC
II	O
expression	O
.	O

We	O
report	O
the	O
crystal	O
structure	O
of	O
the	O
hexadecameric	O
nsp7	O
-	O
nsp8	O
supercomplex	O
from	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
at	O
2	O
.	O
4	O
-	O
angstroms	O
resolution	O
.	O

This	O
study	O
provides	O
information	O
on	O
the	O
domain	O
structure	O
partition	O
of	O
SARS	O
-	O
CoV	O
N	O
protein	O
and	O
insights	O
into	O
the	O
differing	O
roles	O
of	O
structured	O
and	O
disordered	O
regions	O
in	O
coronavirus	B-SPEC
nucleocapsid	O
proteins	O
.	O

ABSTRACT	O
:	O
To	O
find	O
the	O
most	O
suitable	O
RT	O
-	O
PCR	O
detection	O
method	O
for	O
SARS	O
-	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
detection	O
in	O
both	O
human	B-SPEC
and	O
animals	B-SPEC
,	O
and	O
to	O
study	O
the	O
source	O
of	O
SARS	O
virus	B-SPEC
by	O
investigating	O
the	O
condition	O
of	O
virus	B-SPEC
carried	O
by	O
wild	O
,	O
domestic	O
animals	B-SPEC
and	O
animals	B-SPEC
sold	O
in	O
market	O
.	O

The	O
assay	O
was	O
applied	O
to	O
the	O
early	O
clinic	O
diagnosis	O
&	O
animal	B-SPEC
tracking	O
.	O

368	O
clinical	O
specimens	O
such	O
as	O
the	O
throat	O
swab	O
,	O
serum	O
,	O
feces	O
,	O
and	O
urine	O
from	O
different	O
cases	O
,	O
52	O
cell	O
cultures	O
and	O
50	O
animal	B-SPEC
specimens	O
were	O
detected	O
by	O
the	O
molecular	O
beacon	O
-	O
based	O
PCR	O
.	O

Furthermore	O
,	O
SARS	O
virus	B-SPEC
RNA	O
was	O
detected	O
in	O
feces	O
and	O
in	O
serum	O
during	O
the	O
acute	O
phase	O
.	O

Other	O
forms	O
of	O
infectious	O
disease	O
that	O
district	O
nurses	O
encounter	O
--	O
such	O
as	O
hepatitis	O
B	O
and	O
C	O
and	O
the	O
HIV	B-SPEC
virus	B-SPEC
that	O
are	O
spread	O
through	O
contact	O
with	O
blood	O
or	O
sexual	O
intercourse	O
--	O
rely	O
far	O
more	O
on	O
the	O
infected	O
individual	O
to	O
act	O
responsibly	O
in	O
preventing	O
others	O
from	O
being	O
infected	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
one	O
of	O
the	O
most	O
destructive	O
agents	O
,	O
responsible	O
for	O
the	O
enteric	O
infections	O
that	O
are	O
lethal	O
for	O
suckling	O
piglets	O
,	O
causing	O
enormous	O
economic	O
loss	O
to	O
the	O
porcine	B-SPEC
fostering	O
industry	O
every	O
year	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
has	O
been	O
known	O
to	O
damage	O
multiple	O
organs	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
its	O
impact	O
on	O
the	O
reproductive	O
system	O
.	O

Blinded	O
studies	O
using	O
RNA	O
extracted	O
from	O
various	O
tissues	O
of	O
a	O
SARS	O
-	O
infected	O
individual	O
showed	O
that	O
STAR	O
correctly	O
identified	O
all	O
samples	O
containing	O
SARS	O
virus	B-SPEC
and	O
yielded	O
negative	O
results	O
for	O
non	O
-	O
SARS	O
control	O
samples	O
.	O

This	O
amino	O
acid	O
substitution	O
is	O
due	O
to	O
a	O
single	O
nucleotide	O
mutation	O
in	O
the	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
genome	O
,	O
CAG	O
/	O
A	O
to	O
CAT	B-SPEC
.	O

TITLE	O
:	O
Alterations	O
in	O
cell	O
signaling	O
in	O
sepsis	B-SPEC
.	O

Identification	O
of	O
patients	O
with	O
cellular	O
phenotypes	O
characterized	O
by	O
increased	O
activation	O
of	O
NF	O
-	O
kappa	O
B	O
,	O
Akt	O
,	O
and	O
protein	O
38	O
,	O
as	O
well	O
as	O
discrete	O
patterns	O
of	O
gene	O
activation	O
,	O
may	O
permit	B-SPEC
identification	O
of	O
patients	O
with	O
sepsis	B-SPEC
who	O
are	O
likely	O
to	O
have	O
a	O
worse	O
clinical	O
outcome	O
,	O
thereby	O
permitting	O
early	O
institution	O
of	O
therapies	O
that	O
modulate	O
deleterious	O
signaling	O
pathways	O
before	O
organ	O
system	O
dysfunction	O
develops	O
,	O
reducing	O
morbidity	O
and	O
improving	O
survival	O
.	O

Similar	O
results	O
were	O
obtained	O
for	O
a	O
vaccine	O
made	O
from	O
a	O
Taiwan	O
Group	O
II	O
IBV	B-SPEC
strain	O
.	O

TITLE	O
:	O
Synthesis	O
and	O
activity	O
of	O
an	O
octapeptide	O
inhibitor	O
designed	O
for	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
.	O

The	O
immunization	O
in	O
dogs	B-SPEC
indicated	O
that	O
the	O
recombinant	O
CAV	B-SPEC
-	O
2	O
could	O
effectively	O
induce	O
the	O
specific	O
antibodies	O
against	O
CCV	O
and	O
CAV	B-SPEC
.	O

In	O
order	B-SPEC
to	O
study	O
the	O
mechanisms	O
responsible	O
for	O
their	O
antiviral	O
effects	O
using	O
a	O
photolabeling	O
approach	O
,	O
we	O
have	O
developed	O
photolabeling	O
probes	O
of	O
ribavirin	O
and	O
EICAR	O
,	O
in	O
which	O
an	O
azido	O
group	O
was	O
introduced	O
into	O
the	O
pseudobases	O
of	O
triazole	O
and	O
imidazole	O
,	O
respectively	O
.	O

An	O
X	O
-	O
ray	B-SPEC
crystal	O
structure	O
of	O
our	O
lead	O
inhibitor	O
(	O
4	O
)	O
bound	O
to	O
SARS	O
-	O
3CLpro	O
provided	O
important	O
drug	O
-	O
design	O
templates	O
for	O
the	O
design	O
of	O
small	O
-	O
molecule	O
inhibitors	O
.	O

These	O
neuromuscular	O
disorders	O
in	O
SARS	O
patients	O
were	O
considered	O
as	O
critical	O
illness	O
neuropathy	O
and	O
myopathy	O
,	O
but	O
the	O
possibility	O
of	O
direct	O
attack	O
by	O
SARS	O
coronavirus	B-SPEC
on	O
the	O
nerve	O
and	O
muscle	O
could	O
not	O
be	O
excluded	O
.	O

Among	O
them	O
were	O
the	O
trials	O
that	O
tested	O
the	O
infusion	O
of	O
activated	O
protein	O
C	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
,	O
tight	O
glycemic	O
control	O
in	O
surgical	O
intensive	O
care	O
patients	O
,	O
and	O
use	O
of	O
lung	O
protective	O
mechanical	O
ventilation	O
by	O
using	O
small	O
tidal	O
volumes	O
in	O
patients	O
with	O
acute	O
lung	O
injury	O
.	O

Whereas	O
FECV	B-SPEC
79	O
-	O
1683	O
causes	O
at	O
the	O
most	O
a	O
mild	O
enteritis	O
in	O
young	O
kittens	O
,	O
FIPV	O
79	O
-	O
1146	O
almost	O
invariably	O
induces	O
a	O
lethal	O
peritonitis	O
.	O

ABSTRACT	O
:	O
Only	O
a	O
relatively	O
few	O
mutations	O
in	O
its	O
spike	O
protein	O
allow	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
to	O
switch	O
from	O
a	O
murine	B-SPEC
-	O
restricted	O
tropism	O
to	O
an	O
extended	O
host	O
range	O
by	O
being	O
passaged	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
To	O
express	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
construct	O
its	O
DNA	O
vaccine	O
.	O

The	O
prokaryotic	O
expression	O
vector	O
pQEN	O
containing	O
N	O
gene	O
was	O
constructed	O
and	O
transformed	O
into	O
the	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

We	O
previously	O
reported	O
that	O
concanavalin	O
A	O
-	O
immobilized	O
polystyrene	O
nanospheres	O
(	O
Con	O
A	O
-	O
NS	O
)	O
could	O
efficiently	O
capture	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
particles	O
and	O
intranasal	O
immunization	O
with	O
inactivated	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
-	O
capturing	O
nanospheres	O
(	O
HIV	B-SPEC
-	O
NS	O
)	O
induced	O
vaginal	O
anti	O
-	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
IgA	O
antibody	O
responses	O
in	O
mice	B-SPEC
.	O

The	O
first	O
qualitative	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
tests	O
for	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
were	O
sensitive	O
and	O
capable	O
of	O
detecting	O
1	O
to	O
10	O
genome	O
equivalents	O
.	O

Serological	O
tests	O
included	O
SARS	O
IgG	O
antibody	O
and	O
IgM	O
antibodies	O
against	O
influenza	O
B	O
,	O
parainfluenza	O
virus	B-SPEC
types	O
1	O
-	O
3	O
,	O
adenovirus	B-SPEC
type	O
3	O
,	O
7	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
by	O
using	O
commercial	O
ELISA	O
kits	O
.	O

The	O
preventive	O
efficacy	O
of	O
interferon	O
against	O
four	O
respiratory	O
viruses	B-SPEC
was	O
different	O
,	O
from	O
high	O
to	O
low	O
,	O
the	O
rank	O
was	O
Flu	O
B	O
(	O
66	O
.	O
76	O
%),	O
parainfluenza	O
types	O
1	O
-	O
3	O
(	O
66	O
.	O
75	O
%),	O
RSV	B-SPEC
(	O
39	O
.	O
61	O
%)	O
and	O
adenovirus	B-SPEC
(	O
32	O
.	O
86	O
%).	O

The	O
recombinant	O
human	B-SPEC
interferon	O
alpha	O
-	O
2b	O
for	O
nasal	O
spray	O
could	O
decrease	O
the	O
rates	O
of	O
common	O
respiratory	O
viruses	B-SPEC
infection	O
in	O
the	O
selected	O
population	O
.	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE	O
-	O
2	O
)	O
has	O
been	O
identified	O
as	O
a	O
functional	O
receptor	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
so	O
its	O
gene	O
was	O
cloned	O
and	O
eukaryotic	O
expressed	O
for	O
further	O
insight	O
into	O
mechanisms	O
in	O
SARS	O
-	O
CoV	O
entry	O
and	O
pathogenesis	O
,	O
as	O
well	O
as	O
development	O
of	O
a	O
safe	O
and	O
reliable	O
neutralization	O
assay	O
for	O
SARS	O
-	O
CoV	O
.	O
Total	O
RNA	O
was	O
extracted	O
from	O
right	O
atrial	O
tissue	O
of	O
a	O
patient	O
with	O
right	O
heart	O
failure	O
resected	O
during	O
a	O
valvular	O
replacement	O
surgery	O
by	O
Trizol	O
one	O
-	O
step	O
method	O
,	O
and	O
the	O
full	O
-	O
length	O
ACE	O
-	O
2	O
encoding	O
gene	O
was	O
acquired	O
by	O
RT	O
-	O
nested	O
-	O
PCR	O
.	O

TITLE	O
:	O
Structural	O
insights	O
into	O
SARS	O
coronavirus	B-SPEC
proteins	O
.	O

CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
accounts	O
for	O
2	O
.	O
4	O
%	O
of	O
community	O
-	O
acquired	O
pneumonia	O
,	O
with	O
2	O
genotypes	O
in	O
the	O
study	O
population	O
.	O

TCB	O
and	O
FNAB	O
specimens	O
collected	O
mainly	O
at	O
necropsy	O
from	O
25	O
cats	B-SPEC
with	O
FIP	O
were	O
analyzed	O
.	O

In	O
this	O
study	O
,	O
we	O
present	O
a	O
very	O
sensitive	O
and	O
specific	O
TaqMan	O
-	O
based	O
,	O
real	O
-	O
time	O
quantitative	O
reverse	O
transcriptase	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
for	O
the	O
rapid	O
detection	O
and	O
quantitation	O
of	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
OC43	O
and	O
229E	O
.	O

Despite	O
advances	O
in	O
critical	O
care	O
therapies	O
and	O
infection	O
control	O
practices	O
,	O
severe	O
sepsis	B-SPEC
remains	O
a	O
major	O
health	O
problem	O
,	O
with	O
an	O
estimated	O
mortality	O
rate	O
of	O
30	O
-	O
50	O
%	O
(	O
Ely	O
,	O
Kleinpell	O
,	O
&	O
Goyett	O
,	O
2003	O
).	O

Patient	O
selection	O
bias	B-SPEC
(	O
which	O
patients	O
were	O
transferred	O
and	O
which	O
were	O
not	O
sent	O
to	O
an	O
ICU	O
)	O
also	O
plays	O
a	O
role	O
in	O
ICU	O
survival	O
rates	O
.	O

Antigenic	O
regions	O
with	O
high	O
density	O
of	O
binders	O
"("""	O
antigenic	O
hot	O
-	O
spots	B-SPEC
""")"	O
represent	O
best	O
targets	O
for	O
vaccine	O
design	O
.	O

Molecular	O
modeling	O
studies	O
based	O
on	O
the	O
X	O
-	O
ray	B-SPEC
structures	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
prompted	O
the	O
synthesis	O
of	O
novel	O
analogues	O
which	O
were	O
tested	O
as	O
anti	O
-	O
HIV	B-SPEC
agents	O
.	O

Previous	O
work	O
in	O
our	O
laboratory	O
has	O
identified	O
four	O
proteins	O
which	O
form	O
ribonucleoprotein	O
complexes	O
with	O
the	O
3	O
'-	O
terminal	O
42	O
nucleotides	O
[	O
3	O
'(+)	O
42	O
]	O
of	O
the	O
MHV	B-SPEC
genome	O
.	O

Defective	O
interfering	O
(	O
DI	O
)	O
RNA	O
replication	O
assays	O
have	O
demonstrated	O
a	O
role	O
for	O
the	O
3	O
'(+)	O
42	O
host	O
protein	O
binding	O
element	O
in	O
the	O
MHV	B-SPEC
life	O
cycle	O
.	O

ABSTRACT	O
:	O
Studies	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
demonstrate	O
that	O
the	O
respiratory	O
tract	O
is	O
a	O
major	O
site	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infection	O
and	O
disease	O
morbidity	O
.	O

Angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
the	O
receptor	O
for	O
both	O
the	O
SARS	O
-	O
CoV	O
and	O
the	O
related	O
human	B-SPEC
respiratory	O
coronavirus	B-SPEC
NL63	O
,	O
was	O
expressed	O
in	O
human	B-SPEC
airway	O
epithelia	O
as	O
well	O
as	O
lung	O
parenchyma	O
.	O

Consistent	O
with	O
the	O
expression	O
pattern	O
of	O
ACE2	O
,	O
the	O
entry	O
of	O
SARS	O
-	O
CoV	O
or	O
a	O
lentivirus	B-SPEC
pseudotyped	O
with	O
SARS	O
-	O
CoV	O
S	O
protein	O
in	O
differentiated	O
epithelia	O
was	O
more	O
efficient	O
when	O
applied	O
to	O
the	O
apical	O
surface	O
.	O

All	O
recombinant	O
viruses	B-SPEC
replicated	O
to	O
wild	O
-	O
type	O
levels	O
in	O
the	O
murine	B-SPEC
model	O
,	O
suggesting	O
that	O
either	O
the	O
group	O
-	O
specific	O
ORFs	O
play	O
little	O
role	O
in	O
in	O
vivo	O
replication	O
efficiency	O
or	O
that	O
the	O
mouse	B-SPEC
model	O
is	O
not	O
of	O
sufficient	O
quality	O
for	O
discerning	O
the	O
role	O
of	O
the	O
group	O
-	O
specific	O
ORFs	O
in	O
disease	O
origin	O
and	O
development	O
.	O

In	O
the	O
current	O
work	O
,	O
using	O
the	O
yeast	B-SPEC
two	O
-	O
hybrid	O
technique	O
,	O
an	O
unexpected	O
interaction	O
between	O
residues	O
1	O
-	O
210	O
and	O
211	O
-	O
290	O
(	O
central	O
region	O
)	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
protein	O
was	O
detected	O
,	O
and	O
SPR	O
results	O
further	O
revealed	O
that	O
the	O
SR	O
-	O
rich	O
motif	O
(	O
amino	O
acids	O
183	O
-	O
197	O
)	O
of	O
SARS	O
-	O
CoV	O
N	O
protein	O
is	O
responsible	O
for	O
such	O
an	O
interaction	O
.	O

This	O
article	O
reviews	O
what	O
is	O
currently	O
known	O
about	O
the	O
virus	B-SPEC
and	O
the	O
disease	O
.	O

ABSTRACT	O
:	O
An	O
indirect	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
compared	O
with	O
the	O
serum	O
neutralization	O
(	O
SN	O
)	O
test	O
by	O
testing	O
46	O
samples	O
from	O
experimentally	O
infected	O
sows	O
,	O
73	O
samples	O
from	O
naive	O
sows	O
,	O
and	O
1	O
,	O
024	O
field	O
sow	O
samples	O
from	O
48	O
commercial	O
swine	B-SPEC
farms	O
of	O
undefined	O
PED	O
status	O
.	O

A	O
previous	O
report	O
(	O
Virology	O
2003	O
,	O
311	O
:	O
16	O
-	O
27	O
)	O
indicated	O
that	O
transfected	O
IBV	B-SPEC
3b	O
localized	O
to	O
the	O
nucleus	O
in	O
mammalian	B-SPEC
cells	O
using	O
a	O
vaccinia	O
-	O
virus	B-SPEC
expression	O
system	O
.	O

IBV	B-SPEC
3b	O
was	O
virtually	O
undetectable	O
by	O
microscopy	O
in	O
mammalian	B-SPEC
cells	O
transfected	O
without	O
vaccinia	B-SPEC
virus	I-SPEC
and	O
in	O
IBV	B-SPEC
-	O
infected	O
mammalian	B-SPEC
cells	O
because	O
of	O
a	O
greatly	O
reduced	O
half	O
-	O
life	O
in	O
these	O
cells	O
.	O

In	O
an	O
extension	O
to	O
these	O
studies	O
,	O
an	O
internal	O
control	O
was	O
constructed	O
and	O
quantitative	O
analysis	O
of	O
virus	B-SPEC
shedding	O
after	O
oral	O
inoculation	O
was	O
established	O
.	O

This	O
suggests	O
that	O
measurement	O
of	O
PEDV	B-SPEC
shedding	O
viral	O
load	O
in	O
pigs	B-SPEC
,	O
by	O
quantitative	O
RT	O
-	O
PCR	O
,	O
may	O
be	O
a	O
useful	O
tool	O
for	O
estimating	O
the	O
transmission	O
potential	O
of	O
PEDV	B-SPEC
in	O
the	O
swine	B-SPEC
population	O
.	O

Rats	B-SPEC
of	O
both	O
genders	O
at	O
three	O
distinct	O
ages	O
(	O
young	O
-	O
adult	O
,	O
3	O
months	O
;	O
middle	O
-	O
aged	O
,	O
12	O
months	O
;	O
old	O
,	O
24	O
months	O
)	O
were	O
evaluated	O
to	O
determine	O
the	O
characteristic	O
of	O
ACE2	O
expression	O
in	O
lung	O
and	O
the	O
effect	O
of	O
aging	O
and	O
gender	O
on	O
its	O
expression	O
.	O

Radiographic	O
progression	O
correlates	O
well	O
with	O
that	O
of	O
important	O
clinical	O
and	O
laboratory	O
parameters	O
and	O
may	O
be	O
used	O
as	O
an	O
objective	O
prognostic	O
indicator	B-SPEC
early	O
in	O
SARS	O
.	O

A	O
hitherto	O
unknown	O
animal	B-SPEC
coronavirus	B-SPEC
(	O
CoV	O
)	O
that	O
had	O
crossed	O
the	O
species	B-SPEC
barrier	O
through	O
close	O
contact	O
of	O
humans	B-SPEC
with	O
infected	O
animals	B-SPEC
was	O
identified	O
as	O
the	O
etiological	O
agent	O
.	O

In	O
this	O
review	O
we	O
present	O
an	O
overview	O
over	O
SARS	O
-	O
Co	O
virus	B-SPEC
biology	O
,	O
the	O
disease	O
and	O
discuss	O
strategies	O
to	O
develop	O
antiviral	O
drugs	O
and	O
vaccines	O
.	O

However	O
,	O
it	O
is	O
now	O
clear	O
that	O
endemic	O
diseases	O
as	O
well	O
as	O
newly	O
emerging	O
ones	O
(	O
e	O
.	O
g	O
.,	O
severe	O
acute	O
respiratory	O
syndrome	O
[	O
SARS	O
]),	O
reemerging	O
ones	O
(	O
e	O
.	O
g	O
.,	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
),	O
and	O
even	O
deliberately	O
disseminated	O
infectious	O
diseases	O
(	O
e	O
.	O
g	O
.,	O
anthrax	B-SPEC
from	O
bioterrorism	O
)	O
continue	O
to	O
pose	O
a	O
substantial	O
threat	O
throughout	O
the	O
world	O
.	O

The	O
replacement	O
of	O
nucleotide	O
637	O
of	O
TGEV	B-SPEC
genome	O
by	O
a	O
T	O
,	O
as	O
in	O
the	O
DI	O
-	O
C	O
sequence	O
,	O
or	O
an	O
A	O
severely	O
affected	O
virus	B-SPEC
recovery	O
from	O
the	O
cDNA	O
,	O
yielding	O
mutant	O
viruses	B-SPEC
with	O
low	O
titers	O
and	O
small	O
plaques	O
compared	O
to	O
those	O
of	O
the	O
wild	O
type	O
.	O

ABSTRACT	O
:	O
Group	O
2	O
coronaviruses	O
encode	O
an	O
accessory	O
envelope	O
glycoprotein	O
species	B-SPEC
,	O
the	O
hemagglutinin	O
esterase	O
(	O
HE	O
),	O
which	O
possesses	O
sialate	O
-	O
O	O
-	O
acetylesterase	O
activity	O
and	O
which	O
,	O
presumably	O
,	O
promotes	O
virus	B-SPEC
spread	O
and	O
entry	O
in	O
vivo	O
by	O
facilitating	O
reversible	O
virion	O
attachment	O
to	O
O	O
-	O
acetylated	O
sialic	O
acids	O
.	O

During	O
the	O
propagation	O
of	O
recombinant	O
MHV	B-SPEC
-	O
HE	O
+,	O
two	O
types	O
of	O
spontaneous	O
mutants	O
accumulated	O
.	O

TITLE	O
:	O
Expression	O
of	O
hemagglutinin	O
esterase	O
protein	O
from	O
recombinant	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
enhances	O
neurovirulence	O
.	O

TITLE	O
:	O
The	O
papain	O
-	O
like	O
protease	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
has	O
deubiquitinating	O
activity	O
.	O

To	O
this	O
end	O
,	O
the	O
soR	O
domain	O
was	O
coupled	O
to	O
single	O
-	O
chain	O
monoclonal	O
antibody	O
425	O
,	O
which	O
is	O
directed	O
against	O
the	O
human	B-SPEC
epidermal	O
growth	O
factor	O
receptor	O
(	O
EGFR	O
),	O
resulting	O
in	O
a	O
bispecific	O
adapter	O
protein	O
(	O
soR	O
-	O
425	O
).	O

To	O
assess	O
infectivity	O
in	O
an	O
in	O
vitro	O
model	O
of	O
human	B-SPEC
ciliated	O
airway	O
epithelia	O
(	O
HAE	O
)	O
derived	O
from	O
nasal	O
and	O
tracheobronchial	O
airway	O
regions	O
,	O
we	O
generated	O
recombinant	O
SARS	O
-	O
CoV	O
by	O
deletion	O
of	O
open	O
reading	O
frame	O
7a	O
/	O
7b	O
(	O
ORF7a	O
/	O
7b	O
)	O
and	O
insertion	O
of	O
the	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
),	O
resulting	O
in	O
SARS	O
-	O
CoV	O
GFP	O
.	O

SARS	O
-	O
CoV	O
GFP	O
replicated	O
to	O
titers	O
similar	O
to	O
those	O
of	O
wild	O
-	O
type	O
viruses	B-SPEC
in	O
cell	O
lines	O
.	O

Testing	O
against	O
feline	B-SPEC
calicivirus	I-SPEC
produced	O
a	O
log10	O
reduction	O
factor	O
of	O
2	O
.	O
38	O
by	O
the	O
test	O
formulation	O
;	O
in	O
contrast	O
,	O
the	O
log10	O
reduction	O
factors	O
with	O
70	O
%	O
ethanol	O
and	O
70	O
%	O
propan	O
-	O
1	O
-	O
ol	O
were	O
0	O
.	O
68	O
and	O
0	O
.	O
70	O
,	O
respectively	O
.	O

The	O
World	O
Health	O
Organization	O
set	O
a	O
""""	O
task	O
force	O
""""	O
to	O
develop	O
a	O
strategy	O
that	O
may	O
help	O
to	O
control	O
the	O
virus	B-SPEC
spread	O
.	O

Attention	O
was	O
focused	O
on	O
possible	O
transmission	O
by	O
the	O
sewage	O
system	O
because	O
laboratory	O
studies	O
showed	O
that	O
patients	O
excreted	O
coronavirus	B-SPEC
RNA	O
in	O
their	O
stools	O
in	O
Amoy	O
Gardens	O
in	O
Hong	O
Kong	O
.	O

Adaptation	O
of	O
the	O
human	B-SPEC
virus	B-SPEC
to	O
murine	B-SPEC
cells	O
led	O
to	O
successful	O
infection	O
of	O
the	O
humanized	O
transgenic	B-SPEC
mice	I-SPEC
.	O

Significant	O
features	O
of	O
this	O
study	O
that	O
unique	O
to	O
the	O
contemporary	O
literature	O
are	O
i	O
)	O
the	O
over	O
-	O
representation	O
of	O
certain	O
breeds	O
(	O
Burmese	O
,	O
Australian	O
Mist	O
,	O
British	O
Shorthaired	O
,	O
and	O
Cornish	O
Rex	O
)	O
and	O
the	O
under	O
-	O
representation	O
of	O
other	O
breeds	O
(	O
Domestic	O
Shorthaired	O
,	O
Persian	O
);	O
ii	O
)	O
the	O
overrepresentation	O
of	O
males	O
;	O
iii	O
)	O
the	O
tendency	O
for	O
effusive	O
disease	O
in	O
Australian	O
Mist	O
cats	B-SPEC
and	O
non	O
-	O
effusive	O
disease	O
in	O
Burmese	O
;	O
iv	O
)	O
the	O
even	O
age	O
distribution	O
of	O
disease	O
seen	O
in	O
cats	B-SPEC
older	O
than	O
2	O
years	O
-	O
of	O
-	O
age	O
;	O
and	O
v	O
)	O
the	O
presence	O
of	O
fulminant	O
immune	O
-	O
mediated	O
haemolytic	O
anaemia	O
in	O
two	O
cats	B-SPEC
in	O
this	O
study	O
.	O

RESULTS	O
:	O
Forty	O
-	O
two	O
cats	B-SPEC
met	O
the	O
inclusion	O
criteria	O
.	O

ABSTRACT	O
:	O
To	O
develop	O
a	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
to	O
detect	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
from	O
commercially	O
-	O
raised	O
poultry	O
in	O
New	O
Zealand	O
and	O
compare	O
results	O
with	O
those	O
from	O
virus	B-SPEC
isolation	O
.	O

Tissues	O
were	O
homogenised	O
and	O
the	O
resultant	O
supernatant	O
used	O
directly	O
in	O
a	O
RT	O
-	O
PCR	O
assay	O
,	O
and	O
also	O
inoculated	O
into	O
the	O
allantoic	O
cavity	O
of	O
10	O
-	O
day	O
-	O
old	O
embryonated	O
eggs	O
for	O
virus	B-SPEC
isolation	O
.	O

SARS	O
is	O
caused	O
by	O
a	O
novel	O
species	B-SPEC
of	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
is	O
the	O
most	O
severe	O
coronavirus	B-SPEC
-	O
mediated	O
human	B-SPEC
disease	O
that	O
has	O
been	O
described	O
so	O
far	O
.	O

In	O
summary	O
,	O
the	O
reactions	O
of	O
nurses	O
when	O
confronted	O
with	O
the	O
possibility	O
of	O
contracting	O
a	O
deadly	O
disease	O
remain	O
altogether	O
human	B-SPEC
,	O
not	O
dissimilar	O
in	O
past	O
or	O
present	O
.	O

TITLE	O
:	O
Preparation	O
and	O
evaluation	O
of	O
anti	O
-	O
SARS	O
coronavirus	B-SPEC
IgY	O
from	O
yolks	O
of	O
immunized	O
SPF	O
chickens	B-SPEC
.	O

Specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
chickens	B-SPEC
were	O
immunized	O
with	O
inactivated	O
SARS	O
coronavirus	B-SPEC
and	O
their	O
eggs	O
were	O
harvested	O
at	O
regular	O
intervals	O
.	O

This	O
study	O
suggests	O
that	O
terascale	O
computing	O
can	O
complement	O
crystallography	O
,	O
broaden	O
the	O
scope	O
of	O
virtual	O
screening	O
,	O
and	O
accelerate	O
the	O
development	O
of	O
therapeutics	O
to	O
treat	O
emerging	O
infectious	O
diseases	O
such	O
as	O
SARS	O
and	O
Bird	B-SPEC
Flu	O
.	O

ABSTRACT	O
:	O
To	O
document	O
the	O
prevalence	O
of	O
respiratory	O
virus	B-SPEC
infections	O
in	O
patients	O
with	O
chronic	O
cardiac	O
or	O
pulmonary	O
disorders	O
admitted	O
to	O
a	O
critical	O
care	O
unit	O
for	O
acute	O
cardiorespiratory	O
failure	O
.	O

The	O
per	O
-	O
1	O
,	O
000	O
positivity	O
rates	O
were	O
influenza	B-SPEC
virus	I-SPEC
66	O
,	O
RSV	B-SPEC
49	O
,	O
rhinovirus	B-SPEC
33	O
,	O
metapneumovirus	B-SPEC
16	O
,	O
and	O
coronavirus	B-SPEC
8	O
.	O

These	O
results	O
show	O
that	O
respiratory	O
virus	B-SPEC
infection	O
-	O
particularly	O
influenza	B-SPEC
virus	I-SPEC
infection	O
during	O
epidemic	O
periods	O
-	O
is	O
common	O
among	O
patients	O
hospitalized	O
for	O
acute	O
cardiorespiratory	O
failure	O
.	O

This	O
rapid	O
assay	O
revealed	O
the	O
presence	O
of	O
an	O
Influenzavirus	B-SPEC
A	I-SPEC
respiratory	O
infection	O
five	O
days	O
after	O
the	O
beginning	O
of	O
the	O
respiratory	O
syndrome	O
.	O

Therefore	O
,	O
we	O
assayed	O
the	O
inhibitory	O
effects	O
of	O
small	O
peptides	O
derived	O
from	O
S	O
protein	O
on	O
the	O
binding	O
of	O
S	O
protein	O
to	O
ACE2	O
and	O
on	O
the	O
S	O
-	O
protein	O
-	O
pseudotyped	O
retrovirus	B-SPEC
infectivity	O
.	O

Interactions	O
between	O
N	O
proteins	O
and	O
RNA	O
are	O
thus	O
crucial	O
for	O
the	O
assembly	O
of	O
infectious	O
virus	B-SPEC
particles	O
.	O

Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
a	O
cellular	O
receptor	O
for	O
two	O
divergent	O
coronaviruses	O
,	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
).	O

The	O
data	O
gathered	O
on	O
the	O
animal	B-SPEC
coronaviruses	O
continue	O
to	O
be	O
helpful	O
in	O
understanding	O
SARS	O
-	O
CoV	O
.	O

TITLE	O
:	O
Functional	O
and	O
genetic	O
analysis	O
of	O
coronavirus	B-SPEC
replicase	O
-	O
transcriptase	O
proteins	O
.	O

Nevertheless	O
,	O
titers	O
produced	O
in	O
CK	O
cells	O
,	O
embryos	O
,	O
and	O
TOCs	O
were	O
similar	O
to	O
those	O
of	O
the	O
wild	O
-	O
type	O
virus	B-SPEC
,	O
although	O
they	O
declined	O
earlier	O
in	O
TOCs	O
,	O
probably	O
due	O
to	O
the	O
absence	O
of	O
the	O
3a	O
protein	O
.	O

Calves	O
were	O
fed	O
either	O
a	O
fixed	O
amount	O
(	O
454	O
g	O
/	O
d	O
)	O
of	O
a	O
20	O
%	O
crude	O
protein	O
(	O
CP	O
),	O
20	O
%	O
fat	O
milk	O
replacer	O
to	O
weaning	O
at	O
28	O
d	O
or	O
a	O
variable	O
amount	O
(	O
454	O
,	O
681	O
,	O
908	O
,	O
and	O
454	O
g	O
/	O
d	O
on	O
d	O
0	O
to	O
7	O
,	O
8	O
to	O
14	O
,	O
15	O
to	O
31	O
,	O
and	O
32	O
to	O
41	O
,	O
respectively	O
)	O
of	O
a	O
milk	O
replacer	O
containing	O
28	O
%	O
CP	O
and	O
17	O
%	O
fat	O
without	O
or	O
with	O
added	O
dietary	O
supplement	O
containing	O
bovine	B-SPEC
serum	O
.	O

Dietary	O
supplement	O
containing	O
bovine	B-SPEC
serum	O
had	O
no	O
effect	O
on	O
any	O
parameter	O
measured	O
.	O

There	O
is	O
continuing	O
use	O
of	O
EM	O
for	O
the	O
investigation	O
of	O
new	O
and	O
emerging	O
agents	O
,	O
such	O
as	O
SARS	O
and	O
human	B-SPEC
monkeypox	B-SPEC
virus	I-SPEC
.	O

Furthermore	O
,	O
EM	O
forms	O
a	O
vital	O
part	O
of	O
the	O
national	O
emergency	O
response	O
programme	O
of	O
many	O
countries	O
and	O
will	O
provide	O
a	O
frontline	O
diagnostic	O
service	O
in	O
the	O
event	O
of	O
a	O
bioterrorism	O
incident	O
,	O
particularly	O
in	O
the	O
scenario	O
of	O
a	O
deliberate	O
release	O
of	O
smallpox	B-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
E	O
protein	O
in	O
phospholipid	O
bilayers	O
:	O
an	O
x	O
-	O
ray	B-SPEC
study	O
.	O

Serum	O
,	O
peripheral	O
-	O
blood	O
mononuclear	O
cells	O
,	O
nasopharyngeal	O
aspirates	O
,	O
throat	O
swabs	O
,	O
and	O
rectal	O
swabs	O
from	O
these	O
patients	O
were	O
assayed	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
by	O
real	O
-	O
time	O
reverse	O
-	O
transcriptase	O
(	O
RT	O
)	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
),	O
and	O
the	O
throat	O
swabs	O
,	O
nasopharyngeal	O
aspirates	O
,	O
and	O
rectal	O
swabs	O
were	O
also	O
assayed	O
for	O
HCoV	O
-	O
NH	O
by	O
RT	O
-	O
PCR	O
.	O

It	O
appeared	O
that	O
disease	O
spread	O
most	O
often	O
in	O
hospitals	O
in	O
health	O
care	O
workers	O
,	O
and	O
patients	O
and	O
among	O
family	B-SPEC
members	O
.	O

Her	O
postoperative	O
course	O
was	O
complicated	O
by	O
severe	O
sepsis	B-SPEC
syndrome	O
with	O
respiratory	O
failure	O
,	O
hypotension	O
,	O
leukocytosis	O
,	O
and	O
DIC	O
.	O

Penicillium	B-SPEC
chrysogenum	I-SPEC
is	O
a	O
rare	O
cause	O
of	O
infection	O
in	O
immunocompetent	O
patients	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
,	O
first	O
characterized	O
in	O
the	O
1960s	O
,	O
are	O
responsible	O
for	O
a	O
substantial	O
proportion	O
of	O
upper	O
respiratory	O
tract	O
infections	O
in	O
children	O
.	O

In	O
a	O
separate	O
experiment	O
,	O
pot	O
plants	B-SPEC
were	O
exposed	O
to	O
ultraviolet	O
(	O
UV	O
)-	O
B	O
radiation	O
(	O
wavelength	O
:	O
280	O
-	O
315	O
nm	O
).	O

The	O
concentrations	O
of	O
glycyrrhizin	O
quantified	O
in	O
the	O
root	O
tissues	O
were	O
highest	O
in	O
the	O
plants	B-SPEC
grown	O
under	O
red	O
light	O
in	O
both	O
hydroponic	O
and	O
pot	O
systems	O
and	O
the	O
concentration	O
increased	O
linearly	O
from	O
1	O
-	O
to	O
3	O
-	O
month	O
-	O
old	O
pot	O
plants	B-SPEC
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
nucleocapsid	O
immunodominant	O
T	O
-	O
cell	O
epitope	O
cluster	O
is	O
common	O
to	O
both	O
exogenous	O
recombinant	O
and	O
endogenous	O
DNA	O
-	O
encoded	O
immunogens	O
.	O

The	O
active	O
agent	O
is	O
heat	O
stable	O
at	O
least	O
up	O
to	O
sterilizing	O
temperature	O
of	O
121	O
degrees	O
C	O
.	O
The	O
crude	O
plant	B-SPEC
extract	O
is	O
a	O
mixture	O
of	O
several	O
small	O
molecules	O
separable	O
by	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
.	O

The	O
HIV	B-SPEC
viral	O
loads	O
were	O
significantly	O
reduced	O
over	O
several	O
months	O
in	O
a	O
few	O
patients	O
monitored	O
after	O
treatment	O
with	O
Secomet	O
-	O
V	O
.	O
Secomet	O
-	O
V	O
was	O
also	O
found	O
to	O
have	O
antiviral	O
activity	O
against	O
the	O
SARS	O
virus	B-SPEC
but	O
not	O
against	O
the	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
.	O

CNS	O
administration	O
of	O
AAV2	B-SPEC
CUhCLN2	O
did	O
not	O
result	O
in	O
any	O
pathological	O
changes	O
in	O
the	O
brain	O
that	O
were	O
attributable	O
to	O
the	O
vector	O
,	O
although	O
microscopic	O
changes	O
were	O
observed	O
along	O
the	O
track	O
consistent	O
with	O
needle	O
trauma	O
.	O

Monkeys	B-SPEC
(	O
n	O
=	O
3	O
at	O
each	O
dose	O
)	O
were	O
killed	O
1	O
,	O
13	O
,	O
26	O
,	O
or	O
52	O
weeks	O
after	O
injection	O
.	O

Controls	O
included	O
sham	O
-	O
injected	O
,	O
saline	O
-	O
injected	O
,	O
and	O
AAV2	B-SPEC
(	O
CU	O
)	O
Null	O
-	O
injected	O
(	O
3	O
.	O
6	O
x	O
10	O
(	O
11	O
)	O
PU	O
)	O
monkeys	B-SPEC
.	O

TITLE	O
:	O
Evaluation	O
of	O
affymetrix	O
severe	O
acute	O
respiratory	O
syndrome	O
resequencing	O
GeneChips	O
in	O
characterization	O
of	O
the	O
genomes	O
of	O
two	O
strains	O
of	O
coronavirus	B-SPEC
infecting	O
humans	B-SPEC
.	O

State	O
-	O
of	O
-	O
the	O
-	O
art	O
manufacturing	O
processes	O
provide	O
a	O
high	O
safety	O
standard	O
by	O
incorporating	O
virus	B-SPEC
elimination	O
procedures	O
into	O
the	O
manufacturing	O
process	O
.	O

Specific	O
best	O
-	O
fit	O
mediators	O
or	O
mediator	O
pairs	O
varied	O
with	O
aspirate	O
type	O
,	O
animal	B-SPEC
type	O
,	O
and	O
time	O
of	O
injury	O
.	O

Another	O
eight	O
IBV	B-SPEC
isolates	O
clustered	O
in	O
genotype	O
IV	O
and	O
showed	O
larger	O
evolutionary	O
distances	O
.	O

The	O
results	O
showed	O
that	O
IBVs	O
in	O
China	O
came	O
from	O
genetic	O
changes	O
both	O
in	O
IBV	B-SPEC
populations	O
that	O
existed	O
before	O
the	O
advent	O
of	O
vaccination	O
and	O
in	O
the	O
viruses	B-SPEC
that	O
were	O
introduced	O
through	O
live	O
vaccines	O
.	O

Anesthetized	O
eNOS	O
-	O
transgenic	O
(	O
Tg	O
)	O
and	O
wild	O
-	O
type	O
(	O
WT	O
)	O
C57BL	O
/	O
6	O
mice	B-SPEC
were	O
ventilated	O
at	O
high	O
or	O
low	O
tidal	O
volume	O
(	O
Vt	O
;	O
20	O
or	O
7	O
ml	O
/	O
kg	O
,	O
respectively	O
)	O
for	O
4	O
h	O
.	O
After	O
MV	O
,	O
lung	O
damage	O
,	O
including	O
neutrophil	O
infiltration	O
,	O
water	O
leakage	O
,	O
and	O
cytokine	O
concentration	O
in	O
bronchoalveolar	O
lavage	O
fluid	O
(	O
BALF	O
)	O
and	O
plasma	O
,	O
was	O
evaluated	O
.	O

Under	O
high	O
Vt	O
conditions	O
,	O
neutrophil	O
infiltration	O
and	O
lung	O
water	O
content	O
were	O
significantly	O
attenuated	O
in	O
eNOS	O
-	O
Tg	O
mice	B-SPEC
compared	O
with	O
WT	O
animals	B-SPEC
.	O

L	O
-	O
NAME	B-SPEC
abrogated	O
the	O
beneficial	O
effect	O
of	O
eNOS	O
overexpression	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
strains	O
isolated	O
in	O
Colombia	O
during	O
2003	O
.	O

ABSTRACT	O
:	O
Sixteen	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
were	O
recovered	O
from	O
broilers	O
and	O
layers	O
from	O
five	O
geographic	O
poultry	O
regions	O
in	O
Colombia	O
.	O

ABSTRACT	O
:	O
In	O
recent	O
years	O
,	O
a	O
number	O
of	O
articles	O
have	O
been	O
published	O
on	O
the	O
treatment	O
of	O
acute	O
pancreatitis	O
in	O
experimental	O
models	O
and	O
most	O
of	O
them	O
were	O
published	O
about	O
animals	B-SPEC
with	O
mild	O
disease	O
.	O

A	O
randomized	O
study	O
has	O
been	O
published	O
to	O
test	O
the	O
hypothesis	O
that	O
probiotics	O
and	O
specific	O
fibres	O
used	O
as	O
supplements	O
in	O
early	O
enteral	O
nutrition	O
may	O
be	O
effective	O
in	O
reducing	O
pancreatic	O
sepsis	B-SPEC
and	O
the	O
number	O
of	O
surgical	O
interventions	O
.	O

TITLE	O
:	O
[	O
A	O
study	O
of	O
pulmonary	O
inflammatory	O
reaction	O
induced	O
by	O
N	O
-	O
protein	O
of	O
SARS	O
-	O
CoV	O
in	O
rat	B-SPEC
models	O
and	O
effects	O
of	O
glucocorticoids	O
on	O
it	O
].	O

The	O
pulmonary	O
inflammatory	O
reaction	O
in	O
rat	B-SPEC
models	O
were	O
induced	O
by	O
intratracheal	O
instillation	O
of	O
N	O
-	O
protein	O
of	O
SARS	O
-	O
CoV	O
with	O
a	O
dose	O
of	O
0	O
.	O
2	O
mg	O
/	O
kg	O
.	O

The	O
rats	B-SPEC
were	O
randomly	O
divided	O
into	O
four	O
groups	O
:	O
normal	O
saline	O
control	O
group	O
(	O
Nc	O
group	O
),	O
N	O
-	O
protein	O
group	O
1	O
(	O
P1	O
group	O
,	O
6	O
h	O
),	O
N	O
-	O
protein	O
group	O
2	O
(	O
P2	O
group	O
,	O
24	O
h	O
),	O
and	O
N	O
-	O
protein	O
+	O
dexamethasone	O
group	O
(	O
P	O
+	O
D	O
group	O
,	O
dexamethasone	O
10	O
mg	O
/	O
kg	O
intraperitoneally	O
).	O

Growth	O
in	O
suckling	O
-	O
mouse	B-SPEC
brain	O
of	O
""""	O
IBV	B-SPEC
-	O
like	O
""""	O
viruses	B-SPEC
from	O
patients	O
with	O
upper	O
respiratory	O
tract	O
disease	O
.	O

These	O
data	O
suggest	O
that	O
some	O
coronaviruses	O
,	O
including	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
SARS	O
-	O
CoV	O
,	O
readily	O
adapt	O
to	O
growth	O
in	O
cells	O
from	O
heterologous	O
species	B-SPEC
.	O

ABSTRACT	O
:	O
Hantavirus	B-SPEC
pulmonary	O
syndrome	O
(	O
HPS	O
)	O
is	O
an	O
acute	O
disease	O
resulting	O
from	O
infection	O
with	O
any	O
one	O
of	O
a	O
number	O
of	O
New	O
World	O
hantaviruses	B-SPEC
.	O

To	O
generate	O
a	O
self	O
-	O
targeted	O
virus	B-SPEC
able	O
to	O
establish	O
multiround	O
infection	O
of	O
the	O
target	O
cells	O
,	O
we	O
subsequently	O
incorporated	O
the	O
gene	O
encoding	O
the	O
bispecific	O
adapter	O
protein	O
as	O
an	O
additional	O
expression	O
cassette	O
into	O
the	O
MHV	B-SPEC
genome	O
through	O
targeted	O
RNA	O
recombination	O
.	O

When	O
inoculated	O
onto	O
murine	B-SPEC
LR7	O
cells	O
,	O
the	O
resulting	O
recombinant	O
virus	B-SPEC
indeed	O
expressed	O
the	O
adapter	O
protein	O
.	O

Coronavirus	B-SPEC
infection	O
of	O
the	O
murine	B-SPEC
CNS	O
illustrates	O
the	O
contributions	O
of	O
both	O
the	O
innate	O
immune	O
response	O
and	O
specific	O
host	O
effector	O
mechanisms	O
that	O
control	O
virus	B-SPEC
replication	O
in	O
distinct	O
CNS	O
cell	O
types	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
interaction	O
between	O
the	O
host	O
cell	O
and	O
the	O
truncated	O
S	O
fragments	O
to	O
identify	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

In	O
bronchoalveolar	O
lavage	O
samples	O
,	O
hMPV	B-SPEC
predominated	O
by	O
far	O
over	O
the	O
other	O
viruses	B-SPEC
,	O
being	O
responsible	O
for	O
60	O
%	O
of	O
positive	O
specimens	O
,	O
whereas	O
other	O
viruses	B-SPEC
were	O
present	O
in	O
nasopharyngeal	O
aspirates	O
at	O
a	O
comparable	O
rate	O
.	O

(	O
i	O
)	O
about	O
50	O
%	O
of	O
respiratory	O
tract	O
infections	O
of	O
lung	O
transplant	O
recipients	O
were	O
associated	O
with	O
one	O
or	O
more	O
respiratory	O
viruses	B-SPEC
;	O
(	O
ii	O
)	O
hMPV	B-SPEC
largely	O
predominates	O
in	O
bronchoalveolar	O
lavage	O
of	O
symptomatic	O
lung	O
transplant	O
recipients	O
,	O
thus	O
suggesting	O
a	O
causative	O
role	O
in	O
lower	O
respiratory	O
tract	O
infections	O
;	O
(	O
iii	O
)	O
RT	O
-	O
PCR	O
appears	O
to	O
be	O
the	O
method	O
of	O
choice	O
for	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
in	O
lung	O
transplant	O
recipients	O
,	O
(	O
iv	O
)	O
a	O
high	O
HCMV	O
load	O
in	O
bronchoalveolar	O
lavage	O
is	O
a	O
risk	O
factor	O
for	O
viral	O
pneumonia	O
,	O
suggesting	O
some	O
measure	O
of	O
intervention	O
for	O
the	O
control	O
of	O
viral	O
infection	O
.	O

ABSTRACT	O
:	O
Laboratory	O
mice	B-SPEC
often	O
exhibit	O
wide	O
differences	O
in	O
susceptibility	O
when	O
infected	O
experimentally	O
with	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Steps	O
were	O
taken	O
to	O
eradicate	O
endemic	O
mouse	B-SPEC
coronavirus	B-SPEC
from	O
a	O
colony	O
that	O
was	O
part	O
of	O
a	O
behavioral	O
project	O
characterizing	O
the	O
genetics	O
of	O
alcohol	O
sensitivity	O
.	O

Selected	O
breeding	O
pairs	O
of	O
the	O
affected	O
lines	O
were	O
divided	O
into	O
four	O
treatment	O
groups	O
:	O
1	O
)	O
transfer	O
of	O
embryos	O
to	O
pseudopregnant	O
B6D2F1	O
female	O
mice	B-SPEC
,	O
2	O
)	O
fostering	O
offspring	O
to	O
B6D2F1	O
dams	O
,	O
3	O
)	O
fostering	O
offspring	O
to	O
a	O
different	O
dam	O
of	O
the	O
same	O
line	O
,	O
and	O
4	O
)	O
offspring	O
raised	O
by	O
the	O
birth	O
dam	O
.	O

Many	O
antigens	O
have	O
been	O
expressed	O
in	O
plants	B-SPEC
.	O

The	O
N	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
bears	B-SPEC
signature	O
motifs	O
for	O
binding	O
to	O
cyclin	O
and	O
phosphorylation	O
by	O
cyclin	O
-	O
dependent	O
kinase	O
(	O
CDK	O
)	O
and	O
has	O
recently	O
been	O
reported	O
by	O
us	O
to	O
get	O
phosphorylated	O
by	O
the	O
cyclin	O
-	O
CDK	O
complex	O
(	O
Surjit	O
,	O
M	O
.,	O
Kumar	O
,	O
R	O
.,	O
Mishra	O
,	O
R	O
.	O
N	O
.,	O
Reddy	O
,	O
M	O
.	O
K	O
.,	O
Chow	O
,	O
V	O
.	O
T	O
.,	O
and	O
Lal	O
,	O
S	O
.	O
K	O
.	O
(	O
2005	O
)	O
J	O
.	O
Virol	O
.	O
79	O
,	O
11476	O
-	O
11486	O
).	O

Maintenance	O
of	O
serum	O
Ab	O
was	O
correlated	O
with	O
tissue	O
distribution	O
of	O
virus	B-SPEC
-	O
specific	O
Ab	O
-	O
secreting	O
cells	O
(	O
ASC	O
).	O

Although	O
virus	B-SPEC
-	O
specific	O
ASC	O
declined	O
in	O
cervical	O
lymph	O
node	O
and	O
spleen	O
after	O
infectious	O
virus	B-SPEC
clearance	O
,	O
virus	B-SPEC
-	O
specific	O
serum	O
Ab	O
was	O
sustained	O
at	O
steady	O
levels	O
,	O
with	O
a	O
delay	O
in	O
neutralizing	O
Ab	O
.	O

Mouse	B-SPEC
fgl2	O
(	O
mfgl2	O
)	O
protein	O
was	O
detected	O
in	O
the	O
endothelium	O
of	O
intrahepatic	O
veins	O
and	O
hepatic	O
sinusoids	O
within	O
the	O
liver	O
24	O
h	O
after	O
MHV	B-SPEC
-	O
3	O
infection	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
there	O
is	O
no	O
other	O
report	O
to	O
date	O
about	O
the	O
detection	O
of	O
this	O
new	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Typing	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
is	O
useful	O
for	O
implementation	O
of	O
control	O
measures	O
and	O
for	O
understanding	O
the	O
epidemiology	O
and	O
evolution	O
of	O
IBV	B-SPEC
.	O

This	O
fragment	O
encompassed	O
all	O
of	O
the	O
genes	O
encoding	O
the	O
structural	O
proteins	O
of	O
the	O
virus	B-SPEC
.	O

Three	O
different	O
restriction	O
endonucleases	O
,	O
AluI	O
,	O
Sau3AI	O
and	O
MnlI	O
,	O
were	O
used	O
to	O
digest	O
the	O
7	O
.	O
5	O
kb	O
PCR	O
product	O
from	O
different	O
IBV	B-SPEC
strains	O
and	O
the	O
resultant	O
RFLP	O
patterns	O
were	O
compared	O
.	O

ABSTRACT	O
:	O
An	O
RT	O
-	O
nPCR	O
assay	O
was	O
used	O
for	O
testing	O
fecal	O
samples	O
of	O
dogs	B-SPEC
,	O
foxes	O
,	O
raccoon	B-SPEC
dogs	I-SPEC
and	O
minks	B-SPEC
for	O
the	O
presence	O
of	O
canine	O
coronavirus	B-SPEC
(	O
CCV	O
).	O

TITLE	O
:	O
Synthesis	O
of	O
cyclopentenyl	O
carbocyclic	O
nucleosides	O
as	O
potential	O
antiviral	O
agents	O
against	O
orthopoxviruses	B-SPEC
and	O
SARS	O
.	O

The	O
compounds	O
were	O
tested	O
against	O
SARS	O
-	O
CoV	O
-	O
induced	O
cell	O
death	O
in	O
Vero	O
or	O
CaCo2	O
cells	O
as	O
a	O
measurement	O
of	O
the	O
inhibiting	O
effects	O
of	O
the	O
compounds	O
on	O
the	O
replication	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Therapy	O
with	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
-	O
neutralizing	O
human	B-SPEC
monoclonal	O
antibody	O
reduces	O
disease	O
severity	O
and	O
viral	O
burden	O
in	O
golden	O
Syrian	B-SPEC
hamsters	I-SPEC
.	O

Our	O
work	O
includes	O
a	O
total	O
of	O
54	O
peptides	O
derived	O
from	O
immunodominant	O
linear	O
epitopes	O
of	O
the	O
T7	O
phage	O
capsid	O
protein	O
,	O
Herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
glycoprotein	O
D	O
,	O
c	O
-	O
myc	O
protein	O
,	O
and	O
three	O
domains	O
of	O
the	O
Human	B-SPEC
coronavirus	I-SPEC
polymerase	O
polyprotein	O
and	O
their	O
cognate	O
mAbs	O
.	O

TITLE	O
:	O
A	O
serological	O
survey	O
of	O
selected	O
pathogens	O
in	O
wild	B-SPEC
boar	I-SPEC
in	O
Slovenia	O
.	O

ABSTRACT	O
:	O
Serum	O
samples	O
collected	O
from	O
178	O
shot	O
wild	B-SPEC
boars	I-SPEC
(	O
Sus	B-SPEC
scrofa	I-SPEC
)	O
were	O
tested	O
for	O
the	O
presence	O
of	O
antibodies	O
against	O
classical	B-SPEC
swine	I-SPEC
fever	I-SPEC
virus	I-SPEC
,	O
Aujeszky	B-SPEC
'	I-SPEC
s	I-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
ADV	O
),	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
,	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
),	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
,	O
swine	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
porcine	B-SPEC
parvovirus	I-SPEC
(	O
PPV	B-SPEC
),	O
swine	B-SPEC
vesicular	O
disease	O
virus	B-SPEC
,	O
Actinobacillus	B-SPEC
pleuropneumoniae	I-SPEC
(	O
APP	O
),	O
Mycoplasma	B-SPEC
hyopneumoniae	I-SPEC
,	O
Salmonella	B-SPEC
spp	O
.,	O
Brucella	B-SPEC
spp	O
.	O

It	O
may	O
be	O
encountered	O
more	O
frequently	O
among	O
patients	O
who	O
have	O
had	O
contact	O
with	O
birds	B-SPEC
and	O
should	O
be	O
considered	O
in	O
the	O
differential	O
diagnosis	O
of	O
atypical	O
pneumonia	O
.	O

TITLE	O
:	O
Automated	O
extraction	O
protocol	O
for	O
quantification	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
RNA	O
in	O
serum	O
:	O
an	O
evaluation	O
study	O
.	O

The	O
utility	O
of	O
the	O
technology	O
will	O
be	O
illustrated	O
by	O
examples	O
from	O
cytomegalovirus	B-SPEC
quantification	O
and	O
monitoring	O
of	O
the	O
viral	O
load	O
of	O
the	O
SARS	O
Coronavirus	B-SPEC
.	O

casei	O
was	O
detected	O
specifically	O
in	O
the	O
intestinal	O
chyme	O
of	O
chickens	B-SPEC
(	O
10	O
d	O
of	O
age	O
,	O
Julia	B-SPEC
strain	O
)	O
fed	O
ad	O
libitum	O
on	O
a	O
diet	O
supplemented	O
with	O
75	O
mg	O
dextran	O
/	O
kg	O
(	O
dextran	O
-	O
supplemented	O
diet	O
,	O
DSD	O
)	O
and	O
administered	O
orally	O
with	O
10	O
(	O
7	O
)	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
L	O
.	O
casei	O
subsp	O
.	O

This	O
preferential	O
infection	O
of	O
mature	O
DCs	O
may	O
inhibit	O
the	O
development	O
of	O
an	O
efficient	O
immune	O
response	O
to	O
the	O
virus	B-SPEC
.	O

Among	O
the	O
vaccine	O
groups	O
,	O
SARS	O
-	O
CoV	O
-	O
specific	O
IgA	O
was	O
found	O
only	O
in	O
the	O
sera	O
of	O
mice	B-SPEC
immunized	O
intranasally	O
with	O
Ad	O
S	O
/	O
N	O
,	O
suggesting	O
that	O
mucosal	O
immunity	O
may	O
play	O
a	O
role	O
in	O
protection	O
for	O
the	O
intranasal	O
Ad	O
S	O
/	O
N	O
delivery	O
system	O
.	O

We	O
compared	O
the	O
cytokine	O
profile	O
in	O
Caco2	O
cells	O
after	O
infection	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
with	O
other	O
respiratory	O
viruses	B-SPEC
including	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
FluAV	O
),	O
and	O
human	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
type	I-SPEC
2	I-SPEC
(	O
hPIV2	O
).	O

SARS	O
-	O
CoV	O
and	O
RSV	B-SPEC
induced	O
high	O
levels	O
of	O
IL	O
-	O
6	O
and	O
RANTES	O
compared	O
with	O
FluAV	O
and	O
hPIV2	O
.	O

As	O
shown	O
in	O
our	O
previous	O
studies	O
,	O
apoptosis	O
occurred	O
in	O
virus	B-SPEC
-	O
infected	O
cells	O
within	O
18	O
h	O
postinfection	O
.	O

Infection	O
control	O
overshadowed	O
the	O
family	B-SPEC
-	O
centred	O
nursing	O
practices	O
in	O
the	O
management	O
of	O
SARS	O
paediatric	O
patients	O
.	O

Our	O
meta	B-SPEC
-	O
analysis	O
,	O
which	O
included	O
all	O
identified	O
studies	O
except	O
those	O
on	O
wild	O
animal	B-SPEC
handlers	O
,	O
yielded	O
an	O
overall	O
seroprevalence	O
of	O
0	O
.	O
10	O
%	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
02	O
-	O
0	O
.	O
18	O
].	O

The	O
phylogenetic	O
tree	O
based	O
on	O
other	O
genes	O
had	O
a	O
very	O
different	O
topology	O
with	O
TCoV	O
isolates	O
randomly	O
forming	O
groups	O
with	O
different	O
IBV	B-SPEC
strains	O
.	O

TITLE	O
:	O
Vaccine	O
-	O
induced	O
memory	O
CD8	O
+	O
T	O
cells	O
cannot	O
prevent	O
central	O
nervous	O
system	O
virus	B-SPEC
reactivation	O
.	O

ABSTRACT	O
:	O
Since	O
global	O
availability	O
of	O
vaccine	O
and	O
antiviral	O
agents	O
against	O
influenza	O
caused	O
by	O
novel	O
human	B-SPEC
subtypes	O
is	O
insufficient	O
,	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
recommends	O
non	O
-	O
pharmaceutical	O
public	O
health	O
interventions	O
to	O
contain	O
infection	O
,	O
delay	O
spread	O
,	O
and	O
reduce	O
the	O
impact	O
of	O
pandemic	O
disease	O
.	O

Virus	B-SPEC
transmission	O
characteristics	O
will	O
not	O
be	O
completely	O
known	O
in	O
advance	O
,	O
but	O
difficulties	O
in	O
influenza	O
control	O
typically	O
include	O
peak	O
infectivity	O
early	O
in	O
illness	O
,	O
a	O
short	O
interval	O
between	O
cases	O
,	O
and	O
to	O
a	O
lesser	O
extent	O
,	O
transmission	O
from	O
persons	O
with	O
incubating	O
or	O
asymptomatic	O
infection	O
.	O

TITLE	O
:	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
replication	O
in	O
cell	O
lines	O
.	O

These	O
results	O
indicated	O
that	O
ISA	B-SPEC
-	O
51	O
/	O
CpG	O
-	O
formulated	O
rN	O
protein	O
was	O
dramatically	O
biased	O
toward	O
a	O
Th1	O
immune	O
response	O
.	O

ABSTRACT	O
:	O
Side	O
effects	O
of	O
interferon	O
-	O
ribavirin	O
combination	O
therapy	O
limit	O
the	O
sustained	O
viral	O
response	O
achievable	O
in	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
)	O
patients	O
.	O

Livers	O
recovered	O
from	O
untreated	O
infected	O
mice	B-SPEC
showed	O
greater	O
than	O
90	O
%	O
necrosis	O
.	O

To	O
address	O
this	O
issue	O
,	O
a	O
series	O
of	O
slippery	O
site	O
mutants	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
frameshift	O
signal	O
were	O
systematically	O
assayed	O
in	O
four	O
different	O
eukaryotic	O
translational	O
systems	O
.	O

Specifically	O
,	O
the	O
median	O
Coronase	O
antibody	O
titres	O
of	O
Siamese	O
,	O
Persians	O
,	O
Domestic	O
Shorthairs	O
and	O
Bengal	O
cats	B-SPEC
(	O
100	O
)	O
were	O
significantly	O
lower	O
than	O
that	O
of	O
British	O
Shorthairs	O
,	O
Cornish	O
Rex	O
and	O
Burmese	O
cats	B-SPEC
(	O
400	O
,	O
P	O
<	O
0	O
.	O
0005	O
).	O

There	O
was	O
no	O
statistical	O
relationship	O
between	O
the	O
Coronase	O
or	O
7B	O
FIP	O
antibody	O
titres	O
and	O
age	O
,	O
gender	O
or	O
overall	O
health	O
status	O
,	O
even	O
when	O
considering	O
only	O
those	O
cats	B-SPEC
in	O
which	O
clinical	O
signs	O
suggestive	O
of	O
FIP	O
were	O
present	O
.	O

CONCLUSIONS	O
:	O
This	O
study	O
reinforces	O
the	O
complexity	O
of	O
interpreting	O
serological	O
tests	O
for	O
FCoV	O
in	O
both	O
healthy	O
cats	B-SPEC
and	O
patients	O
with	O
signs	O
compatible	O
with	O
FIR	B-SPEC
Unique	O
to	O
this	O
study	O
is	O
the	O
detection	O
of	O
a	O
significant	O
relationship	O
between	O
breed	O
and	O
median	O
FCoV	O
antibody	O
titre	O
.	O

TITLE	O
:	O
Disseminated	O
adenovirus	B-SPEC
infection	O
with	O
respiratory	O
failure	O
in	O
pediatric	O
liver	O
transplant	O
recipients	O
:	O
impact	O
of	O
intravenous	O
cidofovir	O
and	O
inhaled	O
nitric	O
oxide	O
.	O

To	O
study	O
the	O
cellular	O
response	O
in	O
the	O
acute	O
phase	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)-	O
host	O
cell	O
interaction	O
,	O
we	O
investigated	O
the	O
induction	O
of	O
chemokines	O
,	O
adhesion	O
molecules	O
,	O
and	O
DC	O
-	O
SIGN	O
(	O
dendritic	O
cell	O
-	O
specific	O
ICAM	O
-	O
3	O
-	O
grabbing	O
nonintegrin	O
)	O
by	O
SARS	O
-	O
CoV	O
.	O
Immunohistochemistry	O
revealed	O
neutrophil	O
,	O
macrophage	O
,	O
and	O
CD8	O
T	O
-	O
cell	O
infiltration	O
in	O
the	O
lung	O
autopsy	O
of	O
a	O
SARS	O
patient	O
who	O
died	O
during	O
the	O
acute	O
phase	O
of	O
illness	O
.	O

ABSTRACT	O
:	O
Australian	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBV	B-SPEC
)	O
have	O
undergone	O
a	O
separate	O
evolution	O
due	O
to	O
geographic	O
isolation	O
.	O

TITLE	O
:	O
[	O
Some	O
medical	O
staff	O
positive	O
for	O
serum	O
SARS	O
coronavirus	B-SPEC
antibody	O
IgG	O
have	O
only	O
mild	O
symptoms	O
].	O

A	O
total	O
of	O
190	O
adult	O
male	O
Sprague	B-SPEC
-	I-SPEC
Dawley	I-SPEC
rats	I-SPEC
weighing	O
250	O
-	O
300	O
g	O
.	O
Endotoxemia	O
was	O
induced	O
by	O
intravenous	O
infusion	O
of	O
lipopolysaccharide	O
.	O

ABSTRACT	O
:	O
A	O
diverse	O
group	O
of	O
cytolytic	O
animal	B-SPEC
viruses	B-SPEC
encodes	O
small	O
,	O
hydrophobic	O
proteins	O
to	O
modify	O
host	O
cell	O
membrane	O
permeability	O
to	O
ions	O
and	O
small	O
molecules	O
during	O
their	O
infection	O
cycles	O
.	O

ABSTRACT	O
:	O
The	O
envelope	O
glycoprotein	O
,	O
termed	O
the	O
spike	O
protein	O
,	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
known	O
to	O
mediate	O
viral	O
entry	O
.	O

The	O
S2	O
-	O
HR2	O
structure	O
,	O
which	O
is	O
the	O
first	O
example	O
of	O
the	O
prefusion	O
form	O
of	O
coronavirus	B-SPEC
envelope	O
,	O
supports	O
the	O
current	O
model	O
of	O
viral	O
membrane	O
fusion	O
and	O
gives	O
insight	O
into	O
the	O
design	O
of	O
structure	O
-	O
based	O
antagonists	O
of	O
SARS	O
.	O

As	O
such	O
,	O
SARS	O
-	O
CoV	O
Mpro	O
is	O
a	O
key	O
target	O
for	O
the	O
identification	O
of	O
specific	O
inhibitors	O
directed	O
against	O
the	O
SARS	O
virus	B-SPEC
.	O

Aimed	O
at	O
generating	O
analogues	O
by	O
metabolic	O
engineering	O
,	O
the	O
valinomycin	O
biosynthetic	O
gene	O
cluster	O
has	O
been	O
cloned	O
from	O
Streptomyces	B-SPEC
tsusimaensis	I-SPEC
ATCC	O
15141	O
.	O

The	O
respective	O
adenylation	O
domains	O
in	O
these	O
two	O
modules	O
contain	O
novel	O
substrate	O
-	O
specificity	O
-	O
conferring	O
codes	O
that	O
might	O
specify	O
for	O
a	O
class	B-SPEC
of	O
hydroxyl	O
acids	O
for	O
the	O
biosynthesis	O
of	O
the	O
depsipeptide	O
natural	O
products	O
.	O

It	O
has	O
also	O
helped	O
to	O
define	O
the	O
impact	O
of	O
previously	O
described	O
ones	O
such	O
as	O
human	B-SPEC
metapneumovirus	I-SPEC
and	O
rhinoviruses	B-SPEC
,	O
which	O
account	O
for	O
the	O
majority	O
of	O
asthma	O
exacerbations	O
and	O
frequent	O
lower	O
respiratory	O
tract	O
illnesses	O
.	O

Progress	O
has	O
been	O
made	O
in	O
development	O
of	O
possible	O
specific	O
interventions	O
for	O
influenza	O
and	O
possibly	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
but	O
effective	O
antivirals	O
and	O
vaccines	O
for	O
most	O
other	O
respiratory	O
viruses	B-SPEC
are	O
currently	O
lacking	O
.	O

ABSTRACT	O
:	O
So	O
far	O
,	O
most	O
monoclonal	O
antibodies	O
have	O
been	O
developed	O
for	O
treating	O
cancer	B-SPEC
or	O
immunological	O
diseases	O
.	O

ABSTRACT	O
:	O
The	O
notion	O
that	O
an	O
infectious	O
respiratory	O
pathogen	O
can	O
damage	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
and	O
lead	O
to	O
neurological	O
disease	O
was	O
tested	O
using	O
a	O
human	B-SPEC
respiratory	O
coronavirus	B-SPEC
,	O
the	O
OC43	O
strain	O
of	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
).	O

First	O
,	O
primary	O
cell	O
cultures	O
were	O
used	O
to	O
determine	O
the	O
susceptibility	O
of	O
each	O
type	O
of	O
neural	O
cells	O
to	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
that	O
first	O
manifested	O
in	O
humans	B-SPEC
in	O
November	O
2002	O
.	O

The	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
identified	O
as	O
the	O
causal	O
agent	O
,	O
but	O
the	O
pathology	O
and	O
pathogenesis	O
are	O
still	O
not	O
quite	O
clear	O
.	O

In	O
addition	O
,	O
electron	O
microscopy	O
revealed	O
viral	O
particles	O
in	O
the	O
cytoplasm	O
of	O
alveolar	O
epithelial	O
cells	O
and	O
endothelial	O
cells	O
corresponding	O
to	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
monitor	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
infection	O
,	O
a	O
coronavirus	B-SPEC
protein	O
microarray	O
that	O
harbors	O
proteins	O
from	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
five	O
additional	O
coronaviruses	O
was	O
constructed	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
the	O
causative	O
agents	O
of	O
respiratory	O
disease	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

Virus	B-SPEC
entry	O
into	O
cells	O
was	O
inhibited	O
by	O
acidotropic	O
bases	O
and	O
by	O
other	O
inhibitors	O
of	O
pH	O
-	O
dependent	O
endocytosis	O
.	O

We	O
carried	O
out	O
fluorescence	O
-	O
dequenching	O
fusion	O
assays	O
of	O
R18	O
-	O
labeled	O
virions	O
and	O
show	O
that	O
for	O
IBV	B-SPEC
,	O
coronavirus	B-SPEC
-	O
cell	O
fusion	O
occurs	O
in	O
a	O
low	O
-	O
pH	O
-	O
dependent	O
manner	O
,	O
with	O
a	O
half	O
-	O
maximal	O
rate	O
of	O
fusion	O
occurring	O
at	O
pH	O
5	O
.	O
5	O
.	O

Particularly	O
,	O
derivative	O
8	O
is	O
a	O
potent	O
IN	O
inhibitor	O
for	O
both	O
steps	O
of	O
the	O
reaction	O
(	O
3	O
'-	O
processing	O
and	O
strand	O
transfer	O
)	O
and	O
exhibits	O
both	O
high	O
antiviral	O
activity	O
against	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
infected	O
cells	O
and	O
low	O
cytotoxicity	O
.	O

Patients	O
suffered	O
from	O
sepsis	B-SPEC
(	O
n	O
=	O
99	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
n	O
=	O
31	O
),	O
severe	O
head	O
injury	O
(	O
n	O
=	O
38	O
),	O
hemorrhagic	O
shock	O
(	O
n	O
=	O
19	O
),	O
intracranial	O
hemorrhage	O
(	O
n	O
=	O
19	O
),	O
and	O
cerebral	O
infarction	O
(	O
n	O
=	O
3	O
).	O

ABSTRACT	O
:	O
To	O
develop	O
a	O
specific	O
SARS	O
virus	B-SPEC
-	O
targeted	O
antibody	O
preparation	O
for	O
emergent	O
prophylaxis	O
and	O
treatment	O
of	O
SARS	O
virus	B-SPEC
infection	O
.	O

The	O
functional	O
Fab	O
antibodies	O
were	O
converted	O
to	O
full	O
human	B-SPEC
IgG	O
antibodies	O
with	O
recombinant	O
baculovirus	B-SPEC
/	O
insect	B-SPEC
cell	O
systems	O
and	O
their	O
neutralizing	O
activities	O
were	O
further	O
determined	O
.	O

After	O
four	O
rounds	O
of	O
the	O
panning	O
,	O
a	O
number	O
of	O
SARS	O
-	O
CoV	O
virus	B-SPEC
-	O
targeted	O
human	B-SPEC
recombinant	O
Fab	O
antibodies	O
were	O
isolated	O
from	O
the	O
SARS	O
patient	O
antibody	O
library	O
.	O

Most	O
of	O
these	O
were	O
identified	O
to	O
recognize	O
both	O
natural	O
and	O
recombinant	O
SARS	O
spike	O
(	O
S	O
)	O
proteins	O
,	O
two	O
Fab	O
antibodies	O
were	O
specific	O
for	O
the	O
virus	B-SPEC
membrane	O
(	O
M	O
)	O
protein	O
,	O
only	O
one	O
bound	O
to	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
.	O

However	O
,	O
the	O
N	O
protein	O
-	O
targeted	O
Fab	O
or	O
IgG	O
antibodies	O
failed	O
to	O
neutralize	O
the	O
virus	B-SPEC
.	O

These	O
results	O
suggested	O
that	O
the	O
S	O
and	O
M	O
protein	O
-	O
specific	O
neutralizing	O
antibodies	O
could	O
recognize	O
conformational	O
epitopes	O
which	O
might	O
be	O
involved	O
in	O
the	O
binding	O
of	O
virions	O
to	O
cellular	O
receptors	O
and	O
the	O
fusion	O
activity	O
of	O
the	O
virus	B-SPEC
.	O

These	O
results	O
suggested	O
that	O
the	O
S	O
and	O
M	O
protein	O
-	O
specific	O
neutralizing	O
antibodies	O
could	O
recognize	O
conformational	O
epitopes	O
which	O
might	O
be	O
involved	O
in	O
the	O
binding	O
of	O
virions	O
to	O
cellular	O
receptors	O
and	O
the	O
fusion	O
activity	O
of	O
the	O
virus	B-SPEC
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
with	O
the	O
recombinant	O
N	O
proteins	O
of	O
SARS	O
-	O
CoV	O
,	O
229E	O
and	O
OC43	O
to	O
obtain	O
the	O
mAbs	O
by	O
means	O
of	O
hybridoma	O
.	O

The	O
recombinant	O
adenovirus	B-SPEC
bearing	O
S	O
-	O
protein	O
gene	O
was	O
generated	O
by	O
ligation	O
method	O
.	O

The	O
high	O
-	O
level	O
expression	O
of	O
S	O
-	O
protein	O
in	O
HEK293	O
cells	O
mediated	O
by	O
adenovirus	B-SPEC
can	O
be	O
achieved	O
under	O
the	O
optimized	O
expression	O
conditions	O
.	O

This	O
finding	O
is	O
likely	O
to	O
be	O
responsible	O
for	O
virus	B-SPEC
-	O
induced	O
apoptotic	O
signalling	O
.	O

TITLE	O
:	O
Close	O
relationship	O
between	O
SARS	O
-	O
coronavirus	B-SPEC
and	O
group	O
2	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
i	O
)	O
To	O
establish	O
the	O
seroprevalence	O
of	O
Feline	B-SPEC
Coronavirus	B-SPEC
(	O
FCoV	B-SPEC
)	O
infection	O
in	O
two	O
defined	O
groups	O
of	O
cats	B-SPEC
in	O
Sydney	O
:	O
owned	O
and	O
feral	O
cats	B-SPEC
;	O
ii	O
)	O
to	O
identify	O
factors	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
infection	O
with	O
FCoV	B-SPEC
;	O
and	O
iii	O
)	O
to	O
establish	O
the	O
seroprevalence	O
and	O
FCoV	B-SPEC
antibody	O
titres	O
of	O
owned	O
cats	B-SPEC
with	O
immunohistochemically	O
confirmed	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

This	O
distinction	O
was	O
not	O
evident	O
in	O
DSH	O
cats	B-SPEC
in	O
these	O
age	O
groups	O
.	O

TITLE	O
:	O
The	O
comparative	O
pathology	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
avian	B-SPEC
influenza	O
A	O
subtype	O
H5N1	O
--	O
a	O
review	O
.	O

LXA	O
(	O
4	O
)	O
is	O
generated	O
in	O
vivo	O
during	O
acute	O
lung	O
injury	O
,	O
and	O
we	O
observed	O
that	O
nanomolar	O
quantities	O
increased	O
basal	O
epithelial	O
cell	O
proliferation	O
and	O
potently	O
blocked	O
acid	O
-	O
triggered	O
interleukin	O
-	O
6	O
release	O
and	O
neutrophil	O
transmigration	O
across	O
well	O
-	O
differentiated	O
normal	O
human	B-SPEC
bronchial	O
epithelial	O
cells	O
.	O

Routine	O
pathologic	O
and	O
microbiologic	O
investigations	O
,	O
as	O
well	O
as	O
immunohistochemical	O
staining	O
for	O
detection	O
of	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
BVDV	B-SPEC
)	O
antigen	O
,	O
were	O
performed	O
on	O
99	O
calves	O
that	O
died	O
or	O
were	O
euthanized	O
within	O
60	O
days	O
after	O
arrival	O
.	O

M	B-SPEC
.	I-SPEC
bovis	I-SPEC
pneumonia	O
and	O
polyarthritis	O
has	O
emerged	O
as	O
an	O
important	O
cause	O
of	O
mortality	O
in	O
Ontario	O
beef	O
feedlots	O
.	O

The	O
inhibitor	O
was	O
identified	O
through	O
high	O
-	O
throughput	O
screening	O
of	O
a	O
compound	O
library	O
using	O
a	O
luciferase	O
-	O
expressing	O
West	O
Nile	O
(	O
WN	O
)	O
virus	B-SPEC
infection	O
assay	O
.	O

The	O
compound	O
inhibited	O
an	O
epidemic	O
strain	O
of	O
WN	O
virus	B-SPEC
without	O
detectable	O
cytotoxicity	O
(	O
a	O
50	O
%	O
effective	O
concentration	O
of	O
28	O
microM	O
and	O
a	O
compound	O
concentration	O
of	O
>	O
or	O
=	O
300	O
microM	O
required	O
to	O
reduce	O
50	O
%	O
cell	O
viability	O
).	O

Besides	O
WN	O
virus	B-SPEC
,	O
the	O
compound	O
also	O
inhibited	O
other	O
flaviviruses	B-SPEC
(	O
dengue	O
,	O
yellow	O
fever	O
,	O
and	O
St	O
.	O
Louis	O
encephalitis	O
viruses	B-SPEC
),	O
an	O
alphavirus	B-SPEC
(	O
Western	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
),	O
a	O
coronavirus	B-SPEC
(	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
),	O
and	O
a	O
rhabdovirus	B-SPEC
(	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
).	O

This	O
novel	O
inhibitor	O
could	O
be	O
developed	O
for	O
potential	O
treatment	O
of	O
flavivirus	B-SPEC
infection	O
.	O

It	O
is	O
the	O
role	O
of	O
the	O
immune	O
system	O
to	O
contain	O
and	O
control	O
the	O
spread	O
of	O
virus	B-SPEC
infection	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
),	O
and	O
paradoxically	O
,	O
this	O
response	O
may	O
also	O
be	O
pathologic	O
.	O

Recombinant	O
fusion	O
proteins	O
comprised	O
of	O
PgsA	O
and	O
the	O
Spike	O
(	O
S	O
)	O
protein	O
segments	O
SA	O
(	O
residues	O
2	O
to	O
114	O
)	O
and	O
SB	O
(	O
residues	O
264	O
to	O
596	O
)	O
were	O
stably	O
expressed	O
in	O
Lactobacillus	B-SPEC
casei	I-SPEC
.	O

Our	O
data	O
suggested	O
that	O
IBV	B-SPEC
induces	O
a	O
G2	O
/	O
M	O
phase	O
arrest	O
in	O
infected	O
cells	O
to	O
promote	O
favorable	O
conditions	O
for	O
viral	O
replication	O
.	O

So	O
far	O
,	O
M	O
(	O
pro	O
)	O
s	O
have	O
been	O
studied	O
only	O
for	O
corona	B-SPEC
-,	O
arteri	O
-,	O
and	O
roniviruses	O
.	O

TGEV	B-SPEC
does	O
not	O
contain	O
a	O
receptor	O
-	O
destroying	O
enzyme	O
and	O
does	O
not	O
depend	O
on	O
the	O
sialic	O
acid	O
binding	O
activity	O
for	O
infection	O
of	O
cultured	O
cells	O
.	O

TITLE	O
:	O
Localisation	O
and	O
distribution	O
of	O
O	O
-	O
acetylated	O
N	O
-	O
acetylneuraminic	O
acids	O
,	O
the	O
endogenous	O
substrates	O
of	O
the	O
hemagglutinin	O
-	O
esterases	O
of	O
murine	B-SPEC
coronaviruses	O
,	O
in	O
mouse	B-SPEC
tissue	O
.	O

ABSTRACT	O
:	O
Infections	O
by	O
mouse	B-SPEC
hepatitis	O
viruses	B-SPEC
result	O
in	O
disease	O
of	O
the	O
liver	O
,	O
the	O
gastrointestinal	O
tract	O
,	O
respiratory	O
tract	O
,	O
and	O
the	O
central	O
nervous	O
system	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
,	O
SCV	B-SPEC
,	O
has	O
been	O
recently	O
responsible	O
of	O
a	O
sudden	O
and	O
widespread	O
infection	O
which	O
caused	O
almost	O
800	O
victims	O
.	O

Here	O
,	O
the	O
quaternary	O
structure	O
of	O
SCV	B-SPEC
helicase	O
has	O
been	O
predicted	O
,	O
which	O
will	O
provide	O
a	O
solid	O
foundation	O
for	O
the	O
rational	O
design	O
of	O
other	O
antiviral	O
helicase	O
inhibitors	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
papain	O
-	O
like	O
protease	O
:	O
structure	O
of	O
a	O
viral	O
deubiquitinating	O
enzyme	O
.	O

This	O
enzyme	O
plays	O
an	O
essential	O
role	O
in	O
viral	O
replication	O
and	O
transcription	O
since	O
a	O
mutation	O
in	O
the	O
related	O
H229E	O
human	B-SPEC
coronavirus	I-SPEC
nsp15	O
gene	O
can	O
abolish	O
viral	O
RNA	O
synthesis	O
.	O

TITLE	O
:	O
Molecular	O
analysis	O
of	O
Brazilian	O
strains	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
reveals	O
a	O
deletion	O
within	O
the	O
hypervariable	O
region	O
of	O
the	O
S1	O
subunit	O
of	O
the	O
spike	O
glycoprotein	O
also	O
found	O
in	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
.	O

TITLE	O
:	O
Isolation	O
of	O
a	O
coronavirus	B-SPEC
from	O
a	O
green	O
-	O
cheeked	O
Amazon	B-SPEC
parrot	I-SPEC
(	O
Amazon	B-SPEC
viridigenalis	O
Cassin	O
).	O

Electron	O
microscopic	O
examination	O
of	O
cytopathic	O
agents	O
derived	O
from	O
both	O
types	O
of	O
cell	O
cultures	O
suggested	O
that	O
it	O
was	O
a	O
coronavirus	B-SPEC
.	O

Several	O
other	O
oligonucleotide	O
primer	O
pairs	O
that	O
give	O
PCR	O
products	O
corresponding	O
to	O
genes	O
3	O
,	O
5	O
,	O
N	O
and	O
the	O
3	O
'-	O
untranslated	O
region	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
,	O
turkey	B-SPEC
coronavirus	B-SPEC
and	O
pheasant	O
coronavirus	B-SPEC
(	O
all	O
in	O
group	O
3	O
)	O
failed	O
to	O
do	O
so	O
with	O
RNA	O
from	O
the	O
parrot	B-SPEC
coronavirus	B-SPEC
.	O

The	O
strains	O
were	O
selected	O
for	O
cross	O
-	O
challenge	O
in	O
specific	O
pathogen	O
free	O
chickens	B-SPEC
and	O
virus	B-SPEC
neutralization	O
in	O
chick	O
embryos	O
on	O
the	O
basis	O
of	O
partial	O
S1	O
sequence	O
amino	O
acid	O
identity	O
values	O
.	O

The	O
severity	O
of	O
his	O
injuries	O
required	O
him	O
to	O
be	O
managed	O
with	O
bilateral	O
underwater	O
seal	B-SPEC
drains	O
,	O
cervical	O
spine	O
stabilisation	O
and	O
sedation	O
with	O
mechanical	O
ventilation	O
.	O

These	O
results	O
provide	O
a	O
structural	O
rationale	O
for	O
the	O
function	O
of	O
a	O
major	O
determinant	O
of	O
SCV	B-SPEC
immunogenicity	O
and	O
neutralization	O
,	O
the	O
development	O
of	O
SCV	B-SPEC
therapeutics	O
based	O
on	O
the	O
antibody	O
paratope	O
and	O
epitope	O
,	O
and	O
a	O
retrovaccinology	O
approach	O
for	O
the	O
design	O
of	O
anti	O
-	O
SCV	B-SPEC
vaccines	O
.	O

The	O
introduction	O
of	O
new	O
detection	O
methods	O
showed	O
that	O
mouse	B-SPEC
parvovirus	B-SPEC
and	O
rat	B-SPEC
parvovirus	B-SPEC
,	O
both	O
members	O
of	O
the	O
Parvoviridae	B-SPEC
family	B-SPEC
,	O
remain	O
a	O
major	O
threat	O
to	O
laboratory	O
mice	B-SPEC
and	O
rats	B-SPEC
.	O

However	O
,	O
the	O
M	O
gene	O
sequence	O
of	O
both	O
BCoV	O
and	O
HCV	B-SPEC
-	O
OC43	O
might	O
not	O
contain	O
a	O
signal	O
peptide	O
,	O
suggesting	O
the	O
M	O
protein	O
might	O
be	O
unlikely	O
to	O
be	O
exposed	O
to	O
the	O
O	O
-	O
glycosylation	O
machinery	O
in	O
vivo	O
.	O

Chest	O
radiographs	O
from	O
several	O
animals	B-SPEC
in	O
groups	O
I	O
and	O
II	O
revealed	O
unifocal	O
or	O
multifocal	O
pneumonia	O
that	O
peaked	O
between	O
days	O
8	O
and	O
10	O
postinfection	O
.	O

The	O
wet	O
-	O
to	O
-	O
dry	O
lung	O
weight	O
ratio	O
and	O
bronchial	O
obstruction	O
scores	O
were	O
lower	O
for	O
sheep	B-SPEC
receiving	O
albuterol	O
.	O

While	O
effective	O
vaccines	O
have	O
been	O
developed	O
for	O
some	O
,	O
such	O
as	O
poliovirus	B-SPEC
and	O
hepatitis	O
A	O
,	O
others	O
such	O
as	O
coxsackievirus	B-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
have	O
no	O
accredited	O
drug	O
treatments	O
.	O

Some	O
inhibitors	O
have	O
also	O
been	O
shown	O
to	O
decrease	O
viral	O
replication	O
in	O
cell	O
culture	O
and	O
animal	B-SPEC
models	O
.	O

To	O
determine	O
the	O
importance	O
of	O
these	O
negatively	O
charged	O
residues	O
,	O
a	O
series	O
of	O
alanine	O
and	O
other	O
charged	O
-	O
residue	O
substitutions	O
were	O
introduced	O
in	O
place	O
of	O
those	O
in	O
the	O
N	O
gene	O
within	O
a	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
A59	O
infectious	O
clone	O
.	O

The	O
compensatory	O
role	O
of	O
the	O
new	O
changes	O
was	O
confirmed	O
by	O
the	O
construction	O
of	O
new	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Inhibition	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infectivity	O
by	O
peptides	O
analogous	O
to	O
the	O
viral	O
spike	O
protein	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
the	O
cause	O
of	O
an	O
atypical	O
pneumonia	O
that	O
affected	O
Asia	O
,	O
North	O
America	O
and	O
Europe	O
in	O
2002	O
-	O
2003	O
.	O

Five	O
regions	O
of	O
high	O
interfacial	O
hydrophobicity	O
spanning	O
the	O
length	O
of	O
the	O
S2	O
subunit	O
of	O
SARS	O
-	O
CoV	O
and	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
were	O
identified	O
.	O

In	O
comparison	O
to	O
SPF	O
cats	B-SPEC
,	O
FIP	O
cats	B-SPEC
had	O
significantly	O
higher	O
IL	O
-	O
1beta	O
levels	O
and	O
lower	O
TNF	O
levels	O
in	O
mesenteric	O
lymph	O
nodes	O
and	O
lower	O
M	O
-	O
CSF	O
levels	O
in	O
the	O
spleen	O
.	O

ABSTRACT	O
:	O
Because	O
of	O
the	O
conflicting	O
data	O
concerning	O
the	O
SARS	O
-	O
CoV	O
inhibitory	O
efficacy	O
of	O
ribavirin	O
,	O
an	O
inosine	O
monophosphate	O
(	O
IMP	O
)	O
dehydrogenase	O
inhibitor	O
,	O
studies	O
were	O
done	O
to	O
evaluate	O
the	O
efficacy	O
of	O
ribavirin	O
and	O
other	O
IMP	O
dehydrogenase	O
inhibitors	O
(	O
5	O
-	O
ethynyl	O
-	O
1	O
-	O
beta	O
-	O
D	O
-	O
ribofuranosylimidazole	O
-	O
4	O
-	O
carboxamide	O
(	O
EICAR	O
),	O
mizoribine	O
,	O
and	O
mycophenolic	O
acid	O
)	O
in	O
preventing	O
viral	O
replication	O
in	O
the	O
lungs	O
of	O
BALB	O
/	O
c	O
mice	B-SPEC
,	O
a	O
replication	O
model	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
infections	O
(	O
Subbarao	O
,	O
K	O
.,	O
McAuliffe	O
,	O
J	O
.,	O
Vogel	O
,	O
L	O
.,	O
Fahle	O
,	O
G	O
.,	O
Fischer	O
,	O
S	O
.,	O
Tatti	O
,	O
K	O
.,	O
Packard	O
,	O
M	O
.,	O
Shieh	O
,	O
W	O
.	O
J	O
.,	O
Zaki	O
,	O
S	O
.,	O
Murphy	O
,	O
B	O
.,	O
2004	O
.	O

In	O
addition	O
,	O
ribavirin	O
treatment	O
seemed	O
also	O
to	O
promote	O
the	O
production	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
4	O
days	O
after	O
cessation	O
of	O
treatment	O
,	O
although	O
after	O
3	O
days	O
of	O
treatment	O
ribavirin	O
inhibited	O
pro	O
-	O
inflammatory	O
cytokine	O
production	O
in	O
infected	O
mice	B-SPEC
,	O
significantly	O
reducing	O
the	O
levels	O
of	O
the	O
cytokines	O
IL	O
-	O
1alpha	O
,	O
interleukin	O
-	O
5	O
(	O
IL	O
-	O
5	O
),	O
monocyte	O
chemotactic	O
protein	O
-	O
1	O
(	O
MCP	O
-	O
1	O
),	O
and	O
granulocyte	O
-	O
macrophage	O
colony	O
stimulating	O
factor	O
(	O
GM	O
-	O
CSF	O
).	O

To	O
investigate	O
if	O
this	O
newly	O
discovered	O
virus	B-SPEC
is	O
associated	O
with	O
acute	O
respiratory	O
infections	O
in	O
pediatric	O
patients	O
in	O
Beijing	O
,	O
tests	O
were	O
developed	O
to	O
detect	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
gene	O
fragments	O
from	O
throat	O
swab	O
and	O
nasopharyngeal	O
aspirates	O
collected	O
from	O
children	O
in	O
outpatient	O
and	O
inpatient	O
departments	O
with	O
ARI	O
in	O
Beijing	O
from	O
Dec	O
.	O
2003	O
to	O
Mar	O
.	O
2004	O
.	O

S2	O
gene	O
fragment	O
was	O
amplified	O
from	O
SARS	O
-	O
CoV	O
GD322	O
genome	O
with	O
RT	O
-	O
PCR	O
and	O
ligated	O
to	O
pGEM	O
-	O
T	O
vector	O
for	O
sequence	O
analysis	O
after	O
transformation	O
of	O
the	O
plasmid	O
into	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
DH5a	O
.	O

In	O
acute	O
lung	O
injury	O
,	O
P	O
-	O
ACV	O
preserves	O
oxygenation	O
and	O
hemodynamic	O
function	O
with	O
less	O
respiratory	O
effort	O
compared	O
with	O
BIPAP	O
and	O
reduces	O
the	O
need	O
for	O
sedation	O
compared	O
with	O
PCV	B-SPEC
.	O

Many	O
of	O
these	O
strategies	O
could	O
be	O
considered	O
for	O
use	O
in	O
the	O
post	O
-	O
2003	O
SARS	O
era	O
,	O
especially	O
in	O
preparation	O
for	O
an	O
influenza	O
or	O
Avian	B-SPEC
influenza	O
pandemic	O
.	O

TITLE	O
:	O
HLA	O
-	O
A	O
*	O
0201	O
T	O
-	O
cell	O
epitopes	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
nucleocapsid	O
and	O
spike	O
proteins	O
.	O

First	O
,	O
we	O
screened	O
SARS	O
N	O
and	O
S	O
amino	O
acid	O
sequences	O
for	O
allele	O
-	O
specific	O
motif	O
matching	O
those	O
in	O
human	B-SPEC
HLA	O
-	O
A2	O
.	O
1	O
MHC	O
-	O
I	O
molecules	O
.	O

Here	O
we	O
combined	O
screening	O
of	O
phage	O
display	O
random	O
peptide	O
libraries	O
with	O
a	O
unique	O
computer	O
algorithm	O
""""	O
Mapitope	O
""""	O
to	O
identify	O
the	O
discontinuous	O
epitope	O
of	O
80R	O
,	O
a	O
potent	O
neutralizing	O
human	B-SPEC
anti	O
-	O
SARS	O
monoclonal	O
antibody	O
against	O
the	O
spike	O
protein	O
.	O

The	O
main	O
research	O
question	O
is	O
:	O
what	O
can	O
we	O
learn	O
from	O
the	O
SARS	O
experience	O
about	O
effective	O
prevention	O
of	O
HIV	B-SPEC
/	O
AIDS	O
?	O

Moreover	O
,	O
this	O
new	O
class	B-SPEC
of	O
bioorganometallic	O
compounds	O
exert	O
antiviral	O
effects	O
with	O
some	O
selectivity	O
toward	O
SARS	O
-	O
CoV	O
infection	O
.	O

The	O
patient	O
was	O
stable	O
with	O
normoxia	O
by	O
day	O
20	O
,	O
in	O
spite	O
of	O
pulmonary	O
congestion	O
-	O
like	O
infiltrates	O
on	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

This	O
was	O
probably	O
due	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
season	O
(	O
the	O
summer	O
months	O
)	O
when	O
the	O
animals	B-SPEC
were	O
commingled	O
.	O

In	O
the	O
six	O
-	O
month	O
period	O
August	O
-	O
February	O
,	O
38	O
%	O
of	O
the	O
animals	B-SPEC
were	O
treated	O
one	O
or	O
more	O
times	O
for	O
BRD	O
and	O
mortality	O
was	O
0	O
.	O
7	O
%.	O

A	O
novel	O
member	O
of	O
the	O
coronavirus	B-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
has	O
been	O
identified	O
as	O
the	O
causative	O
agent	O
.	O

To	O
enrich	O
the	O
low	O
-	O
abundance	O
proteins	O
in	O
human	B-SPEC
plasma	O
,	O
two	O
highly	O
abundant	O
proteins	O
,	O
albumin	O
and	O
IgG	O
,	O
were	O
first	O
removed	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
considered	O
as	O
a	O
protective	O
Ag	O
for	O
vaccine	O
design	O
.	O

Diagnosis	O
and	O
treatment	O
of	O
rhinovirus	B-SPEC
respiratory	O
infections	O
.	O

Association	O
of	O
rhinovirus	B-SPEC
infections	O
with	O
asthma	O
.	O

TITLE	O
:	O
Mitochondrial	O
location	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3b	O
protein	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
a	O
distant	O
member	O
of	O
the	O
Group	O
2	O
coronaviruses	O
,	O
has	O
recently	O
been	O
identified	O
as	O
the	O
etiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

The	O
database	O
comprises	O
data	O
from	O
4	O
,	O
459	O
patients	O
with	O
severe	O
sepsis	B-SPEC
(	O
DrotAA	O
,	O
n	O
=	O
3	O
,	O
228	O
;	O
placebo	O
,	O
n	O
=	O
1	O
,	O
231	O
)	O
included	O
in	O
five	O
clinical	O
trials	O
conducted	O
in	O
tertiary	O
care	O
institutions	O
in	O
28	O
countries	O
.	O

Using	O
an	O
integrated	O
database	O
of	O
five	O
severe	O
sepsis	B-SPEC
trials	O
and	O
appropriate	O
statistical	O
adjustments	O
to	O
reduce	O
sources	O
of	O
potential	O
bias	B-SPEC
,	O
earlier	O
treatment	O
with	O
DrotAA	O
seemed	O
to	O
be	O
associated	O
with	O
a	O
lower	O
risk	O
-	O
adjusted	O
mortality	O
than	O
later	O
treatment	O
.	O

TITLE	O
:	O
SARS	O
-	O
CoV	O
virus	B-SPEC
-	O
host	O
interactions	O
and	O
comparative	O
etiologies	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
as	O
determined	O
by	O
transcriptional	O
and	O
cytokine	O
profiling	O
of	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
tissues	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
may	O
cause	O
a	O
highly	O
lethal	O
infection	O
in	O
cats	B-SPEC
,	O
in	O
spite	O
of	O
a	O
usually	O
strong	O
humoral	O
immune	O
response	O
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
antibodies	O
on	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)-	O
infected	O
monocytes	O
was	O
investigated	O
.	O

ABSTRACT	O
:	O
The	O
primary	O
target	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
epithelial	O
cells	O
in	O
the	O
respiratory	O
and	O
intestinal	O
tract	O
.	O

The	O
virus	B-SPEC
-	O
laden	O
air	O
was	O
then	O
transported	O
by	O
prevailing	O
winds	O
to	O
adjacent	O
buildings	O
at	O
Amoy	O
Gardens	O
,	O
where	O
additional	O
exposures	O
occurred	O
.	O

Leptospirosis	O
,	O
toxoplasmosis	O
and	O
chlamydiosis	O
have	O
been	O
diagnosed	O
as	O
the	O
major	O
causes	O
of	O
abortion	O
in	O
llamas	B-SPEC
and	O
alpacas	B-SPEC
.	O

TITLE	O
:	O
[	O
Emergent	O
viruses	B-SPEC
:	O
SARS	O
-	O
associate	O
coronavirus	B-SPEC
and	O
H5N1	O
influenza	B-SPEC
virus	I-SPEC
].	O

We	O
have	O
independently	O
confirmed	O
that	O
the	O
full	O
polypeptide	O
of	O
E	O
protein	O
can	O
also	O
aggregate	O
as	O
pentamers	O
after	O
expression	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

ABSTRACT	O
:	O
In	O
2005	O
,	O
a	O
new	O
human	B-SPEC
coronavirus	I-SPEC
,	O
HCoV	O
-	O
HKU1	O
,	O
was	O
identified	O
in	O
Hong	O
Kong	O
.	O

We	O
screened	O
respiratory	O
specimens	O
collected	O
from	O
December	O
16	O
,	O
2001	O
,	O
to	O
December	O
15	O
,	O
2002	O
,	O
from	O
children	O
<	O
5	O
years	O
of	O
age	O
who	O
tested	O
negative	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
viruses	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
and	O
adenovirus	B-SPEC
for	O
HCoV	O
-	O
HKU1	O
by	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

TITLE	O
:	O
Phase	O
I	O
trial	O
of	O
the	O
trifunctional	O
anti	O
-	O
HER2	O
x	O
anti	O
-	O
CD3	O
antibody	O
ertumaxomab	O
in	O
metastatic	O
breast	O
cancer	B-SPEC
.	O

The	O
induction	O
of	O
human	B-SPEC
anti	O
-	O
mouse	B-SPEC
/	O
anti	O
-	O
rat	B-SPEC
antibodies	O
was	O
detected	O
in	O
5	O
out	O
of	O
16	O
(	O
31	O
%)	O
patients	O
.	O

Direct	O
involvement	O
of	O
the	O
KKS	O
in	O
the	O
pathogenesis	O
of	O
experimental	O
acute	O
arthritis	O
and	O
acute	O
and	O
chronic	O
enterocolitis	O
has	O
been	O
documented	O
by	O
previous	O
studies	O
from	O
our	O
laboratory	O
using	O
experimental	O
animal	B-SPEC
models	O
.	O

It	O
has	O
been	O
found	O
that	O
in	O
HK	O
deficient	O
Lewis	O
rats	B-SPEC
,	O
experimental	O
IBD	O
was	O
much	O
less	O
severe	O
.	O

We	O
have	O
showed	O
that	O
a	O
monoclonal	O
antibody	O
targeting	O
HK	O
decreases	O
angiogenesis	O
and	O
arrests	O
tumor	O
growth	O
in	O
a	O
syngeneic	O
animal	B-SPEC
model	O
.	O

TITLE	O
:	O
Biochemical	O
aspects	O
of	O
coronavirus	B-SPEC
replication	O
and	O
virus	B-SPEC
-	O
host	O
interaction	O
.	O

The	O
balance	O
between	O
the	O
up	O
-	O
and	O
downregulated	O
genes	O
could	O
explain	O
the	O
pathogenesis	O
caused	O
by	O
these	O
viruses	B-SPEC
.	O

Collectively	O
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
S	O
protein	O
belongs	O
to	O
the	O
type	O
I	O
fusion	O
protein	O
,	O
which	O
is	O
characterized	O
by	O
the	O
existence	O
of	O
two	O
heptad	O
-	O
repeat	O
regions	O
(	O
HR1	O
and	O
HR2	O
),	O
furthermore	O
,	O
the	O
available	O
knowledge	O
concerning	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
fusion	O
core	O
may	O
make	O
it	O
possible	O
to	O
design	O
small	O
molecule	O
or	O
polypeptide	O
drugs	O
targeting	O
the	O
membrane	O
fusion	O
,	O
a	O
crucial	O
step	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Nearly	O
15	O
%	O
of	O
cancer	B-SPEC
patients	O
experience	O
acute	O
respiratory	O
failure	O
(	O
ARF	O
)	O
requiring	O
admission	O
to	O
the	O
intensive	O
care	O
unit	O
,	O
where	O
their	O
mortality	O
is	O
about	O
50	O
%.	O

As	O
PRCoV	O
shares	O
some	O
epitopes	O
for	O
neutralizing	O
antibodies	O
with	O
TGEV	B-SPEC
,	O
it	O
acts	O
like	O
a	O
nature	O
-	O
made	O
vaccine	O
against	O
TGEV	B-SPEC
resulting	O
in	O
a	O
drastic	O
reduction	O
of	O
TGE	O
outbreaks	O
in	O
Europe	O
.	O

As	O
there	O
is	O
currently	O
no	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
-	O
specific	O
and	O
effective	O
vaccine	O
or	O
drug	O
therapy	O
available	O
,	O
we	O
evaluated	O
several	O
existing	O
antiviral	O
drugs	O
and	O
new	O
synthetic	O
compounds	O
as	O
inhibitors	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
targeting	O
multiple	O
stages	O
of	O
the	O
replication	O
cycle	O
.	O

In	O
parallel	O
,	O
another	O
recombinant	O
pHS	O
was	O
generated	O
by	O
introducing	O
a	O
fragment	O
designated	O
S1	O
encoding	O
the	O
major	O
antigen	O
sites	O
of	O
S	O
gene	O
from	O
TGEV	B-SPEC
strain	O
TH	O
-	O
98	O
into	O
a	O
prokaryotic	O
expression	O
vector	O
pP	O
(	O
RO	O
)	O
EX	O
HTc	O
.	O

We	O
show	O
here	O
that	O
while	O
infection	O
of	O
the	O
prototype	O
MHV	B-SPEC
-	O
A59	O
strain	O
is	O
not	O
sensitive	O
to	O
pretreatment	O
with	O
lysosomotropic	O
agents	O
,	O
MHV	B-SPEC
-	O
2	O
replication	O
is	O
significantly	O
inhibited	O
by	O
these	O
agents	O
.	O

The	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
,	O
localizes	O
to	O
the	O
cytoplasm	O
and	O
the	O
nucleolus	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
phylogeny	O
based	O
on	O
2D	O
graphical	O
representation	O
of	O
DNA	O
sequence	O
.	O

Confocal	O
microscopy	O
results	O
indicated	O
that	O
SARS	O
8b	O
is	O
localized	O
in	O
both	O
nucleus	O
and	O
cytoplasm	O
of	O
mammalian	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
We	O
have	O
recently	O
described	O
the	O
discovery	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
coronavirus	B-SPEC
HKU1	O
(	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
),	O
associated	O
with	O
community	O
-	O
acquired	O
pneumonia	O
.	O

In	O
this	O
12	O
-	O
month	O
prospective	O
study	O
,	O
4	O
,	O
181	O
nasopharyngeal	O
aspirates	O
from	O
patients	O
with	O
acute	O
respiratory	O
tract	O
infections	O
were	O
subjected	O
to	O
reverse	O
transcription	O
-	O
PCRs	O
specific	O
for	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
and	O
human	B-SPEC
coronaviruses	O
NL63	O
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
),	O
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
),	O
and	O
229E	O
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
).	O

Coronaviruses	O
were	O
detected	O
in	O
87	O
(	O
2	O
.	O
1	O
%)	O
patients	O
,	O
with	O
13	O
(	O
0	O
.	O
3	O
%)	O
positive	O
for	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
,	O
17	O
(	O
0	O
.	O
4	O
%)	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
53	O
(	O
1	O
.	O
3	O
%)	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
and	O
4	O
(	O
0	O
.	O
1	O
%)	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

The	O
asymptomatic	O
case	O
patient	O
and	O
the	O
second	O
index	O
case	O
patient	O
with	O
SARS	O
in	O
the	O
2003	O
-	O
2004	O
outbreak	O
both	O
worked	O
in	O
the	O
same	O
restaurant	O
,	O
where	O
they	O
served	O
palm	O
civets	B-SPEC
,	O
which	O
were	O
found	O
to	O
carry	O
SARS	O
-	O
associated	O
coronaviruses	O
.	O

Forty	O
-	O
eight	O
respiratory	O
viruses	B-SPEC
were	O
identified	O
:	O
influenza	B-SPEC
virus	I-SPEC
A	O
(	O
n	O
=	O
16	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
(	O
n	O
=	O
5	O
),	O
adenovirus	B-SPEC
(	O
n	O
=	O
8	O
),	O
parainfluenza	O
viruses	B-SPEC
(	O
n	O
=	O
5	O
),	O
enteroviruses	B-SPEC
(	O
n	O
=	O
1	O
),	O
rhinoviruses	B-SPEC
(	O
n	O
=	O
8	O
)	O
and	O
coronavirus	B-SPEC
(	O
n	O
=	O
5	O
).	O

Here	O
,	O
we	O
suggest	O
aspects	O
of	O
an	O
ideal	O
animal	B-SPEC
model	O
for	O
studies	O
of	O
SARS	O
pathogenesis	O
and	O
vaccine	O
development	O
and	O
present	O
our	O
assessment	O
of	O
the	O
strengths	O
and	O
limitations	O
of	O
the	O
current	O
animal	B-SPEC
models	O
for	O
SARS	O
.	O

The	O
virus	B-SPEC
induces	O
severe	O
injury	O
of	O
lung	O
tissue	O
,	O
as	O
well	O
as	O
lymphopenia	O
and	O
destruction	O
of	O
the	O
architecture	O
of	O
lymphatic	O
tissue	O
by	O
as	O
-	O
yet	O
-	O
unknown	O
mechanisms	O
.	O

Microarray	O
analysis	O
was	O
applied	O
to	O
assess	O
changes	O
in	O
cellular	O
expression	O
profiles	O
during	O
different	O
stages	O
of	O
two	O
independent	O
,	O
highly	O
controlled	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infections	O
in	O
vitro	O
.	O

It	O
was	O
concluded	O
that	O
MHV	B-SPEC
-	O
A59	O
infection	O
in	O
fibroblast	O
-	O
like	O
cells	O
triggers	O
very	O
few	O
transcriptional	O
cellular	O
responses	O
in	O
the	O
first	O
3	O
h	O
of	O
infection	O
.	O

Other	O
pathogens	O
identified	O
included	O
coronavirus	B-SPEC
OC43	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
and	O
rhinovirus	B-SPEC
.	O

TITLE	O
:	O
Biophysical	O
characterization	O
of	O
HRC	O
peptide	O
analogs	O
interaction	O
with	O
heptad	O
repeat	O
regions	O
of	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
Spike	O
fusion	O
protein	O
core	O
.	O

We	O
describe	O
the	O
structure	O
of	O
the	O
two	O
proteolytically	O
resistant	O
domains	O
of	O
the	O
N	O
protein	O
from	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
a	O
prototype	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Novel	O
mfgl2	O
antisense	O
plasmid	O
inhibits	O
murine	B-SPEC
fgl2	O
expression	O
and	O
ameliorates	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
3	O
-	O
induced	O
fulminant	O
hepatitis	O
in	O
BALB	O
/	O
cJ	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
the	O
cytokine	O
profiles	O
of	O
clinically	O
healthy	O
cats	B-SPEC
naturally	O
infected	O
with	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
),	O
of	O
cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
and	O
of	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
cats	B-SPEC
were	O
investigated	O
in	O
whole	O
blood	O
using	O
a	O
traditional	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
and	O
a	O
semi	O
-	O
quantitative	O
method	O
of	O
analysis	O
based	O
on	O
computerised	O
quantification	O
of	O
positive	O
bands	O
.	O

Thus	O
,	O
our	O
study	O
provides	O
the	O
evidence	O
that	O
SARS	O
-	O
CoV	O
infection	O
in	O
humans	B-SPEC
can	O
induce	O
cellular	O
immune	O
response	O
that	O
is	O
persistent	O
for	O
a	O
long	O
period	O
of	O
time	O
.	O

Thirty	O
-	O
six	O
healthy	O
dogs	B-SPEC
were	O
randomly	O
divided	O
into	O
normal	O
control	O
group	O
(	O
N	O
group	O
),	O
ARDS	O
group	O
(	O
M	O
group	O
)	O
and	O
ventilation	O
group	O
(	O
A	O
-	O
D	O
groups	O
)	O
based	O
on	O
a	O
series	O
of	O
random	O
number	O
.	O

A	O
total	O
of	O
396	O
cleavage	O
points	O
are	O
found	O
in	O
the	O
36	O
SARS	O
-	O
Coronavirus	B-SPEC
and	O
11	O
cleavable	O
octapeptides	O
abstracted	O
from	O
the	O
396	O
cleavage	O
sites	O
.	O

Such	O
a	O
discovery	O
can	O
be	O
used	O
to	O
rapidly	O
and	O
reliably	O
diagnose	O
SARS	O
coronavirus	B-SPEC
for	O
both	O
basic	O
research	O
in	O
laboratories	O
and	O
practical	O
application	O
in	O
clinics	O
.	O

ABSTRACT	O
:	O
Development	O
of	O
an	O
effective	O
vaccine	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
remains	O
to	O
be	O
a	O
priority	O
to	O
prevent	O
possible	O
re	O
-	O
emergence	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Because	O
enhancement	O
of	O
SARS	O
-	O
CoV	O
infection	O
by	O
subneutralizing	O
antibody	O
concentrations	O
is	O
of	O
concern	O
,	O
we	O
show	O
here	O
that	O
anti	O
-	O
SARS	O
-	O
CoV	O
antibodies	O
do	O
not	O
convert	O
the	O
abortive	O
infection	O
of	O
primary	O
human	B-SPEC
macrophages	O
by	O
SARS	O
-	O
CoV	O
into	O
a	O
productive	O
one	O
.	O

Conversely	O
,	O
the	O
M	O
protein	O
expressed	O
in	O
mammalian	B-SPEC
cells	O
did	O
not	O
induce	O
apoptosis	O
.	O

From	O
our	O
experience	O
,	O
we	O
suggest	O
that	O
computed	O
tomographic	O
scans	O
of	O
the	O
thorax	O
,	O
lung	O
function	O
tests	O
,	O
and	O
careful	O
follow	O
-	O
up	O
monitoring	O
should	O
play	O
a	O
vital	O
role	O
in	O
the	O
assessment	O
of	O
patients	O
during	O
the	O
convalescent	O
period	O
,	O
before	O
certification	O
of	O
fitness	O
to	O
dive	B-SPEC
.	O

TITLE	O
:	O
Conformational	O
states	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
ectodomain	O
.	O

TITLE	O
:	O
Both	O
spike	O
and	O
background	O
genes	O
contribute	O
to	O
murine	B-SPEC
coronavirus	I-SPEC
neurovirulence	O
.	O

ABSTRACT	O
:	O
The	O
close	O
genetic	O
and	O
antigenic	O
relatedness	O
among	O
the	O
group	O
2	O
coronaviruses	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
),	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
and	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHEV	O
)	O
suggests	O
that	O
these	O
three	O
viruses	B-SPEC
with	O
different	O
host	O
specificities	O
diverged	O
fairly	O
recently	O
.	O

After	O
the	O
mice	B-SPEC
had	O
been	O
immunized	O
intramuscularly	O
and	O
/	O
or	O
intraperitoneally	O
with	O
pcDNA3	O
.	O
1	O
-	O
N	O
and	O
rAd	O
-	O
N	O
in	O
prime	O
-	O
triple	O
boost	O
immunization	O
,	O
humoral	O
and	O
cellular	O
immune	O
responses	O
were	O
detected	O
.	O

It	O
appears	O
,	O
therefore	O
,	O
that	O
coronavirus	B-SPEC
E	O
proteins	O
in	O
general	O
,	O
belong	O
to	O
the	O
virus	B-SPEC
ion	O
channels	O
family	B-SPEC
.	O

The	O
decrease	O
in	O
disease	O
severity	O
was	O
not	O
due	O
to	O
a	O
switch	O
from	O
Th1	O
to	O
Th2	O
predominance	O
in	O
rJ	O
.	O
M	O
(	O
Y135Q	O
)-	O
infected	O
mice	B-SPEC
,	O
an	O
effect	O
on	O
CD8	O
T	O
-	O
cell	O
function	O
,	O
or	O
differential	O
expression	O
of	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
by	O
JHMV	O
-	O
specific	O
CD4	O
T	O
cells	O
.	O

These	O
results	O
show	O
that	O
the	O
response	O
to	O
a	O
single	O
virus	B-SPEC
-	O
specific	O
CD4	O
T	O
-	O
cell	O
epitope	O
may	O
contribute	O
to	O
a	O
pathogenic	O
host	O
response	O
in	O
the	O
setting	O
of	O
acute	O
viral	O
disease	O
and	O
that	O
abrogation	O
of	O
this	O
response	O
ameliorates	O
clinical	O
disease	O
without	O
diminishing	O
virus	B-SPEC
clearance	O
.	O

TITLE	O
:	O
[	O
Follow	O
up	O
study	O
on	O
viruses	B-SPEC
associated	O
with	O
SARS	O
among	O
the	O
SARS	O
patients	O
].	O

TITLE	O
:	O
Understanding	O
the	O
accessory	O
viral	O
proteins	O
unique	O
to	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Identification	O
and	O
structure	O
-	O
based	O
optimization	O
of	O
novel	O
dihydropyrones	O
as	O
potent	O
HCV	B-SPEC
RNA	O
polymerase	O
inhibitors	O
.	O

TITLE	O
:	O
Survey	O
of	O
dogs	B-SPEC
in	O
Japan	O
for	O
group	O
2	O
canine	O
coronavirus	B-SPEC
infection	O
.	O

Moreover	O
,	O
MHV	B-SPEC
Nsp10	O
interacts	O
with	O
tRNA	O
,	O
single	O
-	O
stranded	O
RNA	O
,	O
double	O
-	O
stranded	O
DNA	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
single	O
-	O
stranded	O
DNA	O
as	O
shown	O
by	O
gel	O
-	O
shift	O
experiments	O
.	O

A	O
highly	O
conserved	O
RNA	O
structure	O
in	O
the	O
3	O
'	O
non	O
-	O
translated	O
region	O
of	O
the	O
SARS	O
virus	B-SPEC
was	O
cleaved	O
preferentially	O
at	O
one	O
of	O
the	O
unpaired	O
uridylate	O
bases	O
,	O
demonstrating	O
that	O
both	O
RNA	O
structure	O
and	O
base	O
-	O
pairing	O
can	O
affect	O
cleavage	O
by	O
Nsp15	O
.	O

Based	O
on	O
the	O
lessons	O
learnt	O
,	O
Singapore	O
has	O
further	O
strengthened	O
its	O
operational	O
readiness	O
and	O
laboratory	O
safety	O
to	O
respond	O
to	O
SARS	O
,	O
avian	B-SPEC
flu	O
and	O
other	O
emerging	O
diseases	O
.	O

Even	O
if	O
SARS	O
does	O
not	O
reemerge	O
,	O
the	O
experience	O
gained	O
from	O
such	O
planning	O
is	O
valuable	O
in	O
preparing	O
for	O
threats	O
of	O
bioterrorism	O
or	O
a	O
global	O
avian	B-SPEC
influenza	O
A	O
(	O
H5N1	O
)	O
virus	B-SPEC
pandemic	O
.	O

At	O
the	O
beginning	O
of	O
the	O
outbreak	O
,	O
there	O
was	O
practically	O
no	O
information	O
on	O
this	O
disease	O
,	O
which	O
did	O
not	O
even	O
have	O
a	O
name	B-SPEC
until	O
16	O
March	O
2003	O
,	O
except	O
that	O
it	O
was	O
infectious	O
and	O
could	O
result	O
in	O
potentially	O
fatal	O
respiratory	O
failure	O
.	O

The	O
levels	O
of	O
inactivation	O
expressed	O
as	O
log	O
-	O
reduction	O
were	O
as	O
follows	O
:	O
cell	O
-	O
free	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
-	O
1	O
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
),	O
greater	O
than	O
6	O
.	O
8	O
;	O
cell	O
-	O
associated	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
greater	O
than	O
6	O
.	O
4	O
;	O
human	B-SPEC
T	O
-	O
lymphotropic	O
virus	B-SPEC
-	O
I	O
(	O
HTLV	O
-	O
I	O
),	O
4	O
.	O
5	O
;	O
HTLV	O
-	O
II	O
,	O
greater	O
than	O
5	O
.	O
7	O
;	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
)	O
and	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
,	O
greater	O
than	O
4	O
.	O
5	O
;	O
duck	B-SPEC
HBV	B-SPEC
,	O
4	O
.	O
4	O
to	O
4	O
.	O
5	O
;	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
6	O
.	O
0	O
;	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
5	O
.	O
5	O
;	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
6	O
.	O
8	O
;	O
bluetongue	B-SPEC
virus	I-SPEC
,	O
5	O
.	O
1	O
;	O
human	B-SPEC
adenovirus	B-SPEC
5	O
,	O
6	O
.	O
8	O
;	O
Klebsiella	B-SPEC
pneumoniae	I-SPEC
,	O
greater	O
than	O
7	O
.	O
4	O
;	O
Staphylococcus	B-SPEC
epidermidis	I-SPEC
and	O
Yersinia	B-SPEC
enterocolitica	I-SPEC
,	O
greater	O
than	O
7	O
.	O
3	O
;	O
Treponema	B-SPEC
pallidum	I-SPEC
,	O
greater	O
than	O
5	O
.	O
9	O
;	O
Borrelia	B-SPEC
burgdorferi	I-SPEC
,	O
greater	O
than	O
10	O
.	O
6	O
;	O
Plasmodium	B-SPEC
falciparum	I-SPEC
,	O
6	O
.	O
9	O
;	O
Trypanosoma	B-SPEC
cruzi	I-SPEC
,	O
greater	O
than	O
5	O
.	O
0	O
;	O
and	O
Babesia	B-SPEC
microti	I-SPEC
,	O
greater	O
than	O
5	O
.	O
3	O
.	O

However	O
,	O
the	O
emergence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
prompted	O
the	O
discovery	O
of	O
such	O
drugs	O
.	O

Because	O
of	O
availability	O
and	O
shown	O
efficacy	O
,	O
the	O
use	O
of	O
interferons	O
may	O
be	O
considered	O
should	O
SARS	O
-	O
CoV	O
or	O
a	O
related	O
coronavirus	B-SPEC
(	O
re	O
)-	O
emerge	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
can	O
infect	O
a	O
variety	O
of	O
animals	B-SPEC
including	O
poultry	O
,	O
livestock	O
,	O
and	O
humans	B-SPEC
and	O
are	O
currently	O
classified	O
into	O
three	O
groups	O
.	O

Phylogenetic	O
analyses	O
of	O
the	O
spike	O
,	O
envelope	O
,	O
membrane	O
,	O
and	O
nucleoprotein	O
structural	O
proteins	O
and	O
the	O
two	O
conserved	O
replicase	O
domains	O
,	O
putative	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
and	O
RNA	O
helicase	O
,	O
revealed	O
that	O
bat	B-SPEC
coronaviruses	O
cluster	O
in	O
three	O
different	O
groups	O
:	O
group	O
1	O
,	O
another	O
group	O
that	O
includes	O
all	O
SARS	O
and	O
SARS	O
-	O
like	O
coronaviruses	O
(	O
putative	O
group	O
4	O
),	O
and	O
an	O
independent	O
bat	B-SPEC
coronavirus	B-SPEC
group	I-SPEC
(	O
putative	O
group	O
5	O
).	O

A	O
12	O
mer	O
peptide	O
derived	O
from	O
coronavirus	B-SPEC
229E	O
(	O
ETYIKPWWVWL	O
)	O
was	O
the	O
most	O
potent	O
antagonist	O
of	O
the	O
formyl	O
peptide	O
receptor	O
W190	O
with	O
a	O
K	O
(	O
i	O
)	O
of	O
230	O
nM	O
.	O
Fluorescently	O
labeled	O
ETYIKPWWVWL	O
was	O
effectively	O
internalized	O
by	O
all	O
three	O
variants	O
with	O
EC	O
(	O
50	O
)	O
of	O
approximately	O
25	O
nM	O
.	O
An	O
HKU	O
-	O
1	O
coronavirus	B-SPEC
peptide	O
,	O
MYVKWPWYVWL	O
,	O
was	O
a	O
potent	O
antagonist	O
but	O
N	O
-	O
formyl	O
-	O
MYVKWPWYVWL	O
was	O
a	O
potent	O
agonist	O
.	O

TITLE	O
:	O
Human	B-SPEC
memory	O
T	O
cell	O
responses	O
to	O
SARS	O
-	O
CoV	O
E	O
protein	O
.	O

Despite	O
the	O
high	O
toxicity	O
of	O
coral	B-SPEC
snake	I-SPEC
venoms	O
,	O
the	O
prognosis	O
following	O
envenoming	O
is	O
good	O
.	O

TITLE	O
:	O
Frequent	O
detection	O
of	O
human	B-SPEC
rhinoviruses	B-SPEC
,	O
paramyxoviruses	O
,	O
coronaviruses	O
,	O
and	O
bocavirus	B-SPEC
during	O
acute	O
respiratory	O
tract	O
infections	O
.	O

Prior	O
vaccination	O
blocked	O
the	O
serum	O
IFN	O
-	O
gamma	O
response	O
associated	O
with	O
homologous	O
virus	B-SPEC
challenge	O
and	O
altered	O
the	O
kinetics	O
of	O
the	O
response	O
after	O
heterologous	O
challenge	O
.	O

Two	O
other	O
respiratory	O
viruses	B-SPEC
of	O
pigs	B-SPEC
,	O
Porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
and	O
Swine	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
do	O
not	O
appear	O
to	O
induce	O
serum	O
IFN	O
-	O
gamma	O
.	O

The	O
presence	O
of	O
the	O
spike	O
protein	O
from	O
a	O
virulent	O
virus	B-SPEC
did	O
not	O
increase	O
the	O
pathogenicity	O
of	O
the	O
virus	B-SPEC
according	O
to	O
the	O
criteria	O
used	O
.	O

ABSTRACT	O
:	O
Interferons	O
(	O
IFNs	O
)	O
inhibit	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
replication	O
and	O
might	O
be	O
valuable	O
for	O
SARS	O
treatment	O
.	O

Further	O
studies	O
are	O
necessary	O
to	O
assess	O
economic	O
losses	O
due	O
to	O
these	O
avian	B-SPEC
viruses	B-SPEC
and	O
the	O
costs	O
and	O
benefits	O
of	O
countermeasures	O
.	O

Premenstrual	O
symptom	O
frequency	O
was	O
significantly	O
associated	O
with	O
a	O
maternal	O
history	O
of	O
premenstrual	O
syndrome	O
,	O
self	O
-	O
perception	O
of	O
mental	O
stress	O
,	O
physical	O
activity	O
,	O
consumption	O
of	O
sweet	O
-	O
tasting	O
foods	O
,	O
and	O
coffee	B-SPEC
,	O
but	O
these	O
factors	O
only	O
explained	O
14	O
%	O
of	O
the	O
variability	O
in	O
the	O
multiple	O
regression	O
model	O
.	O

Two	O
community	O
contacts	O
with	O
laboratory	O
evidence	O
of	O
SARS	O
coronavirus	B-SPEC
infection	O
had	O
mild	O
or	O
sub	O
-	O
clinical	O
infection	O
,	O
representing	O
3	O
%	O
(	O
2	O
/	O
65	O
)	O
of	O
Vietnamese	O
SARS	O
cases	O
.	O

The	O
zinc	O
finger	O
sequence	O
motifs	O
are	O
conserved	O
among	O
all	O
three	O
coronavirus	B-SPEC
antigenic	O
groups	O
,	O
implicating	O
an	O
essential	O
function	O
for	O
nsp10	O
in	O
all	O
coronaviruses	O
.	O

The	O
crystal	O
structure	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
(	O
MHV	B-SPEC
-	O
A59	O
)	O
nsp15	O
is	O
reported	O
at	O
2	O
.	O
15	O
-	O
A	O
resolution	O
.	O

Interest	O
in	O
this	O
viral	O
family	B-SPEC
has	O
intensified	O
in	O
the	O
past	O
few	O
years	O
as	O
a	O
result	O
of	O
the	O
identification	O
of	O
a	O
newly	O
emerged	O
coronavirus	B-SPEC
as	O
the	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Bovine	B-SPEC
coronavirus	B-SPEC
infection	O
was	O
significantly	O
associated	O
with	O
respiratory	O
tract	O
disease	O
and	O
decreased	O
growth	O
performance	O
in	O
AR	O
calves	O
.	O

Replication	O
and	O
shedding	O
of	O
BCV	B-SPEC
may	O
start	O
in	O
the	O
upper	O
respiratory	O
tract	O
and	O
spread	O
to	O
the	O
gastrointestinal	O
tract	O
.	O

The	O
complex	O
includes	O
an	O
RNA	O
endonuclease	O
,	O
NendoU	O
,	O
that	O
is	O
conserved	O
among	O
nidoviruses	B-SPEC
but	O
no	O
other	O
RNA	O
virus	B-SPEC
,	O
making	O
it	O
a	O
genetic	O
marker	O
of	O
this	O
virus	B-SPEC
order	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
potent	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
3CL	O
protease	O
inhibitor	O
(	O
TG	O
-	O
0205221	O
,	O
Ki	O
=	O
53	O
nM	O
)	O
has	O
been	O
developed	O
.	O

The	O
latter	O
findings	O
appeared	O
to	O
be	O
the	O
result	O
of	O
less	O
symptomatic	O
diversity	O
among	O
patients	O
recruited	O
for	O
this	O
trial	O
,	O
such	O
that	O
subjects	O
who	O
were	O
determined	O
to	O
be	O
influenza	B-SPEC
virus	I-SPEC
positive	O
and	O
subjects	O
who	O
were	O
influenza	B-SPEC
virus	I-SPEC
negative	O
had	O
similar	O
symptoms	O
.	O

This	O
phenomenon	O
revealed	O
a	O
loophole	O
in	O
the	O
control	O
mechanisms	O
of	O
international	O
quarantine	O
procedures	O
,	O
letting	O
travelers	O
carrying	O
a	O
highly	O
contagious	O
virus	B-SPEC
slip	O
by	O
undetected	O
and	O
causing	O
possible	O
multi	O
-	O
country	O
outbreaks	O
of	O
communicable	O
diseases	O
.	O

The	O
development	O
and	O
introduction	O
of	O
new	O
technologies	O
of	O
respiratory	O
support	O
,	O
the	O
emergence	O
of	O
new	O
effective	O
treatments	O
for	O
sepsis	B-SPEC
,	O
and	O
the	O
improvement	O
of	O
general	O
maintenance	O
therapy	O
in	O
patients	O
with	O
ARDS	O
may	O
be	O
a	O
possible	O
explanation	O
for	O
such	O
changes	O
for	O
the	O
best	O
.	O

A	O
phylogenetic	O
analysis	O
of	O
the	O
M	O
gene	O
sequences	O
revealed	O
not	O
only	O
clearly	O
segregating	O
canine	O
coronavirus	B-SPEC
(	O
ccov	O
)	O
in	O
the	O
dogs	B-SPEC
,	O
typical	O
ccov	O
sequences	O
and	O
the	O
recently	O
described	O
fcov	O
-	O
like	O
ccov	O
,	O
but	O
also	O
at	O
least	O
two	O
genetic	O
clusters	O
of	O
fcov	O
in	O
the	O
cats	B-SPEC
,	O
one	O
species	B-SPEC
-	O
specific	O
,	O
the	O
other	O
more	O
closely	O
related	O
to	O
fcov	O
-	O
like	O
ccov	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)	O
as	O
the	O
cause	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
catalyzed	O
the	O
development	O
of	O
rapid	O
diagnostic	O
tests	O
.	O

The	O
debate	O
involves	O
the	O
mode	O
of	O
transmission	O
of	O
a	O
simian	O
virus	B-SPEC
(	O
SIV	B-SPEC
)	O
to	O
humans	B-SPEC
.	O

Both	O
major	O
camps	O
in	O
the	O
argument	O
presume	O
that	O
humans	B-SPEC
are	O
normally	O
free	O
of	O
such	O
viruses	B-SPEC
and	O
assume	O
that	O
once	O
the	O
simian	O
virus	B-SPEC
was	O
transmitted	O
,	O
it	O
immediately	O
infected	O
some	O
T	O
-	O
cells	O
and	O
caused	O
the	O
release	O
of	O
toxic	O
agents	O
that	O
killed	O
off	O
bystander	O
(	O
uninfected	O
)	O
T	O
-	O
cells	O
resulting	O
in	O
AIDS	O
.	O

In	O
this	O
model	O
,	O
AIDS	O
is	O
seen	O
to	O
be	O
the	O
result	O
of	O
the	O
development	O
of	O
resistance	O
of	O
the	O
virus	B-SPEC
(	O
PTRV	O
)	O
to	O
continuous	O
exposure	O
to	O
pro	O
-	O
apoptotic	O
(	O
schizonticidal	O
)	O
aminoquinoline	O
drugs	O
used	O
to	O
prevent	O
malaria	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
recombinant	O
Fab	O
fragments	O
specific	O
for	O
the	O
spike	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
were	O
screened	O
from	O
a	O
human	B-SPEC
Fab	O
library	O
,	O
which	O
was	O
generated	O
from	O
RNAs	O
from	O
peripheral	O
lymphocytes	O
of	O
convalescent	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
Fourteen	O
ORFs	O
have	O
been	O
identified	O
in	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
.	O

These	O
findings	O
show	O
that	O
group	O
1	O
coronaviruses	O
are	O
endemic	O
in	O
these	O
bat	B-SPEC
populations	O
in	O
Hong	O
Kong	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
a	O
main	O
protease	O
,	O
3CLpro	O
,	O
which	O
plays	O
an	O
essential	O
role	O
in	O
the	O
viral	O
life	O
cycle	O
and	O
is	O
currently	O
the	O
prime	O
target	O
for	O
discovering	O
new	O
anti	O
-	O
coronavirus	B-SPEC
agents	O
.	O

Ten	O
consecutive	O
patients	O
(	O
seven	O
men	O
,	O
mean	O
age	O
64	O
+/-	O
12years	O
,	O
mean	O
SAPS	O
II	O
26	O
+/-	O
6	O
)	O
with	O
definite	O
diagnosis	O
of	O
WNV	B-SPEC
related	O
meningoencephalitis	O
and	O
variable	O
proportion	O
of	O
organ	O
/	O
system	O
failure	O
.	O

CONCLUSIONS	O
:	O
Adrenal	O
insufficiency	O
is	O
frequent	O
in	O
severe	O
WNV	B-SPEC
infection	O
and	O
carries	O
a	O
poor	O
outcome	O
.	O

TITLE	O
:	O
Maternal	O
antibody	O
transfer	O
from	O
dams	O
to	O
their	O
egg	O
yolks	O
,	O
egg	O
whites	B-SPEC
,	O
and	O
chicks	O
in	O
meat	O
lines	O
of	O
chickens	B-SPEC
.	O

Chicks	O
synthesized	O
IgM	O
first	O
,	O
followed	O
by	O
IgA	O
and	O
IgY	O
.	O
Anti	O
-	O
NDV	B-SPEC
and	O
anti	O
-	O
IBV	B-SPEC
antibodies	O
were	O
detected	O
in	O
the	O
dams	O
'	O
plasma	O
,	O
egg	O
yolks	O
,	O
and	O
in	O
the	O
chicks	O
'	O
plasma	O
on	O
d	O
3	O
and	O
7	O
,	O
with	O
line	O
2	O
having	O
higher	O
anti	O
-	O
IBV	B-SPEC
and	O
lower	O
anti	O
-	O
NDV	B-SPEC
levels	O
than	O
line	O
1	O
in	O
all	O
samples	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

ABSTRACT	O
:	O
Both	O
the	O
threat	O
of	O
bioterrorism	O
and	O
the	O
natural	O
emergence	O
of	O
contagious	O
diseases	O
underscore	O
the	O
importance	O
of	O
quantitatively	O
understanding	O
disease	O
transmission	O
in	O
structured	O
human	B-SPEC
populations	O
.	O

The	O
full	O
length	O
NP	O
could	O
be	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
at	O
very	O
high	O
level	O
within	O
inclusion	O
bodies	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
causes	O
encephalitis	O
and	O
demyelination	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
susceptible	O
rodents	B-SPEC
.	O

Using	O
various	O
inhibitors	O
of	O
mitogen	O
-	O
activated	O
protein	O
kinases	O
,	O
we	O
identified	O
that	O
the	O
extracellular	O
signal	O
-	O
regulated	O
kinases	O
1	O
/	O
2	O
were	O
involved	O
in	O
the	O
activation	O
of	O
Egr	O
-	O
1	O
transcription	O
by	O
MHV	B-SPEC
infection	O
.	O

Severe	O
sepsis	B-SPEC
includes	O
multiorgan	O
dysfunction	O
syndrome	O
.	O

Expression	O
of	O
nsp1	O
,	O
the	O
most	O
N	O
-	O
terminal	O
gene	O
1	O
protein	O
,	O
prevented	O
Sendai	B-SPEC
virus	I-SPEC
-	O
induced	O
endogenous	O
IFN	O
-	O
beta	O
mRNA	O
accumulation	O
without	O
inhibiting	O
dimerization	O
of	O
IFN	O
regulatory	O
factor	O
3	O
,	O
a	O
protein	O
that	O
is	O
essential	O
for	O
activation	O
of	O
the	O
IFN	O
-	O
beta	O
promoter	O
.	O

ABSTRACT	O
:	O
We	O
have	O
recently	O
demonstrated	O
that	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
receptor	O
angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
also	O
mediates	O
cellular	O
entry	O
of	O
the	O
newly	O
discovered	O
human	B-SPEC
coronavirus	I-SPEC
(	O
hCoV	O
)	O
NL63	O
.	O

Here	O
,	O
we	O
show	O
that	O
expression	O
of	O
DC	O
-	O
SIGN	O
augments	O
NL63	O
spike	O
(	O
S	O
)-	O
protein	O
-	O
driven	O
infection	O
of	O
susceptible	O
cells	O
,	O
while	O
only	O
expression	O
of	O
ACE2	O
but	O
not	O
DC	O
-	O
SIGN	O
is	O
sufficient	O
for	O
entry	O
into	O
nonpermissive	O
cells	O
,	O
indicating	O
that	O
ACE2	O
fulfills	O
the	O
criteria	O
of	O
a	O
bona	O
fide	O
hCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
receptor	O
.	O

Respiratory	O
viruses	B-SPEC
have	O
received	O
particular	O
attention	O
,	O
but	O
this	O
review	O
suggests	O
that	O
infections	O
with	O
coronavirus	B-SPEC
and	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
H5N1	O
)	O
are	O
associated	O
with	O
a	O
high	O
incidence	O
of	O
ARDS	O
.	O

Herpes	O
viruses	B-SPEC
,	O
such	O
as	O
CMV	B-SPEC
or	O
HSV	B-SPEC
type	O
1	O
and	O
2	O
,	O
have	O
been	O
shown	O
to	O
persist	O
from	O
only	O
a	O
few	O
hours	O
up	O
to	O
7	O
days	O
.	O

Based	O
on	O
sequence	O
comparison	O
,	O
the	O
prototype	O
Cal99	O
virus	B-SPEC
is	O
similar	O
to	O
the	O
apathogenic	O
ArkDPI	O
virus	B-SPEC
,	O
except	O
in	O
the	O
S1	O
gene	O
and	O
stretches	O
of	O
sequence	O
in	O
the	O
S2	O
and	O
M	O
structural	O
protein	O
genes	O
,	O
which	O
are	O
more	O
related	O
to	O
Connecticut	O
(	O
Conn	O
)	O
and	O
Massachusetts	O
(	O
Mass	O
)	O
strain	O
viruses	B-SPEC
,	O
respectively	O
.	O

Since	O
Ark	O
,	O
Conn	O
and	O
Mass	O
strains	O
have	O
been	O
simultaneously	O
used	O
as	O
live	O
vaccines	O
in	O
California	B-SPEC
,	O
both	O
point	O
mutations	O
and	O
recombination	O
among	O
vaccine	O
strains	O
may	O
have	O
contributed	O
to	O
the	O
emergence	O
of	O
the	O
Cal99	O
variant	O
virus	B-SPEC
.	O

The	O
diagnostic	O
criteria	O
for	O
virus	B-SPEC
-	O
related	O
nephropathy	O
include	O
detailed	O
clinical	O
and	O
laboratory	O
data	O
,	O
and	O
tissue	O
molecular	O
analysis	O
.	O

Both	O
hantaviruses	B-SPEC
,	O
and	O
coronaviruses	O
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
can	O
lead	O
to	O
acute	O
renal	O
failure	O
.	O

Renal	O
biopsy	O
followed	O
by	O
appropriate	O
serological	O
and	O
molecular	O
testing	O
is	O
essential	O
for	O
defining	O
virus	B-SPEC
-	O
related	O
glomerular	O
lesions	O
and	O
guiding	O
prognostic	O
and	O
therapeutic	O
evaluation	O
.	O

TITLE	O
:	O
Extremely	O
low	O
exposure	O
of	O
a	O
community	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
false	O
seropositivity	O
due	O
to	O
use	O
of	O
bacterially	O
derived	O
antigens	O
.	O

Herein	O
,	O
we	O
screened	O
12	O
,	O
000	O
people	O
in	O
a	O
community	O
stricken	O
by	O
SARS	O
10	O
months	O
previously	O
and	O
found	O
53	O
individuals	O
(	O
0	O
.	O
44	O
%)	O
who	O
had	O
immunoglobulin	O
G	O
antibodies	O
to	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
(	O
N	O
)	O
produced	O
in	O
bacteria	B-SPEC
.	O

TITLE	O
:	O
The	O
large	O
386	O
-	O
nt	O
deletion	O
in	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
:	O
evidence	O
for	O
quasispecies	O
?	O

ABSTRACT	O
:	O
Three	O
commercially	O
available	O
real	O
-	O
time	O
reverse	O
transcriptase	O
PCR	O
assays	O
(	O
the	O
Artus	O
RealArt	O
HPA	O
coronavirus	B-SPEC
LightCycler	O
,	O
the	O
Artus	O
RealArt	O
HPA	O
coronavirus	B-SPEC
Rotor	O
-	O
Gene	O
,	O
and	O
the	O
EraGen	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
POL	O
assay	O
)	O
and	O
three	O
RNA	O
extraction	O
methodologies	O
were	O
evaluated	O
for	O
the	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
RNA	O
from	O
91	O
stool	O
specimens	O
.	O

The	O
transmission	O
of	O
tuberculosis	O
,	O
hepatitis	O
B	O
,	O
and	O
measles	O
from	O
adopted	O
children	O
to	O
family	B-SPEC
members	O
has	O
been	O
documented	O
.	O

TITLE	O
:	O
Accumulation	O
of	O
recombinant	O
SARS	O
-	O
CoV	O
spike	O
protein	O
in	O
plant	B-SPEC
cytosol	O
and	O
chloroplasts	O
indicate	O
potential	O
for	O
development	O
of	O
plant	B-SPEC
-	O
derived	O
oral	O
vaccines	O
.	O

When	O
the	O
S1	O
was	O
expressed	O
in	O
transplastomic	O
tobacco	B-SPEC
,	O
S1	O
messenger	O
RNA	O
and	O
its	O
corresponding	O
protein	O
were	O
detected	O
on	O
Northern	O
and	O
Western	O
blot	O
analyses	O
,	O
respectively	O
.	O

A	O
high	O
degree	O
of	O
sequence	O
identity	O
(	O
79	O
.	O
3	O
%	O
to	O
99	O
.	O
6	O
%)	O
was	O
observed	O
between	O
the	O
S	O
protein	O
sequence	O
of	O
PSH050513	O
and	O
published	O
sequences	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
);	O
only	O
limited	O
identity	O
(<	O
37	O
.	O
8	O
%)	O
was	O
observed	O
with	O
turkey	B-SPEC
coronavirus	B-SPEC
and	O
mammalian	B-SPEC
coronaviruses	O
.	O

PSH050513	O
has	O
been	O
tentatively	O
identified	O
as	O
a	O
novel	O
member	O
of	O
group	O
3	O
coronaviruses	O
that	O
have	O
close	O
genetic	O
relationships	O
with	O
IBV	B-SPEC
strains	O
.	O

There	O
is	O
,	O
however	O
,	O
only	O
minimal	O
understanding	O
of	O
the	O
dynamics	O
of	O
virus	B-SPEC
-	O
laden	O
aerosols	O
,	O
and	O
so	O
the	O
ability	O
to	O
control	O
and	O
prevent	O
virus	B-SPEC
spread	O
is	O
severely	O
reduced	O
,	O
as	O
was	O
clearly	O
demonstrated	O
during	O
the	O
recent	O
severe	O
acute	O
respiratory	O
syndrome	O
epidemic	O
.	O

This	O
new	O
finding	O
suggests	O
that	O
the	O
newly	O
discovered	O
peptide	O
motifs	O
mimic	O
a	O
neutralizing	O
epitope	O
PEDV	B-SPEC
.	O

We	O
present	O
the	O
features	O
,	O
clinical	O
course	O
and	O
outcome	O
of	O
critically	O
ill	O
patients	O
with	O
scleroderma	B-SPEC
that	O
were	O
admitted	O
to	O
the	O
ICU	O
.	O

The	O
observations	O
suggest	O
that	O
the	O
amino	O
-	O
terminal	O
region	O
of	O
the	O
S	O
protein	O
,	O
including	O
the	O
receptor	O
-	O
binding	O
domain	O
,	O
and	O
a	O
region	O
in	O
the	O
central	O
part	O
of	O
the	O
S	O
protein	O
containing	O
HR1	O
and	O
FP	O
,	O
i	O
.	O
e	O
.,	O
regions	O
far	O
apart	O
in	O
the	O
linear	O
sequence	O
,	O
communicate	O
and	O
may	O
even	O
interact	O
physically	O
in	O
the	O
higher	O
-	O
order	B-SPEC
structure	O
of	O
the	O
spike	O
.	O

RESULTS	O
:	O
Injection	O
of	O
either	O
killed	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
or	O
killed	O
pneumococci	O
resulted	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
death	O
in	O
pigs	B-SPEC
.	O

Nearly	O
42	O
%	O
of	O
the	O
nurses	O
did	O
not	O
think	O
that	O
,	O
if	O
there	O
were	O
an	O
outbreak	O
of	O
avian	B-SPEC
flu	O
,	O
their	O
working	O
hospitals	O
would	O
have	O
sufficient	O
infection	O
control	O
measures	O
and	O
equipment	O
to	O
prevent	O
nosocomial	O
infection	O
in	O
their	O
working	O
environment	O
.	O

Ferrets	B-SPEC
have	O
a	O
distinct	O
niche	O
in	O
biomedical	O
research	O
and	O
are	O
hardy	O
animals	B-SPEC
that	O
thrive	O
well	O
in	O
the	O
laboratory	O
.	O

TITLE	O
:	O
Acute	O
otitis	O
media	O
and	O
respiratory	O
viruses	B-SPEC
.	O

Middle	O
ear	O
fluid	O
(	O
MEF	O
)	O
was	O
tested	O
for	O
viral	O
pathogens	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
for	O
bacteria	B-SPEC
by	O
gram	O
-	O
staining	O
and	O
culture	O
.	O

TITLE	O
:	O
Cross	O
-	O
protection	O
against	O
a	O
human	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
and	O
a	O
virulent	O
bovine	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
in	O
gnotobiotic	O
calves	O
.	O

This	O
domain	O
was	O
shown	O
to	O
interact	O
with	O
the	O
genomic	O
RNA	O
for	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Seven	O
landrace	O
pigs	B-SPEC
(	O
mean	O
weight	O
41	O
kg	O
).	O

This	O
unique	O
orientation	O
of	O
the	O
glycine	B-SPEC
residues	O
also	O
stabilizes	O
the	O
trimeric	O
bundle	O
during	O
multi	O
-	O
nanosecond	O
molecular	O
dynamics	O
simulation	O
in	O
a	O
hydrated	O
lipid	O
bilayer	O
.	O

We	O
studied	O
a	O
TNF	O
-	O
alpha	O
single	O
-	O
nucleotide	O
promoter	O
polymorphism	O
(	O
SNP	O
)	O
at	O
position	O
-	O
238	O
(	O
a	O
guanine	O
[	O
G	O
]-	O
to	O
-	O
adenine	O
[	O
A	O
]	O
transition	O
)	O
and	O
ex	O
vivo	O
TNF	O
-	O
alpha	O
production	O
in	O
a	O
recall	O
study	O
of	O
36	O
Belgian	O
patients	O
who	O
had	O
a	O
serologically	O
proven	O
form	O
of	O
Puumala	B-SPEC
virus	I-SPEC
-	O
induced	O
Hantavirus	B-SPEC
infection	O
with	O
the	O
kidney	O
as	O
main	O
target	O
organ	O
.	O

Tropism	O
of	O
IBV	B-SPEC
includes	O
the	O
respiratory	O
tract	O
tissues	O
,	O
proventriculus	O
and	O
caecal	O
tonsils	O
of	O
the	O
alimentary	O
tract	O
,	O
the	O
oviduct	O
and	O
the	O
kidney	O
.	O

Marked	O
histopathological	O
changes	O
in	O
both	O
kidney	O
and	O
trachea	B-SPEC
were	O
observed	O
in	O
experimentally	O
infected	O
chickens	B-SPEC
.	O

RESULTS	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strain	O
closely	O
related	O
to	O
Massachusetts	O
(	O
Mass	O
)	O
serotype	O
was	O
isolated	O
from	O
broiler	O
chickens	B-SPEC
suffering	O
from	O
severe	O
renal	O
and	O
respiratory	O
distresses	O
.	O

Like	O
other	O
nidoviruses	B-SPEC
with	O
large	O
genomes	O
(>	O
26	O
kb	O
),	O
WBV	O
encodes	O
in	O
its	O
ORF1b	O
an	O
extensive	O
set	O
of	O
enzymes	O
,	O
including	O
putative	O
polymerase	O
,	O
helicase	O
,	O
ribose	O
methyltransferase	O
,	O
exoribonuclease	O
,	O
and	O
endoribonuclease	O
activities	O
.	O

Intriguingly	O
,	O
ACE2	O
acts	O
as	O
a	O
protective	O
factor	O
in	O
various	O
experimental	O
models	O
of	O
acute	O
lung	O
failure	O
and	O
,	O
therefore	O
,	O
acts	O
not	O
only	O
as	O
a	O
key	O
determinant	O
for	O
SARS	O
virus	B-SPEC
entry	O
into	O
cells	O
but	O
also	O
contributes	O
to	O
SARS	O
pathogenesis	O
.	O

TITLE	O
:	O
Molecular	O
epizootiology	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
in	O
Russia	O
.	O

ABSTRACT	O
:	O
Molecular	O
characterization	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
isolated	O
between	O
1998	O
and	O
2002	O
from	O
chickens	B-SPEC
in	O
Russia	O
was	O
performed	O
.	O

We	O
also	O
compared	O
S	O
protein	O
sequences	O
of	O
SARS	O
-	O
CoV	O
isolated	O
during	O
the	O
SARS	O
break	O
with	O
that	O
from	O
palm	O
civets	B-SPEC
,	O
a	O
possible	O
source	O
of	O
SARS	O
-	O
CoV	O
found	O
in	O
humans	B-SPEC
.	O

The	O
resultant	O
plasmid	O
pPIC9K	O
-	O
S1	O
was	O
transformed	O
into	O
Pichia	B-SPEC
pastoris	I-SPEC
GS	O
115	O
and	O
the	O
protein	O
expression	O
was	O
induced	O
with	O
methanol	O
.	O

The	O
pathological	O
changes	O
in	O
several	O
human	B-SPEC
organs	O
of	O
patients	O
with	O
SARS	O
have	O
been	O
extensively	O
described	O
.	O

The	O
N	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
recently	O
discovered	O
to	O
self	O
-	O
associate	O
by	O
its	O
carboxyl	O
terminus	O
.	O

ABSTRACT	O
:	O
Two	O
recently	O
detected	O
viruses	B-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
and	O
coronavirus	B-SPEC
NL63	O
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
),	O
have	O
been	O
associated	O
with	O
acute	O
respiratory	O
tract	O
infections	O
,	O
particularly	O
in	O
young	O
children	O
.	O

RESULTS	O
:	O
Viral	O
inactivation	O
by	O
heat	O
treatment	O
at	O
60	O
degrees	O
C	O
required	O
15	O
to	O
30	O
minutes	O
to	O
inactivate	O
the	O
SARS	O
-	O
CoV	O
.	O
UVC	O
efficiently	O
inactivated	O
SARS	O
-	O
CoV	O
in	O
40	O
minutes	O
,	O
whereas	O
UVA	O
required	O
the	O
addition	O
of	O
psoralen	O
to	O
enhance	O
inactivation	O
of	O
the	O
virus	B-SPEC
.	O

Since	O
certain	O
residues	O
at	O
these	O
positively	O
selected	O
sites	O
are	O
associated	O
with	O
receptor	O
recognition	O
and	O
/	O
or	O
membrane	O
fusion	O
,	O
they	O
are	O
likely	O
to	O
be	O
the	O
crucial	O
residues	O
for	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
of	O
SARS	O
-	O
CoVs	O
,	O
and	O
subsequent	O
adaptation	O
to	O
human	B-SPEC
hosts	O
.	O

TITLE	O
:	O
Preparation	O
of	O
His	O
-	O
tagged	O
armored	O
RNA	O
phage	O
particles	O
as	O
a	O
control	O
for	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
PCR	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Armored	O
RNA	O
has	O
been	O
increasingly	O
used	O
as	O
both	O
an	O
external	O
and	O
internal	O
positive	O
control	O
in	O
nucleic	O
acid	O
-	O
based	O
assays	O
for	O
RNA	O
virus	B-SPEC
.	O

In	O
order	B-SPEC
to	O
facilitate	O
armored	O
RNA	O
purification	O
,	O
a	O
His6	O
tag	O
was	O
introduced	O
into	O
the	O
loop	O
region	O
of	O
the	O
MS2	O
coat	O
protein	O
,	O
which	O
allows	O
the	O
exposure	O
of	O
multiple	O
His	O
tags	O
on	O
the	O
surface	O
during	O
armored	O
RNA	O
assembly	O
.	O

In	O
order	B-SPEC
to	O
adapt	O
to	O
these	O
new	O
threats	O
,	O
there	O
is	O
a	O
need	O
for	O
timely	O
identification	O
and	O
reporting	O
,	O
the	O
need	O
to	O
consider	O
health	O
problems	O
from	O
a	O
global	O
perspective	O
,	O
and	O
the	O
need	O
to	O
incorporate	O
practising	O
physicians	O
in	O
the	O
process	O
as	O
much	O
as	O
possible	O
.	O

Sequence	O
comparisons	O
at	O
both	O
genomic	O
and	O
protein	O
levels	O
indicated	O
that	O
PRCV	O
-	O
ISU	O
-	O
1	O
had	O
a	O
closer	O
relationship	O
with	O
TGEV	B-SPEC
Miller	O
strains	O
than	O
Purdue	O
strains	O
.	O

ABSTRACT	O
:	O
Communicable	O
respiratory	O
viruses	B-SPEC
as	O
a	O
causative	O
factor	O
of	O
infectious	O
complication	O
in	O
hemoblastosis	O
and	O
myelodepression	O
were	O
investigated	O
in	O
51	O
patients	O
(	O
aplastic	O
anemia	B-SPEC
--	O
3	O
,	O
multiple	O
myeloma	O
--	O
10	O
,	O
different	O
patterns	O
of	O
acute	O
leukemia	O
--	O
16	O
,	O
chronic	O
leukemia	O
--	O
8	O
and	O
non	O
-	O
Hodgkin	O
'	O
s	O
lymphoma	O
--	O
14	O
).	O

Our	O
clinical	O
evidence	O
obtained	O
with	O
the	O
aid	O
of	O
polymerase	O
chain	O
reaction	O
featured	O
genomes	O
of	O
adenoviruses	B-SPEC
,	O
influenza	O
A	O
and	O
B	O
viruses	B-SPEC
,	O
respiratory	O
-	O
scintillating	O
virus	B-SPEC
and	O
coronaviruses	O
.	O

On	O
the	O
whole	O
,	O
respiratory	O
viral	O
infections	O
were	O
detected	O
in	O
27	O
(	O
52	O
.	O
9	O
%)	O
patients	O
:	O
adenoviruses	B-SPEC
--	O
23	O
.	O
5	O
%,	O
coronaviruses	O
--	O
13	O
.	O
7	O
%,	O
influenza	O
A	O
and	O
B	O
--	O
5	O
.	O
9	O
%	O
and	O
respiratory	O
-	O
scintillating	O
virus	B-SPEC
--	O
3	O
.	O
9	O
%.	O

Therefore	O
,	O
to	O
facilitate	O
comparison	O
of	O
different	O
samples	O
,	O
an	O
external	O
RNA	O
reference	O
was	O
used	O
for	O
normalisation	O
whereby	O
each	O
sample	O
was	O
spiked	O
with	O
the	O
RNA	O
virus	B-SPEC
,	O
Canine	O
Enteric	B-SPEC
Coronavirus	I-SPEC
(	O
CECov	O
),	O
prior	O
to	O
RNA	O
extraction	O
,	O
for	O
comparative	O
purposes	O
.	O

In	O
this	O
study	O
,	O
complete	O
genome	O
sequences	O
of	O
two	O
additional	O
group	O
2b	O
coronaviruses	O
(	O
G2b	O
-	O
CoVs	O
)	O
were	O
determined	O
from	O
horseshoe	B-SPEC
bat	I-SPEC
Rhinolophus	B-SPEC
ferrumequinum	I-SPEC
(	O
G2b	O
-	O
CoV	O
Rf1	O
)	O
and	O
Rhinolophus	B-SPEC
macrotis	I-SPEC
(	O
G2b	O
-	O
CoV	O
Rm1	O
).	O

Sequence	O
analysis	O
of	O
the	O
60	O
-	O
kDa	O
glycoprotein	O
gene	O
identified	O
16	O
IIa	O
subtypes	O
and	O
a	O
new	O
subtype	O
family	B-SPEC
,	O
with	O
120	O
of	O
the	O
216	O
(	O
55	O
.	O
6	O
%)	O
positive	O
specimens	O
having	O
the	O
subtype	O
IIaA18G3R1	O
.	O

ABSTRACT	O
:	O
The	O
authors	O
have	O
previously	O
shown	O
that	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
produces	O
a	O
wide	O
spectrum	O
of	O
pathological	O
processes	O
in	O
patients	O
who	O
die	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
that	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleoprotein	O
is	O
detectable	O
in	O
the	O
lungs	O
,	O
and	O
other	O
organs	O
and	O
tissues	O
,	O
in	O
these	O
patients	O
.	O

For	O
elucidation	O
of	O
the	O
impact	O
of	O
ARF	O
on	O
aseptic	O
ALI	O
,	O
a	O
murine	B-SPEC
two	O
-	O
hit	O
model	O
that	O
consists	O
of	O
acute	O
uremia	O
(	O
AU	O
)	O
and	O
subsequent	O
ALI	O
was	O
developed	O
.	O

ABSTRACT	O
:	O
The	O
results	O
presented	O
here	O
demonstrate	O
that	O
the	O
MHV	B-SPEC
and	O
SARS	O
-	O
CoV	O
nsp2	O
proteins	O
are	O
not	O
required	O
for	O
the	O
production	O
of	O
infectious	O
virus	B-SPEC
,	O
for	O
polyprotein	O
expression	O
or	O
processing	O
,	O
or	O
for	O
viral	O
replication	O
complex	O
formation	O
in	O
cell	O
culture	O
.	O

In	O
fact	O
,	O
the	O
size	O
and	O
amino	O
acid	O
sequence	O
variability	O
of	O
nsp2	O
across	O
the	O
different	O
coronaviruses	O
has	O
led	O
some	O
investigators	O
to	O
speculate	O
that	O
the	O
nsp2	O
protein	O
,	O
along	O
with	O
the	O
nsp1	O
and	O
nsp3	O
proteins	O
,	O
may	O
play	O
host	O
-	O
and	O
/	O
or	O
cell	O
-	O
specific	O
roles	O
in	O
the	O
virus	B-SPEC
life	O
cycle	O
.	O

To	O
determine	O
whether	O
these	O
DNA	O
vaccines	O
could	O
induce	O
T	O
-	O
cell	O
immune	O
responses	O
in	O
humans	B-SPEC
as	O
well	O
as	O
in	O
mice	B-SPEC
,	O
SCID	O
-	O
PBL	O
/	O
hu	O
mice	B-SPEC
were	O
immunized	O
with	O
these	O
DNA	O
vaccines	O
.	O

They	O
can	O
cause	O
respiratory	O
,	O
enteric	O
,	O
and	O
in	O
some	O
cases	O
hepatic	O
and	O
neurological	O
diseases	O
in	O
a	O
wide	O
variety	O
of	O
animals	B-SPEC
and	O
humans	B-SPEC
.	O

Results	O
from	O
a	O
capture	O
assay	O
testing	O
three	O
pseudotyped	O
viruses	B-SPEC
with	O
mutated	O
N	O
-	O
linked	O
glycosylation	O
sites	O
of	O
the	O
S	O
protein	O
indicate	O
that	O
only	O
two	O
pseudotyped	O
viruses	B-SPEC
(	O
N330Q	O
and	O
N357Q	O
,	O
both	O
of	O
which	O
lost	O
glycosylation	O
sites	O
near	O
the	O
SIa5	O
epitope	O
)	O
had	O
diminished	O
DC	O
-	O
SIGN	O
-	O
binding	O
capacity	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
life	O
-	O
threatening	O
infectious	O
disease	O
which	O
has	O
been	O
difficult	O
to	O
study	O
and	O
treat	O
because	O
of	O
the	O
lack	O
of	O
a	O
readily	O
available	O
animal	B-SPEC
model	O
.	O

All	O
MHV	B-SPEC
-	O
1	O
-	O
infected	O
A	O
/	O
J	O
mice	B-SPEC
developed	O
progressive	O
interstitial	O
pneumonitis	O
,	O
including	O
dense	O
macrophage	O
infiltrates	O
,	O
giant	O
cells	O
,	O
and	O
hyaline	O
membranes	O
,	O
resulting	O
in	O
death	O
of	O
all	O
animals	B-SPEC
.	O

Furthermore	O
,	O
FGL2	O
/	O
fibroleukin	O
mRNA	O
transcripts	O
and	O
protein	O
and	O
fibrin	O
deposits	O
were	O
markedly	O
increased	O
in	O
the	O
lungs	O
of	O
infected	O
A	O
/	O
J	O
mice	B-SPEC
.	O

TITLE	O
:	O
Bats	B-SPEC
as	O
a	O
continuing	O
source	O
of	O
emerging	O
infections	O
in	O
humans	B-SPEC
.	O

The	O
prime	O
examples	O
of	O
these	O
are	O
the	O
lyssaviruses	B-SPEC
and	O
Henipavirus	B-SPEC
.	O

The	O
association	O
between	O
the	O
bat	B-SPEC
coronaviruses	O
and	O
certain	O
lyssaviruses	B-SPEC
with	O
particular	O
bat	B-SPEC
species	B-SPEC
implies	O
co	O
-	O
evolution	O
between	O
specific	O
viruses	B-SPEC
and	O
bat	B-SPEC
hosts	O
.	O

TITLE	O
:	O
Phylogenetic	O
analysis	O
of	O
partial	O
S1	O
and	O
N	O
gene	O
sequences	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
from	O
Italy	O
revealed	O
genetic	O
diversity	O
and	O
recombination	O
.	O

TITLE	O
:	O
A	O
""""	O
possible	O
""""	O
involvement	O
of	O
TNF	O
-	O
alpha	O
in	O
apoptosis	O
induction	O
in	O
peripheral	O
blood	O
lymphocytes	O
of	O
cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
TNF	O
-	O
alpha	O
,	O
produced	O
by	O
virus	B-SPEC
-	O
infected	O
macrophages	O
,	O
is	O
responsible	O
for	O
induction	O
of	O
apoptosis	O
in	O
uninfected	O
T	O
cells	O
,	O
primarily	O
CD8	O
+	O
T	O
cells	O
.	O

2	O
.	O
2	O
cmH	O
(	O
2	O
)	O
O	O
/	O
l	O
per	O
second	O
,	O
respectively	O
);	O
on	O
day	O
5	O
static	O
elastance	O
and	O
iso	B-SPEC
-	O
CO	O
(	O
2	O
)	O
minimal	O
resistance	O
values	O
were	O
higher	O
than	O
on	O
day	O
1	O
(	O
21	O
.	O
2	O
+/-	O

Using	O
this	O
evolutionary	O
rate	O
we	O
determined	O
that	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
diverged	O
in	O
the	O
11th	O
century	O
from	O
its	O
closest	O
relative	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
responsible	O
for	O
viral	O
binding	O
with	O
ACE2	O
molecules	O
.	O

TITLE	O
:	O
[	O
Sepsis	B-SPEC
,	O
acute	O
renal	O
failure	O
and	O
multiple	O
organ	O
dysfunction	O
syndrome	O
].	O

TITLE	O
:	O
Baculovirus	B-SPEC
expression	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
nucleocapsid	O
protein	O
and	O
development	O
of	O
a	O
Western	O
blot	O
assay	O
for	O
detection	O
of	O
human	B-SPEC
antibodies	O
against	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
.	O

Further	O
,	O
MHV	B-SPEC
infection	O
did	O
not	O
inhibit	O
IFN	O
-	O
beta	O
production	O
mediated	O
by	O
known	O
host	O
pattern	O
recognition	O
receptors	O
(	O
PRRs	O
)	O
(	O
RIG	O
-	O
I	O
,	O
Mda	O
-	O
5	O
,	O
and	O
TLR3	O
).	O

These	O
results	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
double	O
-	O
stranded	O
RNA	O
,	O
produced	O
during	O
MHV	B-SPEC
infection	O
,	O
is	O
not	O
accessible	O
to	O
cellular	O
PRRs	O
.	O

TITLE	O
:	O
Lethal	O
infection	O
of	O
K18	O
-	O
hACE2	O
mice	B-SPEC
infected	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
resulted	O
in	O
substantial	O
morbidity	O
,	O
mortality	O
,	O
and	O
economic	O
losses	O
during	O
the	O
2003	O
epidemic	O
.	O

TITLE	O
:	O
The	O
ORF7b	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
expressed	O
in	O
virus	B-SPEC
-	O
infected	O
cells	O
and	O
incorporated	O
into	O
SARS	O
-	O
CoV	O
particles	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
demonstrated	O
that	O
infection	O
of	O
cultured	O
cells	O
with	O
murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
resulted	O
in	O
activation	O
of	O
the	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
Raf	O
/	O
MEK	O
/	O
ERK	O
)	O
signal	O
transduction	O
pathway	O
(	O
Y	O
.	O
Cai	O
et	O
al	O
.,	O
Virology	O
355	O
:	O
152	O
-	O
163	O
,	O
2006	O
).	O

ABSTRACT	O
:	O
Avian	B-SPEC
influenza	O
is	O
a	O
panzootic	O
and	O
recurring	O
human	B-SPEC
epidemic	O
with	O
pandemic	O
potential	O
.	O

Donor	O
support	O
in	O
financial	O
,	O
material	O
and	O
technical	O
assistance	O
remains	O
critical	O
to	O
disease	O
control	O
efforts	O
-	O
particularly	O
in	O
developing	O
countries	O
where	O
avian	B-SPEC
influenza	O
predominately	O
occurs	O
at	O
present	O
.	O

Pasteurella	B-SPEC
multocida	I-SPEC
was	O
the	O
most	O
common	O
bacterial	O
pathogen	O
.	O

It	O
was	O
isolated	O
from	O
34	O
%	O
of	O
the	O
TBL	O
samples	O
in	O
28	O
herds	O
and	O
was	O
associated	O
with	O
clinical	O
respiratory	O
disease	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
when	O
other	O
pathogenic	O
bacteria	B-SPEC
or	O
mycoplasma	B-SPEC
were	O
present	O
in	O
the	O
sample	O
.	O

and	O
Histophilus	B-SPEC
somni	I-SPEC
were	O
rarely	O
found	O
.	O

Ureaplasma	B-SPEC
diversum	I-SPEC
was	O
associated	O
with	O
clinical	O
respiratory	O
disease	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

In	O
the	O
herds	O
that	O
had	O
calves	O
seroconverted	O
to	O
BCV	B-SPEC
,	O
respiratory	O
shedding	O
of	O
BCV	B-SPEC
was	O
more	O
frequently	O
observed	O
than	O
faecal	O
shedding	O
.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
designed	O
to	O
investigate	O
the	O
effect	O
of	O
Hochu	O
-	O
ekki	O
-	O
to	O
(	O
TJ	O
-	O
41	O
),	O
a	O
Japanese	O
herbal	O
medicine	O
,	O
on	O
the	O
development	O
of	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
in	O
mice	B-SPEC
.	O

Retrospective	O
chart	O
review	O
of	O
patients	O
admitted	O
to	O
the	O
Pediatric	O
Intensive	O
Care	O
Unit	O
(	O
PICU	B-SPEC
)	O
of	O
a	O
referral	O
children	O
'	O
s	O
hospital	O
in	O
South	O
India	O
with	O
DHF	O
over	O
1	O
.	O
5	O
years	O
(	O
2001	O
-	O
January	O
2003	O
).	O

Twenty	O
-	O
five	O
four	O
-	O
week	O
-	O
old	O
BALB	O
/	O
c	O
female	O
mice	B-SPEC
inoculated	O
intranasally	O
with	O
either	O
ReoV	O
(	O
strain	O
BYD1	O
)	O
alone	O
,	O
or	O
ReoV	O
combined	O
with	O
SARS	O
-	O
CoV	O
(	O
strain	O
BJF	O
)	O
displayed	O
ejecting	O
fur	O
and	O
loss	O
of	O
body	O
weight	O
compared	O
with	O
control	O
animals	B-SPEC
.	O

Mice	B-SPEC
infected	O
firstly	O
with	O
SARS	O
-	O
CoV	O
,	O
followed	O
with	O
ReoV	O
developed	O
a	O
typical	O
diffuse	O
alveolar	O
lesion	O
.	O

Continuous	O
HVHF	O
shows	O
significant	O
beneficial	O
effects	O
on	O
pulmonary	O
function	O
of	O
severe	O
sepsis	B-SPEC
patients	O
with	O
ARDS	O
as	O
a	O
result	O
of	O
removal	O
of	O
cytokines	O
,	O
decrease	O
of	O
TFC	O
and	O
amelioration	O
of	O
disturbance	O
in	O
respiration	O
,	O
hemodynamics	O
and	O
oxygen	O
metabolism	O
.	O

Comparison	O
with	O
other	O
coronavirus	B-SPEC
sequences	O
showed	O
a	O
high	O
similarity	O
to	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
).	O

ABSTRACT	O
:	O
Development	O
of	O
effective	O
vaccines	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
still	O
a	O
priority	O
in	O
prevention	O
of	O
re	O
-	O
emergence	O
of	O
SARS	O
.	O

But	O
it	O
is	O
unknown	O
whether	O
RBD	O
can	O
also	O
induce	O
protective	O
immunity	O
in	O
an	O
animal	B-SPEC
model	O
,	O
a	O
key	O
aspect	O
for	O
vaccine	O
development	O
.	O

TITLE	O
:	O
A	O
serosurvey	O
of	O
viral	O
infections	O
in	O
lions	B-SPEC
(	O
Panthera	B-SPEC
leo	I-SPEC
),	O
from	O
Queen	O
Elizabeth	O
National	O
Park	O
,	O
Uganda	O
.	O

Ten	O
lions	B-SPEC
(	O
71	O
%)	O
had	O
antibodies	O
against	O
FIV	B-SPEC
,	O
11	O
(	O
79	O
%)	O
had	O
antibodies	O
against	O
CDV	B-SPEC
,	O
11	O
(	O
79	O
%)	O
had	O
antibodies	O
against	O
FCV	B-SPEC
,	O
nine	O
(	O
64	O
%)	O
had	O
antibodies	O
against	O
FHV1	O
,	O
and	O
five	O
(	O
36	O
%)	O
had	O
antibodies	O
against	O
FPV	B-SPEC
.	O

Two	O
of	O
the	O
11	O
CDV	B-SPEC
-	O
seropositive	O
lions	B-SPEC
were	O
subadults	O
,	O
indicating	O
recent	O
exposure	O
of	O
this	O
population	O
to	O
CDV	B-SPEC
or	O
a	O
CDV	B-SPEC
-	O
like	O
virus	B-SPEC
.	O

TITLE	O
:	O
Discovering	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3CL	O
protease	O
inhibitors	O
:	O
virtual	O
screening	O
,	O
surface	O
plasmon	O
resonance	O
,	O
and	O
fluorescence	O
resonance	O
energy	O
transfer	O
assays	O
.	O

ABSTRACT	O
:	O
An	O
integrated	O
system	O
has	O
been	O
developed	O
for	O
discovering	O
potent	O
inhibitors	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
(	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
))	O
by	O
virtual	O
screening	O
correlating	O
with	O
surface	O
plasmon	O
resonance	O
(	O
SPR	O
)	O
and	O
fluorescence	O
resonance	O
energy	O
transfer	O
(	O
FRET	O
)	O
technologies	O
-	O
based	O
assays	O
.	O

TGEV	B-SPEC
required	O
R1	O
of	O
fAPN	O
,	O
while	O
FCoV	O
and	O
CCoV	O
required	O
both	O
R1	O
and	O
R2	O
for	O
entry	O
.	O

TITLE	O
:	O
A	O
hypervariable	O
region	O
within	O
the	O
3	O
'	O
cis	B-SPEC
-	O
acting	O
element	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
genome	O
is	O
nonessential	O
for	O
RNA	O
synthesis	O
but	O
affects	O
pathogenesis	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
open	O
reading	O
frame	O
(	O
ORF	O
)	O
3b	O
,	O
ORF	O
6	O
,	O
and	O
nucleocapsid	O
proteins	O
function	O
as	O
interferon	O
antagonists	O
.	O

TITLE	O
:	O
A	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
that	O
lacks	O
the	O
E	O
gene	O
is	O
attenuated	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

No	O
differences	O
in	O
virion	O
stability	O
under	O
a	O
wide	O
range	O
of	O
pH	O
and	O
temperature	O
were	O
detected	O
between	O
the	O
deletion	O
mutant	O
and	O
recombinant	O
wild	O
-	O
type	O
viruses	B-SPEC
.	O

A	O
prime	O
candidate	O
is	O
ORF6	O
,	O
which	O
encodes	O
a	O
63	O
-	O
amino	O
-	O
acid	O
membrane	O
-	O
associated	O
peptide	O
that	O
can	O
dramatically	O
increase	O
the	O
lethality	O
of	O
an	O
otherwise	O
attenuated	O
JHM	O
strain	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
(	O
L	O
.	O
Pewe	O
,	O
H	O
.	O
Zhou	O
,	O
J	O
.	O
Netland	O
,	O
C	O
.	O
Tangudu	O
,	O
H	O
.	O
Olivares	O
,	O
L	O
.	O
Shi	O
,	O
D	O
.	O
Look	O
,	O
T	O
.	O
Gallagher	O
,	O
and	O
S	O
.	O
Perlman	O
,	O
J	O
.	O
Virol	O
.	O

TITLE	O
:	O
Blinded	O
case	O
-	O
control	O
study	O
of	O
the	O
relationship	O
between	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
and	O
Kawasaki	O
syndrome	O
.	O

These	O
data	O
suggest	O
that	O
,	O
although	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
circulating	O
in	O
children	O
in	O
our	O
community	O
during	O
the	O
time	O
of	O
the	O
study	O
,	O
the	O
prevalence	O
of	O
infection	O
with	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
not	O
greater	O
in	O
patients	O
with	O
KS	O
than	O
in	O
control	O
subjects	O
.	O

Caerulein	O
-	O
treated	O
STAT6	O
and	O
STAT4	O
mice	B-SPEC
had	O
markedly	O
increased	O
MPO	O
activity	O
as	O
compared	O
with	O
their	O
saline	O
controls	O
during	O
the	O
first	O
6	O
h	O
.	O
Both	O
caerulein	O
-	O
treated	O
STAT4	O
-	O
and	O
STAT6	O
-	O
deficient	O
mice	B-SPEC
had	O
significantly	O
increased	O
MPO	O
activity	O
in	O
comparison	O
with	O
wild	O
-	O
type	O
mice	B-SPEC
with	O
pancreatitis	O
at	O
6	O
h	O
.	O
We	O
found	O
the	O
maximal	O
lung	O
injury	O
after	O
caerulein	O
-	O
induced	O
pancreatitis	O
occurred	O
at	O
different	O
time	O
-	O
points	O
in	O
STAT4	O
and	O
STAT6	O
-	O
deficient	O
mice	B-SPEC
.	O

We	O
experimentally	O
evaluated	O
the	O
effects	O
of	O
immunodeficiency	O
caused	O
by	O
co	O
-	O
infection	O
with	O
chicken	B-SPEC
anaemia	I-SPEC
virus	I-SPEC
and	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
on	O
the	O
outcome	O
of	O
IBV	B-SPEC
infection	O
.	O

Collectively	O
,	O
these	O
results	O
indicate	O
that	O
viral	O
immunodeficiency	O
most	O
probably	O
plays	O
a	O
relevant	O
role	O
in	O
the	O
epidemiology	O
and	O
outcome	O
of	O
IBV	B-SPEC
infection	O
.	O

CPV	B-SPEC
-	O
2c	O
has	O
been	O
detected	O
initially	O
in	O
Italy	O
and	O
subsequently	O
in	O
Vietnam	O
.	O

Levels	O
of	O
chemokines	O
/	O
cytokines	O
involved	O
in	O
immunoreaction	O
in	O
response	O
to	O
virus	B-SPEC
infection	O
were	O
detected	O
in	O
the	O
supernatants	O
of	O
those	O
cells	O
cultured	O
with	O
the	O
Spike	O
glycoprotein	O
by	O
liquid	O
chip	O
system	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
clinical	O
efficacy	O
and	O
safety	O
of	O
specific	O
immunotherapy	O
(	O
SIT	O
)	O
with	O
standardized	O
house	B-SPEC
dust	I-SPEC
mite	I-SPEC
(	O
HDM	O
)	O
vaccine	O
on	O
allergic	O
asthmatic	O
patients	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
the	O
level	O
of	O
serum	O
sIgE	B-SPEC
against	O
Der	O
p	O
between	O
groups	O
,	O
which	O
was	O
76	O
.	O
80	O
(	O
97	O
.	O
0	O
)	O
kU	O
/	O
L	O
in	O
active	O
group	O
and	O
66	O
.	O
50	O
(	O
99	O
.	O
3	O
)	O
kU	O
/	O
L	O
in	O
the	O
control	O
group	O
(	O
Z	O
=	O
0	O
.	O
232	O
,	O
P	O
>	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Palmitoylation	O
of	O
the	O
cysteine	O
-	O
rich	O
endodomain	O
of	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
is	O
important	O
for	O
spike	O
-	O
mediated	O
cell	O
fusion	O
.	O

ABSTRACT	O
:	O
Both	O
innate	O
and	O
adaptative	O
immune	O
responses	O
contribute	O
to	O
the	O
control	O
of	O
infectious	O
diseases	O
,	O
including	O
by	O
limiting	O
the	O
spreading	O
of	O
zoonotic	O
diseases	O
from	O
animal	B-SPEC
reservoirs	O
to	O
humans	B-SPEC
.	O

Interestingly	O
,	O
primary	O
influenza	B-SPEC
virus	I-SPEC
infection	O
induced	O
long	O
-	O
lived	O
increase	O
of	O
lung	O
CD8	O
(+)	O
T	O
cells	O
and	O
local	O
lymphoproliferative	O
responses	O
.	O

TITLE	O
:	O
Human	B-SPEC
Coronavirus	I-SPEC
-	O
NL63	O
infections	O
in	O
Korean	O
children	O
,	O
2004	O
-	O
2006	O
.	O

CONCLUSIONS	O
:	O
The	O
molecular	O
technique	O
we	O
applied	O
to	O
detect	O
human	B-SPEC
coronavirus	I-SPEC
appears	O
justified	O
as	O
a	O
valuable	O
diagnostic	O
approach	O
to	O
elucidate	O
the	O
prevalence	O
,	O
cause	O
and	O
clinical	O
implications	O
of	O
ALRI	O
among	O
infants	O
and	O
young	O
children	O
.	O

Numerous	O
pathogens	O
,	O
including	O
viruses	B-SPEC
like	O
West	O
Nile	O
,	O
Chikungunya	O
and	O
Japanese	B-SPEC
encephalitis	I-SPEC
on	O
the	O
one	O
hand	O
,	O
and	O
hemorrhagic	O
fever	O
viruses	B-SPEC
like	O
Ebola	O
and	O
Maburg	O
,	O
are	O
particular	O
concerns	O
.	O

We	O
sought	O
to	O
determine	O
the	O
contribution	O
of	O
respiratory	O
viruses	B-SPEC
to	O
asthma	O
exacerbations	O
in	O
children	O
with	O
a	O
panel	O
of	O
PCR	O
assays	O
for	O
common	O
and	O
newly	O
discovered	O
respiratory	O
viruses	B-SPEC
.	O

However	O
,	O
in	O
children	O
without	O
clinically	O
manifested	O
viral	O
respiratory	O
tract	O
illness	O
,	O
the	O
prevalence	O
of	O
rhinovirus	B-SPEC
infection	O
was	O
similar	O
in	O
case	O
patients	O
(	O
29	O
.	O
2	O
%)	O
versus	O
control	O
subjects	O
(	O
23	O
.	O
4	O
%,	O
P	O
>	O
.	O
05	O
).	O

Symptomatic	O
rhinovirus	B-SPEC
infections	O
are	O
an	O
important	O
contributor	O
to	O
asthma	O
exacerbations	O
in	O
children	O
.	O

These	O
results	O
support	O
the	O
need	O
for	O
therapies	O
effective	O
against	O
rhinovirus	B-SPEC
as	O
a	O
means	O
to	O
decrease	O
asthma	O
exacerbations	O
.	O

We	O
provide	O
direct	O
evidence	O
for	O
the	O
functional	O
role	O
of	O
C	O
-	O
terminal	O
domain	O
in	O
stabilization	O
of	O
the	O
catalytic	O
N	O
-	O
terminal	O
domain	O
of	O
SARS	O
coronavirus	B-SPEC
main	O
protease	O
.	O

Subsequent	O
analysis	O
revealed	O
no	O
differences	O
in	O
T	O
cell	O
proliferation	O
,	O
IFN	O
-	O
gamma	O
secretion	O
by	O
virus	B-SPEC
-	O
specific	O
T	O
cells	O
,	O
or	O
CD8	O
+	O
T	O
cell	O
cytolytic	O
activity	O
.	O

Adoptive	O
transfer	O
of	O
splenocytes	O
acquired	O
from	O
MHV	B-SPEC
-	O
immunized	O
CXCL10	O
(-/-)	O
mice	B-SPEC
into	O
MHV	B-SPEC
-	O
infected	O
RAG1	O
(-/-)	O
mice	B-SPEC
resulted	O
in	O
T	O
cell	O
infiltration	O
into	O
the	O
CNS	O
,	O
reduced	O
viral	O
burden	O
,	O
and	O
demyelination	O
comparable	O
to	O
RAG1	O
(-/-)	O
recipients	O
of	O
immune	O
CXCL10	O
(+/+)	O
splenocytes	O
.	O

Collectively	O
,	O
these	O
data	O
imply	O
that	O
CXCL10	O
functions	O
primarily	O
as	O
a	O
T	O
cell	O
chemoattractant	O
and	O
does	O
not	O
significantly	O
influence	O
T	O
cell	O
effector	O
response	O
following	O
MHV	B-SPEC
infection	O
.	O

Respiratory	O
infections	O
may	O
have	O
a	O
human	B-SPEC
source	O
such	O
as	O
tuberculosis	O
or	O
viral	O
diseases	O
or	O
may	O
originate	O
in	O
ventilation	O
systems	O
such	O
as	O
Legionnaire	O
'	O
s	O
disease	O
(	O
Legionella	B-SPEC
pneumophila	I-SPEC
pneumonia	O
).	O

ABSTRACT	O
:	O
The	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
(	O
SARS	O
CoV	O
main	O
proteinase	O
)	O
is	O
required	O
for	O
the	O
replication	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
),	O
the	O
virus	B-SPEC
that	O
causes	O
SARS	O
.	O

TITLE	O
:	O
Participation	O
of	O
both	O
host	O
and	O
virus	B-SPEC
factors	O
in	O
induction	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
F344	O
rats	B-SPEC
infected	O
with	O
SARS	O
coronavirus	B-SPEC
.	O

By	O
contrast	O
,	O
adult	O
rats	B-SPEC
infected	O
with	O
the	O
passaged	O
virus	B-SPEC
showed	O
respiratory	O
symptoms	O
and	O
severe	O
pathological	O
lesions	O
in	O
the	O
lung	O
.	O

Despite	O
the	O
increasing	O
operating	O
cost	O
,	O
declining	O
patient	O
attendance	O
and	O
high	O
price	O
of	O
the	O
PPE	O
,	O
they	O
persist	O
in	O
using	O
PPE	O
and	O
change	O
their	O
behaviour	O
in	O
order	B-SPEC
to	O
reduce	O
the	O
perceived	O
threat	O
to	O
their	O
lives	O
.	O

ABSTRACT	O
:	O
The	O
detection	O
of	O
multiple	O
viruses	B-SPEC
is	O
important	O
for	O
pathogenic	O
diagnosis	O
and	O
disease	O
control	O
.	O

Microarray	O
detection	O
is	O
a	O
good	O
method	O
,	O
but	O
requires	O
complex	O
procedures	O
for	O
multiple	O
virus	B-SPEC
detection	O
.	O

However	O
,	O
the	O
HI	O
titers	O
against	O
the	O
antigens	O
used	O
in	O
this	O
study	O
were	O
relatively	O
similar	O
in	O
10	O
out	O
of	O
the	O
14	O
flocks	O
(	O
71	O
%)	O
and	O
the	O
serotype	O
of	O
IBV	B-SPEC
that	O
these	O
flocks	O
were	O
exposed	O
to	O
could	O
not	O
be	O
determined	O
and	O
the	O
possible	O
causes	O
of	O
this	O
are	O
discussed	O
.	O

Unique	O
human	B-SPEC
mAbs	O
could	O
be	O
used	O
as	O
a	O
cocktail	O
that	O
would	O
simultaneously	O
target	O
several	O
neutralizing	O
epitopes	O
and	O
prevent	O
emergence	O
of	O
escape	O
mutants	O
.	O

Chest	O
x	O
-	O
rays	B-SPEC
were	O
taken	O
6	O
and	O
24	O
hours	O
after	O
treatment	O
.	O

BAL	O
with	O
dilute	O
porcine	B-SPEC
surfactant	O
administered	O
slowly	O
in	O
2	O
.	O
5	O
mL	O
aliquots	O
improved	O
oxygenation	O
and	O
chest	O
x	O
-	O
ray	B-SPEC
findings	O
,	O
without	O
causing	O
major	O
adverse	O
effects	O
,	O
in	O
mechanically	O
ventilated	O
term	O
infants	O
with	O
ARDS	O
due	O
to	O
MAS	O
.	O

TITLE	O
:	O
The	O
cytoplasmic	O
tail	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
contains	O
a	O
novel	O
endoplasmic	O
reticulum	O
retrieval	O
signal	O
that	O
binds	O
COPI	O
and	O
promotes	O
interaction	O
with	O
membrane	O
protein	O
.	O

ABSTRACT	O
:	O
Like	O
other	O
coronaviruses	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
)	O
assembles	O
at	O
and	O
buds	O
into	O
the	O
lumen	O
of	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)-	O
Golgi	O
intermediate	O
compartment	O
(	O
ERGIC	O
).	O

Accumulation	O
of	O
the	O
viral	O
envelope	O
proteins	O
at	O
this	O
compartment	O
is	O
a	O
prerequisite	O
for	O
virus	B-SPEC
assembly	O
.	O

Molecular	O
evolution	O
studies	O
have	O
revealed	O
that	O
SARS	O
must	O
be	O
originated	O
from	O
wild	O
animals	B-SPEC
,	O
and	O
it	O
was	O
demonstrated	O
that	O
the	O
major	O
genetic	O
variations	O
in	O
some	O
critical	O
genes	O
,	O
particularly	O
the	O
Spike	O
gene	O
,	O
was	O
essential	O
for	O
the	O
transition	O
from	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
to	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

In	O
2003	O
,	O
a	O
previously	O
unknown	O
coronavirus	B-SPEC
was	O
identified	O
to	O
be	O
the	O
etiological	O
agent	O
of	O
a	O
global	O
outbreak	O
of	O
a	O
form	O
of	O
life	O
-	O
threatening	O
pneumonia	O
called	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Different	O
variants	O
of	O
TGEV	B-SPEC
-	O
specific	O
SIPs	O
were	O
created	O
,	O
of	O
epsilon	O
and	O
alpha	O
isotypes	O
,	O
by	O
exploiting	O
the	O
dimerizing	O
domains	O
epsilonCH4	O
and	O
alphaCH3	O
of	O
human	B-SPEC
and	O
swine	B-SPEC
origin	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
S	O
is	O
expressed	O
as	O
a	O
single	O
-	O
chain	O
glycoprotein	O
and	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
receptor	O
-	O
binding	O
domain	O
(	O
S1	O
)	O
and	O
a	O
C	O
-	O
terminal	O
transmembrane	O
fusion	O
domain	O
(	O
S2	O
).	O

TITLE	O
:	O
Evaluation	O
of	O
immunomodulators	O
,	O
interferons	O
and	O
known	O
in	O
vitro	O
SARS	O
-	O
coV	O
inhibitors	O
for	O
inhibition	O
of	O
SARS	O
-	O
coV	O
replication	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

Anti	O
-	O
inflammatory	O
agents	O
,	O
chloroquine	O
,	O
amodiaquin	O
and	O
pentoxifylline	O
,	O
were	O
also	O
inactive	O
in	O
vivo	O
,	O
suggesting	O
that	O
although	O
they	O
may	O
be	O
useful	O
in	O
ameliorating	O
the	O
hyperinflammatory	O
response	O
induced	O
by	O
the	O
virus	B-SPEC
infection	O
,	O
they	O
will	O
not	O
significantly	O
reduce	O
the	O
replication	O
of	O
the	O
virus	B-SPEC
,	O
the	O
inducer	O
of	O
inflammatory	O
response	O
.	O

ABSTRACT	O
:	O
A	O
30	O
-	O
year	O
-	O
old	O
woman	O
with	O
malnutrition	O
due	O
to	O
alcoholism	O
and	O
eating	O
disorders	O
was	O
found	O
to	O
have	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
sepsis	B-SPEC
due	O
to	O
severe	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
pneumonia	O
.	O

Oligonucleotide	O
target	O
sequences	O
specific	O
for	O
human	B-SPEC
immunodeficiency	O
,	O
hepatitis	B-SPEC
C	I-SPEC
,	O
and	O
severe	O
acute	O
respiratory	O
viruses	B-SPEC
were	O
assayed	O
simultaneously	O
in	O
a	O
no	O
-	O
wash	O
,	O
sealed	O
chamber	O
,	O
multiplexed	O
experiment	O
in	O
which	O
each	O
of	O
three	O
probe	O
sequences	O
was	O
attached	O
to	O
a	O
different	O
pattern	O
of	O
encoded	O
nanowires	O
.	O

TITLE	O
:	O
SARS	O
,	O
avian	B-SPEC
flu	O
,	O
bioterror	O
:	O
infection	O
control	O
awareness	O
for	O
the	O
optometrist	O
.	O

The	O
Harderian	O
gland	O
and	O
trachea	B-SPEC
of	O
hens	O
and	O
cockerels	O
in	O
both	O
T	O
-	O
and	O
N1	O
/	O
88	O
-	O
infected	O
groups	O
were	O
damaged	O
to	O
a	O
similar	O
extent	O
.	O

The	O
sequential	O
histopathological	O
changes	O
in	O
hens	O
revealed	O
that	O
IBV	B-SPEC
multiplies	O
initially	O
in	O
the	O
Harderian	O
gland	O
,	O
then	O
in	O
the	O
tracheal	O
mucosa	O
and	O
simultaneously	O
in	O
the	O
kidney	O
and	O
regions	O
of	O
the	O
oviduct	O
such	O
as	O
the	O
magnum	O
,	O
tubular	O
shell	O
gland	O
,	O
and	O
shell	O
gland	O
pouch	O
.	O

TITLE	O
:	O
Histopathology	O
of	O
two	O
serotypes	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
laying	O
hens	O
vaccinated	O
in	O
the	O
rearing	O
phase	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
A59	O
nucleocapsid	O
protein	O
is	O
a	O
type	O
I	O
interferon	O
antagonist	O
.	O

We	O
used	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
A59	O
as	O
a	O
model	O
to	O
gain	O
insight	O
into	O
how	O
coronaviruses	O
affect	O
the	O
type	O
I	O
alpha	O
/	O
beta	O
interferon	O
(	O
IFN	O
)	O
system	O
.	O

We	O
used	O
a	O
well	O
-	O
established	O
recombinant	O
vaccinia	B-SPEC
virus	I-SPEC
(	O
VV	O
)-	O
based	O
expression	O
system	O
that	O
lacks	O
the	O
viral	O
IFN	O
antagonist	O
E3L	O
to	O
screen	O
viral	O
genes	O
for	O
their	O
ability	O
to	O
rescue	O
the	O
IFN	O
sensitivity	O
of	O
the	O
mutant	O
.	O

The	O
results	O
indicate	O
that	O
the	O
MHV	B-SPEC
N	O
protein	O
is	O
a	O
type	O
I	O
IFN	O
antagonist	O
that	O
likely	O
plays	O
a	O
role	O
in	O
circumventing	O
the	O
innate	O
immune	O
response	O
.	O

Additionally	O
,	O
we	O
have	O
created	O
substitution	O
mutants	O
in	O
which	O
the	O
MHV	B-SPEC
E	O
gene	O
was	O
replaced	O
by	O
heterologous	O
E	O
genes	O
from	O
viruses	B-SPEC
spanning	O
all	O
three	O
groups	O
of	O
the	O
coronavirus	B-SPEC
family	B-SPEC
.	O

However	O
,	O
the	O
E	O
protein	O
of	O
a	O
group	O
1	O
coronavirus	B-SPEC
,	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
,	O
became	O
functional	O
in	O
MHV	B-SPEC
only	O
after	O
acquisition	O
of	O
particular	O
mutations	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
the	O
prototype	O
of	O
the	O
genus	B-SPEC
Coronavirus	B-SPEC
.	O

It	O
causes	O
a	O
highly	O
contagious	O
disease	O
which	O
affects	O
the	O
respiratory	O
,	O
reproductive	O
,	O
neurological	O
and	O
renal	O
systems	O
of	O
chickens	B-SPEC
,	O
resulting	O
great	O
economic	O
losses	O
in	O
the	O
poultry	O
industry	O
worldwide	O
.	O

X	O
-	O
ray	B-SPEC
diffraction	O
data	O
were	O
collected	O
in	O
-	O
house	O
to	O
2	O
.	O
7	O
A	O
resolution	O
from	O
a	O
single	O
crystal	O
.	O

TITLE	O
:	O
Severe	O
proctitis	O
,	O
perforation	O
,	O
and	O
fatal	O
rectal	O
bleeding	O
secondary	O
to	O
cytomegalovirus	B-SPEC
in	O
an	O
immunocompetent	O
patient	O
:	O
report	O
of	O
a	O
case	O
.	O

TITLE	O
:	O
Public	O
health	O
awareness	O
of	O
emerging	O
zoonotic	O
viruses	B-SPEC
of	O
bats	B-SPEC
:	O
a	O
European	O
perspective	O
.	O

Several	O
bat	B-SPEC
species	B-SPEC
are	O
reservoir	O
hosts	O
of	O
zoonotic	O
viruses	B-SPEC
and	O
therefore	O
can	O
be	O
a	O
public	O
health	O
hazard	O
.	O

Lyssaviruses	B-SPEC
of	O
different	O
genotypes	O
have	O
emerged	O
from	O
bats	B-SPEC
in	O
America	O
(	O
Genotype	O
1	O
rabies	B-SPEC
virus	I-SPEC
;	O
RABV	O
),	O
Europe	O
(	O
European	B-SPEC
bat	I-SPEC
lyssavirus	I-SPEC
;	O
EBLV	O
),	O
and	O
Australia	O
(	O
Australian	B-SPEC
bat	I-SPEC
lyssavirus	I-SPEC
;	O
ABLV	O
),	O
whereas	O
Nipah	B-SPEC
virus	I-SPEC
is	O
the	O
most	O
important	O
recent	O
zoonosis	O
of	O
bat	B-SPEC
origin	O
in	O
Asia	O
.	O

New	O
zoonotic	O
viruses	B-SPEC
may	O
emerge	O
from	O
bat	B-SPEC
reservoirs	O
and	O
known	O
ones	O
may	O
spread	O
to	O
a	O
wider	O
geographical	O
range	O
.	O

Apart	O
from	O
that	O
,	O
detection	O
methods	O
for	O
zoonotic	O
viruses	B-SPEC
that	O
may	O
emerge	O
from	O
bats	B-SPEC
should	O
be	O
implemented	O
.	O

Subsequently	O
,	O
studies	O
will	O
have	O
to	O
be	O
performed	O
to	O
assess	O
the	O
public	O
health	O
hazards	O
of	O
such	O
viruses	B-SPEC
(	O
i	O
.	O
e	O
.,	O
infectivity	O
and	O
risk	O
of	O
infection	O
to	O
people	O
).	O

TITLE	O
:	O
Absence	O
of	O
surface	O
expression	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
antigens	O
on	O
infected	O
cells	O
isolated	O
from	O
cats	B-SPEC
with	O
FIP	O
.	O

In	O
this	O
study	O
,	O
FIPV	O
positive	O
cells	O
were	O
isolated	O
from	O
pyogranulomas	O
and	O
exudates	O
of	O
12	O
naturally	O
FIPV	O
-	O
infected	O
cats	B-SPEC
and	O
the	O
presence	O
of	O
two	O
immunologic	O
targets	O
,	O
viral	O
antigens	O
and	O
MHC	O
I	O
,	O
on	O
their	O
surface	O
was	O
determined	O
.	O

Using	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
replicon	O
particles	O
(	O
VRP	O
)	O
expressing	O
the	O
2003	O
epidemic	O
Urbani	O
SARS	O
-	O
CoV	O
strain	O
spike	O
(	O
S	O
)	O
glycoprotein	O
(	O
VRP	O
-	O
S	O
)	O
or	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
from	O
the	O
same	O
strain	O
(	O
VRP	O
-	O
N	O
),	O
we	O
demonstrate	O
that	O
VRP	O
-	O
S	O
,	O
but	O
not	O
VRP	O
-	O
N	O
vaccines	O
provide	O
complete	O
short	O
-	O
and	O
long	O
-	O
term	O
protection	O
against	O
homologous	O
strain	O
challenge	O
in	O
young	O
and	O
senescent	O
mice	B-SPEC
.	O

VRP	O
-	O
N	O
vaccines	O
not	O
only	O
failed	O
to	O
protect	O
from	O
homologous	O
or	O
heterologous	O
challenge	O
,	O
but	O
resulted	O
in	O
enhanced	O
immunopathology	O
with	O
eosinophilic	O
infiltrates	O
within	O
the	O
lungs	O
of	O
SARS	O
-	O
CoV	O
-	O
challenged	O
mice	B-SPEC
.	O

It	O
is	O
possible	O
that	O
extensive	O
culturing	O
of	O
the	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
laboratory	O
strain	O
resulted	O
in	O
truncation	O
of	O
ORF4	O
.	O

For	O
the	O
follow	O
-	O
up	O
study	O
,	O
the	O
rats	B-SPEC
exposed	O
for	O
3	O
days	O
were	O
scanned	O
using	O
CT	O
and	O
their	O
pathology	O
was	O
examined	O
at	O
7	O
,	O
14	O
,	O
and	O
28	O
days	O
.	O

The	O
parenchymal	O
density	O
of	O
the	O
rats	B-SPEC
exposed	O
to	O
12	O
ppm	O
was	O
significantly	O
higher	O
.	O

In	O
this	O
study	O
,	O
we	O
showed	O
that	O
lipid	O
rafts	O
also	O
play	O
an	O
important	O
role	O
in	O
the	O
life	O
cycle	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

This	O
inhibition	O
was	O
prevented	O
by	O
addition	O
of	O
cholesterol	O
to	O
the	O
culture	O
medium	O
,	O
indicating	O
that	O
the	O
reduction	O
of	O
virus	B-SPEC
particle	O
release	O
was	O
caused	O
by	O
the	O
loss	O
of	O
cholesterol	O
in	O
the	O
cell	O
membrane	O
.	O

In	O
contrast	O
,	O
cholesterol	O
depletion	O
at	O
the	O
post	O
-	O
entry	O
stage	O
(	O
3h	O
post	O
-	O
infection	O
)	O
caused	O
only	O
a	O
limited	O
effect	O
on	O
virus	B-SPEC
particle	O
release	O
.	O

Children	O
and	O
adolescents	O
are	O
susceptible	O
to	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
,	O
although	O
the	O
clinical	O
course	O
and	O
outcome	O
are	O
more	O
favorable	O
in	O
children	O
younger	O
than	O
12	O
years	O
of	O
age	O
compared	O
with	O
adolescents	O
and	O
adults	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
localizes	O
to	O
the	O
cytoplasm	O
and	O
nucleolus	O
and	O
contains	O
an	O
eight	O
-	O
amino	O
-	O
acid	O
nucleolar	O
retention	O
motif	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
analyzed	O
the	O
replication	O
and	O
budding	O
sites	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
at	O
early	O
time	O
points	O
of	O
infection	O
.	O

All	O
patients	O
of	O
snake	B-SPEC
bite	O
that	O
presented	O
to	O
our	O
institution	O
over	O
a	O
period	O
of	O
1	O
1	O
/	O
2	O
years	O
were	O
included	O
in	O
the	O
present	O
study	O
.	O

Mixed	O
infections	O
with	O
more	O
than	O
1	O
species	B-SPEC
of	O
parasite	O
can	O
occur	O
;	O
they	O
commonly	O
involve	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
with	O
the	O
attendant	O
risks	O
of	O
severe	O
malaria	O
.	O

In	O
the	O
UK	O
,	O
the	O
treatment	O
of	O
choice	O
for	O
severe	O
or	O
complicated	O
malaria	O
is	O
currently	O
an	O
infusion	O
of	O
intravenous	O
quinine	B-SPEC
.	O

The	O
treatment	O
of	O
choice	O
for	O
falciparum	O
malaria	O
in	O
pregnancy	O
is	O
quinine	B-SPEC
;	O
doxycycline	O
is	O
contraindicated	O
in	O
pregnancy	O
but	O
clindamycin	O
can	O
be	O
substituted	O
for	O
it	O
,	O
and	O
is	O
equally	O
effective	O
.	O

Primaquine	O
(	O
for	O
eradication	O
of	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
or	O
P	B-SPEC
.	I-SPEC
ovale	I-SPEC
hypnozoites	O
)	O
is	O
contraindicated	O
in	O
pregnancy	O
;	O
after	O
treatment	O
for	O
these	O
infections	O
a	O
pregnant	O
woman	O
should	O
take	O
weekly	O
chloroquine	O
prophylaxis	O
until	O
after	O
delivery	O
when	O
hypnozoite	O
eradication	O
can	O
be	O
considered	O
.	O

In	O
a	O
case	O
-	O
control	O
study	O
,	O
clinical	O
,	O
laboratory	O
and	O
radiological	O
data	O
from	O
322	O
patients	O
with	O
laboratory	O
-	O
confirmed	O
SARS	O
from	O
the	O
2003	O
SARS	O
outbreak	O
were	O
compared	O
with	O
the	O
data	O
of	O
253	O
non	O
-	O
SARS	O
adult	O
patients	O
with	O
confirmed	O
viral	O
respiratory	O
tract	O
infection	O
from	O
2004	O
in	O
order	B-SPEC
to	O
identify	O
discriminatory	O
features	O
.	O

ABSTRACT	O
:	O
Beginning	O
with	O
a	O
cluster	O
of	O
human	B-SPEC
cases	O
in	O
Hong	O
Kong	O
in	O
1997	O
,	O
avian	B-SPEC
influenza	O
(	O
H5N1	O
)	O
has	O
spread	O
progressively	O
through	O
,	O
and	O
beyond	O
,	O
Asia	O
in	O
poultry	O
and	O
other	O
birds	B-SPEC
;	O
and	O
has	O
resulted	O
in	O
sporadic	O
cases	O
of	O
human	B-SPEC
disease	O
associated	O
with	O
high	O
mortality	O
.	O

We	O
adapted	O
the	O
SARS	O
-	O
CoV	O
(	O
Urbani	O
strain	O
)	O
by	O
serial	O
passage	O
in	O
the	O
respiratory	O
tract	O
of	O
young	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

Lethality	O
is	O
preceded	O
by	O
rapid	O
and	O
high	O
titer	O
viral	O
replication	O
in	O
lungs	O
,	O
viremia	O
,	O
and	O
dissemination	O
of	O
virus	B-SPEC
to	O
extrapulmonary	O
sites	O
accompanied	O
by	O
lymphopenia	O
,	O
neutrophilia	O
,	O
and	O
pathological	O
changes	O
in	O
the	O
lungs	O
.	O

These	O
observations	O
suggest	O
that	O
mice	B-SPEC
infected	O
with	O
MA15	O
die	O
from	O
an	O
overwhelming	O
viral	O
infection	O
with	O
extensive	O
,	O
virally	O
mediated	O
destruction	O
of	O
pneumocytes	O
and	O
ciliated	O
epithelial	O
cells	O
.	O

Dissemination	O
of	O
H	B-SPEC
.	I-SPEC
capsulatum	I-SPEC
within	O
macrophages	O
is	O
common	O
and	O
becomes	O
symptomatic	O
primarily	O
in	O
patients	O
with	O
defects	O
in	O
cellular	O
immunity	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
the	O
use	O
of	O
measuring	O
anti	O
-	O
coronavirus	B-SPEC
IgG	O
in	O
CSF	O
for	O
the	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
involving	O
the	O
CNS	O
in	O
cats	B-SPEC
.	O

CSF	O
and	O
serum	O
samples	O
from	O
67	O
cats	B-SPEC
.	O

Cerebrospinal	O
fluid	O
IgG	O
was	O
detected	O
only	O
in	O
cats	B-SPEC
with	O
correspondingly	O
high	O
serum	O
IgG	O
titers	O
(	O
range	O
,	O
1	O
:	O
4	O
,	O
096	O
to	O
1	O
:	O
16	O
,	O
384	O
)	O
and	O
was	O
positively	O
correlated	O
with	O
serum	O
IgG	O
titers	O
(	O
r	O
=	O
0	O
.	O
652	O
;	O
P	O
<	O
0	O
.	O
01	O
),	O
but	O
not	O
with	O
any	O
other	O
CSF	O
parameter	O
.	O

Two	O
recently	O
proposed	O
theories	O
of	O
Kawasaki	O
disease	O
etiology	O
,	O
the	O
toxic	O
shock	O
syndrome	O
toxin	O
-	O
1	O
hypothesis	O
and	O
the	O
coronavirus	B-SPEC
NL	O
-	O
63	O
hypothesis	O
,	O
have	O
been	O
studied	O
extensively	O
and	O
have	O
been	O
disproven	O
.	O

ABSTRACT	O
:	O
The	O
causative	O
agent	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
was	O
identified	O
as	O
a	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
following	O
the	O
outbreak	O
of	O
2002	O
-	O
2003	O
.	O

The	O
aged	O
BALB	O
/	O
c	O
mouse	B-SPEC
model	O
for	O
SARS	O
supports	O
a	O
high	O
level	O
of	O
viral	O
replication	O
in	O
association	O
with	O
clinical	O
illness	O
and	O
disease	O
that	O
mimics	O
SARS	O
in	O
the	O
elderly	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
envelope	O
(	O
E	O
)	O
proteins	O
are	O
small	O
(	O
approximately	O
75	O
-	O
to	O
110	O
-	O
amino	O
-	O
acid	O
)	O
membrane	O
proteins	O
that	O
have	O
a	O
short	O
hydrophilic	O
amino	O
terminus	O
,	O
a	O
relatively	O
long	O
hydrophobic	O
membrane	O
domain	O
,	O
and	O
a	O
long	O
hydrophilic	O
carboxy	O
-	O
terminal	O
domain	O
.	O

Comparison	O
of	O
crystal	O
packing	O
of	O
SARS	O
-	O
CoV	O
and	O
IBV	B-SPEC
N	O
-	O
NTDs	O
suggests	O
a	O
common	O
mode	O
of	O
RNA	O
recognition	O
,	O
but	O
they	O
probably	O
associate	O
differently	O
in	O
vivo	O
during	O
the	O
formation	O
of	O
the	O
ribonucleoprotein	O
complex	O
.	O

Here	O
we	O
report	O
that	O
with	O
the	O
same	O
experimental	O
approach	O
,	O
template	O
switches	O
can	O
be	O
induced	O
in	O
trans	O
from	O
an	O
internal	O
site	O
in	O
the	O
DI	O
RNA	O
to	O
the	O
negative	O
-	O
strand	O
antigenome	O
of	O
the	O
helper	O
virus	B-SPEC
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
cleavage	O
of	O
signal	O
peptide	O
at	O
the	O
C	O
-	O
terminus	O
of	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
core	O
protein	O
by	O
signal	O
peptide	O
peptidase	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
method	O
for	O
bacteria	B-SPEC
and	O
virus	B-SPEC
recovery	O
from	O
heating	O
,	O
ventilation	O
,	O
and	O
air	O
conditioning	O
(	O
HVAC	O
)	O
filters	O
.	O

Nonpathogenic	O
Bacillus	B-SPEC
subtilis	I-SPEC
var	O
.	O

Innate	O
immunity	O
is	O
important	O
for	O
viral	O
clearance	O
in	O
the	O
mouse	B-SPEC
model	O
.	O

The	O
avian	B-SPEC
influenza	O
A	O
-	O
H5N1	O
-	O
virus	B-SPEC
of	O
high	O
pathogenicity	O
has	O
crossed	O
in	O
multiple	O
instances	O
the	O
species	B-SPEC
barriers	O
between	O
humans	B-SPEC
,	O
mammals	B-SPEC
,	O
and	O
birds	B-SPEC
posing	O
a	O
serious	O
pandemic	O
threat	O
.	O

TITLE	O
:	O
Canine	O
coronavirus	B-SPEC
induces	O
apoptosis	O
in	O
cultured	O
cells	O
.	O

ABSTRACT	O
:	O
Canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
is	O
widespread	O
in	O
dogs	B-SPEC
in	O
several	O
countries	O
and	O
causes	O
mild	O
enteric	O
illness	O
evolving	O
to	O
severe	O
enteritis	O
in	O
young	O
pups	O
.	O

TITLE	O
:	O
Comparative	O
immunization	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
with	O
recombinant	O
replication	O
-	O
defective	O
adenovirus	B-SPEC
vector	O
and	O
DNA	O
plasmid	O
expressing	O
a	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
gene	O
.	O

Isolation	O
of	O
Pasteurella	B-SPEC
multocida	I-SPEC
was	O
associated	O
with	O
increased	O
concentrations	O
of	O
all	O
tested	O
acute	O
phase	O
proteins	O
.	O

Although	O
the	O
initial	O
SARS	O
epidemic	O
was	O
contained	O
,	O
sporadic	O
outbreaks	O
of	O
the	O
disease	O
still	O
occur	O
,	O
suggesting	O
a	O
continuous	O
need	O
for	O
a	O
vaccine	O
against	O
this	O
virus	B-SPEC
.	O

Both	O
,	O
S	O
-	O
containing	O
exosomes	O
and	O
the	O
adenoviral	B-SPEC
vector	O
vaccine	O
induced	O
neutralizing	O
antibody	O
titers	O
.	O

In	O
order	B-SPEC
to	O
validate	O
the	O
reliability	O
of	O
these	O
assays	O
,	O
the	O
standard	O
panel	O
should	O
be	O
established	O
.	O

It	O
makes	O
visible	O
how	O
during	O
SARS	O
China	O
eventually	O
complied	O
with	O
the	O
spirit	O
of	O
the	O
international	O
sanitation	O
regulations	O
but	O
the	O
lack	O
of	O
commitment	O
to	O
improving	O
access	O
to	O
health	O
care	O
for	O
persons	O
living	O
with	O
HIV	B-SPEC
/	O
AIDS	O
reflects	O
a	O
failure	O
by	O
China	O
to	O
guarantee	O
the	O
right	O
to	O
adequate	O
health	O
care	O
.	O

Their	O
clinical	O
spectrum	O
goes	B-SPEC
beyond	O
the	O
patients	O
with	O
malignancies	O
,	O
and	O
for	O
example	O
invasive	O
pulmonary	O
aspergillosis	O
has	O
recently	O
been	O
described	O
in	O
critically	O
ill	O
patients	O
without	O
such	O
condition	O
.	O

ABSTRACT	O
:	O
Although	O
many	O
novel	O
members	O
of	O
the	O
Coronaviridae	B-SPEC
have	O
recently	O
been	O
recognized	O
in	O
different	O
species	B-SPEC
,	O
the	O
ecology	O
of	O
coronaviruses	O
has	O
not	O
been	O
established	O
.	O

Furthermore	O
,	O
the	O
most	O
closely	O
related	O
bat	B-SPEC
and	O
SARS	O
coronaviruses	O
diverged	O
in	O
1986	O
,	O
an	O
estimated	O
divergence	O
time	O
of	O
17	O
years	O
prior	O
to	O
the	O
outbreak	O
,	O
suggesting	O
that	O
there	O
may	O
have	O
been	O
transmission	O
via	O
an	O
unknown	O
intermediate	O
host	O
.	O

Analysis	O
of	O
lineage	O
-	O
specific	O
selection	O
pressure	O
also	O
indicated	O
that	O
only	O
SARS	O
coronaviruses	O
in	O
civets	B-SPEC
and	O
humans	B-SPEC
were	O
under	O
significant	O
positive	O
selection	O
,	O
also	O
demonstrating	O
a	O
recent	O
interspecies	O
transmission	O
.	O

ABSTRACT	O
:	O
The	O
development	O
of	O
a	O
prophylactic	O
/	O
therapeutic	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
vaccine	O
based	O
on	O
recombinant	O
proteins	O
is	O
needed	O
for	O
the	O
control	O
of	O
the	O
worldwide	O
AIDS	O
epidemic	O
.	O

Over	O
the	O
past	O
two	O
decades	O
,	O
we	O
have	O
studied	O
the	O
synthesis	O
and	O
clinical	O
applications	O
of	O
core	O
-	O
corona	B-SPEC
polymeric	O
nanospheres	O
composed	O
of	O
hydrophobic	O
polystyrene	O
and	O
hydrophilic	O
macromonomers	O
.	O

TITLE	O
:	O
Epididymal	O
stone	O
formation	O
and	O
decreased	O
sperm	O
production	O
in	O
roosters	O
vaccinated	O
with	O
a	O
killed	O
strain	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Our	O
objective	O
was	O
to	O
determine	O
if	O
vaccination	O
with	O
killed	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
AIBV	B-SPEC
)	O
causes	O
epididymal	O
calcium	O
stones	O
in	O
the	O
rooster	O
as	O
is	O
seen	O
following	O
vaccination	O
with	O
live	O
attenuated	O
AIBV	B-SPEC
.	O

By	O
phylogenetic	O
analysis	O
of	O
the	O
structural	O
proteins	O
,	O
the	O
spike	O
(	O
S	O
)	O
protein	O
was	O
found	O
to	O
cluster	O
with	O
feline	B-SPEC
coronavirus	B-SPEC
type	O
II	O
strain	O
79	O
-	O
1683	O
,	O
whereas	O
,	O
the	O
envelope	O
(	O
E	O
),	O
membrane	O
(	O
M	O
)	O
and	O
nucleocapsid	O
(	O
N	O
)	O
proteins	O
segregated	O
together	O
with	O
the	O
reference	O
strain	O
Purdue	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
of	O
swine	B-SPEC
.	O

Meticillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
and	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
were	O
the	O
commonest	O
pathogens	O
.	O

Furthermore	O
,	O
the	O
present	O
study	O
suggests	O
that	O
rhinoviruses	B-SPEC
can	O
cause	O
olfactory	O
dysfunction	O
through	O
mechanisms	O
other	O
than	O
nasal	O
obstruction	O
and	O
that	O
rhinoviruses	B-SPEC
can	O
induce	O
various	O
severities	O
and	O
different	O
time	O
courses	O
of	O
olfactory	O
dysfunction	O
.	O

Bats	B-SPEC
have	O
been	O
identified	O
as	O
the	O
reservoir	O
hosts	O
of	O
newly	O
emergent	O
viruses	B-SPEC
such	O
as	O
Nipah	B-SPEC
virus	I-SPEC
,	O
Hendra	B-SPEC
virus	I-SPEC
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
like	O
coronaviruses	O
.	O

It	O
briefly	O
reviews	O
the	O
history	O
of	O
chiropteran	O
viruses	B-SPEC
and	O
discusses	O
their	O
emergence	O
in	O
the	O
context	O
of	O
geography	O
,	O
phylogeny	O
,	O
and	O
ecology	O
.	O

TITLE	O
:	O
Enhancing	O
public	O
health	O
response	O
to	O
respiratory	O
epidemics	O
:	O
are	O
family	B-SPEC
physicians	O
ready	O
and	O
willing	O
to	O
help	O
?	O

CONCLUSIONS	O
:	O
Family	B-SPEC
physicians	O
appear	O
to	O
be	O
unprepared	O
for	O
,	O
but	O
willing	O
to	O
address	O
,	O
serious	O
public	O
health	O
emergencies	O
.	O

A	O
sample	O
set	O
contains	O
both	O
the	O
pneumonia	O
and	O
SARS	O
X	O
-	O
ray	B-SPEC
images	O
was	O
built	O
in	O
the	O
first	O
place	O
.	O

In	O
this	O
study	O
,	O
we	O
showed	O
that	O
the	O
3a	O
protein	O
was	O
localized	O
to	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
in	O
3a	O
-	O
transfected	O
monkey	B-SPEC
kidney	O
Vero	O
E6	O
cells	O
.	O

Thus	O
GFP	O
-	O
3a	O
fusion	O
protein	O
could	O
also	O
be	O
used	O
as	O
a	O
biosensor	O
for	O
monitoring	O
the	O
cytopathic	O
features	O
of	O
SARS	O
infection	O
,	O
e	O
.	O
g	O
.	O
lymphopenia	O
,	O
in	O
animal	B-SPEC
model	O
systems	O
,	O
similar	O
to	O
nucleocapsid	O
and	O
7a	O
proteins	O
.	O

Chap10	O
-	O
S2epi	O
fusion	O
protein	O
was	O
successfully	O
constructed	O
and	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

TITLE	O
:	O
Effective	O
inhibition	O
of	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
replication	O
in	O
ST	O
cells	O
by	O
shRNAs	O
targeting	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
.	O

ABSTRACT	O
:	O
Severe	O
immunosuppression	O
is	O
a	O
hallmark	O
of	O
Morbillivirus	B-SPEC
infections	O
.	O

The	O
newly	O
developed	O
cytokine	O
assays	O
strengthen	O
and	O
expand	O
the	O
ferret	B-SPEC
model	O
not	O
only	O
for	O
Morbillivirus	B-SPEC
pathogenesis	O
studies	O
but	O
also	O
for	O
several	O
other	O
human	B-SPEC
respiratory	O
viruses	B-SPEC
including	O
influenza	O
and	O
SARS	O
.	O

These	O
mice	B-SPEC
can	O
be	O
used	O
to	O
analyze	O
the	O
human	B-SPEC
immune	O
response	O
in	O
vivo	O
.	O

SARS	O
M	O
DNA	O
vaccine	O
and	O
N	O
DNA	O
vaccine	O
induced	O
human	B-SPEC
CTL	O
specific	O
for	O
SARS	O
CoV	O
antigens	O
.	O

Alternatively	O
,	O
SARS	O
M	O
DNA	O
vaccines	O
inducing	O
human	B-SPEC
neutralizing	O
antibodies	O
and	O
human	B-SPEC
monoclonal	O
antibodies	O
against	O
SARS	O
CoV	O
are	O
now	O
being	O
developed	O
.	O

A	O
systematic	O
review	O
(	O
Highwire	O
,	O
Medline	O
,	O
Cochrane	O
Library	O
from	O
1976	O
to	O
2004	O
),	O
using	O
the	O
keywords	O
:	O
prone	O
position	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
allowed	O
us	O
to	O
include	O
the	O
human	B-SPEC
studies	O
on	O
PP	O
in	O
ARDS	O
patients	O
,	O
independantly	O
of	O
their	O
objectives	O
or	O
their	O
type	O
of	O
protocol	O
.	O

Probably	O
the	O
major	O
reason	O
for	O
the	O
high	O
profile	O
of	O
IBV	B-SPEC
is	O
the	O
existence	O
of	O
a	O
very	O
large	O
number	O
of	O
serotypes	O
.	O

To	O
evaluate	O
the	O
epidemics	O
and	O
disease	O
spectrum	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
in	O
children	O
in	O
Taiwan	O
,	O
we	O
prospectively	O
screened	O
children	O
admitted	O
to	O
the	O
hospital	O
with	O
respiratory	O
tract	O
infection	O
from	O
May	O
2004	O
to	O
April	O
2005	O
.	O

The	O
most	O
common	O
symptoms	O
/	O
signs	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
were	O
cough	O
,	O
fever	O
,	O
and	O
inspiratory	O
stridor	O
.	O

The	O
odds	O
ratio	O
of	O
croup	O
in	O
children	O
infected	O
with	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
43	O
.	O
4	O
(	O
95	O
%	O
CI	O
8	O
.	O
1	O
approximately	O
233	O
.	O
1	O
).	O

The	O
first	O
series	O
describes	O
the	O
administration	O
of	O
200	O
ml	O
of	O
20	O
%	O
human	B-SPEC
albumin	O
solution	O
over	O
120	O
s	O
in	O
13	O
patients	O
,	O
examining	O
the	O
hypothesis	O
that	O
raising	O
plasma	O
albumin	O
should	O
improve	O
oxygenation	O
.	O

TITLE	O
:	O
The	O
SARS	O
-	O
Coronavirus	B-SPEC
Membrane	O
protein	O
induces	O
apoptosis	O
through	O
modulating	O
the	O
Akt	O
survival	O
pathway	O
.	O

A	O
molecular	O
approach	O
was	O
adopted	O
using	O
specific	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
assays	O
detecting	O
13	O
respiratory	O
viruses	B-SPEC
including	O
metapneumovirus	B-SPEC
(	O
hMPV	B-SPEC
)	O
and	O
the	O
novel	O
coronaviruses	O
NL63	O
and	O
HKU1	O
;	O
most	O
amplified	O
fragments	O
were	O
sequenced	O
to	O
confirm	O
positive	O
results	O
and	O
differentiate	O
the	O
strain	O
.	O

ABSTRACT	O
:	O
To	O
survey	O
the	O
dynamic	O
changing	O
and	O
persistence	O
of	O
the	O
special	O
antibodies	O
,	O
including	O
total	O
IgM	O
,	O
IgG	O
,	O
nucleocapsid	O
protein	O
and	O
spike	O
protein	O
antibodies	O
,	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
patients	O
with	O
SARS	O
.	O

Coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
found	O
in	O
naturally	O
infected	O
palm	O
civet	B-SPEC
(	O
civet	B-SPEC
-	O
CoV	B-SPEC
)	O
represents	O
the	O
closest	O
genetic	O
relative	O
to	O
SARS	O
-	O
CoV	B-SPEC
,	O
but	O
the	O
degree	O
and	O
the	O
determinants	O
of	O
cross	O
-	O
neutralization	O
among	O
these	O
viruses	B-SPEC
remain	O
to	O
be	O
investigated	O
.	O

Fifty	O
percent	O
or	O
more	O
of	O
the	O
cats	B-SPEC
sampled	O
were	O
seropositive	O
for	O
feline	B-SPEC
herpesvirus	I-SPEC
(	O
22	O
of	O
30	O
),	O
feline	B-SPEC
panleukopenia	O
(	O
15	O
of	O
30	O
),	O
and	O
T	B-SPEC
.	I-SPEC
gondii	I-SPEC
(	O
16	O
of	O
30	O
).	O

Five	O
cats	B-SPEC
were	O
positive	O
for	O
FeLV	O
antigen	O
.	O

(	O
2	O
)	O
Management	O
systems	O
of	O
occupational	O
exposure	O
to	O
virus	B-SPEC
and	O
disease	O
surveillance	O
need	O
to	O
be	O
strengthened	O
to	O
take	O
all	O
risk	O
factors	O
into	O
account	O
so	O
as	O
to	O
detect	O
potential	O
patients	O
with	O
infectious	O
disease	O
as	O
early	O
as	O
possible	O
.	O

Platelet	O
aggregation	O
was	O
analyzed	O
by	O
an	O
aggregometer	O
using	O
laser	B-SPEC
light	O
(	O
PA	O
-	O
200	O
,	O
laser	B-SPEC
light	O
scattering	O
).	O

TITLE	O
:	O
Exposure	O
of	O
free	O
-	O
ranging	O
maned	O
wolves	O
(	O
Chrysocyon	B-SPEC
brachyurus	I-SPEC
)	O
to	O
infectious	O
and	O
parasitic	O
disease	O
agents	O
in	O
the	O
Noël	O
Kempff	O
Mercado	O
National	O
Park	O
,	O
Bolivia	O
.	O

Alfacell	O
expanded	O
a	O
research	O
agreement	O
with	O
the	O
National	O
Cancer	B-SPEC
Institute	O
in	O
September	O
2002	O
,	O
allowing	O
the	O
NCI	O
to	O
examine	O
the	O
effects	O
of	O
ranpirnase	O
as	O
a	O
radiation	O
enhancer	O
.	O

Here	O
we	O
show	O
that	O
,	O
whereas	O
both	O
transient	O
transfection	O
and	O
constitutive	O
expression	O
of	O
fAPN	O
on	O
BHK	O
-	O
21	O
cells	O
can	O
rescue	O
FIPV	O
and	O
TGEV	B-SPEC
infection	O
in	O
non	O
-	O
permissive	O
BHK	O
cells	O
,	O
fAPN	O
expression	O
does	O
not	O
rescue	O
infection	O
by	O
the	O
prototype	O
IBV	B-SPEC
strain	O
Mass41	O
.	O

The	O
findings	O
are	O
important	O
in	O
view	O
of	O
potential	O
impending	O
threats	O
of	O
pandemics	O
such	O
as	O
avian	B-SPEC
influenza	O
.	O

Patient	O
purified	O
IgG	O
recognized	O
a	O
band	O
of	O
approximately	O
110	O
kDa	O
on	O
protein	O
extracts	O
of	O
mouse	B-SPEC
cerebellum	O
,	O
cortex	O
and	O
brainstem	O
and	O
immunolabelled	O
cultured	O
Chinese	B-SPEC
hamster	I-SPEC
ovary	O
(	O
CHO	O
)	O
cells	O
,	O
transfected	O
with	O
human	B-SPEC
GABA	O
(	O
B	O
)	O
R1	O
and	O
rat	B-SPEC
GABA	O
(	O
B	O
)	O
R2	O
receptors	O
.	O

Serum	O
AGP	O
concentrations	O
fluctuated	O
over	O
time	O
in	O
clinically	O
healthy	O
cats	B-SPEC
from	O
the	O
cattery	O
with	O
the	O
highest	O
prevalence	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
and	O
significantly	O
increased	O
just	O
before	O
an	O
outbreak	O
of	O
FIP	O
.	O

TITLE	O
:	O
Biologic	O
,	O
antigenic	O
,	O
and	O
full	O
-	O
length	O
genomic	O
characterization	O
of	O
a	O
bovine	B-SPEC
-	O
like	O
coronavirus	B-SPEC
isolated	O
from	O
a	O
giraffe	B-SPEC
.	O

Recently	O
,	O
CoVs	O
were	O
recognized	O
as	O
important	O
pathogens	O
in	O
captive	O
wild	O
ruminants	B-SPEC
.	O

From	O
one	O
of	O
the	O
three	O
giraffe	B-SPEC
samples	O
,	O
a	O
CoV	O
(	O
GiCoV	O
-	O
OH3	O
)	O
was	O
isolated	O
and	O
successfully	O
adapted	O
to	O
serial	O
passage	O
in	O
human	B-SPEC
rectal	O
tumor	O
18	O
cell	O
cultures	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
emergence	O
of	O
novel	O
pathogenic	O
human	B-SPEC
and	O
animal	B-SPEC
coronaviruses	O
has	O
highlighted	O
the	O
need	O
for	O
antiviral	O
therapies	O
that	O
are	O
effective	O
against	O
a	O
spectrum	O
of	O
these	O
viruses	B-SPEC
.	O

However	O
,	O
the	O
strong	O
antiviral	O
effect	O
observed	O
suggests	O
that	O
with	O
further	O
development	O
,	O
P	O
-	O
PMO	O
may	O
provide	O
an	O
effective	O
therapeutic	O
approach	O
against	O
a	O
broad	O
range	O
of	O
coronavirus	B-SPEC
infections	O
.	O

TITLE	O
:	O
Recent	O
developments	O
in	O
the	O
virology	O
and	O
antiviral	O
research	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Antiviral	O
strategies	O
against	O
human	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
Reliability	O
of	O
soiled	O
bedding	O
transfer	O
for	O
detection	O
of	O
mouse	B-SPEC
parvovirus	B-SPEC
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

Nine	O
mAbs	O
raising	O
from	O
the	O
three	O
(	O
poly100	O
)	O
S1	O
proteins	O
recognized	O
five	O
different	O
epitopes	O
of	O
the	O
S1	O
subunit	O
,	O
designated	O
as	O
S1	O
-	O
A	O
,	O
B	O
,	O
C	O
,	O
D	O
and	O
E	O
.	O
Epitopes	O
S1	O
-	O
C	O
and	O
S1	O
-	O
D	O
are	O
common	O
for	O
the	O
three	O
IBV	B-SPEC
strains	O
,	O
while	O
S1	O
-	O
A	O
and	O
S1	O
-	O
B	O
exist	O
on	O
ZJ971	O
and	O
M41	O
strains	O
,	O
and	O
S1	O
-	O
E	O
was	O
a	O
strain	O
-	O
specific	O
epitope	O
for	O
SC	O
strain	O
.	O

These	O
mAbs	O
to	O
(	O
poly100	O
)	O
S1	O
protein	O
were	O
potential	O
candidates	O
for	O
detecting	O
and	O
distinguishing	O
IBV	B-SPEC
strains	O
,	O
and	O
also	O
used	O
to	O
examine	O
antigenic	O
variation	O
of	O
the	O
S1	O
protein	O
.	O

ABSTRACT	O
:	O
In	O
this	O
short	O
report	O
we	O
discuss	O
the	O
temporal	O
association	O
between	O
an	O
acute	O
life	O
threatening	O
event	O
(	O
ALTE	O
)	O
and	O
a	O
RT	O
-	O
PCR	O
confirmed	O
coronavirus	B-SPEC
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
in	O
a	O
4	O
months	O
old	O
otherwise	O
healthy	O
infant	O
.	O

The	O
U48C	O
MHV	B-SPEC
mutant	O
supports	O
both	O
positive	O
-	O
and	O
negative	O
-	O
sense	O
genome	O
-	O
sized	O
RNA	O
synthesis	O
,	O
but	O
fails	O
to	O
direct	O
the	O
synthesis	O
of	O
positive	O
-	O
or	O
negative	O
-	O
sense	O
subgenomic	O
RNAs	O
.	O

Avian	B-SPEC
influenza	O
(	O
H5N1	O
)	O
is	O
a	O
new	O
emerging	O
virus	B-SPEC
usually	O
contracted	O
from	O
direct	O
contact	O
with	O
diseased	O
birds	B-SPEC
.	O

ABSTRACT	O
:	O
Carbohydrate	O
-	O
binding	O
agents	O
(	O
CBAs	O
)	O
inhibit	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
it	O
is	O
proposed	O
that	O
therapy	O
with	O
such	O
agents	O
may	O
have	O
important	O
implications	O
for	O
the	O
future	O
of	O
anti	O
-	O
HIV	B-SPEC
therapy	O
.	O

CBAs	O
prevent	O
not	O
only	O
virus	B-SPEC
infection	O
of	O
susceptible	O
cells	O
,	O
but	O
also	O
inhibit	O
syncytia	O
formation	O
between	O
persistently	O
HIV	B-SPEC
-	O
infected	O
cells	O
and	O
uninfected	O
lymphocytes	O
.	O

Multivariate	O
analyses	O
indicated	O
that	O
factors	O
related	O
to	O
age	O
,	O
full	O
-	O
time	O
employment	O
,	O
perceived	O
susceptibility	O
,	O
perceived	O
efficacy	O
of	O
preventive	O
measures	O
,	O
perceived	O
higher	O
fatality	O
as	O
compared	O
to	O
SARS	O
,	O
perceived	O
chance	O
of	O
a	O
major	O
local	O
outbreak	O
,	O
and	O
being	O
worried	O
about	O
self	O
/	O
family	B-SPEC
members	O
contracting	O
the	O
virus	B-SPEC
were	O
significantly	O
associated	O
with	O
the	O
inclination	O
to	O
adopt	O
self	O
-	O
protective	O
measures	O
.	O

ABSTRACT	O
:	O
The	O
positive	O
strand	O
RNA	O
coronavirus	B-SPEC
,	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
induces	O
a	O
G2	O
/	O
M	O
phase	O
arrest	O
and	O
reduction	O
in	O
the	O
G1	O
and	O
G1	O
/	O
S	O
phase	O
transition	O
regulator	O
cyclin	O
D1	O
.	O

In	O
this	O
study	O
,	O
phage	O
-	O
expressing	O
chicken	B-SPEC
monoclonal	O
scFv	O
antibody	O
was	O
chosen	O
and	O
characterized	O
with	O
phage	O
display	O
antibody	O
technology	O
.	O

In	O
sequence	O
analysis	O
with	O
chicken	B-SPEC
germline	O
gene	O
,	O
five	O
phage	O
clones	O
reacted	O
,	O
with	O
large	O
dissimilarities	O
of	O
between	O
31	O
and	O
62	O
%,	O
in	O
the	O
complementarity	O
-	O
determining	O
regions	O
,	O
one	O
dominant	O
phage	O
4S1	O
had	O
strong	O
binding	O
to	O
fragment	O
Se	O
-	O
e	O
,	O
located	O
between	O
amino	O
acid	O
residues	O
456	O
-	O
650	O
of	O
the	O
spike	O
protein	O
and	O
this	O
particular	O
phage	O
had	O
significantly	O
strong	O
binding	O
to	O
SARS	O
-	O
CoV	O
-	O
infected	O
Vero	O
E6	O
cells	O
.	O

TITLE	O
:	O
Wildlife	O
,	O
environment	O
and	O
(	O
re	O
)-	O
emerging	O
zoonoses	O
,	O
with	O
special	O
reference	O
to	O
sylvatic	O
tick	B-SPEC
-	O
borne	O
zoonoses	O
in	O
North	O
-	O
Western	O
Italy	O
.	O

TITLE	O
:	O
Why	O
G3139	O
works	O
poorly	O
in	O
cancer	B-SPEC
trials	O
but	O
might	O
work	O
well	O
against	O
HIV	B-SPEC
.	O

While	O
this	O
effect	O
on	O
immune	O
cells	O
is	O
usually	O
undesirable	O
,	O
it	O
is	O
exactly	O
what	O
would	O
be	O
useful	O
for	O
activating	O
immune	O
cells	O
,	O
initiating	O
provirus	O
transcription	O
in	O
retrovirus	B-SPEC
-	O
infected	O
cells	O
,	O
and	O
facilitating	O
selective	O
apoptosis	O
of	O
these	O
infected	O
cells	O
.	O

Indeed	O
,	O
G3139	O
has	O
been	O
shown	O
to	O
cause	O
apoptosis	O
in	O
EBV	O
-	O
infected	O
cells	O
leading	O
to	O
clearance	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Genomic	O
RNA	O
sequence	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
strain	O
FCoV	O
C1Je	O
.	O

Yet	O
Drak2	O
-	O
/	O
-	O
mice	B-SPEC
are	O
resistant	O
to	O
MOG	O
-	O
induced	O
experimental	O
autoimmune	O
encephalomyelitis	O
(	O
EAE	O
),	O
suggesting	O
that	O
DRAK2	O
may	O
influence	O
T	O
cell	O
trafficking	O
into	O
the	O
CNS	O
.	O

In	O
order	B-SPEC
to	O
further	O
characterize	O
the	O
molecular	O
mechanisms	O
governing	O
T	O
cell	O
activation	O
and	O
accumulation	O
within	O
the	O
CNS	O
in	O
response	O
to	O
viral	O
infection	O
,	O
MHV	B-SPEC
was	O
instilled	O
into	O
the	O
CNS	O
of	O
Drak2	O
-	O
/	O
-	O
mice	B-SPEC
.	O

Moreover	O
,	O
Drak2	O
-	O
deficient	O
T	O
cell	O
activation	O
,	O
expansion	O
and	O
cytokine	O
production	O
were	O
unimpaired	O
in	O
response	O
to	O
acute	O
MHV	B-SPEC
infection	O
.	O

TITLE	O
:	O
Detection	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
in	O
commercial	O
turkey	B-SPEC
poults	O
in	O
Brazil	O
.	O

TITLE	O
:	O
Identification	O
of	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
A59	O
nucleocapsid	O
protein	O
phosphorylation	O
sites	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
is	O
a	O
multifunctional	O
phosphoprotein	O
that	O
encapsidates	O
the	O
genomic	O
RNA	O
into	O
a	O
helical	O
nucleocapsid	O
within	O
the	O
mature	O
virion	O
.	O

It	O
has	O
been	O
speculated	O
for	O
sometime	O
that	O
phosphorylation	O
could	O
play	O
an	O
important	O
role	O
in	O
regulation	O
of	O
coronavirus	B-SPEC
N	O
protein	O
functions	O
.	O

Recombinant	O
N	O
protein	O
ELISA	O
(	O
rnELISA	O
)	O
demonstrated	O
98	O
.	O
7	O
%	O
specificities	O
among	O
(	O
80	O
)	O
PEDV	B-SPEC
-	O
free	O
individuals	O
,	O
and	O
98	O
%	O
sensitivity	O
ranging	O
among	O
(	O
103	O
)	O
clinical	O
samples	O
with	O
PEDV	B-SPEC
.	O

Since	O
1998	O
,	O
a	O
web	O
based	O
informatics	O
tool	O
has	O
been	O
developed	O
in	O
order	B-SPEC
to	O
allow	O
information	O
to	O
be	O
shared	O
between	O
the	O
relevant	O
public	O
health	O
authorities	O
.	O

TITLE	O
:	O
Human	B-SPEC
immunopathogenesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

ABSTRACT	O
:	O
In	O
total	O
,	O
55	O
isolates	O
of	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
were	O
collected	O
from	O
cases	O
of	O
enteric	O
and	O
respiratory	O
disease	O
occurring	O
between	O
1999	O
and	O
2006	O
in	O
Japan	O
.	O

Furthermore	O
,	O
the	O
positively	O
charged	O
surface	O
area	O
is	O
larger	O
in	O
the	O
SARS	O
-	O
CoV	O
construct	O
than	O
in	O
the	O
IBV	B-SPEC
.	O

Electrospray	O
mass	O
spectrometry	O
indicates	O
a	O
mechanism	O
involving	O
acylation	O
of	O
the	O
active	O
site	O
cysteine	O
thiol	O
for	O
this	O
class	B-SPEC
of	O
inhibitors	O
.	O

The	O
risk	O
of	O
anemia	B-SPEC
,	O
hypomagnesemia	O
,	O
and	O
bradycardia	O
attributable	O
to	O
ribavirin	O
use	O
was	O
27	O
%,	O
45	O
%,	O
and	O
17	O
%,	O
respectively	O
.	O

We	O
present	O
a	O
case	O
of	O
an	O
80	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
a	O
R	B-SPEC
.	I-SPEC
conorii	I-SPEC
infection	O
who	O
developed	O
an	O
acute	O
quadriplegia	O
secondary	O
to	O
an	O
axonal	O
polyneuropathy	O
.	O

Avian	B-SPEC
influenza	O
A	O
H5N1	O
is	O
another	O
emerging	O
infectious	O
disease	O
transmitted	O
from	O
avian	B-SPEC
species	B-SPEC
to	O
humans	B-SPEC
,	O
without	O
clear	O
evidence	O
of	O
transmission	O
from	O
human	B-SPEC
to	O
human	B-SPEC
.	O

It	O
remains	O
to	O
be	O
determined	O
whether	O
EP	O
can	O
be	O
used	O
successfully	O
to	O
treat	O
human	B-SPEC
diseases	O
.	O

The	O
pathogenesis	O
of	O
SARS	O
is	O
highly	O
complex	O
,	O
with	O
multiple	O
factors	O
leading	O
to	O
severe	O
injury	O
in	O
the	O
lungs	O
and	O
dissemination	O
of	O
the	O
virus	B-SPEC
to	O
several	O
other	O
organs	O
.	O

These	O
results	O
demonstrate	O
that	O
nsp10	O
is	O
a	O
critical	O
regulator	O
of	O
coronavirus	B-SPEC
RNA	O
synthesis	O
and	O
may	O
play	O
an	O
important	O
role	O
in	O
polyprotein	O
processing	O
.	O

TITLE	O
:	O
Evaluating	O
the	O
3C	O
-	O
like	O
protease	O
activity	O
of	O
SARS	O
-	O
Coronavirus	B-SPEC
:	O
recommendations	O
for	O
standardized	O
assays	O
for	O
drug	O
discovery	O
.	O

Unlike	O
SARS	O
,	O
direct	O
contact	O
with	O
patient	O
contracted	O
with	O
avian	B-SPEC
influenza	O
at	O
the	O
end	O
of	O
incubation	O
period	O
and	O
in	O
the	O
stage	O
of	O
illness	O
through	O
flying	O
droplets	O
,	O
saliva	O
,	O
mucous	O
membrane	O
and	O
skin	O
injuries	O
will	O
not	O
lead	O
to	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
,	O
indicating	O
the	O
virus	B-SPEC
'	O
ability	O
to	O
pass	O
from	O
human	B-SPEC
to	O
human	B-SPEC
is	O
limited	O
.	O

CONCLUSIONS	O
:	O
Unlike	O
SARS	O
,	O
direct	O
contact	O
with	O
patient	O
contracted	O
with	O
avian	B-SPEC
influenza	O
at	O
the	O
end	O
of	O
incubation	O
period	O
and	O
in	O
the	O
stage	O
of	O
illness	O
through	O
flying	O
droplets	O
,	O
saliva	O
,	O
mucous	O
membrane	O
and	O
skin	O
injuries	O
will	O
not	O
lead	O
to	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
,	O
indicating	O
the	O
virus	B-SPEC
'	O
ability	O
to	O
pass	O
from	O
human	B-SPEC
to	O
human	B-SPEC
is	O
limited	O
.	O

The	O
recent	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
CoV	O
and	O
subsequent	O
identification	O
of	O
two	O
additional	O
human	B-SPEC
coronaviruses	O
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	O
-	O
HKU1	O
)	O
has	O
drawn	O
attention	O
to	O
this	O
virus	B-SPEC
family	B-SPEC
.	O

TITLE	O
:	O
Proteomic	O
analysis	O
of	O
up	O
-	O
regulated	O
proteins	O
in	O
human	B-SPEC
promonocyte	O
cells	O
expressing	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
.	O

ABSTRACT	O
:	O
The	O
pathogenesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
)	O
is	O
an	O
important	O
issue	O
for	O
treatment	O
and	O
prevention	O
of	O
SARS	O
.	O

TITLE	O
:	O
Crystal	O
structure	O
of	O
a	O
monomeric	O
form	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
endonuclease	O
nsp15	O
suggests	O
a	O
role	O
for	O
hexamerization	O
as	O
an	O
allosteric	O
switch	O
.	O

Structure	O
studies	O
of	O
the	O
full	O
-	O
length	O
form	O
of	O
the	O
obligate	O
hexameric	O
enzyme	O
from	O
two	O
CoVs	O
,	O
SARS	O
-	O
CoV	O
and	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
and	O
its	O
monomeric	O
homologue	O
,	O
XendoU	O
from	O
Xenopus	B-SPEC
laevis	I-SPEC
,	O
combined	O
with	O
mutagenesis	O
studies	O
have	O
implicated	O
several	O
residues	O
in	O
enzymatic	O
activity	O
and	O
the	O
N	O
-	O
terminal	O
domain	O
as	O
the	O
major	O
determinant	O
of	O
hexamerization	O
.	O

TITLE	O
:	O
The	O
critically	O
ill	O
avian	B-SPEC
influenza	O
A	O
(	O
H5N1	O
)	O
patient	O
.	O

Our	O
current	O
molecularly	O
cloned	O
IBV	B-SPEC
,	O
strain	O
Beaudette	O
,	O
is	O
non	O
-	O
pathogenic	O
,	O
so	O
we	O
do	O
not	O
know	O
what	O
effect	O
the	O
absence	O
of	O
these	O
proteins	O
would	O
have	O
on	O
pathogenicity	O
.	O

Replacing	O
the	O
S	O
protein	O
gene	O
of	O
Beaudette	O
with	O
that	O
from	O
the	O
pathogenic	O
M41	O
strain	O
resulted	O
in	O
a	O
recombinant	O
virus	B-SPEC
that	O
was	O
still	O
non	O
-	O
pathogenic	O
but	O
which	O
did	O
induce	O
protection	O
against	O
challenge	O
with	O
M41	O
.	O

We	O
have	O
since	O
made	O
other	O
'	O
spike	O
-	O
swapped	O
'	O
recombinants	O
,	O
including	O
ones	O
with	O
chimaera	B-SPEC
S	O
genes	O
.	O

However	O
,	O
before	O
potential	O
clinical	O
application	O
,	O
the	O
antibody	O
needs	O
to	O
be	O
tested	O
in	O
as	O
many	O
animal	B-SPEC
models	O
as	O
possible	O
to	O
ensure	O
its	O
safety	O
and	O
efficiency	O
.	O

ABSTRACT	O
:	O
Blastomyces	B-SPEC
dermatitidis	I-SPEC
,	O
the	O
etiologic	O
agent	O
of	O
blastomycosis	O
,	O
causes	O
severe	O
disease	O
and	O
substantial	O
mortality	O
in	O
those	O
immunocompromised	O
by	O
acquired	O
immunodeficiency	O
syndrome	O
or	O
malignancy	O
.	O

TITLE	O
:	O
Plant	B-SPEC
lectins	O
are	O
potent	O
inhibitors	O
of	O
coronaviruses	O
by	O
interfering	O
with	O
two	O
targets	O
in	O
the	O
viral	O
replication	O
cycle	O
.	O

In	O
addition	O
,	O
a	O
number	O
of	O
galactose	O
-,	O
N	O
-	O
acetylgalactosamine	O
-,	O
glucose	O
-,	O
and	O
N	O
-	O
acetylglucosamine	O
-	O
specific	O
plant	B-SPEC
agglutinines	O
exhibited	O
anti	O
-	O
coronaviral	O
activity	O
.	O

These	O
findings	O
indicated	O
that	O
different	O
genotypes	O
of	O
nephropathogenic	O
IB	O
viruses	B-SPEC
were	O
co	O
-	O
circulating	O
in	O
the	O
chicken	B-SPEC
population	O
in	O
China	O
.	O

In	O
a	O
subset	O
of	O
176	O
patients	O
who	O
had	O
a	O
complete	O
blood	O
cell	O
count	O
performed	O
,	O
the	O
strongest	O
predictors	O
were	O
temperature	O
>	O
or	O
=	O
38	O
degrees	O
C	O
(	O
OR	O
=	O
15	O
.	O
5	O
),	O
lymphocyte	O
count	O
<	O
1000	O
(	O
OR	O
=	O
9	O
.	O
3	O
)	O
and	O
abnormal	O
chest	O
x	O
-	O
ray	B-SPEC
(	O
OR	O
=	O
5	O
.	O
7	O
).	O

In	O
this	O
study	O
,	O
the	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
of	O
the	O
partial	O
S	O
glycoprotein	O
genes	O
of	O
Korean	O
PEDV	B-SPEC
isolates	O
,	O
including	O
epitope	O
region	O
that	O
is	O
capable	O
of	O
inducing	O
PEDV	B-SPEC
-	O
neutralizing	O
antibodies	O
,	O
were	O
determined	O
.	O

In	O
addition	O
,	O
the	O
G1	O
Korean	O
PEDV	B-SPEC
isolates	O
didn	O
'	O
t	O
had	O
several	O
specific	O
nucleotides	O
and	O
amino	O
acids	O
which	O
were	O
found	O
in	O
the	O
G2	O
and	O
G3	O
Korean	O
PEDV	B-SPEC
isolates	O
,	O
and	O
especially	O
the	O
G1	O
-	O
1	O
Korean	O
PEDV	B-SPEC
isolates	O
had	O
specific	O
nucleotides	O
and	O
amino	O
acids	O
which	O
were	O
not	O
found	O
in	O
the	O
G1	O
-	O
2	O
,	O
G1	O
-	O
3	O
,	O
G2	O
,	O
and	O
G3	O
Korean	O
PEDV	B-SPEC
isolates	O
.	O

6	O
-	O
week	O
-	O
old	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
inoculated	O
orally	O
with	O
SL7207	O
(	O
pVAX1	O
-	O
S1	O
)	O
at	O
dosage	O
of	O
5	O
x	O
10	O
(	O
8	O
)	O
CFU	O
,	O
1	O
x	O
10	O
(	O
9	O
)	O
CFU	O
and	O
2	O
x	O
10	O
(	O
9	O
)	O
CFU	O
respectively	O
.	O

The	O
antibodies	O
against	O
MHV	B-SPEC
were	O
also	O
detected	O
in	O
small	O
intestinal	O
mucosal	O
samples	O
from	O
immunized	O
mice	B-SPEC
at	O
2	O
w	O
post	O
-	O
three	O
immunization	O
.	O

Alveolar	O
ventilation	O
is	O
improved	O
by	O
adding	O
tracheal	O
gas	O
insufflation	O
(	O
TGI	O
)	O
to	O
CMV	B-SPEC
.	O

We	O
hypothesized	O
that	O
combined	O
HFO	O
and	O
TGI	O
(	O
HFO	O
-	O
TGI	O
)	O
might	O
result	O
in	O
improved	O
gas	O
exchange	O
relative	O
to	O
both	O
standard	O
HFO	O
and	O
CMV	B-SPEC
according	O
to	O
the	O
ARDS	O
Network	O
protocol	O
.	O

HFO	O
-	O
TGI	O
improved	O
PaO2	O
/	O
FiO2	O
relative	O
to	O
HFO	O
and	O
CMV	B-SPEC
(	O
174	O
.	O
5	O
+/-	O

During	O
HFO	O
-	O
TGI	O
,	O
shunt	O
fraction	O
and	O
mixed	O
venous	O
oxygen	O
saturation	O
improved	O
relative	O
to	O
CMV	B-SPEC
(	O
0	O
.	O
36	O
+/-	O
0	O
.	O
01	O
vs	O
.	O
0	O
.	O
45	O
+/-	O
0	O
.	O
01	O
and	O
77	O
.	O
8	O
%	O
+/-	O

TITLE	O
:	O
Drug	O
-	O
resistant	O
genital	O
tuberculosis	O
of	O
the	O
penis	O
in	O
a	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
non	O
-	O
reactive	O
individual	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
infect	O
many	O
species	B-SPEC
of	O
animals	B-SPEC
,	O
including	O
humans	B-SPEC
.	O

Among	O
them	O
,	O
murine	B-SPEC
coronavirus	I-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
has	O
been	O
well	O
studied	O
as	O
a	O
model	O
of	O
human	B-SPEC
diseases	O
,	O
such	O
as	O
hepatitis	O
and	O
demyelinating	O
disease	O
.	O

The	O
receptors	O
of	O
those	O
two	O
viruses	B-SPEC
have	O
been	O
identified	O
and	O
their	O
cell	O
entry	O
mechanism	O
has	O
been	O
actively	O
investigated	O
.	O

Interestingly	O
,	O
twelve	O
human	B-SPEC
milk	O
samples	O
were	O
positive	O
for	O
IgA	O
against	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
,	O
and	O
this	O
represented	O
5	O
%.	O

TITLE	O
:	O
Intracellular	O
localization	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
protein	O
9b	O
:	O
evidence	O
of	O
active	O
export	O
from	O
the	O
nucleus	O
.	O

These	O
diseases	O
are	O
,	O
amongst	O
others	O
Severe	O
and	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
),	O
Rabies	O
,	O
Lyme	O
disease	O
,	O
African	O
Horse	B-SPEC
Sickness	O
,	O
Blue	O
Tongue	O
,	O
African	O
Swine	B-SPEC
Fever	O
,	O
Ebola	O
Hemorrhagic	O
Fever	O
,	O
Hantavirosis	O
,	O
and	O
Avian	B-SPEC
Influenza	O
.	O

Using	O
SARS	O
-	O
CoV	O
as	O
a	O
model	O
,	O
we	O
will	O
review	O
the	O
current	O
knowledge	O
of	O
the	O
interplay	O
between	O
coronavirus	B-SPEC
infection	O
and	O
the	O
host	O
innate	O
immune	O
system	O
in	O
vivo	O
,	O
and	O
then	O
discuss	O
the	O
mechanisms	O
by	O
which	O
specific	O
gene	O
products	O
antagonize	O
the	O
host	O
innate	O
immune	O
response	O
in	O
cell	O
culture	O
models	O
.	O

We	O
summarize	O
by	O
identifying	O
future	O
points	O
of	O
consideration	O
that	O
will	O
contribute	O
greatly	O
to	O
our	O
understanding	O
of	O
the	O
molecular	O
mechanisms	O
governing	O
coronavirus	B-SPEC
pathogenesis	O
and	O
virulence	O
,	O
and	O
the	O
development	O
of	O
severe	O
disease	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

The	O
second	O
model	O
system	O
,	O
derived	O
from	O
primary	O
cells	O
isolated	O
from	O
human	B-SPEC
airway	O
epithelium	O
and	O
grown	O
on	O
Transwells	O
,	O
form	O
a	O
pseudostratified	O
mucociliary	O
epithelium	O
that	O
recapitulates	O
the	O
morphological	O
and	O
physiological	O
features	O
of	O
the	O
human	B-SPEC
conducting	O
airway	O
in	O
vivo	O
.	O

Newer	O
diagnostic	O
tests	O
such	O
as	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
have	O
greatly	O
expanded	O
our	O
understanding	O
of	O
the	O
importance	O
of	O
these	O
respiratory	O
viruses	B-SPEC
.	O

Community	O
respiratory	O
virus	B-SPEC
infections	O
are	O
increasingly	O
recognized	O
as	O
a	O
significant	O
threat	O
to	O
these	O
patients	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
the	O
alpha	O
/	O
beta	O
interferon	O
response	O
by	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
at	O
multiple	O
levels	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
was	O
used	O
as	O
a	O
model	O
to	O
study	O
the	O
interaction	O
of	O
coronaviruses	O
with	O
the	O
alpha	O
/	O
beta	O
interferon	O
(	O
IFN	O
-	O
alpha	O
/	O
beta	O
)	O
response	O
.	O

Here	O
we	O
provide	O
the	O
first	O
description	O
of	O
a	O
previously	O
unidentified	O
coronavirus	B-SPEC
lineage	O
detected	O
from	O
wild	O
Asian	O
leopard	B-SPEC
cats	I-SPEC
(	O
Prionailurus	B-SPEC
bengalensis	I-SPEC
)	O
and	O
Chinese	O
ferret	B-SPEC
badgers	O
(	O
Melogale	B-SPEC
moschata	I-SPEC
)	O
during	O
virological	O
surveillance	O
in	O
southern	O
China	O
.	O

Phylogenetic	O
analyses	O
revealed	O
that	O
the	O
envelope	O
,	O
membrane	O
,	O
and	O
nucleoprotein	O
structural	O
proteins	O
and	O
the	O
two	O
conserved	O
replicase	O
domains	O
,	O
putative	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
and	O
RNA	O
helicase	O
,	O
of	O
these	O
novel	O
coronaviruses	O
were	O
most	O
closely	O
related	O
to	O
those	O
of	O
group	O
3	O
coronaviruses	O
identified	O
from	O
birds	B-SPEC
,	O
while	O
the	O
spike	O
protein	O
gene	O
was	O
most	O
closely	O
related	O
to	O
that	O
of	O
group	O
1	O
coronaviruses	O
from	O
mammals	B-SPEC
.	O

TITLE	O
:	O
Seroprevalence	O
of	O
selected	O
infectious	O
agents	O
in	O
a	O
free	O
-	O
ranging	O
,	O
low	O
-	O
density	O
lion	B-SPEC
population	O
in	O
the	O
Central	O
Kalahari	O
Game	O
Reserves	O
in	O
Botswana	O
.	O

ABSTRACT	O
:	O
Twenty	O
-	O
one	O
free	O
-	O
ranging	O
Central	O
Kalahari	O
lions	B-SPEC
(	O
Panthera	B-SPEC
leo	I-SPEC
)	O
exhibited	O
a	O
high	O
prevalence	O
rate	O
of	O
feline	B-SPEC
herpesvirus	I-SPEC
(	O
100	O
%)	O
and	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
71	O
.	O
4	O
%).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
lethal	O
diarrhea	O
in	O
piglets	O
that	O
leads	O
to	O
great	O
economic	O
losses	O
in	O
East	O
Asia	O
.	O

Antibodies	O
against	O
canine	B-SPEC
herpesvirus	I-SPEC
and	O
Brucella	B-SPEC
canis	I-SPEC
were	O
not	O
detected	O
in	O
any	O
of	O
the	O
samples	O
.	O

The	O
results	O
of	O
this	O
study	O
emphasize	O
the	O
need	O
for	O
research	O
on	O
and	O
protection	O
against	O
infectious	O
diseases	O
of	O
red	B-SPEC
pandas	I-SPEC
and	O
other	O
endangered	O
species	B-SPEC
in	O
China	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
the	O
first	O
emerging	O
infectious	O
disease	O
of	O
the	O
21st	O
century	O
that	O
has	O
been	O
highly	O
transmissible	O
and	O
fatal	O
and	O
was	O
caused	O
by	O
a	O
previously	O
unknown	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
Human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
hSARS	O
-	O
CoV	O
)	O
is	O
the	O
causative	O
agent	O
for	O
SARS	O
infection	O
.	O

SDS	O
-	O
PAGE	O
analysis	O
showed	O
recombinant	O
truncated	O
M	O
'	O
protein	O
was	O
highly	O
expressed	O
by	O
pGEX	O
-	O
6p	O
-	O
M	O
'	O
and	O
the	O
product	O
fusion	O
protein	O
GST	O
-	O
M	O
'	O
reached	O
45	O
%	O
in	O
the	O
total	O
bacteria	B-SPEC
proteins	O
with	O
the	O
analysis	O
of	O
software	O
AlphaImager2200	O
.	O

The	O
preliminary	O
purified	O
recombinant	O
protein	O
was	O
evaluated	O
for	O
its	O
antigenicity	O
and	O
reactivity	O
through	O
Western	O
blotting	O
and	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
with	O
monoclonal	O
antibody	O
against	O
M	O
protein	O
of	O
PEDV	B-SPEC
and	O
porcine	B-SPEC
polyclonal	O
anti	O
-	O
PEDV	B-SPEC
antiserum	O
as	O
the	O
primary	O
antibody	O
.	O

The	O
specific	O
IgG	O
response	O
to	O
whole	O
virus	B-SPEC
,	O
the	O
fragment	O
from	O
positions	O
450	O
to	O
650	O
of	O
the	O
S	O
protein	O
(	O
S450	O
-	O
650	O
),	O
and	O
the	O
full	O
-	O
length	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
were	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
(	O
ELISAs	O
).	O

TITLE	O
:	O
The	O
detection	O
of	O
feline	B-SPEC
coronaviruses	O
in	O
blood	O
samples	O
from	O
cats	B-SPEC
by	O
mRNA	O
RT	O
-	O
PCR	O
.	O

Overall	O
we	O
found	O
14	O
(	O
54	O
%)	O
of	O
the	O
cats	B-SPEC
were	O
positive	O
for	O
FCoV	O
including	O
the	O
cat	B-SPEC
with	O
clinical	O
disease	O
,	O
but	O
the	O
high	O
rate	O
of	O
positivity	O
among	O
healthy	O
cats	B-SPEC
suggested	O
a	O
poor	O
specificity	O
for	O
the	O
clinical	O
diagnosis	O
of	O
FIP	O
among	O
these	O
cats	B-SPEC
.	O

TITLE	O
:	O
Lithium	O
chloride	O
inhibits	O
the	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
cell	O
culture	O
.	O

The	O
effect	O
of	O
LiCl	O
on	O
the	O
replication	O
of	O
IBV	B-SPEC
was	O
examined	O
in	O
cell	O
culture	O
using	O
two	O
model	O
cell	O
types	O
;	O
Vero	O
cells	O
,	O
an	O
African	B-SPEC
Green	I-SPEC
monkey	I-SPEC
kidney	O
-	O
derived	O
epithelial	O
cell	O
line	O
;	O
and	O
DF	O
-	O
1	O
cells	O
,	O
an	O
immortalized	O
chicken	B-SPEC
embryo	O
fibroblast	O
cell	O
line	O
.	O

ABSTRACT	O
:	O
There	O
are	O
two	O
types	O
of	O
feline	B-SPEC
coronaviruses	O
that	O
can	O
be	O
distinguished	O
by	O
serology	O
and	O
sequence	O
analysis	O
.	O

ABSTRACT	O
:	O
More	O
than	O
four	O
years	O
have	O
passed	O
since	O
the	O
outbreak	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
,	O
and	O
still	O
very	O
little	O
is	O
known	O
about	O
the	O
molecular	O
biology	O
and	O
pathogenesis	O
of	O
this	O
deadly	O
virus	B-SPEC
.	O

TITLE	O
:	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
infection	O
complicated	O
by	O
pneumomediastinum	O
and	O
severe	O
mucositis	O
.	O

M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
-	O
associated	O
mucositis	O
is	O
distinct	O
from	O
the	O
Stevens	O
-	O
Johnson	O
syndrome	O
.	O

In	O
this	O
study	O
we	O
performed	O
genome	O
-	O
wide	O
microarray	O
analyses	O
of	O
the	O
expression	O
patterns	O
of	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
(	O
MHV	B-SPEC
)-	O
infected	O
cells	O
.	O

At	O
the	O
time	O
of	O
MHV	B-SPEC
-	O
induced	O
host	O
translational	O
shutoff	O
,	O
downregulation	O
of	O
numerous	O
mRNAs	O
,	O
many	O
of	O
which	O
encode	O
protein	O
translation	O
-	O
related	O
factors	O
,	O
was	O
observed	O
.	O

We	O
screened	O
these	O
fecal	O
specimens	O
for	O
rotaviruses	B-SPEC
and	O
enteric	O
adenoviruses	B-SPEC
40	O
/	O
41	O
by	O
using	O
commercial	O
EIA	O
kits	O
(	O
Rotaclone	O
and	O
Adenoclone	O
),	O
enteroviruses	B-SPEC
by	O
RT	O
-	O
PCR	O
and	O
Southern	O
blot	O
hybridization	O
,	O
and	O
picobirnaviruses	B-SPEC
by	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
silver	O
staining	O
.	O

Some	O
of	O
the	O
specimens	O
were	O
examined	O
by	O
EM	O
for	O
coronaviruses	O
and	O
noroviruses	B-SPEC
.	O

Electron	O
microscopy	O
showed	O
norovirus	B-SPEC
-	O
like	O
particles	O
in	O
some	O
specimens	O
from	O
both	O
colonies	O
.	O

To	O
analyze	O
the	O
immunogenicity	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
),	O
SARS	O
-	O
CoV	B-SPEC
,	O
spike	O
DNA	O
vaccine	O
and	O
the	O
immunoregulatory	O
activity	O
of	O
interleukin	O
-	O
2	O
(	O
IL	O
-	O
2	O
),	O
DNA	O
vaccine	O
plasmids	O
pcDNA	O
-	O
S	O
and	O
pcDNA	O
-	O
IL	O
-	O
2	O
were	O
constructed	O
and	O
inoculated	O
into	O
BALB	O
/	O
c	O
mice	B-SPEC
with	O
or	O
without	O
pcDNA	O
-	O
IL	O
-	O
2	O
by	O
using	O
three	O
different	O
immunization	O
routes	O
(	O
the	O
intramuscular	O
route	O
,	O
electroporation	O
,	O
or	O
the	O
oral	O
route	O
with	O
live	O
attenuated	O
Salmonella	B-SPEC
enterica	I-SPEC
serovar	O
Typhimurium	O
).	O

The	O
results	O
showed	O
that	O
specific	O
humoral	O
and	O
cellular	O
immunities	O
could	O
be	O
induced	O
in	O
mice	B-SPEC
by	O
inoculating	O
them	O
with	O
SARS	O
-	O
CoV	O
spike	O
DNA	O
vaccine	O
alone	O
or	O
by	O
coinoculation	O
with	O
IL	O
-	O
2	O
-	O
expressing	O
plasmids	O
.	O

However	O
,	O
intramuscular	O
immunization	O
evoked	O
a	O
vigorous	O
antibody	O
response	O
and	O
a	O
weak	O
T	O
-	O
cell	O
response	O
,	O
and	O
vaccination	O
by	O
electroporation	O
evoked	O
a	O
vigorous	O
response	O
with	O
a	O
predominant	O
subclass	B-SPEC
IgG1	O
antibody	O
response	O
and	O
a	O
moderate	O
T	O
-	O
cell	O
response	O
.	O

Our	O
findings	O
show	O
that	O
the	O
spike	O
DNA	O
vaccine	O
has	O
good	O
immunogenicity	O
and	O
can	O
induce	O
specific	O
humoral	O
and	O
cellular	O
immunities	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
,	O
while	O
IL	O
-	O
2	O
plays	O
an	O
immunoadjuvant	O
role	O
and	O
enhances	O
the	O
humoral	O
and	O
cellular	O
immune	O
responses	O
.	O

At	O
admission	O
,	O
temperature	O
,	O
heart	O
rate	O
,	O
blood	O
pressure	O
,	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
,	O
base	O
deficit	O
,	O
hemoglobin	O
,	O
platelets	O
,	O
prothrombin	O
time	O
/	O
International	O
Normalized	O
Ratio	O
,	O
and	O
Injury	O
Severity	O
Score	O
were	O
similar	O
in	O
both	O
groups	O
as	O
were	O
administered	O
units	O
of	O
fresh	O
frozen	O
plasma	O
,	O
fresh	O
whole	O
blood	O
,	O
cryoprecipitate	O
(	O
cryo	O
),	O
and	O
crystalloid	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
associated	O
with	O
an	O
enteric	O
syndrome	O
on	O
a	O
quail	O
farm	O
.	O

ABSTRACT	O
:	O
An	O
enteric	O
syndrome	O
was	O
observed	O
in	O
quail	O
(	O
Coturnix	B-SPEC
coturnix	I-SPEC
)	O
semi	O
-	O
intensively	O
reared	O
for	O
restocking	O
in	O
Apulia	O
(	O
southern	O
Italy	O
).	O

The	O
virus	B-SPEC
could	O
not	O
be	O
cultivated	O
in	O
chicken	B-SPEC
embryos	O
.	O

ABSTRACT	O
:	O
Glycosaminoglycans	O
(	O
GAGs	B-SPEC
),	O
including	O
heparan	O
sulfate	O
(	O
HS	O
),	O
are	O
expressed	O
on	O
the	O
surface	O
of	O
nearly	O
all	O
cells	O
,	O
linked	O
to	O
transmembrane	O
proteins	O
.	O

ABSTRACT	O
:	O
The	O
Bac	O
-	O
to	O
-	O
Bac	O
Baculovirus	B-SPEC
expression	O
system	O
was	O
used	O
to	O
generate	O
a	O
recombinant	O
baculovirus	B-SPEC
capable	O
of	O
expressing	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
3a	O
protein	O
.	O

TITLE	O
:	O
Red	O
blood	O
cell	O
deformability	O
in	O
patients	O
with	O
sepsis	B-SPEC
:	O
a	O
marker	O
for	O
prognosis	O
and	O
monitoring	O
of	O
severity	O
.	O

1128	O
-	O
1159	O
),	O
corresponding	O
to	O
the	O
spike	O
protein	O
(	O
S	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
(	O
SARS	O
CoV	O
)	O
were	O
synthesized	O
and	O
their	O
immunological	O
functions	O
were	O
investigated	O
in	O
three	O
different	O
animals	B-SPEC
models	O
(	O
mice	B-SPEC
,	O
guinea	B-SPEC
pigs	I-SPEC
,	O
and	O
rabbits	B-SPEC
).	O

The	O
peptides	O
mixture	O
formulated	O
either	O
with	O
Freund	O
'	O
s	O
adjuvant	O
or	O
synthetic	O
adjuvant	O
Montanide	O
ISA	B-SPEC
-	O
51	O
/	O
oligodeoxy	O
nucleotide	O
CpG	O
(	O
ISA	B-SPEC
/	O
CpG	O
)	O
could	O
elicit	O
antisera	O
in	O
immunized	O
animals	B-SPEC
which	O
were	O
capable	O
of	O
inhibiting	O
SARS	O
/	O
HIV	B-SPEC
pseudovirus	O
entry	O
into	O
HepG2	O
cells	O
.	O

ABSTRACT	O
:	O
Recently	O
,	O
a	O
paper	O
was	O
published	O
in	O
which	O
it	O
was	O
proposed	O
that	O
the	O
GxxxG	O
motif	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
transmembrane	O
domain	O
plays	O
a	O
vital	O
role	O
in	O
oligomerization	O
of	O
the	O
protein	O
(	O
E	O
.	O
Arbely	O
,	O
Z	O
.	O
Granot	O
,	O
I	O
.	O
Kass	O
,	O
J	O
.	O
Orly	O
,	O
and	O
I	O
.	O
T	O
.	O
Arkin	O
,	O
Biochemistry	O
45	O
:	O
11349	O
-	O
11356	O
,	O
2006	O
).	O

The	O
ResPlex	O
II	O
assay	O
also	O
differentiated	O
RSV	B-SPEC
-	O
A	O
and	O
RSV	B-SPEC
-	O
B	O
and	O
gave	O
positive	O
results	O
for	O
RhV	O
and	O
EnV	O
in	O
31	O
(	O
8	O
.	O
6	O
%)	O
and	O
19	O
(	O
5	O
.	O
3	O
%)	O
specimens	O
,	O
respectively	O
.	O

TITLE	O
:	O
Canine	O
coronavirus	B-SPEC
inactivation	O
with	O
physical	O
and	O
chemical	O
agents	O
.	O

PAF	O
significantly	O
contributed	O
to	O
PLY	O
-	O
induced	O
acute	O
injury	O
in	O
murine	B-SPEC
lungs	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
involved	O
in	O
virus	B-SPEC
replication	O
and	O
modulation	O
of	O
cell	O
processes	O
.	O

TITLE	O
:	O
The	O
nonstructural	O
protein	O
8	O
(	O
nsp8	O
)	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
interacts	O
with	O
its	O
ORF6	O
accessory	O
protein	O
.	O

A	O
mammary	O
-	O
specific	O
expression	O
vector	O
pEBS	O
containing	O
the	O
full	O
-	O
length	O
cDNA	O
of	O
S	O
gene	O
was	O
constructed	O
and	O
expressed	O
in	O
the	O
mouse	B-SPEC
mammary	O
cells	O
(	O
EMT6	O
).	O

The	O
recombinant	O
S	O
protein	O
from	O
culture	O
supernatant	O
of	O
transgenic	O
EMT6	O
was	O
harvested	O
and	O
immunized	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

TITLE	O
:	O
Cleavage	O
of	O
spike	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
by	O
protease	O
factor	O
Xa	O
is	O
associated	O
with	O
viral	O
infectivity	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
known	O
to	O
recognize	O
and	O
bind	O
to	O
host	O
receptors	O
,	O
whose	O
conformational	O
changes	O
then	O
facilitate	O
fusion	O
between	O
the	O
viral	O
envelope	O
and	O
host	O
cell	O
membrane	O
,	O
leading	O
to	O
viral	O
entry	O
into	O
target	O
cells	O
.	O

Four	O
field	O
viruses	B-SPEC
originating	O
from	O
the	O
Stockholm	O
region	O
presented	O
identical	O
sequences	O
and	O
segregated	O
separately	O
from	O
other	O
CCVs	O
characterized	O
so	O
far	O
and	O
from	O
GOT	O
/	O
05	O
,	O
the	O
variant	O
recovered	O
in	O
Western	O
Sweden	O
.	O

In	O
addition	O
,	O
the	O
five	O
viruses	B-SPEC
originating	O
from	O
the	O
same	O
geographical	O
area	O
displayed	O
atypical	O
5	O
'	O
S	O
gene	O
sequences	O
.	O

ABSTRACT	O
:	O
The	O
international	O
outbreak	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2002	O
-	O
2003	O
highlighted	O
the	O
need	O
to	O
develop	O
pretested	O
human	B-SPEC
vaccine	O
vectors	O
that	O
can	O
be	O
used	O
in	O
a	O
rapid	O
response	O
against	O
newly	O
emerging	O
pathogens	O
.	O

We	O
evaluated	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
an	O
avian	B-SPEC
paramyxovirus	I-SPEC
that	O
is	O
highly	O
attenuated	O
in	O
primates	B-SPEC
,	O
as	O
a	O
topical	O
respiratory	O
vaccine	O
vector	O
with	O
SARS	O
-	O
CoV	O
as	O
a	O
test	O
pathogen	O
.	O

Complete	O
recombinant	O
NDV	B-SPEC
was	O
engineered	O
to	O
express	O
the	O
SARS	O
-	O
CoV	O
spike	O
S	O
glycoprotein	O
,	O
the	O
viral	O
neutralization	O
and	O
major	O
protective	O
antigen	O
,	O
from	O
an	O
added	O
transcriptional	O
unit	O
.	O

Furthermore	O
,	O
4	O
sets	O
of	O
parental	O
mice	B-SPEC
and	O
sentinel	O
mice	B-SPEC
from	O
the	O
facility	O
were	O
negative	O
for	O
13	O
viruses	B-SPEC
,	O
bacteria	B-SPEC
,	O
and	O
parasites	O
.	O

TITLE	O
:	O
De	O
novo	O
initiation	O
of	O
RNA	O
synthesis	O
by	O
the	O
arterivirus	B-SPEC
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
.	O

First	O
,	O
101	O
nasal	O
-	O
wash	O
specimens	O
that	O
were	O
positive	O
for	O
HRV	O
,	O
RSV	B-SPEC
,	O
InfV	O
,	O
PIV	O
,	O
or	O
Ad	O
by	O
traditional	O
techniques	O
were	O
reanalyzed	O
by	O
RMA	O
,	O
and	O
all	O
target	O
viruses	B-SPEC
were	O
detected	O
with	O
an	O
overall	O
sensitivity	O
of	O
94	O
%	O
and	O
specificity	O
of	O
99	O
%.	O

Second	O
,	O
103	O
nasal	O
-	O
wash	O
samples	O
from	O
5	O
-	O
year	O
-	O
old	O
children	O
with	O
asthma	O
and	O
respiratory	O
symptoms	O
were	O
analyzed	O
;	O
RMA	O
detected	O
viruses	B-SPEC
in	O
74	O
specimens	O
(	O
71	O
.	O
8	O
%)	O
compared	O
to	O
only	O
24	O
(	O
23	O
.	O
3	O
%)	O
by	O
traditional	O
culture	O
and	O
immunofluorescent	O
-	O
staining	O
techniques	O
.	O

Data	O
from	O
experimental	O
models	O
of	O
sepsis	B-SPEC
,	O
ALI	O
,	O
and	O
ARDS	O
indicate	O
that	O
some	O
of	O
these	O
agents	O
improve	O
lung	O
function	O
and	O
oxygenation	O
.	O

TITLE	O
:	O
Isolation	O
and	O
identification	O
of	O
an	O
scFv	O
antibody	O
against	O
nucleocapsid	O
protein	O
of	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
To	O
develop	O
reagents	O
for	O
early	O
diagnosis	O
and	O
therapeutic	O
drugs	O
against	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
a	O
large	O
(	O
3	O
x	O
10	O
(	O
9	O
))	O
immunized	O
human	B-SPEC
antibody	O
library	O
was	O
constructed	O
from	O
peripheral	O
blood	O
mononuclear	O
cells	O
from	O
six	O
SARS	O
convalescent	O
patients	O
.	O

We	O
further	O
determined	O
that	O
both	O
lung	O
SDF	O
-	O
1	O
protein	O
expression	O
and	O
mRNA	O
expression	O
rise	O
in	O
a	O
delayed	O
but	O
sustained	O
pattern	O
in	O
this	O
mouse	B-SPEC
model	O
and	O
that	O
the	O
major	O
source	O
of	O
the	O
increase	O
in	O
expression	O
appears	O
to	O
be	O
the	O
lung	O
epithelium	O
.	O

ABSTRACT	O
:	O
In	O
this	O
report	O
,	O
we	O
describe	O
a	O
case	O
of	O
pneumonia	O
due	O
to	O
an	O
infection	O
with	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)-	O
OC43	O
in	O
a	O
pediatric	O
leukemia	O
patient	O
with	O
Down	O
syndrome	O
and	O
febrile	O
neutropenia	O
.	O

Results	O
from	O
the	O
protection	O
test	O
showed	O
the	O
two	O
immunizations	O
with	O
rBCG	O
-	O
S1	O
could	O
provide	O
protection	O
for	O
chickens	B-SPEC
from	O
the	O
challenge	O
with	O
virulent	O
nephropathogenic	O
IBV	B-SPEC
strain	O
X	O
.	O
Haemagglutination	O
inhibition	O
titers	O
were	O
also	O
increased	O
in	O
chickens	B-SPEC
immunized	O
with	O
the	O
expressed	O
rBCG	O
-	O
S1	O
,	O
and	O
significantly	O
higher	O
titers	O
were	O
detected	O
after	O
challenge	O
.	O

TITLE	O
:	O
[	O
Construction	O
of	O
recombinant	O
Lactococcus	B-SPEC
lactis	I-SPEC
expressing	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
spike	O
glycoprotein	O
and	O
analysis	O
of	O
immunogenicity	O
].	O

In	O
order	B-SPEC
to	O
detect	O
the	O
location	O
of	O
expressed	O
protein	O
,	O
the	O
yellow	O
and	O
green	O
fluorescence	O
of	O
the	O
recombinant	O
strain	O
pNZ8112	O
-	O
Sa	O
/	O
NZ9000	O
was	O
detected	O
by	O
the	O
IFA	O
experiments	O
,	O
which	O
indicated	O
that	O
the	O
expressed	O
recombinant	O
protein	O
was	O
secreted	O
and	O
located	O
on	O
the	O
surface	O
of	O
the	O
bacterium	B-SPEC
cell	O
.	O

Oral	O
immunization	O
of	O
BALB	O
/	O
c	O
mice	B-SPEC
with	O
recombinant	O
strain	O
that	O
constitutively	O
express	O
the	O
66kDa	O
fragment	O
of	O
the	O
glycoprotein	O
S	O
,	O
Specific	O
anti	O
-	O
TGEV	B-SPEC
glycoprotein	O
S	O
secret	O
immunoglobulin	O
A	O
(	O
sIgA	B-SPEC
)	O
antibodies	O
were	O
detected	O
by	O
indirect	O
enzyme	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
in	O
the	O
feces	O
after	O
immunization	O
.	O

ABSTRACT	O
:	O
The	O
membrane	O
fusion	O
process	O
mediated	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
S	O
protein	O
and	O
its	O
cellular	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
had	O
been	O
reconstituted	O
using	O
two	O
Chinese	B-SPEC
hamster	I-SPEC
ovary	O
(	O
CHO	O
)	O
cell	O
lines	O
that	O
constitutively	O
express	O
these	O
recombinant	O
proteins	O
separately	O
.	O

As	O
we	O
obtained	O
information	O
that	O
a	O
parakeet	B-SPEC
had	O
recently	O
died	O
at	O
her	O
home	O
,	O
minocycline	O
was	O
administered	O
,	O
resulting	O
in	O
prompt	O
improvement	O
of	O
the	O
symptoms	O
,	O
respiratory	O
insufficiency	O
and	O
pulmonary	O
infiltrates	O
.	O

Finally	O
,	O
elevated	O
antibody	O
titers	O
against	O
Chlamydophila	B-SPEC
psittasi	O
confirmed	O
a	O
diagnosis	O
of	O
Psittacosis	O
.	O

TITLE	O
:	O
Cyclooxygenase	O
activity	O
is	O
important	O
for	O
efficient	O
replication	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
at	O
an	O
early	O
stage	O
of	O
infection	O
.	O

Both	O
viral	O
RNA	O
and	O
viral	O
protein	O
synthesis	O
were	O
affected	O
with	O
subsequent	O
loss	O
of	O
progeny	O
virus	B-SPEC
production	O
.	O

The	O
spot	B-SPEC
map	O
effectively	O
illustrated	O
clusters	O
by	O
residency	O
,	O
with	O
the	O
inner	O
-	O
city	O
sustaining	O
the	O
highest	O
attack	O
rate	O
(	O
33	O
.	O
42	O
per	O
100	O
,	O
000	O
),	O
followed	O
by	O
an	O
easterly	O
distribution	O
5	O
-	O
30km	O
away	O
(	O
21	O
.	O
62	O
per	O
10	O
,	O
000	O
),	O
and	O
lowest	O
in	O
districts	O
60	O
-	O
160km	O
away	O
(	O
9	O
.	O
21	O
per	O
100	O
,	O
000	O
).	O

If	O
a	O
spot	B-SPEC
map	O
of	O
incidence	O
density	O
rates	O
was	O
used	O
during	O
the	O
early	O
phase	O
of	O
the	O
outbreak	O
,	O
the	O
inner	O
city	O
might	O
have	O
been	O
identified	O
as	O
a	O
major	O
risk	O
factor	O
requiring	O
rapid	O
quarantining	O
.	O

CONCLUSIONS	O
:	O
In	O
hindsight	O
,	O
the	O
investigation	O
of	O
the	O
Beijing	O
SARS	O
would	O
have	O
benefited	O
from	O
the	O
use	O
of	O
spot	B-SPEC
maping	O
as	O
an	O
essential	O
outbreak	O
tool	O
for	O
early	O
identification	O
of	O
specific	O
geographical	O
area	O
(	O
s	O
)	O
for	O
quarantining	O
.	O

The	O
WD	O
-	O
BCoV	O
-	O
infected	O
animals	B-SPEC
showed	O
epithelial	O
damage	O
in	O
nasal	O
turbinates	O
,	O
trachea	B-SPEC
and	O
lungs	O
,	O
and	O
interstitial	O
pneumonia	O
.	O

Twenty	O
-	O
three	O
subjects	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
OSA	B-SPEC
and	O
23	O
subjects	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
OSA	B-SPEC
plus	O
OHS	O
underwent	O
a	O
1	O
-	O
night	O
trial	O
of	O
CPAP	O
.	O

Endothelial	O
cells	O
from	O
the	O
microvessels	O
in	O
human	B-SPEC
brain	O
,	O
lung	O
,	O
hepatic	O
sennoside	O
,	O
fat	O
adipose	O
tissue	O
,	O
adrenal	O
gland	O
,	O
esophagus	O
,	O
lymph	O
nodes	O
,	O
and	O
bone	O
were	O
culture	O
.	O

TITLE	O
:	O
Bird	B-SPEC
flu	O
:	O
lessons	O
from	O
SARS	O
.	O

Current	O
evidence	O
suggests	O
that	O
the	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
of	O
avian	B-SPEC
influenza	O
is	O
rather	O
inefficient	O
,	O
but	O
mutation	O
might	O
occur	O
in	O
the	O
future	O
resulting	O
in	O
improved	O
transmission	O
and	O
possibly	O
a	O
pandemic	O
in	O
humans	B-SPEC
.	O

Two	O
groups	O
of	O
12	O
conventional	O
,	O
colostrum	O
-	O
deprived	O
,	O
1	O
-	O
day	O
-	O
old	O
,	O
large	B-SPEC
White	I-SPEC
-	O
Duroc	O
cross	O
breed	O
piglets	O
were	O
inoculated	O
orally	O
with	O
PEDV	B-SPEC
(	O
3	O
x	O
10	O
(	O
5	O
)	O
50	O
%	O
tissue	O
culture	O
infective	O
doses	O
),	O
with	O
or	O
without	O
EGF	O
(	O
10	O
microg	O
/	O
kg	O
/	O
day	O
,	O
intraperitoneally	O
once	O
daily	O
for	O
4	O
days	O
after	O
infection	O
)	O
and	O
compared	O
to	O
12	O
uninfected	O
,	O
untreated	O
control	O
piglets	O
.	O

Overall	O
,	O
88	O
%	O
of	O
the	O
flocks	O
were	O
seropositive	O
for	O
M	O
-	O
41	O
antibodies	O
,	O
whereas	O
40	O
,	O
52	O
,	O
and	O
8	O
%	O
of	O
the	O
flocks	O
were	O
positive	O
for	O
D	O
-	O
274	O
,	O
D	O
-	O
1466	O
,	O
and	O
4	O
-	O
91	O
IBV	B-SPEC
strains	O
,	O
respectively	O
.	O

Phospholipase	O
C	O
treatment	O
of	O
the	O
lung	O
and	O
tracheal	O
tissue	O
homogenates	O
from	O
IBV	B-SPEC
-	O
positive	O
chickens	B-SPEC
increased	O
the	O
detection	O
limit	O
for	O
M	O
-	O
41	O
strain	O
from	O
1	O
.	O
3	O
%	O
positive	O
samples	O
in	O
simple	O
hemagglutination	O
assay	O
to	O
30	O
.	O
6	O
%	O
positivity	O
when	O
the	O
same	O
samples	O
were	O
treated	O
with	O
phospholipase	O
C	O
.	O
Similarly	O
,	O
reverse	O
transcription	O
-	O
PCR	O
was	O
a	O
much	O
better	O
M	O
-	O
41	O
detection	O
tool	O
as	O
compared	O
with	O
the	O
classical	O
agar	O
gel	O
precipitation	O
assay	O
utilized	O
to	O
screen	O
tissue	O
homogenates	O
from	O
IBV	B-SPEC
-	O
positive	O
chickens	B-SPEC
.	O

In	O
conclusion	O
,	O
this	O
survey	O
clearly	O
demonstrates	O
that	O
several	O
strains	O
of	O
IBV	B-SPEC
are	O
prevalent	O
in	O
poultry	O
flocks	O
in	O
Pakistan	O
.	O

We	O
show	O
that	O
in	O
vaccinated	O
mice	B-SPEC
and	O
rabbits	B-SPEC
,	O
a	O
heterologous	O
MVA	O
-	O
S	O
prime	O
with	O
Ad5	O
-	O
S	O
boost	O
regimen	O
induces	O
the	O
highest	O
and	O
most	O
persistent	O
level	O
of	O
Nab	O
response	O
when	O
compared	O
with	O
other	O
combinations	O
.	O

Thus	O
,	O
our	O
data	O
provides	O
a	O
promising	O
optimal	O
regimen	O
for	O
vaccine	O
development	O
in	O
humans	B-SPEC
against	O
SARS	O
-	O
CoV	O
infection	O
.	O

Second	O
,	O
because	O
sepsis	B-SPEC
is	O
considered	O
the	O
major	O
risk	O
factor	O
for	O
development	O
of	O
ARDS	O
,	O
we	O
evaluated	O
LPS	O
-	O
treated	O
WT	O
as	O
well	O
as	O
gamma	O
-	O
chain	O
-	O
deficient	O
mice	B-SPEC
for	O
the	O
presence	O
of	O
anti	O
-	O
KC	O
:	O
KC	O
complexes	O
and	O
pulmonary	O
inflammatory	O
responses	O
.	O

onwards	O
,	O
and	O
at	O
all	O
times	O
the	O
respective	O
viral	O
RNA	O
from	O
IBV	B-SPEC
-	O
infected	O
monolayers	O
was	O
demonstrated	O
by	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Leptin	O
treatment	O
ameliorates	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
with	O
cerulein	O
-	O
induced	O
acute	O
pancreatitis	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
1	O
-	O
year	O
outcomes	O
in	O
survivors	O
of	O
SARS	O
and	O
their	O
family	B-SPEC
caregivers	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
ORF6	O
antagonizes	O
STAT1	O
function	O
by	O
sequestering	O
nuclear	O
import	O
factors	O
on	O
the	O
rough	O
endoplasmic	O
reticulum	O
/	O
Golgi	O
membrane	O
.	O

The	O
assay	O
detected	O
influenza	O
A	O
and	O
B	O
viruses	B-SPEC
;	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
subtypes	O
H1	O
,	O
H3	O
,	O
and	O
H5	O
(	O
including	O
subtype	O
H5N1	O
of	O
the	O
Asian	O
lineage	O
);	O
parainfluenza	O
virus	B-SPEC
types	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
;	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
types	O
A	O
and	O
B	O
;	O
adenovirus	B-SPEC
;	O
metapneumovirus	B-SPEC
;	O
rhinovirus	B-SPEC
;	O
enterovirus	B-SPEC
;	O
and	O
coronaviruses	O
OC43	O
,	O
229E	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
NL63	O
,	O
and	O
HKU1	O
.	O

TITLE	O
:	O
Type	O
IVB	O
pilus	O
operon	O
promoter	O
controlling	O
expression	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
nucleocapsid	O
gene	O
in	O
Salmonella	B-SPEC
enterica	I-SPEC
Serovar	O
Typhi	O
elicits	O
full	O
immune	O
response	O
by	O
intranasal	O
vaccination	O
.	O

TITLE	O
:	O
Open	O
reading	O
frame	O
8a	O
of	O
the	O
human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
not	O
only	O
promotes	O
viral	O
replication	O
but	O
also	O
induces	O
apoptosis	O
.	O

ABSTRACT	O
:	O
A	O
unique	O
genomic	O
difference	O
between	O
human	B-SPEC
and	O
civet	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
coronaviruses	O
(	O
SARS	O
-	O
CoVs	O
)	O
is	O
that	O
the	O
former	O
has	O
a	O
deletion	O
of	O
29	O
nucleotides	O
from	O
open	O
reading	O
frame	O
(	O
orf	O
)	O
8a	O
'	O
that	O
results	O
in	O
the	O
generation	O
of	O
orf8a	O
and	O
orf8b	O
.	O

Viral	O
antigens	O
for	O
common	O
respiratory	O
viruses	B-SPEC
were	O
detected	O
by	O
IFA	O
or	O
multiplex	O
PCR	O
.	O

Astrocytes	O
in	O
the	O
adult	O
central	O
nervous	O
system	O
up	O
-	O
regulated	O
class	B-SPEC
I	O
surface	O
expression	O
,	O
albeit	O
delayed	O
compared	O
with	O
microglia	O
.	O

C	B-SPEC
.	I-SPEC
parvum	I-SPEC
oocysts	O
were	O
detected	O
in	O
the	O
feces	O
of	O
78	O
%	O
of	O
the	O
919	O
calves	O
from	O
which	O
all	O
four	O
fecal	O
samples	O
had	O
been	O
collected	O
.	O

TITLE	O
:	O
Quantitative	O
temporal	O
-	O
spatial	O
distribution	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
post	O
-	O
mortem	O
tissues	O
.	O

No	O
studies	O
have	O
examined	O
how	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
loads	O
in	O
different	O
organs	O
with	O
respect	O
to	O
time	O
,	O
post	O
-	O
mortem	O
.	O

This	O
quantitative	O
assessment	O
further	O
supports	O
SARS	O
-	O
CoV	O
has	O
a	O
specific	O
tropism	O
for	O
the	O
human	B-SPEC
respiratory	O
and	O
gastrointestinal	O
tracts	O
,	O
which	O
may	O
be	O
related	O
to	O
the	O
density	O
of	O
SARS	O
-	O
CoV	O
receptors	O
.	O

As	O
there	O
is	O
no	O
well	O
-	O
recognised	O
effective	O
treatment	O
for	O
SARS	O
and	O
avian	B-SPEC
influenza	O
,	O
prevention	O
of	O
infection	O
is	O
most	O
important	O
.	O

The	O
main	O
reasons	O
for	O
ICU	O
admission	O
were	O
sepsis	B-SPEC
(	O
37	O
%)	O
and	O
acute	O
respiratory	O
failure	O
(	O
20	O
%).	O

A	O
performance	O
status	O
>	O
or	O
=	O
2	O
[	O
odds	O
ratio	O
(	O
OR	O
)=	O
5	O
.	O
17	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
CI	O
=	O
1	O
.	O
84	O
-	O
14	O
.	O
53	O
)],	O
advanced	O
cancer	B-SPEC
(	O
TNM	O
stage	O
IV	O
)	O
[	O
OR	O
=	O
3	O
.	O
80	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
28	O
-	O
11	O
.	O
28	O
)],	O
and	O
the	O
number	O
of	O
organ	O
failures	O
[	O
OR	O
=	O
2	O
.	O
87	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
83	O
-	O
4	O
.	O
50	O
)]	O
were	O
associated	O
with	O
increased	O
mortality	O
in	O
multivariate	O
analysis	O
.	O

EPC	O
were	O
tested	O
for	O
their	O
homing	O
in	O
a	O
left	O
-	O
sided	O
rat	B-SPEC
lung	O
transplant	O
model	O
mimicking	O
a	O
severe	O
acute	O
lung	O
injury	O
.	O

EPC	O
were	O
transplanted	O
into	O
the	O
host	O
animal	B-SPEC
by	O
peripheral	O
administration	O
into	O
the	O
femoral	O
vein	O
(	O
10	O
(	O
6	O
)	O
cells	O
).	O

Rats	B-SPEC
were	O
sacrificed	O
1	O
,	O
4	O
or	O
9	O
days	O
after	O
lung	O
transplantation	O
and	O
homing	O
of	O
EPC	O
was	O
evaluated	O
by	O
fluorescence	O
microscopy	O
.	O

We	O
showed	O
that	O
IBV	B-SPEC
strains	O
M41	O
,	O
H52	O
,	O
H120	O
and	O
Gray	O
could	O
be	O
propagated	O
in	O
HeLa	O
cells	O
with	O
distinct	O
cytopathic	O
effect	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
caused	O
a	O
worldwide	O
epidemic	O
in	O
late	O
2002	O
/	O
early	O
2003	O
and	O
a	O
second	O
outbreak	O
in	O
the	O
winter	O
of	O
2003	O
/	O
2004	O
by	O
an	O
independent	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

Two	O
putative	O
hot	O
-	O
spot	B-SPEC
residues	O
in	O
the	O
RBD	O
(	O
Ile	O
-	O
489	O
and	O
Tyr	O
-	O
491	O
)	O
were	O
identified	O
within	O
the	O
SARS	O
-	O
CoV	O
spike	O
that	O
likely	O
contribute	O
to	O
most	O
of	O
the	O
m396	O
-	O
binding	O
energy	O
.	O

The	O
results	O
imply	O
that	O
endocytosis	O
plays	O
a	O
major	O
role	O
in	O
MHV	B-SPEC
-	O
A59	O
infection	O
and	O
the	O
acidic	O
pH	O
of	O
the	O
endosomal	O
compartment	O
triggers	O
a	O
conformational	O
change	O
of	O
the	O
S	O
protein	O
mediating	O
fusion	O
.	O

Genetically	O
the	O
three	O
variant	O
IBV	B-SPEC
strains	O
,	O
designated	O
CA557	O
/	O
03	O
,	O
CA706	O
/	O
03	O
,	O
and	O
CA1737	O
/	O
04	O
,	O
were	O
not	O
related	O
to	O
each	O
other	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
KQ6	O
was	O
an	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
a	O
member	O
of	O
coronavirus	B-SPEC
in	O
group	O
3	O
.	O

The	O
genome	O
sequence	O
of	O
KQ6	O
had	O
extremely	O
high	O
degree	O
of	O
identity	O
with	O
that	O
of	O
a	O
Massachusetts	O
prototype	O
IBV	B-SPEC
M41	O
.	O

Seventeen	O
out	O
of	O
fifty	O
-	O
four	O
(	O
31	O
.	O
48	O
%)	O
peafowl	B-SPEC
serum	O
samples	O
were	O
tested	O
positive	O
for	O
specific	O
antibodies	O
against	O
IBV	B-SPEC
.	O

In	O
this	O
Review	O
,	O
an	O
original	O
therapeutic	O
concept	O
for	O
suppressing	O
enveloped	O
viruses	B-SPEC
is	O
presented	O
that	O
is	O
based	O
on	O
a	O
specific	O
interaction	O
of	O
carbohydrate	O
-	O
binding	O
agents	O
(	O
CBAs	O
)	O
with	O
the	O
glycans	O
present	O
on	O
viral	O
-	O
envelope	O
glycoproteins	O
.	O

Serum	O
antibodies	O
were	O
shown	O
to	O
be	O
virus	B-SPEC
neutralizing	O
.	O

In	O
conclusion	O
,	O
the	O
results	O
suggest	O
that	O
the	O
chicken	B-SPEC
scFv	O
phage	O
display	O
system	O
can	O
be	O
a	O
potential	O
model	O
for	O
mass	O
production	O
of	O
high	O
-	O
affinity	O
antibodies	O
against	O
the	O
SARS	O
-	O
CoV	O
spike	O
protein	O
.	O

TITLE	O
:	O
Expression	O
of	O
a	O
synthetic	O
neutralizing	O
epitope	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
fused	O
with	O
synthetic	O
B	O
subunit	O
of	O
Escherichia	B-SPEC
coli	I-SPEC
heat	O
labile	O
enterotoxin	O
in	O
rice	B-SPEC
endosperm	O
.	O

ABSTRACT	O
:	O
Surface	O
enhanced	O
laser	B-SPEC
desorption	O
ionization	O
-	O
time	O
of	O
flight	O
is	O
a	O
mass	O
spectrometric	O
-	O
based	O
method	O
that	O
requires	O
a	O
minimal	O
amount	O
of	O
sample	O
for	O
analysis	O
and	O
can	O
be	O
used	O
for	O
high	O
-	O
throughput	O
screening	O
.	O

Each	O
of	O
these	O
plasmids	O
was	O
intradermally	O
administered	O
to	O
C57BL	O
/	O
6	O
mice	B-SPEC
in	O
three	O
separate	O
immunizations	O
.	O

Moreover	O
,	O
an	O
in	O
vitro	O
chemotaxis	O
assay	O
showed	O
that	O
motility	O
towards	O
chemokines	O
of	O
THP	O
-	O
1	O
cells	O
and	O
primary	O
monocytes	O
was	O
increased	O
following	O
an	O
acute	O
or	O
persistent	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
.	O

Here	O
we	O
show	O
that	O
SARS	O
-	O
CoV	O
and	O
MHV	B-SPEC
induce	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
and	O
Cxcl2	O
mRNA	O
transcription	O
during	O
infection	O
in	O
vitro	O
.	O

It	O
has	O
been	O
argued	O
that	O
SARS	O
should	O
be	O
regarded	O
as	O
contagious	O
infection	O
,	O
whereas	O
avian	B-SPEC
influenza	O
-	O
as	O
non	O
-	O
contagious	O
.	O

ABSTRACT	O
:	O
A	O
one	O
-	O
year	O
-	O
old	O
female	O
cat	B-SPEC
was	O
unable	O
to	O
stand	O
.	O

After	O
the	O
cat	B-SPEC
died	O
,	O
a	O
pathological	O
examination	O
revealed	O
nonsuppurative	O
encephalomyelitis	O
.	O

TITLE	O
:	O
Immune	O
responses	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
induced	O
by	O
virus	B-SPEC
-	O
like	O
particles	O
in	O
mice	B-SPEC
.	O

Our	O
findings	O
demonstrate	O
that	O
SARS	O
CoV	O
VLPs	O
are	O
immunogenic	O
and	O
can	O
elicit	O
strong	O
SARS	O
CoV	O
-	O
specific	O
humoral	O
and	O
cellular	O
immune	O
responses	O
in	O
mice	B-SPEC
.	O

Because	O
excitement	O
frequently	O
causes	O
leucocytosis	O
in	O
cats	B-SPEC
,	O
a	O
diagnosis	O
of	O
inflammation	O
should	O
therefore	O
be	O
supported	O
by	O
additional	O
findings	O
such	O
as	O
the	O
presence	O
of	O
toxic	O
neutrophils	O
.	O

Disruption	O
of	O
gene	O
7	O
did	O
not	O
affect	O
virus	B-SPEC
replication	O
or	O
morbidity	O
in	O
golden	O
Syrian	B-SPEC
hamsters	I-SPEC
,	O
suggesting	O
that	O
the	O
gene	O
7	O
products	O
are	O
not	O
required	O
for	O
acute	O
infection	O
in	O
vivo	O
.	O

To	O
identify	O
the	O
molecule	O
that	O
interacts	O
with	O
JHMV	O
,	O
we	O
focused	O
on	O
heparan	O
sulfate	O
(	O
HS	O
)	O
since	O
it	O
works	O
as	O
a	O
receptor	O
of	O
a	O
mutant	O
MHV	B-SPEC
-	O
rec1	O
that	O
infects	O
in	O
an	O
MHVR	O
-	O
independent	O
fashion	O
.	O

Studies	O
of	O
the	O
rTGEV	O
-	O
DeltaE	O
subcellular	O
localization	O
by	O
confocal	O
and	O
immunoelectron	O
microscopy	O
in	O
infected	O
E	O
(-)	O
cells	O
showed	O
that	O
in	O
the	O
absence	O
of	O
E	O
protein	O
virus	B-SPEC
trafficking	O
was	O
arrested	O
in	O
the	O
intermediate	O
compartment	O
.	O

Therefore	O
,	O
the	O
absence	O
of	O
E	O
protein	O
in	O
TGEV	B-SPEC
resulted	O
in	O
two	O
actions	O
,	O
a	O
blockade	O
of	O
virus	B-SPEC
trafficking	O
in	O
the	O
membranes	O
of	O
the	O
secretory	O
pathway	O
,	O
and	O
prevention	O
of	O
full	O
virus	B-SPEC
maturation	O
.	O

ABSTRACT	O
:	O
Pulmonary	O
complication	O
in	O
severe	O
Plasmodium	B-SPEC
falciparum	I-SPEC
malaria	O
is	O
manifested	O
as	O
a	O
prolonged	O
impairment	O
of	O
gas	O
transfer	O
or	O
the	O
more	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
showed	O
that	O
parasite	O
sonicates	O
but	O
not	O
intact	O
infected	O
erythrocytes	O
disrupted	O
endothelial	O
barrier	O
function	O
in	O
a	O
Src	O
-	O
family	B-SPEC
kinase	O
-	O
dependent	O
manner	O
.	O

We	O
report	O
here	O
the	O
rational	O
design	O
of	O
an	O
attenuated	O
recombinant	O
coronavirus	B-SPEC
vaccine	O
based	O
on	O
a	O
deletion	O
in	O
the	O
coding	O
sequence	O
of	O
the	O
non	O
-	O
structural	O
protein	O
1	O
(	O
nsp1	O
).	O

In	O
cell	O
culture	O
,	O
nsp1	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
like	O
its	O
SARS	O
-	O
coronavirus	B-SPEC
homolog	O
,	O
strongly	O
reduced	O
cellular	O
gene	O
expression	O
.	O

The	O
effect	O
of	O
nsp1	O
on	O
MHV	B-SPEC
replication	O
in	O
vitro	O
and	O
in	O
vivo	O
was	O
analyzed	O
using	O
a	O
recombinant	O
MHV	B-SPEC
encoding	O
a	O
deletion	O
in	O
the	O
nsp1	O
-	O
coding	O
sequence	O
.	O

The	O
recombinant	O
MHV	B-SPEC
nsp1	O
mutant	O
grew	O
normally	O
in	O
tissue	O
culture	O
,	O
but	O
was	O
severely	O
attenuated	O
in	O
vivo	O
.	O

Literature	O
was	O
identified	O
through	O
MEDLINE	O
(	O
1966	O
-	O
April	O
2007	O
)	O
using	O
combinations	O
of	O
the	O
key	O
words	O
hydrocortisone	O
,	O
adrenal	O
insufficiency	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
pneumonia	O
,	O
sepsis	B-SPEC
,	O
and	O
cortisol	O
.	O

Recent	O
evidence	O
suggests	O
that	O
dialysis	B-SPEC
dosage	O
affects	O
outcomes	O
in	O
critically	O
ill	O
patients	O
with	O
sepsis	B-SPEC
-	O
induced	O
AKI	O
.	O

Given	O
the	O
diversity	O
detected	O
here	O
,	O
larger	O
-	O
scale	O
studies	O
will	O
be	O
necessary	O
to	O
determine	O
whether	O
particular	O
substrains	O
of	O
viruses	B-SPEC
confer	O
an	O
elevated	O
risk	O
of	O
asthma	O
exacerbation	O
.	O

Furthermore	O
,	O
CBA	O
did	O
not	O
inhibit	O
virus	B-SPEC
-	O
cell	O
attachment	O
,	O
but	O
rather	O
affected	O
virus	B-SPEC
entry	O
at	O
a	O
post	O
-	O
binding	O
stage	O
.	O

TITLE	O
:	O
Genomic	O
characterization	O
of	O
equine	B-SPEC
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Regulation	O
of	O
cell	O
death	O
during	O
infection	O
by	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
other	O
coronaviruses	O
.	O

Expeditious	O
research	O
on	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
,	O
one	O
of	O
the	O
latest	O
discovered	O
coronaviruses	O
that	O
infect	O
humans	B-SPEC
,	O
has	O
provided	O
valuable	O
insights	O
into	O
the	O
molecular	O
aspects	O
of	O
cell	O
-	O
death	O
regulation	O
during	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
was	O
caused	O
by	O
the	O
spread	O
of	O
a	O
previously	O
unrecognized	O
infectious	O
agent	O
,	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Although	O
the	O
idea	B-SPEC
is	O
less	O
clear	O
and	O
somewhat	O
controversial	O
,	O
SARS	O
-	O
CoV	O
is	O
thought	O
to	O
use	O
C	O
-	O
type	O
lectins	O
DC	O
-	O
SIGN	O
and	O
/	O
or	O
L	O
-	O
SIGN	O
(	O
collectively	O
referred	O
to	O
as	O
DC	O
/	O
L	O
-	O
SIGN	O
)	O
as	O
alternative	O
receptors	O
or	O
as	O
enhancer	O
factors	O
that	O
facilitate	O
ACE2	O
-	O
mediated	O
virus	B-SPEC
infection	O
.	O

As	O
expected	O
,	O
glycans	O
on	O
spike	O
(	O
S	O
)	O
glycoprotein	O
are	O
important	O
for	O
DC	O
/	O
L	O
-	O
SIGN	O
-	O
mediated	O
virus	B-SPEC
infection	O
.	O

We	O
report	O
the	O
radiographic	O
,	O
high	O
-	O
resolution	O
computed	O
tomography	O
(	O
HRCT	O
),	O
and	O
hematologic	O
appearances	O
in	O
a	O
63	O
-	O
year	O
-	O
old	O
man	B-SPEC
presenting	O
with	O
acute	O
babesisois	O
.	O

In	O
South	O
Korea	O
,	O
PGAR	O
is	O
prevalent	O
in	O
piglets	O
naturally	O
infected	O
with	O
PEDV	B-SPEC
.	O

Piglets	O
naturally	O
co	O
-	O
infected	O
with	O
PEDV	B-SPEC
and	O
PGAR	O
appeared	O
to	O
have	O
severe	O
and	O
prolonged	O
diarrhea	O
that	O
was	O
distinct	O
from	O
that	O
commonly	O
observed	O
.	O

Sequence	O
analysis	O
of	O
the	O
PEDV	B-SPEC
N	O
gene	O
revealed	O
that	O
Korean	O
field	O
PEDV	B-SPEC
isolates	O
had	O
93	O
.	O
6	O
%	O
and	O
89	O
.	O
6	O
%	O
identity	O
with	O
the	O
vaccine	O
virus	B-SPEC
at	O
nucleotide	O
and	O
amino	O
acid	O
sequence	O
levels	O
,	O
respectively	O
,	O
suggesting	O
progressive	O
point	O
mutations	O
of	O
the	O
PEDV	B-SPEC
genome	O
in	O
the	O
field	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
bocavirus	I-SPEC
(	O
HBoV	O
)	O
is	O
a	O
recently	O
discovered	O
parvovirus	B-SPEC
associated	O
with	O
respiratory	O
tract	O
infections	O
in	O
children	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
perform	O
a	O
retrospective	O
analysis	O
of	O
neurological	O
signs	O
in	O
a	O
population	O
of	O
55	O
cats	B-SPEC
with	O
a	O
histopathologically	O
confirmed	O
neurological	O
form	O
of	O
FIP	O
.	O

In	O
particular	O
,	O
the	O
5	O
'-	O
O	O
-	O
benzoyl	O
analogue	O
exhibited	O
the	O
highest	O
potency	O
with	O
an	O
EC	O
(	O
50	O
)	O
of	O
6	O
.	O
1	O
microM	O
in	O
a	O
cell	O
-	O
based	O
HCV	B-SPEC
replicon	O
assay	O
.	O

All	O
cats	B-SPEC
were	O
negative	O
for	O
FeLV	O
.	O

TITLE	O
:	O
Conductance	O
and	O
amantadine	O
binding	O
of	O
a	O
pore	O
formed	O
by	O
a	O
lysine	O
-	O
flanked	O
transmembrane	O
domain	O
of	O
SARS	O
coronavirus	B-SPEC
envelope	O
protein	O
.	O

We	O
investigated	O
factors	O
affecting	O
mortality	O
in	O
a	O
population	O
of	O
naked	B-SPEC
mole	I-SPEC
-	I-SPEC
rats	I-SPEC
struck	O
by	O
a	O
spontaneous	O
,	O
lethal	O
coronavirus	B-SPEC
outbreak	O
.	O

To	O
evaluate	O
this	O
hypothesis	O
,	O
PBMC	O
and	O
PDC	O
were	O
repeatedly	O
isolated	O
from	O
nine	O
patients	O
with	O
acute	O
retinal	O
necrosis	O
(	O
ARN	O
),	O
caused	O
by	O
herpes	O
simplex	O
or	O
varicella	B-SPEC
zoster	I-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
a	O
clinical	O
complication	O
of	O
severe	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
in	O
humans	B-SPEC
,	O
is	O
a	O
leading	O
cause	O
of	O
morbidity	O
and	O
mortality	O
in	O
critically	O
ill	O
patients	O
.	O

Primary	O
rat	B-SPEC
alveolar	O
type	O
II	O
cells	O
were	O
transdifferentiated	O
into	O
the	O
type	O
I	O
cell	O
phenotype	O
.	O

TITLE	O
:	O
High	O
fidelity	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
replication	O
is	O
decreased	O
in	O
nsp14	O
exoribonuclease	O
mutants	O
.	O

A	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
nonstructural	O
protein	O
,	O
nsp14	O
,	O
contains	O
conserved	O
active	O
-	O
site	O
motifs	O
of	O
cellular	O
exonucleases	O
,	O
including	O
DNA	O
proofreading	O
enzymes	O
,	O
and	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	B-SPEC
(	O
SARS	O
-	O
CoV	B-SPEC
)	O
nsp14	O
has	O
3	O
'-	O
to	O
-	O
5	O
'	O
exoribonuclease	O
(	O
ExoN	O
)	O
activity	O
in	O
vitro	O
.	O

Replacement	O
of	O
conserved	O
MHV	B-SPEC
ExoN	O
active	O
-	O
site	O
residues	O
with	O
alanines	O
resulted	O
in	O
viable	O
mutant	O
viruses	B-SPEC
with	O
growth	O
and	O
RNA	O
synthesis	O
defects	O
that	O
during	O
passage	O
accumulated	O
15	O
-	O
fold	O
more	O
mutations	O
than	O
wild	O
-	O
type	O
virus	B-SPEC
without	O
changes	O
in	O
growth	O
fitness	O
.	O

This	O
study	O
developed	O
and	O
evaluated	O
five	O
groups	O
of	O
multiplex	O
nested	O
PCR	O
assays	O
that	O
could	O
simultaneously	O
detect	O
21	O
different	O
respiratory	O
pathogens	O
:	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
H1N1	O
,	O
H3N2	O
,	O
and	O
H5N1	O
);	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
;	O
parainfluenza	O
virus	B-SPEC
types	O
1	O
,	O
2	O
,	O
3	O
,	O
4a	O
,	O
and	O
4b	O
;	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
and	O
B	O
;	O
human	B-SPEC
rhinoviruses	B-SPEC
;	O
human	B-SPEC
enteroviruses	B-SPEC
;	O
human	B-SPEC
coronaviruses	O
OC43	O
and	O
229E	O
;	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
;	O
human	B-SPEC
metapneumoviruses	B-SPEC
;	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
;	O
Chlamydophila	B-SPEC
pneumoniae	I-SPEC
;	O
Legionella	B-SPEC
pneumophila	I-SPEC
;	O
and	O
adenoviruses	B-SPEC
(	O
A	O
to	O
F	O
).	O

Both	O
the	O
MS2	O
and	O
adenovirus	B-SPEC
aerosols	O
were	O
very	O
resistant	O
to	O
UV	O
air	O
disinfection	O
,	O
with	O
a	O
reduction	O
of	O
less	O
than	O
1	O
logarithm	O
in	O
viable	O
viral	O
aerosols	O
at	O
a	O
UV	O
dose	O
of	O
2608	O
microW	O
s	O
/	O
cm2	O
.	O

Sequences	O
of	O
the	O
entire	O
genome	O
revealed	O
that	O
these	O
PCV	B-SPEC
-	O
2	O
strains	O
belonged	O
to	O
a	O
genotype	O
(	O
named	O
PCV	B-SPEC
-	O
2b	O
)	O
that	O
has	O
never	O
been	O
reported	O
in	O
Canada	O
.	O

The	O
appearance	O
of	O
the	O
PCV	B-SPEC
-	O
2b	O
genotype	O
in	O
Canada	O
may	O
explain	O
the	O
death	O
rate	O
increase	O
related	O
to	O
PMWS	O
,	O
but	O
this	O
relationship	O
has	O
to	O
be	O
confirmed	O
.	O

To	O
investigate	O
if	O
mRNA	O
secondary	O
structure	O
improves	O
stability	O
of	O
the	O
complex	O
,	O
we	O
tested	O
a	O
pseudoknot	O
,	O
originating	O
from	O
the	O
genomic	O
RNA	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
a	O
member	O
of	O
the	O
positive	O
-	O
stranded	O
coronavirus	B-SPEC
group	I-SPEC
.	O

Other	O
than	O
the	O
microbiological	O
patterns	O
,	O
the	O
incidence	O
,	O
mortality	O
,	O
and	O
major	O
characteristics	O
of	O
severe	O
sepsis	B-SPEC
in	O
Chinese	O
surgical	O
intensive	O
care	O
units	O
are	O
close	O
to	O
those	O
documented	O
in	O
developed	O
countries	O
.	O

TITLE	O
:	O
Skin	O
fragility	O
syndrome	O
in	O
a	O
cat	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
and	O
hepatic	O
lipidosis	O
.	O

Histopathological	O
evaluation	O
and	O
indirect	O
immunohistochemistry	O
confirmed	O
a	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
,	O
hepatic	O
lipidosis	O
and	O
feline	B-SPEC
skin	O
fragility	O
syndrome	O
.	O

Recently	O
,	O
horseshoe	B-SPEC
bats	I-SPEC
in	O
the	O
genus	B-SPEC
Rhinolophus	I-SPEC
have	O
been	O
identified	O
as	O
natural	O
reservoir	O
of	O
SARS	O
-	O
like	O
coronaviruses	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
-	O
associated	O
pneumonia	O
in	O
previously	O
healthy	O
children	O
.	O

TITLE	O
:	O
Prospective	O
study	O
of	O
Human	B-SPEC
Bocavirus	I-SPEC
(	O
HBoV	O
)	O
infection	O
in	O
a	O
pediatric	O
university	O
hospital	O
in	O
Germany	O
2005	O
/	O
2006	O
.	O

Two	O
days	O
later	O
the	O
patient	O
presented	O
with	O
fever	O
(	O
39	O
.	O
5	O
degrees	O
C	O
),	O
diffuse	O
abdominal	O
pain	O
with	O
tenderness	O
and	O
bloody	O
diarrhea	O
,	O
and	O
diagnosis	O
of	O
CMV	B-SPEC
colitis	O
was	O
achieved	O
;	O
rectal	O
samples	O
were	O
taken	O
for	O
histologic	O
examination	O
,	O
and	O
Clostridium	B-SPEC
difficile	I-SPEC
toxin	O
was	O
isolated	O
.	O

In	O
-	O
frame	O
partial	O
or	O
complete	O
deletions	O
of	O
nsp4	O
;	O
deletions	O
of	O
TM1	O
,	O
-	O
2	O
,	O
and	O
-	O
3	O
;	O
and	O
alanine	O
substitutions	O
of	O
multiple	O
conserved	O
,	O
clustered	O
,	O
charged	O
residues	O
in	O
nsp4	O
resulted	O
in	O
viruses	B-SPEC
that	O
were	O
nonrecoverable	O
,	O
viruses	B-SPEC
highly	O
impaired	O
in	O
growth	O
and	O
RNA	O
synthesis	O
,	O
and	O
viruses	B-SPEC
that	O
were	O
nearly	O
wild	O
type	O
in	O
replication	O
.	O

In	O
phylogenetic	O
analysis	O
,	O
the	O
three	O
bat	B-SPEC
GHV	O
formed	O
a	O
separate	O
clade	O
with	O
similar	O
distance	O
to	O
the	O
Percavirus	B-SPEC
and	O
Rhadinovirus	B-SPEC
clades	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
rotavirus	B-SPEC
(	O
BRV	O
)	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
are	O
important	O
causes	O
of	O
diarrhoea	O
and	O
death	O
in	O
newborn	O
calves	O
.	O

Of	O
all	O
of	O
the	O
viruses	B-SPEC
for	O
which	O
we	O
tested	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
were	O
most	O
strongly	O
linked	O
to	O
child	O
care	O
attendance	O
,	O
occurring	O
in	O
82	O
%	O
and	O
78	O
%	O
of	O
infected	O
children	O
,	O
respectively	O
.	O

Recently	O
identified	O
human	B-SPEC
metapneumovirus	I-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
are	O
important	O
pathogens	O
in	O
community	O
-	O
based	O
illness	O
in	O
children	O
,	O
particularly	O
in	O
those	O
who	O
attend	O
child	O
care	O
.	O

Picornaviruses	B-SPEC
were	O
detected	O
in	O
half	O
of	O
the	O
nose	O
-	O
throat	O
swabs	O
collected	O
during	O
acute	O
respiratory	O
illness	O
in	O
children	O
but	O
resulted	O
in	O
milder	O
illnesses	O
;	O
influenza	O
and	O
adenovirus	B-SPEC
caused	O
the	O
highest	O
-	O
impact	O
illnesses	O
.	O

Two	O
seronegative	O
and	O
virus	B-SPEC
-	O
negative	O
dogs	B-SPEC
served	O
as	O
unvaccinated	O
controls	O
.	O

Virus	B-SPEC
was	O
not	O
detected	O
in	O
faecal	O
samples	O
after	O
the	O
first	O
or	O
second	O
vaccinations	O
by	O
virus	B-SPEC
isolation	O
assays	O
and	O
PCR	O
.	O

The	O
similarity	O
of	O
SARS	O
and	O
avian	B-SPEC
influenza	O
prompted	O
us	O
to	O
examine	O
the	O
relationship	O
between	O
SARS	O
experience	O
and	O
preparedness	O
on	O
a	O
potential	O
avian	B-SPEC
influenza	O
outbreak	O
.	O

About	O
half	O
of	O
them	O
perceived	O
there	O
would	O
be	O
an	O
avian	B-SPEC
influenza	O
outbreak	O
in	O
Hong	O
Kong	O
.	O

Healthcare	O
workers	O
who	O
had	O
been	O
actively	O
involved	O
in	O
SARS	O
work	O
were	O
more	O
""""	O
positive	O
""""	O
in	O
responding	O
to	O
the	O
impending	O
avian	B-SPEC
influenza	O
epidemic	O
.	O

For	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
the	O
percentages	O
of	O
seropositive	O
individuals	O
were	O
57	O
.	O
1	O
%	O
for	O
infants	O
<	O
2	O
months	O
old	O
;	O
38	O
.	O
9	O
%	O
for	O
infants	O
2	O
-	O
3	O
months	O
old	O
;	O
4	O
.	O
7	O
%	O
for	O
infants	O
4	O
-	O
5	O
months	O
old	O
;	O
42	O
.	O
9	O
-	O
50	O
.	O
0	O
%	O
for	O
infants	O
6	O
-	O
12	O
months	O
old	O
;	O
34	O
.	O
8	O
-	O
62	O
.	O
5	O
%	O
for	O
individuals	O
1	O
-	O
20	O
years	O
old	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
characterize	O
the	O
N	O
and	O
E	O
protein	O
encoding	O
genes	O
of	O
a	O
new	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
which	O
was	O
identified	O
from	O
one	O
of	O
the	O
clinical	O
specimens	O
(	O
BJ8081	O
)	O
collected	O
from	O
a	O
12	O
years	O
-	O
old	O
patient	O
with	O
acute	O
respiratory	O
infection	O
in	O
Beijing	O
.	O

These	O
mutations	O
were	O
successfully	O
incorporated	O
into	O
viruses	B-SPEC
named	O
vH262A	O
,	O
vH277A	O
,	O
vG275A	O
,	O
and	O
vH262P	O
+	O
H277A	O
.	O

Interestingly	O
,	O
viruses	B-SPEC
with	O
a	O
mutation	O
at	O
a	O
noncatalytic	O
residue	O
,	O
D324A	O
,	O
could	O
not	O
be	O
recovered	O
despite	O
repeated	O
attempts	O
,	O
and	O
expression	O
of	O
mNsp15	O
containing	O
the	O
D324A	O
mutation	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
resulted	O
in	O
an	O
insoluble	O
protein	O
.	O

Our	O
data	O
demonstrates	O
that	O
the	O
recombinant	O
baculovirus	B-SPEC
can	O
serve	O
as	O
an	O
effective	O
vaccine	O
strategy	O
.	O

It	O
is	O
still	O
tradition	O
in	O
certain	O
parts	O
of	O
the	O
Middle	O
East	O
and	O
is	O
gaining	O
popularity	O
in	O
the	O
United	O
Kingdom	B-SPEC
,	O
the	O
United	O
States	O
,	O
and	O
The	O
Netherlands	O
to	O
curb	O
excessive	O
crying	O
.	O

To	O
overcome	O
the	O
problems	O
we	O
encountered	O
in	O
the	O
existing	O
databases	O
during	O
comparative	O
sequence	O
analysis	O
,	O
we	O
built	O
a	O
comprehensive	O
database	O
,	O
CoVDB	O
(	O
http	O
://	O
covdb	O
.	O
microbiology	O
.	O
hku	O
.	O
hk	O
),	O
of	O
annotated	O
coronavirus	B-SPEC
genes	O
and	O
genomes	O
.	O

For	O
complete	O
genomes	O
,	O
a	O
single	O
representative	O
sequence	O
for	O
each	O
species	B-SPEC
is	O
available	O
for	O
comparative	O
analysis	O
such	O
as	O
phylogenetic	O
studies	O
.	O

ABSTRACT	O
:	O
In	O
2002	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
in	O
humans	B-SPEC
,	O
causing	O
a	O
global	O
epidemic	O
.	O

TITLE	O
:	O
High	O
prevalence	O
of	O
the	O
CD14	O
-	O
159CC	O
genotype	O
in	O
patients	O
infected	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
.	O

Through	O
targeted	O
recombination	O
and	O
reverse	O
genetic	O
manipulation	O
,	O
studies	O
of	O
infection	O
with	O
MHV	B-SPEC
-	O
JHM	O
variants	O
have	O
identified	O
phenotypic	O
differences	O
and	O
examined	O
the	O
effects	O
of	O
these	O
differences	O
on	O
viral	O
pathogenesis	O
and	O
anti	O
-	O
viral	O
host	O
immune	O
responses	O
.	O

Studies	O
employing	O
recombinant	O
viruses	B-SPEC
with	O
a	O
modified	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
MHV	B-SPEC
-	O
JHM	O
have	O
identified	O
the	O
S	O
gene	O
as	O
a	O
major	O
determinant	O
of	O
neurovirulence	O
.	O

Demyelinating	O
disease	O
during	O
MHV	B-SPEC
-	O
JHM	O
infection	O
is	O
immune	O
-	O
mediated	O
,	O
as	O
mice	B-SPEC
that	O
lack	O
T	O
lymphocytes	O
fail	O
to	O
develop	O
disease	O
despite	O
succumbing	O
to	O
encephalitis	O
with	O
high	O
levels	O
of	O
infectious	O
virus	B-SPEC
in	O
the	O
CNS	O
.	O

ABSTRACT	O
:	O
An	O
adult	O
dairy	O
cow	B-SPEC
fatally	O
affected	O
with	O
winter	O
dysentery	O
was	O
investigated	O
pathologically	O
and	O
virologically	O
.	O

These	O
suggest	O
that	O
severe	O
infection	O
of	O
BCV	B-SPEC
in	O
the	O
cow	B-SPEC
without	O
the	O
BCV	B-SPEC
antibody	O
accompanied	O
by	O
severe	O
hemorrhagic	O
anemia	B-SPEC
resulted	O
in	O
the	O
cow	B-SPEC
'	O
s	O
death	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
vaccinated	O
ferrets	B-SPEC
.	O

No	O
evidence	O
of	O
enhanced	O
disease	O
was	O
observed	O
in	O
any	O
of	O
the	O
ferrets	B-SPEC
.	O

All	O
of	O
the	O
ferrets	B-SPEC
cleared	O
the	O
virus	B-SPEC
by	O
day	O
14	O
,	O
1	O
week	O
earlier	O
if	O
vaccinated	O
.	O

These	O
putative	O
lung	O
stem	O
/	O
progenitor	O
cells	O
can	O
also	O
be	O
identified	O
in	O
some	O
non	O
-	O
SARS	O
individuals	O
and	O
can	O
be	O
infected	O
by	O
SARS	O
-	O
coronavirus	B-SPEC
ex	O
vivo	O
.	O

A	O
19	O
year	O
old	O
man	B-SPEC
was	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
for	O
acute	O
respiratory	O
distress	O
with	O
fever	O
(	O
400C	O
),	O
lymph	O
node	O
enlargement	O
,	O
hepatomegaly	O
,	O
splenomegaly	O
and	O
eosinophilia	O
(	O
1640	O
/	O
mm3	O
).	O

We	O
have	O
cloned	O
and	O
expressed	O
the	O
nsp14	O
protein	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
and	O
characterized	O
the	O
nature	O
and	O
the	O
role	O
(	O
s	O
)	O
of	O
the	O
metal	O
ions	O
in	O
the	O
reaction	O
chemistry	O
.	O

However	O
,	O
the	O
relative	O
contributions	O
of	O
type	O
I	O
IFN	O
(	O
IFN	O
-	O
I	O
)	O
to	O
direct	O
,	O
cell	O
-	O
type	O
-	O
specific	O
virus	B-SPEC
control	O
or	O
CD8	O
T	O
-	O
cell	O
-	O
mediated	O
effectors	O
in	O
the	O
CNS	O
are	O
unclear	O
.	O

To	O
investigate	O
this	O
,	O
we	O
infected	O
the	O
susceptible	O
S	O
-	O
line	O
and	O
the	O
more	O
disease	O
-	O
resilient	O
HWL	O
line	O
with	O
the	O
T	O
strain	O
of	O
IBV	B-SPEC
and	O
measured	O
their	O
cytokine	O
response	O
levels	O
.	O

Further	O
,	O
when	O
used	O
therapeutically	O
this	O
antibody	O
led	O
to	O
an	O
approximately	O
4	O
-	O
log	O
(	O
10	O
)	O
decrease	O
in	O
viral	O
burden	O
in	O
infected	O
animal	B-SPEC
lungs	O
.	O

Our	O
data	O
indicate	O
that	O
the	O
phosphorylated	O
form	O
of	O
the	O
IBV	B-SPEC
N	O
protein	O
plays	O
a	O
role	O
in	O
virus	B-SPEC
biology	O
.	O

ABSTRACT	O
:	O
The	O
3C	O
-	O
like	O
main	O
proteinase	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
,	O
SARS	O
-	O
CoV	O
M	O
(	O
pro	O
),	O
is	O
widely	O
considered	O
to	O
be	O
a	O
major	O
drug	O
target	O
for	O
the	O
development	O
of	O
anti	O
-	O
SARS	O
treatment	O
.	O

Therefore	O
,	O
51	O
nucleotide	O
deletions	O
appear	O
to	O
be	O
meaningful	O
and	O
may	O
be	O
significant	O
for	O
PEDV	B-SPEC
pathogenicity	O
,	O
because	O
they	O
lead	O
to	O
changes	O
in	O
the	O
predicted	O
amino	O
acid	O
sequences	O
of	O
attenuated	O
-	O
type	O
PEDVs	O
.	O

Although	O
influenza	O
type	O
A	O
viruses	B-SPEC
that	O
cause	O
infections	O
in	O
the	O
birds	B-SPEC
(	O
avian	B-SPEC
influenza	O
)	O
are	O
species	B-SPEC
-	O
specific	O
,	O
some	O
may	O
cross	O
the	O
species	B-SPEC
barrier	O
to	O
infect	O
humans	B-SPEC
.	O

Since	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
A	O
(	O
H5N1	O
)	O
produces	O
human	B-SPEC
infections	O
with	O
high	O
morbidity	O
and	O
mortality	O
rates	O
,	O
the	O
probability	O
of	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
and	O
its	O
consequences	O
attract	O
a	O
great	O
deal	O
of	O
attention	O
,	O
recently	O
.	O

This	O
number	O
was	O
12	O
cases	O
for	O
Turkey	B-SPEC
with	O
4	O
deaths	O
,	O
however	O
the	O
real	O
number	O
was	O
thought	O
to	O
be	O
higher	O
.	O

Recently	O
,	O
the	O
Food	O
and	O
Drug	O
Administration	O
has	O
announced	O
the	O
first	O
approval	O
in	O
the	O
United	O
States	O
of	O
a	O
vaccine	O
for	O
humans	B-SPEC
against	O
the	O
H5N1	O
influenza	B-SPEC
virus	I-SPEC
on	O
April	O
17h	O
,	O
2007	O
,	O
however	O
the	O
manufacturer	O
(	O
Sanofi	O
Pasteur	O
)	O
won	O
'	O
t	O
sell	O
the	O
vaccine	O
commercially	O
;	O
instead	O
,	O
the	O
vaccine	O
has	O
been	O
purchased	O
by	O
the	O
federal	O
government	O
for	O
inclusion	O
within	O
the	O
National	O
Stockpile	O
(	O
http	O
://	O
www	O
.	O
fda	O
.	O
gov	O
/	O
bbs	O
/	O
topics	O
/	O
NEWS	O
/	O
2007	O
/	O
NEW01611	O
.	O
htm	O
).	O

ABSTRACT	O
:	O
Before	O
the	O
emergence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2003	O
,	O
only	O
12	O
other	O
animal	B-SPEC
or	O
human	B-SPEC
coronaviruses	O
were	O
known	O
.	O

ABSTRACT	O
:	O
Macrophages	O
and	O
microglia	O
are	O
critical	O
in	O
the	O
acute	O
inflammatory	O
response	O
and	O
act	O
as	O
final	O
effector	O
cells	O
of	O
demyelination	O
during	O
chronic	O
infection	O
with	O
the	O
neutrotropic	O
MHV	B-SPEC
-	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
-	O
JHM	O
).	O

ABSTRACT	O
:	O
The	O
clinico	O
-	O
epidemiological	O
significance	O
of	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
detected	O
during	O
the	O
SARS	O
outbreak	O
is	O
unknown	O
.	O

To	O
characterize	O
a	O
nosocomial	O
hMPV	B-SPEC
outbreak	O
during	O
the	O
2003	O
SARS	O
epidemic	O
.	O

In	O
PRCV	O
/	O
DEX	O
pigs	B-SPEC
,	O
significantly	O
milder	O
pneumonia	O
,	O
fewer	O
PRCV	O
-	O
positive	O
cells	O
,	O
and	O
lower	O
viral	O
RNA	O
titers	O
were	O
present	O
in	O
lungs	O
early	O
at	O
PID	O
2	O
;	O
however	O
,	O
at	O
PID	O
4	O
,	O
10	O
,	O
and	O
21	O
,	O
severe	O
bronchointerstitial	O
pneumonia	O
,	O
significantly	O
higher	O
numbers	O
of	O
PRCV	O
-	O
positive	O
cells	O
,	O
and	O
higher	O
viral	O
RNA	O
titers	O
were	O
observed	O
compared	O
to	O
results	O
for	O
PRCV	O
/	O
PBS	O
pigs	B-SPEC
.	O

We	O
were	O
only	O
able	O
to	O
meta	B-SPEC
-	O
analyse	O
case	O
-	O
control	O
data	O
.	O

We	O
hypothesized	O
that	O
a	O
tandem	O
repeat	O
polymorphism	O
(	O
AC	O
)	O
n	O
in	O
the	O
CXCL2	O
gene	O
,	O
previously	O
associated	O
with	O
susceptibility	O
to	O
severe	O
sepsis	B-SPEC
,	O
contributes	O
to	O
morbidity	O
and	O
mortality	O
in	O
severe	O
sepsis	B-SPEC
.	O

Our	O
data	O
suggest	O
that	O
a	O
tandem	O
repeat	O
polymorphism	O
(	O
AC	O
)	O
n	O
at	O
position	O
-	O
665	O
in	O
the	O
CXCL2	O
gene	O
may	O
be	O
an	O
independent	O
predictor	O
of	O
mortality	O
for	O
severe	O
sepsis	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
identification	O
in	O
2003	O
of	O
a	O
coronavirus	B-SPEC
as	O
the	O
aetiological	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
intensified	O
efforts	O
to	O
understand	O
the	O
biology	O
of	O
coronaviruses	O
in	O
general	O
and	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
particular	O
.	O

This	O
report	O
presents	O
an	O
overview	O
of	O
the	O
current	O
knowledge	O
of	O
the	O
four	O
human	B-SPEC
coronavirus	I-SPEC
that	O
are	O
now	O
circulating	O
in	O
the	O
human	B-SPEC
population	O
.	O

On	O
evidence	O
-	O
based	O
medicine	O
,	O
We	O
undertook	O
some	O
large	O
-	O
sample	O
randomized	O
clinical	O
trials	O
in	O
immunity	O
regulation	O
,	O
anticoagulant	O
therapy	O
,	O
promoting	O
motility	O
of	O
intestinal	O
tract	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
mechanical	O
ventilation	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

First	O
,	O
modulation	O
of	O
immunity	O
benefitted	O
MODS	O
/	O
severe	O
sepsis	B-SPEC
;	O
second	O
,	O
early	O
anticoagulant	O
therapy	O
was	O
essential	O
to	O
MODS	O
/	O
severe	O
sepsis	B-SPEC
,	O
because	O
disseminated	O
intravascular	O
coagulopathy	O
occurred	O
in	O
44	O
.	O
1	O
%	O
of	O
MODS	O
;	O
third	O
,	O
Chinese	O
herb	O
medicines	O
could	O
promote	O
and	O
protect	O
gastrointestinal	O
function	O
in	O
MODS	O
/	O
severe	O
sepsis	B-SPEC
;	O
fourth	O
,	O
institution	O
of	O
mechanical	O
ventilation	O
with	O
low	O
tidal	O
volume	O
(	O
VT	O
)	O
was	O
effective	O
and	O
safe	O
in	O
ARDS	O
.	O

ABSTRACT	O
:	O
Tickborne	O
relapsing	O
fever	O
(	O
TBRF	O
)	O
is	O
a	O
bacterial	O
illness	O
caused	O
by	O
certain	O
species	B-SPEC
of	O
Borrelia	B-SPEC
and	O
transmitted	O
through	O
brief	O
and	O
painless	O
bites	O
from	O
Ornithodoros	B-SPEC
ticks	B-SPEC
.	O

Specific	O
-	O
pathogen	O
-	O
free	O
Single	O
Comb	O
White	O
Leghorn	O
cockerels	O
were	O
divided	O
into	O
three	O
treatment	O
groups	O
:	O
no	O
vaccination	O
(	O
NONVAC	O
),	O
vaccination	O
with	O
killed	O
AIBV	O
virus	B-SPEC
(	O
KVAC	O
)	O
or	O
vaccination	O
with	O
live	O
attenuated	O
AIBV	O
virus	B-SPEC
(	O
LVAC	O
).	O

Infected	O
NIH	O
3T3	O
cells	O
could	O
be	O
cultured	O
for	O
up	O
to	O
4	O
weeks	O
without	O
apparent	O
CPE	O
and	O
yet	O
produce	O
virus	B-SPEC
at	O
10	O
(	O
7	O
)	O
to	O
10	O
(	O
8	O
)	O
PFU	O
/	O
ml	O
.	O

Possible	O
activation	O
of	O
mitochondrial	O
apoptotic	O
pathway	O
in	O
S2	O
expressing	O
cells	O
was	O
suggested	O
,	O
as	O
evidenced	O
by	O
the	O
up	O
-	O
regulation	O
of	O
cytochrome	O
c	O
and	O
down	O
-	O
regulation	O
of	O
the	O
Bcl	O
-	O
2	O
family	B-SPEC
anti	O
-	O
apoptotic	O
members	O
.	O

Salmonella	B-SPEC
sp	O
.	O
was	O
isolated	O
from	O
both	O
diarrheic	O
and	O
nondiarrheic	O
calves	O
,	O
but	O
large	O
numbers	O
of	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
were	O
found	O
more	O
commonly	O
in	O
diarrheic	O
calves	O
than	O
in	O
nondiarrheic	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
contribution	O
of	O
DRAK2	O
[	O
death	O
-	O
associated	O
protein	O
kinase	O
(	O
DAPK	O
)-	O
related	O
apoptosis	O
-	O
inducing	O
kinase	O
2	O
]	O
to	O
anti	O
-	O
viral	O
memory	O
T	O
cell	O
responses	O
following	O
infection	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
was	O
examined	O
.	O

Memory	O
T	O
cells	O
derived	O
from	O
MHV	B-SPEC
-	O
immunized	O
Drak2	O
(-/-)	O
mice	B-SPEC
exhibited	O
amplified	O
proliferation	O
and	O
IFN	O
-	O
gamma	O
secretion	O
following	O
stimulation	O
with	O
viral	O
epitopes	O
.	O

In	O
alveolar	O
epithelial	O
cells	O
exposed	O
to	O
severe	O
hypoxia	O
,	O
we	O
have	O
reported	O
that	O
increased	O
production	O
of	O
mitochondrial	O
reactive	O
oxygen	O
species	B-SPEC
leads	O
to	O
Na	O
,	O
K	O
-	O
ATPase	O
endocytosis	O
and	O
degradation	O
.	O

We	O
also	O
evaluated	O
the	O
responses	O
of	O
wild	O
-	O
type	O
and	O
transgenic	B-SPEC
mice	I-SPEC
to	O
SARS	O
-	O
CoV	O
inoculation	O
.	O

These	O
mice	B-SPEC
will	O
be	O
valuable	O
for	O
testing	O
potential	O
vaccine	O
and	O
antiviral	O
drug	O
therapies	O
and	O
for	O
furthering	O
our	O
understanding	O
of	O
SARS	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
For	O
many	O
centuries	O
,	O
man	B-SPEC
is	O
fascinated	O
by	O
bats	B-SPEC
,	O
the	O
only	O
flying	O
mammals	B-SPEC
.	O

TITLE	O
:	O
[	O
Preparation	O
and	O
characterization	O
of	O
the	O
epitopes	O
of	O
SARS	O
coronavirus	B-SPEC
spike	O
protein	O
].	O

Dot	O
blot	O
analysis	O
showed	O
that	O
SARS	O
-	O
CoV	O
spike	O
protein	O
,	O
which	O
was	O
expressed	O
and	O
purified	O
from	O
mammal	B-SPEC
cells	O
,	O
can	O
be	O
detected	O
by	O
anti	O
-	O
Z	O
sera	O
from	O
rabbit	B-SPEC
.	O

The	O
predicted	O
epitopes	O
of	O
Z	O
protein	O
can	O
induce	O
the	O
development	O
of	O
SARS	O
-	O
CoV	O
spike	O
protein	O
antibody	O
in	O
rabbits	B-SPEC
,	O
which	O
provides	O
a	O
new	O
protein	O
for	O
developing	O
vaccine	O
against	O
SARS	O
-	O
CoV	O
.	O
RESULTS	O
:	O
Z	O
gene	O
was	O
successfully	O
designed	O
and	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
BL21	O
(	O
DE3	O
).	O

Intestinal	O
contents	O
were	O
collected	O
from	O
turkeys	B-SPEC
prior	O
to	O
placement	O
,	O
with	O
each	O
flock	O
resampled	O
at	O
2	O
,	O
4	O
,	O
6	O
,	O
8	O
,	O
10	O
,	O
and	O
12	O
wk	O
of	O
age	O
.	O

All	O
of	O
the	O
commercial	O
flocks	O
were	O
positive	O
for	O
rotavirus	B-SPEC
and	O
astrovirus	O
from	O
2	O
until	O
6	O
wk	O
of	O
age	O
,	O
and	O
most	O
were	O
intermittently	O
positive	O
until	O
12	O
wk	O
of	O
age	O
,	O
when	O
the	O
birds	B-SPEC
were	O
processed	O
.	O

Turkeys	B-SPEC
placed	O
on	O
research	O
facilities	O
that	O
had	O
been	O
empty	O
for	O
months	O
and	O
thoroughly	O
cleaned	O
had	O
higher	O
body	O
weights	O
and	O
lower	O
feed	O
conversion	O
rates	O
at	O
5	O
wk	O
of	O
age	O
when	O
compared	O
to	O
turkeys	B-SPEC
placed	O
on	O
commercial	O
farms	O
.	O

This	O
report	O
demonstrates	O
that	O
astroviruses	O
and	O
rotaviruses	B-SPEC
may	O
be	O
present	O
within	O
a	O
turkey	B-SPEC
flock	O
through	O
the	O
life	O
of	O
the	O
flock	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
disease	O
progression	O
in	O
vaccinated	O
chickens	B-SPEC
after	O
challenge	O
was	O
evaluated	O
in	O
a	O
single	O
commercial	O
line	O
of	O
layer	O
chickens	B-SPEC
presenting	O
two	O
different	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
B	O
complex	O
genotypes	O
.	O

The	O
levels	O
of	O
IBV	B-SPEC
-	O
specific	O
IgA	O
in	O
tears	O
of	O
vaccinated	O
and	O
challenged	O
chickens	B-SPEC
did	O
not	O
differ	O
significantly	O
between	O
MHC	O
genotypes	O
.	O

ABSTRACT	O
:	O
Twelve	O
Korean	O
infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
were	O
isolated	O
in	O
the	O
field	O
from	O
chickens	B-SPEC
suspected	O
of	O
being	O
carriers	O
of	O
infectious	O
bronchitis	O
between	O
2001	O
and	O
2003	O
.	O

For	O
a	O
comparison	O
with	O
the	O
published	O
sequences	O
for	O
non	O
-	O
Korean	O
IBV	B-SPEC
strains	O
,	O
amplified	O
PCR	O
products	O
from	O
the	O
twelve	O
isolates	O
were	O
cloned	O
and	O
sequenced	O
.	O

Phylogenetic	O
tree	O
analysis	O
revealed	O
that	O
some	O
of	O
the	O
IBV	B-SPEC
isolates	O
appear	O
to	O
belong	O
to	O
a	O
new	O
group	O
,	O
different	O
from	O
the	O
non	O
-	O
Korean	O
IBV	B-SPEC
strains	O
or	O
from	O
previously	O
isolated	O
Korean	O
IBV	B-SPEC
strains	O
.	O

Bands	O
were	O
characterized	O
by	O
matrix	O
-	O
assisted	O
laser	B-SPEC
desorption	O
/	O
ionization	O
-	O
time	O
of	O
flight	O
(	O
MALDI	O
-	O
TOF	O
).	O

ABSTRACT	O
:	O
To	O
warrant	O
potential	O
clinical	O
testing	O
,	O
the	O
equine	B-SPEC
anti	O
-	O
SARS	O
-	O
CoV	O
F	O
(	O
ab	O
')(	O
2	O
)	O
requires	O
evaluation	O
in	O
as	O
many	O
animal	B-SPEC
models	O
as	O
possible	O
and	O
a	O
safety	O
test	O
in	O
a	O
primate	B-SPEC
model	O
.	O

In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
pharmacokinetics	O
,	O
tolerance	O
and	O
immunity	O
of	O
this	O
kind	O
of	O
antibody	O
in	O
macaques	B-SPEC
and	O
rats	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
characteristics	O
of	O
patients	O
with	O
a	O
suspected	O
SARS	O
hospitalized	O
in	O
a	O
Paris	B-SPEC
hospital	O
were	O
studied	O
to	O
analyze	O
the	O
hypothetic	O
differences	O
between	O
epidemiologic	O
and	O
clinical	O
teams	O
in	O
the	O
management	O
of	O
an	O
epidemic	O
emerging	O
disease	O
,	O
and	O
to	O
gather	O
experience	O
for	O
the	O
management	O
of	O
the	O
next	O
outbreak	O
.	O

ABSTRACT	O
:	O
The	O
MHV	B-SPEC
-	O
JHM	O
strain	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
is	O
much	O
more	O
neurovirulent	O
than	O
the	O
MHV	B-SPEC
-	O
A59	O
strain	O
,	O
although	O
both	O
strains	O
use	O
murine	B-SPEC
CEACAM1a	O
(	O
mCEACAM1a	O
)	O
as	O
the	O
receptor	O
to	O
infect	O
murine	B-SPEC
cells	O
.	O

In	O
vitro	O
,	O
MHV	B-SPEC
-	O
JHM	O
,	O
but	O
not	O
MHV	B-SPEC
-	O
A59	O
,	O
can	O
spread	O
from	O
infected	O
murine	B-SPEC
cells	O
to	O
cells	O
that	O
lack	O
mCEACAM1a	O
,	O
a	O
phenomenon	O
called	O
receptor	O
-	O
independent	O
spread	O
.	O

inoculation	O
with	O
10	O
(	O
6	O
)	O
PFU	O
of	O
recombinant	O
wild	O
-	O
type	O
MHV	B-SPEC
-	O
A59	O
(	O
RA59	O
)	O
virus	B-SPEC
,	O
these	O
mice	B-SPEC
were	O
killed	O
by	O
recombinant	O
MHV	B-SPEC
-	O
JHM	O
(	O
RJHM	O
)	O
and	O
a	O
chimeric	O
virus	B-SPEC
containing	O
the	O
spike	O
of	O
MHV	B-SPEC
-	O
JHM	O
in	O
the	O
MHV	B-SPEC
-	O
A59	O
genome	O
(	O
SJHM	O
/	O
RA59	O
).	O

RJHM	O
can	O
initiate	O
infection	O
in	O
the	O
brains	O
of	O
Ceacam1a	O
(-/-)	O
mice	B-SPEC
,	O
but	O
expression	O
of	O
mCEACAM1a	O
increases	O
susceptibility	O
to	O
infection	O
.	O

In	O
this	O
study	O
we	O
demonstrate	O
that	O
endogenous	O
ferret	B-SPEC
CXCL10	O
exhibits	O
similar	O
mRNA	O
expression	O
patterns	O
in	O
the	O
lungs	O
of	O
deceased	O
SARS	O
patients	O
and	O
ferrets	B-SPEC
experimentally	O
infected	O
with	O
SARS	O
coronavirus	B-SPEC
.	O

Concerns	O
about	O
SARS	O
adversely	O
affected	O
the	O
willingness	O
of	O
respondents	O
to	O
perform	O
SCPR	O
or	O
CCPR	O
on	O
strangers	O
and	O
to	O
perform	O
SCPR	O
on	O
family	B-SPEC
members	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
protein	O
7a	O
binds	O
directly	O
and	O
specifically	O
to	O
human	B-SPEC
lymphocyte	O
function	O
-	O
associated	O
antigen	O
1	O
(	O
LFA	O
-	O
1	O
)	O
on	O
the	O
cell	O
surface	O
of	O
Jurkat	O
cells	O
.	O

In	O
particular	O
,	O
our	O
data	O
suggest	O
LFA	O
-	O
1	O
to	O
be	O
an	O
attachment	O
factor	O
or	O
the	O
receptor	O
for	O
SARS	O
-	O
CoV	O
on	O
human	B-SPEC
leukocytes	O
.	O

Our	O
results	O
show	O
that	O
the	O
IBV	B-SPEC
pseudoknot	O
requires	O
a	O
higher	O
force	O
than	O
its	O
corresponding	O
hairpins	O
to	O
unfold	O
.	O

TITLE	O
:	O
Coinfection	O
of	O
pigs	B-SPEC
with	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
and	O
Bordetella	B-SPEC
bronchiseptica	I-SPEC
.	O

Bordetella	B-SPEC
bronchiseptica	I-SPEC
and	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
)	O
are	O
respiratory	O
pathogens	O
of	O
pigs	B-SPEC
whose	O
relatives	O
,	O
B	B-SPEC
.	I-SPEC
pertussis	I-SPEC
and	O
the	O
SARS	O
virus	B-SPEC
,	O
cause	O
respiratory	O
disease	O
in	O
humans	B-SPEC
.	O

In	O
an	O
initial	O
experiment	O
,	O
the	O
effect	O
of	O
coinfection	O
of	O
PRCV	O
and	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
was	O
examined	O
in	O
thirty	O
,	O
4	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
(	O
10	O
pigs	B-SPEC
/	O
group	O
)	O
that	O
were	O
infected	O
with	O
either	O
PRCV	O
or	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
,	O
or	O
both	O
PRCV	O
and	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
.	O

Thus	O
,	O
there	O
appears	O
to	O
be	O
a	O
synergistic	O
effect	O
between	O
PRCV	O
and	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
with	O
regards	O
to	O
proinflammatory	O
cytokine	O
transcription	O
that	O
may	O
partially	O
explain	O
the	O
increased	O
severity	O
of	O
pneumonia	O
in	O
coinfected	O
pigs	B-SPEC
.	O

Type	O
II	O
cell	O
cultures	O
supported	O
SARS	O
-	O
CoV	O
replication	O
as	O
evidenced	O
by	O
RT	O
-	O
PCR	O
detection	O
of	O
viral	O
subgenomic	O
RNA	O
and	O
an	O
increase	O
in	O
virus	B-SPEC
titer	O
.	O

Virus	B-SPEC
titers	O
were	O
maximal	O
by	O
24	O
h	O
and	O
peaked	O
at	O
approximately	O
10	O
(	O
5	O
)	O
pfu	O
/	O
mL	O
.	O
Two	O
cell	O
types	O
within	O
the	O
cultures	O
were	O
infected	O
.	O

Nuclear	O
inclusion	O
protein	O
a	O
(	O
NIa	B-SPEC
)	O
proteases	O
obtained	O
from	O
the	O
family	B-SPEC
Potyviridae	B-SPEC
have	O
become	O
promising	O
due	O
to	O
their	O
high	O
activities	O
and	O
stringencies	O
of	O
sequences	O
recognition	O
.	O

Recombinant	O
PPV	B-SPEC
NIa	B-SPEC
protease	O
expressed	O
and	O
purified	O
from	O
Escherichia	B-SPEC
coli	I-SPEC
demonstrated	O
efficient	O
and	O
specific	O
processing	O
of	O
recombinant	O
GFP	O
and	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
,	O
with	O
site	O
F	O
(	O
N	O
V	O
V	O
V	O
H	O
Q	O
black	O
triangle	O
down	O
A	O
)	O
for	O
PPV	B-SPEC
NIa	B-SPEC
protease	O
artificially	O
inserted	O
between	O
the	O
fusion	O
tags	O
and	O
the	O
target	O
proteins	O
.	O

These	O
included	O
the	O
emergence	O
of	O
effective	O
'	O
champions	O
'	O
for	O
such	O
policies	O
,	O
an	O
ethos	O
of	O
pragmatism	O
and	O
receptivity	O
to	O
evidence	O
,	O
growing	O
collaboration	O
across	O
public	O
health	O
,	O
police	O
and	O
other	O
sectors	O
,	O
the	O
influence	O
of	O
contingent	O
events	O
such	O
as	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
and	O
pressure	O
from	O
donors	O
and	O
international	O
organizations	O
to	O
adopt	O
best	O
practice	O
in	O
HIV	B-SPEC
prevention	O
.	O

RESULTS	O
:	O
In	O
order	B-SPEC
to	O
assess	O
the	O
predictive	O
power	O
of	O
the	O
model	O
,	O
the	O
case	O
study	O
of	O
the	O
global	O
spread	O
of	O
SARS	O
is	O
considered	O
.	O

Leucopenia	O
(	O
acute	O
lymphopenia	O
)	O
occurred	O
in	O
all	O
infected	O
dogs	B-SPEC
,	O
with	O
values	O
dropping	O
below	O
60	O
%	O
of	O
the	O
initial	O
counts	O
.	O

This	O
subgroup	O
maps	O
to	O
two	O
previously	O
identified	O
domains	O
within	O
S2	O
,	O
a	O
putative	O
fusion	O
peptide	O
and	O
a	O
heptad	O
repeat	O
,	O
both	O
conserved	O
features	O
of	O
class	B-SPEC
I	O
fusion	O
proteins	O
.	O

ABSTRACT	O
:	O
The	O
upstream	O
end	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
genome	O
contains	O
two	O
essential	O
and	O
overlapping	O
RNA	O
secondary	O
structures	O
,	O
a	O
bulged	O
stem	O
-	O
loop	O
and	O
a	O
pseudoknot	O
,	O
which	O
have	O
been	O
proposed	O
to	O
be	O
elements	O
of	O
a	O
molecular	O
switch	O
that	O
is	O
critical	O
for	O
viral	O
RNA	O
synthesis	O
.	O

We	O
strongly	O
recommend	O
BC	O
as	O
a	O
useful	O
virucidal	O
agent	O
,	O
especially	O
in	O
the	O
manufacture	O
of	O
vaccines	O
for	O
these	O
viruses	B-SPEC
.	O

It	O
has	O
become	O
clear	O
that	O
certain	O
bacteria	B-SPEC
and	O
viruses	B-SPEC
subvert	O
this	O
process	O
to	O
their	O
advantage	O
.(	O
3	O
)	O

Recently	O
,	O
emerging	O
new	O
infections	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
or	O
bird	B-SPEC
flu	O
,	O
have	O
placed	O
significant	O
occupational	O
and	O
psychological	O
stress	O
on	O
epidemiologists	O
,	O
especially	O
in	O
South	O
-	O
East	O
Asia	O
,	O
resulting	O
in	O
a	O
high	O
intent	O
to	O
change	O
their	O
career	O
.	O

In	O
order	B-SPEC
to	O
find	O
drugs	O
that	O
treat	O
coronavirus	B-SPEC
infections	O
,	O
including	O
SARS	O
,	O
we	O
screened	O
traditional	O
medicinal	O
herbal	O
extracts	O
and	O
evaluated	O
their	O
antiviral	O
activities	O
on	O
coronavirus	B-SPEC
replication	O
.	O

The	O
extracts	O
selected	O
strongly	O
inhibited	O
MHV	B-SPEC
replication	O
and	O
could	O
be	O
potential	O
candidates	O
for	O
new	O
anti	O
-	O
coronavirus	B-SPEC
drugs	O
.	O

Case	O
onset	O
dates	O
from	O
the	O
2003	O
Shenzhen	O
SARS	O
epidemic	O
and	O
investigational	O
results	O
from	O
Taiwan	O
on	O
viremia	O
in	O
humans	B-SPEC
are	O
used	O
to	O
estimate	O
the	O
number	O
of	O
cases	O
that	O
were	O
viremic	O
throughout	O
the	O
epidemic	O
.	O

Although	O
IFN	O
-	O
gamma	O
and	O
the	O
chemokines	O
were	O
detected	O
in	O
CD	O
-	O
1	O
mice	B-SPEC
,	O
they	O
were	O
at	O
significantly	O
lower	O
levels	O
compared	O
to	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

After	O
intranasal	O
inoculation	O
,	O
the	O
virus	B-SPEC
was	O
isolated	O
from	O
respiratory	O
swabs	O
on	O
days	O
2	O
-	O
7	O
postinoculation	O
(	O
p	O
.	O
i	O
.)	O
and	O
virus	B-SPEC
genome	O
was	O
detected	O
in	O
intestinal	O
tissues	O
on	O
day	O
7	O
p	O
.	O
i	O
.	O

Virus	B-SPEC
was	O
not	O
detected	O
after	O
intragastric	O
inoculation	O
.	O

The	O
virus	B-SPEC
appears	O
to	O
spread	O
into	O
and	O
perhaps	O
via	O
the	O
intestinal	O
and	O
lymphatic	O
systems	O
.	O

Few	O
data	O
about	O
the	O
molecular	O
epidemiology	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
in	O
developing	O
countries	O
,	O
such	O
as	O
Jordan	O
,	O
are	O
available	O
.	O

HRSV	B-SPEC
was	O
detected	O
in	O
43	O
%	O
(	O
140	O
/	O
326	O
)	O
of	O
the	O
nasopharyngeal	O
aspirates	O
.	O

HRSV	B-SPEC
was	O
found	O
more	O
frequently	O
during	O
the	O
winter	O
(	O
January	O
/	O
February	O
),	O
being	O
less	O
frequent	O
or	O
negligible	O
by	O
spring	O
(	O
March	O
/	O
April	O
).	O

ABSTRACT	O
:	O
To	O
systematically	O
review	O
evidence	O
for	O
the	O
effectiveness	O
of	O
physical	O
interventions	O
to	O
interrupt	O
or	O
reduce	O
the	O
spread	O
of	O
respiratory	O
viruses	B-SPEC
.	O

Heterogeneity	O
precluded	O
meta	B-SPEC
-	O
analysis	O
of	O
most	O
data	O
except	O
that	O
from	O
six	O
case	O
-	O
control	O
studies	O
.	O

Meta	B-SPEC
-	O
analysis	O
of	O
six	O
case	O
-	O
control	O
studies	O
suggests	O
that	O
physical	O
measures	O
are	O
highly	O
effective	O
in	O
preventing	O
the	O
spread	O
of	O
SARS	O
:	O
handwashing	O
more	O
than	O
10	O
times	O
daily	O
(	O
odds	O
ratio	O
0	O
.	O
45	O
,	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
36	O
to	O
0	O
.	O
57	O
;	O
number	O
needed	O
to	O
treat	O
=	O
4	O
,	O
95	O
%	O
confidence	O
interval	O
3	O
.	O
65	O
to	O
5	O
.	O
52	O
);	O
wearing	O
masks	O
(	O
0	O
.	O
32	O
,	O
0	O
.	O
25	O
to	O
0	O
.	O
40	O
;	O
NNT	O
=	O
6	O
,	O
4	O
.	O
54	O
to	O
8	O
.	O
03	O
);	O
wearing	O
N95	O
masks	O
(	O
0	O
.	O
09	O
,	O
0	O
.	O
03	O
to	O
0	O
.	O
30	O
;	O
NNT	O
=	O
3	O
,	O
2	O
.	O
37	O
to	O
4	O
.	O
06	O
);	O
wearing	O
gloves	O
(	O
0	O
.	O
43	O
,	O
0	O
.	O
29	O
to	O
0	O
.	O
65	O
;	O
NNT	O
=	O
5	O
,	O
4	O
.	O
15	O
to	O
15	O
.	O
41	O
);	O
wearing	O
gowns	O
(	O
0	O
.	O
23	O
,	O
0	O
.	O
14	O
to	O
0	O
.	O
37	O
;	O
NNT	O
=	O
5	O
,	O
3	O
.	O
37	O
to	O
7	O
.	O
12	O
);	O
and	O
handwashing	O
,	O
masks	O
,	O
gloves	O
,	O
and	O
gowns	O
combined	O
(	O
0	O
.	O
09	O
,	O
0	O
.	O
02	O
to	O
0	O
.	O
35	O
;	O
NNT	O
=	O
3	O
,	O
2	O
.	O
66	O
to	O
4	O
.	O
97	O
).	O

A	O
significant	O
body	O
of	O
evidence	O
has	O
accumulated	O
in	O
the	O
area	O
of	O
SARS	O
-	O
CoV	O
and	O
host	O
interactions	O
that	O
indicate	O
that	O
the	O
accessory	O
proteins	O
might	O
play	O
an	O
important	O
role	O
in	O
modulating	O
the	O
host	O
response	O
to	O
virus	B-SPEC
infection	O
and	O
thereby	O
,	O
contribute	O
to	O
pathogenesis	O
.	O

The	O
gene	O
order	B-SPEC
was	O
either	O
5	O
'-	O
Pol	O
-	O
S	O
-	O
X1	O
-	O
E	O
-	O
M	O
-	O
N	O
-	O
UTR	O
-	O
3	O
'	O
or	O
5	O
'-	O
Pol	O
-	O
S	O
-	O
X1	O
-	O
E	O
-	O
M	O
-	O
5b	O
-	O
N	O
-	O
UTR	O
-	O
3	O
'.	O

This	O
study	O
has	O
demonstrated	O
for	O
the	O
first	O
time	O
the	O
existence	O
of	O
a	O
naturally	O
occurring	O
IBV	B-SPEC
genotype	O
devoid	O
of	O
some	O
of	O
the	O
genes	O
coding	O
for	O
nonstructural	O
proteins	O
and	O
has	O
also	O
indicated	O
that	O
all	O
of	O
the	O
accessory	O
genes	O
are	O
dispensable	O
for	O
the	O
growth	O
of	O
IBV	B-SPEC
and	O
that	O
such	O
viruses	B-SPEC
are	O
able	O
to	O
cause	O
clinical	O
disease	O
and	O
economic	O
loss	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
provide	O
current	O
information	O
on	O
the	O
epidemiology	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)-	O
infected	O
patients	O
admitted	O
to	O
ICU	O
during	O
the	O
era	O
of	O
highly	O
active	O
antiretroviral	O
therapy	O
(	O
HAART	O
)	O
and	O
to	O
review	O
issues	O
related	O
to	O
the	O
administration	O
of	O
antiretroviral	O
therapy	O
relevant	O
to	O
the	O
ICU	O
staff	O
.	O

A	O
neutral	O
red	O
uptake	O
assay	O
was	O
used	O
to	O
determine	O
50	O
%	O
virus	B-SPEC
-	O
inhibitory	O
concentrations	O
(	O
EC50	O
)	O
of	O
test	O
compounds	O
and	O
their	O
50	O
%	O
cytotoxicity	O
concentration	O
(	O
CC50	O
)	O
in	O
uninfected	O
Madin	O
-	O
Darby	O
canine	O
kidney	O
,	O
Vero	O
,	O
and	O
Vero	O
76	O
cells	O
;	O
selectivity	O
indices	O
(	O
ratio	O
of	O
CC50	O
to	O
EC50	O
)	O
were	O
derived	O
from	O
the	O
data	O
.	O

The	O
compound	O
4	O
-(	O
6	O
,	O
8	O
-	O
dibromo	O
-	O
4	O
-	O
oxo	O
-	O
2	O
-	O
phenyl	O
quinazolin	O
-	O
3	O
(	O
4H	O
)-	O
yl	O
)-	O
N	O
-(	O
4	O
,	O
5	O
-	O
dimethyloxazol	O
-	O
2yl	O
)	O
benzenesulphonamide	O
15	O
inhibited	O
the	O
replication	O
of	O
avian	B-SPEC
influenza	O
(	O
H5N1	O
)	O
virus	B-SPEC
(	O
EC50	O
=	O
8	O
.	O
4	O
microg	O
/	O
ml	O
,	O
CC50	O
>	O
100	O
microg	O
/	O
ml	O
,	O
SI	O
>	O
11	O
.	O
9	O
)	O
as	O
did	O
4	O
-(	O
6	O
-	O
bromo	O
-	O
4oxo	O
-	O
2phenylquinazolin	O
-	O
3	O
(	O
4H	O
)-	O
yl	O
)	O
benzene	O
]	O
sulphonamide	O
5	O
(	O
EC50	O
=	O
3	O
microg	O
/	O
ml	O
,	O
CC50	O
=	O
32	O
microg	O
/	O
ml	O
,	O
SI	O
=	O
11	O
).	O

Three	O
of	O
those	O
genes	O
,	O
called	O
X4	O
,	O
X5	O
and	O
ORF10	O
,	O
were	O
synthesized	O
and	O
introduced	O
into	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
to	O
induce	O
expression	O
.	O

Recommendations	O
are	O
grouped	O
into	O
those	O
directly	O
targeting	O
severe	O
sepsis	B-SPEC
,	O
recommendations	O
targeting	O
general	O
care	O
of	O
the	O
critically	O
ill	O
patient	O
that	O
are	O
considered	O
high	O
priority	O
in	O
severe	O
sepsis	B-SPEC
,	O
and	O
pediatric	O
considerations	O
.	O

ABSTRACT	O
:	O
Differential	O
gene	O
expression	O
profiles	O
in	O
Balb	O
/	O
cJ	O
mouse	B-SPEC
model	O
of	O
acute	O
hepatic	O
failure	O
infected	O
with	O
MHV	B-SPEC
-	O
3	O
virus	B-SPEC
intervened	O
by	O
anti	O
-	O
hepatic	O
failure	O
compound	O
(	O
AHFC	O
)	O
and	O
the	O
changes	O
of	O
cytokines	O
regulated	O
by	O
genes	O
were	O
investigated	O
.	O

It	O
was	O
suggested	O
that	O
AHFC	O
can	O
balance	O
the	O
immune	O
state	O
of	O
mouse	B-SPEC
model	O
of	O
acute	O
hepatic	O
failure	O
infected	O
with	O
MHV	B-SPEC
-	O
3	O
virus	B-SPEC
mainly	O
through	O
regulating	O
the	O
expression	O
of	O
immune	O
related	O
genes	O
,	O
decrease	O
the	O
immune	O
damage	O
and	O
inhibit	O
liver	O
cell	O
apoptosis	O
of	O
mouse	B-SPEC
acute	O
hepatic	O
failure	O
model	O
obviously	O
so	O
as	O
to	O
increase	O
the	O
survival	O
rate	O
of	O
mouse	B-SPEC
models	O
of	O
acute	O
hepatic	O
failure	O
.	O

We	O
hypothesized	O
that	O
the	O
I	O
/	O
D	O
polymorphism	O
also	O
confers	O
susceptibility	O
to	O
sepsis	B-SPEC
and	O
is	O
a	O
predisposing	O
factor	O
for	O
morbidity	O
and	O
mortality	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

TITLE	O
:	O
Human	B-SPEC
monoclonal	O
antibodies	O
by	O
immortalization	O
of	O
memory	O
B	O
cells	O
.	O

Gas	O
exchange	O
was	O
severely	O
impaired	O
and	O
a	O
chest	O
x	O
-	O
ray	B-SPEC
indicated	O
chemical	O
pneumonitis	O
.	O

TITLE	O
:	O
Tumor	O
necrosis	O
factor	O
alpha	O
is	O
not	O
a	O
pathogenic	O
determinant	O
in	O
acute	O
lethal	O
encephalitis	O
induced	O
by	O
a	O
highly	O
neurovirulent	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

The	O
results	O
showed	O
that	O
the	O
monkeys	B-SPEC
infected	O
with	O
SARS	O
-	O
CoV	O
developed	O
the	O
typical	O
SARS	O
according	O
to	O
clinical	O
,	O
virological	O
,	O
and	O
pathological	O
findings	O
.	O

Furthermore	O
,	O
a	O
reverse	O
genetic	O
system	O
was	O
established	O
for	O
this	O
FCoV	O
strain	O
by	O
cloning	O
a	O
full	O
-	O
length	O
cDNA	O
copy	O
into	O
vaccinia	B-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
Difference	O
in	O
receptor	O
usage	O
between	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
and	O
SARS	O
-	O
like	O
coronavirus	B-SPEC
of	O
bat	B-SPEC
origin	O
.	O

Second	O
,	O
the	O
SARS	O
-	O
CoV	O
S	O
failed	O
to	O
enter	O
cells	O
expressing	O
the	O
bat	B-SPEC
ACE2	O
.	O

ABSTRACT	O
:	O
Recent	O
outbreak	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
that	O
caused	O
almost	O
800	O
victims	O
requires	O
a	O
development	O
of	O
efficient	O
inhibitor	O
against	O
SARS	O
coronavirus	B-SPEC
(	O
SCV	B-SPEC
).	O

There	O
were	O
significantly	O
more	O
negative	O
faecal	O
samples	O
among	O
the	O
healthy	O
dogs	B-SPEC
(	O
82	O
.	O
0	O
per	O
cent	O
)	O
compared	O
with	O
55	O
.	O
8	O
per	O
cent	O
in	O
dogs	B-SPEC
with	O
acute	O
haemorrhagic	O
diarrhoea	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
protein	O
(	O
S	O
)	O
is	O
a	O
major	O
target	O
for	O
neutralizing	O
antibody	O
.	O

ABSTRACT	O
:	O
More	O
than	O
200	O
antigenically	O
distinct	O
viruses	B-SPEC
have	O
been	O
documented	O
as	O
causes	O
of	O
sporadic	O
or	O
epidemic	O
respiratory	O
infections	O
in	O
infants	O
and	O
children	O
.	O

Since	O
more	O
30	O
years	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
were	O
added	O
to	O
influenza	O
,	O
adenovirus	B-SPEC
and	O
measles	B-SPEC
virus	I-SPEC
as	O
causes	O
of	O
respiratory	O
tract	O
infections	O
.	O

This	O
provides	O
a	O
feasible	O
animal	B-SPEC
model	O
for	O
designing	O
wide	O
-	O
spectrum	O
inhibitors	O
against	O
CoV	O
-	O
associated	O
diseases	O
.	O

Therefore	O
,	O
this	O
viral	O
surface	O
protein	O
differs	O
from	O
the	O
S	O
proteins	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
which	O
are	O
retained	O
at	O
a	O
pre	O
-	O
Golgi	O
compartment	O
or	O
transported	O
to	O
the	O
cell	O
surface	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Replication	O
of	O
the	O
neurotropic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
JHM	O
(	O
JHMV	O
)	O
is	O
controlled	O
primarily	O
by	O
CD8	O
(+)	O
T	O
-	O
cell	O
effectors	O
utilizing	O
gamma	O
interferon	O
(	O
IFN	O
-	O
gamma	O
)	O
and	O
perforin	O
-	O
mediated	O
cytotoxicity	O
.	O

Both	O
wild	O
-	O
type	O
donor	O
CD90	O
.	O
1	O
and	O
recipient	O
CD90	O
.	O
2	O
CD4	O
(+)	O
T	O
cells	O
trafficked	O
into	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
parenchyma	O
and	O
localized	O
to	O
infected	O
white	O
matter	O
,	O
correlating	O
with	O
decreased	O
numbers	O
of	O
virus	B-SPEC
-	O
infected	O
oligodendrocytes	O
in	O
the	O
CNS	O
.	O

Although	O
the	O
antiviral	O
effector	O
mechanism	O
is	O
initially	O
independent	O
of	O
IFN	O
-	O
gamma	O
secretion	O
,	O
sustained	O
control	O
of	O
CNS	O
virus	B-SPEC
replication	O
by	O
CD4	O
(+)	O
T	O
cells	O
requires	O
IFN	O
-	O
gamma	O
.	O

TITLE	O
:	O
Mechanisms	O
of	O
zoonotic	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
host	O
range	O
expansion	O
in	O
human	B-SPEC
airway	O
epithelium	O
.	O

Zoonotic	O
SARS	O
-	O
CoV	O
likely	O
evolved	O
to	O
infect	O
humans	B-SPEC
by	O
a	O
series	O
of	O
transmission	O
events	O
between	O
humans	B-SPEC
and	O
animals	B-SPEC
for	O
sale	O
in	O
China	O
.	O

Further	O
,	O
these	O
viruses	B-SPEC
were	O
neutralized	O
by	O
a	O
human	B-SPEC
monoclonal	O
antibody	O
(	O
MAb	O
),	O
S230	O
.	O
15	O
,	O
but	O
the	O
parent	O
icSZ16	O
-	O
S	O
K479N	O
strain	O
was	O
eight	O
times	O
more	O
resistant	O
than	O
the	O
mutants	O
.	O

ABSTRACT	O
:	O
The	O
epidemic	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
2003	O
was	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	B-SPEC
),	O
designated	O
SARS	O
-	O
CoV	B-SPEC
.	O
The	O
RNA	O
genome	O
of	O
SARS	O
-	O
CoV	O
is	O
complexed	O
by	O
the	O
nucleocapsid	O
protein	O
(	O
N	O
)	O
to	O
form	O
a	O
helical	O
nucleocapsid	O
.	O

ABSTRACT	O
:	O
SARS	O
,	O
like	O
HIV	B-SPEC
,	O
placed	O
healthcare	O
workers	O
at	O
risk	O
and	O
raised	O
issues	O
about	O
the	O
duty	O
to	O
treat	O
.	O

The	O
second	O
issue	O
concerns	O
the	O
conflicts	O
that	O
arise	O
between	O
professional	O
duties	O
and	O
family	B-SPEC
duties	O
.	O

RESULTS	O
:	O
Key	O
recommendations	O
,	O
listed	O
by	O
category	O
,	O
include	O
early	O
goal	O
-	O
directed	O
resuscitation	O
of	O
the	O
septic	O
patient	O
during	O
the	O
first	O
6	O
hrs	O
after	O
recognition	O
(	O
1C	O
);	O
blood	O
cultures	O
before	O
antibiotic	O
therapy	O
(	O
1C	O
);	O
imaging	O
studies	O
performed	O
promptly	O
to	O
confirm	O
potential	O
source	O
of	O
infection	O
(	O
1C	O
);	O
administration	O
of	O
broad	O
-	O
spectrum	O
antibiotic	O
therapy	O
within	O
1	O
hr	O
of	O
diagnosis	O
of	O
septic	O
shock	O
(	O
1B	O
)	O
and	O
severe	O
sepsis	B-SPEC
without	O
septic	O
shock	O
(	O
1D	O
);	O
reassessment	O
of	O
antibiotic	O
therapy	O
with	O
microbiology	O
and	O
clinical	O
data	O
to	O
narrow	O
coverage	O
,	O
when	O
appropriate	O
(	O
1C	O
);	O
a	O
usual	O
7	O
-	O
10	O
days	O
of	O
antibiotic	O
therapy	O
guided	O
by	O
clinical	O
response	O
(	O
1D	O
);	O
source	O
control	O
with	O
attention	O
to	O
the	O
balance	O
of	O
risks	O
and	O
benefits	O
of	O
the	O
chosen	O
method	O
(	O
1C	O
);	O
administration	O
of	O
either	O
crystalloid	O
or	O
colloid	O
fluid	O
resuscitation	O
(	O
1B	O
);	O
fluid	O
challenge	O
to	O
restore	O
mean	O
circulating	O
filling	O
pressure	O
(	O
1C	O
);	O
reduction	O
in	O
rate	O
of	O
fluid	O
administration	O
with	O
rising	O
filing	O
pressures	O
and	O
no	O
improvement	O
in	O
tissue	O
perfusion	O
(	O
1D	O
);	O
vasopressor	O
preference	O
for	O
norepinephrine	O
or	O
dopamine	O
to	O
maintain	O
an	O
initial	O
target	O
of	O
mean	O
arterial	O
pressure	O
>	O
or	O
=	O
65	O
mm	O
Hg	O
(	O
1C	O
);	O
dobutamine	O
inotropic	O
therapy	O
when	O
cardiac	O
output	O
remains	O
low	O
despite	O
fluid	O
resuscitation	O
and	O
combined	O
inotropic	O
/	O
vasopressor	O
therapy	O
(	O
1C	O
);	O
stress	O
-	O
dose	O
steroid	O
therapy	O
given	O
only	O
in	O
septic	O
shock	O
after	O
blood	O
pressure	O
is	O
identified	O
to	O
be	O
poorly	O
responsive	O
to	O
fluid	O
and	O
vasopressor	O
therapy	O
(	O
2C	O
);	O
recombinant	O
activated	O
protein	O
C	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
clinical	O
assessment	O
of	O
high	O
risk	O
for	O
death	O
(	O
2B	O
except	O
2C	O
for	O
postoperative	O
patients	O
).	O

In	O
humans	B-SPEC
low	O
concentrations	O
of	O
MBL	O
in	O
serum	O
have	O
been	O
associated	O
with	O
susceptibility	O
to	O
several	O
viral	O
diseases	O
.	O

However	O
,	O
by	O
21	O
d	O
post	O
-	O
infection	O
,	O
74	O
%	O
of	O
CCR1	O
-/-	O
mice	B-SPEC
had	O
succumbed	O
to	O
death	O
compared	O
to	O
only	O
32	O
%	O
mortality	O
of	O
CCR1	O
+/+	O
mice	B-SPEC
,	O
indicating	O
that	O
chemokine	O
signaling	O
through	O
CCR1	O
significantly	O
(	O
p	O
<	O
or	O
=	O
0	O
.	O
04	O
)	O
enhanced	O
survival	O
following	O
IC	O
infection	O
with	O
MHV	B-SPEC
.	O

Therefore	O
,	O
differential	O
diagnosis	O
of	O
these	O
virus	B-SPEC
pathogens	O
is	O
frequently	O
required	O
for	O
single	O
clinical	O
samples	O
.	O

A	O
total	O
of	O
129	O
viruses	B-SPEC
were	O
identified	O
:	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
/	O
B	O
(	O
38	O
.	O
0	O
%/	O
7	O
.	O
8	O
%),	O
influenza	B-SPEC
virus	I-SPEC
A	O
/	O
B	O
(	O
10	O
.	O
1	O
%/	O
5	O
.	O
4	O
%),	O
parainfluenza	O
virus	B-SPEC
1	O
/	O
2	O
/	O
3	O
(	O
7	O
.	O
0	O
%/	O
3	O
.	O
1	O
%/	O
7	O
.	O
8	O
%),	O
coronavirus	B-SPEC
229E	O
or	O
NL63	O
(	O
6	O
.	O
2	O
%),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
4	O
.	O
7	O
%),	O
adenovirus	B-SPEC
(	O
4	O
.	O
7	O
%),	O
rhinovirus	B-SPEC
(	O
3	O
.	O
9	O
%),	O
and	O
coronavirus	B-SPEC
OC43	O
(	O
1	O
.	O
6	O
%).	O

TITLE	O
:	O
Severe	O
pulmonary	O
oedema	O
following	O
therapeutic	O
embolization	O
with	O
Onyx	B-SPEC
for	O
cerebral	O
arteriovenous	O
malformation	O
.	O

ABSTRACT	O
:	O
Three	O
(	O
KT2	O
,	O
133	O
,	O
and	O
DAE	O
)	O
transmissible	O
gastroenteritis	O
viruses	B-SPEC
(	O
TGEVs	O
)	O
were	O
isolated	O
from	O
pigs	B-SPEC
suspected	O
of	O
having	O
TGE	O
in	O
Korea	O
.	O

Differences	O
in	O
growth	O
rate	O
and	O
CPE	O
between	O
the	O
KT2	O
-	O
L	O
and	O
KT2	O
-	O
H	O
strains	O
were	O
discovered	O
in	O
swine	B-SPEC
testicular	O
cells	O
(	O
STCs	O
).	O

One	O
or	O
more	O
respiratory	O
viruses	B-SPEC
were	O
found	O
in	O
88	O
of	O
112	O
(	O
79	O
%)	O
cases	O
.	O

Together	O
rhinoviruses	B-SPEC
,	O
coronaviruses	O
,	O
HMPV	B-SPEC
,	O
and	O
HBoV	O
accounted	O
for	O
60	O
%	O
(	O
65	O
of	O
109	O
)	O
of	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Residues	O
on	O
the	O
dimer	O
interface	O
of	O
SARS	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
:	O
dimer	O
stability	O
characterization	O
and	O
enzyme	O
catalytic	O
activity	O
analysis	O
.	O

We	O
revealed	O
that	O
all	O
seven	O
single	O
mutated	O
proteases	O
still	O
have	O
the	O
dimeric	O
species	B-SPEC
but	O
the	O
monomer	O
-	O
dimer	O
equilibria	O
of	O
these	O
mutants	O
vary	O
from	O
each	O
other	O
,	O
implying	O
that	O
these	O
residues	O
might	O
contribute	O
differently	O
to	O
the	O
dimer	O
stability	O
.	O

TITLE	O
:	O
Respiratory	O
disease	O
associated	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
infection	O
in	O
cattle	B-SPEC
herds	O
in	O
Southern	O
Italy	O
.	O

Bovine	B-SPEC
coronavirus	B-SPEC
was	O
isolated	O
from	O
respiratory	O
specimens	O
from	O
all	O
outbreaks	O
except	O
outbreak	O
1	O
,	O
in	O
which	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
found	O
very	O
low	O
viral	O
titers	O
in	O
nasal	O
swabs	O
.	O

TITLE	O
:	O
Comparison	O
of	O
serologic	O
techniques	O
for	O
the	O
detection	O
of	O
antibodies	O
against	O
feline	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
Importance	O
of	O
conserved	O
cysteine	O
residues	O
in	O
the	O
coronavirus	B-SPEC
envelope	O
protein	O
.	O

In	O
contrast	O
,	O
replacement	O
of	O
all	O
three	O
cysteines	O
resulted	O
in	O
crippled	O
virus	B-SPEC
with	O
significantly	O
reduced	O
yields	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
infection	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
was	O
the	O
first	O
major	O
novel	O
infectious	O
disease	O
at	O
the	O
beginning	O
of	O
the	O
21st	O
century	O
,	O
with	O
China	O
especially	O
affected	O
.	O

In	O
this	O
study	O
,	O
we	O
aim	O
to	O
search	O
for	O
and	O
compare	O
immunodominant	O
regions	O
of	O
the	O
spike	O
(	O
S	O
)	O
and	O
nucleocapsid	O
(	O
N	O
)	O
proteins	O
which	O
are	O
recognized	O
by	O
sera	O
from	O
different	O
animal	B-SPEC
species	B-SPEC
,	O
including	O
mouse	B-SPEC
,	O
rat	B-SPEC
,	O
rabbit	B-SPEC
,	O
civet	B-SPEC
,	O
pig	B-SPEC
and	O
horse	B-SPEC
.	O

ABSTRACT	O
:	O
Most	O
coronaviruses	O
infecting	O
humans	B-SPEC
cause	O
mild	O
diseases	O
,	O
whereas	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
associated	O
coronavirus	B-SPEC
is	O
an	O
extremely	O
dangerous	O
pathogen	O
.	O

Here	O
,	O
we	O
report	O
the	O
development	O
of	O
a	O
serologic	O
assay	O
for	O
detection	O
of	O
antibodies	O
to	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
based	O
on	O
recombinant	O
nucleocapsid	O
(	O
N	O
)	O
proteins	O
of	O
all	O
known	O
pathogenic	O
strains	O
(	O
229E	O
,	O
NL63	O
,	O
OC43	O
,	O
HKU1	O
,	O
SARS	O
).	O

Feline	B-SPEC
infectious	O
peritonitis	O
was	O
confirmed	O
by	O
histology	O
or	O
immunostaining	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
antigen	O
in	O
effusion	O
or	O
tissue	O
macrophages	O
or	O
both	O
.	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
the	O
survival	O
time	O
of	O
cats	B-SPEC
treated	O
with	O
FeIFN	O
-	O
omega	O
versus	O
placebo	O
or	O
in	O
any	O
other	O
variable	O
evaluated	O
(	O
with	O
the	O
exception	O
of	O
the	O
lymphocyte	O
count	O
).	O

There	O
was	O
only	O
1	O
long	O
-	O
term	O
survivor	O
(>	O
3	O
months	O
),	O
and	O
the	O
cat	B-SPEC
was	O
in	O
the	O
FeIFN	O
-	O
omega	O
group	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
in	O
2002	O
,	O
and	O
detailed	O
phylogenetic	O
and	O
epidemiological	O
analyses	O
have	O
suggested	O
that	O
it	O
originated	O
from	O
animals	B-SPEC
.	O

TITLE	O
:	O
Expression	O
of	O
transgenes	O
from	O
newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
with	O
a	O
segmented	O
genome	O
.	O

We	O
were	O
able	O
to	O
detect	O
the	O
expression	O
of	O
both	O
reporter	O
genes	O
in	O
the	O
same	O
cell	O
infected	O
with	O
the	O
virus	B-SPEC
possessing	O
a	O
segmented	O
genome	O
,	O
and	O
viral	O
particles	O
can	O
contain	O
either	O
one	O
or	O
two	O
types	O
of	O
RNA	O
segments	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
glycoprotein	O
(	O
S	O
)	O
is	O
a	O
class	B-SPEC
I	O
viral	O
fusion	O
protein	O
that	O
binds	O
to	O
its	O
receptor	O
glycoprotein	O
,	O
human	B-SPEC
angiotensin	O
converting	O
enzyme	O
2	O
(	O
hACE2	O
),	O
and	O
mediates	O
virus	B-SPEC
entry	O
and	O
cell	O
-	O
cell	O
fusion	O
.	O

Because	O
the	O
JMD	O
is	O
so	O
highly	O
conserved	O
in	O
all	O
coronavirus	B-SPEC
S	O
proteins	O
,	O
it	O
is	O
a	O
potential	O
target	O
for	O
development	O
of	O
drugs	O
that	O
may	O
inhibit	O
virus	B-SPEC
entry	O
and	O
/	O
or	O
cell	O
-	O
cell	O
fusion	O
mediated	O
by	O
S	O
proteins	O
of	O
all	O
coronaviruses	O
.	O

TITLE	O
:	O
Impact	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
the	O
perceived	O
avian	B-SPEC
influenza	O
epidemic	O
on	O
the	O
increased	O
rate	O
of	O
influenza	O
vaccination	O
among	O
nurses	O
in	O
Hong	O
Kong	O
.	O

The	O
glycosylation	O
sequence	O
Asn	O
-	O
Phe	O
-	O
Thr	O
was	O
highly	O
conserved	O
in	O
the	O
M	O
proteins	O
of	O
six	O
PEDV	B-SPEC
isolates	O
.	O

The	O
six	O
PEDV	B-SPEC
isolates	O
showed	O
nucleotide	O
sequence	O
homology	O
between	O
98	O
.	O
8	O
and	O
100	O
%	O
and	O
deduced	O
amino	O
acid	O
sequence	O
homology	O
between	O
98	O
.	O
2	O
and	O
100	O
%	O
with	O
each	O
other	O
.	O

A	O
drastic	O
virus	B-SPEC
population	O
shift	O
was	O
demonstrated	O
along	O
time	O
and	O
the	O
novel	O
Italy	O
02	O
serotype	O
was	O
shown	O
to	O
have	O
displaced	O
the	O
previous	O
predominant	O
serotype	O
4	O
/	O
91	O
in	O
the	O
field	O
.	O

ABSTRACT	O
:	O
A	O
new	O
strain	O
of	O
coronavirus	B-SPEC
has	O
caused	O
an	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
from	O
2002	O
to	O
2003	O
resulting	O
in	O
774	O
deaths	O
worldwide	O
.	O

Further	O
analyses	O
using	O
specific	O
endocytic	O
pathway	O
inhibitors	O
and	O
dominant	O
-	O
negative	O
Eps15	O
as	O
well	O
as	O
caveolin	O
-	O
1	O
colocalization	O
study	O
suggested	O
that	O
virus	B-SPEC
entry	O
was	O
mediated	O
by	O
a	O
clathrin	O
-	O
and	O
caveolae	O
-	O
independent	O
mechanism	O
.	O

Others	O
were	O
6	O
cases	O
of	O
acute	O
membrane	O
laryngotracheobronchitis	O
,	O
3	O
cases	O
of	O
congenital	O
main	O
respiratory	O
tract	O
stenosis	B-SPEC
,	O
2	O
cases	O
of	O
congenital	O
laryngeal	O
webs	O
,	O
2	O
cases	O
of	O
vocal	O
cord	O
paralysis	O
,	O
3	O
cases	O
of	O
Pierre	O
Robin	O
syndrome	O
,	O
2	O
cases	O
of	O
Cri	O
-	O
du	O
-	O
chat	B-SPEC
syndrome	O
.	O

Positive	O
antibody	O
titers	O
were	O
found	O
only	O
against	O
CDV	B-SPEC
,	O
CPV	B-SPEC
,	O
and	O
T	B-SPEC
.	I-SPEC
gondii	I-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
was	O
a	O
worldwide	O
epidemic	O
caused	O
by	O
a	O
coronavirus	B-SPEC
that	O
has	O
a	O
cysteine	O
protease	O
(	O
3CLpro	O
)	O
essential	O
to	O
its	O
life	O
cycle	O
.	O

TITLE	O
:	O
Genetic	O
diversity	O
-	O
independent	O
neutralization	O
of	O
pandemic	O
viruses	B-SPEC
(	O
e	O
.	O
g	O
.	O
HIV	B-SPEC
),	O
potentially	O
pandemic	O
(	O
e	O
.	O
g	O
.	O
H5N1	O
strain	O
of	O
influenza	O
)	O
and	O
carcinogenic	O
(	O
e	O
.	O
g	O
.	O
HBV	B-SPEC
and	O
HCV	B-SPEC
)	O
viruses	B-SPEC
and	O
possible	O
agents	O
of	O
bioterrorism	O
(	O
variola	B-SPEC
)	O
by	O
enveloped	O
virus	B-SPEC
neutralizing	O
compounds	O
(	O
EVNCs	O
).	O

This	O
study	O
identified	O
profound	O
lymphopenia	O
and	O
young	O
age	O
as	O
independent	O
predictors	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
-	O
related	O
lower	O
respiratory	O
tract	O
infections	O
in	O
immunocompromised	O
children	O
.	O

As	O
measured	O
by	O
qRT	O
-	O
PCR	O
,	O
the	O
replication	O
of	O
NDV	B-SPEC
strains	O
B1	O
,	O
VG	O
/	O
GA	O
,	O
and	O
C2	O
did	O
not	O
interfere	O
with	O
the	O
growth	O
of	O
IBV	B-SPEC
Mass	O
and	O
Ark	O
strain	O
vaccines	O
in	O
the	O
combined	O
vaccine	O
treatment	O
groups	O
.	O

Samples	O
of	O
enteric	O
contents	O
were	O
taken	O
as	O
pools	O
of	O
five	O
birds	B-SPEC
from	O
each	O
of	O
18	O
poultry	O
farms	O
(	O
17	O
broiler	O
and	O
one	O
laying	O
farm	O
)	O
from	O
five	O
Brazilian	O
states	O
between	O
2002	O
and	O
2006	O
.	O

Birds	B-SPEC
were	O
presenting	O
watery	O
diarrhea	O
and	O
poor	O
general	O
condition	O
but	O
were	O
without	O
respiratory	O
,	O
renal	O
,	O
or	O
reproductive	O
signs	O
.	O

Conventional	O
antibacterial	O
and	O
anticoccidial	O
therapies	O
were	O
unsuccessful	O
and	O
,	O
furthermore	O
,	O
all	O
samples	O
proved	O
negative	O
for	O
rotavirus	B-SPEC
,	O
reovirus	B-SPEC
,	O
and	O
astrovirus	O
.	O

ABSTRACT	O
:	O
Asian	O
bats	B-SPEC
have	O
been	O
identified	O
as	O
potential	O
reservoir	O
hosts	O
of	O
coronaviruses	O
associated	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
Recent	O
studies	O
have	O
suggested	O
that	O
bats	B-SPEC
are	O
the	O
natural	O
reservoir	O
of	O
a	O
range	O
of	O
coronaviruses	O
(	O
CoVs	O
),	O
and	O
that	O
rhinolophid	O
bats	B-SPEC
harbor	O
viruses	B-SPEC
closely	O
related	O
to	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
CoV	O
,	O
which	O
caused	O
an	O
outbreak	O
of	O
respiratory	O
illness	O
in	O
humans	B-SPEC
during	O
2002	O
-	O
2003	O
.	O

Disruption	O
or	O
alteration	O
of	O
intracellular	O
signaling	O
pathways	O
by	O
viral	O
capsids	O
may	O
benefit	O
replication	O
of	O
the	O
virus	B-SPEC
by	O
affecting	O
innate	O
immunity	O
and	O
in	O
some	O
cases	O
,	O
may	O
underlie	O
disease	O
progression	O
.	O

ABSTRACT	O
:	O
Leptospiral	B-SPEC
involvement	O
of	O
the	O
cardiovascular	O
system	O
often	O
remains	O
an	O
under	O
-	O
estimated	O
critical	O
clinical	O
factor	O
.	O

We	O
assessed	O
the	O
role	O
of	O
lymphocytic	O
bronchiolitis	O
as	O
a	O
risk	O
factor	O
for	O
bronchiolitis	O
obliterans	O
syndrome	O
(	O
BOS	B-SPEC
)	O
and	O
death	O
after	O
lung	O
transplantation	O
.	O

Chest	O
X	O
-	O
ray	B-SPEC
showed	O
diffuse	O
bilateral	O
alveolar	O
infiltrates	O
similar	O
to	O
acute	O
pulmonary	O
edema	O
and	O
Kerley	O
'	O
s	O
striae	O
.	O

China	O
plays	O
a	O
huge	O
role	O
in	O
the	O
global	O
poultry	O
industry	O
,	O
with	O
a	O
poultry	O
population	O
of	O
14	O
billion	O
birds	B-SPEC
,	O
70	O
%-	O
80	O
%	O
of	O
which	O
are	O
reared	O
in	O
backyard	O
conditions	O
.	O

Each	O
child	O
was	O
observed	O
for	O
1	O
year	O
to	O
assess	O
the	O
occurrence	O
of	O
URI	O
,	O
acute	O
OM	O
(	O
AOM	O
),	O
and	O
OM	O
with	O
effusion	O
(	O
OME	O
)	O
complicating	O
URI	O
due	O
to	O
specific	O
viruses	B-SPEC
.	O

The	O
strategy	O
may	O
be	O
more	O
effective	O
if	O
the	O
priority	O
is	O
given	O
to	O
development	O
of	O
means	O
to	O
prevent	O
URI	O
associated	O
with	O
adenovirus	B-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
.	O

Among	O
uncircumcised	O
men	O
,	O
HPV	O
prevalence	O
in	O
the	O
foreskin	O
(	O
44	O
%)	O
was	O
comparable	O
to	O
that	O
in	O
the	O
glans	O
/	O
corona	B-SPEC
,	O
and	O
type	O
-	O
specific	O
positivity	O
was	O
observed	O
between	O
the	O
2	O
sites	O
(	O
kappa	O
=	O
0	O
.	O
52	O
).	O

We	O
treated	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
)-	O
infected	O
conventional	O
pigs	B-SPEC
with	O
the	O
corticosteroid	O
dexamethasone	O
(	O
DEX	O
)	O
as	O
a	O
model	O
for	O
SARS	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
prevalence	O
of	O
infectious	O
diseases	O
of	O
dogs	B-SPEC
and	O
cats	B-SPEC
that	O
impact	O
their	O
health	O
,	O
could	O
spill	O
over	O
to	O
native	O
wildlife	O
,	O
or	O
sentinel	O
diseases	O
of	O
concern	O
to	O
humans	B-SPEC
.	O

The	O
isolation	O
of	O
dogs	B-SPEC
and	O
cats	B-SPEC
in	O
the	O
Galapagos	O
protects	O
them	O
from	O
diseases	O
common	O
in	O
mainland	O
populations	O
.	O

Our	O
previous	O
study	O
has	O
demonstrated	O
that	O
vaccination	O
with	O
adeno	B-SPEC
-	I-SPEC
associated	I-SPEC
virus	I-SPEC
encoding	O
RBD	O
(	O
RBD	O
-	O
rAAV	O
)	O
induces	O
high	O
titer	O
of	O
neutralizing	O
antibodies	O
.	O

Since	O
T	O
cell	O
epitopes	O
are	O
highly	O
conserved	O
and	O
boosting	O
with	O
peptides	O
may	O
induce	O
the	O
production	O
of	O
effector	O
memory	O
T	O
cells	O
,	O
which	O
may	O
be	O
effective	O
against	O
viruses	B-SPEC
with	O
mutations	O
in	O
the	O
neutralizing	O
epitopes	O
,	O
our	O
results	O
suggest	O
that	O
the	O
vaccination	O
protocol	O
used	O
may	O
be	O
ideal	O
for	O
providing	O
effective	O
,	O
broad	O
and	O
long	O
-	O
term	O
protection	O
against	O
SARS	O
-	O
CoV	O
infection	O
.	O

The	O
possible	O
role	O
of	O
adults	O
in	O
the	O
epidemiology	O
of	O
coronavirus	B-SPEC
infection	O
in	O
mithuns	O
is	O
also	O
discussed	O
.	O

TITLE	O
:	O
Two	O
-	O
year	O
prospective	O
study	O
of	O
single	O
infections	O
and	O
co	O
-	O
infections	O
by	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
and	O
viruses	B-SPEC
identified	O
recently	O
in	O
infants	O
with	O
acute	O
respiratory	O
disease	O
.	O

Co	O
-	O
infection	O
rates	O
were	O
higher	O
for	O
hMPVs	O
,	O
hCoVs	O
,	O
and	O
hBoV	O
(	O
38	O
.	O
3	O
%,	O
46	O
.	O
4	O
%,	O
and	O
57	O
.	O
1	O
%,)	O
and	O
lower	O
for	O
RSV	B-SPEC
(	O
23	O
.	O
3	O
%).	O

ABSTRACT	O
:	O
Infection	O
of	O
mice	B-SPEC
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
strain	O
JHM	O
(	O
RJHM	O
)	O
induces	O
lethal	O
encephalitis	O
,	O
with	O
high	O
macrophage	O
and	O
neutrophil	O
,	O
but	O
minimal	O
T	O
-	O
cell	O
,	O
infiltration	O
into	O
the	O
brain	O
when	O
compared	O
to	O
the	O
neuroattenuated	O
strain	O
RA59	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
novel	O
infectious	O
disease	O
caused	O
by	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Translation	O
initiation	O
factor	O
eIF2alpha	O
is	O
highly	O
phosphorylated	O
during	O
MHV	B-SPEC
infection	O
,	O
and	O
translation	O
of	O
cellular	O
mRNAs	O
is	O
attenuated	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nsp1	O
suppresses	O
host	O
gene	O
expression	O
,	O
including	O
that	O
of	O
type	O
I	O
interferon	O
,	O
in	O
infected	O
cells	O
.	O

TITLE	O
:	O
Recent	O
advances	O
in	O
the	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
-	O
angiotensin	O
(	O
1	O
-	O
7	O
)-	O
Mas	O
axis	B-SPEC
.	O

In	O
this	O
review	O
,	O
we	O
will	O
focus	O
on	O
the	O
recent	O
findings	O
related	O
to	O
the	O
ACE2	O
-	O
Ang	O
(	O
1	O
-	O
7	O
)-	O
Mas	O
axis	B-SPEC
and	O
,	O
in	O
particular	O
,	O
on	O
its	O
putative	O
role	O
as	O
an	O
ACE	O
-	O
Ang	O
II	O
-	O
AT	O
(	O
1	O
)	O
receptor	O
counter	O
-	O
regulatory	O
axis	B-SPEC
within	O
the	O
RAS	O
.	O

TITLE	O
:	O
Amiodarone	O
alters	O
late	O
endosomes	O
and	O
inhibits	O
SARS	O
coronavirus	B-SPEC
infection	O
at	O
a	O
post	O
-	O
endosomal	O
level	O
.	O

TITLE	O
:	O
Peptide	O
mimicrying	O
between	O
SARS	O
coronavirus	B-SPEC
spike	O
protein	O
and	O
human	B-SPEC
proteins	O
reacts	O
with	O
SARS	O
patient	O
serum	O
.	O

Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
new	O
human	B-SPEC
respiratory	O
infectious	O
disease	O
caused	O
by	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
numbers	O
of	O
CD4	O
+	O
forkhead	O
box	O
P3	O
+	O
cells	O
increased	O
in	O
the	O
livers	O
from	O
low	O
pathogenic	O
CL12	O
-	O
MHV3	O
and	O
YAC	O
-	O
MHV3	O
-	O
infected	O
mice	B-SPEC
.	O

However	O
,	O
because	O
the	O
primers	O
used	O
in	O
this	O
study	O
were	O
designed	O
specifically	O
for	O
3	O
types	O
of	O
IBV	B-SPEC
,	O
other	O
types	O
might	O
have	O
been	O
present	O
but	O
not	O
detected	O
.	O

ABSTRACT	O
:	O
During	O
several	O
months	O
of	O
2002	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
caused	O
by	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spread	O
rapidly	O
from	O
China	O
throughout	O
the	O
world	O
causing	O
more	O
than	O
800	O
deaths	O
due	O
to	O
the	O
development	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Importantly	O
,	O
our	O
recent	O
studies	O
using	O
ACE2	O
knockout	O
mice	B-SPEC
have	O
demonstrated	O
that	O
ACE2	O
protects	O
murine	B-SPEC
lungs	O
from	O
ARDS	O
.	O

ABSTRACT	O
:	O
Although	O
multiple	O
viruses	B-SPEC
utilize	O
host	O
cell	O
cyclophilins	O
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	O
-	O
1	O
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
),	O
their	O
role	O
in	O
infection	O
is	O
poorly	O
understood	O
.	O

Infected	O
animals	B-SPEC
become	O
less	O
aggressive	O
and	O
develop	O
pyrexia	O
,	O
lethargy	O
and	O
diarrhoea	O
.	O

These	O
parallels	O
suggest	O
that	O
civets	B-SPEC
may	O
be	O
used	O
as	O
an	O
animal	B-SPEC
model	O
of	O
this	O
infection	O
to	O
gain	O
insight	O
into	O
the	O
pathogenesis	O
of	O
SARS	O
and	O
for	O
evaluation	O
of	O
candidate	O
vaccines	O
and	O
antiviral	O
drugs	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
the	O
monocyte	O
/	O
macrophage	O
lineage	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	B-SPEC
)	O
is	O
enhanced	O
in	O
the	O
presence	O
of	O
anti	O
-	O
FIPV	B-SPEC
antibodies	O
(	O
antibody	O
-	O
dependent	O
enhancement	O
or	O
ADE	O
).	O

TITLE	O
:	O
Identification	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
from	O
a	O
beluga	B-SPEC
whale	I-SPEC
by	O
using	O
a	O
panviral	O
microarray	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
viruses	B-SPEC
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
Nipah	B-SPEC
virus	I-SPEC
has	O
underscored	O
the	O
role	O
of	O
animal	B-SPEC
reservoirs	O
in	O
human	B-SPEC
disease	O
and	O
the	O
need	O
for	O
reservoir	O
surveillance	O
.	O

The	O
species	B-SPEC
of	O
snake	B-SPEC
was	O
identified	O
in	O
34	O
.	O
5	O
%	O
of	O
the	O
venomous	O
bites	O
.	O

Clinical	O
investigation	O
of	O
respiratory	O
viral	O
infections	O
in	O
HIV	B-SPEC
-	O
infected	O
patients	O
should	O
not	O
be	O
restricted	O
to	O
prototype	O
viruses	B-SPEC
and	O
also	O
need	O
to	O
target	O
all	O
the	O
different	O
family	B-SPEC
of	O
viruses	B-SPEC
as	O
it	O
seems	O
likely	O
that	O
these	O
viruses	B-SPEC
contribute	O
to	O
pulmonary	O
complications	O
and	O
morbidity	O
in	O
this	O
population	O
.	O

RESULTS	O
:	O
Between	O
November	O
2003	O
and	O
November	O
2006	O
,	O
59	O
bronchoalveolar	O
episodes	O
from	O
55	O
HIV	B-SPEC
-	O
infected	O
patients	O
were	O
analysed	O
.	O

pyramidalis	O
,	O
Pistacia	B-SPEC
palaestina	I-SPEC
,	O
Salvia	B-SPEC
officinalis	I-SPEC
,	O
and	O
Satureja	B-SPEC
thymbra	I-SPEC
was	O
determined	O
by	O
GC	O
/	O
MS	O
analysis	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
phagocytic	O
cells	O
in	O
enhanced	O
susceptibility	O
of	O
broilers	O
to	O
colibacillosis	O
after	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Colibacillosis	O
results	O
from	O
infection	O
with	O
avian	B-SPEC
pathogenic	O
Escherichia	B-SPEC
coli	I-SPEC
bacteria	B-SPEC
.	O

A	O
PBS	O
control	O
and	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
group	O
without	O
previous	O
virus	B-SPEC
inoculation	O
were	O
also	O
included	O
.	O

In	O
spleen	O
samples	O
of	O
IBV	B-SPEC
-	O
infected	O
animals	B-SPEC
reduced	O
expression	O
of	O
IL	O
-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
IL	O
-	O
10	O
,	O
IL	O
-	O
18	O
and	O
IFN	O
-	O
gamma	O
mRNA	O
was	O
found	O
1dpi	O
.	O

RESULTS	O
:	O
The	O
mRNA	O
of	O
human	B-SPEC
beta	O
actin	O
gene	O
could	O
be	O
amplified	O
efficiently	O
in	O
all	O
the	O
tissue	O
samples	O
.	O

TITLE	O
:	O
Role	O
of	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
and	O
human	B-SPEC
bocavirus	I-SPEC
in	O
infants	O
and	O
young	O
children	O
with	O
acute	O
wheezing	O
.	O

We	O
present	O
five	O
cases	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
infection	O
of	O
the	O
lower	O
respiratory	O
tract	O
in	O
immunocompromised	O
adults	O
suffering	O
from	O
severe	O
respiratory	O
insufficiency	O
leading	O
to	O
bilateral	O
pneumonia	O
and	O
fulfilling	O
the	O
criteria	O
for	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
may	O
be	O
an	O
underestimated	O
cause	O
of	O
severe	O
respiratory	O
failure	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
the	O
immunocompromised	O
adult	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
.	O

Cultures	O
of	O
pleural	O
fluids	O
were	O
positive	O
for	O
Fusobacterium	B-SPEC
necrophorum	I-SPEC
.	O

TITLE	O
:	O
Persistent	O
replication	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
human	B-SPEC
tubular	O
kidney	O
cells	O
selects	O
for	O
adaptive	O
mutations	O
in	O
the	O
membrane	O
protein	O
.	O

ABSTRACT	O
:	O
Containment	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SCV	B-SPEC
)	O
outbreak	O
was	O
accompanied	O
by	O
the	O
rapid	O
characterization	O
of	O
this	O
new	O
pathogen	O
'	O
s	O
genome	O
sequence	O
in	O
2003	O
,	O
encouraging	O
the	O
development	O
of	O
anti	O
-	O
SCV	B-SPEC
therapeutics	O
using	O
short	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
inhibitors	O
.	O

Zoonoses	O
must	O
be	O
dealt	O
with	O
at	O
the	O
interface	O
of	O
human	B-SPEC
and	O
animal	B-SPEC
health	O
by	O
all	O
available	O
information	O
.	O

Lessons	O
learned	O
from	O
the	O
emergence	O
of	O
and	O
response	O
to	O
agents	O
like	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
H5N1	O
avian	B-SPEC
influenza	O
,	O
SARS	O
and	O
bovine	B-SPEC
spongiform	O
encephalopathy	O
,	O
the	O
cause	O
of	O
new	O
-	O
variant	O
Creutzfeldt	O
-	O
Jakob	O
disease	O
in	O
humans	B-SPEC
,	O
must	O
be	O
used	O
to	O
create	O
better	O
plans	O
for	O
response	O
and	O
meet	O
the	O
challenge	O
for	O
public	O
health	O
and	O
biodefense	O
.	O

Fifty	O
adult	O
male	O
Sprague	B-SPEC
-	I-SPEC
Dawley	I-SPEC
rats	I-SPEC
weighing	O
250	O
-	O
300	O
g	O
.	O
We	O
employed	O
a	O
conscious	O
and	O
unrestrained	O
rat	B-SPEC
model	O
.	O

To	O
establish	O
specific	O
diagnostic	O
methods	O
,	O
we	O
generated	O
nine	O
clones	O
of	O
monoclonal	O
antibodies	O
to	O
nucleocapsid	O
protein	O
(	O
NP	O
)	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

Thus	O
,	O
this	O
study	O
shows	O
that	O
exacerbated	O
pneumonia	O
in	O
mice	B-SPEC
results	O
from	O
co	O
-	O
infection	O
with	O
SARS	O
-	O
CoV	O
and	O
a	O
respiratory	O
bacterium	B-SPEC
that	O
induces	O
elastase	O
production	O
in	O
the	O
lungs	O
,	O
suggesting	O
a	O
possible	O
role	O
for	O
elastase	O
in	O
the	O
exacerbation	O
of	O
pneumonia	O
.	O

ABSTRACT	O
:	O
The	O
European	O
Centre	O
for	O
Disease	O
Prevention	O
and	O
Control	O
was	O
founded	O
in	O
response	O
to	O
newly	O
emerging	O
infections	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
avian	B-SPEC
influenza	O
.	O

Overall	O
,	O
these	O
observations	O
suggest	O
that	O
isogenic	O
demyelinating	O
and	O
nondemyelinating	O
strains	O
of	O
MHV	B-SPEC
,	O
differing	O
in	O
the	O
spike	O
protein	O
expressed	O
,	O
infect	O
neurons	O
and	O
glial	O
cells	O
in	O
different	O
proportions	O
and	O
that	O
differential	O
tropism	O
to	O
a	O
particular	O
CNS	O
cell	O
type	O
may	O
play	O
a	O
significant	O
role	O
in	O
mediating	O
the	O
onset	O
and	O
mechanisms	O
of	O
demyelination	O
.	O

This	O
report	O
describes	O
an	O
Armored	O
RNA	O
(	O
aRNA	B-SPEC
)	O
internal	O
control	O
developed	O
originally	O
to	O
be	O
multiplexed	O
in	O
a	O
real	O
time	O
RT	O
-	O
PCR	O
assay	O
for	O
detecting	O
SARS	O
-	O
associated	O
Coronavirus	B-SPEC
,	O
but	O
can	O
be	O
incorporated	O
into	O
any	O
RT	O
-	O
PCR	O
assay	O
.	O

Because	O
it	O
is	O
difficult	O
to	O
obtain	O
regulatory	O
approval	O
of	O
vaccine	O
based	O
on	O
live	O
viruses	B-SPEC
,	O
we	O
constructed	O
a	O
replication	O
-	O
defective	O
single	O
-	O
cycle	O
VSV	O
vector	O
in	O
which	O
we	O
replaced	O
the	O
VSV	O
glycoprotein	O
(	O
G	O
)	O
gene	O
with	O
the	O
SARS	O
-	O
CoV	O
S	O
gene	O
.	O

The	O
overall	O
mortality	O
of	O
ARDS	O
was	O
61	O
.	O
0	O
%	O
(	O
64	O
/	O
105	O
),	O
9	O
times	O
as	O
high	O
as	O
that	O
of	O
the	O
7269	O
severe	O
cases	O
in	O
PICU	B-SPEC
.	O

46	O
-	O
68	O
and	O
78	O
-	O
100	O
)	O
are	O
predicted	O
to	O
be	O
the	O
primary	O
type	O
helices	B-SPEC
,	O
which	O
will	O
be	O
able	O
to	O
penetrate	O
into	O
membrane	O
by	O
themselves	O
,	O
while	O
the	O
first	O
trans	O
-	O
membrane	O
region	O
(	O
a	O
.	O
a	O
.	O

Young	O
age	O
and	O
ongoing	O
lactation	O
,	O
but	O
not	O
sex	O
or	O
existing	O
gravidity	O
,	O
correlated	O
significantly	O
with	O
coronavirus	B-SPEC
detection	O
.	O

Here	O
,	O
however	O
,	O
we	O
show	O
that	O
some	O
group	O
1	O
coronavirus	B-SPEC
spike	O
proteins	O
carry	O
a	O
furin	O
enzyme	O
recognition	O
motif	O
and	O
can	O
actually	O
be	O
cleaved	O
,	O
as	O
demonstrated	O
for	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
.	O

We	O
identified	O
a	O
similar	O
cell	O
culture	O
adaptation	O
for	O
the	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
.	O

TITLE	O
:	O
Proliferative	O
and	O
necrotising	O
pneumonia	O
and	O
severe	O
vascular	O
lesions	O
in	O
pigs	B-SPEC
naturally	O
infected	O
with	O
porcine	B-SPEC
circovirus	I-SPEC
type	I-SPEC
2	I-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
disease	O
induced	O
by	O
porcine	B-SPEC
circovirus	I-SPEC
type	I-SPEC
2	I-SPEC
(	O
PCV2	O
)	O
was	O
observed	O
in	O
three	O
pigs	B-SPEC
originating	O
from	O
a	O
large	O
herd	O
affected	O
by	O
respiratory	O
and	O
digestive	O
signs	O
as	O
well	O
as	O
wasting	O
.	O

TITLE	O
:	O
Interferon	O
-	O
gamma	O
in	O
the	O
serum	O
and	O
effusions	O
of	O
cats	B-SPEC
with	O
feline	B-SPEC
coronavirus	B-SPEC
infection	O
.	O

Moreover	O
,	O
the	O
concentration	O
of	O
IFN	O
-	O
gamma	O
was	O
significantly	O
higher	O
in	O
the	O
effusions	O
than	O
in	O
the	O
serum	O
of	O
cats	B-SPEC
with	O
FIP	O
,	O
probably	O
due	O
to	O
IFN	O
-	O
gamma	O
production	O
within	O
lesions	O
.	O

TITLE	O
:	O
[	O
Emerging	O
infectious	O
diseases	O
among	O
swine	B-SPEC
workers	O
].	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
viral	O
cause	O
of	O
laryngeal	O
croup	O
by	O
use	O
of	O
highly	O
sensitive	O
methods	O
,	O
and	O
including	O
recently	O
recognized	O
viruses	B-SPEC
in	O
the	O
analysis	O
.	O

Furthermore	O
,	O
residues	O
Y29	O
and	O
F173	O
of	O
FCoV	O
nsp16	O
,	O
which	O
may	O
be	O
the	O
functional	O
counterparts	O
of	O
aromatic	O
residues	O
involved	O
in	O
substrate	O
recognition	O
by	O
the	O
vaccinia	B-SPEC
virus	I-SPEC
MTase	O
VP39	O
,	O
were	O
found	O
to	O
be	O
essential	O
for	O
both	O
substrate	O
binding	O
and	O
2	O
'	O
O	O
-	O
MTase	O
activity	O
.	O

ABSTRACT	O
:	O
Virus	B-SPEC
-	O
specific	O
CD8	O
(+)	O
T	O
cells	O
are	O
critical	O
for	O
protection	O
against	O
neurotropic	O
coronaviruses	O
;	O
however	O
,	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
infection	O
with	O
the	O
recombinant	O
JHM	O
(	O
RJHM	O
)	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
elicits	O
a	O
weak	O
CD8	O
(+)	O
T	O
-	O
cell	O
response	O
in	O
the	O
brain	O
and	O
causes	O
lethal	O
encephalomyelitis	O
.	O

Lack	O
of	O
efficacy	O
of	O
promazine	O
on	O
SARS	O
-	O
CoV	O
replication	O
in	O
a	O
mouse	B-SPEC
model	O
.	O

Adding	O
a	O
propylamino	O
group	O
to	O
give	O
promazine	O
reduced	O
virus	B-SPEC
yields	O
(	O
VYR	O
assay	O
)	O
with	O
an	O
EC	O
(	O
90	O
)=	O
8	O
.	O
3	O
+/-	O
2	O
.	O
8	O
microM	O
,	O
but	O
without	O
selectivity	O
.	O

These	O
data	O
portended	O
the	O
poor	O
efficacy	O
of	O
promazine	O
in	O
a	O
SARS	O
-	O
CoV	O
mouse	B-SPEC
lung	O
replication	O
model	O
.	O

Thus	O
,	O
promazine	O
did	O
not	O
affect	O
SARS	O
-	O
CoV	O
replication	O
in	O
vitro	O
or	O
in	O
vivo	O
,	O
nor	O
were	O
any	O
other	O
phenothiazines	O
efficacious	O
in	O
reducing	O
virus	B-SPEC
replication	O
.	O

TITLE	O
:	O
Detection	O
of	O
antigenic	O
heterogeneity	O
in	O
feline	B-SPEC
coronavirus	B-SPEC
nucleocapsid	O
in	O
feline	B-SPEC
pyogranulomatous	O
meningoencephalitis	O
.	O

ABSTRACT	O
:	O
A	O
new	O
monoclonal	O
antibody	O
(	O
mAb	O
),	O
CCV2	O
-	O
2	O
,	O
was	O
compared	O
with	O
the	O
widely	O
used	O
FIPV3	O
-	O
70	O
mAb	O
,	O
both	O
directed	O
against	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
),	O
as	O
a	O
diagnostic	O
and	O
research	O
tool	O
.	O

In	O
all	O
regions	O
where	O
MAC	B-SPEC
387	O
-	O
positive	O
cells	O
were	O
present	O
,	O
positive	O
staining	O
with	O
the	O
CCV2	O
-	O
2	O
mAb	O
was	O
systematically	O
detected	O
,	O
except	O
at	O
some	O
levels	O
in	O
1	O
cat	B-SPEC
.	O

ABSTRACT	O
:	O
From	O
2002	O
to	O
2007	O
,	O
23	O
ferrets	B-SPEC
from	O
Europe	O
and	O
the	O
United	O
States	O
were	O
diagnosed	O
with	O
systemic	O
pyogranulomatous	O
inflammation	O
resembling	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

Frequent	O
hematologic	O
findings	O
were	O
mild	O
anemia	B-SPEC
,	O
thrombocytopenia	O
,	O
and	O
hypergammaglobulinemia	O
.	O

Electron	O
microscopic	O
examination	O
of	O
inflammatory	O
lesions	O
identified	O
particles	O
with	O
coronavirus	B-SPEC
morphology	O
in	O
the	O
cytoplasm	O
of	O
macrophages	O
.	O

Immunohistochemical	O
stain	O
showed	O
O	B-SPEC
.	I-SPEC
tsutsugamushi	I-SPEC
antigen	O
depositions	O
in	O
the	O
endothelial	O
cells	O
.	O

Utilization	O
of	O
the	O
lower	O
inflection	O
point	O
of	O
the	O
pressure	O
-	O
volume	O
curve	O
in	O
the	O
ventilation	O
strategies	O
considered	O
in	O
this	O
study	O
resulted	O
in	O
comparable	O
efficacy	O
with	O
regards	O
to	O
oxygenation	O
and	O
hemodynamics	O
,	O
a	O
high	O
PaCO2	O
level	O
and	O
a	O
lower	O
pH	O
.	O
In	O
addition	O
,	O
a	O
greater	O
number	O
of	O
normal	O
alveoli	O
were	O
found	O
after	O
protective	O
conventional	O
ventilation	O
in	O
an	O
animal	B-SPEC
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

RESULTS	O
:	O
Postmortem	O
examination	O
of	O
brain	O
revealed	O
a	O
tauopathy	O
,	O
with	O
deposition	O
of	O
abnormal	O
phosphorylated	O
tau	O
in	O
threads	O
and	O
in	O
coiled	O
-	O
shaped	O
as	O
well	O
as	O
globose	O
tangles	O
in	O
the	O
brainstem	O
,	O
subthalamic	O
nuclei	O
and	O
hippocampus	B-SPEC
.	O

Bottom	O
ashes	O
were	O
dominated	O
by	O
low	O
molecular	O
weight	O
PAHs	O
(	O
LM	O
-	O
PAH	O
;	O
containing	O
two	O
-	O
to	O
three	O
-	O
ringed	O
PAHs	O
)	O
and	O
medium	O
molecular	O
weight	O
PAHs	O
(	O
MM	O
-	O
PAH	O
;	O
containing	O
four	O
-	O
ringed	O
PAHs	O
),	O
while	O
fly	B-SPEC
ashes	O
were	O
abundant	O
in	O
MM	O
-	O
PAH	O
and	O
high	O
molecular	O
weight	O
PAHs	O
(	O
HM	O
-	O
PAH	O
,	O
containing	O
five	O
-	O
to	O
six	O
-	O
ringed	O
PAHs	O
).	O

In	O
this	O
study	O
,	O
three	O
fragments	O
[	O
N1	O
(	O
residues	O
:	O
1	O
-	O
422	O
);	O
N2	O
(	O
residues	O
:	O
1	O
-	O
109	O
);	O
N3	O
(	O
residues	O
:	O
110	O
-	O
422	O
)]	O
of	O
N	O
protein	O
of	O
SARS	O
-	O
CoV	O
were	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
analyzed	O
by	O
pooled	O
sera	O
of	O
convalescence	O
phase	O
of	O
SARS	O
patients	O
.	O

Each	O
of	O
the	O
three	O
peripheral	O
HR2	O
helices	B-SPEC
shows	O
prominent	O
contacts	O
with	O
the	O
hydrophobic	O
surface	O
of	O
the	O
central	O
HR1	O
coiled	O
-	O
coil	O
.	O

In	O
this	O
investigation	O
,	O
we	O
applied	O
recombinant	O
protein	O
and	O
synthetic	O
peptide	O
-	O
based	O
biophysical	O
assays	O
to	O
characterize	O
the	O
biological	O
activities	O
of	O
the	O
HR	O
helices	B-SPEC
.	O

In	O
a	O
parallel	O
experiment	O
,	O
we	O
employed	O
a	O
HIV	B-SPEC
-	O
luc	O
/	O
SARS	O
pseudotyped	O
virus	B-SPEC
entry	O
inhibition	O
assay	O
to	O
screen	O
for	O
potent	O
inhibitory	O
activities	O
on	O
HR	O
peptides	O
derived	O
from	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
HR	O
regions	O
and	O
a	O
series	O
of	O
other	O
small	O
-	O
molecule	O
drugs	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
was	O
designed	O
to	O
investigate	O
whether	O
administration	O
of	O
CoPPIX	O
,	O
an	O
HO	O
-	O
1	O
inducer	O
,	O
could	O
significantly	O
inhibit	O
TNF	O
-	O
alpha	O
and	O
Hmgb1	O
expression	O
and	O
thus	O
attenuate	O
the	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
induced	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
in	O
mice	B-SPEC
.	O

HFOV	O
was	O
used	O
as	O
a	O
rescue	O
after	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
for	O
4	O
.	O
4	O
+/-	O

TITLE	O
:	O
Evaluation	O
of	O
cotton	B-SPEC
rats	I-SPEC
as	O
a	O
model	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

However	O
,	O
infected	O
animals	B-SPEC
were	O
capable	O
of	O
producing	O
neutralizing	O
antibodies	O
against	O
SARS	O
-	O
CoV	O
,	O
suggesting	O
the	O
seroconversion	O
did	O
occur	O
.	O

Cortisol	O
levels	O
are	O
elevated	O
in	O
patients	O
with	O
RSV	B-SPEC
and	O
Ebola	O
,	O
and	O
cortisol	O
was	O
higher	O
in	O
SARS	O
patients	O
with	O
lymphopenia	O
before	O
any	O
steroid	O
therapy	O
.	O

Proliferation	O
of	O
human	B-SPEC
peripheral	O
blood	O
lymphocytes	O
and	O
other	O
human	B-SPEC
cell	O
lines	O
was	O
significantly	O
inhibited	O
by	O
the	O
infection	O
of	O
recombinant	O
retrovirus	B-SPEC
expressing	O
SARS	O
-	O
CoV	O
N	O
protein	O
.	O

One	O
of	O
these	O
accessory	O
proteins	O
is	O
set	O
apart	O
by	O
its	O
function	O
in	O
the	O
context	O
of	O
a	O
related	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infection	O
.	O

Protein	O
6	O
with	O
C	O
-	O
terminal	O
deletion	O
mutations	O
no	O
longer	O
interfered	O
with	O
nuclear	O
import	O
processes	O
but	O
still	O
retained	O
much	O
of	O
the	O
capacity	O
to	O
augment	O
MHV	B-SPEC
infections	O
.	O

Our	O
findings	O
indicated	O
that	O
protein	O
6	O
-	O
mediated	O
nuclear	O
import	O
blocks	O
augmented	O
MHV	B-SPEC
infections	O
but	O
is	O
clearly	O
not	O
the	O
only	O
way	O
that	O
this	O
accessory	O
protein	O
operates	O
to	O
create	O
a	O
milieu	O
conducive	O
to	O
robust	O
virus	B-SPEC
growth	O
.	O

These	O
structures	O
,	O
combined	O
with	O
a	O
previously	O
determined	O
structure	O
of	O
human	B-SPEC
ACE2	O
complexed	O
with	O
the	O
RBD	O
from	O
a	O
human	B-SPEC
SARS	O
-	O
CoV	O
strain	O
,	O
have	O
revealed	O
a	O
structural	O
basis	O
for	O
understanding	O
the	O
major	O
species	B-SPEC
barriers	O
between	O
humans	B-SPEC
and	O
civets	B-SPEC
for	O
SARS	O
-	O
CoV	O
infections	O
.	O

Notably	O
,	O
injection	O
of	O
SARS	O
-	O
CoV	O
Spike	O
into	O
mice	B-SPEC
worsens	O
acute	O
lung	O
failure	O
in	O
vivo	O
,	O
which	O
can	O
be	O
attenuated	O
by	O
blocking	O
the	O
renin	O
-	O
angiotensin	O
pathway	O
,	O
suggesting	O
that	O
the	O
activation	O
of	O
the	O
pulmonary	O
RAS	O
influences	O
the	O
pathogenesis	O
of	O
ALI	O
/	O
ARDS	O
and	O
SARS	O
.	O

TITLE	O
:	O
SARS	O
-	O
coronavirus	B-SPEC
replication	O
/	O
transcription	O
complexes	O
are	O
membrane	O
-	O
protected	O
and	O
need	O
a	O
host	O
factor	O
for	O
activity	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
replication	O
and	O
transcription	O
are	O
mediated	O
by	O
a	O
replication	O
/	O
transcription	O
complex	O
(	O
RTC	O
)	O
of	O
which	O
virus	B-SPEC
-	O
encoded	O
,	O
non	O
-	O
structural	O
proteins	O
(	O
nsps	O
)	O
are	O
the	O
primary	O
constituents	O
.	O

Given	O
the	O
continuing	O
threat	O
of	O
current	O
and	O
future	O
airborne	O
viruses	B-SPEC
with	O
potential	O
for	O
epidemic	O
spread	O
and	O
devastating	O
outcomes	O
,	O
preparedness	O
strategies	O
are	O
certainly	O
needed	O
.	O

Five	O
coronaviruses	O
currently	O
infect	O
humans	B-SPEC
:	O
HCoVs	O
229E	O
and	O
OC43	O
,	O
identified	O
in	O
the	O
1960s	O
,	O
SARS	O
-	O
CoV	O
identified	O
in	O
March	O
2003	O
during	O
the	O
SARS	O
epidemic	O
,	O
and	O
the	O
HCoVs	O
NL63	O
and	O
HKU1	O
,	O
identified	O
in	O
2004	O
and	O
2005	O
respectively	O
.	O

Human	B-SPEC
coronaviruses	O
may	O
be	O
also	O
involved	O
in	O
enteric	O
and	O
neurologic	O
diseases	O
.	O

The	O
detection	O
of	O
these	O
viruses	B-SPEC
is	O
difficult	O
and	O
mainly	O
based	O
on	O
molecular	O
assays	O
(	O
RT	O
-	O
PCR	O
).	O

RESULTS	O
:	O
Forty	O
-	O
seven	O
(	O
26	O
.	O
4	O
%)	O
of	O
178	O
NPAs	O
were	O
positive	O
:	O
18	O
rhinovirus	B-SPEC
,	O
15	O
hMPV	B-SPEC
,	O
4	O
RSV	B-SPEC
A	O
,	O
3	O
coronavirus	B-SPEC
OC43	O
,	O
3	O
influenza	B-SPEC
virus	I-SPEC
A	O
,	O
2	O
adenovirus	B-SPEC
,	O
1	O
coronavirus	B-SPEC
NL63	O
,	O
and	O
1	O
RSV	B-SPEC
B	O
.	O
Based	O
on	O
maximum	O
identity	O
,	O
each	O
of	O
the	O
sequences	O
indicating	O
rhinovirus	B-SPEC
,	O
hMPV	B-SPEC
,	O
and	O
coronavirus	B-SPEC
OC43	O
matched	O
to	O
the	O
corresponding	O
viruses	B-SPEC
with	O
homology	O
of	O
94	O
-	O
98	O
%,	O
96	O
-	O
99	O
%,	O
and	O
98	O
-	O
100	O
%,	O
respectively	O
.	O

The	O
culprit	O
,	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
was	O
detected	O
in	O
patient	O
specimens	O
by	O
traditional	O
cell	O
culture	O
using	O
an	O
unusual	O
cell	O
line	O
for	O
respiratory	O
viruses	B-SPEC
,	O
Vero	O
E6	O
,	O
and	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
targeting	O
the	O
polymerase	O
1	O
B	O
region	O
of	O
the	O
genome	O
.	O

rSARS	O
-	O
CoV	O
-	O
DeltaE	O
-	O
immunized	O
hamsters	B-SPEC
remained	O
active	O
following	O
wild	O
-	O
type	O
virus	B-SPEC
challenge	O
,	O
while	O
mock	O
-	O
immunized	O
hamsters	B-SPEC
displayed	O
decreased	O
activity	O
.	O

Despite	O
being	O
attenuated	O
in	O
replication	O
in	O
the	O
respiratory	O
tract	O
,	O
rSARS	O
-	O
CoV	O
-	O
DeltaE	O
is	O
an	O
immunogenic	O
and	O
efficacious	O
vaccine	O
in	O
hamsters	B-SPEC
.	O

In	O
our	O
study	O
,	O
it	O
has	O
been	O
shown	O
that	O
the	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
a	O
high	O
binding	O
affinity	O
for	O
the	O
leader	O
sequence	O
of	O
SARS	O
-	O
CoV	O
genome	O
.	O

Although	O
SARS	O
is	O
etiologically	O
linked	O
to	O
a	O
new	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
functional	O
cell	O
receptor	O
has	O
been	O
identified	O
,	O
the	O
pathogenesis	O
of	O
the	O
virus	B-SPEC
infection	O
is	O
largely	O
unclear	O
.	O

To	O
understand	O
its	O
pathogenesis	O
,	O
we	O
developed	O
an	O
animal	B-SPEC
model	O
using	O
BALB	O
/	O
c	O
mice	B-SPEC
and	O
the	O
mouse	B-SPEC
-	O
passaged	O
Frankfurt	O
1	O
isolate	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

However	O
,	O
intraperitoneal	O
interferon	O
-	O
gamma	O
injection	O
protected	O
adult	O
mice	B-SPEC
from	O
the	O
lethal	O
respiratory	O
illness	O
.	O

TITLE	O
:	O
Complete	O
genomic	O
sequence	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
),	O
one	O
of	O
the	O
least	O
characterized	O
of	O
all	O
known	O
coronaviruses	O
,	O
was	O
isolated	O
from	O
an	O
outbreak	O
of	O
acute	O
enteritis	O
in	O
young	O
turkeys	B-SPEC
in	O
Ontario	O
,	O
Canada	O
,	O
and	O
the	O
full	O
-	O
length	O
genomic	O
sequence	O
was	O
determined	O
.	O

Viruses	B-SPEC
take	O
all	O
opportunities	O
in	O
our	O
changing	O
world	O
and	O
have	O
many	O
more	O
surprises	O
in	O
store	O
for	O
us	O
.	O

On	O
the	O
other	O
hand	O
,	O
oral	O
acute	O
toxicity	O
test	O
demonstrated	O
that	O
HC	O
was	O
non	O
-	O
toxic	O
to	O
laboratory	O
animals	B-SPEC
following	O
oral	O
administration	O
at	O
16	O
g	O
/	O
kg	O
.	O

Microarray	O
analysis	O
of	O
lung	O
tissue	O
from	O
PbA	O
-	O
infected	O
mice	B-SPEC
identified	O
a	O
significant	O
up	O
-	O
regulation	O
of	O
expressed	O
genes	O
associated	O
with	O
the	O
gene	O
ontology	O
categories	O
of	O
defense	O
and	O
immune	O
response	O
.	O

Severity	O
of	O
malaria	O
-	O
induced	O
ALI	O
varied	O
in	O
a	O
panel	O
of	O
inbred	O
mouse	B-SPEC
strains	O
,	O
and	O
development	O
of	O
ALI	O
correlated	O
with	O
peripheral	O
parasite	O
burden	O
but	O
not	O
CM	O
susceptibility	O
.	O

In	O
only	O
persistently	O
infected	O
fetuses	O
,	O
encephaloclastic	O
lesions	O
resulting	O
in	O
pseudocysts	O
were	O
observed	O
in	O
the	O
subependymal	O
zone	O
in	O
the	O
region	O
of	O
the	O
median	O
eminence	O
and	O
adjacent	O
corona	B-SPEC
radiata	O
as	O
well	O
as	O
in	O
the	O
region	O
of	O
the	O
external	O
capsule	O
associated	O
with	O
lenticulostriate	O
arteries	O
.	O

In	O
this	O
paper	O
,	O
a	O
novel	O
phylogenomic	O
method	O
,	O
named	O
as	O
Base	O
-	O
Base	O
Correlation	O
(	O
BBC	O
),	O
has	O
been	O
proposed	O
to	O
infer	O
phylogenetic	O
relationships	O
from	O
complete	O
genomes	O
,	O
with	O
particular	O
emphasis	O
on	O
coronavirus	B-SPEC
phylogeny	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
causes	O
neuronal	O
death	O
in	O
the	O
absence	O
of	O
encephalitis	O
in	O
mice	B-SPEC
transgenic	O
for	O
human	B-SPEC
ACE2	O
.	O

Death	O
of	O
the	O
animal	B-SPEC
likely	O
results	O
from	O
dysfunction	O
and	O
/	O
or	O
death	O
of	O
infected	O
neurons	O
,	O
especially	O
those	O
located	O
in	O
cardiorespiratory	O
centers	O
in	O
the	O
medulla	O
.	O

Seven	O
of	O
the	O
13	O
children	O
became	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
seropositive	O
during	O
follow	O
-	O
up	O
,	O
whereas	O
only	O
2	O
became	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
seropositive	O
.	O

We	O
conclude	O
that	O
on	O
average	O
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
seroconversion	O
occurs	O
before	O
children	O
reach	O
the	O
age	O
of	O
3	O
.	O
5	O
years	O
.	O

Mean	O
EVLW	O
indexed	O
to	O
ActBW	O
was	O
12	O
.	O
7	O
mg	O
/	O
kg	O
for	O
ARDS	O
patients	O
and	O
7	O
.	O
8	O
mg	O
/	O
kg	O
for	O
non	O
-	O
ARDS	O
sepsis	B-SPEC
patients	O
(	O
p	O
<	O
.	O
0001	O
).	O

CRCoV	O
has	O
been	O
associated	O
with	O
respiratory	O
disease	O
,	O
particularly	O
in	O
kenneled	O
dog	B-SPEC
populations	O
.	O

Chickens	B-SPEC
immunized	O
with	O
the	O
H5N1	O
/	O
PR8	O
-	O
5B19	O
inactivated	O
vaccine	O
produced	O
high	O
levels	O
of	O
HI	O
antibody	O
and	O
a	O
measurable	O
antibody	O
response	O
against	O
the	O
MHV	B-SPEC
5B19	O
epitope	O
,	O
and	O
were	O
fully	O
protected	O
against	O
subsequent	O
challenge	O
with	O
different	O
highly	O
pathogenic	O
H5N1	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
.	O

CONCLUSIONS	O
:	O
The	O
finding	O
of	O
many	O
divergent	O
and	O
previously	O
unrecognized	O
HRV	O
strains	O
has	O
drawn	O
attention	O
and	O
resources	O
back	O
to	O
the	O
most	O
widespread	O
and	O
frequent	O
infectious	O
agent	O
of	O
humans	B-SPEC
;	O
providing	O
us	O
the	O
chance	O
to	O
seize	O
the	O
advantage	O
in	O
a	O
decades	O
-	O
long	O
cold	O
war	O
.	O

For	O
the	O
entire	O
population	O
,	O
median	O
PaO	O
(	O
2	O
)/	O
F	O
(	O
I	O
)	O
O	O
(	O
2	O
)	O
rose	B-SPEC
from	O
87	O
(	O
range	O
,	O
56	O
-	O
161	O
)	O
before	O
PP	O
to	O
194	O
(	O
range	O
,	O
94	O
-	O
460	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
after	O
it	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
capacity	O
of	O
alveolar	O
type	O
II	O
(	O
AT	O
II	O
)	O
cells	O
for	O
water	O
and	O
sodium	O
transport	O
in	O
rats	B-SPEC
with	O
early	O
-	O
stage	O
oleic	O
acid	O
-	O
induced	O
acute	O
lung	O
injury	O
(	O
ALI	O
)/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

A	O
commercial	O
ELISA	O
kit	O
for	O
detecting	O
SARS	O
-	O
CoV	O
antibody	O
was	O
modified	O
for	O
detecting	O
coronavirus	B-SPEC
antibodies	O
in	O
bat	B-SPEC
serum	O
samples	O
.	O

The	O
sera	O
of	O
55	O
fulvous	O
fruit	O
bats	B-SPEC
(	O
Rousettus	B-SPEC
dasymallus	O
)	O
were	O
tested	O
using	O
the	O
SPA	O
-	O
ELISA	O
.	O

ABSTRACT	O
:	O
Respiratory	O
failure	O
may	O
develop	O
during	O
the	O
later	O
stages	O
of	O
pregnancy	O
and	O
is	O
usually	O
associated	O
with	O
tocolysis	O
or	O
other	O
co	O
-	O
existing	O
conditions	O
such	O
as	O
pneumonia	O
,	O
sepsis	B-SPEC
,	O
pre	O
-	O
eclampsia	O
or	O
amniotic	O
fluid	O
embolism	O
syndrome	O
.	O

TITLE	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
of	O
the	O
CNS	O
:	O
a	O
model	O
for	O
defense	O
,	O
disease	O
,	O
and	O
repair	O
.	O

To	O
evaluate	O
the	O
utility	O
of	O
this	O
system	O
we	O
constructed	O
DeltaE1	O
/	O
DeltaE2	O
vector	O
carrying	O
different	O
classes	O
of	O
protein	O
,	O
that	O
is	O
,	O
the	O
gene	O
coding	O
for	O
spike	O
protein	O
derived	O
from	O
the	O
Coronavirus	B-SPEC
causing	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
),	O
a	O
gene	O
coding	O
for	O
the	O
SARS	O
-	O
CoV	O
receptor	O
or	O
the	O
genes	O
coding	O
for	O
an	O
antibody	O
shown	O
to	O
bind	O
and	O
neutralize	O
SARS	O
-	O
CoV	O
(	O
SARS	O
-	O
AB	O
).	O

TITLE	O
:	O
Complete	O
nucleotide	O
sequence	O
of	O
polyprotein	O
gene	O
1	O
and	O
genome	O
organization	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
.	O

The	O
antimesentric	O
surface	O
of	O
the	O
cecum	O
was	O
perforated	O
and	O
the	O
cecum	O
was	O
gently	O
compressed	O
until	O
fecal	O
matter	O
was	O
extruded	O
to	O
induce	O
sepsis	B-SPEC
.	O

None	O
of	O
the	O
rats	B-SPEC
received	O
antibiotics	O
during	O
the	O
experimental	O
procedures	O
.	O

The	O
lung	O
superoxide	O
dismutase	O
(	O
SOD	O
),	O
catalase	O
and	O
glutathione	O
peroxidase	O
activities	O
were	O
decreased	O
in	O
the	O
sepsis	B-SPEC
group	O
as	O
compared	O
to	O
the	O
group	O
control	O
,	O
sham	O
,	O
leflunomide	O
and	O
sepsis	B-SPEC
+	O
leflunomide	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
SOD	O
activity	O
were	O
significantly	O
higher	O
in	O
group	O
sepsis	B-SPEC
+	O
leflunomide	O
than	O
sham	O
,	O
control	O
,	O
leflunomide	O
and	O
sepsis	B-SPEC
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
lung	O
MPO	O
,	O
malondialdehyde	O
(	O
MDA	O
),	O
protein	O
carbonyl	O
and	O
NO	O
levels	O
were	O
higher	O
in	O
the	O
sepsis	B-SPEC
group	O
when	O
compared	O
to	O
group	O
control	O
,	O
sham	O
,	O
leflunomide	O
and	O
sepsis	B-SPEC
+	O
leflunomide	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
MPO	O
,	O
MDA	O
and	O
NO	O
levels	O
were	O
higher	O
in	O
the	O
sepsis	B-SPEC
+	O
leflunomide	O
group	O
than	O
in	O
the	O
sham	O
,	O
control	O
and	O
leflunomide	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

To	O
better	O
understand	O
the	O
prevalence	O
of	O
this	O
entity	O
,	O
properly	O
designed	O
studies	O
are	O
needed	O
in	O
order	B-SPEC
to	O
establish	O
its	O
epidemiology	O
and	O
clinical	O
characteristics	O
.	O

16	O
out	O
of	O
22	O
IBV	B-SPEC
isolates	O
were	O
grouped	O
into	O
Cluster	O
I	O
,	O
and	O
had	O
higher	O
homology	O
with	O
pigeon	B-SPEC
coronavirus	B-SPEC
isolates	O
but	O
lower	O
homology	O
with	O
the	O
Massachusetts	O
(	O
Mass	O
)	O
type	O
vaccine	O
strains	O
.	O

The	O
organ	O
samples	O
at	O
5	O
days	O
post	O
challenge	O
showed	O
that	O
the	O
viral	O
detection	O
rates	O
were	O
50	O
%-	O
90	O
%	O
and	O
10	O
%-	O
30	O
%	O
for	O
trachea	B-SPEC
and	O
kidney	O
,	O
respectively	O
.	O

Cats	B-SPEC
with	O
higher	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
antibody	O
titers	O
were	O
significantly	O
more	O
likely	O
to	O
shed	O
virus	B-SPEC
,	O
while	O
cats	B-SPEC
with	O
lower	O
titers	O
were	O
significantly	O
less	O
likely	O
to	O
be	O
shedding	O
.	O

Virus	B-SPEC
was	O
detected	O
in	O
415	O
of	O
956	O
independent	O
assays	O
:	O
425	O
CFLI	O
episodes	O
and	O
531	O
non	O
-	O
CFLI	O
periods	O
were	O
sampled	O
;	O
samples	O
from	O
270	O
(	O
64	O
%)	O
CFLI	O
episodes	O
and	O
145	O
(	O
27	O
%)	O
non	O
-	O
CFLI	O
periods	O
contained	O
virus	B-SPEC
detected	O
by	O
PCR	O
.	O

This	O
introduces	O
virus	B-SPEC
-	O
specific	O
biases	O
to	O
estimating	O
the	O
frequencies	O
of	O
specific	O
complications	O
attributable	O
to	O
a	O
vURI	O
when	O
ascertained	O
by	O
CFLI	O
identification	O
.	O

ABSTRACT	O
:	O
We	O
compared	O
conventional	O
treatment	O
with	O
pumpless	O
extracorporeal	O
lung	O
membrane	O
(	O
Interventional	O
Lung	O
Assist	O
[	O
iLA	O
]	O
Novalung	O
;	O
Novalung	O
GmbH	O
,	O
Hechingen	O
,	O
Germany	O
)	O
support	O
in	O
a	O
pig	B-SPEC
model	O
of	O
postpneumonectomy	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
group	O
V	O
pigs	B-SPEC
,	O
the	O
iLA	O
Novalung	O
device	O
diverted	O
17	O
%	O
+/-	O

All	O
but	O
1	O
pig	B-SPEC
belonging	O
to	O
group	O
V	O
could	O
be	O
extubated	O
compared	O
with	O
none	O
in	O
groups	O
III	O
and	O
IV	O
(	O
P	O
<	O
.	O
01	O
),	O
and	O
only	O
their	O
lungs	O
normalized	O
cytokine	O
release	O
(	O
P	O
<	O
.	O
001	O
)	O
and	O
surfactant	O
(	O
P	O
<	O
.	O
03	O
)	O
and	O
displayed	O
fewer	O
parenchymal	O
lesions	O
(	O
P	O
<	O
.	O
05	O
).	O

Thirty	O
-	O
two	O
New	B-SPEC
Zealand	I-SPEC
rabbits	I-SPEC
were	O
randomly	O
divided	O
into	O
four	O
groups	O
,	O
and	O
acute	O
respiratory	O
failure	O
model	O
was	O
reproduced	O
by	O
severe	O
steam	O
inhalation	O
injury	O
.	O

Here	O
we	O
employed	O
multiple	O
chemical	O
and	O
molecular	O
approaches	O
to	O
determine	O
the	O
molecular	O
pathways	O
for	O
MHV	B-SPEC
-	O
2	O
entry	O
.	O

We	O
report	O
the	O
identification	O
of	O
novel	O
groups	O
of	O
astroviruses	O
in	O
apparently	O
healthy	O
insectivorous	O
bats	B-SPEC
found	O
in	O
Hong	O
Kong	O
,	O
in	O
particular	O
,	O
bats	B-SPEC
belonging	O
to	O
the	O
genera	O
Miniopterus	B-SPEC
and	O
Myotis	B-SPEC
.	O

Some	O
bat	B-SPEC
astroviruses	O
may	O
be	O
phylogenetically	O
related	O
to	O
human	B-SPEC
astroviruses	O
,	O
and	O
further	O
studies	O
with	O
a	O
wider	O
range	O
of	O
bat	B-SPEC
species	B-SPEC
in	O
different	O
geographic	O
locations	O
are	O
warranted	O
.	O

ARF1	O
,	O
the	O
cellular	O
effector	O
of	O
GBF1	O
,	O
also	O
appeared	O
to	O
be	O
involved	O
in	O
MHV	B-SPEC
replication	O
,	O
as	O
siRNAs	O
targeting	O
this	O
small	O
GTPase	O
inhibited	O
MHV	B-SPEC
infection	O
significantly	O
.	O

TITLE	O
:	O
A	O
structural	O
view	O
of	O
the	O
inactivation	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
by	O
benzotriazole	O
esters	O
.	O

The	O
in	O
vitro	O
antiviral	O
activity	O
of	O
albumin	O
-	O
IFN	O
-	O
alpha	O
was	O
evaluated	O
against	O
representative	O
bioterrorism	O
viral	O
agents	O
and	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
C	O
-	O
terminal	O
domain	O
(	O
CTD	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nucleocapsid	O
protein	O
(	O
NP	O
)	O
contains	O
a	O
potential	O
RNA	O
-	O
binding	O
region	O
in	O
its	O
N	O
-	O
terminal	O
portion	O
and	O
also	O
serves	O
as	O
a	O
dimerization	O
domain	O
by	O
forming	O
a	O
homodimer	O
with	O
a	O
molecular	O
mass	O
of	O
28	O
kDa	O
.	O

This	O
report	O
describes	O
the	O
usage	O
of	O
two	O
short	O
peptides	O
from	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
SARS	O
-	O
N	O
)	O
protein	O
as	O
protein	O
tags	O
.	O

TITLE	O
:	O
The	O
management	O
of	O
coronavirus	B-SPEC
infections	O
with	O
particular	O
reference	O
to	O
SARS	O
.	O

Based	O
on	O
the	O
X	O
-	O
ray	B-SPEC
structure	O
of	O
3CL	O
(	O
Pro	O
)	O
co	O
-	O
crystallized	O
with	O
a	O
trans	O
-	O
alpha	O
,	O
beta	O
-	O
unsaturated	O
ethyl	O
ester	O
(	O
Michael	O
acceptor	O
),	O
a	O
set	O
of	O
QM	O
/	O
QM	O
and	O
QM	O
/	O
MM	O
calculations	O
were	O
performed	O
,	O
yielding	O
three	O
models	O
with	O
increasingly	O
higher	O
the	O
number	O
of	O
atoms	O
.	O

The	O
predominant	O
IBV	B-SPEC
genotypes	O
detected	O
were	O
793B	O
and	O
Massachusetts	O
.	O

Since	O
2004	O
an	O
IBV	B-SPEC
genotype	O
has	O
been	O
detected	O
in	O
Holland	O
,	O
Germany	O
,	O
Belgium	O
and	O
France	O
similar	O
to	O
QX	O
and	O
the	O
incidence	O
has	O
increased	O
.	O

QX	O
was	O
not	O
detected	O
in	O
the	O
United	O
Kingdom	B-SPEC
or	O
Spain	O
.	O

ABSTRACT	O
:	O
Muscular	O
weakness	O
affecting	O
predominantly	O
the	O
proximal	O
limb	O
muscles	O
and	O
neck	O
flexors	O
is	O
the	O
cardinal	B-SPEC
feature	O
of	O
intermediate	O
syndrome	O
with	O
cranial	O
nerve	O
palsies	O
occasionally	O
accompanied	O
.	O

TITLE	O
:	O
Distinct	O
signature	O
type	O
I	O
interferon	O
responses	O
are	O
determined	O
by	O
the	O
infecting	O
virus	B-SPEC
and	O
the	O
target	O
cell	O
.	O

In	O
vitro	O
,	O
distinct	O
signature	O
profiles	O
of	O
SeV	O
and	O
MHV	B-SPEC
-	O
1	O
-	O
inducible	O
gene	O
expression	O
for	O
IFN	O
-	O
alpha2	O
,	O
IFN	O
-	O
alpha4	O
and	O
IFN	O
-	O
alpha5	O
subtypes	O
in	O
L2	O
and	O
L929	O
mouse	B-SPEC
fibroblast	O
cells	O
,	O
in	O
relation	O
to	O
the	O
extent	O
and	O
kinetics	O
of	O
their	O
induction	O
,	O
were	O
identified	O
.	O

Turkey	B-SPEC
coronavirus	B-SPEC
was	O
detected	O
in	O
experimentally	O
infected	O
embryo	O
tissues	O
and	O
also	O
in	O
field	O
samples	O
in	O
100	O
%	O
of	O
ileum	O
-	O
cecal	O
junction	O
and	O
ceca	O
by	O
the	O
3	O
detection	O
procedures	O
.	O

Since	O
dual	O
species	B-SPEC
tropism	O
was	O
preserved	O
in	O
Urbani	O
,	O
it	O
is	O
likely	O
that	O
the	O
virus	B-SPEC
evolved	O
a	O
high	O
affinity	O
for	O
cACE2	O
/	O
hACE2	O
receptors	O
through	O
adaptation	O
via	O
repeated	O
passages	O
between	O
human	B-SPEC
and	O
civet	B-SPEC
hosts	O
.	O

A	O
novel	O
SARS	O
-	O
CoV	O
-	O
associated	O
lesion	O
was	O
tracheo	O
-	O
bronchoadenitis	O
in	O
cats	B-SPEC
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
confers	O
ability	O
to	O
efficiently	O
produce	O
virus	B-SPEC
-	O
like	O
particles	O
when	O
substituted	O
for	O
the	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
nucleocapsid	O
domain	O
.	O

Analysis	O
results	O
indicate	O
that	O
the	O
replacement	O
of	O
NC	O
with	O
the	O
carboxyl	O
-	O
terminal	O
half	O
of	O
the	O
SARS	O
-	O
CoV	O
N	O
resulted	O
in	O
the	O
production	O
of	O
wild	O
type	O
(	O
wt	O
)-	O
level	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
)	O
with	O
the	O
density	O
of	O
a	O
wt	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
particle	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
terminal	O
disease	O
of	O
cats	B-SPEC
caused	O
by	O
systemic	O
infection	O
with	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
).	O

In	O
the	O
case	O
of	O
FIPV	O
-	O
1146	O
and	O
FIPV	O
-	O
DF2	O
,	O
infection	O
of	O
primary	O
feline	B-SPEC
monocytes	O
was	O
also	O
dependent	O
on	O
host	O
cell	O
cathepsin	O
B	O
activity	O
,	O
indicating	O
that	O
host	O
cell	O
cathepsins	O
may	O
play	O
a	O
role	O
in	O
the	O
distinct	O
tropisms	O
displayed	O
by	O
different	O
feline	B-SPEC
coronavirus	B-SPEC
biotypes	O
.	O

The	O
emergence	O
of	O
highly	O
pathogenic	O
strains	O
like	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
the	O
discovery	O
of	O
two	O
new	O
coronaviruses	O
,	O
NL	O
-	O
63	O
and	O
HKU1	O
,	O
corroborates	O
the	O
high	O
rate	O
of	O
mutation	O
and	O
recombination	O
that	O
have	O
enabled	O
them	O
to	O
cross	O
species	B-SPEC
barriers	O
and	O
infect	O
novel	O
hosts	O
.	O

Here	O
3CL	O
(	O
pro	O
)	O
derived	O
from	O
the	O
SARS	O
-	O
CoV	O
was	O
used	O
as	O
the	O
primary	O
target	O
to	O
identify	O
a	O
new	O
class	B-SPEC
of	O
inhibitors	O
containing	O
a	O
halomethyl	O
ketone	O
warhead	O
.	O

In	O
the	O
present	O
study	O
,	O
68	O
household	O
dogs	B-SPEC
showing	O
clinical	O
signs	O
of	O
respiratory	O
infection	O
were	O
examined	O
,	O
and	O
20	O
dogs	B-SPEC
(	O
29	O
.	O
4	O
%)	O
were	O
found	O
to	O
be	O
positive	O
for	O
either	O
of	O
following	O
agents	O
.	O

Neither	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
nor	O
canine	O
bocavirus	B-SPEC
(	O
minute	B-SPEC
virus	I-SPEC
of	I-SPEC
canines	I-SPEC
)	O
was	O
found	O
in	O
any	O
dogs	B-SPEC
examined	O
.	O

In	O
the	O
current	O
study	O
,	O
two	O
recombinant	O
baculovirus	B-SPEC
were	O
generated	O
to	O
express	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
-	O
like	O
coronavirus	B-SPEC
(	O
SL	O
-	O
CoV	O
)	O
isolated	O
from	O
bats	B-SPEC
(	O
vAcBS	O
)	O
and	O
the	O
envelope	O
(	O
E	O
)	O
and	O
membrane	O
(	O
M	O
)	O
proteins	O
of	O
SARS	O
-	O
CoV	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
ORF7b	O
(	O
also	O
called	O
7b	O
)	O
protein	O
is	O
an	O
integral	O
membrane	O
protein	O
that	O
is	O
translated	O
from	O
a	O
bicistronic	O
open	O
reading	O
frame	O
encoded	O
within	O
subgenomic	O
RNA	O
7	O
.	O

This	O
paper	O
is	O
a	O
review	O
of	O
the	O
current	O
literature	O
on	O
the	O
recent	O
genetic	O
evolution	O
of	O
CCoV	O
and	O
emergence	O
of	O
new	O
CoVs	O
in	O
the	O
dog	B-SPEC
.	O

Both	O
chicken	B-SPEC
astrovirus	I-SPEC
and	O
avian	B-SPEC
nephritis	O
virus	B-SPEC
(	O
ANV	O
)	O
were	O
identified	O
in	O
chicken	B-SPEC
samples	O
,	O
and	O
often	O
both	O
viruses	B-SPEC
were	O
detected	O
in	O
the	O
same	O
flock	O
.	O

This	O
study	O
provides	O
updated	O
enteric	O
virus	B-SPEC
prevalence	O
data	O
for	O
the	O
United	O
States	O
using	O
molecular	O
methods	O
,	O
and	O
it	O
reinforces	O
that	O
enteric	O
viruses	B-SPEC
are	O
widespread	O
in	O
poultry	O
throughout	O
the	O
United	O
States	O
,	O
although	O
the	O
clinical	O
importance	O
of	O
most	O
of	O
these	O
viruses	B-SPEC
remains	O
unclear	O
.	O

ABSTRACT	O
:	O
Twelve	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
obtained	O
from	O
commercial	O
chickens	B-SPEC
in	O
China	O
between	O
2005	O
and	O
2006	O
were	O
characterized	O
by	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
the	O
sequencing	O
of	O
the	O
entire	O
S1	O
gene	O
.	O

In	O
addition	O
,	O
the	O
study	O
also	O
revealed	O
that	O
IBV	B-SPEC
strains	O
exhibiting	O
different	O
pathogenicities	O
were	O
found	O
cocirculating	O
in	O
the	O
chicken	B-SPEC
flock	O
in	O
China	O
.	O

TITLE	O
:	O
Genetic	O
diversity	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
in	O
Korea	O
between	O
2003	O
and	O
2006	O
.	O

K	O
-	O
II	O
type	O
IBV	B-SPEC
isolates	O
(	O
n	O
=	O
19	O
)	O
were	O
closely	O
related	O
to	O
nephropathogenic	O
IBV	B-SPEC
variants	O
from	O
China	O
and	O
Japan	O
.	O

Sequence	O
comparisons	O
showed	O
amino	O
acid	O
differences	O
of	O
>	O
27	O
.	O
5	O
%	O
between	O
IBV	B-SPEC
types	O
.	O

Two	O
models	O
of	O
VILI	O
were	O
utilized	O
to	O
explore	O
the	O
role	O
of	O
PBEF	O
using	O
either	O
recombinant	O
PBEF	O
or	O
PBEF	O
(+/-)	O
mice	B-SPEC
.	O

Heterozygous	O
PBEF	O
(+/-)	O
mice	B-SPEC
were	O
significantly	O
protected	O
(	O
reduced	O
BAL	O
protein	O
,	O
BAL	O
IL	O
-	O
6	O
levels	O
,	O
peak	O
inspiratory	O
pressures	O
)	O
when	O
exposed	O
to	O
a	O
model	O
of	O
severe	O
VILI	O
(	O
4	O
h	O
,	O
40	O
ml	O
/	O
kg	O
tidal	O
volume	O
)	O
and	O
exhibited	O
significantly	O
reduced	O
expression	O
of	O
VILI	O
-	O
associated	O
gene	O
expression	O
modules	O
.	O

The	O
second	O
half	O
of	O
the	O
20th	O
century	O
saw	O
the	O
emergence	O
of	O
HIV	B-SPEC
/	O
AIDS	O
(	O
1981	O
),	O
among	O
other	O
viral	O
diseases	O
.	O

When	O
infected	O
with	O
MHV	B-SPEC
,	O
mice	B-SPEC
deficient	O
in	O
IFN	O
-	O
associated	O
receptor	O
expression	O
(	O
IFNAR	O
(-/-))	O
became	O
moribund	O
by	O
48	O
h	O
postinfection	O
.	O

MHV	B-SPEC
also	O
replicated	O
to	O
higher	O
titers	O
and	O
exhibited	O
a	O
more	O
broad	O
tissue	O
tropism	O
in	O
these	O
mice	B-SPEC
,	O
which	O
lack	O
a	O
type	O
I	O
IFN	O
response	O
.	O

These	O
findings	O
suggest	O
that	O
secretion	O
of	O
IFN	O
-	O
beta	O
by	O
macrophages	O
and	O
microglia	O
plays	O
a	O
role	O
in	O
protecting	O
the	O
host	O
from	O
MHV	B-SPEC
infection	O
of	O
the	O
central	O
nervous	O
system	O
.	O

DNA	O
recombination	O
and	O
sequencing	O
,	O
interspecific	O
in	O
vitro	O
fertilization	O
,	O
single	O
-	O
embryo	O
PCR	O
and	O
RT	O
-	O
PCR	O
were	O
employed	O
to	O
establish	O
a	O
sensitive	O
and	O
rapid	O
assay	O
for	O
exploring	O
the	O
vertical	O
transmission	O
of	O
viruses	B-SPEC
via	O
male	O
germ	O
line	O
.	O

The	O
results	O
showed	O
that	O
mutation	O
of	O
the	O
P1	O
Gln	O
to	O
Pro	O
or	O
deletion	O
of	O
the	O
Gln	O
residue	O
in	O
the	O
nsp10	O
-	O
nsp11	O
/	O
12	O
site	O
completely	O
abolished	O
the	O
3CLpro	O
-	O
mediated	O
processing	O
,	O
but	O
allowed	O
production	O
of	O
infectious	O
recombinant	O
viruses	B-SPEC
with	O
variable	O
degrees	O
of	O
growth	O
defect	O
,	O
suggesting	O
that	O
cleavage	O
at	O
the	O
nsp10	O
-	O
nsp11	O
/	O
12	O
site	O
of	O
IBV	B-SPEC
is	O
dispensable	O
for	O
viral	O
replication	O
in	O
cultured	O
cells	O
.	O

Similar	O
approaches	O
would	O
be	O
also	O
applicable	O
to	O
other	O
human	B-SPEC
and	O
animal	B-SPEC
coronaviruses	O
.	O

Influenza	O
(	O
n	O
=	O
7	O
),	O
hMPV	B-SPEC
(	O
n	O
=	O
7	O
),	O
and	O
RSV	B-SPEC
(	O
n	O
=	O
5	O
)	O
accounted	O
for	O
most	O
viral	O
infections	O
;	O
other	O
infections	O
included	O
rhinovirus	B-SPEC
(	O
n	O
=	O
4	O
),	O
parainfluenza	O
(	O
n	O
=	O
3	O
),	O
coronavirus	B-SPEC
(	O
n	O
=	O
4	O
),	O
and	O
adenovirus	B-SPEC
(	O
n	O
=	O
2	O
).	O

Samples	O
also	O
were	O
tested	O
for	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
antigens	O
.	O

In	O
contrast	O
,	O
the	O
structure	O
of	O
the	O
Cys69Ala	O
mutant	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
Nsp9	O
shows	O
the	O
same	O
dimer	O
organization	O
as	O
the	O
SARS	O
-	O
CoV	O
protein	O
.	O

TITLE	O
:	O
The	O
altered	O
adrenal	O
axis	B-SPEC
and	O
treatment	O
with	O
glucocorticoids	O
during	O
critical	O
illness	O
.	O

ABSTRACT	O
:	O
Critical	O
illness	O
is	O
generally	O
hallmarked	O
by	O
activation	O
of	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
adrenal	O
axis	B-SPEC
.	O

We	O
conclude	O
that	O
the	O
cysteine	O
protease	O
inhibitor	O
cystatin	O
C	O
is	O
internalized	O
in	O
significant	O
quantities	O
in	O
various	O
cancer	B-SPEC
cell	O
lines	O
.	O

Twenty	O
-	O
three	O
items	O
of	O
potential	O
risk	O
impacting	O
mortality	O
were	O
calculated	O
by	O
univariate	O
and	O
multivariate	O
Logistic	O
analyses	O
in	O
order	B-SPEC
to	O
find	O
distinctive	O
items	O
in	O
these	O
severe	O
RTI	O
patients	O
.	O

The	O
adjusted	O
ORs	O
with	O
95	O
%	O
CI	O
were	O
denoted	O
with	O
respect	O
to	O
surviving	O
beyond	O
96	O
hours	O
EICU	O
admission	O
(	O
APACHE	O
II	O
score	O
,	O
duration	O
of	O
trauma	O
factor	O
,	O
aspiration	O
of	O
gastric	O
contents	O
),	O
APACHE	O
II	O
score	O
beyond	O
20	O
EICU	O
admission	O
(	O
duration	O
of	O
trauma	O
factor	O
,	O
sepsis	B-SPEC
,	O
duration	O
of	O
mechanical	O
ventilation	O
)	O
and	O
mechanical	O
ventilation	O
beyond	O
7	O
days	O
EICU	O
admission	O
(	O
duration	O
of	O
trauma	O
factor	O
and	O
sepsis	B-SPEC
).	O

However	O
,	O
it	O
was	O
found	O
that	O
a	O
mixture	O
of	O
two	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
proteinase	O
inhibitors	O
,	O
lopinavir	O
and	O
ritonavir	O
,	O
exhibited	O
some	O
signs	O
of	O
effectiveness	O
against	O
the	O
SARS	O
virus	B-SPEC
.	O

This	O
study	O
showed	O
that	O
ApNPV	O
significantly	O
enhanced	O
inflammatory	O
cytokine	O
mRNA	O
expression	O
in	O
chicken	B-SPEC
PBMC	O
and	O
HD	O
11	O
cells	O
through	O
the	O
clathrin	O
-	O
dependent	O
endocytic	O
and	O
endosomal	O
maturation	O
pathway	O
,	O
and	O
up	O
-	O
regulated	O
nitric	O
oxide	O
production	O
in	O
HD	O
11	O
cells	O
.	O

We	O
produced	O
mammalian	B-SPEC
expression	O
vectors	O
encoding	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
accessory	O
proteins	O
with	O
or	O
without	O
the	O
fluorescence	O
protein	O
tag	O
and	O
cell	O
lines	O
with	O
stable	O
expression	O
of	O
these	O
proteins	O
.	O

TITLE	O
:	O
Molecular	O
and	O
genetic	O
characterisation	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
auxiliary	O
protein	O
X1	O
in	O
Drosophila	B-SPEC
.	O

We	O
have	O
established	O
and	O
characterised	O
an	O
in	O
-	O
vivo	O
3a	O
transgenic	O
Drosophila	B-SPEC
model	O
,	O
and	O
demonstrated	O
its	O
usefulness	O
in	O
studying	O
SARS	O
-	O
CoV	O
3a	O
gene	O
function	O
.	O

TITLE	O
:	O
Mechanisms	O
of	O
lymphocyte	O
loss	O
in	O
SARS	O
coronavirus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Investigation	O
of	O
immunogenic	O
T	O
-	O
cell	O
epitopes	O
in	O
SARS	O
virus	B-SPEC
nucleocapsid	O
protein	O
and	O
their	O
role	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
SARS	O
infection	O
.	O

We	O
have	O
demonstrated	O
for	O
the	O
first	O
time	O
that	O
the	O
helicase	O
of	O
a	O
ribonucleic	O
acid	O
virus	B-SPEC
,	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
is	O
a	O
valid	O
target	O
for	O
drug	O
development	O
.	O

Intranasal	O
vaccination	O
with	O
RBD	O
-	O
rAAV	O
induced	O
local	O
IgA	O
and	O
systemic	O
IgG	O
neutralising	O
antibodies	O
and	O
specific	O
T	O
-	O
cell	O
responses	O
,	O
able	O
to	O
protect	O
against	O
SARS	O
-	O
CoV	O
infection	O
in	O
animal	B-SPEC
models	O
.	O

TITLE	O
:	O
Detection	O
of	O
an	O
antigenic	O
group	O
2	O
coronavirus	B-SPEC
in	O
an	O
adult	O
alpaca	B-SPEC
with	O
enteritis	O
.	O

Further	O
studies	O
are	O
necessary	O
to	O
elucidate	O
the	O
complete	O
pulmonary	O
physiopathological	O
mechanism	O
involved	O
with	O
each	O
HIV	B-SPEC
/	O
AIDS	O
-	O
associated	O
disease	O
.	O

It	O
is	O
shown	O
that	O
CRP	O
is	O
prevailed	O
in	O
elder	B-SPEC
age	O
groups	O
(	O
after	O
45	O
years	O
)	O
and	O
noticed	O
in	O
56	O
.	O
7	O
%	O
CHD	O
patients	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
a	O
distinct	O
coronavirus	B-SPEC
,	O
in	O
2003	O
greatly	O
threatened	O
public	O
health	O
in	O
China	O
,	O
Southeast	O
Asia	O
as	O
well	O
as	O
North	O
America	O
.	O

The	O
S1	O
domain	O
mediates	O
the	O
binding	O
of	O
the	O
virus	B-SPEC
to	O
its	O
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
,	O
which	O
is	O
abundantly	O
distributed	O
on	O
the	O
surface	O
of	O
human	B-SPEC
lung	O
cells	O
.	O

FIPV	O
is	O
not	O
internalized	O
through	O
a	O
clathrin	O
-	O
mediated	O
pathway	O
,	O
as	O
chlorpromazine	O
,	O
amantadine	O
and	O
DN	O
eps15	O
did	O
not	O
influence	O
virus	B-SPEC
uptake	O
and	O
FIPV	O
did	O
not	O
co	O
-	O
localize	O
with	O
clathrin	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
a	O
newly	O
described	O
infectious	O
disease	O
caused	O
by	O
the	O
SARS	O
coronavirus	B-SPEC
which	O
attacks	O
the	O
immune	O
system	O
and	O
pulmonary	O
epithelium	O
.	O

Understanding	O
the	O
spillover	O
from	O
bats	B-SPEC
to	O
humans	B-SPEC
and	O
other	O
animals	B-SPEC
,	O
and	O
the	O
associated	O
health	O
risks	O
requires	O
an	O
analysis	O
of	O
the	O
disease	O
dynamics	O
in	O
bat	B-SPEC
populations	O
.	O

We	O
propose	O
a	O
novel	O
combination	O
of	O
computational	O
and	O
adaptive	O
modeling	O
approaches	O
that	O
address	O
the	O
maintenance	O
of	O
emerging	O
diseases	O
in	O
bat	B-SPEC
colonies	O
through	O
individual	O
(	O
intra	O
-	O
host	O
)	O
models	O
of	O
the	O
response	O
of	O
the	O
host	O
to	O
a	O
viral	O
challenge	O
.	O

In	O
addition	O
,	O
a	O
vegetable	O
polular	O
in	O
Taiwan	O
,	O
China	O
and	O
Malaysia	O
,	O
the	O
tender	O
leaf	O
of	O
Toona	B-SPEC
sinensis	I-SPEC
Roem	O
(	O
also	O
known	O
as	O
Cedrela	B-SPEC
sinensis	I-SPEC
,	O
belongs	O
to	O
the	O
family	B-SPEC
Meliacceae	O
)	O
was	O
also	O
recruited	O
under	O
the	O
suggestion	O
of	O
botanic	O
experts	O
.	O

This	O
paper	O
reports	O
for	O
the	O
first	O
time	O
that	O
extract	O
from	O
a	O
vegetable	O
,	O
the	O
tender	O
leaf	O
of	O
Toona	B-SPEC
sinensis	I-SPEC
Roem	O
,	O
can	O
inhibit	O
SARS	O
-	O
CoV	O
in	O
vitro	O
.	O

95	O
serum	O
samples	O
submitted	O
for	O
various	O
diagnostic	O
assays	O
and	O
20	O
samples	O
from	O
specific	O
-	O
pathogen	O
-	O
free	O
cats	B-SPEC
tested	O
as	O
negative	O
control	O
samples	O
.	O

TITLE	O
:	O
[	O
New	O
respiratory	O
viruses	B-SPEC
in	O
children	O
2	O
months	O
to	O
3	O
years	O
old	O
with	O
recurrent	O
wheeze	O
].	O

To	O
evaluate	O
the	O
prevalence	O
and	O
epidemiological	O
features	O
of	O
newer	O
and	O
traditional	O
respiratory	O
viruses	B-SPEC
in	O
infants	O
and	O
young	O
children	O
with	O
recurrent	O
wheeze	O
.	O

A	O
single	O
virus	B-SPEC
was	O
present	O
in	O
75	O
%	O
of	O
the	O
samples	O
,	O
22	O
%	O
had	O
a	O
double	O
co	O
-	O
infection	O
and	O
3	O
%	O
a	O
triple	O
virus	B-SPEC
co	O
-	O
infection	O
.	O

TITLE	O
:	O
Complete	O
genome	O
sequence	O
analysis	O
of	O
a	O
predominant	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strain	O
in	O
China	O
.	O

TITLE	O
:	O
The	O
studies	O
on	O
the	O
aetiology	O
of	O
diarrhoea	O
in	O
neonatal	O
calves	O
and	O
determination	O
of	O
virulence	O
gene	O
markers	O
of	O
Escherichia	B-SPEC
coli	I-SPEC
strains	O
by	O
multiplex	O
PCR	O
.	O

A	O
multiplex	O
PCR	O
was	O
used	O
to	O
characterize	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
strains	O
in	O
all	O
the	O
calves	O
.	O

Of	O
the	O
18	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
isolated	O
from	O
healthy	O
calves	O
,	O
K99	O
(	O
16	O
.	O
6	O
%)	O
and	O
intimin	O
(	O
55	O
.	O
5	O
%)	O
genes	O
were	O
identified	O
by	O
PCR	O
.	O

As	O
a	O
result	O
,	O
this	O
study	O
shows	O
that	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
Enterococcus	B-SPEC
ssp	O
.	O

A	O
total	O
of	O
158	O
nasopharyngeal	O
swab	O
specimens	O
collected	O
from	O
adult	O
patients	O
with	O
acute	O
respiratory	O
tract	O
infection	O
in	O
Beijing	O
were	O
screened	O
for	O
the	O
presence	O
of	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
and	O
HKU1	O
by	O
using	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
and	O
conventional	O
RT	O
-	O
PCR	O
method	O
.	O

The	O
fluorescence	O
quantitative	O
RT	O
-	O
PCR	O
method	O
detected	O
six	O
specimens	O
positive	O
for	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
,	O
five	O
specimens	O
positive	O
for	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
;	O
and	O
conventional	O
RT	O
-	O
PCR	O
method	O
detected	O
three	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
positive	O
and	O
three	O
HCoV	O
-	O
HKU1	O
positive	O
,	O
respectively	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
elicits	O
a	O
weak	O
interferon	O
response	O
compared	O
to	O
traditional	O
interferon	O
-	O
inducing	O
viruses	B-SPEC
.	O

The	O
objective	O
of	O
this	O
research	O
was	O
to	O
characterize	O
the	O
respiratory	O
excretion	O
of	O
these	O
pathogens	O
by	O
acutely	O
infected	O
pigs	B-SPEC
.	O

TITLE	O
:	O
Spinal	O
cryptococcoma	O
in	O
an	O
immunocompetent	O
cat	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
report	O
describes	O
an	O
unusual	O
case	O
of	O
primary	O
cryptococcoma	O
in	O
the	O
proximal	O
thoracic	O
spinal	O
cord	O
of	O
an	O
11	O
-	O
year	O
-	O
old	O
immunocompetent	O
cat	B-SPEC
from	O
a	O
farm	O
on	O
which	O
there	O
were	O
large	O
numbers	O
of	O
pigeons	B-SPEC
.	O

This	O
animal	B-SPEC
was	O
referred	O
for	O
examination	O
with	O
progressive	O
paralysis	O
and	O
shown	O
to	O
be	O
free	O
from	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
leukaemia	O
virus	B-SPEC
,	O
feline	B-SPEC
coronavirus	B-SPEC
and	O
Toxoplasma	B-SPEC
gondii	I-SPEC
.	O

Histopathological	O
examination	O
of	O
the	O
spinal	O
cord	O
revealed	O
severe	O
granulomatous	O
inflammation	O
associated	O
with	O
large	O
numbers	O
of	O
encapsulated	O
yeast	B-SPEC
cells	O
.	O

Further	O
study	O
of	O
the	O
role	O
of	O
viral	O
pathogens	O
other	O
than	O
RSV	B-SPEC
and	O
co	O
-	O
infections	O
with	O
RSV	B-SPEC
in	O
children	O
with	O
bronchiolitis	O
appears	O
warranted	O
.	O

To	O
understand	O
how	O
mice	B-SPEC
with	O
the	O
SOD3	O
embryonic	O
deletion	O
survived	O
without	O
lung	O
injury	O
,	O
gene	O
array	O
analysis	O
was	O
performed	O
.	O

TITLE	O
:	O
Characterization	O
and	O
membrane	O
gene	O
-	O
based	O
phylogenetic	O
analysis	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
Chinese	O
strain	O
HH06	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
structural	O
proteins	O
(	O
S	O
,	O
E	O
,	O
M	O
,	O
and	O
NC	O
)	O
localize	O
in	O
different	O
subcellular	O
positions	O
when	O
expressed	O
individually	O
.	O

Exposure	O
to	O
live	O
birds	B-SPEC
,	O
perceived	O
similar	O
symptoms	O
between	O
influenza	O
and	O
bird	B-SPEC
-	O
to	O
-	O
human	B-SPEC
H5N1	O
avian	B-SPEC
influenza	O
,	O
that	O
bird	B-SPEC
-	O
to	O
-	O
human	B-SPEC
avian	B-SPEC
influenza	O
was	O
more	O
lethal	O
than	O
SARS	O
were	O
predictive	O
use	O
of	O
face	O
mask	O
when	O
having	O
ILI	O
symptoms	O
(	O
OR	O
=	O
4	O
.	O
25	O
-	O
8	O
.	O
34	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
prevalence	O
of	O
IV	O
and	O
use	O
of	O
face	O
mask	O
in	O
the	O
study	O
population	O
may	O
be	O
increasing	O
,	O
which	O
may	O
be	O
related	O
to	O
concerns	O
of	O
avian	B-SPEC
influenza	O
.	O

CONCLUSIONS	O
:	O
The	O
prevalence	O
of	O
IV	O
and	O
use	O
of	O
face	O
mask	O
in	O
the	O
study	O
population	O
may	O
be	O
increasing	O
,	O
which	O
may	O
be	O
related	O
to	O
concerns	O
of	O
avian	B-SPEC
influenza	O
.	O

ABSTRACT	O
:	O
Design	O
,	O
synthesis	O
and	O
biological	O
evaluation	O
of	O
a	O
series	O
of	O
5	O
-	O
chloropyridine	O
ester	O
-	O
derived	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
chymotrypsin	O
-	O
like	O
protease	O
inhibitors	O
is	O
described	O
.	O

We	O
showed	O
that	O
entry	O
of	O
the	O
serotype	O
II	O
feline	B-SPEC
coronavirus	B-SPEC
strains	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
WSU	O
79	O
-	O
1146	O
and	O
DF2	O
into	O
nonpermissive	O
mouse	B-SPEC
3T3	O
cells	O
can	O
be	O
rescued	O
by	O
the	O
expression	O
of	O
human	B-SPEC
DC	O
-	O
SIGN	O
(	O
hDC	O
-	O
SIGN	O
)	O
and	O
that	O
infection	O
of	O
a	O
permissive	O
feline	B-SPEC
cell	O
line	O
(	O
Crandall	O
-	O
Reese	O
feline	B-SPEC
kidney	O
)	O
was	O
markedly	O
enhanced	O
by	O
the	O
overexpression	O
of	O
hDC	O
-	O
SIGN	O
.	O

Exposure	O
of	O
mESCs	O
to	O
the	O
viruses	B-SPEC
over	O
four	O
to	O
five	O
passages	O
but	O
not	O
for	O
6	O
h	O
affected	O
GLT	O
.	O

The	O
data	O
show	O
that	O
GLT	O
is	O
affected	O
by	O
virus	B-SPEC
-	O
contaminated	O
mESCs	O
.	O

Our	O
results	O
provide	O
insights	O
for	O
understanding	O
the	O
role	O
of	O
rh	O
-	O
ACE2	O
in	O
SARS	O
lung	O
pathogenesis	O
in	O
a	O
non	O
-	O
human	B-SPEC
primate	B-SPEC
model	O
.	O

We	O
assessed	O
the	O
potential	O
of	O
prime	O
-	O
boost	O
vaccination	O
protocols	O
based	O
on	O
the	O
nucleocapsid	O
(	O
NC	O
)	O
protein	O
co	O
-	O
administered	O
with	O
a	O
derivative	O
of	O
the	O
mucosal	O
adjuvant	O
MALP	O
-	O
2	O
or	O
expressed	O
by	O
modified	O
Vaccinia	B-SPEC
virus	I-SPEC
Ankara	O
(	O
MVA	O
-	O
NC	O
)	O
to	O
stimulate	O
humoral	O
and	O
cellular	O
immune	O
responses	O
at	O
systemic	O
and	O
mucosal	O
levels	O
.	O

Recombinant	O
NL63	O
viruses	B-SPEC
which	O
contained	O
the	O
expected	O
marker	O
mutations	O
replicated	O
as	O
efficiently	O
as	O
the	O
wild	O
-	O
type	O
NL63	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
highly	O
pathogenic	O
emergent	O
virus	B-SPEC
which	O
replicates	O
in	O
cells	O
that	O
can	O
express	O
ABH	O
histo	O
-	O
blood	O
group	O
antigens	O
.	O

L	B-SPEC
.	I-SPEC
pneumophila	I-SPEC
PCR	O
was	O
positive	O
in	O
only	O
3	O
out	O
of	O
11	O
cases	O
(	O
27	O
%)	O
of	O
Legionnaires	O
'	O
disease	O
(	O
LD	O
).	O

We	O
sought	O
to	O
assess	O
whether	O
coexistent	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
)	O
infection	O
potentiated	O
the	O
hepatotoxic	O
effects	O
of	O
acetaminophen	O
.	O

HCV	B-SPEC
prevalence	O
increased	O
from	O
0	O
.	O
5	O
%	O
to	O
1	O
.	O
5	O
%	O
between	O
1998	O
and	O
2005	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

Rhinovirus	B-SPEC
and	O
coronaviruses	O
were	O
most	O
prevalent	O
in	O
both	O
symptomatic	O
and	O
asymptomatic	O
episodes	O
.	O

All	O
x	O
-	O
rays	B-SPEC
and	O
clinical	O
data	O
were	O
reviewed	O
by	O
three	O
clinicians	O
for	O
acute	O
lung	O
injury	O
classification	O
.	O

Canadian	O
infection	O
control	O
programs	O
in	O
2005	O
continued	O
to	O
fall	O
short	O
of	O
expert	O
recommendations	O
for	O
human	B-SPEC
resources	O
and	O
surveillance	O
and	O
control	O
activities	O
.	O

Conventional	O
herds	O
had	O
a	O
significantly	O
higher	O
mean	O
antibody	O
prevalence	O
to	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
than	O
the	O
organically	O
managed	O
herds	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Animal	B-SPEC
age	O
was	O
significantly	O
associated	O
with	O
increased	O
antibody	O
prevalence	O
(	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
findings	O
of	O
this	O
study	O
suggest	O
that	O
organic	O
farm	O
management	O
may	O
be	O
effective	O
in	O
reducing	O
the	O
seroprevalence	O
of	O
these	O
viruses	B-SPEC
relative	O
to	O
conventional	O
farming	O
methods	O
.	O

ABSTRACT	O
:	O
Epitope	O
-	O
based	O
vaccines	O
designed	O
to	O
induce	O
cellular	O
immune	O
response	O
and	O
antibody	O
responses	O
specific	O
for	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
are	O
being	O
developed	O
as	O
a	O
means	O
for	O
increasing	O
vaccine	O
potency	O
.	O

The	O
novel	O
immunogenic	O
chimeric	O
multi	O
-	O
epitope	O
DNA	O
vaccine	O
revealed	O
in	O
this	O
study	O
provided	O
a	O
new	O
candidate	O
target	O
for	O
IBV	B-SPEC
vaccine	O
development	O
.	O

TITLE	O
:	O
Serosurveillance	O
of	O
viral	O
diseases	O
in	O
Korean	O
native	O
goats	B-SPEC
(	O
Capra	B-SPEC
hircus	I-SPEC
).	O

The	O
individual	O
seropositive	O
rates	O
for	O
each	O
virus	B-SPEC
were	O
13	O
.	O
7	O
%	O
(	O
110	O
/	O
804	O
)	O
for	O
bovine	B-SPEC
herpesvirus	I-SPEC
-	I-SPEC
1	I-SPEC
(	O
BHV	O
-	O
1	O
),	O
9	O
.	O
5	O
%	O
(	O
76	O
/	O
804	O
)	O
for	O
bovine	B-SPEC
parainfluenza	O
type	O
-	O
3	O
virus	B-SPEC
(	O
PI	O
-	O
3V	O
),	O
5	O
.	O
5	O
%	O
(	O
44	O
/	O
804	O
)	O
for	O
Akabane	B-SPEC
virus	I-SPEC
(	O
AKAV	O
),	O
13	O
.	O
3	O
%	O
(	O
107	O
/	O
804	O
)	O
for	O
Aino	O
virus	B-SPEC
(	O
AINV	O
),	O
2	O
.	O
0	O
%	O
(	O
16	O
/	O
804	O
)	O
for	O
Chuzan	O
virus	B-SPEC
(	O
CHUV	O
)	O
and	O
1	O
.	O
0	O
%	O
(	O
8	O
/	O
804	O
)	O
for	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
).	O

Strikingly	O
,	O
however	O
,	O
for	O
both	O
nsp3	O
and	O
nsp6	O
,	O
predictions	O
based	O
on	O
a	O
multiple	O
alignment	O
of	O
27	O
coronavirus	B-SPEC
genome	O
sequences	O
indicate	O
an	O
uneven	O
number	O
of	O
transmembrane	O
domains	O
.	O

To	O
look	O
into	O
this	O
incongruity	O
,	O
we	O
studied	O
the	O
membrane	O
disposition	O
of	O
nsp3	O
and	O
nsp6	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
by	O
analyzing	O
tagged	O
forms	O
of	O
the	O
proteins	O
expressed	O
in	O
cultured	O
cells	O
.	O

In	O
addition	O
,	O
the	O
overexpression	O
of	O
human	B-SPEC
apoD	O
in	O
the	O
neurons	O
of	O
Thy	O
-	O
1	O
/	O
ApoD	O
transgenic	B-SPEC
mice	I-SPEC
results	O
in	O
a	O
threefold	O
increase	O
of	O
the	O
number	O
of	O
mice	B-SPEC
surviving	O
to	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
discovery	O
and	O
optimization	O
of	O
a	O
potent	O
inhibitor	O
against	O
the	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
from	O
the	O
coronavirus	B-SPEC
that	O
causes	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
-	O
CoV	O
).	O

This	O
unique	O
protease	O
is	O
not	O
only	O
responsible	O
for	O
processing	O
the	O
viral	O
polyprotein	O
into	O
its	O
functional	O
units	O
but	O
is	O
also	O
capable	O
of	O
cleaving	O
ubiquitin	O
and	O
ISG15	O
conjugates	O
and	O
plays	O
a	O
significant	O
role	O
in	O
helping	O
SARS	O
-	O
CoV	O
evade	O
the	O
human	B-SPEC
immune	O
system	O
.	O

The	O
X	O
-	O
ray	B-SPEC
structure	O
of	O
PLpro	O
in	O
complex	O
with	O
GRL0617	O
indicates	O
that	O
the	O
compound	O
has	O
a	O
unique	O
mode	O
of	O
inhibition	O
whereby	O
it	O
binds	O
within	O
the	O
S4	O
-	O
S3	O
subsites	O
of	O
the	O
enzyme	O
and	O
induces	O
a	O
loop	O
closure	O
that	O
shuts	O
down	O
catalysis	O
at	O
the	O
active	O
site	O
.	O

Twelve	O
healthy	O
pigs	B-SPEC
were	O
randomly	O
divided	O
into	O
two	O
groups	O
according	O
to	O
the	O
body	O
posture	O
during	O
mechanical	O
ventilation	O
after	O
oleic	O
acid	O
-	O
induced	O
lung	O
injury	O
:	O
supine	O
position	O
group	O
and	O
prone	O
position	O
group	O
.	O

CONCLUSIONS	O
:	O
In	O
pigs	B-SPEC
with	O
ARDS	O
,	O
prone	O
position	O
improves	O
PaO2	O
/	O
FiO2	O
significantly	O
without	O
influence	O
on	O
respiratory	O
mechanics	O
and	O
hemodynamics	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
:	O
unusual	O
lability	O
of	O
the	O
nucleocapsid	O
protein	O
.	O

ABSTRACT	O
:	O
A	O
7	O
-	O
month	O
-	O
old	O
-	O
intact	O
male	O
domestic	O
shorthair	O
cat	B-SPEC
was	O
presented	O
with	O
fever	O
,	O
anterior	O
uveitis	O
in	O
the	O
right	O
eye	O
and	O
respiratory	O
distress	O
when	O
handled	O
.	O

TITLE	O
:	O
Surface	O
-	O
expressed	O
viral	O
proteins	O
in	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
-	O
infected	O
monocytes	O
are	O
internalized	O
through	O
a	O
clathrin	O
-	O
and	O
caveolae	O
-	O
independent	O
pathway	O
.	O

ABSTRACT	O
:	O
Infection	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
),	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
frequently	O
leads	O
to	O
death	O
in	O
spite	O
of	O
a	O
strong	O
humoral	O
immune	O
response	O
.	O

TITLE	O
:	O
What	O
Australians	O
know	O
and	O
believe	O
about	O
bird	B-SPEC
flu	O
:	O
results	O
of	O
a	O
population	O
telephone	O
survey	O
.	O

ABSTRACT	O
:	O
The	O
avian	B-SPEC
influenza	O
A	O
(	O
A	O
/	O
H5N1	O
)	O
virus	B-SPEC
has	O
attracted	O
the	O
attention	O
of	O
governments	O
and	O
health	O
organizations	O
throughout	O
the	O
world	O
because	O
of	O
its	O
pandemic	O
potential	O
.	O

Awareness	O
and	O
concern	O
about	O
bird	B-SPEC
flu	O
is	O
low	O
(	O
lower	O
than	O
a	O
recent	O
survey	O
of	O
U	O
.	O
S	O
.	O
residents	O
).	O

Our	O
study	O
and	O
those	O
examining	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
epidemic	O
suggest	O
that	O
governments	O
,	O
including	O
the	O
Australian	O
government	O
,	O
will	O
encounter	O
a	O
number	O
of	O
significant	O
communication	O
challenges	O
in	O
the	O
event	O
of	O
a	O
bird	B-SPEC
flu	O
outbreak	O
.	O

Since	O
its	O
discovery	O
,	O
many	O
trials	O
have	O
been	O
executed	O
to	O
establish	O
the	O
prophylactic	O
and	O
therapeutics	O
toward	O
SARS	O
using	O
laboratory	O
animals	B-SPEC
.	O

Furthermore	O
,	O
LC16mOrVV	O
-	O
N	O
-	O
immunized	O
mice	B-SPEC
upon	O
infection	O
exhibited	O
significant	O
up	O
-	O
regulation	O
of	O
both	O
Th1	O
(	O
IFN	O
-	O
gamma	O
,	O
IL	O
-	O
2	O
)	O
and	O
Th2	O
(	O
IL	O
-	O
4	O
,	O
IL	O
-	O
5	O
)	O
cytokines	O
and	O
down	O
-	O
regulation	O
of	O
anti	O
-	O
inflammatory	O
cytokines	O
(	O
IL	O
-	O
10	O
,	O
TGF	O
-	O
beta	O
),	O
resulting	O
in	O
robust	O
infiltration	O
of	O
neutrophils	O
,	O
eosinophils	O
,	O
and	O
lymphocytes	O
into	O
the	O
lung	O
,	O
as	O
well	O
as	O
thickening	O
of	O
the	O
alveolar	O
epithelium	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
cause	O
respiratory	O
infections	O
ranging	O
from	O
common	O
colds	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
humans	B-SPEC
.	O

Four	O
human	B-SPEC
and	O
one	O
feline	B-SPEC
coronavirus	B-SPEC
antigen	O
were	O
cloned	O
into	O
baculoviruses	O
expressed	O
in	O
insect	B-SPEC
cells	O
and	O
recovered	O
proteins	O
bound	O
in	O
the	O
solid	O
phase	O
of	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
-	O
based	O
system	O
.	O

No	O
evidence	O
of	O
a	O
significant	O
serological	O
response	O
to	O
the	O
feline	B-SPEC
coronavirus	B-SPEC
was	O
observed	O
.	O

ABSTRACT	O
:	O
Tuberculosis	O
is	O
the	O
most	O
common	O
infectious	O
complication	O
in	O
HIV	B-SPEC
infected	O
patients	O
.	O

Human	B-SPEC
encroachment	O
on	O
remote	O
areas	O
has	O
brought	O
contact	O
with	O
zoonotic	O
diseases	O
never	O
before	O
characterized	O
.	O

TITLE	O
:	O
Novel	O
modifications	O
in	O
the	O
series	O
of	O
O	O
-(	O
2	O
-	O
phthalimidoethyl	O
)-	O
N	O
-	O
substituted	O
thiocarbamates	O
and	O
their	O
ring	O
-	O
opened	O
congeners	O
as	O
non	O
-	O
nucleoside	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
inhibitors	O
.	O

Twenty	O
-	O
two	O
C	O
-	O
TCs	O
displayed	O
nanomolar	O
activity	O
against	O
wild	O
-	O
type	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
a	O
number	O
of	O
analogues	O
were	O
effective	O
against	O
the	O
Y181C	O
mutant	O
.	O

The	O
virus	B-SPEC
was	O
also	O
detectable	O
in	O
the	O
oviduct	O
of	O
vaccinated	O
,	O
challenged	O
hens	O
although	O
the	O
viral	O
load	O
was	O
much	O
lower	O
compared	O
to	O
the	O
viral	O
load	O
in	O
the	O
oviduct	O
of	O
unvaccinated	O
,	O
challenged	O
hens	O
.	O

The	O
PMMA	O
microchip	O
was	O
used	O
for	O
detection	O
of	O
multiplex	O
PCR	O
products	O
of	O
18	O
and	O
36	O
cases	O
with	O
SARS	O
and	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
infection	O
under	O
optimized	O
separation	O
conditions	O
.	O

TITLE	O
:	O
Seroprevalence	O
of	O
SARS	O
Coronavirus	B-SPEC
Among	O
Residents	O
Near	O
a	O
Hospital	O
with	O
a	O
Nosocomial	O
Outbreak	O
.	O

The	O
purpose	O
of	O
our	O
study	O
was	O
to	O
survey	O
the	O
prevalence	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
in	O
a	O
community	O
adjacent	O
to	O
Kaohsiung	O
CGMH	O
and	O
collect	O
demographic	O
data	O
,	O
including	O
basic	O
information	O
about	O
health	O
status	O
,	O
household	O
,	O
and	O
possible	O
risk	O
factors	O
for	O
SARS	O
-	O
CoV	B-SPEC
infection	O
.	O

We	O
found	O
that	O
HeLa	O
cells	O
infected	O
with	O
229E	O
via	O
APN	O
formed	O
syncytia	O
when	O
treated	O
with	O
trypsin	O
or	O
other	O
proteases	O
but	O
not	O
in	O
a	O
low	O
-	O
pH	O
environment	O
,	O
a	O
finding	O
consistent	O
with	O
syncytium	O
formation	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

By	O
using	O
infectious	O
viruses	B-SPEC
and	O
pseudotyped	O
viruses	B-SPEC
bearing	O
the	O
229E	O
S	O
protein	O
,	O
we	O
found	O
that	O
its	O
infection	O
was	O
profoundly	O
blocked	O
by	O
lysosomotropic	O
agents	O
as	O
well	O
as	O
by	O
protease	O
inhibitors	O
that	O
also	O
prevented	O
infection	O
with	O
SARS	O
-	O
CoV	O
but	O
not	O
that	O
caused	O
by	O
murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
JHMV	O
,	O
which	O
enters	O
cells	O
directly	O
from	O
the	O
cell	O
surface	O
.	O

For	O
helicase	O
,	O
spike	O
,	O
and	O
nucleocapsid	O
,	O
they	O
were	O
also	O
clustered	O
with	O
a	O
CoV	O
recently	O
discovered	O
in	O
Asian	O
leopard	B-SPEC
cats	I-SPEC
,	O
for	O
which	O
the	O
complete	O
genome	O
sequence	O
was	O
not	O
available	O
.	O

TITLE	O
:	O
Seroprevalence	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
in	O
North	O
American	O
turkeys	B-SPEC
determined	O
by	O
a	O
newly	O
developed	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
based	O
on	O
recombinant	O
antigen	O
.	O

To	O
address	O
this	O
,	O
the	O
complete	O
nucleocapsid	O
gene	O
was	O
cloned	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

The	O
disease	O
in	O
the	O
lungs	O
of	O
the	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
group	O
and	O
both	O
IBV	B-SPEC
/	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
groups	O
was	O
similar	O
.	O

The	O
mechanism	O
for	O
this	O
is	O
unknown	O
,	O
however	O
the	O
suppression	O
of	O
a	O
key	O
antiviral	O
strategy	O
during	O
a	O
period	O
of	O
physiologic	O
and	O
immunological	O
stress	O
,	O
such	O
as	O
on	O
entry	O
to	O
a	O
kennel	O
,	O
could	O
potentially	O
predispose	O
a	O
dog	B-SPEC
to	O
further	O
pathogenic	O
challenge	O
and	O
the	O
development	O
of	O
respiratory	O
disease	O
.	O

TITLE	O
:	O
Identification	O
of	O
major	O
histocompatibility	O
complex	O
class	B-SPEC
I	O
C	O
molecule	O
as	O
an	O
attachment	O
factor	O
that	O
facilitates	O
coronavirus	B-SPEC
HKU1	O
spike	O
-	O
mediated	O
infection	O
.	O

However	O
,	O
the	O
variation	O
of	O
the	O
S	O
gene	O
between	O
viruses	B-SPEC
may	O
affect	O
the	O
efficacy	O
of	O
a	O
vaccine	O
,	O
particularly	O
for	O
cross	O
-	O
protection	O
against	O
SARS	O
-	O
like	O
CoV	O
(	O
SL	O
-	O
CoV	O
).	O

SAT	O
-	O
SIT	O
technology	O
will	O
find	O
applications	O
in	O
rapid	O
screening	O
of	O
samples	O
for	O
other	O
hemagglutinating	O
emerging	O
viruses	B-SPEC
of	O
animals	B-SPEC
and	O
humans	B-SPEC
(	O
influenza	B-SPEC
virus	I-SPEC
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
).	O

TITLE	O
:	O
Structural	O
and	O
biochemical	O
investigation	O
of	O
heptad	O
repeat	O
derived	O
peptides	O
of	O
human	B-SPEC
SARS	O
corona	B-SPEC
virus	B-SPEC
(	O
hSARS	O
-	O
CoV	O
)	O
spike	O
protein	O
.	O

Fundamental	O
determinants	O
,	O
typically	O
acting	O
in	O
concert	O
,	O
seem	O
to	O
underlie	O
their	O
emergence	O
,	O
and	O
infections	O
such	O
as	O
these	O
are	O
likely	O
to	O
continue	O
to	O
remain	O
challenges	O
to	O
human	B-SPEC
survival	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
the	O
predominant	O
cause	O
of	O
severe	O
entero	O
-	O
pathogenic	O
diarrhea	O
in	O
swine	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
Q7R	O
,	O
which	O
actively	O
inhibited	O
PEDV	B-SPEC
replication	O
with	O
a	O
50	O
%	O
inhibitory	O
concentration	O
(	O
IC	O
(	O
50	O
))	O
of	O
0	O
.	O
014	O
microg	O
/	O
mL	O
.	O
The	O
50	O
%	O
cytotoxicity	O
concentration	O
(	O
CC	O
(	O
50	O
))	O
of	O
Q7R	O
was	O
over	O
100	O
microg	O
/	O
mL	O
and	O
the	O
derived	O
therapeutic	O
index	O
was	O
7142	O
.	O

Q7R	O
could	O
be	O
considered	O
as	O
a	O
lead	O
compound	O
for	O
development	O
of	O
anti	O
-	O
PEDV	B-SPEC
drugs	O
to	O
may	O
be	O
used	O
to	O
during	O
the	O
early	O
stage	O
of	O
PEDV	B-SPEC
replication	O
and	O
the	O
structure	O
-	O
activity	O
data	O
of	O
Q7R	O
may	O
usefully	O
guideline	O
to	O
design	O
other	O
related	O
antiviral	O
agents	O
.	O

Lesions	O
were	O
induced	O
after	O
a	O
single	O
intratracheal	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
infection	O
,	O
and	O
after	O
an	O
infection	O
with	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
preceded	O
5	O
days	O
earlier	O
by	O
an	O
oculo	O
-	O
nasal	O
and	O
intratracheal	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
infection	O
of	O
either	O
the	O
virulent	O
M41	O
strain	O
or	O
the	O
H120	O
vaccine	O
strain	O
.	O

Tissue	O
samples	O
were	O
taken	O
at	O
3h	O
post	O
-	O
inoculation	O
(	O
hpi	O
),	O
and	O
1	O
,	O
2	O
,	O
4	O
and	O
7	O
days	O
post	O
-	O
inoculation	O
(	O
dpi	O
)	O
with	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
.	O

IBV	B-SPEC
antigen	O
was	O
detected	O
in	O
secondary	O
bronchi	O
and	O
airsacs	O
up	O
to	O
2	O
dpi	O
and	O
in	O
the	O
trachea	B-SPEC
up	O
to	O
4	O
dpi	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
varies	O
greatly	O
from	O
causing	O
subclinical	O
or	O
mild	O
enteric	O
infections	O
to	O
fatal	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

The	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
7b	O
of	O
FCoV	O
has	O
been	O
speculated	O
to	O
play	O
a	O
determining	O
role	O
in	O
virulence	O
as	O
deletions	O
were	O
found	O
to	O
be	O
associated	O
with	O
avirulent	O
viruses	B-SPEC
.	O

The	O
ORF7b	O
from	O
the	O
peritoneal	O
/	O
pleural	O
effusions	O
of	O
FIP	O
cats	B-SPEC
and	O
from	O
the	O
rectal	O
swabs	O
of	O
healthy	O
cats	B-SPEC
was	O
amplified	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
cause	O
a	O
broad	O
range	O
of	O
diseases	O
in	O
animals	B-SPEC
and	O
humans	B-SPEC
.	O

Human	B-SPEC
coronavirus	I-SPEC
(	O
hCoV	O
)	O
NL63	O
is	O
associated	O
with	O
up	O
to	O
10	O
%	O
of	O
common	O
colds	O
.	O

Viral	O
plaque	O
assays	O
enable	O
the	O
characterization	O
of	O
virus	B-SPEC
infectivity	O
and	O
allow	O
for	O
purifying	O
virus	B-SPEC
stock	O
solutions	O
.	O

RESULTS	O
:	O
12	O
different	O
cell	O
cultures	O
were	O
tested	O
for	O
susceptibility	O
to	O
hCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
.	O

The	O
application	O
of	O
inhaled	O
nitric	O
oxide	O
(	O
iNO	O
)	O
is	O
a	O
therapeutic	O
option	O
to	O
selectively	O
influence	O
pulmonary	O
blood	O
flow	O
in	O
order	B-SPEC
to	O
improve	O
arterial	O
oxygenation	O
and	O
to	O
decrease	O
pulmonary	O
artery	O
pressure	O
without	O
relevant	O
systemic	O
side	O
effects	O
.	O

TITLE	O
:	O
Formation	O
of	O
stable	O
homodimer	O
via	O
the	O
C	O
-	O
terminal	O
alpha	O
-	O
helical	O
domain	O
of	O
coronavirus	B-SPEC
nonstructural	O
protein	O
9	O
is	O
critical	O
for	O
its	O
function	O
in	O
viral	O
replication	O
.	O

Meanwhile	O
,	O
mutations	O
of	O
some	O
positively	O
charged	O
residues	O
in	O
the	O
beta	O
-	O
barrel	O
regions	O
of	O
the	O
IBV	B-SPEC
nsp9	O
protein	O
significantly	O
reduced	O
its	O
RNA	O
-	O
binding	O
activity	O
,	O
but	O
with	O
no	O
obvious	O
effect	O
on	O
dimerization	O
of	O
the	O
protein	O
.	O

ABSTRACT	O
:	O
Turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
)	O
polyprotein	O
was	O
predicted	O
to	O
be	O
cleaved	O
into	O
15	O
non	O
-	O
structural	O
proteins	O
(	O
nsp2	O
to	O
nsp16	O
),	O
but	O
none	O
of	O
these	O
nsps	O
have	O
been	O
characterized	O
.	O

TCoV	O
nsp15	O
consists	O
of	O
338	O
residues	O
and	O
shares	O
40	O
%	O
sequence	O
similarity	O
to	O
U	O
-	O
specific	O
Nidovirales	B-SPEC
endoribonuclease	O
(	O
NendoU	O
)	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

The	O
TCoV	O
nsp15	O
cleaved	O
hairpin	O
RNA	O
,	O
pRNA	O
,	O
and	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
of	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
very	O
slowly	O
,	O
implying	O
that	O
dsRNA	O
is	O
not	O
a	O
good	O
substrate	O
for	O
the	O
TCoV	O
nsp15	O
.	O

ABSTRACT	O
:	O
The	O
helicase	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
possesses	O
NTPase	O
,	O
duplex	O
RNA	O
/	O
DNA	O
-	O
unwinding	O
and	O
RNA	O
-	O
capping	O
activities	O
that	O
are	O
essential	O
for	O
viral	O
replication	O
and	O
proliferation	O
.	O

This	O
study	O
used	O
a	O
broad	O
capture	O
,	O
rapid	O
and	O
sensitive	O
method	O
(	O
multiplex	O
PCR	O
assay	O
)	O
to	O
detect	O
20	O
different	O
respiratory	O
pathogens	O
including	O
influenza	O
A	O
subtypes	O
H1	O
,	O
H3	O
,	O
and	O
H5	O
;	O
influenza	O
B	O
;	O
parainfluenza	O
types	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
;	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
groups	O
A	O
and	O
B	O
;	O
adenoviruses	B-SPEC
;	O
human	B-SPEC
rhinoviruses	B-SPEC
;	O
enteroviruses	B-SPEC
;	O
human	B-SPEC
metapneumoviruses	B-SPEC
;	O
human	B-SPEC
coronaviruses	O
OC43	O
,	O
229E	O
,	O
and	O
SARS	O
-	O
CoV	O
;	O
Chlamydophila	B-SPEC
pneumoniae	I-SPEC
;	O
Legionella	B-SPEC
pneumophila	I-SPEC
;	O
and	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
;	O
from	O
respiratory	O
specimens	O
of	O
475	O
children	O
hospitalized	O
over	O
a	O
12	O
-	O
month	O
period	O
for	O
acute	O
respiratory	O
tract	O
infections	O
.	O

TITLE	O
:	O
[	O
Isolation	O
and	O
genomic	O
sequence	O
analysis	O
of	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
].	O

TITLE	O
:	O
The	O
expression	O
and	O
antigenicity	O
of	O
a	O
truncated	O
spike	O
-	O
nucleocapsid	O
fusion	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
.	O

The	O
fusion	O
protein	O
was	O
analyzed	O
for	O
reactivity	O
with	O
SARS	O
patients	O
'	O
sera	O
and	O
with	O
anti	O
-	O
sera	O
against	O
the	O
two	O
human	B-SPEC
coronaviruses	O
HCoV	O
229E	O
and	O
HCoV	O
OC43	O
by	O
ELISA	O
,	O
IFA	O
and	O
immunoblot	O
assays	O
.	O

Furthermore	O
,	O
to	O
evaluate	O
the	O
antigen	O
-	O
specific	O
humoral	O
antibody	O
and	O
T	O
-	O
cell	O
responses	O
in	O
mice	B-SPEC
,	O
the	O
fusion	O
protein	O
was	O
injected	O
into	O
6	O
-	O
week	O
-	O
old	O
BALB	O
/	O
c	O
mice	B-SPEC
and	O
a	O
neutralization	O
test	O
as	O
well	O
as	O
a	O
T	O
-	O
cell	O
analysis	O
was	O
performed	O
.	O

To	O
evaluate	O
the	O
antiviral	O
efficacy	O
of	O
immunization	O
,	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
challenged	O
intranasally	O
with	O
SARSCoV	O
at	O
day	O
33	O
post	O
injection	O
and	O
viral	O
loads	O
were	O
determined	O
by	O
fluorescent	O
quantitative	O
RT	O
-	O
PCR	O
.	O

We	O
performed	O
a	O
retrospective	O
study	O
of	O
28	O
patients	O
who	O
were	O
admitted	O
for	O
severe	O
bacterial	O
pneumonia	O
(	O
pneumonia	O
severity	O
index	O
;	O
PSI	O
class	B-SPEC
V	O
).	O

We	O
concentrate	O
on	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
protease	O
inhibitors	O
,	O
as	O
these	O
have	O
made	O
the	O
most	O
significant	O
advances	O
in	O
the	O
recent	O
past	O
.	O

TITLE	O
:	O
Nuclear	O
magnetic	O
resonance	O
structure	O
shows	O
that	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
-	O
unique	O
domain	O
contains	O
a	O
macrodomain	O
fold	O
.	O

TITLE	O
:	O
Novel	O
influenza	B-SPEC
virus	I-SPEC
NS1	O
antagonists	O
block	O
replication	O
and	O
restore	O
innate	O
immune	O
function	O
.	O

Previously	O
,	O
we	O
described	O
the	O
identification	O
of	O
a	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
with	O
the	O
use	O
of	O
the	O
VIDISCA	O
method	O
.	O

TITLE	O
:	O
RT	O
-	O
PCR	O
detection	O
of	O
avian	B-SPEC
coronaviruses	O
of	O
galliform	O
birds	B-SPEC
(	O
chicken	B-SPEC
,	O
turkey	B-SPEC
,	O
pheasant	O
)	O
and	O
in	O
a	O
parrot	B-SPEC
.	O

The	O
gene	O
1	O
primer	O
pair	O
enabled	O
the	O
detection	O
of	O
a	O
new	O
coronavirus	B-SPEC
in	O
a	O
green	O
-	O
checked	O
Amazon	B-SPEC
parrot	I-SPEC
(	O
Amazon	B-SPEC
viridigenalis	O
Cassin	O
).	O

Vaccinia	B-SPEC
virus	I-SPEC
as	O
a	O
vector	O
for	O
the	O
full	O
-	O
length	O
IBV	B-SPEC
cDNA	O
has	O
the	O
advantage	O
that	O
modifications	O
can	O
be	O
introduced	O
into	O
the	O
IBV	B-SPEC
cDNA	O
using	O
homologous	O
recombination	O
,	O
a	O
method	O
frequently	O
used	O
to	O
insert	O
and	O
delete	O
sequences	O
from	O
the	O
vaccinia	B-SPEC
virus	I-SPEC
genome	O
.	O

TITLE	O
:	O
Generation	O
of	O
recombinant	O
coronaviruses	O
using	O
vaccinia	B-SPEC
virus	I-SPEC
as	O
the	O
cloning	O
vector	O
and	O
stable	O
cell	O
lines	O
containing	O
coronaviral	O
replicon	O
RNAs	O
.	O

Here	O
we	O
provide	O
a	O
collection	O
of	O
protocols	O
for	O
the	O
generation	O
,	O
cloning	O
,	O
and	O
modification	O
of	O
full	O
-	O
length	O
coronavirus	B-SPEC
cDNA	O
using	O
vaccinia	B-SPEC
virus	I-SPEC
as	O
a	O
cloning	O
vector	O
.	O

In	O
the	O
second	O
step	O
this	O
chimeric	O
virus	B-SPEC
is	O
used	O
as	O
the	O
recipient	O
for	O
recombination	O
with	O
synthetic	O
donor	O
RNA	O
carrying	O
the	O
original	O
spike	O
gene	O
.	O

Electron	O
microscopy	O
(	O
EM	O
)	O
overcomes	O
some	O
problems	O
associated	O
with	O
particle	O
variability	O
and	O
has	O
been	O
an	O
important	O
tool	O
for	O
investigating	O
coronavirus	B-SPEC
ultrastructure	O
.	O

IBV	B-SPEC
replicates	O
well	O
in	O
the	O
embryonated	O
chicken	B-SPEC
egg	O
,	O
regardless	O
of	O
the	O
inoculation	O
route	O
;	O
however	O
,	O
the	O
allantoic	O
route	O
is	O
favored	O
as	O
the	O
virus	B-SPEC
replicates	O
extensively	O
in	O
chorioallantoic	O
membrane	O
and	O
high	O
titers	O
are	O
found	O
in	O
allantoic	O
fluid	O
.	O

TCoV	O
replicates	O
only	O
in	O
embryo	O
tissues	O
,	O
within	O
epithelium	O
of	O
the	O
intestines	O
and	O
bursa	B-SPEC
of	O
Fabricius	O
;	O
thus	O
amniotic	O
inoculation	O
is	O
required	O
for	O
isolation	O
and	O
propagation	O
of	O
this	O
virus	B-SPEC
.	O

In	O
this	O
chapter	O
,	O
we	O
describe	O
a	O
pancoronavirus	O
degenerate	O
primer	O
-	O
based	O
method	O
that	O
allows	O
the	O
detection	O
of	O
all	O
known	O
and	O
possibly	O
unknown	O
coronaviruses	O
by	O
RT	O
-	O
PCR	O
amplification	O
and	O
sequencing	O
of	O
a	O
251	O
-	O
bp	O
fragment	O
of	O
the	O
coronavirus	B-SPEC
polymerase	O
gene	O
.	O

Also	O
,	O
direct	O
treatment	O
of	O
infected	O
glial	O
cultures	O
with	O
recombinant	O
mouse	B-SPEC
IFN	O
-	O
alpha	O
or	O
IFN	O
-	O
beta	O
inhibits	O
viral	O
replication	O
.	O

ABSTRACT	O
:	O
Numerous	O
studies	O
have	O
evaluated	O
human	B-SPEC
papillomavirus	I-SPEC
(	O
HPV	B-SPEC
)	O
DNA	O
load	O
in	O
women	O
,	O
especially	O
HPV	B-SPEC
-	O
16	O
viral	O
load	O
,	O
and	O
its	O
role	O
in	O
cervical	O
carcinogenicity	O
.	O

This	O
study	O
demonstrates	O
that	O
FGL2	O
is	O
an	O
important	O
effector	O
cytokine	O
of	O
Tregs	O
that	O
contributes	O
to	O
susceptibility	O
to	O
MHV	B-SPEC
-	O
3	O
-	O
induced	O
FH	O
.	O

In	O
an	O
earlier	O
study	O
using	O
sentinel	O
chickens	B-SPEC
we	O
determined	O
the	O
incidence	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
Ontario	O
commercial	O
layer	O
flocks	O
.	O

IBV	B-SPEC
-	O
ON4	O
had	O
98	O
.	O
7	O
%	O
identity	O
with	O
the	O
strain	O
PA	O
/	O
1220	O
/	O
9	O
,	O
a	O
nephropathogenic	O
variant	O
.	O

TITLE	O
:	O
Associations	O
between	O
male	O
anogenital	O
human	B-SPEC
papillomavirus	I-SPEC
infection	O
and	O
circumcision	O
by	O
anatomic	O
site	O
sampled	O
and	O
lifetime	O
number	O
of	O
female	O
sex	O
partners	O
.	O

The	O
new	O
method	O
for	O
detection	O
of	O
these	O
viruses	B-SPEC
was	O
applied	O
simultaneously	O
with	O
real	O
-	O
time	O
PCR	O
for	O
the	O
detection	O
of	O
six	O
bacterial	O
pathogens	O
in	O
clinical	O
samples	O
from	O
1700	O
pediatric	O
patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
).	O

One	O
of	O
these	O
proteins	O
,	O
protein	O
6	O
(	O
p6	O
),	O
which	O
is	O
encoded	O
by	O
ORF6	O
,	O
enhances	O
virus	B-SPEC
replication	O
when	O
introduced	O
into	O
a	O
heterologous	O
murine	B-SPEC
coronavirus	I-SPEC
(	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
[	O
MHV	B-SPEC
])	O
but	O
is	O
not	O
essential	O
for	O
optimal	O
SARS	O
-	O
CoV	O
replication	O
after	O
infection	O
at	O
a	O
relatively	O
high	O
multiplicity	O
of	O
infection	O
(	O
MOI	O
).	O

TITLE	O
:	O
Characterization	O
of	O
a	O
continuous	O
feline	B-SPEC
mammary	O
epithelial	O
cell	O
line	O
susceptible	O
to	O
feline	B-SPEC
epitheliotropic	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Mucosal	O
epithelial	O
cells	O
are	O
the	O
primary	O
targets	O
for	O
many	O
common	O
viral	O
pathogens	O
of	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
infection	O
of	O
293	O
/	O
ACE2	O
cells	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
activated	O
several	O
apoptosis	O
-	O
associated	O
events	O
,	O
namely	O
,	O
cleavage	O
of	O
caspase	O
-	O
3	O
,	O
caspase	O
-	O
8	O
,	O
and	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
1	O
(	O
PARP	O
),	O
and	O
chromatin	O
condensation	O
and	O
the	O
phosphorylation	O
and	O
hence	O
inactivation	O
of	O
the	O
eukaryotic	O
translation	O
initiation	O
factor	O
2alpha	O
(	O
eIF2alpha	O
).	O

LSECtin	O
acts	O
as	O
a	O
pathogen	O
attachment	O
factor	O
for	O
Ebolavirus	B-SPEC
and	O
the	O
SARS	O
coronavirus	B-SPEC
,	O
and	O
its	O
expression	O
can	O
be	O
induced	O
by	O
interleukin	O
-	O
4	O
on	O
monocytes	O
and	O
macrophages	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
in	O
Toronto	O
children	O
:	O
a	O
second	O
look	O
.	O

This	O
report	O
provides	O
an	O
update	O
on	O
pediatric	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infections	O
in	O
Toronto	O
,	O
Ontario	O
,	O
Canada	O
,	O
that	O
includes	O
microbiological	O
findings	O
.	O

Exposure	O
that	O
was	O
limited	O
to	O
visiting	O
a	O
Toronto	O
hospital	O
at	O
which	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
-	O
infected	O
patients	O
were	O
admitted	O
or	O
travel	O
from	O
a	O
country	O
in	O
which	O
severe	O
acute	O
respiratory	O
syndrome	O
had	O
been	O
reported	O
did	O
not	O
result	O
in	O
documented	O
infection	O
in	O
any	O
of	O
our	O
cases	O
.	O

RESULTS	O
:	O
Neutralizing	O
antibody	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
was	O
demonstrated	O
in	O
8	O
of	O
25	O
children	O
admitted	O
with	O
suspect	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Antibody	O
-	O
dependent	O
enhancement	O
occurs	O
upon	O
re	O
-	O
infection	O
with	O
the	O
identical	O
serotype	O
virus	B-SPEC
in	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
infection	O
.	O

These	O
data	O
suggest	O
that	O
re	O
-	O
infection	O
with	O
the	O
same	O
serotype	O
induces	O
ADE	O
in	O
cats	B-SPEC
infected	O
with	O
FIPV	O
.	O

ABSTRACT	O
:	O
The	O
hyperinduction	O
of	O
proinflammatory	O
cytokines	O
and	O
chemokines	O
such	O
as	O
TNF	O
-	O
alpha	O
,	O
IFN	O
-	O
beta	O
,	O
and	O
CCL2	O
/	O
MCP	O
-	O
1	O
in	O
primary	O
human	B-SPEC
macrophages	O
and	O
respiratory	O
epithelial	O
cells	O
by	O
the	O
highly	O
pathogenic	O
avian	B-SPEC
influenza	O
H5N1	O
is	O
believed	O
to	O
contribute	O
to	O
the	O
unusual	O
severity	O
of	O
human	B-SPEC
H5N1	O
disease	O
.	O

Here	O
we	O
show	O
that	O
TNF	O
-	O
alpha	O
,	O
IFN	O
-	O
beta	O
,	O
and	O
IFN	O
-	O
lambda1	O
are	O
the	O
key	O
mediators	O
directly	O
induced	O
by	O
the	O
H5N1	O
virus	B-SPEC
in	O
primary	O
human	B-SPEC
macrophages	O
.	O

ABSTRACT	O
:	O
The	O
swift	B-SPEC
production	O
of	O
type	O
I	O
IFNs	O
is	O
one	O
of	O
the	O
fundamental	O
aspects	O
of	O
innate	O
immune	O
responses	O
against	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
enveloped	O
viruses	B-SPEC
containing	O
the	O
largest	O
reported	O
RNA	O
genomes	O
.	O

An	O
effective	O
IRT	O
system	O
with	O
a	O
strict	O
operating	O
protocol	O
can	O
be	O
rapidly	O
implemented	O
at	O
the	O
entrance	O
of	O
a	O
hospital	O
during	O
SARS	O
or	O
avian	B-SPEC
influenza	O
epidemics	O
.	O

The	O
nine	O
remaining	O
hypoxemic	O
patients	O
had	O
either	O
focal	O
infiltrates	O
or	O
a	O
negative	O
chest	O
X	O
-	O
ray	B-SPEC
.	O

TITLE	O
:	O
Role	O
of	O
regulatory	O
T	O
cells	O
in	O
coronavirus	B-SPEC
-	O
induced	O
acute	O
encephalitis	O
.	O

Increased	O
mortality	O
correlated	O
with	O
a	O
greater	O
number	O
of	O
JHMV	O
-	O
specific	O
CD4	O
T	O
cells	O
in	O
the	O
brains	O
of	O
rJ	O
compared	O
to	O
rJ	O
.	O
M	O
(	O
Y135Q	O
)-	O
infected	O
mice	B-SPEC
.	O

TITLE	O
:	O
Production	O
of	O
protective	O
gamma	O
interferon	O
by	O
natural	O
killer	O
cells	O
during	O
early	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coxsackievirus	B-SPEC
(	O
CV	O
)	O
belongs	O
to	O
the	O
picornavirus	B-SPEC
family	B-SPEC
,	O
which	O
consists	O
of	O
over	O
200	O
medically	O
relevant	O
viruses	B-SPEC
.	O

In	O
picornavirus	B-SPEC
,	O
a	O
chymotrypsin	O
-	O
like	O
protease	O
(	O
3C	O
(	O
pro	O
))	O
is	O
required	O
for	O
viral	O
replication	O
by	O
processing	O
the	O
polyproteins	O
,	O
and	O
thus	O
it	O
is	O
regarded	O
as	O
an	O
antiviral	O
drug	O
target	O
.	O

A	O
3C	O
-	O
like	O
protease	O
(	O
3CL	O
(	O
pro	O
))	O
also	O
exists	O
in	O
human	B-SPEC
coronaviruses	O
(	O
CoV	O
)	O
such	O
as	O
229E	O
and	O
the	O
one	O
causing	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

Nitrile	O
oxides	O
were	O
generated	O
in	O
situ	O
from	O
oximes	O
using	O
a	O
commercial	O
bleaching	O
agent	O
;	O
their	O
cycloaddition	O
with	O
5	O
-	O
ethynyl	O
-	O
2	O
'-	O
deoxyuridine	O
yielded	O
isoxazoles	O
possessing	O
activity	O
against	O
herpes	B-SPEC
simplex	I-SPEC
viruses	I-SPEC
1	O
and	O
2	O
,	O
Encephalomyocarditis	B-SPEC
virus	I-SPEC
,	O
Coxsackie	O
B3	O
,	O
and	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
;	O
these	O
isoxazoles	O
were	O
,	O
however	O
,	O
inactive	O
against	O
corona	B-SPEC
virus	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
and	O
HIV	B-SPEC
.	O

We	O
conclude	O
that	O
these	O
peptide	O
nanoparticles	O
represent	O
a	O
promising	O
platform	O
for	O
vaccine	O
design	O
,	O
in	O
particular	O
for	O
diseases	O
that	O
are	O
characterized	O
by	O
neutralizing	O
epitopes	O
with	O
coiled	O
-	O
coil	O
conformation	O
such	O
as	O
SARS	O
-	O
CoV	O
or	O
other	O
enveloped	O
viruses	B-SPEC
.	O

Nsp9	O
forms	O
a	O
dimer	O
through	O
the	O
interaction	O
of	O
parallel	O
alpha	O
-	O
helices	B-SPEC
containing	O
the	O
protein	O
-	O
protein	O
interaction	O
motif	O
GXXXG	O
.	O

The	O
G104V	O
mutant	O
produced	O
highly	O
debilitated	O
virus	B-SPEC
and	O
eventually	O
reverted	O
back	O
to	O
the	O
wild	O
-	O
type	O
protein	O
sequence	O
through	O
a	O
codon	O
transversion	O
.	O

Infectious	O
disease	O
outbreaks	O
are	O
among	O
the	O
most	O
dramatic	O
aspects	O
of	O
systems	O
failure	O
,	O
and	O
the	O
Canadian	O
cases	O
of	O
SARS	O
(	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
)	O
in	O
Toronto	O
,	O
and	O
the	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
outbreak	O
in	O
Walkerton	O
,	O
serve	O
as	O
useful	O
illustrative	O
examples	O
.	O

ABSTRACT	O
:	O
We	O
examined	O
perceived	O
threats	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
and	O
West	B-SPEC
Nile	I-SPEC
Virus	I-SPEC
using	O
an	O
Internet	O
-	O
based	O
questionnaire	O
.	O

Although	O
its	O
cost	O
and	O
technological	O
availability	O
make	O
it	O
unlikely	O
that	O
this	O
system	O
will	O
very	O
soon	O
be	O
the	O
diagnostic	O
standard	O
worldwide	O
,	O
this	O
system	O
could	O
be	O
useful	O
for	O
the	O
earlier	O
discovery	O
of	O
novel	O
emerging	O
viruses	B-SPEC
and	O
bioterrorism	O
,	O
which	O
are	O
difficult	O
to	O
detect	O
with	O
conventional	O
procedures	O
.	O

Here	O
,	O
we	O
report	O
our	O
findings	O
of	O
a	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
two	O
viral	O
vectors	O
modified	O
vaccinia	O
Ankara	O
(	O
MVA	O
)	O
and	O
a	O
novel	O
replication	O
-	O
competent	O
modified	O
vaccinia	O
Tian	O
Tan	O
(	O
MVTT	O
)	O
for	O
inducing	O
neutralizing	O
antibodies	O
(	O
Nabs	O
)	O
via	O
intramuscular	O
and	O
mucosal	O
vaccinations	O
in	O
mice	B-SPEC
.	O

In	O
particular	O
,	O
a	O
probable	O
origin	O
from	O
the	O
strictly	O
related	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
or	O
,	O
alternatively	O
,	O
from	O
a	O
common	O
ancestor	O
has	O
been	O
suggested	O
for	O
some	O
group	O
2a	O
CoVs	O
,	O
including	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
).	O

The	O
government	O
can	O
promote	O
vaccination	O
by	O
educating	O
the	O
public	O
about	O
the	O
advantages	O
,	O
by	O
publicizing	O
locations	O
where	O
vaccinations	O
are	O
available	O
,	O
and	O
having	O
nursing	O
,	O
other	O
medical	O
staff	O
,	O
family	B-SPEC
and	O
friends	O
encourage	O
elderly	O
people	O
to	O
be	O
vaccinated	O
.	O

Furthermore	O
,	O
we	O
have	O
demonstrated	O
that	O
ACE2	O
expressed	O
in	O
Chinese	B-SPEC
hamster	I-SPEC
ovary	O
cells	O
specifically	O
binds	O
to	O
glutathione	O
-	O
S	O
-	O
transferase	O
-	O
calmodulin	O
,	O
but	O
not	O
glutathione	O
-	O
S	O
-	O
transferase	O
alone	O
,	O
in	O
pull	O
-	O
down	O
assays	O
using	O
cell	O
lysates	O
.	O

ABSTRACT	O
:	O
Among	O
field	O
isolates	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
from	O
recent	O
outbreaks	O
,	O
some	O
isolates	O
that	O
were	O
classified	O
into	O
the	O
4	O
/	O
91	O
genotype	O
,	O
by	O
analysis	O
of	O
the	O
S1	O
gene	O
,	O
have	O
been	O
confirmed	O
to	O
be	O
a	O
new	O
variant	O
in	O
Japan	O
.	O

Previous	O
studies	O
of	O
NDV	B-SPEC
-	O
vectored	O
vaccines	O
in	O
a	O
mouse	B-SPEC
model	O
suggested	O
their	O
potency	O
after	O
delivery	O
by	O
injection	O
or	O
by	O
the	O
intranasal	O
route	O
.	O

We	O
have	O
used	O
a	O
vaccinia	B-SPEC
virus	I-SPEC
-	O
based	O
reverse	O
genetic	O
system	O
to	O
produce	O
recombinant	O
viruses	B-SPEC
encoding	O
ns2	O
proteins	O
with	O
single	O
-	O
amino	O
-	O
acid	O
substitutions	O
in	O
,	O
or	O
adjacent	O
to	O
,	O
these	O
conserved	O
motifs	O
,	O
namely	O
,	O
inf	O
-	O
ns2	O
H46A	O
,	O
inf	O
-	O
ns2	O
S48A	O
,	O
inf	O
-	O
ns2	O
-	O
S120A	O
,	O
and	O
inf	O
-	O
ns2	O
-	O
H126R	O
.	O

These	O
results	O
show	O
that	O
the	O
ns2	O
protein	O
of	O
MHV	B-SPEC
-	O
A59	O
has	O
an	O
important	O
role	O
in	O
virus	B-SPEC
pathogenicity	O
and	O
that	O
a	O
substitution	O
of	O
the	O
histidine	O
residues	O
of	O
the	O
MHV	B-SPEC
-	O
A59	O
ns2	O
His	O
-	O
x	O
-	O
Thr	O
/	O
Ser	O
motifs	O
is	O
critical	O
for	O
virus	B-SPEC
virulence	O
in	O
the	O
liver	O
but	O
not	O
in	O
the	O
brain	O
.	O

Immunization	O
of	O
dams	O
can	O
provide	O
passive	O
protection	O
in	O
neonatal	O
calves	O
;	O
antibodies	O
transferred	O
through	O
colostrum	O
block	O
colonization	O
of	O
bacteria	B-SPEC
,	O
thereby	O
preventing	O
disease	O
.	O

Calves	O
were	O
allowed	O
to	O
nurse	O
immediately	O
after	O
birth	O
,	O
were	O
orally	O
challenged	O
with	O
virulent	O
heterologous	O
enterotoxigenic	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
at	O
1	O
day	O
of	O
age	O
,	O
and	O
were	O
observed	O
for	O
clinical	O
signs	O
of	O
scours	O
for	O
10	O
days	O
.	O

TITLE	O
:	O
Sources	O
of	O
information	O
and	O
health	O
beliefs	O
related	O
to	O
SARS	O
and	O
avian	B-SPEC
influenza	O
among	O
Chinese	O
communities	O
in	O
the	O
United	O
Kingdom	B-SPEC
and	O
The	O
Netherlands	O
,	O
compared	O
to	O
the	O
general	O
population	O
in	O
these	O
countries	O
.	O

British	O
/	O
Dutch	O
Chinese	O
got	O
most	O
information	O
about	O
emerging	O
diseases	O
from	O
family	B-SPEC
and	O
friends	O
,	O
followed	O
by	O
Chinese	O
media	O
and	O
British	O
/	O
Dutch	O
TV	O
.	O

Additionally	O
,	O
experimental	O
studies	O
have	O
indicated	O
that	O
the	O
host	O
range	O
of	O
TCoV	O
,	O
once	O
thought	O
to	O
be	O
restricted	O
to	O
turkeys	B-SPEC
,	O
includes	O
chickens	B-SPEC
.	O

Sequence	O
analyses	O
of	O
TCoV	O
have	O
given	O
credence	O
to	O
the	O
idea	B-SPEC
that	O
TCoV	O
is	O
a	O
variant	O
of	O
IBV	B-SPEC
,	O
as	O
these	O
studies	O
have	O
shown	O
that	O
TCoV	O
and	O
IBV	B-SPEC
are	O
very	O
closely	O
related	O
.	O

ABSTRACT	O
:	O
Currently	O
,	O
there	O
is	O
no	O
agreed	O
naming	O
system	O
for	O
isolates	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
whose	O
host	O
is	O
the	O
domestic	O
fowl	O
(	O
Gallus	B-SPEC
gallus	I-SPEC
domesticus	I-SPEC
).	O

Clearly	O
,	O
the	O
topic	O
of	O
avian	B-SPEC
coronavirus	I-SPEC
species	B-SPEC
differentiation	O
requires	O
debate	O
.	O

For	O
the	O
moment	O
,	O
a	O
naming	O
system	O
for	O
avian	B-SPEC
coronavirus	I-SPEC
isolates	O
is	O
overdue	O
.	O

It	O
is	O
desirable	O
to	O
have	O
a	O
nomenclature	O
for	O
avian	B-SPEC
coronaviruses	O
that	O
indicates	O
the	O
host	O
species	B-SPEC
of	O
origin	O
.	O

The	O
names	B-SPEC
of	O
avian	B-SPEC
paramyxovirus	I-SPEC
(	O
APMV	B-SPEC
)	O
and	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
AIV	O
)	O
isolates	O
have	O
long	O
since	O
contained	O
this	O
information	O
;	O
I	O
suggest	O
that	O
we	O
adopt	O
a	O
similar	O
convention	O
for	O
isolates	O
of	O
avian	B-SPEC
coronaviruses	O
.	O

If	O
the	O
serotype	O
of	O
an	O
isolate	O
has	O
been	O
clearly	O
established	O
,	O
this	O
might	O
be	O
included	O
in	O
the	O
name	B-SPEC
at	O
end	O
,	O
like	O
the	O
serotype	O
designation	O
of	O
AIVs	O
,	O
e	O
.	O
g	O
.	O
chicken	B-SPEC
/	O
China	O
/	O
NRZ	O
/	O
91	O
(	O
Mass	O
.)	O
for	O
the	O
Chinese	O
isolate	O
of	O
the	O
Massachusetts	O
serotype	O
.	O

ABSTRACT	O
:	O
An	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
disease	O
characterized	O
by	O
tracheitis	O
and	O
bronchitis	O
was	O
observed	O
in	O
young	O
goslings	O
on	O
a	O
large	O
-	O
scale	O
goose	B-SPEC
farm	O
in	O
Hungary	O
.	O

Histological	O
examination	O
revealed	O
amphophilic	O
intranuclear	O
inclusion	O
bodies	O
in	O
the	O
superficial	O
epithelial	O
cells	O
of	O
the	O
trachea	B-SPEC
and	O
bronchi	O
.	O

Adenovirus	B-SPEC
-	O
like	O
particles	O
were	O
detected	O
by	O
electron	O
microscopy	O
,	O
and	O
the	O
virus	B-SPEC
isolated	O
from	O
the	O
trachea	B-SPEC
and	O
the	O
lungs	O
was	O
identified	O
as	O
egg	O
drop	O
syndrome	O
(	O
EDS	O
)	O
virus	B-SPEC
by	O
serological	O
and	O
genomic	O
examination	O
.	O

The	O
percentage	O
differences	O
between	O
the	O
nucleotide	O
sequences	O
of	O
genes	O
3	O
and	O
5	O
and	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
turkey	B-SPEC
/	O
UK	O
/	O
412	O
/	O
00	O
when	O
compared	O
with	O
those	O
of	O
IBVs	O
were	O
similar	O
to	O
the	O
differences	O
observed	O
when	O
different	O
strains	O
of	O
IBV	B-SPEC
were	O
compared	O
with	O
each	O
other	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
spike	O
protein	O
-	O
induced	O
innate	O
immune	O
response	O
occurs	O
via	O
activation	O
of	O
the	O
NF	O
-	O
kappaB	O
pathway	O
in	O
human	B-SPEC
monocyte	O
macrophages	O
in	O
vitro	O
.	O

An	O
NF	O
-	O
kappaB	O
inhibitor	O
,	O
TPCK	O
(	O
N	O
-	O
Tosyl	O
-	O
L	O
-	O
Phenylalanine	O
Chloromethyl	O
Ketone	O
)	O
could	O
suppress	O
IL	O
-	O
8	O
production	O
and	O
secretion	O
in	O
response	O
to	O
S	O
protein	O
in	O
PBMC	O
and	O
THP	O
-	O
1	O
cells	O
and	O
in	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
virus	B-SPEC
-	O
infected	O
PBMC	O
.	O

Surprisingly	O
,	O
63	O
%	O
of	O
the	O
apparently	O
healthy	O
calves	O
harbored	O
potentially	O
pathogenic	O
bacteria	B-SPEC
in	O
the	O
lower	O
respiratory	O
tract	O
,	O
60	O
%	O
of	O
these	O
samples	O
contained	O
either	O
pure	O
cultures	O
or	O
many	O
pathogenic	O
bacteria	B-SPEC
in	O
mixed	O
culture	O
.	O

All	O
of	O
these	O
were	O
classified	O
as	O
pure	O
culture	O
or	O
many	O
pathogenic	O
bacteria	B-SPEC
in	O
mixed	O
culture	O
.	O

A	O
higher	O
percentage	O
of	O
the	O
samples	O
were	O
positive	O
for	O
all	O
bacterial	O
species	B-SPEC
in	O
the	O
group	O
of	O
diseased	O
animals	B-SPEC
compared	O
to	O
the	O
clinically	O
healthy	O
animals	B-SPEC
,	O
however	O
this	O
difference	O
was	O
only	O
significant	O
for	O
M	B-SPEC
.	I-SPEC
dispar	I-SPEC
and	O
M	B-SPEC
.	I-SPEC
bovirhinis	I-SPEC
.	O

Mice	B-SPEC
administrated	O
by	O
electroporation	O
induced	O
the	O
highest	O
antibody	O
response	O
among	O
the	O
three	O
immunization	O
groups	O
and	O
a	O
mid	O
-	O
level	O
of	O
cellular	O
response	O
.	O

Complications	O
observed	O
were	O
hepatic	O
dysfunction	O
and	O
jaundice	O
in	O
23	O
(	O
57	O
.	O
5	O
%)	O
patients	O
,	O
renal	O
failure	O
in	O
18	O
(	O
45	O
%)	O
patients	O
,	O
severe	O
anemia	B-SPEC
in	O
13	O
(	O
32	O
.	O
5	O
%)	O
patients	O
,	O
cerebral	O
malaria	O
in	O
5	O
patients	O
(	O
12	O
.	O
5	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
4	O
patients	O
(	O
10	O
%),	O
shock	O
in	O
3	O
patients	O
(	O
7	O
.	O
5	O
%),	O
and	O
hypoglycemia	O
in	O
1	O
(	O
2	O
.	O
5	O
%)	O
patient	O
.	O

In	O
conclusion	O
,	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
are	O
common	O
causes	O
of	O
ICU	O
admission	O
.	O

ABSTRACT	O
:	O
To	O
date	O
,	O
more	O
than	O
two	O
hundred	O
viruses	B-SPEC
,	O
belonging	O
to	O
six	O
different	O
taxonomic	O
families	O
,	O
have	O
been	O
associated	O
with	O
human	B-SPEC
respiratory	O
tract	O
infection	O
.	O

These	O
results	O
were	O
consistent	O
with	O
virus	B-SPEC
isolation	O
and	O
denote	O
the	O
wide	O
tissue	O
tropism	O
of	O
IBV	B-SPEC
M41	O
in	O
the	O
chicken	B-SPEC
embryo	O
.	O

Most	O
importantly	O
,	O
we	O
found	O
infection	O
of	O
vasculature	O
and	O
smooth	O
muscle	O
of	O
the	O
proventriculus	O
which	O
has	O
not	O
seen	O
before	O
with	O
IBV	B-SPEC
strain	O
M41	O
.	O

ABSTRACT	O
:	O
Atypical	O
pneumonia	O
was	O
first	O
described	O
in	O
1938	O
,	O
and	O
over	O
time	O
,	O
Mycoplasma	B-SPEC
,	O
Legionella	B-SPEC
,	O
and	O
Chlamydophila	B-SPEC
were	O
the	O
agents	O
commonly	O
linked	O
with	O
community	O
-	O
associated	O
atypical	O
pneumonia	O
.	O

Enteral	O
administration	O
of	O
fish	B-SPEC
oil	O
,	O
antioxidants	O
and	O
physiologic	O
amounts	O
of	O
arginine	O
improve	O
oxygenation	O
and	O
clinical	O
outcomes	O
in	O
ICU	O
patients	O
with	O
impaired	O
oxygenation	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
health	O
threats	O
posed	O
by	O
airborne	O
pathogens	O
are	O
difficult	O
to	O
handle	O
for	O
healthcare	O
responders	O
due	O
to	O
the	O
fact	O
that	O
the	O
contaminated	O
area	O
is	O
not	O
immediately	O
recognizable	O
.	O

The	O
RBD	O
of	O
the	O
spike	O
glycoprotein	O
is	O
both	O
a	O
functional	O
domain	O
for	O
cell	O
receptor	O
binding	O
and	O
also	O
a	O
major	O
neutralizing	O
determinant	O
of	O
SARS	O
-	O
CoV	O
.	O
The	O
progress	O
in	O
evaluating	O
a	O
therapeutic	O
or	O
vaccine	O
would	O
depend	O
on	O
the	O
avail	O
ability	O
of	O
clinically	O
relevant	O
animal	B-SPEC
model	O
.	O

Five	O
stages	O
arose	O
in	O
the	O
participants	O
'	O
involvement	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
over	O
12	O
weeks	O
:	O
facing	O
shock	O
and	O
chaos	B-SPEC
;	O
searching	O
for	O
reliable	O
sources	O
to	O
clarify	O
myths	O
;	O
developing	O
and	O
adjusting	O
nursing	O
care	O
;	O
supporting	O
nurses	O
and	O
their	O
clients	O
;	O
and	O
rewarding	O
nurses	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
main	O
proteinase	O
(	O
SARS	O
CoVMpro	O
)	O
is	O
an	O
important	O
enzyme	O
for	O
the	O
replication	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
virus	B-SPEC
.	O

TITLE	O
:	O
Rapid	O
and	O
real	O
-	O
time	O
detection	O
technologies	O
for	O
emerging	O
viruses	B-SPEC
of	O
biomedical	O
importance	O
.	O

ABSTRACT	O
:	O
The	O
development	O
of	O
technologies	O
with	O
rapid	O
and	O
sensitive	O
detection	O
capabilities	O
and	O
increased	O
throughput	O
have	O
become	O
crucial	O
for	O
responding	O
to	O
greater	O
number	O
threats	O
posed	O
by	O
emerging	O
and	O
re	O
-	O
emerging	O
viruses	B-SPEC
in	O
the	O
recent	O
past	O
.	O

dengue	O
,	O
Japanese	B-SPEC
encephalitis	I-SPEC
,	O
chikungunya	O
,	O
west	O
Nile	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
SARS	O
)	O
etc	O
.	O

The	O
establishment	O
of	O
these	O
real	O
time	O
molecular	O
assays	O
will	O
certainly	O
facilitate	O
the	O
rapid	O
detection	O
of	O
viruses	B-SPEC
with	O
high	O
degree	O
of	O
precision	O
and	O
accuracy	O
in	O
future	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
major	O
target	O
in	O
the	O
development	O
of	O
diagnostic	O
assays	O
and	O
vaccines	O
,	O
but	O
its	O
antigenic	O
and	O
immunogenic	O
properties	O
remain	O
unclear	O
.	O

The	O
secreted	O
SQ	O
protein	O
in	O
which	O
the	O
transmembrane	O
domain	O
was	O
deleted	O
,	O
as	O
well	O
as	O
the	O
full	O
-	O
length	O
spike	O
protein	O
,	O
showed	O
the	O
most	O
potential	O
to	O
induce	O
the	O
production	O
of	O
neutralizing	O
antibody	O
(	O
nAb	O
)	O
in	O
mice	B-SPEC
.	O

Bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
samples	O
of	O
128	O
patients	O
with	O
atypical	O
pneumonia	O
(	O
HIV	B-SPEC
-	O
infected	O
n	O
=	O
50	O
,	O
hematological	O
malignancy	O
n	O
=	O
51	O
,	O
immunosuppressive	O
treatment	O
n	O
=	O
27	O
)	O
were	O
prospectively	O
evaluated	O
for	O
P	B-SPEC
.	I-SPEC
jirovecii	I-SPEC
and	O
retrospectively	O
for	O
new	O
respiratory	O
viruses	B-SPEC
(	O
HMPV	B-SPEC
,	O
HBoV	O
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
/	O
SARS	O
/	O
HKU1	O
).	O

The	O
one	O
patient	O
with	O
detection	O
of	O
hMPV	B-SPEC
and	O
clinical	O
diagnosis	O
of	O
atypical	O
pneumonia	O
died	O
of	O
pulmonary	O
failure	O
.	O

Upon	O
intranasal	O
inoculation	O
,	O
virus	B-SPEC
replication	O
could	O
initially	O
be	O
observed	O
in	O
the	O
nasal	O
cavity	O
and	O
the	O
cervical	O
lymph	O
nodes	O
,	O
after	O
which	O
the	O
infection	O
spread	O
to	O
the	O
brain	O
and	O
frequently	O
to	O
the	O
eyes	O
.	O

The	O
kinetics	O
of	O
virus	B-SPEC
spread	O
to	O
and	O
clearance	O
from	O
the	O
brain	O
appeared	O
to	O
depend	O
on	O
the	O
inoculation	O
dose	O
.	O

After	O
intraperitoneal	O
inoculation	O
,	O
virus	B-SPEC
replication	O
was	O
predominantly	O
observed	O
in	O
the	O
liver	O
and	O
occasionally	O
in	O
the	O
intestines	O
,	O
but	O
interestingly	O
also	O
in	O
the	O
tail	O
and	O
paws	O
.	O

TITLE	O
:	O
Interaction	O
between	O
SARS	O
-	O
CoV	O
helicase	O
and	O
a	O
multifunctional	O
cellular	O
protein	O
(	O
Ddx5	O
)	O
revealed	O
by	O
yeast	B-SPEC
and	O
mammalian	B-SPEC
cell	O
two	O
-	O
hybrid	O
systems	O
.	O

TITLE	O
:	O
Aryl	O
diketoacids	O
(	O
ADK	O
)	O
selectively	O
inhibit	O
duplex	O
DNA	O
-	O
unwinding	O
activity	O
of	O
SARS	O
coronavirus	B-SPEC
NTPase	O
/	O
helicase	O
.	O

Histopathological	O
analysis	O
of	O
adult	O
male	O
BALB	O
/	O
C	O
mice	B-SPEC
after	O
N	O
-	O
protein	O
infection	O
showed	O
progressive	O
inflammatory	O
reactions	O
,	O
especially	O
pulmonary	O
edema	O
,	O
in	O
accordance	O
with	O
a	O
moderately	O
(	O
approximately	O
13	O
%)	O
elevated	O
level	O
of	O
W	O
/	O
D	O
ratio	O
at	O
24	O
h	O
.	O
Although	O
adult	O
groups	O
underwent	O
a	O
progressive	O
lung	O
inflammation	O
in	O
the	O
acute	O
phase	O
accompanied	O
by	O
raised	O
levels	O
of	O
TNF	O
-	O
alpha	O
in	O
serum	O
,	O
no	O
significant	O
changes	O
in	O
lung	O
TNF	O
-	O
alpha	O
level	O
were	O
reported	O
simultaneously	O
.	O

Moreover	O
,	O
adult	O
SARS	O
infected	O
BALB	O
/	O
c	O
mice	B-SPEC
showed	O
elevated	O
levels	O
of	O
IFN	O
-	O
gamma	O
while	O
IFN	O
-	O
gamma	O
levels	O
in	O
weanling	O
and	O
young	O
groups	O
had	O
no	O
obvious	O
association	O
with	O
lung	O
inflammation	O
.	O

Specimens	O
were	O
tested	O
for	O
respiratory	O
viruses	B-SPEC
by	O
polymerase	O
chain	O
reaction	O
.	O

ABSTRACT	O
:	O
The	O
clinical	O
features	O
and	O
incidence	O
of	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
infections	O
in	O
chronically	O
ill	O
older	O
adults	O
need	O
better	O
definition	O
.	O

RESULTS	O
:	O
The	O
PPS	O
aerosol	O
particles	O
were	O
less	O
than	O
2	O
.	O
0	O
mum	B-SPEC
in	O
size	O
as	O
determined	O
by	O
a	O
laser	B-SPEC
aerosol	O
particle	O
counter	O
.	O

ABSTRACT	O
:	O
Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
(	O
MHV	B-SPEC
-	O
A59	O
)	O
triggers	O
various	O
pathologies	O
in	O
several	O
mouse	B-SPEC
strains	O
,	O
including	O
hypergammaglobulinaemia	O
,	O
hepatitis	O
and	O
thymus	B-SPEC
involution	O
.	O

TITLE	O
:	O
Roles	O
of	O
spike	O
protein	O
in	O
the	O
pathogenesis	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
An	O
oral	O
mucosal	O
DNA	O
vaccine	O
for	O
SARS	O
coronavirus	B-SPEC
infections	O
.	O

Thirty	O
-	O
four	O
patients	O
who	O
had	O
ALI	O
or	O
ARDS	O
with	O
severe	O
sepsis	B-SPEC
were	O
included	O
in	O
this	O
study	O
,	O
and	O
split	O
into	O
two	O
groups	O
:	O
a	O
high	O
-	O
risk	O
for	O
septic	O
shock	O
(	O
H	O
-	O
R	O
)	O
group	O
and	O
a	O
septic	O
shock	O
(	O
S	O
-	O
S	O
)	O
group	O
,	O
based	O
on	O
the	O
cut	O
-	O
off	O
value	O
at	O
a	O
mean	O
arterial	O
pressure	O
of	O
60	O
mmHg	O
.	O

We	O
analyzed	O
the	O
modified	O
APACHE	O
-	O
II	O
score	O
,	O
the	O
sepsis	B-SPEC
-	O
related	O
organ	O
failure	O
assessment	O
(	O
SOFA	O
)	O
score	O
,	O
mean	O
blood	O
pressure	O
(	O
mBP	O
),	O
catecholamine	O
index	O
(	O
CAI	O
),	O
P	O
/	O
F	O
ratio	O
,	O
and	O
28	O
days	O
mortality	O
before	O
and	O
after	O
PMX	O
-	O
DHP	O
treatment	O
.	O

TITLE	O
:	O
Differential	O
stepwise	O
evolution	O
of	O
SARS	O
coronavirus	B-SPEC
functional	O
proteins	O
in	O
different	O
host	O
species	B-SPEC
.	O

TITLE	O
:	O
Comparison	O
of	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
pseudotyped	O
with	O
the	O
S	O
proteins	O
from	O
a	O
porcine	B-SPEC
and	O
a	O
human	B-SPEC
coronavirus	I-SPEC
.	O

The	O
cell	O
tropism	O
of	O
the	O
respective	O
pseudotypes	O
corresponded	O
to	O
the	O
tropism	O
of	O
the	O
viruses	B-SPEC
from	O
which	O
the	O
S	O
protein	O
was	O
derived	O
.	O

Higher	O
infectivity	O
values	O
were	O
obtained	O
with	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
than	O
with	O
the	O
TGEV	B-SPEC
S	O
protein	O
.	O

ABSTRACT	O
:	O
nsp1	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
a	O
group	O
2b	O
CoV	O
,	O
suppresses	O
host	O
gene	O
expression	O
by	O
promoting	O
host	O
mRNA	O
degradation	O
and	O
translation	O
inhibition	O
.	O

The	O
present	O
study	O
analyzed	O
the	O
activities	O
of	O
nsp1	O
proteins	O
from	O
the	O
group	O
2	O
bat	B-SPEC
CoV	O
strains	O
Rm1	O
,	O
133	O
,	O
and	O
HKU9	O
-	O
1	O
,	O
belonging	O
to	O
groups	O
2b	O
,	O
2c	O
,	O
and	O
2d	O
,	O
respectively	O
.	O

Prone	O
position	O
ventilation	O
for	O
48	O
hours	O
or	O
until	O
the	O
oxygenation	O
index	O
was	O
10	O
or	O
less	O
(	O
extended	O
PPV	B-SPEC
).	O

3	O
vs	O
37	O
+/-	O
6	O
,	O
P	O
<	O
.	O
0001	O
)	O
with	O
extended	O
PPV	B-SPEC
.	O

ABSTRACT	O
:	O
Although	O
the	O
SARS	O
outbreak	O
involved	O
few	O
probable	O
cases	O
of	O
infection	O
in	O
Europe	O
,	O
swift	B-SPEC
international	O
spread	O
of	O
infections	O
raised	O
the	O
possibility	O
of	O
outbreaks	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
M	O
protein	O
is	O
an	O
essential	O
component	O
of	O
virion	O
and	O
plays	O
pivotal	O
roles	O
in	O
virion	O
assembly	O
,	O
budding	O
and	O
maturation	O
.	O

To	O
understand	O
the	O
cellular	O
factors	O
that	O
may	O
be	O
involved	O
in	O
virion	O
assembly	O
,	O
budding	O
and	O
maturation	O
processes	O
,	O
IBV	B-SPEC
M	O
was	O
used	O
as	O
the	O
bait	O
in	O
a	O
yeast	B-SPEC
two	O
-	O
hybrid	O
screen	O
,	O
resulting	O
in	O
the	O
identification	O
of	O
beta	O
-	O
actin	O
as	O
a	O
potentially	O
interacting	O
partner	O
.	O

This	O
interaction	O
was	O
subsequently	O
confirmed	O
by	O
coimmunoprecipitation	O
and	O
immunofluorescence	O
microscopy	O
in	O
mammalian	B-SPEC
cells	O
,	O
and	O
mutation	O
of	O
amino	O
acids	O
A159	O
and	O
K160	O
on	O
the	O
M	O
protein	O
abolished	O
the	O
interaction	O
.	O

Vaccinated	O
mice	B-SPEC
were	O
protected	O
from	O
severe	O
respiratory	O
disease	O
in	O
parallel	O
with	O
a	O
low	O
virus	B-SPEC
titer	O
in	O
the	O
lungs	O
and	O
a	O
high	O
neutralizing	O
antibody	O
titer	O
in	O
the	O
plasma	O
.	O

Importantly	O
,	O
the	O
administration	O
of	O
spike	O
protein	O
-	O
specific	O
neutralizing	O
monoclonal	O
antibody	O
protected	O
mice	B-SPEC
from	O
the	O
disease	O
,	O
indicating	O
that	O
the	O
neutralization	O
is	O
sufficient	O
for	O
protection	O
.	O

We	O
conclude	O
that	O
transduction	O
of	O
antigen	O
-	O
presenting	O
cells	O
within	O
the	O
CNS	O
is	O
a	O
likely	O
cause	O
of	O
this	O
response	O
and	O
that	O
caution	O
is	O
warranted	O
when	O
foreign	O
transgenes	O
are	O
used	O
as	O
reporters	O
in	O
gene	O
therapy	O
studies	O
with	O
vectors	O
with	O
broader	O
tropism	O
than	O
AAV2	B-SPEC
.	O

NendoU	O
activity	O
was	O
previously	O
verified	O
in	O
vitro	O
for	O
the	O
coronavirus	B-SPEC
nsp15	O
,	O
but	O
not	O
for	O
any	O
of	O
its	O
distantly	O
related	O
orthologs	O
from	O
other	O
nidovirus	B-SPEC
lineages	O
,	O
like	O
the	O
arterivirus	B-SPEC
nsp11	O
.	O

TITLE	O
:	O
Rapid	O
detection	O
and	O
non	O
-	O
subjective	O
characterisation	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
isolates	O
using	O
high	O
-	O
resolution	O
melt	O
curve	O
analysis	O
and	O
a	O
mathematical	O
model	O
.	O

The	O
development	O
of	O
specific	O
mucosal	O
immune	O
system	O
against	O
duck	B-SPEC
enteritis	I-SPEC
virus	I-SPEC
(	O
DEV	O
)	O
infection	O
for	O
ducks	B-SPEC
has	O
been	O
hindered	O
by	O
a	O
lack	O
of	O
knowledge	O
concerning	O
the	O
purification	O
of	O
immunoglobulin	O
A	O
(	O
IgA	O
)	O
of	O
duck	B-SPEC
.	O

Thus	O
,	O
the	O
loss	O
of	O
8ab	O
in	O
SARS	O
-	O
CoV	O
through	O
viral	O
evolution	O
in	O
animals	B-SPEC
may	O
play	O
a	O
role	O
in	O
its	O
pathogenicity	O
.	O

ABSTRACT	O
:	O
To	O
construct	O
the	O
expression	O
plasmid	O
of	O
S2	O
extracellular	O
domain	O
(	O
S2ED	O
)	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
Cov	O
)	O
spike	O
protein	O
(	O
S	O
protein	O
)	O
and	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
to	O
obtain	O
the	O
fusion	O
protein	O
expressed	O
in	O
prokaryotic	O
cells	O
.	O

A	O
30	O
-	O
year	O
-	O
old	O
,	O
previously	O
healthy	O
man	B-SPEC
presented	O
with	O
sore	O
throat	O
,	O
fever	O
,	O
rigor	O
,	O
and	O
dyspnea	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
is	O
a	O
paramyxovirus	O
that	O
is	O
associated	O
with	O
respiratory	O
tract	O
infection	O
(	O
RTI	O
)	O
mostly	O
in	O
children	O
,	O
but	O
these	O
outbreaks	O
have	O
rarely	O
been	O
reported	O
in	O
adults	O
.	O

The	O
hMPV	B-SPEC
was	O
identified	O
in	O
10	O
of	O
13	O
adults	O
(	O
77	O
%),	O
but	O
negative	O
for	O
the	O
other	O
virus	B-SPEC
.	O

We	O
report	O
this	O
outbreak	O
in	O
a	O
mental	O
hospital	O
to	O
alert	O
the	O
medical	O
profession	O
that	O
this	O
unusual	O
infection	O
of	O
hMPV	B-SPEC
can	O
occur	O
as	O
an	O
outbreak	O
in	O
an	O
adult	O
setting	O
and	O
is	O
an	O
occupational	O
hazard	O
for	O
healthcare	O
personnel	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
papillomavirus	I-SPEC
(	O
HPV	O
)	O
causes	O
cervical	O
cancer	B-SPEC
and	O
is	O
strongly	O
associated	O
with	O
other	O
anogenital	O
cancers	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
main	O
protease	O
(	O
M	O
(	O
pro	O
))	O
plays	O
an	O
essential	O
role	O
in	O
the	O
extensive	O
proteolytic	O
processing	O
of	O
the	O
viral	O
polyproteins	O
(	O
pp1a	O
and	O
pp1ab	O
),	O
and	O
it	O
is	O
an	O
important	O
target	O
for	O
anti	O
-	O
SARS	O
drug	O
development	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
a	O
novel	O
priming	O
mechanism	O
for	O
a	O
viral	O
fusion	O
protein	O
,	O
with	O
a	O
critical	O
proteolytic	O
cleavage	O
event	O
on	O
the	O
SARS	O
-	O
CoV	O
S	O
protein	O
at	O
position	O
797	O
(	O
S2	O
'),	O
acting	O
in	O
concert	O
with	O
the	O
S1	O
-	O
S2	O
cleavage	O
site	O
to	O
mediate	O
membrane	O
fusion	O
and	O
virus	B-SPEC
infectivity	O
.	O

The	O
viruses	B-SPEC
were	O
isolated	O
from	O
the	O
tracheas	O
,	O
lungs	O
,	O
and	O
caecal	O
tonsils	O
of	O
birds	B-SPEC
that	O
were	O
showing	O
respiratory	O
signs	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
responsible	O
for	O
host	O
cell	O
attachment	O
and	O
fusion	O
of	O
the	O
viral	O
and	O
host	O
cell	O
membranes	O
.	O

In	O
order	B-SPEC
to	O
evaluate	O
the	O
clinical	O
applicability	O
of	O
BMMSC	O
transplantation	O
,	O
we	O
tested	O
whether	O
engraftment	O
of	O
minimally	O
cultured	O
BMMSCs	O
ameliorates	O
progressive	O
fibrotic	O
lung	O
injury	O
.	O

The	O
effects	O
of	O
grafting	O
either	O
type	O
of	O
BMMSCs	O
on	O
fibrotic	O
lung	O
injury	O
were	O
then	O
assessed	O
by	O
transfer	O
experiments	O
in	O
a	O
murine	B-SPEC
bleomycin	O
-	O
induced	O
lung	O
fibrosis	O
model	O
,	O
in	O
which	O
donor	O
cells	O
were	O
administered	O
3	O
days	O
after	O
challenge	O
.	O

This	O
study	O
was	O
to	O
determine	O
whether	O
the	O
damage	O
was	O
correlated	O
with	O
expression	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
receptor	O
,	O
angiotensin	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
in	O
different	O
organs	O
,	O
especially	O
in	O
the	O
endocrine	O
tissues	O
of	O
the	O
pancreas	O
,	O
and	O
to	O
elucidate	O
the	O
pathogenesis	O
of	O
glucose	O
intolerance	O
in	O
SARS	O
patients	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
role	O
of	O
CD4	O
-	O
CD8	O
-	O
T	O
cells	O
in	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
3	O
(	O
MHV	B-SPEC
-	O
3	O
)	O
induced	O
chronic	O
viral	O
hepatitis	O
in	O
C3H	O
/	O
Hej	O
mice	B-SPEC
and	O
to	O
identify	O
their	O
surface	O
markers	O
.	O

TITLE	O
:	O
Genetic	O
diversity	O
and	O
phylogenetic	O
analysis	O
of	O
Feline	B-SPEC
Coronavirus	B-SPEC
sequences	O
from	O
Portugal	O
.	O

ABSTRACT	O
:	O
The	O
distribution	O
of	O
FCoV	O
Types	O
I	O
and	O
II	O
in	O
a	O
Portuguese	O
cat	B-SPEC
population	O
was	O
studied	O
by	O
a	O
RT	O
-	O
PCR	O
assay	O
targeting	O
the	O
3	O
'-	O
end	O
of	O
the	O
viral	O
RNA	O
.	O

An	O
ELISA	O
-	O
based	O
IgG	O
antibody	O
detection	O
assay	O
using	O
recombinant	O
HCoV	O
-	O
HKU1	O
nucleocapsid	O
and	O
spike	O
(	O
S	O
)	O
proteins	O
(	O
genotype	O
A	O
)	O
were	O
developed	O
for	O
the	O
diagnosis	O
of	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
infections	O
,	O
Additionally	O
,	O
a	O
neutralization	O
antibody	O
assay	O
using	O
the	O
HCoV	O
-	O
HKU1	O
pseudotyped	O
virus	B-SPEC
was	O
developed	O
to	O
detect	O
the	O
presence	O
of	O
neutralizing	O
antibodies	O
in	O
serum	O
with	O
antibody	O
positivity	O
in	O
an	O
S	O
protein	O
-	O
based	O
ELISA	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)-	O
induced	O
fatal	O
disease	O
of	O
domestic	O
and	O
wild	B-SPEC
cats	I-SPEC
.	O

In	O
this	O
study	O
we	O
demonstrate	O
that	O
these	O
chimeras	O
are	O
capable	O
of	O
packaging	O
large	O
amounts	O
of	O
human	B-SPEC
APOBEC3G	O
(	O
hA3G	O
),	O
and	O
that	O
an	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
Gag	B-SPEC
chimera	O
containing	O
the	O
carboxyl	O
-	O
terminal	O
half	O
of	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
N	O
as	O
a	O
substitute	O
for	O
NC	O
is	O
capable	O
of	O
directing	O
VLP	O
assembly	O
and	O
efficiently	O
packaging	O
hA3G	O
.	O

IBV	B-SPEC
isolated	O
in	O
Japan	O
were	O
classified	O
into	O
six	O
different	O
groups	O
by	O
phylogenetic	O
analysis	O
based	O
on	O
the	O
S2	O
gene	O
.	O

PaO2	O
/	O
FiO2	O
ratio	O
improved	O
but	O
X	O
-	O
ray	B-SPEC
findings	O
showed	O
no	O
improvement	O
and	O
a	O
blood	O
test	O
revealed	O
pancytopenia	O
.	O

Mycobacterium	B-SPEC
tuberculosis	I-SPEC
was	O
also	O
detected	O
in	O
sputum	O
and	O
urine	O
.	O

Three	O
trials	O
accounted	O
for	O
more	O
than	O
85	O
%	O
of	O
total	O
weighting	O
in	O
the	O
meta	B-SPEC
-	O
analyses	O
.	O

In	O
order	B-SPEC
to	O
assess	O
the	O
role	O
of	O
activated	O
neutrophils	O
,	O
pro	O
-	O
and	O
anti	O
-	O
inflammatory	O
cytokines	O
and	O
adhesion	O
molecules	O
at	O
the	O
onset	O
and	O
development	O
of	O
respiratory	O
complications	O
and	O
respiratory	O
failure	O
,	O
we	O
measured	O
the	O
serum	O
levels	O
of	O
pro	O
-	O
inflammatory	O
(	O
IL	O
-	O
1	O
beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
IL	O
-	O
18	O
,	O
TNF	O
-	O
alpha	O
)	O
and	O
anti	O
-	O
inflammatory	O
(	O
IL	O
-	O
1	O
ra	O
,	O
IL	O
-	O
10	O
)	O
cytokines	O
in	O
51	O
AP	O
patients	O
who	O
had	O
been	O
diagnosed	O
with	O
pancreatitis	O
-	O
associated	O
lung	O
injury	O
with	O
and	O
without	O
the	O
development	O
of	O
organ	O
dysfunction	O
.	O

TITLE	O
:	O
Detection	O
of	O
polyoma	B-SPEC
and	O
corona	B-SPEC
viruses	B-SPEC
in	O
bats	B-SPEC
of	O
Canada	O
.	O

Bats	B-SPEC
were	O
sampled	O
from	O
three	O
sources	O
:	O
live	O
-	O
trapped	O
Myotis	B-SPEC
lucifugus	I-SPEC
from	O
Manitoba	O
,	O
rabies	O
-	O
negative	O
Eptesicus	B-SPEC
fuscus	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
lucifugus	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
yumanensis	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
septentrionalis	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
californicus	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
evotis	I-SPEC
,	O
Lasionycteris	B-SPEC
(	O
L	O
.)	O
noctivagans	O
and	O
Lasiurus	B-SPEC
(	O
Las	O
.)	O
cinereus	O
,	O
provided	O
by	O
the	O
Centre	O
of	O
Expertise	O
for	O
Rabies	O
of	O
the	O
Canadian	O
Food	O
Inspection	O
Agency	O
(	O
CFIA	O
),	O
and	O
L	B-SPEC
.	I-SPEC
noctivagans	I-SPEC
,	O
Las	O
.	O

ABSTRACT	O
:	O
The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
plays	O
important	O
roles	O
in	O
both	O
viral	O
replication	O
and	O
modulation	O
of	O
host	O
cell	O
processes	O
.	O

Moreover	O
,	O
the	O
viruses	B-SPEC
use	O
different	O
receptors	O
to	O
enter	O
their	O
target	O
cell	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
is	O
associated	O
with	O
croup	O
in	O
children	O
,	O
whereas	O
all	O
signs	O
suggest	O
that	O
the	O
virus	B-SPEC
probably	O
causes	O
the	O
common	O
cold	O
in	O
healthy	O
adults	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
papain	O
-	O
like	O
protease	O
ubiquitin	O
-	O
like	O
domain	O
and	O
catalytic	O
domain	O
regulate	O
antagonism	O
of	O
IRF3	O
and	O
NF	O
-	O
kappaB	O
signaling	O
.	O

TITLE	O
:	O
The	O
SR	O
-	O
rich	O
motif	O
in	O
SARS	O
-	O
CoV	O
nucleocapsid	O
protein	O
is	O
important	O
for	O
virus	B-SPEC
replication	O
.	O

TITLE	O
:	O
Frequency	O
of	O
BCoV	O
detection	O
by	O
a	O
semi	O
-	O
nested	O
PCR	O
assay	O
in	O
faeces	O
of	O
calves	O
from	O
Brazilian	O
cattle	B-SPEC
herds	O
.	O

GFP	O
was	O
fused	O
to	O
the	O
carboxy	O
-	O
terminus	O
of	O
S1	O
for	O
expression	O
of	O
S1	O
-	O
GFP	O
to	O
show	O
expression	O
of	O
recombinant	O
S1	O
by	O
agroinfiltration	O
of	O
tobacco	B-SPEC
leaves	O
.	O

ABSTRACT	O
:	O
The	O
neurotropic	O
coronavirus	B-SPEC
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
persists	O
in	O
oligodendroglia	O
despite	O
the	O
presence	O
of	O
virus	B-SPEC
-	O
specific	O
CD8	O
T	O
cells	O
.	O

Analysis	O
of	O
virus	B-SPEC
-	O
susceptible	O
target	O
cells	O
in	O
vivo	O
revealed	O
that	O
B7	O
-	O
H1	O
expression	O
was	O
regulated	O
in	O
a	O
cell	O
type	O
-	O
dependent	O
manner	O
.	O

Ab	O
blockade	O
of	O
B7	O
-	O
H1	O
on	O
oligodendroglia	O
in	O
vitro	O
enhanced	O
IFN	O
-	O
gamma	O
secretion	O
by	O
virus	B-SPEC
-	O
specific	O
CD8	O
T	O
cells	O
.	O

TITLE	O
:	O
A	O
candidate	O
modified	O
-	O
live	O
bovine	B-SPEC
coronavirus	B-SPEC
vaccine	O
:	O
safety	O
and	O
immunogenicity	O
evaluation	O
.	O

TITLE	O
:	O
"["""	O
Liquid	O
ecstasy	O
""":"	O
gamma	O
-	O
butyrolactone	O
withdrawal	O
delirium	O
with	O
rhabdomyolysis	O
and	O
dialysis	B-SPEC
dependent	O
renal	O
failure	O
].	O

TITLE	O
:	O
Treatment	O
of	O
Strongyloides	B-SPEC
stercoralis	I-SPEC
hyperinfection	O
-	O
associated	O
septic	O
shock	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
drotrecogin	O
alfa	O
(	O
activated	O
)	O
in	O
a	O
renal	O
transplant	O
recipient	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
Strongyloides	B-SPEC
stercoralis	I-SPEC
hyperinfection	O
syndrome	O
in	O
a	O
renal	O
transplant	O
recipient	O
complicated	O
by	O
septic	O
shock	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
Klebsiella	B-SPEC
pneumoniae	I-SPEC
superinfection	O
.	O

This	O
outcome	O
suggests	O
that	O
drotrecogin	O
alfa	O
(	O
activated	O
)	O
may	O
be	O
useful	O
therapy	O
for	O
transplant	O
recipients	O
who	O
develop	O
severe	O
sepsis	B-SPEC
or	O
septic	O
shock	O
secondary	O
to	O
potentially	O
lethal	O
opportunistic	O
infections	O
.	O

ABSTRACT	O
:	O
Eight	O
accessory	O
proteins	O
have	O
been	O
identified	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

To	O
understand	O
the	O
biodistribution	O
of	O
CPMV	B-SPEC
in	O
the	O
CNS	O
,	O
we	O
examined	O
CPMV	B-SPEC
uptake	O
during	O
infection	O
of	O
mice	B-SPEC
with	O
neurotropic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

These	O
results	O
suggest	O
that	O
CPMV	B-SPEC
particles	O
could	O
be	O
used	O
as	O
a	O
vehicle	O
to	O
deliver	O
therapeutics	O
to	O
the	O
damaged	O
CNS	O
during	O
neurodegenerative	O
and	O
infectious	O
diseases	O
of	O
the	O
CNS	O
.	O

Vaccines	O
,	O
such	O
as	O
those	O
developed	O
for	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
,	O
have	O
the	O
potential	O
to	O
stimulate	O
both	O
mucosal	O
and	O
systemic	O
,	O
as	O
well	O
as	O
,	O
lactogenic	O
immunity	O
as	O
has	O
already	O
been	O
seen	O
in	O
target	O
animal	B-SPEC
trials	O
.	O

The	O
mitochondrial	O
antiviral	O
signaling	O
adaptor	O
,	O
MAVS	O
(	O
IPS	B-SPEC
-	O
1	O
,	O
VISA	O
or	O
Cardif	O
)	O
is	O
critical	O
for	O
host	O
defenses	O
to	O
viral	O
infection	O
by	O
inducing	O
type	O
-	O
1	O
interferons	O
(	O
IFN	O
-	O
I	O
),	O
however	O
its	O
role	O
in	O
virus	B-SPEC
-	O
induced	O
apoptotic	O
responses	O
has	O
not	O
been	O
elucidated	O
.	O

A	O
functional	O
screen	O
identifies	O
the	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
NS3	O
/	O
4A	O
and	O
the	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nonstructural	O
protein	O
(	O
NSP15	O
)	O
as	O
inhibitors	O
of	O
MAVS	O
-	O
induced	O
apoptosis	O
,	O
possibly	O
as	O
a	O
method	O
of	O
immune	O
evasion	O
.	O

TITLE	O
:	O
Broadly	O
targeted	O
multiprobe	O
QPCR	O
for	O
detection	O
of	O
coronaviruses	O
:	O
Coronavirus	B-SPEC
is	O
common	O
among	O
mallard	B-SPEC
ducks	I-SPEC
(	O
Anas	B-SPEC
platyrhynchos	I-SPEC
).	O

TITLE	O
:	O
Expression	O
,	O
crystallization	O
and	O
preliminary	O
crystallographic	O
study	O
of	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
nonstructural	O
protein	O
9	O
.	O

The	O
results	O
demonstrated	O
the	O
stability	O
of	O
recombinant	O
viruses	B-SPEC
depends	O
on	O
the	O
intrinsic	O
properties	O
of	O
the	O
foreign	O
gene	O
itself	O
as	O
well	O
as	O
the	O
position	O
at	O
which	O
the	O
foreign	O
genes	O
were	O
inserted	O
.	O

Soluble	O
ACE2	O
was	O
enzymatically	O
active	O
and	O
partially	O
inhibited	O
virus	B-SPEC
entry	O
into	O
target	O
cells	O
.	O

ABSTRACT	O
:	O
Turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
)	O
causes	O
diarrhoea	O
in	O
young	O
turkey	B-SPEC
poults	O
but	O
little	O
is	O
known	O
about	O
its	O
prevalence	O
in	O
the	O
field	O
.	O

To	O
address	O
this	O
,	O
a	O
portion	O
of	O
the	O
S1	O
region	O
of	O
the	O
spike	O
glycoprotein	O
of	O
TCoV	O
carrying	O
relevant	O
B	O
cell	O
epitopes	O
(	O
amino	O
acid	O
positions	O
54	O
-	O
395	O
)	O
was	O
cloned	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

High	O
seroprevalence	O
of	O
TCoV	O
was	O
found	O
with	O
71	O
.	O
11	O
%	O
of	O
breeders	O
and	O
56	O
.	O
67	O
%	O
of	O
meat	O
turkeys	B-SPEC
testing	O
seropositive	O
.	O

isolates	O
were	O
examined	O
for	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
and	O
Salmonella	B-SPEC
spp	O
.	O

Infection	O
with	O
Salmonella	B-SPEC
spp	O
.	O
was	O
found	O
to	O
be	O
significantly	O
affected	O
by	O
the	O
animal	B-SPEC
age	O
(	O
P	O
<	O
0	O
.	O
05	O
;	O
OR	O
:	O
0	O
.	O
376	O
;	O
CI	O
95	O
%:	O
0	O
.	O
511	O
-	O
1	O
.	O
369	O
),	O
Hygiene	O
(	O
P	O
<	O
0	O
.	O
05	O
;	O
OR	O
:	O
0	O
.	O
628	O
;	O
CI	O
95	O
%:	O
1	O
.	O
729	O
-	O
5	O
.	O
612	O
),	O
and	O
region	O
(	O
P	O
<	O
0	O
.	O
01	O
;	O
OR	O
:	O
0	O
.	O
970	O
;	O
CI	O
95	O
%:	O
0	O
.	O
841	O
-	O
1	O
.	O
624	O
).	O

The	O
results	O
of	O
the	O
present	O
study	O
indicate	O
the	O
importance	O
of	O
PCR	O
as	O
rapid	O
,	O
effective	O
and	O
reliable	O
tool	O
for	O
screening	O
of	O
ETEC	O
and	O
Salmonella	B-SPEC
spp	O
.	O

Chimeric	O
DNA	O
-	O
RNA	O
hammerhead	O
ribozyme	O
targeting	O
MHV	B-SPEC
and	O
SARS	O
-	O
CoV	O
were	O
designed	O
and	O
synthesized	O
.	O

The	O
chimeric	O
DNA	O
-	O
RNA	O
hammerhead	O
ribozyme	O
targeting	O
SARS	O
-	O
CoV	O
significantly	O
inhibited	O
multiplication	O
of	O
MHV	B-SPEC
in	O
DBT	O
cells	O
by	O
about	O
60	O
%.	O

This	O
result	O
demonstrated	O
that	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
expressing	O
scFvs	O
on	O
the	O
cell	O
surface	O
retained	O
functional	O
potency	O
of	O
parent	O
antibody	O
and	O
therefore	O
blocked	O
PEDV	B-SPEC
infection	O
into	O
target	O
cells	O
in	O
vitro	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
cytotoxicity	O
of	O
Isatis	B-SPEC
indigotica	I-SPEC
extracts	O
on	O
human	B-SPEC
leukemia	O
cell	O
line	O
(	O
HL	O
-	O
60	O
)	O
and	O
the	O
antiviral	O
activity	O
on	O
swine	B-SPEC
pseudorabies	B-SPEC
virus	I-SPEC
(	O
PrV	B-SPEC
)	O
in	O
in	O
vitro	O
assays	O
.	O

The	O
cytopathic	O
effect	O
(	O
CPE	O
)	O
reduction	O
,	O
plaque	O
reduction	O
and	O
inhibition	O
assays	O
on	O
viral	O
replication	O
,	O
and	O
virucidal	O
activity	O
were	O
further	O
conducted	O
to	O
investigate	O
the	O
anti	O
-	O
PrV	B-SPEC
activity	O
.	O

Isatis	B-SPEC
indigotica	I-SPEC
posses	O
a	O
valuable	O
virucidal	O
effect	O
in	O
disease	O
control	O
of	O
pseudorabies	B-SPEC
virus	I-SPEC
infection	O
in	O
swine	B-SPEC
.	O

Compared	O
with	O
seropositive	O
controls	O
,	O
the	O
concentration	O
of	O
TSA	O
was	O
higher	O
in	O
cats	B-SPEC
with	O
FIP	O
(	O
556	O
.	O
7	O
+/-	O

ABSTRACT	O
:	O
Since	O
the	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
in	O
2003	O
,	O
the	O
three	O
-	O
dimensional	O
structures	O
of	O
several	O
of	O
the	O
replicase	O
/	O
transcriptase	O
components	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
the	O
non	O
-	O
structural	O
proteins	O
(	O
Nsps	O
),	O
have	O
been	O
determined	O
.	O

To	O
investigate	O
this	O
potential	O
,	O
we	O
redirected	O
the	O
coronavirus	B-SPEC
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
which	O
is	O
normally	O
unable	O
to	O
infect	O
human	B-SPEC
cells	O
,	O
to	O
human	B-SPEC
tumor	O
cells	O
by	O
using	O
a	O
soluble	O
receptor	O
(	O
soR	O
)-	O
based	O
expression	O
construct	O
fused	O
to	O
an	O
epidermal	O
growth	O
factor	O
(	O
EGF	O
)	O
receptor	O
targeting	O
moiety	O
.	O

To	O
investigate	O
the	O
oncolytic	O
capacity	O
of	O
the	O
virus	B-SPEC
in	O
vivo	O
,	O
we	O
used	O
an	O
orthotopic	O
U87DeltaEGFR	O
xenograft	O
mouse	B-SPEC
model	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
of	O
oncolytic	O
activity	O
of	O
a	O
coronavirus	B-SPEC
in	O
vivo	O
.	O

The	O
90	O
%	O
CIs	B-SPEC
for	O
the	O
log	O
-	O
transformed	O
ratios	O
of	O
C	O
(	O
max	O
),	O
AUC	O
(	O
0	O
-	O
t	O
),	O
and	O
AUC	O
(	O
0	O
-	O
infinity	O
)	O
were	O
91	O
.	O
7	O
%	O
to	O
109	O
.	O
7	O
%,	O
91	O
.	O
0	O
%	O
to	O
112	O
.	O
8	O
%,	O
and	O
92	O
.	O
0	O
%	O
to	O
116	O
.	O
3	O
%,	O
respectively	O
(	O
all	O
,	O
P	O
<	O
0	O
.	O
05	O
),	O
which	O
were	O
within	O
the	O
predetermined	O
range	O
for	O
bioequivalence	O
.	O

Standard	O
shell	O
vial	O
culture	O
and	O
immunofluoresence	O
was	O
used	O
to	O
detect	O
the	O
common	O
respiratory	O
viruses	B-SPEC
including	O
RSV	B-SPEC
,	O
influenza	O
A	O
and	O
B	O
viruses	B-SPEC
,	O
parainfluenza	O
viruses	B-SPEC
1	O
,	O
2	O
,	O
3	O
,	O
adenovirus	B-SPEC
and	O
CMV	B-SPEC
.	O

RESULTS	O
:	O
A	O
respiratory	O
virus	B-SPEC
was	O
found	O
in	O
401	O
/	O
1055	O
(	O
38	O
.	O
0	O
%)	O
samples	O
.	O

We	O
studied	O
mice	B-SPEC
infected	O
with	O
the	O
human	B-SPEC
strain	O
of	O
the	O
SARS	O
-	O
CoV	O
and	O
encephalomyocarditis	B-SPEC
virus	I-SPEC
and	O
examined	O
ACE2	O
mRNA	O
and	O
protein	O
expression	O
.	O

Pulmonary	O
infection	O
with	O
the	O
human	B-SPEC
SARS	O
-	O
CoV	O
in	O
mice	B-SPEC
led	O
to	O
an	O
ACE2	O
-	O
dependent	O
myocardial	O
infection	O
with	O
a	O
marked	O
decrease	O
in	O
ACE2	O
expression	O
confirming	O
a	O
critical	O
role	O
of	O
ACE2	O
in	O
mediating	O
SARS	O
-	O
CoV	O
infection	O
in	O
the	O
heart	O
.	O

RESULTS	O
:	O
Pulmonary	O
infection	O
with	O
the	O
human	B-SPEC
SARS	O
-	O
CoV	O
in	O
mice	B-SPEC
led	O
to	O
an	O
ACE2	O
-	O
dependent	O
myocardial	O
infection	O
with	O
a	O
marked	O
decrease	O
in	O
ACE2	O
expression	O
confirming	O
a	O
critical	O
role	O
of	O
ACE2	O
in	O
mediating	O
SARS	O
-	O
CoV	O
infection	O
in	O
the	O
heart	O
.	O

ABSTRACT	O
:	O
The	O
overview	O
presents	O
the	O
currently	O
available	O
data	O
on	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
and	O
its	O
etiological	O
agent	O
,	O
a	O
coronarovirus	O
of	O
swine	B-SPEC
.	O

TITLE	O
:	O
Surveillance	O
of	O
human	B-SPEC
papilloma	I-SPEC
virus	I-SPEC
infection	O
and	O
cervical	O
cancer	B-SPEC
in	O
kidney	O
transplant	O
recipients	O
:	O
preliminary	O
data	O
.	O

One	O
-	O
year	O
incidence	O
of	O
BOS	B-SPEC
was	O
25	O
.	O
0	O
%	O
in	O
CARV	O
-	O
positive	O
versus	O
9	O
.	O
0	O
%	O
in	O
CARV	O
-	O
negative	O
patients	O
(	O
log	O
-	O
rank	O
P	O
=	O
0	O
.	O
01	O
).	O

Risk	O
to	O
develop	O
BOS	B-SPEC
was	O
especially	O
increased	O
after	O
paramyxovirus	O
infection	O
.	O

ABSTRACT	O
:	O
In	O
this	O
review	O
,	O
recent	O
developments	O
in	O
the	O
field	O
of	O
viral	O
diseases	O
of	O
the	O
dog	B-SPEC
and	O
the	O
cat	B-SPEC
are	O
discussed	O
.	O

Infection	O
with	O
equine	B-SPEC
influenza	O
A	O
(	O
H3N8	O
)	O
or	O
a	O
highly	O
related	O
influenza	B-SPEC
virus	I-SPEC
can	O
cause	O
severe	O
respiratory	O
disease	O
and	O
mortality	O
in	O
greyhounds	O
and	O
other	O
dogs	B-SPEC
.	O

TITLE	O
:	O
Comparative	O
analysis	O
of	O
the	O
effect	O
of	O
glycyrrhizin	O
diammonium	O
and	O
lithium	O
chloride	O
on	O
infectious	O
bronchitis	O
virus	B-SPEC
infection	O
in	O
vitro	O
.	O

At	O
the	O
time	O
of	O
writing	O
,	O
there	O
is	O
no	O
non	O
-	O
invasive	O
confirmatory	O
test	O
available	O
for	O
cats	B-SPEC
without	O
effusion	O
.	O

TITLE	O
:	O
Effect	O
of	O
Polyprenyl	O
Immunostimulant	O
on	O
the	O
survival	O
times	O
of	O
three	O
cats	B-SPEC
with	O
the	O
dry	O
form	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

TITLE	O
:	O
The	O
development	O
of	O
a	O
non	O
-	O
contact	O
screening	O
system	O
for	O
rapid	O
medical	O
inspection	O
at	O
a	O
quarantine	O
depot	O
using	O
a	O
laser	B-SPEC
Doppler	O
blood	O
-	O
flow	O
meter	O
,	O
microwave	O
radar	O
and	O
infrared	O
thermography	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
conduct	O
fast	O
screening	O
of	O
passengers	O
with	O
infections	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
or	O
pandemic	O
influenza	O
at	O
a	O
quarantine	O
depot	O
,	O
we	O
developed	O
a	O
non	O
-	O
contact	O
screening	O
system	O
with	O
self	O
-	O
produced	O
program	O
to	O
conduct	O
a	O
human	B-SPEC
screening	O
within	O
five	O
seconds	O
,	O
via	O
a	O
linear	O
discriminant	O
function	O
from	O
non	O
-	O
contact	O
derived	O
variables	O
,	O
i	O
.	O
e	O
.	O
palmer	O
pulse	O
derived	O
from	O
a	O
laser	B-SPEC
Doppler	O
blood	O
-	O
flow	O
meter	O
,	O
respiration	O
rate	O
determined	O
by	O
a	O
10	O
-	O
GHz	O
microwave	O
radar	O
,	O
and	O
facial	O
temperature	O
measured	O
by	O
thermography	O
.	O

ABSTRACT	O
:	O
Events	O
in	O
the	O
last	O
decade	O
have	O
taught	O
us	O
that	O
we	O
are	O
now	O
,	O
more	O
than	O
ever	O
,	O
vulnerable	O
to	O
fatal	O
zoonotic	O
diseases	O
such	O
as	O
those	O
caused	O
by	O
haemorrhagic	O
fever	O
viruses	B-SPEC
,	O
influenza	O
,	O
rabies	O
and	O
BSE	O
/	O
vCJD	O
.	O

Animal	B-SPEC
models	O
that	O
mimic	O
certain	O
diseases	O
are	O
key	O
elements	O
for	O
understanding	O
the	O
underlying	O
mechanisms	O
of	O
disease	O
pathogenesis	O
,	O
as	O
well	O
as	O
for	O
the	O
development	O
and	O
efficacy	O
testing	O
of	O
therapeutics	O
and	O
vaccines	O
.	O

Most	O
of	O
the	O
S	B-SPEC
.	I-SPEC
pyogenes	I-SPEC
strains	O
(	O
as	O
defined	O
by	O
PFGE	O
genotypes	O
)	O
emerged	O
and	O
lasted	O
for	O
only	O
a	O
few	O
years	O
.	O

TITLE	O
:	O
A	O
new	O
Sephadex	O
-	O
based	O
method	O
for	O
removing	O
microbicidal	O
and	O
cytotoxic	O
residues	O
when	O
testing	O
antiseptics	O
against	O
viruses	B-SPEC
:	O
Experiments	O
with	O
a	O
human	B-SPEC
coronavirus	I-SPEC
as	O
a	O
model	O
.	O

To	O
test	O
for	O
associations	O
between	O
coronaviruses	O
and	O
serious	O
mental	O
disorders	O
,	O
we	O
utilized	O
a	O
recently	O
developed	O
assay	O
and	O
measured	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
response	O
against	O
4	O
human	B-SPEC
coronavirus	I-SPEC
strains	O
(	O
229E	O
,	O
HKU1	O
,	O
NL63	O
,	O
and	O
OC43	O
)	O
in	O
106	O
patients	O
with	O
a	O
recent	O
onset	O
of	O
psychotic	O
symptoms	O
and	O
196	O
nonpsychiatric	O
controls	O
.	O

ABSTRACT	O
:	O
A	O
chimeric	O
gene	O
encoding	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
and	O
a	O
S	O
-	O
layer	O
protein	O
from	O
Lactobacillus	B-SPEC
brevis	I-SPEC
KCTC3102	O
,	O
and	O
/	O
or	O
two	O
copies	O
of	O
the	O
Fc	O
-	O
binding	O
Z	O
-	O
domain	O
,	O
a	O
synthetic	O
analog	O
of	O
the	O
B	O
-	O
domain	O
of	O
protein	O
A	O
,	O
was	O
constructed	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
BL21	O
(	O
DE3	O
).	O

We	O
describe	O
a	O
case	O
of	O
a	O
33	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
acute	O
respiratory	O
failure	O
due	O
to	O
cardiovascular	O
crisis	O
and	O
massive	O
hemoptysis	O
as	O
a	O
presenting	O
symptom	O
of	O
pheochromocytoma	O
.	O

The	O
field	O
isolates	O
of	O
4	O
/	O
91	O
genotype	O
IBV	B-SPEC
could	O
be	O
distinguished	O
from	O
other	O
genotypes	O
by	O
using	O
the	O
BalI	O
and	O
Pst	O
I	O
enzymes	O
in	O
addition	O
to	O
the	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
-	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
RFLP	O
)	O
methods	O
of	O
Mase	O
et	O
al	O
.	O
[	O
16	O
]	O
using	O
Hae	O
II	O
and	O
EcoR	O
I	O
enzymes	O
.	O

Neurotoropism	O
of	O
the	O
virus	B-SPEC
has	O
been	O
demonstrated	O
in	O
previous	O
in	O
vivo	O
studies	O
.	O

This	O
paper	O
is	O
presented	O
to	O
highlight	O
that	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
malaria	O
though	O
considered	O
to	O
be	O
a	O
benign	O
entity	O
can	O
also	O
have	O
a	O
severe	O
and	O
complicated	O
course	O
which	O
is	O
usually	O
associated	O
with	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
malaria	O
.	O

Infections	O
with	O
RSV	B-SPEC
were	O
associated	O
with	O
more	O
physician	O
visits	O
than	O
HRV	O
infections	O
(	O
P	O
=	O
0	O
.	O
06	O
).	O

Magnetic	O
resonance	O
images	O
(	O
MRI	O
)	O
and	O
X	O
-	O
rays	B-SPEC
of	O
hips	O
,	O
knees	O
,	O
shoulders	O
,	O
ankles	O
and	O
wrists	O
were	O
taken	O
as	O
part	O
of	O
the	O
post	O
-	O
SARS	O
follow	O
-	O
up	O
assessments	O
.	O

Rats	B-SPEC
with	O
LC	O
+	O
CASP	O
also	O
had	O
distinct	O
aspects	O
of	O
inflammation	O
compared	O
with	O
CASP	O
alone	O
,	O
i	O
.	O
e	O
.,	O
significantly	O
higher	O
levels	O
of	O
IL	O
-	O
10	O
(	O
5	O
and	O
24	O
h	O
),	O
IL	O
-	O
1beta	O
(	O
24	O
h	O
),	O
CINC	O
-	O
1	O
(	O
24	O
h	O
),	O
and	O
MCP	O
-	O
1	O
(	O
24	O
h	O
),	O
and	O
significantly	O
lower	O
levels	O
of	O
MPO	O
(	O
5	O
h	O
),	O
MIP	O
-	O
2	O
(	O
5	O
h	O
),	O
and	O
CINC	O
-	O
1	O
(	O
5	O
h	O
).	O

Multiplex	O
PCR	O
tests	O
sentinel	O
the	O
appearance	O
of	O
pandemic	O
influenza	B-SPEC
viruses	I-SPEC
including	O
H1N1	O
swine	B-SPEC
influenza	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
turn	O
of	O
the	O
century	O
seven	O
new	O
respiratory	O
viruses	B-SPEC
have	O
infected	O
man	B-SPEC
and	O
two	O
of	O
these	O
have	O
resulted	O
in	O
worldwide	O
epidemics	O
.	O

TITLE	O
:	O
Altered	O
pathogenicity	O
,	O
immunogenicity	O
,	O
tissue	O
tropism	O
and	O
3	O
'-	O
7kb	O
region	O
sequence	O
of	O
an	O
avian	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
strain	O
after	O
serial	O
passage	O
in	O
embryos	O
.	O

This	O
influences	O
human	B-SPEC
behaviour	O
and	O
should	O
hence	O
be	O
considered	O
during	O
risk	O
communication	O
and	O
implementation	O
of	O
pandemic	O
control	O
measures	O
.	O

ABSTRACT	O
:	O
The	O
glycosylated	O
membrane	O
protein	O
M	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
the	O
main	O
structural	O
component	O
of	O
the	O
virion	O
and	O
mediates	O
assembly	O
and	O
budding	O
of	O
viral	O
particles	O
.	O

Data	O
regarding	O
the	O
correlates	O
of	O
protection	O
,	O
animal	B-SPEC
models	O
and	O
the	O
available	O
evidence	O
regarding	O
potential	O
vaccine	O
enhancement	O
of	O
SARS	O
disease	O
are	O
discussed	O
.	O

TITLE	O
:	O
Coadministration	O
of	O
chicken	B-SPEC
GM	O
-	O
CSF	O
with	O
a	O
DNA	O
vaccine	O
expressing	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
S1	O
glycoprotein	O
enhances	O
the	O
specific	O
immune	O
response	O
and	O
protects	O
against	O
IBV	B-SPEC
infection	O
.	O

Among	O
all	O
hosts	O
,	O
the	O
diversity	O
of	O
coronaviruses	O
is	O
most	O
evidenced	O
in	O
bats	B-SPEC
and	O
birds	B-SPEC
,	O
which	O
may	O
be	O
a	O
result	O
of	O
their	O
species	B-SPEC
diversity	O
,	O
ability	O
to	O
fly	B-SPEC
,	O
environmental	O
pressures	O
,	O
and	O
habits	O
of	O
roosting	O
and	O
flocking	O
.	O

Adult	O
male	O
Sprague	B-SPEC
-	I-SPEC
Dawley	I-SPEC
rats	I-SPEC
were	O
randomly	O
divided	O
into	O
three	O
groups	O
:	O
control	O
,	O
lipopolysaccharide	O
,	O
and	O
lipopolysaccharide	O
+	O
dobutamine	O
.	O

ABSTRACT	O
:	O
The	O
nsp14	O
protein	O
,	O
an	O
exoribonuclease	O
of	O
the	O
DEDD	O
superfamily	B-SPEC
encoded	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
was	O
expressed	O
in	O
fusion	O
with	O
different	O
affinity	O
tags	O
.	O

TITLE	O
:	O
Proteolytic	O
activation	O
of	O
the	O
spike	O
protein	O
at	O
a	O
novel	O
RRRR	O
/	O
S	O
motif	O
is	O
implicated	O
in	O
furin	O
-	O
dependent	O
entry	O
,	O
syncytium	O
formation	O
,	O
and	O
infectivity	O
of	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
cultured	O
cells	O
.	O

Furthermore	O
,	O
sequence	O
analysis	O
of	O
CoV	O
S	O
proteins	O
by	O
multiple	O
alignments	O
showed	O
conservation	O
of	O
an	O
XXXR	O
/	O
S	O
motif	O
,	O
cleavable	O
by	O
either	O
furin	O
or	O
other	O
trypsin	O
-	O
like	O
proteases	O
,	O
at	O
a	O
position	O
equivalent	O
to	O
the	O
second	O
IBV	B-SPEC
furin	O
site	O
.	O

C3H	O
/	O
HeJ	O
mice	B-SPEC
harbor	O
a	O
natural	O
mutation	O
in	O
the	O
gene	O
that	O
encodes	O
Toll	O
-	O
like	O
receptor	O
4	O
(	O
TLR4	O
)	O
that	O
disrupts	O
TLR4	O
signaling	O
.	O

We	O
examined	O
the	O
distribution	O
of	O
respiratory	O
viruses	B-SPEC
and	O
their	O
association	O
with	O
seasons	O
in	O
acute	O
and	O
stable	O
asthmatic	O
children	O
in	O
Trinidad	O
.	O

The	O
predominant	O
pathogens	O
detected	O
in	O
acute	O
versus	O
stable	O
asthmatics	O
were	O
the	O
rhinovirus	B-SPEC
(	O
RV	O
)	O
(	O
n	O
=	O
18	O
,	O
25	O
.	O
7	O
%	O
vs	O
.	O
n	O
=	O
7	O
,	O
8	O
.	O
8	O
%;	O
p	O
=	O
0	O
.	O
005	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
B	O
(	O
RSV	B-SPEC
B	O
)	O
(	O
n	O
=	O
2	O
,	O
2	O
.	O
9	O
%	O
vs	O
.	O
n	O
=	O
4	O
,	O
5	O
.	O
0	O
%),	O
and	O
enterovirus	B-SPEC
(	O
n	O
=	O
1	O
,	O
1	O
.	O
4	O
%	O
vs	O
.	O
n	O
=	O
2	O
,	O
2	O
.	O
5	O
%).	O

CONCLUSIONS	O
:	O
Emergent	O
wheezing	O
illnesses	O
during	O
childhood	O
can	O
be	O
linked	O
to	O
infection	O
with	O
rhinovirus	B-SPEC
in	O
Trinidad	O
'	O
s	O
tropical	O
environment	O
.	O

The	O
serum	O
samples	O
were	O
initially	O
tested	O
with	O
the	O
virus	B-SPEC
neutralisation	O
(	O
VN	O
)	O
test	O
and	O
the	O
results	O
were	O
then	O
compared	O
with	O
the	O
ELISA	O
.	O

The	O
ELISA	O
-	O
negative	O
sera	O
were	O
also	O
found	O
to	O
be	O
free	O
of	O
feline	B-SPEC
coronoviruses	O
-	O
specific	O
antibodies	O
by	O
Western	O
blotting	O
.	O

Late	O
in	O
the	O
study	O
,	O
94	O
skin	O
samples	O
(	O
ear	O
notches	O
)	O
were	O
tested	O
for	O
Bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
BVDV	B-SPEC
)	O
by	O
immunohistochemistry	O
(	O
IHC	O
).	O

TITLE	O
:	O
Pneumonia	O
and	O
respiratory	O
failure	O
from	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
H1N1	O
)	O
in	O
Mexico	O
.	O

TITLE	O
:	O
Survey	O
of	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
and	O
feline	B-SPEC
coronaviruses	O
in	O
captive	O
neotropical	O
wild	O
felids	B-SPEC
from	O
Southern	O
Brazil	O
.	O

To	O
determine	O
whether	O
the	O
spike	O
protein	O
is	O
responsible	O
for	O
the	O
difference	O
,	O
a	O
recombinant	O
virus	B-SPEC
,	O
Penn	O
-	O
98	O
-	O
1	O
,	O
that	O
contains	O
the	O
A59	O
genome	O
with	O
a	O
spike	O
from	O
MHV	B-SPEC
-	O
2	O
was	O
used	O
to	O
infect	O
DBT	O
cells	O
.	O

In	O
this	O
study	O
we	O
show	O
that	O
an	O
intact	O
type	O
I	O
interferon	O
system	O
and	O
the	O
adaptive	O
immune	O
responses	O
are	O
required	O
for	O
controlling	O
MHV	B-SPEC
-	O
1	O
replication	O
and	O
preventing	O
morbidity	O
and	O
mortality	O
in	O
resistant	O
C57BL	O
/	O
6J	O
mice	B-SPEC
after	O
infection	O
.	O

The	O
NK	O
cell	O
response	O
also	O
helps	O
minimize	O
the	O
severity	O
of	O
illness	O
following	O
MHV	B-SPEC
-	O
1	O
infection	O
of	O
C57BL	O
/	O
6J	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
host	O
and	O
cell	O
specificities	O
are	O
determined	O
by	O
specific	O
interactions	O
between	O
the	O
viral	O
spike	O
(	O
S	O
)	O
protein	O
and	O
host	O
cell	O
receptor	O
(	O
s	O
).	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
inoculated	O
orally	O
with	O
SL7207	O
(	O
pVAX	O
-	O
S	O
)	O
at	O
different	O
dosages	O
,	O
the	O
bacterium	B-SPEC
was	O
safe	O
to	O
mice	B-SPEC
at	O
dosage	O
of	O
2x10	O
(	O
9	O
)	O
CFU	O
and	O
eventually	O
eliminated	O
from	O
the	O
spleen	O
and	O
liver	O
at	O
week	O
4	O
post	O
-	O
immunization	O
.	O

DNA	O
vaccine	O
plasmids	O
,	O
pcDNA	O
-	O
N	O
and	O
pcDNA	O
-	O
IL2	O
,	O
were	O
constructed	O
and	O
inoculated	O
into	O
BALB	O
/	O
c	O
mice	B-SPEC
with	O
or	O
without	O
pcDNA	O
-	O
IL2	O
by	O
intramuscular	O
injection	O
.	O

The	O
nucleocapsid	O
DNA	O
vaccine	O
had	O
good	O
immunogenicity	O
and	O
can	O
induce	O
specific	O
humoral	O
and	O
cellular	O
immunity	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
,	O
while	O
IL	O
-	O
2	O
plays	O
an	O
immunoadjuvant	O
role	O
and	O
enhances	O
specific	O
immune	O
responses	O
.	O

TITLE	O
:	O
Host	O
cell	O
proteins	O
interacting	O
with	O
the	O
3	O
'	O
end	O
of	O
TGEV	B-SPEC
coronavirus	B-SPEC
genome	O
influence	O
virus	B-SPEC
replication	O
.	O

To	O
identify	O
cellular	O
proteins	O
involved	O
in	O
coronavirus	B-SPEC
RNA	O
synthesis	O
,	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
genome	O
ends	O
,	O
harboring	O
essential	O
cis	B-SPEC
-	O
acting	O
signals	O
for	O
replication	O
,	O
were	O
used	O
as	O
baits	O
for	O
RNA	O
affinity	O
protein	O
purification	O
.	O

During	O
the	O
vaccination	O
course	O
,	O
the	O
candidate	O
peptide	O
vaccines	O
induced	O
strong	O
humoral	O
and	O
cellular	O
response	O
,	O
and	O
provided	O
up	O
to	O
80	O
.	O
0	O
%	O
immune	O
protection	O
,	O
while	O
all	O
non	O
-	O
immunized	O
chickens	B-SPEC
in	O
the	O
negative	O
control	O
group	O
manifested	O
obvious	O
typical	O
symptoms	O
and	O
died	O
after	O
virus	B-SPEC
challenge	O
.	O

S1	O
gene	O
analysis	O
showed	O
that	O
a	O
recombination	O
event	O
had	O
occurred	O
in	O
the	O
virus	B-SPEC
'	O
s	O
evolutionary	O
process	O
.	O

Full	O
length	O
SARS	O
-	O
CoV	O
E	O
displayed	O
channel	O
activity	O
when	O
transiently	O
expressed	O
in	O
human	B-SPEC
embryonic	O
kidney	O
293	O
(	O
HEK	O
-	O
293	O
)	O
cells	O
in	O
a	O
whole	O
-	O
cell	O
patch	O
clamp	O
set	O
-	O
up	O
.	O

Three	O
trans	O
-	O
membrane	O
non	O
-	O
structural	O
proteins	O
,	O
nsp3	O
,	O
nsp4	O
and	O
nsp6	O
,	O
are	O
understood	O
to	O
be	O
membrane	O
anchors	O
of	O
the	O
coronavirus	B-SPEC
replication	O
complex	O
.	O

The	O
observation	O
of	O
reduced	O
outpatient	O
mortality	O
might	O
be	O
caused	O
by	O
bias	B-SPEC
,	O
confounding	O
,	O
or	O
chance	O
,	O
but	O
is	O
biologically	O
plausible	O
,	O
has	O
potential	O
for	O
public	O
health	O
impact	O
,	O
and	O
should	O
be	O
explored	O
in	O
future	O
studies	O
.	O

Although	O
the	O
transmission	O
of	O
infectious	O
diseases	O
to	O
airline	O
passengers	O
inside	O
an	O
aircraft	O
is	O
a	O
rare	O
occurrence	O
,	O
it	O
is	O
essential	O
to	O
implement	O
entry	O
and	O
exit	O
screening	O
procedures	O
at	O
airports	O
within	O
the	O
context	O
of	O
the	O
International	O
Health	O
Regulations	O
(	O
IHR	O
)	O
in	O
order	B-SPEC
to	O
slow	O
down	O
the	O
spread	O
of	O
infection	O
,	O
especially	O
during	O
the	O
early	O
phases	O
of	O
a	O
pandemic	O
event	O
.	O

TITLE	O
:	O
[	O
A	O
case	O
of	O
Legionella	B-SPEC
pneumonia	O
with	O
diabetic	O
ketoacidosis	O
rescued	O
despite	O
the	O
development	O
of	O
acute	O
renal	O
failure	O
and	O
ARDS	O
].	O

Despite	O
the	O
severe	O
complications	O
in	O
his	O
clinical	O
course	O
,	O
including	O
diabetic	O
ketoacidosis	O
,	O
acute	O
renal	O
failure	O
and	O
ARDS	O
,	O
detection	O
of	O
Legionella	B-SPEC
pneumophila	I-SPEC
by	O
a	O
urinary	O
antigen	O
test	O
,	O
Gimenez	O
stain	O
and	O
sputum	O
culture	O
made	O
prompt	O
and	O
proper	O
administration	O
of	O
antibiotics	O
possible	O
,	O
finally	O
yielding	O
a	O
desirable	O
outcome	O
.	O

Cases	O
of	O
novel	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
infection	O
have	O
included	O
rapidly	O
progressive	O
lower	O
respiratory	O
tract	O
disease	O
resulting	O
in	O
respiratory	O
failure	O
,	O
development	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
prolonged	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
admission	O
.	O

ABSTRACT	O
:	O
An	O
ideal	O
animal	B-SPEC
model	O
for	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
(	O
HEV	B-SPEC
)	O
research	O
is	O
still	O
unavailable	O
.	O

Two	O
gerbils	B-SPEC
from	O
both	O
groups	O
were	O
necropsied	O
weekly	O
,	O
pathological	O
changes	O
were	O
recorded	O
and	O
tissue	O
samples	O
collected	O
for	O
further	O
investigation	O
.	O

A	O
HeLa	O
cell	O
line	O
stably	O
expressing	O
rdACE2	O
was	O
established	O
;	O
Western	O
blot	O
analyses	O
and	O
an	O
enzyme	O
-	O
activity	O
assay	O
indicated	O
that	O
the	O
cell	O
line	O
expressed	O
ACE2	O
at	O
a	O
similar	O
level	O
to	O
two	O
previously	O
established	O
cell	O
lines	O
that	O
express	O
ACE2	O
from	O
human	B-SPEC
and	O
masked	B-SPEC
palm	I-SPEC
civet	I-SPEC
,	O
respectively	O
.	O

This	O
study	O
provides	O
useful	O
data	O
to	O
elucidate	O
the	O
role	O
of	O
raccoon	B-SPEC
dog	I-SPEC
in	O
SARS	O
outbreaks	O
.	O

Recombinant	O
L	B-SPEC
.	I-SPEC
lactis	I-SPEC
,	O
expressing	O
the	O
SN	O
protein	O
,	O
was	O
constructed	O
with	O
the	O
pNZ8112	O
plasmid	O
.	O

We	O
found	O
that	O
the	O
number	O
of	O
birds	B-SPEC
positive	O
for	O
IBV	B-SPEC
vaccine	O
following	O
vaccination	O
in	O
the	O
field	O
resembled	O
a	O
parabolic	O
-	O
shaped	O
curve	O
that	O
peaked	O
around	O
14	O
days	O
postvaccination	O
,	O
or	O
it	O
resembled	O
a	O
sinusoidal	O
-	O
type	O
wave	O
with	O
a	O
frequency	O
of	O
about	O
2	O
wk	O
.	O

TITLE	O
:	O
CpG	O
oligodeoxynucleotides	O
activate	O
innate	O
immune	O
response	O
that	O
suppresses	O
infectious	O
bronchitis	O
virus	B-SPEC
replication	O
in	O
chicken	B-SPEC
embryos	O
.	O

TITLE	O
:	O
The	O
pediatric	O
burden	O
of	O
human	B-SPEC
coronaviruses	O
evaluated	O
for	O
twenty	O
years	O
.	O

It	O
was	O
reported	O
that	O
aminopeptidase	O
N	O
(	O
APN	O
)	O
was	O
the	O
receptor	O
for	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
Human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
and	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FeCoV	O
)	O
which	O
all	O
belonged	O
to	O
group	O
I	O
coronavirus	B-SPEC
including	O
PEDV	B-SPEC
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
lethal	O
complications	O
of	O
Legionella	B-SPEC
pneumonia	O
.	O

Six	O
deaths	O
occurred	O
(	O
mortality	O
rate	O
9	O
.	O
2	O
%),	O
4	O
of	O
which	O
were	O
due	O
to	O
septic	O
shock	O
/	O
multiple	O
organ	O
dysfunction	O
syndrome	O
(	O
MODS	O
)	O
(	O
2	O
patients	O
)	O
or	O
interstitial	O
pneumonia	O
/	O
pulmonary	O
fibrosis	O
after	O
Legionella	B-SPEC
pneumonia	O
(	O
2	O
patients	O
),	O
whereas	O
the	O
other	O
2	O
deaths	O
were	O
due	O
to	O
causes	O
unrelated	O
to	O
Legionella	B-SPEC
pneumonia	O
.	O

Herein	O
the	O
mRT	O
-	O
PCR	O
was	O
compared	O
to	O
the	O
commercial	O
Luminex	O
mPCR	O
-	O
microsphere	O
flow	O
cytometry	O
assay	O
(	O
Resplex	O
II	O
)	O
which	O
allows	O
the	O
detection	O
of	O
12	O
different	O
viruses	B-SPEC
.	O

In	O
this	O
overview	O
,	O
we	O
describe	O
in	O
vitro	O
models	O
of	O
highly	O
differentiated	O
alveolar	O
epithelial	O
cells	O
that	O
are	O
currently	O
being	O
used	O
to	O
study	O
the	O
innate	O
immune	O
response	O
to	O
coronavirus	B-SPEC
infection	O
.	O

With	O
VT	O
<	O
6	O
ml	O
/	O
kg	O
,	O
severe	O
acidosis	O
could	O
only	O
be	O
avoided	O
if	O
PCV	B-SPEC
was	O
combined	O
with	O
av	O
-	O
ECLA	O
.	O

The	O
samples	O
were	O
tested	O
by	O
RT	O
-	O
PCR	O
for	O
the	O
presence	O
of	O
both	O
type	O
I	O
and	O
type	O
II	O
CECoV	O
.	O
Seven	O
samples	O
were	O
positive	O
(	O
three	O
from	O
dogs	B-SPEC
in	O
the	O
same	O
household	O
),	O
a	O
prevalence	O
of	O
2	O
.	O
8	O
%	O
(	O
95	O
%	O
confidence	O
intervals	O
1	O
.	O
1	O
-	O
5	O
.	O
7	O
).	O

Both	O
the	O
type	O
I	O
and	O
II	O
IFN	O
response	O
,	O
which	O
were	O
more	O
pronounced	O
in	O
mice	B-SPEC
with	O
a	O
higher	O
viral	O
load	O
,	O
were	O
not	O
observed	O
in	O
129SvEv	O
mice	B-SPEC
,	O
which	O
are	O
much	O
less	O
susceptible	O
to	O
infection	O
with	O
MHV	B-SPEC
.	O

We	O
speculate	O
that	O
the	O
additional	O
type	O
I	O
IFN	O
-	O
dependent	O
genes	O
that	O
we	O
discovered	O
may	O
also	O
be	O
important	O
for	O
protection	O
against	O
MHV	B-SPEC
infection	O
.	O

The	O
impact	O
of	O
'	O
other	O
'	O
viruses	B-SPEC
(	O
RSV	B-SPEC
,	O
influenza	O
,	O
adenovirus	B-SPEC
,	O
parainfluenza	O
,	O
rhinovirus	B-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
[	O
hMPV	B-SPEC
],	O
coronavirus	B-SPEC
,	O
boca	O
-	O
virus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
paraechovirus	O
)	O
has	O
been	O
investigated	O
.	O

Following	O
PRCV	O
infection	O
,	O
more	O
severe	O
PRRSV	B-SPEC
-	O
related	O
pulmonary	O
alveolar	O
macrophage	O
(	O
PAM	O
)	O
apoptosis	O
occurred	O
,	O
as	O
determined	O
by	O
an	O
in	O
situ	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
dUTP	O
nick	O
end	O
labelling	O
assay	O
,	O
suggesting	O
increased	O
PRRSV	B-SPEC
replication	O
in	O
PAMs	O
.	O

In	O
this	O
study	O
,	O
the	O
authors	O
hypothesized	O
that	O
the	O
hemorrhagic	O
enteritis	O
virus	B-SPEC
(	O
HEV	B-SPEC
),	O
an	O
avian	B-SPEC
adenovirus	I-SPEC
that	O
causes	O
illness	O
among	O
turkeys	B-SPEC
,	O
might	O
infect	O
humans	B-SPEC
.	O

Using	O
an	O
enzyme	O
immunosorbent	O
assay	O
,	O
the	O
authors	O
compared	O
sera	O
from	O
95	O
turkey	B-SPEC
-	O
exposed	O
individuals	O
with	O
sera	O
from	O
82	O
nonexposed	O
controls	O
for	O
serologic	O
evidence	O
of	O
infection	O
with	O
HEV	B-SPEC
.	O

TITLE	O
:	O
Large	O
Arf1	O
guanine	O
nucleotide	O
exchange	O
factors	O
:	O
evolution	O
,	O
domain	O
structure	O
,	O
and	O
roles	O
in	O
membrane	O
trafficking	O
and	O
human	B-SPEC
disease	O
.	O

The	O
large	O
Arf1	O
GEFs	O
have	O
been	O
implicated	O
in	O
several	O
human	B-SPEC
diseases	O
.	O

In	O
this	O
study	O
,	O
we	O
expressed	O
the	O
recombinant	O
receptor	O
-	O
binding	O
domain	O
(	O
rRBD	O
)	O
in	O
mammalian	B-SPEC
(	O
293T	O
)	O
cells	O
,	O
insect	B-SPEC
(	O
Sf9	O
)	O
cells	O
,	O
and	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
respectively	O
,	O
and	O
compared	O
their	O
immunogenicity	O
and	O
protection	O
against	O
SARS	O
-	O
CoV	O
infection	O
in	O
an	O
established	O
mouse	B-SPEC
model	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
the	O
etiological	O
agent	O
of	O
a	O
newly	O
emerged	O
disease	O
SARS	O
.	O

ABSTRACT	O
:	O
Hyperinfection	O
syndrome	O
with	O
Strongyloides	B-SPEC
stercoralis	I-SPEC
is	O
not	O
uncommon	O
in	O
immunocompromised	O
patients	O
.	O

Clinical	O
manifestations	O
of	O
unexplained	O
wheezing	O
and	O
respiratory	O
failure	O
,	O
increased	O
infiltration	O
on	O
chest	O
radiograph	O
,	O
Gram	O
-	O
negative	O
bacteremia	O
,	O
and	O
aseptic	O
meningitis	O
may	O
all	O
be	O
clues	O
of	O
Strongyloides	B-SPEC
hyperinfection	O
.	O

Additionally	O
,	O
enterohaemorrhagic	O
Escherichia	B-SPEC
coli	I-SPEC
O157	O
:	O
H7	O
infection	O
has	O
increased	O
worldwide	O
with	O
severe	O
disease	O
.	O

Phylogenetic	O
analysis	O
based	O
on	O
that	O
region	O
revealed	O
that	O
these	O
viruses	B-SPEC
were	O
separated	O
into	O
two	O
groups	O
(	O
I	O
and	O
II	O
).	O

ABSTRACT	O
:	O
Two	O
giant	B-SPEC
pandas	I-SPEC
(	O
Ailuropoda	B-SPEC
melanoleuca	I-SPEC
)	O
died	O
of	O
unknown	O
causes	O
in	O
a	O
Chinese	O
zoo	O
.	O

Studies	O
in	O
the	O
putative	O
human	B-SPEC
VASP	O
promoter	O
identified	O
NF	O
-	O
kappaB	O
as	O
a	O
key	O
regulator	O
of	O
VASP	O
transcription	O
.	O

TITLE	O
:	O
The	O
antiviral	O
action	O
of	O
common	O
household	O
disinfectants	O
and	O
antiseptics	O
against	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
a	O
potential	O
surrogate	O
for	O
SARS	O
coronavirus	B-SPEC
.	O

In	O
an	O
outbreak	O
caused	O
by	O
novel	O
agents	O
,	O
it	O
is	O
important	O
to	O
know	O
the	O
effectiveness	O
of	O
disinfectants	O
and	O
antiseptics	O
to	O
prevent	O
or	O
reduce	O
the	O
possibility	O
of	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
via	O
surfaces	O
.	O

Legal	O
medicine	O
autopsy	O
identified	O
aggressive	O
Candida	B-SPEC
famata	I-SPEC
mycosis	O
.	O

Despite	O
the	O
autopsy	O
findings	O
,	O
all	O
intravital	O
specimens	O
collected	O
(	O
blood	O
,	O
urine	O
,	O
and	O
tracheal	O
mucus	O
)	O
and	O
all	O
clinical	O
Candida	B-SPEC
antigen	O
tests	O
were	O
unsuspicious	O
.	O

Clostridium	B-SPEC
difficile	I-SPEC
-	O
associated	O
diarrhea	O
(	O
CDAD	O
)	O
rates	O
,	O
trended	O
up	O
from	O
1999	O
to	O
2005	O
(	O
F	O
=	O
2	O
.	O
9	O
,	O
P	O
=	O
0	O
.	O
09	O
).	O

The	O
proportion	O
of	O
hospitals	O
that	O
reported	O
having	O
new	O
nosocomial	O
Vancomycin	O
-	O
resistant	O
Enterococcus	B-SPEC
(	O
VRE	O
)	O
cases	O
was	O
greater	O
in	O
2005	O
than	O
in	O
1999	O
(	O
X	O
=	O
10	O
.	O
5	O
,	O
P	O
=	O
0	O
.	O
001	O
).	O

ABSTRACT	O
:	O
A	O
73	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
underlying	O
chronic	O
renal	O
failure	O
,	O
angina	O
pectoris	O
,	O
chronic	O
heart	O
failure	O
,	O
and	O
respiratory	O
failure	O
reporting	O
three	O
-	O
day	O
appetite	O
loss	O
,	O
fever	O
,	O
and	O
drowsiness	O
was	O
admitted	O
for	O
lower	O
right	O
lung	O
pneumonia	O
.	O

To	O
study	O
the	O
role	O
of	O
ORF	O
7b	O
in	O
the	O
context	O
of	O
virus	B-SPEC
replication	O
,	O
we	O
cloned	O
a	O
full	O
genome	O
cDNA	O
copy	O
of	O
Frankfurt	O
-	O
1	O
in	O
a	O
bacterial	O
artificial	O
chromosome	O
downstream	O
of	O
a	O
T7	O
RNA	O
polymerase	O
promoter	O
.	O

In	O
Syrian	B-SPEC
Golden	I-SPEC
Hamsters	I-SPEC
inoculated	O
intranasally	O
with	O
10e4	O
plaque	O
forming	O
units	O
of	O
either	O
virus	B-SPEC
,	O
mean	O
titers	O
of	O
infectious	O
virus	B-SPEC
and	O
viral	O
RNA	O
in	O
the	O
lungs	O
after	O
24	O
h	O
were	O
increased	O
23	O
-	O
and	O
94	O
.	O
8	O
-	O
fold	O
,	O
respectively	O
,	O
with	O
the	O
deleted	O
virus	B-SPEC
.	O

TITLE	O
:	O
Two	O
-	O
step	O
conformational	O
changes	O
in	O
a	O
coronavirus	B-SPEC
envelope	O
glycoprotein	O
mediated	O
by	O
receptor	O
binding	O
and	O
proteolysis	O
.	O

Thirty	O
-	O
two	O
months	O
after	O
presentation	O
of	O
the	O
initial	O
symptoms	O
,	O
the	O
patient	O
died	O
due	O
to	O
complications	O
related	O
to	O
leukaemia	O
recurrence	O
(	O
haemorrhage	O
,	O
sepsis	B-SPEC
and	O
respiratory	O
distress	O
syndrome	O
).	O

RESULTS	O
:	O
Severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
accounts	O
for	O
25	O
.	O
4	O
%	O
of	O
admission	O
to	O
the	O
ICU	O
during	O
Hajj	O
.	O

LBP	O
serum	O
levels	O
at	O
study	O
entry	O
,	O
at	O
48	O
hours	O
and	O
at	O
day	O
-	O
7	O
were	O
measured	O
in	O
180	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

TITLE	O
:	O
Absence	O
of	O
antibody	O
-	O
dependent	O
,	O
complement	O
-	O
mediated	O
lysis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
-	O
infected	O
cells	O
.	O

ABSTRACT	O
:	O
Hemagglutinin	O
esterases	O
(	O
HEs	O
),	O
closely	O
related	O
envelope	O
glycoproteins	O
in	O
influenza	O
C	O
and	O
corona	B-SPEC
-	O
and	O
toroviruses	B-SPEC
,	O
mediate	O
reversible	O
attachment	O
to	O
O	O
-	O
acetylated	O
sialic	O
acids	O
(	O
Sias	O
).	O

The	O
selective	O
forces	O
underlying	O
HE	O
diversity	O
and	O
the	O
molecular	O
basis	O
for	O
Sia	B-SPEC
specificity	O
are	O
poorly	O
understood	O
.	O

Structure	O
-	O
guided	O
biochemical	O
analysis	O
of	O
the	O
esterase	O
domains	O
revealed	O
that	O
a	O
functionally	O
,	O
but	O
not	O
structurally	O
conserved	O
arginine	O
-	O
Sia	B-SPEC
carboxylate	O
interaction	O
is	O
critical	O
for	O
the	O
binding	O
and	O
positioning	O
of	O
glycosidically	O
bound	O
Sias	O
in	O
the	O
catalytic	O
pocket	O
.	O

The	O
use	O
of	O
corticosteroids	O
to	O
treat	O
critically	O
ill	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
severe	O
infections	O
,	O
such	O
as	O
sepsis	B-SPEC
and	O
pneumonia	O
,	O
is	O
still	O
a	O
matter	O
of	O
intense	O
debate	O
in	O
the	O
scientific	O
and	O
medical	O
community	O
with	O
evidence	O
both	O
for	O
and	O
against	O
its	O
use	O
in	O
these	O
patients	O
.	O

The	O
spectrum	O
of	O
interferon	O
(	O
IFN	O
)-	O
gamma	O
responses	O
of	O
Balb	O
/	O
c	O
mice	B-SPEC
immunized	O
against	O
two	O
different	O
forms	O
of	O
SARS	O
CoV	O
-	O
N	O
plasmid	O
was	O
then	O
analyzed	O
.	O

The	O
results	O
showed	O
marked	O
differences	O
in	O
the	O
responses	O
of	O
the	O
immunized	O
mice	B-SPEC
.	O

These	O
results	O
indicate	O
that	O
the	O
developed	O
TaqMan	O
assay	O
is	O
a	O
highly	O
sensitive	O
diagnostic	O
test	O
for	O
rapid	O
detection	O
of	O
TGEV	B-SPEC
in	O
pig	B-SPEC
fecal	O
samples	O
.	O

Goal	O
-	O
directed	O
hemodynamic	O
therapy	O
has	O
been	O
shown	O
to	O
be	O
of	O
benefit	O
to	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
,	O
acute	O
lung	O
injury	O
and	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
for	O
surgical	O
patients	O
in	O
the	O
operating	O
room	O
.	O

The	O
recombinant	O
S	O
protein	O
-	O
based	O
ELISA	O
appeared	O
to	O
be	O
100	O
%	O
sensitive	O
for	O
TGEV	B-SPEC
and	O
PRCoV	O
detection	O
and	O
highly	O
specific	O
for	O
TGEV	B-SPEC
and	O
PRCoV	O
detection	O
(	O
100	O
%	O
and	O
92	O
.	O
06	O
%,	O
respectively	O
),	O
when	O
qualitative	O
results	O
(	O
positive	O
or	O
negative	O
)	O
were	O
compared	O
with	O
those	O
of	O
the	O
reference	O
technique	O
.	O

TITLE	O
:	O
Macrophage	O
interleukin	O
-	O
6	O
and	O
tumour	O
necrosis	O
factor	O
-	O
alpha	O
are	O
induced	O
by	O
coronavirus	B-SPEC
fixation	O
to	O
Toll	O
-	O
like	O
receptor	O
2	O
/	O
heparan	O
sulphate	O
receptors	O
but	O
not	O
carcinoembryonic	O
cell	O
adhesion	O
antigen	O
1a	O
.	O

The	O
induction	O
of	O
IL	O
-	O
6	O
and	O
TNF	O
-	O
alpha	O
production	O
was	O
related	O
rather	O
to	O
the	O
fixation	O
of	O
the	O
spike	O
(	O
S	O
)	O
protein	O
of	O
MHV3	O
on	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
in	O
regions	O
enriched	O
in	O
heparan	O
sulphate	O
and	O
did	O
not	O
rely	O
on	O
viral	O
replication	O
,	O
as	O
demonstrated	O
with	O
denatured	O
S	O
protein	O
and	O
UV	O
-	O
inactivated	O
virus	B-SPEC
.	O

Depending	O
on	O
mouse	B-SPEC
strain	O
,	O
the	O
viral	O
fixation	O
to	O
heparan	O
sulfate	O
/	O
TLR2	O
stimulated	O
differently	O
the	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
and	O
nuclear	O
factor	O
(	O
NF	O
)-	O
kappaB	O
in	O
the	O
induction	O
of	O
IL	O
-	O
6	O
and	O
TNF	O
-	O
alpha	O
.	O

TITLE	O
:	O
A	O
synergistic	O
interferon	O
-	O
gamma	O
production	O
is	O
induced	O
by	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
in	O
interleukin	O
-	O
12	O
(	O
IL	O
-	O
12	O
)/	O
IL	O
-	O
18	O
-	O
activated	O
natural	O
killer	O
cells	O
and	O
modulated	O
by	O
carcinoembryonic	O
antigen	O
-	O
related	O
cell	O
adhesion	O
molecules	O
(	O
CEACAM	O
)	O
1a	O
receptor	O
.	O

Ex	O
vivo	O
and	O
in	O
vitro	O
experiments	O
revealed	O
that	O
NK	O
cells	O
,	O
expressing	O
carcinoembryonic	O
antigen	O
-	O
related	O
cell	O
adhesion	O
molecules	O
(	O
CEACAM	O
)	O
1a	O
(	O
the	O
MHV	B-SPEC
receptor	O
),	O
can	O
produce	O
a	O
higher	O
level	O
of	O
IFN	O
-	O
gamma	O
in	O
the	O
presence	O
of	O
both	O
L2	O
-	O
MHV3	O
and	O
interleukin	O
-	O
12	O
(	O
IL	O
-	O
12	O
)/	O
IL	O
-	O
18	O
.	O

We	O
previously	O
demonstrated	O
that	O
nucleocapsid	O
-	O
derived	O
peptides	O
chemically	O
coupled	O
to	O
the	O
surface	O
of	O
liposomes	O
effectively	O
elicited	O
SARS	O
-	O
CoV	O
-	O
specific	O
CTLs	O
in	O
mice	B-SPEC
.	O

We	O
previously	O
generated	O
human	B-SPEC
mAbs	O
specific	O
to	O
the	O
S1	O
region	O
of	O
SARS	O
-	O
CoV	O
S	O
protein	O
.	O

However	O
,	O
a	O
mixture	O
of	O
antibodies	O
could	O
effectively	O
neutralize	O
a	O
range	O
of	O
mutant	O
viruses	B-SPEC
.	O

U49	O
or	O
U51	O
substitution	O
mutants	O
all	O
are	O
viable	O
;	O
C47	O
substitution	O
mutants	O
also	O
are	O
viable	O
but	O
produce	O
slightly	O
smaller	O
plaques	O
than	O
wild	O
-	O
type	O
virus	B-SPEC
.	O

Fecal	O
samples	O
from	O
calves	O
with	O
(	O
n	O
=	O
68	O
)	O
or	O
without	O
(	O
n	O
=	O
691	O
)	O
diarrhea	O
were	O
analyzed	O
for	O
the	O
presence	O
of	O
Cryptosporidium	B-SPEC
,	O
Giardia	B-SPEC
,	O
and	O
Eimeria	B-SPEC
species	B-SPEC
.	O

Non	O
-	O
randomised	O
studies	O
were	O
assessed	O
for	O
the	O
presence	O
of	O
potential	O
confounders	O
and	O
classified	O
as	O
being	O
at	O
low	O
,	O
medium	O
,	O
or	O
high	O
risk	O
of	O
bias	B-SPEC
.	O

The	O
enhanced	O
protection	O
appears	O
to	O
be	O
dependent	O
upon	O
the	O
prior	O
development	O
of	O
inducible	O
bronchus	B-SPEC
-	O
associated	O
lymphoid	O
tissue	O
(	O
iBALT	O
)	O
in	O
the	O
lung	O
in	O
response	O
to	O
the	O
PCN	O
treatment	O
and	O
to	O
be	O
mediated	O
through	O
CD4	O
+	O
T	O
cell	O
and	O
B	O
cell	O
dependent	O
mechanisms	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
consensus	O
microarray	O
method	O
for	O
identification	O
of	O
some	O
highly	O
pathogenic	O
viruses	B-SPEC
.	O

To	O
decrease	O
the	O
interference	O
of	O
the	O
host	O
genome	O
in	O
hybridization	O
,	O
the	O
consensus	O
genus	B-SPEC
primers	O
were	O
designed	O
and	O
used	O
to	O
reverse	O
transcribe	O
only	O
virus	B-SPEC
genome	O
.	O

Using	O
this	O
method	O
,	O
one	O
unknown	O
virus	B-SPEC
isolated	O
from	O
pig	B-SPEC
brain	O
in	O
Shanxi	O
Province	O
,	O
China	O
was	O
identified	O
.	O

ABSTRACT	O
:	O
Previous	O
studies	O
have	O
shown	O
that	O
proinflammatory	O
cytokines	O
,	O
such	O
as	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
and	O
interleukin	O
6	O
(	O
IL	O
-	O
6	O
),	O
are	O
differentially	O
induced	O
in	O
primary	O
mouse	B-SPEC
astrocytes	O
by	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
(	O
MHV	B-SPEC
-	O
A59	O
)	O
and	O
MHV	B-SPEC
-	O
2	O
.	O

However	O
,	O
the	O
signaling	O
events	O
that	O
trigger	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
6	O
induction	O
in	O
these	O
cells	O
upon	O
MHV	B-SPEC
infection	O
remain	O
unknown	O
.	O

Using	O
inhibitors	O
specific	O
for	O
three	O
mitogen	O
-	O
activated	O
protein	O
kinases	O
,	O
we	O
showed	O
that	O
induction	O
of	O
TNF	O
-	O
alpha	O
and	O
IL	O
-	O
6	O
by	O
MHV	B-SPEC
-	O
A59	O
infection	O
was	O
mediated	O
through	O
activation	O
of	O
the	O
Janus	O
N	O
-	O
terminal	O
kinase	O
signaling	O
pathway	O
,	O
but	O
not	O
through	O
the	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
or	O
p38	O
signaling	O
pathway	O
.	O

ABSTRACT	O
:	O
A	O
diversity	O
of	O
strategies	O
is	O
evolved	O
by	O
RNA	O
viruses	B-SPEC
to	O
manipulate	O
the	O
host	O
translation	O
machinery	O
in	O
order	B-SPEC
to	O
create	O
an	O
optimal	O
environment	O
for	O
viral	O
replication	O
and	O
progeny	O
production	O
.	O

Taken	O
together	O
,	O
these	O
results	O
confirm	O
that	O
IBV	B-SPEC
has	O
developed	O
a	O
combination	O
of	O
two	O
mechanisms	O
,	O
i	O
.	O
e	O
.,	O
blocking	O
PKR	O
activation	O
and	O
inducing	O
GADD34	O
expression	O
,	O
to	O
maintain	O
de	O
novo	O
protein	O
synthesis	O
in	O
IBV	B-SPEC
-	O
infected	O
cells	O
and	O
,	O
meanwhile	O
,	O
to	O
enhance	O
viral	O
replication	O
.	O

The	O
recombinant	O
strains	O
were	O
induced	O
to	O
express	O
interest	O
protein	O
,	O
which	O
was	O
detected	O
by	O
Western	O
blotting	O
,	O
immunofluorescence	O
microscopy	O
and	O
the	O
whole	O
bacteria	B-SPEC
ELISA	O
.	O

The	O
recombinant	O
PEDV	B-SPEC
N	O
protein	O
showed	O
the	O
antigenic	O
specificity	O
,	O
and	O
was	O
located	O
on	O
the	O
bacterial	O
cell	O
walls	O
of	O
pPG	O
-	O
1	O
-	O
n	O
transformed	O
L	B-SPEC
.	I-SPEC
casei	I-SPEC
.	O

Both	O
virus	B-SPEC
-	O
specific	O
CD4	O
and	O
CD8	O
T	O
cells	O
are	O
functional	O
,	O
as	O
assessed	O
by	O
cytokine	O
expression	O
and	O
degranulation	O
after	O
peptide	O
exposure	O
.	O

However	O
,	O
PCD	O
therapy	O
used	O
in	O
a	O
timely	O
manner	O
for	O
drainage	O
may	O
decrease	O
mortality	O
in	O
patients	O
with	O
SAP	O
,	O
decrease	O
inflammatory	O
mediator	O
release	O
,	O
and	O
avoid	O
incidence	O
of	O
severe	O
sepsis	B-SPEC
or	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
emergency	O
surgery	O
.	O

TITLE	O
:	O
Distant	O
relatives	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
close	O
relatives	O
of	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
in	O
bats	B-SPEC
,	O
Ghana	O
.	O

Leaf	B-SPEC
-	I-SPEC
nosed	I-SPEC
bats	I-SPEC
pertaining	O
to	O
Hipposideros	B-SPEC
ruber	I-SPEC
by	O
morphology	O
had	O
group	O
1	O
and	O
group	O
2	O
CoVs	O
.	O

FCoV	O
exhibits	O
2	O
biotypes	O
:	O
the	O
pathogenic	O
disease	O
and	O
a	O
benign	O
infection	O
with	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
).	O

Every	O
country	O
with	O
an	O
intensive	O
poultry	O
industry	O
has	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Infection	O
of	O
RNase	O
L	O
deficient	O
(	O
RL	O
(-/-))	O
mice	B-SPEC
with	O
a	O
sub	O
-	O
lethal	O
,	O
demyelinating	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
variant	O
revealed	O
that	O
the	O
majority	O
of	O
mice	B-SPEC
succumbed	O
to	O
infection	O
by	O
day	O
12	O
p	O
.	O
i	O
.	O

However	O
,	O
RNase	O
L	O
deficiency	O
did	O
not	O
affect	O
overall	O
control	O
of	O
infectious	O
virus	B-SPEC
,	O
or	O
diminish	O
IFN	O
-	O
alpha	O
/	O
beta	O
expression	O
in	O
the	O
CNS	O
.	O

CONCLUSIONS	O
:	O
Human	B-SPEC
A	O
/	O
H5N1	O
infection	O
is	O
a	O
severe	O
and	O
rapidly	O
progressive	O
disease	O
mostly	O
manifested	O
as	O
ARDS	O
.	O

Then	O
,	O
we	O
summarized	O
the	O
phylogenetic	O
findings	O
in	O
relation	O
to	O
its	O
zoonotic	O
origins	O
and	O
the	O
proposed	O
inter	O
-	O
species	B-SPEC
viral	O
transmission	O
events	O
.	O

Fever	O
,	O
headache	O
and	O
myalgia	O
after	O
exposure	O
to	O
a	O
rodent	B-SPEC
-	O
contaminated	O
environment	O
raised	O
clinical	O
suspicion	O
.	O

Serum	O
samples	O
from	O
251	O
dogs	B-SPEC
of	O
varying	O
age	O
,	O
breed	O
and	O
clinical	O
histories	O
were	O
tested	O
for	O
the	O
presence	O
of	O
antibodies	O
to	O
CRCoV	O
and	O
CIV	B-SPEC
,	O
using	O
indirect	O
fluorescent	O
antibody	O
(	O
IFA	O
)	O
analysis	O
.	O

Young	O
dogs	B-SPEC
are	O
less	O
likely	O
to	O
be	O
seropositive	O
than	O
older	O
dogs	B-SPEC
,	O
probably	O
due	O
to	O
increased	O
opportunity	O
for	O
exposure	O
to	O
CRCoV	O
over	O
time	O
.	O

Veterinarians	O
should	O
consider	O
CRCoV	O
as	O
a	O
differential	O
diagnosis	O
in	O
cases	O
of	O
respiratory	O
disease	O
in	O
dogs	B-SPEC
in	O
New	O
Zealand	O
.	O

None	O
was	O
seropositive	O
for	O
CIV	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
human	B-SPEC
pulmonary	O
microvascular	O
endothelial	O
cells	O
(	O
hPMEC	O
)	O
had	O
a	O
clearly	O
higher	O
susceptibility	O
to	O
infection	O
by	O
H5N1	O
HPAIV	O
than	O
to	O
infection	O
by	O
human	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
.	O

H5N1	O
virus	B-SPEC
infection	O
was	O
also	O
associated	O
with	O
an	O
elevated	O
rate	O
of	O
cell	O
death	O
.	O

TITLE	O
:	O
The	O
replicase	O
gene	O
of	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
is	O
a	O
determinant	O
of	O
pathogenicity	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
in	O
two	O
cat	B-SPEC
populations	O
in	O
Malaysia	O
.	O

RNA	O
extracted	O
from	O
the	O
faecal	O
material	O
was	O
subjected	O
to	O
a	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
using	O
primers	O
flanking	O
for	O
a	O
conserved	O
region	O
of	O
the	O
virus	B-SPEC
genome	O
.	O

ABSTRACT	O
:	O
The	O
envelope	O
glycoproteins	O
S1	O
and	O
S2	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
mediate	O
viral	O
entry	O
by	O
conformational	O
change	O
from	O
a	O
prefusion	O
state	O
to	O
a	O
postfusion	O
state	O
that	O
enables	O
fusion	O
of	O
the	O
viral	O
and	O
target	O
membranes	O
.	O

Infants	O
with	O
RV	O
infection	O
had	O
higher	O
blood	O
eosinophil	O
counts	O
than	O
infants	O
with	O
bronchiolitis	O
from	O
RSV	B-SPEC
and	O
hBoV	O
(	O
307	O
+/-	O
436	O
vs	O
138	O
+/-	O
168	O
vs	O
89	O
+/-	O
19	O
n	O
/	O
mm	O
(	O
3	O
);	O
p	O
<	O
0	O
.	O
05	O
).	O

30	O
dogs	B-SPEC
with	O
naturally	O
acquired	O
idiopathic	O
conjunctivitis	O
and	O
a	O
control	O
population	O
of	O
30	O
dogs	B-SPEC
without	O
ocular	O
disease	O
.	O

Canine	B-SPEC
herpesvirus	I-SPEC
-	O
1	O
was	O
isolated	O
from	O
2	O
conjunctival	O
samples	O
and	O
detected	O
by	O
use	O
of	O
PCR	O
assay	O
in	O
5	O
conjunctival	O
samples	O
.	O

ABSTRACT	O
:	O
Type	O
II	O
mixed	O
cryoglobulin	O
syndrome	O
is	O
a	O
systematic	O
vasculitis	O
mainly	O
linked	O
to	O
immune	O
complex	O
deposition	O
in	O
several	O
organs	O
and	O
to	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
infection	O
.	O

In	O
addition	O
to	O
intensive	O
care	O
standard	O
therapy	O
for	O
coma	B-SPEC
and	O
shock	O
,	O
a	O
non	O
-	O
invasive	O
cooling	O
device	O
(	O
Arctic	O
Sun	O
2000	O
((	O
R	O
)),	O
Medivance	O
Inc	O
.,	O
USA	O
),	O
originally	O
designed	O
to	O
induce	O
mild	O
therapeutic	O
hypothermia	O
in	O
patients	O
after	O
cardiopulmonary	O
resuscitation	O
,	O
was	O
used	O
to	O
lower	O
body	O
temperature	O
.	O

TITLE	O
:	O
Reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
for	O
the	O
rapid	O
detection	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
infected	O
chicken	B-SPEC
tissues	O
.	O

As	O
virus	B-SPEC
production	O
increased	O
,	O
aberrant	O
viral	O
forms	O
appeared	O
with	O
greater	O
frequency	O
.	O

As	O
this	O
mutant	O
virus	B-SPEC
is	O
more	O
neurovirulent	O
in	O
mice	B-SPEC
,	O
our	O
results	O
also	O
suggest	O
that	O
two	O
mutations	O
in	O
the	O
S	O
glycoprotein	O
could	O
eventually	O
modulate	O
viral	O
neuropathogenesis	O
.	O

ABSTRACT	O
:	O
Turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
)	O
is	O
a	O
causative	O
agent	O
associated	O
with	O
poult	O
enteritis	O
and	O
mortality	O
syndrome	O
(	O
PEMS	O
)	O
in	O
turkeys	B-SPEC
worldwide	O
.	O

In	O
relation	O
to	O
gene	O
3	O
,	O
samples	O
showed	O
a	O
greater	O
relationship	O
with	O
chicken	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
while	O
gene	O
5	O
showed	O
greater	O
identity	O
with	O
pheasant	O
coronavirus	B-SPEC
(	O
PhCoV	O
).	O

These	O
data	O
demonstrated	O
,	O
for	O
the	O
first	O
time	O
in	O
Tunisia	O
,	O
the	O
cocirculation	O
of	O
IBV	B-SPEC
variant	O
serotypes	O
along	O
with	O
the	O
Massachusetts	O
type	O
,	O
causing	O
severe	O
clinical	O
diseases	O
and	O
high	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
.	O

TITLE	O
:	O
Evasion	O
by	O
stealth	O
:	O
inefficient	O
immune	O
activation	O
underlies	O
poor	O
T	O
cell	O
response	O
and	O
severe	O
disease	O
in	O
SARS	O
-	O
CoV	O
-	O
infected	O
mice	B-SPEC
.	O

Here	O
,	O
we	O
show	O
that	O
severe	O
disease	O
is	O
correlated	O
with	O
slow	O
kinetics	O
of	O
virus	B-SPEC
clearance	O
and	O
delayed	O
activation	O
and	O
transit	O
of	O
respiratory	O
dendritic	O
cells	O
(	O
rDC	O
)	O
to	O
the	O
draining	O
lymph	O
nodes	O
(	O
DLN	O
)	O
with	O
a	O
consequent	O
deficient	O
virus	B-SPEC
-	O
specific	O
T	O
cell	O
response	O
.	O

The	O
inhibitory	O
effects	O
of	O
AM	O
can	O
also	O
be	O
nullified	O
if	O
mice	B-SPEC
or	O
AMs	O
are	O
pretreated	O
with	O
poly	O
I	O
:	O
C	O
,	O
which	O
directly	O
activate	O
AMs	O
and	O
rDCs	O
through	O
toll	O
-	O
like	O
receptors	O
3	O
(	O
TLR3	O
).	O

Alignment	O
and	O
comparison	O
of	O
the	O
15E2	O
-	O
defined	O
epitope	O
sequence	O
with	O
the	O
sequences	O
of	O
other	O
corona	B-SPEC
-	O
viruses	B-SPEC
indicated	O
that	O
the	O
epitope	O
is	O
well	O
conserved	O
among	O
chicken	B-SPEC
and	O
turkey	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
A	O
new	O
mouse	B-SPEC
-	O
adapted	O
strain	O
of	O
SARS	O
-	O
CoV	O
as	O
a	O
lethal	O
model	O
for	O
evaluating	O
antiviral	O
agents	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Infection	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
initiated	O
by	O
specific	O
interactions	O
between	O
the	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
and	O
its	O
receptor	O
ACE2	O
.	O

TITLE	O
:	O
Age	O
-	O
dependent	O
resistance	O
to	O
Porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
replication	O
in	O
swine	B-SPEC
.	O

Systematic	O
detection	O
and	O
treatment	O
of	O
group	B-SPEC
A	I-SPEC
Streptococcus	I-SPEC
should	O
be	O
intensified	O
.	O

Since	O
treatment	O
of	O
ARDS	O
,	O
IPF	O
and	O
plastic	O
bronchitis	O
will	O
require	O
repeated	O
administration	O
of	O
pf	O
-	O
tPA	O
,	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
safety	O
of	O
prolonged	O
,	O
repeated	O
administration	O
of	O
pf	O
-	O
mouse	B-SPEC
tPA	O
(	O
pf	O
-	O
mtPA	O
)	O
to	O
the	O
lungs	O
of	O
healthy	O
mice	B-SPEC
.	O

RESULTS	O
:	O
The	O
low	O
dose	O
of	O
pf	O
-	O
mtPA	O
was	O
well	O
tolerated	O
by	O
both	O
female	O
and	O
male	O
mice	B-SPEC
.	O

TITLE	O
:	O
The	O
open	O
reading	O
frame	O
3a	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
promotes	O
membrane	O
rearrangement	O
and	O
cell	O
death	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
lethal	O
systemic	O
disease	O
caused	O
by	O
FIP	O
virus	B-SPEC
(	O
FIPV	O
),	O
a	O
virulent	O
mutant	O
of	O
apathogenic	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
).	O

ABSTRACT	O
:	O
During	O
the	O
past	O
decade	O
,	O
the	O
global	O
public	O
health	O
community	O
has	O
been	O
challenged	O
by	O
the	O
emergence	O
and	O
rapid	O
worldwide	O
spread	O
of	O
novel	O
influenza	O
strains	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
chikungunya	B-SPEC
virus	I-SPEC
,	O
drug	O
-	O
resistant	O
tuberculosis	O
,	O
and	O
other	O
conditions	O
and	O
pathogens	O
.	O

TITLE	O
:	O
Community	O
-	O
acquired	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
pneumonia	O
and	O
ARDS	O
:	O
1	O
-	O
year	O
follow	O
-	O
up	O
.	O

Moreover	O
,	O
JHMV	O
infection	O
of	O
CXCR2	O
-/-	O
mice	B-SPEC
resulted	O
in	O
an	O
approximate	O
60	O
%	O
reduction	O
of	O
PMN	O
migration	O
into	O
the	O
CNS	O
,	O
yet	O
these	O
mice	B-SPEC
survived	O
infection	O
and	O
controlled	O
viral	O
replication	O
within	O
the	O
brain	O
.	O

ABSTRACT	O
:	O
Persistent	O
infection	O
of	O
domestic	B-SPEC
cats	I-SPEC
with	O
feline	B-SPEC
coronaviruses	O
(	O
FCoVs	O
)	O
can	O
lead	O
to	O
a	O
highly	O
lethal	O
,	O
immunopathological	O
disease	O
termed	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

A	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
identified	O
as	O
the	O
etiological	O
agent	O
of	O
SARS	O
,	O
and	O
initial	O
assessments	O
determined	O
that	O
the	O
virus	B-SPEC
crossed	O
to	O
human	B-SPEC
hosts	O
from	O
zoonotic	O
reservoirs	O
,	O
including	O
bats	B-SPEC
,	O
Himalayan	O
palm	O
civets	B-SPEC
(	O
Paguma	B-SPEC
larvata	I-SPEC
),	O
and	O
raccoon	B-SPEC
dogs	I-SPEC
(	O
Nyctereutes	B-SPEC
procyonoides	I-SPEC
),	O
sold	O
in	O
exotic	O
animal	B-SPEC
markets	O
in	O
Guangdong	O
Province	O
.	O

Our	O
findings	O
show	O
that	O
H5N1	O
-	O
infected	O
mice	B-SPEC
develop	O
the	O
typical	O
PF	O
during	O
restoration	O
period	O
,	O
which	O
will	O
contribute	O
to	O
the	O
investigation	O
of	O
fibrogenesis	O
and	O
potential	O
therapeutic	O
intervention	O
in	O
human	B-SPEC
H5N1	O
disease	O
.	O

Since	O
neutralization	O
of	O
CXCL8	O
with	O
polyclonal	O
antibody	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
severity	O
of	O
ALI	O
/	O
ARDS	O
in	O
animal	B-SPEC
models	O
,	O
we	O
explored	O
the	O
potential	O
of	O
humanized	O
anti	O
-	O
CXCL8	O
antibody	O
as	O
a	O
preventive	O
or	O
therapeutic	O
agent	O
for	O
ALI	O
.	O

We	O
used	O
a	O
'	O
two	O
-	O
hit	O
'	O
protocol	O
to	O
induce	O
ALI	O
in	O
rabbits	B-SPEC
that	O
showed	O
extensive	O
edema	O
in	O
the	O
alveolar	O
lumina	O
,	O
marked	O
infiltration	O
of	O
neutrophils	O
in	O
the	O
lung	O
tissue	O
,	O
fibrin	O
deposition	O
in	O
alveolar	O
space	O
,	O
and	O
destruction	O
of	O
pulmonary	O
architecture	O
,	O
culminating	O
in	O
severe	O
hypoxemia	O
.	O

The	O
canine	B-SPEC
adenovirus	I-SPEC
(	O
CAV	B-SPEC
-	O
1	O
)	O
and	O
canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
)	O
titers	O
in	O
vaccinated	O
group	O
were	O
both	O
positive	O
,	O
but	O
titers	O
were	O
not	O
high	O
and	O
varied	O
among	O
individual	O
except	O
one	O
vaccinated	O
panda	B-SPEC
had	O
extremely	O
high	O
CAV	B-SPEC
-	O
1	O
titer	O
,	O
indicating	O
infection	O
with	O
the	O
field	O
virus	B-SPEC
following	O
vaccination	O
.	O

A	O
specific	O
one	O
-	O
step	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RRT	O
-	O
PCR	O
)	O
assay	O
for	O
detection	O
and	O
quantitation	O
of	O
TCoV	O
in	O
the	O
turkey	B-SPEC
tissues	O
was	O
developed	O
using	O
a	O
dual	O
-	O
labeled	O
fluorescent	O
probe	O
.	O

In	O
order	B-SPEC
to	O
gain	O
insight	O
into	O
the	O
molecular	O
basis	O
of	O
protease	O
cleavage	O
and	O
its	O
impact	O
on	O
the	O
efficiency	O
of	O
viral	O
entry	O
,	O
we	O
investigated	O
the	O
susceptibility	O
of	O
a	O
recombinant	O
native	O
full	O
-	O
length	O
S	O
-	O
protein	O
trimer	O
(	O
triSpike	O
)	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
to	O
cleavage	O
by	O
various	O
airway	O
proteases	O
.	O

A	O
recent	O
meta	B-SPEC
-	O
analysis	O
provides	O
support	O
for	O
prolonged	O
corticosteroid	O
treatment	O
in	O
ALI	O
-	O
ARDS	O
.	O

ABSTRACT	O
:	O
A	O
52	O
-	O
year	O
-	O
old	O
man	B-SPEC
presented	O
with	O
unproductive	O
cough	O
,	O
fever	O
and	O
chill	O
in	O
our	O
emergency	O
department	O
.	O

ABSTRACT	O
:	O
The	O
use	O
of	O
intensive	O
care	O
units	O
(	O
ICU	O
)	O
resources	O
for	O
HIV	B-SPEC
-	O
Infected	O
patients	O
has	O
been	O
controversial	O
since	O
the	O
first	O
reported	O
cases	O
,	O
raising	O
practical	O
ethical	O
and	O
economic	O
issues	O
about	O
aggressive	O
treatment	O
.	O

More	O
HIV	B-SPEC
-	O
infected	O
patients	O
surviving	O
ICU	O
admission	O
are	O
more	O
likely	O
to	O
need	O
critical	O
care	O
for	O
problems	O
unrelated	O
to	O
HIV	B-SPEC
infection	O
or	O
for	O
conditions	O
related	O
to	O
HAART	O
toxicity	O
.	O

In	O
dogs	B-SPEC
,	O
infectious	O
respiratory	O
disease	O
is	O
a	O
common	O
problem	O
,	O
particularly	O
in	O
housed	O
animals	B-SPEC
.	O

In	O
agreement	O
with	O
previous	O
reports	O
,	O
the	O
original	O
type	O
CPV	B-SPEC
-	O
2	O
was	O
shown	O
not	O
to	O
circulate	O
in	O
European	O
dogs	B-SPEC
.	O

The	O
recently	O
identified	O
virus	B-SPEC
variant	O
CPV	B-SPEC
-	O
2c	O
was	O
predominant	O
in	O
Italy	O
and	O
Germany	O
and	O
present	O
at	O
high	O
rates	O
in	O
Spain	O
and	O
France	O
but	O
was	O
not	O
detected	O
in	O
the	O
UK	O
or	O
Belgium	O
.	O

In	O
this	O
study	O
,	O
we	O
assessed	O
the	O
pathogenic	O
and	O
antigenic	O
characteristics	O
of	O
a	O
K	O
-	O
IIb	O
type	O
field	O
strain	O
of	O
IBV	B-SPEC
that	O
emerged	O
in	O
Korea	O
since	O
2003	O
,	O
such	O
as	O
Kr	O
/	O
Q43	O
/	O
06	O
.	O

TITLE	O
:	O
Infection	O
with	O
a	O
pathogenic	O
turkey	B-SPEC
coronavirus	B-SPEC
isolate	O
negatively	O
affects	O
growth	O
performance	O
and	O
intestinal	O
morphology	O
of	O
young	O
turkey	B-SPEC
poults	O
in	O
Canada	O
.	O

TITLE	O
:	O
Effect	O
of	O
a	O
live	O
Mycoplasma	B-SPEC
synoviae	I-SPEC
vaccine	O
on	O
the	O
production	O
of	O
eggshell	O
apex	O
abnormalities	O
induced	O
by	O
a	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
infection	O
preceded	O
by	O
an	O
infection	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
D1466	O
.	O

ABSTRACT	O
:	O
An	O
experimental	O
study	O
was	O
conducted	O
to	O
assess	O
the	O
effect	O
of	O
a	O
live	O
Mycoplasma	B-SPEC
synoviae	I-SPEC
vaccine	O
(	O
Vaxsafe	O
MS	O
;	O
Bioproperties	O
Pty	O
Ltd	O
,	O
Ringwood	O
,	O
Victoria	B-SPEC
,	O
Australia	O
)	O
on	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
-	O
induced	O
eggshell	O
apex	O
abnormalities	O
(	O
EAA	O
).	O

The	O
fourth	O
group	O
was	O
not	O
vaccinated	O
but	O
was	O
challenged	O
with	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
(	O
non	O
-	O
vaccinated	O
challenged	O
(	O
NVC	O
)).	O

The	O
mean	O
daily	O
egg	O
production	O
per	O
chicken	B-SPEC
was	O
significantly	O
lower	O
in	O
the	O
NVC	O
group	O
(	O
0	O
.	O
48	O
+/-	O
0	O
.	O
03	O
eggs	O
)	O
compared	O
with	O
that	O
of	O
the	O
NVNC	O
group	O
(	O
0	O
.	O
60	O
+/-	O
0	O
.	O
03	O
eggs	O
),	O
but	O
not	O
significantly	O
different	O
from	O
other	O
groups	O
.	O

The	O
ability	O
of	O
the	O
strains	O
to	O
inhibit	O
trachea	B-SPEC
epithelium	O
ciliary	O
activity	O
,	O
to	O
induce	O
immune	O
response	O
,	O
to	O
replicate	O
and	O
to	O
cause	O
histopathological	O
lesions	O
in	O
designated	O
organs	O
was	O
followed	O
by	O
repeated	O
samplings	O
during	O
a	O
period	O
of	O
42	O
days	O
post	O
infection	O
.	O

TITLE	O
:	O
Characterization	O
of	O
the	O
cytokine	O
and	O
maturation	O
responses	O
of	O
pure	O
populations	O
of	O
porcine	B-SPEC
plasmacytoid	O
dendritic	O
cells	O
to	O
porcine	B-SPEC
viruses	B-SPEC
and	O
toll	O
-	O
like	O
receptor	O
agonists	O
.	O

While	O
a	O
substantial	O
IFN	O
-	O
alpha	O
response	O
was	O
also	O
elicited	O
from	O
the	O
porcine	B-SPEC
pDCs	O
by	O
pseudorabies	B-SPEC
virus	I-SPEC
(	O
PrV	B-SPEC
),	O
swine	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
SIV	B-SPEC
),	O
and	O
TLR7	O
and	O
9	O
agonists	O
,	O
there	O
was	O
an	O
agent	O
-	O
dependent	O
induction	O
of	O
varying	O
amounts	O
of	O
IL	O
-	O
2	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
IL	O
-	O
12	O
,	O
IFN	O
-	O
gamma	O
,	O
and	O
TNF	O
-	O
alpha	O
.	O

Moreover	O
,	O
whereas	O
pDCs	O
exposed	O
to	O
TGEV	B-SPEC
or	O
the	O
TLR9	O
agonist	O
rapidly	O
increased	O
IRF	O
-	O
7	O
production	O
and	O
morphed	O
into	O
DCs	O
with	O
enhanced	O
CD80	O
/	O
86	O
expression	O
,	O
similar	O
alterations	O
were	O
not	O
observed	O
during	O
incubation	O
with	O
PRRSV	B-SPEC
.	O

ABSTRACT	O
:	O
Multiple	O
Sclerosis	O
(	O
MS	O
)	O
is	O
an	O
immune	O
-	O
mediated	O
demyelinating	O
disease	O
of	O
humans	B-SPEC
.	O

Using	O
yeast	B-SPEC
surface	O
display	O
,	O
the	O
binding	O
sites	O
of	O
these	O
antibodies	O
were	O
defined	O
to	O
two	O
linear	O
regions	O
on	O
the	O
RBD	O
:	O
S	O
(	O
337	O
-	O
360	O
)	O
and	O
S	O
(	O
380	O
-	O
399	O
).	O

Yeast	B-SPEC
surface	O
display	O
combined	O
with	O
phage	O
peptide	O
library	O
screening	O
provides	O
a	O
convenient	O
strategy	O
for	O
the	O
identification	O
of	O
epitope	O
peptides	O
from	O
certain	O
antigenic	O
proteins	O
.	O

All	O
the	O
rabbits	B-SPEC
were	O
randomly	O
divided	O
by	O
random	O
digit	O
table	O
into	O
4	O
groups	O
(	O
n	O
=	O
7	O
each	O
):	O
a	O
control	O
group	O
,	O
a	O
PS	O
group	O
,	O
a	O
RM	O
group	O
and	O
a	O
PS	O
+	O
RM	O
group	O
.	O

Seroprevalences	O
of	O
the	O
free	O
-	O
ranging	O
cheetahs	B-SPEC
were	O
below	O
5	O
%	O
for	O
all	O
nine	O
viruses	B-SPEC
,	O
which	O
is	O
significantly	O
lower	O
than	O
seroprevalences	O
in	O
nonvaccinated	O
captive	O
cheetahs	B-SPEC
and	O
those	O
for	O
five	O
of	O
seven	O
viruses	B-SPEC
in	O
previously	O
studied	O
free	O
-	O
ranging	O
cheetahs	B-SPEC
from	O
north	O
-	O
central	O
Namibia	B-SPEC
(	O
L	O
.	O
Munson	O
,	O
L	O
.	O
Marker	O
,	O
E	O
.	O
Dubovi	O
,	O
J	O
.	O
A	O
.	O
Spencer	O
,	O
J	O
.	O
F	O
.	O
Evermann	O
,	O
and	O
S	O
.	O
J	O
.	O
O	O
'	O
Brien	O
,	O
J	O
.	O
Wildl	O
.	O

Impact	O
of	O
sepsis	B-SPEC
,	O
DIC	O
and	O
duration	O
of	O
trauma	O
that	O
predict	O
progression	O
of	O
ALI	O
exists	O
throughout	O
the	O
entire	O
treatment	O
period	O
while	O
aspiration	O
of	O
gastric	O
contents	O
and	O
APACHE	O
II	O
score	O
might	O
affect	O
aggravation	O
of	O
ALI	O
only	O
during	O
the	O
early	O
period	O
;	O
due	O
to	O
deterioration	O
of	O
pulmonary	O
function	O
and	O
severely	O
traumatic	O
injury	O
,	O
advanced	O
age	O
is	O
still	O
an	O
independent	O
risk	O
factor	O
;	O
patients	O
with	O
these	O
risk	O
factors	O
need	O
aggressive	O
supportive	O
cares	O
as	O
early	O
as	O
possible	O
in	O
order	B-SPEC
to	O
prevent	O
further	O
aggravations	O
.	O

Low	O
-	O
dose	O
heparin	O
can	O
decrease	O
the	O
mortality	O
rate	O
of	O
sepsis	B-SPEC
and	O
improve	O
the	O
prognosis	O
of	O
patients	O
.	O

The	O
immunized	O
mice	B-SPEC
released	O
IFN	O
-	O
gamma	O
and	O
lysed	O
target	O
cells	O
upon	O
stimulation	O
with	O
Sp8	O
peptide	O
-	O
pulsed	O
autologous	O
dendritic	O
cells	O
in	O
comparison	O
to	O
other	O
candidates	O
.	O

TITLE	O
:	O
Association	O
of	O
Bartonella	B-SPEC
species	B-SPEC
,	O
feline	B-SPEC
calicivirus	I-SPEC
,	O
and	O
feline	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
infection	O
with	O
gingivostomatitis	O
in	O
cats	B-SPEC
.	O

Additionally	O
,	O
fresh	O
oral	O
biopsies	O
from	O
cats	B-SPEC
with	O
FGS	O
(	O
n	O
=	O
42	O
)	O
and	O
19	O
healthy	O
controls	O
were	O
tested	O
for	O
FCV	B-SPEC
RNA	O
,	O
FHV	O
-	O
1	O
DNA	O
and	O
Bartonella	B-SPEC
species	B-SPEC
DNA	O
.	O

Only	O
FCV	B-SPEC
RNA	O
was	O
present	O
in	O
significantly	O
more	O
cats	B-SPEC
with	O
FGS	O
(	O
40	O
.	O
5	O
%)	O
than	O
control	O
cats	B-SPEC
(	O
0	O
%).	O

The	O
results	O
suggest	O
that	O
FCV	B-SPEC
was	O
associated	O
with	O
FGS	O
in	O
some	O
of	O
the	O
cats	B-SPEC
.	O

Meanwhile	O
,	O
vector	O
-	O
transmitted	O
,	O
chronic	O
,	O
and	O
protozoan	O
infections	O
have	O
been	O
neglected	O
,	O
as	O
have	O
crucial	O
processes	O
such	O
as	O
cross	O
-	O
species	B-SPEC
transmission	O
.	O

TITLE	O
:	O
Effect	O
of	O
recombinant	O
lactobacillus	B-SPEC
expressing	O
canine	O
GM	O
-	O
CSF	O
on	O
immune	O
function	O
in	O
dogs	B-SPEC
.	O

ABSTRACT	O
:	O
Many	O
Lactobacillus	B-SPEC
strains	O
have	O
been	O
promoted	O
as	O
good	O
probiotics	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
diseases	O
.	O

After	O
the	O
administration	O
of	O
CCV	O
vaccine	O
,	O
CCV	O
-	O
specific	O
IgG	O
in	O
serum	O
increased	O
more	O
in	O
the	O
group	O
supplemented	O
with	O
L	B-SPEC
.	I-SPEC
casei	I-SPEC
expressing	O
cGM	O
-	O
CSF	O
than	O
the	O
other	O
two	O
groups	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
respiratory	O
disease	O
(	O
BRD	O
)	O
research	O
has	O
provided	O
significant	O
understanding	O
of	O
the	O
disease	O
over	O
the	O
past	O
26	O
years	O
.	O

ABSTRACT	O
:	O
The	O
murine	B-SPEC
coronavirus	I-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
strain	O
A59	O
,	O
causes	O
acute	O
encephalitis	O
and	O
chronic	O
demyelinating	O
disease	O
as	O
well	O
as	O
hepatitis	O
in	O
mice	B-SPEC
.	O

The	O
JHM	O
strain	O
(	O
also	O
called	O
MHV	B-SPEC
-	O
4	O
or	O
JHM	O
.	O
SD	O
)	O
causes	O
fatal	O
encephalitis	O
and	O
only	O
minimal	O
hepatitis	O
.	O

Rats	B-SPEC
with	O
LC	O
,	O
CASP	O
,	O
LC	O
+	O
CASP	O
all	O
had	O
severe	O
lung	O
injury	O
compared	O
with	O
uninjured	O
controls	O
based	O
on	O
decreased	O
arterial	O
oxygenation	O
or	O
increased	O
BAL	O
albumin	O
at	O
5	O
or	O
24	O
hours	O
postinsult	O
.	O

However	O
,	O
the	O
injury	O
groups	O
had	O
distinct	O
overall	O
patterns	O
of	O
inflammation	O
that	O
allowed	O
them	O
to	O
be	O
discriminated	O
accurately	O
by	O
hierarchical	O
cluster	O
analysis	O
(	O
29	O
of	O
30	O
and	O
35	O
of	O
37	O
rats	B-SPEC
were	O
correctly	O
classified	O
in	O
hierarchical	O
clusters	O
at	O
5	O
and	O
24	O
hours	O
,	O
respectively	O
).	O

Moreover	O
,	O
predictive	O
analyses	O
based	O
on	O
an	O
extension	O
of	O
standard	O
receiver	O
-	O
operator	O
characteristic	O
methodology	O
discriminated	O
individual	O
animals	B-SPEC
and	O
groups	O
with	O
similar	O
high	O
accuracy	O
based	O
on	O
a	O
maximum	O
of	O
two	O
inflammatory	O
parameters	O
per	O
group	O
(	O
29	O
of	O
30	O
and	O
36	O
of	O
37	O
rats	B-SPEC
were	O
correctly	O
classified	O
at	O
5	O
hours	O
and	O
24	O
hours	O
,	O
respectively	O
).	O

RESULTS	O
:	O
Rats	B-SPEC
with	O
LC	O
,	O
CASP	O
,	O
LC	O
+	O
CASP	O
all	O
had	O
severe	O
lung	O
injury	O
compared	O
with	O
uninjured	O
controls	O
based	O
on	O
decreased	O
arterial	O
oxygenation	O
or	O
increased	O
BAL	O
albumin	O
at	O
5	O
or	O
24	O
hours	O
postinsult	O
.	O

Since	O
the	O
discovery	O
of	O
SARS	O
-	O
like	O
coronaviruses	O
in	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
,	O
attempts	O
to	O
isolate	O
a	O
SL	O
-	O
CoV	O
from	O
bats	B-SPEC
have	O
failed	O
and	O
attempts	O
to	O
isolate	O
other	O
bat	B-SPEC
-	O
borne	O
viruses	B-SPEC
in	O
various	O
mammalian	B-SPEC
cell	O
lines	O
have	O
been	O
similarly	O
unsuccessful	O
.	O

New	O
stable	O
bat	B-SPEC
cell	O
lines	O
are	O
needed	O
to	O
help	O
with	O
these	O
investigations	O
and	O
as	O
tools	O
to	O
assist	O
in	O
the	O
study	O
of	O
bat	B-SPEC
immunology	O
and	O
virus	B-SPEC
-	O
host	O
interactions	O
.	O

We	O
are	O
in	O
the	O
process	O
of	O
generating	O
further	O
cell	O
lines	O
from	O
a	O
number	O
of	O
different	O
bat	B-SPEC
species	B-SPEC
using	O
the	O
methodology	O
established	O
in	O
this	O
study	O
.	O

TITLE	O
:	O
Annexin	O
A2	O
on	O
lung	O
epithelial	O
cell	O
surface	O
is	O
recognized	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
spike	O
domain	O
2	O
antibodies	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
infection	O
causes	O
lung	O
failure	O
characterized	O
by	O
atypical	O
pneumonia	O
.	O

ABSTRACT	O
:	O
The	O
Chinese	O
rufous	O
horseshoe	B-SPEC
bat	I-SPEC
(	O
Rhinolophus	B-SPEC
sinicus	I-SPEC
)	O
has	O
been	O
suggested	O
to	O
carry	O
the	O
direct	O
ancestor	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SCoV	O
),	O
and	O
the	O
diversity	O
of	O
SARS	O
-	O
like	O
CoVs	O
(	O
SLCoV	O
)	O
within	O
this	O
Rhinolophus	B-SPEC
species	B-SPEC
is	O
therefore	O
worth	O
investigating	O
.	O

Moreover	O
,	O
this	O
strain	O
possesses	O
a	O
distinctive	O
579	O
nt	O
deletion	O
in	O
the	O
nsp3	O
region	O
that	O
was	O
also	O
found	O
in	O
a	O
human	B-SPEC
SCoV	O
from	O
the	O
late	O
-	O
phase	O
epidemic	O
.	O

These	O
findings	O
reveal	O
a	O
closer	O
evolutionary	O
linkage	O
between	O
SCoV	O
in	O
humans	B-SPEC
and	O
SLCoVs	O
in	O
R	B-SPEC
.	I-SPEC
sinicus	I-SPEC
,	O
defining	O
the	O
scope	O
of	O
surveillance	O
to	O
search	O
for	O
the	O
direct	O
ancestor	O
of	O
human	B-SPEC
SCoVs	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
population	O
characteristics	O
,	O
injuries	O
,	O
emergency	O
diagnostic	O
testing	O
,	O
and	O
outcome	O
of	O
dogs	B-SPEC
with	O
blunt	O
trauma	O
requiring	O
intensive	O
care	O
in	O
an	O
urban	O
hospital	O
.	O

ABSTRACT	O
:	O
Analyses	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
),	O
an	O
enteric	O
disease	O
virus	B-SPEC
that	O
is	O
highly	O
similar	O
to	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
an	O
upper	O
-	O
respiratory	O
tract	O
disease	O
virus	B-SPEC
in	O
chickens	B-SPEC
,	O
were	O
conducted	O
to	O
determine	O
the	O
adaptive	O
potential	O
,	O
and	O
genetic	O
changes	O
associated	O
with	O
emergence	O
of	O
this	O
group	O
3	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
the	O
novel	O
A	O
/	O
H1N1	O
virus	B-SPEC
has	O
made	O
pandemic	O
preparedness	O
a	O
crucial	O
issue	O
for	O
public	O
health	O
worldwide	O
.	O

TITLE	O
:	O
Recombinant	O
canine	O
coronaviruses	O
in	O
dogs	B-SPEC
,	O
Europe	O
.	O

However	O
,	O
the	O
possibility	O
of	O
within	O
-	O
flight	O
transmission	O
of	O
H1N1	O
has	O
not	O
been	O
evaluated	O
;	O
although	O
it	O
is	O
known	O
that	O
smallpox	B-SPEC
,	O
measles	O
,	O
tuberculosis	O
,	O
SARS	O
and	O
seasonal	O
influenza	O
can	O
be	O
transmitted	O
during	O
commercial	O
flights	O
.	O

Most	O
of	O
the	O
knowledge	O
about	O
the	O
pathogenesis	O
of	O
MS	O
has	O
been	O
derived	O
from	O
murine	B-SPEC
models	O
,	O
such	O
as	O
experimental	O
autoimmune	O
encephalomyelitis	O
and	O
viral	O
encephalomyelitis	O
.	O

The	O
results	O
indicate	O
that	O
tempol	O
ameliorates	O
murine	B-SPEC
viral	O
encephalomyelitis	O
by	O
altering	O
the	O
redox	O
status	O
of	O
the	O
infectious	O
environment	O
that	O
contributes	O
to	O
an	O
attenuated	O
CNS	O
inflammatory	O
response	O
.	O

The	O
RCT	O
and	O
meta	B-SPEC
-	O
analysis	O
consistently	O
demonstrated	O
improved	O
oxygenation	O
and	O
shorter	O
duration	O
of	O
mechanical	O
ventilation	O
with	O
methylprednisolone	O
.	O

Infection	O
of	O
BALB	O
/	O
c	O
(	O
H	O
-	O
2	O
(	O
d	O
))	O
mice	B-SPEC
expressing	O
a	O
dominant	O
negative	O
gamma	O
interferon	O
(	O
IFN	O
-	O
gamma	O
)	O
receptor	O
specifically	O
in	O
oligodendrocytes	O
was	O
examined	O
to	O
determine	O
the	O
influence	O
of	O
IFN	O
-	O
gamma	O
signaling	O
on	O
pathogenesis	O
.	O

ABSTRACT	O
:	O
Little	O
is	O
known	O
about	O
clinical	O
and	O
virologic	O
manifestations	O
of	O
rhinovirus	B-SPEC
(	O
HRV	O
)	O
and	O
coronavirus	B-SPEC
(	O
HCoV	O
)	O
infections	O
after	O
hematopoietic	O
cell	O
transplantation	O
(	O
HCT	O
).	O

TITLE	O
:	O
Multivalent	O
DNA	O
vaccine	O
enhanced	O
protection	O
efficacy	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
chickens	B-SPEC
.	O

Cytokines	O
are	O
promising	O
adjuvants	O
because	O
they	O
are	O
human	B-SPEC
-	O
derived	O
safe	O
material	O
and	O
display	O
potent	O
immune	O
-	O
modulating	O
functions	O
.	O

The	O
infection	O
of	O
cells	O
with	O
srr7	O
(	O
soluble	O
-	O
receptor	O
-	O
resistant	O
mutant	O
7	O
)	O
is	O
dependent	O
on	O
a	O
known	O
MHV	B-SPEC
receptor	O
(	O
MHVR	O
),	O
carcinoembryonic	O
cell	O
adhesion	O
molecule	O
1a	O
,	O
whereas	O
cl	O
-	O
2	O
shows	O
MHVR	O
-	O
independent	O
infection	O
.	O

In	O
order	B-SPEC
to	O
decide	O
on	O
whether	O
to	O
make	O
changes	O
to	O
the	O
screening	O
levels	O
,	O
a	O
review	O
was	O
conducted	O
to	O
determine	O
the	O
prevalence	O
of	O
scoliosis	O
among	O
the	O
10	O
-	O
year	O
-	O
old	O
girls	O
(	O
in	O
Primary	O
5	O
)	O
and	O
12	O
-	O
year	O
-	O
old	O
girls	O
(	O
in	O
Secondary	O
1	O
).	O

Eighty	O
nine	O
percent	O
of	O
the	O
sampled	O
animals	B-SPEC
were	O
positive	O
for	O
the	O
presence	O
of	O
FCoV	O
.	O
Among	O
the	O
FCoV	O
positive	O
cats	B-SPEC
,	O
80	O
%	O
of	O
cats	B-SPEC
were	O
males	O
and	O
64	O
%	O
were	O
below	O
2	O
years	O
of	O
age	O
.	O

CoVs	O
are	O
known	O
for	O
their	O
high	O
potential	O
for	O
interspecies	O
transmission	O
,	O
including	O
zoonotic	O
transmission	O
with	O
bats	B-SPEC
as	O
reservoir	O
hosts	O
.	O

Not	O
wearing	O
a	O
surgical	O
mask	O
either	O
by	O
the	O
exposed	O
persons	O
during	O
contact	O
with	O
the	O
index	O
cases	O
(	O
4	O
/	O
4	O
vs	O
264	O
/	O
832	O
,	O
P	O
=	O
0	O
.	O
010	O
)	O
or	O
vice	O
versa	O
(	O
4	O
/	O
4	O
vs	O
300	O
/	O
832	O
,	O
P	O
=	O
0	O
.	O
017	O
,	O
Fisher	B-SPEC
'	O
s	O
exact	O
test	O
)	O
were	O
found	O
to	O
be	O
significant	O
risk	O
factors	O
for	O
nosocomial	O
acquisition	O
of	O
S	O
-	O
OIV	O
.	O

We	O
carried	O
out	O
the	O
first	O
study	O
to	O
investigate	O
the	O
migration	O
pattern	O
and	O
SARSr	O
-	O
Rh	O
-	O
BatCoV	O
genome	O
epidemiology	O
in	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
during	O
a	O
4	O
-	O
year	O
period	O
.	O

Of	O
the	O
intestinal	O
contents	O
collected	O
from	O
43	O
PES	O
cases	O
,	O
25	O
were	O
positive	O
for	O
rotavirus	B-SPEC
and	O
13	O
for	O
small	O
round	O
viruses	B-SPEC
by	O
electron	O
microscopy	O
(	O
EM	O
).	O

The	O
viruses	B-SPEC
from	O
all	O
cases	O
were	O
detected	O
either	O
alone	O
or	O
in	O
combination	O
of	O
2	O
or	O
3	O
by	O
RT	O
-	O
PCR	O
.	O

The	O
use	O
of	O
sensitive	O
molecular	O
methods	O
that	O
can	O
simultaneously	O
detect	O
a	O
large	O
panel	O
of	O
respiratory	O
viruses	B-SPEC
may	O
help	O
better	O
define	O
their	O
effects	O
.	O

BAL	O
samples	O
underwent	O
multiplex	O
testing	O
for	O
a	O
panel	O
of	O
19	O
respiratory	O
viral	O
types	O
/	O
subtypes	O
using	O
the	O
Luminex	O
xTAG	O
respiratory	O
virus	B-SPEC
panel	O
assay	O
.	O

ABSTRACT	O
:	O
Ferret	B-SPEC
systemic	I-SPEC
coronavirus	I-SPEC
(	O
FRSCV	O
)	O
infection	O
is	O
associated	O
with	O
an	O
emerging	O
,	O
highly	O
fatal	O
disease	O
of	O
ferrets	B-SPEC
.	O

The	O
virus	B-SPEC
has	O
spread	O
throughout	O
the	O
world	O
and	O
become	O
a	O
pandemic	O
flu	O
,	O
for	O
the	O
first	O
time	O
since	O
1968	O
.	O

This	O
article	O
addresses	O
the	O
global	O
aspects	O
of	O
the	O
outbreak	O
of	O
this	O
new	O
pandemic	O
influenza	O
,	O
starting	O
from	O
the	O
first	O
event	O
of	O
""""	O
Avian	B-SPEC
Flu	O
""""	O
in	O
1997	O
in	O
Hong	O
Kong	O
,	O
through	O
the	O
outbreaks	O
of	O
SARS	O
in	O
2003	O
,	O
and	O
the	O
Avian	B-SPEC
Flu	O
,	O
which	O
also	O
began	O
in	O
2003	O
,	O
and	O
is	O
still	O
endemic	O
in	O
some	O
countries	O
.	O

We	O
have	O
characterized	O
the	O
LVCVs	O
,	O
TBs	O
and	O
CMSs	O
,	O
and	O
found	O
that	O
the	O
CoV	O
-	O
induced	O
structures	O
appear	O
in	O
a	O
strict	O
order	B-SPEC
.	O

TITLE	O
:	O
Physical	O
interventions	O
to	O
interrupt	O
or	O
reduce	O
the	O
spread	O
of	O
respiratory	O
viruses	B-SPEC
.	O

Only	O
case	O
-	O
control	O
data	O
were	O
sufficiently	O
homogeneous	O
to	O
allow	O
meta	B-SPEC
-	O
analysis	O
.	O

The	O
highest	O
quality	O
cluster	O
RCTs	O
suggest	O
respiratory	O
virus	B-SPEC
spread	O
can	O
be	O
prevented	O
by	O
hygienic	O
measures	O
,	O
such	O
as	O
handwashing	O
,	O
especially	O
around	O
younger	O
children	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
an	O
autopsy	O
case	O
of	O
a	O
patient	O
with	O
pandemic	O
influenza	O
(	O
A	O
/	O
H1N1pdm	O
)	O
virus	B-SPEC
infection	O
in	O
Japan	O
,	O
who	O
developed	O
rapidly	O
progressive	O
viral	O
pneumonia	O
exhibiting	O
diffuse	O
alveolar	O
damage	O
.	O

She	O
was	O
a	O
public	O
health	O
nurse	O
with	O
no	O
underlying	O
disease	O
and	O
had	O
had	O
contact	O
with	O
a	O
group	O
of	O
elementary	O
school	O
students	O
who	O
had	O
been	O
infected	O
with	O
the	O
influenza	O
(	O
A	O
/	O
H1N1pdm	O
)	O
virus	B-SPEC
1	O
week	O
earlier	O
.	O

TITLE	O
:	O
Classification	O
of	O
IBV	B-SPEC
S1	O
genotypes	O
by	O
direct	O
reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
relationship	O
between	O
serotypes	O
and	O
genotypes	O
of	O
strains	O
isolated	O
between	O
1998	O
and	O
2008	O
in	O
Japan	O
.	O

Then	O
,	O
to	O
evaluate	O
the	O
usefulness	O
of	O
the	O
S1	O
genotype	O
-	O
specific	O
RT	O
-	O
PCR	O
,	O
we	O
examined	O
the	O
relationship	O
between	O
S1	O
genotypes	O
and	O
serotypes	O
of	O
IBV	B-SPEC
in	O
Japan	O
.	O

ABSTRACT	O
:	O
Legionnaires	O
'	O
disease	O
(	O
LD	O
)	O
is	O
a	O
pneumonia	O
caused	O
by	O
Legionella	B-SPEC
pneumophila	I-SPEC
(	O
LP	O
).	O

TITLE	O
:	O
Avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
susceptibility	O
to	O
botanical	O
oleoresins	O
and	O
essential	O
oils	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Treatment	O
decreased	O
the	O
severity	O
of	O
clinical	O
signs	O
and	O
lesions	O
in	O
the	O
birds	B-SPEC
,	O
and	O
lowered	O
the	O
amount	O
of	O
viral	O
RNA	O
in	O
the	O
trachea	B-SPEC
.	O

To	O
this	O
end	O
,	O
LAB	O
strains	O
selected	O
on	O
the	O
basis	O
of	O
previous	O
in	O
vitro	O
trials	O
were	O
co	O
-	O
incubated	O
with	O
cell	O
line	O
monolayers	O
,	O
which	O
were	O
subsequently	O
challenged	O
with	O
rotavirus	B-SPEC
(	O
RV	O
)	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
).	O

Clear	O
indications	O
on	O
the	O
nature	O
of	O
the	O
antiviral	O
effect	O
were	O
evident	O
only	O
in	O
the	O
case	O
of	O
the	O
L	B-SPEC
.	I-SPEC
casei	I-SPEC
Shirota	O
against	O
TGEV	B-SPEC
and	O
with	O
L	B-SPEC
.	I-SPEC
plantarum	I-SPEC
PCA236	O
against	O
both	O
RV	O
and	O
TGEV	B-SPEC
.	O

TITLE	O
:	O
The	O
N	O
-	O
terminal	O
region	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
protein	O
6	O
induces	O
membrane	O
rearrangement	O
and	O
enhances	O
virus	B-SPEC
replication	O
.	O

Today	O
,	O
ticks	B-SPEC
transmit	O
the	O
most	O
common	O
arthropod	B-SPEC
-	O
borne	O
infectious	O
disease	O
in	O
the	O
United	O
States	O
(	O
US	O
),	O
Lyme	O
disease	O
(	O
LD	O
);	O
and	O
the	O
most	O
lethal	O
arthropod	B-SPEC
-	O
borne	O
infectious	O
disease	O
in	O
the	O
US	O
,	O
Rocky	O
Mountain	O
spotted	O
fever	O
(	O
RMSF	O
).	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
caused	O
substantial	O
morbidity	O
and	O
mortality	O
in	O
2002	O
-	O
2003	O
.	O

hACE2	O
Tg	O
mice	B-SPEC
,	O
which	O
express	O
the	O
human	B-SPEC
SARS	O
-	O
CoV	O
receptor	O
,	O
are	O
extremely	O
susceptible	O
to	O
infection	O
.	O

We	O
also	O
show	O
that	O
rSARS	O
-	O
CoV	O
-	O
DeltaE	O
and	O
rSARS	O
-	O
CoV	O
-	O
Delta	O
[	O
E	O
,	O
6	O
-	O
9b	O
]	O
induced	O
anti	O
-	O
virus	B-SPEC
T	O
cell	O
and	O
antibody	O
responses	O
.	O

Further	O
,	O
the	O
E	O
-	O
deleted	O
viruses	B-SPEC
were	O
stable	O
after	O
16	O
blind	O
passages	O
through	O
tissue	O
culture	O
cells	O
,	O
with	O
only	O
a	O
single	O
mutation	O
in	O
the	O
surface	O
glycoprotein	O
detected	O
.	O

Only	O
4	O
bovine	B-SPEC
coronavirus	B-SPEC
isolates	O
have	O
been	O
completely	O
sequenced	O
and	O
thus	O
,	O
the	O
information	O
about	O
the	O
genetics	O
of	O
the	O
virus	B-SPEC
is	O
still	O
limited	O
.	O

ABSTRACT	O
:	O
N	O
-	O
glycans	O
were	O
released	O
from	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
glycoprotein	O
produced	O
in	O
Vero	O
E6	O
cells	O
and	O
their	O
structures	O
were	O
determined	O
by	O
a	O
combination	O
of	O
matrix	O
-	O
assisted	O
laser	B-SPEC
desorption	O
/	O
ionization	O
(	O
MALDI	O
)	O
mass	O
spectrometry	O
,	O
negative	O
ion	O
electrospray	O
collision	O
-	O
induced	O
dissociation	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
and	O
normal	O
-	O
phase	O
high	O
-	O
performance	O
liquid	O
chromatography	O
with	O
exoglycosidase	O
digestion	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
determined	O
the	O
complete	O
nucleotide	O
sequences	O
of	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
genes	O
of	O
seven	O
Korean	O
PEDV	B-SPEC
isolates	O
.	O

Collectively	O
,	O
the	O
sequence	O
analysis	O
data	O
indicate	O
the	O
diversity	O
of	O
the	O
PEDV	B-SPEC
isolates	O
currently	O
prevalent	O
in	O
Korea	O
that	O
represents	O
a	O
heterogeneous	O
group	O
.	O

TITLE	O
:	O
Delayed	O
clearance	O
of	O
viral	O
load	O
and	O
marked	O
cytokine	O
activation	O
in	O
severe	O
cases	O
of	O
pandemic	O
H1N1	O
2009	O
influenza	B-SPEC
virus	I-SPEC
infection	O
.	O

Here	O
,	O
we	O
show	O
that	O
SARS	O
-	O
CoV	O
-	O
infected	O
aged	O
macaques	B-SPEC
develop	O
more	O
severe	O
pathology	O
than	O
young	O
adult	O
animals	B-SPEC
,	O
even	O
though	O
viral	O
replication	O
levels	O
are	O
similar	O
.	O

We	O
performed	O
a	O
3D	O
telomere	O
analysis	O
after	O
quantitative	O
fluorescent	O
in	O
situ	O
hybridization	O
on	O
5	O
mum	B-SPEC
tissue	O
sections	O
on	O
two	O
LMP1	O
-	O
expressing	O
HL	O
cases	O
and	O
showed	O
highly	O
significant	O
telomere	O
shortening	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
formation	O
of	O
telomere	O
aggregates	O
in	O
RS	O
cells	O
(	O
P	O
<	O
0	O
.	O
0001	O
),	O
when	O
compared	O
with	O
the	O
mononuclear	O
precursor	O
Hodgkin	O
cells	O
(	O
H	O
cells	O
).	O

TITLE	O
:	O
Hexokinase	O
II	O
gene	O
transfer	O
protects	O
against	O
neurodegeneration	O
in	O
the	O
rotenone	O
and	O
MPTP	O
mouse	B-SPEC
models	O
of	O
Parkinson	O
'	O
s	O
disease	O
.	O

Rotenone	O
or	O
1	O
-	O
methyl	O
-	O
4	O
-	O
phenyl	O
-	O
1	O
,	O
2	O
,	O
3	O
,	O
6	O
-	O
tetrahydropyridine	O
(	O
MPTP	O
)	O
inhibit	O
the	O
mitochondrial	O
complex	O
I	O
and	O
they	O
cause	O
the	O
death	O
of	O
substantia	O
nigra	O
dopaminergic	O
neurons	O
,	O
thereby	O
providing	O
acute	O
murine	B-SPEC
models	O
of	O
Parkinson	O
'	O
s	O
disease	O
.	O

As	O
a	O
result	O
,	O
we	O
have	O
studied	O
the	O
effects	O
of	O
hexokinase	O
II	O
gene	O
transfer	O
in	O
vivo	O
using	O
a	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
amplicon	O
vector	O
.	O

K2p170	O
also	O
had	O
no	O
virulence	O
reversion	O
after	O
five	O
back	O
passages	O
in	O
chickens	B-SPEC
.	O

In	O
conclusion	O
,	O
K2p170	O
exhibits	O
a	O
fine	O
balance	O
between	O
attenuation	O
and	O
immunogenicity	O
,	O
possesses	O
cross	O
-	O
protective	O
efficacy	O
,	O
and	O
merits	O
further	O
investigation	O
as	O
a	O
potential	O
live	O
vaccine	O
as	O
an	O
alternative	O
means	O
of	O
protection	O
against	O
the	O
recently	O
emergent	O
nephropathogenic	O
IBV	B-SPEC
infection	O
in	O
many	O
Eurasian	O
countries	O
.	O

The	O
lung	O
samples	O
of	O
a	O
20	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
had	O
suffered	O
a	O
serious	O
motorbike	O
accident	O
were	O
obtained	O
for	O
histological	O
examination	O
.	O

ABSTRACT	O
:	O
In	O
retroviruses	B-SPEC
and	O
the	O
double	O
-	O
stranded	O
RNA	O
totiviruses	O
,	O
the	O
efficiency	O
of	O
programmed	O
-	O
1	O
ribosomal	O
frameshifting	O
is	O
critical	O
for	O
ensuring	O
the	O
proper	O
ratios	O
of	O
upstream	O
-	O
encoded	O
capsid	O
proteins	O
to	O
downstream	O
-	O
encoded	O
replicase	O
enzymes	O
.	O

The	O
genomic	O
organizations	O
of	O
many	O
other	O
frameshifting	O
viruses	B-SPEC
,	O
including	O
the	O
coronaviruses	O
,	O
are	O
very	O
different	O
,	O
in	O
that	O
their	O
upstream	O
open	O
reading	O
frames	O
encode	O
nonstructural	O
proteins	O
,	O
the	O
frameshift	O
-	O
dependent	O
downstream	O
open	O
reading	O
frames	O
encode	O
enzymes	O
involved	O
in	O
transcription	O
and	O
replication	O
,	O
and	O
their	O
structural	O
proteins	O
are	O
encoded	O
by	O
subgenomic	O
mRNAs	O
.	O

Second	O
,	O
a	O
series	O
of	O
frameshift	O
-	O
promoting	O
mRNA	O
pseudoknot	O
mutants	O
was	O
employed	O
to	O
demonstrate	O
that	O
the	O
frameshift	O
signals	O
of	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
have	O
evolved	O
to	O
promote	O
optimal	O
frameshift	O
efficiencies	O
.	O

Many	O
of	O
these	O
glycoproteins	O
,	O
including	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
(	O
S	O
)	O
protein	O
form	O
trimeric	O
units	O
in	O
the	O
membrane	O
of	O
the	O
native	O
virion	O
.	O

TITLE	O
:	O
Multiplex	O
nested	O
RT	O
-	O
PCR	O
for	O
the	O
detection	O
of	O
porcine	B-SPEC
enteric	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
and	O
porcine	B-SPEC
group	B-SPEC
A	I-SPEC
rotavirus	I-SPEC
(	O
PRV	B-SPEC
-	O
A	O
)	O
are	O
major	O
viruses	B-SPEC
causing	O
enteric	O
diseases	O
of	O
piglets	O
.	O

Eighteen	O
(	O
32	O
%)	O
developed	O
BOS	B-SPEC
,	O
at	O
a	O
mean	O
age	O
at	O
diagnosis	O
of	O
57	O
years	O
(	O
range	O
16	O
-	O
74	O
).	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
frequently	O
results	O
in	O
death	O
in	O
cats	B-SPEC
.	O

In	O
order	B-SPEC
to	O
elucidate	O
the	O
multifactorial	O
aetiology	O
of	O
porcine	B-SPEC
respiratory	O
disease	O
complex	O
(	O
PRDC	O
)	O
in	O
Denmark	O
,	O
lungs	O
from	O
148	O
finishing	O
pigs	B-SPEC
with	O
cranioventral	O
bronchopneumonia	O
(	O
case	O
group	O
)	O
and	O
60	O
pigs	B-SPEC
without	O
lung	O
lesions	O
(	O
control	O
group	O
)	O
were	O
collected	O
from	O
abattoirs	O
.	O

These	O
results	O
indicated	O
that	O
a	O
component	O
of	O
coronavirus	B-SPEC
PLP	O
-	O
mediated	O
interferon	O
antagonism	O
was	O
independent	O
of	O
protease	O
and	O
DUB	O
activity	O
.	O

Overall	O
,	O
these	O
results	O
demonstrate	O
the	O
multifunctional	O
nature	O
of	O
the	O
coronavirus	B-SPEC
PLP	O
domain	O
as	O
a	O
viral	O
protease	O
,	O
DUB	O
,	O
and	O
IFN	O
antagonist	O
and	O
suggest	O
that	O
these	O
independent	O
activities	O
may	O
provide	O
multiple	O
targets	O
for	O
antiviral	O
therapies	O
.	O

Infectious	O
bronchitis	O
viruses	B-SPEC
from	O
slaughtered	O
chickens	B-SPEC
revealed	O
intertypic	O
genetic	O
recombination	O
and	O
antigenic	O
diversity	O
.	O

Weight	O
gain	O
of	O
embryos	O
in	O
the	O
SIAMP	O
-	O
IBV	B-SPEC
intermixture	O
group	O
was	O
significantly	O
higher	O
than	O
the	O
IBV	B-SPEC
-	O
infected	O
embryos	O
(	O
P	O
<	O
0	O
.	O
01	O
),	O
which	O
was	O
also	O
higher	O
than	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Structural	O
considerations	O
in	O
the	O
fitness	O
landscape	O
of	O
a	O
virus	B-SPEC
.	O

To	O
investigate	O
the	O
causal	O
relation	O
between	O
a	O
mutation	O
in	O
a	O
viral	O
genome	O
and	O
adaptive	O
evolution	O
of	O
a	O
viral	O
population	O
,	O
we	O
developed	O
a	O
mathematical	O
model	O
that	O
describes	O
the	O
population	O
dynamics	O
of	O
viruses	B-SPEC
,	O
antibodies	O
,	O
and	O
normal	O
/	O
infected	O
cells	O
within	O
a	O
host	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
early	O
oxygenation	O
improvement	O
after	O
prone	O
positioning	O
might	O
be	O
associated	O
with	O
an	O
improved	O
28	O
-	O
day	O
outcome	O
and	O
may	O
be	O
an	O
indicator	B-SPEC
to	O
maintain	O
prolonged	O
prone	O
positioning	O
in	O
patients	O
with	O
severe	O
ARDS	O
.	O

ABSTRACT	O
:	O
Transmissible	O
proventriculitis	O
associated	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
was	O
at	O
first	O
seen	O
in	O
eastern	O
China	O
in	O
mid	O
-	O
1995	O
,	O
and	O
is	O
now	O
endemic	O
in	O
China	O
.	O

TITLE	O
:	O
[	O
What	O
degree	O
of	O
hypoxemia	O
is	O
tolerable	O
for	O
human	B-SPEC
beings	O
?].	O

ABSTRACT	O
:	O
The	O
genome	O
of	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
displays	O
genetic	O
diversity	O
especially	O
in	O
gene	O
3	O
region	O
.	O

In	O
addition	O
,	O
this	O
study	O
indicated	O
the	O
presence	O
of	O
different	O
TGEV	B-SPEC
strains	O
within	O
the	O
same	O
pig	B-SPEC
herds	O
in	O
China	O
.	O

ABSTRACT	O
:	O
Global	O
predictions	O
of	O
the	O
secondary	O
structure	O
of	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
5	O
'	O
untranslated	O
regions	O
and	O
adjacent	O
coding	O
sequences	O
revealed	O
the	O
presence	O
of	O
conserved	O
structural	O
elements	O
.	O

Structure	O
probing	O
confirmed	O
the	O
existence	O
of	O
these	O
hairpins	O
in	O
the	O
group	O
I	O
Human	B-SPEC
coronavirus	I-SPEC
-	O
229E	O
and	O
the	O
group	O
II	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

1	O
.	O
03	O
quadrants	O
)	O
and	O
bacterial	O
coinfection	O
,	O
(	O
25	O
%;	O
mostly	O
with	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
).	O

Our	O
findings	O
underline	O
the	O
importance	O
of	O
a	O
common	O
data	O
collection	O
platform	O
,	O
especially	O
in	O
an	O
emerging	O
epidemic	O
,	O
in	O
order	B-SPEC
to	O
identify	O
and	O
explain	O
consistencies	O
and	O
differences	O
in	O
the	O
eventual	O
clinical	O
and	O
public	O
health	O
outcomes	O
of	O
infectious	O
disease	O
outbreaks	O
,	O
which	O
is	O
becoming	O
increasingly	O
important	O
in	O
our	O
highly	O
interconnected	O
world	O
.	O

In	O
this	O
setting	O
,	O
sensitivity	O
and	O
uncertainty	O
analytical	O
techniques	O
are	O
used	O
in	O
order	B-SPEC
to	O
analyze	O
the	O
impact	O
of	O
the	O
uncertainty	O
in	O
the	O
parameter	O
estimates	O
on	O
the	O
results	O
obtained	O
and	O
to	O
determine	O
which	O
parameters	O
have	O
the	O
largest	O
impact	O
on	O
driving	O
the	O
disease	O
dynamics	O
.	O

Coronaviruses	O
were	O
detected	O
by	O
RT	O
-	O
PCR	O
in	O
14	O
out	O
of	O
36	O
horseshoe	B-SPEC
bat	I-SPEC
(	O
Rhinolophus	B-SPEC
hipposideros	I-SPEC
)	O
fecal	O
samples	O
,	O
with	O
38	O
.	O
8	O
%	O
virus	B-SPEC
prevalence	O
.	O

MHV	B-SPEC
-	O
JHM	O
that	O
induces	O
syncytia	O
in	O
infected	O
cells	O
entered	O
directly	O
from	O
cell	O
surface	O
,	O
i	O
.	O
e	O
.,	O
fusion	O
of	O
envelope	O
and	O
plasma	O
membrane	O
,	O
whereas	O
SARS	O
-	O
CoV	O
and	O
MHV	B-SPEC
-	O
2	O
that	O
fail	O
to	O
induce	O
syncytia	O
entered	O
via	O
endosome	O
in	O
a	O
protease	O
-	O
dependent	O
fashion	O
,	O
i	O
.	O
e	O
.,	O
fusion	O
of	O
envelope	O
and	O
endosomal	O
membrane	O
.	O

It	O
was	O
also	O
reveled	O
that	O
a	O
highly	O
neurovirulent	O
JHM	O
spread	O
in	O
a	O
receptor	O
-	O
independent	O
fashion	O
,	O
which	O
could	O
result	O
in	O
a	O
high	O
neuropathogenicity	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Dual	O
interference	O
with	O
novel	O
genes	O
mfgl2	O
and	O
mTNFR1	O
ameliorates	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
3	O
-	O
induced	O
fulminant	O
hepatitis	O
in	O
BALB	O
/	O
cJ	O
mice	B-SPEC
.	O

Cotransfection	O
of	O
individual	O
shRNA	O
plasmids	O
and	O
pcDNA3	O
.	O
0	O
-	O
mfgl2	O
and	O
pcDNA3	O
.	O
0	O
-	O
mTNFR1	O
expression	O
constructs	O
into	O
Chinese	B-SPEC
hamster	I-SPEC
ovary	O
(	O
CHO	O
)	O
cells	O
significantly	O
inhibited	O
mfgl2	O
and	O
mTNFR1	O
gene	O
expression	O
,	O
as	O
evidenced	O
by	O
fluorescence	O
microscopy	O
,	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
,	O
and	O
Western	O
blotting	O
.	O

However	O
,	O
the	O
vaccines	O
which	O
can	O
be	O
delivered	O
safely	O
by	O
this	O
method	O
are	O
limited	O
and	O
there	O
is	O
no	O
currently	O
licensed	O
embryo	O
-	O
safe	O
vaccine	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

TITLE	O
:	O
High	O
mortality	O
from	O
respiratory	O
failure	O
secondary	O
to	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
H1N1	O
)	O
in	O
South	O
Africa	O
.	O

While	O
the	O
type	O
I	O
IFN	O
response	O
is	O
a	O
crucial	O
aspect	O
of	O
host	O
defense	O
against	O
MHV	B-SPEC
in	O
its	O
natural	O
host	O
,	O
there	O
is	O
little	O
if	O
any	O
induction	O
of	O
IFN	O
following	O
infection	O
of	O
mouse	B-SPEC
fibroblast	O
cell	O
lines	O
in	O
vitro	O
.	O

In	O
the	O
present	O
work	O
,	O
the	O
authors	O
investigated	O
an	O
outbreak	O
of	O
enteritis	O
in	O
puppies	O
from	O
a	O
Greek	O
kennel	O
for	O
the	O
presence	O
of	O
CCoV	O
.	O
Dogs	B-SPEC
were	O
presented	O
with	O
clinical	O
signs	O
of	O
diarrhea	O
,	O
anorexia	O
,	O
weakness	O
,	O
depression	O
,	O
dehydration	O
,	O
and	O
1	O
death	O
.	O

The	O
method	O
was	O
evaluated	O
using	O
the	O
data	O
available	O
at	O
the	O
early	O
stage	O
of	O
some	O
recent	O
outbreaks	O
of	O
infectious	O
diseases	O
,	O
including	O
the	O
influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
in	O
2009	O
,	O
and	O
the	O
evaluation	O
supports	O
the	O
design	O
idea	B-SPEC
.	O

Two	O
potential	O
surrogates	O
were	O
evaluated	O
in	O
this	O
study	O
;	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
were	O
used	O
to	O
determine	O
effects	O
of	O
AT	O
and	O
RH	O
on	O
the	O
survival	O
of	O
coronaviruses	O
on	O
stainless	O
steel	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
a	O
Chinese	O
vaccine	O
strain	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
:	O
mutations	O
that	O
may	O
contribute	O
to	O
attenuation	O
.	O

Our	O
findings	O
from	O
phylogenetic	O
analysis	O
may	O
enhance	O
our	O
understanding	O
of	O
the	O
evolution	O
of	O
TGEV	B-SPEC
,	O
as	O
well	O
as	O
the	O
other	O
coronaviruses	O
.	O

TITLE	O
:	O
How	O
to	O
reduce	O
the	O
impact	O
of	O
""""	O
low	O
-	O
risk	O
patients	O
""""	O
following	O
a	O
bioterrorist	O
incident	O
:	O
lessons	O
from	O
SARS	O
,	O
anthrax	B-SPEC
,	O
and	O
pneumonic	O
plague	O
.	O

We	O
further	O
evaluated	O
the	O
efficacy	O
of	O
antivirals	O
directed	O
against	O
SARS	O
-	O
CoV	O
infection	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

Significantly	O
high	O
levels	O
of	O
mouse	B-SPEC
IP	O
-	O
10	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
was	O
also	O
detected	O
when	O
SARS	O
-	O
CoV	O
-	O
infected	O
mice	B-SPEC
were	O
treated	O
with	O
the	O
interferon	O
inducer	O
,	O
polyriboinosinic	O
-	O
polyribocytidylic	O
acid	O
stabilized	O
with	O
poly	O
-	O
L	O
-	O
lysine	O
and	O
carboxymethyl	O
cellulose	O
(	O
poly	O
IC	O
:	O
LC	O
).	O

Moreover	O
,	O
coronavirus	B-SPEC
-	O
like	O
particles	O
have	O
been	O
seen	O
by	O
electron	O
microscope	O
in	O
stools	O
,	O
and	O
SARS	O
-	O
HCoV	O
has	O
been	O
isolated	O
from	O
intestinal	O
tissue	O
and	O
detected	O
in	O
stool	O
samples	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
virus	B-SPEC
distribution	O
and	O
viral	O
load	O
in	O
organs	O
and	O
gut	O
compartments	O
of	O
specified	O
-	O
pathogen	O
-	O
free	O
cats	B-SPEC
,	O
orally	O
infected	O
with	O
non	O
-	O
virulent	O
type	O
I	O
FCoV	O
,	O
over	O
different	O
time	O
periods	O
and	O
with	O
or	O
without	O
detectable	O
viraemia	O
.	O

Phylogenetic	O
analysis	O
of	O
all	O
non	O
-	O
structural	O
and	O
most	O
structural	O
genes	O
shows	O
that	O
TW	O
IBV	B-SPEC
is	O
genetically	O
distinct	O
from	O
the	O
US	O
strain	O
and	O
more	O
similar	O
to	O
Chinese	O
(	O
CH	O
)	O
IBV	B-SPEC
.	O

Outcomes	O
were	O
kidney	O
injury	O
and	O
kidney	O
failure	O
defined	O
using	O
RIFLE	O
(	O
risk	O
,	O
injury	O
,	O
failure	O
,	O
loss	O
,	O
end	O
-	O
stage	O
disease	O
)	O
criteria	O
or	O
need	O
for	O
dialysis	B-SPEC
therapy	O
.	O

The	O
chickens	B-SPEC
were	O
immunized	O
primely	O
on	O
day	O
7	O
and	O
boosted	O
2	O
weeks	O
later	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
support	O
a	O
mechanism	O
involving	O
gap	O
junctional	O
intercellular	O
communication	O
in	O
the	O
bystander	O
permeabilization	O
effect	O
observed	O
in	O
healthy	O
cells	O
co	O
-	O
cultured	O
with	O
poliovirus	B-SPEC
2B	O
-	O
expressing	O
cells	O
.	O

In	O
this	O
paper	O
,	O
a	O
case	O
with	O
a	O
complicated	O
,	O
partially	O
organized	O
hemorrhagic	O
pneumonia	O
and	O
DAD	O
is	O
presented	O
in	O
a	O
patient	O
with	O
H1N1	O
virus	B-SPEC
positivity	O
,	O
which	O
can	O
be	O
referred	O
as	O
a	O
classical	O
pulmonary	O
change	O
.	O

The	O
data	O
presented	O
herein	O
show	O
that	O
(	O
1	O
)	O
ligand	O
presentation	O
does	O
not	O
disrupt	O
ELP	O
(	O
BC	O
)	O
self	O
-	O
assembly	O
;	O
(	O
2	O
)	O
both	O
multivalent	O
ligand	O
presentation	O
and	O
upregulated	O
receptor	O
expression	O
are	O
needed	O
for	O
receptor	O
-	O
mediated	O
interaction	O
;	O
(	O
3	O
)	O
increased	O
size	O
of	O
the	O
hydrophobic	O
segment	O
of	O
the	O
block	O
copolymer	O
promotes	O
multivalent	O
interaction	O
with	O
membrane	O
receptors	O
,	O
potentially	O
due	O
to	O
changes	O
in	O
the	O
nanoscale	O
architecture	O
of	O
the	O
micelle	O
;	O
and	O
(	O
4	O
)	O
nanoscale	O
presentation	O
of	O
the	O
ligand	O
is	O
important	O
,	O
as	O
presentation	O
of	O
the	O
ligand	O
by	O
micrometer	O
-	O
sized	O
aggregates	O
of	O
an	O
ELP	O
showed	O
a	O
low	O
level	O
of	O
binding	O
/	O
uptake	O
by	O
receptor	O
-	O
positive	O
cells	O
compared	O
to	O
its	O
presentation	O
on	O
the	O
corona	B-SPEC
of	O
a	O
micelle	O
.	O

Interestingly	O
,	O
we	O
found	O
that	O
SARS	O
coronavirus	B-SPEC
was	O
present	O
in	O
feces	O
from	O
infected	O
mice	B-SPEC
lacking	O
receptors	O
for	O
both	O
type	O
I	O
and	O
type	O
III	O
IFN	O
but	O
not	O
in	O
those	O
from	O
mice	B-SPEC
lacking	O
single	O
receptors	O
,	O
supporting	O
the	O
view	O
that	O
IFN	O
-	O
lambda	O
contributes	O
to	O
the	O
control	O
of	O
viral	O
infections	O
in	O
epithelial	O
cells	O
of	O
both	O
respiratory	O
and	O
gastrointestinal	O
tracts	O
.	O

TITLE	O
:	O
Identification	O
of	O
key	O
amino	O
acid	O
residues	O
required	O
for	O
horseshoe	B-SPEC
bat	I-SPEC
angiotensin	O
-	O
I	O
converting	O
enzyme	O
2	O
to	O
function	O
as	O
a	O
receptor	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
I	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
the	O
receptor	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

This	O
study	O
aimed	O
to	O
quantify	O
the	O
variation	O
in	O
individual	O
test	O
-	O
day	O
milk	O
yield	O
and	O
somatic	O
cell	O
count	O
,	O
risk	O
of	O
reproductive	O
failure	O
after	O
first	O
service	O
of	O
dairy	O
cows	B-SPEC
,	O
and	O
risk	O
of	O
death	O
of	O
calves	O
and	O
heifers	O
according	O
to	O
the	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
status	O
of	O
the	O
herd	O
.	O

For	O
this	O
purpose	O
,	O
serial	O
10	O
-	O
fold	O
dilutions	O
of	O
the	O
respective	O
inactivated	O
vaccines	O
were	O
prepared	O
and	O
groups	O
of	O
SPF	O
chickens	B-SPEC
were	O
vaccinated	O
with	O
a	O
double	O
dose	O
of	O
the	O
vaccine	O
dilutions	O
.	O

After	O
a	O
period	O
of	O
21	O
days	O
,	O
the	O
animals	B-SPEC
were	O
revaccinated	O
with	O
a	O
single	O
dose	O
.	O

Viral	O
RNA	O
is	O
also	O
detectable	O
in	O
the	O
serum	O
of	O
patients	O
with	O
RSV	B-SPEC
,	O
influenza	O
,	O
and	O
MPV	B-SPEC
pneumonia	O
and	O
may	O
correlate	O
with	O
the	O
severity	O
of	O
disease	O
.	O

All	O
infants	O
<	O
6	O
months	O
old	O
hospitalized	O
for	O
severe	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
bronchiolitis	O
,	O
who	O
developed	O
ARDS	O
(	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
-	O
ARDS	O
group	O
);	O
all	O
infants	O
<	O
6	O
months	O
old	O
diagnosed	O
with	O
ARDS	O
secondary	O
to	O
other	O
causes	O
(	O
ARDS	O
group	O
);	O
and	O
infants	O
<	O
6	O
months	O
old	O
who	O
needed	O
ventilation	O
for	O
reasons	O
other	O
than	O
any	O
lung	O
disease	O
(	O
control	O
group	O
).	O

ABSTRACT	O
:	O
The	O
development	O
of	O
effective	O
therapies	O
for	O
acute	O
liver	O
failure	O
(	O
ALF	O
)	O
is	O
limited	O
by	O
our	O
knowledge	O
of	O
the	O
pathophysiology	O
of	O
this	O
condition	O
,	O
and	O
the	O
lack	O
of	O
suitable	O
large	O
animal	B-SPEC
models	O
of	O
acetaminophen	O
toxicity	O
.	O

35kg	O
pigs	B-SPEC
were	O
maintained	O
under	O
general	O
anaesthesia	O
and	O
invasively	O
monitored	O
.	O

Cytochrome	O
p450	O
levels	O
in	O
phenobarbital	O
pre	O
-	O
treated	O
animals	B-SPEC
were	O
significantly	O
higher	O
than	O
non	O
pre	O
-	O
treated	O
animals	B-SPEC
(	O
300	O
vs	O
100	O
pmol	O
/	O
mg	O
protein	O
).	O

Of	O
nine	O
pigs	B-SPEC
that	O
received	O
acetaminophen	O
,	O
four	O
survived	O
20	O
hours	O
and	O
two	O
survived	O
28	O
hours	O
.	O

Animals	B-SPEC
displayed	O
evidence	O
of	O
renal	O
impairment	O
;	O
mean	O
creatinine	O
levels	O
280	O
.	O
2	O
+/-	O

Corn	B-SPEC
oil	O
was	O
mixed	O
with	O
distilled	O
water	O
to	O
form	O
fatty	O
micelles	O
.	O

Intravenous	O
administration	O
of	O
or	O
introduction	O
of	O
fatty	O
micelles	O
in	O
anesthetized	O
rats	B-SPEC
or	O
isolated	O
perfused	O
lungs	O
caused	O
severe	O
alveolar	O
damage	O
.	O

Our	O
clinical	O
observation	O
and	O
animal	B-SPEC
experimentation	O
revealed	O
that	O
infusion	O
of	O
fatty	O
acids	O
caused	O
physical	O
phase	O
,	O
resulting	O
in	O
microvascular	O
obstruction	O
accompanied	O
by	O
pulmonary	O
hypertension	O
and	O
increased	O
capillary	O
permeability	O
.	O

It	O
allows	O
us	O
to	O
show	O
that	O
the	O
SARS	O
-	O
CoV	O
is	O
most	O
closely	O
related	O
to	O
a	O
coronavirus	B-SPEC
from	O
the	O
palm	O
civet	B-SPEC
not	O
from	O
a	O
bird	B-SPEC
as	O
initially	O
suspected	O
,	O
and	O
the	O
newly	O
discovered	O
human	B-SPEC
coronavirus	I-SPEC
HCoV	O
-	O
HKU1	O
is	O
more	O
closely	O
related	O
to	O
SARS	O
than	O
to	O
any	O
other	O
known	O
member	O
of	O
group	O
2	O
coronavirus	B-SPEC
.	O

The	O
MHV	B-SPEC
receptor	O
is	O
a	O
carcinoembryonic	O
antigen	O
-	O
related	O
cell	O
adhesion	O
molecule	O
,	O
CEACAM1a	O
;	O
paradoxically	O
,	O
CEACAM1a	O
is	O
poorly	O
expressed	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
),	O
leading	O
to	O
speculation	O
of	O
an	O
additional	O
receptor	O
.	O

ELISA	O
and	O
Western	O
blotting	O
also	O
showed	O
that	O
this	O
epitope	O
was	O
recognized	O
by	O
IBV	B-SPEC
-	O
positive	O
chicken	B-SPEC
serum	O
.	O

The	O
identified	O
epitope	O
might	O
be	O
useful	O
for	O
clinical	O
applications	O
and	O
as	O
a	O
tool	O
for	O
further	O
study	O
of	O
the	O
structure	O
and	O
function	O
of	O
the	O
IBV	B-SPEC
N	O
protein	O
.	O

In	O
addition	O
,	O
outbreaks	O
of	O
avian	B-SPEC
influenza	O
caused	O
by	O
an	O
H5N1	O
virus	B-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
caused	O
by	O
a	O
coronavirus	B-SPEC
A	O
and	O
the	O
recent	O
pandemic	O
caused	O
by	O
an	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
have	O
heightened	O
concern	O
about	O
occupational	O
infectious	O
illnesses	O
among	O
workers	O
in	O
healthcare	O
and	O
agriculture	O
.	O

Early	O
fracture	O
stabilization	O
contributes	O
to	O
reducing	O
the	O
ICU	O
stay	O
,	O
the	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
multiple	O
organ	O
failure	O
(	O
MOF	O
)	O
and	O
sepsis	B-SPEC
,	O
thus	O
improving	O
patient	O
survival	O
.	O

Six	O
HLAA2	O
-	O
restricted	O
mouse	B-SPEC
CTL	O
epitopes	O
were	O
identified	O
,	O
including	O
two	O
new	O
epitopes	O
which	O
have	O
never	O
been	O
reported	O
before	O
.	O

To	O
address	O
this	O
question	O
,	O
we	O
evaluated	O
the	O
role	O
of	O
innate	O
immune	O
signaling	O
in	O
protection	O
from	O
human	B-SPEC
(	O
Urbani	O
)	O
and	O
a	O
recombinant	O
mouse	B-SPEC
adapted	O
SARS	O
-	O
CoV	O
,	O
designated	O
rMA15	O
.	O

This	O
suggests	O
that	O
type	O
I	O
,	O
II	O
and	O
III	O
interferon	O
signaling	O
play	O
minor	O
roles	O
in	O
regulating	O
SARS	O
pathogenesis	O
in	O
mouse	B-SPEC
models	O
.	O

Of	O
which	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
observed	O
in	O
3	O
specimens	O
(	O
11	O
.	O
5	O
%),	O
HCoV	O
-	O
HKU1	O
in	O
3	O
(	O
11	O
.	O
5	O
%)	O
and	O
HMPV	B-SPEC
in	O
20	O
(	O
76	O
.	O
9	O
%).	O

Our	O
data	O
showed	O
that	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
is	O
a	O
common	O
and	O
important	O
pathogen	O
in	O
adult	O
patients	O
with	O
acute	O
respiratory	O
symptoms	O
but	O
usually	O
resulted	O
in	O
milder	O
influenza	O
-	O
like	O
illnesses	O
.	O

There	O
might	O
have	O
a	O
local	O
outbreak	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
in	O
Beijing	O
,	O
Oct	O
-	O
Dec	O
,	O
2007	O
.	O

CONCLUSIONS	O
:	O
Our	O
data	O
showed	O
that	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
is	O
a	O
common	O
and	O
important	O
pathogen	O
in	O
adult	O
patients	O
with	O
acute	O
respiratory	O
symptoms	O
but	O
usually	O
resulted	O
in	O
milder	O
influenza	O
-	O
like	O
illnesses	O
.	O

ABSTRACT	O
:	O
A	O
69	O
-	O
year	O
-	O
old	O
man	B-SPEC
visited	O
another	O
hospital	O
due	O
to	O
dyspnea	O
and	O
bloody	O
sputum	O
.	O

A	O
diagnosis	O
of	O
pulmonary	O
tuberculosis	O
was	O
given	O
because	O
of	O
multiple	O
nodular	O
shadows	O
and	O
consolidation	O
on	O
chest	O
radiography	O
and	O
positive	O
testing	O
for	O
acid	O
-	O
fast	O
bacilli	B-SPEC
in	O
his	O
sputum	O
;	O
he	O
was	O
then	O
referred	O
to	O
our	O
hospital	O
for	O
treatment	O
.	O

TITLE	O
:	O
Detection	O
and	O
molecular	O
characterization	O
of	O
enteric	O
viruses	B-SPEC
in	O
breeder	O
turkeys	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
was	O
undertaken	O
to	O
detect	O
and	O
characterize	O
enteric	O
viruses	B-SPEC
(	O
rotavirus	B-SPEC
,	O
astrovirus	O
,	O
reovirus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
)	O
in	O
breeder	O
poults	O
.	O

Five	O
turkey	B-SPEC
breeder	O
flocks	O
were	O
selected	O
.	O

This	O
knowledge	O
can	O
be	O
useful	O
to	O
improve	O
the	O
average	O
efficacy	O
of	O
IBV	B-SPEC
vaccination	O
in	O
the	O
field	O
.	O

ABSTRACT	O
:	O
Recently	O
,	O
the	O
causal	O
relationship	O
between	O
eggshell	O
apex	O
abnormalities	O
(	O
EAA	O
)	O
and	O
Mycoplasma	B-SPEC
synoviae	I-SPEC
was	O
described	O
.	O

The	O
present	O
results	O
suggest	O
that	O
broiler	O
breeder	O
hens	O
are	O
less	O
susceptible	O
to	O
producing	O
eggs	O
with	O
EAA	O
after	O
an	O
infection	O
with	O
a	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
EAA	O
strain	O
preceded	O
by	O
an	O
IBV	B-SPEC
infection	O
,	O
compared	O
with	O
table	O
egg	O
layers	O
.	O

Infectious	B-SPEC
laryngotracheitis	I-SPEC
virus	I-SPEC
(	O
ILTV	B-SPEC
)	O
exists	O
as	O
a	O
single	O
type	O
with	O
a	O
wide	O
range	O
of	O
disease	O
severity	O
.	O

Recent	O
work	O
has	O
distinguished	O
molecular	O
differences	O
between	O
vaccine	O
and	O
field	O
strains	O
and	O
vaccine	O
virus	B-SPEC
can	O
be	O
a	O
cause	O
of	O
disease	O
.	O

ABSTRACT	O
:	O
The	O
discovery	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
CoV	B-SPEC
)	O
as	O
the	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
has	O
highlighted	O
the	O
need	O
for	O
a	O
better	O
understanding	O
of	O
CoV	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
During	O
the	O
early	O
stages	O
of	O
infection	O
,	O
SARS	O
-	O
CoV	O
produces	O
more	O
severe	O
perturbation	O
of	O
host	O
cell	O
gene	O
expression	O
in	O
a	O
human	B-SPEC
epithelial	O
cell	O
line	O
of	O
liver	O
origin	O
than	O
the	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

TITLE	O
:	O
Clinical	O
features	O
and	O
molecular	O
epidemiology	O
of	O
coronavirus	B-SPEC
-	O
HKU1	O
-	O
associated	O
community	O
-	O
acquired	O
pneumonia	O
.	O

Coronavirus	B-SPEC
(	O
CoV	O
)-	O
HKU1	O
accounts	O
for	O
2	O
.	O
4	O
%	O
of	O
community	O
-	O
acquired	O
pneumonia	O
.	O

By	O
recombinant	O
expression	O
and	O
purification	O
of	O
secretory	O
HE	O
(	O
recHE	O
)	O
proteins	O
,	O
receptor	O
-	O
binding	O
and	O
quantitative	O
analyses	O
of	O
enzymatic	O
activities	O
displayed	O
by	O
ISAV	B-SPEC
HE	O
molecules	O
are	O
presented	O
for	O
the	O
first	O
time	O
.	O

Patients	O
suffered	O
even	O
more	O
,	O
not	O
only	O
due	O
to	O
physical	O
discomfort	O
,	O
but	O
also	O
because	O
of	O
the	O
fear	O
of	O
isolation	O
and	O
death	O
away	O
from	O
family	B-SPEC
and	O
friends	O
.	O

TITLE	O
:	O
The	O
envelope	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
interacts	O
with	O
the	O
non	O
-	O
structural	O
protein	O
3	O
and	O
is	O
ubiquitinated	O
.	O

ABSTRACT	O
:	O
There	O
is	O
little	O
information	O
on	O
the	O
role	O
of	O
nitric	O
oxide	O
(	O
NO	O
)	O
in	O
innate	O
immunity	O
to	O
respiratory	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infections	O
.	O

This	O
is	O
the	O
first	O
in	O
vivo	O
study	O
to	O
report	O
the	O
synergistic	O
interaction	O
between	O
a	O
virus	B-SPEC
and	O
LTA	O
in	O
enhancing	O
the	O
severity	O
of	O
respiratory	O
disease	O
in	O
the	O
pig	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
relationship	O
between	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
)	O
and	O
canine	O
influenza	B-SPEC
virus	I-SPEC
(	O
CIV	B-SPEC
)	O
seropositivity	O
in	O
dogs	B-SPEC
in	O
Korea	O
was	O
examined	O
.	O

Nineteen	O
animals	B-SPEC
were	O
seropositive	O
for	O
CIV	B-SPEC
by	O
ELISA	O
out	O
of	O
the	O
385	O
samples	O
tested	O
.	O

The	O
migration	O
of	O
humans	B-SPEC
has	O
provided	O
the	O
route	O
of	O
spread	O
for	O
infectious	O
diseases	O
and	O
zoonoses	O
(	O
for	O
example	O
,	O
plague	O
,	O
yellow	O
fever	O
,	O
monkey	B-SPEC
pox	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
).	O

The	O
expression	O
of	O
stretch	O
-	O
responsive	O
genes	O
containing	O
putative	O
ATF3	O
cis	B-SPEC
-	O
regulatory	O
regions	O
was	O
significantly	O
altered	O
in	O
ATF3	O
-	O
deficient	O
mice	B-SPEC
.	O

TITLE	O
:	O
Rapid	O
differentiation	O
of	O
vaccine	O
strain	O
and	O
Chinese	O
field	O
strains	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
by	O
restriction	O
fragment	O
length	O
polymorphism	O
of	O
the	O
N	O
gene	O
.	O

These	O
findings	O
suggest	O
that	O
Chinese	O
strains	O
of	O
TGEV	B-SPEC
are	O
evolving	O
continuously	O
.	O

Human	B-SPEC
metapneumovirus	I-SPEC
,	O
human	B-SPEC
bocavirus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
,	O
KI	O
virus	B-SPEC
,	O
and	O
WU	O
virus	B-SPEC
were	O
detected	O
for	O
the	O
first	O
time	O
in	O
the	O
Philippines	O
;	O
Melaka	O
virus	B-SPEC
was	O
not	O
found	O
.	O

The	O
most	O
prominent	O
of	O
these	O
viruses	B-SPEC
is	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
which	O
causes	O
acute	O
respiratory	O
and	O
gastrointestinal	O
infection	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Fatalities	O
associated	O
with	O
the	O
2009	O
H1N1	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
in	O
New	O
York	O
city	O
.	O

ABSTRACT	O
:	O
We	O
report	O
a	O
complicated	O
case	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
from	O
severe	O
sepsis	B-SPEC
,	O
in	O
which	O
we	O
measured	O
the	O
ratio	O
of	O
physiologic	O
dead	O
space	O
to	O
tidal	O
volume	O
(	O
V	O
(	O
D	O
)/	O
V	O
(	O
T	O
))	O
with	O
volumetric	O
capnography	O
prior	O
to	O
,	O
during	O
,	O
and	O
after	O
therapy	O
with	O
human	B-SPEC
recombinant	O
activated	O
protein	O
C	O
.	O
Previous	O
studies	O
hypothesized	O
that	O
early	O
in	O
ARDS	O
,	O
elevated	O
V	O
(	O
D	O
)/	O
V	O
(	O
T	O
)	O
primarily	O
reflects	O
increased	O
alveolar	O
V	O
(	O
D	O
),	O
probably	O
caused	O
by	O
pronounced	O
thrombi	O
formation	O
in	O
the	O
pulmonary	O
microvasculature	O
.	O

TITLE	O
:	O
In	O
vitro	O
reconstitution	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
mRNA	O
cap	O
methylation	O
.	O

ABSTRACT	O
:	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
genome	O
expression	O
depends	O
on	O
the	O
synthesis	O
of	O
a	O
set	O
of	O
mRNAs	O
,	O
which	O
presumably	O
are	O
capped	O
at	O
their	O
5	O
'	O
end	O
and	O
direct	O
the	O
synthesis	O
of	O
all	O
viral	O
proteins	O
in	O
the	O
infected	O
cell	O
.	O

Furthermore	O
,	O
sensitive	O
in	O
vitro	O
inhibition	O
assays	O
of	O
both	O
activities	O
show	O
that	O
aurintricarboxylic	O
acid	O
,	O
active	O
in	O
SARS	O
-	O
CoV	O
infected	O
cells	O
,	O
targets	O
both	O
MTases	O
with	O
IC	O
(	O
50	O
)	O
values	O
in	O
the	O
micromolar	O
range	O
,	O
providing	O
a	O
validated	O
basis	O
for	O
anti	O
-	O
coronavirus	B-SPEC
drug	O
design	O
.	O

ABSTRACT	O
:	O
The	O
murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
induced	O
the	O
expression	O
of	O
type	O
I	O
interferon	O
(	O
alpha	O
/	O
beta	O
interferon	O
[	O
IFN	O
-	O
alpha	O
/	O
beta	O
])	O
in	O
mouse	B-SPEC
oligodendrocytic	O
N20	O
.	O
1	O
cells	O
.	O

TITLE	O
:	O
Exchange	O
of	O
the	O
coronavirus	B-SPEC
replicase	O
polyprotein	O
cleavage	O
sites	O
alters	O
protease	O
specificity	O
and	O
processing	O
.	O

We	O
demonstrate	O
that	O
exchange	O
of	O
CS1	O
and	O
/	O
or	O
CS2	O
with	O
the	O
CS3	O
p4	O
-	O
p1	O
amino	O
acids	O
in	O
engineered	O
MHV	B-SPEC
mutants	O
switches	O
specificity	O
from	O
PLP1	O
to	O
PLP2	O
at	O
CS2	O
,	O
but	O
not	O
at	O
CS1	O
,	O
and	O
results	O
in	O
altered	O
protein	O
processing	O
and	O
virus	B-SPEC
replication	O
.	O

Patient	O
with	O
AMAN	O
variant	O
of	O
GBS	O
after	O
severe	O
bilateral	O
pneumonia	O
and	O
ARDS	O
due	O
to	O
the	O
novel	O
pandemic	O
H1N1	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
is	O
presented	O
.	O

This	O
issue	O
of	O
Veterinaria	O
Italiana	O
presents	O
information	O
on	O
the	O
risk	O
of	O
animal	B-SPEC
diseases	O
;	O
their	O
impact	O
on	O
animals	B-SPEC
and	O
humans	B-SPEC
at	O
the	O
international	O
,	O
national	O
,	O
industry	O
,	O
and	O
societal	O
levels	O
;	O
and	O
the	O
responses	O
to	O
them	O
.	O

Lessons	O
learnt	O
following	O
major	O
crises	O
generated	O
by	O
the	O
emergence	O
of	O
zoonotic	O
diseases	O
,	O
such	O
as	O
bovine	B-SPEC
spongiform	O
encephalopathy	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
avian	B-SPEC
influenza	O
,	O
are	O
provided	O
.	O

TITLE	O
:	O
Influenza	O
A	O
(	O
pH1N1	O
)	O
infection	O
in	O
children	O
admitted	O
to	O
a	O
pediatric	O
intensive	O
care	O
unit	O
:	O
differences	O
with	O
other	O
respiratory	O
viruses	B-SPEC
.	O

None	O
of	O
them	O
had	O
bronchiolitis	O
on	O
PICU	B-SPEC
admission	O
;	O
12	O
(	O
40	O
%)	O
had	O
bilateral	O
pneumonia	O
;	O
15	O
(	O
50	O
%)	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
and	O
nine	O
(	O
30	O
%)	O
had	O
shock	O
.	O

When	O
both	O
groups	O
were	O
compared	O
,	O
patients	O
with	O
influenza	O
A	O
pH1N1	O
infection	O
were	O
older	O
;	O
pneumonia	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
shock	O
were	O
more	O
frequently	O
seen	O
at	O
the	O
time	O
of	O
PICU	B-SPEC
admission	O
,	O
although	O
length	O
of	O
stay	O
and	O
mortality	O
were	O
similar	O
.	O

ABSTRACT	O
:	O
A	O
multiplex	O
reverse	O
transcription	O
-	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
nPCR	O
)	O
method	O
was	O
developed	O
for	O
the	O
detection	O
and	O
differentiation	O
of	O
wild	O
-	O
type	O
and	O
vaccine	O
strains	O
of	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
).	O

Fish	B-SPEC
oil	O
-	O
containing	O
lipid	O
emulsions	O
have	O
been	O
used	O
in	O
parenteral	O
nutrition	O
in	O
adult	O
patients	O
post	O
-	O
surgery	O
(	O
mainly	O
gastrointestinal	O
).	O

Perioperative	O
administration	O
of	O
fish	B-SPEC
oil	O
may	O
be	O
superior	O
to	O
post	O
-	O
operative	O
.	O

Parenteral	O
fish	B-SPEC
oil	O
has	O
been	O
used	O
in	O
critically	O
ill	O
adults	O
.	O

A	O
formula	O
including	O
fish	B-SPEC
oil	O
,	O
borage	B-SPEC
oil	O
and	O
antioxidants	O
has	O
demonstrated	O
marked	O
benefits	O
on	O
gas	O
exchange	O
,	O
ventilation	O
requirement	O
,	O
new	O
organ	O
failures	O
,	O
ICU	O
stay	O
and	O
mortality	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
acute	O
lung	O
injury	O
or	O
severe	O
sepsis	B-SPEC
.	O

Either	O
of	O
the	O
two	O
mutations	O
was	O
proved	O
to	O
enhance	O
significantly	O
the	O
3CLpro	O
-	O
mediated	O
cleavage	O
efficiency	O
at	O
the	O
nsp15	O
-	O
16	O
site	O
with	O
a	O
P1	O
-	O
Asn	O
substitution	O
and	O
compensate	O
for	O
the	O
detrimental	O
effects	O
on	O
recovery	O
of	O
infectious	O
virus	B-SPEC
.	O

TITLE	O
:	O
Image	O
findings	O
of	O
patients	O
with	O
H1N1	O
virus	B-SPEC
pneumonia	O
and	O
acute	O
respiratory	O
failure	O
.	O

We	O
have	O
raised	O
polyclonal	O
and	O
monoclonal	O
antibodies	O
(	O
Abs	O
)	O
using	O
a	O
recombinant	O
form	O
of	O
the	O
SARS	O
virus	B-SPEC
nucleocapsid	O
protein	O
.	O

Further	O
,	O
the	O
limits	O
of	O
replication	O
infidelity	O
during	O
replication	O
of	O
large	O
RNA	O
genomes	O
and	O
how	O
decreased	O
fidelity	O
impacts	O
virus	B-SPEC
fitness	O
over	O
time	O
are	O
not	O
known	O
.	O

High	O
anti	O
-	O
TNF	O
-	O
alpha	O
activity	O
was	O
detected	O
in	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluids	O
,	O
peritoneal	O
lavage	O
fluids	O
and	O
serum	O
of	O
all	O
animals	B-SPEC
for	O
at	O
least	O
8h	O
post	O
-	O
inoculation	O
(	O
HPI	O
).	O

They	O
were	O
inoculated	O
intratracheally	O
with	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
(	O
PRCV	O
)	O
followed	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
24h	O
later	O
.	O

TNF	O
-	O
alpha	O
was	O
completely	O
neutralized	O
in	O
3	O
of	O
the	O
4	O
animals	B-SPEC
euthanized	O
at	O
4	O
HPI	O
and	O
significantly	O
lower	O
than	O
in	O
the	O
PRCV	O
-	O
LPS	O
group	O
at	O
all	O
times	O
.	O

Immunofluorescence	O
was	O
used	O
to	O
validate	O
changes	O
in	O
the	O
subcellular	O
localization	O
of	O
vimentin	O
and	O
myosin	O
VI	O
in	O
IBV	B-SPEC
-	O
infected	O
cells	O
.	O

Blood	O
cultures	O
grew	O
gram	O
-	O
positive	O
cocci	B-SPEC
,	O
which	O
later	O
proved	O
to	O
be	O
Streptococcus	B-SPEC
agalactiae	I-SPEC
(	O
GBS	O
).	O

Compounds	O
were	O
tested	O
in	O
cell	O
-	O
based	O
assays	O
against	O
viruses	B-SPEC
representative	O
of	O
:	O
i	O
)	O
two	O
of	O
the	O
three	O
genera	O
of	O
the	O
Flaviviridae	B-SPEC
family	B-SPEC
,	O
i	O
.	O
e	O
.	O
Pestiviruses	B-SPEC
and	O
Flaviviruses	B-SPEC
;	O
ii	O
)	O
other	O
RNA	O
virus	B-SPEC
families	O
,	O
such	O
as	O
Retroviridae	B-SPEC
,	O
Picornaviridae	B-SPEC
,	O
Paramyxoviridae	B-SPEC
,	O
Rhabdoviridae	B-SPEC
and	O
Reoviridae	B-SPEC
;	O
iii	O
)	O
two	O
DNA	O
virus	B-SPEC
families	O
(	O
Herpesviridae	B-SPEC
and	O
Poxviridae	B-SPEC
)	O
as	O
well	O
as	O
for	O
cytotoxicity	O
tests	O
,	O
run	O
in	O
parallel	O
with	O
antiviral	O
assays	O
,	O
against	O
MDBK	O
,	O
BHK	O
and	O
Vero	O
76	O
cells	O
.	O

However	O
,	O
our	O
understanding	O
of	O
the	O
pathophysiology	O
of	O
sepsis	B-SPEC
has	O
changed	O
since	O
the	O
concept	O
of	O
pattern	O
recognition	O
receptors	O
and	O
pathogen	O
-	O
associated	O
molecular	O
patterns	O
was	O
introduced	O
.	O

Phylogenetic	O
analysis	O
revealed	O
close	O
correlations	O
between	O
one	O
of	O
the	O
positive	O
samples	O
and	O
SARS	O
-	O
related	O
CoV	O
belonging	O
to	O
the	O
genus	B-SPEC
Betacoronavirus	B-SPEC
.	O

This	O
review	O
summarizes	O
the	O
recent	O
advances	O
in	O
viral	O
encoded	O
ion	O
channel	O
proteins	O
(	O
or	O
viroporins	O
),	O
including	O
PBCV	O
-	O
1	O
KcV	O
,	O
influenza	O
M2	O
,	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
Vpu	O
,	O
HCV	B-SPEC
p7	O
,	O
picornavirus	B-SPEC
2B	O
,	O
and	O
coronavirus	B-SPEC
E	O
and	O
3a	O
.	O

However	O
,	O
their	O
effect	O
against	O
cancer	B-SPEC
cells	O
is	O
not	O
well	O
explored	O
.	O

In	O
patients	O
with	O
relapse	O
/	O
remission	O
(	O
R	O
/	O
R	O
)	O
MS	O
we	O
have	O
found	O
high	O
loads	O
of	O
VZV	B-SPEC
DNA	O
in	O
lymphocytes	O
and	O
in	O
cerebrospinal	O
fluid	O
(	O
CSF	O
),	O
as	O
well	O
as	O
abundant	O
viral	O
particles	O
in	O
CSF	O
visualized	O
by	O
electron	O
microscopy	O
at	O
the	O
time	O
of	O
relapse	O
.	O

RESULTS	O
:	O
VZV	B-SPEC
DNA	O
was	O
found	O
in	O
the	O
CSF	O
from	O
65	O
%	O
of	O
cases	O
with	O
progressive	O
MS	O
-	O
and	O
VZV	B-SPEC
-	O
like	O
viral	O
particles	O
were	O
found	O
in	O
30	O
%	O
of	O
these	O
patients	O
.	O

CONCLUSIONS	O
:	O
Similar	O
to	O
findings	O
in	O
patients	O
with	O
R	O
/	O
R	O
MS	O
,	O
VZV	B-SPEC
might	O
be	O
associated	O
to	O
progressive	O
MS	O
,	O
but	O
in	O
minor	O
quantity	O
.	O

ABSTRACT	O
:	O
Recently	O
,	O
a	O
coronavirus	B-SPEC
strain	O
(	O
179	O
/	O
07	O
-	O
11	O
)	O
was	O
isolated	O
from	O
water	B-SPEC
buffalo	I-SPEC
(	O
Bubalus	B-SPEC
bubalis	I-SPEC
)	O
and	O
the	O
virus	B-SPEC
which	O
displayed	O
a	O
strict	O
genetic	O
and	O
biological	O
relatedness	O
with	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
was	O
referred	O
to	O
as	O
bubaline	O
coronavirus	B-SPEC
(	O
BuCoV	O
).	O

In	O
this	O
study	O
we	O
investigated	O
the	O
role	O
of	O
the	O
UPS	O
in	O
different	O
steps	O
of	O
the	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infection	O
cycle	O
.	O

Stress	O
-	O
induced	O
phosphorylation	O
of	O
eukaryotic	O
translation	O
initiation	O
factor	O
2alpha	O
(	O
eIF2alpha	O
)	O
generally	O
results	O
in	O
impaired	O
initiation	O
of	O
protein	O
synthesis	O
,	O
but	O
the	O
sensitivity	O
of	O
MHV	B-SPEC
infection	O
to	O
proteasome	O
inhibitors	O
was	O
unchanged	O
in	O
cells	O
lacking	O
a	O
phosphorylatable	O
eIF2alpha	O
.	O

MHV	B-SPEC
infection	O
was	O
affected	O
not	O
only	O
by	O
inhibition	O
of	O
the	O
proteasome	O
but	O
also	O
by	O
interfering	O
with	O
protein	O
ubiquitination	O
.	O

By	O
analogy	O
to	O
other	O
viral	O
models	O
,	O
HCV	B-SPEC
may	O
induce	O
DMVs	O
by	O
activating	O
the	O
autophagy	O
pathway	O
.	O

More	O
detailed	O
characterization	O
of	O
these	O
virus	B-SPEC
-	O
cell	O
interactions	O
may	O
facilitate	O
the	O
development	O
of	O
new	O
treatments	O
active	O
against	O
HCV	B-SPEC
and	O
other	O
RNA	O
viruses	B-SPEC
that	O
are	O
dependent	O
on	O
newly	O
synthesized	O
cellular	O
membranes	O
for	O
replication	O
.	O

TITLE	O
:	O
Live	O
attenuated	O
Salmonella	B-SPEC
enterica	I-SPEC
serovar	O
Typhimurium	O
expressing	O
swine	B-SPEC
interferon	O
-	O
alpha	O
has	O
antiviral	O
activity	O
and	O
alleviates	O
clinical	O
signs	O
induced	O
by	O
infection	O
with	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
in	O
piglets	O
.	O

In	O
the	O
Swedish	O
beef	O
cattle	B-SPEC
population	O
however	O
,	O
no	O
investigations	O
have	O
yet	O
been	O
performed	O
regarding	O
the	O
prevalence	O
and	O
geographical	O
distribution	O
of	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
.	O

Another	O
area	O
in	O
middle	O
-	O
west	O
Sweden	O
(	O
Värmland	O
-	O
Dalarna	O
)	O
had	O
also	O
a	O
lower	O
prevalence	O
for	O
BRSV	B-SPEC
(	O
7	O
.	O
9	O
%).	O

CONCLUSIONS	O
:	O
These	O
results	O
form	O
a	O
basis	O
for	O
further	O
investigations	O
of	O
between	O
-	O
herds	O
dynamics	O
and	O
risk	O
factors	O
for	O
these	O
infections	O
in	O
order	B-SPEC
to	O
design	O
effective	O
control	O
strategies	O
.	O

Overall	O
,	O
the	O
present	O
data	O
provide	O
evidence	O
for	O
molecular	O
mechanisms	O
involving	O
the	O
concerted	O
actions	O
of	O
SUD	O
-	O
M	O
and	O
SUD	O
-	O
C	O
,	O
which	O
result	O
in	O
specific	O
RNA	O
binding	O
that	O
might	O
be	O
unique	O
to	O
the	O
SUD	O
and	O
,	O
thus	O
,	O
to	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
develop	O
a	O
dose	O
-	O
response	O
model	O
for	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
the	O
pooled	O
data	O
sets	O
for	O
infection	O
of	O
transgenic	B-SPEC
mice	I-SPEC
susceptible	O
to	O
SARS	O
-	O
CoV	O
and	O
infection	O
of	O
mice	B-SPEC
with	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
1	O
,	O
which	O
may	O
be	O
a	O
clinically	O
relevant	O
model	O
of	O
SARS	O
,	O
were	O
fit	O
to	O
beta	O
-	O
Poisson	O
and	O
exponential	O
models	O
with	O
the	O
maximum	O
likelihood	O
method	O
.	O

ABSTRACT	O
:	O
The	O
spectrum	O
of	O
the	O
clinical	O
presentation	O
and	O
severity	O
of	O
malaria	O
infections	O
is	O
broad	O
,	O
ranging	O
from	O
uncomplicated	O
febrile	O
illness	O
to	O
severe	O
forms	O
of	O
disease	O
such	O
as	O
cerebral	O
malaria	O
(	O
CM	O
),	O
acute	O
lung	O
injury	O
(	O
ALI	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
pregnancy	O
-	O
associated	O
malaria	O
(	O
PAM	O
)	O
or	O
severe	O
anemia	B-SPEC
(	O
SA	O
).	O

TITLE	O
:	O
Elastase	O
-	O
mediated	O
activation	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
spike	O
protein	O
at	O
discrete	O
sites	O
within	O
the	O
S2	O
domain	O
.	O

ABSTRACT	O
:	O
Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
in	O
Alaska	O
Native	O
children	O
from	O
the	O
Yukon	O
Kuskokwim	O
(	O
YK	O
)	O
Delta	O
is	O
associated	O
with	O
a	O
hospitalization	O
rate	O
five	O
times	O
higher	O
than	O
that	O
reported	O
for	O
the	O
general	O
US	O
child	O
population	O
.	O

Polymerase	O
chain	O
reaction	O
detection	O
of	O
viruses	B-SPEC
was	O
performed	O
on	O
nasopharyngeal	O
samples	O
.	O

TITLE	O
:	O
Expression	O
,	O
crystallization	O
and	O
preliminary	O
crystallographic	O
study	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
nucleocapsid	O
protein	O
C	O
-	O
terminal	O
domain	O
.	O

The	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
,	O
one	O
of	O
the	O
structural	O
proteins	O
,	O
interacts	O
with	O
the	O
30	O
.	O
4	O
kb	O
virus	B-SPEC
genomic	O
RNA	O
to	O
form	O
the	O
helical	O
nucleocapsid	O
and	O
associates	O
with	O
the	O
membrane	O
glycoprotein	O
via	O
its	O
C	O
-	O
terminus	O
to	O
stabilize	O
virion	O
assembly	O
.	O

IBV	B-SPEC
encodes	O
15	O
nonstructural	O
proteins	O
(	O
nsp2	O
-	O
nsp16	O
)	O
which	O
play	O
crucial	O
roles	O
in	O
RNA	O
transcription	O
and	O
genome	O
replication	O
.	O

Our	O
result	O
shows	O
that	O
herds	O
that	O
were	O
antibody	O
positive	O
to	O
BCV	B-SPEC
and	O
/	O
or	O
BRSV	B-SPEC
had	O
a	O
higher	O
BMSCC	O
compared	O
with	O
herds	O
negative	O
to	O
BCV	B-SPEC
and	O
BRSV	B-SPEC
.	O

The	O
results	O
present	O
the	O
first	O
standard	O
proteomic	O
profile	O
of	O
IBV	B-SPEC
and	O
may	O
facilitate	O
the	O
understanding	O
of	O
the	O
pathogenic	O
mechanisms	O
.	O

ABSTRACT	O
:	O
Multiple	O
sclerosis	O
(	O
MS	O
)	O
is	O
a	O
human	B-SPEC
demyelinating	O
disease	O
characterized	O
by	O
multifocal	O
regions	O
of	O
inflammation	O
,	O
progressive	O
myelin	O
loss	O
within	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
),	O
and	O
eventual	O
failure	O
to	O
remyelinate	O
damaged	O
axons	O
.	O

Infection	O
of	O
the	O
mouse	B-SPEC
CNS	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
results	O
in	O
an	O
immune	O
-	O
mediated	O
demyelinating	O
disease	O
with	O
clinical	O
and	O
histologic	O
similarities	O
to	O
MS	O
.	O

PCLSs	O
should	O
also	O
be	O
a	O
valuable	O
tool	O
for	O
investigation	O
of	O
other	O
respiratory	O
pathogens	O
,	O
such	O
as	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
.	O

Here	O
,	O
we	O
show	O
that	O
,	O
in	O
apparent	O
contrast	O
to	O
human	B-SPEC
and	O
ungulate	O
host	O
range	O
variants	O
of	O
Betacoronavirus	B-SPEC
-	O
1	O
,	O
murine	B-SPEC
coronaviruses	O
actually	O
bind	O
to	O
O	O
-	O
Ac	O
-	O
Sias	O
via	O
HE	O
exclusively	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoV	O
),	O
including	O
SARS	O
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
are	O
enveloped	O
RNA	O
viruses	B-SPEC
that	O
induce	O
formation	O
of	O
double	O
-	O
membrane	O
vesicles	O
(	O
DMVs	O
)	O
and	O
target	O
their	O
replication	O
and	O
transcription	O
complexes	O
(	O
RTCs	O
)	O
on	O
the	O
DMV	O
-	O
limiting	O
membranes	O
.	O

TITLE	O
:	O
Molecular	O
epidemiology	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
China	O
.	O

Chinese	O
PEDV	B-SPEC
field	O
strains	O
(	O
excluding	O
CH	O
/	O
GSJIII	O
/	O
07	O
)	O
have	O
a	O
close	O
phylogenetic	O
relationship	O
to	O
Korean	O
strains	O
and	O
are	O
genetically	O
different	O
from	O
the	O
PEDV	B-SPEC
vaccine	O
strains	O
.	O

Incubation	O
of	O
the	O
GA08	O
strain	O
of	O
IBV	B-SPEC
at	O
56	O
degrees	O
C	O
and	O
passage	O
in	O
embryonated	O
eggs	O
was	O
used	O
as	O
a	O
method	O
to	O
fast	O
track	O
the	O
attenuation	O
process	O
.	O

Among	O
the	O
CCoV	O
-	O
positive	O
dogs	B-SPEC
,	O
65	O
.	O
5	O
%	O
and	O
72	O
.	O
7	O
%	O
showed	O
to	O
be	O
positive	O
for	O
CCoV	O
types	O
I	O
and	O
II	O
,	O
respectively	O
,	O
and	O
simultaneous	O
detection	O
rate	O
of	O
both	O
types	O
was	O
high	O
at	O
40	O
.	O
0	O
%.	O

These	O
findings	O
indicate	O
that	O
CCoV	O
type	O
I	O
and	O
TGEV	B-SPEC
-	O
like	O
CCoV	O
are	O
already	O
circulating	O
in	O
Japan	O
,	O
though	O
no	O
reports	O
have	O
been	O
presented	O
to	O
date	O
.	O

ABSTRACT	O
:	O
In	O
Normandy	O
(	O
France	O
),	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
hRSV	B-SPEC
)	O
was	O
detected	O
in	O
64	O
.	O
1	O
%	O
of	O
acute	O
bronchiolitis	O
in	O
hospitalized	O
children	O
,	O
rhinovirus	B-SPEC
in	O
26	O
.	O
8	O
%,	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
in	O
7	O
.	O
6	O
%,	O
and	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
)	O
in	O
3	O
.	O
4	O
%.	O

During	O
virus	B-SPEC
replication	O
,	O
a	O
3	O
'	O
coterminal	O
nested	O
set	O
of	O
five	O
to	O
eight	O
subgenomic	O
(	O
sg	O
)	O
mRNAs	O
are	O
made	O
that	O
are	O
also	O
5	O
'	O
coterminal	O
with	O
the	O
genome	O
,	O
because	O
they	O
carry	O
the	O
genomic	O
leader	O
as	O
the	O
result	O
of	O
discontinuous	O
transcription	O
at	O
intergenic	O
donor	O
signals	O
during	O
(-)-	O
strand	O
synthesis	O
when	O
templates	O
for	O
sgmRNA	O
synthesis	O
are	O
made	O
.	O

ABSTRACT	O
:	O
This	O
study	O
investigated	O
the	O
anticipated	O
vaccination	O
rate	O
against	O
pandemic	O
human	B-SPEC
influenza	O
A	O
(	O
H1N1	O
)	O
2009	O
in	O
the	O
health	O
care	O
setting	O
.	O

Further	O
,	O
the	O
alteration	O
of	O
several	O
key	O
residues	O
either	O
decreased	O
or	O
enhanced	O
bat	B-SPEC
ACE2	O
receptor	O
efficiency	O
,	O
as	O
predicted	O
from	O
a	O
structural	O
modeling	O
study	O
of	O
the	O
different	O
bat	B-SPEC
ACE2	O
molecules	O
.	O

TITLE	O
:	O
Identifying	O
the	O
probable	O
timing	O
and	O
setting	O
of	O
respiratory	O
virus	B-SPEC
infections	O
.	O

We	O
used	O
the	O
incubation	O
period	O
of	O
9	O
respiratory	O
viruses	B-SPEC
to	O
derive	O
decision	O
rules	O
for	O
distinguishing	O
between	O
community	O
-	O
and	O
hospital	O
-	O
acquired	O
infection	O
.	O

We	O
report	O
a	O
case	O
of	O
bilateral	O
pneumonia	O
in	O
an	O
80	O
year	O
old	O
caucasian	O
man	B-SPEC
who	O
developed	O
very	O
rapidly	O
an	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
with	O
a	O
PaO2	O
/	O
FiO2	O
ratio	O
of	O
55	O
,	O
requiring	O
mechanical	O
ventilation	O
and	O
adrenergic	O
support	O
.	O

A	O
few	O
cases	O
of	O
acute	O
pneumonia	O
requiring	O
mechanical	O
ventilation	O
due	O
to	O
toxocara	B-SPEC
have	O
been	O
published	O
but	O
this	O
is	O
,	O
to	O
our	O
knowledge	O
,	O
is	O
the	O
first	O
reported	O
case	O
of	O
ARDS	O
with	O
multi	O
-	O
organ	O
failure	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
interactions	O
between	O
MBL	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
(	O
S	O
)	O
glycoprotein	O
(	O
SARS	O
-	O
S	O
).	O

MBL	O
was	O
found	O
to	O
selectively	O
bind	O
to	O
retroviral	B-SPEC
particles	O
pseudotyped	O
with	O
SARS	O
-	O
S	O
.	O
Unlike	O
several	O
other	O
viral	O
envelopes	O
to	O
which	O
MBL	O
can	O
bind	O
,	O
both	O
recombinant	O
and	O
plasma	O
-	O
derived	O
human	B-SPEC
MBL	O
directly	O
inhibited	O
SARS	O
-	O
S	O
-	O
mediated	O
viral	O
infection	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
3	O
'	O
terminal	O
7	O
.	O
2	O
kb	O
of	O
the	O
genome	O
of	O
a	O
recently	O
isolated	O
variant	O
of	O
IBV	B-SPEC
(	O
N1	O
/	O
03	O
)	O
was	O
sequenced	O
and	O
compared	O
with	O
the	O
sequences	O
of	O
classical	O
and	O
novel	O
strains	O
of	O
IBV	B-SPEC
,	O
the	O
two	O
main	O
groups	O
of	O
these	O
viruses	B-SPEC
in	O
Australia	O
.	O

However	O
,	O
to	O
realize	O
this	O
bio	O
-	O
medical	O
potential	O
,	O
a	O
high	O
density	O
single	O
nucleotide	O
polymorphism	O
(	O
SNP	O
)	O
map	O
is	O
required	O
in	O
order	B-SPEC
to	O
accomplish	O
disease	O
and	O
phenotype	O
association	O
discovery	O
.	O

The	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
mediates	O
virus	B-SPEC
entry	O
by	O
binding	O
cellular	O
receptors	O
and	O
inducing	O
fusion	O
between	O
the	O
viral	O
envelope	O
and	O
the	O
host	O
cell	O
membrane	O
.	O

This	O
study	O
evaluated	O
the	O
effect	O
of	O
matching	O
/	O
mismatching	O
vaccine	O
strains	O
,	O
type	O
/	O
subtype	O
pattern	O
changes	O
in	O
Taiwan	O
'	O
s	O
influenza	B-SPEC
viruses	I-SPEC
,	O
and	O
the	O
impact	O
of	O
post	O
-	O
SARS	O
(	O
severe	O
acute	O
respiratory	O
syndrome	O
)	O
public	O
health	O
efforts	O
on	O
excess	O
influenza	O
-	O
associated	O
mortalities	O
among	O
the	O
elderly	O
.	O

Second	O
ACE2	O
was	O
identified	O
as	O
an	O
essential	O
receptor	O
for	O
the	O
SARS	O
coronavirus	B-SPEC
that	O
causes	O
severe	O
acute	O
lung	O
failure	O
.	O

Special	O
attention	O
has	O
been	O
provided	O
to	O
the	O
use	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
as	O
vector	O
for	O
the	O
expression	O
of	O
PRRSV	B-SPEC
antigens	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
fatal	O
disease	O
in	O
domestic	O
and	O
nondomestic	O
felids	B-SPEC
caused	O
by	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
).	O

When	O
the	O
amount	O
of	O
virus	B-SPEC
preinoculated	O
into	O
the	O
test	O
cells	O
was	O
increased	O
to	O
mimic	O
the	O
high	O
viral	O
load	O
present	O
in	O
the	O
target	O
cells	O
of	O
FIP	O
cats	B-SPEC
,	O
GNA	O
and	O
nelfinavir	O
by	O
themselves	O
lost	O
their	O
inhibitory	O
effect	O
.	O

ABSTRACT	O
:	O
The	O
N	O
-	O
terminal	O
domain	O
of	O
nucleocapsid	O
protein	O
from	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
N	O
-	O
NTD	O
)	O
mostly	O
contains	O
positively	O
charged	O
residues	O
and	O
has	O
been	O
identified	O
as	O
being	O
responsible	O
for	O
RNA	O
binding	O
during	O
ribonucleocapsid	O
formation	O
in	O
the	O
coronavirus	B-SPEC
.	O

The	O
predominant	O
IBV	B-SPEC
phenotype	O
contained	O
in	O
the	O
vaccine	O
(	O
before	O
inoculation	O
)	O
became	O
a	O
minor	O
or	O
nondetectable	O
population	O
at	O
all	O
times	O
in	O
all	O
tissues	O
after	O
replication	O
in	O
the	O
majority	O
of	O
the	O
chickens	B-SPEC
,	O
corroborating	O
our	O
previous	O
findings	O
.	O

TITLE	O
:	O
Molecular	O
epidemiology	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
in	O
Brazil	O
from	O
2007	O
to	O
2008	O
in	O
breeders	O
,	O
broilers	O
,	O
and	O
layers	O
.	O

ABSTRACT	O
:	O
Multiple	O
lineages	O
of	O
Brazilian	O
strains	O
from	O
2007	O
to	O
2008	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
detected	O
in	O
flocks	O
of	O
breeders	O
,	O
broilers	O
,	O
and	O
layers	O
.	O

ABSTRACT	O
:	O
A	O
dysregulated	O
innate	O
immune	O
response	O
and	O
exuberant	O
cytokine	O
/	O
chemokine	O
expression	O
are	O
believed	O
to	O
be	O
critical	O
factors	O
in	O
the	O
pathogenesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
caused	O
by	O
a	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Identification	O
of	O
GBV	O
-	O
D	O
,	O
a	O
novel	O
GB	O
-	O
like	O
flavivirus	B-SPEC
from	O
old	O
world	O
frugivorous	O
bats	B-SPEC
(	O
Pteropus	B-SPEC
giganteus	I-SPEC
)	O
in	O
Bangladesh	O
.	O

TITLE	O
:	O
Bovine	B-SPEC
respiratory	O
coronavirus	B-SPEC
.	O

This	O
review	O
focuses	O
on	O
recent	O
studies	O
using	O
either	O
mouse	B-SPEC
neural	O
stem	O
cells	O
(	O
NSCs	O
)	O
or	O
human	B-SPEC
oligodendrocyte	O
progenitor	O
cells	O
(	O
OPCs	O
)	O
derived	O
from	O
human	B-SPEC
embryonic	O
stem	O
cell	O
(	O
hESC	O
)	O
to	O
promote	O
remyelination	O
in	O
mice	B-SPEC
persistently	O
infected	O
with	O
MHV	B-SPEC
.	O

BAL	O
samples	O
also	O
underwent	O
conventional	O
testing	O
(	O
direct	O
immunoflorescence	O
and	O
viral	O
culture	O
)	O
for	O
respiratory	O
virus	B-SPEC
at	O
the	O
clinician	O
'	O
s	O
discretion	O
.	O

Clinical	O
characteristics	O
alone	O
were	O
insufficient	O
to	O
separate	O
patients	O
with	O
and	O
without	O
respiratory	O
virus	B-SPEC
.	O

The	O
presence	O
of	O
respiratory	O
virus	B-SPEC
was	O
associated	O
with	O
increased	O
levels	O
of	O
interferon	O
gamma	O
-	O
inducible	O
protein	O
10	O
(	O
IP	O
-	O
10	O
)	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
eotaxin	O
-	O
1	O
(	O
p	O
=	O
0	O
.	O
017	O
)	O
in	O
BAL	O
.	O

ABSTRACT	O
:	O
Food	O
-	O
and	O
waterborne	O
viruses	B-SPEC
pose	O
serious	O
health	O
risks	O
to	O
humans	B-SPEC
and	O
were	O
associated	O
with	O
many	O
outbreaks	O
worldwide	O
.	O

The	O
virus	B-SPEC
detection	O
limit	O
by	O
SERS	O
using	O
gold	O
substrates	O
reached	O
a	O
titer	O
of	O
10	O
(	O
2	O
).	O

Finally	O
,	O
the	O
RNA	O
suppression	O
property	O
and	O
the	O
enhancement	O
of	O
heterologous	O
replicon	O
activity	O
by	O
the	O
7a	O
protein	O
were	O
confirmed	O
for	O
animal	B-SPEC
cell	O
lines	O
.	O

TITLE	O
:	O
A	O
simple	O
procedure	O
for	O
the	O
derivation	O
of	O
electron	O
density	O
based	O
surfaces	O
of	O
drug	O
-	O
receptor	O
complexes	O
from	O
a	O
combination	O
of	O
X	O
-	O
ray	B-SPEC
data	O
and	O
theoretical	O
calculations	O
.	O

The	O
combination	O
of	O
experimental	O
X	O
-	O
ray	B-SPEC
structural	O
information	O
and	O
aspherical	O
atomic	O
electron	O
density	O
data	O
from	O
theoretical	O
calculations	O
resulted	O
in	O
properties	O
like	O
the	O
electrostatic	O
potential	O
and	O
the	O
Hirshfeld	O
surface	O
which	O
allowed	O
a	O
study	O
of	O
electronic	O
complementarity	O
and	O
the	O
identification	O
of	O
sites	O
and	O
strengths	O
of	O
drug	O
-	O
receptor	O
interactions	O
.	O

In	O
the	O
second	O
example	O
,	O
the	O
interaction	O
of	O
epoxide	O
inhibitors	O
with	O
the	O
main	O
protease	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
was	O
investigated	O
.	O

A	O
locked	O
nucleic	O
acid	O
probe	O
-	O
based	O
reverse	O
transcription	O
real	O
-	O
time	O
PCR	O
test	O
was	O
designed	O
and	O
used	O
to	O
detect	O
the	O
IBV	B-SPEC
strain	O
N1	O
/	O
88	O
from	O
the	O
oviduct	O
and	O
feces	O
of	O
unvaccinated	O
and	O
vaccinated	O
laying	O
hens	O
.	O

TITLE	O
:	O
Influenza	B-SPEC
virus	I-SPEC
variation	O
in	O
susceptibility	O
to	O
inactivation	O
by	O
pomegranate	O
polyphenols	O
is	O
determined	O
by	O
envelope	O
glycoproteins	O
.	O

Despite	O
increased	O
inflammatory	O
cells	O
and	O
markers	O
of	O
inflammation	O
,	O
survival	O
in	O
Sftpd	O
(-/-)	O
mice	B-SPEC
after	O
indirect	O
lung	O
injury	O
was	O
paradoxically	O
increased	O
.	O

Therefore	O
,	O
interaction	O
of	O
a	O
human	B-SPEC
respiratory	O
coronavirus	B-SPEC
with	O
the	O
central	O
nervous	O
system	O
may	O
modulate	O
virus	B-SPEC
and	O
host	O
factors	O
resulting	O
in	O
a	O
modified	O
neuropathogenesis	O
in	O
genetically	O
susceptible	O
individuals	O
.	O

ABSTRACT	O
:	O
Four	O
truncated	O
porcine	B-SPEC
aminopeptidase	O
N	O
(	O
pAPN	O
,	O
a	O
cellular	O
receptor	O
for	O
porcine	B-SPEC
coronaviruses	O
)	O
proteins	O
were	O
expressed	O
in	O
prokaryotic	O
cells	O
.	O

The	O
inhibitory	O
effect	O
of	O
these	O
proteins	O
to	O
cell	O
infection	O
by	O
TGEV	B-SPEC
was	O
analyzed	O
using	O
plaque	O
assays	O
.	O

A	O
monoclonal	O
gammopathy	O
occurred	O
in	O
four	O
cats	B-SPEC
;	O
one	O
with	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
one	O
with	O
lymphoma	O
and	O
two	O
cases	O
of	O
splenic	O
plasmacytoma	O
(	O
one	O
suspected	O
,	O
one	O
confirmed	O
).	O

The	O
route	O
of	O
introduction	O
of	O
BVDV	B-SPEC
-	I-SPEC
2	I-SPEC
into	O
Israel	O
could	O
not	O
be	O
elucidated	O
.	O

To	O
learn	O
about	O
the	O
functions	O
of	O
N	O
protein	O
domains	O
in	O
the	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
we	O
replaced	O
the	O
MHV	B-SPEC
N	O
gene	O
with	O
its	O
counterpart	O
from	O
the	O
closely	O
related	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
).	O

Histopathological	O
changes	O
in	O
lungs	O
from	O
2	O
of	O
these	O
seals	B-SPEC
included	O
a	O
necrotizing	O
lymphocytic	O
and	O
histocytic	O
lobar	O
pneumonia	O
with	O
intra	O
-	O
lesional	O
bacteria	B-SPEC
.	O

A	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
was	O
detected	O
in	O
archived	O
tissues	O
from	O
1	O
of	O
the	O
5	O
seals	B-SPEC
via	O
a	O
degenerate	O
PCR	O
for	O
nidoviral	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
),	O
and	O
was	O
subsequently	O
confirmed	O
via	O
specific	O
PCR	O
.	O

The	O
virus	B-SPEC
is	O
tentatively	O
named	O
harbor	B-SPEC
seal	I-SPEC
coronavirus	B-SPEC
(	O
HSCoV	O
).	O

TITLE	O
:	O
Mixed	O
infections	O
with	O
Chlamydia	B-SPEC
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
-	O
a	O
new	O
in	O
vitro	O
model	O
of	O
chlamydial	O
persistence	O
.	O

Dual	O
infections	O
with	O
Chlamydia	B-SPEC
abortus	I-SPEC
revealed	O
a	O
heterogenous	O
mix	O
of	O
inclusion	O
types	O
including	O
small	O
inclusions	O
consisting	O
of	O
aberrant	O
bodies	O
(	O
ABs	O
),	O
medium	O
-	O
sized	O
inclusions	O
consisting	O
of	O
ABs	O
and	O
reticulate	O
bodies	O
and	O
normal	O
inclusions	O
.	O

In	O
the	O
present	O
study	O
we	O
confirm	O
that	O
PEDV	B-SPEC
co	O
-	O
infection	O
alters	O
the	O
developmental	O
cycle	O
of	O
member	O
species	B-SPEC
of	O
the	O
family	B-SPEC
Chlamydiaceae	I-SPEC
,	O
in	O
a	O
similar	O
manner	O
to	O
other	O
well	O
-	O
described	O
persistence	O
induction	O
methods	O
.	O

FIPV	O
arises	O
from	O
FECV	B-SPEC
by	O
mutation	O
.	O

Hence	O
,	O
the	O
aim	O
of	O
the	O
present	O
work	O
was	O
the	O
detailed	O
study	O
of	O
the	O
epidemiologically	O
most	O
relevant	O
viruses	B-SPEC
,	O
the	O
avirulent	O
serotype	O
I	O
viruses	B-SPEC
.	O

Faecal	O
virus	B-SPEC
,	O
i	O
.	O
e	O
.	O
genomic	O
RNA	O
,	O
was	O
detected	O
during	O
persistent	O
FECV	B-SPEC
infection	O
only	O
in	O
the	O
large	O
intestine	O
,	O
downstream	O
of	O
the	O
appendix	O
,	O
and	O
could	O
occasionally	O
be	O
observed	O
also	O
in	O
the	O
blood	O
.	O

This	O
short	O
review	O
describes	O
the	O
pathologic	O
features	O
of	O
SARS	O
in	O
relation	O
to	O
their	O
clinical	O
presentation	O
in	O
human	B-SPEC
cases	O
.	O

It	O
also	O
looks	O
at	O
animal	B-SPEC
susceptibility	O
after	O
experimental	O
infection	O
,	O
animal	B-SPEC
models	O
of	O
SARS	O
,	O
and	O
the	O
pathogenesis	O
of	O
this	O
disease	O
.	O

TITLE	O
:	O
A	O
new	O
cistron	O
in	O
the	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
replicase	O
gene	O
.	O

Like	O
its	O
PL2	O
(	O
pro	O
)	O
paralogs	O
from	O
several	O
coronaviruses	O
,	O
TGEV	B-SPEC
PL1	O
(	O
pro	O
)	O
was	O
also	O
found	O
to	O
have	O
deubiquitinating	O
activity	O
in	O
an	O
in	O
vitro	O
cleavage	O
assay	O
,	O
implicating	O
it	O
in	O
counteracting	O
ubiquitin	O
-	O
regulated	O
host	O
cell	O
pathways	O
,	O
likely	O
including	O
innate	O
immune	O
responses	O
.	O

ABSTRACT	O
:	O
Serum	O
cell	O
-	O
free	O
DNA	O
concentrations	O
have	O
been	O
reported	O
to	O
increase	O
in	O
many	O
acute	O
diseases	O
as	O
well	O
as	O
in	O
some	O
chronic	O
conditions	O
such	O
as	O
cancer	B-SPEC
and	O
autoimmune	O
diseases	O
.	O

ABSTRACT	O
:	O
The	O
species	B-SPEC
barrier	O
is	O
not	O
perfect	O
for	O
Influenza	O
A	O
and	O
numerous	O
transmissions	O
of	O
the	O
virus	B-SPEC
from	O
pigs	B-SPEC
or	O
poultry	O
to	O
humans	B-SPEC
have	O
been	O
described	O
these	O
years	O
.	O

Sporadic	O
human	B-SPEC
cases	O
were	O
described	O
in	O
direct	O
contact	O
with	O
diseased	O
chicken	B-SPEC
or	O
other	O
poultry	O
.	O

The	O
strong	O
pathogenicity	O
of	O
the	O
virus	B-SPEC
is	O
still	O
not	O
completely	O
explained	O
,	O
but	O
the	O
deep	O
location	O
of	O
infection	O
in	O
the	O
lungs	O
and	O
the	O
deregulation	O
of	O
cytokine	O
production	O
by	O
the	O
target	O
cells	O
,	O
particularly	O
macrophages	O
,	O
may	O
be	O
part	O
of	O
the	O
explanation	O
.	O

ABSTRACT	O
:	O
Forsythoside	O
A	O
is	O
a	O
polyphenolic	O
constituent	O
of	O
the	O
fruits	O
of	O
Forsythia	B-SPEC
suspensa	I-SPEC
Vahl	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
effects	O
of	O
forsythoside	O
A	O
on	O
cell	O
infection	O
by	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
were	O
assessed	O
.	O

Fruit	O
bats	B-SPEC
infected	O
with	O
virus	B-SPEC
did	O
not	O
show	O
clinical	O
signs	O
of	O
infection	O
.	O

This	O
coronavirus	B-SPEC
caused	O
an	O
enteric	O
disease	O
called	O
epizootic	O
catarrhal	O
enteritis	O
(	O
ECE	O
).	O

ABSTRACT	O
:	O
Bats	B-SPEC
may	O
host	O
emerging	O
viruses	B-SPEC
,	O
including	O
coronaviruses	O
(	O
CoV	O
).	O

All	O
three	O
clades	O
present	O
in	O
Miniopterus	B-SPEC
bats	B-SPEC
in	O
China	O
(	O
HKU7	O
,	O
HKU8	O
,	O
and	O
1A	O
related	O
)	O
were	O
also	O
present	O
in	O
European	O
Miniopterus	B-SPEC
bats	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
LAMP	O
)	O
assay	O
was	O
developed	O
specifically	O
for	O
detection	O
and	O
differentiation	O
of	O
pseudorabies	B-SPEC
virus	I-SPEC
(	O
PRV	B-SPEC
).	O

In	O
control	O
lungs	O
,	O
reduction	O
in	O
VT	O
from	O
10	O
to	O
6	O
ml	O
/	O
kg	O
reduced	O
the	O
DeltaPP	O
reaction	O
by	O
40	O
%,	O
although	O
it	O
remained	O
a	O
statistically	O
valid	O
indicator	B-SPEC
of	O
hypovolemia	O
regardless	O
of	O
the	O
RR	O
value	O
.	O

ABSTRACT	O
:	O
Information	O
about	O
the	O
electrophoretic	O
distribution	O
of	O
CK	O
-	O
MM	O
,	O
CK	O
-	O
MB	O
,	O
and	O
CK	O
-	O
BB	O
,	O
serum	O
creatine	O
kinase	O
(	O
CK	O
)	O
isoenzymes	O
that	O
are	O
indicators	O
of	O
skeletal	O
muscle	O
,	O
cardiac	O
muscle	O
,	O
and	O
brain	O
lesions	O
,	O
respectively	O
,	O
and	O
CK	O
macroenzymes	O
(	O
macro	O
-	O
CK1	O
and	O
macro	O
-	O
CK2	O
)	O
in	O
dogs	B-SPEC
and	O
cats	B-SPEC
with	O
and	O
without	O
central	O
neurologic	O
disease	O
is	O
scant	O
and	O
equivocal	O
.	O

In	O
dogs	B-SPEC
,	O
CK	O
-	O
MB	O
was	O
essentially	O
absent	O
from	O
both	O
serum	O
and	O
homogenized	O
hearts	O
.	O

TITLE	O
:	O
Molecular	O
mapping	O
of	O
the	O
RNA	O
Cap	O
2	O
'-	O
O	O
-	O
methyltransferase	O
activation	O
interface	O
between	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nsp10	O
and	O
nsp16	O
.	O

Shortly	O
thereafter	O
,	O
in	O
Holland	O
in	O
2004	O
,	O
another	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
was	O
isolated	O
from	O
a	O
seven	O
-	O
month	O
old	O
infant	O
suffering	O
from	O
respiratory	O
symptoms	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
has	O
been	O
shown	O
to	O
infect	O
mainly	O
children	O
and	O
the	O
immunocommpromised	O
,	O
who	O
presented	O
with	O
either	O
mild	O
upper	O
respiratory	O
symptoms	O
(	O
cough	O
,	O
fever	O
and	O
rhinorrhoea	O
)	O
or	O
more	O
serious	O
lower	O
respiratory	O
tract	O
involvement	O
such	O
as	O
bronchiolitis	O
and	O
croup	O
,	O
which	O
was	O
observed	O
mainly	O
in	O
younger	O
children	O
.	O

TITLE	O
:	O
Coexistence	O
of	O
different	O
genotypes	O
in	O
the	O
same	O
bat	B-SPEC
and	O
serological	O
characterization	O
of	O
Rousettus	B-SPEC
bat	I-SPEC
coronavirus	I-SPEC
HKU9	I-SPEC
belonging	O
to	O
a	O
novel	O
Betacoronavirus	B-SPEC
subgroup	O
.	O

Complete	O
genome	O
sequencing	O
of	O
the	O
distinct	O
genotypes	O
from	O
two	O
bats	B-SPEC
,	O
using	O
degenerate	O
/	O
genome	O
-	O
specific	O
primers	O
with	O
overlapping	O
sequences	O
confirmed	O
by	O
specific	O
PCR	O
,	O
supported	O
the	O
coexistence	O
of	O
at	O
least	O
two	O
distinct	O
genomes	O
in	O
each	O
bat	B-SPEC
.	O

TITLE	O
:	O
[	O
Avian	B-SPEC
infectious	O
bronchitis	O
disease	O
in	O
Tunisia	O
:	O
seroprevalence	O
,	O
pathogenicity	O
and	O
compatibility	O
studies	O
of	O
vaccine	O
-	O
field	O
isolates	O
].	O

A	O
plaque	O
assay	O
was	O
used	O
to	O
evaluate	O
the	O
effects	O
of	O
19	O
extracts	O
,	O
and	O
the	O
concentration	O
of	O
extract	O
required	O
to	O
inhibit	O
50	O
%	O
of	O
the	O
replication	O
(	O
EC	O
(	O
50	O
))	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
A59	O
strain	O
(	O
MHV	B-SPEC
-	O
A59	O
)	O
was	O
determined	O
.	O

On	O
review	O
of	O
our	O
database	O
held	O
from	O
September	O
1989	O
until	O
date	O
,	O
there	O
were	O
four	O
patients	O
with	O
sputum	O
-	O
confirmed	O
Panton	O
-	O
Valentine	O
leukocidin	O
expressing	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
pneumonia	O
managed	O
with	O
extracorporeal	O
membrane	O
oxygenation	O
.	O

Herein	O
,	O
we	O
characterize	O
a	O
variant	O
virus	B-SPEC
from	O
B6	O
-	O
GKO	O
mice	B-SPEC
persistently	O
infected	O
with	O
JHMV	O
.	O

TITLE	O
:	O
Association	O
between	O
mannose	O
-	O
binding	O
lectin	O
gene	O
polymorphism	O
and	O
pediatric	O
cytomegalovirus	B-SPEC
infection	O
.	O

Histophilus	B-SPEC
somni	I-SPEC
was	O
detected	O
in	O
2	O
/	O
40	O
(	O
5	O
%)	O
cases	O
,	O
while	O
bovine	B-SPEC
herpesvirus	I-SPEC
-	I-SPEC
1	I-SPEC
,	O
bovine	B-SPEC
viral	O
diarrhoea	O
virus	B-SPEC
and	O
parainfluenza	O
virus	B-SPEC
-	O
3	O
were	O
each	O
found	O
in	O
1	O
/	O
40	O
(	O
2	O
.	O
5	O
%)	O
case	O
.	O

Mastadenovirus	B-SPEC
,	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
or	O
Chlamydiaceae	B-SPEC
were	O
not	O
detected	O
.	O

Faecal	O
samples	O
were	O
collected	O
from	O
preweaned	O
calves	O
,	O
young	O
stock	O
and	O
cows	B-SPEC
.	O

TITLE	O
:	O
Production	O
and	O
characterization	O
of	O
a	O
monoclonal	O
antibody	O
against	O
spike	O
protein	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
.	O

The	O
MAb	O
achieved	O
in	O
this	O
study	O
can	O
be	O
used	O
as	O
a	O
specific	O
diagnostic	O
reagent	O
for	O
detecting	O
TGEV	B-SPEC
S	O
protein	O
.	O

TITLE	O
:	O
A	O
conserved	O
domain	O
in	O
the	O
coronavirus	B-SPEC
membrane	O
protein	O
tail	O
is	O
important	O
for	O
virus	B-SPEC
assembly	O
.	O

The	O
importance	O
of	O
the	O
CD	O
(	O
SWWSFNPETNNL	O
)	O
in	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
was	O
investigated	O
with	O
a	O
panel	O
of	O
mutant	O
proteins	O
,	O
using	O
genetic	O
analysis	O
and	O
transient	O
-	O
expression	O
assays	O
.	O

TITLE	O
:	O
Culturing	O
the	O
unculturable	O
:	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
infects	O
,	O
replicates	O
,	O
and	O
produces	O
progeny	O
virions	O
in	O
human	B-SPEC
ciliated	O
airway	O
epithelial	O
cell	O
cultures	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
is	O
prevalent	O
in	O
winter	O
and	O
is	O
associated	O
with	O
younger	O
age	O
and	O
with	O
shorter	O
fever	O
duration	O
.	O

RESULTS	O
:	O
Viruses	B-SPEC
were	O
identified	O
in	O
147	O
(	O
80	O
.	O
8	O
%)	O
of	O
the	O
182	O
croup	O
patients	O
.	O

Agreement	O
with	O
reference	O
tests	O
was	O
optimal	O
for	O
BCoV	O
(	O
kappa	O
=	O
0	O
.	O
833	O
)	O
and	O
substantial	O
for	O
rotavirus	B-SPEC
detection	O
(	O
kappa	O
=	O
0	O
.	O
648	O
).	O

Compound	O
2a	O
showed	O
better	O
antiviral	O
activity	O
against	O
the	O
entire	O
tested	O
virus	B-SPEC
.	O

A	O
PEDV	B-SPEC
outbreak	O
was	O
observed	O
in	O
March	O
2008	O
in	O
a	O
swine	B-SPEC
herd	O
in	O
Thailand	O
.	O

PEDV	B-SPEC
infection	O
during	O
the	O
first	O
30	O
days	O
of	O
pregnancy	O
resulted	O
in	O
a	O
decrease	O
of	O
TB	O
by	O
1	O
.	O
4	O
(	O
11	O
.	O
7	O
vs	O
.	O
10	O
.	O
3	O
piglets	O
/	O
litter	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
a	O
decrease	O
of	O
BA	O
by	O
2	O
.	O
2	O
(	O
10	O
.	O
7	O
vs	O
.	O
8	O
.	O
5	O
piglets	O
/	O
litter	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
in	O
the	O
gilts	O
'	O
litters	O
,	O
while	O
the	O
influence	O
of	O
PEDV	B-SPEC
infection	O
on	O
TB	O
and	O
BA	O
was	O
not	O
significant	O
in	O
sows	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

It	O
was	O
concluded	O
that	O
natural	O
infection	O
of	O
PEDV	B-SPEC
in	O
the	O
pregnant	O
gilts	O
and	O
sows	O
caused	O
a	O
reduction	O
of	O
subsequent	O
reproductive	O
performance	O
.	O

ABSTRACT	O
:	O
A	O
sensitive	O
reverse	O
-	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
RT	O
-	O
LAMP	O
)	O
assay	O
was	O
developed	O
for	O
the	O
rapid	O
visual	O
detection	O
of	O
turkey	B-SPEC
coronavirus	B-SPEC
(	O
TCoV	O
)	O
infection	O
.	O

Among	O
the	O
infections	O
,	O
25	O
(	O
83	O
%)	O
were	O
monoinfections	O
,	O
whereas	O
5	O
(	O
17	O
%)	O
were	O
multiple	O
infections	O
associating	O
influenza	O
A	O
/	O
H1N1v	O
virus	B-SPEC
with	O
coronavirus	B-SPEC
(	O
CoV	O
),	O
human	B-SPEC
bocavirus	I-SPEC
(	O
HBoV	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
or	O
human	B-SPEC
rhinoviruses	B-SPEC
(	O
HRVs	O
).	O

Standard	O
curves	O
with	O
high	O
accuracy	O
for	O
TGEV	B-SPEC
quantization	O
was	O
constructed	O
by	O
adding	O
1	O
×	O
SYBR	O
greenI	O
in	O
the	O
LAMP	O
reaction	O
.	O

TITLE	O
:	O
SARS	O
-	O
coronavirus	B-SPEC
protein	O
6	O
conformations	O
required	O
to	O
impede	O
protein	O
import	O
into	O
the	O
nucleus	O
.	O

TITLE	O
:	O
Intra	O
-	O
abdominal	O
hypertension	O
in	O
fulminant	O
Clostridium	B-SPEC
difficile	I-SPEC
infection	O
--	O
an	O
under	O
-	O
recognized	O
treatable	O
complication	O
.	O

Male	O
Sprague	B-SPEC
-	I-SPEC
Dawley	I-SPEC
rats	I-SPEC
were	O
intratracheally	O
instilled	O
with	O
LPS	O
(	O
2	O
mg	O
/	O
kg	O
)	O
to	O
induce	O
ALI	O
.	O

VIGOR	O
is	O
a	O
user	O
friendly	O
web	O
-	O
based	O
genome	O
annotation	O
program	O
for	O
five	O
different	O
viral	O
agents	O
,	O
influenza	O
,	O
rotavirus	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
and	O
SARS	O
coronavirus	B-SPEC
.	O

RESULTS	O
:	O
we	O
have	O
developed	O
VIGOR	O
(	O
Viral	O
Genome	O
ORF	O
Reader	O
),	O
a	O
web	O
application	O
tool	O
for	O
gene	O
prediction	O
in	O
influenza	B-SPEC
virus	I-SPEC
,	O
rotavirus	B-SPEC
,	O
rhinovirus	B-SPEC
and	O
coronavirus	B-SPEC
subtypes	O
.	O

One	O
of	O
these	O
(	O
an	O
H	O
-	O
to	O
-	O
R	O
substitution	O
at	O
residue	O
1	O
,	O
381	O
)	O
was	O
first	O
detected	O
in	O
PEDV	B-SPEC
isolated	O
after	O
eight	O
passages	O
,	O
and	O
both	O
this	O
virus	B-SPEC
(	O
MK	O
-	O
p8	O
)	O
and	O
MK	O
-	O
p10	O
showed	O
enhanced	O
syncytium	O
formation	O
relative	O
to	O
the	O
original	O
MK	O
strain	O
and	O
viruses	B-SPEC
isolated	O
after	O
two	O
,	O
four	O
,	O
and	O
six	O
passages	O
,	O
suggesting	O
the	O
possibility	O
that	O
the	O
H	O
-	O
to	O
-	O
R	O
mutation	O
was	O
responsible	O
for	O
this	O
activity	O
.	O

This	O
mutation	O
could	O
be	O
also	O
involved	O
in	O
the	O
increased	O
virulence	O
of	O
PEDV	B-SPEC
observed	O
for	O
MK	O
-	O
p10	O
.	O

Since	O
its	O
first	O
description	O
four	O
decades	O
ago	O
,	O
our	O
knowledge	O
about	O
the	O
aetiology	O
,	O
physiology	O
,	O
histology	O
and	O
epidemiology	O
of	O
this	O
lethal	O
pulmonary	O
complication	O
of	O
severe	O
acute	O
diseases	O
such	O
as	O
pneumonia	O
or	O
sepsis	B-SPEC
has	O
been	O
increasing	O
steadily	O
.	O

Ninety	O
apparently	O
healthy	O
individuals	O
were	O
included	O
as	O
controls	O
and	O
10	O
%	O
of	O
these	O
samples	O
tested	O
positive	O
for	O
one	O
or	O
more	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
which	O
emerged	O
with	O
highly	O
contagious	O
and	O
life	O
-	O
threatening	O
characteristics	O
in	O
2002	O
,	O
remains	O
a	O
potential	O
risk	O
for	O
future	O
outbreaks	O
.	O

Following	O
MHV	B-SPEC
infection	O
,	O
T3	O
-	O
and	O
T9	O
-	O
injured	O
mice	B-SPEC
exhibited	O
increased	O
mortality	O
in	O
comparison	O
to	O
un	O
-	O
injured	O
and	O
laminectomy	O
controls	O
.	O

Investigation	O
of	O
anti	O
-	O
viral	O
immune	O
responses	O
revealed	O
impairment	O
of	O
cellular	O
infiltration	O
and	O
effector	O
functions	O
in	O
mice	B-SPEC
with	O
SCI	O
.	O

In	O
humans	B-SPEC
and	O
in	O
an	O
ovine	O
model	O
of	O
combined	O
smoke	O
inhalation	O
and	O
burn	O
injury	O
,	O
bronchospasm	O
and	O
acute	O
airway	O
obstruction	O
contribute	O
to	O
progressive	O
pulmonary	O
insufficiency	O
.	O

Randomized	O
,	O
prospective	O
study	O
involving	O
32	O
sheep	B-SPEC
.	O

A	O
63	O
-	O
year	O
-	O
old	O
man	B-SPEC
presented	O
with	O
acute	O
-	O
onset	O
proximal	O
upper	O
extremity	O
pain	O
and	O
weakness	O
.	O

We	O
report	O
here	O
that	O
biosafe	O
coronavirus	B-SPEC
-	O
based	O
vaccine	O
vectors	O
facilitate	O
delivery	O
of	O
multiple	O
antigens	O
and	O
immunostimulatory	O
cytokines	O
to	O
professional	O
antigen	O
-	O
presenting	O
cells	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Furthermore	O
,	O
human	B-SPEC
DCs	O
transduced	O
with	O
Melan	O
-	O
A	O
-	O
recombinant	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
efficiently	O
activated	O
tumor	O
-	O
specific	O
CD8	O
(+)	O
T	O
cells	O
.	O

It	O
indicated	O
that	O
the	O
single	O
dose	O
in	O
ovo	B-SPEC
vaccination	O
of	O
the	O
GM	O
-	O
CSF	O
fused	O
or	O
co	O
-	O
administered	O
with	O
S1	O
of	O
IBV	B-SPEC
could	O
enhance	O
significantly	O
the	O
humoral	O
,	O
cellular	O
immune	O
responses	O
and	O
provide	O
complete	O
protection	O
against	O
nephropathogenic	O
IBV	B-SPEC
challenge	O
.	O

ABSTRACT	O
:	O
A	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)/	O
high	O
-	O
resolution	O
melt	O
(	O
HRM	O
)	O
curve	O
analysis	O
protocol	O
was	O
developed	O
in	O
our	O
laboratory	O
to	O
differentiate	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
virus	B-SPEC
reference	O
strains	O
.	O

SAP	O
model	O
was	O
reproduced	O
by	O
reverse	O
injection	O
of	O
sodium	O
deoxycholate	O
into	O
the	O
common	O
bile	O
-	O
pancreatic	O
duct	O
of	O
rats	B-SPEC
.	O

TITLE	O
:	O
Antiseptic	O
properties	O
of	O
two	O
calix	O
[	O
4	O
]	O
arenes	O
derivatives	O
on	O
the	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
.	O

These	O
data	O
demonstrate	O
that	O
inhibition	O
of	O
the	O
cellular	O
proteasome	O
attenuates	O
pneumonitis	O
and	O
cytokine	O
gene	O
expression	O
in	O
vivo	O
by	O
reducing	O
MHV	B-SPEC
-	O
1	O
replication	O
and	O
the	O
resulting	O
inflammatory	O
response	O
.	O

This	O
time	O
-	O
consuming	O
procedure	O
is	O
unacceptable	O
,	O
especially	O
when	O
highly	O
fatal	O
and	O
infectious	O
virus	B-SPEC
arises	O
such	O
as	O
SARS	O
and	O
H1N1	O
,	O
which	O
forces	O
the	O
scoring	O
task	O
to	O
be	O
done	O
in	O
a	O
limited	O
time	O
.	O

This	O
paper	O
presents	O
how	O
to	O
leverage	O
the	O
computational	O
power	O
of	O
GPU	O
to	O
accelerate	O
Dock6	O
'	O
s	O
(	O
http	O
://	O
dock	B-SPEC
.	O
compbio	O
.	O
ucsf	O
.	O
edu	O
/	O
DOCK_6	O
/)	O
Amber	O
(	O
J	O
.	O
Comput	O
.	O

In	O
recent	O
years	O
,	O
however	O
,	O
the	O
Organization	O
'	O
s	O
powers	O
have	O
undergone	O
substantial	O
revision	O
following	O
a	O
series	O
of	O
interconnected	O
global	O
events	O
including	O
the	O
2003	O
severe	O
acute	O
respiratory	O
syndrome	O
outbreak	O
,	O
the	O
revised	O
International	O
Health	O
Regulations	O
,	O
the	O
emergence	O
and	O
spread	O
of	O
avian	B-SPEC
influenza	O
,	O
and	O
more	O
recently	O
,	O
the	O
2009	O
H1N1	O
Swine	B-SPEC
Flu	O
pandemic	O
.	O

Two	O
doses	O
of	O
WI	O
-	O
SARS	O
with	O
and	O
without	O
Adjuvant	O
Systems	O
were	O
highly	O
efficacious	O
in	O
mice	B-SPEC
.	O

RESULTS	O
:	O
We	O
identified	O
53	O
laboratory	O
-	O
confirmed	O
secondary	O
case	O
patients	O
with	O
pH1N1	O
virus	B-SPEC
infection	O
,	O
for	O
an	O
SAR	O
of	O
45	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
35	O
.	O
6	O
%-	O
53	O
.	O
5	O
%).	O

Mice	B-SPEC
were	O
divided	O
into	O
two	O
groups	O
,	O
each	O
according	O
to	O
the	O
type	O
of	O
resuscitation	O
.	O

Samples	O
of	O
thymus	B-SPEC
and	O
spleen	O
were	O
harvested	O
at	O
2	O
,	O
6	O
,	O
24	O
,	O
48	O
,	O
and	O
72	O
h	O
after	O
resuscitation	O
.	O

Plasma	O
levels	O
of	O
interleukin	O
(	O
IL	O
)-	O
6	O
,	O
TNF	O
-	O
α	O
,	O
MCP	O
-	O
1	O
,	O
and	O
IL	O
-	O
10	O
increased	O
at	O
2	O
h	O
.	O
Both	O
in	O
wild	O
type	O
and	O
iNOS	O
knockout	O
mice	B-SPEC
,	O
hypertonic	O
saline	O
resuscitation	O
decreased	O
plasma	O
IL	O
-	O
6	O
,	O
TNF	O
-	O
α	O
,	O
and	O
MCP	O
-	O
1	O
levels	O
at	O
2	O
h	O
;	O
CD4	O
(+)	O
T	O
cells	O
in	O
spleen	O
and	O
thymus	B-SPEC
decreased	O
at	O
24	O
,	O
48	O
,	O
and	O
72	O
h	O
,	O
and	O
Foxp3	O
(+)	O
Tregs	O
in	O
spleen	O
at	O
48	O
h	O
increased	O
,	O
however	O
,	O
hypertonic	O
saline	O
resuscitation	O
did	O
not	O
affect	O
the	O
Foxp3	O
(+).	O

TITLE	O
:	O
Anti	O
-	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
activity	O
of	O
1	O
,	O
8	O
-	O
cineole	O
:	O
effect	O
on	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
characteristics	O
of	O
patients	O
admitted	O
to	O
our	O
intensive	O
care	O
unit	O
with	O
severe	O
acute	O
respiratory	O
illness	O
and	O
influenza	O
-	O
like	O
syndrome	O
during	O
the	O
first	O
months	O
of	O
the	O
pandemic	O
influenza	O
A	O
(	O
H1N1	O
)	O
2009	O
in	O
Argentina	B-SPEC
.	O

Six	O
patients	O
died	O
(	O
19	O
%);	O
they	O
were	O
all	O
over	O
75	O
years	O
old	O
,	O
had	O
cancer	B-SPEC
or	O
immune	O
-	O
suppression	O
.	O

ABSTRACT	O
:	O
Influenza	B-SPEC
viruses	I-SPEC
are	O
thought	O
to	O
be	O
spread	O
by	O
droplets	O
,	O
but	O
the	O
role	O
of	O
aerosol	O
dissemination	O
is	O
unclear	O
and	O
has	O
not	O
been	O
assessed	O
by	O
previous	O
studies	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
small	O
envelope	O
(	O
E	O
)	O
protein	O
plays	O
a	O
crucial	O
,	O
but	O
poorly	O
defined	O
,	O
role	O
in	O
the	O
assembly	O
of	O
virions	O
.	O

The	O
ΔE	O
virus	B-SPEC
formed	O
tiny	O
plaques	O
and	O
reached	O
optimal	O
infectious	O
titers	O
many	O
orders	O
of	O
magnitude	O
below	O
those	O
of	O
wild	O
-	O
type	O
virus	B-SPEC
.	O

On	O
the	O
other	O
hand	O
,	O
production	O
of	O
virus	B-SPEC
in	O
TMPRSS2	O
-	O
expressing	O
cells	O
did	O
not	O
result	O
in	O
S	O
-	O
protein	O
cleavage	O
or	O
increased	O
infectivity	O
of	O
the	O
resulting	O
virus	B-SPEC
.	O

Thus	O
,	O
TMPRSS2	O
affects	O
the	O
entry	O
of	O
virus	B-SPEC
but	O
not	O
other	O
phases	O
of	O
virus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Effective	O
prediction	O
of	O
future	O
viral	O
zoonoses	O
requires	O
an	O
in	O
-	O
depth	O
understanding	O
of	O
the	O
heterologous	O
viral	O
population	O
in	O
key	O
animal	B-SPEC
species	B-SPEC
that	O
will	O
likely	O
serve	O
as	O
reservoir	O
hosts	O
or	O
intermediates	O
during	O
the	O
next	O
viral	O
epidemic	O
.	O

Streptococcus	B-SPEC
pneumoniae	I-SPEC
(	O
in	O
62	O
patients	O
[	O
54	O
.	O
8	O
%])	O
was	O
identified	O
as	O
the	O
most	O
prevalent	O
bacteria	B-SPEC
.	O

This	O
work	O
provides	O
clear	O
evidence	O
that	O
bacterial	O
coinfection	O
is	O
a	O
contributor	O
to	O
increased	O
consumption	O
of	O
health	O
resources	O
by	O
critical	O
patients	O
infected	O
with	O
the	O
virus	B-SPEC
and	O
is	O
the	O
virus	B-SPEC
that	O
causes	O
critical	O
illness	O
in	O
the	O
vast	O
majority	O
of	O
cases	O
.	O

In	O
this	O
Review	O
we	O
survey	O
the	O
research	O
on	O
the	O
host	O
jumps	O
of	O
influenza	O
A	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
,	O
canine	O
parvovirus	B-SPEC
and	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
to	O
illustrate	O
the	O
insights	O
that	O
can	O
arise	O
from	O
combining	O
genetic	O
surveillance	O
with	O
microbiological	O
experimentation	O
in	O
the	O
context	O
of	O
epidemiological	O
data	O
.	O

ABSTRACT	O
:	O
Little	O
is	O
known	O
about	O
the	O
prevalence	O
of	O
mucosal	O
antibodies	O
induced	O
by	O
infection	O
with	O
human	B-SPEC
coronaviruses	O
(	O
HCoV	O
),	O
including	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
and	O
-	O
OC43	O
and	O
recently	O
described	O
strains	O
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
-	O
HKU1	O
).	O

More	O
patients	O
had	O
serum	O
antibody	O
to	O
each	O
HCoV	O
strain	O
(	O
104	O
[	O
99	O
%]	O
had	O
antibody	O
to	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
105	O
[	O
100	O
%]	O
had	O
antibody	O
to	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
103	O
[	O
98	O
%]	O
had	O
antibody	O
to	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
and	O
96	O
[	O
91	O
%]	O
had	O
antibody	O
to	O
HCoV	O
-	O
HKU1	O
)	O
than	O
had	O
antibody	O
to	O
each	O
HCoV	O
strain	O
in	O
nasal	O
wash	O
specimens	O
(	O
12	O
[	O
11	O
%]	O
had	O
antibody	O
to	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
22	O
[	O
22	O
%]	O
had	O
antibody	O
to	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
8	O
[	O
8	O
%]	O
had	O
antibody	O
to	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
and	O
31	O
[	O
31	O
%]	O
had	O
antibody	O
to	O
HCoV	O
-	O
HKU1	O
),	O
respectively	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

These	O
results	O
are	O
discussed	O
in	O
the	O
context	O
of	O
a	O
model	O
of	O
coronavirus	B-SPEC
MHV	B-SPEC
nsp16	O
structure	O
.	O

We	O
utilized	O
a	O
highly	O
sensitive	O
antibody	O
profiling	O
technology	O
to	O
study	O
autoantibodies	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
severe	O
sepsis	B-SPEC
,	O
conditions	O
characterized	O
by	O
intensive	O
immune	O
activation	O
leading	O
to	O
multiple	O
organ	O
dysfunction	O
.	O

Available	O
longitudinal	O
samples	O
from	O
different	O
seropositive	O
ARDS	O
and	O
sepsis	B-SPEC
patient	O
samples	O
,	O
starting	O
from	O
within	O
the	O
first	O
two	O
days	O
after	O
admission	O
to	O
the	O
intensive	O
care	O
,	O
were	O
then	O
analyzed	O
for	O
changes	O
in	O
autoantibody	O
over	O
time	O
.	O

The	O
rapid	O
induction	O
of	O
autoantibodies	O
in	O
ARDS	O
and	O
severe	O
sepsis	B-SPEC
suggests	O
that	O
ongoing	O
systemic	O
inflammation	O
and	O
associated	O
tissue	O
destruction	O
mediate	O
the	O
break	O
in	O
tolerance	O
against	O
these	O
self	O
proteins	O
.	O

ABSTRACT	O
:	O
The	O
3C	O
-	O
like	O
protease	O
(	O
3CL	O
(	O
pro	O
))	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
is	O
required	O
for	O
autoprocessing	O
of	O
the	O
polyprotein	O
,	O
and	O
is	O
a	O
potential	O
target	O
for	O
treating	O
coronaviral	O
infection	O
.	O

One	O
-	O
day	O
-	O
old	O
chickens	B-SPEC
were	O
vaccinated	O
by	O
wing	O
-	O
web	O
puncture	O
with	O
the	O
two	O
rFPVs	O
,	O
and	O
the	O
induced	O
humoral	O
and	O
cellular	O
responses	O
were	O
evaluated	O
.	O

The	O
aerosol	O
infection	O
model	O
(	O
aerosolized	O
rabbitpox	O
infection	O
)	O
embodies	O
many	O
of	O
the	O
desired	O
aspects	O
of	O
the	O
disease	O
syndrome	O
that	O
involves	O
the	O
respiratory	O
system	O
and	O
thus	O
may	O
serve	O
as	O
an	O
appropriate	O
model	O
for	O
evaluation	O
of	O
antivirals	O
under	O
development	O
for	O
the	O
therapeutic	O
treatment	O
of	O
human	B-SPEC
smallpox	B-SPEC
.	O

The	O
membrane	O
(	O
M	O
)	O
protein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
highly	O
abundant	O
during	O
viral	O
infections	O
and	O
is	O
a	O
critical	O
element	O
for	O
viral	O
assembly	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
establish	O
the	O
eukaryotic	O
cell	O
lines	O
for	O
inducible	O
control	O
of	O
SARS	O
-	O
CoV	O
nucleocapsid	O
gene	O
expression	O
.	O

Moreover	O
,	O
a	O
strong	O
cellular	O
immune	O
response	O
demonstrated	O
by	O
elevated	O
IFN	O
-	O
γ	O
and	O
IL	O
-	O
6	O
levels	O
was	O
also	O
observed	O
in	O
these	O
mice	B-SPEC
.	O

These	O
results	O
demonstrated	O
that	O
the	O
immunogenicity	O
of	O
the	O
SL	O
-	O
CoV	O
S	O
protein	O
is	O
distinct	O
from	O
that	O
of	O
SARS	O
-	O
CoV	O
,	O
which	O
may	O
cause	O
the	O
immunological	O
differences	O
between	O
human	B-SPEC
SARS	O
-	O
CoV	O
and	O
bat	B-SPEC
SL	O
-	O
CoV	O
.	O
Furthermore	O
,	O
the	O
recombinant	O
virus	B-SPEC
could	O
serve	O
as	O
a	O
potential	O
vaccine	O
candidate	O
against	O
bat	B-SPEC
SL	O
-	O
CoV	O
infection	O
.	O

TGEV	B-SPEC
TS	O
showed	O
a	O
close	O
evolutionary	O
relationship	O
to	O
the	O
American	O
Miller	O
cluster	O
but	O
had	O
a	O
5	O
'	O
non	O
-	O
translated	O
region	O
(	O
NTR	O
)	O
sequence	O
closely	O
related	O
to	O
the	O
American	O
Purdue	O
cluster	O
.	O

This	O
paper	O
looks	O
at	O
two	O
cases	O
in	O
which	O
the	O
Chinese	O
government	O
securitized	O
infectious	O
disease	O
(	O
SARS	O
and	O
avian	B-SPEC
influenza	O
)	O
and	O
examines	O
the	O
pros	O
and	O
cons	O
of	O
securitization	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
a	O
highly	O
basic	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
which	O
can	O
inhibit	O
the	O
synthesis	O
of	O
type	O
I	O
interferon	O
(	O
IFN	O
),	O
but	O
the	O
molecular	O
mechanism	O
of	O
this	O
antagonism	O
remains	O
to	O
be	O
identified	O
.	O

(	O
i	O
)	O
Most	O
were	O
similarly	O
regulated	O
in	O
response	O
to	O
influenza	B-SPEC
virus	I-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Newly	O
emerging	O
viruses	B-SPEC
often	O
circulate	O
as	O
a	O
heterogeneous	O
swarm	O
in	O
wild	O
animal	B-SPEC
reservoirs	O
prior	O
to	O
their	O
emergence	O
in	O
humans	B-SPEC
,	O
and	O
their	O
antigenic	O
identities	O
are	O
often	O
unknown	O
until	O
an	O
outbreak	O
situation	O
.	O

Nevertheless	O
,	O
systematic	O
studies	O
on	O
the	O
association	O
between	O
these	O
viruses	B-SPEC
and	O
mood	O
disorders	O
are	O
lacking	O
.	O

Socioeconomic	O
factors	O
,	O
inflammatory	O
markers	O
,	O
and	O
axis	B-SPEC
II	O
psychopathology	O
were	O
not	O
assessed	O
.	O

TITLE	O
:	O
Early	O
gene	O
expression	O
events	O
in	O
ferrets	B-SPEC
in	O
response	O
to	O
SARS	O
coronavirus	B-SPEC
infection	O
versus	O
direct	O
interferon	O
-	O
alpha2b	O
stimulation	O
.	O

These	O
signatures	O
can	O
be	O
useful	O
markers	O
to	O
evaluate	O
the	O
status	O
of	O
IFN	O
responses	O
during	O
a	O
viral	O
infection	O
and	O
specific	O
features	O
of	O
different	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
enterovirus	B-SPEC
71	O
(	O
EV	O
-	O
71	O
)	O
emerged	O
as	O
a	O
significant	O
pathogen	O
able	O
to	O
cause	O
large	O
outbreaks	O
involving	O
severe	O
neurological	O
cases	O
and	O
children	O
fatalities	O
in	O
Asia	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
8b	O
reduces	O
viral	O
replication	O
by	O
down	O
-	O
regulating	O
E	O
via	O
an	O
ubiquitin	O
-	O
independent	O
proteasome	O
pathway	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
8b	O
negatively	O
modulates	O
virus	B-SPEC
replication	O
by	O
down	O
-	O
regulating	O
E	O
via	O
an	O
ubiquitin	O
-	O
independent	O
proteasome	O
pathway	O
.	O

TITLE	O
:	O
Antiviral	O
activities	O
of	O
ISG20	O
in	O
positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
infections	O
.	O

Overexpression	O
of	O
ISG20	O
,	O
however	O
,	O
did	O
not	O
inhibit	O
propagation	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
a	O
highly	O
-	O
pathogenic	O
human	B-SPEC
coronavirus	I-SPEC
in	O
Huh7	O
.	O
5	O
cells	O
.	O

The	O
closely	O
related	O
cellular	O
exonucleases	O
,	O
ISG20L1	O
and	O
ISG20L2	O
,	O
did	O
not	O
inhibit	O
HCV	B-SPEC
replication	O
.	O

Here	O
,	O
we	O
investigated	O
the	O
influence	O
of	O
EPs	O
®	O
7630	O
on	O
replication	O
of	O
a	O
panel	O
of	O
respiratory	O
viruses	B-SPEC
.	O

The	O
proportion	O
of	O
patients	O
having	O
severe	O
manifestations	O
,	O
which	O
included	O
severe	O
anemia	B-SPEC
,	O
thrombocytopenia	O
,	O
cerebral	O
malaria	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
hepatic	O
dysfunction	O
,	O
renal	O
dysfunction	O
,	O
abnormal	O
bleeding	O
was	O
significantly	O
high	O
in	O
association	O
with	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
monoinfection	O
in	O
0	O
-	O
5	O
year	O
age	O
group	O
,	O
while	O
the	O
same	O
was	O
significantly	O
high	O
in	O
association	O
with	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
monoinfection	O
in	O
5	O
-	O
10	O
year	O
age	O
group	O
.	O

Kidney	O
screening	O
with	O
IHC	O
showed	O
sensitivity	O
,	O
specificity	O
,	O
PPV	B-SPEC
and	O
NPV	O
of	O
95	O
.	O
45	O
%,	O
73	O
.	O
68	O
%,	O
80	O
.	O
77	O
%	O
and	O
93	O
.	O
33	O
%,	O
respectively	O
.	O

Based	O
on	O
WNv	B-SPEC
screening	O
of	O
kidney	O
tissue	O
,	O
IHC	O
and	O
RT	O
-	O
PCR	O
were	O
in	O
agreement	O
with	O
95	O
.	O
45	O
%	O
(	O
21	O
/	O
22	O
)	O
for	O
positive	O
dead	O
birds	B-SPEC
and	O
were	O
in	O
100	O
%	O
(	O
22	O
/	O
22	O
)	O
agreement	O
when	O
multi	O
-	O
organ	O
screening	O
by	O
IHC	O
was	O
performed	O
.	O

We	O
previously	O
identified	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
S	O
protein	O
as	O
a	O
major	O
target	O
of	O
neutralizing	O
antibodies	O
in	O
animal	B-SPEC
models	O
and	O
thus	O
proposed	O
a	O
RBD	O
-	O
based	O
vaccine	O
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
viruses	B-SPEC
with	O
naturally	O
occurring	O
genomic	O
rearrangement	O
and	O
gene	O
deletion	O
.	O

202	O
specimens	O
collected	O
from	O
adult	O
patients	O
with	O
signs	O
of	O
respiratory	O
infection	O
from	O
November	O
,	O
2008	O
to	O
May	O
,	O
2009	O
were	O
used	O
for	O
evaluating	O
the	O
performance	O
of	O
the	O
three	O
commercial	O
PRV	B-SPEC
assays	O
.	O

When	O
compared	O
to	O
culture	O
,	O
the	O
xTAG	O
PRV	B-SPEC
showed	O
a	O
sensitivity	O
and	O
specificity	O
of	O
100	O
%	O
and	O
91	O
%,	O
compared	O
to	O
MultiCode	O
-	O
PLx	O
with	O
89	O
%	O
and	O
87	O
%,	O
and	O
ResPlex	O
II	O
with	O
89	O
%	O
and	O
94	O
%,	O
respectively	O
.	O

Each	O
panel	O
showed	O
differences	O
in	O
sensitivities	O
for	O
individual	O
viruses	B-SPEC
.	O

Lower	O
respiratory	O
tract	O
infection	O
(	O
LRTI	O
)	O
was	O
half	O
as	O
common	O
in	O
children	O
with	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
(	O
48	O
.	O
6	O
%)	O
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
(	O
47	O
.	O
1	O
%)	O
as	O
in	O
children	O
with	O
RSV	B-SPEC
(	O
82	O
.	O
3	O
%)	O
(	O
both	O
P	O
<	O
0	O
.	O
01	O
).	O

HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
are	O
common	O
among	O
hospitalized	O
Norwegian	O
children	O
with	O
RTI	O
.	O

Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
belongs	O
to	O
gamma	O
-	O
coronaviruses	O
and	O
causes	O
a	O
costly	O
respiratory	O
viral	O
disease	O
in	O
chickens	B-SPEC
.	O

Sequence	O
analysis	O
showed	O
that	O
the	O
detected	O
viruses	B-SPEC
are	O
gamma	O
-	O
coronaviruses	O
related	O
to	O
IBV	B-SPEC
.	O

These	O
findings	O
suggest	O
that	O
wild	O
birds	B-SPEC
are	O
able	O
to	O
carry	O
gamma	O
-	O
coronaviruses	O
asymptomatically	O
.	O

One	O
group	O
of	O
20	O
patients	O
with	O
bacterial	O
sepsis	B-SPEC
-	O
ARDS	O
and	O
another	O
group	O
of	O
15	O
healthy	O
volunteers	O
were	O
added	O
to	O
compare	O
their	O
cytokine	O
levels	O
with	O
pandemic	O
influenza	O
groups	O
.	O

Since	O
perceived	O
sufficiency	O
of	O
information	O
about	O
the	O
A	O
/	O
H1N1	O
influenza	O
prognosis	O
was	O
associated	O
with	O
reduced	O
degree	O
of	O
worry	O
,	O
hospital	O
managers	O
and	O
consultation	O
-	O
liaison	O
psychiatry	O
services	O
should	O
try	O
to	O
provide	O
for	O
HCWs	O
'	O
need	O
for	O
information	O
,	O
in	O
order	B-SPEC
to	O
offer	O
favourable	O
working	O
conditions	O
in	O
times	O
of	O
extreme	O
distress	O
,	O
such	O
as	O
the	O
current	O
and	O
future	O
pandemics	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
44	O
-	O
year	O
-	O
old	O
Caucasian	O
man	B-SPEC
with	O
Legionella	B-SPEC
pneumonia	O
with	O
successive	O
development	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

NATs	O
provide	O
fast	O
,	O
accurate	O
and	O
sensitive	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
and	O
have	O
significantly	O
increased	O
our	O
understanding	O
of	O
the	O
epidemiology	O
of	O
these	O
viruses	B-SPEC
.	O

The	O
final	O
chapter	O
in	O
the	O
evolution	O
of	O
respiratory	O
virus	B-SPEC
diagnostics	O
will	O
be	O
the	O
addition	O
of	O
allelic	O
discrimination	O
and	O
detection	O
of	O
single	O
nucleotide	O
polymorphisms	O
associated	O
with	O
antiviral	O
resistance	O
to	O
multiplex	O
assays	O
.	O

Oleic	O
acid	O
was	O
injected	O
into	O
the	O
pulmonary	O
circulation	O
until	O
PaO2	O
:	O
FiO2	O
≤	O
60	O
mm	O
Hg	O
,	O
followed	O
by	O
transition	O
to	O
a	O
protective	O
CMV	B-SPEC
protocol	O
(	O
n	O
=	O
5	O
)	O
or	O
TLV	O
(	O
n	O
=	O
5	O
)	O
for	O
24	O
hours	O
.	O

Here	O
we	O
show	O
that	O
a	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
(	O
WNV	B-SPEC
)	O
mutant	O
(	O
E218A	O
)	O
that	O
lacks	O
2	O
'-	O
O	O
MTase	O
activity	O
was	O
attenuated	O
in	O
wild	O
-	O
type	O
primary	O
cells	O
and	O
mice	B-SPEC
but	O
was	O
pathogenic	O
in	O
the	O
absence	O
of	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
signalling	O
.	O

TITLE	O
:	O
Predictors	O
of	O
pandemic	O
(	O
H1N1	O
)	O
2009	O
virus	B-SPEC
positivity	O
and	O
adverse	O
outcomes	O
among	O
hospitalized	O
patients	O
with	O
a	O
compatible	O
syndrome	O
.	O

ABSTRACT	O
:	O
A	O
pandemic	O
(	O
H1N1	O
)	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
was	O
identified	O
in	O
2009	O
.	O

Antibody	O
-	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
of	O
FIPV	O
infection	O
has	O
been	O
recognized	O
,	O
and	O
cellular	O
immunity	O
is	O
considered	O
to	O
play	O
an	O
important	O
role	O
in	O
preventing	O
the	O
onset	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

The	O
tropism	O
of	O
this	O
TGEV	B-SPEC
-	O
derived	O
vector	O
was	O
modified	O
by	O
replacing	O
the	O
spike	O
S	O
protein	O
with	O
the	O
homologous	O
protein	O
from	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
).	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
impact	O
of	O
inflammation	O
,	O
water	O
metabolism	O
and	O
immune	O
function	O
on	O
the	O
establishment	O
of	O
a	O
mouse	B-SPEC
model	O
of	O
damp	O
-	O
heat	O
syndrome	O
with	O
MHV	B-SPEC
-	O
A59	O
infection	O
.	O

The	O
expression	O
of	O
NF	O
-	O
κB	O
and	O
CD4	O
(+)/	O
CD8	O
(+)	O
ratio	O
in	O
the	O
virus	B-SPEC
and	O
model	O
groups	O
were	O
significantly	O
higher	O
than	O
those	O
in	O
the	O
damp	O
-	O
heat	O
and	O
control	O
groups	O
,	O
while	O
the	O
expression	O
of	O
AQP4	O
was	O
significantly	O
higher	O
in	O
the	O
model	O
and	O
damp	O
-	O
heat	O
groups	O
than	O
in	O
the	O
other	O
groups	O
.	O

ABSTRACT	O
:	O
Caveolin	O
-	O
1	O
(	O
cav	B-SPEC
-	O
1	O
),	O
a	O
22	O
-	O
kDa	O
transmembrane	O
scaffolding	O
protein	O
,	O
is	O
the	O
principal	O
structural	O
component	O
of	O
caveolae	O
.	O

Abundant	O
in	O
almost	O
every	O
cell	O
type	O
in	O
the	O
lung	O
,	O
including	O
type	O
I	O
epithelial	O
cells	O
,	O
endothelial	O
cells	O
,	O
smooth	O
muscle	O
cells	O
,	O
fibroblasts	O
,	O
macrophages	O
,	O
and	O
neutrophils	O
,	O
cav	B-SPEC
-	O
1	O
plays	O
a	O
crucial	O
role	O
in	O
the	O
pathogenesis	O
of	O
acute	O
lung	O
injury	O
(	O
ALI	O
).	O

We	O
further	O
discuss	O
the	O
potential	O
molecular	O
and	O
cellular	O
mechanisms	O
by	O
which	O
cav	B-SPEC
-	O
1	O
expression	O
contributes	O
to	O
ALI	O
.	O

All	O
pigs	B-SPEC
were	O
co	O
-	O
infected	O
with	O
other	O
viruses	B-SPEC
and	O
bacteria	B-SPEC
and	O
this	O
might	O
have	O
resulted	O
in	O
age	O
variation	O
and	O
clinical	O
signs	O
in	O
the	O
affected	O
pigs	B-SPEC
.	O

These	O
findings	O
imply	O
the	O
presence	O
of	O
only	O
one	O
genogroup	O
of	O
PHEV	O
,	O
regardless	O
of	O
porcine	B-SPEC
age	O
,	O
clinical	O
signs	O
,	O
and	O
geographical	O
location	O
.	O

Typically	O
,	O
Fisher	B-SPEC
syndrome	O
has	O
a	O
fairly	O
good	O
natural	O
course	O
.	O

TITLE	O
:	O
Detection	O
and	O
genetic	O
characterization	O
of	O
canine	O
parvoviruses	B-SPEC
and	O
coronaviruses	O
in	O
southern	O
Ireland	O
.	O

Enterococcus	B-SPEC
and	O
C	B-SPEC
.	I-SPEC
albicans	I-SPEC
were	O
the	O
main	O
isolated	O
microorganisms	O
in	O
the	O
bile	O
.	O

Immuno	O
-	O
histochemical	O
and	O
Western	O
immunoblot	O
studies	O
in	O
mice	B-SPEC
confirmed	O
a	O
)	O
the	O
presence	O
of	O
NEP	O
in	O
the	O
alveolar	O
wall	O
,	O
a	O
critical	O
target	O
in	O
ALI	O
/	O
ARDS	O
,	O
and	O
b	O
)	O
a	O
decrease	O
in	O
its	O
expression	O
in	O
HCl	O
-	O
and	O
LPS	O
-	O
induced	O
ALI	O
.	O

One	O
diagnostic	O
challenge	O
is	O
that	O
respiratory	O
infections	O
,	O
which	O
can	O
be	O
caused	O
by	O
several	O
viral	O
pathogens	O
including	O
RSV	B-SPEC
,	O
usually	O
present	O
with	O
similar	O
signs	O
and	O
symptoms	O
that	O
are	O
nearly	O
indistinguishable	O
by	O
clinical	O
diagnosis	O
.	O

Three	O
pairs	O
of	O
primers	O
targeting	O
the	O
nucleocapsid	O
(	O
N	O
)	O
gene	O
of	O
TGEV	B-SPEC
were	O
synthesized	O
and	O
used	O
in	O
the	O
RT	O
-	O
LAMP	O
.	O

The	O
approach	O
is	O
suitable	O
for	O
detecting	O
TGEV	B-SPEC
for	O
field	O
diagnostics	O
or	O
in	O
less	O
-	O
equipped	O
laboratories	O
due	O
to	O
its	O
convenience	O
and	O
simplicity	O
.	O

We	O
use	O
this	O
distance	O
measure	O
to	O
classify	O
chromosomes	O
according	O
to	O
species	B-SPEC
of	O
origin	O
,	O
to	O
build	O
the	O
phylogenetic	O
tree	O
of	O
24	O
complete	O
genome	O
sequences	O
of	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
a	O
common	O
and	O
severe	O
form	O
of	O
acute	O
lung	O
injury	O
,	O
resulting	O
from	O
both	O
direct	O
(	O
eg	O
,	O
pneumonia	O
)	O
and	O
indirect	O
(	O
eg	O
,	O
sepsis	B-SPEC
)	O
pulmonary	O
insults	O
.	O

This	O
is	O
the	O
first	O
report	O
on	O
the	O
detection	O
of	O
the	O
CoV	O
genome	O
in	O
captive	O
birds	B-SPEC
in	O
Brazil	O
.	O

TITLE	O
:	O
Pathogenesis	O
of	O
neurotropic	O
murine	B-SPEC
coronavirus	I-SPEC
is	O
multifactorial	O
.	O

ABSTRACT	O
:	O
Although	O
coronavirus	B-SPEC
tropism	O
is	O
most	O
often	O
ascribed	O
to	O
receptor	O
availability	O
,	O
increasing	O
evidence	O
suggests	O
that	O
for	O
the	O
neurotropic	O
strains	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
spike	O
-	O
receptor	O
interactions	O
cannot	O
fully	O
explain	O
neurovirulence	O
.	O

TITLE	O
:	O
Clinical	O
manifestations	O
of	O
influenza	O
caused	O
by	O
A	O
/	O
H1N1v	O
virus	B-SPEC
among	O
children	O
and	O
teenagers	O
consulted	O
in	O
general	O
practice	O
.	O

The	O
course	O
of	O
influenza	O
caused	O
by	O
virus	B-SPEC
A	O
/	O
H1N1v	O
in	O
children	O
younger	O
than	O
14	O
years	O
observed	O
in	O
a	O
primary	O
care	O
setting	O
was	O
mild	O
and	O
self	O
-	O
limited	O
without	O
the	O
necessity	O
of	O
antiviral	O
treatment	O
in	O
most	O
cases	O
.	O

However	O
,	O
pooled	O
data	O
from	O
two	O
meta	B-SPEC
-	O
analyses	O
showed	O
significant	O
higher	O
survival	O
in	O
the	O
most	O
severe	O
patients	O
both	O
with	O
the	O
use	O
of	O
higher	O
PEEP	O
and	O
prone	O
positioning	O
.	O

An	O
enlarged	O
left	O
atrium	O
was	O
found	O
in	O
all	O
cats	B-SPEC
and	O
two	O
of	O
three	O
cats	B-SPEC
also	O
had	O
spontaneous	O
echocardiographic	O
contrast	O
.	O

The	O
CTL	O
-	O
based	O
liposomal	O
technique	O
might	O
be	O
applicable	O
for	O
developing	O
vaccines	O
against	O
influenza	O
and	O
other	O
viruses	B-SPEC
,	O
such	O
as	O
hepatitis	B-SPEC
C	I-SPEC
,	O
HIV	B-SPEC
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
,	O
which	O
frequently	O
change	O
their	O
surface	O
antigenic	O
molecules	O
.	O

Human	B-SPEC
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
infection	O
exists	O
in	O
children	O
with	O
respiratory	O
tract	O
infections	O
in	O
Lanzhou	O
region	O
.	O

3	O
-(	O
4	O
,	O
5	O
-	O
dimethylthiazol	O
-	O
2	O
-	O
yl	O
)-	O
2	O
,	O
5	O
-	O
diphenyl	O
tetrazolium	O
bromide	O
(	O
MTT	O
)	O
assays	O
confirmed	O
the	O
protective	O
effect	O
of	O
the	O
peptides	O
on	O
cell	O
infection	O
by	O
TGEV	B-SPEC
.	O

TITLE	O
:	O
Interferon	O
interplay	O
helps	O
tissue	O
cells	O
to	O
cope	O
with	O
SARS	O
-	O
coronavirus	B-SPEC
infection	O
.	O

In	O
addition	O
,	O
patients	O
positive	O
for	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infections	O
were	O
more	O
likely	O
to	O
be	O
co	O
-	O
infected	O
with	O
other	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
applied	O
a	O
quantitative	O
proteomic	O
approach	O
,	O
based	O
on	O
SILAC	O
,	O
to	O
investigate	O
the	O
interactions	O
of	O
coronaviruses	O
with	O
the	O
secretory	O
pathway	O
of	O
the	O
host	O
cell	O
,	O
with	O
the	O
aim	O
to	O
identify	O
host	O
factors	O
involved	O
in	O
coronavirus	B-SPEC
replication	O
.	O

Comparison	O
of	O
the	O
protein	O
profiles	O
of	O
Golgi	O
-	O
enriched	O
fractions	O
of	O
cells	O
that	O
were	O
either	O
mock	O
infected	O
or	O
infected	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
revealed	O
the	O
significant	O
depletion	O
or	O
enrichment	O
of	O
116	O
proteins	O
.	O

The	O
respiratory	O
virus	B-SPEC
is	O
a	O
mutated	O
form	O
that	O
may	O
be	O
a	O
consequence	O
of	O
the	O
gastroenteritis	O
virus	B-SPEC
'	O
s	O
evolution	O
.	O

Intensive	O
passages	O
of	O
the	O
virus	B-SPEC
in	O
its	O
natural	O
host	O
may	O
enhance	O
the	O
appearance	O
of	O
mutations	O
and	O
therefore	O
may	O
contribute	O
to	O
any	O
attenuated	O
form	O
of	O
the	O
virus	B-SPEC
.	O

Thus	O
,	O
as	O
supported	O
by	O
a	O
demonstrated	O
resilience	O
of	O
pDC	O
to	O
PRRSV	B-SPEC
infection	O
,	O
this	O
pathogen	O
may	O
interact	O
with	O
a	O
cell	O
surface	O
protein	O
(	O
s	O
)	O
to	O
selectively	O
impede	O
the	O
completion	O
of	O
cascades	O
involved	O
in	O
cytokine	O
production	O
by	O
stimulated	O
pDC	O
.	O

The	O
ASC	O
survival	O
factors	O
B	O
cell	O
-	O
activating	O
factor	O
of	O
the	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
family	B-SPEC
(	O
BAFF	O
)	O
and	O
a	O
proliferating	O
-	O
inducing	O
ligand	O
(	O
APRIL	O
)	O
were	O
also	O
significantly	O
elevated	O
in	O
the	O
infected	O
CNS	O
,	O
albeit	O
delayed	O
relative	O
to	O
the	O
chemokines	O
.	O

TITLE	O
:	O
Partial	O
deletion	O
in	O
the	O
spike	O
endodomain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
decreases	O
the	O
cytopathic	O
effect	O
but	O
maintains	O
foreign	O
protein	O
expression	O
in	O
infected	O
cells	O
.	O

Previously	O
,	O
a	O
13	O
-	O
residue	O
deletion	O
in	O
the	O
MHV	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
endodomain	O
was	O
found	O
to	O
reduce	O
syncytium	O
formation	O
dramatically	O
while	O
inhibiting	O
virus	B-SPEC
replication	O
slightly	O
.	O

RESULTS	O
:	O
In	O
the	O
present	O
study	O
,	O
the	O
immune	O
responses	O
of	O
BALB	O
/	O
c	O
mice	B-SPEC
immunized	O
via	O
intranasal	O
(	O
i	O
.	O
n	O
.)	O
route	O
with	O
SARS	O
DNA	O
vaccine	O
(	O
pci	O
-	O
S	O
)	O
in	O
a	O
PEI	O
/	O
pci	O
-	O
S	O
complex	O
form	O
have	O
been	O
examined	O
.	O

The	O
percentage	O
of	O
IFN	O
-	O
γ	O
-,	O
TNF	O
-	O
α	O
-	O
and	O
IL	O
-	O
2	O
-	O
producing	O
cells	O
were	O
higher	O
in	O
PEI	O
/	O
pci	O
-	O
S	O
vaccinated	O
mice	B-SPEC
than	O
in	O
control	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
caused	O
enteric	O
disease	O
with	O
devastating	O
impact	O
since	O
the	O
first	O
identification	O
of	O
PEDV	B-SPEC
in	O
1992	O
in	O
Korea	O
.	O

TITLE	O
:	O
Sequence	O
analysis	O
of	O
the	O
nucleocapsid	O
gene	O
of	O
feline	B-SPEC
coronaviruses	O
circulating	O
in	O
Italy	O
.	O

The	O
birds	B-SPEC
in	O
the	O
latter	O
five	O
farms	O
were	O
suffering	O
from	O
nephropathogenic	O
lesions	O
,	O
however	O
,	O
the	O
virus	B-SPEC
was	O
isolated	O
from	O
kidney	O
but	O
not	O
from	O
trachea	B-SPEC
in	O
these	O
cases	O
.	O

ABSTRACT	O
:	O
The	O
antibody	O
-	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
infection	O
has	O
been	O
recognized	O
in	O
experimentally	O
infected	O
cats	B-SPEC
,	O
and	O
cellular	O
immunity	O
is	O
considered	O
to	O
play	O
an	O
important	O
role	O
in	O
preventing	O
the	O
onset	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

Eight	O
peptides	O
containing	O
Th1	O
epitopes	O
were	O
identified	O
in	O
N	O
protein	O
,	O
and	O
3	O
peptides	O
derived	O
from	O
residues	O
81	O
to	O
100	O
and	O
137	O
to	O
164	O
showed	O
strong	O
inductivity	O
of	O
fIFN	O
-	O
γ	O
production	O
in	O
PBMCs	O
isolated	O
from	O
type	O
I	O
FIPV	O
-	O
and	O
type	O
II	O
FIPV	O
-	O
infected	O
non	O
-	O
FIP	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
recombinant	O
fowlpox	B-SPEC
virus	I-SPEC
(	O
rFPV	O
-	O
IFNγS1	O
)	O
that	O
co	O
-	O
expressed	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
S1	O
gene	O
and	O
the	O
chicken	B-SPEC
interferon	O
-	O
γ	O
gene	O
has	O
been	O
constructed	O
.	O

In	O
addition	O
,	O
the	O
lesions	O
and	O
the	O
amount	O
of	O
virus	B-SPEC
shedding	O
were	O
less	O
severe	O
in	O
the	O
vaccinated	O
groups	O
challenged	O
by	O
strains	O
LX4	O
,	O
LHB	O
and	O
LHLJ04XI	O
when	O
compared	O
with	O
the	O
other	O
groups	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
average	O
body	O
weight	O
of	O
the	O
chickens	B-SPEC
in	O
all	O
groups	O
(	O
all	O
p	O
>	O
0	O
.	O
05	O
).	O

Notably	O
,	O
the	O
induction	O
of	O
type	O
I	O
interferon	O
by	O
viruses	B-SPEC
deficient	O
in	O
2	O
'-	O
O	O
-	O
methyltransferase	O
was	O
dependent	O
on	O
the	O
cytoplasmic	O
RNA	O
sensor	O
Mda5	O
.	O

TITLE	O
:	O
Characterization	O
and	O
utility	O
of	O
monoclonal	O
antibodies	O
against	O
spike	O
protein	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
.	O

TITLE	O
:	O
Sudden	O
death	O
of	O
an	O
immunocompetent	O
young	O
adult	O
caused	O
by	O
novel	O
(	O
swine	B-SPEC
origin	O
)	O
influenza	O
A	O
/	O
H1N1	O
-	O
associated	O
myocarditis	O
.	O

TITLE	O
:	O
Distinct	O
patterns	O
of	O
IFITM	O
-	O
mediated	O
restriction	O
of	O
filoviruses	O
,	O
SARS	O
coronavirus	B-SPEC
,	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
.	O

Moreover	O
,	O
murine	B-SPEC
Ifitm5	O
and	O
6	O
did	O
not	O
restrict	O
IAV	O
,	O
but	O
efficiently	O
inhibited	O
filovirus	B-SPEC
entry	O
.	O

These	O
results	O
suggest	O
that	O
natural	O
genetic	O
recombination	O
between	O
heterologous	O
strains	O
classified	O
into	O
different	O
genetic	O
groups	O
has	O
occurred	O
and	O
may	O
have	O
caused	O
the	O
emergence	O
of	O
new	O
IBV	B-SPEC
strains	O
.	O

After	O
1	O
-	O
minute	O
contact	O
time	O
,	O
for	O
TGEV	B-SPEC
,	O
there	O
was	O
a	O
log	O
(	O
10	O
)	O
reduction	O
factor	O
of	O
3	O
.	O
2	O
for	O
70	O
%	O
ethanol	O
,	O
2	O
.	O
0	O
for	O
phenolic	O
,	O
2	O
.	O
3	O
for	O
OPA	O
,	O
0	O
.	O
35	O
for	O
1	O
:	O
100	O
hypochlorite	O
,	O
4	O
.	O
0	O
for	O
62	O
%	O
ethanol	O
,	O
and	O
3	O
.	O
5	O
for	O
71	O
%	O
ethanol	O
.	O

Germicides	O
must	O
be	O
chosen	O
carefully	O
to	O
ensure	O
they	O
are	O
effective	O
against	O
viruses	B-SPEC
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

RESULTS	O
:	O
After	O
1	O
-	O
minute	O
contact	O
time	O
,	O
for	O
TGEV	B-SPEC
,	O
there	O
was	O
a	O
log	O
(	O
10	O
)	O
reduction	O
factor	O
of	O
3	O
.	O
2	O
for	O
70	O
%	O
ethanol	O
,	O
2	O
.	O
0	O
for	O
phenolic	O
,	O
2	O
.	O
3	O
for	O
OPA	O
,	O
0	O
.	O
35	O
for	O
1	O
:	O
100	O
hypochlorite	O
,	O
4	O
.	O
0	O
for	O
62	O
%	O
ethanol	O
,	O
and	O
3	O
.	O
5	O
for	O
71	O
%	O
ethanol	O
.	O

Sixty	O
herds	O
with	O
a	O
herd	O
size	O
of	O
≥	O
160	O
cows	B-SPEC
were	O
visited	O
once	O
between	O
December	O
2005	O
and	O
March	O
2006	O
.	O

The	O
herd	O
status	O
regarding	O
the	O
calves	O
'	O
passive	O
transfer	O
(	O
total	O
protein	O
),	O
levels	O
of	O
α	O
-	O
tocopherol	O
,	O
β	O
-	O
carotene	O
and	O
retinol	O
,	O
and	O
excretion	O
of	O
faecal	O
pathogens	O
(	O
Cryptosporidium	B-SPEC
spp	O
.,	O
Escherichia	B-SPEC
coli	I-SPEC
F5	O
,	O
rota	O
and	O
corona	B-SPEC
virus	B-SPEC
)	O
was	O
evaluated	O
based	O
on	O
targeted	O
sampling	O
of	O
high	O
risk	O
calf	O
groups	O
;	O
in	O
each	O
herd	O
,	O
blood	O
and	O
faecal	O
samples	O
were	O
collected	O
from	O
calves	O
1	O
-	O
7	O
and	O
1	O
-	O
14	O
days	O
old	O
,	O
respectively	O
.	O

Chronically	O
instrumented	O
sheep	B-SPEC
were	O
allocated	O
to	O
a	O
sham	O
-	O
injured	O
group	O
(	O
n	O
=	O
6	O
),	O
an	O
injured	O
and	O
untreated	O
group	O
(	O
n	O
=	O
6	O
),	O
or	O
an	O
injured	O
group	O
treated	O
with	O
simultaneous	O
infusion	O
of	O
selective	O
inducible	O
and	O
neuronal	O
NO	O
synthase	O
inhibitors	O
(	O
n	O
=	O
5	O
).	O

The	O
Virochip	O
is	O
a	O
panviral	O
DNA	O
microarray	O
that	O
is	O
capable	O
of	O
detecting	O
all	O
known	O
viruses	B-SPEC
,	O
as	O
well	O
as	O
novel	O
viruses	B-SPEC
related	O
to	O
known	O
viral	O
families	O
,	O
in	O
a	O
single	O
assay	O
and	O
has	O
been	O
used	O
to	O
successfully	O
identify	O
known	O
and	O
novel	O
viral	O
agents	O
in	O
clinical	O
human	B-SPEC
specimens	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
),	O
a	O
deubiquitinating	O
enzyme	O
,	O
reportedly	O
blocks	O
poly	O
I	O
:	O
C	O
-	O
induced	O
activation	O
of	O
interferon	O
regulatory	O
factor	O
3	O
and	O
nuclear	O
factor	O
kappa	O
B	O
,	O
reducing	O
interferon	O
(	O
IFN	O
)	O
induction	O
.	O

As	O
the	O
costs	O
of	O
next	O
-	O
generation	O
sequencing	O
decrease	O
,	O
the	O
pathogen	O
diversity	O
described	O
by	O
virus	B-SPEC
metagenomes	O
will	O
provide	O
an	O
unbiased	O
guide	O
for	O
subsequent	O
cell	O
culture	O
and	O
quantitative	O
pathogen	O
analyses	O
and	O
ensures	O
that	O
highly	O
enriched	O
and	O
relevant	O
pathogens	O
are	O
not	O
neglected	O
in	O
exposure	O
and	O
risk	O
assessments	O
.	O

TITLE	O
:	O
Isolation	O
of	O
an	O
equine	B-SPEC
coronavirus	B-SPEC
from	O
adult	O
horses	B-SPEC
with	O
pyrogenic	O
and	O
enteric	O
disease	O
and	O
its	O
antigenic	O
and	O
genomic	O
characterization	O
in	O
comparison	O
with	O
the	O
NC99	O
strain	O
.	O

On	O
comparing	O
the	O
isolated	O
virus	B-SPEC
(	O
isolate	O
Tokachi09	O
)	O
with	O
the	O
equine	B-SPEC
coronavirus	B-SPEC
NC99	O
strain	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
in	O
several	O
biological	O
properties	O
such	O
as	O
hemagglutinating	O
activity	O
,	O
antigenicity	O
(	O
in	O
indirect	O
immunofluorescence	O
and	O
neutralization	O
tests	O
),	O
and	O
one	O
-	O
step	O
growth	O
(	O
in	O
cell	O
culture	O
).	O

ABSTRACT	O
:	O
Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
causes	O
respiratory	O
infections	O
during	O
the	O
first	O
year	O
of	O
life	O
.	O

In	O
LPS	O
-	O
treated	O
rats	B-SPEC
,	O
we	O
observed	O
increased	O
levels	O
of	O
oxidative	O
products	O
,	O
decreased	O
levels	O
of	O
antioxidants	O
in	O
lung	O
tissues	O
and	O
increased	O
levels	O
of	O
serum	O
marker	O
enzymes	O
,	O
suggesting	O
multiple	O
organ	O
injury	O
.	O

In	O
the	O
control	O
group	O
,	O
the	O
viruses	B-SPEC
most	O
frequently	O
found	O
were	O
rhinovirus	B-SPEC
(	O
24	O
.	O
2	O
%)	O
and	O
adenovirus	B-SPEC
(	O
21	O
.	O
2	O
%).	O

Sequence	O
alignment	O
and	O
structural	O
bioinformatics	O
analyses	O
revealed	O
that	O
the	O
catalytic	O
residues	O
(	O
Cys51	O
and	O
His148	O
)	O
are	O
highly	O
conserved	O
in	O
FMDV	B-SPEC
Lb	O
(	O
pro	O
)	O
of	O
all	O
seven	O
serotypes	O
and	O
that	O
the	O
topology	O
of	O
FMDV	B-SPEC
Lb	O
(	O
pro	O
)	O
is	O
remarkably	O
similar	O
to	O
that	O
of	O
ubiquitin	O
-	O
specific	O
protease	O
14	O
(	O
USP14	O
),	O
a	O
cellular	O
deubiquitylation	O
enzyme	O
(	O
DUB	O
),	O
and	O
to	O
that	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
),	O
a	O
coronaviral	O
DUB	O
.	O

We	O
show	O
that	O
these	O
siRNAs	O
could	O
effectively	O
and	O
specifically	O
block	O
the	O
isolated	O
N	O
gene	O
expression	O
in	O
mammal	B-SPEC
cells	O
.	O

Earlier	O
research	O
determined	O
metabolic	O
oxidative	O
stress	O
in	O
hosts	O
deficient	O
in	O
antioxidant	O
selenium	O
(	O
Se	O
)	O
(<	O
1	O
μMol	O
Se	O
/	O
L	O
of	O
blood	O
)	O
induces	O
both	O
impaired	O
human	B-SPEC
host	O
immunocompetence	O
and	O
rapidly	O
mutated	O
benign	O
variants	O
of	O
RNA	O
viruses	B-SPEC
to	O
virulence	O
.	O

Herein	O
is	O
described	O
the	O
role	O
of	O
micronutrient	O
Se	O
deficiency	O
on	O
the	O
evolution	O
of	O
some	O
contemporary	O
RNA	O
viruses	B-SPEC
and	O
their	O
subsequent	O
VIDs	O
.	O

TITLE	O
:	O
Distinct	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
-	O
induced	O
acute	O
lung	O
injury	O
pathways	O
in	O
two	O
different	O
nonhuman	O
primate	B-SPEC
species	B-SPEC
.	O

In	O
summary	O
,	O
we	O
show	O
that	O
TMPRSS2	O
might	O
promote	O
viral	O
spread	O
and	O
pathogenesis	O
by	O
diminishing	O
viral	O
recognition	O
by	O
neutralizing	O
antibodies	O
and	O
by	O
activating	O
SARS	O
S	O
for	O
cell	O
-	O
cell	O
and	O
virus	B-SPEC
-	O
cell	O
fusion	O
.	O

This	O
paper	O
describes	O
the	O
particular	O
analyses	O
of	O
the	O
transcriptome	O
of	O
human	B-SPEC
lung	O
tissue	O
that	O
was	O
infected	O
by	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

The	O
result	O
showed	O
that	O
random	O
-	O
priming	O
cDNA	O
library	O
is	O
valid	O
for	O
the	O
investigation	O
of	O
transcript	O
diversity	O
in	O
the	O
virus	B-SPEC
-	O
infected	O
tissue	O
.	O

TITLE	O
:	O
A	O
case	O
of	O
successfully	O
treated	O
acute	O
respiratory	O
distress	O
syndrome	O
complicating	O
Plasmodium	B-SPEC
falciparum	I-SPEC
malaria	O
.	O

Virus	B-SPEC
replication	O
assay	O
in	O
17C1	O
-	O
1	O
cells	O
showed	O
the	O
plaque	O
phenotype	O
and	O
replication	O
characterization	O
of	O
constructed	O
Wu	O
"""-"	O
ts18	O
(	O
cd	O
)	O
were	O
indistinguishable	O
from	O
the	O
reported	O
ts	O
mutant	O
Wu	O
"""-"	O
ts18	O
.	O

Then	O
we	O
cultured	O
the	O
ts	O
mutant	O
Wu	O
"""-"	O
ts18	O
(	O
cd	O
)	O
at	O
non	O
-	O
permissive	O
temperature	O
39	O
.	O
5	O
°	O
C	O
,	O
which	O
""""	O
forced	O
""""	O
the	O
ts	O
recombinant	O
virus	B-SPEC
to	O
use	O
second	O
-	O
site	O
mutation	O
to	O
revert	O
from	O
a	O
ts	O
to	O
a	O
non	O
-	O
ts	O
phenotype	O
.	O

Both	O
passage	O
levels	O
were	O
tested	O
for	O
efficacy	O
in	O
SPF	O
chickens	B-SPEC
and	O
passage	O
level	O
85	O
was	O
tested	O
for	O
efficacy	O
in	O
commercial	O
chickens	B-SPEC
with	O
maternally	O
derived	O
antibodies	O
(	O
MDA	O
)	O
against	O
a	O
challenge	O
with	O
QX	O
-	O
like	O
strain	O
IB	O
D388	O
.	O

Yet	O
in	O
critical	O
illness	O
other	O
factors	O
also	O
affect	O
respiratory	O
muscle	O
function	O
,	O
including	O
prolonged	O
use	O
of	O
neuromuscular	O
blocking	O
agents	O
,	O
administration	O
of	O
corticosteroids	O
,	O
and	O
sepsis	B-SPEC
.	O

Only	O
17	O
human	B-SPEC
,	O
animal	B-SPEC
,	O
or	O
lung	O
-	O
model	O
studies	O
have	O
examined	O
these	O
claims	O
,	O
either	O
directly	O
or	O
indirectly	O
.	O

Prehospital	O
use	O
of	O
statins	O
may	O
be	O
protective	O
against	O
sepsis	B-SPEC
and	O
acute	O
lung	O
injury	O
.	O

ABSTRACT	O
:	O
Granulocytes	O
play	O
an	O
important	O
role	O
in	O
the	O
host	O
defense	O
against	O
invading	O
microorganisms	O
such	O
as	O
bacteria	B-SPEC
and	O
fungi	B-SPEC
(	O
1	O
,	O
2	O
).	O

Furthermore	O
,	O
the	O
mode	O
of	O
action	O
of	O
UDA	O
in	O
vitro	O
was	O
further	O
investigated	O
using	O
live	O
SARS	O
-	O
CoV	O
Urbani	O
strain	O
virus	B-SPEC
and	O
retroviral	B-SPEC
particles	O
pseudotyped	O
with	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
).	O

In	O
addition	O
,	O
we	O
demonstrated	O
that	O
UDA	O
neutralizes	O
the	O
virus	B-SPEC
infectivity	O
,	O
presumably	O
by	O
binding	O
to	O
the	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
glycoprotein	O
.	O

Finally	O
,	O
the	O
target	O
molecule	O
for	O
the	O
inhibition	O
of	O
virus	B-SPEC
replication	O
was	O
partially	O
characterized	O
.	O

Similarly	O
,	O
the	O
low	O
levels	O
of	O
CCoV	O
observed	O
after	O
basolateral	O
exposure	O
to	O
virus	B-SPEC
was	O
abolished	O
following	O
mAb	O
treatment	O
of	O
that	O
side	O
.	O

TITLE	O
:	O
[	O
Isolation	O
and	O
characteristics	O
of	O
virus	B-SPEC
culture	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
LJB	O
/	O
03	O
].	O

Taken	O
together	O
,	O
these	O
tests	O
showed	O
positive	O
isolation	O
of	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
Mobility	O
and	O
interactions	O
of	O
coronavirus	B-SPEC
nonstructural	O
protein	O
4	O
.	O

TITLE	O
:	O
Comparative	O
anti	O
-	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
activity	O
of	O
(-)-	O
pinene	O
:	O
effect	O
on	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
.	O

To	O
improve	O
the	O
functionality	O
of	O
the	O
vaccine	O
and	O
investigate	O
its	O
potential	O
as	O
a	O
delivery	O
vector	O
for	O
foreign	O
antigens	O
and	O
immunomodulatory	O
proteins	O
,	O
we	O
developed	O
a	O
derivative	O
of	O
ts	O
-	O
11	O
expressing	O
infectious	O
bronchitis	O
virus	B-SPEC
-	O
S1	O
glycoprotein	O
(	O
IBV	B-SPEC
-	O
S1	O
)	O
and	O
releasing	O
chicken	B-SPEC
interleukin	O
-	O
6	O
into	O
the	O
extracellular	O
milieu	O
(	O
MG	O
ts	O
-	O
11	O
C3	O
(+	O
CS	O
))	O
using	O
a	O
transposon	O
-	O
based	O
delivery	O
vector	O
.	O

TITLE	O
:	O
Emodin	O
inhibits	O
current	O
through	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
3a	O
protein	O
.	O

Here	O
we	O
demonstrate	O
that	O
emodin	O
can	O
inhibit	O
the	O
3a	O
ion	O
channel	O
of	O
coronavirus	B-SPEC
SARS	O
-	O
CoV	O
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
as	O
well	O
as	O
virus	B-SPEC
release	O
from	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
with	O
a	O
K1	O
/	O
2	O
value	O
of	O
about	O
20	O
μM	O
.	O
We	O
suggest	O
that	O
viral	O
ion	O
channels	O
,	O
in	O
general	O
,	O
may	O
be	O
a	O
good	O
target	O
for	O
the	O
development	O
of	O
antiviral	O
agents	O
.	O

It	O
remains	O
unknown	O
whether	O
unrelated	O
infections	O
will	O
compromise	O
numbers	O
of	O
Plasmodium	B-SPEC
-	O
specific	O
memory	O
CD8	O
T	O
cells	O
and	O
thus	O
limit	O
the	O
duration	O
of	O
antimalarial	O
immunity	O
generated	O
by	O
subunit	O
vaccination	O
.	O

However	O
,	O
and	O
of	O
relevance	O
to	O
deployment	O
of	O
Plasmodium	B-SPEC
vaccines	O
in	O
areas	O
endemic	O
to	O
malaria	O
,	O
attrition	O
of	O
memory	O
CD8	O
T	O
cells	O
was	O
reversed	O
by	O
booster	O
immunization	O
,	O
which	O
restored	O
protection	O
.	O

These	O
data	O
suggest	O
that	O
regular	O
booster	O
immunizations	O
may	O
be	O
required	O
to	O
sustain	O
protective	O
vaccine	O
-	O
induced	O
Plasmodium	B-SPEC
-	O
specific	O
memory	O
CD8	O
T	O
cells	O
in	O
the	O
face	O
of	O
attrition	O
caused	O
by	O
unrelated	O
infections	O
.	O

In	O
this	O
study	O
we	O
sequentially	O
followed	O
up	O
19	O
recovered	O
SARS	O
patients	O
over	O
a	O
3	O
-	O
y	O
period	O
in	O
order	B-SPEC
to	O
characterize	O
the	O
dynamic	O
changes	O
in	O
antibody	O
responses	O
against	O
viral	O
components	O
in	O
detail	O
.	O

For	O
neutralizing	O
antibodies	O
,	O
neutralizing	O
activity	O
was	O
detectable	O
in	O
89	O
%	O
of	O
recovered	O
patients	O
in	O
the	O
3rd	O
y	O
.	O
S	O
protein	O
-	O
specific	O
IgG	O
levels	O
(	O
r	O
=	O
0	O
.	O
717	O
)	O
correlated	O
better	O
with	O
neutralizing	O
activity	O
than	O
SARS	O
coronavirus	B-SPEC
-	O
specific	O
IgG	O
levels	O
(	O
r	O
=	O
0	O
.	O
571	O
).	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
:	O
a	O
clinically	O
important	O
virus	B-SPEC
?	O

Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
have	O
only	O
recently	O
been	O
shown	O
to	O
cause	O
both	O
lower	O
and	O
upper	O
respiratory	O
tract	O
infections	O
.	O

Infection	O
with	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
has	O
since	O
been	O
shown	O
to	O
be	O
a	O
common	O
worldwide	O
occurrence	O
and	O
has	O
been	O
associated	O
with	O
many	O
clinical	O
symptoms	O
and	O
diagnoses	O
,	O
including	O
severe	O
lower	O
respiratory	O
tract	O
infection	O
,	O
croup	O
and	O
bronchiolitis	O
.	O

In	O
this	O
study	O
we	O
demonstrate	O
the	O
ability	O
of	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
mediated	O
RNA	O
interference	O
(	O
RNAi	O
)	O
to	O
inhibit	O
the	O
replication	O
of	O
virulent	O
FCoV	O
strain	O
FIPV	O
WSU	O
79	O
-	O
1146	O
in	O
an	O
immortalised	O
feline	B-SPEC
cell	O
line	O
.	O

These	O
results	O
suggested	O
that	O
the	O
four	O
species	B-SPEC
of	O
siRNAs	O
can	O
efficiently	O
inhibit	O
PHE	O
-	O
CoV	O
genome	O
replication	O
and	O
infectious	O
virus	B-SPEC
production	O
.	O

To	O
this	O
aim	O
,	O
we	O
designed	O
,	O
through	O
a	O
bioinformatic	O
approach	O
,	O
8	O
potentially	O
immunogenic	O
peptides	O
from	O
the	O
protein	O
N	O
corresponding	O
to	O
sequences	O
of	O
residues	O
14	O
,	O
182	O
,	O
198	O
detected	O
only	O
in	O
FCoVs	O
from	O
FIP	O
cats	B-SPEC
(	O
virulent	O
strains	O
),	O
only	O
in	O
FCoVs	O
from	O
healthy	O
cats	B-SPEC
(	O
avirulent	O
strains	O
)	O
and	O
both	O
in	O
FIP	O
and	O
in	O
healthy	O
cats	B-SPEC
(	O
mixed	O
strains	O
).	O

The	O
peptides	O
or	O
a	O
sham	O
solution	O
were	O
incubated	O
with	O
whole	O
blood	O
from	O
16	O
cats	B-SPEC
(	O
7	O
healthy	O
and	O
9	O
with	O
chronic	O
diseases	O
other	O
than	O
FIP	O
)	O
and	O
IFN	O
-	O
γ	O
concentration	O
was	O
measured	O
on	O
plasma	O
using	O
an	O
ELISA	O
system	O
.	O

The	O
mean	O
plasma	O
concentration	O
of	O
IFN	O
-	O
γ	O
in	O
samples	O
incubated	O
with	O
peptides	O
decreased	O
and	O
the	O
expression	O
of	O
IFN	O
-	O
γmRNA	O
did	O
not	O
change	O
compared	O
with	O
the	O
sham	O
solution	O
,	O
except	O
for	O
some	O
cats	B-SPEC
with	O
chronic	O
diseases	O
(	O
which	O
probably	O
have	O
a	O
""""	O
pre	O
-	O
activated	O
""""	O
immune	O
response	O
).	O

The	O
severity	O
of	O
pandemic	O
influenza	O
A	O
/	O
H1N1	O
/	O
2009	O
was	O
determined	O
by	O
massive	O
bilateral	O
pneumonia	O
,	O
interstitial	O
(	O
alveolar	O
)	O
pulmonary	O
edema	O
,	O
formation	O
of	O
diffuse	O
bilateral	O
lung	O
fibrosis	O
at	O
the	O
outcome	O
of	O
severe	O
virus	B-SPEC
pneumonia	O
(	O
acute	O
respiratory	O
distress	O
syndrome	O
)	O
with	O
a	O
decrease	O
in	O
vital	O
and	O
diffusing	O
capacities	O
,	O
thereby	O
generating	O
a	O
need	O
to	O
follow	O
up	O
this	O
patient	O
category	O
and	O
,	O
possibly	O
,	O
to	O
elaborate	O
special	O
rehabilitation	O
programs	O
.	O

Adenovirus	B-SPEC
,	O
coronavirus	B-SPEC
or	O
enterovirus	B-SPEC
was	O
not	O
detected	O
.	O

These	O
data	O
provide	O
a	O
better	O
understanding	O
of	O
the	O
viral	O
etiology	O
of	O
outpatients	O
with	O
ILI	O
and	O
describe	O
for	O
the	O
first	O
time	O
importance	O
of	O
these	O
viruses	B-SPEC
in	O
different	O
age	O
group	O
and	O
their	O
period	O
of	O
circulation	O
.	O

TITLE	O
:	O
Amplification	O
of	O
emerging	O
viruses	B-SPEC
in	O
a	O
bat	B-SPEC
colony	O
.	O

TITLE	O
:	O
Crystallization	O
and	O
diffraction	O
analysis	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
nsp10	O
-	O
nsp16	O
complex	O
.	O

Although	O
palm	O
civet	B-SPEC
was	O
suspected	O
to	O
be	O
the	O
carrier	O
of	O
SARS	O
,	O
it	O
was	O
interesting	O
to	O
note	O
that	O
,	O
after	O
the	O
SARS	O
epidemic	O
,	O
the	O
proportion	O
of	O
people	O
surveyed	O
who	O
ate	O
palm	O
civets	B-SPEC
had	O
declined	O
only	O
slightly	O
.	O

Based	O
on	O
the	O
high	O
specificity	O
,	O
sensitivity	O
,	O
and	O
stability	O
of	O
the	O
immunochromatographic	O
strip	O
,	O
it	O
would	O
be	O
suitable	O
for	O
on	O
-	O
site	O
detection	O
of	O
PHEV	O
antibodies	O
in	O
order	B-SPEC
to	O
monitor	O
PHEV	O
infections	O
in	O
an	O
animal	B-SPEC
population	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
teschovirus	I-SPEC
polioencephalomyelitis	O
in	O
western	O
Canada	O
.	O

ABSTRACT	O
:	O
Beginning	O
in	O
2002	O
,	O
a	O
small	O
number	O
of	O
pig	B-SPEC
farms	O
in	O
western	O
Canada	O
began	O
reporting	O
4	O
-	O
7	O
-	O
week	O
-	O
old	O
pigs	B-SPEC
with	O
bilateral	O
hind	O
-	O
end	O
paresis	O
or	O
paralysis	O
.	O

Low	O
numbers	O
of	O
pigs	B-SPEC
were	O
affected	O
,	O
some	O
died	O
,	O
most	O
had	O
to	O
be	O
euthanized	O
,	O
and	O
those	O
that	O
survived	O
had	O
reduced	O
weight	O
gains	O
and	O
neurological	O
deficits	O
.	O

Of	O
these	O
,	O
37	O
samples	O
tested	O
positive	O
for	O
bovine	B-SPEC
kobuvirus	I-SPEC
.	O

A	O
neighbor	O
-	O
joining	O
tree	O
grouped	O
36	O
of	O
the	O
Korean	O
kobuvirus	B-SPEC
strains	O
(	O
with	O
the	O
exception	O
of	O
the	O
KB8	O
strain	O
)	O
into	O
three	O
clusters	O
(	O
G1	O
,	O
G3	O
,	O
and	O
G4	O
),	O
while	O
strains	O
derived	O
from	O
Thailand	O
and	O
Japan	O
(	O
except	O
the	O
U1	O
strain	O
)	O
were	O
included	O
in	O
the	O
G2	O
cluster	O
.	O

All	O
3	O
species	B-SPEC
of	O
HRV	O
were	O
detected	O
with	O
HRV	O
-	O
C	O
being	O
the	O
most	O
common	O
(	O
52	O
%)	O
followed	O
by	O
HRV	O
-	O
A	O
(	O
37	O
%)	O
and	O
HRV	O
-	O
B	O
(	O
11	O
%).	O

Infection	O
with	O
other	O
respiratory	O
viruses	B-SPEC
occurred	O
in	O
20	O
/	O
128	O
(	O
16	O
%)	O
of	O
HRV	O
-	O
positive	O
children	O
and	O
in	O
26	O
/	O
92	O
(	O
28	O
%)	O
of	O
HRV	O
-	O
negative	O
samples	O
.	O

V	O
-	O
B	O
,	O
and	O
adenovirus	B-SPEC
,	O
RS	O
virus	B-SPEC
,	O
metapneumovirus	B-SPEC
,	O
and	O
bocavirus	B-SPEC
--	O
were	O
compared	O
to	O
NAT	O
results	O
.	O

TITLE	O
:	O
The	O
polypyrimidine	O
tract	O
-	O
binding	O
protein	O
affects	O
coronavirus	B-SPEC
RNA	O
accumulation	O
levels	O
and	O
relocalizes	O
viral	O
RNAs	O
to	O
novel	O
cytoplasmic	O
domains	O
different	O
from	O
replication	O
-	O
transcription	O
sites	O
.	O

TITLE	O
:	O
A	O
virus	B-SPEC
-	O
binding	O
hot	O
spot	B-SPEC
on	O
human	B-SPEC
angiotensin	O
-	O
converting	O
enzyme	O
2	O
is	O
critical	O
for	O
binding	O
of	O
two	O
different	O
coronaviruses	O
.	O

We	O
recently	O
determined	O
the	O
crystal	O
structures	O
of	O
NL63	O
coronavirus	B-SPEC
(	O
NL63	O
-	O
CoV	O
)	O
and	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
receptor	O
-	O
binding	O
domains	O
(	O
RBDs	O
),	O
each	O
complexed	O
with	O
their	O
common	O
receptor	O
,	O
human	B-SPEC
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
hACE2	O
),	O
and	O
proposed	O
the	O
existence	O
of	O
a	O
virus	B-SPEC
-	O
binding	O
hot	O
spot	B-SPEC
on	O
hACE2	O
.	O

Here	O
we	O
investigated	O
the	O
function	O
of	O
this	O
hypothetical	O
hot	O
spot	B-SPEC
using	O
structure	O
-	O
guided	O
biochemical	O
and	O
functional	O
assays	O
.	O

The	O
hot	O
spot	B-SPEC
consists	O
of	O
a	O
salt	O
bridge	O
surrounded	O
by	O
hydrophobic	O
tunnel	O
walls	O
.	O

Furthermore	O
,	O
NL63	O
-	O
CoV	O
RBD	O
inhibits	O
hACE2	O
-	O
dependent	O
transduction	O
by	O
SARS	O
-	O
CoV	O
spike	O
protein	O
,	O
a	O
successful	O
application	O
of	O
the	O
hot	O
spot	B-SPEC
theory	O
that	O
has	O
the	O
potential	O
to	O
become	O
a	O
new	O
antiviral	O
strategy	O
against	O
SARS	O
-	O
CoV	O
infections	O
.	O

Multiplex	O
PCR	O
assays	O
have	O
additional	O
advantages	O
in	O
providing	O
an	O
economical	O
and	O
comprehensive	O
panel	O
for	O
many	O
common	O
respiratory	O
viruses	B-SPEC
.	O

Targets	O
not	O
detected	O
by	O
the	O
RVP	O
Fast	O
assay	O
included	O
primarily	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
,	O
parainfluenza	B-SPEC
virus	I-SPEC
type	I-SPEC
2	I-SPEC
,	O
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
.	O

Antigenic	O
and	O
genomic	O
characterizations	O
of	O
the	O
virus	B-SPEC
(	O
isolate	O
PHEV	O
-	O
JLsp09	O
)	O
were	O
based	O
on	O
multiplex	O
PCR	O
and	O
negative	O
staining	O
electron	O
microscopy	O
and	O
sequence	O
analysis	O
of	O
the	O
Hemagglutinin	O
-	O
esterase	O
(	O
HE	O
)	O
gene	O
.	O

Mice	B-SPEC
were	O
infected	O
with	O
the	O
isolated	O
virus	B-SPEC
.	O

This	O
viral	O
strain	O
(	O
isolate	O
PHEV	O
-	O
JLsp09	O
)	O
found	O
in	O
the	O
Siping	O
area	O
of	O
Jilin	O
Province	O
in	O
China	O
is	O
evolutionally	O
closest	O
to	O
the	O
HEV	B-SPEC
-	O
67N	O
stain	O
(	O
North	O
American	O
strain	O
),	O
indicating	O
that	O
this	O
viral	O
strain	O
evolved	O
from	O
the	O
PHEV	O
from	O
North	O
America	O
.	O

Comparisons	O
of	O
global	O
miRNA	O
profiles	O
in	O
animal	B-SPEC
models	O
of	O
ALI	O
and	O
VILI	O
identified	O
several	O
miRNAs	O
(	O
eg	O
,	O
miR	O
-	O
146a	O
and	O
miR	O
-	O
155	O
)	O
previously	O
implicated	O
in	O
immune	O
response	O
and	O
inflammatory	O
pathways	O
.	O

By	O
virtue	O
of	O
their	O
unknown	O
biology	O
,	O
newly	O
-	O
emerging	O
diseases	O
are	O
more	O
challenging	O
than	O
familiar	O
human	B-SPEC
scourges	O
.	O

To	O
provide	O
the	O
most	O
accurate	O
and	O
timely	O
advice	O
possible	O
,	O
especially	O
about	O
the	O
possible	O
impact	O
of	O
measures	O
designed	O
to	O
control	O
diseases	O
caused	O
by	O
novel	O
human	B-SPEC
pathogens	O
,	O
we	O
must	O
appreciate	O
the	O
value	O
and	O
difficulty	O
of	O
policy	O
-	O
oriented	O
modeling	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
highly	O
contagious	O
respiratory	O
coronavirus	B-SPEC
of	O
domestic	O
chickens	B-SPEC
.	O

These	O
preliminary	O
data	O
provide	O
important	O
clues	O
regarding	O
potential	O
mechanisms	O
for	O
IBV	B-SPEC
tissue	O
tropism	O
and	O
spread	O
and	O
show	O
that	O
the	O
nature	O
of	O
the	O
virus	B-SPEC
isolate	O
influences	O
the	O
early	O
progression	O
of	O
IBV	B-SPEC
infection	O
.	O

Using	O
cycloheximide	O
and	O
puromycin	O
,	O
we	O
have	O
studied	O
the	O
effect	O
of	O
translation	O
inhibition	O
on	O
the	O
RNA	O
synthesis	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

To	O
identify	O
potential	O
smaller	O
,	O
5	O
'-	O
common	O
signals	O
,	O
each	O
of	O
three	O
stem	O
-	O
loop	O
(	O
SL	O
)	O
signaling	O
domains	O
and	O
one	O
inter	O
-	O
stem	O
-	O
loop	O
domain	O
from	O
the	O
BCoV	O
5	O
'	O
UTR	O
was	O
tested	O
by	O
replacing	O
its	O
counterpart	O
in	O
the	O
MHV	B-SPEC
genome	O
.	O

TITLE	O
:	O
Simultaneous	O
detection	O
of	O
antibodies	O
to	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
recombinant	O
structural	O
proteins	O
by	O
a	O
microsphere	O
-	O
based	O
multiplex	O
fluorescence	O
immunoassay	O
.	O

The	O
reactivities	O
of	O
236	O
naturally	O
infected	O
mouse	B-SPEC
sera	O
were	O
examined	O
;	O
227	O
samples	O
were	O
positive	O
by	O
MFI	O
using	O
S2	O
antigen	O
(	O
96	O
%	O
sensitivity	O
),	O
and	O
208	O
samples	O
were	O
positive	O
using	O
N	O
antigen	O
(	O
88	O
%	O
sensitivity	O
).	O

Thus	O
,	O
this	O
MFI	O
-	O
based	O
serologic	O
assay	O
using	O
the	O
S2	O
and	O
N	O
antigens	O
promises	O
to	O
be	O
a	O
reliable	O
diagnostic	O
method	O
,	O
representing	O
a	O
highly	O
sensitive	O
and	O
specific	O
alternative	O
to	O
traditional	O
ELISA	O
for	O
detection	O
of	O
coronavirus	B-SPEC
infections	O
in	O
laboratory	O
mouse	B-SPEC
and	O
rat	B-SPEC
colonies	O
.	O

We	O
retrospectively	O
analyzed	O
medical	O
charts	O
of	O
patients	O
admitted	O
in	O
""""	O
Swine	B-SPEC
Flu	O
ICU	O
""""	O
with	O
ARDS	O
from	O
August	O
2009	O
to	O
May	O
2010	O
.	O

TITLE	O
:	O
Improved	O
prediction	O
of	O
MHC	O
class	B-SPEC
I	O
binders	O
/	O
non	O
-	O
binders	O
peptides	O
through	O
artificial	O
neural	O
network	O
using	O
variable	O
learning	O
rate	O
:	O
SARS	O
corona	B-SPEC
virus	B-SPEC
,	O
a	O
case	O
study	O
.	O

The	O
presence	O
of	O
bronchiectasis	O
(	O
0	O
%	O
in	O
SARS	O
)	O
may	O
point	O
towards	O
metapneumovirus	B-SPEC
while	O
crazy	O
paving	O
pattern	O
is	O
more	O
suggestive	O
of	O
SARS	O
.	O

This	O
method	O
uses	O
a	O
natural	O
representation	O
of	O
genomic	O
data	O
by	O
binary	O
indicator	B-SPEC
sequences	O
of	O
each	O
nucleotide	O
(	O
adenine	O
(	O
A	O
),	O
cytosine	O
(	O
C	O
),	O
guanine	O
(	O
G	O
),	O
and	O
thymine	O
(	O
T	O
)).	O

Equid	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
and	O
equine	B-SPEC
rhinitis	I-SPEC
A	I-SPEC
virus	I-SPEC
were	O
prevalent	O
,	O
and	O
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
and	O
equid	B-SPEC
herpesvirus	I-SPEC
3	I-SPEC
were	O
detected	O
over	O
a	O
wide	O
area	O
though	O
their	O
rates	O
of	O
antibody	O
-	O
positivity	O
were	O
not	O
high	O
.	O

Bovine	B-SPEC
coronavirus	B-SPEC
antibodies	O
were	O
detected	O
at	O
a	O
high	O
rate	O
,	O
but	O
it	O
was	O
not	O
clear	O
whether	O
they	O
were	O
due	O
to	O
horse	B-SPEC
coronavirus	B-SPEC
.	O

Common	O
complications	O
of	O
influenza	B-SPEC
virus	I-SPEC
include	O
upper	O
and	O
lower	O
respiratory	O
tract	O
infections	O
,	O
otitis	O
media	O
,	O
myocarditis	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multi	O
-	O
organ	O
failure	O
.	O

Of	O
75	O
stool	O
samples	O
,	O
31	O
contained	O
at	O
least	O
1	O
parasitic	O
infection	O
,	O
including	O
Taeniid	O
tapeworms	B-SPEC
,	O
the	O
nematodes	B-SPEC
Toxocara	B-SPEC
canis	I-SPEC
and	O
Toxascaris	B-SPEC
leonina	I-SPEC
,	O
and	O
the	O
protozoans	O
Isospora	B-SPEC
sp	O
.,	O
Giardia	B-SPEC
sp	O
.,	O
Cryptosporidium	B-SPEC
sp	O
.,	O
and	O
Sarcocystis	B-SPEC
sp	O
.	O
This	O
work	O
provides	O
a	O
sound	O
baseline	O
for	O
future	O
monitoring	O
of	O
infectious	O
agents	O
that	O
could	O
affect	O
dogs	B-SPEC
,	O
sympatric	O
wild	O
canids	B-SPEC
,	O
other	O
wildlife	O
,	O
and	O
humans	B-SPEC
.	O

TITLE	O
:	O
[	O
Expression	O
of	O
green	O
fluorescent	O
protein	O
using	O
an	O
infectious	O
cDNA	O
clone	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
].	O

Overall	O
,	O
PIKA	B-SPEC
could	O
be	O
a	O
good	O
mucosal	O
adjuvant	O
candidate	O
for	O
inactivated	O
SARS	O
-	O
CoV	O
vaccine	O
for	O
use	O
in	O
possible	O
future	O
pandemic	O
.	O

Fifty	O
-	O
three	O
compounds	O
from	O
35	O
main	O
groups	O
were	O
tested	O
in	O
an	O
in	O
vitro	O
assay	O
for	O
inhibition	O
of	O
3CL	O
(	O
pro	O
)	O
expressed	O
by	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

Bronchoalveolar	O
lavage	O
and	O
serum	O
from	O
patients	O
with	O
acute	O
exacerbation	O
of	O
idiopathic	O
pulmonary	O
fibrosis	O
,	O
stable	O
disease	O
,	O
and	O
acute	O
lung	O
injury	O
were	O
tested	O
for	O
viral	O
nucleic	O
acid	O
using	O
multiplex	O
polymerase	O
chain	O
reaction	O
,	O
pan	B-SPEC
-	O
viral	O
microarray	O
,	O
and	O
high	O
-	O
throughput	O
cDNA	O
sequencing	O
.	O

TITLE	O
:	O
[	O
Experimental	O
study	O
on	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
analysis	O
of	O
relevant	O
factors	O
in	O
rabbits	B-SPEC
subjected	O
to	O
thoracic	O
blast	O
trauma	O
].	O

ABSTRACT	O
:	O
To	O
reproduce	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
model	O
in	O
rabbit	B-SPEC
induced	O
by	O
chest	O
blast	O
injury	O
and	O
to	O
analyze	O
the	O
pathogenesis	O
and	O
causes	O
of	O
early	O
death	O
in	O
order	B-SPEC
to	O
provide	O
the	O
basis	O
for	O
the	O
early	O
diagnosis	O
of	O
lung	O
blast	O
injury	O
and	O
its	O
early	O
warning	O
system	O
to	O
facilitate	O
an	O
early	O
treatment	O
.	O

The	O
rabbits	B-SPEC
survived	O
in	O
poor	O
general	O
condition	O
,	O
and	O
arterial	O
partial	O
pressure	O
of	O
oxygen	O
(	O
PaO	O
(	O
2	O
))	O
lowered	O
within	O
6	O
hours	O
.	O

It	O
was	O
suggested	O
that	O
vascular	O
permeability	O
factors	O
,	O
including	O
VEGF	O
,	O
produced	O
by	O
FIPV	O
-	O
infected	O
monocytes	O
/	O
macrophages	O
might	O
increase	O
the	O
vascular	O
permeability	O
and	O
the	O
amounts	O
of	O
effusion	O
in	O
cats	B-SPEC
with	O
FIP	O
.	O

Out	O
of	O
total	O
42	O
patients	O
,	O
main	O
etiologies	O
were	O
sepsis	B-SPEC
(	O
30	O
.	O
7	O
%),	O
polytrauma	O
(	O
25	O
%),	O
fat	O
embolism	O
syndrome	O
(	O
25	O
%),	O
acute	O
severe	O
pancreatitis	O
(	O
5	O
.	O
7	O
%)	O
pneumonia	O
(	O
5	O
.	O
7	O
%)	O
and	O
others	O
(	O
8	O
.	O
3	O
%).	O

I	O
also	O
use	O
the	O
example	O
of	O
HIV	B-SPEC
and	O
CMV	B-SPEC
to	O
illustrate	O
how	O
two	O
unrelated	O
enveloped	O
viruses	B-SPEC
use	O
a	O
similar	O
SCHOOL	O
mechanism	O
to	O
modulate	O
the	O
host	O
immune	O
response	O
mediated	O
by	O
two	O
functionally	O
different	O
receptors	O
:	O
T	O
cell	O
antigen	O
receptor	O
and	O
natural	O
killer	O
cell	O
receptor	O
,	O
NKp30	O
.	O

(	O
142	O
/	O
597	O
,	O
23	O
.	O
8	O
%),	O
coronavirus	B-SPEC
(	O
129	O
/	O
597	O
,	O
21	O
.	O
6	O
%)	O
and	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
(	O
104	O
/	O
597	O
,	O
17	O
.	O
4	O
%).	O

For	O
arboviruses	O
,	O
84	O
%	O
of	O
the	O
laboratory	O
infections	O
had	O
aerosol	O
as	O
the	O
source	O
;	O
for	O
alphaviruses	B-SPEC
alone	O
,	O
aerosol	O
exposure	O
accounted	O
for	O
94	O
%	O
of	O
accidental	O
infections	O
.	O

Of	O
the	O
12	O
infections	O
with	O
viruses	B-SPEC
with	O
preferential	O
mucocutaneous	O
transmission	O
,	O
seven	O
occurred	O
percutaneously	O
,	O
aerosol	O
was	O
implicated	O
as	O
a	O
possible	O
source	O
of	O
infection	O
in	O
two	O
cases	O
,	O
and	O
one	O
atypical	O
infection	O
with	O
Macacine	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
with	O
fatal	O
encephalitis	O
as	O
the	O
outcome	O
occurred	O
through	O
a	O
louse	B-SPEC
bite	O
.	O

One	O
outbreak	O
of	O
norovirus	B-SPEC
infection	O
among	O
hospital	O
staff	O
had	O
as	O
its	O
probable	O
mode	O
of	O
infection	O
the	O
ingestion	O
of	O
inocula	O
spread	O
in	O
the	O
environment	O
by	O
fomites	O
.	O

ABSTRACT	O
:	O
An	O
increasing	O
incidence	O
of	O
enteric	O
disorders	O
clinically	O
suggestive	O
of	O
the	O
poult	O
enteritis	O
complex	O
has	O
been	O
observed	O
in	O
turkeys	B-SPEC
in	O
France	O
since	O
2003	O
.	O

Phylogenetic	O
analysis	O
revealed	O
that	O
both	O
the	O
NA	O
TCoV	O
and	O
French	O
TCoV	O
(	O
Fr	O
TCoV	O
)	O
lineages	O
included	O
some	O
IBV	B-SPEC
relatives	O
,	O
which	O
were	O
however	O
different	O
in	O
the	O
two	O
lineages	O
.	O

CONCLUSIONS	O
:	O
Patients	O
with	O
clinically	O
stable	O
asthma	O
and	O
healthy	O
controls	O
have	O
similar	O
detection	O
rates	O
of	O
respiratory	O
viruses	B-SPEC
in	O
samples	O
from	O
nasopharynx	O
,	O
sputum	O
and	O
exhaled	O
air	O
.	O

The	O
infection	O
was	O
caused	O
by	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
.	O

Rapid	O
identification	O
of	O
Panton	O
-	O
Valentine	O
leukocidin	O
in	O
methicillin	O
-	O
sensitive	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
isolates	O
causing	O
severe	O
infections	O
is	O
necessary	O
so	O
as	O
not	O
to	O
miss	O
their	O
potentially	O
devastating	O
consequences	O
.	O

This	O
study	O
demonstrates	O
that	O
CXCR3	O
mediates	O
CNS	O
accumulation	O
of	O
ASC	O
during	O
neurotropic	O
coronavirus	B-SPEC
-	O
induced	O
encephalomyelitis	O
.	O

Furthermore	O
,	O
in	O
contrast	O
to	O
the	O
reduction	O
of	O
ASC	O
in	O
the	O
CNS	O
,	O
neither	O
virus	B-SPEC
-	O
specific	O
ASC	O
trafficking	O
to	O
bone	O
marrow	O
nor	O
antiviral	O
serum	O
antibody	O
was	O
reduced	O
relative	O
to	O
levels	O
in	O
control	O
mice	B-SPEC
.	O

TITLE	O
:	O
Phylogenetic	O
distribution	O
and	O
predominant	O
genotype	O
of	O
the	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
in	O
China	O
during	O
2008	O
-	O
2009	O
.	O

It	O
is	O
the	O
purpose	O
of	O
this	O
article	O
to	O
provide	O
an	O
overview	O
of	O
the	O
definition	O
,	O
clinical	O
features	O
,	O
and	O
pathogenesis	O
of	O
ARDS	O
,	O
and	O
to	O
present	O
and	O
discuss	O
therapeutic	O
options	O
currently	O
available	O
in	O
order	B-SPEC
to	O
effectively	O
treat	O
this	O
severe	O
disorder	O
.	O

TITLE	O
:	O
Immunogenic	O
characterization	O
and	O
epitope	O
mapping	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
RNA	O
dependent	O
RNA	O
polymerase	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
RNA	O
synthesis	O
is	O
a	O
sophisticated	O
process	O
performed	O
by	O
a	O
viral	O
multienzymatic	O
replicase	O
complex	O
,	O
together	O
with	O
cellular	O
factors	O
.	O

The	O
statistical	O
properties	O
of	O
the	O
spinned	O
Poisson	O
distribution	O
are	O
developed	O
and	O
illustrated	O
using	O
infectious	O
smallpox	B-SPEC
incidence	O
in	O
Abakaliki	O
,	O
Nigeria	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
sialosides	O
modified	O
at	O
the	O
4	O
-	O
and	O
9	O
-	O
hydroxy	O
group	O
were	O
synthesised	O
and	O
tested	O
for	O
inhibition	O
of	O
the	O
viral	O
haemagglutinin	O
-	O
esterase	O
activity	O
from	O
various	O
Orthomyxoviruses	B-SPEC
and	O
Coronaviruses	O
.	O

While	O
no	O
inhibition	O
of	O
the	O
sialate	O
-	O
4	O
-	O
O	O
-	O
acetylesterases	O
from	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
S	O
or	O
sialodacryoadenitis	O
virus	B-SPEC
was	O
found	O
,	O
a	O
9	O
-	O
O	O
-	O
methyl	O
derivative	O
displayed	O
inhibitory	O
activity	O
against	O
recombinant	O
sialate	O
-	O
9	O
-	O
O	O
-	O
acetylesterase	O
from	O
influenza	B-SPEC
C	I-SPEC
virus	I-SPEC
.	O

Nasopharyngeal	O
aspiration	O
fluid	O
samples	O
were	O
sent	O
for	O
virus	B-SPEC
culture	O
,	O
for	O
direct	O
immunofluorescence	O
test	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
for	O
rapid	O
influenza	O
viral	O
identification	O
,	O
and	O
for	O
polymerase	O
chain	O
reaction	O
of	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
human	B-SPEC
boca	O
virus	B-SPEC
(	O
hBoV	O
),	O
and	O
human	B-SPEC
corona	B-SPEC
virus	B-SPEC
.	O

The	O
proportions	O
of	O
IL	O
-	O
10	O
-	O
producing	O
cells	O
were	O
initially	O
similar	O
in	O
CD8	O
(+)	O
and	O
CD4	O
(+)	O
T	O
cells	O
but	O
diminished	O
rapidly	O
in	O
CD8	O
(+)	O
T	O
cells	O
as	O
the	O
virus	B-SPEC
was	O
controlled	O
.	O

Overall	O
,	O
the	O
majority	O
of	O
IL	O
-	O
10	O
-	O
producing	O
CD8	O
(+)	O
T	O
cells	O
were	O
specific	O
for	O
the	O
immunodominant	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
class	B-SPEC
I	O
epitope	O
.	O

Disease	O
-	O
specific	O
guidance	O
documents	O
on	O
tuberculosis	O
,	O
SARS	O
,	O
meningococcal	O
infections	O
,	O
measles	O
,	O
rubella	O
,	O
Ebola	O
and	O
Marburg	O
haemorrhagic	O
fevers	O
,	O
Lassa	O
fever	O
,	O
smallpox	B-SPEC
and	O
anthrax	B-SPEC
were	O
the	O
result	O
of	O
consultations	O
of	O
disease	O
-	O
specific	O
expert	O
panels	O
.	O

Secondly	O
,	O
we	O
collected	O
serum	O
,	O
fecal	O
,	O
nasal	O
,	O
ophthalmic	O
,	O
and	O
vaginal	O
samples	O
from	O
pre	O
-	O
immune	O
mice	B-SPEC
and	O
after	O
the	O
first	O
immunization	O
(	O
on	O
days	O
7	O
,	O
14	O
,	O
21	O
,	O
28	O
,	O
35	O
,	O
and	O
42	O
)	O
that	O
were	O
used	O
to	O
analyze	O
the	O
levels	O
of	O
immunoglobulins	O
G	O
and	O
A	O
against	O
TGEV	B-SPEC
by	O
using	O
ELISA	O
.	O

This	O
study	O
characterizes	O
critical	O
disease	O
models	O
in	O
the	O
evaluation	O
and	O
licensure	O
of	O
therapeutic	O
strategies	O
against	O
SARS	O
-	O
CoV	O
for	O
human	B-SPEC
use	O
.	O

ABSTRACT	O
:	O
The	O
focus	O
of	O
this	O
protocol	O
is	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
with	O
occasional	O
references	O
to	O
other	O
coronaviruses	O
.	O

TITLE	O
:	O
In	O
silico	O
investigations	O
of	O
possible	O
routes	O
of	O
assembly	O
of	O
ORF	O
3a	O
from	O
SARS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
ORF	O
3a	O
of	O
human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
has	O
been	O
identified	O
as	O
a	O
274	O
amino	O
acid	O
membrane	O
protein	O
.	O

TITLE	O
:	O
Development	O
of	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
assay	O
for	O
detection	O
of	O
human	B-SPEC
coronavirus	I-SPEC
-	O
NL63	O
.	O

CONCLUSIONS	O
:	O
These	O
findings	O
indicate	O
that	O
existing	O
building	O
HVAC	O
filters	O
may	O
be	O
used	O
as	O
a	O
method	O
of	O
detection	O
for	O
airborne	O
viruses	B-SPEC
.	O

Using	O
the	O
Virochip	O
,	O
we	O
have	O
identified	O
the	O
full	O
spectrum	O
of	O
viruses	B-SPEC
associated	O
with	O
respiratory	O
infections	O
,	O
including	O
cases	O
of	O
unexplained	O
critical	O
illness	O
in	O
hospitalized	O
patients	O
,	O
with	O
a	O
sensitivity	O
equivalent	O
to	O
or	O
superior	O
to	O
conventional	O
clinical	O
testing	O
.	O

The	O
Virochip	O
has	O
also	O
been	O
used	O
to	O
identify	O
novel	O
viruses	B-SPEC
,	O
including	O
the	O
SARS	O
coronavirus	B-SPEC
,	O
a	O
novel	O
rhinovirus	B-SPEC
clade	O
,	O
XMRV	O
(	O
a	O
retrovirus	B-SPEC
linked	O
to	O
prostate	O
cancer	B-SPEC
),	O
avian	B-SPEC
bornavirus	I-SPEC
(	O
the	O
cause	O
of	O
a	O
wasting	O
disease	O
in	O
parrots	B-SPEC
),	O
and	O
a	O
novel	O
cardiovirus	B-SPEC
in	O
children	O
with	O
respiratory	O
and	O
diarrheal	O
illness	O
.	O

Sequence	O
analyses	O
revealed	O
a	O
strong	O
selection	O
for	O
the	O
S	O
gene	O
of	O
83P	O
-	O
5	O
in	O
Vero	O
cells	O
,	O
and	O
virtually	O
all	O
mutations	O
occurring	O
at	O
the	O
34th	O
and	O
61st	O
passages	O
had	O
been	O
carried	O
over	O
to	O
the	O
100th	O
-	O
passaged	O
virus	B-SPEC
.	O

The	O
inhibitory	O
effect	O
of	O
LiCl	O
against	O
TGEV	B-SPEC
infection	O
and	O
transcription	O
was	O
confirmed	O
by	O
RT	O
-	O
PCR	O
and	O
real	O
-	O
time	O
PCR	O
targeting	O
viral	O
S	O
and	O
3CL	O
-	O
protease	O
genes	O
.	O

The	O
time	O
-	O
of	O
-	O
addition	O
effect	O
of	O
the	O
drug	O
on	O
TGEV	B-SPEC
infection	O
indicated	O
that	O
LiCl	O
acted	O
on	O
the	O
initial	O
and	O
late	O
stage	O
of	O
TGEV	B-SPEC
infection	O
.	O

The	O
inhibitory	O
effect	O
of	O
LiCl	O
was	O
also	O
observed	O
with	O
porcine	B-SPEC
epidemic	O
diarrhea	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Identification	O
of	O
RNA	O
pseudoknot	O
-	O
binding	O
ligand	O
that	O
inhibits	O
the	O
-	O
1	O
ribosomal	O
frameshifting	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
by	O
structure	O
-	O
based	O
virtual	O
screening	O
.	O

TITLE	O
:	O
Fully	O
human	B-SPEC
monoclonal	O
antibody	O
directed	O
to	O
proteolytic	O
cleavage	O
site	O
in	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
S	O
protein	O
neutralizes	O
the	O
virus	B-SPEC
in	O
a	O
rhesus	B-SPEC
macaque	I-SPEC
SARS	O
model	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
a	O
fully	O
human	B-SPEC
monoclonal	O
antibody	O
capable	O
of	O
neutralizing	O
SARS	O
-	O
CoV	O
in	O
vitro	O
in	O
a	O
Rhesus	B-SPEC
macaque	I-SPEC
model	O
of	O
SARS	O
.	O

This	O
study	O
represents	O
a	O
platform	O
to	O
produce	O
fully	O
human	B-SPEC
antibodies	O
against	O
emerging	O
infectious	O
diseases	O
in	O
a	O
timely	O
and	O
safe	O
manner	O
.	O

The	O
virus	B-SPEC
particles	O
revealed	O
the	O
characteristic	O
morphology	O
of	O
feline	B-SPEC
FCoV	O
represented	O
by	O
envelope	O
viruses	B-SPEC
surrounded	O
by	O
peplomers	O
.	O

ABSTRACT	O
:	O
The	O
absence	O
of	O
interleukin	O
-	O
10	O
(	O
IL	O
-	O
10	O
),	O
a	O
potent	O
anti	O
-	O
inflammatory	O
cytokine	O
results	O
in	O
increased	O
immune	O
-	O
mediated	O
demyelination	O
in	O
mice	B-SPEC
infected	O
with	O
a	O
neurotropic	O
coronavirus	B-SPEC
(	O
recombinant	O
J2	O
.	O
2	O
-	O
V	O
-	O
1	O
[	O
rJ2	O
.	O
2	O
]).	O

We	O
demonstrate	O
that	O
viral	O
expression	O
of	O
IL	O
-	O
10	O
,	O
which	O
occurs	O
during	O
the	O
peak	O
of	O
virus	B-SPEC
replication	O
and	O
at	O
the	O
site	O
of	O
disease	O
,	O
enhanced	O
survival	O
and	O
diminished	O
morbidity	O
in	O
rJ2	O
.	O
2	O
-	O
infected	O
wild	O
-	O
type	O
B6	O
and	O
IL	O
-	O
10	O
(-/-)	O
mice	B-SPEC
.	O

Following	O
oral	O
and	O
nasal	O
administration	O
to	O
chickens	B-SPEC
,	O
the	O
serum	O
and	O
mucosal	O
samples	O
were	O
collected	O
and	O
antibodies	O
against	O
IBV	B-SPEC
were	O
measured	O
.	O

Chickens	B-SPEC
were	O
then	O
challenged	O
with	O
IBV	B-SPEC
strain	O
M41	O
by	O
the	O
nasal	O
-	O
ocular	O
route	O
3	O
weeks	O
after	O
boosting	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
survive	O
and	O
propagate	O
,	O
RNA	O
viruses	B-SPEC
must	O
achieve	O
a	O
balance	O
between	O
the	O
capacity	O
for	O
adaptation	O
to	O
new	O
environmental	O
conditions	O
or	O
host	O
cells	O
with	O
the	O
need	O
to	O
maintain	O
an	O
intact	O
and	O
replication	O
competent	O
genome	O
.	O

Elucidation	O
of	O
the	O
mechanisms	O
of	O
nsp14	O
-	O
mediated	O
proofreading	O
will	O
have	O
major	O
implications	O
for	O
our	O
understanding	O
of	O
the	O
evolution	O
of	O
RNA	O
viruses	B-SPEC
,	O
and	O
also	O
will	O
provide	O
a	O
robust	O
model	O
to	O
investigate	O
the	O
balance	O
between	O
fidelity	O
,	O
diversity	O
and	O
pathogenesis	O
.	O

Compared	O
with	O
untreated	O
rats	B-SPEC
,	O
the	O
lungs	O
of	O
rats	B-SPEC
treated	O
with	O
DCQD	O
showed	O
significantly	O
lower	O
levels	O
of	O
proinflammatory	O
cytokine	O
IL	O
-	O
1β	O
and	O
IL	O
-	O
6	O
mRNA	O
.	O

TITLE	O
:	O
Characterisation	O
and	O
evaluation	O
of	O
antiviral	O
recombinant	O
peptides	O
based	O
on	O
the	O
heptad	O
repeat	O
regions	O
of	O
NDV	B-SPEC
and	O
IBV	B-SPEC
fusion	O
glycoproteins	O
.	O

Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
)	O
and	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
serious	O
threats	O
to	O
the	O
poultry	O
industry	O
,	O
can	O
give	O
rise	O
to	O
complex	O
mixed	O
infections	O
that	O
hinder	O
diagnosis	O
and	O
prevention	O
.	O

Microbiology	O
from	O
one	O
ferret	B-SPEC
yielded	O
a	O
pure	O
culture	O
of	O
gram	O
-	O
negative	O
bacteria	B-SPEC
identified	O
phenotypically	O
as	O
Pseudomonas	B-SPEC
luteola	I-SPEC
.	O

ABSTRACT	O
:	O
We	O
have	O
shown	O
that	O
mice	B-SPEC
infected	O
with	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
A59	O
develop	O
autoantibodies	O
(	O
autoAb	O
)	O
to	O
liver	O
and	O
kidney	O
fumarylacetoacetate	O
hydrolase	O
(	O
FAH	O
).	O

Mice	B-SPEC
subjected	O
to	O
MHV	B-SPEC
infection	O
had	O
increased	O
plasmatic	O
uric	O
acid	O
concentration	O
that	O
significantly	O
decreased	O
after	O
20	O
days	O
of	O
daily	O
treatment	O
with	O
allopurinol	O
and	O
,	O
simultaneously	O
,	O
autoAb	O
to	O
FAH	O
were	O
undetected	O
.	O

In	O
order	B-SPEC
to	O
explore	O
this	O
,	O
we	O
used	O
two	O
different	O
approaches	O
:	O
we	O
infected	O
either	O
Vero	O
cells	O
in	O
the	O
presence	O
of	O
trypsin	O
or	O
Vero	O
cells	O
that	O
constitutively	O
express	O
the	O
membrane	O
-	O
associated	O
protease	O
TMPRSS2	O
(	O
Vero	O
/	O
TMPRSS2	O
cells	O
).	O

This	O
unique	O
observation	O
in	O
coronavirus	B-SPEC
infection	O
suggests	O
that	O
the	O
actions	O
of	O
proteases	O
are	O
reminiscent	O
of	O
that	O
of	O
the	O
influenza	B-SPEC
virus	I-SPEC
neuraminidase	O
protein	O
.	O

In	O
this	O
line	O
of	O
thought	O
,	O
we	O
hypothesize	O
that	O
injurious	O
mechanical	O
ventilation	O
could	O
be	O
responsible	O
for	O
the	O
perpetuation	O
and	O
worsening	O
of	O
sepsis	B-SPEC
in	O
some	O
patients	O
and	O
for	O
the	O
development	O
of	O
a	O
sepsis	B-SPEC
-	O
like	O
syndrome	O
in	O
others	O
.	O

ABSTRACT	O
:	O
Hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
core	O
antibody	O
(	O
HBcAb	O
)-	O
positive	O
organ	O
donors	O
have	O
the	O
potential	O
to	O
transmit	O
infection	O
to	O
transplant	O
recipients	O
.	O

In	O
the	O
18	O
patients	O
who	O
underwent	O
prophylaxis	O
,	O
we	O
did	O
not	O
find	O
any	O
seroconversion	O
or	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
)	O
transmission	O
.	O

These	O
results	O
suggest	O
that	O
kidney	O
transplantation	O
from	O
HBcAb	O
-	O
positive	O
donors	O
is	O
safe	O
with	O
a	O
low	O
rate	O
of	O
HBV	B-SPEC
transmission	O
.	O

TITLE	O
:	O
Crystal	O
structure	O
and	O
functional	O
analysis	O
of	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
RNA	O
cap	O
2	O
'-	O
O	O
-	O
methyltransferase	O
nsp10	O
/	O
nsp16	O
complex	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
characterized	O
lesions	O
in	O
the	O
respiratory	O
tract	O
and	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
ferrets	B-SPEC
(	O
n	O
=	O
8	O
)	O
inoculated	O
intranasally	O
with	O
influenza	B-SPEC
virus	I-SPEC
A	O
/	O
Indonesia	O
/	O
5	O
/	O
2005	O
(	O
H5N1	O
).	O

Seasonal	O
variability	O
in	O
bat	B-SPEC
mortality	O
rates	O
,	O
specifically	O
low	O
mortality	O
during	O
hibernation	O
,	O
allows	O
long	O
-	O
term	O
bat	B-SPEC
population	O
viability	O
.	O

This	O
study	O
confirms	O
a	O
positive	O
association	O
between	O
nasopharyngeal	O
bacterial	O
load	O
and	O
clinical	O
ear	O
state	O
,	O
exacerbated	O
by	O
respiratory	O
viruses	B-SPEC
,	O
in	O
Indigenous	O
children	O
.	O

Varicella	B-SPEC
zoster	I-SPEC
virus	I-SPEC
(	O
VZV	B-SPEC
)	O
has	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
multiple	O
sclerosis	O
(	O
MS	O
).	O

TITLE	O
:	O
Enteral	O
nutrition	O
with	O
eicosapentaenoic	O
acid	O
,	O
γ	O
-	O
linolenic	O
acid	O
and	O
antioxidants	O
in	O
the	O
early	O
treatment	O
of	O
sepsis	B-SPEC
:	O
results	O
from	O
a	O
multicenter	O
,	O
prospective	O
,	O
randomized	O
,	O
double	O
-	O
blinded	O
,	O
controlled	O
study	O
:	O
the	O
INTERSEPT	O
study	O
.	O

TITLE	O
:	O
Receptor	O
-	O
bound	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
spike	O
protein	O
cleaved	O
by	O
trypsin	O
induces	O
membrane	O
fusion	O
.	O

However	O
,	O
trypsin	O
treatment	O
of	O
viruses	B-SPEC
before	O
receptor	O
binding	O
did	O
not	O
enhance	O
infectivity	O
,	O
indicating	O
that	O
receptor	O
binding	O
is	O
essentially	O
required	O
for	O
trypsin	O
-	O
mediated	O
entry	O
upon	O
PEDV	B-SPEC
infection	O
.	O

Unexpectedly	O
,	O
MHV	B-SPEC
NTD	O
contains	O
a	O
core	O
structure	O
that	O
has	O
the	O
same	O
β	O
-	O
sandwich	O
fold	O
as	O
human	B-SPEC
galectins	O
(	O
S	O
-	O
lectins	O
)	O
and	O
additional	O
structural	O
motifs	O
that	O
bind	O
to	O
the	O
N	O
-	O
terminal	O
Ig	O
-	O
like	O
domain	O
of	O
mCEACAM1a	O
.	O

Despite	O
its	O
galectin	O
fold	O
,	O
MHV	B-SPEC
NTD	O
does	O
not	O
bind	O
sugars	O
,	O
but	O
instead	O
binds	O
mCEACAM1a	O
through	O
exclusive	O
protein	O
-	O
protein	O
interactions	O
.	O

TITLE	O
:	O
Contribution	O
of	O
common	O
and	O
recently	O
described	O
respiratory	O
viruses	B-SPEC
to	O
annual	O
hospitalizations	O
in	O
children	O
in	O
South	O
Africa	O
.	O

ABSTRACT	O
:	O
The	O
contribution	O
of	O
viruses	B-SPEC
to	O
lower	O
respiratory	O
tract	O
disease	O
in	O
sub	O
-	O
Saharan	O
Africa	O
where	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
may	O
exacerbate	O
respiratory	O
infections	O
is	O
not	O
well	O
defined	O
.	O

RSV	B-SPEC
,	O
hPMV	O
,	O
PIV	O
-	O
3	O
,	O
and	O
influenza	B-SPEC
viruses	I-SPEC
had	O
defined	O
seasons	O
while	O
rhinovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
infections	O
occurred	O
year	O
round	O
in	O
this	O
temporal	O
region	O
of	O
sub	O
-	O
Saharan	O
Africa	O
.	O

Therefore	O
,	O
it	O
is	O
essential	O
to	O
properly	O
evaluate	O
the	O
efficacy	O
of	O
antiseptics	O
-	O
disinfectants	O
(	O
ATS	O
-	O
D	O
)	O
on	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
gene	O
7	O
counteracts	O
host	O
defenses	O
and	O
modulates	O
virus	B-SPEC
virulence	O
.	O

We	O
postulated	O
that	O
TGEV	B-SPEC
protein	O
7	O
may	O
counteract	O
host	O
antiviral	O
response	O
by	O
its	O
association	O
with	O
PP1c	O
.	O

From	O
6	O
to	O
9	O
days	O
postinfection	O
,	O
DAD	O
with	O
severe	O
alveolar	O
collapse	O
was	O
observed	O
in	O
the	O
lungs	O
of	O
all	O
of	O
dying	O
and	O
dead	O
mice	B-SPEC
.	O

Inhibition	O
of	O
the	O
development	O
of	O
DAD	O
with	O
alveolar	O
collapse	O
may	O
decrease	O
the	O
mortality	O
rate	O
in	O
severe	O
viral	O
pneumonia	O
caused	O
by	O
influenza	B-SPEC
virus	I-SPEC
infection	O
.	O

In	O
contrast	O
to	O
prior	O
studies	O
showing	O
no	O
activity	O
with	O
bacterially	O
produced	O
S	O
protein	O
,	O
results	O
indicated	O
that	O
polyclonal	O
serum	O
recognized	O
TGEV	B-SPEC
-	O
infected	O
cells	O
and	O
reduced	O
infection	O
by	O
100	O
%.	O

ABSTRACT	O
:	O
A	O
one	O
-	O
step	O
real	O
time	O
quantitative	O
RT	O
-	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
assay	O
was	O
developed	O
to	O
detect	O
all	O
published	O
Dugbe	B-SPEC
virus	I-SPEC
(	O
DUGV	O
)	O
genomes	O
of	O
the	O
Nairovirus	B-SPEC
genus	B-SPEC
.	O

The	O
specificity	O
of	O
the	O
primers	O
and	O
probe	O
was	O
confirmed	O
with	O
the	O
closely	O
related	O
Nairoviruses	B-SPEC
CCHFV	B-SPEC
and	O
Hazara	B-SPEC
virus	B-SPEC
,	O
and	O
on	O
the	O
non	O
-	O
related	O
viruses	B-SPEC
Coronavirus	B-SPEC
and	O
Influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
.	O

PaO2	O
/	O
Fio2	O
ratio	O
was	O
lower	O
in	O
airway	O
pressure	O
release	O
ventilation	O
vs	O
.	O
conventional	O
mechanical	O
ventilation	O
pigs	B-SPEC
at	O
12	O
,	O
18	O
,	O
and	O
24	O
hrs	O
(	O
p	O
<	O
.	O
05	O
)	O
but	O
not	O
at	O
48	O
hrs	O
.	O

Mean	O
airway	O
pressures	O
were	O
higher	O
in	O
airway	O
pressure	O
release	O
ventilation	O
animals	B-SPEC
between	O
6	O
and	O
48	O
hrs	O
(	O
p	O
<	O
.	O
05	O
).	O

Correspondingly	O
,	O
virus	B-SPEC
-	O
specific	O
CD8	O
T	O
cell	O
response	O
was	O
dramatically	O
diminished	O
in	O
TNFR1	O
(-/-)	O
mice	B-SPEC
.	O

Fecal	O
pathogens	O
(	O
bovine	B-SPEC
coronavirus	B-SPEC
[	O
BCV	B-SPEC
],	O
bovine	B-SPEC
rotavirus	B-SPEC
group	I-SPEC
A	I-SPEC
,	O
and	O
O157	O
:	O
H7	O
)	O
shed	O
or	O
detected	O
in	O
runoff	O
were	O
almost	O
nonexistent	O
;	O
only	O
BCV	B-SPEC
was	O
detected	O
in	O
feces	O
of	O
one	O
cow	B-SPEC
in	O
August	O
of	O
2008	O
.	O

Viruses	B-SPEC
containing	O
separate	O
deletions	O
of	O
SL4a	O
and	O
SL4b	O
are	O
viable	O
.	O

A	O
single	O
oral	O
co	O
-	O
administration	O
of	O
S	B-SPEC
.	I-SPEC
enterica	I-SPEC
serovar	O
Typhimurium	O
expressing	O
swIFN	O
-	O
α	O
and	O
swIL	O
-	O
18	O
induced	O
enhanced	O
alleviation	O
of	O
the	O
severity	O
of	O
diarrhea	O
caused	O
by	O
TGEV	B-SPEC
infection	O
,	O
compared	O
to	O
piglets	O
administered	O
S	B-SPEC
.	I-SPEC
enterica	I-SPEC
serovar	O
Typhimurium	O
expressing	O
swIFN	O
-	O
α	O
or	O
swIL	O
-	O
18	O
alone	O
.	O

Epidemiologic	O
data	O
suggests	O
that	O
the	O
genetic	O
background	O
of	O
the	O
cat	B-SPEC
contributes	O
to	O
the	O
manifestation	O
of	O
FIP	O
.	O

However	O
,	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
FIV	B-SPEC
),	O
which	O
was	O
previously	O
absent	O
from	O
HiP	O
,	O
appears	O
to	O
have	O
been	O
introduced	O
into	O
the	O
lion	B-SPEC
population	O
through	O
translocation	O
.	O

Bovine	B-SPEC
tuberculosis	O
posed	O
a	O
major	O
threat	O
to	O
the	O
inbred	O
native	O
lion	B-SPEC
population	O
,	O
but	O
not	O
to	O
translocated	O
lions	B-SPEC
and	O
their	O
offspring	O
.	O

We	O
observed	O
suspected	O
TMV	B-SPEC
virions	O
in	O
HeLa	O
cells	O
by	O
TEM	O
(	O
transmission	O
electron	O
microscopy	O
).	O

The	O
meta	B-SPEC
-	O
analysis	O
on	O
individual	O
data	O
of	O
these	O
three	O
studies	O
showed	O
that	O
the	O
hospital	O
mortality	O
was	O
not	O
significantly	O
different	O
between	O
the	O
two	O
groups	O
of	O
patients	O
,	O
was	O
significantly	O
lower	O
in	O
the	O
higher	O
PEEP	O
group	O
in	O
the	O
subset	O
of	O
ARDS	O
patients	O
(	O
PaO	O
(	O
2	O
)/	O
F	O
(	O
I	O
)	O
O	O
(	O
2	O
)	O
≤	O
200	O
mm	O
Hg	O
),	O
and	O
tended	O
to	O
be	O
higher	O
in	O
the	O
higher	O
PEEP	O
group	O
in	O
the	O
subset	O
of	O
patients	O
with	O
acute	O
lung	O
injury	O
(	O
200	O
<	O
PaO	O
(	O
2	O
)/	O
F	O
(	O
I	O
)	O
O	O
(	O
2	O
)	O
≤	O
300	O
mm	O
Hg	O
).	O

Gross	O
examination	O
was	O
performed	O
on	O
brain	O
,	O
heart	O
,	O
lung	O
,	O
liver	O
,	O
kidney	O
,	O
spleen	O
,	O
bursa	B-SPEC
of	O
fabricius	O
,	O
gastrointestinal	O
tract	O
,	O
skeletal	O
muscle	O
,	O
pancreas	O
,	O
reproductive	O
tract	O
,	O
and	O
skin	O
.	O

Heart	O
and	O
pancreas	O
were	O
positive	O
in	O
63	O
%	O
while	O
brain	O
was	O
positive	O
in	O
36	O
.	O
5	O
%	O
of	O
the	O
infected	O
crows	B-SPEC
.	O

We	O
included	O
67	O
studies	O
including	O
randomised	O
controlled	O
trials	O
and	O
observational	O
studies	O
with	O
a	O
mixed	O
risk	O
of	O
bias	B-SPEC
.	O

Nine	O
case	O
-	O
control	O
studies	O
suggested	O
implementing	O
transmission	O
barriers	O
,	O
isolation	O
and	O
hygienic	O
measures	O
are	O
effective	O
at	O
containing	O
respiratory	O
virus	B-SPEC
epidemics	O
.	O

This	O
empirical	O
rule	O
was	O
shown	O
to	O
govern	O
inter	O
-	O
individual	O
transmission	O
dynamics	O
for	O
many	O
pathogens	O
in	O
several	O
species	B-SPEC
,	O
and	O
individuals	O
who	O
infect	O
disproportionately	O
more	O
secondary	O
contacts	O
,	O
as	O
compared	O
to	O
most	O
others	O
,	O
became	O
known	O
as	O
super	O
-	O
spreaders	O
.	O

Other	O
Gag	B-SPEC
proteins	O
,	O
including	O
those	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
),	O
murine	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
MLV	O
),	O
foamy	B-SPEC
virus	I-SPEC
and	O
retrotransposons	O
in	O
Schizosaccharomyces	B-SPEC
pombe	I-SPEC
and	O
Drosophila	B-SPEC
,	O
have	O
also	O
been	O
detected	O
in	O
the	O
nucleus	O
,	O
suggesting	O
that	O
nuclear	O
trafficking	O
of	O
Gag	B-SPEC
proteins	O
is	O
a	O
common	O
property	O
of	O
retroviruses	B-SPEC
and	O
retrotransposons	O
.	O

Similarly	O
,	O
nuclear	O
trafficking	O
of	O
the	O
RSV	B-SPEC
Gag	B-SPEC
protein	O
is	O
required	O
for	O
efficient	O
encapsidation	O
of	O
the	O
viral	O
genomic	O
RNA	O
(	O
gRNA	O
)	O
into	O
assembling	O
virus	B-SPEC
particles	O
.	O
19	O
Recently	O
,	O
we	O
reported	O
that	O
the	O
viral	O
RNA	O
itself	O
appears	O
to	O
be	O
a	O
key	O
factor	O
in	O
controlling	O
the	O
nucleus	O
/	O
cytosol	O
distribution	O
of	O
RSV	B-SPEC
Gag	B-SPEC
.	O
22	O
Our	O
data	O
demonstrate	O
that	O
binding	O
of	O
RSV	B-SPEC
RNA	O
to	O
the	O
Gag	B-SPEC
protein	O
promotes	O
Gag	B-SPEC
-	O
CRM1	O
-	O
RanGTP	O
binding	O
,	O
resulting	O
in	O
export	O
of	O
the	O
retroviral	B-SPEC
RNP	O
from	O
the	O
nucleus	O
.	O

The	O
reason	O
for	O
this	O
emerging	O
debate	O
is	O
twofold	O
:	O
the	O
recent	O
occurrence	O
of	O
pandemic	O
viruses	B-SPEC
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
H1N1	O
,	O
and	O
the	O
emergence	O
of	O
highly	O
resistant	O
strains	O
of	O
infectious	O
pathogens	O
such	O
as	O
multi	O
and	O
extensively	O
drug	O
-	O
resistant	O
tuberculosis	O
(	O
TB	O
).	O

Rather	O
,	O
the	O
data	O
suggested	O
that	O
recombination	O
events	O
have	O
homogenized	O
the	O
portions	O
of	O
the	O
genome	O
other	O
than	O
the	O
S	O
gene	O
between	O
the	O
two	O
groups	O
of	O
viruses	B-SPEC
,	O
while	O
continuing	O
to	O
maintain	O
the	O
two	O
distinct	O
,	O
anciently	O
diverged	O
versions	O
of	O
the	O
S	O
gene	O
.	O

TITLE	O
:	O
Use	O
of	O
a	O
novel	O
virus	B-SPEC
detection	O
assay	O
to	O
identify	O
coronavirus	B-SPEC
HKU1	O
in	O
the	O
lungs	O
of	O
a	O
hematopoietic	O
stem	O
cell	O
transplant	O
recipient	O
with	O
fatal	O
pneumonia	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
PD	O
-	O
1	O
signaling	O
plays	O
an	O
essential	O
role	O
in	O
decreasing	O
the	O
immunopathological	O
damage	O
induced	O
by	O
MHV	B-SPEC
-	O
3	O
and	O
that	O
manipulation	O
of	O
this	O
signal	O
might	O
be	O
a	O
useful	O
strategy	O
for	O
FH	O
immunotherapy	O
.	O

These	O
data	O
imply	O
that	O
the	O
ability	O
of	O
MHV	B-SPEC
to	O
replicate	O
in	O
macrophages	O
is	O
a	O
prerequisite	O
for	O
replication	O
in	O
the	O
liver	O
and	O
induction	O
of	O
hepatitis	O
but	O
not	O
for	O
replication	O
or	O
disease	O
in	O
the	O
CNS	O
,	O
underscoring	O
the	O
importance	O
of	O
IFN	O
signaling	O
in	O
macrophages	O
in	O
vivo	O
for	O
protection	O
of	O
the	O
host	O
from	O
hepatitis	O
.	O

The	O
new	O
viruses	B-SPEC
cause	O
respiratory	O
symptoms	O
like	O
the	O
common	O
cold	O
,	O
cough	O
,	O
bronchitis	O
,	O
bronchiolitis	O
,	O
exacerbations	O
of	O
asthma	O
and	O
chronic	O
obstructive	O
pulmonary	O
disease	O
and	O
pneumonia	O
.	O

None	O
experienced	O
coma	B-SPEC
.	O

We	O
developed	O
a	O
novel	O
method	O
to	O
produce	O
high	O
levels	O
of	O
a	O
recombinant	O
SARS	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
VLPs	O
)	O
vaccine	O
containing	O
the	O
SARS	O
spike	O
(	O
S	O
)	O
protein	O
and	O
the	O
influenza	O
M1	O
protein	O
using	O
the	O
baculovirus	B-SPEC
insect	B-SPEC
cell	O
expression	O
system	O
.	O

To	O
elucidate	O
the	O
biogeographic	O
origin	O
of	O
SARS	O
-	O
CoV	O
and	O
investigate	O
the	O
role	O
that	O
bats	B-SPEC
played	O
in	O
its	O
emergence	O
,	O
we	O
amplified	O
coronavirus	B-SPEC
sequences	O
from	O
bat	B-SPEC
species	B-SPEC
captured	O
throughout	O
Thailand	O
and	O
assessed	O
the	O
phylogenetic	O
relationships	O
to	O
each	O
other	O
and	O
to	O
other	O
published	O
coronavirus	B-SPEC
sequences	O
.	O

We	O
report	O
for	O
the	O
first	O
time	O
the	O
presence	O
of	O
14	O
coronaviruses	O
in	O
9	O
Iberian	O
bat	B-SPEC
species	B-SPEC
.	O

TITLE	O
:	O
[	O
Expression	O
and	O
purification	O
of	O
different	O
segments	O
from	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
nucleocapsid	O
protein	O
and	O
their	O
application	O
in	O
detection	O
of	O
antibodies	O
].	O

Four	O
fragments	O
coding	O
spike	O
proteins	O
(	O
S1	O
,	O
S2	O
,	O
RL	O
and	O
RS	O
)	O
from	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
were	O
amplified	O
and	O
cloned	O
into	O
the	O
expression	O
vector	O
derived	O
from	O
vaccinia	B-SPEC
virus	I-SPEC
(	O
Tiantan	O
strain	O
),	O
and	O
recombinant	O
vaccinia	O
viruses	B-SPEC
expressing	O
four	O
segments	O
of	O
spike	O
proteins	O
were	O
generated	O
(	O
vJSC1175	O
-	O
S1	O
;	O
vJSC1175	O
-	O
S2	O
;	O
vJSC1175	O
-	O
RL	O
;	O
vJSC1175	O
-	O
RS	O
),	O
respectively	O
.	O

TITLE	O
:	O
Emerging	O
theme	O
:	O
cellular	O
PDZ	O
proteins	O
as	O
common	O
targets	O
of	O
pathogenic	O
viruses	B-SPEC
.	O

These	O
findings	O
reveal	O
a	O
new	O
theme	O
in	O
virology	O
wherein	O
many	O
different	O
virus	B-SPEC
families	O
encode	O
proteins	O
that	O
bind	O
and	O
perturb	O
the	O
function	O
of	O
cellular	O
PDZ	O
proteins	O
.	O

We	O
previously	O
reported	O
that	O
antibody	O
elicited	O
by	O
a	O
SARS	O
-	O
CoV	O
vaccine	O
candidate	O
based	O
on	O
recombinant	O
full	O
-	O
length	O
Spike	O
-	O
protein	O
trimers	O
potentiated	O
infection	O
of	O
human	B-SPEC
B	O
cell	O
lines	O
despite	O
eliciting	O
in	O
vivo	O
a	O
neutralizing	O
and	O
protective	O
immune	O
response	O
in	O
rodents	B-SPEC
.	O

The	O
selectivity	O
of	O
the	O
sensing	O
device	O
was	O
successfully	O
demonstrated	O
using	O
H1N1	O
viruses	B-SPEC
and	O
house	O
dust	O
allergens	O
.	O

Coronavirus	B-SPEC
HKU1	O
were	O
detected	O
in	O
12	O
patients	O
(	O
1	O
.	O
03	O
%)	O
out	O
of	O
the	O
1165	O
children	O
.	O

ABSTRACT	O
:	O
Even	O
though	O
males	O
represent	O
only	O
8	O
%-	O
12	O
%	O
of	O
the	O
birds	B-SPEC
of	O
a	O
breeder	O
flock	O
,	O
their	O
role	O
in	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
dissemination	O
is	O
largely	O
unknown	O
.	O

The	O
egg	O
internal	O
and	O
external	O
quality	O
was	O
negatively	O
affected	O
in	O
hens	O
inseminated	O
with	O
semen	O
containing	O
IBV	B-SPEC
.	O

These	O
results	O
provide	O
experimental	O
evidence	O
for	O
IBV	B-SPEC
venereal	O
transmission	O
.	O

In	O
this	O
study	O
,	O
we	O
assess	O
the	O
inflammatory	O
response	O
mediated	O
by	O
cytokines	O
at	O
the	O
local	O
and	O
systemic	O
levels	O
in	O
three	O
cases	O
of	O
severe	O
pneumonia	O
caused	O
by	O
Influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
.	O

Our	O
results	O
showed	O
that	O
:	O
(	O
i	O
)	O
deletion	O
of	O
18aa	O
from	O
the	O
C	O
-	O
terminus	O
enhanced	O
the	O
S	O
protein	O
accumulation	O
and	O
virus	B-SPEC
entry	O
,	O
which	O
might	O
be	O
due	O
to	O
the	O
deletion	O
of	O
intracellular	O
retention	O
signals	O
;	O
(	O
ii	O
)	O
further	O
deletion	O
to	O
residue	O
29	O
also	O
enhanced	O
the	O
amount	O
of	O
S	O
protein	O
on	O
the	O
cell	O
surface	O
and	O
in	O
virion	O
,	O
but	O
reduced	O
virus	B-SPEC
entry	O
by	O
25	O
%,	O
suggesting	O
that	O
residues	O
19	O
-	O
29	O
contributes	O
to	O
membrane	O
fusion	O
;	O
(	O
iii	O
)	O
a	O
29aa	O
-	O
deletion	O
mutant	O
had	O
a	O
defect	O
in	O
anchoring	O
on	O
the	O
plasma	O
membrane	O
,	O
which	O
led	O
to	O
a	O
dramatic	O
decrease	O
of	O
S	O
protein	O
in	O
virion	O
and	O
virus	B-SPEC
entry	O
;	O
(	O
iv	O
)	O
a	O
total	O
of	O
15	O
residues	O
(	O
Y498	O
,	O
V499	O
,	O
V531	O
,	O
G534	O
,	O
G537	O
,	O
D538	O
,	O
S540	O
,	O
G575	O
,	O
S576	O
,	O
E582	O
,	O
W585	O
,	O
Y590	O
,	O
T591	O
,	O
V593	O
and	O
G594	O
)	O
within	O
RBD	O
were	O
important	O
for	O
receptor	O
binding	O
and	O
virus	B-SPEC
entry	O
.	O

ABSTRACT	O
:	O
The	O
3	O
'-	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
the	O
group	O
2	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
genome	O
contains	O
a	O
predicted	O
bulged	O
stem	O
-	O
loop	O
(	O
designated	O
P0ab	O
),	O
a	O
conserved	O
cis	B-SPEC
-	O
acting	O
pseudoknot	O
(	O
PK	O
),	O
and	O
a	O
more	O
distal	O
stem	O
-	O
loop	O
(	O
designated	O
P2	O
).	O

TITLE	O
:	O
Coronavirus	B-SPEC
nsp6	O
proteins	O
generate	O
autophagosomes	O
from	O
the	O
endoplasmic	O
reticulum	O
via	O
an	O
omegasome	O
intermediate	O
.	O

Degradation	O
through	O
autophagy	O
can	O
provide	O
an	O
innate	O
defence	O
against	O
virus	B-SPEC
infection	O
,	O
or	O
conversely	O
autophagosomes	O
can	O
promote	O
infection	O
by	O
facilitating	O
assembly	O
of	O
replicase	O
proteins	O
.	O

These	O
multiple	O
-	O
spanning	O
transmembrane	O
proteins	O
located	O
to	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
where	O
they	O
generated	O
Atg5	O
and	O
LC3II	O
-	O
positive	O
vesicles	O
,	O
and	O
vesicle	O
formation	O
was	O
dependent	O
on	O
Atg5	O
and	O
class	B-SPEC
III	O
PI3	O
kinase	O
.	O

The	O
coronavirus	B-SPEC
nsp6	O
proteins	O
activated	O
omegasome	O
and	O
autophagosome	O
formation	O
independently	O
of	O
starvation	O
,	O
but	O
activation	O
did	O
not	O
involve	O
direct	O
inhibition	O
of	O
mTOR	O
signalling	O
,	O
activation	O
of	O
sirtuin1	O
or	O
induction	O
of	O
ER	O
stress	O
.	O

The	O
requirement	O
of	O
MMP9	O
in	O
BBB	O
disruption	O
was	O
thus	O
assessed	O
in	O
JHMV	O
infected	O
MMP9	O
deficient	O
(	O
MMP9	O
(-/-))	O
mice	B-SPEC
.	O

TITLE	O
:	O
Identification	O
of	O
small	O
-	O
molecule	O
inhibitors	O
of	O
the	O
XendoU	O
endoribonucleases	O
family	B-SPEC
.	O

The	O
identified	O
compounds	O
,	O
while	O
allowing	O
deep	O
investigation	O
of	O
the	O
molecular	O
functions	O
of	O
this	O
enzyme	O
family	B-SPEC
,	O
may	O
also	O
represent	O
leads	O
for	O
the	O
development	O
of	O
new	O
therapeutic	O
tools	O
.	O

TITLE	O
:	O
17β	O
-	O
Estradiol	O
administration	O
attenuates	O
seawater	O
aspiration	O
-	O
induced	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
emerged	O
as	O
the	O
causal	O
agent	O
of	O
an	O
endemic	O
atypical	O
pneumonia	O
,	O
infecting	O
thousands	O
of	O
people	O
worldwide	O
.	O

This	O
assay	O
system	O
can	O
be	O
easily	O
adapted	O
to	O
screen	O
entry	O
inhibitors	O
against	O
other	O
viruses	B-SPEC
with	O
the	O
careful	O
selection	O
of	O
matching	O
partner	O
virus	B-SPEC
envelopes	O
.	O

A	O
prospective	O
study	O
in	O
88	O
patients	O
with	O
acute	O
liver	O
failure	O
has	O
shown	O
a	O
nonsignificant	O
trend	O
in	O
improvement	O
of	O
survival	O
after	O
acute	O
liver	O
failure	O
by	O
multipass	O
albumin	O
dialysis	B-SPEC
and	O
filtering	O
.	O

We	O
excluded	O
case	O
reports	O
,	O
animal	B-SPEC
-	O
or	O
laboratory	O
-	O
based	O
studies	O
,	O
trials	O
describing	O
NMBA	O
use	O
during	O
rapid	O
sequence	O
intubation	O
or	O
in	O
the	O
operating	O
room	O
,	O
and	O
studies	O
published	O
in	O
languages	O
other	O
than	O
English	O
or	O
French	O
.	O

This	O
is	O
the	O
most	O
comprehensive	O
study	O
of	O
the	O
epidemiology	O
of	O
respiratory	O
viruses	B-SPEC
in	O
Greece	O
,	O
indicating	O
influenza	O
,	O
rhinovirus	B-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
as	O
major	O
contributors	O
to	O
influenza	O
-	O
like	O
illness	O
in	O
children	O
.	O

TITLE	O
:	O
In	O
vitro	O
and	O
in	O
vivo	O
effects	O
of	O
Houttuynia	B-SPEC
cordata	I-SPEC
on	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Results	O
showed	O
that	O
HC	O
had	O
more	O
than	O
90	O
%	O
inhibition	O
rate	O
against	O
IBV	B-SPEC
infection	O
in	O
Vero	O
cells	O
and	O
chicken	B-SPEC
embryo	O
kidney	O
cells	O
,	O
and	O
decreased	O
more	O
than	O
90	O
%	O
apoptotic	O
cells	O
caused	O
by	O
IBV	B-SPEC
.	O

HC	O
fully	O
protected	O
the	O
SPF	O
embryos	O
,	O
and	O
had	O
more	O
than	O
50	O
%	O
protection	O
rate	O
in	O
SPF	O
chickens	B-SPEC
,	O
against	O
IBV	B-SPEC
challenge	O
.	O

This	O
was	O
a	O
multicenter	O
,	O
prospective	O
inception	O
cohort	O
study	O
including	O
adult	O
patients	O
with	O
acute	O
respiratory	O
failure	O
requiring	O
mechanical	O
ventilation	O
(	O
MV	O
)	O
admitted	O
to	O
20	O
ICUs	O
in	O
Argentina	B-SPEC
between	O
June	O
and	O
September	O
of	O
2009	O
during	O
the	O
influenza	O
A	O
(	O
H1N1	O
)	O
pandemic	O
.	O

ABSTRACT	O
:	O
Although	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
-	O
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
)	O
is	O
the	O
coronavirus	B-SPEC
most	O
commonly	O
associated	O
with	O
human	B-SPEC
infections	O
,	O
little	O
is	O
known	O
about	O
its	O
molecular	O
epidemiology	O
and	O
evolution	O
.	O

The	O
results	O
of	O
the	O
present	O
study	O
showed	O
a	O
significant	O
decline	O
in	O
prevalence	O
of	O
variant	O
IBVs	O
and	O
a	O
further	O
spread	O
of	O
QX	O
-	O
type	O
isolates	O
in	O
commercial	O
chicken	B-SPEC
flocks	O
in	O
Russia	O
as	O
compared	O
with	O
the	O
1998	O
to	O
2002	O
data	O
.	O

TITLE	O
:	O
Update	O
on	O
rhinovirus	B-SPEC
and	O
coronavirus	B-SPEC
infections	O
.	O

The	O
epidemiology	O
of	O
these	O
newly	O
described	O
viruses	B-SPEC
will	O
help	O
us	O
develop	O
better	O
intervention	O
strategies	O
.	O

Modern	O
molecular	O
technology	O
has	O
now	O
made	O
it	O
possible	O
to	O
detect	O
other	O
RVIs	O
including	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
bocavirus	B-SPEC
,	O
and	O
the	O
role	O
of	O
these	O
viruses	B-SPEC
in	O
causing	O
serious	O
disease	O
in	O
transplant	O
recipients	O
is	O
still	O
being	O
worked	O
out	O
.	O

This	O
primer	O
set	O
compared	O
to	O
that	O
designed	O
according	O
to	O
the	O
original	O
CODEHOP	O
rules	O
showed	O
10	O
-	O
10	O
(	O
3	O
)	O
folds	O
greater	O
sensitivity	O
for	O
5	O
of	O
the	O
6	O
evaluated	O
corona	B-SPEC
-/	O
torovirus	B-SPEC
templates	O
.	O

The	O
number	O
of	O
proteins	O
bound	O
to	O
the	O
surface	O
of	O
the	O
LPD	O
complexes	O
(	O
158	O
,	O
133	O
of	O
which	O
are	O
common	O
to	O
lipoplexes	O
)	O
is	O
intermediate	O
between	O
those	O
found	O
in	O
the	O
protein	O
corona	B-SPEC
of	O
both	O
CLs	O
and	O
lipoplexes	O
.	O

About	O
half	O
of	O
them	O
were	O
found	O
in	O
the	O
protein	O
corona	B-SPEC
of	O
CLs	O
.	O

The	O
advent	O
of	O
polymerase	O
chain	O
reaction	O
and	O
other	O
molecular	O
techniques	O
has	O
been	O
associated	O
with	O
the	O
detection	O
of	O
a	O
higher	O
prevalence	O
of	O
common	O
respiratory	O
viruses	B-SPEC
than	O
previously	O
suspected	O
.	O

ABSTRACT	O
:	O
Caspase	O
-	O
8	O
(	O
casp8	O
)	O
is	O
required	O
for	O
extrinsic	O
apoptosis	O
,	O
and	O
mice	B-SPEC
deficient	O
in	O
casp8	O
fail	O
to	O
develop	O
and	O
die	O
in	O
utero	O
while	O
ultimately	O
failing	O
to	O
maintain	O
the	O
proliferation	O
of	O
T	O
cells	O
,	O
B	O
cells	O
,	O
and	O
a	O
host	O
of	O
other	O
cell	O
types	O
.	O

TITLE	O
:	O
Disease	O
burden	O
of	O
the	O
most	O
commonly	O
detected	O
respiratory	O
viruses	B-SPEC
in	O
hospitalized	O
patients	O
calculated	O
using	O
the	O
disability	O
adjusted	O
life	O
year	O
(	O
DALY	O
)	O
model	O
.	O

Adenoviruses	B-SPEC
were	O
among	O
the	O
leading	O
cause	O
of	O
respiratory	O
presentations	O
in	O
children	O
but	O
not	O
adults	O
.	O

ABSTRACT	O
:	O
In	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
recruitment	O
sessions	O
of	O
high	O
-	O
frequency	O
oscillation	O
(	O
HFO	O
)	O
and	O
tracheal	O
gas	O
insufflation	O
(	O
TGI	O
)	O
with	O
short	O
-	O
lasting	O
recruitment	O
manoeuvres	O
(	O
RMs	O
)	O
may	O
improve	O
oxygenation	O
and	O
enable	O
reduction	O
of	O
subsequent	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
pressures	O
.	O

We	O
determined	O
the	O
effect	O
of	O
adding	O
HFO	O
-	O
TGI	O
sessions	O
to	O
lung	O
-	O
protective	O
CMV	B-SPEC
on	O
early	O
/	O
severe	O
ARDS	O
outcome	O
.	O

We	O
enrolled	O
125	O
(	O
first	O
period	O
,	O
n	O
=	O
54	O
)	O
patients	O
with	O
arterial	O
oxygen	O
tension	O
(	O
P	O
(	O
a	O
,	O
O	O
(	O
2	O
)))/	O
inspiratory	O
oxygen	O
fraction	O
(	O
F	O
(	O
I	O
,	O
O	O
(	O
2	O
)))	O
of	O
<	O
150	O
mmHg	O
for	O
>	O
12	O
consecutive	O
hours	O
at	O
an	O
end	O
-	O
expiratory	O
pressure	O
of	O
≥	O
8	O
cmH	O
(	O
2	O
)	O
O	O
.	O
Patients	O
were	O
randomly	O
assigned	O
to	O
an	O
HFO	O
-	O
TGI	O
group	O
(	O
receiving	O
HFO	O
-	O
TGI	O
sessions	O
with	O
RMs	O
,	O
interspersed	O
with	O
lung	O
-	O
protective	O
CMV	B-SPEC
;	O
n	O
=	O
61	O
)	O
or	O
CMV	B-SPEC
group	O
(	O
receiving	O
lung	O
-	O
protective	O
CMV	B-SPEC
and	O
RMs	O
;	O
n	O
=	O
64	O
).	O

TITLE	O
:	O
Objective	O
assessment	O
of	O
increase	O
in	O
breathing	O
resistance	O
of	O
N95	O
respirators	O
on	O
human	B-SPEC
subjects	O
.	O

TITLE	O
:	O
Genetic	O
variation	O
of	O
the	O
human	B-SPEC
α	O
-	O
2	O
-	O
Heremans	O
-	O
Schmid	O
glycoprotein	O
(	O
AHSG	O
)	O
gene	O
associated	O
with	O
the	O
risk	O
of	O
SARS	O
-	O
CoV	O
infection	O
.	O

In	O
addition	O
,	O
a	O
meta	B-SPEC
-	O
analysis	O
was	O
conducted	O
on	O
the	O
association	O
between	O
sudden	O
infant	O
death	O
syndrome	O
(	O
SIDS	O
)	O
and	O
maternal	O
smoking	O
during	O
pregnancy	O
as	O
well	O
as	O
postnatal	O
exposure	O
to	O
environmental	O
tobacco	B-SPEC
smoke	O
(	O
ETS	O
).	O

The	O
positive	O
test	O
results	O
varied	O
significantly	O
among	O
different	O
facilities	O
and	O
species	B-SPEC
.	O

TITLE	O
:	O
Changes	O
in	O
nonstructural	O
protein	O
3	O
are	O
associated	O
with	O
attenuation	O
in	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

TITLE	O
:	O
The	O
sialic	O
acid	O
binding	O
activity	O
of	O
the	O
S	O
protein	O
facilitates	O
infection	O
by	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
.	O

A	O
TGEV	B-SPEC
PUR46	O
mutant	O
(	O
HAD3	O
)	O
deficient	O
in	O
sialic	O
acid	O
binding	O
showed	O
a	O
77	O
%	O
lower	O
titer	O
than	O
the	O
parental	O
virus	B-SPEC
after	O
a	O
5	O
min	O
adsorption	O
time	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
sialic	O
acid	O
binding	O
activity	O
facilitates	O
the	O
infection	O
by	O
TGEV	B-SPEC
under	O
unfavorable	O
environmental	O
conditions	O
.	O

RESULTS	O
:	O
Desialylation	O
of	O
cells	O
only	O
had	O
a	O
minor	O
effect	O
on	O
the	O
infection	O
by	O
TGEV	B-SPEC
strain	O
Purdue	O
46	O
when	O
an	O
adsorption	O
period	O
of	O
60	O
min	O
was	O
allowed	O
for	O
initiation	O
of	O
infection	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
may	O
cause	O
severe	O
lower	O
respiratory	O
disease	O
with	O
underlying	O
conditions	O
.	O

CONCLUSIONS	O
:	O
hMPV	B-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
are	O
important	O
causes	O
of	O
acute	O
respiratory	O
illness	O
among	O
hospitalized	O
Saudi	O
children	O
.	O

Similar	O
to	O
our	O
previous	O
findings	O
with	O
BeauR	O
-	O
M41	O
(	O
S	O
),	O
clinical	O
signs	O
observations	O
showed	O
that	O
the	O
S	O
gene	O
of	O
the	O
pathogenic	O
4	O
/	O
91	O
virus	B-SPEC
did	O
not	O
confer	O
pathogenicity	O
to	O
the	O
rIBV	O
BeauR	O
-	O
4	O
/	O
91	O
(	O
S	O
).	O

Furthermore	O
,	O
protection	O
studies	O
showed	O
there	O
was	O
homologous	O
protection	O
;	O
BeauR	O
-	O
4	O
/	O
91	O
(	O
S	O
)	O
conferred	O
protection	O
against	O
challenge	O
with	O
wild	O
type	O
4	O
/	O
91	O
virus	B-SPEC
as	O
shown	O
by	O
the	O
absence	O
of	O
clinical	O
signs	O
,	O
IBV	B-SPEC
RNA	O
assessed	O
by	O
qRT	O
-	O
PCR	O
and	O
the	O
fact	O
that	O
no	O
virus	B-SPEC
was	O
isolated	O
from	O
tracheas	O
removed	O
from	O
birds	B-SPEC
primarily	O
infected	O
with	O
BeauR	O
-	O
4	O
/	O
91	O
(	O
S	O
)	O
and	O
challenged	O
with	O
IBV	B-SPEC
4	O
/	O
91	O
(	O
UK	O
).	O

Suppression	O
of	O
the	O
ATR	O
kinase	O
activity	O
by	O
chemical	O
inhibitors	O
and	O
siRNA	O
-	O
mediated	O
knockdown	O
of	O
ATR	O
reduced	O
the	O
IBV	B-SPEC
-	O
induced	O
ATR	O
signaling	O
and	O
inhibited	O
the	O
replication	O
of	O
IBV	B-SPEC
.	O

The	O
5	O
-	O
hydroxychromones	O
(	O
5b	O
-	O
5g	O
)	O
thus	O
prepared	O
showed	O
anti	O
-	O
HCV	B-SPEC
activity	O
and	O
,	O
depending	O
on	O
the	O
aromatic	O
substituents	O
on	O
the	O
2	O
-	O
arylmethyloxy	O
moiety	O
,	O
some	O
of	O
the	O
derivatives	O
(	O
5b	O
-	O
5f	O
)	O
were	O
also	O
active	O
against	O
SCV	B-SPEC
.	O

Possible	O
enterococcal	B-SPEC
infection	O
pathways	O
and	O
mechanisms	O
of	O
ARDS	O
development	O
are	O
discussed	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
an	O
important	O
emerging	O
virus	B-SPEC
that	O
is	O
highly	O
pathogenic	O
in	O
aged	O
populations	O
and	O
is	O
maintained	O
with	O
great	O
diversity	O
in	O
zoonotic	O
reservoirs	O
.	O

These	O
data	O
raise	O
significant	O
concerns	O
regarding	O
DIV	O
vaccine	O
safety	O
and	O
highlight	O
the	O
need	O
for	O
additional	O
studies	O
of	O
the	O
molecular	O
mechanisms	O
governing	O
DIV	O
-	O
induced	O
eosinophilia	O
and	O
vaccine	O
failure	O
,	O
especially	O
in	O
the	O
more	O
vulnerable	O
aged	O
-	O
animal	B-SPEC
models	O
of	O
human	B-SPEC
disease	O
.	O

ABSTRACT	O
:	O
The	O
new	O
methods	O
of	O
cannabis	B-SPEC
consumption	O
(	O
home	O
made	O
water	O
pipe	O
or	O
""""	O
bang	O
""")"	O
may	O
be	O
responsible	O
for	O
fatal	O
respiratory	O
complications	O
.	O

We	O
draw	O
attention	O
to	O
the	O
extremely	O
serious	O
potential	O
consequences	O
of	O
new	O
methods	O
of	O
using	O
cannabis	B-SPEC
,	O
particularly	O
the	O
use	O
of	O
""""	O
bang	O
""""	O
in	O
homemade	O
plastic	O
materials	O
.	O

ABSTRACT	O
:	O
Differences	O
in	O
clinical	O
presentation	O
and	O
outcomes	O
among	O
patients	O
infected	O
with	O
pandemic	O
2009	O
influenza	O
A	O
H1N1	O
(	O
pH1N1	O
)	O
compared	O
to	O
other	O
respiratory	O
viruses	B-SPEC
have	O
not	O
been	O
fully	O
elucidated	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
is	O
comprised	O
of	O
two	O
pathogenic	O
biotypes	O
consisting	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
and	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
),	O
which	O
are	O
both	O
divided	O
into	O
two	O
serotypes	O
.	O

Phylogenetic	O
analyses	O
of	O
these	O
coronaviruses	O
suggest	O
that	O
there	O
is	O
a	O
diversity	O
of	O
gammacoronaviruses	O
and	O
deltacoronaviruses	O
circulating	O
in	O
birds	B-SPEC
.	O

TITLE	O
:	O
Glutamate	O
excitotoxicity	O
is	O
involved	O
in	O
the	O
induction	O
of	O
paralysis	O
in	O
mice	B-SPEC
after	O
infection	O
by	O
a	O
human	B-SPEC
coronavirus	I-SPEC
with	O
a	O
single	O
point	O
mutation	O
in	O
its	O
spike	O
protein	O
.	O

ABSTRACT	O
:	O
One	O
-	O
hundred	O
and	O
thirty	O
confirmed	O
cases	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
were	O
recruited	O
to	O
evaluate	O
their	O
anti	O
-	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
antibody	O
status	O
and	O
human	B-SPEC
leukocyte	O
antigen	O
(	O
HLA	O
)	O
types	O
in	O
September	O
2006	O
,	O
3	O
y	O
after	O
the	O
SARS	O
outbreaks	O
in	O
Taiwan	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
characterize	O
cellular	O
mechanisms	O
exploited	O
by	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
to	O
regulate	O
the	O
induction	O
of	O
two	O
pro	O
-	O
inflammatory	O
cytokines	O
,	O
interleukin	O
(	O
IL	O
)-	O
6	O
and	O
IL	O
-	O
8	O
,	O
at	O
the	O
transcriptional	O
level	O
.	O

Feedback	O
from	O
family	B-SPEC
medicine	O
and	O
public	O
health	O
educator	O
-	O
practitioners	O
regarding	O
the	O
set	O
of	O
proposed	O
""""	O
essential	O
""""	O
competencies	O
indicated	O
the	O
need	O
for	O
a	O
more	O
limited	O
,	O
feasible	O
set	O
of	O
""""	O
priority	O
""""	O
areas	O
to	O
be	O
highlighted	O
during	O
residency	O
training	O
.	O

TITLE	O
:	O
IL	O
-	O
17	O
boosts	O
proinflammatory	O
outcome	O
of	O
antiviral	O
response	O
in	O
human	B-SPEC
cells	O
.	O

TITLE	O
:	O
Quercetin	O
7	O
-	O
rhamnoside	O
reduces	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
replication	O
via	O
independent	O
pathway	O
of	O
viral	O
induced	O
reactive	O
oxygen	O
species	B-SPEC
.	O

Furthermore	O
,	O
ROS	O
increased	O
the	O
infection	O
of	O
PEDV	B-SPEC
,	O
which	O
was	O
strongly	O
decreased	O
by	O
N	O
-	O
acetyl	O
-	O
L	O
-	O
cysteins	O
(	O
NAC	O
).	O

In	O
support	O
of	O
this	O
model	O
,	O
we	O
reported	O
that	O
the	O
S	O
protein	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
type	O
2	O
(	O
MHV	B-SPEC
-	O
2	O
),	O
which	O
is	O
highly	O
similar	O
to	O
the	O
S	O
protein	O
of	O
SARS	O
-	O
CoV	O
,	O
requires	O
two	O
-	O
step	O
conformational	O
changes	O
mediated	O
by	O
sequential	O
receptor	O
binding	O
and	O
proteolysis	O
to	O
be	O
activated	O
for	O
membrane	O
fusion	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL	I-SPEC
-	O
63	O
infection	O
in	O
a	O
Brazilian	O
patient	O
suspected	O
of	O
H1N1	O
2009	O
influenza	O
infection	O
:	O
description	O
of	O
a	O
fatal	O
case	O
.	O

ABSTRACT	O
:	O
CH	O
/	O
S	O
is	O
a	O
virulent	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
strain	O
and	O
is	O
used	O
as	O
the	O
virulent	O
strain	O
to	O
evaluate	O
the	O
protection	O
rates	O
of	O
vaccines	O
against	O
PEDV	B-SPEC
infection	O
in	O
China	O
.	O

However	O
,	O
TMPRSS2	O
but	O
not	O
HAT	O
expression	O
rendered	O
SARS	O
-	O
S	O
-	O
driven	O
virus	B-SPEC
-	O
cell	O
fusion	O
independent	O
of	O
cathepsin	O
activity	O
,	O
indicating	O
that	O
HAT	O
and	O
TMPRSS2	O
activate	O
SARS	O
-	O
S	O
differentially	O
.	O

Laboratory	O
cats	B-SPEC
inoculated	O
with	O
a	O
mixture	O
of	O
two	O
closely	O
related	O
variants	O
from	O
the	O
same	O
FIP	O
cat	B-SPEC
developed	O
disease	O
from	O
one	O
or	O
the	O
other	O
variant	O
,	O
but	O
not	O
both	O
.	O

In	O
this	O
study	O
,	O
the	O
full	O
-	O
length	O
genomes	O
of	O
eight	O
avian	B-SPEC
gamma	O
-	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
were	O
sequenced	O
and	O
along	O
with	O
other	O
full	O
-	O
length	O
IBV	B-SPEC
genomes	O
available	O
from	O
GenBank	O
were	O
analyzed	O
for	O
recombination	O
.	O

Additionally	O
,	O
FilmArray	O
RP	O
detected	O
138	O
pathogens	O
(	O
confirmed	O
as	O
true	O
positives	O
)	O
not	O
included	O
in	O
the	O
Prodesse	O
assays	O
(	O
rhinovirus	B-SPEC
[	O
RV	O
]/	O
enterovirus	B-SPEC
[	O
EV	O
],	O
118	O
;	O
bocavirus	B-SPEC
,	O
8	O
;	O
coronavirus	B-SPEC
,	O
7	O
;	O
parainfluenza	O
virus	B-SPEC
4	O
,	O
4	O
;	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
,	O
1	O
).	O

The	O
FDA	O
-	O
cleared	O
version	O
includes	O
the	O
following	O
targets	O
:	O
adenovirus	B-SPEC
,	O
coronaviruses	O
HKU1	O
and	O
NL63	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
to	O
type	O
level	O
only	O
),	O
influenza	O
A	O
H1	O
seasonal	O
virus	B-SPEC
,	O
influenza	O
A	O
H3	O
seasonal	O
virus	B-SPEC
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
H1	O
-	O
2009	O
,	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
viruses	B-SPEC
1	O
to	O
4	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
and	O
RV	O
/	O
EV	O
(	O
no	O
differentiation	O
).	O

The	O
complete	O
spike	O
gene	O
of	O
selected	O
isolates	O
from	O
IBV	B-SPEC
cases	O
was	O
amplified	O
and	O
sequenced	O
using	O
conventional	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Crosstalk	O
between	O
innate	O
and	O
adaptive	O
immune	O
responses	O
to	O
infectious	O
bronchitis	O
virus	B-SPEC
after	O
vaccination	O
and	O
challenge	O
of	O
chickens	B-SPEC
varying	O
in	O
serum	O
mannose	O
-	O
binding	O
lectin	O
concentrations	O
.	O

The	O
present	O
study	O
shows	O
that	O
serum	O
MBL	O
levels	O
influence	O
the	O
ability	O
of	O
chickens	B-SPEC
to	O
clear	O
the	O
respiratory	O
tract	O
of	O
virus	B-SPEC
genomes	O
after	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
infection	O
.	O

In	O
conclusion	O
,	O
our	O
results	O
are	O
consistent	O
with	O
mitochondrial	O
AIF	O
and	O
cyclophilin	O
D	O
being	O
central	O
in	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
-	O
induced	O
PCD	O
,	O
while	O
caspases	O
appear	O
not	O
to	O
be	O
essential	O
.	O

X	O
-	O
ray	B-SPEC
crystallography	O
provided	O
insights	O
into	O
the	O
protein	O
-	O
ligand	O
interactions	O
.	O

Each	O
mishandling	O
treatment	O
was	O
experimentally	O
applied	O
under	O
laboratory	O
conditions	O
and	O
then	O
samples	O
were	O
assayed	O
for	O
antibodies	O
against	O
IBV	B-SPEC
,	O
AEV	O
and	O
CAV	B-SPEC
using	O
commercial	O
ELISA	O
kits	O
.	O

Moderate	O
levels	O
of	O
haemolysis	O
had	O
a	O
similar	O
,	O
but	O
less	O
consistent	O
,	O
effect	O
to	O
that	O
of	O
severe	O
haemolysis	O
,	O
producing	O
results	O
that	O
were	O
significantly	O
different	O
from	O
the	O
reference	O
standard	O
only	O
for	O
the	O
IBV	B-SPEC
(	O
less	O
positive	O
)	O
and	O
AEV	O
(	O
more	O
positive	O
)	O
ELISAs	O
.	O

Microscopically	O
,	O
most	O
of	O
the	O
birds	B-SPEC
had	O
acute	O
nephrosis	O
and	O
interstitial	O
nephritis	O
.	O

Immunohistochemistry	O
was	O
strongly	O
positive	O
for	O
IBV	B-SPEC
antigen	O
in	O
the	O
cytoplasm	O
of	O
tubular	O
epithelial	O
cells	O
in	O
the	O
kidneys	O
and	O
also	O
in	O
the	O
epithelium	O
of	O
the	O
respiratory	O
tract	O
,	O
salivary	O
glands	O
,	O
proventriculus	O
,	O
intestine	O
,	O
and	O
bursa	B-SPEC
of	O
Fabricius	O
.	O

ABSTRACT	O
:	O
Between	O
2006	O
and	O
2009	O
,	O
seven	O
strains	O
of	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
isolated	O
from	O
vaccinated	O
chicken	B-SPEC
flocks	O
on	O
different	O
chicken	B-SPEC
farms	O
in	O
China	O
.	O

The	O
results	O
from	O
this	O
study	O
indicate	O
that	O
different	O
IBV	B-SPEC
strains	O
cocirculate	O
in	O
the	O
chicken	B-SPEC
population	O
in	O
China	O
.	O

As	O
most	O
detected	O
enteric	O
viruses	B-SPEC
have	O
been	O
directly	O
demonstrated	O
in	O
healthy	O
turkey	B-SPEC
flocks	O
as	O
well	O
,	O
the	O
epidemiology	O
of	O
this	O
disease	O
complex	O
remains	O
unclear	O
,	O
suggesting	O
that	O
a	O
certain	O
combination	O
of	O
pathogens	O
,	O
environmental	O
factors	O
,	O
or	O
both	O
are	O
necessary	O
for	O
the	O
development	O
of	O
clinical	O
signs	O
.	O

SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
two	O
S	O
-	O
adenosyl	O
-	O
L	O
-	O
methionine	O
(	O
SAM	O
)-	O
dependent	O
methyltransferases	O
(	O
MTase	O
)	O
which	O
sequentially	O
methylate	O
the	O
RNA	O
cap	O
at	O
guanosine	O
-	O
N7	O
and	O
ribose	O
2	O
'-	O
O	O
positions	O
,	O
catalyzed	O
by	O
nsp14	O
N7	O
-	O
MTase	O
and	O
nsp16	O
2	O
'-	O
O	O
-	O
MTase	O
,	O
respectively	O
.	O

These	O
results	O
suggest	O
that	O
nsp16	O
/	O
nsp10	O
interface	O
may	O
represent	O
a	O
better	O
drug	O
target	O
than	O
the	O
viral	O
MTase	O
active	O
site	O
for	O
developing	O
highly	O
specific	O
anti	O
-	O
coronavirus	B-SPEC
drugs	O
.	O

For	O
17	O
sepsis	B-SPEC
cases	O
diagnosed	O
with	O
secondary	O
AKI	O
,	O
comparisons	O
between	O
their	O
urine	O
sTREM	O
-	O
1	O
,	O
urine	O
output	O
,	O
CCr	O
,	O
SCr	O
and	O
BUN	O
at	O
diagnosis	O
and	O
48	O
h	O
before	O
diagnosis	O
were	O
made	O
.	O

On	O
the	O
day	O
of	O
admission	O
to	O
the	O
ICU	O
,	O
and	O
compared	O
with	O
the	O
SIRS	O
group	O
,	O
the	O
sepsis	B-SPEC
group	O
exhibited	O
higher	O
levels	O
of	O
urine	O
sTREM	O
-	O
1	O
and	O
Acute	O
Physiologic	O
Assessment	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
(	O
APACHE	O
II	O
)	O
scores	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Besides	O
being	O
non	O
-	O
invasive	O
,	O
urine	O
sTREM	O
-	O
1	O
testing	O
is	O
more	O
sensitive	O
than	O
testing	O
WBC	O
,	O
serum	O
CRP	O
,	O
and	O
serum	O
PCT	O
for	O
the	O
early	O
diagnosis	O
of	O
sepsis	B-SPEC
,	O
as	O
well	O
as	O
for	O
dynamic	O
assessments	O
of	O
severity	O
and	O
prognosis	O
.	O

Our	O
study	O
was	O
aim	O
at	O
setting	O
a	O
guide	O
for	O
safeguard	O
against	O
nephropathogenic	O
IBV	B-SPEC
-	O
caused	O
disease	O
in	O
China	O
.	O

Current	O
laboratory	O
tests	O
are	O
unable	O
to	O
distinguish	O
between	O
virus	B-SPEC
biotypes	O
of	O
FCoV	O
.	O
FECV	B-SPEC
is	O
highly	O
contagious	O
and	O
easily	O
spreads	O
in	O
multicat	O
environments	O
;	O
therefore	O
,	O
the	O
challenges	O
to	O
animal	B-SPEC
shelters	O
are	O
tremendous	O
.	O

TITLE	O
:	O
The	O
SARS	O
-	O
coronavirus	B-SPEC
-	O
host	O
interactome	O
:	O
identification	O
of	O
cyclophilins	O
as	O
target	O
for	O
pan	B-SPEC
-	O
coronavirus	B-SPEC
inhibitors	O
.	O

Knowledge	O
of	O
host	O
cell	O
proteins	O
that	O
take	O
part	O
in	O
pivotal	O
virus	B-SPEC
-	O
host	O
interactions	O
could	O
define	O
broad	O
-	O
spectrum	O
antiviral	O
targets	O
.	O

Recombinant	O
human	B-SPEC
EC	O
-	O
SOD	O
(	O
rhEC	O
-	O
SOD	O
)	O
was	O
produced	O
from	O
a	O
synthetic	O
cassette	O
constructed	O
in	O
the	O
methylotrophic	O
yeast	B-SPEC
Pichia	B-SPEC
pastoris	I-SPEC
.	O

Female	O
CD	O
-	O
1	O
mice	B-SPEC
were	O
exposed	O
in	O
hyperoxia	O
(	O
FiO2	O
>	O
95	O
%)	O
to	O
induce	O
lung	O
injury	O
.	O

TITLE	O
:	O
[	O
Viral	O
gastroenteritis	O
in	O
domestic	O
animals	B-SPEC
and	O
zoonoses	O
].	O

ABSTRACT	O
:	O
Etiologic	O
investigations	O
of	O
infectious	O
diarrhea	O
were	O
long	O
limited	O
to	O
bacteria	B-SPEC
and	O
protozoa	O
.	O

However	O
,	O
derivatives	O
belonging	O
to	O
all	O
classes	O
showed	O
activity	O
against	O
BVDV	B-SPEC
.	O

When	O
tested	O
in	O
a	O
replicon	O
assay	O
,	O
compound	O
2h	O
was	O
the	O
sole	O
derivative	O
to	O
also	O
display	O
anti	O
-	O
HCV	B-SPEC
activity	O
(	O
EC	O
(	O
50	O
)=	O
3	O
.	O
1	O
μM	O
).	O

In	O
enzyme	O
assays	O
,	O
1m	O
,	O
2h	O
,	O
5m	O
and	O
5n	O
proved	O
to	O
be	O
potent	O
inhibitors	O
of	O
the	O
BVDV	B-SPEC
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
),	O
while	O
only	O
2h	O
also	O
inhibited	O
the	O
recombinant	O
HCV	B-SPEC
enzyme	O
.	O

Flow	O
cytometry	O
is	O
a	O
recurrent	O
technology	O
used	O
for	O
the	O
immunophenotyping	O
of	O
birds	B-SPEC
.	O

Studies	O
,	O
however	O
,	O
have	O
focused	O
on	O
the	O
mechanism	O
of	O
specific	O
diseases	O
or	O
have	O
used	O
animals	B-SPEC
whose	O
immunological	O
condition	O
could	O
be	O
biased	O
-	O
by	O
vaccination	O
or	O
environmental	O
stressors	O
,	O
for	O
example	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
immune	O
status	O
of	O
specific	O
-	O
pathogen	O
-	O
free	O
birds	B-SPEC
across	O
different	O
age	O
ranges	O
to	O
characterize	O
the	O
natural	O
changes	O
that	O
occur	O
over	O
time	O
.	O

Several	O
lymphocyte	O
subsets	O
vary	O
naturally	O
with	O
aging	O
,	O
so	O
the	O
interpretation	O
of	O
results	O
using	O
animals	B-SPEC
of	O
different	O
age	O
ranges	O
must	O
proceed	O
with	O
care	O
.	O

ABSTRACT	O
:	O
In	O
response	O
to	O
environmental	O
cues	O
the	O
human	B-SPEC
pathogen	O
Staphylococcus	B-SPEC
aureus	I-SPEC
synthesizes	O
and	O
releases	O
proteinaceous	O
enterotoxins	O
.	O

ABSTRACT	O
:	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
causes	O
severe	O
acute	O
respiratory	O
tract	O
disease	O
characterized	O
by	O
diffuse	O
alveolar	O
damage	O
and	O
hyaline	O
membrane	O
formation	O
.	O

The	O
mutations	O
in	O
S	O
likely	O
increase	O
recognition	O
of	O
the	O
mouse	B-SPEC
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
receptor	O
not	O
only	O
in	O
MA15	O
but	O
also	O
in	O
two	O
additional	O
,	O
independently	O
isolated	O
mouse	B-SPEC
-	O
adapted	O
SARS	O
-	O
CoVs	O
.	O

ABSTRACT	O
:	O
Four	O
new	O
tetromycin	O
derivatives	O
,	O
tetromycins	O
1	O
-	O
4	O
and	O
a	O
previously	O
known	O
one	O
,	O
tetromycin	O
B	O
(	O
5	O
)	O
were	O
isolated	O
from	O
Streptomyces	B-SPEC
axinellae	I-SPEC
Pol001	O
(	O
T	O
)	O
cultivated	O
from	O
the	O
Mediterranean	O
sponge	B-SPEC
Axinella	B-SPEC
polypoides	I-SPEC
.	O

Here	O
,	O
we	O
profiled	O
the	O
substrate	O
specificities	O
of	O
3CL	O
(	O
pro	O
)	O
from	O
human	B-SPEC
CoV	O
NL63	O
(	O
group	O
1	O
),	O
human	B-SPEC
CoV	O
OC43	O
(	O
group	O
2a	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
(	O
group	O
2b	O
)	O
and	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
(	O
group	O
3	O
),	O
by	O
measuring	O
their	O
activity	O
against	O
a	O
substrate	O
library	O
of	O
19	O
×	O
8	O
of	O
variants	O
with	O
single	O
substitutions	O
at	O
P5	O
to	O
P3	O
'	O
positions	O
.	O

Despite	O
3CL	O
(	O
pro	O
)	O
from	O
different	O
groups	O
of	O
CoVs	O
share	O
many	O
similarities	O
in	O
substrate	O
specificities	O
,	O
differences	O
in	O
substrate	O
specificities	O
were	O
observed	O
at	O
P4	O
positions	O
,	O
with	O
IBV	B-SPEC
3CL	O
(	O
pro	O
)	O
prefers	O
P4	O
-	O
Pro	O
and	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
prefers	O
P4	O
-	O
Val	O
.	O

In	O
total	O
,	O
540	O
one	O
-	O
day	O
-	O
old	O
Cobb	O
500	O
broilers	O
were	O
randomly	O
assigned	O
to	O
receive	O
1	O
of	O
5	O
(	O
n	O
=	O
108	O
birds	B-SPEC
/	O
group	O
)	O
treatments	O
:	O
1	O
)	O
no	O
vaccination	O
;	O
2	O
)	O
simplified	O
vaccination	O
,	O
which	O
included	O
the	O
infectious	O
bronchitis	O
vaccine	O
(	O
H120	O
),	O
the	O
inactivated	O
avian	B-SPEC
influenza	O
vaccine	O
(	O
AI	O
),	O
the	O
live	O
vaccine	O
strain	O
Clone	O
-	O
30	O
of	O
the	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
and	O
the	O
combined	O
inactive	O
vaccine	O
for	O
infectious	O
bursal	O
diseases	O
and	O
the	O
Newcastle	O
disease	O
vaccine	O
(	O
ND	O
-	O
IB	O
);	O
3	O
)	O
normal	O
vaccination	O
(	O
simplified	O
vaccination	O
+	O
second	O
dose	O
of	O
ND	O
-	O
IB	O
,	O
H120	O
,	O
and	O
AI	O
);	O
4	O
)	O
lipopolysaccharide	O
(	O
LPS	O
)	O
stress	O
(	O
normal	O
vaccination	O
+	O
LPS	O
);	O
or	O
5	O
)	O
cyclophosphamide	O
(	O
CPM	O
)	O
stress	O
(	O
normal	O
vaccination	O
+	O
CPM	O
).	O
The	O
results	O
showed	O
that	O
the	O
average	O
BW	O
and	O
average	O
feed	O
intake	O
decreased	O
significantly	O
after	O
treatment	O
with	O
LPS	O
or	O
CPM	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Chickens	B-SPEC
that	O
were	O
challenged	O
by	O
LPS	O
or	O
CPM	O
had	O
a	O
lower	O
ileal	O
CP	O
digestibility	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
01	O
).	O

Clinical	O
signs	O
of	O
diarrhea	O
,	O
depression	O
,	O
and	O
dullness	O
were	O
observed	O
in	O
group	O
A	O
.	O
Birds	B-SPEC
in	O
group	O
B	O
also	O
showed	O
clinical	O
signs	O
similar	O
to	O
those	O
in	O
group	O
A	O
,	O
although	O
the	O
signs	O
were	O
milder	O
in	O
nature	O
.	O

TITLE	O
:	O
Virus	B-SPEC
-	O
binding	O
activity	O
of	O
the	O
truncated	O
C	O
subunit	O
of	O
porcine	B-SPEC
aminopeptidase	O
N	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

An	O
integrative	O
sequencing	O
analysis	O
of	O
both	O
small	O
RNAs	O
and	O
long	O
transcripts	O
from	O
the	O
same	O
samples	O
showed	O
that	O
the	O
results	O
revealing	O
differential	O
expression	O
of	O
miRNAs	O
during	O
infection	O
were	O
largely	O
due	O
to	O
transcriptional	O
regulation	O
and	O
that	O
the	O
predicted	O
miRNA	O
-	O
mRNA	O
network	O
could	O
modulate	O
global	O
host	O
responses	O
to	O
virus	B-SPEC
infection	O
in	O
a	O
combinatorial	O
fashion	O
.	O

These	O
data	O
suggest	O
that	O
FOXO	O
transcription	O
factors	O
mediate	O
pro	O
-	O
apoptotic	O
effects	O
of	O
CCoV	O
-	O
II	O
,	O
in	O
part	O
due	O
to	O
activation	O
of	O
extrinsic	O
apoptosis	O
pathway	O
,	O
while	O
some	O
Sirtuin	O
family	B-SPEC
members	O
(	O
such	O
as	O
SIRT3	O
and	O
SIRT4	O
)	O
may	O
be	O
involved	O
in	O
intrinsic	O
apoptotic	O
pathway	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
strain	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
commonly	O
causes	O
upper	O
respiratory	O
tract	O
infections	O
.	O

Twenty	O
-	O
three	O
privately	O
owned	O
cats	B-SPEC
with	O
FIP	O
.	O

We	O
also	O
review	O
the	O
functions	O
of	O
coronavirus	B-SPEC
proteins	O
,	O
structural	O
,	O
enzymatic	O
,	O
and	O
accessory	O
,	O
with	O
an	O
emphasis	O
on	O
roles	O
in	O
pathogenesis	O
.	O

TITLE	O
:	O
Virus	B-SPEC
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
epidemiology	O
,	O
management	O
and	O
outcome	O
.	O

Among	O
the	O
respiratory	O
viruses	B-SPEC
that	O
can	O
affect	O
the	O
lung	O
and	O
cause	O
ARDS	O
,	O
pandemic	O
viruses	B-SPEC
head	O
the	O
list	O
,	O
with	O
influenza	B-SPEC
viruses	I-SPEC
H5N1	O
and	O
H1N1	O
2009	O
being	O
the	O
most	O
recently	O
identified	O
.	O

CMV	B-SPEC
pneumonia	O
can	O
also	O
occur	O
in	O
mechanically	O
ventilated	O
patients	O
,	O
but	O
is	O
difficult	O
to	O
diagnose	O
because	O
virus	B-SPEC
recovery	O
does	O
not	O
necessarily	O
mean	O
viral	O
disease	O
.	O

RESULTS	O
:	O
Overall	O
,	O
HCoV	O
was	O
detected	O
in	O
113	O
(	O
7	O
.	O
6	O
%)	O
of	O
1481	O
hospitalized	O
children	O
(	O
83	O
[	O
5	O
.	O
7	O
%]	O
after	O
excluding	O
30	O
cases	O
coinfected	O
with	O
other	O
viruses	B-SPEC
)	O
and	O
53	O
(	O
7	O
.	O
1	O
%)	O
of	O
742	O
controls	O
.	O

The	O
above	O
observations	O
and	O
the	O
peculiar	O
features	O
of	O
VZV	B-SPEC
,	O
mainly	O
characterized	O
by	O
its	O
neurotropism	O
and	O
long	O
periods	O
of	O
latency	O
followed	O
by	O
viral	O
reactivation	O
,	O
support	O
the	O
idea	B-SPEC
on	O
the	O
participation	O
of	O
VZV	B-SPEC
in	O
the	O
etiology	O
of	O
MS	O
.	O

Lymphoid	O
depletion	O
degree	O
in	O
lymph	O
tissues	O
of	O
PMWS	O
and	O
PRDC	O
affected	O
pigs	B-SPEC
was	O
determined	O
.	O

The	O
phylogenetic	O
analysis	O
of	O
the	O
hemagglutinin	O
gene	O
of	O
the	O
local	O
wild	O
-	O
type	O
CDV	B-SPEC
strains	O
revealed	O
that	O
the	O
seven	O
local	O
isolates	O
all	O
belonged	O
to	O
the	O
Asia	O
-	O
1	O
lineage	O
,	O
and	O
were	O
clustered	O
closely	O
with	O
one	O
another	O
at	O
the	O
same	O
location	O
.	O

Critically	O
ill	O
patients	O
with	O
pneumonia	O
caused	O
by	O
influenza	B-SPEC
virus	I-SPEC
may	O
develop	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
srr7	O
mutant	O
was	O
isolated	O
from	O
the	O
MHV	B-SPEC
strain	O
cl	O
-	O
2	O
,	O
which	O
induces	O
characteristic	O
spongiform	O
degeneration	O
in	O
the	O
brain	O
.	O

These	O
results	O
demonstrate	O
that	O
,	O
under	O
practical	O
conditions	O
as	O
applied	O
to	O
grow	O
influenza	B-SPEC
viruses	I-SPEC
,	O
contaminating	O
viruses	B-SPEC
can	O
be	O
effectively	O
removed	O
by	O
passages	O
in	O
MDCK	O
cells	O
.	O

EC	O
(	O
50	O
)	O
values	O
were	O
determined	O
to	O
be	O
54μM	O
for	O
HBeAg	O
,	O
61μM	O
for	O
HBsAg	O
and	O
2	O
.	O
66μM	O
for	O
supernatant	O
HBV	B-SPEC
DNA	O
,	O
as	O
compared	O
to	O
1671	O
,	O
1570	O
,	O
169μM	O
,	O
respectively	O
,	O
for	O
the	O
commercially	O
-	O
available	O
hepatitis	O
B	O
drug	O
adefovir	O
dipivoxil	O
(	O
ADV	O
).	O

Stool	O
specimens	O
were	O
frozen	O
in	O
dry	O
ice	O
and	O
remotely	O
tested	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
Rotavirus	B-SPEC
,	O
Astrovirus	O
,	O
Adenovirus	B-SPEC
,	O
Entamoeba	B-SPEC
histolytica	I-SPEC
,	O
Giardia	B-SPEC
,	O
and	O
Cryptosporidium	B-SPEC
and	O
polymerase	O
chain	O
reaction	O
for	O
enterotoxigenic	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
Campylobacter	B-SPEC
,	O
Shigella	B-SPEC
,	O
Vibrio	B-SPEC
,	O
Salmonella	B-SPEC
,	O
and	O
Norovirus	B-SPEC
.	O

Eight	O
(	O
4	O
for	O
Campylobacter	B-SPEC
jejuni	I-SPEC
,	O
2	O
for	O
Campylobacter	B-SPEC
coli	I-SPEC
,	O
1	O
for	O
Norovirus	B-SPEC
genogroup	O
II	O
,	O
and	O
1	O
for	O
both	O
Campylobacter	B-SPEC
coli	I-SPEC
and	O
enterotoxigenic	O
Escherichia	B-SPEC
coli	I-SPEC
)	O
of	O
10	O
samples	O
were	O
positive	O
for	O
at	O
least	O
1	O
enteric	O
pathogen	O
.	O

TITLE	O
:	O
High	O
-	O
level	O
mucosal	O
and	O
systemic	O
immune	O
responses	O
induced	O
by	O
oral	O
administration	O
with	O
Lactobacillus	B-SPEC
-	O
expressed	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
S1	O
region	O
combined	O
with	O
Lactobacillus	B-SPEC
-	O
expressed	O
N	O
protein	O
.	O

Nonethless	O
new	O
pathogens	O
have	O
recently	O
been	O
identified	O
,	O
coronavirus	B-SPEC
for	O
SRASS	O
,	O
H5N1	O
for	O
avian	B-SPEC
Flu	O
,	O
N1N1	O
for	O
pandemic	O
Flu	O
,	O
35	O
years	O
after	O
the	O
identification	O
of	O
Legionella	B-SPEC
pneumophila	I-SPEC
.	O

RNA	O
interference	O
(	O
RNAi	O
)	O
pathways	O
have	O
emerged	O
as	O
important	O
regulators	O
of	O
virus	B-SPEC
-	O
host	O
cell	O
interactions	O
.	O

The	O
epidemiological	O
features	O
of	O
the	O
three	O
outbreaks	O
were	O
similar	O
to	O
those	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
infection	O
,	O
except	O
for	O
the	O
absence	O
of	O
bloody	O
diarrhea	O
,	O
with	O
diarrhea	O
spreading	O
among	O
most	O
adult	O
cows	B-SPEC
,	O
but	O
not	O
in	O
calves	O
,	O
within	O
several	O
days	O
and	O
diarrhea	O
lasting	O
for	O
3	O
-	O
5	O
days	O
with	O
anorexia	O
.	O

Detection	O
of	O
urinary	O
Blastomyces	B-SPEC
antigen	O
is	O
a	O
recent	O
addition	O
to	O
diagnostic	O
options	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
an	O
infectious	O
respiratory	O
disease	O
of	O
domestic	O
fowl	O
that	O
affects	O
poultry	O
of	O
all	O
ages	O
causing	O
economic	O
problems	O
for	O
the	O
poultry	O
industry	O
worldwide	O
.	O

ABSTRACT	O
:	O
Most	O
new	O
emerging	O
viruses	B-SPEC
are	O
derived	O
from	O
strains	O
circulating	O
in	O
zoonotic	O
reservoirs	O
.	O

Coronaviruses	O
,	O
which	O
had	O
an	O
established	O
potential	O
for	O
cross	O
-	O
species	B-SPEC
transmission	O
within	O
domesticated	O
animals	B-SPEC
,	O
suddenly	O
became	O
relevant	O
with	O
the	O
unexpected	O
emergence	O
of	O
the	O
highly	O
pathogenic	O
human	B-SPEC
SARS	O
-	O
CoV	O
strain	O
from	O
zoonotic	O
reservoirs	O
in	O
2002	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
sense	O
RNA	O
((+)	O
RNA	O
)	O
viruses	B-SPEC
such	O
as	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
exploit	O
host	O
cells	O
by	O
subverting	O
host	O
proteins	O
,	O
remodelling	O
subcellular	O
membranes	O
,	O
co	O
-	O
opting	O
and	O
modulating	O
protein	O
and	O
ribonucleoprotein	O
complexes	O
,	O
and	O
altering	O
cellular	O
metabolic	O
pathways	O
during	O
infection	O
.	O

To	O
facilitate	O
RNA	O
replication	O
,	O
(+)	O
RNA	O
viruses	B-SPEC
interact	O
with	O
numerous	O
host	O
molecules	O
through	O
protein	O
-	O
protein	O
,	O
RNA	O
-	O
protein	O
and	O
protein	O
-	O
lipid	O
interactions	O
.	O

These	O
resistance	O
assays	O
,	O
together	O
with	O
viral	O
load	O
assays	O
,	O
will	O
enable	O
clinical	O
laboratories	O
to	O
provide	O
physicians	O
with	O
new	O
and	O
important	O
information	O
for	O
optimal	O
treatment	O
of	O
respiratory	O
virus	B-SPEC
infections	O
.	O

TITLE	O
:	O
The	O
dominance	O
of	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
and	O
NL63	O
infections	O
in	O
infants	O
.	O

Also	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
was	O
rarely	O
observed	O
after	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
(	O
1	O
out	O
of	O
5	O
).	O

This	O
potential	O
intermediate	O
in	O
nucleocapsid	O
formation	O
,	O
which	O
was	O
not	O
observed	O
in	O
coronavirus	B-SPEC
-	O
infected	O
cells	O
,	O
suggests	O
that	O
arterivirus	B-SPEC
RNA	O
synthesis	O
and	O
assembly	O
are	O
coordinated	O
in	O
intracellular	O
space	O
.	O

Since	O
no	O
specific	O
pharmacologic	O
intervention	O
exists	O
for	O
ARDS	O
,	O
our	O
objective	O
was	O
to	O
determine	O
the	O
effect	O
of	O
treatment	O
with	O
ergothioneine	O
-	O
a	O
safe	O
agent	O
with	O
multiple	O
anti	O
-	O
inflammatory	O
and	O
antioxidant	O
properties	O
on	O
the	O
development	O
of	O
lung	O
injury	O
and	O
inflammation	O
in	O
rats	B-SPEC
insufflated	O
with	O
cytokines	O
found	O
in	O
lung	O
lavages	O
of	O
ARDS	O
patients	O
.	O

METHODS	O
:	O
Sprague	B-SPEC
-	I-SPEC
Dawley	I-SPEC
rats	I-SPEC
(	O
3	O
-	O
10	O
/	O
group	O
)	O
were	O
given	O
15	O
mg	O
/	O
kg	O
or	O
150	O
mg	O
/	O
kg	O
l	O
-	O
ergothioneine	O
intravenously	O
1h	O
before	O
or	O
18	O
h	O
after	O
cytokine	O
(	O
IL	O
-	O
1	O
and	O
IFNγ	O
)	O
insufflation	O
.	O

TITLE	O
:	O
Overview	O
of	O
plant	B-SPEC
-	O
derived	O
vaccine	O
antigens	O
:	O
Dengue	B-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
This	O
review	O
highlights	O
the	O
advantages	O
and	O
current	O
status	O
of	O
plant	B-SPEC
-	O
derived	O
vaccine	O
development	O
with	O
special	O
reference	O
to	O
the	O
dengue	B-SPEC
virus	I-SPEC
.	O

In	O
3	O
studies	O
of	O
commingled	O
,	O
mixed	O
-	O
source	O
calves	O
,	O
BCV	B-SPEC
was	O
recovered	O
from	O
calves	O
at	O
entry	O
to	O
the	O
feedlot	O
and	O
the	O
infections	O
were	O
cleared	O
by	O
day	O
8	O
.	O

Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
should	O
be	O
considered	O
along	O
with	O
other	O
bovine	B-SPEC
respiratory	O
viruses	B-SPEC
in	O
the	O
diagnosis	O
of	O
etiologies	O
in	O
bovine	B-SPEC
respiratory	O
disease	O
,	O
especially	O
for	O
animals	B-SPEC
that	O
become	O
sick	O
shortly	O
after	O
arrival	O
.	O

TITLE	O
:	O
Hantavirus	B-SPEC
pulmonary	O
syndrome	O
clinical	O
findings	O
:	O
evaluating	O
a	O
surveillance	O
case	O
definition	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
use	O
of	O
venovenous	O
extracorporeal	O
membrane	O
oxygenation	O
with	O
a	O
single	O
dual	O
lumen	O
cannula	B-SPEC
in	O
a	O
42	O
-	O
year	O
-	O
old	O
patient	O
suffering	O
from	O
a	O
post	O
-	O
pneumonectomy	O
fistula	O
and	O
severe	O
respiratory	O
insufficiency	O
,	O
avoiding	O
the	O
classical	O
approach	O
of	O
invasive	O
mechanical	O
ventilation	O
.	O

The	O
recombinant	O
S1	O
(	O
rS1	O
)	O
and	O
N	O
(	O
rN	O
)	O
proteins	O
of	O
the	O
M41	O
strain	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
were	O
tested	O
,	O
and	O
the	O
live	O
attenuated	O
vaccine	O
H120	O
was	O
used	O
as	O
a	O
positive	O
control	O
.	O

These	O
results	O
further	O
support	O
and	O
expand	O
our	O
initial	O
hypothesis	O
for	O
fundamental	O
differences	O
in	O
immune	O
responses	O
leading	O
to	O
elicitation	O
of	O
bnAbs	O
against	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
compared	O
to	O
SARS	O
CoV	O
and	O
Hendra	B-SPEC
virus	I-SPEC
.	O

Instead	O
,	O
Th1	O
responses	O
were	O
correlated	O
with	O
the	O
capacity	O
to	O
induce	O
IFN	O
-	O
α	O
secretion	O
,	O
which	O
in	O
cord	O
cells	O
were	O
induced	O
by	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
and	O
influenza	B-SPEC
virus	I-SPEC
alone	O
.	O

TITLE	O
:	O
Human	B-SPEC
serum	O
albumin	O
:	O
from	O
bench	O
to	O
bedside	O
.	O

Indeed	O
,	O
HSA	O
represents	O
the	O
main	O
carrier	O
for	O
fatty	O
acids	O
,	O
affects	O
pharmacokinetics	O
of	O
many	O
drugs	O
,	O
provides	O
the	O
metabolic	O
modification	O
of	O
some	O
ligands	O
,	O
renders	O
potential	O
toxins	O
harmless	O
,	O
accounts	O
for	O
most	O
of	O
the	O
anti	O
-	O
oxidant	O
capacity	O
of	O
human	B-SPEC
plasma	O
,	O
and	O
displays	O
(	O
pseudo	O
-)	O
enzymatic	O
properties	O
.	O

HSA	O
is	O
a	O
valuable	O
biomarker	O
of	O
many	O
diseases	O
,	O
including	O
cancer	B-SPEC
,	O
rheumatoid	O
arthritis	O
,	O
ischemia	O
,	O
post	O
-	O
menopausal	O
obesity	O
,	O
severe	O
acute	O
graft	O
-	O
versus	O
-	O
host	O
disease	O
,	O
and	O
diseases	O
that	O
need	O
monitoring	O
of	O
the	O
glycemic	O
control	O
.	O

Arterial	O
blood	O
gas	O
,	O
leukocyte	O
count	O
in	O
the	O
bronchial	O
alveolar	O
lavage	O
fluid	O
and	O
blood	O
,	O
virus	B-SPEC
titers	O
,	O
and	O
cytokine	O
levels	O
in	O
the	O
lung	O
were	O
measured	O
at	O
various	O
times	O
post	O
-	O
inoculation	O
.	O

These	O
results	O
suggested	O
that	O
we	O
successfully	O
established	O
an	O
ARDS	O
mouse	B-SPEC
model	O
induced	O
by	O
a	O
virulent	O
2009	O
H1N1	O
variant	O
without	O
previous	O
adaptation	O
,	O
which	O
may	O
be	O
of	O
benefit	O
for	O
evaluating	O
the	O
pathogenesis	O
or	O
therapy	O
of	O
human	B-SPEC
ARDS	O
caused	O
by	O
2009	O
H1N1	O
virus	B-SPEC
.	O

TITLE	O
:	O
Functional	O
transcriptional	O
regulatory	O
sequence	O
(	O
TRS	O
)	O
RNA	O
binding	O
and	O
helix	O
destabilizing	O
determinants	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
.	O

Treatment	O
with	O
intraperitoneal	O
recombinant	O
human	B-SPEC
(	O
rh	O
)	O
ACE2	O
(	O
2	O
mg	O
/	O
kg	O
)	O
for	O
21	O
days	O
improved	O
survival	O
,	O
exercise	O
capacity	O
,	O
and	O
lung	O
function	O
and	O
decreased	O
lung	O
inflammation	O
and	O
fibrosis	O
in	O
male	O
BLM	O
-	O
WT	O
mice	B-SPEC
.	O

TITLE	O
:	O
Prevalence	O
of	O
antibodies	O
to	O
selected	O
viral	O
pathogens	O
in	O
wild	B-SPEC
boars	I-SPEC
(	O
Sus	B-SPEC
scrofa	I-SPEC
)	O
in	O
Croatia	O
in	O
2005	O
-	O
06	O
and	O
2009	O
-	O
10	O
.	O

ABSTRACT	O
:	O
We	O
determined	O
prevalence	O
of	O
antibody	O
to	O
selected	O
viral	O
pathogens	O
important	O
for	O
domestic	B-SPEC
pigs	I-SPEC
and	O
livestock	O
in	O
556	O
wild	B-SPEC
boar	I-SPEC
(	O
Sus	B-SPEC
scrofa	I-SPEC
)	O
sera	O
collected	O
during	O
2005	O
-	O
06	O
and	O
2009	O
-	O
10	O
in	O
four	O
counties	O
in	O
Croatia	O
.	O

Our	O
results	O
provide	O
information	O
on	O
the	O
current	O
disease	O
exposure	O
and	O
health	O
status	O
of	O
wild	B-SPEC
boars	I-SPEC
in	O
Croatia	O
and	O
suggest	O
that	O
wild	B-SPEC
boars	I-SPEC
may	O
act	O
as	O
a	O
reservoir	O
for	O
several	O
pathogens	O
and	O
a	O
source	O
of	O
infection	O
for	O
domestic	B-SPEC
pigs	I-SPEC
and	O
other	O
livestock	O
as	O
well	O
as	O
humans	B-SPEC
,	O
especially	O
for	O
ADV	O
.	O

Antibodies	O
to	O
FCoV	O
,	O
CDV	B-SPEC
,	O
FPV	B-SPEC
,	O
and	O
T	B-SPEC
.	I-SPEC
gondii	I-SPEC
were	O
detected	O
in	O
43	O
,	O
15	O
,	O
68	O
,	O
and	O
42	O
%	O
of	O
tigers	B-SPEC
,	O
respectively	O
.	O

We	O
recommend	O
continued	O
monitoring	O
of	O
wild	O
tigers	B-SPEC
throughout	O
Asia	O
,	O
development	O
of	O
standardized	O
sampling	O
and	O
postmortem	O
examination	O
procedures	O
,	O
and	O
additional	O
research	O
to	O
better	O
understand	O
potential	O
domestic	O
and	O
wild	O
animal	B-SPEC
sources	O
for	O
these	O
pathogens	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
infection	O
of	O
rat	B-SPEC
dorsal	O
root	O
ganglia	O
:	O
ultrastructural	O
characterization	O
of	O
viral	O
replication	O
,	O
transfer	O
,	O
and	O
the	O
early	O
response	O
of	O
satellite	O
cells	O
.	O

Released	O
HEV	B-SPEC
particles	O
were	O
subsequently	O
taken	O
up	O
by	O
the	O
adjacent	O
satellite	O
cells	O
.	O

We	O
further	O
demonstrate	O
that	O
PI4KB	O
does	O
not	O
affect	O
virus	B-SPEC
entry	O
at	O
the	O
SARS	O
-	O
CoV	O
S	O
-	O
ACE2	O
binding	O
interface	O
or	O
at	O
the	O
stage	O
of	O
virus	B-SPEC
internalization	O
but	O
rather	O
at	O
or	O
before	O
virus	B-SPEC
fusion	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
3b	O
accessory	O
protein	O
modulates	O
transcriptional	O
activity	O
of	O
RUNX1b	O
.	O

These	O
results	O
were	O
further	O
confirmed	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
in	O
IBV	B-SPEC
-	O
infected	O
embryonated	O
chicken	B-SPEC
eggs	O
,	O
chicken	B-SPEC
fibroblast	O
cells	O
and	O
mammalian	B-SPEC
cells	O
at	O
transcriptional	O
and	O
translational	O
levels	O
,	O
respectively	O
.	O

We	O
hypothesized	O
that	O
chemically	O
modified	O
tetracycline	O
3	O
(	O
CMT	O
-	O
3	O
),	O
an	O
anti	O
-	O
inflammatory	O
agent	O
that	O
blocks	O
multiple	O
proteases	O
and	O
cytokines	O
,	O
would	O
prevent	O
ARDS	O
and	O
injury	O
in	O
other	O
organs	O
in	O
a	O
clinically	O
applicable	O
,	O
porcine	B-SPEC
model	O
of	O
inflammation	O
-	O
induced	O
lung	O
injury	O
.	O

Pigs	B-SPEC
(	O
n	O
=	O
15	O
)	O
were	O
anesthetized	O
and	O
instrumented	O
for	O
monitoring	O
.	O

Animals	B-SPEC
were	O
randomized	O
into	O
two	O
groups	O
:	O
CMT	O
-	O
3	O
group	O
(	O
n	O
=	O
7	O
)	O
received	O
CMT	O
-	O
3	O
(	O
200	O
mg	O
/	O
kg	O
);	O
placebo	O
group	O
(	O
n	O
=	O
9	O
)	O
received	O
the	O
same	O
dose	O
of	O
a	O
CMT	O
-	O
3	O
vehicle	O
(	O
carboxymethylcellulose	O
).	O

A	O
cell	O
culture	O
adapted	O
bovine	B-SPEC
coronavirus	B-SPEC
,	O
diluted	O
in	O
growth	O
media	O
or	O
in	O
bovine	B-SPEC
fecal	O
suspensions	O
to	O
simulate	O
fecal	O
contamination	O
was	O
used	O
to	O
spike	O
romaine	O
lettuce	O
.	O

Thus	O
,	O
it	O
is	O
possible	O
that	O
contaminated	O
vegetables	O
may	O
be	O
potential	O
vehicles	O
for	O
coronavirus	B-SPEC
zoonotic	O
transmission	O
to	O
humans	B-SPEC
.	O

TITLE	O
:	O
Application	O
of	O
network	O
analysis	O
parameters	O
in	O
risk	O
-	O
based	O
surveillance	O
-	O
examples	O
based	O
on	O
cattle	B-SPEC
trade	O
data	O
and	O
bovine	B-SPEC
infections	O
in	O
Sweden	O
.	O

It	O
is	O
concluded	O
that	O
network	O
measures	O
for	O
the	O
relevant	O
time	O
period	O
based	O
on	O
updated	O
databases	O
of	O
animal	B-SPEC
movements	O
can	O
provide	O
a	O
simple	O
and	O
straight	O
forward	O
tool	O
for	O
risk	O
-	O
based	O
sampling	O
.	O

ABSTRACT	O
:	O
In	O
vitro	O
infection	O
of	O
Vero	O
E6	O
cells	O
by	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
blocked	O
by	O
hexapeptide	O
Tyr	O
-	O
Lys	O
-	O
Tyr	O
-	O
Arg	O
-	O
Tyr	O
-	O
Leu	O
.	O

The	O
peptide	O
also	O
inhibits	O
proliferation	O
of	O
coronavirus	B-SPEC
NL63	O
.	O

Based	O
on	O
this	O
information	O
the	O
peptide	O
can	O
be	O
used	O
as	O
lead	O
structure	O
to	O
design	O
potential	O
entry	O
inhibitors	O
against	O
SARS	O
-	O
CoV	O
and	O
related	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
71	O
-	O
year	O
-	O
old	O
man	B-SPEC
was	O
admitted	O
to	O
the	O
hospital	O
complaining	O
of	O
productive	O
cough	O
and	O
weight	O
loss	O
.	O

Forty	O
percent	O
of	O
coronavirus	B-SPEC
isolates	O
from	O
FIP	O
tissues	O
had	O
an	O
intact	O
3c	O
gene	O
,	O
while	O
60	O
%	O
had	O
mutations	O
that	O
truncated	O
the	O
gene	O
product	O
.	O

Coronavirus	B-SPEC
from	O
FIP	O
diseased	O
tissues	O
consistently	O
induced	O
FIP	O
when	O
given	O
either	O
oronasally	O
or	O
intraperitoneally	O
(	O
i	O
.	O
p	O
.),	O
regardless	O
of	O
the	O
functional	O
status	O
of	O
their	O
3c	O
genes	O
,	O
thus	O
confirming	O
them	O
to	O
be	O
FIPVs	O
.	O

Only	O
one	O
in	O
three	O
cats	B-SPEC
shed	O
FECV	B-SPEC
in	O
the	O
feces	O
following	O
i	O
.	O
p	O
.	O

Infections	O
with	O
respiratory	O
viruses	B-SPEC
in	O
childhood	O
increase	O
the	O
risk	O
of	O
subsequently	O
developing	O
asthma	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
from	O
palm	O
civets	B-SPEC
has	O
twice	O
evolved	O
the	O
capacity	O
to	O
infect	O
humans	B-SPEC
by	O
gaining	O
binding	O
affinity	O
for	O
human	B-SPEC
receptor	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
).	O

In	O
one	O
lineage	O
of	O
murine	B-SPEC
coronaviruses	O
,	O
however	O
,	O
HE	O
esterase	O
substrate	O
and	O
lectin	O
ligand	O
specificity	O
changed	O
dramatically	O
as	O
these	O
viruses	B-SPEC
evolved	O
to	O
use	O
4	O
-	O
O	O
-	O
acetylated	O
Sias	O
instead	O
.	O

Our	O
findings	O
illustrate	O
the	O
ease	O
with	O
which	O
viruses	B-SPEC
can	O
change	O
receptor	O
-	O
binding	O
specificity	O
with	O
potential	O
consequences	O
for	O
host	O
-,	O
organ	O
and	O
/	O
or	O
cell	O
tropism	O
,	O
and	O
for	O
pathogenesis	O
.	O

Rural	O
dogs	B-SPEC
were	O
0	O
.	O
421	O
times	O
(	O
P	O
≤	O
0	O
.	O
0001	O
)	O
less	O
likely	O
to	O
be	O
positive	O
for	O
CRCoV	O
than	O
dogs	B-SPEC
admitted	O
to	O
the	O
shelter	O
.	O

Dogs	B-SPEC
from	O
Fort	O
Resolution	O
,	O
NWT	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
less	O
likely	O
to	O
have	O
moderate	O
or	O
high	O
antibody	O
titers	O
to	O
the	O
3	O
agents	O
than	O
dogs	B-SPEC
in	O
the	O
shelter	O
.	O

The	O
endoribonuclease	O
activity	O
of	O
the	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
A59	O
Nsp15	O
was	O
also	O
increased	O
by	O
pRb	O
in	O
vitro	O
,	O
and	O
an	O
MHV	B-SPEC
with	O
mutations	O
in	O
the	O
LXCXE	O
/	O
D	O
-	O
motif	O
,	O
named	O
vLC	O
,	O
exhibited	O
a	O
smaller	O
plaque	O
diameter	O
and	O
reduced	O
the	O
virus	B-SPEC
titer	O
by	O
∼	O
1	O
log	O
.	O

To	O
enhance	O
the	O
immune	O
efficiency	O
of	O
CEA	B-SPEC
in	O
mice	B-SPEC
that	O
received	O
,	O
we	O
fused	O
a	O
partial	O
CEA	B-SPEC
gene	O
with	O
exogenous	O
SARS	O
-	O
CoV	O
fragments	O
.	O

This	O
study	O
also	O
revealed	O
a	O
previously	O
unknown	O
diversity	O
of	O
coronaviruses	O
in	O
bats	B-SPEC
,	O
which	O
are	O
important	O
natural	O
reservoir	O
for	O
coronaviruses	O
including	O
SARS	O
-	O
CoV	O
-	O
like	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
in	O
children	O
:	O
epidemiology	O
,	O
disease	O
spectrum	O
,	O
and	O
genetic	O
diversity	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
was	O
associated	O
with	O
younger	O
age	O
,	O
croup	O
,	O
febrile	O
convulsion	O
,	O
and	O
acute	O
gastroenteritis	O
.	O

TITLE	O
:	O
The	O
Effects	O
of	O
Temperature	O
and	O
Relative	O
Humidity	O
on	O
the	O
Viability	O
of	O
the	O
SARS	O
Coronavirus	B-SPEC
.	O

The	O
stability	O
of	O
the	O
virus	B-SPEC
at	O
different	O
temperatures	O
and	O
relative	O
humidity	O
on	O
smooth	O
surfaces	O
were	O
studied	O
.	O

However	O
,	O
virus	B-SPEC
viability	O
was	O
rapidly	O
lost	O
(>	O
3	O
log	O
(	O
10	O
))	O
at	O
higher	O
temperatures	O
and	O
higher	O
relative	O
humidity	O
(	O
e	O
.	O
g	O
.,	O
38	O
°	O
C	O
,	O
and	O
relative	O
humidity	O
of	O
>	O
95	O
%).	O

TITLE	O
:	O
Coronavirus	B-SPEC
papain	O
-	O
like	O
proteases	O
negatively	O
regulate	O
antiviral	O
innate	O
immune	O
response	O
through	O
disruption	O
of	O
STING	O
-	O
mediated	O
signaling	O
.	O

The	O
reason	O
for	O
ANA	O
was	O
unclear	O
:	O
reactive	O
samples	O
were	O
negative	O
for	O
Erhlichia	O
canis	B-SPEC
antibodies	O
;	O
seven	O
were	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
positive	O
,	O
but	O
15	O
were	O
negative	O
.	O

We	O
used	O
conditional	O
targeting	O
of	O
pDC	O
-	O
specific	O
transcription	O
factor	O
E2	O
-	O
2	O
to	O
generate	O
mice	B-SPEC
that	O
constitutively	O
lack	O
pDCs	O
in	O
peripheral	O
lymphoid	O
organs	O
and	O
tissues	O
.	O

The	O
profound	O
impact	O
of	O
pDC	O
deficiency	O
on	O
innate	O
antiviral	O
responses	O
was	O
revealed	O
by	O
the	O
failure	O
to	O
control	O
acute	O
infection	O
with	O
the	O
cytopathic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

Adoptive	O
transfer	O
of	O
LCMV	B-SPEC
-	O
specific	O
T	O
cells	O
revealed	O
that	O
both	O
CD4	O
(+)	O
and	O
CD8	O
(+)	O
T	O
cells	O
required	O
IFN	O
-	O
I	O
for	O
expansion	O
,	O
but	O
only	O
CD4	O
(+)	O
T	O
cells	O
required	O
the	O
presence	O
of	O
pDCs	O
.	O

These	O
data	O
suggest	O
that	O
pDCs	O
facilitate	O
CD4	O
(+)	O
helper	O
T	O
-	O
cell	O
responses	O
to	O
persistent	O
viruses	B-SPEC
independently	O
of	O
direct	O
antigen	O
presentation	O
.	O

TITLE	O
:	O
Mojave	O
toxin	O
-	O
type	O
ascending	O
flaccid	O
paralysis	O
after	O
an	O
envenomation	O
by	O
a	O
Southern	B-SPEC
Pacific	I-SPEC
Rattlesnake	I-SPEC
in	O
a	O
dog	B-SPEC
.	O

Meta	B-SPEC
-	O
analysis	O
of	O
the	O
3	O
RCTs	O
(	O
310	O
patients	O
,	O
159	O
of	O
them	O
treated	O
with	O
ECMO	O
)	O
revealed	O
ECMO	O
did	O
not	O
decrease	O
the	O
mortality	O
of	O
ARDS	O
patients	O
[	O
odds	O
ratio	O
(	O
OR	O
)=	O
0	O
.	O
75	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
95	O
%	O
CI	O
)	O
0	O
.	O
45	O
-	O
1	O
.	O
24	O
,	O
P	O
=	O
0	O
.	O
27	O
].	O

Immunohistochemistry	O
revealed	O
small	O
numbers	O
of	O
macrophages	O
around	O
necrotic	O
foci	O
that	O
were	O
positively	O
stained	O
for	O
anti	O
-	O
mouse	B-SPEC
feline	B-SPEC
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Fatal	O
outbreaks	O
in	O
dogs	B-SPEC
associated	O
with	O
pantropic	O
canine	O
coronavirus	B-SPEC
in	O
France	O
and	O
Belgium	O
.	O

(	O
3	O
)	O
The	O
detection	O
rates	O
of	O
2	O
or	O
more	O
viruses	B-SPEC
were	O
38	O
.	O
2	O
%,	O
36	O
.	O
4	O
%,	O
30	O
.	O
2	O
%	O
and	O
15	O
.	O
2	O
%	O
in	O
groups	O
of	O
<	O
1	O
year	O
old	O
,	O
1	O
-	O
<	O
3	O
years	O
old	O
,	O
3	O
-	O
<	O
6	O
years	O
old	O
and	O
≥	O
6	O
years	O
old	O
,	O
respectively	O
.	O

The	O
highest	O
prevalence	O
for	O
a	O
virus	B-SPEC
infection	O
was	O
demonstrated	O
for	O
canine	O
parvovirus	B-SPEC
(	O
19	O
.	O
9	O
%),	O
followed	O
by	O
coronavirus	B-SPEC
(	O
17	O
.	O
3	O
%),	O
and	O
paramyxovirus	O
(	O
13	O
.	O
9	O
%).	O

Based	O
on	O
clinical	O
parameters	O
it	O
is	O
not	O
possible	O
to	O
differentiate	O
a	O
virus	B-SPEC
-	O
positive	O
from	O
a	O
virus	B-SPEC
-	O
negative	O
dog	B-SPEC
or	O
to	O
diagnose	O
a	O
certain	O
virus	B-SPEC
species	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
summarize	O
the	O
clinical	O
experiences	O
and	O
indications	O
of	O
extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
)	O
for	O
severe	O
ARDS	O
caused	O
by	O
novel	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
virus	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
have	O
prepared	O
full	O
-	O
length	O
SARS	O
-	O
CoV	O
NP	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
purified	O
.	O

Ten	O
of	O
the	O
14	O
HPeV	O
patients	O
with	O
respiratory	O
syndrome	O
were	O
co	O
-	O
infected	O
with	O
other	O
respiratory	O
viruses	B-SPEC
(	O
eight	O
with	O
rhinovirus	B-SPEC
and	O
two	O
with	O
coronavirus	B-SPEC
OC43	O
).	O

TGEV	B-SPEC
infection	O
up	O
-	O
regulated	O
FasL	O
,	O
activated	O
FasL	O
-	O
mediated	O
apoptotic	O
pathway	O
,	O
leading	O
to	O
activation	O
of	O
caspase	O
-	O
8	O
and	O
cleavage	O
of	O
Bid	O
.	O

An	O
online	O
questionnaire	O
was	O
designed	O
and	O
electronically	O
distributed	O
to	O
the	O
staff	O
of	O
a	O
teaching	O
medical	O
institution	O
in	O
the	O
United	O
Kingdom	B-SPEC
.	O

ABSTRACT	O
:	O
Increasing	O
concerns	O
about	O
the	O
spread	O
of	O
airborne	O
pathogens	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
novel	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
H1N1	O
)	O
have	O
attracted	O
public	O
attention	O
to	O
bioaerosols	O
and	O
protection	O
against	O
them	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
genomes	O
are	O
translated	O
into	O
polyproteins	O
that	O
are	O
processed	O
by	O
viral	O
proteases	O
to	O
yield	O
functional	O
intermediate	O
and	O
mature	O
proteins	O
.	O

Replacement	O
with	O
the	O
BCoV	O
32	O
-	O
nucleotide	O
(	O
nt	O
)	O
inter	O
-	O
stem	O
-	O
loop	O
fourth	O
domain	O
between	O
stem	O
-	O
loops	O
III	O
and	O
IV	O
,	O
however	O
,	O
required	O
blind	O
cell	O
passaging	O
for	O
virus	B-SPEC
recovery	O
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
drug	O
FK506	O
(	O
Tacrolimus	O
)	O
inhibited	O
strongly	O
the	O
growth	O
of	O
human	B-SPEC
coronaviruses	O
SARS	O
-	O
CoV	O
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
at	O
low	O
,	O
non	O
-	O
cytotoxic	O
concentrations	O
in	O
cell	O
culture	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
is	O
one	O
of	O
the	O
most	O
severe	O
devastating	O
diseases	O
of	O
the	O
Felidae	B-SPEC
.	O

TITLE	O
:	O
Flavonoid	O
-	O
mediated	O
inhibition	O
of	O
SARS	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
expressed	O
in	O
Pichia	B-SPEC
pastoris	I-SPEC
.	O

Bronchial	O
lavage	O
on	O
day	O
10	O
showed	O
blood	O
-	O
tinged	O
fluid	O
and	O
hemosiderin	O
-	O
laden	O
macrophages	O
,	O
but	O
no	O
bacteria	B-SPEC
or	O
fungi	B-SPEC
.	O

The	O
clinical	O
appearance	O
was	O
similar	O
to	O
that	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
.	O

The	O
sequence	O
data	O
indicate	O
that	O
this	O
PEDV	B-SPEC
variant	O
prevails	O
in	O
China	O
.	O

TITLE	O
:	O
First	O
evidence	O
of	O
the	O
emergence	O
of	O
novel	O
putative	O
infectious	O
bronchitis	O
virus	B-SPEC
genotypes	O
in	O
Cuba	O
.	O

TITLE	O
:	O
[	O
Experience	O
with	O
empirical	O
treatment	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
due	O
to	O
coronavirus	B-SPEC
,	O
genotype	O
IV	O
].	O

TITLE	O
:	O
Rapid	O
detection	O
of	O
Betacoronavirus	B-SPEC
1	I-SPEC
from	O
clinical	O
fecal	O
specimens	O
by	O
a	O
novel	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
assay	O
.	O

The	O
assay	O
displayed	O
high	O
specificity	O
detecting	O
only	O
BCoV	O
-	O
1	O
with	O
no	O
cross	O
reaction	O
with	O
other	O
viruses	B-SPEC
.	O

Four	O
patients	O
were	O
identified	O
with	O
capillary	O
leak	O
syndrome	O
associated	O
with	O
a	O
primary	O
diagnosis	O
:	O
cardiac	O
transplant	O
rejection	O
in	O
one	O
,	O
septic	O
shock	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
two	O
,	O
and	O
neonatal	O
hydrops	B-SPEC
fetalis	O
in	O
one	O
patient	O
.	O

TITLE	O
:	O
Viruses	B-SPEC
and	O
interactomes	O
in	O
translation	O
.	O

ABSTRACT	O
:	O
A	O
decade	O
of	O
high	O
-	O
throughput	O
screenings	O
for	O
intraviral	O
and	O
virus	B-SPEC
-	O
host	O
protein	O
-	O
protein	O
interactions	O
led	O
to	O
the	O
accumulation	O
of	O
data	O
and	O
to	O
the	O
development	O
of	O
theories	O
on	O
laws	O
governing	O
interactome	O
organization	O
for	O
many	O
viruses	B-SPEC
.	O

If	O
intraviral	O
networks	O
seem	O
to	O
behave	O
similarly	O
,	O
they	O
are	O
clearly	O
different	O
from	O
the	O
human	B-SPEC
interactome	O
.	O

Although	O
previous	O
studies	O
indicated	O
that	O
susceptibility	O
is	O
determined	O
by	O
a	O
single	O
gene	O
,	O
Ceacam1	O
,	O
our	O
recent	O
work	O
in	O
gene	O
-	O
replaced	O
mice	B-SPEC
with	O
chimeric	O
Ceacam1	O
pointed	O
toward	O
the	O
involvement	O
of	O
other	O
host	O
factors	O
(	O
genes	O
)	O
in	O
the	O
susceptibility	O
.	O

ARDS	O
is	O
associated	O
with	O
many	O
diagnoses	O
,	O
including	O
trauma	O
and	O
sepsis	B-SPEC
,	O
can	O
lead	O
to	O
multiple	O
organ	O
failure	O
and	O
has	O
high	O
mortality	O
.	O

TITLE	O
:	O
Etiology	O
and	O
clinical	O
characterization	O
of	O
respiratory	O
virus	B-SPEC
infections	O
in	O
adult	O
patients	O
attending	O
an	O
emergency	O
department	O
in	O
Beijing	O
.	O

A	O
retrospective	O
comparison	O
of	O
the	O
signalment	O
between	O
cats	B-SPEC
with	O
confirmed	O
FIP	O
and	O
the	O
general	O
cat	B-SPEC
population	O
was	O
designed	O
.	O

A	O
significantly	O
higher	O
proportion	O
of	O
male	O
cats	B-SPEC
had	O
FIP	O
compared	O
with	O
female	O
cats	B-SPEC
.	O

The	O
Extracorporeal	O
Support	O
Study	O
Group	O
was	O
created	O
in	O
order	B-SPEC
to	O
practice	O
ECMO	O
and	O
to	O
employ	O
it	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
severe	O
hypoxemia	O
.	O

Furthermore	O
,	O
using	O
four	O
additional	O
fecal	O
samples	O
containing	O
two	O
viruses	B-SPEC
(	O
GBR	O
and	O
BCV	B-SPEC
or	O
BToV	O
),	O
two	O
amplified	O
products	O
of	O
the	O
expected	O
sizes	O
were	O
obtained	O
simultaneously	O
.	O

We	O
analyzed	O
in	O
this	O
study	O
the	O
impact	O
of	O
Tregs	O
on	O
the	O
development	O
of	O
acute	O
viral	O
encephalomyelitis	O
,	O
T	O
cell	O
-	O
mediated	O
antiviral	O
protection	O
,	O
and	O
prevention	O
of	O
CNS	O
autoimmunity	O
following	O
intranasal	O
infection	O
with	O
the	O
gliatropic	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
A59	O
.	O

Phylogenetic	O
analysis	O
of	O
partial	O
S1	O
gene	O
sequences	O
of	O
IBV	B-SPEC
strains	O
showed	O
that	O
the	O
European	O
QX	O
-	O
like	O
genotype	O
comprises	O
strains	O
that	O
have	O
been	O
predominantly	O
circulating	O
in	O
this	O
continent	O
for	O
the	O
past	O
decade	O
.	O

RESULTS	O
:	O
Twelve	O
patients	O
had	O
pneumonia	O
and	O
sepsis	B-SPEC
with	O
progression	O
to	O
ARDS	O
.	O

ABSTRACT	O
:	O
A	O
conserved	O
cysteine	O
-	O
rich	O
motif	O
located	O
between	O
the	O
transmembrane	O
domain	O
and	O
the	O
endodomain	O
is	O
essential	O
for	O
membrane	O
fusion	O
and	O
assembly	O
of	O
coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
.	O

TITLE	O
:	O
Virological	O
Survey	O
in	O
free	O
-	O
ranging	O
wildcats	O
(	O
Felis	B-SPEC
silvestris	I-SPEC
)	O
and	O
feral	O
domestic	B-SPEC
cats	I-SPEC
in	O
Portugal	O
.	O

We	O
studied	O
the	O
lung	O
inflammatory	O
response	O
to	O
postpartum	O
hemorrhagic	O
shock	O
and	O
resuscitation	O
in	O
a	O
rabbit	B-SPEC
model	O
and	O
the	O
role	O
of	O
the	O
nuclear	O
factor	O
-	O
κB	O
pathway	O
.	O

After	O
hemorrhagic	O
shock	O
and	O
resuscitation	O
,	O
median	O
survival	O
time	O
in	O
obstetric	O
rabbits	B-SPEC
(	O
3	O
days	O
)	O
was	O
significantly	O
shorter	O
(	O
p	O
<.	O
05	O
)	O
than	O
that	O
in	O
nonobstetric	O
rabbits	B-SPEC
(	O
5	O
days	O
).	O

After	O
hemorrhage	O
and	O
resuscitation	O
,	O
obstetric	O
rabbits	B-SPEC
had	O
significantly	O
shorter	O
survival	O
time	O
and	O
more	O
severe	O
lung	O
injury	O
than	O
nonobstetric	O
rabbits	B-SPEC
.	O

The	O
complications	O
seen	O
in	O
the	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
cases	O
were	O
:	O
thrombocytopenia	O
;	O
hepatic	O
dysfunction	O
;	O
renal	O
damage	O
;	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Various	O
samples	O
including	O
spleen	O
,	O
liver	O
and	O
lymphocytes	O
from	O
mice	B-SPEC
of	O
two	O
model	O
groups	O
and	O
the	O
controls	O
were	O
examined	O
for	O
KCTD9	O
expression	O
by	O
real	O
time	O
quantitative	O
PCR	O
and	O
Immunohistochemistry	O
.	O

TITLE	O
:	O
Visualizing	O
coronavirus	B-SPEC
RNA	O
synthesis	O
in	O
time	O
by	O
using	O
click	O
chemistry	O
.	O

Our	O
data	O
indicate	O
that	O
ACE2	O
utilization	O
preceded	O
the	O
emergence	O
of	O
SARS	O
-	O
CoV	O
-	O
like	O
viruses	B-SPEC
from	O
bats	B-SPEC
.	O

This	O
has	O
been	O
due	O
to	O
a	O
combination	O
of	O
factors	O
including	O
the	O
emergence	O
of	O
highly	O
virulent	O
zoonotic	O
pathogens	O
,	O
such	O
as	O
Hendra	O
,	O
Nipah	O
,	O
SARS	O
and	O
Ebola	B-SPEC
viruses	I-SPEC
,	O
and	O
the	O
high	O
rate	O
of	O
detection	O
of	O
a	O
large	O
number	O
of	O
previously	O
unknown	O
viral	O
sequences	O
in	O
bat	B-SPEC
specimens	O
.	O

The	O
structure	O
-	O
activity	O
relationships	O
(	O
SARs	O
)	O
of	O
caudatin	O
derivatives	O
had	O
been	O
discussed	O
,	O
which	O
were	O
useful	O
for	O
caudatin	O
derivatives	O
to	O
be	O
explored	O
and	O
developed	O
as	O
novel	O
anti	O
-	O
HBV	B-SPEC
agents	O
.	O

The	O
results	O
demonstrate	O
that	O
(	O
1	O
)	O
STAT3	O
is	O
activated	O
by	O
P	B-SPEC
.	I-SPEC
berghei	I-SPEC
ANKA	O
(	O
PBA	O
)	O
infection	O
in	O
vivo	O
and	O
Heme	O
in	O
vitro	O
.	O

ABSTRACT	O
:	O
A	O
total	O
of	O
128	O
1	O
-	O
week	O
-	O
old	O
chicks	O
were	O
classified	O
into	O
four	O
groups	O
;	O
T	O
-	O
2	O
toxin	O
fed	O
(	O
T	O
-	O
2	O
),	O
IBV	B-SPEC
infected	O
(	O
IBV	B-SPEC
),	O
T	O
-	O
2	O
toxin	O
fed	O
and	O
co	O
-	O
infected	O
with	O
IBV	B-SPEC
(	O
T	O
-	O
2	B-SPEC
+	I-SPEC
IBV	I-SPEC
),	O
and	O
untreated	O
(	O
control	O
)	O
for	O
a	O
period	O
of	O
6	O
weeks	O
.	O

Within	O
their	O
respective	O
groups	O
,	O
the	O
birds	B-SPEC
belonged	O
to	O
T	O
-	O
2	O
and	O
T	O
-	O
2	B-SPEC
+	I-SPEC
IBV	I-SPEC
were	O
exposed	O
to	O
2	O
ppm	O
of	O
T	O
-	O
2	O
toxin	O
contaminated	O
feed	O
for	O
6	O
weeks	O
,	O
and	O
0	O
.	O
2	O
ml	O
of	O
10	O
EID	O
(	O
50	O
)	O
(	O
10	O
(	O
5	O
.	O
69	O
)/	O
0	O
.	O
2	O
ml	O
)	O
inoculums	O
of	O
IBV	B-SPEC
isolate	O
(	O
India	O
/	O
LKW	O
/	O
56	O
/	O
IVRI	O
/	O
08	O
)	O
was	O
used	O
to	O
challenge	O
the	O
chicks	O
belonged	O
to	O
IBV	B-SPEC
alone	O
and	O
T	O
-	O
2	B-SPEC
+	I-SPEC
IBV	I-SPEC
groups	O
after	O
3	O
weeks	O
of	O
the	O
experiment	O
.	O

Similarly	O
,	O
the	O
mean	O
IBV	B-SPEC
ELISA	O
antibody	O
titres	O
in	O
the	O
toxin	O
fed	O
groups	O
were	O
significantly	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
reduced	O
as	O
compared	O
with	O
the	O
IBV	B-SPEC
ELISA	O
antibody	O
titres	O
of	O
IBV	B-SPEC
infected	O
but	O
not	O
toxin	O
fed	O
group	O
,	O
at	O
all	O
intervals	O
.	O

However	O
,	O
CD	O
(	O
4	O
)(+):	O
CD	O
(	O
8	O
)(+)	O
ratios	O
of	O
IBV	B-SPEC
infected	O
group	O
at	O
42	O
(	O
21	O
)	O
DTF	O
(	O
DPI	O
)	O
were	O
found	O
significantly	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
higher	O
than	O
the	O
values	O
in	O
control	O
birds	B-SPEC
.	O

The	O
findings	O
of	O
the	O
present	O
experiment	O
revealed	O
immunosuppressive	O
effects	O
of	O
T	O
-	O
2	O
toxin	O
and	O
aggravated	O
the	O
pathology	O
and	O
pathogenesis	O
of	O
IBV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
lethal	O
immunopathological	O
disease	O
caused	O
by	O
feline	B-SPEC
coronaviruses	O
(	O
FCoVs	O
).	O

Besides	O
inhibiting	O
BVDV	B-SPEC
,	O
two	O
compounds	O
(	O
35	O
and	O
38	O
)	O
showed	O
a	O
moderate	O
activity	O
also	O
against	O
YFV	B-SPEC
(	O
EC	O
(	O
50	O
)	O
=	O
13	O
μM	O
).	O

Interestingly	O
,	O
35	O
was	O
moderately	O
active	O
also	O
against	O
RSV	B-SPEC
(	O
EC	O
(	O
50	O
)	O
=	O
25	O
μM	O
).	O

TITLE	O
:	O
Comparative	O
evaluation	O
of	O
two	O
hemagglutinating	O
encephalomyelitis	O
coronavirus	B-SPEC
vaccine	O
candidates	O
in	O
mice	B-SPEC
.	O

Here	O
we	O
use	O
a	O
murine	B-SPEC
model	O
for	O
evaluation	O
of	O
the	O
induction	O
of	O
humoral	O
and	O
cellular	O
immune	O
responses	O
by	O
inactivated	O
and	O
PHE	O
-	O
CoV	O
DNA	O
vaccines	O
in	O
order	B-SPEC
to	O
define	O
the	O
immune	O
correlates	O
for	O
protection	O
against	O
PHE	O
-	O
CoV	O
.	O
The	O
inactivated	O
vaccine	O
was	O
composed	O
of	O
purified	O
PHE	O
-	O
CoV	O
and	O
aluminum	O
hydroxide	O
gel	O
(	O
alum	O
),	O
which	O
was	O
chosen	O
as	O
an	O
adjuvant	O
because	O
of	O
its	O
long	O
history	O
of	O
safety	O
for	O
human	B-SPEC
use	O
.	O

ABSTRACT	O
:	O
A	O
total	O
of	O
127	O
porcine	B-SPEC
samples	O
were	O
collected	O
from	O
48	O
farms	O
in	O
six	O
provinces	O
in	O
south	O
China	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
partial	O
S	O
gene	O
showed	O
that	O
all	O
the	O
south	O
China	O
PEDV	B-SPEC
strains	O
and	O
two	O
Thailand	O
strains	O
(	O
08UB01	O
and	O
08RB07	O
)	O
belong	O
to	O
the	O
same	O
group	O
and	O
differ	O
genetically	O
from	O
European	O
strains	O
and	O
early	O
domestic	O
strains	O
.	O

ABSTRACT	O
:	O
Recently	O
a	O
commercial	O
antigen	O
-	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
kit	O
in	O
the	O
form	O
of	O
a	O
dipstick	O
(	O
Bovine	B-SPEC
Enterichek	O
,	O
Biovet	O
Inc	O
.)	O
was	O
made	O
available	O
to	O
bovine	B-SPEC
practitioners	O
and	O
producers	O
for	O
the	O
rapid	O
detection	O
of	O
Betacoronavirus	B-SPEC
1	I-SPEC
(	O
BCV	B-SPEC
-	O
1	O
),	O
Rotavirus	B-SPEC
A	I-SPEC
(	O
RV	O
-	O
A	O
),	O
Escherichia	B-SPEC
coli	I-SPEC
K99	O
(+),	O
and	O
Cryptosporidium	B-SPEC
parvum	I-SPEC
in	O
feces	O
from	O
diarrheic	O
calves	O
.	O

The	O
current	O
study	O
suggested	O
that	O
Bovine	B-SPEC
Enterichek	O
can	O
be	O
a	O
rapid	O
test	O
tool	O
in	O
the	O
field	O
for	O
detection	O
of	O
RV	O
-	O
A	O
,	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
,	O
or	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
K99	O
(+)	O
in	O
feces	O
from	O
calves	O
at	O
acute	O
stage	O
of	O
clinical	O
disease	O
.	O

However	O
,	O
test	O
results	O
for	O
BCV	B-SPEC
-	O
1	O
by	O
the	O
kit	O
should	O
be	O
interpreted	O
with	O
caution	O
due	O
to	O
low	O
specificity	O
and	O
sensitivity	O
of	O
the	O
kit	O
.	O

A	O
needle	O
-	O
free	O
delivery	O
approach	O
is	O
a	O
convenient	O
and	O
cost	O
effective	O
method	O
of	O
vaccine	O
administration	O
,	O
especially	O
for	O
respiratory	O
infections	O
in	O
economic	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
virulent	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
strain	O
,	O
DR13	O
,	O
was	O
obtained	O
from	O
suckling	O
pigs	B-SPEC
suspected	O
of	O
having	O
porcine	B-SPEC
epidemic	O
diarrhea	O
in	O
1999	O
in	O
Korea	O
,	O
and	O
its	O
attenuated	O
counterpart	O
was	O
derived	O
from	O
virulent	O
strain	O
DR13	O
by	O
serial	O
propagation	O
in	O
Vero	O
cells	O
.	O

We	O
previously	O
identified	O
the	O
antiviral	O
activities	O
of	O
the	O
scorpion	B-SPEC
-	O
venom	O
-	O
peptide	O
-	O
derived	O
mucroporin	O
-	O
M1	O
for	O
three	O
RNA	O
viruses	B-SPEC
(	O
measles	O
viruses	B-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
and	O
H5N1	O
).	O

While	O
avian	B-SPEC
flu	O
or	O
SARS	O
were	O
mistaken	O
as	O
examples	O
of	O
past	O
pandemics	O
,	O
almost	O
all	O
participants	O
were	O
able	O
to	O
associate	O
the	O
recent	O
""""	O
swine	B-SPEC
flu	O
""""	O
situation	O
as	O
an	O
example	O
of	O
a	O
pandemic	O
event	O
.	O

TITLE	O
:	O
The	O
presence	O
of	O
viral	O
subpopulations	O
in	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
vaccine	O
with	O
differing	O
pathogenicity	O
--	O
a	O
preliminary	O
study	O
.	O

Predominantly	O
,	O
IBV	B-SPEC
causes	O
clinical	O
signs	O
associated	O
with	O
respiratory	O
or	O
kidney	O
disease	O
,	O
which	O
subsequently	O
cause	O
an	O
increase	O
in	O
mortality	O
rate	O
.	O

ABSTRACT	O
:	O
Fifty	O
-	O
six	O
isolates	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
were	O
obtained	O
from	O
different	O
field	O
outbreaks	O
in	O
China	O
in	O
2010	O
,	O
and	O
they	O
were	O
genotyped	O
by	O
comparison	O
with	O
19	O
reference	O
strains	O
in	O
the	O
present	O
study	O
.	O

The	O
most	O
important	O
finding	O
of	O
the	O
study	O
is	O
the	O
isolation	O
and	O
identification	O
of	O
Taiwan	O
II	O
-	O
type	O
(	O
TW	O
II	O
-	O
type	O
)	O
strains	O
of	O
IBV	B-SPEC
in	O
mainland	O
China	O
in	O
recent	O
years	O
.	O

Cell	O
death	O
induced	O
by	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
is	O
independent	O
of	O
TRAIL	O
,	O
FasL	O
,	O
tumor	O
necrosis	O
factor	O
alpha	O
,	O
and	O
caspase	O
activity	O
,	O
indicating	O
that	O
viral	O
replication	O
is	O
directly	O
responsible	O
for	O
the	O
observed	O
cytopathic	O
effects	O
.	O

The	O
consequence	O
of	O
DC	O
death	O
at	O
the	O
early	O
stage	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infection	O
may	O
have	O
an	O
impact	O
on	O
the	O
early	O
control	O
of	O
viral	O
dissemination	O
and	O
on	O
the	O
establishment	O
of	O
long	O
-	O
lasting	O
immune	O
memory	O
,	O
since	O
people	O
can	O
be	O
reinfected	O
multiple	O
times	O
by	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

By	O
the	O
time	O
this	O
coronavirus	B-SPEC
,	O
labeled	O
SCoV	O
,	O
apparently	O
receded	O
from	O
human	B-SPEC
hosts	O
in	O
July	O
2003	O
,	O
nearly	O
10	O
percent	O
of	O
more	O
than	O
8	O
,	O
000	O
individuals	O
who	O
fit	O
the	O
probable	O
case	O
definition	O
had	O
died	O
of	O
the	O
disease	O
now	O
known	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
(	O
World	O
Health	O
Organization	O
[	O
WHO	O
],	O
2003a	O
).	O

In	O
sum	O
,	O
our	O
results	O
show	O
that	O
TMPRSS2	O
and	O
HAT	O
are	O
expressed	O
by	O
important	O
influenza	O
and	O
SARS	O
-	O
coronavirus	B-SPEC
target	O
cells	O
and	O
could	O
thus	O
support	O
viral	O
spread	O
in	O
the	O
human	B-SPEC
host	O
.	O

However	O
,	O
no	O
commercial	O
vaccines	O
that	O
are	O
specific	O
for	O
this	O
type	O
of	O
IBV	B-SPEC
are	O
currently	O
available	O
.	O

Therefore	O
,	O
there	O
is	O
an	O
urgent	O
need	O
to	O
develop	O
novel	O
vaccines	O
that	O
prevent	O
QX	O
-	O
like	O
IBV	B-SPEC
infection	O
.	O

Specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
chickens	B-SPEC
that	O
were	O
vaccinated	O
with	O
rMDV	O
-	O
S1	O
were	O
protected	O
when	O
challenged	O
with	O
the	O
QX	O
-	O
like	O
IBV	B-SPEC
.	O

However	O
,	O
because	O
of	O
the	O
examples	O
of	O
host	O
switching	O
among	O
CoVs	O
after	O
relatively	O
minor	O
sequence	O
changes	O
in	O
S1	O
domain	O
of	O
spike	O
protein	O
,	O
a	O
further	O
surveillance	O
in	O
animal	B-SPEC
reservoirs	O
and	O
understanding	O
the	O
interface	O
between	O
host	O
susceptibility	O
is	O
critical	O
for	O
predicting	O
and	O
preventing	O
the	O
potential	O
threat	O
of	O
bat	B-SPEC
CoVs	O
to	O
public	O
health	O
.	O

The	O
results	O
demonstrated	O
that	O
the	O
IRFIBV32	O
virus	B-SPEC
has	O
wide	O
tissue	O
distribution	O
for	O
respiratory	O
,	O
urogenital	O
,	O
and	O
digestive	O
systems	O
.	O

During	O
the	O
infection	O
,	O
the	O
viruses	B-SPEC
employ	O
different	O
strategies	O
to	O
which	O
the	O
cells	O
have	O
developed	O
respective	O
responses	O
.	O

Although	O
it	O
seems	O
to	O
have	O
a	O
benign	O
course	O
,	O
it	O
may	O
also	O
be	O
lethal	O
and	O
severe	O
in	O
some	O
cases	O
,	O
especially	O
in	O
the	O
form	O
of	O
hydrops	B-SPEC
and	O
/	O
or	O
cardiopulmonary	O
failure	O
.	O

Mutations	O
of	O
Thr16	O
did	O
not	O
impact	O
virus	B-SPEC
assembly	O
as	O
judged	O
by	O
virus	B-SPEC
-	O
like	O
particle	O
production	O
,	O
suggesting	O
that	O
alteration	O
of	O
secretory	O
pathway	O
and	O
assembly	O
are	O
independent	O
activities	O
.	O

TITLE	O
:	O
Isolation	O
and	O
molecular	O
characterization	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
from	O
recent	O
outbreaks	O
in	O
broiler	O
flocks	O
reveals	O
emergence	O
of	O
novel	O
strain	O
in	O
India	O
.	O

TITLE	O
:	O
A	O
novel	O
method	O
for	O
high	O
-	O
throughput	O
screening	O
to	O
quantify	O
antiviral	O
activity	O
against	O
viruses	B-SPEC
that	O
induce	O
limited	O
CPE	O
.	O

Following	O
infection	O
of	O
Vero118	O
cells	O
,	O
virus	B-SPEC
-	O
induced	O
CPE	O
was	O
too	O
low	O
to	O
allow	O
readout	O
based	O
on	O
classical	O
colorimetric	O
methods	O
(	O
such	O
as	O
the	O
MTS	O
assay	O
),	O
even	O
following	O
prolonged	O
incubation	O
times	O
(>	O
7	O
days	O
).	O

However	O
,	O
there	O
are	O
no	O
natural	O
or	O
synthetic	O
compounds	O
currently	O
available	O
that	O
can	O
inhibit	O
SARS	O
-	O
CoV	O
.	O
We	O
examined	O
the	O
inhibitory	O
effects	O
of	O
64	O
purified	O
natural	O
compounds	O
against	O
the	O
activity	O
of	O
SARS	O
helicase	O
,	O
nsP13	O
,	O
and	O
the	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
)	O
helicase	O
,	O
NS3h	O
,	O
by	O
conducting	O
fluorescence	O
resonance	O
energy	O
transfer	O
(	O
FRET	O
)-	O
based	O
double	O
-	O
strand	O
(	O
ds	O
)	O
DNA	O
unwinding	O
assay	O
or	O
by	O
using	O
a	O
colorimetry	O
-	O
based	O
ATP	O
hydrolysis	O
assay	O
.	O

The	O
cellular	O
and	O
molecular	O
mechanisms	O
leading	O
to	O
the	O
development	O
of	O
ALI	O
/	O
ARDS	O
are	O
not	O
completely	O
understood	O
,	O
but	O
there	O
is	O
evidence	O
that	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
)	O
generated	O
by	O
inflammatory	O
cells	O
as	O
well	O
as	O
epithelial	O
and	O
endothelial	O
cells	O
are	O
responsible	O
for	O
inflammatory	O
response	O
,	O
lung	O
damage	O
,	O
and	O
abnormal	O
repair	O
.	O

TITLE	O
:	O
CXCR2	O
signaling	O
and	O
host	O
defense	O
following	O
coronavirus	B-SPEC
-	O
induced	O
encephalomyelitis	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
-	O
cell	O
entry	O
programs	O
involve	O
virus	B-SPEC
-	O
cell	O
membrane	O
fusions	O
mediated	O
by	O
viral	O
spike	O
(	O
S	O
)	O
proteins	O
.	O

Severity	O
scores	O
were	O
similar	O
to	O
those	O
from	O
a	O
random	O
selection	O
of	O
young	O
children	O
who	O
were	O
positive	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
at	O
a	O
different	O
time	O
but	O
from	O
the	O
same	O
specimen	O
population	O
.	O

During	O
the	O
cooler	O
months	O
of	O
2004	O
,	O
sensitive	O
and	O
specific	O
RT	O
-	O
rtPCRs	O
identified	O
the	O
concurrent	O
circulation	O
of	O
all	O
four	O
HCoVs	O
,	O
a	O
quarter	O
of	O
which	O
co	O
-	O
occurred	O
with	O
another	O
virus	B-SPEC
and	O
most	O
of	O
which	O
were	O
from	O
children	O
under	O
the	O
age	O
of	O
two	O
years	O
.	O

A	O
total	O
of	O
18	O
cases	O
with	O
laboratory	O
-	O
confirmed	O
adenovirus	B-SPEC
infections	O
in	O
487	O
cases	O
with	O
CAP	O
were	O
observed	O
clinically	O
.	O

TITLE	O
:	O
Characterization	O
of	O
a	O
recombinant	O
canine	O
coronavirus	B-SPEC
with	O
a	O
distinct	O
receptor	O
-	O
binding	O
(	O
S1	O
)	O
domain	O
.	O

CCoV	O
-	O
A76	O
can	O
use	O
canine	O
aminopeptidase	O
N	O
(	O
cAPN	O
)	O
receptor	O
for	O
infection	O
of	O
cells	O
,	O
but	O
was	O
unable	O
to	O
use	O
feline	B-SPEC
APN	O
(	O
fAPN	O
).	O

These	O
data	O
suggest	O
that	O
CCoV	O
-	O
A76	O
represents	O
a	O
recombinant	O
coronavirus	B-SPEC
form	O
,	O
with	O
distinct	O
host	O
cell	O
tropism	O
.	O

We	O
studied	O
the	O
influence	O
of	O
the	O
inhibitory	O
CD200	O
-	O
CD200R	O
axis	B-SPEC
on	O
clearance	O
and	O
pathology	O
in	O
two	O
different	O
virus	B-SPEC
infection	O
models	O
.	O

We	O
find	O
that	O
lack	O
of	O
CD200R	O
signaling	O
strongly	O
enhances	O
type	O
I	O
interferon	O
(	O
IFN	O
)	O
production	O
and	O
viral	O
clearance	O
and	O
improves	O
the	O
outcome	O
of	O
mouse	B-SPEC
hepatitis	O
corona	B-SPEC
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
infection	O
,	O
particularly	O
in	O
female	O
mice	B-SPEC
.	O

In	O
contrast	O
,	O
SARS	O
-	O
CoV	O
and	O
TGEV	B-SPEC
EGFP	O
-	O
nsp15s	O
distributed	O
smoothly	O
in	O
the	O
whole	O
cell	O
and	O
did	O
not	O
form	O
speckles	O
.	O

Further	O
domain	O
swapping	O
experiments	O
uncovered	O
additional	O
speckle	O
-	O
inducing	O
and	O
-	O
suppressive	O
elements	O
in	O
nsp15s	O
of	O
SARS	O
-	O
CoV	O
and	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
,	O
containing	O
two	O
subunits	O
,	O
S1	O
and	O
S2	O
,	O
is	O
the	O
major	O
immunity	O
-	O
eliciting	O
antigen	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
a	O
highly	O
contagious	O
disease	O
of	O
chickens	B-SPEC
.	O

Consistently	O
,	O
SEL1L	O
or	O
LC3	O
silencing	O
impair	O
the	O
MHV	B-SPEC
life	O
cycle	O
.	O

This	O
virus	B-SPEC
'	O
prevalence	O
was	O
also	O
analyzed	O
among	O
people	O
suffering	O
from	O
acute	O
respiratory	O
disease	O
being	O
attended	O
at	O
the	O
state	O
of	O
Mexico	O
'	O
s	O
Autonomous	O
University	O
'	O
s	O
medical	O
research	O
centre	O
.	O

This	O
effect	O
is	O
due	O
to	O
rapid	O
,	O
TRAIL	O
(	O
TNF	O
-	O
related	O
apoptosis	O
-	O
inducing	O
ligand	O
)-	O
dependent	O
apoptosis	O
of	O
MHV	B-SPEC
-	O
3	O
-	O
infected	O
macrophages	O
in	O
BTLA	O
-/-	O
mice	B-SPEC
.	O

The	O
importance	O
of	O
TNFα	O
in	O
MHV	B-SPEC
-	O
3	O
-	O
induced	O
pathology	O
was	O
demonstrated	O
by	O
increased	O
mortality	O
in	O
TNFα	O
-	O
treated	O
MHV	B-SPEC
-	O
3	O
-	O
infected	O
BTLA	O
-/-	O
mice	B-SPEC
,	O
whereas	O
TNFα	O
-/-	O
mice	B-SPEC
were	O
resistant	O
to	O
the	O
infection	O
.	O

BTLA	O
promotes	O
the	O
pathogenesis	O
of	O
virus	B-SPEC
-	O
induced	O
FH	O
by	O
enhancing	O
macrophage	O
viability	O
and	O
function	O
.	O

RESULTS	O
:	O
FGL2	O
production	O
,	O
liver	O
and	O
spleen	O
damage	O
,	O
and	O
mortality	O
were	O
significantly	O
reduced	O
in	O
BTLA	O
-/-	O
mice	B-SPEC
infected	O
with	O
MHV	B-SPEC
-	O
3	O
.	O

Numerous	O
studies	O
have	O
been	O
carried	O
out	O
to	O
identify	O
new	O
bat	B-SPEC
viruses	B-SPEC
related	O
to	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
bat	B-SPEC
-	O
SARS	O
-	O
like	O
CoVs	O
)	O
using	O
a	O
reverse	O
-	O
transcribed	O
-	O
polymerase	O
chain	O
reaction	O
assay	O
.	O

ABSTRACT	O
:	O
Based	O
on	O
our	O
previous	O
structure	O
-	O
activity	O
relationship	O
and	O
antiviral	O
mechanism	O
studies	O
,	O
a	O
series	O
of	O
14	O
-	O
aminophenanthroindolizidines	O
(	O
1a	O
-	O
i	O
,	O
2	O
,	O
and	O
3	O
)	O
were	O
designed	O
,	O
targeting	O
tobacco	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
(	O
TMV	B-SPEC
)	O
RNA	O
,	O
and	O
synthesized	O
and	O
systematically	O
evaluated	O
for	O
their	O
antiviral	O
activity	O
against	O
TMV	B-SPEC
.	O

The	O
bioassay	O
results	O
showed	O
that	O
most	O
of	O
these	O
compounds	O
exhibited	O
good	O
to	O
excellent	O
in	O
vivo	O
anti	O
-	O
TMV	B-SPEC
activity	O
,	O
of	O
which	O
compounds	O
1d	O
and	O
1h	O
displayed	O
significantly	O
higher	O
activity	O
than	O
commercial	O
ningnanmycin	O
,	O
and	O
thus	O
emerged	O
as	O
potential	O
inhibitors	O
of	O
plant	B-SPEC
virus	B-SPEC
.	O

The	O
influenza	B-SPEC
virus	I-SPEC
is	O
known	O
to	O
cause	O
immunologic	O
defects	O
.	O

Additionally	O
,	O
the	O
2009	O
-	O
pandemic	O
H1N1	O
virus	B-SPEC
is	O
associated	O
with	O
increased	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
requiring	O
treatment	O
with	O
systemic	O
steroids	O
.	O

Subsequently	O
,	O
severe	O
wound	O
infection	O
with	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
severe	O
pneumonia	O
,	O
respiratory	O
failure	O
,	O
systemic	O
inflammatory	O
response	O
syndrome	O
,	O
nephropathy	O
,	O
and	O
hypoproteinemia	O
had	O
developed	O
3	O
months	O
after	O
the	O
radiation	O
injury	O
.	O

VIGOR	O
has	O
been	O
extended	O
to	O
predict	O
genes	O
for	O
12	O
viruses	B-SPEC
:	O
measles	B-SPEC
virus	I-SPEC
,	O
mumps	B-SPEC
virus	I-SPEC
,	O
rubella	B-SPEC
virus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
alphavirus	B-SPEC
and	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
,	O
norovirus	B-SPEC
,	O
metapneumovirus	B-SPEC
,	O
yellow	B-SPEC
fever	I-SPEC
virus	I-SPEC
,	O
Japanese	B-SPEC
encephalitis	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
and	O
Sendai	B-SPEC
virus	I-SPEC
.	O

Purebreds	O
from	O
northern	O
regions	O
of	O
Japan	O
were	O
likely	O
to	O
be	O
seropositive	O
(	O
76	O
.	O
6	O
%	O
in	O
Hokkaido	O
,	O
80	O
.	O
0	O
%	O
in	O
Tohoku	O
),	O
indicating	O
cattery	O
cats	B-SPEC
in	O
cold	O
climates	O
might	O
be	O
more	O
closely	O
confined	O
.	O

Among	O
purebreds	O
,	O
the	O
American	O
shorthair	O
,	O
Himalayan	O
,	O
Oriental	O
,	O
Persian	O
,	O
and	O
Siamese	O
showed	O
low	O
seroprevalence	O
,	O
while	O
the	O
American	O
curl	O
,	O
Maine	O
coon	O
,	O
Norwegian	O
forest	O
cat	B-SPEC
,	O
ragdoll	O
and	O
Scottish	O
fold	O
showed	O
high	O
seroprevalence	O
.	O

TITLE	O
:	O
Differences	O
in	O
neutralizing	O
antigenicity	O
between	O
laboratory	O
and	O
clinical	O
isolates	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
isolated	O
in	O
Japan	O
in	O
2004	O
-	O
2008	O
depend	O
on	O
the	O
S1	O
region	O
sequence	O
of	O
the	O
spike	O
protein	O
.	O

In	O
this	O
study	O
,	O
we	O
compared	O
four	O
Japanese	O
isolates	O
with	O
the	O
standard	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
strain	O
obtained	O
from	O
ATCC	O
(	O
ATCC	O
-	O
VR740	O
)	O
by	O
focusing	O
on	O
the	O
spike	O
(	O
S	O
)	O
protein	O
,	O
a	O
major	O
determinant	O
of	O
neutralizing	O
antigen	O
and	O
pathogenicity	O
.	O

We	O
determined	O
the	O
quantities	O
of	O
Ceacam1	O
transcripts	O
encoding	O
membrane	O
-	O
bound	O
and	O
secreted	O
isoforms	O
in	O
mouse	B-SPEC
organs	O
and	O
a	O
set	O
of	O
cell	O
lines	O
.	O

While	O
the	O
quantities	O
of	O
the	O
receptor	O
transcripts	O
varied	O
between	O
mouse	B-SPEC
organs	O
,	O
their	O
abundance	O
did	O
not	O
correlate	O
with	O
susceptibility	O
to	O
MHV	B-SPEC
infection	O
.	O

TITLE	O
:	O
Should	O
lower	O
respiratory	O
tract	O
secretions	O
from	O
intensive	O
care	O
patients	O
be	O
systematically	O
screened	O
for	O
influenza	B-SPEC
virus	I-SPEC
during	O
the	O
influenza	O
season	O
?	O

TITLE	O
:	O
Spike	O
protein	O
fusion	O
peptide	O
and	O
feline	B-SPEC
coronavirus	B-SPEC
virulence	O
.	O

As	O
a	O
result	O
,	O
we	O
identified	O
2	O
alternative	O
amino	O
acid	O
differences	O
in	O
the	O
putative	O
fusion	O
peptide	O
of	O
the	O
spike	O
protein	O
that	O
together	O
distinguish	O
FIPV	O
from	O
FECV	B-SPEC
in	O
>	O
95	O
%	O
of	O
cases	O
.	O

TITLE	O
:	O
Replication	O
-	O
dependent	O
downregulation	O
of	O
cellular	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
protein	O
expression	O
by	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
.	O

All	O
specimens	O
were	O
also	O
tested	O
for	O
the	O
presence	O
of	O
other	O
common	O
respiratory	O
viruses	B-SPEC
and	O
newly	O
identified	O
viruses	B-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
and	O
human	B-SPEC
bocavirus	I-SPEC
(	O
HBoV	O
).	O

TITLE	O
:	O
Comparison	O
of	O
nasopharyngeal	O
flocked	O
swabs	O
and	O
nasopharyngeal	O
wash	O
collection	O
methods	O
for	O
respiratory	O
virus	B-SPEC
detection	O
in	O
hospitalized	O
children	O
using	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
.	O

A	O
consensuses	O
standard	O
was	O
used	O
to	O
determine	O
sensitivity	O
and	O
compare	O
cycle	O
thresholds	O
(	O
C	O
(	O
T	O
))	O
of	O
washes	O
and	O
flocked	O
swabs	O
for	O
each	O
virus	B-SPEC
and	O
group	O
of	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
in	O
hospitalized	O
children	O
with	O
respiratory	O
infection	O
:	O
a	O
2	O
-	O
year	O
study	O
from	O
Chongqing	O
,	O
China	O
.	O

We	O
detected	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
via	O
reverse	O
transcriptional	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
in	O
eight	O
out	O
of	O
878	O
respiratory	O
specimens	O
freshly	O
collected	O
from	O
hospitalized	O
children	O
with	O
ALRTI	O
between	O
April	O
2006	O
and	O
March	O
2008	O
in	O
Childrens	O
Hospital	O
of	O
Chongqing	O
Medical	O
University	O
.	O

We	O
examined	O
the	O
role	O
of	O
PTX3	O
in	O
coronavirus	B-SPEC
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
1	O
(	O
MHV	B-SPEC
-	O
1	O
)-	O
induced	O
acute	O
lung	O
injury	O
,	O
a	O
previously	O
reported	O
animal	B-SPEC
model	O
for	O
SARS	O
.	O

Administration	O
of	O
recombinant	O
PTX3	O
significantly	O
accelerated	O
viral	O
clearance	O
in	O
the	O
lung	O
,	O
attenuated	O
MHV	B-SPEC
-	O
1	O
-	O
induced	O
lung	O
injury	O
,	O
and	O
reduced	O
early	O
neutrophil	O
influx	O
and	O
elevation	O
of	O
inflammatory	O
mediators	O
in	O
the	O
lung	O
.	O

ABSTRACT	O
:	O
To	O
increase	O
immune	O
responses	O
of	O
plant	B-SPEC
-	O
based	O
vaccines	O
in	O
intestine	O
mucosal	O
immune	O
systems	O
,	O
a	O
synthetic	O
neutralizing	O
epitope	O
(	O
sCOE	O
)	O
gene	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
was	O
fused	O
with	O
M	O
cell	O
-	O
targeting	O
ligand	O
(	O
Co1	O
)	O
and	O
introduced	O
into	O
a	O
plant	B-SPEC
expression	O
vector	O
under	O
the	O
control	O
of	O
rice	B-SPEC
amylase	O
3D	O
promoter	O
.	O

The	O
sCOE	O
-	O
Co1	O
fusion	O
gene	O
was	O
introduced	O
into	O
rice	B-SPEC
calli	O
via	O
the	O
particle	O
bombardment	O
-	O
mediated	O
transformation	O
method	O
.	O

All	O
patients	O
presented	O
with	O
fever	O
,	O
hemoptysis	O
,	O
bilateral	O
pulmonary	O
infiltrates	O
in	O
chest	O
radiographs	O
,	O
and	O
thrombocytopenia	O
and	O
had	O
compatible	O
epidemiological	O
history	O
with	O
leptospirosis	O
;	O
3	O
patients	O
had	O
anemia	B-SPEC
,	O
3	O
had	O
renal	O
failure	O
,	O
2	O
had	O
increased	O
creatine	O
kinase	O
,	O
whereas	O
bilirubin	O
was	O
slightly	O
increased	O
in	O
only	O
1	O
patient	O
.	O

Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
,	O
Simplified	O
Acute	O
Physiology	O
Score	O
II	O
and	O
Sepsis	B-SPEC
-	O
Related	O
Organ	O
Failure	O
Assessment	O
scoring	O
systems	O
were	O
unable	O
to	O
predict	O
the	O
outcome	O
of	O
the	O
patients	O
with	O
leptospirosis	O
-	O
associated	O
severe	O
pulmonary	O
hemorrhagic	O
syndrome	O
.	O

Adoptive	O
transfer	O
of	O
TCRγδ	O
(+)	O
DN	O
T	O
cells	O
led	O
to	O
dramatically	O
decreased	O
survival	O
in	O
MHV	B-SPEC
-	O
3	O
-	O
infected	O
mice	B-SPEC
,	O
accompanied	O
by	O
deteriorated	O
histopathology	O
and	O
elevated	O
ALT	O
and	O
AST	O
levels	O
.	O

These	O
results	O
indicate	O
that	O
liver	O
TCRγδ	O
(+)	O
DN	O
T	O
cells	O
play	O
a	O
critical	O
role	O
in	O
the	O
liver	O
injury	O
in	O
MHV	B-SPEC
-	O
3	O
-	O
induced	O
hepatitis	O
,	O
via	O
a	O
TNF	O
-	O
α	O
dependent	O
pathway	O
.	O

T	O
(	O
reg	O
)	O
induction	O
or	O
activation	O
in	O
the	O
pathogenesis	O
of	O
disease	O
has	O
been	O
described	O
in	O
both	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
,	O
lactate	O
dehydrogenase	O
elevating	O
virus	B-SPEC
,	O
and	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
.	O

TITLE	O
:	O
Protective	O
role	O
of	O
Toll	O
-	O
like	O
Receptor	O
3	O
-	O
induced	O
type	O
I	O
interferon	O
in	O
murine	B-SPEC
coronavirus	I-SPEC
infection	O
of	O
macrophages	O
.	O

Cytomegalovirus	B-SPEC
infection	O
appears	O
to	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
death	O
in	O
this	O
syndrome	O
.	O

A	O
recent	O
meta	B-SPEC
analysis	O
showed	O
that	O
HFOV	O
might	O
have	O
reduced	O
mortality	O
in	O
pediatric	O
and	O
adult	O
patients	O
compared	O
with	O
conventional	O
ventilation	O
.	O

CONCLUSIONS	O
:	O
High	O
-	O
flow	O
nasal	O
cannula	B-SPEC
O	O
(	O
2	O
)	O
therapy	O
appears	O
to	O
be	O
an	O
innovative	O
and	O
effective	O
modality	O
for	O
early	O
treatment	O
of	O
adults	O
with	O
SARI	O
.	O

TITLE	O
:	O
[	O
Progress	O
on	O
development	O
and	O
research	O
of	O
coronavirus	B-SPEC
based	O
vector	O
].	O

From	O
1996	O
to	O
2010	O
,	O
19	O
patient	O
deaths	O
with	O
a	O
clinical	O
diagnosis	O
of	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
infection	O
occurred	O
in	O
a	O
tertiary	O
care	O
center	O
in	O
the	O
Brazilian	O
Amazon	B-SPEC
.	O

Nested	O
polymerase	O
chain	O
reaction	O
was	O
performed	O
in	O
paraffinized	O
samples	O
of	O
spleen	O
and	O
lung	O
to	O
confirm	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
monoinfection	O
.	O

Of	O
17	O
autopsies	O
,	O
13	O
revealed	O
that	O
death	O
could	O
be	O
attributed	O
to	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
infection	O
;	O
in	O
the	O
remaining	O
4	O
,	O
acute	O
diseases	O
other	O
than	O
malaria	O
were	O
found	O
to	O
be	O
the	O
cause	O
of	O
death	O
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
replication	O
is	O
severely	O
impaired	O
by	O
MG132	O
due	O
to	O
proteasome	O
-	O
independent	O
inhibition	O
of	O
M	O
-	O
calpain	O
.	O

In	O
a	O
fibrotic	O
cell	O
model	O
with	O
transforming	O
growth	O
factor	O
beta	O
-	O
1	O
induction	O
,	O
the	O
human	B-SPEC
lung	O
epithelial	O
A549	O
acquired	O
a	O
mesenchymal	O
phenotype	O
and	O
an	O
increase	O
of	O
vimentin	O
expression	O
with	O
a	O
concomitant	O
decrease	O
of	O
E	O
-	O
cadherin	O
.	O

The	O
findings	O
provide	O
an	O
insight	O
into	O
the	O
preventive	O
and	O
therapeutic	O
potentials	O
of	O
Cordyceps	B-SPEC
for	O
the	O
treatment	O
of	O
lung	O
fibrosis	O
.	O

Fecal	O
samples	O
were	O
collected	O
within	O
24	O
hours	O
after	O
admission	O
from	O
50	O
dogs	B-SPEC
with	O
normal	O
feces	O
and	O
50	O
dogs	B-SPEC
with	O
diarrhea	O
.	O

Dogs	B-SPEC
with	O
diarrhea	O
were	O
significantly	O
more	O
likely	O
to	O
be	O
infected	O
with	O
≥	O
1	O
enteropathogens	O
(	O
96	O
%)	O
than	O
were	O
dogs	B-SPEC
with	O
normal	O
feces	O
(	O
78	O
%).	O

TITLE	O
:	O
Mechanisms	O
of	O
coronavirus	B-SPEC
cell	O
entry	O
mediated	O
by	O
the	O
viral	O
spike	O
protein	O
.	O

It	O
is	O
classified	O
as	O
a	O
class	B-SPEC
I	O
fusion	O
protein	O
,	O
and	O
is	O
responsible	O
for	O
binding	O
to	O
the	O
receptor	O
on	O
the	O
host	O
cell	O
as	O
well	O
as	O
mediating	O
the	O
fusion	O
of	O
host	O
and	O
viral	O
membranes	O
-	O
A	O
process	O
driven	O
by	O
major	O
conformational	O
changes	O
of	O
the	O
S	O
protein	O
.	O

We	O
investigated	O
the	O
effects	O
of	O
the	O
two	O
zinc	O
salts	O
,	O
zinc	O
chloride	O
(	O
ZnCl	O
(	O
2	O
))	O
and	O
zinc	O
sulfate	O
(	O
ZnSO	O
(	O
4	O
)),	O
on	O
infection	O
of	O
swine	B-SPEC
testicle	O
(	O
ST	O
)	O
cells	O
with	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
compared	O
it	O
to	O
the	O
effects	O
of	O
a	O
control	O
salt	O
,	O
magnesium	O
sulfate	O
(	O
MgSO	O
(	O
4	O
)).	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
accessory	O
proteins	O
6	O
and	O
9b	O
interact	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
The	O
outbreaks	O
of	O
SARS	O
,	O
avian	B-SPEC
influenza	O
,	O
and	O
Nipah	B-SPEC
virus	I-SPEC
in	O
Asian	O
countries	O
clearly	O
demonstrated	O
that	O
new	O
highly	O
infectious	O
agents	O
periodically	O
emerge	O
at	O
the	O
human	B-SPEC
-	O
animal	B-SPEC
interface	O
.	O

TITLE	O
:	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
admissions	O
and	O
risk	O
of	O
mortality	O
in	O
a	O
tertiary	O
-	O
care	O
children	O
'	O
s	O
hospital	O
in	O
North	O
India	O
.	O

ABSTRACT	O
:	O
To	O
assess	O
whether	O
alpha	O
-	O
1	O
-	O
acid	O
glycoprotein	O
(	O
AGP	O
)	O
can	O
be	O
detected	O
on	O
the	O
membrane	O
of	O
feline	B-SPEC
circulating	O
leucocytes	O
.	O

TITLE	O
:	O
Comparison	O
of	O
three	O
multiplex	O
PCR	O
assays	O
for	O
the	O
detection	O
of	O
respiratory	O
viral	O
infections	O
:	O
evaluation	O
of	O
xTAG	O
respiratory	O
virus	B-SPEC
panel	O
fast	O
assay	O
,	O
RespiFinder	O
19	O
assay	O
and	O
RespiFinder	O
SMART	O
22	O
assay	O
.	O

To	O
compare	O
the	O
analytical	O
sensitivity	O
of	O
the	O
multiplex	O
assays	O
,	O
samples	O
were	O
inoculated	O
with	O
13	O
different	O
quantified	O
viruses	B-SPEC
in	O
the	O
range	O
of	O
10	O
(	O
1	O
)	O
to	O
10	O
(	O
5	O
)	O
copies	O
/	O
ml	O
.	O

The	O
RespiFinder	O
-	O
19	O
and	O
the	O
RespiFinder	O
-	O
SMART	O
-	O
22	O
showed	O
a	O
higher	O
analytical	O
sensitivity	O
for	O
adenoviruses	B-SPEC
and	O
coronaviruses	O
,	O
whereas	O
the	O
RVP	O
was	O
incapable	O
to	O
detect	O
adenovirus	B-SPEC
and	O
coronavirus	B-SPEC
in	O
concentrations	O
of	O
10	O
(	O
4	O
)	O
copies	O
/	O
ml	O
.	O

To	O
analyze	O
possible	O
competitive	O
amplification	O
reactions	O
between	O
the	O
different	O
viruses	B-SPEC
,	O
samples	O
were	O
further	O
inoculated	O
with	O
only	O
4	O
different	O
viruses	B-SPEC
in	O
one	O
sample	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
partial	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
suggested	O
that	O
one	O
of	O
the	O
detected	O
BtCoVs	O
was	O
a	O
novel	O
alphacoronavirus	B-SPEC
,	O
while	O
the	O
others	O
belonged	O
to	O
the	O
genus	B-SPEC
Betacoronavirus	B-SPEC
.	O

TITLE	O
:	O
Co	O
-	O
infections	O
with	O
influenza	O
and	O
other	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Genomic	O
analysis	O
of	O
16	O
Colorado	O
human	B-SPEC
NL63	O
coronaviruses	O
identifies	O
a	O
new	O
genotype	O
,	O
high	O
sequence	O
diversity	O
in	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
spike	O
gene	O
and	O
evidence	O
of	O
recombination	O
.	O

Laser	B-SPEC
was	O
effective	O
in	O
treatment	O
and	O
decreasing	O
the	O
progression	O
of	O
ROP	O
.	O

ABSTRACT	O
:	O
The	O
incidence	O
and	O
clinical	O
features	O
of	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
among	O
Brazilian	O
patients	O
with	O
respiratory	O
illness	O
are	O
not	O
well	O
known	O
.	O

To	O
determine	O
influenza	O
effects	O
on	O
P	O
(	O
a	O
)	O
O	O
(	O
2	O
):	O
F	O
(	O
i	O
)	O
O	O
(	O
2	O
),	O
mice	B-SPEC
were	O
challenged	O
with	O
10	O
,	O
000	O
p	O
.	O
f	O
..	O

CONCLUSIONS	O
:	O
mAbs	O
against	O
N	O
protein	O
of	O
MHV	B-SPEC
with	O
high	O
activity	O
and	O
specificity	O
were	O
prepared	O
successfully	O
,	O
which	O
provides	O
a	O
potential	O
basis	O
for	O
further	O
researches	O
on	O
N	O
protein	O
function	O
and	O
diagnostic	O
methods	O
.	O

Not	O
detected	O
were	O
Coronavirus	B-SPEC
,	O
Cardiovirus	B-SPEC
,	O
Cosavirus	B-SPEC
,	O
Salivirus	B-SPEC
,	O
Sapovirus	B-SPEC
,	O
and	O
Norovirus	B-SPEC
.	O

Repeated	O
administration	O
of	O
oral	O
poliovirus	B-SPEC
vaccine	O
resulted	O
in	O
progressively	O
shorter	O
periods	O
of	O
poliovirus	B-SPEC
detection	O
.	O

In	O
these	O
viruses	B-SPEC
,	O
the	O
envelope	O
spike	O
glycoprotein	O
(	O
S	O
)	O
mediates	O
the	O
attachment	O
of	O
the	O
virus	B-SPEC
particles	O
to	O
APN	O
and	O
subsequent	O
cell	O
entry	O
,	O
which	O
can	O
be	O
blocked	O
by	O
neutralizing	O
antibodies	O
.	O

Comparison	O
of	O
the	O
RBDs	O
of	O
TGEV	B-SPEC
and	O
PRCV	O
to	O
those	O
of	O
other	O
related	O
CoVs	O
,	O
suggests	O
that	O
the	O
conformation	O
of	O
the	O
S	O
receptor	O
-	O
binding	O
region	O
determines	O
cell	O
entry	O
receptor	O
specificity	O
.	O

Here	O
,	O
we	O
present	O
an	O
unusual	O
case	O
of	O
TM	O
from	O
C	O
difficile	O
infection	O
induced	O
by	O
topical	O
silver	O
sulphadiazine	O
in	O
a	O
60	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
immune	O
-	O
bullous	O
pemphigus	B-SPEC
vulgaris	O
.	O

TITLE	O
:	O
Complete	O
genome	O
sequence	O
of	O
a	O
highly	O
prevalent	O
isolate	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
South	O
China	O
.	O

TITLE	O
:	O
Laninamivir	O
octanoate	O
and	O
artificial	O
surfactant	O
combination	O
therapy	O
significantly	O
increases	O
survival	O
of	O
mice	B-SPEC
infected	O
with	O
lethal	O
influenza	O
H1N1	O
Virus	B-SPEC
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
inoculated	O
with	O
several	O
viral	O
doses	O
of	O
influenza	O
A	O
/	O
Puerto	O
Rico	O
/	O
8	O
/	O
34	O
(	O
PR8	O
)	O
virus	B-SPEC
(	O
H1N1	O
).	O

However	O
,	O
virus	B-SPEC
titer	O
,	O
lung	O
weight	O
and	O
cytokine	O
/	O
chemokine	O
responses	O
were	O
not	O
different	O
between	O
the	O
groups	O
.	O

ABSTRACT	O
:	O
In	O
the	O
search	O
for	O
anti	O
-	O
SARS	O
-	O
CoV	O
,	O
tanshinones	O
derived	O
from	O
Salvia	B-SPEC
miltiorrhiza	I-SPEC
were	O
found	O
to	O
be	O
specific	O
and	O
selective	O
inhibitors	O
for	O
the	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
and	O
PL	O
(	O
pro	O
),	O
viral	O
cysteine	O
proteases	O
.	O

TITLE	O
:	O
Effects	O
of	O
chicken	B-SPEC
anaemia	I-SPEC
virus	I-SPEC
and	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
-	O
induced	O
immunodeficiency	O
on	O
infectious	O
bronchitis	O
virus	B-SPEC
replication	O
and	O
genotypic	O
drift	O
.	O

ABSTRACT	O
:	O
Enteropathogenic	O
Escherichia	B-SPEC
coli	I-SPEC
(	O
EPEC	O
)	O
bacteria	B-SPEC
frequently	O
cause	O
severe	O
enteric	O
diseases	O
primarily	O
in	O
children	O
and	O
in	O
young	O
rabbits	B-SPEC
.	O

Among	O
predisposing	O
factors	O
occurring	O
on	O
farms	O
,	O
feed	O
protein	O
content	O
increased	O
by	O
20	O
%	O
(	O
26	O
.	O
3	O
%	O
crude	O
protein	O
,	O
provided	O
by	O
48	O
%	O
soybean	B-SPEC
meal	O
)	O
seemed	O
to	O
enhance	O
EPEC	O
colonisation	O
and	O
resulted	O
in	O
the	O
mobilisation	O
of	O
spontaneous	O
latent	O
EPEC	O
/	O
ETEC	O
infection	O
.	O

We	O
also	O
investigated	O
possible	O
risk	O
factors	O
for	O
post	O
-	O
dive	B-SPEC
acute	O
respiratory	O
symptoms	O
.	O

These	O
values	O
increased	O
when	O
cats	B-SPEC
with	O
lymphoma	O
or	O
bacterial	O
infections	O
were	O
excluded	O
,	O
or	O
when	O
only	O
cats	B-SPEC
≤	O
2	O
years	O
were	O
considered	O
.	O

ABSTRACT	O
:	O
Phylogenetic	O
analysis	O
has	O
demonstrated	O
that	O
some	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
can	O
be	O
classified	O
into	O
the	O
picornavirus	B-SPEC
-	O
like	O
supercluster	O
,	O
which	O
includes	O
picornaviruses	B-SPEC
,	O
caliciviruses	O
,	O
and	O
coronaviruses	O
.	O

We	O
previously	O
reported	O
the	O
structure	O
-	O
based	O
design	O
and	O
synthesis	O
of	O
potent	O
protease	O
inhibitors	O
of	O
Norwalk	B-SPEC
virus	I-SPEC
(	O
NV	O
),	O
a	O
member	O
of	O
the	O
Caliciviridae	B-SPEC
family	B-SPEC
.	O

S	O
-	O
pseudovirus	O
and	O
SARS	O
-	O
CoV	O
produced	O
in	O
the	O
presence	O
of	O
α	O
-	O
glucosidase	O
inhibitors	O
,	O
which	O
disrupt	O
the	O
interaction	O
between	O
calnexin	O
and	O
its	O
substrates	O
,	O
showed	O
significantly	O
lower	O
infectivity	O
than	O
each	O
virus	B-SPEC
produced	O
in	O
the	O
absence	O
of	O
those	O
compounds	O
.	O

ABSTRACT	O
:	O
In	O
the	O
2002	O
-	O
2003	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
epidemic	O
,	O
no	O
patients	O
under	O
24	O
years	O
of	O
age	O
died	O
,	O
while	O
mortality	O
was	O
greater	O
than	O
50	O
%	O
in	O
those	O
over	O
65	O
years	O
.	O

Intranasal	O
pretreatment	O
with	O
IFN	O
-	O
β	O
or	O
IFN	O
-	O
γ	O
but	O
not	O
IL	O
-	O
1β	O
or	O
TNF	O
also	O
protected	O
aged	O
mice	B-SPEC
,	O
consistent	O
with	O
the	O
notion	O
that	O
poly	O
(	O
I	O
·	O
C	O
)	O
pretreatment	O
functioned	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
inducing	O
IFN	O
-	O
β	O
and	O
IFN	O
-	O
γ	O
.	O

ABSTRACT	O
:	O
Since	O
early	O
2010	O
,	O
outbreaks	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
have	O
been	O
observed	O
frequently	O
in	O
immunized	O
swine	B-SPEC
herds	O
in	O
southern	O
China	O
.	O

The	O
suckling	O
piglets	O
are	O
particularly	O
susceptible	O
to	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
with	O
a	O
high	O
mortality	O
rate	O
(	O
90	O
%).	O

TITLE	O
:	O
No	O
serologic	O
evidence	O
for	O
zoonotic	O
canine	O
respiratory	O
coronavirus	B-SPEC
infections	O
among	O
immunocompetent	O
adults	O
.	O

A	O
competitive	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
developed	O
to	O
detect	O
human	B-SPEC
antibodies	O
against	O
CRCoV	O
while	O
controlling	O
for	O
cross	O
-	O
reacting	O
antibodies	O
against	O
the	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
.	O

TITLE	O
:	O
The	O
first	O
complete	O
genome	O
sequences	O
of	O
clinical	O
isolates	O
of	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
has	O
been	O
identified	O
in	O
the	O
mid	O
-	O
1960s	O
,	O
yet	O
still	O
only	O
one	O
full	O
-	O
genome	O
sequence	O
is	O
available	O
.	O

In	O
the	O
reporter	O
assays	O
,	O
three	O
of	O
four	O
shRNA	O
expression	O
plasmids	O
were	O
able	O
to	O
inhibit	O
significantly	O
the	O
expression	O
of	O
ORF	O
7	O
gene	O
and	O
replication	O
of	O
TGEV	B-SPEC
,	O
as	O
shown	O
by	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
analysis	O
of	O
viral	O
ORF	O
7	O
and	O
N	O
genes	O
and	O
detection	O
of	O
virus	B-SPEC
titers	O
(	O
TCID50	O
/	O
ml	O
).	O

The	O
chi	O
-	O
square	O
and	O
Fisher	B-SPEC
exact	O
tests	O
were	O
used	O
to	O
evaluate	O
differences	O
in	O
proportions	O
between	O
patient	O
subgroups	O
.	O

TITLE	O
:	O
Recent	O
transmission	O
of	O
a	O
novel	O
alphacoronavirus	B-SPEC
,	O
bat	B-SPEC
coronavirus	B-SPEC
HKU10	O
,	O
from	O
Leschenault	B-SPEC
'	I-SPEC
s	I-SPEC
rousettes	I-SPEC
to	O
pomona	O
leaf	B-SPEC
-	I-SPEC
nosed	I-SPEC
bats	I-SPEC
:	O
first	O
evidence	O
of	O
interspecies	O
transmission	O
of	O
coronavirus	B-SPEC
between	O
bats	B-SPEC
of	O
different	O
suborders	O
.	O

The	O
data	O
suggested	O
recent	O
interspecies	O
transmission	O
from	O
Leschenault	B-SPEC
'	I-SPEC
s	I-SPEC
rousettes	I-SPEC
to	O
Pomona	O
leaf	B-SPEC
-	I-SPEC
nosed	I-SPEC
bats	I-SPEC
in	O
southern	O
China	O
.	O

SARS	O
is	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
and	O
one	O
of	O
its	O
components	O
,	O
a	O
viral	O
helicase	O
,	O
is	O
emerging	O
as	O
a	O
promising	O
target	O
for	O
the	O
development	O
of	O
chemical	O
SARS	O
inhibitors	O
.	O

Surprisingly	O
,	O
however	O
,	O
infected	O
dKO	O
mice	B-SPEC
remained	O
healthy	O
,	O
whereas	O
infected	O
STAT1	O
-	O
deficient	O
mice	B-SPEC
developed	O
liver	O
pathology	O
and	O
eventually	O
succumbed	O
to	O
neurological	O
disease	O
.	O

Our	O
data	O
suggest	O
that	O
the	O
failure	O
of	O
STAT1	O
-	O
deficient	O
mice	B-SPEC
to	O
control	O
initial	O
SARS	O
-	O
CoV	O
replication	O
efficiently	O
in	O
the	O
lung	O
is	O
due	O
to	O
impaired	O
type	O
I	O
and	O
type	O
III	O
IFN	O
signalling	O
,	O
whereas	O
the	O
failure	O
to	O
control	O
subsequent	O
systemic	O
viral	O
spread	O
is	O
due	O
to	O
unrelated	O
defects	O
in	O
STAT1	O
-	O
deficient	O
mice	B-SPEC
.	O

Rapid	O
administration	O
of	O
antibiotics	O
and	O
resuscitative	O
measures	O
in	O
case	O
of	O
sepsis	B-SPEC
and	O
septic	O
shock	O
associated	O
with	O
protective	O
ventilatory	O
strategies	O
and	O
early	O
short	O
-	O
term	O
paralysis	O
associated	O
with	O
differential	O
ventilatory	O
techniques	O
(	O
recruitment	O
maneuvers	O
with	O
adequate	O
positive	O
end	O
-	O
expiratory	O
pressure	O
titration	O
,	O
prone	O
position	O
,	O
and	O
new	O
extracorporeal	O
membrane	O
oxygenation	O
techniques	O
)	O
in	O
severe	O
ARDS	O
can	O
help	O
improve	O
its	O
prognosis	O
.	O

TITLE	O
:	O
Henoch	O
-	O
Schonlein	O
purpura	B-SPEC
in	O
children	O
from	O
the	O
eastern	O
province	O
of	O
Saudi	O
Arabia	O
.	O

Henoch	O
-	O
Schonlein	O
purpura	B-SPEC
is	O
a	O
mild	O
disease	O
in	O
the	O
eastern	O
province	O
of	O
Saudi	O
Arabia	O
and	O
with	O
no	O
significant	O
differences	O
in	O
the	O
epidemic	O
and	O
clinical	O
profile	O
than	O
that	O
reported	O
elsewhere	O
.	O

ABSTRACT	O
:	O
Many	O
serious	O
emerging	O
zoonotic	O
infections	O
have	O
recently	O
arisen	O
from	O
bats	B-SPEC
,	O
including	O
Ebola	O
,	O
Marburg	O
,	O
SARS	O
-	O
coronavirus	B-SPEC
,	O
Hendra	O
,	O
Nipah	O
,	O
and	O
a	O
number	O
of	O
rabies	O
and	O
rabies	O
-	O
related	O
viruses	B-SPEC
,	O
consistent	O
with	O
the	O
overall	O
observation	O
that	O
wildlife	O
are	O
an	O
important	O
source	O
of	O
emerging	O
zoonoses	O
for	O
the	O
human	B-SPEC
population	O
.	O

Mechanisms	O
underlying	O
the	O
recognized	O
association	O
between	O
ecosystem	O
health	O
and	O
human	B-SPEC
health	O
remain	O
poorly	O
understood	O
and	O
responding	O
appropriately	O
to	O
the	O
ecological	O
,	O
social	O
and	O
economic	O
conditions	O
that	O
facilitate	O
disease	O
emergence	O
and	O
transmission	O
represents	O
a	O
substantial	O
societal	O
challenge	O
.	O

In	O
this	O
review	O
,	O
we	O
propose	O
a	O
novel	O
framework	O
for	O
the	O
holistic	O
and	O
interdisciplinary	O
investigation	O
of	O
zoonotic	O
disease	O
emergence	O
and	O
its	O
drivers	O
,	O
using	O
the	O
spillover	O
of	O
bat	B-SPEC
pathogens	O
as	O
a	O
case	O
study	O
.	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
a	O
variant	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
China	O
.	O

Amino	O
acid	O
sequence	O
analysis	O
based	O
on	O
individual	O
virus	B-SPEC
genes	O
indicated	O
a	O
close	O
relationship	O
between	O
the	O
spike	O
protein	O
gene	O
of	O
CHGD	O
-	O
01	O
and	O
the	O
field	O
strain	O
KNU0802	O
in	O
Korea	O
.	O

Our	O
findings	O
strongly	O
demonstrated	O
that	O
PGRN	O
could	O
effectively	O
ameliorate	O
the	O
LPS	O
-	O
induced	O
ALI	O
in	O
mice	B-SPEC
,	O
suggesting	O
a	O
potential	O
application	O
for	O
PGRN	O
-	O
based	O
therapy	O
to	O
treat	O
clinical	O
ARDS	O
.	O

RESULTS	O
:	O
Viruses	B-SPEC
were	O
detected	O
in	O
84	O
(	O
51	O
.	O
2	O
%)	O
patients	O
by	O
VRDAL	O
multiplex	O
PCR	O
,	O
and	O
8	O
(	O
4	O
.	O
9	O
%)	O
of	O
cases	O
were	O
mixed	O
infections	O
.	O

Identified	O
viruses	B-SPEC
included	O
37	O
of	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
22	O
.	O
6	O
%	O
of	O
cases	O
),	O
32	O
of	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
19	O
.	O
5	O
%),	O
30	O
of	O
parainfluenzavirus	O
-	O
2	O
(	O
18	O
.	O
3	O
%),	O
23	O
of	O
parainfluenzavirus	O
-	O
3	O
(	O
14	O
.	O
0	O
%),	O
15	O
of	O
human	B-SPEC
enterovirus	B-SPEC
(	O
9	O
.	O
1	O
%),	O
14	O
each	O
of	O
parainfluenzavirus	O
-	O
1	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
B	O
and	O
adenovirus	B-SPEC
(	O
8	O
.	O
5	O
%),	O
8	O
of	O
coronavirus	B-SPEC
229E	O
/	O
NL63	O
(	O
4	O
.	O
9	O
%),	O
6	O
of	O
human	B-SPEC
bocavirus	I-SPEC
(	O
3	O
.	O
7	O
%),	O
5	O
each	O
of	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
(	O
3	O
.	O
0	O
%),	O
3	O
of	O
parainfluenzavirus	O
-	O
4	O
(	O
1	O
.	O
8	O
%),	O
2	O
of	O
coronavirus	B-SPEC
OC43	O
/	O
HKU1	O
(	O
1	O
.	O
2	O
%),	O
and	O
1	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
0	O
.	O
6	O
%).	O

In	O
this	O
study	O
,	O
diarylheptanoids	O
1	O
-	O
9	O
were	O
isolated	O
from	O
Alnus	B-SPEC
japonica	I-SPEC
,	O
and	O
the	O
inhibitory	O
activities	O
of	O
these	O
compounds	O
against	O
PL	O
(	O
pro	O
)	O
were	O
determined	O
.	O

the	O
SARS	O
-	O
CoV	O
N	O
gene	O
was	O
cloned	O
into	O
pQE	O
-	O
80L	O
vector	O
,	O
and	O
the	O
constructs	O
were	O
transformed	O
into	O
Escherichia	B-SPEC
coli	I-SPEC
BL21	O
.	O

For	O
the	O
DNA	O
viruses	B-SPEC
,	O
five	O
samples	O
were	O
positive	O
for	O
bocavirus	B-SPEC
and	O
one	O
for	O
adenovirus	B-SPEC
.	O

Of	O
these	O
HBoV	O
positive	O
cases	O
,	O
19	O
(	O
32	O
.	O
76	O
%)	O
had	O
co	O
-	O
pathogens	O
including	O
influenza	B-SPEC
virus	I-SPEC
(	O
n	O
=	O
5	O
),	O
RSV	B-SPEC
(	O
n	O
=	O
5	O
),	O
parainfluenza	O
(	O
n	O
=	O
4	O
),	O
adenovirus	B-SPEC
(	O
n	O
=	O
1	O
),	O
coronavirus	B-SPEC
(	O
n	O
=	O
7	O
).	O

A	O
prospective	O
study	O
of	O
33	O
asymptomatic	O
children	O
detected	O
respiratory	O
viruses	B-SPEC
in	O
8	O
of	O
33	O
(	O
24	O
%)	O
patients	O
before	O
HCT	O
.	O

Of	O
the	O
11	O
asymptomatic	O
patients	O
where	O
respiratory	O
virus	B-SPEC
was	O
detected	O
,	O
3	O
(	O
27	O
%)	O
later	O
developed	O
an	O
upper	O
respiratory	O
tract	O
infection	O
,	O
from	O
the	O
same	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
Gammacoronavirus	B-SPEC
of	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
and	O
is	O
a	O
causative	O
agent	O
of	O
an	O
economically	O
important	O
disease	O
in	O
poultry	O
.	O

These	O
observations	O
support	O
the	O
hypothesis	O
that	O
human	B-SPEC
CoVs	O
are	O
capable	O
of	O
establishing	O
zoonotic	O
-	O
reverse	O
zoonotic	O
transmission	O
cycles	O
that	O
may	O
allow	O
some	O
CoVs	O
to	O
readily	O
circulate	O
and	O
exchange	O
genetic	O
material	O
between	O
strains	O
found	O
in	O
bats	B-SPEC
and	O
other	O
mammals	B-SPEC
,	O
including	O
humans	B-SPEC
.	O

TITLE	O
:	O
[	O
Peculiarities	O
of	O
clinical	O
and	O
X	O
-	O
ray	B-SPEC
picture	O
of	O
pneumonia	O
in	O
patients	O
with	O
influenza	O
A	O
(	O
H1N1	O
)].	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strain	O
H120	O
was	O
successfully	O
rescued	O
as	O
infectious	O
clone	O
by	O
reverse	O
genetics	O
.	O

In	O
addition	O
,	O
both	O
R	O
-	O
H120	O
and	O
H120	O
induced	O
a	O
comparable	O
titer	O
of	O
HA	O
inhibition	O
(	O
HI	O
)	O
antibody	O
in	O
immunized	O
chickens	B-SPEC
and	O
also	O
provided	O
up	O
to	O
85	O
%	O
of	O
immune	O
protection	O
to	O
the	O
chickens	B-SPEC
that	O
were	O
challenged	O
with	O
Mass41	O
IBV	B-SPEC
strain	O
.	O

A	O
single	O
genetic	O
lineage	O
of	O
coronavirus	B-SPEC
NL63	O
was	O
revealed	O
in	O
human	B-SPEC
subjects	O
in	O
Changsha	O
.	O

The	O
outbreak	O
caused	O
30	O
%	O
morbidity	O
in	O
the	O
resident	O
population	O
and	O
also	O
affected	O
two	O
cohorts	O
of	O
cattle	B-SPEC
that	O
were	O
newly	O
introduced	O
to	O
the	O
property	O
.	O

For	O
15	O
patients	O
with	O
AKI	O
,	O
urine	O
sCD163	O
levels	O
at	O
AKI	O
diagnosis	O
were	O
significantly	O
higher	O
than	O
those	O
of	O
the	O
remaining	O
35	O
sepsis	B-SPEC
patients	O
upon	O
ICU	O
admission	O
(	O
121	O
.	O
0	O
;	O
74	O
.	O
6	O
-	O
299	O
.	O
1	O
ng	O
/	O
ml	O
vs	O
.	O
61	O
.	O
8	O
;	O
42	O
.	O
8	O
-	O
128	O
.	O
3	O
ng	O
/	O
ml	O
,	O
P	O
=	O
0	O
.	O
049	O
).	O

Mice	B-SPEC
lacking	O
STAT1	O
have	O
greater	O
weight	O
loss	O
,	O
severe	O
lung	O
pathology	O
with	O
pre	O
-	O
pulmonary	O
-	O
fibrosis	O
-	O
like	O
lesions	O
,	O
and	O
an	O
altered	O
immune	O
response	O
following	O
infection	O
with	O
SARS	O
-	O
CoV	O
.	O
We	O
hypothesized	O
that	O
STAT1	O
plays	O
a	O
role	O
in	O
the	O
polarization	O
of	O
the	O
immune	O
response	O
,	O
specifically	O
in	O
macrophages	O
,	O
resulting	O
in	O
a	O
worsened	O
outcome	O
.	O

In	O
penehyclidine	O
hydrochloride	O
sequential	O
to	O
atropine	O
group	O
,	O
except	O
for	O
1	O
case	O
of	O
cancer	B-SPEC
of	O
gastric	O
cardia	O
with	O
poisoning	O
after	O
operation	O
showing	O
intermediate	O
syndrome	O
of	O
poisoning	O
,	O
the	O
remaining	O
patients	O
did	O
not	O
have	O
any	O
complication	O
,	O
and	O
the	O
incidence	O
of	O
complications	O
was	O
1	O
.	O
67	O
％.	O
No	O
death	O
occurred	O
in	O
all	O
the	O
patients	O
,	O
and	O
the	O
cure	O
rate	O
was	O
100	O
.	O
00	O
％.	O
Time	O
of	O
recovery	O
from	O
ChE	O
activity	O
to	O
70	O
％	O
was	O

A	O
McAb	O
,	O
4D4	O
,	O
directed	O
against	O
the	O
M	O
protein	O
of	O
PEDV	B-SPEC
,	O
was	O
obtained	O
,	O
and	O
the	O
4D4	O
-	O
defined	O
minimal	O
epitope	O
sequence	O
was	O
195WAFYVR200	O
.	O

Here	O
we	O
use	O
a	O
SARS	O
-	O
CoV	O
infection	O
-	O
reinfection	O
ferret	B-SPEC
model	O
and	O
a	O
functional	O
genomics	O
approach	O
to	O
gain	O
insight	O
into	O
SARS	O
immunopathogenesis	O
and	O
to	O
identify	O
correlates	O
of	O
immune	O
protection	O
during	O
SARS	O
-	O
CoV	O
-	O
challenge	O
in	O
ferrets	B-SPEC
previously	O
infected	O
with	O
SARS	O
-	O
CoV	O
or	O
immunized	O
with	O
a	O
SARS	O
virus	B-SPEC
vaccine	O
.	O

The	O
relatively	O
few	O
hospitalizations	O
for	O
pneumonia	O
-	O
influenza	O
in	O
recent	O
years	O
reflect	O
,	O
at	O
least	O
in	O
part	O
,	O
the	O
effectiveness	O
of	O
influenza	O
vaccines	O
against	O
the	O
predominant	O
circulating	O
strains	O
of	O
influenza	B-SPEC
viruses	I-SPEC
.	O

Factors	O
found	O
to	O
be	O
associated	O
with	O
less	O
willingness	O
were	O
:	O
being	O
female	O
,	O
being	O
in	O
a	O
supportive	O
staff	O
position	O
,	O
working	O
part	O
-	O
time	O
,	O
the	O
peak	O
phase	O
of	O
the	O
influenza	O
emergency	O
,	O
concern	O
for	O
family	B-SPEC
and	O
loved	O
ones	O
,	O
and	O
personal	O
obligations	O
.	O

Interventions	O
that	O
resulted	O
in	O
the	O
greatest	O
increase	O
in	O
the	O
HCP	O
'	O
s	O
willingness	O
to	O
work	O
were	O
preferential	O
access	O
to	O
Tamiflu	O
for	O
the	O
HCP	O
and	O
his	O
/	O
her	O
family	B-SPEC
,	O
and	O
the	O
provision	O
of	O
a	O
vaccine	O
for	O
the	O
individual	O
and	O
his	O
/	O
her	O
family	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
accordance	O
with	O
the	O
Public	O
Health	O
Security	O
and	O
Bioterrorism	O
Preparedness	O
and	O
Response	O
Act	O
of	O
2002	O
,	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
(	O
CDC	O
)	O
located	O
within	O
the	O
Department	O
of	O
Health	O
and	O
Human	B-SPEC
Services	O
(	O
HHS	O
)	O
has	O
reviewed	O
the	O
list	O
of	O
biological	O
agents	O
and	O
toxins	O
that	O
have	O
the	O
potential	O
to	O
pose	O
a	O
severe	O
threat	O
to	O
public	O
health	O
and	O
safety	O
and	O
is	O
republishing	O
that	O
list	O
.	O

A	O
total	O
of	O
120	O
viruses	B-SPEC
were	O
detected	O
from	O
113	O
children	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
was	O
the	O
most	O
common	O
pathogen	O
and	O
was	O
identified	O
in	O
43	O
.	O
4	O
%	O
of	O
the	O
cases	O
.	O

SDS	O
-	O
PAGE	O
and	O
Western	O
blot	O
results	O
indicated	O
that	O
EpiC	O
was	O
successfully	O
expressed	O
and	O
had	O
good	O
immunoreactivity	O
with	O
chicken	B-SPEC
anti	O
-	O
IBV	B-SPEC
serum	O
.	O

These	O
results	O
indicate	O
that	O
it	O
is	O
feasible	O
to	O
use	O
L	B-SPEC
.	I-SPEC
lactis	I-SPEC
as	O
an	O
antigen	O
delivery	O
vehicle	O
in	O
developing	O
oral	O
vaccines	O
against	O
IBV	B-SPEC
infection	O
.	O

Some	O
scientists	O
have	O
used	O
or	O
adopted	O
the	O
related	O
quasispecies	O
frame	O
to	O
explain	O
IBV	B-SPEC
evolution	O
.	O

Instead	O
,	O
it	O
seems	O
that	O
IBV	B-SPEC
populations	O
evolving	O
by	O
the	O
generation	O
of	O
genetic	O
variability	O
and	O
selection	O
on	O
replicons	O
follow	O
the	O
evolutionary	O
mechanisms	O
originally	O
proposed	O
by	O
Darwin	O
.	O

Understanding	O
the	O
mechanisms	O
underlying	O
the	O
evolution	O
of	O
IBV	B-SPEC
is	O
of	O
basic	O
relevance	O
and	O
,	O
without	O
doubt	O
,	O
essential	O
to	O
appropriately	O
control	O
and	O
prevent	O
the	O
disease	O
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
subpopulations	O
in	O
vaccinated	O
chickens	B-SPEC
after	O
challenge	O
.	O

These	O
results	O
provide	O
scientific	O
evidence	O
for	O
the	O
assumption	O
that	O
poor	O
vaccination	O
contributes	O
to	O
the	O
emergence	O
of	O
new	O
IBV	B-SPEC
strains	O
via	O
mutation	O
and	O
/	O
or	O
selection	O
.	O

Of	O
the	O
120	O
pooled	O
samples	O
tested	O
,	O
70	O
%	O
were	O
positive	O
for	O
TAstV	O
-	O
2	O
,	O
45	O
%	O
for	O
avian	B-SPEC
rotavirus	B-SPEC
,	O
and	O
18	O
%	O
for	O
avian	B-SPEC
reovirus	I-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
,	O
a	O
disease	O
of	O
chickens	B-SPEC
caused	O
by	O
Avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
leads	O
to	O
severe	O
economic	O
losses	O
for	O
the	O
poultry	O
industry	O
worldwide	O
.	O

We	O
employed	O
a	O
reverse	O
transcription	O
(	O
RT	O
)-	O
PCR	O
assay	O
and	O
CODEHOP	O
-	O
based	O
primers	O
(	O
CT12	O
-	O
mCODEHOP	O
)	O
previously	O
developed	O
to	O
recognize	O
known	O
and	O
unknown	O
corona	B-SPEC
-	O
and	O
toroviruses	B-SPEC
.	O

Care	O
was	O
taken	O
to	O
consider	O
the	O
remaining	O
vessels	O
and	O
bronchus	B-SPEC
,	O
which	O
regulate	O
the	O
direction	O
of	O
device	O
placement	O
.	O

Real	O
time	O
PCR	O
,	O
DFA	O
and	O
cell	O
culture	O
method	O
were	O
used	O
for	O
detection	O
of	O
C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
,	O
RSV	B-SPEC
antigen	O
and	O
influenza	B-SPEC
virus	I-SPEC
respectively	O
.	O

No	O
C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
DNA	O
was	O
detected	O
in	O
the	O
samples	O
.	O

Virus	B-SPEC
was	O
detected	O
in	O
43	O
cases	O
from	O
larynx	O
swabs	O
(	O
43	O
/	O
109	O
,	O
39	O
.	O
4	O
%).	O

Geoffroy	B-SPEC
'	I-SPEC
s	I-SPEC
cats	I-SPEC
had	O
detectable	O
antibody	O
to	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
FCV	B-SPEC
),	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
feline	B-SPEC
panleukopenia	I-SPEC
virus	I-SPEC
(	O
FPV	B-SPEC
),	O
Toxoplasma	B-SPEC
gondii	I-SPEC
,	O
Leptospira	B-SPEC
interrogans	I-SPEC
(	O
serovars	O
Ictero	O
/	O
Icter	O
and	O
Ballum	O
),	O
and	O
Dirofilaria	B-SPEC
immitis	I-SPEC
.	O

This	O
is	O
the	O
first	O
report	O
of	O
exposure	O
to	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
in	O
Neotropical	O
free	O
-	O
ranging	O
wild	O
canids	B-SPEC
.	O

TITLE	O
:	O
Structural	O
basis	O
for	O
multifunctional	O
roles	O
of	O
mammalian	B-SPEC
aminopeptidase	O
N	O
.	O
ABSTRACT	O
:	O
Mammalian	B-SPEC
aminopeptidase	O
N	O
(	O
APN	O
)	O
plays	O
multifunctional	O
roles	O
in	O
many	O
physiological	O
processes	O
,	O
including	O
peptide	O
metabolism	O
,	O
cell	O
motility	O
and	O
adhesion	O
,	O
and	O
coronavirus	B-SPEC
entry	O
.	O

Genome	O
sequencing	O
showed	O
that	O
this	O
virus	B-SPEC
belongs	O
to	O
the	O
group	O
C	O
species	B-SPEC
of	O
the	O
genus	B-SPEC
betacoronavirus	B-SPEC
and	O
phylogenetically	O
related	O
to	O
the	O
bat	B-SPEC
coronaviruses	O
HKU4	O
and	O
HKU5	O
previously	O
found	O
in	O
lesser	B-SPEC
bamboo	I-SPEC
bat	I-SPEC
and	O
Japanese	O
Pipistrelle	O
bat	B-SPEC
of	O
Hong	O
Kong	O
respectively	O
.	O

The	O
virus	B-SPEC
represents	O
a	O
novel	O
betacoronavirus	B-SPEC
species	B-SPEC
.	O

Here	O
,	O
the	O
clinical	O
data	O
,	O
virus	B-SPEC
isolation	O
,	O
and	O
molecular	O
identification	O
are	O
presented	O
.	O

We	O
performed	O
a	O
retrospective	O
study	O
of	O
obstetric	O
patients	O
admitted	O
to	O
an	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
for	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
.	O

RESULTS	O
:	O
Pyelonephritis	O
was	O
the	O
most	O
common	O
etiology	O
overall	O
(	O
37	O
%)	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
was	O
the	O
most	O
common	O
organ	O
injury	O
in	O
both	O
severe	O
sepsis	B-SPEC
(	O
50	O
%)	O
and	O
septic	O
shock	O
(	O
80	O
%).	O

TITLE	O
:	O
The	O
United	O
Kingdom	B-SPEC
public	O
health	O
response	O
to	O
an	O
imported	O
laboratory	O
confirmed	O
case	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
September	O
2012	O
.	O

TITLE	O
:	O
Severe	O
respiratory	O
illness	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
in	O
a	O
patient	O
transferred	O
to	O
the	O
United	O
Kingdom	B-SPEC
from	O
the	O
Middle	O
East	O
,	O
September	O
2012	O
.	O

Here	O
,	O
we	O
have	O
determined	O
at	O
1	O
.	O
55	O
Å	O
resolution	O
the	O
crystal	O
structure	O
of	O
BCoV	O
NTD	O
,	O
which	O
also	O
has	O
the	O
human	B-SPEC
galectin	O
fold	O
.	O

During	O
a	O
5	O
-	O
year	O
period	O
(	O
2004	O
-	O
2009	O
),	O
133	O
patients	O
with	O
severe	O
TBI	O
[	O
Glasgow	O
Coma	B-SPEC
Scale	O
(	O
GCS	O
)	O
score	O
≤	O
8	O
]	O
were	O
prospectively	O
included	O
.	O

A	O
household	O
survey	O
was	O
conducted	O
in	O
those	O
cases	O
with	O
confirmed	O
A	O
(	O
H1N1	O
)	O
infection	O
,	O
to	O
identify	O
contacts	O
and	O
history	O
related	O
to	O
influenza	B-SPEC
virus	I-SPEC
transmission	O
.	O

ABSTRACT	O
:	O
Besides	O
being	O
a	O
common	O
threat	O
to	O
farm	O
animals	B-SPEC
and	O
poultry	O
,	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
was	O
responsible	O
for	O
the	O
human	B-SPEC
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
in	O
2002	O
-	O
4	O
.	O

The	O
new	O
predictor	O
can	O
be	O
a	O
useful	O
tool	O
for	O
better	O
epidemiological	O
,	O
clinical	O
,	O
and	O
structural	O
understanding	O
of	O
behavior	O
of	O
both	O
newly	O
emerging	O
viruses	B-SPEC
and	O
viruses	B-SPEC
that	O
have	O
been	O
known	O
for	O
a	O
long	O
time	O
.	O

ABSTRACT	O
:	O
Non	O
-	O
specific	O
symptoms	O
of	O
acute	O
respiratory	O
viral	O
infections	O
make	O
it	O
difficult	O
for	O
many	O
countries	O
without	O
ongoing	O
transmission	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
to	O
rule	O
out	O
other	O
possibilities	O
including	O
influenza	O
before	O
isolating	O
imported	O
febrile	O
individuals	O
with	O
a	O
possible	O
exposure	O
history	O
.	O

In	O
January	O
2011	O
,	O
it	O
was	O
announced	O
that	O
the	O
worldwide	O
phase	O
3	O
randomized	O
trial	O
of	O
a	O
novel	O
anti	O
-	O
Toll	O
-	O
like	O
receptor	O
-	O
4	O
compound	O
,	O
eritoran	O
tetrasodium	O
,	O
had	O
failed	O
to	O
demonstrate	O
an	O
improvement	O
in	O
the	O
mortality	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

However	O
,	O
the	O
timing	O
,	O
incidence	O
,	O
and	O
nature	O
of	O
the	O
immunosuppression	O
remain	O
poorly	O
characterized	O
,	O
especially	O
in	O
humans	B-SPEC
.	O

The	O
most	O
common	O
pathogens	O
found	O
in	O
diarrheic	O
calves	O
are	O
cryptosporidium	B-SPEC
,	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
Salmonella	B-SPEC
,	O
attaching	O
and	O
effacing	O
E	O
coli	O
and	O
F5	O
(	O
K99	O
)	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

A	O
wide	O
range	O
of	O
respiratory	O
viruses	B-SPEC
,	O
including	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
influenza	O
A	O
and	O
B	O
viruses	B-SPEC
,	O
parainfluenza	O
viruses	B-SPEC
(	O
PIVs	O
),	O
adenovirus	B-SPEC
,	O
rhinovirus	B-SPEC
(	O
HRV	O
),	O
have	O
repeatedly	O
been	O
detected	O
in	O
acute	O
lower	O
respiratory	O
tract	O
infections	O
(	O
LRTI	O
)	O
in	O
children	O
in	O
the	O
past	O
decades	O
.	O

These	O
discoveries	O
have	O
heavily	O
modified	O
previous	O
knowledge	O
on	O
respiratory	O
infections	O
mainly	O
highlighting	O
that	O
pediatric	O
population	O
is	O
exposed	O
to	O
a	O
variety	O
of	O
viruses	B-SPEC
with	O
similar	O
seasonal	O
patterns	O
.	O

ABSTRACT	O
:	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
-	O
induced	O
gene	O
3	O
(	O
EBI3	O
)	O
associates	O
with	O
p28	O
and	O
p35	O
to	O
form	O
the	O
immunomodulatory	O
cytokines	O
IL	O
-	O
27	O
and	O
IL	O
-	O
35	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
heptide	O
repeat	O
(	O
HR	O
)	O
region	O
in	O
the	O
spike	O
protein	O
induces	O
neutralizing	O
antibodies	O
that	O
block	O
the	O
postfusion	O
core	O
formation	O
and	O
inhibit	O
virus	B-SPEC
entry	O
into	O
target	O
cells	O
.	O

The	O
polyclonal	O
antibodies	O
also	O
potently	O
cross	O
-	O
neutralized	O
viruses	B-SPEC
from	O
the	O
same	O
serogroup	O
.	O

TITLE	O
:	O
Mortality	O
,	O
severe	O
acute	O
respiratory	O
infection	O
,	O
and	O
influenza	O
-	O
like	O
illness	O
associated	O
with	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
in	O
Argentina	B-SPEC
,	O
2009	O
.	O

Of	O
the	O
10	O
cats	B-SPEC
positive	O
for	O
FHV	O
-	O
1	O
on	O
D0	O
,	O
4	O
were	O
negative	O
and	O
6	O
reduced	O
viral	O
loads	O
.	O

Of	O
the	O
11	O
FCoV	O
positive	O
cats	B-SPEC
,	O
9	O
reduced	O
viral	O
loads	O
.	O

Enterotropic	O
strains	O
predominate	O
in	O
natural	O
infections	O
,	O
and	O
molecular	O
techniques	O
for	O
the	O
detection	O
of	O
MHV	B-SPEC
shedding	O
in	O
feces	O
are	O
powerful	O
enough	O
to	O
diagnose	O
active	O
infections	O
.	O

A	O
reverse	O
transcription	O
-	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
RT	O
-	O
LAMP	O
)	O
technique	O
was	O
developed	O
for	O
the	O
detection	O
of	O
rodent	B-SPEC
coronaviruses	O
within	O
90	O
min	O
.	O

An	O
evaluation	O
of	O
the	O
diagnostic	O
performance	O
of	O
RT	O
-	O
LAMP	O
performed	O
in	O
duplicate	O
using	O
mouse	B-SPEC
fecal	O
specimens	O
showed	O
that	O
the	O
sensitivity	O
and	O
specificity	O
with	O
respect	O
to	O
nested	O
RT	O
-	O
PCR	O
were	O
85	O
.	O
7	O
%	O
and	O
100	O
%,	O
respectively	O
.	O

Fecal	O
samples	O
were	O
collected	O
from	O
sick	O
and	O
healthy	O
horses	B-SPEC
for	O
the	O
PCR	O
detection	O
of	O
ECoV	O
.	O
All	O
four	O
outbreaks	O
involved	O
primarily	O
adult	O
horses	B-SPEC
.	O

Blood	O
work	O
was	O
available	O
from	O
10	O
horses	B-SPEC
with	O
clinical	O
disease	O
and	O
common	O
hematological	O
abnormalities	O
were	O
leucopenia	O
due	O
to	O
neutropenia	O
and	O
/	O
or	O
lymphopenia	O
.	O

TITLE	O
:	O
Extraordinary	O
GU	O
-	O
rich	O
single	O
-	O
strand	O
RNA	O
identified	O
from	O
SARS	O
coronavirus	B-SPEC
contributes	O
an	O
excessive	O
innate	O
immune	O
response	O
.	O

Moreover	O
,	O
SARS	O
-	O
CoV	O
ssRNA	O
was	O
able	O
to	O
cause	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
with	O
a	O
high	O
mortality	O
rate	O
in	O
vivo	O
experiment	O
.	O

ABSTRACT	O
:	O
The	O
degradative	O
activity	O
of	O
the	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
reverse	O
transcriptase	O
(	O
RT	O
),	O
termed	O
ribonuclease	O
H	O
(	O
RNase	O
H	O
),	O
which	O
hydrolyzes	O
the	O
RNA	O
component	O
of	O
the	O
heteroduplex	O
RNA	O
:	O
DNA	O
replication	O
intermediate	O
,	O
is	O
an	O
excellent	O
target	O
for	O
drug	O
discovery	O
.	O

RESULTS	O
:	O
Six	O
series	O
of	O
new	O
AQ	O
derivatives	O
with	O
various	O
substituents	O
at	O
positions	O
1	O
,	O
2	O
,	O
3	O
and	O
4	O
of	O
the	O
AQ	O
ring	O
were	O
tested	O
,	O
and	O
new	O
analogs	O
able	O
to	O
inhibit	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
-	O
associated	O
RNase	O
H	O
activity	O
in	O
the	O
low	O
micromolar	O
range	O
were	O
found	O
.	O

The	O
cross	O
-	O
reactivity	O
test	O
for	O
this	O
assay	O
against	O
23	O
types	O
of	O
non	O
-	O
respiratory	O
viruses	B-SPEC
showed	O
negative	O
results	O
for	O
all	O
viruses	B-SPEC
tested	O
.	O

TITLE	O
:	O
Acute	O
intermittent	O
porphyria	B-SPEC
with	O
SIADH	O
and	O
fluctuating	O
dysautonomia	O
.	O

ABSTRACT	O
:	O
Three	O
cases	O
of	O
acute	O
intermittent	O
porphyria	B-SPEC
are	O
reported	O
.	O

This	O
case	O
involves	O
a	O
74	O
-	O
year	O
-	O
old	O
man	B-SPEC
suffering	O
from	O
IgG	O
Kappa	O
myeloma	O
treated	O
with	O
bortezomib	O
,	O
melphalan	O
,	O
and	O
dexamethasone	O
.	O

Laboratory	O
markers	O
,	O
interventions	O
,	O
medications	O
,	O
systemic	O
inflammatory	O
response	O
syndrome	O
(	O
SIRS	O
)	O
and	O
sepsis	B-SPEC
criteria	O
,	O
length	O
of	O
stay	O
,	O
and	O
hospital	O
mortality	O
as	O
well	O
as	O
expected	O
mortality	O
,	O
based	O
on	O
the	O
SAPSII	O
-	O
expanded	O
score	O
,	O
were	O
assessed	O
retrospectively	O
.	O

Brachial	O
plexus	O
block	O
using	O
a	O
non	O
-	O
stimulation	O
needle	O
with	O
an	O
external	O
indwelling	O
cannula	B-SPEC
has	O
favorable	O
intra	O
-	O
operative	O
anesthetic	O
benefit	O
and	O
provides	O
an	O
excellent	O
postoperative	O
analgesic	O
outcome	O
.	O

Ochroconis	B-SPEC
gallopavum	O
is	O
a	O
neurotropic	O
dematiaceous	O
mold	O
responsible	O
for	O
life	O
-	O
threatening	O
respiratory	O
and	O
central	O
nervous	O
system	O
infections	O
in	O
domestic	O
poultry	O
and	O
in	O
immunologically	O
compromised	O
humans	B-SPEC
.	O

Compared	O
with	O
previous	O
PEDV	B-SPEC
strains	O
,	O
all	O
of	O
the	O
S	O
genes	O
have	O
common	O
characteristics	O
,	O
namely	O
,	O
a	O
4	O
-	O
aa	O
(	O
GENQ	O
)	O
insertion	O
between	O
positions	O
55	O
and	O
56	O
,	O
a	O
1	O
-	O
aa	O
(	O
N	O
)	O
insertion	O
between	O
positions	O
135	O
and	O
136	O
,	O
and	O
a	O
2	O
-	O
aa	O
(	O
DG	O
)	O
deletion	O
between	O
positions	O
155	O
and	O
156	O
,	O
similar	O
or	O
identical	O
to	O
Korean	O
KNU	O
-	O
serial	O
strains	O
reported	O
in	O
recent	O
years	O
.	O

The	O
higher	O
positive	O
IBV	B-SPEC
RT	O
-	O
PCR	O
percentage	O
noted	O
in	O
the	O
cecal	O
tonsil	O
samples	O
demonstrates	O
how	O
important	O
the	O
choice	O
of	O
organs	O
is	O
for	O
diagnostic	O
purposes	O
.	O

Among	O
all	O
influenza	O
cases	O
,	O
54	O
(	O
95	O
%)	O
were	O
influenza	O
A	O
and	O
3	O
(	O
5	O
%)	O
were	O
influenza	O
B	O
.	O
Of	O
the	O
influenza	O
A	O
viruses	B-SPEC
,	O
16	O
(	O
30	O
%)	O
were	O
A	O
(	O
H1N1	O
)	O
pdm09	O
,	O
29	O
(	O
54	O
%)	O
were	O
seasonal	O
A	O
(	O
H1N1	O
),	O
6	O
(	O
11	O
%)	O
were	O
A	O
(	O
H3N2	O
),	O
and	O
4	O
(	O
7	O
%)	O
were	O
unsubtyped	O
.	O

This	O
study	O
for	O
the	O
first	O
time	O
,	O
describes	O
the	O
isolation	O
and	O
biotypes	O
determination	O
of	O
type	O
I	O
and	O
type	O
II	O
FCoV	O
from	O
naturally	O
infected	O
cats	B-SPEC
in	O
Malaysia	O
.	O

Physicians	O
must	O
be	O
familiar	O
with	O
it	O
as	O
a	O
cause	O
of	O
white	O
lung	O
X	O
-	O
ray	B-SPEC
pattern	O
.	O

Phylogenetic	O
analysis	O
,	O
and	O
pairwise	O
comparison	O
of	O
full	O
-	O
length	O
genomes	O
and	O
the	O
nine	O
genes	O
,	O
identified	O
the	O
occurrence	O
of	O
recombination	O
events	O
in	O
the	O
genome	O
of	O
strain	O
CK	O
/	O
VH	O
/	O
LHLJ	O
/	O
07VII	O
,	O
which	O
suggests	O
that	O
this	O
virus	B-SPEC
originated	O
from	O
recombination	O
events	O
between	O
M41	O
-	O
and	O
H120	O
-	O
like	O
strains	O
at	O
the	O
switch	O
site	O
located	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
nucleocapsid	O
(	O
N	O
)	O
genes	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
time	O
that	O
evidence	O
for	O
the	O
evolution	O
and	O
natural	O
recombination	O
under	O
field	O
conditions	O
between	O
Mass	O
-	O
type	O
pathogenic	O
and	O
vaccinal	O
IBV	B-SPEC
strains	O
has	O
been	O
documented	O
.	O

Real	O
time	O
RT	O
-	O
PCR	O
indicated	O
that	O
infection	O
was	O
cleared	O
more	O
efficiently	O
in	O
trachea	B-SPEC
,	O
lungs	O
and	O
kidneys	O
of	O
B2	O
/	O
B2	O
and	O
B8	O
/	O
B8	O
birds	B-SPEC
compared	O
with	O
B19	O
/	O
B19	O
birds	B-SPEC
.	O

TITLE	O
:	O
Characterization	O
of	O
a	O
recombinant	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
with	O
distinct	O
S1	O
subunits	O
of	O
spike	O
and	O
nucleocapsid	O
genes	O
and	O
a	O
3	O
'	O
untranslated	O
region	O
.	O

TITLE	O
:	O
The	O
role	O
of	O
accessory	O
proteins	O
in	O
the	O
replication	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
in	O
peripheral	O
blood	O
monocytes	O
.	O

ABSTRACT	O
:	O
Equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
(	O
EAV	B-SPEC
)	O
is	O
an	O
enveloped	O
,	O
positive	O
-	O
strand	O
RNA	O
virus	B-SPEC
.	O

We	O
performed	O
a	O
yeast	B-SPEC
two	O
-	O
hybrid	O
screen	O
using	O
as	O
bait	O
the	O
carboxy	O
-	O
terminal	O
endodomain	O
of	O
S	O
,	O
which	O
faces	O
the	O
cytosol	O
during	O
and	O
after	O
opening	O
of	O
the	O
fusion	O
pore	O
at	O
early	O
stages	O
of	O
the	O
virus	B-SPEC
life	O
cycle	O
.	O

Ezrin	O
interacts	O
with	O
SARS	O
-	O
CoV	O
S	O
endodomain	O
and	O
limits	O
virus	B-SPEC
entry	O
and	O
fusion	O
.	O

These	O
data	O
indicate	O
that	O
HmAbs	O
which	O
bind	O
to	O
conserved	O
regions	O
of	O
the	O
S	O
protein	O
are	O
more	O
suitable	O
for	O
conferring	O
protection	O
against	O
a	O
wide	O
range	O
of	O
SARS	O
-	O
CoV	O
variants	O
and	O
have	O
implications	O
for	O
generating	O
therapeutic	O
antibodies	O
or	O
subunit	O
vaccines	O
against	O
other	O
enveloped	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
enteropathogenic	O
coronavirus	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
causes	O
severe	O
disease	O
in	O
young	O
piglets	O
.	O

Virus	B-SPEC
yields	O
of	O
the	O
E	B-SPEC
.	I-SPEC
faecium	I-SPEC
-	O
treated	O
cultures	O
were	O
reduced	O
by	O
up	O
to	O
three	O
log10	O
units	O
.	O

C	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
and	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
were	O
detected	O
in	O
4	O
and	O
3	O
patients	O
,	O
respectively	O
.	O
:	O
Human	B-SPEC
rhinovirus	I-SPEC
was	O
the	O
most	O
common	O
virus	B-SPEC
detected	O
in	O
children	O
with	O
cancer	B-SPEC
and	O
posthematopoietic	O
stem	O
cell	O
transplant	O
hospitalized	O
with	O
an	O
acute	O
respiratory	O
illness	O
,	O
and	O
was	O
not	O
associated	O
with	O
increased	O
morbidity	O
.	O

Furthermore	O
,	O
both	O
compounds	O
showed	O
prominent	O
activity	O
against	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
,	O
suggesting	O
broader	O
anticoronaviral	O
activity	O
.	O

ABSTRACT	O
:	O
The	O
Coronaviridae	B-SPEC
family	B-SPEC
,	O
an	O
enveloped	O
RNA	O
virus	B-SPEC
family	B-SPEC
,	O
and	O
,	O
more	O
particularly	O
,	O
human	B-SPEC
coronaviruses	O
(	O
HCoV	O
),	O
were	O
historically	O
known	O
to	O
be	O
responsible	O
for	O
a	O
large	O
portion	O
of	O
common	O
colds	O
and	O
other	O
upper	O
respiratory	O
tract	O
infections	O
.	O

In	O
2002	O
-	O
2003	O
,	O
the	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
due	O
to	O
a	O
newly	O
discovered	O
coronavirus	B-SPEC
,	O
the	O
SARS	O
-	O
associated	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
);	O
led	O
to	O
a	O
new	O
awareness	O
of	O
the	O
medical	O
importance	O
of	O
the	O
Coronaviridae	B-SPEC
family	B-SPEC
.	O

Another	O
interesting	O
feature	O
of	O
coronaviruses	O
is	O
their	O
potential	O
environmental	O
resistance	O
,	O
despite	O
the	O
accepted	O
fragility	O
of	O
enveloped	O
viruses	B-SPEC
.	O

The	O
NIAID	O
-	O
sponsored	O
Virus	B-SPEC
Pathogen	O
Database	O
and	O
Analysis	O
Resource	O
(	O
ViPR	O
,	O
www	O
.	O
viprbrc	O
.	O
org	O
)	O
supports	O
bioinformatics	O
workflows	O
for	O
a	O
broad	O
range	O
of	O
human	B-SPEC
virus	B-SPEC
pathogens	O
and	O
other	O
related	O
viruses	B-SPEC
,	O
including	O
the	O
entire	O
Coronaviridae	B-SPEC
family	B-SPEC
.	O

This	O
provides	O
the	O
virus	B-SPEC
with	O
a	O
platform	O
for	O
the	O
assembly	O
of	O
viral	O
replication	O
complexes	O
,	O
improving	O
efficiency	O
of	O
RNA	O
synthesis	O
.	O

Analysis	O
of	O
sequences	O
of	O
membrane	O
(	O
M	O
)	O
and	O
spike	O
(	O
S	O
)	O
gene	O
fragments	O
revealed	O
strains	O
in	O
the	O
genus	B-SPEC
Alphacoronavirus	B-SPEC
,	O
including	O
three	O
distinct	O
strains	O
in	O
hyenas	B-SPEC
and	O
one	O
distinct	O
strain	O
in	O
a	O
jackal	O
.	O

ABSTRACT	O
:	O
Inoculation	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
into	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
susceptible	O
strains	O
of	O
mice	B-SPEC
results	O
in	O
an	O
acute	O
encephalomyelitis	O
in	O
which	O
virus	B-SPEC
preferentially	O
replicates	O
within	O
glial	O
cells	O
while	O
excluding	O
neurons	O
.	O

ABSTRACT	O
:	O
Despite	O
intense	O
efforts	O
to	O
develop	O
novel	O
and	O
better	O
tools	O
to	O
identify	O
known	O
viruses	B-SPEC
and	O
to	O
discover	O
new	O
viruses	B-SPEC
,	O
establishing	O
etiological	O
roles	O
for	O
viruses	B-SPEC
in	O
human	B-SPEC
disease	O
is	O
challenging	O
.	O

To	O
overcome	O
this	O
problem	O
,	O
a	O
novel	O
method	O
for	O
the	O
detection	O
of	O
viruses	B-SPEC
is	O
described	O
in	O
the	O
current	O
manuscript	O
.	O

Expedient	O
diagnosis	O
from	O
history	O
,	O
examination	O
and	O
x	O
-	O
ray	B-SPEC
study	O
,	O
and	O
simple	O
treatment	O
by	O
passage	O
of	O
feeding	O
tube	O
and	O
gastric	O
decompression	O
relieved	O
the	O
distress	O
and	O
helped	O
us	O
overcome	O
the	O
acute	O
crisis	O
.	O

Unlike	O
the	O
majority	O
of	O
reported	O
coronavirus	B-SPEC
3CLpro	O
inhibitors	O
that	O
act	O
via	O
covalent	O
modification	O
of	O
the	O
enzyme	O
,	O
16	O
-(	O
R	O
)	O
is	O
a	O
noncovalent	O
SARS	O
-	O
CoV	O
3CLpro	O
inhibitor	O
with	O
moderate	O
MW	O
and	O
good	O
enzyme	O
and	O
antiviral	O
inhibitory	O
activity	O
.	O

ABSTRACT	O
:	O
We	O
describe	O
the	O
third	O
confirmed	O
case	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
infection	O
in	O
a	O
resident	O
of	O
the	O
Arabian	O
Peninsula	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
EMC	O
does	O
not	O
require	O
the	O
SARS	O
-	O
coronavirus	B-SPEC
receptor	O
and	O
maintains	O
broad	O
replicative	O
capability	O
in	O
mammalian	B-SPEC
cell	O
lines	O
.	O

Knowledge	O
of	O
the	O
receptor	O
is	O
highly	O
critical	O
because	O
the	O
restriction	O
of	O
the	O
SARS	O
receptor	O
to	O
deep	O
compartments	O
of	O
the	O
human	B-SPEC
respiratory	O
tract	O
limited	O
the	O
spread	O
of	O
SARS	O
.	O

Monkey	B-SPEC
and	O
human	B-SPEC
kidney	O
cells	O
(	O
LLC	O
-	O
MK2	O
,	O
Vero	O
,	O
and	O
769	O
-	O
P	O
)	O
and	O
swine	B-SPEC
kidney	O
cells	O
were	O
permissive	O
for	O
both	O
viruses	B-SPEC
,	O
but	O
only	O
SARS	O
-	O
CoV	O
infection	O
could	O
be	O
blocked	O
by	O
anti	O
-	O
hACE2	O
antibody	O
and	O
could	O
be	O
neutralized	O
by	O
preincubation	O
of	O
virus	B-SPEC
with	O
soluble	O
ACE2	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
HRV	O
)	O
were	O
the	O
most	O
common	O
additional	O
respiratory	O
viruses	B-SPEC
,	O
Lower	O
respiratory	O
tract	O
infections	O
were	O
the	O
most	O
frequent	O
diagnoses	O
made	O
in	O
the	O
hospital	O
,	O
in	O
which	O
there	O
were	O
52	O
pneumonia	O
(	O
30	O
.	O
4	O
%)	O
cases	O
.	O

An	O
amantadine	O
-	O
folate	O
conjugate	O
was	O
inhibitory	O
on	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
replication	O
in	O
primary	O
human	B-SPEC
lymphocytes	O
,	O
and	O
one	O
N	O
-	O
phenacyl	O
amantadine	O
derivative	O
was	O
inhibitory	O
towards	O
low	O
pathogenic	O
avian	B-SPEC
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
H5N1	O
)	O
replication	O
in	O
vitro	O
.	O

TITLE	O
:	O
[	O
Clinical	O
and	O
laboratory	O
profile	O
of	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
patients	O
hospitalized	O
in	O
Apartadó	O
,	O
Colombia	O
].	O

Only	O
4	O
.	O
82	O
%	O
(	O
4	O
/	O
83	O
)	O
of	O
patients	O
with	O
complicated	O
malaria	O
were	O
treated	O
with	O
intravenous	O
quinine	B-SPEC
,	O
no	O
one	O
died	O
.	O

ABSTRACT	O
:	O
All	O
positive	O
strand	O
RNA	O
viruses	B-SPEC
are	O
known	O
to	O
replicate	O
their	O
genomes	O
in	O
close	O
association	O
with	O
intracellular	O
membranes	O
.	O

Wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
B7	O
-	O
H1	O
-/-	O
mice	B-SPEC
were	O
infected	O
with	O
a	O
gliatropic	O
coronavirus	B-SPEC
and	O
CD4	O
T	O
cells	O
depleted	O
to	O
specifically	O
block	O
T	O
helper	O
function	O
in	O
the	O
CNS	O
.	O

Enhanced	O
production	O
of	O
IFN	O
-	O
γ	O
,	O
interleukin	O
(	O
IL	O
)-	O
10	O
and	O
IL	O
-	O
21	O
mRNA	O
was	O
seen	O
in	O
CD4	O
T	O
cells	O
from	O
infected	O
B7	O
-	O
H1	O
-/-	O
compared	O
with	O
WT	O
mice	B-SPEC
,	O
suggesting	O
that	O
over	O
-	O
activated	O
CD4	O
T	O
cells	O
primarily	O
contribute	O
to	O
the	O
increased	O
pathology	O
.	O

Moreover	O
,	O
the	O
increased	O
effector	O
activity	O
by	O
CD8	O
T	O
cells	O
in	O
the	O
CNS	O
of	O
B7	O
-	O
H1	O
-/-	O
mice	B-SPEC
is	O
attributable	O
not	O
only	O
to	O
the	O
absence	O
of	O
B7	O
-	O
H1	O
upregulation	O
on	O
major	O
histocompatibility	O
complex	O
class	B-SPEC
I	O
-	O
presenting	O
resident	O
target	O
cells	O
,	O
but	O
also	O
to	O
enhanced	O
local	O
CD4	O
T	O
-	O
cell	O
function	O
.	O

Despite	O
nearly	O
six	O
decades	O
having	O
passed	O
since	O
its	O
first	O
emergence	O
,	O
different	O
studies	O
have	O
shown	O
that	O
type	O
II	O
FCoV	O
represents	O
only	O
a	O
small	O
portion	O
of	O
the	O
total	O
FCoV	O
seropositivity	O
in	O
cats	B-SPEC
;	O
hence	O
,	O
there	O
is	O
very	O
limited	O
knowledge	O
of	O
the	O
evolution	O
of	O
type	O
II	O
FCoV	O
.	O
To	O
elucidate	O
the	O
correlation	O
between	O
viral	O
emergence	O
and	O
FIP	O
,	O
a	O
local	O
isolate	O
(	O
NTU156	O
)	O
that	O
was	O
derived	O
from	O
a	O
FIP	O
cat	B-SPEC
was	O
analyzed	O
along	O
with	O
other	O
worldwide	O
strains	O
.	O

TITLE	O
:	O
Rapid	O
NK	O
-	O
cell	O
activation	O
in	O
chicken	B-SPEC
after	O
infection	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
M41	O
.	O

In	O
this	O
study	O
we	O
focussed	O
on	O
NK	O
cell	O
and	O
interferon	O
(	O
IFN	O
)	O
responses	O
after	O
infection	O
with	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Forty	O
-	O
one	O
percent	O
were	O
viral	O
coinfections	O
,	O
which	O
were	O
significantly	O
younger	O
than	O
virus	B-SPEC
negative	O
patients	O
,	O
had	O
a	O
higher	O
leukocyte	O
count	O
and	O
were	O
hospitalized	O
for	O
a	O
longer	O
time	O
.	O

Of	O
these	O
specimens	O
,	O
21	O
/	O
40	O
(	O
52	O
.	O
5	O
%)	O
were	O
identified	O
as	O
species	B-SPEC
HKU1	O
,	O
7	O
/	O
40	O
(	O
17	O
.	O
5	O
%)	O
as	O
OC43	O
,	O
6	O
/	O
40	O
(	O
15	O
%)	O
as	O
229E	O
,	O
and	O
6	O
/	O
40	O
(	O
15	O
%)	O
as	O
NL63	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
the	O
only	O
mammals	B-SPEC
capable	O
of	O
sustained	O
flight	O
and	O
are	O
notorious	O
reservoir	O
hosts	O
for	O
some	O
of	O
the	O
world	O
'	O
s	O
most	O
highly	O
pathogenic	O
viruses	B-SPEC
,	O
including	O
Nipah	O
,	O
Hendra	O
,	O
Ebola	O
,	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
being	O
increasingly	O
recognized	O
as	O
an	O
important	O
reservoir	O
of	O
zoonotic	O
viruses	B-SPEC
of	O
different	O
families	O
,	O
including	O
SARS	O
coronavirus	B-SPEC
,	O
Nipah	B-SPEC
virus	I-SPEC
,	O
Hendra	B-SPEC
virus	I-SPEC
and	O
Ebola	B-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
To	O
establish	O
a	O
animal	B-SPEC
model	O
of	O
hepatic	O
steatosis	O
induced	O
by	O
chronic	O
viral	O
hepatitis	O
in	O
C	O
(	O
57	O
)	O
BL	O
/	O
6	O
mice	B-SPEC
.	O

To	O
investigate	O
and	O
analyze	O
the	O
reason	O
of	O
this	O
outbreak	O
,	O
the	O
M	O
and	O
ORF3	O
genes	O
of	O
15	O
porcine	B-SPEC
epidemic	O
diarrhea	O
viruses	B-SPEC
(	O
PEDV	B-SPEC
),	O
which	O
were	O
collected	O
from	O
different	O
areas	O
of	O
central	O
China	O
during	O
October	O
2010	O
and	O
December	O
2011	O
,	O
were	O
amplified	O
by	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
,	O
cloned	O
,	O
sequenced	O
,	O
and	O
analyzed	O
.	O

TITLE	O
:	O
Transgenic	O
CCL2	O
expression	O
in	O
the	O
central	O
nervous	O
system	O
results	O
in	O
a	O
dysregulated	O
immune	O
response	O
and	O
enhanced	O
lethality	O
after	O
coronavirus	B-SPEC
infection	O
.	O

To	O
examine	O
the	O
role	O
of	O
CCL2	O
during	O
virus	B-SPEC
infection	O
,	O
we	O
infected	O
mice	B-SPEC
transgenically	O
expressing	O
CCL2	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CCL2	O
Tg	O
)	O
with	O
an	O
attenuated	O
neurotropic	O
coronavirus	B-SPEC
(	O
rJ2	O
.	O
2	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
).	O

TITLE	O
:	O
Structure	O
of	O
alphacoronavirus	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
nsp1	O
has	O
implications	O
for	O
coronavirus	B-SPEC
nsp1	O
function	O
and	O
evolution	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
nsp1	O
has	O
been	O
shown	O
to	O
induce	O
suppression	O
of	O
host	O
gene	O
expression	O
and	O
to	O
interfere	O
with	O
the	O
host	O
immune	O
response	O
.	O

ABSTRACT	O
:	O
The	O
FilmArray	O
respiratory	O
virus	B-SPEC
panel	O
detects	O
15	O
viral	O
agents	O
in	O
respiratory	O
specimens	O
using	O
polymerase	O
chain	O
reaction	O
.	O

Forty	O
-	O
four	O
percent	O
(	O
7	O
/	O
16	O
)	O
of	O
cheetahs	B-SPEC
had	O
detectable	O
FCoV	O
in	O
feces	O
,	O
and	O
the	O
proportion	O
of	O
positive	O
samples	O
for	O
individual	O
animals	B-SPEC
ranged	O
from	O
13	O
to	O
93	O
%.	O

Cheetahs	B-SPEC
shed	O
virus	B-SPEC
persistently	O
,	O
intermittently	O
,	O
or	O
rarely	O
over	O
30	O
-	O
46	O
days	O
.	O

One	O
of	O
the	O
common	O
pathogens	O
involved	O
is	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
),	O
however	O
little	O
is	O
known	O
regarding	O
its	O
pathogenesis	O
and	O
the	O
role	O
it	O
plays	O
in	O
the	O
development	O
of	O
CIRD	O
.	O

The	O
pathogenesis	O
of	O
five	O
geographically	O
unrelated	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
)	O
isolates	O
was	O
investigated	O
.	O

A	O
high	O
proportion	O
of	O
daycare	O
attendees	O
had	O
multiple	O
viruses	B-SPEC
detected	O
during	O
respiratory	O
illnesses	O
.	O

HCoV	O
-	O
EMC	O
may	O
represent	O
a	O
sporadic	O
spillover	O
to	O
humans	B-SPEC
from	O
an	O
unknown	O
animal	B-SPEC
reservoir	O
.	O

TITLE	O
:	O
Detection	O
rate	O
and	O
clinical	O
impact	O
of	O
respiratory	O
viruses	B-SPEC
in	O
children	O
with	O
Kawasaki	O
disease	O
.	O

A	O
positive	O
RT	O
-	O
PCR	O
for	O
currently	O
epidemic	O
respiratory	O
viruses	B-SPEC
should	O
not	O
be	O
used	O
as	O
an	O
evidence	O
against	O
the	O
diagnosis	O
of	O
KD	O
.	O

TITLE	O
:	O
Solution	O
structure	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
nsp3a	O
and	O
determinants	O
of	O
the	O
interaction	O
with	O
MHV	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
.	O

ABSTRACT	O
:	O
The	O
high	O
mutation	O
rate	O
of	O
RNA	O
viruses	B-SPEC
enables	O
a	O
diverse	O
genetic	O
population	O
of	O
viral	O
genotypes	O
to	O
exist	O
within	O
a	O
single	O
infected	O
host	O
.	O

ABSTRACT	O
:	O
Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
is	O
the	O
main	O
cause	O
of	O
severe	O
acute	O
respiratory	O
infection	O
(	O
SARI	O
)	O
in	O
infants	O
and	O
young	O
children	O
.	O

This	O
study	O
aimed	O
to	O
identify	O
risk	O
factors	O
for	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
admission	O
,	O
prolonged	O
length	O
of	O
stay	O
(	O
PLOS	O
),	O
and	O
mortality	O
in	O
patients	O
hospitalized	O
with	O
SARI	O
caused	O
by	O
RSV	B-SPEC
.	O

Early	O
recognition	O
of	O
risk	O
factors	O
for	O
complicated	O
RSV	B-SPEC
disease	O
on	O
admission	O
prompts	O
early	O
interventions	O
and	O
early	O
ICU	O
admissions	O
for	O
these	O
children	O
.	O

We	O
found	O
,	O
however	O
,	O
a	O
correlation	O
between	O
HBP	O
levels	O
and	O
development	O
of	O
ARDS	O
(	O
P	O
=	O
0	O
.	O
026	O
,	O
n	O
=	O
47	O
),	O
but	O
not	O
to	O
severe	O
sepsis	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
newly	O
identified	O
betacoronavirus	B-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
EMC	O
(	O
HCoV	O
-	O
EMC	O
),	O
has	O
been	O
isolated	O
from	O
several	O
patients	O
with	O
respiratory	O
and	O
renal	O
disease	O
in	O
the	O
Middle	O
East	O
.	O

In	O
a	O
recent	O
article	O
in	O
mBio	O
,	O
Müller	O
et	O
al	O
.	O
described	O
several	O
important	O
differences	O
between	O
the	O
two	O
viruses	B-SPEC
[	O
M	O
.	O
A	O
.	O
Müller	O
et	O
al	O
.,	O
mBio	O
3	O
(	O
6	O
):	O
e00515	O
-	O
12	O
,	O
2012	O
,	O
doi	O
:	O
10	O
.	O
1128	O
/	O
mBio	O
.	O
00515	O
-	O
12	O
].	O

We	O
collected	O
cases	O
of	O
severe	O
adenovirus	B-SPEC
infection	O
between	O
November	O
2010	O
and	O
June	O
2011	O
to	O
analyze	O
their	O
clinical	O
characteristics	O
in	O
two	O
medical	O
centers	O
in	O
northern	O
Taiwan	O
.	O

Although	O
autophagy	O
has	O
been	O
studied	O
in	O
many	O
animal	B-SPEC
species	B-SPEC
,	O
reagents	O
to	O
study	O
autophagy	O
in	O
avian	B-SPEC
systems	O
are	O
lacking	O
.	O

IBV	B-SPEC
induced	O
autophagic	O
signaling	O
in	O
mammalian	B-SPEC
Vero	O
cells	O
but	O
not	O
primary	O
avian	B-SPEC
chick	O
kidney	O
cells	O
or	O
the	O
avian	B-SPEC
DF1	O
cell	O
line	O
.	O

This	O
may	O
suggest	O
that	O
IBV	B-SPEC
can	O
inhibit	O
or	O
control	O
autophagy	O
in	O
avian	B-SPEC
cells	O
,	O
although	O
IBV	B-SPEC
did	O
not	O
appear	O
to	O
inhibit	O
autophagy	O
induced	O
by	O
starvation	O
or	O
rapamycin	O
treatment	O
.	O

Further	O
studies	O
show	O
that	O
PEDV	B-SPEC
E	O
protein	O
induced	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
and	O
activated	O
NF	O
-	O
κB	O
which	O
is	O
responsible	O
for	O
the	O
up	O
-	O
regulation	O
of	O
IL	O
-	O
8	O
and	O
Bcl	O
-	O
2	O
expression	O
.	O

HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
infection	O
was	O
not	O
more	O
frequent	O
in	O
children	O
with	O
preexisting	O
conditions	O
.	O

In	O
our	O
population	O
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
infections	O
generally	O
caused	O
upper	O
respiratory	O
tract	O
infection	O
,	O
but	O
can	O
be	O
associated	O
with	O
lower	O
respiratory	O
tract	O
infection	O
especially	O
in	O
those	O
coinfected	O
with	O
other	O
respiratory	O
viruses	B-SPEC
.	O

Viruses	B-SPEC
were	O
identified	O
in	O
89	O
clinical	O
episodes	O
that	O
occurred	O
in	O
58	O
patients	O
.	O

RESULTS	O
:	O
Data	O
from	O
193	O
patients	O
(	O
44	O
±	O
18	O
y	O
;	O
77	O
%	O
male	O
;	O
admission	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
4	O
±	O
2	O
)	O
were	O
reviewed	O
.	O

These	O
results	O
represent	O
the	O
most	O
complete	O
description	O
of	O
human	B-SPEC
virus	B-SPEC
diversity	O
in	O
any	O
wastewater	O
sample	O
to	O
date	O
,	O
provide	O
engineers	O
and	O
environmental	O
scientists	O
with	O
critical	O
information	O
on	O
important	O
viral	O
agents	O
and	O
routes	O
of	O
infection	O
from	O
exposure	O
to	O
wastewater	O
and	O
sewage	O
sludge	O
,	O
and	O
represent	O
a	O
significant	O
leap	O
forward	O
in	O
understanding	O
the	O
pathogen	O
content	O
of	O
class	B-SPEC
B	O
biosolids	O
.	O

Compared	O
with	O
WT	O
mice	B-SPEC
,	O
ADORA2A	O
(-/-)	O
mice	B-SPEC
exposed	O
to	O
IT	O
LPS	O
and	O
60	O
%	O
oxygen	O
demonstrated	O
significantly	O
more	O
histologic	O
lung	O
injury	O
,	O
alveolar	O
neutrophils	O
,	O
and	O
protein	O
.	O

Chest	O
X	O
-	O
ray	B-SPEC
revealed	O
diffuse	O
reticulonodular	O
shadows	O
and	O
high	O
-	O
resolution	O
computed	O
tomography	O
showed	O
randomly	O
distributed	O
small	O
nodules	O
.	O

Recommendations	O
were	O
classified	O
into	O
three	O
groups	O
:	O
1	O
)	O
those	O
directly	O
targeting	O
severe	O
sepsis	B-SPEC
;	O
2	O
)	O
those	O
targeting	O
general	O
care	O
of	O
the	O
critically	O
ill	O
patient	O
and	O
considered	O
high	O
priority	O
in	O
severe	O
sepsis	B-SPEC
;	O
and	O
3	O
)	O
pediatric	O
considerations	O
.	O

Recommendations	O
specific	O
to	O
pediatric	O
severe	O
sepsis	B-SPEC
include	O
:	O
therapy	O
with	O
face	O
mask	O
oxygen	O
,	O
high	O
flow	O
nasal	O
cannula	B-SPEC
oxygen	O
,	O
or	O
nasopharyngeal	O
continuous	O
PEEP	O
in	O
the	O
presence	O
of	O
respiratory	O
distress	O
and	O
hypoxemia	O
(	O
2C	O
),	O
use	O
of	O
physical	O
examination	O
therapeutic	O
endpoints	O
such	O
as	O
capillary	O
refill	O
(	O
2C	O
);	O
for	O
septic	O
shock	O
associated	O
with	O
hypovolemia	O
,	O
the	O
use	O
of	O
crystalloids	O
or	O
albumin	O
to	O
deliver	O
a	O
bolus	O
of	O
20	O
mL	O
/	O
kg	O
of	O
crystalloids	O
(	O
or	O
albumin	O
equivalent	O
)	O
over	O
5	O
to	O
10	O
mins	O
(	O
2C	O
);	O
more	O
common	O
use	O
of	O
inotropes	O
and	O
vasodilators	O
for	O
low	O
cardiac	O
output	O
septic	O
shock	O
associated	O
with	O
elevated	O
systemic	O
vascular	O
resistance	O
(	O
2C	O
);	O
and	O
use	O
of	O
hydrocortisone	O
only	O
in	O
children	O
with	O
suspected	O
or	O
proven	O
""""	O
absolute	O
"""'"	O
adrenal	O
insufficiency	O
(	O
2C	O
).	O

Recommendations	O
specific	O
to	O
pediatric	O
severe	O
sepsis	B-SPEC
include	O
:	O
therapy	O
with	O
face	O
mask	O
oxygen	O
,	O
high	O
flow	O
nasal	O
cannula	B-SPEC
oxygen	O
,	O
or	O
nasopharyngeal	O
continuous	O
PEEP	O
in	O
the	O
presence	O
of	O
respiratory	O
distress	O
and	O
hypoxemia	O
(	O
2C	O
),	O
use	O
of	O
physical	O
examination	O
therapeutic	O
endpoints	O
such	O
as	O
capillary	O
refill	O
(	O
2C	O
);	O
for	O
septic	O
shock	O
associated	O
with	O
hypovolemia	O
,	O
the	O
use	O
of	O
crystalloids	O
or	O
albumin	O
to	O
deliver	O
a	O
bolus	O
of	O
20	O
mL	O
/	O
kg	O
of	O
crystalloids	O
(	O
or	O
albumin	O
equivalent	O
)	O
over	O
5	O
-	O
10	O
min	O
(	O
2C	O
);	O
more	O
common	O
use	O
of	O
inotropes	O
and	O
vasodilators	O
for	O
low	O
cardiac	O
output	O
septic	O
shock	O
associated	O
with	O
elevated	O
systemic	O
vascular	O
resistance	O
(	O
2C	O
);	O
and	O
use	O
of	O
hydrocortisone	O
only	O
in	O
children	O
with	O
suspected	O
or	O
proven	O
""""	O
absolute	O
"""'"	O
adrenal	O
insufficiency	O
(	O
2C	O
).	O

RV16	O
demonstrated	O
higher	O
sensitivity	O
than	O
RV15	O
for	O
the	O
detection	O
of	O
adenovirus	B-SPEC
(	O
100	O
%	O
versus	O
82	O
.	O
1	O
%;	O
P	O
<	O
0	O
.	O
05	O
).	O

Sequencing	O
analysis	O
of	O
64	O
rhinovirus	B-SPEC
-	O
positive	O
samples	O
revealed	O
that	O
RV16	O
accurately	O
differentiated	O
between	O
rhinovirus	B-SPEC
and	O
enterovirus	B-SPEC
.	O

In	O
a	O
screen	O
of	O
606	O
bats	B-SPEC
from	O
42	O
different	O
species	B-SPEC
in	O
Campeche	O
,	O
Chiapas	O
and	O
Mexico	O
City	O
we	O
identified	O
13	O
distinct	O
CoVs	O
.	O

The	O
presence	O
of	O
the	O
allele	O
D	O
of	O
the	O
ACE	O
gene	O
is	O
associated	O
with	O
ARDS	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

Importantly	O
,	O
these	O
studies	O
and	O
modeling	O
approaches	O
not	O
only	O
provide	O
templates	O
for	O
evaluating	O
virus	B-SPEC
antagonism	O
of	O
nuclear	O
import	O
processes	O
but	O
also	O
can	O
reveal	O
candidate	O
cellular	O
genes	O
and	O
pathways	O
that	O
may	O
significantly	O
influence	O
disease	O
outcomes	O
following	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
vivo	O
.	O

In	O
5	O
/	O
6	O
children	O
with	O
HCoVs	O
detected	O
in	O
stools	O
,	O
the	O
viruses	B-SPEC
were	O
also	O
detected	O
in	O
NP	O
swabs	O
.	O

Although	O
HCoVs	O
were	O
more	O
frequently	O
detected	O
in	O
patients	O
with	O
AGE	O
than	O
in	O
the	O
control	O
group	O
,	O
high	O
prevalence	O
of	O
HCoVs	O
in	O
NP	O
swabs	O
compounded	O
by	O
their	O
low	O
occurrence	O
in	O
stool	O
samples	O
and	O
detection	O
of	O
other	O
viruses	B-SPEC
in	O
stool	O
samples	O
,	O
indicate	O
that	O
HCoVs	O
probably	O
play	O
only	O
a	O
minor	O
role	O
in	O
causing	O
gastrointestinal	O
illness	O
in	O
children	O
<	O
6	O
years	O
old	O
.	O

During	O
2006	O
-	O
2011	O
,	O
74	O
.	O
0	O
%	O
(	O
94	O
/	O
127	O
)	O
of	O
samples	O
from	O
32	O
swine	B-SPEC
-	O
raising	O
farms	O
in	O
15	O
provinces	O
were	O
positive	O
for	O
PEDV	B-SPEC
by	O
reverse	O
transcription	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
nested	O
PCR	O
).	O

Human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
has	O
not	O
been	O
confirmed	O
for	O
the	O
other	O
biological	O
agents	O
and	O
therefore	O
they	O
pose	O
a	O
very	O
low	O
risk	O
for	O
population	O
.	O

TITLE	O
:	O
Protection	O
of	O
chickens	B-SPEC
against	O
infectious	O
bronchitis	O
virus	B-SPEC
with	O
a	O
multivalent	O
DNA	O
vaccine	O
and	O
boosting	O
with	O
an	O
inactivated	O
vaccine	O
.	O

The	O
serum	O
antibody	O
titers	O
in	O
the	O
prime	O
-	O
boost	O
birds	B-SPEC
were	O
significantly	O
higher	O
than	O
those	O
of	O
the	O
multivalent	O
DNA	O
vaccine	O
group	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
but	O
not	O
significantly	O
different	O
compared	O
to	O
the	O
inactivated	O
vaccine	O
group	O
at	O
49	O
days	O
of	O
age	O
.	O

TITLE	O
:	O
Sequence	O
and	O
phylogenetic	O
analysis	O
of	O
nucleocapsid	O
genes	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
strains	O
in	O
China	O
.	O

To	O
obtain	O
data	O
that	O
would	O
facilitate	O
this	O
estimation	O
,	O
a	O
meta	B-SPEC
-	O
analysis	O
was	O
performed	O
on	O
the	O
data	O
from	O
18	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccination	O
-	O
challenge	O
experiments	O
performed	O
at	O
the	O
Dutch	O
Animal	B-SPEC
Health	O
Service	O
Deventer	O
,	O
the	O
Netherlands	O
(	O
GD	O
)	O
in	O
order	B-SPEC
to	O
determine	O
and	O
quantify	O
the	O
source	O
of	O
variation	O
in	O
the	O
mean	O
level	O
of	O
protection	O
of	O
different	O
groups	O
.	O

For	O
the	O
calculations	O
,	O
137	O
groups	O
of	O
chickens	B-SPEC
were	O
subdivided	O
into	O
10	O
clusters	O
based	O
on	O
age	O
(	O
young	O
or	O
adult	O
),	O
vaccination	O
(	O
none	O
,	O
homologous	O
or	O
heterologous	O
),	O
challenge	O
(	O
IBV	B-SPEC
or	O
mock	O
infected	O
)	O
and	O
location	O
of	O
vaccination	O
(	O
isolator	O
at	O
GD	O
or	O
in	O
the	O
field	O
).	O

The	O
results	O
were	O
used	O
to	O
estimate	O
the	O
required	O
number	O
of	O
chickens	B-SPEC
per	O
group	O
for	O
the	O
different	O
clusters	O
using	O
2	O
,	O
5	O
or	O
10	O
TOCs	O
per	O
chicken	B-SPEC
to	O
be	O
able	O
to	O
detect	O
effect	O
sizes	O
of	O
6	O
.	O
25	O
%,	O
12	O
.	O
5	O
%,	O
25	O
%	O
and	O
50	O
%	O
between	O
groups	O
of	O
chickens	B-SPEC
with	O
95	O
%	O
confidence	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
80	O
%	O
power	O
.	O

PMVEC	O
isolated	O
from	O
human	B-SPEC
lung	O
were	O
treated	O
in	O
vitro	O
with	O
septic	O
stimulation	O
(	O
lipopolysaccharide	O
[	O
LPS	O
],	O
a	O
mixture	O
of	O
clinically	O
-	O
relevant	O
cytokines	O
[	O
cytomix	O
],	O
or	O
plasma	O
from	O
patients	O
with	O
severe	O
sepsis	B-SPEC
),	O
and	O
the	O
trans	O
-	O
PMVEC	O
leak	O
of	O
Evans	O
Blue	O
dye	O
-	O
labeled	O
albumin	O
assessed	O
.	O

The	O
virus	B-SPEC
can	O
affect	O
the	O
upper	O
respiratory	O
tract	O
and	O
the	O
reproductive	O
tract	O
,	O
and	O
some	O
strains	O
can	O
cause	O
a	O
nephritis	O
.	O

TITLE	O
:	O
Deubiquitinase	O
function	O
of	O
arterivirus	B-SPEC
papain	O
-	O
like	O
protease	O
2	O
suppresses	O
the	O
innate	O
immune	O
response	O
in	O
infected	O
host	O
cells	O
.	O

Arteriviruses	B-SPEC
are	O
economically	O
important	O
positive	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
that	O
encode	O
an	O
ovarian	O
tumor	O
(	O
OTU	O
)	O
domain	O
DUB	O
known	O
as	O
papain	O
-	O
like	O
protease	O
2	O
(	O
PLP2	O
).	O

Our	O
findings	O
not	O
only	O
establish	O
PLP2	O
DUB	O
activity	O
as	O
a	O
critical	O
factor	O
in	O
arteriviral	O
innate	O
immune	O
evasion	O
,	O
but	O
the	O
selective	O
inactivation	O
of	O
DUB	O
activity	O
also	O
opens	O
unique	O
possibilities	O
for	O
developing	O
improved	O
live	O
attenuated	O
vaccines	O
against	O
arteriviruses	B-SPEC
and	O
other	O
viruses	B-SPEC
encoding	O
similar	O
dual	O
-	O
specificity	O
proteases	O
.	O

Plain	O
X	O
-	O
ray	B-SPEC
and	O
computed	O
tomography	O
scans	O
confirmed	O
the	O
presence	O
of	O
postpneumonectomy	O
-	O
like	O
syndrome	O
secondary	O
to	O
his	O
parenchymal	O
lung	O
destruction	O
.	O

ABSTRACT	O
:	O
The	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
)	O
K37	O
strain	O
of	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
,	O
group	O
2	O
,	O
was	O
isolated	O
in	O
South	O
Korea	O
.	O

When	O
OSA	B-SPEC
is	O
diagnosed	O
preoperatively	O
,	O
the	O
rate	O
of	O
postoperative	O
pulmonary	O
complications	O
is	O
low	O
and	O
not	O
associated	O
with	O
OSA	B-SPEC
severity	O
.	O

Strategies	O
based	O
on	O
preoperative	O
and	O
immediate	O
postoperative	O
clinical	O
signs	O
and	O
symptoms	O
can	O
help	O
identify	O
patients	O
with	O
a	O
high	O
likelihood	O
of	O
OSA	B-SPEC
,	O
postoperative	O
desaturations	O
,	O
and	O
pulmonary	O
complications	O
.	O

TITLE	O
:	O
Low	O
-	O
dose	O
interferon	O
-	O
α	O
treatment	O
improves	O
survival	O
and	O
inflammatory	O
responses	O
in	O
a	O
mouse	B-SPEC
model	O
of	O
fulminant	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Therefore	O
,	O
we	O
investigated	O
how	O
this	O
cytokine	O
affected	O
ARDS	O
in	O
a	O
mouse	B-SPEC
model	O
.	O

Administration	O
of	O
low	O
-	O
dose	O
IFN	O
-	O
α	O
prolonged	O
survival	O
of	O
fulminant	O
ARDS	O
mice	B-SPEC
,	O
but	O
higher	O
doses	O
of	O
IFN	O
-	O
α	O
did	O
not	O
.	O

The	O
circulation	O
of	O
highly	O
variable	O
CCoV	O
-	O
I	O
and	O
CCoV	O
-	O
IIb	O
emerging	O
strains	O
,	O
as	O
well	O
as	O
the	O
detection	O
of	O
the	O
divergent	O
strain	O
,	O
raise	O
concerns	O
on	O
the	O
importance	O
of	O
these	O
new	O
strains	O
as	O
primary	O
pathogens	O
of	O
diarrhoeic	O
syndromes	O
diagnosed	O
in	O
dogs	B-SPEC
.	O

The	O
infection	O
rates	O
were	O
15	O
.	O
8	O
%	O
for	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
14	O
.	O
4	O
&	O
percnt	O
;	O
for	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
,	O
9	O
.	O
7	O
%	O
for	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
B	O
,	O
10	O
.	O
1	O
%	O
for	O
human	B-SPEC
adenovirus	B-SPEC
,	O
5	O
.	O
4	O
%	O
for	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
1	O
.	O
7	O
%	O
for	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
,	O
4	O
.	O
7	O
%	O
for	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
2	O
.	O
3	O
%	O
for	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
,	O
1	O
.	O
9	O
%	O
for	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
/	O
NL63	O
,	O
3	O
.	O
7	O
%	O
for	O
human	B-SPEC
parainfluenza	O
virus	B-SPEC
(	O
HPIV	B-SPEC
)-	O
1	O
,	O
1	O
.	O
1	O
%	O
for	O
HPIV	B-SPEC
-	O
2	O
,	O
and	O
5	O
.	O
3	O
%	O
for	O
HPIV	B-SPEC
-	O
3	O
.	O

ABSTRACT	O
:	O
In	O
continuation	O
of	O
our	O
efforts	O
toward	O
identification	O
and	O
optimization	O
of	O
novel	O
non	O
-	O
nucleoside	O
reverse	O
transcriptase	O
inhibitors	O
(	O
NNRTIs	O
),	O
we	O
have	O
employed	O
a	O
structure	O
-	O
based	O
bioisosterism	O
strategy	O
,	O
with	O
which	O
a	O
new	O
series	O
of	O
diarylpyridazine	O
(	O
DAPD	O
)	O
derivatives	O
were	O
synthesized	O
and	O
evaluated	O
for	O
their	O
anti	O
-	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
(	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
)	O
activity	O
.	O

Culturing	O
primary	O
human	B-SPEC
alveolar	O
type	O
II	O
cells	O
at	O
an	O
air	O
-	O
liquid	O
interface	O
(	O
A	O
/	O
L	O
)	O
improved	O
their	O
differentiation	O
and	O
greatly	O
increased	O
their	O
susceptibility	O
to	O
infection	O
,	O
allowing	O
us	O
to	O
define	O
their	O
primary	O
interferon	O
and	O
chemokine	O
responses	O
.	O

TITLE	O
:	O
Discovery	O
and	O
SARs	O
of	O
trans	O
-	O
3	O
-	O
aryl	O
acrylic	O
acids	O
and	O
their	O
analogs	O
as	O
novel	O
anti	O
-	O
tobacco	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
(	O
TMV	B-SPEC
)	O
agents	O
.	O

ABSTRACT	O
:	O
A	O
series	O
of	O
trans	O
-	O
3	O
-	O
aryl	O
acrylic	O
acids	O
1	O
-	O
27	O
and	O
their	O
derivatives	O
28	O
-	O
34	O
were	O
prepared	O
and	O
evaluated	O
for	O
their	O
antiviral	O
activity	O
against	O
tobacco	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
(	O
TMV	B-SPEC
)	O
for	O
the	O
first	O
time	O
.	O

Surprisingly	O
,	O
by	O
visualizing	O
HCoV	O
infection	O
by	O
confocal	O
microscopy	O
,	O
we	O
observed	O
that	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
employs	O
a	O
target	O
cell	O
tropism	O
for	O
nonciliated	O
cells	O
,	O
whereas	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
HCoV	O
-	O
HKU1	O
,	O
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
all	O
infect	O
ciliated	O
cells	O
.	O

Collectively	O
,	O
the	O
data	O
demonstrate	O
that	O
HAE	O
cell	O
cultures	O
,	O
which	O
morphologically	O
and	O
functionally	O
resemble	O
human	B-SPEC
airways	O
in	O
vivo	O
,	O
represent	O
a	O
robust	O
universal	O
culture	O
system	O
for	O
isolating	O
and	O
comparing	O
all	O
contemporary	O
HCoV	O
strains	O
.	O

In	O
contrast	O
,	O
mesentery	O
and	O
kidney	O
from	O
FIP	O
cats	B-SPEC
did	O
not	O
show	O
any	O
difference	O
when	O
compared	O
to	O
healthy	O
non	O
-	O
infected	O
control	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
recent	O
years	O
,	O
pharmaceutical	O
chemists	O
have	O
synthesized	O
large	O
numbers	O
of	O
andrographolide	O
derivatives	O
,	O
which	O
bear	B-SPEC
important	O
biological	O
activities	O
such	O
as	O
anti	O
-	O
inflammatory	O
,	O
antibacterial	O
,	O
antivirus	O
,	O
antitumor	O
,	O
antidiabetic	O
,	O
and	O
antifeedant	O
.	O

We	O
demonstrate	O
that	O
HCoV	O
-	O
EMC	O
resembles	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
productively	O
infecting	O
primary	O
and	O
continuous	O
cells	O
of	O
the	O
human	B-SPEC
airways	O
and	O
in	O
preventing	O
the	O
induction	O
of	O
interferon	O
regulatory	O
factor	O
3	O
(	O
IRF	O
-	O
3	O
)-	O
mediated	O
antiviral	O
alpha	O
/	O
beta	O
interferon	O
(	O
IFN	O
-	O
α	O
/	O
β	O
)	O
responses	O
.	O

The	O
immune	O
reaction	O
of	O
granuloma	O
formation	O
evolved	O
in	O
order	B-SPEC
to	O
combat	O
mycobacteria	B-SPEC
with	O
the	O
aim	O
of	O
localizing	O
mycobacteria	B-SPEC
and	O
to	O
avoid	O
spreading	O
of	O
mycobacteria	B-SPEC
throughout	O
the	O
body	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
on	O
S	O
.	O
agalactiae	O
natural	O
infection	O
in	O
domestic	B-SPEC
rabbits	I-SPEC
.	O

TITLE	O
:	O
The	O
spike	O
protein	O
of	O
the	O
emerging	O
betacoronavirus	B-SPEC
EMC	O
uses	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
receptor	O
for	O
entry	O
,	O
can	O
be	O
activated	O
by	O
TMPRSS2	O
,	O
and	O
is	O
targeted	O
by	O
neutralizing	O
antibodies	O
.	O

We	O
found	O
that	O
the	O
spike	O
protein	O
of	O
hCoV	O
-	O
EMC	O
(	O
EMC	O
-	O
S	O
)	O
is	O
incorporated	O
into	O
lentiviral	O
particles	O
and	O
mediates	O
transduction	O
of	O
human	B-SPEC
cell	O
lines	O
derived	O
from	O
different	O
organs	O
,	O
including	O
the	O
lungs	O
,	O
kidneys	O
,	O
and	O
colon	O
,	O
as	O
well	O
as	O
primary	O
human	B-SPEC
macrophages	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	B-SPEC
(	O
including	O
adenovirus	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
rhinovirus	B-SPEC
)	O
cause	O
a	O
broad	O
spectrum	O
of	O
disease	O
in	O
humans	B-SPEC
,	O
ranging	O
from	O
mild	O
influenza	O
-	O
like	O
symptoms	O
to	O
acute	O
respiratory	O
failure	O
.	O

Research	O
utilizing	O
in	O
vitro	O
and	O
in	O
vivo	O
models	O
to	O
study	O
the	O
ability	O
of	O
respiratory	O
viruses	B-SPEC
to	O
use	O
the	O
eye	O
as	O
a	O
portal	O
of	O
entry	O
as	O
well	O
as	O
a	O
primary	O
site	O
of	O
virus	B-SPEC
replication	O
is	O
highlighted	O
.	O

Birds	B-SPEC
without	O
clinical	O
signs	O
most	O
frequently	O
harbored	O
TAstV	O
-	O
1	O
and	O
rotavirus	B-SPEC
.	O

Prevaccination	O
antibody	O
titers	O
to	O
Newcastle	O
disease	O
,	O
infectious	O
bronchitis	O
,	O
and	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
were	O
higher	O
in	O
HYPER	O
chicks	O
during	O
1	O
wk	O
of	O
age	O
,	O
although	O
not	O
different	O
in	O
their	O
dams	O
.	O

We	O
apply	O
it	O
to	O
assess	O
the	O
transmissibility	O
of	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
H3N2v	O
-	O
M	O
virus	B-SPEC
in	O
the	O
US	O
,	O
Nipah	B-SPEC
virus	I-SPEC
in	O
Malaysia	O
and	O
Bangladesh	O
,	O
and	O
also	O
present	O
a	O
non	O
-	O
zoonotic	O
example	O
(	O
cholera	O
in	O
the	O
Dominican	O
Republic	O
).	O

TITLE	O
:	O
Serological	O
evidence	O
of	O
Toxoplasma	B-SPEC
gondii	I-SPEC
infection	O
in	O
five	O
species	B-SPEC
of	O
bats	B-SPEC
in	O
China	O
.	O

Antibody	O
titers	O
ranged	O
from	O
1	O
:	O
25	O
to	O
1	O
:	O
400	O
,	O
with	O
titers	O
of	O
1	O
:	O
200	O
detected	O
in	O
4	O
of	O
the	O
5	O
bat	B-SPEC
species	B-SPEC
.	O

Studies	O
with	O
hamsters	B-SPEC
demonstrated	O
that	O
in	O
leptospirosis	O
a	O
noncardiogenic	O
pulmonary	O
edema	O
occurs	O
consequently	O
to	O
a	O
decrease	O
in	O
the	O
clearance	O
of	O
alveolar	O
fluid	O
,	O
due	O
to	O
a	O
decrease	O
in	O
sodium	O
transporter	O
in	O
the	O
luminal	O
membrane	O
(	O
ENaC	O
)	O
and	O
an	O
increase	O
in	O
the	O
NKCC1	O
basolateral	O
membrane	O
transporter	O
.	O

Viral	O
genome	O
analysis	O
revealed	O
close	O
relatedness	O
to	O
coronaviruses	O
found	O
in	O
bats	B-SPEC
.	O

In	O
addition	O
,	O
it	O
will	O
contribute	O
critically	O
to	O
our	O
understanding	O
of	O
the	O
pathogenesis	O
and	O
epidemiology	O
of	O
this	O
emerging	O
human	B-SPEC
coronavirus	I-SPEC
,	O
and	O
may	O
facilitate	O
the	O
development	O
of	O
intervention	O
strategies	O
.	O

TITLE	O
:	O
Update	O
:	O
severe	O
respiratory	O
illness	O
associated	O
with	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
--	O
worldwide	O
,	O
2012	O
-	O
2013	O
.	O

ABSTRACT	O
:	O
CDC	O
continues	O
to	O
work	O
closely	O
with	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
and	O
other	O
partners	O
to	O
better	O
understand	O
the	O
public	O
health	O
risk	O
posed	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
was	O
first	O
reported	O
to	O
cause	O
human	B-SPEC
infection	O
in	O
September	O
2012	O
.	O

As	O
of	O
March	O
7	O
,	O
2013	O
,	O
a	O
total	O
of	O
14	O
confirmed	O
cases	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
infection	O
have	O
been	O
reported	O
to	O
WHO	O
,	O
with	O
eight	O
deaths	O
.	O

Co	O
-	O
infection	O
with	O
HIV	B-SPEC
was	O
relatively	O
common	O
but	O
compared	O
to	O
studies	O
in	O
children	O
,	O
bacteraemia	O
was	O
uncommon	O
.	O

In	O
addition	O
,	O
we	O
showed	O
that	O
,	O
in	O
cells	O
transfected	O
with	O
plasmids	O
that	O
encoded	O
the	O
mutant	O
(	O
R106A	O
)	O
N	O
protein	O
and	O
infected	O
with	O
virus	B-SPEC
,	O
the	O
level	O
of	O
the	O
matrix	O
protein	O
gene	O
was	O
decreased	O
by	O
7	O
-	O
fold	O
compared	O
to	O
cells	O
that	O
were	O
transfected	O
with	O
the	O
wild	O
-	O
type	O
N	O
protein	O
.	O

The	O
results	O
also	O
indicate	O
that	O
the	O
strength	O
of	O
N	O
protein	O
/	O
RNA	O
interactions	O
is	O
critical	O
for	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
replication	O
.	O

TITLE	O
:	O
Detection	O
of	O
Alphacoronavirus	B-SPEC
in	O
velvety	O
free	B-SPEC
-	I-SPEC
tailed	I-SPEC
bats	I-SPEC
(	O
Molossus	B-SPEC
molossus	I-SPEC
)	O
and	O
Brazilian	B-SPEC
free	I-SPEC
-	I-SPEC
tailed	I-SPEC
bats	I-SPEC
(	O
Tadarida	B-SPEC
brasiliensis	I-SPEC
)	O
from	O
urban	O
area	O
of	O
Southern	O
Brazil	O
.	O

Our	O
findings	O
point	O
to	O
the	O
need	O
for	O
risk	O
assessment	O
and	O
continued	O
surveillance	O
of	O
coronavirus	B-SPEC
infections	O
of	O
bats	B-SPEC
in	O
Brazil	O
.	O

Total	O
47	O
patients	O
fulfilling	O
criterion	O
of	O
complicated	O
malaria	O
due	O
to	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
who	O
presented	O
with	O
fever	O
having	O
positive	O
trophozoites	O
of	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
in	O
blood	O
smear	O
were	O
included	O
in	O
this	O
study	O
.	O

Sepsis	B-SPEC
is	O
characterized	O
by	O
dysfunctional	O
activation	O
of	O
platelets	O
,	O
and	O
antiplatelet	O
therapy	O
could	O
improve	O
the	O
outcomes	O
of	O
septic	O
patients	O
.	O

In	O
a	O
small	O
percentage	O
of	O
cats	B-SPEC
,	O
FCoV	O
infection	O
is	O
associated	O
with	O
the	O
fatal	O
disease	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

Genetically	O
distinct	O
virulent	O
and	O
avirulent	O
strains	O
of	O
FCoV	O
might	O
coexist	O
within	O
a	O
cat	B-SPEC
population	O
.	O

To	O
determine	O
whether	O
the	O
strains	O
of	O
FCoV	O
in	O
FIP	O
-	O
affected	O
cats	B-SPEC
are	O
closely	O
related	O
or	O
genetically	O
distinct	O
from	O
the	O
fecally	O
derived	O
strains	O
of	O
FCoV	O
in	O
contemporary	O
-	O
asymptomatic	O
cats	B-SPEC
during	O
an	O
epizootic	O
outbreak	O
of	O
FIP	O
.	O

Four	O
cats	B-SPEC
euthanized	O
because	O
of	O
FIP	O
and	O
16	O
asymptomatic	O
cats	B-SPEC
.	O

This	O
prospective	O
outbreak	O
investigation	O
was	O
initiated	O
during	O
an	O
outbreak	O
of	O
FIP	O
in	O
cats	B-SPEC
within	O
or	O
rehomed	O
from	O
a	O
rescue	O
/	O
rehoming	O
center	O
.	O

TITLE	O
:	O
Evidence	O
of	O
person	O
-	O
to	O
-	O
person	O
transmission	O
within	O
a	O
family	B-SPEC
cluster	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
infections	O
,	O
United	O
Kingdom	B-SPEC
,	O
February	O
2013	O
.	O

ABSTRACT	O
:	O
In	O
February	O
2013	O
,	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
nCoV	O
)	O
infection	O
was	O
diagnosed	O
in	O
an	O
adult	O
male	O
in	O
the	O
United	O
Kingdom	B-SPEC
with	O
severe	O
respiratory	O
illness	O
,	O
who	O
had	O
travelled	O
to	O
Pakistan	O
and	O
Saudi	O
Arabia	O
10	O
days	O
before	O
symptom	O
onset	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
develop	O
a	O
nested	O
polymerase	O
chain	O
reaction	O
(	O
nested	O
PCR	O
)	O
for	O
the	O
rapid	O
detection	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
of	O
pigs	B-SPEC
.	O

Two	O
Histophilus	B-SPEC
somni	I-SPEC
-	O
associated	O
syndromes	O
were	O
identified	O
:	O
systemic	O
histophilosis	O
(	O
n	O
=	O
4	O
)	O
and	O
abortion	O
(	O
n	O
=	O
1	O
).	O

These	O
findings	O
confirm	O
the	O
participation	O
of	O
H	B-SPEC
.	I-SPEC
somni	I-SPEC
in	O
the	O
pathological	O
alterations	O
observed	O
in	O
this	O
study	O
and	O
represent	O
the	O
first	O
description	O
of	O
histophilosis	O
in	O
cattle	B-SPEC
from	O
Brazil	O
.	O

At	O
35	O
days	O
post	O
-	O
immunization	O
,	O
the	O
recombinant	O
DNA	O
plasmids	O
bearing	O
full	O
-	O
length	O
S	O
genes	O
of	O
TGEV	B-SPEC
and	O
PEDV	B-SPEC
stimulated	O
higher	O
levels	O
of	O
specific	O
antibodies	O
and	O
neutralizing	O
antibodies	O
in	O
immunized	O
mice	B-SPEC
.	O

The	O
catalytic	O
domain	O
of	O
TMPRSS2	O
was	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
used	O
for	O
an	O
inhibitor	O
screen	O
with	O
previously	O
synthesized	O
inhibitors	O
of	O
various	O
trypsin	O
-	O
like	O
serine	O
proteases	O
.	O

ABSTRACT	O
:	O
The	O
emerging	O
novel	O
human	B-SPEC
betacoronavirus	B-SPEC
2c	O
EMC	O
/	O
2012	O
(	O
HCoV	O
-	O
EMC	O
)	O
was	O
recently	O
isolated	O
from	O
patients	O
with	O
severe	O
pneumonia	O
and	O
renal	O
failure	O
and	O
was	O
associated	O
with	O
an	O
unexplained	O
high	O
crude	O
fatality	O
rate	O
of	O
56	O
%.	O

In	O
order	B-SPEC
of	O
frequency	O
,	O
identified	O
pathogens	O
were	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
32	O
.	O
0	O
%),	O
adenovirus	B-SPEC
(	O
26	O
.	O
2	O
%),	O
parainfluenza	O
viruses	B-SPEC
type	O
1	O
-	O
4	O
(	O
19	O
.	O
4	O
%),	O
rhinovirus	B-SPEC
(	O
18	O
.	O
4	O
%),	O
influenza	O
A	O
and	O
B	O
(	O
12	O
.	O
6	O
%),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
12	O
.	O
6	O
%),	O
coronavirus	B-SPEC
(	O
2	O
.	O
9	O
%),	O
and	O
bocavirus	B-SPEC
(	O
0	O
.	O
9	O
%).	O

The	O
synthesized	O
2	O
-(	O
3	O
-	O
amino	O
-	O
4	O
-	O
piperazinylphenyl	O
)-	O
chromones	O
showed	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
corona	B-SPEC
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)-	O
specific	O
antiviral	O
activity	O
.	O

During	O
this	O
process	O
,	O
gene	O
recombinations	O
often	O
occur	O
,	O
resulting	O
in	O
novel	O
subtype	O
or	O
coronavirus	B-SPEC
emerge	O
constantly	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
T	O
-	O
cell	O
Immunoglobulin	O
and	O
Mucin	O
-	O
domain	O
containing	O
proteins	O
(	O
TIM1	O
,	O
3	O
,	O
and	O
4	O
)	O
specifically	O
bind	O
phosphatidylserine	O
(	O
PS	O
).	O

Taken	O
together	O
our	O
data	O
show	O
that	O
TIM1	O
and	O
related	O
PS	O
-	O
binding	O
proteins	O
promote	O
infection	O
of	O
diverse	O
families	O
of	O
enveloped	O
viruses	B-SPEC
,	O
and	O
may	O
therefore	O
be	O
useful	O
targets	O
for	O
broad	O
-	O
spectrum	O
antiviral	O
therapies	O
.	O

The	O
present	O
study	O
for	O
the	O
first	O
time	O
has	O
documented	O
significantly	O
increased	O
MCs	O
in	O
CPV	B-SPEC
-	O
2	O
-	O
associated	O
ECA	O
as	O
was	O
previously	O
reported	O
for	O
IBD	O
,	O
showing	O
that	O
MCs	O
may	O
also	O
play	O
an	O
important	O
role	O
in	O
CPV	B-SPEC
-	O
2	O
-	O
associated	O
ECA	O
.	O

Further	O
studies	O
involving	O
more	O
CPV	B-SPEC
-	O
infected	O
dogs	B-SPEC
are	O
recommended	O
to	O
substantiate	O
the	O
findings	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
N	O
protein	O
prolongs	O
S	O
-	O
phase	O
cell	O
cycle	O
,	O
induces	O
endoplasmic	O
reticulum	O
stress	O
,	O
and	O
up	O
-	O
regulates	O
interleukin	O
-	O
8	O
expression	O
.	O

The	O
results	O
show	O
that	O
the	O
PEDV	B-SPEC
N	O
protein	O
localizes	O
in	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
),	O
inhibits	O
the	O
IEC	O
growth	O
and	O
prolongs	O
S	O
-	O
phase	O
cell	O
cycle	O
.	O

The	O
IEC	O
expressing	O
PEDV	B-SPEC
N	O
protein	O
can	O
express	O
higher	O
levels	O
of	O
IL	O
-	O
8	O
than	O
control	O
cells	O
.	O

Characterising	O
the	O
viruses	B-SPEC
of	O
candidate	O
reservoir	O
species	B-SPEC
in	O
geographical	O
hot	O
spots	B-SPEC
for	O
viral	O
emergence	O
is	O
a	O
sensible	O
approach	O
to	O
develop	O
tools	O
to	O
predict	O
,	O
prevent	O
,	O
or	O
contain	O
emergence	O
events	O
.	O

These	O
habitat	O
impacts	O
could	O
enhance	O
disease	O
risk	O
by	O
increasing	O
contact	O
with	O
domestic	O
animals	B-SPEC
and	O
by	O
altering	O
patterns	O
of	O
exposure	O
to	O
other	O
wild	O
felids	B-SPEC
.	O

In	O
May	O
2010	O
,	O
a	O
malnourished	O
young	O
adult	O
male	O
mountain	O
lion	B-SPEC
(	O
Puma	B-SPEC
concolor	I-SPEC
)	O
from	O
Kern	O
County	O
,	O
California	B-SPEC
,	O
USA	O
was	O
euthanized	O
because	O
of	O
concern	O
for	O
public	O
safety	O
,	O
and	O
a	O
postmortem	O
examination	O
was	O
performed	O
.	O

Although	O
coronavirus	B-SPEC
infection	O
has	O
been	O
documented	O
in	O
mountain	O
lions	B-SPEC
by	O
serology	O
,	O
this	O
is	O
the	O
first	O
confirmed	O
report	O
of	O
FIP	O
.	O

In	O
premature	O
infants	O
,	O
CMV	B-SPEC
infection	O
is	O
often	O
protracted	O
and	O
causes	O
a	O
diffuse	O
interstitial	O
pneumonitis	O
leading	O
to	O
fibrosis	O
and	O
bronchopulmonary	O
dysplasia	O
(	O
BPD	O
).	O

Data	O
on	O
the	O
efficacy	O
of	O
antiviral	O
therapy	O
for	O
infants	O
with	O
respiratory	O
CMV	B-SPEC
diseases	O
are	O
lacking	O
and	O
only	O
anecdotal	O
case	O
reports	O
are	O
available	O
.	O

Since	O
then	O
,	O
the	O
threat	O
of	O
H5N1	O
avian	B-SPEC
influenza	O
,	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
epidemic	O
,	O
and	O
the	O
2009	O
H1N1	O
influenza	O
pandemic	O
have	O
underscored	O
the	O
importance	O
of	O
considering	O
infectious	O
events	O
within	O
such	O
a	O
framework	O
.	O

Influenza	B-SPEC
virus	I-SPEC
was	O
associated	O
with	O
a	O
substantial	O
amount	O
of	O
severe	O
disease	O
in	O
Kenya	O
and	O
Guatemala	O
.	O

ABSTRACT	O
:	O
Zoonotic	O
coronaviruses	O
,	O
including	O
the	O
one	O
that	O
caused	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
cause	O
significant	O
morbidity	O
and	O
mortality	O
in	O
humans	B-SPEC
.	O

We	O
previously	O
showed	O
that	O
recombinant	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
(	O
Urbani	O
strain	O
based	O
)	O
lacking	O
envelope	O
(	O
E	O
)	O
protein	O
expression	O
(	O
rU	O
-	O
ΔE	O
)	O
provided	O
good	O
but	O
not	O
perfect	O
protection	O
in	O
young	O
mice	B-SPEC
against	O
challenge	O
with	O
virulent	O
mouse	B-SPEC
-	O
adapted	O
SARS	O
-	O
CoV	O
(	O
MA15	O
).	O

This	O
approach	O
will	O
be	O
generally	O
useful	O
for	O
development	O
of	O
vaccines	O
protective	O
against	O
human	B-SPEC
coronaviruses	O
as	O
well	O
as	O
against	O
coronaviruses	O
that	O
cause	O
disease	O
in	O
domestic	O
and	O
companion	O
animals	B-SPEC
.	O

Sequencing	O
analyses	O
revealed	O
that	O
all	O
the	O
genes	O
from	O
these	O
three	O
viruses	B-SPEC
were	O
of	O
avian	B-SPEC
origin	O
,	O
with	O
six	O
internal	O
genes	O
from	O
avian	B-SPEC
influenza	O
A	O
(	O
H9N2	O
)	O
viruses	B-SPEC
.	O

RESULTS	O
:	O
A	O
novel	O
reassortant	O
avian	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
was	O
isolated	O
from	O
respiratory	O
specimens	O
obtained	O
from	O
all	O
three	O
patients	O
and	O
was	O
identified	O
as	O
H7N9	O
.	O

ABSTRACT	O
:	O
Immobilized	O
fibrinogen	O
and	O
fibrin	O
facilitate	O
leukocyte	O
adhesion	O
,	O
as	O
they	O
are	O
potent	O
ligands	O
for	O
leukocyte	O
MAC	B-SPEC
-	O
1	O
(	O
CD11b	O
/	O
CD18	O
).	O

Soluble	O
fibrinogen	O
functioned	O
as	O
a	O
natural	O
antagonist	O
of	O
neutrophil	O
functions	O
that	O
are	O
dependent	O
on	O
MAC	B-SPEC
-	O
1	O
,	O
such	O
as	O
the	O
respiratory	O
burst	O
induced	O
by	O
unopsonized	O
zymosan	O
and	O
adhesion	O
to	O
ICAM	O
-	O
1	O
and	O
heparin	O
.	O

RESULTS	O
:	O
Two	O
(	O
2	O
.	O
1	O
%)	O
animal	B-SPEC
handlers	O
had	O
IF	O
antibody	O
titer	O
of	O
≥	O
1	O
:	O
20	O
against	O
both	O
HCoV	O
-	O
EMC	O
and	O
SARS	O
-	O
CoV	O
with	O
neutralizing	O
antibody	O
titer	O
of	O
<	O
1	O
:	O
10	O
.	O

Subsequently	O
,	O
either	O
S1	O
or	O
nucleocapsid	O
(	O
N	O
)	O
genes	O
of	O
IBV	B-SPEC
were	O
positioned	O
between	O
AMPV	O
M	O
and	O
F	O
genes	O
,	O
while	O
later	O
a	O
bivalent	O
recombinant	O
was	O
prepared	O
by	O
inserting	O
S1	O
and	O
N	O
at	O
AMPV	O
MF	O
and	O
GL	O
junctions	O
respectively	O
.	O

Human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
has	O
not	O
been	O
observed	O
,	O
but	O
zoonotic	O
infections	O
of	O
nrH7N9	O
from	O
birds	B-SPEC
to	O
humans	B-SPEC
appear	O
to	O
be	O
associated	O
with	O
live	O
poultry	O
markets	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
a	O
family	B-SPEC
of	O
large	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
that	O
are	O
responsible	O
for	O
a	O
wide	O
range	O
of	O
important	O
veterinary	O
and	O
human	B-SPEC
diseases	O
.	O

ABSTRACT	O
:	O
We	O
present	O
a	O
serological	O
assay	O
for	O
the	O
specific	O
detection	O
of	O
IgM	O
and	O
IgG	O
antibodies	O
against	O
the	O
emerging	O
human	B-SPEC
coronavirus	I-SPEC
hCoV	O
-	O
EMC	O
and	O
the	O
SARS	O
-	O
CoV	O
based	O
on	O
protein	O
microarray	O
technology	O
.	O

We	O
identified	O
PEDV	B-SPEC
replicase	O
encoded	O
papain	O
-	O
like	O
protease	O
2	O
(	O
PLP2	O
)	O
as	O
an	O
IFN	O
antagonist	O
that	O
depends	O
on	O
catalytic	O
activity	O
for	O
its	O
function	O
.	O

As	O
a	O
model	O
of	O
infectious	O
disease	O
-	O
related	O
small	O
DNA	O
molecules	O
,	O
the	O
spike	O
glycoprotein	O
(	O
S	O
)	O
gene	O
of	O
the	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
virus	B-SPEC
was	O
amplified	O
using	O
reverse	O
transcript	O
polymerase	O
chain	O
reaction	O
.	O

In	O
order	B-SPEC
to	O
identify	O
optimal	O
ventilation	O
strategies	O
to	O
limit	O
VILI	O
and	O
treat	O
ARDS	O
,	O
it	O
is	O
necessary	O
to	O
understand	O
the	O
complex	O
interplay	O
between	O
biological	O
and	O
physical	O
mechanisms	O
of	O
VILI	O
,	O
first	O
at	O
the	O
alveolar	O
level	O
,	O
and	O
then	O
in	O
aggregate	O
at	O
the	O
whole	O
-	O
lung	O
level	O
.	O

Virus	B-SPEC
-	O
based	O
ELISA	O
demonstrated	O
that	O
MAb	O
7G7	O
can	O
be	O
used	O
as	O
a	O
highly	O
specific	O
diagnostic	O
reagent	O
for	O
TGEV	B-SPEC
.	O

The	O
viral	O
spike	O
(	O
S	O
)	O
protein	O
of	O
TGEV	B-SPEC
mediates	O
interaction	O
between	O
TGEV	B-SPEC
and	O
its	O
susceptible	O
cells	O
.	O

No	O
surviving	O
virus	B-SPEC
was	O
detected	O
after	O
10	O
days	O
storage	O
at	O
+	O
21	O
.	O
6	O
±	O
1	O
.	O
4	O
°	O
C	O
or	O
after	O
40	O
days	O
storage	O
at	O
+	O
4	O
.	O
1	O
±	O
1	O
.	O
6	O
°	O
C	O
,	O
these	O
temperatures	O
being	O
representative	O
of	O
the	O
mean	O
summer	O
and	O
winter	O
temperatures	O
,	O
respectively	O
,	O
in	O
the	O
major	O
French	O
poultry	O
-	O
producing	O
region	O
.	O

During	O
the	O
hospital	O
stay	O
,	O
hypoxaemia	O
was	O
persistent	O
with	O
very	O
little	O
improvement	O
of	O
pneumonia	O
;	O
a	O
number	O
of	O
differentials	O
,	O
such	O
as	O
pneumocystis	B-SPEC
jirovecii	I-SPEC
pneumonia	O
,	O
lymph	O
-	O
node	O
tuberculosis	O
,	O
were	O
added	O
to	O
the	O
problems	O
.	O

DNA	O
from	O
38	O
Birman	O
cats	B-SPEC
that	O
died	O
of	O
FIP	O
and	O
161	O
healthy	O
cats	B-SPEC
from	O
breeders	O
in	O
Denmark	O
and	O
USA	O
were	O
selected	O
for	O
genotyping	O
using	O
63K	O
SNPs	O
distributed	O
across	O
the	O
feline	B-SPEC
genome	O
.	O

The	O
2003	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
highlighted	O
the	O
potentially	O
lethal	O
consequences	O
of	O
CoV	O
-	O
induced	O
disease	O
in	O
humans	B-SPEC
.	O

Viruses	B-SPEC
related	O
to	O
the	O
novel	O
human	B-SPEC
betacoronavirus	B-SPEC
EMC	O
/	O
2012	O
were	O
detected	O
in	O
46	O
(	O
24	O
.	O
9	O
%)	O
of	O
185	O
Nycteris	B-SPEC
bats	B-SPEC
and	O
40	O
(	O
14	O
.	O
7	O
%)	O
of	O
272	O
Pipistrellus	B-SPEC
bats	B-SPEC
.	O

Their	O
genetic	O
relatedness	O
indicated	O
EMC	O
/	O
2012	O
originated	O
from	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
develop	O
and	O
optimize	O
the	O
molecular	O
detection	O
assays	O
for	O
recently	O
identified	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
infection	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
assembles	O
into	O
virions	O
via	O
its	O
carboxy	O
-	O
terminus	O
,	O
which	O
is	O
composed	O
of	O
a	O
transmembrane	O
domain	O
and	O
an	O
endodomain	O
.	O

Of	O
these	O
,	O
7	O
risk	O
factors	O
were	O
significantly	O
associated	O
with	O
severe	O
ALRI	O
in	O
a	O
consistent	O
manner	O
across	O
studies	O
,	O
with	O
the	O
following	O
meta	B-SPEC
-	O
analysis	O
estimates	O
of	O
odds	O
ratios	O
(	O
with	O
95	O
%	O
confidence	O
intervals	O
):	O
low	O
birth	O
weight	O
3	O
.	O
18	O
(	O
1	O
.	O
02	O
-	O
9	O
.	O
90	O
),	O
lack	O
of	O
exclusive	O
breastfeeding	O
2	O
.	O
34	O
(	O
1	O
.	O
42	O
-	O
3	O
.	O
88	O
),	O
crowding	O
-	O
more	O
than	O
7	O
persons	O
per	O
household	O
1	O
.	O
96	O
(	O
1	O
.	O
53	O
-	O
2	O
.	O
52	O
),	O
exposure	O
to	O
indoor	O
air	O
pollution	O
1	O
.	O
57	O
(	O
1	O
.	O
06	O
-	O
2	O
.	O
31	O
),	O
incomplete	O
immunization	O
1	O
.	O
83	O
(	O
1	O
.	O
32	O
-	O
2	O
.	O
52	O
),	O
undernutrition	O
-	O
weight	O
-	O
for	O
-	O
age	O
less	O
than	O
2	O
standard	O
deviations	O
4	O
.	O
47	O
(	O
2	O
.	O
10	O
-	O
9	O
.	O
49	O
),	O
and	O
HIV	B-SPEC
infection	O
4	O
.	O
15	O
(	O
2	O
.	O
57	O
-	O
9	O
.	O
74	O
).	O

When	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
less	O
common	O
viruses	B-SPEC
were	O
included	O
,	O
at	O
least	O
one	O
virus	B-SPEC
was	O
detected	O
in	O
50	O
.	O
4	O
%	O
(	O
40	O
.	O
0	O
%-	O
60	O
.	O
7	O
%)	O
of	O
all	O
hospitalized	O
severe	O
ALRI	O
episodes	O
.	O

Our	O
results	O
can	O
be	O
used	O
in	O
further	O
cost	O
-	O
effectiveness	O
analyses	O
of	O
vaccine	O
development	O
and	O
implementation	O
for	O
a	O
number	O
of	O
respiratory	O
viruses	B-SPEC
.	O

Identification	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
causing	O
fatal	O
respiratory	O
infection	O
in	O
humans	B-SPEC
raises	O
concerns	O
about	O
a	O
possible	O
widespread	O
outbreak	O
of	O
severe	O
respiratory	O
infection	O
similar	O
to	O
the	O
one	O
caused	O
by	O
SARS	O
-	O
CoV	O
.	O
Using	O
a	O
human	B-SPEC
lung	O
epithelial	O
cell	O
line	O
and	O
global	O
transcriptomic	O
profiling	O
,	O
we	O
identified	O
differences	O
in	O
the	O
host	O
response	O
between	O
HCoV	O
-	O
EMC	O
and	O
SARS	O
-	O
CoV	O
.	O
This	O
enables	O
rapid	O
assessment	O
of	O
viral	O
properties	O
and	O
the	O
ability	O
to	O
anticipate	O
possible	O
differences	O
in	O
human	B-SPEC
clinical	O
responses	O
to	O
HCoV	O
-	O
EMC	O
and	O
SARS	O
-	O
CoV	O
.	O
We	O
used	O
this	O
information	O
to	O
predict	O
potential	O
effective	O
drugs	O
against	O
HCoV	O
-	O
EMC	O
,	O
a	O
method	O
that	O
could	O
be	O
more	O
generally	O
used	O
to	O
identify	O
candidate	O
therapeutics	O
in	O
future	O
disease	O
outbreaks	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
plays	O
a	O
multifunctional	O
role	O
in	O
the	O
virus	B-SPEC
life	O
cycle	O
,	O
from	O
regulation	O
of	O
replication	O
and	O
transcription	O
and	O
genome	O
packaging	O
to	O
modulation	O
of	O
host	O
cell	O
processes	O
.	O

By	O
investigating	O
a	O
recently	O
identified	O
regulatory	O
element	O
upstream	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
-	O
1	O
frameshifting	O
site	O
,	O
it	O
is	O
shown	O
that	O
a	O
minimal	O
functional	O
element	O
with	O
hairpin	O
forming	O
potential	O
is	O
sufficient	O
to	O
down	O
-	O
regulate	O
-	O
1	O
frameshifting	O
activity	O
.	O

The	O
investigations	O
indicate	O
that	O
the	O
hairpin	O
is	O
indeed	O
a	O
cis	B-SPEC
-	O
acting	O
programmed	O
reading	O
-	O
frame	O
switch	O
modulator	O
.	O

TITLE	O
:	O
Differentiated	O
phenotypes	O
of	O
primary	O
murine	B-SPEC
alveolar	O
epithelial	O
cells	O
and	O
their	O
susceptibility	O
to	O
infection	O
by	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Viral	O
infections	O
of	O
rabbits	B-SPEC
.	O

ABSTRACT	O
:	O
Viral	O
diseases	O
of	O
rabbits	B-SPEC
have	O
been	O
used	O
historically	O
to	O
study	O
oncogenesis	O
(	O
e	O
.	O
g	O
.	O
rabbit	B-SPEC
fibroma	I-SPEC
virus	I-SPEC
,	O
cottontail	B-SPEC
rabbit	I-SPEC
papillomavirus	I-SPEC
)	O
and	O
biologically	O
to	O
control	O
feral	O
rabbit	B-SPEC
populations	O
(	O
e	O
.	O
g	O
.	O
myxoma	B-SPEC
virus	I-SPEC
).	O

Three	O
avirulent	O
leporid	O
herpesviruses	B-SPEC
are	O
found	O
in	O
domestic	B-SPEC
rabbits	I-SPEC
.	O

A	O
fourth	O
highly	O
pathogenic	O
virus	B-SPEC
designated	O
leporid	B-SPEC
herpesvirus	I-SPEC
4	I-SPEC
has	O
been	O
described	O
in	O
Canada	O
and	O
Alaska	O
.	O

In	O
vivo	O
study	O
using	O
cats	B-SPEC
with	O
experimentally	O
induced	O
FIP	O
,	O
the	O
clinical	O
score	O
of	O
chloroquine	O
-	O
treatment	O
groups	O
were	O
better	O
than	O
in	O
chloroquine	O
-	O
untreated	O
group	O
.	O

The	O
immunoreactivity	O
between	O
PEDV	B-SPEC
particles	O
or	O
the	O
bacterially	O
expressed	O
N	O
protein	O
and	O
rabbit	B-SPEC
anti	O
-	O
PEDV	B-SPEC
serum	O
was	O
confirmed	O
by	O
immunofluorescence	O
assays	O
and	O
Western	O
blot	O
.	O

TITLE	O
:	O
A	O
combination	O
of	O
epitope	O
prediction	O
and	O
molecular	O
docking	O
allows	O
for	O
good	O
identification	O
of	O
MHC	O
class	B-SPEC
I	O
restricted	O
T	O
-	O
cell	O
epitopes	O
.	O

ABSTRACT	O
:	O
In	O
silico	O
identification	O
of	O
T	O
-	O
cell	O
epitopes	O
is	O
emerging	O
as	O
a	O
new	O
methodology	O
for	O
the	O
study	O
of	O
epitope	O
-	O
based	O
vaccines	O
against	O
viruses	B-SPEC
and	O
cancer	B-SPEC
.	O

In	O
order	B-SPEC
to	O
improve	O
accuracy	O
of	O
prediction	O
,	O
we	O
designed	O
a	O
novel	O
approach	O
,	O
using	O
epitope	O
prediction	O
methods	O
in	O
combination	O
with	O
molecular	O
docking	O
techniques	O
,	O
to	O
identify	O
MHC	O
class	B-SPEC
I	O
restricted	O
T	O
-	O
cell	O
epitopes	O
.	O

Analysis	O
of	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
p24	O
protein	O
and	O
influenza	B-SPEC
virus	I-SPEC
matrix	O
protein	O
revealed	O
that	O
the	O
present	O
approach	O
is	O
effective	O
,	O
yielding	O
prediction	O
accuracy	O
of	O
over	O
80	O
%	O
with	O
respect	O
to	O
experimental	O
data	O
.	O

We	O
suggest	O
the	O
use	O
of	O
epitope	O
prediction	O
methods	O
in	O
combination	O
with	O
3D	O
structural	O
modelling	O
of	O
peptide	O
-	O
MHC	O
-	O
TCR	O
complex	O
to	O
identify	O
MHC	O
class	B-SPEC
I	O
restricted	O
T	O
-	O
cell	O
epitopes	O
for	O
use	O
in	O
epitope	O
based	O
vaccines	O
like	O
HIV	B-SPEC
and	O
human	B-SPEC
cancers	O
,	O
which	O
should	O
provide	O
a	O
valuable	O
step	O
forward	O
for	O
the	O
design	O
of	O
better	O
vaccines	O
and	O
may	O
provide	O
in	O
depth	O
understanding	O
about	O
activation	O
of	O
T	O
-	O
cell	O
epitopes	O
by	O
MHC	O
binding	O
peptides	O
.	O

Our	O
previous	O
studies	O
demonstrated	O
that	O
TGEV	B-SPEC
could	O
activate	O
FasL	O
-	O
and	O
mitochondria	O
-	O
mediated	O
pathways	O
to	O
induce	O
apoptosis	O
in	O
PK	O
-	O
15	O
cells	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
is	O
an	O
infectious	O
and	O
highly	O
contagious	O
disease	O
that	O
is	O
caused	O
by	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
for	O
which	O
there	O
are	O
currently	O
no	O
approved	O
treatments	O
.	O

Isolates	O
of	O
NIB	O
virus	B-SPEC
(	O
NIBV	O
)--	O
DMV	O
/	O
1639	O
/	O
11	O
,	O
DMV	O
/	O
3432	O
/	O
11	O
,	O
and	O
DMV	O
/	O
3902	O
/	O
11	O
--	O
were	O
characterized	O
by	O
sequence	O
analysis	O
of	O
the	O
N	O
-	O
terminal	O
subunit	O
(	O
S1	O
)	O
of	O
the	O
spike	O
(	O
S	O
)	O
gene	O
.	O

Mass	O
+	O
Ark	O
vaccinations	O
,	O
applied	O
under	O
commercial	O
conditions	O
in	O
the	O
hatchery	O
(	O
spray	O
)	O
and	O
on	O
-	O
farm	O
(	O
spray	O
),	O
did	O
not	O
protect	O
the	O
trachea	B-SPEC
or	O
kidney	O
from	O
DMV	O
/	O
1639	O
/	O
11	O
challenge	O
.	O

ABSTRACT	O
:	O
We	O
designed	O
a	O
series	O
of	O
mutations	O
to	O
separately	O
destabilize	O
two	O
helical	O
stems	O
(	O
designated	O
S3	O
and	O
S4	O
)	O
predicted	O
by	O
a	O
covariation	O
-	O
based	O
model	O
of	O
the	O
coronavirus	B-SPEC
3	O
'	O
UTR	O
(	O
Zust	O
et	O
al	O
.,	O
2008	O
).	O

Recent	O
data	O
suggest	O
that	O
influenza	B-SPEC
virus	I-SPEC
can	O
exert	O
both	O
direct	O
and	O
indirect	O
effects	O
on	O
the	O
lung	O
endothelium	O
,	O
activating	O
it	O
and	O
inducing	O
microvascular	O
leak	O
.	O

Influenza	O
A	O
(	O
Flu	O
A	O
),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
and	O
human	B-SPEC
bocavirus	I-SPEC
(	O
BoCA	O
)	O
were	O
found	O
4	O
.	O
4	O
%,	O
3	O
.	O
7	O
%	O
and	O
2	O
.	O
2	O
%,	O
respectively	O
.	O

TITLE	O
:	O
Anti	O
-	O
inflammatory	O
mechanisms	O
of	O
apolipoprotein	O
A	O
-	O
I	O
mimetic	O
peptide	O
in	O
acute	O
respiratory	O
distress	O
syndrome	O
secondary	O
to	O
sepsis	B-SPEC
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
due	O
to	O
sepsis	B-SPEC
has	O
a	O
high	O
mortality	O
rate	O
with	O
limited	O
treatment	O
options	O
.	O

We	O
also	O
analyzed	O
serum	O
from	O
non	O
-	O
lung	O
disease	O
intubated	O
patients	O
(	O
controls	O
)	O
and	O
sepsis	B-SPEC
-	O
mediated	O
ARDS	O
patients	O
.	O

Molecular	O
clock	O
analysis	O
showed	O
that	O
the	O
2	O
human	B-SPEC
infections	O
of	O
this	O
betacoronavirus	B-SPEC
in	O
June	O
2012	O
(	O
EMC	O
/	O
2012	O
)	O
and	O
September	O
2012	O
(	O
England	O
/	O
Qatar	O
/	O
2012	O
)	O
share	O
a	O
common	O
virus	B-SPEC
ancestor	O
most	O
likely	O
considerably	O
before	O
early	O
2012	O
,	O
suggesting	O
the	O
human	B-SPEC
diversity	O
is	O
the	O
result	O
of	O
multiple	O
zoonotic	O
events	O
.	O

Demographic	O
differences	O
were	O
observed	O
between	O
patients	O
with	O
different	O
viruses	B-SPEC
,	O
suggesting	O
that	O
host	O
and	O
viral	O
factors	O
play	O
a	O
role	O
in	O
phenotypic	O
expression	O
of	O
viral	O
illness	O
.	O

Thus	O
,	O
RNase	O
L	O
activation	O
during	O
MHV	B-SPEC
infection	O
is	O
cell	O
type	O
specific	O
and	O
correlates	O
with	O
relatively	O
high	O
levels	O
of	O
expression	O
of	O
OAS	O
genes	O
,	O
which	O
are	O
necessary	O
but	O
not	O
sufficient	O
for	O
induction	O
of	O
an	O
effective	O
RNase	O
L	O
antiviral	O
response	O
.	O

TITLE	O
:	O
Binding	O
and	O
repressive	O
activities	O
of	O
apolipoprotein	O
E3	O
and	O
E4	O
isoforms	O
on	O
the	O
human	B-SPEC
ApoD	O
promoter	O
.	O

We	O
previously	O
showed	O
that	O
transgenic	B-SPEC
mice	I-SPEC
that	O
overexpress	O
human	B-SPEC
ApoD	O
show	O
a	O
better	O
resistance	O
against	O
paraquat	O
or	O
OC43	O
coronavirus	B-SPEC
-	O
induced	O
neurodegeneration	O
.	O

The	O
positive	O
rate	O
of	O
respiratory	O
viruses	B-SPEC
was	O
52	O
.	O
1	O
%	O
(	O
1	O
,	O
033	O
/	O
1	O
,	O
983	O
)	O
and	O
the	O
total	O
number	O
of	O
detected	O
viruses	B-SPEC
was	O
1	O
,	O
100	O
.	O

TITLE	O
:	O
Family	B-SPEC
cluster	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infections	O
.	O

Amongst	O
the	O
lymphoid	O
tissues	O
,	O
histopathological	O
changes	O
were	O
found	O
most	O
frequently	O
in	O
the	O
bursa	B-SPEC
of	O
Fabricius	O
.	O

Serum	O
tests	O
for	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
FIV	B-SPEC
)	O
and	O
feline	B-SPEC
leukaemia	O
virus	B-SPEC
(	O
FeLV	O
)	O
were	O
negative	O
.	O

Functional	O
animal	B-SPEC
models	O
and	O
clinically	O
applicable	O
case	O
definitions	O
for	O
ALI	O
and	O
ARDS	O
were	O
instrumental	O
in	O
gaining	O
these	O
new	O
insights	O
.	O

Examples	O
include	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
and	O
Nipah	O
,	O
lymphocytic	O
choriomeningitis	O
,	O
West	O
Nile	O
,	O
Cache	O
Valley	O
,	O
and	O
Heartland	O
viruses	B-SPEC
.	O

After	O
the	O
emergence	O
of	O
a	O
novel	O
influenza	B-SPEC
virus	I-SPEC
of	O
swine	B-SPEC
origin	O
in	O
1976	O
,	O
national	O
,	O
state	O
,	O
and	O
local	O
US	O
public	O
health	O
authorities	O
began	O
planning	O
efforts	O
to	O
respond	O
to	O
future	O
pandemics	O
.	O

ABSTRACT	O
:	O
To	O
clarify	O
the	O
evolutionary	O
relationships	O
among	O
betavoronaviruses	O
that	O
infect	O
bats	B-SPEC
,	O
we	O
analyzed	O
samples	O
collected	O
during	O
2010	O
-	O
2011	O
from	O
14	O
insectivorous	O
bat	B-SPEC
species	B-SPEC
in	O
China	O
.	O

In	O
patients	O
as	O
well	O
as	O
in	O
mice	B-SPEC
,	O
severe	O
edema	O
and	O
impaired	O
gas	O
exchange	O
are	O
associated	O
with	O
abundant	O
inflammatory	O
infiltrates	O
consisting	O
of	O
mainly	O
mononuclear	O
cells	O
and	O
parasite	O
sequestration	O
,	O
and	O
the	O
pathogenesis	O
appears	O
different	O
from	O
cerebral	O
malaria	O
(	O
CM	O
).	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
novel	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
using	O
TOCE	O
technology	O
compared	O
with	O
culture	O
and	O
Seeplex	O
RV15	O
for	O
simultaneous	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
.	O

Sensitivities	O
of	O
RV16	O
,	O
RV15	O
,	O
and	O
culture	O
for	O
virus	B-SPEC
tested	O
were	O
as	O
follows	O
:	O
100	O
/	O
93	O
/	O
63	O
%	O
for	O
influenza	O
A	O
,	O
90	O
/	O
80	O
/	O
69	O
%	O
for	O
influenza	O
B	O
,	O
98	O
/	O
94	O
/	O
63	O
%	O
for	O
RSV	B-SPEC
,	O
98	O
/	O
52	O
/	O
23	O
%	O
for	O
adenovirus	B-SPEC
,	O
and	O
100	O
/	O
75	O
/	O
46	O
%	O
for	O
PIV	O
.	O

For	O
viruses	B-SPEC
not	O
covered	O
by	O
culture	O
,	O
sensitivities	O
of	O
RV16	O
and	O
RV15	O
were	O
as	O
follows	O
:	O
99	O
/	O
81	O
%	O
for	O
rhinovirus	B-SPEC
,	O
92	O
/	O
100	O
%	O
for	O
coronavirus	B-SPEC
OC43	O
,	O
100	O
/	O
56	O
%	O
for	O
coronavirus	B-SPEC
229E	O
/	O
NL63	O
,	O
92	O
/	O
88	O
%	O
for	O
metapneumovirus	B-SPEC
,	O
100	O
/	O
62	O
%	O
for	O
bocavirus	B-SPEC
,	O
and	O
91	O
/	O
91	O
%	O
for	O
enterovirus	B-SPEC
.	O

TITLE	O
:	O
Immunocytochemical	O
demonstration	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
within	O
cerebrospinal	O
fluid	O
macrophages	O
.	O

In	O
simultaneous	O
-	O
treatment	O
assay	O
,	O
compounds	O
2	O
-	O
5	O
except	O
compound	O
1	O
exhibited	O
antiviral	O
activities	O
of	O
a	O
50	O
%	O
inhibitory	O
concentration	O
(	O
IC₅₀	O
)	O
with	O
the	O
ranging	O
from	O
10	O
.	O
8	O
±	O
1	O
.	O
4	O
to	O
22	O
.	O
5	O
±	O
2	O
.	O
2	O
μM	O
against	O
PEDV	B-SPEC
.	O

The	O
RBD	O
(	O
RL	O
and	O
RS	O
)	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
were	O
expressed	O
majorly	O
as	O
inclusion	O
body	O
when	O
expressed	O
in	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
BL21pLys	O
S	O
under	O
different	O
conditions	O
.	O

ABSTRACT	O
:	O
Since	O
late	O
2010	O
,	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
been	O
re	O
-	O
emerging	O
in	O
central	O
China	O
.	O

To	O
explore	O
the	O
possible	O
reason	O
of	O
the	O
PEDV	B-SPEC
outbreaks	O
,	O
twelve	O
PEDV	B-SPEC
field	O
strains	O
were	O
isolated	O
from	O
different	O
swine	B-SPEC
breeding	O
farms	O
in	O
central	O
China	O
during	O
2010	O
-	O
2012	O
,	O
and	O
molecular	O
diversity	O
,	O
phylogenetic	O
relationships	O
of	O
these	O
strains	O
with	O
other	O
PEDV	B-SPEC
reference	O
strains	O
were	O
investigated	O
.	O

These	O
results	O
imply	O
that	O
a	O
rapid	O
variation	O
and	O
evolution	O
of	O
central	O
China	O
PEDV	B-SPEC
strains	O
has	O
occurred	O
in	O
recent	O
years	O
,	O
and	O
a	O
more	O
efficient	O
vaccine	O
strain	O
should	O
be	O
selected	O
to	O
prevent	O
and	O
control	O
outbreaks	O
of	O
PEDV	B-SPEC
in	O
China	O
.	O

TITLE	O
:	O
Update	O
:	O
Severe	O
respiratory	O
illness	O
associated	O
with	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)--	O
worldwide	O
,	O
2012	O
-	O
2013	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
(	O
N	O
)	O
plays	O
an	O
essential	O
structural	O
role	O
in	O
virions	O
through	O
a	O
network	O
of	O
interactions	O
with	O
positive	O
-	O
strand	O
viral	O
genomic	O
RNA	O
,	O
the	O
envelope	O
membrane	O
protein	O
(	O
M	O
),	O
and	O
other	O
N	O
molecules	O
.	O

Additionally	O
,	O
N	O
protein	O
participates	O
in	O
at	O
least	O
one	O
stage	O
of	O
the	O
complex	O
mechanism	O
of	O
coronavirus	B-SPEC
RNA	O
synthesis	O
.	O

This	O
was	O
found	O
through	O
analysis	O
of	O
revertants	O
of	O
a	O
severely	O
defective	O
mutant	O
of	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
in	O
which	O
the	O
N	O
gene	O
was	O
replaced	O
with	O
that	O
of	O
its	O
close	O
relative	O
,	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
).	O

There	O
is	O
only	O
limited	O
data	O
on	O
neotropical	O
bat	B-SPEC
CoVs	O
.	O

Based	O
on	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRp	O
)-	O
based	O
grouping	O
units	O
(	O
RGUs	O
)	O
as	O
a	O
surrogate	O
for	O
CoV	O
species	B-SPEC
identification	O
,	O
the	O
50	O
viruses	B-SPEC
represented	O
five	O
different	O
alphacoronavirus	B-SPEC
RGUs	O
and	O
two	O
betacoronavirus	B-SPEC
RGUs	O
.	O

We	O
examined	O
a	O
furin	O
cleavage	O
site	O
in	O
the	O
region	O
between	O
receptor	O
-	O
binding	O
(	O
S1	O
)	O
and	O
fusion	O
(	O
S2	O
)	O
domains	O
of	O
the	O
spike	O
of	O
serotype	O
1	O
FCoV	O
.	O
FECV	B-SPEC
sequences	O
were	O
compared	O
with	O
FIPV	O
sequences	O
.	O

These	O
warm	O
-	O
blooded	O
vertebrates	B-SPEC
display	O
high	O
species	B-SPEC
biodiversity	O
,	O
roosting	O
and	O
migratory	O
behavior	O
,	O
and	O
a	O
unique	O
adaptive	O
immune	O
system	O
,	O
which	O
are	O
favorable	O
characteristics	O
for	O
asymptomatic	O
shedding	O
,	O
dissemination	O
,	O
and	O
mixing	O
of	O
different	O
viruses	B-SPEC
for	O
the	O
generation	O
of	O
novel	O
mutant	O
,	O
recombinant	O
,	O
or	O
reassortant	O
RNA	O
viruses	B-SPEC
.	O

This	O
conclusion	O
was	O
supported	O
by	O
the	O
ultrastructure	O
images	O
of	O
the	O
early	O
stage	O
of	O
DEV	O
infection	O
,	O
which	O
showed	O
that	O
the	O
replication	O
of	O
virus	B-SPEC
nucleic	O
acid	O
and	O
the	O
formation	O
of	O
the	O
capsid	O
in	O
the	O
cell	O
nucleus	O
were	O
suppressed	O
.	O

The	O
complications	O
seen	O
in	O
vivax	O
malaria	O
were	O
:	O
thrombocytopenia	O
(	O
68	O
%),	O
leukopenia	O
(	O
19	O
%),	O
ARDS	O
(	O
3	O
%),	O
high	O
bilirubin	O
(	O
5	O
%),	O
acute	O
renal	O
failure	O
(	O
3	O
.	O
5	O
%),	O
anemia	B-SPEC
(	O
3	O
%),	O
mucosal	O
bleeding	O
(	O
8	O
%),	O
cerebral	O
malaria	O
(	O
3	O
.	O
5	O
%),	O
hypotension	O
(	O
5	O
%),	O
metabolic	O
acidosis	O
(	O
4	O
%)	O
and	O
death	O
(	O
1	O
.	O
77	O
%).	O

The	O
complications	O
seen	O
in	O
vivax	O
malaria	O
were	O
:	O
thrombocytopenia	O
(	O
68	O
%),	O
leukopenia	O
(	O
19	O
%),	O
ARDS	O
(	O
3	O
%),	O
high	O
bilirubin	O
(	O
5	O
%),	O
acute	O
renal	O
failure	O
(	O
3	O
.	O
5	O
%),	O
anemia	B-SPEC
(	O
3	O
%),	O
mucosal	O
bleeding	O
(	O
8	O
%),	O
cerebral	O
malaria	O
(	O
3	O
.	O
5	O
%),	O
hypotension	O
(	O
5	O
%),	O
metabolic	O
acidosis	O
(	O
4	O
%)	O
and	O
death	O
(	O
1	O
.	O
77	O
%).	O

Statistical	O
analysis	O
included	O
analysis	O
of	O
variance	O
,	O
Fisher	B-SPEC
'	O
s	O
exact	O
,	O
Kaplan	O
-	O
Meier	O
(	O
KM	O
)	O
survival	O
curves	O
,	O
and	O
multiple	O
logistic	O
regression	O
.	O

A	O
73	O
-	O
year	O
-	O
old	O
man	B-SPEC
from	O
Abu	O
Dhabi	O
,	O
United	O
Arab	O
Emirates	O
,	O
was	O
transferred	O
to	O
Klinikum	O
Schwabing	O
on	O
March	O
19	O
,	O
2013	O
,	O
on	O
day	O
11	O
of	O
illness	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
the	O
recently	O
emerged	O
human	B-SPEC
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
mediates	O
infection	O
by	O
binding	O
to	O
the	O
cellular	O
receptor	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
).	O

Finally	O
,	O
we	O
urge	O
that	O
adequate	O
data	O
be	O
collected	O
on	O
future	O
cases	O
to	O
permit	B-SPEC
rigorous	O
assessment	O
of	O
the	O
transmission	O
characteristics	O
and	O
severity	O
of	O
MERS	O
-	O
CoV	O
,	O
and	O
the	O
public	O
health	O
threat	O
it	O
may	O
pose	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
):	O
challenges	O
in	O
identifying	O
its	O
source	O
and	O
controlling	O
its	O
spread	O
.	O

We	O
look	O
at	O
a	O
case	O
of	O
a	O
38	O
-	O
year	O
-	O
old	O
man	B-SPEC
living	O
in	O
a	O
malaria	O
endemic	O
area	O
who	O
presented	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
caused	O
by	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
.	O

TITLE	O
:	O
A	O
case	O
of	O
Staphylococcus	B-SPEC
toxic	O
shock	O
syndrome	O
presenting	O
with	O
multiple	O
pneumatocoeles	O
in	O
the	O
chest	O
.	O

We	O
report	O
a	O
case	O
of	O
Staphylococcus	B-SPEC
TSS	O
presenting	O
with	O
cough	O
and	O
expectoration	O
along	O
with	O
multiple	O
pneumatoceles	O
visible	O
on	O
the	O
chest	O
radiograph	O
that	O
progressed	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
with	O
eventual	O
foci	O
in	O
brain	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
peptides	O
modified	O
with	O
cholesterol	O
or	O
3	O
U	O
of	O
polyethylene	O
glycol	O
(	O
PEG3	O
)	O
conjugated	O
to	O
the	O
peptides	O
'	O
N	O
termini	O
showed	O
even	O
more	O
promising	O
antiviral	O
activities	O
when	O
tested	O
in	O
animal	B-SPEC
models	O
.	O

Both	O
cholesterol	O
-	O
and	O
cholesterol	O
-	O
PEG3	O
-	O
tagged	O
peptides	O
were	O
able	O
to	O
protect	O
chicken	B-SPEC
embryos	O
from	O
infection	O
with	O
different	O
serotypes	O
of	O
NDV	B-SPEC
and	O
IBV	B-SPEC
when	O
administered	O
12	O
h	O
prior	O
to	O
virus	B-SPEC
inoculation	O
.	O

It	O
also	O
has	O
the	O
potential	O
to	O
cross	O
the	O
blood	O
-	O
brain	O
barrier	O
to	O
enter	O
the	O
avian	B-SPEC
central	O
nervous	O
system	O
(	O
CNS	O
).	O

At	O
least	O
3	O
different	O
adventitious	O
viruses	B-SPEC
were	O
present	O
in	O
the	O
batch	O
of	O
contaminated	O
RPTEC	O
.	O

Importantly	O
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
replicates	O
to	O
high	O
titers	O
in	O
some	O
primary	O
human	B-SPEC
kidney	O
cells	O
.	O

RESULTS	O
:	O
Cytomegalovirus	B-SPEC
(	O
CMV	B-SPEC
)	O
was	O
detected	O
in	O
some	O
RPTEC	O
by	O
cytology	O
,	O
an	O
immunofluorescence	O
assay	O
,	O
and	O
PCR	O
.	O

Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
was	O
isolated	O
and	O
identified	O
by	O
RT	O
-	O
PCR	O
and	O
sequencing	O
,	O
and	O
its	O
replication	O
in	O
a	O
fresh	O
batch	O
of	O
RPTEC	O
and	O
another	O
type	O
of	O
primary	O
human	B-SPEC
kidney	O
cells	O
was	O
confirmed	O
.	O

TITLE	O
:	O
Canine	O
kobuviruses	B-SPEC
in	O
diarrhoeic	O
dogs	B-SPEC
in	O
Italy	O
.	O

The	O
diagnostic	O
accuracy	O
in	O
predetermined	O
subgroups	O
(	O
those	O
with	O
diffuse	O
alveolar	O
damage	O
,	O
with	O
≥	O
3	O
affected	O
chest	O
x	O
-	O
ray	B-SPEC
quadrants	O
,	O
with	O
diagnosis	O
≥	O
3	O
days	O
,	O
with	O
pulmonary	O
vs	O
extrapulmonary	O
cause	O
)	O
was	O
also	O
examined	O
.	O

As	O
an	O
example	O
of	O
the	O
latter	O
,	O
a	O
research	O
program	O
was	O
reported	O
that	O
identified	O
compounds	O
with	O
activity	O
against	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
-	O
2	O
,	O
herpes	B-SPEC
virus	I-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
and	O
Coxsackie	O
virus	B-SPEC
(	O
Dejmek	O
,	O
M	O
.	O
et	O
al	O
.,	O
Abst	O
35	O
),	O
while	O
studies	O
with	O
Griffithsin	O
,	O
a	O
red	O
algae	B-SPEC
-	O
derived	O
protein	O
with	O
potent	O
,	O
broad	O
antiviral	O
activity	O
against	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
,	O
coronavirus	B-SPEC
and	O
Japanese	B-SPEC
encephalitis	I-SPEC
virus	I-SPEC
,	O
among	O
others	O
,	O
showed	O
it	O
also	O
inhibited	O
HIV	B-SPEC
,	O
although	O
only	O
when	O
the	O
tight	O
dimer	O
structure	O
is	O
respected	O
(	O
Xue	O
,	O
J	O
.	O
et	O
al	O
.,	O
Abst	O
104	O
).	O

Control	O
of	O
IBV	B-SPEC
has	O
been	O
attempted	O
using	O
live	O
attenuated	O
and	O
inactivated	O
vaccines	O
.	O

From	O
the	O
300	O
field	O
samples	O
tested	O
,	O
the	O
duplex	O
rRT	O
-	O
PCR	O
yielded	O
a	O
total	O
of	O
80	O
samples	O
that	O
were	O
positive	O
for	O
IBV	B-SPEC
(	O
26	O
.	O
67	O
%),	O
73	O
samples	O
identified	O
as	O
the	O
IBV	B-SPEC
Mass	O
.	O
serotype	O
and	O
seven	O
samples	O
as	O
identified	O
as	O
the	O
IBV	B-SPEC
non	O
-	O
Mass	O
.	O

ABSTRACT	O
:	O
A	O
54	O
-	O
year	O
-	O
old	O
man	B-SPEC
presented	O
with	O
fever	O
and	O
dyspnea	O
about	O
a	O
week	O
before	O
his	O
admission	O
.	O

Therefore	O
,	O
we	O
repeated	O
the	O
Legionella	B-SPEC
urinary	O
antigen	O
test	O
,	O
which	O
was	O
positive	O
.	O

Common	O
and	O
novel	O
respiratory	O
viruses	B-SPEC
can	O
occasionally	O
cause	O
epidemics	O
of	O
viral	O
pneumonitis	O
with	O
severe	O
acute	O
respiratory	O
symptoms	O
(	O
sars	O
).	O

The	O
genome	O
and	O
the	O
immunoglobulin	O
genes	O
in	O
rhesus	B-SPEC
macaques	I-SPEC
and	O
humans	B-SPEC
are	O
highly	O
homologous	O
;	O
therefore	O
,	O
we	O
investigated	O
whether	O
neutralizing	O
mAbs	O
that	O
are	O
highly	O
homologous	O
to	O
those	O
of	O
humans	B-SPEC
(	O
human	B-SPEC
-	O
like	O
)	O
could	O
be	O
generated	O
.	O

The	O
in	O
vivo	O
protection	O
experiments	O
demonstrated	O
that	O
the	O
mAbs	O
effectively	O
protected	O
the	O
mice	B-SPEC
even	O
when	O
administered	O
up	O
to	O
3	O
days	O
after	O
infection	O
with	O
H5N1	O
influenza	B-SPEC
virus	I-SPEC
.	O

Viruses	B-SPEC
have	O
developed	O
diverse	O
strategies	O
to	O
subvert	O
host	O
defense	O
mechanisms	O
and	O
increase	O
their	O
survival	O
.	O

Four	O
simple	O
types	O
of	O
door	O
design	O
were	O
tested	O
:	O
variable	O
speed	O
single	O
and	O
double	O
,	O
sliding	O
and	O
hinged	O
doors	O
,	O
in	O
combination	O
with	O
the	O
moving	O
human	B-SPEC
figure	O
.	O

Adalimumab	O
is	O
a	O
recombinant	O
human	B-SPEC
monoclonal	O
antibody	O
that	O
blocks	O
the	O
effects	O
of	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
.	O

TITLE	O
:	O
Estimates	O
and	O
determinants	O
of	O
economic	O
impacts	O
from	O
influenza	O
-	O
like	O
illnesses	O
caused	O
by	O
respiratory	O
viruses	B-SPEC
in	O
Australian	O
children	O
attending	O
childcare	O
:	O
a	O
cohort	O
study	O
.	O

Specimens	O
were	O
available	O
for	O
117	O
ILIs	O
:	O
five	O
were	O
positive	O
by	O
RT	O
-	O
PCR	O
for	O
A	O
(	O
H1N1	O
)	O
pdm09	O
,	O
39	O
for	O
adenovirus	B-SPEC
,	O
39	O
for	O
rhinovirus	B-SPEC
,	O
15	O
for	O
a	O
coronavirus	B-SPEC
and	O
27	O
for	O
a	O
polyomavirus	B-SPEC
.	O

Our	O
findings	O
on	O
the	O
estimates	O
and	O
determinants	O
of	O
economic	O
impacts	O
from	O
respiratory	O
virus	B-SPEC
infection	O
highlight	O
the	O
importance	O
and	O
feasibility	O
of	O
an	O
interdisciplinary	O
(	O
epidemiology	O
/	O
health	O
economics	O
)	O
approach	O
to	O
such	O
research	O
.	O

Pyelonephritis	O
remains	O
a	O
common	O
cause	O
of	O
sepsis	B-SPEC
during	O
pregnancy	O
,	O
and	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
occurs	O
more	O
commonly	O
than	O
in	O
the	O
nonpregnant	O
population	O
.	O

TITLE	O
:	O
Molecular	O
basis	O
of	O
binding	O
between	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
MERS	O
-	O
CoV	O
and	O
its	O
receptor	O
CD26	O
.	O

ABSTRACT	O
:	O
The	O
newly	O
emergent	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
can	O
cause	O
severe	O
pulmonary	O
disease	O
in	O
humans	B-SPEC
,	O
representing	O
the	O
second	O
example	O
of	O
a	O
highly	O
pathogenic	O
coronavirus	B-SPEC
,	O
the	O
first	O
being	O
SARS	O
-	O
CoV	O
.	O
CD26	O
(	O
also	O
known	O
as	O
dipeptidyl	O
peptidase	O
4	O
,	O
DPP4	O
)	O
was	O
recently	O
identified	O
as	O
the	O
cellular	O
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
The	O
engagement	O
of	O
the	O
MERS	O
-	O
CoV	O
spike	O
protein	O
with	O
CD26	O
mediates	O
viral	O
attachment	O
to	O
host	O
cells	O
and	O
virus	B-SPEC
-	O
cell	O
fusion	O
,	O
thereby	O
initiating	O
infection	O
.	O

Sequence	O
alignment	O
indicates	O
,	O
among	O
betacoronaviruses	O
,	O
a	O
possible	O
structural	O
conservation	O
for	O
the	O
region	O
homologous	O
to	O
the	O
MERS	O
-	O
CoV	O
RBD	O
core	O
,	O
but	O
a	O
high	O
variation	O
in	O
the	O
external	O
receptor	O
binding	O
motif	O
region	O
for	O
virus	B-SPEC
-	O
specific	O
pathogenesis	O
such	O
as	O
receptor	O
recognition	O
.	O

To	O
deliver	O
viral	O
antigens	O
to	O
the	O
mucosal	O
immune	O
system	O
of	O
chickens	B-SPEC
safely	O
and	O
effectively	O
,	O
we	O
constructed	O
a	O
Lactococcus	B-SPEC
lactis	I-SPEC
strain	O
carrying	O
IBV	B-SPEC
multi	O
-	O
epitope	O
gene	O
EpiC	O
fused	O
with	O
the	O
gene	O
of	O
the	O
cell	O
-	O
wall	O
anchoring	O
domain	O
of	O
Staphylococcus	B-SPEC
aureus	I-SPEC
protein	O
A	O
.	O
SDS	O
-	O
PAGE	O
and	O
Western	O
blot	O
results	O
indicated	O
that	O
the	O
fused	O
peptide	O
was	O
located	O
partially	O
on	O
the	O
cell	O
surface	O
.	O

ABSTRACT	O
:	O
The	O
spike	O
glycoprotein	O
(	O
S	O
)	O
of	O
recently	O
identified	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
targets	O
the	O
cellular	O
receptor	O
,	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
).	O

TITLE	O
:	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
as	O
a	O
Vector	O
for	O
the	O
Expression	O
of	O
Heterologous	O
Genes	O
.	O

ABSTRACT	O
:	O
The	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
the	O
causative	O
agent	O
of	O
the	O
respiratory	O
disease	O
infectious	O
bronchitis	O
of	O
domestic	O
fowl	O
,	O
and	O
is	O
controlled	O
by	O
routine	O
vaccination	O
.	O

The	O
replacement	O
of	O
Gene	O
5	O
with	O
an	O
IBV	B-SPEC
codon	O
-	O
optimised	O
version	O
of	O
the	O
hRluc	O
gene	O
also	O
resulted	O
in	O
successful	O
rescue	O
of	O
infectious	O
rIBV	O
.	O

The	O
lack	O
of	O
efficient	O
respiratory	O
droplet	O
transmission	O
was	O
corroborated	O
by	O
low	O
receptor	O
-	O
binding	O
specificity	O
for	O
human	B-SPEC
-	O
like	O
α2	O
,	O
6	O
-	O
linked	O
sialosides	O
.	O

The	O
emergence	O
of	O
this	O
novel	B-SPEC
coronavirus	I-SPEC
prompts	O
the	O
need	O
for	O
a	O
small	O
animal	B-SPEC
model	O
to	O
study	O
the	O
pathogenesis	O
of	O
this	O
virus	B-SPEC
and	O
to	O
test	O
the	O
efficacy	O
of	O
potential	O
intervention	O
strategies	O
.	O

ABSTRACT	O
:	O
In	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
combined	O
high	O
-	O
frequency	O
oscillation	O
(	O
HFO	O
)	O
and	O
tracheal	O
gas	O
insufflation	O
(	O
TGI	O
)	O
improves	O
gas	O
exchange	O
compared	O
with	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
).	O

Transient	O
improvements	O
were	O
observed	O
after	O
4	O
hours	O
of	O
HFO	O
-	O
TGI	O
versus	O
pre	O
-	O
HFO	O
-	O
TGI	O
CMV	B-SPEC
in	O
PaCO2	O
(	O
37	O
.	O
7	O
±	O
9	O
.	O
9	O
versus	O
41	O
.	O
2	O
±	O
10	O
.	O
8	O
mm	O
Hg	O
;	O
P	O
<	O
0	O
.	O
01	O
),	O
ICP	O
(	O
17	O
.	O
2	O
±	O
5	O
.	O
4	O
versus	O
19	O
.	O
7	O
±	O
5	O
.	O
9	O
mm	O
Hg	O
;	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
CPP	O
(	O
77	O
.	O
2	O
±	O
14	O
.	O
6	O
versus	O
71	O
.	O
9	O
±	O
14	O
.	O
8	O
mm	O
Hg	O
;	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
most	O
common	O
subtypes	O
of	O
HCoV	O
were	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
(	O
33	O
.	O
80	O
%)	O
and	O
HCoV	O
-	O
HKU1	O
(	O
32	O
.	O
39	O
%).	O

TITLE	O
:	O
High	O
-	O
dose	O
acetylsalicylic	O
acid	O
is	O
superior	O
to	O
low	O
-	O
dose	O
as	O
well	O
as	O
to	O
clopidogrel	O
in	O
preventing	O
lipopolysaccharide	O
-	O
induced	O
lung	O
injury	O
in	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Legionella	B-SPEC
is	O
a	O
common	O
cause	O
of	O
community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
)	O
and	O
is	O
second	O
only	O
to	O
Pneumococcal	O
pneumonia	O
as	O
a	O
cause	O
of	O
severe	O
CAP	O
that	O
requires	O
treatment	O
in	O
an	O
intensive	O
care	O
unit	O
.	O

Current	O
studies	O
revealed	O
that	O
MHV	B-SPEC
infection	O
is	O
associated	O
with	O
the	O
pronounced	O
activation	O
of	O
microglia	O
during	O
acute	O
inflammation	O
,	O
as	O
evidenced	O
by	O
characteristic	O
changes	O
in	O
cellular	O
morphology	O
and	O
increased	O
expression	O
of	O
microglia	O
-	O
specific	O
proteins	O
,	O
Iba1	O
(	O
ionized	O
calcium	O
-	O
binding	O
adaptor	O
molecule	O
1	O
),	O
which	O
is	O
a	O
macrophage	O
/	O
microglia	O
-	O
specific	O
novel	O
calcium	O
-	O
binding	O
protein	O
and	O
involved	O
in	O
membrane	O
ruffling	O
and	O
phagocytosis	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
fatal	O
disease	O
caused	O
by	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
infection	O
.	O

TITLE	O
:	O
Humoral	O
and	O
cell	O
-	O
mediated	O
immune	O
responses	O
to	O
different	O
doses	O
of	O
attenuated	O
vaccine	O
against	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
.	O

Animals	B-SPEC
were	O
mechanically	O
ventilated	O
for	O
24	O
-	O
48	O
hours	O
,	O
and	O
then	O
animals	B-SPEC
were	O
weaned	O
from	O
ventilation	O
and	O
cared	O
for	O
until	O
day	O
7	O
.	O

TITLE	O
:	O
A	O
sorghum	B-SPEC
xylanase	O
inhibitor	O
-	O
like	O
protein	O
with	O
highly	O
potent	O
antifungal	O
,	O
antitumor	O
and	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
inhibitory	O
activities	O
.	O

In	O
conclusion	O
,	O
sorghum	B-SPEC
XILP	O
is	O
thermostable	O
and	O
pH	O
stable	O
and	O
exhibits	O
potent	O
antifungal	O
,	O
antiproliferative	O
,	O
and	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
inhibitory	O
activities	O
.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
performed	O
to	O
clarify	O
the	O
acute	O
phase	O
response	O
following	O
infectious	O
bronchitis	O
virus	B-SPEC
inoculation	O
.	O

This	O
is	O
particularly	O
true	O
for	O
the	O
very	O
real	O
threat	O
of	O
""""	O
novel	O
pathogens	O
""""	O
such	O
as	O
the	O
avian	B-SPEC
-	O
origin	O
influenzas	O
H7N9	O
and	O
H5N1	O
,	O
and	O
new	O
coronaviruses	O
such	O
as	O
hCoV	O
-	O
EMC	O
.	O

ABSTRACT	O
:	O
Efficient	O
and	O
productive	O
virus	B-SPEC
infection	O
often	O
requires	O
viral	O
countermeasures	O
that	O
block	O
innate	O
immunity	O
.	O

In	O
addition	O
,	O
VP3	O
-	O
CTD	O
expressed	O
transiently	O
in	O
mammalian	B-SPEC
cells	O
depleted	O
2	O
-	O
5A	O
levels	O
induced	O
by	O
OAS	O
activation	O
with	O
poly	O
(	O
rI	O
):	O
poly	O
(	O
rC	O
),	O
preventing	O
RNase	O
L	O
activation	O
.	O

Thus	O
,	O
VP3	O
-	O
CTD	O
is	O
a	O
2	O
',	O
5	O
'-	O
PDE	O
able	O
to	O
functionally	O
substitute	O
for	O
ns2	O
in	O
MHV	B-SPEC
infection	O
.	O

Remarkably	O
,	O
therefore	O
,	O
two	O
disparate	O
RNA	O
viruses	B-SPEC
encode	O
proteins	O
with	O
homologous	O
2	O
',	O
5	O
'-	O
PDEs	O
that	O
antagonize	O
activation	O
of	O
innate	O
immunity	O
.	O

Although	O
PLV	O
has	O
been	O
shown	O
to	O
improve	O
gas	O
exchange	O
and	O
to	O
reduce	O
inflammation	O
in	O
experimental	O
models	O
of	O
ALI	O
,	O
a	O
previous	O
systematic	O
review	O
did	O
not	O
find	O
any	O
evidence	O
to	O
support	O
or	O
refute	O
its	O
use	O
in	O
humans	B-SPEC
with	O
ALI	O
and	O
ARDS	O
.	O

No	O
evidence	O
indicated	O
that	O
'	O
high	O
'-	O
dose	O
PLV	O
either	O
reduced	O
mortality	O
at	O
28	O
d	O
(	O
risk	O
ratio	O
(	O
RR	O
)	O
1	O
.	O
21	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
0	O
.	O
79	O
to	O
1	O
.	O
85	O
,	O
P	O
=	O
0	O
.	O
37	O
)	O
or	O
increased	O
the	O
number	O
of	O
days	O
free	O
of	O
CMV	B-SPEC
at	O
28	O
d	O
(	O
mean	O
difference	O
(	O
MD	O
)	O
-	O
2	O
.	O
24	O
,	O
95	O
%	O
CI	O
-	O
4	O
.	O
71	O
to	O
0	O
.	O
23	O
,	O
P	O
=	O
0	O
.	O
08	O
).	O

The	O
pooled	O
estimate	O
of	O
effect	O
for	O
bradycardia	O
in	O
those	O
who	O
received	O
PLV	O
was	O
significantly	O
greater	O
than	O
in	O
those	O
who	O
received	O
CMV	B-SPEC
(	O
RR	O
2	O
.	O
51	O
,	O
95	O
%	O
CI	O
1	O
.	O
31	O
to	O
4	O
.	O
81	O
,	O
P	O
=	O
0	O
.	O
005	O
).	O

While	O
MERS	O
-	O
CoV	O
has	O
already	O
spread	O
to	O
and	O
within	O
other	O
countries	O
,	O
these	O
mass	O
gatherings	O
could	O
further	O
amplify	O
and	O
/	O
or	O
accelerate	O
its	O
international	O
dissemination	O
,	O
especially	O
since	O
the	O
origins	O
and	O
geographic	O
source	O
of	O
the	O
virus	B-SPEC
remain	O
poorly	O
understood	O
.	O

But	O
this	O
method	O
also	O
provides	O
quantitative	O
kinetic	O
rate	O
parameters	O
for	O
intermediate	O
steps	O
in	O
the	O
coronavirus	B-SPEC
fusion	O
pathway	O
,	O
which	O
to	O
our	O
knowledge	O
have	O
not	O
been	O
obtained	O
before	O
.	O

TITLE	O
:	O
Saudi	O
Arabia	O
and	O
the	O
emergence	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
novel	B-SPEC
coronavirus	I-SPEC
disease	O
outbreak	O
in	O
Saudi	O
Arabia	O
in	O
2012	O
predominately	O
affected	O
males	O
and	O
those	O
living	O
in	O
urban	O
areas	O
.	O

A	O
second	O
Riyadh	O
family	B-SPEC
cluster	O
is	O
being	O
investigated	O
.	O

Following	O
the	O
discovery	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
infection	O
(	O
nCoV	O
)	O
in	O
the	O
Arabian	O
peninsula	O
in	O
September	O
2012	O
,	O
stored	O
respiratory	O
and	O
serum	O
samples	O
of	O
patients	O
from	O
this	O
outbreak	O
were	O
retested	O
and	O
the	O
diagnosis	O
of	O
nCoV	O
was	O
confirmed	O
in	O
2	O
deceased	O
patients	O
.	O

TITLE	O
:	O
The	O
early	O
response	O
to	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
the	O
Middle	O
East	O
.	O

This	O
review	O
describes	O
WHO	O
'	O
s	O
communication	O
response	O
to	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
event	O
'	O
and	O
its	O
efforts	O
to	O
provide	O
early	O
,	O
accurate	O
information	O
via	O
various	O
media	O
to	O
keep	O
the	O
public	O
appraised	O
of	O
the	O
situation	O
,	O
and	O
its	O
commitment	O
to	O
continued	O
communication	O
on	O
an	O
ongoing	O
basis	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
account	O
for	O
the	O
majority	O
of	O
the	O
acute	O
respiratory	O
tract	O
infections	O
(	O
ARIs	O
)	O
globally	O
with	O
a	O
mortality	O
exceeding	O
4	O
million	O
deaths	O
per	O
year	O
.	O

ABSTRACT	O
:	O
Following	O
the	O
discovery	O
in	O
September	O
2012	O
of	O
2	O
patients	O
,	O
both	O
with	O
links	O
to	O
the	O
Eastern	O
Mediterranean	O
Region	O
,	O
with	O
serious	O
respiratory	O
illness	O
due	O
to	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
all	O
countries	O
have	O
instigated	O
surveillance	O
and	O
laboratory	O
activities	O
to	O
detect	O
further	O
cases	O
,	O
with	O
intensive	O
case	O
-	O
contact	O
investigations	O
undertaken	O
on	O
laboratory	O
confirmation	O
of	O
cases	O
.	O

To	O
date	O
,	O
transmission	O
studies	O
have	O
shown	O
a	O
low	O
risk	O
of	O
onward	O
human	B-SPEC
transmission	O
,	O
with	O
clinical	O
presentation	O
remaining	O
severe	O
for	O
the	O
majority	O
.	O

TITLE	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
infection	O
of	O
primary	O
human	B-SPEC
type	O
II	O
alveolar	O
epithelial	O
cells	O
:	O
cytopathic	O
effects	O
and	O
innate	O
immune	O
response	O
.	O

All	O
developed	O
signs	O
of	O
prolonged	O
postoperative	O
sepsis	B-SPEC
with	O
hepatosplenomegaly	O
and	O
pancytopenia	O
,	O
requiring	O
intensive	O
care	O
support	O
.	O

as	O
an	O
indicator	B-SPEC
of	O
when	O
and	O
where	O
influenza	O
was	O
occurring	O
.	O

We	O
compared	O
the	O
spike	O
protein	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
the	O
spike	O
protein	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

The	O
present	O
study	O
demonstrates	O
that	O
among	O
major	O
complications	O
,	O
low	O
output	O
syndrome	O
,	O
renal	O
failure	O
requiring	O
renal	O
replacement	O
therapy	O
and	O
sepsis	B-SPEC
,	O
dramatically	O
impaired	O
the	O
postoperative	O
course	O
patients	O
aged	O
over	O
80	O
years	O
undergoing	O
CABG	O
,	O
AVR	O
or	O
combined	O
CABG	O
and	O
AVR	O
.	O

A	O
multivariate	O
analysis	O
revealed	O
that	O
advanced	O
age	O
(	O
OR	O
1	O
.	O
130	O
,	O
95	O
%	O
CI	O
;	O
1	O
.	O
017	O
-	O
1	O
.	O
256	O
,	O
p	O
=	O
0	O
.	O
023	O
),	O
low	O
output	O
syndrome	O
(	O
OR	O
5	O
.	O
094	O
,	O
95	O
%	O
CI	O
;	O
1	O
.	O
1635	O
-	O
15	O
.	O
871	O
,	O
p	O
=	O
0	O
.	O
005	O
),	O
renal	O
failure	O
(	O
OR	O
8	O
.	O
128	O
,	O
95	O
%	O
CI	O
;	O
3	O
.	O
347	O
-	O
19	O
.	O
742	O
,	O
p	O
=	O
0	O
.	O
0001	O
)	O
and	O
sepsis	B-SPEC
(	O
OR	O
4	O
.	O
975	O
,	O
95	O
%	O
CI	O
;	O
1	O
.	O
420	O
-	O
17	O
.	O
426	O
,	O
p	O
=	O
0	O
.	O
012	O
)	O
as	O
independent	O
risk	O
factors	O
.	O

Alarmingly	O
,	O
the	O
virus	B-SPEC
demonstrates	O
the	O
capability	O
of	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
,	O
raising	O
the	O
possibility	O
of	O
global	O
spread	O
and	O
endangering	O
world	O
health	O
and	O
economy	O
.	O

This	O
study	O
also	O
presents	O
a	O
structural	O
comparison	O
of	O
MERS	O
-	O
CoV	O
RBD	O
with	O
other	O
coronavirus	B-SPEC
RBDs	O
,	O
successfully	O
positioning	O
MERS	O
-	O
CoV	O
on	O
the	O
landscape	O
of	O
coronavirus	B-SPEC
evolution	O
and	O
providing	O
insights	O
into	O
receptor	O
binding	O
by	O
MERS	O
-	O
CoV	O
.	O
Furthermore	O
,	O
we	O
found	O
that	O
MERS	O
-	O
CoV	O
RBD	O
functions	O
as	O
an	O
effective	O
entry	O
inhibitor	O
of	O
MERS	O
-	O
CoV	O
.	O
The	O
identified	O
MERS	O
-	O
CoV	O
RBD	O
may	O
also	O
serve	O
as	O
a	O
potential	O
candidate	O
for	O
MERS	O
-	O
CoV	O
subunit	O
vaccines	O
.	O

Overall	O
,	O
this	O
study	O
enhances	O
our	O
understanding	O
of	O
the	O
evolution	O
of	O
coronavirus	B-SPEC
RBDs	O
,	O
provides	O
insights	O
into	O
receptor	O
recognition	O
by	O
MERS	O
-	O
CoV	O
,	O
and	O
may	O
help	O
control	O
the	O
transmission	O
of	O
MERS	O
-	O
CoV	O
in	O
humans	B-SPEC
.	O

Previously	O
,	O
we	O
demonstrated	O
that	O
this	O
locus	O
,	O
which	O
contains	O
the	O
gene	O
for	O
accessory	O
protein	O
3a	O
from	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
encodes	O
a	O
protein	O
that	O
forms	O
ion	O
channels	O
and	O
regulates	O
virus	B-SPEC
release	O
.	O

The	O
ORF4a	O
proteins	O
formed	O
homo	B-SPEC
-	O
oligomers	O
through	O
disulfide	O
bridges	O
and	O
possessed	O
ion	O
channel	O
activity	O
in	O
both	O
Xenopus	B-SPEC
oocytes	O
and	O
yeast	B-SPEC
.	O

Based	O
on	O
multivariable	O
logistic	O
regression	O
analysis	O
,	O
the	O
PRESERVE	O
(	O
PRedicting	O
dEath	O
for	O
SEvere	O
ARDS	O
on	O
VV	O
-	O
ECMO	O
)	O
score	O
(	O
0	O
-	O
14	O
points	O
)	O
was	O
constructed	O
with	O
eight	O
pre	O
-	O
ECMO	O
parameters	O
,	O
i	O
.	O
e	O
.	O
age	O
,	O
body	O
mass	O
index	O
,	O
immunocompromised	O
status	O
,	O
prone	O
positioning	O
,	O
days	O
of	O
mechanical	O
ventilation	O
,	O
sepsis	B-SPEC
-	O
related	O
organ	O
failure	O
assessment	O
,	O
plateau	O
pressure	O
andpositive	O
end	O
-	O
expiratory	O
pressure	O
.	O

Aqueous	O
humor	O
cytology	O
was	O
diagnostic	O
in	O
no	O
cats	B-SPEC
and	O
two	O
dogs	B-SPEC
,	O
both	O
with	O
neoplasia	O
.	O

The	O
expression	O
of	O
CD11b	O
and	O
CD18	O
,	O
that	O
combine	O
to	O
form	O
the	O
β2	O
integrin	O
macrophage	O
-	O
1	O
antigen	O
(	O
Mac	B-SPEC
-	O
1	O
),	O
was	O
elevated	O
on	O
monocytes	O
,	O
whereas	O
the	O
density	O
of	O
CD49d	O
was	O
reduced	O
on	O
this	O
population	O
in	O
FIP	O
.	O

ABSTRACT	O
:	O
The	O
protein	O
C	O
system	O
plays	O
an	O
active	O
role	O
in	O
modulating	O
severe	O
systemic	O
inflammatory	O
processes	O
such	O
as	O
sepsis	B-SPEC
,	O
trauma	O
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
via	O
its	O
anticoagulant	O
and	O
anti	O
-	O
inflammatory	O
properties	O
.	O

Thus	O
,	O
following	O
positive	O
results	O
of	O
preclinical	O
studies	O
,	O
a	O
clinical	O
trial	O
(	O
PROWESS	O
)	O
with	O
high	O
continuous	O
doses	O
of	O
recombinant	O
human	B-SPEC
aPC	O
given	O
for	O
4	O
days	O
demonstrated	O
a	O
survival	O
benefit	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

Thus	O
whether	O
aPC	O
will	O
continue	O
to	O
be	O
used	O
to	O
modulate	O
the	O
acute	O
inflammatory	O
response	O
in	O
humans	B-SPEC
remains	O
uncertain	O
.	O

These	O
cell	O
lines	O
are	O
valuable	O
tools	O
to	O
perform	O
in	O
vitro	O
studies	O
in	O
a	O
mouse	B-SPEC
cell	O
system	O
that	O
reflects	O
the	O
species	B-SPEC
used	O
for	O
in	O
vivo	O
studies	O
of	O
SARS	O
-	O
CoV	O
-	O
MA15	O
pathogenesis	O
.	O

Intriguingly	O
,	O
bats	B-SPEC
infected	O
by	O
these	O
different	O
viruses	B-SPEC
seldom	O
display	O
clinical	O
symptoms	O
of	O
illness	O
.	O

Ongoing	O
epidemiological	O
investigations	O
together	O
with	O
retrospective	O
studies	O
have	O
found	O
61	O
laboratory	O
-	O
confirmed	O
cases	O
of	O
infection	O
with	O
this	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
including	O
34	O
deaths	O
to	O
date	O
.	O

It	O
is	O
extremely	O
urgent	O
and	O
important	O
to	O
identify	O
a	O
novel	O
virus	B-SPEC
near	O
-	O
instantaneously	O
to	O
develop	O
an	O
active	O
preventive	O
and	O
/	O
or	O
control	O
strategy	O
.	O

As	O
a	O
culture	O
-	O
independent	O
approach	O
,	O
viral	O
metagenomics	O
has	O
been	O
widely	O
used	O
to	O
investigate	O
highly	O
divergent	O
and	O
completely	O
new	O
viruses	B-SPEC
in	O
humans	B-SPEC
,	O
animals	B-SPEC
,	O
and	O
even	O
environmental	B-SPEC
samples	I-SPEC
in	O
the	O
past	O
decade	O
.	O

We	O
validated	O
the	O
importance	O
of	O
the	O
urokinase	O
pathway	O
for	O
SARS	O
-	O
CoV	O
disease	O
severity	O
using	O
genetically	O
defined	O
knockout	O
mice	B-SPEC
,	O
proteomic	O
correlates	O
of	O
pathway	O
activation	O
,	O
and	O
pathological	O
disease	O
severity	O
.	O

Surprisingly	O
,	O
this	O
length	O
was	O
found	O
to	O
vary	O
throughout	O
infection	O
from	O
~	O
45	O
nt	O
immediately	O
after	O
virus	B-SPEC
entry	O
(	O
at	O
0	O
to	O
4	O
hpi	O
)	O
to	O
~	O
65	O
nt	O
later	O
on	O
(	O
at	O
6	O
h	O
to	O
9	O
hpi	O
)	O
and	O
from	O
~	O
65	O
nt	O
(	O
at	O
6	O
h	O
to	O
9	O
hpi	O
)	O
to	O
~	O
30	O
nt	O
(	O
at	O
120	O
-	O
144	O
hpi	O
).	O

RSV	B-SPEC
was	O
the	O
most	O
prevalent	O
virus	B-SPEC
detected	O
among	O
hospitalized	O
children	O
,	O
whereas	O
IFV	B-SPEC
was	O
the	O
most	O
frequently	O
identified	O
virus	B-SPEC
in	O
the	O
outpatient	O
group	O
.	O

Reverse	O
transcription	O
(	O
RT	O
)	O
PCRs	O
were	O
performed	O
to	O
detect	O
common	O
respiratory	O
tract	O
viruses	B-SPEC
including	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
HRV	O
),	O
influenza	B-SPEC
virus	I-SPEC
(	O
IFV	B-SPEC
),	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
)	O
type	O
1	O
-	O
4	O
,	O
adenovirus	B-SPEC
(	O
ADV	O
),	O
enterovirus	B-SPEC
(	O
EV	O
),	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCOV	O
),	O
human	B-SPEC
metapneumonia	O
virus	B-SPEC
(	O
HMPV	B-SPEC
)	O
and	O
human	B-SPEC
bocavirus	I-SPEC
(	O
HBOV	O
).	O

CONCLUSIONS	O
:	O
Respiratory	O
viruses	B-SPEC
play	O
an	O
important	O
role	O
in	O
children	O
with	O
ARI	O
,	O
especially	O
in	O
young	O
children	O
.	O

TITLE	O
:	O
Development	O
of	O
transgenic	B-SPEC
mice	I-SPEC
expressing	O
a	O
coronavirus	B-SPEC
-	O
specific	O
public	O
CD4	O
T	O
cell	O
receptor	O
.	O

We	O
applied	O
an	O
iterative	O
process	O
in	O
which	O
we	O
identified	O
a	O
TCR	O
-	O
β	O
chain	O
expressed	O
by	O
all	O
mice	B-SPEC
that	O
were	O
examined	O
('	O
public	O
sequence	O
').	O

A	O
TCR	O
-	O
α	O
chain	O
that	O
paired	O
with	O
this	O
TCR	O
-	O
β	O
was	O
then	O
identified	O
and	O
used	O
to	O
generate	O
a	O
second	O
set	O
of	O
TCR	O
(	O
α	O
/	O
β	O
)	O
retrogenic	O
mice	B-SPEC
.	O

Results	O
were	O
confirmed	O
by	O
virus	B-SPEC
neutralisation	O
tests	O
for	O
MERS	O
-	O
CoV	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Respiratory	O
infections	O
stemming	O
from	O
influenza	B-SPEC
viruses	I-SPEC
and	O
the	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
corona	B-SPEC
virus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
represent	O
a	O
serious	O
public	O
health	O
threat	O
as	O
emerging	O
pandemics	O
.	O

Despite	O
efforts	O
to	O
identify	O
the	O
critical	O
interactions	O
of	O
these	O
viruses	B-SPEC
with	O
host	O
machinery	O
,	O
the	O
key	O
regulatory	O
events	O
that	O
lead	O
to	O
disease	O
pathology	O
remain	O
poorly	O
targeted	O
with	O
therapeutics	O
.	O

Here	O
we	O
implement	O
an	O
integrated	O
network	O
interrogation	O
approach	O
,	O
in	O
which	O
proteome	O
and	O
transcriptome	O
datasets	O
from	O
infection	O
of	O
both	O
viruses	B-SPEC
in	O
human	B-SPEC
lung	O
epithelial	O
cells	O
are	O
utilized	O
to	O
predict	O
regulatory	O
genes	O
involved	O
in	O
the	O
host	O
response	O
.	O

We	O
take	O
advantage	O
of	O
a	O
novel	O
""""	O
crowd	O
-	O
based	O
""""	O
approach	O
to	O
identify	O
and	O
combine	O
ranking	O
metrics	O
that	O
isolate	O
genes	O
/	O
proteins	O
likely	O
related	O
to	O
the	O
pathogenicity	O
of	O
SARS	O
-	O
CoV	O
and	O
influenza	B-SPEC
virus	I-SPEC
.	O

Although	O
the	O
majority	O
of	O
infections	O
caused	O
by	O
coronaviruses	O
in	O
humans	B-SPEC
are	O
relatively	O
mild	O
,	O
the	O
SARS	O
outbreak	O
of	O
2002	O
to	O
2003	O
and	O
the	O
emergence	O
of	O
the	O
human	B-SPEC
coronavirus	I-SPEC
Middle	O
Eastern	O
respiratory	O
syndrome	O
(	O
MERS	O
-	O
CoV	O
)	O
in	O
2012	O
highlight	O
the	O
ability	O
of	O
these	O
viruses	B-SPEC
to	O
cause	O
severe	O
pathology	O
and	O
fatality	O
.	O

TITLE	O
:	O
Bugs	B-SPEC
in	O
the	O
system	O
.	O

Thus	O
,	O
an	O
Ark	O
-	O
type	O
IBV	B-SPEC
ocular	O
vaccine	O
induces	O
a	O
central	O
memory	O
IFN	O
-	O
γ	O
response	O
in	O
the	O
spleen	O
while	O
the	O
cytotoxic	O
effector	O
memory	O
response	O
,	O
as	O
measured	O
by	O
GZMA	O
and	O
perforin	O
mRNA	O
expression	O
,	O
remains	O
associated	O
with	O
CALT	O
after	O
boosting	O
.	O

We	O
performed	O
a	O
structured	O
search	O
on	O
Pubmed	O
,	O
EMBASE	O
,	O
Lilacs	B-SPEC
,	O
and	O
the	O
Cochrane	O
Library	O
for	O
randomized	O
controlled	O
trials	O
and	O
observational	O
case	O
-	O
control	O
studies	O
with	O
severity	O
-	O
paired	O
patients	O
,	O
evaluating	O
the	O
use	O
of	O
ECMO	O
on	O
severe	O
acute	O
respiratory	O
failure	O
in	O
adult	O
patients	O
.	O

Our	O
results	O
suggest	O
that	O
these	O
new	O
PEDV	B-SPEC
variant	O
strains	O
in	O
Gansu	O
Province	O
might	O
be	O
from	O
South	O
Korean	O
or	O
South	O
China	O
,	O
and	O
the	O
effectiveness	O
of	O
the	O
CV777	O
-	O
based	O
vaccine	O
needs	O
to	O
be	O
evaluated	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
replicates	O
primarily	O
in	O
the	O
respiratory	O
tract	O
and	O
grows	O
in	O
various	O
organs	O
in	O
chickens	B-SPEC
,	O
with	O
or	O
without	O
pathological	O
effects	O
.	O

The	O
diversity	O
of	O
this	O
virus	B-SPEC
has	O
been	O
verified	O
by	O
sequence	O
analysis	O
of	O
the	O
S1	O
glycoprotein	O
gene	O
,	O
but	O
this	O
method	O
must	O
be	O
supplemented	O
with	O
further	O
analysis	O
for	O
characterization	O
of	O
the	O
agent	O
.	O

To	O
increase	O
our	O
understanding	O
of	O
the	O
pathogenesis	O
of	O
the	O
disease	O
caused	O
by	O
this	O
virus	B-SPEC
,	O
we	O
investigated	O
the	O
response	O
of	O
chickens	B-SPEC
to	O
2	O
IBV	B-SPEC
with	O
different	O
genotypes	O
,	O
KIIa	O
and	O
ChVI	O
.	O

ABSTRACT	O
:	O
During	O
the	O
10	O
days	O
commencing	O
April	O
29	O
,	O
2013	O
,	O
the	O
Iowa	O
State	O
University	O
Veterinary	O
Diagnostic	O
Laboratory	O
received	O
the	O
first	O
4	O
of	O
many	O
submissions	O
from	O
swine	B-SPEC
farms	O
experiencing	O
explosive	O
epidemics	O
of	O
diarrhea	O
and	O
vomiting	O
affecting	O
all	O
ages	O
,	O
with	O
90	O
-	O
95	O
%	O
mortality	O
in	O
suckling	O
pigs	B-SPEC
.	O

However	O
,	O
many	O
key	O
issues	O
need	O
to	O
be	O
addressed	O
,	O
including	O
identification	O
of	O
the	O
proximate	O
,	O
presumably	O
zoonotic	O
,	O
source	O
of	O
the	O
infection	O
,	O
the	O
prevalence	O
of	O
the	O
infection	O
in	O
human	B-SPEC
populations	O
,	O
details	O
regarding	O
clinical	O
and	O
pathological	O
features	O
of	O
the	O
human	B-SPEC
infection	O
,	O
the	O
establishment	O
of	O
a	O
small	O
rodent	B-SPEC
model	O
for	O
the	O
infection	O
,	O
and	O
the	O
virological	O
and	O
immune	O
basis	O
for	O
the	O
severe	O
disease	O
observed	O
in	O
most	O
patients	O
.	O

TITLE	O
:	O
Establishment	O
of	O
feline	B-SPEC
intestinal	O
epithelial	O
cell	O
cultures	O
for	O
the	O
propagation	O
and	O
study	O
of	O
feline	B-SPEC
enteric	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
the	O
most	O
feared	O
infectious	O
cause	O
of	O
death	O
in	O
cats	B-SPEC
,	O
induced	O
by	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
).	O

CoVs	O
express	O
a	O
3	O
'-	O
to	O
-	O
5	O
'	O
exoribonuclease	O
in	O
nonstructural	O
protein	O
14	O
(	O
nsp14	O
-	O
ExoN	O
)	O
that	O
is	O
required	O
for	O
high	O
-	O
fidelity	O
replication	O
and	O
is	O
conserved	O
across	O
the	O
CoV	O
family	B-SPEC
.	O

Endothelial	O
nitric	O
oxide	O
synthase	O
(	O
eNOS	O
)	O
was	O
proposed	O
to	O
be	O
a	O
guardian	O
of	O
basal	O
barrier	O
function	O
,	O
since	O
eNOS	O
knock	O
-	O
out	O
mice	B-SPEC
display	O
an	O
impaired	O
expression	O
of	O
inter	O
-	O
endothelial	O
junction	O
proteins	O
and	O
as	O
such	O
an	O
increased	O
vascular	O
permeability	O
,	O
as	O
compared	O
to	O
wild	O
type	O
mice	B-SPEC
.	O

Immunization	O
with	O
C	O
vaccine	O
allowed	O
to	O
harvest	O
eggs	O
with	O
satisfactory	O
levels	O
of	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
rotavirus	B-SPEC
and	O
coronavirus	B-SPEC
IgY	O
antibodies	O
which	O
may	O
be	O
used	O
to	O
evaluate	O
their	O
protective	O
effect	O
by	O
oral	O
administration	O
in	O
calves	O
.	O

MERS	O
-	O
CoV	O
human	B-SPEC
infection	O
is	O
similar	O
to	O
SARS	O
-	O
CoV	O
in	O
having	O
a	O
high	O
fatality	O
rate	O
and	O
the	O
ability	O
to	O
spread	O
from	O
person	O
to	O
person	O
which	O
resulted	O
in	O
secondary	O
cases	O
among	O
close	O
contacts	O
including	O
healthcare	O
workers	O
without	O
travel	O
history	O
to	O
the	O
Middle	O
East	O
.	O

New	O
cases	O
of	O
MERS	O
-	O
CoV	O
infection	O
in	O
humans	B-SPEC
continue	O
to	O
occur	O
with	O
the	O
origins	O
of	O
the	O
virus	B-SPEC
still	O
unknown	O
in	O
many	O
cases	O
.	O

Studies	O
based	O
on	O
laser	B-SPEC
visualization	O
technique	O
with	O
smoke	O
particles	O
as	O
smokers	O
in	O
the	O
human	B-SPEC
patient	O
simulator	O
has	O
shown	O
that	O
oxygen	O
therapy	O
via	O
Hudson	O
mask	O
and	O
nasal	O
cannula	B-SPEC
could	O
disperse	O
exhaled	O
air	O
of	O
patients	O
to	O
0	O
.	O
4	O
and	O
1	O
m	O
respectively	O
whereas	O
jet	O
nebulizer	O
could	O
disperse	O
exhaled	O
air	O
>	O
0	O
.	O
8	O
m	O
from	O
the	O
patient	O
.	O

Furthermore	O
,	O
one	O
small	O
molecule	O
HIV	B-SPEC
entry	O
inhibitor	O
targeting	O
gp41	O
(	O
ADS	O
-	O
J1	B-SPEC
)	O
and	O
the	O
3	O
-	O
hydroxyphthalic	O
anhydride	O
-	O
modified	O
human	B-SPEC
serum	O
albumin	O
(	O
HP	O
-	O
HSA	O
)	O
could	O
significantly	O
inhibit	O
MERS	O
-	O
CoV	O
pseudovirus	O
infection	O
.	O

Taken	O
together	O
,	O
the	O
established	O
MERS	O
-	O
CoV	O
inhibition	O
assay	O
is	O
a	O
safe	O
and	O
convenient	O
pseudovirus	O
-	O
based	O
alternative	O
to	O
BSL	O
-	O
3	O
live	O
-	O
virus	B-SPEC
restrictions	O
and	O
can	O
be	O
used	O
to	O
rapidly	O
screen	O
MERS	O
-	O
CoV	O
entry	O
inhibitors	O
,	O
as	O
well	O
as	O
evaluate	O
vaccine	O
-	O
induced	O
neutralizing	O
antibodies	O
against	O
the	O
highly	O
pathogenic	O
MERS	O
-	O
CoV	O
.	O
RESULTS	O
:	O
Our	O
results	O
demonstrated	O
that	O
the	O
generated	O
MERS	O
-	O
CoV	O
pseudovirus	O
allows	O
for	O
single	O
-	O
cycle	O
infection	O
of	O
a	O
variety	O
of	O
cells	O
expressing	O
dipeptidyl	O
peptidase	O
-	O
4	O
(	O
DPP4	O
),	O
the	O
confirmed	O
receptor	O
for	O
MERS	O
-	O
CoV	O
.	O
Consistent	O
with	O
the	O
results	O
from	O
a	O
live	O
MERS	O
-	O
CoV	O
-	O
based	O
inhibition	O
assay	O
,	O
the	O
antisera	O
of	O
mice	B-SPEC
vaccinated	O
with	O
a	O
recombinant	O
protein	O
containing	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
,	O
residues	O
377	O
-	O
662	O
)	O
of	O
MERS	O
-	O
CoV	O
S	O
fused	O
with	O
Fc	O
of	O
human	B-SPEC
IgG	O
exhibited	O
neutralizing	O
antibody	O
response	O
against	O
infection	O
of	O
MERS	O
-	O
CoV	O
pseudovirus	O
.	O

Here	O
,	O
we	O
constructed	O
recombinant	O
modified	O
vaccinia	B-SPEC
virus	I-SPEC
Ankara	O
(	O
MVA	O
)	O
expressing	O
full	O
-	O
length	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
(	O
MVA	O
-	O
MERS	O
-	O
S	O
).	O

We	O
report	O
a	O
case	O
of	O
a	O
64	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
a	O
medical	O
history	O
of	O
alchoholism	O
and	O
paranoid	O
symptoms	O
,	O
treated	O
with	O
risperidone	O
at	O
low	O
doses	O
.	O

A	O
docking	O
study	O
involving	O
binding	O
between	O
the	O
dipeptidic	O
lead	O
compound	O
4	O
and	O
3CLpro	O
suggested	O
the	O
modification	O
of	O
a	O
structurally	O
flexible	O
P3	O
N	O
-(	O
3	O
-	O
methoxyphenyl	O
)	O
glycine	B-SPEC
with	O
various	O
rigid	O
P3	O
moieties	O
in	O
4	O
.	O

P	B-SPEC
.	I-SPEC
vivax	I-SPEC
has	O
immense	O
potential	O
to	O
cause	O
life	O
threatening	O
complications	O
and	O
even	O
death	O
,	O
more	O
research	O
is	O
required	O
to	O
understand	O
the	O
exact	O
pathogenesis	O
of	O
various	O
complications	O
encountered	O
in	O
vivax	O
malaria	O
.	O

The	O
infectious	O
virus	B-SPEC
was	O
rescued	O
and	O
propagated	O
in	O
cells	O
expressing	O
the	O
E	O
protein	O
in	O
trans	O
,	O
indicating	O
that	O
this	O
virus	B-SPEC
was	O
replication	O
competent	O
and	O
propagation	O
defective	O
.	O

Taken	O
together	O
,	O
this	O
study	O
shed	O
new	O
insight	O
into	O
the	O
diversity	O
,	O
distribution	O
,	O
evolution	O
and	O
control	O
of	O
avian	B-SPEC
CoVs	O
.	O

TITLE	O
:	O
Differential	O
sensitivity	O
of	O
bat	B-SPEC
cells	O
to	O
infection	O
by	O
enveloped	O
RNA	O
viruses	B-SPEC
:	O
coronaviruses	O
,	O
paramyxoviruses	O
,	O
filoviruses	O
,	O
and	O
influenza	B-SPEC
viruses	I-SPEC
.	O

None	O
of	O
the	O
cells	O
were	O
sensitive	O
to	O
infection	O
by	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
a	O
porcine	B-SPEC
coronavirus	B-SPEC
,	O
or	O
to	O
infection	O
mediated	O
by	O
the	O
Spike	O
(	O
S	O
)	O
protein	O
of	O
SARS	O
-	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
incorporated	O
into	O
pseudotypes	O
based	O
on	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
(	O
VSV	O
).	O

By	O
contrast	O
,	O
viral	O
pseudotypes	O
containing	O
the	O
surface	O
protein	O
GP	O
of	O
Marburg	B-SPEC
virus	I-SPEC
from	O
the	O
family	B-SPEC
Filoviridae	I-SPEC
infected	O
all	O
six	O
cell	O
lines	O
though	O
at	O
different	O
efficiency	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
identified	O
in	O
174	O
encounters	O
,	O
34	O
of	O
these	O
via	O
BAL	O
.	O

In	O
addition	O
,	O
the	O
sponge	B-SPEC
model	O
accounts	O
for	O
the	O
mechanism	O
through	O
which	O
the	O
positive	O
end	O
-	O
expiratory	O
pressure	O
acts	O
as	O
counterforce	O
to	O
oppose	O
the	O
collapsing	O
,	O
compressing	O
forces	O
.	O

The	O
more	O
homogeneous	O
distribution	O
of	O
inflation	O
(	O
i	O
.	O
e	O
.	O
of	O
stress	O
and	O
strain	O
)	O
decreases	O
/	O
prevents	O
the	O
ventilator	O
-	O
induced	O
lung	O
injury	O
,	O
as	O
consistently	O
shown	O
in	O
animal	B-SPEC
experiments	O
.	O

Importantly	O
,	O
the	O
coronavirus	B-SPEC
is	O
thought	O
to	O
enter	O
cells	O
via	O
two	O
distinct	O
pathways	O
,	O
one	O
mediated	O
by	O
TMPRSS2	O
at	O
the	O
cell	O
surface	O
and	O
the	O
other	O
mediated	O
by	O
cathepsin	O
L	O
in	O
the	O
endosome	O
.	O

In	O
contrast	O
,	O
a	O
single	O
camostat	O
treatment	O
suppressed	O
MERS	O
-	O
CoV	O
entry	O
into	O
human	B-SPEC
bronchial	O
submucosal	O
gland	O
-	O
derived	O
Calu	O
-	O
3	O
cells	O
by	O
10	O
-	O
fold	O
and	O
virus	B-SPEC
growth	O
by	O
270	O
-	O
fold	O
,	O
although	O
treatment	O
with	O
both	O
camostat	O
and	O
(	O
23	O
,	O
25	O
)-	O
trans	O
-	O
epoxysuccinyl	O
-	O
L	O
-	O
leucylamindo	O
-	O
3	O
-	O
methylbutane	O
ethyl	O
ester	O
,	O
a	O
cathepsin	O
inhibitor	O
,	O
or	O
treatment	O
with	O
leupeptin	O
,	O
an	O
inhibitor	O
of	O
cysteine	O
,	O
serine	O
,	O
and	O
threonine	O
peptidases	O
,	O
was	O
no	O
more	O
efficacious	O
than	O
treatment	O
with	O
camostat	O
alone	O
.	O

To	O
test	O
for	O
conservation	O
of	O
nsp5	O
structure	O
-	O
function	O
determinants	O
,	O
we	O
engineered	O
chimeric	O
betacoronavirus	B-SPEC
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
genomes	O
encoding	O
nsp5	O
proteases	O
of	O
human	B-SPEC
and	O
bat	B-SPEC
alphacoronaviruses	O
and	O
betacoronaviruses	O
.	O

ABSTRACT	O
:	O
A	O
survey	O
of	O
Turkey	B-SPEC
Coronavirus	B-SPEC
(	O
TCoV	O
)	O
and	O
Astrovirus	O
(	O
TAstV	O
-	O
2	O
)	O
prevalence	O
was	O
carried	O
out	O
from	O
February	O
to	O
December	O
during	O
2006	O
year	O
in	O
semiarid	O
region	O
of	O
Brazil	O
,	O
from	O
a	O
turkey	B-SPEC
producer	O
area	O
,	O
localized	O
in	O
South	O
Eastern	O
of	O
Brazil	O
.	O

ABSTRACT	O
:	O
This	O
article	O
reports	O
the	O
use	O
of	O
the	O
GsuI	O
restriction	O
enzyme	O
to	O
differentiate	O
genotypes	O
of	O
Bovine	B-SPEC
Coronavirus	B-SPEC
(	O
BCoV	O
),	O
based	O
on	O
an	O
18	O
-	O
nucleotide	O
deletion	O
of	O
S1	O
-	O
coding	O
region	O
found	O
in	O
one	O
of	O
the	O
two	O
genotypes	O
.	O

the	O
key	O
words	O
""""	O
bronchiolitis	O
""","	O
""""	O
risk	O
factor	O
""","	O
""""	O
genetics	O
""""	O
and	O
""""	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
""","	O
and	O
all	O
combinations	O
among	O
them	O
were	O
used	O
to	O
perform	O
a	O
search	O
in	O
the	O
PubMed	O
,	O
SciELO	O
,	O
and	O
Lilacs	B-SPEC
databases	O
,	O
of	O
articles	O
published	O
after	O
the	O
year	O
2000	O
that	O
included	O
individuals	O
younger	O
than	O
2	O
years	O
of	O
age	O
.	O

the	O
severity	O
of	O
AVB	O
by	O
RSV	B-SPEC
is	O
a	O
phenomenon	O
that	O
depends	O
on	O
the	O
varying	O
degrees	O
of	O
interaction	O
among	O
epidemiological	O
,	O
environmental	O
,	O
and	O
genetic	O
variables	O
.	O

Eighteen	O
NDV	B-SPEC
strains	O
,	O
fourteen	O
AIV	O
strains	O
,	O
and	O
twelve	O
other	O
(	O
negative	O
control	O
)	O
strains	O
viruses	B-SPEC
were	O
isolated	O
from	O
allantoic	O
fluids	O
of	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
),	O
embryonated	O
eggs	O
.	O

To	O
further	O
elucidate	O
the	O
role	O
of	O
S2	O
the	O
spike	O
ectodomains	O
of	O
virulent	O
IBV	B-SPEC
M41	O
and	O
chimeras	O
of	O
M41	O
and	O
Beaudette	O
were	O
analyzed	O
for	O
their	O
binding	O
to	O
CAM	O
,	O
chicken	B-SPEC
trachea	B-SPEC
and	O
mammalian	B-SPEC
cell	O
lines	O
.	O

In	O
addition	O
,	O
we	O
ablated	O
expression	O
of	O
the	O
accessory	O
protein	O
ORF5	O
(	O
rMERS	O
•	O
ORF5	O
)	O
and	O
replaced	O
it	O
with	O
tomato	B-SPEC
red	O
fluorescent	O
protein	O
(	O
rMERS	O
-	O
RFP	O
)	O
or	O
deleted	O
the	O
entire	O
ORF3	O
,	O
4	O
,	O
and	O
5	O
accessory	O
cluster	O
(	O
rMERS	O
-	O
ΔORF3	O
-	O
5	O
).	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
can	O
cause	O
either	O
asymptomatic	O
enteric	O
infection	O
or	O
fatal	O
peritonitis	O
in	O
cats	B-SPEC
.	O

Although	O
the	O
mutation	O
of	O
FCoV	O
accessory	O
gene	O
3c	O
has	O
been	O
suggested	O
to	O
be	O
related	O
to	O
the	O
occurrence	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
how	O
the	O
3C	O
protein	O
is	O
involved	O
in	O
this	O
phenomenon	O
remains	O
unknown	O
.	O

TITLE	O
:	O
Transmission	O
and	O
evolution	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
Saudi	O
Arabia	O
:	O
a	O
descriptive	O
genomic	O
study	O
.	O

We	O
found	O
evidence	O
that	O
a	O
Th1	O
-	O
biased	O
cytokine	O
/	O
chemokine	O
response	O
and	O
eicosanoid	O
-	O
derived	O
inflammation	O
accompany	O
persistent	O
MHV	B-SPEC
infection	O
and	O
that	O
antigen	O
presentation	O
is	O
ongoing	O
.	O

Lastly	O
,	O
expression	O
of	O
several	O
genes	O
involved	O
in	O
osteoclast	O
or	O
bone	O
-	O
resident	O
macrophage	O
function	O
,	O
most	O
notably	O
TREM2	O
and	O
DAP12	O
,	O
was	O
upregulated	O
in	O
persistently	O
infected	O
mouse	B-SPEC
spinal	O
cord	O
.	O

ABSTRACT	O
:	O
Two	O
studies	O
were	O
conducted	O
to	O
determine	O
the	O
role	O
of	O
enteric	O
viruses	B-SPEC
in	O
Light	O
Turkey	B-SPEC
Syndrome	O
(	O
LTS	O
),	O
which	O
is	O
characterized	O
by	O
lower	O
weight	O
in	O
market	O
age	O
turkeys	B-SPEC
than	O
their	O
standard	O
breed	O
character	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
by	O
anti	O
-	O
CD26	O
monoclonal	O
antibody	O
.	O

Phylogenetically	O
,	O
the	O
nucleotide	O
similarity	O
of	O
both	O
the	O
Ukraine	O
specimens	O
and	O
reference	O
A	O
/	O
California	B-SPEC
/	O
7	O
/	O
2009	O
(	O
pH1N1	O
)	O
was	O
99	O
.	O
2	O
-	O
99	O
.	O
3	O
%.	O

Seventy	O
nine	O
1	O
to	O
8	O
day	O
old	O
male	O
Holstein	O
calves	O
on	O
a	O
California	B-SPEC
calf	O
ranch	O
were	O
block	O
randomized	O
to	O
one	O
of	O
3	O
treatments	O
within	O
24h	O
from	O
their	O
first	O
onset	O
of	O
diarrhea	O
.	O

TITLE	O
:	O
Seroepidemiology	O
for	O
MERS	O
coronavirus	B-SPEC
using	O
microneutralisation	O
and	O
pseudoparticle	O
virus	B-SPEC
neutralisation	O
assays	O
reveal	O
a	O
high	O
prevalence	O
of	O
antibody	O
in	O
dromedary	B-SPEC
camels	B-SPEC
in	O
Egypt	O
,	O
June	O
2013	O
.	O

Sera	O
from	O
dromedary	B-SPEC
camels	B-SPEC
had	O
a	O
high	O
prevalence	O
of	O
antibody	O
reactive	O
to	O
MERS	O
-	O
CoV	O
by	O
MERS	O
NT	O
(	O
93	O
.	O
6	O
%)	O
and	O
MERS	O
ppNT	O
(	O
98	O
.	O
2	O
%)	O
assay	O
.	O

The	O
cat	B-SPEC
had	O
tracheal	O
resection	O
and	O
subsequently	O
developed	O
laryngeal	O
paralysis	O
.	O

Mice	B-SPEC
with	O
viral	O
-	O
induced	O
and	O
EAE	O
demyelinating	O
diseases	O
demonstrated	O
similar	O
patterns	O
and	O
distributions	O
of	O
demyelination	O
that	O
accumulated	O
over	O
the	O
course	O
of	O
the	O
disease	O
.	O

Inflammation	O
was	O
restricted	O
mainly	O
to	O
white	O
matter	O
at	O
all	O
times	O
in	O
EAE	O
,	O
whereas	O
inflammation	O
initially	O
largely	O
involved	O
gray	O
matter	O
in	O
acute	O
MHV	B-SPEC
-	O
induced	O
disease	O
and	O
then	O
is	O
subsequently	O
localized	O
only	O
in	O
white	O
matter	O
in	O
the	O
chronic	O
disease	O
phase	O
.	O

The	O
results	O
can	O
help	O
to	O
reconsider	O
the	O
strategy	O
of	O
PEDV	B-SPEC
vaccine	O
management	O
and	O
prevent	O
outbreaks	O
of	O
PEDV	B-SPEC
-	O
induced	O
diarrhea	O
more	O
efficiently	O
.	O

ABSTRACT	O
:	O
The	O
swine	B-SPEC
-	O
origin	O
H1N1	O
virus	B-SPEC
which	O
emerged	O
in	O
2009	O
resulted	O
in	O
the	O
first	O
influenza	O
pandemic	O
of	O
the	O
21	O
(	O
st	O
)	O
century	O
.	O

We	O
compared	O
two	O
isolates	O
from	O
the	O
2009	O
H1N1	O
pandemic	O
;	O
A	O
/	O
California	B-SPEC
/	O
07	O
/	O
09	O
(	O
CA	O
/	O
07	O
)	O
and	O
A	O
/	O
Netherlands	O
/	O
602	O
/	O
09	O
(	O
NL	O
/	O
602	O
)	O
viruses	B-SPEC
that	O
share	O
greater	O
than	O
99	O
%	O
sequence	O
identity	O
.	O

Codon	O
usage	O
(	O
CU	O
)	O
was	O
measured	O
for	O
the	O
viral	O
spike	O
(	O
S	O
),	O
nucleocapsid	O
(	O
N	O
),	O
nonstructural	O
protein	O
2	O
(	O
NSP2	O
)	O
and	O
papain	O
-	O
like	O
protease	O
(	O
PL	O
(	O
pro	O
))	O
genes	O
from	O
a	O
diverse	O
set	O
of	O
A	B-SPEC
.	I-SPEC
coronavirus	I-SPEC
lineages	O
and	O
for	O
G	B-SPEC
.	I-SPEC
gallus	I-SPEC
genes	O
(	O
lung	O
surfactant	O
protein	O
A	O
,	O
intestinal	O
cholecystokinin	O
,	O
oviduct	O
ovomucin	O
alpha	O
subunit	O
,	O
kidney	O
vitamin	O
D	O
receptor	O
and	O
the	O
ubiquitary	O
beta	O
-	O
actin	O
)	O
for	O
different	O
A	B-SPEC
.	I-SPEC
coronavirus	I-SPEC
replicating	O
sites	O
.	O

Thus	O
,	O
the	O
administration	O
of	O
a	O
feline	B-SPEC
TNF	O
-	O
alpha	O
-	O
neutralizing	O
antibody	O
to	O
cats	B-SPEC
with	O
FIP	O
may	O
reduce	O
the	O
disease	O
progression	O
.	O

Molecular	O
multiplex	O
assay	O
for	O
12	O
respiratory	O
viruses	B-SPEC
was	O
performed	O
by	O
the	O
regional	O
reference	O
laboratory	O
.	O

Positive	O
predictive	O
value	O
(	O
PPV	B-SPEC
)	O
of	O
ILI	O
for	O
influenza	O
was	O
17	O
%.	O

Influenza	O
and	O
RSV	B-SPEC
peak	O
periods	O
were	O
contemporary	O
.	O

The	O
titer	O
of	O
anti	O
-	O
varicella	B-SPEC
zoster	I-SPEC
virus	I-SPEC
(	O
VZV	B-SPEC
)	O
IgG	O
antibodies	O
was	O
increased	O
,	O
that	O
indicated	O
VZV	B-SPEC
reactivation	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
),	O
although	O
VZV	B-SPEC
DNA	O
PCR	O
was	O
not	O
detected	O
.	O

Furthermore	O
,	O
recent	O
studies	O
have	O
suggested	O
that	O
the	O
exacerbation	O
of	O
asthma	O
,	O
namely	O
virus	B-SPEC
-	O
induced	O
asthma	O
,	O
may	O
be	O
associated	O
with	O
a	O
wide	O
variety	O
of	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
as	O
an	O
avian	B-SPEC
coronavirus	I-SPEC
is	O
still	O
posing	O
a	O
persistent	O
and	O
imminent	O
threat	O
to	O
the	O
poultry	O
industry	O
worldwide	O
.	O

Patients	O
with	O
RSV	B-SPEC
were	O
significantly	O
younger	O
whereas	O
children	O
infected	O
with	O
the	O
influenza	B-SPEC
viruses	I-SPEC
were	O
significantly	O
older	O
.	O

Comparison	O
of	O
symptoms	O
revealed	O
that	O
fever	O
and	O
headache	O
occurred	O
more	O
frequently	O
with	O
the	O
influenza	B-SPEC
viruses	I-SPEC
than	O
the	O
other	O
viruses	B-SPEC
combined	O
(	O
P	O
<	O
0	O
.	O
001	O
,	O
<	O
0	O
.	O
05	O
).	O

We	O
show	O
that	O
bat	B-SPEC
DPP4	O
genes	O
have	O
been	O
subject	O
to	O
significant	O
adaptive	O
evolution	O
,	O
suggestive	O
of	O
a	O
long	O
-	O
term	O
arms	O
-	O
race	O
between	O
bats	B-SPEC
and	O
MERS	O
related	O
CoVs	O
.	O

Our	O
study	O
suggests	O
that	O
the	O
evolutionary	O
lineage	O
leading	O
to	O
MERS	O
-	O
CoV	O
may	O
have	O
circulated	O
in	O
bats	B-SPEC
for	O
a	O
substantial	O
time	O
period	O
.	O

TITLE	O
:	O
Generation	O
of	O
a	O
monoclonal	O
antibody	O
to	O
S1	O
protein	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
Gene	O
encoding	O
the	O
N	O
-	O
terminal	O
half	O
of	O
spike	O
protein	O
(	O
S1	O
)	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
was	O
cloned	O
and	O
expressed	O
as	O
a	O
recombinant	O
protein	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
BL21	O
(	O
DE3	O
).	O

MAb	O
5E12	O
not	O
only	O
reacted	O
with	O
rS1	O
protein	O
indirect	O
ELISA	O
and	O
Western	O
blot	O
,	O
but	O
also	O
recognized	O
PEDV	B-SPEC
transiently	O
expressed	O
in	O
Vero	O
E6	O
cells	O
in	O
indirect	O
immunofluorescence	O
examinations	O
.	O

This	O
work	O
suggests	O
that	O
5E12	O
would	O
be	O
a	O
useful	O
tool	O
as	O
a	O
specific	O
diagnostic	O
reagent	O
for	O
detecting	O
PEDV	B-SPEC
S	O
protein	O
.	O

CONCLUSIONS	O
:	O
Children	O
with	O
multiple	O
viral	O
findings	O
in	O
their	O
respiratory	O
secretions	O
were	O
older	O
than	O
those	O
with	O
a	O
single	O
detected	O
virus	B-SPEC
.	O

Neither	O
enterotoxigenic	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
Clostridium	B-SPEC
perfringens	I-SPEC
type	O
A	O
or	O
C	O
,	O
Clostridium	B-SPEC
difficile	I-SPEC
,	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
Cryptosporidium	B-SPEC
spp	O
,	O
Giardia	B-SPEC
spp	O
,	O
Cystoisospora	B-SPEC
suis	I-SPEC
nor	O
Strongyloides	B-SPEC
ransomi	I-SPEC
were	O
associated	O
with	O
diarrhoea	O
in	O
the	O
investigated	O
outbreaks	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
20	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
mandibuloacral	O
dysplasia	O
,	O
an	O
extremely	O
rare	O
premature	O
ageing	O
syndrome	O
,	O
and	O
severe	O
symptomatic	O
aortic	O
stenosis	B-SPEC
,	O
referred	O
to	O
our	O
center	O
for	O
TAVI	O
after	O
being	O
considered	O
unsuitable	O
for	O
surgical	O
aortic	O
valve	O
replacement	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
and	O
canine	O
coronaviruses	O
(	O
FCoV	O
and	O
CCoV	O
,	O
respectively	O
)	O
are	O
common	O
pathogens	O
of	O
cats	B-SPEC
and	O
dogs	B-SPEC
sometimes	O
leading	O
to	O
lethal	O
infections	O
named	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
and	O
canine	O
pantropic	O
coronavirus	B-SPEC
infection	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
prevalence	O
of	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)-	O
infected	O
cats	B-SPEC
according	O
to	O
their	O
contact	O
with	O
dogs	B-SPEC
and	O
to	O
genetically	O
analyse	O
the	O
CoV	B-SPEC
strains	O
infecting	O
cats	B-SPEC
.	O

Moreover	O
,	O
the	O
ORF3	O
genes	O
recovered	O
from	O
the	O
feline	B-SPEC
strains	O
exhibited	O
shared	O
deletions	O
,	O
never	O
described	O
before	O
,	O
suggesting	O
that	O
these	O
deletions	O
could	O
be	O
critical	O
in	O
the	O
adaptation	O
of	O
these	O
strains	O
to	O
the	O
feline	B-SPEC
host	O
.	O

HRV	O
was	O
the	O
most	O
common	O
virus	B-SPEC
detected	O
in	O
children	O
with	O
sickle	O
cell	O
disease	O
and	O
acute	O
respiratory	O
illness	O
,	O
and	O
was	O
not	O
associated	O
with	O
increased	O
morbidity	O
.	O

CONCLUSIONS	O
:	O
HRV	O
was	O
the	O
most	O
common	O
virus	B-SPEC
detected	O
in	O
children	O
with	O
sickle	O
cell	O
disease	O
and	O
acute	O
respiratory	O
illness	O
,	O
and	O
was	O
not	O
associated	O
with	O
increased	O
morbidity	O
.	O

Two	O
patients	O
had	O
Plasmodium	B-SPEC
falciparum	I-SPEC
infection	O
and	O
one	O
patient	O
had	O
Plasmodium	B-SPEC
vivax	I-SPEC
and	O
Plasmodium	B-SPEC
ovale	I-SPEC
co	O
-	O
infection	O
.	O

Anti	O
-	O
malarial	O
therapy	O
consisted	O
in	O
intravenous	O
quinine	B-SPEC
(	O
in	O
two	O
patients	O
)	O
and	O
intravenous	O
quinidine	O
(	O
in	O
one	O
patient	O
),	O
plus	O
clindamycin	O
or	O
doxycycline	O
.	O

Here	O
we	O
report	O
the	O
emergence	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
in	O
the	O
United	O
States	O
and	O
determination	O
of	O
its	O
origin	O
,	O
evolution	O
,	O
and	O
genotypes	O
based	O
on	O
temporal	O
and	O
geographical	O
evidence	O
.	O

The	O
ongoing	O
outbreaks	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
humans	B-SPEC
from	O
countries	O
in	O
or	O
near	O
the	O
Arabian	O
Peninsula	O
and	O
the	O
historical	O
deadly	O
nature	O
of	O
the	O
2002	O
outbreaks	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
create	O
further	O
anxiety	O
over	O
the	O
emergence	O
of	O
PEDV	B-SPEC
in	O
the	O
United	O
States	O
due	O
to	O
the	O
lack	O
of	O
scientific	O
information	O
about	O
the	O
origin	O
and	O
evolution	O
of	O
this	O
emerging	O
coronavirus	B-SPEC
.	O

Here	O
,	O
we	O
show	O
how	O
feature	O
selection	O
techniques	O
can	O
be	O
used	O
to	O
reliably	O
classify	O
viral	O
sequences	O
by	O
host	O
species	B-SPEC
,	O
and	O
to	O
identify	O
the	O
crucial	O
minority	O
of	O
host	O
-	O
specific	O
sites	O
in	O
pathogen	O
genomic	O
data	O
.	O

We	O
illustrate	O
the	O
power	O
of	O
these	O
methods	O
by	O
:	O
1	O
)	O
identifying	O
the	O
sites	O
explaining	O
SARS	O
coronavirus	B-SPEC
differences	O
between	O
human	B-SPEC
,	O
bat	B-SPEC
and	O
palm	O
civet	B-SPEC
samples	O
;	O
2	O
)	O
showing	O
how	O
cross	O
species	B-SPEC
jumps	O
of	O
rabies	B-SPEC
virus	I-SPEC
among	O
bat	B-SPEC
populations	O
can	O
be	O
readily	O
identified	O
;	O
and	O
3	O
)	O
de	O
novo	O
identification	O
of	O
likely	O
functional	O
influenza	O
host	O
discriminant	O
markers	O
.	O

METHODS	O
:	O
Nasopharyngeal	O
aspirate	O
specimens	O
(	O
NPA	O
)	O
from	O
349	O
patients	O
(	O
1	O
from	O
each	O
)	O
and	O
130	O
cerebrospinal	O
fluids	O
(	O
CSF	O
)	O
specimens	O
were	O
collected	O
from	O
children	O
who	O
were	O
admitted	O
to	O
the	O
PICU	B-SPEC
of	O
Second	O
Affiliated	O
Hospital	O
of	O
Shantou	O
University	O
Medical	O
College	O
.	O

Fluorescence	O
quantitative	O
PCR	O
was	O
applied	O
to	O
detect	O
13	O
viruses	B-SPEC
from	O
CSF	O
and	O
to	O
analyze	O
the	O
clinical	O
data	O
of	O
positive	O
cases	O
.	O

A	O
novel	O
betacoronavirus	B-SPEC
species	B-SPEC
in	O
a	O
phylogenetic	O
sister	O
relationship	O
to	O
MERS	O
-	O
CoV	O
and	O
clade	O
c	O
bat	B-SPEC
CoVs	O
was	O
detected	O
and	O
characterized	O
on	O
the	O
whole	O
-	O
genome	O
level	O
.	O

Detailed	O
analyses	O
of	O
the	O
full	O
hedgehog	B-SPEC
intestine	O
showed	O
the	O
highest	O
EriCoV	O
concentrations	O
in	O
lower	O
gastrointestinal	O
tract	O
specimens	O
,	O
compatible	O
with	O
viral	O
replication	O
in	O
the	O
lower	O
intestine	O
and	O
fecal	O
-	O
oral	O
transmission	O
.	O

Single	O
-	O
patient	O
and	O
meta	B-SPEC
-	O
analyses	O
drawing	O
from	O
the	O
four	O
major	O
trials	O
showed	O
significant	O
survival	O
benefit	O
in	O
patients	O
with	O
PaO2	O
/	O
FiO2	O
lower	O
than	O
100	O
.	O

The	O
results	O
presented	O
in	O
this	O
work	O
show	O
that	O
minimal	O
toxicity	O
was	O
induced	O
by	O
a	O
range	O
of	O
single	O
and	O
repeated	O
daily	O
subcutaneous	O
doses	O
of	O
GRFT	O
in	O
two	O
rodent	B-SPEC
species	B-SPEC
,	O
although	O
we	O
noted	O
treatment	O
-	O
associated	O
increases	O
in	O
spleen	O
and	O
liver	O
mass	O
suggestive	O
of	O
an	O
antidrug	O
immune	O
response	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
novel	O
corona	B-SPEC
MERS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
generates	O
spherules	O
from	O
zippered	O
endoplasmic	O
reticulum	O
membranes	O
.	O

Here	O
we	O
describe	O
a	O
detailed	O
study	O
of	O
the	O
membrane	O
rearrangements	O
induced	O
by	O
the	O
avian	B-SPEC
gammacoronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
in	O
a	O
mammalian	B-SPEC
cell	O
line	O
but	O
also	O
in	O
primary	O
avian	B-SPEC
cells	O
and	O
in	O
epithelial	O
cells	O
of	O
ex	O
vivo	O
tracheal	O
organ	O
cultures	O
.	O

In	O
all	O
cell	O
types	O
,	O
structures	O
novel	O
to	O
IBV	B-SPEC
infection	O
were	O
identified	O
that	O
we	O
have	O
termed	O
zippered	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
and	O
spherules	O
.	O

Here	O
,	O
we	O
characterized	O
structures	O
novel	O
to	O
IBV	B-SPEC
infection	O
:	O
zippered	O
ER	O
and	O
small	O
vesicles	O
tethered	O
to	O
the	O
zippered	O
ER	O
termed	O
spherules	O
.	O

TITLE	O
:	O
Detection	O
and	O
molecular	O
diversity	O
of	O
spike	O
gene	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
China	O
.	O

PEDV	B-SPEC
has	O
a	O
high	O
detection	O
rate	O
in	O
pig	B-SPEC
herds	O
in	O
China	O
.	O

Moreover	O
,	O
decreased	O
CD4	O
⁺	O
T	O
cell	O
recruitment	O
into	O
the	O
CNS	O
parenchyma	O
of	O
TIMP	O
-	O
1	O
deficient	O
mice	B-SPEC
was	O
not	O
associated	O
with	O
impaired	O
T	O
cell	O
recruiting	O
chemokines	O
or	O
MMP	O
expression	O
,	O
and	O
no	O
compensation	O
by	O
other	O
TIMP	O
molecules	O
was	O
identified	O
.	O

Abnormal	O
levels	O
of	O
five	O
plasma	O
biomarkers	O
including	O
three	O
biomarkers	O
generated	O
by	O
lung	O
epithelium	O
(	O
SP	O
-	O
D	O
,	O
RAGE	O
,	O
CC	O
-	O
16	O
)	O
provided	O
excellent	O
discrimination	O
for	O
diagnosis	O
of	O
ARDS	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
.	O

Altered	O
levels	O
of	O
plasma	O
biomarkers	O
may	O
be	O
useful	O
biologic	O
confirmation	O
of	O
the	O
diagnosis	O
of	O
ARDS	O
in	O
patients	O
with	O
sepsis	B-SPEC
,	O
and	O
also	O
potentially	O
for	O
selecting	O
patients	O
for	O
clinical	O
trials	O
that	O
are	O
designed	O
to	O
reduce	O
lung	O
epithelial	O
injury	O
.	O

Subjects	O
with	O
pulmonary	O
artery	O
catheters	O
for	O
the	O
treatment	O
of	O
traumatic	O
injuries	O
,	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
,	O
cardiovascular	O
collapse	O
,	O
adult	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
postsurgical	O
care	O
were	O
studied	O
.	O

RESULTS	O
:	O
IBV	B-SPEC
infection	O
contributed	O
to	O
differential	O
expression	O
of	O
1777	O
genes	O
,	O
of	O
which	O
876	O
were	O
up	O
-	O
regulated	O
and	O
901	O
down	O
-	O
regulated	O
in	O
the	O
kidney	O
compared	O
to	O
those	O
of	O
control	O
chickens	B-SPEC
and	O
103	O
associated	O
with	O
immune	O
and	O
inflammatory	O
responses	O
may	O
play	O
important	O
roles	O
in	O
the	O
host	O
defense	O
response	O
during	O
IBV	B-SPEC
infection	O
.	O

There	O
were	O
168	O
cases	O
of	O
acute	O
inflammatory	O
demyelinating	O
polyneuropathy	O
(	O
AIDP	O
),	O
17	O
of	O
acute	O
motor	O
axonal	O
neuropathy	O
(	O
AMAN	O
),	O
4	O
of	O
acute	O
motor	O
and	O
sensory	O
axonal	O
neuropathy	O
(	O
AMSAN	O
),	O
and	O
35	O
of	O
Miller	O
-	O
Fisher	B-SPEC
syndrome	O
(	O
MFS	O
).	O

TITLE	O
:	O
Isolation	O
and	O
characterization	O
of	O
a	O
bat	B-SPEC
SARS	O
-	O
like	O
coronavirus	B-SPEC
that	O
uses	O
the	O
ACE2	O
receptor	O
.	O

ABSTRACT	O
:	O
The	O
2002	O
-	O
3	O
pandemic	O
caused	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
one	O
of	O
the	O
most	O
significant	O
public	O
health	O
events	O
in	O
recent	O
history	O
.	O

An	O
ongoing	O
outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
suggests	O
that	O
this	O
group	O
of	O
viruses	B-SPEC
remains	O
a	O
key	O
threat	O
and	O
that	O
their	O
distribution	O
is	O
wider	O
than	O
previously	O
recognized	O
.	O

Although	O
bats	B-SPEC
have	O
been	O
suggested	O
to	O
be	O
the	O
natural	O
reservoirs	O
of	O
both	O
viruses	B-SPEC
,	O
attempts	O
to	O
isolate	O
the	O
progenitor	O
virus	B-SPEC
of	O
SARS	O
-	O
CoV	O
from	O
bats	B-SPEC
have	O
been	O
unsuccessful	O
.	O

Here	O
we	O
report	O
whole	O
-	O
genome	O
sequences	O
of	O
two	O
novel	O
bat	B-SPEC
coronaviruses	O
from	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
(	O
family	B-SPEC
:	O
Rhinolophidae	B-SPEC
)	O
in	O
Yunnan	O
,	O
China	O
:	O
RsSHC014	O
and	O
Rs3367	O
.	O

TITLE	O
:	O
Reselection	O
of	O
a	O
genomic	O
upstream	O
open	O
reading	O
frame	O
in	O
mouse	B-SPEC
hepatitis	O
coronavirus	B-SPEC
5	O
'-	O
untranslated	O
-	O
region	O
mutants	O
.	O

ABSTRACT	O
:	O
An	O
AUG	O
-	O
initiated	O
upstream	O
open	O
reading	O
frame	O
(	O
uORF	O
)	O
encoding	O
a	O
potential	O
polypeptide	O
of	O
3	O
to	O
13	O
amino	O
acids	O
(	O
aa	O
)	O
is	O
found	O
within	O
the	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
>	O
75	O
%	O
of	O
coronavirus	B-SPEC
genomes	O
based	O
on	O
38	O
reference	O
strains	O
.	O

(	O
i	O
)	O
When	O
the	O
uORF	O
AUG	O
-	O
initiating	O
codon	O
was	O
replaced	O
with	O
a	O
UAG	O
stop	O
codon	O
along	O
with	O
a	O
U112A	O
mutation	O
to	O
maintain	O
a	O
uORF	O
-	O
harboring	O
stem	O
-	O
loop	O
4	O
structure	O
,	O
an	O
unimpaired	O
virus	B-SPEC
with	O
wild	O
-	O
type	O
(	O
WT	O
)	O
growth	O
kinetics	O
was	O
recovered	O
.	O

ABSTRACT	O
:	O
Plus	O
-	O
strand	O
RNA	O
virus	B-SPEC
replication	O
occurs	O
in	O
tight	O
association	O
with	O
cytoplasmic	O
host	O
cell	O
membranes	O
.	O

Children	O
with	O
an	O
acute	O
febrile	O
illness	O
of	O
a	O
duration	O
of	O
<	O
7	O
days	O
,	O
which	O
was	O
confirmed	O
as	O
Plasmodium	B-SPEC
vivax	I-SPEC
positive	O
malaria	O
by	O
testing	O
the	O
peripheral	O
smears	O
and	O
/	O
or	O
by	O
Rapid	O
Diagnostic	O
Testing	O
,	O
who	O
were	O
admitted	O
in	O
the	O
paediatric	O
ward	O
of	O
a	O
tertiary	O
care	O
hospital	O
in	O
New	O
Delhi	O
(	O
India	O
),	O
during	O
May	O
2011	O
to	O
October	O
2011	O
,	O
Case	O
records	O
of	O
context	O
cases	O
were	O
analysed	O
retrospectively	O
.	O

ABSTRACT	O
:	O
Plasmodium	B-SPEC
ovale	I-SPEC
is	O
one	O
of	O
the	O
causative	O
agents	O
of	O
human	B-SPEC
malaria	O
.	O

Sequencing	O
of	O
the	O
malaria	O
parasite	O
DNA	O
from	O
both	O
cases	O
,	O
followed	O
by	O
multiple	O
sequence	O
alignment	O
and	O
phylogenetic	O
tree	O
construction	O
suggested	O
that	O
the	O
causative	O
agent	O
for	O
both	O
malaria	O
cases	O
was	O
P	B-SPEC
.	I-SPEC
ovale	I-SPEC
curtisi	I-SPEC
.	O

TITLE	O
:	O
Ecology	O
,	O
evolution	O
and	O
classification	O
of	O
bat	B-SPEC
coronaviruses	O
in	O
the	O
aftermath	O
of	O
SARS	O
.	O

We	O
also	O
demonstrate	O
a	O
geographic	O
bias	B-SPEC
within	O
available	O
studies	O
on	O
bat	B-SPEC
CoVs	O
,	O
and	O
identify	O
a	O
critical	O
lack	O
of	O
information	O
from	O
biodiversity	O
hotspots	O
in	O
Africa	O
,	O
Asia	O
and	O
Latin	O
America	O
.	O

This	O
paper	O
forms	O
part	O
of	O
a	O
symposium	O
in	O
Antiviral	O
Research	O
on	O
""""	O
from	O
SARS	O
to	O
MERS	O
:	O
10years	O
of	O
research	O
on	O
highly	O
pathogenic	O
human	B-SPEC
coronaviruses	O
"""."	O

A	O
phylogenetic	O
analysis	O
of	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
sequence	O
fragments	O
aided	O
in	O
identifying	O
two	O
alphacoronaviruses	O
from	O
Kuhl	B-SPEC
'	I-SPEC
s	I-SPEC
pipistrelle	I-SPEC
(	O
Pipistrellus	B-SPEC
kuhlii	I-SPEC
),	O
three	O
clade	O
2b	O
betacoronaviruses	O
from	O
lesser	B-SPEC
horseshoe	I-SPEC
bats	I-SPEC
(	O
Rhinolophus	B-SPEC
hipposideros	I-SPEC
),	O
and	O
10	O
clade	O
2c	O
betacoronaviruses	O
from	O
Kuhl	B-SPEC
'	I-SPEC
s	I-SPEC
pipistrelle	I-SPEC
,	O
common	O
noctule	B-SPEC
(	O
Nyctalus	B-SPEC
noctula	I-SPEC
),	O
and	O
Savi	B-SPEC
'	I-SPEC
s	I-SPEC
pipistrelle	I-SPEC
(	O
Hypsugo	B-SPEC
savii	I-SPEC
).	O

TITLE	O
:	O
Biochemical	O
analysis	O
and	O
application	O
of	O
molecular	O
display	O
technology	O
on	O
Candida	B-SPEC
albicans	I-SPEC
for	O
diagnosing	O
and	O
preventing	O
candidiasis	O
.	O

However	O
,	O
emerging	O
infectious	O
diseases	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
AIDS	O
,	O
as	O
well	O
as	O
re	O
-	O
emerging	O
infectious	O
diseases	O
such	O
as	O
Japanese	B-SPEC
encephalitis	I-SPEC
and	O
dengue	O
fever	O
,	O
have	O
been	O
spreading	O
in	O
recent	O
times	O
.	O

TITLE	O
:	O
ORF7	O
-	O
encoded	O
accessory	O
protein	O
7a	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
as	O
a	O
counteragent	O
against	O
IFN	O
-	O
α	O
-	O
induced	O
antiviral	O
response	O
.	O

TITLE	O
:	O
Fatal	O
colchicine	O
poisoning	O
by	O
accidental	O
ingestion	O
of	O
Colchicum	B-SPEC
persicum	I-SPEC
:	O
a	O
case	O
report	O
.	O

The	O
unknown	O
cause	O
of	O
death	O
was	O
disclosed	O
after	O
determination	O
of	O
colchicine	O
in	O
the	O
plant	B-SPEC
and	O
botanical	O
identification	O
as	O
Colchicum	B-SPEC
persicum	I-SPEC
.	O

Here	O
we	O
describe	O
two	O
PEDV	B-SPEC
isolates	O
(	O
ISU13	O
-	O
19338E	O
and	O
ISU13	O
-	O
22038	O
)	O
successfully	O
obtained	O
from	O
the	O
small	O
intestines	O
of	O
piglets	O
from	O
sow	O
farms	O
in	O
Indiana	O
and	O
Iowa	O
,	O
respectively	O
.	O

TITLE	O
:	O
Ifit2	O
deficiency	O
results	O
in	O
uncontrolled	O
neurotropic	O
coronavirus	B-SPEC
replication	O
and	O
enhanced	O
encephalitis	O
via	O
impaired	O
alpha	O
/	O
beta	O
interferon	O
induction	O
in	O
macrophages	O
.	O

Currently	O
,	O
the	O
viruses	B-SPEC
virulence	O
determinants	O
and	O
host	O
gene	O
expressions	O
during	O
FIPV	O
infection	O
are	O
not	O
fully	O
understood	O
.	O

Treg	O
in	O
the	O
CNS	O
were	O
highest	O
during	O
initial	O
T	O
cell	O
mediated	O
virus	B-SPEC
control	O
,	O
decreased	O
and	O
then	O
remained	O
relatively	O
stable	O
during	O
persistence	O
.	O

ABSTRACT	O
:	O
Progress	O
in	O
the	O
development	O
of	O
antivirals	O
for	O
non	O
-	O
influenza	O
respiratory	O
viruses	B-SPEC
has	O
been	O
slow	O
with	O
the	O
result	O
that	O
many	O
unmet	O
medical	O
needs	O
and	O
few	O
approved	O
agents	O
currently	O
exist	O
.	O

The	O
Brazilian	O
strains	O
of	O
CCoV	O
-	O
IIb	O
displayed	O
an	O
aminoacid	O
insertion	O
that	O
was	O
also	O
described	O
in	O
CCoV	O
-	O
IIb	O
-	O
UCD	O
-	O
1	O
and	O
TGEV	B-SPEC
strains	O
.	O

To	O
reduce	O
the	O
lung	O
inflammation	O
caused	O
by	O
intestinal	O
I	O
/	O
R	O
,	O
we	O
have	O
acutely	O
treated	O
male	O
rats	B-SPEC
with	O
estradiol	O
.	O

Clearance	O
of	O
virus	B-SPEC
was	O
associated	O
with	O
a	O
specific	O
antibody	O
response	O
against	O
the	O
nucleocapsid	O
of	O
BdCoV	O
HKU22	O
.	O

HCoV	O
strain	O
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
)	O
can	O
infect	O
and	O
persist	O
in	O
human	B-SPEC
neural	O
cells	O
and	O
activate	O
neuroinflammatory	O
and	O
neurodegenerative	O
mechanisms	O
,	O
suggesting	O
that	O
it	O
could	O
be	O
involved	O
in	O
neurological	O
disease	O
of	O
unknown	O
etiology	O
in	O
humans	B-SPEC
.	O

Mutations	O
in	O
the	O
surface	O
spike	O
(	O
S	O
)	O
protein	O
of	O
human	B-SPEC
respiratory	O
coronavirus	B-SPEC
OC43	O
appear	O
after	O
persistent	O
infection	O
of	O
human	B-SPEC
cells	O
of	O
the	O
central	O
nervous	O
system	O
,	O
a	O
possible	O
viral	O
adaptation	O
to	O
this	O
environment	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
poly	O
(	O
adenosine	O
diphosphate	O
-	O
ribose	O
)	O
polymerase	O
attenuates	O
lung	O
-	O
kidney	O
crosstalk	O
induced	O
by	O
intratracheal	O
lipopolysaccharide	O
instillation	O
in	O
rats	B-SPEC
.	O

In	O
this	O
issue	O
,	O
Klaus	O
et	O
al	O
.	O
(	O
2013	O
)	O
identify	O
the	O
cargo	O
receptor	O
endoplasmic	O
reticulum	O
(	O
ER	O
)-	O
Golgi	O
intermediate	O
compartment	O
53	O
kDa	O
protein	O
(	O
ERGIC	O
-	O
53	O
)	O
as	O
a	O
binding	O
partner	O
for	O
viral	O
GPs	O
and	O
a	O
crucial	O
cellular	O
factor	O
required	O
for	O
infectious	O
virus	B-SPEC
production	O
.	O

ABSTRACT	O
:	O
AlphaCoV	O
and	O
lineage	O
C	O
betaCoV	O
,	O
genetically	O
similar	O
to	O
those	O
identified	O
in	O
Spanish	O
related	O
bat	B-SPEC
species	B-SPEC
,	O
have	O
been	O
detected	O
in	O
Italian	O
Myotis	B-SPEC
blithii	O
and	O
Eptesicus	B-SPEC
serotinus	I-SPEC
,	O
respectively	O
,	O
out	O
of	O
75	O
anal	O
swabs	O
collected	O
from	O
Vespertilionidae	B-SPEC
between	O
2009	O
and	O
2012	O
.	O

TITLE	O
:	O
Adenosine	O
deaminase	O
acts	O
as	O
a	O
natural	O
antagonist	O
for	O
dipeptidyl	O
peptidase	O
4	O
-	O
mediated	O
entry	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Since	O
the	O
recognition	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
in	O
2003	O
,	O
novel	O
viruses	B-SPEC
seem	O
to	O
emerge	O
more	O
frequently	O
.	O

Novel	O
influenza	O
strains	O
,	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
identified	O
last	O
year	O
in	O
the	O
Middle	O
East	O
,	O
other	O
novel	O
viruses	B-SPEC
,	O
and	O
increasing	O
numbers	O
of	O
immunocompromised	O
patients	O
that	O
can	O
be	O
felled	O
by	O
acute	O
respiratory	O
infections	O
all	O
demand	O
a	O
need	O
for	O
rapid	O
recognition	O
of	O
the	O
etiology	O
of	O
viral	O
respiratory	O
illnesses	O
.	O

RSV	B-SPEC
accounted	O
for	O
the	O
highest	O
virus	B-SPEC
-	O
associated	O
hospitalization	O
incidence	O
(	O
34	O
.	O
6	O
/	O
10	O
,	O
000	O
,	O
95	O
%	O
CI	O
26	O
.	O
3	O
-	O
44	O
.	O
7	O
)	O
and	O
20	O
%	O
of	O
hospitalizations	O
.	O

Incoming	O
data	O
reveal	O
that	O
the	O
virus	B-SPEC
is	O
highly	O
virulent	O
to	O
humans	B-SPEC
.	O

Alveolar	O
macrophages	O
from	O
acid	O
-	O
injured	O
Akt2	O
(-/-)	O
mice	B-SPEC
demonstrated	O
the	O
alternative	O
activation	O
phenotype	O
(	O
M2	O
).	O

TITLE	O
:	O
Effect	O
of	O
coronavirus	B-SPEC
infection	O
on	O
reproductive	O
performance	O
of	O
turkey	B-SPEC
hens	O
.	O

In	O
both	O
experimental	O
trials	O
an	O
average	O
of	O
28	O
%-	O
29	O
%	O
drop	O
in	O
egg	O
production	O
was	O
observed	O
in	O
TCoV	O
-	O
infected	O
turkey	B-SPEC
hens	O
between	O
4	O
and	O
7	O
DPI	O
.	O

ABSTRACT	O
:	O
Antiviral	O
peptides	O
(	O
AVPs	O
)	O
have	O
exhibited	O
huge	O
potential	O
in	O
inhibiting	O
viruses	B-SPEC
by	O
targeting	O
various	O
stages	O
of	O
their	O
life	O
cycle	O
.	O

TITLE	O
:	O
Tumor	O
necrosis	O
factor	O
α	O
(	O
TNF	O
-	O
α	O
)	O
receptor	O
-	O
I	O
is	O
required	O
for	O
TNF	O
-	O
α	O
-	O
mediated	O
fulminant	O
virus	B-SPEC
hepatitis	O
caused	O
by	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
-	O
3	O
infection	O
.	O

These	O
combined	O
results	O
indicate	O
that	O
signaling	O
through	O
TNFR1	O
plays	O
an	O
essential	O
role	O
in	O
the	O
pathogenesis	O
of	O
FH	O
caused	O
by	O
MHV	B-SPEC
-	O
3	O
infection	O
,	O
and	O
interruption	O
of	O
this	O
signaling	O
pathway	O
could	O
be	O
useful	O
for	O
clinical	O
therapy	O
.	O

Many	O
life	O
-	O
threatening	O
diseases	O
,	O
such	O
as	O
AIDS	O
,	O
SARS	O
,	O
hepatitis	O
and	O
some	O
cancers	O
,	O
are	O
caused	O
by	O
viruses	B-SPEC
.	O

Based	O
on	O
the	O
analysis	O
of	O
the	O
partial	O
S	O
glycoprotein	O
genes	O
,	O
the	O
Thai	O
PEDV	B-SPEC
isolates	O
were	O
clustered	O
into	O
2	O
groups	O
related	O
to	O
Korean	O
and	O
Chinese	O
field	O
isolates	O
.	O

To	O
investigate	O
the	O
epidemic	O
characteristics	O
of	O
PEDV	B-SPEC
,	O
the	O
complete	O
ORF3	O
genes	O
of	O
14	O
PEDV	B-SPEC
field	O
strains	O
from	O
central	O
China	O
during	O
2012	O
to	O
2013	O
were	O
cloned	O
,	O
sequenced	O
and	O
compared	O
with	O
reference	O
strains	O
.	O

Phylogenetic	O
classification	O
showed	O
that	O
63	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
isolates	O
belonged	O
to	O
groups	O
B1	O
(	O
52	O
.	O
4	O
%),	O
A	O
(	O
25	O
.	O
4	O
%)	O
and	O
B2	O
(	O
22	O
.	O
2	O
%).	O

Eggs	O
of	O
Toxocara	B-SPEC
sp	O
.	O
were	O
found	O
in	O
three	O
parks	O
and	O
genetic	O
material	O
of	O
bovine	B-SPEC
Coronavirus	B-SPEC
was	O
identified	O
in	O
one	O
sample	O
of	O
one	O
park	O
.	O

No	O
Salmonella	B-SPEC
spp	O
.	O

The	O
presence	O
of	O
R	B-SPEC
.	I-SPEC
equi	I-SPEC
,	O
Toxocara	B-SPEC
sp	O
,	O
bovine	B-SPEC
Coronavirus	B-SPEC
and	O
virulent	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
isolates	O
in	O
the	O
environment	O
of	O
parks	O
indicates	O
that	O
the	O
sanitary	O
conditions	O
of	O
the	O
sand	O
should	O
be	O
improved	O
in	O
order	B-SPEC
to	O
reduce	O
the	O
risks	O
of	O
fecal	O
transmission	O
of	O
pathogens	O
of	O
zoonotic	O
potential	O
to	O
humans	B-SPEC
in	O
these	O
places	O
.	O

This	O
series	O
of	O
review	O
articles	O
will	O
discuss	O
the	O
pathophysiology	O
of	O
sepsis	B-SPEC
;	O
comorbidities	O
,	O
such	O
as	O
multiorgan	O
dysfunction	O
syndrome	O
(	O
MODS	O
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
and	O
endocrine	O
issues	O
;	O
and	O
finally	O
,	O
management	O
of	O
sepsis	B-SPEC
and	O
septic	O
shock	O
.	O

TITLE	O
:	O
Extracting	O
Computational	O
and	O
Semantic	O
Features	O
from	O
Portable	O
Chest	O
X	O
-	O
rays	B-SPEC
for	O
Diagnosis	O
of	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

In	O
humans	B-SPEC
and	O
chickens	B-SPEC
,	O
several	O
studies	O
have	O
shown	O
that	O
MBL	O
participates	O
in	O
the	O
protection	O
of	O
hosts	O
against	O
virus	B-SPEC
infections	O
.	O

Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
a	O
highly	O
contagious	O
disease	O
of	O
economic	O
importance	O
in	O
the	O
poultry	O
industry	O
caused	O
by	O
the	O
coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Furthermore	O
,	O
the	O
higher	O
antibody	O
response	O
in	O
L10H	O
chickens	B-SPEC
receiving	O
vaccine	O
and	O
FOS	O
makes	O
FOS	O
a	O
potential	O
adjuvant	O
candidate	O
in	O
an	O
IBV	B-SPEC
vaccine	O
.	O

The	O
Bland	O
-	O
Altman	O
analyses	O
of	O
data	O
demonstrated	O
good	O
agreement	O
between	O
serum	O
and	O
milk	O
antibody	O
titers	O
for	O
both	O
viruses	B-SPEC
.	O

The	O
peptide	O
(	O
FP5	O
)	O
exhibiting	O
the	O
most	O
effective	O
antiviral	O
effect	O
was	O
further	O
combined	O
with	O
a	O
known	O
anti	O
-	O
viral	O
agent	O
,	O
human	B-SPEC
interferon	O
-	O
α	O
(	O
IFN	O
-	O
α	O
),	O
and	O
a	O
significant	O
synergistic	O
antiviral	O
effect	O
was	O
observed	O
.	O

Of	O
1898	O
specimens	O
prospectively	O
tested	O
for	O
other	O
viruses	B-SPEC
between	O
16	O
March	O
2010	O
and	O
18	O
March	O
2012	O
,	O
474	O
samples	O
did	O
not	O
have	O
other	O
common	O
respiratory	O
viruses	B-SPEC
detected	O
.	O

In	O
this	O
study	O
we	O
identified	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
spike	O
of	O
the	O
prototype	O
IBV	B-SPEC
strain	O
M41	O
.	O

Our	O
results	O
may	O
help	O
to	O
understand	O
the	O
differences	O
between	O
IBV	B-SPEC
S1	O
genotypes	O
and	O
the	O
ultimate	O
pathogenesis	O
of	O
IBV	B-SPEC
in	O
chickens	B-SPEC
.	O

Rat	B-SPEC
coronavirus	B-SPEC
(	O
RCoV	O
)	O
causes	O
respiratory	O
disease	O
in	O
adult	O
rats	B-SPEC
,	O
characterized	O
by	O
an	O
early	O
PMN	O
response	O
,	O
viral	O
replication	O
and	O
inflammatory	O
lesions	O
in	O
the	O
lungs	O
,	O
mild	O
weight	O
loss	O
and	O
effective	O
resolution	O
of	O
infection	O
.	O

Development	O
of	O
effective	O
therapeutics	O
and	O
vaccines	O
is	O
crucial	O
to	O
save	O
lives	O
and	O
halt	O
the	O
spread	O
of	O
MERS	O
-	O
CoV	O
.	O
Here	O
,	O
we	O
show	O
that	O
a	O
recombinant	O
protein	O
containing	O
a	O
212	O
-	O
amino	O
acid	O
fragment	O
(	O
residues	O
377	O
-	O
588	O
)	O
in	O
the	O
truncated	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
:	O
residues	O
367	O
-	O
606	O
)	O
of	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
fused	O
with	O
human	B-SPEC
IgG	O
Fc	O
fragment	O
(	O
S377	O
-	O
588	O
-	O
Fc	O
)	O
is	O
highly	O
expressed	O
in	O
the	O
culture	O
supernatant	O
of	O
transfected	O
293T	O
cells	O
.	O

The	O
recombinant	O
S377	O
-	O
588	O
-	O
Fc	O
is	O
able	O
to	O
induce	O
in	O
the	O
vaccinated	O
mice	B-SPEC
strong	O
MERS	O
-	O
CoV	O
S	O
-	O
specific	O
antibodies	O
,	O
which	O
blocks	O
the	O
binding	O
of	O
RBD	O
to	O
DPP4	O
receptor	O
and	O
effectively	O
neutralizes	O
MERS	O
-	O
CoV	O
infection	O
.	O

Genetic	O
variation	O
affecting	O
interferon	O
lambda	O
(	O
IFN	O
-	O
λ	O
)	O
expression	O
is	O
now	O
known	O
to	O
influence	O
the	O
outcome	O
of	O
both	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
and	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
infection	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
A	O
genome	O
-	O
wide	O
association	O
study	O
identifies	O
major	O
loci	O
affecting	O
the	O
immune	O
response	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
chicken	B-SPEC
.	O

Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
belonging	O
to	O
gamma	O
-	O
coronaviruses	O
,	O
causes	O
a	O
highly	O
infectious	O
respiratory	O
viral	O
disease	O
and	O
can	O
result	O
in	O
catastrophic	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
worldwide	O
.	O

A	O
genome	O
-	O
wide	O
association	O
study	O
using	O
43	O
,	O
211	O
single	O
nucleotide	O
polymorphism	O
markers	O
was	O
performed	O
to	O
identify	O
the	O
major	O
loci	O
affecting	O
the	O
immune	O
response	O
against	O
IBV	B-SPEC
.	O

A	O
genomic	O
region	O
containing	O
a	O
cluster	O
of	O
13	O
beta	O
-	O
defensin	O
(	O
GAL1	O
-	O
13	O
)	O
and	O
interleukin	O
-	O
17F	O
genes	O
on	O
GGA3	O
probably	O
plays	O
an	O
important	O
role	O
in	O
the	O
immune	O
response	O
against	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
associated	O
with	O
production	O
inefficiencies	O
in	O
domestic	O
fowl	O
,	O
and	O
causes	O
massive	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
worldwide	O
.	O

BacMam	O
virus	B-SPEC
,	O
a	O
modified	O
baculovirus	B-SPEC
mediating	O
transgene	O
expression	O
under	O
the	O
control	O
of	O
a	O
mammalian	B-SPEC
promoter	O
,	O
has	O
emerged	O
as	O
a	O
versatile	O
and	O
safe	O
vector	O
during	O
vaccine	O
development	O
.	O

ABSTRACT	O
:	O
Between	O
June	O
and	O
September	O
2013	O
,	O
sera	O
from	O
11	O
dromedary	B-SPEC
camels	B-SPEC
,	O
150	O
goats	B-SPEC
,	O
126	O
sheep	B-SPEC
and	O
91	O
cows	B-SPEC
were	O
collected	O
in	O
Jordan	O
,	O
where	O
the	O
first	O
human	B-SPEC
Middle	O
-	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
cluster	O
appeared	O
in	O
2012	O
.	O

All	O
sera	O
were	O
tested	O
for	O
MERS	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
specific	O
antibodies	O
by	O
protein	O
microarray	O
with	O
confirmation	O
by	O
virus	B-SPEC
neutralisation	O
.	O

ABSTRACT	O
:	O
Powered	O
by	O
advances	O
in	O
electron	O
tomography	O
,	O
recent	O
studies	O
have	O
extended	O
our	O
understanding	O
of	O
how	O
viruses	B-SPEC
construct	O
""""	O
replication	O
factories	O
""""	O
inside	O
infected	O
cells	O
.	O

Their	O
function	O
,	O
however	O
,	O
remains	O
an	O
area	O
of	O
speculation	O
with	O
important	O
implications	O
for	O
human	B-SPEC
health	O
.	O

TITLE	O
:	O
FiO2	O
predicts	O
outcome	O
in	O
infants	O
with	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

One	O
hundred	O
twenty	O
-	O
nine	O
mechanically	O
ventilated	O
infants	O
with	O
RSV	B-SPEC
-	O
induced	O
ARDS	O
.	O

A	O
higher	O
baseline	O
FiO	O
(	O
2	O
)	O
was	O
independently	O
associated	O
with	O
a	O
longer	O
duration	O
of	O
MV	O
(	O
HR	O
0	O
.	O
12	O
,	O
CI	O
0	O
.	O
02	O
-	O
0	O
.	O
87	O
,	O
P	O
=	O
0	O
.	O
036	O
)	O
and	O
increased	O
LOS	O
in	O
the	O
PICU	B-SPEC
(	O
HR	O
0	O
.	O
09	O
,	O
CI	O
0	O
.	O
01	O
-	O
0	O
.	O
57	O
,	O
P	O
=	O
0	O
.	O
023	O
).	O

ABSTRACT	O
:	O
Gastroenteritis	O
is	O
one	O
of	O
the	O
leading	O
causes	O
of	O
morbidity	O
and	O
mortality	O
among	O
young	O
and	O
newborn	O
animals	B-SPEC
and	O
is	O
often	O
caused	O
by	O
multiple	O
intestinal	O
infections	O
,	O
with	O
rotavirus	B-SPEC
and	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
being	O
the	O
main	O
viral	O
causes	O
in	O
cattle	B-SPEC
.	O

TITLE	O
:	O
Effect	O
of	O
microtubule	O
disruption	O
on	O
neuronal	O
spread	O
and	O
replication	O
of	O
demyelinating	O
and	O
nondemyelinating	O
strains	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
in	O
vitro	O
.	O

All	O
camels	B-SPEC
had	O
MERS	O
-	O
CoV	O
spike	O
-	O
binding	O
antibodies	O
that	O
correlated	O
well	O
with	O
the	O
presence	O
of	O
neutralising	O
antibodies	O
to	O
MERS	O
-	O
CoV	O
.	O
Our	O
study	O
provides	O
virological	O
confirmation	O
of	O
MERS	O
-	O
CoV	O
in	O
camels	B-SPEC
and	O
suggests	O
a	O
recent	O
outbreak	O
affecting	O
both	O
human	B-SPEC
beings	O
and	O
camels	B-SPEC
.	O

The	O
purified	O
recombinant	O
proteins	O
of	O
these	O
constructs	O
were	O
compared	O
for	O
their	O
antigenicity	O
,	O
functionality	O
and	O
immunogenicity	O
in	O
mice	B-SPEC
using	O
alum	O
as	O
the	O
adjuvant	O
.	O

ABSTRACT	O
:	O
This	O
paper	O
describes	O
the	O
diagnostic	O
and	O
clinical	O
observations	O
of	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
variant	O
,	O
referred	O
to	O
as	O
Q1	O
,	O
in	O
clinically	O
ill	O
chickens	B-SPEC
in	O
Italy	O
.	O

This	O
IBV	B-SPEC
variant	O
was	O
described	O
for	O
the	O
first	O
time	O
in	O
1998	O
in	O
China	O
.	O

Despite	O
these	O
findings	O
and	O
the	O
isolation	O
of	O
the	O
Q1	O
IB	O
virus	B-SPEC
directly	O
from	O
proventricular	O
tissue	O
,	O
further	O
studies	O
are	O
necessary	O
to	O
confirm	O
the	O
role	O
of	O
this	O
IBV	B-SPEC
strain	O
in	O
the	O
development	O
of	O
proventricular	O
lesions	O
.	O

ABSTRACT	O
:	O
The	O
emerging	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
pulmonary	O
disease	O
in	O
humans	B-SPEC
and	O
represents	O
the	O
second	O
example	O
of	O
a	O
highly	O
pathogenic	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
following	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	B-SPEC
).	O

ABSTRACT	O
:	O
Influenza	O
is	O
a	O
contagious	O
respiratory	O
disease	O
caused	O
by	O
viruses	B-SPEC
belonging	O
to	O
the	O
family	B-SPEC
Ortomyxoviridae	O
.	O

Impairment	O
of	O
the	O
kidney	O
is	O
not	O
typically	O
seen	O
in	O
Coronavirus	B-SPEC
infections	O
.	O

CONCLUSIONS	O
:	O
Epidemiological	O
studies	O
should	O
analyze	O
kidney	O
impairment	O
and	O
its	O
characteristics	O
in	O
MERS	O
-	O
CoV	O
.	O
Virus	B-SPEC
replication	O
in	O
the	O
kidney	O
with	O
potential	O
shedding	O
in	O
urine	O
might	O
constitute	O
a	O
way	O
of	O
transmission	O
,	O
and	O
could	O
explain	O
untraceable	O
transmission	O
chains	O
leading	O
to	O
new	O
cases	O
.	O

From	O
the	O
combined	O
results	O
of	O
the	O
two	O
meta	B-SPEC
-	O
analyses	O
and	O
the	O
last	O
randomized	O
controlled	O
trial	O
,	O
there	O
is	O
a	O
very	O
strong	O
signal	O
to	O
use	O
prone	O
position	O
in	O
patients	O
with	O
severe	O
ARDS	O
,	O
as	O
early	O
as	O
possible	O
and	O
for	O
long	O
sessions	O
.	O

ABSTRACT	O
:	O
A	O
unique	O
avian	B-SPEC
-	O
origin	O
A	O
/	O
H7N9	O
influenza	B-SPEC
virus	I-SPEC
has	O
so	O
far	O
caused	O
134	O
cases	O
with	O
44	O
deaths	O
.	O

The	O
present	O
analysis	O
provides	O
reported	O
data	O
on	O
the	O
H7N9	O
influenza	O
-	O
induced	O
""""	O
cytokine	O
storm	O
""""	O
at	O
the	O
site	O
of	O
infection	O
in	O
humans	B-SPEC
and	O
identifies	O
the	O
rs12252	O
-	O
C	O
genotype	O
that	O
compromises	O
IFITM3	O
function	O
as	O
a	O
primary	O
genetic	O
correlate	O
of	O
severe	O
H7N9	O
pneumonia	O
.	O

ABSTRACT	O
:	O
Treatment	O
with	O
positive	O
airway	O
pressure	O
devices	O
improved	O
signs	O
and	O
symptoms	O
of	O
obstructive	O
sleep	O
apnea	O
syndrome	O
(	O
OSA	B-SPEC
);	O
however	O
,	O
auto	O
-	O
adjusting	O
positive	O
pressure	O
(	O
APAP	O
)	O
device	O
was	O
not	O
as	O
effective	O
as	O
continuous	O
positive	O
airway	O
pressure	O
(	O
CPAP	O
)	O
in	O
reducing	O
arterial	O
blood	O
pressure	O
and	O
insulin	O
resistance	O
.	O

TITLE	O
:	O
Novel	O
avian	B-SPEC
coronavirus	I-SPEC
and	O
fulminating	O
disease	O
in	O
guinea	B-SPEC
fowl	I-SPEC
,	O
France	O
.	O

ABSTRACT	O
:	O
For	O
decades	O
,	O
French	O
guinea	B-SPEC
fowl	I-SPEC
have	O
been	O
affected	O
by	O
fulminating	O
enteritis	O
of	O
unclear	O
origin	O
.	O

These	O
results	O
demonstrate	O
that	O
chimeric	O
VLPs	O
have	O
the	O
potential	O
for	O
use	O
in	O
vaccines	O
against	O
IBV	B-SPEC
infection	O
.	O

Influenza	B-SPEC
virus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
and	O
coronaviruses	O
showed	O
a	O
seasonal	O
peak	O
during	O
the	O
winter	O
season	O
,	O
while	O
picornaviruses	B-SPEC
and	O
adenoviruses	B-SPEC
were	O
less	O
frequently	O
detected	O
in	O
these	O
periods	O
.	O

ABSTRACT	O
:	O
Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
is	O
the	O
leading	O
cause	O
of	O
viral	O
respiratory	O
tract	O
infections	O
in	O
infants	O
and	O
young	O
children	O
.	O

We	O
conclude	O
that	O
RSV	B-SPEC
infections	O
can	O
be	O
severe	O
,	O
and	O
some	O
patients	O
may	O
require	O
mechanical	O
ventilation	O
.	O

This	O
mechanism	O
for	O
responding	O
to	O
emerging	O
communicable	O
diseases	O
allowed	O
China	O
to	O
successfully	O
deal	O
with	O
outbreaks	O
of	O
the	O
H5N1	O
bird	B-SPEC
flu	O
,	O
H1N1	O
flu	O
,	O
and	O
H7N9	O
bird	B-SPEC
flu	O
.	O

ABSTRACT	O
:	O
From	O
1	O
January	O
2009	O
to	O
31	O
May	O
2013	O
,	O
15	O
287	O
respiratory	O
specimens	O
submitted	O
to	O
the	O
Clinical	O
Virology	O
Laboratory	O
at	O
the	O
Children	O
'	O
s	O
Hospital	O
Colorado	O
were	O
tested	O
for	O
human	B-SPEC
coronavirus	I-SPEC
RNA	O
by	O
reverse	O
transcription	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
Much	O
research	O
is	O
now	O
being	O
conducted	O
in	O
order	B-SPEC
to	O
understand	O
the	O
role	O
of	O
cytokines	O
in	O
the	O
development	O
of	O
the	O
inflammatory	O
response	O
following	O
trauma	O
.	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
therapeutic	O
efficacy	O
of	O
noninvasive	O
positive	O
pressure	O
ventilation	O
(	O
NPPV	O
)	O
in	O
the	O
treatment	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
following	O
esophagectomy	O
for	O
esophageal	O
cancer	B-SPEC
.	O

In	O
this	O
retrospective	O
evaluation	O
,	O
we	O
included	O
64	O
patients	O
with	O
ARDS	O
following	O
esophagectomy	O
for	O
esophageal	O
cancer	B-SPEC
between	O
January	O
2009	O
and	O
December	O
2011	O
.	O

ABSTRACT	O
:	O
Individual	O
enteropathogen	O
infections	O
in	O
healthy	O
and	O
clinically	O
ill	O
cats	B-SPEC
are	O
well	O
described	O
,	O
but	O
prevalence	O
and	O
patterns	O
of	O
enteropathogen	O
co	O
-	O
infection	O
have	O
only	O
been	O
reported	O
on	O
a	O
limited	O
basis	O
.	O

(	O
Cr	O
),	O
and	O
Toxoplasma	B-SPEC
gondii	I-SPEC
(	O
To	O
).	O

More	O
cats	B-SPEC
were	O
negative	O
for	O
all	O
8	O
enteropathogens	O
tested	O
(	O
12	O
.	O
7	O
%)	O
than	O
expected	O
.	O

In	O
contrast	O
,	O
the	O
relatively	O
high	O
percentage	O
of	O
cats	B-SPEC
negative	O
for	O
all	O
8	O
enteropathogens	O
tested	O
could	O
indicate	O
an	O
innate	O
resistance	O
to	O
infection	O
.	O

TITLE	O
:	O
The	O
effects	O
of	O
Nigella	B-SPEC
sativa	I-SPEC
(	O
Ns	O
),	O
Anthemis	B-SPEC
hyalina	I-SPEC
(	O
Ah	O
)	O
and	O
Citrus	B-SPEC
sinensis	I-SPEC
(	O
Cs	O
)	O
extracts	O
on	O
the	O
replication	O
of	O
coronavirus	B-SPEC
and	O
the	O
expression	O
of	O
TRP	O
genes	O
family	B-SPEC
.	O

Here	O
we	O
report	O
our	O
findings	O
that	O
(	O
a	O
)	O
the	O
production	O
of	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
progeny	O
viruses	B-SPEC
,	O
whose	O
budding	O
occurs	O
at	O
the	O
ER	O
-	O
Golgi	O
intermediate	O
compartment	O
(	O
ERGIC	O
),	O
markedly	O
decreases	O
in	O
the	O
presence	O
of	O
BST2	O
;	O
and	O
(	O
b	O
)	O
BST2	O
knockdown	O
expression	O
results	O
in	O
enhanced	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
virion	O
production	O
.	O

TITLE	O
:	O
The	O
SARS	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
--	O
forms	O
and	O
functions	O
.	O

The	O
aims	O
of	O
the	O
study	O
were	O
to	O
investigate	O
the	O
etiological	O
role	O
of	O
BRSV	B-SPEC
and	O
other	O
respiratory	O
viruses	B-SPEC
in	O
epidemics	O
of	O
BRD	O
and	O
to	O
perform	O
phylogenetic	O
analysis	O
of	O
Norwegian	O
BRSV	B-SPEC
strains	O
.	O

The	O
results	O
demonstrated	O
that	O
BRSV	B-SPEC
is	O
the	O
most	O
important	O
etiological	O
agent	O
of	O
epidemics	O
of	O
BRD	O
in	O
Norway	O
and	O
that	O
it	O
often	O
acts	O
as	O
the	O
only	O
viral	O
agent	O
.	O

The	O
identification	O
of	O
co	O
-	O
infections	O
in	O
dogs	B-SPEC
is	O
important	O
to	O
determine	O
the	O
prognosis	O
and	O
to	O
plan	O
strategies	O
for	O
their	O
treatment	O
and	O
prophylaxis	O
.	O

(	O
14	O
/	O
104	O
dogs	B-SPEC
,	O
13	O
.	O
5	O
%).	O

Cells	O
and	O
supernatants	O
were	O
harvested	O
separately	O
and	O
virus	B-SPEC
titers	O
were	O
quantified	O
by	O
plaque	O
assay	O
.	O

However	O
,	O
treatment	O
with	O
S	B-SPEC
.	I-SPEC
nigra	I-SPEC
extracts	O
reduced	O
virus	B-SPEC
titers	O
by	O
four	O
orders	O
of	O
magnitude	O
at	O
a	O
multiplicity	O
of	O
infection	O
(	O
MOI	O
)	O
of	O
1	O
in	O
a	O
dose	O
-	O
responsive	O
manner	O
.	O

Using	O
phospholipid	O
-	O
coated	O
oxygen	O
microbubbles	O
(	O
OMBs	O
),	O
we	O
demonstrate	O
100	O
%	O
survival	O
for	O
rats	B-SPEC
experiencing	O
acute	O
lung	O
trauma	O
to	O
at	O
least	O
2	O
h	O
.	O
In	O
contrast	O
,	O
all	O
untreated	O
rats	B-SPEC
and	O
rats	B-SPEC
treated	O
with	O
peritoneal	O
oxygenated	O
saline	O
died	O
within	O
30	O
min	O
.	O

We	O
tested	O
whether	O
pseudoknots	O
bound	O
with	O
an	O
anti	O
-	O
frameshifting	O
ligand	O
exhibited	O
a	O
similar	O
correlation	O
between	O
conformational	O
plasticity	O
and	O
-	O
1	O
PRF	O
efficiency	O
by	O
measuring	O
the	O
effects	O
of	O
a	O
ligand	O
that	O
was	O
found	O
to	O
inhibit	O
-	O
1	O
PRF	O
in	O
the	O
SARS	O
coronavirus	B-SPEC
on	O
the	O
conformational	O
dynamics	O
of	O
the	O
SARS	O
pseudoknot	O
.	O

Multivariate	O
logistic	O
regression	O
analysis	O
showed	O
that	O
the	O
underlying	O
disease	O
scores	O
[	O
odds	O
ratio	O
(	O
OR	O
)=	O
1	O
.	O
874	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
95	O
%	O
CI	O
)	O
1	O
.	O
138	O
-	O
3	O
.	O
084	O
,	O
P	O
=	O
0	O
.	O
014	O
],	O
whether	O
patients	O
occurrence	O
of	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
(	O
OR	O
=	O
0	O
.	O
167	O
,	O
95	O
%	O
CI	O
0	O
.	O
064	O
-	O
0	O
.	O
435	O
,	O
P	O
=	O
0	O
.	O
000	O
)	O
and	O
SOFA	O
scores	O
(	O
OR	O
=	O
1	O
.	O
498	O
,	O
95	O
%	O
CI	O
1	O
.	O
283	O
-	O
1	O
.	O
750	O
,	O
P	O
=	O
0	O
.	O
000	O
)	O
were	O
independent	O
factors	O
for	O
predicting	O
28	O
-	O
day	O
mortality	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infections	O
and	O
diseases	O
represents	O
a	O
potential	O
threat	O
for	O
worldwide	O
spread	O
and	O
requires	O
development	O
of	O
effective	O
therapeutic	O
strategies	O
.	O

Using	O
a	O
standard	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
neutralization	O
test	O
,	O
serial	O
sera	O
from	O
three	O
sheep	B-SPEC
and	O
three	O
horses	B-SPEC
were	O
all	O
negative	O
while	O
sera	O
from	O
9	O
of	O
11	O
dromedary	B-SPEC
camels	B-SPEC
from	O
Dubai	O
were	O
positive	O
for	O
antibodies	O
supported	O
by	O
similar	O
results	O
in	O
a	O
MERS	O
-	O
CoV	O
recombinant	O
partial	O
spike	O
protein	O
antibody	O
ELISA	O
.	O

ABSTRACT	O
:	O
Replicative	O
capacity	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
assessed	O
in	O
cell	O
lines	O
derived	O
from	O
livestock	O
and	O
peridomestic	O
small	O
mammals	B-SPEC
on	O
the	O
Arabian	O
Peninsula	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
protective	O
efficacy	O
of	O
the	O
synthetic	O
peptide	O
vaccine	O
containing	O
the	O
T	O
-	O
helper	O
1	O
epitope	O
with	O
CpG	O
oligodeoxynucleotide	O
against	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
infection	O
in	O
cats	B-SPEC
.	O

Drugs	O
that	O
inhibit	O
the	O
ion	O
channel	O
can	O
,	O
therefore	O
,	O
inhibit	O
virus	B-SPEC
release	O
,	O
and	O
they	O
could	O
be	O
a	O
source	O
for	O
development	O
of	O
novel	O
therapeutic	O
antiviral	O
agents	O
.	O

The	O
MERS	O
-	O
CoV	O
RT	O
-	O
RPA	O
showed	O
cross	O
-	O
detection	O
neither	O
of	O
any	O
of	O
the	O
RNAs	O
of	O
several	O
coronaviruses	O
and	O
respiratory	O
viruses	B-SPEC
affecting	O
humans	B-SPEC
nor	O
of	O
the	O
human	B-SPEC
genome	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
influence	O
of	O
the	O
variation	O
of	O
the	O
original	O
skeletons	O
of	O
natural	O
phenanthroindo	O
/	O
quinolizidine	O
alkaloids	O
on	O
antiviral	O
activities	O
,	O
two	O
types	O
of	O
structurally	O
totally	O
novel	O
analogues	O
7a	O
,	O
7b	O
,	O
16a	O
,	O
and	O
16b	O
were	O
designed	O
,	O
synthesized	O
,	O
and	O
evaluated	O
against	O
tobacco	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
(	O
TMV	B-SPEC
)	O
for	O
the	O
first	O
time	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
,	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
has	O
caused	O
outbreaks	O
of	O
a	O
SARS	O
-	O
like	O
illness	O
with	O
high	O
case	O
fatality	O
rate	O
.	O

Here	O
we	O
characterize	O
the	O
six	O
-	O
helix	O
bundle	O
fusion	O
core	O
structure	O
of	O
MERS	O
-	O
CoV	O
spike	O
protein	O
S2	O
subunit	O
by	O
X	O
-	O
ray	B-SPEC
crystallography	O
and	O
biophysical	O
analysis	O
.	O

Forty	O
two	O
Wistar	B-SPEC
rats	I-SPEC
were	O
randomly	O
divided	O
into	O
three	O
groups	O
:	O
6	O
rats	B-SPEC
were	O
treated	O
with	O
saline	O
solution	O
by	O
intratracheal	O
instillation	O
(	O
control	O
group	O
),	O
18	O
rats	B-SPEC
were	O
treated	O
with	O
LPS	O
by	O
intratracheal	O
instillation	O
(	O
LPS	O
group	O
)	O
and	O
the	O
other	O
18	O
rats	B-SPEC
received	O
PFC	O
through	O
femoral	O
vein	O
prior	O
to	O
LPS	O
instillation	O
(	O
LPS	O
+	O
PFC	O
group	O
).	O

WHO	O
guidelines	O
for	O
treatment	O
of	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
malaria	O
need	O
to	O
be	O
reinforced	O
.	O

CONCLUSIONS	O
:	O
We	O
found	O
that	O
some	O
common	O
respiratory	O
viruses	B-SPEC
,	O
such	O
as	O
adenoviruses	B-SPEC
,	O
enteroviruses	B-SPEC
,	O
rhinoviruses	B-SPEC
,	O
and	O
coronaviruses	O
,	O
were	O
associated	O
with	O
KD	O
cases	O
.	O

TITLE	O
:	O
Respiratory	O
viruses	B-SPEC
within	O
homeless	O
shelters	O
in	O
Marseille	O
,	O
France	O
.	O

Following	O
a	O
clinical	O
examination	O
,	O
we	O
collected	O
nasal	O
specimens	O
from	O
which	O
the	O
RT	O
-	O
PCR	O
detection	O
of	O
10	O
respiratory	O
viruses	B-SPEC
was	O
performed	O
through	O
snapshot	O
investigations	O
.	O

We	O
developed	O
a	O
novel	O
high	O
-	O
throughput	O
screening	O
assay	O
to	O
identify	O
small	O
molecules	O
that	O
can	O
prevent	O
cathepsin	O
L	O
cleavage	O
of	O
viral	O
glycoproteins	O
derived	O
from	O
SARS	O
-	O
CoV	O
and	O
Ebola	O
,	O
Hendra	O
,	O
and	O
Nipah	O
viruses	B-SPEC
that	O
are	O
required	O
for	O
their	O
entry	O
into	O
the	O
host	O
cell	O
.	O

Mapping	O
of	O
revertants	O
of	O
the	O
resulting	O
chimeric	O
viruses	B-SPEC
provided	O
evidence	O
for	O
extensive	O
intramolecular	O
interactions	O
between	O
the	O
two	O
RNA	O
-	O
binding	O
domains	O
.	O

Further	O
,	O
we	O
compared	O
the	O
ability	O
of	O
MERS	O
-	O
CoV	O
PLpro	O
and	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
PLpro	O
to	O
block	O
innate	O
immune	O
signaling	O
of	O
proinflammatory	O
cytokines	O
.	O

TITLE	O
:	O
Induction	O
of	O
innate	O
immune	O
response	O
following	O
infectious	O
bronchitis	O
corona	B-SPEC
virus	B-SPEC
infection	O
in	O
the	O
respiratory	O
tract	O
of	O
chickens	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
replicates	O
in	O
the	O
epithelial	O
cells	O
of	O
trachea	B-SPEC
and	O
lungs	O
of	O
chicken	B-SPEC
,	O
however	O
the	O
mechanism	O
of	O
generation	O
of	O
innate	O
immune	O
response	O
against	O
IBV	B-SPEC
infection	O
in	O
these	O
tissues	O
has	O
not	O
been	O
fully	O
characterized	O
.	O

Our	O
objective	O
was	O
to	O
study	O
innate	O
responses	O
induced	O
early	O
following	O
IBV	B-SPEC
infection	O
in	O
chickens	B-SPEC
.	O

Initiation	O
of	O
the	O
transcription	O
of	O
selected	O
innate	O
immune	O
genes	O
such	O
as	O
TLR3	O
,	O
TLR7	O
,	O
MyD88	O
,	O
IL	O
-	O
1β	O
and	O
IFN	O
-	O
β	O
,	O
as	O
well	O
as	O
recruitment	O
of	O
macrophages	O
,	O
were	O
evident	O
following	O
an	O
initial	O
down	O
regulation	O
of	O
some	O
of	O
the	O
observed	O
genes	O
(	O
TLR3	O
,	O
IL	O
-	O
1β	O
,	O
and	O
IFN	O
-	O
γ	O
)	O
in	O
trachea	B-SPEC
and	O
lung	O
.	O

About	O
4000	O
HCPS	O
cases	O
have	O
been	O
reported	O
in	O
South	O
America	O
up	O
to	O
2013	O
,	O
associated	O
with	O
the	O
following	O
hantaviruses	B-SPEC
:	O
Andes	B-SPEC
,	O
Anajatuba	O
,	O
Araraquara	O
(	O
ARQV	O
),	O
Paranoá	O
,	O
Bermejo	O
,	O
Castelo	O
dos	O
Sonhos	O
,	O
Juquitiba	O
,	O
Araucária	O
,	O
Laguna	O
Negra	O
,	O
Lechiguanas	O
,	O
Maripa	B-SPEC
,	O
Oran	O
,	O
Rio	O
Mamore	O
and	O
Tunari	O
.	O

M	O
protein	O
from	O
human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
does	O
not	O
inhibit	O
IFN	O
production	O
.	O

TM1	O
targets	O
SARS	O
coronavirus	B-SPEC
M	O
protein	O
and	O
heterologous	O
proteins	O
to	O
the	O
Golgi	O
apparatus	O
,	O
yet	O
Golgi	O
localization	O
is	O
required	O
but	O
not	O
sufficient	O
for	O
IFN	O
antagonism	O
.	O

Out	O
of	O
the	O
15	O
positive	O
fecal	O
samples	O
,	O
virus	B-SPEC
from	O
only	O
seven	O
was	O
able	O
to	O
infect	O
vero	O
cell	O
line	O
.	O

TITLE	O
:	O
[	O
Bats	B-SPEC
,	O
viruses	B-SPEC
and	O
humans	B-SPEC
:	O
coronaviruses	O
on	O
the	O
rise	O
?].	O

With	O
the	O
analysis	O
of	O
the	O
papain	O
-	O
like	O
protease	O
of	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
came	O
the	O
realization	O
of	O
the	O
multifunctional	O
nature	O
of	O
these	O
enzymes	O
.	O

Recently	O
,	O
the	O
MERS	O
-	O
CoV	O
and	O
its	O
neutralizing	O
antibodies	O
were	O
detected	O
in	O
dromedary	B-SPEC
camels	B-SPEC
.	O

TITLE	O
:	O
Myosins	O
1	O
and	O
6	O
,	O
myosin	O
light	O
chain	O
kinase	O
,	O
actin	O
and	O
microtubules	O
cooperate	O
during	O
antibody	O
-	O
mediated	O
internalisation	O
and	O
trafficking	O
of	O
membrane	O
-	O
expressed	O
viral	O
antigens	O
in	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
infected	O
monocytes	O
.	O

TITLE	O
:	O
Influence	O
of	O
hydrophobic	O
and	O
electrostatic	O
residues	O
on	O
SARS	O
-	O
coronavirus	B-SPEC
S2	O
protein	O
stability	O
:	O
insights	O
into	O
mechanisms	O
of	O
general	O
viral	O
fusion	O
and	O
inhibitor	O
design	O
.	O

The	O
triterpenoids	O
of	O
licorice	B-SPEC
has	O
the	O
potential	O
to	O
become	O
a	O
novel	O
broad	O
-	O
spectrum	O
antiviral	O
medicine	O
and	O
will	O
be	O
widely	O
used	O
in	O
the	O
clinical	O
treatment	O
.	O

This	O
review	O
provided	O
a	O
summary	O
of	O
the	O
recent	O
anti	O
-	O
virus	B-SPEC
research	O
progress	O
on	O
several	O
triterpenoids	O
in	O
licorice	B-SPEC
,	O
such	O
as	O
glycyrrhizic	O
acid	O
,	O
glycyrrhizin	O
,	O
glycyrrhetinic	O
acid	O
and	O
its	O
derivatives	O
.	O

The	O
antiviral	O
roles	O
of	O
triterpenoids	O
in	O
licorice	B-SPEC
against	O
herpes	B-SPEC
virus	I-SPEC
,	O
HIV	B-SPEC
,	O
hepatitis	O
virus	B-SPEC
,	O
SARS	O
coronavirus	B-SPEC
and	O
influenza	B-SPEC
virus	I-SPEC
were	O
briefly	O
summarized	O
.	O

PACT	O
targeting	O
might	O
be	O
a	O
common	O
strategy	O
used	O
by	O
different	O
viruses	B-SPEC
,	O
including	O
Ebola	B-SPEC
virus	I-SPEC
and	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
1	I-SPEC
,	O
to	O
counteract	O
innate	O
immunity	O
.	O

It	O
will	O
therefore	O
be	O
critical	O
to	O
clarify	O
how	O
MERS	O
-	O
CoV	O
cripples	O
the	O
host	O
proteins	O
that	O
sense	O
viruses	B-SPEC
and	O
to	O
compare	O
MERS	O
-	O
CoV	O
with	O
its	O
ancestral	O
viruses	B-SPEC
in	O
bats	B-SPEC
in	O
the	O
counteraction	O
of	O
virus	B-SPEC
sensing	O
.	O

TITLE	O
:	O
Inhibitory	O
effect	O
of	O
silver	O
nanomaterials	O
on	O
transmissible	O
virus	B-SPEC
-	O
induced	O
host	O
cell	O
infections	O
.	O

Herein	O
,	O
four	O
representative	O
Ag	O
NMs	O
including	O
spherical	O
Ag	O
nanoparticles	O
(	O
Ag	O
NPs	O
,	O
NM	O
-	O
300	O
),	O
two	O
kinds	O
of	O
silver	O
nanowires	O
(	O
XFJ011	O
)	O
and	O
silver	O
colloids	O
(	O
XFJ04	O
)	O
were	O
selected	O
to	O
study	O
their	O
inhibitory	O
effect	O
on	O
TGEV	B-SPEC
-	O
induced	O
host	O
cell	O
infection	O
in	O
vitro	O
.	O

The	O
yeast	B-SPEC
system	O
was	O
applied	O
to	O
the	O
screening	O
of	O
3000	O
natural	O
product	O
extracts	O
,	O
and	O
three	O
were	O
observed	O
to	O
more	O
potently	O
inhibit	O
the	O
activity	O
of	O
coronavirus	B-SPEC
than	O
human	B-SPEC
N7	O
-	O
MTase	O
.	O

ABSTRACT	O
:	O
Papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
is	O
one	O
of	O
two	O
cysteine	O
proteases	O
involved	O
in	O
the	O
proteolytic	O
processing	O
of	O
the	O
polyproteins	O
of	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
[	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
):	O
bats	B-SPEC
or	O
dromedary	B-SPEC
,	O
which	O
of	O
them	O
is	O
responsible	O
?].	O

As	O
the	O
new	O
disease	O
was	O
very	O
similar	O
to	O
the	O
deadly	O
SARS	O
(	O
2002	O
-	O
2003	O
)	O
and	O
since	O
it	O
was	O
provoked	O
by	O
a	O
Betacoronavirus	B-SPEC
,	O
chiroptera	B-SPEC
were	O
first	O
suspected	O
to	O
be	O
at	O
the	O
origin	O
of	O
this	O
infection	O
.	O

ABSTRACT	O
:	O
Our	O
previous	O
studies	O
showed	O
that	O
TGEV	B-SPEC
infection	O
could	O
induce	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
via	O
activation	O
of	O
p53	O
signaling	O
in	O
cultured	O
host	O
cells	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
TGEV	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
on	O
PK	O
-	O
15	O
cells	O
.	O

Moreover	O
,	O
the	O
expression	O
of	O
TGEV	B-SPEC
N	O
gene	O
promoted	O
translocation	O
of	O
Bax	O
to	O
mitochondria	O
,	O
which	O
in	O
turn	O
caused	O
the	O
release	O
of	O
cytochrome	O
c	O
,	O
followed	O
by	O
activation	O
of	O
caspase	O
-	O
3	O
,	O
resulting	O
in	O
cell	O
apoptosis	O
in	O
the	O
transfected	O
PK	O
-	O
15	O
cells	O
following	O
cell	O
cycle	O
arrest	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
first	O
documented	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
(	O
KSA	O
)	O
in	O
2012	O
and	O
,	O
to	O
date	O
,	O
has	O
been	O
identified	O
in	O
180	O
cases	O
with	O
43	O
%	O
mortality	O
.	O

MERS	O
-	O
CoV	O
adaptation	O
toward	O
higher	O
rates	O
of	O
sustained	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
appears	O
not	O
to	O
have	O
occurred	O
yet	O
.	O

TITLE	O
:	O
Identification	O
and	O
characterization	O
of	O
a	O
proteolytically	O
primed	O
form	O
of	O
the	O
murine	B-SPEC
coronavirus	I-SPEC
spike	O
proteins	O
after	O
fusion	O
with	O
the	O
target	O
cell	O
.	O

We	O
developed	O
an	O
approach	O
to	O
characterize	O
structural	O
components	O
of	O
virus	B-SPEC
particles	O
after	O
entering	O
new	O
target	O
cells	O
.	O

Human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
is	O
now	O
confirmed	O
showing	O
potential	O
for	O
another	O
pandemic	O
of	O
zoonotic	O
disease	O
,	O
with	O
an	O
extremely	O
high	O
mortality	O
rate	O
.	O

Cross	O
-	O
reactivity	O
with	O
sera	O
from	O
pigs	B-SPEC
infected	O
with	O
Mycoplasma	B-SPEC
hyopneumoniae	I-SPEC
,	O
Porcine	B-SPEC
circovirus	I-SPEC
-	O
2	O
,	O
Porcine	B-SPEC
parvovirus	I-SPEC
,	O
Porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
,	O
and	O
Porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
with	O
this	O
MIA	O
was	O
not	O
observed	O
.	O

Oral	O
valganciclovir	O
treatment	O
reduces	O
the	O
risk	O
of	O
hearing	O
loss	O
in	O
congenital	O
CMV	B-SPEC
infection	O
.	O

Cases	O
consisted	O
of	O
patients	O
with	O
either	O
sepsis	B-SPEC
or	O
trauma	O
and	O
ALI	O
/	O
ARDS	O
;	O
controls	O
consisted	O
of	O
equivalent	O
numbers	O
of	O
matched	O
patients	O
with	O
either	O
sepsis	B-SPEC
or	O
trauma	O
alone	O
.	O

25	O
-	O
OHD	O
levels	O
did	O
not	O
differ	O
between	O
cases	O
with	O
ALI	O
/	O
ARDS	O
and	O
controls	O
in	O
either	O
the	O
sepsis	B-SPEC
or	O
trauma	O
cohorts	O
.	O

Serum	O
25	O
-	O
OHD	O
measured	O
early	O
after	O
admission	O
to	O
intensive	O
care	O
is	O
not	O
associated	O
with	O
the	O
development	O
of	O
acute	O
lung	O
injury	O
,	O
hospital	O
or	O
one	O
-	O
year	O
mortality	O
in	O
critically	O
ill	O
patients	O
with	O
sepsis	B-SPEC
although	O
lower	O
25	O
-	O
OHD	O
levels	O
were	O
associated	O
with	O
higher	O
one	O
-	O
year	O
mortality	O
in	O
patients	O
with	O
severe	O
trauma	O
.	O

TITLE	O
:	O
Structural	O
basis	O
for	O
the	O
identification	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
as	O
an	O
antiviral	O
target	O
.	O

Using	O
human	B-SPEC
CoV	O
-	O
OC43	O
(	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
)	O
as	O
a	O
model	O
for	O
CoV	O
,	O
we	O
present	O
the	O
3D	O
structure	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
N	O
-	O
NTD	O
complexed	O
with	O
ribonucleoside	O
5	O
'-	O
monophosphates	O
to	O
identify	O
a	O
distinct	O
ribonucleotide	O
-	O
binding	O
pocket	O
.	O

TITLE	O
:	O
The	O
discovery	O
of	O
asunaprevir	O
(	O
BMS	O
-	O
650032	O
),	O
an	O
orally	O
efficacious	O
NS3	O
protease	O
inhibitor	O
for	O
the	O
treatment	O
of	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
infection	O
.	O

The	O
antiviral	O
activity	O
,	O
preclincial	O
PK	O
profile	O
,	O
and	O
toxicology	O
studies	O
in	O
rat	B-SPEC
and	O
dog	B-SPEC
supported	O
clinical	O
development	O
of	O
BMS	O
-	O
650032	O
(	O
24	O
).	O

ABSTRACT	O
:	O
Until	O
recently	O
,	O
there	O
were	O
no	O
effective	O
drugs	O
available	O
blocking	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infection	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

Knockdown	O
of	O
the	O
cellular	O
Cyclophilin	O
A	O
(	O
CypA	B-SPEC
/	O
PPIA	O
)	O
gene	O
in	O
Caco	O
-	O
2	O
cells	O
prevents	O
replication	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
suggesting	O
that	O
CypA	B-SPEC
is	O
required	O
for	O
virus	B-SPEC
replication	O
.	O

Bocavirus	B-SPEC
was	O
associated	O
with	O
ARI	O
even	O
after	O
adjustment	O
for	O
coinfections	O
with	O
other	O
viruses	B-SPEC
and	O
was	O
associated	O
with	O
severe	O
disease	O
.	O

Enterovirus	B-SPEC
and	O
coronavirus	B-SPEC
were	O
equally	O
common	O
in	O
case	O
patients	O
and	O
control	O
subjects	O
.	O

Giardia	B-SPEC
spp	O
.	O

A	O
mono	O
-	O
infection	O
with	O
Giardia	B-SPEC
spp	O
.	O

ABSTRACT	O
:	O
Structure	O
-	O
guided	O
design	O
was	O
used	O
to	O
generate	O
a	O
series	O
of	O
noncovalent	O
inhibitors	O
with	O
nanomolar	O
potency	O
against	O
the	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
from	O
the	O
SARS	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

X	O
-	O
ray	B-SPEC
structural	O
analyses	O
of	O
inhibitor	O
-	O
bound	O
crystal	O
structures	O
revealed	O
subtle	O
differences	O
between	O
binding	O
modes	O
of	O
the	O
initial	O
benzodioxolane	O
lead	O
(	O
15g	O
)	O
and	O
the	O
most	O
potent	O
analogues	O
3k	O
and	O
3j	O
,	O
featuring	O
a	O
monofluoro	O
substitution	O
at	O
para	O
and	O
meta	B-SPEC
positions	O
of	O
the	O
benzyl	O
ring	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
proposed	O
to	O
be	O
a	O
zoonotic	O
disease	O
;	O
however	O
,	O
the	O
reservoir	O
and	O
mechanism	O
for	O
transmission	O
of	O
the	O
causative	O
agent	O
,	O
the	O
MERS	O
coronavirus	B-SPEC
,	O
are	O
unknown	O
.	O

We	O
found	O
no	O
evidence	O
of	O
infection	O
in	O
domestic	B-SPEC
sheep	I-SPEC
or	O
domestic	B-SPEC
goats	I-SPEC
.	O

We	O
hypothesized	O
that	O
viral	O
genomic	O
material	O
is	O
present	O
in	O
tonsils	O
of	O
children	O
with	O
OSA	B-SPEC
.	O

TITLE	O
:	O
Mouse	B-SPEC
dipeptidyl	O
peptidase	O
4	O
is	O
not	O
a	O
functional	O
receptor	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
dipeptidyl	O
peptidase	O
4	O
(	O
hDPP4	O
)	O
was	O
recently	O
identified	O
as	O
the	O
receptor	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
,	O
suggesting	O
that	O
other	O
mammalian	B-SPEC
DPP4	O
orthologs	O
may	O
also	O
support	O
infection	O
.	O

However	O
,	O
employing	O
mouse	B-SPEC
DPP4	O
as	O
a	O
scaffold	O
,	O
we	O
identified	O
two	O
critical	O
amino	O
acids	O
(	O
A288L	O
and	O
T330R	O
)	O
that	O
regulate	O
species	B-SPEC
specificity	O
in	O
the	O
mouse	B-SPEC
.	O

ABSTRACT	O
:	O
Leptospirosis	O
is	O
a	O
zoonotic	O
disease	O
of	O
global	O
reach	O
caused	O
by	O
pathogenic	O
spirochetes	B-SPEC
of	O
the	O
genus	B-SPEC
Leptospira	I-SPEC
.	O

The	O
A	O
/	O
Hong	O
Kong	O
/	O
470129	O
/	O
2013	O
virus	B-SPEC
is	O
a	O
novel	O
reassortant	O
derived	O
from	O
A	O
/	O
Guangdong	O
/	O
1	O
/	O
2013	O
virus	B-SPEC
.	O

We	O
investigated	O
the	O
clinical	O
characteristics	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
in	O
patients	O
<	O
5	O
years	O
of	O
age	O
during	O
a	O
recent	O
coronavirus	B-SPEC
season	O
.	O

Coinfections	O
were	O
detected	O
in	O
35	O
%	O
and	O
38	O
%	O
of	O
children	O
with	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
,	O
respectively	O
.	O

Overall	O
,	O
a	O
substantial	O
burden	O
of	O
disease	O
associated	O
with	O
both	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
observed	O
for	O
hospitalized	O
children	O
<	O
5	O
years	O
of	O
age	O
.	O

Examples	O
are	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
novel	O
variants	O
of	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
such	O
as	O
H5N1	O
and	O
pandemic	O
H1N1	O
.	O

The	O
reporting	O
rates	O
of	O
syncope	B-SPEC
or	O
loss	O
of	O
consciousness	O
and	O
seizures	O
were	O
6	O
.	O
4	O
and	O
0	O
.	O
4	O
,	O
for	O
the	O
other	O
vaccines	O
.	O

This	O
virus	B-SPEC
,	O
named	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)-	O
CoV	O
,	O
is	O
phylogenetically	O
related	O
to	O
bat	B-SPEC
CoVs	O
,	O
but	O
other	O
animal	B-SPEC
species	B-SPEC
like	O
dromedary	B-SPEC
camels	B-SPEC
may	O
potentially	O
act	O
as	O
intermediate	O
hosts	O
by	O
spreading	O
the	O
virus	B-SPEC
to	O
humans	B-SPEC
.	O

Vaccination	O
with	O
a	O
single	O
dose	O
of	O
the	O
THEV	O
commercial	O
inactivated	O
vaccine	O
available	O
in	O
Italy	O
seems	O
does	O
not	O
protect	O
the	O
birds	B-SPEC
from	O
the	O
infection	O
.	O

TITLE	O
:	O
The	O
emergence	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Over	O
a	O
year	O
after	O
the	O
emergence	O
of	O
this	O
novel	B-SPEC
coronavirus	I-SPEC
--	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)--	O
it	O
has	O
caused	O
178	O
laboratory	O
-	O
confirmed	O
cases	O
and	O
76	O
deaths	O
.	O

TITLE	O
:	O
Comparative	O
in	O
vivo	O
analysis	O
of	O
recombinant	O
type	O
II	O
feline	B-SPEC
coronaviruses	O
with	O
truncated	O
and	O
completed	O
ORF3	O
region	O
.	O

The	O
recombinant	O
PBFIPV	O
-	O
DF	O
-	O
2	O
-	O
R3i	O
with	O
completed	O
ORF3abc	O
gained	O
biological	O
properties	O
that	O
differentiate	O
between	O
the	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
(	O
FECV	B-SPEC
)	O
and	O
FIPV	O
biotypes	O
such	O
as	O
intensive	O
replication	O
in	O
the	O
gut	O
,	O
absence	O
of	O
viremia	O
and	O
weak	O
or	O
no	O
serological	O
response	O
.	O

ABSTRACT	O
:	O
Community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
)	O
is	O
a	O
common	O
cause	O
of	O
sepsis	B-SPEC
.	O

Active	O
full	O
-	O
length	O
caspase	O
-	O
12	O
(	O
CASP12L	O
),	O
confined	O
to	O
the	O
people	O
of	O
African	O
descent	O
,	O
has	O
been	O
associated	O
with	O
increased	O
susceptibility	O
to	O
and	O
mortality	O
from	O
severe	O
sepsis	B-SPEC
.	O

Next	O
generation	O
sequencing	O
technologies	O
have	O
been	O
utilized	O
for	O
analysis	O
of	O
clinical	O
and	O
environmental	B-SPEC
samples	I-SPEC
to	O
identify	O
viral	O
pathogens	O
that	O
may	O
be	O
present	O
.	O

After	O
7	O
days	O
,	O
the	O
x	O
-	O
ray	B-SPEC
film	O
showed	O
considerable	O
clearing	O
of	O
shadows	O
.	O

Here	O
,	O
we	O
show	O
that	O
mice	B-SPEC
were	O
sensitized	O
to	O
MERS	O
-	O
CoV	O
infection	O
by	O
prior	O
transduction	O
with	O
adenoviral	B-SPEC
vectors	O
expressing	O
the	O
human	B-SPEC
host	O
-	O
cell	O
receptor	O
dipeptidyl	O
peptidase	O
4	O
.	O

Mice	B-SPEC
developed	O
a	O
pneumonia	O
characterized	O
by	O
extensive	O
inflammatory	O
-	O
cell	O
infiltration	O
with	O
virus	B-SPEC
clearance	O
occurring	O
6	O
-	O
8	O
d	O
after	O
infection	O
.	O

Using	O
these	O
mice	B-SPEC
,	O
we	O
demonstrated	O
the	O
efficacy	O
of	O
a	O
therapeutic	O
intervention	O
(	O
poly	O
I	O
:	O
C	O
)	O
and	O
a	O
potential	O
vaccine	O
[	O
Venezuelan	O
equine	B-SPEC
encephalitis	O
replicon	O
particles	O
expressing	O
MERS	O
-	O
CoV	O
spike	O
protein	O
].	O

We	O
also	O
found	O
little	O
protective	O
cross	O
-	O
reactivity	O
between	O
MERS	O
-	O
CoV	O
and	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
CoV	O
.	O
Our	O
results	O
demonstrate	O
that	O
this	O
system	O
will	O
be	O
useful	O
for	O
MERS	O
-	O
CoV	O
studies	O
and	O
for	O
the	O
rapid	O
development	O
of	O
relevant	O
animal	B-SPEC
models	O
for	O
emerging	O
respiratory	O
viral	O
infections	O
.	O

The	O
type	O
II	O
transmembrane	O
serine	O
protease	O
TMPRSS2	O
is	O
expressed	O
in	O
the	O
respiratory	O
tract	O
and	O
is	O
capable	O
of	O
activating	O
a	O
variety	O
of	O
respiratory	O
viruses	B-SPEC
,	O
including	O
low	O
-	O
pathogenic	O
(	O
LP	O
)	O
IAVs	O
possessing	O
a	O
single	O
arginine	O
residue	O
at	O
the	O
cleavage	O
site	O
.	O

In	O
TMPRSS2	O
KO	O
mice	B-SPEC
infected	O
with	O
LP	O
IAVs	O
,	O
cleavage	O
of	O
HA	O
was	O
severely	O
impaired	O
,	O
and	O
consequently	O
,	O
the	O
majority	O
of	O
LP	O
IAV	O
progeny	O
particles	O
failed	O
to	O
gain	O
infectivity	O
,	O
while	O
the	O
viruses	B-SPEC
were	O
fully	O
activated	O
proteolytically	O
in	O
TMPRSS2	O
+/+	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
77	O
-	O
year	O
-	O
old	O
man	B-SPEC
underwent	O
thoracic	O
surgery	O
.	O

Preoperative	O
examinations	O
including	O
chest	O
x	O
-	O
ray	B-SPEC
,	O
spirogram	O
and	O
CT	O
were	O
not	O
remarkable	O
.	O

ABSTRACT	O
:	O
As	O
a	O
continuation	O
of	O
our	O
efforts	O
to	O
discover	O
and	O
develop	O
back	O
-	O
up	O
analogs	O
of	O
DAPYs	O
,	O
novel	O
substituted	O
nitropyridine	O
derivatives	O
were	O
designed	O
via	O
a	O
structure	O
-	O
based	O
core	O
refining	O
approach	O
,	O
synthesized	O
and	O
evaluated	O
for	O
their	O
in	O
vitro	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
activity	O
in	O
MT	O
-	O
4	O
cells	O
.	O

Here	O
,	O
we	O
show	O
that	O
a	O
chimeric	O
S	O
protein	O
,	O
containing	O
the	O
six	O
C	O
-	O
terminal	O
amino	O
acids	O
of	O
the	O
glycoprotein	O
G	O
of	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
(	O
VSV	O
)	O
is	O
no	O
longer	O
retained	O
intracellularly	O
,	O
despite	O
the	O
presence	O
of	O
the	O
tyrosine	O
tetrapeptide	O
motif	O
.	O

TITLE	O
:	O
C5a	O
/	O
C5aR	O
pathway	O
is	O
essential	O
for	O
the	O
pathogenesis	O
of	O
murine	B-SPEC
viral	O
fulminant	O
hepatitis	O
by	O
way	O
of	O
potentiating	O
Fgl2	O
/	O
fibroleukin	O
expression	O
.	O

Therefore	O
,	O
radical	O
scavengers	B-SPEC
are	O
promising	O
compounds	O
for	O
the	O
treatment	O
of	O
neuronal	O
dysfunction	O
in	O
RS	O
and	O
deserve	O
further	O
detailed	O
evaluation	O
.	O

TITLE	O
:	O
High	O
-	O
level	O
protein	O
expression	O
following	O
single	O
and	O
dual	O
gene	O
cloning	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
N	O
and	O
S	O
genes	O
using	O
baculovirus	B-SPEC
systems	O
.	O

The	O
nucleocapsid	O
gene	O
(	O
N	O
)	O
of	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
was	O
cloned	O
in	O
a	O
baculovirus	B-SPEC
expression	O
system	O
for	O
insect	B-SPEC
cell	O
expression	O
.	O

Transduction	O
of	O
mammalian	B-SPEC
and	O
avian	B-SPEC
cells	O
with	O
BacMam	O
viruses	B-SPEC
revealed	O
that	O
dual	O
expression	O
cassettes	O
yielded	O
high	O
levels	O
of	O
protein	O
from	O
both	O
transcription	O
units	O
.	O

Using	O
the	O
SIV	B-SPEC
model	O
of	O
AIDS	O
,	O
we	O
performed	O
a	O
comparative	O
analysis	O
of	O
the	O
molecular	O
and	O
cellular	O
characteristics	O
of	O
host	O
responses	O
in	O
the	O
gut	O
and	O
lung	O
.	O

TITLE	O
:	O
Comparative	O
proteome	O
analysis	O
of	O
tracheal	O
tissues	O
in	O
response	O
to	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
,	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
and	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
H9	O
subtype	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
),	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
and	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
AIV	O
)	O
H9	O
subtype	O
are	O
major	O
pathogens	O
of	O
chickens	B-SPEC
causing	O
serious	O
respiratory	O
tract	O
disease	O
and	O
heavy	O
economic	O
losses	O
.	O

In	O
this	O
study	O
an	O
IBV	B-SPEC
,	O
ck	O
/	O
CH	O
/	O
LJL	O
/	O
111054	O
,	O
was	O
isolated	O
from	O
a	O
H120	O
-	O
vaccinated	O
chicken	B-SPEC
,	O
which	O
presented	O
with	O
a	O
suspected	O
IBV	B-SPEC
infection	O
.	O

Applying	O
our	O
method	O
to	O
data	O
from	O
the	O
three	O
largest	O
outbreaks	O
of	O
influenza	O
A	O
/	O
H7N9	O
outbreak	O
in	O
China	O
in	O
2013	O
,	O
we	O
found	O
evidence	O
that	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
accounted	O
for	O
13	O
%	O
(	O
95	O
%	O
credible	O
interval	O
1	O
%-	O
32	O
%)	O
of	O
cases	O
overall	O
.	O

Once	O
there	O
,	O
infection	O
of	O
CNS	O
cells	O
(	O
neurotropism	O
)	O
could	O
lead	O
to	O
human	B-SPEC
health	O
problems	O
,	O
such	O
as	O
encephalitis	O
and	O
long	O
-	O
term	O
neurological	O
diseases	O
.	O

Human	B-SPEC
Coronaviruses	O
(	O
HCoV	O
)	O
usually	O
infect	O
the	O
upper	O
respiratory	O
tract	O
,	O
where	O
they	O
are	O
mainly	O
associated	O
with	O
common	O
colds	O
.	O

TITLE	O
:	O
SARS	O
coronavirus	B-SPEC
papain	O
-	O
like	O
protease	O
inhibits	O
the	O
type	O
I	O
interferon	O
signaling	O
pathway	O
through	O
interaction	O
with	O
the	O
STING	O
-	O
TRAF3	O
-	O
TBK1	O
complex	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
replicase	O
-	O
reporter	O
fusions	O
provide	O
quantitative	O
analysis	O
of	O
replication	O
and	O
replication	O
complex	O
formation	O
.	O

Replication	O
is	O
associated	O
with	O
multiple	O
virus	B-SPEC
-	O
induced	O
membrane	O
structures	O
that	O
evolve	O
during	O
infection	O
;	O
however	O
,	O
the	O
dynamics	O
of	O
this	O
process	O
remain	O
poorly	O
understood	O
.	O

The	O
results	O
of	O
this	O
study	O
showed	O
that	O
simultaneous	O
colonization	O
of	O
the	O
intestinal	O
mucosa	O
by	O
adherent	O
non	O
-	O
ETEC	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
Enterococcus	B-SPEC
spp	O
.	O
can	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
neonatal	O
porcine	B-SPEC
diarrhea	O
.	O

These	O
bacteria	B-SPEC
should	O
be	O
considered	O
in	O
diagnosis	O
of	O
diarrhea	O
in	O
piglets	O
,	O
when	O
detection	O
of	O
common	O
,	O
well	O
-	O
known	O
enteric	O
agents	O
is	O
unsuccessful	O
.	O

The	O
pathogenesis	O
of	O
M	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
infection	O
remains	O
largely	O
unknown	O
.	O

TITLE	O
:	O
Molecular	O
characterizations	O
of	O
subcellular	O
localization	O
signals	O
in	O
the	O
nucleocapsid	O
protein	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
infection	O
in	O
aged	O
nonhuman	O
primates	B-SPEC
is	O
associated	O
with	O
modulated	O
pulmonary	O
and	O
systemic	O
immune	O
responses	O
.	O

Although	O
there	O
was	O
a	O
trend	O
of	O
higher	O
titers	O
in	O
respiratory	O
tissues	O
at	O
day	O
5	O
post	O
infection	O
,	O
this	O
did	O
not	O
reach	O
statistical	O
significance	O
and	O
virus	B-SPEC
was	O
cleared	O
from	O
all	O
animals	B-SPEC
by	O
day	O
10	O
,	O
regardless	O
of	O
age	O
.	O

TITLE	O
:	O
Protein	O
interferon	O
-	O
stimulated	O
gene	O
15	O
conjugation	O
delays	O
but	O
does	O
not	O
overcome	O
coronavirus	B-SPEC
proliferation	O
in	O
a	O
model	O
of	O
fulminant	O
hepatitis	O
.	O

Infecting	O
USP18	O
(-/-)	O
mice	B-SPEC
with	O
MHV	B-SPEC
-	O
3	O
resulted	O
in	O
extended	O
survival	O
(	O
8	O
±	O
1	O
.	O
2	O
versus	O
4	O
days	O
)	O
and	O
in	O
improved	O
liver	O
histology	O
,	O
a	O
decreased	O
inflammatory	O
response	O
,	O
and	O
viral	O
titers	O
1	O
to	O
2	O
logs	O
lower	O
than	O
in	O
USP18	O
(+/+)	O
mice	B-SPEC
.	O

There	O
have	O
been	O
a	O
number	O
of	O
serious	O
worldwide	O
pandemics	O
due	O
to	O
widespread	O
infections	O
by	O
coronavirus	B-SPEC
.	O

This	O
virus	B-SPEC
(	O
in	O
its	O
many	O
forms	O
)	O
is	O
difficult	O
to	O
treat	O
,	O
in	O
part	O
because	O
it	O
is	O
very	O
good	O
at	O
finding	O
""""	O
holes	O
""""	O
in	O
the	O
way	O
that	O
the	O
host	O
(	O
the	O
infected	O
individual	O
)	O
tries	O
to	O
control	O
and	O
eliminate	O
the	O
virus	B-SPEC
.	O

These	O
data	O
provide	O
insight	O
into	O
host	O
-	O
virus	B-SPEC
interactions	O
during	O
coronavirus	B-SPEC
infection	O
and	O
suggest	O
that	O
the	O
ISG15	O
pathway	O
is	O
a	O
reasonable	O
target	O
for	O
controlling	O
severe	O
coronavirus	B-SPEC
infection	O
although	O
the	O
best	O
treatment	O
will	O
likely	O
involve	O
multiple	O
pathways	O
and	O
targets	O
.	O

Partially	O
,	O
F	O
gene	O
from	O
hMPV	B-SPEC
positive	O
samples	O
were	O
sequenced	O
and	O
used	O
for	O
genotyping	O
by	O
phylogenetic	O
tree	O
analysis	O
.	O

The	O
prevalence	O
of	O
hMPV	B-SPEC
for	O
all	O
age	O
groups	O
was	O
6	O
.	O
3	O
%.	O

Dromedary	B-SPEC
camels	B-SPEC
have	O
been	O
implicated	O
as	O
possible	O
viral	O
reservoirs	O
.	O

Dromedary	B-SPEC
camels	B-SPEC
from	O
the	O
United	O
Arab	O
Emirates	O
were	O
infected	O
at	O
high	O
rates	O
with	O
MERS	O
-	O
CoV	O
or	O
a	O
closely	O
related	O
,	O
probably	O
conspecific	O
,	O
virus	B-SPEC
long	O
before	O
the	O
first	O
human	B-SPEC
MERS	O
cases	O
.	O

Antibodies	O
against	O
the	O
recombinant	O
nucleocapsid	O
protein	O
of	O
the	O
virus	B-SPEC
,	O
which	O
we	O
named	O
dromedary	B-SPEC
camel	B-SPEC
coronavirus	B-SPEC
(	O
DcCoV	O
)	O
UAE	O
-	O
HKU23	O
,	O
were	O
detected	O
in	O
52	O
%	O
of	O
59	O
dromedary	B-SPEC
serum	O
samples	O
tested	O
.	O

One	O
critical	O
characteristic	O
of	O
persistence	O
/	O
stress	O
is	O
that	O
the	O
chlamydiae	B-SPEC
remain	O
viable	O
and	O
can	O
reenter	O
the	O
normal	O
developmental	O
cycle	O
when	O
the	O
stressor	O
is	O
removed	O
.	O

Because	O
the	O
PEDV	B-SPEC
host	O
cell	O
receptor	O
(	O
CD13	O
or	O
aminopeptidase	O
N	O
)	O
stimulates	O
cellular	O
signaling	O
pathways	O
in	O
the	O
absence	O
of	O
PEDV	B-SPEC
infection	O
,	O
we	O
suspect	O
that	O
PEDV	B-SPEC
co	O
-	O
infection	O
might	O
alter	O
CD13	O
function	O
and	O
induce	O
the	O
chlamydiae	B-SPEC
to	O
enter	O
the	O
persistent	O
state	O
.	O

TITLE	O
:	O
Multi	O
-	O
organ	O
lesions	O
in	O
suckling	O
mice	B-SPEC
infected	O
with	O
SARS	O
-	O
associated	O
mammalian	B-SPEC
reovirus	B-SPEC
linked	O
with	O
apoptosis	O
induced	O
by	O
viral	O
proteins	O
μ1	O
and	O
σ1	O
.	O

Collectively	O
,	O
our	O
data	O
suggest	O
that	O
BYD1	O
μ1	O
-	O
and	O
σ1	O
-	O
induced	O
apoptosis	O
is	O
involved	O
in	O
the	O
multi	O
-	O
organ	O
lesions	O
in	O
a	O
suckling	O
mouse	B-SPEC
BYD1	O
infection	O
model	O
.	O

Unlike	O
some	O
subgroup	O
2b	O
SARS	O
-	O
CoV	O
vaccines	O
that	O
elicit	O
a	O
strong	O
eosinophilia	O
following	O
challenge	O
,	O
we	O
demonstrate	O
that	O
BtCoV	O
HKU5	O
and	O
MERS	O
-	O
CoV	O
N	O
-	O
expressing	O
Venezuelan	B-SPEC
equine	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
replicon	O
particle	O
(	O
VRP	O
)	O
vaccines	O
do	O
not	O
cause	O
extensive	O
eosinophilia	O
following	O
BtCoV	O
HKU5	O
-	O
SE	O
challenge	O
.	O

Because	O
no	O
small	O
animal	B-SPEC
model	O
exists	O
to	O
evaluate	O
MERS	O
-	O
CoV	O
pathogenesis	O
or	O
to	O
test	O
vaccines	O
,	O
we	O
constructed	O
a	O
recombinant	O
BtCoV	O
HKU5	O
that	O
expressed	O
a	O
region	O
of	O
the	O
SARS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
glycoprotein	O
,	O
thereby	O
allowing	O
the	O
recombinant	O
virus	B-SPEC
to	O
grow	O
in	O
cell	O
culture	O
and	O
in	O
mice	B-SPEC
.	O

This	O
study	O
holds	O
significance	O
as	O
a	O
strategy	O
to	O
control	O
newly	O
emerging	O
viruses	B-SPEC
.	O

Detection	O
of	O
IBV	B-SPEC
in	O
a	O
flock	O
,	O
the	O
farm	O
type	O
and	O
flock	O
size	O
were	O
identified	O
as	O
potential	O
risk	O
factors	O
for	O
the	O
production	O
of	O
eggs	O
with	O
poor	O
Haugh	O
units	O
.	O

Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
causes	O
diarrhea	O
in	O
piglets	O
with	O
an	O
age	O
-	O
dependent	O
decrease	O
of	O
severity	O
.	O

Oral	O
challenge	O
infection	O
with	O
TGEV	B-SPEC
was	O
performed	O
when	O
the	O
pigs	B-SPEC
had	O
been	O
fed	O
for	O
1	O
week	O
with	O
the	O
respective	O
diet	O
.	O

Molecular	O
docking	O
of	O
compound	O
Ih	O
with	O
wt	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
was	O
performed	O
to	O
understand	O
the	O
binding	O
mode	O
between	O
these	O
inhibitors	O
and	O
the	O
wt	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
and	O
to	O
rationalize	O
some	O
SARs	O
.	O

TITLE	O
:	O
Pathogenicity	O
and	O
molecular	O
characteristics	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strains	O
isolated	O
from	O
broilers	O
showing	O
diarrhoea	O
and	O
respiratory	O
disease	O
.	O

The	O
possibility	O
that	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
variants	O
isolated	O
from	O
broilers	O
with	O
enteric	O
and	O
respiratory	O
problems	O
have	O
a	O
different	O
tropism	O
and	O
pathological	O
outcome	O
from	O
those	O
IBV	B-SPEC
strains	O
causing	O
classical	O
respiratory	O
disease	O
was	O
investigated	O
.	O

Electron	O
microscopy	O
analysis	O
demonstrated	O
the	O
morphology	O
changes	O
of	O
ER	O
post	O
-	O
PEDV	B-SPEC
infection	O
.	O

The	O
results	O
suggested	O
that	O
PEDV	B-SPEC
infection	O
induced	O
UPR	O
in	O
Vero	O
cells	O
.	O

Meanwhile	O
,	O
we	O
silenced	O
the	O
expression	O
of	O
PKR	O
-	O
like	O
ER	O
kinase	O
(	O
PERK	O
)	O
by	O
shRNA	O
,	O
we	O
found	O
that	O
the	O
knockdown	O
of	O
PERK	O
increased	O
virus	B-SPEC
loads	O
in	O
the	O
cells	O
,	O
which	O
was	O
consistent	O
with	O
the	O
result	O
on	O
4	O
-	O
phenylbutyrate	O
(	O
4	O
-	O
PBA	O
)	O
treatment	O
.	O

Plaque	O
formation	O
assay	O
,	O
RT	O
-	O
PCR	O
and	O
Western	O
blot	O
analysis	O
suggested	O
that	O
2	O
-	O
DG	O
might	O
inhibit	O
virus	B-SPEC
infection	O
by	O
affecting	O
viral	O
protein	O
translation	O
during	O
the	O
early	O
stage	O
of	O
virus	B-SPEC
infection	O
.	O

Adenovirus	B-SPEC
,	O
bocavirus	B-SPEC
-	O
1	O
,	O
coronavirus	B-SPEC
,	O
enteroviruses	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
metapneumovirus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
were	O
detected	O
using	O
PCR	O
.	O

Samples	O
of	O
IBV	B-SPEC
-	O
positive	O
flocks	O
were	O
obtained	O
from	O
60	O
different	O
farms	O
.	O

Alternatively	O
,	O
a	O
subpopulation	O
of	O
the	O
Ark	O
vaccine	O
isolated	O
from	O
a	O
vaccinated	O
bird	B-SPEC
,	O
Ark	O
-	O
RI	O
-	O
EP1	O
,	O
showed	O
a	O
peak	O
titer	O
at	O
7	O
-	O
10	O
days	O
of	O
age	O
when	O
given	O
by	O
the	O
same	O
routes	O
,	O
suggesting	O
that	O
the	O
Ark	O
-	O
RI	O
-	O
EP1	O
was	O
more	O
fit	O
with	O
regard	O
to	O
infection	O
,	O
replication	O
in	O
the	O
birds	B-SPEC
,	O
or	O
both	O
.	O

ABSTRACT	O
:	O
Positive	O
-	O
stranded	O
viruses	B-SPEC
synthesize	O
their	O
RNA	O
in	O
membrane	O
-	O
bound	O
organelles	O
,	O
but	O
it	O
is	O
not	O
clear	O
how	O
this	O
benefits	O
the	O
virus	B-SPEC
or	O
the	O
host	O
.	O

During	O
a	O
3	O
month	O
period	O
,	O
June	O
to	O
August	O
2013	O
,	O
there	O
were	O
12	O
positive	O
MERS	O
-	O
CoV	O
cases	O
reported	O
from	O
the	O
Hafr	O
Al	O
-	O
Batin	O
region	O
district	O
in	O
the	O
north	O
east	O
region	O
of	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

While	O
camels	B-SPEC
appear	O
as	O
the	O
likely	O
source	O
,	O
other	O
sources	O
have	O
not	O
been	O
ruled	O
out	O
.	O

TITLE	O
:	O
Novel	B-SPEC
coronavirus	I-SPEC
and	O
astrovirus	O
in	O
Delaware	O
Bay	O
shorebirds	B-SPEC
.	O

The	O
rapid	O
test	O
was	O
used	O
for	O
detection	O
of	O
influenza	B-SPEC
virus	I-SPEC
(	O
Kit	O
Biotrin	O
,	O
Inc	O
.	O
Ireland	O
),	O
and	O
real	O
-	O
time	O
multiplex	O
polymerase	O
chain	O
reaction	O
(	O
FTD	O
,	O
Respiratory	O
pathogens	O
,	O
multiplex	O
Fast	O
Trade	O
Kit	O
,	O
Malta	O
)	O
for	O
detection	O
of	O
influenza	B-SPEC
virus	I-SPEC
(	O
H1N1	O
,	O
B	O
),	O
rhinovirus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
parechovirus	I-SPEC
,	O
bocavirus	B-SPEC
,	O
metapneumovirus	B-SPEC
,	O
and	O
human	B-SPEC
coronavirus	I-SPEC
.	O

The	O
median	O
age	O
was	O
12	O
±	O
5	O
.	O
2	O
years	O
,	O
51	O
%	O
males	O
,	O
68	O
%	O
whites	B-SPEC
,	O
32	O
%	O
had	O
repeated	O
ARIs	O
,	O
32	O
%	O
prior	O
antibiotic	O
use	O
,	O
19	O
.	O
8	O
%	O
cough	O
,	O
and	O
8	O
%	O
contact	O
with	O
ARIs	O
.	O

the	O
prevalence	O
of	O
respiratory	O
viruses	B-SPEC
was	O
relevant	O
in	O
the	O
infectious	O
episode	O
,	O
with	O
no	O
increase	O
in	O
morbidity	O
and	O
mortality	O
.	O

ABSTRACT	O
:	O
Poxviruses	B-SPEC
are	O
important	O
pathogens	O
of	O
man	B-SPEC
and	O
numerous	O
domestic	O
and	O
wild	O
animal	B-SPEC
species	B-SPEC
.	O

Bats	B-SPEC
are	O
a	O
diverse	O
order	B-SPEC
of	O
mammals	B-SPEC
known	O
to	O
carry	O
lethal	O
viral	O
zoonoses	O
such	O
as	O
Rabies	O
,	O
Hendra	O
,	O
Nipah	O
,	O
and	O
SARS	O
.	O

CONCLUSIONS	O
:	O
High	O
initial	O
radiologic	O
score	O
is	O
associated	O
with	O
mortality	O
in	O
patients	O
with	O
avian	B-SPEC
influenza	O
H7N9	O
pneumonia	O
.	O

We	O
demonstrated	O
minimal	O
delay	O
and	O
retention	O
of	O
unprimed	O
neutrophils	O
transiting	O
the	O
healthy	O
human	B-SPEC
pulmonary	O
vasculature	O
,	O
but	O
marked	O
retention	O
of	O
primed	O
neutrophils	O
;	O
these	O
latter	O
cells	O
then	O
'	O
deprime	O
'	O
and	O
are	O
re	O
-	O
released	O
into	O
the	O
systemic	O
circulation	O
.	O

TITLE	O
:	O
In	O
vitro	O
antiviral	O
activity	O
of	O
circular	O
triple	O
helix	O
forming	O
oligonucleotide	O
RNA	O
towards	O
Feline	B-SPEC
Infectious	O
Peritonitis	O
virus	B-SPEC
replication	O
.	O

Six	O
herbal	O
extracts	O
,	O
one	O
each	O
from	O
Gentianae	O
Radix	B-SPEC
(	O
lóng	O
dǎn	O
;	O
the	O
dried	O
rhizome	O
of	O
Gentiana	B-SPEC
scabra	I-SPEC
),	O
Dioscoreae	O
Rhizoma	O
(	O
shān	O
yào	O
;	O
the	O
tuber	B-SPEC
of	O
Dioscorea	B-SPEC
batatas	I-SPEC
),	O
Cassiae	O
Semen	O
(	O
jué	O
míng	O
zǐ	O
;	O
the	O
dried	O
seed	O
of	O
Cassia	B-SPEC
tora	I-SPEC
)	O
and	O
Loranthi	O
Ramus	O
(	O
sāng	O
jì	O
shēng	O
;	O
the	O
dried	O
stem	O
,	O
with	O
leaf	O
of	O
Taxillus	B-SPEC
chinensis	I-SPEC
)	O
(	O
designated	O
as	O
GSH	O
,	O
DBM	O
,	O
CTH	O
and	O
TCH	O
,	O
respectively	O
),	O
and	O
two	O
from	O
Rhizoma	O
Cibotii	O
(	O
gǒu	O
jǐ	O
;	O
the	O
dried	O
rhizome	O
of	O
Cibotium	B-SPEC
barometz	I-SPEC
)	O
(	O
designated	O
as	O
CBE	O
and	O
CBM	O
),	O
were	O
found	O
to	O
be	O
potent	O
inhibitors	O
of	O
SARS	O
-	O
CoV	O
at	O
concentrations	O
between	O
25	O
and	O
200	O
μg	O
/	O
ml	O
.	O

TITLE	O
:	O
Anti	O
-	O
inflammatory	O
and	O
antiviral	O
effects	O
of	O
indirubin	O
derivatives	O
in	O
influenza	O
A	O
(	O
H5N1	O
)	O
virus	B-SPEC
infected	O
primary	O
human	B-SPEC
peripheral	O
blood	O
-	O
derived	O
macrophages	O
and	O
alveolar	O
epithelial	O
cells	O
.	O

We	O
found	O
that	O
both	O
of	O
the	O
indirubin	O
derivatives	O
strongly	O
suppress	O
the	O
pro	O
-	O
inflammatory	O
cytokines	O
including	O
IP	O
-	O
10	O
(	O
CXCL10	O
),	O
one	O
of	O
the	O
key	O
factors	O
which	O
contribute	O
to	O
the	O
lung	O
inflammation	O
during	O
H5N1	O
virus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Prophylactic	O
and	O
therapeutic	O
strategies	O
are	O
urgently	O
needed	O
to	O
combat	O
infections	O
caused	O
by	O
the	O
newly	O
emerged	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Here	O
,	O
we	O
have	O
developed	O
a	O
neutralizing	O
monoclonal	O
antibody	O
(	O
MAb	O
),	O
designated	O
Mersmab1	O
,	O
which	O
potently	O
blocks	O
MERS	O
-	O
CoV	O
entry	O
into	O
human	B-SPEC
cells	O
.	O

A	O
61	O
-	O
year	O
-	O
old	O
female	O
who	O
had	O
rapidly	O
progressive	O
pneumonia	O
with	O
respiratory	O
distress	O
and	O
bilateral	O
exduation	O
and	O
consolidation	O
changes	O
on	O
chest	O
X	O
-	O
ray	B-SPEC
and	O
computerized	O
tomography	O
(	O
CT	O
)	O
scan	O
that	O
did	O
not	O
respond	O
to	O
ordinary	O
antibiotics	O
was	O
diagnosed	O
with	O
influenza	O
A	O
(	O
H7N9	O
)	O
infection	O
in	O
our	O
hospital	O
on	O
July	O
19	O
,	O
2013	O
.	O

TITLE	O
:	O
Cytokine	O
storm	O
plays	O
a	O
direct	O
role	O
in	O
the	O
morbidity	O
and	O
mortality	O
from	O
influenza	B-SPEC
virus	I-SPEC
infection	O
and	O
is	O
chemically	O
treatable	O
with	O
a	O
single	O
sphingosine	O
-	O
1	O
-	O
phosphate	O
agonist	O
molecule	O
.	O

In	O
a	O
previous	O
study	O
,	O
the	O
endogenous	O
peptide	O
adrenomedullin	O
(	O
AM	O
)	O
protected	O
murine	B-SPEC
lungs	O
from	O
VILI	O
.	O

Lung	O
and	O
blood	O
bacterial	O
burden	O
was	O
not	O
affected	O
by	O
MV	O
pneumonia	O
and	O
MV	O
increased	O
lung	O
AM	O
expression	O
,	O
whereas	O
receptor	O
activity	O
modifying	O
protein	O
(	O
RAMP	B-SPEC
)	O
1	O
-	O
3	O
expression	O
was	O
increased	O
in	O
pneumonia	O
and	O
reduced	O
by	O
MV	O
.	O

The	O
spike	O
glycoprotein	O
is	O
the	O
major	O
immunodominant	O
antigen	O
of	O
coronaviruses	O
and	O
has	O
proven	O
to	O
be	O
an	O
excellent	O
target	O
for	O
vaccine	O
designs	O
that	O
seek	O
to	O
block	O
coronavirus	B-SPEC
entry	O
and	O
promote	O
antibody	O
targeting	O
of	O
infected	O
cells	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
entry	O
and	O
release	O
in	O
polarized	O
epithelial	O
cells	O
:	O
a	O
review	O
.	O

In	O
this	O
study	O
,	O
an	O
attenuated	O
TGEV	B-SPEC
(	O
STC3	O
)	O
and	O
a	O
virulent	O
TGEV	B-SPEC
(	O
SHXB	O
)	O
were	O
used	O
to	O
determine	O
whether	O
porcine	B-SPEC
DCs	O
play	O
an	O
important	O
role	O
in	O
pathogenetic	O
differences	O
between	O
these	O
two	O
TGEVs	O
.	O

ABSTRACT	O
:	O
In	O
2011	O
,	O
autochthonous	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
emerged	O
in	O
a	O
focal	O
geographical	O
area	O
in	O
Greece	O
after	O
importation	O
by	O
immigrants	O
from	O
the	O
Indian	O
subcontinent	O
.	O

This	O
review	O
focuses	O
on	O
studies	O
performed	O
using	O
preclinical	O
animal	B-SPEC
models	O
of	O
SCI	O
to	O
evaluate	O
how	O
injury	O
impacts	O
T	O
and	O
B	O
lymphocyte	O
responses	O
following	O
either	O
viral	O
infection	O
or	O
antigenic	O
challenge	O
.	O

Furthermore	O
,	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
is	O
the	O
main	O
cause	O
of	O
croup	O
in	O
children	O
.	O

Lyophilized	O
virus	B-SPEC
preparations	O
can	O
be	O
stored	O
either	O
at	O
ambient	O
temperature	O
or	O
at	O
+	O
4	O
°	O
C	O
.	O

PEDV	B-SPEC
was	O
found	O
in	O
5	O
.	O
2	O
%	O
of	O
trailers	O
not	O
contaminated	O
at	O
arrival	O
,	O
,	O
suggesting	O
that	O
the	O
transport	O
process	O
is	O
a	O
source	O
of	O
transmission	O
if	O
adequate	O
hygiene	O
measures	O
are	O
not	O
implemented	O
.	O

The	O
bioassay	O
results	O
showed	O
that	O
most	O
of	O
these	O
compounds	O
exhibited	O
excellent	O
in	O
vivo	O
anti	O
-	O
TMV	B-SPEC
activity	O
,	O
of	O
which	O
7	O
-	O
methoxycryptopleurine	O
salt	O
derivatives	O
16	O
,	O
19	O
,	O
and	O
23	O
displayed	O
significantly	O
higher	O
activity	O
than	O
7	O
-	O
methoxycryptopleurine	O
(	O
1	O
)	O
and	O
commercial	O
ribavirin	O
and	O
ningnanmycin	O
.	O

The	O
observed	O
enhancement	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
infection	O
by	O
IFNs	O
may	O
underlie	O
the	O
propensity	O
of	O
the	O
virus	B-SPEC
to	O
invade	O
the	O
lower	O
respiratory	O
tract	O
under	O
inflammatory	O
conditions	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
was	O
detected	O
in	O
185	O
samples	O
originating	O
from	O
chicken	B-SPEC
flocks	O
of	O
various	O
commodity	O
groups	O
in	O
Canada	O
.	O

Based	O
on	O
the	O
field	O
situation	O
,	O
the	O
effectiveness	O
of	O
current	O
vaccination	O
practices	O
mostly	O
based	O
on	O
Massachusetts	O
and	O
Connecticut	O
-	O
type	O
vaccines	O
appeared	O
generally	O
satisfactory	O
for	O
minimizing	O
the	O
damage	O
due	O
to	O
infection	O
with	O
Canadian	O
variant	O
and	O
US	O
variant	O
-	O
like	O
viruses	B-SPEC
.	O

Coronavirus	B-SPEC
-	O
like	O
particles	O
were	O
observed	O
by	O
electron	O
microscopy	O
.	O

In	O
a	O
second	O
experiment	O
,	O
we	O
compared	O
protection	O
conferred	O
by	O
priming	O
with	O
rLS	O
/	O
IBV	B-SPEC
.	O
S2	O
and	O
boosting	O
with	O
Mass	O
(	O
rLS	O
/	O
IBV	B-SPEC
.	O
S2	O
+	O
Mass	O
)	O
versus	O
priming	O
and	O
boosting	O
with	O
Mass	O
(	O
Mass	O
+	O
Mass	O
).	O

ABSTRACT	O
:	O
Factors	O
responsible	O
for	O
the	O
persistence	O
of	O
Arkansas	O
Delmarva	O
Poultry	O
Industry	O
(	O
ArkDPI	O
)-	O
derived	O
infectious	O
bronchitis	O
vaccines	O
in	O
commercial	O
flocks	O
and	O
the	O
high	O
frequency	O
of	O
isolation	O
of	O
ArkDPI	O
-	O
type	O
infectious	O
bronchitis	O
viruses	B-SPEC
in	O
respiratory	O
cases	O
are	O
still	O
unclear	O
.	O

Vaccine	O
virus	B-SPEC
persistence	O
may	O
offer	O
genetic	O
material	O
for	O
recombination	O
or	O
may	O
undergo	O
mutations	O
with	O
the	O
potential	O
to	O
result	O
in	O
increased	O
virulence	O
.	O

ABSTRACT	O
:	O
The	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
3a	O
protein	O
functions	O
as	O
an	O
ion	O
channel	O
,	O
induces	O
apoptosis	O
and	O
is	O
important	O
for	O
viral	O
pathogenesis	O
.	O

The	O
increased	O
human	B-SPEC
cases	O
and	O
high	O
mortality	O
rate	O
of	O
MERS	O
-	O
CoV	O
infection	O
make	O
it	O
essential	O
to	O
develop	O
safe	O
and	O
effective	O
vaccines	O
.	O

How	O
to	O
improve	O
the	O
efficacy	O
of	O
subunit	O
vaccines	O
through	O
novel	O
adjuvant	O
formulations	O
and	O
routes	O
of	O
administration	O
as	O
well	O
as	O
currently	O
available	O
animal	B-SPEC
models	O
for	O
evaluating	O
the	O
in	O
vivo	O
efficacy	O
of	O
MERS	O
-	O
CoV	O
vaccines	O
are	O
also	O
addressed	O
.	O

In	O
contrast	O
,	O
91	O
%	O
of	O
the	O
tissue	O
samples	O
from	O
cats	B-SPEC
with	O
FIP	O
and	O
89	O
%	O
from	O
cats	B-SPEC
without	O
FIP	O
had	O
a	O
leucine	O
codon	O
at	O
position	O
1058	O
,	O
consistent	O
with	O
a	O
systemic	O
form	O
of	O
FCoV	O
.	O
These	O
results	O
suggest	O
that	O
the	O
methionine	O
to	O
leucine	O
substitution	O
at	O
position	O
1058	O
in	O
the	O
FCoV	O
spike	O
protein	O
is	O
indicative	O
of	O
systemic	O
spread	O
of	O
FCoV	O
from	O
the	O
intestine	O
,	O
rather	O
than	O
a	O
virus	B-SPEC
with	O
the	O
potential	O
to	O
cause	O
FIP	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
was	O
identified	O
in	O
Saudi	O
Arabia	O
and	O
Qatar	O
as	O
the	O
causative	O
agent	O
of	O
severe	O
acute	O
respiratory	O
diseases	O
in	O
2012	O
.	O

ABSTRACT	O
:	O
Three	O
strains	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
were	O
isolated	O
from	O
dead	O
or	O
diseased	O
pigs	B-SPEC
at	O
different	O
swine	B-SPEC
farms	O
in	O
Guangdong	O
during	O
2011	O
-	O
2013	O
,	O
and	O
their	O
S	O
genes	O
were	O
sequenced	O
.	O

In	O
the	O
same	O
period	O
,	O
seven	O
PEDV	B-SPEC
strains	O
were	O
also	O
isolated	O
in	O
Guangdong	O
by	O
other	O
laboratories	O
.	O

In	O
addition	O
,	O
the	O
USA	O
-	O
Colorado	O
-	O
2013	O
strain	O
had	O
the	O
same	O
amino	O
acid	O
substitutions	O
in	O
the	O
neutralizing	O
regions	O
as	O
the	O
Guangdong	O
strains	O
except	O
GDS03	O
,	O
which	O
suggests	O
that	O
the	O
information	O
and	O
strategies	O
in	O
this	O
study	O
may	O
play	O
role	O
in	O
PEDV	B-SPEC
variant	O
research	O
in	O
other	O
countries	O
.	O

Nonhuman	O
primates	B-SPEC
(	O
NHP	B-SPEC
)	O
are	O
considered	O
the	O
gold	O
standard	O
model	O
for	O
studying	O
the	O
underlying	O
immune	O
activation	O
/	O
suppression	O
associated	O
with	O
immunopathogenic	O
viruses	B-SPEC
such	O
as	O
hantaviruses	B-SPEC
;	O
however	O
,	O
to	O
date	O
an	O
NHP	B-SPEC
model	O
for	O
HPS	O
has	O
not	O
been	O
described	O
.	O

Consensus	O
dromedary	B-SPEC
MERS	O
-	O
CoV	O
genome	O
sequences	O
were	O
the	O
same	O
with	O
either	O
template	O
source	O
and	O
identical	O
to	O
published	O
human	B-SPEC
MERS	O
-	O
CoV	O
sequences	O
.	O

Camel	B-SPEC
-	O
derivedMERS	O
-	O
CoV	O
sequences	O
(	O
3	O
,	O
754	O
nucleotides	O
assembled	O
from	O
partial	O
sequences	O
of	O
the	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
1a	O
,	O
spike	O
,	O
and	O
ORF4b	O
genes	O
)	O
from	O
Oman	O
and	O
Qatar	O
were	O
slightly	O
different	O
from	O
each	O
other	O
,	O
but	O
closely	O
related	O
to	O
human	B-SPEC
MERS	O
-	O
CoV	O
sequences	O
from	O
the	O
same	O
geographical	O
areas	O
,	O
suggesting	O
local	O
zoonotic	O
transmission	O
.	O

Furthermore	O
,	O
IC	O
activity	O
conferred	O
better	O
fitness	O
in	O
competition	O
assays	O
,	O
suggesting	O
that	O
ion	O
conductivity	O
represents	O
an	O
advantage	O
for	O
the	O
virus	B-SPEC
.	O

Knocking	O
down	O
E	O
protein	O
IC	O
activity	O
did	O
not	O
significantly	O
affect	O
virus	B-SPEC
growth	O
in	O
infected	O
mice	B-SPEC
but	O
decreased	O
edema	O
accumulation	O
,	O
the	O
major	O
determinant	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
leading	O
to	O
death	O
.	O

Importance	O
:	O
A	O
novel	O
human	B-SPEC
coronavirus	I-SPEC
,	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
was	O
found	O
to	O
infect	O
humans	B-SPEC
with	O
a	O
high	O
mortality	O
rate	O
in	O
2012	O
,	O
just	O
1	O
decade	O
after	O
the	O
appearance	O
of	O
the	O
first	O
highly	O
pathogenic	O
coronavirus	B-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

One	O
hundred	O
thirty	O
-	O
four	O
viruses	B-SPEC
were	O
identified	O
for	O
107	O
illnesses	O
.	O

These	O
findings	O
suggest	O
that	O
sputum	O
would	O
benefit	O
for	O
the	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
by	O
nucleic	O
acid	O
amplification	O
tests	O
(	O
NAATs	O
)	O
in	O
patients	O
who	O
produce	O
sputum	O
.	O

However	O
,	O
the	O
range	O
of	O
reagents	O
available	O
to	O
measure	O
the	O
ferret	B-SPEC
immune	O
response	O
is	O
very	O
limited	O
.	O

TITLE	O
:	O
Proteolytic	O
activation	O
of	O
the	O
porcine	B-SPEC
epidemic	O
diarrhea	O
coronavirus	B-SPEC
spike	O
fusion	O
protein	O
by	O
trypsin	O
in	O
cell	O
culture	O
.	O

Importance	O
:	O
Recurring	O
PEDV	B-SPEC
epidemics	O
constitute	O
a	O
serious	O
animal	B-SPEC
health	O
threat	O
and	O
an	O
economic	O
burden	O
,	O
particularly	O
in	O
Asia	O
but	O
,	O
as	O
of	O
recently	O
,	O
also	O
on	O
the	O
North	O
-	O
American	O
subcontinent	O
.	O

96	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
ARDS	O
admitted	O
from	O
July	O
2012	O
to	O
September	O
2013	O
to	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
of	O
Liuzhou	O
People	O
'	O
s	O
Hospital	O
in	O
Guangxi	O
Zhuang	O
Autonomous	O
Region	O
were	O
enrolled	O
and	O
divided	O
into	O
severe	O
ARDS	O
group	O
(	O
n	O
=	O
48	O
)	O
and	O
moderate	O
ARDS	O
group	O
(	O
n	O
=	O
48	O
)	O
according	O
to	O
the	O
Berlin	O
definition	O
of	O
ARDS	O
.	O

All	O
patients	O
with	O
diagnosis	O
in	O
accordance	O
with	O
the	O
2008	O
international	O
septic	O
shock	O
and	O
severe	O
sepsis	B-SPEC
treatment	O
guidelines	O
were	O
provided	O
with	O
comprehensive	O
treatment	O
and	O
mechanical	O
ventilation	O
on	O
the	O
basis	O
of	O
analgesia	O
and	O
sedation	O
.	O

Vergadi	O
et	O
al	O
.	O
are	O
the	O
first	O
to	O
demonstrate	O
that	O
depletion	O
of	O
Akt2	O
kinase	O
and	O
microRNA	O
-	O
146a	O
induction	O
in	O
mice	B-SPEC
resulted	O
in	O
polarization	O
of	O
alveolar	O
macrophages	O
towards	O
an	O
M2	O
activation	O
phenotype	O
and	O
resulted	O
in	O
less	O
severe	O
injury	O
following	O
acid	O
-	O
induced	O
lung	O
injury	O
.	O

Pathological	O
findings	O
and	O
biomolecular	O
diagnostic	O
test	O
results	O
were	O
compatible	O
with	O
an	O
initial	O
FPV	B-SPEC
infection	O
that	O
,	O
in	O
consequence	O
of	O
the	O
lymphoid	O
depletion	O
,	O
has	O
fostered	O
coinfection	O
or	O
reactivation	O
of	O
chronic	O
-	O
latent	O
infections	O
with	O
FeHV	O
-	O
1	O
,	O
FCV	B-SPEC
,	O
and	O
FCoV	O
.	O
In	O
the	O
reported	O
case	O
,	O
the	O
simultaneous	O
presence	O
of	O
different	O
viruses	B-SPEC
exacerbated	O
the	O
clinical	O
status	O
of	O
the	O
host	O
,	O
resulting	O
in	O
multiple	O
organ	O
damage	O
and	O
leading	O
it	O
to	O
its	O
death	O
.	O

TITLE	O
:	O
Diffuse	O
alveolar	O
damage	O
in	O
a	O
patient	O
with	O
Epstein	O
Barr	O
virus	B-SPEC
(	O
EBV	O
)-	O
positive	O
diffuse	O
large	O
B	O
-	O
cell	O
lymphoma	O
,	O
severely	O
low	O
serum	O
folate	O
,	O
and	O
megaloblastic	O
anemia	B-SPEC
:	O
a	O
case	O
report	O
of	O
autopsy	O
.	O

Autopsy	O
revealed	O
diffuse	O
alveolar	O
damage	O
(	O
DAD	O
)	O
in	O
the	O
lungs	O
and	O
systemic	O
lymph	O
node	O
swelling	O
by	O
EBV	O
-	O
positive	O
diffuse	O
large	O
B	O
-	O
cell	O
lymphoma	O
,	O
in	O
addition	O
to	O
megaloblastic	O
anemia	B-SPEC
in	O
the	O
bone	O
marrow	O
.	O

TITLE	O
:	O
Whole	O
-	O
genome	O
analysis	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
from	O
eastern	O
China	O
.	O

The	O
full	O
-	O
length	O
genome	O
was	O
28	O
,	O
038	O
nucleotides	O
(	O
nt	O
)	O
in	O
length	O
without	O
the	O
poly	O
(	O
A	O
)	O
tail	O
,	O
and	O
it	O
was	O
similar	O
to	O
that	O
of	O
other	O
reported	O
PEDV	B-SPEC
strains	O
,	O
with	O
the	O
characteristic	O
gene	O
order	B-SPEC
5	O
'-	O
replicase	O
(	O
1a	O
/	O
1b	O
)	O
-	O
S	O
-	O
ORF3	O
-	O
E	O
-	O
M	O
-	O
N	O
-	O
3	O
'.	O

This	O
report	O
describes	O
the	O
complete	O
genome	O
sequence	O
of	O
SHQP	O
/	O
YM	O
/	O
2013	O
,	O
and	O
the	O
data	O
will	O
promote	O
a	O
better	O
understanding	O
of	O
the	O
molecular	O
epidemiology	O
and	O
genetic	O
diversity	O
of	O
PEDV	B-SPEC
field	O
isolates	O
in	O
eastern	O
China	O
.	O

TITLE	O
:	O
[	O
Determination	O
of	O
the	O
frequency	O
of	O
human	B-SPEC
bocavirus	I-SPEC
and	O
other	O
respiratory	O
viruses	B-SPEC
among	O
0	O
-	O
2	O
years	O
age	O
group	O
children	O
diagnosed	O
as	O
acute	O
bronchiolitis	O
].	O

Nasopharyngeal	O
aspirates	O
were	O
collected	O
from	O
the	O
study	O
groups	O
and	O
the	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
[	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
A	O
&	O
B	O
;	O
rhinovirus	B-SPEC
(	O
RV	O
);	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
A	O
&	O
B	O
;	O
influenza	B-SPEC
virus	I-SPEC
type	I-SPEC
A	I-SPEC
[	O
H1N1	O
,	O
H3N2	O
,	O
H1N1v	O
],	O
B	O
&	O
C	O
;	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
)	O
type	O
1	O
,	O
2	O
,	O
3	O
&	O
4A	O
/	O
B	O
;	O
adenovirus	B-SPEC
(	O
AdV	O
);	O
HBoV	O
;	O
coronavirus	B-SPEC
(	O
CoV	O
229E	O
);	O
enterovirus	B-SPEC
(	O
EV	O
)],	O
were	O
performed	O
by	O
using	O
a	O
commercial	O
system	O
namely	O
CLART	O
®	O
Pneumovir	O
(	O
Clinical	O
Array	O
Technology	O
,	O
Genomica	O
,	O
Spain	O
)	O
based	O
on	O
the	O
principle	O
of	O
multiplex	O
polymerase	O
chain	O
reaction	O
(	O
M	O
-	O
PCR	O
)	O
and	O
DNA	O
microarray	O
.	O

TITLE	O
:	O
Respiratory	O
viruses	B-SPEC
in	O
exacerbations	O
of	O
non	O
-	O
cystic	O
fibrosis	O
bronchiectasis	O
in	O
children	O
.	O

Our	O
study	O
aimed	O
to	O
determine	O
the	O
point	O
prevalence	O
of	O
viruses	B-SPEC
associated	O
with	O
exacerbations	O
and	O
evaluate	O
clinical	O
and	O
investigational	O
differences	O
between	O
virus	B-SPEC
-	O
positive	O
and	O
-	O
negative	O
exacerbations	O
in	O
children	O
with	O
bronchiectasis	O
.	O

We	O
infected	O
importin	O
-	O
α7	O
gene	O
-	O
deficient	O
(	O
α7	O
(-/-))	O
mice	B-SPEC
with	O
a	O
recombinant	O
H1N1	O
influenza	B-SPEC
virus	I-SPEC
and	O
compared	O
the	O
in	O
vivo	O
viral	O
kinetics	O
with	O
those	O
in	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	B-SPEC
.	O

Viral	O
infection	O
and	O
replication	O
in	O
the	O
alveoli	O
of	O
the	O
respiratory	O
tract	O
are	O
believed	O
to	O
be	O
crucial	O
for	O
the	O
development	O
of	O
the	O
acute	O
respiratory	O
distress	O
syndrome	O
associated	O
with	O
fatal	O
outcomes	O
in	O
influenza	B-SPEC
virus	I-SPEC
-	O
infected	O
patients	O
.	O

TITLE	O
:	O
An	O
update	O
on	O
feline	B-SPEC
infectious	O
peritonitis	O
:	O
virology	O
and	O
immunopathogenesis	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
SSYA10	O
-	O
001	O
as	O
a	O
replication	O
inhibitor	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
mouse	B-SPEC
hepatitis	O
,	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronaviruses	O
.	O

In	O
2012	O
,	O
a	O
similar	O
previously	O
unknown	O
coronavirus	B-SPEC
emerged	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
thus	O
far	O
causing	O
over	O
650	O
laboratory	O
-	O
confirmed	O
infections	O
,	O
with	O
an	O
unexplained	O
steep	O
rise	O
in	O
the	O
number	O
of	O
cases	O
being	O
recorded	O
over	O
recent	O
months	O
.	O

Moreover	O
,	O
the	O
pace	O
of	O
drug	O
development	O
and	O
registration	O
for	O
human	B-SPEC
use	O
is	O
generally	O
incompatible	O
with	O
strategies	O
to	O
combat	O
emerging	O
infectious	O
diseases	O
.	O

Systems	O
biology	O
and	O
genetic	O
technologies	O
maximize	O
opportunities	O
for	O
identifying	O
critical	O
host	O
and	O
viral	O
genetic	O
factors	O
that	O
regulate	O
susceptibility	O
and	O
virus	B-SPEC
-	O
induced	O
disease	O
severity	O
.	O

NPCs	O
engrafted	O
into	O
spinal	O
cords	O
of	O
JHMV	O
-	O
infected	O
mice	B-SPEC
exhibited	O
diminished	O
migration	O
velocities	O
and	O
increased	O
proliferation	O
compared	O
with	O
transplanted	O
cells	O
in	O
noninfected	O
mice	B-SPEC
.	O

Employing	O
models	O
of	O
the	O
human	B-SPEC
airway	O
,	O
transcriptomics	O
and	O
proteomics	O
datasets	O
were	O
used	O
to	O
compare	O
ISG	O
response	O
patterns	O
following	O
highly	O
pathogenic	O
H5N1	O
avian	B-SPEC
influenza	O
(	O
HPAI	O
)	O
A	O
virus	B-SPEC
,	O
2009	O
pandemic	O
H1N1	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

In	O
addition	O
,	O
the	O
data	O
revealed	O
that	O
highly	O
virulent	O
HPAI	O
virus	B-SPEC
and	O
MERS	O
-	O
CoV	O
induce	O
repressive	O
histone	O
modifications	O
,	O
which	O
downregulate	O
expression	O
of	O
ISG	O
subsets	O
.	O

Notably	O
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
NS1	O
appears	O
to	O
play	O
a	O
central	O
role	O
in	O
this	O
histone	O
-	O
mediated	O
downregulation	O
in	O
highly	O
pathogenic	O
influenza	O
strains	O
.	O

Using	O
a	O
novel	O
screening	O
approach	O
,	O
specific	O
comparison	O
between	O
highly	O
pathogenic	O
influenza	B-SPEC
viruses	I-SPEC
and	O
coronaviruses	O
revealed	O
similarities	O
and	O
differences	O
in	O
strategies	O
to	O
control	O
the	O
interferon	O
and	O
innate	O
immune	O
response	O
.	O

Inactivated	O
whole	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
-	I-SPEC
related	I-SPEC
coronavirus	I-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
vaccines	O
induce	O
neutralizing	O
antibodies	O
in	O
mouse	B-SPEC
models	O
;	O
however	O
,	O
they	O
also	O
cause	O
increased	O
eosinophilic	O
immunopathology	O
in	O
the	O
lungs	O
upon	O
SARS	O
-	O
CoV	O
challenge	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
emergence	O
of	O
zoonotic	O
diseases	O
such	O
as	O
Highly	O
Pathogenic	O
Avian	B-SPEC
Influenza	O
(	O
HPAI	O
)	O
and	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
have	O
contributed	O
to	O
dominant	O
Global	O
Health	O
narratives	O
around	O
health	O
securitisation	O
and	O
pandemic	O
preparedness	O
,	O
calling	O
for	O
greater	O
co	O
-	O
operation	O
between	O
the	O
health	O
,	O
veterinary	O
and	O
environmental	O
sectors	O
in	O
the	O
ever	O
-	O
evolving	O
One	O
Health	O
movement	O
.	O

Furthermore	O
,	O
using	O
the	O
aforementioned	O
techniques	O
along	O
with	O
Northern	O
blot	O
assay	O
,	O
we	O
specifically	O
defined	O
the	O
cis	B-SPEC
-	O
acting	O
RNA	O
elements	O
within	O
the	O
3	O
'-	O
terminal	O
55	O
nucleotides	O
(	O
nts	O
)	O
which	O
function	O
in	O
the	O
synthesis	O
of	O
(-)-	O
or	O
(+)-	O
strand	O
BCoV	O
DI	O
RNA	O
.	O

ABSTRACT	O
:	O
Subphenotypes	O
have	O
been	O
identified	O
within	O
heterogeneous	O
diseases	O
such	O
as	O
asthma	O
and	O
breast	O
cancer	B-SPEC
,	O
with	O
important	O
therapeutic	O
implications	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
encodes	O
a	O
papain	O
-	O
like	O
protease	O
(	O
PLpro	O
)	O
with	O
both	O
deubiquitinating	O
(	O
DUB	O
)	O
and	O
deISGylating	O
activities	O
that	O
are	O
proposed	O
to	O
counteract	O
the	O
post	O
-	O
translational	O
modification	O
of	O
signaling	O
molecules	O
that	O
activate	O
the	O
innate	O
immune	O
response	O
.	O

TITLE	O
:	O
Toll	O
-	O
like	O
receptor	O
-	O
based	O
adjuvants	O
:	O
enhancing	O
the	O
immune	O
response	O
to	O
vaccines	O
against	O
infectious	O
diseases	O
of	O
chicken	B-SPEC
.	O

ABSTRACT	O
:	O
Huge	O
productivity	O
loss	O
due	O
to	O
infectious	O
diseases	O
in	O
chickens	B-SPEC
is	O
a	O
major	O
problem	O
and	O
,	O
hence	O
,	O
robust	O
development	O
of	O
the	O
poultry	O
industry	O
requires	O
control	O
of	O
poultry	O
health	O
.	O

TITLE	O
:	O
Emerging	O
respiratory	O
viruses	B-SPEC
other	O
than	O
influenza	O
.	O

Adenovirus	B-SPEC
14	O
has	O
been	O
increasingly	O
recognized	O
in	O
severe	O
acute	O
respiratory	O
illness	O
in	O
both	O
military	O
and	O
civilian	O
individuals	O
.	O

ABSTRACT	O
:	O
Housing	O
preweaned	O
dairy	O
calves	O
in	O
pairs	O
rather	O
than	O
individually	O
has	O
been	O
found	O
to	O
positively	O
affect	O
behavioral	O
responses	O
in	O
novel	O
social	O
and	O
environmental	O
situations	O
,	O
but	O
concerns	O
have	O
been	O
raised	O
that	O
close	O
contact	O
among	O
very	O
young	O
animals	B-SPEC
may	O
impair	O
their	O
health	O
.	O

ABSTRACT	O
:	O
This	O
review	O
is	O
concerned	O
with	O
what	O
has	O
been	O
learned	O
about	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
diagnostics	O
and	O
therapeutics	O
since	O
the	O
publication	O
of	O
an	O
extensive	O
overview	O
of	O
literature	O
covering	O
the	O
period	O
1963	O
-	O
2009	O
.	O

Camels	B-SPEC
may	O
act	O
as	O
a	O
direct	O
source	O
of	O
human	B-SPEC
MERS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
We	O
performed	O
revascularization	O
by	O
an	O
anti	O
-	O
anatomical	O
bypass	O
in	O
a	O
40	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
extended	O
ischemia	O
of	O
both	O
legs	O
beyond	O
12	O
hr	O
after	O
onset	O
because	O
of	O
traumatic	O
aortic	O
dissection	O
.	O

A	O
mouse	B-SPEC
RPE	O
/	O
choroid	O
DNA	O
expression	O
library	O
was	O
screened	O
using	O
sera	O
from	O
virus	B-SPEC
infected	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

Alternative	O
screening	O
approaches	O
for	O
antivirals	O
against	O
the	O
recently	O
emergent	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
may	O
provide	O
lead	O
compounds	O
to	O
address	O
this	O
need	O
.	O

We	O
then	O
used	O
reverse	O
-	O
transcription	O
PCR	O
to	O
look	O
for	O
the	O
coronavirus	B-SPEC
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
in	O
fecal	O
samples	O
collected	O
from	O
27	O
little	B-SPEC
Japanese	I-SPEC
horseshoe	I-SPEC
bats	I-SPEC
and	O
found	O
eight	O
were	O
provisionally	O
positive	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
a	O
porcine	B-SPEC
enteropathogenic	O
coronavirus	B-SPEC
,	O
causes	O
lethal	O
watery	O
diarrhea	O
in	O
piglets	O
and	O
results	O
in	O
large	O
economic	O
losses	O
in	O
many	O
Asian	O
and	O
European	O
countries	O
.	O

Together	O
,	O
our	O
findings	O
demonstrate	O
a	O
new	O
mechanism	O
evolved	O
by	O
PEDV	B-SPEC
to	O
circumvent	O
the	O
host	O
'	O
s	O
antiviral	O
immunity	O
.	O

Here	O
we	O
screened	O
a	O
collection	O
of	O
16671	O
diverse	O
compounds	O
for	O
anti	O
-	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
activity	O
and	O
identified	O
an	O
inhibitor	O
,	O
designated	O
K22	O
,	O
that	O
specifically	O
targets	O
membrane	O
-	O
bound	O
coronaviral	O
RNA	O
synthesis	O
.	O

We	O
expect	O
this	O
mode	O
of	O
action	O
to	O
serve	O
as	O
a	O
paradigm	O
for	O
the	O
development	O
of	O
potent	O
antiviral	O
drugs	O
to	O
combat	O
many	O
animal	B-SPEC
and	O
human	B-SPEC
virus	B-SPEC
infections	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
the	O
etiologic	O
agent	O
of	O
a	O
highly	O
lethal	O
pneumonia	O
.	O

Here	O
,	O
we	O
report	O
the	O
full	O
-	O
genome	O
sequence	O
of	O
the	O
Jordan	O
-	O
N3	O
/	O
2012	O
strain	O
after	O
serial	O
passage	O
in	O
two	O
distinct	O
mammalian	B-SPEC
cell	O
lines	O
.	O

By	O
using	O
sialylated	O
compounds	O
as	O
competitive	O
inhibitors	O
,	O
it	O
was	O
demonstrated	O
that	O
sialyllactose	O
(	O
2	O
,	O
6	O
-	O
α	O
-	O
linked	O
over	O
2	O
,	O
3	O
-	O
α	O
-	O
linked	O
)	O
notably	O
reduced	O
infectivity	O
of	O
NA	O
-	O
treated	O
viruses	B-SPEC
,	O
whereas	O
bovine	B-SPEC
submaxillary	O
mucin	O
inhibited	O
both	O
treated	O
and	O
untreated	O
viruses	B-SPEC
.	O

In	O
conclusion	O
,	O
this	O
study	O
demonstrated	O
that	O
FECV	B-SPEC
had	O
a	O
sialic	O
acid	O
binding	O
capacity	O
,	O
which	O
was	O
partially	O
masked	O
by	O
virus	B-SPEC
-	O
associated	O
sialic	O
acids	O
,	O
and	O
that	O
attachment	O
to	O
sialylated	O
compounds	O
could	O
facilitate	O
enterocyte	O
infections	O
.	O

Compared	O
to	O
9	O
patients	O
without	O
daytime	O
,	O
nocturnal	O
,	O
or	O
postexercise	O
hypoxia	O
,	O
25	O
patients	O
with	O
hypoxia	O
under	O
at	O
least	O
one	O
of	O
these	O
three	O
conditions	O
had	O
greater	O
anemia	B-SPEC
severity	O
(	O
P	O
=	O
0	O
.	O
01	O
),	O
lower	O
HbF	O
levels	O
(	O
P	O
=	O
0	O
.	O
04	O
),	O
and	O
higher	O
aspartate	O
aminotransferase	O
levels	O
(	O
P	O
=	O
0	O
.	O
03	O
).	O

TITLE	O
:	O
A	O
highly	O
conserved	O
WDYPKCDRA	O
epitope	O
in	O
the	O
RNA	O
directed	O
RNA	O
polymerase	O
of	O
human	B-SPEC
coronaviruses	O
can	O
be	O
used	O
as	O
epitope	O
-	O
based	O
universal	O
vaccine	O
design	O
.	O

Here	O
we	O
suggest	O
in	O
vivo	O
study	O
of	O
our	O
identified	O
novel	O
peptide	O
antigen	O
in	O
RNA	O
directed	O
RNA	O
polymerase	O
protein	O
for	O
universal	O
vaccine	O
--	O
which	O
may	O
be	O
the	O
way	O
to	O
prevent	O
all	O
human	B-SPEC
coronavirus	I-SPEC
disease	O
.	O

ABSTRACT	O
:	O
Public	O
health	O
risks	O
associated	O
to	O
infection	O
by	O
human	B-SPEC
coronaviruses	O
remain	O
considerable	O
and	O
vaccination	O
is	O
a	O
key	O
option	O
for	O
preventing	O
the	O
resurgence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

These	O
observations	O
prompted	O
us	O
to	O
investigate	O
the	O
molecular	O
mechanisms	O
and	O
responses	O
to	O
antibody	O
-	O
mediated	O
infection	O
in	O
human	B-SPEC
macrophages	O
.	O

The	O
data	O
extracted	O
from	O
the	O
RCTs	O
were	O
combined	O
in	O
a	O
cumulative	O
meta	B-SPEC
-	O
analysis	O
and	O
analyzed	O
using	O
methods	O
recommended	O
by	O
the	O
Cochrane	O
Collaboration	O
.	O

This	O
meta	B-SPEC
-	O
analysis	O
revealed	O
that	O
,	O
compared	O
with	O
supine	O
positioning	O
,	O
PP	O
decreased	O
the	O
28	O
-	O
to	O
30	O
-	O
day	O
mortality	O
of	O
ARDS	O
patients	O
with	O
a	O
ratio	O
of	O
partial	O
pressure	O
of	O
arterial	O
oxygen	O
/	O
fraction	O
of	O
inspired	O
oxygen	O
≤	O
100	O
mmHg	O
(	O
n	O
=	O
508	O
,	O
risk	O
ratio	O
(	O
RR	O
)	O
=	O
0	O
.	O
71	O
,	O
95	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
0	O
.	O
57	O
to	O
0	O
.	O
89	O
;	O
P	O
=	O
0	O
.	O
003	O
).	O

We	O
will	O
include	O
comparative	O
preclinical	O
studies	O
(	O
randomized	O
and	O
non	O
-	O
randomized	O
)	O
of	O
acute	O
lung	O
injury	O
in	O
which	O
MSCs	O
were	O
administered	O
and	O
outcomes	O
compared	O
to	O
animals	B-SPEC
given	O
a	O
vehicle	O
control	O
.	O

ABSTRACT	O
:	O
Carbohydrate	O
structures	O
,	O
including	O
Lewis	O
X	O
(	O
Le	O
(	O
x	O
)),	O
which	O
is	O
not	O
synthesized	O
in	O
mutant	O
mice	B-SPEC
that	O
lack	O
α1	O
,	O
3	O
-	O
fucosyltransferase	O
9	O
(	O
Fut9	O
(-/-)),	O
are	O
involved	O
in	O
cell	O
-	O
cell	O
recognition	O
and	O
inflammation	O
.	O

Western	O
blots	O
demonstrated	O
that	O
peptide	O
H	O
interacted	O
with	O
PEDV	B-SPEC
spike	O
protein	O
and	O
that	O
pre	O
-	O
treatment	O
of	O
PEDV	B-SPEC
with	O
peptide	O
H	O
led	O
to	O
a	O
higher	O
inhibition	O
than	O
synchronous	O
incubation	O
with	O
cells	O
.	O

These	O
results	O
indicate	O
direct	O
interaction	O
with	O
the	O
virus	B-SPEC
is	O
necessary	O
to	O
inhibit	O
infectivity	O
.	O

However	O
,	O
IL	O
-	O
10	O
production	O
by	O
virus	B-SPEC
-	O
specific	O
CD4	O
+	O
T	O
cells	O
was	O
reduced	O
significantly	O
.	O

TITLE	O
:	O
Human	B-SPEC
mesenchymal	O
stem	O
cells	O
reduce	O
the	O
severity	O
of	O
acute	O
lung	O
injury	O
in	O
a	O
sheep	B-SPEC
model	O
of	O
bacterial	O
pneumonia	O
.	O

Adult	O
sheep	B-SPEC
(	O
30	O
-	O
40	O
kg	O
)	O
were	O
surgically	O
prepared	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
occurrence	O
of	O
IBV	B-SPEC
in	O
commercial	O
poultry	O
flocks	O
from	O
3	O
important	O
producing	O
regions	O
in	O
Brazil	O
and	O
to	O
determine	O
the	O
tropism	O
of	O
the	O
main	O
circulating	O
genotypes	O
to	O
3	O
different	O
avian	B-SPEC
physiological	O
systems	O
(	O
respiratory	O
,	O
digestive	O
,	O
urinary	O
/	O
reproductive	O
).	O

In	O
addition	O
,	O
MERS	O
-	O
CoV	O
was	O
isolated	O
from	O
the	O
patient	O
and	O
the	O
camel	B-SPEC
.	O

These	O
findings	O
provide	O
important	O
insights	O
into	O
the	O
structural	O
and	O
functional	O
properties	O
of	O
coronaviral	O
PLpro	O
family	B-SPEC
,	O
which	O
is	O
applicable	O
to	O
develop	O
strategies	O
inhibiting	O
PLpro	O
against	O
highly	O
pathogenic	O
coronaviruses	O
.	O

In	O
cancer	B-SPEC
patients	O
,	O
90	O
%	O
of	O
ARDS	O
cases	O
are	O
infection	O
-	O
related	O
,	O
including	O
one	O
-	O
third	O
due	O
to	O
invasive	O
fungal	O
infections	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
emerged	O
in	O
2012	O
.	O

Modeling	O
the	O
binding	O
energies	O
of	O
MERS	O
-	O
CoV	O
spike	O
protein	O
RBD	O
to	O
DPP4	O
of	O
human	B-SPEC
(	O
susceptible	O
)	O
or	O
hamster	B-SPEC
(	O
nonsusceptible	O
)	O
identified	O
five	O
amino	O
acid	O
residues	O
involved	O
in	O
the	O
DPP4	O
-	O
RBD	O
interaction	O
.	O

We	O
discuss	O
the	O
clinical	O
condition	O
of	O
Strongyloides	B-SPEC
hyperinfection	O
syndrome	O
presenting	O
with	O
severe	O
hypoxemia	O
and	O
complicated	O
by	O
severe	O
diffuse	O
alveolar	O
hemorrhage	O
leading	O
to	O
death	O
.	O

TITLE	O
:	O
Genomic	O
profiling	O
of	O
collaborative	O
cross	O
founder	O
mice	B-SPEC
infected	O
with	O
respiratory	O
viruses	B-SPEC
reveals	O
novel	O
transcripts	O
and	O
infection	O
-	O
related	O
strain	O
-	O
specific	O
gene	O
and	O
isoform	O
expression	O
.	O

Of	O
these	O
novel	O
transcripts	O
,	O
2150	O
could	O
be	O
aligned	O
to	O
human	B-SPEC
or	O
rat	B-SPEC
genomes	O
,	O
but	O
not	O
to	O
existing	O
mouse	B-SPEC
genomes	O
,	O
suggesting	O
functionally	O
conserved	O
sequences	O
not	O
yet	O
recorded	O
in	O
mouse	B-SPEC
genomes	O
.	O

GAPDH	O
pre	O
-	O
injected	O
mice	B-SPEC
were	O
protected	O
from	O
septic	O
death	O
,	O
and	O
their	O
serum	O
levels	O
of	O
proinflammatory	O
cytokines	O
were	O
significantly	O
suppressed	O
.	O

Coronaviruses	O
are	O
RNA	O
viruses	B-SPEC
that	O
replicate	O
in	O
the	O
host	O
cytoplasm	O
and	O
evade	O
innate	O
immune	O
sensing	O
in	O
most	O
cell	O
types	O
,	O
either	O
passively	O
by	O
hiding	O
their	O
viral	O
signatures	O
and	O
limiting	O
exposure	O
to	O
sensors	O
or	O
actively	O
,	O
by	O
encoding	O
viral	O
antagonists	O
to	O
counteract	O
the	O
effects	O
of	O
interferons	O
.	O

Thus	O
,	O
transmission	O
of	O
virus	B-SPEC
from	O
an	O
animal	B-SPEC
reservoir	O
to	O
human	B-SPEC
are	O
more	O
easily	O
detected	O
,	O
accentuating	O
the	O
feeling	O
of	O
increasing	O
phenomenon	O
.	O

Replacing	O
proline	O
939	O
with	O
the	O
corresponding	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
residue	O
,	O
leucine	O
,	O
decreased	O
the	O
ability	O
MHV	B-SPEC
to	O
induce	O
cell	O
-	O
cell	O
fusion	O
,	O
providing	O
experimental	O
support	O
for	O
an	O
earlier	O
proposal	O
that	O
residues	O
929	O
-	O
944	O
make	O
up	O
the	O
fusion	O
peptide	O
of	O
the	O
MHV	B-SPEC
S	O
protein	O
.	O

Coinfection	O
by	O
at	O
least	O
two	O
viruses	B-SPEC
was	O
observed	O
in	O
37	O
cases	O
(	O
43	O
.	O
5	O
%).	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
:	O
chest	O
CT	O
findings	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
chest	O
CT	O
findings	O
in	O
seven	O
patients	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

TITLE	O
:	O
Unanswered	O
questions	O
about	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

These	O
data	O
are	O
fully	O
accessible	O
through	O
the	O
MOuse	B-SPEC
NOn	O
-	O
Code	O
Lung	O
interactive	O
database	O
(	O
MONOCLdb	O
).	O

TITLE	O
:	O
[	O
Genotypes	O
and	O
serotypes	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
viruses	B-SPEC
isolated	O
during	O
2009	O
-	O
2011	O
in	O
Guangxi	O
,	O
China	O
].	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
investigate	O
the	O
prevalence	O
and	O
track	O
genetic	O
and	O
antigenic	O
evolutions	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
their	O
prevalence	O
in	O
Guangxi	O
,	O
China	O
since	O
1985	O
,	O
gene	O
amplification	O
and	O
sequencing	O
and	O
virus	B-SPEC
neutralization	O
(	O
VN	O
)	O
test	O
on	O
chicken	B-SPEC
embryo	O
tracheal	O
organ	O
cultures	O
were	O
used	O
in	O
genotyping	O
and	O
serotyping	O
of	O
28	O
IBV	B-SPEC
isolates	O
during	O
2009	O
-	O
2011	O
in	O
Guangxi	O
.	O

Human	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
bocavirus	I-SPEC
were	O
the	O
most	O
common	O
pathogens	O
,	O
tending	O
to	O
occur	O
in	O
co	O
-	O
infection	O
with	O
other	O
respiratory	O
viruses	B-SPEC
.	O

The	O
coronavirus	B-SPEC
nonstructural	O
integral	O
membrane	O
proteins	O
(	O
nsps	O
)	O
3	O
,	O
4	O
and	O
6	O
,	O
are	O
key	O
players	O
in	O
the	O
formation	O
of	O
the	O
rearranged	O
membranes	O
.	O

TITLE	O
:	O
Differences	O
in	O
the	O
tissue	O
tropism	O
to	O
chicken	B-SPEC
oviduct	O
epithelial	O
cells	O
between	O
avian	B-SPEC
coronavirus	I-SPEC
IBV	B-SPEC
strains	O
QX	O
and	O
B1648	O
are	O
not	O
related	O
to	O
the	O
sialic	O
acid	O
binding	O
properties	O
of	O
their	O
spike	O
proteins	O
.	O

ABSTRACT	O
:	O
The	O
avian	B-SPEC
coronavirus	I-SPEC
(	O
AvCoV	O
)	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
major	O
poultry	O
pathogen	O
.	O

As	O
most	O
IBV	B-SPEC
strains	O
do	O
not	O
infect	O
permanent	O
cell	O
lines	O
and	O
show	O
infection	O
only	O
in	O
primary	O
chicken	B-SPEC
cells	O
of	O
the	O
target	O
organs	O
,	O
we	O
developed	O
a	O
culture	O
system	O
for	O
chicken	B-SPEC
oviduct	O
explants	O
.	O

The	O
molecular	O
assays	O
detected	O
53	O
and	O
31	O
CPV	B-SPEC
-	O
and	O
CCoV	O
-	O
positive	O
specimens	O
,	O
respectively	O
,	O
with	O
mixed	O
CPV	B-SPEC
-	O
CCoV	O
infections	O
diagnosed	O
in	O
28	O
dogs	B-SPEC
.	O

ABSTRACT	O
:	O
Since	O
October	O
2010	O
,	O
porcine	B-SPEC
diarrhea	O
outbreaks	O
have	O
occurred	O
widely	O
,	O
resulting	O
in	O
major	O
losses	O
in	O
suckling	O
piglets	O
in	O
China	O
.	O

Standard	O
dilutions	O
included	O
in	O
each	O
test	O
allowed	O
quantification	O
of	O
the	O
amount	O
of	O
PEDV	B-SPEC
.	O

Official	O
indications	O
for	O
ECMO	O
are	O
unclear	O
for	O
immunocompromised	O
and	O
HIV	B-SPEC
-	O
positive	O
patients	O
affected	O
by	O
severe	O
hypoxemia	O
.	O

However	O
,	O
the	O
care	O
of	O
patients	O
with	O
HIV	B-SPEC
infection	O
has	O
advanced	O
since	O
the	O
introduction	O
of	O
highly	O
active	O
antiretroviral	O
therapy	O
(	O
HAART	O
),	O
with	O
increased	O
life	O
expectancy	O
and	O
decreased	O
mortality	O
.	O

ECMO	O
was	O
effective	O
in	O
three	O
HIV	B-SPEC
-	O
positive	O
patients	O
with	O
an	O
otherwise	O
fatal	O
respiratory	O
failure	O
.	O

A	O
multidisciplinary	O
critical	O
team	O
is	O
needed	O
to	O
individualize	O
the	O
use	O
of	O
ECMO	O
in	O
immunocompromised	O
patients	O
,	O
including	O
those	O
with	O
HIV	B-SPEC
infection	O
.	O

As	O
a	O
result	O
,	O
animals	B-SPEC
rescued	O
from	O
hoarding	O
frequently	O
have	O
a	O
variety	O
of	O
medical	O
conditions	O
including	O
respiratory	O
infections	O
,	O
gastrointestinal	O
disease	O
,	O
parasitism	O
,	O
malnutrition	O
,	O
and	O
other	O
evidence	O
of	O
neglect	O
.	O

Records	O
were	O
reviewed	O
retrospectively	O
from	O
four	O
large	O
-	O
scale	O
seizures	O
of	O
cats	B-SPEC
from	O
failed	O
sanctuaries	O
from	O
November	O
2009	O
through	O
March	O
2012	O
.	O

Cats	B-SPEC
from	O
large	O
-	O
scale	O
hoarding	O
cases	O
had	O
high	O
risk	O
for	O
enteric	O
and	O
respiratory	O
infections	O
,	O
retroviruses	B-SPEC
,	O
and	O
dermatophytosis	O
.	O

Meta	B-SPEC
-	O
analyses	O
showed	O
reduced	O
28	O
-	O
day	O
mortality	O
with	O
a	O
48	O
-	O
hour	O
infusion	O
of	O
cis	B-SPEC
-	O
atracurium	O
in	O
early	O
ARDS	O
(	O
relative	O
risk	O
0	O
.	O
66	O
,	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
50	O
to	O
0	O
.	O
87	O
;	O
431	O
patients	O
,	O
138	O
deaths	O
).	O

Cis	B-SPEC
-	O
atracurium	O
is	O
a	O
promising	O
treatment	O
for	O
early	O
moderate	O
-	O
severe	O
ARDS	O
(	O
using	O
Berlin	O
definition	O
nomenclature	O
)	O
and	O
merits	O
further	O
investigation	O
in	O
a	O
large	O
RCT	O
.	O

TITLE	O
:	O
SOCS3	O
expression	O
correlates	O
with	O
severity	O
of	O
inflammation	O
in	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
3	O
-	O
induced	O
acute	O
liver	O
failure	O
and	O
HBV	B-SPEC
-	O
ACLF	O
.	O

Majority	O
of	O
HIV	B-SPEC
-	O
positive	O
patients	O
(	O
80	O
%)	O
were	O
newly	O
diagnosed	O
cases	O
.	O

Virus	B-SPEC
infection	O
was	O
observed	O
in	O
lung	O
,	O
liver	O
,	O
and	O
brain	O
tissue	O
.	O

The	O
identification	O
of	O
FBAHV1	O
makes	O
a	O
considerable	O
contribution	O
to	O
our	O
understanding	O
of	O
simplexviruses	B-SPEC
associated	O
with	O
bats	B-SPEC
.	O

We	O
enrolled	O
hospitalized	O
all	O
-	O
age	O
patients	O
with	O
ALRI	O
,	O
and	O
collected	O
respiratory	O
specimens	O
,	O
blood	O
or	O
serum	O
collected	O
for	O
diagnostic	O
testing	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
human	B-SPEC
influenza	B-SPEC
virus	I-SPEC
,	O
adenoviruses	B-SPEC
(	O
ADV	O
),	O
human	B-SPEC
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
),	O
human	B-SPEC
coronavirus	I-SPEC
(	O
hCoV	O
)	O
and	O
human	B-SPEC
bocavirus	I-SPEC
(	O
hBoV	O
).	O

There	O
were	O
clear	O
seasonal	O
peaks	O
for	O
RSV	B-SPEC
,	O
influenza	O
,	O
PIV	O
,	O
hBoV	O
and	O
hMPV	B-SPEC
infections	O
.	O

TITLE	O
:	O
Surveillance	O
of	O
avian	B-SPEC
coronaviruses	O
in	O
wild	O
bird	B-SPEC
populations	O
of	O
Korea	O
.	O

After	O
2	O
-	O
hour	O
automatic	O
ventilation	O
,	O
a	O
disconnection	O
of	O
the	O
animal	B-SPEC
from	O
the	O
ventilator	O
was	O
carried	O
out	O
for	O
10	O
seconds	O
,	O
simulating	O
a	O
frequent	O
clinical	O
scenario	O
for	O
routine	O
clinical	O
care	O
or	O
intra	O
-	O
hospital	O
transport	O
.	O

RESULTS	O
:	O
This	O
pilot	O
study	O
of	O
seven	O
pigs	B-SPEC
showed	O
stable	O
and	O
robust	O
response	O
for	O
oxygenation	O
,	O
plateau	O
pressure	O
and	O
pH	O
value	O
using	O
the	O
automated	O
system	O
.	O

TITLE	O
:	O
Clinico	O
-	O
epidemiological	O
characteristics	O
of	O
acute	O
respiratory	O
infections	O
caused	O
by	O
coronavirus	B-SPEC
OC43	O
,	O
NL63	O
and	O
229E	O
.	O

The	O
majority	O
of	O
these	O
infections	O
are	O
due	O
to	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Detection	O
and	O
genetic	O
characterization	O
of	O
deltacoronavirus	O
in	O
pigs	B-SPEC
,	O
Ohio	O
,	O
USA	O
,	O
2014	O
.	O

The	O
complete	O
genome	O
sequence	O
and	O
phylogenetic	O
analysis	O
of	O
the	O
virus	B-SPEC
confirmed	O
that	O
the	O
virus	B-SPEC
is	O
closely	O
related	O
to	O
a	O
porcine	B-SPEC
deltacoronavirus	O
(	O
porcine	B-SPEC
coronavirus	B-SPEC
HKU15	O
)	O
reported	O
in	O
Hong	O
Kong	O
in	O
2012	O
.	O

TITLE	O
:	O
Utility	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
antibody	O
tests	O
.	O

The	O
IFAT	O
and	O
ELISA	O
tests	O
were	O
best	O
for	O
obtaining	O
an	O
antibody	O
titre	O
and	O
for	O
working	O
in	O
the	O
presence	O
of	O
virus	B-SPEC
.	O

Sensitivity	O
was	O
100	O
%	O
for	O
the	O
ELISA	O
,	O
one	O
FCoV	O
IFAT	O
and	O
one	O
TGEV	B-SPEC
IFAT	O
;	O
and	O
98	O
.	O
2	O
%	O
for	O
a	O
second	O
TGEV	B-SPEC
IFA	O
and	O
96	O
.	O
1	O
%	O
for	O
a	O
second	O
FCoV	O
IFAT	O
.	O

TITLE	O
:	O
Plasmodium	B-SPEC
vivax	I-SPEC
malaria	O
--	O
is	O
it	O
really	O
benign	O
?	O

ABSTRACT	O
:	O
Emergence	O
of	O
viruses	B-SPEC
belonging	O
to	O
the	O
coronavirus	B-SPEC
family	B-SPEC
has	O
been	O
widespread	O
in	O
the	O
past	O
,	O
causing	O
respiratory	O
infections	O
in	O
humans	B-SPEC
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

The	O
most	O
common	O
respiratory	O
virus	B-SPEC
was	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
detected	O
in	O
57	O
.	O
7	O
%	O
of	O
the	O
positive	O
samples	O
,	O
followed	O
by	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
23	O
.	O
1	O
%)	O
and	O
human	B-SPEC
coronaviruses	O
(	O
19	O
.	O
2	O
%).	O

To	O
gain	O
insight	O
into	O
the	O
interaction	O
between	O
the	O
virus	B-SPEC
and	O
host	O
cells	O
,	O
changes	O
in	O
global	O
gene	O
expression	O
in	O
the	O
cerebral	O
cortex	O
of	O
PHEV	O
-	O
or	O
mock	O
-	O
infected	O
mice	B-SPEC
were	O
investigated	O
using	O
DNA	O
microarray	O
analysis	O
and	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

In	O
dogs	B-SPEC
with	O
acute	O
respiratory	O
signs	O
,	O
37	O
.	O
7	O
%	O
tested	O
positive	O
for	O
CPIV	O
,	O
9	O
.	O
8	O
%	O
for	O
CRCoV	O
and	O
78	O
.	O
7	O
%	O
for	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
.	O

In	O
acute	O
exacerbations	O
of	O
bronchial	O
asthma	O
(	O
AEBA	O
)	O
including	O
near	O
fatal	O
and	O
fatal	O
asthma	O
,	O
viral	O
agents	O
,	O
particularly	O
human	B-SPEC
rhinovirus	I-SPEC
-	O
C	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
and	O
influenza	O
A	O
appear	O
to	O
be	O
the	O
more	O
prevalent	O
and	O
recurring	O
threats	O
.	O

Coronavirus	B-SPEC
infection	O
of	O
cultured	O
cells	O
was	O
previously	O
shown	O
to	O
cause	O
ER	O
stress	O
and	O
induce	O
the	O
unfolded	O
protein	O
response	O
(	O
UPR	O
),	O
a	O
process	O
that	O
aims	O
to	O
restore	O
the	O
ER	O
homeostasis	O
by	O
global	O
translation	O
shutdown	O
and	O
increasing	O
the	O
ER	O
folding	O
capacity	O
.	O

Accumulating	O
evidence	O
from	O
recent	O
studies	O
has	O
shown	O
that	O
induction	O
of	O
ER	O
stress	O
and	O
UPR	O
may	O
constitute	O
a	O
major	O
aspect	O
of	O
coronavirus	B-SPEC
-	O
host	O
interaction	O
.	O

In	O
this	O
review	O
,	O
we	O
summarize	O
the	O
current	O
knowledge	O
on	O
coronavirus	B-SPEC
-	O
induced	O
ER	O
stress	O
and	O
UPR	O
activation	O
,	O
with	O
emphasis	O
on	O
their	O
cross	O
-	O
talking	O
to	O
apoptotic	O
signaling	O
.	O

The	O
prevalence	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
infection	O
among	O
these	O
patients	O
was	O
assessed	O
using	O
two	O
different	O
OneStep	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assays	O
.	O

In	O
addition	O
,	O
some	O
novel	O
unique	O
clusters	O
(	O
UNT	O
)	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
were	O
found	O
in	O
the	O
S	O
-	O
and	O
N	O
-	O
based	O
phylogenetic	O
trees	O
.	O

This	O
paper	O
forms	O
part	O
of	O
a	O
series	O
of	O
invited	O
articles	O
in	O
Antiviral	O
Research	O
on	O
""""	O
From	O
SARS	O
to	O
MERS	O
:	O
10	O
years	O
of	O
research	O
on	O
highly	O
pathogenic	O
human	B-SPEC
coronaviruses	O
""""	O
(	O
see	O
Introduction	O
by	O
Hilgenfeld	O
and	O
Peiris	O
(	O
2013	O
)).	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
positive	O
stranded	O
RNA	O
viruses	B-SPEC
that	O
cause	O
respiratory	O
,	O
enteric	O
and	O
central	O
nervous	O
system	O
diseases	O
in	O
many	O
species	B-SPEC
,	O
including	O
humans	B-SPEC
.	O

Clinically	O
significant	O
infections	O
in	O
humans	B-SPEC
after	O
a	O
bite	O
are	O
often	O
associated	O
with	O
the	O
presence	O
of	O
immune	O
deficiency	O
.	O

In	O
addition	O
,	O
patients	O
with	O
immune	O
deficiency	O
are	O
susceptible	O
to	O
serious	O
life	O
-	O
threatening	O
nosocomial	O
infections	O
,	O
which	O
may	O
also	O
influence	O
the	O
prognosis	O
of	O
patients	O
with	O
Capnocytophaga	B-SPEC
canimorsus	I-SPEC
infection	O
.	O

She	O
improved	O
within	O
2	O
weeks	O
but	O
,	O
despite	O
all	O
efforts	O
to	O
prevent	O
nosocomial	O
infection	O
,	O
her	O
hospital	O
course	O
was	O
complicated	O
by	O
Enterococcus	B-SPEC
species	I-SPEC
and	O
Candida	B-SPEC
albicans	I-SPEC
pleuropneumonia	B-SPEC
that	O
prolonged	O
her	O
stay	O
in	O
the	O
intensive	O
care	O
unit	O
,	O
and	O
necessitated	O
ventilation	O
support	O
for	O
2	O
months	O
.	O

Phylogenetic	O
analysis	O
revealed	O
that	O
all	O
Chinese	O
IBV	B-SPEC
strains	O
were	O
clustered	O
into	O
six	O
distinct	O
genetic	O
groups	O
(	O
I	O
-	O
VI	O
).	O

The	O
patient	O
owned	O
a	O
rabbit	B-SPEC
and	O
,	O
before	O
the	O
onset	O
of	O
the	O
disease	O
,	O
repaired	O
some	O
rubber	O
pipes	O
damaged	O
by	O
rodents	B-SPEC
.	O

Chest	O
X	O
-	O
ray	B-SPEC
analysis	O
was	O
suggestive	O
of	O
non	O
-	O
cardiac	O
pulmonary	O
edema	O
in	O
view	O
of	O
bilateral	O
fluffy	O
opacity	O
without	O
cardiomegaly	O
.	O

Assessment	O
of	O
micturition	O
patterns	O
by	O
filter	O
paper	O
assay	O
determined	O
an	O
increase	O
in	O
the	O
number	O
of	O
small	O
and	O
large	O
urine	O
spots	B-SPEC
in	O
CIE	O
mice	B-SPEC
starting	O
from	O
the	O
second	O
week	O
after	O
inoculation	O
.	O

The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
PEDV	B-SPEC
is	O
a	O
type	O
1	O
transmembrane	O
envelope	O
glycoprotein	O
and	O
consists	O
of	O
the	O
S1	O
and	O
S2	O
domains	O
,	O
which	O
are	O
responsible	O
for	O
virus	B-SPEC
binding	O
and	O
fusion	O
,	O
respectively	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
induces	O
caspase	O
-	O
independent	O
apoptosis	O
through	O
activation	O
of	O
mitochondrial	O
apoptosis	O
-	O
inducing	O
factor	O
.	O

Interestingly	O
,	O
mitochondrial	O
apoptosis	O
-	O
inducing	O
factor	O
(	O
AIF	O
)	O
was	O
found	O
to	O
translocate	O
to	O
the	O
nucleus	O
during	O
PEDV	B-SPEC
infection	O
,	O
and	O
AIF	O
relocalization	O
was	O
completely	O
abrogated	O
by	O
the	O
presence	O
of	O
cyclosporin	O
A	O
(	O
CsA	O
),	O
an	O
inhibitor	O
of	O
cyclophilin	O
D	O
(	O
CypD	O
)	O
that	O
is	O
an	O
essential	O
component	O
of	O
the	O
mitochondrial	O
permeabilization	O
transition	O
pore	O
(	O
mPTP	O
)	O
complex	O
.	O

Altogether	O
,	O
our	O
results	O
indicate	O
that	O
a	O
caspase	O
-	O
independent	O
mitochondrial	O
AIF	O
-	O
mediated	O
pathway	O
plays	O
a	O
central	O
role	O
in	O
PEDV	B-SPEC
-	O
induced	O
apoptosis	O
to	O
facilitate	O
viral	O
replication	O
and	O
pathogenesis	O
.	O

Our	O
data	O
showed	O
significant	O
differential	O
up	O
-	O
regulation	O
of	O
IFN	O
-	O
γ	O
,	O
IL	O
-	O
8	O
(	O
CXCLi2	O
)	O
and	O
MIP	O
-	O
1β	O
genes	O
and	O
suppression	O
of	O
IL	O
-	O
6	O
gene	O
expression	O
being	O
associated	O
with	O
inhibition	O
of	O
IBV	B-SPEC
replication	O
in	O
lungs	O
tissue	O
retrieved	O
from	O
embryos	O
pre	O
-	O
treated	O
with	O
CpG	O
ODN	O
.	O

Influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
was	O
detected	O
in	O
58	O
.	O
3	O
%	O
of	O
specimens	O
,	O
with	O
a	O
case	O
fatality	O
rate	O
of	O
11	O
.	O
3	O
%.	O

In	O
this	O
cross	O
-	O
sectional	O
case	O
control	O
study	O
,	O
in	O
addition	O
to	O
bacteria	B-SPEC
,	O
we	O
aimed	O
to	O
determine	O
respiratory	O
viruses	B-SPEC
using	O
,	O
for	O
the	O
first	O
time	O
in	O
our	O
country	O
,	O
the	O
Reverse	O
Transcription	O
PCR	O
DNA	O
Microarray	O
method	O
,	O
and	O
we	O
also	O
aimed	O
to	O
evaluate	O
its	O
diagnostic	O
performance	O
.	O

In	O
this	O
study	O
we	O
assessed	O
whether	O
PEDV	B-SPEC
could	O
become	O
airborne	O
and	O
if	O
so	O
,	O
whether	O
the	O
virus	B-SPEC
was	O
infectious	O
.	O

The	O
common	O
viruses	B-SPEC
detected	O
from	O
children	O
(	O
2	O
,	O
800	O
total	O
patients	O
)	O
were	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
hRV	O
)	O
(	O
31	O
.	O
8	O
%),	O
adenovirus	B-SPEC
(	O
AdV	O
)	O
(	O
19	O
.	O
2	O
%),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
A	O
(	O
17	O
.	O
4	O
%),	O
RSV	B-SPEC
B	O
(	O
11	O
.	O
7	O
%),	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
)	O
(	O
9	O
.	O
8	O
%).	O

TITLE	O
:	O
Rooting	O
the	O
phylogenetic	O
tree	O
of	O
middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
by	O
characterization	O
of	O
a	O
conspecific	O
virus	B-SPEC
from	O
an	O
African	O
bat	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
currently	O
the	O
focus	O
of	O
global	O
attention	O
.	O

We	O
searched	O
MEDLINE	O
,	O
Embase	O
,	O
LILACS	B-SPEC
(	O
Literatura	O
Latino	O
Americana	O
em	O
Ciências	O
da	O
Saúde	O
),	O
and	O
ISI	O
Web	O
of	O
Science	O
,	O
in	O
addition	O
to	O
grey	O
literature	O
and	O
clinical	O
trials	O
registries	O
.	O

ABSTRACT	O
:	O
A	O
severe	O
viral	O
illness	O
caused	O
by	O
a	O
newly	O
discovered	O
coronavirus	B-SPEC
was	O
first	O
reported	O
in	O
the	O
Middle	O
East	O
in	O
2012	O
.	O

The	O
source	O
of	O
the	O
virus	B-SPEC
remains	O
unclear	O
,	O
but	O
camels	B-SPEC
are	O
a	O
possible	O
source	O
.	O

Neither	O
a	O
vaccine	O
nor	O
effective	O
therapy	O
against	O
the	O
virus	B-SPEC
is	O
available	O
.	O

The	O
crystal	O
structure	O
of	O
the	O
free	O
SARS	O
coronavirus	B-SPEC
M	O
(	O
pro	O
)	O
and	O
its	O
dependence	O
on	O
pH	O
is	O
discussed	O
,	O
as	O
are	O
efforts	O
to	O
design	O
inhibitors	O
on	O
the	O
basis	O
of	O
these	O
structures	O
.	O

Also	O
,	O
detailed	O
clinical	O
histories	O
of	O
any	O
MERS	O
-	O
CoV	O
cases	O
with	O
epidemiological	O
and	O
laboratory	O
investigations	O
carried	O
out	O
for	O
any	O
animal	B-SPEC
exposure	O
must	O
be	O
considered	O
to	O
identify	O
any	O
animal	B-SPEC
source	O
.	O

Moreover	O
,	O
increased	O
numbers	O
of	O
both	O
IgA	O
and	O
IgG	O
IBV	B-SPEC
-	O
specific	O
antibody	O
secreting	O
lymphocytes	O
were	O
detected	O
in	O
the	O
spleen	O
after	O
challenge	O
.	O

The	O
fact	O
that	O
a	O
single	O
vaccination	O
with	O
Ad	O
/	O
IBVS1	O
.	O
C2	O
provides	O
protection	O
against	O
IBV	B-SPEC
challenge	O
is	O
promising	O
,	O
because	O
Ad	O
-	O
vectored	O
vaccines	O
can	O
be	O
mass	O
delivered	O
by	O
in	O
ovo	B-SPEC
inoculation	O
using	O
automated	O
in	O
ovo	B-SPEC
injectors	O
.	O

One	O
explanation	O
for	O
this	O
observation	O
is	O
the	O
high	O
genetic	O
variability	O
of	O
IBV	B-SPEC
.	O

Furthermore	O
,	O
IgA	O
IBV	B-SPEC
-	O
specific	O
antibody	O
levels	O
significantly	O
increased	O
over	O
controls	O
3	O
days	O
earlier	O
in	O
tears	O
and	O
4	O
days	O
earlier	O
in	O
plasma	O
than	O
did	O
IgG	O
antibodies	O
.	O

Thus	O
,	O
lower	O
mucosal	O
IgA	O
antibody	O
levels	O
are	O
observed	O
upon	O
secondary	O
exposure	O
to	O
IBV	B-SPEC
,	O
which	O
may	O
contribute	O
to	O
vulnerability	O
of	O
host	O
epithelial	O
cells	O
to	O
infection	O
by	O
IBV	B-SPEC
and	O
persistence	O
of	O
the	O
Ark	O
serotype	O
.	O

A	O
subset	O
of	O
sputum	O
samples	O
positive	O
for	O
10	O
common	O
viruses	B-SPEC
by	O
a	O
uniplex	O
RT	O
-	O
PCR	O
was	O
selected	O
.	O

Virus	B-SPEC
-	O
specific	O
CD8	O
T	O
cells	O
are	O
required	O
for	O
pathogen	O
clearance	O
following	O
primary	O
SARS	O
-	O
CoV	O
infection	O
.	O

TITLE	O
:	O
Chimeric	O
influenza	O
-	O
virus	B-SPEC
-	O
like	O
particles	O
containing	O
the	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
GP5	O
protein	O
and	O
the	O
influenza	B-SPEC
virus	I-SPEC
HA	O
and	O
M1	O
proteins	O
.	O

ABSTRACT	O
:	O
Both	O
porcine	B-SPEC
reproductive	O
and	O
respiratory	O
syndrome	O
and	O
swine	B-SPEC
influenza	O
are	O
acute	O
,	O
highly	O
contagious	O
swine	B-SPEC
diseases	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
developed	O
a	O
chimeric	O
virus	B-SPEC
-	O
like	O
particle	O
(	O
VLP	O
)	O
vaccine	O
candidate	O
for	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
)	O
and	O
H3N2	O
influenza	B-SPEC
virus	I-SPEC
and	O
investigated	O
its	O
immunogenicity	O
in	O
mice	B-SPEC
.	O

To	O
address	O
this	O
issue	O
,	O
a	O
dual	O
-	O
lumen	O
,	O
single	O
venovenous	O
cannula	B-SPEC
was	O
introduced	O
.	O

These	O
cases	O
were	O
mostly	O
conjoined	O
to	O
the	O
implantation	O
phase	O
or	O
the	O
early	O
postoperative	O
phase	O
and	O
vary	O
between	O
right	O
heart	O
perforation	O
to	O
migration	O
of	O
the	O
cannula	B-SPEC
.	O

This	O
review	O
focuses	O
on	O
complications	O
allied	O
to	O
commercially	O
available	O
dual	O
-	O
lumen	O
,	O
single	O
,	O
venovenous	O
cannula	B-SPEC
implantation	O
,	O
pointing	O
out	O
the	O
critical	O
segments	O
of	O
the	O
implantation	O
process	O
and	O
analyzing	O
the	O
structure	O
of	O
the	O
device	O
.	O

Quantitative	O
-	O
PCR	O
and	O
immunofluorescence	O
staining	O
results	O
indicate	O
that	O
SARS	O
-	O
CoV	O
is	O
capable	O
of	O
replication	O
in	O
HL	O
-	O
CZ	O
cells	O
,	O
and	O
of	O
displaying	O
virus	B-SPEC
-	O
induced	O
cytopathic	O
effects	O
and	O
increased	O
levels	O
of	O
TNF	O
-	O
α	O
,	O
IL	O
-	O
4	O
and	O
IL	O
-	O
6	O
two	O
days	O
post	O
-	O
infection	O
.	O

It	O
is	O
traditionally	O
defined	O
as	O
a	O
triad	O
of	O
acute	O
renal	O
failure	O
,	O
hemolytic	O
anemia	B-SPEC
and	O
thrombocytopenia	O
that	O
occur	O
within	O
a	O
week	O
after	O
prodromal	O
hemorrhagic	O
enterocolitis	O
.	O

CONCLUSIONS	O
:	O
It	O
is	O
necessary	O
to	O
keep	O
the	O
surveillance	O
and	O
further	O
studies	O
in	O
order	B-SPEC
to	O
assess	O
the	O
impact	O
on	O
international	O
public	O
health	O
.	O

TITLE	O
:	O
Identification	O
of	O
cis	B-SPEC
-	O
acting	O
elements	O
on	O
positive	O
-	O
strand	O
subgenomic	O
mRNA	O
required	O
for	O
the	O
synthesis	O
of	O
negative	O
-	O
strand	O
counterpart	O
in	O
bovine	B-SPEC
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Clathrin	O
-	O
and	O
serine	O
proteases	O
-	O
dependent	O
uptake	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
into	O
Vero	O
cells	O
.	O

Here	O
,	O
we	O
determined	O
the	O
entry	O
mechanism	O
of	O
PEDV	B-SPEC
into	O
Vero	O
cells	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
onset	O
of	O
epidemics	O
caused	O
by	O
viruses	B-SPEC
such	O
as	O
Ebola	O
,	O
Marburg	O
,	O
Nipah	O
,	O
Lassa	O
,	O
coronavirus	B-SPEC
,	O
West	O
-	O
Nile	O
encephalitis	O
,	O
Saint	O
Louis	O
encephalitis	O
,	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
dengue	O
,	O
yellow	O
fever	O
and	O
Venezuelan	O
hemorrhagic	O
fever	O
alerts	O
about	O
the	O
risk	O
these	O
agents	O
represent	O
for	O
the	O
global	O
health	O
.	O

Surged	O
from	O
remote	O
African	O
regions	O
,	O
this	O
virus	B-SPEC
has	O
become	O
endemic	O
in	O
the	O
Indic	O
ocean	O
basin	O
,	O
the	O
Indian	O
subcontinent	O
and	O
the	O
southeast	O
of	O
Asia	O
,	O
causing	O
serious	O
epidemics	O
in	O
Africa	O
,	O
Indic	O
Ocean	O
Islands	O
,	O
Asia	O
and	O
Europe	O
.	O

TITLE	O
:	O
The	O
vaccine	O
efficacy	O
of	O
recombinant	O
duck	B-SPEC
enteritis	I-SPEC
virus	I-SPEC
expressing	O
secreted	O
E	O
with	O
or	O
without	O
PrM	O
proteins	O
of	O
duck	B-SPEC
tembusu	B-SPEC
virus	I-SPEC
.	O

In	O
contrast	O
,	O
MERS	O
is	O
relatively	O
inefficiently	O
transmitted	O
to	O
humans	B-SPEC
but	O
has	O
a	O
high	O
mortality	O
rate	O
.	O

This	O
review	O
highlights	O
pathological	O
aspects	O
related	O
to	O
two	O
pre	O
-	O
clinical	O
viral	O
models	O
for	O
MS	O
;	O
data	O
are	O
consistent	O
between	O
these	O
two	O
models	O
as	O
experimental	O
infection	O
of	O
susceptible	O
mice	B-SPEC
can	O
induce	O
axonal	O
degeneration	O
associated	O
with	O
demyelination	O
.	O

ABSTRACT	O
:	O
Since	O
its	O
initial	O
detection	O
in	O
May	O
2013	O
,	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
spread	O
rapidly	O
throughout	O
the	O
US	O
swine	B-SPEC
industry	O
.	O

Here	O
we	O
provide	O
proof	O
of	O
concept	O
of	O
this	O
risk	O
by	O
describing	O
a	O
novel	O
means	O
for	O
recovering	O
PEDV	B-SPEC
-	O
contaminated	O
complete	O
feed	O
material	O
from	O
commercial	O
swine	B-SPEC
sites	O
and	O
conducting	O
an	O
in	O
vivo	O
experiment	O
to	O
prove	O
its	O
infectivity	O
.	O

Bronchoscopy	O
with	O
BAL	O
in	O
critically	O
ill	O
patients	O
with	O
sepsis	B-SPEC
and	O
ALI	O
is	O
well	O
tolerated	O
with	O
low	O
risk	O
of	O
complications	O
,	O
primarily	O
related	O
to	O
manageable	O
hypoxemia	O
.	O

Diketo	O
acid	O
(	O
DKA	O
)	O
derivatives	O
are	O
active	O
site	O
Mg	O
(	O
2	O
+)-	O
binding	O
inhibitors	O
of	O
both	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RNase	O
H	O
and	O
integrase	O
(	O
IN	O
)	O
activities	O
.	O

The	O
modification	O
or	O
deletion	O
of	O
different	O
motifs	O
within	O
E	O
protein	O
,	O
including	O
the	O
transmembrane	O
domain	O
that	O
harbors	O
an	O
ion	O
channel	O
activity	O
,	O
small	O
sequences	O
within	O
the	O
middle	O
region	O
of	O
the	O
carboxy	O
-	O
terminus	O
of	O
E	O
protein	O
,	O
and	O
its	O
most	O
carboxy	O
-	O
terminal	O
end	O
,	O
which	O
contains	O
a	O
PDZ	O
domain	O
-	O
binding	O
motif	O
(	O
PBM	O
),	O
is	O
sufficient	O
to	O
attenuate	O
the	O
virus	B-SPEC
.	O

We	O
demonstrate	O
that	O
the	O
CoVs	O
SARS	O
CoV	O
and	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
induce	O
macropinocytosis	O
,	O
which	O
occurs	O
late	O
during	O
infection	O
,	O
is	O
continuous	O
,	O
and	O
is	O
not	O
associated	O
with	O
virus	B-SPEC
entry	O
.	O

TITLE	O
:	O
Investigation	O
into	O
the	O
role	O
of	O
potentially	O
contaminated	O
feed	O
as	O
a	O
source	O
of	O
the	O
first	O
-	O
detected	O
outbreaks	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
in	O
Canada	O
.	O

ABSTRACT	O
:	O
In	O
January	O
2014	O
,	O
approximately	O
9	O
months	O
following	O
the	O
initial	O
detection	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
in	O
the	O
USA	O
,	O
the	O
first	O
case	O
of	O
PED	O
was	O
confirmed	O
in	O
a	O
swine	B-SPEC
herd	O
in	O
south	O
-	O
western	O
Ontario	O
.	O

We	O
found	O
that	O
although	O
mutations	O
that	O
confer	O
resistance	O
arise	O
quickly	O
,	O
the	O
resistant	O
viruses	B-SPEC
replicate	O
slowly	O
and	O
do	O
not	O
cause	O
lethal	O
disease	O
in	O
mice	B-SPEC
.	O

Mutation	O
of	O
the	O
catalytic	O
cysteine	O
residue	O
of	O
PLpro	O
or	O
addition	O
of	O
a	O
PLpro	O
inhibitor	O
blocked	O
deISGylation	O
in	O
virus	B-SPEC
-	O
infected	O
cells	O
.	O

TITLE	O
:	O
Detection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
using	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
RT	O
-	O
LAMP	O
).	O

The	O
RT	O
-	O
LAMP	O
assay	O
was	O
capable	O
of	O
detecting	O
as	O
few	O
as	O
3	O
.	O
4	O
copies	O
of	O
MERS	O
-	O
CoV	O
RNA	O
,	O
and	O
was	O
highly	O
specific	O
,	O
with	O
no	O
cross	O
-	O
reaction	O
to	O
other	O
respiratory	O
viruses	B-SPEC
.	O

Adult	O
patients	O
microscopically	O
diagnosed	O
to	O
have	O
P	O
.	O
vivax	O
/	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
infections	O
from	O
the	O
year	O
2007	O
-	O
2011	O
were	O
evaluated	O
based	O
on	O
their	O
hospital	O
records	O
.	O

RESULTS	O
:	O
Of	O
922	O
malaria	O
cases	O
included	O
in	O
the	O
study	O
,	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
was	O
the	O
largest	O
(	O
63	O
.	O
4	O
%,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
60	O
.	O
3	O
-	O
66	O
.	O
5	O
%)	O
infecting	O
species	B-SPEC
,	O
followed	O
by	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
(	O
34	O
.	O
4	O
%,	O
95	O
%	O
CI	O
31	O
.	O
3	O
-	O
37	O
.	O
5	O
%)	O
and	O
their	O
mixed	O
infection	O
(	O
2	O
.	O
2	O
%,	O
95	O
%	O
CI	O
1	O
.	O
3	O
-	O
3	O
.	O
2	O
%).	O

ABSTRACT	O
:	O
Originally	O
developed	O
and	O
commercialized	O
as	O
an	O
antiprotozoal	O
agent	O
,	O
nitazoxanide	O
was	O
later	O
identified	O
as	O
a	O
first	O
-	O
in	O
-	O
class	B-SPEC
broad	O
-	O
spectrum	O
antiviral	O
drug	O
and	O
has	O
been	O
repurposed	O
for	O
the	O
treatment	O
of	O
influenza	O
.	O

It	O
is	O
synergistic	O
with	O
neuraminidase	O
inhibitors	O
,	O
and	O
combination	O
therapy	O
with	O
oseltamivir	O
is	O
being	O
studied	O
in	O
humans	B-SPEC
as	O
part	O
of	O
ongoing	O
Phase	O
3	O
clinical	O
development	O
.	O

However	O
,	O
over	O
the	O
last	O
decade	O
it	O
has	O
become	O
clear	O
that	O
aggressive	O
fluid	O
resuscitation	O
leading	O
to	O
fluid	O
overload	O
is	O
associated	O
with	O
increased	O
morbidity	O
and	O
mortality	O
across	O
a	O
diverse	O
group	O
of	O
patients	O
,	O
including	O
patients	O
with	O
severe	O
sepsis	B-SPEC
as	O
well	O
as	O
elective	O
surgical	O
and	O
trauma	O
patients	O
and	O
those	O
with	O
pancreatitis	O
.	O

TITLE	O
:	O
Emergent	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
caused	O
by	O
adenovirus	B-SPEC
type	O
55	O
in	O
immunocompetent	O
adults	O
in	O
2013	O
:	O
a	O
prospective	O
observational	O
study	O
.	O

Second	O
,	O
in	O
the	O
absence	O
of	O
exogenous	O
proteases	O
,	O
both	O
MERS	O
-	O
CoV	O
and	O
HKU4	O
spikes	O
mediate	O
pseudovirus	O
entry	O
into	O
bat	B-SPEC
cells	O
,	O
whereas	O
only	O
MERS	O
-	O
CoV	O
spike	O
,	O
but	O
not	O
HKU4	O
spike	O
,	O
mediates	O
pseudovirus	O
entry	O
into	O
human	B-SPEC
cells	O
.	O

They	O
also	O
suggest	O
that	O
DPP4	O
-	O
recognizing	O
bat	B-SPEC
coronaviruses	O
threaten	O
human	B-SPEC
health	O
because	O
of	O
their	O
spikes	O
'	O
capability	O
to	O
adapt	O
to	O
human	B-SPEC
cells	O
for	O
cross	O
-	O
species	B-SPEC
transmissions	O
.	O

To	O
this	O
end	O
,	O
C57BL	O
/	O
6NCrl	O
mice	B-SPEC
were	O
challenged	O
with	O
lipopolysaccharide	O
(	O
LPS	O
;	O
15	O
mg	O
/	O
kg	O
,	O
i	O
.	O
p	O
.)	O
followed	O
18	O
h	O
later	O
by	O
injection	O
of	O
oleic	O
acid	O
(	O
OA	O
;	O
0	O
.	O
12	O
mL	O
/	O
kg	O
,	O
i	O
.	O
v	O
.).	O

Among	O
all	O
open	O
reading	O
frames	O
(	O
orfs	O
)	O
of	O
this	O
virus	B-SPEC
,	O
the	O
orf3a	O
is	O
the	O
largest	O
,	O
and	O
encodes	O
a	O
protein	O
of	O
274	O
amino	O
acids	O
,	O
named	O
as	O
3a	O
protein	O
.	O

The	O
discovery	O
that	O
PEDV	B-SPEC
infects	O
and	O
replicates	O
in	O
alveolar	O
macrophages	O
provides	O
new	O
insights	O
into	O
its	O
pathogenesis	O
.	O

Respiratory	O
syndromes	O
caused	O
by	O
coronavirus	B-SPEC
infections	O
in	O
humans	B-SPEC
range	O
in	O
severity	O
from	O
the	O
common	O
cold	O
to	O
severe	O
acute	O
respiratory	O
syndrome	O
associated	O
with	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
and	O
other	O
viral	O
strains	O
.	O

This	O
review	O
will	O
summarize	O
the	O
research	O
progress	O
in	O
the	O
functions	O
of	O
coronavirus	B-SPEC
accessory	O
genes	O
.	O

ABSTRACT	O
:	O
The	O
type	O
II	O
transmembrane	O
serine	O
protease	O
(	O
TTSP	O
)	O
TMPRSS2	O
cleaves	O
and	O
activates	O
the	O
influenza	B-SPEC
virus	I-SPEC
and	O
coronavirus	B-SPEC
surface	O
proteins	O
.	O

In	O
sum	O
,	O
we	O
identified	O
two	O
host	O
cell	O
proteases	O
that	O
could	O
promote	O
the	O
amplification	O
of	O
influenza	B-SPEC
viruses	I-SPEC
and	O
emerging	O
coronaviruses	O
in	O
humans	B-SPEC
and	O
might	O
constitute	O
targets	O
for	O
antiviral	O
intervention	O
.	O

However	O
,	O
16	O
.	O
7	O
%	O
(	O
4	O
/	O
24	O
)	O
FIP	O
cats	B-SPEC
and	O
9	O
.	O
8	O
%	O
(	O
6	O
/	O
61	O
)	O
clinically	O
healthy	O
cats	B-SPEC
were	O
found	O
to	O
possess	O
antibodies	O
against	O
both	O
viruses	B-SPEC
.	O

The	O
7b	O
gene	O
was	O
affected	O
by	O
deletions	O
only	O
in	O
one	O
cat	B-SPEC
.	O

All	O
analysed	O
genome	O
fragments	O
of	O
the	O
coronavirus	B-SPEC
strains	O
shared	O
different	O
evolutionary	O
branches	O
,	O
resulting	O
in	O
a	O
different	O
phylogenetic	O
tree	O
topology	O
.	O

ABSTRACT	O
:	O
An	O
indirect	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
anti	O
-	O
immunoglobulin	O
(	O
Ig	O
)	O
G	O
ELISA	O
based	O
on	O
the	O
S1	O
portion	O
of	O
the	O
spike	O
protein	O
was	O
validated	O
and	O
compared	O
with	O
an	O
indirect	O
immunofluorescence	O
assay	O
.	O

The	O
S1	O
ELISA	O
showed	O
no	O
cross	O
-	O
reactivity	O
with	O
antibodies	O
against	O
other	O
porcine	B-SPEC
coronaviruses	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
oxidative	O
stress	O
represents	O
a	O
mechanism	O
for	O
modulating	O
the	O
virus	B-SPEC
-	O
specific	O
T	O
cell	O
response	O
.	O

ABSTRACT	O
:	O
FTY720	O
(	O
fingolimod	O
)	O
is	O
the	O
first	O
oral	O
drug	O
approved	O
by	O
the	O
Food	O
and	O
Drug	O
Administration	O
for	O
treatment	O
of	O
patients	O
with	O
the	O
relapsing	O
-	O
remitting	O
form	O
of	O
the	O
human	B-SPEC
demyelinating	O
disease	O
multiple	O
sclerosis	O
.	O

We	O
hypothesized	O
that	O
FTY720	O
treatment	O
would	O
affect	O
lymphocyte	O
migration	O
to	O
the	O
CNS	O
and	O
influence	O
disease	O
severity	O
in	O
a	O
mouse	B-SPEC
model	O
of	O
viral	O
-	O
induced	O
neurologic	O
disease	O
.	O

RESULTS	O
:	O
Administration	O
of	O
FTY720	O
to	O
JHMV	O
-	O
infected	O
mice	B-SPEC
resulted	O
in	O
increased	O
clinical	O
disease	O
severity	O
and	O
mortality	O
.	O

TITLE	O
:	O
Experimental	O
inoculation	O
of	O
equine	B-SPEC
coronavirus	B-SPEC
into	O
Japanese	O
draft	O
horses	B-SPEC
.	O

All	O
horses	B-SPEC
excreted	O
a	O
large	O
amount	O
of	O
virus	B-SPEC
into	O
their	O
feces	O
for	O
more	O
than	O
9	O
days	O
after	O
inoculation	O
regardless	O
of	O
the	O
presence	O
or	O
absence	O
of	O
clinical	O
signs	O
,	O
which	O
suggests	O
that	O
feces	O
are	O
an	O
important	O
source	O
of	O
ECoV	O
infection	O
.	O

Both	O
symptomatic	O
horses	B-SPEC
developed	O
viremia	O
,	O
while	O
the	O
asymptomatic	O
horse	B-SPEC
did	O
not	O
.	O

Most	O
of	O
the	O
marmosets	B-SPEC
developed	O
a	O
progressive	O
severe	O
pneumonia	O
leading	O
to	O
euthanasia	O
of	O
some	O
animals	B-SPEC
.	O

Some	O
animals	B-SPEC
were	O
also	O
viremic	O
;	O
high	O
viral	O
loads	O
were	O
detected	O
in	O
the	O
lungs	O
of	O
all	O
infected	O
animals	B-SPEC
,	O
and	O
total	O
RNAseq	O
demonstrated	O
the	O
induction	O
of	O
immune	O
and	O
inflammatory	O
pathways	O
.	O

Together	O
,	O
these	O
data	O
support	O
the	O
hypothesis	O
that	O
reduced	O
BDNF	O
signaling	O
and	O
respiratory	O
dysfunction	O
in	O
RTT	O
are	O
linked	O
,	O
and	O
establish	O
the	O
proof	O
-	O
of	O
-	O
concept	O
that	O
treatment	O
with	O
a	O
small	O
-	O
molecule	O
structural	O
mimetic	O
of	O
a	O
BDNF	O
loop	O
domain	O
and	O
a	O
TrkB	O
partial	O
agonist	O
can	O
acutely	O
reverse	O
abnormal	O
breathing	O
at	O
rest	O
and	O
in	O
response	O
to	O
behavioral	O
arousal	O
in	O
symptomatic	O
RTT	O
mice	B-SPEC
.	O

Most	O
of	O
the	O
tested	O
compounds	O
were	O
proved	O
to	O
be	O
effective	O
in	O
inhibiting	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
(	O
IIIB	B-SPEC
)	O
replication	O
with	O
EC50	O
ranging	O
from	O
0	O
.	O
15	O
μM	O
to	O
24	O
.	O
2	O
μM	O
,	O
thereinto	O
compound	O
15	O
was	O
the	O
most	O
active	O
lead	O
with	O
favorable	O
inhibitory	O
activity	O
against	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
(	O
IIIB	B-SPEC
)	O
(	O
EC50	O
=	O
0	O
.	O
15	O
μM	O
,	O
SI	O
=	O
684	O
).	O

For	O
this	O
faeces	O
and	O
/	O
or	O
ascites	O
samples	O
from	O
19	O
cats	B-SPEC
suffering	O
from	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
as	O
well	O
as	O
from	O
20	O
FECV	B-SPEC
-	O
infected	O
healthy	O
cats	B-SPEC
were	O
used	O
.	O

In	O
contrast	O
,	O
in	O
samples	O
obtained	O
from	O
faeces	O
of	O
healthy	O
cats	B-SPEC
,	O
the	O
ORF3c	O
was	O
never	O
affected	O
by	O
such	O
mutations	O
.	O

ABSTRACT	O
:	O
Canine	O
enteric	B-SPEC
coronavirus	I-SPEC
(	O
CCoV	O
)	O
is	O
an	O
alphacoronavirus	B-SPEC
infecting	O
dogs	B-SPEC
that	O
is	O
closely	O
related	O
to	O
enteric	O
coronaviruses	O
of	O
cats	B-SPEC
and	O
pigs	B-SPEC
.	O

Consequently	O
,	O
CCoV	O
is	O
now	O
considered	O
to	O
be	O
an	O
emerging	O
infectious	O
disease	O
of	O
dogs	B-SPEC
.	O

In	O
addition	O
to	O
the	O
two	O
known	O
serotypes	O
of	O
CCoV	O
,	O
novel	O
recombinant	O
variants	O
of	O
CCoV	O
have	O
been	O
found	O
containing	O
spike	O
protein	O
N	O
-	O
terminal	O
domains	O
(	O
NTDs	O
)	O
that	O
are	O
closely	O
related	O
to	O
those	O
of	O
feline	B-SPEC
and	O
porcine	B-SPEC
strains	O
.	O

Cell	O
cultures	O
of	O
Crandell	O
-	O
Rees	O
feline	B-SPEC
kidney	O
cells	O
.	O

In	O
vitro	O
replication	O
of	O
FCoV	O
was	O
specifically	O
inhibited	O
by	O
siRNAs	O
that	O
targeted	O
coding	O
and	O
noncoding	O
regions	O
of	O
the	O
viral	O
genome	O
,	O
suggesting	O
a	O
potential	O
therapeutic	O
application	O
of	O
RNA	O
interference	O
in	O
treatment	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

The	O
tested	O
siRNA	O
combinations	O
resulted	O
in	O
approximately	O
95	O
%	O
reduction	O
in	O
viral	O
replication	O
(	O
based	O
on	O
virus	B-SPEC
titration	O
results	O
),	O
compared	O
with	O
findings	O
in	O
negative	O
control	O
,	O
nontargeting	O
siRNA	O
-	O
treated	O
,	O
FCoV	O
-	O
infected	O
cells	O
.	O

ABSTRACT	O
:	O
Strategies	O
to	O
contain	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
depend	O
on	O
knowledge	O
of	O
the	O
rate	O
of	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
,	O
including	O
subclinical	O
infections	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
61	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
past	O
medical	O
history	O
of	O
chronic	O
respiratory	O
failure	O
with	O
emphysema	O
,	O
and	O
a	O
known	O
multiple	O
myeloma	O
(	O
Durie	O
and	O
Salmon	O
stage	O
III	O
B	O
and	O
t	O
(	O
4	O
;	O
14	O
)	O
translocation	O
).	O

TITLE	O
:	O
Recombinant	O
nucleocapsid	O
protein	O
based	O
single	O
serum	O
dilution	O
ELISA	O
for	O
the	O
detection	O
of	O
antibodies	O
to	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
poultry	O
.	O

These	O
studies	O
provide	O
a	O
new	O
insight	O
from	O
the	O
perspective	O
of	O
the	O
epithelial	O
barrier	O
and	O
microfilaments	O
into	O
the	O
pathogenesis	O
of	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
.	O

RSV	B-SPEC
was	O
a	O
most	O
common	O
viral	O
etiology	O
in	O
the	O
hospitalized	O
young	O
children	O
less	O
than	O
5	O
years	O
of	O
age	O
with	O
pneumonia	O
.	O

We	O
characterised	O
MERS	O
-	O
CoV	O
viruses	B-SPEC
from	O
dromedaries	B-SPEC
in	O
Saudi	O
Arabia	O
and	O
Egypt	O
and	O
compared	O
them	O
with	O
a	O
human	B-SPEC
MERS	O
-	O
CoV	O
reference	O
strain	O
.	O

We	O
assessed	O
viral	O
replication	O
kinetics	O
and	O
competence	O
in	O
Vero	O
-	O
E6	O
cells	O
(	O
rhesus	B-SPEC
monkey	I-SPEC
),	O
tissue	O
tropism	O
in	O
cultures	O
of	O
ex	O
-	O
vivo	O
human	B-SPEC
bronchial	O
and	O
lung	O
tissues	O
,	O
and	O
cytokine	O
and	O
chemokine	O
induction	O
,	O
gene	O
expression	O
,	O
and	O
quantification	O
of	O
viral	O
RNA	O
in	O
Calu	O
-	O
3	O
cells	O
(	O
human	B-SPEC
respiratory	O
tract	O
).	O

CONCLUSIONS	O
:	O
Respiratory	O
virus	B-SPEC
was	O
not	O
a	O
bystander	O
,	O
but	O
pathogenic	O
in	O
pneumonia	O
and	O
was	O
a	O
common	O
cause	O
of	O
CAP	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
transmission	O
and	O
phylogenetic	O
evolution	O
.	O

Humans	B-SPEC
can	O
become	O
infected	O
within	O
their	O
communities	O
and	O
transmission	O
can	O
then	O
be	O
amplified	O
in	O
the	O
healthcare	O
setting	O
.	O

Sepsis	B-SPEC
-	O
associated	O
cardiac	O
dysfunction	O
occurred	O
in	O
44	O
patients	O
(	O
36	O
.	O
1	O
%).	O

Cardiac	O
dysfunction	O
in	O
mechanically	O
ventilated	O
patients	O
with	O
sepsis	B-SPEC
did	O
not	O
impact	O
ARDS	O
incidence	O
,	O
clinical	O
outcome	O
in	O
ARDS	O
patients	O
,	O
or	O
mortality	O
.	O

In	O
addition	O
,	O
the	O
3	O
'-	O
terminal	O
recombination	O
sites	O
of	O
M91	O
-	O
267	O
,	O
KUK	O
-	O
H	O
/	O
L	O
and	O
Tokyo	O
/	O
cat	B-SPEC
/	O
130627	O
were	O
different	O
from	O
one	O
another	O
within	O
the	O
genes	O
encoding	O
membrane	O
and	O
spike	O
proteins	O
,	O
and	O
the	O
5	O
'-	O
terminal	O
recombination	O
sites	O
were	O
also	O
located	O
at	O
different	O
regions	O
of	O
ORF1	O
.	O

Transfer	O
of	O
memory	O
CD8	O
T	O
cells	O
to	O
reduce	O
viral	O
load	O
in	O
CD4	O
-	O
depleted	O
mice	B-SPEC
reverted	O
the	O
recipient	O
CNS	O
CD8	O
T	O
-	O
cell	O
phenotype	O
to	O
that	O
in	O
wild	O
-	O
type	O
control	O
mice	B-SPEC
.	O

Conducted	O
research	O
showed	O
that	O
heparan	O
sulfate	O
proteoglycans	O
function	O
as	O
adhesion	O
molecules	O
,	O
increasing	O
the	O
virus	B-SPEC
density	O
on	O
cell	O
surface	O
and	O
possibly	O
facilitating	O
the	O
interaction	O
between	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
its	O
receptor	O
.	O

This	O
case	O
demonstrates	O
that	O
early	O
induction	O
of	O
ECMO	O
support	O
can	O
be	O
a	O
reasonable	O
therapeutic	O
option	O
for	O
PVL	O
-	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
-	O
associated	O
pneumonia	O
.	O

It	O
,	O
however	O
,	O
fails	O
to	O
eradicate	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
infection	O
thoroughly	O
.	O

BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
with	O
both	O
candidate	O
vaccines	O
intramuscularly	O
and	O
boosted	O
three	O
weeks	O
later	O
intranasally	O
.	O

EID	O
such	O
as	O
MERS	O
-	O
CoV	O
and	O
H7N9	O
are	O
highly	O
pathogenic	O
for	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
previously	O
attenuated	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strain	O
CK	O
/	O
CH	O
/	O
LDL	O
/	O
97I	O
and	O
found	O
that	O
it	O
can	O
convey	O
protection	O
against	O
the	O
homologous	O
pathogenic	O
virus	B-SPEC
.	O

CDV	B-SPEC
RT	O
-	O
iiPCR	O
demonstrated	O
excellent	O
sensitivity	O
(	O
100	O
%)	O
and	O
specificity	O
(	O
100	O
%),	O
compared	O
to	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

Wild	O
type	O
mice	B-SPEC
were	O
treated	O
with	O
or	O
without	O
antagonists	O
of	O
C5aR	O
or	O
TNF	O
-	O
α	O
,	O
and	O
mice	B-SPEC
deficient	O
for	O
C5aR	O
(	O
C5aR	O
(-/-)),	O
Fgl2	O
(	O
Fgl2	O
(-/-)),	O
and	O
Tnfα	O
(	O
Tnfα	O
(-/-))	O
mice	B-SPEC
were	O
not	O
treated	O
with	O
the	O
antagonists	O
.	O

The	O
results	O
also	O
indicate	O
that	O
the	O
indole	O
-	O
based	O
α	O
-	O
amino	O
acids	O
as	O
efficient	O
NNRTIs	O
displayed	O
comparable	O
anti	O
-	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
activities	O
to	O
the	O
reference	O
drug	O
NVP	O
.	O

Agents	O
given	O
the	O
highest	O
priority	O
due	O
to	O
a	O
known	O
transfusion	O
-	O
transmission	O
threat	O
and	O
severe	O
/	O
fatal	O
disease	O
in	O
recipients	O
were	O
the	O
vCJD	O
prion	O
,	O
dengue	B-SPEC
viruses	I-SPEC
and	O
the	O
obligate	O
red	O
-	O
cell	O
parasite	O
that	O
causes	O
babesiosis	O
(	O
Since	O
the	O
publication	O
of	O
the	O
Supplement	O
,	O
six	O
new	O
FSs	O
(	O
yellow	B-SPEC
fever	I-SPEC
viruses	I-SPEC
-	O
including	O
vaccine	O
breakthrough	O
infections	O
,	O
miscellaneous	O
arboviruses	O
,	O
XMRV	O
,	O
human	B-SPEC
parvoviruses	B-SPEC
/	O
bocaviruses	B-SPEC
other	O
than	O
B19	O
,	O
and	O
most	O
recently	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
MERS	O
-	O
CoV	O
)	O
were	O
added	O
and	O
14	O
existing	O
FSs	O
updated	O
(	O
Anaplasma	B-SPEC
,	O
Babesia	B-SPEC
,	O
Bartonella	B-SPEC
,	O
Erhlichia	O
,	O
chronic	O
wasting	O
disease	O
-	O
CWD	O
,	O
human	B-SPEC
prions	O
other	O
than	O
vCJD	O
,	O
vCJD	O
,	O
The	O
process	O
and	O
final	O
product	O
(	O
toolkit	O
)	O
including	O
methods	O
to	O
monitor	O
EID	O
agent	O
emergence	O
,	O
identification	O
/	O
recognition	O
of	O
a	O
transfusion	O
-	O
transmission	O
threat	O
,	O
methods	O
for	O
quantitative	O
risk	O
assessments	O
,	O
and	O
the	O
appropriate	O
management	O
of	O
such	O
threats	O
should	O
be	O
considered	O
for	O
implementation	O
by	O
all	O
blood	O
systems	O
.	O

TITLE	O
:	O
Bat	B-SPEC
origins	O
of	O
MERS	O
-	O
CoV	O
supported	O
by	O
bat	B-SPEC
coronavirus	I-SPEC
HKU4	I-SPEC
usage	O
of	O
human	B-SPEC
receptor	O
CD26	O
.	O

Taken	O
together	O
,	O
our	O
results	O
demonstrate	O
the	O
feasibility	O
of	O
highly	O
expressing	O
SARS	O
subunit	O
vaccine	O
RBD	O
,	O
indicating	O
its	O
potential	O
in	O
subsequent	O
development	O
of	O
a	O
plant	B-SPEC
-	O
derived	O
recombinant	O
subunit	O
vaccine	O
and	O
reagents	O
production	O
for	O
antibody	O
detection	O
in	O
SARS	O
serological	O
tests	O
.	O

TITLE	O
:	O
Cell	O
culture	O
isolation	O
and	O
sequence	O
analysis	O
of	O
genetically	O
diverse	O
US	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strains	O
including	O
a	O
novel	O
strain	O
with	O
a	O
large	O
deletion	O
in	O
the	O
spike	O
gene	O
.	O

Currently	O
there	O
are	O
no	O
efficacious	O
preventive	O
measures	O
or	O
therapeutic	O
tools	O
to	O
control	O
PEDV	B-SPEC
in	O
the	O
US	O
.	O

Consequently	O
,	O
we	O
have	O
hypothesized	O
that	O
germline	O
antibodies	O
may	O
not	O
bind	O
to	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
envelope	O
glycoprotein	O
(	O
Env	O
)	O
because	O
they	O
are	O
so	O
different	O
compared	O
to	O
the	O
highly	O
somatically	O
mutated	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
-	O
specific	O
bnAbs	O
.	O

The	O
new	O
assays	O
were	O
used	O
on	O
samples	O
of	O
lung	O
and	O
trachea	B-SPEC
as	O
well	O
as	O
virus	B-SPEC
from	O
allantoic	O
fluid	O
and	O
cell	O
culture	O
.	O

ABSTRACT	O
:	O
The	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
a	O
major	O
target	O
of	O
protective	O
immunity	O
in	O
vivo	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
a	O
large	O
panel	O
of	O
human	B-SPEC
nAbs	O
against	O
an	O
epitope	O
that	O
overlaps	O
the	O
interface	O
between	O
the	O
RBD	O
and	O
its	O
receptor	O
,	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
),	O
to	O
assess	O
their	O
cross	O
-	O
neutralization	O
activities	O
against	O
a	O
panel	O
of	O
human	B-SPEC
and	O
zoonotic	O
SARS	O
-	O
CoVs	O
and	O
neutralization	O
escape	O
mutants	O
.	O

Broadly	O
neutralizing	O
antibodies	O
(	O
nAbs	O
)	O
that	O
prevent	O
infection	O
of	O
related	O
viruses	B-SPEC
represent	O
an	O
important	O
immunostrategy	O
for	O
combating	O
coronavirus	B-SPEC
infections	O
;	O
however	O
,	O
for	O
this	O
strategy	O
to	O
succeed	O
,	O
it	O
is	O
essential	O
to	O
uncover	O
nAb	O
-	O
mediated	O
escape	O
pathways	O
and	O
to	O
pioneer	O
strategies	O
that	O
prevent	O
escape	O
.	O

Here	O
,	O
we	O
used	O
SARS	O
-	O
CoV	O
as	O
a	O
research	O
model	O
and	O
examined	O
the	O
escape	O
pathways	O
of	O
broad	O
nAbs	O
that	O
target	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
virus	B-SPEC
.	O

Plasmodium	B-SPEC
falciparum	I-SPEC
infection	O
,	O
more	O
than	O
three	O
days	O
of	O
history	O
of	O
fever	O
,	O
haemoglobinuria	O
,	O
renal	O
failure	O
,	O
shock	O
,	O
leucocytosis	O
,	O
severe	O
thrombocytopaenia	O
and	O
every	O
10	O
mmHg	O
fall	O
in	O
systolic	O
blood	O
pressure	O
were	O
the	O
independent	O
predictors	O
of	O
more	O
than	O
seven	O
days	O
of	O
hospitalization	O
.	O

PE	O
/	O
ARDS	O
alone	O
in	O
Plasmodium	B-SPEC
vivax	I-SPEC
may	O
result	O
in	O
mortality	O
,	O
whereas	O
multiorgan	O
involvement	O
is	O
common	O
in	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
related	O
mortalities	O
.	O

Salmonella	B-SPEC
spp	O
.	O
were	O
found	O
in	O
three	O
and	O
four	O
samples	O
,	O
from	O
calves	O
that	O
were	O
1	O
-	O
5	O
and	O
9	O
-	O
21	O
days	O
-	O
old	O
,	O
respectively	O
.	O

At	O
the	O
calf	O
level	O
,	O
the	O
odds	O
of	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
shedding	O
and	O
of	O
co	O
-	O
infection	O
with	O
any	O
combination	O
of	O
pathogens	O
were	O
greater	O
in	O
calves	O
that	O
were	O
9	O
-	O
21	O
than	O
1	O
-	O
5	O
days	O
-	O
old	O
.	O

TITLE	O
:	O
Searching	O
for	O
an	O
ideal	O
vaccine	O
candidate	O
among	O
different	O
MERS	O
coronavirus	B-SPEC
receptor	O
-	O
binding	O
fragments	O
--	O
the	O
importance	O
of	O
immunofocusing	O
in	O
subunit	O
vaccine	O
design	O
.	O

This	O
virus	B-SPEC
can	O
cause	O
severe	O
respiratory	O
infections	O
,	O
particularly	O
in	O
patients	O
with	O
underlying	O
conditions	O
.	O

NO	O
has	O
direct	O
antiviral	O
properties	O
against	O
some	O
viruses	B-SPEC
,	O
whereas	O
during	O
other	O
virus	B-SPEC
infections	O
NO	O
can	O
mediate	O
immunopathology	O
and	O
/	O
or	O
inhibit	O
the	O
antiviral	O
immune	O
response	O
to	O
promote	O
chronic	O
infection	O
.	O

TITLE	O
:	O
Incidence	O
rate	O
of	O
community	O
-	O
acquired	O
sepsis	B-SPEC
among	O
hospitalized	O
acute	O
medical	O
patients	O
-	O
a	O
population	O
-	O
based	O
survey	O
.	O

Incidence	O
rate	O
of	O
sepsis	B-SPEC
of	O
any	O
severity	O
.	O

TITLE	O
:	O
A	O
review	O
of	O
genetic	O
methods	O
and	O
models	O
for	O
analysis	O
of	O
coronavirus	B-SPEC
-	O
induced	O
severe	O
pneumonitis	O
.	O

TITLE	O
:	O
Detection	O
of	O
Influenza	O
and	O
Other	O
Respiratory	O
Viruses	B-SPEC
Carried	O
Out	O
in	O
the	O
Influenza	O
Project	O
-	O
Monitoring	O
Vaccine	O
Effectiveness	O
(	O
I	O
-	O
MOVE	O
).	O

Laboratory	O
studies	O
using	O
molecular	O
RT	O
-	O
PCR	O
biology	O
methods	O
for	O
detection	O
of	O
genetic	O
material	O
of	O
influenza	B-SPEC
virus	I-SPEC
and	O
other	O
respiratory	O
viruses	B-SPEC
were	O
performed	O
by	O
Voivodeship	O
Sanitary	O
-	O
Epidemiological	O
Stations	O
in	O
Poland	O
.	O

The	O
results	O
show	O
that	O
although	O
influenza	B-SPEC
viruses	I-SPEC
predominated	O
in	O
the	O
2010	O
/	O
2011	O
season	O
in	O
Poland	O
,	O
other	O
flu	O
-	O
like	O
viruses	B-SPEC
also	O
abounded	O
.	O

TITLE	O
:	O
An	O
evaluation	O
of	O
a	O
liquid	O
antimicrobial	O
(	O
Sal	O
CURB	O
®)	O
for	O
reducing	O
the	O
risk	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infection	O
of	O
naïve	O
pigs	B-SPEC
during	O
consumption	O
of	O
contaminated	O
feed	O
.	O

Recently	O
,	O
contaminated	O
feed	O
was	O
confirmed	O
as	O
a	O
vehicle	O
for	O
PEDV	B-SPEC
infection	O
of	O
naïve	O
piglets	O
.	O

Sal	O
CURB	O
®	O
(	O
Kemin	O
Industries	O
,	O
Des	O
Moines	O
,	O
IA	O
,	O
USA	O
)	O
is	O
a	O
FDA	O
-	O
approved	O
liquid	O
antimicrobial	O
used	O
to	O
control	O
Salmonella	B-SPEC
contamination	O
in	O
poultry	O
and	O
swine	B-SPEC
diets	O
.	O

These	O
data	O
provide	O
proof	O
of	O
concept	O
that	O
feed	O
treated	O
with	O
Sal	O
CURB	O
®	O
can	O
serve	O
as	O
a	O
means	O
to	O
reduce	O
the	O
risk	O
of	O
PEDV	B-SPEC
infection	O
through	O
contaminated	O
feed	O
.	O

Moreover	O
,	O
by	O
engineering	O
cell	O
lines	O
conditionally	O
expressing	O
various	O
TRIM56	O
mutants	O
,	O
we	O
demonstrated	O
that	O
TRIM56	O
'	O
s	O
antiflavivirus	O
effects	O
required	O
both	O
the	O
E3	O
ligase	O
activity	O
that	O
lies	O
in	O
the	O
N	O
-	O
terminal	O
RING	O
domain	O
and	O
the	O
integrity	O
of	O
its	O
C	O
-	O
terminal	O
portion	O
,	O
while	O
the	O
restriction	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
relied	O
upon	O
the	O
TRIM56	O
E3	O
ligase	O
activity	O
alone	O
.	O

IFITM3	O
is	O
essential	O
for	O
control	O
of	O
influenza	B-SPEC
virus	I-SPEC
infection	O
in	O
mice	B-SPEC
and	O
humans	B-SPEC
.	O

In	O
this	O
study	O
,	O
the	O
effects	O
of	O
mechanical	O
stretch	O
on	O
the	O
intracellular	O
Ca	O
(	O
2	O
+)	O
concentration	O
([	O
Ca	O
(	O
2	O
+)]	O
i	O
)	O
and	O
ATP	O
release	O
were	O
investigated	O
in	O
primary	O
human	B-SPEC
lung	O
fibroblasts	O
.	O

TITLE	O
:	O
Computer	O
aided	O
prediction	O
and	O
identification	O
of	O
potential	O
epitopes	O
in	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
spike	O
(	O
S	O
)	O
glycoprotein	O
of	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
belongs	O
to	O
the	O
coronaviridae	B-SPEC
family	B-SPEC
.	O

A	O
9	O
-	O
mer	O
epitope	O
CYSSLILDY	O
displayed	O
interactions	O
with	O
the	O
maximum	O
number	O
of	O
MHC	O
class	B-SPEC
-	O
I	O
molecules	O
and	O
projected	O
the	O
highest	O
peak	O
in	O
the	O
B	O
-	O
cell	O
antigenicity	O
plot	O
which	O
concludes	O
that	O
it	O
could	O
be	O
a	O
better	O
choice	O
for	O
designing	O
an	O
epitope	O
based	O
peptide	O
vaccine	O
against	O
MERSCoV	O
considering	O
that	O
it	O
must	O
undergo	O
further	O
in	O
vitro	O
and	O
in	O
vivo	O
experiments	O
.	O

Multidimensional	O
scaling	O
(	O
MDS	O
)	O
segregated	O
the	O
107	O
cats	B-SPEC
into	O
three	O
distinct	O
families	O
based	O
primarily	O
on	O
a	O
common	O
sire	O
(	O
s	O
),	O
and	O
resistant	O
and	O
susceptible	O
cats	B-SPEC
were	O
equally	O
distributed	O
within	O
each	O
family	B-SPEC
.	O

Genome	O
-	O
wide	O
association	O
studies	O
(	O
GWAS	O
)	O
on	O
73	O
cats	B-SPEC
that	O
died	O
of	O
FIP	O
after	O
one	O
or	O
more	O
exposures	O
(	O
cases	O
)	O
and	O
34	O
cats	B-SPEC
that	O
survived	O
(	O
controls	O
)	O
demonstrated	O
four	O
significant	O
associations	O
after	O
100k	O
permutations	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
evolutionary	O
process	O
by	O
which	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
in	O
the	O
United	O
States	O
hypothetically	O
descended	O
from	O
strains	O
in	O
China	O
,	O
we	O
analyzed	O
PEDV	B-SPEC
-	O
positive	O
samples	O
collected	O
in	O
China	O
during	O
January	O
2012	O
-	O
July	O
2013	O
.	O

Multiple	O
genetic	O
mechanisms	O
,	O
including	O
recombinations	O
,	O
mutations	O
,	O
insertions	O
and	O
deletions	O
,	O
are	O
likely	O
to	O
have	O
contributed	O
to	O
the	O
emergence	O
of	O
this	O
IBV	B-SPEC
strain	O
.	O

Samples	O
of	O
heart	O
,	O
liver	O
,	O
spleen	O
,	O
lung	O
,	O
trachea	B-SPEC
,	O
kidney	O
and	O
duodenum	O
were	O
collected	O
and	O
the	O
N	O
gene	O
was	O
detected	O
by	O
Sybr	O
Green	O
I	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
assays	O
.	O

The	O
results	O
of	O
this	O
study	O
,	O
showed	O
that	O
the	O
Jin	O
-	O
13	O
strain	O
can	O
cause	O
prolonged	O
virus	B-SPEC
excertion	O
in	O
chickens	B-SPEC
with	O
severe	O
renal	O
damage	O
.	O

TITLE	O
:	O
Spred	O
-	O
2	O
deficiency	O
exacerbates	O
lipopolysaccharide	O
-	O
induced	O
acute	O
lung	O
inflammation	O
in	O
mice	B-SPEC
.	O

In	O
multivariable	O
analysis	O
,	O
high	O
T	O
-	O
reg	O
%	O
(	O
HR	O
0	O
.	O
41	O
,	O
95	O
%	O
CI	O
0	O
.	O
20	O
-	O
0	O
.	O
81	O
)	O
and	O
high	O
CMV	B-SPEC
-	O
reactive	O
CD4	O
+	O
T	O
-	O
cell	O
%	O
(	O
HR	O
1	O
.	O
69	O
,	O
95	O
%	O
CI	O
1	O
.	O
03	O
-	O
2	O
.	O
78	O
)	O
were	O
predictive	O
of	O
respiratory	O
viral	O
infection	O
.	O

Collectively	O
,	O
our	O
data	O
indicate	O
that	O
the	O
bat	B-SPEC
-	O
influenza	B-SPEC
viruses	I-SPEC
recently	O
identified	O
are	O
authentic	O
viruses	B-SPEC
that	O
pose	O
little	O
,	O
if	O
any	O
,	O
pandemic	O
threat	O
to	O
humans	B-SPEC
;	O
however	O
,	O
they	O
provide	O
new	O
insights	O
into	O
the	O
evolution	O
and	O
basic	O
biology	O
of	O
influenza	B-SPEC
viruses	I-SPEC
.	O

Diarrhea	O
was	O
observed	O
in	O
challenged	O
pigs	B-SPEC
beginning	O
for	O
some	O
on	O
dpi	O
2	O
,	O
affecting	O
a	O
majority	O
of	O
pigs	B-SPEC
by	O
dpi	O
6	O
and	O
subsiding	O
by	O
dpi	O
10	O
.	O

Average	O
daily	O
gain	O
was	O
significantly	O
lower	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
for	O
one	O
week	O
post	O
-	O
infection	O
in	O
challenged	O
pigs	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
considered	O
an	O
emergent	O
pathogen	O
associated	O
with	O
high	O
economic	O
losses	O
in	O
many	O
pig	B-SPEC
rearing	O
areas	O
.	O

ABSTRACT	O
:	O
Serological	O
,	O
molecular	O
and	O
phylogenetic	O
analyses	O
of	O
a	O
recently	O
imported	O
case	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
Greece	O
are	O
reported	O
.	O

TITLE	O
:	O
Pathogenesis	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Nucleocapsid	O
phosphorylation	O
and	O
RNA	O
helicase	O
DDX1	O
recruitment	O
enables	O
coronavirus	B-SPEC
transition	O
from	O
discontinuous	O
to	O
continuous	O
transcription	O
.	O

Therefore	O
,	O
polysaccharide	O
possessing	O
effective	O
inhibitory	O
effect	O
on	O
viral	O
attachment	O
and	O
entry	O
steps	O
of	O
PEDV	B-SPEC
life	O
cycle	O
is	O
a	O
good	O
candidate	O
for	O
development	O
of	O
antivirals	O
.	O

Anemia	B-SPEC
was	O
observed	O
in	O
78	O
%	O
of	O
the	O
sample	O
.	O

ABSTRACT	O
:	O
To	O
report	O
the	O
experience	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
at	O
a	O
single	O
center	O
in	O
Saudi	O
Arabia	O
.	O

Seropositivity	O
for	O
Leishmania	B-SPEC
spp	O
was	O
not	O
associated	O
with	O
signalment	O
,	O
living	O
conditions	O
,	O
season	O
of	O
sampling	O
and	O
health	O
status	O
of	O
the	O
cats	B-SPEC
or	O
with	O
seropositivity	O
to	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
coronavirus	B-SPEC
,	O
Toxoplasma	B-SPEC
gondii	I-SPEC
and	O
Bartonella	B-SPEC
henselae	I-SPEC
.	O

The	O
study	O
suggests	O
significant	O
RNA	O
structure	O
conservation	O
among	O
members	O
of	O
the	O
genus	B-SPEC
Alphacoronavirus	B-SPEC
but	O
also	O
across	O
genus	B-SPEC
boundaries	O
.	O

Overall	O
,	O
the	O
conservation	O
pattern	O
identified	O
for	O
5	O
'	O
and	O
3	O
'-	O
terminal	O
RNA	O
structural	O
elements	O
in	O
the	O
genomes	O
of	O
alpha	O
-	O
and	O
betacoronaviruses	O
is	O
in	O
agreement	O
with	O
the	O
widely	O
used	O
replicase	O
polyprotein	O
-	O
based	O
classification	O
of	O
the	O
Coronavirinae	B-SPEC
,	O
suggesting	O
co	O
-	O
evolution	O
of	O
the	O
coronavirus	B-SPEC
replication	O
machinery	O
with	O
cognate	O
cis	B-SPEC
-	O
acting	O
RNA	O
elements	O
.	O

TITLE	O
:	O
[	O
Hantavirus	B-SPEC
pulmonary	O
syndrome	O
with	O
multiple	O
organ	O
dysfunctions	O
:	O
case	O
report	O
].	O

ABSTRACT	O
:	O
Hantavirus	B-SPEC
infection	O
is	O
a	O
zoonose	O
with	O
worldwide	O
distribution	O
.	O

During	O
sepsis	B-SPEC
,	O
hemodynamic	O
instability	O
and	O
perpetuation	O
of	O
inflammatory	O
state	O
may	O
result	O
from	O
adrenal	O
insufficiency	O
(	O
AI	O
).	O

TITLE	O
:	O
Alterations	O
in	O
nerve	O
-	O
evoked	O
bladder	O
contractions	O
in	O
a	O
coronavirus	B-SPEC
-	O
induced	O
mouse	B-SPEC
model	O
of	O
multiple	O
sclerosis	O
.	O

ABSTRACT	O
:	O
Severe	O
sepsis	B-SPEC
represents	O
the	O
systemic	O
inflammatory	O
response	O
resulting	O
from	O
an	O
infection	O
,	O
associated	O
with	O
one	O
of	O
the	O
following	O
:	O
cardiovascular	O
organ	O
dysfunction	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
or	O
two	O
or	O
more	O
organ	O
dysfunctions	O
.	O

ABSTRACT	O
:	O
Varicella	O
is	O
an	O
exantematic	O
disease	O
caused	O
by	O
varicella	B-SPEC
-	I-SPEC
zoster	I-SPEC
virus	I-SPEC
.	O

We	O
report	O
two	O
cases	O
of	O
ARDS	O
secondary	O
to	O
varicella	B-SPEC
-	I-SPEC
zoster	I-SPEC
virus	I-SPEC
pneumonia	O
.	O

TITLE	O
:	O
[	O
Strongyloides	B-SPEC
Stercoralis	I-SPEC
hyperinfection	O
syndrome	O
:	O
case	O
report	O
].	O

Rotavirus	B-SPEC
was	O
detected	O
in	O
49	O
(	O
5	O
.	O
76	O
%)	O
fecal	O
samples	O
collected	O
from	O
33	O
calves	O
(	O
49	O
.	O
2	O
%).	O

Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
was	O
detected	O
in	O
93	O
fecal	O
samples	O
collected	O
from	O
46	O
calves	O
(	O
68	O
.	O
6	O
%).	O

Our	O
data	O
may	O
facilitate	O
the	O
future	O
studies	O
of	O
potential	O
avian	B-SPEC
H9N2	O
disease	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
are	O
the	O
major	O
contributors	O
to	O
the	O
morbidity	O
and	O
mortality	O
of	O
upper	O
and	O
lower	O
acute	O
respiratory	O
infections	O
(	O
ARIs	O
)	O
for	O
all	O
age	O
groups	O
.	O

Severe	O
hyperammonemia	O
(	O
677	O
μmol	O
/	O
L	O
,	O
reference	O
range	O
≤	O
60	O
μmol	O
/	O
L	O
)	O
was	O
identified	O
in	O
one	O
animal	B-SPEC
with	O
signs	O
of	O
encephalopathic	O
disease	O
that	O
subsequently	O
died	O
.	O

These	O
data	O
indicate	O
that	O
the	O
Region	O
has	O
developed	O
significant	O
capability	O
to	O
detect	O
this	O
emerging	O
virus	B-SPEC
in	O
accordance	O
with	O
WHO	O
and	O
ECDC	O
guidance	O
.	O

TITLE	O
:	O
An	O
observational	O
,	O
laboratory	O
-	O
based	O
study	O
of	O
outbreaks	O
of	O
middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
Jeddah	O
and	O
Riyadh	O
,	O
kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
,	O
2014	O
.	O

Viruses	B-SPEC
from	O
Riyadh	O
and	O
Jeddah	O
were	O
isolated	O
and	O
studied	O
in	O
cell	O
culture	O
.	O

All	O
travellers	O
,	O
including	O
the	O
two	O
cases	O
,	O
completed	O
a	O
questionnaire	O
focussing	O
on	O
potential	O
human	B-SPEC
,	O
animal	B-SPEC
and	O
food	O
exposures	O
to	O
MERS	O
-	O
CoV	O
.	O

In	O
parallel	O
,	O
DNA	O
aptamers	O
that	O
form	O
G4s	O
have	O
been	O
described	O
as	O
inhibitors	O
and	O
diagnostic	O
tools	O
to	O
detect	O
viruses	B-SPEC
[	O
e	O
.	O
g	O
.,	O
hepatitis	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
HAV	O
),	O
EBV	O
,	O
cauliflower	B-SPEC
mosaic	I-SPEC
virus	I-SPEC
(	O
CaMV	B-SPEC
),	O
severe	O
acute	O
respiratory	O
syndrome	O
virus	B-SPEC
(	O
SARS	O
),	O
simian	B-SPEC
virus	I-SPEC
40	I-SPEC
(	O
SV40	B-SPEC
)].	O

Furthermore	O
,	O
in	O
the	O
liver	O
of	O
infected	O
chickens	B-SPEC
,	O
the	O
MBL	O
expression	O
was	O
upregulated	O
at	O
day	O
7	O
p	O
.	O
i	O
.,	O
despite	O
the	O
fact	O
that	O
the	O
MBL	O
serum	O
concentrations	O
were	O
decreased	O
below	O
baseline	O
at	O
that	O
time	O
point	O
.	O

No	O
increase	O
was	O
observed	O
in	O
the	O
number	O
of	O
TCRγδ	O
+	O
CD8α	O
+	O
cells	O
in	O
the	O
blood	O
of	O
the	O
infected	O
L10H	O
and	O
L10L	O
chickens	B-SPEC
.	O

Thus	O
,	O
these	O
results	O
indicate	O
that	O
MBL	O
is	O
produced	O
locally	O
and	O
may	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
cellular	O
immune	O
response	O
after	O
an	O
IBV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
Liberia	O
,	O
Sierra	O
Leone	O
,	O
and	O
Guinea	B-SPEC
lack	O
the	O
public	O
health	O
infrastructure	O
,	O
economic	O
stability	O
,	O
and	O
overall	O
governance	O
to	O
stem	O
the	O
spread	O
of	O
Ebola	O
.	O

However	O
,	O
HIV	B-SPEC
has	O
a	O
comorbidity	O
impact	O
on	O
the	O
diabetes	O
.	O

It	O
is	O
notable	O
that	O
HIV	B-SPEC
and	O
SARS	O
similarly	O
dysregulated	O
11	O
genes	O
and	O
3	O
pathways	O
.	O

In	O
Patagonia	O
the	O
disease	O
is	O
caused	O
by	O
the	O
Andes	B-SPEC
Virus	I-SPEC
(	O
AND	O
)	O
and	O
transmitted	O
by	O
the	O
rodent	B-SPEC
Oligoryzomys	B-SPEC
longicaudatus	I-SPEC
.	O

Because	O
most	O
of	O
the	O
viral	O
envelope	O
glycoproteins	O
contain	O
N	O
-	O
linked	O
glycans	O
,	O
inhibition	O
of	O
ER	O
glucosidases	O
with	O
derivatives	O
of	O
1	O
-	O
deoxynojirimycin	O
,	O
i	O
.	O
e	O
.,	O
iminosugars	O
,	O
efficiently	O
disrupts	O
the	O
morphogenesis	O
of	O
a	O
broad	O
spectrum	O
of	O
enveloped	O
viruses	B-SPEC
.	O

Our	O
analysis	O
is	O
based	O
on	O
a	O
branching	O
process	O
model	O
that	O
permits	B-SPEC
statistical	O
comparison	O
of	O
both	O
the	O
strength	O
and	O
heterogeneity	O
of	O
transmission	O
for	O
two	O
distinct	O
types	O
of	O
cases	O
.	O

Lastly	O
,	O
we	O
evaluate	O
surveillance	O
requirements	O
for	O
detecting	O
a	O
change	O
in	O
the	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
of	O
monkeypox	O
since	O
the	O
cessation	O
of	O
cross	O
-	O
protective	O
smallpox	B-SPEC
vaccination	O
.	O

Immunoblotting	O
and	O
real	O
-	O
time	O
quantitative	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
demonstrated	O
that	O
TGEV	B-SPEC
infection	O
induces	O
STAT1	O
phosphorylation	O
and	O
nuclear	O
translocation	O
,	O
as	O
well	O
as	O
ISG	O
expression	O
.	O

Lung	O
tissues	O
were	O
negative	O
for	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
,	O
canine	O
respiratory	O
coronavirus	B-SPEC
,	O
and	O
canine	B-SPEC
adenovirus	I-SPEC
2	O
.	O

ABSTRACT	O
:	O
Neurotropic	O
recombinant	O
strain	O
of	O
Mouse	B-SPEC
Hepatitis	O
Virus	B-SPEC
,	O
RSA59	O
,	O
induces	O
meningo	O
-	O
encephalitis	O
,	O
myelitis	O
and	O
demyelination	O
following	O
intracranial	O
inoculation	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
virus	B-SPEC
that	O
manifests	O
itself	O
in	O
viral	O
infection	O
with	O
fever	O
,	O
cough	O
,	O
shortness	O
of	O
breath	O
,	O
renal	O
failure	O
and	O
severe	O
acute	O
pneumonia	O
,	O
which	O
often	O
result	O
in	O
a	O
fatal	O
outcome	O
.	O

Taken	O
together	O
,	O
the	O
present	O
study	O
closes	O
a	O
gap	O
in	O
the	O
understanding	O
of	O
host	O
-	O
IBV	B-SPEC
interaction	O
and	O
paves	O
the	O
way	O
for	O
further	O
characterization	O
of	O
the	O
mechanisms	O
underlying	O
immune	O
evasion	O
strategies	O
as	O
well	O
as	O
the	O
pathogenesis	O
of	O
gammacoronaviruses	O
.	O

TITLE	O
:	O
Identification	O
of	O
avian	B-SPEC
coronavirus	I-SPEC
in	O
wild	O
aquatic	O
birds	B-SPEC
of	O
the	O
central	O
and	O
eastern	O
USA	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
enveloped	O
RNA	O
viruses	B-SPEC
that	O
have	O
evolved	O
complex	O
relationships	O
with	O
their	O
host	O
cells	O
,	O
and	O
modulate	O
their	O
lipid	O
composition	O
,	O
lipid	O
synthesis	O
and	O
signalling	O
.	O

The	O
recent	O
emergence	O
of	O
virulent	O
enteric	O
coronaviruses	O
[	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)]	O
in	O
North	O
America	O
and	O
Asia	O
,	O
for	O
which	O
no	O
vaccines	O
are	O
available	O
,	O
remains	O
a	O
challenge	O
for	O
the	O
global	O
swine	B-SPEC
industry	O
.	O

The	O
current	O
findings	O
demonstrate	O
that	O
ACE2	O
plays	O
a	O
critical	O
role	O
in	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
-	O
induced	O
acute	O
lung	O
injury	O
,	O
and	O
suggest	O
that	O
might	O
be	O
a	O
useful	O
potential	O
therapeutic	O
target	O
for	O
future	O
influenza	O
A	O
(	O
H7N9	O
)	O
outbreaks	O
.	O

Thus	O
,	O
we	O
aimed	O
to	O
define	O
the	O
healthy	O
microbiota	B-SPEC
and	O
the	O
viral	O
pathogen	O
-	O
affected	O
microbiota	B-SPEC
in	O
the	O
upper	O
respiratory	O
tract	O
.	O

Interventions	O
to	O
decrease	O
the	O
probability	O
of	O
virus	B-SPEC
spillover	O
can	O
be	O
implemented	O
at	O
multiple	O
levels	O
from	O
targeting	O
the	O
reservoir	O
host	O
to	O
managing	O
recipient	O
host	O
exposure	O
and	O
susceptibility	O
.	O

Dromedary	B-SPEC
camels	B-SPEC
are	O
currently	O
the	O
most	O
likely	O
animal	B-SPEC
to	O
be	O
linked	O
to	O
human	B-SPEC
MERS	O
-	O
CoV	O
cases	O
.	O

Killed	O
PEDV	B-SPEC
SM98	O
vaccine	O
induced	O
higher	O
antibody	O
levels	O
.	O

Among	O
recombinant	O
spike	O
S1	O
,	O
S2	O
,	O
S3	O
,	O
and	O
nucleocapsid	O
N	O
protein	O
of	O
PEDV	B-SPEC
,	O
S3	O
protein	O
presented	O
the	O
highest	O
antibody	O
level	O
in	O
the	O
K	O
/	O
K	O
group	O
.	O

Nevertheless	O
,	O
data	O
on	O
camel	B-SPEC
zoonoses	O
are	O
limited	O
.	O

On	O
the	O
basis	O
of	O
a	O
distinct	O
reservoir	O
and	O
ecological	O
niche	O
,	O
sequence	O
analyses	O
,	O
and	O
expression	O
of	O
flagella	O
,	O
we	O
designate	O
these	O
isolates	O
as	O
a	O
novel	O
Bartonella	B-SPEC
sp	O
.	O
named	O
Bartonella	B-SPEC
dromedarii	O
sp	O
.	O
nov	O
.	O
Further	O
studies	O
are	O
required	O
to	O
explore	O
its	O
zoonotic	O
potential	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
recently	O
isolated	O
betacoronavirus	B-SPEC
identified	O
as	O
the	O
etiologic	O
agent	O
of	O
a	O
frequently	O
fatal	O
disease	O
in	O
Western	O
Asia	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
.	O

Finally	O
,	O
sequential	O
passage	O
of	O
MERS	O
-	O
CoV	O
in	O
permissive	O
bat	B-SPEC
cells	O
established	O
persistent	O
infection	O
with	O
concomitant	O
downregulation	O
of	O
CD26	O
/	O
DPP4	O
surface	O
expression	O
.	O

ABSTRACT	O
:	O
Acquisition	O
of	O
new	O
proteins	O
by	O
viruses	B-SPEC
usually	O
occurs	O
through	O
horizontal	O
gene	O
transfer	O
or	O
through	O
gene	O
duplication	O
,	O
but	O
another	O
,	O
less	O
common	O
mechanism	O
is	O
the	O
usage	O
of	O
completely	O
or	O
partially	O
overlapping	O
reading	O
frames	O
.	O

We	O
analyzed	O
the	O
evolution	O
of	O
orf9b	O
in	O
concert	O
with	O
orf9a	O
using	O
sequence	O
data	O
of	O
betacoronavirus	B-SPEC
-	O
lineage	O
b	O
and	O
found	O
that	O
orf9b	O
,	O
which	O
encodes	O
the	O
overprinting	O
protein	O
,	O
evolved	O
largely	O
independent	O
of	O
the	O
overprinted	O
orf9a	O
.	O

TITLE	O
:	O
Carrageenan	O
nasal	O
spray	O
in	O
virus	B-SPEC
confirmed	O
common	O
cold	O
:	O
individual	O
patient	O
data	O
analysis	O
of	O
two	O
randomized	O
controlled	O
trials	O
.	O

Nasopharyngeal	O
swabs	O
and	O
sputum	O
samples	O
were	O
assayed	O
for	O
16	O
respiratory	O
viruses	B-SPEC
,	O
using	O
polymerase	O
chain	O
reaction	O
assays	O
.	O

The	O
most	O
common	O
viruses	B-SPEC
found	O
in	O
patients	O
experiencing	O
exacerbations	O
were	O
coronavirus	B-SPEC
(	O
19	O
of	O
65	O
,	O
39	O
.	O
2	O
%),	O
rhinovirus	B-SPEC
(	O
16	O
of	O
65	O
,	O
24	O
.	O
6	O
%),	O
and	O
influenza	O
A	O
/	O
B	O
viruses	B-SPEC
(	O
16	O
of	O
65	O
,	O
24	O
.	O
6	O
%).	O

Saffold	O
virus	B-SPEC
was	O
detected	O
in	O
outpatient	O
but	O
not	O
in	O
hospitalized	O
children	O
.	O

Adding	O
up	O
the	O
deep	O
sequencing	O
results	O
to	O
the	O
PCR	O
data	O
,	O
79	O
.	O
2	O
%	O
of	O
250	O
hospitalized	O
and	O
76	O
.	O
6	O
%	O
of	O
526	O
ambulatory	O
patients	O
were	O
positive	O
for	O
viruses	B-SPEC
,	O
and	O
all	O
other	O
children	O
,	O
but	O
one	O
,	O
had	O
pathogenic	O
respiratory	O
bacteria	B-SPEC
identified	O
.	O

These	O
results	O
suggest	O
that	O
at	O
least	O
in	O
the	O
type	O
of	O
populations	O
studied	O
and	O
with	O
the	O
sampling	O
methods	O
used	O
the	O
odds	O
of	O
finding	O
novel	O
,	O
clinically	O
relevant	O
viruses	B-SPEC
,	O
in	O
pediatric	O
respiratory	O
infections	O
are	O
low	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
emerged	O
in	O
the	O
Arabian	O
Gulf	O
region	O
,	O
with	O
its	O
epicentre	O
in	O
Saudi	O
Arabia	O
,	O
the	O
host	O
of	O
the	O
'	O
Hajj	O
'	O
which	O
is	O
the	O
world	O
'	O
s	O
the	O
largest	O
mass	O
gathering	O
.	O

Infection	O
control	O
and	O
appropriate	O
vaccination	O
are	O
necessary	O
to	O
prevent	O
transmission	O
of	O
respiratory	O
viruses	B-SPEC
at	O
Hajj	O
and	O
other	O
mass	O
gatherings	O
.	O

TITLE	O
:	O
Replication	O
and	O
shedding	O
of	O
MERS	O
-	O
CoV	O
in	O
upper	O
respiratory	O
tract	O
of	O
inoculated	O
dromedary	B-SPEC
camels	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
2012	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
associated	O
with	O
severe	O
respiratory	O
disease	O
in	O
humans	B-SPEC
emerged	O
in	O
the	O
Middle	O
East	O
.	O

Clinical	O
signs	O
of	O
the	O
MERS	O
-	O
CoV	O
infection	O
were	O
benign	O
,	O
but	O
each	O
of	O
the	O
camels	B-SPEC
shed	O
large	O
quantities	O
of	O
virus	B-SPEC
from	O
the	O
upper	O
respiratory	O
tract	O
.	O

This	O
is	O
in	O
part	O
due	O
to	O
increased	O
production	O
of	O
reactive	O
oxygen	O
species	B-SPEC
.	O

A	O
non	O
-	O
invasive	O
method	O
for	O
assessing	O
lung	O
elastance	O
(	O
EL	O
),	O
called	O
lung	O
barometry	O
,	O
was	O
previously	O
described	O
on	O
an	O
animal	B-SPEC
model	O
.	O

TITLE	O
:	O
MERS	O
coronavirus	B-SPEC
neutralizing	O
antibodies	O
in	O
camels	B-SPEC
,	O
Eastern	O
Africa	O
,	O
1983	O
-	O
1997	O
.	O

TITLE	O
:	O
Gardening	O
can	O
induce	O
pulmonary	O
failure	O
:	O
Aspergillus	B-SPEC
ARDS	O
in	O
an	O
immunocompetent	O
patient	O
,	O
a	O
case	O
report	O
.	O

Bovine	B-SPEC
coronavirus	B-SPEC
was	O
isolated	O
in	O
human	B-SPEC
rectal	O
tumor	O
cells	O
from	O
swabs	O
of	O
colon	O
surfaces	O
of	O
all	O
animals	B-SPEC
.	O

To	O
determine	O
whether	O
this	O
attenuated	O
phenotype	O
is	O
applicable	O
to	O
multiple	O
disease	O
models	O
,	O
we	O
mutated	O
the	O
catalytic	O
residue	O
in	O
the	O
JHM	O
strain	O
of	O
MHV	B-SPEC
(	O
JHMV	O
),	O
which	O
causes	O
acute	O
and	O
chronic	O
encephalomyelitis	O
,	O
using	O
a	O
newly	O
developed	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)-	O
based	O
MHV	B-SPEC
reverse	O
genetics	O
system	O
.	O

The	O
coronavirus	B-SPEC
macrodomain	O
has	O
ADP	O
-	O
ribose	O
-	O
1	O
"""-"	O
phosphatase	O
activity	O
;	O
however	O
,	O
its	O
function	O
during	O
infection	O
remains	O
unclear	O
as	O
does	O
the	O
reason	O
that	O
coronaviruses	O
have	O
maintained	O
this	O
enzymatic	O
activity	O
throughout	O
evolution	O
.	O

These	O
data	O
indicate	O
that	O
this	O
domain	O
is	O
vital	O
for	O
the	O
virus	B-SPEC
to	O
replicate	O
and	O
cause	O
disease	O
.	O

For	O
example	O
,	O
highly	O
similar	O
coronavirus	B-SPEC
S1	O
-	O
CTDs	O
within	O
the	O
same	O
genus	B-SPEC
can	O
recognize	O
different	O
receptors	O
,	O
whereas	O
very	O
different	O
coronavirus	B-SPEC
S1	O
-	O
CTDs	O
from	O
different	O
genera	O
can	O
recognize	O
the	O
same	O
receptor	O
.	O

Structural	O
studies	O
in	O
the	O
past	O
decade	O
have	O
elucidated	O
many	O
of	O
the	O
puzzles	O
associated	O
with	O
coronavirus	B-SPEC
-	O
receptor	O
interactions	O
.	O

It	O
also	O
summarizes	O
important	O
principles	O
that	O
govern	O
receptor	O
recognition	O
by	O
viruses	B-SPEC
in	O
general	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
nonstructural	O
protein	O
1	O
:	O
Common	O
and	O
distinct	O
functions	O
in	O
the	O
regulation	O
of	O
host	O
and	O
viral	O
gene	O
expression	O
.	O

A	O
fossil	O
-	O
calibrated	O
timetree	O
and	O
biogeographical	O
analyses	O
estimated	O
that	O
Rhinolophidae	B-SPEC
and	O
Hipposideridae	B-SPEC
diverged	O
in	O
Africa	O
during	O
the	O
Eocene	O
approximately	O
42	O
Ma	O
.	O

It	O
has	O
been	O
shown	O
that	O
host	O
phylogeny	O
is	O
the	O
primary	O
factor	O
that	O
determines	O
a	O
virus	B-SPEC
'	O
s	O
persistence	O
,	O
replicative	O
ability	O
,	O
and	O
can	O
act	O
as	O
a	O
predictor	O
of	O
new	O
emerging	O
disease	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
an	O
important	O
pathogen	O
that	O
causes	O
vomiting	O
,	O
diarrhea	O
,	O
and	O
dehydration	O
,	O
leading	O
to	O
serious	O
damage	O
to	O
the	O
swine	B-SPEC
industry	O
worldwide	O
.	O

This	O
technique	O
saves	O
time	O
and	O
is	O
efficient	O
,	O
and	O
is	O
thus	O
expected	O
to	O
be	O
useful	O
for	O
the	O
diagnosis	O
of	O
PEDV	B-SPEC
infection	O
in	O
the	O
field	O
.	O

It	O
also	O
summarizes	O
currently	O
available	O
animal	B-SPEC
models	O
for	O
MERS	O
-	O
CoV	O
and	O
proposes	O
a	O
future	O
direction	O
for	O
MERS	O
vaccines	O
.	O

The	O
exceptionally	O
high	O
fatality	O
rate	O
resulting	O
from	O
MERS	O
-	O
CoV	O
infection	O
in	O
conjunction	O
with	O
the	O
paucity	O
of	O
knowledge	O
about	O
this	O
emerging	O
virus	B-SPEC
has	O
led	O
to	O
major	O
public	O
and	O
international	O
concern	O
.	O

In	O
the	O
last	O
years	O
,	O
much	O
effort	O
has	O
been	O
undertaken	O
to	O
address	O
the	O
role	O
of	O
the	O
avian	B-SPEC
coronavirus	I-SPEC
spike	O
protein	O
in	O
the	O
various	O
steps	O
of	O
the	O
virus	B-SPEC
'	O
live	O
cycle	O
.	O

Here	O
we	O
discuss	O
the	O
most	O
recent	O
studies	O
on	O
the	O
structure	O
of	O
the	O
MERS	O
-	O
CoV	O
spike	O
protein	O
and	O
its	O
role	O
in	O
virus	B-SPEC
binding	O
and	O
entry	O
,	O
and	O
the	O
development	O
of	O
MERS	O
-	O
CoV	O
entry	O
/	O
fusion	O
inhibitors	O
targeting	O
the	O
S1	O
subunit	O
,	O
particularly	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
),	O
and	O
the	O
S2	O
subunit	O
,	O
especially	O
the	O
HR1	O
region	O
,	O
of	O
the	O
MERS	O
-	O
CoV	O
spike	O
protein	O
.	O

Additional	O
validation	O
studies	O
with	O
the	O
top	O
3	O
inhibitors	O
(	O
hexachlorophene	O
,	O
nitazoxanide	O
and	O
homoharringtonine	O
)	O
demonstrated	O
robust	O
anti	O
-	O
coronavirus	B-SPEC
activities	O
(	O
a	O
reduction	O
of	O
6	O
to	O
8log10	O
in	O
virus	B-SPEC
titer	O
)	O
with	O
an	O
IC50	O
ranging	O
from	O
11nM	O
to	O
1	O
.	O
2μM	O
.	O
Furthermore	O
,	O
homoharringtonine	O
and	O
hexachlorophene	O
exhibited	O
broad	O
antiviral	O
activity	O
against	O
diverse	O
species	B-SPEC
of	O
human	B-SPEC
and	O
animal	B-SPEC
coronaviruses	O
.	O

ABSTRACT	O
:	O
The	O
simian	B-SPEC
hemorrhagic	I-SPEC
fever	I-SPEC
virus	I-SPEC
(	O
SHFV	O
)	O
genome	O
differs	O
from	O
those	O
of	O
other	O
members	O
of	O
the	O
family	B-SPEC
Arteriviridae	I-SPEC
in	O
encoding	O
three	O
papain	O
-	O
like	O
one	O
proteases	O
(	O
PLP1α	O
,	O
PLP1β	O
and	O
PLP1γ	O
)	O
at	O
the	O
5	O
'	O
end	O
and	O
two	O
adjacent	O
sets	O
of	O
four	O
minor	O
structural	O
proteins	O
at	O
the	O
3	O
'	O
end	O
.	O

SHFV	O
causes	O
a	O
fatal	O
hemorrhagic	O
fever	O
in	O
macaques	B-SPEC
but	O
asymptomatic	O
,	O
persistent	O
infections	O
in	O
natural	O
hosts	O
such	O
as	O
baboons	B-SPEC
.	O

Macrophage	O
cultures	O
from	O
the	O
two	O
types	O
of	O
animals	B-SPEC
differed	O
dramatically	O
in	O
the	O
percentage	O
of	O
cells	O
infected	O
.	O

It	O
is	O
important	O
to	O
increase	O
awareness	O
of	O
travelers	O
about	O
the	O
risks	O
and	O
appropriate	O
preventive	O
measures	O
and	O
for	O
health	O
professionals	O
to	O
be	O
on	O
alert	O
if	O
a	O
patient	O
with	O
severe	O
respiratory	O
symptoms	O
reports	O
a	O
recent	O
history	O
of	O
travel	O
to	O
the	O
region	O
affected	O
with	O
MERS	O
-	O
CoV	O
.	O
Measures	O
should	O
be	O
taken	O
by	O
local	O
health	O
authorities	O
of	O
the	O
affected	O
countries	O
in	O
order	B-SPEC
to	O
improve	O
hospital	O
hygiene	O
.	O

Treatment	O
also	O
included	O
transfusion	O
of	O
two	O
red	O
-	O
cell	O
pack	O
on	O
day	O
1	O
and	O
2	O
after	O
admission	O
in	O
order	B-SPEC
to	O
maintain	O
hemoglobin	O
level	O
above	O
8g	O
/	O
dL	O
,	O
and	O
a	O
daily	O
folic	O
acid	O
supplementation	O
.	O

Further	O
studies	O
comparing	O
the	O
incidence	O
of	O
these	O
viral	O
families	O
in	O
healthy	O
and	O
sick	O
dromedaries	B-SPEC
will	O
reveal	O
their	O
pathogenic	O
potential	O
.	O

The	O
initial	O
study	O
sample	O
was	O
positive	O
in	O
15	O
patients	O
with	O
the	O
following	O
respiratory	O
viruses	B-SPEC
:	O
rhinovirus	B-SPEC
(	O
6	O
),	O
metapneumovirus	B-SPEC
(	O
1	O
),	O
coronavirus	B-SPEC
(	O
2	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
2	O
),	O
parainfluenza	O
virus	B-SPEC
(	O
2	O
),	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
2	O
).	O

Self	O
-	O
collected	O
nasal	O
swabs	O
provide	O
a	O
convenient	O
,	O
feasible	O
,	O
and	O
patient	O
-	O
acceptable	O
methodology	O
for	O
longitudinal	O
monitoring	O
of	O
upper	O
respiratory	O
virus	B-SPEC
infection	O
in	O
SOT	O
recipients	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
OC43	O
,	O
229E	O
,	O
NL63	O
and	O
HKU1	O
are	O
common	O
causes	O
of	O
respiratory	O
infections	O
.	O

HCoVs	O
were	O
present	O
in	O
the	O
stools	O
of	O
eight	O
(	O
4	O
.	O
7	O
%)	O
of	O
the	O
172	O
children	O
with	O
AGE	O
;	O
in	O
six	O
of	O
these	O
cases	O
,	O
the	O
nasal	O
swab	O
sample	O
was	O
also	O
positive	O
for	O
the	O
respective	O
HCoV	O
.	O
Additionally	O
,	O
in	O
six	O
of	O
the	O
eight	O
cases	O
,	O
the	O
stool	O
sample	O
contained	O
either	O
rotavirus	B-SPEC
or	O
calicivirus	O
.	O

A	O
resazurin	O
-	O
based	O
cytopathic	O
effect	O
inhibition	O
assay	O
,	O
which	O
detects	O
viable	O
cells	O
through	O
their	O
reduction	O
of	O
the	O
substrate	O
resazurin	O
to	O
fluorescent	O
resorufin	O
,	O
was	O
developed	O
for	O
screening	O
compounds	O
for	O
antiviral	O
efficacy	O
against	O
FCoV	O
.	O
Plaque	O
reduction	O
and	O
virus	B-SPEC
yield	O
reduction	O
assays	O
were	O
performed	O
to	O
confirm	O
antiviral	O
effects	O
of	O
candidate	O
compounds	O
identified	O
during	O
screening	O
,	O
and	O
the	O
possible	O
antiviral	O
mechanisms	O
of	O
action	O
of	O
these	O
compounds	O
were	O
investigated	O
using	O
virucidal	O
suspension	O
assays	O
and	O
CPE	O
inhibition	O
and	O
IFA	O
-	O
based	O
time	O
of	O
addition	O
assays	O
.	O

These	O
results	O
suggest	O
that	O
these	O
direct	O
acting	O
antiviral	O
compounds	O
,	O
or	O
their	O
derivatives	O
,	O
warrant	O
further	O
investigation	O
for	O
clinical	O
use	O
in	O
cats	B-SPEC
with	O
FIP	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
implications	O
for	O
health	O
care	O
facilities	O
.	O

Commercial	O
SDBP	O
powder	O
was	O
inoculated	O
with	O
PEDV	B-SPEC
to	O
an	O
average	O
final	O
titer	O
of	O
2	O
.	O
8	O
log10	O
TCID50	O
/	O
g	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
its	O
milder	O
form	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
may	O
result	O
from	O
various	O
diseases	O
and	O
situations	O
including	O
sepsis	B-SPEC
,	O
pneumonia	O
,	O
trauma	O
,	O
acute	O
pancreatitis	O
,	O
aspiration	O
of	O
gastric	O
contents	O
,	O
near	O
-	O
drowning	O
etc	O
.	O

Patience	O
thus	O
has	O
the	O
genomic	O
profile	O
of	O
a	O
virus	B-SPEC
that	O
evolved	O
primarily	O
in	O
one	O
type	O
of	O
host	O
genetic	O
landscape	O
(	O
moderate	O
-	O
GC	O
bacteria	B-SPEC
)	O
but	O
has	O
found	O
its	O
way	O
into	O
a	O
distinctly	O
different	O
high	O
-	O
GC	O
environment	O
.	O

ABSTRACT	O
:	O
Since	O
1990	O
,	O
several	O
novel	O
respiratory	O
viruses	B-SPEC
affecting	O
humans	B-SPEC
have	O
been	O
described	O
.	O

We	O
conducted	O
a	O
seroprevalence	O
study	O
of	O
banked	O
human	B-SPEC
serum	O
samples	O
collected	O
in	O
2012	O
from	O
Southern	O
Saudi	O
Arabia	O
.	O

ABSTRACT	O
:	O
Omega	O
-	O
3	O
fatty	O
acids	O
contained	O
in	O
fish	B-SPEC
oils	O
have	O
shown	O
efficacy	O
in	O
the	O
treatment	O
of	O
chronic	O
and	O
acute	O
inflammatory	O
diseases	O
due	O
to	O
their	O
pleiotropic	O
effects	O
on	O
inflammatory	O
cell	O
signalling	O
pathways	O
.	O

ABSTRACT	O
:	O
A	O
common	O
feature	O
of	O
infection	O
by	O
positive	O
-	O
sense	O
RNA	O
virus	B-SPEC
is	O
the	O
modification	O
of	O
host	O
cell	O
cytoplasmic	O
membranes	O
that	O
serve	O
as	O
sites	O
of	O
viral	O
RNA	O
synthesis	O
.	O

Mutations	O
that	O
altered	O
DMV	O
morphology	O
but	O
not	O
glycosylation	O
did	O
not	O
affect	O
virus	B-SPEC
fitness	O
while	O
viruses	B-SPEC
lacking	O
nsp4	O
glycosylation	O
exhibited	O
a	O
loss	O
in	O
fitness	O
.	O

All	O
positive	O
-	O
sense	O
RNA	O
viruses	B-SPEC
modify	O
host	O
cytoplasmic	O
membranes	O
for	O
viral	O
replication	O
complex	O
formation	O
.	O

Published	O
sequences	O
for	O
the	O
15	O
human	B-SPEC
coronaviruses	O
were	O
used	O
to	O
design	O
a	O
consensus	O
PCR	O
targeting	O
the	O
replicase	O
open	O
reading	O
frame	O
1b	O
.	O

ABSTRACT	O
:	O
H5N1	O
influenza	O
continues	O
to	O
smolder	O
in	O
Southeast	O
Asia	O
over	O
the	O
past	O
5	O
years	O
,	O
but	O
the	O
emergence	O
of	O
H7N9	O
in	O
China	O
in	O
2012	O
raised	O
concerns	O
for	O
a	O
new	O
avian	B-SPEC
influenza	O
threat	O
.	O

On	O
day	O
3	O
in	O
the	O
PICU	B-SPEC
,	O
EVLWI	O
dropped	O
to	O
6	O
ml	O
/	O
kg	O
,	O
GEDVI	O
dropped	O
to	O
370	O
ml	O
/	O
m²	O
,	O
and	O
the	O
oxygenation	O
index	O
increased	O
to	O
180	O
mmHg	O
.	O

TITLE	O
:	O
Antiviral	O
activity	O
of	O
a	O
Bacillus	B-SPEC
sp	I-SPEC
.	O
P34	O
peptide	O
against	O
pathogenic	O
viruses	B-SPEC
of	O
domestic	O
animals	B-SPEC
.	O

Preparedness	O
efforts	O
are	O
hampered	O
by	O
considerable	O
uncertainty	O
about	O
the	O
nature	O
and	O
intensity	O
of	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
,	O
with	O
previous	O
reproduction	O
number	O
estimates	O
ranging	O
from	O
0	O
.	O
4	O
to	O
1	O
.	O
5	O
.	O

TITLE	O
:	O
Looking	O
for	O
a	O
needle	O
in	O
a	O
haystack	O
:	O
Cellular	O
proteins	O
that	O
may	O
interact	O
with	O
the	O
tyrosine	O
-	O
based	O
sorting	O
signal	O
of	O
the	O
TGEV	B-SPEC
S	O
protein	O
.	O

Immunofluorescence	O
assays	O
confirmed	O
a	O
co	O
-	O
localization	O
between	O
the	O
TGEV	B-SPEC
S	O
protein	O
and	O
filamin	O
A	O
.	O
Further	O
experiments	O
have	O
to	O
be	O
performed	O
to	O
prove	O
a	O
significant	O
impact	O
of	O
filamin	O
A	O
on	O
TGEV	B-SPEC
infection	O
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
Cryptosporidium	B-SPEC
parvum	I-SPEC
from	O
two	O
different	O
Japanese	O
prefectures	O
,	O
Okinawa	O
and	O
Hokkaido	O
.	O

Commercial	O
immunochromatography	O
testing	O
of	O
all	O
four	O
pathogens	O
and	O
molecular	O
analysis	O
of	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
with	O
diarrhea	O
in	O
calves	O
from	O
southernmost	O
Okinawa	O
and	O
northernmost	O
Hokkaido	O
,	O
Japan	O
,	O
were	O
conducted	O
.	O

TITLE	O
:	O
Tackling	O
feline	B-SPEC
infectious	O
peritonitis	O
via	O
reverse	O
genetics	O
.	O

This	O
requires	O
a	O
more	O
detailed	O
understanding	O
of	O
virus	B-SPEC
-	O
host	O
cell	O
interactions	O
to	O
identify	O
candidates	O
for	O
targeted	O
virus	B-SPEC
attenuation	O
.	O

In	O
our	O
recent	O
work	O
,	O
we	O
identified	O
the	O
structures	O
induced	O
by	O
IBV	B-SPEC
during	O
infection	O
of	O
cultured	O
cells	O
,	O
as	O
well	O
as	O
primary	O
cells	O
and	O
ex	O
vivo	O
organ	O
culture	O
.	O

We	O
identified	O
structures	O
novel	O
to	O
the	O
coronavirus	B-SPEC
family	B-SPEC
,	O
which	O
strongly	O
resemble	O
replication	O
sites	O
of	O
other	O
positive	O
sense	O
RNA	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Interactions	O
between	O
live	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
avian	B-SPEC
metapneumovirus	I-SPEC
(	O
aMPV	O
)	O
and	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccines	O
following	O
simultaneous	O
vaccination	O
of	O
day	O
old	O
specific	O
pathogen	O
free	O
(	O
SPF	O
)	O
chicks	O
were	O
evaluated	O
.	O

Three	O
respiratory	O
clinical	O
samples	O
were	O
tested	O
on	O
well	O
-	O
differentiated	O
pseudostratified	O
tracheobronchial	O
human	B-SPEC
airway	O
epithelial	O
(	O
HAE	O
)	O
cultures	O
grown	O
at	O
an	O
air	O
-	O
liquid	O
interface	O
,	O
which	O
resemble	O
the	O
airway	O
epithelium	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
mainly	O
infects	O
neonatal	O
pigs	B-SPEC
,	O
resulting	O
in	O
significant	O
morbidity	O
and	O
mortality	O
.	O

Owing	O
to	O
problems	O
such	O
as	O
long	O
periods	O
of	O
virus	B-SPEC
shedding	O
,	O
existing	O
vaccines	O
cannot	O
provide	O
complete	O
protection	O
from	O
PEDV	B-SPEC
infection	O
.	O

The	O
PEDV	B-SPEC
genome	O
encodes	O
two	O
polyprotein	O
precursors	O
required	O
for	O
genome	O
replication	O
and	O
transcription	O
.	O

TITLE	O
:	O
Crystallization	O
and	O
preliminary	O
crystallographic	O
study	O
of	O
Feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
main	O
protease	O
in	O
complex	O
with	O
an	O
inhibitor	O
.	O

As	O
a	O
member	O
of	O
the	O
genus	B-SPEC
Alphacoronavirus	B-SPEC
,	O
FIPV	O
encodes	O
two	O
polyprotein	O
precursors	O
required	O
for	O
genome	O
replication	O
and	O
transcription	O
.	O

Complications	O
included	O
sepsis	B-SPEC
(	O
36	O
%),	O
renal	O
failure	O
requiring	O
continuous	O
renal	O
replacement	O
therapy	O
(	O
30	O
%),	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
25	O
%),	O
and	O
empyema	O
(	O
23	O
%).	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
is	O
a	O
significant	O
problem	O
.	O

The	O
differences	O
between	O
patients	O
with	O
sepsis	B-SPEC
who	O
walk	O
into	O
the	O
emergency	O
department	O
(	O
ED	O
)	O
and	O
those	O
who	O
are	O
transported	O
via	O
emergency	O
medical	O
services	O
(	O
EMS	O
)	O
have	O
not	O
been	O
clarified	O
.	O

TITLE	O
:	O
p53	O
degradation	O
by	O
a	O
coronavirus	B-SPEC
papain	O
-	O
like	O
protease	O
suppresses	O
type	O
I	O
interferon	O
signaling	O
.	O

A	O
tunable	O
laser	B-SPEC
from	O
the	O
National	O
Institute	O
of	O
Standards	O
and	O
Technology	O
was	O
used	O
to	O
isolate	O
single	O
UV	O
wavelengths	O
at	O
10	O
nm	O
intervals	O
between	O
210	O
and	O
290	O
nm	O
.	O

B	B-SPEC
.	I-SPEC
pumilus	I-SPEC
spores	O
were	O
more	O
sensitive	O
to	O
UV	O
light	O
at	O
220	O
nm	O
than	O
any	O
of	O
the	O
coliphage	O
.	O

There	O
is	O
evidence	O
that	O
there	O
are	O
mutant	O
A	O
(	O
H1N1	O
)	O
pdm09	O
viruses	B-SPEC
that	O
have	O
high	O
pneumotropicity	O
.	O

ABSTRACT	O
:	O
With	O
the	O
increase	O
in	O
prevalence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
),	O
healthcare	O
workers	O
(	O
HCWs	O
)	O
are	O
at	O
risk	O
of	O
acquiring	O
and	O
subsequently	O
transmitting	O
this	O
lethal	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
caused	O
by	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
infection	O
,	O
is	O
a	O
highly	O
lethal	O
disease	O
without	O
effective	O
therapy	O
and	O
prevention	O
.	O

To	O
start	O
gaining	O
information	O
about	O
bat	B-SPEC
-	O
transmitted	O
viruses	B-SPEC
in	O
Hungary	O
,	O
we	O
tested	O
multiple	O
bat	B-SPEC
species	B-SPEC
for	O
several	O
virus	B-SPEC
groups	O
between	O
2012	O
and	O
2013	O
.	O

A	O
total	O
of	O
447	O
fecal	O
samples	O
,	O
representing	O
24	O
European	O
bat	B-SPEC
species	B-SPEC
were	O
tested	O
.	O

Out	O
of	O
the	O
447	O
tested	O
samples	O
,	O
40	O
(	O
9	O
%)	O
bats	B-SPEC
were	O
positive	O
for	O
at	O
least	O
one	O
virus	B-SPEC
.	O

However	O
,	O
for	O
some	O
IBV	B-SPEC
types	O
(	O
Mass41	O
and	O
Conn	O
on	O
the	O
SmartCycler	O
II	O
and	O
Ark	O
,	O
Mass41	O
,	O
Conn	O
,	O
and	O
GA98	O
on	O
the	O
ABI	O
7500	O
)	O
the	O
qRT	O
-	O
PCR	O
assay	O
was	O
more	O
sensitive	O
than	O
virus	B-SPEC
detection	O
in	O
embryonated	O
eggs	O
.	O

We	O
also	O
found	O
that	O
the	O
IBV	B-SPEC
type	O
-	O
specific	O
primers	O
and	O
probe	O
sets	O
designed	O
in	O
this	O
study	O
were	O
in	O
general	O
less	O
sensitive	O
than	O
the	O
universal	O
IBV	B-SPEC
primers	O
and	O
probe	O
set	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
recently	O
emerging	O
betacoronavirus	B-SPEC
with	O
high	O
fatality	O
.	O

In	O
this	O
report	O
,	O
we	O
provide	O
a	O
tool	O
for	O
prediction	O
of	O
the	O
host	O
tropism	O
of	O
the	O
virus	B-SPEC
based	O
on	O
the	O
host	O
receptor	O
binding	O
interface	O
.	O

Changes	O
in	O
these	O
residues	O
correspond	O
to	O
profound	O
decrease	O
in	O
virus	B-SPEC
binding	O
to	O
cells	O
.	O

This	O
study	O
shows	O
that	O
formulation	O
of	O
SARS	O
-	O
CoV	O
spike	O
protein	O
or	O
inactivated	O
whole	O
-	O
virus	B-SPEC
vaccines	O
with	O
novel	O
delta	O
inulin	O
-	O
based	O
polysaccharide	O
adjuvants	O
enhances	O
neutralizing	O
-	O
antibody	O
titers	O
and	O
protection	O
against	O
clinical	O
disease	O
but	O
at	O
the	O
same	O
time	O
also	O
protects	O
against	O
development	O
of	O
lung	O
eosinophilic	O
immunopathology	O
.	O

Human	B-SPEC
plasma	O
-	O
derived	O
C1	O
-	O
INH	O
(	O
pdC1	O
-	O
INH	O
)	O
concentrate	O
is	O
indicated	O
for	O
the	O
treatment	O
of	O
both	O
acute	O
HAE	O
attacks	O
and	O
pre	O
-	O
procedure	O
prevention	O
of	O
HAE	O
episodes	O
in	O
patients	O
undergoing	O
medical	O
,	O
dental	O
,	O
or	O
surgical	O
procedures	O
.	O

Infrared	O
thermography	O
(	O
IRT	O
)	O
can	O
be	O
implemented	O
at	O
international	O
airports	O
in	O
order	B-SPEC
to	O
detect	O
febrile	O
passengers	O
and	O
prevent	O
the	O
introduction	O
and	O
spread	O
of	O
infectious	O
diseases	O
to	O
other	O
countries	O
.	O

A	O
single	O
intravenous	O
infusion	O
of	O
allogeneic	O
,	O
bone	O
marrow	O
-	O
derived	O
human	B-SPEC
MSCs	O
was	O
well	O
tolerated	O
in	O
nine	O
patients	O
with	O
moderate	O
to	O
severe	O
ARDS	O
.	O

Such	O
genotype	O
shift	O
may	O
be	O
an	O
adapting	O
mechanism	O
for	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
maintaining	O
its	O
epidemic	O
.	O

TITLE	O
:	O
Levels	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
in	O
blood	O
,	O
effusions	O
,	O
and	O
various	O
tissues	O
and	O
the	O
role	O
of	O
lymphopenia	O
in	O
disease	O
outcome	O
following	O
experimental	O
infection	O
.	O

High	O
tissue	O
virus	B-SPEC
loads	O
were	O
measured	O
in	O
severely	O
affected	O
tissues	O
such	O
as	O
the	O
omentum	O
,	O
mesenteric	O
lymph	O
nodes	O
and	O
spleen	O
.	O

Replicating	O
virus	B-SPEC
was	O
strongly	O
associated	O
with	O
macrophages	O
by	O
immunohistochemistry	O
.	O

The	O
present	O
study	O
thus	O
provides	O
protein	O
-	O
related	O
information	O
about	O
interaction	O
of	O
TGEV	B-SPEC
N	O
protein	O
with	O
host	O
cell	O
that	O
should	O
be	O
useful	O
for	O
understanding	O
host	O
cell	O
response	O
to	O
coronavirus	B-SPEC
pathogenesis	O
infection	O
and	O
the	O
underlying	O
mechanism	O
of	O
coronavirus	B-SPEC
replication	O
.	O

Rhinovirus	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
infections	O
were	O
associated	O
with	O
elevated	O
MxA	O
responses	O
.	O

Blood	O
MxA	O
protein	O
levels	O
are	O
increased	O
in	O
young	O
children	O
with	O
symptomatic	O
respiratory	O
virus	B-SPEC
infections	O
,	O
including	O
rhinovirus	B-SPEC
infections	O
.	O

MxA	O
is	O
an	O
informative	O
general	O
marker	O
for	O
the	O
most	O
common	O
acute	O
virus	B-SPEC
infections	O
.	O

Since	O
the	O
1960s	O
,	O
there	O
has	O
been	O
a	O
radical	O
change	O
in	O
dromedary	B-SPEC
camel	B-SPEC
farming	O
practices	O
in	O
the	O
Arabian	O
Peninsula	O
with	O
an	O
intensification	O
of	O
the	O
production	O
and	O
a	O
concentration	O
of	O
the	O
production	O
around	O
cities	O
.	O

Under	O
hyperoxic	O
conditions	O
,	O
the	O
lungs	O
of	O
NLRP3	O
(-/-)	O
mice	B-SPEC
exhibited	O
reduced	O
inflammatory	O
responses	O
,	O
such	O
as	O
inflammatory	O
cell	O
infiltration	O
and	O
cytokine	O
expression	O
,	O
as	O
well	O
as	O
increased	O
and	O
decreased	O
expression	O
of	O
MMP	O
-	O
9	O
and	O
Bcl	O
-	O
2	O
,	O
respectively	O
.	O

TITLE	O
:	O
New	O
insights	O
on	O
the	O
role	O
of	O
paired	O
membrane	O
structures	O
in	O
coronavirus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
The	O
replication	O
of	O
coronaviruses	O
,	O
as	O
in	O
other	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
,	O
is	O
closely	O
tied	O
to	O
the	O
formation	O
of	O
membrane	O
-	O
bound	O
replicative	O
organelles	O
inside	O
infected	O
cells	O
.	O

Here	O
,	O
we	O
collect	O
and	O
interpret	O
the	O
recent	O
experimental	O
evidence	O
about	O
the	O
role	O
and	O
importance	O
of	O
membrane	O
-	O
bound	O
organelles	O
in	O
coronavirus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
coronavirus	B-SPEC
infections	O
have	O
known	O
as	O
they	O
are	O
specific	O
to	O
pigs	B-SPEC
with	O
predominantly	O
enteric	O
or	O
respiratory	O
diseases	O
.	O

We	O
confirmed	O
the	O
susceptibility	O
to	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
one	O
of	O
the	O
porcine	B-SPEC
coronaviruses	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
reproductive	O
and	O
respiratory	O
syndrome	O
(	O
PRRS	O
)	O
is	O
one	O
of	O
the	O
most	O
serious	O
diseases	O
affecting	O
the	O
swine	B-SPEC
industry	O
worldwide	O
;	O
however	O
,	O
there	O
are	O
no	O
efficient	O
control	O
strategies	O
against	O
PRRS	O
virus	B-SPEC
(	O
PRRSV	B-SPEC
)	O
at	O
present	O
.	O

Virus	B-SPEC
titration	O
assay	O
was	O
performed	O
to	O
determine	O
the	O
virus	B-SPEC
infectivity	O
.	O

Further	O
studies	O
confirmed	O
that	O
LiCl	O
inhibited	O
PRRSV	B-SPEC
replication	O
at	O
an	O
early	O
stage	O
and	O
TNF	O
-	O
α	O
,	O
an	O
antiviral	O
cytokine	O
,	O
was	O
significantly	O
increased	O
after	O
LiCl	O
treatment	O
.	O

Thus	O
,	O
we	O
suggested	O
that	O
LiCl	O
inhibited	O
PRRSV	B-SPEC
infection	O
by	O
up	O
-	O
regulating	O
the	O
level	O
of	O
antiviral	O
cytokine	O
TNF	O
-	O
α	O
at	O
an	O
early	O
infection	O
stage	O
.	O

TITLE	O
:	O
Mechanical	O
ventilation	O
for	O
ARDS	O
patients	O
--	O
for	O
a	O
better	O
understanding	O
of	O
the	O
2012	O
Surviving	O
Sepsis	B-SPEC
Campaign	O
Guidelines	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infections	O
have	O
resulted	O
in	O
a	O
severe	O
economic	O
loss	O
in	O
the	O
swine	B-SPEC
industry	O
in	O
many	O
countries	O
due	O
to	O
no	O
effective	O
treatment	O
approach	O
.	O

Fifteen	O
oleanane	O
triterpenes	O
(	O
1	O
-	O
15	O
),	O
including	O
nine	O
new	O
ones	O
(	O
1	O
-	O
4	O
and	O
10	O
-	O
14	O
),	O
were	O
isolated	O
from	O
the	O
flowers	O
of	O
Camellia	B-SPEC
japonica	I-SPEC
,	O
and	O
their	O
molecular	O
structures	O
were	O
determined	O
by	O
extensive	O
spectroscopic	O
methods	O
.	O

We	O
observed	O
that	O
olfactory	O
cues	O
present	O
in	O
bodily	O
products	O
of	O
mice	B-SPEC
in	O
an	O
acute	O
inflammatory	O
state	O
or	O
infected	O
with	O
a	O
viral	O
pathogen	O
are	O
aversive	O
to	O
conspecifics	O
.	O

ABSTRACT	O
:	O
Infections	O
with	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
and	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BoCV	O
)	O
are	O
endemic	O
to	O
the	O
cattle	B-SPEC
populations	O
in	O
most	O
countries	O
,	O
causing	O
respiratory	O
and	O
/	O
or	O
enteric	O
disease	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
challenge	O
the	O
hypothesis	O
of	O
a	O
lower	O
occurrence	O
of	O
BRSV	B-SPEC
and	O
BoCV	O
in	O
OM	O
compared	O
to	O
CM	O
dairy	O
herds	O
.	O

The	O
antibody	O
status	O
regarding	O
BRSV	B-SPEC
and	O
BoCV	O
was	O
analysed	O
with	O
commercial	O
indirect	O
ELISAs	O
.	O

Bioinformatics	O
,	O
GO	O
annotation	O
and	O
pathway	O
analysis	O
indicated	O
that	O
five	O
of	O
these	O
genes	O
(	O
Plexin	O
B1	O
,	O
TRIM27	O
,	O
PDGFC	O
,	O
SETBP1	O
and	O
USP7	O
)	O
may	O
be	O
important	O
for	O
the	O
generation	O
of	O
protective	O
antibodies	O
against	O
NDV	B-SPEC
and	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
are	O
economically	O
important	O
swine	B-SPEC
enteropathogenic	O
coronaviruses	O
.	O

One	O
-	O
way	O
cross	O
-	O
reactions	O
were	O
observed	O
by	O
CCIF	O
between	O
TGEV	B-SPEC
Miller	O
hyperimmune	O
pig	B-SPEC
antisera	O
and	O
all	O
PEDV	B-SPEC
strains	O
.	O

Our	O
data	O
indicate	O
that	O
both	O
structural	O
and	O
nonstructural	O
proteins	O
contribute	O
to	O
MHV	B-SPEC
liver	O
pathogenesis	O
and	O
support	O
previous	O
reports	O
that	O
nsp1	O
is	O
a	O
Betacoronavirus	B-SPEC
virulence	O
factor	O
.	O

We	O
have	O
developed	O
this	O
transgenic	O
mouse	B-SPEC
model	O
as	O
indicated	O
in	O
this	O
study	O
.	O

The	O
standard	O
small	O
animals	B-SPEC
,	O
mice	B-SPEC
,	O
hamsters	B-SPEC
,	O
and	O
ferrets	B-SPEC
,	O
all	O
lack	O
the	O
functional	O
MERS	O
-	O
CoV	O
receptor	O
and	O
are	O
not	O
susceptible	O
to	O
infection	O
.	O

A	O
transversal	O
prospective	O
study	O
was	O
conducted	O
to	O
analyze	O
the	O
seasonality	O
of	O
CRS	O
using	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
to	O
detect	O
respiratory	O
virus	B-SPEC
genomes	O
in	O
secretions	O
and	O
tissue	O
samples	O
from	O
patients	O
with	O
CRS	O
with	O
and	O
without	O
nasal	O
polyps	O
.	O

TITLE	O
:	O
IFITM	O
-	O
Family	B-SPEC
Proteins	O
:	O

The	O
three	O
patients	O
presented	O
with	O
severe	O
neurologic	O
syndrome	O
which	O
included	O
altered	O
level	O
of	O
consciousness	O
ranging	O
from	O
confusion	O
to	O
coma	B-SPEC
,	O
ataxia	O
,	O
and	O
focal	O
motor	O
deficit	O
.	O

Mast	O
cells	O
can	O
release	O
various	O
inflammatory	O
mediators	O
known	O
to	O
be	O
involved	O
in	O
the	O
development	O
of	O
lung	O
edema	O
following	O
scorpion	B-SPEC
venom	O
injection	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDv	B-SPEC
)	O
infected	O
approximately	O
50	O
%	O
of	O
the	O
US	O
swine	B-SPEC
breeding	O
herds	O
from	O
July	O
2013	O
to	O
July	O
2014	O
as	O
estimated	O
by	O
the	O
Swine	B-SPEC
Health	O
Monitoring	O
Project	O
.	O

Thus	O
,	O
a	O
naturally	O
attenuated	O
form	O
of	O
PEDv	B-SPEC
provided	O
significant	O
passive	O
immune	O
protection	O
for	O
seven	O
months	O
against	O
piglet	O
challenge	O
with	O
virulent	O
PEDv	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
case	O
of	O
a	O
30	O
year	O
-	O
old	O
man	B-SPEC
presenting	O
with	O
severe	O
systemic	O
chickenpox	O
with	O
refractory	O
hypoxemia	O
,	O
central	O
nervous	O
system	O
vasculitis	O
and	O
anuric	O
renal	O
failure	O
is	O
described	O
.	O

TITLE	O
:	O
High	O
secretion	O
of	O
interferons	O
by	O
human	B-SPEC
plasmacytoid	O
dendritic	O
cells	O
upon	O
recognition	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
emerged	O
in	O
2012	O
as	O
the	O
causative	O
agent	O
of	O
a	O
severe	O
respiratory	O
disease	O
with	O
a	O
fatality	O
rate	O
of	O
approximately	O
30	O
%.	O

Taken	O
together	O
,	O
our	O
results	O
point	O
toward	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
)-	O
dependent	O
endosomal	O
uptake	O
and	O
subsequent	O
infection	O
of	O
human	B-SPEC
pDCs	O
by	O
MERS	O
-	O
CoV	O
.	O
However	O
,	O
the	O
replication	O
cycle	O
is	O
stopped	O
after	O
early	O
gene	O
expression	O
.	O

Recently	O
,	O
confirmed	O
human	B-SPEC
cases	O
have	O
increased	O
dramatically	O
in	O
both	O
number	O
and	O
geographic	O
distribution	O
.	O

A	O
mouse	B-SPEC
-	O
adapted	O
SARS	O
-	O
CoV	O
(	O
SARS	O
-	O
CoV	O
-	O
MA15	O
)	O
lacking	O
the	O
envelope	O
(	O
E	O
)	O
protein	O
(	O
rSARS	O
-	O
CoV	O
-	O
MA15	O
-	O
ΔE	O
)	O
is	O
attenuated	O
in	O
vivo	O
.	O

The	O
attenuated	O
viruses	B-SPEC
completely	O
protected	O
mice	B-SPEC
against	O
challenge	O
with	O
the	O
lethal	O
parental	O
virus	B-SPEC
,	O
indicating	O
that	O
these	O
viruses	B-SPEC
are	O
promising	O
vaccine	O
candidates	O
.	O

TITLE	O
:	O
Molecular	O
detection	O
of	O
infectious	O
bronchitis	O
and	O
avian	B-SPEC
metapneumoviruses	B-SPEC
in	O
Oman	O
backyard	O
poultry	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
avian	B-SPEC
metapneumovirus	I-SPEC
(	O
aMPV	O
)	O
are	O
economically	O
important	O
viral	O
pathogens	O
infecting	O
chickens	B-SPEC
globally	O
.	O

Identification	O
of	O
endemic	O
IBV	B-SPEC
and	O
aMPV	O
strains	O
promotes	O
better	O
control	O
of	O
both	O
diseases	O
and	O
prevents	O
production	O
losses	O
.	O

Swabs	O
from	O
each	O
flock	O
were	O
examined	O
by	O
RT	O
-	O
PCR	O
using	O
part	O
-	O
S1	O
and	O
G	O
gene	O
primers	O
for	O
IBV	B-SPEC
and	O
aMPV	O
respectively	O
.	O

The	O
improvement	O
of	O
humanized	O
mouse	B-SPEC
models	O
over	O
the	O
past	O
30	O
years	O
has	O
greatly	O
facilitated	O
researchers	O
'	O
abilities	O
to	O
study	O
host	O
responses	O
to	O
viral	O
infections	O
in	O
a	O
cost	O
effective	O
and	O
ethical	O
manner	O
.	O

TITLE	O
:	O
Entry	O
screening	O
for	O
infectious	O
diseases	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
development	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
dual	O
inhibitors	O
is	O
a	O
highly	O
innovative	O
approach	O
aimed	O
at	O
reducing	O
drug	O
toxic	O
side	O
effects	O
as	O
well	O
as	O
therapeutic	O
costs	O
.	O

HIV	B-SPEC
-	I-SPEC
1	I-SPEC
integrase	O
(	O
IN	O
)	O
and	O
reverse	O
transcriptase	O
-	O
associated	O
ribonuclease	O
H	O
(	O
RNase	O
H	O
)	O
are	O
both	O
selective	O
targets	O
for	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
chemotherapy	O
,	O
and	O
the	O
identification	O
of	O
dual	O
IN	O
/	O
RNase	O
H	O
inhibitors	O
is	O
an	O
attractive	O
strategy	O
for	O
new	O
drug	O
development	O
.	O

TITLE	O
:	O
Development	O
and	O
validation	O
of	O
a	O
rapid	O
immunochromatographic	O
assay	O
for	O
detection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
antigen	O
in	O
dromedary	B-SPEC
camels	B-SPEC
.	O

A	O
77	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
was	O
diagnosed	O
with	O
a	O
huge	O
HCC	O
was	O
admitted	O
for	O
TACE	O
.	O

ABSTRACT	O
:	O
Currently	O
the	O
only	O
captive	O
population	O
of	O
beira	O
antelope	B-SPEC
(	O
Dorcatragus	B-SPEC
megalotis	O
)	O
is	O
held	O
at	O
the	O
Al	O
Wabra	O
Wildlife	O
Preservation	O
,	O
Qatar	O
.	O

In	O
the	O
absence	O
of	O
adjuvant	O
,	O
S377	O
-	O
588	O
-	O
Fc	O
alone	O
induced	O
readily	O
detectable	O
neutralizing	O
antibody	O
and	O
T	O
-	O
cell	O
responses	O
in	O
immunized	O
mice	B-SPEC
.	O

TITLE	O
:	O
Detection	O
of	O
coronavirus	B-SPEC
genomes	O
in	O
Moluccan	B-SPEC
naked	I-SPEC
-	I-SPEC
backed	I-SPEC
fruit	I-SPEC
bats	I-SPEC
in	O
Indonesia	O
.	O

A	O
partial	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
gene	O
sequence	O
was	O
detected	O
in	O
feces	O
and	O
tissues	O
samples	O
from	O
the	O
fruit	O
bats	B-SPEC
,	O
and	O
the	O
region	O
between	O
the	O
RdRp	O
and	O
helicase	O
genes	O
could	O
also	O
be	O
amplified	O
from	O
fecal	O
samples	O
.	O

The	O
iiRT	O
-	O
PCR	O
assay	O
accurately	O
detected	O
CSFV	O
as	O
early	O
as	O
2	O
days	O
post	O
-	O
inoculation	O
in	O
RNA	O
extracted	O
from	O
serum	O
samples	O
of	O
experimentally	O
infected	O
pigs	B-SPEC
,	O
before	O
appearance	O
of	O
clinical	O
signs	O
.	O

The	O
other	O
horse	B-SPEC
(	O
case	O
No	O
.	O
2	O
)	O
had	O
hyperammonemic	O
encephalopathy	O
with	O
Alzheimer	O
type	O
II	O
astrocytosis	O
throughout	O
the	O
cerebral	O
cortex	O
.	O

Coronavirus	B-SPEC
-	O
like	O
particles	O
characterized	O
by	O
spherical	O
,	O
moderately	O
electron	O
lucent	O
,	O
enveloped	O
virions	O
with	O
distinct	O
peplomer	O
-	O
like	O
structures	O
projecting	O
from	O
the	O
surface	O
were	O
detected	O
by	O
negatively	O
stained	O
transmission	O
electron	O
microscopy	O
in	O
small	O
intestine	O
in	O
case	O
No	O
.	O
1	O
,	O
and	O
transmission	O
electron	O
microscopy	O
of	O
fixed	O
small	O
intestinal	O
tissue	O
from	O
the	O
same	O
case	O
revealed	O
similar	O
85	O
-	O
to	O
100	O
-	O
nm	O
intracytoplasmic	O
particles	O
located	O
in	O
vacuoles	O
and	O
free	O
in	O
the	O
cytoplasm	O
of	O
unidentified	O
(	O
presumably	O
epithelial	O
)	O
cells	O
.	O

Vaccinating	O
cows	B-SPEC
against	O
calf	O
enteropathogens	O
(	O
OR	O
=	O
0	O
.	O
2	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
1	O
-	O
0	O
.	O
9	O
;	O
P	O
=	O
0	O
.	O
03	O
),	O
administering	O
waste	O
milk	O
(	O
from	O
mastitis	O
and	O
/	O
or	O
containing	O
antibiotics	O
;	O
OR	O
=	O
0	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
1	O
-	O
0	O
.	O
8	O
;	O
P	O
=	O
0	O
.	O
01	O
),	O
the	O
sex	O
of	O
calves	O
(	O
females	O
compared	O
to	O
males	O
OR	O
=	O
0	O
.	O
2	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
07	O
-	O
0	O
.	O
7	O
;	O
P	O
<	O
0	O
.	O
01	O
),	O
and	O
the	O
use	O
of	O
straw	O
for	O
bedding	O
(	O
OR	O
=	O
0	O
.	O
2	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
03	O
-	O
0	O
.	O
9	O
;	O
P	O
=	O
0	O
.	O
03	O
)	O
decreased	O
the	O
odds	O
of	O
liquid	O
faeces	O
.	O

Cardiotonic	O
steroids	O
were	O
shown	O
to	O
inhibit	O
entry	O
of	O
MHV	B-SPEC
at	O
an	O
early	O
stage	O
,	O
resulting	O
in	O
accumulation	O
of	O
virions	O
close	O
to	O
the	O
cell	O
surface	O
and	O
,	O
as	O
a	O
consequence	O
,	O
in	O
reduced	O
fusion	O
.	O

Viral	O
RNA	O
replication	O
was	O
not	O
affected	O
when	O
these	O
compounds	O
were	O
added	O
after	O
virus	B-SPEC
entry	O
.	O

U	O
ranges	O
among	O
virus	B-SPEC
isolates	O
from	O
30	O
.	O
7	O
%	O
to	O
40	O
.	O
3	O
%,	O
and	O
C	O
makes	O
the	O
opposite	O
movement	O
from	O
20	O
.	O
0	O
%	O
to	O
12	O
.	O
9	O
%,	O
respectively	O
.	O

MERS	O
-	O
CoV	O
sequences	O
have	O
since	O
been	O
found	O
in	O
a	O
bat	B-SPEC
and	O
the	O
virus	B-SPEC
appears	O
to	O
be	O
enzootic	O
among	O
dromedary	B-SPEC
camels	B-SPEC
across	O
the	O
Arabian	O
Peninsula	O
and	O
in	O
parts	O
of	O
Africa	O
.	O

TITLE	O
:	O
Development	O
of	O
an	O
antigen	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
virus	B-SPEC
detection	O
based	O
on	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
monoclonal	O
antibodies	O
.	O

TITLE	O
:	O
Antiviral	O
effect	O
of	O
lithium	O
chloride	O
on	O
infection	O
of	O
cells	O
by	O
porcine	B-SPEC
parvovirus	I-SPEC
.	O

TITLE	O
:	O
Genetic	O
characterization	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
Korea	O
from	O
1998	O
to	O
2013	O
.	O

In	O
order	B-SPEC
to	O
assess	O
whether	O
cysteine	O
or	O
serine	O
proteases	O
promote	O
viral	O
spread	O
in	O
the	O
host	O
,	O
we	O
compared	O
the	O
antiviral	O
activity	O
of	O
an	O
optimized	O
K11777	O
-	O
derivative	O
with	O
that	O
of	O
camostat	O
,	O
an	O
inhibitor	O
of	O
TMPRSS2	O
and	O
related	O
serine	O
proteases	O
.	O

Our	O
results	O
indicate	O
that	O
camostat	O
,	O
or	O
similar	O
serine	O
protease	O
inhibitors	O
,	O
might	O
be	O
an	O
effective	O
option	O
for	O
treatment	O
of	O
SARS	O
and	O
potentially	O
MERS	O
,	O
while	O
vinyl	O
sulfone	O
-	O
based	O
inhibitors	O
are	O
excellent	O
lead	O
candidates	O
for	O
Ebola	B-SPEC
virus	I-SPEC
therapeutics	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
complete	O
coding	O
genome	O
sequences	O
of	O
six	O
FCoVs	O
:	O
three	O
from	O
faecal	O
samples	O
from	O
healthy	O
cats	B-SPEC
and	O
three	O
from	O
tissue	O
lesion	O
samples	O
from	O
cats	B-SPEC
with	O
confirmed	O
FIP	O
.	O

HRV	O
was	O
co	O
-	O
detected	O
with	O
bocavirus	B-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
,	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
in	O
21	O
(	O
24	O
.	O
7	O
%),	O
17	O
(	O
20	O
.	O
0	O
%),	O
and	O
14	O
(	O
16	O
.	O
5	O
%),	O
respectively	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
diarrhea	O
outbreaks	O
caused	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
occurred	O
in	O
China	O
with	O
significant	O
losses	O
of	O
piglets	O
since	O
2010	O
.	O

Regional	O
and	O
national	O
surveys	O
have	O
revealed	O
the	O
presence	O
of	O
several	O
different	O
enteric	O
viruses	B-SPEC
in	O
PEC	O
including	O
rotavirus	B-SPEC
,	O
astrovirus	O
,	O
reovirus	B-SPEC
and	O
coronavirus	B-SPEC
either	O
alone	O
or	O
in	O
combination	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
aminopeptidase	O
N	O
mediated	O
polarized	O
infection	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
target	O
cells	O
.	O

ABSTRACT	O
:	O
Infection	O
of	O
polarized	O
intestinal	O
epithelial	O
cells	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
was	O
characterized	O
.	O

TITLE	O
:	O
Rapid	O
detection	O
of	O
equine	B-SPEC
coronavirus	B-SPEC
by	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
.	O

Specificity	O
of	O
the	O
RT	O
-	O
LAMP	O
assay	O
was	O
confirmed	O
using	O
several	O
equine	B-SPEC
intestinal	O
and	O
respiratory	O
pathogens	O
in	O
addition	O
to	O
ECoV	O
.	O
The	O
novel	O
assay	O
failed	O
to	O
cross	O
-	O
react	O
with	O
the	O
other	O
pathogens	O
tested	O
,	O
suggesting	O
it	O
is	O
highly	O
specific	O
for	O
ECoV	O
.	O
Using	O
artificially	O
synthesized	O
ECoV	O
RNA	O
,	O
the	O
50	O
%	O
detection	O
limit	O
of	O
the	O
RT	O
-	O
LAMP	O
assay	O
was	O
10	O
(	O
1	O
.	O
8	O
)	O
copies	O
/	O
reaction	O
.	O

In	O
this	O
study	O
,	O
nine	O
alkylated	O
chalcones	O
(	O
1	O
-	O
9	O
)	O
and	O
four	O
coumarins	O
(	O
10	O
-	O
13	O
)	O
were	O
isolated	O
from	O
Angelica	B-SPEC
keiskei	I-SPEC
,	O
and	O
the	O
inhibitory	O
activities	O
of	O
these	O
constituents	O
against	O
SARS	O
-	O
CoV	O
proteases	O
(	O
3CL	O
(	O
pro	O
)	O
and	O
PL	O
(	O
pro	O
))	O
were	O
determined	O
(	O
cell	O
-	O
free	O
/	O
based	O
).	O

Of	O
the	O
isolated	O
alkylated	O
chalcones	O
,	O
chalcone	O
6	O
,	O
containing	O
the	O
perhydroxyl	O
group	O
,	O
exhibited	O
the	O
most	O
potent	O
3CL	O
(	O
pro	O
)	O
and	O
PL	O
(	O
pro	O
)	O
inhibitory	O
activity	O
with	O
IC50	O
values	O
of	O
11	O
.	O
4	O
and	O
1	O
.	O
2	O
µM	O
.	O
Our	O
detailed	O
protein	O
-	O
inhibitor	O
mechanistic	O
analysis	O
of	O
these	O
species	B-SPEC
indicated	O
that	O
the	O
chalcones	O
exhibited	O
competitive	O
inhibition	O
characteristics	O
to	O
the	O
SARS	O
-	O
CoV	O
3CL	O
(	O
pro	O
),	O
whereas	O
noncompetitive	O
inhibition	O
was	O
observed	O
with	O
the	O
SARS	O
-	O
CoV	O
PL	O
(	O
pro	O
).	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
initially	O
recognized	O
as	O
a	O
source	O
of	O
severe	O
respiratory	O
illness	O
and	O
renal	O
failure	O
in	O
2012	O
.	O

ABSTRACT	O
:	O
Between	O
March	O
and	O
June	O
2014	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
(	O
KSA	O
)	O
had	O
a	O
large	O
outbreak	O
of	O
MERS	O
-	O
CoV	O
,	O
renewing	O
fears	O
of	O
a	O
major	O
outbreak	O
during	O
the	O
Hajj	O
this	O
October	O
.	O

Variation	O
up	O
to	O
22	O
.	O
3	O
%	O
was	O
detected	O
within	O
local	O
Mass	O
-	O
type	O
strains	O
,	O
supporting	O
the	O
hypothesis	O
that	O
multiple	O
IBV	B-SPEC
serotypes	O
may	O
co	O
-	O
circulate	O
in	O
the	O
same	O
region	O
simultaneously	O
.	O

The	O
percentage	O
of	O
FCoV	O
seropositive	O
and	O
seronegative	O
cats	B-SPEC
that	O
died	O
in	O
spite	O
of	O
supportive	O
veterinary	O
treatment	O
was	O
33	O
%	O
(	O
21	O
/	O
63	O
)	O
and	O
12	O
%	O
(	O
13	O
/	O
106	O
),	O
respectively	O
.	O

Common	O
clinical	O
manifestations	O
include	O
disorientation	O
,	O
confusion	O
,	O
hypersomnolence	O
,	O
deep	O
coma	B-SPEC
and	O
""""	O
coma	B-SPEC
vigil	O
","""	O
or	O
akinetic	O
mutism	O
(	O
awake	O
unresponsiveness	O
),	O
as	O
well	O
as	O
severe	O
memory	O
impairment	O
.	O

TITLE	O
:	O
Genomic	O
and	O
epidemiological	O
characteristics	O
provide	O
new	O
insights	O
into	O
the	O
phylogeographical	O
and	O
spatiotemporal	O
spread	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
Asia	O
.	O

Genotyping	O
and	O
phylogeny	O
-	O
based	O
geographical	O
dissection	O
based	O
on	O
219	O
S	O
genes	O
revealed	O
the	O
complexity	O
and	O
severity	O
of	O
PEDV	B-SPEC
epidemics	O
in	O
Asia	O
.	O

However	O
,	O
small	O
-	O
molecule	O
inhibitors	O
against	O
the	O
3CLpro	O
enzymes	O
of	O
FCoV	O
and	O
FCV	B-SPEC
have	O
not	O
been	O
previously	O
identified	O
.	O

Intraperitoneal	O
administration	O
of	O
two	O
3CLpro	O
inhibitors	O
in	O
mice	B-SPEC
infected	O
with	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
A59	O
,	O
a	O
hepatotropic	O
coronavirus	B-SPEC
,	O
resulted	O
in	O
significant	O
reductions	O
in	O
virus	B-SPEC
titers	O
and	O
pathological	O
lesions	O
in	O
the	O
liver	O
compared	O
to	O
the	O
findings	O
for	O
the	O
controls	O
.	O

The	O
genomes	O
of	O
these	O
distinct	O
viruses	B-SPEC
,	O
which	O
belong	O
to	O
different	O
virus	B-SPEC
families	O
,	O
encode	O
a	O
structurally	O
and	O
functionally	O
conserved	O
3C	O
-	O
like	O
protease	O
(	O
3CLpro	O
)	O
which	O
is	O
a	O
potential	O
target	O
for	O
broad	O
-	O
spectrum	O
antiviral	O
drug	O
development	O
.	O

In	O
this	O
study	O
,	O
we	O
explored	O
the	O
structure	O
-	O
activity	O
relationships	O
of	O
the	O
derivatives	O
of	O
3CLpro	O
inhibitors	O
and	O
identified	O
inhibitors	O
with	O
potent	O
dual	O
activities	O
against	O
these	O
viruses	B-SPEC
.	O

Furthermore	O
,	O
we	O
show	O
that	O
a	O
CoV	O
encoding	O
the	O
mutant	O
Ubl	O
domain	O
is	O
unable	O
to	O
replicate	O
at	O
high	O
temperature	O
or	O
cause	O
lethal	O
disease	O
in	O
mice	B-SPEC
.	O

The	O
clinical	O
symptoms	O
of	O
SP	O
,	O
its	O
incidence	O
,	O
relationship	O
between	O
SP	O
and	O
sepsis	B-SPEC
are	O
considered	O
along	O
with	O
predictors	O
of	O
adverse	O
outcome	O
.	O

The	O
main	O
phenotypes	O
of	O
SP	O
are	O
distinguished	O
according	O
the	O
leading	O
resuscitation	O
syndrome	O
(	O
SP	O
with	O
sepsis	B-SPEC
without	O
multiple	O
organ	O
failure	O
(	O
6	O
.	O
9	O
%)	O
including	O
SP	O
with	O
clinical	O
manifestations	O
of	O
acute	O
respiratory	O
failure	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
4	O
.	O
0	O
%),	O
SP	O
with	O
severe	O
sepsis	B-SPEC
(	O
93	O
.	O
1	O
%)	O
including	O
SP	O
with	O
septic	O
shock	O
(	O
26	O
.	O
7	O
%).	O

We	O
did	O
not	O
identify	O
Middle	O
East	O
respiratory	O
coronavirus	B-SPEC
carriage	O
.	O

TITLE	O
:	O
Differential	O
effects	O
of	O
viroporin	O
inhibitors	O
against	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
serotypes	O
I	O
and	O
II	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIP	O
virus	B-SPEC
:	O
FIPV	O
),	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
of	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
,	O
causes	O
a	O
fatal	O
disease	O
called	O
FIP	O
in	O
wild	O
and	O
domestic	B-SPEC
cat	I-SPEC
species	B-SPEC
.	O

No	O
such	O
difference	O
was	O
observed	O
for	O
influenza	B-SPEC
virus	I-SPEC
.	O

ABSTRACT	O
:	O
Treatment	O
of	O
infections	O
caused	O
by	O
multidrug	O
-	O
resistant	O
Pseudomonas	B-SPEC
species	B-SPEC
is	O
difficult	O
because	O
few	O
antibiotics	O
active	O
against	O
such	O
organisms	O
are	O
available	O
.	O

Strains	O
of	O
P	B-SPEC
.	I-SPEC
putida	I-SPEC
producing	O
metallo	O
-	O
beta	O
-	O
lactamases	O
have	O
become	O
more	O
widespread	O
in	O
recent	O
years	O
.	O

TITLE	O
:	O
Limitations	O
of	O
global	O
end	O
-	O
diastolic	O
volume	O
index	O
as	O
a	O
parameter	O
of	O
cardiac	O
preload	O
in	O
the	O
early	O
phase	O
of	O
severe	O
sepsis	B-SPEC
:	O
a	O
subgroup	O
analysis	O
of	O
a	O
multicenter	O
,	O
prospective	O
observational	O
study	O
.	O

To	O
evaluate	O
the	O
relationship	O
between	O
attainment	O
of	O
cardiac	O
preload	O
optimization	O
and	O
GEDI	O
value	O
,	O
GEDI	O
with	O
SVV	B-SPEC
≤	O
13	O
%	O
and	O
SVV	B-SPEC
>	O
13	O
%	O
was	O
compared	O
in	O
both	O
the	O
SIMD	O
and	O
non	O
-	O
SIMD	O
groups	O
.	O

Sequence	O
analysis	O
comparing	O
Pteropus	B-SPEC
alecto	I-SPEC
furin	O
and	O
cathepsin	O
L	O
to	O
proteases	O
from	O
other	O
mammalian	B-SPEC
species	B-SPEC
showed	O
a	O
high	O
degree	O
of	O
conservation	O
;	O
however	O
significant	O
amino	O
acid	O
variation	O
occurs	O
at	O
the	O
C	O
-	O
terminus	O
of	O
Pteropus	B-SPEC
alecto	I-SPEC
furin	O
.	O

RESULTS	O
:	O
Calves	O
with	O
initial	O
antibody	O
titers	O
against	O
BRSV	B-SPEC
<	O
1	O
:	O
64	O
that	O
were	O
treated	O
for	O
BRD	O
had	O
a	O
slower	O
rate	O
of	O
anti	O
-	O
BRSV	B-SPEC
antibody	O
decay	O
than	O
did	O
similar	O
calves	O
that	O
were	O
not	O
treated	O
for	O
BRD	O
.	O

TITLE	O
:	O
Full	O
genome	O
sequence	O
of	O
guinea	B-SPEC
fowl	I-SPEC
coronavirus	B-SPEC
associated	O
with	O
fulminating	O
disease	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
CoV	O
)	O
infection	O
has	O
recently	O
emerged	O
as	O
a	O
cause	O
of	O
severe	O
potentially	O
fatal	O
pneumonia	O
.	O

TITLE	O
:	O
The	O
preparation	O
of	O
chicken	B-SPEC
kidney	O
cell	O
cultures	O
for	O
virus	B-SPEC
propagation	O
.	O

IBV	B-SPEC
and	O
pheasant	O
coronavirus	B-SPEC
replicate	O
well	O
in	O
the	O
embryonated	O
chicken	B-SPEC
egg	O
,	O
regardless	O
of	O
inoculation	O
route	O
;	O
however	O
,	O
the	O
allantoic	O
route	O
is	O
favored	O
as	O
these	O
viruses	B-SPEC
replicate	O
well	O
in	O
epithelium	O
lining	O
the	O
chorioallantoic	O
membrane	O
,	O
with	O
high	O
virus	B-SPEC
titers	O
found	O
in	O
these	O
membranes	O
and	O
associated	O
allantoic	O
fluids	O
.	O

In	O
this	O
chapter	O
we	O
provide	O
a	O
detailed	O
description	O
of	O
three	O
techniques	O
to	O
estimate	O
the	O
number	O
of	O
viable	O
infectious	O
avian	B-SPEC
coronaviruses	O
in	O
a	O
sample	O
.	O

TITLE	O
:	O
Purification	O
of	O
coronavirus	B-SPEC
virions	O
for	O
Cryo	O
-	O
EM	O
and	O
proteomic	O
analysis	O
.	O

Here	O
,	O
we	O
describe	O
a	O
method	O
for	O
incorporating	O
a	O
proteinaceous	O
viral	O
receptor	O
,	O
feline	B-SPEC
aminopeptidase	O
N	O
(	O
fAPN	O
),	O
into	O
SLBs	O
using	O
cell	O
blebbing	O
of	O
mammalian	B-SPEC
cells	O
expressing	O
fAPN	O
in	O
the	O
plasma	O
membrane	O
.	O

This	O
receptor	O
binds	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FECV	B-SPEC
1683	O
).	O

Female	O
BALB	O
/	O
c	O
mice	B-SPEC
were	O
immunized	O
with	O
the	O
purified	O
recombinant	O
S	O
protein	O
,	O
and	O
a	O
monoclonal	O
antibody	O
(	O
MAb	O
)	O
designated	O
as	O
2D1	O
against	O
S	O
protein	O
was	O
achieved	O
by	O
hybridoma	O
technique	O
.	O

Diagnosis	O
of	O
pulmonary	O
tuberculosis	O
was	O
made	O
10days	O
after	O
admission	O
on	O
examination	O
of	O
cavitary	O
and	O
diffuse	O
infiltrates	O
on	O
a	O
second	O
CT	O
scan	O
,	O
in	O
addition	O
to	O
presence	O
of	O
acid	O
-	O
fast	O
bacilli	B-SPEC
on	O
smear	O
examination	O
of	O
bronchial	O
aspirates	O
.	O

In	O
samples	O
from	O
symptomatic	O
children	O
,	O
parainfluenza	O
viruses	B-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
and	O
coronavirus	B-SPEC
OC43	O
were	O
detected	O
in	O
addition	O
to	O
those	O
mentioned	O
above	O
.	O

Specimens	O
from	O
healthy	O
animals	B-SPEC
were	O
also	O
collected	O
.	O

Monitoring	O
of	O
influenza	B-SPEC
viruses	I-SPEC
must	O
be	O
a	O
priority	O
but	O
other	O
respiratory	O
viruses	B-SPEC
and	O
non	O
-	O
viral	O
causes	O
may	O
be	O
of	O
interest	O
too	O
.	O

No	O
pathogens	O
were	O
identified	O
in	O
animal	B-SPEC
specimens	O
.	O

TITLE	O
:	O
VHL	O
negatively	O
regulates	O
SARS	O
coronavirus	B-SPEC
replication	O
by	O
modulating	O
nsp16	O
ubiquitination	O
and	O
stability	O
.	O

SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
nonstructural	O
protein	O
nsp16	O
functions	O
as	O
a	O
methyltransferase	O
,	O
to	O
methylate	O
mRNA	O
cap	O
-	O
0	O
structure	O
at	O
the	O
ribose	O
2	O
'-	O
O	O
position	O
of	O
the	O
first	O
nucleotide	O
to	O
form	O
cap	O
-	O
1	O
structures	O
.	O

TITLE	O
:	O
MERS	O
coronavirus	B-SPEC
envelope	O
protein	O
has	O
a	O
single	O
transmembrane	O
domain	O
that	O
forms	O
pentameric	O
ion	O
channels	O
.	O

We	O
retrospectively	O
analyzed	O
data	O
from	O
patients	O
reported	O
to	O
the	O
US	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
with	O
a	O
diagnosis	O
of	O
malaria	O
parasite	O
single	O
-	O
species	B-SPEC
infection	O
between	O
1985	O
and	O
2011	O
.	O

Compared	O
with	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
(	O
n	O
=	O
163	O
),	O
the	O
odds	O
of	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
cases	O
classified	O
as	O
severely	O
ill	O
(	O
n	O
=	O
1416	O
)	O
were	O
1	O
.	O
9	O
(	O
P	O
=	O
.	O
0006	O
),	O
.	O
5	O
(	O
P	O
=	O
.	O
001	O
),	O
and	O
1	O
.	O
3	O
times	O
(	O
P	O
=	O
.	O
1	O
)	O
as	O
likely	O
to	O
present	O
as	O
cerebral	O
,	O
acute	O
respiratory	O
distress	O
,	O
and	O
renal	O
syndromes	O
,	O
respectively	O
.	O

Nineteen	O
cats	B-SPEC
had	O
a	O
definitive	O
histopathological	O
diagnosis	O
of	O
FIP	O
(	O
seven	O
of	O
these	O
with	O
neurological	O
and	O
/	O
or	O
ocular	O
signs	O
),	O
and	O
15	O
cats	B-SPEC
had	O
other	O
diseases	O
but	O
similar	O
clinical	O
signs	O
(	O
three	O
of	O
these	O
with	O
neurological	O
and	O
/	O
or	O
ocular	O
signs	O
).	O

Real	O
-	O
time	O
RT	O
-	O
PCR	O
of	O
CSF	O
showed	O
a	O
specificity	O
of	O
100	O
%	O
in	O
diagnosing	O
FIP	O
,	O
a	O
sensitivity	O
of	O
42	O
.	O
1	O
%,	O
a	O
PPV	B-SPEC
of	O
100	O
%	O
and	O
an	O
NPV	O
of	O
57	O
.	O
7	O
%.	O

The	O
sensitivity	O
of	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
of	O
CSF	O
in	O
cats	B-SPEC
with	O
neurological	O
and	O
/	O
or	O
ocular	O
signs	O
was	O
85	O
.	O
7	O
%.	O

Subsequent	O
structural	O
modification	O
on	O
p	O
-	O
HAP	O
and	O
its	O
glycoside	O
led	O
to	O
the	O
synthesis	O
of	O
28	O
additional	O
derivatives	O
,	O
of	O
which	O
13	O
compounds	O
showed	O
activity	O
inhibiting	O
hepatitis	O
B	O
surface	O
antigen	O
(	O
HBsAg	O
)	O
secretion	O
;	O
and	O
18	O
compounds	O
possessed	O
inhibition	O
on	O
HBV	B-SPEC
DNA	O
replication	O
.	O

TITLE	O
:	O
Synthesis	O
of	O
erythrocentaurin	O
derivatives	O
as	O
a	O
new	O
class	B-SPEC
of	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
inhibitors	O
.	O

Eight	O
compounds	O
1	O
,	O
2	O
,	O
5	O
,	O
8	O
,	O
9	O
,	O
1e	O
,	O
1k	O
,	O
and	O
1m	O
increased	O
activity	O
against	O
HBV	B-SPEC
DNA	O
replication	O
with	O
the	O
SI	O
values	O
higher	O
than	O
11	O
.	O

A	O
37	O
-	O
year	O
-	O
old	O
man	B-SPEC
complaining	O
of	O
persisting	O
cough	O
was	O
referred	O
to	O
our	O
hospital	O
.	O

TITLE	O
:	O
From	O
the	O
traditional	O
Chinese	O
medicine	O
plant	B-SPEC
Schisandra	B-SPEC
chinensis	I-SPEC
new	O
scaffolds	O
effective	O
on	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
resistant	O
to	O
non	O
-	O
nucleoside	O
inhibitors	O
.	O

fruits	O
,	O
commonly	O
used	O
in	O
Traditional	O
Chinese	O
Medicine	O
,	O
to	O
affect	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
functions	O
.	O

In	O
this	O
study	O
,	O
U	O
.	O
S	O
.	O
PDCoV	O
strain	O
OH	O
-	O
FD22	O
from	O
intestinal	O
contents	O
of	O
a	O
diarrheic	O
pig	B-SPEC
from	O
Ohio	O
was	O
isolated	O
in	O
swine	B-SPEC
testicular	O
(	O
ST	O
)	O
and	O
LLC	O
porcine	B-SPEC
kidney	O
(	O
LLC	O
-	O
PK	O
)	O
cell	O
cultures	O
by	O
using	O
various	O
medium	O
additives	O
.	O

ABSTRACT	O
:	O
To	O
retrospectively	O
evaluate	O
the	O
efficacy	O
and	O
safety	O
of	O
rituximab	O
(	O
Rtx	O
)	O
treatment	O
in	O
patients	O
with	O
anti	O
-	O
synthetase	O
syndrome	O
(	O
ASS	B-SPEC
)	O
and	O
severe	O
interstitial	O
lung	O
disease	O
(	O
ILD	O
).	O

Patients	O
with	O
severe	O
ILD	O
and	O
>	O
12	O
months	O
follow	O
-	O
up	O
post	O
-	O
Rtx	O
were	O
identified	O
from	O
the	O
Oslo	O
University	O
Hospital	O
ASS	B-SPEC
cohort	O
(	O
n	O
=	O
112	O
).	O

The	O
mortality	O
rate	O
in	O
the	O
Rtx	O
-	O
treated	O
group	O
was	O
comparable	O
to	O
that	O
of	O
the	O
remaining	O
ASS	B-SPEC
cohort	O
(	O
25	O
/	O
78	O
deceased	O
;	O
32	O
%).	O

ABSTRACT	O
:	O
We	O
report	O
a	O
case	O
of	O
an	O
adult	O
patient	O
with	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
ventilator	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
caused	O
by	O
multidrug	O
resistant	O
(	O
MDR	O
)	O
bacteria	B-SPEC
that	O
was	O
successfully	O
managed	O
with	O
veno	O
-	O
venous	O
extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
).	O

The	O
optimum	O
conditions	O
for	O
differentiation	O
between	O
anti	O
-	O
TCoV	O
hyperimmune	O
serum	O
and	O
normal	O
turkey	B-SPEC
serum	O
were	O
recombinant	O
TCoV	O
N	O
protein	O
concentration	O
at	O
20	O
μg	O
/	O
ml	O
,	O
serum	O
dilution	O
at	O
1	O
:	O
800	O
,	O
and	O
conjugate	O
dilution	O
at	O
1	O
:	O
10	O
,	O
000	O
.	O

In	O
addition	O
,	O
inhibitory	O
activity	O
of	O
this	O
compound	O
was	O
selective	O
for	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
PLpro	O
enzymes	O
over	O
two	O
human	B-SPEC
homologues	O
,	O
the	O
ubiquitin	O
C	O
-	O
terminal	O
hydrolases	O
1	O
and	O
3	O
(	O
hUCH	O
-	O
L1	O
and	O
hUCH	O
-	O
L3	O
).	O

Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
represents	O
the	O
most	O
recent	O
outbreak	O
of	O
a	O
completely	O
novel	O
respiratory	O
virus	B-SPEC
,	O
which	O
occurred	O
in	O
Saudi	O
Arabia	O
in	O
2012	O
and	O
presents	O
a	O
significant	O
threat	O
to	O
human	B-SPEC
health	O
.	O

TITLE	O
:	O
[	O
Recombinant	O
human	B-SPEC
interferon	O
alpha	O
2b	O
broad	O
-	O
spectrum	O
anti	O
-	O
respiratory	O
viruses	B-SPEC
pharmacodynamics	O
study	O
in	O
vitro	O
].	O

Recombinant	O
human	B-SPEC
interferon	O
alpha	O
2b	O
in	O
vitro	O
has	O
broad	O
spectrum	O
antiviral	O
activities	O
,	O
low	O
toxicity	O
and	O
high	O
therapeutic	O
index	O
.	O

TITLE	O
:	O
Origin	O
,	O
evolution	O
,	O
and	O
virulence	O
of	O
porcine	B-SPEC
deltacoronaviruses	O
in	O
the	O
United	O
States	O
.	O

The	O
finding	O
that	O
PdCV	O
is	O
a	O
significant	O
enteric	O
disease	O
of	O
swine	B-SPEC
highlights	O
the	O
need	O
to	O
develop	O
effective	O
measures	O
to	O
control	O
this	O
disease	O
.	O

The	O
innate	O
immune	O
response	O
is	O
the	O
first	O
line	O
of	O
antiviral	O
defense	O
that	O
culminates	O
with	O
the	O
synthesis	O
of	O
interferon	O
and	O
proinflammatory	O
cytokines	O
to	O
limit	O
virus	B-SPEC
replication	O
.	O

ABSTRACT	O
:	O
We	O
present	O
a	O
female	O
patient	O
with	O
preterm	O
labor	O
,	O
severe	O
viral	O
hepatitis	O
B	O
of	O
acute	O
phase	O
,	O
hepatic	O
encephalopathy	O
stage	O
III	O
and	O
coma	B-SPEC
.	O

There	O
are	O
currently	O
no	O
vaccines	O
or	O
norovirus	B-SPEC
-	O
specific	O
antiviral	O
therapeutics	O
available	O
for	O
the	O
management	O
of	O
norovirus	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
All	O
medical	O
staff	O
and	O
travellers	O
to	O
the	O
Arabian	O
Peninsula	O
should	O
be	O
aware	O
of	O
a	O
new	O
epidemic	O
caused	O
by	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
which	O
has	O
emerged	O
in	O
the	O
Arabian	O
Peninsula	O
(	O
2012	O
),	O
secondary	O
cases	O
have	O
been	O
seen	O
in	O
Africa	O
,	O
Europe	O
,	O
Asia	O
and	O
the	O
United	O
States	O
.	O

Epidemiological	O
and	O
genetic	O
studies	O
point	O
at	O
zoonotic	O
transmission	O
of	O
MERS	O
-	O
CoV	O
from	O
camels	B-SPEC
and	O
possibly	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
article	O
reviews	O
the	O
clinical	O
and	O
treatment	O
aspects	O
of	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
and	O
the	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Mortality	O
,	O
ADG	O
and	O
FCR	O
were	O
significantly	O
different	O
in	O
PEDv	B-SPEC
-	O
positive	O
(	O
infected	O
)	O
compared	O
with	O
PEDv	B-SPEC
-	O
negative	O
(	O
control	O
)	O
batches	O
,	O
with	O
a	O
mean	O
increase	O
of	O
mortality	O
and	O
FCR	O
of	O
11	O
%	O
and	O
0	O
.	O
5	O
,	O
respectively	O
,	O
and	O
a	O
decrease	O
of	O
ADG	O
of	O
0	O
.	O
16	O
lb	O
/	O
day	O
.	O

These	O
findings	O
help	O
to	O
quantify	O
the	O
impact	O
of	O
PEDv	B-SPEC
infection	O
in	O
the	O
US	O
and	O
,	O
ultimately	O
,	O
contribute	O
to	O
efforts	O
to	O
quantify	O
the	O
cost	O
-	O
effectiveness	O
of	O
disease	O
prevention	O
and	O
control	O
measures	O
.	O

Originally	O
considered	O
to	O
be	O
restricted	O
to	O
humans	B-SPEC
,	O
it	O
is	O
now	O
clear	O
that	O
HEV	B-SPEC
and	O
HEV	B-SPEC
-	I-SPEC
like	I-SPEC
viruses	I-SPEC
have	O
several	O
animal	B-SPEC
reservoirs	O
with	O
complex	O
ecology	O
and	O
genetic	O
diversity	O
,	O
as	O
exemplified	O
by	O
the	O
recent	O
discovery	O
of	O
HEV	B-SPEC
in	O
dromedaries	B-SPEC
,	O
a	O
previously	O
underestimated	O
reservoir	O
of	O
zoonotic	O
viruses	B-SPEC
prior	O
to	O
the	O
emergence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
.	O

Zoonotic	O
foodborne	O
transmission	O
from	O
pigs	B-SPEC
and	O
feral	O
animals	B-SPEC
such	O
as	O
wild	B-SPEC
boar	I-SPEC
is	O
of	O
increasing	O
importance	O
in	O
the	O
rapidly	O
industrializing	O
countries	O
of	O
the	O
Asia	O
Pacific	O
region	O
.	O

In	O
carbohydrate	O
microarray	O
analyses	O
,	O
we	O
explored	O
the	O
molecular	O
basis	O
underlying	O
the	O
striking	O
differences	O
in	O
the	O
spectrum	O
of	O
anti	O
-	O
virus	B-SPEC
activities	O
of	O
the	O
two	O
probes	O
.	O

ABSTRACT	O
:	O
Emerging	O
infectious	O
diseases	O
are	O
often	O
the	O
result	O
of	O
a	O
host	O
shift	O
,	O
where	O
the	O
pathogen	O
originates	O
from	O
a	O
different	O
host	O
species	B-SPEC
.	O

Advances	O
in	O
vaccination	O
and	O
diagnosis	O
should	O
help	O
reduce	O
the	O
amount	O
of	O
disease	O
due	O
to	O
S	B-SPEC
.	I-SPEC
pneumoniae	I-SPEC
,	O
the	O
commonest	O
cause	O
of	O
CAP	O
.	O

Adenovirus	B-SPEC
,	O
astrovirus	O
,	O
norovirus	B-SPEC
GI	O
,	O
norovirus	B-SPEC
GII	O
,	O
rotavirus	B-SPEC
,	O
and	O
sapovirus	B-SPEC
were	O
detected	O
in	O
95	O
(	O
10	O
.	O
0	O
%),	O
33	O
(	O
3	O
.	O
5	O
%),	O
8	O
(	O
0	O
.	O
9	O
%),	O
90	O
(	O
9	O
.	O
6	O
%),	O
49	O
(	O
5	O
.	O
2	O
%),	O
and	O
2	O
(	O
0	O
.	O
2	O
%)	O
of	O
the	O
pediatric	O
samples	O
,	O
respectively	O
.	O

RT	O
-	O
PCR	O
detected	O
99	O
of	O
111	O
(	O
89	O
%)	O
adenovirus	B-SPEC
-	O
positive	O
samples	O
versus	O
12	O
(	O
11	O
%)	O
by	O
EM	O
,	O
and	O
186	O
of	O
192	O
(	O
97	O
%)	O
sapovirus	B-SPEC
/	O
astrovirus	O
/	O
norovirus	B-SPEC
-	O
positive	O
samples	O
versus	O
21	O
(	O
11	O
%)	O
by	O
EM	O
.	O

Noroviruses	B-SPEC
and	O
adenoviruses	B-SPEC
are	O
common	O
causes	O
of	O
gastroenteritis	O
in	O
children	O
.	O

Eight	O
-	O
to	O
11	O
-	O
week	O
-	O
old	O
female	O
C57BL	O
/	O
6OlaHsd	O
mice	B-SPEC
were	O
inoculated	O
with	O
the	O
rodent	B-SPEC
-	O
specific	O
pneumovirus	B-SPEC
pneumonia	B-SPEC
virus	I-SPEC
of	I-SPEC
mice	I-SPEC
(	O
PVM	B-SPEC
)	O
strain	O
J3666	O
and	O
received	O
multiple	O
injections	O
of	O
zVAD	O
or	O
vehicle	O
(	O
control	O
)	O
during	O
the	O
course	O
of	O
disease	O
,	O
after	O
which	O
they	O
were	O
studied	O
for	O
markers	O
of	O
apoptosis	O
,	O
inflammation	O
,	O
and	O
lung	O
injury	O
on	O
day	O
7	O
after	O
infection	O
.	O

We	O
conclude	O
that	O
zVAD	O
has	O
an	O
adverse	O
effect	O
in	O
severe	O
pneumovirus	B-SPEC
disease	O
in	O
mice	B-SPEC
by	O
enhancing	O
the	O
lung	O
proinflammatory	O
response	O
.	O

A	O
total	O
of	O
126	O
proteins	O
were	O
identified	O
that	O
were	O
differentially	O
expressed	O
between	O
the	O
PEDV	B-SPEC
-	O
infected	O
and	O
mock	O
-	O
infected	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
quantitative	O
ratio	O
≥	O
1	O
.	O
2	O
),	O
among	O
which	O
the	O
expression	O
of	O
58	O
proteins	O
was	O
up	O
-	O
regulated	O
and	O
that	O
of	O
68	O
proteins	O
was	O
down	O
-	O
regulated	O
in	O
the	O
PEDV	B-SPEC
-	O
infected	O
Vero	O
E6	O
cells	O
,	O
involving	O
in	O
integrin	O
β2	O
/	O
β3	O
,	O
cystatin	O
-	O
C	O
.	O
The	O
Gene	O
Ontology	O
analysis	O
indicated	O
that	O
the	O
molecular	O
function	O
of	O
the	O
differentially	O
expressed	O
proteins	O
(	O
DEPs	O
)	O
was	O
primarily	O
related	O
to	O
binding	O
and	O
catalytic	O
activity	O
,	O
and	O
that	O
the	O
biological	O
functions	O
in	O
which	O
the	O
DEPs	O
are	O
involved	O
included	O
metabolism	O
,	O
organismal	O
systems	O
,	O
cellular	O
processes	O
,	O
genetic	O
information	O
processing	O
,	O
environmental	O
information	O
processing	O
,	O
and	O
diseases	O
.	O

Peer	O
-	O
reviewed	O
articles	O
were	O
identified	O
through	O
searches	O
of	O
PubMed	O
using	O
the	O
terms	O
""""	O
Middle	O
East	O
respiratory	O
syndrome	O
","""	O
""""	O
coronavirus	B-SPEC
respiratory	O
illness	O
in	O
Saudi	O
Arabia	O
","""	O
and	O
""""	O
novel	O
(	O
beta	O
)	O
coronavirus	B-SPEC
and	O
human	B-SPEC
coronavirus	I-SPEC
Erasmus	O
Medical	O
Center	O
"""."	O

Within	O
months	O
after	O
its	O
emergence	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
was	O
reported	O
in	O
several	O
countries	O
worldwide	O
in	O
people	O
who	O
had	O
traveled	O
from	O
the	O
Middle	O
East	O
.	O

There	O
is	O
currently	O
no	O
recommended	O
treatment	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
although	O
supportive	O
treatment	O
has	O
played	O
an	O
important	O
role	O
.	O

Meta	B-SPEC
-	O
analysis	O
was	O
performed	O
using	O
both	O
a	O
fixed	O
-	O
effect	O
and	O
a	O
random	O
-	O
effects	O
model	O
.	O

TITLE	O
:	O
Receptor	O
usage	O
and	O
cell	O
entry	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
coronavirus	B-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
significantly	O
damaged	O
America	O
'	O
s	O
pork	O
industry	O
.	O

Here	O
we	O
investigate	O
the	O
receptor	O
usage	O
and	O
cell	O
entry	O
of	O
PEDV	B-SPEC
.	O

In	O
contrast	O
,	O
nearly	O
all	O
camels	B-SPEC
in	O
the	O
Middle	O
East	O
have	O
been	O
infected	O
with	O
MERS	O
-	O
CoV	O
.	O
Here	O
,	O
we	O
show	O
that	O
sera	O
obtained	O
from	O
MERS	O
-	O
immune	O
camels	B-SPEC
augment	O
the	O
kinetics	O
of	O
MERS	O
-	O
CoV	O
clearance	O
and	O
reduce	O
the	O
severity	O
of	O
pathological	O
changes	O
in	O
infected	O
lungs	O
,	O
with	O
efficacy	O
proportional	O
to	O
the	O
titer	O
of	O
MERS	O
-	O
CoV	O
-	O
neutralizing	O
serum	O
antibody	O
.	O

The	O
vast	O
majority	O
of	O
,	O
if	O
not	O
all	O
,	O
camels	B-SPEC
in	O
the	O
Middle	O
East	O
have	O
been	O
infected	O
with	O
MERS	O
-	O
CoV	O
,	O
and	O
some	O
contain	O
high	O
titers	O
of	O
antibody	O
to	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Next	O
generation	O
sequencing	O
technologies	O
:	O
tool	O
to	O
study	O
avian	B-SPEC
virus	B-SPEC
diversity	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
),	O
caused	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
is	O
a	O
highly	O
contagious	O
,	O
acute	O
enteric	O
viral	O
disease	O
of	O
swine	B-SPEC
characterized	O
by	O
vomiting	O
,	O
watery	O
diarrhea	O
,	O
dehydration	O
and	O
death	O
.	O

TITLE	O
:	O
Development	O
of	O
animal	B-SPEC
models	O
against	O
emerging	O
coronaviruses	O
:	O
From	O
SARS	O
to	O
MERS	O
coronavirus	B-SPEC
.	O

We	O
investigated	O
potential	O
sources	O
of	O
heterogeneity	O
by	O
a	O
univariant	O
metaregression	O
analysis	O
and	O
calculated	O
the	O
combined	O
incidence	O
of	O
viral	O
infections	O
,	O
viral	O
infections	O
mixed	O
with	O
other	O
pathogens	O
and	O
individual	O
respiratory	O
virus	B-SPEC
species	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
recent	O
emergence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
from	O
the	O
Middle	O
East	O
and	O
the	O
discovery	O
of	O
the	O
virus	B-SPEC
from	O
dromedary	B-SPEC
camels	B-SPEC
have	O
boosted	O
interest	O
in	O
the	O
search	O
for	O
novel	O
viruses	B-SPEC
in	O
dromedaries	B-SPEC
.	O

We	O
describe	O
the	O
discovery	O
of	O
a	O
novel	O
picornavirus	B-SPEC
,	O
dromedary	B-SPEC
camel	B-SPEC
enterovirus	B-SPEC
(	O
DcEV	O
),	O
from	O
dromedaries	B-SPEC
in	O
Dubai	O
.	O

The	O
low	O
ratios	O
of	O
the	O
number	O
of	O
nonsynonymous	O
substitutions	O
per	O
non	O
-	O
synonymous	O
site	O
to	O
the	O
number	O
of	O
synonymous	O
substitutions	O
per	O
synonymous	O
site	O
(	O
Ka	O
/	O
Ks	O
)	O
of	O
various	O
coding	O
regions	O
suggested	O
that	O
dromedaries	B-SPEC
are	O
the	O
natural	O
reservoir	O
in	O
which	O
DcEV	O
has	O
been	O
stably	O
evolving	O
.	O

Western	O
blot	O
analysis	O
using	O
recombinant	O
DcEV	O
VP1	O
polypeptide	O
showed	O
a	O
high	O
seroprevalence	O
of	O
52	O
%	O
among	O
serum	O
samples	O
from	O
172	O
dromedaries	B-SPEC
for	O
IgG	O
,	O
concurring	O
with	O
its	O
much	O
higher	O
infection	O
rates	O
in	O
dromedary	B-SPEC
calves	O
than	O
in	O
adults	O
.	O

Further	O
studies	O
are	O
important	O
to	O
understand	O
the	O
pathogenicity	O
,	O
epidemiology	O
and	O
genetic	O
evolution	O
of	O
DcEV	O
in	O
this	O
unique	O
group	O
of	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
source	O
of	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
epidemic	O
was	O
traced	O
to	O
wildlife	O
market	O
civets	B-SPEC
and	O
ultimately	O
to	O
bats	B-SPEC
.	O

They	O
should	O
be	O
evaluated	O
in	O
suitable	O
animal	B-SPEC
models	O
before	O
clinical	O
trials	O
.	O

TITLE	O
:	O
Dissection	O
of	O
amino	O
-	O
terminal	O
functional	O
domains	O
of	O
murine	B-SPEC
coronavirus	I-SPEC
nonstructural	O
protein	O
3	O
.	O

ABSTRACT	O
:	O
We	O
identified	O
unusual	O
rotavirus	B-SPEC
strains	O
in	O
fecal	O
specimens	O
from	O
sheltered	O
dogs	B-SPEC
in	O
Hungary	O
by	O
viral	O
metagenomics	O
.	O

RVs	O
were	O
found	O
in	O
262	O
patients	O
(	O
27	O
.	O
5	O
%):	O
influenza	B-SPEC
virus	I-SPEC
A	O
(	O
IFV	B-SPEC
A	O
,	O
9	O
.	O
9	O
%)	O
comprised	O
of	O
pandemic	O
H1N1	O
(	O
6	O
.	O
7	O
%)	O
and	O
seasonal	O
H3N2	O
(	O
3	O
.	O
5	O
%),	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
4	O
.	O
3	O
%),	O
adenovirus	B-SPEC
(	O
4	O
.	O
2	O
%),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
1	O
.	O
8	O
%),	O
parainfluenza	O
virus	B-SPEC
1	O
,	O
3	O
and	O
2	O
(	O
1	O
.	O
7	O
%,	O
1	O
.	O
5	O
%	O
and	O
1	O
.	O
2	O
%).	O

Collectively	O
,	O
these	O
findings	O
provide	O
new	O
avenues	O
of	O
investigation	O
into	O
the	O
molecular	O
mechanisms	O
of	O
NF	O
-	O
κB	O
activation	O
induced	O
by	O
PEDV	B-SPEC
infection	O
.	O

TITLE	O
:	O
Co	O
-	O
infections	O
with	O
respiratory	O
viruses	B-SPEC
in	O
dogs	B-SPEC
with	O
bacterial	O
pneumonia	O
.	O

Canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
(	O
CPIV	O
),	O
canine	B-SPEC
adenovirus	I-SPEC
,	O
canine	O
herpes	B-SPEC
virus	I-SPEC
,	O
canine	O
influenzavirus	B-SPEC
,	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
)	O
and	O
canine	O
pneumovirus	B-SPEC
,	O
as	O
well	O
as	O
B	O
.	O
bronchiseptica	O
and	O
Mycoplasma	B-SPEC
spp	O
.	O
were	O
analyzed	O
in	O
respiratory	O
samples	O
using	O
PCR	O
assays	O
.	O

TITLE	O
:	O
Serum	O
biomarkers	O
of	O
oxidative	O
stress	O
in	O
cats	B-SPEC
with	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

PON1	O
was	O
measured	O
by	O
spectrophotometric	O
assays	O
using	O
three	O
different	O
substrates	O
:	O
p	O
-	O
nitrophenyl	O
acetate	O
(	O
pNA	O
),	O
phenyl	O
acetate	O
(	O
PA	O
)	O
and	O
5	O
-	O
thiobutil	O
butyrolactone	O
(	O
TBBL	O
),	O
in	O
order	B-SPEC
to	O
evaluate	O
possible	O
differences	O
between	O
them	O
.	O

A	O
34	O
-	O
year	O
-	O
old	O
,	O
88	O
-	O
kg	O
Caucasian	O
man	B-SPEC
with	O
a	O
history	O
of	O
polysubstance	O
abuse	O
fell	O
from	O
a	O
bridge	O
approximately	O
30	O
-	O
ft	O
high	O
,	O
landing	O
head	O
first	O
in	O
about	O
2	O
-	O
3	O
ft	O
of	O
water	O
.	O

ABSTRACT	O
:	O
An	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
method	O
based	O
on	O
a	O
novel	O
multi	O
-	O
epitope	O
antigen	O
of	O
S	O
protein	O
(	O
SE	O
)	O
was	O
developed	O
for	O
antibodies	O
detection	O
against	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

This	O
assay	O
is	O
sensitive	O
and	O
specific	O
for	O
detection	O
of	O
antibodies	O
against	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
and	O
influenza	B-SPEC
virus	I-SPEC
proteolytic	O
priming	O
takes	O
place	O
in	O
tetraspanin	O
-	O
enriched	O
membrane	O
microdomains	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
and	O
low	O
-	O
pathogenicity	O
influenza	O
A	O
viruses	B-SPEC
(	O
LP	O
IAVs	O
)	O
depend	O
on	O
target	O
cell	O
proteases	O
to	O
cleave	O
their	O
viral	O
glycoproteins	O
and	O
prime	O
them	O
for	O
virus	B-SPEC
-	O
cell	O
membrane	O
fusion	O
.	O

Implications	O
of	O
these	O
findings	O
extend	O
to	O
the	O
use	O
of	O
virus	B-SPEC
entry	O
antagonists	O
,	O
such	O
as	O
protease	O
inhibitors	O
,	O
which	O
might	O
be	O
most	O
effective	O
when	O
localized	O
to	O
these	O
microdomains	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infection	O
:	O
Etiology	O
,	O
epidemiology	O
,	O
pathogenesis	O
and	O
immunoprophylaxis	O
.	O

Endemic	O
PED	O
is	O
a	O
significant	O
problem	O
,	O
which	O
is	O
exacerbated	O
by	O
the	O
emergence	O
(	O
or	O
potential	O
importation	O
)	O
of	O
multiple	O
PEDV	B-SPEC
variants	O
.	O

This	O
review	O
focuses	O
on	O
the	O
etiology	O
,	O
epidemiology	O
,	O
disease	O
mechanisms	O
and	O
pathogenesis	O
as	O
well	O
as	O
immunoprophylaxis	O
against	O
PEDV	B-SPEC
infection	O
.	O

The	O
most	O
variable	O
ORFs	O
in	O
descending	O
order	B-SPEC
were	O
E	O
,	O
3b	O
,	O
5	O
'	O
UTR	O
,	O
N	O
,	O
1a	O
,	O
S	O
,	O
1ab	O
,	O
M	O
,	O
4c	O
,	O
5a	O
,	O
6b	O
.	O

At	O
PIDs	O
1	O
-	O
5	O
,	O
PEDV	B-SPEC
-	O
infected	O
pigs	B-SPEC
exhibited	O
mildly	O
to	O
extensively	O
disorganized	O
,	O
irregular	O
distribution	O
and	O
reduced	O
expression	O
of	O
ZO	O
-	O
1	O
or	O
E	O
-	O
Cadherin	O
in	O
villous	O
,	O
but	O
not	O
crypt	O
epithelial	O
cells	O
of	O
the	O
jejunum	O
and	O
ileum	O
,	O
but	O
not	O
in	O
the	O
large	O
intestine	O
,	O
when	O
compared	O
to	O
the	O
negative	O
controls	O
.	O

After	O
a	O
retrospective	O
search	O
of	O
our	O
database	O
,	O
DIFF	O
and	O
BASO	O
counts	O
,	O
and	O
the	O
ΔTNC	O
from	O
cats	B-SPEC
with	O
and	O
without	O
FIP	O
were	O
compared	O
to	O
each	O
other	O
.	O

Effusions	O
from	O
20	O
FIP	O
and	O
31	O
non	O
-	O
FIP	O
cats	B-SPEC
were	O
analyzed	O
.	O

Most	O
of	O
the	O
synthesized	O
derivatives	O
showed	O
effective	O
anti	O
-	O
HBV	B-SPEC
activity	O
.	O

Samples	O
were	O
tested	O
by	O
multiplex	O
polymerase	O
chain	O
reaction	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
viruses	B-SPEC
1	O
-	O
4	O
,	O
influenza	O
A	O
and	O
B	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
adenovirus	B-SPEC
,	O
and	O
human	B-SPEC
rhinoviruses	B-SPEC
,	O
coronaviruses	O
,	O
and	O
bocavirus	B-SPEC
.	O

Of	O
458	O
patients	O
,	O
116	O
(	O
25	O
%)	O
had	O
respiratory	O
viruses	B-SPEC
detected	O
pre	O
-	O
HCT	O
.	O

Overall	O
,	O
patients	O
with	O
viruses	B-SPEC
detected	O
pre	O
-	O
HCT	O
had	O
fewer	O
days	O
alive	O
and	O
out	O
of	O
the	O
hospital	O
and	O
lower	O
survival	O
at	O
day	O
100	O
(	O
adjusted	O
hazard	O
ratio	O
[	O
aHR	O
],	O
2	O
.	O
4	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
1	O
.	O
3	O
-	O
4	O
.	O
5	O
;	O
P	O
=	O
.	O
007	O
)	O
than	O
patients	O
with	O
negative	O
samples	O
;	O
this	O
risk	O
was	O
also	O
present	O
with	O
rhinovirus	B-SPEC
alone	O
(	O
aHR	O
for	O
mortality	O
,	O
2	O
.	O
6	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
2	O
-	O
5	O
.	O
5	O
;	O
P	O
=	O
.	O
01	O
).	O

In	O
symptomatic	O
patients	O
,	O
those	O
with	O
respiratory	O
viruses	B-SPEC
detected	O
had	O
increased	O
overall	O
mortality	O
compared	O
with	O
patients	O
without	O
viruses	B-SPEC
detected	O
(	O
unadjusted	O
HR	O
,	O
3	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
12	O
.	O
1	O
;	O
P	O
=	O
.	O
05	O
);	O
among	O
asymptomatic	O
patients	O
,	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
was	O
not	O
associated	O
with	O
increased	O
mortality	O
.	O

These	O
data	O
support	O
routine	O
testing	O
for	O
respiratory	O
viruses	B-SPEC
among	O
symptomatic	O
patients	O
before	O
HCT	O
,	O
and	O
delay	O
of	O
transplant	O
with	O
virus	B-SPEC
detection	O
when	O
feasible	O
,	O
even	O
for	O
detection	O
of	O
rhinovirus	B-SPEC
alone	O
.	O

In	O
symptomatic	O
patients	O
,	O
those	O
with	O
respiratory	O
viruses	B-SPEC
detected	O
had	O
increased	O
overall	O
mortality	O
compared	O
with	O
patients	O
without	O
viruses	B-SPEC
detected	O
(	O
unadjusted	O
HR	O
,	O
3	O
.	O
5	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
12	O
.	O
1	O
;	O
P	O
=	O
.	O
05	O
);	O
among	O
asymptomatic	O
patients	O
,	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
was	O
not	O
associated	O
with	O
increased	O
mortality	O
.	O

Histologic	O
lung	O
injury	O
score	O
increased	O
four	O
-	O
fold	O
by	O
HVt	O
but	O
not	O
in	O
simvastatin	O
-	O
pretreated	O
mice	B-SPEC
.	O

Many	O
patients	O
with	O
sepsis	B-SPEC
are	O
unable	O
to	O
provide	O
nutrition	O
for	O
themselves	O
,	O
and	O
therefore	O
initiating	O
artificial	O
nutrition	O
has	O
become	O
part	O
of	O
routine	O
care	O
for	O
these	O
patients	O
.	O

Unlike	O
other	O
enveloped	O
viruses	B-SPEC
,	O
CoVs	O
bud	O
and	O
assemble	O
at	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)-	O
Golgi	O
intermediate	O
compartment	O
(	O
ERGIC	O
).	O

No	O
change	O
in	O
5	O
-	O
FU	O
sensitivity	O
was	O
observed	O
for	O
R80A	O
/	O
E82A	O
-	O
ExoN	O
(-)	O
relative	O
to	O
MHV	B-SPEC
-	O
ExoN	O
(-),	O
indicating	O
that	O
the	O
decreased	O
-	O
fidelity	O
phenotype	O
of	O
R80A	O
/	O
E82A	O
-	O
ExoN	O
(-)	O
is	O
linked	O
to	O
the	O
presence	O
of	O
ExoN	O
activity	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
an	O
emerging	O
human	B-SPEC
coronavirus	I-SPEC
,	O
causes	O
severe	O
acute	O
respiratory	O
illness	O
with	O
a	O
35	O
%	O
mortality	O
rate	O
.	O

The	O
resulting	O
assays	O
could	O
detect	O
0	O
.	O
02	O
to	O
0	O
.	O
2	O
plaque	O
forming	O
units	O
(	O
PFU	O
)	O
(	O
5	O
to	O
50	O
PFU	O
/	O
ml	O
)	O
of	O
MERS	O
-	O
CoV	O
in	O
infected	O
cell	O
culture	O
supernatants	O
within	O
30	O
to	O
50	O
min	O
and	O
did	O
not	O
cross	O
-	O
react	O
with	O
common	O
human	B-SPEC
respiratory	O
pathogens	O
.	O

Additionally	O
,	O
we	O
tested	O
serum	O
samples	O
from	O
shepherds	O
and	O
abattoir	O
workers	O
with	O
occupational	O
exposure	O
to	O
camels	B-SPEC
.	O

First	O
,	O
the	O
lack	O
of	O
a	O
suitable	O
animal	B-SPEC
model	O
for	O
MERS	O
complicates	O
the	O
in	O
vivo	O
testing	O
of	O
candidate	O
vaccines	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
caused	O
by	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

In	O
addition	O
,	O
anti	O
-	O
PDCoV	O
IgG	O
antibodies	O
were	O
detected	O
in	O
archived	O
samples	O
collected	O
in	O
2010	O
,	O
perhaps	O
indicating	O
an	O
earlier	O
undetected	O
introduction	O
into	O
the	O
U	O
.	O
S	O
.	O
pig	B-SPEC
population	O
.	O

Since	O
its	O
introduction	O
to	O
the	O
United	O
States	O
in	O
2013	O
,	O
PEDV	B-SPEC
has	O
spread	O
quickly	O
across	O
the	O
country	O
and	O
has	O
caused	O
significant	O
financial	O
losses	O
to	O
pork	O
producers	O
.	O

After	O
an	O
epidemiologic	O
investigation	O
,	O
an	O
outsourced	O
,	O
pelleted	O
piglet	O
diet	O
was	O
identified	O
for	O
assessment	O
,	O
and	O
a	O
bioassay	O
,	O
where	O
naïve	O
piglets	O
were	O
fed	O
the	O
suspected	O
feed	O
pellets	O
,	O
was	O
initiated	O
to	O
test	O
the	O
pellets	O
for	O
infectious	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
An	O
inactivated	O
vaccine	O
made	O
from	O
a	O
U	O
.	O
S	O
.	O
field	O
isolate	O
of	O
porcine	B-SPEC
epidemic	O
disease	O
virus	B-SPEC
is	O
immunogenic	O
in	O
pigs	B-SPEC
as	O
demonstrated	O
by	O
a	O
dose	O
-	O
titration	O
.	O

Inactivated	O
adjuvanted	O
monovalent	O
vaccines	O
were	O
administered	O
intramuscularly	O
to	O
five	O
week	O
old	O
pigs	B-SPEC
in	O
a	O
dose	O
titration	O
experimental	O
design	O
,	O
ranging	O
from	O
6	O
.	O
0	O
-	O
8	O
.	O
0	O
log10	O
tissue	O
culture	O
infective	O
dose	O
(	O
TCID50	O
/	O
mL	O
),	O
to	O
evaluate	O
immunogenicity	O
using	O
a	O
fluorescent	O
foci	O
neutralization	O
assay	O
(	O
FFN	O
),	O
fluorescent	O
microsphere	O
immunoassay	O
(	O
FMIA	O
),	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
on	O
sera	O
.	O

The	O
Th17	O
/	O
Treg	O
imbalance	O
favoring	O
a	O
Th17	O
shift	O
represents	O
a	O
potential	O
therapeutic	O
target	O
to	O
alleviate	O
lung	O
injury	O
and	O
a	O
novel	O
risk	O
indicator	B-SPEC
in	O
patients	O
with	O
early	O
ARDS	O
.	O

PCV2	O
and	O
HEV	B-SPEC
are	O
both	O
highly	O
prevalent	O
in	O
pig	B-SPEC
farms	O
in	O
China	O
.	O

We	O
speculate	O
that	O
co	O
-	O
infection	O
with	O
PCV2	O
and	O
HEV	B-SPEC
may	O
bring	O
some	O
negative	O
effect	O
on	O
pig	B-SPEC
production	O
and	O
recommend	O
that	O
more	O
attention	O
should	O
be	O
paid	O
to	O
this	O
phenomenon	O
.	O

These	O
results	O
suggest	O
that	O
the	O
novel	O
curcumin	O
analog	O
c26	O
has	O
remarkable	O
protective	O
effects	O
on	O
LPS	O
-	O
induced	O
ALI	O
in	O
rat	B-SPEC
.	O

This	O
study	O
aims	O
to	O
reveal	O
the	O
etiological	O
role	O
of	O
TGEV	B-SPEC
in	O
piglet	O
diarrhea	O
via	O
molecular	O
characterization	O
and	O
phylogenetic	O
analysis	O
.	O

No	O
mixed	O
respiratory	O
virus	B-SPEC
infection	O
was	O
found	O
.	O

Hemoptysis	O
associated	O
with	O
anemia	B-SPEC
and	O
pulmonary	O
infiltrates	O
suggest	O
the	O
diagnosis	O
of	O
alveolar	O
hemorrhage	O
,	O
but	O
may	O
be	O
absent	O
in	O
one	O
third	O
of	O
cases	O
including	O
patients	O
in	O
respiratory	O
distress	O
.	O

TITLE	O
:	O
Analysis	O
of	O
Hypoxemia	O
in	O
Early	O
Ventilator	O
-	O
Associated	O
Pneumonia	O
Secondary	O
to	O
Haemophilus	B-SPEC
in	O
Trauma	O
Patients	O
.	O

CONCLUSIONS	O
:	O
Haemophilus	B-SPEC
species	B-SPEC
bacteria	B-SPEC
pneumonia	O
in	O
trauma	O
patients	O
is	O
associated	O
with	O
high	O
rates	O
of	O
transient	O
hypoxemia	O
and	O
a	O
high	O
tracheostomy	O
rate	O
,	O
although	O
subsequent	O
outcomes	O
are	O
not	O
affected	O
.	O

The	O
data	O
suggested	O
de	O
-	O
N	O
-	O
sulfated	O
heparin	O
,	O
but	O
not	O
N	O
-	O
acetyl	O
-	O
de	O
-	O
O	O
-	O
sulfated	O
heparin	O
,	O
inhibits	O
PEDV	B-SPEC
infection	O
.	O

In	O
summary	O
,	O
our	O
studies	O
revealed	O
that	O
heparan	O
sulfate	O
acts	O
as	O
the	O
attachment	O
factor	O
of	O
PEDV	B-SPEC
in	O
Vero	O
cells	O
.	O

TITLE	O
:	O
IFN	O
-	O
α2a	O
or	O
IFN	O
-	O
β1a	O
in	O
combination	O
with	O
ribavirin	O
to	O
treat	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
pneumonia	O
:	O
a	O
retrospective	O
study	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
associated	O
with	O
significant	O
mortality	O
.	O

Following	O
National	O
Institute	O
for	O
Health	O
Research	O
'	O
s	O
Research	O
Centre	O
(	O
London	O
,	O
United	O
Kingdom	B-SPEC
)	O
approval	O
,	O
the	O
authors	O
of	O
this	O
study	O
conducted	O
a	O
survey	O
of	O
specialist	O
registrars	O
'	O
knowledge	O
of	O
the	O
respiratory	O
and	O
skin	O
protection	O
requirements	O
needed	O
during	O
a	O
resuscitation	O
scenario	O
with	O
Advanced	O
Life	O
Support	O
.	O

TITLE	O
:	O
Phylogenetic	O
Analysis	O
of	O
the	O
Spike	O
(	O
S	O
)	O
Gene	O
of	O
the	O
New	O
Variants	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhoea	I-SPEC
Virus	I-SPEC
in	O
Taiwan	O
.	O

ABSTRACT	O
:	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
(	O
WNV	B-SPEC
)	O
and	O
Dengue	B-SPEC
virus	I-SPEC
(	O
DENV	O
)	O
are	O
important	O
human	B-SPEC
pathogens	O
for	O
which	O
there	O
are	O
presently	O
no	O
vaccine	O
or	O
specific	O
antivirals	O
.	O

Further	O
synthesis	O
of	O
various	O
triazole	O
bioisosteres	O
demonstrated	O
clear	O
structure	O
-	O
activity	O
relationships	O
(	O
SARs	O
)	O
in	O
which	O
the	O
antiviral	O
activity	O
against	O
WNV	B-SPEC
and	O
DENV	O
hinges	O
largely	O
on	O
both	O
the	O
5	O
'-	O
silyl	O
group	O
and	O
the	O
substituent	O
of	O
3	O
'-	O
triazole	O
or	O
its	O
bioisosteres	O
.	O

The	O
lack	O
of	O
vaccine	O
-	O
mediated	O
protection	O
was	O
most	O
pronounced	O
in	O
the	O
1	O
-	O
day	O
-	O
old	O
vaccination	O
group	O
and	O
to	O
a	O
lesser	O
extent	O
the	O
7	O
-	O
day	O
-	O
old	O
group	O
,	O
while	O
the	O
14	O
-	O
day	O
-	O
old	O
and	O
older	O
chickens	B-SPEC
were	O
protected	O
.	O

These	O
data	O
strongly	O
support	O
IBV	B-SPEC
vaccination	O
after	O
day	O
7	O
post	O
hatch	O
.	O

In	O
concert	O
with	O
its	O
reduced	O
genome	O
,	O
the	O
atypical	O
domain	O
architecture	O
indicates	O
that	O
this	O
virus	B-SPEC
represents	O
a	O
unique	O
lineage	O
within	O
the	O
order	B-SPEC
Nidovirales	I-SPEC
.	O

The	O
presence	O
of	O
coronavirus	B-SPEC
in	O
the	O
left	O
eye	O
was	O
confirmed	O
by	O
positive	O
immunohistochemistry	O
.	O

Reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
on	O
formalin	O
fixed	O
paraffin	O
embedded	O
tissue	O
from	O
the	O
lung	O
,	O
spleen	O
,	O
and	O
kidney	O
was	O
negative	O
for	O
FRSCV	O
and	O
positive	O
for	O
ferret	B-SPEC
enteric	I-SPEC
coronavirus	I-SPEC
(	O
FRECV	O
).	O

Systemic	O
coronavirus	B-SPEC
disease	O
in	O
ferrets	B-SPEC
closely	O
resembles	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
in	O
domestic	B-SPEC
cats	I-SPEC
,	O
which	O
can	O
manifest	O
with	O
anterior	O
uveitis	O
,	O
chorioretinitis	O
,	O
optic	O
neuritis	O
,	O
and	O
retinal	O
detachment	O
.	O

The	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
)	O
II	O
,	O
APACHE	O
III	O
,	O
Multiple	O
Organ	O
Dysfunction	O
Score	O
(	O
MODS	O
),	O
Simplified	O
Acute	O
Physiology	O
Score	O
II	O
(	O
SAPS	O
II	O
),	O
and	O
Sepsis	B-SPEC
-	O
related	O
Organ	O
Failure	O
Assessment	O
(	O
SOFA	O
)	O
scores	O
were	O
calculated	O
for	O
patients	O
.	O

One	O
such	O
approach	O
(	O
the	O
Buxco	O
platform	O
)	O
performs	O
unrestrained	O
whole	O
body	O
plethysmography	O
on	O
mice	B-SPEC
which	O
infers	O
thoracic	O
movements	O
from	O
pressure	O
differences	O
from	O
the	O
act	O
of	O
inhalation	O
and	O
exhalation	O
.	O

The	O
interaction	O
between	O
S	O
(	O
1	O
-	O
291	O
),	O
S	O
(	O
277	O
-	O
794	O
),	O
S	O
(	O
548	O
-	O
868	O
)	O
and	O
NCAM	O
were	O
detected	O
by	O
a	O
GST	O
pull	O
-	O
down	O
experiment	O
and	O
yeast	B-SPEC
two	O
-	O
hybrid	O
assay	O
.	O

TITLE	O
:	O
The	O
Prevalence	O
of	O
Human	B-SPEC
Bocavirus	I-SPEC
,	O
Human	B-SPEC
Coronavirus	I-SPEC
-	O
NL63	O
,	O
Human	B-SPEC
Metapneumovirus	I-SPEC
,	O
Human	B-SPEC
Polyomavirus	B-SPEC
KI	O
and	O
WU	O
in	O
Respiratory	O
Tract	O
Infections	O
in	O
Kuwait	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
samples	O
.	O

TITLE	O
:	O
Human	B-SPEC
Coronavirus	I-SPEC
HKU1	I-SPEC
Spike	O
Protein	O
Uses	O
O	O
-	O
Acetylated	O
Sialic	O
Acid	O
as	O
an	O
Attachment	O
Receptor	O
Determinant	O
and	O
Employs	O
Hemagglutinin	O
-	O
Esterase	O
Protein	O
as	O
a	O
Receptor	O
-	O
Destroying	O
Enzyme	O
.	O

Using	O
primary	O
human	B-SPEC
ciliated	O
airway	O
epithelial	O
(	O
HAE	O
)	O
cell	O
cultures	O
,	O
the	O
only	O
in	O
vitro	O
replication	O
model	O
for	O
hCoV	O
-	O
HKU1	O
infection	O
,	O
we	O
confirmed	O
that	O
pretreatment	O
of	O
HAE	O
cells	O
with	O
HE	O
but	O
not	O
the	O
enzymatically	O
inactive	O
mutant	O
blocked	O
hCoV	O
-	O
HKU1	O
infection	O
.	O

These	O
results	O
demonstrate	O
that	O
hCoV	O
-	O
HKU1	O
exploits	O
O	O
-	O
Ac	O
-	O
Sia	B-SPEC
as	O
a	O
cellular	O
attachment	O
receptor	O
determinant	O
to	O
initiate	O
the	O
infection	O
of	O
host	O
cells	O
and	O
that	O
its	O
HE	O
protein	O
possesses	O
the	O
corresponding	O
sialate	O
-	O
O	O
-	O
acetylesterase	O
RDE	O
activity	O
.	O

Human	B-SPEC
coronaviruses	O
(	O
hCoV	O
)	O
are	O
important	O
human	B-SPEC
respiratory	O
pathogens	O
.	O

Interestingly	O
,	O
the	O
virus	B-SPEC
seems	O
to	O
employ	O
a	O
type	O
of	O
sialic	O
acid	O
different	O
from	O
those	O
employed	O
by	O
other	O
group	O
2a	O
CoVs	O
.	O

Calves	O
with	O
a	O
negative	O
serostatus	O
for	O
BCV	B-SPEC
(	O
HR	O
=	O
1	O
.	O
7	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
0	O
-	O
2	O
.	O
8	O
))	O
or	O
BRSV	B-SPEC
(	O
HR	O
=	O
2	O
.	O
0	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
0	O
-	O
3	O
.	O
9	O
))	O
had	O
an	O
increased	O
BRD	O
hazard	O
.	O

TITLE	O
:	O
Comparative	O
pathogenesis	O
of	O
US	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
strain	O
PC21A	O
in	O
conventional	O
9	O
-	O
day	O
-	O
old	O
nursing	O
piglets	O
vs	O
.	O
26	O
-	O
day	O
-	O
old	O
weaned	O
pigs	B-SPEC
.	O

Biologic	O
mediators	O
that	O
promote	O
crypt	O
stem	O
cell	O
regeneration	O
would	O
be	O
targets	O
to	O
improve	O
the	O
intestinal	O
epithelium	O
renewal	O
during	O
PEDV	B-SPEC
infection	O
.	O

Pigs	B-SPEC
S3	O
and	O
S4	O
were	O
PCR	O
and	O
antibody	O
negative	O
following	O
commingling	O
.	O

TITLE	O
:	O
Structures	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
3C	O
-	O
like	O
protease	O
reveal	O
insights	O
into	O
substrate	O
specificity	O
.	O

After	O
virus	B-SPEC
inoculation	O
,	O
neither	O
clinical	O
signs	O
nor	O
evident	O
gross	O
lesions	O
were	O
observed	O
.	O

ABSTRACT	O
:	O
This	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
effects	O
of	O
open	O
endotracheal	O
suctioning	O
on	O
gas	O
exchange	O
and	O
respiratory	O
mechanics	O
in	O
ARF	O
patients	O
under	O
the	O
modes	O
of	O
PCV	B-SPEC
or	O
VCV	O
.	O

TITLE	O
:	O
Progress	O
and	O
challenges	O
toward	O
the	O
development	O
of	O
vaccines	O
against	O
avian	B-SPEC
infectious	O
bronchitis	O
.	O

In	O
concordance	O
with	O
the	O
16s	O
-	O
tag	O
data	O
,	O
Stenotrohomonas	O
maltophilia	O
(	O
Xanthomonadaceae	B-SPEC
)	O
and	O
Ochrobactrum	B-SPEC
anthropi	I-SPEC
(	O
Brucellaceae	B-SPEC
)	O
were	O
isolated	O
from	O
lungs	O
of	O
mice	B-SPEC
from	O
both	O
groups	O
.	O

Sepsis	B-SPEC
is	O
one	O
of	O
the	O
main	O
illnesses	O
among	O
ARDS	O
causes	O
.	O

Of	O
these	O
15	O
patients	O
,	O
none	O
were	O
hospitalized	O
,	O
5	O
were	O
infected	O
with	O
coronavirus	B-SPEC
alone	O
,	O
8	O
were	O
co	O
-	O
infected	O
with	O
another	O
virus	B-SPEC
,	O
and	O
2	O
were	O
co	O
-	O
infected	O
with	O
2	O
other	O
viruses	B-SPEC
.	O

He	O
had	O
left	O
a	O
polytetrafluoroethylene	O
-	O
coated	O
pan	B-SPEC
on	O
a	O
gas	O
-	O
burning	O
stove	O
for	O
10	O
hours	O
while	O
unconscious	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
developed	O
a	O
new	O
real	O
-	O
time	O
RT	O
-	O
LAMP	O
method	O
,	O
which	O
is	O
rapid	O
,	O
sensitive	O
and	O
efficient	O
to	O
detect	O
PEDV	B-SPEC
.	O
This	O
method	O
holds	O
great	O
promises	O
not	O
only	O
in	O
laboratory	O
detection	O
and	O
discrimination	O
of	O
PEDV	B-SPEC
but	O
also	O
in	O
large	O
scale	O
field	O
and	O
clinical	O
studies	O
.	O

TITLE	O
:	O
A	O
Single	O
Point	O
Mutation	O
Creating	O
a	O
Furin	O
Cleavage	O
Site	O
in	O
the	O
Spike	O
Protein	O
Renders	O
Porcine	B-SPEC
Epidemic	O
Diarrhea	O
Coronavirus	B-SPEC
Trypsin	O
Independent	O
for	O
Cell	O
Entry	O
and	O
Fusion	O
.	O

ABSTRACT	O
:	O
The	O
emerging	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
requires	O
trypsin	O
supplementation	O
to	O
activate	O
its	O
S	O
protein	O
for	O
membrane	O
fusion	O
and	O
virus	B-SPEC
propagation	O
in	O
cell	O
culture	O
.	O

PEDV	B-SPEC
-	O
SFCS	O
exhibited	O
trypsin	O
-	O
independent	O
cell	O
-	O
cell	O
fusion	O
and	O
was	O
able	O
to	O
replicate	O
in	O
culture	O
cells	O
independently	O
of	O
trypsin	O
,	O
though	O
to	O
low	O
titer	O
.	O

TITLE	O
:	O
In	O
vivo	O
assessment	O
of	O
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
vaccine	O
improvement	O
by	O
disabling	O
the	O
deubiquitinase	O
activity	O
of	O
papain	O
-	O
like	O
protease	O
2	O
.	O

By	O
comparing	O
data	O
from	O
mutant	O
versus	O
wild	O
-	O
type	O
virus	B-SPEC
and	O
host	O
strains	O
,	O
RNA	O
versus	O
protein	O
differential	O
expression	O
,	O
and	O
infection	O
with	O
genetically	O
similar	O
strains	O
,	O
these	O
data	O
can	O
be	O
used	O
to	O
further	O
investigate	O
genetic	O
and	O
physiological	O
determinants	O
of	O
host	O
responses	O
to	O
viral	O
infection	O
.	O

The	O
recent	O
rise	O
of	O
PEDV	B-SPEC
outbreaks	O
in	O
Asia	O
and	O
North	O
America	O
warrants	O
an	O
urgent	O
search	O
for	O
effective	O
vaccines	O
.	O

Here	O
,	O
we	O
engineered	O
VeroE6	O
cells	O
to	O
stably	O
express	O
porcine	B-SPEC
aminopeptidase	O
N	O
(	O
pAPN	O
)	O
and	O
used	O
them	O
as	O
a	O
platform	O
to	O
obtain	O
a	O
high	O
-	O
growth	O
variant	O
of	O
PEDV	B-SPEC
,	O
termed	O
PEDVAVCT12	O
.	O

Hospitalized	O
patients	O
with	O
respiratory	O
tract	O
infections	O
(	O
RTI	O
)	O
were	O
investigated	O
for	O
15	O
respiratory	O
viruses	B-SPEC
by	O
using	O
sensitive	O
molecular	O
techniques	O
.	O

The	O
highest	O
combination	O
of	O
viral	O
mixed	O
detection	O
was	O
identified	O
with	O
HRV	O
and	O
AdV	O
(	O
2	O
%),	O
followed	O
by	O
HRV	O
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
(	O
1	O
.	O
4	O
%).	O

We	O
have	O
studied	O
experimental	O
acute	O
lung	O
injury	O
(	O
ALI	O
)	O
in	O
mice	B-SPEC
following	O
airway	O
deposition	O
of	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
or	O
the	O
recombinant	O
mouse	B-SPEC
complement	O
anaphylatoxin	O
,	O
C5a	O
.	O

We	O
detected	O
ticks	B-SPEC
on	O
most	O
(	O
81	O
%)	O
coyotes	B-SPEC
,	O
with	O
Amblyomma	B-SPEC
americanum	I-SPEC
detected	O
on	O
83	O
%	O
of	O
those	O
with	O
ticks	B-SPEC
.	O

TITLE	O
:	O
3D	O
tissue	O
-	O
like	O
assemblies	O
:	O
A	O
novel	O
approach	O
to	O
investigate	O
virus	B-SPEC
-	O
cell	O
interactions	O
.	O

ABSTRACT	O
:	O
Camels	B-SPEC
carry	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
but	O
little	O
is	O
known	O
about	O
infection	O
age	O
or	O
prevalence	O
.	O

This	O
syndrome	O
constitutes	O
an	O
acute	O
,	O
epidemic	O
,	O
and	O
time	O
-	O
limited	O
infection	O
in	O
camels	B-SPEC
<	O
4	O
years	O
of	O
age	O
,	O
particularly	O
calves	O
.	O

ABSTRACT	O
:	O
Humans	B-SPEC
constantly	O
encounter	O
threats	O
from	O
many	O
infectious	O
,	O
zoonotic	O
,	O
and	O
devastating	O
pathogens	O
.	O

The	O
animal	B-SPEC
hosts	O
,	O
including	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
and	O
reservoir	O
hosts	O
(	O
fruit	O
bats	B-SPEC
),	O
play	O
a	O
significant	O
role	O
in	O
transmission	O
and	O
maintenance	O
of	O
EBOV	O
in	O
nature	O
.	O

These	O
fecal	O
and	O
blood	O
meal	O
isolates	O
or	O
a	O
chloroform	O
extract	O
of	O
blood	O
meal	O
induced	O
severe	O
diarrhea	O
and	O
mortality	O
in	O
experimentally	O
infected	O
neonatal	O
pigs	B-SPEC
.	O

Such	O
outbreaks	O
could	O
potentially	O
become	O
more	O
common	O
with	O
the	O
discontinuation	O
of	O
the	O
cross	O
-	O
protective	O
smallpox	B-SPEC
vaccination	O
.	O

Typical	O
for	O
these	O
diseases	O
is	O
a	O
natural	O
circulation	O
between	O
reservoir	O
animals	B-SPEC
in	O
remote	O
areas	O
.	O

Subsequent	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
can	O
lead	O
to	O
epidemics	O
,	O
such	O
as	O
the	O
current	O
outbreak	O
of	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
in	O
West	O
Africa	O
.	O

TITLE	O
:	O
Bats	B-SPEC
as	O
reservoirs	O
of	O
severe	O
emerging	O
infectious	O
diseases	O
.	O

Furthermore	O
,	O
daily	O
weight	O
gain	O
was	O
influenced	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
by	O
dietary	O
treatments	O
throughout	O
the	O
trial	O
,	O
so	O
that	O
the	O
birds	B-SPEC
fed	O
on	O
antibiotics	O
and	O
20	O
to	O
80	O
mg	O
/	O
kg	O
genistein	O
diets	O
revealed	O
the	O
greater	O
weight	O
gains	O
compared	O
with	O
other	O
experimental	O
groups	O
.	O

The	O
best	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
feed	O
conversion	O
ratio	O
assigned	O
to	O
the	O
birds	B-SPEC
fed	O
on	O
diets	O
containing	O
antibiotics	O
and	O
moderate	O
levels	O
(	O
40	O
to	O
80	O
mg	O
/	O
kg	O
)	O
of	O
genistein	O
.	O

Although	O
the	O
relative	O
weights	O
of	O
thymus	B-SPEC
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
bursa	B-SPEC
of	O
Fabricius	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
were	O
greater	O
in	O
birds	B-SPEC
fed	O
on	O
genistein	O
-	O
supplemented	O
diets	O
compared	O
with	O
antibiotics	O
-	O
supplemented	O
birds	B-SPEC
,	O
the	O
spleen	O
weight	O
was	O
not	O
affected	O
by	O
experimental	O
diets	O
.	O

The	O
multivariate	O
analysis	O
carried	O
out	O
on	O
the	O
entire	O
population	O
associated	O
the	O
following	O
factors	O
with	O
higher	O
rates	O
for	O
bronchiolitis	O
hospitalization	O
:	O
male	O
gender	O
;	O
prenatal	O
treatment	O
with	O
corticosteroids	O
;	O
prenatal	O
exposure	O
to	O
maternal	O
smoking	O
;	O
singleton	O
delivery	O
;	O
respiratory	O
diseases	O
in	O
neonatal	O
period	O
;	O
surfactant	O
therapy	O
;	O
lack	O
of	O
breastfeeding	O
;	O
siblings	O
<	O
10	O
years	O
old	O
;	O
living	O
in	O
crowded	O
conditions	O
and	O
/	O
or	O
in	O
unhealthy	O
households	O
and	O
early	O
exposure	O
to	O
the	O
epidemic	O
RSV	B-SPEC
season	O
.	O

To	O
this	O
end	O
,	O
we	O
sequenced	O
complete	O
nsp12	O
,	O
S	O
,	O
and	O
N	O
genes	O
of	O
15	O
molecular	O
isolates	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
from	O
clinical	O
samples	O
and	O
compared	O
them	O
to	O
available	O
data	O
from	O
the	O
USA	O
,	O
Belgium	O
,	O
and	O
Hong	O
-	O
Kong	O
.	O

Identification	O
of	O
these	O
recombinant	O
viruses	B-SPEC
,	O
together	O
with	O
temporal	O
analysis	O
and	O
tMRCA	O
estimation	O
,	O
provides	O
important	O
information	O
for	O
understanding	O
the	O
dynamics	O
of	O
the	O
evolution	O
of	O
these	O
epidemic	O
coronaviruses	O
.	O

TITLE	O
:	O
Toll	O
-	O
Like	O
Receptor	O
3	O
Signaling	O
via	O
TRIF	O
Contributes	O
to	O
a	O
Protective	O
Innate	O
Immune	O
Response	O
to	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
.	O

A	O
total	O
of	O
62	O
patients	O
with	O
sepsis	B-SPEC
,	O
167	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
32	O
healthy	O
volunteers	O
were	O
enrolled	O
in	O
this	O
prospective	O
observational	O
study	O
.	O

The	O
AUC	O
of	O
TF	O
for	O
predicting	O
30	O
-	O
day	O
mortality	O
in	O
severe	O
sepsis	B-SPEC
patients	O
was	O
0	O
.	O
718	O
(	O
95	O
%	O
CI	O
0	O
.	O
641	O
-	O
0	O
.	O
794	O
).	O

Our	O
data	O
showed	O
that	O
tissue	O
factor	O
is	O
a	O
valuable	O
diagnostic	O
biomarker	O
for	O
the	O
diagnosis	O
of	O
sepsis	B-SPEC
-	O
induced	O
ARDS	O
.	O

In	O
this	O
study	O
,	O
the	O
complete	O
genomes	O
of	O
three	O
Vietnamese	O
PEDV	B-SPEC
isolates	O
were	O
characterized	O
.	O

These	O
three	O
isolates	O
were	O
isolated	O
from	O
3	O
-	O
day	O
-	O
old	O
pigs	B-SPEC
experiencing	O
diarrhea	O
.	O

Two	O
isolates	O
were	O
from	O
swine	B-SPEC
farms	O
in	O
the	O
south	O
,	O
and	O
the	O
other	O
was	O
from	O
northern	O
Vietnam	O
.	O

The	O
whole	O
genome	O
sequences	O
of	O
these	O
isolates	O
are	O
28	O
,	O
035	O
nucleotides	O
in	O
length	O
and	O
have	O
characteristics	O
similar	O
to	O
those	O
of	O
other	O
PEDV	B-SPEC
isolates	O
.	O

TITLE	O
:	O
Factors	O
secreted	O
from	O
dental	O
pulp	O
stem	O
cells	O
show	O
multifaceted	O
benefits	O
for	O
treating	O
acute	O
lung	O
injury	O
in	O
mice	B-SPEC
.	O

We	O
evaluated	O
the	O
use	O
of	O
stem	O
cells	O
derived	O
from	O
human	B-SPEC
exfoliated	O
deciduous	O
teeth	O
(	O
SHEDs	O
)	O
or	O
SHED	O
-	O
derived	O
serum	O
-	O
free	O
conditioned	O
medium	O
(	O
SHED	O
-	O
CM	O
)	O
as	O
treatments	O
for	O
bleomycin	O
(	O
BLM	O
)-	O
induced	O
mice	B-SPEC
acute	O
lung	O
injury	O
(	O
ALI	O
),	O
exhibiting	O
several	O
pathogenic	O
features	O
associated	O
with	O
the	O
human	B-SPEC
disease	O
ARDS	O
.	O

This	O
investigation	O
suggests	O
a	O
beneficial	O
effect	O
of	O
continuous	O
statin	O
therapy	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
-	O
associated	O
ARDS	O
and	O
a	O
history	O
of	O
prior	O
statin	O
therapy	O
.	O

TITLE	O
:	O
Influenza	O
induces	O
IL	O
-	O
8	O
and	O
GM	O
-	O
CSF	O
secretion	O
by	O
human	B-SPEC
alveolar	O
epithelial	O
cells	O
through	O
HGF	O
/	O
c	O
-	O
Met	O
and	O
TGF	O
-	O
α	O
/	O
EGFR	O
signaling	O
.	O

Electronic	O
searches	O
were	O
made	O
in	O
PubMed	O
,	O
EMBASE	O
,	O
Web	O
of	O
Science	O
,	O
Cochrane	O
Library	O
,	O
and	O
Scopus	B-SPEC
with	O
the	O
following	O
specific	O
keywords	O
:	O
noninvasive	O
ventilation	O
,	O
noninvasive	O
positive	O
pressure	O
ventilation	O
,	O
continuous	O
positive	O
airway	O
pressure	O
,	O
and	O
high	O
-	O
flow	O
nasal	O
cannula	B-SPEC
.	O

Binding	O
of	O
all	O
coronaviral	O
S1	O
proteins	O
was	O
dependent	O
on	O
sialic	O
acids	O
;	O
however	O
,	O
while	O
chicken	B-SPEC
CoV	O
S1	O
preferred	O
sialic	O
acids	O
type	O
I	O
lactosamine	O
(	O
Gal	O
(	O
1	O
-	O
3	O
)	O
GlcNAc	O
)	O
over	O
type	O
II	O
(	O
Gal	O
(	O
1	O
-	O
4	O
)	O
GlcNAc	O
),	O
the	O
fine	O
glycan	O
specificities	O
of	O
pigeon	B-SPEC
and	O
partridge	O
CoVs	O
were	O
different	O
,	O
as	O
chicken	B-SPEC
CoV	O
S1	O
-	O
specific	O
sialylglycopolymers	O
could	O
not	O
block	O
their	O
binding	O
to	O
tissues	O
.	O

Variant	O
viruses	B-SPEC
evolve	O
due	O
to	O
spontaneous	O
mutations	O
and	O
recombinations	O
,	O
causing	O
disease	O
in	O
vaccinated	O
flocks	O
of	O
all	O
ages	O
.	O

The	O
nsp5	O
of	O
the	O
newly	O
emerging	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
identified	O
as	O
3CLpro	O
and	O
its	O
canonical	O
cleavage	O
sites	O
(	O
between	O
nsps	O
)	O
were	O
predicted	O
based	O
on	O
sequence	O
alignment	O
,	O
but	O
the	O
cleavability	O
of	O
these	O
cleavage	O
sites	O
remains	O
to	O
be	O
experimentally	O
confirmed	O
and	O
putative	O
non	O
-	O
canonical	O
cleavage	O
sites	O
(	O
inside	O
one	O
nsp	O
)	O
within	O
the	O
pp1a	O
/	O
1ab	O
awaits	O
further	O
analysis	O
.	O

More	O
intensive	O
surveillance	O
studies	O
in	O
bats	B-SPEC
and	O
other	O
animals	B-SPEC
may	O
reveal	O
the	O
natural	O
host	O
of	O
HCoV	O
-	O
EMC	O
.	O

Therefore	O
,	O
as	O
a	O
proof	O
of	O
principle	O
,	O
the	O
current	O
results	O
indicate	O
that	O
coronavirus	B-SPEC
2	O
'-	O
O	O
-	O
MTase	O
activity	O
can	O
be	O
targeted	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
aminopeptidase	O
N	O
(	O
pAPN	O
)	O
is	O
a	O
functional	O
receptor	O
for	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

Although	O
PEDV	B-SPEC
is	O
known	O
to	O
use	O
the	O
pAPN	O
as	O
the	O
major	O
receptor	O
for	O
cell	O
entry	O
,	O
the	O
crucial	O
domain	O
of	O
the	O
pAPN	O
that	O
interacts	O
with	O
the	O
PEDV	B-SPEC
is	O
still	O
unknown	O
.	O

TITLE	O
:	O
Cerebral	O
pyogranuloma	O
associated	O
with	O
systemic	O
coronavirus	B-SPEC
infection	O
in	O
a	O
ferret	B-SPEC
.	O

In	O
the	O
case	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
the	O
activity	O
was	O
highly	O
promising	O
with	O
an	O
EC50	O
<	O
10	O
μM	O
and	O
a	O
CC50	O
>	O
100	O
μM	O
.	O
As	O
such	O
,	O
these	O
doubly	O
flexible	O
nucleoside	O
analogues	O
are	O
viewed	O
as	O
a	O
novel	O
new	O
class	B-SPEC
of	O
drug	O
candidates	O
with	O
potential	O
for	O
potent	O
inhibition	O
of	O
coronaviruses	O
.	O

Of	O
the	O
100	O
HCPs	O
tested	O
during	O
the	O
winter	O
,	O
34	O
subjects	O
were	O
colonized	O
with	O
at	O
least	O
1	O
bacterium	B-SPEC
,	O
and	O
11	O
tested	O
positive	O
for	O
at	O
least	O
1	O
virus	B-SPEC
.	O

RESULTS	O
:	O
Of	O
the	O
100	O
HCPs	O
tested	O
during	O
the	O
winter	O
,	O
34	O
subjects	O
were	O
colonized	O
with	O
at	O
least	O
1	O
bacterium	B-SPEC
,	O
and	O
11	O
tested	O
positive	O
for	O
at	O
least	O
1	O
virus	B-SPEC
.	O

The	O
viral	O
genome	O
harbors	O
a	O
tandem	O
repeat	O
which	O
is	O
rare	O
in	O
vertebrate	B-SPEC
RNA	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Viroporins	O
are	O
members	O
of	O
a	O
rapidly	O
growing	O
family	B-SPEC
of	O
channel	O
-	O
forming	O
small	O
polypeptides	O
found	O
in	O
viruses	B-SPEC
.	O

In	O
addition	O
,	O
searches	O
for	O
protein	O
-	O
protein	O
interactions	O
using	O
yeast	B-SPEC
-	O
two	O
hybrid	O
techniques	O
have	O
shed	O
light	O
on	O
possible	O
functional	O
roles	O
for	O
their	O
exposed	O
cytoplasmic	O
domains	O
.	O

TITLE	O
:	O
Ligand	O
-	O
induced	O
Dimerization	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
Coronavirus	B-SPEC
nsp5	O
Protease	O
(	O
3CLpro	O
):	O
IMPLICATIONS	O
FOR	O
nsp5	O
REGULATION	O
AND	O
THE	O
DEVELOPMENT	O
OF	O
ANTIVIRALS	O
.	O

ABSTRACT	O
:	O
All	O
coronaviruses	O
,	O
including	O
the	O
recently	O
emerged	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
from	O
the	O
β	O
-	O
CoV	O
subgroup	O
,	O
require	O
the	O
proteolytic	O
activity	O
of	O
the	O
nsp5	O
protease	O
(	O
also	O
known	O
as	O
3C	O
-	O
like	O
protease	O
,	O
3CL	O
(	O
pro	O
))	O
during	O
virus	B-SPEC
replication	O
,	O
making	O
it	O
a	O
high	O
value	O
target	O
for	O
the	O
development	O
of	O
anti	O
-	O
coronavirus	B-SPEC
therapeutics	O
.	O

Although	O
HKU4	O
spike	O
cannot	O
mediate	O
viral	O
entry	O
into	O
human	B-SPEC
cells	O
,	O
two	O
mutations	O
enabled	O
it	O
to	O
do	O
so	O
by	O
allowing	O
it	O
to	O
be	O
activated	O
by	O
human	B-SPEC
proteases	O
.	O

These	O
mutations	O
are	O
present	O
in	O
MERS	O
-	O
CoV	O
spike	O
,	O
explaining	O
why	O
MERS	O
-	O
CoV	O
infects	O
human	B-SPEC
cells	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
exploit	O
molecules	O
on	O
the	O
target	O
membrane	O
as	O
receptors	O
for	O
attachment	O
and	O
entry	O
into	O
host	O
cells	O
.	O

Glycan	O
array	O
analyses	O
revealed	O
that	O
,	O
in	O
contrast	O
to	O
the	O
S1	O
protein	O
of	O
IBV	B-SPEC
,	O
S1	O
proteins	O
of	O
enteric	O
gammacoronaviruses	O
recognize	O
a	O
unique	O
set	O
of	O
nonsialylated	O
type	O
2	O
poly	O
-	O
N	O
-	O
acetyl	O
-	O
lactosamines	O
.	O

Here	O
,	O
we	O
identify	O
a	O
novel	O
glycan	O
receptor	O
for	O
enteric	O
avian	B-SPEC
coronaviruses	O
,	O
which	O
will	O
further	O
support	O
the	O
development	O
of	O
vaccines	O
.	O

This	O
virus	B-SPEC
gradually	O
became	O
the	O
main	O
subtype	O
of	O
PEDV	B-SPEC
worldwide	O
.	O

The	O
S	O
gene	O
of	O
FL2013	O
has	O
a	O
7	O
-	O
aa	O
deletion	O
(	O
FEKVHVQ	O
)	O
in	O
the	O
C	O
-	O
terminus	O
comparison	O
with	O
the	O
other	O
G2	O
PEDV	B-SPEC
sequences	O
.	O

This	O
strain	O
is	O
closely	O
related	O
to	O
the	O
genogroup	O
-	O
2	O
PEDV	B-SPEC
strains	O
prevalent	O
in	O
the	O
U	O
.	O
S	O
.	O
and	O
China	O
currently	O
,	O
but	O
had	O
a	O
short	O
deletion	O
at	O
the	O
3	O
'-	O
end	O
of	O
the	O
spike	O
gene	O
.	O

ABSTRACT	O
:	O
Infection	O
with	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
damage	O
to	O
intestinal	O
epithelial	O
cells	O
and	O
results	O
in	O
acute	O
diarrhea	O
and	O
dehydration	O
with	O
high	O
mortality	O
rates	O
in	O
swine	B-SPEC
.	O

Bocaparvovirus	O
is	O
a	O
genetically	O
distinct	O
group	O
of	O
viruses	B-SPEC
which	O
has	O
been	O
recently	O
detected	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

Other	O
viruses	B-SPEC
were	O
also	O
investigated	O
in	O
this	O
study	O
with	O
the	O
first	O
report	O
of	O
PCV	B-SPEC
,	O
PAdV	O
and	O
lineage	O
I	O
G5	O
RVA	O
in	O
Ireland	O
.	O

Since	O
vascular	O
leak	O
can	O
also	O
be	O
observed	O
consistently	O
in	O
rats	B-SPEC
injected	O
intravenously	O
with	O
LeTx	O
,	O
the	O
latter	O
might	O
present	O
a	O
simple	O
physiologically	O
relevant	O
animal	B-SPEC
model	O
of	O
acute	O
lung	O
injury	O
(	O
ALI	O
).	O

We	O
investigated	O
the	O
effects	O
of	O
human	B-SPEC
MSC	O
MVs	O
on	O
lung	O
inflammation	O
,	O
protein	O
permeability	O
,	O
bacterial	O
clearance	O
,	O
and	O
survival	O
after	O
severe	O
bacterial	O
pneumonia	O
.	O

We	O
tested	O
the	O
effects	O
of	O
MVs	O
derived	O
from	O
human	B-SPEC
MSCs	O
on	O
Escherichia	B-SPEC
coli	I-SPEC
pneumonia	O
in	O
mice	B-SPEC
.	O

Possible	O
and	O
proven	O
lower	O
respiratory	O
tract	O
disease	O
was	O
less	O
common	O
compared	O
to	O
other	O
respiratory	O
viruses	B-SPEC
except	O
RhV	O
/	O
EnV	O
.	O

ABSTRACT	O
:	O
The	O
elevated	O
level	O
of	O
endothelin	O
-	O
1	O
(	O
ET	O
-	O
1	O
)	O
has	O
been	O
detected	O
in	O
the	O
bronchoalveolar	O
lavage	O
of	O
patients	O
with	O
severe	O
asthma	O
,	O
acute	O
lung	O
injury	O
,	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
and	O
sepsis	B-SPEC
.	O

CONCLUSIONS	O
:	O
We	O
found	O
there	O
to	O
be	O
a	O
definite	O
gap	O
in	O
the	O
recognition	O
of	O
avian	B-SPEC
influenza	O
between	O
the	O
two	O
subject	O
groups	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
therefore	O
to	O
assess	O
the	O
association	O
between	O
specific	O
respiratory	O
viruses	B-SPEC
and	O
childhood	O
CAP	O
.	O

Viruses	B-SPEC
were	O
detected	O
in	O
81	O
%	O
of	O
the	O
cases	O
(	O
n	O
=	O
98	O
)	O
and	O
56	O
%	O
of	O
the	O
controls	O
(	O
n	O
=	O
134	O
).	O

There	O
was	O
no	O
association	O
with	O
parainfluenza	O
virus	B-SPEC
,	O
human	B-SPEC
enterovirus	B-SPEC
or	O
rhinovirus	B-SPEC
and	O
coronavirus	B-SPEC
and	O
bocavirus	B-SPEC
were	O
negatively	O
associated	O
with	O
CAP	O
.	O

Positive	O
samples	O
were	O
more	O
commonly	O
found	O
among	O
young	O
animals	B-SPEC
(<	O
4	O
years	O
of	O
age	O
)	O
than	O
adults	O
(>	O
4	O
years	O
of	O
age	O
).	O

These	O
findings	O
further	O
our	O
understanding	O
of	O
MERS	O
-	O
CoV	O
infection	O
in	O
dromedary	B-SPEC
camels	B-SPEC
and	O
may	O
help	O
inform	O
intervention	O
strategies	O
to	O
reduce	O
zoonotic	O
infections	O
.	O

Stroke	O
,	O
acute	O
ocular	O
conditions	O
,	O
leg	O
ulcers	O
,	O
priapism	O
,	O
and	O
anemia	B-SPEC
are	O
common	O
complications	O
of	O
sickle	O
cell	O
disease	O
.	O

TITLE	O
:	O
[	O
Advances	O
in	O
the	O
researches	O
of	O
genomic	O
characterization	O
and	O
molecular	O
detection	O
of	O
Middel	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
].	O

Some	O
evidences	O
indicated	O
it	O
maybe	O
came	O
from	O
the	O
bats	B-SPEC
or	O
dromedary	B-SPEC
.	O

Mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
is	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
in	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
and	O
was	O
used	O
as	O
a	O
coronavirus	B-SPEC
replication	O
model	O
.	O

These	O
results	O
support	O
the	O
hypothesis	O
that	O
RNAi	O
is	O
a	O
part	O
of	O
the	O
antiviral	O
immunity	O
responses	O
in	O
mammalian	B-SPEC
cells	O
.	O

Coronavirus	B-SPEC
-	O
associated	O
illnesses	O
(	O
percent	O
of	O
illnesses	O
,	O
group	O
1	O
vs	O
group	O
2	O
)	O
were	O
characterized	O
by	O
myalgias	O
(	O
21	O
%	O
vs	O
68	O
%,	O
P	O
<	O
.	O
01	O
),	O
chills	O
(	O
50	O
%	O
vs	O
52	O
%),	O
dyspnea	O
(	O
71	O
%	O
vs	O
24	O
%,	O
P	O
<	O
.	O
01	O
),	O
headache	O
(	O
64	O
%	O
vs	O
72	O
%),	O
malaise	O
(	O
64	O
%	O
vs	O
84	O
%),	O
cough	O
(	O
86	O
%	O
vs	O
68	O
%),	O
sputum	O
production	O
(	O
86	O
%	O
vs	O
60	O
%),	O
sore	O
throat	O
(	O
64	O
%	O
vs	O
80	O
%),	O
and	O
nasal	O
congestion	O
(	O
93	O
%	O
vs	O
96	O
%).	O

METHODS	O
:	O
We	O
treated	O
human	B-SPEC
lung	O
fibroblasts	O
(	O
HLF	O
)	O
with	O
PDGF	O
,	O
or	O
TGFβ1	O
,	O
or	O
combined	O
,	O
and	O
examined	O
the	O
activation	O
of	O
p38	O
MAPK	O
,	O
p42	O
/	O
p44	O
MAPK	O
and	O
SMAD3	O
.	O

ABSTRACT	O
:	O
A	O
72	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
had	O
been	O
diagnosed	O
with	O
type	O
B	O
influenza	O
infection	O
and	O
high	O
fever	O
4	O
days	O
previously	O
was	O
admitted	O
to	O
our	O
hospital	O
.	O

Hantavirus	B-SPEC
pulmonary	O
syndrome	O
is	O
a	O
severe	O
acute	O
disease	O
that	O
is	O
associated	O
with	O
respiratory	O
failure	O
,	O
pulmonary	O
edema	O
and	O
cardiogenic	O
shock	O
.	O

To	O
date	O
,	O
there	O
are	O
no	O
reports	O
of	O
avian	B-SPEC
influenza	O
transmission	O
to	O
HCPs	O
from	O
affected	O
cases	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
continuously	O
threaten	O
human	B-SPEC
health	O
.	O

In	O
this	O
study	O
,	O
we	O
characterized	O
the	O
evolution	O
of	O
the	O
major	O
antigen	O
-	O
spike	O
(	O
S	O
)	O
gene	O
in	O
the	O
most	O
prevalent	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
OC43	O
using	O
phylogenetic	O
and	O
phylodynamic	O
analysis	O
.	O

Among	O
the	O
five	O
known	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
genotypes	O
(	O
A	O
to	O
E	O
),	O
higher	O
substitution	O
rates	O
and	O
dN	O
/	O
dS	O
values	O
as	O
well	O
as	O
more	O
positive	O
selection	O
sites	O
were	O
detected	O
in	O
the	O
S	O
gene	O
of	O
genotype	O
D	O
,	O
corresponding	O
to	O
the	O
most	O
dominant	O
HCoV	O
epidemic	O
in	O
recent	O
years	O
.	O

A	O
codon	O
-	O
optimized	O
PEDV	B-SPEC
S1	O
gene	O
consisting	O
of	O
amino	O
acid	O
residues	O
25	O
-	O
749	O
was	O
synthesized	O
and	O
used	O
to	O
establish	O
a	O
stable	O
porcine	B-SPEC
cell	O
line	O
constitutively	O
expressing	O
a	O
recombinant	O
PEDV	B-SPEC
S1	O
protein	O
containing	O
the	O
chicken	B-SPEC
immunoglobulin	O
Fc	O
fragment	O
at	O
its	O
C	O
-	O
terminus	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
newly	O
discovered	O
enterotropic	O
swine	B-SPEC
coronavirus	B-SPEC
that	O
causes	O
enteritis	O
and	O
diarrhea	O
in	O
piglets	O
.	O

Of	O
these	O
spots	B-SPEC
,	O
10	O
protein	O
spots	B-SPEC
showed	O
a	O
statistically	O
significant	O
alteration	O
,	O
including	O
8	O
up	O
-	O
regulated	O
and	O
2	O
down	O
-	O
regulated	O
protein	O
spots	B-SPEC
and	O
were	O
picked	O
for	O
subsequent	O
protein	O
identification	O
by	O
peptide	O
mass	O
fingerprinting	O
following	O
matrix	O
-	O
assisted	O
laser	B-SPEC
desorption	O
/	O
ionization	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
is	O
an	O
infection	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

These	O
data	O
suggest	O
that	O
serotonin	O
receptor	O
signaling	O
influences	O
cellular	O
activities	O
that	O
regulate	O
entry	O
of	O
diverse	O
virus	B-SPEC
families	O
and	O
provides	O
a	O
new	O
,	O
potentially	O
broad	O
-	O
spectrum	O
target	O
for	O
antiviral	O
drug	O
development	O
.	O

From	O
April	O
2010	O
to	O
May	O
2011	O
,	O
1082	O
nasopharyngeal	O
swabs	O
were	O
screened	O
for	O
respiratory	O
viruses	B-SPEC
by	O
PCR	O
.	O

Six	O
weeks	O
after	O
immunization	O
,	O
anti	O
-	O
IBV	B-SPEC
neutralizing	O
titer	O
and	O
anti	O
-	O
S1	O
ELISA	O
titer	O
were	O
determined	O
;	O
immunized	O
chickens	B-SPEC
then	O
were	O
inoculated	O
with	O
IBV	B-SPEC
via	O
the	O
trachea	B-SPEC
and	O
ciliary	O
activity	O
was	O
observed	O
.	O

In	O
conclusion	O
,	O
the	O
neutralizing	O
antigenicity	O
of	O
recombinant	O
S1	O
protein	O
expressed	O
from	O
mammalian	B-SPEC
cells	O
was	O
decreased	O
,	O
and	O
was	O
not	O
sufficient	O
to	O
induce	O
neutralizing	O
antibodies	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O
highly	O
enteropathogenic	O
coronavirus	B-SPEC
of	O
swine	B-SPEC
that	O
causes	O
acute	O
enteritis	O
with	O
high	O
mortality	O
in	O
nursery	O
piglets	O
.	O

To	O
date	O
,	O
the	O
cellular	O
factors	O
involved	O
in	O
PEDV	B-SPEC
replication	O
have	O
not	O
been	O
well	O
defined	O
.	O

These	O
findings	O
indicate	O
that	O
the	O
ERK	O
signaling	O
pathway	O
plays	O
an	O
important	O
role	O
in	O
the	O
PEDV	B-SPEC
life	O
cycle	O
and	O
beneficially	O
contributes	O
to	O
viral	O
infection	O
.	O

ABSTRACT	O
:	O
Viral	O
pathogenesis	O
studies	O
in	O
mice	B-SPEC
have	O
relied	O
on	O
markers	O
of	O
severe	O
systemic	O
disease	O
,	O
rather	O
than	O
clinically	O
relevant	O
measures	O
,	O
to	O
evaluate	O
respiratory	O
virus	B-SPEC
infection	O
;	O
thus	O
confounding	O
connections	O
to	O
human	B-SPEC
disease	O
.	O

Together	O
,	O
the	O
work	O
highlights	O
the	O
utility	O
of	O
examining	O
respiratory	O
function	O
following	O
infection	O
in	O
order	B-SPEC
to	O
fully	O
understand	O
viral	O
pathogenesis	O
.	O

Immune	O
responses	O
and	O
protection	O
efficacy	O
of	O
the	O
vaccination	O
vector	O
were	O
assessed	O
in	O
both	O
mice	B-SPEC
and	O
pig	B-SPEC
models	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
was	O
first	O
identified	O
in	O
Hong	O
Kong	O
in	O
a	O
regional	O
surveillance	O
study	O
for	O
Coronaviruses	O
in	O
2012	O
and	O
was	O
detected	O
for	O
the	O
first	O
time	O
in	O
United	O
States	O
(	O
US	O
)	O
swine	B-SPEC
in	O
February	O
2014	O
.	O

Each	O
chicken	B-SPEC
in	O
the	O
control	O
and	O
infected	O
group	O
was	O
intranasally	O
inoculated	O
with	O
0	O
.	O
2	O
mL	O
sterile	O
physiological	O
saline	O
and	O
virus	B-SPEC
,	O
respectively	O
,	O
after	O
which	O
serum	O
antioxidant	O
parameters	O
and	O
renal	O
XOD	O
mRNA	O
expression	O
in	O
growing	O
layers	O
were	O
evaluated	O
at	O
8	O
,	O
15	O
and	O
22	O
days	O
post	O
-	O
inoculation	O
(	O
dpi	O
).	O

The	O
outbreak	O
of	O
Varroa	B-SPEC
destructor	I-SPEC
infestation	O
could	O
have	O
overcome	O
these	O
adaptations	O
by	O
promoting	O
the	O
transmission	O
of	O
viruses	B-SPEC
.	O

These	O
results	O
contribute	O
to	O
our	O
understanding	O
of	O
honey	B-SPEC
bee	I-SPEC
colony	O
losses	O
in	O
temperate	O
regions	O
.	O

Additionally	O
,	O
the	O
lack	O
of	O
small	O
animal	B-SPEC
models	O
for	O
these	O
infections	O
hinders	O
the	O
in	O
vivo	O
testing	O
of	O
potential	O
therapeutics	O
.	O

The	O
results	O
showed	O
that	O
the	O
rapid	O
growth	O
period	O
of	O
the	O
virus	B-SPEC
load	O
of	O
all	O
the	O
3	O
generations	O
was	O
approximately	O
12	O
-	O
36	O
h	O
post	O
-	O
infection	O
;	O
the	O
peak	O
of	O
the	O
virus	B-SPEC
load	O
appeared	O
at	O
36	O
h	O
post	O
-	O
infection	O
and	O
then	O
decreased	O
gradually	O
in	O
the	O
order	B-SPEC
of	O
20th	O
>	O
54th	O
>	O
87th	O
for	O
the	O
3	O
generations	O
of	O
CEK	O
-	O
adapted	O
strains	O
;	O
the	O
dynamic	O
change	O
curve	O
of	O
the	O
IBV	B-SPEC
load	O
in	O
the	O
supernatant	O
of	O
primary	O
CEK	O
cells	O
showed	O
a	O
single	O
peak	O
.	O

The	O
χ	O
,	O
Fisher	B-SPEC
'	O
s	O
exact	O
,	O
and	O
Cochran	O
-	O
Mantel	O
-	O
Haenszel	O
tests	O
were	O
used	O
to	O
determine	O
if	O
there	O
were	O
significant	O
differences	O
in	O
practice	O
patterns	O
.	O

Severity	O
of	O
clinical	O
signs	O
and	O
mortality	O
in	O
young	O
suckling	O
pigs	B-SPEC
varied	O
significantly	O
between	O
the	O
two	O
affected	O
sow	O
farms	O
.	O

Moreover	O
,	O
the	O
German	O
strains	O
showed	O
very	O
high	O
nucleotide	O
identity	O
(	O
99	O
.	O
4	O
%)	O
with	O
a	O
variant	O
of	O
PEDV	B-SPEC
(	O
OH851	O
)	O
that	O
was	O
isolated	O
in	O
the	O
United	O
States	O
in	O
January	O
2014	O
.	O

In	O
this	O
case	O
report	O
we	O
demonstrate	O
that	O
acute	O
outbreaks	O
of	O
PEDV	B-SPEC
occurred	O
in	O
southern	O
Germany	O
in	O
2014	O
.	O

Moreover	O
,	O
the	O
present	O
case	O
report	O
indicates	O
that	O
variant	O
strains	O
of	O
PEDV	B-SPEC
,	O
containing	O
insertions	O
and	O
deletions	O
in	O
the	O
S	O
gene	O
,	O
which	O
were	O
reported	O
to	O
be	O
of	O
lower	O
virulence	O
,	O
might	O
be	O
able	O
to	O
cause	O
high	O
mortality	O
in	O
suckling	O
piglets	O
.	O

Surprisingly	O
and	O
in	O
contrast	O
,	O
the	O
initial	O
steps	O
that	O
lead	O
to	O
the	O
emergence	O
of	O
several	O
viruses	B-SPEC
,	O
and	O
of	O
their	O
associated	O
diseases	O
,	O
remain	O
still	O
poorly	O
understood	O
.	O

Indeed	O
,	O
by	O
virtue	O
of	O
their	O
genetic	O
andphysiological	O
similarities	O
,	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
(	O
NHPs	O
)	O
are	O
considered	O
to	O
be	O
likely	O
the	O
sources	O
of	O
viruses	B-SPEC
that	O
can	O
infect	O
humans	B-SPEC
and	O
thus	O
may	O
pose	O
a	O
significant	O
threat	O
to	O
human	B-SPEC
population	O
.	O

This	O
is	O
well	O
illustrated	O
by	O
retroviruses	B-SPEC
,	O
which	O
have	O
the	O
ability	O
to	O
cross	O
species	B-SPEC
,	O
adapt	O
to	O
a	O
new	O
host	O
and	O
sometimes	O
spread	O
within	O
these	O
new	O
species	B-SPEC
.	O

The	O
situation	O
for	O
Human	B-SPEC
T	O
cell	O
Lymphotropic	O
virus	B-SPEC
type	O
1	O
(	O
HTLV	O
-	O
1	O
)	O
is	O
,	O
for	O
certain	O
aspects	O
,	O
quite	O
comparable	O
.	O

Such	O
infection	O
is	O
a	O
unique	O
natural	O
model	O
to	O
study	O
the	O
different	O
mechanisms	O
of	O
restriction	O
of	O
retroviral	B-SPEC
emergence	O
in	O
Humans	B-SPEC
.	O

The	O
age	O
,	O
gender	O
,	O
vital	O
signs	O
,	O
laboratory	O
results	O
,	O
underlying	O
disease	O
,	O
the	O
mortality	O
in	O
emergency	O
department	O
sepsis	B-SPEC
(	O
MEDS	O
)	O
score	O
and	O
lung	O
injury	O
prediction	O
score	O
(	O
LIPS	O
)	O
were	O
collected	O
.	O

TITLE	O
:	O
Inability	O
of	O
rat	B-SPEC
DPP4	O
to	O
allow	O
MERS	O
-	O
CoV	O
infection	O
revealed	O
by	O
using	O
a	O
VSV	O
pseudotype	O
bearing	O
truncated	O
MERS	O
-	O
CoV	O
spike	O
protein	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
(	O
Co	O
-	O
V	O
)	O
contains	O
a	O
single	O
spike	O
(	O
S	O
)	O
protein	O
,	O
which	O
binds	O
to	O
a	O
receptor	O
molecule	O
,	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
;	O
also	O
known	O
as	O
CD26	O
),	O
and	O
serves	O
as	O
a	O
neutralizing	O
antigen	O
.	O

In	O
this	O
study	O
,	O
we	O
constructed	O
a	O
series	O
of	O
cytoplasmic	O
deletion	O
mutants	O
of	O
MERS	O
-	O
CoV	O
S	O
and	O
compared	O
the	O
efficiency	O
with	O
which	O
they	O
formed	O
pseudotypes	O
with	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
.	O

The	O
virus	B-SPEC
was	O
reassorted	O
with	O
the	O
HA	O
gene	O
of	O
clade	O
2	O
.	O
3	O
.	O
4	O
.	O
4	O
H5	O
,	O
the	O
internal	O
genes	O
of	O
clade	O
2	O
.	O
3	O
.	O
2	O
.	O
1	O
H5	O
,	O
and	O
the	O
NA	O
gene	O
of	O
the	O
H6N6	O
avian	B-SPEC
virus	B-SPEC
.	O

To	O
this	O
end	O
,	O
Renilla	B-SPEC
luciferase	O
-	O
encoding	O
SARS	O
-	O
CoV	O
replicons	O
with	O
selectively	O
deleted	O
macrodomains	O
were	O
constructed	O
and	O
their	O
ability	O
to	O
modulate	O
the	O
RTC	O
activity	O
was	O
examined	O
.	O

In	O
2011	O
,	O
there	O
were	O
an	O
estimated	O
29	O
,	O
892	O
total	O
severe	O
influenza	O
cases	O
in	O
HIV	B-SPEC
-	O
uninfected	O
individuals	O
and	O
17	O
,	O
289	O
in	O
HIV	B-SPEC
-	O
infected	O
individuals	O
.	O

In	O
contrast	O
,	O
OAS1	O
in	O
macaques	B-SPEC
exhibits	O
a	O
level	O
of	O
polymorphism	O
far	O
greater	O
than	O
the	O
genomic	O
average	O
,	O
which	O
is	O
consistent	O
with	O
the	O
action	O
of	O
balancing	O
selection	O
.	O

ABSTRACT	O
:	O
Virus	B-SPEC
Counter	O
was	O
applied	O
for	O
the	O
quantitation	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
);	O
the	O
working	O
range	O
and	O
reproducibility	O
of	O
the	O
quantification	O
were	O
characterized	O
,	O
and	O
the	O
performance	O
of	O
Virus	B-SPEC
Counter	O
was	O
evaluated	O
using	O
the	O
plaque	O
assay	O
as	O
the	O
gold	O
standard	O
.	O

Then	O
three	O
virus	B-SPEC
batches	O
from	O
independent	O
virus	B-SPEC
propagations	O
were	O
harvested	O
at	O
interval	O
of	O
16	O
-	O
20	O
h	O
and	O
serial	O
-	O
diluted	O
;	O
The	O
correlation	O
between	O
the	O
calculated	O
titer	O
and	O
the	O
results	O
obtained	O
by	O
Virus	B-SPEC
Counter	O
were	O
better	O
than	O
those	O
obtained	O
by	O
using	O
the	O
plaque	O
assay	O
.	O

The	O
comparison	O
between	O
the	O
plaque	O
assay	O
data	O
and	O
the	O
Virus	B-SPEC
Counter	O
results	O
revealed	O
a	O
linear	O
relationship	O
(	O
slope	O
=	O
1	O
.	O
155	O
±	O
0	O
.	O
46	O
,	O
R	O
(	O
2	O
)=	O
0	O
.	O
9665	O
)	O
with	O
a	O
significant	O
Pearson	O
correlation	O
(	O
r	O
=	O
0	O
.	O
9809	O
,	O
p	O
<	O
0	O
.	O
0001	O
).	O

RESULTS	O
:	O
The	O
aeration	O
score	O
of	O
the	O
lung	O
at	O
T1	O
,	O
T2	O
,	O
T3	O
,	O
T4	O
was	O
significantly	O
reduced	O
than	O
T0	O
all	O
,	O
the	O
ventilation	O
situation	O
of	O
mainly	O
areas	O
was	O
improved	O
after	O
2	O
h	O
PPV	B-SPEC
(	O
P	O
<	O
0	O
.	O
05	O
),	O
4	O
h	O
later	O
it	O
was	O
not	O
distinguished	O
(	O
P	O
>	O
0	O
.	O
05	O
);	O
the	O
value	O
of	O
PaO	O
(	O
2	O
),	O
PaO	O
(	O
2	O
)/	O
FiO	O
(	O
2	O
)	O
was	O
greater	O
at	O
T1	O
,	O
T2	O
,	O
T3	O
,	O
T4	O
than	O
T0	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
the	O
value	O
of	O
the	O
oxygen	O
fraction	O
was	O
significant	O
increased	O
at	O
T2	O
than	O
T1	O
(	O
t	O
=	O
2	O
.	O
840	O
,	O
P	O
<	O
0	O
.	O
05	O
);	O
the	O
number	O
of	O
patients	O
with	O
oxygen	O
fractions	O
>	O
300	O
mmHg	O
after	O
5	O
days	O
PPV	B-SPEC
was	O
65	O
(	O
83	O
.	O
3	O
%);	O
there	O
were	O
30	O
(	O
38	O
.	O
5	O
%)	O
patients	O
free	O
of	O
mechanical	O
ventilation	O
after	O
7	O
days	O
;	O
the	O
28	O
-	O
day	O
mortality	O
was	O
7	O
(	O
8	O
.	O
97	O
%).	O

In	O
contrast	O
to	O
the	O
M41	O
challenge	O
strain	O
,	O
all	O
Brazilian	O
isolates	O
replicated	O
in	O
kidney	O
tissue	O
in	O
a	O
high	O
percentage	O
of	O
non	O
-	O
vaccinated	O
challenged	O
birds	B-SPEC
,	O
clearly	O
showing	O
that	O
they	O
are	O
nephropathogenic	O
.	O

We	O
show	O
that	O
a	O
high	O
proportion	O
of	O
camels	B-SPEC
presenting	O
for	O
slaughter	O
in	O
Qatar	O
show	O
evidence	O
for	O
nasal	O
MERS	O
-	O
CoV	O
shedding	O
(	O
62	O
/	O
105	O
).	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
review	O
signalment	O
,	O
clinical	O
signs	O
and	O
laboratory	O
features	O
in	O
a	O
large	O
number	O
of	O
naturally	O
occurring	O
cases	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
and	O
to	O
evaluate	O
potential	O
changes	O
in	O
diagnostic	O
criteria	O
for	O
FIP	O
and	O
compare	O
findings	O
in	O
cats	B-SPEC
with	O
and	O
without	O
effusion	O
.	O

Lymphopenia	O
,	O
observed	O
significantly	O
more	O
often	O
with	O
effusion	O
,	O
was	O
documented	O
in	O
only	O
26	O
.	O
8	O
%	O
of	O
cats	B-SPEC
without	O
effusion	O
.	O

While	O
serum	O
total	O
protein	O
was	O
increased	O
in	O
only	O
17	O
.	O
5	O
%	O
of	O
cats	B-SPEC
,	O
hyperglobulinaemia	O
was	O
documented	O
in	O
89	O
.	O
1	O
%.	O

Clinical	O
syndromes	O
resulting	O
from	O
FIV	B-SPEC
infection	O
include	O
immunodeficiency	O
,	O
opportunistic	O
infections	O
,	O
and	O
neoplasia	O
.	O

Endpoint	O
dilution	O
studies	O
with	O
serial	O
dilutions	O
of	O
an	O
ATCC	O
FIV	B-SPEC
type	O
strain	O
showed	O
that	O
the	O
sensitivity	O
of	O
lyophilized	O
FIV	B-SPEC
RT	O
-	O
iiPCR	O
reagent	O
was	O
comparable	O
to	O
that	O
of	O
a	O
reference	O
nested	O
PCR	O
.	O

In	O
order	B-SPEC
to	O
elucidate	O
the	O
structural	O
reasons	O
for	O
such	O
potent	O
HKU4	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
inhibition	O
by	O
the	O
peptidomimetics	O
having	O
the	O
22A	O
backbone	O
,	O
we	O
determined	O
the	O
X	O
-	O
ray	B-SPEC
structures	O
of	O
HKU4	O
-	O
CoV	O
3CL	O
(	O
pro	O
)	O
in	O
complex	O
with	O
three	O
peptidomimetic	O
inhibitors	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
,	O
also	O
known	O
as	O
septicemia	O
,	O
is	O
one	O
of	O
the	O
10	O
leading	O
causes	O
of	O
death	O
worldwide	O
.	O

In	O
order	B-SPEC
to	O
work	O
with	O
MERS	O
-	O
CoV	O
in	O
a	O
laboratory	O
setting	O
,	O
the	O
US	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
(	O
CDC	O
)	O
has	O
determined	O
that	O
MERS	O
-	O
CoV	O
should	O
be	O
handled	O
at	O
a	O
biosafety	O
level	O
(	O
BSL	O
)	O
3	O
(	O
BSL	O
-	O
3	O
)	O
biocontainment	O
level	O
.	O

ABSTRACT	O
:	O
Since	O
1996	O
a	O
new	O
Infectious	O
Bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
genotype	O
,	O
referred	O
to	O
as	O
Q1	O
,	O
circulated	O
in	O
China	O
and	O
was	O
reported	O
for	O
the	O
first	O
time	O
in	O
Italy	O
in	O
2011	O
,	O
associated	O
with	O
an	O
increase	O
of	O
mortality	O
,	O
kidney	O
lesions	O
and	O
proventriculitis	O
.	O

The	O
initially	O
developed	O
animal	B-SPEC
models	O
comprise	O
two	O
nonhuman	O
primate	B-SPEC
species	B-SPEC
,	O
the	O
rhesus	B-SPEC
macaque	I-SPEC
and	O
the	O
common	B-SPEC
marmoset	I-SPEC
.	O

Although	O
normal	O
mice	B-SPEC
are	O
not	O
susceptible	O
to	O
MERS	O
-	O
CoV	O
,	O
expression	O
of	O
the	O
human	B-SPEC
DPP4	O
(	O
hDPP4	O
)	O
overcomes	O
the	O
lack	O
of	O
susceptibility	O
.	O

This	O
article	O
forms	O
part	O
of	O
a	O
symposium	O
in	O
Antiviral	O
Research	O
on	O
""""	O
From	O
SARS	O
to	O
MERS	O
:	O
research	O
on	O
highly	O
pathogenic	O
human	B-SPEC
coronaviruses	O
.	O

Despite	O
the	O
availability	O
of	O
PEDV	B-SPEC
vaccines	O
in	O
the	O
domestic	O
market	O
,	O
the	O
disease	O
continues	O
to	O
plague	O
the	O
Korean	O
pork	O
industry	O
,	O
raising	O
issues	O
regarding	O
their	O
protective	O
efficacy	O
and	O
new	O
vaccine	O
development	O
.	O

Mycoplasma	B-SPEC
cynos	I-SPEC
(	O
29	O
.	O
2	O
%),	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
(	O
19	O
.	O
5	O
%),	O
CAV	B-SPEC
-	O
2	O
(	O
12	O
.	O
5	O
%),	O
CDV	B-SPEC
(	O
7	O
.	O
4	O
%)	O
and	O
CPIV	O
(	O
3	O
.	O
2	O
%)	O
were	O
the	O
most	O
commonly	O
detected	O
pathogens	O
.	O

To	O
determine	O
the	O
relevance	O
of	O
TNF	O
-	O
α	O
in	O
disrupting	O
bronchial	O
endothelial	O
cell	O
function	O
,	O
we	O
stimulated	O
human	B-SPEC
THP	O
-	O
1	O
macrophages	O
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
and	O
used	O
the	O
resulting	O
cytokine	O
-	O
supplemented	O
media	O
to	O
disrupt	O
normal	O
endothelial	O
cell	O
functions	O
.	O

Brain	O
invasion	O
was	O
observed	O
only	O
in	O
MHV3	O
-	O
infected	O
mice	B-SPEC
and	O
correlated	O
with	O
enhanced	O
BBB	O
permeability	O
associated	O
with	O
decreased	O
expression	O
of	O
zona	O
occludens	O
protein	O
1	O
(	O
ZO	O
-	O
1	O
),	O
VE	O
-	O
cadherin	O
,	O
and	O
occludin	O
,	O
but	O
not	O
claudin	O
-	O
5	O
,	O
in	O
the	O
brain	O
or	O
in	O
cultured	O
BMECs	O
.	O

CD8	O
(+)	O
cells	O
were	O
significantly	O
higher	O
in	O
group	O
II	O
than	O
those	O
in	O
group	O
I	O
at	O
21	O
and	O
28	O
doa	B-SPEC
.	O

Importantly	O
,	O
our	O
results	O
suggested	O
that	O
MERS	O
-	O
CoV	O
efficiently	O
infected	O
T	O
cells	O
from	O
the	O
peripheral	O
blood	O
and	O
from	O
human	B-SPEC
lymphoid	O
organs	O
,	O
including	O
the	O
spleen	O
and	O
the	O
tonsil	O
.	O

The	O
NH	O
-	O
group	O
of	O
the	O
lactam	O
moiety	O
was	O
clearly	O
required	O
for	O
anti	O
-	O
HCV	B-SPEC
activity	O
.	O

The	O
tested	O
detection	O
limit	O
was	O
0	O
.	O
01	O
%	O
(	O
w	O
/	O
w	O
)	O
feline	B-SPEC
meat	O
in	O
binary	O
and	O
ternary	O
admixed	O
as	O
well	O
as	O
meatball	O
matrices	O
.	O

Importantly	O
,	O
using	O
mice	B-SPEC
transduced	O
with	O
adenovirus	B-SPEC
expressing	O
human	B-SPEC
CD26	O
and	O
infected	O
with	O
MERS	O
-	O
CoV	O
,	O
we	O
show	O
that	O
LCA60	O
can	O
effectively	O
protect	O
in	O
both	O
prophylactic	O
and	O
postexposure	O
settings	O
.	O

This	O
antibody	O
can	O
be	O
used	O
for	O
prophylaxis	O
,	O
for	O
postexposure	O
prophylaxis	O
of	O
individuals	O
at	O
risk	O
,	O
or	O
for	O
the	O
treatment	O
of	O
human	B-SPEC
cases	O
of	O
MERS	O
-	O
CoV	O
infection	O
.	O

The	O
fact	O
that	O
it	O
took	O
only	O
4	O
mo	O
from	O
the	O
initial	O
screening	O
of	O
B	O
cells	O
derived	O
from	O
a	O
convalescent	O
patient	O
for	O
the	O
development	O
of	O
a	O
stable	O
chinese	B-SPEC
hamster	I-SPEC
ovary	O
(	O
CHO	O
)	O
cell	O
line	O
producing	O
neutralizing	O
antibodies	O
at	O
more	O
than	O
5	O
g	O
/	O
L	O
provides	O
an	O
example	O
of	O
a	O
rapid	O
pathway	O
toward	O
the	O
generation	O
of	O
effective	O
antiviral	O
therapies	O
against	O
emerging	O
viruses	B-SPEC
.	O

Serological	O
analysis	O
and	O
isolation	O
of	O
murine	B-SPEC
monoclonal	O
antibodies	O
revealed	O
that	O
immunization	O
elicits	O
NAbs	O
to	O
RBD	O
and	O
,	O
non	O
-	O
RBD	O
portions	O
of	O
S1	O
and	O
S2	O
subunit	O
.	O

Patients	O
with	O
sepsis	B-SPEC
-	O
related	O
acute	O
respiratory	O
distress	O
syndrome	O
have	O
higher	O
mortality	O
.	O

Animals	B-SPEC
that	O
received	O
LPS	O
showed	O
circulatory	O
failure	O
,	O
multiple	O
organ	O
dysfunction	O
,	O
metabolic	O
acidosis	O
,	O
hyperventilation	O
,	O
lung	O
edema	O
,	O
and	O
high	O
mortality	O
.	O

These	O
results	O
indicate	O
that	O
the	O
K40	O
/	O
09	O
vaccine	O
could	O
be	O
helpful	O
for	O
the	O
reduction	O
of	O
economic	O
losses	O
caused	O
by	O
recently	O
emergent	O
nephropathogenic	O
IBV	B-SPEC
infection	O
in	O
many	O
countries	O
.	O

TITLE	O
:	O
Full	O
-	O
length	O
genome	O
analysis	O
of	O
canine	O
coronavirus	B-SPEC
type	O
I	O
.	O
ABSTRACT	O
:	O
Canine	O
coronavirus	B-SPEC
types	O
I	O
(	O
CCoV	O
-	O
I	O
)	O
and	O
II	O
(	O
CCoV	O
-	O
II	O
)	O
are	O
usually	O
responsible	O
for	O
mild	O
enteritis	O
in	O
dogs	B-SPEC
.	O

CCoV	O
-	O
I	O
strain	O
23	O
/	O
03	O
has	O
a	O
genome	O
of	O
30	O
,	O
000	O
nucleotides	O
,	O
excluding	O
the	O
3	O
'	O
poly	O
(	O
A	O
)	O
tail	O
,	O
displaying	O
the	O
typical	O
Alphacoronavirus	B-SPEC
-	O
1	O
organization	O
and	O
the	O
highest	O
genetic	O
relatedness	O
to	O
CCoV	O
-	O
II	O
.	O

Furthermore	O
,	O
Ark	O
vaccine	O
virus	B-SPEC
RNA	O
was	O
not	O
detectable	O
until	O
10	O
DPV	O
in	O
most	O
tear	O
samples	O
from	O
chickens	B-SPEC
vaccinated	O
with	O
both	O
Ark	O
and	O
Mass	O
vaccines	O
at	O
varying	O
Ark	O
vaccine	O
doses	O
,	O
while	O
high	O
concentrations	O
of	O
Mass	O
virus	B-SPEC
RNA	O
were	O
detectable	O
at	O
3	O
-	O
7	O
DPV	O
.	O

In	O
contrast	O
,	O
Ark	O
vaccine	O
virus	B-SPEC
replicated	O
effectively	O
early	O
after	O
vaccination	O
in	O
chickens	B-SPEC
vaccinated	O
with	O
Ark	O
vaccine	O
alone	O
.	O

All	O
cases	O
are	O
epidemiologically	O
linked	O
to	O
the	O
Arabian	O
Penninsula	O
with	O
most	O
cases	O
reported	O
from	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

The	O
best	O
diagnostic	O
tests	O
rely	O
on	O
the	O
identification	O
of	O
MERS	O
-	O
CoV	O
by	O
PCR	O
,	O
and	O
lower	O
respiratory	O
tract	O
samples	O
should	O
be	O
favoured	O
for	O
the	O
diagnosis	O
whenever	O
this	O
is	O
possible	O
in	O
order	B-SPEC
to	O
avoid	O
false	O
negative	O
results	O
.	O

TITLE	O
:	O
Genotypes	O
of	O
infectious	O
bronchitis	O
viruses	B-SPEC
circulating	O
in	O
the	O
Middle	O
East	O
between	O
2009	O
and	O
2014	O
.	O

Therefore	O
,	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
develop	O
and	O
validate	O
multiple	O
improved	O
serological	O
assays	O
for	O
PEDV	B-SPEC
,	O
including	O
an	O
indirect	O
ELISA	O
(	O
iELISA	O
);	O
a	O
highly	O
specific	O
monoclonal	O
antibody	O
-	O
based	O
blocking	O
ELISA	O
(	O
bELISA	O
);	O
fluorescent	O
microsphere	O
immunoassays	O
(	O
FMIA	O
)	O
that	O
can	O
be	O
multiplexed	O
to	O
monitor	O
exposure	O
to	O
multiple	O
antigens	O
and	O
pathogens	O
simultaneously	O
;	O
and	O
a	O
fluorescent	O
focus	O
neutralization	O
assay	O
(	O
FFN	O
)	O
to	O
measure	O
functional	O
virus	B-SPEC
neutralizing	O
antibodies	O
.	O

TITLE	O
:	O
Assessment	O
of	O
the	O
awareness	O
level	O
of	O
dental	O
students	O
toward	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Infection	O
prevention	O
and	O
control	O
measures	O
are	O
critical	O
to	O
prevent	O
the	O
possible	O
spread	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
healthcare	O
facilities	O
.	O

The	O
sources	O
of	O
information	O
for	O
the	O
students	O
were	O
:	O
college	O
(	O
27	O
%),	O
MOH	O
(	O
25	O
%),	O
media	O
(	O
24	O
%),	O
and	O
social	O
community	O
(	O
23	O
%),	O
while	O
17	O
%	O
of	O
the	O
students	O
interviewed	O
had	O
no	O
idea	B-SPEC
about	O
it	O
.	O

The	O
sources	O
of	O
information	O
for	O
the	O
students	O
were	O
:	O
college	O
(	O
27	O
%),	O
MOH	O
(	O
25	O
%),	O
media	O
(	O
24	O
%),	O
and	O
social	O
community	O
(	O
23	O
%),	O
while	O
17	O
%	O
of	O
the	O
students	O
interviewed	O
had	O
no	O
idea	B-SPEC
about	O
it	O
.	O

Our	O
sequencing	O
results	O
demonstrate	O
a	O
co	O
-	O
circulation	O
of	O
wild	O
-	O
type	O
infectious	O
bronchitis	O
viruses	B-SPEC
in	O
broiler	O
chickens	B-SPEC
.	O

TITLE	O
:	O
Crystallographic	O
analysis	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
.	O

A	O
survey	O
based	O
on	O
the	O
nested	O
RT	O
-	O
PCR	O
established	O
indicated	O
that	O
the	O
monoinfection	O
of	O
PDCoV	O
(	O
33	O
.	O
71	O
%)	O
and	O
coinfection	O
of	O
PDCoV	O
(	O
19	O
.	O
66	O
%)	O
with	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
were	O
common	O
in	O
diarrhoeal	O
pigs	B-SPEC
in	O
Jiangxi	O
,	O
China	O
.	O

Furthermore	O
,	O
CoV	O
detected	O
in	O
two	O
different	O
bird	B-SPEC
species	B-SPEC
,	O
Amazona	B-SPEC
vinacea	I-SPEC
and	O
Brotogeris	B-SPEC
tirica	I-SPEC
,	O
clustered	O
with	O
a	O
CoV	O
isolated	O
from	O
Sparrow	B-SPEC
(	O
SpaCoV	O
HKU17	O
)	O
belonging	O
to	O
a	O
monophyletic	O
group	O
related	O
with	O
the	O
CoVs	O
isolated	O
from	O
swines	B-SPEC
(	O
PorCoV	O
HKU15	O
),	O
both	O
belonging	O
to	O
the	O
DeltaCoV	O
genus	B-SPEC
,	O
previously	O
unreported	O
in	O
South	O
America	O
.	O

Therefore	O
,	O
the	O
accurate	O
diagnosis	O
,	O
serological	O
monitoring	O
,	O
and	O
surveillance	O
of	O
specific	O
antibodies	O
in	O
pigs	B-SPEC
resulting	O
from	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
or	O
vaccination	O
would	O
be	O
essential	O
in	O
helping	O
to	O
control	O
the	O
spread	O
of	O
PED	O
.	O

On	O
admission	O
,	O
the	O
patient	O
'	O
s	O
chest	O
X	O
-	O
ray	B-SPEC
showed	O
that	O
a	O
small	O
amount	O
of	O
infiltration	O
in	O
the	O
lung	O
.	O

Virus	B-SPEC
in	O
sputum	O
disappeared	O
after	O
treatment	O
,	O
but	O
pleural	O
effusion	O
was	O
not	O
completely	O
absorbed	O
.	O

ABSTRACT	O
:	O
Canine	O
kobuviruses	B-SPEC
(	O
CaKVs	O
)	O
are	O
newly	O
recognized	O
picornaviruses	B-SPEC
that	O
have	O
been	O
recently	O
detected	O
in	O
dogs	B-SPEC
in	O
the	O
U	O
.	O
S	O
.	O
A	O
.,	O
Italy	O
,	O
U	O
.	O
K	O
.,	O
the	O
Republic	O
of	O
Korea	O
and	O
Tanzania	O
.	O

To	O
trace	O
the	O
evolution	O
of	O
CaKV	O
strains	O
,	O
a	O
total	O
of	O
201	O
fecal	O
samples	O
from	O
rectal	O
swabs	O
of	O
diarrheic	O
dogs	B-SPEC
,	O
which	O
were	O
obtained	O
from	O
May	O
2014	O
to	O
April	O
2015	O
in	O
northeast	O
China	O
,	O
were	O
detected	O
by	O
reverse	O
transcription	O
-	O
PCR	O
targeting	O
a	O
partial	O
(	O
504	O
bp	O
)	O
fragment	O
of	O
the	O
3D	O
gene	O
.	O

We	O
review	O
aspects	O
of	O
husbandry	O
,	O
animal	B-SPEC
movements	O
and	O
trade	O
and	O
the	O
use	O
and	O
consumption	O
of	O
camel	B-SPEC
dairy	O
and	O
meat	O
products	O
in	O
the	O
Middle	O
East	O
that	O
may	O
be	O
relevant	O
to	O
the	O
epidemiology	O
of	O
MERS	O
.	O

The	O
disordered	O
NS3pro	O
appears	O
to	O
be	O
needed	O
for	O
binding	O
a	O
human	B-SPEC
host	O
factor	O
to	O
trigger	O
the	O
membrane	O
remodeling	O
.	O

Molecular	O
characterisation	O
of	O
those	O
viruses	B-SPEC
revealed	O
some	O
nucleotide	O
and	O
aminoacid	O
differences	O
in	O
relation	O
to	O
reference	O
strains	O
.	O

Although	O
two	O
SARS	O
-	O
related	O
Rhinolophus	B-SPEC
sinicus	I-SPEC
bat	B-SPEC
CoVs	O
(	O
SARSr	O
-	O
Rs	O
-	O
BatCoVs	O
)	O
previously	O
detected	O
in	O
Chinese	O
horseshoe	B-SPEC
bats	I-SPEC
(	O
Rhinolophus	B-SPEC
sinicus	I-SPEC
)	O
in	O
Yunnan	O
,	O
RsSHC014	O
and	O
Rs3367	O
,	O
possessed	O
95	O
%	O
genome	O
identities	O
to	O
human	B-SPEC
and	O
civet	B-SPEC
SARSr	O
-	O
CoVs	O
,	O
their	O
ORF8	O
protein	O
exhibited	O
only	O
32	O
.	O
2	O
to	O
33	O
%	O
amino	O
acid	O
identities	O
to	O
that	O
of	O
human	B-SPEC
/	O
civet	B-SPEC
SARSr	O
-	O
CoVs	O
.	O

Molecular	O
clock	O
analysis	O
using	O
ORF1ab	O
showed	O
that	O
SARSr	O
-	O
Rf	O
-	O
BatCoV	O
YNLF_31C	O
and	O
YNLF_34C	O
diverged	O
from	O
civet	B-SPEC
/	O
human	B-SPEC
SARSr	O
-	O
CoVs	O
in	O
approximately	O
1990	O
.	O

TITLE	O
:	O
Complete	O
genome	O
analysis	O
of	O
equine	B-SPEC
coronavirus	B-SPEC
isolated	O
in	O
Japan	O
.	O

Coefficients	O
of	O
variation	O
of	O
this	O
assay	O
were	O
lower	O
than	O
10	O
%,	O
and	O
no	O
cross	O
-	O
reactivity	O
between	O
the	O
coated	O
antigen	O
BE	O
and	O
antiserum	O
against	O
newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
or	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
was	O
observed	O
.	O

ABSTRACT	O
:	O
On	O
26	O
May	O
2015	O
,	O
an	O
imported	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
identified	O
in	O
Guangdong	O
Province	O
,	O
China	O
,	O
and	O
found	O
to	O
be	O
closely	O
related	O
to	O
the	O
MERS	O
-	O
CoV	O
strain	O
prevalent	O
in	O
South	O
Korea	O
.	O

The	O
first	O
component	O
is	O
used	O
to	O
form	O
a	O
corona	B-SPEC
around	O
C60	O
while	O
exhibiting	O
a	O
significant	O
miscibility	O
with	O
water	O
.	O

Taphozous	B-SPEC
perforatus	O
bats	B-SPEC
are	O
the	O
incriminated	O
reservoir	O
host	O
and	O
camels	B-SPEC
are	O
the	O
currently	O
confirmed	O
animal	B-SPEC
linker	O
.	O

To	O
identify	O
the	O
mechanism	O
of	O
PEDV	B-SPEC
intervention	O
with	O
dsRNA	O
-	O
mediated	O
IFN	O
-	O
β	O
expression	O
more	O
accurately	O
,	O
the	O
role	O
of	O
individual	O
molecules	O
of	O
RIG	O
-	O
I	O
signaling	O
pathway	O
were	O
investigated	O
.	O

A	O
common	O
feature	O
among	O
these	O
viruses	B-SPEC
is	O
their	O
ability	O
to	O
dramatically	O
modify	O
cellular	O
membranes	O
to	O
serve	O
as	O
platforms	O
for	O
genome	O
replication	O
and	O
assembly	O
of	O
new	O
virions	O
.	O

In	O
this	O
study	O
we	O
characterized	O
the	O
concentration	O
and	O
size	O
distribution	O
of	O
inhalable	O
particles	O
that	O
transport	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	O
),	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
),	O
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
generated	O
by	O
acutely	O
infected	O
pigs	B-SPEC
and	O
assessed	O
virus	B-SPEC
viability	O
for	O
each	O
particle	O
size	O
range	O
.	O

Upon	O
MERS	O
viral	O
challenge	O
,	O
all	O
of	O
the	O
monkeys	B-SPEC
in	O
the	O
control	O
-	O
vaccinated	O
group	O
developed	O
characteristic	O
disease	O
,	O
including	O
pneumonia	O
.	O

Given	O
the	O
mutations	O
of	O
avian	B-SPEC
flu	O
viruses	B-SPEC
such	O
as	O
H7N9	O
,	O
H6N1	O
,	O
and	O
H10N8	O
,	O
all	O
countries	O
,	O
including	O
Taiwan	O
,	O
must	O
equip	O
themselves	O
to	O
face	O
a	O
possible	O
epidemic	O
or	O
pandemic	O
.	O

ABSTRACT	O
:	O
New	O
cases	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
were	O
reported	O
in	O
Gulf	O
countries	O
in	O
2014	O
,	O
and	O
to	O
date	O
,	O
it	O
has	O
reportedly	O
infected	O
837	O
people	O
and	O
killed	O
291	O
globally	O
.	O

ABSTRACT	O
:	O
studies	O
in	O
our	O
laboratory	O
showed	O
that	O
the	O
Arkansas	O
-	O
Delmarva	O
Poultry	O
Industry	O
(	O
Ark	O
-	O
DPI	O
)	O
vaccine	O
given	O
to	O
1	O
-	O
day	O
-	O
old	O
chickens	B-SPEC
by	O
hatchery	O
spray	O
cabinet	O
replicated	O
poorly	O
and	O
failed	O
to	O
adequately	O
protect	O
broilers	O
against	O
homologous	O
virus	B-SPEC
challenge	O
,	O
whereas	O
the	O
same	O
vaccine	O
given	O
by	O
eye	O
-	O
drop	O
did	O
replicate	O
and	O
the	O
birds	B-SPEC
were	O
protected	O
following	O
homologous	O
virus	B-SPEC
challenge	O
.	O

TITLE	O
:	O
Putative	O
phage	O
-	O
display	O
epitopes	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
S1	O
protein	O
and	O
their	O
anti	O
-	O
viral	O
activity	O
.	O

We	O
describe	O
the	O
discovery	O
of	O
a	O
novel	O
dromedary	B-SPEC
camel	B-SPEC
AstV	O
(	O
DcAstV	O
)	O
from	O
dromedaries	B-SPEC
in	O
Dubai	O
.	O

A	O
computationally	O
derived	O
model	O
of	O
MHV	B-SPEC
PLP2	O
bound	O
to	O
ubiquitin	O
was	O
generated	O
,	O
and	O
the	O
potential	O
interactions	O
between	O
ubiquitin	O
and	O
PLP2	O
were	O
probed	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O

TITLE	O
:	O
Construction	O
of	O
an	O
oral	O
vaccine	O
for	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
based	O
on	O
the	O
TGEV	B-SPEC
N	O
gene	O
expressed	O
in	O
an	O
attenuated	O
Salmonella	B-SPEC
typhimurium	O
vector	O
.	O

TITLE	O
:	O
Immune	O
Responses	O
to	O
Virulent	O
and	O
Vaccine	O
Strains	O
of	O
Infectious	O
Bronchitis	O
Viruses	B-SPEC
in	O
Chickens	B-SPEC
.	O

Studies	O
on	O
adaptive	O
immune	O
activation	O
and	O
the	O
role	O
of	O
humoral	O
and	O
cellular	O
immunity	O
in	O
IBV	B-SPEC
clearance	O
are	O
also	O
reviewed	O
.	O

In	O
view	O
of	O
recent	O
reports	O
of	O
emergent	O
IBV	B-SPEC
variants	O
in	O
many	O
countries	O
,	O
there	O
is	O
renewed	O
interest	O
in	O
a	O
more	O
complete	O
understanding	O
of	O
poultry	O
immune	O
responses	O
to	O
both	O
virulent	O
and	O
vaccine	O
strains	O
of	O
IBVs	O
.	O

Based	O
on	O
pathology	O
,	O
immunohistochemistry	O
and	O
molecular	O
analysis	O
,	O
ferret	B-SPEC
systemic	I-SPEC
coronavirus	I-SPEC
(	O
FRSCV	O
)-	O
associated	O
disease	O
was	O
diagnosed	O
for	O
the	O
first	O
time	O
in	O
South	O
America	O
.	O

Ninety	O
-	O
three	O
(	O
41	O
.	O
9	O
%)	O
of	O
the	O
192	O
patients	O
with	O
KD	O
had	O
a	O
positive	O
respiratory	O
viral	O
PCR	O
,	O
and	O
the	O
majority	O
were	O
positive	O
for	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
.	O

A	O
virus	B-SPEC
neutralization	O
test	O
with	O
sera	O
of	O
7	O
different	O
OD	O
values	O
showed	O
a	O
positive	O
correlation	O
between	O
the	O
OD	O
values	O
and	O
virus	B-SPEC
neutralization	O
.	O

Further	O
studies	O
should	O
focus	O
on	O
the	O
relationship	O
between	O
OD	O
values	O
of	O
sera	O
and	O
its	O
virus	B-SPEC
neutralization	O
.	O

TITLE	O
:	O
Genome	O
-	O
Wide	O
Screen	O
Reveals	O
Valosin	O
-	O
Containing	O
Protein	O
Requirement	O
for	O
Coronavirus	B-SPEC
Exit	O
from	O
Endosomes	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
nsp1	O
Inhibits	O
Host	O
Gene	O
Expression	O
by	O
Selectively	O
Targeting	O
mRNAs	O
Transcribed	O
in	O
the	O
Nucleus	O
while	O
Sparing	O
mRNAs	O
of	O
Cytoplasmic	O
Origin	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
present	O
the	O
first	O
MERS	O
case	O
from	O
Turkey	B-SPEC
identified	O
by	O
molecular	O
methods	O
and	O
the	O
results	O
of	O
viral	O
sequence	O
analysis	O
.	O

A	O
42	O
-	O
year	O
-	O
old	O
male	O
Turkish	O
citizen	O
who	O
worked	O
as	O
an	O
employee	O
in	O
Jeddah	O
,	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
,	O
admitted	O
to	O
hospital	O
with	O
the	O
complaints	O
of	O
fever	O
and	O
malaise	O
on	O
25	O
-	O
26	O
September	O
2014	O
.	O

There	O
was	O
no	O
nucleotide	O
or	O
aminoacid	O
change	O
in	O
our	O
isolate	O
,	O
namely	O
ANK	O
/	O
1079	O
/	O
2014	O
when	O
compared	O
with	O
human	B-SPEC
Betacoronavirus	B-SPEC
2c	O
EMC	O
/	O
2012	O
reference	O
strain	O
found	O
in	O
Genbank	O
database	O
.	O

The	O
previous	O
studies	O
indicated	O
that	O
,	O
the	O
viral	O
genomes	O
detected	O
in	O
the	O
earliest	O
cases	O
of	O
humans	B-SPEC
(	O
clade	O
A	O
)	O
are	O
genetically	O
distinct	O
from	O
the	O
others	O
(	O
clade	O
B	O
)	O
which	O
were	O
isolated	O
from	O
dromedary	B-SPEC
camels	B-SPEC
and	O
humans	B-SPEC
.	O

TITLE	O
:	O
A	O
Multicenter	O
Retrospective	O
Review	O
of	O
Prone	O
Position	O
Ventilation	O
(	O
PPV	B-SPEC
)	O
in	O
Treatment	O
of	O
Severe	O
Human	B-SPEC
H7N9	O
Avian	B-SPEC
Flu	O
.	O

Prone	O
position	O
ventilation	O
(	O
PPV	B-SPEC
)	O
has	O
been	O
shown	O
to	O
improve	O
the	O
prognosis	O
of	O
patients	O
with	O
severe	O
ARDS	O
.	O

Individuals	O
admitted	O
to	O
four	O
hospitals	O
designated	O
for	O
H7N9	O
patients	O
in	O
Guangdong	O
province	O
were	O
treated	O
with	O
PPV	B-SPEC
,	O
and	O
their	O
clinical	O
data	O
were	O
recorded	O
before	O
and	O
after	O
receiving	O
PPV	B-SPEC
.	O

PPV	B-SPEC
provided	O
improved	O
oxygenation	O
that	O
was	O
sustained	O
after	O
returning	O
to	O
a	O
supine	O
position	O
,	O
and	O
resulted	O
in	O
decreased	O
carbon	O
dioxide	O
retention	O
.	O

Cardiovascular	O
risk	O
of	O
anemia	B-SPEC
may	O
be	O
more	O
harmful	O
than	O
the	O
risk	O
of	O
blood	O
transfusion	O
in	O
older	O
patients	O
.	O

ABSTRACT	O
:	O
Replication	O
of	O
coronaviruses	O
is	O
inhibited	O
in	O
vitro	O
by	O
cyclosporin	O
A	O
,	O
a	O
well	O
-	O
known	O
immunosuppressive	O
drug	O
which	O
binds	O
to	O
cellular	O
cyclophilins	O
thus	O
inactivating	O
their	O
enzymatic	O
cis	B-SPEC
-	O
trans	O
peptidyl	O
-	O
prolyl	O
isomerase	O
function	O
.	O

Histologically	O
,	O
granulomas	O
were	O
observed	O
in	O
the	O
liver	O
,	O
spleen	O
,	O
bone	O
marrow	O
,	O
and	O
lymph	O
nodes	O
,	O
composed	O
mainly	O
of	O
aggregated	O
epithelioid	O
macrophages	O
,	O
some	O
of	O
which	O
were	O
positive	O
to	O
an	O
anti	O
-	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
;	O
Alphacoronavirus	B-SPEC
1	I-SPEC
)	O
antibody	O
in	O
immunohistochemistry	O
.	O

Most	O
of	O
the	O
previous	O
studies	O
related	O
to	O
the	O
PED	O
were	O
focused	O
on	O
the	O
pathology	O
and	O
etiology	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

After	O
the	O
fifth	O
round	O
of	O
biopanning	O
with	O
Escherichia	B-SPEC
coli	I-SPEC
-	O
synthesized	O
ORF6	O
-	O
His	O
tagged	O
protein	O
,	O
the	O
relative	O
binding	O
affinity	O
of	O
phage	O
clones	O
to	O
ORF6	O
was	O
determined	O
using	O
direct	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

ABSTRACT	O
:	O
Plasmodium	B-SPEC
falciparum	I-SPEC
(	O
Pf	O
)	O
is	O
associated	O
with	O
numerous	O
complications	O
and	O
high	O
mortality	O
,	O
whereas	O
Plasmodium	B-SPEC
vivax	I-SPEC
(	O
Pv	O
)	O
infection	O
is	O
generally	O
considered	O
to	O
be	O
benign	O
.	O

More	O
than	O
sixty	O
viruses	B-SPEC
have	O
been	O
detected	O
or	O
isolated	O
in	O
bats	B-SPEC
;	O
these	O
animals	B-SPEC
are	O
therefore	O
involved	O
in	O
the	O
natural	O
cycles	O
of	O
many	O
of	O
them	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
envelope	O
(	O
E	O
)	O
protein	O
is	O
a	O
viroporin	O
involved	O
in	O
virulence	O
.	O

The	O
most	O
frequently	O
observed	O
co	O
-	O
infection	O
patterns	O
were	O
RSV	B-SPEC
-	O
Rhinovirus	B-SPEC
(	O
23	O
patients	O
,	O
11	O
.	O
3	O
%,	O
GENDRES	O
cohort	O
)	O
and	O
RSV	B-SPEC
-	O
bocavirus	B-SPEC
/	O
bocavirus	B-SPEC
-	O
influenza	O
(	O
5	O
patients	O
,	O
5	O
.	O
2	O
%,	O
UK	O
cohort	O
).	O

Seventy	O
clinical	O
samples	O
(	O
35	O
%)	O
from	O
55	O
patients	O
(	O
30	O
children	O
and	O
25	O
adults	O
)	O
were	O
positive	O
for	O
1	O
or	O
more	O
viruses	B-SPEC
.	O

In	O
adult	O
patients	O
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
was	O
the	O
most	O
frequently	O
detected	O
respiratory	O
virus	B-SPEC
followed	O
by	O
rhinoviruses	B-SPEC
.	O

TITLE	O
:	O
[	O
A	O
Case	O
of	O
Nasopharyngeal	O
Cancer	B-SPEC
with	O
Febrile	O
Neutropenia	O
Followed	O
by	O
Death	O
during	O
Adjuvant	O
Chemotherapy	O
].	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
induced	O
by	O
severe	O
sepsis	B-SPEC
can	O
trigger	O
persistent	O
inflammation	O
and	O
fibrosis	O
.	O

We	O
have	O
been	O
suggested	O
that	O
treatment	O
of	O
septic	O
baboons	B-SPEC
with	O
compstatin	O
,	O
a	O
C3	O
convertase	O
inhibitor	O
protects	O
against	O
ARDS	O
-	O
induced	O
fibroproliferation	O
.	O

Systematic	O
dissection	O
of	O
single	O
-	O
cycle	O
replication	O
revealed	O
that	O
ns12	O
.	O
9	O
protein	O
had	O
no	O
measurable	O
effect	O
on	O
virus	B-SPEC
entry	O
,	O
subgenomic	O
mRNA	O
(	O
sgmRNA	O
)	O
synthesis	O
,	O
and	O
protein	O
expression	O
.	O

Of	O
95	O
CPV	B-SPEC
-	O
2	O
strains	O
,	O
Tyr324Ile	O
and	O
Thr440Ala	O
substitutions	O
accounted	O
for	O
100	O
%	O
and	O
64	O
.	O
21	O
%,	O
respectively	O
;	O
all	O
type	O
new2b	O
strains	O
exhibited	O
the	O
Thr440Ala	O
substitution	O
,	O
while	O
the	O
unique	O
Gln370Arg	O
substitution	O
was	O
found	O
in	O
all	O
type	O
2c	O
strains	O
.	O

The	O
replication	O
of	O
MVvac2	O
-	O
CoV	O
-	O
S	O
in	O
Vero	O
cells	O
turned	O
out	O
to	O
be	O
comparable	O
to	O
that	O
of	O
the	O
control	O
virus	B-SPEC
MVvac2	O
-	O
GFP	O
(	O
encoding	O
green	O
fluorescent	O
protein	O
),	O
while	O
titers	O
of	O
MVvac2	O
-	O
CoV	O
-	O
solS	O
were	O
impaired	O
approximately	O
3	O
-	O
fold	O
.	O

Additionally	O
,	O
induction	O
of	O
specific	O
T	O
cells	O
was	O
demonstrated	O
by	O
T	O
cell	O
proliferation	O
,	O
antigen	O
-	O
specific	O
T	O
cell	O
cytotoxicity	O
,	O
and	O
gamma	O
interferon	O
secretion	O
after	O
stimulation	O
of	O
splenocytes	O
with	O
MERS	O
-	O
CoV	O
-	O
S	O
presented	O
by	O
murine	B-SPEC
dendritic	O
cells	O
.	O

Ingenuity	O
Pathway	O
Analysis	O
was	O
employed	O
to	O
investigate	O
the	O
canonical	O
pathways	O
and	O
functional	O
networks	O
involved	O
in	O
both	O
PEDV	B-SPEC
infections	O
.	O

Porcine	B-SPEC
epidemic	O
diarrhea	O
is	O
now	O
worldwide	O
distributed	O
and	O
causing	O
huge	O
economic	O
losses	O
to	O
swine	B-SPEC
industry	O
.	O

Serial	O
lactate	O
monitoring	O
is	O
a	O
useful	O
tool	O
to	O
gauge	O
global	O
tissue	O
hypoxia	O
in	O
emergency	O
department	O
(	O
ED	O
)	O
patients	O
with	O
sepsis	B-SPEC
.	O

This	O
is	O
a	O
retrospective	O
observational	O
cohort	O
study	O
of	O
adult	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
patients	O
with	O
elevated	O
lactate	O
presenting	O
to	O
a	O
large	O
academic	O
ED	O
.	O

The	O
quick	O
release	O
of	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
)	O
by	O
the	O
infected	O
macrophages	O
suggests	O
a	O
plausible	O
viral	O
initiation	O
of	O
NLRP3	O
inflammasome	O
activation	O
.	O

RESULTS	O
:	O
Between	O
2003	O
and	O
2012	O
,	O
influenza	O
B	O
,	O
RSV	B-SPEC
,	O
and	O
coronavirus	B-SPEC
showed	O
shifts	O
in	O
their	O
occurrence	O
when	O
influenza	O
A	O
epidemics	O
occurred	O
earlier	O
than	O
usual	O
(	O
before	O
week	O
1	O
).	O

Occurrence	O
of	O
rhinovirus	B-SPEC
,	O
norovirus	B-SPEC
,	O
rotavirus	B-SPEC
,	O
and	O
enterovirus	B-SPEC
did	O
not	O
change	O
.	O

ABSTRACT	O
:	O
The	O
MERS	O
-	O
CoV	O
is	O
an	O
emerging	O
virus	B-SPEC
,	O
which	O
already	O
infected	O
more	O
than	O
1	O
,	O
300	O
humans	B-SPEC
with	O
high	O
(∼	O
36	O
%)	O
mortality	O
.	O

The	O
antiviral	O
screening	O
of	O
levopimaric	O
acid	O
diene	O
adducts	O
derivatives	O
was	O
carried	O
out	O
with	O
minimal	O
effect	O
on	O
SARS	O
and	O
influenza	O
type	O
B	O
viruses	B-SPEC
.	O

Wheezing	O
was	O
present	O
in	O
81	O
.	O
5	O
%	O
of	O
all	O
rhinovirus	B-SPEC
infections	O
and	O
in	O
only	O
33	O
.	O
3	O
%	O
of	O
all	O
adenovirus	B-SPEC
infections	O
.	O

In	O
conclusion	O
,	O
the	O
current	O
study	O
identified	O
the	O
nsp3	O
gene	O
as	O
an	O
alternative	O
marker	O
for	O
a	O
rapid	O
and	O
unequivocal	O
classification	O
of	O
the	O
circulating	O
PEDV	B-SPEC
strains	O
which	O
provides	O
complementary	O
information	O
to	O
the	O
S	O
gene	O
in	O
identifying	O
the	O
emergence	O
of	O
epidemic	O
strain	O
resulting	O
from	O
recombination	O
.	O

Identifying	O
host	O
factors	O
that	O
regulate	O
SARS	O
-	O
CoV	O
pathogenesis	O
is	O
critical	O
to	O
understanding	O
how	O
this	O
lethal	O
virus	B-SPEC
causes	O
disease	O
.	O

To	O
compare	O
the	O
genetic	O
diversity	O
of	O
bat	B-SPEC
viruses	B-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
we	O
tested	O
historical	O
isolates	O
and	O
diagnostic	O
specimens	O
sampled	O
globally	O
over	O
10	O
years	O
.	O

Analyses	O
of	O
four	O
full	O
genomes	O
from	O
229E	O
-	O
related	O
bat	B-SPEC
CoVs	O
revealed	O
an	O
eighth	O
open	O
reading	O
frame	O
(	O
ORF8	O
)	O
located	O
at	O
the	O
genomic	O
3	O
'	O
end	O
.	O

Maternal	O
antibodies	O
began	O
to	O
decrease	O
in	O
the	O
2nd	O
month	O
for	O
BRSV	B-SPEC
,	O
BHV	O
-	O
1	O
and	O
BAV	O
-	O
3	O
(	O
97	O
.	O
8	O
%,	O
25	O
.	O
5	O
%	O
and	O
91	O
.	O
4	O
%)	O
and	O
in	O
the	O
3rd	O
month	O
for	O
PI	O
-	O
3	O
,	O
BVDV	B-SPEC
and	O
BCoV	O
(	O
85	O
.	O
1	O
%,	O
67	O
%	O
and	O
93	O
.	O
6	O
%).	O

A	O
high	O
ratio	O
under	O
CMV	B-SPEC
raises	O
questions	O
about	O
the	O
use	O
of	O
HFOV	O
in	O
such	O
patients	O
.	O

These	O
results	O
suggest	O
that	O
a	O
longer	O
duration	O
of	O
PMX	O
-	O
DHP	O
therapy	O
can	O
be	O
expected	O
to	O
improve	O
the	O
hemodynamics	O
and	O
pulmonary	O
oxygenation	O
capacity	O
of	O
patients	O
with	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
.	O

Both	O
mAbs	O
potently	O
bind	O
to	O
MERS	O
-	O
RBD	O
and	O
block	O
virus	B-SPEC
entry	O
in	O
vitro	O
with	O
high	O
efficacy	O
.	O

Based	O
on	O
the	O
structure	O
,	O
we	O
further	O
humanized	O
4C2	O
by	O
preserving	O
only	O
the	O
paratope	O
residues	O
and	O
substituting	O
the	O
remaining	O
amino	O
acids	O
with	O
the	O
counterparts	O
from	O
human	B-SPEC
immunoglobulins	O
.	O

ABSTRACT	O
:	O
To	O
establish	O
strategic	O
priorities	O
for	O
the	O
Public	O
Health	O
Agency	O
of	O
Sweden	O
we	O
prioritized	O
pathogens	O
according	O
to	O
their	O
public	O
health	O
relevance	O
in	O
Sweden	O
in	O
order	B-SPEC
to	O
guide	O
resource	O
allocation	O
.	O

We	O
will	O
evaluate	O
the	O
possibilities	O
of	O
surveillance	O
for	O
the	O
pathogens	O
in	O
the	O
highest	O
priority	O
group	O
where	O
we	O
currently	O
do	O
not	O
have	O
any	O
ongoing	O
surveillance	O
and	O
evaluate	O
the	O
need	O
of	O
surveillance	O
for	O
the	O
pathogens	O
from	O
the	O
low	O
priority	O
group	O
where	O
there	O
is	O
ongoing	O
surveillance	O
in	O
order	B-SPEC
to	O
focus	O
our	O
work	O
on	O
the	O
pathogens	O
with	O
the	O
highest	O
relevance	O
.	O

In	O
addition	O
to	O
this	O
,	O
we	O
found	O
that	O
independently	O
of	O
its	O
accessory	O
proteins	O
,	O
IBV	B-SPEC
inhibits	O
IFN	O
-	O
mediated	O
phosphorylation	O
and	O
translocation	O
of	O
STAT1	O
.	O

Results	O
suggest	O
that	O
this	O
biosensor	O
has	O
the	O
potential	O
to	O
simultaneously	O
identify	O
common	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
emerging	O
infectious	O
disease	O
that	O
can	O
present	O
with	O
flu	O
-	O
like	O
symptoms	O
.	O

We	O
found	O
14	O
.	O
7	O
%	O
pooled	O
swabs	O
positive	O
by	O
PCR	O
for	O
NDV	B-SPEC
and	O
14	O
.	O
6	O
%	O
for	O
IBV	B-SPEC
.	O

A	O
number	O
of	O
vaccine	O
candidates	O
have	O
been	O
developed	O
on	O
the	O
basis	O
of	O
viral	O
vectors	O
,	O
recombinant	O
proteins	O
,	O
DNAs	O
,	O
nanoparticles	O
,	O
and	O
recombinant	O
MERS	O
-	O
CoV	O
,	O
and	O
some	O
of	O
them	O
have	O
shown	O
efficacy	O
in	O
laboratory	O
animals	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
ongoing	O
moratorium	O
on	O
gain	O
-	O
of	O
-	O
function	O
(	O
GOF	O
)	O
research	O
with	O
highly	O
pathogenic	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
has	O
drawn	O
attention	O
to	O
the	O
current	O
debate	O
on	O
these	O
research	O
practices	O
and	O
the	O
potential	O
benefits	O
and	O
risks	O
they	O
present	O
.	O

In	O
this	O
study	O
,	O
the	O
full	O
-	O
length	O
nucleocapsid	O
protein	O
(	O
NP	O
)	O
gene	O
of	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
cloned	O
and	O
expressed	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

Multicellular	O
organisms	O
employ	O
a	O
wide	O
range	O
of	O
sensors	O
to	O
detect	O
viruses	B-SPEC
and	O
other	O
pathogens	O
.	O

ABSTRACT	O
:	O
In	O
March	O
2013	O
,	O
the	O
Chinese	O
Centre	O
for	O
Disease	O
Control	O
and	O
Prevention	O
confirmed	O
the	O
first	O
reported	O
case	O
of	O
human	B-SPEC
infection	O
with	O
an	O
avian	B-SPEC
influenza	O
A	O
H7N9	O
virus	B-SPEC
.	O

A	O
single	O
immunization	O
with	O
the	O
adjuvanted	O
vaccine	O
elicited	O
a	O
strong	O
humoral	O
response	O
and	O
protected	O
mice	B-SPEC
against	O
an	O
otherwise	O
lethal	O
challenge	O
.	O

Studies	O
are	O
currently	O
ongoing	O
to	O
better	O
characterize	O
the	O
immune	O
response	O
elicited	O
by	O
the	O
plant	B-SPEC
-	O
derived	O
VLP	O
vaccines	O
.	O

These	O
viruses	B-SPEC
are	O
characterized	O
by	O
a	O
set	O
of	O
unique	O
accessory	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
that	O
are	O
located	O
between	O
the	O
M	O
and	O
N	O
genes	O
.	O

The	O
aims	O
of	O
our	O
study	O
were	O
to	O
investigate	O
differences	O
in	O
innate	O
immune	O
responses	O
to	O
PEDV	B-SPEC
infection	O
in	O
suckling	O
and	O
weaned	O
pigs	B-SPEC
and	O
to	O
examine	O
if	O
disease	O
severity	O
coincides	O
with	O
reduced	O
innate	O
immune	O
responses	O
.	O

The	O
pigs	B-SPEC
were	O
observed	O
daily	O
for	O
clinical	O
signs	O
,	O
virus	B-SPEC
shedding	O
and	O
were	O
euthanized	O
at	O
post	O
-	O
inoculation	O
days	O
(	O
PIDs	O
)	O
1	O
and	O
5	O
to	O
assay	O
immune	O
responses	O
.	O

In	O
conclusion	O
,	O
the	O
observations	O
of	O
impaired	O
lytic	O
activity	O
and	O
IFN	O
-	O
γ	O
production	O
by	O
NK	O
cells	O
in	O
suckling	O
pigs	B-SPEC
coincided	O
with	O
the	O
increased	O
severity	O
of	O
PEDV	B-SPEC
infection	O
in	O
the	O
suckling	O
pigs	B-SPEC
compared	O
with	O
the	O
weaned	O
pigs	B-SPEC
.	O

Considerable	O
research	O
has	O
been	O
directed	O
to	O
understand	O
the	O
role	O
of	O
respiratory	O
virus	B-SPEC
immunomodulatory	O
proteins	O
and	O
how	O
they	O
influence	O
the	O
host	O
immune	O
response	O
.	O

We	O
review	O
here	O
efforts	O
to	O
develop	O
next	O
-	O
generation	O
vaccines	O
through	O
targeting	O
these	O
key	O
immunomodulatory	O
genes	O
in	O
influenza	B-SPEC
virus	I-SPEC
,	O
coronaviruses	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
measles	B-SPEC
virus	I-SPEC
,	O
and	O
mumps	B-SPEC
virus	I-SPEC
.	O

The	O
S	O
-	O
phase	O
arrest	O
is	O
associated	O
with	O
a	O
decrease	O
in	O
level	O
of	O
cyclin	O
A	O
.	O
Furthermore	O
,	O
our	O
results	O
revealed	O
that	O
the	O
M	O
protein	O
of	O
PEDV	B-SPEC
does	O
not	O
induce	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
and	O
does	O
not	O
activate	O
NF	O
-	O
κB	O
which	O
is	O
responsible	O
for	O
IL	O
-	O
8	O
and	O
Bcl	O
-	O
2	O
expression	O
.	O

The	O
sequences	O
of	O
Anand	O
isolates	O
revealed	O
further	O
genetic	O
changes	O
in	O
the	O
circulating	O
IBV	B-SPEC
in	O
comparison	O
to	O
previous	O
isolate	O
of	O
Gujarat	O
as	O
well	O
as	O
higher	O
differences	O
with	O
the	O
strains	O
isolated	O
in	O
other	O
states	O
showing	O
substantial	O
changes	O
at	O
genetic	O
level	O
in	O
Indian	O
IBV	B-SPEC
isolates	O
,	O
which	O
may	O
partially	O
explain	O
the	O
increasing	O
incidences	O
of	O
IB	O
in	O
the	O
country	O
in	O
spite	O
of	O
the	O
vaccination	O
.	O

ABSTRACT	O
:	O
In	O
2012	O
,	O
a	O
nephrologist	O
reported	O
the	O
development	O
of	O
a	O
multiorgan	O
thrombotic	O
syndromic	O
complex	O
resembling	O
thrombotic	O
thrombocytopenic	O
purpura	B-SPEC
(	O
TTP	O
)	O
in	O
patients	O
who	O
were	O
abusing	O
long	O
acting	O
oxymorphone	O
hydrochloride	O
;	O
all	O
patients	O
had	O
hemolytic	O
anemia	B-SPEC
and	O
thrombocytopenia	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
was	O
identified	O
in	O
the	O
United	O
States	O
(	O
U	O
.	O
S	O
.)	O
swine	B-SPEC
population	O
for	O
the	O
first	O
time	O
in	O
April	O
2013	O
and	O
rapidly	O
spread	O
nationwide	O
.	O

The	O
main	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
oral	O
minimum	O
infectious	O
dose	O
of	O
PEDV	B-SPEC
in	O
naïve	O
conventional	O
neonatal	O
piglets	O
and	O
weaned	O
pigs	B-SPEC
.	O

Dilutions	O
with	O
theoretical	O
infectious	O
titers	O
from	O
560	O
to	O
0	O
.	O
0056	O
TCID50	O
/	O
ml	O
together	O
with	O
a	O
medium	O
control	O
were	O
orogastrically	O
inoculated	O
(	O
10ml	O
/	O
pig	B-SPEC
)	O
into	O
7	O
groups	O
of	O
5	O
-	O
day	O
-	O
old	O
neonatal	O
pigs	B-SPEC
(	O
n	O
=	O
4	O
per	O
group	O
)	O
and	O
7	O
groups	O
of	O
21	O
-	O
day	O
-	O
old	O
weaned	O
pigs	B-SPEC
(	O
n	O
=	O
6	O
per	O
group	O
).	O

ABSTRACT	O
:	O
Acute	O
lower	O
respiratory	O
infection	O
(	O
ALRI	O
)	O
remains	O
a	O
major	O
cause	O
of	O
childhood	O
hospitalization	O
and	O
mortality	O
in	O
young	O
children	O
and	O
the	O
causal	O
attribution	O
of	O
respiratory	O
viruses	B-SPEC
in	O
the	O
aetiology	O
of	O
ALRI	O
is	O
unclear	O
.	O

Lung	O
pathology	O
and	O
transcriptomic	O
data	O
from	O
mice	B-SPEC
genetically	O
deficient	O
in	O
Trim55	O
were	O
used	O
to	O
validate	O
its	O
role	O
in	O
SARS	O
-	O
CoV	O
-	O
induced	O
vascular	O
cuffing	O
and	O
inflammation	O
.	O

Here	O
,	O
we	O
seek	O
to	O
identify	O
genes	O
conferring	O
resistance	O
to	O
this	O
coronavirus	B-SPEC
,	O
which	O
could	O
help	O
in	O
selective	O
breeding	O
programs	O
to	O
rear	O
chickens	B-SPEC
which	O
do	O
not	O
succumb	O
to	O
the	O
effects	O
of	O
this	O
disease	O
.	O

Potential	O
candidate	O
genes	O
for	O
resistance	O
to	O
IBV	B-SPEC
are	O
highlighted	O
.	O

TITLE	O
:	O
The	O
use	O
of	O
convalescent	O
plasma	O
to	O
treat	O
emerging	O
infectious	O
diseases	O
:	O
focus	O
on	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	B-SPEC
)	O
in	O
dog	B-SPEC
in	O
Japan	O
:	O
detection	O
of	O
CCoV	B-SPEC
RNA	O
and	O
retrospective	O
serological	O
analysis	O
.	O

ABSTRACT	O
:	O
To	O
assemble	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)-	O
like	O
particles	O
bearing	O
the	O
recombinant	O
spike	O
protein	O
and	O
investigate	O
the	O
humoral	O
immune	O
responses	O
in	O
chickens	B-SPEC
.	O

All	O
of	O
the	O
studies	O
in	O
this	O
review	O
reported	O
no	O
occurrence	O
of	O
ECMO	O
cannula	B-SPEC
dislodgment	O
,	O
and	O
2	O
studies	O
reported	O
cannula	B-SPEC
site	O
bleeding	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
a	O
viral	O
avian	B-SPEC
disease	O
with	O
economic	O
importance	O
in	O
the	O
world	O
,	O
including	O
Iran	O
.	O

The	O
most	O
frequently	O
detected	O
viruses	B-SPEC
were	O
of	O
the	O
Var2	O
-	O
like	O
(	O
IS	O
/	O
1494	O
/	O
06	O
-	O
like	O
)	O
genotype	O
,	O
with	O
an	O
overall	O
prevalence	O
of	O
34	O
%.	O

Each	O
set	O
of	O
multiplex	O
methods	O
detected	O
four	O
viruses	B-SPEC
,	O
the	O
first	O
set	O
:	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
rhinovirus	B-SPEC
,	O
enterovirus	B-SPEC
;	O
the	O
second	O
set	O
:	O
parainfluenza	O
viruses	B-SPEC
1	O
-	O
4	O
(	O
PIV1	O
-	O
4	O
);	O
the	O
third	O
set	O
:	O
coronaviruses	O
NL63	O
,	O
229E	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
and	O
OC43	O
.	O

Results	O
Seventeen	O
(	O
85	O
%)	O
of	O
the	O
effusion	O
samples	O
from	O
20	O
cats	B-SPEC
with	O
FIP	O
were	O
positive	O
for	O
FCoV	O
RNA	O
,	O
whereas	O
none	O
of	O
the	O
23	O
cats	B-SPEC
with	O
other	O
diseases	O
were	O
positive	O
.	O

In	O
order	B-SPEC
to	O
consider	O
occurrence	O
factor	O
of	O
PED	O
outbreaks	O
,	O
we	O
determined	O
the	O
whole	O
-	O
genome	O
sequences	O
of	O
38	O
PED	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
strains	O
from	O
diarrheal	O
samples	O
collected	O
at	O
swine	B-SPEC
farms	O
in	O
18	O
prefectures	O
between	O
2013	O
and	O
2014	O
using	O
next	O
-	O
generation	O
sequencing	O
technology	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
,	O
we	O
examined	O
the	O
association	O
among	O
clinical	O
signs	O
,	O
ciliostasis	O
,	O
virus	B-SPEC
detection	O
,	O
and	O
histopathology	O
for	O
evaluating	O
protection	O
of	O
vaccinated	O
chickens	B-SPEC
against	O
homologous	O
and	O
heterologous	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
challenge	O
.	O

Twenty	O
Bordetella	B-SPEC
avium	I-SPEC
colonies	O
were	O
recovered	O
from	O
one	O
of	O
five	O
fully	O
protected	O
birds	B-SPEC
,	O
and	O
only	O
five	O
colonies	O
were	O
isolated	O
from	O
two	O
of	O
five	O
partially	O
protected	O
birds	B-SPEC
without	O
ciliostasis	O
,	O
whereas	O
in	O
birds	B-SPEC
with	O
ciliostasis	O
,	O
numerous	O
colonies	O
were	O
isolated	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
examining	O
both	O
criteria	O
would	O
be	O
important	O
when	O
evaluating	O
IBV	B-SPEC
vaccine	O
efficacy	O
.	O

Partial	O
spike	O
glycoprotein	O
gene	O
sequences	O
revealed	O
seven	O
distinct	O
genotypes	O
,	O
including	O
Mass	O
,	O
793	O
/	O
B	O
,	O
IS720	O
,	O
Variant	O
2	O
,	O
QX	O
,	O
IR	O
-	O
I	O
,	O
and	O
IR	O
-	O
II	O
,	O
to	O
be	O
circulating	O
in	O
the	O
chicken	B-SPEC
farms	O
.	O

The	O
current	O
work	O
constitutes	O
the	O
first	O
comprehensive	O
survey	O
of	O
IBV	B-SPEC
in	O
Iran	O
and	O
emphasizes	O
the	O
need	O
for	O
continuous	O
monitoring	O
and	O
rethinking	O
of	O
current	O
preventative	O
measures	O
.	O

Particularly	O
,	O
compounds	O
4	O
,	O
11b	O
,	O
11c	O
,	O
13c	O
,	O
15a	O
,	O
18	O
and	O
21	O
resulted	O
active	O
against	O
BVDV	B-SPEC
at	O
concentrations	O
ranging	O
from	O
1	O
.	O
3	O
to	O
5	O
μM	O
.	O
Compound	O
21	O
was	O
also	O
evaluated	O
for	O
its	O
activity	O
on	O
the	O
BVDV	B-SPEC
RdRp	O
.	O

Compound	O
4	O
was	O
also	O
tested	O
as	O
potential	O
anti	O
-	O
HCV	B-SPEC
compound	O
in	O
a	O
subgenomic	O
replication	O
assay	O
.	O

The	O
remaining	O
five	O
IBV	B-SPEC
isolates	O
,	O
ck	O
/	O
CH	O
/	O
LHB	O
/	O
111172	O
,	O
ck	O
/	O
CH	O
/	O
LSD	O
/	O
111219	O
,	O
ck	O
/	O
CH	O
/	O
LHB	O
/	O
130598	O
,	O
ck	O
/	O
CH	O
/	O
LDL	O
/	O
110931	O
,	O
and	O
ck	O
/	O
CH	O
/	O
LHB	O
/	O
130573	O
,	O
were	O
shown	O
to	O
have	O
originated	O
from	O
natural	O
recombination	O
events	O
between	O
an	O
H120	O
-	O
like	O
vaccine	O
strain	O
and	O
other	O
types	O
of	O
viruses	B-SPEC
.	O

Sequences	O
of	O
full	O
-	O
length	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
from	O
10	O
patients	O
and	O
a	O
partial	O
sequence	O
of	O
MERS	O
-	O
CoV	O
from	O
another	O
patient	O
,	O
when	O
compared	O
with	O
other	O
MERS	O
-	O
CoV	O
sequences	O
,	O
demonstrated	O
that	O
this	O
outbreak	O
was	O
part	O
of	O
a	O
larger	O
outbreak	O
that	O
affected	O
multiple	O
health	O
care	O
facilities	O
in	O
Riyadh	O
and	O
possibly	O
arose	O
from	O
a	O
single	O
zoonotic	O
transmission	O
event	O
that	O
occurred	O
in	O
December	O
2013	O
(	O
95	O
%	O
highest	O
posterior	O
density	O
interval	O
November	O
8	O
,	O
2013	O
-	O
February	O
10	O
,	O
2014	O
).	O

Compound	O
(	O
R	O
,	O
R	O
)-	O
17	O
showed	O
the	O
best	O
anti	O
-	O
TMV	B-SPEC
activity	O
in	O
vitro	O
(	O
70	O
%/	O
500	O
μg	O
/	O
mL	O
and	O
33	O
%/	O
100	O
μg	O
/	O
mL	O
)	O
and	O
in	O
vivo	O
(	O
inactivation	O
effect	O
,	O
68	O
%/	O
500	O
μg	O
/	O
mL	O
and	O
30	O
%/	O
100	O
μg	O
/	O
mL	O
;	O
curative	O
effect	O
,	O
64	O
%/	O
500	O
μg	O
/	O
mL	O
and	O
31	O
%/	O
100	O
μg	O
/	O
mL	O
;	O
protection	O
effect	O
,	O
66	O
%/	O
500	O
μg	O
/	O
mL	O
and	O
31	O
%/	O
100	O
μg	O
/	O
mL	O
),	O
which	O
is	O
higher	O
than	O
that	O
of	O
ningnanmycin	O
and	O
lead	O
compound	O
18	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Causes	O
Multiple	O
Organ	O
Damage	O
and	O
Lethal	O
Disease	O
in	O
Mice	B-SPEC
Transgenic	O
for	O
Human	B-SPEC
Dipeptidyl	O
Peptidase	O
4	O
.	O

ABSTRACT	O
:	O
The	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
identified	O
in	O
2003	O
has	O
infected	O
∼	O
8000	O
people	O
worldwide	O
,	O
killing	O
nearly	O
10	O
%	O
of	O
them	O
.	O

Hence	O
,	O
the	O
role	O
of	O
the	O
RBM	O
is	O
a	O
bi	O
-	O
functional	O
bioactive	O
surface	O
that	O
can	O
be	O
demonstrated	O
by	O
antibodies	O
such	O
as	O
the	O
neutralizing	O
human	B-SPEC
anti	O
-	O
SARS	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
80R	O
which	O
targets	O
the	O
RBM	O
and	O
competes	O
with	O
the	O
ACE2	O
receptor	O
for	O
binding	O
.	O

ABSTRACT	O
:	O
Adenovirus	B-SPEC
14p1	O
(	O
Ad14p1	O
)	O
is	O
an	O
emergent	O
variant	O
of	O
Ad	O
serotype	O
14	O
(	O
Ad14	O
)	O
that	O
has	O
caused	O
increased	O
severity	O
of	O
respiratory	O
illnesses	O
during	O
globally	O
distributed	O
outbreaks	O
,	O
including	O
cases	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
death	O
.	O

The	O
only	O
previous	O
study	O
focusing	O
on	O
the	O
in	O
vitro	O
activity	O
of	O
nsp9	O
of	O
an	O
arterivirus	B-SPEC
(	O
equine	B-SPEC
arteritis	I-SPEC
virus	I-SPEC
;	O
EAV	B-SPEC
)	O
reported	O
weak	O
de	O
novo	O
polymerase	O
activity	O
on	O
homopolymeric	O
RNA	O
templates	O
.	O

ABSTRACT	O
:	O
A	O
novel	O
reassortant	O
avian	B-SPEC
-	O
origin	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
was	O
found	O
to	O
infect	O
three	O
Chinese	O
residents	O
,	O
the	O
first	O
H7N9	O
infection	O
in	O
humans	B-SPEC
in	O
Asia	O
.	O

TITLE	O
:	O
Application	O
of	O
RT	O
-	O
Bst	O
to	O
enhance	O
detection	O
of	O
pathogenic	O
viruses	B-SPEC
of	O
the	O
respiratory	O
tract	O
.	O

The	O
most	O
common	O
viruses	B-SPEC
were	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
.	O

The	O
flocked	O
nasal	O
swab	O
samples	O
respiratory	O
viruses	B-SPEC
well	O
,	O
even	O
among	O
patients	O
whose	O
primary	O
complaint	O
is	O
a	O
sore	O
throat	O
.	O

Except	O
for	O
Influenza	B-SPEC
virus	I-SPEC
and	O
Respiratory	B-SPEC
Syncytial	I-SPEC
virus	I-SPEC
,	O
mostly	O
viral	O
aetiology	O
of	O
AVRI	O
remains	O
undiagnosed	O
.	O

In	O
contrast	O
,	O
during	O
SARS	O
-	O
CoV	O
-∆	O
E	O
passage	O
in	O
mice	B-SPEC
,	O
the	O
virus	B-SPEC
incorporated	O
a	O
mutated	O
variant	O
of	O
8a	O
protein	O
,	O
resulting	O
in	O
reversion	O
to	O
a	O
virulent	O
phenotype	O
.	O

Ten	O
pigs	B-SPEC
with	O
severe	O
lavage	O
-	O
induced	O
lung	O
injury	O
were	O
mechanically	O
ventilated	O
in	O
a	O
decremental	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
trial	O
that	O
was	O
reduced	O
from	O
20	O
to	O
6	O
cm	O
H2O	O
after	O
full	O
-	O
lung	O
recruitment	O
.	O

ABSTRACT	O
:	O
The	O
Hendra	B-SPEC
virus	I-SPEC
(	O
HeV	B-SPEC
)	O
poses	O
a	O
significant	O
challenge	O
to	O
public	O
health	O
in	O
Australia	O
.	O

RSV	B-SPEC
infection	O
occurred	O
pre	O
-	O
or	O
during	O
induction	O
therapy	O
(	O
n	O
=	O
8	O
)	O
and	O
during	O
consolidation	O
therapy	O
(	O
n	O
=	O
4	O
).	O

ABSTRACT	O
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
is	O
an	O
important	O
viral	O
pathogen	O
associated	O
with	O
neonatal	O
calf	O
diarrhea	O
.	O

Our	O
aim	O
was	O
to	O
investigate	O
the	O
incidence	O
of	O
BCoV	O
in	O
diarrhea	O
outbreaks	O
in	O
beef	O
and	O
dairy	O
herds	O
from	O
Argentina	B-SPEC
during	O
1994	O
-	O
2010	O
.	O

Interestingly	O
,	O
Argentinean	O
strains	O
are	O
distantly	O
related	O
(	O
at	O
both	O
the	O
nucleotide	O
and	O
amino	O
acid	O
levels	O
)	O
with	O
the	O
Mebus	O
historic	O
reference	O
BCoV	O
strain	O
included	O
in	O
the	O
vaccines	O
currently	O
available	O
in	O
Argentina	B-SPEC
.	O

We	O
performed	O
meta	B-SPEC
-	O
analyses	O
of	O
studies	O
on	O
tuberculosis	O
,	O
influenza	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
SARS	O
-	O
Coronavirus	B-SPEC
and	O
pneumonia	O
.	O

Compared	O
to	O
control	O
group	O
,	O
an	O
intense	O
NIRF	O
signal	O
was	O
observed	O
in	O
ALI	O
induced	O
rats	B-SPEC
in	O
the	O
window	O
6	O
-	O
24	O
h	O
post	O
-	O
IL	O
-	O
1beta	O
instillation	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
respiratory	O
infectious	O
phenotypes	O
and	O
their	O
impact	O
on	O
length	O
of	O
stay	O
(	O
LOS	O
)	O
and	O
the	O
COPD	O
Assessment	O
Test	O
(	O
CAT	B-SPEC
)	O
Scale	O
in	O
acute	O
exacerbation	O
of	O
COPD	O
(	O
AECOPD	O
).	O

Viruses	B-SPEC
were	O
detected	O
in	O
38	O
subjects	O
,	O
bacteria	B-SPEC
in	O
17	O
,	O
and	O
of	O
these	O
,	O
seven	O
had	O
both	O
.	O

Influenza	B-SPEC
virus	I-SPEC
was	O
the	O
most	O
frequently	O
isolated	O
virus	B-SPEC
,	O
followed	O
by	O
enterovirus	B-SPEC
/	O
rhinovirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
bocavirus	B-SPEC
,	O
metapneumovirus	B-SPEC
,	O
parainfluenza	O
virus	B-SPEC
types	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
,	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
.	O

Bacteriologic	O
analyses	O
of	O
sputum	O
showed	O
that	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
was	O
the	O
most	O
common	O
bacteria	B-SPEC
,	O
followed	O
by	O
Acinetobacter	B-SPEC
baumannii	I-SPEC
,	O
Klebsiella	B-SPEC
,	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
and	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
.	O

CAT	B-SPEC
score	O
was	O
positively	O
correlated	O
with	O
LOS	O
.	O

In	O
this	O
study	O
,	O
we	O
developed	O
a	O
Vero	O
cell	O
line	O
that	O
stably	O
expresses	O
PEDV	B-SPEC
ORF3	O
gene	O
.	O

We	O
further	O
verified	O
whether	O
or	O
not	O
this	O
gene	O
enhances	O
virus	B-SPEC
production	O
.	O

As	O
the	O
recent	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
and	O
MERS	O
-	O
CoV	O
outbreaks	O
demonstrate	O
,	O
the	O
modern	O
epidemics	O
and	O
large	O
-	O
scale	O
infectious	O
outbreaks	O
emerge	O
and	O
spread	O
quickly	O
.	O

ABSTRACT	O
:	O
Nucleocapsid	O
protein	O
(	O
NP	O
),	O
an	O
essential	O
RNA	O
-	O
binding	O
viral	O
protein	O
in	O
human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
)-	O
infected	O
cells	O
,	O
is	O
required	O
for	O
the	O
replication	O
and	O
transcription	O
of	O
viral	O
RNA	O
.	O

Recent	O
studies	O
suggested	O
that	O
human	B-SPEC
CoV	O
NP	O
is	O
a	O
valid	O
target	O
for	O
antiviral	O
drug	O
development	O
.	O

Our	O
findings	O
provide	O
insight	O
into	O
the	O
development	O
of	O
new	O
therapeutics	O
that	O
disrupt	O
the	O
interaction	O
between	O
RNA	O
and	O
viral	O
NP	O
in	O
the	O
HCoV	O
.	O
The	O
discovery	O
of	O
the	O
new	O
compound	O
would	O
be	O
an	O
impetus	O
to	O
design	O
novel	O
NP	O
inhibitors	O
against	O
human	B-SPEC
CoV	O
.	O

However	O
,	O
there	O
are	O
no	O
methods	O
available	O
to	O
detect	O
DNA	O
and	O
RNA	O
viruses	B-SPEC
in	O
the	O
same	O
reaction	O
system	O
in	O
preclinical	O
level	O
.	O

PCV2	O
and	O
TGEV	B-SPEC
are	O
selected	O
as	O
representatives	O
of	O
the	O
two	O
different	O
types	O
of	O
viruses	B-SPEC
.	O

No	O
cross	O
-	O
reaction	O
was	O
observed	O
with	O
other	O
viruses	B-SPEC
.	O

This	O
adaptative	O
mechanism	O
could	O
potentially	O
be	O
associated	O
with	O
human	B-SPEC
encephalitis	O
or	O
other	O
neurological	O
degenerative	O
pathologies	O
.	O

ABSTRACT	O
:	O
Cystine	O
knot	O
α	O
-	O
amylase	O
inhibitors	O
are	O
cysteine	O
-	O
rich	O
,	O
proline	O
-	O
rich	O
peptides	O
found	O
in	O
the	O
Amaranthaceae	B-SPEC
and	O
Apocynaceae	B-SPEC
plant	B-SPEC
species	B-SPEC
.	O

Thus	O
far	O
,	O
only	O
the	O
α	O
-	O
amylase	O
inhibition	O
activity	O
has	O
been	O
described	O
for	O
members	O
of	O
this	O
family	B-SPEC
.	O

Using	O
the	O
SARS	O
-	O
CoV	O
reverse	O
genetics	O
system	O
,	O
we	O
generated	O
and	O
characterized	O
a	O
chimeric	O
virus	B-SPEC
expressing	O
the	O
spike	O
of	O
bat	B-SPEC
coronavirus	B-SPEC
SHC014	O
in	O
a	O
mouse	B-SPEC
-	O
adapted	O
SARS	O
-	O
CoV	O
backbone	O
.	O

The	O
results	O
indicate	O
that	O
group	O
2b	O
viruses	B-SPEC
encoding	O
the	O
SHC014	O
spike	O
in	O
a	O
wild	O
-	O
type	O
backbone	O
can	O
efficiently	O
use	O
multiple	O
orthologs	O
of	O
the	O
SARS	O
receptor	O
human	B-SPEC
angiotensin	O
converting	O
enzyme	O
II	O
(	O
ACE2	O
),	O
replicate	O
efficiently	O
in	O
primary	O
human	B-SPEC
airway	O
cells	O
and	O
achieve	O
in	O
vitro	O
titers	O
equivalent	O
to	O
epidemic	O
strains	O
of	O
SARS	O
-	O
CoV	O
.	O
Additionally	O
,	O
in	O
vivo	O
experiments	O
demonstrate	O
replication	O
of	O
the	O
chimeric	O
virus	B-SPEC
in	O
mouse	B-SPEC
lung	O
with	O
notable	O
pathogenesis	O
.	O

Exposure	O
to	O
copper	O
destroyed	O
the	O
viral	O
genomes	O
and	O
irreversibly	O
affected	O
virus	B-SPEC
morphology	O
,	O
including	O
disintegration	O
of	O
envelope	O
and	O
dispersal	O
of	O
surface	O
spikes	O
.	O

We	O
show	O
here	O
that	O
a	O
closely	O
related	O
human	B-SPEC
coronavirus	I-SPEC
,	O
229E	O
,	O
which	O
causes	O
upper	O
respiratory	O
tract	O
infection	O
in	O
healthy	O
individuals	O
and	O
serious	O
disease	O
in	O
patients	O
with	O
comorbidities	O
,	O
remained	O
infectious	O
on	O
surface	O
materials	O
common	O
to	O
public	O
and	O
domestic	O
areas	O
for	O
several	O
days	O
.	O

RESULTS	O
:	O
One	O
hundred	O
and	O
twenty	O
cats	B-SPEC
met	O
the	O
inclusion	O
criteria	O
.	O

Risk	O
of	O
bias	B-SPEC
,	O
although	O
acceptable	O
in	O
the	O
view	O
of	O
the	O
review	O
authors	O
,	O
was	O
inevitable	O
:	O
Blinding	O
of	O
participants	O
and	O
carers	O
to	O
treatment	O
allocation	O
was	O
not	O
possible	O
(	O
face	O
-	O
up	O
vs	O
face	O
-	O
down	O
).	O
Primary	O
analyses	O
of	O
short	O
-	O
and	O
longer	O
-	O
term	O
mortality	O
pooled	O
from	O
six	O
trials	O
demonstrated	O
an	O
RR	O
of	O
0	O
.	O
84	O
to	O
0	O
.	O
86	O
in	O
favour	O
of	O
the	O
prone	O
position	O
(	O
PP	O
),	O
but	O
findings	O
were	O
not	O
statistically	O
significant	O
:	O
In	O
the	O
short	O
term	O
,	O
mortality	O
for	O
those	O
ventilated	O
prone	O
was	O
33	O
.	O
4	O
%	O
(	O
363	O
/	O
1086	O
)	O
and	O
supine	O
38	O
.	O
3	O
%	O
(	O
395	O
/	O
1031	O
).	O

The	O
quality	O
of	O
the	O
evidence	O
for	O
both	O
outcomes	O
was	O
rated	O
as	O
low	O
as	O
a	O
result	O
of	O
important	O
potential	O
bias	B-SPEC
and	O
serious	O
inconsistency	O
.	O

Extrapulmonary	O
loci	O
of	O
virus	B-SPEC
replication	O
seem	O
possible	O
.	O

ABSTRACT	O
:	O
High	O
consequence	O
human	B-SPEC
pathogenic	O
viruses	B-SPEC
must	O
be	O
handled	O
at	O
biosafety	O
level	O
2	O
,	O
3	O
or	O
4	O
and	O
must	O
be	O
rendered	O
non	O
-	O
infectious	O
before	O
they	O
can	O
be	O
utilized	O
for	O
molecular	O
or	O
immunological	O
applications	O
at	O
lower	O
biosafety	O
levels	O
.	O

Here	O
we	O
evaluate	O
psoralen	O
-	O
inactivated	O
Arena	O
-,	O
Bunya	O
-,	O
Corona	B-SPEC
-,	O
Filo	O
-,	O
Flavi	O
-	O
and	O
Orthomyxoviruses	B-SPEC
for	O
their	O
suitability	O
as	O
antigen	O
in	O
immunological	O
processes	O
and	O
as	O
template	O
for	O
reverse	O
transcription	O
PCR	O
and	O
sequencing	O
.	O

TITLE	O
:	O
Modeling	O
[(	O
18	O
)	O
F	O
]-	O
FDG	O
lymphoid	O
tissue	O
kinetics	O
to	O
characterize	O
nonhuman	O
primate	B-SPEC
immune	O
response	O
to	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
aerosol	O
challenge	O
.	O

Two	O
-	O
way	O
repeated	O
measures	O
analysis	O
of	O
variance	O
revealed	O
alterations	O
in	O
K	O
i	O
that	O
was	O
associated	O
with	O
the	O
time	O
point	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
after	O
virus	B-SPEC
exposure	O
and	O
the	O
location	O
of	O
lymphoid	O
tissue	O
(	O
p	O
=	O
0	O
.	O
0004	O
).	O

These	O
compounds	O
are	O
represented	O
by	O
tenofovir	O
(	O
PMPA	O
),	O
a	O
medicine	O
for	O
both	O
HIV	B-SPEC
and	O
HBV	B-SPEC
,	O
and	O
adefovir	O
as	O
an	O
anti	O
-	O
HBV	B-SPEC
agent	O
.	O

We	O
have	O
developed	O
a	O
method	O
for	O
rapid	O
de	O
novo	O
assembly	O
of	O
the	O
novel	O
influenza	O
A	O
H7N9	O
virus	B-SPEC
genome	O
directly	O
from	O
the	O
tracheal	O
aspirate	O
of	O
a	O
patient	O
using	O
semiconductor	O
sequencer	O
without	O
culture	O
and	O
prior	O
sequence	O
information	O
.	O

An	O
important	O
astrocytic	O
response	O
in	O
many	O
areas	O
of	O
the	O
CNS	O
of	O
all	O
cats	B-SPEC
,	O
including	O
the	O
periventricular	O
areas	O
of	O
lateral	O
ventricles	O
and	O
fourth	O
ventricle	O
,	O
the	O
molecular	O
layer	O
of	O
the	O
cerebellum	O
and	O
cerebral	O
cortex	O
,	O
was	O
visualized	O
.	O

TITLE	O
:	O
Asymptomatic	O
MERS	O
-	O
CoV	O
Infection	O
in	O
Humans	B-SPEC
Possibly	O
Linked	O
to	O
Infected	O
Dromedaries	B-SPEC
Imported	O
from	O
Oman	O
to	O
United	O
Arab	O
Emirates	O
,	O
May	O
2015	O
.	O

In	O
general	O
,	O
the	O
order	B-SPEC
,	O
number	O
and	O
size	O
of	O
ORFs	O
were	O
consistent	O
with	O
other	O
gammacoronaviruses	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
a	O
novel	O
infectious	O
disease	O
caused	O
by	O
a	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
first	O
reported	O
in	O
Saudi	O
Arabia	O
in	O
September	O
2012	O
.	O

ABSTRACT	O
:	O
The	O
production	O
and	O
use	O
of	O
pseudotyped	O
viral	O
particles	O
are	O
widely	O
established	O
for	O
many	O
viruses	B-SPEC
,	O
and	O
applications	O
in	O
the	O
fields	O
of	O
serology	O
and	O
vaccine	O
development	O
are	O
manifold	O
.	O

Pseudotypes	O
allow	O
for	O
accurate	O
,	O
sequence	O
-	O
directed	O
,	O
sensitive	O
antibody	O
neutralisation	O
assays	O
and	O
antiviral	O
screening	O
to	O
be	O
conducted	O
within	O
a	O
low	O
biosecurity	O
facility	O
and	O
offer	O
a	O
safe	O
and	O
efficient	O
alternative	O
to	O
wildtype	O
virus	B-SPEC
use	O
.	O

TITLE	O
:	O
Benchmark	O
Study	O
for	O
the	O
Cysteine	O
-	O
Histidine	O
Proton	O
Transfer	O
Reaction	O
in	O
a	O
Protein	O
Environment	O
:	O
Gas	O
Phase	O
,	O
COSMO	B-SPEC
,	O
QM	O
/	O
MM	O
Approaches	O
.	O

PED	O
in	O
locally	O
-	O
exposed	O
farms	O
was	O
associated	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
with	O
increased	O
farm	O
size	O
(	O
in	O
100	O
pig	B-SPEC
increments	O
),	O
shorter	O
distances	O
to	O
the	O
closest	O
PED	O
-	O
positive	O
farm	O
(	O
less	O
than1	O
,	O
001m	O
),	O
and	O
a	O
disinfectant	O
contact	O
time	O
of	O
less	O
than	O
20min	O
.	O

Two	O
litters	O
of	O
age	O
-	O
matched	O
piglets	O
were	O
inoculated	O
with	O
either	O
the	O
original	O
US	O
PEDV	B-SPEC
PC21A	O
or	O
mock	O
as	O
positive	O
and	O
negative	O
controls	O
,	O
respectively	O
.	O

The	O
air	O
emitted	O
by	O
15	O
participants	O
with	O
laboratory	O
-	O
confirmed	O
influenza	B-SPEC
virus	I-SPEC
infection	O
was	O
sampled	O
.	O

However	O
,	O
influenza	B-SPEC
virus	I-SPEC
and	O
SARS	O
-	O
CoV	O
may	O
be	O
shed	O
into	O
the	O
environment	O
and	O
be	O
transferred	O
from	O
environmental	O
surfaces	O
to	O
hands	O
of	O
patients	O
and	O
healthcare	O
providers	O
.	O

Assessments	O
of	O
viral	O
protein	O
and	O
RNA	O
levels	O
in	O
infected	O
cells	O
showed	O
that	O
both	O
viruses	B-SPEC
were	O
impaired	O
in	O
their	O
ability	O
to	O
replicate	O
in	O
these	O
cells	O
.	O

Cell	O
culture	O
medium	O
and	O
porcine	B-SPEC
plasma	O
at	O
different	O
pH	O
(	O
7	O
.	O
2	O
,	O
9	O
.	O
2	O
,	O
10	O
.	O
2	O
)	O
and	O
temperature	O
conditions	O
(	O
4	O
°	O
C	O
,	O
40	O
°	O
C	O
,	O
44	O
°	O
C	O
,	O
48	O
°	O
C	O
)	O
were	O
inoculated	O
to	O
a	O
final	O
titer	O
of	O
5	O
.	O
5	O
log10	O
TCID50	O
PEDV	B-SPEC
/	O
ml	O
,	O
incubated	O
for	O
up	O
to	O
120	O
min	O
and	O
the	O
residual	O
infectivity	O
was	O
determined	O
by	O
endpoint	O
dilution	O
assay	O
.	O

Inactivation	O
of	O
8	O
log10	O
TCID50	O
/	O
ml	O
plasma	O
within	O
30	O
min	O
(	O
8D	O
value	O
<	O
30	O
min	O
)	O
by	O
moderate	O
pH	O
and	O
temperature	O
would	O
denote	O
potential	O
industrial	O
processing	O
conditions	O
that	O
ensure	O
safety	O
towards	O
PEDV	B-SPEC
while	O
limiting	O
denaturation	O
of	O
bioactive	O
components	O
.	O

In	O
this	O
study	O
,	O
we	O
conducted	O
retrospective	O
testing	O
of	O
samples	O
submitted	O
to	O
three	O
veterinary	O
diagnostic	O
laboratories	O
where	O
qualifying	O
biological	O
samples	O
were	O
derived	O
from	O
previously	O
submitted	O
diagnostic	O
case	O
submissions	O
from	O
US	O
commercial	O
swine	B-SPEC
farms	O
with	O
a	O
clinical	O
history	O
of	O
enteric	O
disease	O
or	O
from	O
cases	O
that	O
had	O
been	O
previously	O
tested	O
for	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
,	O
PEDV	B-SPEC
,	O
or	O
rotavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Influenza	O
A	O
and	O
B	O
,	O
and	O
many	O
unrelated	O
viruses	B-SPEC
including	O
rhinovirus	B-SPEC
,	O
RSV	B-SPEC
,	O
adenovirus	B-SPEC
,	O
metapneumovirus	B-SPEC
and	O
coronavirus	B-SPEC
share	O
the	O
same	O
seasonality	O
,	O
since	O
these	O
viral	O
acute	O
respiratory	O
tract	O
infections	O
(	O
vARIs	O
)	O
are	O
much	O
more	O
common	O
in	O
winter	O
than	O
summer	O
.	O

However	O
,	O
recent	O
studies	O
have	O
shown	O
that	O
histones	O
,	O
also	O
known	O
as	O
chromatin	O
-	O
basic	O
structure	O
proteins	O
,	O
could	O
be	O
released	O
into	O
the	O
extracellular	O
space	O
during	O
severe	O
stress	O
and	O
physical	O
challenges	O
to	O
the	O
body	O
(	O
e	O
.	O
g	O
.,	O
sepsis	B-SPEC
and	O
ARDS	O
).	O

Due	O
to	O
their	O
cytotoxic	O
and	O
proinflammatory	O
effects	O
,	O
extracellular	O
histones	O
can	O
lead	O
to	O
excessive	O
and	O
overwhelming	O
cell	O
damage	O
and	O
death	O
,	O
thus	O
contributing	O
to	O
the	O
pathogenesis	O
of	O
both	O
sepsis	B-SPEC
and	O
ARDS	O
.	O

The	O
IgG	O
antibody	O
levels	O
of	O
serum	O
from	O
mice	B-SPEC
immunized	O
with	O
purified	O
S	O
protein	O
were	O
markedly	O
high	O
.	O

Antigenicity	O
was	O
compared	O
by	O
detection	O
of	O
polyclonal	O
antibodies	O
(	O
PAbs	O
)	O
against	O
the	O
virus	B-SPEC
and	O
S	O
protein	O
using	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
),	O
an	O
indirect	O
immunofluorescence	O
assay	O
(	O
IFA	O
),	O
and	O
a	O
serum	O
cross	O
-	O
neutralization	O
(	O
SN	O
)	O
assay	O
.	O

The	O
resulting	O
limits	O
of	O
detection	O
(	O
LOD	O
)	O
for	O
virus	B-SPEC
-	O
spiked	O
samples	O
,	O
bacteria	B-SPEC
and	O
DNA	O
fragments	O
were	O
0	O
.	O
16	O
-	O
1	O
.	O
6	O
TCID50	O
(	O
PFU	O
/	O
reaction	O
),	O
1	O
.	O
3	O
-	O
13	O
CFU	O
/	O
reaction	O
and	O
10	O
-	O
100	O
copies	O
/	O
reaction	O
,	O
respectively	O
.	O

TITLE	O
:	O
Altered	O
pathogenicity	O
of	O
a	O
tl	O
/	O
CH	O
/	O
LDT3	O
/	O
03	O
genotype	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
due	O
to	O
natural	O
recombination	O
in	O
the	O
5	O
'-	O
17kb	O
region	O
of	O
the	O
genome	O
.	O

We	O
found	O
that	O
influenza	O
pneumonia	O
was	O
dramatically	O
attenuated	O
in	O
Card9	O
-	O
deficient	O
mice	B-SPEC
,	O
which	O
showed	O
improved	O
mortality	O
with	O
reduced	O
inflammatory	O
cytokines	O
and	O
chemokines	O
in	O
the	O
infected	O
lungs	O
.	O

Nine	O
monkeys	B-SPEC
were	O
randomly	O
assigned	O
to	O
high	O
-	O
dose	O
,	O
low	O
-	O
dose	O
and	O
mock	O
groups	O
,	O
which	O
were	O
immunized	O
with	O
different	O
doses	O
of	O
rRBD	O
plus	O
alum	O
adjuvant	O
or	O
adjuvant	O
alone	O
at	O
different	O
time	O
points	O
(	O
0	O
,	O
8	O
,	O
25	O
weeks	O
).	O

Monkeys	B-SPEC
were	O
euthanized	O
3	O
days	O
after	O
challenge	O
and	O
multiple	O
specimens	O
from	O
tissues	O
were	O
collected	O
for	O
pathological	O
,	O
virological	O
and	O
immunological	O
tests	O
.	O

The	O
existing	O
IBVs	O
continue	O
to	O
evolve	O
in	O
various	O
geographic	O
areas	O
in	O
Asia	O
,	O
which	O
results	O
in	O
the	O
recombination	O
and	O
co	O
-	O
circulation	O
between	O
IBV	B-SPEC
types	O
.	O

The	O
present	O
review	O
provides	O
an	O
overview	O
of	O
IBV	B-SPEC
circulation	O
and	O
the	O
dynamic	O
emergence	O
of	O
new	O
variants	O
found	O
throughout	O
Asia	O
via	O
the	O
recombination	O
of	O
IBV	B-SPEC
strains	O
.	O

In	O
addition	O
to	O
commercial	O
poultry	O
,	O
backyard	O
poultry	O
and	O
free	O
-	O
ranging	O
birds	B-SPEC
may	O
serve	O
as	O
a	O
'	O
hub	O
'	O
for	O
ACoV	O
transmission	O
within	O
a	O
particular	O
area	O
.	O

These	O
findings	O
provide	O
a	O
rationale	O
for	O
the	O
novel	O
pathogenesis	O
of	O
MERS	O
-	O
CoV	O
as	O
well	O
as	O
a	O
basis	O
for	O
developing	O
a	O
candidate	O
therapeutic	O
against	O
this	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
detected	O
by	O
monoclonal	O
antibody	O
-	O
based	O
nucleocapsid	O
protein	O
-	O
capture	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
),	O
RNA	O
detection	O
,	O
and	O
viral	O
culture	O
from	O
the	O
nasal	O
sample	O
of	O
a	O
1	O
-	O
month	O
-	O
old	O
dromedary	B-SPEC
calf	O
in	O
Dubai	O
with	O
sudden	O
death	O
.	O

Phylogeographic	O
analyses	O
of	O
RdRp	O
sequences	O
show	O
that	O
several	O
CoVs	O
strains	O
circulate	O
in	O
European	O
bats	B-SPEC
:	O
(	O
i	O
)	O
old	O
strains	O
detected	O
that	O
have	O
probably	O
diverged	O
a	O
long	O
time	O
ago	O
and	O
are	O
detected	O
in	O
different	O
bat	B-SPEC
subspecies	O
;	O
(	O
ii	O
)	O
strains	O
detected	O
in	O
Myotis	B-SPEC
and	O
Pipistrellus	B-SPEC
bat	B-SPEC
species	B-SPEC
that	O
have	O
more	O
recently	O
diverged	O
.	O

Here	O
,	O
we	O
performed	O
a	O
meta	B-SPEC
-	O
analysis	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
real	O
-	O
time	O
PCR	O
for	O
diagnosing	O
nCoV	O
infection	O
.	O

We	O
analyzed	O
the	O
stability	O
and	O
publication	O
bias	B-SPEC
as	O
well	O
as	O
examined	O
the	O
heterogeneity	O
inspection	O
of	O
real	O
-	O
time	O
PCR	O
detection	O
in	O
contrast	O
to	O
smear	O
staining	O
and	O
culture	O
identification	O
.	O

Pigs	B-SPEC
were	O
assigned	O
to	O
the	O
following	O
three	O
groups	O
:	O
group	O
1	O
(	O
n	O
=	O
4	O
):	O
control	O
group	O
with	O
conventional	O
ventilation	O
;	O
group	O
2	O
(	O
n	O
=	O
5	O
):	O
standard	O
vv	O
-	O
ECMO	O
;	O
group	O
3	O
(	O
n	O
=	O
5	O
):	O
vv	O
-	O
ILIAS	O
.	O

Sinonasal	O
Questionnaire	O
scores	O
of	O
the	O
patients	O
with	O
CRS	O
who	O
tested	O
positive	O
for	O
viruses	B-SPEC
were	O
higher	O
but	O
not	O
statistically	O
different	O
than	O
those	O
without	O
a	O
positive	O
screen	O
(	O
p	O
=	O
0	O
.	O
31	O
).	O

TITLE	O
:	O
Structural	O
Factors	O
of	O
the	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Outbreak	O
as	O
a	O
Public	O
Health	O
Crisis	O
in	O
Korea	O
and	O
Future	O
Response	O
Strategies	O
.	O

Limited	O
preemptive	O
knowledge	O
impeded	O
the	O
understanding	O
of	O
PEDV	B-SPEC
introduction	O
,	O
spread	O
,	O
and	O
prospective	O
economic	O
impacts	O
in	O
the	O
United	O
States	O
.	O

TITLE	O
:	O
Pathogenicity	O
and	O
tissue	O
tropism	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
is	O
associated	O
with	O
elevated	O
apoptosis	O
and	O
innate	O
immune	O
responses	O
.	O

The	O
continued	O
emergence	O
and	O
reemergence	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
underscore	O
the	O
importance	O
of	O
studying	O
how	O
this	O
virus	B-SPEC
manipulates	O
the	O
immune	O
responses	O
of	O
its	O
hosts	O
.	O

Mechanistically	O
,	O
the	O
cysteine	O
protease	O
activity	O
of	O
PEDV	B-SPEC
nsp5	O
mediates	O
proteolysis	O
of	O
NEMO	O
,	O
the	O
key	O
adaptor	O
for	O
IFN	O
synthesis	O
,	O
and	O
NEMO	O
is	O
cleaved	O
at	O
glutamine	O
231	O
(	O
Q231	O
).	O

The	O
new	O
molecular	O
details	O
and	O
determinants	O
impacting	O
NEMO	O
scission	O
by	O
PEDV	B-SPEC
nsp5	O
delineated	O
in	O
this	O
study	O
are	O
fundamental	O
to	O
our	O
understanding	O
of	O
critical	O
virus	B-SPEC
-	O
host	O
interactions	O
that	O
determine	O
PEDV	B-SPEC
pathogenesis	O
.	O

ABSTRACT	O
:	O
A	O
highly	O
pathogenic	O
human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	B-SPEC
),	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	B-SPEC
),	O
has	O
emerged	O
in	O
Jeddah	O
and	O
other	O
places	O
in	O
Saudi	O
Arabia	O
,	O
and	O
has	O
quickly	O
spread	O
to	O
European	O
and	O
Asian	O
countries	O
since	O
September	O
2012	O
.	O

The	O
user	O
-	O
friendly	O
assay	O
detected	O
and	O
differentiated	O
between	O
four	O
viruses	B-SPEC
[	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
),	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
porcine	B-SPEC
circovirus	I-SPEC
type	I-SPEC
2	I-SPEC
,	O
porcine	B-SPEC
respiratory	O
corona	B-SPEC
virus	B-SPEC
],	O
four	O
bacteria	B-SPEC
(	O
Mycoplasma	B-SPEC
hyopneumoniae	I-SPEC
,	O
Pasteurella	B-SPEC
multocida	I-SPEC
,	O
Salmonella	B-SPEC
enterica	I-SPEC
serovar	O
Choleraesuis	O
,	O
Streptococcus	B-SPEC
suis	I-SPEC
),	O
and	O
further	O
differentiated	O
between	O
type	O
1	O
and	O
type	O
2	O
PRRSV	B-SPEC
as	O
well	O
as	O
toxigenic	O
and	O
non	O
-	O
toxigenic	O
P	O
.	O
multocida	O
.	O

We	O
aimed	O
to	O
explore	O
whether	O
these	O
results	O
would	O
be	O
replicated	O
when	O
implementing	O
similar	O
ventilation	O
strategies	O
in	O
a	O
high	O
-	O
fidelity	O
computational	O
simulator	O
,	O
tuned	O
to	O
match	O
data	O
on	O
the	O
responses	O
of	O
a	O
number	O
of	O
human	B-SPEC
ARDS	O
patients	O
to	O
different	O
ventilator	O
inputs	O
.	O

Currently	O
,	O
available	O
vaccines	O
are	O
not	O
completely	O
effective	O
and	O
feedback	O
methods	O
utilizing	O
PEDV	B-SPEC
infected	O
material	O
has	O
variable	O
success	O
in	O
preventing	O
reinfection	O
.	O

Therefore	O
,	O
our	O
goal	O
in	O
this	O
study	O
was	O
to	O
quantify	O
PEDV	B-SPEC
specific	O
IgA	O
and	O
IgG	O
B	O
cell	O
responses	O
in	O
sows	O
at	O
approximately	O
1	O
and	O
6	O
months	O
post	O
-	O
infection	O
in	O
commercial	O
swine	B-SPEC
herds	O
,	O
including	O
parity	O
one	O
and	O
higher	O
sows	O
.	O

TITLE	O
:	O
HEALTH	O
-	O
SCREENING	O
PROTOCOLS	O
FOR	O
VINACEOUS	O
AMAZONS	O
(	O
AMAZONA	B-SPEC
VINACEA	I-SPEC
)	O
IN	O
A	O
REINTRODUCTION	O
PROJECT	O
.	O

The	O
vinaceous	O
Amazon	B-SPEC
parrot	I-SPEC
(	O
Amazona	B-SPEC
vinacea	I-SPEC
)	O
is	O
extinct	O
in	O
several	O
areas	O
,	O
and	O
a	O
project	O
to	O
release	O
confiscated	O
individuals	O
to	O
their	O
former	O
range	O
is	O
currently	O
underway	O
.	O

We	O
hypothesize	O
that	O
a	O
minimum	O
panel	O
of	O
tests	O
of	O
pooled	O
samples	O
can	O
serve	O
as	O
an	O
alternative	O
approach	O
that	O
minimizes	O
costs	O
and	O
overall	O
workload	O
and	O
supports	O
projects	O
intended	O
to	O
restore	O
and	O
promote	O
flagship	O
species	B-SPEC
and	O
hamper	O
their	O
illegal	O
trade	O
.	O

However	O
,	O
protein	O
interacting	O
with	O
NIMA	O
(	O
Pin1	O
),	O
a	O
member	O
of	O
the	O
parvulin	O
subfamily	B-SPEC
of	O
PPIases	O
that	O
differs	O
from	O
Cyps	O
and	O
FKBPs	O
,	O
is	O
essential	O
for	O
various	O
signaling	O
pathways	O
.	O

In	O
addition	O
,	O
a	O
vitamin	O
D	O
analog	O
(	O
paricalcitol	O
)	O
was	O
administered	O
to	O
WT	O
mice	B-SPEC
in	O
order	B-SPEC
to	O
investigate	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
the	O
alveolar	O
epithelial	O
barrier	O
following	O
exposure	O
to	O
LPS	O
.	O

Paricalcitol	O
treatment	O
partially	O
inhibited	O
these	O
pathological	O
changes	O
in	O
WT	O
mice	B-SPEC
by	O
maintaining	O
the	O
mRNA	O
and	O
protein	O
expression	O
levels	O
of	O
occludin	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
ZO	O
‑	O
1	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Upon	O
MHV	B-SPEC
infection	O
,	O
a	O
significant	O
downregulation	O
of	O
Cx43	O
was	O
observed	O
in	O
the	O
virus	B-SPEC
-	O
infected	O
mouse	B-SPEC
brain	O
.	O

We	O
found	O
that	O
MHV	B-SPEC
infection	O
leads	O
to	O
the	O
downregulation	O
of	O
Cx43	O
in	O
vivo	O
in	O
the	O
CNS	O
.	O

MERS	O
-	O
CoV	O
was	O
detected	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
viable	O
virus	B-SPEC
was	O
isolated	O
by	O
cultures	O
.	O

In	O
addition	O
,	O
MERS	O
-	O
CoV	O
was	O
isolated	O
from	O
environmental	O
objects	O
such	O
as	O
bed	O
sheets	O
,	O
bedrails	O
,	O
IV	O
fluid	O
hangers	O
,	O
and	O
X	O
-	O
ray	B-SPEC
devices	O
.	O

During	O
the	O
late	O
clinical	O
phase	O
of	O
MERS	O
,	O
viable	O
virus	B-SPEC
could	O
be	O
isolated	O
in	O
3	O
of	O
the	O
4	O
enrolled	O
patients	O
on	O
day	O
18	O
to	O
day	O
25	O
after	O
symptom	O
onset	O
.	O

ABSTRACT	O
:	O
In	O
2013	O
,	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
was	O
reported	O
in	O
Japan	O
for	O
the	O
first	O
time	O
in	O
7years	O
and	O
caused	O
significant	O
economic	O
losses	O
.	O

Since	O
then	O
the	O
disease	O
has	O
been	O
reported	O
in	O
Europe	O
and	O
Asia	O
,	O
but	O
the	O
most	O
severe	O
outbreaks	O
have	O
occurred	O
predominantly	O
in	O
Asian	O
swine	B-SPEC
-	O
producing	O
countries	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
have	O
been	O
recognized	O
as	O
the	O
natural	O
reservoirs	O
of	O
a	O
large	O
variety	O
of	O
viruses	B-SPEC
.	O

On	O
the	O
other	O
hand	O
,	O
diverse	O
coronaviruses	O
phylogenetically	O
related	O
to	O
MERS	O
-	O
CoV	O
have	O
been	O
discovered	O
worldwide	O
in	O
a	O
wide	O
range	O
of	O
bat	B-SPEC
species	B-SPEC
,	O
some	O
of	O
which	O
can	O
be	O
classified	O
to	O
the	O
same	O
coronavirus	B-SPEC
species	B-SPEC
as	O
MERS	O
-	O
CoV	O
.	O
Coronaviruses	O
genetically	O
related	O
to	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
and	O
NL63	O
have	O
been	O
detected	O
in	O
bats	B-SPEC
as	O
well	O
.	O

TITLE	O
:	O
Coronaviruses	O
:	O
emerging	O
and	O
re	O
-	O
emerging	O
pathogens	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
:	O
virus	B-SPEC
-	O
host	O
cell	O
interactions	O
and	O
implications	O
on	O
pathogenesis	O
.	O

However	O
,	O
the	O
induction	O
of	O
antiviral	O
cytokines	O
and	O
proinflammatory	O
cytokines	O
/	O
chemokines	O
are	O
substantially	O
dampened	O
in	O
the	O
infected	O
epithelial	O
cells	O
,	O
due	O
to	O
the	O
antagonistic	O
mechanisms	O
evolved	O
by	O
the	O
virus	B-SPEC
.	O

MERS	O
-	O
CoV	O
can	O
also	O
effectively	O
infect	O
human	B-SPEC
primary	O
T	O
cells	O
and	O
induce	O
massive	O
apoptosis	O
in	O
these	O
cells	O
.	O

ABSTRACT	O
:	O
The	O
cellular	O
actin	O
cytoskeleton	O
presents	O
a	O
barrier	O
that	O
must	O
be	O
overcome	O
by	O
many	O
viruses	B-SPEC
,	O
and	O
it	O
has	O
become	O
increasingly	O
apparent	O
many	O
viral	O
species	B-SPEC
have	O
developed	O
a	O
diverse	O
repertoire	O
of	O
mechanisms	O
to	O
hijack	O
cellular	O
actin	O
-	O
regulating	O
signalling	O
pathways	O
as	O
part	O
of	O
their	O
cell	O
entry	O
processes	O
.	O

Here	O
,	O
we	O
describe	O
the	O
current	O
literature	O
on	O
the	O
role	O
of	O
Cdc42	O
in	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)-	O
1	O
cell	O
entry	O
,	O
which	O
represents	O
the	O
most	O
investigated	O
instance	O
of	O
Cdc42	O
function	O
in	O
viral	O
cell	O
entry	O
processes	O
,	O
and	O
also	O
review	O
evidence	O
of	O
Cdc42	O
use	O
in	O
other	O
RNA	O
virus	B-SPEC
cell	O
entries	O
,	O
demonstrating	O
prime	O
areas	O
for	O
more	O
extensive	O
research	O
using	O
similar	O
techniques	O
.	O

TITLE	O
:	O
Modeling	O
the	O
Transmission	O
of	O
Middle	O
East	O
Respirator	O
Syndrome	O
Corona	B-SPEC
Virus	B-SPEC
in	O
the	O
Republic	O
of	O
Korea	O
.	O

ABSTRACT	O
:	O
Risk	O
factors	O
for	O
primary	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
illness	O
in	O
humans	B-SPEC
are	O
incompletely	O
understood	O
.	O

Further	O
investigation	O
is	O
needed	O
to	O
better	O
understand	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
of	O
MERS	O
-	O
CoV	O
.	O

The	O
coronavirus	B-SPEC
3CL	O
(	O
pro	O
)	O
provides	O
a	O
highly	O
validated	O
drug	O
target	O
and	O
as	O
there	O
is	O
a	O
high	O
degree	O
of	O
sequence	O
homology	O
and	O
conservation	O
in	O
main	O
chain	O
architecture	O
the	O
design	O
of	O
broad	O
spectrum	O
inhibitors	O
is	O
viable	O
.	O

TITLE	O
:	O
MERS	O
coronavirus	B-SPEC
:	O
diagnostics	O
,	O
epidemiology	O
and	O
transmission	O
.	O

The	O
KSA	O
is	O
the	O
focal	O
point	O
of	O
MERS	O
,	O
with	O
the	O
majority	O
of	O
human	B-SPEC
cases	O
.	O

In	O
humans	B-SPEC
,	O
MERS	O
is	O
mostly	O
known	O
as	O
a	O
lower	O
respiratory	O
tract	O
(	O
LRT	O
)	O
disease	O
involving	O
fever	O
,	O
cough	O
,	O
breathing	O
difficulties	O
and	O
pneumonia	O
that	O
may	O
progress	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
multiorgan	O
failure	O
and	O
death	O
in	O
20	O
%	O
to	O
40	O
%	O
of	O
those	O
infected	O
.	O

While	O
the	O
basic	O
virology	O
of	O
MERS	O
-	O
CoV	O
has	O
advanced	O
over	O
the	O
past	O
three	O
years	O
,	O
understanding	O
of	O
the	O
interplay	O
between	O
camel	B-SPEC
,	O
environment	O
,	O
and	O
human	B-SPEC
remains	O
limited	O
.	O

TITLE	O
:	O
Antiviral	O
Indolosesquiterpenoid	O
Xiamycins	O
C	O
-	O
E	O
from	O
a	O
Halophilic	O
Actinomycete	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
April	O
2013	O
,	O
a	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
epidemic	O
began	O
in	O
the	O
United	O
States	O
.	O

TITLE	O
:	O
Multi	O
-	O
Organ	O
Damage	O
in	O
Human	B-SPEC
Dipeptidyl	O
Peptidase	O
4	O
Transgenic	B-SPEC
Mice	I-SPEC
Infected	O
with	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
.	O

Five	O
subjects	O
,	O
including	O
3	O
health	O
-	O
care	O
workers	O
,	O
were	O
discharged	O
from	O
hospital	O
and	O
were	O
alive	O
after	O
1	O
y	O
.	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
pneumonia	O
with	O
ARDS	O
has	O
high	O
mortality	O
in	O
subjects	O
with	O
comorbidities	O
.	O

Conclusions	O
and	O
relevance	O
A	O
positive	O
result	O
is	O
highly	O
indicative	O
of	O
the	O
presence	O
of	O
FIP	O
,	O
but	O
as	O
none	O
of	O
the	O
control	O
cats	B-SPEC
tested	O
positive	O
by	O
RT	O
-	O
nPCR	O
,	O
it	O
was	O
not	O
possible	O
to	O
confirm	O
that	O
the	O
FCoV	O
mutant	O
described	O
can	O
only	O
be	O
found	O
in	O
cats	B-SPEC
with	O
FIP	O
.	O

Sow	O
sites	O
had	O
the	O
highest	O
incidence	O
of	O
PEDv	B-SPEC
during	O
the	O
outbreak	O
(	O
80	O
.	O
0	O
percent	O
).	O

The	O
former	O
method	O
indicated	O
PEDv	B-SPEC
spread	O
was	O
south	O
to	O
slightly	O
southwest	O
,	O
and	O
the	O
latter	O
indicated	O
spread	O
was	O
to	O
the	O
southeast	O
.	O

At	O
post	O
-	O
inoculation	O
days	O
3	O
-	O
4	O
,	O
infected	O
pigs	B-SPEC
showed	O
severe	O
watery	O
diarrhea	O
and	O
/	O
or	O
vomiting	O
and	O
mainly	O
,	O
diffuse	O
,	O
severe	O
atrophic	O
enteritis	O
,	O
with	O
mild	O
to	O
moderate	O
cytoplasmic	O
vacuolation	O
of	O
the	O
enterocytes	O
lining	O
the	O
atrophied	O
villous	O
epithelium	O
.	O

ABSTRACT	O
:	O
Worldwide	O
diarrhea	O
outbreaks	O
in	O
cattle	B-SPEC
herds	O
are	O
more	O
frequently	O
detected	O
in	O
calves	O
being	O
that	O
diarrhea	O
outbreaks	O
in	O
adult	O
cattle	B-SPEC
are	O
not	O
common	O
.	O

Other	O
enteric	O
microorganisms	O
occasionally	O
identified	O
in	O
adult	O
cattle	B-SPEC
and	O
evaluated	O
in	O
this	O
study	O
such	O
as	O
bovine	B-SPEC
groups	O
A	O
,	O
B	O
,	O
and	O
C	O
rotavirus	B-SPEC
,	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
bovine	B-SPEC
torovirus	I-SPEC
,	O
aichivirus	O
B	O
,	O
and	O
Eimeria	B-SPEC
sp	O
.	O
were	O
not	O
identified	O
in	O
the	O
fecal	O
samples	O
.	O

This	O
case	O
report	O
describes	O
the	O
first	O
detection	O
of	O
PEDV	B-SPEC
in	O
Austria	O
.	O

Gastrointestinal	O
symptoms	O
among	O
fattening	O
pigs	B-SPEC
were	O
generally	O
mild	O
,	O
quickly	O
resolving	O
and	O
did	O
not	O
lead	O
to	O
death	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
nearly	O
complete	O
PEDV	B-SPEC
spike	O
gene	O
shows	O
that	O
the	O
Austrian	O
PEDV	B-SPEC
strain	O
is	O
highly	O
similar	O
to	O
other	O
strains	O
involved	O
in	O
recent	O
outbreaks	O
in	O
Western	O
and	O
Central	O
Europe	O
.	O

All	O
cases	O
were	O
associated	O
with	O
nosocomial	O
transmission	O
except	O
the	O
index	O
case	O
and	O
two	O
possible	O
family	B-SPEC
infections	O
.	O

ECBC	O
pipelines	O
also	O
correctly	O
identified	O
pathogens	O
in	O
human	B-SPEC
samples	O
containing	O
arenavirus	B-SPEC
in	O
addition	O
to	O
animal	B-SPEC
samples	O
containing	O
flavivirus	B-SPEC
and	O
coronavirus	B-SPEC
.	O

RESULTS	O
:	O
The	O
HIV	B-SPEC
-	O
infected	O
patients	O
displayed	O
decreased	O
GM	O
volume	O
,	O
mainly	O
located	O
in	O
the	O
bilateral	O
frontal	O
cortices	O
,	O
bilateral	O
anterior	O
cingulate	O
cortex	O
,	O
and	O
left	O
supplementary	O
motor	O
area	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
false	O
discovery	O
rate	O
-	O
corrected	O
).	O

There	O
are	O
no	O
reports	O
on	O
molecular	O
characterization	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
in	O
Ireland	O
,	O
and	O
little	O
data	O
exists	O
apart	O
from	O
serological	O
studies	O
.	O

Thus	O
,	O
monitoring	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
in	O
Ireland	O
is	O
important	O
as	O
the	O
current	O
isolates	O
in	O
circulation	O
in	O
the	O
south	O
of	O
Ireland	O
may	O
be	O
diverging	O
from	O
the	O
available	O
vaccine	O
strain	O
,	O
which	O
may	O
have	O
implications	O
regarding	O
future	O
BCoV	O
vaccine	O
efficacy	O
.	O

Quantitative	O
analysis	O
showed	O
significantly	O
higher	O
levels	O
of	O
pulmonary	O
neutrophil	O
infiltration	O
and	O
higher	O
amounts	O
of	O
pulmonary	O
viral	O
antigen	O
in	O
marmosets	B-SPEC
.	O

These	O
results	O
suggest	O
that	O
increased	O
virus	B-SPEC
replication	O
and	O
the	O
local	O
immune	O
response	O
to	O
MERS	O
-	O
CoV	O
infection	O
likely	O
play	O
a	O
role	O
in	O
pulmonary	O
pathology	O
severity	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
cases	O
of	O
human	B-SPEC
respiratory	O
disease	O
.	O

Such	O
an	O
introduction	O
through	O
travelling	O
led	O
to	O
the	O
emergence	O
of	O
a	O
MERS	O
-	O
CoV	O
outbreak	O
in	O
Korea	O
in	O
May	O
2015	O
,	O
which	O
caused	O
more	O
than	O
140	O
confirmed	O
human	B-SPEC
cases	O
in	O
less	O
than	O
a	O
month	O
.	O

To	O
study	O
the	O
genetic	O
factors	O
that	O
regulate	O
pathogenesis	O
and	O
transmission	O
,	O
we	O
developed	O
a	O
molecular	O
clone	O
of	O
PEDV	B-SPEC
strain	O
PC22A	O
.	O

However	O
,	O
the	O
diarrheic	O
scores	O
in	O
icPEDV	O
-	O
ΔORF3	O
-	O
RFP	O
-	O
infected	O
pigs	B-SPEC
were	O
lower	O
than	O
those	O
in	O
wild	O
-	O
type	O
-	O
virus	B-SPEC
-	O
or	O
icPEDV	O
-	O
infected	O
pigs	B-SPEC
,	O
and	O
the	O
virus	B-SPEC
formed	O
smaller	O
plaques	O
than	O
those	O
of	O
PC22A	O
.	O

TITLE	O
:	O
Factors	O
associated	O
with	O
development	O
of	O
Canine	O
Infectious	O
Respiratory	O
Disease	O
Complex	O
(	O
CIRDC	O
)	O
in	O
dogs	B-SPEC
in	O
5	O
Canadian	O
small	O
animal	B-SPEC
clinics	O
.	O

An	O
outbreak	O
investigation	O
was	O
conducted	O
and	O
it	O
was	O
hypothesized	O
that	O
feed	O
containing	O
spray	O
-	O
dried	O
porcine	B-SPEC
plasma	O
contaminated	O
with	O
the	O
virus	B-SPEC
was	O
a	O
risk	O
factor	O
in	O
the	O
introduction	O
and	O
spread	O
of	O
the	O
disease	O
in	O
Ontario	O
.	O

TITLE	O
:	O
Clinical	O
Implications	O
of	O
5	O
Cases	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
in	O
a	O
South	O
Korean	O
Outbreak	O
.	O

TITLE	O
:	O
Heterologous	O
live	O
infectious	O
bronchitis	O
virus	B-SPEC
vaccination	O
in	O
day	O
-	O
old	O
commercial	O
broiler	O
chicks	O
:	O
clinical	O
signs	O
,	O
ciliary	O
health	O
,	O
immune	O
responses	O
and	O
protection	O
against	O
variant	O
infectious	O
bronchitis	O
viruses	B-SPEC
.	O

The	O
Mass2	O
+	O
793B2	O
group	O
showed	O
the	O
worst	O
clinical	O
signs	O
,	O
higher	O
mortality	O
and	O
severe	O
lesions	O
following	O
vaccination	O
,	O
but	O
had	O
the	O
highest	O
tracheal	O
immune	O
responses	O
and	O
demonstrated	O
the	O
best	O
protection	O
against	O
all	O
three	O
challenge	O
viruses	B-SPEC
.	O

CONCLUSIONS	O
:	O
Understanding	O
epidemiology	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
in	O
Taiwan	O
provides	O
an	O
insight	O
for	O
worldwide	O
surveillance	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
infection	O
.	O

These	O
data	O
are	O
valuable	O
for	O
veterinarians	O
in	O
advising	O
clients	O
on	O
the	O
anticipated	O
impact	O
and	O
time	O
to	O
re	O
-	O
achieve	O
a	O
stable	O
state	O
with	O
regards	O
to	O
PEDV	B-SPEC
.	O

The	O
basic	O
steps	O
of	O
treatment	O
are	O
:	O
the	O
use	O
of	O
different	O
types	O
of	O
ventilatory	O
support	O
in	O
order	B-SPEC
to	O
achieve	O
adequate	O
oxygenation	O
,	O
dealing	O
with	O
possible	O
hemodynamic	O
instability	O
,	O
and	O
,	O
when	O
needed	O
,	O
other	O
specific	O
procedures	O
.	O

The	O
clinical	O
presentation	O
of	O
the	O
children	O
infected	O
with	O
the	O
pandemic	O
(	O
H1N1	O
)	O
2009	O
influenza	B-SPEC
virus	I-SPEC
did	O
not	O
differ	O
significantly	O
from	O
that	O
of	O
children	O
infected	O
with	O
seasonal	O
influenza	O
.	O

The	O
FR	O
(-	O
9	O
.	O
6	O
%),	O
RR	O
(+	O
9	O
.	O
8	O
%),	O
TB	O
(-	O
1	O
.	O
6	O
),	O
BA	O
(-	O
1	O
.	O
1	O
),	O
WPL	O
(-	O
1	O
.	O
1	O
),	O
sows	O
mated	O
by	O
7	O
days	O
after	O
weaning	O
(-	O
6	O
.	O
9	O
%),	O
WFSI	O
(+	O
0	O
.	O
8	O
days	O
),	O
NPDs	O
(+	O
6	O
.	O
9	O
days	O
)	O
and	O
sow	O
culling	O
rate	O
(+	O
7	O
.	O
2	O
%)	O
were	O
significantly	O
different	O
between	O
the	O
1	O
-	O
year	O
pre	O
-	O
PEDV	B-SPEC
outbreak	O
period	O
and	O
the	O
post	O
-	O
PEDV	B-SPEC
outbreak	O
period	O
.	O

Of	O
16	O
PEDV	B-SPEC
nonstructural	O
proteins	O
(	O
nsps	O
),	O
nsp1	O
,	O
nsp3	O
,	O
nsp7	O
,	O
nsp14	O
,	O
nsp15	O
and	O
nsp16	O
were	O
found	O
to	O
inhibit	O
the	O
IFN	O
-	O
β	O
and	O
IRF3	O
promoter	O
activities	O
.	O

In	O
2011	O
,	O
158	O
samples	O
(	O
65	O
%)	O
were	O
found	O
to	O
be	O
positive	O
for	O
at	O
least	O
one	O
virus	B-SPEC
,	O
and	O
the	O
most	O
frequently	O
detected	O
were	O
HRV	O
(	O
29	O
%),	O
AdV	O
(	O
12	O
%),	O
and	O
enterovirus	B-SPEC
(	O
9	O
%).	O

Ten	O
patients	O
(	O
2	O
%)	O
were	O
diagnosed	O
with	O
pneumonia	O
,	O
and	O
six	O
of	O
these	O
tested	O
positive	O
for	O
viral	O
infection	O
(	O
4	O
HRV	O
,	O
1	O
RSV	B-SPEC
,	O
and	O
1	O
AdV	O
).	O

Thus	O
,	O
this	O
study	O
identified	O
the	O
most	O
common	O
respiratory	O
viruses	B-SPEC
found	O
in	O
preschool	O
children	O
in	O
the	O
study	O
region	O
and	O
demonstrated	O
their	O
high	O
frequency	O
,	O
highlighting	O
the	O
need	O
for	O
improved	O
data	O
collection	O
,	O
and	O
case	O
management	O
in	O
order	B-SPEC
to	O
stimulate	O
preventive	O
measures	O
against	O
these	O
infections	O
.	O

ABSTRACT	O
:	O
Natural	O
products	O
,	O
especially	O
derived	O
from	O
TCMH	O
,	O
have	O
been	O
found	O
to	O
exert	O
antiviral	O
effects	O
against	O
influenza	B-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
A	O
molecular	O
arms	O
race	O
between	O
host	O
innate	O
antiviral	O
response	O
and	O
emerging	O
human	B-SPEC
coronaviruses	O
.	O

TITLE	O
:	O
The	O
Hemagglutinin	O
Stem	O
-	O
Binding	O
Monoclonal	O
Antibody	O
VIS410	O
Controls	O
Influenza	B-SPEC
Virus	I-SPEC
-	O
Induced	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

We	O
evaluated	O
the	O
effect	O
of	O
treatment	O
with	O
VIS410	O
,	O
a	O
human	B-SPEC
monoclonal	O
antibody	O
targeting	O
the	O
HA	O
stem	O
region	O
,	O
on	O
the	O
development	O
of	O
ARDS	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
after	O
infection	O
with	O
influenza	O
A	O
(	O
H7N9	O
)	O
viruses	B-SPEC
.	O

A	O
single	O
therapeutic	O
dose	O
of	O
VIS410	O
given	O
24	O
h	O
after	O
virus	B-SPEC
inoculation	O
resulted	O
in	O
dose	O
-	O
dependent	O
protection	O
of	O
up	O
to	O
100	O
%	O
of	O
mice	B-SPEC
inoculated	O
with	O
neuraminidase	O
inhibitor	O
-	O
susceptible	O
or	O
-	O
resistant	O
A	O
(	O
H7N9	O
)	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
outbreak	O
,	O
the	O
largest	O
outbreak	O
outside	O
the	O
Middle	O
East	O
in	O
2012	O
,	O
occurred	O
in	O
the	O
Republic	O
of	O
Korea	O
and	O
resulted	O
in	O
a	O
large	O
number	O
of	O
cases	O
,	O
with	O
186	O
infected	O
people	O
,	O
including	O
38	O
deaths	O
.	O

Both	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
MERS	O
-	O
CoV	O
originated	O
in	O
bats	B-SPEC
and	O
spread	O
to	O
humans	B-SPEC
via	O
an	O
intermediate	O
host	O
.	O

Quantification	O
of	O
variables	O
by	O
calculating	O
the	O
area	O
under	O
the	O
ROC	O
curve	O
(	O
AUC	O
),	O
sensitivity	O
and	O
sensitivity	O
,	O
positive	O
predictive	O
value	O
(	O
PPV	B-SPEC
)	O
and	O
negative	O
predictive	O
value	O
(	O
NPV	O
),	O
allowed	O
a	O
better	O
appreciation	O
of	O
these	O
prognostic	O
scores	O
.	O

In	O
vivo	O
pulmonary	O
activity	O
of	O
S	O
-	O
MB	O
DATK	O
surfactant	O
was	O
measured	O
in	O
ventilated	O
rabbits	B-SPEC
with	O
surfactant	O
deficiency	O
/	O
dysfunction	O
induced	O
by	O
repeated	O
lung	O
lavages	O
that	O
resulted	O
in	O
arterial	O
PO2	O
values	O
<	O
100	O
mmHg	O
.	O

An	O
intense	O
immunoreaction	O
for	O
FIV	B-SPEC
antigen	O
in	O
the	O
cytoplasm	O
and	O
nucleus	O
of	O
lymphocytes	O
and	O
the	O
cytoplasm	O
of	O
some	O
macrophages	O
was	O
observed	O
via	O
immunohistochemistry	O
(	O
IHC	O
).	O

ABSTRACT	O
:	O
Radiologic	O
findings	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
infection	O
,	O
have	O
been	O
rarely	O
reported	O
.	O

The	O
compound	O
was	O
also	O
an	O
inhibitor	O
of	O
the	O
RNase	O
H	O
activity	O
of	O
wild	O
-	O
type	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
group	O
O	O
RT	O
,	O
although	O
we	O
observed	O
a	O
6	O
.	O
5	O
-	O
fold	O
increase	O
in	O
the	O
IC50	O
in	O
comparison	O
with	O
the	O
prototypic	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
group	O
M	O
subtype	O
B	O
enzyme	O
.	O

ABSTRACT	O
:	O
Clinical	O
data	O
available	O
on	O
coinfections	O
are	O
contradictory	O
concerning	O
both	O
the	O
number	O
of	O
viruses	B-SPEC
involved	O
and	O
the	O
severity	O
of	O
the	O
condition	O
.	O

The	O
results	O
of	O
this	O
study	O
indicate	O
that	O
the	O
DIA	O
is	O
a	O
rapid	O
,	O
sensitive	O
,	O
reliable	O
method	O
for	O
determining	O
IBV	B-SPEC
vaccine	O
titer	O
in	O
embryonated	O
eggs	O
at	O
a	O
relatively	O
low	O
cost	O
.	O

Motifs	O
M1	O
-	O
M6	O
were	O
shared	O
by	O
strains	O
from	O
more	O
than	O
two	O
countries	O
,	O
and	O
seemed	O
to	O
originate	O
from	O
one	O
PEDV	B-SPEC
strain	O
,	O
Indiana12	O
.	O
83	O
/	O
USA	O
/	O
2013	O
,	O
among	O
the	O
119	O
strains	O
studied	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
improve	O
the	O
tactics	O
of	O
treatment	O
of	O
bronchoobstructive	O
syndrome	O
(	O
BOS	B-SPEC
)	O
in	O
associative	O
course	O
with	O
gastroesophageal	O
reflux	O
disease	O
(	O
GERD	O
)	O
in	O
children	O
.	O

In	O
a	O
severe	O
course	O
of	O
bronchial	O
asthma	O
GERD	O
was	O
detected	O
3	O
,	O
4	O
times	O
more	O
frequently	O
in	O
the	O
boys	O
,	O
while	O
in	O
a	O
lengthy	O
course	O
of	O
pneumonia	O
with	O
BOS	B-SPEC
--	O
1	O
,	O
9	O
times	O
more	O
frequently	O
in	O
the	O
girls	O
.	O

The	O
designed	O
individual	O
anti	O
-	O
reflux	O
programs	O
in	O
complex	O
therapy	O
of	O
respiratory	O
organs	O
'	O
diseases	O
with	O
BOS	B-SPEC
associated	O
with	O
GERD	O
reduce	O
the	O
frequency	O
of	O
exacerbations	O
and	O
hospitalizations	O
of	O
patients	O
with	O
BA	O
,	O
improve	O
their	O
life	O
quality	O
.	O

Prevalence	O
in	O
broiler	O
flocks	O
was	O
39	O
.	O
4	O
%	O
(	O
26	O
/	O
66	O
)	O
and	O
in	O
local	O
chicken	B-SPEC
flocks	O
was	O
11	O
.	O
9	O
%	O
(	O
5	O
/	O
42	O
).	O

Exposure	O
was	O
associated	O
with	O
dog	B-SPEC
sex	O
and	O
age	O
,	O
lack	O
of	O
health	O
care	O
and	O
the	O
number	O
of	O
people	O
in	O
the	O
households	O
.	O

Since	O
many	O
virological	O
and	O
immunological	O
data	O
on	O
FECV	B-SPEC
infections	O
are	O
lacking	O
,	O
the	O
present	O
study	O
investigated	O
these	O
missing	O
links	O
during	O
experimental	O
infection	O
of	O
three	O
SPF	O
cats	B-SPEC
with	O
FECV	B-SPEC
strain	O
UCD	O
.	O

There	O
is	O
substantial	O
evidence	O
that	O
the	O
recent	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)-	O
CoV	O
outbreak	O
is	O
fueled	O
by	O
zoonotic	O
transmission	O
from	O
dromedary	B-SPEC
camels	B-SPEC
.	O

TITLE	O
:	O
Molecular	O
characterization	O
of	O
human	B-SPEC
coronaviruses	O
and	O
their	O
circulation	O
dynamics	O
in	O
Kenya	O
,	O
2009	O
-	O
2012	O
.	O

The	O
isolated	O
viruses	B-SPEC
were	O
characterized	O
by	O
RT	O
-	O
PCR	O
amplification	O
and	O
sequencing	O
of	O
the	O
partial	O
polymerase	O
(	O
pol	O
)	O
gene	O
.	O

When	O
treated	O
with	O
dihydro	O
-	O
resveratrol	O
,	O
pulmonary	O
architectural	O
distortion	O
,	O
hemorrhage	O
,	O
interstitial	O
edema	O
,	O
and	O
alveolar	O
thickening	O
were	O
significantly	O
reduced	O
in	O
rats	B-SPEC
with	O
acute	O
pancreatitis	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
major	O
cause	O
of	O
poor	O
weight	O
gain	O
and	O
mortality	O
among	O
chicks	O
.	O

Offspring	O
of	O
generation	O
0	O
(	O
G0	O
)	O
were	O
screened	O
to	O
identify	O
G1	O
transgenic	O
chickens	B-SPEC
(	O
Tg	O
).	O

Monocytes	O
from	O
G1	O
Tg	O
were	O
stimulated	O
with	O
IBV	B-SPEC
in	O
vitro	O
.	O

Monocytes	O
producing	O
siRNA	O
efficiently	O
inhibit	O
IBV	B-SPEC
replication	O
.	O

Whole	O
genome	O
sequences	O
of	O
the	O
PEDV	B-SPEC
prototype	O
and	O
S	O
-	O
INDEL	O
-	O
variant	O
strains	O
were	O
determined	O
,	O
but	O
the	O
molecular	O
basis	O
of	O
virulence	O
differences	O
between	O
these	O
PEDV	B-SPEC
strains	O
remains	O
to	O
be	O
elucidated	O
using	O
a	O
reverse	O
genetics	O
approach	O
.	O

Based	O
on	O
400	O
-	O
nt	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
(	O
RdRP	O
)	O
sequence	O
analysis	O
,	O
eight	O
belonged	O
to	O
genus	B-SPEC
Alphacoronavirus	B-SPEC
and	O
42	O
to	O
Betacoronavirus	B-SPEC
.	O

The	O
present	O
study	O
has	O
identified	O
additional	O
numbers	O
of	O
genetically	O
diverse	O
bat	B-SPEC
-	O
borne	O
coronaviruses	O
with	O
a	O
wide	O
distribution	O
in	O
China	O
.	O

Two	O
new	O
species	B-SPEC
of	O
bat	B-SPEC
CoV	O
,	O
identified	O
through	O
sequence	O
comparison	O
and	O
phylogenetic	O
analysis	O
,	O
are	O
proposed	O
.	O

These	O
pathological	O
changes	O
are	O
accompanied	O
by	O
a	O
loss	O
of	O
motor	O
coordination	O
of	O
mice	B-SPEC
as	O
assayed	O
by	O
the	O
rota	O
-	O
rod	O
test	O
.	O

Repeated	O
application	O
of	O
these	O
methods	O
to	O
small	O
scale	O
outbreaks	O
at	O
the	O
start	O
of	O
an	O
epidemic	O
would	O
permit	B-SPEC
accurate	O
estimates	O
of	O
key	O
parameters	O
.	O

Progression	O
to	O
FIP	O
was	O
prevented	O
in	O
2	O
out	O
of	O
3	O
cats	B-SPEC
treated	O
with	O
mAb	O
2	O
-	O
4	O
,	O
whereas	O
all	O
3	O
cats	B-SPEC
developed	O
FIP	O
in	O
the	O
placebo	O
control	O
group	O
.	O

All	O
MR	O
-	O
RTs	O
exhibited	O
similar	O
sensitivity	O
toward	O
RNase	O
H	O
inhibitors	O
belonging	O
to	O
different	O
inhibitor	O
classes	O
,	O
indicating	O
the	O
importance	O
of	O
developing	O
RNase	O
H	O
inhibitors	O
further	O
as	O
anti	O
-	O
HIV	B-SPEC
drugs	O
.	O

To	O
estimate	O
the	O
number	O
of	O
MERS	O
-	O
CoV	O
infections	O
that	O
have	O
occurred	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
,	O
we	O
applied	O
a	O
statistical	O
model	O
to	O
a	O
line	O
list	O
describing	O
721	O
MERS	O
-	O
CoV	O
infections	O
detected	O
between	O
June	O
7	O
,	O
2012	O
,	O
and	O
July	O
25	O
,	O
2014	O
.	O

extract	O
,	O
quercetin	O
,	O
quercetrin	O
and	O
cinanserin	O
on	O
murine	B-SPEC
coronavirus	I-SPEC
and	O
dengue	B-SPEC
virus	I-SPEC
infection	O
.	O

The	O
antiviral	O
activities	O
of	O
various	O
concentrations	O
of	O
the	O
EA	O
fraction	O
of	O
H	O
.	O
cordata	O
and	O
flavonoids	O
were	O
assessed	O
using	O
virus	B-SPEC
neutralization	O
tests	O
against	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
and	O
DENV	O
type	O
2	O
(	O
DENV	O
-	O
2	O
).	O

The	O
mice	B-SPEC
fed	O
with	O
the	O
EA	O
fraction	O
up	O
to	O
2000	O
mg	O
/	O
kg	O
did	O
not	O
induce	O
any	O
signs	O
of	O
acute	O
toxicity	O
,	O
with	O
normal	O
histological	O
features	O
of	O
major	O
organs	O
.	O

The	O
emergence	O
of	O
both	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
and	O
Middle	O
East	O
Respiratory	O
syndrome	O
CoVs	O
as	O
well	O
as	O
the	O
yearly	O
circulation	O
of	O
four	O
common	O
CoVs	O
highlights	O
the	O
importance	O
of	O
elucidating	O
the	O
different	O
mechanisms	O
employed	O
by	O
these	O
viruses	B-SPEC
to	O
evade	O
the	O
host	O
immune	O
response	O
,	O
determine	O
their	O
tropism	O
and	O
identify	O
antiviral	O
compounds	O
.	O

This	O
phenomenon	O
,	O
known	O
as	O
the	O
protein	O
corona	B-SPEC
,	O
is	O
well	O
established	O
in	O
the	O
field	O
of	O
synthetic	O
nanotechnology	O
but	O
has	O
not	O
been	O
described	O
in	O
the	O
context	O
of	O
plant	B-SPEC
virus	B-SPEC
nanoparticles	O
(	O
VNPs	O
).	O

The	O
impact	O
of	O
the	O
VNP	O
protein	O
corona	B-SPEC
on	O
molecular	O
recognition	O
and	O
cell	O
targeting	O
in	O
the	O
context	O
of	O
cancer	B-SPEC
and	O
thrombosis	O
is	O
investigated	O
.	O

After	O
retrieving	O
163	O
,	O
433	O
news	O
records	O
mentioning	O
the	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
and	O
H1N1	O
pandemics	O
,	O
a	O
maximum	O
entropy	O
model	O
for	O
inductive	O
machine	O
learning	O
was	O
used	O
to	O
identify	O
relationships	O
among	O
500	O
randomly	O
sampled	O
news	O
records	O
that	O
correlated	O
with	O
systematic	O
human	B-SPEC
assessments	O
of	O
their	O
scientific	O
quality	O
and	O
sensationalism	O
.	O

Anti	O
-	O
infectious	O
therapy	O
was	O
escalated	O
to	O
additional	O
linezolid	O
and	O
liposomal	O
amphotericine	O
-	O
B	O
.	O
BAL	O
revealed	O
a	O
significant	O
viral	O
load	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

CONCLUSIONS	O
:	O
This	O
report	O
emphasizes	O
the	O
fatal	O
consequences	O
of	O
common	O
respiratory	O
virus	B-SPEC
infections	O
in	O
immunocompromised	O
patients	O
.	O

These	O
viruses	B-SPEC
have	O
evolved	O
diverse	O
strategies	O
to	O
evade	O
and	O
block	O
host	O
immune	O
responses	O
,	O
facilitating	O
infection	O
and	O
transmission	O
.	O

Finally	O
,	O
comparison	O
with	O
crystal	O
structures	O
of	O
human	B-SPEC
coronavirus	I-SPEC
S	O
domains	O
allows	O
rationalization	O
of	O
the	O
molecular	O
basis	O
for	O
species	B-SPEC
specificity	O
based	O
on	O
the	O
use	O
of	O
spatially	O
contiguous	O
but	O
distinct	O
domains	O
.	O

TITLE	O
:	O
Clinicopathologic	O
,	O
Immunohistochemical	O
,	O
and	O
Ultrastructural	O
Findings	O
of	O
a	O
Fatal	O
Case	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
in	O
the	O
United	O
Arab	O
Emirates	O
,	O
April	O
2014	O
.	O

It	O
'	O
s	O
a	O
46	O
-	O
year	O
-	O
old	O
Chinese	O
man	B-SPEC
presented	O
with	O
sore	O
throat	O
,	O
hemoptysis	O
,	O
fever	O
,	O
dyspnea	O
and	O
multiple	O
lung	O
nodules	O
.	O

These	O
results	O
demonstrate	O
that	O
IFN	O
-	O
I	O
and	O
IMM	O
promote	O
lethal	O
SARS	O
-	O
CoV	O
infection	O
and	O
identify	O
IFN	O
-	O
I	O
and	O
IMMs	O
as	O
potential	O
therapeutic	O
targets	O
in	O
patients	O
infected	O
with	O
pathogenic	O
coronavirus	B-SPEC
and	O
perhaps	O
other	O
respiratory	O
viruses	B-SPEC
.	O

In	O
Thailand	O
,	O
the	O
epidemiology	O
of	O
the	O
viruses	B-SPEC
causing	O
community	O
-	O
acquired	O
pneumonia	O
(	O
CAP	O
)	O
among	O
children	O
is	O
poorly	O
defined	O
.	O

By	O
contrast	O
,	O
the	O
CoVs	O
responsible	O
for	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
which	O
were	O
discovered	O
in	O
Hong	O
Kong	O
,	O
China	O
,	O
in	O
2003	O
,	O
and	O
in	O
Saudi	O
Arabia	O
in	O
2012	O
,	O
respectively	O
,	O
have	O
received	O
global	O
attention	O
over	O
the	O
past	O
12	O
years	O
owing	O
to	O
their	O
ability	O
to	O
cause	O
community	O
and	O
health	O
-	O
care	O
-	O
associated	O
outbreaks	O
of	O
severe	O
infections	O
in	O
human	B-SPEC
populations	O
.	O

This	O
lineage	O
C	O
betacoronavirus	B-SPEC
has	O
been	O
reported	O
to	O
cause	O
a	O
wide	O
range	O
of	O
disease	O
severity	O
in	O
humans	B-SPEC
,	O
ranging	O
from	O
asymptomatic	O
to	O
progressive	O
fatal	O
pneumonia	O
that	O
may	O
be	O
accompanied	O
by	O
renal	O
or	O
multiorgan	O
failure	O
.	O

This	O
review	O
provides	O
an	O
overview	O
of	O
the	O
current	O
state	O
of	O
knowledge	O
on	O
human	B-SPEC
MERS	O
-	O
CoV	O
infections	O
,	O
the	O
probable	O
origin	O
of	O
MERS	O
-	O
CoV	O
,	O
and	O
the	O
available	O
animal	B-SPEC
models	O
of	O
MERS	O
-	O
CoV	O
infection	O
.	O

In	O
this	O
study	O
,	O
using	O
a	O
previously	O
established	O
reverse	O
genetics	O
system	O
,	O
we	O
generated	O
a	O
recombinant	O
IBV	B-SPEC
virus	B-SPEC
based	O
on	O
the	O
IBV	B-SPEC
H120	O
vaccine	O
strain	O
expressing	O
the	O
haemagglutinin	O
-	O
neuraminidase	O
(	O
HN	O
)	O
protein	O
of	O
NDV	B-SPEC
.	O

Meanwhile	O
,	O
fluorescent	O
quantitative	O
PCR	O
results	O
show	O
that	O
the	O
secretion	O
of	O
IFN	O
-	O
γ	O
in	O
avian	B-SPEC
splenic	O
lymphocytes	O
increases	O
after	O
Sp6	O
stimulation	O
.	O

Approximately	O
three	O
quarters	O
of	O
reported	O
malaria	O
cases	O
in	O
the	O
UK	O
are	O
caused	O
by	O
Plasmodium	B-SPEC
falciparum	I-SPEC
,	O
which	O
is	O
capable	O
of	O
invading	O
a	O
high	O
proportion	O
of	O
red	O
blood	O
cells	O
and	O
rapidly	O
leading	O
to	O
severe	O
or	O
life	O
-	O
threatening	O
multi	O
-	O
organ	O
disease	O
.	O

Most	O
non	O
-	O
falciparum	O
malaria	O
cases	O
are	O
caused	O
by	O
Plasmodium	B-SPEC
vivax	I-SPEC
;	O
a	O
few	O
cases	O
are	O
caused	O
by	O
the	O
other	O
species	B-SPEC
of	O
plasmodium	B-SPEC
:	O
Plasmodium	B-SPEC
ovale	I-SPEC
,	O
Plasmodium	B-SPEC
malariae	I-SPEC
or	O
Plasmodium	B-SPEC
knowlesi	I-SPEC
.	O

RDTs	O
for	O
other	O
Plasmodium	B-SPEC
species	B-SPEC
are	O
not	O
as	O
reliable	O
.	O

Uncomplicated	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
malaria	O
should	O
be	O
treated	O
with	O
an	O
artemisinin	O
combination	O
therapy	O
(	O
Grade	O
1A	O
).	O

Quinine	B-SPEC
or	O
atovaquone	O
-	O
proguanil	O
(	O
Malarone	O
(®))	O
can	O
be	O
used	O
if	O
an	O
ACT	O
is	O
not	O
available	O
.	O

An	O
oral	O
ACT	O
is	O
preferred	O
for	O
a	O
mixed	O
infection	O
,	O
if	O
there	O
is	O
uncertainty	O
about	O
the	O
infecting	O
species	B-SPEC
,	O
or	O
for	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
infection	O
from	O
areas	O
where	O
chloroquine	O
resistance	O
is	O
common	O
(	O
Grade	O
1B	O
).	O

Primaquine	O
(	O
for	O
eradication	O
of	O
P	B-SPEC
.	I-SPEC
vivax	I-SPEC
or	O
P	B-SPEC
.	I-SPEC
ovale	I-SPEC
hypnozoites	O
)	O
is	O
contraindicated	O
in	O
pregnancy	O
and	O
when	O
breastfeeding	O
(	O
until	O
the	O
G6PD	O
status	O
of	O
child	O
is	O
known	O
);	O
after	O
initial	O
treatment	O
for	O
these	O
infections	O
a	O
pregnant	O
woman	O
should	O
take	O
weekly	O
chloroquine	O
prophylaxis	O
until	O
after	O
delivery	O
or	O
cessation	O
of	O
breastfeeding	O
when	O
hypnozoite	O
eradication	O
can	O
be	O
considered	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
the	O
causative	O
agent	O
of	O
a	O
highly	O
contagious	O
disease	O
that	O
results	O
in	O
severe	O
economic	O
losses	O
to	O
the	O
global	O
poultry	O
industry	O
.	O

The	O
virus	B-SPEC
exists	O
in	O
a	O
wide	O
variety	O
of	O
genetically	O
distinct	O
viral	O
types	O
,	O
and	O
both	O
phylogenetic	O
analysis	O
and	O
measures	O
of	O
pairwise	O
similarity	O
among	O
nucleotide	O
or	O
amino	O
acid	O
sequences	O
have	O
been	O
used	O
to	O
classify	O
IBV	B-SPEC
strains	O
.	O

At	O
least	O
one	O
respiratory	O
tract	O
pathogen	O
was	O
detected	O
by	O
polymerase	O
chain	O
reaction	O
in	O
78	O
.	O
6	O
%	O
(	O
n	O
=	O
140	O
)	O
of	O
the	O
patients	O
:	O
influenza	O
A	O
33	O
.	O
5	O
%,	O
influenza	O
B	O
16	O
.	O
4	O
%,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
9	O
.	O
2	O
%,	O
adenovirus	B-SPEC
7	O
.	O
8	O
%,	O
rhinovirus	B-SPEC
7	O
.	O
1	O
%,	O
coronavirus	B-SPEC
7	O
.	O
1	O
%,	O
human	B-SPEC
metapneumovirus	I-SPEC
5	O
.	O
7	O
%,	O
human	B-SPEC
bocavirus	I-SPEC
5	O
.	O
7	O
%,	O
parainfluenza	O
virus	B-SPEC
3	O
.	O
5	O
%,	O
coinfection	O
2	O
.	O
8	O
%.	O

IBV	B-SPEC
has	O
many	O
genotypes	O
that	O
do	O
not	O
confer	O
any	O
cross	O
-	O
protection	O
.	O

TITLE	O
:	O
Human	B-SPEC
polyclonal	O
immunoglobulin	O
G	O
from	O
transchromosomic	O
bovines	B-SPEC
inhibits	O
MERS	O
-	O
CoV	O
in	O
vivo	O
.	O

Tc	O
bovines	B-SPEC
,	O
combined	O
with	O
the	O
ability	O
to	O
quickly	O
produce	O
Tc	O
hIgG	O
and	O
develop	O
in	O
vitro	O
assays	O
and	O
animal	B-SPEC
model	O
(	O
s	O
),	O
potentially	O
offer	O
a	O
platform	O
to	O
rapidly	O
produce	O
a	O
therapeutic	O
to	O
prevent	O
and	O
/	O
or	O
treat	O
MERS	O
-	O
CoV	O
infection	O
and	O
/	O
or	O
other	O
emerging	O
infectious	O
diseases	O
.	O

In	O
this	O
work	O
,	O
we	O
replaced	O
the	O
membrane	O
(	O
M	O
)	O
protein	O
of	O
the	O
model	O
coronavirus	B-SPEC
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
with	O
its	O
counterpart	O
from	O
a	O
heterologous	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
The	O
C	O
-	O
Terminal	O
Tail	O
of	O
TRIM56	O
Dictates	O
Antiviral	O
Restriction	O
of	O
Influenza	O
A	O
and	O
B	O
Viruses	B-SPEC
by	O
Impeding	O
Viral	O
RNA	O
Synthesis	O
.	O

Of	O
>	O
70	O
TRIMs	O
,	O
TRIM56	O
is	O
a	O
restriction	O
factor	O
of	O
several	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
,	O
including	O
three	O
members	O
of	O
the	O
family	B-SPEC
Flaviviridae	I-SPEC
(	O
yellow	B-SPEC
fever	I-SPEC
virus	I-SPEC
,	O
dengue	B-SPEC
virus	I-SPEC
,	O
and	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
)	O
and	O
a	O
human	B-SPEC
coronavirus	I-SPEC
(	O
OC43	O
),	O
and	O
this	O
ability	O
invariably	O
depends	O
upon	O
the	O
E3	O
ligase	O
activity	O
of	O
TRIM56	O
.	O

Unlike	O
its	O
antiviral	O
actions	O
against	O
positive	O
-	O
strand	O
RNA	O
viruses	B-SPEC
,	O
the	O
anti	O
-	O
influenza	B-SPEC
virus	I-SPEC
activity	O
of	O
TRIM56	O
was	O
independent	O
of	O
the	O
E3	O
ligase	O
activity	O
.	O

In	O
this	O
study	O
,	O
the	O
structure	O
determination	O
of	O
the	O
N	O
-	O
terminal	O
region	O
of	O
the	O
MERS	O
-	O
CoV	O
N	O
protein	O
via	O
X	O
-	O
ray	B-SPEC
diffraction	O
measurements	O
is	O
reported	O
at	O
a	O
resolution	O
of	O
2	O
.	O
4	O
Å	O
.	O
Since	O
the	O
first	O
30	O
amino	O
acids	O
were	O
not	O
resolved	O
by	O
X	O
-	O
ray	B-SPEC
diffraction	O
,	O
the	O
structural	O
study	O
was	O
completed	O
by	O
a	O
SAXS	O
experiment	O
to	O
propose	O
a	O
structural	O
model	O
including	O
the	O
IDR	O
.	O

This	O
model	O
presents	O
the	O
N	O
-	O
terminal	O
region	O
of	O
the	O
MERS	O
-	O
CoV	O
as	O
a	O
monomer	O
that	O
displays	O
structural	O
features	O
in	O
common	O
with	O
other	O
coronavirus	B-SPEC
NTDs	O
.	O

Nevertheless	O
,	O
full	O
-	O
body	O
necropsy	O
could	O
not	O
be	O
performed	O
in	O
13	O
/	O
29	O
control	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
Although	O
Lewis	O
X	O
(	O
Le	O
(	O
x	O
)),	O
a	O
carbohydrate	O
structure	O
,	O
is	O
involved	O
in	O
innate	O
immunity	O
through	O
cell	O
-	O
to	O
-	O
cell	O
and	O
pathogen	O
recognition	O
,	O
its	O
expression	O
has	O
not	O
been	O
observed	O
in	O
mouse	B-SPEC
monocytes	O
/	O
macrophages	O
(	O
Mo	O
/	O
Mas	O
).	O

Here	O
we	O
can	O
now	O
analyze	O
malaria	O
,	O
blood	O
gases	O
,	O
cell	O
counts	O
,	O
PK	O
-	O
value	O
,	O
liver	O
status	O
,	O
pneumococci	O
and	O
legionella	B-SPEC
as	O
well	O
as	O
perform	O
routine	O
pre	O
-	O
transfusion	O
testing	O
.	O

CCL94	O
(	O
cat	B-SPEC
kidney	O
)	O
cells	O
could	O
be	O
infected	O
efficiently	O
by	O
TGEV	B-SPEC
but	O
not	O
PEDV	B-SPEC
.	O

After	O
24	O
h	O
,	O
the	O
animals	B-SPEC
with	O
PaO2	O
/	O
FIO2	O
between	O
200	O
and	O
300	O
mmHg	O
were	O
randomized	O
into	O
2	O
groups	O
:	O
prone	O
position	O
(	O
n	O
=	O
6	O
)	O
and	O
supine	O
position	O
(	O
n	O
=	O
6	O
).	O

ABSTRACT	O
:	O
To	O
evaluate	O
the	O
safety	O
and	O
effectiveness	O
of	O
a	O
novel	O
therapeutic	O
regimen	O
for	O
bronchiolitis	O
obliterans	O
sydrome	O
(	O
BOS	B-SPEC
)	O
affter	O
hematopoietic	O
stem	O
cell	O
transplantation	O
(	O
HSCT	O
).	O

MSC	O
combined	O
with	O
budesonide	O
,	O
almeterol	O
and	O
azithromycin	O
has	O
been	O
confirmed	O
to	O
be	O
generally	O
safe	O
and	O
can	O
reduce	O
the	O
dose	O
of	O
glucocorticoid	O
in	O
treatment	O
of	O
BOS	B-SPEC
after	O
HSCT	O
.	O

Phylogenetic	O
analysis	O
of	O
the	O
spike	O
gene	O
showed	O
that	O
the	O
majority	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
isolates	O
were	O
grouped	O
into	O
two	O
previously	O
undefined	O
genotypes	O
,	O
provisionally	O
assigned	O
as	O
novel	O
lineage	O
1	O
and	O
novel	O
lineage	O
2	O
.	O

Finally	O
,	O
protein	O
-	O
protein	O
docking	O
was	O
performed	O
to	O
prove	O
accuracy	O
of	O
model	O
structures	O
of	O
the	O
MHV	B-SPEC
N	O
and	O
to	O
clarify	O
the	O
interaction	O
with	O
nsp3	O
.	O

TITLE	O
:	O
High	O
-	O
Resolution	O
Analysis	O
of	O
Coronavirus	B-SPEC
Gene	O
Expression	O
by	O
RNA	O
Sequencing	O
and	O
Ribosome	O
Profiling	O
.	O

Triplet	O
phasing	O
of	O
the	O
profiling	O
data	O
allowed	O
precise	O
determination	O
of	O
translated	O
reading	O
frames	O
and	O
revealed	O
several	O
translated	O
short	O
open	O
reading	O
frames	O
upstream	O
of	O
,	O
or	O
embedded	O
within	O
,	O
known	O
virus	B-SPEC
protein	O
-	O
coding	O
regions	O
.	O

Furthermore	O
,	O
coronavirus	B-SPEC
co	O
-	O
infection	O
was	O
detected	O
in	O
all	O
six	O
bat	B-SPEC
species	B-SPEC
,	O
a	O
phenomenon	O
that	O
fosters	O
recombination	O
and	O
promotes	O
the	O
emergence	O
of	O
novel	O
virus	B-SPEC
strains	O
.	O

ABSTRACT	O
:	O
We	O
conducted	O
a	O
six	O
-	O
year	O
epidemiological	O
study	O
on	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
circulating	O
in	O
Hong	O
Kong	O
,	O
using	O
8275	O
nasopharyngeal	O
samples	O
from	O
patients	O
with	O
acute	O
respiratory	O
tract	O
infections	O
.	O

Intriguingly	O
,	O
the	O
detection	O
rate	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
in	O
the	O
age	O
group	O
of	O
>	O
80	O
years	O
(	O
26	O
/	O
2380	O
,	O
1	O
.	O
09	O
%)	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
age	O
group	O
of	O
0	O
-	O
10	O
years	O
(	O
12	O
/	O
2529	O
,	O
0	O
.	O
47	O
%)	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Responses	O
of	O
the	O
Toll	O
-	O
like	O
receptor	O
and	O
melanoma	O
differentiation	O
-	O
associated	O
protein	O
5	O
signaling	O
pathways	O
to	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
infection	O
in	O
chicks	O
.	O

Laboratory	O
tests	O
were	O
negative	O
for	O
viruses	B-SPEC
known	O
to	O
cause	O
myocarditis	O
.	O

Further	O
SARs	O
were	O
also	O
discussed	O
for	O
the	O
first	O
time	O
under	O
the	O
chiral	O
scenario	O
,	O
demonstrating	O
that	O
both	O
spatial	O
configuration	O
and	O
3D	O
conformation	O
of	O
the	O
molecules	O
are	O
crucial	O
for	O
keeping	O
high	O
anti	O
-	O
TMV	B-SPEC
activity	O
.	O

Treatment	O
of	O
RSV	B-SPEC
in	O
immunocompromised	O
patients	O
varied	O
greatly	O
.	O

The	O
presence	O
of	O
such	O
heterogeneity	O
demonstrates	O
the	O
need	O
for	O
further	O
studies	O
defining	O
optimal	O
treatment	O
of	O
RSV	B-SPEC
in	O
immunocompromised	O
hosts	O
.	O

Three	O
of	O
12	O
centers	O
,	O
in	O
severe	O
cases	O
,	O
treated	O
parainfluenza	O
and	O
metapneumovirus	B-SPEC
,	O
and	O
1	O
/	O
12	O
treated	O
coronavirus	B-SPEC
.	O

Furthermore	O
,	O
near	O
-	O
identical	O
strains	O
of	O
MERS	O
-	O
CoV	O
have	O
been	O
isolated	O
from	O
epidemiologically	O
linked	O
humans	B-SPEC
and	O
camels	B-SPEC
,	O
confirming	O
inter	O
-	O
transmission	O
,	O
most	O
probably	O
from	O
camels	B-SPEC
to	O
humans	B-SPEC
.	O

Here	O
,	O
we	O
analyzed	O
the	O
phylogenetic	O
,	O
temporal	O
distribution	O
,	O
population	O
history	O
,	O
and	O
clinical	O
manifestations	O
among	O
patients	O
infected	O
with	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

Molecular	O
dating	O
analysis	O
indicated	O
that	O
the	O
origin	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
dated	O
to	O
1921	O
,	O
before	O
it	O
diverged	O
into	O
genotype	O
A	O
(	O
1975	O
),	O
genotype	O
B	O
(	O
1996	O
),	O
and	O
genotype	O
C	O
(	O
2003	O
).	O

The	O
study	O
described	O
the	O
seasonality	O
,	O
molecular	O
diversity	O
,	O
and	O
evolutionary	O
dynamics	O
of	O
human	B-SPEC
alphacoronavirus	B-SPEC
infections	O
in	O
a	O
tropical	O
region	O
.	O

Here	O
,	O
we	O
show	O
the	O
rapid	O
emergence	O
and	O
spread	O
of	O
a	O
mutant	O
MERS	O
-	O
CoV	O
with	O
reduced	O
affinity	O
to	O
the	O
human	B-SPEC
CD26	O
receptor	O
during	O
the	O
South	O
Korean	O
outbreak	O
.	O

Strikingly	O
,	O
both	O
mutations	O
result	O
in	O
reduced	O
affinity	O
of	O
RBD	O
to	O
human	B-SPEC
CD26	O
compared	O
to	O
wild	O
-	O
type	O
RBD	O
,	O
as	O
measured	O
by	O
surface	O
plasmon	O
resonance	O
analysis	O
and	O
cellular	O
binding	O
assay	O
.	O

We	O
not	O
only	O
found	O
that	O
TGEV	B-SPEC
infection	O
stimulates	O
F	O
-	O
actin	O
to	O
gather	O
at	O
the	O
cell	O
membrane	O
but	O
the	O
disruption	O
of	O
F	O
-	O
actin	O
inhibits	O
TGEV	B-SPEC
entry	O
as	O
well	O
.	O

The	O
TGEV	B-SPEC
spike	O
protein	O
is	O
capable	O
of	O
binding	O
with	O
EGFR	O
,	O
activating	O
the	O
downstream	O
phosphoinositide	O
-	O
3	O
kinase	O
(	O
PI3K	O
),	O
then	O
causing	O
the	O
phosphorylation	O
of	O
cofilin	O
and	O
F	O
-	O
actin	O
polymerization	O
via	O
Rac1	O
/	O
Cdc42	O
GTPases	O
.	O

In	O
conlusion	O
,	O
these	O
results	O
provide	O
valuable	O
data	O
of	O
the	O
mechanisms	O
which	O
are	O
responsible	O
for	O
the	O
TGEV	B-SPEC
pathogenesis	O
and	O
may	O
lead	O
to	O
the	O
development	O
of	O
new	O
methods	O
about	O
controlling	O
TGEV	B-SPEC
.	O

Cell	O
tropism	O
and	O
host	O
range	O
is	O
determined	O
in	O
part	O
by	O
the	O
coronavirus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
,	O
which	O
binds	O
cellular	O
receptors	O
and	O
mediates	O
membrane	O
fusion	O
.	O

Surprisingly	O
,	O
89	O
%	O
ferrets	B-SPEC
in	O
Japan	O
had	O
been	O
infected	O
with	O
FRCoV	O
.	O
These	O
results	O
indicated	O
that	O
our	O
established	O
ELISA	O
using	O
a	O
.	O
a	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
viral	O
respiratory	O
disease	O
.	O

Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
known	O
to	O
cause	O
severe	O
acute	O
respiratory	O
illness	O
associated	O
with	O
a	O
high	O
risk	O
of	O
mortality	O
Various	O
factors	O
may	O
have	O
contributed	O
to	O
the	O
successful	O
outcome	O
of	O
this	O
patient	O
such	O
as	O
young	O
age	O
,	O
presentation	O
during	O
the	O
last	O
stages	O
of	O
pregnancy	O
,	O
and	O
possible	O
differences	O
in	O
immune	O
response	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
are	O
found	O
in	O
a	O
wide	O
variety	O
of	O
wild	O
and	O
domestic	O
animals	B-SPEC
,	O
and	O
constitute	O
a	O
risk	O
for	O
zoonotic	O
and	O
emerging	O
infectious	O
disease	O
.	O

In	O
poultry	O
,	O
the	O
genetic	O
diversity	O
,	O
evolution	O
,	O
distribution	O
and	O
taxonomy	O
of	O
some	O
coronaviruses	O
have	O
been	O
well	O
described	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
features	O
of	O
CoVs	O
in	O
wild	O
birds	B-SPEC
.	O

The	O
highest	O
prevalence	O
was	O
found	O
in	O
the	O
diving	O
ducks	B-SPEC
--	O
mainly	O
Greater	O
Scaup	O
(	O
Aythya	B-SPEC
marila	I-SPEC
;	O
51	O
.	O
5	O
%)--	O
and	O
the	O
dabbling	B-SPEC
duck	I-SPEC
Mallard	B-SPEC
(	O
Anas	B-SPEC
platyrhynchos	I-SPEC
;	O
19	O
.	O
2	O
%).	O

Suspected	O
nitrite	O
toxicity	O
in	O
lambs	B-SPEC
associated	O
with	O
feeding	O
broccoli	O
.	O

ABSTRACT	O
:	O
With	O
>	O
1600	O
documented	O
human	B-SPEC
infections	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
a	O
case	O
fatality	O
rate	O
of	O
approximately	O
36	O
%,	O
medical	O
countermeasures	O
are	O
needed	O
to	O
prevent	O
and	O
limit	O
the	O
disease	O
.	O

TITLE	O
:	O
Recombinant	O
duck	B-SPEC
enteritis	O
viruses	B-SPEC
expressing	O
major	O
structural	O
proteins	O
of	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
provide	O
protection	O
against	O
infectious	O
bronchitis	O
in	O
chickens	B-SPEC
.	O

ABSTRACT	O
:	O
Because	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
is	O
an	O
enzyme	O
whose	O
catalytic	O
activity	O
depends	O
on	O
its	O
heterodimeric	O
structure	O
,	O
this	O
system	O
could	O
be	O
a	O
target	O
for	O
inhibitors	O
that	O
perturb	O
the	O
interactions	O
between	O
the	O
protein	O
subunits	O
,	O
p51	O
and	O
p66	O
.	O

Patients	O
infected	O
by	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
are	O
typically	O
young	O
children	O
with	O
upper	O
and	O
lower	O
respiratory	O
tract	O
infection	O
,	O
presenting	O
with	O
symptoms	O
including	O
croup	O
,	O
bronchiolitis	O
,	O
and	O
pneumonia	O
.	O

We	O
aimed	O
to	O
assess	O
the	O
role	O
of	O
Zika	B-SPEC
virus	I-SPEC
and	O
dengue	B-SPEC
virus	I-SPEC
infection	O
in	O
developing	O
Guillain	O
-	O
Barré	O
syndrome	O
.	O

Controls	O
were	O
age	O
-	O
matched	O
,	O
sex	O
-	O
matched	O
,	O
and	O
residence	O
-	O
matched	O
patients	O
who	O
presented	O
at	O
the	O
hospital	O
with	O
a	O
non	O
-	O
febrile	O
illness	O
(	O
control	O
group	O
1	O
;	O
n	O
=	O
98	O
)	O
and	O
age	O
-	O
matched	O
patients	O
with	O
acute	O
Zika	B-SPEC
virus	I-SPEC
disease	O
and	O
no	O
neurological	O
symptoms	O
(	O
control	O
group	O
2	O
;	O
n	O
=	O
70	O
).	O

39	O
(	O
93	O
%)	O
patients	O
with	O
Guillain	O
-	O
Barré	O
syndrome	O
had	O
Zika	B-SPEC
virus	I-SPEC
IgM	O
and	O
37	O
(	O
88	O
%)	O
had	O
experienced	O
a	O
transient	O
illness	O
in	O
a	O
median	O
of	O
6	O
days	O
(	O
IQR	O
4	O
-	O
10	O
)	O
before	O
the	O
onset	O
of	O
neurological	O
symptoms	O
,	O
suggesting	O
recent	O
Zika	B-SPEC
virus	I-SPEC
infection	O
.	O

After	O
establishment	O
of	O
mice	B-SPEC
model	O
,	O
we	O
observed	O
the	O
clinical	O
signs	O
of	O
disease	O
,	O
virus	B-SPEC
replication	O
,	O
immunopathogenesis	O
and	O
antibody	O
response	O
.	O

Notably	O
,	O
given	O
that	O
teicoplanin	O
has	O
routinely	O
been	O
used	O
in	O
the	O
clinic	O
with	O
low	O
toxicity	O
,	O
our	O
work	O
provides	O
a	O
promising	O
prospect	O
for	O
the	O
prophylaxis	O
and	O
treatment	O
of	O
Ebola	O
,	O
MERS	O
,	O
and	O
SARS	O
virus	B-SPEC
infection	O
.	O

In	O
conclusion	O
,	O
both	O
assays	O
were	O
able	O
to	O
detect	O
Mass	O
and	O
BR	O
genotypes	O
,	O
allowing	O
rapid	O
and	O
easy	O
IBV	B-SPEC
molecular	O
typing	O
from	O
allantoic	O
fluids	O
and	O
clinical	O
samples	O
.	O

IBV	B-SPEC
strain	O
GD	O
was	O
isolated	O
from	O
southern	O
China	O
in	O
2013	O
and	O
the	O
complete	O
genome	O
sequencing	O
and	O
phylogenetic	O
analysis	O
were	O
performed	O
.	O

TITLE	O
:	O
Antigenic	O
Drift	O
of	O
A	O
/	O
H3N2	O
/	O
Virus	B-SPEC
and	O
Circulation	O
of	O
Influenza	O
-	O
Like	O
Viruses	B-SPEC
During	O
the	O
2014	O
/	O
2015	O
Influenza	O
Season	O
in	O
Poland	O
.	O

Their	O
effectiveness	O
depends	O
on	O
whether	O
there	O
is	O
a	O
good	O
antigenic	O
match	O
between	O
circulating	O
viruses	B-SPEC
and	O
vaccine	O
strains	O
.	O

TITLE	O
:	O
Thinking	O
Outside	O
the	O
Triangle	O
:	O
Replication	O
Fidelity	O
of	O
the	O
Largest	O
RNA	O
Viruses	B-SPEC
.	O

ABSTRACT	O
:	O
When	O
judged	O
by	O
ubiquity	O
,	O
adaptation	O
,	O
and	O
emergence	O
of	O
new	O
diseases	O
,	O
RNA	O
viruses	B-SPEC
are	O
arguably	O
the	O
most	O
successful	O
biological	O
organisms	O
.	O

TITLE	O
:	O
Glycan	O
Engagement	O
by	O
Viruses	B-SPEC
:	O
Receptor	O
Switches	O
and	O
Specificity	O
.	O

ABSTRACT	O
:	O
A	O
large	O
number	O
of	O
viruses	B-SPEC
,	O
including	O
many	O
human	B-SPEC
pathogens	O
,	O
bind	O
cell	O
-	O
surface	O
glycans	O
during	O
the	O
initial	O
steps	O
of	O
infection	O
.	O

Here	O
,	O
we	O
review	O
current	O
knowledge	O
about	O
virus	B-SPEC
-	O
glycan	O
interactions	O
using	O
representative	O
crystal	O
structures	O
of	O
viral	O
attachment	O
proteins	O
in	O
complex	O
with	O
glycans	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
Host	O
Range	O
Expansion	O
and	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Emergence	O
:	O
Biochemical	O
Mechanisms	O
and	O
Evolutionary	O
Perspectives	O
.	O

Here	O
,	O
we	O
review	O
the	O
current	O
knowledge	O
of	O
coronavirus	B-SPEC
cross	O
-	O
species	B-SPEC
transmission	O
,	O
with	O
particular	O
focus	O
on	O
MERS	O
-	O
CoV	O
.	O
MERS	O
-	O
CoV	O
is	O
still	O
circulating	O
in	O
the	O
human	B-SPEC
population	O
,	O
and	O
the	O
mechanisms	O
governing	O
its	O
cross	O
-	O
species	B-SPEC
transmission	O
have	O
been	O
only	O
partially	O
elucidated	O
,	O
highlighting	O
a	O
need	O
for	O
further	O
investigation	O
.	O

Coronaviruses	O
encode	O
proofreading	O
machinery	O
,	O
unique	O
in	O
the	O
RNA	O
virus	B-SPEC
world	O
,	O
to	O
ensure	O
the	O
maintenance	O
of	O
their	O
large	O
genome	O
size	O
.	O

ABSTRACT	O
:	O
MERS	O
-	O
CoV	O
is	O
a	O
newly	O
emerged	O
human	B-SPEC
coronavirus	I-SPEC
reported	O
closely	O
related	O
with	O
HKU4	O
and	O
HKU5	O
Bat	B-SPEC
coronaviruses	O
.	O

We	O
found	O
that	O
MERS	O
-	O
CoV	O
shared	O
30	O
%	O
of	O
its	O
S	O
protein	O
antigenic	O
sites	O
with	O
HKU4	O
and	O
70	O
%	O
with	O
HKU5	O
bat	B-SPEC
-	O
CoV	O
.	O
Whereas	O
100	O
%	O
of	O
its	O
E	O
,	O
M	O
and	O
N	O
protein	O
'	O
s	O
antigenic	O
sites	O
are	O
found	O
to	O
be	O
conserved	O
with	O
those	O
in	O
HKU4	O
and	O
HKU5	O
.	O

RESULTS	O
:	O
Multiple	O
sequence	O
alignment	O
of	O
the	O
spike	O
(	O
S	O
),	O
membrane	O
(	O
M	O
),	O
enveloped	O
(	O
E	O
)	O
and	O
nucleocapsid	O
(	O
N	O
)	O
proteins	O
was	O
employed	O
to	O
identify	O
the	O
sequence	O
conservation	O
among	O
MERS	O
and	O
Bat	B-SPEC
(	O
HKU4	O
,	O
HKU5	O
)	O
coronaviruses	O
.	O

TITLE	O
:	O
Natural	O
resistance	O
to	O
experimental	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
infection	O
is	O
decreased	O
rather	O
than	O
increased	O
by	O
positive	O
genetic	O
selection	O
.	O

TITLE	O
:	O
The	O
host	O
immune	O
response	O
in	O
respiratory	O
virus	B-SPEC
infection	O
:	O
balancing	O
virus	B-SPEC
clearance	O
and	O
immunopathology	O
.	O

Thus	O
,	O
the	O
antiviral	O
immune	O
response	O
represents	O
a	O
balancing	O
act	O
between	O
the	O
elimination	O
of	O
virus	B-SPEC
and	O
immune	O
-	O
mediated	O
pulmonary	O
injury	O
.	O

A	O
total	O
of	O
15	O
consecutive	O
severe	O
CAP	O
patients	O
with	O
laboratory	O
-	O
confirmed	O
adenovirus	B-SPEC
infections	O
were	O
included	O
.	O

Ingredients	O
imported	O
to	O
the	O
USA	O
from	O
China	O
,	O
including	O
organic	O
&	O
conventional	O
soybeans	B-SPEC
and	O
meal	O
,	O
lysine	O
hydrochloride	O
,	O
D	O
-	O
L	O
methionine	O
,	O
tryptophan	O
,	O
Vitamins	O
A	O
,	O
D	O
&	O
E	O
,	O
choline	O
,	O
carriers	O
(	O
rice	B-SPEC
hulls	O
,	O
corn	B-SPEC
cobs	O
)	O
and	O
feed	O
grade	O
tetracycline	O
,	O
were	O
inoculated	O
with	O
PEDV	B-SPEC
.	O

In	O
contrast	O
,	O
viable	O
PEDV	B-SPEC
was	O
not	O
detected	O
in	O
any	O
samples	O
treated	O
with	O
LA	O
or	O
MCFA	O
.	O

RESULTS	O
:	O
Ingredients	O
imported	O
to	O
the	O
USA	O
from	O
China	O
,	O
including	O
organic	O
&	O
conventional	O
soybeans	B-SPEC
and	O
meal	O
,	O
lysine	O
hydrochloride	O
,	O
D	O
-	O
L	O
methionine	O
,	O
tryptophan	O
,	O
Vitamins	O
A	O
,	O
D	O
&	O
E	O
,	O
choline	O
,	O
carriers	O
(	O
rice	B-SPEC
hulls	O
,	O
corn	B-SPEC
cobs	O
)	O
and	O
feed	O
grade	O
tetracycline	O
,	O
were	O
inoculated	O
with	O
PEDV	B-SPEC
.	O

In	O
contrast	O
,	O
viable	O
PEDV	B-SPEC
was	O
not	O
detected	O
in	O
any	O
samples	O
treated	O
with	O
LA	O
or	O
MCFA	O
.	O

Mixed	O
infectious	O
bronchitis	O
(	O
IBV	B-SPEC
)	O
and	O
avian	B-SPEC
influenza	O
(	O
AI	O
)-	O
H9N2	O
viruses	B-SPEC
were	O
the	O
most	O
common	O
infection	O
(	O
41	O
.	O
7	O
%).	O

In	O
conclusion	O
,	O
mixed	O
viral	O
infections	O
,	O
especially	O
with	O
IBV	B-SPEC
and	O
AI	O
-	O
H9N2	O
viruses	B-SPEC
,	O
are	O
the	O
predominant	O
etiology	O
of	O
respiratory	O
disease	O
problems	O
in	O
broiler	O
chickens	B-SPEC
in	O
Egypt	O
.	O

TITLE	O
:	O
The	O
Characteristics	O
of	O
Middle	O
Eastern	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Transmission	O
Dynamics	O
in	O
South	O
Korea	O
.	O

TITLE	O
:	O
Neonatal	O
Fc	O
Receptor	O
-	O
Mediated	O
IgG	O
Transport	O
Across	O
Porcine	B-SPEC
Intestinal	O
Epithelial	O
Cells	O
:	O
Potentially	O
Provide	O
the	O
Mucosal	O
Protection	O
.	O

A	O
distinguished	O
group	O
of	O
PH	O
leaders	O
in	O
Saudi	O
Arabia	O
was	O
gathered	O
in	O
a	O
structured	O
workshop	O
that	O
was	O
organized	O
by	O
the	O
Al	O
Imam	O
Mohammad	O
Ibn	O
Saud	O
Islamic	O
University	O
,	O
college	O
of	O
medicine	O
to	O
discuss	O
the	O
current	O
status	O
and	O
future	O
needs	O
of	O
PH	O
education	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
association	O
of	O
plasma	O
adiponectin	O
level	O
at	O
ICU	O
admission	O
with	O
ARDS	O
and	O
30	O
-	O
day	O
mortality	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
.	O

This	O
review	O
explains	O
immune	O
responses	O
resulting	O
from	O
MERS	O
-	O
CoV	O
infection	O
,	O
describes	O
MERS	O
vaccine	O
criteria	O
,	O
and	O
presents	O
available	O
small	O
animal	B-SPEC
models	O
to	O
evaluate	O
the	O
efficacy	O
of	O
MERS	O
vaccines	O
.	O

TITLE	O
:	O
High	O
-	O
Frequency	O
Jet	O
Ventilation	O
against	O
Small	O
-	O
Volume	O
Conventional	O
Mechanical	O
Ventilation	O
in	O
the	O
Rabbit	B-SPEC
Models	O
of	O
Neonatal	O
Acute	O
Lung	O
Injury	O
.	O

The	O
issue	O
was	O
addressed	O
by	O
comparing	O
the	O
effects	O
on	O
lung	O
function	O
of	O
CMV	B-SPEC
and	O
HFJV	O
in	O
two	O
rabbit	B-SPEC
models	O
of	O
neonatal	O
acute	O
lung	O
injury	O
:	O
repetitive	O
saline	O
lung	O
lavage	O
(	O
LAV	O
)	O
and	O
meconium	O
aspiration	O
syndrome	O
(	O
MAS	O
)	O
induced	O
by	O
intratracheal	O
meconium	O
instillation	O
.	O

Palivizumab	O
,	O
an	O
anti	O
-	O
RSV	B-SPEC
monoclonal	O
antibody	O
,	O
effectively	O
prevents	O
RSV	B-SPEC
infection	O
in	O
high	O
-	O
risk	O
paediatric	O
populations	O
.	O

The	O
animals	B-SPEC
were	O
free	O
of	O
eight	O
other	O
microorganisms	O
tested	O
,	O
but	O
some	O
were	O
seropositive	O
for	O
porcine	B-SPEC
circovirus	I-SPEC
2	I-SPEC
(	O
PCV2	O
),	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
(	O
PRRSV	B-SPEC
),	O
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
).	O

To	O
modulate	O
carbon	O
dioxide	O
extraction	O
,	O
ECMO	O
gas	O
flow	O
(	O
GF	O
)	O
was	O
decreased	O
from	O
baseline	O
resting	O
protective	O
conditions	O
(	O
i	O
.	O
e	O
.,	O
GF100	O
%,	O
set	O
to	O
obtain	O
pressure	O
generated	O
in	O
the	O
first	O
100	O
ms	O
of	O
inspiration	O
against	O
an	O
occluded	O
airway	O
less	O
than	O
2	O
cm	O
H2O	O
,	O
respiratory	O
rate	O
less	O
than	O
or	O
equal	O
to	O
25	O
bpm	O
,	O
tidal	O
volume	O
less	O
than	O
6	O
ml	O
/	O
kg	O
,	O
and	O
peak	O
airway	O
pressure	O
less	O
than	O
25	O
cm	O
H2O	O
)	O
to	O
GF50	O
%-	O
GF25	O
%-	O
GF0	O
%	O
during	O
both	O
PSV	O
and	O
NAVA	O
(	O
random	O
order	B-SPEC
for	O
ventilation	O
mode	O
).	O

A	O
specific	O
mutation	O
within	O
zinc	O
finger	O
1	O
(	O
ZF	O
-	O
C	O
)	O
led	O
to	O
production	O
of	O
a	O
viable	O
virus	B-SPEC
with	O
growth	O
and	O
viral	O
RNA	O
synthesis	O
kinetics	O
similar	O
to	O
that	O
of	O
the	O
parental	O
virus	B-SPEC
.	O

Limited	O
literature	O
is	O
available	O
regarding	O
a	O
syndrome	O
of	O
this	O
type	O
in	O
adult	O
black	B-SPEC
-	I-SPEC
footed	I-SPEC
ferrets	I-SPEC
.	O

Primers	O
targeting	O
the	O
conserved	O
region	O
of	O
known	O
IBV	B-SPEC
serotypes	O
were	O
used	O
in	O
the	O
RT	O
-	O
PCR	O
assay	O
.	O

ABSTRACT	O
:	O
The	O
term	O
sepsis	B-SPEC
-	O
associated	O
encephalopathy	O
(	O
SAE	O
)	O
has	O
been	O
applied	O
to	O
animal	B-SPEC
models	O
,	O
postmortem	O
studies	O
in	O
patients	O
,	O
and	O
severe	O
cases	O
of	O
sepsis	B-SPEC
.	O

Clinical	O
data	O
for	O
sepsis	B-SPEC
-	O
associated	O
delirium	O
(	O
SAD	O
)	O
have	O
been	O
accumulating	O
since	O
the	O
establishment	O
of	O
definitions	O
of	O
coma	B-SPEC
or	O
delirium	O
and	O
the	O
introduction	O
of	O
validated	O
screening	O
tools	O
.	O

Once	O
the	O
respiratory	O
and	O
hemodynamic	O
states	O
are	O
stabilized	O
,	O
patients	O
with	O
severe	O
sepsis	B-SPEC
or	O
septic	O
shock	O
should	O
receive	O
rehabilitation	O
as	O
soon	O
as	O
possible	O
because	O
early	O
initiation	O
of	O
rehabilitation	O
can	O
reduce	O
the	O
duration	O
of	O
delirium	O
.	O

At	O
least	O
one	O
virus	B-SPEC
was	O
identified	O
in	O
each	O
of	O
65	O
·	O
4	O
%	O
children	O
,	O
of	O
which	O
29	O
·	O
5	O
%	O
were	O
coinfections	O
;	O
27	O
·	O
3	O
%	O
were	O
positive	O
for	O
human	B-SPEC
adenovirus	B-SPEC
(	O
hAdV	O
),	O
13	O
·	O
2	O
%	O
for	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
hRSV	B-SPEC
),	O
11	O
·	O
5	O
%	O
for	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
RV	O
/	O
EV	O
),	O
10	O
·	O
6	O
%	O
for	O
human	B-SPEC
bocavirus	I-SPEC
(	O
hBoV	O
),	O
9	O
·	O
8	O
%	O
for	O
influenza	B-SPEC
virus	I-SPEC
(	O
Inf	O
),	O
6	O
·	O
6	O
%	O
for	O
human	B-SPEC
parainfluenza	O
virus	B-SPEC
(	O
hPIV	O
),	O
5	O
·	O
7	O
%	O
for	O
human	B-SPEC
coronavirus	I-SPEC
(	O
hCoV	O
),	O
and	O
2	O
·	O
3	O
%	O
for	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
).	O

Respiratory	O
viruses	B-SPEC
were	O
associated	O
with	O
a	O
high	O
burden	O
of	O
hospitalizations	O
among	O
children	O
in	O
Cameroon	O
.	O

While	O
hRSV	B-SPEC
showed	O
seasonal	O
patterns	O
,	O
hAdV	O
and	O
RV	O
/	O
EV	O
were	O
detected	O
throughout	O
the	O
year	O
and	O
no	O
evident	O
temporal	O
patterns	O
were	O
observed	O
for	O
the	O
remaining	O
viruses	B-SPEC
.	O

It	O
was	O
recently	O
discovered	O
that	O
dromedary	B-SPEC
camels	B-SPEC
in	O
Saudi	O
Arabia	O
harbor	O
three	O
different	O
HCoV	O
species	B-SPEC
,	O
including	O
a	O
dominant	O
MERS	O
HCoV	O
lineage	O
that	O
was	O
responsible	O
for	O
the	O
outbreaks	O
in	O
the	O
Middle	O
East	O
and	O
South	O
Korea	O
during	O
2015	O
.	O

Feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
,	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
,	O
and	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
seroprevalence	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
was	O
6	O
.	O
1	O
,	O
6	O
.	O
1	O
,	O
and	O
39	O
.	O
0	O
%,	O
respectively	O
.	O

TITLE	O
:	O
Monitoring	O
the	O
Spread	O
of	O
Swine	B-SPEC
Enteric	B-SPEC
Coronavirus	I-SPEC
Diseases	O
in	O
the	O
United	O
States	O
in	O
the	O
Absence	O
of	O
a	O
Regulatory	O
Framework	O
.	O

TGEV	B-SPEC
is	O
an	O
enteropathogenic	O
coronavirus	B-SPEC
that	O
causes	O
highly	O
fatal	O
acute	O
diarrhoea	O
in	O
newborn	O
pigs	B-SPEC
.	O

An	O
oral	O
Lactobacillus	B-SPEC
casei	I-SPEC
(	O
L	B-SPEC
.	I-SPEC
casei	I-SPEC
)	O
vaccine	O
against	O
anti	O
-	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
developed	O
in	O
our	O
laboratory	O
was	O
used	O
to	O
study	O
mucosal	O
immune	O
responses	O
.	O

We	O
found	O
that	O
the	O
recombinant	O
Lactobacillus	B-SPEC
stimulated	O
IL	O
-	O
17	O
expression	O
in	O
both	O
the	O
systemic	O
and	O
mucosal	O
immune	O
responses	O
against	O
TGEV	B-SPEC
infection	O
.	O

Furthermore	O
,	O
the	O
Lactobacillus	B-SPEC
vaccine	O
stimulated	O
an	O
anti	O
-	O
TGEV	B-SPEC
infection	O
Th17	O
pathway	O
.	O

The	O
TGEV	B-SPEC
immune	O
protection	O
was	O
primarily	O
dependent	O
on	O
mucosal	O
immunity	O
.	O

Overall	O
,	O
19	O
out	O
of	O
34	O
(	O
55	O
.	O
88	O
%)	O
samples	O
were	O
IBV	B-SPEC
positive	O
and	O
contained	O
the	O
genotype	O
793B	O
(	O
n	O
=	O
13	O
;	O
68	O
.	O
42	O
%),	O
D274	O
(	O
n	O
=	O
4	O
;	O
21	O
.	O
05	O
%)	O
or	O
Massachusetts	O
(	O
n	O
=	O
2	O
;	O
10	O
.	O
53	O
%).	O

NS4b	O
proteins	O
are	O
distinct	O
from	O
lineage	O
ABetacoronavirusPDEs	O
and	O
rotavirus	B-SPEC
gene	O
-	O
encoded	O
PDEs	O
,	O
in	O
having	O
an	O
amino	O
-	O
terminal	O
nuclear	O
localization	O
signal	O
(	O
NLS	O
)	O
and	O
are	O
localized	O
mostly	O
to	O
the	O
nucleus	O
.	O

The	O
diversity	O
of	O
coronaviruses	O
in	O
many	O
mammalian	B-SPEC
species	B-SPEC
is	O
contributed	O
by	O
relatively	O
high	O
mutation	O
and	O
recombination	O
rates	O
during	O
replication	O
.	O

This	O
dynamic	O
nature	O
of	O
coronaviruses	O
may	O
facilitate	O
cross	O
-	O
species	B-SPEC
transmission	O
and	O
shifts	O
in	O
tissue	O
or	O
cell	O
tropism	O
in	O
a	O
host	O
,	O
resulting	O
in	O
substantial	O
change	O
in	O
virulence	O
.	O

Here	O
,	O
we	O
evaluated	O
the	O
therapeutic	O
efficacy	O
of	O
our	O
3CLpro	O
inhibitor	O
in	O
laboratory	O
cats	B-SPEC
with	O
FIP	O
.	O

These	O
findings	O
may	O
provide	O
important	O
insights	O
into	O
devising	O
therapeutic	O
strategies	O
and	O
selection	O
of	O
antiviral	O
compounds	O
for	O
further	O
development	O
for	O
important	O
coronaviruses	O
in	O
animals	B-SPEC
and	O
humans	B-SPEC
.	O

RESULTS	O
:	O
Among	O
624	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
,	O
251	O
(	O
40	O
.	O
2	O
%)	O
fulfilled	O
the	O
definition	O
of	O
American	O
-	O
European	O
Consensus	O
Conference	O
definition	O
of	O
ALI	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
TGEV	B-SPEC
infection	O
increased	O
the	O
number	O
of	O
autophagosome	O
-	O
like	O
double	O
-	O
and	O
single	O
-	O
membrane	O
vesicles	O
in	O
the	O
cytoplasm	O
of	O
host	O
cells	O
,	O
a	O
phenomenon	O
that	O
is	O
known	O
to	O
be	O
related	O
to	O
autophagy	O
.	O

Furthermore	O
,	O
TGEV	B-SPEC
replication	O
was	O
inhibited	O
when	O
autophagy	O
was	O
activated	O
by	O
rapamycin	O
.	O

We	O
previously	O
showed	O
that	O
if	O
the	O
five	O
interacting	O
amino	O
acids	O
which	O
differ	O
between	O
hamster	B-SPEC
and	O
human	B-SPEC
DPP4	O
are	O
changed	O
to	O
the	O
residues	O
found	O
in	O
human	B-SPEC
DPP4	O
,	O
hamster	B-SPEC
DPP4	O
does	O
act	O
as	O
a	O
receptor	O
.	O

Although	O
the	O
amino	O
acid	O
sequences	O
of	O
these	O
two	O
pFPs	O
differed	O
significantly	O
from	O
that	O
of	O
MERS	O
-	O
CoV	O
and	O
each	O
other	O
,	O
most	O
of	O
the	O
pFP	O
mutants	O
of	O
SARS	O
-	O
CoV	O
and	O
MHV	B-SPEC
also	O
failed	O
to	O
mediate	O
membrane	O
fusion	O
,	O
suggesting	O
that	O
these	O
pFPs	O
are	O
also	O
the	O
functional	O
FPs	O
.	O

Laboratory	O
testing	O
of	O
the	O
50	O
crias	O
included	O
in	O
this	O
study	O
revealed	O
that	O
80	O
%	O
were	O
infected	O
with	O
Eimeria	B-SPEC
spp	O
.,	O
40	O
%	O
with	O
coronavirus	B-SPEC
,	O
34	O
%	O
with	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
32	O
%	O
with	O
rotavirus	B-SPEC
,	O
22	O
%	O
with	O
Clostridium	B-SPEC
spp	O
.,	O
and	O
20	O
%	O
with	O
Cryptosporidium	B-SPEC
spp	O
.	O

RESULTS	O
:	O
Laboratory	O
testing	O
of	O
the	O
50	O
crias	O
included	O
in	O
this	O
study	O
revealed	O
that	O
80	O
%	O
were	O
infected	O
with	O
Eimeria	B-SPEC
spp	O
.,	O
40	O
%	O
with	O
coronavirus	B-SPEC
,	O
34	O
%	O
with	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
,	O
32	O
%	O
with	O
rotavirus	B-SPEC
,	O
22	O
%	O
with	O
Clostridium	B-SPEC
spp	O
.,	O
and	O
20	O
%	O
with	O
Cryptosporidium	B-SPEC
spp	O
.	O

TITLE	O
:	O
[	O
Successful	O
Treatment	O
of	O
Seasonal	O
Influenza	O
A	O
(	O
H3N2	O
)	O
infection	O
-	O
related	O
Hemophagocytic	O
Lymphocytosis	O
in	O
an	O
Elderly	O
Man	B-SPEC
].	O

ABSTRACT	O
:	O
A	O
79	O
-	O
year	O
-	O
old	O
man	B-SPEC
experienced	O
severe	O
chronic	O
obstructive	O
pulmonary	O
disease	O
(	O
COPD	O
)	O
and	O
was	O
receiving	O
treatment	O
for	O
ischemic	O
heart	O
disease	O
.	O

Of	O
three	O
eukaryotic	O
expression	O
systems	O
tested	O
(	O
yeast	B-SPEC
,	O
insect	B-SPEC
-	O
cell	O
,	O
and	O
mammalian	B-SPEC
),	O
expression	O
by	O
HEK	O
-	O
293	O
T	O
cells	O
gave	O
the	O
highest	O
yield	O
of	O
protein	O
that	O
was	O
N	O
-	O
glycosylated	O
and	O
was	O
the	O
most	O
appropriate	O
candidate	O
for	O
vaccination	O
.	O

However	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
diarrhea	O
,	O
body	O
weight	O
and	O
virus	B-SPEC
shedding	O
.	O

We	O
did	O
not	O
detect	O
any	O
SARS	O
-	O
like	O
betacoronaviruses	O
,	O
despite	O
targeting	O
rhinolophid	O
bats	B-SPEC
,	O
the	O
putative	O
natural	O
host	O
taxa	O
.	O

Our	O
findings	O
support	O
the	O
virus	B-SPEC
-	O
host	O
co	O
-	O
evolution	O
hypothesis	O
,	O
with	O
the	O
detection	O
of	O
Miniopterus	B-SPEC
bat	I-SPEC
coronavirus	I-SPEC
HKU8	I-SPEC
(	O
previously	O
reported	O
in	O
Miniopterus	B-SPEC
species	B-SPEC
in	O
China	O
,	O
Hong	O
Kong	O
and	O
Bulgaria	B-SPEC
)	O
in	O
Australian	O
Miniopterus	B-SPEC
species	B-SPEC
.	O

Fecal	O
samples	O
were	O
tested	O
by	O
PEDV	B-SPEC
real	O
-	O
time	O
reverse	O
transcriptase	O
PCR	O
.	O

The	O
molecular	O
diversity	O
and	O
phylogenetic	O
relationships	O
between	O
porcine	B-SPEC
epidemic	O
diarrhea	O
viruses	B-SPEC
(	O
PEDV	B-SPEC
)	O
prevalent	O
in	O
Gansu	O
were	O
probed	O
,	O
and	O
the	O
resultant	O
proteins	O
were	O
characterized	O
.	O

In	O
sequence	O
analysis	O
,	O
F	O
and	O
N	O
gene	O
sequences	O
could	O
only	O
be	O
obtained	O
successfully	O
from	O
46	O
out	O
of	O
76	O
HMPV	B-SPEC
positive	O
samples	O
.	O

Since	O
then	O
,	O
the	O
virus	B-SPEC
has	O
spread	O
to	O
over	O
30	O
states	O
and	O
caused	O
significant	O
economic	O
losses	O
in	O
the	O
US	O
swine	B-SPEC
industry	O
due	O
to	O
the	O
high	O
mortality	O
in	O
newborn	O
piglets	O
less	O
than	O
2	O
weeks	O
of	O
age	O
.	O

Here	O
,	O
we	O
report	O
histological	O
changes	O
in	O
the	O
small	O
intestines	O
of	O
five	O
piglets	O
infected	O
with	O
the	O
variant	O
strain	O
OH851	O
of	O
PEDV	B-SPEC
.	O

Analytical	O
sensitivities	O
of	O
the	O
PEDV	B-SPEC
RT	O
-	O
iiPCR	O
,	O
PDCoV	O
RT	O
-	O
iiPCR	O
and	O
duplex	O
PEDV	B-SPEC
/	O
PDCoV	O
rRT	O
-	O
PCR	O
were	O
determined	O
using	O
in	O
vitro	O
transcribed	O
RNA	O
as	O
well	O
as	O
viral	O
RNA	O
extracted	O
from	O
ten	O
-	O
fold	O
serial	O
dilutions	O
of	O
PEDV	B-SPEC
and	O
PDCoV	O
cell	O
culture	O
isolates	O
.	O

Compared	O
to	O
the	O
reference	O
PEDV	B-SPEC
rRT	O
-	O
PCR	O
,	O
the	O
sensitivity	O
,	O
specificity	O
and	O
accuracy	O
of	O
the	O
PEDV	B-SPEC
RT	O
-	O
iiPCR	O
were	O
97	O
.	O
73	O
%,	O
98	O
.	O
78	O
%,	O
and	O
98	O
.	O
24	O
%,	O
respectively	O
,	O
and	O
those	O
of	O
the	O
duplex	O
PEDV	B-SPEC
/	O
PDCoV	O
rRT	O
-	O
PCR	O
were	O
98	O
.	O
86	O
%,	O
96	O
.	O
34	O
%,	O
and	O
97	O
.	O
65	O
%,	O
respectively	O
.	O

Compared	O
to	O
the	O
reference	O
PDCoV	O
rRT	O
-	O
PCR	O
,	O
the	O
sensitivity	O
,	O
specificity	O
and	O
accuracy	O
of	O
the	O
PDCoV	O
RT	O
-	O
iiPCR	O
were	O
100	O
%,	O
100	O
%,	O
and	O
100	O
%,	O
respectively	O
,	O
and	O
those	O
of	O
the	O
PEDV	B-SPEC
/	O
PDCoV	O
duplex	O
rRT	O
-	O
PCR	O
were	O
96	O
.	O
34	O
%,	O
100	O
%,	O
and	O
98	O
.	O
24	O
%,	O
respectively	O
.	O

Results	O
TRALI	O
was	O
tested	O
in	O
the	O
context	O
of	O
severe	O
thrombocytopenia	O
provoked	O
by	O
the	O
administration	O
of	O
diphtheria	O
toxin	O
(	O
DT	O
)	O
in	O
transgenic	O
iDTR	O
mice	B-SPEC
selectively	O
expressing	O
DT	O
receptor	O
in	O
megakaryocytes	O
.	O

TITLE	O
:	O
The	O
effect	O
of	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
challenge	O
on	O
growing	O
pigs	B-SPEC
I	O
:	O
Growth	O
performance	O
and	O
digestibility	O
.	O

Treatments	O
included	O
1	O
)	O
a	O
control	O
,	O
2	O
)	O
PRRS	O
virus	B-SPEC
infected	O
,	O
3	O
)	O
PED	O
virus	B-SPEC
infected	O
,	O
and	O
4	O
)	O
PRRS	O
+	O
PED	O
coinfection	O
(	O
PRP	O
).	O

Infection	O
with	O
PRRS	O
virus	B-SPEC
was	O
confirmed	O
by	O
quantitative	O
PCR	O
and	O
seroconversion	O
.	O

No	O
significant	O
differences	O
in	O
apparent	O
ileal	O
digestibility	O
(	O
AID	O
)	O
were	O
detected	O
between	O
virus	B-SPEC
challenges	O
.	O

Active	O
transport	O
of	O
glucose	O
was	O
increased	O
in	O
PRRS	O
pigs	B-SPEC
over	O
CON	O
pigs	B-SPEC
(	O
<	O
0	O
.	O
01	O
),	O
whereas	O
PED	O
had	O
pigs	B-SPEC
increased	O
(	O
<	O
0	O
.	O
01	O
)	O
active	O
glutamine	O
transport	O
over	O
the	O
CON	O
pigs	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
conducted	O
a	O
challenge	O
/	O
rechallenge	O
trial	O
in	O
which	O
3	O
alpacas	B-SPEC
were	O
infected	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

In	O
the	O
last	O
years	O
,	O
electron	O
tomography	O
has	O
revealed	O
substantial	O
differences	O
between	O
the	O
structures	O
induced	O
by	O
these	O
different	O
virus	B-SPEC
groups	O
.	O

TITLE	O
:	O
Development	O
of	O
a	O
SARS	O
Coronavirus	B-SPEC
Vaccine	O
from	O
Recombinant	O
Spike	O
Protein	O
Plus	O
Delta	O
Inulin	O
Adjuvant	O
.	O

The	O
overall	O
PICU	B-SPEC
mortality	O
of	O
our	O
severe	O
ARDS	O
at	O
28	O
days	O
was	O
16	O
.	O
7	O
%.	O

We	O
demonstrated	O
that	O
elevated	O
numbers	O
of	O
gut	O
-	O
homing	O
CD8	O
(+)	O
T	O
cells	O
(	O
which	O
express	O
α4β7	O
and	O
CCR9	O
molecules	O
)	O
were	O
presented	O
in	O
porcine	B-SPEC
inguinal	O
lymph	O
nodes	O
and	O
were	O
recruited	O
to	O
the	O
small	O
intestine	O
by	O
RA	O
.	O

Possible	O
related	O
risk	O
factors	O
for	O
RSV	B-SPEC
infection	O
were	O
low	O
age	O
upon	O
entry	O
,	O
attendance	O
of	O
daycare	O
,	O
low	O
gestational	O
age	O
,	O
and	O
low	O
educational	O
level	O
of	O
the	O
father	O
.	O

At	O
present	O
,	O
differential	O
diagnosis	O
of	O
PDCoV	O
,	O
PEDV	B-SPEC
,	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
essential	O
to	O
control	O
viral	O
diarrheas	O
in	O
US	O
swine	B-SPEC
.	O

TITLE	O
:	O
Extensive	O
Viable	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
Coronavirus	B-SPEC
Contamination	O
in	O
Air	O
and	O
Surrounding	O
Environment	O
in	O
MERS	O
Isolation	O
Wards	O
.	O

This	O
included	O
studies	O
that	O
simulated	O
contamination	O
with	O
fluorescent	O
markers	O
or	O
a	O
non	O
-	O
pathogenic	O
virus	B-SPEC
.	O

Two	O
authors	O
independently	O
selected	O
studies	O
,	O
extracted	O
data	O
and	O
assessed	O
risk	O
of	O
bias	B-SPEC
in	O
included	O
trials	O
.	O

However	O
,	O
the	O
data	O
all	O
come	O
from	O
single	O
studies	O
with	O
high	O
risk	O
of	O
bias	B-SPEC
and	O
we	O
are	O
uncertain	O
about	O
the	O
estimates	O
of	O
effects	O
.	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
M	O
protein	O
suppresses	O
type	O
I	O
interferon	O
expression	O
through	O
the	O
inhibition	O
of	O
TBK1	O
-	O
dependent	O
phosphorylation	O
of	O
IRF3	O
.	O

TITLE	O
:	O
BCX4430	O
-	O
A	O
broad	O
-	O
spectrum	O
antiviral	O
adenosine	O
nucleoside	O
analog	O
under	O
development	O
for	O
the	O
treatment	O
of	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
.	O

In	O
nonclinical	O
studies	O
involving	O
lethal	O
infections	O
with	O
Ebola	O
virus	B-SPEC
,	I-SPEC
Marburg	I-SPEC
virus	B-SPEC
,	O
Rift	B-SPEC
Valley	I-SPEC
fever	I-SPEC
virus	I-SPEC
,	O
and	O
Yellow	B-SPEC
Fever	I-SPEC
virus	I-SPEC
,	O
BCX4430	O
has	O
demonstrated	O
pronounced	O
efficacy	O
.	O

PPV	B-SPEC
and	O
NPV	O
were	O
85	O
.	O
0	O
%	O
and	O
83	O
.	O
3	O
%.	O

TITLE	O
:	O
Respiratory	O
viruses	B-SPEC
associated	O
with	O
severe	O
pneumonia	O
in	O
children	O
under	O
2	O
years	O
old	O
in	O
a	O
rural	O
community	O
in	O
Pakistan	O
.	O

Of	O
the	O
nasopharyngeal	O
swabs	O
collected	O
,	O
77	O
.	O
8	O
%	O
(	O
179	O
/	O
230	O
)	O
were	O
positive	O
for	O
one	O
or	O
more	O
of	O
the	O
above	O
mentioned	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
having	O
a	O
severe	O
effect	O
on	O
the	O
pig	B-SPEC
breeding	O
industry	O
in	O
central	O
China	O
.	O

Negative	O
-	O
staining	O
electron	O
microscopy	O
(	O
EM	O
)	O
revealed	O
the	O
presence	O
of	O
coronavirus	B-SPEC
-	O
like	O
particles	O
in	O
the	O
samples	O
.	O

ABSTRACT	O
:	O
Eight	O
hundred	O
and	O
thirteen	O
European	O
rodents	B-SPEC
and	O
shrews	B-SPEC
encompassing	O
seven	O
different	O
species	B-SPEC
were	O
screened	O
for	O
alphacoronaviruses	O
using	O
PCR	O
detection	O
.	O

As	O
such	O
they	O
might	O
represent	O
distinct	O
species	B-SPEC
of	O
alphacoronaviruses	O
.	O

ABSTRACT	O
:	O
The	O
last	O
century	O
has	O
witnessed	O
the	O
emergence	O
of	O
several	O
previously	O
unknown	O
viruses	B-SPEC
as	O
life	O
-	O
threatening	O
human	B-SPEC
pathogens	O
.	O

TITLE	O
:	O
Comparison	O
of	O
SYBR	O
green	O
I	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
with	O
conventional	O
agarose	O
gel	O
-	O
based	O
RT	O
-	O
PCR	O
for	O
the	O
diagnosis	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
infection	O
in	O
chickens	B-SPEC
in	O
Morocco	O
.	O

All	O
negative	O
controls	O
,	O
such	O
as	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
and	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
were	O
not	O
detected	O
.	O

ABSTRACT	O
:	O
Multisystemic	O
granulomatous	O
lesions	O
are	O
the	O
most	O
common	O
finding	O
in	O
ferrets	B-SPEC
infected	O
by	O
ferret	B-SPEC
systemic	I-SPEC
coronavirus	I-SPEC
(	O
FRSCV	O
).	O

There	O
were	O
87	O
/	O
114	O
(	O
76	O
.	O
3	O
%)	O
swabs	O
positive	O
for	O
at	O
least	O
one	O
virus	B-SPEC
by	O
at	O
least	O
one	O
test	O
.	O

BRSV	B-SPEC
was	O
only	O
identified	O
by	O
PCR	O
testing	O
.	O

TITLE	O
:	O
Active	O
screening	O
and	O
surveillance	O
in	O
the	O
United	O
Kingdom	B-SPEC
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
in	O
returning	O
travellers	O
and	O
pilgrims	O
from	O
the	O
Middle	O
East	O
:	O
a	O
prospective	O
descriptive	O
study	O
for	O
the	O
period	O
2013	O
-	O
2015	O
.	O

TITLE	O
:	O
THE	O
PATIENT	O
-	O
DOCTOR	O
-	O
PSYCHOLOGIST	O
TRIANGLE	O
IN	O
A	O
CASE	O
Of	O
SEVERE	O
IMUNOSUPRESSION	O
IN	O
THE	O
HIV	B-SPEC
INFECTION	O
.	O

Tests	O
later	O
proved	O
positive	O
for	O
HIV	B-SPEC
,	O
the	O
patient	O
being	O
included	O
in	O
the	O
stage	O
AIDS	O
C3	O
(	O
acute	O
immunodeficiency	O
syndrome	O
).	O

The	O
established	O
alphacoronavirus	B-SPEC
genome	O
sequences	O
showed	O
high	O
similarity	O
to	O
other	O
alphacoronaviruses	O
found	O
in	O
other	O
Miniopterus	B-SPEC
species	B-SPEC
,	O
suggesting	O
that	O
their	O
transmission	O
in	O
different	O
Miniopterus	B-SPEC
species	B-SPEC
may	O
provide	O
opportunities	O
for	O
recombination	O
with	O
different	O
alphacoronaviruses	O
.	O

TITLE	O
:	O
Structural	O
basis	O
for	O
the	O
dimerization	O
and	O
substrate	O
recognition	O
specificity	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
3C	O
-	O
like	O
protease	O
.	O

Structural	O
characterization	O
,	O
mutagenesis	O
and	O
biochemical	O
analysis	O
reveal	O
the	O
substrate	O
-	O
binding	O
pockets	O
and	O
the	O
residues	O
that	O
comprise	O
the	O
active	O
site	O
of	O
PEDV	B-SPEC
3CL	O
(	O
pro	O
).	O

The	O
changes	O
in	O
respiratory	O
mechanics	O
and	O
oxygenation	O
indexes	O
were	O
compared	O
before	O
and	O
after	O
PPV	B-SPEC
treatment	O
in	O
all	O
the	O
patients	O
.	O

So	O
oxygen	O
inhalation	O
via	O
nasal	O
cannula	B-SPEC
was	O
changed	O
to	O
HFNC	O
after	O
2	O
days	O
.	O

The	O
indicators	O
with	O
statistically	O
significant	O
difference	O
from	O
the	O
univariate	O
analysis	O
were	O
further	O
analyzed	O
by	O
multivariate	O
logistic	O
regression	O
,	O
and	O
the	O
indices	O
included	O
in	O
the	O
regression	O
model	O
were	O
age	O
≥	O
65	O
years	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
95	O
%	O
CI	O
)	O
=	O
0	O
.	O
176	O
-	O
1	O
.	O
974	O
,	O
P	O
=	O
0	O
.	O
019	O
],	O
APACHE	O
II	O
score	O
≥	O
21	O
(	O
95	O
%	O
CI	O
=	O
0	O
.	O
121	O
-	O
2	O
.	O
725	O
,	O
P	O
=	O
0	O
.	O
032	O
),	O
GCS	O
<	O
6	O
(	O
95	O
%	O
CI	O
=	O
0	O
.	O
201	O
-	O
3	O
.	O
221	O
,	O
P	O
=	O
0	O
.	O
026	O
),	O
severe	O
sepsis	B-SPEC
(	O
95	O
%	O
CI	O
=	O
0	O
.	O
421	O
-	O
2	O
.	O
735	O
,	O
P	O
=	O
0	O
.	O
008	O
)	O
or	O
septic	O
shock	O
(	O
95	O
%	O
CI	O
=	O
0	O
.	O
430	O
-	O
3	O
.	O
636	O
,	O
P	O
=	O
0	O
.	O
013	O
),	O
with	O
assigning	O
scores	O
of	O
1	O
.	O
0	O
,	O
1	O
.	O
5	O
,	O
1	O
.	O
5	O
,	O
1	O
.	O
5	O
,	O
2	O
.	O
0	O
,	O
respectively	O
.	O

TITLE	O
:	O
Human	B-SPEC
herpesviruses	B-SPEC
respiratory	O
infections	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
(	O
ARDS	O
).	O

The	O
presence	O
of	O
this	O
group	O
of	O
herpesviruses	B-SPEC
,	O
in	O
addition	O
to	O
the	O
research	O
of	O
influenza	B-SPEC
viruses	I-SPEC
and	O
other	O
common	O
respiratory	O
viruses	B-SPEC
,	O
was	O
investigated	O
in	O
respiratory	O
samples	O
from	O
54	O
patients	O
hospitalized	O
in	O
ICU	O
,	O
without	O
a	O
known	O
microbiological	O
causative	O
agent	O
.	O

Our	O
analyses	O
show	O
:	O
1	O
)	O
28	O
potential	O
recombinant	O
sequences	O
were	O
detected	O
and	O
they	O
can	O
be	O
classified	O
into	O
seven	O
potential	O
recombinant	O
types	O
;	O
2	O
)	O
The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
MERS	O
-	O
CoV	O
was	O
under	O
strong	O
positive	O
selection	O
when	O
MERS	O
-	O
CoV	O
transmitted	O
from	O
their	O
natural	O
host	O
to	O
human	B-SPEC
;	O
3	O
)	O
Six	O
out	O
of	O
nine	O
positive	O
selection	O
sites	O
detected	O
in	O
spike	O
(	O
S	O
)	O
protein	O
are	O
located	O
in	O
its	O
receptor	O
-	O
binding	O
domain	O
which	O
is	O
in	O
direct	O
contact	O
with	O
host	O
cells	O
;	O
4	O
)	O
MERS	O
-	O
CoV	O
frequently	O
transmitted	O
back	O
and	O
forth	O
between	O
human	B-SPEC
and	O
camel	B-SPEC
after	O
it	O
had	O
acquired	O
the	O
human	B-SPEC
-	O
camel	B-SPEC
infection	O
capability	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
potential	O
recombination	O
events	O
might	O
have	O
happened	O
frequently	O
during	O
MERS	O
-	O
CoV	O
'	O
s	O
evolutionary	O
history	O
and	O
the	O
positive	O
selection	O
sites	O
in	O
MERS	O
-	O
CoV	O
'	O
s	O
S	O
protein	O
might	O
enable	O
it	O
to	O
infect	O
human	B-SPEC
.	O

TITLE	O
:	O
Trigger	O
factor	O
assisted	O
soluble	O
expression	O
of	O
recombinant	O
spike	O
protein	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

ABSTRACT	O
:	O
The	O
Influenza	B-SPEC
virus	I-SPEC
is	O
a	O
leading	O
cause	O
of	O
respiratory	O
disease	O
in	O
the	O
United	O
States	O
each	O
year	O
.	O

Nanotrap	O
particles	O
with	O
reactive	O
red	O
baits	O
concentrated	O
numerous	O
respiratory	O
viruses	B-SPEC
including	O
various	O
strains	O
and	O
subtypes	O
of	O
Influenza	B-SPEC
virus	I-SPEC
,	O
Coronavirus	B-SPEC
,	O
and	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
from	O
saliva	O
,	O
nasal	O
fluid	O
swab	O
specimens	O
,	O
and	O
nasal	O
aspirates	O
.	O

TITLE	O
:	O
The	O
contribution	O
of	O
the	O
cytoplasmic	O
retrieval	O
signal	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
to	O
intracellular	O
accumulation	O
of	O
S	O
proteins	O
and	O
incorporation	O
of	O
S	O
protein	O
into	O
virus	B-SPEC
-	O
like	O
particles	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
2012	O
brought	O
back	O
memories	O
of	O
the	O
occurrence	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
in	O
2002	O
.	O

However	O
,	O
the	O
virus	B-SPEC
exhibited	O
a	O
clear	O
tendency	O
to	O
cause	O
large	O
outbreaks	O
outside	O
the	O
Arabian	O
Peninsula	O
as	O
exemplified	O
by	O
the	O
outbreak	O
in	O
the	O
Republic	O
of	O
Korea	O
.	O

After	O
determining	O
the	O
optimal	O
combinations	O
of	O
these	O
mAbs	O
,	O
we	O
developed	O
an	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
and	O
a	O
rapid	O
immunochromatographic	O
antigen	O
detection	O
test	O
that	O
can	O
be	O
reliably	O
used	O
for	O
laboratory	O
diagnosis	O
of	O
MERS	O
-	O
CoV	O
.	O
Thus	O
,	O
this	O
study	O
provides	O
strong	O
evidence	O
that	O
the	O
wheat	B-SPEC
germ	O
cell	O
-	O
free	O
system	O
is	O
useful	O
for	O
the	O
production	O
of	O
diagnostic	O
mAbs	O
against	O
emerging	O
pathogens	O
.	O

ABSTRACT	O
:	O
The	O
bone	O
marrow	O
stromal	O
cell	O
antigen	O
2	O
(	O
BST	O
-	O
2	O
)	O
protein	O
was	O
identified	O
as	O
a	O
novel	O
virus	B-SPEC
restriction	O
factor	O
that	O
potently	O
restricts	O
the	O
replication	O
and	O
egress	O
of	O
enveloped	O
viruses	B-SPEC
.	O

Indirect	O
immunofluorescence	O
assay	O
and	O
western	O
blot	O
analysis	O
showed	O
that	O
the	O
MAb	O
was	O
specifically	O
reacted	O
with	O
the	O
overexpressed	O
porcine	B-SPEC
BST	O
-	O
2	O
protein	O
in	O
Vero	O
cells	O
.	O

For	O
CPV	B-SPEC
,	O
the	O
control	O
dogs	B-SPEC
had	O
significantly	O
(	O
P	O
<	O
0	O
.	O
002	O
)	O
higher	O
serum	O
neutralization	O
(	O
SN	O
)	O
titers	O
than	O
the	O
lean	O
geriatric	O
dogs	B-SPEC
and	O
the	O
obese	O
geriatric	O
dogs	B-SPEC
.	O

For	O
CDV	B-SPEC
SN	O
titers	O
,	O
the	O
only	O
statistically	O
significant	O
(	O
P	O
=	O
0	O
.	O
01	O
)	O
difference	O
was	O
that	O
the	O
control	O
dogs	B-SPEC
had	O
higher	O
SN	O
titers	O
than	O
the	O
lean	O
geriatric	O
dogs	B-SPEC
.	O

The	O
pharmacophoric	O
information	O
was	O
used	O
to	O
retrieve	O
a	O
putative	O
binding	O
site	O
on	O
the	O
surface	O
of	O
the	O
BVDV	B-SPEC
RdRp	O
and	O
to	O
guide	O
compound	O
docking	O
within	O
the	O
protein	O
binding	O
site	O
.	O

In	O
addition	O
,	O
within	O
these	O
animals	B-SPEC
,	O
low	O
levels	O
of	O
viral	O
RNA	O
were	O
detected	O
in	O
lungs	O
and	O
livers	O
with	O
higher	O
levels	O
in	O
spleens	O
.	O

In	O
Experiment	O
1	O
,	O
eggs	O
were	O
collected	O
from	O
day	O
1	O
to	O
day	O
13	O
post	O
-	O
inoculation	O
(	O
p	O
.	O
i	O
.)	O
from	O
unvaccinated	O
laying	O
hens	O
challenged	O
with	O
IBV	B-SPEC
wild	O
strains	O
T	O
and	O
N1	O
/	O
88	O
and	O
from	O
a	O
negative	O
control	O
group	O
of	O
hens	O
.	O

A	O
seasonal	O
pattern	O
of	O
hantavirus	B-SPEC
disease	O
in	O
the	O
dry	O
season	O
is	O
clear	O
.	O

Meanwhile	O
,	O
the	O
results	O
of	O
the	O
virus	B-SPEC
neutralization	O
test	O
indicated	O
that	O
the	O
strains	O
of	O
JX	O
/	O
99	O
/	O
01	O
,	O
GD	O
,	O
SAIBK	O
,	O
LDT3	O
showed	O
cross	O
-	O
reactivity	O
with	O
the	O
ZZ2004	O
isolate	O
,	O
and	O
hardly	O
any	O
cross	O
-	O
neutralization	O
of	O
IBV	B-SPEC
ZZ2004	O
was	O
observed	O
with	O
the	O
strains	O
of	O
M41	O
,	O
H120	O
,	O
Gray	O
,	O
Holte	O
,	O
or	O
Aust	O
-	O
T	O
.	O
Phylogenetic	O
analysis	O
suggested	O
that	O
there	O
were	O
large	O
differences	O
between	O
ZZ2004	O
and	O
other	O
IBV	B-SPEC
reference	O
strains	O
on	O
the	O
S1	O
subunit	O
.	O

TITLE	O
:	O
Patient	O
characteristics	O
infected	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
a	O
tertiary	O
hospital	O
.	O

ABSTRACT	O
:	O
In	O
2012	O
,	O
a	O
new	O
SARS	O
-	O
like	O
coronavirus	B-SPEC
emerged	O
in	O
the	O
Middle	O
East	O
,	O
namely	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

ABSTRACT	O
:	O
Bats	B-SPEC
harbor	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
like	O
coronaviruses	O
(	O
SL	O
-	O
CoVs	O
)	O
from	O
which	O
the	O
causative	O
agent	O
of	O
the	O
2002	O
-	O
2003	O
SARS	O
pandemic	O
is	O
thought	O
to	O
have	O
originated	O
.	O

A	O
virus	B-SPEC
infection	O
assay	O
showed	O
that	O
rWIV1	O
-	O
ΔX	O
replicated	O
as	O
efficiently	O
as	O
rWIV1	O
in	O
Vero	O
E6	O
,	O
Calu	O
-	O
3	O
,	O
and	O
HeLa	O
-	O
hACE2	O
cells	O
.	O

Bats	B-SPEC
harbor	O
genetically	O
diverse	O
SARS	O
-	O
like	O
coronaviruses	O
(	O
SL	O
-	O
CoVs	O
),	O
and	O
some	O
of	O
them	O
have	O
the	O
potential	O
for	O
interspecies	O
transmission	O
.	O

Like	O
the	O
coronavirus	B-SPEC
2	O
'-	O
O	O
-	O
MTase	O
,	O
the	O
roniviral	O
2	O
'-	O
O	O
-	O
MTase	O
harbors	O
a	O
catalytic	O
K	O
-	O
D	O
-	O
K	O
-	O
E	O
tetrad	O
that	O
is	O
conserved	O
among	O
2	O
'-	O
O	O
-	O
MTases	O
and	O
can	O
target	O
only	O
the	O
N7	O
-	O
methylated	O
cap	O
structure	O
of	O
adenylate	O
-	O
primed	O
RNA	O
substrates	O
.	O

These	O
results	O
extend	O
our	O
current	O
understanding	O
of	O
nidovirus	B-SPEC
RNA	O
cap	O
formation	O
and	O
methylation	O
beyond	O
the	O
coronavirus	B-SPEC
family	B-SPEC
.	O

It	O
is	O
known	O
that	O
coronavirus	B-SPEC
nsp14	O
acts	O
as	O
an	O
N7	O
-(	O
guanine	O
)-	O
methyltransferase	O
(	O
MTase	O
)	O
and	O
nsp16	O
as	O
a	O
2	O
'-	O
O	O
-	O
MTase	O
,	O
which	O
are	O
involved	O
in	O
the	O
modification	O
of	O
RNA	O
cap	O
structure	O
.	O

These	O
results	O
extend	O
our	O
understanding	O
of	O
nidovirus	B-SPEC
RNA	O
capping	O
and	O
methylation	O
beyond	O
coronaviruses	O
and	O
also	O
strengthen	O
the	O
evolutionary	O
and	O
functional	O
links	O
between	O
roniviruses	O
and	O
coronaviruses	O
.	O

In	O
a	O
mouse	B-SPEC
model	O
with	O
a	O
direct	O
pulmonary	O
injection	O
,	O
PLpro	O
stimulated	O
macrophage	O
infiltration	O
into	O
lung	O
,	O
up	O
-	O
regulating	O
Egr	O
-	O
1	O
,	O
TSP	O
-	O
1	O
,	O
TGF	O
-	O
β1	O
and	O
vimentin	O
expression	O
in	O
lung	O
tissues	O
.	O

TITLE	O
:	O
Some	O
serum	O
acute	O
phase	O
proteins	O
and	O
immunoglobulins	O
concentrations	O
in	O
calves	O
with	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
F5	O
and	O
Eimeria	B-SPEC
species	B-SPEC
.	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
effect	O
of	O
andrographolide	O
sulfonate	O
,	O
a	O
water	O
-	O
soluble	O
form	O
of	O
andrographolide	O
(	O
trade	O
name	B-SPEC
:	O
Xi	O
-	O
Yan	O
-	O
Ping	O
Injection	O
),	O
on	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
ALI	O
and	O
inflammation	O
.	O

TITLE	O
:	O
Qingfei	O
Xiaoyan	O
Wan	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
formula	O
,	O
ameliorates	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
-	O
induced	O
acute	O
lung	O
inflammation	O
by	O
regulation	O
of	O
PI3K	O
/	O
AKT	O
and	O
Ras	O
/	O
MAPK	O
pathways	O
.	O

Parasitological	O
examination	O
of	O
the	O
Giemsa	O
-	O
stained	O
peripheral	O
blood	O
smear	O
of	O
these	O
two	O
patients	O
demonstrated	O
ring	O
forms	O
compatible	O
with	O
P	B-SPEC
.	I-SPEC
falciparum	I-SPEC
.	O

Significantly	O
higher	O
detection	O
rates	O
of	O
coronaviral	O
RNA	O
were	O
found	O
in	O
female	O
bats	B-SPEC
and	O
Scotophilus	B-SPEC
kuhlii	I-SPEC
roosting	O
in	O
palm	O
trees	O
.	O

The	O
results	O
showed	O
that	O
the	O
variant	O
PEDV	B-SPEC
were	O
the	O
dominant	O
pathogens	O
of	O
viral	O
diarrhea	O
diseases	O
in	O
these	O
areas	O
.	O

Six	O
novel	O
variant	O
PEDV	B-SPEC
strains	O
(	O
FJAX1	O
,	O
FJAX2	O
,	O
HeNPDS1	O
,	O
HeNPDS2	O
,	O
HeNPY3	O
,	O
and	O
HeNPY4	O
)	O
with	O
two	O
amino	O
acids	O
(	O
aa	O
)	O
deletion	O
at	O
the	O
56	O
-	O
57	O
aa	O
of	O
S	O
protein	O
were	O
identified	O
.	O

The	O
results	O
revealed	O
that	O
the	O
subgroup	O
Va	O
in	O
variant	O
PEDV	B-SPEC
group	O
were	O
the	O
dominant	O
subgroup	O
and	O
the	O
spread	O
trend	O
of	O
variant	O
PEDV	B-SPEC
strains	O
seemed	O
to	O
be	O
from	O
the	O
southeast	O
coastal	O
districts	O
to	O
other	O
coastal	O
districts	O
and	O
interior	O
districts	O
.	O

The	O
virus	B-SPEC
is	O
classified	O
in	O
genotypes	O
with	O
different	O
epidemiological	O
relevance	O
and	O
clinical	O
implications	O
.	O

Finally	O
,	O
we	O
demonstrate	O
that	O
this	O
preference	O
for	O
C	O
-	O
terminal	O
proline	O
residues	O
was	O
observed	O
in	O
Hendra	B-SPEC
virus	I-SPEC
-	O
derived	O
peptides	O
presented	O
by	O
Ptal	O
-	O
N	O
*	O
01	O
:	O
01	O
on	O
the	O
surface	O
of	O
infected	O
cells	O
.	O

Six	O
-	O
day	O
-	O
old	O
piglets	O
born	O
to	O
vaccinated	O
or	O
unvaccinated	O
sows	O
were	O
challenged	O
with	O
the	O
homogeneous	O
KNU	O
-	O
141112	O
virus	B-SPEC
.	O

Altogether	O
,	O
our	O
data	O
demonstrated	O
that	O
durable	O
lactogenic	O
immunity	O
was	O
present	O
in	O
dams	O
administrated	O
with	O
the	O
inactivated	O
vaccine	O
and	O
subsequently	O
conferred	O
critical	O
passive	O
immune	O
protection	O
to	O
their	O
own	O
litters	O
against	O
virulent	O
PEDV	B-SPEC
infection	O
.	O

After	O
excluding	O
88	O
patients	O
(	O
40	O
with	O
AE	O
-	O
COPD	O
and	O
48	O
with	O
CP	O
-	O
COPD	O
)	O
who	O
did	O
not	O
undergo	O
a	O
multiplex	O
RT	O
-	O
PCR	O
test	O
for	O
respiratory	O
viruses	B-SPEC
,	O
the	O
demographic	O
characteristics	O
,	O
identified	O
viruses	B-SPEC
,	O
and	O
clinical	O
outcomes	O
of	O
the	O
AE	O
-	O
COPD	O
and	O
CP	O
-	O
COPD	O
groups	O
were	O
compared	O
.	O

Whereas	O
serological	O
assays	O
have	O
been	O
widely	O
used	O
to	O
monitor	O
prior	O
exposure	O
to	O
the	O
virus	B-SPEC
and	O
to	O
evaluate	O
the	O
efficacy	O
of	O
novel	O
vaccine	O
candidates	O
or	O
vaccination	O
strategies	O
.	O

TITLE	O
:	O
Development	O
of	O
Medical	O
Countermeasures	O
to	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Preclinical	O
development	O
of	O
and	O
research	O
on	O
potential	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
medical	O
countermeasures	O
remain	O
preliminary	O
;	O
advancements	O
are	O
needed	O
before	O
most	O
countermeasures	O
are	O
ready	O
to	O
be	O
tested	O
in	O
human	B-SPEC
clinical	O
trials	O
.	O

Results	O
suggested	O
that	O
some	O
pathogens	O
might	O
be	O
enzootic	O
on	O
the	O
Alaska	O
Peninsula	O
(	O
e	O
.	O
g	O
.,	O
CAV	B-SPEC
and	O
CHV	O
)	O
while	O
others	O
may	O
be	O
epizootic	O
(	O
e	O
.	O
g	O
.,	O
CCV	O
,	O
N	B-SPEC
.	I-SPEC
caninum	I-SPEC
,	O
T	B-SPEC
.	I-SPEC
gondii	I-SPEC
).	O

From	O
her	O
history	O
and	O
physical	O
examination	O
,	O
she	O
was	O
found	O
to	O
be	O
suffering	O
from	O
scleroderma	B-SPEC
and	O
mild	O
interstitial	O
pneumonia	O
.	O

TITLE	O
:	O
Immune	O
evasion	O
of	O
porcine	B-SPEC
enteric	O
coronaviruses	O
and	O
viral	O
modulation	O
of	O
antiviral	O
innate	O
signaling	O
.	O

In	O
particular	O
,	O
we	O
examine	O
the	O
spike	O
protein	O
as	O
a	O
determinant	O
of	O
viral	O
tropism	O
,	O
entry	O
and	O
virulence	O
,	O
ORF3	O
and	O
its	O
association	O
with	O
cell	O
culture	O
adaptation	O
,	O
and	O
the	O
nucleocapsid	O
protein	O
and	O
its	O
potential	O
role	O
in	O
modulating	O
PEDV	B-SPEC
pathogenicity	O
.	O

In	O
2013	O
-	O
2014	O
,	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
outbreak	O
led	O
to	O
$	O
900	O
million	O
to	O
$	O
1	O
.	O
8	O
billion	O
in	O
annual	O
losses	O
to	O
US	O
swine	B-SPEC
producers	O
.	O

ABSTRACT	O
:	O
Bat	B-SPEC
species	B-SPEC
around	O
the	O
world	O
have	O
recently	O
been	O
recognized	O
as	O
major	O
reservoirs	O
of	O
several	O
zoonotic	O
viruses	B-SPEC
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
Nipah	B-SPEC
virus	I-SPEC
and	O
Hendra	B-SPEC
virus	I-SPEC
.	O

Samples	O
tested	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
negative	O
for	O
foot	B-SPEC
-	I-SPEC
and	I-SPEC
-	I-SPEC
mouth	I-SPEC
disease	I-SPEC
virus	I-SPEC
,	O
porcine	B-SPEC
delta	O
coronavirus	B-SPEC
,	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
,	O
porcine	B-SPEC
rotavirus	B-SPEC
types	O
A	O
,	O
B	O
and	O
C	O
,	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
,	O
and	O
porcine	B-SPEC
reproductive	I-SPEC
and	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
virus	I-SPEC
.	O

This	O
is	O
the	O
first	O
case	O
report	O
in	O
the	O
United	O
States	O
associating	O
SV	O
-	O
A	O
with	O
a	O
clinical	O
course	O
of	O
severe	O
but	O
transient	O
neonatal	O
morbidity	O
and	O
mortality	O
followed	O
by	O
vesicular	O
lesions	O
in	O
breeding	O
stock	O
animals	B-SPEC
.	O

Our	O
results	O
showed	O
that	O
PEDV	B-SPEC
activates	O
p38	O
MAPK	O
and	O
JNK1	O
/	O
2	O
up	O
to	O
24h	O
post	O
-	O
infection	O
,	O
whereas	O
,	O
thereafter	O
their	O
phosphorylation	O
levels	O
recede	O
to	O
baseline	O
levels	O
or	O
even	O
fall	O
below	O
them	O
.	O

The	O
EqCoV	O
S	O
protein	O
-	O
based	O
ELISA	O
could	O
be	O
used	O
effectively	O
for	O
seroepidemiologic	O
studies	O
in	O
order	B-SPEC
to	O
better	O
characterize	O
the	O
overall	O
infection	O
rate	O
of	O
EqCoV	O
in	O
various	O
horse	B-SPEC
populations	O
.	O

Through	O
this	O
study	O
,	O
we	O
obtained	O
information	O
on	O
emergency	O
nurses	O
'	O
ethical	O
problems	O
during	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
outbreak	O
and	O
identified	O
the	O
factors	O
that	O
influence	O
them	O
.	O

Three	O
factors	O
were	O
found	O
to	O
influence	O
emergency	O
nurses	O
'	O
ethical	O
problems	O
(	O
in	O
order	B-SPEC
of	O
influence	O
):	O
cognition	O
of	O
social	O
stigmatization	O
,	O
level	O
of	O
agreement	O
with	O
infection	O
control	O
measures	O
,	O
and	O
perceived	O
risk	O
.	O

Human	B-SPEC
and	O
dromedary	B-SPEC
viral	O
genomes	O
have	O
intermingled	O
,	O
indicating	O
that	O
multiple	O
camel	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
events	O
have	O
occurred	O
.	O

TITLE	O
:	O
Time	O
Course	O
of	O
MERS	O
-	O
CoV	O
Infection	O
and	O
Immunity	O
in	O
Dromedary	B-SPEC
Camels	B-SPEC
.	O

Here	O
,	O
we	O
isolated	O
seven	O
Japanese	O
PEDV	B-SPEC
strains	O
from	O
intestinal	O
tissue	O
samples	O
collected	O
in	O
2014	O
and	O
determined	O
the	O
spike	O
gene	O
sequences	O
of	O
13	O
Japanese	O
PEDV	B-SPEC
strains	O
,	O
including	O
the	O
above	O
seven	O
isolates	O
.	O

TITLE	O
:	O
A	O
Computationally	O
Designed	O
Serological	O
Assay	O
for	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
.	O

Mo	O
-	O
DCs	O
incubated	O
with	O
UV	O
-	O
PEDV	B-SPEC
produce	O
higher	O
levels	O
of	O
IL	O
-	O
12	O
and	O
INF	O
-	O
γ	O
compared	O
to	O
mock	O
-	O
infected	O
Mo	O
-	O
DCs	O
.	O

Consistent	O
with	O
these	O
results	O
,	O
there	O
is	O
an	O
enhancement	O
in	O
the	O
ability	O
of	O
porcine	B-SPEC
intestinal	O
DCs	O
to	O
activate	O
T	O
-	O
cell	O
proliferation	O
in	O
vivo	O
.	O

TITLE	O
:	O
Neurological	O
Complications	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
:	O
A	O
Report	O
of	O
Two	O
Cases	O
and	O
Review	O
of	O
the	O
Literature	O
.	O

TITLE	O
:	O
HTCC	O
:	O
Broad	O
Range	O
Inhibitor	O
of	O
Coronavirus	B-SPEC
Entry	O
.	O

TITLE	O
:	O
The	O
proteome	O
of	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
Beau	O
-	O
R	O
virion	O
.	O

It	O
was	O
thought	O
that	O
coronavirus	B-SPEC
virions	O
were	O
composed	O
of	O
three	O
major	O
viral	O
structural	O
proteins	O
until	O
investigations	O
of	O
other	O
coronaviruses	O
showed	O
that	O
the	O
virions	O
also	O
include	O
viral	O
non	O
-	O
structural	O
and	O
genus	B-SPEC
-	O
specific	O
accessory	O
proteins	O
as	O
well	O
as	O
host	O
-	O
cell	O
proteins	O
.	O

Recently	O
,	O
it	O
has	O
been	O
reported	O
that	O
the	O
N	O
-	O
terminal	O
domain	O
(	O
NTD	O
)	O
of	O
S1	O
domain	O
of	O
PEDV	B-SPEC
spike	O
protein	O
is	O
responsible	O
for	O
binding	O
to	O
the	O
5	O
-	O
N	O
-	O
acetylneuraminic	O
acid	O
(	O
Neu5Ac	O
),	O
a	O
possible	O
sugar	O
co	O
-	O
receptor	O
.	O

Through	O
a	O
combined	O
modelling	O
approach	O
,	O
we	O
estimate	O
the	O
rates	O
of	O
generation	O
of	O
cases	O
along	O
the	O
zoonotic	O
and	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
routes	O
and	O
assess	O
their	O
spatiotemporal	O
heterogeneity	O
.	O

TITLE	O
:	O
A	O
retrospective	O
comparison	O
of	O
helicopter	O
transport	O
versus	O
ground	O
transport	O
in	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
.	O

The	O
patients	O
transported	O
by	O
HEMS	O
had	O
a	O
significantly	O
faster	O
median	O
transport	O
time	O
(	O
1	O
.	O
3	O
versus	O
1	O
.	O
7	O
h	O
,	O
p	O
<	O
0	O
.	O
01	O
),	O
faster	O
time	O
to	O
meeting	O
criteria	O
for	O
severe	O
sepsis	B-SPEC
or	O
septic	O
shock	O
(	O
1	O
.	O
2	O
versus	O
2	O
.	O
9	O
h	O
,	O
p	O
<	O
0	O
.	O
01	O
),	O
a	O
higher	O
SOFA	O
score	O
(	O
9	O
versus	O
7	O
,	O
p	O
<	O
0	O
.	O
01	O
),	O
higher	O
incidence	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
38	O
versus	O
18	O
%,	O
p	O
=	O
0	O
.	O
013	O
),	O
higher	O
need	O
for	O
invasive	O
mechanical	O
ventilation	O
(	O
60	O
versus	O
41	O
%	O
p	O
=	O
0	O
.	O
014	O
),	O
higher	O
ICU	O
mortality	O
(	O
13	O
.	O
3	O
versus	O
4	O
.	O
1	O
%,	O
p	O
=	O
0	O
.	O
024	O
),	O
and	O
an	O
increased	O
hospital	O
mortality	O
(	O
17	O
versus	O
30	O
%,	O
p	O
=	O
0	O
.	O
04	O
)	O
when	O
compared	O
to	O
those	O
transported	O
by	O
ground	O
.	O

MHV3	O
-	O
induced	O
fulminant	O
hepatitis	O
in	O
WT	O
mice	B-SPEC
correlated	O
with	O
higher	O
hepatic	O
expression	O
of	O
interferon	O
-	O
β	O
,	O
interleukin	O
-	O
6	O
,	O
tumour	O
necrosis	O
factor	O
-	O
α	O
,	O
CXCL1	O
,	O
CCL2	O
,	O
CXCL10	O
and	O
alarmin	O
(	O
interleukin	O
-	O
33	O
)	O
than	O
in	O
MHV	B-SPEC
-	O
A59	O
-	O
infected	O
WT	O
mice	B-SPEC
and	O
in	O
MHV3	O
-	O
infected	O
TLR2	O
KO	O
mice	B-SPEC
.	O

Group1	O
,	O
2	O
and	O
3	O
were	O
inoculated	O
intra	O
oculo	O
-	O
nasally	O
with	O
103	O
.	O
5	O
EID50	O
of	O
Italy02	O
viruses	B-SPEC
,	O
and	O
group	O
4	O
was	O
kept	O
as	O
control	O
.	O

The	O
specific	O
histological	O
lesions	O
finding	O
in	O
all	O
infected	O
birds	B-SPEC
,	O
exhibited	O
tracheal	O
lesions	O
with	O
mucosal	O
thickening	O
,	O
hyperplasia	O
of	O
the	O
surface	O
epithelium	O
,	O
mononuclear	O
inflammatory	O
cell	O
infiltrate	O
of	O
lamina	O
propria	O
.	O

Since	O
PDCoV	O
was	O
just	O
recently	O
linked	O
with	O
clinical	O
disease	O
,	O
few	O
specific	O
antibody	O
-	O
based	O
reagents	O
were	O
available	O
to	O
assist	O
in	O
diagnosis	O
of	O
PDCoV	O
and	O
limited	O
serological	O
capabilities	O
were	O
available	O
to	O
detect	O
an	O
antibody	O
response	O
to	O
this	O
virus	B-SPEC
.	O

Both	O
ELISA	O
and	O
FMIA	O
detected	O
seroconversion	O
of	O
challenged	O
pigs	B-SPEC
between	O
8	O
-	O
14	O
days	O
post	O
-	O
infection	O
(	O
DPI	O
).	O

TITLE	O
:	O
Homology	O
-	O
Based	O
Identification	O
of	O
a	O
Mutation	O
in	O
the	O
Coronavirus	B-SPEC
RNA	O
-	O
Dependent	O
RNA	O
Polymerase	O

We	O
modeled	O
the	O
CoV	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
nsp12	O
-	O
RdRp	O
structure	O
and	O
superimposed	O
it	O
on	O
solved	O
picornaviral	O
RdRp	O
structures	O
.	O

RNA	O
viruses	B-SPEC
have	O
evolutionarily	O
fine	O
-	O
tuned	O
replication	O
fidelity	O
to	O
balance	O
requirements	O
for	O
genetic	O
stability	O
and	O
diversity	O
.	O

Importantly	O
,	O
we	O
found	O
that	O
5b	O
-	O
null	O
viruses	B-SPEC
,	O
unlike	O
wild	O
-	O
type	O
viruses	B-SPEC
,	O
induce	O
production	O
of	O
high	O
concentrations	O
of	O
type	O
I	O
interferon	O
protein	O
in	O
vitro	O
,	O
indicating	O
that	O
host	O
shutoff	O
by	O
IBV	B-SPEC
plays	O
an	O
important	O
role	O
in	O
antagonizing	O
the	O
host	O
'	O
s	O
innate	O
immune	O
response	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
accessory	O
protein	O
5b	O
of	O
IBV	B-SPEC
plays	O
a	O
crucial	O
role	O
in	O
the	O
onset	O
of	O
host	O
shutoff	O
.	O

Here	O
,	O
we	O
showed	O
that	O
induction	O
of	O
airway	O
memory	O
CD4	O
(+)	O
T	O
cells	O
specific	O
for	O
a	O
conserved	O
epitope	O
shared	O
by	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
is	O
a	O
potential	O
strategy	O
for	O
developing	O
pan	B-SPEC
-	O
coronavirus	B-SPEC
vaccines	O
.	O

The	O
conserved	O
epitope	O
was	O
also	O
recognized	O
in	O
SARS	O
-	O
CoV	O
-	O
and	O
MERS	O
-	O
CoV	O
-	O
infected	O
human	B-SPEC
leukocyte	O
antigen	O
DR2	O
and	O
DR3	O
transgenic	B-SPEC
mice	I-SPEC
,	O
indicating	O
potential	O
relevance	O
in	O
human	B-SPEC
populations	O
.	O

ABSTRACT	O
:	O
Longitudinal	O
samples	O
from	O
two	O
production	O
sites	O
were	O
used	O
to	O
(	O
1	O
)	O
describe	O
the	O
pattern	O
of	O
PEDV	B-SPEC
shedding	O
(	O
rRT	O
-	O
PCR	O
)	O
in	O
individual	O
rectal	O
swabs	O
,	O
pen	O
fecal	O
samples	O
,	O
and	O
pen	O
oral	O
fluids	O
(	O
OF	O
);	O
(	O
2	O
)	O
describe	O
the	O
kinetics	O
of	O
PEDV	B-SPEC
antibody	O
by	O
ELISA	O
(	O
IgA	O
,	O
IgG	O
)	O
testing	O
of	O
pig	B-SPEC
serum	O
and	O
pen	O
oral	O
fluid	O
samples	O
;	O
and	O
(	O
3	O
)	O
establish	O
cutoffs	O
and	O
performance	O
estimates	O
for	O
PEDV	B-SPEC
WV	O
ELISAs	O
(	O
IgA	O
,	O
IgG	O
).	O

Site	O
One	O
was	O
PEDV	B-SPEC
positive	O
;	O
Site	O
Two	O
was	O
PEDV	B-SPEC
negative	O
.	O

On	O
Site	O
One	O
,	O
pen	O
samples	O
(	O
feces	O
and	O
oral	O
fluids	O
)	O
and	O
pig	B-SPEC
samples	O
(	O
rectal	O
swabs	O
and	O
sera	O
)	O
were	O
collected	O
both	O
before	O
and	O
after	O
the	O
population	O
was	O
exposed	O
to	O
PEDV	B-SPEC
.	O

On	O
Site	O
Two	O
,	O
pen	O
oral	O
fluid	O
samples	O
and	O
individual	O
pig	B-SPEC
serum	O
samples	O
were	O
negative	O
for	O
both	O
PEDV	B-SPEC
antibody	O
and	O
nucleic	O
acid	O
.	O

RESULTS	O
:	O
On	O
Site	O
Two	O
,	O
pen	O
oral	O
fluid	O
samples	O
and	O
individual	O
pig	B-SPEC
serum	O
samples	O
were	O
negative	O
for	O
both	O
PEDV	B-SPEC
antibody	O
and	O
nucleic	O
acid	O
.	O

Comprehensive	O
information	O
on	O
neutralizing	O
activity	O
(	O
NA	O
)	O
against	O
PEDV	B-SPEC
in	O
mammary	O
secretions	O
is	O
critically	O
important	O
for	O
assessing	O
the	O
protective	O
capacity	O
of	O
sows	O
.	O

Although	O
unique	O
structural	O
features	O
of	O
the	O
blood	O
-	O
brain	O
-	O
barrier	O
(	O
BBB	O
)	O
provide	O
a	O
physical	O
and	O
physiological	O
barrier	O
,	O
a	O
number	O
of	O
neurotropic	O
viruses	B-SPEC
are	O
able	O
to	O
enter	O
the	O
CNS	O
resulting	O
in	O
a	O
variety	O
of	O
pathological	O
outcomes	O
.	O

TITLE	O
:	O
Salmonella	B-SPEC
Typhi	O
-	O
Induced	O
Septic	O
Shock	O
and	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
in	O
a	O
Previously	O
Healthy	O
Teenage	O
Patient	O
Treated	O
With	O
High	O
-	O
Dose	O
Dexamethasone	O
.	O

The	O
method	O
employed	O
six	O
specially	O
designed	O
primers	O
that	O
recognized	O
eight	O
distinct	O
regions	O
of	O
the	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
nucleocapsid	O
protein	O
gene	O
for	O
amplification	O
of	O
target	O
sequences	O
under	O
isothermal	O
conditions	O
at	O
63	O
degrees	O
C	O
for	O
1	O
h	O
Amplification	O
of	O
RT	O
-	O
LAMP	O
was	O
monitored	O
by	O
addition	O
of	O
calcein	O
before	O
amplification	O
.	O

Specificity	O
of	O
the	O
RT	O
-	O
LAMP	O
assay	O
was	O
validated	O
by	O
cross	O
-	O
reaction	O
with	O
different	O
human	B-SPEC
coronaviruses	O
,	O
norovirus	B-SPEC
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
and	O
influenza	B-SPEC
B	I-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
[	O
Sequencing	O
and	O
Serologic	O
Identification	O
of	O
S1	O
Genes	O
of	O
Infectious	O
Bronchitis	O
Viruses	B-SPEC
Isolated	O
during	O
2012	O
-	O
2013	O
in	O
Guangxi	O
Province	O
,	O
China	O
].	O

Phylogenetic	O
analyses	O
of	O
the	O
S1	O
gene	O
suggested	O
that	O
15	O
IBV	B-SPEC
isolates	O
were	O
classified	O
into	O
eight	O
genotypes	O
,	O
with	O
the	O
predominant	O
genotype	O
being	O
new	O
-	O
type	O
II	O
.	O

Our	O
study	O
provides	O
new	O
evidence	O
for	O
understanding	O
of	O
the	O
molecular	O
mechanisms	O
of	O
IBV	B-SPEC
variations	O
,	O
and	O
the	O
development	O
of	O
new	O
vaccines	O
against	O
IBVs	O
.	O

Most	O
viruses	B-SPEC
(	O
8	O
of	O
9	O
)	O
from	O
these	O
13	O
individuals	O
belonged	O
to	O
NRC	O
-	O
2015	O
.	O

Our	O
findings	O
document	O
the	O
spread	O
and	O
eventual	O
predominance	O
of	O
NRC	O
-	O
2015	O
in	O
humans	B-SPEC
in	O
Saudi	O
Arabia	O
during	O
the	O
first	O
half	O
of	O
2015	O
.	O

TITLE	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
prevents	O
lipopolysaccharide	O
-	O
induced	O
rat	B-SPEC
acute	O
lung	O
injury	O
via	O
suppressing	O
the	O
ERK1	O
/	O
2	O
and	O
NF	O
-	O
κB	O
signaling	O
pathways	O
.	O

Two	O
weeks	O
after	O
gene	O
transfer	O
,	O
animals	B-SPEC
received	O
LPS	O
(	O
7	O
.	O
5	O
mg	O
/	O
Kg	O
)	O
injection	O
alone	O
or	O
in	O
combination	O
with	O
Mas	O
receptor	O
antagonist	O
A779	O
(	O
10	O
μg	O
/	O
Kg	O
)	O
or	O
ACE2	O
inhibitor	O
MLN	O
-	O
4760	O
(	O
1	O
mg	O
/	O
Kg	O
)	O
pretreatment	O
.	O

Recent	O
efforts	O
of	O
antiviral	O
lead	O
discovery	O
for	O
RNA	O
targets	O
have	O
provided	O
drug	O
-	O
like	O
small	O
molecules	O
that	O
inhibit	O
viral	O
replication	O
and	O
include	O
inhibitors	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
),	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
),	O
severe	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
CoV	O
),	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
.	O

TITLE	O
:	O
Kidney	O
Cell	O
-	O
Adapted	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
Arkansas	O
Delmarva	O
Poultry	O
Industry	O
Vaccine	O
Confers	O
Effective	O
Protection	O
Against	O
Challenge	O
.	O

From	O
an	O
applied	O
perspective	O
,	O
the	O
CEK	O
-	O
adapted	O
IBV	B-SPEC
ArkDPI	O
-	O
derived	O
vaccine	O
is	O
an	O
improved	O
and	O
effective	O
vaccine	O
candidate	O
with	O
which	O
to	O
protect	O
chickens	B-SPEC
against	O
virulent	O
Ark	O
-	O
type	O
strains	O
.	O

Negative	O
stain	O
electron	O
microscopy	O
of	O
the	O
intestinal	O
contents	O
revealed	O
coronavirus	B-SPEC
particles	O
.	O

A	O
coronavirus	B-SPEC
was	O
isolated	O
from	O
the	O
intestine	O
of	O
chicken	B-SPEC
embryos	O
but	O
not	O
from	O
the	O
allantoic	O
sac	O
inoculated	O
with	O
the	O
intestinal	O
contents	O
of	O
the	O
broiler	O
chicks	O
.	O

In	O
contrast	O
to	O
the	O
field	O
infection	O
,	O
birds	B-SPEC
in	O
the	O
experimental	O
group	O
showed	O
clear	O
respiratory	O
signs	O
and	O
lesions	O
in	O
the	O
upper	O
respiratory	O
tract	O
.	O

Although	O
respiratory	O
viruses	B-SPEC
are	O
commonly	O
associated	O
with	O
this	O
condition	O
,	O
the	O
etiologic	O
significance	O
of	O
this	O
finding	O
remains	O
unclear	O
and	O
is	O
therefore	O
the	O
subject	O
of	O
this	O
study	O
.	O

ABSTRACT	O
:	O
We	O
have	O
recently	O
described	O
sustained	O
clinical	O
recovery	O
associated	O
with	O
dampened	O
neuroinflammation	O
and	O
remyelination	O
following	O
transplantation	O
of	O
neural	O
precursor	O
cells	O
(	O
NPCs	O
)	O
derived	O
from	O
human	B-SPEC
embryonic	O
stem	O
cells	O
(	O
hESCs	O
)	O
in	O
a	O
viral	O
model	O
of	O
the	O
human	B-SPEC
demyelinating	O
disease	O
multiple	O
sclerosis	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
continuously	O
spreading	O
and	O
causing	O
severe	O
and	O
fatal	O
acute	O
respiratory	O
disease	O
in	O
humans	B-SPEC
.	O

206	O
APE	B-SPEC
patients	O
were	O
evaluated	O
by	O
portable	O
monitoring	O
and	O
polysomnography	O
.	O

This	O
study	O
suggests	O
that	O
Euphorbia	B-SPEC
characias	I-SPEC
extracts	O
represent	O
a	O
good	O
source	O
of	O
natural	O
bioactive	O
compounds	O
which	O
could	O
be	O
useful	O
for	O
pharmaceutical	O
application	O
as	O
well	O
as	O
in	O
food	O
system	O
for	O
the	O
prevention	O
of	O
the	O
growth	O
of	O
food	O
-	O
borne	O
bacteria	B-SPEC
and	O
to	O
extend	O
the	O
shelf	O
-	O
life	O
of	O
processed	O
foods	O
.	O

Moreover	O
,	O
we	O
summarize	O
the	O
recent	O
progress	O
on	O
the	O
proteolytic	O
activation	O
of	O
PEDV	B-SPEC
S	O
proteins	O
,	O
and	O
discuss	O
factors	O
that	O
may	O
determine	O
tissue	O
tropism	O
of	O
PEDV	B-SPEC
in	O
vivo	O
.	O

While	O
,	O
at	O
first	O
,	O
it	O
appeared	O
as	O
a	O
disease	O
affecting	O
feeder	O
pigs	B-SPEC
,	O
fattening	O
-	O
and	O
adult	O
swine	B-SPEC
,	O
it	O
later	O
also	O
became	O
pathogenic	O
for	O
neonatal	O
and	O
suckling	O
pigs	B-SPEC
hereby	O
drastically	O
increasing	O
its	O
economic	O
impact	O
.	O

Isolation	O
of	O
the	O
causative	O
virus	B-SPEC
revealed	O
a	O
new	O
porcine	B-SPEC
coronavirus	B-SPEC
,	O
the	O
origin	O
of	O
which	O
has	O
never	O
been	O
clarified	O
.	O

Disease	O
patterns	O
in	O
field	O
outbreaks	O
showed	O
muchvariation	O
but	O
,	O
while	O
farm	O
related	O
factors	O
played	O
a	O
role	O
,	O
possible	O
genetic	O
variations	O
of	O
virus	B-SPEC
strains	O
in	O
Europe	O
have	O
not	O
been	O
examined	O
and	O
are	O
thus	O
unknown	O
.	O

Over	O
the	O
past	O
few	O
decades	O
new	O
zoonotic	O
infectious	O
diseases	O
of	O
humans	B-SPEC
caused	O
by	O
pathogens	O
arising	O
from	O
animal	B-SPEC
reservoirs	O
have	O
included	O
West	B-SPEC
Nile	I-SPEC
virus	I-SPEC
,	O
Yellow	B-SPEC
fever	I-SPEC
virus	I-SPEC
,	O
Ebola	B-SPEC
virus	I-SPEC
,	O
Nipah	B-SPEC
virus	I-SPEC
,	O
Lassa	O
Fever	O
virus	B-SPEC
,	O
Hanta	O
virus	B-SPEC
,	O
Dengue	O
fever	O
virus	B-SPEC
,	O
Rift	B-SPEC
Valley	I-SPEC
fever	I-SPEC
virus	I-SPEC
,	O
Crimean	B-SPEC
-	I-SPEC
Congo	I-SPEC
haemorrhagic	I-SPEC
fever	I-SPEC
virus	I-SPEC
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
highly	O
pathogenic	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
,	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
,	O
and	O
Zika	B-SPEC
virus	I-SPEC
.	O

Based	O
on	O
the	O
partial	O
S1	O
sequencing	O
,	O
27	O
IBV	B-SPEC
strains	O
originating	O
from	O
Spain	O
and	O
nine	O
from	O
Italy	O
were	O
initially	O
classified	O
as	O
being	O
closely	O
related	O
to	O
the	O
Guandong	O
/	O
Xindadi	O
(	O
XDN	O
)	O
genotype	O
.	O

TITLE	O
:	O
Identify	O
-	O
Isolate	O
-	O
Inform	O
:	O
A	O
Tool	O
for	O
Initial	O
Detection	O
and	O
Management	O
of	O
Zika	B-SPEC
Virus	I-SPEC
Patients	O
in	O
the	O
Emergency	O
Department	O
.	O

ABSTRACT	O
:	O
First	O
isolated	O
in	O
1947	O
from	O
a	O
monkey	B-SPEC
in	O
the	O
Zika	O
forest	O
in	O
Uganda	O
,	O
and	O
from	O
mosquitoes	B-SPEC
in	O
the	O
same	O
forest	O
the	O
following	O
year	O
,	O
Zika	B-SPEC
virus	I-SPEC
has	O
gained	O
international	O
attention	O
due	O
to	O
concerns	O
for	O
infection	O
in	O
pregnant	O
women	O
potentially	O
causing	O
fetal	O
microcephaly	O
.	O

More	O
than	O
one	O
million	O
people	O
have	O
been	O
infected	O
since	O
the	O
appearance	O
of	O
the	O
virus	B-SPEC
in	O
Brazil	O
in	O
2015	O
.	O

An	O
association	O
with	O
microcephaly	O
and	O
other	O
birth	O
defects	O
as	O
well	O
as	O
Guillain	O
-	O
Barre	O
Syndrome	O
has	O
led	O
to	O
a	O
World	O
Health	O
Organization	O
declaration	O
of	O
Zika	B-SPEC
virus	I-SPEC
as	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
in	O
February	O
2016	O
.	O

Emergency	O
department	O
(	O
ED	O
)	O
personnel	O
must	O
be	O
prepared	O
to	O
address	O
concerns	O
from	O
patients	O
presenting	O
with	O
symptoms	O
consistent	O
with	O
acute	O
Zika	B-SPEC
virus	I-SPEC
infection	O
,	O
especially	O
those	O
who	O
are	O
pregnant	O
or	O
planning	O
travel	O
to	O
Zika	O
-	O
endemic	O
regions	O
,	O
as	O
well	O
as	O
those	O
women	O
planning	O
to	O
become	O
pregnant	O
and	O
their	O
partners	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
identification	O
of	O
the	O
first	O
patients	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
2012	O
,	O
over	O
1	O
,	O
600	O
cases	O
have	O
been	O
reported	O
as	O
of	O
February	O
2016	O
.	O

The	O
phylogenetic	O
analyses	O
indicate	O
that	O
diversity	O
of	O
CoV	O
in	O
bats	B-SPEC
is	O
higher	O
than	O
previously	O
known	O
.	O

Scientific	O
advancements	O
since	O
the	O
2002	O
-	O
2003	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
pandemic	O
allowed	O
for	O
rapid	O
progress	O
in	O
our	O
understanding	O
of	O
the	O
epidemiology	O
and	O
pathogenesis	O
of	O
MERS	O
-	O
CoV	O
and	O
the	O
development	O
of	O
therapeutics	O
.	O

This	O
study	O
analyzed	O
a	O
large	O
collection	O
of	O
the	O
Spike	O
protein	O
coding	O
gene	O
to	O
infer	O
the	O
spatial	O
-	O
temporal	O
diffusion	O
history	O
of	O
PEDV	B-SPEC
.	O

Partial	O
nucleotide	O
sequences	O
of	O
the	O
S1	O
spike	O
gene	O
was	O
determined	O
from	O
the	O
PEDV	B-SPEC
-	O
positive	O
samples	O
and	O
compared	O
with	O
S1	O
sequences	O
from	O
other	O
countries	O
.	O

Phylogenetic	O
analysis	O
indicated	O
that	O
PEDV	B-SPEC
strains	O
in	O
the	O
Philippines	O
segregate	O
into	O
two	O
groups	O
.	O

TITLE	O
:	O
Severe	O
Acute	O
Infection	O
Due	O
to	O
Serratia	B-SPEC
marcescens	I-SPEC
Causing	O
Respiratory	O
Distress	O
in	O
An	O
Immunocompetent	O
Adult	O
.	O

In	O
this	O
study	O
,	O
the	O
full	O
-	O
length	O
genome	O
sequences	O
of	O
two	O
genetically	O
distinct	O
PEDV	B-SPEC
isolates	O
from	O
the	O
outbreaks	O
were	O
characterized	O
.	O

HSCs	O
were	O
stably	O
transduced	O
with	O
the	O
miRNA	O
-	O
expressing	O
lentivirus	B-SPEC
vector	O
that	O
produced	O
the	O
most	O
effective	O
viral	O
inhibition	O
in	O
a	O
feline	B-SPEC
cell	O
line	O
.	O

TITLE	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
in	O
adenovirus	B-SPEC
type	O
4	O
pneumonia	O
:	O
A	O
case	O
report	O
.	O

The	O
objective	O
of	O
this	O
research	O
was	O
to	O
investigate	O
the	O
prevalence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
primarily	O
in	O
dromedary	B-SPEC
camel	B-SPEC
farms	O
and	O
the	O
relationship	O
of	O
those	O
infections	O
with	O
infections	O
in	O
humans	B-SPEC
in	O
the	O
Emirate	O
of	O
Abu	O
Dhabi	O
.	O

ABSTRACT	O
:	O
Little	O
is	O
known	O
about	O
the	O
effects	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
during	O
pregnancy	O
.	O

This	O
information	O
will	O
be	O
useful	O
for	O
understanding	O
the	O
pathogenesis	O
of	O
FRCoV	O
in	O
ferrets	B-SPEC
.	O

Specificity	O
was	O
estimated	O
by	O
using	O
28	O
nasopharyngeal	O
swabs	O
that	O
were	O
positive	O
for	O
other	O
respiratory	O
viruses	B-SPEC
.	O

Exogenous	O
administration	O
of	O
corticosteroids	O
at	O
moderate	O
dose	O
,	O
i	O
.	O
e	O
.,	O
<	O
400	O
mg	O
of	O
hydrocortisone	O
or	O
equivalent	O
for	O
>	O
96	O
h	O
,	O
may	O
help	O
reversing	O
sepsis	B-SPEC
-	O
associated	O
shock	O
and	O
organ	O
dysfunction	O
.	O

Although	O
ALI	O
/	O
ARDS	O
might	O
be	O
an	O
essential	O
therapeutic	O
target	O
during	O
the	O
management	O
of	O
sepsis	B-SPEC
,	O
severe	O
sepsis	B-SPEC
should	O
be	O
treated	O
effectively	O
and	O
as	O
soon	O
as	O
identified	O
.	O

We	O
have	O
classified	O
three	O
phases	O
,	O
ranging	O
from	O
sepsis	B-SPEC
to	O
organ	O
dysfunction	O
,	O
characterizing	O
the	O
interaction	O
between	O
neutrophils	O
and	O
platelets	O
.	O

In	O
this	O
review	O
we	O
propose	O
the	O
possibility	O
that	O
IL	O
-	O
6	O
blockade	O
may	O
constitute	O
a	O
novel	O
therapeutic	O
strategy	O
for	O
other	O
types	O
of	O
cytokine	O
storm	O
,	O
such	O
as	O
the	O
systemic	O
inflammatory	O
response	O
syndrome	O
including	O
sepsis	B-SPEC
,	O
macrophage	O
activation	O
syndrome	O
and	O
hemophagocytic	O
lymphohistiocytosis	O
.	O

Here	O
,	O
we	O
review	O
the	O
strategies	O
exploited	O
by	O
coronavirus	B-SPEC
to	O
modulate	O
cellular	O
stress	O
response	O
pathways	O
.	O

However	O
,	O
the	O
molecular	O
mechanisms	O
by	O
which	O
PEDV	B-SPEC
antagonizes	O
the	O
antiviral	O
effects	O
of	O
interferon	O
have	O
not	O
been	O
fully	O
characterized	O
.	O

On	O
day	O
48	O
,	O
he	O
suddenly	O
developed	O
severe	O
abdominal	O
pain	O
with	O
free	O
air	O
,	O
observable	O
on	O
an	O
abdominal	O
X	O
-	O
ray	B-SPEC
,	O
and	O
underwent	O
emergency	O
ileocecal	O
resection	O
.	O

This	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
diagnostic	O
and	O
prognostic	O
value	O
of	O
Presepsin	O
in	O
ICU	O
patients	O
with	O
severe	O
sepsis	B-SPEC
(	O
SS	O
),	O
septic	O
shock	O
(	O
SSh	O
)	O
and	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
(	O
sCAP	O
).	O

The	O
results	O
indicated	O
the	O
virus	B-SPEC
showed	O
the	O
characters	O
of	O
inducing	O
dwarf	O
embryo	O
after	O
inocubation	O
,	O
the	O
sensibility	O
to	O
lipid	O
solvent	O
and	O
the	O
hemagglutination	O
capacity	O
after	O
pancreatic	O
enzyme	O
treatment	O
,	O
the	O
typical	O
morphology	O
of	O
coronavirus	B-SPEC
,	O
the	O
interference	O
to	O
NDV	B-SPEC
replication	O
and	O
the	O
homology	O
among	O
84	O
.	O
7	O
%	O
-	O
99	O
%	O
of	O
the	O
particial	O
N	O
gene	O
sequences	O
to	O
the	O
reference	O
IBV	B-SPEC
(	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
)	O
strains	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
enteric	O
coronaviruses	O
(	O
CoVs	O
)	O
cause	O
severe	O
disease	O
in	O
the	O
porcine	B-SPEC
herds	O
worldwide	O
,	O
leading	O
to	O
important	O
economic	O
losses	O
.	O

With	O
this	O
information	O
,	O
and	O
using	O
reverse	O
genetics	O
systems	O
,	O
it	O
is	O
possible	O
to	O
design	O
viruses	B-SPEC
with	O
modifications	O
in	O
the	O
viral	O
proteins	O
acting	O
as	O
virulence	O
factors	O
,	O
which	O
may	O
lead	O
to	O
attenuated	O
viruses	B-SPEC
and	O
,	O
therefore	O
,	O
vaccine	O
candidates	O
.	O

ABSTRACT	O
:	O
In	O
2015	O
,	O
a	O
large	O
outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
occurred	O
following	O
a	O
single	O
patient	O
exposure	O
in	O
an	O
emergency	O
room	O
at	O
the	O
Samsung	O
Medical	O
Center	O
,	O
a	O
tertiary	O
-	O
care	O
hospital	O
in	O
Seoul	O
,	O
South	O
Korea	O
.	O

ABSTRACT	O
:	O
Influenza	O
A	O
(	O
H5N1	O
)	O
virus	B-SPEC
infects	O
a	O
variety	O
of	O
animals	B-SPEC
,	O
birds	B-SPEC
and	O
humans	B-SPEC
.	O

It	O
causes	O
a	O
wide	O
spectrum	O
of	O
clinical	O
features	O
in	O
human	B-SPEC
beings	O
ranging	O
from	O
mild	O
respiratory	O
tract	O
infection	O
to	O
a	O
fatal	O
pneumonia	O
leading	O
to	O
multi	O
organ	O
system	O
failure	O
.	O

In	O
B1648	O
inoculated	O
animals	B-SPEC
,	O
10	O
(	O
2	O
.	O
7	O
-	O
6	O
.	O
8	O
)	O
viral	O
RNA	O
copies	O
/	O
100	O
mg	O
were	O
detected	O
in	O
tracheal	O
secretions	O
at	O
2	O
,	O
4	O
,	O
6	O
,	O
8	O
,	O
10	O
and	O
12	O
days	O
post	O
inoculation	O
(	O
dpi	O
),	O
10	O
(	O
2	O
.	O
4	O
-	O
4	O
.	O
5	O
)	O
viral	O
RNA	O
copies	O
/	O
mL	O
in	O
plasma	O
at	O
2	O
,	O
4	O
,	O
6	O
,	O
8	O
,	O
10	O
and	O
12	O
dpi	O
and	O
10	O
(	O
1	O
.	O
8	O
-	O
4	O
.	O
4	O
)	O
viral	O
RNA	O
copies	O
/	O
10	O
(	O
6	O
)	O
mononuclear	O
cells	O
in	O
blood	O
at	O
2	O
,	O
4	O
,	O
6	O
and	O
8	O
dpi	O
.	O

Five	O
patients	O
were	O
discharged	O
after	O
giving	O
up	O
of	O
treatment	O
by	O
parents	O
due	O
to	O
poor	O
efficacy	O
on	O
primary	O
disease	O
;	O
3	O
cases	O
were	O
transferred	O
to	O
other	O
departments	O
for	O
further	O
treatment	O
;	O
15	O
cases	O
were	O
discharged	O
with	O
a	O
feeding	O
tube	O
for	O
family	B-SPEC
nutrition	O
and	O
specialist	O
out	O
-	O
patient	O
treatment	O
.	O

TITLE	O
:	O
CONSISE	O
statement	O
on	O
the	O
reporting	O
of	O
Seroepidemiologic	O
Studies	O
for	O
influenza	O
(	O
ROSES	B-SPEC
-	O
I	O
statement	O
):	O
an	O
extension	O
of	O
the	O
STROBE	O
statement	O
.	O

The	O
extent	O
of	O
pulmonary	O
infiltration	O
observed	O
on	O
the	O
first	O
chest	O
X	O
-	O
ray	B-SPEC
and	O
the	O
diagnosis	O
of	O
invasive	O
fungal	O
infection	O
were	O
the	O
most	O
relevant	O
early	O
predictive	O
factors	O
of	O
the	O
severity	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Recently	O
,	O
the	O
American	O
Thoracic	O
Society	O
(	O
ATS	O
)	O
updated	O
the	O
concept	O
of	O
IPS	B-SPEC
and	O
extended	O
the	O
concept	O
to	O
a	O
wider	O
range	O
;	O
it	O
defined	O
IPS	B-SPEC
as	O
""""	O
an	O
idiopathic	O
syndrome	O
of	O
pneumopathy	O
after	O
HSCT	O
,	O
with	O
evidence	O
of	O
widespread	O
alveolar	O
injury	O
and	O
in	O
which	O
infectious	O
aetiologies	O
and	O
cardiac	O
dysfunction	O
,	O
acute	O
renal	O
failure	O
,	O
or	O
iatrogenic	O
fluid	O
overload	O
have	O
been	O
excluded	O
.	O

Since	O
the	O
therapeutic	O
strategies	O
for	O
IPS	B-SPEC
are	O
clearly	O
different	O
from	O
those	O
of	O
infectious	O
diseases	O
,	O
and	O
therapeutic	O
delay	O
causes	O
a	O
poor	O
prognosis	O
,	O
radiologists	O
should	O
be	O
aware	O
of	O
some	O
characteristic	O
HRCT	O
findings	O
of	O
IPS	B-SPEC
,	O
which	O
includes	O
a	O
wide	O
spectrum	O
of	O
entities	O
.	O

Coronaviruses	O
are	O
enveloped	O
viruses	B-SPEC
,	O
with	O
the	O
spike	O
proteins	O
present	O
on	O
their	O
surface	O
responsible	O
for	O
virus	B-SPEC
entry	O
into	O
the	O
target	O
cell	O
.	O

Although	O
TRPV4	O
knockout	O
mice	B-SPEC
show	O
relatively	O
mild	O
phenotypes	O
,	O
some	O
mutations	O
in	O
TRPV4	O
cause	O
severe	O
developmental	O
abnormalities	O
,	O
such	O
as	O
the	O
skeletal	O
dyplasia	O
and	O
arthropathy	O
.	O

TITLE	O
:	O
Association	O
between	O
Australian	O
Hajj	O
Pilgrims	O
'	O
awareness	O
of	O
MERS	O
-	O
CoV	O
,	O
and	O
their	O
compliance	O
with	O
preventive	O
measures	O
and	O
exposure	O
to	O
camels	B-SPEC
.	O

ABSTRACT	O
:	O
Three	O
experiments	O
were	O
conducted	O
to	O
evaluate	O
the	O
effect	O
of	O
yeast	B-SPEC
-	O
derived	O
carbohydrates	O
(	O
YDC	O
),	O
and	O
a	O
blend	O
of	O
probiotics	O
and	O
YDC	O
(	O
synbiotic	O
,	O
SNB	O
)	O
on	O
serum	O
IgG	O
concentration	O
,	O
maternal	O
-	O
derived	O
antibody	O
(	O
MDA	O
)	O
decay	O
,	O
and	O
specific	O
antibody	O
-	O
mediated	O
immune	O
response	O
in	O
chick	O
pullets	O
following	O
immunization	O
with	O
T	O
-	O
cell	O
dependent	O
antigens	O
.	O

This	O
situation	O
led	O
to	O
a	O
nationwide	O
chaos	B-SPEC
.	O

Thereafter	O
,	O
186	O
Korean	O
people	O
were	O
infected	O
with	O
the	O
MERS	O
-	O
CoV	O
in	O
a	O
short	O
time	O
through	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

Korea	O
experienced	O
an	O
outbreak	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
in	O
2015	O
,	O
which	O
was	O
characterized	O
by	O
superspreading	O
events	O
in	O
healthcare	O
settings	O
.	O

This	O
relationship	O
was	O
consistent	O
(	O
HR	O
0	O
.	O
83	O
[	O
95	O
%	O
CI	O
,	O
0	O
.	O
74	O
-	O
0	O
.	O
93	O
]	O
per	O
one	O
illness	O
day	O
increase	O
)	O
in	O
the	O
multivariable	O
analysis	O
incorporating	O
clinical	O
characteristics	O
,	O
the	O
order	B-SPEC
of	O
generation	O
,	O
and	O
a	O
link	O
to	O
superspreaders	O
.	O

Further	O
research	O
should	O
be	O
focused	O
on	O
characterizing	O
superspreaders	O
in	O
comparison	O
to	O
non	O
-	O
transmitting	O
cases	O
with	O
regard	O
to	O
environmental	O
,	O
behavioral	O
,	O
and	O
virologic	O
and	O
host	O
genetic	O
factors	O
in	O
order	B-SPEC
to	O
better	O
prepare	O
for	O
future	O
outbreaks	O
of	O
MERS	O
-	O
CoV	O
.	O
RESULTS	O
:	O
The	O
estimated	O
median	O
incubation	O
period	O
was	O
7	O
.	O
4	O
days	O
(	O
95	O
%	O
CI	O
,	O
6	O
.	O
9	O
-	O
8	O
.	O
0	O
).	O

A	O
total	O
of	O
186	O
patients	O
,	O
including	O
36	O
deaths	O
,	O
had	O
been	O
diagnosed	O
with	O
MERS	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
as	O
of	O
September	O
30th	O
,	O
2015	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
-	O
induced	O
cardiogenic	O
shock	O
in	O
combination	O
with	O
severe	O
acute	O
respiratory	O
failure	O
represents	O
a	O
life	O
-	O
threatening	O
combination	O
that	O
is	O
often	O
refractory	O
to	O
the	O
conventional	O
methods	O
of	O
treatment	O
.	O

12	O
hrs	O
after	O
DH	O
in	O
mice	B-SPEC
the	O
local	O
and	O
systemic	O
cytokines	O
and	O
chemokines	O
were	O
quantified	O
by	O
multiplex	O
bead	O
array	O
or	O
ELISA	O
,	O
activated	O
caspase	O
-	O
3	O
by	O
western	O
blot	O
.	O

Abrogation	O
of	O
the	O
latter	O
dramatically	O
decreases	O
replication	O
of	O
an	O
HEV	B-SPEC
subgenomic	O
replicon	O
.	O

Using	O
two	O
murine	B-SPEC
ALI	O
models	O
and	O
cells	O
culture	O
,	O
we	O
examined	O
the	O
presence	O
of	O
sCD74	O
in	O
circulation	O
and	O
alveolar	O
space	O
and	O
preliminarily	O
assessed	O
the	O
biological	O
function	O
of	O
sCD74	O
.	O

Several	O
clinical	O
trials	O
have	O
evaluated	O
the	O
utility	O
of	O
corticoids	O
but	O
none	O
of	O
them	O
has	O
demonstrated	O
a	O
definitive	O
benefit	O
due	O
to	O
small	O
sample	O
sizes	O
,	O
selection	O
bias	B-SPEC
,	O
patient	O
heterogeneity	O
,	O
and	O
time	O
of	O
initiation	O
of	O
treatment	O
or	O
duration	O
of	O
therapy	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
aminopeptidase	O
N	O
is	O
not	O
a	O
cellular	O
receptor	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
but	O
promotes	O
its	O
infectivity	O
via	O
aminopeptidase	O
activity	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
a	O
causative	O
agent	O
of	O
pig	B-SPEC
diarrhoea	O
,	O
has	O
recently	O
caused	O
significant	O
economic	O
damage	O
worldwide	O
.	O

In	O
contrast	O
to	O
TGEV	B-SPEC
,	O
PEDV	B-SPEC
did	O
not	O
bind	O
soluble	O
porcine	B-SPEC
aminopeptidases	O
(	O
pAPs	O
)	O
and	O
infection	O
was	O
not	O
inhibited	O
by	O
the	O
soluble	O
form	O
of	O
pAPs	O
.	O

However	O
,	O
the	O
lack	O
of	O
detailed	O
data	O
on	O
modes	O
of	O
transmission	O
from	O
the	O
animal	B-SPEC
reservoir	O
and	O
between	O
humans	B-SPEC
means	O
that	O
the	O
drivers	O
of	O
MERS	O
-	O
CoV	O
epidemics	O
remain	O
poorly	O
characterized	O
.	O

The	O
ongoing	O
exposure	O
of	O
humans	B-SPEC
to	O
MERS	O
-	O
CoV	O
from	O
the	O
reservoir	O
is	O
of	O
major	O
concern	O
,	O
given	O
the	O
continued	O
risk	O
of	O
substantial	O
outbreaks	O
in	O
health	O
care	O
systems	O
.	O

ABSTRACT	O
:	O
Viral	O
Infectious	O
clone	O
systems	O
serve	O
as	O
robust	O
platforms	O
to	O
study	O
viral	O
gene	O
or	O
replicative	O
function	O
by	O
reverse	O
genetics	O
,	O
formulate	O
vaccines	O
and	O
adapt	O
a	O
wild	O
type	O
-	O
virus	B-SPEC
to	O
an	O
animal	B-SPEC
host	O
.	O

TITLE	O
:	O
Detection	O
of	O
RSV	B-SPEC
Antibodies	O
in	O
Human	B-SPEC
Plasma	O
by	O
Enzyme	O
Immunoassays	O
.	O

The	O
outbreaks	O
of	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
and	O
the	O
continuing	O
diagnosis	O
of	O
new	O
MERS	O
cases	O
highlight	O
the	O
need	O
for	O
finding	O
therapeutics	O
for	O
these	O
diseases	O
and	O
potential	O
future	O
coronavirus	B-SPEC
outbreaks	O
.	O

The	O
MERS	O
-	O
CoV	O
spike	O
(	O
S	O
)	O
protein	O
is	O
an	O
important	O
viral	O
antigen	O
known	O
to	O
mediate	O
host	O
-	O
receptor	O
binding	O
and	O
virus	B-SPEC
entry	O
,	O
as	O
well	O
as	O
induce	O
robust	O
humoral	O
and	O
cell	O
-	O
mediated	O
responses	O
in	O
humans	B-SPEC
during	O
infection	O
.	O

This	O
inhibitory	O
effect	O
of	O
poIFN	O
-	O
λ3	O
on	O
PEDV	B-SPEC
was	O
observed	O
under	O
three	O
different	O
treatment	O
conditions	O
.	O

In	O
this	O
study	O
we	O
demonstrated	O
that	O
the	O
last	O
39	O
amino	O
acid	O
stretches	O
of	O
Alphacoronavirus	B-SPEC
spike	O
cytoplasmic	O
domains	O
of	O
the	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
,	O
NL63	O
,	O
and	O
the	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
TGEV	B-SPEC
interact	O
with	O
tubulin	O
alpha	O
and	O
beta	O
chains	O
.	O

These	O
data	O
demonstrate	O
that	O
interaction	O
of	O
Alphacoronavirus	B-SPEC
spike	O
proteins	O
with	O
tubulin	O
supports	O
S	O
protein	O
transport	O
and	O
incorporation	O
into	O
virus	B-SPEC
particles	O
.	O

TITLE	O
:	O
Viral	O
RNA	O
in	O
Blood	O
as	O
Indicator	B-SPEC
of	O
Severe	O
Outcome	O
in	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
.	O

ABSTRACT	O
:	O
We	O
evaluated	O
the	O
diagnostic	O
and	O
clinical	O
usefulness	O
of	O
blood	O
specimens	O
to	O
detect	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
21	O
patients	O
from	O
the	O
2015	O
outbreak	O
in	O
South	O
Korea	O
.	O

Rhinovirus	B-SPEC
predominated	O
in	O
December	O
(	O
54	O
%),	O
March	O
(	O
36	O
%),	O
and	O
April	O
(	O
33	O
%).	O

Influenza	B-SPEC
virus	I-SPEC
predominated	O
in	O
January	O
(	O
51	O
%).	O

TITLE	O
:	O
Update	O
on	O
Human	B-SPEC
Rhinovirus	I-SPEC
and	O
Coronavirus	B-SPEC
Infections	O
.	O

New	O
species	B-SPEC
of	O
HRVs	O
and	O
HCoVs	O
have	O
been	O
diagnosed	O
in	O
the	O
past	O
decade	O
.	O

Recent	O
identification	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
viruses	B-SPEC
causing	O
serious	O
respiratory	O
illnesses	O
has	O
led	O
to	O
renewed	O
efforts	O
for	O
vaccine	O
development	O
.	O

Infections	O
caused	O
by	O
human	B-SPEC
coronaviruses	O
(	O
hCoVs	O
)	O
are	O
mostly	O
associated	O
with	O
the	O
respiratory	O
,	O
enteric	O
,	O
and	O
nervous	O
systems	O
.	O

TITLE	O
:	O
Control	O
Measures	O
for	O
Human	B-SPEC
Respiratory	O
Viral	O
Infection	O
.	O

Spike	O
glycoprotein	O
of	O
coronavirus	B-SPEC
is	O
responsible	O
for	O
induction	O
of	O
neutralizing	O
antibody	O
response	O
.	O

A	O
high	O
H5	O
positive	O
rate	O
was	O
detected	O
in	O
environmental	B-SPEC
samples	I-SPEC
from	O
local	O
live	O
poultry	O
markets	O
.	O

TITLE	O
:	O
Molecular	O
Characterization	O
of	O
the	O
ORF3	O
and	O
S1	O
Genes	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Non	O
S	O
-	O
INDEL	O
Strains	O
in	O
Seven	O
Regions	O
of	O
China	O
,	O
2015	O
.	O

TITLE	O
:	O
Occurrence	O
and	O
sequence	O
analysis	O
of	O
porcine	B-SPEC
deltacoronaviruses	O
in	O
southern	O
China	O
.	O

Notably	O
,	O
all	O
five	O
PDCoV	O
-	O
positive	O
piglets	O
were	O
co	O
-	O
infected	O
by	O
PEDV	B-SPEC
.	O

C57BL	O
/	O
6J	O
mice	B-SPEC
underwent	O
left	O
pneumonectomy	O
.	O

A	O
total	O
of	O
23	O
Saudi	O
patients	O
with	O
severe	O
MERS	O
-	O
CoV	O
infection	O
were	O
typed	O
for	O
HLA	O
class	B-SPEC
II	O
,	O
results	O
were	O
compared	O
with	O
those	O
of	O
161	O
healthy	O
controls	O
.	O

ABSTRACT	O
:	O
Garlic	B-SPEC
is	O
a	O
plant	B-SPEC
has	O
been	O
used	O
as	O
a	O
flavor	O
,	O
and	O
anti	O
-	O
microbial	O
and	O
anti	O
-	O
diarrheal	O
agent	O
.	O

RESULTS	O
:	O
Based	O
on	O
our	O
results	O
,	O
in	O
the	O
second	O
group	O
,	O
IBV	B-SPEC
vaccine	O
strain	O
(	O
4	O
/	O
91	O
)	O
at	O
all	O
titration	O
and	O
M41	O
in	O
10	O
(-	O
2	O
)	O
and	O
10	O
(-	O
3	O
)	O
titration	O
and	O
in	O
the	O
third	O
group	O
both	O
variants	O
of	O
virus	B-SPEC
the	O
embryonic	O
Index	O
(	O
EI	O
)	O
was	O
significantly	O
increased	O
.	O

in	O
bovine	B-SPEC
feces	O
(	O
bio	O
-	O
X	O
Diagnostics	O
®,	O
Belgium	O
).	O

ABSTRACT	O
:	O
We	O
are	O
interested	O
in	O
the	O
influence	O
of	O
nucleotide	O
composition	O
on	O
the	O
fundamental	O
characteristics	O
of	O
the	O
virus	B-SPEC
RNA	O
genome	O
.	O

Most	O
RNA	O
viruses	B-SPEC
have	O
genomes	O
with	O
a	O
distinct	O
nucleotide	O
composition	O
,	O
e	O
.	O
g	O
.	O
ranging	O
from	O
minimally	O
12	O
.	O
9	O
%	O
to	O
maximally	O
40	O
.	O
3	O
%	O
(	O
C	O
-	O
and	O
U	O
-	O
count	O
,	O
respectively	O
,	O
in	O
coronavirus	B-SPEC
HKU	O
).	O

The	O
results	O
showed	O
that	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
(	O
CPIV	O
)	O
was	O
the	O
most	O
commonly	O
detected	O
CIRD	O
pathogen	O
,	O
followed	O
by	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
),	O
Bordetella	B-SPEC
bronchiseptica	I-SPEC
,	O
Mycoplasma	B-SPEC
cynos	I-SPEC
,	O
Mycoplasma	B-SPEC
canis	I-SPEC
and	O
canine	O
pneumovirus	B-SPEC
(	O
CnPnV	O
).	O

Some	O
classical	O
CIRD	O
agents	O
,	O
such	O
as	O
canine	O
adenoviruses	B-SPEC
,	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
and	O
canid	B-SPEC
herpesvirus	I-SPEC
1	I-SPEC
,	O
were	O
not	O
detected	O
at	O
all	O
,	O
as	O
were	O
not	O
other	O
emerging	O
respiratory	O
viruses	B-SPEC
(	O
canine	O
influenza	B-SPEC
virus	I-SPEC
,	O
canine	O
hepacivirus	B-SPEC
)	O
and	O
bacteria	B-SPEC
(	O
Streptococcus	O
equi	O
subsp	O
.	O

Interestingly	O
,	O
only	O
the	O
association	O
of	O
M	B-SPEC
.	I-SPEC
cynos	I-SPEC
(	O
alone	O
or	O
in	O
combination	O
with	O
either	O
CRCoV	O
or	O
M	B-SPEC
.	I-SPEC
canis	I-SPEC
)	O
with	O
severe	O
clinical	O
forms	O
was	O
statistically	O
significant	O
.	O

One	O
gene	O
of	O
dromedary	B-SPEC
viruses	B-SPEC
exists	O
in	O
two	O
versions	O
in	O
camels	B-SPEC
,	O
full	O
length	O
and	O
deleted	O
,	O
whereas	O
only	O
the	O
deleted	O
version	O
exists	O
in	O
humans	B-SPEC
.	O

However	O
,	O
inefficient	O
replication	O
in	O
several	O
mucosa	O
-	O
derived	O
cell	O
lines	O
and	O
airway	O
epithelial	O
cultures	O
suggested	O
lack	O
of	O
adaptation	O
to	O
the	O
human	B-SPEC
host	O
.	O

HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
evolution	O
provides	O
a	O
scenario	O
for	O
MERS	O
-	O
CoV	O
emergence	O
.	O

ABSTRACT	O
:	O
To	O
date	O
,	O
there	O
have	O
been	O
several	O
systematic	O
reviews	O
with	O
meta	B-SPEC
-	O
analysis	O
that	O
have	O
shown	O
no	O
reduction	O
in	O
mortality	O
with	O
the	O
use	O
of	O
inhaled	O
nitric	O
oxide	O
(	O
iNO	O
)	O
in	O
patients	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
We	O
explored	O
the	O
feasibility	O
of	O
collecting	O
convalescent	O
plasma	O
for	O
passive	O
immunotherapy	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
by	O
using	O
ELISA	O
to	O
screen	O
serum	O
samples	O
from	O
443	O
potential	O
plasma	O
donors	O
:	O
196	O
patients	O
with	O
suspected	O
or	O
laboratory	O
-	O
confirmed	O
MERS	O
-	O
CoV	O
infection	O
,	O
230	O
healthcare	O
workers	O
,	O
and	O
17	O
household	O
contacts	O
exposed	O
to	O
MERS	O
-	O
CoV	O
.	O
ELISA	O
-	O
reactive	O
samples	O
were	O
further	O
tested	O
by	O
indirect	O
fluorescent	O
antibody	O
and	O
microneutralization	O
assays	O
.	O

Several	O
neutralizing	O
human	B-SPEC
monoclonal	O
antibodies	O
(	O
mAbs	O
),	O
including	O
m336	O
,	O
a	O
germline	O
-	O
like	O
human	B-SPEC
mAb	O
,	O
have	O
been	O
chosen	O
as	O
promising	O
MCM	O
for	O
MERS	O
-	O
CoV	O
.	O
However	O
,	O
their	O
clinical	O
development	O
has	O
been	O
hindered	O
by	O
the	O
lack	O
of	O
a	O
robust	O
animal	B-SPEC
model	O
that	O
recapitulate	O
the	O
morbidity	O
and	O
mortality	O
of	O
human	B-SPEC
infections	O
.	O

We	O
assessed	O
the	O
prophylactic	O
and	O
therapeutic	O
efficacy	O
of	O
m336	O
by	O
using	O
well	O
-	O
characterized	O
transgenic	B-SPEC
mice	I-SPEC
shown	O
to	O
be	O
highly	O
sensitive	O
to	O
MERS	O
-	O
CoV	O
infection	O
and	O
disease	O
.	O

Next	O
,	O
we	O
showed	O
that	O
feline	B-SPEC
venous	O
ECs	O
become	O
activated	O
when	O
exposed	O
to	O
supernatant	O
from	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)-	O
infected	O
monocytes	O
,	O
as	O
indicated	O
by	O
increased	O
adhesion	O
molecule	O
expression	O
.	O

Syndecan	O
-	O
1	O
is	O
elevated	O
in	O
emergency	O
department	O
sepsis	B-SPEC
nonsurvivors	O
.	O

In	O
order	B-SPEC
to	O
understand	O
if	O
these	O
animals	B-SPEC
could	O
be	O
infected	O
,	O
we	O
challenged	O
young	O
goats	B-SPEC
and	O
horses	B-SPEC
and	O
adult	O
sheep	B-SPEC
with	O
MERS	O
-	O
CoV	O
by	O
intranasal	O
inoculation	O
.	O

MERS	O
is	O
caused	O
by	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
,	O
and	O
no	O
specific	O
drugs	O
or	O
vaccines	O
are	O
currently	O
available	O
to	O
prevent	O
MERS	O
-	O
CoV	O
infection	O
.	O

MERS	O
-	O
CoV	O
is	O
an	O
enveloped	O
virus	B-SPEC
,	O
and	O
its	O
envelope	O
protein	O
(	O
S	O
protein	O
)	O
mediates	O
membrane	O
fusion	O
at	O
the	O
plasma	O
membrane	O
or	O
endosomal	O
membrane	O
.	O

Here	O
,	O
we	O
developed	O
a	O
cell	O
-	O
based	O
fusion	O
assay	O
for	O
S	O
in	O
a	O
TMPRSS2	O
-	O
dependent	O
manner	O
using	O
cell	O
lines	O
expressing	O
Renilla	B-SPEC
luciferase	O
(	O
RL	O
)-	O
based	O
split	O
reporter	O
proteins	O
.	O

Herein	O
,	O
a	O
facile	O
approach	O
to	O
formulate	O
synthetic	O
virus	B-SPEC
-	O
like	O
particles	O
(	O
sVLPs	O
)	O
is	O
demonstrated	O
by	O
exploiting	O
the	O
phenomenon	O
of	O
protein	O
corona	B-SPEC
formation	O
induced	O
by	O
the	O
high	O
-	O
energy	O
surfaces	O
of	O
synthetic	O
nanoparticles	O
.	O

Furthermore	O
,	O
treatment	O
of	O
TGEV	B-SPEC
-	O
infected	O
IPEC	O
-	O
J2	O
cells	O
with	O
the	O
NF	O
-	O
κB	O
-	O
specific	O
inhibitor	O
BAY	O
11	O
-	O
7082	O
resulted	O
in	O
down	O
-	O
regulation	O
of	O
pFcRn	O
expression	O
.	O

ABSTRACT	O
:	O
In	O
cells	O
,	O
positive	O
strand	O
RNA	O
viruses	B-SPEC
,	O
such	O
as	O
Retroviridae	B-SPEC
,	O
must	O
selectively	O
recognize	O
their	O
full	O
-	O
length	O
RNA	O
genome	O
among	O
abundant	O
cellular	O
RNAs	O
to	O
assemble	O
and	O
release	O
particles	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
is	O
an	O
important	O
pathogen	O
in	O
poultry	O
worldwide	O
.	O

TITLE	O
:	O
Antagonism	O
of	O
RNase	O
L	O
Is	O
Required	O
for	O
Murine	B-SPEC
Coronavirus	I-SPEC
Replication	O
in	O
Kupffer	O
Cells	O
and	O
Liver	O
Sinusoidal	O
Endothelial	O
Cells	O
but	O
Not	O
in	O
Hepatocytes	O
.	O

ABSTRACT	O
:	O
The	O
parapoxvirus	B-SPEC
Orf	B-SPEC
virus	I-SPEC
(	O
ORFV	O
),	O
has	O
long	O
been	O
recognized	O
for	O
its	O
immunomodulatory	O
properties	O
in	O
permissive	O
and	O
non	O
-	O
permissive	O
animal	B-SPEC
species	B-SPEC
.	O

The	O
PEDV	B-SPEC
S	O
was	O
inserted	O
into	O
the	O
ORFV121	O
gene	O
locus	O
,	O
an	O
immunomodulatory	O
gene	O
that	O
inhibits	O
activation	O
of	O
the	O
NF	O
-	O
κB	O
signalling	O
pathway	O
and	O
contributes	O
to	O
ORFV	O
virulence	O
in	O
the	O
natural	O
host	O
.	O

Manifestations	O
of	O
severe	O
falciparum	O
malaria	O
included	O
hepatopathy	O
(	O
38	O
%),	O
renal	O
failure	O
(	O
28	O
%),	O
shock	O
(	O
9	O
%),	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
7	O
%),	O
hypoglycemia	O
(	O
3	O
%),	O
and	O
severe	O
anemia	B-SPEC
(	O
1	O
%).	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
produces	O
infectious	O
bronchitis	O
(	O
IB	O
)	O
disease	O
in	O
poultry	O
worldwide	O
.	O

We	O
therefore	O
performed	O
a	O
study	O
to	O
compare	O
the	O
transpulmonary	O
pressure	O
(	O
P	O
L	O
)	O
during	O
conventional	O
mechanical	O
ventilation	O
(	O
CMV	B-SPEC
)	O
and	O
different	O
levels	O
of	O
mean	O
airway	O
pressure	O
(	O
mPaw	O
)	O
during	O
HFOV	O
.	O

Lactobacillus	B-SPEC
plantarum	I-SPEC
-	O
Biocenol	O
(	O
TM	O
)	O
LP96	O
(	O
CCM	O
7512	O
),	O
Lactobacillus	B-SPEC
fermentum	I-SPEC
-	O
Biocenol	O
(	O
TM	O
)	O
LF99	O
(	O
CCM	O
7514	O
)	O
and	O
flaxseed	B-SPEC
(	O
rich	O
in	O
n	O
-	O
3	O
polyunsaturated	O
fatty	O
acids	O
)	O
were	O
administered	O
to	O
36	O
conventional	O
piglets	O
from	O
a	O
problematic	O
breed	O
with	O
confirmed	O
presence	O
of	O
enterotoxigenic	O
Escherichia	B-SPEC
coli	I-SPEC
and	O
Coronavirus	B-SPEC
.	O

©	O
2015	O
Japanese	O
Society	O
of	O
Animal	B-SPEC
Science	O
.	O

TITLE	O
:	O
Human	B-SPEC
Respiratory	O
Coronaviruses	O
Detected	O
In	O
Patients	O
with	O
Influenza	O
-	O
Like	O
Illness	O
in	O
Arkansas	O
,	O
USA	O
.	O

Samples	O
were	O
pre	O
-	O
screened	O
,	O
using	O
a	O
quantitative	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
qRT	O
-	O
PCR	O
)	O
multiprobe	O
for	O
coronavirus	B-SPEC
,	O
and	O
subjected	O
to	O
confirmatory	O
pancoronavirus	O
and	O
/	O
or	O
strain	O
-	O
specific	O
reverse	O
transcriptase	O
(	O
RT	O
)-	O
PCR	O
followed	O
by	O
sequence	O
analysis	O
.	O

Peshawari	O
birds	B-SPEC
indicated	O
higher	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
concentration	O
of	O
glucose	O
,	O
total	O
protein	O
,	O
albumin	O
,	O
uric	O
acid	O
,	O
creatinine	O
,	O
and	O
titers	O
to	O
NDV	B-SPEC
and	O
IBV	B-SPEC
.	O

Birds	B-SPEC
of	O
LK	O
and	O
SN	O
varieties	O
also	O
indicated	O
maximum	O
antibody	O
titer	O
against	O
NDV	B-SPEC
and	O
IBV	B-SPEC
,	O
respectively	O
.	O

The	O
results	O
highlight	O
that	O
CF	O
rearing	O
system	O
expediently	O
affects	O
glucose	O
and	O
total	O
protein	O
levels	O
in	O
birds	B-SPEC
;	O
SI	O
and	O
FR	O
confer	O
maximum	O
antibody	O
titers	O
to	O
NDV	B-SPEC
and	O
IBV	B-SPEC
.	O

Birds	B-SPEC
of	O
PW	O
variety	O
indicated	O
higher	O
glucose	O
,	O
total	O
protein	O
,	O
albumin	O
,	O
uric	O
acid	O
,	O
and	O
creatinine	O
,	O
the	O
lowest	O
cholesterol	O
under	O
FR	O
and	O
the	O
enhanced	O
antibody	O
titer	O
against	O
NDV	B-SPEC
and	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
mucosal	O
immune	O
response	O
against	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
very	O
important	O
in	O
piglets	O
.	O

We	O
demonstrated	O
that	O
whole	O
recombinant	O
yeast	B-SPEC
can	O
be	O
used	O
as	O
a	O
PEDV	B-SPEC
vaccine	O
vector	O
for	O
inducing	O
high	O
levels	O
of	O
IgA	O
against	O
PEDV	B-SPEC
in	O
piglets	O
.	O

This	O
could	O
be	O
a	O
good	O
vaccine	O
candidate	O
for	O
PEDV	B-SPEC
control	O
in	O
piglets	O
.	O

TITLE	O
:	O
Epidemiological	O
survey	O
of	O
enteric	O
viruses	B-SPEC
in	O
wild	B-SPEC
boars	I-SPEC
in	O
the	O
Czech	O
Republic	O
:	O
First	O
evidence	O
of	O
close	O
relationship	O
between	O
wild	B-SPEC
boar	I-SPEC
and	O
human	B-SPEC
rotavirus	B-SPEC
A	I-SPEC
strains	O
.	O

In	O
this	O
study	O
,	O
21	O
-	O
day	O
-	O
old	O
commercial	O
laying	O
hens	O
were	O
infected	O
with	O
IBV	B-SPEC
strain	O
YN	O
.	O

IBV	B-SPEC
strain	O
YN	O
infection	O
caused	O
a	O
death	O
rate	O
of	O
40	O
.	O
5	O
%.	O

In	O
order	B-SPEC
to	O
prevent	O
global	O
outbreaks	O
such	O
as	O
the	O
one	O
seen	O
in	O
South	O
Korea	O
,	O
it	O
is	O
critical	O
for	O
high	O
-	O
risk	O
countries	O
to	O
be	O
prepared	O
and	O
have	O
appropriate	O
screening	O
and	O
triage	O
protocols	O
in	O
place	O
to	O
identify	O
travel	O
-	O
related	O
cases	O
of	O
MERS	O
-	O
CoV	O
.	O
The	O
results	O
from	O
the	O
model	O
can	O
be	O
used	O
by	O
countries	O
to	O
prioritize	O
their	O
airport	O
and	O
hospital	O
screening	O
and	O
triage	O
protocols	O
.	O

A	O
deletion	O
at	O
position	O
63	O
and	O
an	O
I69A	O
/	O
S	O
substitution	O
mutation	O
associated	O
with	O
virus	B-SPEC
tropism	O
were	O
detected	O
in	O
the	O
receptor	O
-	O
binding	O
sites	O
.	O

Our	O
data	O
suggest	O
that	O
both	O
mutation	O
and	O
recombination	O
may	O
be	O
contributing	O
to	O
the	O
emergence	O
of	O
IBV	B-SPEC
variants	O
.	O

Acute	O
encephalomyelitis	O
and	O
immune	O
-	O
mediated	O
demyelination	O
were	O
induced	O
by	O
intracranial	O
injection	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
into	O
C57BL	O
/	O
6	O
miR	O
-	O
155	O
(+/+)	O
wildtype	O
(	O
WT	O
)	O
mice	B-SPEC
or	O
miR	O
-	O
155	O
(-/-)	O
mice	B-SPEC
.	O

Both	O
IFN	O
-	O
γ	O
secretion	O
and	O
trafficking	O
were	O
impaired	O
in	O
miR	O
-	O
155	O
(-/-)	O
,	O
virus	B-SPEC
-	O
specific	O
CD4	O
(+)	O
T	O
cells	O
;	O
however	O
,	O
expression	O
of	O
the	O
chemokine	O
homing	O
receptors	O
analyzed	O
on	O
CD4	O
(+)	O
cells	O
was	O
not	O
affected	O
.	O

TITLE	O
:	O
Multivariable	O
fractional	O
polynomial	O
interaction	O
to	O
investigate	O
continuous	O
effect	O
modifiers	O
in	O
a	O
meta	B-SPEC
-	O
analysis	O
on	O
higher	O
versus	O
lower	O
PEEP	O
for	O
patients	O
with	O
ARDS	O
.	O

Pools	O
of	O
trachea	B-SPEC
,	O
lungs	O
,	O
reproductive	O
tract	O
,	O
kidneys	O
,	O
and	O
enteric	O
contents	O
from	O
quail	O
and	O
laying	O
hens	O
kept	O
in	O
the	O
same	O
farms	O
and	O
from	O
quail	O
-	O
only	O
farms	O
as	O
well	O
as	O
from	O
both	O
healthy	O
birds	B-SPEC
and	O
those	O
showing	O
infectious	O
bronchitis	O
-	O
like	O
symptoms	O
were	O
sampled	O
in	O
this	O
study	O
.	O

The	O
samples	O
were	O
screened	O
using	O
nested	O
RT	O
-	O
PCR	O
targeting	O
the	O
3	O
'-	O
untranslated	O
region	O
of	O
the	O
Gammacoronavirus	B-SPEC
genus	B-SPEC
.	O

These	O
results	O
suggest	O
that	O
quail	O
are	O
susceptible	O
to	O
Gammacoronavirus	B-SPEC
and	O
Deltacoronavirus	O
viruses	B-SPEC
and	O
indicate	O
that	O
the	O
Massachusetts	O
vaccination	O
was	O
not	O
controlling	O
IBV	B-SPEC
in	O
quail	O
or	O
chickens	B-SPEC
.	O

Infants	O
with	O
DS	O
showed	O
a	O
higher	O
rate	O
of	O
hospitalization	O
due	O
to	O
acute	O
lower	O
respiratory	O
tract	O
infection	O
and	O
RSV	B-SPEC
infection	O
compared	O
to	O
non	O
-	O
DS	O
infants	O
.	O

TITLE	O
:	O
Glycan	O
shield	O
and	O
epitope	O
masking	O
of	O
a	O
coronavirus	B-SPEC
spike	O
protein	O
observed	O
by	O
cryo	O
-	O
electron	O
microscopy	O
.	O

Bat	B-SPEC
-	O
borne	O
viruses	B-SPEC
have	O
become	O
serious	O
concern	O
world	O
-	O
wide	O
.	O

A	O
Survey	O
of	O
bats	B-SPEC
for	O
novel	O
viruses	B-SPEC
in	O
this	O
region	O
would	O
help	O
in	O
recognizing	O
emerging	O
viruses	B-SPEC
and	O
combating	O
diseases	O
caused	O
by	O
them	O
.	O

ABSTRACT	O
:	O
During	O
a	O
severe	O
outbreak	O
of	O
diarrhoea	O
and	O
vomiting	O
in	O
a	O
pig	B-SPEC
herd	O
in	O
Central	O
Eastern	O
Europe	O
,	O
faecal	O
samples	O
were	O
tested	O
positive	O
for	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
negative	O
for	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
using	O
a	O
commercial	O
RT	O
-	O
qPCR	O
assay	O
that	O
can	O
detect	O
both	O
of	O
these	O
coronaviruses	O
.	O

A	O
closely	O
related	O
virus	B-SPEC
was	O
detected	O
in	O
archived	O
samples	O
in	O
Germany	O
from	O
2012	O
,	O
but	O
has	O
not	O
been	O
detected	O
subsequently	O
.	O

ABSTRACT	O
:	O
Sequencing	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
spike	O
genes	O
re	O
-	O
isolated	O
from	O
vaccinated	O
chicks	O
revealed	O
that	O
many	O
sequence	O
changes	O
are	O
found	O
on	O
the	O
S1	O
spike	O
gene	O
.	O

Furthermore	O
,	O
commercial	O
poultry	O
farm	O
owners	O
have	O
become	O
concerned	O
about	O
the	O
risk	O
represented	O
by	O
contagious	O
avian	B-SPEC
diseases	O
that	O
nearby	O
backyard	O
poultry	O
could	O
transmit	O
.	O

Despite	O
publication	O
of	O
the	O
MIQE	O
(	O
Minimum	O
Information	O
for	O
Publication	O
of	O
Quantitative	O
Real	O
-	O
Time	O
PCR	O
Experiments	O
)	O
guidelines	O
in	O
2009	O
,	O
single	O
un	O
-	O
tested	O
reference	O
genes	O
are	O
often	O
used	O
for	O
normalization	O
of	O
qPCR	O
assays	O
in	O
avian	B-SPEC
research	O
studies	O
.	O

Here	O
,	O
we	O
use	O
the	O
geNorm	O
algorithm	O
to	O
identify	O
suitable	O
reference	O
genes	O
in	O
different	O
avian	B-SPEC
cell	O
types	O
during	O
infection	O
with	O
apathogenic	O
and	O
pathogenic	O
strains	O
of	O
IBV	B-SPEC
.	O

A	O
subacute	O
cardiac	O
catheterization	O
showed	O
no	O
signs	O
of	O
significant	O
coronary	O
stenosis	B-SPEC
.	O

Evidence	O
of	O
antibody	O
-	O
dependent	O
enhancement	O
(	O
ADE	O
)	O
of	O
SARS	O
-	O
CoV	O
infection	O
in	O
vitro	O
and	O
in	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
clouds	O
the	O
prospects	O
for	O
a	O
safe	O
vaccine	O
.	O

The	O
two	O
multiplex	O
PCR	O
assays	O
were	O
then	O
validated	O
on	O
102	O
respiratory	O
samples	O
collected	O
from	O
51	O
dogs	B-SPEC
with	O
respiratory	O
illness	O
by	O
sensitivity	O
and	O
specificity	O
determination	O
in	O
comparison	O
to	O
conventional	O
simplex	O
PCR	O
and	O
a	O
rapid	O
three	O
-	O
antigen	O
test	O
kit	O
.	O

TITLE	O
:	O
Biochemical	O
Characterization	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Helicase	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
helicase	O
is	O
a	O
superfamily	B-SPEC
1	O
helicase	O
containing	O
seven	O
conserved	O
motifs	O
.	O

Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
discovered	O
in	O
2012	O
and	O
is	O
responsible	O
for	O
acute	O
respiratory	O
syndrome	O
in	O
humans	B-SPEC
in	O
the	O
Middle	O
East	O
,	O
Europe	O
,	O
North	O
Africa	O
,	O
and	O
the	O
United	O
States	O
of	O
America	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
nucleoprotein	O
contributes	O
to	O
HMGB1	O
transcription	O
and	O
release	O
by	O
interacting	O
with	O
C	O
/	O
EBP	O
-	O
β	O
.	O

Our	O
studies	O
demonstrated	O
that	O
PEDV	B-SPEC
infection	O
resulted	O
in	O
the	O
up	O
-	O
regulation	O
of	O
proinflammatory	O
cytokines	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O
member	O
of	O
the	O
genus	B-SPEC
Alphacoronavirus	B-SPEC
,	O
in	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
,	O
of	O
the	O
Nidovirales	B-SPEC
order	B-SPEC
and	O
outbreaks	O
of	O
porcine	B-SPEC
epidemic	O
diarrhoea	O
(	O
PED	O
)	O
were	O
first	O
recorded	O
in	O
England	O
in	O
the	O
1970s	O
.	O

While	O
a	O
new	O
analysis	O
of	O
PEDV	B-SPEC
genomes	O
demonstrates	O
a	O
wider	O
heterogeneity	O
of	O
PEDV	B-SPEC
than	O
previously	O
anticipated	O
with	O
at	O
least	O
five	O
rather	O
than	O
two	O
genotypes	O
,	O
biological	O
features	O
of	O
the	O
virus	B-SPEC
and	O
its	O
replication	O
also	O
point	O
towards	O
credible	O
control	O
strategies	O
to	O
limit	O
the	O
impact	O
of	O
this	O
re	O
-	O
emerging	O
virus	B-SPEC
.	O

Here	O
,	O
we	O
detected	O
coronavirus	B-SPEC
sequences	O
in	O
next	O
-	O
generation	O
sequence	O
data	O
created	O
from	O
Eonycteris	B-SPEC
spelaea	I-SPEC
faeces	O
and	O
urine	O
.	O

The	O
addition	O
of	O
sequence	O
data	O
from	O
this	O
group	O
of	O
viruses	B-SPEC
will	O
allow	O
us	O
to	O
better	O
understand	O
coronavirus	B-SPEC
evolution	O
and	O
host	O
specificity	O
.	O

Majority	O
of	O
these	O
viruses	B-SPEC
have	O
not	O
been	O
isolated	O
and	O
there	O
is	O
little	O
information	O
regarding	O
their	O
biology	O
in	O
bats	B-SPEC
.	O

Here	O
we	O
describe	O
a	O
method	O
to	O
establish	O
and	O
immortalize	O
big	B-SPEC
brown	I-SPEC
bat	I-SPEC
(	O
Eptesicus	B-SPEC
fuscus	I-SPEC
)	O
kidney	O
(	O
Efk3	O
)	O
cells	O
using	O
the	O
Myotis	B-SPEC
polyomavirus	B-SPEC
T	O
-	O
antigen	O
.	O

In	O
this	O
paper	O
,	O
we	O
apply	O
two	O
data	O
mining	O
techniques	O
in	O
order	B-SPEC
to	O
better	O
understand	O
the	O
stability	O
and	O
the	O
possibility	O
of	O
recovery	O
from	O
MERS	O
-	O
CoV	O
infections	O
.	O

TITLE	O
:	O
Understanding	O
bat	B-SPEC
SARS	O
-	O
like	O
coronaviruses	O
for	O
the	O
preparation	O
of	O
future	O
coronavirus	B-SPEC
outbreaks	O
-	O
Implications	O
for	O
coronavirus	B-SPEC
vaccine	O
development	O
.	O

We	O
made	O
analog	O
comparison	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
and	O
chikungunya	B-SPEC
virus	I-SPEC
in	O
terms	O
of	O
DNA	O
mutation	O
and	O
global	O
movement	O
to	O
provide	O
further	O
research	O
recommendation	O
.	O

There	O
are	O
some	O
evidence	O
available	O
through	O
mice	B-SPEC
models	O
and	O
direct	O
isolation	O
of	O
ZIKV	O
in	O
affected	O
pregnancies	O
on	O
kindly	O
causal	O
relationship	O
but	O
not	O
convincible	O
enough	O
.	O

The	O
2	O
other	O
animals	B-SPEC
were	O
treated	O
with	O
THAM	O
but	O
without	O
hemofiltration	O
.	O

During	O
gliatropic	O
coronavirus	B-SPEC
induced	O
encephalomyelitis	O
,	O
accumulation	O
of	O
protective	O
antibody	O
secreting	O
cells	O
is	O
preceded	O
by	O
infiltration	O
of	O
B	O
cells	O
with	O
a	O
naïve	O
and	O
early	O
differentiation	O
phenotype	O
(	O
Phares	O
et	O
al	O
.,	O
2014	O
).	O

TITLE	O
:	O
The	O
effect	O
of	O
inhibition	O
of	O
PP1	O
and	O
TNFα	O
signaling	O
on	O
pathogenesis	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

RESULTS	O
:	O
We	O
validated	O
our	O
predictions	O
in	O
18	O
different	O
knockout	O
(	O
KO	O
)	O
mouse	B-SPEC
strains	O
,	O
showing	O
that	O
network	O
topology	O
provides	O
significant	O
predictive	O
power	O
to	O
identify	O
genes	O
that	O
are	O
important	O
for	O
viral	O
infection	O
.	O

Recent	O
technological	O
developments	O
in	O
single	O
particle	O
cryo	O
-	O
electron	O
microscopy	O
allowed	O
us	O
to	O
determine	O
the	O
first	O
structure	O
of	O
a	O
coronavirus	B-SPEC
S	O
glycoprotein	O
trimer	O
which	O
provided	O
a	O
framework	O
to	O
understand	O
the	O
mechanisms	O
of	O
viral	O
entry	O
and	O
suggested	O
potential	O
inhibition	O
strategies	O
for	O
this	O
family	B-SPEC
of	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Respiratory	O
viruses	B-SPEC
and	O
influenza	O
-	O
like	O
illness	O
:	O
Epidemiology	O
and	O
outcomes	O
in	O
children	O
aged	O
6	O
months	O
to	O
10	O
years	O
in	O
a	O
multi	O
-	O
country	O
population	O
sample	O
.	O

RESULTS	O
The	O
PCR	O
cycle	O
threshold	O
(	O
Ct	O
)	O
decreased	O
by	O
approximately	O
10	O
when	O
PEDV	B-SPEC
was	O
added	O
to	O
feed	O
,	O
compared	O
with	O
results	O
for	O
equivalent	O
PEDV	B-SPEC
diluted	O
in	O
tissue	O
culture	O
medium	O
.	O

Overall	O
,	O
results	O
indicated	O
5	O
.	O
6	O
×	O
10	O
(	O
1	O
)	O
TCID50	O
/	O
g	O
was	O
the	O
minimum	O
PEDV	B-SPEC
dose	O
in	O
feed	O
that	O
can	O
lead	O
to	O
infection	O
in	O
10	O
-	O
day	O
-	O
old	O
pigs	B-SPEC
under	O
the	O
conditions	O
of	O
this	O
study	O
.	O

TITLE	O
:	O
SURVEILLANCE	O
FOR	O
VIRAL	O
AND	O
PARASITIC	O
PATHOGENS	O
IN	O
A	O
VULNERABLE	O
AFRICAN	O
LION	B-SPEC
(	O
PANTHERA	B-SPEC
LEO	I-SPEC
)	O
POPULATION	O
IN	O
THE	O
NORTHERN	O
TULI	O
GAME	O
RESERVE	O
,	O
BOTSWANA	O
.	O

ABSTRACT	O
:	O
African	O
lion	B-SPEC
(	O
Panthera	B-SPEC
leo	I-SPEC
)	O
numbers	O
are	O
decreasing	O
rapidly	O
and	O
populations	O
are	O
becoming	O
smaller	O
and	O
more	O
fragmented	O
.	O

including	O
several	O
genetic	O
variants	O
of	O
Babesia	B-SPEC
felis	I-SPEC
,	O
Babesia	B-SPEC
lengau	I-SPEC
,	O
and	O
Babesia	B-SPEC
canis	I-SPEC
and	O
a	O
group	O
of	O
novel	O
Babesia	B-SPEC
sequences	O
which	O
were	O
only	O
96	O
%	O
similar	O
to	O
other	O
Babesia	B-SPEC
spp	O
.	O

This	O
allowed	O
demonstrating	O
,	O
by	O
accomplishing	O
all	O
Hill	O
'	O
s	O
criteria	O
for	O
causation	O
,	O
the	O
cause	O
-	O
effect	O
relationship	O
between	O
the	O
vaccine	O
administration	O
/	O
withdrawal	O
and	O
the	O
variation	O
in	O
viral	O
population	O
dynamics	O
and	O
,	O
above	O
all	O
,	O
IBV	B-SPEC
related	O
outbreaks	O
.	O

TITLE	O
:	O
The	O
evidence	O
of	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
induced	O
nonsuppurative	O
encephalitis	O
as	O
the	O
cause	O
of	O
death	O
in	O
piglets	O
.	O

Furthmore	O
,	O
PHEV	O
-	O
positive	O
labeling	O
of	O
neurons	O
in	O
cortices	O
of	O
dead	O
piglets	O
and	O
infected	O
mice	B-SPEC
supported	O
the	O
viral	O
infections	O
of	O
the	O
nervous	O
system	O
.	O

These	O
findings	O
suggested	O
that	O
the	O
virus	B-SPEC
had	O
a	O
strong	O
tropism	O
for	O
CNS	O
,	O
in	O
this	O
way	O
,	O
inducing	O
nonsuppurative	O
encephalitis	O
as	O
the	O
cause	O
of	O
death	O
in	O
piglets	O
.	O

Although	O
the	O
virus	B-SPEC
is	O
similar	O
to	O
Rousettus	B-SPEC
bat	I-SPEC
coronavirus	I-SPEC
HKU9	I-SPEC
(	O
Ro	O
-	O
BatCoV	O
HKU9	O
)	O
in	O
genome	O
characteristics	O
,	O
it	O
is	O
sufficiently	O
distinct	O
to	O
be	O
classified	O
as	O
a	O
new	O
species	B-SPEC
according	O
to	O
the	O
criteria	O
defined	O
by	O
the	O
International	O
Committee	O
of	O
Taxonomy	O
of	O
Viruses	B-SPEC
(	O
ICTV	O
).	O

More	O
striking	O
was	O
that	O
Ro	O
-	O
BatCoV	O
GCCDC1	O
contained	O
a	O
unique	O
gene	O
integrated	O
into	O
the	O
3	O
'-	O
end	O
of	O
the	O
genome	O
that	O
has	O
no	O
homologs	O
in	O
any	O
known	O
coronavirus	B-SPEC
,	O
but	O
which	O
sequence	O
and	O
phylogeny	O
analyses	O
indicated	O
most	O
likely	O
originated	O
from	O
the	O
p10	O
gene	O
of	O
a	O
bat	B-SPEC
orthoreovirus	B-SPEC
.	O

This	O
study	O
was	O
conducted	O
to	O
investigate	O
the	O
existence	O
of	O
enteric	O
viruses	B-SPEC
in	O
two	O
Egyptian	O
farms	O
with	O
a	O
history	O
of	O
recurrent	O
diarrhea	O
.	O

Overall	O
,	O
76	O
%	O
(	O
19	O
/	O
25	O
)	O
of	O
samples	O
tested	O
positive	O
for	O
one	O
or	O
more	O
viruses	B-SPEC
.	O

The	O
present	O
study	O
provides	O
the	O
first	O
description	O
of	O
two	O
monoclonal	O
antibodies	O
(	O
mAbs	O
)	O
(	O
5E8	O
and	O
3D7	O
)	O
directed	O
against	O
the	O
TGEV	B-SPEC
N	O
protein	O
linker	O
region	O
(	O
LKR	O
)	O
and	O
carboxyl	O
terminal	O
domain	O
(	O
CTD	O
).	O

The	O
mAb	O
5E8	O
can	O
be	O
applied	O
for	O
different	O
approaches	O
to	O
diagnosis	O
of	O
TGEV	B-SPEC
infection	O
.	O

The	O
results	O
also	O
showed	O
that	O
from	O
0	O
to	O
12h	O
after	O
TGEV	B-SPEC
infection	O
of	O
porcine	B-SPEC
IECs	O
,	O
the	O
intracellular	O
viral	O
RNA	O
content	O
did	O
not	O
change	O
significantly	O
.	O

A	O
respiratory	O
or	O
enteric	O
virus	B-SPEC
was	O
detected	O
in	O
72	O
.	O
9	O
%	O
of	O
children	O
with	O
febrile	O
seizures	O
and	O
in	O
51	O
.	O
4	O
%	O
of	O
healthy	O
controls	O
.	O

The	O
viruses	B-SPEC
most	O
strongly	O
associated	O
with	O
febrile	O
seizures	O
were	O
influenza	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
parainfluenza	O
,	O
human	B-SPEC
coronavirus	I-SPEC
,	O
and	O
rotavirus	B-SPEC
.	O

TITLE	O
:	O
Tissue	O
localization	O
,	O
shedding	O
,	O
virus	B-SPEC
carriage	O
,	O
antibody	O
response	O
,	O
and	O
aerosol	O
transmission	O
of	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
following	O
inoculation	O
of	O
4	O
-	O
week	O
-	O
old	O
feeder	O
pigs	B-SPEC
.	O

Shedding	O
occurred	O
primarily	O
during	O
the	O
first	O
2	O
weeks	O
postinoculation	O
,	O
peaking	O
at	O
5	O
-	O
6	O
dpi	O
;	O
however	O
,	O
some	O
pigs	B-SPEC
had	O
PEDV	B-SPEC
nucleic	O
acid	O
detected	O
in	O
swabs	O
collected	O
at	O
21	O
and	O
28	O
dpi	O
.	O

TITLE	O
:	O
Increase	O
in	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
Cases	O
in	O
Saudi	O
Arabia	O
Linked	O
to	O
Hospital	O
Outbreak	O
With	O
Continued	O
Circulation	O
of	O
Recombinant	O
Virus	B-SPEC
,	O
July	O
1	O
-	O
August	O
31	O
,	O
2015	O
.	O

TITLE	O
:	O
The	O
Emulsified	O
PFC	O
Oxycyte	O
ABSTRACT	O
:	O
Perfluorocarbons	O
(	O
PFCs	O
)	O
can	O
transport	O
50	O
times	O
more	O
oxygen	O
than	O
human	B-SPEC
plasma	O
.	O

Infants	O
less	O
than	O
6	O
months	O
old	O
with	O
RSV	B-SPEC
ALRI	O
tend	O
to	O
be	O
afebrile	O
at	O
presentation	O
.	O

TITLE	O
:	O
Constitutively	O
Expressed	O
IFITM3	O
Protein	O
in	O
Human	B-SPEC
Endothelial	O
Cells	O
Poses	O
an	O
Early	O
Infection	O
Block	O
to	O
Human	B-SPEC
Influenza	B-SPEC
Viruses	I-SPEC
.	O

ABSTRACT	O
:	O
A	O
role	O
for	O
pulmonary	O
endothelial	O
cells	O
in	O
the	O
orchestration	O
of	O
cytokine	O
production	O
and	O
leukocyte	O
recruitment	O
during	O
influenza	B-SPEC
virus	I-SPEC
infection	O
,	O
leading	O
to	O
severe	O
lung	O
damage	O
,	O
has	O
been	O
recently	O
identified	O
.	O

IFITM3	O
knockdown	O
by	O
small	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
could	O
partially	O
rescue	O
H1N1	O
virus	B-SPEC
infection	O
in	O
HULEC	O
,	O
suggesting	O
IFITM3	O
proteins	O
were	O
involved	O
in	O
blocking	O
human	B-SPEC
influenza	B-SPEC
virus	I-SPEC
infection	O
in	O
endothelial	O
cells	O
.	O

Collectively	O
,	O
our	O
study	O
demonstrates	O
that	O
the	O
human	B-SPEC
pulmonary	O
endothelium	O
possesses	O
intrinsic	O
immunity	O
to	O
human	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
,	O
in	O
part	O
due	O
to	O
the	O
constitutive	O
expression	O
of	O
IFITM3	O
proteins	O
.	O

Although	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
and	O
progressive	O
pulmonary	O
endothelial	O
damage	O
are	O
known	O
to	O
be	O
present	O
during	O
severe	O
human	B-SPEC
infections	O
,	O
the	O
role	O
of	O
pulmonary	O
endothelial	O
cells	O
in	O
the	O
pathogenesis	O
of	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
infections	O
is	O
largely	O
unknown	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
cis	B-SPEC
-	O
Acting	O
RNA	O
Elements	O
.	O

Coronavirus	B-SPEC
protein	O
synthesis	O
not	O
only	O
involves	O
cap	O
-	O
dependent	O
translation	O
mechanisms	O
but	O
also	O
employs	O
regulatory	O
mechanisms	O
,	O
such	O
as	O
ribosomal	O
frameshifting	O
.	O

We	O
discuss	O
the	O
recent	O
progress	O
in	O
the	O
development	O
of	O
FCoV	O
reverse	O
genetics	O
systems	O
suitable	O
to	O
generate	O
recombinant	O
field	O
viruses	B-SPEC
containing	O
appropriate	O
mutations	O
for	O
in	O
vivo	O
studies	O
.	O

The	O
chapter	O
summarizes	O
the	O
recent	O
progress	O
in	O
the	O
development	O
of	O
coronavirus	B-SPEC
(	O
CoV	B-SPEC
)	O
vaccines	O
,	O
focusing	O
on	O
two	O
zoonotic	O
CoVs	O
,	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	B-SPEC
(	O
SARS	O
-	O
CoV	B-SPEC
),	O
and	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	B-SPEC
,	O
both	O
of	O
which	O
cause	O
deadly	O
disease	O
and	O
epidemics	O
in	O
humans	B-SPEC
.	O

The	O
development	O
of	O
attenuated	O
virus	B-SPEC
vaccines	O
to	O
combat	O
infections	O
caused	O
by	O
highly	O
pathogenic	O
CoVs	O
was	O
largely	O
based	O
on	O
the	O
identification	O
and	O
characterization	O
of	O
viral	O
virulence	O
proteins	O
that	O
,	O
for	O
example	O
,	O
interfere	O
with	O
the	O
innate	O
and	O
adaptive	O
immune	O
response	O
or	O
are	O
involved	O
in	O
interactions	O
with	O
specific	O
cell	O
types	O
,	O
such	O
as	O
macrophages	O
,	O
dendritic	O
and	O
epithelial	O
cells	O
,	O
and	O
T	O
lymphocytes	O
,	O
thereby	O
modulating	O
antiviral	O
host	O
responses	O
and	O
viral	O
pathogenesis	O
and	O
potentially	O
resulting	O
in	O
deleterious	O
side	O
effects	O
following	O
vaccination	O
.	O

Using	O
this	O
new	O
structural	O
insight	O
,	O
we	O
review	O
the	O
changes	O
in	O
the	O
S	O
protein	O
that	O
relate	O
to	O
changes	O
in	O
virus	B-SPEC
tropism	O
.	O

A	O
thorough	O
understanding	O
of	O
the	O
key	O
role	O
of	O
the	O
S	O
protein	O
in	O
CoV	O
entry	O
is	O
critical	O
to	O
further	O
our	O
understanding	O
of	O
virus	B-SPEC
cross	O
-	O
species	B-SPEC
transmission	O
and	O
pathogenesis	O
and	O
for	O
development	O
of	O
intervention	O
strategies	O
.	O

ABSTRACT	O
:	O
Between	O
19	O
April	O
and	O
23	O
June	O
2015	O
,	O
52	O
laboratory	O
-	O
confirmed	O
cases	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
due	O
to	O
coronavirus	B-SPEC
(	O
MERS	O
)	O
were	O
reported	O
from	O
Al	O
-	O
Ahssa	O
region	O
,	O
eastern	O
Saudi	O
Arabia	O
.	O

The	O
index	O
case	O
was	O
a	O
62	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
a	O
history	O
of	O
close	O
contact	O
with	O
dromedary	B-SPEC
camels	B-SPEC
;	O
three	O
of	O
the	O
seven	O
infected	O
family	B-SPEC
members	O
and	O
18	O
people	O
in	O
hospitals	O
died	O
(	O
case	O
-	O
fatality	O
rate	O
,	O
40	O
.	O
4	O
%).	O

TITLE	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
:	O
current	O
knowledge	O
and	O
future	O
considerations	O
.	O

The	O
study	O
aims	O
were	O
to	O
determine	O
the	O
seroprevalence	O
at	O
herd	O
level	O
,	O
to	O
evaluate	O
risk	O
factors	O
for	O
BRSV	B-SPEC
and	O
BCoV	O
seropositivity	O
,	O
and	O
to	O
assess	O
how	O
these	O
factors	O
were	O
associated	O
with	O
the	O
spatial	O
distribution	O
of	O
positive	O
herds	O
.	O

Local	O
dependence	O
and	O
the	O
contribution	O
of	O
risk	O
factors	O
to	O
this	O
effect	O
were	O
assessed	O
using	O
the	O
residuals	O
from	O
two	O
logistic	O
regression	O
models	O
for	O
each	O
virus	B-SPEC
.	O

For	O
BRSV	B-SPEC
the	O
number	O
of	O
clusters	O
was	O
reduced	O
from	O
six	O
to	O
four	O
,	O
for	O
BCoV	O
the	O
number	O
of	O
clusters	O
remained	O
the	O
same	O
,	O
however	O
the	O
log	O
-	O
likelihood	O
ratios	O
changed	O
notably	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
novel	O
zoonotic	O
pathogen	O
.	O

Viruses	B-SPEC
that	O
are	O
known	O
foodborne	O
threats	O
include	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
,	O
tick	B-SPEC
-	I-SPEC
borne	I-SPEC
encephalitis	I-SPEC
virus	I-SPEC
,	O
enteroviruses	B-SPEC
,	O
adenovirus	B-SPEC
,	O
and	O
astroviruses	O
,	O
among	O
others	O
.	O

Viruses	B-SPEC
may	O
potentially	O
evolve	O
and	O
emerge	O
as	O
a	O
result	O
of	O
modern	O
agricultural	O
practices	O
which	O
can	O
concentrate	O
livestock	O
and	O
bring	O
them	O
into	O
contact	O
with	O
wild	O
animals	B-SPEC
.	O

This	O
chapter	O
emphasizes	O
the	O
fundamental	O
characteristics	O
and	O
clinical	O
importance	O
of	O
the	O
various	O
RNA	O
viruses	B-SPEC
that	O
cause	O
upper	O
and	O
lower	O
respiratory	O
tract	O
diseases	O
in	O
the	O
immunocompromised	O
host	O
.	O

Adenoids	O
had	O
an	O
average	O
of	O
2	O
.	O
4	O
viruses	B-SPEC
compared	O
to	O
0	O
.	O
92	O
for	O
tonsils	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

Here	O
we	O
systematically	O
investigated	O
the	O
roles	O
of	O
different	O
proteases	O
in	O
PEDV	B-SPEC
entry	O
using	O
pseudovirus	O
entry	O
,	O
biochemical	O
,	O
and	O
live	O
virus	B-SPEC
infection	O
assays	O
.	O

We	O
further	O
pinpointed	O
cathepsin	O
L	O
and	O
cathepsin	O
B	O
as	O
the	O
lysosomal	O
cysteine	O
proteases	O
that	O
activate	O
the	O
PEDV	B-SPEC
spike	O
.	O

Results	O
showed	O
PEDV	B-SPEC
infection	O
was	O
restricted	O
to	O
pAPN	O
and	O
pAPN	O
domain	O
VII	O
expressing	O
NIH3T3	O
cells	O
.	O

Collectively	O
,	O
our	O
results	O
demonstrate	O
that	O
PEDV	B-SPEC
recognizes	O
pAPN	O
and	O
that	O
the	O
main	O
interactive	O
point	O
is	O
lodged	O
within	O
domain	O
VII	O
of	O
the	O
pAPN	O
.	O

We	O
found	O
that	O
,	O
compared	O
with	O
a	O
laboratory	O
strain	O
isolated	O
in	O
1966	O
and	O
passaged	O
for	O
a	O
half	O
century	O
,	O
clinical	O
isolates	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
were	O
less	O
likely	O
to	O
utilize	O
cathepsin	O
L	O
;	O
rather	O
,	O
they	O
showed	O
a	O
preference	O
for	O
TMPRSS2	O
.	O

Human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
)	O
utilizes	O
endosomal	O
cathepsin	O
L	O
to	O
activate	O
the	O
spike	O
protein	O
after	O
receptor	O
binding	O
.	O

Here	O
,	O
we	O
found	O
that	O
clinical	O
isolates	O
of	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
preferentially	O
utilize	O
the	O
cell	O
surface	O
protease	O
TMPRSS2	O
rather	O
than	O
endosomal	O
cathepsin	O
L	O
.	O
The	O
endosome	O
is	O
a	O
main	O
site	O
of	O
Toll	O
-	O
like	O
receptor	O
recognition	O
,	O
which	O
then	O
triggers	O
an	O
innate	O
immune	O
response	O
;	O
therefore	O
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
presumably	O
evolved	O
to	O
bypass	O
the	O
endosome	O
by	O
entering	O
the	O
cell	O
via	O
TMPRSS2	O
.	O

In	O
particular	O
,	O
Rotavirus	B-SPEC
is	O
the	O
cause	O
of	O
more	O
than	O
2	O
million	O
hospitalizations	O
and	O
over	O
half	O
a	O
million	O
deaths	O
from	O
acute	O
GE	O
in	O
infants	O
and	O
young	O
children	O
.	O

TITLE	O
:	O
Detection	O
of	O
nidoviruses	B-SPEC
in	O
live	O
pythons	B-SPEC
and	O
boas	B-SPEC
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
establish	O
the	O
use	O
of	O
a	O
conventional	O
PCR	O
for	O
the	O
detection	O
of	O
nidoviruses	B-SPEC
in	O
samples	O
from	O
live	O
animals	B-SPEC
and	O
to	O
extend	O
the	O
list	O
of	O
susceptible	O
species	B-SPEC
.	O

and	O
Boa	B-SPEC
constrictor	I-SPEC
.	O

CONCLUSIONS	O
:	O
The	O
PCR	O
described	O
here	O
can	O
be	O
used	O
for	O
the	O
detection	O
of	O
nidoviruses	B-SPEC
in	O
oral	O
swabs	O
from	O
live	O
snakes	B-SPEC
.	O

This	O
paper	O
reports	O
the	O
first	O
complete	O
genome	O
sequence	O
of	O
a	O
Brazil	O
type	O
of	O
this	O
virus	B-SPEC
(	O
27	O
,	O
615	O
nucleotides	O
[	O
nt	O
])	O
isolated	O
from	O
the	O
kidneys	O
of	O
a	O
chicken	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
view	O
of	O
the	O
restricted	O
knowledge	O
on	O
the	O
diversity	O
of	O
coronaviruses	O
in	O
poultry	O
other	O
than	O
chicken	B-SPEC
,	O
this	O
study	O
aimed	O
to	O
investigate	O
the	O
genetic	O
diversity	O
of	O
coronaviruses	O
in	O
quail	O
,	O
pheasant	O
,	O
and	O
partridge	O
from	O
two	O
regions	O
of	O
Northern	O
Italy	O
.	O

TITLE	O
:	O
Hydrocortisone	O
treatment	O
in	O
early	O
sepsis	B-SPEC
-	O
associated	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
results	O
of	O
a	O
randomized	O
controlled	O
trial	O
.	O

ABSTRACT	O
:	O
Resistance	O
to	O
respiratory	O
pathogens	O
,	O
including	O
coronavirus	B-SPEC
-	O
induced	O
infection	O
and	O
clinical	O
illness	O
in	O
chickens	B-SPEC
has	O
been	O
correlated	O
with	O
the	O
B	O
(	O
MHC	O
)	O
complex	O
and	O
differential	O
ex	O
vivo	O
macrophage	O
responses	O
.	O

TITLE	O
:	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
Aggravates	O
Renal	O
Injury	O
through	O
Cytokines	O
and	O
Direct	O
Renal	O
Injury	O
.	O

TITLE	O
:	O
A	O
recombinant	O
receptor	O
-	O
binding	O
domain	O
of	O
MERS	O
-	O
CoV	O
in	O
trimeric	O
form	O
protects	O
human	B-SPEC
dipeptidyl	O
peptidase	O
4	O
(	O
hDPP4	O
)	O
transgenic	B-SPEC
mice	I-SPEC
from	O
MERS	O
-	O
CoV	O
infection	O
.	O

It	O
bound	O
strongly	O
to	O
the	O
receptor	O
of	O
MERS	O
-	O
CoV	O
,	O
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
),	O
and	O
elicited	O
robust	O
RBD	O
-	O
specific	O
neutralizing	O
antibodies	O
in	O
mice	B-SPEC
,	O
maintaining	O
long	O
-	O
term	O
neutralizing	O
activity	O
against	O
MERS	O
-	O
CoV	O
infection	O
.	O

One	O
or	O
more	O
viruses	B-SPEC
were	O
detected	O
in	O
250	O
(	O
63	O
.	O
3	O
%)	O
episodes	O
and	O
viral	O
coinfections	O
in	O
72	O
(	O
18	O
.	O
2	O
%)	O
episodes	O
.	O

The	O
results	O
of	O
our	O
study	O
are	O
consistent	O
with	O
available	O
,	O
yet	O
very	O
limited	O
,	O
published	O
data	O
regarding	O
the	O
potential	O
pathways	O
of	O
transmission	O
of	O
MERS	O
-	O
CoV	O
at	O
the	O
animal	B-SPEC
-	O
human	B-SPEC
interface	O
.	O

Between	O
2008	O
and	O
2011	O
,	O
we	O
collected	O
serum	O
samples	O
from	O
14	O
lions	B-SPEC
(	O
Panthera	B-SPEC
leo	I-SPEC
),	O
four	O
leopards	B-SPEC
(	O
Panthera	B-SPEC
pardus	I-SPEC
),	O
19	O
spotted	B-SPEC
hyenas	I-SPEC
(	O
Crocuta	B-SPEC
crocuta	I-SPEC
),	O
and	O
six	O
cheetahs	B-SPEC
(	O
Acinonyx	B-SPEC
jubatus	I-SPEC
)	O
in	O
the	O
Okavango	O
.	O

High	O
antibody	O
prevalence	O
(>	O
90	O
%)	O
was	O
only	O
found	O
to	O
FHV	O
-	O
1	O
and	O
FIV	B-SPEC
in	O
lions	B-SPEC
.	O

TITLE	O
:	O
Outcomes	O
in	O
Critically	O
Ill	O
Patients	O
with	O
Cancer	B-SPEC
-	O
Related	O
Complications	O
.	O

In	O
multivariable	O
analysis	O
,	O
the	O
presence	O
of	O
cancer	B-SPEC
-	O
related	O
complications	O
per	O
se	O
was	O
not	O
associated	O
with	O
mortality	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
1	O
.	O
25	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
94	O
-	O
1	O
.	O
66	O
),	O
P	O
=	O
0	O
.	O
131	O
].	O

RESULTS	O
:	O
Out	O
of	O
2	O
,	O
028	O
patients	O
,	O
456	O
(	O
23	O
%)	O
had	O
cancer	B-SPEC
-	O
related	O
complications	O
.	O

However	O
,	O
among	O
the	O
individual	O
cancer	B-SPEC
-	O
related	O
complications	O
,	O
VCS	O
[	O
OR	O
=	O
3	O
.	O
79	O
(	O
1	O
.	O
11	O
-	O
12	O
.	O
92	O
),	O
P	O
=	O
0	O
.	O
033	O
],	O
gastrointestinal	O
involvement	O
[	O
OR	O
=	O
3	O
.	O
05	O
(	O
1	O
.	O
57	O
-	O
5	O
.	O
91	O
),	O
P	O
=	O
<	O
0	O
.	O
001	O
]	O
and	O
respiratory	O
failure	O
[	O
OR	O
=	O
1	O
.	O
96	O
(	O
1	O
.	O
04	O
-	O
3	O
.	O
71	O
),	O
P	O
=	O
0	O
.	O
038	O
]	O
were	O
independently	O
associated	O
with	O
in	O
-	O
hospital	O
mortality	O
.	O

extracts	O
inhibited	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
-	O
associated	O
RNase	O
H	O
activity	O
.	O

Viral	O
DNA	O
production	O
and	O
time	O
of	O
addition	O
studies	O
showed	O
that	O
Sennoside	O
A	O
targets	O
the	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcription	O
process	O
.	O

TITLE	O
:	O
Nur77	O
attenuates	O
endothelin	O
-	O
1	O
expression	O
via	O
downregulation	O
of	O
NF	O
-	O
κB	O
and	O
p38	O
MAPK	O
in	O
A549	O
cells	O
and	O
in	O
an	O
ARDS	O
rat	B-SPEC
model	O
.	O

Pharmacological	O
activation	O
of	O
Nur77	O
by	O
cytosporone	O
B	O
(	O
CsnB	O
)	O
inhibited	O
ET	O
-	O
1	O
expression	O
in	O
ARDS	O
rats	B-SPEC
,	O
decreased	O
LPS	O
-	O
induced	O
phosphorylation	O
of	O
NF	O
-	O
κB	O
and	O
p38	O
MAPK	O
,	O
and	O
relieved	O
lung	O
,	O
liver	O
,	O
and	O
kidney	O
injury	O
.	O

These	O
results	O
indicated	O
that	O
Nur77	O
decreases	O
ET	O
-	O
1	O
expression	O
by	O
suppressing	O
NF	O
-	O
κB	O
and	O
p38	O
MAPK	O
in	O
LPS	O
-	O
stimulated	O
A549	O
cells	O
in	O
vitro	O
,	O
and	O
,	O
in	O
an	O
LPS	O
-	O
induced	O
ARDS	O
rat	B-SPEC
model	O
,	O
CsnB	O
reduced	O
ET	O
-	O
1	O
expression	O
and	O
lung	O
injury	O
in	O
ARDS	O
rats	B-SPEC
.	O

TITLE	O
:	O
Characterization	O
of	O
a	O
pathogenic	O
full	O
-	O
length	O
cDNA	O
clone	O
of	O
a	O
virulent	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strain	O
AH2012	O
/	O
12	O
in	O
China	O
.	O

This	O
study	O
provided	O
a	O
strong	O
basis	O
for	O
the	O
development	O
of	O
live	O
attenuated	O
vaccines	O
and	O
for	O
research	O
into	O
the	O
pathogenic	O
mechanisms	O
of	O
this	O
virus	B-SPEC
.	O

Faecal	O
samples	O
from	O
puppies	O
with	O
(	O
n	O
=	O
113	O
)	O
and	O
without	O
(	O
n	O
=	O
56	O
)	O
acute	O
diarrhoea	O
were	O
collected	O
and	O
screened	O
for	O
Canine	O
Parvovirus	B-SPEC
(	O
CPV	B-SPEC
),	O
Canine	O
Coronavirus	B-SPEC
(	O
CCoV	O
),	O
Salmonella	B-SPEC
spp	O
.,	O
Campylobacter	B-SPEC
spp	O
.,	O
Clostridium	B-SPEC
perfringens	I-SPEC
,	O
Clostridium	B-SPEC
difficile	I-SPEC
,	O
β	O
-	O
hemolytic	O
Eschericha	O
coli	O
(	O
hEC	O
),	O
Giardia	B-SPEC
spp	O
.,	O
Toxocara	B-SPEC
spp	O
.,	O
Cystoisospora	B-SPEC
spp	O
.,	O
and	O
Cyniclomyces	B-SPEC
guttulatus	I-SPEC
.	O

We	O
conclude	O
that	O
routine	O
screening	O
for	O
CPV	B-SPEC
,	O
CCoV	O
and	O
hEC	O
is	O
recommended	O
in	O
puppies	O
with	O
acute	O
diarrhoea	O
,	O
especially	O
if	O
they	O
are	O
under	O
3	O
months	O
of	O
age	O
and	O
originate	O
from	O
high	O
-	O
volume	O
dog	B-SPEC
breeders	O
.	O

Since	O
June	O
2012	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
caused	O
1	O
,	O
106	O
laboratory	O
-	O
confirmed	O
infections	O
,	O
with	O
421	O
MERS	O
-	O
CoV	O
-	O
associated	O
deaths	O
as	O
of	O
16	O
April	O
2015	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
emergence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
Singapore	O
has	O
enhanced	O
its	O
national	O
surveillance	O
system	O
to	O
detect	O
the	O
potential	O
importation	O
of	O
this	O
novel	O
pathogen	O
.	O

Two	O
hundred	O
and	O
thirty	O
(	O
88	O
%)	O
of	O
the	O
hospitalized	O
patients	O
were	O
also	O
investigated	O
for	O
influenza	B-SPEC
virus	I-SPEC
by	O
RT	O
-	O
PCR	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
respiratory	O
infections	O
that	O
can	O
be	O
life	O
-	O
threatening	O
.	O

PEDV	B-SPEC
vaccines	O
are	O
available	O
in	O
Asia	O
and	O
Europe	O
,	O
and	O
conditionally	O
-	O
licensed	O
vaccines	O
recently	O
became	O
available	O
in	O
the	O
United	O
States	O
but	O
the	O
efficacies	O
of	O
these	O
vaccines	O
in	O
eliminating	O
PEDV	B-SPEC
from	O
swine	B-SPEC
populations	O
are	O
questionable	O
.	O

Camel	B-SPEC
vaccines	O
can	O
be	O
developed	O
in	O
a	O
faster	O
time	O
with	O
fewer	O
regulations	O
and	O
lower	O
costs	O
and	O
could	O
clear	O
this	O
virus	B-SPEC
from	O
the	O
Arabian	O
Peninsula	O
if	O
accompanied	O
by	O
efficient	O
public	O
health	O
measures	O
.	O

Among	O
these	O
patients	O
Haemophilus	B-SPEC
influenzae	I-SPEC
(	O
n	O
=	O
39	O
)	O
and	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
(	O
n	O
=	O
30	O
)	O
were	O
isolated	O
most	O
commonly	O
;	O
atypical	O
bacteria	B-SPEC
were	O
identified	O
in	O
44	O
(	O
15	O
.	O
1	O
%)	O
patients	O
.	O

Nucleocapsid	O
(	O
N	O
)	O
protein	O
is	O
the	O
RNA	O
-	O
binding	O
protein	O
of	O
PEDV	B-SPEC
,	O
which	O
plays	O
an	O
important	O
role	O
for	O
virus	B-SPEC
life	O
cycle	O
.	O

ABSTRACT	O
:	O
Endoribonuclease	O
(	O
NendoU	O
)	O
is	O
unique	O
and	O
conserved	O
as	O
a	O
major	O
genetic	O
marker	O
in	O
nidoviruses	B-SPEC
that	O
infect	O
vertebrate	B-SPEC
hosts	O
.	O

Arterivirus	B-SPEC
nonstructural	O
protein	O
11	O
(	O
nsp11	O
)	O
was	O
shown	O
to	O
have	O
NendoU	O
activity	O
and	O
play	O
essential	O
roles	O
in	O
the	O
viral	O
life	O
cycle	O
.	O

TITLE	O
:	O
Creating	O
an	O
Artificial	O
Tail	O
Anchor	O
as	O
a	O
Novel	O
Strategy	O
To	O
Enhance	O
the	O
Potency	O
of	O
Peptide	O
-	O
Based	O
HIV	B-SPEC
Fusion	O
Inhibitors	O
.	O

WQ	O
-	O
IDL	O
and	O
MT	O
-	O
WQ	O
-	O
IDL	O
were	O
also	O
more	O
effective	O
than	O
WQ	O
in	O
blocking	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
Env	O
-	O
mediated	O
membrane	O
fusion	O
and	O
had	O
higher	O
levels	O
of	O
binding	O
affinity	O
with	O
NHR	O
peptide	O
N46	O
.	O

We	O
solved	O
the	O
crystal	O
structure	O
of	O
the	O
6	O
-	O
HB	O
formed	O
by	O
MT	O
-	O
WQ	O
-	O
IDL	O
and	O
N46	O
and	O
found	O
that	O
,	O
besides	O
the	O
N	O
-	O
terminal	O
MT	O
hook	O
tail	O
,	O
the	O
IDL	O
tail	O
anchor	O
of	O
MT	O
-	O
WQ	O
-	O
IDL	O
also	O
binds	O
with	O
the	O
shallow	O
hydrophobic	O
pocket	O
outside	O
the	O
groove	O
of	O
the	O
NHR	O
trimer	O
,	O
resulting	O
in	O
enhanced	O
inhibition	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
fusion	O
with	O
the	O
target	O
cell	O
.	O

The	O
hydrophobic	O
groove	O
of	O
the	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
gp41	O
NHR	O
trimer	O
has	O
been	O
known	O
as	O
the	O
classic	O
drug	O
target	O
to	O
develop	O
fusion	O
inhibitors	O
derived	O
from	O
the	O
gp41	O
CHR	O
.	O

TITLE	O
:	O
Pivotal	O
Role	O
of	O
Receptor	O
-	O
Interacting	O
Protein	O
Kinase	O
1	O
and	O
Mixed	O
Lineage	O
Kinase	O
Domain	O
-	O
Like	O
in	O
Neuronal	O
Cell	O
Death	O
Induced	O
by	O
the	O
Human	B-SPEC
Neuroinvasive	O
Coronavirus	B-SPEC
OC43	O
.	O

Here	O
,	O
a	O
novel	O
circovirus	B-SPEC
,	O
designated	O
porcine	B-SPEC
circovirus	I-SPEC
3	O
(	O
PCV3	O
),	O
was	O
identified	O
in	O
sows	O
that	O
died	O
acutely	O
with	O
PDNS	O
-	O
like	O
clinical	O
signs	O
.	O

The	O
apparent	O
prevalence	O
of	O
Babesia	B-SPEC
sp	O
.	O
and	O
Borrelia	B-SPEC
sp	O
.	O
in	O
blood	O
smears	O
was	O
consistent	O
with	O
previous	O
studies	O
.	O

Coronaviruses	O
were	O
recently	O
found	O
to	O
have	O
little	O
intrinsic	O
disorder	O
compared	O
with	O
many	O
other	O
virus	B-SPEC
families	O
.	O

These	O
findings	O
suggest	O
that	O
adenoviruses	B-SPEC
and	O
circoviruses	O
are	O
circulating	O
in	O
fur	O
seal	B-SPEC
populations	O
found	O
along	O
the	O
coast	O
of	O
Rio	O
Grande	O
do	O
Sul	O
State	O
,	O
Brazil	O
.	O

Frequently	O
,	O
patients	O
with	O
severe	O
ARDS	O
also	O
show	O
signs	O
of	O
severe	O
sepsis	B-SPEC
.	O

TITLE	O
:	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
3C	O
-	O
Like	O
Protease	O
-	O
Mediated	O
Nucleocapsid	O
Processing	O
:	O
Possible	O
Link	O
to	O
Viral	O
Cell	O
Culture	O
Adaptability	O
.	O

This	O
cleavage	O
motif	O
is	O
present	O
in	O
the	O
majority	O
of	O
cell	O
culture	O
-	O
adapted	O
PEDV	B-SPEC
strains	O
but	O
is	O
missing	O
in	O
emerging	O
field	O
isolates	O
.	O

Characterization	O
of	O
viral	O
proteins	O
provides	O
important	O
clues	O
to	O
mechanisms	O
by	O
which	O
viruses	B-SPEC
survive	O
and	O
spread	O
.	O

These	O
findings	O
may	O
direct	O
us	O
to	O
a	O
more	O
complete	O
understanding	O
of	O
PEDV	B-SPEC
replication	O
and	O
pathogenicity	O
.	O

When	O
we	O
vaccinated	O
mice	B-SPEC
,	O
chemically	O
inactivated	O
BNSP333	O
-	O
S1	O
induced	O
high	O
-	O
titer	O
neutralizing	O
antibodies	O
.	O

This	O
novel	O
vaccine	O
is	O
easy	O
to	O
produce	O
and	O
may	O
be	O
useful	O
to	O
protect	O
target	O
animals	B-SPEC
,	O
such	O
as	O
camels	B-SPEC
,	O
as	O
well	O
as	O
humans	B-SPEC
from	O
deadly	O
MERS	O
-	O
CoV	O
and	O
RABV	O
infections	O
.	O

TITLE	O
:	O
Directional	O
and	O
reoccurring	O
sequence	O
change	O
in	O
zoonotic	O
RNA	O
virus	B-SPEC
genomes	O
visualized	O
by	O
time	O
-	O
series	O
word	O
count	O
.	O

In	O
addition	O
,	O
common	O
directional	O
changes	O
in	O
human	B-SPEC
influenza	O
A	O
viruses	B-SPEC
were	O
observed	O
for	O
three	O
subtypes	O
,	O
whose	O
epidemics	O
started	O
independently	O
.	O

ABSTRACT	O
:	O
Emerging	O
acute	O
respiratory	O
infectious	O
diseases	O
,	O
such	O
as	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
and	O
the	O
Avian	B-SPEC
Influenza	O
A	O
/	O
H5N1	O
virus	B-SPEC
are	O
contagious	O
with	O
high	O
morbidity	O
and	O
mortality	O
rates	O
.	O

PACUs	B-SPEC
were	O
excluded	O
because	O
there	O
are	O
aspects	O
of	O
the	O
presence	O
of	O
visitors	O
to	O
these	O
units	O
that	O
are	O
very	O
specific	O
,	O
and	O
differ	O
from	O
the	O
general	O
visits	O
to	O
patients	O
who	O
are	O
not	O
in	O
the	O
immediate	O
post	O
-	O
operative	O
stage	O
.	O

Here	O
,	O
we	O
present	O
a	O
sequence	O
-	O
independent	O
method	O
to	O
rapidly	O
amplify	O
viral	O
genomic	O
RNA	O
while	O
simultaneously	O
abolishing	O
both	O
viral	O
and	O
genomic	O
RNA	O
infectivity	O
across	O
multiple	O
single	O
-	O
stranded	O
positive	O
-	O
sense	O
RNA	O
(	O
ssRNA	O
+)	O
virus	B-SPEC
families	O
.	O

Variables	O
associated	O
with	O
mortality	O
included	O
immunosuppression	O
,	O
shock	O
at	O
time	O
of	O
admission	O
,	O
acute	O
renal	O
failure	O
,	O
occurrence	O
of	O
heparin	O
-	O
induced	O
thrombocytopenia	O
antibodies	O
,	O
nosocomial	O
sepsis	B-SPEC
and	O
duration	O
of	O
ECMO	O
.	O

We	O
are	O
the	O
first	O
to	O
characterize	O
the	O
swim	O
bladder	O
of	O
the	O
zebrafish	B-SPEC
larva	O
,	O
which	O
is	O
similar	O
to	O
the	O
mammalian	B-SPEC
lung	O
,	O
as	O
a	O
real	O
-	O
time	O
in	O
vivo	O
model	O
for	O
examining	O
pulmonary	O
neutrophil	O
infiltration	O
during	O
ALI	O
.	O

Blood	O
and	O
bronchial	O
alveolar	O
lavage	O
fluid	O
(	O
BAL	O
)	O
from	O
humans	B-SPEC
(	O
n	O
=	O
10	O
-	O
13	O
)	O
with	O
ARDS	O
and	O
controls	O
(	O
n	O
=	O
5	O
-	O
10	O
)	O
as	O
well	O
as	O
a	O
murine	B-SPEC
model	O
of	O
ARDS	O
(	O
n	O
=	O
5	O
-	O
6	O
)	O
with	O
controls	O
(	O
n	O
=	O
6	O
-	O
7	O
)	O
were	O
studied	O
.	O

sPD	O
-	O
1	O
levels	O
in	O
murine	B-SPEC
blood	O
(	O
AUC	O
=	O
1	O
(	O
1	O
-	O
1	O
),	O
p	O
=	O
0	O
.	O
006	O
),	O
murine	B-SPEC
BAL	O
fluid	O
(	O
AUC	O
=	O
0	O
.	O
905	O
(	O
0	O
.	O
717	O
-	O
1	O
.	O
093	O
),	O
p	O
=	O
0	O
.	O
015	O
),	O
and	O
human	B-SPEC
BAL	O
(	O
AUC	O
=	O
1	O
(	O
1	O
-	O
1	O
),	O
p	O
=	O
0	O
.	O
001	O
)	O
fluid	O
predicted	O
ARDS	O
.	O

ABSTRACT	O
:	O
The	O
economic	O
losses	O
of	O
Porcine	B-SPEC
Epidemic	O
Diarrhea	O
(	O
PED	O
)	O
and	O
the	O
net	O
benefits	O
of	O
strategies	O
to	O
control	O
the	O
virus	B-SPEC
are	O
calculated	O
for	O
individual	O
farrow	O
-	O
to	O
-	O
finish	O
herds	O
.	O

The	O
IBV	B-SPEC
S1	O
spike	O
is	O
a	O
viral	O
structural	O
protein	O
that	O
is	O
responsible	O
for	O
attachment	O
to	O
host	O
receptors	O
and	O
is	O
a	O
major	O
target	O
for	O
neutralizing	O
antibodies	O
.	O

The	O
work	O
on	O
SARS	O
-	O
CoV	O
widens	O
our	O
knowledge	O
on	O
the	O
epidemiology	O
,	O
pathophysiology	O
and	O
immunology	O
of	O
coronaviruses	O
and	O
may	O
shed	O
light	O
on	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Interestingly	O
,	O
the	O
plaque	O
-	O
purified	O
virus	B-SPEC
had	O
a	O
large	O
deletion	O
in	O
ORF3abc	O
and	O
E	O
genes	O
(	O
1	O
,	O
165	O
nt	O
),	O
and	O
a	O
short	O
deletion	O
in	O
ORF7b	O
gene	O
(	O
60	O
nt	O
),	O
suggesting	O
that	O
these	O
regions	O
are	O
not	O
necessary	O
for	O
in	O
vitro	O
replication	O
of	O
CCoV	O
.	O
Next	O
,	O
the	O
antigenicity	O
between	O
the	O
isolated	O
CCoV	O
-	O
IIb	O
and	O
the	O
other	O
CCoV	O
-	O
IIa	O
was	O
compared	O
by	O
VN	O
test	O
,	O
revealing	O
that	O
antigenicty	O
of	O
the	O
isolated	O
CCoV	O
is	O
equal	O
or	O
higher	O
than	O
that	O
of	O
the	O
other	O
CCoV	O
.	O
In	O
summary	O
,	O
two	O
subgenotypes	O
of	O
CCoV	O
-	O
II	O
are	O
spreading	O
among	O
Vietnamese	O
dogs	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
meta	B-SPEC
-	O
analysis	O
synthesized	O
current	O
evidence	O
from	O
10	O
trials	O
to	O
evaluate	O
the	O
association	O
between	O
steroid	O
therapy	O
and	O
osteonecrosis	O
incidence	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

The	O
present	O
meta	B-SPEC
-	O
analysis	O
aimed	O
to	O
examine	O
the	O
dose	O
-	O
response	O
association	O
between	O
steroid	O
therapy	O
and	O
osteonecrosis	O
incidence	O
in	O
SARS	O
patients	O
.	O

Our	O
data	O
demonstrate	O
that	O
infection	O
with	O
TGEV	B-SPEC
resulted	O
in	O
increased	O
glucose	O
uptake	O
and	O
augmented	O
expression	O
of	O
EGFR	O
,	O
SGLT1	O
and	O
GLUT2	O
.	O

Moreover	O
,	O
inhibition	O
studies	O
showed	O
that	O
EGFR	O
modulated	O
glucose	O
uptake	O
in	O
control	O
and	O
TGEV	B-SPEC
infected	O
cells	O
.	O

The	O
higher	O
detection	O
of	O
rhinoviruses	B-SPEC
both	O
in	O
patient	O
and	O
control	O
groups	O
give	O
rise	O
to	O
thought	O
that	O
these	O
viruses	B-SPEC
may	O
be	O
responsible	O
for	O
asthma	O
exacerbations	O
and	O
may	O
be	O
related	O
with	O
long	O
duration	O
of	O
virus	B-SPEC
shedding	O
.	O

Statistically	O
significant	O
differences	O
in	O
the	O
detection	O
of	O
influenza	B-SPEC
virus	I-SPEC
A	O
(	O
P	O
=	O
0	O
.	O
000	O
),	O
the	O
total	O
detection	O
of	O
parainfluenza	O
viruses	B-SPEC
(	O
P	O
=	O
0	O
.	O
008	O
)	O
and	O
coinfection	O
(	O
P	O
=	O
0	O
.	O
004	O
)	O
were	O
observed	O
between	O
the	O
patient	O
and	O
control	O
groups	O
.	O

Both	O
QSAR	O
and	O
molecular	O
docking	O
showed	O
that	O
IDX	O
-	O
184	O
is	O
superior	O
compared	O
to	O
Ribavirin	O
against	O
MERS	O
CoV	O
,	O
a	O
result	O
that	O
was	O
also	O
reported	O
for	O
HCV	B-SPEC
.	O

However	O
,	O
the	O
current	O
methods	O
are	O
limited	O
to	O
antigen	O
detection	O
by	O
conjugating	O
IgG	O
antibodies	O
on	O
S	B-SPEC
.	I-SPEC
aureus	I-SPEC
nanoparticles	O
.	O

TITLE	O
:	O
Severe	O
ARDS	O
caused	O
by	O
adenovirus	B-SPEC
:	O
early	O
initiation	O
of	O
ECMO	O
plus	O
continuous	O
renal	O
replacement	O
therapy	O
.	O

TITLE	O
:	O
Monitoring	O
respiratory	O
virus	B-SPEC
infection	O
in	O
the	O
metropolitan	O
area	O
of	O
Belo	O
Horizonte	O
,	O
Brazil	O
,	O
2011	O
-	O
2013	O
.	O

Influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
accounted	O
for	O
half	O
the	O
isolated	O
viruses	B-SPEC
,	O
especially	O
subtype	O
A	O
(	O
H1N1	O
)	O
pdm09	O
among	O
patients	O
aged	O
20	O
-	O
59	O
years	O
old	O
,	O
and	O
subtype	O
A	O
(	O
H3N2	O
)	O
in	O
those	O
aged	O
60	O
or	O
over	O
;	O
the	O
most	O
frequently	O
identified	O
respiratory	O
virus	B-SPEC
among	O
children	O
under	O
five	O
years	O
old	O
was	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
65	O
.	O
6	O
%),	O
followed	O
by	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
21	O
.	O
2	O
%);	O
influenza	B-SPEC
virus	I-SPEC
circulated	O
in	O
all	O
seasons	O
of	O
the	O
year	O
and	O
its	O
periods	O
of	O
greatest	O
incidence	O
were	O
interspersed	O
with	O
those	O
of	O
higher	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
activity	O
.	O

RESULTS	O
:	O
Influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
accounted	O
for	O
half	O
the	O
isolated	O
viruses	B-SPEC
,	O
especially	O
subtype	O
A	O
(	O
H1N1	O
)	O
pdm09	O
among	O
patients	O
aged	O
20	O
-	O
59	O
years	O
old	O
,	O
and	O
subtype	O
A	O
(	O
H3N2	O
)	O
in	O
those	O
aged	O
60	O
or	O
over	O
;	O
the	O
most	O
frequently	O
identified	O
respiratory	O
virus	B-SPEC
among	O
children	O
under	O
five	O
years	O
old	O
was	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
65	O
.	O
6	O
%),	O
followed	O
by	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
21	O
.	O
2	O
%);	O
influenza	B-SPEC
virus	I-SPEC
circulated	O
in	O
all	O
seasons	O
of	O
the	O
year	O
and	O
its	O
periods	O
of	O
greatest	O
incidence	O
were	O
interspersed	O
with	O
those	O
of	O
higher	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
activity	O
.	O

Typical	O
severe	O
atrophic	O
enteritis	O
of	O
PEDV	B-SPEC
infection	O
was	O
observed	O
at	O
dpi	O
3	O
in	O
both	O
age	O
groups	O
,	O
and	O
at	O
dpi	O
4	O
and	O
14	O
fecal	O
shedding	O
patterns	O
were	O
also	O
similar	O
.	O

PEDV	B-SPEC
IgA	O
antibodies	O
were	O
detected	O
in	O
feces	O
of	O
approximately	O
50	O
%	O
of	O
the	O
pigs	B-SPEC
at	O
dpi	O
44	O
.	O

Using	O
real	O
time	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
of	O
pediatric	O
patients	O
revealed	O
that	O
9	O
out	O
of	O
552	O
(	O
1	O
.	O
6	O
%)	O
was	O
positive	O
in	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

Interestingly	O
,	O
in	O
2014	O
,	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
caused	O
not	O
only	O
upper	O
respiratory	O
infections	O
but	O
also	O
LRTIs	O
more	O
commonly	O
than	O
in	O
other	O
years	O
.	O

However	O
,	O
compared	O
with	O
that	O
of	O
RSV	B-SPEC
infection	O
,	O
the	O
disease	O
course	O
HCoV	O
was	O
short	O
.	O

Immune	O
gene	O
expression	O
profiling	O
by	O
PCR	O
array	O
showed	O
chickens	B-SPEC
infected	O
with	O
3575	O
/	O
08	O
had	O
delayed	O
expression	O
of	O
a	O
subset	O
of	O
early	O
innate	O
immune	O
genes	O
,	O
whereas	O
chickens	B-SPEC
infected	O
with	O
the	O
wild	O
-	O
type	O
or	O
attenuated	O
-	O
type	O
2575	O
/	O
08	O
revealed	O
quick	O
gene	O
induction	O
and	O
efficient	O
virus	B-SPEC
control	O
.	O

Description	O
of	O
the	O
case	O
:	O
A	O
17	O
-	O
year	O
-	O
old	O
male	O
was	O
transferred	O
to	O
the	O
emergency	O
department	O
unconscious	O
(	O
Glasgow	O
coma	B-SPEC
scale	O
:	O
6	O
/	O
15	O
)	O
after	O
heroin	O
inhalation	O
.	O

Recent	O
international	O
public	O
health	O
events	O
,	O
such	O
as	O
the	O
appearance	O
of	O
Middle	O
Eastern	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
the	O
reappearance	O
of	O
Ebola	O
in	O
West	O
Africa	O
,	O
have	O
highlighted	O
the	O
importance	O
of	O
early	O
detection	O
of	O
disease	O
events	O
and	O
the	O
interconnectedness	O
of	O
countries	O
.	O

Detection	O
of	O
EHV	B-SPEC
-	I-SPEC
2	I-SPEC
DNA	O
in	O
TW	O
was	O
also	O
significantly	O
associated	O
with	O
excess	O
tracheal	O
mucus	O
(	O
OR	O
2	O
.	O
1	O
;	O
P	O
=	O
0	O
.	O
02	O
).	O

Thus	O
,	O
the	O
possibility	O
of	O
MERS	O
-	O
CoV	O
circulation	O
in	O
animals	B-SPEC
other	O
than	O
dromedaries	B-SPEC
,	O
such	O
as	O
llamas	B-SPEC
and	O
pigs	B-SPEC
,	O
is	O
not	O
negligible	O
.	O

It	O
has	O
been	O
demonstrated	O
that	O
the	O
conformation	O
of	O
MHC	O
class	B-SPEC
I	O
(	O
MHC	O
I	O
)	O
molecules	O
can	O
be	O
adjusted	O
by	O
the	O
presented	O
peptide	O
,	O
which	O
impacts	O
T	O
cell	O
activation	O
.	O

TITLE	O
:	O
A	O
review	O
on	O
antiviral	O
activity	O
of	O
the	O
Himalayan	O
medicinal	O
plants	B-SPEC
traditionally	O
used	O
to	O
treat	O
bronchitis	O
and	O
related	O
symptoms	O
.	O

Legionnaires	O
'	O
disease	O
should	O
be	O
considered	O
during	O
the	O
late	O
spring	O
and	O
summer	O
months	O
in	O
patients	O
with	O
a	O
history	O
of	O
tobacco	B-SPEC
use	O
and	O
various	O
comorbidities	O
.	O

TITLE	O
:	O
Comparative	O
Proteome	O
Analysis	O
of	O
Porcine	B-SPEC
Jejunum	O
Tissues	O
in	O
Response	O
to	O
a	O
Virulent	O
Strain	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
and	O
Its	O
Attenuated	O
Strain	O
.	O

Chicks	O
were	O
divided	O
into	O
seven	O
groups	O
,	O
with	O
two	O
groups	O
receiving	O
single	O
Massachusetts	O
(	O
Mass	O
)	O
vaccinations	O
while	O
the	O
other	O
four	O
were	O
inoculated	O
with	O
combinations	O
of	O
different	O
IBV	B-SPEC
serotypes	O
;	O
Mass	O
,	O
793B	O
,	O
D274	O
and	O
Arkansas	O
(	O
Ark	O
).	O

Because	O
the	O
main	O
concerns	O
of	O
this	O
study	O
were	O
awareness	O
and	O
preparedness	O
,	O
which	O
required	O
human	B-SPEC
interaction	O
,	O
the	O
SP	O
methodology	O
was	O
the	O
optimal	O
simulation	O
modality	O
.	O

It	O
also	O
provides	O
a	O
solid	O
basis	O
for	O
further	O
research	O
into	O
the	O
poorly	O
understood	O
interactions	O
between	O
the	O
innate	O
immune	O
system	O
and	O
virus	B-SPEC
-	O
induced	O
replication	O
structures	O
.	O

Viruses	B-SPEC
with	O
a	O
positive	O
-	O
strand	O
RNA	O
genome	O
establish	O
a	O
membrane	O
-	O
associated	O
replication	O
organelle	O
by	O
hijacking	O
and	O
remodeling	O
intracellular	O
host	O
membranes	O
,	O
a	O
process	O
deemed	O
essential	O
for	O
their	O
efficient	O
replication	O
.	O

ABSTRACT	O
:	O
A	O
survey	O
was	O
conducted	O
into	O
respiratory	O
infectious	O
diseases	O
of	O
poultry	O
on	O
a	O
chicken	B-SPEC
breeder	O
farm	O
run	O
by	O
the	O
Ethiopian	O
Institute	O
of	O
Agricultural	O
Research	O
(	O
EIAR	O
),	O
located	O
in	O
Debre	O
Zeit	O
,	O
Ethiopia	O
.	O

For	O
the	O
first	O
time	O
in	O
Ethiopia	O
,	O
we	O
report	O
the	O
detection	O
of	O
variant	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
793B	O
genotype	O
),	O
avian	B-SPEC
metapneumovirus	I-SPEC
subtype	O
B	O
and	O
Mycoplasma	B-SPEC
synoviae	I-SPEC
in	O
poultry	O
.	O

TITLE	O
:	O
Targeting	O
Neutrophils	O
to	O
Prevent	O
Malaria	O
-	O
Associated	O
Acute	O
Lung	O
Injury	O
/	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
in	O
Mice	B-SPEC
.	O

The	O
depletion	O
of	O
neutrophils	O
,	O
treatment	O
with	O
AMD3100	O
(	O
a	O
CXCR4	O
antagonist	O
),	O
Pulmozyme	O
(	O
human	B-SPEC
recombinant	O
DNase	O
)	O
or	O
Sivelestat	O
(	O
inhibitor	O
of	O
neutrophil	O
elastase	O
)	O
decreased	O
the	O
development	O
of	O
malaria	O
-	O
associated	O
ALI	O
/	O
ARDS	O
and	O
significantly	O
increased	O
mouse	B-SPEC
survival	O
.	O

Treatment	O
options	O
for	O
patients	O
with	O
risk	O
factors	O
for	O
Pseudomonas	B-SPEC
species	B-SPEC
include	O
administration	O
of	O
an	O
antipseudomonal	O
antibiotic	O
and	O
an	O
aminoglycoside	O
,	O
plus	O
azithromycin	O
or	O
a	O
fluoroquinolone	O
.	O

Patients	O
with	O
risk	O
factors	O
for	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
should	O
be	O
given	O
vancomycin	O
or	O
linezolid	O
,	O
or	O
ceftaroline	O
in	O
resistant	O
cases	O
.	O

In	O
Europe	O
and	O
North	O
America	O
most	O
victims	O
are	O
breeders	O
,	O
with	O
a	O
few	O
snakebites	O
from	O
wild	O
native	O
American	O
rattlesnakes	B-SPEC
.	O

He	O
developed	O
severe	O
neuromuscular	O
dysfunction	O
after	O
sepsis	B-SPEC
,	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Thus	O
,	O
it	O
is	O
important	O
to	O
expand	O
our	O
knowledge	O
of	O
the	O
presence	O
of	O
viruses	B-SPEC
in	O
bats	B-SPEC
which	O
could	O
represent	O
a	O
risk	O
to	O
humans	B-SPEC
.	O

The	O
βCoVs	O
group	O
is	O
known	O
to	O
include	O
some	O
coronaviruses	O
highly	O
pathogenic	O
to	O
human	B-SPEC
,	O
such	O
as	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
All	O
coronavirus	B-SPEC
sequences	O
generated	O
from	O
frugivorous	O
bats	B-SPEC
(	O
family	B-SPEC
Pteropodidae	I-SPEC
)	O
(	O
n	O
=	O
55	O
)	O
clustered	O
with	O
other	O
bat	B-SPEC
βCoVs	O
of	O
lineage	O
D	O
,	O
whereas	O
one	O
coronavirus	B-SPEC
from	O
Pipistrellus	B-SPEC
coromandra	I-SPEC
fell	O
in	O
the	O
lineage	O
C	O
of	O
βCoVs	O
which	O
also	O
includes	O
the	O
MERS	O
-	O
CoV	O
.	O
αCoVs	O
were	O
all	O
detected	O
in	O
various	O
genera	O
of	O
insectivorous	O
bats	B-SPEC
and	O
clustered	O
with	O
diverse	O
bat	B-SPEC
αCoV	O
sequences	O
previously	O
published	O
.	O

ABSTRACT	O
:	O
The	O
genus	B-SPEC
Rotavirus	I-SPEC
comprises	O
eight	O
species	B-SPEC
designated	O
A	O
to	O
H	O
and	O
one	O
tentative	O
species	B-SPEC
,	O
Rotavirus	B-SPEC
I	O
.	O
In	O
a	O
virus	B-SPEC
metagenomic	O
analysis	O
of	O
Schreiber	O
'	O
s	O
bats	B-SPEC
sampled	O
in	O
Serbia	O
in	O
2014	O
we	O
obtained	O
sequences	O
likely	O
representing	O
novel	O
rotavirus	B-SPEC
species	B-SPEC
.	O

Using	O
Pteropus	B-SPEC
alecto	I-SPEC
(	O
P	B-SPEC
.	I-SPEC
alecto	I-SPEC
)	O
GM	O
-	O
CSF	O
plus	O
IL4	O
,	O
FLT3L	O
and	O
CSF	O
-	O
1	O
,	O
we	O
successfully	O
generated	O
bat	B-SPEC
bone	O
marrow	O
-	O
derived	O
DC	O
and	O
macrophages	O
.	O

In	O
this	O
study	O
,	O
a	O
functionalized	O
nanoparticles	O
-	O
based	O
PCR	O
method	O
(	O
UNDP	O
-	O
PCR	O
)	O
specific	O
for	O
PEDV	B-SPEC
was	O
developed	O
through	O
systematic	O
optimization	O
of	O
functionalized	O
magnetic	O
beads	O
and	O
gold	O
nanoparticles	O
which	O
were	O
further	O
used	O
to	O
specifically	O
enrich	O
viral	O
RNA	O
from	O
the	O
lysate	O
of	O
PEDV	B-SPEC
stool	O
samples	O
,	O
forming	O
a	O
MMPs	O
-	O
RNA	O
-	O
AuNPs	O
complex	O
.	O

Then	O
,	O
oligonucleotides	O
specific	O
for	O
PEDV	B-SPEC
coated	O
on	O
AuNPs	O
were	O
eluted	O
from	O
the	O
complex	O
and	O
were	O
further	O
amplified	O
and	O
characterized	O
by	O
PCR	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
important	O
emerging	O
respiratory	O
pathogen	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
caused	O
extensive	O
economic	O
losses	O
to	O
pig	B-SPEC
producers	O
in	O
many	O
countries	O
.	O

TITLE	O
:	O
Full	O
genome	O
analysis	O
of	O
Australian	O
infectious	O
bronchitis	O
viruses	B-SPEC
suggests	O
frequent	O
recombination	O
events	O
between	O
vaccine	O
strains	O
and	O
multiple	O
phylogenetically	O
distant	O
avian	B-SPEC
coronaviruses	O
of	O
unknown	O
origin	O
.	O

ABSTRACT	O
:	O
Australian	O
strains	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
have	O
been	O
evolving	O
independently	O
for	O
many	O
years	O
,	O
with	O
control	O
achieved	O
by	O
vaccination	O
with	O
local	O
attenuated	O
strains	O
.	O

As	O
the	O
subgroup	O
2	O
strains	O
have	O
not	O
been	O
isolated	O
for	O
at	O
least	O
20	O
years	O
,	O
it	O
appears	O
likely	O
that	O
an	O
unknown	O
avian	B-SPEC
coronavirus	I-SPEC
that	O
was	O
the	O
donor	O
of	O
the	O
S1	O
glycoprotein	O
sequence	O
of	O
N1	O
/	O
88	O
in	O
the	O
1980s	O
is	O
still	O
recombining	O
with	O
IBV	B-SPEC
strains	O
in	O
the	O
field	O
.	O

TITLE	O
:	O
Quantifying	O
the	O
effect	O
of	O
lactogenic	O
antibody	O
on	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infection	O
in	O
neonatal	O
piglets	O
.	O

In	O
this	O
study	O
,	O
a	O
Chinese	O
PDCoV	O
strain	O
,	O
designated	O
CHN	O
-	O
HN	O
-	O
2014	O
,	O
was	O
isolated	O
from	O
piglets	O
with	O
severe	O
diarrhea	O
on	O
a	O
pig	B-SPEC
farm	O
in	O
Henan	O
Province	O
,	O
China	O
,	O
and	O
examined	O
with	O
a	O
specific	O
immunofluorescence	O
assay	O
and	O
electron	O
microscopy	O
.	O

Influenza	O
was	O
the	O
predominant	O
virus	B-SPEC
(	O
14	O
.	O
17	O
%,	O
137	O
/	O
967	O
),	O
detected	O
from	O
21	O
.	O
35	O
%	O
(	O
76	O
/	O
356	O
)	O
of	O
the	O
outpatients	O
and	O
9	O
.	O
98	O
%	O
(	O
61	O
/	O
611	O
)	O
of	O
the	O
inpatients	O
.	O

These	O
mutations	O
led	O
to	O
virus	B-SPEC
attenuation	O
and	O
a	O
modest	O
reduction	O
of	O
viral	O
loads	O
in	O
infected	O
mice	B-SPEC
,	O
despite	O
normal	O
replication	O
in	O
cell	O
culture	O
.	O

Further	O
,	O
macrodomain	O
mutant	O
virus	B-SPEC
elicited	O
an	O
early	O
,	O
enhanced	O
interferon	O
(	O
IFN	O
),	O
interferon	O
-	O
stimulated	O
gene	O
(	O
ISG	O
),	O
and	O
proinflammatory	O
cytokine	O
response	O
in	O
mice	B-SPEC
and	O
in	O
a	O
human	B-SPEC
bronchial	O
epithelial	O
cell	O
line	O
.	O

All	O
coronaviruses	O
contain	O
a	O
macrodomain	O
,	O
suggesting	O
that	O
ADP	O
-	O
ribosylation	O
impacts	O
coronavirus	B-SPEC
infection	O
.	O

TITLE	O
:	O
The	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
-	O
A	O
Continuing	O
Risk	O
to	O
Global	O
Health	O
Security	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O
highly	O
contagious	O
coronavirus	B-SPEC
that	O
causes	O
severe	O
diarrhea	O
and	O
death	O
,	O
particularly	O
in	O
neonatal	O
piglets	O
.	O

However	O
,	O
the	O
characterization	O
of	O
epitopes	O
on	O
the	O
PEDV	B-SPEC
N	O
protein	O
remains	O
largely	O
unknown	O
.	O

Here	O
,	O
two	O
monoclonal	O
antibodies	O
(	O
MAbs	O
)	O
specific	O
to	O
the	O
N	O
protein	O
of	O
a	O
PEDV	B-SPEC
strain	O
,	O
FJzz1	O
/	O
2011	O
,	O
were	O
generated	O
and	O
screened	O
against	O
a	O
partially	O
overlapping	O
library	O
of	O
24	O
GST	O
-	O
fusion	O
N	O
protein	O
-	O
truncated	O
constructs	O
.	O

Indirect	O
immunofluorescence	O
(	O
IFA	O
)	O
assays	O
confirmed	O
no	O
cross	O
-	O
reaction	O
between	O
these	O
two	O
MAbs	O
and	O
TGEV	B-SPEC
.	O

However	O
,	O
the	O
lack	O
of	O
a	O
vaccine	O
,	O
together	O
with	O
the	O
increasing	O
resistance	O
to	O
the	O
highly	O
active	O
anti	O
-	O
retroviral	B-SPEC
therapy	O
(	O
HAART	O
),	O
make	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
infection	O
still	O
a	O
serious	O
global	O
emergency	O
.	O

Over	O
the	O
last	O
years	O
,	O
aptamer	O
technology	O
has	O
been	O
used	O
in	O
a	O
wide	O
range	O
of	O
diagnostic	O
and	O
therapeutic	O
applications	O
and	O
,	O
concretely	O
,	O
several	O
strategies	O
are	O
currently	O
being	O
explored	O
using	O
aptamers	O
against	O
virus	B-SPEC
proteins	O
.	O

These	O
findings	O
support	O
further	O
evaluation	O
of	O
GRFT	O
for	O
pre	O
-	O
exposure	O
prophylaxis	O
against	O
emerging	O
epidemics	O
for	O
which	O
specific	O
therapeutics	O
are	O
not	O
available	O
,	O
including	O
systemic	O
and	O
enteric	O
infections	O
caused	O
by	O
susceptible	O
enveloped	O
viruses	B-SPEC
.	O

In	O
addition	O
,	O
GRFT	O
should	O
be	O
considered	O
for	O
antiviral	O
therapy	O
and	O
the	O
prevention	O
of	O
rectal	O
transmission	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
and	O
other	O
susceptible	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Human	B-SPEC
lung	O
ex	O
vivo	O
infection	O
models	O
.	O

TITLE	O
:	O
A	O
novel	O
experimental	O
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
pig	B-SPEC
.	O

ABSTRACT	O
:	O
Chicken	B-SPEC
astroviruses	O
have	O
been	O
known	O
to	O
cause	O
severe	O
disease	O
in	O
chickens	B-SPEC
leading	O
to	O
increased	O
mortality	O
and	O
""""	O
white	O
chicks	O
""""	O
condition	O
.	O

The	O
basis	O
for	O
their	O
generation	O
lies	O
in	O
the	O
capacity	O
of	O
some	O
viruses	B-SPEC
,	O
such	O
as	O
murine	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
MLV	O
),	O
to	O
incorporate	O
envelope	O
glycoproteins	O
of	O
other	O
viruses	B-SPEC
into	O
a	O
pseudotyped	O
virus	B-SPEC
particle	O
.	O

STBI	O
is	O
frequently	O
followed	O
by	O
severe	O
sepsis	B-SPEC
,	O
which	O
is	O
not	O
usually	O
treated	O
with	O
CS	O
.	O

The	O
study	O
involved	O
an	O
analysis	O
of	O
the	O
treatment	O
results	O
in	O
267	O
patients	O
with	O
STBI	O
followed	O
by	O
severe	O
sepsis	B-SPEC
and	O
ARDS	O
,	O
who	O
were	O
treated	O
with	O
and	O
without	O
CS	O
.	O

TITLE	O
:	O
Binding	O
of	O
the	O
Methyl	O
Donor	O
ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
nonstructural	O
protein	O
16	O
(	O
nsp16	O
)	O
is	O
an	O

TITLE	O
:	O
Noninvasive	O
ventilation	O
during	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
patients	O
with	O
cancer	B-SPEC
:	O
Trends	O
in	O
use	O
and	O
outcome	O
.	O

sVLP	O
retained	O
certain	O
parvovirus	B-SPEC
characteristics	O
,	O
such	O
as	O
the	O
ability	O
to	O
agglutinate	O
pig	B-SPEC
erythrocytes	O
,	O
and	O
structural	O
morphology	O
similar	O
to	O
CPV	B-SPEC
virions	O
.	O

sVLP	O
-	O
specific	O
antisera	O
from	O
these	O
animals	B-SPEC
were	O
able	O
to	O
prevent	O
pseudotyped	O
MERS	O
-	O
CoV	O
entry	O
into	O
susceptible	O
cells	O
,	O
with	O
neutralizing	O
antibody	O
titers	O
reaching	O
1	O
:	O
320	O
.	O

The	O
results	O
suggest	O
potential	O
linkages	O
among	O
viral	O
strategies	O
for	O
the	O
regulation	O
of	O
cell	O
survival	O
activities	O
,	O
possibly	O
through	O
an	O
interaction	O
of	O
N	O
protein	O
with	O
NPM1	O
which	O
prevents	O
its	O
proteolytic	O
cleavage	O
and	O
enhances	O
cell	O
survival	O
,	O
thus	O
ultimately	O
promoting	O
the	O
replication	O
of	O
PEDV	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
is	O
caused	O
by	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Health	O
-	O
care	O
workers	O
(	O
HCWs	O
)	O
are	O
at	O
risk	O
of	O
acquiring	O
and	O
transmitting	O
this	O
virus	B-SPEC
,	O
so	O
the	O
concerns	O
of	O
HCWs	O
in	O
Saudi	O
Arabia	O
regarding	O
MERS	O
were	O
evaluated	O
.	O

It	O
was	O
due	O
to	O
the	O
presentation	O
of	O
shivering	O
in	O
the	O
ICU	O
,	O
that	O
a	O
blood	O
film	O
was	O
done	O
on	O
the	O
second	O
day	O
that	O
revealed	O
the	O
presence	O
of	O
P	B-SPEC
.	I-SPEC
knowlesi	I-SPEC
with	O
a	O
parasite	O
count	O
of	O
520	O
,	O
000	O
/	O
μL	O
.	O
The	O
patient	O
was	O
subsequently	O
treated	O
with	O
artesunate	O
-	O
doxycycline	O
and	O
made	O
a	O
good	O
recovery	O
after	O
nine	O
days	O
in	O
ICU	O
.	O

Signature	O
amino	O
acid	O
substitutions	O
and	O
a	O
glycine	B-SPEC
residue	O
insertion	O
at	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
S1	O
subunit	O
of	O
the	O
spike	O
gene	O
,	O
among	O
others	O
,	O
exhibited	O
further	O
distinction	O
in	O
a	O
recombination	O
pattern	O
,	O
to	O
which	O
these	O
clusters	O
were	O
classified	O
as	O
genotypes	O
F	O
and	O
G	O
.	O
The	O
phylogeographic	O
mapping	O
of	O
the	O
global	O
spike	O
gene	O
indicated	O
that	O
the	O
genetically	O
similar	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
genotypes	O
F	O
and	O
G	O
strains	O
were	O
potentially	O
circulating	O
in	O
China	O
,	O
Japan	O
,	O
Thailand	O
and	O
Europe	O
as	O
early	O
as	O
the	O
late	O
2000s	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
human	B-SPEC
infections	O
and	O
dromedary	B-SPEC
camels	B-SPEC
are	O
considered	O
an	O
intermediary	O
host	O
.	O

The	O
Chinese	O
government	O
and	O
military	O
forces	O
have	O
paid	O
a	O
great	O
deal	O
of	O
attention	O
to	O
infectious	O
disease	O
prevention	O
and	O
control	O
,	O
and	O
using	O
military	O
-	O
civilian	O
cooperation	O
,	O
they	O
have	O
successfully	O
prevented	O
numerous	O
severe	O
epidemic	O
situations	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
influenza	O
A	O
(	O
H1N1	O
),	O
avian	B-SPEC
influenza	O
H5N1	O
and	O
H7N9	O
,	O
and	O
Ebola	O
hemorrhagic	O
fever	O
,	O
while	O
actively	O
maintained	O
public	O
health	O
,	O
economic	O
development	O
,	O
and	O
national	O
construction	O
.	O

The	O
most	O
important	O
imaging	O
techniques	O
include	O
chest	O
X	B-SPEC
‑	I-SPEC
ray	I-SPEC
and	O
computed	O
tomography	O
(	O
CT	O
)	O
of	O
the	O
chest	O
.	O

Although	O
a	O
definite	O
diagnosis	O
is	O
sometimes	O
difficult	O
or	O
even	O
impossible	O
to	O
establish	O
using	O
chest	O
X	B-SPEC
‑	I-SPEC
ray	I-SPEC
or	O
CT	O
,	O
there	O
are	O
several	O
findings	O
indicative	O
of	O
intrapulmonary	O
or	O
extrapulmonary	O
complications	O
of	O
pneumonia	O
.	O

TITLE	O
:	O
Understanding	O
the	O
early	O
dynamics	O
of	O
the	O
2014	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
outbreak	O
in	O
Ontario	O
using	O
the	O
incidence	O
decay	O
and	O
exponential	O
adjustment	O
(	O
IDEA	B-SPEC
)	O
model	O
.	O

Using	O
our	O
simple	O
,	O
2	O
-	O
parameter	O
IDEA	B-SPEC
model	O
,	O
we	O
have	O
evaluated	O
the	O
early	O
epidemic	O
dynamics	O
of	O
PEDV	B-SPEC
on	O
Ontario	O
swine	B-SPEC
farms	O
.	O

We	O
estimated	O
the	O
best	O
-	O
fit	O
R	O
The	O
emergence	O
and	O
spread	O
of	O
PEDV	B-SPEC
represents	O
an	O
important	O
agricultural	O
emergency	O
.	O

The	O
virus	B-SPEC
presents	O
a	O
significant	O
ongoing	O
threat	O
to	O
the	O
Canadian	O
swine	B-SPEC
industry	O
.	O

TITLE	O
:	O
Modified	O
Vaccinia	B-SPEC
Virus	I-SPEC
Ankara	O
:	O
History	O
,	O
Value	O
in	O
Basic	O
Research	O
,	O
and	O
Current	O
Perspectives	O
for	O
Vaccine	O
Development	O
.	O

This	O
review	O
summarizes	O
our	O
current	O
knowledge	O
about	O
MVA	O
as	O
a	O
unique	O
strain	O
of	O
vaccinia	B-SPEC
virus	I-SPEC
,	O
and	O
discusses	O
the	O
prospects	O
of	O
exploiting	O
this	O
virus	B-SPEC
as	O
research	O
tool	O
in	O
poxvirus	B-SPEC
biology	O
or	O
as	O
safe	O
viral	O
vector	O
vaccine	O
to	O
challenge	O
existing	O
and	O
future	O
bottlenecks	O
in	O
vaccinology	O
.	O

Moreover	O
,	O
promoting	O
support	O
from	O
family	B-SPEC
and	O
friends	O
is	O
required	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
major	O
poultry	O
pathogen	O
.	O

ck	O
/	O
CH	O
/	O
LGX	O
/	O
111119	O
is	O
a	O
nephropathogenic	O
strain	O
,	O
although	O
it	O
had	O
broader	O
tissue	O
tropism	O
(	O
respiratory	O
,	O
digestive	O
,	O
urinary	O
,	O
and	O
reproductive	O
tracts	O
)	O
among	O
chickens	B-SPEC
challenged	O
at	O
one	O
day	O
old	O
.	O

ABSTRACT	O
:	O
Neurotropic	O
viruses	B-SPEC
are	O
important	O
causes	O
of	O
morbidity	O
and	O
mortality	O
in	O
human	B-SPEC
populations	O
.	O

Regulatory	O
T	O
cells	O
,	O
especially	O
those	O
that	O
are	O
specific	O
for	O
antigens	O
recognized	O
by	O
pathogenic	O
T	O
cells	O
,	O
and	O
IL	O
-	O
10	O
are	O
two	O
anti	O
-	O
inflammatory	O
/	O
pro	O
-	O
resolution	O
factors	O
that	O
demonstrate	O
efficacy	O
in	O
experimental	O
models	O
of	O
virus	B-SPEC
-	O
induced	O
demyelination	O
and	O
may	O
be	O
useful	O
in	O
patients	O
infected	O
with	O
viruses	B-SPEC
that	O
cause	O
demyelination	O
.	O

This	O
article	O
outlines	O
current	O
understanding	O
of	O
the	O
epidemiological	O
and	O
clinical	O
features	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
.	O

Ricin	O
-	O
intoxicated	O
pigs	B-SPEC
suffered	O
from	O
increased	O
lung	O
permeability	O
accompanied	O
by	O
cytokine	O
storming	O
.	O

We	O
will	O
also	O
suggest	O
to	O
control	O
this	O
epidemic	O
of	O
obesity	O
and	O
OSA	B-SPEC
so	O
that	O
the	O
corrective	O
measure	O
could	O
be	O
taken	O
at	O
health	O
ministry	O
level	O
to	O
help	O
people	O
of	O
this	O
region	O
to	O
fight	O
against	O
obesity	O
and	O
related	O
disorders	O
,	O
primarily	O
OSA	B-SPEC
.	O

TITLE	O
:	O
Electrostatic	O
layer	O
-	O
by	O
-	O
layer	O
construction	O
of	O
fibrous	O
TMV	B-SPEC
biofilms	O
.	O

In	O
neutral	O
aqueous	O
media	O
,	O
TMV	B-SPEC
-	O
wt	O
assumes	O
an	O
anionic	O
surface	O
charge	O
.	O

TITLE	O
:	O
Surveillance	O
of	O
Bat	B-SPEC
Coronaviruses	O
in	O
Kenya	O
Identifies	O
Relatives	O
of	O
Human	B-SPEC
Coronaviruses	O
NL63	O
and	O
229E	O
and	O
Their	O
Recombination	O
History	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
harbor	O
a	O
large	O
diversity	O
of	O
coronaviruses	O
(	O
CoVs	O
),	O
several	O
of	O
which	O
are	O
related	O
to	O
zoonotic	O
pathogens	O
that	O
cause	O
severe	O
disease	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
a	O
significant	O
respiratory	O
pathogen	O
of	O
commercial	O
poultry	O
that	O
causes	O
millions	O
of	O
dollars	O
in	O
lost	O
revenue	O
worldwide	O
each	O
year	O
.	O

Data	O
from	O
the	O
Saudi	O
Ministry	O
of	O
Health	O
of	O
confirmed	O
outbreak	O
and	O
non	O
-	O
outbreak	O
cases	O
of	O
MERS	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infections	O
from	O
September	O
2012	O
through	O
October	O
2015	O
were	O
abstracted	O
and	O
analysed	O
.	O

ABSTRACT	O
:	O
Over	O
the	O
past	O
two	O
decades	O
a	O
number	O
of	O
severe	O
acute	O
respiratory	O
infection	O
outbreaks	O
such	O
as	O
the	O
2009	O
influenza	O
A	O
(	O
H1N1	O
)	O
and	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
have	O
emerged	O
and	O
presented	O
a	O
considerable	O
global	O
public	O
health	O
threat	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
conduct	O
a	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
of	O
published	O
reports	O
documenting	O
the	O
prevalence	O
of	O
diabetes	O
in	O
H1N1	O
and	O
MERS	O
-	O
CoV	O
and	O
compare	O
its	O
frequency	O
in	O
the	O
two	O
viral	O
conditions	O
.	O

Influenza	O
,	O
coronavirus	B-SPEC
or	O
rhinovirus	B-SPEC
were	O
detected	O
in	O
three	O
participants	O
;	O
all	O
in	O
the	O
placebo	O
group	O
.	O

TITLE	O
:	O
Functionalized	O
triazines	O
as	O
potent	O
HCV	B-SPEC
entry	O
inhibitors	O
.	O

In	O
addition	O
,	O
>	O
99	O
%	O
inactivation	O
,	O
which	O
increased	O
with	O
solvent	O
exposure	O
time	O
,	O
was	O
also	O
observed	O
for	O
pathogens	O
without	O
exposed	O
lipid	O
membranes	O
including	O
community	O
-	O
associated	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
Clostridium	B-SPEC
difficile	I-SPEC
spores	O
and	O
vegetative	O
cells	O
,	O
and	O
adenovirus	B-SPEC
type	O
5	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
emergence	O
,	O
mixed	O
infection	O
,	O
and	O
genetic	O
characterization	O
of	O
15	O
novel	O
field	O
PEDV	B-SPEC
variants	O
with	O
large	O
genomic	O
deletions	O
.	O

A	O
bronchoalveolar	O
lavage	O
sample	O
was	O
positive	O
via	O
PCR	O
for	O
adenovirus	B-SPEC
which	O
we	O
suspect	O
exacerbated	O
a	O
pre	O
-	O
existing	O
bacterial	O
pneumonia	O
and	O
led	O
to	O
a	O
severe	O
and	O
non	O
-	O
responsive	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Elimination	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
in	O
an	O
Animal	B-SPEC
Feed	O
Manufacturing	O
Facility	O
.	O

TITLE	O
:	O
Viral	O
-	O
induced	O
suppression	O
of	O
self	O
-	O
reactive	O
T	O
cells	O
:	O
Lessons	O
from	O
neurotropic	O
coronavirus	B-SPEC
-	O
induced	O
demyelination	O
.	O

ABSTRACT	O
:	O
The	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
is	O
the	O
etiological	O
agent	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
a	O
lethal	O
disease	O
of	O
felids	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
current	O
study	O
was	O
designed	O
to	O
assess	O
the	O
inhibitory	O
activity	O
of	O
Broussonetia	B-SPEC
papyrifera	I-SPEC
-	O
derived	O
polyphenols	O
against	O
3	O
-	O
chymotrypsin	O
-	O
like	O
and	O
papain	O
-	O
like	O
coronavirus	B-SPEC
cysteine	O
proteases	O
.	O

A	O
significantly	O
greater	O
proportion	O
of	O
FmoPV	O
RNA	O
-	O
positive	O
cats	B-SPEC
had	O
street	O
access	O
compared	O
with	O
non	O
-	O
infected	O
cats	B-SPEC
.	O

Two	O
FmoPV	O
-	O
positive	O
cats	B-SPEC
were	O
also	O
positive	O
for	O
feline	B-SPEC
coronavirus	B-SPEC
RNA	O
and	O
one	O
cat	B-SPEC
for	O
feline	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
RNA	O
and	O
feline	B-SPEC
leukaemia	O
virus	B-SPEC
proviral	O
DNA	O
.	O

Similar	O
clinical	O
signs	O
were	O
also	O
seen	O
in	O
the	O
morbillivirus	B-SPEC
RNA	O
-	O
negative	O
sick	O
cats	B-SPEC
.	O

Significant	O
histopathology	O
of	O
FmoPV	O
RNA	O
-	O
positive	O
dead	O
cats	B-SPEC
included	O
tubulointerstitial	O
nephritis	O
characterised	O
by	O
severe	O
granular	O
and	O
vacuolar	O
degeneration	O
of	O
the	O
epithelial	O
cells	O
of	O
the	O
cortical	O
and	O
medullary	O
tubules	O
as	O
well	O
as	O
mononuclear	O
cell	O
infiltrates	O
.	O

TITLE	O
:	O
Novel	O
Approach	O
for	O
Isolation	O
and	O
Identification	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
Strain	O
NJ	O
Using	O
Porcine	B-SPEC
Intestinal	O
Epithelial	O
Cells	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
emerged	O
as	O
a	O
new	O
pathogen	O
,	O
causing	O
severe	O
complications	O
and	O
a	O
high	O
case	O
fatality	O
rate	O
.	O

High	O
immune	O
responses	O
require	O
further	O
study	O
in	O
animal	B-SPEC
models	O
,	O
such	O
as	O
human	B-SPEC
receptor	O
-	O
expressing	O
mice	B-SPEC
,	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
,	O
and	O
camels	B-SPEC
.	O

ABSTRACT	O
:	O
Dendritic	O
cell	O
-	O
specific	O
intercellular	O
adhesion	O
molecule	O
-	O
3	O
-	O
grabbing	O
non	O
-	O
integrin	O
(	O
DC	O
-	O
SIGN	O
),	O
a	O
C	O
-	O
type	O
lectin	O
expressed	O
on	O
the	O
plasma	O
membrane	O
by	O
human	B-SPEC
immature	O
dendritic	O
cells	O
,	O
is	O
a	O
receptor	O
for	O
numerous	O
viruses	B-SPEC
including	O
Ebola	O
,	O
SARS	O
and	O
dengue	O
.	O

TITLE	O
:	O
Spontaneous	O
intracranial	O
hemorrhage	O
in	O
a	O
patient	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
novel	O
positive	O
sense	O
singlestranded	O
ribonucleic	O
acid	O
virus	B-SPEC
of	O
the	O
genus	B-SPEC
Beta	O
corona	B-SPEC
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
(	O
CoV	O
)	O
replication	O
and	O
transcription	O
are	O
carried	O
out	O
in	O
close	O
proximity	O
to	O
restructured	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
membranes	O
in	O
replication	O
/	O
transcription	O
complexes	O
(	O
RTC	O
).	O

nsp15	O
contains	O
an	O
endoribonuclease	O
domain	O
that	O
is	O
conserved	O
in	O
the	O
CoV	O
family	B-SPEC
.	O

We	O
conclude	O
that	O
respiratory	O
viruses	B-SPEC
are	O
important	O
contributors	O
to	O
AECOPD	O
in	O
India	O
.	O

RESULTS	O
:	O
Fifteen	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
positive	O
samples	O
were	O
identified	O
(	O
5	O
.	O
5	O
%	O
positive	O
).	O

ABSTRACT	O
:	O
A	O
phytochemical	O
investigation	O
of	O
the	O
flowers	O
of	O
Chrysanthemum	B-SPEC
indicum	I-SPEC
yielded	O
sesquiterpenoids	O
1	O
-	O
25	O
with	O
various	O
carbocyclic	O
skeletons	O
,	O
including	O
10	O
new	O
(	O
1	O
-	O
10	O
)	O
and	O
15	O
known	O
(	O
11	O
-	O
25	O
)	O
analogues	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
are	O
of	O
veterinary	O
and	O
medical	O
importance	O
and	O
include	O
highly	O
pathogenic	O
zoonotic	O
viruses	B-SPEC
,	O
such	O
as	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
They	O
are	O
known	O
to	O
efficiently	O
evade	O
early	O
innate	O
immune	O
responses	O
,	O
manifesting	O
in	O
almost	O
negligible	O
expression	O
of	O
type	O
-	O
I	O
interferons	O
(	O
IFN	O
-	O
I	O
).	O

Here	O
we	O
show	O
that	O
the	O
coronavirus	B-SPEC
endonuclease	O
(	O
EndoU	O
)	O
activity	O
is	O
key	O
to	O
prevent	O
early	O
induction	O
of	O
double	O
-	O
stranded	O
RNA	O
(	O
dsRNA	O
)	O
host	O
cell	O
responses	O
.	O

Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
(	O
APACHE	O
)	O
scores	O
and	O
several	O
plasma	O
biological	O
markers	O
have	O
been	O
identified	O
to	O
predict	O
the	O
death	O
or	O
treatment	O
outcome	O
of	O
sepsis	B-SPEC
induced	O
ALI	O
.	O

The	O
distribution	O
of	O
these	O
antigens	O
was	O
comparatively	O
evaluated	O
in	O
different	O
anatomical	O
compartments	O
of	O
thymus	B-SPEC
,	O
spleen	O
,	O
mesenteric	O
,	O
and	O
tracheobronchial	O
lymph	O
nodes	O
.	O

TITLE	O
:	O
Nidovirus	B-SPEC
RNA	O
polymerases	O
:	O
Complex	O
enzymes	O
handling	O
exceptional	O
RNA	O
genomes	O
.	O

In	O
arteriviruses	B-SPEC
,	O
the	O
nsp1	O
subunit	O
was	O
found	O
to	O
maintain	O
the	O
balance	O
between	O
genome	O
replication	O
and	O
subgenomic	O
mRNA	O
production	O
.	O

Most	O
research	O
has	O
been	O
focused	O
on	O
isolation	O
,	O
genome	O
sequencing	O
,	O
pathogenicity	O
,	O
and	O
virulence	O
of	O
these	O
viruses	B-SPEC
,	O
but	O
there	O
is	O
little	O
information	O
on	O
long	O
-	O
term	O
growth	O
performance	O
and	O
tissue	O
accretion	O
of	O
pigs	B-SPEC
inoculated	O
with	O
PEDV	B-SPEC
or	O
PDCoV	O
.	O
Therefore	O
,	O
our	O
objective	O
was	O
to	O
determine	O
the	O
effect	O
of	O
PEDV	B-SPEC
or	O
PDCoV	O
infection	O
on	O
growth	O
performance	O
and	O
tissue	O
accretion	O
over	O
42	O
d	O
following	O
inoculation	O
.	O

Compared	O
to	O
Control	O
and	O
PDCoV	O
pigs	B-SPEC
,	O
the	O
overall	O
42	O
d	O
ADFI	O
was	O
reduced	O
in	O
the	O
challenged	O
PEDV	B-SPEC
pigs	B-SPEC
(	O
<	O
0	O
.	O
05	O
)	O
by	O
19	O
and	O
27	O
%,	O
respectively	O
.	O

We	O
'	O
ve	O
investigated	O
the	O
development	O
of	O
URT	O
and	O
systemic	O
,	O
cell	O
-	O
mediated	O
and	O
humoral	O
immunity	O
in	O
commercial	O
broiler	O
chickens	B-SPEC
vaccinated	O
with	O
Ma5	O
and	O
/	O
or	O
4	O
/	O
91	O
strains	O
at	O
hatch	O
day	O
.	O

China	O
ranked	O
first	O
on	O
SARS	O
,	O
Turkey	B-SPEC
ranked	O
first	O
on	O
Crimean	O
-	O
Congo	O
fever	O
,	O
while	O
the	O
United	O
States	O
of	O
America	O
ranked	O
first	O
on	O
the	O
remaining	O
six	O
diseases	O
.	O

Nevertheless	O
,	O
only	O
22	O
%	O
of	O
respondents	O
believed	O
that	O
camels	B-SPEC
are	O
the	O
zoonotic	O
reservoir	O
of	O
MERS	O
-	O
CoV	O
.	O
Those	O
who	O
were	O
concerned	O
about	O
contracting	O
MERS	O
-	O
CoV	O
(	O
aOR	O
:	O
1	O
.	O
6	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
2	O
-	O
2	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
those	O
who	O
thought	O
MERS	O
-	O
CoV	O
to	O
be	O
a	O
severe	O
disease	O
only	O
for	O
those	O
with	O
high	O
-	O
risk	O
conditions	O
(	O
aOR	O
:	O
1	O
.	O
5	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
1	O
-	O
2	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
were	O
more	O
likely	O
to	O
believe	O
that	O
camels	B-SPEC
are	O
the	O
zoonotic	O
source	O
.	O

Caveolin	O
-	O
1	O
(	O
Cav	B-SPEC
-	O
1	O
)	O
is	O
highly	O
expressed	O
in	O
pulmonary	O
microvascular	O
ECs	O
and	O
plays	O
a	O
key	O
role	O
in	O
maintaining	O
vascular	O
homeostasis	O
.	O

To	O
better	O
understand	O
the	O
prevalence	O
situation	O
,	O
we	O
conducted	O
molecular	O
epidemiological	O
analyses	O
of	O
38	O
PEDV	B-SPEC
strains	O
isolated	O
from	O
13	O
cities	O
in	O
Shandong	O
Province	O
.	O

Although	O
MERS	O
has	O
been	O
associated	O
with	O
30	O
%	O
case	O
fatality	O
in	O
human	B-SPEC
beings	O
,	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
in	O
dromedaries	B-SPEC
is	O
usually	O
asymptomatic	O
.	O

ABSTRACT	O
:	O
Equine	B-SPEC
coronavirus	B-SPEC
(	O
ECoV	O
)	O
is	O
considered	O
an	O
enteric	O
pathogen	O
of	O
foals	O
and	O
has	O
only	O
recently	O
been	O
associated	O
with	O
infections	O
in	O
adult	O
horses	B-SPEC
.	O

Geographic	O
region	O
(	O
Mid	O
-	O
West	O
;	O
P	O
=	O
0	O
.	O
008	O
),	O
breed	O
(	O
Draft	O
horses	B-SPEC
;	O
P	O
=	O
0	O
.	O
003	O
)	O
and	O
specific	O
uses	O
of	O
horses	B-SPEC
(	O
ranch	O
/	O
farm	O
,	O
P	O
=	O
0	O
.	O
034	O
;	O
breeding	O
use	O
,	O
P	O
=	O
0	O
.	O
016	O
)	O
were	O
all	O
statistically	O
significant	O
risk	O
factors	O
for	O
seropositivity	O
.	O

Although	O
lower	O
than	O
other	O
RNA	O
viruses	B-SPEC
such	O
as	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
,	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
did	O
exhibit	O
quasi	O
-	O
species	B-SPEC
.	O

Here	O
,	O
we	O
report	O
a	O
case	O
of	O
acute	O
necrotizing	O
pancreatitis	O
in	O
a	O
29	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
presented	O
with	O
severe	O
abdominal	O
pain	O
,	O
nausea	O
and	O
vomiting	O
.	O

RESULTS	O
:	O
Resveratrol	O
significantly	O
inhibited	O
MERS	O
-	O
CoV	O
infection	O
and	O
prolonged	O
cellular	O
survival	O
after	O
virus	B-SPEC
infection	O
.	O

She	O
suffered	O
significant	O
hemorrhage	O
requiring	O
transfusion	O
of	O
platelets	O
and	O
multidrug	O
-	O
resistant	O
Acinetobacter	B-SPEC
Baumannii	I-SPEC
infection	O
during	O
ECMO	O
support	O
.	O

We	O
detected	O
a	O
suppressive	O
effect	O
on	O
the	O
early	O
activation	O
of	O
TLR7	O
pathway	O
,	O
followed	O
by	O
lower	O
expression	O
levels	O
of	O
inflammatory	O
related	O
genes	O
induced	O
by	O
challenge	O
with	O
the	O
IBV	B-SPEC
B	O
isolate	O
when	O
compared	O
to	O
the	O
challenge	O
with	O
to	O
the	O
IBV	B-SPEC
A	O
isolate	O
.	O

Poor	O
prognosis	O
of	O
severe	O
adenovirus	B-SPEC
pneumonia	O
in	O
children	O
is	O
associated	O
with	O
anemia	B-SPEC
,	O
low	O
serum	O
albumin	O
,	O
inflammatory	O
response	O
,	O
concurrent	O
multiple	O
complications	O
and	O
underlying	O
lung	O
diseases	O
.	O

TITLE	O
:	O
Reactivity	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Structural	O
Proteins	O
to	O
Antibodies	O
against	O
Porcine	B-SPEC
Enteric	O
Coronaviruses	O
:	O
Diagnostic	O
Implications	O
.	O

As	O
DOX	O
is	O
used	O
extensively	O
in	O
pig	B-SPEC
husbandry	O
,	O
uncontrolled	O
application	O
poses	O
a	O
significant	O
threat	O
of	O
viral	O
infection	O
,	O
so	O
stricter	O
policies	O
on	O
its	O
usage	O
should	O
be	O
required	O
.	O

ΔTNC	O
was	O
measured	O
on	O
fresh	O
samples	O
and	O
on	O
frozen	O
-	O
thawed	O
supernatants	O
after	O
the	O
addition	O
of	O
feline	B-SPEC
blood	O
at	O
1	O
:	O
10	O
dilution	O
.	O

Supernatants	O
of	O
frozen	O
effusions	O
from	O
FIP	O
cats	B-SPEC
retain	O
the	O
ability	O
to	O
induce	O
cell	O
clumping	O
,	O
thus	O
the	O
modified	O
ΔTNC	O
measurement	O
is	O
a	O
reliable	O
tool	O
to	O
diagnose	O
FIP	O
on	O
samples	O
that	O
cannot	O
be	O
analyzed	O
immediately	O
.	O

Extrapulmonary	O
organ	O
dysfunction	O
was	O
common	O
,	O
generally	O
occurred	O
concurrent	O
with	O
respiratory	O
dysfunction	O
(	O
especially	O
in	O
sepsis	B-SPEC
),	O
and	O
was	O
a	O
major	O
risk	O
factor	O
for	O
mortality	O
in	O
pediatric	O
acute	O
respiratory	O
failure	O
.	O

To	O
address	O
the	O
relevance	O
of	O
small	O
non	O
-	O
coding	O
RNAs	O
in	O
SARS	O
-	O
CoV	O
pathology	O
,	O
we	O
deep	O
sequenced	O
RNAs	O
from	O
the	O
lungs	O
of	O
infected	O
mice	B-SPEC
and	O
discovered	O
three	O
18	O
-	O
22	O
nt	O
small	O
viral	O
RNAs	O
(	O
svRNAs	O
).	O

TITLE	O
:	O
Simultaneous	O
detection	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
,	O
and	O
related	O
bat	B-SPEC
coronaviruses	O
by	O
real	O
-	O
time	O
reverse	O
transcription	O
PCR	O
.	O

Primers	O
and	O
probes	O
that	O
target	O
the	O
conserved	O
spike	O
S2	O
region	O
of	O
human	B-SPEC
SARS	O
-	O
CoV	O
,	O
MERS	O
-	O
CoV	O
,	O
and	O
their	O
related	O
bat	B-SPEC
CoVs	O
were	O
designed	O
.	O

ABSTRACT	O
:	O
In	O
2012	O
,	O
a	O
Dog	B-SPEC
circovirus	B-SPEC
(	O
DogCV	O
)	O
was	O
discovered	O
in	O
the	O
USA	O
,	O
which	O
was	O
followed	O
by	O
further	O
descriptions	O
of	O
the	O
virus	B-SPEC
in	O
the	O
USA	O
,	O
Italy	O
and	O
Germany	O
.	O

In	O
approximately	O
50	O
%	O
of	O
the	O
DogCV	O
-	O
positive	O
dogs	B-SPEC
,	O
infections	O
with	O
other	O
enteropathogenic	O
organisms	O
were	O
diagnosed	O
.	O

Despite	O
both	O
OME	O
and	O
control	O
patients	O
presented	O
similar	O
rates	O
of	O
viruses	B-SPEC
and	O
bacteria	B-SPEC
at	O
the	O
adenoid	O
,	O
children	O
with	O
OME	O
presented	O
higher	O
prevalence	O
of	O
S	O
.	O
pneumonia	O
,	O
M	B-SPEC
.	I-SPEC
catarrhalis	I-SPEC
in	O
middle	O
ear	O
and	O
adenovirus	B-SPEC
in	O
adenoids	O
when	O
compared	O
to	O
controls	O
.	O

We	O
describe	O
the	O
histopathological	O
,	O
immunohistochemical	O
,	O
and	O
ultrastructural	O
findings	O
from	O
rhesus	B-SPEC
macaque	I-SPEC
and	O
common	B-SPEC
marmoset	I-SPEC
animal	B-SPEC
models	O
of	O
MERS	O
-	O
CoV	O
infection	O
.	O

The	O
main	O
histopathological	O
findings	O
in	O
the	O
lungs	O
of	O
rhesus	B-SPEC
macaques	I-SPEC
and	O
common	B-SPEC
marmosets	I-SPEC
were	O
varying	O
degrees	O
of	O
pulmonary	O
lesions	O
,	O
including	O
pneumonia	O
,	O
pulmonary	O
oedema	O
,	O
haemorrhage	O
,	O
degeneration	O
and	O
necrosis	O
of	O
the	O
pneumocytes	O
and	O
bronchial	O
epithelial	O
cells	O
,	O
and	O
inflammatory	O
cell	O
infiltration	O
.	O

MERS	O
-	O
CoV	O
antigens	O
and	O
viral	O
RNA	O
were	O
identified	O
in	O
type	O
I	O
and	O
II	O
pneumocytes	O
,	O
alveolar	O
macrophages	O
and	O
bronchial	O
epithelial	O
cells	O
,	O
and	O
ultrastructural	O
observations	O
showed	O
that	O
viral	O
protein	O
was	O
found	O
in	O
type	O
II	O
pneumocytes	O
and	O
inflammatory	O
cells	O
in	O
both	O
species	B-SPEC
.	O

Thai	O
PEDV	B-SPEC
spike	O
gene	O
have	O
higher	O
evolutionary	O
rate	O
compare	O
to	O
that	O
of	O
the	O
US	O
sequences	O
.	O

The	O
MERS	O
-	O
CoV	O
S	O
nanoparticle	O
vaccine	O
produced	O
high	O
titer	O
anti	O
-	O
S	O
neutralizing	O
antibody	O
and	O
protected	O
mice	B-SPEC
from	O
MERS	O
-	O
CoV	O
infection	O
in	O
vivo	O
.	O

These	O
results	O
suggested	O
that	O
during	O
mouse	B-SPEC
pneumonia	O
,	O
changes	O
in	O
the	O
expression	O
of	O
gene	O
clusters	O
and	O
the	O
complex	O
interactions	O
among	O
genes	O
lead	O
to	O
significant	O
changes	O
in	O
function	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
an	O
emerging	O
swine	B-SPEC
enteropathogenic	O
coronavirus	B-SPEC
.	O

In	O
RSV	B-SPEC
-	O
Rhinovirus	B-SPEC
(	O
RV	B-SPEC
)	O
multiple	O
infections	O
,	O
a	O
low	O
viral	O
load	O
of	O
RV	B-SPEC
was	O
correlated	O
with	O
a	O
high	O
length	O
of	O
hospital	O
stay	O
and	O
a	O
high	O
duration	O
of	O
extra	O
oxygen	O
use	O
.	O

The	O
mean	O
CT	O
value	O
for	O
RV	O
,	O
HCoV	O
and	O
Parainfluenza	O
virus	B-SPEC
was	O
significantly	O
lower	O
in	O
single	O
-	O
versus	O
multiple	O
infections	O
.	O

Group	B-SPEC
A	I-SPEC
streptococcus	I-SPEC
(	O
GAS	O
)	O
is	O
the	O
only	O
established	O
pathogen	O
in	O
PTA	O
.	O

To	O
explore	O
the	O
microbiology	O
of	O
PTA	O
with	O
a	O
special	O
attention	O
to	O
Fusobacterium	B-SPEC
necrophorum	I-SPEC
(	O
FN	O
).	O

FN	O
-	O
positive	O
patients	O
displayed	O
significantly	O
higher	O
infection	O
markers	O
(	O
CRP	O
and	O
neutrophil	O
counts	O
)	O
than	O
patients	O
infected	O
with	O
other	O
bacteria	B-SPEC
(	O
P	O
=	O
0	O
.	O
01	O
and	O
P	O
<	O
0	O
.	O
001	O
,	O
respectively	O
).	O

Using	O
PCR	O
analysis	O
for	O
the	O
presence	O
of	O
herpes	O
simplex	O
1	O
and	O
2	O
,	O
adenovirus	B-SPEC
,	O
influenza	O
A	O
and	O
B	O
,	O
Epstein	B-SPEC
-	I-SPEC
Barr	I-SPEC
virus	I-SPEC
(	O
EBV	O
),	O
and	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
A	O
and	O
B	O
,	O
we	O
explored	O
a	O
possible	O
role	O
of	O
viruses	B-SPEC
in	O
PTA	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
fatal	O
disease	O
with	O
no	O
clinically	O
effective	O
treatment	O
.	O

The	O
origin	O
of	O
these	O
emerging	O
respiratory	O
viruses	B-SPEC
may	O
be	O
zoonotic	O
(	O
by	O
crossing	O
species	B-SPEC
barrier	O
,	O
after	O
changes	O
to	O
RNA	O
viruses	B-SPEC
such	O
as	O
avian	O
influenza	B-SPEC
virus	I-SPEC
type	I-SPEC
A	I-SPEC
or	O
coronaviruses	O
),	O
or	O
related	O
to	O
the	O
use	O
of	O
new	O
identification	O
techniques	O
(	O
metapneumovirus	B-SPEC
,	O
bocavirus	B-SPEC
).	O

ABSTRACT	O
:	O
This	O
article	O
reviews	O
the	O
current	O
epidemiology	O
and	O
clinical	O
presentation	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
and	O
describes	O
the	O
preparedness	O
plan	O
of	O
several	O
countries	O
.	O

MERS	O
-	O
CoV	O
is	O
a	O
relatively	O
new	O
virus	B-SPEC
,	O
and	O
this	O
work	O
is	O
intended	O
to	O
add	O
to	O
the	O
still	O
-	O
sparse	O
data	O
on	O
its	O
epidemiology	O
,	O
modes	O
of	O
transmission	O
,	O
natural	O
history	O
,	O
and	O
clinical	O
features	O
as	O
well	O
as	O
to	O
describe	O
the	O
preparedness	O
plan	O
for	O
MERS	O
-	O
CoV	O
infection	O
in	O
several	O
countries	O
.	O

WN	O
surveillance	O
can	O
help	O
to	O
deepen	O
our	O
knowledge	O
of	O
horse	B-SPEC
neurological	O
disorders	O
investigating	O
their	O
causes	O
and	O
incidence	O
.	O

ABSTRACT	O
:	O
Immune	O
response	O
of	O
gilts	O
following	O
single	O
and	O
double	O
infection	O
with	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
at	O
gilt	O
acclimatization	O
and	O
prepartum	O
were	O
investigated	O
.	O

Immunofluorescence	O
confocal	O
microscopy	O
showed	O
that	O
PEDV	B-SPEC
was	O
trapped	O
at	O
cellular	O
junctional	O
regions	O
upon	O
macropinocytosis	O
inhibitor	O
treatment	O
,	O
indicating	O
that	O
occludin	O
may	O
serve	O
as	O
a	O
scaffold	O
in	O
the	O
vicinity	O
of	O
virus	B-SPEC
entry	O
.	O

Our	O
observation	O
may	O
provide	O
novel	O
insights	O
into	O
PEDV	B-SPEC
infection	O
and	O
related	O
pathogenesis	O
.	O

TITLE	O
:	O
Characterization	O
of	O
Chinese	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
with	O
Novel	O
Insertions	O
and	O
Deletions	O
in	O
Genome	O
.	O

It	O
is	O
necessary	O
to	O
strengthen	O
the	O
monitoring	O
of	O
PEDV	B-SPEC
variations	O
.	O

Nevertheless	O
,	O
its	O
optimal	O
immunogen	O
dosage	O
and	O
immunization	O
interval	O
,	O
key	O
factors	O
for	O
human	B-SPEC
-	O
used	O
vaccines	O
that	O
induce	O
protective	O
immunity	O
,	O
have	O
never	O
been	O
investigated	O
.	O

Like	O
related	O
animal	B-SPEC
β1CoVs	O
,	O
OC43	O
uses	O
9	O
-	O
O	O
-	O
acetylated	O
sialic	O
acid	O
as	O
receptor	O
determinant	O
.	O

Human	B-SPEC
rhinovirus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
and	O
coronavirus	B-SPEC
have	O
been	O
considered	O
as	O
the	O
most	O
important	O
respiratory	O
pathogens	O
and	O
relatively	O
little	O
attention	O
has	O
been	O
paid	O
to	O
the	O
role	O
of	O
parainfluenza	O
viruses	B-SPEC
(	O
hPIVs	O
).	O

In	O
this	O
review	O
,	O
we	O
summarized	O
the	O
basic	O
epidemiology	O
and	O
immunology	O
of	O
hPIVs	O
and	O
addressed	O
the	O
more	O
recent	O
data	O
implicating	O
the	O
role	O
of	O
parainfluenza	O
viruses	B-SPEC
in	O
the	O
exacerbation	O
of	O
chronic	O
airway	O
disorders	O
.	O

ABSTRACT	O
:	O
Although	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
has	O
caused	O
huge	O
economic	O
losses	O
in	O
the	O
pork	O
industry	O
worldwide	O
,	O
an	O
effective	O
live	O
,	O
attenuated	O
vaccine	O
is	O
lacking	O
.	O

Based	O
on	O
the	O
severity	O
of	O
clinical	O
signs	O
,	O
histopathological	O
lesions	O
and	O
the	O
distribution	O
of	O
PEDV	B-SPEC
antigens	O
in	O
the	O
gut	O
,	O
the	O
virulence	O
of	O
P100	O
and	O
above	O
,	O
but	O
not	O
P95C13	O
(	O
CCL81	O
),	O
was	O
markedly	O
reduced	O
in	O
4	O
-	O
day	O
-	O
old	O
,	O
caesarian	O
-	O
derived	O
,	O
colostrum	O
-	O
deprived	O
piglets	O
.	O

Compared	O
with	O
P120	O
,	O
P160	O
replicated	O
less	O
efficiently	O
in	O
the	O
intestine	O
of	O
pigs	B-SPEC
and	O
induced	O
a	O
lower	O
rate	O
of	O
protection	O
after	O
challenge	O
.	O

However	O
,	O
the	O
overall	O
pattern	O
of	O
attenuation	O
-	O
related	O
genetic	O
changes	O
in	O
PC22A	O
differed	O
from	O
those	O
of	O
the	O
other	O
four	O
pairs	O
of	O
PEDV	B-SPEC
wild	O
type	O
strains	O
and	O
their	O
attenuated	O
derivatives	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
high	O
mortality	O
in	O
pigs	B-SPEC
.	O

TITLE	O
:	O
Resection	O
and	O
Primary	O
Closure	O
of	O
Edematous	O
Glossoepiglottic	O
Mucosa	O
in	O
a	O
Dog	B-SPEC
Causing	O
Laryngeal	O
Obstruction	O
.	O

Static	O
displacement	O
of	O
the	O
GE	O
mucosa	O
may	O
occur	O
in	O
patients	O
with	O
BOAS	B-SPEC
.	O

In	O
Morocco	O
,	O
more	O
than	O
50	O
cases	O
of	O
malaria	O
occur	O
each	O
year	O
,	O
83	O
%	O
of	O
which	O
with	O
Plasmodium	B-SPEC
falciparum	I-SPEC
malaria	O
.	O

This	O
study	O
explores	O
the	O
mechanism	O
of	O
autophagy	O
induction	O
by	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHEV	B-SPEC
)	O
in	O
Neuro	O
-	O
2a	O
cells	O
,	O
and	O
examines	O
the	O
role	O
of	O
autophagy	O
in	O
PHEV	B-SPEC
replication	O
.	O

Viral	O
agents	O
were	O
identified	O
by	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
,	O
bacteria	B-SPEC
were	O
identified	O
by	O
aerobic	O
culture	O
,	O
and	O
Mycoplasma	B-SPEC
bovis	I-SPEC
(	O
M	B-SPEC
.	I-SPEC
bovis	I-SPEC
)	O
isolates	O
were	O
speciated	O
by	O
PCR	O
.	O

For	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
),	O
agreement	O
with	O
TTW	O
was	O
moderate	O
for	O
NS	O
,	O
good	O
for	O
NPS	O
,	O
and	O
very	O
good	O
for	O
BAL	O
.	O

McNemar	O
'	O
s	O
test	O
was	O
significant	O
only	O
for	O
BCV	B-SPEC
,	O
indicating	O
that	O
for	O
this	O
pathogen	O
the	O
proportion	O
of	O
positive	O
results	O
from	O
NS	O
and	O
NPS	O
could	O
not	O
be	O
considered	O
comparable	O
to	O
TTW	O
.	O

We	O
reviewed	O
the	O
cases	O
of	O
RVI	O
in	O
allo	O
-	O
HSCT	O
recipients	O
and	O
explored	O
the	O
predictive	O
value	O
of	O
the	O
immunodeficiency	O
scoring	O
index	O
(	O
ISI	O
)	O
established	O
for	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
and	O
its	O
applicability	O
for	O
RVI	O
caused	O
by	O
other	O
respiratory	O
viruses	B-SPEC
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
infections	O
in	O
horses	B-SPEC
in	O
Saudi	O
Arabia	O
and	O
Oman	O
.	O

Based	O
on	O
these	O
findings	O
,	O
we	O
further	O
confirmed	O
that	O
N30	O
provided	O
a	O
strong	O
inhibition	O
on	O
the	O
replication	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
coronavirus	B-SPEC
,	O
enterovirus	B-SPEC
71	O
and	O
a	O
diverse	O
strains	O
of	O
coxsackie	O
B	B-SPEC
virus	I-SPEC
.	O

RESULTS	O
:	O
The	O
results	O
demonstrated	O
that	O
N30	O
inhibited	O
the	O
replication	O
of	O
H1N1	O
,	O
H3N2	O
,	O
influenza	O
B	O
viruses	B-SPEC
,	O
including	O
oseltamivir	O
and	O
amantadine	O
resistant	O
strains	O
in	O
vitro	O
.	O

In	O
this	O
study	O
,	O
we	O
found	O
the	O
miR	O
-	O
21a	O
-	O
5p	O
is	O
notably	O
up	O
-	O
regulated	O
in	O
the	O
brains	O
of	O
mice	B-SPEC
and	O
N2a	O
cells	O
infected	O
with	O
PHEV	O
,	O
and	O
it	O
down	O
-	O
regulated	O
the	O
expression	O
of	O
CASK	O
-	O
interactive	O
protein1	O
(	O
Caskin1	O
)	O
by	O
directly	O
targeting	O
the	O
3	O
'-	O
UTR	O
of	O
Caskin1	O
using	O
a	O
Dual	O
-	O
Luciferase	O
reporter	O
assay	O
.	O

Phylogenetic	O
tree	O
analysis	O
of	O
ORF3	O
showed	O
that	O
the	O
eight	O
TGEV	B-SPEC
ORF3	O
genes	O
all	O
belonged	O
to	O
the	O
Miller	O
cluster	O
.	O

Furthermore	O
,	O
we	O
found	O
the	O
first	O
evidence	O
for	O
a	O
large	O
deletion	O
in	O
ORF3	O
resulting	O
in	O
the	O
loss	O
of	O
ORF3a	O
,	O
previously	O
reported	O
in	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
,	O
in	O
three	O
field	O
strains	O
(	O
CH	O
-	O
LNCT	O
,	O
CH	O
-	O
MZL	O
,	O
and	O
CH	O
-	O
SH	O
)	O
of	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Arkansas	O
Delmarva	O
Poultry	O
Industry	O
(	O
ArkDPI	O
)	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccine	O
is	O
effective	O
when	O
administered	O
by	O
eye	O
drop	O
,	O
where	O
the	O
vaccine	O
virus	B-SPEC
is	O
able	O
to	O
infect	O
and	O
replicate	O
well	O
in	O
birds	B-SPEC
and	O
is	O
able	O
to	O
induce	O
protection	O
against	O
homologous	O
challenge	O
.	O

The	O
choanal	O
cleft	O
of	O
each	O
bird	B-SPEC
was	O
swabbed	O
at	O
7	O
and	O
10	O
days	O
postvaccination	O
,	O
and	O
real	O
-	O
time	O
reverse	O
-	O
transcriptase	O
PCR	O
was	O
performed	O
.	O

ABSTRACT	O
:	O
Respiratory	O
viruses	B-SPEC
are	O
frequently	O
detected	O
in	O
association	O
with	O
chronic	O
tonsillar	O
hypertrophy	O
in	O
the	O
absence	O
of	O
symptoms	O
of	O
acute	O
respiratory	O
infection	O
(	O
ARI	O
).	O

Inoculation	O
did	O
not	O
cause	O
disease	O
,	O
but	O
a	O
low	O
level	O
of	O
virus	B-SPEC
replication	O
,	O
shedding	O
,	O
and	O
seroconversion	O
were	O
observed	O
.	O

Here	O
we	O
have	O
collected	O
samples	O
from	O
Mallards	B-SPEC
(	O
Anas	B-SPEC
platyrhynchos	I-SPEC
)	O
residing	O
in	O
a	O
pond	O
in	O
central	O
Uppsala	O
,	O
Sweden	O
,	O
from	O
January	O
2013	O
to	O
January	O
2014	O
.	O

Furthermore	O
,	O
in	O
comparison	O
to	O
wild	O
ducks	B-SPEC
,	O
autumnal	O
prevalence	O
of	O
IAV	O
and	O
CoV	O
are	O
lower	O
in	O
this	O
urban	O
population	O
.	O

ABSTRACT	O
:	O
The	O
possible	O
role	O
of	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
in	O
lower	O
respiratory	O
tract	O
disease	O
(	O
LRTD	O
)	O
in	O
hematopoietic	O
cell	O
transplant	O
(	O
HCT	O
)	O
recipients	O
and	O
patients	O
with	O
hematologic	O
malignancies	O
(	O
HM	O
)	O
has	O
not	O
been	O
well	O
studied	O
.	O

Mortality	O
associated	O
with	O
HCoV	O
LRTD	O
in	O
HCT	O
recipients	O
appears	O
to	O
be	O
similar	O
to	O
that	O
seen	O
with	O
RSV	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
and	O
PIV	O
.	O

TITLE	O
:	O
Outcome	O
and	O
Management	O
of	O
Refractory	O
Respiratory	O
Failure	O
With	O
Timely	O
Extracorporeal	O
Membrane	O
Oxygenation	O
:	O
Single	O
-	O
Center	O
Experience	O
With	O
Legionella	B-SPEC
Pneumonia	O
.	O

ABSTRACT	O
:	O
MERS	O
-	O
coronavirus	B-SPEC
is	O
a	O
novel	O
zoonotic	O
pathogen	O
which	O
spread	O
rapidly	O
to	O
>	O
25	O
countries	O
since	O
2012	O
.	O

Fifty	O
-	O
three	O
animals	B-SPEC
presented	O
for	O
slaughter	O
were	O
sampled	O
.	O

ABSTRACT	O
:	O
A	O
cross	O
-	O
sectional	O
study	O
was	O
conducted	O
in	O
Egypt	O
to	O
determine	O
the	O
prevalence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
imported	O
and	O
resident	O
camels	B-SPEC
and	O
bats	B-SPEC
,	O
as	O
well	O
as	O
to	O
assess	O
possible	O
transmission	O
of	O
the	O
virus	B-SPEC
to	O
domestic	O
ruminants	B-SPEC
and	O
equines	B-SPEC
.	O

All	O
tested	O
samples	O
from	O
domestic	O
animals	B-SPEC
and	O
bats	B-SPEC
were	O
negative	O
for	O
MERS	O
-	O
CoV	O
antibodies	O
except	O
one	O
sheep	B-SPEC
sample	O
which	O
showed	O
a	O
1	O
:	O
640	O
titre	O
.	O

Of	O
1	O
,	O
078	O
camels	B-SPEC
,	O
41	O
(	O
3	O
.	O
8	O
%)	O
were	O
positive	O
for	O
MERS	O
-	O
CoV	O
genetic	O
material	O
.	O

The	O
presence	O
of	O
neutralising	O
antibodies	O
in	O
one	O
sheep	B-SPEC
apparently	O
in	O
contact	O
with	O
seropositive	O
camels	B-SPEC
calls	O
for	O
further	O
studies	O
on	O
domestic	O
animals	B-SPEC
in	O
contact	O
with	O
camels	B-SPEC
.	O

TITLE	O
:	O
Recombinant	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
expressing	O
the	O
infectious	O
bronchitis	O
virus	B-SPEC
S1	O
gene	O
protects	O
chickens	B-SPEC
against	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
and	O
infectious	O
bronchitis	O
virus	B-SPEC
challenge	O
.	O

In	O
addition	O
,	O
vaccination	O
with	O
the	O
rLaSota	O
-	O
S1	O
strain	O
induced	O
IBV	B-SPEC
-	O
specific	O
IgG	O
antibodies	O
and	O
cellular	O
immunity	O
;	O
however	O
,	O
a	O
single	O
vaccination	O
provided	O
partial	O
protection	O
with	O
reduced	O
virus	B-SPEC
shedding	O
.	O

A	O
small	O
animal	B-SPEC
model	O
that	O
develops	O
progressive	O
pulmonary	O
manifestations	O
when	O
infected	O
with	O
MERS	O
-	O
CoV	O
would	O
advance	O
the	O
field	O
.	O

Moreover	O
,	O
coinfection	O
was	O
not	O
uncommon	O
in	O
this	O
study	O
,	O
in	O
which	O
17	O
.	O
3	O
%	O
of	O
the	O
infected	O
patients	O
had	O
dual	O
infections	O
due	O
to	O
several	O
combinations	O
of	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
evaluated	O
the	O
nosocomial	O
outbreak	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
Coronavirus	B-SPEC
(	O
CoV	O
)	O
in	O
the	O
Republic	O
of	O
Korea	O
,	O
2015	O
,	O
from	O
a	O
healthcare	O
operations	O
management	O
perspective	O
.	O

Samples	O
from	O
other	O
bat	B-SPEC
species	B-SPEC
were	O
negative	O
for	O
these	O
viruses	B-SPEC
,	O
indicating	O
that	O
the	O
least	B-SPEC
horseshoe	I-SPEC
bat	I-SPEC
represents	O
one	O
of	O
the	O
natural	O
reservoirs	O
and	O
mixers	O
for	O
strains	O
of	O
CoVs	O
and	O
has	O
a	O
pivotal	O
role	O
in	O
the	O
evolution	O
and	O
dissemination	O
of	O
these	O
viruses	B-SPEC
.	O

Furthermore	O
,	O
both	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
replication	O
and	O
IL	O
-	O
1	O
were	O
shown	O
to	O
upregulate	O
a	O
small	O
set	O
of	O
genes	O
encoding	O
immunomodulatory	O
factors	O
that	O
bind	O
p65	O
at	O
promoters	O
and	O
require	O
IKKβ	O
activity	O
and	O
p65	O
for	O
expression	O
.	O

The	O
virus	B-SPEC
infects	O
the	O
intestinal	O
epithelium	O
and	O
causes	O
villous	O
atrophy	O
,	O
resulting	O
in	O
diarrhea	O
and	O
dehydration	O
.	O

The	O
presence	O
of	O
13	O
different	O
viral	O
pathogens	O
(	O
influenza	O
A	O
[	O
H1N1	O
]	O
pdm09	O
;	O
A	O
/	O
H3N2	O
;	O
A	O
/	O
H5	O
;	O
A	O
/	O
H7	O
and	O
B	O
;	O
para	O
influenza	O
1	O
,	O
2	O
,	O
3	O
;	O
RSV	B-SPEC
;	O
HMPV	B-SPEC
;	O
adeno	O
;	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
CoV	O
and	O
rhino	O
)	O
was	O
tested	O
by	O
conventional	O
/	O
real	O
-	O
time	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
.	O

Severe	O
pediatric	O
pneumonia	O
accounts	O
for	O
a	O
significant	O
number	O
of	O
PICU	B-SPEC
admissions	O
and	O
is	O
associated	O
with	O
significant	O
mortality	O
risk	O
.	O

The	O
VCL	O
-	O
D841H	O
variant	O
was	O
engineered	O
and	O
either	O
coexpressed	O
with	O
cardiac	O
sodium	O
channel	O
(	O
SCN5A	O
)	O
in	O
HEK293	O
cells	O
or	O
overexpressed	O
in	O
human	B-SPEC
induced	O
pluripotent	O
stem	O
-	O
cell	O
-	O
derived	O
cardiomyocytes	O
to	O
examine	O
its	O
effects	O
on	O
sodium	O
channel	O
function	O
using	O
the	O
whole	O
-	O
cell	O
patch	O
-	O
clamp	O
method	O
.	O

Enhanced	O
susceptibility	O
of	O
male	O
mice	B-SPEC
to	O
SARS	O
-	O
CoV	O
was	O
associated	O
with	O
elevated	O
virus	B-SPEC
titers	O
,	O
enhanced	O
vascular	O
leakage	O
,	O
and	O
alveolar	O
edema	O
.	O

Furthermore	O
,	O
ovariectomy	O
or	O
treating	O
female	O
mice	B-SPEC
with	O
an	O
estrogen	O
receptor	O
antagonist	O
increased	O
mortality	O
,	O
indicating	O
a	O
protective	O
effect	O
for	O
estrogen	O
receptor	O
signaling	O
in	O
mice	B-SPEC
infected	O
with	O
SARS	O
-	O
CoV	O
.	O
Together	O
,	O
these	O
data	O
suggest	O
that	O
sex	O
differences	O
in	O
the	O
susceptibility	O
to	O
SARS	O
-	O
CoV	O
in	O
mice	B-SPEC
parallel	O
those	O
observed	O
in	O
patients	O
and	O
also	O
identify	O
estrogen	O
receptor	O
signaling	O
as	O
critical	O
for	O
protection	O
in	O
females	O
.	O

TITLE	O
:	O
Chelation	O
Motifs	O
Affecting	O
Metal	O
-	O
dependent	O
Viral	O
Enzymes	O
:	O
ABSTRACT	O
:	O
Human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
)	O
infection	O
,	O
still	O
represent	O
a	O
serious	O
global	O
health	O
emergency	O
.	O

Two	O
thermal	O
processing	O
experiments	O
were	O
designed	O
to	O
determine	O
if	O
different	O
pellet	O
mill	O
conditioner	O
retention	O
times	O
and	O
temperatures	O
would	O
impact	O
PEDV	B-SPEC
quantity	O
and	O
infectivity	O
by	O
analysis	O
of	O
quantitative	O
reverse	O
transcription	O
PCR	O
and	O
bioassay	O
.	O

However	O
,	O
infectivity	O
was	O
detected	O
by	O
bioassay	O
only	O
in	O
pigs	B-SPEC
from	O
the	O
37	O
.	O
8	O
and	O
46	O
.	O
1	O
°	O
C	O
conditioning	O
temperatures	O
.	O

These	O
results	O
indicate	O
that	O
indirect	O
PEDV	B-SPEC
transmission	O
through	O
contaminated	O
PPE	O
occurs	O
rapidly	O
(	O
within	O
24	O
h	O
)	O
under	O
modeled	O
conditions	O
.	O

Our	O
observations	O
picture	O
the	O
antibody	O
epitope	O
landscape	O
of	O
the	O
PEDV	B-SPEC
S1	O
subunit	O
and	O
reveal	O
that	O
its	O
cell	O
attachment	O
domains	O
are	O
key	O
targets	O
of	O
neutralizing	O
antibodies	O
.	O

All	O
newly	O
-	O
identified	O
betacoronaviruses	O
were	O
SARS	O
-	O
related	O
Rhinolophus	B-SPEC
bat	B-SPEC
coronaviruses	O
(	O
SARSr	O
-	O
Rh	O
-	O
BatCoV	O
).	O

These	O
results	O
suggested	O
that	O
the	O
Brazilian	O
BCoV	O
evolved	O
from	O
being	O
solely	O
enteric	O
to	O
a	O
dual	O
enteric	O
and	O
respiratory	O
tropic	O
virus	B-SPEC
.	O

In	O
this	O
study	O
,	O
using	O
real	O
-	O
time	O
PCR	O
and	O
multiplex	O
bead	O
-	O
based	O
immunoassay	O
,	O
the	O
expression	O
profiles	O
of	O
several	O
immune	O
mediators	O
were	O
examined	O
in	O
Crandell	O
-	O
Reese	O
feline	B-SPEC
kidney	O
(	O
CRFK	O
)	O
cells	O
infected	O
with	O
the	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	B-SPEC
)	O
strain	O
FIPV	O
79	O
-	O
1146	O
and	O
in	O
samples	O
obtained	O
from	O
FCoV	B-SPEC
-	O
positive	O
cats	B-SPEC
.	O

Higher	O
viral	O
load	O
was	O
also	O
detected	O
in	O
the	O
supernatant	O
of	O
peritoneal	O
effusions	O
compared	O
to	O
in	O
the	O
plasma	O
of	O
FCoV	O
-	O
positive	O
cats	B-SPEC
.	O

As	O
previously	O
reported	O
,	O
LiCl	O
has	O
obviously	O
inhibition	O
effects	O
on	O
a	O
variety	O
of	O
viruses	B-SPEC
such	O
as	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
),	O
and	O
pseudorabies	O
herpesvirus	B-SPEC
and	O
EV	O
-	O
A71	O
virus	B-SPEC
.	O

Virus	B-SPEC
titration	O
assay	O
was	O
calculated	O
by	O
the	O
50	O
%	O
tissue	O
culture	O
infected	O
dose	O
(	O
TCID	O

Further	O
sequence	O
conservation	O
analysis	O
of	O
six	O
human	B-SPEC
-	O
infecting	O
coronaviruses	O
revealed	O
that	O
the	O
fusion	O
peptide	O
,	O
HR1	O
region	O
and	O
the	O
central	O
helix	O
are	O
potential	O
targets	O
for	O
eliciting	O
broadly	O
neutralizing	O
antibodies	O
.	O

In	O
addition	O
,	O
drugs	O
that	O
bind	O
the	O
active	O
site	O
inhibited	O
both	O
coronavirus	B-SPEC
binding	O
to	O
cell	O
surface	O
APN	O
and	O
infection	O
;	O
the	O
drugs	O
probably	O
hindered	O
APN	O
transition	O
to	O
the	O
virus	B-SPEC
-	O
specific	O
open	O
form	O
.	O

The	O
method	O
was	O
used	O
for	O
screening	O
of	O
synthetic	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
Mycobacterium	B-SPEC
tuberculosis	I-SPEC
(	O
MTB	O
),	O
and	O
human	B-SPEC
papillomavirus	I-SPEC
(	O
HPV	O
)	O
DNA	O
based	O
on	O
a	O
colorimetric	O
paper	O
-	O
based	O
analytical	O
device	O
developed	O
using	O
the	O
aforementioned	O
principle	O
.	O

Given	O
the	O
on	O
-	O
going	O
risk	O
of	O
emerging	O
infectious	O
disease	O
outbreaks	O
in	O
an	O
era	O
of	O
unprecedented	O
population	O
density	O
,	O
international	O
travel	O
and	O
human	B-SPEC
impact	O
on	O
the	O
environment	O
it	O
is	O
pertinent	O
to	O
focus	O
on	O
improving	O
the	O
research	O
and	O
development	O
landscape	O
for	O
treatments	O
of	O
emerging	O
and	O
epidemic	O
-	O
prone	O
infections	O
.	O

ABSTRACT	O
:	O
As	O
of	O
January	O
2016	O
,	O
1	O
,	O
633	O
laboratory	O
-	O
confirmed	O
cases	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
and	O
587	O
MERS	O
-	O
related	O
deaths	O
have	O
been	O
reported	O
by	O
the	O
World	O
Health	O
Organization	O
globally	O
.	O

Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
may	O
occur	O
sporadically	O
in	O
communities	O
or	O
may	O
be	O
transmitted	O
within	O
families	O
or	O
hospitals	O
.	O

TITLE	O
:	O
Three	O
Hypothetical	O
Inflammation	O
Pathobiology	O
Phenotypes	O
and	O
Pediatric	O
Sepsis	B-SPEC
-	O
Induced	O
Multiple	O
Organ	O
Failure	O
Outcome	O
.	O

ABSTRACT	O
:	O
We	O
hypothesize	O
that	O
three	O
inflammation	O
pathobiology	O
phenotypes	O
are	O
associated	O
with	O
increased	O
inflammation	O
,	O
proclivity	O
to	O
develop	O
features	O
of	O
macrophage	O
activation	O
syndrome	O
,	O
and	O
multiple	O
organ	O
failure	O
-	O
related	O
death	O
in	O
pediatric	O
severe	O
sepsis	B-SPEC
.	O

Furthermore	O
,	O
our	O
results	O
statistically	O
confirm	O
that	O
especially	O
young	O
birds	B-SPEC
are	O
susceptible	O
to	O
infection	O
with	O
rotavirus	B-SPEC
and	O
astrovirus	O
.	O

RESULTS	O
:	O
Overall	O
,	O
137	O
(	O
66	O
.	O
2	O
%,	O
95	O
%	O
CI	O
:	O
59	O
.	O
3	O
-	O
72	O
.	O
6	O
)	O
of	O
the	O
207	O
turkey	B-SPEC
flocks	O
sampled	O
were	O
infected	O
with	O
one	O
or	O
more	O
enteric	O
viruses	B-SPEC
.	O

Comprehensive	O
analysis	O
of	O
ubiquitin	O
-	O
conjugated	O
proteins	O
using	O
immunoprecipitation	O
and	O
nanoLC	O
-	O
MS	O
/	O
MS	O
indicated	O
that	O
SARS	O
-	O
CoV	O
PLpro	O
caused	O
the	O
change	O
in	O
the	O
ubiquitination	O
profile	O
of	O
Rho	O
GTPase	O
family	B-SPEC
proteins	O
,	O
in	O
which	O
linked	O
with	O
the	O
increase	O
of	O
Rho	O
-	O
like	O
GTPase	O
family	B-SPEC
proteins	O
.	O

TITLE	O
:	O
Airway	O
proteases	O
:	O
an	O
emerging	O
drug	O
target	O
for	O
influenza	O
and	O
other	O
respiratory	O
virus	B-SPEC
infections	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
and	O
rodents	B-SPEC
are	O
being	O
increasingly	O
recognized	O
as	O
reservoirs	O
of	O
emerging	O
zoonotic	O
viruses	B-SPEC
.	O

Further	O
,	O
coronavirus	B-SPEC
RNA	O
was	O
detected	O
in	O
12	O
of	O
270	O
(	O
4	O
.	O
4	O
%)	O
of	O
rat	B-SPEC
faecal	O
samples	O
;	O
all	O
samples	O
tested	O
negative	O
for	O
paramyxovirus	O
.	O

Phylogenetic	O
analysis	O
revealed	O
that	O
the	O
bat	B-SPEC
paramyxoviruses	O
and	O
bat	B-SPEC
and	O
rat	B-SPEC
coronaviruses	O
were	O
related	O
to	O
viruses	B-SPEC
circulating	O
in	O
bat	B-SPEC
and	O
rodent	B-SPEC
populations	O
globally	O
,	O
but	O
showed	O
no	O
cross	O
-	O
species	B-SPEC
mixing	O
of	O
viruses	B-SPEC
between	O
bat	B-SPEC
and	O
rat	B-SPEC
populations	O
within	O
Viet	O
Nam	O
.	O

Finally	O
,	O
we	O
confirmed	O
through	O
our	O
observations	O
that	O
Ark	O
vaccines	O
administered	O
by	O
hatchery	O
spray	O
cabinet	O
elicit	O
weaker	O
immune	O
responses	O
and	O
protection	O
against	O
an	O
IBV	B-SPEC
homologous	O
challenge	O
compared	O
to	O
the	O
same	O
vaccine	O
delivered	O
via	O
ocular	O
route	O
.	O

We	O
used	O
adult	O
C57Bl6	O
wild	O
-	O
type	O
(	O
WT	O
)	O
and	O
IL	O
-	O
6	O
knock	O
-	O
out	O
(	O
IL	O
-	O
6KO	O
)	O
mice	B-SPEC
.	O

In	O
other	O
experiments	O
,	O
right	O
ventricular	O
systolic	O
pressure	O
was	O
recorded	O
during	O
hypoxic	O
challenges	O
in	O
uninjured	O
WT	O
mice	B-SPEC
pretreated	O
with	O
rHuIL	O
-	O
6	O
or	O
rHuIL	O
-	O
6	O
+	O
non	O
-	O
selective	O
nitric	O
oxide	O
synthase	O
inhibitor	O
L	O
-	O
NAME	B-SPEC
or	O
vehicle	O
.	O

However	O
,	O
unlike	O
severe	O
sepsis	B-SPEC
,	O
antibiotics	O
provide	O
no	O
benefit	O
.	O

We	O
successfully	O
detected	O
previously	O
unidentified	O
respiratory	O
viruses	B-SPEC
in	O
26	O
of	O
40	O
specimens	O
using	O
our	O
proposed	O
NGS	O
pipeline	O
.	O

ABSTRACT	O
:	O
1	O
,	O
4	O
-	O
Pentadien	O
-	O
3	O
-	O
one	O
derivatives	O
derived	O
from	O
curcumin	O
possess	O
excellent	O
inhibitory	O
activity	O
against	O
plant	B-SPEC
viruses	B-SPEC
.	O

TITLE	O
:	O
Structure	O
of	O
the	O
S1	O
subunit	O
C	O
-	O
terminal	O
domain	O
from	O
bat	B-SPEC
-	O
derived	O
coronavirus	B-SPEC
HKU5	O
spike	O
protein	O
.	O

TITLE	O
:	O
Protective	O
Effects	O
of	O
Cell	O
-	O
Free	O
Supernatant	O
and	O
Live	O
Lactic	O
Acid	O
Bacteria	B-SPEC
Isolated	O
from	O
Thai	O
Pigs	B-SPEC
Against	O
a	O
Pandemic	O
Strain	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
.	O

faecium	O
and	O
Pediococcus	B-SPEC
strains	O
.	O

Oxygenation	O
and	O
compliance	O
in	O
the	O
control	O
animals	B-SPEC
continued	O
to	O
decline	O
during	O
the	O
4	O
-	O
hour	O
in	O
vivo	O
perfusion	O
period	O
,	O
and	O
3	O
of	O
the	O
4	O
animals	B-SPEC
died	O
of	O
severe	O
hypoxia	O
within	O
4	O
hours	O
.	O

Sepsis	B-SPEC
is	O
one	O
of	O
the	O
most	O
prevalent	O
causes	O
of	O
this	O
condition	O
(	O
30	O
-	O
50	O
%).	O

TITLE	O
:	O
Plasminogen	O
Activator	O
Inhibitor	O
-	O
1	O
Is	O
Critical	O
in	O
Alcohol	O
-	O
Enhanced	O
Acute	O
Lung	O
Injury	O
in	O
Mice	B-SPEC
.	O

The	O
preferential	O
expression	O
of	O
DPP4	O
in	O
the	O
intestinal	O
tract	O
of	O
insectivorous	O
bats	B-SPEC
,	O
suggests	O
that	O
transmission	O
of	O
MERS	O
-	O
like	O
-	O
CoVs	O
mainly	O
occurs	O
via	O
the	O
fecal	O
-	O
oral	O
route	O
.	O

Our	O
results	O
highlight	O
differences	O
in	O
the	O
distribution	O
of	O
DPP4	O
expression	O
among	O
MERS	O
-	O
CoV	O
susceptible	O
species	B-SPEC
,	O
which	O
might	O
influence	O
variability	O
in	O
virus	B-SPEC
tropism	O
,	O
pathogenesis	O
and	O
transmission	O
route	O
.	O

Zika	B-SPEC
virus	I-SPEC
(	O
ZIKV	O
),	O
Ebola	B-SPEC
virus	I-SPEC
(	O
EBOV	O
),	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
as	O
(	O
re	O
-)	O
emerging	O
viral	O
pathogens	O
and	O
other	O
enveloped	O
viruses	B-SPEC
could	O
be	O
efficiently	O
inactivated	O
by	O
both	O
WHO	O
formulations	O
,	O
implicating	O
their	O
use	O
in	O
healthcare	O
systems	O
and	O
viral	O
outbreak	O
situations	O
.	O

Surveillance	O
data	O
showed	O
importance	O
of	O
serogroup	O
B	O
MD	O
in	O
North	O
Africa	O
and	O
serogroup	O
W	O
expansion	O
in	O
Turkey	B-SPEC
and	O
South	O
Africa	O
.	O

TITLE	O
:	O
Optimization	O
of	O
the	O
Production	O
Process	O
and	O
Characterization	O
of	O
the	O
Yeast	B-SPEC
-	O
Expressed	O
SARS	O
-	O
CoV	O
Recombinant	O
Receptor	O
-	O
Binding	O
Domain	O
(	O
RBD219	O
-	O
N1	O
),	O
a	O
SARS	O
Vaccine	O
Candidate	O
.	O

Although	O
far	O
less	O
advanced	O
than	O
for	O
influenza	O
,	O
antiviral	O
drugs	O
and	O
vaccines	O
are	O
in	O
different	O
stages	O
of	O
development	O
for	O
several	O
of	O
these	O
viruses	B-SPEC
,	O
but	O
no	O
interventions	O
have	O
been	O
licensed	O
.	O

Three	O
sheep	B-SPEC
that	O
received	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
endotoxin	O
were	O
treated	O
with	O
veno	O
-	O
venous	O
ECMO	O
support	O
in	O
group	O
2	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
epidermal	O
growth	O
factor	O
receptor	O
attenuates	O
LPS	O
-	O
induced	O
inflammation	O
and	O
acute	O
lung	O
injury	O
in	O
rats	B-SPEC
.	O

In	O
vitro	O
,	O
both	O
pharmacological	O
inhibitors	O
(	O
AG1478	O
and	O
451	O
)	O
and	O
si	O
-	O
RNA	O
silencing	O
of	O
EGFR	O
significantly	O
inhibited	O
LPS	O
-	O
induced	O
EGFR	O
signaling	O
activation	O
and	O
inflammatory	O
response	O
in	O
human	B-SPEC
lung	O
epithelial	O
cells	O
or	O
macrophages	O
.	O

To	O
research	O
the	O
immunogenicity	O
differences	O
of	O
PEDV	B-SPEC
G1	O
and	O
G2	O
genotype	O
strains	O
and	O
obtain	O
a	O
neutralizing	O
monoclonal	O
antibody	O
(	O
mAb	O
),	O
we	O
inoculated	O
specific	O
-	O
pathogen	O
-	O
free	O
BALB	O
/	O
c	O
mice	B-SPEC
with	O
a	O
newly	O
emerged	O
strain	O
,	O
PEDV	B-SPEC
-	O
LNCT2	O
.	O

ABSTRACT	O
:	O
Strongyloidiasis	O
is	O
a	O
chronic	O
parasitic	O
infection	O
caused	O
by	O
Strongyloides	B-SPEC
stercoralis	I-SPEC
.	O

Severe	O
strongyloidiasis	O
was	O
defined	O
by	O
the	O
presence	O
of	O
any	O
of	O
the	O
following	O
:	O
1	O
)	O
the	O
identification	O
of	O
S	B-SPEC
.	I-SPEC
stercoralis	I-SPEC
from	O
extra	O
gastrointestinal	O
specimens	O
,	O
2	O
)	O
sepsis	B-SPEC
,	O
3	O
)	O
meningitis	O
,	O
4	O
)	O
acute	O
respiratory	O
failure	O
,	O
or	O
5	O
)	O
respiratory	O
tract	O
hemorrhage	O
.	O

RESULTS	O
:	O
Bivariate	O
logistic	O
analysis	O
showed	O
that	O
mortality	O
and	O
worse	O
outcomes	O
were	O
correlated	O
with	O
FFP	O
transfusion	O
and	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

ABSTRACT	O
:	O
The	O
M1	O
family	B-SPEC
of	O
metalloproteases	O
represents	O
a	O
large	O
number	O
of	O
exopeptidases	O
that	O
cleave	O
single	O
amino	O
acid	O
residues	O
from	O
the	O
N	O
-	O
terminus	O
of	O
peptide	O
substrates	O
.	O

The	O
proteolytic	O
activity	O
of	O
APN	O
promotes	O
cancer	B-SPEC
angiogenesis	O
and	O
metastasis	O
making	O
it	O
an	O
important	O
target	O
for	O
cancer	B-SPEC
therapy	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
genetic	O
and	O
epidemiological	O
relationship	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
isolates	O
from	O
commercial	O
poultry	O
to	O
attenuated	O
live	O
IBV	B-SPEC
vaccines	O
we	O
conducted	O
a	O
phylogenetic	O
network	O
analysis	O
on	O
the	O
full	O
-	O
length	O
S1	O
sequence	O
for	O
Arkansas	O
(	O
Ark	O
),	O
Massachusetts	O
(	O
Mass	O
)	O
and	O
Delmarva	O
/	O
1639	O
(	O
DMV	O
/	O
1639	O
)	O
type	O
viruses	B-SPEC
isolated	O
in	O
2015	O
from	O
clinical	O
cases	O
by	O
3	O
different	O
diagnostic	O
laboratories	O
.	O

In	O
addition	O
,	O
a	O
number	O
of	O
satellite	O
groups	O
surrounding	O
the	O
two	O
predominant	O
populations	O
were	O
observed	O
for	O
the	O
Ark	O
type	O
virus	B-SPEC
,	O
which	O
is	O
likely	O
due	O
to	O
mutations	O
associated	O
with	O
the	O
nature	O
of	O
this	O
vaccine	O
to	O
persist	O
in	O
flocks	O
.	O

The	O
antibody	O
recognizes	O
the	O
receptor	O
-	O
binding	O
domain	O
of	O
MERS	O
-	O
CoV	O
S	O
glycoprotein	O
and	O
interferes	O
with	O
the	O
interaction	O
between	O
viral	O
S	O
and	O
the	O
human	B-SPEC
cellular	O
receptor	O
human	B-SPEC
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
).	O

To	O
our	O
knowledge	O
,	O
this	O
study	O
is	O
the	O
first	O
to	O
report	O
a	O
human	B-SPEC
neutralizing	O
monoclonal	O
antibody	O
that	O
completely	O
inhibits	O
MERS	O
-	O
CoV	O
replication	O
in	O
common	B-SPEC
marmosets	I-SPEC
.	O

The	O
article	O
examines	O
two	O
recent	O
cases	O
:	O
the	O
first	O
detection	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
outbreak	O
in	O
Saudi	O
Arabia	O
,	O
and	O
the	O
first	O
months	O
of	O
the	O
Ebola	O
outbreak	O
in	O
Guinea	B-SPEC
.	O

The	O
present	O
study	O
was	O
done	O
in	O
a	O
tertiary	O
care	O
children	O
'	O
s	O
hospital	O
for	O
rapid	O
identification	O
of	O
viruses	B-SPEC
causing	O
SARI	O
among	O
children	O
less	O
than	O
or	O
equal	O
to	O
five	O
years	O
of	O
age	O
using	O
multiplex	O
real	O
-	O
time	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
kit	O
.	O

RESULTS	O
:	O
The	O
overall	O
positivity	O
for	O
viruses	B-SPEC
in	O
the	O
study	O
was	O
found	O
to	O
be	O
72	O
.	O
9	O
per	O
cent	O
with	O
a	O
co	O
-	O
infection	O
rate	O
of	O
19	O
.	O
5	O
per	O
cent	O
.	O

We	O
investigated	O
evidence	O
of	O
highly	O
pathogenic	O
coronavirus	B-SPEC
infections	O
including	O
MERSCoV	O
in	O
a	O
large	O
group	O
of	O
commensal	O
baboons	B-SPEC
accompanied	O
by	O
feral	O
dogs	B-SPEC
,	O
on	O
the	O
outskirts	O
of	O
Ta	O
'	O
if	O
city	O
,	O
KSA	O
,	O
in	O
February	O
2013	O
.	O

TITLE	O
:	O
Epidemiology	O
and	O
Clinical	O
Features	O
of	O
Human	B-SPEC
Coronaviruses	O
in	O
the	O
Pediatric	O
Population	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
demonstrate	O
that	O
coronavirus	B-SPEC
nsp15	O
is	O
critical	O
for	O
evasion	O
of	O
host	O
dsRNA	O
sensors	O
in	O
macrophages	O
and	O
reveal	O
that	O
modulating	O
nsp15	O
stability	O
and	O
activity	O
is	O
a	O
strategy	O
for	O
generating	O
live	O
-	O
attenuated	O
vaccines	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
developed	O
a	O
novel	O
porcine	B-SPEC
model	O
of	O
septic	O
shock	O
induced	O
by	O
ARDS	O
due	O
to	O
severe	O
MRSA	O
pneumonia	O
with	O
characteristic	O
hyperdynamic	O
and	O
hypodynamic	O
phases	O
in	O
24	O
h	O
,	O
which	O
mimicked	O
the	O
hemodynamic	O
changing	O
of	O
septic	O
shock	O
in	O
human	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
work	O
describes	O
the	O
diagnosis	O
and	O
successful	O
treatment	O
of	O
a	O
2	O
-	O
year	O
-	O
old	O
domestic	B-SPEC
cat	I-SPEC
infected	O
with	O
Considering	O
the	O
increasing	O
number	O
of	O
feline	B-SPEC
leishmaniosis	O
cases	O
and	O
the	O
inconsistent	O
results	O
of	O
most	O
therapeutic	O
protocols	O
described	O
in	O
the	O
literature	O
,	O
the	O
use	O
of	O
new	O
approaches	O
,	O
especially	O
in	O
refractory	O
cases	O
,	O
is	O
essential	O
.	O

The	O
virus	B-SPEC
exists	O
in	O
many	O
different	O
genetic	O
forms	O
which	O
made	O
the	O
disease	O
control	O
very	O
difficult	O
.	O

Uveitis	O
is	O
common	O
in	O
these	O
cats	B-SPEC
.	O

How	O
the	O
differences	O
observed	O
in	O
growth	O
and	O
immune	O
parameters	O
in	O
the	O
three	O
chicken	B-SPEC
lines	O
influence	O
the	O
immune	O
protection	O
against	O
infection	O
needs	O
to	O
be	O
studied	O
further	O
.	O

Flow	O
cytometry	O
markers	O
CD38	O
and	O
CD73	O
characterizing	O
murine	B-SPEC
Bmem	O
from	O
lymphoid	O
tissue	O
showed	O
more	O
diverse	O
expression	O
patterns	O
on	O
corresponding	O
CNS	O
-	O
derived	O
B	O
cell	O
subsets	O
.	O

Using	O
the	O
optimized	O
TLR7	O
/	O
8	O
stimulation	O
protocol	O
,	O
we	O
compared	O
virus	B-SPEC
-	O
specific	O
IgG	O
Bmem	O
versus	O
pre	O
-	O
existing	O
ASC	O
within	O
the	O
brain	O
and	O
spinal	O
cord	O
.	O

Recombination	O
analysis	O
of	O
strain	O
CU	O
/	O
4	O
/	O
2014	O
showed	O
evidence	O
for	O
recombination	O
from	O
at	O
least	O
three	O
different	O
IBV	B-SPEC
strains	O
,	O
namely	O
,	O
the	O
Italian	O
strain	O
90254	O
/	O
2005	O
(	O
QX	O
-	O
like	O
strain	O
),	O
4	O
/	O
91	O
,	O
and	O
H120	O
.	O

Bats	B-SPEC
are	O
known	O
to	O
host	O
viruses	B-SPEC
closely	O
related	O
to	O
important	O
EIDs	O
.	O

However	O
,	O
we	O
found	O
that	O
bats	B-SPEC
infected	O
with	O
either	O
astro	O
-	O
or	O
coronaviruses	O
were	O
likely	O
to	O
be	O
coinfected	O
with	O
the	O
respective	O
other	O
virus	B-SPEC
.	O

TITLE	O
:	O
Molecular	O
aspects	O
of	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
betacoronavirus	B-SPEC
which	O
can	O
cause	O
acute	O
respiratory	O
distress	O
in	O
humans	B-SPEC
and	O
is	O
associated	O
with	O
a	O
relatively	O
high	O
mortality	O
rate	O
.	O

Human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
appears	O
to	O
require	O
close	O
contact	O
with	O
infected	O
persons	O
,	O
with	O
outbreaks	O
mainly	O
occurring	O
in	O
hospital	O
environments	O
.	O

Using	O
the	O
PRISMA	O
guidelines	O
for	O
systematic	O
reviews	O
and	O
meta	B-SPEC
-	O
analysis	O
,	O
MEDLINE	O
and	O
EMBASE	O
were	O
systematically	O
searched	O
for	O
studies	O
reporting	O
complications	O
and	O
hospital	O
mortality	O
of	O
adult	O
patients	O
receiving	O
veno	O
-	O
venous	O
ECMO	O
for	O
severe	O
and	O
refractory	O
ARDS	O
.	O

Studies	O
were	O
screened	O
for	O
low	O
bias	B-SPEC
risk	O
and	O
assessed	O
for	O
study	O
size	O
effect	O
.	O

Models	O
with	O
potential	O
moderators	O
were	O
explored	O
using	O
random	O
effects	O
meta	B-SPEC
-	O
regression	O
.	O

TITLE	O
:	O
Differential	O
Protein	O
Analysis	O
of	O
IPEC	O
-	O
J2	O
Cells	O
Infected	O
with	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Pandemic	O
and	O
Classical	O
Strains	O
Elucidates	O
the	O
Pathogenesis	O
of	O
Infection	O
.	O

ABSTRACT	O
:	O
Although	O
canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
)	O
is	O
an	O
important	O
respiratory	O
pathogen	O
that	O
is	O
prevalent	O
in	O
many	O
countries	O
,	O
only	O
one	O
complete	O
genome	O
sequence	O
of	O
CRCoV	O
(	O
South	O
Korea	O
strain	O
K37	O
)	O
has	O
been	O
obtained	O
to	O
date	O
.	O

TITLE	O
:	O
Matrix	O
stiffness	O
regulates	O
migration	O
of	O
human	B-SPEC
lung	O
fibroblasts	O
.	O

Expression	O
of	O
GPC3	O
leads	O
to	O
an	O
increased	O
apoptosis	O
response	O
in	O
human	B-SPEC
lung	O
carcinoma	O
tumor	O
cells	O
,	O
and	O
is	O
considered	O
to	O
be	O
a	O
candidate	O
lung	O
tumor	O
suppressor	O
gene	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
prevalence	O
of	O
pearly	O
penile	O
papules	O
(	O
PPP	O
)	O
among	O
young	O
men	O
in	O
Eskisehir	O
,	O
Turkey	B-SPEC
.	O

During	O
11	O
weeks	O
of	O
the	O
influenza	O
epidemic	O
period	O
in	O
January	O
-	O
March	O
2012	O
,	O
consecutive	O
adult	O
patients	O
suspected	O
to	O
be	O
septic	O
(	O
n	O
=	O
432	O
)	O
were	O
analyzed	O
with	O
cultures	O
from	O
blood	O
and	O
nasopharynx	O
plus	O
multiplex	O
PCR	O
for	O
respiratory	O
viruses	B-SPEC
on	O
the	O
nasopharyngeal	O
specimen	O
.	O

The	O
role	O
of	O
respiratory	O
viral	O
infections	O
in	O
patients	O
presenting	O
with	O
a	O
clinical	O
picture	O
of	O
sepsis	B-SPEC
is	O
underestimated	O
.	O

No	O
antibodies	O
were	O
detected	O
in	O
any	O
of	O
the	O
tested	O
pigs	B-SPEC
to	O
PRRSV	B-SPEC
,	O
TGEV	B-SPEC
,	O
PRCV	O
,	O
or	O
CSFV	O
.	O

The	O
present	O
study	O
was	O
done	O
to	O
evaluate	O
protection	O
caused	O
by	O
two	O
different	O
serotype	O
vaccines	O
(	O
Massachusetts	O
and	O
793	O
/	O
B	O
)	O
in	O
order	B-SPEC
to	O
evaluate	O
protection	O
against	O
challenge	O
with	O
IS	O
/	O
1494	O
/	O
06	O
-	O
like	O
virus	B-SPEC
(	O
variant	O
2	O
-	O
like	O
virus	B-SPEC
),	O
which	O
is	O
prevalent	O
in	O
the	O
Middle	O
East	O
.	O

The	O
S1	O
subunit	O
of	O
the	O
viral	O
S	O
glycoprotein	O
is	O
responsible	O
for	O
virus	B-SPEC
binding	O
to	O
host	O
-	O
cell	O
receptors	O
,	O
induction	O
of	O
neutralizing	O
antibody	O
and	O
hemagglutinin	O
activity	O
.	O

Patients	O
were	O
randomly	O
assigned	O
(	O
1	O
:	O
1	O
)	O
by	O
computer	O
-	O
generated	O
randomisation	O
schedule	O
with	O
variable	O
block	O
size	O
stratified	O
by	O
site	O
and	O
presence	O
of	O
severe	O
sepsis	B-SPEC
requiring	O
vasopressors	O
to	O
receive	O
either	O
recombinant	O
human	B-SPEC
KGF	O
(	O
palifermin	O
60	O
μg	O
/	O
kg	O
)	O
or	O
placebo	O
(	O
0	O
·	O
9	O
%	O
sodium	O
chloride	O
solution	O
)	O
daily	O
for	O
a	O
maximum	O
of	O
6	O
days	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
severe	O
diarrhea	O
and	O
high	O
fatality	O
of	O
piglets	O
,	O
influencing	O
the	O
swine	B-SPEC
industry	O
.	O

TITLE	O
:	O
Persistent	O
infections	O
support	O
maintenance	O
of	O
a	O
coronavirus	B-SPEC
in	O
a	O
population	O
of	O
Australian	O
bats	B-SPEC
(	O
Myotis	B-SPEC
macropus	I-SPEC
).	O

While	O
bat	B-SPEC
-	O
borne	O
viruses	B-SPEC
are	O
of	O
concern	O
to	O
public	O
health	O
,	O
investigations	O
into	O
their	O
dynamics	O
have	O
been	O
limited	O
by	O
a	O
lack	O
of	O
longitudinal	O
data	O
from	O
individual	O
bats	B-SPEC
.	O

These	O
findings	O
,	O
using	O
rare	O
CMR	O
data	O
from	O
longitudinal	O
samples	O
of	O
individual	O
bats	B-SPEC
,	O
increase	O
our	O
understanding	O
of	O
transmission	O
dynamics	O
of	O
bat	B-SPEC
viral	O
infectious	O
diseases	O
.	O

Based	O
on	O
recent	O
data	O
suggesting	O
its	O
role	O
as	O
entheropathogen	O
,	O
a	O
case	O
-	O
control	O
study	O
was	O
conducted	O
between	O
2013	O
and	O
2016	O
to	O
investigate	O
the	O
association	O
of	O
CanineCV	O
with	O
gastroenteritis	O
in	O
dogs	B-SPEC
,	O
alone	O
or	O
in	O
combination	O
with	O
other	O
viral	O
pathogens	O
,	O
including	O
canine	O
parvovirus	B-SPEC
(	O
CPV	B-SPEC
),	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
and	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
).	O

Here	O
,	O
we	O
report	O
the	O
identification	O
and	O
isolation	O
of	O
vaccine	O
strains	O
of	O
avian	B-SPEC
paramyxovirus	I-SPEC
serotype	O
1	O
(	O
APMV1	O
)	O
and	O
avian	B-SPEC
coronaviruses	O
(	O
ACoV	O
)	O
from	O
different	O
wild	O
bird	B-SPEC
species	B-SPEC
across	O
eight	O
Egyptian	O
governorates	O
between	O
January	O
2014	O
and	O
December	O
2015	O
.	O

TITLE	O
:	O
Crystal	O
structure	O
of	O
the	O
receptor	O
binding	O
domain	O
of	O
the	O
spike	O
glycoprotein	O
of	O
human	B-SPEC
betacoronavirus	B-SPEC
HKU1	O
.	O

The	O
present	O
study	O
confirmed	O
the	O
pathogenicity	O
of	O
the	O
PEDVPT	O
isolate	O
in	O
conventional	O
post	O
-	O
weaning	O
pigs	B-SPEC
.	O

A	O
retrospective	O
study	O
of	O
patients	O
admitted	O
at	O
Indira	O
Gandhi	O
Medical	O
College	O
Hospital	O
,	O
Shimla	O
with	O
snake	B-SPEC
bite	O
-	O
induced	O
AKI	O
from	O
July	O
2003	O
to	O
June	O
2016	O
.	O

Aliquots	O
were	O
removed	O
at	O
various	O
time	O
points	O
followed	O
by	O
preparing	O
serial	O
10	O
-	O
fold	O
dilutions	O
and	O
inoculating	O
in	O
cell	O
cultures	O
to	O
determine	O
the	O
amount	O
of	O
surviving	O
virus	B-SPEC
.	O

There	O
was	O
also	O
a	O
moderate	O
negative	O
correlation	O
between	O
TGEV	B-SPEC
survival	O
and	O
ether	O
extract	O
content	O
(	O
r	O
=	O
-	O
0	O
.	O
51	O
,	O
P	O
=	O
0	O
.	O
01	O
).	O

We	O
enrolled	O
86	O
ICU	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
.	O

Our	O
results	O
indicate	O
that	O
during	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
,	O
a	O
decrease	O
in	O
plasma	O
concentrations	O
of	O
kallistatin	O
reflects	O
increased	O
severity	O
and	O
poorer	O
outcome	O
of	O
disease	O
.	O

However	O
,	O
structural	O
similarity	O
between	O
the	O
catalytic	O
cores	O
of	O
vDUBs	O
and	O
human	B-SPEC
DUBs	O
complicates	O
the	O
development	O
of	O
selective	O
small	O
molecule	O
vDUB	O
inhibitors	O
.	O

TITLE	O
:	O
The	O
Epidemiology	O
of	O
Hospital	O
Death	O
Following	O
Pediatric	O
Severe	O
Sepsis	B-SPEC
:	O
When	O
,	O
Why	O
,	O
and	O
How	O
Children	O
With	O
Sepsis	B-SPEC
Die	O
.	O

The	O
median	O
time	O
to	O
death	O
was	O
8	O
days	O
(	O
interquartile	O
range	O
,	O
1	O
-	O
12	O
d	O
)	O
with	O
25	O
%,	O
35	O
%,	O
and	O
49	O
%	O
of	O
cumulative	O
deaths	O
within	O
1	O
,	O
3	O
,	O
and	O
7	O
days	O
of	O
sepsis	B-SPEC
recognition	O
,	O
respectively	O
.	O

The	O
evolution	O
and	O
ecology	O
of	O
coronaviruses	O
in	O
rodent	B-SPEC
have	O
not	O
been	O
fully	O
investigated	O
.	O

ABSTRACT	O
:	O
Our	O
previous	O
screening	O
of	O
50	O
240	O
structurally	O
diverse	O
compounds	O
led	O
to	O
the	O
identification	O
of	O
39	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
infection	O
inhibitors	O
(	O
Kao	O
R	O
.	O
Y	O
.,	O
Yang	O
D	O
.,	O
Lau	O
L	O
.	O
S	O
.,	O
Tsui	O
W	O
.	O
H	O
.,	O
Hu	O
L	O
.	O
et	O
al	O
.	O
Nat	O
Biotechnol	O
2010	O
;	O
28	O
:	O
600	O
-	O
605	O
).	O

Outcomes	O
were	O
modeled	O
with	O
multivariable	O
regressions	O
adjusted	O
for	O
baseline	O
covariates	O
,	O
age	O
,	O
sex	O
,	O
race	O
,	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
III	O
(	O
APACHE	O
III	O
),	O
vasopressor	O
use	O
,	O
modified	O
lung	O
injury	O
score	O
,	O
diabetes	O
mellitus	O
,	O
cancer	B-SPEC
status	O
,	O
body	O
mass	O
index	O
,	O
pre	O
-	O
ICU	O
location	O
,	O
ICU	O
location	O
,	O
and	O
study	O
.	O

The	O
hepatitis	B-SPEC
C	I-SPEC
virus	I-SPEC
(	O
HCV	B-SPEC
)	O
is	O
known	O
to	O
infiltrate	O
the	O
brain	O
,	O
yet	O
findings	O
from	O
studies	O
on	O
associated	O
neurocognitive	O
and	O
neuropathological	O
changes	O
are	O
mixed	O
.	O

This	O
study	O
examined	O
the	O
longitudinal	O
relationship	O
between	O
neurocognitive	O
and	O
neurophysiologic	O
markers	O
among	O
healthy	O
HCV	B-SPEC
-	O
controls	O
and	O
HCV	O
+	O
adults	O
following	O
successful	O
HCV	B-SPEC
eradication	O
.	O

The	O
clinical	O
and	O
necropsy	O
findings	O
presented	O
here	O
are	O
consistent	O
with	O
ARDS	O
secondary	O
to	O
disseminated	O
toxoplasmosis	O
in	O
a	O
cat	B-SPEC
.	O

HPS	O
is	O
endemic	O
in	O
Argentina	B-SPEC
,	O
as	O
well	O
as	O
other	O
countries	O
of	O
North	O
and	O
South	O
American	O
.	O

TITLE	O
:	O
Analysis	O
of	O
the	O
Genome	O
Sequence	O
and	O
Prediction	O
of	O
B	O
-	O
Cell	O
Epitopes	O
of	O
the	O
Envelope	O
Protein	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
South	O
Korea	O
in	O
April	O
2015	O
led	O
to	O
186	O
infections	O
and	O
37	O
deaths	O
by	O
the	O
end	O
of	O
October	O
2015	O
.	O

Signature	O
genes	O
were	O
identified	O
for	O
each	O
virus	B-SPEC
and	O
included	O
host	O
defense	O
genes	O
for	O
PR8	O
,	O
tissue	O
remodeling	O
genes	O
for	O
RV1B	O
,	O
and	O
transcription	O
factors	O
for	O
MHV	B-SPEC
-	O
1	O
.	O

ABSTRACT	O
:	O
Despite	O
the	O
fact	O
that	O
there	O
had	O
been	O
multiple	O
small	O
outbreaks	O
of	O
Ebola	B-SPEC
Virus	I-SPEC
Disease	O
,	O
when	O
a	O
large	O
outbreak	O
occurred	O
in	O
2014	O
there	O
were	O
no	O
vaccines	O
or	O
drugs	O
available	O
for	O
use	O
.	O

Therefore	O
,	O
dromedary	B-SPEC
camels	B-SPEC
are	O
considered	O
the	O
only	O
animal	B-SPEC
source	O
of	O
infection	O
.	O

ChAdOx1	O
and	O
MVA	O
vectored	O
vaccines	O
have	O
been	O
safely	O
evaluated	O
in	O
camels	B-SPEC
and	O
humans	B-SPEC
and	O
these	O
MERS	O
vaccine	O
candidates	O
should	O
now	O
be	O
tested	O
in	O
camels	B-SPEC
and	O
in	O
clinical	O
trials	O
.	O

TITLE	O
:	O
Comparative	O
epidemiology	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
Saudi	O
Arabia	O
and	O
South	O
Korea	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
an	O
emerging	O
and	O
re	O
-	O
emerging	O
viral	O
pathogen	O
of	O
pigs	B-SPEC
that	O
is	O
causing	O
significant	O
economic	O
concerns	O
in	O
the	O
global	O
pork	O
industry	O
.	O

The	O
virulent	O
G2b	O
PEDV	B-SPEC
subgroup	O
,	O
which	O
was	O
responsible	O
for	O
the	O
2013	O
-	O
2014	O
pandemics	O
on	O
the	O
American	O
and	O
Asian	O
continents	O
,	O
hit	O
Jeju	O
Island	O
in	O
2014	O
,	O
which	O
had	O
been	O
PEDV	B-SPEC
-	O
free	O
since	O
2004	O
.	O

This	O
study	O
presents	O
molecular	O
characterization	O
of	O
a	O
novel	O
PEDV	B-SPEC
variant	O
with	O
a	O
5	O
-	O
amino	O
acid	O
(	O
aa	O
)	O
insertion	O
(	O
DTHPE	O
)	O
in	O
the	O
spike	O
(	O
S	O
)	O
gene	O
(	O
an	O
S	O
-	O
insertion	O
)	O
that	O
was	O
identified	O
in	O
diarrheic	O
piglets	O
from	O
Jeju	O
Island	O
.	O

KNU	O
-	O
1601	O
shares	O
99	O
.	O
5	O
-	O
99	O
.	O
6	O
%	O
nucleotide	O
sequence	O
identity	O
at	O
the	O
genome	O
level	O
and	O
98	O
.	O
0	O
-	O
98	O
.	O
6	O
%	O
amino	O
acid	O
sequence	O
identity	O
at	O
the	O
S	O
gene	O
level	O
with	O
other	O
global	O
G2b	O
PEDV	B-SPEC
strains	O
.	O

Rapid	O
and	O
accurate	O
testing	O
at	O
the	O
point	O
-	O
of	O
-	O
need	O
(	O
PON	O
)	O
supports	O
prevention	O
of	O
virus	B-SPEC
spread	O
and	O
management	O
of	O
clinical	O
disease	O
.	O

A	O
retrospective	O
study	O
including	O
116	O
clinical	O
plasma	O
and	O
serum	O
samples	O
that	O
had	O
been	O
tested	O
with	O
virus	B-SPEC
isolation	O
,	O
real	O
-	O
time	O
PCR	O
and	O
ELISA	O
,	O
and	O
a	O
prospective	O
study	O
including	O
150	O
clinical	O
plasma	O
and	O
serum	O
samples	O
were	O
implemented	O
to	O
evaluate	O
the	O
clinical	O
performances	O
of	O
the	O
iiPCR	O
-	O
based	O
methods	O
for	O
FeLV	O
detection	O
.	O

Both	O
reactions	O
had	O
analytical	O
sensitivity	O
comparable	O
to	O
a	O
reference	O
real	O
-	O
time	O
PCR	O
(	O
qPCR	O
)	O
and	O
did	O
not	O
detect	O
five	O
non	O
-	O
target	O
feline	B-SPEC
pathogens	O
.	O

Taken	O
together	O
,	O
our	O
present	O
study	O
confirms	O
that	O
both	O
MHV	B-SPEC
and	O
SARS	O
-	O
CoV	O
N	O
proteins	O
can	O
perturb	O
the	O
function	O
of	O
cellular	O
PACT	O
to	O
circumvent	O
the	O
innate	O
antiviral	O
response	O
.	O

We	O
generated	O
264	O
F2	O
mice	B-SPEC
between	O
these	O
strains	O
,	O
and	O
infected	O
them	O
with	O
SARS	O
-	O
CoV	O
.	O
Weight	O
loss	O
,	O
pulmonary	O
hemorrhage	O
,	O
and	O
viral	O
load	O
were	O
all	O
highly	O
correlated	O
disease	O
phenotypes	O
.	O

PEDV	B-SPEC
was	O
confirmed	O
by	O
PCR	O
and	O
its	O
whole	O
genome	O
sequence	O
was	O
determined	O
.	O

Major	O
advances	O
in	O
the	O
study	O
of	O
the	O
molecular	O
biology	O
of	O
IBV	B-SPEC
have	O
resulted	O
from	O
the	O
development	O
of	O
reverse	O
genetics	O
systems	O
for	O
the	O
highly	O
attenuated	O
,	O
cell	O
culture	O
-	O
adapted	O
,	O
IBV	B-SPEC
strain	O
Beaudette	O
.	O

A	O
wild	O
-	O
type	O
recombinant	O
IBV	B-SPEC
was	O
constructed	O
,	O
containing	O
several	O
synonymous	O
marker	O
mutations	O
.	O

Targeted	O
RNA	O
recombination	O
allows	O
for	O
the	O
generation	O
of	O
recombinant	O
IBV	B-SPEC
strains	O
that	O
are	O
not	O
able	O
to	O
infect	O
and	O
propagate	O
in	O
continuous	O
cell	O
lines	O
.	O

RESULTS	O
:	O
Targeted	O
RNA	O
recombination	O
allowed	O
for	O
the	O
modification	O
of	O
the	O
3	O
'-	O
end	O
of	O
the	O
IBV	B-SPEC
genome	O
,	O
encoding	O
all	O
structural	O
and	O
accessory	O
genes	O
.	O

ABSTRACT	O
:	O
Severe	O
inflammatory	O
conditions	O
,	O
as	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
related	O
to	O
high	O
morbidity	O
and	O
mortality	O
.	O

We	O
included	O
randomized	O
-	O
controlled	O
trials	O
on	O
the	O
use	O
of	O
CVVH	O
as	O
blood	O
purification	O
technique	O
in	O
comparison	O
to	O
conventional	O
therapy	O
in	O
adult	O
patients	O
with	O
severe	O
sepsis	B-SPEC
/	O
septic	O
shock	O
or	O
ARDS	O
but	O
no	O
acute	O
kidney	O
injury	O
needing	O
renal	O
replacement	O
therapy	O
.	O

Studies	O
investigating	O
the	O
mechanism	O
of	O
fluoropolymer	O
-	O
related	O
respiratory	O
illness	O
in	O
humans	B-SPEC
have	O
been	O
difficult	O
to	O
perform	O
for	O
the	O
following	O
reasons	O
:	O
chemical	O
formulation	O
of	O
these	O
products	O
is	O
proprietary	O
,	O
chemical	O
formulations	O
are	O
intermittently	O
reformulated	O
,	O
product	O
labels	O
and	O
safety	O
data	O
sheets	O
(	O
SDS	O
)	O
may	O
not	O
report	O
fluorocarbon	O
presence	O
if	O
present	O
only	O
in	O
small	O
amounts	O
[	O
3	O
].	O

Twenty	O
-	O
one	O
U	O
.	O
S	O
.	O
PICUs	B-SPEC
.	O

Eight	O
(	O
62	O
%)	O
received	O
antibiotics	O
despite	O
identification	O
of	O
CoV	B-SPEC
-	I-SPEC
HKU1	I-SPEC
.	O

Limiting	O
viral	O
spread	O
from	O
symptomatic	O
human	B-SPEC
cases	O
to	O
health	O
care	O
workers	O
and	O
family	B-SPEC
members	O
,	O
on	O
the	O
other	O
hand	O
,	O
could	O
be	O
achieved	O
through	O
prophylactic	O
administration	O
of	O
MERS	O
-	O
CoV	O
neutralizing	O
antibodies	O
and	O
vaccines	O
.	O

Finding	O
an	O
animal	B-SPEC
model	O
of	O
disease	O
is	O
key	O
to	O
develop	O
vaccines	O
or	O
antivirals	O
against	O
such	O
emerging	O
pathogens	O
and	O
to	O
understand	O
its	O
pathogenesis	O
.	O

TITLE	O
:	O
Dromedary	B-SPEC
camels	B-SPEC
in	O
northern	O
Mali	O
have	O
high	O
seropositivity	O
to	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
A	O
high	O
percentage	O
(	O
up	O
to	O
90	O
%)	O
of	O
dromedary	B-SPEC
camels	B-SPEC
in	O
the	O
Middle	O
East	O
as	O
well	O
as	O
eastern	O
and	O
central	O
Africa	O
have	O
antibodies	O
to	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Here	O
we	O
report	O
comparably	O
high	O
positivity	O
of	O
MERS	O
-	O
CoV	O
antibodies	O
in	O
dromedary	B-SPEC
camels	B-SPEC
from	O
northern	O
Mali	O
.	O

However	O
,	O
cSP	O
-	O
A	O
expression	O
in	O
the	O
respiratory	O
tract	O
of	O
chickens	B-SPEC
after	O
viral	O
co	O
-	O
infection	O
remains	O
unclear	O
.	O

In	O
comparison	O
,	O
for	O
the	O
PBS	O
group	O
as	O
the	O
negative	O
group	O
and	O
the	O
NDV	B-SPEC
-	O
infected	O
group	O
as	O
the	O
positive	O
group	O
,	O
the	O
histological	O
changes	O
showed	O
that	O
the	O
lesions	O
of	O
the	O
AIV	O
+	O
IBV	B-SPEC
co	O
-	O
infected	O
group	O
were	O
more	O
serious	O
compared	O
to	O
the	O
AIV	O
-	O
infected	O
group	O
and	O
the	O
IBV	B-SPEC
-	O
infected	O
group	O
.	O

A	O
vaccination	O
-	O
challenge	O
test	O
found	O
that	O
vaccination	O
with	O
the	O
4	O
/	O
91	O
vaccine	O
strain	O
did	O
not	O
provide	O
protection	O
against	O
challenge	O
with	O
the	O
recombinant	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
causes	O
considerable	O
damage	O
to	O
the	O
poultry	O
industry	O
worldwide	O
and	O
the	O
proportion	O
of	O
QX	O
-	O
like	O
genotype	O
isolates	O
have	O
increased	O
over	O
time	O
.	O

Sequence	O
analyses	O
revealed	O
that	O
SD	O
and	O
SZ	O
isolates	O
belong	O
to	O
the	O
QX	O
-	O
like	O
IBV	B-SPEC
genotype	O
and	O
share	O
high	O
homology	O
in	O
their	O
full	O
-	O
length	O
genomes	O
.	O

Collectively	O
,	O
these	O
findings	O
provide	O
important	O
information	O
about	O
the	O
epidemiology	O
and	O
pathogenicity	O
of	O
IBV	B-SPEC
,	O
which	O
may	O
benefit	O
the	O
control	O
of	O
IB	O
in	O
the	O
poultry	O
industry	O
.	O

TITLE	O
:	O
Pseudo	O
-	O
thrombotic	O
thrombocytopenic	O
purpura	B-SPEC
presenting	O
as	O
multi	O
-	O
organ	O
dysfunction	O
syndrome	O
:	O
A	O
rare	O
complication	O
of	O
pernicious	O
anemia	B-SPEC
.	O

Finally	O
,	O
TGEV	B-SPEC
GFP	O
is	O
a	O
recombinant	O
strain	O
that	O
obtained	O
its	O
main	O
body	O
from	O
TGEV	B-SPEC
PUR	O
46	O
-	O
MAD	O
,	O
but	O
its	O
spike	O
protein	O
from	O
TGEV	B-SPEC
PUR	O
-	O
C11	O
that	O
showed	O
high	O
mortality	O
in	O
piglets	O
in	O
vivo	O
.	O

TGEV	B-SPEC
Miller	O
mildly	O
and	O
TGEV	B-SPEC
GFP	O
extensively	O
infected	O
the	O
cells	O
in	O
the	O
jejunum	O
based	O
on	O
the	O
amount	O
of	O
positive	O
stained	O
epithelial	O
cells	O
.	O

This	O
study	O
is	O
the	O
first	O
to	O
link	O
HSP27	O
to	O
PEDV	B-SPEC
replication	O
via	O
the	O
innate	O
immunity	O
response	O
,	O
which	O
contributed	O
to	O
further	O
clarify	O
the	O
mechanism	O
of	O
PEDV	B-SPEC
infection	O
and	O
the	O
development	O
of	O
novel	O
antiviral	O
therapies	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
belong	O
to	O
the	O
genus	B-SPEC
Betacoronavirus	B-SPEC
of	O
the	O
family	B-SPEC
Coronaviridae	I-SPEC
.	O

Despite	O
this	O
,	O
only	O
6	O
%	O
of	O
all	O
CoV	O
sequences	O
in	O
GenBank	O
are	O
from	O
bats	B-SPEC
.	O

We	O
identified	O
sequences	O
representing	O
100	O
discrete	O
phylogenetic	O
clusters	O
,	O
ninety	O
-	O
one	O
of	O
which	O
were	O
found	O
in	O
bats	B-SPEC
,	O
and	O
used	O
ecological	O
and	O
epidemiologic	O
analyses	O
to	O
show	O
that	O
patterns	O
of	O
CoV	O
diversity	O
correlate	O
with	O
those	O
of	O
bat	B-SPEC
diversity	O
.	O

This	O
cements	O
bats	B-SPEC
as	O
the	O
major	O
evolutionary	O
reservoirs	O
and	O
ecological	O
drivers	O
of	O
CoV	O
diversity	O
.	O

However	O
,	O
parental	O
asthma	O
,	O
ever	O
wheezing	O
and	O
environmental	O
tobacco	B-SPEC
smoke	O
exposure	O
are	O
risk	O
factors	O
for	O
severe	O
viral	O
pneumonia	O
in	O
children	O
.	O

73	O
anaesthetised	O
rats	B-SPEC
(	O
acid	O
aspiration	O
model	O
)	O
were	O
ventilated	O
(	O
protective	O
or	O
non	O
-	O
protective	O
)	O
for	O
up	O
to	O
4	O
hours	O
to	O
generate	O
a	O
spectrum	O
of	O
lung	O
injury	O
.	O

The	O
detection	O
of	O
Coronavirus	B-SPEC
HKU15	O
in	O
respiratory	O
tracts	O
of	O
pigs	B-SPEC
implies	O
that	O
in	O
addition	O
to	O
enteric	O
infections	O
,	O
Coronavirus	B-SPEC
HKU15	O
may	O
be	O
able	O
to	O
cause	O
respiratory	O
infections	O
in	O
pigs	B-SPEC
and	O
that	O
in	O
addition	O
to	O
fecal	O
-	O
oral	O
transmission	O
,	O
the	O
virus	B-SPEC
could	O
possibly	O
spread	O
through	O
the	O
respiratory	O
route	O
.	O

Quasispecies	O
were	O
unprecedentedly	O
observed	O
in	O
the	O
5	O
'-	O
untranslated	O
region	O
of	O
coronavirus	B-SPEC
genomes	O
.	O

There	O
was	O
evidence	O
of	O
reinfection	O
of	O
camels	B-SPEC
that	O
were	O
previously	O
seropositive	O
,	O
thus	O
suggesting	O
that	O
prior	O
infection	O
does	O
not	O
provide	O
complete	O
immunity	O
from	O
reinfection	O
,	O
a	O
finding	O
that	O
is	O
relevant	O
to	O
camel	B-SPEC
vaccination	O
strategies	O
as	O
a	O
means	O
to	O
prevent	O
zoonotic	O
transmission	O
.	O

After	O
controlling	O
for	O
research	O
effort	O
,	O
the	O
proportion	O
of	O
zoonotic	O
viruses	B-SPEC
per	O
species	B-SPEC
is	O
predicted	O
by	O
phylogenetic	O
relatedness	O
to	O
humans	B-SPEC
,	O
host	O
taxonomy	O
and	O
human	B-SPEC
population	O
within	O
a	O
species	B-SPEC
range	O
-	O
which	O
may	O
reflect	O
human	B-SPEC
-	O
wildlife	O
contact	O
.	O

We	O
then	O
performed	O
combination	O
studies	O
of	O
Lupeol	O
and	O
the	O
active	O
site	O
RNase	O
H	O
inhibitor	O
RDS1759	O
,	O
and	O
blind	O
docking	O
calculations	O
,	O
demonstrating	O
that	O
Lupeol	O
binds	O
to	O
an	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
RT	O
allosteric	O
pocket	O
.	O

On	O
the	O
bases	O
of	O
these	O
results	O
and	O
searching	O
for	O
potential	O
multitarget	O
active	O
drug	O
supplement	O
,	O
we	O
also	O
investigated	O
the	O
anti	O
-	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
activity	O
of	O
Hemidesmus	B-SPEC
indicus	I-SPEC
,	O
an	O
Ayurveda	O
medicinal	O
plant	B-SPEC
containing	O
Lupeol	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
27	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
who	O
developed	O
HIT	O
while	O
on	O
venovenous	O
ECMO	O
with	O
continuous	O
venovenous	O
hemofiltration	O
.	O

We	O
found	O
that	O
tylophorine	O
-	O
based	O
compounds	O
target	O
the	O
TGEV	B-SPEC
viral	O
RNA	O
and	O
effectively	O
inhibit	O
TGEV	B-SPEC
replication	O
.	O

Compared	O
to	O
other	O
+	O
RNA	O
viruses	B-SPEC
,	O
coronaviruses	O
have	O
an	O
exceptionally	O
large	O
genome	O
and	O
employ	O
a	O
complex	O
genome	O
expression	O
strategy	O
.	O

Next	O
to	O
a	O
role	O
in	O
basic	O
virus	B-SPEC
replication	O
or	O
virus	B-SPEC
assembly	O
,	O
many	O
of	O
the	O
coronavirus	B-SPEC
proteins	O
expressed	O
in	O
the	O
infected	O
cell	O
contribute	O
to	O
the	O
coronavirus	B-SPEC
-	O
host	O
interplay	O
.	O

Clinicians	O
should	O
be	O
aware	O
of	O
the	O
characteristics	O
of	O
the	O
assays	O
they	O
use	O
,	O
since	O
different	O
assays	O
show	O
different	O
detectability	O
for	O
each	O
virus	B-SPEC
.	O

TITLE	O
:	O
Rapamycin	O
adjuvant	O
and	O
exacerbation	O
of	O
severe	O
influenza	O
in	O
an	O
experimental	O
mouse	B-SPEC
model	O
.	O

ABSTRACT	O
:	O
In	O
August	O
2015	O
,	O
the	O
Corona	B-SPEC
outbreak	O
caused	O
by	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
the	O
9th	O
episode	O
since	O
June	O
2012	O
in	O
Saudi	O
Arabia	O
.	O

TITLE	O
:	O
The	O
S2	O
glycoprotein	O
subunit	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
contains	O
immunodominant	O
neutralizing	O
epitopes	O
.	O

ABSTRACT	O
:	O
The	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
spike	O
(	O
S	O
)	O
protein	O
is	O
the	O
major	O
target	O
of	O
neutralizing	O
antibodies	O
against	O
PEDV	B-SPEC
.	O

Here	O
immunodominant	O
neutralizing	O
epitopes	O
of	O
PEDV	B-SPEC
were	O
identified	O
using	O
a	O
panel	O
of	O
S	O
-	O
specific	O
monoclonal	O
antibodies	O
(	O
mAbs	O
).	O

ABSTRACT	O
:	O
Highly	O
pathogenic	O
H5N1	O
virus	B-SPEC
(	O
H5N1	O
)	O
entry	O
is	O
a	O
key	O
target	O
for	O
the	O
development	O
of	O
novel	O
anti	O
-	O
influenza	O
agents	O
with	O
new	O
mechanisms	O
of	O
action	O
.	O

Virus	B-SPEC
was	O
present	O
in	O
nasal	O
swabs	O
of	O
infected	O
animals	B-SPEC
,	O
and	O
limited	O
amounts	O
of	O
viral	O
RNA	O
,	O
but	O
no	O
infectious	O
virus	B-SPEC
were	O
detected	O
in	O
the	O
direct	O
contact	O
pigs	B-SPEC
.	O

Furthermore	O
,	O
direct	O
and	O
indirect	O
contact	O
pigs	B-SPEC
did	O
not	O
develop	O
specific	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
.	O
Therefore	O
,	O
the	O
role	O
of	O
pigs	B-SPEC
as	O
reservoir	O
is	O
probably	O
negligible	O
,	O
although	O
it	O
deserves	O
further	O
confirmation	O
.	O

ABSTRACT	O
:	O
We	O
identified	O
from	O
suckling	O
piglets	O
with	O
diarrhea	O
in	O
China	O
a	O
new	O
bat	B-SPEC
-	O
HKU2	O
-	O
like	O
porcine	B-SPEC
coronavirus	B-SPEC
(	O
porcine	B-SPEC
enteric	O
alphacoronavirus	B-SPEC
).	O

Twenty	O
-	O
four	O
IBV	B-SPEC
isolates	O
were	O
of	O
the	O
Q1	O
genotype	O
.	O

The	O
experiments	O
also	O
included	O
comparing	O
the	O
ability	O
of	O
six	O
vaccination	O
programmes	O
to	O
induce	O
virus	B-SPEC
neutralizing	O
antibodies	O
(	O
VNA	O
)	O
in	O
layers	O
against	O
four	O
selected	O
Chilean	O
strains	O
.	O

These	O
differences	O
were	O
seen	O
in	O
embryonated	O
eggs	O
,	O
in	O
cell	O
culture	O
,	O
in	O
pathogenicity	O
and	O
in	O
level	O
of	O
cross	O
-	O
protection	O
by	O
IBV	B-SPEC
Massachusetts	O
(	O
Mass	O
)	O
vaccination	O
.	O

Multiplex	O
real	O
-	O
time	O
PCR	O
for	O
19	O
respiratory	O
viruses	B-SPEC
or	O
subtypes	O
was	O
performed	O
.	O

CONCLUSIONS	O
:	O
Young	O
children	O
living	O
in	O
a	O
group	O
context	O
have	O
a	O
high	O
risk	O
of	O
respiratory	O
virus	B-SPEC
infections	O
,	O
especially	O
rhinovirus	B-SPEC
.	O

ABSTRACT	O
:	O
Slackia	B-SPEC
exigua	I-SPEC
(	O
S	B-SPEC
.	I-SPEC
exigua	I-SPEC
)	O
is	O
an	O
obligatory	O
anaerobic	O
coccobacillus	O
under	O
the	O
family	B-SPEC
of	O
Coriobacteriaceae	B-SPEC
.	O

Therefore	O
,	O
this	O
study	O
aims	O
to	O
explore	O
what	O
healthcare	O
providers	O
,	O
who	O
survived	O
coronavirus	B-SPEC
infection	O
,	O
have	O
experienced	O
as	O
a	O
MERS	O
patient	O
and	O
how	O
the	O
infection	O
affected	O
their	O
relationship	O
with	O
their	O
colleagues	O
.	O

ABSTRACT	O
:	O
Two	O
highly	O
pathogenic	O
human	B-SPEC
coronaviruses	O
associated	O
with	O
severe	O
respiratory	O
syndromes	O
emerged	O
since	O
the	O
beginning	O
of	O
the	O
century	O
.	O

Based	O
on	O
comparison	O
of	O
103	O
nucleotides	O
of	O
the	O
UL24	O
-	O
UL25	O
gene	O
,	O
the	O
FHV	O
-	O
1	O
sequences	O
were	O
99	O
-	O
100	O
%	O
similar	O
to	O
the	O
FHV	O
-	O
1	O
strain	O
of	O
domestic	B-SPEC
cats	I-SPEC
.	O

The	O
FIV	B-SPEC
nucleotide	O
sequence	O
detected	O
in	O
the	O
free	O
-	O
ranging	O
puma	B-SPEC
,	O
based	O
on	O
comparison	O
of	O
444	O
nucleotides	O
of	O
the	O
pol	O
gene	O
,	O
grouped	O
with	O
other	O
lentiviruses	O
described	O
in	O
pumas	B-SPEC
,	O
and	O
had	O
82	O
.	O
4	O
%	O
identity	O
with	O
a	O
free	O
-	O
ranging	O
puma	B-SPEC
from	O
Yellowstone	O
Park	O
and	O
79	O
.	O
5	O
%	O
with	O
a	O
captive	O
puma	B-SPEC
from	O
Brazil	O
.	O

The	O
sequence	O
similarity	O
between	O
Iranian	O
793	O
/	O
B	O
-	O
like	O
IBV	B-SPEC
isolates	O
is	O
87	O
.	O
69	O
%-	O
100	O
%.	O

In	O
this	O
study	O
,	O
we	O
successfully	O
isolated	O
two	O
PEDV	B-SPEC
isolates	O
(	O
QIAP1401	O
and	O
QIAP1402	O
)	O
from	O
naturally	O
infected	O
piglets	O
at	O
Jeju	O
-	O
do	O
,	O
Korea	O
.	O

ABSTRACT	O
:	O
To	O
provide	O
optimal	O
cut	O
-	O
off	O
values	O
of	O
anti	O
-	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
serologic	O
tests	O
,	O
we	O
evaluated	O
performance	O
of	O
ELISA	O
IgG	O
,	O
ELISA	O
IgA	O
,	O
IFA	O
IgM	O
,	O
and	O
IFA	O
IgG	O
using	O
138	O
serum	O
samples	O
of	O
49	O
MERS	O
-	O
CoV	O
-	O
infected	O
patients	O
and	O
219	O
serum	O
samples	O
of	O
219	O
rRT	O
-	O
PCR	O
-	O
negative	O
MERS	O
-	O
CoV	O
-	O
exposed	O
healthcare	O
personnel	O
and	O
patients	O
.	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
is	O
one	O
of	O
the	O
most	O
lethal	O
diseases	O
encountered	O
in	O
the	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
).	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
non	O
-	O
survivors	O
and	O
survivors	O
regarding	O
the	O
types	O
of	O
pathogen	O
,	O
incidence	O
of	O
multiple	O
virus	B-SPEC
infection	O
,	O
gender	O
,	O
age	O
,	O
clinical	O
features	O
,	O
and	O
treatment	O
.	O

ABSTRACT	O
:	O
The	O
last	O
years	O
an	O
increase	O
of	O
severe	O
cases	O
of	O
invasive	O
disease	O
(	O
ID	O
)	O
due	O
to	O
Streptococcus	B-SPEC
pyogenes	I-SPEC
or	O
streptococcus	B-SPEC
b	O
-	O
hemolytic	O
group	O
A	O
(	O
SGA	O
)	O
had	O
been	O
detected	O
.	O

Skin	O
and	O
soft	O
tissue	O
infections	O
were	O
diagnosed	O
in	O
14	O
patients	O
(	O
26	O
.	O
9	O
%),	O
14	O
(	O
26	O
.	O
9	O
%)	O
pneumonias	O
,	O
12	O
(	O
23	O
.	O
1	O
%)	O
bones	O
and	O
joints	O
infections	O
,	O
10	O
(	O
19	O
.	O
2	O
%)	O
SSTS	O
,	O
6	O
(	O
11	O
.	O
5	O
%)	O
occult	O
bacteremia	O
,	O
4	O
(	O
7	O
.	O
7	O
%)	O
meningitis	O
and	O
2	O
(	O
3	O
.	O
8	O
%)	O
sepsis	B-SPEC
.	O

TITLE	O
:	O
Kanyawara	O
Virus	B-SPEC
:	O
A	O
Novel	O
Rhabdovirus	B-SPEC
Infecting	O

Newly	O
Discovered	O
Nycteribiid	O
Bat	B-SPEC
Flies	I-SPEC
Infesting	O
Previously	O
Unknown	O
Pteropodid	O
Bats	B-SPEC
in	O
Uganda	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
natural	O
reservoir	O
hosts	O
of	O
highly	O
virulent	O
pathogens	O
such	O
as	O
Marburg	B-SPEC
virus	I-SPEC
,	O
Nipah	B-SPEC
virus	I-SPEC
,	O
and	O
SARS	O
coronavirus	B-SPEC
.	O

The	O
coding	O
-	O
complete	O
genome	O
of	O
the	O
new	O
virus	B-SPEC
,	O
named	O
Kanyawara	O
virus	B-SPEC
(	O
KYAV	O
),	O
is	O
only	O
distantly	O
related	O
to	O
that	O
of	O
its	O
closest	O
known	O
relative	O
,	O
Mount	B-SPEC
Elgon	I-SPEC
bat	I-SPEC
virus	I-SPEC
,	O
and	O
was	O
found	O
at	O
high	O
titers	O
in	O
bat	B-SPEC
flies	I-SPEC
but	O
not	O
in	O
blood	O
or	O
on	O
mucosal	O
surfaces	O
of	O
host	O
bats	B-SPEC
.	O

TITLE	O
:	O
Novel	O
Alphacoronaviruses	O
and	O
Paramyxoviruses	O
Cocirculate	O
with	O
Type	O
1	O
and	O
Severe	O
Acute	O
Respiratory	O
System	O
(	O
SARS	O
)-	O
Related	O
Betacoronaviruses	O
in	O
Synanthropic	O
Bats	B-SPEC
of	O
Luxembourg	O
.	O

ABSTRACT	O
:	O
Several	O
infectious	O
disease	O
outbreaks	O
with	O
high	O
mortality	O
in	O
humans	B-SPEC
have	O
been	O
attributed	O
to	O
viruses	B-SPEC
that	O
are	O
thought	O
to	O
have	O
evolved	O
from	O
bat	B-SPEC
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
This	O
study	O
investigated	O
the	O
availability	O
of	O
relevant	O
structural	O
and	O
human	B-SPEC
resources	O
needed	O
for	O
the	O
clinical	O
management	O
of	O
patients	O
with	O
severe	O
acute	O
respiratory	O
infections	O
and	O
sepsis	B-SPEC
in	O
critical	O
care	O
units	O
in	O
Vietnam	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
NF	O
-	O
κB	O
activity	O
by	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
nonstructural	O
protein	O
1	O
for	O
innate	O
immune	O
evasion	O
.	O

TITLE	O
:	O
No	O
Serologic	O
Evidence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
Among	O
Camel	B-SPEC
Farmers	O
Exposed	O
to	O
Highly	O
Seropositive	O
Camel	B-SPEC
Herds	O
:	O

Human	B-SPEC
and	O
camel	B-SPEC
sera	O
were	O
tested	O
for	O
anti	O
-	O
MERS	O
-	O
CoV	O
IgG	O
using	O
a	O
commercial	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
test	O
.	O

TITLE	O
:	O
Molecular	O
and	O
phylogenetic	O
characterization	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
virus	B-SPEC
isolated	O
from	O
dairy	O
cattle	B-SPEC
in	O
Central	O
Region	O
,	O
Thailand	O
.	O

This	O
study	O
reports	O
the	O
first	O
molecular	O
detection	O
of	O
BCoV	O
in	O
a	O
diarrhea	O
outbreak	O
in	O
dairy	O
cows	B-SPEC
in	O
the	O
Central	O
Region	O
,	O
Thailand	O
.	O

Xenosurveillance	O
is	O
a	O
method	O
that	O
utilizes	O
mosquitoes	B-SPEC
as	O
sampling	O
devices	O
to	O
search	O
for	O
genetic	O
signatures	O
of	O
pathogens	O
in	O
vertebrates	B-SPEC
.	O

The	O
current	O
platform	O
has	O
been	O
optimized	O
to	O
include	O
a	O
novel	O
double	O
inactivation	O
procedure	O
in	O
order	B-SPEC
to	O
ensure	O
a	O
highly	O
robust	O
inactivation	O
procedure	O
for	O
novel	O
emerging	O
viruses	B-SPEC
.	O

The	O
potential	O
of	O
the	O
platform	O
for	O
development	O
of	O
vaccines	O
against	O
other	O
emerging	O
viruses	B-SPEC
such	O
as	O
Zika	B-SPEC
virus	I-SPEC
is	O
described	O
.	O

These	O
results	O
suggest	O
that	O
careful	O
surveillance	O
of	O
coronaviruses	O
from	O
bats	B-SPEC
should	O
be	O
continued	O
,	O
because	O
animal	B-SPEC
and	O
human	B-SPEC
infections	O
may	O
result	O
from	O
the	O
genetic	O
variants	O
present	O
in	O
bat	B-SPEC
coronavirus	B-SPEC
reservoirs	O
.	O

After	O
accounting	O
for	O
confounders	O
,	O
the	O
adjusted	O
rate	O
ratio	O
(	O
aRR	O
)	O
of	O
delays	O
in	O
the	O
diagnosis	O
was	O
independently	O
associated	O
with	O
unknown	O
source	O
of	O
infection	O
(	O
aRR	O
1	O
.	O
68	O
)	O
and	O
close	O
contact	O
with	O
camels	B-SPEC
(	O
aRR	O
1	O
.	O
58	O
).	O

TITLE	O
:	O
Antibody	O
-	O
dependent	O
enhancement	O
of	O
serotype	O
II	O
feline	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
infection	O
in	O
primary	O
feline	B-SPEC
monocytes	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
resembles	O
a	O
severe	O
form	O
of	O
community	O
-	O
acquired	O
pneumonia	O
initially	O
reported	O
in	O
Saudi	O
Arabia	O
in	O
2012	O
.	O

ABSTRACT	O
:	O
An	O
analysis	O
of	O
cardiac	O
injury	O
markers	O
in	O
patients	O
with	O
OSA	B-SPEC
who	O
sustain	O
an	O
episode	O
of	O
acute	O
coronary	O
syndrome	O
(	O
ACS	O
)	O
may	O
contribute	O
to	O
a	O
better	O
understanding	O
of	O
the	O
interactions	O
and	O
impact	O
of	O
OSA	B-SPEC
in	O
subjects	O
with	O
ACS	O
.	O

We	O
included	O
89	O
patients	O
with	O
OSA	B-SPEC
and	O
38	O
patients	O
without	O
OSA	B-SPEC
with	O
an	O
apnea	O
-	O
hypopnea	O
index	O
of	O
a	O
median	O
of	O
32	O
(	O
interquartile	O
range	O
[	O
IQR	O
],	O
20	O
.	O
8	O
-	O
46	O
.	O
6	O
/	O
h	O
and	O
4	O
.	O
8	O
[	O
IQR	O
,	O
1	O
.	O
6	O
-	O
9	O
.	O
6	O
]/	O
h	O
,	O
respectively	O
.	O

The	O
possible	O
role	O
of	O
OSA	B-SPEC
in	O
cardioprotection	O
should	O
be	O
explored	O
in	O
future	O
studies	O
.	O

While	O
bat	B-SPEC
,	O
camel	B-SPEC
,	O
and	O
human	B-SPEC
DPP4	O
support	O
MERS	O
-	O
CoV	O
infection	O
,	O
several	O
DPP4	O
orthologs	O
,	O
including	O
mouse	B-SPEC
,	O
ferret	B-SPEC
,	O
hamster	B-SPEC
,	O
and	O
guinea	B-SPEC
pig	I-SPEC
DPP4	O
,	O
do	O
not	O
.	O

The	O
IBV	B-SPEC
isolates	O
were	O
genetically	O
diverse	O
and	O
underwent	O
continuing	O
evolution	O
.	O

ABSTRACT	O
:	O
Prone	O
position	O
ventilation	O
(	O
PPV	B-SPEC
)	O
has	O
been	O
shown	O
to	O
improve	O
oxygenation	O
and	O
decrease	O
pulmonary	O
vascular	O
resistance	O
and	O
mortality	O
in	O
patients	O
with	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Besides	O
the	O
biological	O
interest	O
behind	O
the	O
SARS	O
coronavirus	B-SPEC
non	O
-	O
structural	O
protein	O
1	O
(	O
nsp1	O
,	O
117	O
amino	O
acids	O
),	O
this	O
study	O
model	O
has	O
two	O
structural	O
features	O
that	O
motivated	O
its	O
use	O
in	O
this	O
work	O
:	O
1	O
-	O
its	O
recombinant	O
production	O
is	O
dependent	O
on	O
the	O
temperature	O
,	O
with	O
greater	O
solubility	O
when	O
expressed	O
at	O
low	O
temperatures	O
.	O

However	O
,	O
he	O
suddenly	O
developed	O
acute	O
respiratory	O
distress	O
-	O
like	O
symptoms	O
,	O
with	O
a	O
chest	O
X	O
-	O
ray	B-SPEC
suggesting	O
organized	O
pneumonia	O
.	O

Control	O
of	O
the	O
infectious	O
agents	O
and	O
multidrug	O
resistant	O
bacteria	B-SPEC
in	O
the	O
veterinary	O
sector	O
is	O
on	O
the	O
frontline	O
for	O
infection	O
control	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
highly	O
virulent	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
variants	O
in	O
China	O
caused	O
huge	O
economic	O
losses	O
in	O
2010	O
.	O

We	O
share	O
our	O
successful	O
experience	O
of	O
ECMO	O
treatment	O
in	O
the	O
casualties	O
of	O
the	O
Formosa	B-SPEC
Water	O
Park	O
Dust	O
Explosion	O
Disaster	O
.	O

TITLE	O
:	O
Genetic	O
characteristics	O
,	O
pathogenicity	O
,	O
and	O
immunogenicity	O
associated	O
with	O
cell	O
adaptation	O
of	O
a	O
virulent	O
genotype	O
2b	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

Animal	B-SPEC
inoculation	O
studies	O
revealed	O
that	O
the	O
virulence	O
of	O
both	O
S	O
DEL2	O
/	O
ORF3	O
and	O
S	O
DEL5	O
/	O
ORF3	O
viruses	B-SPEC
with	O
a	O
large	O
46	O
-	O
nt	O
deletion	O
in	O
the	O
intergenic	O
portion	O
of	O
S	O
and	O
ORF3	O
was	O
remarkably	O
diminished	O
,	O
indicating	O
viral	O
attenuation	O
in	O
the	O
natural	O
host	O
.	O

Furthermore	O
,	O
these	O
cell	O
-	O
adapted	O
strains	O
elicited	O
potent	O
neutralizing	O
antibody	O
responses	O
in	O
immunized	O
pigs	B-SPEC
.	O

Taken	O
together	O
,	O
our	O
data	O
indicate	O
that	O
the	O
cell	O
-	O
attenuated	O
S	O
DEL2	O
/	O
ORF3	O
and	O
S	O
DEL5	O
/	O
ORF3	O
strains	O
are	O
promising	O
candidates	O
for	O
the	O
development	O
of	O
a	O
safe	O
and	O
effective	O
live	O
PEDV	B-SPEC
vaccine	O
.	O

Here	O
,	O
one	O
of	O
these	O
proteins	O
,	O
called	O
7b	O
(	O
206	O
residues	O
),	O
was	O
investigated	O
using	O
a	O
reverse	O
genetic	O
approach	O
established	O
for	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
strain	O
79	O
-	O
1146	O
.	O

The	O
data	O
show	O
that	O
(	O
i	O
)	O
7b	O
localizes	O
to	O
and	O
is	O
retained	O
in	O
the	O
medial	O
-	O
and	O
/	O
or	O
trans	O
-	O
Golgi	O
compartment	O
,	O
(	O
ii	O
)	O
the	O
C	O
-	O
terminal	O
KTEL	O
sequence	O
acts	O
as	O
a	O
Golgi	O
[	O
rather	O
than	O
an	O
endoplasmic	O
reticulum	O
(	O
ER	O
)]	O
retention	O
signal	O
,	O
(	O
iii	O
)	O
minor	O
changes	O
in	O
the	O
KTEL	O
motif	O
(	O
such	O
as	O
KTE	O
,	O
KTEV	O
,	O
or	O
the	O
addition	O
of	O
a	O
C	O
-	O
terminal	O
tag	O
)	O
abolish	O
Golgi	O
retention	O
,	O
resulting	O
in	O
relocalization	O
and	O
secretion	O
of	O
7b	O
,	O
and	O
(	O
iv	O
)	O
a	O
KTEL	O
-	O
to	O
-	O
KDEL	O
replacement	O
causes	O
retention	O
of	O
7b	O
in	O
the	O
ER	O
of	O
rFIPV	O
-	O
infected	O
feline	B-SPEC
cells	O
.	O

TITLE	O
:	O
The	O
tetraspanin	O
CD9	O
facilitates	O
MERS	O
-	O
coronavirus	B-SPEC
entry	O
by	O
scaffolding	O
host	O
cell	O
receptors	O
and	O
proteases	O
.	O

RESULTS	O
:	O
FIPV	O
was	O
detected	O
in	O
the	O
effusion	O
of	O
25	O
/	O
59	O
cats	B-SPEC
,	O
one	O
of	O
them	O
being	O
a	O
control	O
cat	B-SPEC
with	O
chronic	O
kidney	O
disease	O
.	O

Effective	O
number	O
of	O
codons	O
(	O
ENc	O
)	O
analysis	O
reveals	O
a	O
general	O
slight	O
codon	O
usage	O
bias	B-SPEC
.	O

TITLE	O
:	O
Evolution	O
and	O
Emergence	O
of	O
Pathogenic	O
Viruses	B-SPEC
:	O
Past	O
,	O
Present	O
,	O
and	O
Future	O
.	O

Though	O
significant	O
progress	O
in	O
controlling	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
and	O
hepatitis	O
viruses	B-SPEC
has	O
been	O
achieved	O
,	O
the	O
unpredictable	O
nature	O
of	O
evolving	O
viruses	B-SPEC
and	O
the	O
rare	O
occasions	O
of	O
outbreaks	O
severely	O
hamper	O
control	O
and	O
preventive	O
modalities	O
.	O

The	O
causative	O
agent	O
,	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
an	O
RNA	O
virus	B-SPEC
with	O
great	O
ability	O
for	O
mutation	O
and	O
recombination	O
;	O
thus	O
,	O
capable	O
of	O
generating	O
new	O
virus	B-SPEC
strains	O
that	O
are	O
difficult	O
to	O
control	O
.	O

Currently	O
,	O
information	O
on	O
the	O
epidemiology	O
,	O
strain	O
diversity	O
,	O
and	O
global	O
distribution	O
of	O
IBV	B-SPEC
has	O
not	O
been	O
comprehensively	O
reported	O
.	O

This	O
review	O
is	O
an	O
update	O
of	O
current	O
knowledge	O
on	O
the	O
distribution	O
,	O
genetic	O
relationship	O
,	O
and	O
diversity	O
of	O
the	O
IBV	B-SPEC
strains	O
found	O
worldwide	O
.	O

ABSTRACT	O
:	O
Influenza	B-SPEC
virus	I-SPEC
and	O
coronavirus	B-SPEC
epidemics	O
or	O
pandemics	O
have	O
occurred	O
in	O
succession	O
worldwide	O
throughout	O
the	O
early	O
21st	O
century	O
.	O

ABSTRACT	O
:	O
Coronaviruses	O
as	O
well	O
as	O
influenza	O
A	O
viruses	B-SPEC
are	O
widely	O
spread	O
in	O
pig	B-SPEC
fattening	O
and	O
can	O
cause	O
high	O
economical	O
loss	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
causing	O
major	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
.	O

Further	O
studies	O
are	O
needed	O
and	O
should	O
include	O
the	O
isolation	O
and	O
full	O
-	O
length	O
molecular	O
characterization	O
of	O
IBV	B-SPEC
in	O
Iran	O
.	O

Studies	O
of	O
the	O
genetics	O
and	O
molecular	O
mechanisms	O
of	O
this	O
virus	B-SPEC
are	O
expected	O
to	O
facilitate	O
the	O
development	O
of	O
vaccines	O
in	O
the	O
future	O
.	O

Human	B-SPEC
metapneumovirus	I-SPEC
can	O
lead	O
to	O
severe	O
respiratory	O
illness	O
during	O
pregnancy	O
.	O

TITLE	O
:	O
Propagation	O
of	O
respiratory	O
viruses	B-SPEC
in	O
human	B-SPEC
airway	O
epithelia	O
reveals	O
persistent	O
virus	B-SPEC
-	O
specific	O
signatures	O
.	O

Based	O
upon	O
data	O
arising	O
from	O
S1	O
sequence	O
and	O
phylogenetic	O
analyses	O
,	O
the	O
three	O
IBV	B-SPEC
isolates	O
were	O
genetically	O
different	O
from	O
other	O
known	O
IBV	B-SPEC
types	O
,	O
which	O
represented	O
a	O
novel	O
genotype	O
(	O
GI	O
-	O
29	O
).	O

Sequence	O
analysis	O
of	O
complete	O
H	O
gene	O
and	O
partial	O
N	O
gene	O
confirmed	O
the	O
aetiological	O
agent	O
as	O
PPR	O
virus	B-SPEC
lineage	O
IV	O
.	O

This	O
report	O
extends	O
host	O
range	O
and	O
demands	O
enhanced	O
surveillance	O
among	O
subfamily	B-SPEC
bovinae	I-SPEC
to	O
strengthen	O
PPR	O
eradication	O
programme	O
.	O

These	O
results	O
suggest	O
that	O
Brazilian	O
IBV	B-SPEC
variants	O
probably	O
underwent	O
drastic	O
mutations	O
at	O
various	O
points	O
between	O
1983	O
and	O
2003	O
and	O
that	O
the	O
selection	O
processes	O
became	O
silent	O
after	O
achieving	O
a	O
sufficiently	O
effective	O
antigenic	O
structure	O
for	O
invasion	O
and	O
replication	O
in	O
their	O
hosts	O
.	O

Previous	O
activities	O
and	O
exercises	O
conducted	O
by	O
the	O
Nebraska	O
Biocontainment	O
Unit	O
have	O
focused	O
on	O
transporting	O
and	O
caring	O
for	O
up	O
to	O
3	O
patients	O
with	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
or	O
other	O
special	O
pathogens	O
.	O

Here	O
we	O
use	O
structure	O
-	O
based	O
design	O
to	O
develop	O
a	O
generalizable	O
strategy	O
for	O
retaining	O
coronavirus	B-SPEC
S	O
proteins	O
in	O
the	O
antigenically	O
optimal	O
prefusion	O
conformation	O
and	O
demonstrate	O
that	O
our	O
engineered	O
immunogen	O
is	O
able	O
to	O
elicit	O
high	O
neutralizing	O
antibody	O
titers	O
against	O
MERS	O
-	O
CoV	O
.	O
We	O
also	O
determined	O
high	O
-	O
resolution	O
structures	O
of	O
the	O
trimeric	O
MERS	O
-	O
CoV	O
S	O
ectodomain	O
in	O
complex	O
with	O
G4	O
,	O
a	O
stem	O
-	O
directed	O
neutralizing	O
antibody	O
.	O

Both	O
assays	O
provided	O
the	O
same	O
results	O
,	O
and	O
R	O
The	O
results	O
demonstrated	O
that	O
the	O
RT	O
-	O
RPA	O
assay	O
offers	O
an	O
alternative	O
tool	O
for	O
simple	O
,	O
rapid	O
,	O
and	O
reliable	O
detection	O
of	O
CDV	B-SPEC
both	O
in	O
the	O
laboratory	O
and	O
point	O
-	O
of	O
-	O
care	O
facility	O
,	O
especially	O
in	O
the	O
resource	O
-	O
limited	O
settings	O
.	O

Anaesthetized	O
,	O
mechanically	O
ventilated	O
animals	B-SPEC
underwent	O
right	O
lung	O
ischaemia	O
(	O
series	O
1	O
,	O
30	O
minutes	O
;	O
series	O
2	O
,	O
60	O
minutes	O
)	O
followed	O
by	O
reperfusion	O
for	O
300	O
minutes	O
.	O

Interestingly	O
,	O
passive	O
transfer	O
of	O
serum	O
from	O
previously	O
infected	O
rabbits	B-SPEC
to	O
naïve	O
rabbits	B-SPEC
was	O
associated	O
with	O
enhanced	O
inflammation	O
upon	O
infection	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
examines	O
the	O
susceptibility	O
of	O
mouse	B-SPEC
induced	O
pluripotent	O
stem	O
cell	O
-	O
derived	O
neural	O
precursor	O
cells	O
(	O
iPSC	O
-	O
NPCs	O
)	O
to	O
infection	O
with	O
the	O
neurotropic	O
JHM	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
).	O

ABSTRACT	O
:	O
In	O
the	O
past	O
five	O
years	O
,	O
there	O
have	O
been	O
1	O
,	O
936	O
laboratory	O
-	O
confirmed	O
cases	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
in	O
27	O
countries	O
,	O
with	O
a	O
mortality	O
rate	O
of	O
35	O
.	O
6	O
%.	O

Most	O
cases	O
have	O
arisen	O
in	O
the	O
Middle	O
East	O
,	O
particularly	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
,	O
however	O
there	O
was	O
a	O
large	O
hospital	O
-	O
associated	O
outbreak	O
in	O
the	O
Republic	O
of	O
Korea	O
in	O
2015	O
.	O

For	O
the	O
first	O
time	O
,	O
a	O
natural	O
recombination	O
strain	O
of	O
a	O
TGEV	B-SPEC
Anhui	O
Hefei	O
(	O
AHHF	O
)	O
virus	B-SPEC
between	O
the	O
Purdue	O
and	O
the	O
Miller	O
clusters	O
was	O
isolated	O
from	O
the	O
small	O
intestine	O
content	O
of	O
piglets	O
in	O
China	O
.	O

A	O
phylogenetic	O
tree	O
based	O
on	O
a	O
complete	O
genome	O
sequence	O
placed	O
the	O
TGEV	B-SPEC
AHHF	O
strain	O
between	O
the	O
Purdue	O
and	O
the	O
Miller	O
clusters	O
.	O

Such	O
viruses	B-SPEC
have	O
become	O
a	O
more	O
common	O
cause	O
of	O
severe	O
respiratory	O
-	O
tract	O
infections	O
,	O
especially	O
in	O
children	O
with	O
underlying	O
lung	O
disease	O
such	O
as	O
asthma	O
.	O

The	O
results	O
showed	O
that	O
some	O
cells	O
were	O
able	O
to	O
survive	O
the	O
infection	O
,	O
as	O
demonstrated	O
by	O
continued	O
tdTomato	O
expression	O
after	O
virus	B-SPEC
antigen	O
could	O
no	O
longer	O
be	O
detected	O
.	O

TITLE	O
:	O
A	O
persistently	O
infecting	O
coronavirus	B-SPEC
in	O
hibernating	O
Myotis	B-SPEC
lucifugus	I-SPEC
,	O
the	O
North	O
American	O
little	B-SPEC
brown	I-SPEC
bat	I-SPEC
.	O

TITLE	O
:	O
Imported	O
case	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
from	O
Oman	O
to	O
Thailand	O
,	O
June	O
2015	O
.	O

Subsequent	O
examination	O
of	O
sputum	O
later	O
on	O
day	O
3	O
confirmed	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

Co	O
-	O
localization	O
of	O
PEDV	B-SPEC
and	O
autophagosomes	O
suggests	O
that	O
PEDV	B-SPEC
could	O
be	O
a	O
target	O
of	O
autophagy	O
.	O

Moreover	O
,	O
alleviation	O
of	O
PEDV	B-SPEC
-	O
induced	O
cell	O
death	O
in	O
IPEC	O
-	O
J2	O
cells	O
pretreated	O
with	O
rapamycin	O
demonstrates	O
a	O
protective	O
effect	O
of	O
rapamycin	O
against	O
PEDV	B-SPEC
-	O
induced	O
epithelial	O
cell	O
death	O
.	O

ABSTRACT	O
:	O
MERS	O
-	O
CoV	O
is	O
the	O
only	O
lethal	O
human	B-SPEC
CoV	O
still	O
endemic	O
in	O
the	O
Arabian	O
Peninsula	O
and	O
neither	O
vaccine	O
nor	O
therapeutics	O
against	O
MERS	O
-	O
CoV	O
infection	O
is	O
available	O
.	O

During	O
2015	O
-	O
2016	O
,	O
a	O
total	O
of	O
104	O
diarrheic	O
fecal	O
samples	O
were	O
collected	O
from	O
puppies	O
and	O
adult	O
dogs	B-SPEC
,	O
with	O
or	O
without	O
hemorrhagic	O
gastroenteritis	O
,	O
on	O
the	O
Caribbean	O
island	O
of	O
St	O
.	O
Kitts	O
(	O
KNA	O
).	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
an	O
enteropathogenic	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
of	O
porcine	B-SPEC
,	O
causes	O
lethal	O
watery	O
diarrhea	O
and	O
severe	O
dehydration	O
in	O
piglets	O
and	O
leads	O
to	O
severe	O
economic	O
losses	O
in	O
the	O
swine	B-SPEC
industry	O
.	O

ABSTRACT	O
:	O
Aichivirus	O
B	O
has	O
been	O
reported	O
worldwide	O
in	O
calves	O
and	O
adult	O
cattle	B-SPEC
with	O
and	O
without	O
diarrhea	O
.	O

RT	O
-	O
PCR	O
assays	O
were	O
performed	O
for	O
the	O
detection	O
of	O
aichivirus	O
B	O
RdRP	O
and	O
VP1	O
genes	O
and	O
for	O
rotavirus	B-SPEC
A	I-SPEC
VP7	O
and	O
VP4	O
genes	O
in	O
fecal	O
samples	O
.	O

SIV	B-SPEC
,	O
RESULTS	O
:	O
According	O
to	O
the	O
pathology	O
and	O
bacteriology	O
of	O
the	O
lung	O
samples	O
,	O
APP	O
and	O

An	O
indirect	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
was	O
developed	O
based	O
on	O
the	O
recombinant	O
S1	O
protein	O
of	O
PDCoV	O
.	O
This	O
assay	O
was	O
used	O
to	O
test	O
609	O
serum	O
samples	O
of	O
pigs	B-SPEC
with	O
diarrhea	O
symptoms	O
collected	O
from	O
10	O
provinces	O
between	O
2015	O
and	O
2016	O
.	O

Western	O
blot	O
and	O
indirect	O
immunofluorescence	O
assay	O
showed	O
that	O
nsp1	O
was	O
highly	O
expressed	O
in	O
transfected	O
cells	O
and	O
PEDV	B-SPEC
-	O
infected	O
cells	O
.	O

The	O
results	O
have	O
laid	O
a	O
foundation	O
for	O
further	O
understanding	O
the	O
immune	O
evasion	O
mechanism	O
of	O
PEDV	B-SPEC
and	O
for	O
developing	O
new	O
effective	O
vaccine	O
against	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
Identification	O
of	O
two	O
mutation	O
sites	O
in	O
spike	O
and	O
envelope	O
proteins	O
mediating	O
optimal	O
cellular	O
infection	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
from	O
different	O
pathways	O
.	O

Further	O
analysis	O
confirmed	O
that	O
this	O
mutation	O
was	O
responsible	O
for	O
optimal	O
cell	O
-	O
adaptation	O
,	O
but	O
not	O
the	O
determinant	O
for	O
trypsin	O
-	O
dependent	O
entry	O
of	O
PEDV	B-SPEC
.	O

The	O
results	O
highlight	O
the	O
pulmonary	O
and	O
extrapulmonary	O
pathological	O
changes	O
of	O
MERS	O
-	O
CoV	O
infection	O
and	O
provide	O
the	O
first	O
evidence	O
of	O
the	O
viral	O
presence	O
in	O
human	B-SPEC
renal	O
tissue	O
,	O
which	O
suggests	O
tissue	O
trophism	O
for	O
MERS	O
-	O
CoV	O
in	O
kidney	O
.	O

ABSTRACT	O
:	O
In	O
the	O
continuous	O
effort	O
to	O
identify	O
new	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
inhibitors	O
endowed	O
with	O
innovative	O
mechanisms	O
,	O
the	O
dual	O
inhibition	O
of	O
different	O
viral	O
functions	O
would	O
provide	O
a	O
significant	O
advantage	O
against	O
drug	O
-	O
resistant	O
variants	O
.	O

Especially	O
,	O
compound	O
g18	O
showed	O
excellent	O
curative	O
and	O
protective	O
activities	O
against	O
CMV	B-SPEC
,	O
with	O
half	O
-	O
maximal	O
effective	O
concentration	O
(	O
EC	O

Sickle	O
-	O
cell	O
anemia	B-SPEC
(	O
SCA	O
),	O
the	O
most	O
severe	O
form	O
of	O
this	O
disease	O
,	O
is	O
the	O
most	O
common	O
inherited	O
blood	O
disorder	O
in	O
the	O
United	O
States	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
resulted	O
in	O
multiple	O
healthcare	O
associated	O
outbreaks	O
.	O

It	O
also	O
explores	O
the	O
experimental	O
evidence	O
accumulated	O
for	O
inhibitors	O
of	O
TTSPs	O
as	O
novel	O
,	O
broad	O
-	O
spectrum	O
antivirals	O
against	O
various	O
influenza	B-SPEC
virus	I-SPEC
subtypes	O
.	O

TITLE	O
:	O
Ultrastructural	O
Characterization	O
of	O
Membrane	O
Rearrangements	O
Induced	O
by	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Infection	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
respiratory	O
disease	O
with	O
significant	O
mortality	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
have	O
been	O
shown	O
as	O
important	O
mammal	B-SPEC
resevoirs	O
to	O
carry	O
a	O
variety	O
of	O
zoonotic	O
pathogens	O
.	O

TITLE	O
:	O
Virulence	O
of	O
current	O
German	O
PEDV	B-SPEC
strains	O
in	O
suckling	O
pigs	B-SPEC
and	O
investigation	O
of	O
protective	O
effects	O
of	O
maternally	O
derived	O
antibodies	O
.	O

All	O
structure	O
activity	O
relationships	O
(	O
SARs	O
)	O
were	O
tested	O
on	O
the	O
human	B-SPEC
norovirus	B-SPEC
surrogate	O
phage	O
MS2	O
and	O
phage	O
P100	O
representing	O
non	O
-	O
enveloped	O
DNA	O
viruses	B-SPEC
.	O

Therefore	O
,	O
the	O
present	O
study	O
was	O
conducted	O
to	O
determine	O
whether	O
cellular	O
or	O
/	O
and	O
viral	O
cholesterol	O
levels	O
play	O
a	O
role	O
in	O
porcine	B-SPEC
nidovirus	B-SPEC
infection	O
.	O

Cytomegalovirus	B-SPEC
infection	O
was	O
diagnosed	O
by	O
Polymerase	O
Chain	O
Reaction	O
(	O
PCR	O
)	O
in	O
blood	O
and	O
histopathological	O
examination	O
of	O
lung	O
biopsy	O
.	O

Results	O
:	O
Of	O
the	O
228	O
participants	O
analyzed	O
,	O
85	O
.	O
5	O
%	O
believed	O
their	O
work	O
put	O
them	O
at	O
risk	O
of	O
infection	O
,	O
and	O
two	O
-	O
thirds	O
believed	O
their	O
family	B-SPEC
was	O
exposed	O
to	O
a	O
greater	O
risk	O
of	O
infection	O
.	O

ABSTRACT	O
:	O
Frequently	O
touched	O
surfaces	O
of	O
a	O
university	O
classroom	O
that	O
is	O
cleaned	O
daily	O
contained	O
viable	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
CoV	O
-	O
229E	O
).	O

ABSTRACT	O
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
is	O
a	O
viral	O
enteric	O
pathogen	O
associated	O
with	O
calf	O
diarrhea	O
worldwide	O
being	O
,	O
in	O
Argentina	B-SPEC
,	O
mostly	O
detected	O
in	O
dairy	O
husbandry	O
systems	O
.	O

Animals	B-SPEC
were	O
classified	O
into	O
two	O
groups	O
depending	O
on	O
their	O
initial	O
BCoV	O
IgG1	O
Ab	O
titers	O
.	O

MERS	O
is	O
caused	O
by	O
a	O
coronavirus	B-SPEC
known	O
as	O
MERS	O
-	O
CoV	O
,	O
which	O
attacks	O
the	O
respiratory	O
system	O
.	O

TITLE	O
:	O
Role	O
of	O
the	O
inflammasome	O
-	O
related	O
cytokines	O
Il	O
-	O
1	O
and	O
Il	O
-	O
18	O
during	O
infection	O
with	O
murine	B-SPEC
coronavirus	I-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
used	O
murine	B-SPEC
coronavirus	I-SPEC
,	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
infection	O
of	O
the	O
central	O
nervous	O
system	O
and	O
liver	O
to	O
assess	O
of	O
the	O
role	O
of	O
the	O
inflammasome	O
and	O
its	O
related	O
cytokines	O
on	O
pathogenesis	O
and	O
host	O
defense	O
during	O
viral	O
infection	O
.	O

In	O
the	O
absence	O
of	O
IL	O
-	O
18	O
,	O
mice	B-SPEC
had	O
elevated	O
viral	O
replication	O
and	O
poor	O
survival	O
,	O
and	O
this	O
protective	O
effect	O
of	O
IL	O
-	O
18	O
was	O
found	O
to	O
be	O
due	O
to	O
promotion	O
of	O
interferon	O
gamma	O
production	O
in	O
αβ	O
T	O
cells	O
.	O

We	O
also	O
characterized	O
the	O
antigenicity	O
,	O
pathogenesis	O
,	O
tissue	O
tropism	O
and	O
spreading	O
of	O
three	O
IBV	B-SPEC
isolates	O
by	O
experimental	O
infection	O
of	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
chickens	B-SPEC
and	O
contact	O
sentinel	O
birds	B-SPEC
.	O

ABSTRACT	O
:	O
To	O
date	O
,	O
1841	O
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
have	O
been	O
reported	O
worldwide	O
,	O
with	O
652	O
deaths	O
.	O

Fourteen	O
cats	B-SPEC
presented	O
with	O
wet	O
or	O
dry	O
-	O
to	O
-	O
wet	O
FIP	O
and	O
six	O
cats	B-SPEC
presented	O
with	O
dry	O
FIP	O
.	O

ABSTRACT	O
:	O
Camels	B-SPEC
are	O
known	O
carriers	O
for	O
many	O
viral	O
pathogens	O
,	O
including	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Some	O
viral	O
sequences	O
belong	O
to	O
known	O
camel	B-SPEC
or	O
human	B-SPEC
viruses	B-SPEC
and	O
others	O
are	O
from	O
potentially	O
novel	O
camel	B-SPEC
viruses	B-SPEC
with	O
only	O
limited	O
sequence	O
similarity	O
to	O
virus	B-SPEC
sequences	O
in	O
GenBank	O
.	O

Nasopharyngeal	O
swab	O
submitted	O
for	O
multiplex	O
amplified	O
nucleic	O
acid	O
testing	O
yielded	O
enterovirus	B-SPEC
-	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
EV	O
-	O
HRV	O
).	O

Study	O
subjects	O
were	O
5	O
,	O
298	O
patients	O
,	O
who	O
underwent	O
multiplex	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
for	O
simultaneous	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
,	O
among	O
who	O
visited	O
the	O
emergency	O
department	O
or	O
outpatient	O
clinic	O
with	O
respiratory	O
symptoms	O
at	O
Ulsan	O
University	O
Hospital	O
between	O
April	O
2013	O
and	O
March	O
2016	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
251	O
clinically	O
significant	O
bacteria	B-SPEC
were	O
identified	O
in	O
233	O
patients	O
with	O
post	O
-	O
viral	O
bacterial	O
pneumonia	O
.	O

TITLE	O
:	O
Identification	O
of	O
a	O
Novel	O
Inhibitor	O
against	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

During	O
December	O
2015	O
-	O
May	O
2016	O
,	O
a	O
series	O
of	O
unannounced	O
""""	O
mystery	O
patient	O
drills	B-SPEC
""""	O
was	O
carried	O
out	O
to	O
assess	O
New	O
York	O
City	O
Emergency	O
Departments	O
'	O
(	O
EDs	O
)	O
abilities	O
to	O
identify	O
and	O
respond	O
to	O
patients	O
with	O
communicable	O
diseases	O
of	O
public	O
health	O
concern	O
.	O

Our	O
results	O
show	O
that	O
,	O
in	O
the	O
lungs	O
of	O
infected	O
mice	B-SPEC
,	O
the	O
percentage	O
of	O
γδT	O
cells	O
,	O
but	O
not	O
the	O
percentages	O
of	O
CD4	O

We	O
have	O
developed	O
a	O
live	O
recombinant	O
vaccine	O
,	O
a	O
swinepox	B-SPEC
virus	I-SPEC
vector	O
that	O
expresses	O
a	O
truncated	O
S	O
protein	O
(	O
rSPV	O
-	O
St	O
)	O
from	O
a	O
recent	O
PEDV	B-SPEC
strain	O
,	O
SQ2014	O
,	O
and	O
evaluated	O
its	O
immunogenicity	O
and	O
effectiveness	O
in	O
a	O
swine	B-SPEC
model	O
.	O

Vaccination	O
of	O
swine	B-SPEC
with	O
rSPV	O
-	O
St	O
elicited	O
a	O
robust	O
antibody	O
response	O
specific	O
for	O
the	O
homologous	O
PEDV	B-SPEC
SQ2014	O
.	O

One	O
change	O
in	O
the	O
1b	O
gene	O
altered	O
the	O
normally	O
highly	O
conserved	O
final	O
5	O
nucleotides	O
of	O
the	O
transcription	O
regulatory	O
sequence	O
of	O
the	O
S	O
gene	O
,	O
common	O
to	O
all	O
IBV	B-SPEC
QX	O
genes	O
.	O

As	O
part	O
of	O
a	O
bigger	O
study	O
investigating	O
pathogens	O
in	O
African	O
bats	B-SPEC
we	O
screened	O
animals	B-SPEC
for	O
the	O
presence	O
of	O
known	O
and	O
unknown	O
viruses	B-SPEC
.	O

We	O
isolated	O
and	O
characterised	O
a	O
novel	O
reovirus	B-SPEC
from	O
blood	O
of	O
free	B-SPEC
-	I-SPEC
tailed	I-SPEC
bats	I-SPEC
(	O
Chaereophon	O
aloysiisabaudiae	O
)	O
captured	O
in	O
2006	O
in	O
Côte	O
d	O
'	O
Ivoire	O
.	O

The	O
probability	O
for	O
severe	O
illness	O
originated	O
from	O
delayed	O
utilization	O
of	O
health	O
services	O
,	O
delayed	O
prescription	O
of	O
neuraminidase	O
inhibitors	O
(	O
NAIs	B-SPEC
)	O
and	O
inappropriate	O
use	O
of	O
antibiotics	O
was	O
assessed	O
.	O

More	O
severe	O
form	O
of	O
the	O
virus	B-SPEC
appeared	O
in	O
2006	O
,	O
when	O
the	O
second	O
wave	O
of	O
Var2	O
epidemic	O
has	O
spread	O
over	O
the	O
Middle	O
East	O
region	O
.	O

In	O
the	O
present	O
study	O
,	O
a	O
meta	B-SPEC
-	O
analysis	O
was	O
performed	O
to	O
evaluate	O
the	O
effects	O
of	O
NAC	O
for	O
adult	O
patients	O
with	O
ARDS	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
)	O
are	O
known	O
respiratory	O
pathogens	O
associated	O
with	O
a	O
range	O
of	O
respiratory	O
outcomes	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
has	O
caused	O
huge	O
economic	O
losses	O
in	O
the	O
poultry	O
industry	O
.	O

Previous	O
studies	O
have	O
reported	O
that	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
infection	O
can	O
produce	O
cytopathic	O
effects	O
(	O
CPE	O
)	O
and	O
apoptosis	O
in	O
some	O
mammalian	B-SPEC
cells	O
and	O
primary	O
cells	O
.	O

In	O
this	O
study	O
,	O
chicken	B-SPEC
macrophage	O
HD11	O
cells	O
were	O
established	O
as	O
a	O
cellular	O
model	O
that	O
is	O
permissive	O
to	O
IBV	B-SPEC
infection	O
.	O

UV	O
-	O
inactivated	O
IBV	B-SPEC
also	O
lost	O
the	O
ability	O
of	O
apoptosis	O
induction	O
.	O

We	O
suggest	O
not	O
using	O
corticosteroids	O
in	O
adult	O
patients	O
with	O
sepsis	B-SPEC
without	O
shock	O
(	O
conditional	O
recommendation	O
,	O
moderate	O
quality	O
of	O
evidence	O
).	O

TITLE	O
:	O
Macromolecular	O
Antiviral	O
Agents	O
against	O
Zika	O
,	O
Ebola	O
,	O
SARS	O
,	O
and	O
Other	O
Pathogenic	O
Viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Humans	B-SPEC
infected	O
with	O
H7N9	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
can	O
result	O
in	O
severe	O
pneumonia	O
and	O
acute	O
respiratory	O
syndrome	O
with	O
an	O
approximately	O
40	O
%	O
mortality	O
rate	O
,	O
and	O
there	O
is	O
an	O
urgent	O
need	O
to	O
develop	O
an	O
effective	O
vaccine	O
to	O
reduce	O
its	O
pandemic	O
potential	O
.	O

After	O
immunizing	O
BALB	O
/	O
c	O
mice	B-SPEC
intramuscularly	O
,	O
rH7HA	O
proteins	O
formulated	O
in	O
this	O
adjuvant	O
instead	O
of	O
an	O
alum	O
adjuvant	O
elicited	O
higher	O
IgG	O
,	O
hemagglutination	O
-	O
inhibition	O
,	O
and	O
virus	B-SPEC
neutralizing	O
antibodies	O
in	O
sera	O
;	O
induced	O
higher	O
numbers	O
of	O
H7HA	O
-	O
specific	O
IFN	O
-	O
γ	O
-	O
secreting	O
T	O
cells	O
and	O
antibody	O
secreting	O
cells	O
in	O
spleen	O
;	O
and	O
provided	O
improved	O
protection	O
against	O
live	O
virus	B-SPEC
challenges	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
causes	O
devastating	O
impact	O
on	O
global	O
pig	B-SPEC
-	O
breeding	O
industry	O
and	O
current	O
vaccines	O
have	O
become	O
not	O
effective	O
against	O
the	O
circulating	O
PEDV	B-SPEC
variants	O
since	O
2011	O
.	O

Complete	O
genomes	O
of	O
two	O
PEDV	B-SPEC
representatives	O
(	O
XM1	O
-	O
2	O
and	O
XM2	O
-	O
4	O
)	O
were	O
determined	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHEV	O
)	O
is	O
a	O
highly	O
neurovirulent	O
coronavirus	B-SPEC
that	O
invades	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
in	O
piglets	O
.	O

Our	O
goal	O
was	O
to	O
determine	O
resistance	O
and	O
susceptibility	O
of	O
MHC	O
B	O
haplotype	O
in	O
congenic	O
and	O
inbred	O
chicken	B-SPEC
lines	O
in	O
order	B-SPEC
to	O
establish	O
a	O
resistant	O
-	O
susceptible	O
model	O
.	O

ABSTRACT	O
:	O
We	O
previously	O
demonstrated	O
that	O
chickens	B-SPEC
primed	O
with	O
a	O
recombinant	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
LaSota	O
(	O
rLS	O
)	O
expressing	O
the	O
S2	O
gene	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
boosted	O
with	O
an	O
attenuated	O
IBV	B-SPEC
Massachusetts	O
(	O
Mass	O
)-	O
type	O
vaccine	O
were	O
protected	O
against	O
IBV	B-SPEC
Arkansas	O
(	O
Ark	O
)-	O
type	O
virulent	O
challenge	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
whether	O
performing	O
alveolar	O
recruitment	O
or	O
adding	O
inspiratory	O
pauses	O
could	O
promote	O
physiologic	O
benefits	O
(	O
VT	O
)	O
during	O
moderately	O
-	O
high	O
-	O
frequency	O
positive	O
pressure	O
ventilation	O
(	O
MHFPPV	O
)	O
delivered	O
by	O
a	O
conventional	O
ventilator	O
in	O
a	O
porcine	B-SPEC
model	O
of	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

The	O
greatest	O
number	O
of	O
bloodmeals	O
identified	O
was	O
from	O
domestic	O
chicken	B-SPEC
(	O
Gallus	B-SPEC
gallus	I-SPEC
domesticus	I-SPEC
L	O
.)	O
(	O
38	O
%	O
of	O
bloodmeals	O
),	O
house	B-SPEC
sparrow	I-SPEC
(	O
Passer	B-SPEC
domesticus	I-SPEC
L	O
.)	O
(	O
23	O
%),	O
house	B-SPEC
finch	I-SPEC
(	O
Haemorhous	O
mexicanus	O
Müller	O
)	O
(	O
17	O
%),	O
American	B-SPEC
crow	I-SPEC
(	O
Corvus	B-SPEC
brachyrhynchos	I-SPEC
L	O
.)	O
(	O
4	O
%),	O
and	O
mourning	B-SPEC
dove	I-SPEC
(	O
Zenaida	B-SPEC
macroura	I-SPEC
L	O
.)	O
(	O
3	O
%).	O

The	O
separate	O
sampling	O
of	O
tracheas	O
and	O
kidneys	O
for	O
IBV	B-SPEC
detection	O
using	O
reverse	O
transcriptase	O
PCR	O
was	O
very	O
useful	O
,	O
as	O
different	O
genotypes	O
or	O
significant	O
differences	O
in	O
sequences	O
of	O
the	O
same	O
genotype	O
were	O
detected	O
between	O
both	O
organs	O
.	O

The	O
data	O
of	O
this	O
survey	O
also	O
provided	O
valuable	O
information	O
about	O
the	O
replication	O
of	O
IBD	O
vaccines	O
and	O
subsequent	O
infectious	B-SPEC
bursal	I-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
IBDV	B-SPEC
)	O
antibody	O
responses	O
under	O
field	O
conditions	O
.	O

ABSTRACT	O
:	O
Ricin	O
,	O
a	O
plant	B-SPEC
-	O
derived	O
toxin	O
originating	O
from	O
the	O
seeds	O
of	O
Ricinus	B-SPEC
communis	I-SPEC
(	O
castor	B-SPEC
beans	I-SPEC
),	O
is	O
one	O
of	O
the	O
most	O
lethal	O
toxins	O
known	O
,	O
particularly	O
if	O
inhaled	O
.	O

TITLE	O
:	O
Analysis	O
of	O
skeletal	O
muscle	O
microcirculation	O
in	O
a	O
porcine	B-SPEC
polytrauma	O
model	O
with	O
haemorrhagic	O
shock	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
changes	O
in	O
the	O
microcirculation	O
in	O
musculature	O
over	O
time	O
during	O
shock	O
and	O
subsequent	O
resuscitation	O
in	O
a	O
porcine	B-SPEC
model	O
of	O
haemorrhagic	O
shock	O
and	O
polytrauma	O
.	O

We	O
report	O
the	O
case	O
of	O
a	O
man	B-SPEC
who	O
presented	O
after	O
with	O
a	O
severe	O
traumatic	O
brain	O
injury	O
including	O
intracranial	O
and	O
extradural	O
haemorrhage	O
.	O

ABSTRACT	O
:	O
We	O
investigated	O
cross	O
-	O
protective	O
immunity	O
of	O
a	O
US	O
spike	O
-	O
insertion	O
deletion	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
Iowa106	O
(	O
S	O
-	O
INDEL	O
)	O
strain	O
against	O
the	O
original	O
US	O
PEDV	B-SPEC
(	O
PC21A	O
)	O
strain	O
in	O
nursing	O
piglets	O
.	O

In	O
patients	O
with	O
non	O
-	O
pulmonary	O
sepsis	B-SPEC
,	O
syndecan	O
-	O
1	O
levels	O
were	O
associated	O
with	O
ARDS	O
(	O
p	O
=	O
0	O
.	O
05	O
).	O

Regardless	O
of	O
etiology	O
of	O
sepsis	B-SPEC
,	O
higher	O
syndecan	O
-	O
1	O
levels	O
were	O
associated	O
with	O
hepatic	O
(	O
p	O
<	O
0	O
.	O
001	O
),	O
renal	O
(	O
p	O
=	O
0	O
.	O
003	O
),	O
coagulation	O
(	O
p	O
=	O
0	O
.	O
001	O
),	O
and	O
circulatory	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
failure	O
as	O
well	O
as	O
in	O
-	O
hospital	O
mortality	O
(	O
p	O
=	O
0	O
.	O
001	O
),	O
and	O
there	O
was	O
a	O
significant	O
association	O
between	O
syndecan	O
-	O
1	O
levels	O
and	O
the	O
number	O
of	O
vasopressors	O
required	O
in	O
the	O
first	O
24	O
h	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

TITLE	O
:	O
The	O
bulky	O
and	O
the	O
sweet	O
:	O
How	O
neutralizing	O
antibodies	O
and	O
glycan	O
receptors	O
compete	O
for	O
virus	B-SPEC
binding	O
.	O

ABSTRACT	O
:	O
Numerous	O
viruses	B-SPEC
rely	O
on	O
glycan	O
receptor	O
binding	O
as	O
the	O
initial	O
step	O
in	O
host	O
cell	O
infection	O
.	O

In	O
this	O
review	O
,	O
we	O
examine	O
the	O
locations	O
and	O
architecture	O
of	O
the	O
glycan	O
-	O
and	O
antibody	O
-	O
binding	O
sites	O
in	O
four	O
different	O
viruses	B-SPEC
with	O
stalk	O
-	O
like	O
attachment	O
proteins	O
(	O
reovirus	B-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
,	O
norovirus	B-SPEC
,	O
and	O
coronavirus	B-SPEC
)	O
and	O
investigate	O
the	O
mechanisms	O
by	O
which	O
antibodies	O
block	O
glycan	O
recognition	O
.	O

MERS	O
-	O
CoV	O
RNA	O
from	O
infected	O
camels	B-SPEC
was	O
not	O
detected	O
beyond	O
2	O
weeks	O
after	O
the	O
first	O
positive	O
result	O
was	O
detected	O
in	O
nasal	O
swabs	O
obtained	O
from	O
infected	O
camels	B-SPEC
.	O

Anti	O
-	O
MERS	O
ELISA	O
assays	O
showed	O
that	O
70	O
.	O
9	O
%	O
of	O
camels	B-SPEC
related	O
to	O
human	B-SPEC
cases	O
had	O
antibodies	O
to	O
MERS	O
-	O
CoV	O
.	O
The	O
full	O
genome	O
sequences	O
of	O
the	O
ten	O
MERS	O
-	O
CoV	O
camel	B-SPEC
isolates	O
were	O
identical	O
to	O
their	O
corresponding	O
patients	O
and	O
were	O
grouped	O
together	O
within	O
the	O
larger	O
MERS	O
-	O
CoV	O
sequences	O
cluster	O
for	O
human	B-SPEC
and	O
camel	B-SPEC
isolates	O
reported	O
form	O
the	O
Arabian	O
Peninsula	O
.	O

TITLE	O
:	O
Antibody	O
response	O
to	O
equine	B-SPEC
coronavirus	B-SPEC
in	O
horses	B-SPEC
inoculated	O
with	O
a	O
bovine	B-SPEC
coronavirus	B-SPEC
vaccine	O
.	O

This	O
study	O
investigated	O
antibody	O
response	O
to	O
ECoV	O
in	O
horses	B-SPEC
inoculated	O
with	O
BCoV	O
vaccine	O
.	O

In	O
addition	O
,	O
the	O
complete	O
S	O
genes	O
from	O
11	O
representative	O
PEDV	B-SPEC
strains	O
were	O
sequenced	O
and	O
analyzed	O
.	O

The	O
results	O
of	O
this	O
study	O
will	O
contribute	O
to	O
the	O
understanding	O
of	O
the	O
epidemiology	O
and	O
genetic	O
characteristics	O
of	O
PEDV	B-SPEC
in	O
China	O
.	O

ABSTRACT	O
:	O
Two	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
strains	O
(	O
Binh21	O
and	O
HaNoi6	O
)	O
were	O
isolated	O
from	O
two	O
pig	B-SPEC
farms	O
in	O
North	O
Vietnam	O
.	O

In	O
light	O
of	O
the	O
pathogenic	O
mechanism	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
that	O
relies	O
on	O
endosomal	O
acidification	O
for	O
cytoplasmic	O
entry	O
,	O
a	O
novel	O
vacuolar	O
ATPase	O
blocker	O
,	O
diphyllin	O
,	O
and	O
its	O
nanoformulation	O
are	O
herein	O
investigated	O
for	O
their	O
antiviral	O
activity	O
against	O
the	O
type	O
II	O
feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
).	O

TITLE	O
:	O
Origins	O
and	O
pathogenesis	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
associated	O
coronavirus	B-SPEC
:	O
recent	O
advances	O
.	O

TITLE	O
:	O
HIV	B-SPEC
positive	O
patient	O
with	O
GBS	O
-	O
like	O
syndrome	O
.	O

Release	O
assay	O
in	O
vitro	O
showed	O
that	O
both	O
NDV	B-SPEC
and	O
IBV	B-SPEC
could	O
be	O
sustainably	O
released	O
from	O
the	O
nanoparticles	O
after	O
an	O
initial	O
burst	O
release	O
.	O

ABSTRACT	O
:	O
Much	O
concern	O
has	O
arisen	O
regarding	O
serious	O
epidemics	O
due	O
to	O
the	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
.	O

None	O
of	O
the	O
patients	O
had	O
MERS	O
-	O
CoV	O
but	O
influenza	B-SPEC
viruses	I-SPEC
were	O
detected	O
in	O
12	O
.	O
7	O
%	O
with	O
high	O
circulation	O
of	O
influenza	O
A	O
/	O
H1N1	O
(	O
47	O
.	O
1	O
%).	O

RESULTS	O
:	O
None	O
of	O
the	O
patients	O
had	O
MERS	O
-	O
CoV	O
but	O
influenza	B-SPEC
viruses	I-SPEC
were	O
detected	O
in	O
12	O
.	O
7	O
%	O
with	O
high	O
circulation	O
of	O
influenza	O
A	O
/	O
H1N1	O
(	O
47	O
.	O
1	O
%).	O

Lung	O
Microbiota	B-SPEC
Is	O
Related	O
to	O
Smoking	O
Status	O
and	O
to	O
Development	O
of	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
in	O
Critically	O
Ill	O
Trauma	O
Patients	O
.	O

ABSTRACT	O
:	O
While	O
dromedary	B-SPEC
camels	B-SPEC
are	O
the	O
immediate	O
animal	B-SPEC
source	O
of	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
,	O
the	O
evolutionary	O
origin	O
of	O
MERS	O
-	O
CoV	O
remains	O
obscure	O
.	O

Recombination	O
analysis	O
showed	O
potential	O
recombination	O
events	O
in	O
five	O
strains	O
from	O
dromedaries	B-SPEC
in	O
Saudi	O
Arabia	O
,	O
with	O
recombination	O
between	O
lineage	O
B5	O
and	O
B3	O
in	O
four	O
strains	O
,	O
and	O
between	O
lineage	O
B3	O
and	O
B4	O
in	O
one	O
strain	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
non	O
-	O
structural	O
proteins	O
8	O
and	O
12	O
form	O
stable	O
complex	O
independent	O
of	O
the	O
non	O
-	O
translated	O
regions	O
of	O
viral	O
RNA	O
and	O
other	O
viral	O
proteins	O
.	O

TITLE	O
:	O
Structural	O
insights	O
of	O
a	O
self	O
-	O
assembling	O
9	O
-	O
residue	O
peptide	O
from	O
the	O
C	O
-	O
terminal	O
tail	O
of	O
the	O
SARS	O
corona	B-SPEC
virus	B-SPEC
E	O
-	O
protein	O
in	O
DPC	O
and	O
SDS	O
micelles	O
:	O
A	O
combined	O
high	O
and	O
low	O
resolution	O
spectroscopic	O
study	O
.	O

TITLE	O
:	O
Nosocomial	O
amplification	O
of	O
MERS	O
-	O
coronavirus	B-SPEC
in	O
South	O
Korea	O
,	O
2015	O
.	O

TITLE	O
:	O
Murine	B-SPEC
Hepatitis	O
Virus	B-SPEC
nsp14	O
Exoribonuclease	O
Activity	O
Is	O
Required	O
for	O
Resistance	O
to	O
Innate	O
Immunity	O
.	O

Outside	O
of	O
the	O
order	B-SPEC

ABSTRACT	O
:	O
The	O
generation	O
of	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
)	O
plays	O
an	O
important	O
role	O
for	O
the	O
maintenance	O
of	O
cellular	O
processes	O
and	O
functions	O
in	O
the	O
body	O
.	O

Presence	O
of	O
influenza	O
A	O
and	O
B	O
,	O
parainfluenza	O
1	O
,	O
2	O
,	O
3	O
and	O
4	O
,	O
human	B-SPEC
adeno	O
-,	O
boca	O
-,	O
corona	B-SPEC
-,	O
metapneumo	O
-,	O
rhino	O
-	O
and	O
respiratory	O
syncytial	O
viruses	B-SPEC
was	O
determined	O
by	O
real	O
-	O
time	O
PCR	O
.	O

TITLE	O
:	O
Early	O
Antibody	O
Response	O
Contributes	O
to	O
the	O
Virus	B-SPEC
Eradication	O
and	O
Clinical	O
Recovery	O
of	O
H7N9	O
Influenza	O
Infection	O
.	O

ABSTRACT	O
:	O
A	O
new	O
type	O
of	O
highly	O
pathogenic	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
,	O
H7N9	O
,	O
has	O
been	O
a	O
great	O
threat	O
to	O
public	O
health	O
since	O
its	O
2013	O
outbreak	O
.	O

A	O
Systematic	O
Review	O
and	O
Meta	B-SPEC
-	O
Analysis	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
parainfluenza	O
,	O
rhino	O
,	O
corona	B-SPEC
and	O
influenza	B-SPEC
viruses	I-SPEC
were	O
found	O
in	O
2	O
.	O
5	O
%	O
(	O
1	O
/	O
40	O
),	O
7	O
.	O
5	O
%	O
(	O
3	O
/	O
40	O
),	O
10	O
%	O
(	O
4	O
/	O
40	O
),	O
2	O
.	O
5	O
%	O
(	O
1	O
/	O
40	O
)	O
and	O
0	O
%	O
(	O
0	O
/	O
40	O
)	O
of	O
cases	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
an	O
enteric	B-SPEC
coronavirus	I-SPEC
,	O
is	O
the	O
causative	O
agent	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
that	O
damages	O
intestinal	O
epithelial	O
cells	O
and	O
results	O
in	O
severe	O
diarrhea	O
and	O
dehydration	O
in	O
neonatal	O
suckling	O
pigs	B-SPEC
with	O
up	O
to	O
100	O
%	O
mortality	O
.	O

ABSTRACT	O
:	O
Bilateral	O
acute	O
iris	B-SPEC
transillumination	O
(	O
BAIT	O
)	O
is	O
a	O
poorly	O
-	O
understood	O
ocular	O
syndrome	O
in	O
which	O
patients	O
present	O
with	O
acute	O
iridocyclitis	O
and	O
pigmentary	O
dispersion	O
with	O
or	O
without	O
ocular	O
hypertension	O
.	O

The	O
Trabectome	O
remains	O
a	O
viable	O
option	O
for	O
management	O
of	O
pigmentary	O
and	O
uveitic	O
glaucoma	B-SPEC
resistant	O
to	O
medical	O
treatment	O
.	O

TITLE	O
:	O
Cryo	O
-	O
Electron	O
Microscopy	O
Structure	O
of	O
Porcine	B-SPEC
Deltacoronavirus	O
Spike	O
Protein	O
in	O
the	O
Prefusion	O
State	O
ABSTRACT	O
:	O
Coronavirus	B-SPEC
spike	O
proteins	O
from	O
different	O
genera	O
are	O
divergent	O
,	O
although	O
they	O
all	O
mediate	O
coronavirus	B-SPEC
entry	O
into	O
cells	O
by	O
binding	O
to	O
host	O
receptors	O
and	O
fusing	O
viral	O
and	O
cell	O
membranes	O
.	O

PdCoV	O
spike	O
possesses	O
several	O
structural	O
features	O
that	O
may	O
facilitate	O
immune	O
evasion	O
by	O
the	O
virus	B-SPEC
,	O
such	O
as	O
its	O
compact	O
structure	O
,	O
concealed	O
receptor	O
-	O
binding	O
sites	O
,	O
and	O
shielded	O
critical	O
epitopes	O
.	O

The	O
observed	O
similarity	O
between	O
postfusion	O
coronavirus	B-SPEC
S	O
and	O
paramyxovirus	O
F	O
structures	O
demonstrates	O
that	O
a	O
conserved	O
refolding	O
trajectory	O
mediates	O
entry	O
of	O
these	O
viruses	B-SPEC
and	O
supports	O
the	O
evolutionary	O
relatedness	O
of	O
their	O
fusion	O
subunits	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
strains	O
from	O
the	O
G1b	O
cluster	O
are	O
considered	O
less	O
pathogenic	O
compared	O
to	O
the	O
G2b	O
cluster	O
.	O

Thirty	O
-	O
nine	O
PEDV	B-SPEC
naïve	O
pigs	B-SPEC
were	O
randomly	O
divided	O
into	O
five	O
groups	O
:	O
EXP	O
-	O
IM	O
-	O
1b	O
(	O
intramuscular	O
G1b	O
exposure	O
;	O
G2b	O
challenge	O
),	O
EXP	O
-	O
ORAL	O
-	O
1b	O
(	O
oral	O
G1b	O
exposure	O
;	O
G2b	O
challenge	O
),	O
VAC	O
-	O
IM	O
-	O
2b	O
(	O
intramuscular	O
commercial	O
inactivated	O
G2b	O
vaccination	O
;	O
G2b	O
challenge	O
),	O
POS	O
-	O
CONTROL	O
(	O
sham	O
-	O
vaccination	O
;	O
G2b	O
challenge	O
)	O
and	O
NEG	O
-	O
CONTROL	O
(	O
sham	O
-	O
vaccination	O
;	O
sham	O
-	O
challenge	O
).	O

ABSTRACT	O
:	O
Acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
develops	O
in	O
patients	O
with	O
predisposing	O
conditions	O
that	O
induce	O
systemic	O
inflammatory	O
response	O
such	O
as	O
sepsis	B-SPEC
,	O
pneumonia	O
,	O
acute	O
pancreatitis	O
,	O
major	O
trauma	O
,	O
or	O
multiple	O
transfusions	O
.	O

Epidemic	O
infectious	O
disease	O
agents	O
(	O
e	O
.	O
g	O
.,	O
Ebola	B-SPEC
virus	I-SPEC
,	O
Coronavirus	B-SPEC
,	O
Zika	B-SPEC
virus	I-SPEC
)	O
could	O
be	O
controlled	O
more	O
easily	O
by	O
testing	O
travelers	O
on	O
-	O
site	O
at	O
the	O
country	O
borders	O
to	O
prevent	O
outbreaks	O
from	O
spreading	O
.	O

ABSTRACT	O
:	O
Ten	O
reference	O
genes	O
were	O
investigated	O
for	O
normalisation	O
of	O
candidate	O
target	O
gene	O
expression	O
data	O
in	O
the	O
shell	O
gland	O
and	O
spleen	O
of	O
laying	O
hens	O
challenged	O
with	O
two	O
strains	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

ChAd	O
vectors	O
are	O
safe	O
and	O
induce	O
antigen	O
-	O
specific	O
cellular	O
and	O
humoral	O
immunity	O
in	O
all	O
age	O
groups	O
,	O
as	O
well	O
as	O
circumventing	O
the	O
problem	O
of	O
pre	O
-	O
existing	O
immunity	O
encountered	O
with	O
human	B-SPEC
Ad	O
vectors	O
.	O

Magnetic	O
functionality	O
is	O
bestowed	O
to	O
the	O
nanoparticles	O
through	O
encapsulation	O
of	O
superparamagnetic	O
iron	O
-	O
oxide	O
particles	O
,	O
which	O
enable	O
influenza	B-SPEC
virus	I-SPEC
enrichment	O
via	O
magnetic	O
extraction	O
.	O

Visual	O
analog	O
scale	O
(	O
VAS	O
)	O
score	O
,	O
Harris	O
score	O
and	O
Association	O
Research	O
Circulation	O
Osseous	O
(	O
ARCO	B-SPEC
)	O
stage	O
of	O
imaging	O
examination	O
were	O
compared	O
among	O
those	O
before	O
treatment	O
,	O
and	O
at	O
1	O
,	O
3	O
,	O
6	O
,	O
9	O
and	O
12	O
years	O
after	O
treatment	O
.	O

Flushing	O
animal	B-SPEC
food	O
-	O
contact	O
surfaces	O
with	O
low	O
-	O
risk	O
feed	O
is	O
commonly	O
used	O
to	O
reduce	O
cross	O
-	O
contamination	O
in	O
animal	B-SPEC
feed	O
manufacturing	O
.	O

The	O
isolated	O
virus	B-SPEC
was	O
infectious	O
in	O
pigs	B-SPEC
when	O
inoculated	O
orally	O
into	O
3	O
-	O
day	O
-	O
old	O
newborn	O
piglets	O
,	O
leading	O
to	O
clinical	O
signs	O
of	O
diarrhea	O
and	O
fecal	O
virus	B-SPEC
shedding	O
.	O

TITLE	O
:	O
Effects	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infection	O
on	O
nursery	O
pig	B-SPEC
intestinal	O
function	O
and	O
barrier	O
integrity	O
.	O

Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
recently	O
detected	O
in	O
North	O
America	O
,	O
exemplifies	O
intestinal	O
epithelial	O
insult	O
.	O

TITLE	O
:	O
Genetic	O
and	O
biological	O
characterization	O
of	O
a	O
Porcine	B-SPEC
Reproductive	I-SPEC
and	I-SPEC
Respiratory	I-SPEC
Syndrome	I-SPEC
Virus	I-SPEC
2	O
(	O
PRRSV	B-SPEC
-	O
2	O
)	O
causing	O
significant	O
clinical	O
disease	O
in	O
the	O
field	O
.	O

In	O
November	O
2010	O
,	O
a	O
pig	B-SPEC
herd	O
in	O
the	O
Northern	O
part	O
of	O
Denmark	O
experienced	O
an	O
infection	O
with	O
PRRSV	B-SPEC
-	O
2	O
with	O
clinical	O
signs	O
that	O
were	O
much	O
more	O
severe	O
than	O
normally	O
reported	O
from	O
current	O
Danish	O
PRRSV	B-SPEC
-	O
2	O
affected	O
herds	O
.	O

ABSTRACT	O
:	O
Two	O
different	O
genotypes	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
the	O
classical	O
and	O
variant	O
strains	O
,	O
are	O
classified	O
by	O
multiple	O
insertions	O
and	O
deletions	O
in	O
their	O
S	O
genes	O
.	O

In	O
the	O
present	O
study	O
,	O
a	O
novel	O
duplex	O
TaqMan	O
RT	O
-	O
PCR	O
was	O
developed	O
for	O
detecting	O
and	O
differentiating	O
PEDV	B-SPEC
strains	O
in	O
China	O
.	O

These	O
included	O
:	O
Histophilus	B-SPEC
somni	I-SPEC
,	O
Mannheimia	B-SPEC
haemolytica	I-SPEC
,	O
Pasteurella	B-SPEC
multocida	I-SPEC
,	O
Mycoplasma	B-SPEC
bovis	I-SPEC
,	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
),	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
),	O
bovine	B-SPEC
viral	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
BVDV	B-SPEC
),	O
bovine	B-SPEC
alphaherpesvirus	O
1	O
(	O
BoHV	B-SPEC
-	I-SPEC
1	I-SPEC
),	O
and	O
bovine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
3	I-SPEC
(	O
BPIV	O
-	O
3	O
).	O

TITLE	O
:	O
Synthesis	O
and	O
biological	O
evaluation	O
of	O
NH	O
ABSTRACT	O
:	O
Neuraminidase	O
inhibitors	O
can	O
deter	O
nascent	O
viruses	B-SPEC
from	O
infecting	O
intact	O
cells	O
by	O
preventing	O
their	O
release	O
from	O
host	O
cells	O
.	O

ABSTRACT	O
:	O
The	O
current	O
study	O
was	O
intended	O
to	O
evaluate	O
the	O
knowledge	O
and	O
awareness	O
toward	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
of	O
pilgrims	O
from	O
Saudi	O
Arabia	O
and	O
from	O
different	O
Arabian	O
countries	O
.	O

It	O
was	O
clear	O
that	O
the	O
Saudi	O
pilgrims	O
were	O
more	O
oriented	O
about	O
different	O
aspects	O
of	O
MERS	O
-	O
CoV	O
including	O
the	O
nature	O
of	O
the	O
causative	O
agent	O
,	O
the	O
signs	O
,	O
the	O
severity	O
of	O
the	O
disease	O
,	O
the	O
animals	B-SPEC
that	O
can	O
transmit	O
the	O
infection	O
to	O
humans	B-SPEC
,	O
the	O
risk	O
groups	O
,	O
and	O
when	O
one	O
need	O
to	O
be	O
screened	O
for	O
infection	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
the	O
syndrome	O
New	O
Neonatal	O
Porcine	B-SPEC
Diarrhoea	O
Syndrome	O
(	O
NNPDS	O
)	O
is	O
associated	O
with	O
a	O
viral	O
aetiology	O
.	O

A	O
total	O
of	O
91	O
.	O
7	O
%	O
of	O
the	O
animals	B-SPEC
tested	O
positive	O
by	O
reverse	O
transcription	O
qPCR	O
(	O
RT	O
-	O
qPCR	O
)	O
for	O
porcine	B-SPEC
kobuvirus	B-SPEC
1	O
(	O
PKV	O
-	O
1	O
)	O
while	O
9	O
%	O
and	O
3	O
%	O
were	O
found	O
to	O
be	O
positive	O
for	O
rotavirus	B-SPEC
A	I-SPEC
and	O
porcine	B-SPEC
teschovirus	I-SPEC
(	O
PTV	B-SPEC
),	O
respectively	O
.	O

No	O
animals	B-SPEC
tested	O
positive	O
for	O
rotavirus	B-SPEC
C	I-SPEC
,	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
,	O
PEDV	B-SPEC
and	O
PRCV	O
),	O
sapovirus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
parechovirus	B-SPEC
,	O
saffoldvirus	O
,	O
cosavirus	B-SPEC
,	O
klassevirus	B-SPEC
or	O
porcine	B-SPEC
circovirus	I-SPEC
type	I-SPEC
2	I-SPEC
(	O
PCV2	O
).	O

The	O
camel	B-SPEC
MERS	O
-	O
CoV	O
genomes	O
from	O
this	O
study	O
represent	O
3	O
known	O
and	O
2	O
potentially	O
new	O
lineages	O
within	O
clade	O
B	O
.	O
Within	O
lineages	O
,	O
diversity	O
of	O
camel	B-SPEC
and	O
human	B-SPEC
MERS	O
-	O
CoV	O
sequences	O
are	O
intermixed	O
.	O

The	O
most	O
frequent	O
recombination	O
breakpoint	O
was	O
the	O
junctions	O
between	O
ORF1b	O
and	O
S	O
.	O
Evidence	O
suggests	O
MERS	O
-	O
CoV	O
infection	O
in	O
humans	B-SPEC
results	O
from	O
continued	O
introductions	O
of	O
distinct	O
MERS	O
-	O
CoV	O
lineages	O
from	O
camels	B-SPEC
.	O

By	O
using	O
this	O
technology	O
,	O
effective	O
and	O
potential	O
siRNAs	O
can	O
be	O
designed	O
,	O
delivered	O
and	O
their	O
efficacy	O
with	O
toxic	O
effects	O
and	O
immunogenic	O
responses	O
can	O
be	O
tested	O
against	O
MERS	O
-	O
CoV	O
.	O
CONCLUSIONS	O
:	O
The	O
efficacy	O
of	O
siRNA	O
-	O
based	O
therapeutics	O
has	O
been	O
used	O
not	O
only	O
against	O
many	O
viral	O
diseases	O
but	O
also	O
against	O
non	O
-	O
viral	O
diseases	O
,	O
cancer	B-SPEC
,	O
dominant	O
genetic	O
disorders	O
,	O
and	O
autoimmune	O
disease	O
.	O

There	O
was	O
a	O
significant	O
difference	O
in	O
the	O
rates	O
of	O
positive	O
and	O
negative	O
influenza	B-SPEC
virus	I-SPEC
tests	O
between	O
Hajj	O
pilgrims	O
with	O
symptoms	O
and	O
those	O
without	O
.	O

Our	O
results	O
revealed	O
up	O
to	O
13	O
amino	O
acid	O
substitutions	O
among	O
vaccines	O
and	O
some	O
of	O
them	O
were	O
localized	O
in	O
regions	O
of	O
the	O
S1	O
glycoprotein	O
that	O
play	O
a	O
role	O
in	O
virus	B-SPEC
-	O
host	O
interaction	O
.	O

The	O
possible	O
routes	O
of	O
infection	O
may	O
include	O
the	O
following	O
:	O
respiratory	O
invasion	O
of	O
aerosols	O
contaminated	O
with	O
MERS	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
through	O
a	O
gap	O
between	O
the	O
face	O
and	O
mask	O
;	O
mucosal	O
exposure	O
to	O
sweat	O
contaminated	O
with	O
MERS	O
-	O
CoV	O
;	O
and	O
contamination	O
during	O
doffing	O
of	O
personal	O
protective	O
equipment	O
.	O

We	O
also	O
found	O
that	O
IBV	B-SPEC
can	O
cleave	O
MAVS	O
,	O
an	O
adaptor	O
protein	O
downstream	O
of	O
RIG	O
-	O
I	O
and	O
MDA5	O
that	O
acts	O
as	O
a	O
platform	O
for	O
antiviral	O
innate	O
immunity	O
at	O
an	O
early	O
stage	O
of	O
infection	O
.	O

ABSTRACT	O
:	O
This	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
quantified	O
the	O
protective	O
effect	O
of	O
facemasks	O
and	O
respirators	O
against	O
respiratory	O
infections	O
among	O
healthcare	O
workers	O
.	O

Meta	B-SPEC
-	O
analysis	O
of	O
observational	O
studies	O
provided	O
evidence	O
of	O
a	O
protective	O
effect	O
of	O
masks	O
(	O
OR	O
=	O
0	O
.	O
13	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
03	O
-	O
0	O
.	O
62	O
)	O
and	O
respirators	O
(	O
OR	O
=	O
0	O
.	O
12	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
06	O
-	O
0	O
.	O
26	O
)	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
).	O

TITLE	O
:	O
Entry	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
NL63	I-SPEC
into	O
the	O
Cell	O
.	O

In	O
this	O
study	O
,	O
we	O
mapped	O
the	O
process	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
entry	O
into	O
the	O
LLC	O
-	O
Mk2	O
cell	O
line	O
and	O

miR	O
-	O
223	O
expression	O
is	O
increased	O
in	O
the	O
lungs	O
of	O
MTD	O
-	O
induced	O
mice	B-SPEC
or	O
ARDS	O
patients	O
following	O
trauma	O
/	O
transfusion	O
or	O
following	O
the	O
physiological	O
remission	O
of	O
ALI	O
/	O
ARDS	O
.	O

Finally	O
,	O
elimination	O
of	O
peripheral	O
Ly6G	O
+	O
neutrophils	O
and	O
pharmacological	O
blockade	O
of	O
the	O
miR	O
-	O
223	O
-	O
NLRP3	O
-	O
IL	O
-	O
1β	O
signalling	O
axis	B-SPEC
could	O
alleviate	O
MTD	O
-	O
induced	O
ALI	O
.	O

ABSTRACT	O
:	O
Medications	O
with	O
methyl	O
-	O
prednisolone	O
sodium	O
succinate	O
containing	O
lactose	O
,	O
which	O
potentially	O
contains	O
traces	O
of	O
cow	B-SPEC
'	O
s	O
milk	O
proteins	O
(	O
CMP	O
),	O
could	O
cause	O
allergic	O
reactions	O
or	O
compromise	O
treatment	O
of	O
acute	O
allergic	O
reactions	O
in	O
sensitized	O
patients	O
.	O

TITLE	O
:	O
Human	B-SPEC
intestinal	O
tract	O
serves	O
as	O
an	O
alternative	O
infection	O
route	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Macrophage	O
scavenger	B-SPEC
receptor	O
1	O
contributes	O
to	O
pathogenesis	O
of	O
fulminant	O
hepatitis	O
via	O
neutrophil	O
-	O
mediated	O
complement	O
activation	O
.	O

Virus	B-SPEC
-	O
induced	O
fulminant	O
hepatitis	O
(	O
FH	O
)	O
is	O
a	O
disease	O
with	O
a	O
high	O
mortality	O
worldwide	O
.	O

Herein	O
,	O
we	O
demonstrate	O
that	O
mice	B-SPEC
deficient	O
in	O
Msr1	O
are	O
resistant	O
to	O
FH	O
induced	O
by	O
MHV	B-SPEC
-	O
A59	O
,	O
and	O
the	O
Msr1	O
inhibitor	O
fucoidan	O
suppresses	O
the	O
progression	O
of	O
FH	O
in	O
mice	B-SPEC
.	O

Despite	O
progress	O
in	O
other	O
fields	O
of	O
tissue	O
imaging	O
,	O
histopathology	O
remains	O
the	O
most	O
conclusive	O
and	O
practical	O
read	O
out	O
tool	O
for	O
the	O
descriptive	O
and	O
semiquantitative	O
evaluation	O
of	O
mouse	B-SPEC
pneumonia	O
and	O
therapeutic	O
interventions	O
.	O

Corticosteroid	O
therapy	O
in	O
patients	O
with	O
MERS	O
was	O
not	O
associated	O
with	O
a	O
difference	O
in	O
mortality	O
after	O
adjustment	O
for	O
time	O
-	O
varying	O
confounders	O
but	O
was	O
associated	O
with	O
delayed	O
MERS	O
coronavirus	B-SPEC
RNA	O
clearance	O
.	O

Updates	O
were	O
presented	O
on	O
several	O
therapeutics	O
currently	O
in	O
clinical	O
trials	O
,	O
including	O
influenza	O
polymerase	O
inhibitors	O
pimodivir	O
/	O
JNJ6362387	O
,	O
S033188	O
,	O
favipiravir	O
,	O
monoclonal	O
antibodies	O
MHAA45449A	O
and	O
VIS410	O
,	O
and	O
host	O
directed	O
strategies	O
for	O
influenza	O
including	O
nitazoxanide	O
,	O
and	O
polymerase	O
ALS	O
-	O
008112	O
and	O
fusion	O
inhibitors	O
AK0529	O
,	O
GS	O
-	O
5806	O
for	O
RSV	B-SPEC
.	O

ABSTRACT	O
:	O
Betacoronaviruses	O
,	O
such	O
as	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
are	O
important	O
pathogens	O
causing	O
potentially	O
lethal	O
infections	O
in	O
humans	B-SPEC
and	O
animals	B-SPEC
.	O

The	O
interleukin	O
(	O
IL	O
)-	O
36	O
cytokines	O
(	O
IL	O
-	O
36α	O
,	O
IL	O
-	O
36β	O
and	O
IL	O
-	O
36γ	O
)	O
are	O
newly	O
described	O
IL	O
-	O
1	O
like	O
family	B-SPEC
cytokines	O
that	O
promote	O
inflammatory	O
response	O
via	O
binding	O
to	O
the	O
IL	O
-	O
36	O
receptor	O
(	O
IL	O
-	O
36R	O
).	O

The	O
intratracheal	O
administration	O
of	O
flagellated	B-SPEC
cytotoxic	O
P	B-SPEC
.	I-SPEC
aeruginosa	I-SPEC
(	O
ATCC	O
19660	O
)	O
upregulated	O
IL	O
-	O
36α	O
and	O
IL	O
-	O
36γ	O
,	O
but	O
not	O
IL	O
-	O
36β	O
,	O
in	O
the	O
lungs	O
.	O

Thus	O
,	O
IL	O
-	O
36γ	O
and	O
its	O
receptor	O
signal	O
not	O
only	O
impaired	O
bacterial	O
clearance	O
in	O
a	O
possible	O
PGE2	O
dependent	O
fashion	O
but	O
also	O
mediated	O
lung	O
injury	O
during	O
P	B-SPEC
.	I-SPEC
aeruginosa	I-SPEC
infection	O
.	O

TITLE	O
:	O
Inhibition	O
of	O
Cytosolic	O
Phospholipase	O
A	O
ABSTRACT	O
:	O
Coronavirus	B-SPEC
replication	O
is	O
associated	O
with	O
intracellular	O
membrane	O
rearrangements	O
in	O
infected	O
cells	O
,	O
resulting	O
in	O
the	O
formation	O
of	O
double	O
-	O
membrane	O
vesicles	O
(	O
DMVs	O
)	O
and	O
other	O
membranous	O
structures	O
that	O
are	O
referred	O
to	O
as	O
replicative	O
organelles	O
(	O
ROs	O
).	O

There	O
is	O
increasing	O
evidence	O
that	O
plus	O
-	O
strand	O
RNA	O
(+	O
RNA	O
)	O
virus	B-SPEC
replication	O
,	O
including	O
RO	O
formation	O
and	O
virion	O
morphogenesis	O
,	O
affects	O
cellular	O
lipid	O
metabolism	O
and	O
critically	O
depends	O
on	O
enzymes	O
involved	O
in	O
lipid	O
synthesis	O
and	O
processing	O
.	O

IBV	B-SPEC
titers	O
in	O
infected	O
CEK	O
cells	O
treated	O
with	O
APS	O
were	O
significantly	O
reduced	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
,	O
indicating	O
that	O
APS	O
inhibited	O
IBV	B-SPEC
replication	O
in	O
vitro	O
.	O

These	O
findings	O
,	O
together	O
with	O
sophisticated	O
molecular	O
structure	O
analyses	O
,	O
omics	O
tools	O
and	O
computer	O
-	O
based	O
models	O
,	O
have	O
helped	O
delineate	O
the	O
interaction	O
between	O
respiratory	O
viruses	B-SPEC
and	O
the	O
host	O
immune	O
system	O
,	O
which	O
will	O
facilitate	O
the	O
development	O
of	O
novel	O
treatment	O
strategies	O
and	O
vaccines	O
with	O
enhanced	O
efficacy	O
.	O

Disease	O
occurrence	O
and	O
severity	O
were	O
significantly	O
reduced	O
in	O
dogs	B-SPEC
vaccinated	O
against	O
classic	O
CIRD	O
agents	O
,	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
canine	B-SPEC
adenovirus	I-SPEC
2	O
(	O
CAV	B-SPEC
-	O
2	O
)	O
and	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
(	O
CPIV	O
),	O
but	O
substantial	O
proportions	O
(	O
65	O
.	O
7	O
%;	O
201	O
/	O
306	O
)	O
of	O
vaccinated	O
dogs	B-SPEC
remained	O
affected	O
.	O

Involvement	O
of	O
M	B-SPEC
.	I-SPEC
cynos	I-SPEC
and	O
influenza	O
A	O
in	O
CIRD	O
was	O
less	O
apparent	O
.	O

Despite	O
45	O
%	O
of	O
dogs	B-SPEC
being	O
seropositive	O
for	O
M	B-SPEC
.	I-SPEC
cynos	I-SPEC
,	O
only	O
0	O
.	O
9	O
%	O
were	O
PCR	O
positive	O
for	O
M	B-SPEC
.	I-SPEC
cynos	I-SPEC
.	O

The	O
clustering	O
of	O
gene	O
expression	O
profile	O
among	O
the	O
three	O
virus	B-SPEC
inoculated	O
groups	O
indicated	O
that	O
the	O
majority	O
of	O
up	O
-	O
regulated	O
DE	O
genes	O
on	O
apoptosis	O
in	O
very	O
virulent	O
SCDY2	O
group	O
were	O
up	O
-	O
regulated	O
more	O
or	O
less	O
in	O
virulent	O
SCK2	O
group	O
and	O
those	O
down	O
-	O
regulated	O
on	O
innate	O
immune	O
response	O
in	O
SCDY2	O
group	O
were	O
also	O
down	O
-	O
regulated	O
differently	O
in	O
SCK2	O
group	O
.	O

While	O
vast	O
improvements	O
were	O
made	O
in	O
the	O
status	O
of	O
state	O
animal	B-SPEC
disease	O
response	O
plans	O
from	O
2011	O
to	O
2016	O
,	O
there	O
is	O
nonetheless	O
significant	O
room	O
for	O
enhancing	O
consistency	O
between	O
and	O
identifying	O
gaps	O
in	O
FAD	O
/	O
HCD	O
plans	O
.	O

TITLE	O
:	O
Identification	O
of	O
Alpha	O
and	O
Beta	O
Coronavirus	B-SPEC
in	O
Wildlife	O
Species	B-SPEC
in	O
France	O
:	O
Bats	B-SPEC
,	O
Rodents	B-SPEC
,	O
Rabbits	B-SPEC
,	O
and	O
Hedgehogs	B-SPEC
.	O

IFN	O
-	O
λ1	O
and	O
IFN	O
-	O
λ3	O
inhibited	O
PEDV	B-SPEC
replication	O
,	O
indicating	O
the	O
anti	O
-	O
PEDV	B-SPEC
activity	O
of	O
type	O
III	O
IFNs	O
.	O

The	O
peroxisome	O
is	O
the	O
innate	O
antiviral	O
signaling	O
platform	O
for	O
the	O
activation	O
of	O
IRF1	O
-	O
mediated	O
IFN	O
-	O
λ	O
production	O
,	O
and	O
the	O
numbers	O
of	O
peroxisomes	O
were	O
found	O
to	O
be	O
decreased	O
in	O
PEDV	B-SPEC
-	O
infected	O
cells	O
.	O

PEDV	B-SPEC
nsp1	O
blocked	O
the	O
nuclear	O
translocation	O
of	O
IRF1	O
and	O
reduced	O
the	O
number	O
of	O
peroxisomes	O
to	O
suppress	O
IRF1	O
-	O
mediated	O
type	O
III	O
IFNs	O
.	O

Our	O
study	O
for	O
the	O
first	O
time	O
provides	O
evidence	O
that	O
the	O
porcine	B-SPEC
enteric	O
virus	B-SPEC
PEDV	B-SPEC
downregulates	O
and	O
evades	O
IRF1	O
-	O
mediated	O
type	O
III	O
IFN	O
responses	O
by	O
reducing	O
the	O
number	O
of	O
peroxisomes	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
test	O
the	O
efficacy	O
of	O
an	O
accelerated	O
hydrogen	O
peroxide	O
(	O
AHP	O
)	O
disinfectant	O
for	O
inactivating	O
PEDV	B-SPEC
in	O
swine	B-SPEC
feces	O
on	O
metal	O
surfaces	O
under	O
freezing	O
conditions	O
.	O

This	O
study	O
also	O
suggests	O
that	O
a	O
positive	O
RT	O
-	O
qPCR	O
result	O
for	O
PEDV	B-SPEC
on	O
an	O
environmental	O
sample	O
should	O
be	O
expected	O
when	O
the	O
AHP	O
disinfectant	O
is	O
applied	O
under	O
freezing	O
conditions	O
,	O
but	O
does	O
not	O
necessarily	O
indicate	O
that	O
an	O
infectious	O
dose	O
of	O
PEDV	B-SPEC
remains	O
after	O
disinfection	O
.	O

ABSTRACT	O
:	O
ADP	O
-	O
ribosylation	O
is	O
a	O
common	O
post	O
-	O
translational	O
modification	O
,	O
although	O
how	O
it	O
modulates	O
RNA	O
virus	B-SPEC
infection	O
is	O
not	O
well	O
understood	O
.	O

TITLE	O
:	O
Transmissible	O
Gastroenteritis	O
Virus	B-SPEC
Papain	O
-	O
Like	O
Protease	O
1	O
Antagonizes	O
Production	O
of	O
Interferon	O
-	O
ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
),	O
such	O
as	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
),	O
severe	O
acute	O
respiratory	O
syndrome	O
CoV	O
(	O
SARS	O
-	O
CoV	O
),	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
),	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
and	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
encode	O
papain	O
-	O
like	O
(	O
PL	O
)	O
proteases	O
that	O
inhibit	O
Sendai	B-SPEC
virus	I-SPEC
-	O
(	O
SeV	O
-)	O
induced	O
interferon	O
(	O
IFN	O
-	O

RESULTS	O
:	O
Of	O
the	O
11	O
countries	O
contacted	O
,	O
8	O
responded	O
:	O
Burkina	O
Faso	O
,	O
Cote	O
d	O
'	O
Ivoire	O
,	O
Mali	O
,	O
Mauritania	O
,	O
Niger	B-SPEC
,	O
Nigeria	O
,	O
Sierra	O
Leone	O
and	O
Togo	B-SPEC
.	O

ABSTRACT	O
:	O
Heptad	O
repeat	O
(	O
HR	O
)	O
regions	O
are	O
highly	O
conserved	O
motifs	O
located	O
in	O
the	O
glycoproteins	O
of	O
enveloped	O
viruses	B-SPEC
that	O
form	O
a	O
six	O
-	O
helix	O
bundle	O
structure	O
and	O
is	O
important	O
in	O
the	O
process	O
of	O
virus	B-SPEC
fusion	O
.	O

Further	O
study	O
indicated	O
that	O
immunization	O
of	O
HR2P	O
in	O
mice	B-SPEC
elicited	O
antibodies	O
capable	O
of	O
neutralizing	O
PEDV	B-SPEC
infection	O
in	O
vitro	O
.	O

Targeted	O
research	O
remains	O
key	O
to	O
developing	O
control	O
strategies	O
for	O
MERS	O
-	O
CoV	O
,	O
a	O
cause	O
of	O
mild	O
illness	O
in	O
its	O
camel	B-SPEC
reservoir	O
.	O

An	O
AHT	O
animal	B-SPEC
model	O
was	O
developed	O
on	O
12	O
-	O
day	O
-	O
old	O
mice	B-SPEC
subjected	O
to	O
90	O
°	O
head	O
extension	O
-	O
flexion	O
sagittal	O
shaking	O
repeated	O
30	O
,	O
60	O
,	O
80	O
and	O
100	O
times	O
.	O

There	O
was	O
a	O
severe	O
reduction	O
in	O
cerebral	O
blood	O
perfusion	O
immediately	O
after	O
the	O
trauma	O
that	O
did	O
not	O
significantly	O
improve	O
within	O
24	O
h	O
.	O
The	O
injured	O
mice	B-SPEC
began	O
to	O
experience	O
reversible	O
sensorimotor	O
function	O
at	O
9	O
days	O
postinjury	O
(	O
dpi	O
),	O
which	O
had	O
completely	O
recovered	O
at	O
28	O
dpi	O
.	O

This	O
mouse	B-SPEC
model	O
of	O
repetitive	O
brain	O
injury	O
by	O
rotational	O
head	O
acceleration	O
-	O
deceleration	O
partially	O
mimics	O
the	O
major	O
pathophysiological	O
and	O
behavioral	O
events	O
that	O
occur	O
in	O
children	O
with	O
AHT	O
.	O

The	O
resultant	O
hypoxia	O
/	O
ischemia	O
suggests	O
a	O
potential	O
mechanism	O
underlying	O
the	O
secondary	O
rotational	O
acceleration	O
-	O
deceleration	O
-	O
induced	O
brain	O
injury	O
in	O
developing	O
mice	B-SPEC
.	O

Parainfluenza	O
virus	B-SPEC
4	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
B	O
and	O
enterovirus	B-SPEC
were	O
the	O
most	O
common	O
viruses	B-SPEC
in	O
the	O
clinical	O
sample	O
;	O
present	O
in	O
93	O
.	O
8	O
%	O
(	O
15	O
/	O
16	O
)	O
of	O
clinical	O
subjects	O
,	O
and	O
6	O
.	O
7	O
%	O
(	O
5	O
/	O
75	O
)	O
of	O
community	O
subjects	O
(	O
significant	O
difference	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

Coronavirus	B-SPEC
OC43	O
was	O
the	O
most	O
common	O
virus	B-SPEC
detected	O
in	O
community	O
members	O
(	O
13	O
.	O
3	O
%,	O
10	O
/	O
75	O
).	O

A	O
different	O
strain	O
,	O
Coronavirus	B-SPEC
OC	O
229	O
E	O
/	O
NL63	O
was	O
detected	O
among	O
subjects	O
from	O
the	O
clinic	O
(	O
2	O
/	O
16	O
)	O
and	O
not	O
detected	O
in	O
the	O
community	O
.	O

However	O
,	O
it	O
remains	O
unclear	O
how	O
SIVcpz	O
has	O
evolved	O
into	O
pandemic	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
in	O
humans	B-SPEC
.	O

Moreover	O
,	O
viral	O
RNA	O
sequencing	O
of	O
MB897	O
-	O
infected	O
humanized	O
mice	B-SPEC
identified	O
a	O
nonsynonymous	O
mutation	O
in	O

TITLE	O
:	O
microRNA	O
-	O
4331	O
Promotes	O
Transmissible	O
Gastroenteritis	O
Virus	B-SPEC
(	O
TGEV	B-SPEC
)-	O
induced	O
Mitochondrial	O
Damage	O
Via	O
Targeting	O
RB1	O
,	O
Upregulating	O
Interleukin	O
-	O
1	O
Receptor	O
Accessory	O
Protein	O
(	O
IL1RAP	O
),	O
and	O
Activating	O
p38	O
MAPK	O
Pathway	O
ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
a	O
member	O
of	O
the	O
coronaviridae	B-SPEC
family	B-SPEC
,	O
could	O
cause	O
fatal	O
diarrhea	O
of	O
piglets	O
and	O
result	O
in	O
numerous	O
economic	O
losses	O
.	O

HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
SL1	O
and	O
SL2	O
mutants	O
generated	O
by	O
reverse	O
genetics	O
were	O
used	O
to	O
study	O
the	O
effects	O
on	O
viral	O
replication	O
of	O
single	O
-	O
nucleotide	O
substitutions	O
predicted	O
to	O
destabilize	O
the	O
SL1	O
and	O
SL2	O
structures	O
.	O

Detection	O
data	O
from	O
clinical	O
specimens	O
showed	O
that	O
the	O
rMLA	O
had	O
diagnostic	O
sensitivities	O
of	O
97	O
.	O
10	O
%	O
for	O
FluA	O
,	O
94	O
.	O
59	O
%	O
for	O
FluB	O
,	O
98	O
.	O
68	O
%	O
for	O
PIV	O
-	O
3	O
,	O
94	O
.	O
87	O
%	O
for	O
RSV	B-SPEC
and	O
95	O
.	O
92	O
%	O
for	O
MPV	B-SPEC
(	O
No	O
Data	O
for	O
MERS	O
-	O
CoV	O
due	O
to	O
the	O
lack	O
of	O
positive	O
specimens	O
).	O

We	O
have	O
previously	O
demonstrated	O
that	O
estradiol	O
exerts	O
a	O
protective	O
effect	O
on	O
lung	O
edema	O
and	O
cytokine	O
release	O
caused	O
by	O
intestinal	O
IR	O
in	O
male	O
rats	B-SPEC
.	O

For	O
sows	O
,	O
a	O
significant	O
decrease	O
of	O
observed	O
species	B-SPEC
was	O
found	O
in	O
diarrheal	O
sows	O
than	O
that	O
in	O
healthy	O
sows	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Of	O
the	O
two	O
known	O
upstream	O
MAPK	O
kinases	O
(	O
MKK	O
),	O
MKK7	O
,	O
but	O
not	O
MKK4	O
,	O
was	O
shown	O
to	O
be	O
responsible	O
for	O
IBV	B-SPEC
-	O
induced	O
JNK	O
activation	O
.	O

These	O
cases	O
of	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
involve	O
close	O
contact	O
and	O
have	O
occurred	O
primarily	O
in	O
healthcare	O
settings	O
,	O
and	O
they	O
are	O
suspected	O
to	O
result	O
from	O
repeated	O
zoonotic	O
introductions	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
novel	O
zoonotic	O
pathogen	O
.	O

To	O
identify	O
the	O
molecular	O
characteristics	O
of	O
the	O
PEDV	B-SPEC
Spike	O
(	O
S	O
)	O
gene	O
in	O
Mexico	O
,	O
116	O
samples	O
of	O
the	O
intestine	O
and	O
diarrhea	O
of	O
piglets	O
with	O
clinical	O
signs	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
were	O
obtained	O
.	O

Samples	O
were	O
collected	O
from	O
14	O
farms	O
located	O
in	O
six	O
states	O
of	O
Mexico	O
(	O
Jalisco	O
,	O
Puebla	O
,	O
Sonora	B-SPEC
,	O
Veracruz	O
,	O
Guanajuato	O
,	O
and	O
Michoacán	O
)	O
from	O
2013	O
to	O
2016	O
.	O

PEDV	B-SPEC
pathogenesis	O
is	O
strain	O
-	O
specific	O
,	O
and	O
studies	O
in	O
neonatal	O
pigs	B-SPEC
have	O
demonstrated	O
that	O
the	O
PEDV	B-SPEC
non	O
-	O
S	O
-	O
INDEL	O
strains	O
are	O
more	O
pathogenic	O
than	O
the	O
PEDV	B-SPEC
S	O
-	O
INDEL	O
strains	O
.	O

RNA	O
viruses	B-SPEC
,	O
including	O
PEDV	B-SPEC
,	O
can	O
interact	O
with	O
a	O
large	O
number	O
of	O
pattern	O
recognition	O
receptors	O
(	O
PRRs	O
)	O
in	O
the	O
intestinal	O
mucosa	O
,	O
including	O
toll	O
-	O
like	O
receptors	O
(	O
TLRs	O
)	O
and	O
RIG	O
-	O
I	O
-	O
like	O
receptors	O
(	O
RLRs	O
).	O

The	O
replication	O
of	O
these	O
viruses	B-SPEC
was	O
compared	O
in	O
the	O
same	O
parental	O
Huh7	O
cells	O
and	O
in	O
CypA	B-SPEC
-	O
knockout	O
Huh7	O
cells	O
generated	O
using	O
CRISPR	O
/	O
Cas9	O
-	O
technology	O
.	O

This	O
study	O
reveals	O
that	O
the	O
replication	O
of	O
nidoviruses	B-SPEC
can	O
differ	O
strikingly	O
in	O
its	O
dependence	O
on	O
cellular	O
CypA	B-SPEC
.	O

Virus	B-SPEC
isolation	O
was	O
attempted	O
by	O
inoculation	O
in	O
different	O
cell	O
lines	O
.	O

An	O
81	O
-	O
year	O
-	O
old	O
previously	O
healthy	O
Korean	O
man	B-SPEC
presented	O
with	O
cough	O
,	O
dyspnea	O
,	O
and	O
febrile	O
sensation	O
.	O

We	O
found	O
that	O
three	O
distinct	O
mutations	O
in	O
IFITM1	O
or	O
IFITM3	O
converted	O
the	O
host	O
restriction	O
factors	O
to	O
enhance	O
entry	O
driven	O
by	O
the	O
spike	O
proteins	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
/	O
or	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

First	O
,	O
replacement	O
of	O
IFITM3	O
tyrosine	O
20	O
with	O
either	O
alanine	O
or	O
aspartic	O
acid	O
to	O
mimic	O
unphosphorylated	O
or	O
phosphorylated	O
IFITM3	O
reduced	O
its	O
activity	O
to	O
inhibit	O
the	O
entry	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
-	O
229E	O
but	O
enhanced	O
the	O
entry	O
of	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
Second	O
,	O
replacement	O
of	O
IFITM3	O
tyrosine	O
99	O
with	O
either	O
alanine	O
or	O
aspartic	O
acid	O
reduced	O
its	O
activity	O
to	O
inhibit	O
the	O
entry	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
and	O
SARS	O
-	O
CoV	O
but	O
promoted	O
the	O
entry	O
of	O
MERS	O
-	O
CoV	O
.	O
Third	O
,	O
deletion	O
of	O
the	O
carboxyl	O
-	O
terminal	O
12	O
amino	O
acid	O
residues	O
from	O
IFITM1	O
enhanced	O
the	O
entry	O
of	O
MERS	O
-	O
CoV	O
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
novel	O
zoonotic	O
virus	B-SPEC
that	O
causes	O
severe	O
respiratory	O
disease	O
in	O
humans	B-SPEC
with	O
a	O
case	O
fatality	O
rate	O
close	O
to	O
40	O
%,	O
but	O
for	O
which	O
no	O
vaccines	O
are	O
available	O
.	O

TITLE	O
:	O
Attenuated	O
accumulation	O
of	O
regulatory	O
T	O
cells	O
and	O
reduced	O
production	O
of	O
interleukin	O
10	O
lead	O
to	O
the	O
exacerbation	O
of	O
tissue	O
injury	O
in	O
a	O
mouse	B-SPEC
model	O
of	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

In	O
α	O
-	O
GalCer	O
/	O
LPS	O
-	O
treated	O
mice	B-SPEC
,	O
the	O
number	O
of	O
CD4	O

TITLE	O
:	O
Coronavirus	B-SPEC
and	O
paramyxovirus	O
in	O
bats	B-SPEC
from	O
Northwest	O
Italy	O
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
report	O
of	O
CoVs	O
in	O
Plecotus	B-SPEC
auritus	I-SPEC
and	O
M	B-SPEC
.	I-SPEC
oxygnathus	I-SPEC
,	O
and	O
of	O
PMVs	O
in	O
P	B-SPEC
.	I-SPEC
kuhlii	I-SPEC
.	O

In	O
addition	O
to	O
activating	O
the	O
complement	O
,	O
MBL	O
can	O
induce	O
cytokine	O
production	O
and	O
contribute	O
to	O
a	O
deleterious	O
inflammatory	O
response	O
with	O
severe	O
A	O
(	O
H1N1	O
)	O
pdm09	O
virus	B-SPEC
infection	O
.	O

In	O
particular	O
,	O
group	O
C	O
betacoronavirus	B-SPEC
were	O
associated	O
with	O
mosaic	O
habitats	O
found	O
in	O
anthropized	O
environments	O
.	O

ABSTRACT	O
:	O
Viral	O
metagenomics	O
,	O
modeling	O
of	O
protein	O
structure	O
,	O
and	O
manipulation	O
of	O
viral	O
genetics	O
are	O
key	O
approaches	O
that	O
have	O
laid	O
the	O
foundations	O
of	O
our	O
understanding	O
of	O
coronavirus	B-SPEC
biology	O
.	O

Of	O
the	O
57	O
agents	O
surveyed	O
,	O
Plasmodium	B-SPEC
was	O
the	O
most	O
common	O
agent	O
detected	O
.	O

Linear	O
regression	O
of	O
fully	O
-	O
adjusted	O
mean	O
cycle	O
threshold	O
(	O
Ct	O
)	O
values	O
for	O
Plasmodium	B-SPEC
also	O
identified	O
statistically	O
significant	O
lower	O
mean	O
Ct	O
values	O
for	O
older	O
children	O
(	O
20	O
.	O
8	O
),	O
patients	O
presenting	O
with	O
severe	O
fever	O
(	O
21	O
.	O
1	O
)	O
and	O
headache	O
(	O
21	O
.	O
5	O
),	O
as	O
well	O
as	O
patients	O
admitted	O
for	O
in	O
-	O
patient	O
care	O
and	O
treatment	O
(	O
22	O
.	O
4	O
).	O

Making	O
use	O
of	O
recombinant	O
viruses	B-SPEC
either	O
devoid	O
of	O
the	O
E	O
protein	O
or	O
harboring	O
mutations	O
either	O
in	O
putative	O
transmembrane	O
domain	O
or	O
PDZ	O
-	O
binding	O
motif	O
,	O
we	O
demonstrated	O
that	O
a	O
fully	O
functional	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
E	O
protein	O
is	O
first	O
needed	O
for	O
optimal	O
production	O
of	O
recombinant	O
infectious	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
one	O
of	O
the	O
most	O
important	O
causative	O
pathogens	O
of	O
swine	B-SPEC
diarrhea	O
,	O
which	O
is	O
widely	O
prevalent	O
throughout	O
the	O
world	O
and	O
is	O
responsible	O
for	O
significant	O
economic	O
losses	O
in	O
the	O
commercial	O
pig	B-SPEC
industry	O
,	O
both	O
domestic	O
and	O
abroad	O
.	O

Although	O
many	O
studies	O
have	O
unraveled	O
pathological	O
and	O
molecular	O
characteristics	O
of	O
PED	O
virus	B-SPEC
(	O
PEDV	B-SPEC
),	O
the	O
mechanism	O
for	O
within	O
-	O
farm	O
spread	O
is	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
screened	O
a	O
library	O
of	O
1000	O
compounds	O
and	O
identified	O
two	O
specific	O
inhibitors	O
,	O
designated	O
compounds	O
2	O
and	O
3	O
,	O
which	O
target	O
the	O
PRRSV	B-SPEC
3C	O
-	O
like	O
serine	O
protease	O
(	O
3CLSP	O
).	O

Memory	O
CD8	O
T	O
cells	O
rapidly	O
produced	O
IFN	O
-	O
γ	O
following	O
RSV	B-SPEC
infection	O
resulting	O
in	O
elevated	O
protein	O
levels	O
in	O
the	O
lung	O
and	O
periphery	O
.	O

TITLE	O
:	O
Improving	O
Virus	B-SPEC
Taxonomy	O
by	O
Recontextualizing	O
Sequence	O
-	O
Based	O
Classification	O
with	O
Biologically	O
Relevant	O
Data	O
:	O
the	O
Case	O
of	O
the	O
ABSTRACT	O
:	O
The	O
difficulties	O
related	O
to	O
virus	B-SPEC
taxonomy	O
have	O
been	O
amplified	O
by	O
recent	O
advances	O
in	O
next	O
-	O
generation	O
sequencing	O
and	O
metagenomics	O
,	O
prompting	O
the	O
field	O
to	O
revisit	O
the	O
question	O
of	O
what	O
constitutes	O
a	O
useful	O
viral	O
classification	O
.	O

Notably	O
,	O
through	O
the	O
longitudinal	O
observation	O
,	O
we	O
identified	O
the	O
dynamic	O
evolution	O
of	O
Ro	O
-	O
BatCoV	O
GCCDC1	O
in	O
bats	B-SPEC
represented	O
by	O
continuously	O
recombination	O
events	O
.	O

In	O
the	O
vaccinated	O
sow	O
,	O
DC	O
-	O
targeted	O
PEDV	B-SPEC
vaccine	O
enhanced	O
T	O
helper	O
1	O
-	O
like	O
cluster	O
of	O
differentiation	O
(	O
CD	O
)	O
4	O
T	O
cell	O
responses	O
and	O
induced	O
IgG	O
but	O
not	O
IgA	O
-	O
specific	O
immune	O
responses	O
.	O

TITLE	O
:	O
The	O
burden	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
associated	O
acute	O
lower	O
respiratory	O
infections	O
in	O
children	O
with	O
Down	O
syndrome	O
:	O
A	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
.	O

Though	O
limited	O
by	O
a	O
small	O
number	O
of	O
articles	O
,	O
this	O
review	O
found	O
sufficient	O
evidence	O
to	O
conclude	O
DS	O
was	O
a	O
significant	O
independent	O
risk	O
factor	O
for	O
the	O
development	O
of	O
severe	O
RSV	B-SPEC
-	O
associated	O
ALRI	O
requiring	O
hospitalisation	O
.	O

Determining	O
benefits	O
of	O
immunoprophylaxis	O
or	O
future	O
vaccines	O
against	O
RSV	B-SPEC
in	O
this	O
at	O
-	O
risk	O
population	O
is	O
warranted	O
.	O

ABSTRACT	O
:	O
To	O
establish	O
an	O
association	O
between	O
mitochondrial	O
dysfunction	O
and	O
apoptosis	O
following	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
infection	O
,	O
HD11	O
avian	B-SPEC
macrophage	O
cells	O
were	O
infected	O
with	O
the	O
Massachusetts	O
41	O
(	O
M41	O
)	O
strain	O
.	O

ABSTRACT	O
:	O
Here	O
we	O
review	O
the	O
evolving	O
story	O
of	O
the	O
coronavirus	B-SPEC
endoribonuclease	O
(	O
EndoU	O
).	O

Bundle	O
treatment	O
group	O
was	O
given	O
bundle	O
treatment	O
on	O
the	O
basis	O
of	O
conventional	O
treatment	O
,	O
including	O
isolation	O
,	O
anti	O
-	O
virus	B-SPEC
,	O
respiratory	O
support	O
,	O
restrictive	O
fluid	O
management	O
,	O
immunotherapy	O
,	O
inhibition	O
of	O
inflammation	O
,	O
antibiotic	O
therapy	O
,	O
nutritional	O
support	O
,	O
prevention	O
of	O
hospital	O
acquired	O
infection	O
(	O
HAP	O
),	O
individual	O
sedation	O
,	O
continuous	O
blood	O
purification	O
(	O
CBP	O
)	O
for	O
acute	O
kidney	O
injury	O
(	O
AKI	O
)	O
and	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
patients	O
,	O
and	O
intensive	O
care	O
.	O

TITLE	O
:	O
[	O
Effect	O
mechanism	O
of	O
α	O
-	O
adrenoceptor	O
on	O
sepsis	B-SPEC
-	O
induced	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

The	O
hypothalamus	O
-	O
pituitary	O
-	O
adrenal	O
cortical	O
(	O
HPA	O
)	O
axis	B-SPEC
and	O
sympathetic	O
-	O
adrenal	O
medulla	O
axis	B-SPEC
were	O
activated	O
and	O
participated	O
the	O
initiation	O
and	O
progression	O
of	O
the	O
stress	O
response	O
through	O
the	O
production	O
of	O
adrenocorticotropic	O
hormone	O
(	O
ACTH	O
),	O
glucocorticoid	O
(	O
GC	O
),	O
epinephrine	O
and	O
norepinephrine	O
(	O
NE	O
).	O

As	O
the	O
main	O
hormones	O
during	O
sepsis	B-SPEC
,	O
catecholamines	O
(	O
CA	O
),	O
including	O
epinephrine	O
and	O
NE	O
,	O
could	O
bind	O
to	O
adrenergic	O
receptor	O
(	O
AR	O
).	O

TITLE	O
:	O
Differential	O
induction	O
of	O
malaria	O
liver	O
pathology	O
in	O
mice	B-SPEC
infected	O
with	O
Plasmodium	B-SPEC
chabaudi	I-SPEC
AS	O
or	O
Plasmodium	B-SPEC
berghei	I-SPEC
NK65	O
.	O

In	O
P	B-SPEC
.	I-SPEC
berghei	I-SPEC
NK65	O
infected	O
mice	B-SPEC
,	O
which	O
concomitantly	O
develop	O
lethal	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
the	O
liver	O
tissue	O
is	O
characterized	O
by	O
an	O
excess	O
oxidative	O
stress	O
response	O
and	O
reduced	O
antioxidant	O
defenses	O
while	O
in	O
P	B-SPEC
.	I-SPEC
chabaudi	I-SPEC
AS	O
infected	O
mice	B-SPEC
hepatopathy	O
does	O
not	O
lead	O
to	O
lipid	O
alterations	O
or	O
reduction	O
of	O
antioxidant	O
enzymes	O
,	O
but	O
rather	O
to	O
inflammation	O
and	O
cytokine	O
burst	O
,	O
as	O
shown	O
earlier	O
,	O
that	O
may	O
favour	O
parasite	O
killing	O
and	O
clearance	O
of	O
the	O
infection	O
.	O

These	O
results	O
may	O
help	O
understanding	O
the	O
different	O
clinical	O
profiles	O
described	O
in	O
human	B-SPEC
malaria	O
hepatopathy	O
.	O

RESULTS	O
:	O
In	O
the	O
livers	O
of	O
P	B-SPEC
.	I-SPEC
berghei	I-SPEC
NK65	O
infected	O
mice	B-SPEC
both	O
parasites	O
and	O
haemozoin	O
accumulated	O
to	O
a	O
greater	O
extent	O
than	O
in	O
livers	O
of	O
P	B-SPEC
.	I-SPEC
chabaudi	I-SPEC
AS	O
infected	O
mice	B-SPEC
although	O
in	O
the	O
latter	O
hepatomegaly	O
was	O
more	O
prominent	O
.	O

ABSTRACT	O
:	O
The	O
study	O
was	O
aimed	O
to	O
explore	O
the	O
functions	O
of	O
circulating	O
fibrocytes	O
(	O
CFs	O
)	O
on	O
injury	O
repair	O
in	O
acute	O
lung	O
injury	O
/	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ALI	O
/	O
ARDS	O
)	O
mice	B-SPEC
model	O
and	O
its	O
clinical	O
value	O
as	O
a	O
biomarker	O
for	O
ALI	O
/	O
ARDS	O
.	O

ALI	O
/	O
ARDS	O
mice	B-SPEC
model	O
was	O
established	O
by	O
intratracheal	O
instillation	O
of	O
lipopolysaccharide	O
(	O
LPS	O
).	O

To	O
compare	O
the	O
effects	O
of	O
assisted	O
pressure	O
support	O
ventilation	O
(	O
PSV	O
)	O
with	O
pressure	O
-	O
controlled	O
ventilation	O
(	O
PCV	B-SPEC
)	O
on	O
lung	O
function	O
,	O
histology	O
and	O
biological	O
markers	O
at	O
two	O
different	O
PEEP	O
levels	O
in	O
mild	O
ARDS	O
in	O
rats	B-SPEC
.	O

Additional	O
nonventilated	O
animals	B-SPEC
(	O
n	O
=	O
7	O
)	O
were	O
used	O
as	O
a	O
control	O
for	O
postmortem	O
analysis	O
.	O

RESULTS	O
:	O
In	O
both	O
PCV	B-SPEC
and	O
PSV	O
,	O
peak	O
transpulmonary	O
pressure	O
was	O
lower	O
,	O
whereas	O
E	O
-	O
cadherin	O
tissue	O
expression	O
,	O
which	O
is	O
related	O
to	O
epithelial	O
integrity	O
,	O
was	O
higher	O
at	O
PEEP	O
=	O
5	O
cmH2O	O
than	O
at	O
PEEP	O
=	O
2	O
cmH2O	O
.	O

ABSTRACT	O
:	O
Most	O
patients	O
with	O
severe	O
infection	O
with	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
IAV	O
)	O
progress	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
even	O
multiple	O
organ	O
dysfunction	O
syndrome	O
(	O
MODS	O
).	O

ABSTRACT	O
:	O
Despite	O
increased	O
understanding	O
of	O
how	O
viral	O
infection	O
is	O
involved	O
in	O
asthma	O
exacerbations	O
,	O
it	O
is	O
less	O
clear	O
which	O
viruses	B-SPEC
are	O
involved	O
and	O
to	O
what	O
extent	O
they	O
contribute	O
to	O
asthma	O
exacerbations	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
caused	O
by	O
a	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
is	O
characterized	O
by	O
hypoxemic	O
respiratory	O
failure	O
.	O

Commercial	O
-	O
inactivated	O
vaccines	O
against	O
avian	B-SPEC
influenza	O
(	O
AI	O
)	O
and	O
Newcastle	O
disease	O
(	O
ND	O
)	O
viruses	B-SPEC
,	O
and	O
living	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
vaccine	O
were	O
administered	O
by	O
spray	O
method	O
.	O

Neither	O
antibody	O
titers	O
against	O
viruses	B-SPEC
nor	O
lymphoid	O
tissues	O
weight	O
were	O
affected	O
by	O
RP	O
and	O
/	O
or	O
VE	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
treatments	O
.	O

TITLE	O
:	O
Circulation	O
of	O
Alphacoronavirus	B-SPEC
,	O
Betacoronavirus	B-SPEC
and	O
Paramyxovirus	O
in	O
Hipposideros	B-SPEC
bat	B-SPEC
species	B-SPEC
in	O
Zimbabwe	O
.	O

Our	O
results	O
highlighted	O
the	O
importance	O
of	O
monitoring	O
virus	B-SPEC
circulation	O
in	O
wildlife	O
,	O
especially	O
bats	B-SPEC
,	O
in	O
the	O
context	O
of	O
intense	O
human	B-SPEC
-	O
wildlife	O
interfaces	O
in	O
order	B-SPEC
to	O
strengthen	O
prevention	O
measures	O
among	O
local	O
populations	O
and	O
to	O
implement	O
sentinel	O
surveillance	O
in	O
sites	O
with	O
high	O
zoonotic	O
diseases	O
transmission	O
potential	O
.	O

The	O
partial	O
genomic	O
sequences	O
(	O
6	O
.	O
8	O
kb	O
)	O
comprising	O
the	O
S	O
-	O
3a	O
/	O
3b	O
-	O
E	O
-	O
M	O
-	O
intergenic	O
region	O
-	O
5a	O
/	O
5b	O
-	O
N	O
gene	O
order	B-SPEC
of	O
11	O
Malaysian	O
IBVs	O
isolated	O
in	O
2014	O
and	O
2015	O
were	O
sequenced	O
using	O
next	O
-	O
generation	O
sequencing	O
technology	O
.	O

ABSTRACT	O
:	O
Convergent	O
evolution	O
dictates	O
that	O
diverse	O
groups	O
of	O
viruses	B-SPEC
will	O
target	O
both	O
similar	O
and	O
distinct	O
host	O
pathways	O
to	O
manipulate	O
the	O
immune	O
response	O
and	O
improve	O
infection	O
.	O

We	O
conducted	O
a	O
retrospective	O
study	O
of	O
the	O
clinicopathological	O
spectrum	O
of	O
AKI	O
due	O
to	O
multiple	O
Hymenoptera	B-SPEC
stings	O
over	O
13	O
years	O
(	O
July	O
2003	O
-	O
June	O
2016	O
).	O

The	O
level	O
of	O
suppressor	O
of	O
cytokine	O
signaling	O
3	O
,	O
an	O
anti	O
-	O
inflammatory	O
mediator	O
that	O
decreases	O
pSTAT3	O
signaling	O
,	O
was	O
significantly	O
decreased	O
in	O
the	O
BAL	O
fluid	O
of	O
SPC	O
-	O
TK	O
/	O
SPC	O
-	O
KO	O
mice	B-SPEC
.	O

TITLE	O
:	O
Species	B-SPEC
-	O
specific	O
clinical	O
characteristics	O
of	O
human	B-SPEC
coronavirus	I-SPEC
infection	O
among	O
otherwise	O
healthy	O
adolescents	O
and	O
adults	O
.	O

ABSTRACT	O
:	O
In	O
order	B-SPEC
to	O
prevent	O
spread	O
of	O
the	O
endemic	O
pathogens	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	O
)	O
and	O
bovine	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
BRSV	B-SPEC
)	O
between	O
herds	O
,	O
knowledge	O
of	O
indirect	O
transmission	O
by	O
personnel	O
and	O
fomites	O
is	O
fundamental	O
.	O

TITLE	O
:	O
Detection	O
and	O
genetic	O
characterization	O
of	O
porcine	B-SPEC
deltacoronavirus	O
in	O
Tibetan	O
pigs	B-SPEC
surrounding	O
the	O
Qinghai	O
-	O
Tibet	O
Plateau	O
of	O
China	O
.	O

The	O
resulting	O
recombinant	O
(	O
r	O
)	O
rIBV	O
-	O
Δ3ab	O
,	O
rIBV	O
-	O
Δ5ab	O
,	O
and	O
rIBV	O
-	O
Δ3ab5ab	O
could	O
be	O
rescued	O
and	O
grew	O
to	O
the	O
same	O
virus	B-SPEC
titer	O
as	O
recombinant	O
and	O
wild	O
type	O
IBV	B-SPEC
strain	O
H52	O
.	O

Taken	O
together	O
,	O
deletion	O
of	O
accessory	O
genes	O
3ab	O
and	O
/	O
or	O
5ab	O
in	O
IBV	B-SPEC
resulted	O
in	O
mutant	O
viruses	B-SPEC
with	O
an	O
attenuated	O
phenotype	O
and	O
the	O
ability	O
to	O
induce	O
protection	O
in	O
chickens	B-SPEC
.	O

Transient	O
presence	O
of	O
the	O
PEDV	B-SPEC
genome	O
was	O
detected	O
by	O
RT	O
-	O
qPCR	O
in	O
the	O
seminal	O
(	O
5	O
.	O
06	O
×	O
10	O

High	O
-	O
flow	O
nasal	O
cannula	B-SPEC
oxygen	O
therapy	O
is	O
another	O
supportive	O
strategy	O
which	O
serves	O
to	O
improve	O
the	O
symptoms	O
of	O
hypoxic	O
respiratory	O
failure	O
.	O

TITLE	O
:	O
Microglia	O
are	O
required	O
for	O
protection	O
against	O
lethal	O
coronavirus	B-SPEC
encephalitis	O
in	O
mice	B-SPEC
.	O

TITLE	O
:	O
Pathogenic	O
mechanisms	O
of	O
invasive	O
group	B-SPEC
A	I-SPEC
Streptococcus	I-SPEC
infections	O
by	O
influenza	B-SPEC
virus	I-SPEC
-	O
group	B-SPEC
A	I-SPEC
Streptococcus	I-SPEC
superinfection	O
.	O

ABSTRACT	O
:	O
Group	B-SPEC
A	I-SPEC
Streptococcus	I-SPEC
(	O
GAS	O
)	O
are	O
pathogenic	O
bacteria	B-SPEC
of	O
the	O
genus	B-SPEC
Streptococcus	I-SPEC
and	O
cause	O
severe	O
invasive	O
infections	O
that	O
comprise	O
a	O
wide	O
range	O
of	O
diverse	O
diseases	O
,	O
including	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
renal	O
failure	O
,	O
toxic	O
shock	O
-	O
like	O
syndrome	O
,	O
sepsis	B-SPEC
,	O
cellulitis	O
and	O
necrotizing	O
fasciitis	O
.	O

In	O
this	O
period	O
,	O
we	O
found	O
a	O
moderate	O
but	O
statistically	O
significant	O
decline	O
of	O
overall	O
anti	O
-	O
HEV	B-SPEC
IgG	O
prevalence	O
from	O
18	O
.	O
6	O
%	O
to	O
15	O
.	O
3	O
%.	O

The	O
age	O
distribution	O
revealed	O
that	O
children	O
(	O
especially	O
those	O
<	O
3	O
years	O
old	O
)	O
and	O
old	O
people	O
(>	O
50	O
years	O
)	O
were	O
both	O
high	O
risk	O
groups	O
to	O
be	O
infected	O
by	O
HCoV	O
.	O
Of	O
the	O
294	O
HCoV	O
positive	O
patients	O
,	O
34	O
.	O
69	O
%	O
(	O
101	O
cases	O
)	O
were	O
co	O
-	O
infected	O
by	O
other	O
common	O
respiratory	O
viruses	B-SPEC
,	O
and	O
influenza	B-SPEC
virus	I-SPEC
was	O
the	O
most	O
common	O
co	O
-	O
infecting	O
virus	B-SPEC
(	O
30	O
/	O
101	O
,	O
29	O
.	O
70	O
%).	O

Thus	O
,	O
this	O
movement	O
of	O
pigs	B-SPEC
is	O
suggested	O
as	O
the	O
main	O
way	O
for	O
introducing	O
PEDV	B-SPEC
to	O
Ecuador	O
.	O

Results	O
from	O
in	O
vitro	O
and	O
animal	B-SPEC
studies	O
suggest	O
that	O
a	O
combination	O
of	O
lopinavir	O
/	O
ritonavir	O
and	O
interferon	O
-	O
β1b	O
(	O
IFN	O
-	O
β1b	O
)	O
may	O
be	O
effective	O
against	O
MERS	O
-	O
CoV	O
.	O
The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
the	O
efficacy	O
of	O
treatment	O
with	O
a	O
combination	O
of	O
lopinavir	O
/	O
ritonavir	O
and	O
recombinant	O
IFN	O
-	O
β1b	O
provided	O
with	O
standard	O
supportive	O
care	O
,	O
compared	O
to	O
treatment	O
with	O
placebo	O
provided	O
with	O
standard	O
supportive	O
care	O
in	O
patients	O
with	O
laboratory	O
-	O
confirmed	O
MERS	O
requiring	O
hospital	O
admission	O
.	O

Therefore	O
,	O
we	O
determined	O
whether	O
EGFR	O
activation	O
affected	O
PEDV	B-SPEC
infection	O
by	O
using	O
an	O
activator	O
or	O
overexpression	O
assay	O
.	O

ABSTRACT	O
:	O
Guillain	O
-	O
Barre	O
Syndrome	O
,	O
an	O
acute	O
flaccid	O
paralysis	O
known	O
to	O
be	O
caused	O
by	O
recent	O
Gastro	O
-	O
intestinal	O
infections	O
mainly	O
campylobacter	B-SPEC
,	O
and	O
Respiratory	O
infections	O
mainly	O
mycoplasma	B-SPEC
pneumoniae	I-SPEC
and	O
influenza	O
.	O

TITLE	O
:	O
Genetic	O
epidemiology	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
circulating	O
in	O
China	O
in	O
2012	O
-	O
2017	O
based	O
on	O
spike	O
gene	O
.	O

Spike	O
gene	O
is	O
divergent	O
and	O
important	O
for	O
understanding	O
the	O
genetic	O
relations	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
field	O
strains	O
,	O
the	O
epidemiological	O
status	O
of	O
the	O
virus	B-SPEC
and	O
vaccine	O
development	O
.	O

Human	B-SPEC
rhinovirus	I-SPEC
(	O
HRV	O
)	O
showed	O
the	O
highest	O
detection	O
rate	O
(	O
8	O
.	O
6	O
%),	O
followed	O
by	O
influenza	B-SPEC
virus	I-SPEC
(	O
Flu	O
,	O
7	O
.	O
3	O
%),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
,	O
6	O
.	O
1	O
%),	O
human	B-SPEC
coronavirus	I-SPEC
(	O
hCoV	O
,	O
4	O
.	O
3	O
%),	O
human	B-SPEC
parainfluenza	O
(	O
PIV	O
,	O
4	O
.	O
0	O
%),	O
adenovirus	B-SPEC
(	O
ADV	O
,	O
2	O
.	O
1	O
%),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
hMPV	B-SPEC
,	O
1	O
.	O
6	O
%),	O
and	O
human	B-SPEC
bocavirus	I-SPEC
(	O
hBoV	O
,	O
0	O
.	O
7	O
%).	O

During	O
this	O
hospitalization	O
,	O
the	O
clinical	O
picture	O
of	O
fever	O
,	O
cutaneous	O
rashes	O
,	O
lymphadenitis	O
,	O
hepatitis	O
,	O
leukopenia	O
,	O
anemia	B-SPEC
,	O
hyperferritinemia	O
,	O
hypertriglyceridemia	O
,	O
high	O
level	O
of	O
auto	O
-	O
antibodies	O
,	O
and	O
low	O
NK	O
activity	O
suggested	O
an	O
hemophagocytic	O
lymphohistiocytosis	O
syndrome	O
,	O
even	O
if	O
bone	O
marrow	O
biopsy	O
was	O
negative	O
for	O
hemophagocytosis	O
.	O

These	O
data	O
provides	O
information	O
about	O
the	O
circulating	O
viruses	B-SPEC
in	O
ECC	O
and	O
highlights	O
the	O
importance	O
of	O
searching	O
both	O
viruses	B-SPEC
and	O
atypical	O
bacteria	B-SPEC
in	O
severe	O
ARI	O
.	O

TITLE	O
:	O
Bilateral	O
acute	O
iris	B-SPEC
transillumination	O
syndrome	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
embryo	O
lung	O
cellular	O
protein	O
interacting	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
nonstructural	O
protein	O
-	O
10	O
(	O
HEPIS	O
)	O
is	O
a	O
novel	O
transcriptional	O
repressor	O
,	O
the	O
expression	O
profile	O
and	O
promoter	O
activity	O
of	O
which	O
have	O
not	O
been	O
well	O
studied	O
.	O

Anonymized	O
datasets	O
from	O
all	O
pig	B-SPEC
farms	O
were	O
provided	O
by	O
Kagoshima	O
(	O
709	O
farms	O
)	O
and	O
Miyazaki	O
Prefectures	O
(	O
506	O
farms	O
).	O

For	O
diagnostic	O
investigations	O
in	O
the	O
affected	O
farms	O
,	O
real	O
time	O
RT	O
-	O
PCR	O
was	O
performed	O
to	O
detect	O
PEDV	B-SPEC
RNA	O
in	O
individually	O
taken	O
fecal	O
samples	O
,	O
and	O
two	O
commercial	O
ELISA	O
kits	O
,	O
both	O
based	O
on	O
the	O
N	O
protein	O
of	O
PEDV	B-SPEC
,	O
were	O
used	O
to	O
detect	O
IgG	O
in	O
serum	O
samples	O
of	O
pigs	B-SPEC
experiencing	O
acute	O
signs	O
of	O
the	O
disease	O
.	O

TITLE	O
:	O
Emerging	O
Respiratory	O
Viruses	B-SPEC
in	O
Children	O
.	O

Coupons	O
in	O
the	O
positive	O
control	O
and	O
disinfectant	O
treatment	O
groups	O
were	O
contaminated	O
with	O
2	O
mL	O
of	O
feces	O
spiked	O
with	O
PEDV	B-SPEC
.	O

Genome	O
-	O
wide	O
analysis	O
of	O
differentially	O
expressed	O
genes	O
(	O
DEGs	O
)	O
was	O
performed	O
in	O
Vero	O
E6	O
cells	O
post	O
-	O
PEDV	B-SPEC
infection	O
.	O

Taking	O
advantage	O
of	O
these	O
characteristics	O
,	O
this	O
attenuated	O
virus	B-SPEC
was	O
transformed	O
into	O
a	O
versatile	O
chimeric	O
or	O
recombinant	O
vaccine	O
vector	O
with	O
demonstrated	O
proof	O
-	O
of	O
-	O
principle	O
in	O
humans	B-SPEC
and	O
a	O
preclinical	O
track	O
record	O
of	O
rapid	O
adaptability	O
and	O
effectiveness	O
for	O
a	O
variety	O
of	O
pathogens	O
.	O

Most	O
patients	O
died	O
from	O
causes	O
unrelated	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
48	O
.	O
7	O
%	O
of	O
nonsurvivors	O
died	O
from	O
multisystem	O
organ	O
failure	O
,	O
and	O
cancer	B-SPEC
or	O
brain	O
injury	O
was	O
involved	O
in	O
37	O
.	O
1	O
%	O
of	O
deaths	O
.	O

Towards	O
the	O
end	O
of	O
the	O
study	O
(	O
5	O
and	O
7	O
days	O
following	O
the	O
IBV	B-SPEC
infection	O
),	O
the	O
recruited	O
macrophages	O
appear	O
to	O
be	O
a	O
significant	O
source	O
IL	O
-	O
1β	O
.	O

TITLE	O
:	O
Insights	O
into	O
the	O
homo	B-SPEC
-	O
oligomerization	O
properties	O
of	O
N	O
-	O
terminal	O
coiled	O
-	O
coil	O
domain	O
of	O
Ebola	B-SPEC
virus	I-SPEC
VP35	O
protein	O
.	O

No	O
significant	O
differences	O
in	O
sex	O
were	O
seen	O
across	O
species	B-SPEC
,	O
although	O
a	O
significant	O
difference	O
in	O
age	O
distribution	O
was	O
noted	O
.	O

No	O
significant	O
differences	O
in	O
sex	O
were	O
seen	O
across	O
species	B-SPEC
,	O
although	O
a	O
significant	O
difference	O
in	O
age	O
distribution	O
was	O
noted	O
.	O

TITLE	O
:	O
Comparison	O
of	O
the	O
performance	O
of	O
laboratory	O
tests	O
in	O
the	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
.	O

This	O
enteric	O
virus	B-SPEC
is	O
transmitted	O
via	O
the	O
feco	O
-	O
oral	O
route	O
and	O
horses	B-SPEC
become	O
infected	O
by	O
ingesting	O
fecally	O
contaminated	O
feed	O
and	O
water	O
.	O

Other	O
variables	O
were	O
associated	O
with	O
ARDS	O
in	O
univariate	O
but	O
not	O
in	O
multivariate	O
analysis	O
:	O
body	O
mass	O
index	O
(	O
p	O
=	O
.	O
06	O
),	O
transfusions	O
(	O
p	O
=	O
.	O
001	O
)	O
and	O
sepsis	B-SPEC
(	O
p	O
<	O
.	O
0001	O
).	O

TITLE	O
:	O
Case	O
report	O
of	O
severe	O
myocarditis	O
in	O
an	O
immunocompromised	O
child	O
with	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
infection	O
.	O

Lack	O
of	O
acclimation	O
to	O
heat	O
and	O
physical	O
fitness	O
decreases	O
the	O
survival	O
of	O
heat	O
stroked	O
dogs	B-SPEC
.	O

For	O
the	O
purpose	O
of	O
this	O
study	O
,	O
only	O
non	O
-	O
sleepy	O
patients	O
with	O
moderate	O
or	O
severe	O
OSA	B-SPEC
and	O
randomized	O
to	O
receive	O
CPAP	O
treatment	O
were	O
analysed	O
(	O
n	O
=	O
357	O
).	O

The	O
results	O
revealed	O
that	O
the	O
small	O
intestinal	O
microbiota	B-SPEC
of	O
suckling	O
piglets	O
infected	O
with	O
PEDV	B-SPEC
showed	O
low	O
diversity	O
and	O
was	O
dominated	O
by	O
Proteobacteria	B-SPEC
(	O
49	O
.	O
1	O
%).	O

Influenza	B-SPEC
virus	I-SPEC
,	O
human	B-SPEC
parainfluenza	O
viruses	B-SPEC
and	O
human	B-SPEC
respiratory	I-SPEC
syncytial	I-SPEC
virus	I-SPEC
as	O
well	O
as	O
human	B-SPEC
rhinovirus	I-SPEC
,	O
human	B-SPEC
coronavirus	I-SPEC
and	O
human	B-SPEC
metapneumovirus	I-SPEC
were	O
detected	O
significantly	O
more	O
frequently	O
in	O
LRTI	O
patients	O
than	O
in	O
controls	O
.	O

TITLE	O
:	O
Assessment	O
of	O
Mycoplasma	B-SPEC
gallisepticum	I-SPEC
vaccine	O
efficacy	O
in	O
a	O
co	O
-	O
infection	O
challenge	O
model	O
with	O
QX	O
-	O
like	O
infectious	O
bronchitis	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
Mycoplasma	B-SPEC
gallisepticum	I-SPEC
(	O
MG	O
)	O
is	O
the	O
primary	O
cause	O
of	O
chronic	O
respiratory	O
disease	O
in	O
poultry	O
.	O

We	O
investigated	O
the	O
protective	O
efficacy	O
of	O
the	O
live	O
-	O
attenuated	O
ts	O
-	O
11	O
and	O
6	O
/	O
85	O
MG	O
vaccines	O
against	O
a	O
local	O
MG	O
strain	O
and	O
,	O
in	O
order	B-SPEC
to	O
enhance	O
signs	O
and	O
mimic	O
a	O
typical	O
field	O
situation	O
,	O
we	O
co	O
-	O
infected	O
birds	B-SPEC
with	O
a	O
virulent	O
strain	O
of	O
QX	O
-	O
like	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

One	O
of	O
the	O
limitations	O
in	O
using	O
traditional	O
culture	O
systems	O
from	O
non	O
-	O
reservoir	O
species	B-SPEC
is	O
that	O
cell	O
types	O
and	O
culture	O
conditions	O
may	O
not	O
be	O
compatible	O
for	O
isolation	O
of	O
bat	B-SPEC
-	O
borne	O
viruses	B-SPEC
.	O

Other	O
studies	O
are	O
required	O
to	O
attempt	O
the	O
clinical	O
and	O
antigenic	O
implications	O
of	O
these	O
astrovirus	O
genotypes	O
in	O
dogs	B-SPEC
.	O

Knowledge	O
about	O
age	O
-	O
specific	O
pattern	O
of	O
CoV	O
infection	O
in	O
P	B-SPEC
.	I-SPEC
lylei	I-SPEC
,	O
prevalence	O
,	O
and	O
viral	O
shedding	O
at	O
roosts	O
and	O
foraging	O
sites	O
may	O
have	O
an	O
impact	O
on	O
infection	O
-	O
age	O
-	O
structure	O
model	O
to	O
control	O
CoV	O
outbreak	O
.	O

Whether	O
viral	O
reactivation	O
during	O
parturition	O
period	O
or	O
stress	O
is	O
responsible	O
in	O
maintaining	O
transmission	O
in	O
the	O
bat	B-SPEC
colony	O
needs	O
to	O
be	O
explored	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
detecting	O
PEDV	B-SPEC
bearing	O
large	O
spike	O
gene	O
deletion	O
in	O
clinical	O
swine	B-SPEC
samples	O
in	O
the	O
USA	O
.	O

Data	O
from	O
clinical	O
,	O
in	O
vitro	O
and	O
in	O
vivo	O
suggest	O
that	O
virus	B-SPEC
-	O
induced	O
cytokine	O
dysregulation	O
could	O
be	O
a	O
contributory	O
factor	O
to	O
the	O
pathogenesis	O
of	O
human	B-SPEC
H5N1	O
disease	O
.	O

Clinically	O
normal	O
Holstein	O
-	O
Friesian	O
and	O
Jersey	O
breed	O
bull	O
calves	O
(	O
n	O
=	O
72	O
)	O
were	O
group	O
housed	O
in	O
4	O
pens	O
using	O
a	O
factorial	O
design	O
with	O
calves	O
of	O
different	O
breeds	O
and	O
planes	B-SPEC
of	O
nutrition	O
in	O
each	O
pen	O
.	O

That	O
said	O
,	O
the	O
identified	O
coronaviruses	O
were	O
consistently	O
associated	O
with	O
a	O
particular	O
bat	B-SPEC
species	B-SPEC
or	O
genus	B-SPEC
,	O
and	O
these	O
relationships	O
were	O
maintained	O
no	O
matter	O
the	O
geographic	O
location	O
.	O

RT	O
-	O
qPCR	O
method	O
tested	O
provided	O
a	O
sensitivity	O
and	O
rapid	O
approach	O
for	O
screening	O
on	O
IBV	B-SPEC
detection	O
and	O
Mass	O
genotyping	O
from	O
IBV	B-SPEC
isolates	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
a	O
highly	O
contagious	O
disease	O
in	O
newborn	O
piglets	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
has	O
infected	O
at	O
least	O
2040	O
patients	O
and	O
caused	O
712	O
deaths	O
since	O
its	O
first	O
appearance	O
in	O
2012	O
,	O
yet	O
neither	O
pathogen	O
-	O
specific	O
therapeutics	O
nor	O
approved	O
vaccines	O
are	O
available	O
.	O

In	O
addition	O
,	O
hCD26	O
/	O
dipeptidyl	O
peptidase	O
-	O
4	O
(	O
DPP4	O
)	O
transgenic	B-SPEC
mice	I-SPEC
vaccinated	O
with	O
AddaVax	O
-	O
adjuvanted	O
S377	O
-	O
588	O
-	O
Fc	O
could	O
produce	O
neutralizing	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
and	O
survived	O
for	O
at	O
least	O
21	O
days	O
after	O
challenge	O
with	O
live	O
MERS	O
-	O
CoV	O
with	O
no	O
evidence	O
of	O
immunological	O
toxicity	O
or	O
eosinophilic	O
immune	O
enhancement	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
are	O
a	O
unique	O
group	O
of	O
mammals	B-SPEC
well	O
suited	O
to	O
be	O
hosts	O
for	O
emerging	O
viruses	B-SPEC
.	O

With	O
current	O
rates	O
of	O
deforestation	O
and	O
urbanization	O
,	O
redistribution	O
of	O
bat	B-SPEC
habitats	O
to	O
urban	O
and	O
suburban	O
areas	O
may	O
bring	O
bats	B-SPEC
into	O
closer	O
contact	O
with	O
livestock	O
and	O
humans	B-SPEC
.	O

In	O
pigs	B-SPEC
,	O
the	O
newly	O
emerged	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
and	O
re	O
-	O
emerged	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
reported	O
in	O
the	O
US	O
and	O
Asia	O
,	O
as	O
well	O
as	O
the	O
discovery	O
of	O
novel	O
CoVs	O
in	O
wild	O
bats	B-SPEC
or	O
birds	B-SPEC
,	O
has	O
necessitated	O
development	O
of	O
improved	O
detection	O
and	O
control	O
measures	O
for	O
these	O
CoVs	O
.	O

Because	O
the	O
previous	O
pancoronavirus	O
(	O
panCoV	O
)	O
RT	O
-	O
PCR	O
established	O
in	O
our	O
laboratory	O
in	O
2007	O
-	O
2011	O
did	O
not	O
detect	O
deltacoronaviruses	O
(	O
δ	O
-	O
CoVs	O
)	O
in	O
swine	B-SPEC
fecal	O
and	O
serum	O
samples	O
,	O
our	O
goal	O
was	O
to	O
develop	O
a	O
new	O
panCoV	O
RT	O
-	O
PCR	O
assay	O
to	O
detect	O
known	O
human	B-SPEC
and	O
animal	B-SPEC
CoVs	O
,	O
including	O
δ	O
-	O
CoVs	O
.	O

400	O
avian	B-SPEC
fecal	O
(	O
RNA	O
)	O
samples	O
were	O
further	O
tested	O
simultaneously	O
for	O
CoV	O
by	O
the	O
new	O
panCoV	O
RT	O
-	O
PCR	O
and	O
a	O
one	O
-	O
step	O
RT	O
-	O
PCR	O
assay	O
with	O
the	O
δ	O
-	O
CoV	O
nucleocapsid	O
-	O
specific	O
universal	O
primers	O
.	O

A	O
multiplex	O
TaqMan	O
real	O
-	O
time	O
PCR	O
method	O
was	O
developed	O
for	O
the	O
detection	O
and	O
differentiation	O
of	O
four	O
antigenic	O
types	O
of	O
CPV	B-SPEC
.	O

Another	O
set	O
of	O
primers	O
and	O
probes	O
,	O
CPV	B-SPEC
-	O
426F	O
/	O
CPV	B-SPEC
-	O
426R	O
and	O
CPV	B-SPEC
-	O
2	O
-	O
426P	O
(	O
for	O
CPV	B-SPEC
-	O
2	O
and	O
2a	O
)/	O
CPV	B-SPEC
-	O
2b	O
-	O
426P	O
(	O
for	O
CPV	B-SPEC
-	O
2b	O
)/	O
CPV	B-SPEC
-	O
2c	O
-	O
426P	O
(	O
for	O
CPV	B-SPEC
-	O
2c	O
),	O
was	O
able	O
to	O
differentiate	O
CPV	B-SPEC
-	O
2a	O
(	O
2	O
),	O
CPV	B-SPEC
-	O
2b	O
,	O
and	O
CPV	B-SPEC
-	O
2c	O
.	O

With	O
these	O
primers	O
and	O
probes	O
,	O
the	O
multiplex	O
TaqMan	O
real	O
-	O
time	O
PCR	O
assay	O
detected	O
effectively	O
and	O
differentiated	O
CPV	B-SPEC
-	O
2	O
,	O
2a	O
,	O
2b	O
and	O
2c	O
by	O
two	O
separate	O
real	O
-	O
time	O
PCRs	O
.	O

To	O
investigate	O
the	O
epidemiology	O
and	O
genetic	O
diversity	O
of	O
these	O
coronaviruses	O
,	O
we	O
conducted	O
a	O
longitudinal	O
surveillance	O
in	O
fruit	O
bats	B-SPEC
in	O
Yunnan	O
province	O
,	O
China	O
during	O
2009	O
-	O
2016	O
.	O

Quantitative	O
PCR	O
revealed	O
that	O
the	O
intestine	O
was	O
the	O
primary	O
infection	O
organ	O
of	O
BatCoV	O
HKU9	O
and	O
GCCDC1	O
,	O
but	O
some	O
HKU9	O
was	O
also	O
detected	O
in	O
the	O
heart	O
,	O
kidney	O
,	O
and	O
lung	O
tissues	O
of	O
bats	B-SPEC
.	O

Nano	O
silicon	O
could	O
quickly	O
activate	O
innate	O
and	O
adaptive	O
immunity	O
by	O
stimulating	O
Toll	O
-	O
like	O
receptor	O
signaling	O
pathways	O
,	O
indicating	O
that	O
the	O
nano	O
silicon	O
adjuvant	O
enhanced	O
long	O
-	O
term	O
humoral	O
and	O
early	O
cellular	O
immune	O
responses	O
when	O
combined	O
with	O
inactivated	O
TGEV	B-SPEC
vaccine	O
.	O

PEDV	B-SPEC
infection	O
of	O
two	O
APN	O
-	O
knockout	O
Vero	O
cells	O
had	O
the	O
same	O
efficiency	O
as	O
the	O
Vero	O
cells	O
with	O
or	O
without	O
neuraminidase	O
treatment	O
.	O

We	O
genetically	O
and	O
phenotypically	O
characterized	O
MERS	O
-	O
CoV	O
from	O
dromedaries	B-SPEC
sampled	O
in	O
Morocco	O
,	O
Burkina	O
Faso	O
,	O
Nigeria	O
,	O
and	O
Ethiopia	O
.	O

TITLE	O
:	O
Rapid	O
detection	O
of	O
MERS	O
coronavirus	B-SPEC
-	O
like	O
viruses	B-SPEC
in	O
bats	B-SPEC
:	O
pote1ntial	O
for	O
tracking	O
MERS	O
coronavirus	B-SPEC
transmission	O
and	O
animal	B-SPEC
origin	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
usefulness	O
of	O
this	O
assay	O
to	O
detect	O
other	O
lineage	O
C	O
betacoronaviruses	O
closely	O
related	O
to	O
MERS	O
-	O
CoV	O
in	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
Infections	O
caused	O
by	O
respiratory	O
viruses	B-SPEC
are	O
important	O
problems	O
worldwide	O
,	O
especially	O
in	O
children	O
.	O

In	O
total	O
,	O
545	O
nasopharyngeal	O
(	O
NP	O
)	O
specimens	O
from	O
individuals	O
with	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
who	O
were	O
negative	O
for	O
other	O
seven	O
respiratory	O
viruses	B-SPEC
were	O
analyzed	O
for	O
the	O
presence	O
of	O
hMPV	B-SPEC
.	O

hMPV	B-SPEC
was	O
further	O
detected	O
in	O
several	O
cases	O
of	O
SARS	O
and	O
it	O
was	O
the	O
only	O
virus	B-SPEC
detected	O
in	O
three	O
deaths	O
.	O

TITLE	O
:	O
Comparative	O
analysis	O
of	O
Mouse	B-SPEC
Inoculation	O
Test	O
and	O
Virus	B-SPEC
Isolation	O
in	O
Cell	O
Culture	O
for	O
rabies	O
diagnosis	O
in	O
animals	B-SPEC
of	O
Parana	O
,	O
Brazil	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
VICC	O
with	O
MIT	O
,	O
in	O
terms	O
of	O
accuracy	O
,	O
biosafety	O
and	O
occupational	O
health	O
,	O
supply	O
and	O
equipment	O
costs	O
,	O
bioethics	O
and	O
animal	B-SPEC
welfare	O
,	O
in	O
a	O
Brazilian	O
public	O
health	O
lab	O
.	O

We	O
then	O
showed	O
that	O
selected	O
RBD	O
-	O
specific	O
,	O
non	O
-	O
RBD	O
S1	O
-	O
specific	O
,	O
and	O
S2	O
-	O
specific	O
MAbs	O
given	O
prophylactically	O
prevented	O
MERS	O
-	O
CoV	O
replication	O
in	O
lungs	O
and	O
protected	O
mice	B-SPEC
from	O
lethal	O
challenge	O
.	O

TITLE	O
:	O
Identification	O
of	O
H209	O
as	O
Essential	O
for	O
pH	O
8	O
-	O
Triggered	O
Receptor	O
-	O
Independent	O
Syncytium	O
Formation	O
by	O
S	O
Protein	O
of	O
Mouse	B-SPEC
Hepatitis	O
Virus	B-SPEC
A59	O
.	O

Replacement	O
of	O
H209	O
with	O
Ala	O
had	O
no	O
effect	O
on	O
receptor	O
binding	O
,	O
but	O
in	O
murine	B-SPEC
17Cl	O
.	O
1	O
cells	O
mutant	O
H209A	O
MHV	B-SPEC
-	O
A59	O
showed	O
delayed	O
growth	O
kinetics	O
and	O
was	O
readily	O
outcompeted	O
by	O
wild	O
-	O
type	O
virus	B-SPEC
when	O
mixed	O
together	O
,	O
indicating	O
that	O
the	O
H209A	O
mutation	O
caused	O
a	O
defect	O
in	O
virus	B-SPEC
fitness	O
.	O

All	O
AvCoV	O
isolates	O
induced	O
clinical	O
signs	O
,	O
gross	O
lesions	O
in	O
the	O
trachea	B-SPEC
,	O
moderate	O
histopathological	O
changes	O
in	O
the	O
respiratory	O
tract	O
,	O
and	O
mild	O
changes	O
in	O
other	O
tissues	O
.	O

TITLE	O
:	O
Immunohistochemical	O
characterization	O
of	O
feline	B-SPEC
lymphoplasmacytic	O
anterior	O
uveitis	O
.	O

Overall	O
,	O
these	O
features	O
demonstrate	O
that	O
the	O
more	O
severe	O
clinical	O
signs	O
observed	O
upon	O
infection	O
with	O
the	O
HP	O
PR40	O
strain	O
are	O
sustained	O
by	O
remarkable	O
changes	O
in	O
the	O
peripheral	O
blood	O
distribution	O
of	O
immune	O
cells	O
and	O
provide	O
further	O
insights	O
into	O
the	O
immune	O
regulation	O
/	O
immunopathogenesis	O
induced	O
by	O
PRRSV	B-SPEC
-	O
1	O
subtype	O
1	O
European	O
isolates	O
.	O

These	O
findings	O
provide	O
novel	O
information	O
about	O
the	O
function	O
of	O
the	O
poorly	O
characterized	O
TGEV	B-SPEC
non	O
-	O
structural	O
protein	O
7	O
.	O

TITLE	O
:	O
Knowledge	O
and	O
attitude	O
towards	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
among	O
healthcare	O
personnel	O
in	O
the	O
southern	O
region	O
of	O
Saudi	O
Arabia	O
.	O

ABSTRACT	O
:	O
A	O
significant	O
proportion	O
of	O
cancer	B-SPEC
patients	O
use	O
complementary	O
and	O
alternative	O
medicine	O
(	O
CAM	O
)	O
along	O
with	O
conventional	O
therapies	O
(	O
CT	O
),	O
whereas	O
a	O
smaller	O
proportion	O
delay	O
or	O
defer	O
CT	O
in	O
favor	O
of	O
CAM	O
.	O

In	O
this	O
report	O
,	O
PEDV	B-SPEC
N	O
protein	O
was	O
discovered	O
to	O
colocalize	O
with	O
cellular	O
hnRNP	O
A1	O
in	O
perinuclear	O
region	O
of	O
PEDV	B-SPEC
infected	O
cells	O
.	O

Co	O
-	O
immunoprecipitation	O
(	O
CO	O
-	O
IP	O
)	O
results	O
clearly	O
demonstrated	O
that	O
PEDV	B-SPEC
N	O
protein	O
could	O
bind	O
to	O
human	B-SPEC
hnRNP	O
A1	O
.	O

They	O
have	O
been	O
approved	O
for	O
treatment	O
of	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
-	O
1	O
,	O
HIV	B-SPEC
,	O
HBV	B-SPEC
,	O
HCV	B-SPEC
,	O
and	O
influenza	O
,	O
and	O
new	O
drugs	O
are	O
being	O
developed	O
for	O
the	O
treatment	O
of	O
RSV	B-SPEC
,	O
Ebola	O
,	O
coronavirus	B-SPEC
MERS	O
,	O
and	O
other	O
emerging	O
viruses	B-SPEC
.	O

Sequence	O
comparisons	O
between	O
PEDVs	O
collected	O
from	O
primary	O
and	O
secondary	O
outbreaks	O
in	O
three	O
herds	O
revealed	O
that	O
the	O
disease	O
has	O
developed	O
to	O
an	O
endemic	O
stage	O
in	O
which	O
PEDV	B-SPEC
could	O
persist	O
for	O
nearly	O
two	O
years	O
in	O
the	O
herds	O
or	O
local	O
regions	O
,	O
causing	O
subsequent	O
epidemics	O
.	O

She	O
was	O
reasonably	O
considered	O
to	O
be	O
infected	O
with	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
as	O
well	O
,	O
and	O
azithromycin	O
and	O
moxifloxacin	O
were	O
added	O
to	O
her	O
treatment	O
.	O

CONCLUSIONS	O
:	O
In	O
patients	O
with	O
confirmed	O
influenza	O
A	O
H7N9	O
infection	O
whose	O
condition	O
worsens	O
again	O
,	O
especially	O
with	O
new	O
infiltration	O
or	O
lung	O
ground	O
-	O
glass	O
infiltration	O
,	O
one	O
should	O
suspect	O
infection	O
by	O
other	O
pathogens	O
such	O
as	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
a	O
member	O
of	O
the	O
Coronaviridae	B-SPEC
family	B-SPEC
,	O
causes	O
acute	O
diarrhea	O
,	O
vomiting	O
,	O
dehydration	O
,	O
and	O
high	O
mortality	O
rates	O
in	O
neonatal	O
piglets	O
.	O

These	O
potential	O
hotspots	O
,	O
determined	O
using	O
anthropogenic	O
,	O
system	O
and	O
trade	O
characterizations	O
should	O
guide	O
selection	O
of	O
sampling	O
/	O
surveillance	O
sites	O
,	O
high	O
-	O
risk	O
locations	O
,	O
critical	O
areas	O
for	O
interventions	O
and	O
policy	O
development	O
in	O
Kenya	O
,	O
as	O
well	O
as	O
instigate	O
further	O
virological	O
examination	O
of	O
camels	B-SPEC
.	O

The	O
assay	O
could	O
only	O
detect	O
the	O
TGEV	B-SPEC
,	O
and	O
there	O
was	O
no	O
cross	O
-	O
reaction	O
with	O
other	O
pathogens	O
tested	O
.	O

Fourteen	O
samples	O
were	O
TGEV	B-SPEC
RNA	O
positive	O
in	O
RT	O
-	O
RPA	O
(	O
18	O
.	O
4	O
%,	O
14	O
/	O
76	O
),	O
which	O
were	O
also	O
positive	O
in	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
.	O

TITLE	O
:	O
Early	O
identification	O
of	O
pneumonia	O
patients	O
at	O
increased	O
risk	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
infection	O
in	O
Saudi	O
Arabia	O
.	O

Coronaviruses	O
,	O
including	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
fuse	O
at	O
the	O
plasma	O
membrane	O
or	O
use	O
receptor	O
-	O
mediated	O
endocytosis	O
and	O
fuse	O
with	O
endosomes	O
,	O
depending	O
on	O
the	O
cell	O
or	O
tissue	O
type	O
.	O

The	O
virus	B-SPEC
spike	O
(	O
S	O
)	O
protein	O
mediates	O
fusion	O
with	O
the	O
host	O
cell	O
membrane	O
.	O

Blood	O
serum	O
samples	O
were	O
tested	O
by	O
an	O
electrophoretic	O
method	O
for	O
the	O
assessment	O
of	O
immunoglobulin	O
(	O
Ig	O
)	O
concentration	O
,	O
whereas	O
fecal	O
samples	O
were	O
submitted	O
to	O
ELISA	O
test	O
for	O
positivity	O
to	O
Escherichia	B-SPEC
coli	I-SPEC
K99	O
,	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
Cryptosporidium	B-SPEC
spp	O
.	O

Even	O
if	O
estimated	O
on	O
a	O
small	O
number	O
of	O
calves	O
,	O
those	O
with	O
FTPI	O
had	O
higher	O
risks	O
of	O
enteric	O
infections	O
by	O
rotavirus	B-SPEC
(	O
odds	O
ratio	O
=	O
12	O
;	O

95	O
%	O
CI	O
=	O
1	O
-	O
137	O
)	O
and	O
Cryptosporidium	B-SPEC
spp	O
.	O

ABSTRACT	O
:	O
By	O
means	O
of	O
structure	O
-	O
based	O
molecular	O
hybridization	O
strategy	O
,	O
a	O
series	O
of	O
novel	O
diarylpyri	O
(	O
mi	O
)	O
dine	O
derivatives	O
targeting	O
the	O
entrance	O
channel	O
of	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
reverse	O
transcriptase	O
(	O
RT	O
)	O
were	O
designed	O
,	O
synthesized	O
and	O
evaluated	O
as	O
potent	O
non	O
-	O
nucleoside	O
reverse	O
transcriptase	O
inhibitors	O
(	O
NNRTIs	O
).	O

To	O
better	O
respond	O
to	O
a	O
virus	B-SPEC
outbreak	O
,	O
government	O
agencies	O
need	O
to	O
improve	O
hierarchical	O
communication	O
among	O
different	O
levels	O
of	O
governments	O
,	O
horizontal	O
communication	O
and	O
cooperation	O
between	O
same	O
types	O
or	O
different	O
types	O
of	O
agencies	O
,	O
and	O
information	O
systems	O
.	O

ABSTRACT	O
:	O
Enterovirus	B-SPEC
D68	O
(	O
EV	O
-	O
D68	O
)	O
is	O
a	O
medically	O
important	O
respiratory	O
plus	O
-	O
strand	O
RNA	O
virus	B-SPEC
of	O
children	O
that	O
has	O
been	O
linked	O
to	O
acute	O
flaccid	O
myelitis	O
.	O

ABSTRACT	O
:	O
Influenza	B-SPEC
virus	I-SPEC
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
parainfluenza	O
virus	B-SPEC
,	O
coronaviruses	O
,	O
and	O
rhinoviruses	B-SPEC
are	O
among	O
the	O
most	O
common	O
viruses	B-SPEC
causing	O
mild	O
seasonal	O
colds	O
.	O

In	O
addition	O
,	O
swine	B-SPEC
and	O
avian	B-SPEC
influenza	B-SPEC
viruses	I-SPEC
,	O
together	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
associated	O
and	O
Middle	O
Eastern	O
respiratory	O
syndrome	O
coronaviruses	O
,	O
represent	O
significant	O
pandemic	O
threats	O
to	O
the	O
general	O
population	O
.	O

This	O
includes	O
molecules	O
with	O
very	O
broad	O
antiviral	O
spectrum	O
such	O
as	O
ribavirin	O
and	O
T	O
-	O
705	O
(	O
favipiravir	O
),	O
and	O
others	O
targeting	O
more	O
specifically	O
one	O
or	O
a	O
few	O
virus	B-SPEC
families	O
.	O

Recent	O
advances	O
in	O
our	O
understanding	O
of	O
the	O
structure	O
(	O
s	O
)	O
and	O
function	O
(	O
s	O
)	O
of	O
respiratory	O
virus	B-SPEC
polymerases	O
will	O
likely	O
support	O
the	O
discovery	O
and	O
development	O
of	O
novel	O
nucleoside	O
analogs	O
.	O

Little	O
is	O
known	O
about	O
the	O
pathogenesis	O
and	O
innate	O
antiviral	O
response	O
in	O
primary	O
human	B-SPEC
monocyte	O
-	O
derived	O
macrophages	O
(	O
MDMs	O
)	O
and	O
dendritic	O
cells	O
(	O
MDDCs	O
)	O
upon	O
MERS	O
-	O
CoV	O
infection	O
.	O

The	O
sows	O
were	O
categorized	O
into	O
six	O
groups	O
based	O
on	O
the	O
period	O
in	O
which	O
they	O
were	O
exposed	O
to	O
PED	O
virus	B-SPEC
between	O
days	O
0	O
-	O
30	O
(	O
G1	O
),	O
31	O
-	O
60	O
(	O
G2	O
),	O
61	O
-	O
90	O
(	O
G3	O
),	O
or	O
after	O
91	O
days	O
of	O
pregnancy	O
(	O
G4	O
),	O
during	O
lactation	O
(	O
L	O
),	O
and	O
after	O
weaning	O
(	O
W	O
).	O

Compared	O
with	O
the	O
uninfected	O
group	O
,	O
there	O
was	O
no	O
reduction	O
in	O
the	O
number	O
of	O
pigs	B-SPEC
born	O
alive	O
in	O
the	O
G1	O
-	O
G4	O
groups	O
.	O

Sows	O
of	O
the	O
G4	O
and	O
L	O
groups	O
,	O
however	O
,	O
had	O
4	O
-	O
9	O
pigs	B-SPEC
fewer	O
pigs	B-SPEC
weaned	O
,	O
and	O
a	O
36	O
%-	O
77	O
%	O
greater	O
pre	O
-	O
weaning	O
mortality	O
than	O
the	O
uninfected	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

TITLE	O
:	O
Complete	O
Genome	O
Sequence	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
NL63	I-SPEC
CN0601	O
/	O
14	O
,	O
First	O
Isolated	O
in	O
South	O
Korea	O
.	O

Here	O
we	O
isolated	O
a	O
strain	O
of	O
PDCoV	O
,	O
named	O
CHN	O
-	O
GD	O
-	O
2016	O
,	O
from	O
the	O
intestinal	O
content	O
of	O
a	O
diseased	O
newborn	O
piglet	O
with	O
severe	O
diarrhea	O
in	O
a	O
pig	B-SPEC
farm	O
in	O
Guangdong	O
,	O
China	O
.	O

PDCoV	O
CHN	O
-	O
GD	O
-	O
2016	O
could	O
be	O
identified	O
by	O
immunofluorescence	O
with	O
PDCoV	O
specific	O
rabbit	B-SPEC
antisera	O
,	O
and	O
typical	O
crown	O
-	O
shaped	O
particles	O
with	O
spiky	O
surface	O
projections	O
of	O
this	O
PDCoV	O
were	O
observed	O
with	O
electron	O
microscopy	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
is	O
the	O
etiological	O
agent	O
of	O
a	O
highly	O
contagious	O
disease	O
,	O
which	O
results	O
in	O
severe	O
economic	O
losses	O
to	O
the	O
poultry	O
industry	O
.	O

Phylodynamic	O
analysis	O
demonstrated	O
that	O
IBV	B-SPEC
GI	O
-	O
11	O
lineage	O
was	O
introduced	O
in	O
Brazil	O
in	O
the	O
1950s	O
(	O
1951	O
,	O
1917	O
-	O
1975	O
95	O
%	O
HPD	O
)	O
and	O
population	O
dynamics	O
was	O
mostly	O
constant	O
throughout	O
the	O
time	O
.	O

Highly	O
active	O
antiretroviral	O
therapy	O
(	O
HAART	O
)	O
has	O
improved	O
survival	O
rates	O
in	O
compliant	O
HIV	B-SPEC
patients	O
and	O
reversible	O
severe	O
respiratory	O
failure	O
may	O
warrant	O
ECMO	O
in	O
this	O
group	O
.	O

TITLE	O
:	O
DYSFUNCTION	O
OF	O
VARIOUS	O
ORGAN	O
SYSTEMS	O
INDUCED	O
BY	O
SEPSIS	B-SPEC
WITH	O
UNDERLYING	O
SEVERE	O
MYELOMIC	O
DISEASES	O
AND	O
PROSTATE	O
CANCER	B-SPEC
(	O
CASE	O
REPORT	O
).	O

By	O
the	O
mentioned	O
case	O
there	O
is	O
sepsis	B-SPEC
-	O
induced	O
polyorganic	O
insufficiency	O
with	O
underlying	O
severe	O
somatic	O
pathological	O
condition	O
,	O
with	O
violation	O
of	O
hemodynamics	O
.	O

ABSTRACT	O
:	O
Species	B-SPEC
within	O
the	O
Neoromicia	B-SPEC
bat	B-SPEC
genus	B-SPEC
are	O
abundant	O
and	O
widely	O
distributed	O
in	O
Africa	O
.	O

The	O
new	O
genome	O
shared	O
97	O
.	O
2	O
%	O
overall	O
nucleotide	O
identity	O
to	O
a	O
previous	O
Neoromicia	B-SPEC
-	O
associated	O
MERS	O
-	O
related	O
virus	B-SPEC
,	O
also	O
from	O
South	O
Africa	O
.	O

ABSTRACT	O
:	O
Acute	O
lung	O
injury	O
(	O
ALI	O
)	O
and	O
its	O
severe	O
form	O
,	O
known	O
as	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
),	O
are	O
caused	O
by	O
direct	O
pulmonary	O
insults	O
and	O
indirect	O
systemic	O
inflammatory	O
responses	O
that	O
result	O
from	O
conditions	O
such	O
as	O
sepsis	B-SPEC
,	O
trauma	O
,	O
and	O
major	O
surgery	O
.	O

TITLE	O
:	O
Identification	O
of	O
enteric	O
viruses	B-SPEC
circulating	O
in	O
a	O
dog	B-SPEC
population	O
with	O
low	O
vaccine	O
coverage	O
.	O

There	O
is	O
a	O
large	O
population	O
of	O
nonimmunized	O
dogs	B-SPEC
and	O
few	O
studies	O
about	O
the	O
identification	O
of	O
the	O
viruses	B-SPEC
associated	O
with	O
diarrhea	O
.	O

To	O
address	O
this	O
situation	O
,	O
stool	O
samples	O
from	O
325	O
dogs	B-SPEC
were	O
analyzed	O
by	O
polymerase	O
chain	O
reaction	O
for	O
the	O
detection	O
of	O
common	O
enteric	O
viruses	B-SPEC
such	O
as	O
Canine	B-SPEC
adenovirus	I-SPEC
(	O
CAdV	O
),	O
Canine	O
coronavirus	B-SPEC
(	O
CCoV	O
),	O
Canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
Canine	O
rotavirus	B-SPEC
(	O
CRV	O
)	O
and	O
Carnivorous	O
protoparvovirus	O
1	O
(	O
canine	O
parvovirus	B-SPEC
2	O
;	O
CPV	B-SPEC
-	O
2	O
).	O

Mice	B-SPEC
subjected	O
to	O
VILI	O
after	O
HCl	O
or	O
LPS	O
instillation	O
displayed	O
augmented	O
lung	O
injury	O
,	O
compared	O
to	O
singular	O
lung	O
injury	O
.	O

TITLE	O
:	O
Therapeutic	O
potentials	O
of	O
Houttuynia	B-SPEC
cordata	I-SPEC
Thunb	O
.	O

H	B-SPEC
.	I-SPEC
cordata	I-SPEC
extracts	O
and	O
its	O
bioactive	O
molecules	O
were	O
shown	O
to	O
have	O
both	O
anti	O
-	O
inflammatory	O
and	O
anti	O
-	O
oxidative	O
properties	O
.	O

In	O
this	O
study	O
,	O
we	O
provide	O
an	O
overview	O
of	O
surveillance	O
components	O
for	O
the	O
two	O
diseases	O
in	O
Ontario	O
(	O
Canada	O
),	O
as	O
well	O
as	O
PEDV	B-SPEC
and	O
PDCoV	O
incidence	O
and	O
prevalence	O
measures	O
.	O

ABSTRACT	O
:	O
Singapore	O
remains	O
vulnerable	O
to	O
worldwide	O
epidemics	O
due	O
to	O
high	O
air	O
traffic	O
with	O
other	O
countries	O
This	O
study	O
aims	O
to	O
measure	O
the	O
public	O
'	O
s	O
awareness	O
of	O
the	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
and	O
Avian	B-SPEC
Influenza	O
A	O
(	O
H7N9	O
),	O
identify	O
population	O
groups	O
who	O
are	O
uninformed	O
or	O
misinformed	O
about	O
the	O
diseases	O
,	O
understand	O
their	O
choice	O
of	O
outbreak	O
information	O
source	O
,	O
and	O
assess	O
the	O
effectiveness	O
of	O
communication	O
channels	O
in	O
Singapore	O
.	O

TITLE	O
:	O
Severe	O
Plasmodium	B-SPEC
ovale	I-SPEC
malaria	O
complicated	O
by	O
acute	O
respiratory	O
distress	O
syndrome	O
in	O
a	O
young	O
Caucasian	O
man	B-SPEC
.	O

ABSTRACT	O
:	O
Although	O
Plasmodium	B-SPEC
ovale	I-SPEC
is	O
considered	O
the	O
cause	O
of	O
only	O
mild	O
malaria	O
,	O
a	O
case	O
of	O
severe	O
malaria	O
due	O
to	O
P	B-SPEC
.	I-SPEC
ovale	I-SPEC
with	O
acute	O
respiratory	O
distress	O
syndrome	O
is	O
reported	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
Deltacoronavirus	O
Engages	O
the	O
Transmissible	O
Gastroenteritis	O
Virus	B-SPEC
Functional	O
Receptor	O
Porcine	B-SPEC
Aminopeptidase	O
N	O
for	O
Infectious	O
Cellular	O
Entry	O
.	O

The	O
fourth	O
CoV	O
genus	B-SPEC
,	O

Although	O
Ark	O
-	O
type	O
viruses	B-SPEC
are	O
not	O
widespread	O
in	O
China	O
,	O
surveillance	O
and	O
updating	O
the	O
currently	O
applied	O
vaccination	O
strategy	O
for	O
sound	O
protection	O
against	O
IBV	B-SPEC
disease	O
are	O
important	O
because	O
this	O
type	O
of	O
virus	B-SPEC
has	O
caused	O
heavy	O
economic	O
losses	O
in	O
the	O
United	O
States	O
.	O

In	O
addition	O
,	O
its	O
infection	O
leads	O
to	O
reduced	O
fertility	O
and	O
hatchability	O
in	O
layer	O
birds	B-SPEC
.	O

Staphylococcal	O
protein	O
A	O
and	O
rabbit	B-SPEC
anti	O
-	O
N	O
protein	O
IgG	O
were	O
blotted	O
on	O
a	O
nitrocellulose	O
membrane	O
for	O
the	O
test	O
and	O
control	O
lines	O
,	O
respectively	O
.	O

ABSTRACT	O
:	O
Research	O
evidence	O
exists	O
that	O
poor	O
prognosis	O
is	O
common	O
in	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
patients	O
.	O

We	O
used	O
in	O
vitro	O
model	O
systems	O
,	O
a	O
mouse	B-SPEC
model	O
of	O
ARDS	O
,	O
and	O
samples	O
from	O
patients	O
with	O
acute	O
bronchiolitis	O
.	O

Methyl	O
-	O
β	O
-	O
cyclodextrin	O
(	O
MβCD	O
)	O
restored	O
surfactant	O
function	O
to	O
normal	O
in	O
both	O
human	B-SPEC
and	O
animal	B-SPEC
samples	O
.	O

TITLE	O
:	O
Contribution	O
of	O
porcine	B-SPEC
aminopeptidase	O
N	O
to	O
porcine	B-SPEC
deltacoronavirus	O
infection	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
),	O
a	O
member	O
of	O
genus	B-SPEC
Deltacoronavirus	O
,	O
is	O
an	O
emerging	O
swine	B-SPEC
enteropathogenic	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

To	O
elucidate	O
the	O
viral	O
diversity	O
of	O
Cameroonian	O
fruit	O
bats	B-SPEC
,	O
we	O
collected	O
and	O
metagenomically	O
screened	O
eighty	O
-	O
seven	O
fecal	O
samples	O
of	O

TITLE	O
:	O
A	O
novel	O
mechanism	O
of	O
RNase	O
L	O
inhibition	O
:	O
Theiler	O
'	O
s	O
virus	B-SPEC
L	O
*	O
protein	O
prevents	O
2	O
-	O
5A	O
from	O
binding	O
to	O
RNase	O
L	O
.	O
ABSTRACT	O
:	O
The	O
OAS	O
/	O
RNase	O
L	O
pathway	O
is	O
one	O
of	O
the	O
best	O
-	O
characterized	O
effector	O
pathways	O
of	O
the	O
IFN	O
antiviral	O
response	O
.	O

TITLE	O
:	O
Detection	O
and	O
characterisation	O
of	O
coronaviruses	O
in	O
migratory	O
and	O
non	O
-	O
migratory	O
Australian	O
wild	O
birds	B-SPEC
.	O

The	O
detection	O
rate	O
of	O
coronaviruses	O
was	O
improved	O
by	O
using	O
multiple	O
PCR	O
assays	O
,	O
as	O
no	O
single	O
assay	O
could	O
detect	O
all	O
coronavirus	B-SPEC
positive	O
samples	O
.	O

Sequencing	O
of	O
the	O
relatively	O
conserved	O
Orf1	O
PCR	O
amplicons	O
found	O
that	O
Australian	O
duck	B-SPEC
gammacoronaviruses	O
were	O
similar	O
to	O
duck	B-SPEC
gammacoronaviruses	O
around	O
the	O
world	O
.	O

Deltacoronavirus	O
sequences	O
from	O
shorebirds	B-SPEC
formed	O
a	O
lineage	O
with	O
a	O
deltacoronavirus	O
from	O
a	O
ruddy	B-SPEC
turnstone	I-SPEC
detected	O
in	O
the	O
United	O
States	O
.	O

ABSTRACT	O
:	O
APOBEC3	O
family	B-SPEC
members	O
are	O
cytidine	O
deaminases	O
with	O
roles	O
in	O
intrinsic	O
responses	O
to	O
infection	O
by	O
retroviruses	B-SPEC
and	O
retrotransposons	O
,	O
and	O
in	O
the	O
control	O
of	O
other	O
DNA	O
viruses	B-SPEC
,	O
such	O
as	O
herpesviruses	B-SPEC
,	O
parvoviruses	B-SPEC
and	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
.	O

Here	O
,	O
we	O
investigated	O
APOBEC3	O
-	O
mediated	O
restriction	O
of	O
Coronaviridae	B-SPEC
.	O

A	O
national	O
,	O
multicenter	O
,	O
point	O
-	O
prevalence	O
study	O
was	O
conducted	O
to	O
determine	O
the	O
prevalence	O
,	O
causative	O
microorganisms	O
,	O
and	O
outcome	O
of	O
sepsis	B-SPEC
in	O
intensive	O
care	O
units	O
(	O
ICUs	O
)	O
in	O
Turkey	B-SPEC
.	O

The	O
various	O
factors	O
associated	O
with	O
the	O
need	O
for	O
mechanical	O
ventilation	O
were	O
partial	O
pressure	O
of	O
oxygen	O
:	O
fraction	O
of	O
inspired	O
oxygen	O
ratio	O
<	O
150	O
,	O
quick	O
sequential	O
(	O
sepsis	B-SPEC
-	O
related	O
)	O
organ	O
failure	O
assessment	O
(	O
qSOFA	O
)	O
>	O
2	O
,	O
and	O
early	O
bacterial	O
coinfection	O
.	O

Mice	B-SPEC
are	O
commonly	O
used	O
to	O
model	O
these	O
diseases	O
,	O
dictating	O
an	O
increasingly	O
high	O
demand	O
for	O
murine	B-SPEC
ECs	O
isolation	O
and	O
culture	O
.	O

HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
was	O
the	O
most	O
frequent	O
virus	B-SPEC
detected	O
6	O
days	O
following	O
symptom	O
onset	O
(	O
8	O
.	O
9	O
%),	O
followed	O
by	O
rhinovirus	B-SPEC
(	O
6	O
.	O
7	O
%).	O

TITLE	O
:	O
Unusual	O
presentation	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
leading	O
to	O
a	O
large	O
outbreak	O
in	O
Riyadh	O
during	O
2017	O
.	O

One	O
hundred	O
seventy	O
one	O
(	O
171	O
)	O
serum	O
samples	O
were	O
collected	O
from	O
healthy	O
dromedary	B-SPEC
camels	B-SPEC
with	O
different	O
ages	O
and	O
genders	O
in	O
Tabuk	O
city	O
and	O
tested	O
for	O
specific	O
serum	O
IgG	O
by	O
ELISA	O
using	O
the	O
receptor	O
-	O
binding	O
S1	O
subunits	O
of	O
spike	O
proteins	O
of	O
MERS	O
-	O
CoV	O
.	O
144	O
(	O
84	O
,	O
21	O
%)	O
of	O
the	O
total	O
camel	B-SPEC
sera	O
shown	O
the	O
presence	O
of	O
protein	O
-	O
specific	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
.	O
These	O
results	O
may	O
provide	O
evidence	O
that	O
MERS	O
-	O
CoV	O
has	O
previously	O
infected	O
dromedary	B-SPEC
camels	B-SPEC
in	O
Tabuk	O
and	O
may	O
support	O
the	O
possible	O
role	O
of	O
camels	B-SPEC
in	O
the	O
human	B-SPEC
infection	O
.	O

TITLE	O
:	O
Clinical	O
outcomes	O
of	O
current	O
medical	O
approaches	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
:	O
A	O
systematic	O
review	O
and	O
meta	B-SPEC
-	O
analysis	O
.	O

The	O
role	O
of	O
S100A12	O
in	O
parasite	O
and	O
viral	O
infections	O
is	O
also	O
difficult	O
to	O
study	O
in	O
traditional	O
animal	B-SPEC
models	O
due	O
to	O
the	O
lack	O
of	O
S100A12	O
expression	O
in	O
rodents	B-SPEC
.	O

The	O
results	O
of	O
logistic	O
regression	O
analyses	O
showed	O
that	O
age	O
,	O
urolithiasis	O
,	O
hyperuricemia	O
,	O
coronary	O
artery	O
disease	O
,	O
thiazide	O
drugs	O
intake	O
,	O
family	B-SPEC
history	O
of	O
diabetes	O
and	O
hypertension	O
were	O
all	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
metabolic	O
syndrome	O
(	O
OR	O
>	O
1	O
).	O

The	O
individual	O
risk	O
of	O
infection	O
over	O
the	O
6	O
-	O
month	O
period	O
was	O
93	O
.	O
4	O
%,	O
80	O
.	O
1	O
%,	O
71	O
.	O
6	O
%,	O
61	O
.	O
5	O
%,	O
and	O
37	O
.	O
1	O
%	O
for	O
any	O
virus	B-SPEC
,	O
RV	O
,	O
HCoV	O
,	O
AdV	O
,	O
and	O
RSV	B-SPEC
,	O
respectively	O
.	O

TITLE	O
:	O
Discovery	O
of	O
Novel	O
Bat	B-SPEC
Coronaviruses	O
in	O
South	O
China	O
That	O
Use	O
the	O
Same	O
Receptor	O
as	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

TITLE	O
:	O
A	O
systematic	O
review	O
of	O
emerging	O
respiratory	O
viruses	B-SPEC
at	O
the	O
Hajj	O
and	O
possible	O
coinfection	O
with	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
.	O

The	O
retrieved	O
articles	O
were	O
summarized	O
based	O
on	O
the	O
methodology	O
of	O
testing	O
for	O
these	O
viruses	B-SPEC
.	O

Influenza	O
,	O
rhinovirus	B-SPEC
and	O
parainfluenza	O
were	O
the	O
most	O
common	O
viruses	B-SPEC
detected	O
among	O
pilgrims	O
.	O

However	O
,	O
the	O
spread	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDv	B-SPEC
)	O
in	O
U	O
.	O
S	O
.	O
swine	B-SPEC
represents	O
one	O
of	O
the	O
best	O
documented	O
emergences	O
of	O
a	O
highly	O
infectious	O
pathogen	O
in	O
the	O
U	O
.	O
S	O
.	O
livestock	O
industry	O
,	O
providing	O
an	O
opportunity	O
to	O
parameterize	O
models	O
of	O
pathogen	O
spread	O
via	O
direct	O
and	O
indirect	O
transmission	O
mechanisms	O
in	O
swine	B-SPEC
.	O

By	O
modifying	O
the	O
likelihood	O
of	O
each	O
transmission	O
mechanism	O
and	O
fitting	O
this	O
model	O
to	O
observed	O
epidemiological	O
dynamics	O
,	O
our	O
results	O
suggest	O
that	O
between	O
-	O
farm	O
transmission	O
was	O
primarily	O
driven	O
by	O
direct	O
mechanisms	O
related	O
to	O
animal	B-SPEC
movement	O
and	O
indirect	O
mechanisms	O
related	O
to	O
local	O
spatial	O
spread	O
based	O
on	O
geographic	O
proximity	O
.	O

However	O
,	O
other	O
forms	O
of	O
indirect	O
transmission	O
among	O
farms	O
,	O
including	O
contact	O
via	O
contaminated	O
vehicles	O
and	O
feed	O
,	O
were	O
responsible	O
for	O
high	O
consequence	O
transmission	O
events	O
resulting	O
in	O
the	O
introduction	O
of	O
the	O
virus	B-SPEC
into	O
new	O
geographic	O
areas	O
.	O

TITLE	O
:	O
A	O
multiplex	O
PCR	O
method	O
for	O
the	O
simultaneous	O
detection	O
of	O
three	O
viruses	B-SPEC
associated	O
with	O
canine	O
viral	O
enteric	O
infections	O
.	O

The	O
specificity	O
of	O
the	O
mPCR	O
results	O
showed	O
no	O
amplification	O
of	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
(	O
CPIV	O
),	O
or	O
pseudorabies	B-SPEC
virus	I-SPEC
(	O
PRV	B-SPEC
),	O
indicating	O
that	O
the	O
method	O
had	O
good	O
specificity	O
.	O

Bat	B-SPEC
-	O
Origin	O
Coronaviruses	O
Expand	O
Their	O
Host	O
Range	O
to	O
Pigs	B-SPEC
.	O

Up	O
to	O
50	O
%	O
of	O
MERS	O
-	O
CoV	O
cases	O
in	O
Saudi	O
Arabia	O
have	O
been	O
classified	O
as	O
secondary	O
,	O
occurring	O
from	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
through	O
contact	O
with	O
asymptomatic	O
or	O
symptomatic	O
individuals	O
infected	O
with	O
MERS	O
-	O
CoV	O
.	O
Hospital	O
outbreaks	O
of	O
MERS	O
-	O
CoV	O
are	O
a	O
hallmark	O
of	O
MERS	O
-	O
CoV	O
infection	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
cryo	O
-	O
EM	O
structure	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
coronavirus	B-SPEC
(	O
IBV	B-SPEC
)	O
spike	O
protein	O
from	O
the	O
γ	O
-	O
genus	B-SPEC
.	O

While	O
IBV	B-SPEC
S2	O
is	O
structurally	O
similar	O
to	O
those	O
from	O
the	O
other	O
genera	O
,	O
IBV	B-SPEC
S1	O
possesses	O
structural	O
features	O
that	O
are	O
unique	O
to	O
different	O
other	O
genera	O
,	O
thereby	O
bridging	O
these	O
diverse	O
spikes	O
into	O
an	O
evolutionary	O
spectrum	O
.	O

This	O
study	O
has	O
provided	O
insight	O
into	O
the	O
evolutionary	O
relationships	O
among	O
coronavirus	B-SPEC
spikes	O
and	O
deepened	O
our	O
understanding	O
of	O
their	O
structural	O
and	O
functional	O
diversity	O
.	O

ABSTRACT	O
:	O
To	O
study	O
the	O
roles	O
of	O
hypervariable	O
regions	O
(	O
HVRs	O
)	O
in	O
receptor	O
-	O
binding	O
subunit	O
S1	O
of	O
the	O
spike	O
protein	O
,	O
we	O
manipulated	O
the	O
genome	O
of	O
the	O
IBV	B-SPEC
Beaudette	O
strain	O
using	O
a	O
reverse	O
genetics	O
system	O
to	O
construct	O
seven	O
recombinant	O
strains	O
by	O
separately	O
or	O
simultaneously	O
replacing	O
the	O
three	O
HVRs	O
of	O
the	O
Beaudette	O
strain	O
with	O
the	O
corresponding	O
fragments	O
from	O
a	O
QX	O
-	O
like	O
nephropathogenic	O
isolate	O
ck	O
/	O
CH	O
/	O
LDL	O
/	O
091022	O
from	O
China	O
.	O

Presence	O
of	O
macroscopic	O
debris	O
in	O
the	O
EPD	O
was	O
recorded	O
and	O
graded	O
as	O
minor	O
(	O
minimal	O
debris	O
)	O
or	O
major	O
(	O
large	O
thrombus	B-SPEC
or	O
plaque	O
).	O

While	O
some	O
viruses	B-SPEC
simply	O
cause	O
symptoms	O
of	O
the	O
common	O
cold	O
,	O
many	O
respiratory	O
viruses	B-SPEC
induce	O
severe	O
bronchiolitis	O
,	O
pneumonia	O
,	O
and	O
even	O
death	O
following	O
infection	O
.	O

Despite	O
the	O
immense	O
clinical	O
burden	O
,	O
the	O
majority	O
of	O
the	O
most	O
common	O
pulmonary	O
viruses	B-SPEC
lack	O
long	O
-	O
lasting	O
efficacious	O
vaccines	O
.	O

We	O
screened	O
case	O
records	O
of	O
all	O
children	O
aged	O
1	O
month	O
to	O
17	O
years	O
of	O
age	O
admitted	O
to	O
the	O
Pediatric	O
Intensive	O
Care	O
Unit	O
(	O
PICU	B-SPEC
)	O
over	O
a	O
3	O
-	O
year	O
period	O
(	O
2015	O
-	O
2017	O
)	O
for	O
presence	O
of	O
any	O
respiratory	O
difficulty	O
at	O
admission	O
or	O
during	O
PICU	B-SPEC
stay	O
.	O

ABSTRACT	O
:	O
During	O
the	O
last	O
two	O
decades	O
,	O
scientists	O
have	O
grown	O
increasingly	O
aware	O
that	O
viruses	B-SPEC
are	O
emerging	O
from	O
the	O
human	B-SPEC
-	O
animal	B-SPEC
interface	O
.	O

In	O
particular	O
,	O
respiratory	O
infections	O
are	O
problematic	O
;	O
in	O
early	O
2003	O
,	O
World	O
Health	O
Organization	O
issued	O
a	O
worldwide	O
alert	O
for	O
a	O
previously	O
unrecognized	O
illness	O
that	O
was	O
subsequently	O
found	O
to	O
be	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
[	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
virus	B-SPEC
].	O

A	O
total	O
of	O
114	O
faecal	O
samples	O
from	O
beef	O
and	O
dairy	O
calves	O
with	O
or	O
without	O
clinical	O
symptoms	O
of	O
diarrhoea	O
from	O
five	O
Brazilian	O
states	O
(	O
São	O
Paulo	O
,	O
Minas	O
Gerais	O
,	O
Santa	O
Catarina	O
,	O
Mato	O
Grosso	O
and	O
Bahia	B-SPEC
)	O
were	O
evaluated	O
between	O
2008	O
and	O
2015	O
by	O
technique	O
of	O
Semi	O
-	O
nested	O
RT	O
-	O
PCR	O
for	O
gene	O
N	O
and	O
genealogical	O
analysis	O
.	O

TITLE	O
:	O
Lectin	O
Affinity	O
Plasmapheresis	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
-	O
Coronavirus	B-SPEC
and	O
Marburg	B-SPEC
Virus	I-SPEC
Glycoprotein	O
Elimination	O
.	O

Tests	O
were	O
carried	O
out	O
on	O
the	O
feline	B-SPEC
calicivirus	I-SPEC
(	O
FCV	B-SPEC
)	O
vaccine	O
strain	O
F9	O
,	O
which	O
is	O
a	O
surrogate	O
of	O
airborne	O
pathogen	O
human	B-SPEC
norovirus	B-SPEC
.	O

TITLE	O
:	O
Evaluation	O
of	O
full	O
S1	O
gene	O
sequencing	O
of	O
classical	O
and	O
variant	O
infectious	O
bronchitis	O
viruses	B-SPEC
extracted	O
from	O
allantoic	O
fluid	O
and	O
FTA	O
cards	O
.	O

We	O
hypothesized	O
that	O
ARDS	O
in	O
children	O
with	O
HMP	O
was	O
similar	O
in	O
incidence	O
,	O
risk	O
factors	O
,	O
clinical	O
course	O
,	O
and	O
outcomes	O
to	O
ARDS	O
in	O
children	O
with	O
RSV	B-SPEC
.	O

Patients	O
included	O
were	O
<	O
18	O
years	O
old	O
with	O
HMP	O
or	O
RSV	B-SPEC
detected	O
from	O
nasopharyngeal	O
specimens	O
by	O
commercial	O
reverse	O
transcriptase	O
polymerase	O
chain	O
reaction	O
assay	O
admitted	O
to	O
a	O
study	O
site	O
.	O

Children	O
with	O
either	O
virus	B-SPEC
and	O
a	O
neurologic	O
comorbidity	O
or	O
an	O
increased	O
PIM	O
3	O
probability	O
of	O
mortality	O
were	O
at	O
increased	O
risk	O
for	O
PARDS	O
.	O

However	O
,	O
members	O
of	O
this	O
family	B-SPEC
recognize	O
different	O
cellular	O
receptors	O
and	O
exploit	O
different	O
entry	O
routes	O
,	O
what	O
affects	O
their	O
species	B-SPEC
specificity	O
and	O
virulence	O
.	O

Repeat	O
infections	O
by	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
were	O
not	O
accompanied	O
by	O
detectable	O
genotype	O
switching	O
.	O

DTI	O
parameters	O
were	O
correlated	O
with	O
clinical	O
variables	O
(	O
age	O
,	O
CD4	O
DTI	O
quantified	O
diffusion	O
alterations	O
in	O
the	O
corpus	O
callosum	O
and	O
corona	B-SPEC
radiata	O
(	O
MD	O
increased	O
significantly	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
chronic	O
axonal	O
injury	O
in	O
the	O
corpus	O
callosum	O
,	O
corona	B-SPEC
radiata	O
,	O
internal	O
capsule	O
,	O
external	O
capsule	O
,	O
posterior	O
thalamic	O
radiation	O
,	O
sagittal	O
stratum	O
,	O
and	O
superior	O
longitudinal	O
fasciculus	O
(	O
AD	O
increased	O
significantly	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
continues	O
to	O
cause	O
serious	O
economic	O
losses	O
in	O
global	O
chicken	B-SPEC
production	O
.	O

Viral	O
antigen	O
detection	O
and	O
microbiome	O
analyses	O
of	O
oral	O
swab	O
and	O
nasopharyngeal	O
aspirate	O
specimens	O
verified	O
an	O
RSV	B-SPEC
infection	O
,	O
while	O
bacterial	O
culture	O
of	O
blood	O
specimens	O
yielded	O
negative	O
results	O
.	O

The	O
RSV	B-SPEC
strain	O
detected	O
in	O
this	O
patient	O
was	O
subtyped	O
as	O
RSVB9	O
,	O
and	O
no	O
mutation	O
was	O
found	O
in	O
the	O
six	O
antigenic	O
sites	O
for	O
targeted	O
drugs	O
or	O
vaccines	O
.	O

Second	O
,	O
to	O
help	O
radiologists	O
differentiate	O
viral	O
infections	O
,	O
viruses	B-SPEC
in	O
the	O
same	O
viridae	B-SPEC
that	O
have	O
similar	O
pathogenesis	O
and	O
can	O
have	O
similar	O
imaging	O
characteristics	O
are	O
shown	O
.	O

TITLE	O
:	O
Development	O
of	O
fluorescent	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
RT	O
-	O
LAMP	O
)	O
using	O
quenching	O
probes	O
for	O
the	O
detection	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
[	O
Role	O
of	O
noninvasive	O
mechanical	O
ventilation	O
in	O
patients	O
with	O
severe	O
avian	B-SPEC
influenza	O
A	O
(	O
H7N9	O
)	O
complicated	O
with	O
acute	O
respiratory	O
distress	O
syndrome	O
].	O

A	O
patient	O
,	O
suffered	O
from	O
severe	O
avian	B-SPEC
influenza	O
A	O
(	O
H7N9	O
)	O
and	O
complicated	O
with	O
ARDS	O
,	O
was	O
admitted	O
to	O
the	O
Second	O
Affiliated	O
Hospital	O
of	O
Guizhou	O
Medical	O
University	O
in	O
January	O
2017	O
.	O

Considering	O
the	O
low	O
priority	O
of	O
health	O
policies	O
since	O
the	O
economic	O
reform	O
,	O
the	O
limitation	O
of	O
the	O
""""	O
third	O
sector	O
""""	O
activity	O
permitted	O
in	O
authoritarian	O
China	O
,	O
together	O
with	O
the	O
political	O
sensitivity	O
of	O
the	O
HIV	B-SPEC
/	O
AIDS	O
problem	O
in	O
the	O
country	O
,	O
this	O
article	O
aims	O
to	O
explain	O
the	O
proliferation	O
of	O
HIV	B-SPEC
/	O
AIDS	O
-	O
focused	O
NGOs	O
in	O
China	O
with	O
the	O
usage	O
of	O
the	O
securitization	O
framework	O
in	O
the	O
field	O
of	O
international	O
relations	O
(	O
IR	O
).	O

Such	O
restriction	O
on	O
the	O
concerted	O
efforts	O
of	O
HIV	B-SPEC
/	O
AIDS	O
-	O
related	O
NGOs	O
in	O
China	O
would	O
make	O
achievement	O
of	O
the	O
Sustainable	O
Development	O
Goals	O
(	O
SDGs	O
)	O
to	O
foster	O
stronger	O
partnerships	O
between	O
the	O
government	O
and	O
civil	O
society	O
difficult	O
,	O
which	O
in	O
turn	O
hindering	O
the	O
realization	O
of	O
ending	O
HIV	B-SPEC
/	O
AIDS	O
in	O
the	O
world	O
by	O
2030	O
.	O

However	O
,	O
how	O
the	O
virus	B-SPEC
-	O
induced	O
ER	O
stress	O
influences	O
coronavirus	B-SPEC
replication	O
and	O
pathogenesis	O
remains	O
controversial	O
.	O

Four	O
novel	O
deltacoronaviruses	O
were	O
detected	O
from	O
eight	O
birds	B-SPEC
of	O
four	O
species	B-SPEC
by	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
):	O
FalCoV	O
UAE	O
-	O
HKU27	O
from	O
a	O
falcon	O
,	O
HouCoV	O
UAE	O
-	O
HKU28	O
from	O
a	O
houbara	O
bustard	O
,	O
PiCoV	O
UAE	O
-	O
HKU29	O
from	O
a	O
pigeon	B-SPEC
,	O
and	O
QuaCoV	O
UAE	O
-	O
HKU30	O
from	O
five	O
quails	O
.	O

Unsupervised	O
CyTOF	O
analysis	O
of	O
alveolar	O
leukocytes	O
from	O
human	B-SPEC
subjects	O
has	O
potential	O
to	O
identify	O
expected	O
and	O
potentially	O
novel	O
myeloid	O
populations	O
that	O
may	O
be	O
linked	O
with	O
clinical	O
outcomes	O
.	O

In	O
the	O
present	O
study	O
,	O
FCoVs	O
were	O
analyzed	O
for	O
the	O
frequency	O
and	O
location	O
of	O
mutations	O
in	O
the	O
S	O
and	O
3c	O
genes	O
from	O
faecal	O
samples	O
of	O
cats	B-SPEC
in	O
an	O
animal	B-SPEC
shelter	O
and	O
the	O
faeces	O
,	O
effusions	O
,	O
and	O
tissues	O
of	O
cats	B-SPEC
that	O
were	O
referred	O
to	O
veterinary	O
hospitals	O
.	O

It	O
was	O
also	O
suggested	O
that	O
mutational	O
analysis	O
of	O
the	O
3c	O
gene	O
could	O
be	O
useful	O
for	O
studying	O
the	O
horizontal	O
transmission	O
of	O
FCoVs	O
in	O
multi	O
-	O
cat	B-SPEC
environments	O
.	O

Over	O
75	O
%	O
of	O
EIDs	O
affecting	O
humans	B-SPEC
are	O
,	O
or	O
were	O
originally	O
,	O
zoonoses	O
(	O
infectious	O
diseases	O
transmitted	O
from	O
animals	B-SPEC
to	O
humans	B-SPEC
).	O

As	O
there	O
are	O
few	O
readily	O
available	O
animal	B-SPEC
models	O
that	O
accurately	O
mimic	O
human	B-SPEC
disease	O
,	O
it	O
has	O
been	O
a	O
challenge	O
to	O
ethically	O
determine	O
what	O
optimum	O
treatment	O
strategies	O
can	O
be	O
used	O
for	O
this	O
disease	O
.	O

We	O
used	O
in	O
-	O
vitro	O
and	O
human	B-SPEC
ex	O
-	O
vivo	O
explant	O
cultures	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
immunomodulatory	O
agents	O
,	O
interferon	O
alpha	O
and	O
cyclosporine	O
,	O
singly	O
and	O
in	O
combination	O
,	O
on	O
MERS	O
-	O
CoV	O
replication	O
.	O

On	O
presentation	O
,	O
the	O
ferret	B-SPEC
was	O
thin	O
,	O
and	O
an	O
approximately	O
3	O
-	O
cm	O
mass	O
was	O
palpable	O
in	O
the	O
cranial	O
abdomen	O
.	O

We	O
determined	O
that	O
GS	O
-	O
441524	O
was	O
non	O
-	O
toxic	O
in	O
feline	B-SPEC
cells	O
at	O
concentrations	O
as	O
high	O
as	O
100	O
uM	O
and	O
effectively	O
inhibited	O
FIPV	O
replication	O
in	O
cultured	O
CRFK	O
cells	O
and	O
in	O
naturally	O
infected	O
feline	B-SPEC
peritoneal	O
macrophages	O
at	O
concentrations	O
as	O
low	O
as	O
1	O
uM	O
.	O
We	O
determined	O
the	O
pharmacokinetics	O
of	O
GS	O
-	O
441524	O
in	O
cats	B-SPEC
in	O
vivo	O
and	O
established	O
a	O
dosage	O
that	O
would	O
sustain	O
effective	O
blood	O
levels	O
for	O
24	O
h	O
.	O
In	O
an	O
experimental	O
FIPV	O
infection	O
of	O
cats	B-SPEC
,	O
GS	O
-	O
441524	O
treatment	O
caused	O
a	O
rapid	O
reversal	O
of	O
disease	O
signs	O
and	O
return	O
to	O
normality	O
with	O
as	O
little	O
as	O
two	O
weeks	O
of	O
treatment	O
in	O
10	O
/	O
10	O
cats	B-SPEC
and	O
with	O
no	O
apparent	O
toxicity	O
.	O

In	O
summary	O
,	O
feeding	O
anti	O
-	O
IL	O
-	O
10	O
antibodies	O
was	O
associated	O
with	O
increased	O
fecal	O
pH	O
,	O
reduced	O
risk	O
of	O
respiratory	O
disease	O
later	O
in	O
the	O
preweaning	O
period	O
,	O
and	O
decreased	O
antibiotic	O
usage	O
despite	O
higher	O
rotavirus	B-SPEC
infection	O
.	O

These	O
data	O
demonstrate	O
the	O
existence	O
of	O
persistent	O
infection	O
of	O
BCoV	O
in	O
the	O
respiratory	O
tissues	O
of	O
cattle	B-SPEC
.	O

A	O
virus	B-SPEC
missing	O
both	O
the	O
E	O
and	O
3a	O
proteins	O
was	O
not	O
viable	O
,	O
whereas	O
the	O
presence	O
of	O
either	O
protein	O
with	O
a	O
functional	O
PBM	O
restored	O
virus	B-SPEC
viability	O
.	O

Two	O
of	O
the	O
variants	O
are	O
similar	O
to	O
those	O
identified	O
in	O
Japan	O
:	O
one	O
contains	O
a	O
194	O
-	O
aa	O
deletion	O
,	O
the	O
same	O
as	O
PEDV	B-SPEC
variant	O
TTR	O
-	O
2	O
/	O
JPN	O
/	O
2014	O
,	O
while	O
the	O
other	O
contains	O
a	O
204	O
-	O
aa	O
deletion	O
,	O
the	O
same	O
as	O
PEDV	B-SPEC
variant	O
JKa	O
-	O
292	O
/	O
CS1de204	O
.	O

Two	O
new	O
S1	O
NTD	O
-	O
del	O
PEDV	B-SPEC
variants	O
were	O
found	O
:	O
one	O
contains	O
a	O
201	O
-	O
aa	O
deletion	O
located	O
at	O
residues	O
30	O
-	O
230	O
and	O
the	O
other	O
contains	O
a	O
202	O
-	O
aa	O
deletion	O
located	O
at	O
residues	O
24	O
-	O
225	O
of	O
the	O
S	O
protein	O
.	O

The	O
cyclopropylquinoline	O
derivative	O
IV	O
displayed	O
high	O
potency	O
towards	O
Rift	B-SPEC
Valley	I-SPEC
fever	I-SPEC
virus	I-SPEC
(	O
RVFV	B-SPEC
)	O
and	O
Tacaribe	B-SPEC
virus	I-SPEC
(	O
TCRV	O
)	O
towards	O
Rift	B-SPEC
Valley	I-SPEC
fever	I-SPEC
virus	I-SPEC
(	O
RVFV	B-SPEC
).	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
first	O
identified	O
in	O
Saudi	O
Arabia	O
,	O
is	O
an	O
emerging	O
zoonotic	O
pathogen	O
that	O
causes	O
severe	O
acute	O
respiratory	O
illness	O
in	O
humans	B-SPEC
with	O
a	O
high	O
fatality	O
rate	O
.	O

Several	O
important	O
pathogenic	O
mechanisms	O
common	O
for	O
various	O
hemorrhagic	O
fevers	O
were	O
studied	O
on	O
experimental	O
SHF	O
of	O
macaques	B-SPEC
.	O

This	O
model	O
is	O
uniquely	O
safe	O
and	O
adequate	O
for	O
the	O
assessment	O
of	O
therapy	O
of	O
hemorrhagic	O
fevers	O
dangerous	O
for	O
humans	B-SPEC
.	O

We	O
used	O
the	O
Human	B-SPEC
Genome	O
Diversity	O
Panel	O
to	O
identify	O
specific	O
populations	O
harboring	O
pathogen	O
-	O
interacting	O
genes	O
that	O
have	O
undergone	O
positive	O
selection	O
.	O

For	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
,	O
GWAS	O
demonstrate	O
that	O
some	O
naturally	O
selected	O
variants	O
in	O
the	O
host	O
-	O
pathogen	O
protein	O
interaction	O
networks	O
continue	O
to	O
have	O
functional	O
consequences	O
for	O
susceptibility	O
to	O
these	O
pathogens	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
through	O
p53	O
-	O
dependent	O
pathway	O
causes	O
cell	O
cycle	O
arrest	O
in	O
the	O
G0	O
/	O
G1	O
phase	O
.	O

The	O
results	O
demonstrated	O
that	O
PEDV	B-SPEC
infection	O
induces	O
cell	O
cycle	O
arrest	O
at	O
G0	O
/	O
G1	O
phase	O
in	O
Vero	O
cells	O
,	O
while	O
UV	O
-	O
inactivated	O
PEDV	B-SPEC
does	O
not	O
cause	O
cell	O
cycle	O
arrest	O
.	O

In	O
addition	O
,	O
PEDV	B-SPEC
infection	O
of	O
the	O
cells	O
synchronized	O
in	O
various	O
stages	O
of	O
cell	O
cycle	O
showed	O
that	O
viral	O
subgenomic	O
RNA	O
and	O
virus	B-SPEC
titer	O
were	O
higher	O
in	O
the	O
cells	O
released	O
from	O
G0	O
/	O
G1	O
phase	O
synchronized	O
cells	O
than	O
that	O
in	O
the	O
cells	O
released	O
from	O
the	O
G1	O
/	O
S	O
phase	O
and	O
G2	O
/	O
M	O
phase	O
synchronized	O
or	O
asynchronous	O
cells	O
after	O
18	O
h	O
p	O
.	O
i	O
..	O

The	O
results	O
showed	O
that	O
their	O
affinities	O
were	O
too	O
low	O
to	O
form	O
complexes	O
,	O
which	O
suggest	O
that	O
pAPN	O
may	O
be	O
controversial	O
as	O
the	O
genuine	O
receptor	O
for	O
PEDV	B-SPEC
.	O

An	O
independent	O
laboratory	O
tested	O
efficacy	O
against	O
Staphylococcus	B-SPEC
aureus	I-SPEC
,	O
Pseudomonas	B-SPEC
aeruginosa	I-SPEC
,	O
Vibrio	B-SPEC
cholerae	I-SPEC
,	O
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
.	O

Against	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
,	O
0	O
.	O
5	O
%	O
sodium	O
hypochlorite	O
alone	O
failed	O
disinfection	O
success	O
criteria	O
,	O
whereas	O
0	O
.	O
5	O
%	O
sodium	O
hypochlorite	O
with	O
color	O
additive	O
achieved	O
full	O
viral	O
inactivation	O
(≥	O
4	O
.	O
50	O
log	O
This	O
color	O
additive	O
can	O
be	O
combined	O
with	O
chlorine	O
disinfectants	O
without	O
adversely	O
affecting	O
antimicrobial	O
efficacy	O
or	O
skin	O
safety	O
.	O

Hydrophobic	O
residues	O
at	O
the	O
a	O
and	O
d	O
positions	O
of	O
HR	O
helices	B-SPEC
stabilize	O
the	O
whole	O
system	O
,	O
with	O
minimal	O
changes	O
in	O
RMSD	O
.	O

However	O
,	O
a	O
common	O
working	O
diagnosis	O
system	O
involves	O
identifying	O
PEDV	B-SPEC
-	O
infected	O
animals	B-SPEC
individually	O
,	O
which	O
is	O
a	O
costly	O
and	O
time	O
-	O
consuming	O
approach	O
.	O

Given	O
the	O
above	O
information	O
,	O
the	O
thrusts	O
of	O
this	O
study	O
were	O
to	O
develop	O
a	O
real	O
-	O
time	O
fluorescent	O
reverse	O
transcription	O
loop	O
-	O
mediated	O
isothermal	O
amplification	O
(	O
RtF	O
-	O
RT	O
-	O
LAMP	O
)	O
assay	O
and	O
establish	O
a	O
pooled	O
testing	O
system	O
using	O
faecal	O
sample	O
to	O
identify	O
PEDV	B-SPEC
-	O
infected	O
herd	O
.	O

In	O
the	O
age	O
-	O
group	O
(≥	O
2	O
,	O
<	O
5	O
),	O
Adv	O
predominated	O
with	O
37	O
/	O
147	O
samples	O
(	O
25	O
.	O
2	O
%),	O
followed	O
by	O
HRV	O
,	O
RSV	B-SPEC
,	O
coronavirus	B-SPEC
(	O
all	O
types	O
),	O
and	O
influenza	O
,	O
Hmpv	B-SPEC
and	O
PIV	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
a	O
highly	O
contagious	O
disease	O
,	O
and	O
hazardous	O
to	O
the	O
poultry	O
industry	O
.	O

The	O
100th	O
generation	O
of	O
CEK	O
-	O
adapted	O
strain	O
,	O
designated	O
SczyC100	O
,	O
was	O
safe	O
to	O
use	O
on	O
one	O
-	O
day	O
old	O
specific	O
pathogen	O
-	O
free	O
(	O
SPF	O
)	O
chicken	B-SPEC
as	O
determined	O
by	O
pathogenicity	O
and	O
virulence	O
reversion	O
test	O
.	O

In	O
the	O
present	O
meta	B-SPEC
-	O
analysis	O
,	O
we	O
examined	O
the	O
efficacy	O
of	O
statins	O
in	O
ALI	O
/	O
ARDS	O
patients	O
.	O

At	O
the	O
present	O
,	O
there	O
exists	O
no	O
specific	O
therapy	O
for	O
HEV	B-SPEC
.	O

The	O
natural	O
compound	O
silvestrol	O
has	O
a	O
potent	O
antiviral	O
effect	O
against	O
the	O
(-)-	O
strand	O
RNA	O
-	O
virus	B-SPEC
Ebola	B-SPEC
virus	I-SPEC
,	O
and	O
also	O
against	O
the	O
(+)-	O
strand	O
RNA	O
viruses	B-SPEC
Corona	B-SPEC
-,	O
Picorna	O
-,	O
and	O
Zika	B-SPEC
virus	I-SPEC
.	O

The	O
inhibitory	O
effect	O
on	O
virus	B-SPEC
spread	O
is	O
due	O
to	O
an	O
inhibition	O
of	O
the	O
DEAD	O
-	O
box	O
RNA	O
helicase	O
eIF4A	O
,	O
which	O
is	O
required	O
to	O
unwind	O
structured	O
5	O
'-	O
untranslated	O
regions	O
(	O
UTRs	O
).	O

This	O
goes	B-SPEC
along	O
with	O
a	O
strongly	O
reduced	O
HEV	B-SPEC
capsid	O
protein	O
translation	O
,	O
retention	O
of	O
viral	O
RNA	O
inside	O
the	O
cytoplasm	O
,	O
and	O
without	O
major	O
cytotoxic	O
effects	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronaviruses	O
(	O
CoVs	O
)	O
are	O
increasingly	O
recognized	O
as	O
important	O
respiratory	O
pathogens	O
associated	O
with	O
a	O
broad	O
range	O
of	O
clinical	O
diseases	O
.	O

TITLE	O
:	O
Metagenomics	O
detection	O
and	O
characterisation	O
of	O
viruses	B-SPEC
in	O
faecal	O
samples	O
from	O
Australian	O
wild	O
birds	B-SPEC
.	O

ABSTRACT	O
:	O
We	O
present	O
an	O
optimised	O
metagenomics	O
method	O
for	O
detection	O
and	O
characterisation	O
of	O
all	O
virus	B-SPEC
types	O
including	O
single	O
and	O
double	O
stranded	O
DNA	O
/	O
RNA	O
and	O
enveloped	O
and	O
non	O
-	O
enveloped	O
viruses	B-SPEC
.	O

We	O
then	O
present	O
a	O
detailed	O
analysis	O
of	O
selected	O
virus	B-SPEC
sequences	O
in	O
the	O
avian	B-SPEC
samples	O
that	O
were	O
somewhat	O
similar	O
to	O
known	O
viruses	B-SPEC
,	O
and	O
had	O
good	O
quality	O
(	O
Q20	O
or	O
higher	O
)	O
and	O
quantity	O
of	O
next	O
-	O
generation	O
sequencing	O
reads	O
,	O
and	O
was	O
of	O
interest	O
from	O
a	O
virological	O
point	O
of	O
view	O
,	O
for	O
example	O
,	O
avian	B-SPEC
coronavirus	I-SPEC
and	O
avian	B-SPEC
paramyxovirus	I-SPEC
6	I-SPEC
.	O

TITLE	O
:	O
First	O
detection	O
of	O
bovine	B-SPEC
noroviruses	B-SPEC
and	O
detection	O
of	O
bovine	B-SPEC
coronavirus	B-SPEC
in	O
Australian	O
dairy	O
cattle	B-SPEC
.	O

It	O
also	O
sought	O
to	O
determine	O
whether	O
bovine	B-SPEC
coronaviruses	O
,	O
also	O
associated	O
with	O
neonatal	O
enteritis	O
in	O
calves	O
,	O
could	O
be	O
detected	O
in	O
the	O
same	O
faecal	O
samples	O
.	O

To	O
detect	O
the	O
geographic	O
origin	O
and	O
timing	O
of	O
USA	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
isolates	O
,	O
we	O
conducted	O
a	O
retrospective	O
study	O
to	O
isolate	O
19	O
PEDV	B-SPEC
strains	O
from	O
positive	O
samples	O
obtained	O
prior	O
to	O
April	O
2013	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
causes	O
severe	O
diarrhea	O
and	O
high	O
mortality	O
in	O
newborn	O
piglets	O
.	O

APN	O
and	O
EGFR	O
synergistically	O
promote	O
TGEV	B-SPEC
invasion	O
.	O

Data	O
were	O
retrospectively	O
collected	O
on	O
children	O
aged	O
1	O
day	O
to	O
18	O
years	O
admitted	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
)	O
with	O
ARF	O
between	O
2010	O
and	O
2013	O
.	O

In	O
patients	O
with	O
ARF	O
and	O
AKI	O
,	O
AKI	O
is	O
associated	O
with	O
ARDS	O
and	O
longer	O
PICU	B-SPEC
and	O
hospital	O
length	O
of	O
stay	O
.	O

MucilAir	O
™,	O
a	O
human	B-SPEC
standardized	O
air	O
-	O
liquid	O
interface	O
3D	O
airway	O
epithelial	O
culture	O
holds	O
in	O
vitro	O
specific	O
mechanisms	O
to	O
counter	O
invaders	O
comparable	O
to	O
the	O
in	O
vivo	O
situation	O
,	O
such	O
as	O
mucus	O
production	O
,	O
mucociliary	O
clearance	O
,	O
and	O
secretion	O
of	O
defensive	O
molecules	O
.	O

In	O
addition	O
we	O
found	O
that	O
Rhinovirus	B-SPEC
B14	O
,	O
C15	O
and	O
influenza	O
A	O
(	O
H1N1	O
)	O
induce	O
significant	O
increase	O
of	O
β	O
Defensins	O
2	O
and	O
Cathelicidin	O
release	O
with	O
different	O
time	O
course	O
.	O

The	O
strain	O
ZYY	O
-	O
2014	O
inoculated	O
birds	B-SPEC
presented	O
typical	O
IBV	B-SPEC
clinical	O
signs	O
with	O
a	O
mortality	O
of	O
43	O
%,	O
while	O
the	O
attenuated	O
strain	O
ZYYR	O
-	O
2014	O
inoculated	O
birds	B-SPEC
remained	O
healthy	O
.	O

Vaccine	O
titers	O
were	O
compared	O
among	O
groups	O
and	O
within	O
the	O
same	O
group	O
among	O
a	O
10	O
-	O
bird	B-SPEC
pooled	O
sample	O
and	O
10	O
swabs	O
from	O
individually	O
sampled	O
birds	B-SPEC
.	O

Spine	O
magnetic	O
resonance	O
imaging	O
showed	O
abnormal	O
enhancement	O
of	O
the	O
conus	B-SPEC
medullaris	O
with	O
thick	O
enhanced	O
cauda	O
equina	O
nerve	O
roots	O
,	O
consistent	O
with	O
a	O
possible	O
case	O
of	O
Guillain	O
-	O
Barré	O
syndrome	O
.	O

In	O
clinical	O
practice	O
,	O
it	O
has	O
made	O
its	O
niche	O
almost	O
exclusively	O
for	O
the	O
treatment	O
of	O
the	O
hepatitisC	O
virus	B-SPEC
.	O

We	O
conducted	O
a	O
review	O
of	O
the	O
indications	O
of	O
the	O
main	O
drug	O
agencies	O
(	O
Spanish	O
,	O
European	O
and	O
American	O
)	O
and	O
other	O
possible	O
indications	O
,	O
mainly	O
haemorrhagic	O
fevers	O
and	O
coronavirus	B-SPEC
.	O

Information	O
on	O
respiratory	O
viruses	B-SPEC
in	O
non	O
-	O
severe	O
CAP	O
cases	O
is	O
scarce	O
.	O

To	O
estimate	O
the	O
frequency	O
of	O
respiratory	O
viruses	B-SPEC
among	O
non	O
-	O
severe	O
CAP	O
cases	O
.	O

Out	O
of	O
820	O
children	O
aged	O
2	O
-	O
59	O
months	O
with	O
non	O
-	O
severe	O
CAP	O
diagnosed	O
by	O
pediatricians	O
(	O
respiratory	O
complaints	O
and	O
radiographic	O
pulmonary	O
infiltrate	O
/	O
consolidation	O
),	O
recruited	O
in	O
a	O
clinical	O
trial	O
(	O
ClinicalTrials	O
.	O
gov	O
Identifier	O
NCT01200706	O
),	O
nasopharyngeal	O
aspirate	O
samples	O
were	O
obtained	O
from	O
774	O
(	O
94	O
.	O
4	O
%)	O
patients	O
and	O
tested	O
for	O
16	O
respiratory	O
viruses	B-SPEC
by	O
PCRs	O
.	O

The	O
most	O
frequent	O
combination	O
comprised	O
rhinovirus	B-SPEC
plus	O
adenovirus	B-SPEC
.	O

Conversely	O
,	O
rhinovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
bocavirus	B-SPEC
,	O
PIV2	O
,	O
PIV3	O
,	O
metapneumovirus	B-SPEC
,	O
coronavirus	B-SPEC
OC43	O
,	O
NL63	O
,	O
229E	O
were	O
significantly	O
more	O
frequent	O
among	O
cases	O
with	O
multiple	O
virus	B-SPEC
detection	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
degradation	O
,	O
subcellular	O
localisation	O
,	O
and	O
function	O
of	O
TGEV	B-SPEC
N	O
protein	O
by	O
examining	O
its	O
effects	O
on	O
cycle	O
progression	O
,	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
stress	O
,	O
interleukin	O
-	O
8	O
(	O
IL	O
-	O
8	O
)	O
expression	O
,	O
and	O
cell	O
survival	O
.	O

Evidence	O
for	O
the	O
circulation	O
of	O
MERS	O
-	O
CoV	O
in	O
dromedaries	B-SPEC
has	O
been	O
reported	O
from	O
almost	O
all	O
the	O
countries	O
of	O
the	O
Middle	O
East	O
,	O
except	O
Israel	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
a	O
pathogen	O
first	O
detected	O
in	O
US	O
domestic	O
swine	B-SPEC
in	O
2013	O
,	O
has	O
rapidly	O
spilled	O
over	O
into	O
feral	O
swine	B-SPEC
populations	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
histiocytic	O
sarcoma	O
(	O
HS	O
)	O
is	O
an	O
aggressive	O
and	O
uncommon	O
tumor	O
originating	O
from	O
dendritic	O
cells	O
/	O
macrophages	O
.	O

Here	O
,	O
a	O
feline	B-SPEC
HS	O
cell	O
line	O
,	O
FHS	O
-	O
1	O
,	O
was	O
established	O
from	O
a	O
case	O
of	O
feline	B-SPEC
HS	O
and	O
characterized	O
.	O

TITLE	O
:	O
Epitope	O
selection	O
and	O
their	O
placement	O
for	O
increased	O
virus	B-SPEC
neutralization	O
in	O
a	O
novel	O
vaccination	O
strategy	O
for	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
utilizing	O
the	O
Hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
core	O
antigen	O
.	O

Data	O
were	O
retrospectively	O
analyzed	O
from	O
patients	O
with	O
severe	O
sepsis	B-SPEC
and	O
septic	O
shock	O
receiving	O
non	O
-	O
cardiac	O
operation	O
and	O
admitted	O
to	O
Department	O
of	O
Critical	O
Care	O
Medicine	O
of	O
the	O
Second	O
Affiliated	O
Hospital	O
of	O
Kunming	O
Medical	O
University	O
from	O
January	O
1st	O
,	O
2013	O
to	O
December	O
31st	O
,	O
2015	O
.	O
The	O
patients	O
were	O
divided	O
into	O
the	O
senior	O
group	O
(≥	O
65	O
years	O
old	O
)	O
and	O
the	O
younger	O
group	O
(＜	O
65	O
years	O
old	O
),	O
the	O
high	O
-	O
procalcitonin	O
(	O
PCT	O
)	O
group	O
(	O
PCT	O
＞	O
100	O
μg	O
/	O
L	O
)	O
and	O
the	O
control	O
group	O
(	O
PCT	O
≤	O
100	O
μg	O
/	O
L	O
).	O
The	O
stage	O
of	O
early	O
resuscitation	O
was	O
set	O
to	O
the	O
first	O
6	O
hours	O
.	O

TITLE	O
:	O
Investigation	O
of	O
the	O
role	O
of	O
GBF1	O
in	O
the	O
replication	O
of	O
positive	O
-	O
sense	O
single	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
.	O

To	O
assess	O
whether	O
a	O
GBF1	O
/	O
class	B-SPEC
II	O
Arf	O
pathway	O
is	O
conserved	O
among	O
positive	O
-	O
sense	O
single	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
,	O
we	O
investigated	O
yellow	B-SPEC
fever	I-SPEC
virus	I-SPEC
(	O
YFV	B-SPEC
),	O
Sindbis	B-SPEC
virus	I-SPEC
(	O
SINV	O
),	O
coxsackievirus	B-SPEC
B4	O
(	O
CVB4	O
)	O
and	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
).	O

In	O
contrast	O
,	O
the	O
depletion	O
of	O
Arf	O
pairs	O
suggested	O
that	O
class	B-SPEC
II	O
Arfs	O
could	O
be	O
involved	O
in	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
YFV	B-SPEC
and	O
SINV	O
infection	O
,	O
as	O
for	O
HCV	B-SPEC
,	O
but	O
not	O
in	O
CVB4	O
infection	O
.	O

Collectively	O
,	O
our	O
results	O
revealed	O
novel	O
functions	O
of	O
TCs	O
in	O
VILA	B-SPEC
repair	O
and	O
shed	O
light	O
on	O
the	O
complications	O
that	O
are	O
caused	O
by	O
MV	O
.	O

TITLE	O
:	O
A	O
survey	O
of	O
canine	O
respiratory	O
pathogens	O
in	O
New	O
Zealand	O
dogs	B-SPEC
.	O

ABSTRACT	O
:	O
AIMS	O
To	O
determine	O
which	O
of	O
the	O
common	O
canine	O
respiratory	O
pathogens	O
circulate	O
among	O
selected	O
populations	O
of	O
healthy	O
and	O
diseased	O
dogs	B-SPEC
in	O
New	O
Zealand	O
.	O

METHODS	O
Coagulated	O
blood	O
samples	O
for	O
serology	O
and	O
oropharyngeal	O
swabs	O
for	O
virology	O
were	O
collected	O
from	O
healthy	O
dogs	B-SPEC
(	O
n	O
=	O
47	O
)	O
and	O
from	O
dogs	B-SPEC
with	O
acute	O
respiratory	O
disease	O
(	O
n	O
=	O
49	O
).	O

zooepidemicus	O
,	O
and	O
Mycoplasma	B-SPEC
cynos	I-SPEC
nucleic	O
acids	O
by	O
quantitative	O
PCR	O
(	O
qPCR	O
).	O

In	O
total	O
,	O
20	O
/	O
94	O
(	O
21	O
%)	O
dogs	B-SPEC
were	O
positive	O
for	O
at	O
least	O
one	O
agent	O
by	O
qPCR	O
.	O

Diseased	O
dogs	B-SPEC
were	O
most	O
commonly	O
positive	O
for	O
M	B-SPEC
.	I-SPEC
cynos	I-SPEC
(	O
8	O
/	O
47	O
,	O
17	O
%),	O
followed	O
by	O
CPIV	O
(	O
3	O
/	O
47	O
,	O
6	O
%)	O
and	O
B	B-SPEC
.	I-SPEC
bronchiseptica	I-SPEC
(	O
3	O
/	O
47	O
,	O
6	O
%),	O
while	O
healthy	O
dogs	B-SPEC
were	O
most	O
commonly	O
positive	O
for	O
CAdV	O
-	O
2	O
(	O
6	O
/	O
47	O
,	O
13	O
%),	O
followed	O
by	O
M	B-SPEC
.	I-SPEC
cynos	I-SPEC
(	O
2	O
/	O
47	O
,	O
4	O
%).	O

Making	O
use	O
of	O
our	O
already	O
described	O
animal	B-SPEC
model	O
of	O
HCoV	O
neuropathogenesis	O
,	O
we	O
describe	O
the	O
route	O
of	O
neuropropagation	O
from	O
the	O
nasal	O
cavity	O
to	O
the	O
olfactory	O
bulb	O
and	O
piriform	O
cortex	O
and	O
then	O
the	O
brain	O
stem	O
.	O

Interestingly	O
,	O
size	O
exclusion	O
chromatography	O
and	O
analytical	O
ultracentrifugation	O
analyses	O
indicate	O
that	O
the	O
PDCoV	O
nsp9	O
-	O
ΔN7	O
and	O
PEDV	B-SPEC
nsp9	O
-	O
C59A	O
mutants	O
are	O
monomeric	O
in	O
solution	O
.	O

In	O
addition	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
microscale	O
thermophoresis	O
analysis	O
indicate	O
that	O
the	O
monomeric	O
forms	O
of	O
PDCoV	O
nsp9	O
and	O
PEDV	B-SPEC
nsp9	O
still	O
have	O
nucleic	O
acid	O
binding	O
affinity	O
,	O
although	O
it	O
is	O
lower	O
than	O
that	O
of	O
the	O
wild	O
type	O
.	O

ABSTRACT	O
:	O
Since	O
2013	O
,	O
influenza	O
A	O
H7N9	O
virus	B-SPEC
has	O
emerged	O
as	O
the	O
most	O
common	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
subtype	O
causing	O
human	B-SPEC
infection	O
,	O
and	O
it	O
is	O
associated	O
with	O
a	O
high	O
fatality	O
risk	O
.	O

Species	B-SPEC
frequency	O
distributions	O
were	O
flatter	O
than	O
random	O
expectation	O
in	O
young	O
individuals	O
(	O
X	O
The	O
application	O
of	O
epidemiological	O
methods	O
and	O
ecological	O
theory	O
to	O
respiratory	O
tract	O
samples	O
has	O
yielded	O
novel	O
insights	O
into	O
the	O
factors	O
that	O
drive	O
microbial	O
community	O
composition	O
.	O

Overexpression	O
of	O
wild	O
-	O
type	O
or	O
dominant	O
-	O
negative	O
ULK1	O
constructs	O
does	O
not	O
affect	O
virus	B-SPEC
replication	O
,	O
indicating	O
that	O
ULK1	O
degradation	O
may	O
be	O
a	O
side	O
effect	O
of	O
the	O
ULK1	O
-	O
independent	O
signaling	O
mechanism	O
used	O
by	O
PV	O
,	O
inducing	O
complex	O
instability	O
.	O

ACTB	O
-	O
actin	O
beta	O
;	O
ATG13	O
-	O
autophagy	O
related	O
13	O
;	O
ATG14	O
-	O
autophagy	O
related	O
14	O
;	O
ATG101	O
-	O
autophagy	O
related	O
101	O
;	O
BECN1	O
-	O
beclin	O
1	O
;	O
CVB3	O
-	O
coxsackievirus	B-SPEC
B3	O
;	O
DMV	O
-	O
double	O
-	O
membraned	O
vesicles	O
;	O
EM	O
-	O
electron	O
microscopy	O
;	O
EMCV	B-SPEC
-	O
encephalomyocarditis	B-SPEC
virus	I-SPEC
;	O
EV	O
-	O
71	O
-	O
enterovirus	B-SPEC
71	O
;	O
FMDV	B-SPEC
-	O
foot	B-SPEC
and	I-SPEC
mouth	I-SPEC
disease	I-SPEC
virus	I-SPEC
;	O
GFP	O
-	O
green	O
fluorescent	O
protein	O
;	O
MAP1LC3B	O
/	O
LC3B	O
-	O
microtubule	O
associated	O
protein	O
1	O
light	O
chain	O
3	O
beta	O
;	O
MOI	O
-	O
multiplicity	O
of	O
infection	O
;	O
MTOR	O
-	O
mechanistic	O
target	O
of	O
rapamycin	O
kinase	O
;	O
PIK3C3	O
-	O
phosphatidylinositol	O
3	O
-	O
kinase	O
catalytic	O
subunit	O
type	O
3	O
;	O
PRKAA2	O
-	O
protein	O
kinase	O
AMP	O
-	O
activated	O
catalytic	O
subunit	O
alpha	O
2	O
;	O
PSMG1	O
-	O
proteasome	O
assembly	O
chaperone	O
1	O
;	O
PSMG2	O
-	O
proteasome	O
assembly	O
chaperone	O
2PV	O
-	O
poliovirus	B-SPEC
;	O
RB1CC1	O
-	O
RB1	O
inducible	O
coiled	O
-	O
coil	O
1	O
;	O
SQSTM1	O
-	O
sequestosome	O
1	O
;	O
ULK1	O
-	O
unc	O
-	O
51	O
like	O
autophagy	O
activating	O
kinase	O
1	O
;	O
ULK2	O
-	O
unc	O
-	O
51	O
like	O
autophagy	O
activating	O
kinase	O
2	O
;	O
WIPI1	O
-	O
WD	O
repeat	O
domain	O
,	O
phosphoinositide	O
interacting	O
1	O
.	O

This	O
study	O
was	O
conducted	O
to	O
determine	O
any	O
variations	O
in	O
the	O
influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
status	O
according	O
to	O
sex	O
,	O
age	O
group	O
,	O
sample	O
type	O
,	O
or	O
location	O
within	O
the	O
Eastern	O
Province	O
of	O
the	O
Kingdom	B-SPEC
of	O
Saudi	O
Arabia	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
induces	O
caspase	O
-	O
dependent	O
apoptosis	O
through	O
activation	O
of	O
the	O
cytochrome	O
c	O
-	O
mediated	O
intrinsic	O
mitochondrial	O
pathway	O
.	O

Replication	O
interference	O
between	O
these	O
two	O
viruses	B-SPEC
was	O
described	O
using	O
cell	O
cultures	O
(	O
CC	O
)	O
and	O
embryonated	O
chicken	B-SPEC
eggs	O
(	O
ECE	O
).	O

Chicken	B-SPEC
embryo	O
lung	O
(	O
CEL	O
)	O
and	O
ECE	O
were	O
simultaneously	O
or	O
sequentially	O
infected	O
with	O
IBV	B-SPEC
vaccine	O
strain	O
(	O
H120	O
)	O
and	O
LPAIV	O
-	O
H9N2	O
(	O
A	O
/	O
Ck	O
/	O
TUN	O
/	O
145	O
/	O
2012	O
)	O
to	O
evaluate	O
viral	O
interactionsin	O
vitro	O
and	O
in	O
ovo	B-SPEC
,	O
respectively	O
.	O

CONCLUSIONS	O
:	O
The	O
pulmonary	O
effects	O
of	O
alcohol	O
misuse	O
are	O
many	O
but	O
further	O
investigations	O
into	O
the	O
mechanism	O
by	O
which	O
alcohol	O
might	O
predispose	O
to	O
lung	O
cancer	B-SPEC
are	O
necessary	O
.	O

TITLE	O
:	O
Distinct	O
Gene	O
Profiles	O
of	O
Bone	O
Marrow	O
-	O
Derived	O
Macrophages	O
and	O
Microglia	O
During	O
Neurotropic	O
Coronavirus	B-SPEC
-	O
Induced	O
Demyelination	O
.	O

Dietary	O
yeast	B-SPEC
nucleotides	O
increased	O
intestinal	O
bacterial	O
diversity	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
and	O
the	O
abundance	O
of	O
Lactobacillus	B-SPEC
(	O
P	O
<	O
0	O
.	O
05	O
).	O

At	O
day	O
10	O
,	O
17	O
,	O
24	O
,	O
31	O
,	O
38	O
,	O
and	O
45	O
,	O
the	O
serum	O
IBV	B-SPEC
antibody	O
titers	O
were	O
tested	O
.	O

We	O
aimed	O
at	O
investigating	O
the	O
global	O
seasonal	O
occurrence	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
outbreaks	O
.	O

TITLE	O
:	O
Experimental	O
infection	O
of	O
dromedaries	B-SPEC
with	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
Coronavirus	B-SPEC
is	O
accompanied	O
by	O
massive	O
ciliary	O
loss	O
and	O
depletion	O
of	O
the	O
cell	O
surface	O
receptor	O
dipeptidyl	O
peptidase	O
4	O
.	O

MERS	O
-	O
CoV	O
infection	O
in	O
mock	O
-	O
vaccinated	O
dromedaries	B-SPEC
revealed	O
high	O
numbers	O
of	O
MERS	O
-	O
CoV	O
-	O
nucleocapsid	O
positive	O
cells	O
,	O
T	O
cells	O
,	O
and	O
macrophages	O
within	O
nasal	O
turbinates	O
and	O
trachea	B-SPEC
at	O
day	O
four	O
post	O
infection	O
.	O

TITLE	O
:	O
HEALTH	O
STATUS	O
OF	O
REINTRODUCED	O
WOOD	O
BISON	B-SPEC
(	O
BISON	B-SPEC
BISON	I-SPEC
ATHABASCAE	I-SPEC
):	O
ASSESSING	O
THE	O
CONSERVATION	O
VALUE	O
OF	O
AN	O
ISOLATED	O
POPULATION	O
IN	O
NORTHWESTERN	O
CANADA	O
.	O

ABSTRACT	O
:	O
Viruses	B-SPEC
are	O
obligate	O
intracellular	O
parasites	O
of	O
the	O
host	O
cells	O
.	O

Our	O
results	O
also	O
showed	O
that	O
piglets	O
in	O
the	O
S	O
-	O
Bac	O
group	O
elicited	O
superior	O
PEDV	B-SPEC
-	O
specific	O
neutralizing	O
antibodies	O
than	O
those	O
of	O
the	O
S1	O
-	O
Bac	O
and	O
control	O
groups	O
.	O

It	O
is	O
imperative	O
to	O
develop	O
safe	O
and	O
efficient	O
candidate	O
vaccines	O
to	O
control	O
IBV	B-SPEC
infection	O
.	O

Lung	O
microbiome	O
might	O
become	O
enriched	O
with	O
gut	O
-	O
associated	O
microbes	O
as	O
recently	O
demonstrated	O
in	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

ABSTRACT	O
:	O
3C	O
-	O
like	O
protease	O
also	O
called	O
the	O
main	O
protease	O
is	O
an	O
essential	O
enzyme	O
for	O
the	O
completion	O
of	O
the	O
life	O
cycle	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

In	O
our	O
study	O
we	O
predicted	O
compounds	O
which	O
are	O
capable	O
of	O
inhibiting	O
3C	O
-	O
like	O
protease	O
,	O
and	O
thus	O
inhibit	O
the	O
lifecycle	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
using	O
in	O
silico	O
methods	O
.	O

ABSTRACT	O
:	O
Endocan	O
is	O
a	O
circulating	O
proteoglycan	O
measured	O
at	O
high	O
blood	O
levels	O
during	O
severe	O
sepsis	B-SPEC
,	O
with	O
a	O
likely	O
lung	O
anti	O
-	O
inflammatory	O
function	O
.	O

Samples	O
were	O
tested	O
for	O
PEDV	B-SPEC
antibodies	O
utilising	O
three	O
different	O
serological	O
methods	O
:	O
commercially	O
-	O
available	O
indirect	O
ELISA	O
,	O
in	O
-	O
house	O
blocking	O
ELISA	O
test	O
and	O
Immunoperoxidase	O
Monolayer	O
Assay	O
(	O
IPMA	O
)	O
test	O
.	O

The	O
development	O
of	O
an	O
appropriate	O
animal	B-SPEC
model	O
is	O
necessary	O
to	O
study	O
the	O
pathogenesis	O
and	O
to	O
evaluate	O
the	O
intervening	O
measures	O
against	O
MERS	O
-	O
CoV	O
infection	O
.	O

In	O
addition	O
,	O
rhesus	B-SPEC
macaques	I-SPEC
,	O
common	B-SPEC
marmosets	I-SPEC
,	O
and	O
dromedary	B-SPEC
camels	B-SPEC
were	O
also	O
utilized	O
as	O
the	O
models	O
for	O
MERS	O
-	O
CoV	O
study	O
.	O

Cats	B-SPEC
with	O
lymphoma	O
were	O
significantly	O
younger	O
than	O
those	O
with	O
carcinoma	O
.	O

TITLE	O
:	O
A	O
Fatal	O
Case	O
of	O
Community	O
Acquired	O
ABSTRACT	O
:	O
A	O
67	O
-	O
year	O
-	O
old	O
man	B-SPEC
was	O
admitted	O
to	O
the	O
Intensive	O
Care	O
Unit	O
with	O
acute	O
respiratory	O
failure	O
.	O

ABSTRACT	O
:	O
Newly	O
approved	O
immunotherapeutic	O
agents	O
,	O
like	O
CTLA	O
-	O
4	O
inhibitors	O
and	O
antibodies	O
against	O
PD	O
-	O
1	O
,	O
are	O
a	O
promising	O
therapeutic	O
option	O
in	O
cancer	B-SPEC
therapy	O
.	O

Although	O
viral	O
RNA	O
was	O
detected	O
in	O
air	O
samples	O
with	O
both	O
strains	O
,	O
the	O
indirect	O
contact	O
pigs	B-SPEC
remained	O
free	O
from	O
infection	O
with	O
the	O
InDel	O
strain	O
in	O
contrast	O
to	O
the	O
non	O
-	O
InDel	O
group	O
in	O
which	O
airborne	O
transmission	O
occurred	O
in	O
the	O
indirect	O
contact	O
pigs	B-SPEC
.	O

We	O
also	O
showed	O
that	O
both	O
alignment	O
-	O
based	O
and	O
alignment	O
-	O
free	O
methods	O
can	O
accurately	O
predict	O
the	O
hosts	O
of	O
viruses	B-SPEC
.	O

The	O
newly	O
discovered	O
type	O
III	O
IFN	O
,	O
which	O
plays	O
a	O
crucial	O
role	O
in	O
antiviral	O
immunity	O
,	O
has	O
strong	O
antiviral	O
activity	O
against	O
PEDV	B-SPEC
proliferation	O
in	O
IPEC	O
-	O
J2	O
cells	O
.	O

Subsequently	O
,	O
we	O
demonstrated	O
that	O
the	O
inhibition	O
of	O
poly	O
(	O
I	O
:	O
C	O
)-	O
induced	O
IFN	O
-	O
λ3	O
production	O
by	O
PEDV	B-SPEC
N	O
protein	O
was	O
dependent	O
on	O
the	O
blocking	O
of	O
nuclear	O
factor	O
-	O
κB	O
(	O
NF	O
-	O
κB	O
)	O
nuclear	O
translocation	O
.	O

ABSTRACT	O
:	O
Hypervirulent	O
Klebsiella	B-SPEC
pneumoniae	I-SPEC
(	O
hvKp	O
)	O
has	O
emerged	O
as	O
a	O
leading	O
cause	O
of	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
,	O
liver	O
abscess	O
and	O
disseminated	O
infection	O
in	O
the	O
Far	O
East	O
.	O

The	O
result	O
is	O
a	O
700	O
-	O
fold	O
reduction	O
in	O
the	O
bacterial	O
burden	O
of	O
the	O
lungs	O
and	O
improvement	O
of	O
sepsis	B-SPEC
-	O
associated	O
thrombocytopaenia	O
and	O
blood	O
markers	O
of	O
endothelial	O
injury	O
.	O

TITLE	O
:	O
TMPRSS11A	O
activates	O
the	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
hemagglutinin	O
and	O
the	O
MERS	O
coronavirus	B-SPEC
spike	O
protein	O
and	O
is	O
insensitive	O
against	O
blockade	O
by	O
HAI	O
-	O
1	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
the	O
highly	O
contagious	O
,	O
causative	O
agent	O
of	O
an	O
economically	O
important	O
acute	O
enteric	O
disease	O
in	O
pigs	B-SPEC
of	O
all	O
ages	O
.	O

Phylogenetic	O
analysis	O
showed	O
a	O
very	O
high	O
nucleotide	O
similarity	O
with	O
a	O
variant	O
of	O
PEDV	B-SPEC
that	O
was	O
isolated	O
in	O
the	O
US	O
in	O
January	O
2014	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
vaccine	O
evaluation	O
using	O
a	O
newly	O
isolated	O
strain	O
from	O
Korea	O
.	O

Besides	O
,	O
we	O
successfully	O
isolated	O
and	O
reported	O
the	O
genetic	O
characterization	O
two	O
novel	O
PEDV	B-SPEC
strains	O
,	O
PEDV	B-SPEC
-	O
LA1	O
and	O
PEDV	B-SPEC
-	O
LY4	O
-	O
98	O
,	O
found	O
on	O
the	O
Chinese	O
mainland	O
,	O
which	O
had	O
significant	O
variations	O
in	O
the	O
S	O
gene	O
.	O

Meanwhile	O
,	O
the	O
virulence	O
of	O
the	O
new	O
mutants	O
may	O
be	O
changed	O
,	O
the	O
PEDV	B-SPEC
-	O
LY4	O
-	O
98	O
strain	O
,	O
which	O
has	O
multiple	O
mutations	O
in	O
the	O
signal	O
peptide	O
-	O
encoding	O
fragment	O
of	O
the	O
S	O
gene	O
showed	O
delayed	O
cytopathic	O
effects	O
and	O
smaller	O
plaque	O
size	O
compared	O
with	O
strain	O
PEDV	B-SPEC
-	O
LA1	O
,	O
which	O
lacks	O
these	O
mutations	O
.	O

This	O
study	O
improves	O
our	O
understanding	O
of	O
ongoing	O
PEDV	B-SPEC
outbreaks	O
in	O
China	O
,	O
and	O
it	O
will	O
guide	O
further	O
efforts	O
to	O
develop	O
effective	O
measures	O
to	O
control	O
this	O
virus	B-SPEC
.	O

Sensitive	O
diagnostics	O
and	O
efficacious	O
vaccines	O
are	O
necessary	O
to	O
combat	O
IBV	B-SPEC
infections	O
in	O
chickens	B-SPEC
.	O

Specific	O
immunoreactivity	O
of	O
the	O
recombinant	O
protein	O
was	O
confirmed	O
by	O
Western	O
blot	O
using	O
antiserum	O
obtained	O
from	O
vaccinated	O
and	O
naturally	O
infected	O
chicken	B-SPEC
from	O
Turkey	B-SPEC
as	O
well	O
as	O
using	O
a	O
monoclonal	O
antibody	O
raised	O
against	O
the	O
N	O
protein	O
of	O
the	O
IBV	B-SPEC
Massachusetts	O
strain	O
.	O

TITLE	O
:	O
Gastrointestinal	O
microbiota	B-SPEC
contributes	O
to	O
the	O
development	O
of	O
murine	B-SPEC
transfusion	O
-	O
related	O
acute	O
lung	O
injury	O
.	O

ABSTRACT	O
:	O
To	O
explore	O
the	O
effect	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
on	O
microRNA	O
expression	O
profiles	O
of	O
porcine	B-SPEC
kidney	O
15cell	O
(	O
PK	O
-	O
15	O
),	O
total	O
RNA	O
was	O
isolated	O
from	O
PK	O
-	O
15	O
cells	O
with	O
or	O
without	O
PEDV	B-SPEC
infection	O
.	O

Analyses	O
based	O
on	O
full	O
genomes	O
of	O
BCoV	O
and	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
and	O
on	O
both	O
human	B-SPEC
and	O
bovine	B-SPEC
mRNAs	O
sequences	O
of	O
cholecystokinin	O
(	O
CCK	O
)	O
and	O
surfactant	O
protein	O
1	O
A	O
(	O
SFTP1	O
-	O
A	O
),	O
representing	O
the	O
enteric	O
and	O
respiratory	O
tract	O
codon	O
usage	O
,	O
respectively	O
,	O
have	O
shown	O
natural	O
selection	O
leading	O
to	O
optimization	O
or	O
deoptimization	O
of	O
viral	O
codon	O
usage	O
to	O
the	O
human	B-SPEC
enteric	O
and	O
respiratory	O
tracts	O
depending	O
on	O
the	O
virus	B-SPEC
genes	O
under	O
consideration	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
is	O
a	O
kind	O
of	O
respiratory	O
disease	O
Caused	O
by	O
Middle	O
East	O
respiratory	O
syndrome	O
Coronavirus	B-SPEC
.	O

Now	O
the	O
disease	O
has	O
spread	O
to	O
27	O
countries	O
around	O
the	O
world	O
,	O
more	O
than	O
1806	O
people	O
infected	O
and	O
more	O
than	O
600	O
people	O
were	O
killed	O
,	O
and	O
four	O
countries	O
have	O
reported	O
cases	O
of	O
camel	B-SPEC
infection	O
MERS	O
.	O

ABSTRACT	O
:	O
The	O
recurrence	O
of	O
new	O
human	B-SPEC
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
underscores	O
the	O
need	O
for	O
effective	O
therapeutic	O
countermeasures	O
.	O

A	O
set	O
of	O
in	O
vitro	O
experiments	O
revealed	O
that	O
the	O
vasoconstrictive	O
properties	O
of	O
xylometazoline	O
HCl	O
and	O
the	O
antiviral	O
effectiveness	O
of	O
iota	O
-	O
carrageenan	O
against	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
hRV	O
)	O
1a	O
,	O
hRV8	O
and	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
were	O
maintained	O
in	O
the	O
formulation	O
containing	O
these	O
two	O
compounds	O
.	O

Finally	O
,	O
in	O
the	O
local	O
tolerance	O
and	O
toxicity	O
study	O
,	O
it	O
was	O
shown	O
that	O
the	O
formulation	O
was	O
well	O
tolerated	O
at	O
the	O
application	O
site	O
with	O
no	O
occurrence	O
of	O
erythema	O
or	O
edema	O
in	O
the	O
nostrils	O
of	O
all	O
rabbits	B-SPEC
or	O
any	O
signs	O
of	O
toxicity	O
in	O
any	O
of	O
the	O
organs	O
and	O
tissues	O
inspected	O
.	O

Nasopharyngeal	O
samples	O
obtained	O
from	O
269	O
hospitalized	O
children	O
were	O
analyzed	O
for	O
viral	O
respiratory	O
pathogens	O
using	O
the	O
xTAG	O
Respiratory	O
Virus	B-SPEC
Panel	O
Fast	O
assay	O
,	O
and	O
the	O
data	O
were	O
correlated	O
with	O
the	O
clinical	O
and	O
demographic	O
information	O
available	O
for	O
these	O
patients	O
.	O

TITLE	O
:	O
Proficiency	O
testing	O
for	O
the	O
detection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
demonstrates	O
global	O
capacity	O
to	O
detect	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
The	O
S2	O
Subunit	O
of	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
Beaudette	O
Is	O
a	O
Determinant	O
of	O
Cellular	O
Tropism	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
utilizes	O
host	O
cellular	O
proteases	O
to	O
enter	O
cells	O
.	O

Here	O
we	O
mapped	O
33	O
host	O
protein	O
interactions	O
of	O
CD81	O
in	O
primary	O
human	B-SPEC
liver	O
and	O
hepatoma	O
cells	O
using	O
high	O
-	O
resolution	O
quantitative	O
proteomics	O
.	O

CAPN5	O
and	O
CBLB	O
were	O
required	O
for	O
a	O
post	O
-	O
binding	O
and	O
pre	O
-	O
replication	O
step	O
in	O
the	O
HCV	B-SPEC
life	O
cycle	O
.	O

A	O
possible	O
treatment	O
to	O
suppress	O
Zika	O
replication	O
is	O
represented	O
by	O
short	O
interfering	O
RNAs	O
(	O
siRNAs	O
),	O
since	O
they	O
have	O
been	O
successfully	O
used	O
even	O
against	O
Ebola	O
,	O
H5N1	O
and	O
SARS	O
viruses	B-SPEC
and	O
clinical	O
trials	O
of	O
siRNA	O
-	O
based	O
drugs	O
are	O
ongoing	O
.	O

For	O
years	O
,	O
the	O
prevailing	O
model	O
was	O
that	O
these	O
viruses	B-SPEC
exit	O
from	O
cells	O
exclusively	O
through	O
cell	O
lysis	O
.	O

The	O
study	O
and	O
control	O
group	O
were	O
homogenous	O
based	O
on	O
family	B-SPEC
social	O
-	O
economic	O
status	O
,	O
parents	O
education	O
,	O
mean	O
parental	O
age	O
,	O
mother	O
health	O
status	O
,	O
to	O
minimize	O
the	O
bias	B-SPEC
.	O

HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
structural	O
(	O
membrane	O
M	O
and	O
nucleocapsid	O
N	O
)	O
and	O
accessory	O
proteins	O
(	O
ns2a	O
and	O
ns5a	O
)	O
were	O
expressed	O
individually	O
in	O
human	B-SPEC
embryonic	O
kidney	O
293	O
(	O
HEK	O
-	O
293	O
)	O
cells	O
.	O

Consequently	O
,	O
cardiac	O
glycosides	O
have	O
emerged	O
as	O
potential	O
broad	O
-	O
spectrum	O
antiviral	O
drugs	O
,	O
with	O
the	O
great	O
advantage	O
of	O
targeting	O
cell	O
host	O
proteins	O
,	O
which	O
help	O
to	O
minimize	O
resistance	O
to	O
antiviral	O
treatments	O
,	O
making	O
them	O
a	O
very	O
promising	O
strategy	O
against	O
human	B-SPEC
viral	O
infections	O
.	O

TITLE	O
:	O
Modeling	O
pathogenesis	O
of	O
emergent	O
and	O
pre	O
-	O
emergent	O
human	B-SPEC
coronaviruses	O
in	O
mice	B-SPEC
.	O

TITLE	O
:	O
Transmission	O
of	O
rhinovirus	B-SPEC
in	O
the	O
Utah	O
BIG	O
-	O
LoVE	O
families	O
:	O
Consequences	O
of	O
age	O
and	O
household	O
structure	O
.	O

RESULTS	O
:	O
Acquisition	O
of	O
HRV	O
was	O
less	O
probable	O
in	O
older	O
individuals	O
and	O
those	O
infected	O
with	O
a	O
coronavirus	B-SPEC
,	O
and	O
higher	O
with	O
a	O
higher	O
proportion	O
of	O
other	O
household	O
members	O
infected	O
.	O

For	O
this	O
purpose	O
,	O
we	O
review	O
how	O
mathematical	O
modeling	O
of	O
viral	O
dynamics	O
helped	O
to	O
understand	O
the	O
virus	B-SPEC
-	O
host	O
interactions	O
and	O
disease	O
progression	O
or	O
clearance	O
.	O

ABSTRACT	O
:	O
The	O
present	O
study	O
was	O
conducted	O
to	O
examine	O
whether	O
cellular	O
and	O
/	O
or	O
viral	O
cholesterol	O
levels	O
play	O
a	O
role	O
in	O
porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
replication	O
.	O

This	O
study	O
demonstrates	O
that	O
nucleic	O
acids	O
from	O
a	O
number	O
of	O
targeted	O
viruses	B-SPEC
were	O
present	O
in	O
pig	B-SPEC
oral	O
secretions	O
and	O
pig	B-SPEC
fecal	O
samples	O
,	O
and	O
that	O
several	O
viruses	B-SPEC
were	O
detected	O
in	O
bioaerosol	O
samples	O
or	O
in	O
the	O
nasal	O
passages	O
of	O
humans	B-SPEC
with	O
occupational	O
exposure	O
to	O
pigs	B-SPEC
.	O

These	O
results	O
demonstrate	O
the	O
need	O
for	O
future	O
research	O
in	O
strengthening	O
viral	O
surveillance	O
at	O
the	O
human	B-SPEC
-	O
animal	B-SPEC
interface	O
,	O
specifically	O
through	O
expanded	O
bioaerosol	O
sampling	O
efforts	O
and	O
a	O
seroepidemiological	O
study	O
of	O
individuals	O
with	O
exposure	O
to	O
pigs	B-SPEC
in	O
this	O
region	O
for	O
PCV2	O
infection	O
.	O

We	O
aimed	O
to	O
present	O
Influenza	O
Like	O
Illness	O
(	O
ILI	O
)	O
and	O
Severe	O
Acute	O
Respiratory	O
Infection	O
(	O
SARI	O
)	O
surveillance	O
data	O
and	O
characterize	O
influenza	B-SPEC
viruses	I-SPEC
circulating	O
in	O
the	O
country	O
over	O
three	O
influenza	O
seasons	O
.	O

32	O
%	O
(	O
397	O
/	O
1248	O
)	O
of	O
ILI	O
and	O
29	O
%	O
(	O
581	O
/	O
1997	O
)	O
of	O
SARI	O
patients	O
tested	O
were	O
positive	O
for	O
influenza	B-SPEC
viruses	I-SPEC
.	O

In	O
2014	O
-	O
2015	O
the	O
median	O
week	O
of	O
influenza	O
detection	O
was	O
week	O
7	O
/	O
2015	O
with	O
B	O
/	O
Yamagata	O
lineage	O
viruses	B-SPEC
dominating	O
(	O
79	O
%);	O
in	O
2015	O
-	O
2016	O
-	O
week	O
5	O
/	O
2016	O
was	O
the	O
median	O
with	O
A	O
/	O
H1N1pdm09	O
viruses	B-SPEC
prevailing	O
(	O
83	O
%);	O
and	O
in	O
2016	O
-	O
2017	O
a	O
bimodal	O
distribution	O
of	O
influenza	O
activity	O
was	O
observed	O
-	O
the	O
first	O
wave	O
was	O
caused	O
by	O
A	O
/	O
H3N2	O
(	O
55	O
%)	O
with	O
median	O
week	O
51	O
/	O
2016	O
and	O
the	O
second	O
by	O
B	O
/	O
Victoria	B-SPEC
lineage	O
viruses	B-SPEC
(	O
45	O
%)	O
with	O
median	O
week	O
9	O
/	O
2017	O
.	O

In	O
Georgia	O
influenza	B-SPEC
virus	I-SPEC
activity	O
occurred	O
mainly	O
from	O
December	O
through	O
March	O
in	O
all	O
seasons	O
,	O
with	O
varying	O
peak	O
weeks	O
and	O
predominating	O
viruses	B-SPEC
.	O

Another	O
potential	O
mitigation	O
strategy	O
would	O
be	O
using	O
chemically	O
treated	O
rice	B-SPEC
hulls	O
flushed	O
through	O
the	O
feed	O
manufacturing	O
equipment	O
.	O

However	O
,	O
PEDV	B-SPEC
RNA	O
was	O
not	O
detected	O
in	O
any	O
of	O
the	O
10	O
%	O
MCFA	O
rice	B-SPEC
hull	O
flush	O
samples	O
.	O

Then	O
,	O
rice	B-SPEC
hulls	O
treated	O
with	O
10	O
%	O
MCFA	O
were	O
mixed	O
and	O
discharged	O
through	O
a	O
production	O
scale	O
mixer	O
and	O
bucket	O
elevator	O
following	O
PEDV	B-SPEC
-	O
positive	O
feed	O
.	O

However	O
,	O
dust	O
collected	O
immediately	O
after	O
the	O
10	O
%	O
MCFA	O
rice	B-SPEC
hull	O
flush	O
batch	O
had	O
a	O
reduced	O
quantity	O
of	O
PEDV	B-SPEC
RNA	O
(	O
Ct	O
=	O
33	O
.	O
7	O
)	O
and	O
did	O
not	O
cause	O
infection	O
.	O

Finally	O
,	O
dust	O
collected	O
after	O
manufacturing	O
PEDV	B-SPEC
-	O
inoculated	O
feed	O
has	O
the	O
potential	O
to	O
serve	O
as	O
a	O
vector	O
for	O
PEDV	B-SPEC
transmission	O
.	O

Initial	O
ischemic	O
damage	O
following	O
reperfusion	O
therapy	O
and	O
damage	O
secondary	O
to	O
sepsis	B-SPEC
and	O
subarachnoid	O
hemorrhage	O
may	O
have	O
led	O
to	O
rapid	O
malignant	O
brain	O
swelling	O
in	O
this	O
patient	O
.	O

ABSTRACT	O
:	O
The	O
highly	O
infectious	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
which	O
belongs	O
to	O
the	O
coronaviruses	O
(	O
CoVs	O
),	O
causes	O
diarrhea	O
and	O
high	O
mortality	O
rates	O
in	O
piglets	O
,	O
resulting	O
in	O
severe	O
economic	O
losses	O
in	O
the	O
pork	O
industry	O
worldwide	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
Lactobacillus	B-SPEC
plantarum	I-SPEC
(	O
L	B-SPEC
.	I-SPEC
plantarum	I-SPEC
)	O
to	O
anchor	O
the	O
expression	O
of	O
TGEV	B-SPEC
antigen	O
(	O
S	O
)	O
to	O
dendritic	O
cells	O
(	O
DCs	O
)	O
via	O
dendritic	O
cell	O
-	O
targeting	O
peptides	O
(	O
DCpep	O
).	O

Here	O
,	O
we	O
used	O
information	O
on	O
the	O
substrate	O
specificity	O
of	O
bafinivirus	B-SPEC
3C	O
-	O
like	O
proteases	O
to	O
express	O
WBV	O
ExoN	O
in	O
an	O
active	O
form	O
in	O
Escherichia	B-SPEC
coli	I-SPEC
.	O

The	O
values	O
for	O
feline	B-SPEC
leukemia	I-SPEC
virus	I-SPEC
(	O
FeLV	O
;	O
52	O
.	O
9	O
%)	O
and	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
;	O
47	O
.	O
1	O
%)	O
were	O
amongst	O
the	O
highest	O
reported	O
for	O
wildcats	O
.	O

Piglets	O
orally	O
fed	O
with	O
JS	O
-	O
2	O
/	O
2014	O
G90	O
showed	O
no	O
clinical	O
symptoms	O
,	O
and	O
no	O
virus	B-SPEC
was	O
detected	O
in	O
the	O
feces	O
and	O
nasal	O
fluid	O
.	O

Input	O
variables	O
were	O
test	O
sensitivity	O
,	O
the	O
probability	O
of	O
introduction	O
through	O
animal	B-SPEC
purchase	O
and	O
local	O
transmission	O
.	O

The	O
results	O
show	O
that	O
PostPFree	O
provides	O
a	O
better	O
estimate	O
of	O
herd	O
-	O
level	O
BTM	O
status	O
for	O
both	O
BRSV	B-SPEC
and	O
BCV	B-SPEC
than	O
what	O
can	O
be	O
achieved	O
by	O
relying	O
solely	O
on	O
the	O
previous	O
test	O
-	O
result	O
.	O

TITLE	O
:	O
Reverse	O
Genetics	O
for	O
Type	O
I	O
Feline	B-SPEC
Coronavirus	B-SPEC
Field	O
Isolate	O

FIPVs	O
are	O
suggested	O
to	O
emerge	O
from	O
feline	B-SPEC
enteric	O
coronaviruses	O
(	O
FECVs	O
)	O
by	O
acquiring	O
mutations	O
in	O
specific	O
genes	O
in	O
the	O
course	O
of	O
persistent	O
infections	O
.	O

Although	O
numerous	O
studies	O
identified	O
mutations	O
predicted	O
to	O
be	O
responsible	O
for	O
the	O
FECV	B-SPEC
-	O
FIPV	O
biotype	O
switch	O
,	O
the	O
presumed	O
roles	O
of	O
specific	O
genetic	O
changes	O
in	O
FIP	O
pathogenesis	O
have	O
not	O
been	O
confirmed	O
experimentally	O
.	O

for	O
all	O
viruses	B-SPEC
,	O
while	O
growing	O
to	O
the	O
same	O
titre	O
as	O
wild	O
-	O
type	O
rIBV	O
at	O
48	O
h	O
p	O
.	O
i	O
.	O

When	O
administered	O
to	O
1	O
-	O
day	O
-	O
old	O
chickens	B-SPEC
,	O
rIBV	O
-	O
Δ3a	O
,	O
rIBV	O
-	O
Δ3b	O
,	O
rIBV	O
-	O
Δ5a	O
and	O
rIBV	O
-	O
Δ5b	O
showed	O
reduced	O
ciliostasis	O
in	O
comparison	O
to	O
the	O
wild	O
-	O
type	O
viruses	B-SPEC
.	O

These	O
modifications	O
ultimately	O
enabled	O
the	O
discovery	O
of	O
1	O
as	O
a	O
second	O
-	O
generation	O
MI	O
that	O
combines	O
broad	O
coverage	O
of	O
polymorphic	O
viruses	B-SPEC
(	O
EC	O

The	O
impact	O
of	O
SG	O
formation	O
on	O
virus	B-SPEC
replication	O
varies	O
among	O
different	O
viruses	B-SPEC
,	O
and	O
the	O
significance	O
of	O
SGs	O
in	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
replication	O
is	O
largely	O
unknown	O
.	O

Disaster	O
diplomacy	O
permits	B-SPEC
deeper	O
investigation	O
and	O
analysis	O
of	O
connections	O
amongst	O
health	O
,	O
disaster	O
,	O
and	O
diplomatic	O
activities	O
by	O
viewing	O
efforts	O
on	O
acute	O
public	O
health	O
events	O
as	O
being	O
political	O
through	O
disaster	O
risk	O
reduction	O
(	O
beforehand	O
)	O
and	O
disaster	O
response	O
(	O
during	O
and	O
afterwards	O
).	O

Further	O
studies	O
to	O
evaluate	O
the	O
field	O
efficacy	O
and	O
combining	O
these	O
attenuated	O
IBV	B-SPEC
strains	O
to	O
induce	O
a	O
wider	O
protection	O
against	O
heterologous	O
IBV	B-SPEC
challenge	O
are	O
suggested	O
.	O

ABSTRACT	O
:	O
The	O
group	O
2b	O
(	O
G2b	O
)	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
that	O
emerged	O
in	O
2013	O
has	O
since	O
caused	O
devastating	O
diseases	O
and	O
economic	O
loss	O
.	O

Recently	O
,	O
PEDV	B-SPEC
had	O
a	O
large	O
negative	O
economic	O
impact	O
on	O
the	O
swine	B-SPEC
industries	O
in	O
Asia	O
and	O
North	O
America	O
.	O

In	O
2014	O
,	O
PEDV	B-SPEC
re	O
-	O
emerged	O
in	O
many	O
European	O
countries	O
,	O
but	O
most	O
countries	O
only	O
reported	O
a	O
few	O
sporadic	O
cases	O
.	O

TITLE	O
:	O
A	O
Recombinant	O
Newcastle	B-SPEC
Disease	I-SPEC
Virus	I-SPEC
(	O
NDV	B-SPEC
)	O
Expressing	O
S	O
Protein	O
of	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
(	O
IBV	B-SPEC
)	O
Protects	O
Chickens	B-SPEC
against	O
IBV	B-SPEC
and	O
NDV	B-SPEC
.	O

These	O
results	O
suggest	O
that	O
the	O
rNDV	O
expressing	O
the	O
S	O
protein	O
of	O
IBV	B-SPEC
is	O
a	O
safe	O
and	O
effective	O
bivalent	O
vaccine	O
candidate	O
for	O
both	O
IBV	B-SPEC
and	O
NDV	B-SPEC
.	O

Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
-	O
free	O
swine	B-SPEC
feed	O
was	O
manufactured	O
to	O
represent	O
the	O
negative	O
control	O
.	O

In	O
addition	O
,	O
we	O
studied	O
the	O
structures	O
of	O
the	O
SARS	O
-	O
CoV	O
S	O
glycoprotein	O
and	O
its	O
complexes	O
with	O
ACE2	O
in	O
different	O
in	O
vitro	O
conditions	O
,	O
which	O
may	O
mimic	O
different	O
conformational	O
states	O
of	O
the	O
S	O
glycoprotein	O
during	O
virus	B-SPEC
entry	O
.	O

Molecular	O
clock	O
analysis	O
showed	O
that	O
divergence	O
of	O
the	O
GII	O
-	O
c	O
subgroup	O
spike	O
gene	O
occurred	O
in	O
April	O
2010	O
,	O
suggesting	O
that	O
the	O
subgroup	O
originated	O
from	O
recombination	O
events	O
before	O
the	O
PEDV	B-SPEC
re	O
-	O
emergence	O
outbreaks	O
.	O

TITLE	O
:	O
Cerebral	O
toxoplasmosis	O
in	O
a	O
cat	B-SPEC
with	O
feline	B-SPEC
leukemia	O
and	O
feline	B-SPEC
infectious	O
peritonitis	O
viral	O
infections	O
.	O

Infection	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
by	O
the	O
neuroadapted	O
John	O
Howard	O
Mueller	O
(	O
JHM	O
)	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
JHMV	O
)	O
provides	O
an	O
excellent	O
example	O
of	O
how	O
chemokines	O
aid	O
in	O
host	O
defense	O
as	O
well	O
as	O
contribute	O
to	O
disease	O
.	O

We	O
examined	O
the	O
biological	O
functions	O
of	O
nsp1	O
in	O
infected	O
cells	O
and	O
its	O
role	O
in	O
virus	B-SPEC
replication	O
by	O
using	O
wild	O
-	O
type	O
MERS	O
-	O
CoV	O
and	O
two	O
mutant	O
viruses	B-SPEC
with	O
specific	O
mutations	O
in	O
the	O
nsp1	O
;	O
one	O
mutant	O
lacked	O
both	O
biological	O
functions	O
,	O
while	O
the	O
other	O
lacked	O
the	O
RNA	O
cleavage	O
function	O
but	O
retained	O
the	O
translation	O
inhibition	O
function	O
.	O

All	O
but	O
9	O
/	O
3	O
patients	O
suffered	O
from	O
leuco	O
-/	O
thrombocytopenia	O
due	O
to	O
anti	O
-	O
cancer	B-SPEC
treatment	O
or	O
underlying	O
disease	O
.	O

The	O
interaction	O
between	O
inactivated	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
and	O
porcine	B-SPEC
monocyte	O
-	O
derived	O
dendritic	O
cells	O
(	O
Mo	O
-	O
DCs	O
)	O
has	O
been	O
reported	O
.	O

Firstly	O
,	O
a	O
method	O
to	O
isolate	O
DCs	O
from	O
porcine	B-SPEC
PPs	O
was	O
established	O
,	O
in	O
which	O
the	O
purity	O
of	O
SWC3a	O

TITLE	O
:	O
Development	O
of	O
a	O
diagnostic	O
system	O
for	O
detection	O
of	O
specific	O
antibodies	O
and	O
antigens	O
against	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

We	O
hypothesize	O
that	O
SES	O
is	O
caused	O
by	O
an	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
strain	O
since	O
it	O
is	O
known	O
that	O
IBV	B-SPEC
replicates	O
in	O
the	O
shell	O
gland	O
causing	O
various	O
eggshell	O
abnormalities	O
.	O

Accordingly	O
,	O
the	O
serological	O
detection	O
of	O
corresponding	O
antibodies	O
would	O
be	O
beneficial	O
to	O
diagnose	O
PEDV	B-SPEC
indirectly	O
to	O
control	O
the	O
disease	O
.	O

TITLE	O
:	O
Histopathology	O
of	O
Bordetella	B-SPEC
pertussis	I-SPEC
in	O
the	O
Baboon	B-SPEC
Model	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
role	O
of	O
gamma	O
delta	O
T	O
cell	O
receptors	O
(	O
γδ	O
)	O
T	O
cells	O
in	O
the	O
pathogenesis	O
of	O
fulminant	O
viral	O
hepatitis	O
(	O
FVH	O
)	O
induced	O
by	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
strain	O
3	O
(	O
MHV	B-SPEC
-	O
3	O
).	O

In	O
March	O
2017	O
,	O
the	O
Turlock	O
branch	O
of	O
the	O
California	B-SPEC
Animal	B-SPEC
Health	O
and	O
Food	O
Safety	O
laboratory	O
system	O
encountered	O
an	O
unusual	O
clinical	O
and	O
pathologic	O
presentation	O
of	O
infectious	O
coryza	O
in	O
6	O
live	O
,	O
29	O
-	O
d	O
-	O
old	O
,	O
commercial	O
broiler	O
chickens	B-SPEC
that	O
were	O
submitted	O
for	O
diagnostic	O
investigation	O
.	O

To	O
explore	O
the	O
effect	O
of	O
PERK	O
inhibition	O
on	O
VILI	O
,	O
we	O
ventilated	O
live	O
rats	B-SPEC
and	O
compared	O
lung	O
injury	O
parameters	O
to	O
non	O
-	O
ventilated	O
controls	O
.	O

TITLE	O
:	O
Characterization	O
of	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
pseudotyped	O
with	O
the	O
spike	O
protein	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

After	O
controlling	O
for	O
potential	O
confounders	O
(	O
age	O
,	O
sex	O
,	O
recruitment	O
site	O
,	O
days	O
from	O
symptom	O
onset	O
to	O
enrollment	O
,	O
and	O
underlying	O
illnesses	O
),	O
children	O
with	O
RSV	B-SPEC
and	O
metapneumovirus	B-SPEC
infections	O
showed	O
a	O
greater	O
likelihood	O
of	O
hospitalization	O
than	O
those	O
infected	O
by	O
parainfluenza	O
viruses	B-SPEC
(	O
OR	O
2	O
.	O
7	O
and	O
1	O
.	O
9	O
,	O
respectively	O
),	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
OR	O
3	O
.	O
1	O
and	O
2	O
.	O
1	O
,	O
respectively	O
),	O
coronaviruses	O
(	O
OR	O
4	O
.	O
9	O
and	O
3	O
.	O
4	O
,	O
respectively	O
),	O
adenovirus	B-SPEC
(	O
OR	O
4	O
.	O
6	O
and	O
3	O
.	O
2	O
,	O
respectively	O
),	O
and	O
influenza	O
(	O
OR	O
6	O
.	O
3	O
and	O
4	O
.	O
4	O
,	O
respectively	O
).	O

After	O
controlling	O
for	O
potential	O
confounders	O
(	O
age	O
,	O
sex	O
,	O
recruitment	O
site	O
,	O
days	O
from	O
symptom	O
onset	O
to	O
enrollment	O
,	O
and	O
underlying	O
illnesses	O
),	O
children	O
with	O
RSV	B-SPEC
and	O
metapneumovirus	B-SPEC
infections	O
showed	O
a	O
greater	O
likelihood	O
of	O
hospitalization	O
than	O
those	O
infected	O
by	O
parainfluenza	O
viruses	B-SPEC
(	O
OR	O
2	O
.	O
7	O
and	O
1	O
.	O
9	O
,	O
respectively	O
),	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
OR	O
3	O
.	O
1	O
and	O
2	O
.	O
1	O
,	O
respectively	O
),	O
coronaviruses	O
(	O
OR	O
4	O
.	O
9	O
and	O
3	O
.	O
4	O
,	O
respectively	O
),	O
adenovirus	B-SPEC
(	O
OR	O
4	O
.	O
6	O
and	O
3	O
.	O
2	O
,	O
respectively	O
),	O
and	O
influenza	O
(	O
OR	O
6	O
.	O
3	O
and	O
4	O
.	O
4	O
,	O
respectively	O
).	O

In	O
Asia	O
,	O
modified	O
live	O
attenuated	O
vaccines	O
have	O
been	O
used	O
to	O
control	O
PEDV	B-SPEC
infection	O
in	O
recent	O
years	O
.	O

TITLE	O
:	O
A	O
fast	O
and	O
simple	O
one	O
-	O
step	O
duplex	O
PCR	O
assay	O
for	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
)	O
and	O
canine	O
coronavirus	B-SPEC
(	O
CCoV	O
)	O
detection	O
.	O

The	O
mice	B-SPEC
were	O
highly	O
susceptible	O
to	O
infection	O
by	O
MERS	O
-	O
CoV	O
clinical	O
strain	O
hCoV	O
-	O
EMC	O
,	O
which	O
induced	O
severe	O
diffuse	O
pulmonary	O
disease	O
in	O
the	O
animals	B-SPEC
,	O
and	O
could	O
also	O
be	O
infected	O
by	O
an	O
optimized	O
pseudotyped	O
MERS	O
-	O
CoV	O
.	O
Administration	O
of	O
the	O
neutralizing	O
monoclonal	O
antibodies	O
,	O
H111	O
-	O
1	O
and	O
m336	O
,	O
as	O
well	O
as	O
a	O
fusion	O
inhibitor	O
peptide	O
,	O
HR2P	O
-	O
M2	O
,	O
protected	O
mice	B-SPEC
from	O
challenge	O
with	O
authentic	O
and	O
pseudotyped	O
MERS	O
-	O
CoV	O
.	O
These	O
results	O
confirmed	O
that	O
the	O
hDPP4	O
-	O
knockin	O
mouse	B-SPEC
is	O
a	O
novel	O
model	O
for	O
studies	O
of	O
MERS	O
-	O
CoV	O
pathogenesis	O
and	O
anti	O
-	O
MERS	O
-	O
CoV	O
antiviral	O
agents	O
in	O
BSL	O
-	O
3	O
and	O
BSL	O
-	O
2facilities	O
,	O
respectively	O
.	O

To	O
detect	O
and	O
isolate	O
PEDV	B-SPEC
rapidly	O
and	O
accurately	O
is	O
important	O
for	O
the	O
control	O
and	O
further	O
research	O
of	O
the	O
clinical	O
PEDV	B-SPEC
strains	O
.	O

In	O
2012	O
,	O
a	O
new	O
human	B-SPEC
disease	O
called	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
emerged	O
in	O
the	O
Middle	O
East	O
.	O

The	O
exact	O
origin	O
of	O
MERS	O
-	O
CoV	O
remains	O
unknown	O
,	O
but	O
the	O
transmission	O
pattern	O
and	O
evidence	O
from	O
virological	O
studies	O
suggest	O
that	O
dromedary	B-SPEC
camels	B-SPEC
are	O
the	O
major	O
reservoir	O
host	O
,	O
from	O
which	O
human	B-SPEC
infections	O
may	O
sporadically	O
occur	O
through	O
the	O
zoonotic	O
transmission	O
.	O

Cloacal	O
swabs	O
and	O
the	O
positive	O
rRT	O
-	O
PCR	O
tracheal	O
swabs	O
were	O
inoculated	O
in	O
10	O
-	O
day	O
-	O
old	O
SPF	O
embryonated	O
chicken	B-SPEC
eggs	O
(	O
ECE	O
)	O
to	O
confirm	O
rRT	O
-	O
PCR	O
results	O
.	O

Internal	O
organs	O
(	O
kidney	O
,	O
trachea	B-SPEC
,	O
and	O
spleen	O
)	O
from	O
all	O
chicken	B-SPEC
groups	O
were	O
collected	O
weekly	O
for	O
histopathological	O
examination	O
to	O
determine	O
severity	O
of	O
the	O
lesions	O
.	O

The	O
humoral	O
immune	O
response	O
against	O
H9N2	O
AIV	O
,	O
NDV	B-SPEC
,	O
and	O
IBV	B-SPEC
revealed	O
a	O
significant	O
increase	O
in	O
H9N2	O
AIV	O
titer	O
in	O
Groups	O
1	O
and	O
5	O
,	O
NDV	B-SPEC
titer	O
showed	O
a	O
significant	O
increase	O
in	O
Group	O
7	O
,	O
and	O
IBV	B-SPEC
titer	O
increased	O
in	O
Groups	O
1	O
,	O
3	O
,	O
and	O
5	O
.	O

With	O
this	O
expansion	O
,	O
the	O
global	O
laboratory	O
community	O
has	O
started	O
to	O
focus	O
on	O
laboratory	O
biosafety	O
and	O
biosecurity	O
in	O
order	B-SPEC
to	O
prevent	O
the	O
accidental	O
and	O
/	O
or	O
intentional	O
release	O
of	O
these	O
agents	O
.	O

The	O
global	O
community	O
needs	O
to	O
increase	O
its	O
investment	O
in	O
early	O
warning	O
and	O
detection	O
systems	O
that	O
can	O
provide	O
information	O
that	O
enables	O
action	O
to	O
be	O
taken	O
at	O
the	O
national	O
,	O
regional	O
and	O
global	O
levels	O
in	O
the	O
event	O
of	O
an	O
outbreak	O
of	O
a	O
transboundary	O
animal	B-SPEC
disease	O
(	O
TAD	O
).	O

TITLE	O
:	O
Neutralizing	O
antibodies	O
against	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
block	O
virus	B-SPEC
attachment	O
and	O
internalization	O
.	O

Interaction	O
of	O
the	O
viral	O
spike	O
(	O
S	O
)	O
surface	O
glycoprotein	O
with	O
the	O
host	O
cell	O
receptor	O
is	O
recognized	O
as	O
the	O
first	O
step	O
of	O
infection	O
and	O
is	O
the	O
main	O
determinant	O
of	O
virus	B-SPEC
tropism	O
.	O

This	O
study	O
is	O
the	O
first	O
retrospective	O
investigation	O
for	O
SADS	O
-	O
CoV	O
and	O
provides	O
the	O
epidemiological	O
information	O
of	O
this	O
new	O
virus	B-SPEC
in	O
China	O
,	O
which	O
highlights	O
the	O
urgency	O
to	O
develop	O
effective	O
measures	O
to	O
control	O
SADS	O
-	O
CoV	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
viruses	B-SPEC
(	O
IBVs	O
)	O
circulating	O
in	O
Malaysia	O
are	O
classified	O
into	O
two	O
groups	O
as	O
Malaysian	O
QX	O
-	O
like	O
and	O
variant	O
strains	O
.	O

TITLE	O
:	O
Three	O
Main	O
Inducers	O
of	O
Alphacoronavirus	B-SPEC
Infection	O
of	O
Enterocytes	O
:	O
Sialic	O
Acid	O
,	O
Proteases	O
,	O
and	O
Low	O
pH	O
.	O
ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
and	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
are	O
similar	O
coronaviruses	O
,	O
causing	O
diseases	O
characterized	O
by	O
vomiting	O
,	O
diarrhea	O
,	O
and	O
death	O
from	O
severe	O
dehydration	O
in	O
piglets	O
.	O

This	O
review	O
emphasizes	O
the	O
role	O
of	O
three	O
factors	O
in	O
the	O
invasion	O
of	O
TGEV	B-SPEC
and	O
PEDV	B-SPEC
into	O
porcine	B-SPEC
enterocytes	O
and	O
offers	O
more	O
insights	O
into	O
Alphacoronavirus	B-SPEC
infection	O
in	O
the	O
intestinal	O
environment	O
.	O

In	O
252	O
live	O
deliveries	O
,	O
identification	O
of	O
non	O
-	O
vigorous	O
neonates	O
,	O
use	O
of	O
suction	O
,	O
and	O
use	O
of	O
PPV	B-SPEC
increased	O
by	O
21	O
%,	O
25	O
%,	O
and	O
23	O
%	O
respectively	O
(	O
all	O
p	O
<	O
0	O
.	O
01	O
)	O
between	O
weeks	O
1	O
-	O
3	O
and	O
4	O
-	O
8	O
.	O

TITLE	O
:	O
Novel	B-SPEC
coronavirus	I-SPEC
-	O
like	O
particles	O
targeting	O
cells	O
lining	O
the	O
respiratory	O
tract	O
.	O

Major	O
structural	O
proteins	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
have	O
been	O
expressed	O
in	O
tagged	O
or	O
native	O
form	O
,	O
and	O
their	O
assembly	O
to	O
form	O
VLPs	O
was	O
evaluated	O
.	O

Subsequent	O
peaks	O
of	O
febrile	O
illness	O
were	O
found	O
to	O
incorporate	O
smaller	O
outbreaks	O
of	O
dengue	B-SPEC
virus	I-SPEC
serotypes	O
1	O
and	O
4	O
and	O
Zika	B-SPEC
virus	I-SPEC
,	O
with	O
identification	O
of	O
additional	O
infections	O
with	O
Mayaro	B-SPEC
virus	I-SPEC
,	O
enterovirus	B-SPEC
D68	O
,	O
and	O
coronavirus	B-SPEC
NL63	O
.	O

TITLE	O
:	O
Chiral	O
zirconium	O
quantum	O
dots	O
:	O
A	O
new	O
class	B-SPEC
of	O
nanocrystals	O
for	O
optical	O
detection	O
of	O
coronavirus	B-SPEC
.	O

MTT	O
assay	O
was	O
performed	O
to	O
test	O
the	O
cytotoxicity	O
of	O
the	O
synthesized	O
Zr	O
QDs	O
against	O
rat	B-SPEC
brain	O
glioma	O
C6	O
cells	O
.	O

ABSTRACT	O
:	O
Toxic	O
industrial	O
chemicals	O
include	O
chlorine	O
,	O
phosgene	O
,	O
hydrogen	O
sulfide	O
,	O
and	O
ammonia	B-SPEC
have	O
variable	O
effects	O
on	O
the	O
respiratory	O
tract	O
,	O
and	O
maybe	O
seen	O
alone	O
or	O
in	O
combination	O
,	O
secondary	O
to	O
inhalation	O
injury	O
.	O

We	O
observed	O
significantly	O
decreased	O
plasma	O
HRG	O
levels	O
in	O
an	O
acute	O
pancreatitis	O
mouse	B-SPEC
model	O
.	O

I	O
enveloped	O
viruses	B-SPEC
share	O
similarities	O
in	O
their	O
apparent	O
use	O
of	O
a	O
hexameric	O
coiled	O
-	O
coil	O
assembly	O
to	O
drive	O
the	O
merging	O
of	O
virus	B-SPEC
and	O
host	O
cell	O
membranes	O
.	O

In	O
addition	O
,	O
vaccinated	O
and	O
challenged	O
birds	B-SPEC
had	O
significantly	O
less	O
challenge	O
virus	B-SPEC
,	O
an	O
important	O
measure	O
of	O
protection	O
,	O
compared	O
to	O
non	O
-	O
vaccinated	O
and	O
challenged	O
controls	O
.	O

The	O
full	O
-	O
length	O
genomes	O
of	O
viruses	B-SPEC
from	O
egg	O
passages	O
1	O
,	O
20	O
,	O
40	O
,	O
and	O
60	O
were	O
sequenced	O
using	O
the	O
Illumina	O
platform	O
and	O
the	O
data	O
showed	O
single	O
nucleotide	O
polymorphisms	O
(	O
SNPs	O
)	O
had	O
accumulated	O
in	O
regions	O
of	O
the	O
genome	O
associated	O
with	O
viral	O
replication	O
,	O
pathogenicity	O
,	O
and	O
cell	O
tropism	O
.	O

TITLE	O
:	O
Origin	O
and	O
dissemination	O
of	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
genotype	O
C	O
in	O
East	O
Asia	O
revealed	O
by	O
phylodynamic	O
analysis	O
and	O
historical	O
correlates	O
.	O

The	O
most	O
recent	O
common	O
ancestor	O
of	O
HBV	B-SPEC
/	O
C	O
was	O
traced	O
back	O
to	O
the	O
early	O
1900s	O
in	O
China	O
,	O
where	O
it	O
eventually	O
diverged	O
into	O
two	O
major	O
lineages	O
during	O
the	O
1930s	O
-	O
1960s	O
that	O
gave	O
rise	O
to	O
distinct	O
epidemic	O
waves	O
spreading	O
exponentially	O
to	O
other	O
East	O
Asian	O
countries	O
and	O
the	O
USA	O
.	O

Although	O
additional	O
factors	O
cannot	O
be	O
ruled	O
out	O
,	O
we	O
provide	O
evidence	O
to	O
suggest	O
this	O
bottleneck	O
was	O
the	O
result	O
of	O
limited	O
human	B-SPEC
movement	O
from	O
/	O
to	O
China	O
during	O
the	O
SARS	O
outbreak	O
in	O
2003	O
.	O

TITLE	O
:	O
Description	O
and	O
initial	O
characterization	O
of	O
metatranscriptomic	O
nidovirus	B-SPEC
-	O
like	O
genomes	O
from	O
the	O
proposed	O
new	O
family	B-SPEC
Abyssoviridae	O
,	O
and	O
from	O
a	O
sister	O
group	O
to	O
the	O
Coronavirinae	B-SPEC
,	O
the	O
proposed	O
genus	B-SPEC
Alphaletovirus	O
.	O

TITLE	O
:	O
Infectious	O
Bronchitis	O
Virus	B-SPEC
Nonstructural	O
Protein	O
4	O
Alone	O
Induces	O
Membrane	O
Pairing	O
.	O

Respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
)	O
was	O
detected	O
only	O
among	O
children	O
under	O
5	O
years	O
old	O
in	O
August	O
and	O
September	O
while	O
coronavirus	B-SPEC
was	O
present	O
in	O
all	O
age	O
groups	O
,	O
during	O
the	O
months	O
of	O
October	O
and	O
December	O
.	O

TITLE	O
:	O
The	O
effect	O
of	O
chemical	O
clarification	O
of	O
oral	O
fluids	O
on	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
antibody	O
responses	O
.	O

ABSTRACT	O
:	O
This	O
case	O
study	O
report	O
describes	O
a	O
transmissible	O
gastroenteritis	O
coronavirus	B-SPEC
(	O
TGEV	B-SPEC
)	O
infection	O
presented	O
in	O
a	O
commercial	O
pig	B-SPEC
herd	O
.	O

The	O
amplicons	O
,	O
obtained	O
from	O
five	O
different	O
species	B-SPEC
of	O
bats	B-SPEC
,	O
were	O
sequenced	O
.	O

TITLE	O
:	O
Genomic	O
characterization	O
and	O
infectivity	O
of	O
a	O
novel	O
SARS	O
-	O
like	O
coronavirus	B-SPEC
in	O
Chinese	O
bats	B-SPEC
.	O

To	O
further	O
understand	O
the	O
evolutionary	O
relationship	O
between	O
SARS	O
-	O
CoV	O
and	O
its	O
reservoirs	O
,	O
334	O
bats	B-SPEC
were	O
collected	O
from	O
Zhoushan	O
city	O
,	O
Zhejiang	O
province	O
,	O
China	O
,	O
between	O
2015	O
and	O
2017	O
.	O

Importantly	O
,	O
using	O
pathogenic	O
tests	O
,	O
we	O
found	O
that	O
the	O
virus	B-SPEC
can	O
reproduce	O
and	O
cause	O
disease	O
in	O
suckling	O
rats	B-SPEC
,	O
and	O
further	O
studies	O
showed	O
that	O
the	O
virus	B-SPEC
-	O
like	O
particles	O
can	O
be	O
observed	O
in	O
the	O
brains	O
of	O
suckling	O
rats	B-SPEC
by	O
electron	O
microscopy	O
.	O

Thus	O
,	O
this	O
study	O
increased	O
our	O
understanding	O
of	O
the	O
genetic	O
diversity	O
of	O
the	O
SL	O
-	O
CoVs	O
carried	O
by	O
bats	B-SPEC
and	O
also	O
provided	O
a	O
new	O
perspective	O
to	O
study	O
the	O
possibility	O
of	O
cross	O
-	O
species	B-SPEC
transmission	O
of	O
SL	O
-	O
CoVs	O
using	O
suckling	O
rats	B-SPEC
as	O
an	O
animal	B-SPEC
model	O
.	O

Indeed	O
,	O
an	O
important	O
recent	O
study	O
(	O
Stanaway	O
and	O
others	O
2015	O
)	O
found	O
that	O
viral	O
hepatitis	O
led	O
to	O
an	O
estimated	O
0	O
.	O
9	O
million	O
deaths	O
in	O
1990	O
(	O
including	O
hepatitis	O
-	O
caused	O
deaths	O
from	O
cirrhosis	O
and	O
liver	O
cancer	B-SPEC
).	O

Infected	O
individuals	O
mostly	O
worked	O
with	O
poultry	O
,	O
suggesting	O
H7N9	O
virus	B-SPEC
-	O
infected	O
poultry	O
as	O
the	O
primary	O
source	O
of	O
human	B-SPEC
infection	O
.	O

Reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
rRT	O
-	O
PCR	O
)	O
is	O
the	O
gold	O
standard	O
diagnostic	O
test	O
for	O
H7N9	O
avian	B-SPEC
influenza	O
.	O

Synthetic	O
cannabinoids	O
can	O
have	O
a	O
more	O
intense	O
and	O
long	O
-	O
lasting	O
effect	O
than	O
natural	O
cannabis	B-SPEC
.	O

Sequences	O
were	O
obtained	O
from	O
amplicons	O
using	O
consensus	O
primers	O
targeting	O
conserved	O
genes	O
of	O
the	O
virus	B-SPEC
families	O
Paramyxoviridae	B-SPEC
,	O
Coronaviridae	B-SPEC
,	O
Adenoviridae	B-SPEC
,	O
and	O
Herpesviridae	B-SPEC
.	O

All	O
adenovirus	B-SPEC
samples	O
were	O
identified	O
as	O
Aviadenovirus	B-SPEC
,	O
related	O
to	O
a	O
gull	B-SPEC
and	O
falcon	O
adenovirus	B-SPEC
(	O
Bayesian	O
posterior	O
probability	O
=	O
0	O
.	O
86	O
).	O

In	O
this	O
vaccine	O
,	O
B	O
cell	O
epitopes	O
derived	O
from	O
the	O
second	O
heptad	O
repeat	O
(	O
HR2	O
)	O
region	O
of	O
IBV	B-SPEC
spike	O
proteins	O
were	O
repetitively	O
presented	O
in	O
its	O
native	O
trimeric	O
conformation	O
.	O

TITLE	O
:	O
Structurally	O
-	O
and	O
dynamically	O
-	O
driven	O
allostery	O
of	O
the	O
chymotrypsin	O
-	O
like	O
proteases	O
of	O
SARS	O
,	O
Dengue	O
and	O
Zika	O
viruses	B-SPEC
.	O

In	O
the	O
lower	O
inferior	O
vena	O
cava	O
,	O
upper	O
inferior	O
vena	O
cava	O
,	O
and	O
right	O
atrium	O
drainage	O
cannula	B-SPEC
positions	O
at	O
3	O
L	O
/	O
min	O
,	O
SaO	O
With	O
respect	O
to	O
blood	O
oxygenation	O
,	O
the	O
optimal	O
position	O
for	O
the	O
drainage	O
cannula	B-SPEC
was	O
the	O
upper	O
inferior	O
vena	O
cava	O
.	O

Exploring	O
the	O
effects	O
of	O
CVC1303	O
on	O
the	O
immune	O
induction	O
to	O
PEDV	B-SPEC
vaccine	O
was	O
of	O
vital	O
importance	O
to	O
the	O
clinical	O
application	O
.	O

ABSTRACT	O
:	O
Infrared	O
(	O
IR	O
)	O
modalities	O
represent	O
the	O
only	O
currently	O
viable	O
mass	O
fever	O
screening	O
approaches	O
for	O
outbreaks	O
of	O
infectious	O
disease	O
pandemics	O
such	O
as	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
.	O

In	O
addition	O
,	O
Caerin1	O
.	O
1	O
showed	O
powerful	O
antiviral	O
activity	O
without	O
interfering	O
with	O
the	O
binding	O
progress	O
between	O
PEDV	B-SPEC
and	O
the	O
receptor	O
of	O
the	O
cells	O
,	O
therefore	O
,	O
it	O
could	O
be	O
used	O
as	O
a	O
potential	O
antiviral	O
drug	O
or	O
as	O
a	O
microbicide	O
compound	O
for	O
prevention	O
and	O
control	O
of	O
PEDV	B-SPEC
.	O

TITLE	O
:	O
Attenuation	O
of	O
Influenza	B-SPEC
A	I-SPEC
Virus	I-SPEC
Disease	O
Severity	O
by	O
Viral	O
Coinfection	O
in	O
a	O
Mouse	B-SPEC
Model	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
has	O
catastrophic	O
impacts	O
on	O
the	O
global	O
pig	B-SPEC
industry	O
.	O

Firstly	O
,	O
PEDV	B-SPEC
can	O
develop	O
a	O
transient	O
nasal	O
epithelium	O
infection	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
evaluate	O
the	O
percentage	O
of	O
respiratory	O
viruses	B-SPEC
in	O
children	O
with	O
FS	O
.	O

RESULTS	O
:	O
During	O
the	O
study	O
period	O
,	O
at	O
least	O
one	O
virus	B-SPEC
was	O
detected	O
in	O
82	O
.	O
7	O
%	O
(	O
144	O
/	O
174	O
)	O
of	O
children	O
with	O
FS	O
.	O

Furthermore	O
,	O
Bland	O
-	O
Altman	O
analysis	O
revealed	O
a	O
corresponding	O
bias	B-SPEC
of	O
0	O
.	O
02	O
and	O
0	O
.	O
14	O
s	O
within	O
the	O
limits	O
of	O
agreement	O
ranging	O
from	O
-	O
0	O
.	O
50	O
to	O
0	O
.	O
65	O
s	O
for	O
the	O
aforementioned	O
calculation	O
methods	O
.	O

High	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
analyses	O
showed	O
that	O
TGEV	B-SPEC
infection	O
leads	O
to	O
reduced	O
arginine	O
uptake	O
at	O
48	O
hours	O
post	O
-	O
infection	O
(	O
hpi	O
).	O

We	O
measured	O
baseline	O
plasma	O
25	O
(	O
OH	O
)	O
D	O
in	O
711	O
sepsis	B-SPEC
cases	O
and	O
in	O
992	O
participants	O
randomly	O
selected	O
from	O
the	O
REGARDS	O
cohort	O
.	O

TITLE	O
:	O
Proviral	O
MicroRNAs	O
Detected	O
in	O
Extracellular	O
Vesicles	O
From	O
Bronchoalveolar	O
Lavage	O
Fluid	O
of	O
Patients	O
With	O
Influenza	B-SPEC
Virus	I-SPEC
-	O
Induced	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
.	O

This	O
xMAP	O
detection	O
demonstrated	O
no	O
nonspecific	O
reactions	O
with	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
(	O
AIV	O
),	O
avian	B-SPEC
leukosis	I-SPEC
virus	I-SPEC
(	O
ALV	B-SPEC
),	O
newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
),	O
and	O
Marek	B-SPEC
'	I-SPEC
s	I-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
MDV	O
).	O

METHODS	O
:	O
The	O
microspheres	O
coated	O
with	O
purified	O
recombinant	O
glycoprotein	O
D	O
(	O
gD	O
)	O
of	O
ILTV	B-SPEC
or	O
nucleocapsid	O
(	O
N	O
)	O
protein	O
of	O
IBV	B-SPEC
were	O
incubated	O
with	O
serum	O
samples	O
.	O

The	O
results	O
showed	O
that	O
the	O
coincidence	O
rates	O
were	O
84	O
.	O
44	O
and	O
100	O
%	O
for	O
ILTV	B-SPEC
and	O
IBV	B-SPEC
detection	O
,	O
respectively	O
.	O

Lipopolysaccharide	O
was	O
intratracheally	O
administered	O
to	O
rats	B-SPEC
to	O
establish	O
experimental	O
ARDS	O
.	O

Mucosal	O
immunity	O
is	O
believed	O
to	O
play	O
an	O
important	O
role	O
in	O
PEDV	B-SPEC
control	O
and	O
mucosal	O
delivery	O
of	O
vaccines	O
induces	O
mucosal	O
immunity	O
more	O
efficiently	O
than	O
parenteral	O
vaccination	O
.	O

We	O
used	O
in	O
vivo	O
and	O
in	O
vitro	O
models	O
,	O
respectively	O
,	O
using	O
lipopolysaccharide	O
(	O
LPS	O
)	O
to	O
induce	O
ALI	O
in	O
mice	B-SPEC
and	O
exposing	O
J774	O
and	O
BEAS	O
-	O
2B	O
cells	O
to	O
LPS	O
.	O

Finally	O
,	O
we	O
observed	O
interaction	O
between	O
broiler	O
chickens	B-SPEC
and	O
wild	O
birds	B-SPEC
(	O
finches	O
)	O
inside	O
broiler	O
pens	O
,	O
as	O
well	O
as	O
the	O
presence	O
of	O
backyard	O
chickens	B-SPEC
inside	O
property	O
limits	O
of	O
study	O
farms	O
.	O

The	O
resulting	O
virus	B-SPEC
replicated	O
like	O
SARS	O
-	O
CoV	O
in	O
Vero	O
cells	O
but	O
was	O
suppressed	O
in	O
IFN	O
competent	O
MA	O
-	O
104	O
(	O
3	O
.	O
7	O
-	O
fold	O
),	O
Calu	O
-	O
3	O
(	O
2	O
.	O
6	O
-	O
fold	O
)	O
and	O
human	B-SPEC
airway	O
epithelial	O
cells	O
(	O
10	O
.	O
3	O
-	O
fold	O
).	O

TITLE	O
:	O
First	O
retrospective	O
studies	O
with	O
etiological	O
confirmation	O
of	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
infection	O
in	O
Argentina	B-SPEC
.	O

This	O
study	O
aimed	O
to	O
reveal	O
the	O
presence	O
of	O
these	O
viruses	B-SPEC
in	O
the	O
backyard	O
chickens	B-SPEC
in	O
Ahvaz	O
,	O
located	O
in	O
the	O
Southwest	O
of	O
Iran	O
.	O

The	O
blood	O
samples	O
were	O
assessed	O
for	O
the	O
antibodies	O
against	O
NDV	B-SPEC
and	O
AIV	O
by	O
haemagglutination	O
inhibition	O
test	O
,	O
and	O
against	O
IBV	B-SPEC
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

The	O
results	O
demonstrated	O
that	O
the	O
Iranian	O
backyard	O
chickens	B-SPEC
were	O
infected	O
with	O
NDV	B-SPEC
,	O
AIV	O
,	O
and	O
IBV	B-SPEC
.	O

TITLE	O
:	O
Elevated	O
Human	B-SPEC
Dipeptidyl	O
Peptidase	O
4	O
Expression	O
Reduces	O
the	O
Susceptibility	O
of	O
hDPP4	O
Transgenic	B-SPEC
Mice	I-SPEC
to	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
and	O
Disease	O
.	O

ABSTRACT	O
:	O
The	O
ongoing	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infections	O
pose	O
threats	O
to	O
public	O
health	O
worldwide	O
,	O
making	O
an	O
understanding	O
of	O
MERS	O
pathogenesis	O
and	O
development	O
of	O
effective	O
medical	O
countermeasures	O
(	O
MCMs	O
)	O
urgent	O
.	O

TITLE	O
:	O
microRNA	O
-	O
222	O
Attenuates	O
Mitochondrial	O
Dysfunction	O
During	O
Transmissible	O
Gastroenteritis	O
Virus	B-SPEC
Infection	O
.	O

Lysosomal	O
Proteases	O
Are	O
a	O
Determinant	O
of	O
Coronavirus	B-SPEC
Tropism	O
.	O

Our	O
results	O
showed	O
that	O
lysosomal	O
proteases	O
from	O
bat	B-SPEC
cells	O
support	O
coronavirus	B-SPEC
spike	O
-	O
mediated	O
pseudovirus	O
entry	O
and	O
cell	O
-	O
cell	O
fusion	O
more	O
effectively	O
than	O
their	O
counterparts	O
from	O
human	B-SPEC
cells	O
.	O

The	O
committee	O
determined	O
that	O
,	O
given	O
their	O
potential	O
to	O
cause	O
a	O
public	O
health	O
emergency	O
and	O
the	O
absence	O
of	O
efficacious	O
drugs	O
and	O
/	O
or	O
vaccines	O
,	O
there	O
is	O
an	O
urgent	O
need	O
for	O
accelerated	O
R	O
&	O
D	O
for	O
(	O
in	O
no	O
order	B-SPEC
of	O
priority	O
)	O

Crimean	O
-	O
Congo	O
haemorrhagic	O
fever	O
,	O
Ebola	B-SPEC
virus	I-SPEC
and	O
Marburg	B-SPEC
virus	I-SPEC
disease	O
,	O
Lassa	O
fever	O
,	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
and	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
),	O
Nipah	O
and	O
henipaviral	O
diseases	O
,	O
Rift	O
Valley	O
fever	O
and	O
Zika	B-SPEC
virus	I-SPEC
disease	O
.	O

TITLE	O
:	O
First	O
identification	O
of	O
a	O
single	O
amino	O
acid	O
change	O
in	O
the	O
spike	O
protein	O
region	O
of	O
feline	B-SPEC
coronavirus	B-SPEC
detected	O
from	O
a	O
coronavirus	B-SPEC
-	O
associated	O
cutaneous	O
nodule	O
in	O
a	O
cat	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
32	O
-	O
month	O
-	O
old	O
spayed	O
female	O
Singapura	O
cat	B-SPEC
presented	O
with	O
a	O
non	O
-	O
pruritic	O
erythematous	O
nodule	O
on	O
the	O
upper	O
lip	O
.	O

To	O
detect	O
and	O
study	O
the	O
evolution	O
of	O
PEDV	B-SPEC
and	O
PDCoV	O
in	O
central	O
China	O
(	O
Shanxi	O
,	O
Henan	O
,	O
Hubei	O
province	O
),	O
70	O
clinical	O
intestinal	O
and	O
fecal	O
samples	O
from	O
piglets	O
with	O
severe	O
watery	O
diarrhea	O
during	O
August	O
2015	O
and	O
June	O
2016	O
were	O
collected	O
,	O
tested	O
and	O
analyzed	O
.	O

ABSTRACT	O
:	O
With	O
outbreaks	O
of	O
new	O
respiratory	O
viruses	B-SPEC
such	O
as	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
swine	B-SPEC
-	O
origin	O
influenza	O
A	O
/	O
H1N1	O
,	O
the	O
nucleic	O
acid	O
-	O
based	O
amplification	O
test	O
was	O
introduced	O
to	O
identify	O
causative	O
agents	O
.	O

The	O
implementation	O
of	O
the	O
rapid	O
test	O
for	O
the	O
detection	O
of	O
respiratory	O
viruses	B-SPEC
improved	O
the	O
diagnostic	O
efficiency	O
of	O
the	O
laboratory	O
and	O
greatly	O
reduced	O
lead	O
time	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
an	O
acute	O
,	O
highly	O
contagious	O
,	O
and	O
economically	O
important	O
viral	O
disease	O
of	O
chickens	B-SPEC
.	O

A	O
total	O
of	O
1	O
,	O
556	O
blood	O
samples	O
were	O
collected	O
from	O
80	O
case	O
and	O
non	O
-	O
case	O
farms	O
from	O
pigs	B-SPEC
over	O
6	O
months	O
old	O
.	O

Serial	O
serum	O
dilutions	O
were	O
subjected	O
to	O
serological	O
examination	O
for	O
PEDV	B-SPEC
presence	O
using	O
Neutralization	O
test	O
(	O
NT	O
).	O

Seropositive	O
animals	B-SPEC
in	O
non	O
-	O
case	O
farms	O
were	O
detected	O
by	O
NT	O
in	O
a	O
sero	O
-	O
survey	O
by	O
sampling	O
at	O
slaughterhouses	O
.	O

In	O
recent	O
years	O
,	O
the	O
rapid	O
spread	O
of	O
severe	O
infections	O
such	O
as	O
HIV	B-SPEC
,	O
SARS	O
,	O
Ebola	O
,	O
and	O
Zika	O
have	O
highlighted	O
the	O
dire	O
need	O
for	O
global	O
preparedness	O
for	O
pandemics	O
,	O
which	O
necessitates	O
the	O
extremely	O
rapid	O
development	O
and	O
comprehensive	O
distribution	O
of	O
vaccines	O
against	O
potentially	O
previously	O
unknown	O
pathogens	O
.	O

Chlordecone	O
also	O
accelerated	O
the	O
death	O
of	O
mice	B-SPEC
infected	O
by	O
murine	B-SPEC
hepatitis	O
virus	B-SPEC
and	O
enhanced	O
the	O
entry	O
of	O
the	O
virus	B-SPEC
into	O
the	O
cervical	O
spinal	O
cord	O
in	O
infected	O
mice	B-SPEC
,	O
leading	O
to	O
considerable	O
neurological	O
damage	O
.	O

We	O
previously	O
generated	O
a	O
genogroup	O
2b	O
(	O
G2b	O
)	O
PEDV	B-SPEC
Taiwan	O
Pintung	O
52	O
(	O
PEDVPT	O
)	O
strain	O
,	O
PEDVPT	O
-	O
P96	O
,	O
and	O
determined	O
its	O
promising	O
host	O
immune	O
response	O
against	O
the	O
virulent	O
PEDVPT	O
-	O
P5	O
strain	O
.	O

Hendra	B-SPEC
virus	I-SPEC
(	O
HeV	B-SPEC
)	O
causes	O
respiratory	O
and	O
neurological	O
disease	O
and	O
death	O
in	O
man	B-SPEC
and	O
horses	B-SPEC
.	O

We	O
tested	O
sera	O
by	O
an	O
indirect	O
fluorescence	O
antibody	O
test	O
for	O
antibodies	O
to	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
(	O
CDV	B-SPEC
),	O
canine	O
coronavirus	B-SPEC
(	O
CCV	O
),	O
canine	O
parvovirus	B-SPEC
type	O
2	O
(	O
CPV	B-SPEC
-	O
2	O
),	O
canine	B-SPEC
adenovirus	I-SPEC
,	O
canine	O
parainfluenza	B-SPEC
virus	I-SPEC
type	I-SPEC
2	I-SPEC
(	O
CPIV	O
-	O
2	O
),	O
and	O
canine	B-SPEC
herpesvirus	I-SPEC
type	O
1	O
(	O
CHV	O
-	O
1	O
).	O

Both	O
patients	O
had	O
Coccidioides	B-SPEC
immitis	I-SPEC
cultured	O
from	O
respiratory	O
samples	O
.	O

One	O
was	O
a	O
69	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
had	O
been	O
treated	O
with	O
combination	O
fluconazole	O
and	O
liposomal	O
amphotericin	O
for	O
over	O
6	O
weeks	O
,	O
with	O
persistent	O
fever	O
and	O
pneumonia	O
.	O

TITLE	O
:	O
Epidemiology	O
and	O
outcome	O
of	O
acute	O
kidney	O
injury	O
due	O
to	O
venomous	O
animals	B-SPEC
from	O
a	O
subtropical	O
region	O
of	O
India	O
.	O

Outcomes	O
of	O
requirement	O
for	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
support	O
,	O
treatment	O
with	O
dialysis	B-SPEC
,	O
survival	O
,	O
and	O
mortality	O
were	O
analyzed	O
.	O

Cells	O
from	O
cotton	B-SPEC
rat	B-SPEC
,	O
goat	B-SPEC
,	O
and	O
sheep	B-SPEC
provided	O
control	O
scenarios	O
that	O
represent	O
host	O
systems	O
in	O
which	O
SARS	O
-	O
CoV	O
is	O
neither	O
endemic	O
nor	O
epidemic	O
.	O

Through	O
surveillance	O
in	O
Pakistan	O
,	O
nasal	O
(	O
n	O
=	O
776	O
)	O
and	O
serum	O
(	O
n	O
=	O
1050	O
)	O
samples	O
were	O
collected	O
from	O
camels	B-SPEC
between	O
November	O
2015	O
and	O
February	O
2018	O
.	O

An	O
in	O
-	O
house	O
ELISA	O
was	O
developed	O
to	O
detect	O
IgG	O
against	O
MERS	O
-	O
CoV	O
.	O
A	O
total	O
of	O
794	O
camels	B-SPEC
were	O
found	O
seropositive	O
for	O
MERS	O
-	O
CoV	O
.	O
Prevalence	O
increased	O
with	O
the	O
age	O
and	O
the	O
highest	O
seroprevalence	O
was	O
recorded	O
in	O
camels	B-SPEC
aged	O
>	O
10	O
years	O
(	O
81	O
.	O
37	O
%)	O
followed	O
by	O
those	O
aged	O
3	O
.	O
1	O
-	O
10	O
years	O
(	O
78	O
.	O
65	O
%)	O
and	O
≤	O
3	O
years	O
(	O
58	O
.	O
19	O
%).	O

Although	O
we	O
found	O
a	O
high	O
rate	O
of	O
MERS	O
-	O
CoV	O
antibody	O
positive	O
dromedaries	B-SPEC
(	O
75	O
.	O
62	O
%)	O
in	O
Pakistan	O
,	O
no	O
neutralizing	O
antibodies	O
were	O
detected	O
in	O
humans	B-SPEC
with	O
and	O
without	O
contact	O
to	O
camels	B-SPEC
.	O

In	O
conclusion	O
,	O
a	O
novel	O
co	O
-	O
culture	O
of	O
porcine	B-SPEC
enterocytes	O
with	O
myofibroblasts	O
was	O
established	O
,	O
which	O
can	O
be	O
used	O
for	O
the	O
investigation	O
of	O
the	O
replication	O
of	O
enteric	O
viruses	B-SPEC
.	O

The	O
presence	O
of	O
virus	B-SPEC
nucleic	O
acid	O
was	O
determined	O
by	O
PCR	O
.	O

Oropharyngeal	O
(	O
OP	O
)	O
swabs	O
were	O
taken	O
from	O
eight	O
birds	B-SPEC
per	O
flock	O
and	O
accompanied	O
with	O
flock	O
health	O
information	O
.	O

Flock	O
ages	O
ranged	O
from	O
3	O
to	O
72	O
weeks	O
old	O
,	O
and	O
the	O
average	O
flock	O
size	O
was	O
17	O
,	O
633	O
birds	B-SPEC
.	O

PCR	O
detected	O
65	O
(	O
49	O
.	O
6	O
%),	O
59	O
(	O
45	O
%)	O
and	O
8	O
(	O
6	O
.	O
1	O
%)	O
flocks	O
as	O
positive	O
for	O
IBV	B-SPEC
,	O
Mg	O
/	O
Ms	O
and	O
aMPV	O
respectively	O
.	O

RESULTS	O
:	O
The	O
presence	O
of	O
PAstV	O
and	O
PSaV	O
was	O
studied	O
in	O
411	O
rectal	O
swabs	O
collected	O
from	O
healthy	O
(	O
n	O
=	O
251	O
)	O
and	O
diarrheic	O
(	O
n	O
=	O
160	O
)	O
pigs	B-SPEC
of	O
different	O
age	O
categories	O
:	O
suckling	O
(	O
n	O
=	O
143	O
),	O
weaned	O
(	O
n	O
=	O
147	O
)	O
and	O
fattening	O
(	O
n	O
=	O
121	O
)	O
animals	B-SPEC
on	O
farms	O
in	O
Slovakia	O
.	O

A	O
third	O
(	O
39	O
.	O
36	O
%)	O
reported	O
contact	O
with	O
an	O
index	O
case	O
,	O
developed	O
the	O
disease	O
after	O
6	O
.	O
2days	O
and	O
continued	O
to	O
shed	O
the	O
virus	B-SPEC
for	O
13	O
.	O
17days	O
on	O
average	O
.	O

We	O
observed	O
that	O
TGEV	B-SPEC
infection	O
promoted	O
TfR1	O
internalization	O
,	O
clustering	O
,	O
and	O
co	O
-	O
localization	O
with	O
TfR1	O
early	O
in	O
infection	O
,	O
while	O
TfR1	O
expression	O
was	O
significantly	O
down	O
-	O
regulated	O
as	O
TGEV	B-SPEC
infection	O
proceeded	O
.	O

RESULTS	O
:	O
Our	O
study	O
investigated	O
the	O
possibility	O
that	O
TfR1	O
can	O
serve	O
as	O
a	O
receptor	O
for	O
TGEV	B-SPEC
infection	O
and	O
enables	O
the	O
invasion	O
and	O
replication	O
of	O
TGEV	B-SPEC
.	O

We	O
have	O
previously	O
reported	O
the	O
efficacy	O
of	O
a	O
protease	O
inhibitor	O
in	O
cats	B-SPEC
with	O
FIP	O
,	O
demonstrating	O
that	O
a	O
virally	O
encoded	O
3C	O
-	O
like	O
protease	O
(	O
3CLpro	O
)	O
is	O
a	O
valid	O
target	O
for	O
antiviral	O
drug	O
development	O
for	O
coronavirus	B-SPEC
infections	O
.	O

Coronavirus	B-SPEC
subtypes	O
were	O
described	O
for	O
the	O
first	O
time	O
in	O
Tunisia	O
.	O

The	O
viral	O
spike	O
glycoprotein	O
(	O
S	O
)	O
utilizes	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
as	O
a	O
host	O
protein	O
receptor	O
and	O
mediates	O
fusion	O
of	O
the	O
viral	O
and	O
host	O
membranes	O
,	O
making	O
S	O
essential	O
to	O
viral	O
entry	O
into	O
host	O
cells	O
and	O
host	O
species	B-SPEC
tropism	O
.	O

In	O
this	O
study	O
,	O
we	O
performed	O
qRT	O
-	O
PCR	O
and	O
viral	O
metagenomic	O
analysis	O
of	O
the	O
extraction	O
efficiency	O
of	O
four	O
commonly	O
used	O
Qiagen	O
extraction	O
kits	O
:	O
QIAamp	O
Viral	O
RNA	O
Mini	O
Kit	O
(	O
VRMK	O
),	O
QIAamp	O
MinElute	O
Virus	B-SPEC
Spin	O
Kit	O
(	O
MVSK	O
),	O
RNeasy	O
Mini	O
Kit	O
(	O
RMK	O
),	O
and	O
RNeasy	O
Plus	O
Micro	O
Kit	O
(	O
RPMK	O
),	O
using	O
a	O
mixed	O
respiratory	O
clinical	O
sample	O
without	O
any	O
pre	O
-	O
treatment	O
.	O

In	O
this	O
international	O
,	O
prospective	O
,	O
cross	O
-	O
sectional	O
,	O
observational	O
study	O
,	O
145	O
paediatric	O
intensive	O
care	O
units	O
(	O
PICUs	B-SPEC
)	O
from	O
27	O
countries	O
were	O
recruited	O
,	O
and	O
over	O
a	O
continuous	O
5	O
day	O
period	O
across	O
10	O
weeks	O
all	O
patients	O
were	O
screened	O
for	O
enrolment	O
.	O

Of	O
the	O
63	O
samples	O
tested	O
for	O
other	O
viruses	B-SPEC
,	O
58	O
were	O
positive	O
:	O
influenza	O
H1N1	O
(	O
43	O
.	O
1	O
%	O
of	O
positive	O
samples	O
),	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
41	O
.	O
4	O
%),	O
respiratory	O
syncytial	O
vírus	O
(	O
12	O
.	O
1	O
%),	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
12	O
.	O
1	O
%),	O
adenovirus	B-SPEC
(	O
6	O
.	O
9	O
%),	O
and	O
bocavirus	B-SPEC
(	O
3	O
.	O
5	O
%).	O

Other	O
viruses	B-SPEC
can	O
be	O
implicated	O
in	O
SARI	O
in	O
children	O
.	O

METHODS	O
:	O
Longitudinal	O
observational	O
retrospective	O
study	O
,	O
with	O
patients	O
aged	O
0	O
-	O
18	O
years	O
,	O
admitted	O
to	O
11	O
PICUs	B-SPEC
in	O
Rio	O
de	O
Janeiro	O
,	O
with	O
suspected	O
H1N1	O
infection	O
,	O
from	O
June	O
to	O
November	O
,	O
2009	O
.	O

RESULTS	O
:	O
Of	O
71	O
samples	O
,	O
38	O
%	O
tested	O
positive	O
for	O
H1N1	O
virus	B-SPEC
.	O

Comparing	O
the	O
groups	O
with	O
mono	O
-	O
detection	O
and	O
co	O
-	O
dection	O
of	O
any	O
virus	B-SPEC
,	O
no	O
difference	O
was	O
found	O
regarding	O
the	O
association	O
with	O
any	O
clinical	O
variable	O
.	O

We	O
report	O
our	O
successful	O
use	O
of	O
venovenous	O
ECMO	O
in	O
a	O
29	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
presented	O
with	O
severe	O
respiratory	O
distress	O
secondary	O
to	O
Pneumocystis	B-SPEC
jirovecii	I-SPEC
pneumonia	O
associated	O
with	O
undiagnosed	O
infection	O
with	O
the	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
and	O
acquired	O
immune	O
deficiency	O
syndrome	O
.	O

Recently	O
,	O
the	O
IBV	B-SPEC
QX	O
genotype	O
has	O
been	O
detected	O
in	O
Iran	O
.	O

TITLE	O
:	O
Identification	O
of	O
Pantropic	O
Canine	O
Coronavirus	B-SPEC
in	O
a	O
Wolf	O
(	O
Canis	B-SPEC
lupus	I-SPEC
italicus	O
)	O
in	O
Italy	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
a	O
highly	O
lethal	O
respiratory	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
is	O
an	O
emerging	O
disease	O
with	O
high	O
potential	O
for	O
epidemic	O
spread	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
was	O
first	O
detected	O
in	O
Hong	O
Kong	O
and	O
has	O
recently	O
spread	O
to	O
many	O
countries	O
around	O
the	O
world	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
regulatory	O
relationship	O
between	O
miRNA	O
-	O
221	O
-	O
5p	O
and	O
PEDV	B-SPEC
infection	O
,	O
finding	O
that	O
miR	O
-	O
221	O
-	O
5p	O
overexpression	O
inhibited	O
PEDV	B-SPEC
replication	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
,	O
and	O
that	O
silencing	O
endogenous	O
miR	O
-	O
221	O
-	O
5p	O
enhanced	O
viral	O
replication	O
.	O

These	O
results	O
demonstrated	O
the	O
ability	O
of	O
miR	O
-	O
221	O
-	O
5p	O
to	O
inhibit	O
PEDV	B-SPEC
replication	O
by	O
targeting	O
the	O
3	O
'	O
UTR	O
of	O
the	O
viral	O
genome	O
and	O
activating	O
the	O
NF	O
-	O
κB	O
-	O
signaling	O
pathway	O
.	O

Moreover	O
,	O
this	O
competitive	O
ELISA	O
method	O
has	O
other	O
properties	O
,	O
such	O
as	O
high	O
feasibility	O
of	O
testing	O
sera	O
without	O
pre	O
-	O
treatment	O
and	O
automatic	O
and	O
instrument	O
-	O
mediated	O
revealing	O
,	O
that	O
makes	O
it	O
appropriate	O
for	O
large	O
-	O
scale	O
screenings	O
of	O
affected	O
pig	B-SPEC
farms	O
in	O
endemic	O
regions	O
or	O
for	O
monitoring	O
plans	O
in	O
PEDV	B-SPEC
-	O
free	O
areas	O
.	O

Three	O
and	O
half	O
years	O
after	O
the	O
first	O
known	O
human	B-SPEC
infection	O
was	O
detected	O
,	O
cases	O
continue	O
to	O
be	O
reported	O
every	O
month	O
,	O
over	O
85	O
%	O
of	O
which	O
have	O
been	O
from	O
Saudi	O
Arabia	O
and	O
other	O
countries	O
in	O
the	O
Arabian	O
Peninsula	O
.	O

Annual	O
epidemics	O
of	O
seasonal	O
influenza	O
cause	O
an	O
estimated	O
3	O
-	O
5	O
million	O
cases	O
of	O
severe	O
illness	O
and	O
more	O
than	O
500	O
000	O
deaths	O
,	O
with	O
the	O
prospect	O
of	O
pandemic	O
influenza	B-SPEC
viruses	I-SPEC
causing	O
far	O
greater	O
impact	O
.	O

An	O
increase	O
to	O
a	O
pH	O
12	O
of	O
liquid	O
manure	O
by	O
liming	O
led	O
to	O
the	O
absence	O
of	O
PEDV	B-SPEC
detection	O
by	O
RT	O
-	O
PCR	O
after	O
seven	O
days	O
.	O

Peak	O
activity	O
occurred	O
between	O
weeks	O
1	O
and	O
16	O
/	O
2017	O
,	O
with	O
biphasic	O
distribution	O
:	O
A	O
viruses	B-SPEC
were	O
replaced	O
by	O
B	O
viruses	B-SPEC
from	O
week	O
9	O
/	O
2017	O
;	O
B	O
viruses	B-SPEC
predominated	O
(	O
66	O
.	O
1	O
%).	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
recombination	O
-	O
resistant	O
coronavirus	B-SPEC
as	O
a	O
broadly	O
applicable	O
,	O
rapidly	O
implementable	O
vaccine	O
platform	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
life	O
-	O
threatening	O
respiratory	O
disease	O
with	O
a	O
high	O
case	O
fatality	O
rate	O
;	O
however	O
,	O
its	O
risk	O
factors	O
remain	O
unclear	O
.	O

Doctors	O
and	O
nurses	O
embraced	O
CPAP	O
use	O
but	O
identified	O
barriers	O
to	O
implementation	O
which	O
will	O
need	O
to	O
be	O
addressed	O
in	O
order	B-SPEC
not	O
to	O
impact	O
on	O
safety	O
and	O
quality	O
of	O
care	O
.	O

The	O
literature	O
data	O
demonstrate	O
that	O
immunization	O
of	O
animals	B-SPEC
with	O
the	O
TGEV	B-SPEC
antigen	O
coupled	O
to	O
gold	O
nanoparticles	O
(	O
GNPs	O
)	O
not	O
only	O
activates	O
antigen	O
-	O
presenting	O
cells	O
but	O
also	O
increases	O
the	O
proliferative	O
activity	O
of	O
splenic	O
lymphoid	O
(	O
antibody	O
-	O
forming	O
)	O
cells	O
.	O

These	O
results	O
can	O
be	O
used	O
to	O
develop	O
vaccines	O
against	O
this	O
infection	O
by	O
employing	O
TGEV	B-SPEC
antigen	O
coupled	O
to	O
gold	O
nanoparticles	O
as	O
a	O
carrier	O
.	O

The	O
activation	O
or	O
cleavage	O
of	O
main	O
apoptosis	O
-	O
associated	O
molecular	O
such	O
as	O
AIFM1	O
,	O
caspase	O
-	O
3	O
,	O
caspase	O
-	O
8	O
,	O
caspase	O
-	O
9	O
and	O
PARP	O
in	O
PEDV	B-SPEC
infected	O
host	O
cells	O
were	O
analyzed	O
by	O
western	O
blotting	O
.	O

To	O
investigate	O
their	O
role	O
in	O
viral	O
pathogenicity	O
,	O
we	O
generated	O
three	O
recombinant	O
PEDVs	O
by	O
introducing	O
deletions	O
or	O
a	O
mutation	O
in	O
the	O
two	O
motifs	O
of	O
the	O
infectious	O
clone	O
of	O
PEDV	B-SPEC
PC22A	O
strain	O
(	O
icPC22A	O
):	O
(	O
i	O
)	O
icΔ10aa	O
(	O
ΔYxxΦEKVHVQ	O
),	O
(	O
ii	O
)	O
icΔ5aa	O
(	O
ΔKVHVQ	O
),	O
and	O
(	O
iii	O
)	O
icYA	O
(	O
Y1378A	O
,	O
to	O
an	O
inactivated	O
motif	O
,	O
AEVF	O
).	O

Second	O
,	O
a	O
panel	O
of	O
MLN	O
FNA	O
samples	O
was	O
collected	O
from	O
a	O
series	O
of	O
cats	B-SPEC
representing	O
non	O
-	O
effusive	O
FIP	O
cases	O
(	O
n	O
=	O
20	O
),	O
FCoV	O
-	O
seropositive	O
individuals	O
(	O
n	O
=	O
8	O
)	O
and	O
FCoV	O
-	O
seronegative	O
individuals	O
(	O
n	O
=	O
18	O
).	O

A	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
induced	O
ALI	O
rat	B-SPEC
model	O
was	O
established	O
through	O
intratracheal	O
instillation	O
.	O

TITLE	O
:	O
Functional	O
analysis	O
of	O
potential	O
cleavage	O
sites	O
in	O
the	O
MERS	O
-	O
coronavirus	B-SPEC
spike	O
protein	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
related	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
can	O
cause	O
severe	O
disease	O
and	O
has	O
pandemic	O
potential	O
.	O

In	O
this	O
review	O
article	O
,	O
we	O
describe	O
the	O
most	O
recent	O
findings	O
associated	O
to	O
neurologic	O
complications	O
,	O
along	O
with	O
data	O
about	O
the	O
possible	O
invasion	O
routes	O
of	O
these	O
viruses	B-SPEC
in	O
humans	B-SPEC
and	O
their	O
various	O
effects	O
on	O
the	O
CNS	O
,	O
as	O
studied	O
in	O
animal	B-SPEC
models	O
.	O

ABSTRACT	O
:	O
The	O
prognosis	O
of	O
mycoplasma	B-SPEC
pneumonia	O
in	O
adults	O
is	O
generally	O
favorable	O
,	O
but	O
a	O
few	O
patients	O
show	O
progression	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

We	O
have	O
described	O
the	O
management	O
of	O
a	O
patient	O
who	O
showed	O
progression	O
of	O
mycoplasma	B-SPEC
pneumonia	O
to	O
ARDS	O
.	O

The	O
risk	O
of	O
primary	O
and	O
repeated	O
infections	O
with	O
the	O
same	O
virus	B-SPEC
was	O
evaluated	O
using	O
Poisson	O
regression	O
.	O

The	O
incidence	O
of	O
subsequent	O
infection	O
did	O
not	O
change	O
when	O
previous	O
infection	O
with	O
the	O
same	O
or	O
another	O
respiratory	O
virus	B-SPEC
occurred	O
.	O

The	O
major	O
cause	O
of	O
myocarditis	O
in	O
the	O
paediatric	O
population	O
is	O
viral	O
infection	O
,	O
including	O
coxsackievirus	B-SPEC
B3	O
,	O
adenovirus	B-SPEC
,	O
herpesvirus	B-SPEC
,	O
parvovirus	B-SPEC
,	O
influenza	O
A	O
and	O
B	O
,	O
and	O
hepatitis	O
.	O

Molecular	O
tests	O
showed	O
the	O
presence	O
of	O
rhinovirus	B-SPEC
C	O
genetic	O
material	O
in	O
both	O
serum	O
and	O
swab	O
samples	O
.	O

We	O
report	O
the	O
possible	O
association	O
of	O
rhinovirus	B-SPEC
C	O
and	O
myocarditis	O
in	O
a	O
child	O
presenting	O
with	O
acute	O
onset	O
of	O
dilated	O
cardiomyopathy	O
.	O

TITLE	O
:	O
Molecular	O
identification	O
of	O
Betacoronavirus	B-SPEC
in	O
bats	B-SPEC
from	O
Sardinia	O
(	O
Italy	O
):	O
first	O
detection	O
and	O
phylogeny	O
.	O

Approximately	O
41	O
.	O
8	O
%	O
(	O
41	O
/	O
98	O
)	O
of	O
diarrhoeic	O
samples	O
and	O
5	O
.	O
7	O
%	O
(	O
4	O
/	O
70	O
)	O
of	O
non	O
-	O
diarrhoeic	O
samples	O
were	O
nebovirus	B-SPEC
-	O
positive	O
based	O
on	O
RT	O
-	O
PCR	O
results	O
,	O
and	O
some	O
diarrhoeic	O
samples	O
were	O
co	O
-	O
infected	O
with	O
bovine	B-SPEC
rotavirus	B-SPEC
(	O
73	O
.	O
2	O
%),	O
bovine	B-SPEC
coronavirus	B-SPEC
(	O
36	O
.	O
6	O
%)	O
and	O
/	O
or	O
bovine	B-SPEC
viral	O
diarrhoea	O
virus	B-SPEC
(	O
31	O
.	O
7	O
%).	O

TITLE	O
:	O
The	O
In	O
Ovo	B-SPEC
Delivery	O
of	O
CpG	O
Oligonucleotides	O
Protects	O
against	O
Infectious	O
Bronchitis	O
with	O
the	O
Recruitment	O
of	O
Immune	O
Cells	O
into	O
the	O
Respiratory	O
Tract	O
of	O
Chickens	B-SPEC
.	O

At	O
3	O
days	O
post	O
infection	O
(	O
dpi	O
),	O
we	O
found	O
an	O
increased	O
recruitment	O
of	O
macrophages	O
,	O
cluster	O
of	O
differentiation	O
(	O
CD	O
)	O
8α	O
+	O
and	O
CD4	O
+	O
T	O
lymphocytes	O
,	O
and	O
an	O
up	O
-	O
regulation	O
of	O
interferon	O
(	O
IFN	O
)-	O
γ	O
mRNA	O
in	O
the	O
respiratory	O
tract	O
of	O
the	O
chickens	B-SPEC
.	O

Overall	O
,	O
it	O
may	O
be	O
inferred	O
that	O
CpG	O
ODNs	O
,	O
when	O
delivered	O
in	O
ovo	B-SPEC
,	O
provide	O
protection	O
against	O
IBV	B-SPEC
infection	O
induced	O
morbidity	O
and	O
mortality	O
with	O
an	O
enhanced	O
immune	O
response	O
.	O

Phylogenetic	O
analysis	O
conducted	O
on	O
bat	B-SPEC
Alpha	O
-	O
CoV	O
strains	O
revealed	O
their	O
evolutive	O
correlation	O
to	O
human	B-SPEC
strains	O
,	O
suggesting	O
their	O
origin	O
in	O
bats	B-SPEC
.	O

The	O
complete	O
genome	O
analysis	O
showed	O
the	O
correlation	O
of	O
the	O
Italians	O
strains	O
with	O
a	O
Chinese	O
strain	O
detected	O
in	O
2013	O
and	O
,	O
based	O
on	O
CoV	O
molecular	O
species	B-SPEC
demarcation	O
,	O
two	O
new	O
Alpha	O
-	O
CoV	O
species	B-SPEC
were	O
established	O
.	O

ABSTRACT	O
:	O
Respiratory	O
problems	O
are	O
common	O
in	O
Morquio	O
-	O
A	O
syndrome	O
(	O
MPS	O
IVA	B-SPEC
)	O
but	O
objective	O
data	O
on	O
sleep	O
-	O
disordered	O
breathing	O
are	O
scarce	O
.	O

Among	O
the	O
10	O
patients	O
with	O
OSA	B-SPEC
,	O
3	O
had	O
prior	O
adenoidectomy	O
±	O
tonsillectomy	O
and	O
6	O
were	O
on	O
enzyme	O
replacement	O
therapy	O
.	O

Prevalence	O
of	O
OSA	B-SPEC
is	O
high	O
in	O
patients	O
with	O
MPS	O
IVA	B-SPEC
,	O
underlying	O
the	O
importance	O
of	O
a	O
systematic	O
screening	O
for	O
sleep	O
-	O
disordered	O
breathing	O
.	O

RESULTS	O
:	O
In	O
wt	O
mice	B-SPEC
,	O
lung	O
mechanics	O
,	O
body	O
weight	O
and	O
body	O
temperature	O
deteriorated	O
in	O
the	O
LPS	O
-	O
group	O
during	O
the	O
early	O
phase	O
(	O
up	O
to	O
d4	O
);	O
these	O
alterations	O
were	O
accompanied	O
by	O
increased	O
leukocyte	O
numbers	O
and	O
inflammatory	O
cytokine	O
levels	O
in	O
the	O
BALF	O
.	O

TITLE	O
:	O
Characteristics	O
,	O
management	O
,	O
and	O
in	O
-	O
hospital	O
mortality	O
among	O
patients	O
with	O
severe	O
sepsis	B-SPEC
in	O
intensive	O
care	O
units	O
in	O
Japan	O
:	O
the	O
FORECAST	O
study	O
.	O

ABSTRACT	O
:	O
Sepsis	B-SPEC
is	O
a	O
leading	O
cause	O
of	O
death	O
and	O
long	O
-	O
term	O
disability	O
in	O
developed	O
countries	O
.	O

The	O
median	O
Sepsis	B-SPEC
-	O
related	O
Organ	O
Failure	O
Assessment	O
(	O
SOFA	O
)	O
score	O
was	O
9	O
(	O
IQR	O
6	O
-	O
11	O
).	O

RESULTS	O
:	O
In	O
total	O
,	O
1184	O
patients	O
(	O
median	O
age	O
73	O
years	O
,	O
interquartile	O
range	O
(	O
IQR	O
)	O
64	O
-	O
81	O
)	O
with	O
severe	O
sepsis	B-SPEC
were	O
admitted	O
to	O
the	O
ICU	O
during	O
the	O
study	O
period	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
lncRNA	O
expression	O
profiles	O
during	O
PEDV	B-SPEC
infection	O
in	O
intestinal	O
porcine	B-SPEC
epithelial	O
cell	O
-	O
jejunum	O
2	O
(	O
IPEC	O
-	O
J2	O
)	O
cell	O
lines	O
by	O
next	O
-	O
generation	O
sequencing	O
and	O
identified	O
6188	O
novel	O
lncRNAs	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
a	O
major	O
pathogen	O
of	O
the	O
domestic	O
fowl	O
,	O
exhibits	O
extensive	O
antigenic	O
variation	O
.	O

In	O
this	O
study	O
,	O
we	O
compared	O
the	O
TW	O
-	O
like	O
IBV	B-SPEC
GD	O
strain	O
and	O
the	O
predominant	O
QX	O
-	O
like	O
SD	O
strain	O
in	O
terms	O
of	O
serology	O
and	O
pathogenicity	O
to	O
3	O
-	O
week	O
-	O
old	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	B-SPEC
.	O

Moreover	O
,	O
chickens	B-SPEC
infected	O
with	O
the	O
GD	O
strain	O
showed	O
inefficient	O
recovery	O
of	O
damaged	O
cilia	O
after	O
infection	O
.	O

ABSTRACT	O
:	O
TGEV	B-SPEC
can	O
induce	O
IFN	O
-	O
β	O
production	O
,	O
which	O
in	O
turn	O
plays	O
a	O
vital	O
role	O
in	O
host	O
antiviral	O
immune	O
responses	O
.	O

Our	O
previous	O
studies	O
showed	O
that	O
TGEV	B-SPEC
infection	O
activated	O
p53	O
signaling	O
to	O
induce	O
host	O
cell	O
apoptosis	O
,	O
which	O
might	O
influence	O
virus	B-SPEC
replication	O
.	O

Critically	O
,	O
only	O
14	O
%	O
of	O
the	O
birds	B-SPEC
receiving	O
the	O
vaccine	O
plus	O
Aleta	O
had	O
titer	O
levels	O
below	O
the	O
critical	O
titer	O
threshold	O
for	O
immunity	O
compared	O
to	O
28	O
%	O
of	O
the	O
birds	B-SPEC
receiving	O
the	O
vaccine	O
alone	O
and	O
40	O
%	O
of	O
the	O
unvaccinated	O
birds	B-SPEC
.	O

TITLE	O
:	O
The	O
role	O
of	O
the	O
hotel	O
industry	O
in	O
the	O
response	O
to	O
emerging	O
epidemics	O
:	O
a	O
case	O
study	O
of	O
SARS	O
in	O
2003	O
and	O
H1N1	O
swine	B-SPEC
flu	O
in	O
2009	O
in	O
Hong	O
Kong	O
.	O

TITLE	O
:	O
Gene	O
Variations	O
in	O
Cis	B-SPEC
-	O
Acting	O
Elements	O
between	O
the	O
Taiwan	O
and	O
Prototype	O
Strains	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Alter	O
Viral	O
Gene	O
Expression	O
.	O

ABSTRACT	O
:	O
In	O
2013	O
,	O
the	O
outbreak	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
in	O
Taiwan	O
caused	O
serious	O
economic	O
losses	O
.	O

This	O
risk	O
has	O
been	O
recently	O
reinforced	O
by	O
human	B-SPEC
epidemics	O
in	O
Singapore	O
of	O
SARS	O
coronavirus	B-SPEC
,	O
2009	O
pandemic	O
H1N1	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
,	O
and	O
enterovirus	B-SPEC
71	O
.	O

This	O
virus	B-SPEC
is	O
lethal	O
and	O
is	O
a	O
close	O
relative	O
of	O
a	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
which	O
is	O
responsible	O
for	O
more	O
than	O
3000	O
deaths	O
in	O
2002	O
-	O
2003	O
.	O

Until	O
we	O
don	O
'	O
t	O
have	O
proper	O
structure	O
and	O
the	O
treatment	O
of	O
MERS	O
-	O
CoV	O
,	O
We	O
should	O
take	O
precautions	O
,	O
especially	O
the	O
health	O
care	O
workers	O
,	O
Camel	B-SPEC
owners	O
and	O
Pilgrims	O
during	O
Hajj	O
and	O
Umrah	O
,	O
because	O
they	O
are	O
at	O
a	O
higher	O
risk	O
of	O
getting	O
infected	O
.	O

Therefore	O
,	O
a	O
more	O
detailed	O
study	O
was	O
undertaken	O
in	O
SPF	O
layer	O
-	O
type	O
chickens	B-SPEC
primed	O
with	O
IBV	B-SPEC
Mass	O
and	O
793B	O
vaccines	O
.	O

The	O
parameters	O
assessed	O
were	O
serological	O
response	O
,	O
respiratory	O
signs	O
,	O
egg	O
production	O
,	O
post	O
mortem	O
abnormalities	O
in	O
the	O
reproductive	O
organs	O
and	O
abdomen	O
,	O
and	O
incidence	O
of	O
IBV	B-SPEC
antigen	O
in	O
kidneys	O
.	O

In	O
dogs	B-SPEC
,	O
PAH	O
is	O
poorly	O
characterized	O
and	O
is	O
generally	O
considered	O
to	O
be	O
idiopathic	O
or	O
secondary	O
to	O
(	O
for	O
example	O
)	O
congenital	O
left	O
-	O
to	O
right	O
cardiovascular	O
shunts	O
or	O
heartworm	O
disease	O
.	O

An	O
11	O
-	O
year	O
-	O
old	O
,	O
intact	O
male	O
German	O
Shepherd	O
dog	B-SPEC
(	O
GSD	O
)	O
was	O
presented	O
with	O
a	O
2	O
-	O
day	O
history	O
of	O
acute	O
-	O
onset	O
dyspnea	O
and	O
generalized	O
weakness	O
.	O

No	O
causal	O
variants	O
were	O
found	O
in	O
the	O
genes	O
that	O
are	O
known	O
to	O
be	O
involved	O
in	O
human	B-SPEC
PVOD	O
and	O
PAH	O
.	O

This	O
case	O
report	O
confirms	O
that	O
PVOD	O
should	O
be	O
a	O
diagnostic	O
consideration	O
in	O
dogs	B-SPEC
presenting	O
with	O
dyspnea	O
and	O
unexplained	O
PH	O
.	O

CONCLUSIONS	O
:	O
Precise	O
administration	O
of	O
low	O
-	O
dose	O
iCO	O
is	O
feasible	O
,	O
well	O
-	O
tolerated	O
,	O
and	O
appears	O
to	O
be	O
safe	O
in	O
patients	O
with	O
sepsis	B-SPEC
-	O
induced	O
ARDS	O
.	O

While	O
pigs	B-SPEC
showed	O
severe	O
ciliary	O
loss	O
in	O
the	O
nasal	O
mucosa	O
both	O
on	O
days	O
2	O
and	O
4	O
p	O
.	O
i	O
.	O

Newborn	O
animals	B-SPEC
and	O
humans	B-SPEC
have	O
only	O
limited	O
immunity	O
upon	O
birth	O
,	O
but	O
their	O
immune	O
functions	O
are	O
expected	O
to	O
develop	O
within	O
weeks	O
to	O
months	O
and	O
eventually	O
to	O
reach	O
a	O
maturity	O
that	O
will	O
provide	O
full	O
protection	O
.	O

Although	O
data	O
reported	O
here	O
are	O
largely	O
based	O
on	O
murine	B-SPEC
and	O
bovine	B-SPEC
models	O
,	O
it	O
is	O
likely	O
that	O
this	O
test	O
will	O
be	O
applicable	O
to	O
humans	B-SPEC
as	O
well	O
.	O

RESULTS	O
:	O
Although	O
whole	O
genome	O
sequencing	O
of	O
these	O
two	O
Mass	O
IBV	B-SPEC
isolates	O
showed	O
low	O
similarity	O
with	O
the	O
M41	O
vaccinal	O
strain	O
,	O
they	O
had	O
an	O
identical	O
nucleotide	O
sequence	O
at	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
3a	O
,	O
3b	O
,	O
envelop	O
(	O
E	O
),	O
matrix	O
(	O
M	O
),	O
5a	O
and	O
5b	O
.	O

Nevertheless	O
,	O
both	O
IBV	B-SPEC
isolates	O
elicited	O
host	O
responses	O
characterized	O
by	O
significant	O
macrophage	O
recruitment	O
to	O
the	O
respiratory	O
tract	O
and	O
there	O
was	O
evidence	O
that	O
both	O
IBV	B-SPEC
isolates	O
replicated	O
within	O
tracheal	O
and	O
lung	O
macrophages	O
.	O

Additionally	O
,	O
our	O
in	O
vivo	O
findings	O
suggested	O
that	O
TRIM8	O
knockdown	O
effectively	O
attenuated	O
LPS	O
-	O
induced	O
lung	O
injury	O
nu	O
decrease	O
of	O
lung	O
wet	O
/	O
dry	O
(	O
W	O
/	O
T	O
)	O
ratio	O
,	O
protein	O
concentrations	O
,	O
neutrophil	O
infiltration	O
,	O
myeloperoxidase	O
(	O
MPO	O
)	O
activity	O
,	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
)	O
production	O
and	O
superoxide	O
dismutase	O
(	O
SOD	O
)	O
depletion	O
.	O

Furthermore	O
,	O
TRIM8	O
knockdown	O
evidently	O
improved	O
nuclear	O
factor	O
-	O
erythroid	O
2	O
related	O
factor	O
2	O
(	O
Nrf2	O
)	O
and	O
heme	O
oxygenase	O
-	O
1	O
(	O
HO	O
-	O
1	O
)	O
expressions	O
in	O
lung	O
of	O
LPS	O
-	O
treated	O
mice	B-SPEC
.	O

In	O
this	O
study	O
,	O
the	O
circRNA	O
expression	O
profile	O
during	O
porcine	B-SPEC
endemic	O
diarrhea	O
virus	B-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
in	O
IPEC	O
-	O
J2	O
cell	O
line	O
was	O
investigated	O
using	O
the	O
next	O
-	O
generation	O
sequencing	O
technology	O
.	O

Further	O
analysis	O
verified	O
the	O
existence	O
of	O
eight	O
selected	O
circRNAs	O
and	O
confirmed	O
that	O
PEDV	B-SPEC
infection	O
alerted	O
the	O
expression	O
patterns	O
of	O
circRNAs	O
and	O
their	O
linear	O
parent	O
genes	O
in	O
IPEC	O
-	O
J2	O
cell	O
line	O
.	O

Bat	B-SPEC
dipeptidyl	O
peptidase	O
4	O
(	O
DPP4	O
)	O
sequences	O
were	O
closely	O
related	O
to	O
those	O
of	O
human	B-SPEC
and	O
non	O
-	O
human	B-SPEC
primates	B-SPEC
but	O
distinct	O
from	O
dromedary	B-SPEC
DPP4	O
sequence	O
.	O

TITLE	O
:	O
Erratum	O
for	O
Byukusenge	O
et	O
al	O
.,	O
""""	O
Complete	O
Genome	O
Sequences	O
of	O
Four	O
Bovine	B-SPEC
Coronavirus	B-SPEC
Isolates	O
from	O
Pennsylvania	O
"""."	O

The	O
indel	O
sites	O
of	O
the	O
spike	O
(	O
S	O
)	O
gene	O
of	O
CH	O
/	O
FJWT	O
/	O
2018	O
were	O
most	O
similar	O
to	O
those	O
of	O
bat	B-SPEC
-	O
origin	O
SADS	O
-	O
related	O
coronaviruses	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
coronavirus	I-SPEC
,	O
the	O
causative	O
agent	O
of	O
avian	B-SPEC
infectious	O
bronchitis	O
,	O
occurs	O
as	O
multiple	O
genotypes	O
and	O
lineages	O
,	O
and	O
full	O
genomes	O
are	O
not	O
available	O
for	O
the	O
majority	O
of	O
them	O
.	O

We	O
evaluated	O
this	O
ventilator	O
/	O
concentrator	O
system	O
with	O
closed	O
loop	O
control	O
of	O
oxygen	O
output	O
in	O
a	O
porcine	B-SPEC
model	O
.	O

Lung	O
injury	O
for	O
experiments	O
2	O
and	O
3	O
was	O
induced	O
in	O
the	O
animals	B-SPEC
by	O
warmed	O
saline	O
lavage	O
via	O
the	O
endotracheal	O
tube	O
until	O
PaO2	O
/	O
FIO2	O
decreased	O
to	O
<	O
100	O
.	O

ABSTRACT	O
:	O
Patients	O
with	O
severe	O
malaria	O
or	O
sepsis	B-SPEC
are	O
at	O
risk	O
of	O
developing	O
life	O
-	O
threatening	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Serial	O
point	O
-	O
of	O
-	O
care	O
lung	O
ultrasound	O
studies	O
were	O
performed	O
on	O
four	O
consecutive	O
days	O
in	O
a	O
planned	O
sub	O
study	O
of	O
an	O
observational	O
cohort	O
of	O
patients	O
with	O
malaria	O
or	O
sepsis	B-SPEC
in	O
Bangladesh	O
.	O

This	O
study	O
examined	O
the	O
combined	O
use	O
of	O
an	O
ELISA	O
and	O
Western	O
blot	O
(	O
WB	O
)	O
to	O
detect	O
antibodies	O
against	O
the	O
nucleocapsid	O
protein	O
(	O
N	O
)	O
of	O
IBV	B-SPEC
.	O

Out	O
of	O
244	O
sera	O
that	O
scored	O
positive	O
in	O
the	O
commercial	O
ELISA	O
IDEXX	O
IBV	B-SPEC
Ab	O
Test	O
,	O
220	O
were	O
also	O
positive	O
in	O
the	O
ELISA	O
-	O
rN	O
,	O
yielding	O
an	O
ELISA	O
-	O
rN	O
test	O
sensitivity	O
of	O
90	O
.	O
16	O
%.	O

ABSTRACT	O
:	O
Cardiac	O
dysfunction	O
is	O
a	O
common	O
accompaniment	O
to	O
severe	O
sepsis	B-SPEC
.	O

RSV	B-SPEC
is	O
more	O
dominant	O
and	O
can	O
be	O
subtyped	O
as	O
RSV	B-SPEC
-	O
A	O
and	O
RSV	B-SPEC
-	O
B	O
(	O
BA	O
-	O
9	O
,	O
BA	O
-	O
10	O
,	O
and	O
BA	O
-	O
13	O
).	O

TITLE	O
:	O
SARS	O
,	O
MERS	O
and	O
coronavirus	B-SPEC
infections	O
.	O

In	O
2013	O
,	O
China	O
WHO	O
reported	O
new	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
H7N9	O
infected	O
to	O
human	B-SPEC
.	O

Travelers	O
'	O
diarrhea	O
is	O
the	O
most	O
common	O
and	O
caused	O
by	O
diarrheagenic	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
and	O
other	O
patho	O
-	O
gens	O
.	O

TITLE	O
:	O
Severe	O
aortic	O
regurgitation	O
masked	O
as	O
sepsis	B-SPEC
-	O
induced	O
ARDS	O
in	O
a	O
patient	O
with	O
ABSTRACT	O
:	O
Septic	O
shock	O
is	O
the	O
most	O
common	O
type	O
of	O
shock	O
in	O
the	O
intensive	O
care	O
unit	O
with	O
an	O
associated	O
mortality	O
close	O
to	O
50	O
%.	O

More	O
female	O
camels	B-SPEC
were	O
significantly	O
seropositive	O
(	O
74	O
.	O
28	O
%,	O
95	O
%	O
CI	O
71	O
.	O
14	O
-	O
77	O
.	O
19	O
)	O
than	O
male	O
camels	B-SPEC
(	O
P	O
<	O
0	O
.	O
001	O
)	O
(	O
53	O
.	O
74	O
%,	O
95	O
%	O
CI	O
48	O
.	O
48	O
-	O
58	O
.	O
90	O
).	O

Further	O
one	O
-	O
health	O
surveillance	O
approaches	O
in	O
camels	B-SPEC
,	O
wildlife	O
,	O
and	O
human	B-SPEC
populations	O
are	O
needed	O
.	O

This	O
shortcoming	O
appears	O
particularly	O
relevant	O
since	O
the	O
described	O
scenario	O
could	O
likely	O
be	O
shared	O
by	O
many	O
other	O
IBV	B-SPEC
genotypes	O
and	O
pathogens	O
in	O
general	O
.	O

Furthermore	O
,	O
the	O
case	O
1	O
patient	O
carried	O
the	O
H7N9	O
virus	B-SPEC
for	O
a	O
prolonged	O
period	O
,	O
reaching	O
28	O
days	O
,	O
and	O
both	O
of	O
them	O
stayed	O
in	O
the	O
hospital	O
for	O
more	O
than	O
two	O
months	O
.	O

To	O
identify	O
the	O
cellular	O
proteins	O
that	O
interact	O
with	O
the	O
TGEV	B-SPEC
M	O
protein	O
,	O
yeast	B-SPEC
two	O
-	O
hybrid	O
screening	O
was	O
employed	O
,	O
and	O
seven	O
cellular	O
proteins	O
were	O
identified	O
M	O
-	O
binding	O
partners	O
.	O

A	O
knockdown	O
of	O
EIF4A2	O
by	O
siRNA	O
markedly	O
decreased	O
M	O
protein	O
proliferation	O
and	O
TGEV	B-SPEC
replication	O
in	O
target	O
cells	O
.	O

TITLE	O
:	O
Coronaviruses	O
in	O
Avian	B-SPEC
Species	B-SPEC
-	O
Review	O
with	O
Focus	O
on	O
Epidemiology	O
and	O
Diagnosis	O
in	O
Wild	O
Birds	B-SPEC
.	O

TITLE	O
:	O
Changing	O
epidemiological	O
patterns	O
of	O
HIV	B-SPEC
and	O
AIDS	O
in	O
China	O
in	O
the	O
post	O
-	O
SARS	O
era	O
identified	O
by	O
the	O
nationwide	O
surveillance	O
system	O
.	O

HIV	B-SPEC
and	O
AIDS	O
showed	O
an	O
increasing	O
trend	O
in	O
China	O
from	O
2004	O
to	O
2014	O
,	O
respectively	O
,	O
but	O
the	O
epidemic	O
tended	O
to	O
be	O
under	O
control	O
among	O
provinces	O
and	O
young	O
people	O
that	O
used	O
to	O
have	O
a	O
high	O
HIV	B-SPEC
and	O
AIDS	O
incidence	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
483	O
,	O
010	O
newly	O
HIV	B-SPEC
infections	O
and	O
214	O
,	O
205	O
AIDS	O
cases	O
were	O
reported	O
between	O
2004	O
and	O
2014	O
nationwide	O
.	O

To	O
explore	O
whether	O
the	O
inhibition	O
of	O
MK2	O
activation	O
has	O
the	O
same	O
effect	O
in	O
experimental	O
animals	B-SPEC
,	O
MMI	O
-	O
0100	O
,	O
a	O
peptide	O
-	O
mediated	O
inhibitor	O
of	O
MK2	O
,	O
was	O
used	O
to	O
verify	O
whether	O
MMI	O
-	O
0100	O
can	O
ameliorate	O
lung	O
inflammation	O
in	O
a	O
mouse	B-SPEC
model	O
of	O
ARDS	O
by	O
reducing	O
endothelial	O
expression	O
of	O
ICAM	O
-	O
1	O
.	O

The	O
mRNA	O
expression	O
of	O
ICAM	O
-	O
1	O
in	O
mouse	B-SPEC
PMVECs	O
was	O
determined	O
using	O
RT	O
-	O
PCR	O
,	O
and	O
the	O
protein	O
expression	O
of	O
MK2	O
and	O
ICAM	O
-	O
1	O
in	O
mouse	B-SPEC
PMVECs	O
was	O
analyzed	O
using	O
Western	O
blotting	O
and	O
immunohistochemistry	O
.	O

The	O
mRNA	O
and	O
protein	O
expression	O
of	O
ICAM	O
-	O
1	O
in	O
the	O
LPS	O
group	O
was	O
significantly	O
higher	O
than	O
in	O
the	O
control	O
group	O
in	O
mouse	B-SPEC
PMVECs	O
,	O
and	O
the	O
ICAM	O
-	O
1	O
level	O
was	O
reduced	O
after	O
the	O
administration	O
of	O
MMI	O
-	O
0100	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
PEDV	B-SPEC
can	O
be	O
shed	O
in	O
semen	O
from	O
SPF	O
(	O
specific	O
pathogens	O
free	O
)	O
boars	B-SPEC
infected	O
by	O
a	O
French	O
S	O
-	O
InDel	O
PEDV	B-SPEC
strain	O
(	O
PEDV	B-SPEC
/	O
FR	O
/	O
001	O
/	O
2014	O
)	O
and	O
in	O
case	O
of	O
positive	O
semen	O
to	O
determine	O
the	O
infectivity	O
of	O
that	O
semen	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
induces	O
TLR3	O
,	O
IL	O
-	O
12	O
,	O
IFN	O
-	O
α	O
,	O
IFN	O
-	O
β	O
and	O
PKR	O
mRNA	O
expression	O
in	O
infected	O
Peyer	O
'	O
s	O
patches	O
in	O
vivo	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
newly	O
identified	O
swine	B-SPEC
enteropathogenic	O
coronavirus	B-SPEC
that	O
causes	O
watery	O
diarrhea	O
in	O
piglets	O
and	O
results	O
in	O
significant	O
economic	O
losses	O
to	O
the	O
pig	B-SPEC
industry	O
.	O

TITLE	O
:	O
Effect	O
of	O
route	O
of	O
inoculation	O
on	O
innate	O
and	O
adaptive	O
immune	O
responses	O
to	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infection	O
in	O
suckling	O
pigs	B-SPEC
.	O

Intranasal	O
inoculation	O
elicited	O
significantly	O
higher	O
titers	O
of	O
virus	B-SPEC
-	O
specific	O
IgG	O
antibodies	O
in	O
serum	O
.	O

PEDV	B-SPEC
-	O
infected	O
and	O
control	O
pigs	B-SPEC
had	O
low	O
,	O
but	O
detectable	O
NK	O
cell	O
activities	O
at	O
14	O
and	O
21	O
dpi	O
,	O
however	O
,	O
NK	O
cell	O
activities	O
were	O
barely	O
detectable	O
at	O
7	O
dpi	O
whether	O
the	O
pigs	B-SPEC
were	O
infected	O
or	O
not	O
.	O

Serum	O
IL	O
-	O
10	O
levels	O
were	O
induced	O
drastically	O
in	O
orally	O
infected	O
pigs	B-SPEC
at	O
7	O
dpi	O
and	O
then	O
gradually	O
declined	O
.	O

ABSTRACT	O
:	O
Spotted	B-SPEC
fever	I-SPEC
group	I-SPEC
of	O
rickettsial	O
infections	O
are	O
emerging	O
in	O
Sri	O
Lanka	B-SPEC
.	O

TITLE	O
:	O
Alterations	O
in	O
sialic	O
-	O
acid	O
O	O
-	O
acetylation	O
glycoforms	O
during	O
murine	B-SPEC
erythrocyte	O
development	O
.	O

Finally	O
,	O
by	O
using	O
dual	O
R18	O
/	O
DiOC	O
labeled	O
IBV	B-SPEC
,	O
we	O
observed	O
that	O
membrane	O
fusion	O
was	O
induced	O
after	O
1	O
h	O
.	O
p	O
.	O
i	O
.	O

This	O
ncRNA	O
consists	O
of	O
563	O
nucleotides	O
excluding	O
a	O
poly	O
(	O
A	O
)	O
tail	O
,	O
is	O
mainly	O
derived	O
from	O
the	O
3	O
'-	O
untranslated	O
region	O
of	O
IBV	B-SPEC
genome	O
,	O
and	O
contains	O
a	O
63	O
-	O
nt	O
-	O
long	O
of	O
terminal	O
leader	O
sequence	O
derived	O
from	O
the	O
5	O
'	O
end	O
of	O
the	O
viral	O
genome	O
.	O

TITLE	O
:	O
Respiratory	O
Viral	O
Infections	O
in	O
Patients	O
With	O
Cancer	B-SPEC
or	O
Undergoing	O
Hematopoietic	O
Cell	O
Transplant	O
.	O

CNS	O
infection	O
with	O
the	O
neurotropic	O
strain	O
of	O
mouse	B-SPEC
hepatitis	O
virus	B-SPEC
(	O
MHV	B-SPEC
)	O
induces	O
an	O
acute	O
encephalomyelitis	O
associated	O
with	O
focal	O
areas	O
of	O
demyelination	O
,	O
which	O
is	O
sustained	O
during	O
viral	O
persistence	O
.	O

Mice	B-SPEC
deficient	O
for	O
RIPK1	O
,	O
specifically	O
in	O
liver	O
parenchymal	O
cells	O
(	O
Ripk1	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
prevalence	O
of	O
human	B-SPEC
bocavirus	I-SPEC
(	O
hBoV	O
),	O
human	B-SPEC
coronaviruses	O
(	O
hCoV	O
),	O
and	O
human	B-SPEC
polyomaviruses	B-SPEC
(	O
hPyV	O
)	O
among	O
patients	O
with	O
severe	O
acute	O
respiratory	O
illness	O
(	O
SARI	O
),	O
in	O
South	O
Africa	O
.	O

Next	O
,	O
the	O
site	O
-	O
specific	O
editing	O
of	O
pAPN	O
porcine	B-SPEC
fetal	O
fibroblasts	O
were	O
produced	O
,	O
and	O
then	O
the	O
cell	O
colonies	O
were	O
used	O
as	O
donor	O
cells	O
to	O
generate	O
the	O
site	O
-	O
specific	O
editing	O
of	O
pAPN	O
pigs	B-SPEC
.	O

Clinical	O
features	O
of	O
ECoV	O
infection	O
have	O
been	O
described	O
,	O
but	O
no	O
study	O
has	O
compared	O
these	O
features	O
to	O
those	O
of	O
Salmonella	B-SPEC
infections	O
.	O

These	O
include	O
CoVs	O
that	O
cause	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
),	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
),	O
porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
and	O
severe	O
acute	O
diarrhea	O
syndrome	O
(	O
SADS	O
).	O

We	O
speculate	O
about	O
future	O
studies	O
that	O
are	O
critical	O
to	O
identify	O
how	O
bats	B-SPEC
can	O
harbor	O
multiple	O
strains	O
of	O
CoVs	O
and	O
factors	O
that	O
enable	O
these	O
viruses	B-SPEC
to	O
""""	O
jump	O
""""	O
from	O
bats	B-SPEC
to	O
other	O
mammals	B-SPEC
.	O

TITLE	O
:	O
Development	O
of	O
a	O
Whole	O
-	O
Virus	B-SPEC
ELISA	O
for	O
Serological	O
Evaluation	O
of	O
Domestic	O
Livestock	O
as	O
Possible	O
Hosts	O
of	O
Human	B-SPEC
Coronavirus	I-SPEC
NL63	I-SPEC
.	O

Optimization	O
of	O
the	O
ELISA	O
showed	O
a	O
capability	O
of	O
the	O
assay	O
to	O
significantly	O
distinguish	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
from	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
(	O
U	O
=	O
27	O
.	O
50	O
,	O

After	O
inoculation	O
,	O
P3	O
caused	O
diarrhea	O
in	O
all	O
pigs	B-SPEC
with	O
a	O
high	O
level	O
of	O
fecal	O
viral	O
RNA	O
shedding	O
.	O

Compared	O
with	O
the	O
P120	O
group	O
,	O
pigs	B-SPEC
in	O
the	O
P100C4	O
group	O
had	O
a	O
more	O
rapid	O
decline	O
in	O
fecal	O
PEDV	B-SPEC
RNA	O
shedding	O
titers	O
,	O
higher	O
titers	O
of	O
serum	O
PEDV	B-SPEC
-	O
specific	O
IgG	O
,	O
IgA	O
,	O
and	O
VN	O
Abs	O
,	O
and	O
higher	O
numbers	O
of	O
intestinal	O
IgA	O
Ab	O
-	O
secreting	O
cells	O
.	O

Influenza	O
A	O
(	O
other	O
than	O
H1N1	O
),	O
Influenza	O
B	O
,	O
Human	B-SPEC
Coronavirus	I-SPEC
229E	I-SPEC
and	O
Enterovirus	B-SPEC
were	O
not	O
detected	O
.	O

Moreover	O
,	O
using	O
time	O
-	O
of	O
-	O
addition	O
assays	O
and	O
RT	O
-	O
qPCR	O
,	O
we	O
found	O
that	O
delayed	O
addition	O
of	O
Griffithsin	O
had	O
a	O
weaker	O
inhibitory	O
effect	O
on	O
PEDV	B-SPEC
than	O
earlier	O
treatment	O
.	O

These	O
preliminary	O
data	O
may	O
suggest	O
a	O
possible	O
role	O
of	O
polyomaviruses	B-SPEC
in	O
SARI	O
among	O
immunocompromised	O
adult	O
patients	O
.	O

We	O
investigated	O
the	O
cross	O
protection	O
of	O
the	O
vaccine	O
by	O
assessing	O
the	O
traqueal	O
ciliostasis	O
,	O
virus	B-SPEC
recovery	O
,	O
and	O
histopathological	O
changes	O
typically	O
observed	O
in	O
the	O
respiratory	O
tract	O
.	O

TITLE	O
:	O
Genetic	O
and	O
biological	O
characteristics	O
of	O
four	O
novel	O
recombinant	O
avian	B-SPEC
infectious	O
bronchitis	O
viruses	B-SPEC
isolated	O
in	O
China	O
.	O

In	O
order	B-SPEC
to	O
confirm	O
the	O
previous	O
results	O
and	O
further	O
extend	O
our	O
understanding	O
about	O
the	O
characteristics	O
of	O
the	O
four	O
recombinant	O
IBV	B-SPEC
strains	O
we	O
had	O
previously	O
identified	O
(	O
I0718	O
/	O
17	O
,	O
I0722	O
/	O
17	O
,	O
I0724	O
/	O
17	O
,	O
and	O
I0737	O
/	O
17	O
),	O
we	O
conducted	O
phylogenetic	O
analysis	O
by	O
comparing	O
their	O
complete	O
S1	O
gene	O
sequences	O
with	O
those	O
of	O
71	O
reference	O
strains	O
of	O
different	O
genotypes	O
and	O
lineages	O
.	O

Pretreatment	O
(	O
exclusion	O
assay	O
),	O
coincubation	O
(	O
competition	O
assay	O
),	O
and	O
post	O
-	O
treatment	O
(	O
displacement	O
assay	O
)	O
of	O
PEDV	B-SPEC
-	O
infected	O
Vero	O
cells	O
with	O
the	O
S	O
-	O
layer	O
protein	O
was	O
examined	O
.	O

Interestingly	O
,	O
significant	O
inhibition	O
of	O
PEDV	B-SPEC
by	O
S	O
-	O
layer	O
protein	O
was	O
only	O
observed	O
in	O
the	O
exclusion	O
assay	O
.	O

The	O
molecule	O
is	O
present	O
as	O
a	O
dimer	O
in	O
the	O
crystal	O
structure	O
and	O
this	O
oligomerization	O
state	O
is	O
confirmed	O
in	O
solution	O
,	O
as	O
measured	O
by	O
additional	O
methods	O
including	O
small	O
-	O
angle	O
X	O
-	O
ray	B-SPEC
scattering	O
measurements	O
.	O

ABSTRACT	O
:	O
Bats	B-SPEC
have	O
long	O
been	O
observed	O
to	O
be	O
the	O
hosts	O
and	O
the	O
origin	O
of	O
numerous	O
human	B-SPEC
diseases	O
.	O

Bats	B-SPEC
,	O
like	O
all	O
mammals	B-SPEC
,	O
rely	O
on	O
a	O
number	O
of	O
innate	O
immune	O
mechanisms	O
to	O
combat	O
invading	O
pathogens	O
,	O
including	O
the	O
interferon	O
type	O
I	O
,	O
II	O
and	O
III	O
responses	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
emerged	O
in	O
2012	O
and	O
caused	O
continual	O
outbreaks	O
worldwide	O
with	O
high	O
mortality	O
.	O

TITLE	O
:	O
Single	O
Chain	O
Fragment	O
Variable	O
(	O
scFv	O
)	O
Antibodies	O
Targeting	O
the	O
Spike	O
Protein	O
of	O
Porcine	B-SPEC
Epidemic	I-SPEC
Diarrhea	I-SPEC
Virus	I-SPEC
Provide	O
Protection	O
against	O
Viral	O
Infection	O
in	O
Piglets	O
.	O

These	O
scFvs	O
were	O
shown	O
to	O
inhibit	O
PEDV	B-SPEC
infectivity	O
by	O
the	O
plaque	O
reduction	O
neutralization	O
assay	O
.	O

The	O
potential	O
of	O
scFvs	O
to	O
provide	O
prevention	O
against	O
PEDV	B-SPEC
infections	O
in	O
piglets	O
was	O
further	O
investigated	O
.	O

In	O
this	O
review	O
,	O
we	O
focus	O
on	O
our	O
current	O
understanding	O
of	O
the	O
epidemiology	O
,	O
pathogenesis	O
,	O
prevention	O
,	O
and	O
treatment	O
of	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
,	O
as	O
well	O
as	O
provides	O
details	O
on	O
the	O
pivotal	O
structure	O
and	O
function	O
of	O
the	O
spike	O
proteins	O
(	O
S	O
proteins	O
)	O
on	O
the	O
surface	O
of	O
each	O
of	O
these	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Both	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
porcine	B-SPEC
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
),	O
which	O
cause	O
high	O
mortality	O
in	O
piglets	O
and	O
produce	O
similar	O
clinical	O
symptoms	O
and	O
histopathological	O
morphology	O
,	O
belong	O
to	O
the	O
genus	B-SPEC
Alphacoronavirus	B-SPEC
.	O

Understanding	O
how	O
cellular	O
lipids	O
may	O
modulate	O
the	O
pathogenicity	O
of	O
human	B-SPEC
-	O
pathogenic	O
coronaviruses	O
remains	O
poor	O
.	O

Utilizing	O
a	O
variety	O
of	O
platforms	O
,	O
several	O
vaccine	O
approaches	O
have	O
shown	O
efficacy	O
in	O
animal	B-SPEC
models	O
and	O
begun	O
to	O
enter	O
clinical	O
trials	O
.	O

The	O
mAbs	O
were	O
prepared	O
by	O
using	O
PEDV	B-SPEC
positive	O
hybridoma	O
cells	O
that	O
were	O
selected	O
by	O
using	O
cell	O
surface	O
fluorescence	O
immunosorbent	O
assay	O
(	O
CSFIA	O
).	O

The	O
new	O
ICA	O
was	O
used	O
to	O
measure	O
PEDV	B-SPEC
in	O
phosphate	O
buffer	O
containing	O
tween	O
-	O
20	O
.	O

The	O
present	O
study	O
is	O
a	O
prospective	O
study	O
of	O
critically	O
ill	O
adults	O
with	O
sepsis	B-SPEC
and	O
acute	O
respiratory	O
failure	O
(	O
age	O
≥	O
18	O
years	O
)	O
enrolled	O
in	O
the	O
Validating	O
Acute	O
Lung	O
Injury	O
markers	O
for	O
Diagnosis	O
(	O
VALID	O
)	O
study	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronaviruses	O
(	O
FCoVs	O
)	O
are	O
the	O
causative	O
agents	O
of	O
severe	O
systemic	O
disease	O
(	O
feline	B-SPEC
infectious	O
peritonitis	O
:	O
FIP	O
)	O
in	O
domestic	O
and	O
wild	B-SPEC
cats	I-SPEC
.	O

ABSTRACT	O
:	O
With	O
sequencing	O
technologies	O
becoming	O
cheaper	O
and	O
easier	O
to	O
use	O
,	O
more	O
groups	O
are	O
able	O
to	O
obtain	O
whole	O
genome	O
sequences	O
of	O
viruses	B-SPEC
of	O
public	O
health	O
and	O
scientific	O
importance	O
.	O

In	O
terms	O
of	O
gene	O
expression	O
(	O
mRNA	O
)	O
in	O
blood	O
there	O
have	O
been	O
found	O
to	O
be	O
increases	O
in	O
neutrophil	O
-	O
related	O
genes	O
in	O
sepsis	B-SPEC
-	O
induced	O
and	O
influenza	O
-	O
induced	O
ARDS	O
,	O
but	O
whole	O
blood	O
expression	O
does	O
not	O
give	O
a	O
robust	O
diagnostic	O
test	O
for	O
ARDS	O
.	O

Dromedary	B-SPEC
camels	B-SPEC
remain	O
the	O
only	O
documented	O
zoonotic	O
source	O
of	O
human	B-SPEC
infection	O
,	O
but	O
MERS	O
-	O
like	O
CoVs	O
have	O
been	O
detected	O
in	O
bat	B-SPEC
species	B-SPEC
globally	O
,	O
as	O
well	O
as	O
in	O
dromedary	B-SPEC
camels	B-SPEC
throughout	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O

There	O
have	O
been	O
sustained	O
health	O
care	O
-	O
associated	O
human	B-SPEC
outbreaks	O
in	O
Saudi	O
Arabia	O
and	O
South	O
Korea	O
,	O
the	O
latter	O
originating	O
from	O
one	O
traveler	O
returning	O
from	O
the	O
Middle	O
East	O
.	O

The	O
phylogenetic	O
analysis	O
indicated	O
that	O
all	O
the	O
15	O
PEDV	B-SPEC
isolates	O
clustered	O
into	O
G2	O
genotype	O
associated	O
with	O
the	O
current	O
circulating	O
strains	O
.	O

Compared	O
with	O
oral	O
infection	O
,	O
intramuscular	O
infection	O
could	O
also	O
cause	O
typical	O
clinical	O
signs	O
but	O
with	O
a	O
slightly	O
delayed	O
onset	O
,	O
confirming	O
that	O
the	O
variant	O
PEDV	B-SPEC
isolate	O
FJzz1	O
was	O
highly	O
pathogenic	O
to	O
suckling	O
piglets	O
.	O

We	O
conducted	O
a	O
literature	O
search	O
on	O
the	O
prevalence	O
of	O
PEDV	B-SPEC
infection	O
in	O
pigs	B-SPEC
between	O
Jan	O
1	O
,	O
1988	O
and	O
Aug	O
20	O
,	O
2018	O
in	O
English	O
and	O
Chinese	O
databases	O
,	O
including	O
PubMed	O
,	O
Google	O
scholar	O
,	O
Cochrane	O
library	O
,	O
Clinical	O
Trials	O
,	O
VIP	O
,	O
CNKI	O
and	O
WanFang	O
database	O
.	O

It	O
is	O
therefore	O
necessary	O
to	O
carry	O
out	O
further	O
research	O
and	O
monitor	O
the	O
prevalence	O
of	O
PEDV	B-SPEC
infection	O
.	O

Furthermore	O
,	O
powerful	O
and	O
effective	O
regulatory	O
measures	O
should	O
be	O
taken	O
in	O
order	B-SPEC
to	O
prevent	O
the	O
transmission	O
and	O
spread	O
of	O
PEDV	B-SPEC
among	O
pig	B-SPEC
populations	O
.	O

These	O
viruses	B-SPEC
are	O
well	O
-	O
recognized	O
for	O
their	O
ability	O
to	O
change	O
tissue	O
tropism	O
,	O
to	O
hurdle	O
the	O
interspecies	O
barriers	O
and	O
to	O
adapt	O
ecological	O
variations	O
.	O

There	O
has	O
been	O
an	O
increase	O
in	O
reported	O
cases	O
of	O
primary	O
peritonitis	O
due	O
to	O
Streptococcus	B-SPEC
pyogenes	I-SPEC
affecting	O
mostly	O
women	O
.	O

Although	O
viral	O
lung	O
loads	O
were	O
not	O
reduced	O
in	O
LCA60	O
-	O
treated	O
animals	B-SPEC
as	O
compared	O
to	O
controls	O
,	O
there	O
were	O
fewer	O
pathological	O
changes	O
in	O
the	O
lungs	O
.	O

TITLE	O
:	O
A	O
Fluorogenic	O
Peptide	O
Cleavage	O
Assay	O
to	O
Screen	O
for	O
Proteolytic	O
Activity	O
:	O
Applications	O
for	O
coronavirus	B-SPEC
spike	O
protein	O
activation	O
.	O

Often	O
viruses	B-SPEC
exhibit	O
cell	O
and	O
tissue	O
tropism	O
and	O
are	O
adapted	O
to	O
specific	O
cell	O
or	O
tissue	O
proteases	O
.	O

The	O
χ	O
or	O
the	O
Fisher	B-SPEC
exact	O
tests	O
were	O
used	O
.	O

The	O
respiratory	O
signs	O
,	O
post	O
-	O
mortem	O
lesions	O
(	O
tracheitis	O
and	O
pneumonia	O
)	O
and	O
histopathological	O
findings	O
of	O
lungs	O
,	O
trachea	B-SPEC
,	O
and	O
air	O
sacs	O
in	O
the	O
experimentally	O
infected	O
broiler	O
chickens	B-SPEC
appeared	O
to	O
be	O
more	O
prominent	O
in	O
the	O
chickens	B-SPEC
of	O
group	O
1	O
than	O
group	O
2	O
.	O

Expression	O
of	O
genes	O
encoding	O
inflammatory	O
cytokines	O
and	O
chemokines	O
,	O
including	O
interleukin	O
(	O
IL	O
)-	O
1β	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
15	O
,	O
tumour	O
necrosis	O
factor	O
(	O
TNF	O
)-	O
α	O
,	O
CXCL10	O
,	O
CCL8	O
,	O
interferon	O
(	O
IFN	O
)-	O
α	O
,	O
IFN	O
-	O
β	O
and	O
IFN	O
-	O
γ	O
,	O
was	O
higher	O
in	O
cats	B-SPEC
with	O
FIP	O
,	O
consistent	O
with	O
inflammatory	O
pathway	O
activation	O
.	O

ABSTRACT	O
:	O
Immunohistochemistry	O
(	O
IHC	O
)	O
of	O
tissue	O
samples	O
is	O
considered	O
the	O
gold	O
standard	O
for	O
diagnosing	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
and	O
,	O
in	O
cats	B-SPEC
without	O
body	O
cavity	O
effusion	O
,	O
IHC	O
is	O
the	O
only	O
method	O
available	O
to	O
establish	O
definitive	O
antemortem	O
diagnosis	O
.	O

Histopathology	O
of	O
biopsies	O
of	O
the	O
lesions	O
detected	O
nodular	O
pyogranulomatous	O
dermatitis	O
with	O
vasculitis	O
and	O
necrosis	O
,	O
leading	O
to	O
a	O
suspicion	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

ABSTRACT	O
:	O
Avian	B-SPEC
respiratory	O
disease	O
causes	O
significant	O
economic	O
losses	O
in	O
commercial	O
poultry	O
.	O

Cases	O
with	O
symptom	O
onset	O
between	O
January	O
2015	O
-	O
December	O
2017	O
were	O
obtained	O
from	O
a	O
publicly	O
available	O
line	O
list	O
of	O
human	B-SPEC
MERS	O
cases	O
maintained	O
by	O
the	O
World	O
Health	O
Organization	O
.	O

The	O
present	O
study	O
describes	O
development	O
and	O
evaluation	O
of	O
a	O
multiplexed	O
magnetic	O
microsphere	O
immunoassay	O
(	O
MMIA	O
)	O
to	O
simultaneously	O
detect	O
immunoglobulin	O
G	O
(	O
IgG	O
)	O
antibodies	O
specific	O
for	O
recombinant	O
nucleocapsid	O
proteins	O
(	O
recN	O
)	O
from	O
hCoVs	O
229E	O
,	O
NL63	O
,	O
OC43	O
,	O
HKU1	O
,	O
SARS	O
-	O
CoV	O
,	O
and	O
MERS	O
-	O
CoV	O
.	O
We	O
used	O
paired	O
human	B-SPEC
sera	O
to	O
screen	O
for	O
IgG	O
with	O
reactivity	O
against	O
six	O
hCoVs	O
to	O
determine	O
assay	O
sensitivity	O
,	O
specificity	O
and	O
reproducibility	O
.	O

It	O
can	O
be	O
emphasized	O
that	O
some	O
care	O
should	O
be	O
taken	O
to	O
manage	O
diarrheic	O
calves	O
:	O
the	O
pathological	O
agent	O
must	O
be	O
diagnosed	O
prior	O
to	O
treatment	O
;	O
antibacterial	O
treatment	O
should	O
be	O
with	O
antimicrobials	O
with	O
a	O
different	O
mechanism	O
of	O
action	O
;	O
and	O
finally	O
,	O
treated	O
animals	B-SPEC
should	O
be	O
maintained	O
separately	O
from	O
others	O
because	O
they	O
can	O
carry	O
micro	O
-	O
organisms	O
with	O
a	O
resistant	O
profile	O
.	O

Here	O
,	O
we	O
asked	O
if	O
the	O
EndoU	O
activity	O
of	O
porcine	B-SPEC
epidemic	O
diarrhea	O
coronavirus	B-SPEC
(	O
PEDV	B-SPEC
),	O
which	O
causes	O
acute	O
diarrhea	O
in	O
swine	B-SPEC
,	O
plays	O
a	O
role	O
in	O
antagonizing	O
the	O
innate	O
response	O
in	O
porcine	B-SPEC
epithelial	O
cells	O
and	O
macrophages	O
,	O
the	O
sites	O
of	O
viral	O
replication	O
.	O

The	O
aim	O
here	O
was	O
to	O
screen	O
symptomatic	O
pilgrims	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
other	O
viral	O
etiologies	O
.	O

TITLE	O
:	O
Construction	O
and	O
characterization	O
of	O
porcine	B-SPEC
single	O
-	O
chain	O
fragment	O
variable	O
antibodies	O
that	O
neutralize	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
in	O
vitro	O
.	O

In	O
this	O
study	O
,	O
a	O
recombinant	O
scFv	O
antibody	O
phage	O
display	O
library	O
was	O
constructed	O
from	O
peripheral	O
blood	O
lymphocytes	O
of	O
piglets	O
infected	O
with	O
TGEV	B-SPEC
.	O

All	O
three	O
scFv	O
clones	O
identified	O
had	O
neutralizing	O
activity	O
against	O
TGEV	B-SPEC
.	O

The	O
3D8	O
single	O
chain	O
variable	O
fragment	O
(	O
scFv	O
)	O
protein	O
is	O
a	O
recombinant	O
antibody	O
with	O
nuclease	O
activity	O
that	O
shows	O
antiviral	O
effects	O
against	O
various	O
DNA	O
and	O
RNA	O
viruses	B-SPEC
in	O
mice	B-SPEC
and	O
chickens	B-SPEC
.	O

In	O
all	O
,	O
19	O
.	O
3	O
%	O
of	O
patients	O
had	O
medical	O
comorbidities	O
including	O
hypertension	O
,	O
diabetes	O
,	O
obesity	O
,	O
hypothyroidism	O
,	O
and	O
anemia	B-SPEC
.	O

TITLE	O
:	O
Development	O
of	O
a	O
recombinant	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
-	O
vectored	O
vaccine	O
for	O
infectious	O
bronchitis	O
virus	B-SPEC
variant	O
strains	O
circulating	O
in	O
Egypt	O
.	O

Single	O
-	O
dose	O
vaccination	O
of	O
1	O
-	O
day	O
-	O
old	O
SPF	O
White	O
Leghorn	O
chicks	O
with	O
the	O
rNDVs	O
expressing	O
IBV	B-SPEC
S	O
protein	O
provided	O
significant	O
protection	O
against	O
clinical	O
disease	O
after	O
IBV	B-SPEC
challenge	O
but	O
did	O
not	O
show	O
reduction	O
in	O
tracheal	O
viral	O
shedding	O
.	O

These	O
results	O
indicate	O
that	O
the	O
NDV	B-SPEC
-	O
vectored	O
IBV	B-SPEC
vaccines	O
are	O
promising	O
bivalent	O
vaccine	O
candidates	O
to	O
control	O
both	O
infectious	O
bronchitis	O
and	O
Newcastle	O
disease	O
in	O
Egypt	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
HKU1	I-SPEC
(	O
HCoV	O
-	O
HKU1	O
)	O
was	O
first	O
detected	O
in	O
a	O
patient	O
with	O
viral	O
pneumonia	O
from	O
Hong	O
Kong	O
in	O
2004	O
.	O

TITLE	O
:	O
Genetic	O
Characterization	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
,	O
South	O
Korea	O
,	O
2018	O
.	O

ABSTRACT	O
:	O
We	O
evaluated	O
genetic	O
variation	O
in	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
imported	O
to	O
South	O
Korea	O
in	O
2018	O
using	O
specimens	O
from	O
a	O
patient	O
and	O
isolates	O
from	O
infected	O
Caco	O
-	O
2	O
cells	O
.	O

The	O
full	O
-	O
length	O
genome	O
of	O
QdCoV	O
detected	O
in	O
quails	O
with	O
enteritis	O
in	O
Poland	O
has	O
similar	O
organization	O
as	O
Middle	O
Eastern	O
viruses	B-SPEC
although	O
there	O
is	O
no	O
NSP7c	O
gene	O
.	O

TITLE	O
:	O
Genetic	O
and	O
antigenic	O
heterogeneity	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
South	O
America	O
:	O
implications	O
for	O
control	O
programmes	O
.	O

Since	O
most	O
IBV	B-SPEC
vaccines	O
are	O
type	O
-	O
specific	O
,	O
there	O
is	O
a	O
need	O
for	O
constant	O
surveillance	O
of	O
the	O
circulating	O
lineages	O
and	O
knowledge	O
about	O
their	O
genetic	O
and	O
antigenic	O
properties	O
.	O

The	O
GI	O
-	O
16	O
lineage	O
emerged	O
around	O
1979	O
,	O
and	O
is	O
currently	O
circulating	O
in	O
most	O
South	O
American	O
territories	O
(	O
Argentina	B-SPEC
,	O
Chile	O
,	O
Uruguay	O
,	O
Colombia	O
and	O
Peru	O
).	O

A	O
strong	O
correlation	O
was	O
found	O
between	O
PIV	O
,	O
Flu	O
(	O
influenza	O
of	O
any	O
type	O
),	O
RSV	B-SPEC
,	O
and	O
HCoV	O
with	O
the	O
incidence	O
of	O
coinfections	O
.	O

Patients	O
with	O
pediatric	O
cancer	B-SPEC
have	O
a	O
high	O
burden	O
of	O
respiratory	O
viral	O
infections	O
and	O
a	O
high	O
incidence	O
of	O
coinfections	O
.	O

HCoV	O
was	O
associated	O
with	O
bronchiolitis	O
;	O
rhinovirus	B-SPEC
was	O
associated	O
with	O
hospital	O
admission	O
.	O

ABSTRACT	O
:	O
Vaccination	O
programs	O
are	O
implemented	O
in	O
poultry	O
farms	O
to	O
limit	O
outbreaks	O
and	O
spread	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
which	O
is	O
a	O
substantial	O
economic	O
burden	O
in	O
the	O
poultry	O
industry	O
.	O

Rhinovirus	B-SPEC
and	O
coronavirus	B-SPEC
were	O
most	O
frequently	O
detected	O
.	O

ABSTRACT	O
:	O
A	O
maximum	O
clade	O
credibility	O
tree	O
constructed	O
using	O
the	O
full	O
-	O
length	O
spike	O
(	O
S	O
)	O
and	O
hemagglutinin	O
-	O
esterase	O
genes	O
revealed	O
that	O
Vietnamese	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCoV	B-SPEC
)	O
strains	O
belong	O
to	O
a	O
single	O
cluster	O
(	O
C1	O
);	O
therefore	O
,	O
they	O
might	O
share	O
a	O
common	O
origin	O
with	O
Cuban	O
and	O
Chinese	O
BCoV	B-SPEC
strains	O
.	O

Surveillance	O
was	O
instrumental	O
in	O
identifying	O
the	O
initial	O
case	O
and	O
in	O
minimizing	O
the	O
spread	O
of	O
the	O
virus	B-SPEC
to	O
other	O
farms	O
.	O

ABSTRACT	O
:	O
Insectivorous	O
bats	B-SPEC
are	O
speculated	O
to	O
be	O
ancestral	O
hosts	O
of	O
Middle	O
-	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
(	O
CoV	O
).	O

ABSTRACT	O
:	O
Since	O
pyrithiobac	O
(	O
PTB	O
)	O
is	O
a	O
successful	O
commercial	O
herbicide	O
with	O
very	O
low	O
toxicity	O
against	O
mammals	B-SPEC
,	O
it	O
is	O
worth	O
exploring	O
its	O
derivatives	O
for	O
an	O
extensive	O
study	O
.	O

From	O
the	O
bioassay	O
results	O
,	O
the	O
best	O
AHAS	O
inhibitor	O
6	O
-	O
22	O
displayed	O
weaker	O
herbicidal	O
activity	O
but	O
stronger	O
anti	O
-	O
Candida	B-SPEC
activity	O
than	O
PTB	O
did	O
.	O

For	O
plant	B-SPEC
pathogenic	O
fungi	B-SPEC
,	O
6	O
-	O
26	O
showed	O
excellent	O
activity	O
at	O
50	O
mg	O
/	O
L	O
dosage	O
.	O

ABSTRACT	O
:	O
In	O
2015	O
,	O
a	O
One	O
Health	O
Working	O
Group	O
was	O
established	O
in	O
Qatar	O
to	O
conduct	O
a	O
survey	O
in	O
the	O
Gulf	O
Cooperation	O
Council	O
countries	O
,	O
Egypt	O
,	O
and	O
Jordan	O
to	O
monitor	O
preparedness	O
of	O
public	O
health	O
and	O
veterinary	O
health	O
authorities	O
in	O
response	O
to	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
epidemic	O
.	O

Compliance	O
with	O
the	O
bundles	O
proposed	O
in	O
the	O
Surviving	O
Sepsis	B-SPEC
Campaign	O
Guidelines	O
2012	O
,	O
in	O
-	O
hospital	O
mortality	O
,	O
disposition	O
after	O
discharge	O
,	O
and	O
the	O
number	O
of	O
ICU	O
and	O
ventilator	O
-	O
free	O
days	O
were	O
evaluated	O
.	O

TITLE	O
:	O
Enhanced	O
Ability	O
of	O
Oligomeric	O
Nanobodies	O
Targeting	O
MERS	O
Coronavirus	B-SPEC
Receptor	O
-	O
Binding	O
Domain	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
an	O
infectious	O
coronavirus	B-SPEC
first	O
reported	O
in	O
2012	O
,	O
has	O
a	O
mortality	O
rate	O
greater	O
than	O
35	O
%.	O

Risk	O
adaptive	O
modeling	O
incorporating	O
disease	O
profile	O
,	O
patient	O
demographics	O
,	O
lymphodepletion	O
,	O
cell	O
dosing	O
,	O
CAR	B-SPEC
T	O
construct	O
,	O
and	O
potentially	O
cytokine	O
gene	O
polymorphisms	O
may	O
be	O
instructive	O
to	O
assess	O
individualized	O
risk	O
and	O
optimal	O
CRS	O
/	O
neurotoxicity	O
management	O
.	O

Controlled	O
clinical	O
trials	O
on	O
the	O
therapy	O
of	O
adenovirus	B-SPEC
pneumonia	O
are	O
non	O
existent	O
and	O
thus	O
there	O
is	O
no	O
established	O
therapy	O
so	O
far	O
.	O

Moderate	O
cytostatic	O
activity	O
against	O
cervix	O
carcinoma	O
(	O
HeLa	O
),	O
murine	B-SPEC
leukemia	O
(	O
L1210	O
)	O
and	O
human	B-SPEC
lymphocyte	O
(	O
CEM	O
)	O
tumor	O
cell	O
lines	O
was	O
displayed	O
by	O
the	O
protected	O
3	O
΄-	O
deoxy	O
derivatives	O
12b	O
,	O
12c	O
,	O
12d	O
,	O
and	O
the	O
3	O
΄-	O
deoxy	O
-	O
3	O
΄-	O
methyl	O
18a	O
,	O
18b	O
,	O
18c	O
.	O

TITLE	O
:	O
Point	O
-	O
of	O
-	O
care	O
diagnostic	O
assay	O
for	O
rapid	O
detection	O
of	O
porcine	B-SPEC
deltacoronavirus	O
using	O
the	O
recombinase	O
polymerase	O
amplification	O
method	O
.	O

Myong	O
Ji	O
Hospital	O
learned	O
two	O
important	O
lessons	O
in	O
responding	O
to	O
emerging	O
infectious	O
diseases	O
;	O
the	O
first	O
was	O
to	O
prepare	O
a	O
form	O
of	O
workforce	O
,	O
facility	O
,	O
manual	O
and	O
drills	B-SPEC
;	O
the	O
second	O
was	O
to	O
prepare	O
proper	O
communication	O
methods	O
.	O

ABSTRACT	O
:	O
Evaluation	O
of	O
the	O
thermal	O
and	O
physical	O
conditions	O
for	O
inactivation	O
of	O
adenovirus	B-SPEC
(	O
AdV	O
),	O
porcine	B-SPEC
sapelovirus	I-SPEC
1	O
(	O
PSV1	O
)	O
and	O
the	O
economically	O
important	O
viruses	B-SPEC
porcine	B-SPEC
epidemic	I-SPEC
diarrhoea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
porcine	B-SPEC
circovirus	I-SPEC
2	I-SPEC
(	O
PCV2	O
)	O
in	O
the	O
production	O
of	O
spray	O
-	O
dried	O
porcine	B-SPEC
plasma	O
(	O
SDPP	O
).	O

At	O
pH	O
10	O
·	O
2	O
and	O
3	O
°	O
C	O
,	O
infectivity	O
of	O
PEDV	B-SPEC
in	O
plasma	O
was	O
reduced	O
with	O
a	O
reduction	O
factor	O
of	O
4	O
·	O
2	O
log	O
10	O
(	O
LRF	O
)	O
at	O
10	O
h	O
contact	O
time	O
,	O
whereas	O
heating	O
to	O
44	O
°	O
C	O
for	O
at	O
least	O
1	O
min	O
at	O
alkali	O
pH	O
was	O
needed	O
to	O
achieve	O
a	O
LRF	O
of	O
4	O
·	O
2	O
for	O
AdV	O
.	O
Spray	O
drying	O
at	O
an	O
outlet	O
temperature	O
of	O
80	O
°	O
C	O
reduced	O
AdV	O
infectivity	O
effectively	O
(	O
LRF	O
=	O
5	O
·	O
2	O
)	O
and	O
PEDV	B-SPEC
infectivity	O
for	O
95	O
%	O
(	O
LRF	O
=	O
1	O
·	O
4	O
).	O

Lower	O
induction	O
of	O
apoptosis	O
-	O
associated	O
speck	O
-	O
like	O
protein	O
containing	O
a	O
CARD	O
(	O
ASC	O
)	O
speck	O
formation	O
and	O
secretion	O
of	O
interleukin	O
-	O
1β	O
in	O
response	O
to	O
both	O
'	O
sterile	O
'	O
stimuli	O
and	O
infection	O
with	O
multiple	O
zoonotic	O
viruses	B-SPEC
including	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(-	O
single	O
-	O
stranded	O
(	O
ss	O
)	O
RNA	O
),	O
Melaka	O
virus	B-SPEC
(	O
PRV3M	O
,	O
double	O
-	O
stranded	O
RNA	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(+	O
ssRNA	O
)	O
was	O
observed	O
.	O

Therefore	O
,	O
it	O
is	O
necessary	O
to	O
develop	O
an	O
effective	O
oral	O
vaccine	O
against	O
PEDV	B-SPEC
infection	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
and	O
reemergence	O
of	O
coronavirus	B-SPEC
epidemics	O
sparked	O
renewed	O
concerns	O
from	O
global	O
epidemiology	O
researchers	O
and	O
public	O
health	O
administrators	O
.	O

Endothelium	O
hyperpermeability	O
is	O
considered	O
the	O
hallmark	O
of	O
severe	O
lung	O
inflammation	O
,	O
and	O
the	O
cardinal	B-SPEC
feature	O
of	O
the	O
lethal	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Prevention	O
of	O
RSV	B-SPEC
is	O
limited	O
to	O
prophylaxis	O
with	O
palivizumab	O
in	O
select	O
children	O
.	O

TITLE	O
:	O
Design	O
,	O
Synthesis	O
and	O
Evaluation	O
of	O
Novel	O
Heteroaryldihydropyrimidines	O
Derivatives	O
as	O
Non	O
-	O
nucleoside	O
Hepatitis	B-SPEC
B	I-SPEC
Virus	I-SPEC
Inhibitors	O
by	O
Exploring	O
the	O
Solvent	O
-	O
exposed	O
Region	O
.	O

ABSTRACT	O
:	O
In	O
continuation	O
of	O
our	O
efforts	O
toward	O
the	O
discovery	O
of	O
potent	O
non	O
-	O
nucleoside	O
HBV	B-SPEC
inhibitors	O
with	O
novel	O
structures	O
,	O
we	O
have	O
explored	O
the	O
solvent	O
-	O
exposed	O
protein	O
region	O
of	O
heteroaryldihydropyrimidines	O
(	O
HAPs	O
)	O
derivatives	O
.	O

When	O
antibiotics	O
were	O
prescribed	O
for	O
respiratory	O
-	O
related	O
indications	O
,	O
viruses	B-SPEC
were	O
identified	O
in	O
52	O
%	O
of	O
those	O
instances	O
.	O

The	O
kidney	O
profile	O
showed	O
a	O
group	O
IV	O
genotype	O
,	O
whereas	O
the	O
trachea	B-SPEC
profile	O
showed	O
an	O
unclassified	O
group	O
.	O

Alveolar	O
macrophages	O
underwent	O
functional	O
polarization	O
in	O
acutely	O
infected	O
macaques	B-SPEC
,	O
demonstrating	O
simultaneously	O
both	O
proinflammatory	O
and	O
wound	O
-	O
healing	O
characteristics	O
.	O

TITLE	O
:	O
Bat	B-SPEC
Coronaviruses	O
in	O
China	O
.	O

Dromedary	B-SPEC
camels	B-SPEC
are	O
the	O
primary	O
zoonotic	O
reservoir	O
for	O
human	B-SPEC
infections	O
.	O

Interruption	O
of	O
the	O
zoonotic	O
transmission	O
chain	O
from	O
camels	B-SPEC
to	O
humans	B-SPEC
,	O
therefore	O
,	O
may	O
be	O
an	O
effective	O
strategy	O
to	O
control	O
the	O
ongoing	O
MERS	O
-	O
CoV	O
outbreak	O
.	O

Together	O
,	O
these	O
data	O
indicate	O
that	O
induction	O
of	O
robust	O
neutralizing	O
humoral	O
immune	O
responses	O
by	O
vaccination	O
of	O
naïve	O
animals	B-SPEC
reduces	O
shedding	O
that	O
potentially	O
could	O
diminish	O
the	O
risk	O
of	O
zoonotic	O
transmission	O
.	O

TITLE	O
:	O
Can	O
Bats	B-SPEC
Serve	O
as	O
Reservoirs	O
for	O
Arboviruses	O
?	O

Two	O
types	O
of	O
respiratory	O
viruses	B-SPEC
were	O
detected	O
in	O
7	O
cases	O
.	O

Pneumonia	O
severity	O
index	O
score	O
is	O
an	O
important	O
factor	O
for	O
assessing	O
the	O
prognosis	O
of	O
patients	O
with	O
community	O
-	O
acquired	O
pneumonia	O
,	O
regardless	O
of	O
respiratory	O
virus	B-SPEC
detection	O
.	O

TITLE	O
:	O
Phylogeographic	O
investigation	O
of	O
2014	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
transmission	O
in	O
Taiwan	O
.	O

Acknowledging	O
the	O
absence	O
of	O
a	O
thorough	O
investigation	O
at	O
the	O
geographic	O
level	O
,	O
we	O
used	O
2014	O
outbreak	O
sequence	O
information	O
from	O
the	O
Taiwan	O
government	O
'	O
s	O
open	O
access	O
databases	O
plus	O
GenBank	O
records	O
to	O
analyze	O
PEDV	B-SPEC
dissemination	O
among	O
Taiwanese	O
pig	B-SPEC
farms	O
.	O

Genetic	O
sequences	O
,	O
locations	O
,	O
and	O
dates	O
of	O
identified	O
PEDV	B-SPEC
-	O
positive	O
cases	O
were	O
used	O
to	O
assess	O
spatial	O
,	O
temporal	O
,	O
clustering	O
,	O
GIS	O
,	O
and	O
phylogeographic	O
factors	O
affecting	O
PEDV	B-SPEC
dissemination	O
.	O

These	O
results	O
solidify	O
the	O
importance	O
of	O
N	O
in	O
PEDV	B-SPEC
recovery	O
and	O
propagation	O
and	O
suggest	O
a	O
potentially	O
useful	O
consideration	O
in	O
designing	O
vaccine	O
production	O
platforms	O
for	O
PEDV	B-SPEC
or	O
closely	O
related	O
pathogens	O
.	O

TITLE	O
:	O
Molecular	O
epidemiology	O
,	O
evolution	O
and	O
phylogeny	O
of	O
SARS	O
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Shortly	O
after	O
its	O
emergence	O
in	O
southern	O
China	O
in	O
2002	O
/	O
2003	O
,	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
was	O
confirmed	O
to	O
be	O
the	O
cause	O
of	O
SARS	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
corona	B-SPEC
virus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
highly	O
pathogenic	O
.	O

TITLE	O
:	O
PEDV	B-SPEC
nsp16	O
negatively	O
regulates	O
innate	O
immunity	O
to	O
promote	O
viral	O
proliferation	O
.	O

Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
which	O
causes	O
diarrhea	O
in	O
swine	B-SPEC
of	O
all	O
ages	O
,	O
is	O
a	O
worldwide	O
-	O
distributed	O
alphacoronavirus	B-SPEC
with	O
economic	O
importance	O
.	O

Whereas	O
the	O
PEDV	B-SPEC
nsp13	O
barely	O
regulates	O
type	O
I	O
IFN	O
,	O
inflammatory	O
cytokines	O
(	O
IL	O
-	O
6	O
,	O
TNF	O
-	O
a	O
)	O
and	O
MHCII	O
,	O
nsp16	O
and	O
nsp14	O
(	O
to	O
a	O
lesser	O
extent	O
)	O
down	O
-	O
regulate	O
these	O
antiviral	O
effectors	O
.	O

In	O
addition	O
,	O
numerous	O
pathogens	O
have	O
been	O
found	O
to	O
encode	O
Ub	O
(	O
l	O
)-	O
ligases	O
and	O
deconjugating	O
enzymes	O
in	O
order	B-SPEC
to	O
facilitate	O
infection	O
and	O
fight	O
the	O
host	O
immune	O
response	O
.	O

Studying	O
the	O
activity	O
of	O
DUBs	O
and	O
Ubl	O
-	O
specific	O
proteases	O
,	O
both	O
human	B-SPEC
as	O
well	O
as	O
pathogen	O
-	O
derived	O
,	O
gives	O
fundamental	O
insights	O
into	O
their	O
physiological	O
roles	O
.	O

If	O
the	O
respiratory	O
secretions	O
test	O
negative	O
by	O
qPCR	O
for	O
a	O
panel	O
of	O
respiratory	O
pathogens	O
,	O
feces	O
already	O
submitted	O
to	O
the	O
laboratory	O
should	O
be	O
tested	O
for	O
ECoV	O
.	O
RESULTS	O
:	O
The	O
total	O
number	O
of	O
horses	B-SPEC
testing	O
qPCR	O
-	O
positive	O
for	O
ECoV	O
in	O
feces	O
was	O
20	O
(	O
7	O
.	O
2	O
%),	O
4	O
of	O
which	O
also	O
tested	O
qPCR	O
-	O
positive	O
for	O
ECoV	O
in	O
nasal	O
secretions	O
.	O

TITLE	O
:	O
Decline	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
and	O
its	O
complex	O
evolutionary	O
relationship	O
with	O
porcine	B-SPEC
respiratory	O
coronavirus	B-SPEC
in	O
the	O
United	O
States	O
.	O

Therefore	O
,	O
this	O
study	O
provides	O
insight	O
into	O
the	O
occurrence	O
,	O
origin	O
,	O
genetic	O
characteristics	O
,	O
and	O
evolution	O
of	O
TGEV	B-SPEC
and	O
PRCV	O
circulating	O
in	O
the	O
US	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
membrane	O
(	O
M	O
)	O
protein	O
is	O
the	O
most	O
abundant	O
structural	O
protein	O
playing	O
a	O
critical	O
role	O
in	O
virion	O
assembly	O
.	O

TITLE	O
:	O
PEDV	B-SPEC
and	O
PDCoV	O
Pathogenesis	O
:	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
caused	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
a	O
highly	O
contagious	O
disease	O
in	O
newborn	O
piglets	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
incidence	O
of	O
cannula	B-SPEC
-	O
related	O
thrombosis	O
and	O
its	O
risk	O
factors	O
after	O
venovenous	O
extracorporeal	O
membrane	O
oxygenation	O
.	O

Acquisition	O
rates	O
of	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
,	O
coronavirus	B-SPEC
229E	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
were	O
respectively	O
38	O
.	O
6	O
%,	O
19	O
.	O
8	O
%	O
and	O
2	O
.	O
0	O
%.	O

The	O
present	O
study	O
reports	O
the	O
first	O
complete	O
genome	O
sequence	O
of	O
a	O
feline	B-SPEC
coronavirus	B-SPEC
from	O
Brazil	O
.	O

This	O
immunization	O
protocol	O
elicited	O
significant	O
increases	O
in	O
serum	O
and	O
lachrymal	O
levels	O
of	O
anti	O
-	O
IBV	B-SPEC
IgG	O
antibodies	O
and	O
upregulated	O
the	O
expression	O
of	O
CMI	O
response	O
genes	O
,	O
such	O
as	O
those	O
encoding	O
CD8β	O
chain	O
and	O
Granzyme	O
homolog	O
A	O
in	O
tracheal	O
and	O
kidney	O
tissues	O
at	O
3	O
,	O
7	O
,	O
and	O
11	O
days	O
post	O
-	O
infection	O
in	O
the	O
vaccinated	O
chickens	B-SPEC
.	O

This	O
systematic	O
review	O
aims	O
to	O
compile	O
and	O
analyse	O
all	O
published	O
data	O
on	O
MERS	O
-	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
in	O
the	O
global	O
camel	B-SPEC
population	O
to	O
provide	O
an	O
overview	O
of	O
current	O
knowledge	O
on	O
the	O
distribution	O
,	O
spread	O
and	O
risk	O
factors	O
of	O
infections	O
in	O
dromedary	B-SPEC
camels	B-SPEC
.	O

Animals	B-SPEC
were	O
exposed	O
to	O
4	O
Gy	O
of	O
6	O
MV	O
X	O
rays	B-SPEC
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
(	O
NDV	B-SPEC
)	O
are	O
two	O
poultry	O
pathogens	O
seriously	O
affecting	O
the	O
poultry	O
industry	O
.	O

ABSTRACT	O
:	O
The	O
porcine	B-SPEC
hemagglutinating	O
encephalomyelitis	O
virus	B-SPEC
(	O
PHEV	O
)	O
is	O
classified	O
as	O
a	O
member	O
of	O
genus	B-SPEC

The	O
pathogenesis	O
involves	O
interactions	O
between	O
bacteria	B-SPEC
,	O
viruses	B-SPEC
,	O
environment	O
and	O
management	O
factors	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
use	O
metagenomic	O
sequencing	O
to	O
characterize	O
the	O
respiratory	O
viromes	O
of	O
paired	O
nasal	O
swabs	O
and	O
tracheal	O
washes	O
from	O
western	O
Canadian	O
feedlot	O
cattle	B-SPEC
,	O
with	O
or	O
without	O
BRD	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infection	O
Dynamics	O
and	O
Antibody	O
Responses	O
among	O
Clinically	O
Diverse	O
Patients	O
,	O
Saudi	O
Arabia	O
.	O

Examples	O
of	O
the	O
many	O
applications	O
these	O
pseudotype	O
particles	O
can	O
be	O
used	O
in	O
include	O
investigation	O
of	O
host	O
cell	O
susceptibility	O
and	O
tropism	O
and	O
testing	O
the	O
effects	O
of	O
virus	B-SPEC
entry	O
inhibitors	O
to	O
dissect	O
viral	O
entry	O
pathways	O
used	O
.	O

TITLE	O
:	O
The	O
battle	O
against	O
SARS	O
and	O
MERS	O
coronaviruses	O
:	O
Reservoirs	O
and	O
Animal	B-SPEC
Models	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
zoonotic	O
pathogen	O
that	O
causes	O
respiratory	O
infection	O
in	O
humans	B-SPEC
,	O
ranging	O
from	O
asymptomatic	O
to	O
severe	O
pneumonia	O
.	O

In	O
dromedary	B-SPEC
camels	B-SPEC
,	O
the	O
virus	B-SPEC
only	O
causes	O
a	O
mild	O
infection	O
but	O
it	O
spreads	O
efficiently	O
between	O
animals	B-SPEC
.	O

Their	O
knowledge	O
was	O
evaluated	O
against	O
facts	O
published	O
by	O
Mayo	B-SPEC
Clinic	O
Foundation	O
,	O
and	O
its	O
percentage	O
mean	O
score	O
(	O
PMS	O
)	O
±	O
standard	O
deviation	O
was	O
calculated	O
.	O

ABSTRACT	O
:	O
The	O
data	O
on	O
the	O
seasonality	O
of	O
respiratory	O
viruses	B-SPEC
helps	O
to	O
ensure	O
the	O
optimal	O
vaccination	O
period	O
and	O
to	O
monitor	O
the	O
possible	O
outbreaks	O
of	O
variant	O
type	O
.	O

FLU	O
was	O
the	O
most	O
frequently	O
detected	O
virus	B-SPEC
(	O
273	O
/	O
1362	O
[	O
20	O
.	O
0	O
%]),	O
followed	O
by	O
human	B-SPEC
rhinovirus	I-SPEC
(	O
146	O
/	O
1362	O
[	O
10	O
.	O
7	O
%]).	O

To	O
assess	O
the	O
potential	O
association	O
of	O
spike	O
mutations	O
with	O
superspreading	O
events	O
,	O
we	O
collected	O
virus	B-SPEC
genetic	O
information	O
reported	O
during	O
the	O
outbreak	O
and	O
systemically	O
analyzed	O
the	O
relationship	O
of	O
spike	O
sequences	O
and	O
epidemiology	O
.	O

ABSTRACT	O
:	O
Avian	B-SPEC
coronaviruses	O
,	O
including	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
),	O
are	O
important	O
respiratory	O
pathogens	O
of	O
poultry	O
.	O

TITLE	O
:	O
Glass	O
Wool	O
Concentration	O
Optimization	O
for	O
the	O
Detection	O
of	O
Enveloped	O
and	O
Non	O
-	O
enveloped	O
Waterborne	O
Viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
which	O
is	O
caused	O
by	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
),	O
is	O
an	O
intestinal	O
communicable	O
disease	O
.	O

Our	O
results	O
demonstrated	O
that	O
simultaneous	O
expression	O
of	O
these	O
specific	O
shRNA	O
molecules	O
inhibited	O
expression	O
of	O
PEDV	B-SPEC
M	O
gene	O
,	O
SADS	O
-	O
CoV	O
M	O
gene	O
,	O
and	O
PDCoV	O
N	O
gene	O
RNA	O
by	O
99	O
.	O
7	O
%,	O
99	O
.	O
4	O
%,	O
and	O
98	O
.	O
8	O
%,	O
respectively	O
,	O
in	O
infected	O
cell	O
cultures	O
.	O

We	O
extended	O
and	O
optimized	O
our	O
previous	O
recombinant	O
adenovirus	B-SPEC
5	O
(	O
rAd5	O
)-	O
based	O
vaccine	O
platform	O
characterized	O
by	O
in	O
vivo	O
amplified	O
and	O
CD40	O
-	O
mediated	O
specific	O
responses	O
to	O
generate	O
MERS	O
-	O
CoV	O
S1	O
subunit	O
-	O
based	O
vaccine	O
.	O

Immunization	O
of	O
hDPP4	O
Tg	O
+	O
mice	B-SPEC
with	O
a	O
single	O
dose	O
of	O
rAd5	O
-	O
S1	O
/	O
F	O
/	O
CD40L	O
elicited	O
as	O
robust	O
and	O
significant	O
specific	O
immunoglobulin	O
G	O
and	O
neutralizing	O
antibodies	O
as	O
those	O
induced	O
with	O
2	O
doses	O
of	O
rAd5	O
-	O
S1	O
.	O

Therefore	O
,	O
we	O
conducted	O
a	O
systematic	O
literature	O
review	O
of	O
animal	B-SPEC
models	O
combining	O
features	O
of	O
experimental	O
ARDS	O
with	O
ECMO	O
to	O
better	O
understand	O
this	O
situation	O
.	O

Variables	O
related	O
to	O
four	O
key	O
features	O
:	O
(	O
1	O
)	O
study	O
design	O
,	O
(	O
2	O
)	O
animals	B-SPEC
and	O
their	O
peri	O
-	O
experimental	O
care	O
,	O
(	O
3	O
)	O
models	O
of	O
ARDS	O
and	O
mechanical	O
ventilation	O
,	O
and	O
(	O
4	O
)	O
ECMO	O
and	O
its	O
intra	O
-	O
experimental	O
management	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
nonstructural	O
protein	O
8	O
(	O
nsp8	O
)	O
has	O
been	O
suggested	O
to	O
have	O
diverse	O
activities	O
,	O
including	O
noncanonical	O
template	O
-	O
dependent	O
polymerase	O
activities	O
.	O

TITLE	O
:	O
Frequency	O
of	O
diarrhoea	O
-	O
associated	O
viruses	B-SPEC
in	O
swine	B-SPEC
of	O
various	O
ages	O
in	O
Hungary	O
.	O

This	O
observational	O
retrospective	O
study	O
analyzed	O
onco	O
-	O
hematological	O
patients	O
with	O
ARpF	O
in	O
the	O
Intensive	O
Care	O
Unit	O
(	O
ICU	O
)	O
of	O
a	O
cancer	B-SPEC
center	O
in	O
southern	O
Brazil	O
between	O
2010	O
-	O
2016	O
,	O
who	O
required	O
mechanical	O
ventilation	O
and	O
were	O
submitted	O
to	O
open	O
SLB	O
.	O

ABSTRACT	O
:	O
Mycoplasma	B-SPEC
pneumonia	O
is	O
one	O
of	O
the	O
most	O
common	O
types	O
of	O
pneumonia	O
,	O
although	O
it	O
is	O
often	O
not	O
diagnosed	O
due	O
to	O
mild	O
clinical	O
course	O
.	O

Delayed	O
initiation	O
of	O
proper	O
treatment	O
allowed	O
our	O
patient	O
'	O
s	O
mycoplasma	B-SPEC
pneumonia	O
to	O
progress	O
to	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
acute	O
kidney	O
injury	O
.	O

The	O
British	O
Thoracic	O
Society	O
does	O
not	O
recommend	O
blanket	O
empiric	O
treatment	O
of	O
mycoplasma	B-SPEC
pneumonia	O
,	O
although	O
other	O
European	O
and	O
American	O
guidelines	O
do	O
,	O
and	O
so	O
it	O
is	O
important	O
to	O
consider	O
this	O
organism	O
in	O
high	O
-	O
risk	O
groups	O
to	O
prevent	O
severe	O
complications	O
.	O

ABSTRACT	O
:	O
The	O
yak	B-SPEC
(	O
Bosgrunniens	O
)	O
is	O
a	O
unique	O
domestic	O
bovine	B-SPEC
species	B-SPEC
that	O
plays	O
an	O
indispensable	O
role	O
for	O
herdsmen	O
in	O
the	O
Qinghai	O
-	O
Tibet	O
Plateau	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
is	O
the	O
etiologic	O
agent	O
of	O
transmissible	O
gastroenteritis	O
in	O
pigs	B-SPEC
,	O
and	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
TGEV	B-SPEC
spike	O
protein	O
is	O
generally	O
recognized	O
as	O
both	O
the	O
virulence	O
determinant	O
and	O
enteric	O
tropism	O
determinant	O
.	O

Using	O
a	O
novel	O
approach	O
,	O
the	O
clustered	O
regularly	O
interspaced	O
short	O
palindromic	O
repeat	O
(	O
CRISPR	O
)/	O
CRISPR	O
-	O
associated	O
protein	O
9	O
(	O
Cas9	O
)	O
systems	O
efficiently	O
and	O
rapidly	O
rescued	O
another	O
recombinant	O
virus	B-SPEC
with	O
a	O
224	O
-	O
amino	O
-	O
acid	O
deletion	O
in	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
TGEV	B-SPEC

TITLE	O
:	O
Prevalence	O
,	O
phylogenetic	O
and	O
evolutionary	O
analysis	O
of	O
porcine	B-SPEC
deltacoronavirus	O
in	O
Henan	O
province	O
,	O
China	O
.	O

Passive	O
immunization	O
with	O
potently	O
as	O
well	O
as	O
with	O
poorly	O
neutralizing	O
antibodies	O
protected	O
mice	B-SPEC
from	O
lethal	O
MERS	O
-	O
CoV	O
challenge	O
.	O

TITLE	O
:	O
First	O
report	O
and	O
phylogenetic	O
analysis	O
of	O
porcine	B-SPEC
deltacoronavirus	O
in	O
Mexico	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
has	O
caused	O
great	O
economic	O
losses	O
in	O
the	O
swine	B-SPEC
industry	O
worldwide	O
.	O

This	O
relationship	O
is	O
probably	O
related	O
to	O
the	O
commercial	O
exchange	O
of	O
pigs	B-SPEC
between	O
the	O
US	O
and	O
Mexico	O
and	O
the	O
geographical	O
proximity	O
of	O
these	O
two	O
countries	O
.	O

ABSTRACT	O
:	O
The	O
4a	O
and	O
4b	O
proteins	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
have	O
been	O
described	O
for	O
their	O
antagonism	O
on	O
host	O
innate	O
immunity	O
.	O

Specimens	O
were	O
examined	O
at	O
our	O
collaborating	O
institutions	O
with	O
a	O
panel	O
of	O
molecular	O
assays	O
for	O
viral	O
pathogens	O
including	O
influenza	O
A	O
(	O
IAV	O
),	O
IBV	B-SPEC
,	O
ICV	O
,	O
and	O
IDV	O
,	O
human	B-SPEC
adenovirus	B-SPEC
(	O
AdV	O
),	O
human	B-SPEC
enterovirus	B-SPEC
(	O
EV	O
),	O
human	B-SPEC
coronavirus	I-SPEC
(	O
CoV	O
),	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
subtype	O
A	O
(	O
RSV	B-SPEC
-	O
A	O
)	O
or	O
RSV	B-SPEC
-	O
B	O
,	O
and	O
parainfluenza	O
virus	B-SPEC
(	O
PIV	O
)	O
types	O
1	O
-	O
4	O
.	O
Of	O
599	O
samples	O
examined	O
,	O
288	O
(	O
48	O
%)	O
had	O
molecular	O
evidence	O
of	O
1	O
or	O
more	O
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
A	O
multiplex	O
reverse	O
transcription	O
polymerase	O
chain	O
rection	O
(	O
mRT	O
-	O
PCR	O
)	O
was	O
developed	O
for	O
simultaneous	O
detection	O
of	O
four	O
RNA	O
viruses	B-SPEC
in	O
swine	B-SPEC
.	O

TITLE	O
:	O
Effects	O
of	O
different	O
corticosteroid	O
doses	O
and	O
durations	O
on	O
smoke	O
inhalation	O
-	O
induced	O
acute	O
lung	O
injury	O
and	O
pulmonary	O
fibrosis	O
in	O
the	O
rat	B-SPEC
.	O

Although	O
a	O
major	O
GBS	O
phenotype	O
,	O
Fisher	B-SPEC
syndrome	O
(	O
FS	O
),	O
has	O
been	O
shown	O
to	O
be	O
preceded	O
by	O
infections	O
similar	O
to	O
those	O
preceding	O
GBS	O
,	O
whether	O
or	O
not	O
the	O
clinical	O
features	O
in	O
FS	O
also	O
vary	O
according	O
to	O
antecedent	O
infection	O
remains	O
unclarified	O
.	O

An	O
overexpression	O
and	O
knockdown	O
assay	O
indicated	O
that	O
CH25H	O
has	O
significant	O
antiviral	O
action	O
against	O
PEDV	B-SPEC
,	O
and	O
a	O
CH25H	O
mutant	O
(	O
CH25H	O
-	O
M	O
)	O
that	O
lacks	O
hydroxylase	O
activity	O
also	O
retains	O
antiviral	O
activity	O
to	O
a	O
lesser	O
extent	O
.	O

Taken	O
together	O
,	O
CH25H	O
as	O
a	O
natural	O
host	O
restriction	O
factor	O
could	O
inhibit	O
PEDV	B-SPEC
and	O
TGEV	B-SPEC
infection	O
.	O

In	O
our	O
study	O
,	O
using	O
a	O
number	O
of	O
techniques	O
,	O
we	O
showed	O
that	O
all	O
three	O
viruses	B-SPEC
are	O
indeed	O
able	O
to	O
bind	O
to	O
sialic	O
acids	O
to	O
a	O
different	O
extent	O
,	O
but	O
these	O
molecules	O
render	O
the	O
cells	O
permissive	O
only	O
for	O
the	O
clinical	O
strain	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
,	O
while	O
for	O
others	O
they	O
serve	O
only	O
as	O
attachment	O
receptors	O
.	O

However	O
,	O
the	O
presence	O
of	O
wild	O
animals	B-SPEC
and	O
daily	O
dung	O
removal	O
were	O
negatively	O
associated	O
with	O
seroprevalence	O
.	O

In	O
conclusion	O
,	O
the	O
risk	O
factors	O
identified	O
in	O
this	O
study	O
can	O
be	O
considered	O
to	O
be	O
predictors	O
of	O
MERS	O
-	O
CoV	O
infection	O
in	O
camels	B-SPEC
and	O
should	O
be	O
taken	O
into	O
account	O
when	O
developing	O
an	O
efficient	O
and	O
cost	O
-	O
effective	O
control	O
strategy	O
.	O

TITLE	O
:	O
Analysis	O
of	O
long	O
non	O
-	O
coding	O
RNAs	O
in	O
neonatal	O
piglets	O
at	O
different	O
stages	O
of	O
porcine	B-SPEC
deltacoronavirus	O
infection	O
.	O

TITLE	O
:	O
Surveillance	O
for	O
Avibacterium	B-SPEC
paragallinarum	I-SPEC
in	O
autopsy	O
cases	O
of	O
birds	B-SPEC
from	O
small	O
chicken	B-SPEC
flocks	O
using	O
a	O
real	O
-	O
time	O
PCR	O
assay	O
.	O

From	O
the	O
294	O
samples	O
collected	O
for	O
our	O
study	O
,	O
86	O
(	O
30	O
%)	O
were	O
PCR	O
-	O
positive	O
for	O
A	B-SPEC
.	I-SPEC
paragallinarum	I-SPEC
.	O

Updates	O
were	O
presented	O
on	O
several	O
influenza	O
antivirals	O
including	O
baloxavir	O
,	O
CC	O
-	O
42344	O
,	O
VIS410	O
,	O
immunoglobulin	O
,	O
immune	O
plasma	O
,	O
MHAA4549A	O
,	O
pimodivir	O
(	O
JNJ	O
-	O
63623872	O
),	O
umifenovir	O
,	O
and	O
HA	O
minibinders	O
;	O
RSV	B-SPEC
antivirals	O
including	O
presatovir	O
(	O
GS	O
-	O
5806	O
),	O
ziresovir	O
(	O
AK0529	O
),	O
lumicitabine	O
(	O
ALS	O
-	O
008176	O
),	O
JNJ	O
-	O
53718678	O
,	O
JNJ	O
-	O
64417184	O
,	O
and	O
EDP	O
-	O
938	O
;	O
broad	O
spectrum	O
antivirals	O
such	O
as	O
favipiravir	O
,	O
VH244	O
,	O
remdesivir	O
,	O
and	O
EIDD	O
-	O
1931	O
/	O
EIDD	O
-	O
2801	O
;	O
and	O
host	O
directed	O
strategies	O
including	O
nitazoxanide	O
,	O
eritoran	O
,	O
and	O
diltiazem	O
.	O

The	O
highest	O
rates	O
were	O
reported	O
for	O
RSV	B-SPEC
(	O
485	O
cases	O
,	O
45	O
.	O
2	O
%),	O
PIV	O
(	O
125	O
,	O
11	O
.	O
6	O
%),	O
and	O
adenovirus	B-SPEC
(	O
105	O
,	O
9	O
.	O
8	O
%).	O

To	O
determine	O
whether	O
Fc	O
fusion	O
affects	O
the	O
immunogenicity	O
of	O
MERS	O
-	O
CoV	O
antigen	O
,	O
we	O
constructed	O
a	O
Fcassociated	O
MERS	O
-	O
CoV	O
spike	O
protein	O
(	O
eS770	O
-	O
Fc	O
,	O
110	O
kDa	O
),	O
whereby	O
human	B-SPEC
IgG4	O
Fc	O
domain	O
was	O
fused	O
to	O
MERS	O
-	O
CoV	O
spike	O
protein	O
(	O
eS770	O
)	O
via	O
a	O
Gly	O
/	O
Pro	O
linker	O
using	O
baculovirus	B-SPEC
as	O
the	O
expression	O
system	O
.	O

There	O
is	O
also	O
potential	O
for	O
human	B-SPEC
-	O
originated	O
outbreaks	O
emanating	O
from	O
laboratory	O
accidents	O
or	O
intentional	O
biological	O
attacks	O
.	O

These	O
emerging	O
infections	O
,	O
including	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
the	O
pandemic	O
influenza	O
A	O
(	O
H1N1	O
)	O
and	O
avian	B-SPEC
influenza	O
(	O
AI	O
)	O
viruses	B-SPEC
,	O
have	O
seriously	O
threatened	O
global	O
health	O
and	O
the	O
economy	O
.	O

Mice	B-SPEC
were	O
exposed	O
intranasally	O
to	O
FF	O
or	O
UFP	O
according	O
to	O
acute	O
(	O
10	O
,	O
50	O
or	O
100	O
µg	O
of	O
PM	O
)	O
and	O
repeated	O
(	O
10	O
µg	O
of	O
PM	O
3	O
times	O
a	O
week	O
during	O
1	O
or	O
3	O
months	O
)	O
exposure	O
protocols	O
.	O

TITLE	O
:	O
Visual	O
detection	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
using	O
a	O
novel	O
reverse	O
transcription	O
polymerase	O
spiral	O
reaction	O
method	O
.	O

A	O
naïve	O
human	B-SPEC
scFv	O
library	O
with	O
kappa	O
light	O
chain	O
repertoire	O
with	O
a	O
library	O
size	O
of	O
10	O

She	O
required	O
a	O
high	O
-	O
flow	O
nasal	O
cannula	B-SPEC
with	O
a	O
subsequent	O
upgrade	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
for	O
increasing	O
respiratory	O
compromise	O
.	O

EK1	O
,	O
the	O
optimized	O
form	O
of	O
OC43	O
-	O
HR2P	O
,	O
showed	O
substantially	O
improved	O
pan	B-SPEC
-	O
CoV	O
fusion	O
inhibitory	O
activity	O
and	O
pharmaceutical	O
properties	O
.	O

Crystal	O
structures	O
indicated	O
that	O
EK1	O
can	O
form	O
a	O
stable	O
six	O
-	O
helix	O
bundle	O
structure	O
with	O
both	O
short	O
α	O
-	O
HCoV	O
and	O
long	O
β	O
-	O
HCoV	O
HR1s	O
,	O
further	O
supporting	O
the	O
role	O
of	O
HR1	O
region	O
as	O
a	O
viable	O
pan	B-SPEC
-	O
CoV	O
target	O
site	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
induces	O
an	O
often	O
fatal	O
gastrointestinal	O
disease	O
in	O
piglets	O
.	O

We	O
orally	O
inoculated	O
a	O
neonatal	O
Microminipig	O
with	O
an	O
intestinal	O
homogenate	O
of	O
a	O
PEDV	B-SPEC
-	O
infected	O
pig	B-SPEC
and	O
housed	O
it	O
in	O
a	O
small	O
cage	O
originally	O
designed	O
for	O
rats	B-SPEC
in	O
an	O
animal	B-SPEC
biosafety	O
level	O
2	O
facility	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
can	O
cause	O
diarrhea	O
in	O
nursing	O
piglets	O
.	O

Many	O
of	O
the	O
emerging	O
pathogens	O
are	O
zoonoses	O
and	O
,	O
as	O
such	O
,	O
there	O
is	O
scope	O
for	O
intervention	O
at	O
the	O
animal	B-SPEC
/	O
insect	B-SPEC
/	O
environmental	O
reservoir	O
.	O

Kazakhstan	O
is	O
the	O
world	O
'	O
s	O
ninth	O
largest	O
country	O
;	O
however	O
,	O
little	O
is	O
understood	O
about	O
the	O
prevalence	O
and	O
diversity	O
of	O
bat	B-SPEC
-	O
borne	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Camel	B-SPEC
contact	O
is	O
a	O
recognized	O
risk	O
factor	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

On	O
multivariable	O
analyses	O
,	O
working	O
as	O
a	O
camel	B-SPEC
salesman	O
,	O
handling	O
live	O
camels	B-SPEC
or	O
their	O
waste	O
,	O
and	O
having	O
diabetes	O
were	O
associated	O
with	O
seropositivity	O
among	O
all	O
workers	O
,	O
whereas	O
handling	O
live	O
camels	B-SPEC
and	O
either	O
administering	O
medications	O
or	O
cleaning	O
equipment	O
was	O
associated	O
with	O
seropositivity	O
among	O
market	O
workers	O
.	O

As	O
the	O
results	O
conducted	O
meta	B-SPEC
-	O
analyses	O
to	O
comprehensively	O
analyze	O
the	O
correlations	O
of	O
factors	O
influencing	O
disaster	O
response	O
from	O
a	O
Korean	O
context	O
,	O
the	O
findings	O
show	O
that	O
the	O
legislative	O
factor	O
had	O
direct	O
and	O
indirect	O
influence	O
on	O
the	O
overall	O
process	O
of	O
infectious	O
disease	O
response	O
and	O
that	O
Leadership	O
of	O
the	O
central	O
government	O
,	O
establishment	O
of	O
an	O
intergovernmental	O
response	O
system	O
,	O
the	O
need	O
for	O
communication	O
,	O
information	O
sharing	O
and	O
disclosure	O
and	O
onsite	O
response	O
were	O
identified	O
as	O
key	O
factors	O
influencing	O
effective	O
infectious	O
disease	O
response	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
virus	B-SPEC
(	O
FIPV	O
)	O
causes	O
a	O
severe	O
,	O
immune	O
-	O
mediated	O
disease	O
called	O
FIP	O
in	O
domestic	O
and	O
wild	B-SPEC
cats	I-SPEC
.	O

TITLE	O
:	O
Protection	O
conferred	O
by	O
a	O
vaccine	O
derived	O
from	O
an	O
inactivated	O
Egyptian	O
variant	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
:	O
a	O
challenge	O
experiment	O
.	O

Two	O
-	O
week	O
-	O
old	O
,	O
specific	O
-	O
pathogen	O
-	O
free	O
chickens	B-SPEC
were	O
subcutaneously	O
inoculated	O
with	O
a	O
single	O
dose	O
of	O
the	O
vaccine	O
containing	O
10	O

Canine	B-SPEC
adenovirus	I-SPEC
,	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
,	O
coronavirus	B-SPEC
,	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
(	O
H3N2	O
and	O
H3N8	O
),	O
Bordetella	B-SPEC
bronchiseptica	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
canis	I-SPEC
,	O
M	B-SPEC
.	I-SPEC
cynos	I-SPEC
and	O
Streptococcus	O
equi	O
subsp	O
.	O

Considering	O
the	O
diversity	O
of	O
bat	B-SPEC
coronaviruses	O
,	O
bat	B-SPEC
species	B-SPEC
and	O
populations	O
,	O
we	O
expect	O
to	O
discover	O
more	O
bat	B-SPEC
CoVs	O
through	O
virus	B-SPEC
surveillance	O
.	O

However	O
,	O
our	O
understanding	O
of	O
its	O
function	O
regarding	O
virus	B-SPEC
and	O
host	O
interaction	O
is	O
still	O
limited	O
.	O

A	O
TaqMan	O
-	O
probe	O
-	O
based	O
multiplex	O
real	O
-	O
time	O
RT	O
-	O
qPCR	O
assay	O
was	O
developed	O
and	O
optimized	O
to	O
simultaneously	O
detect	O
these	O
swine	B-SPEC
enteric	O
coronaviruses	O
.	O

However	O
,	O
the	O
effects	O
of	O
VIP	O
on	O
the	O
activation	O
of	O
murine	B-SPEC
fibroblast	O
and	O
expression	O
of	O
IL	O
-	O
17	O
receptor	O
(	O
IL	O
-	O
17R	O
)	O
in	O
ARDS	O
remain	O
unclear	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
infections	O
induce	O
apoptosis	O
in	O
Vero	O
cells	O
via	O
a	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
)/	O
p53	O
,	O
but	O
not	O
p38	O
MAPK	O
and	O
SAPK	O
/	O
JNK	O
signalling	O
pathways	O
.	O

In	O
addition	O
,	O
we	O
also	O
found	O
that	O
p38	O
MAPK	O
and	O
SAPK	O
/	O
JNK	O
were	O
activated	O
in	O
PEDV	B-SPEC
-	O
infected	O
Vero	O
cells	O
.	O

Activated	O
p38	O
MAPK	O
and	O
SAPK	O
/	O
JNK	O
exerted	O
no	O
influence	O
on	O
PEDV	B-SPEC
-	O
induced	O
apoptosis	O
.	O

TITLE	O
:	O
Interaction	O
of	O
coronavirus	B-SPEC
nucleocapsid	O
protein	O
with	O
the	O
5	O
'-	O
and	O
3	O
'-	O
ends	O
of	O
the	O
coronavirus	B-SPEC
genome	O
is	O
involved	O
in	O
genome	O
circularization	O
and	O
negative	O
-	O
strand	O
RNA	O
synthesis	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
is	O
capable	O
of	O
inducing	O
a	O
storm	O
of	O
proinflammatory	O
cytokines	O
.	O

ABSTRACT	O
:	O
To	O
determine	O
the	O
frequency	O
of	O
infections	O
caused	O
by	O
Influenza	B-SPEC
viruses	I-SPEC
,	O
i	O
.	O
e	O
.	O
Influenza	O
A	O
(	O
H1N1	O
)	O
pdm09	O
,	O
Influenza	O
A	O
(	O
H3N2	O
)	O
and	O
Influenza	O
B	O
in	O
patients	O
presenting	O
with	O
respiratory	O
tract	O
infections	O
,	O
i	O
.	O
e	O
.	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
)	O
and	O
severe	O
acute	O
respiratory	O
illness	O
(	O
SARI	O
).	O

However	O
,	O
it	O
did	O
not	O
vary	O
in	O
response	O
to	O
IBV	B-SPEC
challenge	O
in	O
the	O
isthmus	O
and	O
magnum	O
regions	O
of	O
the	O
oviduct	O
.	O

The	O
gene	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
A	O
,	O
flavoprotein	O
variant	O
(	O
SDHA	O
)	O
was	O
down	O
-	O
regulated	O
in	O
the	O
shell	O
gland	O
by	O
IBV	B-SPEC
challenge	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
while	O
other	O
genes	O
being	O
studied	O
did	O
not	O
show	O
responses	O
to	O
the	O
challenge	O
(	O
P	O
>	O
0	O
.	O
05	O
).	O

M41	O
-	O
CK	O
,	O
a	O
virulent	O
lab	O
-	O
adapted	O
strain	O
of	O
IBV	B-SPEC
,	O
was	O
egg	O
passaged	O
over	O
100	O
times	O
in	O
four	O
parallel	O
independent	O
replicates	O
.	O

Overlapping	O
12	O
-	O
mer	O
peptides	O
(	O
n	O
=	O
28	O
,	O
426	O
)	O
across	O
the	O
entire	O
Pp1ab	O
were	O
arrayed	O
on	O
peptide	O
chips	O
and	O
reacted	O
with	O
pooled	O
sera	O
from	O
coronavirus	B-SPEC
seropositive	O
cats	B-SPEC
and	O
from	O
one	O
seronegative	O
cat	B-SPEC
.	O

Empiric	O
data	O
describing	O
the	O
distribution	O
of	O
bio	O
-	O
aerosols	O
enable	O
discernment	O
of	O
potential	O
exposure	O
risk	O
to	O
respiratory	O
viruses	B-SPEC
.	O

The	O
mortality	O
rate	O
of	O
severe	O
sepsis	B-SPEC
has	O
been	O
improved	O
;	O
however	O
,	O
DIC	O
is	O
still	O
associated	O
with	O
the	O
poor	O
prognosis	O
of	O
these	O
patients	O
.	O

TITLE	O
:	O
Emerging	O
respiratory	O
infections	O
:	O
The	O
infectious	O
disease	O
pathology	O
of	O
SARS	O
,	O
MERS	O
,	O
pandemic	O
influenza	O
,	O
and	O
Legionella	B-SPEC
.	O

Although	O
we	O
perhaps	O
most	O
frequently	O
think	O
of	O
viruses	B-SPEC
when	O
discussing	O
emerging	O
respiratory	O
infections	O
,	O
bacteria	B-SPEC
have	O
not	O
been	O
left	O
out	O
of	O
the	O
mix	O
,	O
as	O
we	O
have	O
witnessed	O
an	O
increase	O
in	O
the	O
number	O
of	O
infections	O
from	O
Legionella	B-SPEC
spp	O
.	O

Therefore	O
,	O
the	O
development	O
of	O
a	O
sensitive	O
,	O
specific	O
,	O
and	O
easily	O
performed	O
assay	O
is	O
crucial	O
for	O
the	O
rapid	O
detection	O
and	O
surveillance	O
of	O
IBV	B-SPEC
infections	O
.	O

The	O
ICS	O
showed	O
high	O
specificity	O
in	O
detecting	O
IBV	B-SPEC
antigens	O
,	O
including	O
several	O
IBV	B-SPEC
genotypes	O
and	O
novel	O
variants	O
,	O
as	O
opposed	O
to	O
three	O
other	O
common	O
avian	B-SPEC
respiratory	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
a	O
pathogen	O
belonging	O
to	O
the	O
genus	B-SPEC

TITLE	O
:	O
Synthesis	O
and	O
anti	O
-	O
coronavirus	B-SPEC
activity	O
of	O
a	O
series	O
of	O
1	O
-	O
thia	B-SPEC
-	O
4	O
-	O
azaspiro	O
[	O
4	O
.	O
5	O
]	O
decan	O
-	O
3	O
-	O
one	O
derivatives	O
.	O

The	O
most	O
active	O
compound	O
was	O
N	O
-(	O
2	O
-	O
methyl	O
-	O
8	O
-	O
tert	O
-	O
butyl	O
-	O
3	O
-	O
oxo	O
-	O
1	O
-	O
thia	B-SPEC
-	O
4	O
-	O
azaspiro	O
[	O
4	O
.	O
5	O
]	O
decan	O
-	O
4	O
-	O
yl	O
)-	O
3	O
-	O
phenylpropanamide	O
(	O
8n	O
),	O
with	O
an	O
EC	O

A	O
total	O
of	O
556	O
patients	O
were	O
included	O
:	O
138	O
with	O
postsurgical	O
and	O
418	O
with	O
medical	O
sepsis	B-SPEC
.	O

RESULTS	O
:	O
A	O
total	O
of	O
556	O
patients	O
were	O
included	O
:	O
138	O
with	O
postsurgical	O
and	O
418	O
with	O
medical	O
sepsis	B-SPEC
.	O

In	O
addition	O
,	O
the	O
S	O
gene	O
of	O
16BO133	O
was	O
found	O
to	O
contain	O
the	O
amino	O
acid	O
substitution	O
of	O
two	O
critical	O
residues	O
(	O
N479S	O
and	O
T487	O
V	O
)	O
associated	O
with	O
human	B-SPEC
infection	O
.	O

In	O
conclusion	O
,	O
we	O
firstly	O
carried	O
out	O
whole	O
genome	O
characterization	O
of	O
the	O
SARS	O
-	O
like	O
bat	B-SPEC
coronavirus	B-SPEC
discovered	O
in	O
the	O
Republic	O
of	O
Korea	O
;	O
however	O
,	O
it	O
presumably	O
has	O
no	O
human	B-SPEC
infectivity	O
.	O

In	O
this	O
study	O
,	O
a	O
conserved	O
segment	O
containing	O
one	O
SNP	O
A4408C	O
of	O
parvovirus	B-SPEC
was	O
used	O
for	O
real	O
-	O
time	O
PCR	O
amplification	O
.	O

TITLE	O
:	O
Prevalence	O
of	O
a	O
novel	O
bovine	B-SPEC
coronavirus	B-SPEC
strain	O
with	O
a	O
recombinant	O
hemagglutinin	O
/	O
esterase	O
gene	O
in	O
dairy	O
calves	O
in	O
China	O
.	O

In	O
conclusion	O
,	O
S	O
gene	O
and	O
5a	O
accessory	O
gene	O
are	O
responsible	O
for	O
the	O
attenuation	O
of	O
virulent	O
IBV	B-SPEC
.	O

TITLE	O
:	O
The	O
Protection	O
Potential	O
of	O
Antioxidant	O
Vitamins	O
Against	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
:	O
a	O
Rat	B-SPEC
Trial	O
.	O

In	O
2018	O
,	O
a	O
GI	O
-	O
22	O
genotype	O
strain	O
CK	O
/	O
CH	O
/	O
LGD	O
/	O
2018	O
(	O
abbreviated	O
'	O
LGD	O
')	O
was	O
isolated	O
in	O
northern	O
China	O
,	O
which	O
caused	O
10	O
%-	O
30	O
%	O
morality	O
in	O
H120	O
-	O
vaccinated	O
chickens	B-SPEC
.	O

Our	O
findings	O
add	O
new	O
knowledge	O
to	O
the	O
regulatory	O
mechanisms	O
governing	O
coronavirus	B-SPEC
-	O
induced	O
autophagy	O
,	O
highlighting	O
an	O
extensive	O
cross	O
-	O
talk	O
among	O
cellular	O
signaling	O
pathways	O
during	O
coronavirus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Occurrence	O
of	O
infectious	O
bronchitis	O
in	O
layer	O
birds	B-SPEC
in	O
Plateau	O
state	O
,	O
north	O
central	O
Nigeria	O
.	O

TITLE	O
:	O
Investigation	O
of	O
suspected	O
Newcastle	O
disease	O
(	O
ND	O
)	O
outbreaks	O
in	O
Egypt	O
uncovers	O
a	O
high	O
virus	B-SPEC
velogenic	O
ND	O
virus	B-SPEC
burden	O
in	O
small	O
-	O
scale	O
holdings	O
and	O
the	O
presence	O
of	O
multiple	O
pathogens	O
.	O

Virulent	O
NDV	B-SPEC
was	O
confirmed	O
only	O
in	O
group	O
A	O
(	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
caused	O
by	O
infection	O
with	O
feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
).	O

TITLE	O
:	O
[	O
Indirect	O
immunofluorescence	O
technique	O
versus	O
polymerase	O
chain	O
reaction	O
for	O
the	O
diagnosis	O
of	O
respiratory	O
viruses	B-SPEC
in	O
children	O
admitted	O
to	O
a	O
hospital	O
in	O
the	O
Metropolitan	O
Region	O
].	O

The	O
IIF	O
presented	O
sensitivity	O
:	O
85	O
.	O
7	O
%,	O
specificity	O
:	O
73	O
.	O
6	O
%,	O
PPV	B-SPEC
:	O
82	O
.	O
7	O
%,	O
NPV	O
:	O
77	O
.	O
7	O
%	O
and	O
kappa	O
:	O
0	O
.	O
5990	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
3636	O
-	O
0	O
.	O
8346	O
)	O
for	O
RSV	B-SPEC
.	O

RESULTS	O
:	O
The	O
IIF	O
detected	O
only	O
RSV	B-SPEC
(	O
29	O
;	O
61	O
.	O
7	O
%).	O

The	O
IIF	O
presented	O
sensitivity	O
:	O
85	O
.	O
7	O
%,	O
specificity	O
:	O
73	O
.	O
6	O
%,	O
PPV	B-SPEC
:	O
82	O
.	O
7	O
%,	O
NPV	O
:	O
77	O
.	O
7	O
%	O
and	O
kappa	O
:	O
0	O
.	O
5990	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
3636	O
-	O
0	O
.	O
8346	O
)	O
for	O
RSV	B-SPEC
.	O

CONCLUSIONS	O
:	O
The	O
IIF	O
presents	O
good	O
sensitivity	O
,	O
but	O
moderate	O
specificity	O
for	O
RSV	B-SPEC
.	O

PARP14	O
was	O
also	O
important	O
for	O
the	O
induction	O
of	O
interferon	O
in	O
mouse	B-SPEC
and	O
human	B-SPEC
cells	O
,	O
indicating	O
a	O
critical	O
role	O
for	O
this	O
PARP	O
in	O
the	O
regulation	O
of	O
innate	O
immunity	O
.	O

A	O
laboratory	O
-	O
confirmed	O
case	O
of	O
human	B-SPEC
infection	O
with	O
avian	B-SPEC
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
was	O
treated	O
in	O
our	O
hospital	O
.	O

Analyses	O
of	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
showed	O
that	O
NB1	O
differed	O
from	O
18	O
other	O
Korean	O
PEDV	B-SPEC
mostly	O
in	O
4	O
protein	O
coding	O
genes	O
:	O
ORF1a	O
,	O
ORF1b	O
,	O
S	O
,	O
and	O
N	O
.	O
Two	O
amino	O
acid	O
substitutions	O
(	O
V635E	O
and	O
Y681Q	O
)	O
in	O
the	O
COE	O
and	O
S1D	O
neutralizing	O
epitopes	O
of	O
NB1	O
resulted	O
in	O
antigenic	O
index	O
alteration	O
of	O
the	O
adjacent	O
sites	O
,	O
one	O
of	O
which	O
contributed	O
to	O
a	O
mutation	O
that	O
escaped	O
neutralizing	O
antibodies	O
.	O

TITLE	O
:	O
Novel	O
Gold	O
Nanorod	O
-	O
Based	O
HR1	O
Peptide	O
Inhibitor	O
for	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
.	O

The	O
PCR	O
screen	O
,	O
which	O
included	O
canine	O
parvovirus	B-SPEC
2	O
(	O
CPV	B-SPEC
-	O
2	O
),	O
canine	B-SPEC
distemper	I-SPEC
virus	I-SPEC
,	O
canine	B-SPEC
herpesvirus	I-SPEC
,	O

In	O
this	O
study	O
,	O
blood	O
samples	O
from	O
627	O
malaria	O
patients	O
were	O
analyzed	O
for	O
infected	O
parasite	O
species	B-SPEC
,	O
clinical	O
conditions	O
,	O
platelet	O
levels	O
,	O
and	O
key	O
cytokines	O
that	O
are	O
produced	O
in	O
response	O
to	O
infection	O
;	O
samples	O
from	O
176	O
uninfected	O
healthy	O
individuals	O
were	O
used	O
as	O
controls	O
.	O

(	O
Funded	O
by	O
the	O
National	O
Heart	O
,	O
Lung	O
,	O
and	O
Blood	O
Institute	O
;	O
ROSE	B-SPEC
ClinicalTrials	O
.	O
gov	O
number	O
,	O
NCT02509078	O
.).	O

Horses	B-SPEC
negative	O
for	O
ECoV	O
were	O
matched	O
to	O
the	O
ECoV	O
-	O
positive	O
group	O
as	O
controls	O
.	O

ABSTRACT	O
:	O
Bovine	B-SPEC
coronavirus	B-SPEC
(	O
BCV	B-SPEC
)	O
is	O
associated	O
with	O
respiratory	O
infections	O
in	O
cattle	B-SPEC
of	O
all	O
ages	O
;	O
however	O
,	O
a	O
temporal	O
study	O
to	O
evaluate	O
the	O
effect	O
of	O
BCV	B-SPEC
immunity	O
on	O
virus	B-SPEC
shedding	O
and	O
bovine	B-SPEC
respiratory	O
disease	O
(	O
BRD	O
)	O
incidence	O
in	O
pre	O
-	O
weaned	O
beef	O
calves	O
has	O
not	O
been	O
reported	O
.	O

O	O
.	O
Mühlemann	O
and	O
Volker	O
Thiel	O
teamed	O
up	O
to	O
unravel	O
the	O
roles	O
of	O
NMD	O
and	O
SGs	O
,	O
and	O
their	O
interconnections	O
in	O
defending	O
cells	O
from	O
alphavirus	B-SPEC
and	O
coronavirus	B-SPEC
infections	O
.	O

TITLE	O
:	O
Bactrian	B-SPEC
camels	I-SPEC
shed	O
large	O
quantities	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
after	O
experimental	O
infection	O
ABSTRACT	O
:	O
In	O
2012	O
,	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
emerged	O
.	O

We	O
analyzed	O
the	O
mechanisms	O
by	O
which	O
HBD	O
2	O
primes	O
innate	O
antiviral	O
immunity	O
and	O
polarized	O
activation	O
of	O
macrophage	O
-	O
like	O
THP	O
-	O
1	O
cells	O
using	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
spike	O
protein	O
(	O
S	O
RBD	O
)	O
as	O
a	O
model	O
antigen	O
.	O

TITLE	O
:	O
Recombinant	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
expressing	O
the	O
spike	O
protein	O
of	O
genotype	O
2b	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
:	O
A	O
platform	O
for	O
vaccine	O
development	O
against	O
emerging	O
epidemic	O
isolates	O
.	O

Given	O
the	O
fastidious	O
isolation	O
of	O
emerging	O
PEDV	B-SPEC
in	O
cell	O
culture	O
and	O
difficulties	O
in	O
retaining	O
the	O
isolate	O
infectivity	O
upon	O
further	O
in	O
vitro	O
passage	O
,	O
highly	O
attenuated	O
recombinant	O
vesicular	B-SPEC
stomatitis	I-SPEC
virus	I-SPEC
(	O
rVSV	O

These	O
results	O
show	O
that	O
AdC68	O
-	O
S	O
can	O
induce	O
protective	O
immune	O
responses	O
in	O
mice	B-SPEC
and	O
represent	O
a	O
promising	O
candidate	O
for	O
further	O
development	O
against	O
MERS	O
-	O
CoV	O
infection	O
in	O
both	O
dromedaries	B-SPEC
and	O
humans	B-SPEC
.	O

TITLE	O
:	O
Delicate	O
structural	O
coordination	O
of	O
the	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
Nsp13	O
upon	O
ATP	O
hydrolysis	O
.	O

TITLE	O
:	O
The	O
viral	O
protein	O
corona	B-SPEC
directs	O
viral	O
pathogenesis	O
and	O
amyloid	O
aggregation	O
.	O

Moreover	O
,	O
we	O
show	O
that	O
corona	B-SPEC
pre	O
-	O
coating	O
differentially	O
affects	O
viral	O
infectivity	O
and	O
immune	O
cell	O
activation	O
.	O

In	O
addition	O
,	O
we	O
demonstrate	O
that	O
viruses	B-SPEC
bind	O
amyloidogenic	O
peptides	O
in	O
their	O
corona	B-SPEC
and	O
catalyze	O
amyloid	O
formation	O
via	O
surface	O
-	O
assisted	O
heterogeneous	O
nucleation	O
.	O

Importantly	O
,	O
we	O
show	O
that	O
HSV	B-SPEC
-	I-SPEC
1	I-SPEC
catalyzes	O
the	O
aggregation	O
of	O
the	O
amyloid	O
β	O
-	O
peptide	O
(	O
Aβ	O

The	O
proportions	O
of	O
positive	O
influenza	B-SPEC
viruses	I-SPEC
(	O
type	O
A	O
,	O
B	O
)	O
and	O
noninfluenza	O
viruses	B-SPEC
(	O
respiratory	O
syncytial	O
,	O
adenovirus	B-SPEC
,	O
human	B-SPEC
parainfluenza	O
,	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
),	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
admission	O
rate	O
,	O
and	O
fatality	O
rate	O
among	O
SARI	O
patients	O
were	O
calculated	O
.	O

Bacterial	O
Outer	O
Membrane	O
Vesicles	O
(	O
OMVs	O
)-	O
based	O
Dual	O
Vaccine	O
for	O
Influenza	O
A	O
H1N1	O
Virus	B-SPEC
and	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Vaccination	O
is	O
the	O
most	O
functional	O
medical	O
intervention	O
to	O
prophylactically	O
control	O
severe	O
diseases	O
caused	O
by	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
or	O
animal	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmissible	O
viral	O
pathogens	O
.	O

Together	O
,	O
those	O
two	O
viruses	B-SPEC
present	O
a	O
significant	O
public	O
health	O
burden	O
in	O
areas	O
where	O
they	O
circulate	O
.	O

M	B-SPEC
.	I-SPEC
piperita	I-SPEC
,	O
O	B-SPEC
.	I-SPEC
vulgare	I-SPEC
and	O
T	B-SPEC
.	I-SPEC
vulgaris	I-SPEC
extracts	O
had	O
>	O
60	O
SI	O
.	O

PDCoV	O
N	O
protein	O
targeted	O
porcine	B-SPEC
retinoic	O
acid	O
-	O
inducible	O
gene	O
I	O
(	O
pRIG	O
-	O
I	O
)	O
and	O
porcine	B-SPEC
TNF	O
receptor	O
associated	O
factor	O
3	O
(	O
pTRAF3	O
)	O
by	O
directly	O
interacting	O
with	O
them	O
.	O

We	O
analyzed	O
samples	O
from	O
103	O
bats	B-SPEC
from	O
two	O
distinct	O
regions	O
in	O
Brazil	O
.	O

Coronavirus	B-SPEC
from	O
the	O
Alphacoronavirus	B-SPEC
genus	B-SPEC
was	O
detected	O
in	O
12	O
animals	B-SPEC
,	O
11	O
from	O
São	O
José	O
do	O
Rio	O
Preto	O
-	O
SP	O
region	O
and	O
1	O
from	O
Barreiras	O
-	O
BA	O
region	O
,	O
resulting	O
in	O
a	O
prevalence	O
of	O
17	O
.	O
18	O
%	O
and	O
2	O
.	O
56	O
%	O
respectively	O
.	O

Studies	O
on	O
the	O
circulation	O
of	O
these	O
viruses	B-SPEC
in	O
bats	B-SPEC
remain	O
important	O
to	O
understand	O
the	O
ecology	O
and	O
evolutionary	O
relationship	O
of	O
these	O
pathogens	O
.	O

Thoracic	O
X	O
-	O
ray	B-SPEC
revealed	O
bilateral	O
pulmonary	O
infiltrates	O
,	O
whereas	O
abdominal	O
and	O
heart	O
ultrasound	O
detected	O
hepatomegaly	O
and	O
small	O
pericardial	O
infusion	O
,	O
respectively	O
.	O

CCoVs	O
with	O
different	O
variations	O
are	O
typically	O
pantropic	O
and	O
pathogenic	O
in	O
dogs	B-SPEC
.	O

Cell	O
tropism	O
experiments	O
suggested	O
that	O
HLJ	O
-	O
073	O
could	O
effectively	O
replicate	O
in	O
canine	O
macrophages	O
/	O
monocytes	O
and	O
human	B-SPEC
THP	O
-	O
1	O
cells	O
.	O

Nasopharyngeal	O
aspirates	O
were	O
positive	O
for	O
at	O
least	O
one	O
virus	B-SPEC
in	O
236	O
patients	O
.	O

The	O
occurrence	O
of	O
complications	O
such	O
as	O
sepsis	B-SPEC
(	O
40	O
.	O
1	O
%	O

Most	O
common	O
primary	O
etiologies	O
were	O
pneumonia	O
,	O
severe	O
sepsis	B-SPEC
,	O
and	O
scrub	O
typhus	O
.	O

A	O
homogeneous	O
cell	O
line	O
,	O
designated	O
IPI	O
-	O
FX	O
,	O
obtained	O
from	O
IPI	O
-	O
2I	O
cells	O
by	O
sub	O
-	O
cloning	O
with	O
limited	O
serial	O
dilutions	O
,	O
was	O
found	O
to	O
be	O
highly	O
susceptible	O
to	O
PEDV	B-SPEC
.	O

Furthermore	O
,	O
IPI	O
-	O
FX	O
cells	O
were	O
also	O
highly	O
susceptible	O
to	O
TGEV	B-SPEC
,	O
PDCoV	O
,	O
as	O
well	O
as	O
PEAV	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
NBP	O
on	O
ALI	O
in	O
lipopolysaccharide	O
(	O
LPS	O
)-	O
treated	O
mice	B-SPEC
.	O

ABSTRACT	O
:	O
Murine	B-SPEC
antisera	O
with	O
neutralising	O
activity	O
for	O
the	O
coronavirus	B-SPEC
causative	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
were	O
induced	O
by	O
immunisation	O
of	O
Balb	O
/	O
c	O
mice	B-SPEC
with	O
the	O
receptor	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
viral	O
Spike	O
protein	O
.	O

A	O
71	O
-	O
year	O
-	O
old	O
man	B-SPEC
with	O
atrial	O
fibrillation	O
,	O
advanced	O
ALS	O
,	O
type	O
II	O
diabetes	O
mellitus	O
,	O
and	O
hypertension	O
presented	O
to	O
the	O
emergency	O
department	O
with	O
dyspnoea	O
and	O
tachycardia	O
.	O

German	O
transfusion	O
centres	O
were	O
the	O
first	O
to	O
start	O
in	O
-	O
house	O
NAT	O
testing	O
of	O
their	O
donations	O
in	O
pools	O
of	O
up	O
to	O
96	O
samples	O
for	O
HCV	B-SPEC
,	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
),	O
and	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
-	O
1	O
(	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
).	O

All	O
samples	O
were	O
tested	O
for	O
influenza	B-SPEC
viruses	I-SPEC
,	O
whereas	O
about	O
38	O
,	O
000	O
samples	O
were	O
tested	O
for	O
influenza	O
and	O
a	O
panel	O
of	O
respiratory	O
viruses	B-SPEC
using	O
Fast	O
Track	O
Diagnostics	O
(	O
FTD	O
)	O
RT	O
-	O
PCR	O
kit	O
.	O

ILIs	O
cases	O
were	O
reported	O
throughout	O
the	O
year	O
,	O
however	O
,	O
influenza	O
,	O
RSV	B-SPEC
,	O
and	O
HMPV	B-SPEC
exhibited	O
strong	O
seasonal	O
peaks	O
in	O
the	O
winter	O
,	O
while	O
HRVs	O
circulated	O
more	O
during	O
fall	O
and	O
spring	O
.	O

While	O
males	O
had	O
higher	O
rates	O
of	O
HRVs	O
(	O
11	O
.	O
9	O
%),	O
enteroviruses	B-SPEC
(	O
1	O
.	O
1	O
%)	O
and	O
MERS	O
CoV	O
(	O
0	O
.	O
2	O
%),	O
females	O
had	O
higher	O
proportions	O
of	O
influenza	O
(	O
26	O
.	O
3	O
%),	O
HPIVs	O
(	O
3	O
.	O
2	O
%)	O
and	O
RSV	B-SPEC
(	O
3	O
.	O
6	O
%)	O
infections	O
.	O

TITLE	O
:	O
Cross	O
-	O
species	B-SPEC
transmission	O
of	O
poultry	O
pathogens	O
in	O
backyard	O
farms	O
:	O
ducks	B-SPEC
as	O
carriers	O
of	O
chicken	B-SPEC
viruses	B-SPEC
.	O

RNA	O
of	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
and	O
duck	B-SPEC
CoV	O
was	O
found	O
in	O
faecal	O
swabs	O
of	O
chickens	B-SPEC
(	O
19	O
.	O
7	O
%	O
and	O
7	O
.	O
1	O
%)	O
and	O
ducks	B-SPEC
(	O
4	O
.	O
1	O
%	O
and	O
44	O
.	O
1	O
%).	O

Here	O
we	O
report	O
our	O
new	O
finding	O
that	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
spike	O
(	O
S	O
)	O
glycoprotein	O
,	O
similar	O
to	O
Vpu	O
,	O
is	O
capable	O
of	O
antagonizing	O
the	O
BST2	O
tethering	O
of	O
SARS	O
-	O
CoV	O
,	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
,	O
and	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
virus	B-SPEC
-	O
like	O
particles	O
via	O
BST2	O
downregulation	O
.	O

We	O
searched	O
the	O
SciFinder	O
database	O
(	O
excluding	O
patent	O
literature	O
)	O
with	O
keywords	O
like	O
""""	O
antiviral	O
""","	O
""""	O
anti	O
-	O
HIV	B-SPEC
""""	O
and	O
""""	O
virus	B-SPEC
"""."	O

TITLE	O
:	O
The	O
re	O
-	O
emerging	O
of	O
SADS	O
-	O
CoV	O
infection	O
in	O
pig	B-SPEC
herds	O
in	O
Southern	O
China	O
.	O

RESULTS	O
:	O
Out	O
of	O
1629	O
children	O
enrolled	O
,	O
a	O
total	O
of	O
204	O
respiratory	O
viruses	B-SPEC
were	O
present	O
in	O
171	O
(	O
10	O
.	O
50	O
%)	O
PSPs	O
including	O
47	O
patients	O
with	O
mild	O
symptoms	O
and	O
124	O
with	O
no	O
symptoms	O
after	O
surgery	O
.	O

TITLE	O
:	O
A	O
shared	O
protocol	O
for	O
porcine	B-SPEC
surfactant	O
use	O
in	O
pediatric	O
acute	O
respiratory	O
distress	O
syndrome	O
:	O
a	O
feasibility	O
study	O
.	O

Sixty	O
-	O
nine	O
children	O
,	O
age	O
0	O
-	O
24	O
months	O
,	O
affected	O
by	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
treated	O
with	O
exogenous	O
porcine	B-SPEC
surfactant	O
were	O
enrolled	O
.	O

TITLE	O
:	O
Combined	O
adjuvant	O
effect	O
of	O
ginseng	B-SPEC
stem	O
-	O
leaf	O
saponins	O
and	O
selenium	O
on	O
immune	O
responses	O
to	O
a	O
live	O
bivalent	O
vaccine	O
of	O
Newcastle	B-SPEC
disease	I-SPEC
virus	I-SPEC
and	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
chickens	B-SPEC
.	O

Viral	O
pathogenicity	O
experiments	O
showed	O
that	O
the	O
isolates	O
caused	O
high	O
morbidity	O
and	O
severe	O
ciliostasis	O
in	O
chickens	B-SPEC
,	O
although	O
they	O
caused	O
milder	O
lethality	O
.	O

The	O
prototype	O
compound	O
of	O
this	O
family	B-SPEC
is	O
a	O
derivative	O
of	O
pentaerythritol	O
with	O
12	O
peripheral	O
Trp	O
groups	O
and	O
trivalent	O
spacer	O
arms	O
.	O

PROSPERO	B-SPEC
CRD42018084370	O
.	O

Both	O
types	O
of	O
specimens	O
had	O
similarly	O
very	O
good	O
kappa	O
values	O
for	O
most	O
of	O
pathogens	O
,	O
except	O
for	O
Mycoplasma	B-SPEC
pneumonia	O
(	O
κ	O
=	O
0	O
.	O
61	O
)	O
and	O
Chlamydia	B-SPEC
pneumoniae	I-SPEC
(	O
κ	O
=	O
0	O
.	O
24	O
).	O

TITLE	O
:	O
SEROLOGICAL	O
SURVEY	O
FOR	O
SELECT	O
INFECTIOUS	O
AGENTS	O
IN	O
WILD	O
MAGELLANIC	O
PENGUINS	B-SPEC
(	O
ABSTRACT	O
:	O
Despite	O
being	O
the	O
most	O
numerous	O
penguin	B-SPEC
species	B-SPEC
in	O
South	O
America	O
,	O
exposure	O
of	O
the	O
Magellanic	O
Penguin	B-SPEC
(	O

ABSTRACT	O
:	O
We	O
previously	O
identified	O
PEPCK	O
-	O
M	O
(	O
encoded	O
by	O
the	O
Pck2	O
gene	O
)	O
to	O
be	O
highly	O
up	O
-	O
regulated	O
in	O
skeletal	O
muscle	O
of	O
pigs	B-SPEC
treated	O
with	O
Ractopamine	O
,	O
an	O
anabolic	O
beta	O
-	O
adrenergic	O
receptor	O
agonist	O
.	O

RESULTS	O
:	O
Viral	O
etiological	O
agents	O
detected	O
in	O
the	O
patients	O
were	O
enterovirus	B-SPEC
D68	O
,	O
dengue	B-SPEC
virus	I-SPEC
type	O
3	O
,	O
rhinovirus	B-SPEC
C	O
,	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
,	O
herpes	B-SPEC
simplex	I-SPEC
virus	I-SPEC
type	I-SPEC
1	I-SPEC
,	O
influenza	B-SPEC
virus	I-SPEC
H1N1	O
,	O
influenza	B-SPEC
virus	I-SPEC
H3N2	O
,	O
human	B-SPEC
metapneumovirus	I-SPEC
,	O
and	O
rhinovirus	B-SPEC
A60	O
.	O

We	O
present	O
a	O
case	O
report	O
of	O
a	O
2	O
-	O
month	O
-	O
old	O
infant	O
affected	O
by	O
a	O
bronchiolitis	O
RSV	B-SPEC
-	O
positive	O
,	O
with	O
syndrome	O
of	O
inappropriate	O
antidiuretic	O
hormone	O
secretion	O
(	O
SIADH	O
)	O
correlated	O
seizure	O
and	O
encephalopathy	O
.	O

RSV	B-SPEC
may	O
be	O
also	O
responsible	O
for	O
SIADH	O
and	O
seizures	O
associated	O
with	O
hyponatremia	O
.	O

After	O
many	O
years	O
of	O
quiescence	O
,	O
PEDV	B-SPEC
was	O
detected	O
in	O
Hungary	O
in	O
2016	O
with	O
a	O
recombination	O
in	O
its	O
S	O
gene	O
.	O

We	O
used	O
a	O
meta	B-SPEC
-	O
transcriptomic	O
approach	O
to	O
characterize	O
the	O
viromes	O
of	O
nine	O
avian	B-SPEC
species	B-SPEC
in	O
the	O
Anseriformes	B-SPEC
(	O
ducks	B-SPEC
)	O
and	O
Charadriiformes	B-SPEC
(	O
shorebirds	B-SPEC
).	O

These	O
viruses	B-SPEC
comprise	O
multi	O
-	O
host	O
generalist	O
viruses	B-SPEC
and	O
those	O
that	O
are	O
host	O
-	O
specific	O
,	O
indicative	O
of	O
both	O
virome	O
connectivity	O
(	O
host	O
sharing	O
)	O
and	O
heterogeneity	O
(	O
host	O
specificity	O
).	O

Qshunt	O
correlated	O
with	O
PFR	O
(	O
r	O
=	O
0	O
.	O
75	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
APRV	O
and	O
(	O
r	O
=	O
0	O
.	O
65	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
CMV	B-SPEC
).	O

The	O
effects	O
of	O
early	O
vaccination	O
on	O
immune	O
responses	O
were	O
further	O
investigated	O
in	O
chickens	B-SPEC
primed	O
at	O
increasing	O
ages	O
,	O
followed	O
by	O
booster	O
vaccination	O
with	O
an	O
attenuated	O
Arkansas	O
(	O
Ark	O
)	O
Delmarva	O
Poultry	O
Industry	O
-	O
type	O
vaccine	O
.	O

CONCLUSIONS	O
:	O
Despite	O
multiple	O
studies	O
in	O
humans	B-SPEC
there	O
is	O
no	O
consensus	O
on	O
the	O
optimal	O
therapy	O
for	O
MERS	O
-	O
CoV	O
.	O
Randomized	O
clinical	O
trials	O
are	O
needed	O
and	O
potential	O
therapies	O
should	O
be	O
evaluated	O
only	O
in	O
such	O
clinical	O
trials	O
.	O

Herein	O
,	O
the	O
structure	O
-	O
activity	O
relationships	O
(	O
SARs	O
)	O
of	O
quassinoids	O
along	O
with	O
the	O
anti	O
-	O
cancer	B-SPEC
mechanisms	O
of	O
four	O
representative	O
quassinoids	O
,	O
eurycomanone	O
,	O
bruceine	O
D	O
,	O
dehydrobruceine	O
B	O
,	O
and	O
brusatol	O
are	O
discussed	O
.	O

This	O
included	O
studies	O
that	O
used	O
simulated	O
contamination	O
with	O
fluorescent	O
markers	O
or	O
a	O
non	O
-	O
pathogenic	O
virus	B-SPEC
.	O

The	O
quality	O
of	O
the	O
evidence	O
is	O
very	O
low	O
for	O
all	O
comparisons	O
because	O
of	O
high	O
risk	O
of	O
bias	B-SPEC
in	O
all	O
studies	O
,	O
indirectness	O
of	O
evidence	O
,	O
and	O
small	O
numbers	O
of	O
participants	O
.	O

Here	O
,	O
we	O
review	O
the	O
current	O
recommendations	O
of	O
transmission	O
-	O
based	O
precautions	O
and	O
the	O
latest	O
evidence	O
on	O
the	O
aerosol	O
transmission	O
of	O
respiratory	O
viruses	B-SPEC
.	O

All	O
patients	O
were	O
screened	O
and	O
evaluated	O
for	O
severe	O
sepsis	B-SPEC
or	O
septic	O
shock	O
.	O

The	O
most	O
commonly	O
detected	O
pathogens	O
were	O
inﬂuenza	O
virus	B-SPEC
(	O
IFV	B-SPEC
;	O
37	O
.	O
39	O
%;	O
123	O
/	O
329	O
),	O
adenovirus	B-SPEC
(	O
AdV	O
;	O
17	O
.	O
02	O
%;	O
56	O
/	O
329	O
),	O
human	B-SPEC
coronaviruses	O
(	O
HCoVs	O
;	O
10	O
.	O
94	O
%;	O
36	O
/	O
329	O
),	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
RV	O
/	O
EV	O
;	O
10	O
.	O
03	O
%;	O
33	O
/	O
329	O
),	O
parainﬂuenza	O
viruses	B-SPEC
(	O
PIVs	O
;	O
8	O
.	O
51	O
%;	O
28	O
/	O
329	O
),	O
and	O
Mycoplasma	B-SPEC
pneumoniae	I-SPEC
(	O
M	O
.	O
pneu	O
;	O
8	O
.	O
51	O
%;	O
28	O
/	O
329	O
),	O
respectively	O
.	O

Remarkably	O
,	O
only	O
the	O
vaccination	O
protocol	O
involving	O
a	O
double	O
vaccination	O
at	O
1	O
D	O
of	O
age	O
was	O
proven	O
protective	O
against	O
IBV	B-SPEC
-	O
induced	O
symptomatology	O
,	O
with	O
the	O
odds	O
of	O
developing	O
disease	O
being	O
4	O
.	O
14	O
[	O
95CI	O
=	O
1	O
.	O
34	O
-	O
14	O
.	O
51	O
]	O
times	O
lower	O
.	O

No	O
non	O
-	O
specific	O
amplifications	O
were	O
observed	O
when	O
the	O
assays	O
were	O
tested	O
with	O
unrelated	O
viruses	B-SPEC
.	O

Here	O
we	O
review	O
emerging	O
infectious	O
disease	O
biological	O
standards	O
development	O
,	O
vaccine	O
clinical	O
assay	O
development	O
and	O
trial	O
execution	O
with	O
the	O
recent	O
experiences	O
of	O
MERS	O
-	O
CoV	O
and	O
Zika	B-SPEC
virus	I-SPEC
as	O
examples	O
.	O

The	O
expression	O
of	O
Claudin	O
-	O
5	O
in	O
the	O
jejunum	O
was	O
significantly	O
lower	O
in	O
PEDV	B-SPEC
-	O
infected	O
piglets	O
than	O
in	O
the	O
normal	O
animals	B-SPEC
(	O
p	O
⟨	O
0	O
.	O
01	O
).	O

TITLE	O
:	O
Paramyxo	O
-	O
and	O
Coronaviruses	O
in	O
Rwandan	O
Bats	B-SPEC
.	O

CFR	O
was	O
significantly	O
higher	O
in	O
patients	O
with	O
HIV	B-SPEC
than	O
in	O
HIV	B-SPEC
-	O
negative	O
controls	O
(	O
OR	O
4	O
.	O
10	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
63	O
-	O
6	O
.	O
27	O
,	O
I²	O
:	O
93	O
.	O
7	O
%).	O

There	O
was	O
no	O
difference	O
for	O
viral	O
respiratory	O
aetiologies	O
(	O
Enterovirus	B-SPEC
,	O
Adenovirus	B-SPEC
,	O
Bocavirus	B-SPEC
,	O
Coronavirus	B-SPEC
,	O
Metapneumovirus	B-SPEC
,	O
Parainfluenza	O
,	O
Influenza	O
,	O
and	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
)	O
of	O
ARTI	O
between	O
HIV	B-SPEC
-	O
positive	O
and	O
HIV	B-SPEC
-	O
negative	O
people	O
,	O
except	O
for	O
Rhinovirus	B-SPEC
where	O
being	O
HIV	B-SPEC
-	O
negative	O
was	O
associated	O
with	O
Rhinovirus	B-SPEC
(	O
OR	O
0	O
.	O
70	O
;	O
95	O
%	O
CI	O
0	O
.	O
51	O
-	O
0	O
.	O
97	O
,	O
I²	O
:	O
63	O
.	O
4	O
%).	O

This	O
study	O
shows	O
an	O
increased	O
risk	O
of	O
deaths	O
among	O
HIV	B-SPEC
-	O
infected	O
individuals	O
with	O
ARTI	O
,	O
however	O
with	O
no	O
difference	O
in	O
viral	O
aetiologies	O
compared	O
to	O
HIV	B-SPEC
-	O
negative	O
individuals	O
in	O
Africa	O
.	O

Fraxin	O
might	O
inhibit	O
the	O
increase	O
in	O
reactive	O
oxygen	O
species	B-SPEC
(	O
ROS	O
)	O
and	O
malondialdehyde	O
(	O
MDA	O
),	O
a	O
product	O
of	O
lipid	O
peroxidation	O
in	O
lung	O
tissues	O
.	O

Thus	O
,	O
fraxin	O
elicited	O
protective	O
effects	O
on	O
mice	B-SPEC
with	O
LPS	O
-	O
induced	O
ARDS	O
and	O
might	O
be	O
used	O
as	O
a	O
drug	O
to	O
cure	O
ARDS	O
induced	O
by	O
Gram	O
-	O
negative	O
bacterial	O
infection	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
an	O
emerging	O
respiratory	O
disease	O
caused	O
by	O
the	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Influenza	B-SPEC
viruses	I-SPEC
have	O
been	O
affecting	O
the	O
human	B-SPEC
population	O
for	O
a	O
long	O
time	O
now	O
;	O
however	O
,	O
their	O
ability	O
to	O
rapidly	O
evolve	O
through	O
antigenic	O
drift	O
and	O
antigenic	O
shift	O
causes	O
the	O
emergence	O
of	O
new	O
strains	O
.	O

The	O
virus	B-SPEC
was	O
first	O
recognized	O
in	O
2012	O
and	O
it	O
is	O
associated	O
with	O
a	O
lower	O
respiratory	O
tract	O
disease	O
that	O
is	O
more	O
severe	O
in	O
patients	O
with	O
comorbidities	O
.	O

Maternal	O
vaccines	O
that	O
can	O
induce	O
lactogenic	O
immunity	O
to	O
protect	O
suckling	O
piglets	O
via	O
colostrums	O
and	O
milk	O
are	O
pivotal	O
for	O
the	O
prevention	O
and	O
control	O
of	O
PEDV	B-SPEC
infection	O
in	O
neonatal	O
suckling	O
piglets	O
.	O

It	O
has	O
been	O
detected	O
that	O
the	O
levels	O
of	O
PEDV	B-SPEC
-	O
specific	O
antibodies	O
(	O
IgG	O
and	O
IgA	O
)	O
in	O
their	O
sera	O
and	O
milks	O
were	O
higher	O
than	O
other	O
negative	O
groups	O
(	O
P	O
<	O
0	O
·	O
001	O
or	O
P	O
<	O
0	O
·	O
05	O
).	O

Furthermore	O
,	O
it	O
has	O
been	O
proved	O
by	O
the	O
neutralization	O
assay	O
that	O
the	O
induced	O
antibodies	O
could	O
significantly	O
inhibit	O
virus	B-SPEC
infection	O
as	O
compared	O
to	O
other	O
negative	O
groups	O
(	O
P	O
<	O
0	O
·	O
01	O
or	O
P	O
<	O
0	O
·	O
05	O
).	O

Importantly	O
,	O
after	O
PEDV	B-SPEC
challenge	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
suckling	O
piglets	O
delivered	O
by	O
the	O
sows	O
in	O
the	O
heterologous	O
prime	O
-	O
boost	O
group	O
were	O
completely	O
protected	O
.	O

The	O
viral	O
spike	O
protein	O
plays	O
pivotal	O
roles	O
in	O
mediating	O
receptor	O
-	O
recognition	O
and	O
membrane	O
-	O
fusion	O
,	O
and	O
is	O
therefore	O
a	O
key	O
factor	O
involved	O
in	O
viral	O
pathogenesis	O
and	O
inter	O
-	O
species	B-SPEC
transmission	O
.	O

Animal	B-SPEC
models	O
,	O
despite	O
being	O
ideal	O
to	O
study	O
the	O
anti	O
-	O
inflammatory	O
responses	O
to	O
influenza	B-SPEC
virus	I-SPEC
infection	O
,	O
are	O
very	O
costly	O
and	O
time	O
-	O
consuming	O
.	O

In	O
this	O
study	O
,	O
we	O
screened	O
seven	O
human	B-SPEC
cell	O
lines	O
and	O
found	O
that	O
the	O
human	B-SPEC
monocytic	O
cell	O
U937	O
supports	O
the	O
replication	O
of	O
different	O
subtypes	O
of	O
influenza	B-SPEC
viruses	I-SPEC
as	O
well	O
as	O
the	O
production	O
of	O
the	O
important	O
pro	O
-	O
inflammatory	O
cytokines	O
and	O
was	O
selected	O
to	O
develop	O
the	O
cell	O
-	O
based	O
model	O
.	O

Best	O
management	O
practices	O
of	O
MERS	O
-	O
CoV	O
patients	O
were	O
significantly	O
higher	O
among	O
dentists	O
with	O
better	O
knowledge	O
of	O
virus	B-SPEC
transmission	O
(	O
odd	O
ration	O
[	O
OR	O
]=	O
1	O
.	O
16	O
,	O
p	O
less	O
than	O
0	O
.	O
0001	O
),	O
patients	O
'	O
identification	O
(	O
OR	O
=	O
1	O
.	O
40	O
,	O
p	O
less	O
than	O
0	O
.	O
0001	O
)	O
and	O
those	O
knowing	O
that	O
corona	B-SPEC
infection	O
can	O
be	O
fatal	O
(	O
OR	O
=	O
2	O
.	O
44	O
,	O
p	O
=	O
0	O
.	O
02	O
).	O

Exposure	O
of	O
rodents	B-SPEC
to	O
hyperoxia	O
mimics	O
many	O
of	O
the	O
features	O
of	O
ARDS	O
.	O

For	O
a	O
random	O
sample	O
of	O
127	O
calves	O
,	O
serum	O
zinc	O
concentrations	O
before	O
and	O
after	O
treatment	O
and	O
a	O
fecal	O
antigen	O
ELISA	O
at	O
diarrhea	O
start	O
and	O
resolution	O
for	O
Escherichia	B-SPEC
coli	I-SPEC
K99	O
,	O
rotavirus	B-SPEC
,	O
coronavirus	B-SPEC
,	O
and	O
Cryptosporidium	B-SPEC
parvum	I-SPEC
were	O
performed	O
.	O

Logistic	O
regression	O
showed	O
that	O
the	O
odds	O
of	O
microbiological	O
cure	O
at	O
diarrhea	O
resolution	O
for	O
rotavirus	B-SPEC
,	O
C	B-SPEC
.	I-SPEC
parvum	I-SPEC
,	O
or	O
any	O
single	O
fecal	O
pathogen	O
was	O
not	O
different	O
between	O
treatment	O
groups	O
.	O

The	O
effect	O
of	O
systemic	O
administration	O
of	O
recombinant	O
human	B-SPEC
endocan	O
was	O
assessed	O
in	O
a	O
model	O
of	O
acute	O
lung	O
inflammation	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
.	O

These	O
results	O
highlight	O
the	O
anti	O
-	O
inflammatory	O
role	O
of	O
human	B-SPEC
endocan	O
and	O
its	O
protective	O
effect	O
against	O
acute	O
lung	O
injury	O
.	O

TITLE	O
:	O
Viral	O
interference	O
between	O
H9N2	O
-	O
low	O
pathogenic	O
avian	B-SPEC
influenza	I-SPEC
virus	I-SPEC
and	O
avian	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
vaccine	O
strain	O
H120	O
in	O
vivo	O
.	O

For	O
more	O
than	O
a	O
decade	O
,	O
high	O
percentages	O
of	O
honeybee	B-SPEC
colony	O
losses	O
have	O
been	O
reported	O
worldwide	O
.	O

Two	O
groups	O
of	O
colonies	O
were	O
set	O
in	O
a	O
Eucalyptus	B-SPEC
grandis	I-SPEC
plantation	O
at	O
the	O
beginning	O
of	O
the	O
flowering	O
period	O
(	O
autumn	O
),	O
replicating	O
a	O
natural	O
scenario	O
with	O
a	O
nutritionally	O
poor	O
food	O
source	O
.	O

Prospectively	O
,	O
nasal	O
and	O
tonsillar	O
swabs	O
from	O
214	O
dogs	B-SPEC
affected	O
with	O
infectious	O
respiratory	O
disease	O
,	O
and	O
50	O
healthy	O
control	O
dogs	B-SPEC
were	O
tested	O
for	O
nucleic	O
acids	O
specific	O
to	O
the	O
various	O
viral	O
infections	O
.	O

Concurrent	O
bronchoalveolar	O
lavage	O
fluid	O
from	O
31	O
dogs	B-SPEC
with	O
chronic	O
respiratory	O
disease	O
was	O
investigated	O
for	O
the	O
same	O
viral	O
pathogens	O
.	O

Serological	O
results	O
showed	O
a	O
significant	O
seroconversion	O
in	O
response	O
to	O
coronavirus	B-SPEC
in	O
50	O
%	O
of	O
the	O
examined	O
cases	O
.	O

Analysis	O
of	O
paired	O
serum	O
samples	O
aids	O
verification	O
of	O
canine	O
coronavirus	B-SPEC
infection	O
in	O
respiratory	O
disease	O
.	O

RESULTS	O
:	O
Canine	O
respiratory	O
coronavirus	B-SPEC
(	O
7	O
.	O
5	O
%)	O
and	O
canine	B-SPEC
parainfluenza	I-SPEC
virus	I-SPEC
(	O
6	O
.	O
5	O
%)	O
were	O
the	O
most	O
commonly	O
detected	O
viruses	B-SPEC
in	O
samples	O
from	O
the	O
upper	O
airways	O
of	O
dogs	B-SPEC
with	O
respiratory	O
infections	O
.	O

The	O
epidemiology	O
of	O
MERS	O
-	O
CoV	O
remain	O
enigmatic	O
as	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
is	O
not	O
fully	O
understood	O
.	O

Hospitalization	O
months	O
significantly	O
differed	O
for	O
these	O
common	O
pathogens	O
(	O
P	O
≤	O
0	O
.	O
01	O
),	O
except	O
for	O
coronavirus	B-SPEC
(	O
P	O
=	O
0	O
.	O
30	O
).	O

The	O
results	O
revealed	O
that	O
microbial	O
dysbiosis	O
by	O
PEDV	B-SPEC
infection	O
occurred	O
in	O
the	O
cecal	O
mucosa	O
and	O
contents	O
of	O
suckling	O
piglets	O
at	O
each	O
microbial	O
taxonomic	O
level	O
.	O

Our	O
findings	O
suggest	O
that	O
determining	O
the	O
intestinal	O
microbiota	B-SPEC
might	O
provide	O
a	O
promising	O
method	O
to	O
prevent	O
PEDV	B-SPEC
and	O
open	O
a	O
new	O
avenue	O
for	O
future	O
research	O
.	O

Regarding	O
the	O
effect	O
of	O
biosecurity	O
measures	O
during	O
PED	O
outbreak	O
on	O
TAC	O
and	O
DP	O
/	O
S	O
,	O
longer	O
TAC	O
was	O
observed	O
in	O
Actinobacillus	B-SPEC
pleuropneumoniae	I-SPEC
-	O
positive	O
farms	O
and	O
farms	O
outsourcing	O
pig	B-SPEC
transport	O
to	O
the	O
slaughterhouse	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
present	O
study	O
investigated	O
the	O
role	O
of	O
the	O
CXCL5	O
/	O
Cxc	O
chemokine	O
receptor	O
2	O
(	O
CXCR2	O
)	O
bio	O
-	O
axis	B-SPEC
in	O
ARDS	O
,	O
and	O
explored	O
the	O
underlying	O
molecular	O
mechanism	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
is	O
a	O
common	O
respiratory	O
virus	B-SPEC
that	O
causes	O
moderately	O
severe	O
infections	O
.	O

Patchy	O
dendrimers	O
bound	O
to	O
the	O
surface	O
of	O
Ad5	O
formed	O
a	O
synthetic	O
polymer	O
corona	B-SPEC
that	O
greatly	O
altered	O
various	O
host	O
interactions	O
of	O
Ad5	O
as	O
well	O
as	O

Three	O
probes	O
specific	O
for	O
AIV	O
,	O
NDV	B-SPEC
,	O
and	O
IBV	B-SPEC
,	O
as	O
well	O
as	O
three	O
other	O
probes	O
for	O
differentiating	O
H5	O
,	O
H7	O
,	O
and	O
H9	O
of	O
AIV	O
,	O
were	O
first	O
designed	O
and	O
jet	O
-	O
printed	O
to	O
predetermined	O
locations	O
of	O
initiator	O
-	O
integrated	O
poly	O
(	O
dimethylsiloxane	O
)	O
for	O
the	O
synchronous	O
detection	O
of	O
the	O
six	O
pathogens	O
.	O

Virus	B-SPEC
transmission	O
occurs	O
through	O
a	O
susceptible	O
individual	O
'	O
s	O
contact	O
with	O
aerosols	O
or	O
respiratory	O
fomites	O
from	O
an	O
infected	O
individual	O
.	O

TITLE	O
:	O
Significance	O
of	O
plasma	O
fibrinogen	O
level	O
and	O
antithrombin	O
activity	O
in	O
sepsis	B-SPEC
:	O
A	O
multicenter	O
cohort	O
study	O
using	O
a	O
cubic	O
spline	O
model	O
.	O

Pituitary	O
axis	B-SPEC
function	O
is	O
frequently	O
altered	O
early	O
after	O
ICU	O
admission	O
,	O
the	O
magnitude	O
of	O
hormonal	O
response	O
being	O
different	O
according	O
to	O
the	O
underlying	O
critical	O
illness	O
.	O

The	O
activation	O
of	O
the	O
hypothalamic	O
pituitary	O
adrenal	O
axis	B-SPEC
was	O
a	O
strong	O
predictor	O
of	O
ICU	O
mortality	O
.	O

In	O
FCoV	O
-	O
positive	O
cats	B-SPEC
,	O
the	O
Firmicutes	B-SPEC
and	O
Bacteroidetes	B-SPEC
were	O
respectively	O
over	O
-	O
and	O
under	O
-	O
represented	O
,	O
compared	O
to	O
the	O
other	O
groups	O
.	O

In	O
our	O
experience	O
we	O
believe	O
that	O
it	O
can	O
be	O
useful	O
enlarge	O
the	O
pre	O
-	O
operatory	O
fasting	O
period	O
and	O
positioning	O
a	O
nasogastric	O
tube	O
during	O
anaesthesia	O
induction	O
that	O
can	O
be	O
performed	O
moreover	O
,	O
in	O
anti	O
-	O
Trendelenburg	O
position	O
,	O
in	O
order	B-SPEC
to	O
prevent	O
pulmonary	O
aspiration	O
.	O

ABSTRACT	O
:	O
After	O
the	O
emergence	O
of	O
new	O
influenza	B-SPEC
viruses	I-SPEC
,	O
the	O
morbidity	O
and	O
mortality	O
of	O
viral	O
pneumonia	O
have	O
received	O
a	O
great	O
attention	O
.	O

Coronaviruses	O
(	O
CoVs	O
)	O
have	O
a	O
penchant	O
for	O
sudden	O
emergence	O
,	O
as	O
evidenced	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Middle	O
East	O
respiratory	O
syndrome	O
CoV	O
(	O
MERS	O
-	O
CoV	O
)	O
and	O
most	O
recently	O
,	O
swine	B-SPEC
acute	O
diarrhea	O
syndrome	O
coronavirus	B-SPEC
(	O
SADS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Fitness	O
Barriers	O
Limit	O
Reversion	O
of	O
a	O
Proofreading	O
-	O
Deficient	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
3	O
'-	O
to	O
-	O
5	O
'	O
exoribonuclease	O
in	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
nonstructural	O
protein	O
14	O
(	O
nsp14	O
-	O
ExoN	O
)	O
mediates	O
RNA	O
proofreading	O
during	O
genome	O
replication	O
.	O

TITLE	O
:	O
Human	B-SPEC
metapneumovirus	I-SPEC
as	O
cause	O
of	O
severe	O
community	O
-	O
acquired	O
pneumonia	O
in	O
adults	O
:	O
insights	O
from	O
a	O
ten	O
-	O
year	O
molecular	O
and	O
epidemiological	O
analysis	O
.	O

This	O
is	O
a	O
retrospective	O
epidemiological	O
study	O
of	O
adult	O
patients	O
with	O
hMPV	B-SPEC
severe	O
CAP	O
admitted	O
to	O
ICU	O
during	O
a	O
ten	O
-	O
year	O
period	O
with	O
admission	O
PSI	O
score	O
≥	O
3	O
.	O

The	O
25	O
%	O
were	O
coinfected	O
with	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
.	O

CONCLUSIONS	O
:	O
Human	B-SPEC
metapneumovirus	I-SPEC
was	O
associated	O
with	O
severe	O
CAP	O
requiring	O
ICU	O
admission	O
among	O
elderly	O
patients	O
or	O
patients	O
with	O
comorbidities	O
,	O
but	O
also	O
in	O
healthy	O
young	O
subjects	O
.	O

In	O
this	O
study	O
,	O
we	O
detected	O
Mycoplasma	B-SPEC
gallisepticum	I-SPEC
(	O
MG	O
),	O
M	B-SPEC
.	I-SPEC
synoviae	I-SPEC
(	O
MS	O
),	O
and	O
IBV	B-SPEC
in	O
several	O
poultry	O
farms	O
in	O
Myanmar	O
.	O

He	O
underwent	O
emergency	O
bronchoscopy	O
,	O
which	O
revealed	O
a	O
considerable	O
amount	O
of	O
yellow	O
mud	O
-	O
like	O
material	O
in	O
the	O
trachea	B-SPEC
and	O
bronchi	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
an	O
enteric	B-SPEC
coronavirus	I-SPEC
causing	O
high	O
morbidity	O
and	O
mortality	O
in	O
porcine	B-SPEC
herds	O
worldwide	O
.	O

The	O
rTGEV	O
-	O
RS	O
-	O
SPEDV	O
vaccine	O
candidate	O
was	O
also	O
attenuated	O
in	O
three	O
-	O
week	O
-	O
old	O
animals	B-SPEC
that	O
were	O
used	O
to	O
evaluate	O
the	O
protection	O
conferred	O
by	O
this	O
virus	B-SPEC
,	O
compared	O
with	O
the	O
protection	O
induced	O
by	O
infection	O
with	O
a	O
virulent	O
PEDV	B-SPEC
US	O
strain	O
(	O
PEDV	B-SPEC
-	O
NVSL	O
).	O

ABSTRACT	O
:	O
Currently	O
,	O
entry	O
inhibitors	O
contribute	O
immensely	O
in	O
developing	O
a	O
new	O
generation	O
of	O
anti	O
-	O
influenza	B-SPEC
virus	I-SPEC
drugs	O
.	O

Mice	B-SPEC
in	O
C	O
-	O
RELAP	O
group	O
showed	O
a	O
delayed	O
recovery	O
of	O
voiding	O
function	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
nsp15	O
antagonizes	O
interferon	O
-	O
β	O
production	O
independently	O
of	O
its	O
endoribonuclease	O
activity	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
an	O
emerging	O
swine	B-SPEC
coronavirus	B-SPEC
causing	O
diarrhea	O
and	O
intestinal	O
damage	O
in	O
nursing	O
piglets	O
.	O

In	O
this	O
retrospective	O
study	O
,	O
22	O
children	O
with	O
laboratory	O
confirmed	O
severe	O
dengue	O
admitted	O
to	O
pediatric	O
intensive	O
care	O
unit	O
(	O
PICU	B-SPEC
)	O
were	O
enrolled	O
.	O

Thrombocytopenia	O
,	O
anemia	B-SPEC
and	O
elevated	O
serum	O
transaminases	O
were	O
noted	O
in	O
91	O
%,	O
41	O
%	O
and	O
30	O
%	O
respectively	O
;	O
coagulopathy	O
and	O
hypoalbuminemia	O
were	O
seen	O
in	O
36	O
%	O
each	O
.	O

Notably	O
,	O
IFN	O
-	O
I	O
administration	O
within	O
1	O
day	O
after	O
infection	O
(	O
before	O
virus	B-SPEC
titers	O
peak	O
)	O
protected	O
mice	B-SPEC
from	O
lethal	O
infection	O
,	O
despite	O
a	O
decrease	O
in	O
IFN	O
-	O
stimulated	O
gene	O
(	O
ISG	O
)	O
and	O
inflammatory	O
cytokine	O
gene	O
expression	O
.	O

TITLE	O
:	O
Spike	O
proteins	O
of	O
novel	O
MERS	O
-	O
coronavirus	B-SPEC
isolates	O
from	O
North	O
-	O
and	O
West	O
-	O
African	O
dromedary	B-SPEC
camels	B-SPEC
mediate	O
robust	O
viral	O
entry	O
into	O
human	B-SPEC
target	O
cells	O
.	O

RESULTS	O
:	O
The	O
approach	O
was	O
demonstrated	O
for	O
the	O
activity	O
of	O
intubation	O
of	O
a	O
patient	O
with	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
or	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Generation	O
and	O
protective	O
efficacy	O
of	O
a	O
cold	O
-	O
adapted	O
attenuated	O
genotype	O
2b	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
generated	O
a	O
cold	O
-	O
adapted	O
live	O
attenuated	O
vaccine	O
candidate	O
(	O
Aram	O
-	O
P29	O
-	O
CA	O
)	O
by	O
short	O
-	O
term	O
passage	O
of	O
a	O
virulent	O
PEDV	B-SPEC
isolate	O
at	O
successively	O
lower	O
temperatures	O
in	O
Vero	O
cells	O
.	O

These	O
results	O
demonstrated	O
that	O
the	O
cold	O
-	O
adapted	O
attenuated	O
virus	B-SPEC
can	O
be	O
used	O
as	O
a	O
live	O
vaccine	O
in	O
maternal	O
vaccination	O
strategies	O
to	O
provide	O
durable	O
lactogenic	O
immunity	O
and	O
confer	O
passive	O
protection	O
to	O
litters	O
against	O
PEDV	B-SPEC
.	O

On	O
the	O
one	O
hand	O
,	O
OSA	B-SPEC
in	O
patients	O
with	O
ACS	O
may	O
worsen	O
prognosis	O
;	O
on	O
the	O
other	O
hand	O
,	O
OSA	B-SPEC
-	O
related	O
hypoxaemia	O
could	O
favour	O
the	O
development	O
of	O
coronary	O
collaterals	O
,	O
thereby	O
exerting	O
a	O
protective	O
effect	O
.	O

ABSTRACT	O
:	O
Continuous	O
renal	O
replacement	O
therapy	O
becomes	O
available	O
utilization	O
for	O
pediatric	O
critically	O
ill	O
,	O
but	O
the	O
impact	O
of	O
mortality	O
rate	O
in	O
severe	O
sepsis	B-SPEC
remains	O
no	O
consistent	O
conclusion	O
.	O

Application	O
of	O
the	O
RNA	O
adjuvant	O
in	O
mouse	B-SPEC
enhanced	O
the	O
efficacy	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
spike	O
protein	O
,	O
a	O
protein	O
-	O
subunit	O
vaccine	O
and	O
human	B-SPEC
papillomavirus	I-SPEC
L1	O
protein	O
,	O
a	O
virus	B-SPEC
-	O
like	O
particle	O
vaccine	O
,	O
by	O
activating	O
innate	O
immune	O
response	O
through	O
TLR7	O
and	O
enhancing	O
pAPC	O
chemotaxis	O
,	O
leading	O
to	O
a	O
balanced	O
Th1	O
/	O
Th2	O
responses	O
.	O

TITLE	O
:	O
Emergence	O
and	O
genetic	O
analysis	O
of	O
variant	O
pathogenic	O
4	O
/	O
91	O
(	O
serotype	O
793	O
/	O
B	O
)	O
infectious	O
bronchitis	O
virus	B-SPEC
in	O
Egypt	O
during	O
2019	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
is	O
to	O
characterize	O
an	O
emerging	O
variant	O
pathogenic	O
IBV	B-SPEC
originating	O
from	O
field	O
outbreaks	O
in	O
vaccinated	O
Egyptian	O
layer	O
flock	O
.	O

Virus	B-SPEC
propagation	O
in	O
embryonated	O
chicken	B-SPEC
eggs	O
(	O
ECEs	O
),	O
after	O
three	O
successive	O
passages	O
,	O
revealed	O
typical	O
IBV	B-SPEC
lesions	O
such	O
as	O
curling	O
and	O
dwarfism	O
.	O

Here	O
we	O
analyzed	O
13	O
out	O
of	O
14	O
contact	O
residues	O
by	O
mutagenesis	O
and	O
identified	O
I22	O
as	O
being	O
essential	O
for	O
receptor	O
binding	O
and	O
virus	B-SPEC
entry	O
.	O

In	O
contrast	O
,	O
replacement	O
of	O
G29	O
with	O
P	O
,	O
a	O
turn	O
-	O
prone	O
residue	O
with	O
a	O
strict	O
conformation	O
,	O
hindered	O
virus	B-SPEC
entry	O
and	O
conformational	O
changes	O
of	O
the	O
S	O
protein	O
triggered	O
by	O
either	O
receptor	O
binding	O
or	O
pH	O
8	O
.	O
0	O
,	O
suggesting	O
that	O
the	O
structural	O
turn	O
around	O
G29	O
and	O
its	O
flexibility	O
are	O
critical	O
.	O

We	O
analysed	O
the	O
changes	O
in	O
S	O
gene	O
and	O
its	O
protein	O
of	O
PEDV	B-SPEC
HLJBY	O
with	O
65	O
historic	O
PEDV	B-SPEC
strains	O
.	O

We	O
revealed	O
that	O
the	O
length	O
of	O
deduced	O
amino	O
acid	O
sequences	O
of	O
ORF3	O
proteins	O
was	O
80	O
-	O
224	O
aa	O
among	O
tested	O
strains	O
and	O
the	O
identity	O
of	O
HLJBY	O
ORF3	O
amino	O
acids	O
with	O
other	O
PEDV	B-SPEC
strains	O
was	O
71	O
.	O
4	O
%-	O
98	O
.	O
9	O
%.	O

CONCLUSIONS	O
:	O
TGEV	B-SPEC
infection	O
can	O
inhibit	O
the	O
activation	O
of	O
the	O
NF	O
-	O
κB	O
signaling	O
pathway	O
,	O
which	O
is	O
mainly	O
mediated	O
by	O
Nsp3	O
through	O
the	O
canonical	O
pathway	O
.	O

TITLE	O
:	O
Application	O
of	O
RNAscope	O
technology	O
to	O
studying	O
the	O
infection	O
dynamics	O
of	O
a	O
Chinese	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
variant	O
strain	O
BJ2011C	O
in	O
neonatal	O
piglets	O
.	O

We	O
found	O
that	O
the	O
PEDV	B-SPEC
strain	O
BJ2011C	O
could	O
quickly	O
colonize	O
the	O
small	O
intestine	O
,	O
which	O
occurred	O
in	O
just	O
6	O
h	O
post	O
infection	O
,	O
with	O
virus	B-SPEC
shedding	O
starting	O
at	O
6	O
hpi	O
and	O
peaking	O
at	O
24	O
hpi	O
.	O

Importantly	O
,	O
we	O
found	O
that	O
TGEV	B-SPEC
elevated	O
the	O
expression	O
of	O
poIRF1	O
and	O
IFN	O
-	O
γ	O
in	O
infected	O
small	O
intestines	O
and	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O

Evidence	O
of	O
at	O
least	O
one	O
respiratory	O
virus	B-SPEC
was	O
significantly	O
higher	O
at	O
URTI	O
onset	O
(	O
52	O
.	O
7	O
%),	O
10	O
days	O
after	O
the	O
URTI	O
(	O
15	O
.	O
2	O
%)	O
and	O
during	O
an	O
AECOPD	O
(	O
38	O
.	O
4	O
%),	O
compared	O
with	O
the	O
stable	O
period	O
(	O
5	O
.	O
3	O
%,	O
p	O
<	O
0	O
.	O
001	O
).	O

During	O
stable	O
visits	O
,	O
rhinovirus	B-SPEC
accounted	O
for	O
54	O
.	O
2	O
%	O
of	O
all	O
viral	O
infections	O
,	O
followed	O
by	O
coronavirus	B-SPEC
(	O
20	O
.	O
5	O
%).	O

A	O
total	O
of	O
seven	O
studies	O
comprising	O
8010	O
patients	O
were	O
included	O
in	O
this	O
meta	B-SPEC
-	O
analysis	O
.	O

Quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
),	O
immunofluorescence	O
assay	O
(	O
IFA	O
),	O
flow	O
cytometry	O
,	O
and	O
fluorescence	O
microscopy	O
were	O
performed	O
and	O
virus	B-SPEC
titer	O
was	O
determined	O
by	O
TCID50	O
.	O

TITLE	O
:	O
Identifying	O
Sepsis	B-SPEC
Populations	O
Benefitting	O
from	O
Anticoagulant	O
Therapy	O
:	O
A	O
Prospective	O
Cohort	O
Study	O
Incorporating	O
a	O
Restricted	O
Cubic	O
Spline	O
Regression	O
Model	O
.	O

We	O
used	O
a	O
prospective	O
nationwide	O
cohort	O
targeting	O
consecutive	O
adult	O
severe	O
sepsis	B-SPEC
patients	O
in	O
59	O
intensive	O
care	O
units	O
in	O
Japan	O
to	O
assess	O
associations	O
between	O
anticoagulant	O
therapy	O
and	O
in	O
-	O
hospital	O
mortality	O
according	O
to	O
DIC	O
(	O
International	O
Society	O
on	O
Thrombosis	O
and	O
Haemostasis	O
[	O
ISTH	O
]	O
overt	O
and	O
Japanese	O
Association	O
for	O
Acute	O
Medicine	O
DIC	O
scores	O
)	O
and	O
disease	O
severity	O
(	O
Acute	O
Physiology	O
and	O
Chronic	O
Health	O
Evaluation	O
II	O
[	O
APACHE	O
II	O
]	O
and	O
Sequential	O
Organ	O
Failure	O
Assessment	O
scores	O
).	O

Coronavirus	B-SPEC
can	O
cause	O
severe	O
immune	O
thrombocytopenic	O
purpura	B-SPEC
(	O
ITP	B-SPEC
).	O
Intracerebral	O
haemorrhage	O
is	O
an	O
uncommon	O
presentation	O
of	O
ITP	B-SPEC
.	O
Intravenous	O
immunoglobulin	O
and	O
steroids	O
are	O
very	O
effective	O
treatments	O
for	O
severe	O
ITP	B-SPEC
.	O

TITLE	O
:	O
Establishment	O
of	O
Primary	O
Transgenic	O
Human	B-SPEC
Airway	O
Epithelial	O
Cell	O
Cultures	O
to	O
Study	O
Respiratory	O
Virus	B-SPEC
-	O
Host	O
Interactions	O
.	O

To	O
further	O
elucidate	O
specific	O
interactions	O
between	O
human	B-SPEC
respiratory	O
viruses	B-SPEC
and	O
important	O
host	O
factors	O
in	O
the	O
airway	O
epithelium	O
,	O
it	O
is	O
important	O
to	O
make	O
hAEC	O
cultures	O
amenable	O
to	O
genetic	O
modification	O
.	O

Respiratory	O
viruses	B-SPEC
were	O
identified	O
in	O
the	O
nasopharyngeal	O
swabs	O
of	O
50	O
patients	O
(	O
45	O
.	O
5	O
%)	O
using	O
the	O
real	O
-	O
time	O
PCR	O
method	O
,	O
with	O
rhinovirus	B-SPEC
(	O
25	O
%),	O
influenza	O
A	O
(	O
13	O
.	O
1	O
%)	O
and	O
coronavirus	B-SPEC
(	O
11	O
.	O
8	O
%)	O
being	O
the	O
most	O
commonly	O
isolated	O
agents	O
.	O

In	O
this	O
study	O
we	O
monitored	O
the	O
major	O
roost	O
sites	O
of	O
bats	B-SPEC
in	O
Singapore	O
,	O
and	O
performed	O
surveillance	O
for	O
zoonotic	O
pathogens	O
in	O
these	O
bats	B-SPEC
.	O

Tertiary	O
referral	O
severe	O
respiratory	O
failure	O
center	O
in	O
a	O
university	O
hospital	O
in	O
the	O
United	O
Kingdom	B-SPEC
.	O

We	O
established	O
a	O
DNA	O
-	O
launched	O
SeACoV	O
infectious	O
clone	O
based	O
on	O
the	O
cell	O
adapted	O
passage	O
-	O
10	O
virus	B-SPEC
and	O
rescued	O
the	O
recombinant	O
virus	B-SPEC
with	O
a	O
unique	O
genetic	O
marker	O
in	O
cultured	O
cells	O
.	O

Till	O
now	O
,	O
the	O
general	O
treatment	O
program	O
on	O
GBS	O
may	O
be	O
still	O
gamma	O
globulin	O
or	O
plasma	O
exchange	O
and	O
a	O
curious	O
judgment	O
of	O
prognosis	O
is	O
essential	O
in	O
order	B-SPEC
to	O
make	O
a	O
reasonable	O
plan	O
.	O

People	O
with	O
acute	O
tetraplegia	O
require	O
less	O
pressure	O
to	O
treat	O
their	O
OSA	B-SPEC
than	O
the	O
nondisabled	O
;	O
however	O
,	O
air	O
leak	O
is	O
high	O
.	O

Despite	O
posing	O
a	O
probable	O
risk	O
for	O
virus	B-SPEC
transmission	O
,	O
asymptomatic	O
to	O
mild	O
infections	O
can	O
go	O
unnoticed	O
;	O
a	O
lack	O
of	O
seroconversion	O
among	O
some	O
PCR	O
-	O
confirmed	O
cases	O
has	O
been	O
reported	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
a	O
deadly	O
viral	O
respiratory	O
disease	O
caused	O
by	O
MERS	O
-	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
is	O
a	O
viral	O
respiratory	O
illness	O
that	O
was	O
recently	O
recognized	O
in	O
humans	B-SPEC
.	O

Using	O
the	O
real	O
time	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
),	O
MERS	O
-	O
CoV	O
was	O
detected	O
in	O
the	O
nasal	O
secretions	O
of	O
a	O
human	B-SPEC
cadaver	O
.	O

Full	O
precautions	O
should	O
be	O
applied	O
and	O
carefully	O
followed	O
to	O
prevent	O
the	O
transmission	O
of	O
the	O
virus	B-SPEC
,	O
especially	O
among	O
health	O
care	O
workers	O
.	O

Even	O
though	O
several	O
technical	O
challenges	O
remain	O
to	O
be	O
addressed	O
to	O
exploit	O
the	O
potential	O
of	O
the	O
nanopore	O
technology	O
fully	O
,	O
our	O
work	O
illustrates	O
that	O
DRS	O
may	O
significantly	O
advance	O
genomic	O
studies	O
of	O
complex	O
virus	B-SPEC
populations	O
,	O
including	O
predictions	O
on	O
long	O
-	O
range	O
interactions	O
in	O
individual	O
full	O
-	O
length	O
viral	O
RNA	O
haplotypes	O
.	O

TITLE	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
isolates	O
from	O
a	O
part	O
of	O
Brazil	O
:	O
insights	O
into	O
molecular	O
epidemiology	O
and	O
phylogeny	O
inferred	O
from	O
the	O
7b	O
gene	O
.	O

The	O
theory	O
of	O
internal	O
mutation	O
suggests	O
that	O
a	O
less	O
virulent	O
biotype	O
of	O
FCoV	O
(	O
FECV	B-SPEC
)	O
would	O
lead	O
to	O
another	O
more	O
pathogenic	O
biotype	O
(	O
FIPV	O
)	O
capable	O
of	O
causing	O
FIP	O
.	O

TITLE	O
:	O
Precision	O
mouse	B-SPEC
models	O
with	O
expanded	O
tropism	O
for	O
human	B-SPEC
pathogens	O
.	O

Lung	O
-	O
only	O
mice	B-SPEC
and	O
bone	O
marrow	O
/	O
liver	O
/	O
thymus	B-SPEC
-	O
lung	O
humanized	O
mice	B-SPEC
substantially	O
increase	O
the	O
number	O
of	O
human	B-SPEC
pathogens	O
that	O
can	O
be	O
studied	O
in	O
vivo	O
,	O
facilitating	O
the	O
in	O
vivo	O
testing	O
of	O
therapeutics	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
causative	O
agent	O
of	O
severe	O
-	O
to	O
-	O
fatal	O
pneumonia	O
especially	O
in	O
patients	O
with	O
pre	O
-	O
existing	O
conditions	O
,	O
such	O
as	O
smoking	O
and	O
chronic	O
obstructive	O
pulmonary	O
disease	O
(	O
COPD	O
).	O

ABSTRACT	O
:	O
Enteric	O
viruses	B-SPEC
exploit	O
bacterial	O
components	O
,	O
including	O
lipopolysaccharides	O
(	O
LPS	O
)	O
and	O
peptidoglycan	O
(	O
PG	O
),	O
to	O
facilitate	O
infection	O
in	O
humans	B-SPEC
.	O

Haemophilus	B-SPEC
influenzae	I-SPEC
(	O
11	O
.	O
7	O
%)	O
and	O
adenovirus	B-SPEC
(	O
9	O
.	O
1	O
%)	O
were	O
the	O
predominant	O
bacterial	O
and	O
viral	O
pathogens	O
isolated	O
,	O
respectively	O
.	O

The	O
children	O
with	O
severe	O
influenza	B-SPEC
virus	I-SPEC
infection	O
who	O
were	O
admitted	O
in	O
the	O
PICU	B-SPEC
were	O
mainly	O
aged	O
<	O
3	O
years	O
.	O

Ten	O
pathogens	O
were	O
tested	O
by	O
a	O
combination	O
of	O
five	O
duplex	O
RT	O
-	O
PCRs	O
or	O
PCRs	O
:	O
influenza	O
A	O
and	O
B	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
metapneumovirus	B-SPEC
(	O
MPV	B-SPEC
),	O
rhinovirus	B-SPEC
/	O
enterovirus	B-SPEC
(	O
RV	O
/	O
EV	O
)),	O
coronavirus	B-SPEC
(	O
HKU1	O
,	O
NL63	O
,	O
229E	O
and	O
OC43	O
),	O
parainfluenza	O
virus	B-SPEC
(	O
1	O
-	O
4	O
),	O
adenovirus	B-SPEC
and	O
bocavirus	B-SPEC
(	O
Respiratory	O
Multi	O
-	O
Well	O
System	O
MWS	O
r	O
-	O
gene	O
®,	O
BioMérieux	O
,	O
Marcy	O
l	O
'	O
Étoile	O
,	O
France	O
).	O

RSV	B-SPEC
infections	O
(	O
n	O
=	O
6	O
)	O
were	O
usually	O
of	O
mild	O
severity	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
has	O
been	O
identified	O
as	O
the	O
aetiological	O
agent	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
),	O
a	O
highly	O
fatal	O
systemic	O
disease	O
in	O
cats	B-SPEC
.	O

ABSTRACT	O
:	O
One	O
Health	O
(	O
OH	O
)	O
is	O
a	O
collaborative	O
effort	O
to	O
attain	O
optimal	O
health	O
for	O
people	O
,	O
animals	B-SPEC
and	O
the	O
environment	O
.	O

TITLE	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
causes	O
diarrhea	O
in	O
various	O
ages	O
of	O
field	O
-	O
infected	O
pigs	B-SPEC
in	O
China	O
.	O

In	O
Henan	O
province	O
of	O
China	O
,	O
three	O
swine	B-SPEC
farms	O
broke	O
out	O
diarrhea	O
in	O
different	O
ages	O
of	O
pigs	B-SPEC
during	O
June	O
of	O
2017	O
,	O
March	O
of	O
2018	O
and	O
January	O
of	O
2019	O
,	O
respectively	O
.	O

TITLE	O
:	O
A	O
Fusion	O
Peptide	O
in	O
the	O
Spike	O
Protein	O
of	O
MERS	O
Coronavirus	B-SPEC
.	O

Middle	O
East	O
respiratory	O
syndrome	O
-	O
related	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
responsible	O
for	O
sporadic	O
infections	O
in	O
mostly	O
Middle	O
Eastern	O
countries	O
,	O
with	O
occasional	O
transfer	O
elsewhere	O
.	O

A	O
key	O
step	O
in	O
the	O
MERS	O
-	O
CoV	O
replication	O
cycle	O
is	O
the	O
fusion	O
of	O
the	O
virus	B-SPEC
and	O
host	O
cell	O
membranes	O
mediated	O
by	O
the	O
virus	B-SPEC
spike	O
protein	O
,	O
S	O
.	O
The	O
location	O
of	O
the	O
fusion	O
peptide	O
within	O
the	O
MERS	O
S	O
protein	O
has	O
not	O
been	O
precisely	O
mapped	O
.	O

These	O
animals	B-SPEC
play	O
important	O
roles	O
in	O
sustaining	O
the	O
virus	B-SPEC
in	O
certain	O
communities	O
and	O
may	O
act	O
as	O
an	O
amplifier	O
of	O
the	O
virus	B-SPEC
by	O
secreting	O
it	O
in	O
their	O
body	O
fluids	O
,	O
especially	O
in	O
nasal	O
and	O
rectal	O
discharges	O
.	O

Overall	O
,	O
there	O
are	O
many	O
unknown	O
/	O
confirmed	O
aspects	O
of	O
the	O
virus	B-SPEC
/	O
human	B-SPEC
/	O
animal	B-SPEC
network	O
.	O

ABSTRACT	O
:	O
Vaccination	O
plays	O
a	O
vital	O
role	O
in	O
controlling	O
diseases	O
caused	O
by	O
chicken	B-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Herein	O
we	O
describe	O
the	O
summit	O
proceedings	O
,	O
""""	O
Translational	O
Immunology	O
Supporting	O
Biomedical	O
Countermeasure	O
Development	O
for	O
Emerging	O
Vector	O
-	O
borne	O
Viral	O
Diseases	O
","""	O
held	O
October	O
2	O
-	O
3	O
,	O
2018	O
,	O
at	O
the	O
Trudeau	O
Institute	O
in	O
Saranac	O
Lake	B-SPEC
,	O
NY	O
.	O

Using	O
fecal	O
samples	O
collected	O
from	O
five	O
bat	B-SPEC
species	B-SPEC
between	O
2014	O
and	O
2016	O
in	O
Finland	O
and	O
RT	O
-	O
PCR	O
,	O
RT	O
-	O
qPCR	O
,	O
and	O
NGS	O
,	O
we	O
identified	O
CoVs	O
in	O
10	O
of	O
79	O
(	O
13	O
%)	O
samples	O
,	O
including	O
two	O
novel	O
bat	B-SPEC
species	B-SPEC
-	O
CoV	O
relationships	O
.	O

Also	O
discussed	O
is	O
the	O
recent	O
exciting	O
discovery	O
that	O
selective	O
coronavirus	B-SPEC
genome	O
packaging	O
is	O
critical	O
for	O
in	O
vivo	O
evasion	O
of	O
the	O
host	O
innate	O
immune	O
response	O
.	O

TITLE	O
:	O
Efficacy	O
and	O
immunogenicity	O
of	O
a	O
live	O
L	B-SPEC
.	I-SPEC
acidophilus	I-SPEC
expressing	O
SAD	O
epitope	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
as	O
an	O
oral	O
vaccine	O
.	O

In	O
orally	O
immunized	O
BALB	O
/	O
c	O
mice	B-SPEC
,	O
the	O
TGEV	B-SPEC
L	B-SPEC
.	I-SPEC
acidophilus	I-SPEC
oral	O
vaccine	O
induced	O
significantly	O
higher	O
level	O
of	O
SIgA	B-SPEC
antibodies	O
specific	O
to	O
TGEV	B-SPEC
compared	O
with	O
the	O
mice	B-SPEC
immunized	O
with	O
a	O
commercial	O
inactivated	O
TGEV	B-SPEC
vaccine	O
and	O
similar	O
levels	O
of	O
IgG	O
specific	O
to	O
TGEV	B-SPEC
as	O
the	O
inactivated	O
vaccine	O
.	O

TITLE	O
:	O
Clinically	O
relevant	O
model	O
of	O
pneumococcal	O
pneumonia	O
,	O
ARDS	O
,	O
and	O
nonpulmonary	O
organ	O
dysfunction	O
in	O
mice	B-SPEC
.	O

We	O
first	O
reviewed	O
the	O
literature	O
of	O
small	O
animal	B-SPEC
models	O
of	O
bacterial	O
pneumonia	O
that	O
incorporated	O
antibiotics	O
.	O

ABSTRACT	O
:	O
A	O
swine	B-SPEC
acute	O
diarrhea	O
syndrome	O
coronavirus	B-SPEC
(	O
SADS	O
-	O
CoV	O
)	O
that	O
causes	O
severe	O
diarrhea	O
in	O
suckling	O
piglets	O
was	O
identified	O
in	O
Southern	O
China	O
in	O
2017	O
.	O

Using	O
phage	O
display	O
technology	O
and	O
periplasmic	O
extraction	O
ELISA	O
(	O
PE	O
-	O
ELISA	O
),	O
anti	O
-	O
PEDV	B-SPEC
N	O
protein	O
nanobodies	O
from	O
three	O
strains	O
of	O
PEDV	B-SPEC
were	O
successfully	O
isolated	O
after	O
three	O
consecutive	O
rounds	O
of	O
bio	O
-	O
panning	O
from	O
a	O
high	O
quality	O
phage	O
display	O
VHH	O
library	O
.	O

In	O
brief	O
,	O
bELISA	O
is	O
a	O
rapid	O
,	O
low	O
-	O
cost	O
,	O
reliable	O
and	O
useful	O
nanobody	O
-	O
based	O
tool	O
for	O
the	O
serological	O
evaluation	O
of	O
current	O
PEDV	B-SPEC
vaccines	O
efficacy	O
and	O
indirect	O
diagnosis	O
of	O
PEDV	B-SPEC
infection	O
.	O

IBV	B-SPEC
mismatch	O
between	O
the	O
trivalent	O
vaccine	O
and	O
the	O
circulating	O
strains	O
occurred	O
.	O

TITLE	O
:	O
Assessing	O
exhibition	O
swine	B-SPEC
as	O
potential	O
disseminators	O
of	O
infectious	O
disease	O
through	O
the	O
detection	O
of	O
five	O
respiratory	O
pathogens	O
at	O
agricultural	O
exhibitions	O
.	O

Influenza	B-SPEC
D	I-SPEC
virus	I-SPEC
was	O
detected	O
in	O
two	O
(	O
0	O
.	O
07	O
%)	O
samples	O
.	O

Here	O
,	O
we	O
sequenced	O
multiple	O
complete	O
genomes	O
of	O
dromedary	B-SPEC
camel	B-SPEC
coronavirus	B-SPEC
HKU23	O
(	O
DcCoV	O
-	O
HKU23	O
)	O
from	O
Nigeria	O
,	O
Morocco	O
,	O
and	O
Ethiopia	O
and	O
identified	O
several	O
genomic	O
positions	O
indicative	O
of	O
cross	O
-	O
species	B-SPEC
virus	B-SPEC
recombination	O
events	O
among	O
other	O
betacoronaviruses	O
of	O
the	O
subgenus	B-SPEC
Embecovirus	O
(	O
clade	O
A	O
beta	O
-	O
CoVs	O
).	O

Our	O
results	O
highlighted	O
active	O
recombination	O
of	O
coronaviruses	O
circulating	O
in	O
dromedaries	B-SPEC
and	O
are	O
also	O
relevant	O
to	O
the	O
emergence	O
and	O
evolution	O
of	O
other	O
betacoronaviruses	O
,	O
including	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Here	O
,	O
we	O
report	O
the	O
cryo	O
-	O
electron	O
microscopy	O
structure	O
of	O
the	O
PEDV	B-SPEC
S	O
protein	O
in	O
the	O
prefusion	O
conformation	O
at	O
a	O
resolution	O
of	O
3	O
.	O
1	O
Å	O
.	O
Our	O
studies	O
revealed	O
that	O
the	O
sialic	O
acid	O
-	O
binding	O
domain	O
at	O
the	O
N	O
terminus	O
of	O
the	O
S1	O
subunit	O
has	O
an	O
orientation	O
that	O
is	O
substantially	O
different	O
from	O
that	O
observed	O
in	O
the	O
previously	O
determined	O
spike	O
structure	O
from	O
human	B-SPEC
alphacoronavirus	B-SPEC
NL63	O
.	O

Molecular	O
analysis	O
of	O
the	O
coronavirus	B-SPEC
spike	O
protein	O
within	O
the	O
tissues	O
identified	O
a	O
specific	O
,	O
functionally	O
relevant	O
amino	O
acid	O
change	O
(	O
R793M	O
),	O
which	O
was	O
only	O
identified	O
in	O
tissues	O
associated	O
with	O
the	O
central	O
nervous	O
system	O
(	O
ie	O
,	O
brain	O
and	O
spinal	O
cord	O
).	O

We	O
found	O
that	O
during	O
evolution	O
three	O
groups	O
evolved	O
with	O
a	O
relatively	O
low	O
codon	O
usage	O
bias	B-SPEC
(	O
effective	O
number	O
of	O
codons	O
(	O
ENC	O
)	O
of	O
52	O
).	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
)	O
is	O
an	O
emerging	O
swine	B-SPEC
enteric	B-SPEC
coronavirus	I-SPEC
that	O
causes	O
diarrhea	O
in	O
neonatal	O
piglets	O
.	O

As	O
a	O
first	O
step	O
toward	O
understanding	O
the	O
biology	O
of	O
the	O
PDCoV	O
accessory	O
proteins	O
,	O
we	O
established	O
a	O
stable	O
porcine	B-SPEC
cell	O
line	O
constitutively	O
expressing	O
the	O
PDCoV	O
NS7	O
protein	O
in	O
order	B-SPEC
to	O
investigate	O
the	O
functional	O
characteristics	O
of	O
NS7	O
for	O
viral	O
replication	O
.	O

TITLE	O
:	O
Force	O
of	O
infection	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
in	O
dromedary	B-SPEC
camels	B-SPEC
in	O
Kenya	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
zoonotic	O
disease	O
transmitted	O
from	O
dromedary	B-SPEC
camels	B-SPEC
to	O
people	O
,	O
which	O
can	O
result	O
in	O
outbreaks	O
with	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

This	O
study	O
estimated	O
the	O
force	O
of	O
infection	O
(	O
FOI	O
)	O
of	O
MERS	O
-	O
CoV	O
in	O
camel	B-SPEC
populations	O
from	O
age	O
-	O
stratified	O
serological	O
data	O
.	O

During	O
reverse	O
transcription	O
,	O
the	O
RNase	O
H	O
activity	O
of	O
human	B-SPEC
immunodeficiency	I-SPEC
virus	I-SPEC
(	O
HIV	B-SPEC
)	O
and	O
hepatitis	B-SPEC
B	I-SPEC
virus	I-SPEC
(	O
HBV	B-SPEC
)	O
degrades	O
the	O
viral	O
genomic	O
RNA	O
to	O
facilitate	O
the	O
synthesis	O
of	O
viral	O
double	O
-	O
stranded	O
DNA	O
.	O

The	O
main	O
objective	O
of	O
this	O
work	O
is	O
to	O
evaluate	O
the	O
risk	O
of	O
entry	O
of	O
animal	B-SPEC
infectious	O
zoonotic	O
and	O
non	O
-	O
zoonotic	O
diseases	O
from	O
North	O
Africa	O
and	O
the	O
Arabian	O
Peninsula	O
to	O
countries	O
of	O
the	O
European	O
Union	O
.	O

ABSTRACT	O
:	O
This	O
study	O
reports	O
the	O
prevalence	O
of	O
potential	O
faecal	O
pathogens	O
in	O
the	O
microbiome	O
detected	O
in	O
a	O
cohort	O
of	O
cats	B-SPEC
and	O
dogs	B-SPEC
with	O
diarrhoea	O
in	O
Perth	O
,	O
Western	O
Australia	O
.	O

Of	O
289	O
feline	B-SPEC
faecal	O
samples	O
reviewed	O
,	O
Salmonella	B-SPEC
spp	O
.	O

(	O
36	O
.	O
3	O
%),	O
C	B-SPEC
.	I-SPEC
perfringens	I-SPEC
(	O
85	O
.	O
4	O
%),	O
Giardia	B-SPEC
spp	O
.	O

The	O
study	O
investigated	O
the	O
antiviral	O
activity	O
of	O
Sambucus	B-SPEC
FormosanaNakai	O
stem	O
ethanol	O
extract	O
and	O
some	O
phenolic	O
acid	O
constituents	O
against	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
.	O

TITLE	O
:	O
Genetic	O
Analysis	O
of	O
Avian	B-SPEC
Coronavirus	I-SPEC
Infectious	O
Bronchitis	O
Virus	B-SPEC
in	O
Yellow	O
Chickens	B-SPEC
in	O
Southern	O
China	O
over	O
the	O
Past	O
Decade	O
:	O
Revealing	O
the	O
Changes	O
of	O
Genetic	O
Diversity	O
,	O
Dominant	O
Genotypes	O
,	O
and	O
Selection	O
Pressure	O
.	O

In	O
order	B-SPEC
to	O
track	O
the	O
genetic	O
evolutionary	O
of	O
IBV	B-SPEC
isolates	O
circulating	O
in	O
yellow	O
chickens	B-SPEC
,	O
we	O
continued	O
to	O
conduct	O
the	O
genetic	O
analyses	O
of	O
the	O
structural	O
genes	O
S1	O
,	O
E	O
,	O
M	O
,	O
and	O
N	O
from	O
64	O
IBV	B-SPEC
isolates	O
in	O
southern	O
China	O
during	O
2009	O
-	O
2017	O
.	O

The	O
studies	O
of	O
MERS	O
patients	O
with	O
severe	O
disease	O
and	O
experimentally	O
infected	O
animals	B-SPEC
showed	O
that	O
robust	O
viral	O
replication	O
and	O
intensive	O
proinflammatory	O
response	O
in	O
lung	O
tissues	O
contribute	O
to	O
high	O
pathogenicity	O
of	O
MERS	O
-	O
CoV	O
.	O
We	O
sought	O
to	O
identify	O
pattern	O
recognition	O
receptor	O
(	O
PRR	O
)	O
signaling	O
pathway	O
(	O
s	O
)	O
that	O
mediates	O
the	O
inflammatory	O
cascade	O
in	O
human	B-SPEC
macrophages	O
upon	O
MERS	O
-	O
CoV	O
infection	O
.	O

ABSTRACT	O
:	O
An	O
immunocompetent	O
adult	O
with	O
asthma	O
developed	O
severe	O
human	B-SPEC
metapneumovirus	I-SPEC
(	O
HMPV	B-SPEC
)	O
illness	O
complicated	O
by	O
group	B-SPEC
A	I-SPEC
Streptococcus	I-SPEC
coinfection	O
,	O
progressing	O
to	O
ARDS	O
and	O
shock	O
.	O

ABSTRACT	O
:	O
Infections	O
caused	O
by	O
Panton	O
-	O
Valentine	O
leukocidin	O
-	O
positive	O
Staphylococcus	B-SPEC
aureus	I-SPEC
(	O
PVL	O
-	O
SA	O
)	O
mostly	O
present	O
as	O
recurrent	O
skin	O
abscesses	O
and	O
furunculosis	O
.	O

The	O
secondary	O
outcomes	O
consist	O
of	O
complications	O
,	O
sepsis	B-SPEC
,	O
abdominal	O
hemorrhage	O
,	O
renal	O
failure	O
,	O
length	O
of	O
hospital	O
stay	O
,	O
and	O
mortality	O
.	O

Infection	O
by	O
FECV	B-SPEC
is	O
generally	O
subclinical	O
,	O
and	O
little	O
is	O
known	O
about	O
the	O
mucosal	O
immune	O
response	O
that	O
controls	O
and	O
eliminates	O
the	O
virus	B-SPEC
.	O

The	O
most	O
common	O
sources	O
of	O
health	O
information	O
included	O
television	O
/	O
radio	O
(	O
47	O
.	O
9	O
%),	O
social	O
media	O
(	O
29	O
.	O
4	O
%),	O
and	O
friends	O
/	O
family	B-SPEC
(	O
28	O
.	O
1	O
%).	O

We	O
isolated	O
a	O
highly	O
virulent	O
IBV	B-SPEC
strain	O
(	O
CK	O
/	O
CH	O
/	O
JS	O
/	O
TAHY	O
)	O
from	O
kidneys	O
of	O
diseased	O
chickens	B-SPEC
.	O

The	O
CITRIS	O
-	O
ALI	O
trial	O
was	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
,	O
multicenter	O
trial	O
conducted	O
in	O
7	O
medical	O
intensive	O
care	O
units	O
in	O
the	O
United	O
States	O
,	O
enrolling	O
patients	O
(	O
N	O
=	O
167	O
)	O
with	O
sepsis	B-SPEC
and	O
ARDS	O
present	O
for	O
less	O
than	O
24	O
hours	O
.	O

TITLE	O
:	O
Small	O
-	O
Molecule	O
Antiviral	O
β	O
-	O
d	O
-	O
ABSTRACT	O
:	O
Coronaviruses	O
(	O
CoVs	O
)	O
have	O
emerged	O
from	O
animal	B-SPEC
reservoirs	O
to	O
cause	O
severe	O
and	O
lethal	O
disease	O
in	O
humans	B-SPEC
,	O
but	O
there	O
are	O
currently	O
no	O
FDA	O
-	O
approved	O
antivirals	O
to	O
treat	O
the	O
infections	O
.	O

Samples	O
were	O
bacteriologically	O
cultured	O
and	O
tested	O
by	O
PCR	O
for	O
E	B-SPEC
.	I-SPEC
coli	I-SPEC
virulence	O
factors	O
genes	O
,	O
C	B-SPEC
.	I-SPEC
perfringens	I-SPEC
types	O
A	O
and	O
C	O
toxins	O
(	O
Cpα	O
,	O
Cpβ	O
,	O
Cpβ2	O
)	O
and	O
C	B-SPEC
.	I-SPEC
difficile	I-SPEC
toxins	O
(	O
TcdA	O
,	O
TcdB	O
).	O

Moreover	O
,	O
Rotavirus	B-SPEC
A	I-SPEC
(	O
RVA	O
),	O
Rotavirus	B-SPEC
B	I-SPEC
(	O
RVB	O
),	O
Rotavirus	B-SPEC
C	I-SPEC
(	O
RVC	O
),	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
and	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
were	O
also	O
determined	O
by	O
RT	O
-	O
qPCR	O
.	O

Epidemiological	O
investigations	O
,	O
patients	O
'	O
measles	O
serology	O
,	O
and	O
phylogenetic	O
analysis	O
of	O
the	O
hemagglutinin	O
(	O
H	O
)	O
and	O
nucleoprotein	O
(	O
N	O
)	O
genes	O
of	O
measles	B-SPEC
virus	I-SPEC
isolates	O
were	O
conducted	O
.	O

TGEV	B-SPEC
infection	O
provokes	O
mitochondrial	O
damage	O
of	O
porcine	B-SPEC
intestinal	O
epthelial	O
cell	O
(	O
IPEC	O
),	O
which	O
is	O
responsible	O
for	O
inflammation	O
and	O
cell	O
death	O
.	O

TITLE	O
:	O
Isolation	O
and	O
growth	O
characterization	O
of	O
novel	O
full	O
length	O
and	O
deletion	O
mutant	O
human	B-SPEC
MERS	O
-	O
CoV	O
strains	O
from	O
clinical	O
specimens	O
collected	O
during	O
2015	O
.	O

Viruses	B-SPEC
with	O
deletions	O
in	O
the	O
5	O
'	O
UTR	O
and	O
ORF1a	O
exhibited	O
impaired	O
viral	O
release	O
in	O
Vero	O
cells	O
.	O

Coronavirus	B-SPEC
,	O
enterovirus	B-SPEC
,	O
bocavirus	B-SPEC
and	O
rhinovirus	B-SPEC
were	O
found	O
by	O
multiplex	O
RT	O
-	O
qPCR	O
as	O
well	O
as	O
by	O
HTS	O
analyses	O
.	O

We	O
sampled	O
surfaces	O
during	O
the	O
Hajj	O
to	O
detect	O
the	O
presence	O
of	O
respiratory	O
bacteria	B-SPEC
and	O
viruses	B-SPEC
.	O

Moreover	O
,	O
other	O
p200	O
family	B-SPEC
proteins	O
that	O
possess	O
HIN	O
domain	O
could	O
also	O
inhibit	O
the	O
IRF7	O
-	O
mediated	O
type	O
I	O
interferons	O
.	O

Furthermore	O
,	O
individual	O
respiratory	O
viruses	B-SPEC
and	O
their	O
association	O
with	O
influenza	O
vaccination	O
were	O
examined	O
.	O

Given	O
the	O
widespread	O
prevalence	O
,	O
a	O
general	O
lack	O
of	O
natural	O
sterilizing	O
immunity	O
,	O
and	O
/	O
or	O
high	O
morbidity	O
and	O
lethality	O
rates	O
of	O
diseases	O
caused	O
by	O
influenza	O
,	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
,	O
coronaviruses	O
,	O
and	O
rhinoviruses	B-SPEC
,	O
this	O
difficult	O
situation	O
is	O
a	O
genuine	O
societal	O
challenge	O
.	O

TITLE	O
:	O
Preparation	O
of	O
virus	B-SPEC
-	O
like	O
particle	O
mimetic	O
nanovesicles	O
displaying	O
the	O
S	O
protein	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
using	O
insect	B-SPEC
cells	O
.	O

The	O
spike	O
(	O
S	O
)	O
protein	O
of	O
MERS	O
-	O
CoV	O
lacking	O
its	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
(	O
SΔTM	O
)	O
was	O
secreted	O
into	O
the	O
hemolymph	O
of	O
silkworm	B-SPEC
larvae	O
using	O
a	O
bombyxin	O
signal	O
peptide	O
and	O
purified	O
using	O
affinity	O
chromatography	O
.	O

TITLE	O
:	O
Nosocomial	O
Transmission	O
of	O
Emerging	O
Viruses	B-SPEC
via	O
Aerosol	O
-	O
Generating	O
Medical	O
Procedures	O
.	O

In	O
summary	O
,	O
we	O
generated	O
a	O
MERS	O
-	O
CoV	O
neutralizing	O
human	B-SPEC
antibody	O
that	O
is	O
reactive	O
to	O
recombinant	O
MERS	O
-	O
CoV	O
S	O
RBD	O
protein	O
for	O
delivery	O
via	O
a	O
pulmonary	O
route	O
by	O
introducing	O
stabilizing	O
mutations	O
into	O
five	O
CDRs	O
.	O

The	O
differences	O
in	O
the	O
p4	O
.	O
7	O
region	O
between	O
the	O
Irish	O
ECoVs	O
and	O
other	O
ECoVs	O
indicated	O
that	O
the	O
Irish	O
viruses	B-SPEC
were	O
distinguishable	O
from	O
those	O
circulating	O
in	O
other	O
countries	O
.	O

The	O
role	O
of	O
epidermal	O
growth	O
factor	O
receptor	O
(	O
EGFR	O
)	O
in	O
influenza	O
pathogenesis	O
,	O
one	O
of	O
the	O
bottleneck	O
regulators	O
with	O
corroborating	O
signals	O
across	O
transcript	O
and	O
protein	O
expression	O
data	O
,	O
was	O
tested	O
and	O
validated	O
in	O
additional	O
mouse	B-SPEC
infection	O
experiments	O
.	O

Our	O
results	O
show	O
that	O
by	O
using	O
association	O
networks	O
,	O
bottleneck	O
genes	O
that	O
lack	O
hub	O
characteristics	O
can	O
be	O
used	O
to	O
predict	O
a	O
gene	O
'	O
s	O
involvement	O
in	O
influenza	B-SPEC
virus	I-SPEC
pathogenicity	O
.	O

She	O
developed	O
very	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
which	O
was	O
treated	O
with	O
rescue	O
high	O
-	O
frequency	O
oscillation	O
),	O
hemodynamic	O
instability	O
,	O
acute	O
kidney	O
injury	O
,	O
rhabdomyolysis	O
,	O
and	O
remained	O
comatose	O
with	O
a	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
of	O
3	O
and	O
gasping	O
respirations	O
for	O
67	O
hours	O
(	O
when	O
the	O
Glasgow	O
Coma	B-SPEC
Scale	O
score	O
improved	O
to	O
6	O
,	O
with	O
tachypnea	O
to	O
Paco	O

Despite	O
global	O
efforts	O
to	O
prevent	O
and	O
treat	O
virus	B-SPEC
infections	O
to	O
limit	O
morbidity	O
and	O
mortality	O
,	O
the	O
continued	O
emergence	O
and	O
re	O
-	O
emergence	O
of	O
new	O
outbreaks	O
as	O
well	O
as	O
common	O
infections	O
such	O
as	O
influenza	O
persist	O
as	O
a	O
health	O
threat	O
.	O

The	O
CC	O
mice	B-SPEC
exhibited	O
a	O
range	O
of	O
disease	O
manifestations	O
upon	O
infections	O
,	O
and	O
we	O
used	O
this	O
natural	O
variation	O
to	O
identify	O
strains	O
with	O
mortality	O
after	O
infection	O
and	O
strains	O
exhibiting	O
no	O
mortality	O
.	O

It	O
is	O
fairly	O
well	O
-	O
accepted	O
in	O
the	O
medical	O
community	O
that	O
GC	O
can	O
be	O
life	O
-	O
saving	O
when	O
used	O
in	O
critically	O
ill	O
patients	O
with	O
severe	O
exacerbations	O
of	O
asthma	O
and	O
chronic	O
obstructive	O
pulmonary	O
disease	O
,	O
HIV	B-SPEC
-	O
associated	O
pneumocystosis	O
,	O
and	O
systemic	O
vasculitides	O
.	O

Ten	O
pathogens	O
were	O
detected	O
in	O
this	O
assay	O
,	O
of	O
which	O
rhinovirus	B-SPEC
,	O
adenovirus	B-SPEC
,	O
and	O
influenza	B-SPEC
virus	I-SPEC
A	O
pdmH1N1	O
(	O
2009	O
)	O
were	O
the	O
most	O
common	O
.	O

TITLE	O
:	O
Molecular	O
epidemiology	O
of	O
coronavirus	B-SPEC
in	O
faeces	O
of	O
Brazilian	O
calves	O
and	O
Peruvian	O
camelid	O
herds	O
.	O

There	O
was	O
a	O
statistically	O
significant	O
agreement	O
between	O
nasal	O
mucosal	O
swab	O
and	O
dacryocystorhinostomy	O
biopsy	O
samples	O
in	O
terms	O
of	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
positivity	O
(	O
kappa	O
=	O
1	O
.	O
000	O
,	O
Although	O
the	O
viral	O
genome	O
was	O
detected	O
in	O
the	O
samples	O
,	O
a	O
direct	O
relationship	O
between	O
viruses	B-SPEC
and	O
pathogenesis	O
of	O
primary	O
acquired	O
nasolacrimal	O
duct	O
obstruction	O
could	O
not	O
be	O
revealed	O
because	O
of	O
the	O
low	O
number	O
of	O
positive	O
results	O
.	O

While	O
overexpression	O
of	O
GILT	O
inhibited	O
the	O
entry	O
mediated	O
by	O
envelope	O
glycoproteins	O
of	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
),	O
Ebola	B-SPEC
virus	I-SPEC
(	O
EBOV	O
)	O
and	O
Lassa	O
fever	O
virus	B-SPEC
(	O
LASV	O
),	O
depletion	O
of	O
GILT	O
enhanced	O
the	O
entry	O
mediated	O
by	O
these	O
viral	O
envelope	O
glycoproteins	O
.	O

ABSTRACT	O
:	O
Therapeutic	O
options	O
for	O
the	O
highly	O
pathogenic	O
human	B-SPEC
coronavirus	I-SPEC
(	O
HCoV	O
)	O
infections	O
are	O
urgently	O
needed	O
.	O

In	O
this	O
work	O
,	O
the	O
antiviral	O
activity	O
of	O
seven	O
different	O
carbon	O
quantum	O
dots	O
(	O
CQDs	O
)	O
for	O
the	O
treatment	O
of	O
human	B-SPEC
coronavirus	I-SPEC
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
infections	O
was	O
investigated	O
.	O

TITLE	O
:	O
Influences	O
of	O
cyclosporin	O
A	O
and	O
non	O
-	O
immunosuppressive	O
derivatives	O
on	O
cellular	O
cyclophilins	O
and	O
viral	O
nucleocapsid	O
protein	O
during	O
human	B-SPEC
coronavirus	I-SPEC
229E	I-SPEC
replication	O
.	O

ABSTRACT	O
:	O
The	O
well	O
-	O
known	O
immunosuppressive	O
drug	O
cyclosporin	O
A	O
inhibits	O
replication	O
of	O
various	O
viruses	B-SPEC
including	O
coronaviruses	O
by	O
binding	O
to	O
cellular	O
cyclophilins	O
thus	O
inactivating	O
their	O
cis	B-SPEC
-	O
trans	O
peptidyl	O
-	O
prolyl	O
isomerase	O
function	O
.	O

The	O
common	O
symptoms	O
of	O
MAS	O
include	O
severe	O
hypertension	O
or	O
arterial	O
insufficiency	O
distal	O
to	O
the	O
stenosis	B-SPEC
.	O

An	O
enterectomy	O
was	O
performed	O
and	O
histopathology	O
revealed	O
severe	O
pyogranulomatous	O
enteritis	O
with	O
vasculitits	O
,	O
compatible	O
with	O
the	O
diagnosis	O
of	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

While	O
AIV	O
and	O
AAVV	O
-	O
1	O
were	O
frequently	O
detected	O
(	O
16	O
to	O
17	O
%	O
of	O
farms	O
),	O
IBV	B-SPEC
and	O
aMPV	O
were	O
rarely	O
detected	O
(	O
in	O
3	O
to	O
5	O
%	O
of	O
farms	O
)	O
and	O
ILTV	B-SPEC
was	O
not	O
detected	O
.	O

Control	O
measures	O
to	O
limit	O
the	O
virus	B-SPEC
burden	O
in	O
chicken	B-SPEC
flocks	O
are	O
discussed	O
.	O

We	O
reviewed	O
hospital	O
records	O
of	O
confirmed	O
cases	O
(	O
detection	O
of	O
virus	B-SPEC
by	O
polymerase	O
chain	O
reaction	O
from	O
respiratory	O
tract	O
samples	O
)	O
of	O
MERS	O
-	O
CoV	O
patients	O
(	O
n	O
=	O
63	O
)	O
admitted	O
to	O
Buraidah	O
Central	O
Hospital	O
in	O
Al	O
-	O
Qassim	O
,	O
Saudi	O
Arabia	O
between	O
2014	O
and	O
2017	O
.	O

They	O
have	O
activity	O
against	O
Escherichia	B-SPEC
coli	I-SPEC
,	O
Hemophilis	O
influenzae	O
,	O
Listeria	B-SPEC
monocytogenesis	O
,	O
Neisseria	B-SPEC
gonorrhoeae	I-SPEC
,	O
Proteus	B-SPEC
mirabilis	I-SPEC
,	O
Salmonella	B-SPEC
,	O
Shigella	B-SPEC
,	O
Staphylococcus	B-SPEC
aureus	I-SPEC
(	O
non	O
-	O
penicillinase	O
producing	O
),	O
Staphyloccocus	O
epidermidis	O
,	O
and	O
Streptococcus	B-SPEC
pneumoniae	I-SPEC
.	O

In	O
contrast	O
,	O
many	O
of	O
them	O
contain	O
antibodies	O
against	O
bat	B-SPEC
HKU8	O
-	O
related	O
(	O
HKU8r	O
)-	O
CoVs	O
.	O

TITLE	O
:	O
One	O
-	O
step	O
triplex	O
reverse	O
-	O
transcription	O
PCR	O
detection	O
of	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
,	O
porcine	B-SPEC
sapelovirus	I-SPEC
,	O
and	O
porcine	B-SPEC
sapovirus	B-SPEC
.	O

A	O
novel	B-SPEC
coronavirus	I-SPEC
related	O
to	O
MERS	O
-	O
CoV	O
,	O

Currently	O
available	O
PEDV	B-SPEC
vaccine	O
strains	O
have	O
limited	O
protective	O
effects	O
against	O
PEDV	B-SPEC
variant	O
strains	O
.	O

TITLE	O
:	O
Extracorporeal	O
Life	O
Support	O
:	O
The	O
Next	O
Step	O
in	O
Moderate	O
to	O
Severe	O
ARDS	O
-	O
A	O
Review	O
and	O
Meta	B-SPEC
-	O
Analysis	O
of	O
the	O
Literature	O
.	O

TITLE	O
:	O
Metagenomic	O
Nanopore	O
Sequencing	O
of	O
Influenza	B-SPEC
Virus	I-SPEC
Direct	O
from	O
Clinical	O
Respiratory	O
Samples	O
.	O

TITLE	O
:	O
Protostemonine	O
alleviates	O
heat	O
-	O
killed	O
methicillin	O
-	O
resistant	O
Staphylococcus	B-SPEC
aureus	I-SPEC
-	O
induced	O
acute	O
lung	O
injury	O
through	O
MAPK	O
and	O
NF	O
-	O
κB	O
signaling	O
pathways	O
.	O

PSN	O
treatment	O
significantly	O
attenuated	O
HKMRSA	O
-	O
induced	O
pathological	O
injury	O
,	O
pulmonary	O
neutrophil	O
infiltration	O
,	O
tissue	O
permeability	O
and	O
the	O
production	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
(	O
TNF	O
-	O
α	O
,	O
IL	O
-	O
1β	O
and	O
IL	O
-	O
6	O
)	O
in	O
murine	B-SPEC
ALI	O
model	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
if	O
the	O
influence	O
of	O
Met	O
on	O
HEV	B-SPEC
infected	O
turkeys	B-SPEC
immune	O
response	O
can	O
be	O
differentiated	O
by	O
both	O
its	O
level	O
and	O
source	O
.	O

RESULTS	O
:	O
The	O
HEV	B-SPEC
added	O
the	O
percentage	O
of	O
CD4	O

Taking	O
consideration	O
of	O
the	O
importance	O
of	O
PEDV	B-SPEC
orf3	O
gene	O
,	O
we	O
have	O
performed	O
comprehensive	O
analysis	O
to	O
investigate	O
its	O
synonymous	O
codon	O
usage	O
patterns	O
.	O

Clinicopathological	O
assessment	O
showed	O
that	O
two	O
of	O
the	O
variants	O
caused	O
high	O
fatality	O
rates	O
of	O
67	O
%	O
and	O
20	O
%	O
in	O
one	O
-	O
day	O
-	O
old	O
SPF	O
chicks	O
,	O
and	O
all	O
the	O
variants	O
possessed	O
multiorgan	O
tropisms	O
,	O
including	O
trachea	B-SPEC
,	O
proventriculus	O
and	O
urogenital	O
tissues	O
.	O

This	O
study	O
identified	O
novel	O
genotypes	O
,	O
serotypes	O
and	O
pathotypes	O
of	O
emerging	O
IBV	B-SPEC
variants	O
circulating	O
in	O
Taiwan	O
.	O

ABSTRACT	O
:	O
Transmissible	O
gastroenteritis	O
virus	B-SPEC
(	O
TGEV	B-SPEC
)	O
infection	O
can	O
cause	O
acute	O
inflammation	O
.	O

In	O
this	O
study	O
,	O
the	O
next	O
-	O
generation	O
sequencing	O
(	O
NGS	O
)	O
technology	O
was	O
used	O
to	O
analyze	O
the	O
profiles	O
of	O
lncRNAs	O
in	O
Mock	O
and	O
TGEV	B-SPEC
-	O
infected	O
porcine	B-SPEC
intestinal	O
epithelial	O
cell	O
-	O
jejunum	O
2	O
(	O
IPEC	O
-	O
J2	O
)	O
cell	O
line	O
.	O

The	O
data	O
showed	O
that	O
differentially	O
expressed	O
lncRNAs	O
might	O
be	O
involved	O
in	O
inflammatory	O
response	O
induced	O
by	O
TGEV	B-SPEC
through	O
acting	O
as	O
miRNA	O
sponges	B-SPEC
,	O
regulating	O
their	O
up	O
/	O
down	O
-	O
stream	O
genes	O
,	O
or	O
directly	O
binding	O
proteins	O
.	O

ABSTRACT	O
:	O
A	O
serological	O
survey	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
conducted	O
among	O
dromedary	B-SPEC
camels	B-SPEC
and	O
herbivorous	O
animals	B-SPEC
sharing	O
the	O
same	O
pasturage	O
in	O
Ethiopia	O
.	O

TITLE	O
:	O
Ecthyma	O
Gangrenosum	O
Secondary	O
to	O
Pseudomonal	O
Sepsis	B-SPEC
Complicated	O
by	O
Acute	O
Respiratory	O
Distress	O
Syndrome	O
Following	O
Craniotomy	O
for	O
Resection	O
of	O
a	O
Metastasis	O
.	O

47	O
client	O
-	O
owned	O
dogs	B-SPEC
.	O

At	O
least	O
1	O
pathogen	O
was	O
detected	O
in	O
21	O
of	O
37	O
(	O
57	O
%;	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
],	O
41	O
%	O
to	O
71	O
%)	O
dogs	B-SPEC
with	O
UMRD	O
,	O
and	O
canine	O
coronavirus	B-SPEC
was	O
detected	O
in	O
1	O
of	O
10	O
(	O
10	O
%;	O
95	O
%	O
CI	O
,	O
2	O
%	O
to	O
40	O
%)	O
dogs	B-SPEC
with	O
CHD	O
.	O

This	O
eventually	O
led	O
to	O
the	O
discovery	O
of	O
a	O
new	O
capsid	O
inhibitor	O
with	O
significantly	O
reduced	O
CYP3A4	O
induction	O
,	O
excellent	O
anti	O
-	O
HBV	B-SPEC
activity	O
,	O
favorable	O
preclinical	O
PK	O
/	O
PD	O
profiles	O
,	O
and	O
no	O
early	O
safety	O
flags	B-SPEC
.	O

However	O
,	O
some	O
animal	B-SPEC
studies	O
have	O
suggested	O
that	O
inadequate	O
immunization	O
against	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
induces	O
a	O
lung	O
eosinophilic	O
immunopathology	O
upon	O
infection	O
.	O

Whereas	O
similar	O
virus	B-SPEC
titers	O
were	O
observed	O
in	O
the	O
control	O
animals	B-SPEC
and	O
the	O
animals	B-SPEC
immunized	O
with	O
S	O
protein	O
with	O
or	O
without	O
AuNPs	O
,	O
Type	O
1	O
interferon	O
and	O
pro	O
-	O
inflammatory	O
responses	O
were	O
moderate	O
in	O
the	O
mice	B-SPEC
treated	O
with	O
S	O
protein	O
with	O
and	O
without	O
AuNPs	O
.	O

Here	O
,	O
we	O
elucidate	O
the	O
determinants	O
for	O
kidney	O
tropism	O
by	O
studying	O
interactions	O
between	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
the	O
viral	O
attachment	O
protein	O
spike	O
from	O
two	O
IBV	B-SPEC
strains	O
with	O
different	O
tropisms	O
.	O

In	O
particular	O
,	O
QX	O
-	O
RBD	O
amino	O
acids	O
110	O
to	O
112	O
(	O
KIP	O
)	O
were	O
sufficient	O
to	O
render	O
IBV	B-SPEC
-	O
M41	O
with	O
the	O
ability	O
to	O
bind	O
to	O
kidney	O
,	O
while	O
the	O
reciprocal	O
mutations	O
in	O
IBV	B-SPEC
-	O
QX	O
abolished	O
kidney	O
binding	O
completely	O
.	O

To	O
combine	O
the	O
safety	O
and	O
efficacy	O
advantages	O
of	O
inactivated	O
and	O
attenuated	O
PEDV	B-SPEC
vaccines	O
,	O
respectively	O
,	O
in	O
this	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
subjecting	O
PEDV	B-SPEC
virions	O
to	O
heat	O
treatment	O
at	O
44	O
°	O
C	O
for	O
10	O
min	O
to	O
reversibly	O
unfold	O
structural	O
proteins	O
,	O
followed	O
by	O
exposure	O
to	O
RNAse	O
to	O
fragment	O
the	O
genome	O
,	O
would	O
result	O
in	O
a	O
vaccine	O
preparation	O
with	O
intact	O
viral	O
structure	O
/	O
antigenicity	O
but	O
highly	O
diminished	O
replicative	O
abilities	O
.	O

This	O
study	O
assesses	O
whether	O
co	O
-	O
infection	O
with	O
2	O
viruses	B-SPEC
as	O
compared	O
with	O
1	O
is	O
associated	O
with	O
increased	O
hospitalization	O
in	O
those	O
with	O
acute	O
respiratory	O
infections	O
.	O

Since	O
2012	O
,	O
more	O
than	O
2425	O
MERS	O
-	O
CoV	O
human	B-SPEC
cases	O
have	O
been	O
reported	O
in	O
27	O
countries	O
.	O

TITLE	O
:	O
Epitope	O
-	O
based	O
peptide	O
vaccine	O
design	O
and	O
target	O
site	O
depiction	O
against	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
:	O
an	O
immune	O
-	O
informatics	O
study	O
.	O

Among	O
T	O
-	O
cell	O
epitopes	O
,	O
MHC	O
class	B-SPEC
-	O
I	O
peptide	O
YKLQPLTFL	O
and	O
MHC	O
class	B-SPEC
-	O
II	O
peptide	O
YCILEPRSG	O
were	O
identified	O
as	O
highly	O
antigenic	O
.	O

TITLE	O
:	O
Humoral	O
Immunogenicity	O
and	O
Efficacy	O
of	O
a	O
Single	O
Dose	O
of	O
ChAdOx1	O
MERS	O
Vaccine	O
Candidate	O
in	O
Dromedary	B-SPEC
Camels	B-SPEC
.	O

Antibody	O
responses	O
in	O
seropositive	O
camels	B-SPEC
were	O
enhancedby	O
the	O
vaccine	O
;	O
these	O
camels	B-SPEC
had	O
a	O
higher	O
average	O
age	O
than	O
seronegative	O
.	O

Additionally	O
,	O
we	O
monitored	O
the	O
spatial	O
and	O
temporal	O
progression	O
of	O
HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
through	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
of	O
live	O
BALB	O
/	O
c	O
mice	B-SPEC
after	O
intranasal	O
or	O
intracerebral	O
inoculation	O
with	O
rOC43	O
-	O
ns2DelRluc	O
.	O

Here	O
,	O
we	O
report	O
the	O
case	O
of	O
an	O
88	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
presented	O
with	O
severe	O
DLI	O
,	O
caused	O
by	O
Sai	O
-	O
rei	O
-	O
to	O
.	O

It	O
is	O
the	O
most	O
common	O
parasite	O
in	O
humans	B-SPEC
all	O
over	O
the	O
world	O
with	O
Giardia	B-SPEC
.	O

Cryptosporidium	B-SPEC
is	O
an	O
important	O
cause	O
of	O
chronic	O
diarrhea	O
in	O
Human	B-SPEC
Immunodeficiency	I-SPEC
Virus	I-SPEC
(	O
HIV	B-SPEC
)/	O
Acquired	O
Immunodeficiency	O
Syndrome	O
(	O
AIDS	O
)	O
patients	O
.	O

TITLE	O
:	O
Rapid	O
manipulation	O
of	O
the	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
genome	O
by	O
CRISPR	O
/	O
Cas9	O
technology	O
.	O

The	O
rescued	O
virus	B-SPEC
(	O
rAJ1102	O
)	O
exhibited	O
similar	O
proliferation	O
characteristics	O
in	O
vitro	O
to	O
the	O
wildtype	O
AJ1102	O
.	O

TITLE	O
:	O
Herpes	O
viruses	B-SPEC
in	O
optic	O
neuritis	O
:	O
Similar	O
to	O
Bell	O
'	O
s	O
palsy	O
.	O

To	O
analyze	O
the	O
potential	O
presence	O
of	O
herpes	O
viruses	B-SPEC
in	O
blood	O
and	O
subarachnoid	O
area	O
at	O
the	O
time	O
of	O
ON	O
and	O
contrast	O
the	O
findings	O
according	O
to	O
long	O
-	O
term	O
evolution	O
either	O
as	O
intracranial	O
neuritis	O
or	O
as	O
progression	O
to	O
multiple	O
sclerosis	O
.	O

The	O
sepsis	B-SPEC
group	O
presented	O
with	O
higher	O
mortality	O
(	O
14	O
[	O
28	O
.	O
0	O
%]	O
vs	O
.	O
17	O
[	O
4	O
.	O
6	O
%],	O
P	O
<	O
0	O
.	O
001	O
)	O
and	O
longer	O
intensive	O
care	O
unit	O
stay	O
(	O
23	O
days	O
[	O
range	O
,	O
11	O
to	O
35	O
days	O
]	O
vs	O
.	O
3	O
days	O
[	O
range	O
,	O
1	O
to	O
9	O
days	O
],	O
P	O
<	O
0	O
.	O
001	O
).	O

It	O
has	O
been	O
8	O
years	O
since	O
the	O
first	O
case	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
was	O
reported	O
in	O
Saudi	O
Arabia	O
and	O
the	O
disease	O
is	O
still	O
being	O
reported	O
in	O
27	O
countries	O
;	O
however	O
,	O
there	O
is	O
no	O
international	O
study	O
to	O
estimate	O
the	O
overall	O
burden	O
related	O
of	O
this	O
emerging	O
infectious	O
disease	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
emerges	O
when	O
feline	B-SPEC
coronaviruses	O
(	O
FCoVs	O
)	O
mutate	O
within	O
their	O
host	O
to	O
a	O
highly	O
virulent	O
biotype	O
and	O
the	O
immune	O
response	O
is	O
not	O
able	O
to	O
control	O
the	O
infection	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Coronavirus	B-SPEC
Virus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
first	O
emerged	O
from	O
Saudi	O
Arabia	O
in	O
2012	O
and	O
has	O
since	O
been	O
recognized	O
as	O
a	O
significant	O
human	B-SPEC
respiratory	O
pathogen	O
on	O
a	O
global	O
level	O
.	O

Thus	O
,	O
the	O
neonatal	O
piglet	O
model	O
of	O
acute	O
lung	O
injury	O
serves	O
as	O
an	O
excellent	O
model	O
to	O
study	O
respiratory	O
failure	O
and	O
is	O
the	O
preferred	O
animal	B-SPEC
model	O
for	O
reasons	O
of	O
availability	O
,	O
body	O
size	O
,	O
similarities	O
of	O
porcine	B-SPEC
and	O
human	B-SPEC
lung	O
,	O
robustness	O
,	O
and	O
costs	O
.	O

ABSTRACT	O
:	O
A	O
high	O
percentage	O
of	O
camel	B-SPEC
handlers	O
in	O
Saudi	O
Arabia	O
are	O
seropositive	O
for	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
MERS	O
-	O
CoV	O
in	O
Camels	B-SPEC
but	O
Not	O
Camel	B-SPEC
Handlers	O
,	O
Sudan	O
,	O
2015	O
and	O
2017	O
.	O

We	O
compared	O
the	O
characteristics	O
and	O
in	O
-	O
hospital	O
mortality	O
of	O
patients	O
administered	O
with	O
antibiotics	O
at	O
varying	O
durations	O
after	O
sepsis	B-SPEC
recognition	O
,	O
i	O
.	O
e	O
.,	O
0	O
-	O
60	O
,	O
61	O
-	O
120	O
,	O
121	O
-	O
180	O
,	O
181	O
-	O
240	O
,	O
241	O
-	O
360	O
,	O
and	O
361	O
-	O
1440	O
min	O
,	O
and	O
estimated	O
the	O
impact	O
of	O
antibiotic	O
timing	O
on	O
risk	O
-	O
adjusted	O
in	O
-	O
hospital	O
mortality	O
using	O
the	O
generalized	O
estimating	O
equation	O
model	O
(	O
GEE	O
)	O
with	O
an	O
exchangeable	O
,	O
within	O
-	O
group	O
correlation	O
matrix	O
,	O
with	O
""""	O
hospital	O
""""	O
as	O
the	O
grouping	O
variable	O
.	O

The	O
short	O
-	O
term	O
and	O
long	O
-	O
term	O
effects	O
of	O
cannabis	B-SPEC
oil	O
inhalation	O
are	O
not	O
well	O
understood	O
.	O

ABSTRACT	O
:	O
We	O
present	O
data	O
on	O
a	O
cohort	O
of	O
patients	O
diagnosed	O
with	O
sepsis	B-SPEC
over	O
a	O
10	O
-	O
year	O
period	O
comparing	O
outcomes	O
in	O
solid	O
organ	O
transplant	O
(	O
SOT	O
)	O
and	O
non	O
-	O
solid	O
organ	O
transplant	O
(	O
non	O
-	O
SOT	O
)	O
recipients	O
.	O

CONCLUSIONS	O
:	O
Sepsis	B-SPEC
in	O
solid	O
organ	O
transplants	O
and	O
non	O
-	O
solid	O
organ	O
transplant	O
patients	O
have	O
similar	O
mortality	O
;	O
however	O
,	O
the	O
subset	O
of	O
heart	O
and	O
lung	O
transplant	O
recipients	O
with	O
sepsis	B-SPEC
has	O
a	O
higher	O
rate	O
of	O
mortality	O
compared	O
with	O
the	O
non	O
-	O
solid	O
organ	O
transplant	O
recipients	O
.	O

Hilar	O
congestion	O
was	O
highlighted	O
on	O
chest	O
x	O
-	O
ray	B-SPEC
.	O

ABSTRACT	O
:	O
QX	O
-	O
like	O
genotype	O
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
)	O
has	O
become	O
prevalent	O
in	O
recent	O
years	O
.	O

Recombinant	O
viruses	B-SPEC
rIBYZ	O
-	O
ScAUG3a	O
,	O
rIBYZ	O
-	O
ScAUG3b	O
and	O
rIBYZ	O
-	O
ScAUG3ab	O
were	O
generated	O
.	O

The	O
rIBYZ	O
-	O
ScAUG3b	O
and	O
rIBYZ	O
-	O
ScAUG3ab	O
strains	O
showed	O
attenuated	O
pathogenicity	O
compared	O
to	O
rIBYZ	O
,	O
as	O
no	O
chickens	B-SPEC
died	O
and	O
all	O
the	O
parameters	O
tested	O
were	O
considerably	O
low	O
.	O

Nonetheless	O
,	O
most	O
epidemiological	O
patterns	O
were	O
similar	O
to	O
other	O
studies	O
globally	O
,	O
suggesting	O
surprising	O
similarities	O
of	O
virus	B-SPEC
-	O
associated	O
ARI	O
across	O
highly	O
diverse	O
settings	O
and	O
a	O
complex	O
impact	O
of	O
population	O
characteristics	O
on	O
respiratory	O
virus	B-SPEC
epidemiology	O
.	O

TITLE	O
:	O
Global	O
virus	B-SPEC
outbreaks	O
:	O
Interferons	O
as	O
1st	O
responders	O
.	O

ABSTRACT	O
:	O
Calf	O
diarrhea	O
caused	O
by	O
infectious	O
agents	O
is	O
associated	O
with	O
economic	O
losses	O
in	O
the	O
cattle	B-SPEC
industry	O
.	O

TITLE	O
:	O
Enhancement	O
of	O
antigen	O
-	O
specific	O
humoral	O
immune	O
responses	O
and	O
protein	O
solubility	O
through	O
conjugation	O
of	O
bacterial	O
flagellin	O
,	O
ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	O
diarrhea	O
(	O
PED	O
)	O
is	O
a	O
highly	O
contagious	O
enteric	O
swine	B-SPEC
disease	O
.	O

It	O
leads	O
to	O
endotheliopathy	O
-	O
associated	O
vascular	O
microthrombotic	O
disease	O
(	O
EA	O
-	O
VMTD	O
),	O
which	O
orchestrates	O
consumptive	O
thrombocytopenia	O
,	O
microangiopathic	O
hemolytic	O
anemia	B-SPEC
,	O
and	O
MODS	O
.	O

TITLE	O
:	O
Molecular	O
Basis	O
of	O
Binding	O
between	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
and	O
CD26	O
from	O
Seven	O
Bat	B-SPEC
Species	B-SPEC
.	O

We	O
retrospectively	O
reviewed	O
data	O
from	O
60	O
children	O
(	O
median	O
age	O
of	O
6	O
.	O
2	O
months	O
,	O
range	O
0	O
.	O
6	O
-	O
70	O
.	O
9	O
)	O
hospitalized	O
for	O
acute	O
respiratory	O
symptoms	O
,	O
with	O
HBoV	O
detected	O
from	O
a	O
respiratory	O
sample	O
,	O
using	O
a	O
reverse	O
transcriptase	O
-	O
PCR	O
for	O
14	O
respiratory	O
viruses	B-SPEC
(	O
including	O
respiratory	B-SPEC
syncytial	I-SPEC
virus	I-SPEC
(	O
RSV	B-SPEC
),	O
influenza	B-SPEC
virus	I-SPEC
A	O
and	O
B	O
,	O
human	B-SPEC
coronavirus	I-SPEC
OC43	O
,	O
229E	O
,	O
NL	O
-	O
63	O
and	O
HUK1	O
,	O
adenovirus	B-SPEC
,	O
rhinovirus	B-SPEC
,	O
parainfluenza	O
virus1	O
-	O
3	O
,	O
and	O
human	B-SPEC
metapneumovirus	I-SPEC
).	O

No	O
differences	O
was	O
observed	O
in	O
age	O
,	O
family	B-SPEC
history	O
for	O
atopy	O
and	O
/	O
or	O
asthma	O
,	O
clinical	O
presentations	O
,	O
chest	O
X	O
-	O
ray	B-SPEC
,	O
or	O
laboratory	O
findings	O
in	O
children	O
with	O
HBoV	O
alone	O
vs	O
.	O
multiple	O
viral	O
detection	O
.	O

Multivariable	O
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
fit	O
the	O
association	O
between	O
multiple	O
respiratory	O
viral	O
infections	O
(≥	O
2	O
strains	O
)	O
and	O
PICU	B-SPEC
admission	O
.	O

Patients	O
with	O
bronchiolitis	O
admitted	O
to	O
the	O
PICU	B-SPEC
tended	O
to	O
have	O
multiple	O
viral	O
infections	O
compared	O
with	O
patients	O
on	O
the	O
general	O
ward	O
(	O
23	O
.	O
0	O
%	O
vs	O
.	O
10	O
.	O
4	O
%,	O
P	O
<	O
0	O
.	O
001	O
).	O

TITLE	O
:	O
A	O
review	O
of	O
asymptomatic	O
and	O
sub	O
-	O
clinical	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Infections	O
.	O

HCoV	B-SPEC
-	I-SPEC
OC43	I-SPEC
may	O
be	O
implicated	O
in	O
healthcare	O
-	O
associated	O
infections	O
.	O

TITLE	O
:	O
Expression	O
and	O
role	O
of	O
HEPIS	O
in	O
breast	O
cancer	B-SPEC
.	O

ABSTRACT	O
:	O
Human	B-SPEC
embryo	O
lung	O
cellular	O
protein	O
interacting	O
with	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
coronavirus	B-SPEC
nonstructural	O
protein	O
-	O
10	O
(	O
HEPIS	O
)	O
is	O
expressed	O
at	O
varying	O
levels	O
in	O
multiple	O
organs	O
and	O
breast	O
cancer	B-SPEC
cell	O
lines	O
.	O

However	O
,	O
its	O
expression	O
and	O
function	O
in	O
breast	O
cancer	B-SPEC
cells	O
has	O
yet	O
to	O
be	O
studied	O
.	O

Finally	O
,	O
we	O
found	O
that	O
the	O
addition	O
of	O
exogenous	O
trypsin	O
also	O
rescues	O
HKU5	O
-	O
CoV	O
,	O
a	O
second	O
bat	B-SPEC
group	O
2c	O
CoV	O
.	O
Together	O
,	O
these	O
results	O
indicate	O
that	O
proteolytic	O
cleavage	O
of	O
the	O
spike	O
,	O
not	O
receptor	O
binding	O
,	O
is	O
the	O
primary	O
infection	O
barrier	O
for	O
these	O
two	O
group	O
2c	O
CoVs	O
.	O

An	O
efficient	O
vaccine	O
for	O
the	O
prophylaxis	O
of	O
humans	B-SPEC
in	O
hotspots	O
of	O
the	O
infection	O
(	O
e	O
.	O
g	O
.,	O
Saudi	O
Arabia	O
)	O
is	O
necessary	O
but	O
no	O
commercial	O
vaccines	O
are	O
yet	O
approved	O
.	O

In	O
BALB	O
/	O
c	O
mice	B-SPEC
,	O
the	O
inactivated	O
chimeric	O
bivalent	O
vaccine	O
induced	O
potent	O
and	O
specific	O
neutralizing	O
antibodies	O
against	O
MERS	O
-	O
CoV	O
and	O
H1N1pdm09	O
.	O

Routine	O
chest	O
x	O
-	O
ray	B-SPEC
is	O
not	O
recommended	O
-	O
except	O
if	O
pulmonary	O
edema	O
is	O
suspected	O
.	O

Docking	O
and	O
site	O
-	O
directed	O
mutagenesis	O
studies	O
have	O
suggested	O
that	O
compound	O
5	O
binds	O
to	O
a	O
previously	O
described	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
IN	O
allosteric	O
pocket	O
.	O

Overall	O
,	O
we	O
identified	O
a	O
new	O
scaffold	O
as	O
a	O
suitable	O
platform	O
for	O
the	O
development	O
of	O
novel	O
dual	O
HIV	B-SPEC
-	I-SPEC
1	I-SPEC
inhibitors	O
.	O

TITLE	O
:	O
Climate	O
factors	O
and	O
incidence	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

TITLE	O
:	O
Identification	O
of	O
the	O
immunodominant	O
neutralizing	O
regions	O
in	O
the	O
spike	O
glycoprotein	O
of	O
porcine	B-SPEC
deltacoronavirus	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
),	O
is	O
an	O
emerging	O
enteropathogenic	O
coronavirus	B-SPEC
in	O
pigs	B-SPEC
,	O
that	O
poses	O
a	O
novel	O
threat	O
to	O
swine	B-SPEC
husbandry	O
worldwide	O
.	O

The	O
study	O
involved	O
a	O
retrospective	O
chart	O
review	O
of	O
confirmed	O
cases	O
of	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infections	O
in	O
a	O
tertiary	O
care	O
referral	O
center	O
in	O
Riyadh	O
,	O
Saudi	O
Arabia	O
,	O
from	O
January	O
2015	O
to	O
October	O
2018	O
.	O

ABSTRACT	O
:	O
Infectious	O
bronchitis	O
(	O
IB	O
)	O
is	O
a	O
highly	O
contagious	O
respiratory	O
disease	O
of	O
poultry	O
,	O
caused	O
by	O
the	O
avian	B-SPEC
coronavirus	I-SPEC
infectious	O
bronchitis	O
virus	B-SPEC
(	O
IBV	B-SPEC
).	O

Both	O
viruses	B-SPEC
induced	O
morphologically	O
comparable	O
lesions	O
in	O
the	O
trachea	B-SPEC
,	O
albeit	O
with	O
a	O
short	O
delay	O
in	O
the	O
vaccinated	O
birds	B-SPEC
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
how	O
a	O
neutralizing	O
monoclonal	O
antibody	O
(	O
MAb	O
),	O
which	O
targets	O
the	O
receptor	O
-	O
binding	O
domain	O
(	O
RBD	O
)	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
coronavirus	B-SPEC
spike	O
,	O
mediates	O
viral	O
entry	O
using	O
pseudovirus	O
entry	O
and	O
biochemical	O
assays	O
.	O

RESULTS	O
:	O
The	O
nucleotide	O
sequence	O
identity	O
ranged	O
from	O
65	O
.	O
7	O
%	O
to	O
99	O
.	O
8	O
%	O
among	O
all	O
the	O
samples	O
collected	O
from	O
human	B-SPEC
and	O
camels	B-SPEC
from	O
various	O
locations	O
in	O
the	O
Kingdom	B-SPEC
.	O

Our	O
data	O
demonstrate	O
that	O
miR	O
-	O
142a	O
-	O
3p	O
promotes	O
PHEV	O
proliferation	O
by	O
directly	O
targeting	O
Rab3a	O
mRNA	O
,	O
and	O
this	O
provides	O
new	O
insights	O
into	O
the	O
mechanisms	O
of	O
PHEV	O
-	O
related	O
pathogenesis	O
and	O
virus	B-SPEC
-	O
host	O
interactions	O
.	O

The	O
IL	O
-	O
12	O
:	O
IL	O
-	O
10	O
ratio	O
,	O
a	O
marker	O
of	O
the	O
immune	O
system	O
'	O
s	O
inflammatory	O
balance	O
,	O
was	O
skewed	O
towards	O
the	O
pro	O
-	O
inflammatory	O
IL	O
-	O
12	O
in	O
the	O
liver	O
of	O
cats	B-SPEC
with	O
FIP	O
.	O

TITLE	O
:	O
Surface	O
-	O
displayed	O
porcine	B-SPEC
IFN	O
-	O
λ3	O
in	O
ABSTRACT	O
:	O
Interferon	O
(	O
IFN	O
)-	O
λ	O
plays	O
an	O
essential	O
role	O
in	O
mucosal	O
cells	O
which	O
exhibit	O
strong	O
antiviral	O
activity	O
.	O

Additionally	O
,	O
overexpressed	O
hDPP4	O
is	O
associated	O
with	O
neurological	O
complications	O
and	O
breeding	O
difficulties	O
in	O
some	O
transgenic	B-SPEC
mice	I-SPEC
,	O
resulting	O
in	O
impeding	O
further	O
studies	O
.	O

ABSTRACT	O
:	O
The	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
a	O
lethal	O
zoonotic	O
pathogen	O
endemic	O
to	O
the	O
Arabian	O
Peninsula	O
.	O

Dromedary	B-SPEC
camels	B-SPEC
are	O
a	O
likely	O
source	O
of	O
infection	O
and	O
the	O
virus	B-SPEC
probably	O
originated	O
in	O
Africa	O
.	O

We	O
determined	O
the	O
prevalence	O
of	O
MERS	O
-	O
CoV	O
infection	O
,	O
age	O
-	O
associated	O
patterns	O
of	O
infection	O
,	O
and	O
undertook	O
phylogeographical	O
and	O
migration	O
analyses	O
to	O
determine	O
intercountry	O
virus	B-SPEC
transmission	O
after	O
local	O
lineage	O
establishment	O
.	O

Although	O
the	O
overall	O
geographical	O
distribution	O
of	O
the	O
virus	B-SPEC
corresponded	O
with	O
the	O
phylogenetic	O
tree	O
topology	O
,	O
some	O
virus	B-SPEC
exchange	O
was	O
observed	O
between	O
countries	O
corresponding	O
with	O
trade	O
routes	O
in	O
the	O
region	O
.	O

East	O
and	O
west	O
African	O
strains	O
of	O
the	O
virus	B-SPEC
appear	O
to	O
be	O
geographically	O
separated	O
,	O
with	O
an	O
origin	O
of	O
west	O
African	O
strains	O
in	O
east	O
Africa	O
.	O

Only	O
CDV	B-SPEC
was	O
significantly	O
more	O
prevalent	O
in	O
CAI	O
than	O
HAI	O
dogs	B-SPEC
.	O

Co	O
-	O
detection	O
of	O
CIV	B-SPEC
and	O
CRCoV	O
was	O
represented	O
the	O
highest	O
proportion	O
and	O
most	O
often	O
found	O
with	O
other	O
CIRD	O
viruses	B-SPEC
.	O

Then	O
,	O
using	O
a	O
combination	O
of	O
the	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
approach	O
and	O
a	O
serum	O
chemistry	O
assay	O
,	O
we	O
performed	O
an	O
epidemiological	O
survey	O
of	O
FIPV	O
infection	O
in	O
cats	B-SPEC
living	O
in	O
Harbin	O
City	O
,	O
Northeast	O
China	O
.	O

However	O
,	O
anthropogenic	O
influences	O
on	O
the	O
landscape	O
and	O
climate	O
can	O
change	O
species	B-SPEC
assemblages	O
and	O
interactions	O
,	O
as	O
well	O
as	O
undermine	O
host	O
-	O
resilience	O
.	O

This	O
study	O
demonstrates	O
a	O
promising	O
vaccine	O
for	O
the	O
control	O
and	O
/	O
or	O
prevention	O
of	O
MERS	O
-	O
CoV	O
infection	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Autophagy	O
is	O
an	O
essential	O
cellular	O
process	O
affecting	O
virus	B-SPEC
infections	O
and	O
other	O
diseases	O
and	O
Beclin1	O
(	O
BECN1	O
)	O
is	O
one	O
of	O
its	O
key	O
regulators	O
.	O

Using	O
a	O
TGEV	B-SPEC
infectious	O
cDNA	O
and	O
enteric	O
(	O
TGEV	B-SPEC
-	O
SC11	O
)	O
or	O
respiratory	O
(	O
TGEV	B-SPEC
-	O
SPTV	O
)	O
isolates	O
,	O
encoding	O
a	O
full	O
-	O
length	O
S	O
protein	O
,	O
a	O
set	O
of	O
chimeric	O
recombinant	O
viruses	B-SPEC
,	O
with	O
a	O
sequential	O
modification	O
in	O
S	O
protein	O
amino	O
terminus	O
,	O
was	O
engineered	O
.	O

The	O
data	O
indicated	O
that	O
U655	O
>	O
G	O
change	O
in	O
S	O
gene	O
(	O
S219A	O
in	O
S	O
protein	O
)	O
was	O
required	O
to	O
confer	O
enteric	O
tropism	O
to	O
a	O
respiratory	O
virus	B-SPEC
that	O
already	O
contains	O
the	O
pAPN	O
and	O
sialic	O
acid	O
binding	O
domains	O
in	O
its	O
S	O
protein	O
.	O

Opportunistic	O
human	B-SPEC
respiratory	O
pathogens	O
could	O
be	O
associated	O
with	O
the	O
triggering	O
or	O
the	O
exacerbation	O
of	O
these	O
disorders	O
whose	O
etiology	O
remains	O
poorly	O
understood	O
.	O

In	O
this	O
study	O
,	O
IL	O
-	O
11	O
expression	O
at	O
mRNA	O
and	O
protein	O
levels	O
were	O
found	O
to	O
be	O
high	O
in	O
Vero	O
cells	O
and	O
the	O
jejunum	O
of	O
piglets	O
during	O
porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
infection	O
,	O
while	O
IL	O
-	O
11	O
expression	O
was	O
found	O
to	O
be	O
positively	O
correlated	O
with	O
the	O
level	O
of	O
viral	O
infection	O
.	O

TITLE	O
:	O
Influenza	O
A	O
H1N1	O
virus	B-SPEC
infection	O
among	O
pregnant	O
women	O
in	O
a	O
tertiary	O
hospital	O
in	O
Belgrade	O
,	O
Serbia	O
.	O

RESULTS	O
:	O
All	O
tested	O
samples	O
which	O
were	O
originally	O
found	O
negative	O
for	O
influenza	O
A	O
H1N1	O
virus	B-SPEC
were	O
also	O
found	O
to	O
be	O
negative	O
for	O
MERS	O
-	O
CoV	O
.	O

However	O
,	O
porcine	B-SPEC
reproductive	O
and	O
respiratory	O
virus	B-SPEC
is	O
known	O
to	O
have	O
a	O
high	O
frequency	O
of	O
genetic	O
mutations	O
,	O
and	O
the	O
primer	O
and	O
probe	O
sequences	O
will	O
need	O
to	O
be	O
checked	O
at	O
a	O
considerable	O
frequency	O
when	O
performing	O
Dempo	O
-	O
PCR	O
from	O
field	O
samples	O
.	O

Now	O
,	O
the	O
first	O
class	B-SPEC
of	O
physicians	O
will	O
enter	O
the	O
workplace	O
in	O
2019	O
,	O
subject	O
to	O
various	O
clinical	O
challenges	O
.	O

ABSTRACT	O
:	O
Herpesviridae	B-SPEC
reactivation	O
among	O
non	O
-	O
immunocompromised	O
critically	O
ill	O
patients	O
is	O
associated	O
with	O
impaired	O
prognosis	O
,	O
especially	O
during	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

In	O
univariate	O
analysis	O
,	O
HSV	B-SPEC
/	O
CMV	B-SPEC
reactivation	O
was	O
associated	O
with	O
a	O
longer	O
duration	O
of	O
mechanical	O
ventilation	O
[(	O
22	O
-	O
52	O
.	O
5	O
)	O
vs	O
.	O
17	O
.	O
5	O
(	O
9	O
-	O
28	O
)	O
days	O
;	O
p	O
<	O
0	O
.	O
01	O
],	O
a	O
longer	O
duration	O
of	O
ECMO	O
[	O
15	O
(	O
10	O
-	O
22	O
.	O
5	O
)	O
vs	O
.	O
9	O
(	O
5	O
-	O
14	O
)	O
days	O
;	O
p	O
<	O
0	O
.	O
01	O
],	O
and	O
a	O
prolonged	O
ICU	O
[	O
29	O
(	O
19	O
.	O
5	O
-	O
47	O
.	O
5	O
)	O
vs	O
.	O
16	O
(	O
9	O
-	O
30	O
)	O
days	O
;	O
p	O
<	O
0	O
.	O
01	O
]	O
and	O
hospital	O
stay	O
[	O
44	O
(	O
29	O
-	O
63	O
.	O
5	O
)	O
vs	O
.	O
24	O
(	O
11	O
-	O
43	O
)	O
days	O
;	O
p	O
<	O
0	O
.	O
01	O
]	O
as	O
compared	O
to	O
non	O
-	O
reactivated	O
patients	O
.	O

In	O
multivariate	O
analysis	O
,	O
HSV	B-SPEC
reactivation	O
remained	O
independently	O
associated	O
with	O
a	O
longer	O
duration	O
of	O
MV	O
and	O
hospital	O
length	O
of	O
stay	O
.	O

Other	O
measures	O
to	O
improve	O
survival	O
are	O
prone	O
position	O
ventilation	O
(	O
PPV	B-SPEC
)	O
and	O
extracorporeal	O
membrane	O
oxygenation	O
.	O

Phylogenetic	O
analysis	O
revealed	O
that	O
PEDVs	O
circulating	O
in	O
Southern	O
China	O
during	O
the	O
last	O
7	O
years	O
were	O
clustered	O
with	O
the	O
variant	O
strains	O
of	O
PEDV	B-SPEC
in	O
genotype	O
IIa	O
.	O

Here	O
,	O
we	O
describe	O
methods	O
for	O
in	O
vitro	O
serial	O
passaging	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
to	O
select	O
for	O
mutations	O
which	O
increase	O
replication	O
on	O
semi	O
-	O
permissive	O
cell	O
lines	O
as	O
described	O
in	O
Letko	O
et	O
al	O
.,	O
Cell	O
Rep	O
24	O
,	O
1730	O
-	O
1737	O
,	O
2018	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
is	O
an	O
emerging	O
zoonotic	O
pathogen	O
with	O
a	O
broad	O
host	O
range	O
.	O

Analysis	O
of	O
coronavirus	B-SPEC
spike	O
proteins	O
by	O
western	O
blot	O
allows	O
the	O
visualization	O
and	O
assessment	O
of	O
proteolytic	O
processing	O
by	O
endogenous	O
or	O
exogenous	O
proteases	O
.	O

TITLE	O
:	O
Bacterial	O
Artificial	O
Chromosome	O
-	O
Based	O
Lambda	O
Red	O
Recombination	O
with	O
the	O
I	O
-	O
SceI	O
Homing	O
Endonuclease	O
for	O
Genetic	O
Alteration	O
of	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Over	O
the	O
past	O
two	O
decades	O
,	O
several	O
coronavirus	B-SPEC
(	O
CoV	O
)	O
infectious	O
clones	O
have	O
been	O
engineered	O
,	O
allowing	O
for	O
the	O
manipulation	O
of	O
their	O
large	O
viral	O
genomes	O
(~	O
30	O
kb	O
)	O
using	O
unique	O
reverse	O
genetic	O
systems	O
.	O

Coronavirus	B-SPEC
(	O
CoV	O
)	O
has	O
an	O
exceptionally	O
large	O
RNA	O
genome	O
(~	O
30	O
kb	O
)	O
and	O
it	O
encodes	O
an	O
essential	O
replicase	O
,	O
the	O
nonstructural	O
protein	O
13	O
(	O
nsp13	O
),	O
a	O
member	O
of	O
superfamily	B-SPEC
1	O
helicases	O
.	O

To	O
date	O
,	O
more	O
than	O
2200	O
laboratory	O
-	O
confirmed	O
human	B-SPEC
cases	O
have	O
been	O
identified	O
in	O
27	O
countries	O
,	O
and	O
more	O
than	O
800	O
MERS	O
-	O
CoV	O
associated	O
deaths	O
have	O
been	O
reported	O
since	O
its	O
outbreak	O
in	O
2012	O
.	O

To	O
study	O
the	O
pathogenesis	O
of	O
MERS	O
-	O
CoV	O
infection	O
and	O
development	O
of	O
medical	O
countermeasures	O
(	O
MCMs	O
)	O
for	O
MERS	O
,	O
a	O
number	O
of	O
genetically	O
modified	O
mouse	B-SPEC
models	O
have	O
been	O
developed	O
,	O
including	O
various	O
versions	O
of	O
transgenic	B-SPEC
mice	I-SPEC
expressing	O
the	O
human	B-SPEC
DPP4	O
viral	O
receptor	O
.	O

In	O
addition	O
to	O
quantifying	O
infectious	O
progeny	O
virus	B-SPEC
which	O
requires	O
high	O
-	O
containment	O
biosafety	O
level	O
(	O
BSL	O
)-	O
3	O
laboratory	O
,	O
here	O
we	O
outlined	O
an	O
established	O
real	O
-	O
time	O
quantitative	O
RT	O
-	O
PCR	O
(	O
RT	O
-	O
qPCR	O
)-	O
based	O
procedure	O
to	O
unequivocally	O
quantify	O
MERS	O
-	O
CoV	O
-	O
specific	O
RNAs	O
within	O
the	O
lungs	O
of	O
infected	O
human	B-SPEC
DPP4	O
(	O
hDPP4	O
,	O
transgenic	O
(	O
hDPP4	O
Tg	O
)	O
mice	B-SPEC
under	O
a	O
standard	O
BSL	O
-	O
2	O
laboratory	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
MERS	O
-	O
CoV	O
Neutralizing	O
Antibodies	O
in	O
Sera	O
Using	O
Live	O
Virus	B-SPEC
Microneutralization	O
Assay	O
.	O

The	O
inability	O
of	O
MERS	O
-	O
CoV	O
to	O
replicate	O
in	O
the	O
respiratory	O
tracts	O
of	O
mice	B-SPEC
,	O
hamsters	B-SPEC
,	O
and	O
ferrets	B-SPEC
stymied	O
initial	O
attempts	O
to	O
generate	O
small	O
animal	B-SPEC
models	O
.	O

Animal	B-SPEC
models	O
are	O
often	O
required	O
to	O
study	O
viral	O
infections	O
and	O
therapies	O
,	O
especially	O
during	O
an	O
initial	O
outbreak	O
.	O

TITLE	O
:	O
Adenovirus	B-SPEC
Type	O
7	O
causing	O
severe	O
lower	O
respiratory	O
tract	O
infection	O
in	O
immunocompetent	O
adults	O
:	O
a	O
comparison	O
of	O
two	O
contrasting	O
cases	O
from	O
an	O
intensive	O
care	O
unit	O
in	O
North	O
West	O
England	O
.	O

Previous	O
proteomics	O
analysis	O
identified	O
the	O
association	O
of	O
TER94	O
with	O
the	O
budded	O
virions	O
(	O
BVs	O
)	O
of	O
baculovirus	B-SPEC
,	O
an	O
enveloped	O
insect	B-SPEC
large	O
DNA	O
virus	B-SPEC
.	O

TITLE	O
:	O
Genetic	O
,	O
antigenic	O
and	O
pathogenic	O
characterization	O
of	O
avian	B-SPEC
coronaviruses	O
isolated	O
from	O
pheasants	O
(	O
Phasianus	B-SPEC
colchicus	I-SPEC
)	O
in	O
China	O
.	O

Further	O
investigations	O
of	O
the	O
antigenicity	O
,	O
complete	O
genome	O
organization	O
,	O
substitutions	O
in	O
multiple	O
genes	O
,	O
and	O
viral	O
pathogenicity	O
,	O
replication	O
,	O
and	O
shedding	O
in	O
chickens	B-SPEC
and	O
pheasants	O
showed	O
obvious	O
differences	O
between	O
PhCoV	O
and	O
IBV	B-SPEC
in	O
terms	O
of	O
antigenicity	O
,	O
and	O
viral	O
pathogenicity	O
,	O
replication	O
,	O
and	O
shedding	O
in	O
chickens	B-SPEC
and	O
pheasants	O
.	O

Although	O
both	O
enzymes	O
belong	O
to	O
the	O
same	O
exo	O
(	O
ribo	O
)	O
nuclease	O
superfamily	B-SPEC
,	O
available	O
data	O
indicate	O
that	O
they	O
are	O
involved	O
in	O
very	O
different	O
pathways	O
.	O

TITLE	O
:	O
Analysis	O
of	O
preferred	O
codon	O
usage	O
in	O
the	O
coronavirus	B-SPEC
N	O
genes	O
and	O
their	O
implications	O
for	O
genome	O
evolution	O
and	O
vaccine	O
design	O
.	O

With	O
continued	O
climate	O
changes	O
,	O
Legionella	B-SPEC
and	O
other	O
pathogens	O
are	O
likely	O
to	O
be	O
a	O
continued	O
threat	O
.	O

Here	O
,	O
we	O
show	O
that	O
remdesivir	O
(	O
RDV	B-SPEC
)	O
and	O
IFNb	O
have	O
superior	O
antiviral	O
activity	O
to	O
LPV	O
and	O
RTV	O
in	O
vitro	O
.	O

Among	O
sampled	O
sheep	B-SPEC
(	O
n	O
=	O
102	O
),	O
goats	B-SPEC
(	O
n	O
=	O
66	O
),	O
and	O
cattle	B-SPEC
(	O
n	O
=	O
1495	O
),	O
the	O
seroprevalence	O
rates	O
were	O
25	O
.	O
8	O
%,	O
43	O
.	O
1	O
%	O
and	O
55	O
.	O
8	O
%.	O

TITLE	O
:	O
Inactivation	O
of	O
three	O
emerging	O
viruses	B-SPEC
-	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
Crimean	B-SPEC
-	I-SPEC
Congo	I-SPEC
haemorrhagic	I-SPEC
fever	I-SPEC
virus	I-SPEC
and	O
Nipah	B-SPEC
virus	I-SPEC
-	O
in	O
platelet	O
concentrates	O
by	O
ultraviolet	O
C	O
light	O
and	O
in	O
plasma	O
by	O
methylene	O
blue	O
plus	O
visible	O
light	O
.	O

CR	O
-	O
31	O
-	O
B	O
(-)	O
inhibited	O
the	O
replication	O
of	O
corona	B-SPEC
-,	O
Zika	O
-,	O
Lassa	O
-,	O
Crimean	O
Congo	O
hemorrhagic	O
fever	O
viruses	B-SPEC
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
hepatitis	B-SPEC
E	I-SPEC
virus	I-SPEC
(	O
HEV	B-SPEC
)	O
at	O
non	O
-	O
cytotoxic	O
low	O
nanomolar	O
concentrations	O
.	O

Moreover	O
,	O
thermodynamic	O
destabilization	O
of	O
the	O
HEV	B-SPEC
5	O
'-	O
UTR	O
led	O
to	O
reduced	O
translational	O
inhibition	O
by	O
Silvestrol	O
,	O
suggesting	O
differences	O
between	O
rocaglates	O
in	O
their	O
mode	O
of	O
action	O
,	O
most	O
probably	O
by	O
engaging	O
Silvestrol	O
'	O
s	O
additional	O
dioxane	O
moiety	O
.	O

Severity	O
and	O
organ	O
failure	O
of	O
sepsis	B-SPEC
were	O
assessed	O
by	O
APACHE	O
II	O
score	O
and	O
SOFA	O
score	O
respectively	O
,	O
and	O
the	O
in	O
-	O
hospital	O
mortality	O
was	O
calculated	O
.	O

Lnc	O
-	O
MALAT1	O
high	O
expression	O
predicts	O
increased	O
ARDS	O
risk	O
,	O
and	O
correlates	O
with	O
severe	O
disease	O
condition	O
and	O
raised	O
mortality	O
in	O
sepsis	B-SPEC
patients	O
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
coronavirus	B-SPEC
(	O
FCoV	O
)	O
is	O
a	O
complex	O
viral	O
agent	O
that	O
causes	O
a	O
variety	O
of	O
clinical	O
manifestations	O
in	O
cats	B-SPEC
,	O
commonly	O
known	O
as	O
feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
).	O

MERS	O
-	O
CoV	O
instillation	O
-	O
inoculated	O
mice	B-SPEC
exhibited	O
clinical	O
signs	O
on	O
day	O
1	O
,	O
obvious	O
lung	O
lesions	O
on	O
days	O
3	O
-	O
5	O
,	O
continuous	O
weight	O
loss	O
,	O
0	O
%	O
survival	O
by	O
day	O
5	O
,	O
and	O
high	O
viral	O
loads	O
in	O
the	O
lungs	O
and	O
brain	O
on	O
days	O
3	O
-	O
5	O
.	O

TITLE	O
:	O
Recent	O
advances	O
in	O
the	O
detection	O
of	O
respiratory	O
virus	B-SPEC
infection	O
in	O
humans	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
causes	O
severe	O
pulmonary	O
infection	O
,	O
with	O
∼	O
35	O
%	O
mortality	O
.	O

We	O
developed	O
77	O
hybridomas	O
and	O
selected	O
five	O
neutralizing	O
mAbs	O
by	O
immunization	O
with	O
SΔTM	O
against	O
MERS	O
-	O
CoV	O
EMC	O
/	O
2012	O
strain	O
S	O
-	O
pseudotyped	O
lentivirus	B-SPEC
.	O

ABSTRACT	O
:	O
Feline	B-SPEC
infectious	O
peritonitis	O
(	O
FIP	O
)	O
is	O
a	O
fatal	O
disease	O
for	O
which	O
no	O
simple	O
antemortem	O
diagnostic	O
assay	O
is	O
available	O
.	O

The	O
fusion	O
protein	O
LTB	O
-	O
COE	O
was	O
successfully	O
expressed	O
by	O
the	O
recombinant	O
adenovirus	B-SPEC
in	O
HEK293	O
cells	O
,	O
and	O
the	O
immunogenicity	O
of	O
the	O
vaccine	O
candidate	O
was	O
assessed	O
in	O
BALB	O
/	O
c	O
mice	B-SPEC
and	O
piglets	O
.	O

One	O
-	O
quarter	O
of	O
the	O
positive	O
specimens	O
were	O
coinfected	O
with	O
two	O
or	O
more	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
Respiratory	O
tract	O
infections	O
(	O
bovine	B-SPEC
respiratory	O
disease	O
)	O
are	O
a	O
major	O
concern	O
in	O
calf	O
rearing	O
.	O

A	O
seasonal	O
effect	O
was	O
shown	O
for	O
bRSV	B-SPEC
only	O
{	O
more	O
in	O
winter	O
compared	O
with	O
autumn	O
[	O
OR	O
=	O
10	O
.	O
3	O
(	O
2	O
.	O
8	O
-	O
37	O
.	O
5	O
)]}.	O
Other	O
factors	O
associated	O
with	O
bRSV	B-SPEC
were	O
PI	O
-	O
3	O
detection	O
[	O
OR	O
=	O
13	O
.	O
4	O
(	O
2	O
.	O
1	O
-	O
86	O
.	O
0	O
)],	O
prevalence	O
of	O
calves	O
with	O
respiratory	O
disease	O
[	O
OR	O
=	O
1	O
.	O
02	O
(	O
1	O
.	O
00	O
-	O
1	O
.	O
04	O
)	O
per	O
1	O
%	O
increase	O
],	O
and	O
number	O
of	O
days	O
with	O
respiratory	O
signs	O
before	O
sampling	O
[	O
OR	O
=	O
0	O
.	O
99	O
(	O
0	O
.	O
98	O
-	O
0	O
.	O
99	O
)	O
per	O
day	O
increase	O
].	O

ABSTRACT	O
:	O
The	O
long	O
-	O
term	O
dynamics	O
of	O
antibody	O
responses	O
in	O
patients	O
with	O
influenza	O
A	O
(	O
H7N9	O
)	O
virus	B-SPEC
infection	O
are	O
not	O
well	O
understood	O
.	O

ABSTRACT	O
:	O
Risk	O
factors	O
associated	O
with	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
infection	O
outcome	O
were	O
established	O
by	O
analyses	O
of	O
WHO	O
data	O
from	O
September	O
23	O
,	O
2012	O
to	O
18	O
June	O
2018	O
.	O

This	O
index	O
was	O
1	O
.	O
43	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
06	O
-	O
1	O
.	O
92	O
]	O
for	O
Saudi	O
patients	O
in	O
comparison	O
to	O
non	O
-	O
Saudi	O
;	O
1	O
.	O
76	O
[	O
95	O
%	O
CI	O
:	O
1	O
.	O
39	O
-	O
2	O
.	O
22	O
]	O
for	O
patient	O
with	O
comorbidity	O
in	O
comparison	O
to	O
those	O
without	O
comorbidity	O
;	O
0	O
.	O
58	O
[	O
95	O
%	O
CI	O
:	O
0	O
.	O
44	O
-	O
0	O
.	O
75	O
]	O
for	O
those	O
who	O
had	O
close	O
contact	O
to	O
a	O
camel	B-SPEC
in	O
the	O
past	O
14	O
days	O
and	O
0	O
.	O
42	O
[	O
95	O
%	O
CI	O
:	O
0	O
.	O
31	O
-	O
0	O
.	O
57	O
]	O
for	O
patients	O
with	O
>	O
14	O
days	O
with	O
onset	O
of	O
signs	O
and	O
hospital	O
admission	O
compared	O
to	O
patients	O
with	O
≤	O
14	O
days	O
.	O

Determining	O
the	O
patterns	O
of	O
influenza	O
-	O
associated	O
severity	O
and	O
how	O
they	O
might	O
differ	O
by	O
virus	B-SPEC
type	O
and	O
subtype	O
can	O
help	O
guide	O
planning	O
and	O
implementation	O
of	O
adequate	O
control	O
and	O
preventive	O
measures	O
during	O
influenza	O
epidemics	O
.	O

TITLE	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Transmission	O
.	O

MERS	O
-	O
CoV	O
is	O
transmitted	O
sporadically	O
from	O
dromedary	B-SPEC
camels	B-SPEC
to	O
humans	B-SPEC
and	O
occasionally	O
through	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
contact	O
.	O

Current	O
epidemiologic	O
evidence	O
supports	O
a	O
major	O
role	O
in	O
transmission	O
for	O
direct	O
contact	O
with	O
live	O
camels	B-SPEC
or	O
humans	B-SPEC
with	O
symptomatic	O
MERS	O
,	O
but	O
little	O
evidence	O
suggests	O
the	O
possibility	O
of	O
transmission	O
from	O
camel	B-SPEC
products	O
or	O
asymptomatic	O
MERS	O
cases	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
deltacoronavirus	O
(	O
PDCoV	O
),	O
first	O
identified	O
in	O
2012	O
,	O
is	O
a	O
swine	B-SPEC
enteropathogen	O
now	O
found	O
in	O
many	O
countries	O
.	O

Of	O
note	O
,	O
the	O
PDCoV	O
EP	O
-	O
4E88	O
sequence	O
shared	O
very	O
low	O
similarity	O
(<	O
22	O
.	O
2	O
%)	O
with	O
other	O
porcine	B-SPEC
coronaviruses	O
(	O
PEDV	B-SPEC
,	O
TGEV	B-SPEC
,	O
PRCV	O
,	O
SADS	O
-	O
CoV	O
,	O
PHEV	O
),	O
demonstrating	O
that	O
it	O
is	O
an	O
epitope	O
that	O
can	O
be	O
used	O
for	O
distinguishing	O
PDCoV	O
and	O
other	O
porcine	B-SPEC
coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
recent	O
emergence	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
),	O
which	O
is	O
causing	O
an	O
outbreak	O
of	O
unusual	O
viral	O
pneumonia	O
in	O
patients	O
in	O
Wuhan	O
,	O
a	O
central	O
city	O
in	O
China	O
,	O
is	O
another	O
warning	O
of	O
the	O
risk	O
of	O
CoVs	O
posed	O
to	O
public	O
health	O
.	O

This	O
review	O
will	O
help	O
understand	O
the	O
biology	O
and	O
potential	O
risk	O
of	O
CoVs	O
that	O
exist	O
in	O
richness	O
in	O
wildlife	O
such	O
as	O
bats	B-SPEC
.	O

ABSTRACT	O
:	O
Middle	O
East	O
respiratory	O
syndrome	O
(	O
MERS	O
)	O
is	O
an	O
acute	O
,	O
high	O
-	O
mortality	O
-	O
rate	O
,	O
severe	O
infectious	O
disease	O
caused	O
by	O
an	O
emerging	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
that	O
causes	O
severe	O
respiratory	O
diseases	O
.	O

We	O
applaud	O
the	O
rapid	O
release	O
to	O
the	O
public	O
of	O
the	O
genome	O
sequence	O
of	O
the	O
new	O
virus	B-SPEC
by	O
Chinese	O
virologists	O
,	O
but	O
we	O
also	O
believe	O
that	O
increased	O
transparency	O
on	O
disease	O
reporting	O
and	O
data	O
sharing	O
with	O
international	O
colleagues	O
are	O
crucial	O
for	O
curbing	O
the	O
spread	O
of	O
this	O
newly	O
emerging	O
virus	B-SPEC
to	O
other	O
parts	O
of	O
the	O
world	O
.	O

TITLE	O
:	O
Gga	O
-	O
miR	O
-	O
30d	O
regulates	O
infectious	O
bronchitis	O
virus	B-SPEC
infection	O
by	O
targeting	O
USP47	O
in	O
HD11	O
cells	O
.	O

TITLE	O
:	O
A	O
recombinant	O
infectious	O
bronchitis	O
virus	B-SPEC
from	O
a	O
chicken	B-SPEC
with	O
a	O
spike	O
gene	O
closely	O
related	O
to	O
that	O
of	O
a	O
turkey	B-SPEC
coronavirus	B-SPEC
.	O

The	O
genome	O
sequence	O
of	O
ahysx	O
-	O
1	O
was	O
found	O
to	O
be	O
very	O
similar	O
to	O
that	O
of	O
IBV	B-SPEC
strain	O
ck	O
/	O
CH	O
/	O
LLN	O
/	O
131040	O
(	O
KX252787	O
),	O
except	O
for	O
the	O
spike	O
gene	O
region	O
,	O
which	O
is	O
similar	O
to	O
that	O
of	O
a	O
turkey	B-SPEC
coronavirus	B-SPEC
strain	O
(	O
EU022526	O
),	O
suggesting	O
that	O
ahysx	O
-	O
1	O
is	O
a	O
recombinant	O
.	O

From	O
Jan	O
10	O
,	O
2020	O
,	O
we	O
enrolled	O
a	O
family	B-SPEC
of	O
six	O
patients	O
who	O
travelled	O
to	O
Wuhan	O
from	O
Shenzhen	O
between	O
Dec	O
29	O
,	O
2019	O
and	O
Jan	O
4	O
,	O
2020	O
.	O

None	O
of	O
the	O
family	B-SPEC
members	O
had	O
contacts	O
with	O
Wuhan	O
markets	O
or	O
animals	B-SPEC
,	O
although	O
two	O
had	O
visited	O
a	O
Wuhan	O
hospital	O
.	O

Our	O
findings	O
are	O
consistent	O
with	O
person	O
-	O
to	O
-	O
person	O
transmission	O
of	O
this	O
novel	B-SPEC
coronavirus	I-SPEC
in	O
hospital	O
and	O
family	B-SPEC
settings	O
,	O
and	O
the	O
reports	O
of	O
infected	O
travellers	O
in	O
other	O
geographical	O
regions	O
.	O

The	O
Shaw	O
Foundation	O
Hong	O
Kong	O
,	O
Michael	O
Seak	O
-	O
Kan	O
Tong	O
,	O
Respiratory	O
Viral	O
Research	O
Foundation	O
Limited	O
,	O
Hui	O
Ming	O
,	O
Hui	O
Hoy	O
and	O
Chow	O
Sin	O
Lan	O
Charity	O
Fund	O
Limited	O
,	O
Marina	B-SPEC
Man	B-SPEC
-	O
Wai	O
Lee	O
,	O
the	O
Hong	O
Kong	O
Hainan	O
Commercial	O
Association	O
South	O
China	O
Microbiology	O
Research	O
Fund	O
,	O
Sanming	O
Project	O
of	O
Medicine	O
(	O
Shenzhen	O
),	O
and	O
High	O
Level	O
-	O
Hospital	O
Program	O
(	O
Guangdong	O
Health	O
Commission	O
).	O

One	O
family	B-SPEC
cluster	O
was	O
found	O
.	O

We	O
performed	O
bioinformatics	O
analysis	O
on	O
a	O
virus	B-SPEC
genome	O
from	O
a	O
patient	O
with	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
and	O
compared	O
it	O
with	O
other	O
related	O
coronavirus	B-SPEC
genomes	O
.	O

Learning	O
from	O
the	O
roles	O
of	O
civet	B-SPEC
in	O
SARS	O
and	O
camel	B-SPEC
in	O
MERS	O
,	O
hunting	O
for	O
the	O
animal	B-SPEC
source	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
and	O
its	O
more	O
ancestral	O
virus	B-SPEC
would	O
be	O
important	O
for	O
understanding	O
the	O
origin	O
and	O
evolution	O
of	O
this	O
novel	O
lineage	O
B	O

TITLE	O
:	O
The	O
Extent	O
of	O
Transmission	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
in	O
Wuhan	O
,	O
China	O
,	O
2020	O
.	O

ABSTRACT	O
:	O
The	O
Democratic	O
Republic	O
of	O
Congo	O
(	O
DRC	O
)	O
is	O
facing	O
its	O
tenth	O
outbreak	O
of	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
(	O
EVD	O
),	O
in	O
North	O
-	O
Kivu	O
and	O
Ituri	O
provinces	O
.	O

TITLE	O
:	O
Updated	O
understanding	O
of	O
the	O
outbreak	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
in	O
Wuhan	O
,	O
China	O
.	O

TITLE	O
:	O
Early	O
Transmission	O
Dynamics	O
in	O
Wuhan	O
,	O
China	O
,	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
-	O
Infected	O
Pneumonia	O
.	O

ABSTRACT	O
:	O
Human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
is	O
primarily	O
associated	O
with	O
common	O
cold	O
in	O
children	O
,	O
elderly	O
and	O
immunocompromised	O
individuals	O
.	O

Outbreaks	O
caused	O
by	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
are	O
rare	O
.	O

Here	O
we	O
report	O
a	O
cluster	O
of	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
cases	O
with	O
severe	O
lower	O
respiratory	O
tract	O
infection	O
that	O
arose	O
in	O
Guangzhou	O
,	O
China	O
,	O
in	O
2018	O
.	O

Pseudotyped	O
virus	B-SPEC
bearing	O
the	O
I507	O
L	O
mutation	O
in	O
RBD	O
showed	O
enhanced	O
entry	O
into	O
host	O
cells	O
as	O
compared	O
to	O
the	O
prototype	O
virus	B-SPEC
.	O

TITLE	O
:	O
Receptor	O
Recognition	O
by	O
the	O
Novel	B-SPEC
Coronavirus	I-SPEC
from	O
Wuhan	O
:	O
an	O
Analysis	O
Based	O
on	O
Decade	O
-	O
Long	O
Structural	O
Studies	O
of	O
SARS	O
Coronavirus	B-SPEC
.	O

ABSTRACT	O
:	O
Recently	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
has	O
emerged	O
from	O
Wuhan	O
,	O
China	O
,	O
causing	O
symptoms	O
in	O
humans	B-SPEC
similar	O
to	O
those	O
caused	O
by	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Drug	O
treatment	O
options	O
for	O
the	O
2019	O
-	O
new	O
coronavirus	B-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
).	O

ABSTRACT	O
:	O
As	O
of	O
January	O
22	O
,	O
2020	O
,	O
a	O
total	O
of	O
571	O
cases	O
of	O
the	O
2019	O
-	O
new	O
coronavirus	B-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
have	O
been	O
reported	O
in	O
25	O
provinces	O
(	O
districts	O
and	O
cities	O
)	O
in	O
China	O
.	O

Out	O
of	O
the	O
total	O
200	O
children	O
,	O
108	O
progressed	O
to	O
sepsis	B-SPEC
,	O
of	O
which	O
26	O
progressed	O
to	O
severe	O
sepsis	B-SPEC
,	O
of	O
which	O
22	O
progressed	O
to	O
septic	O
shock	O
.	O

However	O
,	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
tentative	O
receptor	O
-	O
binding	O
domain	O
resembles	O
that	O
of	O
SARS	O
-	O
CoV	O
,	O
indicating	O
that	O
these	O
viruses	B-SPEC
might	O
use	O
the	O
same	O
receptor	O
.	O

Fifty	O
-	O
six	O
percent	O
of	O
samples	O
were	O
PCR	O
positive	O
for	O
viral	O
or	O
bacterial	O
pathogen	O
with	O
Influenza	O
A	O
as	O
the	O
predominant	O
virus	B-SPEC
(	O
44	O
%).	O

Of	O
the	O
99	O
patients	O
with	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
pneumonia	O
,	O
49	O
(	O
49	O
%)	O
had	O
a	O
history	O
of	O
exposure	O
to	O
the	O
Huanan	O
seafood	O
market	O
.	O

Further	O
investigation	O
is	O
needed	O
to	O
explore	O
the	O
applicability	O
of	O
the	O
MuLBSTA	O
score	O
in	O
predicting	O
the	O
risk	O
of	O
mortality	O
in	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

Phylogenetic	O
analysis	O
revealed	O
that	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
fell	O
within	O
the	O
subgenus	B-SPEC
Sarbecovirus	O
of	O
the	O
genus	B-SPEC
Betacoronavirus	B-SPEC
,	O
with	O
a	O
relatively	O
long	O
branch	O
length	O
to	O
its	O
closest	O
relatives	O
bat	B-SPEC
-	O
SL	O
-	O
CoVZC45	O
and	O
bat	B-SPEC
-	O
SL	O
-	O
CoVZXC21	O
,	O
and	O
was	O
genetically	O
distinct	O
from	O
SARS	O
-	O
CoV	O
.	O
Notably	O
,	O
homology	O
modelling	O
revealed	O
that	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
had	O
a	O
similar	O
receptor	O
-	O
binding	O
domain	O
structure	O
to	O
that	O
of	O
SARS	O
-	O
CoV	O
,	O
despite	O
amino	O
acid	O
variation	O
at	O
some	O
key	O
residues	O
.	O

Although	O
our	O
phylogenetic	O
analysis	O
suggests	O
that	O
bats	B-SPEC
might	O
be	O
the	O
original	O
host	O
of	O
this	O
virus	B-SPEC
,	O
an	O
animal	B-SPEC
sold	O
at	O
the	O
seafood	O
market	O
in	O
Wuhan	O
might	O
represent	O
an	O
intermediate	O
host	O
facilitating	O
the	O
emergence	O
of	O
the	O
virus	B-SPEC
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Novel	B-SPEC
coronavirus	I-SPEC
:	O
From	O
discovery	O
to	O
clinical	O
diagnostics	O
.	O

Dozens	O
of	O
people	O
died	O
in	O
China	O
,	O
and	O
thousands	O
of	O
people	O
infected	O
as	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
continues	O
to	O
spread	O
around	O
the	O
world	O
.	O

TITLE	O
:	O
Preliminary	O
estimation	O
of	O
the	O
basic	O
reproduction	O
number	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
in	O
China	O
,	O
from	O
2019	O
to	O
2020	O
:	O
A	O
data	O
-	O
driven	O
analysis	O
in	O
the	O
early	O
phase	O
of	O
the	O
outbreak	O
.	O

This	O
virus	B-SPEC
causes	O
an	O
economically	O
and	O
,	O
possibly	O
,	O
environmentally	O
,	O
important	O
loss	O
in	O
the	O
poultry	O
industry	O
.	O

However	O
,	O
only	O
one	O
isolate	O
(	O
parrot	B-SPEC
/	O
Indonesia	O
/	O
BX9	O
/	O
16	O
)	O
was	O
sequenced	O
for	O
the	O
partial	O
S1	O
gene	O
with	O
primers	O
XCE2	O
+/	O
XCE2	O
-.	O

The	O
partial	O
nucleotide	O
sequence	O
of	O
this	O
isolate	O
showed	O
100	O
%	O
homology	O
with	O
the	O
IBV	B-SPEC
GI	O
-	O
13	O
lineage	O
,	O
specifically	O
with	O
a	O
field	O
isolate	O
of	O
the	O
4	O
/	O
91	O
variant	O
1	O
Israel	O
and	O
the	O
4	O
/	O
91	O
vaccine	O
on	O
the	O
hypervariable	O
region	O
3	O
site	O
of	O
the	O
S1	O
gene	O
.	O

We	O
carried	O
out	O
virus	B-SPEC
infectivity	O
assays	O
on	O
bat	B-SPEC
cell	O
lines	O
expressing	O
induced	O
and	O
constitutive	O
immune	O
phenotypes	O
,	O
then	O
developed	O
a	O
theoretical	O
model	O
of	O
our	O
Bats	B-SPEC
can	O
carry	O
viruses	B-SPEC
that	O
are	O
deadly	O
to	O
other	O
mammals	B-SPEC
without	O
themselves	O
showing	O
serious	O
symptoms	O
.	O

In	O
fact	O
,	O
bats	B-SPEC
are	O
natural	O
reservoirs	O
for	O
viruses	B-SPEC
that	O
have	O
some	O
of	O
the	O
highest	O
fatality	O
rates	O
of	O
any	O
viruses	B-SPEC
that	O
people	O
acquire	O
from	O
wild	O
animals	B-SPEC
–	O
including	O
rabies	O
,	O
Ebola	O
and	O
the	O
SARS	O
coronavirus	B-SPEC
.	O

For	O
example	O
,	O
some	O
bats	B-SPEC
have	O
an	O
antiviral	O
immune	O
response	O
called	O
the	O
interferon	O
pathway	O
perpetually	O
switched	O
on	O
.	O

However	O
,	O
no	O
one	O
has	O
previously	O
explored	O
how	O
these	O
unique	O
antiviral	O
defenses	O
of	O
bats	B-SPEC
impact	O
the	O
viruses	B-SPEC
themselves	O
.	O

The	O
experiments	O
made	O
use	O
of	O
cells	O
from	O
one	O
bat	B-SPEC
species	B-SPEC
–	O
the	O
black	B-SPEC
flying	I-SPEC
fox	I-SPEC
–	O
in	O
which	O
the	O
interferon	O
pathway	O
is	O
always	O
on	O
,	O
and	O
another	O
–	O
the	O
Egyptian	O
fruit	O
bat	B-SPEC
–	O
in	O
which	O
this	O
pathway	O
is	O
only	O
activated	O
during	O
an	O
infection	O
.	O

The	O
findings	O
may	O
help	O
to	O
explain	O
why	O
bats	B-SPEC
are	O
often	O
the	O
source	O
for	O
viruses	B-SPEC
that	O
are	O
deadly	O
in	O
humans	B-SPEC
.	O

TITLE	O
:	O
Mast	O
cells	O
contribute	O
to	O
coronavirus	B-SPEC
-	O
induced	O
inflammation	O
:	O
new	O
anti	O
-	O
inflammatory	O
strategy	O
.	O

Viral	O
activate	O
MCs	O
release	O
early	O
inflammatory	O
chemical	O
copounds	O
including	O
histamine	O
and	O
protease	O
;	O
while	O
late	O
activation	O
provoke	O
the	O
generation	O
of	O
pro	O
-	O
inflammatory	O
IL	O
-	O
1	O
family	B-SPEC
members	O
including	O
IL	O
-	O
1	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
33	O
.	O

If	O
the	O
transmissibility	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
were	O
similar	O
everywhere	O
domestically	O
and	O
over	O
time	O
,	O
we	O
inferred	O
that	O
epidemics	O
are	O
already	O
growing	O
exponentially	O
in	O
multiple	O
major	O
cities	O
of	O
China	O
with	O
a	O
lag	O
time	O
behind	O
the	O
Wuhan	O
outbreak	O
of	O
about	O
1	O
-	O
2	O
weeks	O
.	O

The	O
identified	O
camel	B-SPEC
IFN	O
-	O
α	O
protein	O
and	O
the	O
subtypes	O
will	O
facilitate	O
a	O
better	O
understanding	O
of	O
the	O
host	O
immune	O
response	O
to	O
viral	O
infections	O
in	O
camel	B-SPEC
and	O
the	O
development	O
of	O
potential	O
antiviral	O
biologicals	O
for	O
zoonotic	O
diseases	O
for	O
which	O
camel	B-SPEC
act	O
as	O
a	O
reservoir	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
outbreak	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
18	O
years	O
ago	O
,	O
a	O
large	O
number	O
of	O
SARS	O
-	O
related	O
coronaviruses	O
(	O
SARSr	O
-	O
CoVs	O
)	O
have	O
been	O
discovered	O
in	O
their	O
natural	O
reservoir	O
host	O
,	O
bats	B-SPEC

TITLE	O
:	O
A	O
new	O
coronavirus	B-SPEC
associated	O
with	O
human	B-SPEC
respiratory	O
disease	O
in	O
China	O
.	O

ABSTRACT	O
:	O
Emerging	O
infectious	O
diseases	O
,	O
such	O
as	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
and	O
Zika	B-SPEC
virus	I-SPEC
disease	O
,	O
present	O
a	O
major	O
threat	O
to	O
public	O
health	O

A	O
search	O
was	O
performed	O
of	O
the	O
Pubmed	O
,	O
Scopus	B-SPEC
,	O
Clinicaltrials	O
.	O
gov	O
,	O
and	O
Virtual	O
Health	O
Library	O
databases	O
for	O
randomized	O
controlled	O
trials	O
(	O
RCT	O
)	O
evaluating	O
28	O
-	O
day	O
mortality	O
in	O
ARDS	O
patients	O
treated	O
with	O
NMBA	O
within	O
48	O
h	O
.	O
An	O
English	O
language	O
restriction	O
was	O
applied	O
.	O

TITLE	O
:	O
Isolated	O
Pauci	O
-	O
Immune	O
Pulmonary	O
Capillaritis	O
Associated	O
with	O
Hydrocarbon	O
Inhalation	O
and	O
Marijuana	B-SPEC
Smoking	O
:	O
An	O
Unusual	O
Case	O
of	O
Severe	O
Hypoxemia	O
.	O

Given	O
the	O
lack	O
of	O
other	O
findings	O
and	O
risk	O
factors	O
,	O
his	O
IPIPC	O
was	O
likely	O
associated	O
with	O
occupational	O
exposures	O
to	O
hydrocarbons	O
as	O
a	O
cabinetmaker	O
compounded	O
by	O
marijuana	B-SPEC
smoking	O
.	O

TITLE	O
:	O
Dynamics	O
of	O
transmissible	O
gastroenteritis	O
virus	B-SPEC
internalization	O
unraveled	O
by	O
single	O
-	O
virus	B-SPEC
tracking	O
in	O
live	O
cells	O
.	O

Furthermore	O
,	O
the	O
interactions	O
of	O
TGEVs	O
with	O
actin	O
and	O
dynamin	O
2	O
in	O
real	O
time	O
during	O
the	O
TGEV	B-SPEC
internalization	O
were	O
visualized	O
.	O

These	O
data	O
demonstrate	O
that	O
Nox2	O
/	O
ROS	O
/	O
ZO	O
-	O
1	O
axis	B-SPEC
is	O
of	O
great	O
importance	O
in	O
AECs	O
damage	O
induced	O
by	O
LPS	O
,	O
and	O
the	O
utilization	O
of	O
VAS2870	O
to	O
inhibit	O
this	O
pathway	O
might	O
lighten	O
LPS	O
-	O
induced	O
ARDS	O
.	O

Herein	O
,	O
we	O
present	O
on	O
an	O
overview	O
of	O
the	O
currently	O
available	O
information	O
on	O
the	O
pathogenesis	O
,	O
epidemiology	O
,	O
clinical	O
presentation	O
,	O
diagnosis	O
,	O
and	O
treatment	O
of	O
this	O
virus	B-SPEC
.	O

Other	O
key	O
drug	O
targets	O
,	O
including	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
and	O
coronavirus	B-SPEC
main	O
proteinase	O
(	O
3CLpro	O
),	O
share	O
a	O
strikingly	O
high	O
(>	O
95	O
%)	O
homology	O
to	O
SARS	O
-	O
CoV	O
.	O
Herein	O
,	O
we	O
suggest	O
four	O
potential	O
drug	O
candidates	O
(	O
an	O
ACE2	O
-	O
based	O
peptide	O
,	O
remdesivir	O
,	O
3CLpro	O
-	O
1	O
and	O
a	O
novel	O
vinylsulfone	O
protease	O
inhibitor	O
)	O
that	O
could	O
be	O
used	O
to	O
treat	O
patients	O
suffering	O
with	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
We	O
also	O
summarize	O
previous	O
efforts	O
into	O
drugging	O
these	O
targets	O
and	O
hope	O
to	O
help	O
in	O
the	O
development	O
of	O
broad	O
-	O
spectrum	O
anti	O
-	O
coronaviral	O
agents	O
for	O
future	O
epidemics	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
pneumonia	O
caused	O
by	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
in	O
Wuhan	O
,	O
Hubei	O
province	O
of	O
China	O
,	O
at	O
the	O
end	O
of	O
2019	O
shaped	O
tremendous	O
challenges	O
to	O
China	O
'	O
s	O
public	O
health	O
and	O
clinical	O
treatment	O
.	O

The	O
virus	B-SPEC
belongs	O
to	O
the	O
β	O
genus	B-SPEC
Coronavirus	B-SPEC
in	O
the	O
family	B-SPEC
Corornaviridae	O
,	O
and	O
is	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
,	O
causing	O
severe	O
symptoms	O
of	O
pneumonia	O
.	O

The	O
emergence	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
reminds	O
us	O
once	O
again	O
of	O
the	O
importance	O
of	O
establishing	O
a	O
systematic	O
coronavirus	B-SPEC
surveillance	O
network	O
.	O

TITLE	O
:	O
[	O
Potential	O
antiviral	O
therapeutics	O
for	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
].	O

2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
categorized	O
as	O
beta	O
genus	B-SPEC
coronavirus	B-SPEC
,	O
same	O
as	O
the	O
two	O
other	O
strains	O
-	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
).	O

Drugs	O
are	O
possibly	O
effective	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
include	O
:	O
remdesivir	O
,	O
lopinavir	O
/	O
ritonavir	O
,	O
lopinavir	O
/	O
ritonavir	O
combined	O
with	O
interferon	O
-	O
β	O
,	O
convalescent	O
plasma	O
,	O
and	O
monoclonal	O
antibodies	O
.	O

The	O
novel	B-SPEC
coronavirus	I-SPEC
has	O
the	O
characteristics	O
of	O
rapid	O
transmission	O
,	O
atypical	O
clinical	O
symptoms	O
,	O
and	O
easy	O
to	O
affect	O
both	O
lungs	O
,	O
leading	O
to	O
missed	O
diagnosis	O
and	O
misdiagnosis	O
,	O
as	O
well	O
as	O
difficult	O
to	O
detection	O
and	O
assessment	O
at	O
early	O
stage	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
rate	O
of	O
disease	O
progression	O
,	O
fever	O
,	O
CT	O
manifestations	O
,	O
hypoxia	O
degree	O
,	O
age	O
,	O
basic	O
diseases	O
,	O
and	O
laboratory	O
indicators	O
can	O
also	O
be	O
used	O
to	O
evaluate	O
the	O
severity	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
.	O

ABSTRACT	O
:	O
Since	O
December	O
2019	O
,	O
an	O
epidemic	O
caused	O
by	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
infection	O
has	O
occurred	O
unexpectedly	O
in	O
China	O
.	O

This	O
rapid	O
advice	O
guideline	O
is	O
suitable	O
for	O
the	O
first	O
frontline	O
doctors	O
and	O
nurses	O
,	O
managers	O
of	O
hospitals	O
and	O
healthcare	O
sections	O
,	O
community	O
residents	O
,	O
public	O
health	O
persons	O
,	O
relevant	O
researchers	O
,	O
and	O
all	O
person	O
who	O
are	O
interested	O
in	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O

TITLE	O
:	O
[	O
Application	O
of	O
extracorporeal	O
membrane	O
oxygenation	O
technique	O
in	O
patients	O
with	O
acute	O
respiratory	O
failure	O
caused	O
by	O
ammonia	B-SPEC
poisoning	O
].	O

ABSTRACT	O
:	O
Acute	O
severe	O
ammonia	B-SPEC
inhalation	O
can	O
seriously	O
affect	O
oxygenation	O
and	O
ventilation	O
function	O
of	O
patients	O
,	O
and	O
even	O
cause	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
).	O

Extracorporeal	O
membrane	O
oxygenation	O
(	O
ECMO	O
)	O
technology	O
is	O
increasingly	O
used	O
in	O
treating	O
patients	O
with	O
ARDS	O
caused	O
by	O
infection	O
,	O
cardiogenic	O
shock	O
,	O
trauma	O
,	O
and	O
drowning	O
with	O
achieved	O
certain	O
effects	O
,	O
but	O
its	O
usage	O
for	O
ARDS	O
caused	O
by	O
ammonia	B-SPEC
is	O
rarely	O
reported	O
.	O

The	O
successful	O
experience	O
was	O
summarized	O
in	O
order	B-SPEC
to	O
provide	O
reference	O
for	O
the	O
treatment	O
of	O
such	O
patients	O
in	O
the	O
future	O
.	O

We	O
report	O
the	O
epidemiological	O
and	O
clinical	O
features	O
of	O
the	O
first	O
patient	O
with	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
pneumonia	O
imported	O
into	O
Korea	O
from	O
Wuhan	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
of	O
zoonotic	O
origin	O
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
has	O
recently	O
been	O
identified	O
in	O
patients	O
with	O
acute	O
respiratory	O
disease	O
.	O

This	O
virus	B-SPEC
is	O
genetically	O
similar	O
to	O
SARS	O
coronavirus	B-SPEC
and	O
bat	B-SPEC
SARS	O
-	O
like	O
coronaviruses	O
.	O

TITLE	O
:	O
Pathogenicity	O
and	O
transmissibility	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
-	O
A	O
quick	O
overview	O
and	O
comparison	O
with	O
other	O
emerging	O
viruses	B-SPEC
.	O

Although	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
can	O
cause	O
a	O
severe	O
respiratory	O
illness	O
like	O
SARS	O
and	O
MERS	O
,	O
evidence	O
from	O
clinics	O
suggested	O
that	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
generally	O
less	O
pathogenic	O
than	O
SARS	O
-	O
CoV	O
,	O
and	O
much	O
less	O
than	O
MERS	O
-	O
CoV	O
.	O
The	O
transmissibility	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
still	O
debated	O
and	O
needs	O
to	O
be	O
further	O
assessed	O
.	O

Mice	B-SPEC
immunized	O
with	O
exosomes	O
from	O
recipients	O
with	O
respiratory	O
viral	O
infections	O
developed	O
immune	O
responses	O
to	O
self	O
-	O
antigens	O
,	O
fibrosis	O
,	O
small	O
airway	O
occlusion	O
,	O
and	O
significant	O
cellular	O
infiltration	O
;	O
mice	B-SPEC
immunized	O
with	O
exosomes	O
from	O
controls	O
did	O
not	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
present	O
consensus	O
statement	O
summarizes	O
current	O
strategies	O
on	O
diagnosis	O
,	O
treatment	O
,	O
and	O
prevention	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
in	O
children	O
.	O

TITLE	O
:	O
Genome	O
Composition	O
and	O
Divergence	O
of	O
the	O
Novel	B-SPEC
Coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
Originating	O
in	O
China	O
.	O

ABSTRACT	O
:	O
At	O
present	O
,	O
the	O
prevention	O
and	O
treatment	O
of	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
in	O
China	O
has	O
reached	O
a	O
critical	O
stage	O
.	O

TITLE	O
:	O
Clinical	O
characteristics	O
and	O
therapeutic	O
procedure	O
for	O
four	O
cases	O
with	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
pneumonia	O
receiving	O
combined	O
Chinese	O
and	O
Western	O
medicine	O
treatment	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
(	O
CoV	O
)	O
envelope	O
(	O
E	O
)	O
protein	O
is	O
a	O
small	O
structural	O
protein	O
critical	O
for	O
virion	O
morphogenesis	O
and	O
release	O
.	O

We	O
utilized	O
TGEV	B-SPEC
as	O
a	O
model	O
pathogen	O
to	O
explore	O
the	O
role	O
of	O
FcRn	O
in	O
resisting	O
viral	O
invasion	O
in	O
overall	O
intestinal	O
mucosal	O
immunity	O
.	O

TGEV	B-SPEC
nucleocapsid	O
(	O
N	O
)	O
protein	O
also	O
enhanced	O
FcRn	O
promoter	O
activity	O
via	O
the	O
NF	O
-	O
κB	O
signaling	O
pathway	O
and	O
its	O
central	O
region	O
(	O
aa	O
128	O
-	O
252	O
)	O
was	O
essential	O
for	O
FcRn	O
activation	O
.	O

Thus	O
,	O
TGEV	B-SPEC
N	O
protein	O
and	O
TGF	O
-	O
β	O
up	O
-	O
regulated	O
FcRn	O
expression	O
,	O
further	O
clarifying	O
the	O
molecular	O
mechanism	O
of	O
up	O
-	O
regulation	O
of	O
FcRn	O
expression	O
by	O
TGEV	B-SPEC
.	O

ABSTRACT	O
:	O
Genetic	O
perturbation	O
screens	O
using	O
RNA	O
interference	O
(	O
RNAi	O
)	O
have	O
been	O
conducted	O
successfully	O
to	O
identify	O
host	O
factors	O
that	O
are	O
essential	O
for	O
the	O
life	O
cycle	O
of	O
bacteria	B-SPEC
or	O
viruses	B-SPEC
.	O

Identification	O
of	O
host	O
factors	O
on	O
a	O
pan	B-SPEC
-	O
pathogen	O
level	O
,	O
i	O
.	O
e	O
.,	O
genes	O
that	O
are	O
crucial	O
for	O
the	O
replication	O
of	O
a	O
diverse	O
group	O
of	O
pathogens	O
has	O
received	O
relatively	O
little	O
attention	O
,	O
despite	O
the	O
fact	O
that	O
such	O
common	O
host	O
factors	O
would	O
be	O
highly	O
relevant	O
,	O
for	O
instance	O
,	O
for	O
devising	O
broad	O
-	O
spectrum	O
anti	O
-	O
pathogenic	O
drugs	O
.	O

In	O
addition	O
,	O
novel	O
pathogens	O
including	O
zoonotic	O
coronaviruses	O
like	O
the	O
agents	O
causing	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
),	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
and	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	O
nCoV	O
)	O
are	O
still	O
being	O
identified	O
.	O

ABSTRACT	O
:	O
Middle	O
East	O
Respiratory	O
Syndrome	O
(	O
MERS	O
)	O
is	O
a	O
respiratory	O
disease	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
was	O
identified	O
in	O
2012	O
in	O
Saudi	O
Arabia	O
.	O

We	O
also	O
looked	O
at	O
the	O
impact	O
of	O
medication	O
history	O
on	O
virus	B-SPEC
transmission	O
.	O

Clinical	O
data	O
from	O
137	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
-	O
infected	O
patients	O
admitted	O
to	O
the	O
respiratory	O
departments	O
of	O
the	O
respiratory	O
departments	O
of	O
nine	O
tertiary	O
hospitals	O
in	O
Hubei	O
province	O
from	O
December	O
30	O
,	O
2019	O
to	O
January	O
24	O
,	O
2020	O
were	O
retrospectively	O
collected	O
,	O
including	O
general	O
status	O
,	O
clinical	O
manifestations	O
,	O
laboratory	O
test	O
results	O
,	O
imaging	O
characteristics	O
,	O
and	O
treatment	O
regimens	O
.	O

The	O
majority	O
of	O
patients	O
with	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
pneumonia	O
present	O
with	O
fever	O
as	O
the	O
first	O
symptom	O
,	O
and	O
most	O
of	O
them	O
still	O
showed	O
typical	O
manifestations	O
of	O
viral	O
pneumonia	O
on	O
chest	O
imaging	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
emergence	O
of	O
the	O
first	O
cases	O
in	O
Wuhan	O
,	O
China	O
,	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
infection	O
has	O
been	O
quickly	O
spreading	O
out	O
to	O
other	O
provinces	O
and	O
neighboring	O
countries	O
.	O

TITLE	O
:	O
Distinct	O
Roles	O
for	O
Sialoside	O
and	O
Protein	O
Receptors	O
in	O
Coronavirus	B-SPEC
Infection	O
.	O

Focusing	O
on	O
two	O
betacoronaviruses	O
,	O
murine	B-SPEC
JHM	O
-	O
CoV	O
and	O
human	B-SPEC
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
we	O
found	O
that	O
virus	B-SPEC
particle	O
binding	O
to	O
cells	O
was	O
mediated	O
by	O
sialic	O
acids	O
;	O
however	O
,	O
the	O
transmembrane	O
protein	O
receptors	O
were	O
required	O
for	O
a	O
subsequent	O
virus	B-SPEC
infection	O
.	O

TITLE	O
:	O
Clinical	O
and	O
biochemical	O
indexes	O
from	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infected	O
patients	O
linked	O
to	O
viral	O
loads	O
and	O
lung	O
injury	O
.	O

We	O
are	O
able	O
to	O
clarify	O
the	O
mechanism	O
of	O
transmission	O
among	O
the	O
countries	O
which	O
have	O
provided	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
sequence	O
isolates	O
from	O
their	O
patients	O
.	O

TITLE	O
:	O
Synanthropic	O
rodents	B-SPEC
as	O
virus	B-SPEC
reservoirs	O
and	O
transmitters	O
.	O

Comprehensive	O
control	O
and	O
preventive	O
activities	O
should	O
include	O
actions	O
such	O
as	O
the	O
elimination	O
or	O
reduction	O
of	O
rat	B-SPEC
and	O
mouse	B-SPEC
populations	O
,	O
sanitary	O
education	O
,	O
reduction	O
of	O
shelters	O
for	O
the	O
animals	B-SPEC
,	O
and	O
restriction	O
of	O
the	O
access	O
of	O
rodents	B-SPEC
to	O
residences	O
,	O
water	O
,	O
and	O
food	O
supplies	O
.	O

ABSTRACT	O
:	O
In	O
late	O
December	O
2019	O
a	O
previous	O
unidentified	O
coronavirus	B-SPEC
,	O
currently	O
named	O
as	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
),	O
emerged	O
from	O
Wuhan	O
,	O
China	O
and	O
resulted	O
in	O
a	O
formidable	O
outbreak	O
in	O
many	O
cities	O
in	O
China	O
and	O
expanding	O
globally	O
,	O
including	O
Thailand	O
,	O
Republic	O
of	O
Korea	O
,	O
Japan	O
,	O
USA	O
,	O
Philippines	O
,	O
Viet	O
Nam	O
,	O
and	O
our	O
country	O
(	O
as	O
of	O
2	O
/	O
6	O
/	O
2020	O
at	O
least	O
25	O
countries	O
).	O

In	O
order	B-SPEC
to	O
assess	O
the	O
potential	O
of	O
the	O
Wuhan	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
to	O
cause	O
maternal	O
,	O
fetal	O
and	O
neonatal	O
morbidity	O
and	O
other	O
poor	O
obstetrical	O
outcomes	O
,	O
this	O
communication	O
reviews	O
the	O
published	O
data	O
addressing	O
the	O
epidemiological	O
and	O
clinical	O
effects	O
of	O
SARS	O
,	O
MERS	O
,	O
and	O
other	O
coronavirus	B-SPEC
infections	O
on	O
pregnant	O
women	O
and	O
their	O
infants	O
.	O

Due	O
to	O
immaturity	O
of	O
immune	O
function	O
and	O
the	O
possibility	O
of	O
mother	O
-	O
fetal	O
vertical	O
transmission	O
,	O
neonates	O
are	O
particularly	O
susceptible	O
to	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
The	O
perinatal	O
-	O
neonatal	O
departments	O
should	O
cooperate	O
closely	O
and	O
take	O
integrated	O
approaches	O
,	O
and	O
the	O
neonatal	O
intensive	O
care	O
unit	O
should	O
prepare	O
the	O
emergency	O
plan	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
as	O
far	O
as	O
possible	O
,	O
so	O
as	O
to	O
ensure	O
the	O
optimal	O
management	O
and	O
treatment	O
of	O
potential	O
victims	O
.	O

Neonates	O
are	O
presumably	O
the	O
high	O
-	O
risk	O
population	O
susceptible	O
to	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
due	O
to	O
immature	O
immune	O
function	O
.	O

ABSTRACT	O
:	O
Since	O
December	O
2019	O
,	O
a	O
cluster	O
of	O
patients	O
have	O
been	O
diagnosed	O
to	O
be	O
infected	O
with	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
in	O
Wuhan	O
,	O
China	O
.	O

Since	O
PDCoV	O
was	O
first	O
detected	O
in	O
2009	O
in	O
Hong	O
Kong	O
,	O
the	O
prevalence	O
of	O
PDCoV	O
has	O
increased	O
in	O
recent	O
years	O
,	O
resulting	O
in	O
serious	O
economic	O
losses	O
to	O
the	O
swine	B-SPEC
industry	O
.	O

CDC	O
activated	O
its	O
Emergency	O
Operations	O
Center	O
on	O
January	O
21	O
and	O
formalized	O
a	O
process	O
for	O
inquiries	O
regarding	O
persons	O
suspected	O
of	O
having	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
(	O
2	O
).	O

Guided	O
by	O
CDC	O
criteria	O
for	O
the	O
evaluation	O
of	O
persons	O
under	O
investigation	O
(	O
PUIs	O
)	O
(	O
5	O
),	O
210	O
symptomatic	O
persons	O
were	O
tested	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
;	O
among	O
these	O
persons	O
,	O
148	O
(	O
70	O
%)	O
had	O
travel	O
-	O
related	O
risk	O
only	O
,	O
42	O
(	O
20	O
%)	O
had	O
close	O
contact	O
with	O
an	O
ill	O
laboratory	O
-	O
confirmed	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
patient	O
or	O
PUI	O
,	O
and	O
18	O
(	O
9	O
%)	O
had	O
both	O
travel	O
-	O
and	O
contact	O
-	O
related	O
risks	O
.	O

Recognizing	O
persons	O
at	O
risk	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
critical	O
to	O
identifying	O
cases	O
and	O
preventing	O
further	O
transmission	O
.	O

Here	O
,	O
we	O
assess	O
the	O
risk	O
of	O
sustained	O
transmission	O
whenever	O
the	O
coronavirus	B-SPEC
arrives	O
in	O
other	O
countries	O
.	O

TITLE	O
:	O
Prophylactic	O
and	O
therapeutic	O
remdesivir	O
(	O
GS	O
-	O
5734	O
)	O
treatment	O
in	O
the	O
rhesus	B-SPEC
macaque	I-SPEC
model	O
of	O
MERS	O
-	O
CoV	O
infection	O
.	O

Substantial	O
advances	O
have	O
been	O
made	O
in	O
the	O
care	O
of	O
patients	O
with	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
(	O
EVD	O
),	O
precipitated	O
by	O
the	O
unprecedented	O
extent	O
of	O
the	O
2014	O
-	O
2016	O
outbreak	O
.	O

As	O
compared	O
to	O
influenza	O
,	O
NIRV	O
were	O
associated	O
with	O
age	O
(	O
median	O
,	O
73	O
years	O
vs	O
.	O
68	O
,	O
P	O
=	O
0	O
.	O
026	O
),	O
chronic	O
respiratory	O
diseases	O
(	O
53	O
%	O
vs	O
.	O
45	O
%,	O
P	O
=	O
0	O
.	O
034	O
),	O
cancer	B-SPEC
(	O
14	O
%	O
vs	O
.	O
9	O
%,	O
P	O
=	O
0	O
.	O
029	O
),	O
and	O
immunosuppressive	O
drugs	O
(	O
21	O
%	O
vs	O
.	O
14	O
%,	O
P	O
=	O
0	O
.	O
028	O
),	O
and	O
inversely	O
associated	O
with	O
diabetes	O
(	O
18	O
%	O
vs	O
.	O
25	O
%,	O
P	O
=	O
0	O
.	O
038	O
).	O

TITLE	O
:	O
[	O
Pharmacotherapeutics	O
for	O
the	O
New	O
Coronavirus	B-SPEC
Pneumonia	O
].	O

ABSTRACT	O
:	O
The	O
New	O
Coronavirus	B-SPEC
Pneumonia	O
(	O
NCP	O
,	O
also	O
named	O
as	O
COVID	O
-	O
19	O
by	O
WHO	O
on	O
Feb	O
11	O
2020	O
,	O
is	O
now	O
causing	O
a	O
severe	O
public	O
health	O
emergency	O
in	O
China	O
since	O
.	O

ABSTRACT	O
:	O
During	O
a	O
short	O
period	O
of	O
time	O
,	O
the	O
outbreak	O
of	O
pneumonia	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
named	O
Novel	B-SPEC
Coronavirus	I-SPEC
Pneumonia	O
(	O
NCP	O
),	O
was	O
first	O
reported	O
in	O
China	O
,	O
spreading	O
to	O
24	O
countries	O
and	O
regions	O
rapidly	O
.	O

Efficient	O
infection	O
control	O
can	O
prevent	O
the	O
virus	B-SPEC
from	O
further	O
spreading	O
,	O
which	O
makes	O
the	O
epidemic	O
situation	O
under	O
control	O
.	O

ABSTRACT	O
:	O
Through	O
literature	O
review	O
and	O
group	O
discussion	O
,	O
Special	O
Expert	O
Group	O
for	O
Control	O
of	O
the	O
Epidemic	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
Pneumonia	O
of	O
the	O
Chinese	O
Preventive	O
Medicine	O
Association	O
formulated	O
an	O
update	O
on	O
the	O
epidemiological	O
characteristics	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
(	O
NCP	O
).	O

The	O
initial	O
source	O
of	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
was	O
the	O
Huanan	O
seafood	O
market	O
in	O
Wuhan	O
,	O
Hubei	O
province	O
,	O
China	O
,	O
with	O
pangolins	B-SPEC
as	O
a	O
potential	O
animal	B-SPEC
host	O
.	O

The	O
virus	B-SPEC
is	O
believed	O
transmitted	O
mostly	O
via	O
droplets	O
or	O
contact	O
.	O

In	O
order	B-SPEC
to	O
implement	O
the	O
central	O
government	O
'	O
s	O
decision	O
-	O
making	O
deployment	O
and	O
defeat	O
the	O
NCP	O
as	O
soon	O
as	O
possible	O
,	O
we	O
had	O
focused	O
on	O
the	O
key	O
points	O
in	O
the	O
clinical	O
work	O
of	O
general	O
surgery	O
according	O
to	O
latest	O
relevant	O
guidelines	O
,	O
literature	O
and	O
experience	O
in	O
epidemic	O
prevention	O
.	O

Like	O
the	O
rH120	O
-	O
infected	O
group	O
and	O
in	O
contrast	O
to	O
the	O
rIBYZ	O
-	O
infected	O
group	O
,	O
no	O
mortality	O
,	O
clinical	O
signs	O
,	O
or	O
lesions	O
were	O
observed	O
in	O
the	O
lungs	O
or	O
kidneys	O
of	O
young	O
chickens	B-SPEC
inoculated	O
with	O
rH120	O
-	O
S1	O
/	O
YZ	O
.	O

ABSTRACT	O
:	O
Based	O
on	O
the	O
announcement	O
of	O
the	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
in	O
2018	O
,	O
the	O
Wuhan	O
pneumonia	O
caused	O
by	O
an	O
unknown	O
etiology	O
should	O
be	O
recognized	O
as	O
the	O
first	O
Disease	O
X	O
.	O
Later	O
,	O
the	O
pathogen	O
was	O
identified	O
to	O
be	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
denoted	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
which	O
has	O
79	O
.	O
5	O
%	O
and	O
96	O
%	O
whole	O
genome	O
sequence	O
identify	O
to	O
SARS	O
-	O
CoV	O
and	O
bat	B-SPEC
SARS	O
-	O
related	O
coronavirus	B-SPEC
(	O
SARSr	O
-	O
CoV	O
-	O
RaTG13	O
),	O
respectively	O
,	O
suggesting	O
its	O
potential	O
bat	B-SPEC
origin	O
.	O

CDV	B-SPEC
RNA	O
was	O
mainly	O
detected	O
in	O
the	O
Canidae	B-SPEC
family	B-SPEC
,	O
with	O
viral	O
nucleic	O
acid	O
recorded	O
between	O
2005	O
and	O
2008	O
with	O
a	O
peak	O
prevalence	O
of	O
67	O
%	O
among	O
the	O
wolf	O
population	O
,	O
followed	O
by	O
a	O
sharp	O
decline	O
,	O
suggesting	O
an	O
epizootic	O
behaviour	O
of	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
Challenges	O
to	O
the	O
system	O
of	O
reserve	O
medical	O
supplies	O
for	O
public	O
health	O
emergencies	O
:	O
reflections	O
on	O
the	O
outbreak	O
of	O
the	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
epidemic	O
in	O
China	O
.	O

TITLE	O
:	O
[	O
Analysis	O
of	O
the	O
first	O
cluster	O
of	O
cases	O
in	O
a	O
family	B-SPEC
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
in	O
Gansu	O
Province	O
].	O

ABSTRACT	O
:	O
In	O
December	O
2019	O
,	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
epidemic	O
occurred	O
in	O
Wuhan	O
,	O
Hubei	O
Province	O
,	O
and	O
spread	O
rapidly	O
across	O
the	O
country	O
.	O

Using	O
data	O
collected	O
during	O
the	O
2015	O
Middle	O
East	O
Respiratory	O
Syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
outbreak	O
in	O
South	O
Korea	O
,	O
this	O
study	O
explores	O
the	O
relationships	O
among	O
social	O
media	O
use	O
,	O
risk	O
perception	O
,	O
and	O
preventive	O
behaviors	O
by	O
examining	O
the	O
mediating	O
role	O
of	O
two	O
self	O
-	O
relevant	O
emotions	O
:	O
fear	O
and	O
anger	O
.	O

ABSTRACT	O
:	O
The	O
newly	O
identified	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
has	O
caused	O
more	O
than	O
11	O
,	O
900	O
laboratory	O
-	O
confirmed	O
human	B-SPEC
infections	O
,	O
including	O
259	O
deaths	O
,	O
posing	O
a	O
serious	O
threat	O
to	O
human	B-SPEC
health	O
.	O

These	O
results	O
suggest	O
that	O
CR3022	O
may	O
have	O
the	O
potential	O
to	O
be	O
developed	O
as	O
candidate	O
therapeutics	O
,	O
alone	O
or	O
in	O
combination	O
with	O
other	O
neutralizing	O
antibodies	O
,	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infections	O
.	O

Interestingly	O
,	O
some	O
of	O
the	O
most	O
potent	O
SARS	O
-	O
CoV	O
-	O
specific	O
neutralizing	O
antibodies	O
(	O
e	O
.	O
g	O
.	O
m396	O
,	O
CR3014	O
)	O
that	O
target	O
the	O
ACE2	O
binding	O
site	O
of	O
SARS	O
-	O
CoV	O
failed	O
to	O
bind	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
spike	O
protein	O
,	O
implying	O
that	O
the	O
difference	O
in	O
the	O
RBD	O
of	O
SARS	O
-	O
CoV	O
and	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
has	O
a	O
critical	O
impact	O
for	O
the	O
cross	O
-	O
reactivity	O
of	O
neutralizing	O
antibodies	O
,	O
and	O
that	O
it	O
is	O
still	O
necessary	O
to	O
develop	O
novel	O
monoclonal	O
antibodies	O
that	O
could	O
bind	O
specifically	O
to	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
RBD	O
.	O

ABSTRACT	O
:	O
Porcine	B-SPEC
epidemic	I-SPEC
diarrhea	I-SPEC
virus	I-SPEC
(	O
PEDV	B-SPEC
)	O
is	O
an	O
emerging	O
porcine	B-SPEC
coronavirus	B-SPEC
that	O
causes	O
a	O
tremendous	O
economic	O
burden	O
on	O
the	O
swine	B-SPEC
industry	O
.	O

The	O
assessment	O
of	O
PEDV	B-SPEC
-	O
neutralizing	O
antibody	O
levels	O
provides	O
a	O
valuable	O
tool	O
to	O
assess	O
and	O
predict	O
herd	O
immunity	O
.	O

TITLE	O
:	O
Molecular	O
and	O
serological	O
investigation	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infected	O
patients	O
:	O
implication	O
of	O
multiple	O
shedding	O
routes	O
.	O

The	O
most	O
frequently	O
used	O
herbs	O
included	O
Radix	B-SPEC
astragali	O
(	O
Huangqi	O
),	O
Radix	B-SPEC
glycyrrhizae	O
(	O
Gancao	O
),	O
Radix	B-SPEC
saposhnikoviae	O
(	O
Fangfeng	B-SPEC
),	O
Rhizoma	O
Atractylodis	O
Macrocephalae	O
(	O
Baizhu	O
),	O
Lonicerae	O
Japonicae	O
Flos	B-SPEC
(	O
Jinyinhua	O
),	O
and	O
Fructus	O
forsythia	B-SPEC
(	O
Lianqiao	O
).	O

The	O
most	O
frequently	O
used	O
herbs	O
included	O
Radix	B-SPEC
astragali	O
(	O
Huangqi	O
),	O
Radix	B-SPEC
glycyrrhizae	O
(	O
Gancao	O
),	O
Radix	B-SPEC
saposhnikoviae	O
(	O
Fangfeng	B-SPEC
),	O
Rhizoma	O
Atractylodis	O
Macrocephalae	O
(	O
Baizhu	O
),	O
Lonicerae	O
Japonicae	O
Flos	B-SPEC
(	O
Jinyinhua	O
),	O
and	O
Fructus	O
forsythia	B-SPEC
(	O
Lianqiao	O
).	O

It	O
can	O
affect	O
all	O
age	O
groups	O
of	O
birds	B-SPEC
.	O

The	O
results	O
demonstrated	O
that	O
intermediate	O
dose	O
of	O
all	O
the	O
three	O
TLR	O
ligands	O
significantly	O
reduced	O
virus	B-SPEC
titers	O
and	O
used	O
in	O
the	O
present	O
study	O
.	O

The	O
present	O
study	O
pointed	O
towards	O
the	O
novel	O
opportunities	O
for	O
rational	O
design	O
of	O
LPS	O
as	O
immuno	O
-	O
stimulatory	O
agent	O
in	O
chickens	B-SPEC
with	O
reference	O
to	O
IBV	B-SPEC
.	O

ABSTRACT	O
:	O
An	O
ongoing	O
outbreak	O
of	O
pneumonia	O
associated	O
with	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
was	O
reported	O
in	O
China	O
.	O

ABSTRACT	O
:	O
During	O
the	O
coronavirus	B-SPEC
pneumonia	O
(	O
NCP	O
)	O
outbreak	O
,	O
the	O
transportation	O
industries	O
are	O
faced	O
with	O
the	O
more	O
burdensome	O
tasks	O
of	O
outbreak	O
prevention	O
and	O
control	O
as	O
well	O
as	O
ensuring	O
smooth	O
transportation	O
.	O

ABSTRACT	O
:	O
In	O
the	O
recent	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
infection	O
in	O
Wuhan	O
,	O
China	O
,	O
significantly	O
abnormal	O
coagulation	O
parameters	O
in	O
severe	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
(	O
NCP	O
)	O
cases	O
were	O
a	O
concern	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
virus	B-SPEC
is	O
spreading	O
rapidly	O
,	O
and	O
scientists	O
are	O
endeavoring	O
to	O
discover	O
drugs	O
for	O
its	O
efficacious	O
treatment	O
in	O
China	O
.	O

ABSTRACT	O
:	O
Pneumonia	O
caused	O
by	O
SARS	B-SPEC
-	I-SPEC
Cov	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
has	O
been	O
reported	O
in	O
Wuhan	O
since	O
December	O
2019	O
,	O
and	O
spread	O
rapidly	O
across	O
the	O
country	O
.	O

The	O
radical	O
operation	O
of	O
colorectal	O
cancer	B-SPEC
is	O
confine	O
operation	O
.	O

Recommending	O
laparoscopy	O
-	O
assisted	O
radical	O
surgery	O
for	O
colorectal	O
cancer	B-SPEC
patients	O
.	O

TITLE	O
:	O
[	O
Treatment	O
strategy	O
for	O
gastrointestinal	O
tumor	O
under	O
the	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
in	O
China	O
].	O

TITLE	O
:	O
[	O
Novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
related	O
liver	O
injury	O
:	O
etiological	O
analysis	O
and	O
treatment	O
strategy	O
].	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
(	O
NCP	O
)	O
caused	O
by	O
2019	O
novel	O
coronavirus	O
has	O
become	O
a	O
global	O
public	O
health	O
challenge	O
.	O

In	O
order	B-SPEC
to	O
guide	O
and	O
regulate	O
the	O
use	O
of	O
chloroquine	O
in	O
patients	O
with	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
,	O
the	O
multicenter	O
collaboration	O
group	O
of	O
Department	O
of	O
Science	O
and	O
Technology	O
of	O
Guangdong	O
Province	O
and	O
Health	O
Commission	O
of	O
Guangdong	O
Province	O
for	O
chloroquine	O
in	O
the	O
treatment	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
developed	O
this	O
expert	O
consensus	O
after	O
extensive	O
discussion	O
.	O

It	O
recommended	O
chloroquine	O
phosphate	O
tablet	O
,	O
500mg	O
twice	O
per	O
day	O
for	O
10	O
days	O
for	O
patients	O
diagnosed	O
as	O
mild	O
,	O
moderate	O
and	O
severe	O
cases	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
and	O
without	O
contraindications	O
to	O
chloroquine	O
.	O

According	O
to	O
research	O
,	O
none	O
of	O
the	O
infected	O
patients	O
in	O
Zhejiang	O
province	O
were	O
ever	O
exposed	O
to	O
the	O
Huanan	O
seafood	O
market	O
,	O
the	O
original	O
source	O
of	O
the	O
virus	B-SPEC
;	O
all	O
studied	O
cases	O
were	O
infected	O
by	O
human	B-SPEC
to	O
human	B-SPEC
transmission	O
.	O

CONCLUSIONS	O
:	O
As	O
of	O
early	O
February	O
2020	O
,	O
compared	O
with	O
patients	O
initially	O
infected	O
with	O
SARS	B-SPEC
-	I-SPEC
Cov	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
Wuhan	O
,	O
the	O
symptoms	O
of	O
patients	O
in	O
Zhejiang	O
province	O
are	O
relatively	O
mild	O
.	O

We	O
aim	O
to	O
investigate	O
the	O
clinical	O
characteristic	O
and	O
allergy	O
status	O
of	O
patients	O
infected	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

CONCLUSIONS	O
:	O
Detailed	O
clinical	O
investigation	O
of	O
140	O
hospitalized	O
COVID	O
-	O
19	O
cases	O
suggests	O
eosinopenia	O
together	O
with	O
lymphopenia	O
may	O
be	O
a	O
potential	O
indicator	B-SPEC
for	O
diagnosis	O
.	O

The	O
protection	O
provisions	O
and	O
control	O
measures	O
aiming	O
to	O
protect	O
lung	O
cancer	B-SPEC
patients	O
from	O
COVID	O
-	O
19	O
have	O
been	O
increasingly	O
concerned	O
.	O

In	O
this	O
paper	O
,	O
combining	O
with	O
the	O
key	O
clinical	O
problems	O
of	O
prevention	O
and	O
control	O
in	O
hospital	O
during	O
the	O
epidemic	O
period	O
of	O
NCP	O
infection	O
,	O
medical	O
evidence	O
,	O
and	O
clinical	O
and	O
management	O
experience	O
,	O
the	O
author	O
formulates	O
prevention	O
and	O
control	O
management	O
strategy	O
of	O
the	O
author	O
'	O
s	O
unit	O
in	O
order	B-SPEC
to	O
provide	O
reference	O
for	O
prevention	O
and	O
control	O
of	O
burn	O
and	O
wound	O
care	O
ward	O
.	O

TITLE	O
:	O
Chest	O
CT	O
Findings	O
in	O
Coronavirus	B-SPEC
Disease	O
-	O
19	O
(	O
COVID	O
-	O
19	O
):	O
Relationship	O
to	O
Duration	O
of	O
Infection	O
.	O

At	O
present	O
,	O
the	O
mortality	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
in	O
China	O
is	O
2	O
.	O
3	O
%,	O
compared	O
with	O
9	O
.	O
6	O
%	O
of	O
SARS	O
and	O
34	O
.	O
4	O
%	O
of	O
MERS	O
reported	O
by	O
WHO	O
.	O

TITLE	O
:	O
Incubation	O
Period	O
and	O
Other	O
Epidemiological	O
Characteristics	O
of	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
Infections	O
with	O
Right	O
Truncation	O
:	O
A	O
Statistical	O
Analysis	O
of	O
Publicly	O
Available	O
Case	O
Data	O
.	O

ABSTRACT	O
:	O
We	O
report	O
the	O
complete	O
genome	O
sequences	O
of	O
five	O
human	B-SPEC
coronavirus	I-SPEC
NL63	I-SPEC
(	O
HCoV	B-SPEC
-	I-SPEC
NL63	I-SPEC
)	O
strains	O
obtained	O
using	O
next	O
-	O
generation	O
sequencing	O
.	O

TITLE	O
:	O
Virus	B-SPEC
Isolation	O
from	O
the	O
First	O
Patient	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
Korea	O
.	O

Cytopathic	O
effects	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
the	O
Vero	O
cell	O
cultures	O
were	O
confluent	O
3	O
days	O
after	O
the	O
first	O
blind	O
passage	O
of	O
the	O
sample	O
.	O

TITLE	O
:	O
Viral	O
Load	O
Kinetics	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
Infection	O
in	O
First	O
Two	O
Patients	O
in	O
Korea	O
.	O

TITLE	O
:	O
Severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
and	O
coronavirus	B-SPEC
disease	O
-	O
2019	O
(	O
COVID	O
-	O
19	O
):	O
The	O
epidemic	O
and	O
the	O
challenges	O
.	O

SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
is	O
closely	O
related	O
to	O
two	O
bat	B-SPEC
-	O
derived	O
severe	O
acute	O
respiratory	O
syndrome	O
-	O
like	O
coronaviruses	O
,	O
bat	B-SPEC
-	O
SL	O
-	O
CoVZC45	O
and	O
bat	B-SPEC
-	O
SL	O
-	O
CoVZXC21	O
.	O

Importantly	O
,	O
there	O
is	O
a	O
clear	O
order	B-SPEC
of	O
cleavage	O
efficiencies	O
,	O
which	O
is	O
influenced	O
by	O
the	O
polyprotein	O
tertiary	O
structure	O
.	O

Its	O
pathogen	O
is	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
which	O
has	O
the	O
characteristics	O
of	O
strong	O
infectivity	O
and	O
general	O
susceptibility	O
.	O

By	O
summarizing	O
the	O
research	O
progress	O
and	O
guidelines	O
in	O
recent	O
years	O
in	O
the	O
fields	O
of	O
colorectal	O
cancer	B-SPEC
disease	O
screening	O
,	O
treatment	O
strategies	O
(	O
including	O
early	O
colorectal	O
cancer	B-SPEC
,	O
locally	O
advanced	O
colorectal	O
cancer	B-SPEC
,	O
obstructive	O
colorectal	O
cancer	B-SPEC
,	O
metastatic	O
colorectal	O
cancer	B-SPEC
and	O
the	O
treatment	O
of	O
patients	O
after	O
neoadjuvant	O
therapy	O
),	O
the	O
choice	O
of	O
medication	O
and	O
time	O
limit	O
for	O
adjuvant	O
therapy	O
,	O
the	O
protective	O
measures	O
for	O
patients	O
undergoing	O
emergency	O
surgery	O
,	O
the	O
re	O
-	O
examination	O
of	O
postoperative	O
patients	O
and	O
the	O
protection	O
of	O
medical	O
staff	O
,	O
etc	O
.,	O
authors	O
improve	O
treatment	O
strategies	O
in	O
order	B-SPEC
to	O
provide	O
more	O
choices	O
for	O
patients	O
to	O
obtain	O
the	O
best	O
treatment	O
under	O
the	O
severe	O
epidemic	O
situation	O
of	O
new	O
coronavirus	B-SPEC
pneumonia	O
.	O

(	O
4	O
)	O
The	O
surgical	O
medical	O
workers	O
who	O
process	O
colorectal	O
cancer	B-SPEC
patients	O
with	O
NCP	O
must	O
be	O
protected	O
by	O
three	O
-	O
level	O
.	O

The	O
availability	O
of	O
connecting	O
flights	O
,	O
the	O
timing	O
of	O
the	O
outbreak	O
during	O
the	O
Chinese	O
(	O
Lunar	O
)	O
New	O
Year	O
,	O
and	O
the	O
massive	O
rail	B-SPEC
transit	O
hub	O
located	O
in	O
Wuhan	O
has	O
enabled	O
the	O
virus	B-SPEC
to	O
perforate	O
throughout	O
China	O
,	O
and	O
eventually	O
,	O
globally	O
.	O

To	O
date	O
,	O
there	O
are	O
no	O
clinically	O
approved	O
vaccines	O
or	O
antiviral	O
drugs	O
available	O
for	O
these	O
human	B-SPEC
coronavirus	I-SPEC
infections	O
.	O

TITLE	O
:	O
[	O
Attention	O
should	O
be	O
paid	O
to	O
the	O
exposure	O
risk	O
of	O
patients	O
with	O
chronic	O
wounds	O
on	O
the	O
way	O
to	O
hospital	O
during	O
corona	B-SPEC
virus	B-SPEC
disease	O
2019	O
epidemic	O
prevention	O
and	O
control	O
].	O

The	O
above	O
underlying	O
diseases	O
and	O
ages	O
of	O
patients	O
are	O
the	O
susceptibility	O
factors	O
of	O
corona	B-SPEC
virus	B-SPEC
disease	O
2019	O
released	O
by	O
National	O
Health	O
Commission	O
of	O
China	O
.	O

On	O
the	O
25th	O
day	O
after	O
the	O
outbreak	O
,	O
the	O
Chinese	O
government	O
implemented	O
strict	O
traffic	O
restrictions	O
on	O
the	O
area	O
where	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
had	O
originated	O
-	O
Hubei	O
province	O
,	O
whose	O
capital	O
city	O
is	O
Wuhan	O
.	O

TITLE	O
:	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
(	O
Wuhan	O
virus	B-SPEC
),	O
a	O
novel	B-SPEC
Coronavirus	I-SPEC
:	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
,	O
travel	O
-	O
related	O
cases	O
,	O
and	O
vaccine	O
readiness	O
.	O

We	O
also	O
present	O
data	O
on	O
the	O
use	O
of	O
in	O
silico	O
docking	O
in	O
gaining	O
insight	O
into	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
Spike	O
-	O
receptor	O
binding	O
to	O
aid	O
in	O
therapeutic	O
development	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
identification	O
of	O
an	O
outbreak	O
of	O
2019	O
-	O
novel	B-SPEC
Coronavirus	I-SPEC
is	O
currently	O
evolving	O
,	O
and	O
the	O
impact	O
on	O
transplantation	O
is	O
unknown	O
.	O

This	O
knowledge	O
can	O
potentially	O
contribute	O
to	O
improvement	O
of	O
virus	B-SPEC
production	O
efficiency	O
in	O
culture	O
,	O
not	O
only	O
for	O
vaccine	O
preparation	O
but	O
also	O
to	O
develop	O
antiviral	O
treatments	O
.	O

TITLE	O
:	O
Swine	B-SPEC
acute	O
diarrhea	O
syndrome	O
coronavirus	B-SPEC
-	O
induced	O
apoptosis	O
is	O
caspase	O
-	O
and	O
cyclophilin	O
D	O
-	O
dependent	O
.	O

ABSTRACT	O
:	O
Swine	B-SPEC
acute	O
diarrhea	O
syndrome	O
coronavirus	B-SPEC
(	O
SADS	O
-	O
CoV	O
),	O
a	O
newly	O
discovered	O
enteric	B-SPEC
coronavirus	I-SPEC
,	O
is	O
the	O
aetiological	O
agent	O
that	O
causes	O
severe	O
clinical	O
diarrhea	O
and	O
intestinal	O
pathological	O
damage	O
in	O
piglets	O
.	O

ABSTRACT	O
:	O
In	O
December	O
2019	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
pneumonia	O
emerged	O
in	O
Wuhan	O
,	O
China	O
.	O

Implementation	O
of	O
a	O
robust	O
plan	O
in	O
the	O
radiology	O
department	O
is	O
required	O
to	O
prevent	O
further	O
transmission	O
of	O
the	O
virus	B-SPEC
to	O
patients	O
and	O
department	O
staff	O
members	O
.	O

We	O
performed	O
genetic	O
analyses	O
of	O
eighty	O
-	O
six	O
complete	O
or	O
near	O
-	O
complete	O
genomes	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
and	O
revealed	O
many	O
mutations	O
and	O
deletions	O
on	O
coding	O
and	O
non	O
-	O
coding	O
regions	O
.	O

The	O
speed	O
of	O
spread	O
and	O
infectivity	O
of	O
COVID	O
-	O
19	O
(	O
also	O
known	O
as	O
Wuhan	O
-	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
are	O
dramatically	O
exceeding	O
those	O
of	O
the	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
and	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
).	O

TITLE	O
:	O
Characteristics	O
of	O
and	O
Public	O
Health	O
Responses	O
to	O
the	O
Coronavirus	B-SPEC
Disease	O
2019	O
Outbreak	O
in	O
China	O
.	O

Long	O
-	O
acting	O
muscarinic	O
antagonists	O
and	O
β	O
Primary	O
human	B-SPEC
nasal	O
(	O
HNE	O
)	O
and	O
tracheal	O
(	O
HTE	O
)	O
epithelial	O
cell	O
cultures	O
were	O
infected	O
with	O
HCoV	B-SPEC
-	I-SPEC
229E	I-SPEC
.	O

TITLE	O
:	O
The	O
antiviral	O
compound	O
remdesivir	O
potently	O
inhibits	O
RNA	O
-	O
dependent	O
RNA	O
polymerase	O
from	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

Of	O
note	O
,	O
the	O
selectivity	O
value	O
for	O
RDV	B-SPEC
-	O
TP	O
obtained	O
here	O
with	O
a	O
steady	O
-	O
state	O
approach	O
suggests	O
that	O
it	O
is	O
more	O
efficiently	O
incorporated	O
than	O
ATP	O
and	O
two	O
other	O
nucleotide	O
analogues	O
.	O

TITLE	O
:	O
High	O
expression	O
of	O
ACE2	O
receptor	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
on	O
the	O
epithelial	O
cells	O
of	O
oral	O
mucosa	O
.	O

After	O
the	O
outbreak	O
of	O
this	O
disease	O
,	O
the	O
overwhelming	O
majority	O
of	O
cities	O
have	O
launched	O
the	O
""""	O
first	O
level	O
response	O
""""	O
and	O
the	O
regular	O
diagnosis	O
and	O
treatment	O
of	O
cancer	B-SPEC
patients	O
are	O
greatly	O
affected	O
.	O

The	O
digestive	O
systemic	O
cancer	B-SPEC
is	O
the	O
most	O
common	O
malignancy	O
.	O

TITLE	O
:	O
Emergence	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
:	O
Need	O
for	O
Rapid	O
Vaccine	O
and	O
Biologics	O
Development	O
.	O

This	O
virus	B-SPEC
is	O
responsible	O
for	O
the	O
ongoing	O
outbreak	O
that	O
causes	O
severe	O
respiratory	O
illness	O
and	O
pneumonia	O
-	O
like	O
infection	O
in	O
humans	B-SPEC
.	O

The	O
goal	O
of	O
this	O
work	O
is	O
to	O
systematically	O
review	O
and	O
compare	O
between	O
SARS	O
-	O
CoV	O
and	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
the	O
context	O
of	O
their	O
virus	B-SPEC
incubation	O
,	O
originations	O
,	O
diagnosis	O
and	O
treatment	O
methods	O
,	O
genomic	O
and	O
proteomic	O
sequences	O
,	O
and	O
pathogenic	O
mechanisms	O
.	O

According	O
to	O
""""	O
the	O
Diagnosis	O
and	O
Treatment	O
of	O
New	O
Coronavirus	B-SPEC
Pneumonia	O
"""("	O
6th	O
edition	O
)	O
of	O
the	O
National	O
Health	O
Commission	O
of	O
the	O
People	O
'	O
s	O
Republic	O
of	O
China	O
,	O
a	O
new	O
guideline	O
for	O
the	O
diagnosis	O
and	O
treatment	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
infection	O
suitable	O
for	O
the	O
military	O
(	O
first	O
trial	O
version	O
)	O
was	O
established	O
.	O

TITLE	O
:	O
Chest	O
Radiographic	O
and	O
CT	O
Findings	O
of	O
the	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
Disease	O
(	O
COVID	O
-	O
19	O
):	O
Analysis	O
of	O
Nine	O
Patients	O
Treated	O
in	O
Korea	O
.	O

ABSTRACT	O
:	O
This	O
study	O
presents	O
a	O
preliminary	O
report	O
on	O
the	O
chest	O
radiographic	O
and	O
computed	O
tomography	O
(	O
CT	O
)	O
findings	O
of	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
pneumonia	O
in	O
Korea	O
.	O

Fisher	B-SPEC
'	O
s	O
exact	O
test	O
was	O
used	O
to	O
compare	O
CT	O
findings	O
depending	O
on	O
the	O
shape	O
of	O
pulmonary	O
lesions	O
.	O

TITLE	O
:	O
Passengers	O
'	O
destinations	O
from	O
China	O
:	O
low	O
risk	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
transmission	O
into	O
Africa	O
and	O
South	O
America	O
.	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
is	O
spreading	O
rapidly	O
.	O

Cancer	B-SPEC
patients	O
are	O
more	O
susceptible	O
to	O
infection	O
and	O
tumor	O
history	O
is	O
defined	O
as	O
an	O
important	O
factor	O
of	O
poor	O
prognosis	O
,	O
which	O
challenges	O
both	O
doctors	O
and	O
patients	O
.	O

TITLE	O
:	O
The	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
resource	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
evolutionary	O
history	O
of	O
the	O
recent	O
outbreak	O
of	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
in	O
China	O
,	O
a	O
total	O
of	O
70	O
genomes	O
of	O
virus	B-SPEC
strains	O
from	O
China	O
and	O
elsewhere	O
with	O
sampling	O
dates	O
between	O
24	O
December	O
2019	O
and	O
3	O
February	O
2020	O
were	O
analyzed	O
.	O

ABSTRACT	O
:	O
Following	O
the	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
another	O
highly	O
pathogenic	O
coronavirus	B-SPEC
named	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
(	O
previously	O
known	O
as	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
emerged	O
in	O
December	O
2019	O
in	O
Wuhan	O
,	O
China	O
,	O
and	O
rapidly	O
spreads	O
around	O
the	O
world	O
.	O

This	O
virus	B-SPEC
shares	O
highly	O
homological	O
sequence	O
with	O
SARS	O
-	O
CoV	O
,	O
and	O
causes	O
acute	O
,	O
highly	O
lethal	O
pneumonia	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
with	O
clinical	O
symptoms	O
similar	O
to	O
those	O
reported	O
for	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
The	O
most	O
characteristic	O
symptom	O
of	O
patients	O
with	O
COVID	O
-	O
19	O
is	O
respiratory	O
distress	O
,	O
and	O
most	O
of	O
the	O
patients	O
admitted	O
to	O
the	O
intensive	O
care	O
could	O
not	O
breathe	O
spontaneously	O
.	O

There	O
is	O
an	O
urgent	O
need	O
for	O
an	O
accurate	O
and	O
rapid	O
test	O
method	O
to	O
quickly	O
identify	O
large	O
number	O
of	O
infected	O
patients	O
and	O
asymptomatic	O
carriers	O
to	O
prevent	O
virus	B-SPEC
transmission	O
and	O
assure	O
timely	O
treatment	O
of	O
patients	O
.	O

In	O
this	O
single	O
-	O
centered	O
,	O
retrospective	O
,	O
observational	O
study	O
,	O
we	O
enrolled	O
52	O
critically	O
ill	O
adult	O
patients	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
pneumonia	O
who	O
were	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
(	O
ICU	O
)	O
of	O
Wuhan	O
Jin	O
Yin	O
-	O
tan	O
hospital	O
(	O
Wuhan	O
,	O
China	O
)	O
between	O
late	O
December	O
,	O
2019	O
,	O
and	O
Jan	O
26	O
,	O
2020	O
.	O

The	O
mortality	O
of	O
critically	O
ill	O
patients	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
pneumonia	O
is	O
considerable	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
an	O
emerging	O
disease	O
with	O
a	O
rapid	O
increase	O
in	O
cases	O
and	O
deaths	O
since	O
its	O
first	O
identification	O
in	O
Wuhan	O
,	O
China	O
,	O
in	O
December	O
2019	O
.	O

ABSTRACT	O
:	O
An	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
caused	O
by	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
began	O
in	O
Wuhan	O
,	O
Hubei	O
Province	O
,	O
China	O
in	O
December	O
2019	O
,	O
and	O
has	O
spread	O
throughout	O
China	O
and	O
to	O
31	O
other	O
countries	O
and	O
territories	O
,	O
including	O
the	O
United	O
States	O
(	O
1	O
).	O

Interim	O
guidance	O
is	O
available	O
at	O
https	O
://	O
www	O
.	O
cdc	O
.	O
gov	O
/	O
coronavirus	B-SPEC
/	O
index	O
.	O
html	O
.	O

ABSTRACT	O
:	O
Fast	O
point	O
-	O
of	O
-	O
use	O
detection	O
of	O
,	O
for	O
example	O
,	O
early	O
-	O
stage	O
zoonoses	O
,	O
e	O
.	O
g	O
.,	O
Q	O
-	O
fever	O
,	O
bovine	B-SPEC
tuberculosis	O
,	O
or	O
the	O
Covid	O
-	O
19	O
coronavirus	B-SPEC
,	O
is	O
beneficial	O
for	O
both	O
humans	B-SPEC
and	O
animal	B-SPEC
husbandry	O
as	O
it	O
can	O
save	O
lives	O
and	O
livestock	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
Disease	O
2019	O
:	O
Coronaviruses	O
and	O
Blood	O
Safety	O
.	O

ABSTRACT	O
:	O
With	O
the	O
outbreak	O
of	O
unknown	O
pneumonia	O
in	O
Wuhan	O
,	O
China	O
,	O
in	O
December	O
2019	O
,	O
a	O
new	O
coronavirus	B-SPEC
,	O
Severe	B-SPEC
Acute	I-SPEC
Respiratory	I-SPEC
Syndrome	I-SPEC
Coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
aroused	O
the	O
attention	O
of	O
the	O
entire	O
world	O
.	O

All	O
the	O
included	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
-	O
infected	O
patients	O
underwent	O
non	O
-	O
contrast	O
enhanced	O
chest	O
computed	O
tomography	O
(	O
CT	O
).	O

SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
can	O
be	O
confirmed	O
based	O
on	O
the	O
patient	O
'	O
s	O
history	O
,	O
clinical	O
manifestations	O
,	O
imaging	O
characteristics	O
,	O
and	O
laboratory	O
tests	O
.	O

Chest	O
CT	O
examination	O
plays	O
an	O
important	O
role	O
in	O
the	O
initial	O
diagnosis	O
of	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
.	O

From	O
the	O
response	O
and	O
disposal	O
process	O
of	O
this	O
epidemic	O
,	O
it	O
is	O
exposed	O
that	O
fundamental	O
disease	O
prevention	O
and	O
control	O
system	O
are	O
insufficient	O
in	O
human	B-SPEC
resources	O
and	O
ability	O
of	O
laboratory	O
testing	O
.	O

TITLE	O
:	O
Clinical	O
characteristics	O
of	O
hospitalized	O
patients	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
:	O
A	O
single	O
arm	O
meta	B-SPEC
-	O
analysis	O
.	O

This	O
meta	B-SPEC
-	O
analysis	O
also	O
has	O
limitations	O
,	O
so	O
the	O
conclusions	O
of	O
this	O
Meta	B-SPEC
-	O
analysis	O
still	O
need	O
to	O
be	O
verified	O
by	O
more	O
relevant	O
studies	O
with	O
more	O
careful	O
design	O
,	O
more	O
rigorous	O
execution	O
,	O
and	O
larger	O
sample	O
size	O
.	O

CONCLUSIONS	O
:	O
Fever	O
and	O
cough	O
are	O
the	O
most	O
common	O
symptoms	O
in	O
patients	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
,	O
and	O
most	O
of	O
these	O
patients	O
have	O
abnormal	O
chest	O
CT	O
examination	O
.	O

TITLE	O
:	O
Development	O
of	O
epitope	O
-	O
based	O
peptide	O
vaccine	O
against	O
novel	B-SPEC
coronavirus	I-SPEC
2019	O
(	O
SARS	B-SPEC
-	I-SPEC
COV	I-SPEC
-	I-SPEC
2	I-SPEC
):	O
Immunoinformatics	O
approach	O
.	O

TITLE	O
:	O
[	O
Discussion	O
on	O
diagnosis	O
and	O
treatment	O
of	O
hepatobiliary	O
malignancies	O
during	O
the	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
].	O

On	O
January	O
20	O
,	O
2020	O
,	O
the	O
National	O
Health	O
Committee	O
classified	O
COVID	O
-	O
19	O
pneumonia	O
as	O
one	O
of	O
B	O
class	B-SPEC
infectious	O
diseases	O
and	O
treated	O
it	O
as	O
class	B-SPEC
A	O
infectious	O
disease	O
.	O

TITLE	O
:	O
Genome	O
Detective	O
Coronavirus	B-SPEC
Typing	O
Tool	O
for	O
rapid	O
identification	O
and	O
characterization	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
genomes	O
.	O

We	O
collect	O
daily	O
reported	O
cumulative	O
confirmed	O
cases	O
for	O
the	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
outbreak	O
for	O
each	O
Chinese	O
province	O
from	O
the	O
National	O
Health	O
Commission	O
of	O
China	O
.	O

TITLE	O
:	O
[	O
The	O
keypoints	O
in	O
treatment	O
of	O
the	O
critical	O
coronavirus	B-SPEC
disease	O
2019	O
patient	O
].	O

ABSTRACT	O
:	O
We	O
reported	O
two	O
cases	O
with	O
community	O
-	O
acquired	O
pneumonia	O
caused	O
by	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
who	O
returned	O
from	O
Wuhan	O
,	O
China	O
in	O
January	O
,	O
2020	O
.	O

Prolonged	O
virus	B-SPEC
shedding	O
is	O
observed	O
in	O
respiratory	O
tract	O
and	O
feces	O
at	O
the	O
convalescent	O
stage	O
.	O

ABSTRACT	O
:	O
A	O
well	O
6	O
-	O
month	O
-	O
old	O
infant	O
with	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
had	O
persistently	O
positive	O
nasopharyngeal	O
swabs	O
to	O
day	O
16	O
of	O
admission	O
.	O

In	O
this	O
study	O
,	O
we	O
performed	O
a	O
preliminary	O
risk	O
assessment	O
of	O
prioritization	O
measures	O
to	O
control	O
the	O
transmission	O
of	O
infection	O
from	O
camels	B-SPEC
to	O
humans	B-SPEC
.	O

TITLE	O
:	O
[	O
Medical	O
diagnosis	O
and	O
treatment	O
strategies	O
for	O
malignant	O
tumors	O
of	O
the	O
digestive	O
system	O
during	O
the	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
].	O

ABSTRACT	O
:	O
Since	O
the	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
in	O
December	O
2019	O
,	O
the	O
diagnosis	O
and	O
treatment	O
of	O
patients	O
with	O
cancer	B-SPEC
have	O
been	O
facing	O
great	O
challenges	O
.	O

TITLE	O
:	O
Clinical	O
characteristics	O
and	O
imaging	O
manifestations	O
of	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
):	O
A	O
multi	O
-	O
center	O
study	O
in	O
Wenzhou	O
city	O
,	O
Zhejiang	O
,	O
China	O
.	O

ABSTRACT	O
:	O
Several	O
recent	O
case	O
reports	O
have	O
described	O
common	O
early	O
chest	O
imaging	O
findings	O
of	O
lung	O
pathology	O
caused	O
by	O
2019	B-SPEC
novel	I-SPEC
Coronavirus	I-SPEC
(	O
SARS	O
-	O
COV2	O
)	O
which	O
appear	O
to	O
be	O
similar	O
to	O
those	O
seen	O
previously	O
in	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
infected	O
patients	O
.	O

ABSTRACT	O
:	O
In	O
this	O
study	O
we	O
execute	O
a	O
rational	O
screen	O
to	O
identify	O
Chinese	O
medical	O
herbs	O
that	O
are	O
commonly	O
used	O
in	O
treating	O
viral	O
respiratory	O
infections	O
and	O
also	O
contain	O
compounds	O
that	O
might	O
directly	O
inhibit	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
),	O
an	O
ongoing	O
novel	B-SPEC
coronavirus	I-SPEC
that	O
causes	O
pneumonia	O
.	O

In	O
the	O
first	O
step	O
we	O
conducted	O
a	O
literature	O
search	O
for	O
natural	O
compounds	O
that	O
had	O
been	O
biologically	O
confirmed	O
as	O
against	O
sever	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
or	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
.	O

These	O
three	O
different	O
kits	O
got	O
the	O
same	O
result	O
for	O
each	O
sample	O
and	O
the	O
positive	O
ratio	O
of	O
nucleic	O
acid	O
detection	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
was	O
only	O
47	O
.	O
4	O
%	O
in	O
the	O
suspect	O
patients	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
and	O
neonate	O
:	O
What	O
neonatologist	O
need	O
to	O
know	O
.	O

There	O
is	O
an	O
international	O
push	O
to	O
contain	O
the	O
virus	B-SPEC
and	O
prevent	O
its	O
spread	O
.	O

Formalin	O
fixation	O
and	O
heating	O
samples	O
to	O
56oC	O
,	O
as	O
used	O
in	O
routine	O
tissue	O
processing	O
,	O
were	O
found	O
to	O
inactivate	O
several	O
coronaviruses	O
and	O
it	O
is	O
believed	O
that	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
would	O
be	O
similarly	O
affected	O
.	O

The	O
evolution	O
of	O
flight	O
in	O
bats	B-SPEC
seem	O
to	O
have	O
selected	O
for	O
a	O
unique	O
set	O
of	O
antiviral	O
immune	O
responses	O
that	O
control	O
virus	B-SPEC
propagation	O
,	O
while	O
limiting	O
self	O
-	O
damaging	O
inflammatory	O
responses	O
.	O

Here	O
,	O
we	O
summarize	O
our	O
current	O
understanding	O
of	O
antiviral	O
immune	O
responses	O
in	O
bats	B-SPEC
and	O
discuss	O
their	O
ability	O
to	O
co	O
-	O
exist	O
with	O
emerging	O
viruses	B-SPEC
that	O
cause	O
serious	O
disease	O
in	O
other	O
mammals	B-SPEC
.	O

Mice	B-SPEC
were	O
then	O
placed	O
on	O
high	O
-	O
volume	O
MV	O
(	O
30	O
ml	O
/	O
kg	O
with	O
3	O
cmH	O

TITLE	O
:	O
Therapeutic	O
strategies	O
in	O
an	O
outbreak	O
scenario	O
to	O
treat	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
originating	O
in	O
Wuhan	O
,	O
China	O
.	O

Herein	O
,	O
I	O
review	O
the	O
potential	O
options	O
to	O
treat	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
in	O
patients	O
,	O
with	O
an	O
emphasis	O
on	O
the	O
necessity	O
for	O
speed	O
and	O
timeliness	O
in	O
developing	O
new	O
and	O
effective	O
therapies	O
in	O
this	O
outbreak	O
.	O

TITLE	O
:	O
Anti	O
-	O
HCV	B-SPEC
,	O
nucleotide	O
inhibitors	O
,	O
repurposing	O
against	O
COVID	O
-	O
19	O
.	O

TITLE	O
:	O
Outbreak	O
of	O
Novel	B-SPEC
Coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
Cov	I-SPEC
-	I-SPEC
2	I-SPEC
):	O

ABSTRACT	O
:	O
To	O
understand	O
the	O
time	O
-	O
dependent	O
risk	O
of	O
infection	O
on	O
a	O
cruise	O
ship	O
,	O
the	O
Diamond	O
Princess	O
,	O
I	O
estimated	O
the	O
incidence	O
of	O
infection	O
with	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
).	O

In	O
order	B-SPEC
to	O
minimise	O
cross	O
-	O
infection	O
of	O
COVID	O
-	O
19	O
,	O
a	O
triage	O
system	O
was	O
set	O
up	O
to	O
identify	O
patients	O
with	O
fever	O
,	O
respiratory	O
symptoms	O
,	O
acute	O
conjunctivitis	O
or	O
recent	O
travel	O
to	O
outbreak	O
areas	O
and	O
to	O
encourage	O
these	O
individuals	O
to	O
postpone	O
their	O
appointments	O
for	O
at	O
least	O
14	O
days	O
.	O

In	O
order	B-SPEC
to	O
minimise	O
transmission	O
of	O
COVID	O
-	O
19	O
,	O
ophthalmologists	O
should	O
work	O
closely	O
with	O
local	O
infection	O
control	O
teams	O
to	O
implement	O
infection	O
control	O
measures	O
that	O
are	O
appropriate	O
for	O
their	O
own	O
clinical	O
settings	O
.	O

TITLE	O
:	O
[	O
Analysis	O
on	O
the	O
epidemic	O
factors	O
for	O
the	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
].	O

Compared	O
with	O
the	O
general	O
population	O
,	O
they	O
are	O
more	O
likely	O
to	O
be	O
infected	O
with	O
the	O
new	O
coronavirus	B-SPEC
.	O

It	O
is	O
necessary	O
to	O
provide	O
more	O
appropriate	O
individualized	O
treatment	O
recommendations	O
for	O
patients	O
with	O
lung	O
cancer	B-SPEC
based	O
on	O
the	O
epidemic	O
situation	O
of	O
the	O
patient	O
'	O
s	O
location	O
and	O
in	O
combination	O
with	O
the	O
patient	O
'	O
s	O
own	O
condition	O
.	O

TITLE	O
:	O
Understanding	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
-	O
Mediated	O
Inflammatory	O
Responses	O
:	O
From	O
Mechanisms	O
to	O
Potential	O
Therapeutic	O
Tools	O
.	O

TITLE	O
:	O
Pretreatment	O
of	O
nafithromycin	O
attenuates	O
inflammatory	O
response	O
in	O
murine	B-SPEC
lipopolysaccharide	O
induced	O
acute	O
lung	O
injury	O
.	O

TITLE	O
:	O
Early	O
transmission	O
patterns	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
in	O
travellers	O
from	O
Wuhan	O
to	O
Thailand	O
,	O
January	O
2020	O
.	O

The	O
natural	O
host	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
may	O
be	O
the	O
bat	B-SPEC
Rhinolophus	B-SPEC
affinis	I-SPEC
as	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
showed	O
96	O
.	O
2	O
%	O
of	O
whole	O
-	O
genome	O
identity	O
to	O
BatCoV	O
RaTG13	O
.	O

2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
can	O
also	O
be	O
transmitted	O
through	O
the	O
saliva	O
,	O
and	O
the	O
fetal	O
-	O
oral	O
routes	O
may	O
also	O
be	O
a	O
potential	O
person	O
-	O
to	O
-	O
person	O
transmission	O
route	O
.	O

Dental	O
professionals	O
play	O
great	O
roles	O
in	O
preventing	O
the	O
transmission	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
Here	O
we	O
recommend	O
the	O
infection	O
control	O
measures	O
during	O
dental	O
practice	O
to	O
block	O
the	O
person	O
-	O
to	O
-	O
person	O
transmission	O
routes	O
in	O
dental	O
clinics	O
and	O
hospitals	O
.	O

A	O
tentative	O
suggestion	O
based	O
on	O
existing	O
therapeutics	O
,	O
which	O
would	O
likely	O
be	O
resistant	O
to	O
new	O
coronavirus	B-SPEC
mutations	O
,	O
is	O
to	O
use	O
available	O
angiotensin	O
receptor	O
1	O
(	O
AT1R	O
)	O
blockers	O
,	O
such	O
as	O
losartan	O
,	O
as	O
therapeutics	O
for	O
reducing	O
the	O
aggressiveness	O
and	O
mortality	O
from	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
virus	B-SPEC
infections	O
.	O

TITLE	O
:	O
Genomic	O
diversity	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
in	O
Coronavirus	B-SPEC
Disease	O
2019	O
patients	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
has	O
infected	O
more	O
than	O
75	O
,	O
000	O
individuals	O
and	O
spread	O
to	O
over	O
20	O
countries	O
.	O

Thus	O
,	O
NK	O
cells	O
represent	O
a	O
promising	O
strategy	O
for	O
adoptive	O
immunotherapy	O
of	O
cancer	B-SPEC
already	O
tested	O
in	O
phase	O
1	O
/	O
2	O
clinical	O
trials	O
.	O

The	O
main	O
idea	B-SPEC
of	O
the	O
proposed	O
model	O
,	O
called	O
FPASSA	O
-	O
ANFIS	O
,	O
is	O
to	O
improve	O
the	O
performance	O
of	O
ANFIS	O
by	O
determining	O
the	O
parameters	O
of	O
ANFIS	O
using	O
FPASSA	O
.	O

ABSTRACT	O
:	O
To	O
describe	O
the	O
infection	O
control	O
preparedness	O
for	O
Coronavirus	B-SPEC
Disease	O
(	O
COVID	O
-	O
19	O
)	O
due	O
to	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
[	O
previously	O
known	O
as	O
2019	O
-	O
novel	B-SPEC
coronavirus	I-SPEC
]	O
in	O
the	O
first	O
42	O
days	O
after	O
announcement	O
of	O
a	O
cluster	O
of	O
pneumonia	O
in	O
China	O
,	O
on	O
31	O
December	O
2019	O
(	O
day	O
1	O
)	O
in	O
Hong	O
Kong	O
.	O

Appropriate	O
hospital	O
infection	O
control	O
measures	O
could	O
prevent	O
nosocomial	O
transmission	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

ABSTRACT	O
:	O
Angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
is	O
the	O
cellular	O
receptor	O
for	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
and	O
the	O
new	O
coronavirus	B-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
that	O
is	O
causing	O
the	O
serious	O
epidemic	O
COVID	O
-	O
19	O
.	O

TITLE	O
:	O
Multicenter	O
Evaluation	O
of	O
the	O
QIAstat	O
-	O
Dx	O
Respiratory	O
Panel	O
for	O
the	O
Detection	O
of	O
Viruses	B-SPEC
and	O
Bacteria	B-SPEC
in	O
Nasopharyngeal	O
Swab	O
Specimens	O
.	O

In	O
this	O
observational	O
study	O
,	O
airway	O
secretions	O
from	O
children	O
(	O
n	O
=	O
104	O
)	O
with	O
CF	O
presenting	O
with	O
pulmonary	O
exacerbations	O
were	O
collected	O
and	O
tested	O
for	O
bacteria	B-SPEC
,	O
fungi	B-SPEC
,	O
mycobacteria	B-SPEC
and	O
viral	O
pathogens	O
using	O
appropriate	O
laboratory	O
techniques	O
.	O

The	O
disease	O
condition	O
associated	O
with	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
referred	O
to	O
as	O
Coronavirus	B-SPEC
disease	O
(	O
COVID	O
-	O
19	O
).	O

The	O
infant	O
was	O
negative	O
for	O
severe	O
acute	O
respiratory	O
coronavirus	B-SPEC
2	O
.	O

This	O
case	O
suggests	O
that	O
mother	O
-	O
to	O
-	O
child	O
transmission	O
is	O
unlikely	O
for	O
this	O
virus	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
late	O
December	O
2019	O
,	O
a	O
previous	O
unidentified	O
coronavirus	B-SPEC
,	O
currently	O
named	O
as	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
#,	O
emerged	O
from	O
Wuhan	O
,	O
China	O
,	O
and	O
resulted	O
in	O
a	O
formidable	O
outbreak	O
in	O
many	O
cities	O
in	O
China	O
and	O
expanded	O
globally	O
,	O
including	O
Thailand	O
,	O
Republic	O
of	O
Korea	O
,	O
Japan	O
,	O
United	O
States	O
,	O
Philippines	O
,	O
Viet	O
Nam	O
,	O
and	O
our	O
country	O
(	O
as	O
of	O
2	O
/	O
6	O
/	O
2020	O
at	O
least	O
25	O
countries	O
).	O

ABSTRACT	O
:	O
Within	O
last	O
17	O
years	O
two	O
widespread	O
epidemics	O
of	O
severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)	O
occurred	O
in	O
China	O
,	O
which	O
were	O
caused	O
by	O
related	O
coronaviruses	O
(	O
CoVs	O
):	O
SARS	O
-	O
CoV	O
and	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

TITLE	O
:	O
Novel	B-SPEC
coronavirus	I-SPEC
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
:	O
prevalence	O
,	O
biological	O
and	O
clinical	O
characteristics	O
comparison	O
with	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
ABSTRACT	O
:	O
Human	B-SPEC
infections	O
with	O
zoonotic	O
coronavirus	B-SPEC
contain	O
emerging	O
and	O
reemerging	O
pathogenic	O
characteristics	O
which	O
have	O
raised	O
great	O
public	O
health	O
concern	O
.	O

The	O
data	O
on	O
the	O
global	O
outbreak	O
of	O
""""	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
SARS	O
-	O
CoV	O
,	O
and	O
MERS	O
-	O
CoV	O
""""	O
were	O
obtained	O
from	O
World	O
Health	O
Organization	O
(	O
WHO	O
),	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
(	O
CDC	O
),	O
concerned	O
ministries	O
and	O
research	O
institutes	O
.	O

However	O
,	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
spread	O
swiftly	O
the	O
global	O
borders	O
of	O
27	O
countries	O
.	O

The	O
detection	O
of	O
this	O
new	O
virus	B-SPEC
in	O
humans	B-SPEC
without	O
knowing	O
the	O
source	O
of	O
the	O
infection	O
has	O
raised	O
greatly	O
heightened	O
concerns	O
not	O
only	O
in	O
China	O
,	O
but	O
also	O
internationally	O
.	O

By	O
simulation	O
and	O
data	O
fitting	O
,	O
the	O
model	O
showed	O
the	O
peak	O
existing	O
confirmed	O
cases	O
of	O
59	O
769	O
arriving	O
on	O
15	O
February	O
2020	O
,	O
with	O
the	O
coefficient	O
of	O
determination	O
close	O
to	O
1	O
and	O
the	O
fitting	O
bias	B-SPEC
3	O
.	O
02	O
%,	O
suggesting	O
high	O
precision	O
of	O
the	O
data	O
-	O
fitting	O
results	O
.	O

We	O
sought	O
to	O
characterize	O
the	O
relationship	O
of	O
the	O
translated	O
proteins	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
with	O
other	O
species	B-SPEC
of	O
Orthocoronavirinae	O
.	O

Two	O
of	O
six	O
Clade	O
2	O
nonstructural	O
proteins	O
,	O
NS7b	O
and	O
NS8	O
,	O
were	O
exclusively	O
conserved	O
among	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
BetaCoV_RaTG	O
,	O
and	O
BatSARS	O
-	O
like	O
Cov	O
.	O

TITLE	O
:	O
Insights	O
into	O
the	O
Recent	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
in	O
Light	O
of	O
Past	O
Human	B-SPEC
Coronavirus	I-SPEC
Outbreaks	O
.	O

ABSTRACT	O
:	O
After	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
outbreak	O
,	O
we	O
estimated	O
the	O
distribution	O
and	O
scale	O
of	O
more	O
than	O
5	O
million	O
migrants	O
residing	O
in	O
Wuhan	O
after	O
they	O
returned	O
to	O
their	O
hometown	O
communities	O
in	O
Hubei	O
Province	O
or	O
other	O
provinces	O
at	O
the	O
end	O
of	O
2019	O
by	O
using	O
the	O
data	O
from	O
the	O
2013	O
-	O
2018	O
China	O
Migrants	O
Dynamic	O
Survey	O
(	O
CMDS	O
).	O

Seemingly	O
healthy	O
imported	O
camels	B-SPEC
are	O
responsible	O
for	O
the	O
ingress	O
of	O
serious	O
diseases	O
into	O
Egypt	O
.	O

Semi	O
-	O
quantitative	O
anti	O
-	O
MERS	O
-	O
CoV	O
IgG	O
ELISAs	O
which	O
utilize	O
the	O
purified	O
spike	O
protein	O
domain	O
S1	O
antigen	O
of	O
MERS	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
S1	O
)	O
were	O
used	O
to	O
detect	O
specific	O
IgG	O
antibodies	O
against	O
the	O
virus	B-SPEC
.	O

Having	O
specific	O
antibodies	O
among	O
the	O
examined	O
camel	B-SPEC
sera	O
was	O
significantly	O
different	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
in	O
relation	O
to	O
various	O
sampling	O
localities	O
,	O
gender	O
and	O
age	O
groups	O
.	O

ABSTRACT	O
:	O
The	O
novel	B-SPEC
coronavirus	I-SPEC
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
first	O
appeared	O
in	O
December	O
2019	O
in	O
Wuhan	O
,	O
China	O
.	O

Several	O
drugs	O
such	O
as	O
chloroquine	O
,	O
arbidol	O
,	O
remdesivir	O
,	O
and	O
favipiravir	O
are	O
currently	O
undergoing	O
clinical	O
studies	O
to	O
test	O
their	O
efficacy	O
and	O
safety	O
in	O
the	O
treatment	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
in	O
China	O
;	O
some	O
promising	O
results	O
have	O
been	O
achieved	O
thus	O
far	O
.	O

A	O
60	O
-	O
year	O
-	O
old	O
nonalcoholic	O
man	B-SPEC
,	O
with	O
normal	O
baseline	O
liver	O
function	O
tests	O
,	O
was	O
admitted	O
with	O
diffuse	O
abdominal	O
pain	O
and	O
AST	O
=	O
499	O
U	O
/	O
L	O
and	O
ALT	O
=	O
539	O
U	O
/	O
L	O
,	O
six	O
days	O
after	O
completing	O
a	O
7	O
-	O
day	O
course	O
of	O
clarithromycin	O
500	O
mg	O
twice	O
daily	O
for	O
suspected	O
upper	O
respiratory	O
infection	O
.	O

TITLE	O
:	O
Early	O
Epidemiological	O
and	O
Clinical	O
Characteristics	O
of	O
28	O
Cases	O
of	O
Coronavirus	B-SPEC
Disease	O
in	O
South	O
Korea	O
.	O

ABSTRACT	O
:	O
The	O
current	O
corona	B-SPEC
virus	B-SPEC
disease	O
2019	O
outbreak	O
caused	O
by	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
started	O
in	O
Wuhan	O
,	O
China	O
in	O
December	O
2019	O
and	O
has	O
put	O
the	O
world	O
on	O
alert	O
.	O

The	O
spike	O
protein	O
of	O
coronavirus	B-SPEC
GX_P2V	O
shares	O
92	O
.	O
2	O
%	O
amino	O
acid	O
identity	O
with	O
that	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
isolate	O
Wuhan	O
-	O
hu	O
-	O
1	O
,	O
and	O
uses	O
ACE2	O
as	O
the	O
receptor	O
for	O
infection	O
just	O
like	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
Three	O
drugs	O
-	O
cepharanthine	O
(	O
CEP	O
),	O
selamectin	O
and	O
mefloquine	O
hydrochloride	O
exhibited	O
complete	O
inhibition	O
of	O
cytopathic	O
effects	O
in	O
cell	O
culture	O
at	O
10	O
μmol	O
/	O
L	O
.	O
CEP	O
demonstrated	O
the	O
most	O
potent	O
inhibition	O
of	O
GX_P2V	O
infection	O
,	O
with	O
a	O
concentration	O
for	O
50	O
%	O
of	O
maximal	O
effect	O
[	O
EC50	O
]	O
of	O
0	O
.	O
98	O
μmol	O
/	O
L	O
.	O
The	O
viral	O
RNA	O
yield	O
in	O
cells	O
treated	O
with	O
10	O
μmol	O
/	O
L	O
CEP	O
was	O
15	O
,	O
393	O
-	O
fold	O
lower	O
than	O
in	O
cells	O
without	O
CEP	O
treatment	O
([	O
6	O
.	O
48	O
±	O
0	O
.	O
02	O
]	O
×	O
10vs	O
.	O

Our	O
pangolin	O
coronavirus	B-SPEC
GX_P2V	O
is	O
a	O
workable	O
model	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
research	O
.	O

CEP	O
,	O
selamectin	O
and	O
mefloquine	O
hydrochloride	O
are	O
potential	O
drugs	O
for	O
treating	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
.	O

Our	O
results	O
strongly	O
suggest	O
that	O
CEP	O
is	O
a	O
wide	O
-	O
spectrum	O
inhibitor	O
of	O
pan	B-SPEC
-	O
betacoronavirus	B-SPEC
,	O
and	O
clinical	O
trial	O
of	O
CEP	O
for	O
treatment	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
is	O
warranted	O
.	O

ABSTRACT	O
:	O
At	O
the	O
end	O
of	O
2019	O
,	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
outbreak	O
emerged	O
in	O
Wuhan	O
,	O
China	O
,	O
and	O
its	O
causative	O
organism	O
has	O
been	O
subsequently	O
designated	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
).	O

Patients	O
who	O
become	O
infected	O
with	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
may	O
initially	O
develop	O
mild	O
upper	O
respiratory	O
tract	O
symptoms	O
.	O

However	O
,	O
there	O
remains	O
no	O
definitive	O
evidence	O
in	O
the	O
literature	O
for	O
or	O
against	O
the	O
utilization	O
of	O
systemic	O
glucocorticoids	O
in	O
seriously	O
ill	O
patients	O
with	O
coronavirus	B-SPEC
-	O
related	O
severe	O
respiratory	O
disease	O
,	O
or	O
indeed	O
in	O
other	O
types	O
of	O
severe	O
respiratory	O
disease	O
.	O

This	O
new	O
virus	B-SPEC
seems	O
to	O
be	O
very	O
contagious	O
and	O
has	O
quickly	O
spread	O
globally	O
.	O

In	O
a	O
meeting	O
on	O
January	O
30	O
,	O
2020	O
,	O
per	O
the	O
International	O
Health	O
Regulations	O
(	O
IHR	O
,	O
2005	O
),	O
the	O
outbreak	O
was	O
declared	O
by	O
the	O
WHO	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
(	O
PHEIC	O
)	O
as	O
it	O
had	O
spread	O
to	O
18	O
countries	O
with	O
four	O
countries	O
reporting	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
.	O

Initially	O
,	O
the	O
new	O
virus	B-SPEC
was	O
called	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
Subsequently	O
,	O
the	O
task	O
of	O
experts	O
of	O
the	O
International	O
Committee	O
on	O
Taxonomy	O
of	O
Viruses	B-SPEC
(	O
ICTV	O
)	O
termed	O
it	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
virus	B-SPEC
as	O
it	O
is	O
very	O
similar	O
to	O
the	O
one	O
that	O
caused	O
the	O
SARS	O
outbreak	O
(	O
SARS	O
-	O
CoVs	O
).	O

They	O
are	O
a	O
large	O
family	B-SPEC
of	O
single	O
-	O
stranded	O
RNA	O
viruses	B-SPEC
(+	O
ssRNA	O
)	O
that	O
can	O
be	O
isolated	O
in	O
different	O
animal	B-SPEC
species	B-SPEC
.[	O
1	O
]	O
For	O
reasons	O
yet	O
to	O
be	O
explained	O
,	O
these	O
viruses	B-SPEC
can	O
cross	O
species	B-SPEC
barriers	O
and	O
can	O
cause	O
,	O
in	O
humans	B-SPEC
,	O
illness	O
ranging	O
from	O
the	O
common	O
cold	O
to	O
more	O
severe	O
diseases	O
such	O
as	O
MERS	O
and	O
SARS	O
.	O

ABSTRACT	O
:	O
We	O
report	O
an	O
asymptomatic	O
child	O
who	O
was	O
positive	O
for	O
a	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
by	O
reverse	O
transcription	O
PCR	O
in	O
a	O
stool	O
specimen	O
17	O
days	O
after	O
the	O
last	O
virus	B-SPEC
exposure	O
.	O

TITLE	O
:	O
Serologic	O
Detection	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
Functional	O
Antibodies	O
.	O

ABSTRACT	O
:	O
We	O
developed	O
and	O
validated	O
2	O
species	B-SPEC
-	O
independent	O
protein	O
-	O
based	O
assays	O
to	O
detect	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
functional	O
antibodies	O
that	O
can	O
block	O
virus	B-SPEC
receptor	O
-	O
binding	O
or	O
sialic	O
acid	O
-	O
attachment	O
.	O

Antibody	O
levels	O
measured	O
in	O
both	O
assays	O
correlated	O
strongly	O
with	O
virus	B-SPEC
-	O
neutralizing	O
antibody	O
titers	O
,	O
proving	O
their	O
use	O
for	O
serologic	O
confirmatory	O
diagnosis	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
.	O

TITLE	O
:	O
Structure	O
of	O
mouse	B-SPEC
coronavirus	B-SPEC
spike	O
protein	O
complexed	O
with	O
receptor	O
reveals	O
mechanism	O
for	O
viral	O
entry	O
.	O

ABSTRACT	O
:	O
The	O
Severe	B-SPEC
Acute	I-SPEC
Respiratory	I-SPEC
Syndrome	I-SPEC
Coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
first	O
broke	O
out	O
in	O
Wuhan	O
(	O
China	O
)	O
and	O
subsequently	O
spread	O
worldwide	O
.	O

We	O
propose	O
that	O
the	O
immunomodulatory	O
effect	O
of	O
hydroxychloroquine	O
also	O
may	O
be	O
useful	O
in	O
controlling	O
the	O
cytokine	O
storm	O
that	O
occurs	O
late	O
-	O
phase	O
in	O
critically	O
ill	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infected	O
patients	O
.	O

Based	O
on	O
PBPK	O
models	O
results	O
,	O
a	O
loading	O
dose	O
of	O
400	O
mg	O
twice	O
daily	O
of	O
hydroxychloroquine	O
sulfate	O
given	O
orally	O
,	O
followed	O
by	O
a	O
maintenance	O
dose	O
of	O
200	O
mg	O
given	O
twice	O
daily	O
for	O
4	O
days	O
is	O
recommended	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
,	O
as	O
it	O
reached	O
three	O
times	O
the	O
potency	O
of	O
chloroquine	O
phosphate	O
when	O
given	O
500	O
mg	O
twice	O
daily	O
5	O
days	O
in	O
advance	O
.	O

TITLE	O
:	O
The	O
Incubation	O
Period	O
of	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
From	O
Publicly	O
Reported	O
Confirmed	O
Cases	O
:	O
Estimation	O
and	O
Application	O
.	O

Amniotic	O
fluid	O
,	O
cord	O
blood	O
,	O
neonatal	O
throat	O
swab	O
,	O
and	O
breastmilk	O
samples	O
from	O
six	O
patients	O
were	O
tested	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
and	O
all	O
samples	O
tested	O
negative	O
for	O
the	O
virus	B-SPEC
.	O

TITLE	O
:	O
[	O
The	O
differential	O
diagnosis	O
for	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
and	O
similar	O
lung	O
diseases	O
in	O
general	O
hospitals	O
].	O

The	O
diagnosis	O
and	O
differential	O
diagnosis	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
pneumonia	O
was	O
facing	O
challenges	O
not	O
only	O
because	O
of	O
large	O
number	O
of	O
tourists	O
increasing	O
dramatically	O
after	O
the	O
relieving	O
of	O
epidemic	O
,	O
but	O
also	O
patients	O
with	O
other	O
diseases	O
return	O
from	O
different	O
areas	O
to	O
search	O
for	O
medical	O
care	O
.	O

Thus	O
,	O
exploration	O
of	O
the	O
virus	B-SPEC
-	O
miRNA	O
interactions	O
occurring	O
in	O
PHEV	O
-	O
infected	O
host	O
may	O
lead	O
to	O
the	O
identification	O
of	O
novel	O
mechanisms	O
combating	O
the	O
virus	B-SPEC
life	O
cycle	O
or	O
pathogenesis	O
.	O

The	O
clinical	O
features	O
and	O
outcomes	O
of	O
10	O
neonates	O
(	O
including	O
2	O
twins	O
)	O
born	O
to	O
9	O
mothers	O
with	O
confirmed	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
in	O
5	O
hospitals	O
from	O
January	O
20	O
to	O
February	O
5	O
,	O
2020	O
were	O
retrospectively	O
analyzed	O
.	O

Perinatal	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
may	O
have	O
adverse	O
effects	O
on	O
newborns	O
,	O
causing	O
problems	O
such	O
as	O
fetal	O
distress	O
,	O
premature	O
labor	O
,	O
respiratory	O
distress	O
,	O
thrombocytopenia	O
accompanied	O
by	O
abnormal	O
liver	O
function	O
,	O
and	O
even	O
death	O
.	O

Due	O
to	O
the	O
immature	O
immune	O
system	O
and	O
the	O
possibility	O
of	O
vertical	O
transmission	O
from	O
mother	O
to	O
infant	O
,	O
neonates	O
have	O
become	O
a	O
high	O
-	O
risk	O
group	O
susceptible	O
to	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
which	O
emphasize	O
a	O
close	O
cooperation	O
from	O
both	O
perinatal	O
and	O
neonatal	O
pediatrics	O
.	O

TITLE	O
:	O
Evaluation	O
of	O
a	O
quantitative	O
RT	O
-	O
PCR	O
assay	O
for	O
the	O
detection	O
of	O
the	O
emerging	O
coronavirus	B-SPEC
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
using	O
a	O
high	O
throughput	O
system	O
.	O

ABSTRACT	O
:	O
The	O
need	O
for	O
timely	O
establishment	O
of	O
diagnostic	O
assays	O
arose	O
when	O
Germany	O
was	O
confronted	O
with	O
the	O
first	O
travel	O
-	O
associated	O
outbreak	O
of	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
in	O
Europe	O
.	O

4880	O
cases	O
that	O
had	O
respiratory	O
infection	O
symptoms	O
or	O
close	O
contact	O
with	O
COVID	O
-	O
19	O
patients	O
in	O
hospital	O
in	O
Wuhan	O
,	O
China	O
,	O
were	O
tested	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
by	O
use	O
of	O
quantitative	O
RT	O
-	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
on	O
samples	O
from	O
the	O
respiratory	O
tract	O
.	O

The	O
currently	O
available	O
literature	O
was	O
reviewed	O
for	O
microbiologically	O
confirmed	O
infections	O
by	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
or	O
COVID	O
-	O
19	O
at	O
the	O
time	O
of	O
writing	O
(	O
13	O
February	O
2020	O
).	O

The	O
still	O
unmet	O
therapeutic	O
need	O
in	O
many	O
cancers	O
,	O
inflammatory	O
diseases	O
or	O
emerging	O
infections	O
such	O
as	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
requires	O
increased	O
effort	O
on	O
the	O
development	O
of	O
improved	O
and	O
novel	O
mAbs	O
.	O

ABSTRACT	O
:	O
Severe	O
acute	O
respiratory	O
syndrome	O
(	O
SARS	O
)-	O
like	O
coronavirus	B-SPEC
sequences	O
were	O
identified	O
in	O
two	O
separate	O
complementary	O
DNA	O
(	O
cDNA	O
)	O
pools	O
.	O

The	O
first	O
pool	O
was	O
from	O
a	O
Carassius	B-SPEC
auratus	I-SPEC
(	O
crusian	O
carp	B-SPEC
)	O
cell	O
line	O
and	O
the	O
second	O
was	O
from	O
Ctenopharyngodon	B-SPEC
idella	I-SPEC
(	O
grass	B-SPEC
carp	I-SPEC
)	O
head	O
kidney	O
tissue	O
.	O

ABSTRACT	O
:	O
We	O
report	O
co	O
-	O
infection	O
with	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
and	O
influenza	B-SPEC
A	I-SPEC
virus	I-SPEC
in	O
a	O
patient	O
with	O
pneumonia	O
in	O
China	O
.	O

We	O
found	O
that	O
the	O
virus	B-SPEC
replicates	O
to	O
high	O
titer	O
in	O
Vero	O
-	O
CCL81	O
cells	O
and	O
Vero	O
E6	O
cells	O
in	O
the	O
absence	O
of	O
trypsin	O
.	O

TITLE	O
:	O
Zoonotic	O
implications	O
of	O
camel	B-SPEC
diseases	O
in	O
Iran	O
.	O

Results	O
show	O
that	O
camels	B-SPEC
are	O
one	O
of	O
the	O
most	O
important	O
sources	O
of	O
infections	O
and	O
diseases	O
in	O
human	B-SPEC
;	O
therefore	O
,	O
continuous	O
monitoring	O
and	O
inspection	O
programs	O
are	O
necessary	O
to	O
prevent	O
the	O
outbreak	O
of	O
zoonotic	O
diseases	O
caused	O
by	O
this	O
animal	B-SPEC
in	O
humans	B-SPEC
.	O

Viruses	B-SPEC
are	O
major	O
causes	O
of	O
acute	O
respiratory	O
infections	O
among	O
children	O
.	O

This	O
paper	O
offers	O
pointers	O
to	O
,	O
and	O
describes	O
,	O
a	O
range	O
of	O
practical	O
online	O
/	O
mobile	O
GIS	O
and	O
mapping	O
dashboards	O
and	O
applications	O
for	O
tracking	O
the	O
2019	O
/	O
2020	O
coronavirus	B-SPEC
epidemic	O
and	O
associated	O
events	O
as	O
they	O
unfold	O
around	O
the	O
world	O
.	O

Given	O
the	O
current	O
growing	O
spread	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
around	O
the	O
world	O
,	O
it	O
is	O
imperative	O
that	O
businesses	O
review	O
their	O
pandemic	O
plans	O
and	O
be	O
prepared	O
in	O
case	O
this	O
epidemic	O
expands	O
and	O
affects	O
more	O
people	O
and	O
communities	O
.	O

TITLE	O
:	O
The	O
emergence	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
their	O
biology	O
and	O
therapeutic	O
options	O
.	O

All	O
patients	O
had	O
a	O
history	O
of	O
exposure	O
to	O
confirmed	O
case	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
or	O
travel	O
to	O
Hubei	O
before	O
illness	O
.	O

The	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
infection	O
caused	O
similar	O
onsets	O
to	O
other	O
pneumonias	O
.	O

A	O
meta	B-SPEC
-	O
analysis	O
of	O
eligible	O
studies	O
that	O
summarized	O
the	O
prevalence	O
of	O
cardiovascular	O
metabolic	O
diseases	O
in	O
COVID	O
-	O
19	O
and	O
compared	O
the	O
incidences	O
of	O
the	O
comorbidities	O
in	O
ICU	O
/	O
severe	O
and	O
non	O
-	O
ICU	O
/	O
severe	O
patients	O
was	O
performed	O
.	O

ABSTRACT	O
:	O
The	O
recently	O
emerged	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
and	O
associated	O
COVID	O
-	O
19	O
disease	O
cause	O
serious	O
or	O
even	O
fatal	O
respiratory	O
tract	O
infection	O
and	O
yet	O
no	O
approved	O
therapeutics	O
or	O
effective	O
treatment	O
is	O
currently	O
available	O
to	O
effectively	O
combat	O
the	O
outbreak	O
.	O

This	O
urgent	O
situation	O
is	O
pressing	O
the	O
world	O
to	O
respond	O
with	O
the	O
development	O
of	O
novel	O
vaccine	O
or	O
a	O
small	O
molecule	O
therapeutics	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

Although	O
the	O
efficacy	O
of	O
AHCC	O
has	O
not	O
yet	O
been	O
specifically	O
evaluated	O
with	O
respect	O
to	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
disease	O
,	O
its	O
action	O
in	O
promoting	O
a	O
protective	O
response	O
to	O
a	O
wide	O
range	O
of	O
viral	O
infections	O
,	O
and	O
the	O
current	O
absence	O
of	O
effective	O
vaccines	O
,	O
could	O
support	O
its	O
use	O
in	O
the	O
prevention	O
of	O
diseases	O
provoked	O
by	O
human	B-SPEC
pathogenic	O
coronavirus	B-SPEC
,	O
including	O
COVID	O
-	O
19	O
.	O

Data	O
indicated	O
that	O
indirect	O
transmission	O
of	O
the	O
causative	O
virus	B-SPEC
occurred	O
,	O
perhaps	O
resulting	O
from	O
virus	B-SPEC
contamination	O
of	O
common	O
objects	O
,	O
virus	B-SPEC
aerosolization	O
in	O
a	O
confined	O
space	O
,	O
or	O
spread	O
from	O
asymptomatic	O
infected	O
persons	O
.	O

TITLE	O
:	O
Circulation	O
of	O
pantropic	O
canine	O
coronavirus	B-SPEC
in	O
autochthonous	O
and	O
imported	O
dogs	B-SPEC
,	O
Italy	O
.	O

Samples	O
from	O
the	O
gut	O
and	O
internal	O
organs	O
of	O
352	O
dogs	B-SPEC
were	O
screened	O
for	O
CCoV	O
;	O
putative	O
pCCoV	O
strains	O
,	O
belonging	O
to	O
subtype	O
CCoV	O
-	O
IIa	O
,	O
were	O
identified	O
in	O
the	O
internal	O
organs	O
of	O
35	O
of	O
the	O
examined	O
dogs	B-SPEC
.	O

ABSTRACT	O
:	O
In	O
December	O
2019	O
,	O
the	O
outbreak	O
of	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
)	O
in	O
Wuhan	O
,	O
China	O
,	O
attracting	O
attention	O
worldwidely	O
.	O

Drugs	O
are	O
possibly	O
effective	O
for	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
include	O
:	O
remdesivir	O
,	O
lopinavir	O
/	O
ritonavir	O
,	O
lopinavir	O
/	O
ritonavir	O
combined	O
with	O
interferon	O
-	O
β	O
,	O
convalescent	O
plasma	O
,	O
and	O
monoclonal	O
antibodies	O
.	O

ABSTRACT	O
:	O
A	O
complete	O
genome	O
sequence	O
was	O
obtained	O
for	O
a	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
strain	O
isolated	O
from	O
an	O
oropharyngeal	O
swab	O
specimen	O
of	O
a	O
Nepalese	O
patient	O
with	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
who	O
had	O
returned	O
to	O
Nepal	O
after	O
traveling	O
to	O
Wuhan	O
,	O
China	O
.	O

ABSTRACT	O
:	O
To	O
identify	O
recommendations	O
from	O
family	B-SPEC
physicians	O
in	O
Canada	O
on	O
how	O
public	O
health	O
agencies	O
and	O
professional	O
organizations	O
might	O
improve	O
future	O
crisis	O
and	O
emergency	O
risk	O
communications	O
.	O

Sixteen	O
family	B-SPEC
physicians	O
who	O
have	O
experienced	O
a	O
public	O
health	O
crisis	O
.	O

PICU	B-SPEC
.	O

The	O
virus	B-SPEC
spreads	O
faster	O
than	O
its	O
two	O
ancestors	O
the	O
SARS	O
-	O
CoV	O
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
),	O
but	O
has	O
lower	O
fatality	O
.	O

TITLE	O
:	O
An	O
exclusive	O
42	O
amino	O
acid	O
signature	O
in	O
pp1ab	O
protein	O
provides	O
insights	O
into	O
the	O
evolutive	O
history	O
of	O
the	O
2019	O
novel	O
human	B-SPEC
-	O
pathogenic	O
coronavirus	B-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

While	O
comparing	O
pp1ab	O
protein	O
with	O
other	O
betacoronaviruses	O
,	O
we	O
found	O
a	O
42	O
amino	O
acid	O
signature	O
that	O
is	O
only	O
present	O
in	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
(	O
AS	O
-	O
SCoV2	O
).	O

ABSTRACT	O
:	O
An	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
occurred	O
in	O
Wuhan	O
and	O
it	O
has	O
rapidly	O
spread	O
to	O
almost	O
all	O
parts	O
of	O
the	O
world	O
.	O

To	O
confirm	O
the	O
result	O
,	O
we	O
discovered	O
that	O
theaflavin	O
has	O
lower	O
binding	O
energy	O
of	O
-	O
8	O
.	O
8	O
kcal	O
/	O
mol	O
when	O
it	O
docks	O
in	O
the	O
catalytic	O
pocket	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
RdRp	O
by	O
using	O
the	O
Blind	O
Docking	O
server	O
.	O

Our	O
results	O
suggest	O
that	O
theaflavin	O
could	O
be	O
a	O
potential	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
RdRp	O
inhibitor	O
for	O
further	O
study	O
.	O

TITLE	O
:	O
The	O
establishment	O
of	O
reference	O
sequence	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
and	O
variation	O
analysis	O
.	O

In	O
this	O
study	O
,	O
we	O
retrieved	O
95	O
full	O
-	O
length	O
genomic	O
sequences	O
of	O
SARAS	O
-	O
CoV	O
-	O
2	O
strains	O
from	O
the	O
National	O
Center	O
for	O
Biotechnology	O
Information	O
and	O
GISAID	O
databases	O
,	O
established	O
the	O
reference	O
sequence	O
by	O
conducting	O
multiple	O
sequence	O
alignment	O
and	O
phylogenetic	O
analyses	O
,	O
and	O
analyzed	O
sequence	O
variations	O
along	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
genome	O
.	O

ABSTRACT	O
:	O
With	O
an	O
increasing	O
number	O
of	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
cases	O
outside	O
of	O
Hubei	O
,	O
emergency	O
departments	O
(	O
EDs	O
)	O
and	O
fever	O
clinics	O
are	O
facing	O
challenges	O
posed	O
by	O
the	O
large	O
number	O
of	O
admissions	O
of	O
patients	O
suspected	O
to	O
have	O
COVID	O
-	O
19	O
.	O

ABSTRACT	O
:	O
The	O
recent	O
outbreak	O
of	O
coronavirus	B-SPEC
infectious	O
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
has	O
gripped	O
the	O
world	O
with	O
apprehension	O
and	O
has	O
evoked	O
a	O
scare	O
of	O
epic	O
proportion	O
regarding	O
its	O
potential	O
to	O
spread	O
and	O
infect	O
humans	B-SPEC
worldwide	O
.	O

ABSTRACT	O
:	O
An	O
acute	O
respiratory	O
disease	O
,	O
caused	O
by	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
previously	O
known	O
as	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
),	O
the	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
has	O
spread	O
throughout	O
China	O
and	O
received	O
worldwide	O
attention	O
.	O

Importantly	O
,	O
increasingly	O
evidence	O
showed	O
sustained	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
,	O
along	O
with	O
many	O
exported	O
cases	O
across	O
the	O
globe	O
.	O

TITLE	O
:	O
Genetic	O
evolution	O
analysis	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
and	O
coronavirus	B-SPEC
from	O
other	O
species	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
caused	O
by	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
is	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
.	O

However	O
,	O
genome	O
and	O
ORF1a	O
homology	O
show	O
that	O
the	O
virus	B-SPEC
is	O
not	O
the	O
same	O
coronavirus	B-SPEC
as	O
the	O
coronavirus	B-SPEC
derived	O
from	O
these	O
five	O
animals	B-SPEC
,	O
whereas	O
the	O
virus	B-SPEC
has	O
the	O
highest	O
homology	O
with	O
Bat	B-SPEC
coronavirus	B-SPEC
isolate	O
RaTG13	O
.	O

Within	O
2	O
mo	O
since	O
the	O
outbreak	O
was	O
first	O
reported	O
on	O
December	O
31	O
,	O
2019	O
,	O
a	O
total	O
of	O
566	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	B-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
cases	O
have	O
been	O
confirmed	O
in	O
26	O
other	O
countries	O
.	O

ABSTRACT	O
:	O
It	O
has	O
been	O
known	O
that	O
,	O
the	O
novel	B-SPEC
Coronavirus	I-SPEC
,	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
,	O
which	O
is	O
considered	O
similar	O
to	O
SARS	O
-	O
CoV	O
and	O
originated	O
from	O
Wuhan	O
(	O
China	O
),	O
invades	O
human	B-SPEC
cells	O
via	O
the	O
receptor	O
angiotensin	O
converting	O
enzyme	O
II	O
(	O
ACE2	O
).	O

To	O
construct	O
a	O
risk	O
map	O
of	O
different	O
human	B-SPEC
organs	O
,	O
we	O
analyzed	O
the	O
single	O
-	O
cell	O
RNA	O
sequencing	O
(	O
scRNA	O
-	O
seq	O
)	O
datasets	O
derived	O
from	O
major	O
human	B-SPEC
physiological	O
systems	O
,	O
including	O
the	O
respiratory	O
,	O
cardiovascular	O
,	O
digestive	O
,	O
and	O
urinary	O
systems	O
.	O

ABSTRACT	O
:	O
The	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
Cov	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
the	O
pathogen	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
),	O
has	O
posed	O
a	O
serious	O
threat	O
to	O
global	O
public	O
health	O
.	O

The	O
WHO	O
has	O
declared	O
the	O
outbreak	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
an	O
international	O
public	O
health	O
emergency	O
.	O

This	O
causative	O
virus	B-SPEC
has	O
been	O
temporarily	O
named	O
as	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
and	O
the	O
relevant	O
infected	O
disease	O
has	O
been	O
named	O
as	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
by	O
the	O
World	O
Health	O
Organization	O
respectively	O
.	O

We	O
used	O
these	O
estimates	O
to	O
assess	O
the	O
potential	O
for	O
sustained	O
human	B-SPEC
-	O
to	O
-	O
human	B-SPEC
transmission	O
to	O
occur	O
in	O
locations	O
outside	O
Wuhan	O
if	O
cases	O
were	O
introduced	O
.	O

Wellcome	O
Trust	O
,	O
Health	O
Data	O
Research	O
UK	O
,	O
Bill	O
&	O
Melinda	B-SPEC
Gates	O
Foundation	O
,	O
and	O
National	O
Institute	O
for	O
Health	O
Research	O
.	O

We	O
analyzed	O
the	O
possibility	O
of	O
aerosol	O
transmission	O
for	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
.	O

TITLE	O
:	O
Induction	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
(	O
IL	O
-	O
1	O
and	O
IL	O
-	O
6	O
)	O
and	O
lung	O
inflammation	O
by	O
Coronavirus	B-SPEC
-	O
19	O
(	O
COVI	O
-	O
19	O
or	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
):	O
anti	O
-	O
inflammatory	O
strategies	O
.	O

ABSTRACT	O
:	O
Cases	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
are	O
now	O
being	O
reported	O
in	O
different	O
regions	O
around	O
the	O
globe	O
,	O
concerning	O
for	O
a	O
possible	O
SARS	O
like	O
epidemic	O
that	O
infected	O
for	O
than	O
8000	O
people	O
in	O
2002	O
-	O
03	O
.	O

This	O
is	O
a	O
retrospective	O
study	O
of	O
patients	O
with	O
new	O
coronavirus	B-SPEC
pneumonia	O
(	O
COVID	O
-	O
19	O
)	O
who	O
were	O
hospitalized	O
in	O
Hainan	O
Provincial	O
People	O
'	O
s	O
Hospital	O
from	O
January	O
15	O
,	O
2020	O
to	O
February	O
18	O
,	O
2020	O
.	O

TITLE	O
:	O
Clinical	O
characteristics	O
of	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
reactivation	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
clinical	O
characteristics	O
of	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
reactivation	O
.	O

ABSTRACT	O
:	O
Studies	O
on	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
have	O
generally	O
been	O
limited	O
to	O
the	O
description	O
of	O
the	O
epidemiology	O
and	O
initial	O
clinical	O
characteristics	O
.	O

ABSTRACT	O
:	O
Background	O
As	O
the	O
number	O
of	O
patients	O
increases	O
,	O
there	O
is	O
a	O
growing	O
understanding	O
of	O
the	O
form	O
of	O
pneumonia	O
sustained	O
by	O
the	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
which	O
has	O
caused	O
an	O
outbreak	O
in	O
China	O
.	O

However	O
,	O
the	O
relationship	O
between	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
and	O
coagulation	O
has	O
been	O
scarcely	O
addressed	O
.	O

This	O
pandemic	O
disease	O
has	O
now	O
been	O
defined	O
as	O
novel	B-SPEC
coronavirus	I-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
),	O
and	O
is	O
sustained	O
by	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

We	O
summarize	O
current	O
understanding	O
of	O
the	O
induction	O
of	O
a	O
proinflammatory	O
cytokine	O
storm	O
by	O
other	O
highly	O
pathogenic	O
human	B-SPEC
coronaviruses	O
,	O
their	O
adaptation	O
to	O
humans	B-SPEC
and	O
their	O
usurpation	O
of	O
the	O
cell	O
death	O
programmes	O
.	O

ECoV	O
should	O
be	O
included	O
as	O
a	O
differential	O
diagnosis	O
for	O
individual	O
horses	B-SPEC
presenting	O
with	O
anorexia	O
,	O
fever	O
,	O
lethargy	O
,	O
and	O
colitis	O
.	O

TITLE	O
:	O
Asymptomatic	O
carrier	O
state	O
,	O
acute	O
respiratory	O
disease	O
,	O
and	O
pneumonia	O
due	O
to	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
):	O
Facts	O
and	O
myths	O
.	O

TITLE	O
:	O
2019	B-SPEC
Novel	I-SPEC
Coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
Pneumonia	O
with	O
Hemoptysis	O
as	O
the	O
Initial	O
Symptom	O
:	O
CT	O
and	O
Clinical	O
Features	O
.	O

This	O
sample	O
belonged	O
to	O
Betacoronavirus	B-SPEC
and	O
shared	O
a	O
more	O
than	O
99	O
%	O
nucleotide	O
(	O
nt	O
)	O
identity	O
with	O
the	O
Wuhan	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
isolates	O
.	O

These	O
results	O
reveal	O
that	O
the	O
JS2012	O
is	O
a	O
novel	O
natural	O
recombinant	O
TGEV	B-SPEC
with	O
high	O
virulence	O
.	O

The	O
present	O
work	O
presents	O
the	O
first	O
review	O
of	O
the	O
fatal	O
novel	B-SPEC
coronavirus	I-SPEC
cases	O
in	O
China	O
.	O

Those	O
patients	O
should	O
now	O
be	O
tested	O
for	O
both	O
MERS	O
-	O
CoV	O
and	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
simultaneously	O
,	O
and	O
with	O
the	O
continuing	O
wide	O
international	O
spread	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
the	O
travel	O
history	O
to	O
China	O
in	O
the	O
last	O
14	O
days	O
will	O
be	O
of	O
less	O
significance	O
.	O

We	O
hope	O
that	O
this	O
article	O
will	O
serve	O
as	O
a	O
start	O
for	O
further	O
research	O
into	O
the	O
ocular	O
implications	O
of	O
human	B-SPEC
CoV	O
infections	O
.	O

ABSTRACT	O
:	O
A	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
first	O
detected	O
in	O
Wuhan	O
,	O
China	O
,	O
has	O
spread	O
rapidly	O
since	O
December	O
2019	O
,	O
causing	O
more	O
than	O
100	O
,	O
000	O
confirmed	O
infections	O
and	O
4000	O
fatalities	O
(	O
as	O
of	O
10	O
March	O
2020	O
).	O

TITLE	O
:	O
Emerging	O
WuHan	O
(	O
COVID	O
-	O
19	O
)	O
coronavirus	B-SPEC
:	O
glycan	O
shield	O
and	O
structure	O
prediction	O
of	O
spike	O
glycoprotein	O
and	O
its	O
interaction	O
with	O
human	B-SPEC
CD26	O
.	O

He	O
was	O
admitted	O
8	O
days	O
later	O
and	O
tested	O
positive	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

Person	O
-	O
to	O
-	O
person	O
transmission	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
occurred	O
between	O
two	O
people	O
with	O
prolonged	O
,	O
unprotected	O
exposure	O
while	O
Patient	O
1	O
was	O
symptomatic	O
.	O

Analysis	O
of	O
host	O
-	O
specific	O
slow	O
codon	O
and	O
di	O
-	O
codon	O
compositions	O
provides	O
links	O
between	O
viral	O
genomic	O
sequences	O
and	O
capability	O
of	O
virus	B-SPEC
replication	O
in	O
host	O
cells	O
that	O
may	O
be	O
useful	O
for	O
surveillance	O
of	O
the	O
transmission	O
potential	O
of	O
novel	O
viruses	B-SPEC
.	O

A	O
meta	B-SPEC
-	O
analysis	O
was	O
performed	O
,	O
with	O
calculation	O
of	O
weighted	O
mean	O
difference	O
(	O
WMD	O
)	O
of	O
platelet	O
number	O
in	O
COVID	O
-	O
19	O
patients	O
with	O
or	O
without	O
severe	O
disease	O
and	O
odds	O
ratio	O
(	O
OR	O
)	O
of	O
thrombocytopenia	O
for	O
severe	O
form	O
of	O
COVID	O
-	O
19	O
.	O

The	O
pooled	O
analysis	O
revealed	O
that	O
platelet	O
count	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
more	O
severe	O
COVID	O
-	O
19	O
(	O
WMD	O
-	O
31	O
×	O
10	O
Low	O
platelet	O
count	O
is	O
associated	O
with	O
increased	O
risk	O
of	O
severe	O
disease	O
and	O
mortality	O
in	O
patients	O
with	O
COVID	O
-	O
19	O
,	O
and	O
thus	O
should	O
serve	O
as	O
clinical	O
indicator	B-SPEC
of	O
worsening	O
illness	O
during	O
hospitalization	O
.	O

We	O
performed	O
a	O
random	O
-	O
effects	O
model	O
meta	B-SPEC
-	O
analysis	O
to	O
calculate	O
pooled	O
prevalences	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CI	O
).	O

TITLE	O
:	O
Risk	O
Factors	O
of	O
Healthcare	O
Workers	O
with	O
Corona	B-SPEC
Virus	B-SPEC
Disease	O
2019	O
:	O
A	O
Retrospective	O
Cohort	O
Study	O
in	O
a	O
Designated	O
Hospital	O
of	O
Wuhan	O
in	O
China	O
.	O

ABSTRACT	O
:	O
An	O
epidemic	O
caused	O
by	O
SARS	B-SPEC
-	I-SPEC
Coronavirus	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
has	O
spread	O
unexpectedly	O
in	O
Wuhan	O
,	O
Hubei	O
Province	O
,	O
China	O
since	O
December	O
2019	O
.	O

We	O
study	O
epidemiological	O
and	O
clinical	O
outcome	O
of	O
55	O
asymptomatic	O
carriers	O
who	O
were	O
laboratory	O
-	O
confirmed	O
positive	O
for	O
the	O
SARS	B-SPEC
-	I-SPEC
Coronavirus	I-SPEC
-	I-SPEC
2	I-SPEC
by	O
testing	O
the	O
nucleic	O
acid	O
of	O
the	O
pharyngeal	O
swab	O
samples	O
.	O

Pediatric	O
patients	O
with	O
COVID	O
-	O
19	O
are	O
mostly	O
owing	O
to	O
family	B-SPEC
cluster	O
or	O
with	O
a	O
close	O
contact	O
history	O
.	O

Their	O
epidemiologic	O
history	O
,	O
chest	O
computed	O
tomography	O
scans	O
,	O
laboratory	O
measurements	O
,	O
and	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
nucleic	O
acid	O
positivity	O
were	O
evaluated	O
.	O

ABSTRACT	O
:	O
The	O
emergence	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
,	O
termed	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
,	O
and	O
the	O
potentially	O
life	O
-	O
threating	O
respiratory	O
disease	O
that	O
it	O
can	O
produce	O
,	O
COVID	O
-	O
19	O
,	O
has	O
rapidly	O
spread	O
across	O
the	O
globe	O
creating	O
a	O
massive	O
public	O
health	O
problem	O
.	O

RESULTS	O
:	O
Of	O
all	O
91	O
patients	O
,	O
88	O
(	O
96	O
.	O
70	O
%)	O
were	O
laboratory	O
-	O
confirmed	O
COVID	O
-	O
19	O
with	O
throat	O
swab	O
samples	O
that	O
tested	O
positive	O
for	O
SARS	B-SPEC
-	I-SPEC
Cov	I-SPEC
-	I-SPEC
2	I-SPEC
while	O
3	O
(	O
3	O
.	O
30	O
%)	O
were	O
clinical	O
-	O
diagnosed	O
COVID	O
-	O
19	O
cases	O
.	O

The	O
newly	O
discovered	O
coronavirus	B-SPEC
is	O
similar	O
to	O
some	O
β	O
-	O
coronaviruses	O
found	O
in	O
bats	B-SPEC
,	O
but	O
different	O
from	O
previously	O
known	O
SARS	O
-	O
CoV	O
and	O
MERS	O
-	O
CoV	O
.	O
High	O
sequence	O
identities	O
and	O
similarities	O
between	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
and	O
SARS	O
-	O
CoV	O
was	O
found	O
.	O

The	O
PLR	O
of	O
patients	O
means	O
the	O
degree	O
of	O
cytokine	O
storm	O
,	O
which	O
might	O
provide	O
a	O
new	O
indicator	B-SPEC
in	O
the	O
monitoring	O
in	O
patients	O
with	O
COVID	O
-	O
19	O
.	O

This	O
is	O
a	O
52	O
-	O
year	O
-	O
old	O
man	B-SPEC
who	O
received	O
kidney	O
transplantation	O
12	O
years	O
ago	O
.	O

TITLE	O
:	O
Perinatal	O
Transmission	O
of	O
COVID	O
-	O
19	O
Associated	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
:	O
Should	O
We	O
Worry	O
?	O

In	O
order	B-SPEC
to	O
control	O
the	O
spread	O
of	O
an	O
epidemic	O
,	O
the	O
effective	O
management	O
of	O
rapidly	O
increased	O
medical	O
waste	O
through	O
establishing	O
a	O
temporary	O
reverse	O
logistics	O
system	O
is	O
of	O
vital	O
importance	O
.	O

TITLE	O
:	O
Prediction	O
of	O
the	O
Epidemic	O
Peak	O
of	O
Coronavirus	B-SPEC
Disease	O
in	O
Japan	O
,	O
2020	O
.	O

Studies	O
thus	O
far	O
have	O
shown	O
that	O
the	O
virus	B-SPEC
'	O
origination	O
is	O
in	O
connection	O
to	O
a	O
seafood	O
market	O
in	O
Wuhan	O
,	O
but	O
specific	O
animal	B-SPEC
associations	O
have	O
not	O
been	O
confirmed	O
.	O

TITLE	O
:	O
The	O
difference	O
in	O
the	O
incubation	O
period	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
infection	O
between	O
travelers	O
to	O
Hubei	O
and	O
non	O
-	O
travelers	O
:	O
The	O
need	O
of	O
a	O
longer	O
quarantine	O
period	O
.	O

ABSTRACT	O
:	O
Since	O
December	O
2019	O
,	O
62	O
medical	O
staff	O
of	O
Zhongnan	O
Hospital	O
in	O
Wuhan	O
,	O
China	O
have	O
been	O
hospitalised	O
with	O
coronavirus	B-SPEC
disease	O
2019	O
.	O

Parallel	O
bioinformatic	O
predictions	O
identified	O
a	O
priori	O
potential	O
B	O
and	O
T	O
cell	O
epitopes	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

ABSTRACT	O
:	O
Nonresolving	O
inflammation	O
,	O
a	O
hallmark	O
of	O
underlying	O
severe	O
inflammatory	O
processes	O
such	O
as	O
sepsis	B-SPEC
,	O
acute	O
respiratory	O
distress	O
syndrome	O
and	O
multiple	O
organ	O
failure	O
is	O
a	O
major	O
cause	O
of	O
admission	O
to	O
the	O
intensive	O
care	O
unit	O
and	O
high	O
mortality	O
rates	O
.	O

Many	O
survivors	O
develop	O
new	O
functional	O
limitations	O
and	O
health	O
problems	O
,	O
and	O
in	O
cases	O
of	O
sepsis	B-SPEC
,	O
approximately	O
40	O
%	O
of	O
patients	O
are	O
rehospitalized	O
within	O
three	O
months	O
.	O

ABSTRACT	O
:	O
Intravenous	O
infusions	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
inhibitors	O
(	O
ACEIs	O
)	O
and	O
angiotensin	O
receptor	O
blockers	O
(	O
ARBs	O
)	O
in	O
experimental	O
animals	B-SPEC
increase	O
the	O
numbers	O
of	O
angiotensin	O
-	O
converting	O
enzyme	O
2	O
(	O
ACE2	O
)	O
receptors	O
in	O
the	O
cardiopulmonary	O
circulation	O
.	O

ACE2	O
receptors	O
serve	O
as	O
binding	O
sites	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
virions	O
in	O
the	O
lungs	O
.	O

ABSTRACT	O
:	O
To	O
investigate	O
the	O
safety	O
,	O
feasibility	O
,	O
and	O
possible	O
adverse	O
events	O
of	O
single	O
-	O
dose	O
human	B-SPEC
umbilical	O
cord	O
-	O
derived	O
mesenchymal	O
stem	O
cells	O
in	O
patients	O
with	O
moderate	O
-	O
to	O
-	O
severe	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

The	O
result	O
of	O
this	O
phase	O
I	O
clinical	O
trial	O
showed	O
that	O
a	O
single	O
-	O
dose	O
IV	O
infusion	O
of	O
human	B-SPEC
umbilical	O
cord	O
-	O
derived	O
mesenchymal	O
stem	O
cells	O
was	O
safe	O
with	O
favorable	O
outcome	O
in	O
nine	O
acute	O
respiratory	O
distress	O
syndrome	O
patients	O
.	O

RESULTS	O
:	O
A	O
total	O
of	O
199	O
patients	O
with	O
laboratory	O
-	O
confirmed	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
underwent	O
randomization	O
;	O
99	O
were	O
assigned	O
to	O
the	O
lopinavir	O
-	O
ritonavir	O
group	O
,	O
and	O
100	O
to	O
the	O
standard	O
-	O
care	O
group	O
.	O

This	O
study	O
highlights	O
the	O
role	O
of	O
viral	O
interferon	O
antagonists	O
in	O
shaping	O
the	O
kinetics	O
and	O
magnitude	O
of	O
the	O
host	O
response	O
during	O
virus	B-SPEC
infection	O
and	O
demonstrates	O
that	O
inactivating	O
a	O
dominant	O
viral	O
antagonist	O
,	O
the	O
coronavirus	B-SPEC
endoribonuclease	O
,	O
dramatically	O
alters	O
the	O
host	O
response	O
in	O
macrophages	O
.	O

The	O
rapid	O
spread	O
of	O
this	O
virus	B-SPEC
across	O
the	O
world	O
in	O
only	O
2	O
months	O
highlights	O
the	O
transmissibility	O
of	O
this	O
family	B-SPEC
of	O
viruses	B-SPEC
and	O
the	O
significant	O
morbidity	O
and	O
mortality	O
that	O
they	O
can	O
cause	O
.	O

TITLE	O
:	O
Correction	O
to	O
:	O
COVID	O
-	O
19	O
:	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
and	O
a	O
novel	O
challenge	O
for	O
critical	O
care	O
.	O

A	O
15	O
-	O
year	O
-	O
old	O
Japanese	O
girl	O
with	O
a	O
history	O
of	O
atopic	O
asthma	O
and	O
dermatitis	O
was	O
admitted	O
to	O
the	O
emergency	O
department	O
with	O
the	O
anaphylactic	O
symptoms	O
of	O
urticaria	O
,	O
skin	O
flushing	O
,	O
throat	O
discomfort	O
,	O
acute	O
dyspnea	O
and	O
severe	O
wheezing	O
that	O
developed	O
shortly	O
after	O
the	O
ingestion	O
of	O
home	O
-	O
cooked	O
buchimgae	O
(	O
Korean	O
pancake	O
)	O
prepared	O
with	O
commercial	O
mixed	O
wheat	B-SPEC
flour	O
.	O

The	O
patient	O
'	O
s	O
serum	O
specific	O
IgE	O
analysis	O
was	O
positive	O
for	O
antibodies	O
to	O
dust	B-SPEC
mite	I-SPEC
allergens	O
.	O

Here	O
we	O
reported	O
the	O
screening	O
,	O
clinical	O
feathers	O
,	O
and	O
treatment	O
process	O
of	O
a	O
family	B-SPEC
cluster	O
involving	O
three	O
COVID	O
-	O
19	O
patients	O
.	O

The	O
shortage	O
of	O
complete	O
genomic	O
sequences	O
available	O
impairs	O
our	O
understanding	O
of	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
introduction	O
and	O
establishment	O
in	O
the	O
country	O
.	O

Continued	O
genomic	O
surveillance	O
strategies	O
are	O
needed	O
to	O
improve	O
monitoring	O
and	O
understanding	O
of	O
the	O
currently	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
epidemics	O
,	O
which	O
might	O
help	O
to	O
attenuate	O
public	O
health	O
impact	O
of	O
infectious	O
diseases	O
.	O

ABSTRACT	O
:	O
We	O
estimate	O
the	O
distribution	O
of	O
serial	O
intervals	O
for	O
468	O
confirmed	O
cases	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
reported	O
in	O
China	O
as	O
of	O
February	O
8	O
,	O
2020	O
.	O

This	O
modified	O
3I	O
Tool	O
will	O
assist	O
emergency	O
and	O
primary	O
care	O
clinicians	O
,	O
as	O
well	O
as	O
out	O
-	O
of	O
-	O
hospital	O
providers	O
,	O
in	O
effectively	O
managing	O
persons	O
with	O
suspected	O
or	O
confirmed	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
:	O
the	O
harms	O
of	O
exaggerated	O
information	O
and	O
non	O
-	O
evidence	O
-	O
based	O
measures	O
.	O

TITLE	O
:	O
The	O
critical	O
role	O
of	O
laboratory	O
medicine	O
during	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
and	O
other	O
viral	O
outbreaks	O
.	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
,	O
abbreviated	O
to	O
COVID	O
-	O
19	O
and	O
sustained	O
by	O
the	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
),	O
is	O
the	O
latest	O
biological	O
hazard	O
to	O
assume	O
the	O
relevance	O
of	O
insidious	O
worldwide	O
threat	O
.	O

ABSTRACT	O
:	O
The	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
on	O
March	O
11	O
,	O
2020	O
,	O
has	O
declared	O
the	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
outbreak	O
a	O
global	O
pandemic	O
(	O
1	O
).	O

TITLE	O
:	O
Association	O
of	O
radiologic	O
findings	O
with	O
mortality	O
of	O
patients	O
infected	O
with	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
in	O
Wuhan	O
,	O
China	O
.	O

ABSTRACT	O
:	O
Switzerland	O
is	O
among	O
the	O
countries	O
with	O
the	O
highest	O
number	O
of	O
coronavirus	B-SPEC
disease	O
-	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
cases	O
per	O
capita	O
in	O
the	O
world	O
.	O

The	O
radical	O
operation	O
of	O
colorectal	O
cancer	B-SPEC
is	O
semi	O
-	O
elective	O
operation	O
.	O

2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
virus	B-SPEC
can	O
be	O
transmitted	O
by	O
asymptomatic	O
infectors	O
,	O
and	O
it	O
has	O
been	O
confirmed	O
to	O
be	O
transmitted	O
by	O
droplets	O
and	O
contact	O
.	O

Based	O
on	O
our	O
experience	O
with	O
laparoscopic	O
colorectal	O
operation	O
,	O
we	O
propose	O
some	O
surgery	O
strategies	O
for	O
colorectal	O
cancer	B-SPEC
patients	O
under	O
the	O
corona	B-SPEC
virus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
situation	O
:	O
the	O
screening	O
process	O
should	O
be	O
strictly	O
carried	O
out	O
before	O
surgery	O
to	O
reduce	O
the	O
risk	O
of	O
nosocomial	O
infection	O
in	O
the	O
later	O
stage	O
;	O
laparoscopic	O
-	O
assisted	O
surgery	O
is	O
recommended	O
for	O
radical	O
surgery	O
for	O
patients	O
with	O
colorectal	O
cancer	B-SPEC
;	O
strict	O
aerosol	O
management	O
must	O
be	O
made	O
during	O
the	O
operation	O
;	O
natural	O
orifice	O
specimen	O
extraction	O
surgery	O
and	O
transanal	O
total	O
mesorectal	O
excision	O
are	O
should	O
be	O
performed	O
prudently	O
;	O
scientific	O
and	O
reasonable	O
prophylactic	O
stoma	O
should	O
be	O
done	O
;	O
personnel	O
protection	O
in	O
surgical	O
ward	O
and	O
operation	O
room	O
must	O
be	O
strengthened	O
.	O

We	O
gathered	O
epidemiological	O
and	O
clinical	O
data	O
from	O
individuals	O
with	O
confirmed	O
COVID	O
-	O
19	O
,	O
via	O
interviews	O
and	O
inpatient	O
medical	O
records	O
,	O
and	O
we	O
did	O
field	O
investigations	O
to	O
assess	O
interactions	O
and	O
possible	O
modes	O
of	O
transmission	O
of	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

TITLE	O
:	O
Clinical	O
features	O
of	O
severe	O
pediatric	O
patients	O
with	O
coronavirus	B-SPEC
disease	O
2019	O
in	O
Wuhan	O
:	O
a	O
single	O
center	O
'	O
s	O
observational	O
study	O
.	O

ABSTRACT	O
:	O
As	O
the	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
outbreak	O
is	O
ongoing	O
,	O
the	O
number	O
of	O
individuals	O
to	O
be	O
tested	O
for	O
COVID	O
-	O
19	O
is	O
rapidly	O
increasing	O
.	O

The	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
a	O
novel	O
virus	B-SPEC
so	O
the	O
majority	O
of	O
world	O
'	O
s	O
population	O
does	O
not	O
have	O
prior	O
immunity	O
to	O
it	O
.	O

Five	O
family	B-SPEC
members	O
had	O
close	O
contact	O
with	O
the	O
first	O
patient	O
during	O
his	O
incubation	O
period	O
,	O
four	O
of	O
them	O
were	O
confirmed	O
to	O
the	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
infection	O
in	O
the	O
subsequent	O
sampling	O
test	O
.	O

TITLE	O
:	O
Molecular	O
basis	O
of	O
COVID	O
-	O
19	O
relationships	O
in	O
different	O
species	B-SPEC
:	O
a	O
one	O
health	O
perspective	O
.	O

TITLE	O
:	O
Network	O
-	O
based	O
drug	O
repurposing	O
for	O
novel	B-SPEC
coronavirus	I-SPEC
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
/	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
.	O

Phylogenetic	O
analyses	O
of	O
15	O
HCoV	O
whole	O
genomes	O
reveal	O
that	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
/	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
shares	O
the	O
highest	O
nucleotide	O
sequence	O
identity	O
with	O
SARS	O
-	O
CoV	O
(	O
79	O
.	O
7	O
%).	O

ABSTRACT	O
:	O
The	O
outbreak	O
of	O
2019	O
-	O
novel	B-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
)	O
that	O
is	O
caused	O
by	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
has	O
spread	O
rapidly	O
in	O
China	O
,	O
and	O
has	O
developed	O
to	O
be	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
.	O

Here	O
,	O
we	O
discuss	O
the	O
COVID	O
-	O
19	O
outbreak	O
in	O
a	O
one	O
health	O
context	O
,	O
highlighting	O
the	O
need	O
for	O
the	O
implementation	O
of	O
one	O
health	O
measures	O
and	O
practices	O
to	O
improve	O
human	B-SPEC
health	O
and	O
reduce	O
the	O
emergence	O
of	O
pandemic	O
viruses	B-SPEC
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
disease	O
2019	O
,	O
named	O
COVID	O
-	O
19	O
officially	O
by	O
the	O
World	O
Health	O
Organization	O
(	O
Geneva	O
,	O
Switzerland	O
)	O
on	O
February	O
12	O
,	O
2020	O
,	O
has	O
spread	O
at	O
unprecedented	O
speed	O
.	O

TITLE	O
:	O
Computed	O
Tomography	O
Manifestations	O
of	O
5	O
Cases	O
of	O
the	O
Novel	B-SPEC
Coronavirus	I-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
Pneumonia	O
From	O
Patients	O
Outside	O
Wuhan	O
.	O

In	O
Patient	O
3	O
,	O
she	O
died	O
12	O
days	O
after	O
PICU	B-SPEC
admission	O
on	O
the	O
87th	O
day	O
from	O
onset	O
.	O

Sixteen	O
patients	O
(	O
80	O
%)	O
were	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
;	O
13	O
patients	O
(	O
81	O
%)	O
had	O
acute	O
respiratory	O
distress	O
syndrome	O
,	O
11	O
were	O
intubated	O
(	O
68	O
.	O
75	O
%),	O
9	O
had	O
acute	O
renal	O
injury	O
(	O
56	O
.	O
25	O
%),	O
and	O
3	O
required	O
dialysis	B-SPEC
(	O
18	O
.	O
75	O
%).	O

ABSTRACT	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
an	O
infectious	O
disease	O
caused	O
by	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
with	O
droplets	O
and	O
contact	O
as	O
the	O
main	O
means	O
of	O
transmission	O
.	O

The	O
pathogenesis	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
in	O
humans	B-SPEC
remains	O
unclear	O
.	O

ABSTRACT	O
:	O
The	O
seasonal	O
cycle	O
of	O
respiratory	O
viral	O
diseases	O
has	O
been	O
widely	O
recognized	O
for	O
thousands	O
of	O
years	O
,	O
as	O
annual	O
epidemics	O
of	O
the	O
common	O
cold	O
and	O
influenza	O
disease	O
hit	O
the	O
human	B-SPEC
population	O
like	O
clockwork	O
in	O
the	O
winter	O
season	O
in	O
temperate	O
regions	O
.	O

The	O
two	O
major	O
contributing	O
factors	O
are	O
the	O
changes	O
in	O
environmental	O
parameters	O
and	O
human	B-SPEC
behavior	O
.	O

We	O
further	O
discuss	O
determinants	O
of	O
host	O
response	O
in	O
the	O
seasonality	O
of	O
respiratory	O
viruses	B-SPEC
by	O
highlighting	O
recent	O
studies	O
in	O
the	O
field	O
.	O

Alternatively	O
,	O
repeated	O
testing	O
can	O
be	O
used	O
because	O
over	O
time	O
,	O
the	O
likelihood	O
of	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
being	O
present	O
in	O
the	O
nasal	O
-	O
pharynx	O
increases	O
.	O

ABSTRACT	O
:	O
In	O
2014	O
,	O
the	O
worst	O
outbreak	O
of	O
Ebola	B-SPEC
virus	I-SPEC
disease	O
(	O
EVD	O
)	O
emerged	O
in	O
sub	O
-	O
Saharan	O
Africa	O
(	O
SSA	O
)	O
causing	O
fear	O
and	O
panic	O
.	O

Unlike	O
common	O
viral	O
agents	O
(	O
such	O
as	O
Adenovirus	B-SPEC
,	O
Rhinovirus	B-SPEC
,	O
Norovirus	B-SPEC
,	O
Influenza	O
,	O
Respiratory	B-SPEC
Syncytial	I-SPEC
Virus	I-SPEC
),	O
Coronaviruses	O
have	O
not	O
shown	O
to	O
cause	O
a	O
more	O
severe	O
disease	O
in	O
immunosuppressed	O
patients	O
.	O

ABSTRACT	O
:	O
Since	O
the	O
first	O
case	O
of	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
)	O
identified	O
on	O
Jan	O
20	O
,	O
2020	O
in	O
South	O
Korea	O
,	O
the	O
number	O
of	O
cases	O
rapidly	O
increased	O
,	O
resulting	O
in	O
6	O
,	O
284	O
cases	O
including	O
42	O
deaths	O
as	O
of	O
March	O
6	O
,	O
2020	O
.	O

ABSTRACT	O
:	O
The	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
a	O
zoonotic	O
viral	O
infection	O
originating	O
from	O
Wuhan	O
,	O
China	O
in	O
December	O
2019	O
.	O

TITLE	O
:	O
2019	B-SPEC
novel	I-SPEC
Coronavirus	I-SPEC
outbreak	O
:	O
a	O
quiz	O
or	O
final	O
exam	O
?	O

To	O
identify	O
the	O
potential	O
candidates	O
,	O
we	O
explored	O
the	O
single	O
cell	O
gene	O
expression	O
atlas	O
including	O
119	O
cell	O
types	O
of	O
13	O
human	B-SPEC
tissues	O
and	O
analyzed	O
the	O
single	O
cell	O
co	O
-	O
expression	O
spectrum	O
of	O
51	O
reported	O
RNA	O
virus	B-SPEC
receptors	O
and	O
400	O
other	O
membrane	O
proteins	O
.	O

Intriguingly	O
,	O
we	O
found	O
that	O
the	O
candidate	O
co	O
-	O
receptors	O
,	O
manifesting	O
the	O
most	O
similar	O
expression	O
patterns	O
with	O
ACE2	O
across	O
13	O
human	B-SPEC
tissues	O
,	O
are	O
all	O
peptidases	O
,	O
including	O
ANPEP	O
,	O
DPP4	O
and	O
ENPEP	O
.	O

Research	O
suggests	O
remarkable	O
genomic	O
resemblance	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
with	O
Severe	O
Acute	O
Respiratory	O
Syndrome	O
(	O
SARS	O
)	O
which	O
has	O
a	O
history	O
of	O
a	O
pandemic	O
in	O
2002	O
.	O

TITLE	O
:	O
Global	O
epidemiology	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
:	O
disease	O
incidence	O
,	O
daily	O
cumulative	O
index	O
,	O
mortality	O
,	O
and	O
their	O
association	O
with	O
country	O
healthcare	O
resources	O
and	O
economic	O
status	O
.	O

As	O
a	O
result	O
,	O
we	O
predicted	O
that	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
tends	O
to	O
utilize	O
ACE2s	O
of	O
various	O
mammals	B-SPEC
,	O
except	O
murines	B-SPEC
,	O
and	O
some	O
birds	B-SPEC
,	O
such	O
as	O
pigeon	B-SPEC
.	O

CNGOF	O
.]	O
ABSTRACT	O
:	O
A	O
new	O
coronavirus	B-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
highlighted	O
at	O
the	O
end	O
of	O
2019	O
in	O
China	O
is	O
spreading	O
across	O
all	O
continents	O
.	O

TITLE	O
:	O
COVID	O
-	O
19	O
:	O
gastrointestinal	O
symptoms	O
and	O
potential	O
sources	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
transmission	O
.	O

TITLE	O
:	O
Cardiovascular	O
Considerations	O
for	O
Patients	O
,	O
Health	O
Care	O
Workers	O
,	O
and	O
Health	O
Systems	O
During	O
the	O
Coronavirus	B-SPEC
Disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
Pandemic	O
.	O

ABSTRACT	O
:	O
The	O
pneumonia	O
caused	O
by	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
in	O
Wuhan	O
,	O
China	O
in	O
December	O
2019	O
is	O
a	O
highly	O
contagious	O
disease	O
.	O

Currently	O
,	O
the	O
research	O
on	O
novel	B-SPEC
coronavirus	I-SPEC
is	O
still	O
in	O
the	O
primary	O
stage	O
.	O

It	O
is	O
concluded	O
that	O
the	O
problem	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
is	O
probably	O
being	O
overestimated	O
,	O
as	O
2	O
.	O
6	O
million	O
people	O
die	O
of	O
respiratory	O
infections	O
each	O
year	O
compared	O
with	O
less	O
than	O
4000	O
deaths	O
for	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
at	O
the	O
time	O
of	O
writing	O
.	O

The	O
mechanisms	O
of	O
transmission	O
of	O
the	O
disease	O
are	O
not	O
fully	O
understood	O
,	O
but	O
MERS	O
-	O
CoV	O
seems	O
to	O
sustain	O
itself	O
in	O
the	O
human	B-SPEC
population	O
through	O
repeated	O
re	O
-	O
introduction	O
from	O
a	O
camel	B-SPEC
reservoir	O
and	O
is	O
able	O
to	O
cause	O
nosocomial	O
outbreaks	O
.	O

ABSTRACT	O
:	O
Recently	O
,	O
two	O
coronaviruses	O
,	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
and	O
Middle	O
East	O
respiratory	O
syndrome	O
coronavirus	B-SPEC
,	O
have	O
emerged	O
to	O
cause	O
unusually	O
severe	O
respiratory	O
disease	O
in	O
humans	B-SPEC
.	O

A	O
large	O
amount	O
of	O
information	O
is	O
now	O
available	O
regarding	O
the	O
virus	B-SPEC
,	O
its	O
structure	O
,	O
route	O
of	O
transmission	O
and	O
its	O
pathophysiology	O
.	O

TITLE	O
:	O
A	O
COVID	O
-	O
19	O
Transmission	O
within	O
a	O
family	B-SPEC
cluster	O
by	O
presymptomatic	O
infectors	O
in	O
China	O
.	O

TITLE	O
:	O
Global	O
coronavirus	B-SPEC
pandemic	O
(	O
2019	B-SPEC
-	I-SPEC
nCOV	I-SPEC
):	O
Implication	O
for	O
an	O
Italian	O
medium	O
size	O
dermatological	O
clinic	O
of	O
a	O
ii	O
level	O
hospital	O
.	O

ABSTRACT	O
:	O
A	O
severe	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
emerged	O
in	O
China	O
in	O
December	O
2019	O
,	O
and	O
spread	O
so	O
rapidly	O
that	O
more	O
than	O
200	O
,	O
000	O
cases	O
have	O
so	O
far	O
been	O
reported	O
worldwide	O
;	O
on	O
January	O
30	O
,	O
2020	O
,	O
the	O
WHO	O
declared	O
it	O
the	O
sixth	O
public	O
health	O
emergency	O
of	O
international	O
concern	O
.	O

ABSTRACT	O
:	O
Preparedness	O
for	O
the	O
ongoing	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
and	O
its	O
spread	O
in	O
India	O
calls	O
for	O
setting	O
up	O
of	O
adequately	O
equipped	O
and	O
dedicated	O
health	O
facilities	O
to	O
manage	O
sick	O
patients	O
while	O
protecting	O
healthcare	O
workers	O
and	O
the	O
environment	O
.	O

These	O
cases	O
were	O
linked	O
to	O
a	O
wet	O
animal	B-SPEC
wholesale	O
market	O
in	O
the	O
region	O
and	O
,	O
after	O
extensive	O
epidemiologic	O
investigation	O
,	O
led	O
to	O
identification	O
of	O
a	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
COVID	O
-	O
19	O
).	O

TITLE	O
:	O
Factors	O
Associated	O
With	O
Mental	O
Health	O
Outcomes	O
Among	O
Health	O
Care	O
Workers	O
Exposed	O
to	O
Coronavirus	B-SPEC
Disease	O
2019	O
.	O

Lastly	O
,	O
we	O
discuss	O
the	O
clinical	O
management	O
of	O
COVID	O
-	O
19	O
patients	O
with	O
existing	O
chronic	O
renal	O
disorders	O
,	O
particularly	O
those	O
in	O
dialysis	B-SPEC
and	O
with	O
kidney	O
transplants	O
.	O

Although	O
feline	B-SPEC
viral	O
diseases	O
can	O
pose	O
serious	O
health	O
hazards	O
to	O
pet	O
cats	B-SPEC
,	O
commercialized	O
preventative	O
vaccines	O
are	O
lacking	O
.	O

In	O
this	O
study	O
,	O
we	O
cloned	O
the	O
genes	O
encoding	O
feIFN	O
-	O
ωa	O
and	O
feIFN	O
-	O
ωb	O
from	O
cat	B-SPEC
spleen	O
lymphocytes	O
.	O

TITLE	O
:	O
[	O
Standardized	O
management	O
guideline	O
for	O
pediatric	O
wards	O
of	O
hematology	O
and	O
oncology	O
during	O
the	O
epidemic	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
].	O

TITLE	O
:	O
Consideration	O
of	O
the	O
respiratory	O
support	O
strategy	O
of	O
severe	O
acute	O
respiratory	O
failure	O
caused	O
by	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
in	O
children	O
.	O

Perinatal	O
and	O
neonatal	O
management	O
plan	O
for	O
prevention	O
and	O
control	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
(	O
2nd	O
Edition	O
)	O
has	O
been	O
worked	O
out	O
by	O
the	O
Editorial	O
Committee	O
of	O
Chinese	O
Journal	O
of	O
Contemporary	O
Pediatrics	O
.	O

ABSTRACT	O
:	O
Since	O
December	O
2019	O
,	O
an	O
outbreak	O
of	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
infection	O
has	O
spread	O
from	O
China	O
to	O
other	O
countries	O
.	O

TITLE	O
:	O
[	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
with	O
gastrointestinal	O
symptoms	O
as	O
the	O
first	O
manifestation	O
in	O
a	O
neonate	O
].	O

Here	O
,	O
this	O
case	O
is	O
reported	O
to	O
improve	O
the	O
understanding	O
of	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
in	O
neonates	O
.	O

RESULTS	O
:	O
All	O
9	O
children	O
had	O
an	O
epidemiological	O
history	O
,	O
and	O
family	B-SPEC
clustering	O
was	O
observed	O
for	O
all	O
infected	O
children	O
.	O

TITLE	O
:	O
[	O
Twin	O
girls	O
infected	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
].	O

TITLE	O
:	O
[	O
Emergency	O
plan	O
for	O
inter	O
-	O
hospital	O
transfer	O
of	O
newborns	O
with	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
].	O

This	O
plan	O
puts	O
forward	O
the	O
indications	O
for	O
neonatal	O
COVID	O
-	O
19	O
transfer	O
,	O
organization	O
management	O
,	O
protection	O
strategies	O
for	O
medical	O
staff	O
,	O
work	O
procedures	O
,	O
and	O
disinfection	O
methods	O
for	O
transfer	O
equipment	O
,	O
in	O
order	B-SPEC
to	O
provide	O
guidance	O
and	O
suggestions	O
for	O
the	O
inter	O
-	O
hospital	O
transfer	O
of	O
suspected	O
or	O
confirmed	O
neonatal	O
COVID	O
-	O
19	O
.	O

TITLE	O
:	O
Imaging	O
Features	O
of	O
Coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
):	O
Evaluation	O
on	O
Thin	O
-	O
Section	O
CT	O
.	O

TITLE	O
:	O
Lianhuaqingwen	O
exerts	O
anti	O
-	O
viral	O
and	O
anti	O
-	O
inflammatory	O
activity	O
against	O
novel	B-SPEC
coronavirus	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
).	O

Pro	O
-	O
inflammatory	O
cytokine	O
expression	O
levels	O
upon	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
infection	O
in	O
Huh	O
-	O
7	O
cells	O
were	O
measured	O
by	O
real	O
-	O
time	O
quantitative	O
PCR	O
assays	O
.	O

RESULTS	O
:	O
LH	O
significantly	O
inhibited	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
replication	O
in	O
Vero	O
E6	O
cells	O
and	O
markedly	O
reduced	O
pro	O
-	O
inflammatory	O
cytokines	O
(	O
TNF	O
-	O
α	O
,	O
IL	O
-	O
6	O
,	O
CCL	O
-	O
2	O
/	O
MCP	O
-	O
1	O
and	O
CXCL	O
-	O
10	O
/	O
IP	O
-	O
10	O
)	O
production	O
at	O
the	O
mRNA	O
levels	O
.	O

ABSTRACT	O
:	O
Canine	O
respiratory	O
coronavirus	B-SPEC
(	O
CRCoV	O
)	O
has	O
been	O
identified	O
as	O
a	O
causative	O
agent	O
of	O
canine	O
infectious	O
respiratory	O
disease	O
,	O
an	O
upper	O
respiratory	O
infection	O
affecting	O
dogs	B-SPEC
.	O

YouTube	O
was	O
searched	O
using	O
the	O
terms	O
'	B-SPEC
2019	I-SPEC
novel	I-SPEC
coronavirus	I-SPEC
',	O
'	O
Wuhan	O
virus	B-SPEC
'	O
and	O
''	O
(	O
Mandarin	O
for	O
Wuhan	O
virus	B-SPEC
)	O
on	O
1st	O
and	O
2nd	O
February	O
2020	O
.	O

RESULTS	O
:	O
Over	O
our	O
study	O
period	O
,	O
no	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
was	O
detected	O
.	O

ABSTRACT	O
:	O
The	O
novel	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
lies	O
behind	O
the	O
ongoing	O
outbreak	O
of	O
coronavirus	B-SPEC
disease	O
2019	O
(	O
COVID	O
-	O
19	O
).	O

ABSTRACT	O
:	O
Since	O
2012	O
and	O
to	O
date	O
,	O
outbreak	O
/	O
new	O
cases	O
of	O
Middle	O
East	O
respiratory	O
syndrome	O
-	O
related	O
coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
were	O
always	O
reported	O
in	O
Saudi	O
Arabia	O
.	O

The	O
sequences	O
of	O
spike	O
glycoprotein	O
of	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
and	O
SARS	O
coronavirus	B-SPEC
(	O
SARS	O
-	O
CoV	O
)	O
were	O
used	O
for	O
the	O
comparison	O
.	O

The	O
structural	O
divergence	O
was	O
determined	O
by	O
using	O
SuperPose	O
Version	O
1	O
.	O
0	O
based	O
on	O
cryo	O
-	O
EM	O
structure	O
of	O
the	O
SARS	O
coronavirus	B-SPEC
spike	O
glycoprotein	O
.	O

Our	O
data	O
suggests	O
that	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
is	O
newly	O
spilled	O
coronavirus	B-SPEC
into	O
humans	B-SPEC
in	O
China	O
is	O
closely	O
related	O
to	O
SARS	O
-	O
CoV	O
,	O
which	O
has	O
only	O
12	O
.	O
8	O
%	O
of	O
difference	O
with	O
SARS	O
-	O
CoV	O
in	O
S	O
protein	O
and	O
has	O
83	O
.	O
9	O
%	O
similarity	O
in	O
minimal	O
receptor	O
-	O
binding	O
domain	O
with	O
SARS	O
-	O
CoV	O
.	O
Addition	O
of	O
a	O
novel	O
glycosylation	O
sites	O
were	O
observed	O
in	O
2019	B-SPEC
-	I-SPEC
nCoV	I-SPEC
.	O
In	O
addition	O
,	O
antigenic	O
analysis	O
proposes	O
that	O
great	O
antigenic	O
differences	O
exist	O
between	O
both	O
the	O
viral	O
strains	O
,	O
but	O
some	O
of	O
the	O
epitopes	O
were	O
found	O
to	O
be	O
similar	O
between	O
both	O
the	O
S	O
proteins	O
.	O

ABSTRACT	O
:	O
Confronting	O
the	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
outbreak	O
has	O
allowed	O
us	O
to	O
appreciate	O
how	O
efficiently	O
highly	O
-	O
resourced	O
settings	O
can	O
respond	O
to	O
crises	O
.	O

TITLE	O
:	O
Mediastinal	O
Emphysema	O
,	O
Giant	O
Bulla	B-SPEC
,	O
and	O
Pneumothorax	O
Developed	O
during	O
the	O
Course	O
of	O
COVID	O
-	O
19	O
Pneumonia	O
.	O

SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
with	O
potential	O
origin	O
of	O
bat	B-SPEC
is	O
still	O
circulating	O
in	O
China	O
.	O

This	O
study	O
is	O
performed	O
to	O
analyze	O
the	O
clinical	O
characteristics	O
of	O
patients	O
who	O
succumbed	O
to	O
and	O
who	O
recovered	O
from	O
2019	B-SPEC
novel	I-SPEC
coronavirus	I-SPEC
disease	O
(	O
COVID	O
-	O
19	O
).	O

Categorical	O
variables	O
were	O
analyzed	O
by	O
χ	O
test	O
or	O
Fisher	B-SPEC
'	O
s	O
exact	O
tests	O
as	O
appropriate	O
.	O

Currently	O
,	O
the	O
global	O
community	O
is	O
facing	O
emerging	O
virus	B-SPEC
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
belonging	O
to	O

Microscopic	O
analysis	O
revealed	O
diffuse	O
filamentous	O
fungi	B-SPEC
throughout	O
the	O
lungs	O
,	O
heart	O
,	O
stomach	O
,	O
thyroid	O
gland	O
,	O
and	O
the	O
pulmonary	O
embolus	O
,	O
which	O
were	O
identified	O
as	O
Invasive	O
aspergillosis	O
should	O
also	O
be	O
considered	O
in	O
immunocompetent	O
patients	O
with	O
severe	O
respiratory	O
failure	O
after	O
non	O
-	O
fatal	O
drowning	O
who	O
do	O
not	O
respond	O
to	O
broad	O
-	O
spectrum	O
antibiotics	O
.	O

This	O
study	O
investigates	O
the	O
transport	O
mechanism	O
and	O
deposition	O
patterns	O
of	O
Middle	O
East	O
Respiratory	O
Syndrome	O
Coronavirus	B-SPEC
(	O
MERS	O
-	O
CoV	O
)	O
within	O
a	O
typical	O
six	O
bedded	O
general	O
inpatient	O
ward	O
cubicle	O
through	O
numerical	O
simulation	O
.	O

Despite	O
Singapore	O
'	O
s	O
efforts	O
,	O
sustained	O
community	O
transmission	O
of	O
the	O
virus	B-SPEC
has	O
continued	O
.	O

TITLE	O
:	O
Coronavirus	B-SPEC
disease	O
2019	O
:	O
initial	O
chest	O
CT	O
findings	O
.	O

We	O
retrospectively	O
reviewed	O
the	O
initial	O
chest	O
CT	O
data	O
of	O
62	O
confirmed	O
coronavirus	B-SPEC
disease	O
2019	O
patients	O
(	O
34	O
men	O
,	O
28	O
women	O
;	O
age	O
range	O
20	O
-	O
91	O
years	O
old	O
)	O
who	O
did	O
not	O
receive	O
any	O
antiviral	O
treatment	O
between	O
January	O
21	O
and	O
February	O
4	O
,	O
2020	O
,	O
in	O
Chongqing	O
,	O
China	O
.	O

The	O
severe	B-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	I-SPEC
(	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
)	O
is	O
not	O
the	O
first	O
,	O
and	O
certainly	O
will	O
not	O
be	O
the	O
last	O
novel	O
virus	B-SPEC
that	O
will	O
lead	O
to	O
worldwide	O
outbreaks	O
.	O

There	O
is	O
an	O
urgent	O
need	O
to	O
understand	O
why	O
the	O
course	O
of	O
the	O
coronavirus	B-SPEC
that	O
started	O
in	O
late	O
2019	O
(	O
COVID	O
-	O
19	O
)	O
is	O
affecting	O
different	O
groups	O
of	O
individuals	O
with	O
varying	O
severity	O
during	O
the	O
ongoing	O
global	O
pandemic	O
.	O

Since	O
December	O
2019	O
,	O
COVID	O
-	O
19	O
（	B-SPEC
corona	I-SPEC
virus	B-SPEC
disease	O
2019	O
）	O
outbreaks	O
caused	O
by	O
SARS	B-SPEC
-	I-SPEC
CoV	I-SPEC
-	I-SPEC
2	I-SPEC
（	B-SPEC
severe	I-SPEC
acute	I-SPEC
respiratory	I-SPEC
syndrome	I-SPEC
coronavirus	I-SPEC
2	O
）	O
has	O
occurred	O
in	O
China	O
and	O
many	O
countries	O
around	O
the	O
world	O
.	O

